0390234|4181656|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4353498|NCT00390234|4181656|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4353499|NCT00390234|4181656|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4353500|NCT00390234|4181656|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353501|NCT00390234|4181656|B1|||Age||years|Median|60|60.0|Full Range|||38.0|78.0|
4353502|NCT00390221|4181664|B4||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4353503|NCT00390221|4181665|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4353504|NCT00390221|4181666|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4353505|NCT00390221|4181667|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4353506|NCT00390221|4181664|B4||Female|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
4353507|NCT00390221|4181665|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4353508|NCT00390221|4181666|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4353509|NCT00390221|4181667|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4353510|NCT00390221|4181664|B4|50 to 55 years||Age, Customized||participants|Number|39|39.0||||||
4353511|NCT00390221|4181665|B3|50 to 55 years||Age, Customized||participants|Number|12|12.0||||||
4353512|NCT00390221|4181666|B2|50 to 55 years||Age, Customized||participants|Number|9|9.0||||||
4353513|NCT00390221|4181667|B1|50 to 55 years||Age, Customized||participants|Number|18|18.0||||||
4353514|NCT00390221|4181664|B4|40 to 49 years||Age, Customized||participants|Number|176|176.0||||||
4353515|NCT00390221|4181665|B3|40 to 49 years||Age, Customized||participants|Number|49|49.0||||||
4353516|NCT00390221|4181666|B2|40 to 49 years||Age, Customized||participants|Number|67|67.0||||||
4353517|NCT00390221|4181667|B1|40 to 49 years||Age, Customized||participants|Number|60|60.0||||||
4353518|NCT00390221|4181664|B4|30 to 39 years||Age, Customized||participants|Number|242|242.0||||||
4353519|NCT00390221|4181665|B3|30 to 39 years||Age, Customized||participants|Number|90|90.0||||||
4353520|NCT00390221|4181666|B2|30 to 39 years||Age, Customized||participants|Number|73|73.0||||||
4353521|NCT00390221|4181667|B1|30 to 39 years||Age, Customized||participants|Number|79|79.0||||||
4353522|NCT00390221|4181664|B4|20 to 29 years||Age, Customized||participants|Number|154|154.0||||||
4353523|NCT00390221|4181665|B3|20 to 29 years||Age, Customized||participants|Number|53|53.0||||||
4353524|NCT00390221|4181666|B2|20 to 29 years||Age, Customized||participants|Number|55|55.0||||||
4353525|NCT00390221|4181667|B1|20 to 29 years||Age, Customized||participants|Number|46|46.0||||||
4353526|NCT00390221|4181664|B4|18 to 19 years||Age, Customized||participants|Number|10|10.0||||||
4353527|NCT00390221|4181665|B3|18 to 19 years||Age, Customized||participants|Number|5|5.0||||||
4353528|NCT00390221|4181666|B2|18 to 19 years||Age, Customized||participants|Number|4|4.0||||||
4353529|NCT00390221|4181667|B1|18 to 19 years||Age, Customized||participants|Number|1|1.0||||||
4353530|NCT00390221|4181664|B4|||Age||years|Mean|35.7|35.7|Standard Deviation|8.88|8.88|||
4353531|NCT00390221|4181665|B3|||Age||years|Mean|35.2|35.2|Standard Deviation|8.67|8.67|||
4353532|NCT00390221|4181666|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|8.94|8.94|||
4353533|NCT00390221|4181667|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|9.02|9.02|||
4353534|NCT00390182|4181690|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4353535|NCT00390182|4181690|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4353536|NCT00390182|4181690|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4353537|NCT00390182|4181690|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4353538|NCT00390182|4181690|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4353539|NCT00390182|4181690|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4353540|NCT00390182|4181690|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353541|NCT00390013|4181696|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353542|NCT00390013|4181697|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353543|NCT00390013|4181698|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353544|NCT00390013|4181699|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353545|NCT00390013|4181696|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353546|NCT00390013|4181697|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353547|NCT00390013|4181698|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353548|NCT00390013|4181699|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353549|NCT00390013|4181696|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4353550|NCT00390013|4181697|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4353551|NCT00390013|4181698|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4353552|NCT00390013|4181699|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4353553|NCT00390013|4181696|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353554|NCT00390013|4181697|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353555|NCT00390013|4181698|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353556|NCT00390013|4181699|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353557|NCT00390013|4181696|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353558|NCT00390013|4181697|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353559|NCT00390013|4181698|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353560|NCT00390013|4181699|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353561|NCT00390013|4181696|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353562|NCT00390013|4181697|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353563|NCT00390013|4181698|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353564|NCT00390013|4181699|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353565|NCT00390013|4181696|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353566|NCT00390013|4181697|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353567|NCT00390013|4181698|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353568|NCT00390013|4181699|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353569|NCT00390013|4181696|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353570|NCT00390013|4181697|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353571|NCT00390013|4181698|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353572|NCT00390013|4181699|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353573|NCT00390013|4181696|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4353574|NCT00390013|4181697|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4353575|NCT00390013|4181698|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4353576|NCT00390013|4181699|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4353577|NCT00390013|4181696|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353578|NCT00390013|4181697|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353579|NCT00390013|4181698|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353580|NCT00390013|4181699|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353581|NCT00390013|4181696|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353582|NCT00390013|4181697|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353583|NCT00390013|4181698|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353584|NCT00390013|4181699|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353585|NCT00390013|4181696|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4353586|NCT00390013|4181697|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4353587|NCT00390013|4181698|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4353588|NCT00390013|4181699|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4353589|NCT00390013|4181696|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353590|NCT00390013|4181697|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353591|NCT00390013|4181698|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353592|NCT00390013|4181699|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353593|NCT00390013|4181696|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4353594|NCT00390013|4181697|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4353595|NCT00390013|4181698|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4353596|NCT00390013|4181699|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4353597|NCT00390013|4181696|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353598|NCT00390013|4181697|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353599|NCT00390013|4181698|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353600|NCT00390013|4181699|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353601|NCT00389974|4181708|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4353602|NCT00389974|4181708|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353603|NCT00389974|4181708|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4353604|NCT00389974|4181708|B1|||Age||years|Median|44|44.0|Full Range|||28.0|78.0|
4353605|NCT00389857|4181712|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4353606|NCT00389857|4181713|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4353607|NCT00389857|4181714|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4353608|NCT00389857|4181712|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4353609|NCT00389857|4181713|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4353610|NCT00389857|4181714|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4353611|NCT00389857|4181712|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4353612|NCT00389857|4181713|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4353613|NCT00389857|4181714|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4353614|NCT00389857|4181712|B3|||Age||Months|Mean|23.0|23.0|Standard Deviation|9.82|9.82|||
4353615|NCT00389857|4181713|B2|||Age||Months|Mean|29.3|29.3|Standard Deviation|6.55|6.55|||
4353616|NCT00389857|4181714|B1|||Age||Months|Mean|15.4|15.4|Standard Deviation|7.40|7.4|||
4353617|NCT00389857|4181712|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353618|NCT00389857|4181713|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353619|NCT00389857|4181714|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353620|NCT00389857|4181712|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4353621|NCT00389857|4181713|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4353622|NCT00389857|4181714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4353623|NCT00389857|4181712|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4353624|NCT00389857|4181713|B2||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4353625|NCT00389857|4181714|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4353626|NCT00389831|4181725|B3|Germany||Region of Enrollment||participants|Number|44|44.0||||||
4353627|NCT00389831|4181726|B2|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4353628|NCT00389831|4181727|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4353629|NCT00389831|4181725|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4353630|NCT00389831|4181726|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4353631|NCT00389831|4181727|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4353632|NCT00389831|4181725|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4353633|NCT00389831|4181726|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4353634|NCT00389831|4181727|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4353635|NCT00389831|4181725|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|7.33|7.33|||
4353636|NCT00389831|4181726|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|7.78|7.78|||
4353637|NCT00389831|4181727|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|5.40|5.4|||
4353638|NCT00389831|4181725|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4353639|NCT00389831|4181726|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4353640|NCT00389831|4181727|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4353641|NCT00389831|4181725|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4353642|NCT00389831|4181726|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4353643|NCT00389831|4181727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4353644|NCT00389831|4181725|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353645|NCT00389831|4181726|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353646|NCT00389831|4181727|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353647|NCT00389818|4181754|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4353648|NCT00389818|4181754|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4353649|NCT00389818|4181754|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4353650|NCT00389818|4181754|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|8.3|8.3|||
4353651|NCT00389818|4181754|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4353652|NCT00389818|4181754|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4353653|NCT00389818|4181754|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353654|NCT00389805|4181758|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4353655|NCT00389805|4181759|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4353656|NCT00389805|4181760|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4353657|NCT00389805|4181758|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4353658|NCT00389805|4181759|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4353659|NCT00389805|4181760|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4353660|NCT00389805|4181758|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4353661|NCT00389805|4181759|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4353662|NCT00389805|4181760|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4353663|NCT00389805|4181758|B3|||Age||years|Median|60|60.0|Full Range|||39.0|80.0|
4353664|NCT00389805|4181759|B2|||Age||years|Median|59|59.0|Full Range|||45.0|80.0|
4353665|NCT00389805|4181760|B1|||Age||years|Median|62|62.0|Full Range|||39.0|79.0|
4353666|NCT00389597|4181787|B5|United States||Region of Enrollment||participants|Number|575|575.0||||||
4353667|NCT00389597|4181788|B4|United States||Region of Enrollment||participants|Number|105|105.0||||||
4353668|NCT00389597|4181789|B3|United States||Region of Enrollment||participants|Number|225|225.0||||||
4353669|NCT00389597|4181790|B2|United States||Region of Enrollment||participants|Number|81|81.0||||||
4353670|NCT00389597|4181791|B1|United States||Region of Enrollment||participants|Number|164|164.0||||||
4353671|NCT00389597|4181787|B5||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4353672|NCT00389597|4181788|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4353673|NCT00389597|4181789|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4353674|NCT00389597|4181790|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4353675|NCT00389597|4181791|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4353676|NCT00389597|4181787|B5||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4353677|NCT00389597|4181788|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4353678|NCT00389597|4181789|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4353679|NCT00389597|4181790|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4353680|NCT00389597|4181791|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4353681|NCT00389597|4181787|B5||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4353682|NCT00389597|4181788|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4353683|NCT00389597|4181789|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4353684|NCT00389597|4181790|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4353685|NCT00389597|4181791|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4353686|NCT00389597|4181787|B5||Between 18 and 65 years|Age||Participants|Count of Participants|564|564.0||||||
4353687|NCT00389597|4181788|B4||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4353688|NCT00389597|4181789|B3||Between 18 and 65 years|Age||Participants|Count of Participants|222|222.0||||||
4353689|NCT00389597|4181790|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4353690|NCT00389597|4181791|B1||Between 18 and 65 years|Age||Participants|Count of Participants|161|161.0||||||
4353691|NCT00389597|4181787|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353692|NCT00389597|4181788|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353693|NCT00389597|4181789|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353694|NCT00389597|4181790|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353695|NCT00389597|4181791|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353696|NCT00389532|4181804|B3|United States||Region of Enrollment||participants|Number|116|116.0||||||
4353697|NCT00389532|4181805|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4353698|NCT00389532|4181806|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4353699|NCT00389532|4181804|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4353700|NCT00389532|4181805|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4353701|NCT00389532|4181806|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4353702|NCT00389532|4181804|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4353703|NCT00389532|4181805|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4353704|NCT00389532|4181806|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4353705|NCT00389532|4181804|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|21.33|21.33|||
4353706|NCT00389532|4181805|B2|||Age||years|Mean|76.4|76.4|Standard Deviation|8.55|8.55|||
4353707|NCT00389532|4181806|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|12.25|12.25|||
4353708|NCT00389532|4181804|B3||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4353709|NCT00389532|4181805|B2||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4353710|NCT00389532|4181806|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353711|NCT00389532|4181804|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4353712|NCT00389532|4181805|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4353713|NCT00389532|4181806|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4353714|NCT00389532|4181804|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353715|NCT00389532|4181805|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353716|NCT00389532|4181806|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353717|NCT00389519|4181815|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4353718|NCT00389519|4181816|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4353719|NCT00389519|4181817|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4353720|NCT00389519|4181818|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4353721|NCT00389519|4181819|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4353722|NCT00389519|4181815|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4353723|NCT00389519|4181816|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4353724|NCT00389519|4181817|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4353725|NCT00389519|4181818|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4353726|NCT00389519|4181819|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4353727|NCT00389519|4181815|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4353728|NCT00389519|4181816|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4353729|NCT00389519|4181817|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4353730|NCT00389519|4181818|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4353731|NCT00389519|4181819|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4353732|NCT00389519|4181815|B5|Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4353733|NCT00389519|4181816|B4|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4353734|NCT00389519|4181817|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4353735|NCT00389519|4181818|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4353736|NCT00389519|4181819|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4353737|NCT00389519|4181815|B5|Black||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4353738|NCT00389519|4181816|B4|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4353739|NCT00389519|4181817|B3|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4353740|NCT00389519|4181818|B2|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4353741|NCT00389519|4181819|B1|Black||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4353742|NCT00389519|4181815|B5||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4353743|NCT00389519|4181816|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4353744|NCT00389519|4181817|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4353745|NCT00389519|4181818|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4353746|NCT00389519|4181819|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4353747|NCT00389519|4181815|B5||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4353748|NCT00389519|4181816|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4353749|NCT00389519|4181817|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4353750|NCT00389519|4181818|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4353751|NCT00389519|4181819|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4353752|NCT00389519|4181815|B5|||Age||years|Mean|12.2|12.2|Standard Deviation|2.99|2.99|||
4353753|NCT00389519|4181816|B4|||Age||years|Mean|12.3|12.3|Standard Deviation|3.06|3.06|||
4353754|NCT00389519|4181817|B3|||Age||years|Mean|12.1|12.1|Standard Deviation|2.81|2.81|||
4353755|NCT00389519|4181818|B2|||Age||years|Mean|12.3|12.3|Standard Deviation|3.03|3.03|||
4353756|NCT00389519|4181819|B1|||Age||years|Mean|12.2|12.2|Standard Deviation|3.06|3.06|||
4353757|NCT00389493|4181848|B4|United States||Region of Enrollment||participants|Number|100|100.0||||||
4353758|NCT00389493|4181849|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4353759|NCT00389493|4181850|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4353760|NCT00389493|4181851|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4353761|NCT00389493|4181848|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4353762|NCT00389493|4181849|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4353763|NCT00389493|4181850|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4353764|NCT00389493|4181851|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4353765|NCT00389493|4181848|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4353766|NCT00389493|4181849|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4353767|NCT00389493|4181850|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4353768|NCT00389493|4181851|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4353769|NCT00389493|4181848|B4|||Age||years|Mean|33.9|33.9|Standard Deviation|11.4|11.4|||
4353770|NCT00389493|4181849|B3|||Age||years|Mean|33.4|33.4|Standard Deviation|10.4|10.4|||
4353771|NCT00389493|4181850|B2|||Age||years|Mean|34.3|34.3|Standard Deviation|12.7|12.7|||
4353772|NCT00389493|4181851|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|10.8|10.8|||
4353773|NCT00389493|4181848|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353774|NCT00389493|4181849|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353775|NCT00389493|4181850|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353776|NCT00389493|4181851|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4353777|NCT00389493|4181848|B4||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4353778|NCT00389493|4181849|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4353779|NCT00389493|4181850|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4353780|NCT00389493|4181851|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4353781|NCT00389493|4181848|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353782|NCT00389493|4181849|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353783|NCT00389493|4181850|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353784|NCT00389493|4181851|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353785|NCT00389467|4181873|B5|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4353786|NCT00389467|4181874|B4|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4353787|NCT00389467|4181875|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4353788|NCT00389467|4181876|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4353789|NCT00389467|4181877|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4353790|NCT00389467|4181873|B5|United States||Region of Enrollment||participants|Number|117|117.0||||||
4353791|NCT00389467|4181874|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
4353792|NCT00389467|4181875|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4353793|NCT00389467|4181876|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4353794|NCT00389467|4181877|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4353795|NCT00389467|4181873|B5||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4353796|NCT00389467|4181874|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4353797|NCT00389467|4181875|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4353798|NCT00389467|4181876|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4353799|NCT00389467|4181877|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4353800|NCT00389467|4181873|B5||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4353801|NCT00389467|4181874|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4353802|NCT00389467|4181875|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4353803|NCT00389467|4181876|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4353804|NCT00389467|4181877|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4353805|NCT00389467|4181873|B5|||Age||years|Mean|65.5|65.5|Standard Deviation|14.6|14.6|||
4353806|NCT00389467|4181874|B4|||Age||years|Mean|69.4|69.4|Standard Deviation|15.9|15.9|||
4353807|NCT00389467|4181875|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|12.0|12.0|||
4353808|NCT00389467|4181876|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|16.9|16.9|||
4353809|NCT00389467|4181877|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|13.2|13.2|||
4353810|NCT00389467|4181873|B5||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4353811|NCT00389467|4181874|B4||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4353812|NCT00389467|4181875|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4353813|NCT00389467|4181876|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4353814|NCT00389467|4181877|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4353815|NCT00389467|4181873|B5||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4353816|NCT00389467|4181874|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4353817|NCT00389467|4181875|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4353818|NCT00389467|4181876|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4353819|NCT00389467|4181877|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4353820|NCT00389467|4181873|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353821|NCT00389467|4181874|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353822|NCT00389467|4181875|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353823|NCT00389467|4181876|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353824|NCT00389467|4181877|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353825|NCT00389441|4181899|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4353826|NCT00389441|4181899|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4353827|NCT00389441|4181899|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|12.1|12.1|||
4353828|NCT00389324|4181908|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4353829|NCT00389324|4181908|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4353830|NCT00389324|4181908|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4353831|NCT00389324|4181908|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4353832|NCT00389324|4181908|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|15.8|15.8|||
4353833|NCT00389324|4181908|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4353834|NCT00389324|4181908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4353835|NCT00389324|4181908|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4353836|NCT00389207|4181915|B4|||Baseline CD4+ cell count|185 NVP QD patients, 188 NVP BID patients and 192 ATZ/R patients had data|Cells/mm^3|Mean|193.2|193.2|Standard Deviation|95.1|95.1|||
4353837|NCT00389207|4181916|B3|||Baseline CD4+ cell count|185 NVP QD patients, 188 NVP BID patients and 192 ATZ/R patients had data|Cells/mm^3|Mean|193.2|193.2|Standard Deviation|95.8|95.8|||
4353838|NCT00389207|4181917|B2|||Baseline CD4+ cell count|185 NVP QD patients, 188 NVP BID patients and 192 ATZ/R patients had data|Cells/mm^3|Mean|202.9|202.9|Standard Deviation|93.6|93.6|||
4353896|NCT00389064|4182043|B1|66 to 75 years||Age, Customized||Participants|Number|197|197.0||||||
4353839|NCT00389207|4181918|B1|||Baseline CD4+ cell count|185 NVP QD patients, 188 NVP BID patients and 192 ATZ/R patients had data|Cells/mm^3|Mean|183.3|183.3|Standard Deviation|95.5|95.5|||
4353840|NCT00389207|4181915|B4|||Baseline log10 HIV viral load|185 NVP QD patients, 188 NVP BID patients and 192 ATZ/R patients had data|log 10 Copies/mL|Mean|5.1|5.1|Standard Deviation|0.7|0.7|||
4353841|NCT00389207|4181916|B3|||Baseline log10 HIV viral load|185 NVP QD patients, 188 NVP BID patients and 192 ATZ/R patients had data|log 10 Copies/mL|Mean|5.1|5.1|Standard Deviation|0.7|0.7|||
4353842|NCT00389207|4181917|B2|||Baseline log10 HIV viral load|185 NVP QD patients, 188 NVP BID patients and 192 ATZ/R patients had data|log 10 Copies/mL|Mean|5.1|5.1|Standard Deviation|0.6|0.6|||
4353843|NCT00389207|4181918|B1|||Baseline log10 HIV viral load|185 NVP QD patients, 188 NVP BID patients and 192 ATZ/R patients had data|log 10 Copies/mL|Mean|5.1|5.1|Standard Deviation|0.7|0.7|||
4353844|NCT00389207|4181915|B4|Baseline HIV viral load > 100,000 copies/mL||Baseline HIV viral load category||participants|Number|362|362.0||||||
4353845|NCT00389207|4181916|B3|Baseline HIV viral load > 100,000 copies/mL||Baseline HIV viral load category||participants|Number|128|128.0||||||
4353846|NCT00389207|4181917|B2|Baseline HIV viral load > 100,000 copies/mL||Baseline HIV viral load category||participants|Number|117|117.0||||||
4353847|NCT00389207|4181918|B1|Baseline HIV viral load > 100,000 copies/mL||Baseline HIV viral load category||participants|Number|117|117.0||||||
4353848|NCT00389207|4181915|B4|Baseline HIV viral load ≤ 100,000 copies/mL||Baseline HIV viral load category||participants|Number|207|207.0||||||
4353849|NCT00389207|4181916|B3|Baseline HIV viral load ≤ 100,000 copies/mL||Baseline HIV viral load category||participants|Number|65|65.0||||||
4353850|NCT00389207|4181917|B2|Baseline HIV viral load ≤ 100,000 copies/mL||Baseline HIV viral load category||participants|Number|71|71.0||||||
4353851|NCT00389207|4181918|B1|Baseline HIV viral load ≤ 100,000 copies/mL||Baseline HIV viral load category||participants|Number|71|71.0||||||
4353852|NCT00389207|4181915|B4||Male|Sex: Female, Male||Participants|Count of Participants|477|477.0||||||
4353853|NCT00389207|4181916|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4353854|NCT00389207|4181917|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4353855|NCT00389207|4181918|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4353856|NCT00389207|4181915|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4353857|NCT00389207|4181916|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4353858|NCT00389207|4181917|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4353859|NCT00389207|4181918|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4353860|NCT00389207|4181915|B4|||Age||years|Mean|38.6|38.6|Standard Deviation|9.9|9.9|||
4353861|NCT00389207|4181916|B3|||Age||years|Mean|37.6|37.6|Standard Deviation|9.5|9.5|||
4353862|NCT00389207|4181917|B2|||Age||years|Mean|40.0|40.0|Standard Deviation|10.5|10.5|||
4353863|NCT00389207|4181918|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|9.7|9.7|||
4353864|NCT00389168|4182022|B3|Sweden||Region of Enrollment||participants|Number|114|114.0||||||
4353865|NCT00389168|4182023|B2|Sweden||Region of Enrollment||participants|Number|56|56.0||||||
4353866|NCT00389168|4182024|B1|Sweden||Region of Enrollment||participants|Number|58|58.0||||||
4353867|NCT00389168|4182022|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4353868|NCT00389168|4182023|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4353869|NCT00389168|4182024|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4353870|NCT00389168|4182022|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4353871|NCT00389168|4182023|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4353872|NCT00389168|4182024|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4353873|NCT00389168|4182022|B3|||Age||years|Mean|54|54.0|Standard Deviation|9|9.0|||
4353874|NCT00389168|4182023|B2|||Age||years|Mean|54|54.0|Standard Deviation|8|8.0|||
4353875|NCT00389168|4182024|B1|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
4353876|NCT00389168|4182022|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4353877|NCT00389168|4182023|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4353878|NCT00389168|4182024|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4353879|NCT00389168|4182022|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4353880|NCT00389168|4182023|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4353881|NCT00389168|4182024|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4353882|NCT00389168|4182022|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353883|NCT00389168|4182023|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353884|NCT00389168|4182024|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4353885|NCT00389064|4182041|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4353886|NCT00389064|4182042|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4353887|NCT00389064|4182043|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4353888|NCT00389064|4182041|B3||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4353889|NCT00389064|4182042|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4353890|NCT00389064|4182043|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4353891|NCT00389064|4182041|B3|> 75 years||Age, Customized||Participants|Number|58|58.0||||||
4353892|NCT00389064|4182042|B2|> 75 years||Age, Customized||Participants|Number|32|32.0||||||
4353893|NCT00389064|4182043|B1|> 75 years||Age, Customized||Participants|Number|26|26.0||||||
4353894|NCT00389064|4182041|B3|66 to 75 years||Age, Customized||Participants|Number|392|392.0||||||
4353895|NCT00389064|4182042|B2|66 to 75 years||Age, Customized||Participants|Number|195|195.0||||||
4353897|NCT00388973|4182070|B3|296.3x - Major depressive disorder, recurrent||DSM IV diagnosis||Participants|Number|286|286.0||||||
4353898|NCT00388973|4182071|B2|296.3x - Major depressive disorder, recurrent||DSM IV diagnosis||Participants|Number|147|147.0||||||
4353899|NCT00388973|4182072|B1|296.3x - Major depressive disorder, recurrent||DSM IV diagnosis||Participants|Number|139|139.0||||||
4353900|NCT00388973|4182070|B3|296.2x - Major depressive disorder, single episode||DSM IV diagnosis||Participants|Number|52|52.0||||||
4353901|NCT00388973|4182071|B2|296.2x - Major depressive disorder, single episode||DSM IV diagnosis||Participants|Number|25|25.0||||||
4353902|NCT00388973|4182072|B1|296.2x - Major depressive disorder, single episode||DSM IV diagnosis||Participants|Number|27|27.0||||||
4353903|NCT00388973|4182070|B3|South America||Region of Enrollment||Participants|Number|37|37.0||||||
4353904|NCT00388973|4182071|B2|South America||Region of Enrollment||Participants|Number|19|19.0||||||
4353905|NCT00388973|4182072|B1|South America||Region of Enrollment||Participants|Number|18|18.0||||||
4353906|NCT00388973|4182070|B3|North America||Region of Enrollment||Participants|Number|51|51.0||||||
4353907|NCT00388973|4182071|B2|North America||Region of Enrollment||Participants|Number|27|27.0||||||
4353908|NCT00388973|4182072|B1|North America||Region of Enrollment||Participants|Number|24|24.0||||||
4353909|NCT00388973|4182070|B3|Europe||Region of Enrollment||Participants|Number|250|250.0||||||
4353910|NCT00388973|4182071|B2|Europe||Region of Enrollment||Participants|Number|126|126.0||||||
4353911|NCT00388973|4182072|B1|Europe||Region of Enrollment||Participants|Number|124|124.0||||||
4353912|NCT00388973|4182070|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4353913|NCT00388973|4182071|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4353914|NCT00388973|4182072|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4353915|NCT00388973|4182070|B3||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4353916|NCT00388973|4182071|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4353917|NCT00388973|4182072|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4353918|NCT00388973|4182070|B3|>75 years||Age, Customized||Participants|Number|66|66.0||||||
4353919|NCT00388973|4182071|B2|>75 years||Age, Customized||Participants|Number|35|35.0||||||
4353920|NCT00388973|4182072|B1|>75 years||Age, Customized||Participants|Number|31|31.0||||||
4353921|NCT00388973|4182070|B3|66 to 75 years||Age, Customized||Participants|Number|272|272.0||||||
4353922|NCT00388973|4182071|B2|66 to 75 years||Age, Customized||Participants|Number|137|137.0||||||
4353923|NCT00388973|4182072|B1|66 to 75 years||Age, Customized||Participants|Number|135|135.0||||||
4353924|NCT00388947|4182093|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353925|NCT00388947|4182093|B1||Female|Sex: Female, Male||Participants|Count of Participants|1590|1590.0||||||
4353926|NCT00388947|4182093|B1|Age <89 years||Age|Patients >89 years old were excluded because protected health information was not collected in this study. Mean age excludes patients >89 years old. Two patients were >89 years old.|participants|Mean|62|62.0|Standard Deviation|12|12.0|||
4353927|NCT00388804|4182098|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4353928|NCT00388804|4182099|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4353929|NCT00388804|4182100|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4353930|NCT00388804|4182098|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4353931|NCT00388804|4182099|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4353932|NCT00388804|4182100|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4353933|NCT00388804|4182098|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353934|NCT00388804|4182099|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353935|NCT00388804|4182100|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353936|NCT00388804|4182098|B3|||Age||years|Median|65.3|65.3|Full Range|||48.0|78.0|
4353937|NCT00388804|4182099|B2|||Age||years|Median|64.5|64.5|Full Range|||48.0|73.0|
4353938|NCT00388804|4182100|B1|||Age||years|Median|66.3|66.3|Full Range|||53.0|78.0|
4353939|NCT00388726|4182107|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4353940|NCT00388726|4182108|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4353941|NCT00388726|4182109|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4353942|NCT00388726|4182107|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353943|NCT00388726|4182108|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353944|NCT00388726|4182109|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353945|NCT00388726|4182107|B3||White|Race (NIH/OMB)||Participants|Count of Participants|703|703.0||||||
4353946|NCT00388726|4182108|B2||White|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
4353947|NCT00388726|4182109|B1||White|Race (NIH/OMB)||Participants|Count of Participants|470|470.0||||||
4353948|NCT00388726|4182107|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4353949|NCT00388726|4182108|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4353950|NCT00388726|4182109|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4353951|NCT00388726|4182107|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353952|NCT00388726|4182108|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353953|NCT00388726|4182109|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353954|NCT00388726|4182107|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4353955|NCT00388726|4182108|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4353956|NCT00388726|4182109|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4353957|NCT00388726|4182107|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353958|NCT00388726|4182108|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353959|NCT00388726|4182109|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4353960|NCT00388726|4182107|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353961|NCT00388726|4182108|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353962|NCT00388726|4182109|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4353963|NCT00388726|4182107|B3||Female|Sex: Female, Male||Participants|Count of Participants|762|762.0||||||
4353964|NCT00388726|4182108|B2||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4353965|NCT00388726|4182109|B1||Female|Sex: Female, Male||Participants|Count of Participants|508|508.0||||||
4353966|NCT00388726|4182107|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|10.37|10.37|||
4353967|NCT00388726|4182108|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|10.43|10.43|||
4353968|NCT00388726|4182109|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|10.34|10.34|||
4353969|NCT00388674|4182122|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4353970|NCT00388674|4182123|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4353971|NCT00388674|4182124|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4353972|NCT00388674|4182122|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4353973|NCT00388674|4182123|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4353974|NCT00388674|4182124|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4353975|NCT00388674|4182122|B3|Other||Race/Ethnicity, Customized||Participants|Number|224|224.0||||||
4353976|NCT00388674|4182123|B2|Other||Race/Ethnicity, Customized||Participants|Number|111|111.0||||||
4353977|NCT00388674|4182124|B1|Other||Race/Ethnicity, Customized||Participants|Number|113|113.0||||||
4353978|NCT00388674|4182122|B3|White||Race/Ethnicity, Customized||Participants|Number|1599|1599.0||||||
4353979|NCT00388674|4182123|B2|White||Race/Ethnicity, Customized||Participants|Number|780|780.0||||||
4353980|NCT00388674|4182124|B1|White||Race/Ethnicity, Customized||Participants|Number|819|819.0||||||
4353981|NCT00388674|4182122|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|127|127.0||||||
4353982|NCT00388674|4182123|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
4353983|NCT00388674|4182124|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
4353984|NCT00388674|4182122|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4353985|NCT00388674|4182123|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4353986|NCT00388674|4182124|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4353987|NCT00388674|4182122|B3|Asian||Race/Ethnicity, Customized||Participants|Number|10422|10422.0||||||
4353988|NCT00388674|4182123|B2|Asian||Race/Ethnicity, Customized||Participants|Number|5201|5201.0||||||
4353989|NCT00388674|4182124|B1|Asian||Race/Ethnicity, Customized||Participants|Number|5221|5221.0||||||
4353990|NCT00388674|4182122|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4353991|NCT00388674|4182123|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4353992|NCT00388674|4182124|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4353993|NCT00388674|4182122|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12068|12068.0||||||
4353994|NCT00388674|4182123|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6008|6008.0||||||
4353995|NCT00388674|4182124|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6060|6060.0||||||
4353996|NCT00388674|4182122|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|307|307.0||||||
4353997|NCT00388674|4182123|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
4353998|NCT00388674|4182124|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4353999|NCT00388674|4182122|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4354000|NCT00388674|4182123|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354001|NCT00388674|4182124|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4354002|NCT00388674|4182122|B3||Male|Sex: Female, Male||Participants|Count of Participants|9385|9385.0||||||
4354003|NCT00388674|4182123|B2||Male|Sex: Female, Male||Participants|Count of Participants|4672|4672.0||||||
4354004|NCT00388674|4182124|B1||Male|Sex: Female, Male||Participants|Count of Participants|4713|4713.0||||||
4354005|NCT00388674|4182122|B3||Female|Sex: Female, Male||Participants|Count of Participants|2993|2993.0||||||
4354006|NCT00388674|4182123|B2||Female|Sex: Female, Male||Participants|Count of Participants|1490|1490.0||||||
4354007|NCT00388674|4182124|B1||Female|Sex: Female, Male||Participants|Count of Participants|1503|1503.0||||||
4354008|NCT00388674|4182122|B3|||Age||years|Mean|39.7|39.7|Standard Deviation|12.12|12.12|||
4354009|NCT00388674|4182123|B2|||Age||years|Mean|39.6|39.6|Standard Deviation|12.14|12.14|||
4354010|NCT00388674|4182124|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|12.11|12.11|||
4354011|NCT00388583|4182141|B3|United States||Region of Enrollment||Participants|Number|807|807.0||||||
4354012|NCT00388583|4182142|B2|United States||Region of Enrollment||Participants|Number|406|406.0||||||
4354013|NCT00388583|4182143|B1|United States||Region of Enrollment||Participants|Number|401|401.0||||||
4354014|NCT00388583|4182141|B3||Male|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4354015|NCT00388583|4182142|B2||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4354016|NCT00388583|4182143|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4354017|NCT00388583|4182141|B3||Female|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4354018|NCT00388583|4182142|B2||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4354019|NCT00388583|4182143|B1||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4354020|NCT00388583|4182141|B3|||Age||Years|Mean|72.5|72.5|Standard Deviation|5.955|5.955|||
4354021|NCT00388583|4182142|B2|||Age||Years|Mean|72.3|72.3|Standard Deviation|5.83|5.83|||
4354022|NCT00388583|4182143|B1|||Age||Years|Mean|72.8|72.8|Standard Deviation|6.08|6.08|||
4354023|NCT00388583|4182141|B3||>=65 years|Age||Participants|Count of Participants|807|807.0||||||
4354024|NCT00388583|4182142|B2||>=65 years|Age||Participants|Count of Participants|406|406.0||||||
4354025|NCT00388583|4182143|B1||>=65 years|Age||Participants|Count of Participants|401|401.0||||||
4354026|NCT00388583|4182141|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4354027|NCT00388583|4182142|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4354028|NCT00388583|4182143|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4354029|NCT00388583|4182141|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354030|NCT00388583|4182142|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354031|NCT00388583|4182143|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354032|NCT00388505|4182156|B3||Male|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4354033|NCT00388505|4182157|B2||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4354034|NCT00388505|4182158|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4354035|NCT00388505|4182156|B3||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4354036|NCT00388505|4182157|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4354037|NCT00388505|4182158|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4354038|NCT00388505|4182156|B3|≥20 years||Age, Customized||participants|Number|357|357.0||||||
4354039|NCT00388505|4182157|B2|≥20 years||Age, Customized||participants|Number|143|143.0||||||
4354040|NCT00388505|4182158|B1|≥20 years||Age, Customized||participants|Number|214|214.0||||||
4354041|NCT00388505|4182156|B3|≥13 to <20 years||Age, Customized||participants|Number|114|114.0||||||
4354042|NCT00388505|4182157|B2|≥13 to <20 years||Age, Customized||participants|Number|48|48.0||||||
4354043|NCT00388505|4182158|B1|≥13 to <20 years||Age, Customized||participants|Number|66|66.0||||||
4354044|NCT00388505|4182156|B3|≥6 to <13 years||Age, Customized||participants|Number|46|46.0||||||
4354045|NCT00388505|4182157|B2|≥6 to <13 years||Age, Customized||participants|Number|18|18.0||||||
4354046|NCT00388505|4182158|B1|≥6 to <13 years||Age, Customized||participants|Number|28|28.0||||||
4354047|NCT00388505|4182156|B3|||Age||years|Mean|25.6|25.6|Standard Deviation|10.90|10.9|||
4354048|NCT00388505|4182157|B2|||Age||years|Mean|25.2|25.2|Standard Deviation|10.20|10.2|||
4354049|NCT00388505|4182158|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|11.36|11.36|||
4354050|NCT00388453|4182181|B4|United States||Region of Enrollment||participants|Number|47|47.0||||||
4354051|NCT00388453|4182182|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4354052|NCT00388453|4182183|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4354053|NCT00388453|4182184|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4354054|NCT00388453|4182181|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4354055|NCT00388453|4182182|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4354056|NCT00388453|4182183|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4354057|NCT00388453|4182184|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4354058|NCT00388453|4182181|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4354059|NCT00388453|4182182|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4354060|NCT00388453|4182183|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4354061|NCT00388453|4182184|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4354062|NCT00388453|4182181|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4354063|NCT00388453|4182182|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4354064|NCT00388453|4182183|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4354065|NCT00388453|4182184|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4354066|NCT00388453|4182181|B4||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4354067|NCT00388453|4182182|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4354068|NCT00388453|4182183|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4354069|NCT00388453|4182184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4354070|NCT00388453|4182181|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354071|NCT00388453|4182182|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354072|NCT00388453|4182183|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354073|NCT00388453|4182184|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354074|NCT00388414|4182203|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4354075|NCT00388414|4182204|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4354076|NCT00388414|4182205|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4354077|NCT00388414|4182203|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4354078|NCT00388414|4182204|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4354079|NCT00388414|4182205|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4354080|NCT00388414|4182203|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354081|NCT00388414|4182204|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354082|NCT00388414|4182205|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354083|NCT00388414|4182203|B3|||Age||years|Mean|36.93|36.93|Standard Deviation|13.05|13.05|||
4354084|NCT00388414|4182204|B2|||Age||years|Mean|42.86|42.86|Standard Deviation|12.56|12.56|||
4354085|NCT00388414|4182205|B1|||Age||years|Mean|31|31.0|Standard Deviation|11.36|11.36|||
4354086|NCT00388414|4182203|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4354087|NCT00388414|4182204|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4354088|NCT00388414|4182205|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4354089|NCT00388414|4182203|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4354090|NCT00388414|4182204|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4354091|NCT00388414|4182205|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4354092|NCT00388414|4182203|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354093|NCT00388414|4182204|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354094|NCT00388414|4182205|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354095|NCT00388362|4182214|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4354096|NCT00388362|4182214|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354097|NCT00388362|4182214|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4354098|NCT00388362|4182214|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4354099|NCT00388362|4182214|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354100|NCT00388362|4182214|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4354101|NCT00388362|4182214|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354102|NCT00388362|4182214|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4354103|NCT00388362|4182214|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4354104|NCT00388362|4182214|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4354105|NCT00388362|4182214|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4354106|NCT00388362|4182214|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4354107|NCT00388362|4182214|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4354108|NCT00388362|4182214|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4354109|NCT00388362|4182214|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354110|NCT00388349|4182219|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4354111|NCT00388349|4182219|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4354112|NCT00388349|4182219|B1||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4354113|NCT00388349|4182219|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4354114|NCT00388349|4182219|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4354115|NCT00388349|4182219|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4354116|NCT00388349|4182219|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354117|NCT00388349|4182219|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4354118|NCT00388349|4182219|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4354119|NCT00388349|4182219|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4354120|NCT00388349|4182219|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4354121|NCT00388349|4182219|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4354122|NCT00388349|4182219|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4354123|NCT00388349|4182219|B1||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
4354124|NCT00388349|4182219|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354125|NCT00388154|4182229|B1|2||Prior chemotherapy regimens|Number of participants with none (0), 1, or 2 prior chemotherapy regimens; Participants may have received an unlimited number of prior chemotherapy agents, including platinum-based therapy, but therapy must have been discontinued 3 weeks before study enrollment.|participants|Number|3|3.0||||||
4354126|NCT00388154|4182229|B1|1||Prior chemotherapy regimens|Number of participants with none (0), 1, or 2 prior chemotherapy regimens; Participants may have received an unlimited number of prior chemotherapy agents, including platinum-based therapy, but therapy must have been discontinued 3 weeks before study enrollment.|participants|Number|6|6.0||||||
4354127|NCT00388154|4182229|B1|0||Prior chemotherapy regimens|Number of participants with none (0), 1, or 2 prior chemotherapy regimens; Participants may have received an unlimited number of prior chemotherapy agents, including platinum-based therapy, but therapy must have been discontinued 3 weeks before study enrollment.|participants|Number|12|12.0||||||
4354154|NCT00388154|4182229|B1|||Age||years|Median|62|62.0|Full Range|||41.0|75.0|
4354155|NCT00388037|4182234|B1|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4354128|NCT00388154|4182229|B1|Yes||Prior radiotherapy|Number of participants with prior radiotherapy treatments. Prior radiotherapy was allowed, but 2 weeks must have elapsed from its completion, and 6 weeks must have elapsed if radiotherapy involved the whole pelvis or >50% of the spine.|participants|Number|14|14.0||||||
4354129|NCT00388154|4182229|B1|No||Prior radiotherapy|Number of participants with prior radiotherapy treatments. Prior radiotherapy was allowed, but 2 weeks must have elapsed from its completion, and 6 weeks must have elapsed if radiotherapy involved the whole pelvis or >50% of the spine.|participants|Number|7|7.0||||||
4354130|NCT00388154|4182229|B1|Recurrent||International Federation of Gynecology & Obstetrics (FIGO) Disease Stage|Number participants with FIGO Stage III or IV or recurrent (any stage) endometrioid endometrial carcinoma. FIGO cancer staging system: IA-Tumor confined to uterus, no or < ½ myometrial invasion; IB-Tumor confined to uterus, > ½ myometrial invasion; I-Cervical stromal invasion, but not beyond uterus; IIIA-Tumor invades serosa or adnexa; IIIB-Vaginal and/or parametrial involvement; IIIC1-Pelvic node involvement; IIIC2- Para-aortic involvement; IVA-Tumor invasion bladder and/or bowel mucosa; IVB-Distant metastases including abdominal metastases and/or inguinal lymph nodes.|participants|Number|16|16.0||||||
4354131|NCT00388154|4182229|B1|IV||International Federation of Gynecology & Obstetrics (FIGO) Disease Stage|Number participants with FIGO Stage III or IV or recurrent (any stage) endometrioid endometrial carcinoma. FIGO cancer staging system: IA-Tumor confined to uterus, no or < ½ myometrial invasion; IB-Tumor confined to uterus, > ½ myometrial invasion; I-Cervical stromal invasion, but not beyond uterus; IIIA-Tumor invades serosa or adnexa; IIIB-Vaginal and/or parametrial involvement; IIIC1-Pelvic node involvement; IIIC2- Para-aortic involvement; IVA-Tumor invasion bladder and/or bowel mucosa; IVB-Distant metastases including abdominal metastases and/or inguinal lymph nodes.|participants|Number|5|5.0||||||
4354132|NCT00388154|4182229|B1|III||International Federation of Gynecology & Obstetrics (FIGO) Disease Stage|Number participants with FIGO Stage III or IV or recurrent (any stage) endometrioid endometrial carcinoma. FIGO cancer staging system: IA-Tumor confined to uterus, no or < ½ myometrial invasion; IB-Tumor confined to uterus, > ½ myometrial invasion; I-Cervical stromal invasion, but not beyond uterus; IIIA-Tumor invades serosa or adnexa; IIIB-Vaginal and/or parametrial involvement; IIIC1-Pelvic node involvement; IIIC2- Para-aortic involvement; IVA-Tumor invasion bladder and/or bowel mucosa; IVB-Distant metastases including abdominal metastases and/or inguinal lymph nodes.|participants|Number|0|0.0||||||
4354133|NCT00388154|4182229|B1|Grade 3||Tumor Grade|Endometrioid cancer grade based on how much cancer forms glands that look similar to glands found in normal, healthy endometrium. In lower-grade cancers, more of the cancerous tissue forms glands while higher-grade cancers have more of the cancer cells arranged in a disorganized way and do not form glands: Grade 1 tumors: 95%/> of cancerous tissue forming glands; Grade 2: 50% - 94% cancerous tissue form glands; and Grade 3 tumors have less than half of cancerous tissue forming glands. The higher grade, the more aggressive the cancer.|participants|Number|8|8.0||||||
4354134|NCT00388154|4182229|B1|Grade 2||Tumor Grade|Endometrioid cancer grade based on how much cancer forms glands that look similar to glands found in normal, healthy endometrium. In lower-grade cancers, more of the cancerous tissue forms glands while higher-grade cancers have more of the cancer cells arranged in a disorganized way and do not form glands: Grade 1 tumors: 95%/> of cancerous tissue forming glands; Grade 2: 50% - 94% cancerous tissue form glands; and Grade 3 tumors have less than half of cancerous tissue forming glands. The higher grade, the more aggressive the cancer.|participants|Number|12|12.0||||||
4354135|NCT00388154|4182229|B1|Grade 1||Tumor Grade|Endometrioid cancer grade based on how much cancer forms glands that look similar to glands found in normal, healthy endometrium. In lower-grade cancers, more of the cancerous tissue forms glands while higher-grade cancers have more of the cancer cells arranged in a disorganized way and do not form glands: Grade 1 tumors: 95%/> of cancerous tissue forming glands; Grade 2: 50% - 94% cancerous tissue form glands; and Grade 3 tumors have less than half of cancerous tissue forming glands. The higher grade, the more aggressive the cancer.|participants|Number|1|1.0||||||
4354136|NCT00388154|4182229|B1|1||Zubrod performance status|Eastern Cooperative Oncology Group (ECOG) performance status (PS) performed at baseline. PS described as 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; etc.|participants|Number|6|6.0||||||
4354137|NCT00388154|4182229|B1|0||Zubrod performance status|Eastern Cooperative Oncology Group (ECOG) performance status (PS) performed at baseline. PS described as 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; etc.|participants|Number|15|15.0||||||
4354138|NCT00388154|4182229|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4354139|NCT00388154|4182229|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354140|NCT00388154|4182229|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4354141|NCT00388154|4182229|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4354142|NCT00388154|4182229|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354143|NCT00388154|4182229|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354144|NCT00388154|4182229|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4354145|NCT00388154|4182229|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4354146|NCT00388154|4182229|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354147|NCT00388154|4182229|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4354148|NCT00388154|4182229|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354149|NCT00388154|4182229|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354150|NCT00388154|4182229|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4354151|NCT00388154|4182229|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4354152|NCT00388154|4182229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4354153|NCT00388154|4182229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354156|NCT00388037|4182234|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354157|NCT00388037|4182234|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4354158|NCT00388037|4182234|B1|||Age||years|Median|57|57.0|Full Range|||37.0|82.0|
4354159|NCT00387959|4182238|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4354160|NCT00387959|4182238|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4354161|NCT00387959|4182238|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4354162|NCT00387959|4182238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4354163|NCT00387959|4182238|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354164|NCT00387894|4182242|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4354165|NCT00387894|4182242|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354166|NCT00387894|4182242|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354167|NCT00387894|4182242|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4354168|NCT00387894|4182242|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354169|NCT00387894|4182242|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354170|NCT00387894|4182242|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4354171|NCT00387894|4182242|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354172|NCT00387894|4182242|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354173|NCT00387894|4182242|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4354174|NCT00387894|4182242|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354175|NCT00387894|4182242|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4354176|NCT00387894|4182242|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4354177|NCT00387894|4182242|B1|||Age||years|Mean|44|44.0|Full Range|||27.0|60.0|
4354178|NCT00387894|4182242|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4354179|NCT00387894|4182242|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4354180|NCT00387894|4182242|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354181|NCT00387881|4182247|B3|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354182|NCT00387881|4182248|B2|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354183|NCT00387881|4182249|B1|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4354184|NCT00387881|4182247|B3|Mixed race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354185|NCT00387881|4182248|B2|Mixed race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354186|NCT00387881|4182249|B1|Mixed race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4354187|NCT00387881|4182247|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|405|405.0||||||
4354188|NCT00387881|4182248|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|206|206.0||||||
4354189|NCT00387881|4182249|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|199|199.0||||||
4354190|NCT00387881|4182247|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4354191|NCT00387881|4182248|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4354192|NCT00387881|4182249|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354193|NCT00387881|4182247|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354194|NCT00387881|4182248|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4354195|NCT00387881|4182249|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354196|NCT00387881|4182247|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4354197|NCT00387881|4182248|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4354198|NCT00387881|4182249|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4354199|NCT00387881|4182247|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4354200|NCT00387881|4182248|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354201|NCT00387881|4182249|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4354202|NCT00387881|4182247|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4354203|NCT00387881|4182248|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4354204|NCT00387881|4182249|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4354205|NCT00387881|4182247|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354206|NCT00387881|4182248|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4354207|NCT00387881|4182249|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354208|NCT00387881|4182247|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|58|58.0||||||
4354209|NCT00387881|4182248|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4354210|NCT00387881|4182249|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4354211|NCT00387881|4182247|B3||Male|Gender||Participants|Count of Participants|129|129.0||||||
4354212|NCT00387881|4182248|B2||Male|Gender||Participants|Count of Participants|59|59.0||||||
4354213|NCT00387881|4182249|B1||Male|Gender||Participants|Count of Participants|70|70.0||||||
4354214|NCT00387881|4182247|B3||Female|Gender||Participants|Count of Participants|371|371.0||||||
4354215|NCT00387881|4182248|B2||Female|Gender||Participants|Count of Participants|195|195.0||||||
4354216|NCT00387881|4182249|B1||Female|Gender||Participants|Count of Participants|176|176.0||||||
4354217|NCT00387881|4182247|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|11.35|11.35|||
4354218|NCT00387881|4182248|B2|||Age||years|Mean|35.8|35.8|Standard Deviation|11.47|11.47|||
4354219|NCT00387881|4182249|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|11.23|11.23|||
4354220|NCT00387829|4182272|B3|United States||Region of Enrollment||participants|Number|343|343.0||||||
4354221|NCT00387829|4182273|B2|United States||Region of Enrollment||participants|Number|166|166.0||||||
4354222|NCT00387829|4182274|B1|United States||Region of Enrollment||participants|Number|177|177.0||||||
4354223|NCT00387829|4182272|B3||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4354224|NCT00387829|4182273|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4354225|NCT00387829|4182274|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4354226|NCT00387829|4182272|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4354227|NCT00387829|4182273|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4354228|NCT00387829|4182274|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4354229|NCT00387829|4182272|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|11.31|11.31|||
4354230|NCT00387829|4182273|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|11.27|11.27|||
4354231|NCT00387829|4182274|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|11.38|11.38|||
4354232|NCT00387829|4182272|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4354233|NCT00387829|4182273|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4354234|NCT00387829|4182274|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4354235|NCT00387829|4182272|B3||Between 18 and 65 years|Age||Participants|Count of Participants|333|333.0||||||
4354236|NCT00387829|4182273|B2||Between 18 and 65 years|Age||Participants|Count of Participants|162|162.0||||||
4354237|NCT00387829|4182274|B1||Between 18 and 65 years|Age||Participants|Count of Participants|171|171.0||||||
4354238|NCT00387829|4182272|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354239|NCT00387829|4182273|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354240|NCT00387829|4182274|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354241|NCT00387790|4182283|B1|Australia||Region of Enrollment|Patients found not to meet the eligibility requirements are excluded from the region baseline measure.|participants|Number|5|5.0||||||
4354242|NCT00387790|4182283|B1|Canada||Region of Enrollment|Patients found not to meet the eligibility requirements are excluded from the region baseline measure.|participants|Number|4|4.0||||||
4354243|NCT00387790|4182283|B1|United States||Region of Enrollment|Patients found not to meet the eligibility requirements are excluded from the region baseline measure.|participants|Number|55|55.0||||||
4354244|NCT00387790|4182283|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Patients found not to meet the eligibility requirements are excluded from the ethnicity baseline measure.|Participants|Count of Participants|5|5.0||||||
4354245|NCT00387790|4182283|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Patients found not to meet the eligibility requirements are excluded from the ethnicity baseline measure.|Participants|Count of Participants|52|52.0||||||
4354246|NCT00387790|4182283|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Patients found not to meet the eligibility requirements are excluded from the ethnicity baseline measure.|Participants|Count of Participants|7|7.0||||||
4354247|NCT00387790|4182283|B1||Unknown or Not Reported|Race (NIH/OMB)|Patients found not to meet the eligibility requirements are excluded from the race baseline measure.|Participants|Count of Participants|9|9.0||||||
4354248|NCT00387790|4182283|B1||More than one race|Race (NIH/OMB)|Patients found not to meet the eligibility requirements are excluded from the race baseline measure.|Participants|Count of Participants|0|0.0||||||
4354249|NCT00387790|4182283|B1||White|Race (NIH/OMB)|Patients found not to meet the eligibility requirements are excluded from the race baseline measure.|Participants|Count of Participants|42|42.0||||||
4354250|NCT00387790|4182283|B1||Black or African American|Race (NIH/OMB)|Patients found not to meet the eligibility requirements are excluded from the race baseline measure.|Participants|Count of Participants|11|11.0||||||
4354251|NCT00387790|4182283|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Patients found not to meet the eligibility requirements are excluded from the race baseline measure.|Participants|Count of Participants|0|0.0||||||
4354252|NCT00387790|4182283|B1||Asian|Race (NIH/OMB)|Patients found not to meet the eligibility requirements are excluded from the race baseline measure.|Participants|Count of Participants|1|1.0||||||
4354253|NCT00387790|4182283|B1||American Indian or Alaska Native|Race (NIH/OMB)|Patients found not to meet the eligibility requirements are excluded from the race baseline measure.|Participants|Count of Participants|1|1.0||||||
4354254|NCT00387790|4182283|B1||Male|Sex: Female, Male|Patients found not to meet the eligibility requirements were not included in the gender baseline measure.|Participants|Count of Participants|30|30.0||||||
4354255|NCT00387790|4182283|B1||Female|Sex: Female, Male|Patients found not to meet the eligibility requirements were not included in the gender baseline measure.|Participants|Count of Participants|34|34.0||||||
4354256|NCT00387790|4182283|B1|||Age|Patients found not to meet the eligibility requirements are excluded from the age baseline measure.|years|Mean|6|6.0|Full Range|||1.0|17.0|
4354257|NCT00387764|4182289|B1|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4354258|NCT00387764|4182289|B1|Japanese/East Asian HER/South East Asian HER||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4354259|NCT00387764|4182289|B1|Central/South Asian Heritage (HER)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4354260|NCT00387764|4182289|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4354261|NCT00387764|4182289|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4354262|NCT00387764|4182289|B1|||Age||Years|Mean|60.5|60.5|Standard Deviation|10.95|10.95|||
4354263|NCT00387751|4182307|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4354264|NCT00387751|4182307|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4354265|NCT00387751|4182307|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4354266|NCT00387751|4182307|B1|||Age||years|Mean|61|61.0|Standard Deviation|3|3.0|||
4354267|NCT00387751|4182307|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4354268|NCT00387751|4182307|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4354269|NCT00387751|4182307|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354270|NCT00387725|4182313|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4354271|NCT00387725|4182314|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4354272|NCT00387725|4182315|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4354273|NCT00387725|4182316|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4354274|NCT00387725|4182317|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4354275|NCT00387725|4182313|B5||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4354276|NCT00387725|4182314|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4354277|NCT00387725|4182315|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4354278|NCT00387725|4182316|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4354279|NCT00387725|4182317|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4354280|NCT00387725|4182313|B5|||Age||years|Mean|10.34|10.34|Standard Deviation|1.25|1.25|||
4354281|NCT00387725|4182314|B4|||Age||years|Mean|10.31|10.31|Standard Deviation|1.29|1.29|||
4354282|NCT00387725|4182315|B3|||Age||years|Mean|10.31|10.31|Standard Deviation|1.24|1.24|||
4354283|NCT00387725|4182316|B2|||Age||years|Mean|10.69|10.69|Standard Deviation|0.95|0.95|||
4354284|NCT00387725|4182317|B1|||Age||years|Mean|10.19|10.19|Standard Deviation|1.44|1.44|||
4354285|NCT00387712|4182338|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4354286|NCT00387712|4182339|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4354287|NCT00387712|4182340|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4354288|NCT00387712|4182338|B3|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4354289|NCT00387712|4182339|B2|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4354290|NCT00387712|4182340|B1|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4354291|NCT00387712|4182338|B3|Race|Latino|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4354292|NCT00387712|4182339|B2|Race|Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4354293|NCT00387712|4182340|B1|Race|Latino|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4354294|NCT00387712|4182338|B3|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
4354295|NCT00387712|4182339|B2|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4354296|NCT00387712|4182340|B1|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4354297|NCT00387712|4182338|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4354298|NCT00387712|4182339|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4354299|NCT00387712|4182340|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4354300|NCT00387712|4182338|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4354301|NCT00387712|4182339|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4354302|NCT00387712|4182340|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4354303|NCT00387712|4182338|B3|||Age||years|Mean|63|63.0|Standard Deviation|3|3.0|||
4354304|NCT00387712|4182339|B2|||Age||years|Mean|64|64.0|Standard Deviation|6|6.0|||
4354305|NCT00387712|4182340|B1|||Age||years|Mean|62|62.0|Standard Deviation|3|3.0|||
4354306|NCT00387712|4182338|B3||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4354307|NCT00387712|4182339|B2||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4354308|NCT00387712|4182340|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4354309|NCT00387712|4182338|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4354310|NCT00387712|4182339|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4354311|NCT00387712|4182340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4354312|NCT00387712|4182338|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354313|NCT00387712|4182339|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354314|NCT00387712|4182340|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354315|NCT00387673|4182351|B1||Male|Sex: Female, Male||||0|0.0||||||
4354316|NCT00387673|4182351|B1||Female|Sex: Female, Male||||0|0.0||||||
4354317|NCT00387660|4182359|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4354318|NCT00387660|4182360|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4354319|NCT00387660|4182361|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4354320|NCT00387660|4182359|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4354321|NCT00387660|4182360|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4354322|NCT00387660|4182361|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4354323|NCT00387660|4182359|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4354324|NCT00387660|4182360|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4354325|NCT00387660|4182361|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4354326|NCT00387660|4182359|B3|||Age||years|Median|65|65.0|Full Range|||43.0|81.0|
4354327|NCT00387660|4182360|B2|||Age||years|Median|65|65.0|Full Range|||43.0|80.0|
4354328|NCT00387660|4182361|B1|||Age||years|Median|67|67.0|Full Range|||50.0|81.0|
4354329|NCT00387647|4182372|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4354330|NCT00387647|4182372|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4354331|NCT00387647|4182372|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4354332|NCT00387647|4182372|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4354333|NCT00387647|4182372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4354334|NCT00387647|4182372|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354335|NCT00387647|4182372|B1|||Age||years|Mean|68.7|68.7|Full Range|||62.0|81.0|
4354336|NCT00387621|4182378|B4|||Body Mass Index|"Body mass index (BMI) is a measure of body fat based on height and weight that applies to adult men and women.~BMI Categories:~Underweight = <18.5 Normal weight = 18.5–24.9 Overweight = 25–29.9 Obesity = BMI of 30 or greater"|kg/m^2|Mean|28.5|28.5|Standard Deviation|5.1|5.1|||
4354337|NCT00387621|4182379|B3|||Body Mass Index|"Body mass index (BMI) is a measure of body fat based on height and weight that applies to adult men and women.~BMI Categories:~Underweight = <18.5 Normal weight = 18.5–24.9 Overweight = 25–29.9 Obesity = BMI of 30 or greater"|kg/m^2|Mean|30|30.0|Standard Deviation|5|5.0|||
4354338|NCT00387621|4182380|B2|||Body Mass Index|"Body mass index (BMI) is a measure of body fat based on height and weight that applies to adult men and women.~BMI Categories:~Underweight = <18.5 Normal weight = 18.5–24.9 Overweight = 25–29.9 Obesity = BMI of 30 or greater"|kg/m^2|Mean|31|31.0|Standard Deviation|5|5.0|||
4354339|NCT00387621|4182381|B1|||Body Mass Index|"Body mass index (BMI) is a measure of body fat based on height and weight that applies to adult men and women.~BMI Categories:~Underweight = <18.5 Normal weight = 18.5–24.9 Overweight = 25–29.9 Obesity = BMI of 30 or greater"|kg/m^2|Mean|25|25.0|Standard Deviation|4|4.0|||
4354340|NCT00387621|4182378|B4|||Blood Urea Nitrogen||mg/dL|Mean|18.2|18.2|Standard Deviation|8.6|8.6|||
4354341|NCT00387621|4182379|B3|||Blood Urea Nitrogen||mg/dL|Mean|23|23.0|Standard Deviation|6|6.0|||
4354342|NCT00387621|4182380|B2|||Blood Urea Nitrogen||mg/dL|Mean|21|21.0|Standard Deviation|10|10.0|||
4354343|NCT00387621|4182381|B1|||Blood Urea Nitrogen||mg/dL|Mean|11|11.0|Standard Deviation|5|5.0|||
4354344|NCT00387621|4182378|B4|||Creatinine||mg/dL|Mean|1.0|1.0|Standard Deviation|0.2|0.2|||
4354345|NCT00387621|4182379|B3|||Creatinine||mg/dL|Mean|1.1|1.1|Standard Deviation|0.3|0.3|||
4354346|NCT00387621|4182380|B2|||Creatinine||mg/dL|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
4354347|NCT00387621|4182381|B1|||Creatinine||mg/dL|Mean|0.9|0.9|Standard Deviation|0.1|0.1|||
4354348|NCT00387621|4182378|B4|United States||Region of Enrollment||participants|Number|58|58.0||||||
4354349|NCT00387621|4182379|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4354350|NCT00387621|4182380|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4354351|NCT00387621|4182381|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4354352|NCT00387621|4182378|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4354353|NCT00387621|4182379|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4354354|NCT00387621|4182380|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4354355|NCT00387621|4182381|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4354356|NCT00387621|4182378|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4354357|NCT00387621|4182379|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4354358|NCT00387621|4182380|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4354359|NCT00387621|4182381|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4354360|NCT00387621|4182378|B4|||Age||years|Mean|57.5|57.5|Standard Deviation|18.4|18.4|||
4354361|NCT00387621|4182379|B3|||Age||years|Mean|72|72.0|Standard Deviation|7|7.0|||
4354362|NCT00387621|4182380|B2|||Age||years|Mean|65|65.0|Standard Deviation|12|12.0|||
4354363|NCT00387621|4182381|B1|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
4354364|NCT00387426|4182412|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4354365|NCT00387426|4182412|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4354366|NCT00387426|4182412|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4354367|NCT00387426|4182412|B1|||Age||years|Median|64|64.0|Full Range|||51.0|79.0|
4354368|NCT00387348|4182416|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4354369|NCT00387348|4182417|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4354370|NCT00387348|4182418|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4354371|NCT00387348|4182419|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4354372|NCT00387348|4182416|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4354373|NCT00387348|4182417|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4354374|NCT00387348|4182418|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4354375|NCT00387348|4182419|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4354376|NCT00387348|4182416|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4354377|NCT00387348|4182417|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4354378|NCT00387348|4182418|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4354379|NCT00387348|4182419|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4354380|NCT00387348|4182416|B4|||Age||years|Mean|58.00|58.0|Standard Deviation|9.68|9.68|||
4354381|NCT00387348|4182417|B3|||Age||years|Mean|58.36|58.36|Standard Deviation|9.41|9.41|||
4354382|NCT00387348|4182418|B2|||Age||years|Mean|59.40|59.4|Standard Deviation|10.84|10.84|||
4354383|NCT00387348|4182419|B1|||Age||years|Mean|56.63|56.63|Standard Deviation|10.51|10.51|||
4354384|NCT00387348|4182416|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4354385|NCT00387348|4182417|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4354386|NCT00387348|4182418|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4354387|NCT00387348|4182419|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4354388|NCT00387348|4182416|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4354389|NCT00387348|4182417|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4354390|NCT00387348|4182418|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4354391|NCT00387348|4182419|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4354392|NCT00387348|4182416|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354393|NCT00387348|4182417|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354394|NCT00387348|4182418|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354395|NCT00387348|4182419|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354396|NCT00387335|4182435|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4354397|NCT00387335|4182436|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4354398|NCT00387335|4182437|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4354399|NCT00387335|4182435|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4354400|NCT00387335|4182436|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4354401|NCT00387335|4182437|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4354402|NCT00387335|4182435|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4354403|NCT00387335|4182436|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4354404|NCT00387335|4182437|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4354405|NCT00387335|4182435|B3|||Age||years|Median|57|57.0|Full Range|||40.0|78.0|
4354406|NCT00387335|4182436|B2|||Age||years|Median|60|60.0|Full Range|||40.0|77.0|
4354407|NCT00387335|4182437|B1|||Age||years|Median|55|55.0|Full Range|43-78|43.0|43.0|78.0|
4354408|NCT00387153|4182450|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4354409|NCT00387153|4182450|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4354410|NCT00387153|4182450|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4354411|NCT00387153|4182450|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|21.9|21.9|||
4354412|NCT00387153|4182450|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4354413|NCT00387153|4182450|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4354414|NCT00387153|4182450|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354415|NCT00387127|4182454|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
4354416|NCT00387127|4182455|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4354417|NCT00387127|4182456|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4354418|NCT00387127|4182454|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4354419|NCT00387127|4182455|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354420|NCT00387127|4182456|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4354421|NCT00387127|4182454|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4354422|NCT00387127|4182455|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4354423|NCT00387127|4182456|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4354424|NCT00387127|4182454|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4354425|NCT00387127|4182455|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4354426|NCT00387127|4182456|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4354427|NCT00387127|4182454|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354428|NCT00387127|4182455|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354429|NCT00387127|4182456|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4354430|NCT00387127|4182454|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4354431|NCT00387127|4182455|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4354432|NCT00387127|4182456|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4354433|NCT00387127|4182454|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4354434|NCT00387127|4182455|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4354435|NCT00387127|4182456|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4354436|NCT00387127|4182454|B3|||Age||Years|Mean|56.1|56.1|Standard Deviation|6.15|6.15|||
4354437|NCT00387127|4182455|B2|||Age||Years|Mean|55.8|55.8|Standard Deviation|5.73|5.73|||
4354438|NCT00387127|4182456|B1|||Age||Years|Mean|56.5|56.5|Standard Deviation|6.61|6.61|||
4354482|NCT00386880|4182578|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4354439|NCT00387088|4182497|B3||Male|Sex: Female, Male|The TS was made up of all randomised and treated participants excluding 74 patients with potential fraudulent data from one investigator site|Participants|Count of Participants|3037|3037.0||||||
4354440|NCT00387088|4182498|B2||Male|Sex: Female, Male|The TS was made up of all randomised and treated participants excluding 74 patients with potential fraudulent data from one investigator site|Participants|Count of Participants|1513|1513.0||||||
4354441|NCT00387088|4182499|B1||Male|Sex: Female, Male|The TS was made up of all randomised and treated participants excluding 74 patients with potential fraudulent data from one investigator site|Participants|Count of Participants|1524|1524.0||||||
4354442|NCT00387088|4182497|B3||Female|Sex: Female, Male|The TS was made up of all randomised and treated participants excluding 74 patients with potential fraudulent data from one investigator site|Participants|Count of Participants|880|880.0||||||
4354443|NCT00387088|4182498|B2||Female|Sex: Female, Male|The TS was made up of all randomised and treated participants excluding 74 patients with potential fraudulent data from one investigator site|Participants|Count of Participants|452|452.0||||||
4354444|NCT00387088|4182499|B1||Female|Sex: Female, Male|The TS was made up of all randomised and treated participants excluding 74 patients with potential fraudulent data from one investigator site|Participants|Count of Participants|428|428.0||||||
4354445|NCT00387088|4182497|B3|||Age|The TS was made up of all randomised and treated participants excluding 74 patients with potential fraudulent data from one investigator site|Years|Mean|64.80|64.8|Standard Deviation|9.00|9.0|||
4354446|NCT00387088|4182498|B2|||Age|The TS was made up of all randomised and treated participants excluding 74 patients with potential fraudulent data from one investigator site|Years|Mean|64.8|64.8|Standard Deviation|9|9.0|||
4354447|NCT00387088|4182499|B1|||Age|The TS was made up of all randomised and treated participants excluding 74 patients with potential fraudulent data from one investigator site|Years|Mean|64.8|64.8|Standard Deviation|9.1|9.1|||
4354448|NCT00387036|4182544|B1|||Standardized Dyspnea Score at isotime at the beginning of placebo|Standardized Dyspnea Score (0 (no discomfort) to 10 (most severe)) at isotime at the beginning of placebo treatment. Isotime is the duration of the shortest exercise test on all treatment days (or the longest exercise time point common to all constant-load exercise tests)|Units on a Scale|Mean|4.75|4.75|Standard Deviation|2.13|2.13|||
4354449|NCT00387036|4182544|B1|||Standardized Dyspnea Score at isotime at the beginning of Fluticasone|Standardized Dyspnea Score (0 (no discomfort) to 10 (most severe)) at isotime at the beginning of Fluticasone Propionate treatment. Isotime is the duration of the shortest exercise test on all treatment days (or the longest exercise time point common to all constant-load exercise tests).|Units on a Scale|Mean|4.50|4.5|Standard Deviation|1.87|1.87|||
4354450|NCT00387036|4182544|B1|||Exercise endurance time at the beginning of placebo treatment|The duration of loaded pedaling at the beginning of placebo treatment|Minutes|Mean|9.42|9.42|Standard Deviation|6.73|6.73|||
4354451|NCT00387036|4182544|B1|||Exercise endurance time at the beginning of Fluticasone Propionate|The duration of loaded pedaling at the beginning of Fluticasone Propionate treatment.|Minutes|Mean|9.67|9.67|Standard Deviation|7.88|7.88|||
4354452|NCT00387036|4182544|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4354453|NCT00387036|4182544|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4354454|NCT00387036|4182544|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|6.7|6.7|||
4354455|NCT00387023|4182553|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4354456|NCT00387023|4182553|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4354457|NCT00387023|4182553|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4354458|NCT00387023|4182553|B1|||Age||years|Median|60|60.0|Full Range|||22.0|79.0|
4354459|NCT00387010|4182557|B1|Other||Primary chronic painful condition||participants|Number|15|15.0||||||
4354460|NCT00387010|4182557|B1|Chronic pancreatitis||Primary chronic painful condition||participants|Number|2|2.0||||||
4354461|NCT00387010|4182557|B1|Cancer||Primary chronic painful condition||participants|Number|3|3.0||||||
4354462|NCT00387010|4182557|B1|Diabetic peripheral neuropathy||Primary chronic painful condition||participants|Number|3|3.0||||||
4354463|NCT00387010|4182557|B1|Complex regional pain syndrome||Primary chronic painful condition||participants|Number|9|9.0||||||
4354464|NCT00387010|4182557|B1|Osteoarthritis||Primary chronic painful condition||participants|Number|11|11.0||||||
4354465|NCT00387010|4182557|B1|Traumatic injury||Primary chronic painful condition||participants|Number|12|12.0||||||
4354466|NCT00387010|4182557|B1|Fibromyalgia||Primary chronic painful condition||participants|Number|13|13.0||||||
4354467|NCT00387010|4182557|B1|Neck pain||Primary chronic painful condition||participants|Number|14|14.0||||||
4354468|NCT00387010|4182557|B1|Back pain||Primary chronic painful condition||participants|Number|136|136.0||||||
4354469|NCT00387010|4182557|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4354470|NCT00387010|4182557|B1|White||Race/Ethnicity, Customized||participants|Number|208|208.0||||||
4354471|NCT00387010|4182557|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4354472|NCT00387010|4182557|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4354473|NCT00387010|4182557|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4354474|NCT00387010|4182557|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4354475|NCT00387010|4182557|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4354476|NCT00387010|4182557|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4354477|NCT00387010|4182557|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4354478|NCT00387010|4182557|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4354479|NCT00387010|4182557|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4354480|NCT00387010|4182557|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|11.03|11.03|||
4354481|NCT00386880|4182578|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4354483|NCT00386880|4182578|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4354484|NCT00386880|4182578|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4354485|NCT00386880|4182578|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4354486|NCT00386880|4182578|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354487|NCT00386776|4182584|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4354488|NCT00386776|4182584|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4354489|NCT00386776|4182584|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4354490|NCT00386776|4182584|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4354491|NCT00386776|4182584|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354492|NCT00386607|4182594|B1||Male|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
4354493|NCT00386607|4182594|B1||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4354494|NCT00386607|4182594|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|11.20|11.2|||
4354495|NCT00386477|4182611|B3|United States||Region of Enrollment||participants|Number|300|300.0||||||
4354496|NCT00386477|4182612|B2|United States||Region of Enrollment||participants|Number|145|145.0||||||
4354497|NCT00386477|4182613|B1|United States||Region of Enrollment||participants|Number|155|155.0||||||
4354498|NCT00386477|4182611|B3|||Race/Ethnicity, Customized|African-American Caucasian Hispanic Other|participants|Number|300|300.0||||||
4354499|NCT00386477|4182612|B2|||Race/Ethnicity, Customized|African-American Caucasian Hispanic Other|participants|Number|145|145.0||||||
4354500|NCT00386477|4182613|B1|||Race/Ethnicity, Customized|African-American Caucasian Hispanic Other|participants|Number|155|155.0||||||
4354501|NCT00386477|4182611|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354502|NCT00386477|4182612|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354503|NCT00386477|4182613|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354504|NCT00386477|4182611|B3||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4354505|NCT00386477|4182612|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4354506|NCT00386477|4182613|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4354507|NCT00386477|4182611|B3|||Age||years|Mean|26.7|26.7|Standard Deviation|5.8|5.8|||
4354508|NCT00386477|4182612|B2|||Age||years|Mean|26.6|26.6|Standard Deviation|5.7|5.7|||
4354509|NCT00386477|4182613|B1|||Age||years|Mean|26.8|26.8|Standard Deviation|5.9|5.9|||
4354510|NCT00386477|4182611|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4354511|NCT00386477|4182612|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4354512|NCT00386477|4182613|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4354513|NCT00386477|4182611|B3||Between 18 and 65 years|Age||Participants|Count of Participants|300|300.0||||||
4354514|NCT00386477|4182612|B2||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
4354515|NCT00386477|4182613|B1||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4354516|NCT00386477|4182611|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354517|NCT00386477|4182612|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354518|NCT00386477|4182613|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354519|NCT00386425|4182620|B4|Unknown||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|61|61.0||||||
4354520|NCT00386425|4182621|B3|Unknown||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|13|13.0||||||
4354521|NCT00386425|4182622|B2|Unknown||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|21|21.0||||||
4354522|NCT00386425|4182623|B1|Unknown||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|27|27.0||||||
4354523|NCT00386425|4182620|B4|Normal||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|18|18.0||||||
4354524|NCT00386425|4182621|B3|Normal||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|0|0.0||||||
4354525|NCT00386425|4182622|B2|Normal||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|9|9.0||||||
4354526|NCT00386425|4182623|B1|Normal||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|9|9.0||||||
4354527|NCT00386425|4182620|B4|Moderate deficiency||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|179|179.0||||||
4354528|NCT00386425|4182621|B3|Moderate deficiency||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|9|9.0||||||
4354529|NCT00386425|4182622|B2|Moderate deficiency||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|76|76.0||||||
4354530|NCT00386425|4182623|B1|Moderate deficiency||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|94|94.0||||||
4354531|NCT00386425|4182620|B4|Severe deficiency||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|228|228.0||||||
4354532|NCT00386425|4182621|B3|Severe deficiency||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|31|31.0||||||
4354533|NCT00386425|4182622|B2|Severe deficiency||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|100|100.0||||||
4354534|NCT00386425|4182623|B1|Severe deficiency||Central laboratory protein C class|"Moderate Protein C Deficiency: A protein C level greater than half the lower limit of normal.~Severe Protein C Deficiency: A protein C level less than or equal to half the lower limit of normal."|participants|Number|97|97.0||||||
4354535|NCT00386425|4182620|B4|||Protein C level||Percent Protein C Activity|Mean|42|42.0|Standard Deviation|20|20.0|||
4354536|NCT00386425|4182621|B3|||Protein C level||Percent Protein C Activity|Mean|30|30.0|Standard Deviation|18|18.0|||
4354537|NCT00386425|4182622|B2|||Protein C level||Percent Protein C Activity|Mean|41|41.0|Standard Deviation|20|20.0|||
4354538|NCT00386425|4182623|B1|||Protein C level||Percent Protein C Activity|Mean|44|44.0|Standard Deviation|19|19.0|||
4354539|NCT00386425|4182620|B4|No||Mechanical ventilation||participants|Number|106|106.0||||||
4354540|NCT00386425|4182621|B3|No||Mechanical ventilation||participants|Number|9|9.0||||||
4354541|NCT00386425|4182622|B2|No||Mechanical ventilation||participants|Number|48|48.0||||||
4354542|NCT00386425|4182623|B1|No||Mechanical ventilation||participants|Number|49|49.0||||||
4354543|NCT00386425|4182620|B4|Yes||Mechanical ventilation||participants|Number|380|380.0||||||
4354544|NCT00386425|4182621|B3|Yes||Mechanical ventilation||participants|Number|44|44.0||||||
4354545|NCT00386425|4182622|B2|Yes||Mechanical ventilation||participants|Number|158|158.0||||||
4354546|NCT00386425|4182623|B1|Yes||Mechanical ventilation||participants|Number|178|178.0||||||
4354547|NCT00386425|4182620|B4|No||Use of vasopressor||participants|Number|62|62.0||||||
4354548|NCT00386425|4182621|B3|No||Use of vasopressor||participants|Number|2|2.0||||||
4354549|NCT00386425|4182622|B2|No||Use of vasopressor||participants|Number|23|23.0||||||
4354550|NCT00386425|4182623|B1|No||Use of vasopressor||participants|Number|37|37.0||||||
4354551|NCT00386425|4182620|B4|Yes||Use of vasopressor||participants|Number|424|424.0||||||
4354552|NCT00386425|4182621|B3|Yes||Use of vasopressor||participants|Number|51|51.0||||||
4354553|NCT00386425|4182622|B2|Yes||Use of vasopressor||participants|Number|183|183.0||||||
4354554|NCT00386425|4182623|B1|Yes||Use of vasopressor||participants|Number|190|190.0||||||
4354555|NCT00386425|4182620|B4|||Acute Physiology And Chronic Health Evaluation (APACHE) II Score|Acute Physiology and Chronic Health Evaluation II. A classification system that assessed a patient’s severity of disease based on 12 physiologic measurements, age, and previous health status. Total scores range from 0 to 71. A higher score indicates increasing severity of disease and a greater likelihood of mortality.|units on a scale|Mean|26.47|26.47|Standard Deviation|7.59|7.59|||
4354556|NCT00386425|4182621|B3|||Acute Physiology And Chronic Health Evaluation (APACHE) II Score|Acute Physiology and Chronic Health Evaluation II. A classification system that assessed a patient’s severity of disease based on 12 physiologic measurements, age, and previous health status. Total scores range from 0 to 71. A higher score indicates increasing severity of disease and a greater likelihood of mortality.|units on a scale|Mean|28.26|28.26|Standard Deviation|8.05|8.05|||
4354557|NCT00386425|4182622|B2|||Acute Physiology And Chronic Health Evaluation (APACHE) II Score|Acute Physiology and Chronic Health Evaluation II. A classification system that assessed a patient’s severity of disease based on 12 physiologic measurements, age, and previous health status. Total scores range from 0 to 71. A higher score indicates increasing severity of disease and a greater likelihood of mortality.|units on a scale|Mean|26.15|26.15|Standard Deviation|7.31|7.31|||
4354558|NCT00386425|4182623|B1|||Acute Physiology And Chronic Health Evaluation (APACHE) II Score|Acute Physiology and Chronic Health Evaluation II. A classification system that assessed a patient’s severity of disease based on 12 physiologic measurements, age, and previous health status. Total scores range from 0 to 71. A higher score indicates increasing severity of disease and a greater likelihood of mortality.|units on a scale|Mean|26.34|26.34|Standard Deviation|7.70|7.7|||
4354559|NCT00386425|4182620|B4|||Total Sequential Organ Failure Assessment (SOFA) score|The presence of 5 organ dysfunctions (cardiovascular, respiratory, renal, hepatic, coagulation) was assessed using a Sequential Organ Failure Assessment (SOFA) score. Each organ has a possible dysfunction score of 0 to 4, for a total SOFA score range of 0 (no organ dysfunction) to 20 (all organs with dysfunction).|units on a scale|Mean|8.57|8.57|Standard Deviation|2.72|2.72|||
4354560|NCT00386425|4182621|B3|||Total Sequential Organ Failure Assessment (SOFA) score|The presence of 5 organ dysfunctions (cardiovascular, respiratory, renal, hepatic, coagulation) was assessed using a Sequential Organ Failure Assessment (SOFA) score. Each organ has a possible dysfunction score of 0 to 4, for a total SOFA score range of 0 (no organ dysfunction) to 20 (all organs with dysfunction).|units on a scale|Mean|9.09|9.09|Standard Deviation|2.25|2.25|||
4354579|NCT00386425|4182620|B4|Yes||Recent Surgery|Recent surgery was defined as an intervention performed under general or regional anesthesia that had some relationship to the present sepsis episode within 30 days of study entry.|participants|Number|154|154.0||||||
4354641|NCT00386425|4182622|B2|East Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4354561|NCT00386425|4182622|B2|||Total Sequential Organ Failure Assessment (SOFA) score|The presence of 5 organ dysfunctions (cardiovascular, respiratory, renal, hepatic, coagulation) was assessed using a Sequential Organ Failure Assessment (SOFA) score. Each organ has a possible dysfunction score of 0 to 4, for a total SOFA score range of 0 (no organ dysfunction) to 20 (all organs with dysfunction).|units on a scale|Mean|8.65|8.65|Standard Deviation|2.70|2.7|||
4354562|NCT00386425|4182623|B1|||Total Sequential Organ Failure Assessment (SOFA) score|The presence of 5 organ dysfunctions (cardiovascular, respiratory, renal, hepatic, coagulation) was assessed using a Sequential Organ Failure Assessment (SOFA) score. Each organ has a possible dysfunction score of 0 to 4, for a total SOFA score range of 0 (no organ dysfunction) to 20 (all organs with dysfunction).|units on a scale|Mean|8.38|8.38|Standard Deviation|2.83|2.83|||
4354563|NCT00386425|4182620|B4|||Time of onset of Second organ dysfunction to start of drug infusion|Mean time between the onset of a second organ dysfunction (cardiovascular, renal, respiratory, hematology, and unexplained metabolic acidosis) to the start of study drug infusion.|hours|Mean|15.3|15.3|Standard Deviation|7.0|7.0|||
4354564|NCT00386425|4182621|B3|||Time of onset of Second organ dysfunction to start of drug infusion|Mean time between the onset of a second organ dysfunction (cardiovascular, renal, respiratory, hematology, and unexplained metabolic acidosis) to the start of study drug infusion.|hours|Mean|15.8|15.8|Standard Deviation|7.2|7.2|||
4354565|NCT00386425|4182622|B2|||Time of onset of Second organ dysfunction to start of drug infusion|Mean time between the onset of a second organ dysfunction (cardiovascular, renal, respiratory, hematology, and unexplained metabolic acidosis) to the start of study drug infusion.|hours|Mean|15.0|15.0|Standard Deviation|7.0|7.0|||
4354566|NCT00386425|4182623|B1|||Time of onset of Second organ dysfunction to start of drug infusion|Mean time between the onset of a second organ dysfunction (cardiovascular, renal, respiratory, hematology, and unexplained metabolic acidosis) to the start of study drug infusion.|hours|Mean|15.3|15.3|Standard Deviation|7.0|7.0|||
4354567|NCT00386425|4182620|B4|||Number of organ dysfunctions|Cardiovascular: systolic blood pressure (SBP) ≤90 mmHg or mean arterial pressure (MAP) ≤70 mmHg for >1 hour despite fluid resuscitation (FR), adequate intravascular volume, or vasopressors to maintain SBP ≥90 mmHg or MAP≥70 mmHg; Renal: average output <0.5 mL/kg/hr for 1 hr despite FR; Respiratory: Pressure of Arterial Oxygen (O2) to Fractional Inspired O2 (PaO2/FiO2) ≤250; Hematology: platelet count <80,000/mm^3 or 50% decrease in count from highest over 3 days prior to study; Unexplained acidosis: pH≤7.3 or base deficit ≥5.0 mEq/L AND plasma lactate level >1.5 times upper limit of normal.|organ dysfunctions|Mean|3.10|3.1|Standard Deviation|0.86|0.86|||
4354568|NCT00386425|4182621|B3|||Number of organ dysfunctions|Cardiovascular: systolic blood pressure (SBP) ≤90 mmHg or mean arterial pressure (MAP) ≤70 mmHg for >1 hour despite fluid resuscitation (FR), adequate intravascular volume, or vasopressors to maintain SBP ≥90 mmHg or MAP≥70 mmHg; Renal: average output <0.5 mL/kg/hr for 1 hr despite FR; Respiratory: Pressure of Arterial Oxygen (O2) to Fractional Inspired O2 (PaO2/FiO2) ≤250; Hematology: platelet count <80,000/mm^3 or 50% decrease in count from highest over 3 days prior to study; Unexplained acidosis: pH≤7.3 or base deficit ≥5.0 mEq/L AND plasma lactate level >1.5 times upper limit of normal.|organ dysfunctions|Mean|3.28|3.28|Standard Deviation|0.93|0.93|||
4354569|NCT00386425|4182622|B2|||Number of organ dysfunctions|Cardiovascular: systolic blood pressure (SBP) ≤90 mmHg or mean arterial pressure (MAP) ≤70 mmHg for >1 hour despite fluid resuscitation (FR), adequate intravascular volume, or vasopressors to maintain SBP ≥90 mmHg or MAP≥70 mmHg; Renal: average output <0.5 mL/kg/hr for 1 hr despite FR; Respiratory: Pressure of Arterial Oxygen (O2) to Fractional Inspired O2 (PaO2/FiO2) ≤250; Hematology: platelet count <80,000/mm^3 or 50% decrease in count from highest over 3 days prior to study; Unexplained acidosis: pH≤7.3 or base deficit ≥5.0 mEq/L AND plasma lactate level >1.5 times upper limit of normal.|organ dysfunctions|Mean|3.08|3.08|Standard Deviation|0.84|0.84|||
4354570|NCT00386425|4182623|B1|||Number of organ dysfunctions|Cardiovascular: systolic blood pressure (SBP) ≤90 mmHg or mean arterial pressure (MAP) ≤70 mmHg for >1 hour despite fluid resuscitation (FR), adequate intravascular volume, or vasopressors to maintain SBP ≥90 mmHg or MAP≥70 mmHg; Renal: average output <0.5 mL/kg/hr for 1 hr despite FR; Respiratory: Pressure of Arterial Oxygen (O2) to Fractional Inspired O2 (PaO2/FiO2) ≤250; Hematology: platelet count <80,000/mm^3 or 50% decrease in count from highest over 3 days prior to study; Unexplained acidosis: pH≤7.3 or base deficit ≥5.0 mEq/L AND plasma lactate level >1.5 times upper limit of normal.|organ dysfunctions|Mean|3.08|3.08|Standard Deviation|0.86|0.86|||
4354571|NCT00386425|4182620|B4|Unknown||Recent Surgery|Recent surgery was defined as an intervention performed under general or regional anesthesia that had some relationship to the present sepsis episode within 30 days of study entry.|participants|Number|1|1.0||||||
4354572|NCT00386425|4182621|B3|Unknown||Recent Surgery|Recent surgery was defined as an intervention performed under general or regional anesthesia that had some relationship to the present sepsis episode within 30 days of study entry.|participants|Number|0|0.0||||||
4354573|NCT00386425|4182622|B2|Unknown||Recent Surgery|Recent surgery was defined as an intervention performed under general or regional anesthesia that had some relationship to the present sepsis episode within 30 days of study entry.|participants|Number|1|1.0||||||
4354574|NCT00386425|4182623|B1|Unknown||Recent Surgery|Recent surgery was defined as an intervention performed under general or regional anesthesia that had some relationship to the present sepsis episode within 30 days of study entry.|participants|Number|0|0.0||||||
4354575|NCT00386425|4182620|B4|No||Recent Surgery|Recent surgery was defined as an intervention performed under general or regional anesthesia that had some relationship to the present sepsis episode within 30 days of study entry.|participants|Number|331|331.0||||||
4354576|NCT00386425|4182621|B3|No||Recent Surgery|Recent surgery was defined as an intervention performed under general or regional anesthesia that had some relationship to the present sepsis episode within 30 days of study entry.|participants|Number|28|28.0||||||
4354577|NCT00386425|4182622|B2|No||Recent Surgery|Recent surgery was defined as an intervention performed under general or regional anesthesia that had some relationship to the present sepsis episode within 30 days of study entry.|participants|Number|144|144.0||||||
4354578|NCT00386425|4182623|B1|No||Recent Surgery|Recent surgery was defined as an intervention performed under general or regional anesthesia that had some relationship to the present sepsis episode within 30 days of study entry.|participants|Number|159|159.0||||||
4354640|NCT00386425|4182621|B3|East Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4354580|NCT00386425|4182621|B3|Yes||Recent Surgery|Recent surgery was defined as an intervention performed under general or regional anesthesia that had some relationship to the present sepsis episode within 30 days of study entry.|participants|Number|25|25.0||||||
4354581|NCT00386425|4182622|B2|Yes||Recent Surgery|Recent surgery was defined as an intervention performed under general or regional anesthesia that had some relationship to the present sepsis episode within 30 days of study entry.|participants|Number|61|61.0||||||
4354582|NCT00386425|4182623|B1|Yes||Recent Surgery|Recent surgery was defined as an intervention performed under general or regional anesthesia that had some relationship to the present sepsis episode within 30 days of study entry.|participants|Number|68|68.0||||||
4354583|NCT00386425|4182620|B4|United States||Region of Enrollment||participants|Number|86|86.0||||||
4354584|NCT00386425|4182621|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4354585|NCT00386425|4182622|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4354586|NCT00386425|4182623|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4354587|NCT00386425|4182620|B4|United Kingdom||Region of Enrollment||participants|Number|71|71.0||||||
4354588|NCT00386425|4182621|B3|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4354589|NCT00386425|4182622|B2|United Kingdom||Region of Enrollment||participants|Number|29|29.0||||||
4354590|NCT00386425|4182623|B1|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
4354591|NCT00386425|4182620|B4|Spain||Region of Enrollment||participants|Number|47|47.0||||||
4354592|NCT00386425|4182621|B3|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4354593|NCT00386425|4182622|B2|Spain||Region of Enrollment||participants|Number|16|16.0||||||
4354594|NCT00386425|4182623|B1|Spain||Region of Enrollment||participants|Number|19|19.0||||||
4354595|NCT00386425|4182620|B4|Puerto Rico||Region of Enrollment||participants|Number|6|6.0||||||
4354596|NCT00386425|4182621|B3|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4354597|NCT00386425|4182622|B2|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4354598|NCT00386425|4182623|B1|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4354599|NCT00386425|4182620|B4|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4354600|NCT00386425|4182621|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4354601|NCT00386425|4182622|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4354602|NCT00386425|4182623|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4354603|NCT00386425|4182620|B4|France||Region of Enrollment||participants|Number|79|79.0||||||
4354604|NCT00386425|4182621|B3|France||Region of Enrollment||participants|Number|9|9.0||||||
4354605|NCT00386425|4182622|B2|France||Region of Enrollment||participants|Number|33|33.0||||||
4354606|NCT00386425|4182623|B1|France||Region of Enrollment||participants|Number|37|37.0||||||
4354607|NCT00386425|4182620|B4|Finland||Region of Enrollment||participants|Number|61|61.0||||||
4354608|NCT00386425|4182621|B3|Finland||Region of Enrollment||participants|Number|2|2.0||||||
4354609|NCT00386425|4182622|B2|Finland||Region of Enrollment||participants|Number|30|30.0||||||
4354610|NCT00386425|4182623|B1|Finland||Region of Enrollment||participants|Number|29|29.0||||||
4354611|NCT00386425|4182620|B4|Germany||Region of Enrollment||participants|Number|27|27.0||||||
4354612|NCT00386425|4182621|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4354613|NCT00386425|4182622|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4354614|NCT00386425|4182623|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4354615|NCT00386425|4182620|B4|Canada||Region of Enrollment||participants|Number|47|47.0||||||
4354616|NCT00386425|4182621|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4354617|NCT00386425|4182622|B2|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4354618|NCT00386425|4182623|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4354619|NCT00386425|4182620|B4|Belgium||Region of Enrollment||participants|Number|56|56.0||||||
4354620|NCT00386425|4182621|B3|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4354621|NCT00386425|4182622|B2|Belgium||Region of Enrollment||participants|Number|23|23.0||||||
4354622|NCT00386425|4182623|B1|Belgium||Region of Enrollment||participants|Number|27|27.0||||||
4354623|NCT00386425|4182620|B4|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4354624|NCT00386425|4182621|B3|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4354625|NCT00386425|4182622|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4354626|NCT00386425|4182623|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4354627|NCT00386425|4182620|B4|West Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4354628|NCT00386425|4182621|B3|West Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4354629|NCT00386425|4182622|B2|West Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4354630|NCT00386425|4182623|B1|West Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354631|NCT00386425|4182620|B4|Native American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354632|NCT00386425|4182621|B3|Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4354633|NCT00386425|4182622|B2|Native American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4354634|NCT00386425|4182623|B1|Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4354635|NCT00386425|4182620|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4354636|NCT00386425|4182621|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4354637|NCT00386425|4182622|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4354638|NCT00386425|4182623|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4354639|NCT00386425|4182620|B4|East Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4354642|NCT00386425|4182623|B1|East Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4354643|NCT00386425|4182620|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|444|444.0||||||
4354644|NCT00386425|4182621|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4354645|NCT00386425|4182622|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|189|189.0||||||
4354646|NCT00386425|4182623|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|204|204.0||||||
4354647|NCT00386425|4182620|B4|African||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4354648|NCT00386425|4182621|B3|African||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4354649|NCT00386425|4182622|B2|African||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4354650|NCT00386425|4182623|B1|African||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4354651|NCT00386425|4182620|B4||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4354652|NCT00386425|4182621|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4354653|NCT00386425|4182622|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4354654|NCT00386425|4182623|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4354655|NCT00386425|4182620|B4||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4354656|NCT00386425|4182621|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4354657|NCT00386425|4182622|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4354658|NCT00386425|4182623|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4354659|NCT00386425|4182620|B4|||Age||years|Mean|62.61|62.61|Standard Deviation|15.12|15.12|||
4354660|NCT00386425|4182621|B3|||Age||years|Mean|66.63|66.63|Standard Deviation|12.82|12.82|||
4354661|NCT00386425|4182622|B2|||Age||years|Mean|61.91|61.91|Standard Deviation|14.44|14.44|||
4354662|NCT00386425|4182623|B1|||Age||years|Mean|62.31|62.31|Standard Deviation|16.11|16.11|||
4354663|NCT00386360|4182649|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4354664|NCT00386360|4182650|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4354665|NCT00386360|4182651|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4354666|NCT00386360|4182649|B3|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4354667|NCT00386360|4182650|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4354668|NCT00386360|4182651|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4354669|NCT00386360|4182649|B3|Argentina||Region of Enrollment||participants|Number|21|21.0||||||
4354670|NCT00386360|4182650|B2|Argentina||Region of Enrollment||participants|Number|15|15.0||||||
4354671|NCT00386360|4182651|B1|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
4354672|NCT00386360|4182649|B3|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
4354673|NCT00386360|4182650|B2|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
4354674|NCT00386360|4182651|B1|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4354675|NCT00386360|4182649|B3|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4354676|NCT00386360|4182650|B2|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4354677|NCT00386360|4182651|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4354678|NCT00386360|4182649|B3|Germany||Region of Enrollment||participants|Number|69|69.0||||||
4354679|NCT00386360|4182650|B2|Germany||Region of Enrollment||participants|Number|46|46.0||||||
4354680|NCT00386360|4182651|B1|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4354681|NCT00386360|4182649|B3|France||Region of Enrollment||participants|Number|33|33.0||||||
4354682|NCT00386360|4182650|B2|France||Region of Enrollment||participants|Number|24|24.0||||||
4354683|NCT00386360|4182651|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4354684|NCT00386360|4182649|B3|Multi-Racial||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4354685|NCT00386360|4182650|B2|Multi-Racial||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4354686|NCT00386360|4182651|B1|Multi-Racial||Race/Ethnicity, Customized|ITT Population|Participants|Number|0|0.0||||||
4354687|NCT00386360|4182649|B3|Hispanic||Race/Ethnicity, Customized|ITT Population|Participants|Number|2|2.0||||||
4354688|NCT00386360|4182650|B2|Hispanic||Race/Ethnicity, Customized|ITT Population|Participants|Number|2|2.0||||||
4354689|NCT00386360|4182651|B1|Hispanic||Race/Ethnicity, Customized|ITT Population|Participants|Number|0|0.0||||||
4354690|NCT00386360|4182649|B3|Caucasian||Race/Ethnicity, Customized|ITT Population|Participants|Number|155|155.0||||||
4354691|NCT00386360|4182650|B2|Caucasian||Race/Ethnicity, Customized|ITT Population|Participants|Number|107|107.0||||||
4354692|NCT00386360|4182651|B1|Caucasian||Race/Ethnicity, Customized|ITT Population|Participants|Number|48|48.0||||||
4354693|NCT00386360|4182649|B3|Asian (Oriental)||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4354694|NCT00386360|4182650|B2|Asian (Oriental)||Race/Ethnicity, Customized|ITT Population|Participants|Number|0|0.0||||||
4354695|NCT00386360|4182651|B1|Asian (Oriental)||Race/Ethnicity, Customized|ITT Population|Participants|Number|1|1.0||||||
4354696|NCT00386360|4182649|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354697|NCT00386360|4182650|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354698|NCT00386360|4182651|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354699|NCT00386360|4182649|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4354700|NCT00386360|4182650|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4354701|NCT00386360|4182651|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4354702|NCT00386360|4182649|B3|||Age|ITT Population|years|Mean|52.6|52.6|Standard Deviation|2.0|2.0|||
4354703|NCT00386360|4182650|B2|||Age|ITT Population|years|Mean|52.6|52.6|Standard Deviation|1.8|1.8|||
4354704|NCT00386360|4182651|B1|||Age|ITT Population|years|Mean|52.5|52.5|Standard Deviation|2.2|2.2|||
4354705|NCT00386334|4182684|B3|||Weight|Participant Weight in Kilograms|kilograms|Mean|76.21|76.21|Standard Deviation|16.89|16.89|||
4354706|NCT00386334|4182685|B2|||Weight|Participant Weight in Kilograms|kilograms|Mean|76.98|76.98|Standard Deviation|16.72|16.72|||
4354707|NCT00386334|4182686|B1|||Weight|Participant Weight in Kilograms|kilograms|Mean|75.44|75.44|Standard Deviation|17.07|17.07|||
4354708|NCT00386334|4182684|B3|||Height||Centimeters|Mean|165.30|165.3|Standard Deviation|9.94|9.94|||
4354709|NCT00386334|4182685|B2|||Height||Centimeters|Mean|164.70|164.7|Standard Deviation|10.04|10.04|||
4354710|NCT00386334|4182686|B1|||Height||Centimeters|Mean|165.90|165.9|Standard Deviation|9.83|9.83|||
4354711|NCT00386334|4182684|B3|||Body Mass Index (BMI)|Body mass index (BMI) is measure of body fat based on height and weight that applies to both adult men and women|Kilograms/Meters squared|Mean|27.76|27.76|Standard Deviation|4.96|4.96|||
4354712|NCT00386334|4182685|B2|||Body Mass Index (BMI)|Body mass index (BMI) is measure of body fat based on height and weight that applies to both adult men and women|Kilograms/Meters squared|Mean|28.25|28.25|Standard Deviation|4.90|4.9|||
4354713|NCT00386334|4182686|B1|||Body Mass Index (BMI)|Body mass index (BMI) is measure of body fat based on height and weight that applies to both adult men and women|Kilograms/Meters squared|Mean|27.28|27.28|Standard Deviation|4.98|4.98|||
4354714|NCT00386334|4182684|B3|United States||Region of Enrollment||participants|Number|388|388.0||||||
4354715|NCT00386334|4182685|B2|United States||Region of Enrollment||participants|Number|194|194.0||||||
4354716|NCT00386334|4182686|B1|United States||Region of Enrollment||participants|Number|194|194.0||||||
4354717|NCT00386334|4182684|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4354718|NCT00386334|4182685|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4354719|NCT00386334|4182686|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4354720|NCT00386334|4182684|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354721|NCT00386334|4182685|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354722|NCT00386334|4182686|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354723|NCT00386334|4182684|B3||White|Race (NIH/OMB)||Participants|Count of Participants|359|359.0||||||
4354724|NCT00386334|4182685|B2||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4354725|NCT00386334|4182686|B1||White|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4354726|NCT00386334|4182684|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4354727|NCT00386334|4182685|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4354728|NCT00386334|4182686|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4354729|NCT00386334|4182684|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4354730|NCT00386334|4182685|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4354731|NCT00386334|4182686|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354732|NCT00386334|4182684|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4354733|NCT00386334|4182685|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4354734|NCT00386334|4182686|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4354735|NCT00386334|4182684|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4354736|NCT00386334|4182685|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4354737|NCT00386334|4182686|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354738|NCT00386334|4182684|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4354739|NCT00386334|4182685|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4354740|NCT00386334|4182686|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4354741|NCT00386334|4182684|B3||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4354742|NCT00386334|4182685|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4354743|NCT00386334|4182686|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4354744|NCT00386334|4182684|B3|||Age||years|Mean|72.0|72.0|Standard Deviation|5.1|5.1|||
4354745|NCT00386334|4182685|B2|||Age||years|Mean|71.6|71.6|Standard Deviation|5.0|5.0|||
4354746|NCT00386334|4182686|B1|||Age||years|Mean|72.4|72.4|Standard Deviation|5.2|5.2|||
4354747|NCT00386334|4182684|B3||>=65 years|Age||Participants|Count of Participants|388|388.0||||||
4354748|NCT00386334|4182685|B2||>=65 years|Age||Participants|Count of Participants|194|194.0||||||
4354749|NCT00386334|4182686|B1||>=65 years|Age||Participants|Count of Participants|194|194.0||||||
4354750|NCT00386334|4182684|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4354751|NCT00386334|4182685|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4354752|NCT00386334|4182686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4354753|NCT00386334|4182684|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354754|NCT00386334|4182685|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354755|NCT00386334|4182686|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354756|NCT00386308|4182829|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354757|NCT00386308|4182830|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354758|NCT00386308|4182831|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354759|NCT00386308|4182829|B3||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4354760|NCT00386308|4182830|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4354761|NCT00386308|4182831|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4354762|NCT00386308|4182829|B3|||Age|Intent to Treat Population|years|Mean|39|39.0|Standard Deviation|7|7.0|||
4354763|NCT00386308|4182830|B2|||Age|Intent to Treat Population|years|Mean|39|39.0|Standard Deviation|7|7.0|||
4354764|NCT00386308|4182831|B1|||Age|Intent to Treat Population|years|Mean|39|39.0|Standard Deviation|6|6.0|||
4354765|NCT00386256|4182844|B5|United States||Region of Enrollment||participants|Number|38|38.0||||||
4354766|NCT00386256|4182845|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4354767|NCT00386256|4182846|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4354768|NCT00386256|4182847|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4354769|NCT00386256|4182848|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4354770|NCT00386256|4182844|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4354771|NCT00386256|4182845|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4354772|NCT00386256|4182846|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4354773|NCT00386256|4182847|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4354774|NCT00386256|4182848|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4354775|NCT00386256|4182844|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354776|NCT00386256|4182845|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354777|NCT00386256|4182846|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354778|NCT00386256|4182847|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354779|NCT00386256|4182848|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354780|NCT00386256|4182844|B5|||Age||years|Mean|72.2|72.2|Standard Deviation|6.6|6.6|||
4354781|NCT00386256|4182845|B4|||Age||years|Mean|76|76.0|Standard Deviation|7.5|7.5|||
4354782|NCT00386256|4182846|B3|||Age||years|Mean|78|78.0|Standard Deviation|4.7|4.7|||
4354783|NCT00386256|4182847|B2|||Age||years|Mean|65|65.0|Standard Deviation|6.1|6.1|||
4354784|NCT00386256|4182848|B1|||Age||years|Mean|69.9|69.9|Standard Deviation|7.9|7.9|||
4354785|NCT00386256|4182844|B5||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4354786|NCT00386256|4182845|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4354787|NCT00386256|4182846|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4354788|NCT00386256|4182847|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4354789|NCT00386256|4182848|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4354790|NCT00386256|4182844|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4354791|NCT00386256|4182845|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4354792|NCT00386256|4182846|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4354793|NCT00386256|4182847|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4354794|NCT00386256|4182848|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4354795|NCT00386256|4182844|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354796|NCT00386256|4182845|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354797|NCT00386256|4182846|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354798|NCT00386256|4182847|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354799|NCT00386256|4182848|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354800|NCT00386243|4182865|B3|United States||Region of Enrollment||participants|Number|242|242.0||||||
4354801|NCT00386243|4182866|B2|United States||Region of Enrollment||participants|Number|121|121.0||||||
4354802|NCT00386243|4182867|B1|United States||Region of Enrollment||participants|Number|121|121.0||||||
4354803|NCT00386243|4182865|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4354804|NCT00386243|4182866|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4354805|NCT00386243|4182867|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4354806|NCT00386243|4182865|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4354807|NCT00386243|4182866|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4354808|NCT00386243|4182867|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4354809|NCT00386243|4182865|B3|||Age||years|Mean|36.7|36.7|Standard Deviation|10.3|10.3|||
4354810|NCT00386243|4182866|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|10.1|10.1|||
4354811|NCT00386243|4182867|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|10.5|10.5|||
4354812|NCT00386243|4182865|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4354813|NCT00386243|4182866|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4354814|NCT00386243|4182867|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4354815|NCT00386243|4182865|B3||Between 18 and 65 years|Age||Participants|Count of Participants|241|241.0||||||
4354816|NCT00386243|4182866|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4354817|NCT00386243|4182867|B1||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4354818|NCT00386243|4182865|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354819|NCT00386243|4182866|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354820|NCT00386243|4182867|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354821|NCT00386152|4182876|B4|Non-Platinum||Chemotherapy Type|Randomization was stratified by chemotherapy type.|participants|Number|144|144.0||||||
4354822|NCT00386152|4182877|B3|Non-Platinum||Chemotherapy Type|Randomization was stratified by chemotherapy type.|participants|Number|48|48.0||||||
4354823|NCT00386152|4182878|B2|Non-Platinum||Chemotherapy Type|Randomization was stratified by chemotherapy type.|participants|Number|48|48.0||||||
4354824|NCT00386152|4182879|B1|Non-Platinum||Chemotherapy Type|Randomization was stratified by chemotherapy type.|participants|Number|48|48.0||||||
4354825|NCT00386152|4182876|B4|Platinum||Chemotherapy Type|Randomization was stratified by chemotherapy type.|participants|Number|91|91.0||||||
4354826|NCT00386152|4182877|B3|Platinum||Chemotherapy Type|Randomization was stratified by chemotherapy type.|participants|Number|30|30.0||||||
4354827|NCT00386152|4182878|B2|Platinum||Chemotherapy Type|Randomization was stratified by chemotherapy type.|participants|Number|32|32.0||||||
4354828|NCT00386152|4182879|B1|Platinum||Chemotherapy Type|Randomization was stratified by chemotherapy type.|participants|Number|29|29.0||||||
4354829|NCT00386152|4182876|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4354830|NCT00386152|4182877|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4354831|NCT00386152|4182878|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4354832|NCT00386152|4182879|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4354833|NCT00386152|4182876|B4||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4354834|NCT00386152|4182877|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4354835|NCT00386152|4182878|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4354836|NCT00386152|4182879|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4354837|NCT00386152|4182876|B4|||Age||years|Mean|64.30|64.3|Standard Deviation|12.07|12.07|||
4354838|NCT00386152|4182877|B3|||Age||years|Mean|63.00|63.0|Standard Deviation|12.05|12.05|||
4354839|NCT00386152|4182878|B2|||Age||years|Mean|64.84|64.84|Standard Deviation|11.66|11.66|||
4354840|NCT00386152|4182879|B1|||Age||years|Mean|65.05|65.05|Standard Deviation|12.54|12.54|||
4354841|NCT00386152|4182876|B4||>=65 years|Age||Participants|Count of Participants|124|124.0||||||
4354842|NCT00386152|4182877|B3||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4354843|NCT00386152|4182878|B2||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4354844|NCT00386152|4182879|B1||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4354845|NCT00386152|4182876|B4||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4354846|NCT00386152|4182877|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4354847|NCT00386152|4182878|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4354848|NCT00386152|4182879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4354849|NCT00386152|4182876|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354850|NCT00386152|4182877|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354851|NCT00386152|4182878|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354852|NCT00386152|4182879|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4354853|NCT00386100|4182898|B3|||Duration of Diabetes|The Safety Population, comprised of all participants who were randomized and received at least one dose of the study medication, was used for all baseline characteristics.|years|Mean|2.429|2.429|Standard Deviation|3.1729|3.1729|||
4354854|NCT00386100|4182899|B2|||Duration of Diabetes|The Safety Population, comprised of all participants who were randomized and received at least one dose of the study medication, was used for all baseline characteristics.|years|Mean|2.293|2.293|Standard Deviation|3.0774|3.0774|||
4354855|NCT00386100|4182900|B1|||Duration of Diabetes|The Safety Population, comprised of all participants who were randomized and received at least one dose of the study medication, was used for all baseline characteristics.|years|Mean|2.570|2.57|Standard Deviation|3.2671|3.2671|||
4354856|NCT00386100|4182898|B3|Not Specified||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4354857|NCT00386100|4182899|B2|Not Specified||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4354858|NCT00386100|4182900|B1|Not Specified||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4354859|NCT00386100|4182898|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4354860|NCT00386100|4182899|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4354861|NCT00386100|4182900|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4354862|NCT00386100|4182898|B3|White – White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|368|368.0||||||
4354863|NCT00386100|4182899|B2|White – White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|183|183.0||||||
4354864|NCT00386100|4182900|B1|White – White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|185|185.0||||||
4354865|NCT00386100|4182898|B3|White – Arabic/North African||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4354866|NCT00386100|4182899|B2|White – Arabic/North African||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4354867|NCT00386100|4182900|B1|White – Arabic/North African||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4354868|NCT00386100|4182898|B3|Asian – South East Asian||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4354869|NCT00386100|4182899|B2|Asian – South East Asian||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4354870|NCT00386100|4182900|B1|Asian – South East Asian||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4354871|NCT00386100|4182898|B3|Asian – Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4354872|NCT00386100|4182899|B2|Asian – Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4354873|NCT00386100|4182900|B1|Asian – Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4354874|NCT00386100|4182898|B3|Asian – East Asian||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4354875|NCT00386100|4182899|B2|Asian – East Asian||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4354876|NCT00386100|4182900|B1|Asian – East Asian||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4354877|NCT00386100|4182898|B3|Asian – Central/South Asian||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4354878|NCT00386100|4182899|B2|Asian – Central/South Asian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4354879|NCT00386100|4182900|B1|Asian – Central/South Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4354880|NCT00386100|4182898|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4354881|NCT00386100|4182899|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4354882|NCT00386100|4182900|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4354883|NCT00386100|4182898|B3|African America/African||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4354884|NCT00386100|4182899|B2|African America/African||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4354885|NCT00386100|4182900|B1|African America/African||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4354886|NCT00386100|4182898|B3||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4354887|NCT00386100|4182899|B2||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4354888|NCT00386100|4182900|B1||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4354889|NCT00386100|4182898|B3||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4354890|NCT00386100|4182899|B2||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4354891|NCT00386100|4182900|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4354892|NCT00386100|4182898|B3|||Age|The Safety Population, comprised of all participants who were randomized and received at least one dose of the study medication, was used for all baseline characteristics.|years|Mean|51.1|51.1|Standard Deviation|10.50|10.5|||
4354893|NCT00386100|4182899|B2|||Age|The Safety Population, comprised of all participants who were randomized and received at least one dose of the study medication, was used for all baseline characteristics.|years|Mean|51.5|51.5|Standard Deviation|10.52|10.52|||
4354894|NCT00386100|4182900|B1|||Age|The Safety Population, comprised of all participants who were randomized and received at least one dose of the study medication, was used for all baseline characteristics.|years|Mean|50.7|50.7|Standard Deviation|10.49|10.49|||
4354895|NCT00386022|4182963|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4354896|NCT00386022|4182964|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4354897|NCT00386022|4182965|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4354898|NCT00386022|4182963|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354899|NCT00386022|4182964|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354900|NCT00386022|4182965|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354901|NCT00386022|4182963|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354902|NCT00386022|4182964|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354903|NCT00386022|4182965|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354904|NCT00386022|4182963|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4354905|NCT00386022|4182964|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4354906|NCT00386022|4182965|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4354907|NCT00386022|4182963|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4354908|NCT00386022|4182964|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354909|NCT00386022|4182965|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4354910|NCT00386022|4182963|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354911|NCT00386022|4182964|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354912|NCT00386022|4182965|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354913|NCT00386022|4182963|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354914|NCT00386022|4182964|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354915|NCT00386022|4182965|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354916|NCT00386022|4182963|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354917|NCT00386022|4182964|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354918|NCT00386022|4182965|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4354919|NCT00386022|4182963|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354920|NCT00386022|4182964|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354921|NCT00386022|4182965|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4354922|NCT00386022|4182963|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4354923|NCT00386022|4182964|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4354924|NCT00386022|4182965|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4354925|NCT00386022|4182963|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|10.6|10.6|||
4354926|NCT00386022|4182964|B2|||Age||years|Mean|72.8|72.8|Standard Deviation|2.88|2.88|||
4354927|NCT00386022|4182965|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|2.46|2.46|||
4354928|NCT00386009|4182974|B3|||Prostate Specific Antigen (PSA)||nanograms per milliliter|Mean|1.55|1.55|Standard Deviation|1.13|1.13|||
4354929|NCT00386009|4182975|B2|||Prostate Specific Antigen (PSA)||nanograms per milliliter|Mean|1.51|1.51|Standard Deviation|1.14|1.14|||
4354930|NCT00386009|4182976|B1|||Prostate Specific Antigen (PSA)||nanograms per milliliter|Mean|1.60|1.6|Standard Deviation|1.13|1.13|||
4354931|NCT00386009|4182974|B3|||Postvoid Residual Volume by Ultrasound||milliliters|Mean|52.51|52.51|Standard Deviation|55.82|55.82|||
4354932|NCT00386009|4182975|B2|||Postvoid Residual Volume by Ultrasound||milliliters|Mean|45.65|45.65|Standard Deviation|49.58|49.58|||
4354933|NCT00386009|4182976|B1|||Postvoid Residual Volume by Ultrasound||milliliters|Mean|59.30|59.3|Standard Deviation|60.87|60.87|||
4354934|NCT00386009|4182974|B3|||Height||centimeters|Mean|178.07|178.07|Standard Deviation|7.79|7.79|||
4354935|NCT00386009|4182975|B2|||Height||centimeters|Mean|178.58|178.58|Standard Deviation|7.50|7.5|||
4354936|NCT00386009|4182976|B1|||Height||centimeters|Mean|177.56|177.56|Standard Deviation|8.07|8.07|||
4354937|NCT00386009|4182974|B3|||Body Weight||kilograms|Mean|93.42|93.42|Standard Deviation|16.49|16.49|||
4354938|NCT00386009|4182975|B2|||Body Weight||kilograms|Mean|93.90|93.9|Standard Deviation|16.49|16.49|||
4354939|NCT00386009|4182976|B1|||Body Weight||kilograms|Mean|92.94|92.94|Standard Deviation|16.55|16.55|||
4354940|NCT00386009|4182974|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square centimeters (kg/cm^2)|Mean|29.45|29.45|Standard Deviation|4.69|4.69|||
4354941|NCT00386009|4182975|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square centimeters (kg/cm^2)|Mean|29.45|29.45|Standard Deviation|4.93|4.93|||
4354942|NCT00386009|4182976|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square centimeters (kg/cm^2)|Mean|29.44|29.44|Standard Deviation|4.47|4.47|||
4354943|NCT00386009|4182974|B3|White||Race/Ethnicity||participants|Number|153|153.0||||||
4354944|NCT00386009|4182975|B2|White||Race/Ethnicity||participants|Number|75|75.0||||||
4354945|NCT00386009|4182976|B1|White||Race/Ethnicity||participants|Number|78|78.0||||||
4354946|NCT00386009|4182974|B3|Hispanic or Latino||Race/Ethnicity||participants|Number|16|16.0||||||
4354947|NCT00386009|4182975|B2|Hispanic or Latino||Race/Ethnicity||participants|Number|8|8.0||||||
4354948|NCT00386009|4182976|B1|Hispanic or Latino||Race/Ethnicity||participants|Number|8|8.0||||||
4354949|NCT00386009|4182974|B3|Black or African American||Race/Ethnicity||participants|Number|25|25.0||||||
4354950|NCT00386009|4182975|B2|Black or African American||Race/Ethnicity||participants|Number|13|13.0||||||
4354951|NCT00386009|4182976|B1|Black or African American||Race/Ethnicity||participants|Number|12|12.0||||||
4354952|NCT00386009|4182974|B3|Asian||Race/Ethnicity||participants|Number|5|5.0||||||
4354953|NCT00386009|4182975|B2|Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4354954|NCT00386009|4182976|B1|Asian||Race/Ethnicity||participants|Number|3|3.0||||||
4354955|NCT00386009|4182974|B3|American Indian or Alaska Native||Race/Ethnicity||participants|Number|1|1.0||||||
4354956|NCT00386009|4182975|B2|American Indian or Alaska Native||Race/Ethnicity||participants|Number|1|1.0||||||
4354957|NCT00386009|4182976|B1|American Indian or Alaska Native||Race/Ethnicity||participants|Number|0|0.0||||||
4354958|NCT00386009|4182974|B3|No||Previous Therapy for Benign Prostatic Hyperplasia||participants|Number|137|137.0||||||
4354959|NCT00386009|4182975|B2|No||Previous Therapy for Benign Prostatic Hyperplasia||participants|Number|70|70.0||||||
4354960|NCT00386009|4182976|B1|No||Previous Therapy for Benign Prostatic Hyperplasia||participants|Number|67|67.0||||||
4354961|NCT00386009|4182974|B3|Yes||Previous Therapy for Benign Prostatic Hyperplasia||participants|Number|63|63.0||||||
4354962|NCT00386009|4182975|B2|Yes||Previous Therapy for Benign Prostatic Hyperplasia||participants|Number|29|29.0||||||
4354963|NCT00386009|4182976|B1|Yes||Previous Therapy for Benign Prostatic Hyperplasia||participants|Number|34|34.0||||||
4354964|NCT00386009|4182974|B3|No||Previous Alpha-Blocker Therapy||participants|Number|157|157.0||||||
4354965|NCT00386009|4182975|B2|No||Previous Alpha-Blocker Therapy||participants|Number|78|78.0||||||
4354966|NCT00386009|4182976|B1|No||Previous Alpha-Blocker Therapy||participants|Number|79|79.0||||||
4354967|NCT00386009|4182974|B3|Yes||Previous Alpha-Blocker Therapy||participants|Number|43|43.0||||||
4354968|NCT00386009|4182975|B2|Yes||Previous Alpha-Blocker Therapy||participants|Number|21|21.0||||||
4354969|NCT00386009|4182976|B1|Yes||Previous Alpha-Blocker Therapy||participants|Number|22|22.0||||||
4354970|NCT00386009|4182974|B3|No||Presence of Erectile Dysfunction||participants|Number|82|82.0||||||
4354971|NCT00386009|4182975|B2|No||Presence of Erectile Dysfunction||participants|Number|41|41.0||||||
4354972|NCT00386009|4182976|B1|No||Presence of Erectile Dysfunction||participants|Number|41|41.0||||||
4354973|NCT00386009|4182974|B3|Yes||Presence of Erectile Dysfunction||participants|Number|118|118.0||||||
4354974|NCT00386009|4182975|B2|Yes||Presence of Erectile Dysfunction||participants|Number|58|58.0||||||
4354975|NCT00386009|4182976|B1|Yes||Presence of Erectile Dysfunction||participants|Number|60|60.0||||||
4354976|NCT00386009|4182974|B3|Severe||Erectile Dysfunction Severity|This measure is only for participants who have Erectile Dysfunction.|participants|Number|14|14.0||||||
4354977|NCT00386009|4182975|B2|Severe||Erectile Dysfunction Severity|This measure is only for participants who have Erectile Dysfunction.|participants|Number|5|5.0||||||
4354978|NCT00386009|4182976|B1|Severe||Erectile Dysfunction Severity|This measure is only for participants who have Erectile Dysfunction.|participants|Number|9|9.0||||||
4354979|NCT00386009|4182974|B3|Moderate||Erectile Dysfunction Severity|This measure is only for participants who have Erectile Dysfunction.|participants|Number|62|62.0||||||
4354980|NCT00386009|4182975|B2|Moderate||Erectile Dysfunction Severity|This measure is only for participants who have Erectile Dysfunction.|participants|Number|31|31.0||||||
4354981|NCT00386009|4182976|B1|Moderate||Erectile Dysfunction Severity|This measure is only for participants who have Erectile Dysfunction.|participants|Number|31|31.0||||||
4355127|NCT00385801|4183143|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4354982|NCT00386009|4182974|B3|Mild||Erectile Dysfunction Severity|This measure is only for participants who have Erectile Dysfunction.|participants|Number|42|42.0||||||
4354983|NCT00386009|4182975|B2|Mild||Erectile Dysfunction Severity|This measure is only for participants who have Erectile Dysfunction.|participants|Number|22|22.0||||||
4354984|NCT00386009|4182976|B1|Mild||Erectile Dysfunction Severity|This measure is only for participants who have Erectile Dysfunction.|participants|Number|20|20.0||||||
4354985|NCT00386009|4182974|B3|> 3 years||Duration of Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms (BPH LUTS)||participants|Number|109|109.0||||||
4354986|NCT00386009|4182975|B2|> 3 years||Duration of Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms (BPH LUTS)||participants|Number|57|57.0||||||
4354987|NCT00386009|4182976|B1|> 3 years||Duration of Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms (BPH LUTS)||participants|Number|52|52.0||||||
4354988|NCT00386009|4182974|B3|1 year to 3 years||Duration of Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms (BPH LUTS)||participants|Number|66|66.0||||||
4354989|NCT00386009|4182975|B2|1 year to 3 years||Duration of Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms (BPH LUTS)||participants|Number|30|30.0||||||
4354990|NCT00386009|4182976|B1|1 year to 3 years||Duration of Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms (BPH LUTS)||participants|Number|36|36.0||||||
4354991|NCT00386009|4182974|B3|6 months to 1 year||Duration of Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms (BPH LUTS)||participants|Number|25|25.0||||||
4354992|NCT00386009|4182975|B2|6 months to 1 year||Duration of Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms (BPH LUTS)||participants|Number|12|12.0||||||
4354993|NCT00386009|4182976|B1|6 months to 1 year||Duration of Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms (BPH LUTS)||participants|Number|13|13.0||||||
4354994|NCT00386009|4182974|B3|Unobstructed (BOOI < 20)||Bladder Outlet Obstruction Index (BOOI)|BOOI, or bladder outlet obstruction index, which is derived from the equation: pdetQmax-2Qmax (where pdetQmax is detrusor pressure at peak urinary flow rate and Qmax is defined as the peak urine flow rate).|participants|Number|64|64.0||||||
4354995|NCT00386009|4182975|B2|Unobstructed (BOOI < 20)||Bladder Outlet Obstruction Index (BOOI)|BOOI, or bladder outlet obstruction index, which is derived from the equation: pdetQmax-2Qmax (where pdetQmax is detrusor pressure at peak urinary flow rate and Qmax is defined as the peak urine flow rate).|participants|Number|31|31.0||||||
4354996|NCT00386009|4182976|B1|Unobstructed (BOOI < 20)||Bladder Outlet Obstruction Index (BOOI)|BOOI, or bladder outlet obstruction index, which is derived from the equation: pdetQmax-2Qmax (where pdetQmax is detrusor pressure at peak urinary flow rate and Qmax is defined as the peak urine flow rate).|participants|Number|33|33.0||||||
4354997|NCT00386009|4182974|B3|Equivocal (BOOI 20-40)||Bladder Outlet Obstruction Index (BOOI)|BOOI, or bladder outlet obstruction index, which is derived from the equation: pdetQmax-2Qmax (where pdetQmax is detrusor pressure at peak urinary flow rate and Qmax is defined as the peak urine flow rate).|participants|Number|69|69.0||||||
4354998|NCT00386009|4182975|B2|Equivocal (BOOI 20-40)||Bladder Outlet Obstruction Index (BOOI)|BOOI, or bladder outlet obstruction index, which is derived from the equation: pdetQmax-2Qmax (where pdetQmax is detrusor pressure at peak urinary flow rate and Qmax is defined as the peak urine flow rate).|participants|Number|34|34.0||||||
4354999|NCT00386009|4182976|B1|Equivocal (BOOI 20-40)||Bladder Outlet Obstruction Index (BOOI)|BOOI, or bladder outlet obstruction index, which is derived from the equation: pdetQmax-2Qmax (where pdetQmax is detrusor pressure at peak urinary flow rate and Qmax is defined as the peak urine flow rate).|participants|Number|35|35.0||||||
4355000|NCT00386009|4182974|B3|Obstructed (BOOI > 40)||Bladder Outlet Obstruction Index (BOOI)|BOOI, or bladder outlet obstruction index, which is derived from the equation: pdetQmax-2Qmax (where pdetQmax is detrusor pressure at peak urinary flow rate and Qmax is defined as the peak urine flow rate).|participants|Number|67|67.0||||||
4355001|NCT00386009|4182975|B2|Obstructed (BOOI > 40)||Bladder Outlet Obstruction Index (BOOI)|BOOI, or bladder outlet obstruction index, which is derived from the equation: pdetQmax-2Qmax (where pdetQmax is detrusor pressure at peak urinary flow rate and Qmax is defined as the peak urine flow rate).|participants|Number|34|34.0||||||
4355002|NCT00386009|4182976|B1|Obstructed (BOOI > 40)||Bladder Outlet Obstruction Index (BOOI)|BOOI, or bladder outlet obstruction index, which is derived from the equation: pdetQmax-2Qmax (where pdetQmax is detrusor pressure at peak urinary flow rate and Qmax is defined as the peak urine flow rate).|participants|Number|33|33.0||||||
4355003|NCT00386009|4182974|B3|Missing Baseline Measure||Baseline Benign Prostatic Hyperplasia (BPH) Lower Urinary Tract Symptom (LUTS) Severity|Severity was determined by the International Prostate Symptom Score (IPSS)Total. The IPSS is obtained by combining the scores of the responses to the 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|3|3.0||||||
4355004|NCT00386009|4182975|B2|Missing Baseline Measure||Baseline Benign Prostatic Hyperplasia (BPH) Lower Urinary Tract Symptom (LUTS) Severity|Severity was determined by the International Prostate Symptom Score (IPSS)Total. The IPSS is obtained by combining the scores of the responses to the 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|2|2.0||||||
4355005|NCT00386009|4182976|B1|Missing Baseline Measure||Baseline Benign Prostatic Hyperplasia (BPH) Lower Urinary Tract Symptom (LUTS) Severity|Severity was determined by the International Prostate Symptom Score (IPSS)Total. The IPSS is obtained by combining the scores of the responses to the 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|1|1.0||||||
4355006|NCT00386009|4182974|B3|Severe (IPSS ≥20)||Baseline Benign Prostatic Hyperplasia (BPH) Lower Urinary Tract Symptom (LUTS) Severity|Severity was determined by the International Prostate Symptom Score (IPSS)Total. The IPSS is obtained by combining the scores of the responses to the 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|128|128.0||||||
4355128|NCT00385801|4183141|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355129|NCT00385801|4183142|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355007|NCT00386009|4182975|B2|Severe (IPSS ≥20)||Baseline Benign Prostatic Hyperplasia (BPH) Lower Urinary Tract Symptom (LUTS) Severity|Severity was determined by the International Prostate Symptom Score (IPSS)Total. The IPSS is obtained by combining the scores of the responses to the 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|62|62.0||||||
4355008|NCT00386009|4182976|B1|Severe (IPSS ≥20)||Baseline Benign Prostatic Hyperplasia (BPH) Lower Urinary Tract Symptom (LUTS) Severity|Severity was determined by the International Prostate Symptom Score (IPSS)Total. The IPSS is obtained by combining the scores of the responses to the 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|66|66.0||||||
4355009|NCT00386009|4182974|B3|Moderate (IPSS <20)||Baseline Benign Prostatic Hyperplasia (BPH) Lower Urinary Tract Symptom (LUTS) Severity|Severity was determined by the International Prostate Symptom Score (IPSS)Total. The IPSS is obtained by combining the scores of the responses to the 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|69|69.0||||||
4355010|NCT00386009|4182975|B2|Moderate (IPSS <20)||Baseline Benign Prostatic Hyperplasia (BPH) Lower Urinary Tract Symptom (LUTS) Severity|Severity was determined by the International Prostate Symptom Score (IPSS)Total. The IPSS is obtained by combining the scores of the responses to the 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|35|35.0||||||
4355011|NCT00386009|4182976|B1|Moderate (IPSS <20)||Baseline Benign Prostatic Hyperplasia (BPH) Lower Urinary Tract Symptom (LUTS) Severity|Severity was determined by the International Prostate Symptom Score (IPSS)Total. The IPSS is obtained by combining the scores of the responses to the 7 component questions. Each question is scored from 0-5 for an IPSS range of 0-35 points; higher numerical scores from the IPSS questionnaire represent greater severity of symptoms.|participants|Number|34|34.0||||||
4355012|NCT00386009|4182974|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4355013|NCT00386009|4182975|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4355014|NCT00386009|4182976|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4355015|NCT00386009|4182974|B3|United States||Region of Enrollment||participants|Number|194|194.0||||||
4355016|NCT00386009|4182975|B2|United States||Region of Enrollment||participants|Number|95|95.0||||||
4355017|NCT00386009|4182976|B1|United States||Region of Enrollment||participants|Number|99|99.0||||||
4355018|NCT00386009|4182974|B3||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4355019|NCT00386009|4182975|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4355020|NCT00386009|4182976|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4355021|NCT00386009|4182974|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355022|NCT00386009|4182975|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355023|NCT00386009|4182976|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355024|NCT00386009|4182974|B3|||Age||years|Mean|58.60|58.6|Standard Deviation|9.26|9.26|||
4355025|NCT00386009|4182975|B2|||Age||years|Mean|58.16|58.16|Standard Deviation|8.82|8.82|||
4355026|NCT00386009|4182976|B1|||Age||years|Mean|59.03|59.03|Standard Deviation|9.69|9.69|||
4355027|NCT00385996|4183015|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4355028|NCT00385996|4183015|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4355029|NCT00385996|4183015|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4355030|NCT00385996|4183015|B1|||Age||years|Median|71|71.0|Full Range|||56.0|82.0|
4355031|NCT00385944|4183022|B3|France||Region of Enrollment||participants|Number|56|56.0||||||
4355032|NCT00385944|4183023|B2|France||Region of Enrollment||participants|Number|27|27.0||||||
4355033|NCT00385944|4183024|B1|France||Region of Enrollment||participants|Number|29|29.0||||||
4355034|NCT00385944|4183022|B3|African||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4355035|NCT00385944|4183023|B2|African||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4355036|NCT00385944|4183024|B1|African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4355037|NCT00385944|4183022|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
4355038|NCT00385944|4183023|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4355039|NCT00385944|4183024|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4355040|NCT00385944|4183022|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4355041|NCT00385944|4183023|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4355042|NCT00385944|4183024|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4355043|NCT00385944|4183022|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4355044|NCT00385944|4183023|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4355045|NCT00385944|4183024|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4355046|NCT00385944|4183022|B3|||Age||years|Mean|61|61.0|Standard Deviation|12.4|12.4|||
4355047|NCT00385944|4183023|B2|||Age||years|Mean|58|58.0|Standard Deviation|10.7|10.7|||
4355048|NCT00385944|4183024|B1|||Age||years|Mean|63|63.0|Standard Deviation|13.7|13.7|||
4355049|NCT00385918|4183067|B3|Paraplegia||Impairment Function|"Tetraplegia- refers to impairment or loss of function in the cervical region with an effect to the upper and lower extremity~Paraplegia- impairment or loss of function to the thoracic, lumbar, or sacral regions with an effect to the lower extremity"|participants|Number|4|4.0||||||
4355130|NCT00385801|4183143|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355131|NCT00385801|4183141|B3|||Age||years|Mean|43|43.0|Standard Deviation|6.1|6.1|||
4355050|NCT00385918|4183068|B2|Paraplegia||Impairment Function|"Tetraplegia- refers to impairment or loss of function in the cervical region with an effect to the upper and lower extremity~Paraplegia- impairment or loss of function to the thoracic, lumbar, or sacral regions with an effect to the lower extremity"|participants|Number|0|0.0||||||
4355051|NCT00385918|4183069|B1|Paraplegia||Impairment Function|"Tetraplegia- refers to impairment or loss of function in the cervical region with an effect to the upper and lower extremity~Paraplegia- impairment or loss of function to the thoracic, lumbar, or sacral regions with an effect to the lower extremity"|participants|Number|4|4.0||||||
4355052|NCT00385918|4183067|B3|Tetraplegia||Impairment Function|"Tetraplegia- refers to impairment or loss of function in the cervical region with an effect to the upper and lower extremity~Paraplegia- impairment or loss of function to the thoracic, lumbar, or sacral regions with an effect to the lower extremity"|participants|Number|14|14.0||||||
4355053|NCT00385918|4183068|B2|Tetraplegia||Impairment Function|"Tetraplegia- refers to impairment or loss of function in the cervical region with an effect to the upper and lower extremity~Paraplegia- impairment or loss of function to the thoracic, lumbar, or sacral regions with an effect to the lower extremity"|participants|Number|6|6.0||||||
4355054|NCT00385918|4183069|B1|Tetraplegia||Impairment Function|"Tetraplegia- refers to impairment or loss of function in the cervical region with an effect to the upper and lower extremity~Paraplegia- impairment or loss of function to the thoracic, lumbar, or sacral regions with an effect to the lower extremity"|participants|Number|8|8.0||||||
4355055|NCT00385918|4183067|B3|ASIA impairment D||ASIA Impairment Scale|"American Spinal Injury Association (ASIA) Impairment Scale is used to grade the degree of sensory & motor impairment.~ASIA impairment scale C- motor function preserved below the neurological level with > half of the key muscles below the neurological level displaying a grade of less than 3 on a 5-pt scale.~ASIA impairment scale D- motor function is preserved below the neurological level with at least half of the key muscles below the neurological level displaying a grade of 3 or more on the 5-pt scale.~for neurological level see: http://asia-spinalinjury.org/elearning/ASIA_ISCOS_high.pdf"|participants|Number|16|16.0||||||
4355056|NCT00385918|4183068|B2|ASIA impairment D||ASIA Impairment Scale|"American Spinal Injury Association (ASIA) Impairment Scale is used to grade the degree of sensory & motor impairment.~ASIA impairment scale C- motor function preserved below the neurological level with > half of the key muscles below the neurological level displaying a grade of less than 3 on a 5-pt scale.~ASIA impairment scale D- motor function is preserved below the neurological level with at least half of the key muscles below the neurological level displaying a grade of 3 or more on the 5-pt scale.~for neurological level see: http://asia-spinalinjury.org/elearning/ASIA_ISCOS_high.pdf"|participants|Number|6|6.0||||||
4355057|NCT00385918|4183069|B1|ASIA impairment D||ASIA Impairment Scale|"American Spinal Injury Association (ASIA) Impairment Scale is used to grade the degree of sensory & motor impairment.~ASIA impairment scale C- motor function preserved below the neurological level with > half of the key muscles below the neurological level displaying a grade of less than 3 on a 5-pt scale.~ASIA impairment scale D- motor function is preserved below the neurological level with at least half of the key muscles below the neurological level displaying a grade of 3 or more on the 5-pt scale.~for neurological level see: http://asia-spinalinjury.org/elearning/ASIA_ISCOS_high.pdf"|participants|Number|10|10.0||||||
4355058|NCT00385918|4183067|B3|ASIA impairment C||ASIA Impairment Scale|"American Spinal Injury Association (ASIA) Impairment Scale is used to grade the degree of sensory & motor impairment.~ASIA impairment scale C- motor function preserved below the neurological level with > half of the key muscles below the neurological level displaying a grade of less than 3 on a 5-pt scale.~ASIA impairment scale D- motor function is preserved below the neurological level with at least half of the key muscles below the neurological level displaying a grade of 3 or more on the 5-pt scale.~for neurological level see: http://asia-spinalinjury.org/elearning/ASIA_ISCOS_high.pdf"|participants|Number|2|2.0||||||
4355059|NCT00385918|4183068|B2|ASIA impairment C||ASIA Impairment Scale|"American Spinal Injury Association (ASIA) Impairment Scale is used to grade the degree of sensory & motor impairment.~ASIA impairment scale C- motor function preserved below the neurological level with > half of the key muscles below the neurological level displaying a grade of less than 3 on a 5-pt scale.~ASIA impairment scale D- motor function is preserved below the neurological level with at least half of the key muscles below the neurological level displaying a grade of 3 or more on the 5-pt scale.~for neurological level see: http://asia-spinalinjury.org/elearning/ASIA_ISCOS_high.pdf"|participants|Number|0|0.0||||||
4355060|NCT00385918|4183069|B1|ASIA impairment C||ASIA Impairment Scale|"American Spinal Injury Association (ASIA) Impairment Scale is used to grade the degree of sensory & motor impairment.~ASIA impairment scale C- motor function preserved below the neurological level with > half of the key muscles below the neurological level displaying a grade of less than 3 on a 5-pt scale.~ASIA impairment scale D- motor function is preserved below the neurological level with at least half of the key muscles below the neurological level displaying a grade of 3 or more on the 5-pt scale.~for neurological level see: http://asia-spinalinjury.org/elearning/ASIA_ISCOS_high.pdf"|participants|Number|2|2.0||||||
4355061|NCT00385918|4183067|B3|||Body Mass|Body mass was determined from a DXA (dual energy x-ray absorptiometry) assessment prior to the 3-month intervention.|kg|Mean|85.3|85.3|Standard Deviation|19.1|19.1|||
4355062|NCT00385918|4183068|B2|||Body Mass|Body mass was determined from a DXA (dual energy x-ray absorptiometry) assessment prior to the 3-month intervention.|kg|Mean|94.3|94.3|Standard Deviation|25.0|25.0|||
4355063|NCT00385918|4183069|B1|||Body Mass|Body mass was determined from a DXA (dual energy x-ray absorptiometry) assessment prior to the 3-month intervention.|kg|Mean|80.8|80.8|Standard Deviation|14.6|14.6|||
4355064|NCT00385918|4183067|B3|||Lower Extremity Motor Score|The motor score assigned to the five key bi-lateral lower extremity muscle groups with values ranging from 0 (total paralysis) to 5 (normal) function for each muscle. Because 10 muscles are being tested (5 in each leg), the total possible motor score is 50.|units on a scale|Mean|34.8|34.8|Standard Deviation|10.3|10.3|||
4355065|NCT00385918|4183068|B2|||Lower Extremity Motor Score|The motor score assigned to the five key bi-lateral lower extremity muscle groups with values ranging from 0 (total paralysis) to 5 (normal) function for each muscle. Because 10 muscles are being tested (5 in each leg), the total possible motor score is 50.|units on a scale|Mean|36.2|36.2|Standard Deviation|8.4|8.4|||
4355132|NCT00385801|4183142|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|5.9|5.9|||
4355133|NCT00385801|4183143|B1|||Age||years|Mean|42.4|42.4|Standard Deviation|6.4|6.4|||
4355066|NCT00385918|4183069|B1|||Lower Extremity Motor Score|The motor score assigned to the five key bi-lateral lower extremity muscle groups with values ranging from 0 (total paralysis) to 5 (normal) function for each muscle. Because 10 muscles are being tested (5 in each leg), the total possible motor score is 50.|units on a scale|Mean|34.2|34.2|Standard Deviation|11.5|11.5|||
4355067|NCT00385918|4183067|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4355068|NCT00385918|4183068|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4355069|NCT00385918|4183069|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4355070|NCT00385918|4183067|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4355071|NCT00385918|4183068|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355072|NCT00385918|4183069|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4355073|NCT00385918|4183067|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|13.2|13.2|||
4355074|NCT00385918|4183068|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|15.4|15.4|||
4355075|NCT00385918|4183069|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|12.7|12.7|||
4355076|NCT00385840|4183093|B3||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4355077|NCT00385840|4183094|B2||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4355078|NCT00385840|4183095|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4355079|NCT00385840|4183093|B3||Female|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4355080|NCT00385840|4183094|B2||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4355081|NCT00385840|4183095|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4355082|NCT00385840|4183093|B3|||Age||Years|Mean|68.3|68.3|Standard Deviation|5.91|5.91|||
4355083|NCT00385840|4183094|B2|||Age||Years|Mean|68.4|68.4|Standard Deviation|5.95|5.95|||
4355084|NCT00385840|4183095|B1|||Age||Years|Mean|68.1|68.1|Standard Deviation|5.78|5.78|||
4355085|NCT00385827|4183116|B4|UNITED STATES||Region of Enrollment||participants|Number|33|33.0||||||
4355086|NCT00385827|4183117|B3|UNITED STATES||Region of Enrollment||participants|Number|13|13.0||||||
4355087|NCT00385827|4183118|B2|UNITED STATES||Region of Enrollment||participants|Number|11|11.0||||||
4355088|NCT00385827|4183119|B1|UNITED STATES||Region of Enrollment||participants|Number|9|9.0||||||
4355089|NCT00385827|4183116|B4|UNITED KINGDOM||Region of Enrollment||participants|Number|11|11.0||||||
4355090|NCT00385827|4183117|B3|UNITED KINGDOM||Region of Enrollment||participants|Number|6|6.0||||||
4355091|NCT00385827|4183118|B2|UNITED KINGDOM||Region of Enrollment||participants|Number|5|5.0||||||
4355092|NCT00385827|4183119|B1|UNITED KINGDOM||Region of Enrollment||participants|Number|0|0.0||||||
4355093|NCT00385827|4183116|B4|SPAIN||Region of Enrollment||participants|Number|11|11.0||||||
4355094|NCT00385827|4183117|B3|SPAIN||Region of Enrollment||participants|Number|4|4.0||||||
4355095|NCT00385827|4183118|B2|SPAIN||Region of Enrollment||participants|Number|7|7.0||||||
4355096|NCT00385827|4183119|B1|SPAIN||Region of Enrollment||participants|Number|0|0.0||||||
4355097|NCT00385827|4183116|B4|GERMANY||Region of Enrollment||participants|Number|9|9.0||||||
4355098|NCT00385827|4183117|B3|GERMANY||Region of Enrollment||participants|Number|5|5.0||||||
4355099|NCT00385827|4183118|B2|GERMANY||Region of Enrollment||participants|Number|4|4.0||||||
4355100|NCT00385827|4183119|B1|GERMANY||Region of Enrollment||participants|Number|0|0.0||||||
4355101|NCT00385827|4183116|B4|FRANCE||Region of Enrollment||participants|Number|27|27.0||||||
4355102|NCT00385827|4183117|B3|FRANCE||Region of Enrollment||participants|Number|12|12.0||||||
4355103|NCT00385827|4183118|B2|FRANCE||Region of Enrollment||participants|Number|15|15.0||||||
4355104|NCT00385827|4183119|B1|FRANCE||Region of Enrollment||participants|Number|0|0.0||||||
4355105|NCT00385827|4183116|B4|BELGIUM||Region of Enrollment||participants|Number|12|12.0||||||
4355106|NCT00385827|4183117|B3|BELGIUM||Region of Enrollment||participants|Number|6|6.0||||||
4355107|NCT00385827|4183118|B2|BELGIUM||Region of Enrollment||participants|Number|6|6.0||||||
4355108|NCT00385827|4183119|B1|BELGIUM||Region of Enrollment||participants|Number|0|0.0||||||
4355109|NCT00385827|4183116|B4|AUSTRIA||Region of Enrollment||participants|Number|3|3.0||||||
4355110|NCT00385827|4183117|B3|AUSTRIA||Region of Enrollment||participants|Number|2|2.0||||||
4355111|NCT00385827|4183118|B2|AUSTRIA||Region of Enrollment||participants|Number|1|1.0||||||
4355112|NCT00385827|4183119|B1|AUSTRIA||Region of Enrollment||participants|Number|0|0.0||||||
4355113|NCT00385827|4183116|B4||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4355114|NCT00385827|4183117|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4355115|NCT00385827|4183118|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4355116|NCT00385827|4183119|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4355117|NCT00385827|4183116|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355118|NCT00385827|4183117|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355119|NCT00385827|4183118|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355120|NCT00385827|4183119|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355121|NCT00385827|4183116|B4|||Age||years|Mean|68|68.0|Standard Deviation|8.46|8.46|||
4355122|NCT00385827|4183117|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|9.28|9.28|||
4355123|NCT00385827|4183118|B2|||Age||years|Mean|67.8|67.8|Standard Deviation|7.83|7.83|||
4355124|NCT00385827|4183119|B1|||Age||years|Mean|69.4|69.4|Standard Deviation|7.89|7.89|||
4355125|NCT00385801|4183141|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4355126|NCT00385801|4183142|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4355134|NCT00385788|4183156|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4355135|NCT00385788|4183157|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4355136|NCT00385788|4183158|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4355137|NCT00385788|4183156|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4355138|NCT00385788|4183157|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4355139|NCT00385788|4183158|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4355140|NCT00385788|4183156|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4355141|NCT00385788|4183157|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4355142|NCT00385788|4183158|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4355143|NCT00385788|4183156|B3|||Age||years|Median|30|30.0|Full Range|||20.0|63.0|
4355144|NCT00385788|4183157|B2|||Age||years|Median|31|31.0|Full Range|||20.0|63.0|
4355145|NCT00385788|4183158|B1|||Age||years|Median|29.5|29.5|Full Range|||21.0|58.0|
4355146|NCT00385762|4183165|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4355147|NCT00385762|4183165|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355148|NCT00385762|4183165|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4355149|NCT00385762|4183165|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4355150|NCT00385762|4183165|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4355151|NCT00385736|4183172|B4|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4355152|NCT00385736|4183173|B3|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4355153|NCT00385736|4183174|B2|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4355154|NCT00385736|4183175|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4355155|NCT00385736|4183172|B4|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4355156|NCT00385736|4183173|B3|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4355157|NCT00385736|4183174|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4355158|NCT00385736|4183175|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4355159|NCT00385736|4183172|B4|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4355160|NCT00385736|4183173|B3|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4355161|NCT00385736|4183174|B2|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4355162|NCT00385736|4183175|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4355163|NCT00385736|4183172|B4|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4355164|NCT00385736|4183173|B3|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4355165|NCT00385736|4183174|B2|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4355166|NCT00385736|4183175|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4355167|NCT00385736|4183172|B4|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4355168|NCT00385736|4183173|B3|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4355169|NCT00385736|4183174|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4355170|NCT00385736|4183175|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4355171|NCT00385736|4183172|B4|Canada||Region of Enrollment||participants|Number|71|71.0||||||
4355172|NCT00385736|4183173|B3|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4355173|NCT00385736|4183174|B2|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4355174|NCT00385736|4183175|B1|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4355175|NCT00385736|4183172|B4|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
4355176|NCT00385736|4183173|B3|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
4355177|NCT00385736|4183174|B2|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4355178|NCT00385736|4183175|B1|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4355179|NCT00385736|4183172|B4|Czech Republic||Region of Enrollment||participants|Number|52|52.0||||||
4355180|NCT00385736|4183173|B3|Czech Republic||Region of Enrollment||participants|Number|18|18.0||||||
4355181|NCT00385736|4183174|B2|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
4355182|NCT00385736|4183175|B1|Czech Republic||Region of Enrollment||participants|Number|23|23.0||||||
4355183|NCT00385736|4183172|B4|Italy||Region of Enrollment||participants|Number|24|24.0||||||
4355184|NCT00385736|4183173|B3|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4355185|NCT00385736|4183174|B2|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4355186|NCT00385736|4183175|B1|Italy||Region of Enrollment||participants|Number|11|11.0||||||
4355187|NCT00385736|4183172|B4|Austria||Region of Enrollment||participants|Number|23|23.0||||||
4355188|NCT00385736|4183173|B3|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4355189|NCT00385736|4183174|B2|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4355190|NCT00385736|4183175|B1|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4355191|NCT00385736|4183172|B4|Slovakia||Region of Enrollment||participants|Number|47|47.0||||||
4355192|NCT00385736|4183173|B3|Slovakia||Region of Enrollment||participants|Number|13|13.0||||||
4355193|NCT00385736|4183174|B2|Slovakia||Region of Enrollment||participants|Number|22|22.0||||||
4355194|NCT00385736|4183175|B1|Slovakia||Region of Enrollment||participants|Number|12|12.0||||||
4355195|NCT00385736|4183172|B4|United States||Region of Enrollment||participants|Number|103|103.0||||||
4355196|NCT00385736|4183173|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4355197|NCT00385736|4183174|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4355198|NCT00385736|4183175|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4355199|NCT00385736|4183172|B4||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4355200|NCT00385736|4183173|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4355201|NCT00385736|4183174|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4355202|NCT00385736|4183175|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4355203|NCT00385736|4183172|B4||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4355204|NCT00385736|4183173|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4355205|NCT00385736|4183174|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4355206|NCT00385736|4183175|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4355207|NCT00385736|4183172|B4|||Age||years|Mean|39.5|39.5|Standard Deviation|13.43|13.43|||
4355208|NCT00385736|4183173|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|13.46|13.46|||
4355209|NCT00385736|4183174|B2|||Age||years|Mean|41.6|41.6|Standard Deviation|13.99|13.99|||
4355210|NCT00385736|4183175|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|12.68|12.68|||
4355211|NCT00385736|4183172|B4||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4355212|NCT00385736|4183173|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4355213|NCT00385736|4183174|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4355214|NCT00385736|4183175|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4355215|NCT00385736|4183172|B4||Between 18 and 65 years|Age||Participants|Count of Participants|369|369.0||||||
4355216|NCT00385736|4183173|B3||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4355217|NCT00385736|4183174|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4355218|NCT00385736|4183175|B1||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4355219|NCT00385736|4183172|B4||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4355220|NCT00385736|4183173|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4355221|NCT00385736|4183174|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4355222|NCT00385736|4183175|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4355223|NCT00385723|4183219|B4|||CES-D|"Center for Epidemiologic Studies Depression Scale (CES-D) score The CES-D is a self-report scale designed to measure current symptoms of depression rated on a four-point likert scale.~Scores range from 0-60, with higher scores indicating a higher frequency of depressive symptoms."|scores on a scale|Median|5|5.0|Inter-Quartile Range|||2.0|10.0|
4355224|NCT00385723|4183220|B3|||CES-D|"Center for Epidemiologic Studies Depression Scale (CES-D) score The CES-D is a self-report scale designed to measure current symptoms of depression rated on a four-point likert scale.~Scores range from 0-60, with higher scores indicating a higher frequency of depressive symptoms."|scores on a scale|Median|6|6.0|Inter-Quartile Range|||2.0|10.0|
4355225|NCT00385723|4183221|B2|||CES-D|"Center for Epidemiologic Studies Depression Scale (CES-D) score The CES-D is a self-report scale designed to measure current symptoms of depression rated on a four-point likert scale.~Scores range from 0-60, with higher scores indicating a higher frequency of depressive symptoms."|scores on a scale|Median|5|5.0|Inter-Quartile Range|||2.0|11.0|
4355226|NCT00385723|4183222|B1|||CES-D|"Center for Epidemiologic Studies Depression Scale (CES-D) score The CES-D is a self-report scale designed to measure current symptoms of depression rated on a four-point likert scale.~Scores range from 0-60, with higher scores indicating a higher frequency of depressive symptoms."|scores on a scale|Median|5|5.0|Inter-Quartile Range|||3.0|9.0|
4355227|NCT00385723|4183219|B4|||Sagittal abdominal diameter||cm|Mean|22.8|22.8|Standard Deviation|3.0|3.0|||
4355228|NCT00385723|4183220|B3|||Sagittal abdominal diameter||cm|Mean|22.9|22.9|Standard Deviation|2.9|2.9|||
4355229|NCT00385723|4183221|B2|||Sagittal abdominal diameter||cm|Mean|23.9|23.9|Standard Deviation|3.4|3.4|||
4355230|NCT00385723|4183222|B1|||Sagittal abdominal diameter||cm|Mean|22.8|22.8|Standard Deviation|3.2|3.2|||
4355231|NCT00385723|4183219|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4355232|NCT00385723|4183220|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4355233|NCT00385723|4183221|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4355234|NCT00385723|4183222|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4355235|NCT00385723|4183219|B4|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4355236|NCT00385723|4183220|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4355237|NCT00385723|4183221|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4355238|NCT00385723|4183222|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4355239|NCT00385723|4183219|B4|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4355240|NCT00385723|4183220|B3|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4355241|NCT00385723|4183221|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4355242|NCT00385723|4183222|B1|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4355243|NCT00385723|4183219|B4|White||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4355244|NCT00385723|4183220|B3|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4355245|NCT00385723|4183221|B2|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4355246|NCT00385723|4183222|B1|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4355247|NCT00385723|4183219|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4355248|NCT00385723|4183220|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4355249|NCT00385723|4183221|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4355250|NCT00385723|4183222|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4355251|NCT00385723|4183219|B4||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4355252|NCT00385723|4183220|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4355253|NCT00385723|4183221|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4355254|NCT00385723|4183222|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4355255|NCT00385723|4183219|B4|||Age||years|Mean|51.0|51.0|Standard Deviation|7.8|7.8|||
4355256|NCT00385723|4183220|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|6.7|6.7|||
4355257|NCT00385723|4183221|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|8.0|8.0|||
4355258|NCT00385723|4183222|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|8.6|8.6|||
4355259|NCT00385684|4183238|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4355260|NCT00385684|4183238|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355261|NCT00385684|4183238|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4355262|NCT00385684|4183238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4355263|NCT00385684|4183238|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4355264|NCT00385671|4183245|B4|No||Comorbidity with Major Depressive Disorder (MDD)|Frequency of current comorbid Major Depressive Disorder-Text revision (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|396|396.0||||||
4355265|NCT00385671|4183246|B3|No||Comorbidity with Major Depressive Disorder (MDD)|Frequency of current comorbid Major Depressive Disorder-Text revision (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|131|131.0||||||
4355266|NCT00385671|4183247|B2|No||Comorbidity with Major Depressive Disorder (MDD)|Frequency of current comorbid Major Depressive Disorder-Text revision (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|135|135.0||||||
4355267|NCT00385671|4183248|B1|No||Comorbidity with Major Depressive Disorder (MDD)|Frequency of current comorbid Major Depressive Disorder-Text revision (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|130|130.0||||||
4355268|NCT00385671|4183245|B4|Yes||Comorbidity with Major Depressive Disorder (MDD)|Frequency of current comorbid Major Depressive Disorder-Text revision (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|11|11.0||||||
4355269|NCT00385671|4183246|B3|Yes||Comorbidity with Major Depressive Disorder (MDD)|Frequency of current comorbid Major Depressive Disorder-Text revision (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|4|4.0||||||
4355270|NCT00385671|4183247|B2|Yes||Comorbidity with Major Depressive Disorder (MDD)|Frequency of current comorbid Major Depressive Disorder-Text revision (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|3|3.0||||||
4355271|NCT00385671|4183248|B1|Yes||Comorbidity with Major Depressive Disorder (MDD)|Frequency of current comorbid Major Depressive Disorder-Text revision (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|4|4.0||||||
4355272|NCT00385671|4183245|B4|No||Comorbidity with Generalized Anxiety Disorder (GAD)|Frequency of current comorbid Generalized Anxiety Disorder-Text-Revised (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|403|403.0||||||
4355273|NCT00385671|4183246|B3|No||Comorbidity with Generalized Anxiety Disorder (GAD)|Frequency of current comorbid Generalized Anxiety Disorder-Text-Revised (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|134|134.0||||||
4355274|NCT00385671|4183247|B2|No||Comorbidity with Generalized Anxiety Disorder (GAD)|Frequency of current comorbid Generalized Anxiety Disorder-Text-Revised (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|138|138.0||||||
4355275|NCT00385671|4183248|B1|No||Comorbidity with Generalized Anxiety Disorder (GAD)|Frequency of current comorbid Generalized Anxiety Disorder-Text-Revised (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|131|131.0||||||
4355276|NCT00385671|4183245|B4|Yes||Comorbidity with Generalized Anxiety Disorder (GAD)|Frequency of current comorbid Generalized Anxiety Disorder-Text-Revised (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|4|4.0||||||
4355277|NCT00385671|4183246|B3|Yes||Comorbidity with Generalized Anxiety Disorder (GAD)|Frequency of current comorbid Generalized Anxiety Disorder-Text-Revised (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|1|1.0||||||
4355278|NCT00385671|4183247|B2|Yes||Comorbidity with Generalized Anxiety Disorder (GAD)|Frequency of current comorbid Generalized Anxiety Disorder-Text-Revised (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|0|0.0||||||
4355279|NCT00385671|4183248|B1|Yes||Comorbidity with Generalized Anxiety Disorder (GAD)|Frequency of current comorbid Generalized Anxiety Disorder-Text-Revised (DSM-IV-TR) based on specific modules of the Mini-International Neuropsychiatric Interview (MINI), a short, structured diagnostic interview developed for DSM-IV psychiatric disorders.|participants|Number|3|3.0||||||
4355385|NCT00385671|4183246|B3|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4355280|NCT00385671|4183245|B4|female participants - pleasure||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|2.12|2.12|Standard Deviation|1.16|1.16|||
4355281|NCT00385671|4183246|B3|female participants - pleasure||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|2.06|2.06|Standard Deviation|1.13|1.13|||
4355282|NCT00385671|4183247|B2|female participants - pleasure||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|2.23|2.23|Standard Deviation|1.18|1.18|||
4355283|NCT00385671|4183248|B1|female participants - pleasure||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|2.06|2.06|Standard Deviation|1.19|1.19|||
4355284|NCT00385671|4183245|B4|male participants - pleasure||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|2.41|2.41|Standard Deviation|1.19|1.19|||
4355285|NCT00385671|4183246|B3|male participants - pleasure||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|2.30|2.3|Standard Deviation|1.11|1.11|||
4355286|NCT00385671|4183247|B2|male participants - pleasure||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|2.50|2.5|Standard Deviation|1.22|1.22|||
4355287|NCT00385671|4183248|B1|male participants - pleasure||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|2.43|2.43|Standard Deviation|1.23|1.23|||
4355288|NCT00385671|4183245|B4|female participants - orgasm||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|7.56|7.56|Standard Deviation|3.84|3.84|||
4355289|NCT00385671|4183246|B3|female participants - orgasm||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|7.53|7.53|Standard Deviation|3.83|3.83|||
4355290|NCT00385671|4183247|B2|female participants - orgasm||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|8.23|8.23|Standard Deviation|3.94|3.94|||
4355291|NCT00385671|4183248|B1|female participants - orgasm||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|6.98|6.98|Standard Deviation|3.75|3.75|||
4355292|NCT00385671|4183245|B4|male participants - orgasm||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|7.49|7.49|Standard Deviation|2.94|2.94|||
4355293|NCT00385671|4183246|B3|male participants - orgasm||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|7.51|7.51|Standard Deviation|3.06|3.06|||
4355294|NCT00385671|4183247|B2|male participants - orgasm||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|7.21|7.21|Standard Deviation|2.85|2.85|||
4355295|NCT00385671|4183248|B1|male participants - orgasm||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|7.77|7.77|Standard Deviation|2.93|2.93|||
4355296|NCT00385671|4183245|B4|female participants - desire/interest||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|5.89|5.89|Standard Deviation|2.63|2.63|||
4355297|NCT00385671|4183246|B3|female participants - desire/interest||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|5.72|5.72|Standard Deviation|2.43|2.43|||
4355298|NCT00385671|4183247|B2|female participants - desire/interest||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|5.97|5.97|Standard Deviation|2.42|2.42|||
4355299|NCT00385671|4183248|B1|female participants - desire/interest||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|5.96|5.96|Standard Deviation|3.01|3.01|||
4355300|NCT00385671|4183245|B4|male participants - desire/interest||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|7.90|7.9|Standard Deviation|2.71|2.71|||
4355301|NCT00385671|4183246|B3|male participants - desire/interest||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|8.06|8.06|Standard Deviation|2.84|2.84|||
4355302|NCT00385671|4183247|B2|male participants - desire/interest||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|7.91|7.91|Standard Deviation|2.72|2.72|||
4355303|NCT00385671|4183248|B1|male participants - desire/interest||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|7.71|7.71|Standard Deviation|2.56|2.56|||
4355304|NCT00385671|4183245|B4|female participants - desire/frequency||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|3.93|3.93|Standard Deviation|1.77|1.77|||
4355305|NCT00385671|4183246|B3|female participants - desire/frequency||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|3.74|3.74|Standard Deviation|1.59|1.59|||
4355306|NCT00385671|4183247|B2|female participants - desire/frequency||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|4.27|4.27|Standard Deviation|1.83|1.83|||
4355307|NCT00385671|4183248|B1|female participants - desire/frequency||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|3.79|3.79|Standard Deviation|1.85|1.85|||
4355308|NCT00385671|4183245|B4|male participants - desire/frequency||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|5.18|5.18|Standard Deviation|1.82|1.82|||
4355309|NCT00385671|4183246|B3|male participants - desire/frequency||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|5.15|5.15|Standard Deviation|1.96|1.96|||
4355310|NCT00385671|4183247|B2|male participants - desire/frequency||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|5.09|5.09|Standard Deviation|1.77|1.77|||
4355311|NCT00385671|4183248|B1|male participants - desire/frequency||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|5.32|5.32|Standard Deviation|1.73|1.73|||
4355312|NCT00385671|4183245|B4|female participants - arousal||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|6.70|6.7|Standard Deviation|3.01|3.01|||
4355313|NCT00385671|4183246|B3|female participants - arousal||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|6.47|6.47|Standard Deviation|3.09|3.09|||
4355314|NCT00385671|4183247|B2|female participants - arousal||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|7.00|7.0|Standard Deviation|2.72|2.72|||
4355315|NCT00385671|4183248|B1|female participants - arousal||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|6.64|6.64|Standard Deviation|3.20|3.2|||
4355316|NCT00385671|4183245|B4|male participants - arousal||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|6.64|6.64|Standard Deviation|3.04|3.04|||
4355317|NCT00385671|4183246|B3|male participants - arousal||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|6.41|6.41|Standard Deviation|3.12|3.12|||
4355318|NCT00385671|4183247|B2|male participants - arousal||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|6.35|6.35|Standard Deviation|2.88|2.88|||
4355319|NCT00385671|4183248|B1|male participants - arousal||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|7.19|7.19|Standard Deviation|3.08|3.08|||
4355386|NCT00385671|4183247|B2|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4355320|NCT00385671|4183245|B4|female participants - total||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|35.43|35.43|Standard Deviation|10.73|10.73|||
4355321|NCT00385671|4183246|B3|female participants - total||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|34.45|34.45|Standard Deviation|10.09|10.09|||
4355322|NCT00385671|4183247|B2|female participants - total||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|36.69|36.69|Standard Deviation|10.43|10.43|||
4355323|NCT00385671|4183248|B1|female participants - total||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|35.21|35.21|Standard Deviation|11.68|11.68|||
4355324|NCT00385671|4183245|B4|male participants - total||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|39.46|39.46|Standard Deviation|9.42|9.42|||
4355325|NCT00385671|4183246|B3|male participants - total||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|39.25|39.25|Standard Deviation|9.75|9.75|||
4355326|NCT00385671|4183247|B2|male participants - total||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|38.81|38.81|Standard Deviation|9.50|9.5|||
4355327|NCT00385671|4183248|B1|male participants - total||Clayton Sexual Functioning Questionnaire (CSFQ)|The CSFQ is a 14-item subject-rated scale designed to assess changes in sexual activity and functioning. The CSFQ is a structured interview/questionnaire, which is designed to measure medication related changes in sexual functioning. The CSFQ measures five dimensions of sexual behavior: pleasure; desire/frequency; desire/interest; arousal; and orgasm. The CSFQ total score is also obtained across all 5 dimensions and ranges from 14 to 70. Subscale score ranges: desire/frequency=2-10; desire/interest=3-15; pleasure=1-5; arousal=3-15; orgasm=3-15. Higher scores indicate greater changes.|units on a scale|Mean|40.41|40.41|Standard Deviation|9.01|9.01|||
4355328|NCT00385671|4183245|B4|||Sheehan Disability Scale (SDS) Global Functional Impairment Total Score|The SDS is completed by the patient and is used to assess the effect of the patient's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the patient's work/social/family life.|units on a scale|Mean|12.55|12.55|Standard Deviation|8.58|8.58|||
4355329|NCT00385671|4183246|B3|||Sheehan Disability Scale (SDS) Global Functional Impairment Total Score|The SDS is completed by the patient and is used to assess the effect of the patient's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the patient's work/social/family life.|units on a scale|Mean|12.69|12.69|Standard Deviation|7.92|7.92|||
4355330|NCT00385671|4183247|B2|||Sheehan Disability Scale (SDS) Global Functional Impairment Total Score|The SDS is completed by the patient and is used to assess the effect of the patient's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the patient's work/social/family life.|units on a scale|Mean|13.49|13.49|Standard Deviation|9.00|9.0|||
4355379|NCT00385671|4183248|B1|||Duration of Diabetic Peripheral Neuropathic Pain|Duration of Diabetic Peripheral Neuropathic Pain Since Onset.|months|Mean|51.54|51.54|Standard Deviation|40.96|40.96|||
4355331|NCT00385671|4183248|B1|||Sheehan Disability Scale (SDS) Global Functional Impairment Total Score|The SDS is completed by the patient and is used to assess the effect of the patient's symptoms on their work/social/family life. Total scores range from 0 to 30 with higher values indicating greater disruption in the patient's work/social/family life.|units on a scale|Mean|11.44|11.44|Standard Deviation|8.72|8.72|||
4355332|NCT00385671|4183245|B4|Quality of Sleep Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|96.15|96.15|Standard Deviation|45.34|45.34|||
4355333|NCT00385671|4183246|B3|Quality of Sleep Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|97.01|97.01|Standard Deviation|45.39|45.39|||
4355334|NCT00385671|4183247|B2|Quality of Sleep Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|95.89|95.89|Standard Deviation|46.82|46.82|||
4355335|NCT00385671|4183248|B1|Quality of Sleep Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|95.54|95.54|Standard Deviation|44.08|44.08|||
4355336|NCT00385671|4183245|B4|Getting to Sleep Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|140.45|140.45|Standard Deviation|62.40|62.4|||
4355337|NCT00385671|4183246|B3|Getting to Sleep Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|145.22|145.22|Standard Deviation|64.73|64.73|||
4355338|NCT00385671|4183247|B2|Getting to Sleep Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|137.61|137.61|Standard Deviation|62.91|62.91|||
4355339|NCT00385671|4183248|B1|Getting to Sleep Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|138.62|138.62|Standard Deviation|59.68|59.68|||
4355340|NCT00385671|4183245|B4|Behavior Following Wakefulness Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|130.88|130.88|Standard Deviation|67.98|67.98|||
4355341|NCT00385671|4183246|B3|Behavior Following Wakefulness Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|131.55|131.55|Standard Deviation|69.61|69.61|||
4355380|NCT00385671|4183245|B4|||Duration of Diabetes||months|Mean|139.09|139.09|Standard Deviation|115.24|115.24|||
4355381|NCT00385671|4183246|B3|||Duration of Diabetes||months|Mean|119.82|119.82|Standard Deviation|93.38|93.38|||
4355382|NCT00385671|4183247|B2|||Duration of Diabetes||months|Mean|147.14|147.14|Standard Deviation|116.04|116.04|||
4355342|NCT00385671|4183247|B2|Behavior Following Wakefulness Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|128.87|128.87|Standard Deviation|65.53|65.53|||
4355343|NCT00385671|4183248|B1|Behavior Following Wakefulness Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|132.22|132.22|Standard Deviation|69.22|69.22|||
4355344|NCT00385671|4183245|B4|Awakening Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|89.75|89.75|Standard Deviation|41.59|41.59|||
4355345|NCT00385671|4183246|B3|Awakening Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|86.70|86.7|Standard Deviation|42.46|42.46|||
4355346|NCT00385671|4183247|B2|Awakening Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|88.63|88.63|Standard Deviation|40.75|40.75|||
4355347|NCT00385671|4183248|B1|Awakening Subscale||Leeds Sleep Evaluation Questionnaire (LSEQ)|The LSEQ assesses the effects of psychoactive compounds on sleep and early morning behavior. Participants mark a series of 100 mm line analogue scales, indicating the direction and magnitude of any changes in behavioral state they experience following administration of the drug. Scores are represented in millimeters, higher scores indicate better sleep and better early morning behvior. Subscale score ranges: going to sleep=0-300, quality of sleep=0-200, awakening=0-200, behavior following wakefullness=0-300.|units on a scale|Mean|93.95|93.95|Standard Deviation|41.55|41.55|||
4355348|NCT00385671|4183245|B4|||Weekly mean of nighttime pain severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the daily nighttime pain severity over the last 24 hours. Scores are based on daily assessments recorded by patients in their diaries.|units on a scale|Mean|5.69|5.69|Standard Deviation|1.97|1.97|||
4355349|NCT00385671|4183246|B3|||Weekly mean of nighttime pain severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the daily nighttime pain severity over the last 24 hours. Scores are based on daily assessments recorded by patients in their diaries.|units on a scale|Mean|5.55|5.55|Standard Deviation|2.11|2.11|||
4355350|NCT00385671|4183247|B2|||Weekly mean of nighttime pain severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the daily nighttime pain severity over the last 24 hours. Scores are based on daily assessments recorded by patients in their diaries.|units on a scale|Mean|5.86|5.86|Standard Deviation|1.74|1.74|||
4355351|NCT00385671|4183248|B1|||Weekly mean of nighttime pain severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the daily nighttime pain severity over the last 24 hours. Scores are based on daily assessments recorded by patients in their diaries.|units on a scale|Mean|5.64|5.64|Standard Deviation|2.06|2.06|||
4355352|NCT00385671|4183245|B4|||Weekly mean of the daily worst pain severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the daily worst pain severity over the last 24 hours. Scores are based on daily assessments recorded by patients in their diaries.|units on a scale|Mean|7.03|7.03|Standard Deviation|1.50|1.5|||
4355353|NCT00385671|4183246|B3|||Weekly mean of the daily worst pain severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the daily worst pain severity over the last 24 hours. Scores are based on daily assessments recorded by patients in their diaries.|units on a scale|Mean|7.05|7.05|Standard Deviation|1.48|1.48|||
4355354|NCT00385671|4183247|B2|||Weekly mean of the daily worst pain severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the daily worst pain severity over the last 24 hours. Scores are based on daily assessments recorded by patients in their diaries.|units on a scale|Mean|7.12|7.12|Standard Deviation|1.46|1.46|||
4355355|NCT00385671|4183248|B1|||Weekly mean of the daily worst pain severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the daily worst pain severity over the last 24 hours. Scores are based on daily assessments recorded by patients in their diaries.|units on a scale|Mean|6.92|6.92|Standard Deviation|1.56|1.56|||
4355383|NCT00385671|4183248|B1|||Duration of Diabetes||months|Mean|150.26|150.26|Standard Deviation|131.60|131.6|||
4355356|NCT00385671|4183245|B4|||Beck Depression Inventory (BDI) Total Score|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|9.74|9.74|Standard Deviation|8.07|8.07|||
4355357|NCT00385671|4183246|B3|||Beck Depression Inventory (BDI) Total Score|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|10.71|10.71|Standard Deviation|8.42|8.42|||
4355358|NCT00385671|4183247|B2|||Beck Depression Inventory (BDI) Total Score|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|9.10|9.1|Standard Deviation|7.20|7.2|||
4355359|NCT00385671|4183248|B1|||Beck Depression Inventory (BDI) Total Score|A 21-item, patient-completed questionnaire to assess characteristics of depression. Each of the 21 items corresponding to a symptom of depression is summed to give a single score. There is a four-point scale for each item ranging from 0 to 3. Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.|units on a scale|Mean|9.45|9.45|Standard Deviation|8.53|8.53|||
4355360|NCT00385671|4183245|B4|||Weekly mean of 24 hour average pain severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the average pain severity over the last 24 hours. Scores are based on daily assessments recorded by patients in their diaries.|units on a scale|Mean|5.76|5.76|Standard Deviation|1.47|1.47|||
4355361|NCT00385671|4183246|B3|||Weekly mean of 24 hour average pain severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the average pain severity over the last 24 hours. Scores are based on daily assessments recorded by patients in their diaries.|units on a scale|Mean|5.78|5.78|Standard Deviation|1.47|1.47|||
4355362|NCT00385671|4183247|B2|||Weekly mean of 24 hour average pain severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the average pain severity over the last 24 hours. Scores are based on daily assessments recorded by patients in their diaries.|units on a scale|Mean|5.81|5.81|Standard Deviation|1.51|1.51|||
4355363|NCT00385671|4183248|B1|||Weekly mean of 24 hour average pain severity|This is an ordinal scale with scores from 0 (no pain) to 10 (worst possible pain). Data presented represent the weekly mean of the scores of the average pain severity over the last 24 hours. Scores are based on daily assessments recorded by patients in their diaries.|units on a scale|Mean|5.69|5.69|Standard Deviation|1.43|1.43|||
4355364|NCT00385671|4183245|B4|Type II||Types of Diabetes Mellitus||participants|Number|376|376.0||||||
4355365|NCT00385671|4183246|B3|Type II||Types of Diabetes Mellitus||participants|Number|126|126.0||||||
4355366|NCT00385671|4183247|B2|Type II||Types of Diabetes Mellitus||participants|Number|129|129.0||||||
4355367|NCT00385671|4183248|B1|Type II||Types of Diabetes Mellitus||participants|Number|121|121.0||||||
4355368|NCT00385671|4183245|B4|Type I||Types of Diabetes Mellitus||participants|Number|31|31.0||||||
4355369|NCT00385671|4183246|B3|Type I||Types of Diabetes Mellitus||participants|Number|9|9.0||||||
4355370|NCT00385671|4183247|B2|Type I||Types of Diabetes Mellitus||participants|Number|9|9.0||||||
4355371|NCT00385671|4183248|B1|Type I||Types of Diabetes Mellitus||participants|Number|13|13.0||||||
4355372|NCT00385671|4183245|B4|||Michigan Neuropathy Screening Instrument (MNSI) Physical Assessment - Total Score|Assesses degree of neuropathy. Responses to 13 out of 15 items are added to obtain total score. Responses of “yes” to items 1,2,3,5,6,8,9,11,12,14,15 are each counted as one point. A “no” response on items 7 and 13 counts as 1 point. Items 4 and 10 are not included in scoring. Total scores range from 0 (no neuropathy) to 13 (severe neuropathy).|units on a scale|Mean|5.86|5.86|Standard Deviation|1.56|1.56|||
4355373|NCT00385671|4183246|B3|||Michigan Neuropathy Screening Instrument (MNSI) Physical Assessment - Total Score|Assesses degree of neuropathy. Responses to 13 out of 15 items are added to obtain total score. Responses of “yes” to items 1,2,3,5,6,8,9,11,12,14,15 are each counted as one point. A “no” response on items 7 and 13 counts as 1 point. Items 4 and 10 are not included in scoring. Total scores range from 0 (no neuropathy) to 13 (severe neuropathy).|units on a scale|Mean|5.94|5.94|Standard Deviation|1.56|1.56|||
4355374|NCT00385671|4183247|B2|||Michigan Neuropathy Screening Instrument (MNSI) Physical Assessment - Total Score|Assesses degree of neuropathy. Responses to 13 out of 15 items are added to obtain total score. Responses of “yes” to items 1,2,3,5,6,8,9,11,12,14,15 are each counted as one point. A “no” response on items 7 and 13 counts as 1 point. Items 4 and 10 are not included in scoring. Total scores range from 0 (no neuropathy) to 13 (severe neuropathy).|units on a scale|Mean|5.73|5.73|Standard Deviation|1.58|1.58|||
4355375|NCT00385671|4183248|B1|||Michigan Neuropathy Screening Instrument (MNSI) Physical Assessment - Total Score|Assesses degree of neuropathy. Responses to 13 out of 15 items are added to obtain total score. Responses of “yes” to items 1,2,3,5,6,8,9,11,12,14,15 are each counted as one point. A “no” response on items 7 and 13 counts as 1 point. Items 4 and 10 are not included in scoring. Total scores range from 0 (no neuropathy) to 13 (severe neuropathy).|units on a scale|Mean|5.91|5.91|Standard Deviation|1.56|1.56|||
4355376|NCT00385671|4183245|B4|||Duration of Diabetic Peripheral Neuropathic Pain|Duration of Diabetic Peripheral Neuropathic Pain Since Onset.|months|Mean|53.34|53.34|Standard Deviation|47.51|47.51|||
4355377|NCT00385671|4183246|B3|||Duration of Diabetic Peripheral Neuropathic Pain|Duration of Diabetic Peripheral Neuropathic Pain Since Onset.|months|Mean|50.32|50.32|Standard Deviation|41.93|41.93|||
4355378|NCT00385671|4183247|B2|||Duration of Diabetic Peripheral Neuropathic Pain|Duration of Diabetic Peripheral Neuropathic Pain Since Onset.|months|Mean|58.08|58.08|Standard Deviation|57.57|57.57|||
4355384|NCT00385671|4183245|B4|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4355387|NCT00385671|4183248|B1|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4355388|NCT00385671|4183245|B4|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4355389|NCT00385671|4183246|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4355390|NCT00385671|4183247|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4355391|NCT00385671|4183248|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4355392|NCT00385671|4183245|B4|Germany||Region of Enrollment||participants|Number|63|63.0||||||
4355393|NCT00385671|4183246|B3|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4355394|NCT00385671|4183247|B2|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4355395|NCT00385671|4183248|B1|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4355396|NCT00385671|4183245|B4|United States||Region of Enrollment||participants|Number|325|325.0||||||
4355397|NCT00385671|4183246|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
4355398|NCT00385671|4183247|B2|United States||Region of Enrollment||participants|Number|112|112.0||||||
4355399|NCT00385671|4183248|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
4355400|NCT00385671|4183245|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4355401|NCT00385671|4183246|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4355402|NCT00385671|4183247|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4355403|NCT00385671|4183248|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4355404|NCT00385671|4183245|B4|West Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4355405|NCT00385671|4183246|B3|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4355406|NCT00385671|4183247|B2|West Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4355407|NCT00385671|4183248|B1|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4355408|NCT00385671|4183245|B4|White||Race/Ethnicity, Customized||participants|Number|333|333.0||||||
4355409|NCT00385671|4183246|B3|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
4355410|NCT00385671|4183247|B2|White||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
4355411|NCT00385671|4183248|B1|White||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4355412|NCT00385671|4183245|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4355413|NCT00385671|4183246|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4355414|NCT00385671|4183247|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4355415|NCT00385671|4183248|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4355416|NCT00385671|4183245|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4355417|NCT00385671|4183246|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4355418|NCT00385671|4183247|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4355419|NCT00385671|4183248|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4355420|NCT00385671|4183245|B4|East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4355421|NCT00385671|4183246|B3|East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4355422|NCT00385671|4183247|B2|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4355423|NCT00385671|4183248|B1|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4355424|NCT00385671|4183245|B4|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4355425|NCT00385671|4183246|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4355426|NCT00385671|4183247|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4355427|NCT00385671|4183248|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4355428|NCT00385671|4183245|B4||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4355429|NCT00385671|4183246|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4355430|NCT00385671|4183247|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4355431|NCT00385671|4183248|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4355432|NCT00385671|4183245|B4||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4355433|NCT00385671|4183246|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4355434|NCT00385671|4183247|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4355435|NCT00385671|4183248|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4355436|NCT00385671|4183245|B4|||Age||years|Mean|61.56|61.56|Standard Deviation|10.56|10.56|||
4355437|NCT00385671|4183246|B3|||Age||years|Mean|61.85|61.85|Standard Deviation|10.84|10.84|||
4355438|NCT00385671|4183247|B2|||Age||years|Mean|60.94|60.94|Standard Deviation|10.18|10.18|||
4355439|NCT00385671|4183248|B1|||Age||years|Mean|61.89|61.89|Standard Deviation|10.70|10.7|||
4355440|NCT00385593|4183404|B3||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4355441|NCT00385593|4183405|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4355442|NCT00385593|4183406|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4355443|NCT00385593|4183404|B3||Female|Sex: Female, Male||Participants|Count of Participants|420|420.0||||||
4355444|NCT00385593|4183405|B2||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4355445|NCT00385593|4183406|B1||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4355446|NCT00385593|4183404|B3|||Age||Years|Mean|44.0|44.0|Standard Deviation|16.5|16.5|||
4355447|NCT00385593|4183405|B2|||Age||Years|Mean|44.3|44.3|Standard Deviation|16.5|16.5|||
4355448|NCT00385593|4183406|B1|||Age||Years|Mean|43.7|43.7|Standard Deviation|16.4|16.4|||
4355449|NCT00385580|4183423|B3|Unknown||Bone-specific Alkaline Phosphatase (BAP) Value from baseline|BAP is a measure of bone metabolism. A decrease in BAP relative to baseline indicates a decrease in bone metabolism.|Participants|Number|5|5.0||||||
4355450|NCT00385580|4183424|B2|Unknown||Bone-specific Alkaline Phosphatase (BAP) Value from baseline|BAP is a measure of bone metabolism. A decrease in BAP relative to baseline indicates a decrease in bone metabolism.|Participants|Number|4|4.0||||||
4355451|NCT00385580|4183425|B1|Unknown||Bone-specific Alkaline Phosphatase (BAP) Value from baseline|BAP is a measure of bone metabolism. A decrease in BAP relative to baseline indicates a decrease in bone metabolism.|Participants|Number|1|1.0||||||
4355452|NCT00385580|4183423|B3|Normal 15-41.3 U/L||Bone-specific Alkaline Phosphatase (BAP) Value from baseline|BAP is a measure of bone metabolism. A decrease in BAP relative to baseline indicates a decrease in bone metabolism.|Participants|Number|48|48.0||||||
4355453|NCT00385580|4183424|B2|Normal 15-41.3 U/L||Bone-specific Alkaline Phosphatase (BAP) Value from baseline|BAP is a measure of bone metabolism. A decrease in BAP relative to baseline indicates a decrease in bone metabolism.|Participants|Number|22|22.0||||||
4355454|NCT00385580|4183425|B1|Normal 15-41.3 U/L||Bone-specific Alkaline Phosphatase (BAP) Value from baseline|BAP is a measure of bone metabolism. A decrease in BAP relative to baseline indicates a decrease in bone metabolism.|Participants|Number|26|26.0||||||
4355455|NCT00385580|4183423|B3|Low <15 U/L||Bone-specific Alkaline Phosphatase (BAP) Value from baseline|BAP is a measure of bone metabolism. A decrease in BAP relative to baseline indicates a decrease in bone metabolism.|Participants|Number|5|5.0||||||
4355456|NCT00385580|4183424|B2|Low <15 U/L||Bone-specific Alkaline Phosphatase (BAP) Value from baseline|BAP is a measure of bone metabolism. A decrease in BAP relative to baseline indicates a decrease in bone metabolism.|Participants|Number|2|2.0||||||
4355457|NCT00385580|4183425|B1|Low <15 U/L||Bone-specific Alkaline Phosphatase (BAP) Value from baseline|BAP is a measure of bone metabolism. A decrease in BAP relative to baseline indicates a decrease in bone metabolism.|Participants|Number|3|3.0||||||
4355458|NCT00385580|4183423|B3|High >41.3 U/L||Bone-specific Alkaline Phosphatase (BAP) Value from baseline|BAP is a measure of bone metabolism. A decrease in BAP relative to baseline indicates a decrease in bone metabolism.|Participants|Number|37|37.0||||||
4355459|NCT00385580|4183424|B2|High >41.3 U/L||Bone-specific Alkaline Phosphatase (BAP) Value from baseline|BAP is a measure of bone metabolism. A decrease in BAP relative to baseline indicates a decrease in bone metabolism.|Participants|Number|19|19.0||||4.0|62.0|
4355460|NCT00385580|4183425|B1|High >41.3 U/L||Bone-specific Alkaline Phosphatase (BAP) Value from baseline|BAP is a measure of bone metabolism. A decrease in BAP relative to baseline indicates a decrease in bone metabolism.|Participants|Number|18|18.0||||6.0|88.0|
4355461|NCT00385580|4183423|B3|Unknown uNTx value||Urinary N-telopeptide (uNTx)Value from Baseline|uNTx is a measure of bone metabolism decrease in the marker relative to baseline indicates a decrease in bone metabolism.|Participants|Number|6|6.0||||||
4355462|NCT00385580|4183424|B2|Unknown uNTx value||Urinary N-telopeptide (uNTx)Value from Baseline|uNTx is a measure of bone metabolism decrease in the marker relative to baseline indicates a decrease in bone metabolism.|Participants|Number|4|4.0||||||
4355463|NCT00385580|4183425|B1|Unknown uNTx value||Urinary N-telopeptide (uNTx)Value from Baseline|uNTx is a measure of bone metabolism decrease in the marker relative to baseline indicates a decrease in bone metabolism.|Participants|Number|2|2.0||||||
4355464|NCT00385580|4183423|B3|>= 60 nmol/mmol creatinine||Urinary N-telopeptide (uNTx)Value from Baseline|uNTx is a measure of bone metabolism decrease in the marker relative to baseline indicates a decrease in bone metabolism.|Participants|Number|35|35.0||||||
4355465|NCT00385580|4183424|B2|>= 60 nmol/mmol creatinine||Urinary N-telopeptide (uNTx)Value from Baseline|uNTx is a measure of bone metabolism decrease in the marker relative to baseline indicates a decrease in bone metabolism.|Participants|Number|15|15.0||||||
4355466|NCT00385580|4183425|B1|>= 60 nmol/mmol creatinine||Urinary N-telopeptide (uNTx)Value from Baseline|uNTx is a measure of bone metabolism decrease in the marker relative to baseline indicates a decrease in bone metabolism.|Participants|Number|20|20.0||||||
4355467|NCT00385580|4183423|B3|< 60 nanomol (nmol)/mmol creatinine||Urinary N-telopeptide (uNTx)Value from Baseline|uNTx is a measure of bone metabolism decrease in the marker relative to baseline indicates a decrease in bone metabolism.|Participants|Number|54|54.0||||||
4355468|NCT00385580|4183424|B2|< 60 nanomol (nmol)/mmol creatinine||Urinary N-telopeptide (uNTx)Value from Baseline|uNTx is a measure of bone metabolism decrease in the marker relative to baseline indicates a decrease in bone metabolism.|Participants|Number|28|28.0||||4.0|86.0|
4355469|NCT00385580|4183425|B1|< 60 nanomol (nmol)/mmol creatinine||Urinary N-telopeptide (uNTx)Value from Baseline|uNTx is a measure of bone metabolism decrease in the marker relative to baseline indicates a decrease in bone metabolism.|Participants|Number|26|26.0||||10.0|89.0|
4355470|NCT00385580|4183423|B3|P8||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|4.00|4.0|Full Range|||0.0|4.0|
4355471|NCT00385580|4183424|B2|P8||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|4.00|4.0|Full Range|||1.0|4.0|
4355552|NCT00385580|4183424|B2|||Age||years|Median|70.0|70.0|Full Range|||54.0|87.0|
4355553|NCT00385580|4183425|B1|||Age||years|Median|68.0|68.0|Full Range|||47.0|85.0|
4355554|NCT00385541|4183515|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4355472|NCT00385580|4183425|B1|P8||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|4.00|4.0|Full Range|||0.0|4.0|
4355473|NCT00385580|4183423|B3|P7||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|4.00|4.0|Full Range|||0.0|4.0|
4355474|NCT00385580|4183424|B2|P7||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|4.00|4.0|Full Range|||0.0|4.0|
4355475|NCT00385580|4183425|B1|P7||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|4.00|4.0|Full Range|||0.0|4.0|
4355476|NCT00385580|4183423|B3|P3||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|4.00|4.0|Full Range|||0.0|4.0|
4355477|NCT00385580|4183424|B2|P3||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|4.00|4.0|Full Range|||1.0|4.0|
4355478|NCT00385580|4183425|B1|P3||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|4.00|4.0|Full Range|||0.0|4.0|
4355479|NCT00385580|4183423|B3|P2||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|3.00|3.0|Full Range|||0.0|4.0|
4355480|NCT00385580|4183424|B2|P2||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|3.00|3.0|Full Range|||0.0|4.0|
4355481|NCT00385580|4183425|B1|P2||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|3.00|3.0|Full Range|||0.0|4.0|
4355510|NCT00385580|4183424|B2|3=needs to be in bed >50% of day, not bedridden||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|0|0.0||||||
4355482|NCT00385580|4183423|B3|C2||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|4.00|4.0|Full Range|||0.0|4.0|
4355483|NCT00385580|4183424|B2|C2||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|4.00|4.0|Full Range|||2.0|4.0|
4355484|NCT00385580|4183425|B1|C2||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|4.00|4.0|Full Range|||0.0|4.0|
4355485|NCT00385580|4183423|B3|GE6||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|2.00|2.0|Full Range|||0.0|4.0|
4355486|NCT00385580|4183424|B2|GE6||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|2.00|2.0|Full Range|||0.0|4.0|
4355487|NCT00385580|4183425|B1|GE6||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|3.00|3.0|Full Range|||0.0|4.0|
4355488|NCT00385580|4183423|B3|GP4||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|3.00|3.0|Full Range|||1.0|4.0|
4355489|NCT00385580|4183424|B2|GP4||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|3.00|3.0|Full Range|||1.0|4.0|
4355490|NCT00385580|4183425|B1|GP4||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|3.00|3.0|Full Range|||1.0|4.0|
4355491|NCT00385580|4183423|B3|GP1||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|3.00|3.0|Full Range|||0.0|4.0|
4355511|NCT00385580|4183425|B1|3=needs to be in bed >50% of day, not bedridden||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|0|0.0||||||
4355492|NCT00385580|4183424|B2|GP1||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|3.00|3.0|Full Range|||0.0|4.0|
4355493|NCT00385580|4183425|B1|GP1||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|3.00|3.0|Full Range|||0.0|4.0|
4355494|NCT00385580|4183423|B3|Total Score||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|26.00|26.0|Full Range|||15.0|31.0|
4355495|NCT00385580|4183424|B2|Total Score||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|26.00|26.0|Full Range|||13.0|31.0|
4355496|NCT00385580|4183425|B1|Total Score||FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline|FAPSI-8:symptom index of important clinician-rated symptoms/concerns to monitor when assessing value of treatment for advanced prostate cancer. Participants respond to each item on a 5-point Likert-type scale from 0 (not at all) to 4 (very much). GP1:I have lack of energy, GP4:I have pain, GE6:I worry that my condition will get worse, C2: I am losing weight, P2:I have certain areas in my body where I experience significant pain,P3:My pain keeps me from doing things I want to do, P7:I have difficulty urinating, P8:My problems with urinating limit my activities.|Units on a scale|Median|26.00|26.0|Full Range|||15.0|31.0|
4355497|NCT00385580|4183423|B3|||Weight continuous||kilogram (Kg)|Mean|90.85|90.85|Standard Deviation|16.60|16.6|||
4355498|NCT00385580|4183424|B2|||Weight continuous||kilogram (Kg)|Mean|89.16|89.16|Standard Deviation|14.72|14.72|||
4355499|NCT00385580|4183425|B1|||Weight continuous||kilogram (Kg)|Mean|92.50|92.5|Standard Deviation|18.25|18.25|||
4355500|NCT00385580|4183423|B3|||Height continuous||centimeter (cm)|Mean|173.58|173.58|Standard Deviation|10.19|10.19|||
4355501|NCT00385580|4183424|B2|||Height continuous||centimeter (cm)|Mean|172.63|172.63|Standard Deviation|12.67|12.67|||
4355502|NCT00385580|4183425|B1|||Height continuous||centimeter (cm)|Mean|174.44|174.44|Standard Deviation|7.35|7.35|||
4355503|NCT00385580|4183423|B3|5=dead||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|0|0.0||||||
4355504|NCT00385580|4183424|B2|5=dead||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|0|0.0||||||
4355505|NCT00385580|4183425|B1|5=dead||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|0|0.0||||||
4355506|NCT00385580|4183423|B3|4=unable to get out of bed||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|0|0.0||||||
4355507|NCT00385580|4183424|B2|4=unable to get out of bed||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|0|0.0||||||
4355508|NCT00385580|4183425|B1|4=unable to get out of bed||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|0|0.0||||||
4355509|NCT00385580|4183423|B3|3=needs to be in bed >50% of day, not bedridden||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|0|0.0||||||
4355550|NCT00385580|4183425|B1|< 65 years||Age, Customized||participants|Number|12|12.0||||||
4355551|NCT00385580|4183423|B3|||Age||years|Median|69.0|69.0|Full Range|||47.0|87.0|
4355512|NCT00385580|4183423|B3|2=symptomatic, but in bed < 50% of the day.||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|1|1.0||||||
4355513|NCT00385580|4183424|B2|2=symptomatic, but in bed < 50% of the day.||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|1|1.0||||||
4355514|NCT00385580|4183425|B1|2=symptomatic, but in bed < 50% of the day.||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|0|0.0||||||
4355515|NCT00385580|4183423|B3|1=symptoms, but fully ambulatory||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|31|31.0||||||
4355516|NCT00385580|4183424|B2|1=symptoms, but fully ambulatory||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|18|18.0||||||
4355517|NCT00385580|4183425|B1|1=symptoms, but fully ambulatory||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|13|13.0||||||
4355518|NCT00385580|4183423|B3|0=normal activity||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|63|63.0||||||
4355519|NCT00385580|4183424|B2|0=normal activity||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|28|28.0||||||
4355520|NCT00385580|4183425|B1|0=normal activity||Eastern Cooperative Oncology Group (ECOG)Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is normal activity; 1 is symptoms, but fully ambulatory; 2 is symptomatic, but in bed < 50% of the day; 3 is needs to be in bed > 50% of the day, but not bedridden; 4 is unable to get out of bed; 5 is dead.|participants|Number|35|35.0||||||
4355521|NCT00385580|4183423|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4355522|NCT00385580|4183424|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4355523|NCT00385580|4183425|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4355524|NCT00385580|4183423|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4355525|NCT00385580|4183424|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4355526|NCT00385580|4183425|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4355527|NCT00385580|4183423|B3|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4355528|NCT00385580|4183424|B2|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4355529|NCT00385580|4183425|B1|White||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4355530|NCT00385580|4183423|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4355531|NCT00385580|4183424|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4355532|NCT00385580|4183425|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4355533|NCT00385580|4183423|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4355534|NCT00385580|4183424|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4355535|NCT00385580|4183425|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4355536|NCT00385580|4183423|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4355537|NCT00385580|4183424|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355538|NCT00385580|4183425|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4355539|NCT00385580|4183423|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4355540|NCT00385580|4183424|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4355541|NCT00385580|4183425|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4355542|NCT00385580|4183423|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355543|NCT00385580|4183424|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355544|NCT00385580|4183425|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355545|NCT00385580|4183423|B3|>=65 years||Age, Customized||participants|Number|70|70.0||||||
4355546|NCT00385580|4183424|B2|>=65 years||Age, Customized||participants|Number|34|34.0||||||
4355547|NCT00385580|4183425|B1|>=65 years||Age, Customized||participants|Number|36|36.0||||||
4355548|NCT00385580|4183423|B3|< 65 years||Age, Customized||participants|Number|25|25.0||||||
4355549|NCT00385580|4183424|B2|< 65 years||Age, Customized||participants|Number|13|13.0||||||
4355555|NCT00385541|4183516|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4355556|NCT00385541|4183517|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4355557|NCT00385541|4183515|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4355558|NCT00385541|4183516|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4355559|NCT00385541|4183517|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4355560|NCT00385541|4183515|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4355561|NCT00385541|4183516|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4355562|NCT00385541|4183517|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4355563|NCT00385541|4183515|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|10|10.0|||
4355564|NCT00385541|4183516|B2|||Age||years|Mean|44|44.0|Standard Deviation|8|8.0|||
4355565|NCT00385541|4183517|B1|||Age||years|Mean|42|42.0|Standard Deviation|12|12.0|||
4355566|NCT00385541|4183515|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4355567|NCT00385541|4183516|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4355568|NCT00385541|4183517|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4355569|NCT00385541|4183515|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4355570|NCT00385541|4183516|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4355571|NCT00385541|4183517|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4355572|NCT00385541|4183515|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4355573|NCT00385541|4183516|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4355574|NCT00385541|4183517|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4355575|NCT00385515|4183532|B3|India||Region of Enrollment||participants|Number|25|25.0||||||
4355576|NCT00385515|4183533|B2|India||Region of Enrollment||participants|Number|7|7.0||||||
4355577|NCT00385515|4183534|B1|India||Region of Enrollment||participants|Number|18|18.0||||||
4355578|NCT00385515|4183532|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4355579|NCT00385515|4183533|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4355580|NCT00385515|4183534|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4355581|NCT00385515|4183532|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4355582|NCT00385515|4183533|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355583|NCT00385515|4183534|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4355584|NCT00385515|4183532|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4355585|NCT00385515|4183533|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4355586|NCT00385515|4183534|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4355587|NCT00385515|4183532|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|12.6|12.6|||
4355588|NCT00385515|4183533|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|12.0|12.0|||
4355589|NCT00385515|4183534|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|12.9|12.9|||
4355590|NCT00385515|4183532|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4355591|NCT00385515|4183533|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4355592|NCT00385515|4183534|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4355593|NCT00385515|4183532|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4355594|NCT00385515|4183533|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4355595|NCT00385515|4183534|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4355596|NCT00385515|4183532|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4355597|NCT00385515|4183533|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4355598|NCT00385515|4183534|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4355599|NCT00385268|4183541|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4355600|NCT00385268|4183542|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4355601|NCT00385268|4183543|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4355602|NCT00385268|4183541|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4355603|NCT00385268|4183542|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4355604|NCT00385268|4183543|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4355605|NCT00385268|4183541|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4355606|NCT00385268|4183542|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4355607|NCT00385268|4183543|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4355608|NCT00385268|4183541|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|7.0|7.0|||
4355609|NCT00385268|4183542|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|7.7|7.7|||
4355610|NCT00385268|4183543|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|8.8|8.8|||
4355611|NCT00385268|4183541|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4355612|NCT00385268|4183542|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4355613|NCT00385268|4183543|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4355614|NCT00385268|4183541|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4355615|NCT00385268|4183542|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4355616|NCT00385268|4183543|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4355617|NCT00385268|4183541|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4355618|NCT00385268|4183542|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4355619|NCT00385268|4183543|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4355620|NCT00385255|4183550|B3|Geographic ancestry|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|33|33.0||||||
4355621|NCT00385255|4183551|B2|Geographic ancestry|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4355622|NCT00385255|4183552|B1|Geographic ancestry|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4355623|NCT00385255|4183550|B3|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1506|1506.0||||||
4355624|NCT00385255|4183551|B2|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|747|747.0||||||
4355625|NCT00385255|4183552|B1|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|759|759.0||||||
4355626|NCT00385255|4183550|B3|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4355627|NCT00385255|4183551|B2|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4355628|NCT00385255|4183552|B1|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4355629|NCT00385255|4183550|B3|Geographic ancestry|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4355630|NCT00385255|4183551|B2|Geographic ancestry|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4355631|NCT00385255|4183552|B1|Geographic ancestry|Native Hawaiian or other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4355632|NCT00385255|4183550|B3|Geographic ancestry|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4355633|NCT00385255|4183551|B2|Geographic ancestry|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4355634|NCT00385255|4183552|B1|Geographic ancestry|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4355635|NCT00385255|4183550|B3|Geographic ancestry|Asian-Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4355636|NCT00385255|4183551|B2|Geographic ancestry|Asian-Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4355637|NCT00385255|4183552|B1|Geographic ancestry|Asian-Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4355638|NCT00385255|4183550|B3|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4355639|NCT00385255|4183551|B2|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4355640|NCT00385255|4183552|B1|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4355641|NCT00385255|4183550|B3|Geographic ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4355642|NCT00385255|4183551|B2|Geographic ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4355643|NCT00385255|4183552|B1|Geographic ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4355644|NCT00385255|4183550|B3|Geographic ancestry|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4355645|NCT00385255|4183551|B2|Geographic ancestry|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4355646|NCT00385255|4183552|B1|Geographic ancestry|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4355647|NCT00385255|4183550|B3|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|151|151.0||||||
4355648|NCT00385255|4183551|B2|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
4355649|NCT00385255|4183552|B1|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
4355650|NCT00385255|4183550|B3||Male|Sex: Female, Male||Participants|Count of Participants|710|710.0||||||
4355651|NCT00385255|4183551|B2||Male|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4355652|NCT00385255|4183552|B1||Male|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4355653|NCT00385255|4183550|B3||Female|Sex: Female, Male||Participants|Count of Participants|1008|1008.0||||||
4355654|NCT00385255|4183551|B2||Female|Sex: Female, Male||Participants|Count of Participants|481|481.0||||||
4355655|NCT00385255|4183552|B1||Female|Sex: Female, Male||Participants|Count of Participants|527|527.0||||||
4355656|NCT00385255|4183550|B3|||Age||Years|Mean|49.12|49.12|Standard Deviation|14.66|14.66|||
4355657|NCT00385255|4183551|B2|||Age||Years|Mean|49.29|49.29|Standard Deviation|14.58|14.58|||
4355658|NCT00385255|4183552|B1|||Age||Years|Mean|48.95|48.95|Standard Deviation|14.74|14.74|||
4355659|NCT00385216|4183617|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4355660|NCT00385216|4183617|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4355661|NCT00385216|4183617|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4355662|NCT00385216|4183617|B1|||Age||years|Mean|23|23.0|Standard Deviation|5|5.0|||
4355663|NCT00385216|4183617|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4355664|NCT00385216|4183617|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4355665|NCT00385216|4183617|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4355666|NCT00385203|4183630|B3||Male|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|21|21.0||||||
4355667|NCT00385203|4183631|B2||Male|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|4|4.0||||||
4355668|NCT00385203|4183632|B1||Male|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|17|17.0||||||
4355669|NCT00385203|4183630|B3||Female|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|14|14.0||||||
4355670|NCT00385203|4183631|B2||Female|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|6|6.0||||||
4355671|NCT00385203|4183632|B1||Female|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|8|8.0||||||
4355672|NCT00385203|4183630|B3|||Age|Age at informed consent|years|Mean|52.8|52.8|Standard Deviation|10.9|10.9|||
4355673|NCT00385203|4183631|B2|||Age|Age at informed consent|years|Mean|44.6|44.6|Standard Deviation|9.4|9.4|||
4355674|NCT00385203|4183632|B1|||Age|Age at informed consent|years|Mean|56.1|56.1|Standard Deviation|9.8|9.8|||
4355675|NCT00385138|4183651|B3|Netherlands||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|60|60.0||||||
4355676|NCT00385138|4183652|B2|Netherlands||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|29|29.0||||||
4355677|NCT00385138|4183653|B1|Netherlands||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|31|31.0||||||
4355678|NCT00385138|4183651|B3|Thailand||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|116|116.0||||||
4355679|NCT00385138|4183652|B2|Thailand||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|58|58.0||||||
4355680|NCT00385138|4183653|B1|Thailand||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|58|58.0||||||
4355681|NCT00385138|4183651|B3|Spain||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|38|38.0||||||
4355682|NCT00385138|4183652|B2|Spain||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|21|21.0||||||
4355683|NCT00385138|4183653|B1|Spain||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|17|17.0||||||
4355684|NCT00385138|4183651|B3|Korea, Republic of||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|325|325.0||||||
4355685|NCT00385138|4183652|B2|Korea, Republic of||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|166|166.0||||||
4355686|NCT00385138|4183653|B1|Korea, Republic of||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|159|159.0||||||
4355687|NCT00385138|4183651|B3|South Africa||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|202|202.0||||||
4355688|NCT00385138|4183652|B2|South Africa||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|100|100.0||||||
4355689|NCT00385138|4183653|B1|South Africa||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|102|102.0||||||
4355690|NCT00385138|4183651|B3|Slovakia||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|60|60.0||||||
4355691|NCT00385138|4183652|B2|Slovakia||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|27|27.0||||||
4355692|NCT00385138|4183653|B1|Slovakia||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|33|33.0||||||
4355693|NCT00385138|4183651|B3|Russian Federation||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|433|433.0||||||
4355694|NCT00385138|4183652|B2|Russian Federation||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|218|218.0||||||
4355695|NCT00385138|4183653|B1|Russian Federation||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|215|215.0||||||
4355696|NCT00385138|4183651|B3|Belarus||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|64|64.0||||||
4355697|NCT00385138|4183652|B2|Belarus||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|31|31.0||||||
4355698|NCT00385138|4183653|B1|Belarus||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|33|33.0||||||
4355699|NCT00385138|4183651|B3|New Zealand||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|42|42.0||||||
4355700|NCT00385138|4183652|B2|New Zealand||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|20|20.0||||||
4355701|NCT00385138|4183653|B1|New Zealand||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|22|22.0||||||
4355702|NCT00385138|4183651|B3|Lithuania||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|109|109.0||||||
4355703|NCT00385138|4183652|B2|Lithuania||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|55|55.0||||||
4355704|NCT00385138|4183653|B1|Lithuania||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|54|54.0||||||
4355705|NCT00385138|4183651|B3|India||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|471|471.0||||||
4355706|NCT00385138|4183652|B2|India||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|236|236.0||||||
4355707|NCT00385138|4183653|B1|India||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|235|235.0||||||
4355708|NCT00385138|4183651|B3|Georgia||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|90|90.0||||||
4355709|NCT00385138|4183652|B2|Georgia||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|43|43.0||||||
4355710|NCT00385138|4183653|B1|Georgia||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|47|47.0||||||
4355711|NCT00385138|4183651|B3|Czech Republic||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|687|687.0||||||
4355712|NCT00385138|4183652|B2|Czech Republic||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|345|345.0||||||
4355713|NCT00385138|4183653|B1|Czech Republic||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|342|342.0||||||
4355714|NCT00385138|4183651|B3|Canada||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|5|5.0||||||
4355715|NCT00385138|4183652|B2|Canada||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|2|2.0||||||
4355716|NCT00385138|4183653|B1|Canada||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|3|3.0||||||
4355717|NCT00385138|4183651|B3|Bulgaria||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|797|797.0||||||
4355718|NCT00385138|4183652|B2|Bulgaria||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|394|394.0||||||
4355719|NCT00385138|4183653|B1|Bulgaria||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|403|403.0||||||
4355720|NCT00385138|4183651|B3|Brazil||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|97|97.0||||||
4355721|NCT00385138|4183652|B2|Brazil||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|49|49.0||||||
4355722|NCT00385138|4183653|B1|Brazil||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|48|48.0||||||
4355723|NCT00385138|4183651|B3|Argentina||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|81|81.0||||||
4355724|NCT00385138|4183652|B2|Argentina||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|42|42.0||||||
4355725|NCT00385138|4183653|B1|Argentina||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|39|39.0||||||
4355726|NCT00385138|4183651|B3|United States||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|1624|1624.0||||||
4355727|NCT00385138|4183652|B2|United States||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|809|809.0||||||
4355728|NCT00385138|4183653|B1|United States||Region of Enrollment|The analysis by region was performed on the mITT population.|participants|Number|815|815.0||||||
4355729|NCT00385138|4183651|B3||Male|Sex: Female, Male|mITT population|Participants|Count of Participants|3772|3772.0||||||
4355730|NCT00385138|4183652|B2||Male|Sex: Female, Male|mITT population|Participants|Count of Participants|1863|1863.0||||||
4355731|NCT00385138|4183653|B1||Male|Sex: Female, Male|mITT population|Participants|Count of Participants|1909|1909.0||||||
4355732|NCT00385138|4183651|B3||Female|Sex: Female, Male|mITT population|Participants|Count of Participants|1529|1529.0||||||
4355733|NCT00385138|4183652|B2||Female|Sex: Female, Male|mITT population|Participants|Count of Participants|782|782.0||||||
4355734|NCT00385138|4183653|B1||Female|Sex: Female, Male|mITT population|Participants|Count of Participants|747|747.0||||||
4355735|NCT00385138|4183651|B3|||Age|mITT population|years|Mean|62.5|62.5|Standard Deviation|11.4|11.4|||
4355736|NCT00385138|4183652|B2|||Age|mITT population|years|Mean|62.5|62.5|Standard Deviation|11.3|11.3|||
4355737|NCT00385138|4183653|B1|||Age|mITT population|years|Mean|62.5|62.5|Standard Deviation|11.4|11.4|||
4355738|NCT00385008|4183698|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355739|NCT00385008|4183699|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355740|NCT00385008|4183700|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355741|NCT00385008|4183698|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355742|NCT00385008|4183699|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355743|NCT00385008|4183700|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355744|NCT00385008|4183698|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4355745|NCT00385008|4183699|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4355746|NCT00385008|4183700|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4355747|NCT00385008|4183698|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355748|NCT00385008|4183699|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355749|NCT00385008|4183700|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355750|NCT00385008|4183698|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355751|NCT00385008|4183699|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355752|NCT00385008|4183700|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355753|NCT00385008|4183698|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355754|NCT00385008|4183699|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355755|NCT00385008|4183700|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355756|NCT00385008|4183698|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355757|NCT00385008|4183699|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355758|NCT00385008|4183700|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4355759|NCT00385008|4183698|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4355760|NCT00385008|4183699|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4355761|NCT00385008|4183700|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4355762|NCT00385008|4183698|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4355763|NCT00385008|4183699|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4355764|NCT00385008|4183700|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4355765|NCT00385008|4183698|B3|||Age||Years|Mean|32|32.0|Standard Deviation|7.27|7.27|||
4355766|NCT00385008|4183699|B2|||Age||Years|Mean|33.3|33.3|Standard Deviation|7.17|7.17|||
4355767|NCT00385008|4183700|B1|||Age||Years|Mean|30.6|30.6|Standard Deviation|7.50|7.5|||
4355768|NCT00384956|4183721|B1|Red blood cell and platelet||Transfusion dependence|Only 10 out of 22 evaluable participants have baseline transfusion dependence.|participants|Number|3|3.0||||||
4355769|NCT00384956|4183721|B1|Platelet||Transfusion dependence|Only 10 out of 22 evaluable participants have baseline transfusion dependence.|participants|Number|3|3.0||||||
4355770|NCT00384956|4183721|B1|Red blood cell||Transfusion dependence|Only 10 out of 22 evaluable participants have baseline transfusion dependence.|participants|Number|4|4.0||||||
4355771|NCT00384956|4183721|B1|||Bone marrow cellularity at baseline||percentage of bone marrow cellularity|Median|68|68.0|Full Range|||20.0|90.0|
4355772|NCT00384956|4183721|B1|High||International Prognostic Scoring System (IPSS)|"Score values:~Low = 0~INT-1 = 0.5-1.0~INT-2 = 1.5-2.0~High = greater than or equal to 2.5~The two lower categories can be further described as the lower risk group while the two upper categories can be further described as the higher risk group.~8 questions (7 symptoms + 1 quality of life) with answers ranging from 0=not at all to 5=almost always. The lower the score the milder the symptoms are."|participants|Number|6|6.0||||||
4355773|NCT00384956|4183721|B1|Int-2||International Prognostic Scoring System (IPSS)|"Score values:~Low = 0~INT-1 = 0.5-1.0~INT-2 = 1.5-2.0~High = greater than or equal to 2.5~The two lower categories can be further described as the lower risk group while the two upper categories can be further described as the higher risk group.~8 questions (7 symptoms + 1 quality of life) with answers ranging from 0=not at all to 5=almost always. The lower the score the milder the symptoms are."|participants|Number|7|7.0||||||
4355774|NCT00384956|4183721|B1|Int-1||International Prognostic Scoring System (IPSS)|"Score values:~Low = 0~INT-1 = 0.5-1.0~INT-2 = 1.5-2.0~High = greater than or equal to 2.5~The two lower categories can be further described as the lower risk group while the two upper categories can be further described as the higher risk group.~8 questions (7 symptoms + 1 quality of life) with answers ranging from 0=not at all to 5=almost always. The lower the score the milder the symptoms are."|participants|Number|8|8.0||||||
4355775|NCT00384956|4183721|B1|Low||International Prognostic Scoring System (IPSS)|"Score values:~Low = 0~INT-1 = 0.5-1.0~INT-2 = 1.5-2.0~High = greater than or equal to 2.5~The two lower categories can be further described as the lower risk group while the two upper categories can be further described as the higher risk group.~8 questions (7 symptoms + 1 quality of life) with answers ranging from 0=not at all to 5=almost always. The lower the score the milder the symptoms are."|participants|Number|1|1.0||||||
4355776|NCT00384956|4183721|B1|Complex||Cytogenetics||participants|Number|11|11.0||||||
4355777|NCT00384956|4183721|B1|Intermediate||Cytogenetics||participants|Number|4|4.0||||||
4355778|NCT00384956|4183721|B1|Normal||Cytogenetics||participants|Number|7|7.0||||||
4355779|NCT00384956|4183721|B1|AML||World Health Organization (WHO) classification|"RA = Refractory anemia~RCMD = Refractory cytopenia with multilineage dysplasia~CMML-1 = Chronic myelomonocytic leukemia type 1~RAEB-1 = Refractory anemia with excess blasts type 1~RAEB-2 = Refractory anemia with excess blasts type 2~AML = Acute myeloid leukemia"|participants|Number|2|2.0||||||
4355780|NCT00384956|4183721|B1|RAEB-2||World Health Organization (WHO) classification|"RA = Refractory anemia~RCMD = Refractory cytopenia with multilineage dysplasia~CMML-1 = Chronic myelomonocytic leukemia type 1~RAEB-1 = Refractory anemia with excess blasts type 1~RAEB-2 = Refractory anemia with excess blasts type 2~AML = Acute myeloid leukemia"|participants|Number|9|9.0||||||
4355781|NCT00384956|4183721|B1|RAEB-1||World Health Organization (WHO) classification|"RA = Refractory anemia~RCMD = Refractory cytopenia with multilineage dysplasia~CMML-1 = Chronic myelomonocytic leukemia type 1~RAEB-1 = Refractory anemia with excess blasts type 1~RAEB-2 = Refractory anemia with excess blasts type 2~AML = Acute myeloid leukemia"|participants|Number|3|3.0||||||
4355782|NCT00384956|4183721|B1|CMML-1||World Health Organization (WHO) classification|"RA = Refractory anemia~RCMD = Refractory cytopenia with multilineage dysplasia~CMML-1 = Chronic myelomonocytic leukemia type 1~RAEB-1 = Refractory anemia with excess blasts type 1~RAEB-2 = Refractory anemia with excess blasts type 2~AML = Acute myeloid leukemia"|participants|Number|2|2.0||||||
4355783|NCT00384956|4183721|B1|RCMD||World Health Organization (WHO) classification|"RA = Refractory anemia~RCMD = Refractory cytopenia with multilineage dysplasia~CMML-1 = Chronic myelomonocytic leukemia type 1~RAEB-1 = Refractory anemia with excess blasts type 1~RAEB-2 = Refractory anemia with excess blasts type 2~AML = Acute myeloid leukemia"|participants|Number|3|3.0||||||
4355784|NCT00384956|4183721|B1|RA||World Health Organization (WHO) classification|"RA = Refractory anemia~RCMD = Refractory cytopenia with multilineage dysplasia~CMML-1 = Chronic myelomonocytic leukemia type 1~RAEB-1 = Refractory anemia with excess blasts type 1~RAEB-2 = Refractory anemia with excess blasts type 2~AML = Acute myeloid leukemia"|participants|Number|3|3.0||||||
4355785|NCT00384956|4183721|B1|RAEB-t||French, American, British (FAB) classification|"RA = refractory anemia~CMML = Chronic myelomonocytic leukemia~RAEB = Refractory Anemia with Excess Blasts in Transmission~RAEB-t =Refractory Anemia with Excess Blasts in Transformation"|participants|Number|2|2.0||||||
4355786|NCT00384956|4183721|B1|RAEB||French, American, British (FAB) classification|"RA = refractory anemia~CMML = Chronic myelomonocytic leukemia~RAEB = Refractory Anemia with Excess Blasts in Transmission~RAEB-t =Refractory Anemia with Excess Blasts in Transformation"|participants|Number|12|12.0||||||
4355787|NCT00384956|4183721|B1|CMML||French, American, British (FAB) classification|"RA = refractory anemia~CMML = Chronic myelomonocytic leukemia~RAEB = Refractory Anemia with Excess Blasts in Transmission~RAEB-t =Refractory Anemia with Excess Blasts in Transformation"|participants|Number|2|2.0||||||
4355788|NCT00384956|4183721|B1|RA||French, American, British (FAB) classification|"RA = refractory anemia~CMML = Chronic myelomonocytic leukemia~RAEB = Refractory Anemia with Excess Blasts in Transmission~RAEB-t =Refractory Anemia with Excess Blasts in Transformation"|participants|Number|6|6.0||||||
4355789|NCT00384956|4183721|B1|||Duration of myelodysplastic syndrome (MDS) at study entry||days|Median|15.5|15.5|Full Range|||0.0|1412.0|
4355826|NCT00384930|4183737|B2|Sexually Active with ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|113|113.0||||||
4355827|NCT00384930|4183738|B1|Sexually Active with ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|115|115.0||||||
4355790|NCT00384956|4183721|B1|Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG Performance Status Grade~0 Fully active able to carry on all predisease performance without restriction~1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~2 Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~3 Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~4 Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~5 Dead"|participants|Number|1|1.0||||||
4355791|NCT00384956|4183721|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG Performance Status Grade~0 Fully active able to carry on all predisease performance without restriction~1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~2 Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~3 Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~4 Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~5 Dead"|participants|Number|2|2.0||||||
4355792|NCT00384956|4183721|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG Performance Status Grade~0 Fully active able to carry on all predisease performance without restriction~1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~2 Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~3 Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~4 Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~5 Dead"|participants|Number|15|15.0||||||
4355793|NCT00384956|4183721|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG Performance Status Grade~0 Fully active able to carry on all predisease performance without restriction~1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (light house work/office work)~2 Ambulatory, capable of all selfcare but unable to carry out any work activities. Up & about more than 50% of waking hours~3 Capable of limited selfcare, confined to bed/chair more than 50% of waking hours~4 Completely disabled. Cannot carry on selfcare. Totally confined to bed/chair~5 Dead"|participants|Number|4|4.0||||||
4355794|NCT00384956|4183721|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4355795|NCT00384956|4183721|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4355796|NCT00384956|4183721|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4355797|NCT00384956|4183721|B1|||Age||years|Median|69.5|69.5|Full Range|||53.0|79.0|
4355798|NCT00384930|4183733|B6|Sexual Activity and/or ED Status is Unknown||Sexually Active and Erectile Dysfunction (ED)||participants|Number|7|7.0||||||
4355799|NCT00384930|4183734|B5|Sexual Activity and/or ED Status is Unknown||Sexually Active and Erectile Dysfunction (ED)||participants|Number|2|2.0||||||
4355800|NCT00384930|4183735|B4|Sexual Activity and/or ED Status is Unknown||Sexually Active and Erectile Dysfunction (ED)||participants|Number|2|2.0||||||
4355801|NCT00384930|4183736|B3|Sexual Activity and/or ED Status is Unknown||Sexually Active and Erectile Dysfunction (ED)||participants|Number|0|0.0||||||
4355802|NCT00384930|4183737|B2|Sexual Activity and/or ED Status is Unknown||Sexually Active and Erectile Dysfunction (ED)||participants|Number|2|2.0||||||
4355803|NCT00384930|4183738|B1|Sexual Activity and/or ED Status is Unknown||Sexually Active and Erectile Dysfunction (ED)||participants|Number|1|1.0||||||
4355804|NCT00384930|4183733|B6|Not Sexually Active without ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|70|70.0||||||
4355805|NCT00384930|4183734|B5|Not Sexually Active without ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|18|18.0||||||
4355806|NCT00384930|4183735|B4|Not Sexually Active without ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|12|12.0||||||
4355807|NCT00384930|4183736|B3|Not Sexually Active without ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|8|8.0||||||
4355808|NCT00384930|4183737|B2|Not Sexually Active without ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|17|17.0||||||
4355809|NCT00384930|4183738|B1|Not Sexually Active without ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|15|15.0||||||
4355810|NCT00384930|4183733|B6|Not Sexually Active with ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|128|128.0||||||
4355811|NCT00384930|4183734|B5|Not Sexually Active with ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|28|28.0||||||
4355812|NCT00384930|4183735|B4|Not Sexually Active with ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|28|28.0||||||
4355813|NCT00384930|4183736|B3|Not Sexually Active with ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|25|25.0||||||
4355814|NCT00384930|4183737|B2|Not Sexually Active with ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|21|21.0||||||
4355815|NCT00384930|4183738|B1|Not Sexually Active with ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|26|26.0||||||
4355816|NCT00384930|4183733|B6|Sexually Active without ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|270|270.0||||||
4355817|NCT00384930|4183734|B5|Sexually Active without ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|45|45.0||||||
4355818|NCT00384930|4183735|B4|Sexually Active without ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|54|54.0||||||
4355819|NCT00384930|4183736|B3|Sexually Active without ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|62|62.0||||||
4355820|NCT00384930|4183737|B2|Sexually Active without ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|55|55.0||||||
4355821|NCT00384930|4183738|B1|Sexually Active without ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|54|54.0||||||
4355822|NCT00384930|4183733|B6|Sexually Active with ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|581|581.0||||||
4355823|NCT00384930|4183734|B5|Sexually Active with ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|116|116.0||||||
4355824|NCT00384930|4183735|B4|Sexually Active with ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|120|120.0||||||
4355825|NCT00384930|4183736|B3|Sexually Active with ED||Sexually Active and Erectile Dysfunction (ED)||participants|Number|117|117.0||||||
4355828|NCT00384930|4183733|B6|Yes||Sexually Active||participants|Number|851|851.0||||||
4355829|NCT00384930|4183734|B5|Yes||Sexually Active||participants|Number|161|161.0||||||
4355830|NCT00384930|4183735|B4|Yes||Sexually Active||participants|Number|174|174.0||||||
4355831|NCT00384930|4183736|B3|Yes||Sexually Active||participants|Number|179|179.0||||||
4355832|NCT00384930|4183737|B2|Yes||Sexually Active||participants|Number|168|168.0||||||
4355833|NCT00384930|4183738|B1|Yes||Sexually Active||participants|Number|169|169.0||||||
4355834|NCT00384930|4183733|B6|No||Sexually Active||participants|Number|205|205.0||||||
4355835|NCT00384930|4183734|B5|No||Sexually Active||participants|Number|48|48.0||||||
4355836|NCT00384930|4183735|B4|No||Sexually Active||participants|Number|42|42.0||||||
4355837|NCT00384930|4183736|B3|No||Sexually Active||participants|Number|33|33.0||||||
4355838|NCT00384930|4183737|B2|No||Sexually Active||participants|Number|40|40.0||||||
4355839|NCT00384930|4183738|B1|No||Sexually Active||participants|Number|42|42.0||||||
4355840|NCT00384930|4183733|B6|Severe||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|109|109.0||||||
4355841|NCT00384930|4183734|B5|Severe||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|26|26.0||||||
4355842|NCT00384930|4183735|B4|Severe||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|22|22.0||||||
4355843|NCT00384930|4183736|B3|Severe||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|21|21.0||||||
4355844|NCT00384930|4183737|B2|Severe||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|18|18.0||||||
4355845|NCT00384930|4183738|B1|Severe||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|22|22.0||||||
4355846|NCT00384930|4183733|B6|Moderate||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|390|390.0||||||
4355847|NCT00384930|4183734|B5|Moderate||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|79|79.0||||||
4355848|NCT00384930|4183735|B4|Moderate||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|72|72.0||||||
4355849|NCT00384930|4183736|B3|Moderate||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|82|82.0||||||
4355850|NCT00384930|4183737|B2|Moderate||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|75|75.0||||||
4355851|NCT00384930|4183738|B1|Moderate||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|82|82.0||||||
4355852|NCT00384930|4183733|B6|Mild||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|217|217.0||||||
4355853|NCT00384930|4183734|B5|Mild||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|40|40.0||||||
4355907|NCT00384930|4183734|B5|Unknown||Erectile Dysfunction||participants|Number|3|3.0||||||
4355908|NCT00384930|4183735|B4|Unknown||Erectile Dysfunction||participants|Number|2|2.0||||||
4355854|NCT00384930|4183735|B4|Mild||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|56|56.0||||||
4355855|NCT00384930|4183736|B3|Mild||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|41|41.0||||||
4355856|NCT00384930|4183737|B2|Mild||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|42|42.0||||||
4355857|NCT00384930|4183738|B1|Mild||Severity of Erectile Dysfunction (ED)|Severity was determine only on participants with Erectile Dysfunction using scores on International Index of Erectile Function (IIEF) EF Domain (sum of the scores for Questions 1 through 5 and Question 15) with a range of 0 to 30. Normal EF (≥26), mild ED (17 to 25), moderate ED (11 to 16), and severe ED (1 to 10).|participants|Number|38|38.0||||||
4355858|NCT00384930|4183733|B6|West Asian||Race/Ethnicity||participants|Number|4|4.0||||||
4355859|NCT00384930|4183734|B5|West Asian||Race/Ethnicity||participants|Number|3|3.0||||||
4355860|NCT00384930|4183735|B4|West Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4355861|NCT00384930|4183736|B3|West Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4355862|NCT00384930|4183737|B2|West Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4355863|NCT00384930|4183738|B1|West Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4355864|NCT00384930|4183733|B6|Hispanic||Race/Ethnicity||participants|Number|123|123.0||||||
4355865|NCT00384930|4183734|B5|Hispanic||Race/Ethnicity||participants|Number|25|25.0||||||
4355866|NCT00384930|4183735|B4|Hispanic||Race/Ethnicity||participants|Number|24|24.0||||||
4355867|NCT00384930|4183736|B3|Hispanic||Race/Ethnicity||participants|Number|25|25.0||||||
4355868|NCT00384930|4183737|B2|Hispanic||Race/Ethnicity||participants|Number|20|20.0||||||
4355869|NCT00384930|4183738|B1|Hispanic||Race/Ethnicity||participants|Number|29|29.0||||||
4355870|NCT00384930|4183733|B6|East Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4355871|NCT00384930|4183734|B5|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4355872|NCT00384930|4183735|B4|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4355873|NCT00384930|4183736|B3|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4355874|NCT00384930|4183737|B2|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4355875|NCT00384930|4183738|B1|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4355876|NCT00384930|4183733|B6|Caucasian||Race/Ethnicity||participants|Number|904|904.0||||||
4355877|NCT00384930|4183734|B5|Caucasian||Race/Ethnicity||participants|Number|176|176.0||||||
4355878|NCT00384930|4183735|B4|Caucasian||Race/Ethnicity||participants|Number|186|186.0||||||
4355879|NCT00384930|4183736|B3|Caucasian||Race/Ethnicity||participants|Number|179|179.0||||||
4355880|NCT00384930|4183737|B2|Caucasian||Race/Ethnicity||participants|Number|184|184.0||||||
4355881|NCT00384930|4183738|B1|Caucasian||Race/Ethnicity||participants|Number|179|179.0||||||
4355882|NCT00384930|4183733|B6|African||Race/Ethnicity||participants|Number|23|23.0||||||
4355883|NCT00384930|4183734|B5|African||Race/Ethnicity||participants|Number|5|5.0||||||
4355884|NCT00384930|4183735|B4|African||Race/Ethnicity||participants|Number|5|5.0||||||
4355885|NCT00384930|4183736|B3|African||Race/Ethnicity||participants|Number|7|7.0||||||
4355886|NCT00384930|4183737|B2|African||Race/Ethnicity||participants|Number|3|3.0||||||
4355887|NCT00384930|4183738|B1|African||Race/Ethnicity||participants|Number|3|3.0||||||
4355888|NCT00384930|4183733|B6|Yes||Previous Therapy for Benign Prostatic Hyperplasia (BPH)||participants|Number|294|294.0||||||
4355889|NCT00384930|4183734|B5|Yes||Previous Therapy for Benign Prostatic Hyperplasia (BPH)||participants|Number|57|57.0||||||
4355890|NCT00384930|4183735|B4|Yes||Previous Therapy for Benign Prostatic Hyperplasia (BPH)||participants|Number|56|56.0||||||
4355891|NCT00384930|4183736|B3|Yes||Previous Therapy for Benign Prostatic Hyperplasia (BPH)||participants|Number|54|54.0||||||
4355892|NCT00384930|4183737|B2|Yes||Previous Therapy for Benign Prostatic Hyperplasia (BPH)||participants|Number|69|69.0||||||
4355893|NCT00384930|4183738|B1|Yes||Previous Therapy for Benign Prostatic Hyperplasia (BPH)||participants|Number|58|58.0||||||
4355894|NCT00384930|4183733|B6|No||Previous Therapy for Benign Prostatic Hyperplasia (BPH)||participants|Number|762|762.0||||||
4355895|NCT00384930|4183734|B5|No||Previous Therapy for Benign Prostatic Hyperplasia (BPH)||participants|Number|152|152.0||||||
4355896|NCT00384930|4183735|B4|No||Previous Therapy for Benign Prostatic Hyperplasia (BPH)||participants|Number|160|160.0||||||
4355897|NCT00384930|4183736|B3|No||Previous Therapy for Benign Prostatic Hyperplasia (BPH)||participants|Number|158|158.0||||||
4355898|NCT00384930|4183737|B2|No||Previous Therapy for Benign Prostatic Hyperplasia (BPH)||participants|Number|139|139.0||||||
4355899|NCT00384930|4183738|B1|No||Previous Therapy for Benign Prostatic Hyperplasia (BPH)||participants|Number|153|153.0||||||
4355900|NCT00384930|4183733|B6|Not Collected||Erectile Dysfunction||participants|Number|1|1.0||||||
4355901|NCT00384930|4183734|B5|Not Collected||Erectile Dysfunction||participants|Number|0|0.0||||||
4355902|NCT00384930|4183735|B4|Not Collected||Erectile Dysfunction||participants|Number|0|0.0||||||
4355903|NCT00384930|4183736|B3|Not Collected||Erectile Dysfunction||participants|Number|0|0.0||||||
4355904|NCT00384930|4183737|B2|Not Collected||Erectile Dysfunction||participants|Number|0|0.0||||||
4355905|NCT00384930|4183738|B1|Not Collected||Erectile Dysfunction||participants|Number|1|1.0||||||
4355906|NCT00384930|4183733|B6|Unknown||Erectile Dysfunction||participants|Number|8|8.0||||||
4355909|NCT00384930|4183736|B3|Unknown||Erectile Dysfunction||participants|Number|0|0.0||||||
4355910|NCT00384930|4183737|B2|Unknown||Erectile Dysfunction||participants|Number|2|2.0||||||
4355911|NCT00384930|4183738|B1|Unknown||Erectile Dysfunction||participants|Number|1|1.0||||||
4355912|NCT00384930|4183733|B6|No||Erectile Dysfunction||participants|Number|331|331.0||||||
4355913|NCT00384930|4183734|B5|No||Erectile Dysfunction||participants|Number|61|61.0||||||
4355914|NCT00384930|4183735|B4|No||Erectile Dysfunction||participants|Number|64|64.0||||||
4355915|NCT00384930|4183736|B3|No||Erectile Dysfunction||participants|Number|68|68.0||||||
4355916|NCT00384930|4183737|B2|No||Erectile Dysfunction||participants|Number|71|71.0||||||
4355917|NCT00384930|4183738|B1|No||Erectile Dysfunction||participants|Number|67|67.0||||||
4355918|NCT00384930|4183733|B6|Yes||Erectile Dysfunction||participants|Number|716|716.0||||||
4355919|NCT00384930|4183734|B5|Yes||Erectile Dysfunction||participants|Number|145|145.0||||||
4355920|NCT00384930|4183735|B4|Yes||Erectile Dysfunction||participants|Number|150|150.0||||||
4355921|NCT00384930|4183736|B3|Yes||Erectile Dysfunction||participants|Number|144|144.0||||||
4355922|NCT00384930|4183737|B2|Yes||Erectile Dysfunction||participants|Number|135|135.0||||||
4355923|NCT00384930|4183738|B1|Yes||Erectile Dysfunction||participants|Number|142|142.0||||||
4355924|NCT00384930|4183733|B6|> 3 years||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|541|541.0||||||
4355925|NCT00384930|4183734|B5|> 3 years||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|100|100.0||||||
4355926|NCT00384930|4183735|B4|> 3 years||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|107|107.0||||||
4355927|NCT00384930|4183736|B3|> 3 years||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|112|112.0||||||
4355928|NCT00384930|4183737|B2|> 3 years||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|117|117.0||||||
4355929|NCT00384930|4183738|B1|> 3 years||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|105|105.0||||||
4355930|NCT00384930|4183733|B6|1 year to 3 years||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|340|340.0||||||
4355931|NCT00384930|4183734|B5|1 year to 3 years||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|70|70.0||||||
4355932|NCT00384930|4183735|B4|1 year to 3 years||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|81|81.0||||||
4355933|NCT00384930|4183736|B3|1 year to 3 years||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|63|63.0||||||
4355934|NCT00384930|4183737|B2|1 year to 3 years||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|64|64.0||||||
4355935|NCT00384930|4183738|B1|1 year to 3 years||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|62|62.0||||||
4355936|NCT00384930|4183733|B6|6 months to 1 year||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|174|174.0||||||
4355937|NCT00384930|4183734|B5|6 months to 1 year||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|39|39.0||||||
4355938|NCT00384930|4183735|B4|6 months to 1 year||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|27|27.0||||||
4355939|NCT00384930|4183736|B3|6 months to 1 year||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|37|37.0||||||
4355940|NCT00384930|4183737|B2|6 months to 1 year||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|27|27.0||||||
4355941|NCT00384930|4183738|B1|6 months to 1 year||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|44|44.0||||||
4355942|NCT00384930|4183733|B6|< 6 months||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|1|1.0||||||
4355943|NCT00384930|4183734|B5|< 6 months||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|0|0.0||||||
4355944|NCT00384930|4183735|B4|< 6 months||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|1|1.0||||||
4355945|NCT00384930|4183736|B3|< 6 months||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|0|0.0||||||
4355946|NCT00384930|4183737|B2|< 6 months||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|0|0.0||||||
4355947|NCT00384930|4183738|B1|< 6 months||Duration of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)||participants|Number|0|0.0||||||
4355948|NCT00384930|4183733|B6|Unknown||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|1|1.0||||||
4355949|NCT00384930|4183734|B5|Unknown||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|0|0.0||||||
4355950|NCT00384930|4183735|B4|Unknown||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|1|1.0||||||
4355982|NCT00384930|4183737|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4355983|NCT00384930|4183738|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4355951|NCT00384930|4183736|B3|Unknown||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|0|0.0||||||
4355952|NCT00384930|4183737|B2|Unknown||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|0|0.0||||||
4355953|NCT00384930|4183738|B1|Unknown||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|0|0.0||||||
4355954|NCT00384930|4183733|B6|Severe (>=20 units on a scale: IPSS)||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|354|354.0||||||
4355955|NCT00384930|4183734|B5|Severe (>=20 units on a scale: IPSS)||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|68|68.0||||||
4355956|NCT00384930|4183735|B4|Severe (>=20 units on a scale: IPSS)||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|72|72.0||||||
4355957|NCT00384930|4183736|B3|Severe (>=20 units on a scale: IPSS)||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|71|71.0||||||
4355958|NCT00384930|4183737|B2|Severe (>=20 units on a scale: IPSS)||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|69|69.0||||||
4355959|NCT00384930|4183738|B1|Severe (>=20 units on a scale: IPSS)||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|74|74.0||||||
4355960|NCT00384930|4183733|B6|Moderate (<20 units on a scale: IPSS)||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|701|701.0||||||
4355961|NCT00384930|4183734|B5|Moderate (<20 units on a scale: IPSS)||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|141|141.0||||||
4355962|NCT00384930|4183735|B4|Moderate (<20 units on a scale: IPSS)||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|143|143.0||||||
4355963|NCT00384930|4183736|B3|Moderate (<20 units on a scale: IPSS)||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|141|141.0||||||
4355964|NCT00384930|4183737|B2|Moderate (<20 units on a scale: IPSS)||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|139|139.0||||||
4355965|NCT00384930|4183738|B1|Moderate (<20 units on a scale: IPSS)||Baseline (Visit 3) Lower Urinary Tract Symptoms (LUTS) Severity|LUTS Severity was measured with the International Prostate Symptom Score (IPSS), which has a scoring range of 0 to 35. Total scores: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic.|participants|Number|137|137.0||||||
4355966|NCT00384930|4183733|B6|United States||Region of Enrollment||participants|Number|540|540.0||||||
4355967|NCT00384930|4183734|B5|United States||Region of Enrollment||participants|Number|108|108.0||||||
4355968|NCT00384930|4183735|B4|United States||Region of Enrollment||participants|Number|106|106.0||||||
4355969|NCT00384930|4183736|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
4355970|NCT00384930|4183737|B2|United States||Region of Enrollment||participants|Number|112|112.0||||||
4355971|NCT00384930|4183738|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
4355972|NCT00384930|4183733|B6|Sweden||Region of Enrollment||participants|Number|20|20.0||||||
4355973|NCT00384930|4183734|B5|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4355974|NCT00384930|4183735|B4|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4355975|NCT00384930|4183736|B3|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4355976|NCT00384930|4183737|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4355977|NCT00384930|4183738|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4355978|NCT00384930|4183733|B6|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4355979|NCT00384930|4183734|B5|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4355980|NCT00384930|4183735|B4|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4355981|NCT00384930|4183736|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4355984|NCT00384930|4183733|B6|Mexico||Region of Enrollment||participants|Number|90|90.0||||||
4355985|NCT00384930|4183734|B5|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
4355986|NCT00384930|4183735|B4|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
4355987|NCT00384930|4183736|B3|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4355988|NCT00384930|4183737|B2|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
4355989|NCT00384930|4183738|B1|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
4355990|NCT00384930|4183733|B6|Italy||Region of Enrollment||participants|Number|48|48.0||||||
4355991|NCT00384930|4183734|B5|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4355992|NCT00384930|4183735|B4|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4355993|NCT00384930|4183736|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4355994|NCT00384930|4183737|B2|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4355995|NCT00384930|4183738|B1|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4355996|NCT00384930|4183733|B6|Greece||Region of Enrollment||participants|Number|50|50.0||||||
4355997|NCT00384930|4183734|B5|Greece||Region of Enrollment||participants|Number|10|10.0||||||
4355998|NCT00384930|4183735|B4|Greece||Region of Enrollment||participants|Number|11|11.0||||||
4355999|NCT00384930|4183736|B3|Greece||Region of Enrollment||participants|Number|12|12.0||||||
4356000|NCT00384930|4183737|B2|Greece||Region of Enrollment||participants|Number|9|9.0||||||
4356001|NCT00384930|4183738|B1|Greece||Region of Enrollment||participants|Number|8|8.0||||||
4356002|NCT00384930|4183733|B6|Germany||Region of Enrollment||participants|Number|164|164.0||||||
4356003|NCT00384930|4183734|B5|Germany||Region of Enrollment||participants|Number|33|33.0||||||
4356004|NCT00384930|4183735|B4|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4356005|NCT00384930|4183736|B3|Germany||Region of Enrollment||participants|Number|39|39.0||||||
4356006|NCT00384930|4183737|B2|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4356007|NCT00384930|4183738|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4356008|NCT00384930|4183733|B6|France||Region of Enrollment||participants|Number|60|60.0||||||
4356009|NCT00384930|4183734|B5|France||Region of Enrollment||participants|Number|11|11.0||||||
4356010|NCT00384930|4183735|B4|France||Region of Enrollment||participants|Number|15|15.0||||||
4356011|NCT00384930|4183736|B3|France||Region of Enrollment||participants|Number|9|9.0||||||
4356012|NCT00384930|4183737|B2|France||Region of Enrollment||participants|Number|12|12.0||||||
4356013|NCT00384930|4183738|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4356014|NCT00384930|4183733|B6|Canada||Region of Enrollment||participants|Number|45|45.0||||||
4356015|NCT00384930|4183734|B5|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4356016|NCT00384930|4183735|B4|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4356017|NCT00384930|4183736|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4356018|NCT00384930|4183737|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4356019|NCT00384930|4183738|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4356020|NCT00384930|4183733|B6|Australia||Region of Enrollment||participants|Number|24|24.0||||||
4356021|NCT00384930|4183734|B5|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4356022|NCT00384930|4183735|B4|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4356023|NCT00384930|4183736|B3|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4356024|NCT00384930|4183737|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4356025|NCT00384930|4183738|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4356026|NCT00384930|4183733|B6||Male|Sex: Female, Male||Participants|Count of Participants|1056|1056.0||||||
4356027|NCT00384930|4183734|B5||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4356028|NCT00384930|4183735|B4||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4356029|NCT00384930|4183736|B3||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4356030|NCT00384930|4183737|B2||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4356031|NCT00384930|4183738|B1||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4356032|NCT00384930|4183733|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356033|NCT00384930|4183734|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356034|NCT00384930|4183735|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356035|NCT00384930|4183736|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356036|NCT00384930|4183737|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356037|NCT00384930|4183738|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356038|NCT00384930|4183733|B6|||Age||years|Mean|62.10|62.1|Standard Deviation|7.91|7.91|||
4356039|NCT00384930|4183734|B5|||Age||years|Mean|62.55|62.55|Standard Deviation|8.09|8.09|||
4356040|NCT00384930|4183735|B4|||Age||years|Mean|62.22|62.22|Standard Deviation|7.20|7.2|||
4356041|NCT00384930|4183736|B3|||Age||years|Mean|61.95|61.95|Standard Deviation|8.17|8.17|||
4356042|NCT00384930|4183737|B2|||Age||years|Mean|62.03|62.03|Standard Deviation|8.42|8.42|||
4356043|NCT00384930|4183738|B1|||Age||years|Mean|61.75|61.75|Standard Deviation|7.69|7.69|||
4356044|NCT00384865|4183796|B5|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
4356045|NCT00384865|4183797|B4|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4356046|NCT00384865|4183798|B3|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4356047|NCT00384865|4183799|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4356048|NCT00384865|4183800|B1|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4356049|NCT00384865|4183796|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4356050|NCT00384865|4183797|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356051|NCT00384865|4183798|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356052|NCT00384865|4183799|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356053|NCT00384865|4183800|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356054|NCT00384865|4183796|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356055|NCT00384865|4183797|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356056|NCT00384865|4183798|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356057|NCT00384865|4183799|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356058|NCT00384865|4183800|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356059|NCT00384865|4183796|B5||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4356060|NCT00384865|4183797|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4356061|NCT00384865|4183798|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4356062|NCT00384865|4183799|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4356063|NCT00384865|4183800|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4356064|NCT00384865|4183796|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4356065|NCT00384865|4183797|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4356066|NCT00384865|4183798|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4356067|NCT00384865|4183799|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4356068|NCT00384865|4183800|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4356069|NCT00384865|4183796|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356070|NCT00384865|4183797|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356071|NCT00384865|4183798|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356072|NCT00384865|4183799|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356073|NCT00384865|4183800|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356074|NCT00384865|4183796|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4356075|NCT00384865|4183797|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4356076|NCT00384865|4183798|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356077|NCT00384865|4183799|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356078|NCT00384865|4183800|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356079|NCT00384865|4183796|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356080|NCT00384865|4183797|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356081|NCT00384865|4183798|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356082|NCT00384865|4183799|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356083|NCT00384865|4183800|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356084|NCT00384865|4183796|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356085|NCT00384865|4183797|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356086|NCT00384865|4183798|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356087|NCT00384865|4183799|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356088|NCT00384865|4183800|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356089|NCT00384865|4183796|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4356090|NCT00384865|4183797|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4356091|NCT00384865|4183798|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4356092|NCT00384865|4183799|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4356093|NCT00384865|4183800|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4356094|NCT00384865|4183796|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4356095|NCT00384865|4183797|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356096|NCT00384865|4183798|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4356097|NCT00384865|4183799|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356098|NCT00384865|4183800|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4356099|NCT00384865|4183796|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4356100|NCT00384865|4183797|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4356101|NCT00384865|4183798|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4356102|NCT00384865|4183799|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4356103|NCT00384865|4183800|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4356104|NCT00384865|4183796|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4356105|NCT00384865|4183797|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4356106|NCT00384865|4183798|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4356107|NCT00384865|4183799|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4356108|NCT00384865|4183800|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4356109|NCT00384865|4183796|B5|||Age||Years|Mean|59.6|59.6|Standard Deviation|13.9|13.9|||
4356110|NCT00384865|4183797|B4|||Age||Years|Mean|63.5|63.5|Standard Deviation|14.2|14.2|||
4356111|NCT00384865|4183798|B3|||Age||Years|Mean|58.6|58.6|Standard Deviation|11.7|11.7|||
4356112|NCT00384865|4183799|B2|||Age||Years|Mean|56.75|56.75|Standard Deviation|13.2|13.2|||
4356113|NCT00384865|4183800|B1|||Age||Years|Mean|59.6|59.6|Standard Deviation|16.6|16.6|||
4356114|NCT00384839|4183821|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4356115|NCT00384839|4183821|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4356116|NCT00384839|4183821|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4356117|NCT00384839|4183821|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4356118|NCT00384839|4183821|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4356119|NCT00384839|4183821|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356120|NCT00384839|4183821|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|9.19|9.19|||
4356121|NCT00384813|4183830|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356122|NCT00384813|4183831|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356123|NCT00384813|4183832|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356124|NCT00384813|4183830|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356125|NCT00384813|4183831|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356126|NCT00384813|4183832|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356127|NCT00384813|4183830|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356128|NCT00384813|4183831|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356129|NCT00384813|4183832|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356130|NCT00384813|4183830|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4356131|NCT00384813|4183831|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4356132|NCT00384813|4183832|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4356133|NCT00384813|4183830|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356134|NCT00384813|4183831|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356135|NCT00384813|4183832|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356136|NCT00384813|4183830|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356137|NCT00384813|4183831|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356138|NCT00384813|4183832|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356139|NCT00384813|4183830|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356140|NCT00384813|4183831|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356141|NCT00384813|4183832|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356142|NCT00384813|4183830|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4356143|NCT00384813|4183831|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4356144|NCT00384813|4183832|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4356145|NCT00384813|4183830|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4356146|NCT00384813|4183831|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4356147|NCT00384813|4183832|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4356148|NCT00384813|4183830|B3|||Age||years|Mean|10.5|10.5|Standard Deviation|1.6|1.6|||
4356149|NCT00384813|4183831|B2|||Age||years|Mean|10.6|10.6|Standard Deviation|1.9|1.9|||
4356150|NCT00384813|4183832|B1|||Age||years|Mean|10.4|10.4|Standard Deviation|1.4|1.4|||
4356151|NCT00384748|4183839|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4356152|NCT00384748|4183840|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4356153|NCT00384748|4183841|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4356154|NCT00384748|4183839|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4356155|NCT00384748|4183840|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4356156|NCT00384748|4183841|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4356157|NCT00384748|4183839|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356158|NCT00384748|4183840|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356159|NCT00384748|4183841|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356160|NCT00384748|4183839|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4356161|NCT00384748|4183840|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4356162|NCT00384748|4183841|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4356163|NCT00384748|4183839|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4356164|NCT00384748|4183840|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4356165|NCT00384748|4183841|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4356166|NCT00384748|4183839|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356167|NCT00384748|4183840|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356168|NCT00384748|4183841|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356169|NCT00384670|4183848|B1|Thailand||Region of Enrollment||participants|Number|7|7.0||||||
4356170|NCT00384670|4183848|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4356171|NCT00384670|4183848|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4356172|NCT00384670|4183848|B1|||Age||years|Mean|6.6|6.6|Standard Deviation|0.5|0.5|||
4356173|NCT00384670|4183848|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356174|NCT00384670|4183848|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4356175|NCT00384670|4183848|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4356176|NCT00384397|4183858|B4|United States||Region of Enrollment||participants|Number|1118|1118.0||||||
4356177|NCT00384397|4183859|B3|United States||Region of Enrollment||participants|Number|418|418.0||||||
4356178|NCT00384397|4183860|B2|United States||Region of Enrollment||participants|Number|293|293.0||||||
4356179|NCT00384397|4183861|B1|United States||Region of Enrollment||participants|Number|407|407.0||||||
4356180|NCT00384397|4183858|B4||Male|Sex: Female, Male||Participants|Count of Participants|556|556.0||||||
4356181|NCT00384397|4183859|B3||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4356182|NCT00384397|4183860|B2||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4356183|NCT00384397|4183861|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4356184|NCT00384397|4183858|B4||Female|Sex: Female, Male||Participants|Count of Participants|562|562.0||||||
4356185|NCT00384397|4183859|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4356186|NCT00384397|4183860|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4356187|NCT00384397|4183861|B1||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4356188|NCT00384397|4183858|B4|||Age||Days|Mean|279.3|279.3|Standard Deviation|10.86|10.86|||
4356189|NCT00384397|4183859|B3|||Age||Days|Mean|279.5|279.5|Standard Deviation|11.11|11.11|||
4356190|NCT00384397|4183860|B2|||Age||Days|Mean|279.8|279.8|Standard Deviation|10.93|10.93|||
4356191|NCT00384397|4183861|B1|||Age||Days|Mean|278.7|278.7|Standard Deviation|10.55|10.55|||
4356192|NCT00384397|4183858|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356193|NCT00384397|4183859|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356194|NCT00384397|4183860|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356195|NCT00384397|4183861|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356196|NCT00384397|4183858|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4356197|NCT00384397|4183859|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4356198|NCT00384397|4183860|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4356199|NCT00384397|4183861|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4356200|NCT00384397|4183858|B4||<=18 years|Age||Participants|Count of Participants|1118|1118.0||||||
4356201|NCT00384397|4183859|B3||<=18 years|Age||Participants|Count of Participants|418|418.0||||||
4356202|NCT00384397|4183860|B2||<=18 years|Age||Participants|Count of Participants|293|293.0||||||
4356203|NCT00384397|4183861|B1||<=18 years|Age||Participants|Count of Participants|407|407.0||||||
4356204|NCT00384332|4183880|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4356205|NCT00384332|4183881|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4356206|NCT00384332|4183882|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4356207|NCT00384332|4183880|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4356208|NCT00384332|4183881|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4356209|NCT00384332|4183882|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4356210|NCT00384332|4183880|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4356211|NCT00384332|4183881|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4356212|NCT00384332|4183882|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4356213|NCT00384332|4183880|B3|||Age|Self-reported age.|years|Mean|38.05|38.05|Standard Deviation|9.2|9.2|||
4356214|NCT00384332|4183881|B2|||Age|Self-reported age.|years|Mean|39.7|39.7|Standard Deviation|9.9|9.9|||
4356215|NCT00384332|4183882|B1|||Age|Self-reported age.|years|Mean|36.4|36.4|Standard Deviation|8.5|8.5|||
4356216|NCT00384332|4183880|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356217|NCT00384332|4183881|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356218|NCT00384332|4183882|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356219|NCT00384332|4183880|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4356220|NCT00384332|4183881|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4356221|NCT00384332|4183882|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4356222|NCT00384332|4183880|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356223|NCT00384332|4183881|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356224|NCT00384332|4183882|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356225|NCT00384293|4183891|B3||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4356226|NCT00384293|4183892|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4356227|NCT00384293|4183893|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4356228|NCT00384293|4183891|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4356229|NCT00384293|4183892|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4356230|NCT00384293|4183893|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4356231|NCT00384293|4183891|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|8.60|8.6|||
4356232|NCT00384293|4183892|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|8.22|8.22|||
4356233|NCT00384293|4183893|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|8.94|8.94|||
4356234|NCT00384241|4183906|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356235|NCT00384241|4183907|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356236|NCT00384241|4183908|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356237|NCT00384241|4183906|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356238|NCT00384241|4183907|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356239|NCT00384241|4183908|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356240|NCT00384241|4183906|B3||White|Race (NIH/OMB)||Participants|Count of Participants|460|460.0||||||
4356241|NCT00384241|4183907|B2||White|Race (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
4356242|NCT00384241|4183908|B1||White|Race (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
4356243|NCT00384241|4183906|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|639|639.0||||||
4356244|NCT00384241|4183907|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|389|389.0||||||
4356245|NCT00384241|4183908|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
4356246|NCT00384241|4183906|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356247|NCT00384241|4183907|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356248|NCT00384241|4183908|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356249|NCT00384241|4183906|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356250|NCT00384241|4183907|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356251|NCT00384241|4183908|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356252|NCT00384241|4183906|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356253|NCT00384241|4183907|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356254|NCT00384241|4183908|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356255|NCT00384241|4183906|B3||Male|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
4356256|NCT00384241|4183907|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4356257|NCT00384241|4183908|B1||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4356258|NCT00384241|4183906|B3||Female|Sex: Female, Male||Participants|Count of Participants|693|693.0||||||
4356259|NCT00384241|4183907|B2||Female|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4356260|NCT00384241|4183908|B1||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4356261|NCT00384241|4183906|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356262|NCT00384241|4183907|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356263|NCT00384241|4183908|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356264|NCT00384241|4183906|B3||Between 18 and 65 years|Age||Participants|Count of Participants|599|599.0||||||
4356265|NCT00384241|4183907|B2||Between 18 and 65 years|Age||Participants|Count of Participants|599|599.0||||||
4356266|NCT00384241|4183908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4356267|NCT00384241|4183906|B3||<=18 years|Age||Participants|Count of Participants|500|500.0||||||
4356268|NCT00384241|4183907|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356269|NCT00384241|4183908|B1||<=18 years|Age||Participants|Count of Participants|500|500.0||||||
4356270|NCT00384189|4183915|B5|Severe||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|552|552.0||||||
4356271|NCT00384189|4183916|B4|Severe||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|79|79.0||||||
4356272|NCT00384189|4183917|B3|Severe||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|164|164.0||||||
4356273|NCT00384189|4183918|B2|Severe||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|161|161.0||||||
4356274|NCT00384189|4183919|B1|Severe||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|148|148.0||||||
4356275|NCT00384189|4183915|B5|Moderate||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|376|376.0||||||
4356276|NCT00384189|4183916|B4|Moderate||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|50|50.0||||||
4356277|NCT00384189|4183917|B3|Moderate||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|104|104.0||||||
4356278|NCT00384189|4183918|B2|Moderate||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|110|110.0||||||
4356279|NCT00384189|4183919|B1|Moderate||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|112|112.0||||||
4356280|NCT00384189|4183915|B5|Mild||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|86|86.0||||||
4356281|NCT00384189|4183916|B4|Mild||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|10|10.0||||||
4356336|NCT00384189|4183916|B4|Russian Federation||Region of Enrollment||participants|Number|27|27.0||||||
4356282|NCT00384189|4183917|B3|Mild||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|29|29.0||||||
4356283|NCT00384189|4183918|B2|Mild||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|22|22.0||||||
4356284|NCT00384189|4183919|B1|Mild||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|25|25.0||||||
4356285|NCT00384189|4183915|B5|Intermittent||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|59|59.0||||||
4356286|NCT00384189|4183916|B4|Intermittent||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|7|7.0||||||
4356287|NCT00384189|4183917|B3|Intermittent||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|13|13.0||||||
4356288|NCT00384189|4183918|B2|Intermittent||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|19|19.0||||||
4356289|NCT00384189|4183919|B1|Intermittent||Asthma Severity According to Global Initiative for Asthma (GINA)||participants|Number|20|20.0||||||
4356290|NCT00384189|4183915|B5|||ICS Pretreatment Dose|The number of participants with ICS pretreatment dose data is 200, 204, 199 and 102 in each treatment arm, respectively.|µg/day|Mean|214.8|214.8|Standard Deviation|182.1|182.1|||
4356291|NCT00384189|4183916|B4|||ICS Pretreatment Dose|The number of participants with ICS pretreatment dose data is 200, 204, 199 and 102 in each treatment arm, respectively.|µg/day|Mean|224.6|224.6|Standard Deviation|178.8|178.8|||
4356292|NCT00384189|4183917|B3|||ICS Pretreatment Dose|The number of participants with ICS pretreatment dose data is 200, 204, 199 and 102 in each treatment arm, respectively.|µg/day|Mean|205.0|205.0|Standard Deviation|177.1|177.1|||
4356293|NCT00384189|4183918|B2|||ICS Pretreatment Dose|The number of participants with ICS pretreatment dose data is 200, 204, 199 and 102 in each treatment arm, respectively.|µg/day|Mean|222.8|222.8|Standard Deviation|188.8|188.8|||
4356294|NCT00384189|4183919|B1|||ICS Pretreatment Dose|The number of participants with ICS pretreatment dose data is 200, 204, 199 and 102 in each treatment arm, respectively.|µg/day|Mean|211.9|211.9|Standard Deviation|181.9|181.9|||
4356295|NCT00384189|4183915|B5|No||Inhaled Glucocorticosteroids (ICS) Pretreatment||participants|Number|368|368.0||||||
4356296|NCT00384189|4183916|B4|No||Inhaled Glucocorticosteroids (ICS) Pretreatment||participants|Number|44|44.0||||||
4356297|NCT00384189|4183917|B3|No||Inhaled Glucocorticosteroids (ICS) Pretreatment||participants|Number|111|111.0||||||
4356298|NCT00384189|4183918|B2|No||Inhaled Glucocorticosteroids (ICS) Pretreatment||participants|Number|108|108.0||||||
4356299|NCT00384189|4183919|B1|No||Inhaled Glucocorticosteroids (ICS) Pretreatment||participants|Number|105|105.0||||||
4356300|NCT00384189|4183915|B5|Yes||Inhaled Glucocorticosteroids (ICS) Pretreatment||participants|Number|705|705.0||||||
4356301|NCT00384189|4183916|B4|Yes||Inhaled Glucocorticosteroids (ICS) Pretreatment||participants|Number|102|102.0||||||
4356302|NCT00384189|4183917|B3|Yes||Inhaled Glucocorticosteroids (ICS) Pretreatment||participants|Number|199|199.0||||||
4356303|NCT00384189|4183918|B2|Yes||Inhaled Glucocorticosteroids (ICS) Pretreatment||participants|Number|204|204.0||||||
4356304|NCT00384189|4183919|B1|Yes||Inhaled Glucocorticosteroids (ICS) Pretreatment||participants|Number|200|200.0||||||
4356305|NCT00384189|4183915|B5|||Duration of Asthma||months|Mean|45.5|45.5|Standard Deviation|27.7|27.7|||
4356306|NCT00384189|4183916|B4|||Duration of Asthma||months|Mean|47.6|47.6|Standard Deviation|28.0|28.0|||
4356307|NCT00384189|4183917|B3|||Duration of Asthma||months|Mean|45.5|45.5|Standard Deviation|27.4|27.4|||
4356308|NCT00384189|4183918|B2|||Duration of Asthma||months|Mean|45.5|45.5|Standard Deviation|27.8|27.8|||
4356309|NCT00384189|4183919|B1|||Duration of Asthma||months|Mean|44.3|44.3|Standard Deviation|27.7|27.7|||
4356310|NCT00384189|4183915|B5|||Weight||kg|Mean|32.5|32.5|Standard Deviation|9.4|9.4|||
4356311|NCT00384189|4183916|B4|||Weight||kg|Mean|32.7|32.7|Standard Deviation|9.7|9.7|||
4356312|NCT00384189|4183917|B3|||Weight||kg|Mean|33.2|33.2|Standard Deviation|9.5|9.5|||
4356313|NCT00384189|4183918|B2|||Weight||kg|Mean|31.9|31.9|Standard Deviation|9.3|9.3|||
4356314|NCT00384189|4183919|B1|||Weight||kg|Mean|32.3|32.3|Standard Deviation|9.1|9.1|||
4356315|NCT00384189|4183915|B5|||Height||cm|Mean|134.9|134.9|Standard Deviation|10.9|10.9|||
4356316|NCT00384189|4183916|B4|||Height||cm|Mean|134.6|134.6|Standard Deviation|11.1|11.1|||
4356317|NCT00384189|4183917|B3|||Height||cm|Mean|135.9|135.9|Standard Deviation|10.8|10.8|||
4356318|NCT00384189|4183918|B2|||Height||cm|Mean|134.5|134.5|Standard Deviation|11.0|11.0|||
4356319|NCT00384189|4183919|B1|||Height||cm|Mean|134.6|134.6|Standard Deviation|10.8|10.8|||
4356320|NCT00384189|4183915|B5|Ukraine||Region of Enrollment||participants|Number|169|169.0||||||
4356321|NCT00384189|4183916|B4|Ukraine||Region of Enrollment||participants|Number|22|22.0||||||
4356322|NCT00384189|4183917|B3|Ukraine||Region of Enrollment||participants|Number|48|48.0||||||
4356323|NCT00384189|4183918|B2|Ukraine||Region of Enrollment||participants|Number|50|50.0||||||
4356324|NCT00384189|4183919|B1|Ukraine||Region of Enrollment||participants|Number|49|49.0||||||
4356325|NCT00384189|4183915|B5|Spain||Region of Enrollment||participants|Number|61|61.0||||||
4356326|NCT00384189|4183916|B4|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4356327|NCT00384189|4183917|B3|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4356328|NCT00384189|4183918|B2|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4356329|NCT00384189|4183919|B1|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4356330|NCT00384189|4183915|B5|South Africa||Region of Enrollment||participants|Number|111|111.0||||||
4356331|NCT00384189|4183916|B4|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
4356332|NCT00384189|4183917|B3|South Africa||Region of Enrollment||participants|Number|32|32.0||||||
4356333|NCT00384189|4183918|B2|South Africa||Region of Enrollment||participants|Number|34|34.0||||||
4356334|NCT00384189|4183919|B1|South Africa||Region of Enrollment||participants|Number|32|32.0||||||
4356335|NCT00384189|4183915|B5|Russian Federation||Region of Enrollment||participants|Number|188|188.0||||||
4356337|NCT00384189|4183917|B3|Russian Federation||Region of Enrollment||participants|Number|55|55.0||||||
4356338|NCT00384189|4183918|B2|Russian Federation||Region of Enrollment||participants|Number|52|52.0||||||
4356339|NCT00384189|4183919|B1|Russian Federation||Region of Enrollment||participants|Number|54|54.0||||||
4356340|NCT00384189|4183915|B5|Romania||Region of Enrollment||participants|Number|60|60.0||||||
4356341|NCT00384189|4183916|B4|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4356342|NCT00384189|4183917|B3|Romania||Region of Enrollment||participants|Number|21|21.0||||||
4356343|NCT00384189|4183918|B2|Romania||Region of Enrollment||participants|Number|16|16.0||||||
4356344|NCT00384189|4183919|B1|Romania||Region of Enrollment||participants|Number|15|15.0||||||
4356345|NCT00384189|4183915|B5|Poland||Region of Enrollment||participants|Number|169|169.0||||||
4356346|NCT00384189|4183916|B4|Poland||Region of Enrollment||participants|Number|23|23.0||||||
4356347|NCT00384189|4183917|B3|Poland||Region of Enrollment||participants|Number|49|49.0||||||
4356348|NCT00384189|4183918|B2|Poland||Region of Enrollment||participants|Number|48|48.0||||||
4356349|NCT00384189|4183919|B1|Poland||Region of Enrollment||participants|Number|49|49.0||||||
4356350|NCT00384189|4183915|B5|Hungary||Region of Enrollment||participants|Number|152|152.0||||||
4356351|NCT00384189|4183916|B4|Hungary||Region of Enrollment||participants|Number|22|22.0||||||
4356352|NCT00384189|4183917|B3|Hungary||Region of Enrollment||participants|Number|43|43.0||||||
4356353|NCT00384189|4183918|B2|Hungary||Region of Enrollment||participants|Number|45|45.0||||||
4356354|NCT00384189|4183919|B1|Hungary||Region of Enrollment||participants|Number|42|42.0||||||
4356355|NCT00384189|4183915|B5|Germany||Region of Enrollment||participants|Number|53|53.0||||||
4356356|NCT00384189|4183916|B4|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4356357|NCT00384189|4183917|B3|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4356358|NCT00384189|4183918|B2|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4356359|NCT00384189|4183919|B1|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4356360|NCT00384189|4183915|B5|Bulgaria||Region of Enrollment||participants|Number|110|110.0||||||
4356361|NCT00384189|4183916|B4|Bulgaria||Region of Enrollment||participants|Number|15|15.0||||||
4356362|NCT00384189|4183917|B3|Bulgaria||Region of Enrollment||participants|Number|33|33.0||||||
4356363|NCT00384189|4183918|B2|Bulgaria||Region of Enrollment||participants|Number|33|33.0||||||
4356364|NCT00384189|4183919|B1|Bulgaria||Region of Enrollment||participants|Number|29|29.0||||||
4356365|NCT00384189|4183915|B5|non-Caucasian||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
4356366|NCT00384189|4183916|B4|non-Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4356367|NCT00384189|4183917|B3|non-Caucasian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4356368|NCT00384189|4183918|B2|non-Caucasian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4356369|NCT00384189|4183919|B1|non-Caucasian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4356370|NCT00384189|4183915|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|965|965.0||||||
4356371|NCT00384189|4183916|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
4356372|NCT00384189|4183917|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|277|277.0||||||
4356373|NCT00384189|4183918|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|279|279.0||||||
4356374|NCT00384189|4183919|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|276|276.0||||||
4356375|NCT00384189|4183915|B5||Male|Gender||Participants|Count of Participants|711|711.0||||||
4356376|NCT00384189|4183916|B4||Male|Gender||Participants|Count of Participants|92|92.0||||||
4356377|NCT00384189|4183917|B3||Male|Gender||Participants|Count of Participants|218|218.0||||||
4356378|NCT00384189|4183918|B2||Male|Gender||Participants|Count of Participants|191|191.0||||||
4356379|NCT00384189|4183919|B1||Male|Gender||Participants|Count of Participants|210|210.0||||||
4356380|NCT00384189|4183915|B5||Female|Gender||Participants|Count of Participants|362|362.0||||||
4356381|NCT00384189|4183916|B4||Female|Gender||Participants|Count of Participants|54|54.0||||||
4356382|NCT00384189|4183917|B3||Female|Gender||Participants|Count of Participants|92|92.0||||||
4356383|NCT00384189|4183918|B2||Female|Gender||Participants|Count of Participants|121|121.0||||||
4356384|NCT00384189|4183919|B1||Female|Gender||Participants|Count of Participants|95|95.0||||||
4356385|NCT00384189|4183915|B5|||Age||years|Mean|8.4|8.4|Standard Deviation|1.6|1.6|||
4356386|NCT00384189|4183916|B4|||Age||years|Mean|8.4|8.4|Standard Deviation|1.7|1.7|||
4356387|NCT00384189|4183917|B3|||Age||years|Mean|8.7|8.7|Standard Deviation|1.6|1.6|||
4356388|NCT00384189|4183918|B2|||Age||years|Mean|8.4|8.4|Standard Deviation|1.6|1.6|||
4356389|NCT00384189|4183919|B1|||Age||years|Mean|8.4|8.4|Standard Deviation|1.7|1.7|||
4356390|NCT00384176|4183980|B4||Male|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|945|945.0||||||
4356391|NCT00384176|4183981|B3||Male|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|119|119.0||||||
4356392|NCT00384176|4183982|B2||Male|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|414|414.0||||||
4356393|NCT00384176|4183983|B1||Male|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|412|412.0||||||
4356394|NCT00384176|4183980|B4||Female|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|669|669.0||||||
4356395|NCT00384176|4183981|B3||Female|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|73|73.0||||||
4356396|NCT00384176|4183982|B2||Female|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|299|299.0||||||
4356397|NCT00384176|4183983|B1||Female|Sex: Female, Male|Gender at informed consent|Participants|Count of Participants|297|297.0||||||
4356398|NCT00384176|4183980|B4|||Age|Age at informed consent|years|Mean|58.6|58.6|Standard Deviation|11.1|11.1|||
4356399|NCT00384176|4183981|B3|||Age|Age at informed consent|years|Mean|59.2|59.2|Standard Deviation|10.59|10.59|||
4356400|NCT00384176|4183982|B2|||Age|Age at informed consent|years|Mean|59.0|59.0|Standard Deviation|10.82|10.82|||
4356401|NCT00384176|4183983|B1|||Age|Age at informed consent|years|Mean|58.1|58.1|Standard Deviation|11.37|11.37|||
4356402|NCT00384085|4184008|B4|SU or meglitinide plus metformin plus TZD||Oral antidiabetic treatment combination at study entry||participants|Number|187|187.0||||||
4356403|NCT00384085|4184009|B3|SU or meglitinide plus metformin plus TZD||Oral antidiabetic treatment combination at study entry||participants|Number|63|63.0||||||
4356404|NCT00384085|4184010|B2|SU or meglitinide plus metformin plus TZD||Oral antidiabetic treatment combination at study entry||participants|Number|61|61.0||||||
4356405|NCT00384085|4184011|B1|SU or meglitinide plus metformin plus TZD||Oral antidiabetic treatment combination at study entry||participants|Number|63|63.0||||||
4356406|NCT00384085|4184008|B4|TZD plus metformin||Oral antidiabetic treatment combination at study entry||participants|Number|80|80.0||||||
4356407|NCT00384085|4184009|B3|TZD plus metformin||Oral antidiabetic treatment combination at study entry||participants|Number|27|27.0||||||
4356408|NCT00384085|4184010|B2|TZD plus metformin||Oral antidiabetic treatment combination at study entry||participants|Number|27|27.0||||||
4356409|NCT00384085|4184011|B1|TZD plus metformin||Oral antidiabetic treatment combination at study entry||participants|Number|26|26.0||||||
4356410|NCT00384085|4184008|B4|SU or meglitinide plus thiazolinedione (TZD)||Oral antidiabetic treatment combination at study entry||participants|Number|28|28.0||||||
4356411|NCT00384085|4184009|B3|SU or meglitinide plus thiazolinedione (TZD)||Oral antidiabetic treatment combination at study entry||participants|Number|10|10.0||||||
4356412|NCT00384085|4184010|B2|SU or meglitinide plus thiazolinedione (TZD)||Oral antidiabetic treatment combination at study entry||participants|Number|9|9.0||||||
4356413|NCT00384085|4184011|B1|SU or meglitinide plus thiazolinedione (TZD)||Oral antidiabetic treatment combination at study entry||participants|Number|9|9.0||||||
4356414|NCT00384085|4184008|B4|sulfonylurea (SU) or meglitinide plus metformin||Oral antidiabetic treatment combination at study entry||participants|Number|293|293.0||||||
4356415|NCT00384085|4184009|B3|sulfonylurea (SU) or meglitinide plus metformin||Oral antidiabetic treatment combination at study entry||participants|Number|97|97.0||||||
4356416|NCT00384085|4184010|B2|sulfonylurea (SU) or meglitinide plus metformin||Oral antidiabetic treatment combination at study entry||participants|Number|99|99.0||||||
4356417|NCT00384085|4184011|B1|sulfonylurea (SU) or meglitinide plus metformin||Oral antidiabetic treatment combination at study entry||participants|Number|97|97.0||||||
4356418|NCT00384085|4184008|B4|||Age at onset of diabetes||years|Mean|45.3|45.3|Standard Deviation|10.05|10.05|||
4356419|NCT00384085|4184009|B3|||Age at onset of diabetes||years|Mean|44.8|44.8|Standard Deviation|10.01|10.01|||
4356420|NCT00384085|4184010|B2|||Age at onset of diabetes||years|Mean|45.1|45.1|Standard Deviation|9.36|9.36|||
4356421|NCT00384085|4184011|B1|||Age at onset of diabetes||years|Mean|46.0|46.0|Standard Deviation|10.74|10.74|||
4356422|NCT00384085|4184008|B4|||Duration of diabetes at study entry||years|Mean|9.3|9.3|Standard Deviation|6.13|6.13|||
4356423|NCT00384085|4184009|B3|||Duration of diabetes at study entry||years|Mean|9.5|9.5|Standard Deviation|5.87|5.87|||
4356424|NCT00384085|4184010|B2|||Duration of diabetes at study entry||years|Mean|9.1|9.1|Standard Deviation|5.70|5.7|||
4356425|NCT00384085|4184011|B1|||Duration of diabetes at study entry||years|Mean|9.4|9.4|Standard Deviation|6.80|6.8|||
4356426|NCT00384085|4184008|B4|||Body Mass Index (BMI)||Kilogram/m^2|Mean|33.1|33.1|Standard Deviation|5.80|5.8|||
4356427|NCT00384085|4184009|B3|||Body Mass Index (BMI)||Kilogram/m^2|Mean|33.4|33.4|Standard Deviation|5.62|5.62|||
4356428|NCT00384085|4184010|B2|||Body Mass Index (BMI)||Kilogram/m^2|Mean|33.4|33.4|Standard Deviation|6.00|6.0|||
4356429|NCT00384085|4184011|B1|||Body Mass Index (BMI)||Kilogram/m^2|Mean|32.7|32.7|Standard Deviation|5.79|5.79|||
4356430|NCT00384085|4184008|B4|||Weight||kilograms (kg)|Mean|96.8|96.8|Standard Deviation|20.21|20.21|||
4356431|NCT00384085|4184009|B3|||Weight||kilograms (kg)|Mean|97.9|97.9|Standard Deviation|20.49|20.49|||
4356432|NCT00384085|4184010|B2|||Weight||kilograms (kg)|Mean|97.2|97.2|Standard Deviation|20.88|20.88|||
4356433|NCT00384085|4184011|B1|||Weight||kilograms (kg)|Mean|95.2|95.2|Standard Deviation|19.21|19.21|||
4356434|NCT00384085|4184008|B4|United States||Region of Enrollment||participants|Number|588|588.0||||||
4356435|NCT00384085|4184009|B3|United States||Region of Enrollment||participants|Number|197|197.0||||||
4356436|NCT00384085|4184010|B2|United States||Region of Enrollment||participants|Number|196|196.0||||||
4356437|NCT00384085|4184011|B1|United States||Region of Enrollment||participants|Number|195|195.0||||||
4356438|NCT00384085|4184008|B4||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4356439|NCT00384085|4184009|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4356440|NCT00384085|4184010|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4356441|NCT00384085|4184011|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4356442|NCT00384085|4184008|B4||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4356443|NCT00384085|4184009|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4356444|NCT00384085|4184010|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4356445|NCT00384085|4184011|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4356446|NCT00384085|4184008|B4|||Age||years|Mean|54.1|54.1|Standard Deviation|10.12|10.12|||
4356447|NCT00384085|4184009|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|10.65|10.65|||
4356448|NCT00384085|4184010|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|9.11|9.11|||
4356449|NCT00384085|4184011|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|10.54|10.54|||
4356450|NCT00384059|4184037|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4356451|NCT00384059|4184038|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4356452|NCT00384059|4184039|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4356453|NCT00384059|4184037|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4356454|NCT00384059|4184038|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4356455|NCT00384059|4184039|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4356456|NCT00384059|4184037|B3|||Age||months|Mean|2.1|2.1|Standard Deviation|0.3|0.3|||
4356457|NCT00384059|4184038|B2|||Age||months|Mean|2.1|2.1|Standard Deviation|0.2|0.2|||
4356458|NCT00384059|4184039|B1|||Age||months|Mean|2.1|2.1|Standard Deviation|0.3|0.3|||
4356459|NCT00384033|4184086|B5|||Clinical global impressions scale-severity (CGI-S) score|CGI-S: 7-point clinician rated scale to assess severity of participant's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill participants). Higher score = more affected. N=160 for placebo treatment group.|Units on a Scale|Mean|4.32|4.32|Standard Deviation|0.50|0.5|||
4356460|NCT00384033|4184087|B4|||Clinical global impressions scale-severity (CGI-S) score|CGI-S: 7-point clinician rated scale to assess severity of participant's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill participants). Higher score = more affected. N=160 for placebo treatment group.|Units on a Scale|Mean|4.28|4.28|Standard Deviation|0.46|0.46|||
4356461|NCT00384033|4184088|B3|||Clinical global impressions scale-severity (CGI-S) score|CGI-S: 7-point clinician rated scale to assess severity of participant's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill participants). Higher score = more affected. N=160 for placebo treatment group.|Units on a Scale|Mean|4.31|4.31|Standard Deviation|0.49|0.49|||
4356462|NCT00384033|4184089|B2|||Clinical global impressions scale-severity (CGI-S) score|CGI-S: 7-point clinician rated scale to assess severity of participant's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill participants). Higher score = more affected. N=160 for placebo treatment group.|Units on a Scale|Mean|4.29|4.29|Standard Deviation|0.48|0.48|||
4356463|NCT00384033|4184090|B1|||Clinical global impressions scale-severity (CGI-S) score|CGI-S: 7-point clinician rated scale to assess severity of participant's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill participants). Higher score = more affected. N=160 for placebo treatment group.|Units on a Scale|Mean|4.39|4.39|Standard Deviation|0.54|0.54|||
4356464|NCT00384033|4184086|B5|||Hamilton psychiatric scale for depression-17 item (HAM-D17) total score|HAM-D17: a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression. Items are scored on either a 3 point (0 to 2) or a 5 point scale (0 to 4), with 0 = none/absent and 4 = most severe, for a maximum total score of 50. N=160 for placebo treatment group.|Units on a Scale|Mean|23.46|23.46|Standard Deviation|2.57|2.57|||
4356465|NCT00384033|4184087|B4|||Hamilton psychiatric scale for depression-17 item (HAM-D17) total score|HAM-D17: a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression. Items are scored on either a 3 point (0 to 2) or a 5 point scale (0 to 4), with 0 = none/absent and 4 = most severe, for a maximum total score of 50. N=160 for placebo treatment group.|Units on a Scale|Mean|22.99|22.99|Standard Deviation|2.45|2.45|||
4356466|NCT00384033|4184088|B3|||Hamilton psychiatric scale for depression-17 item (HAM-D17) total score|HAM-D17: a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression. Items are scored on either a 3 point (0 to 2) or a 5 point scale (0 to 4), with 0 = none/absent and 4 = most severe, for a maximum total score of 50. N=160 for placebo treatment group.|Units on a Scale|Mean|23.49|23.49|Standard Deviation|2.55|2.55|||
4356467|NCT00384033|4184089|B2|||Hamilton psychiatric scale for depression-17 item (HAM-D17) total score|HAM-D17: a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression. Items are scored on either a 3 point (0 to 2) or a 5 point scale (0 to 4), with 0 = none/absent and 4 = most severe, for a maximum total score of 50. N=160 for placebo treatment group.|Units on a Scale|Mean|23.49|23.49|Standard Deviation|2.52|2.52|||
4356468|NCT00384033|4184090|B1|||Hamilton psychiatric scale for depression-17 item (HAM-D17) total score|HAM-D17: a standardized, clinician-administered rating scale that assesses 17 items characteristically associated with major depression. Items are scored on either a 3 point (0 to 2) or a 5 point scale (0 to 4), with 0 = none/absent and 4 = most severe, for a maximum total score of 50. N=160 for placebo treatment group.|Units on a Scale|Mean|23.86|23.86|Standard Deviation|2.68|2.68|||
4356469|NCT00384033|4184086|B5||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4356470|NCT00384033|4184087|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4356471|NCT00384033|4184088|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4356472|NCT00384033|4184089|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4356473|NCT00384033|4184090|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4356474|NCT00384033|4184086|B5||Female|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
4356475|NCT00384033|4184087|B4||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4356476|NCT00384033|4184088|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4356477|NCT00384033|4184089|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4356478|NCT00384033|4184090|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4356479|NCT00384033|4184086|B5|||Age||Years|Mean|39.39|39.39|Standard Deviation|12.50|12.5|||
4356480|NCT00384033|4184087|B4|||Age||Years|Mean|38.94|38.94|Standard Deviation|12.01|12.01|||
4356481|NCT00384033|4184088|B3|||Age||Years|Mean|38.77|38.77|Standard Deviation|12.07|12.07|||
4356482|NCT00384033|4184089|B2|||Age||Years|Mean|40.67|40.67|Standard Deviation|13.20|13.2|||
4356483|NCT00384033|4184090|B1|||Age||Years|Mean|39.24|39.24|Standard Deviation|12.74|12.74|||
4356484|NCT00383942|4184135|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356485|NCT00383942|4184136|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356486|NCT00383942|4184137|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356487|NCT00383942|4184135|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4356488|NCT00383942|4184136|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4356489|NCT00383942|4184137|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4356490|NCT00383942|4184135|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356491|NCT00383942|4184136|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356492|NCT00383942|4184137|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356493|NCT00383942|4184135|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4356494|NCT00383942|4184136|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4356495|NCT00383942|4184137|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4356496|NCT00383942|4184135|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356497|NCT00383942|4184136|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356498|NCT00383942|4184137|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356499|NCT00383786|4184144|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4356500|NCT00383786|4184145|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4356501|NCT00383786|4184146|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4356502|NCT00383786|4184144|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4356503|NCT00383786|4184145|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4356504|NCT00383786|4184146|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4356505|NCT00383786|4184144|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4356506|NCT00383786|4184145|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4356507|NCT00383786|4184146|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4356508|NCT00383786|4184144|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|11.9|11.9|||
4356509|NCT00383786|4184145|B2|||Age||years|Mean|38.7|38.7|Standard Deviation|12.3|12.3|||
4356510|NCT00383786|4184146|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|11.5|11.5|||
4356511|NCT00383786|4184144|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356512|NCT00383786|4184145|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356513|NCT00383786|4184146|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356514|NCT00383786|4184144|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4356515|NCT00383786|4184145|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4356516|NCT00383786|4184146|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4356517|NCT00383786|4184144|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356518|NCT00383786|4184145|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356519|NCT00383786|4184146|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356520|NCT00383760|4184153|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4356521|NCT00383760|4184153|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4356522|NCT00383760|4184153|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4356523|NCT00383760|4184153|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4356524|NCT00383760|4184153|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4356525|NCT00383760|4184153|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356526|NCT00383760|4184153|B1|||Age||years|Median|62|62.0|Full Range|||34.0|79.0|
4356527|NCT00383747|4184167|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4356528|NCT00383747|4184168|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4356529|NCT00383747|4184169|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4356530|NCT00383747|4184167|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4356531|NCT00383747|4184168|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4356532|NCT00383747|4184169|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4356533|NCT00383747|4184167|B3|||Age||years|Mean|43|43.0|Standard Deviation|9|9.0|||
4356534|NCT00383747|4184168|B2|||Age||years|Mean|40|40.0|Standard Deviation|11|11.0|||
4356535|NCT00383747|4184169|B1|||Age||years|Mean|47|47.0|Standard Deviation|8|8.0|||
4356536|NCT00383721|4184192|B6||Male|Sex: Female, Male||Participants|Count of Participants|900|900.0||||||
4356537|NCT00383721|4184193|B5||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4356538|NCT00383721|4184194|B4||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4356539|NCT00383721|4184195|B3||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4356540|NCT00383721|4184196|B2||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4356541|NCT00383721|4184197|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4356542|NCT00383721|4184192|B6||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4356543|NCT00383721|4184193|B5||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4356544|NCT00383721|4184194|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4356545|NCT00383721|4184195|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4356546|NCT00383721|4184196|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4356547|NCT00383721|4184197|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4356548|NCT00383721|4184192|B6|||Age||years|Mean|59.7|59.7|Standard Deviation|9.0|9.0|||
4356549|NCT00383721|4184193|B5|||Age||years|Mean|58.8|58.8|Standard Deviation|9.5|9.5|||
4356550|NCT00383721|4184194|B4|||Age||years|Mean|59.7|59.7|Standard Deviation|8.7|8.7|||
4356551|NCT00383721|4184195|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|8.5|8.5|||
4356552|NCT00383721|4184196|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|9.0|9.0|||
4356553|NCT00383721|4184197|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|9.1|9.1|||
4356554|NCT00383708|4184238|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4356555|NCT00383708|4184238|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4356556|NCT00383708|4184238|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|12.7|12.7|||
4356557|NCT00383643|4184272|B4|United States||Region of Enrollment||participants|Number|48|48.0||||||
4356558|NCT00383643|4184273|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4356559|NCT00383643|4184274|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4356560|NCT00383643|4184275|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4356561|NCT00383643|4184272|B4|Ethnic Minorities||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4356562|NCT00383643|4184273|B3|Ethnic Minorities||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4356563|NCT00383643|4184274|B2|Ethnic Minorities||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4356564|NCT00383643|4184275|B1|Ethnic Minorities||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4356565|NCT00383643|4184272|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4356566|NCT00383643|4184273|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4356567|NCT00383643|4184274|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4356568|NCT00383643|4184275|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4356569|NCT00383643|4184272|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4356570|NCT00383643|4184273|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4356571|NCT00383643|4184274|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4356572|NCT00383643|4184275|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4356573|NCT00383643|4184272|B4|||Age||years|Mean|53.2|53.2|Standard Deviation|12.3|12.3|||
4356574|NCT00383643|4184273|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|16.3|16.3|||
4356575|NCT00383643|4184274|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|10.4|10.4|||
4356576|NCT00383643|4184275|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|9.6|9.6|||
4356577|NCT00383565|4184297|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4356578|NCT00383565|4184297|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4356579|NCT00383565|4184297|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4356580|NCT00383565|4184297|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|12.6|12.6|||
4356581|NCT00383565|4184297|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4356582|NCT00383565|4184297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4356583|NCT00383565|4184297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356584|NCT00383552|4184303|B5||Male|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4356585|NCT00383552|4184304|B4||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4356586|NCT00383552|4184305|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4356587|NCT00383552|4184306|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4356588|NCT00383552|4184307|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4356589|NCT00383552|4184303|B5||Female|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
4356590|NCT00383552|4184304|B4||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4356591|NCT00383552|4184305|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4356592|NCT00383552|4184306|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4356593|NCT00383552|4184307|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4356594|NCT00383552|4184303|B5|||Age||years|Mean|38.3|38.3|Standard Deviation|16.6|16.6|||
4356595|NCT00383552|4184304|B4|||Age||years|Mean|38.1|38.1|Standard Deviation|17.4|17.4|||
4356596|NCT00383552|4184305|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|15.6|15.6|||
4356597|NCT00383552|4184306|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|16.7|16.7|||
4356598|NCT00383552|4184307|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|16.9|16.9|||
4356599|NCT00383500|4184349|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4356600|NCT00383500|4184350|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356601|NCT00383500|4184351|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356602|NCT00383500|4184352|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4356603|NCT00383500|4184349|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356604|NCT00383500|4184350|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356605|NCT00383500|4184351|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356606|NCT00383500|4184352|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356607|NCT00383500|4184349|B4||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4356608|NCT00383500|4184350|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4356609|NCT00383500|4184351|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4356610|NCT00383500|4184352|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4356611|NCT00383500|4184349|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4356612|NCT00383500|4184350|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356613|NCT00383500|4184351|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356614|NCT00383500|4184352|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4356615|NCT00383500|4184349|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4356616|NCT00383500|4184350|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356617|NCT00383500|4184351|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356618|NCT00383500|4184352|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4356619|NCT00383500|4184349|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4356620|NCT00383500|4184350|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4356621|NCT00383500|4184351|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4356622|NCT00383500|4184352|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4356623|NCT00383500|4184349|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356624|NCT00383500|4184350|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356625|NCT00383500|4184351|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356626|NCT00383500|4184352|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356627|NCT00383500|4184349|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356628|NCT00383500|4184350|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356629|NCT00383500|4184351|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356630|NCT00383500|4184352|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356631|NCT00383500|4184349|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4356632|NCT00383500|4184350|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4356633|NCT00383500|4184351|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4356634|NCT00383500|4184352|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4356635|NCT00383500|4184349|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4356636|NCT00383500|4184350|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356637|NCT00383500|4184351|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4356638|NCT00383500|4184352|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356639|NCT00383500|4184349|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356640|NCT00383500|4184350|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356641|NCT00383500|4184351|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356642|NCT00383500|4184352|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356643|NCT00383500|4184349|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4356644|NCT00383500|4184350|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4356645|NCT00383500|4184351|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4356646|NCT00383500|4184352|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4356647|NCT00383500|4184349|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4356648|NCT00383500|4184350|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4356649|NCT00383500|4184351|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4356650|NCT00383500|4184352|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4356651|NCT00383500|4184349|B4||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4356652|NCT00383500|4184350|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4356653|NCT00383500|4184351|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4356654|NCT00383500|4184352|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4356655|NCT00383500|4184349|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356656|NCT00383500|4184350|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356657|NCT00383500|4184351|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356658|NCT00383500|4184352|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356659|NCT00383435|4184365|B6||Male|Sex: Female, Male||Participants|Count of Participants|818|818.0||||||
4356660|NCT00383435|4184366|B5||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4356661|NCT00383435|4184367|B4||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4356662|NCT00383435|4184368|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4356663|NCT00383435|4184369|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4356664|NCT00383435|4184370|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4356665|NCT00383435|4184365|B6||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4356666|NCT00383435|4184366|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4356667|NCT00383435|4184367|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4356668|NCT00383435|4184368|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4356669|NCT00383435|4184369|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4356670|NCT00383435|4184370|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4356671|NCT00383435|4184365|B6|||Age||years|Mean|59.8|59.8|Standard Deviation|8.7|8.7|||
4356672|NCT00383435|4184366|B5|||Age||years|Mean|58.8|58.8|Standard Deviation|8.7|8.7|||
4356673|NCT00383435|4184367|B4|||Age||years|Mean|59.6|59.6|Standard Deviation|8.5|8.5|||
4356674|NCT00383435|4184368|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|8.9|8.9|||
4356675|NCT00383435|4184369|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|8.1|8.1|||
4356676|NCT00383435|4184370|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|9.1|9.1|||
4356677|NCT00383331|4184411|B3|Other||Tumor Cell Type||participants|Number|2|2.0||||||
4356678|NCT00383331|4184412|B2|Other||Tumor Cell Type||participants|Number|2|2.0||||||
4356679|NCT00383331|4184413|B1|Other||Tumor Cell Type||participants|Number|0|0.0||||||
4356680|NCT00383331|4184411|B3|Non-Small Cell Lung, Not Otherwise Specified (NOS)||Tumor Cell Type||participants|Number|6|6.0||||||
4356681|NCT00383331|4184412|B2|Non-Small Cell Lung, Not Otherwise Specified (NOS)||Tumor Cell Type||participants|Number|2|2.0||||||
4356682|NCT00383331|4184413|B1|Non-Small Cell Lung, Not Otherwise Specified (NOS)||Tumor Cell Type||participants|Number|4|4.0||||||
4356683|NCT00383331|4184411|B3|Adenocarcinoma||Tumor Cell Type||participants|Number|8|8.0||||||
4356684|NCT00383331|4184412|B2|Adenocarcinoma||Tumor Cell Type||participants|Number|3|3.0||||||
4356685|NCT00383331|4184413|B1|Adenocarcinoma||Tumor Cell Type||participants|Number|5|5.0||||||
4356686|NCT00383331|4184411|B3|Squamous||Tumor Cell Type||participants|Number|3|3.0||||||
4356687|NCT00383331|4184412|B2|Squamous||Tumor Cell Type||participants|Number|2|2.0||||||
4356688|NCT00383331|4184413|B1|Squamous||Tumor Cell Type||participants|Number|1|1.0||||||
4356689|NCT00383331|4184411|B3|IV||Stage of Lung Cancer||participants|Number|15|15.0||||||
4356690|NCT00383331|4184412|B2|IV||Stage of Lung Cancer||participants|Number|7|7.0||||||
4356691|NCT00383331|4184413|B1|IV||Stage of Lung Cancer||participants|Number|8|8.0||||||
4356692|NCT00383331|4184411|B3|IIIB with pleural effusion||Stage of Lung Cancer||participants|Number|4|4.0||||||
4356693|NCT00383331|4184412|B2|IIIB with pleural effusion||Stage of Lung Cancer||participants|Number|2|2.0||||||
4356694|NCT00383331|4184413|B1|IIIB with pleural effusion||Stage of Lung Cancer||participants|Number|2|2.0||||||
4356695|NCT00383331|4184411|B3|No||Previous Radiation Therapy||participants|Number|15|15.0||||||
4356696|NCT00383331|4184412|B2|No||Previous Radiation Therapy||participants|Number|8|8.0||||||
4356697|NCT00383331|4184413|B1|No||Previous Radiation Therapy||participants|Number|7|7.0||||||
4356698|NCT00383331|4184411|B3|Yes||Previous Radiation Therapy||participants|Number|4|4.0||||||
4356699|NCT00383331|4184412|B2|Yes||Previous Radiation Therapy||participants|Number|1|1.0||||||
4356700|NCT00383331|4184413|B1|Yes||Previous Radiation Therapy||participants|Number|3|3.0||||||
4356701|NCT00383331|4184411|B3|4 - Completely Disabled||Eastern Cooperative Oncology Group Performance Score||participants|Number|0|0.0||||||
4356702|NCT00383331|4184412|B2|4 - Completely Disabled||Eastern Cooperative Oncology Group Performance Score||participants|Number|0|0.0||||||
4356703|NCT00383331|4184413|B1|4 - Completely Disabled||Eastern Cooperative Oncology Group Performance Score||participants|Number|0|0.0||||||
4356704|NCT00383331|4184411|B3|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group Performance Score||participants|Number|0|0.0||||||
4356705|NCT00383331|4184412|B2|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group Performance Score||participants|Number|0|0.0||||||
4356706|NCT00383331|4184413|B1|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group Performance Score||participants|Number|0|0.0||||||
4356707|NCT00383331|4184411|B3|2 - Amublatory, No Work Activities||Eastern Cooperative Oncology Group Performance Score||participants|Number|0|0.0||||||
4356708|NCT00383331|4184412|B2|2 - Amublatory, No Work Activities||Eastern Cooperative Oncology Group Performance Score||participants|Number|0|0.0||||||
4356709|NCT00383331|4184413|B1|2 - Amublatory, No Work Activities||Eastern Cooperative Oncology Group Performance Score||participants|Number|0|0.0||||||
4356710|NCT00383331|4184411|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Score||participants|Number|11|11.0||||||
4356711|NCT00383331|4184412|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Score||participants|Number|5|5.0||||||
4356712|NCT00383331|4184413|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Score||participants|Number|6|6.0||||||
4356713|NCT00383331|4184411|B3|0 - Fully Active||Eastern Cooperative Oncology Group Performance Score||participants|Number|8|8.0||||||
4356714|NCT00383331|4184412|B2|0 - Fully Active||Eastern Cooperative Oncology Group Performance Score||participants|Number|4|4.0||||||
4356715|NCT00383331|4184413|B1|0 - Fully Active||Eastern Cooperative Oncology Group Performance Score||participants|Number|4|4.0||||||
4356716|NCT00383331|4184411|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4356717|NCT00383331|4184412|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4356718|NCT00383331|4184413|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4356719|NCT00383331|4184411|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4356720|NCT00383331|4184412|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4356721|NCT00383331|4184413|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4356722|NCT00383331|4184411|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4356723|NCT00383331|4184412|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4356724|NCT00383331|4184413|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4356725|NCT00383331|4184411|B3|||Age||years|Median|66.0|66.0|Full Range|||48.0|81.0|
4356726|NCT00383331|4184412|B2|||Age||years|Median|63.0|63.0|Full Range|||48.0|74.0|
4356727|NCT00383331|4184413|B1|||Age||years|Median|70.5|70.5|Full Range|||60.0|81.0|
4356728|NCT00383292|4184430|B4|Australia||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4356729|NCT00383292|4184431|B3|Australia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4356730|NCT00383292|4184432|B2|Australia||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4356731|NCT00383292|4184433|B1|Australia||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4356732|NCT00383292|4184430|B4|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
4356733|NCT00383292|4184431|B3|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4356734|NCT00383292|4184432|B2|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4356735|NCT00383292|4184433|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4356736|NCT00383292|4184430|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356737|NCT00383292|4184431|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356738|NCT00383292|4184432|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356739|NCT00383292|4184433|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356740|NCT00383292|4184430|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356741|NCT00383292|4184431|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356742|NCT00383292|4184432|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356743|NCT00383292|4184433|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356744|NCT00383292|4184430|B4||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4356745|NCT00383292|4184431|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4356746|NCT00383292|4184432|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4356747|NCT00383292|4184433|B1||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4356748|NCT00383292|4184430|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356749|NCT00383292|4184431|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356750|NCT00383292|4184432|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356751|NCT00383292|4184433|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356752|NCT00383292|4184430|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356753|NCT00383292|4184431|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356754|NCT00383292|4184432|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356755|NCT00383292|4184433|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356756|NCT00383292|4184430|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356757|NCT00383292|4184431|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356758|NCT00383292|4184432|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356759|NCT00383292|4184433|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356760|NCT00383292|4184430|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356761|NCT00383292|4184431|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356762|NCT00383292|4184432|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356763|NCT00383292|4184433|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356764|NCT00383292|4184430|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4356765|NCT00383292|4184431|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4356766|NCT00383292|4184432|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4356767|NCT00383292|4184433|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4356768|NCT00383292|4184430|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4356769|NCT00383292|4184431|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4356770|NCT00383292|4184432|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4356771|NCT00383292|4184433|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4356772|NCT00383292|4184430|B4|||Age||Years|Mean|59.67|59.67|Standard Deviation|13.34|13.34|||
4356773|NCT00383292|4184431|B3|||Age||Years|Mean|61.35|61.35|Standard Deviation|11.69|11.69|||
4356774|NCT00383292|4184432|B2|||Age||Years|Mean|61.60|61.6|Standard Deviation|15.89|15.89|||
4356775|NCT00383292|4184433|B1|||Age||Years|Mean|58.03|58.03|Standard Deviation|12.68|12.68|||
4356776|NCT00383266|4184463|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4356777|NCT00383266|4184463|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4356778|NCT00383266|4184463|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4356779|NCT00383266|4184463|B1|||Age||years|Median|62|62.0|Full Range|||42.0|71.0|
4356780|NCT00383240|4184472|B5||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4356781|NCT00383240|4184473|B4||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4356782|NCT00383240|4184474|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4356783|NCT00383240|4184475|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4356784|NCT00383240|4184476|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4356785|NCT00383240|4184472|B5||Female|Sex: Female, Male||Participants|Count of Participants|460|460.0||||||
4356786|NCT00383240|4184473|B4||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4356787|NCT00383240|4184474|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4356788|NCT00383240|4184475|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4356789|NCT00383240|4184476|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4356790|NCT00383240|4184472|B5|||Age||years|Mean|42.4|42.4|Standard Deviation|15.4|15.4|||
4356791|NCT00383240|4184473|B4|||Age||years|Mean|41.9|41.9|Standard Deviation|15.3|15.3|||
4356792|NCT00383240|4184474|B3|||Age||years|Mean|41.9|41.9|Standard Deviation|15.3|15.3|||
4356793|NCT00383240|4184475|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|14.9|14.9|||
4356794|NCT00383240|4184476|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|16.3|16.3|||
4356795|NCT00383240|4184472|B5||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4356796|NCT00383240|4184473|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4356797|NCT00383240|4184474|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4356798|NCT00383240|4184475|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4356799|NCT00383240|4184476|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4356800|NCT00383240|4184472|B5||Between 18 and 65 years|Age||Participants|Count of Participants|677|677.0||||||
4356801|NCT00383240|4184473|B4||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
4356802|NCT00383240|4184474|B3||Between 18 and 65 years|Age||Participants|Count of Participants|174|174.0||||||
4356803|NCT00383240|4184475|B2||Between 18 and 65 years|Age||Participants|Count of Participants|173|173.0||||||
4356804|NCT00383240|4184476|B1||Between 18 and 65 years|Age||Participants|Count of Participants|161|161.0||||||
4356805|NCT00383240|4184472|B5||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
4356806|NCT00383240|4184473|B4||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4356807|NCT00383240|4184474|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4356808|NCT00383240|4184475|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4356809|NCT00383240|4184476|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4356810|NCT00383162|4184510|B1|Other - Missing||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4356811|NCT00383162|4184510|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4356812|NCT00383162|4184510|B1|Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4356813|NCT00383162|4184510|B1|South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4356814|NCT00383162|4184510|B1|East Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4356815|NCT00383162|4184510|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4356816|NCT00383162|4184510|B1|White/Caucasian/European heritage||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4356817|NCT00383162|4184510|B1||Male|Gender||Participants|Count of Participants|22|22.0||||||
4356818|NCT00383162|4184510|B1||Female|Gender||Participants|Count of Participants|122|122.0||||||
4356819|NCT00383162|4184510|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|10.34|10.34|||
4356820|NCT00383149|4184553|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4356821|NCT00383149|4184553|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4356822|NCT00383149|4184553|B1|Age less than 65 years||Age, Customized||participants|Number|32|32.0||||||
4356823|NCT00383149|4184553|B1|Age Greater than, equal to 65 years||Age, Customized||participants|Number|22|22.0||||||
4356824|NCT00383149|4184553|B1|||Age||years|Median|63.0|63.0|Full Range|||47.0|84.0|
4356825|NCT00383123|4184570|B3|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|189|189.0||||||
4356826|NCT00383123|4184571|B2|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
4356827|NCT00383123|4184572|B1|Unspecified||Race/Ethnicity, Customized||Participants|Count of Participants|121|121.0||||||
4356828|NCT00383123|4184570|B3|White - caucasian / european heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2271|2271.0||||||
4356829|NCT00383123|4184571|B2|White - caucasian / european heritage||Race/Ethnicity, Customized||Participants|Count of Participants|794|794.0||||||
4356830|NCT00383123|4184572|B1|White - caucasian / european heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1477|1477.0||||||
4356831|NCT00383123|4184570|B3|White - arabic / north african heritage||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4356832|NCT00383123|4184571|B2|White - arabic / north african heritage||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4356833|NCT00383123|4184572|B1|White - arabic / north african heritage||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
4356834|NCT00383123|4184570|B3|Native hawaiian or other pacific island||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4356835|NCT00383123|4184571|B2|Native hawaiian or other pacific island||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4356836|NCT00383123|4184572|B1|Native hawaiian or other pacific island||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4356837|NCT00383123|4184570|B3|Asian - south east asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4356838|NCT00383123|4184571|B2|Asian - south east asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4356839|NCT00383123|4184572|B1|Asian - south east asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4356840|NCT00383123|4184570|B3|Asian - japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4356841|NCT00383123|4184571|B2|Asian - japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4356842|NCT00383123|4184572|B1|Asian - japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4356843|NCT00383123|4184570|B3|Asian - east asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4356844|NCT00383123|4184571|B2|Asian - east asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4356845|NCT00383123|4184572|B1|Asian - east asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4356846|NCT00383123|4184570|B3|Asian - central/south asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4356847|NCT00383123|4184571|B2|Asian - central/south asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4356848|NCT00383123|4184572|B1|Asian - central/south asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4356849|NCT00383123|4184570|B3|American indian or alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
4356850|NCT00383123|4184571|B2|American indian or alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
4356851|NCT00383123|4184572|B1|American indian or alaskan native||Race/Ethnicity, Customized||Participants|Count of Participants|78|78.0||||||
4356852|NCT00383123|4184570|B3|African heritage / african american||Race/Ethnicity, Customized||Participants|Count of Participants|582|582.0||||||
4356853|NCT00383123|4184571|B2|African heritage / african american||Race/Ethnicity, Customized||Participants|Count of Participants|238|238.0||||||
4356854|NCT00383123|4184572|B1|African heritage / african american||Race/Ethnicity, Customized||Participants|Count of Participants|344|344.0||||||
4356855|NCT00383123|4184570|B3||Male|Sex: Female, Male||Participants|Count of Participants|1701|1701.0||||||
4356856|NCT00383123|4184571|B2||Male|Sex: Female, Male||Participants|Count of Participants|624|624.0||||||
4356857|NCT00383123|4184572|B1||Male|Sex: Female, Male||Participants|Count of Participants|1077|1077.0||||||
4356858|NCT00383123|4184570|B3||Female|Sex: Female, Male||Participants|Count of Participants|1624|1624.0||||||
4356859|NCT00383123|4184571|B2||Female|Sex: Female, Male||Participants|Count of Participants|586|586.0||||||
4356860|NCT00383123|4184572|B1||Female|Sex: Female, Male||Participants|Count of Participants|1038|1038.0||||||
4356861|NCT00383123|4184570|B3|||Age||years|Mean|6.8|6.8|Standard Deviation|4.99|4.99|||
4356862|NCT00383123|4184571|B2|||Age||years|Mean|5.5|5.5|Standard Deviation|4.75|4.75|||
4356863|NCT00383123|4184572|B1|||Age||years|Mean|7.6|7.6|Standard Deviation|4.97|4.97|||
4356864|NCT00383110|4184593|B3|||Comorbidity Index|Charlson Comorbidity Index is a valid and reliable weighted index that estimates the risk of death from comorbid disease. The 17-item questionnaire takes into account the number and the seriousness of various comorbid diseases. The total score ranges from 0-37 with higher scores indicating higher predicted mortality.|units on a scale|Mean|1.9|1.9|Standard Deviation|1.9|1.9|||
4356865|NCT00383110|4184594|B2|||Comorbidity Index|Charlson Comorbidity Index is a valid and reliable weighted index that estimates the risk of death from comorbid disease. The 17-item questionnaire takes into account the number and the seriousness of various comorbid diseases. The total score ranges from 0-37 with higher scores indicating higher predicted mortality.|units on a scale|Mean|2.0|2.0|Standard Deviation|2.4|2.4|||
4356866|NCT00383110|4184595|B1|||Comorbidity Index|Charlson Comorbidity Index is a valid and reliable weighted index that estimates the risk of death from comorbid disease. The 17-item questionnaire takes into account the number and the seriousness of various comorbid diseases. The total score ranges from 0-37 with higher scores indicating higher predicted mortality.|units on a scale|Mean|1.8|1.8|Standard Deviation|1.3|1.3|||
4356867|NCT00383110|4184593|B3|> $75,000||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|13|13.0||||||
4356868|NCT00383110|4184594|B2|> $75,000||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|1|1.0||||||
4356869|NCT00383110|4184595|B1|> $75,000||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|12|12.0||||||
4356870|NCT00383110|4184593|B3|$50,000-$74,999||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|27|27.0||||||
4356871|NCT00383110|4184594|B2|$50,000-$74,999||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|13|13.0||||||
4356872|NCT00383110|4184595|B1|$50,000-$74,999||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|14|14.0||||||
4356873|NCT00383110|4184593|B3|$35,000-$49,999||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|38|38.0||||||
4356874|NCT00383110|4184594|B2|$35,000-$49,999||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|18|18.0||||||
4356875|NCT00383110|4184595|B1|$35,000-$49,999||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|20|20.0||||||
4356876|NCT00383110|4184593|B3|$20,000-$34,999||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|81|81.0||||||
4356877|NCT00383110|4184594|B2|$20,000-$34,999||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|32|32.0||||||
4356878|NCT00383110|4184595|B1|$20,000-$34,999||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|49|49.0||||||
4356879|NCT00383110|4184593|B3|< $20,000||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|119|119.0||||||
4356880|NCT00383110|4184594|B2|< $20,000||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|73|73.0||||||
4356881|NCT00383110|4184595|B1|< $20,000||Income|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|46|46.0||||||
4356882|NCT00383110|4184593|B3|Other||Work Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|11|11.0||||||
4356883|NCT00383110|4184594|B2|Other||Work Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|7|7.0||||||
4356884|NCT00383110|4184595|B1|Other||Work Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|4|4.0||||||
4356885|NCT00383110|4184593|B3|Disabled||Work Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|77|77.0||||||
4356886|NCT00383110|4184594|B2|Disabled||Work Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|48|48.0||||||
4356887|NCT00383110|4184595|B1|Disabled||Work Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|29|29.0||||||
4356888|NCT00383110|4184593|B3|Retired||Work Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|121|121.0||||||
4356889|NCT00383110|4184594|B2|Retired||Work Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|50|50.0||||||
4356890|NCT00383110|4184595|B1|Retired||Work Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|71|71.0||||||
4356891|NCT00383110|4184593|B3|Working||Work Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|73|73.0||||||
4356892|NCT00383110|4184594|B2|Working||Work Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|34|34.0||||||
4356893|NCT00383110|4184595|B1|Working||Work Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|39|39.0||||||
4356894|NCT00383110|4184593|B3|||Education||years|Mean|12.8|12.8|Standard Deviation|3.1|3.1|||
4356895|NCT00383110|4184594|B2|||Education||years|Mean|12.3|12.3|Standard Deviation|3.2|3.2|||
4356896|NCT00383110|4184595|B1|||Education||years|Mean|13.4|13.4|Standard Deviation|2.9|2.9|||
4356897|NCT00383110|4184593|B3|||Diabetes Duration||years|Mean|10.8|10.8|Standard Deviation|9.7|9.7|||
4356898|NCT00383110|4184594|B2|||Diabetes Duration||years|Mean|10.0|10.0|Standard Deviation|8.0|8.0|||
4356899|NCT00383110|4184595|B1|||Diabetes Duration||years|Mean|11.6|11.6|Standard Deviation|11.1|11.1|||
4356900|NCT00383110|4184593|B3|Not Married||Marital Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|108|108.0||||||
4356901|NCT00383110|4184594|B2|Not Married||Marital Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|64|64.0||||||
4356902|NCT00383110|4184595|B1|Not Married||Marital Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|44|44.0||||||
4356903|NCT00383110|4184593|B3|Married||Marital Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|185|185.0||||||
4356904|NCT00383110|4184594|B2|Married||Marital Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|84|84.0||||||
4356905|NCT00383110|4184595|B1|Married||Marital Status|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|101|101.0||||||
4356906|NCT00383110|4184593|B3|Male||Gender|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|285|285.0||||||
4356907|NCT00383110|4184594|B2|Male||Gender|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|142|142.0||||||
4356908|NCT00383110|4184595|B1|Male||Gender|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|143|143.0||||||
4356909|NCT00383110|4184593|B3|Female||Gender|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|6|6.0||||||
4356910|NCT00383110|4184594|B2|Female||Gender|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|4|4.0||||||
4356911|NCT00383110|4184595|B1|Female||Gender|Discrepancies in number of participants analyzed is due to some participants choosing not to answer all questions.|participants|Number|2|2.0||||||
4356912|NCT00383110|4184593|B3|||Age||years|Mean|65.93|65.93|Standard Deviation|10.41|10.41|||
4356913|NCT00383110|4184594|B2|||Age||years|Mean|63.78|63.78|Standard Deviation|10.84|10.84|||
4356914|NCT00383110|4184595|B1|||Age||years|Mean|68.11|68.11|Standard Deviation|9.49|9.49|||
4356915|NCT00383084|4184612|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
4356916|NCT00383084|4184613|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4356917|NCT00383084|4184614|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4356918|NCT00383084|4184612|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4356919|NCT00383084|4184613|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4356920|NCT00383084|4184614|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4356921|NCT00383084|4184612|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4356922|NCT00383084|4184613|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4356923|NCT00383084|4184614|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4356924|NCT00383084|4184612|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|10.7|10.7|||
4356925|NCT00383084|4184613|B2|||Age||years|Mean|49|49.0|Standard Deviation|10.2|10.2|||
4356926|NCT00383084|4184614|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|11.6|11.6|||
4356927|NCT00383084|4184612|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356928|NCT00383084|4184613|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356929|NCT00383084|4184614|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4356930|NCT00383084|4184612|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4356931|NCT00383084|4184613|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4356932|NCT00383084|4184614|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4356933|NCT00383084|4184612|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356934|NCT00383084|4184613|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356935|NCT00383084|4184614|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4356936|NCT00383071|4184627|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4356937|NCT00383071|4184628|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356938|NCT00383071|4184629|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4356939|NCT00383071|4184630|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356940|NCT00383071|4184631|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4356941|NCT00383071|4184627|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4356942|NCT00383071|4184628|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356943|NCT00383071|4184629|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356944|NCT00383071|4184630|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356945|NCT00383071|4184631|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356946|NCT00383071|4184627|B5||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4356947|NCT00383071|4184628|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4356948|NCT00383071|4184629|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4356949|NCT00383071|4184630|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4356950|NCT00383071|4184631|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4356951|NCT00383071|4184627|B5||Black|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4356952|NCT00383071|4184628|B4||Black|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4356953|NCT00383071|4184629|B3||Black|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4356954|NCT00383071|4184630|B2||Black|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4356955|NCT00383071|4184631|B1||Black|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4356956|NCT00383071|4184627|B5||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356957|NCT00383071|4184628|B4||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356958|NCT00383071|4184629|B3||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356959|NCT00383071|4184630|B2||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356960|NCT00383071|4184631|B1||Hawaiian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356961|NCT00383071|4184627|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4356962|NCT00383071|4184628|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356963|NCT00383071|4184629|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356964|NCT00383071|4184630|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4356965|NCT00383071|4184631|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356966|NCT00383071|4184627|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356967|NCT00383071|4184628|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356968|NCT00383071|4184629|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356969|NCT00383071|4184630|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356970|NCT00383071|4184631|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356971|NCT00383071|4184627|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356972|NCT00383071|4184628|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4356973|NCT00383071|4184629|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356974|NCT00383071|4184630|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356975|NCT00383071|4184631|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356976|NCT00383071|4184627|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|118|118.0||||||
4356977|NCT00383071|4184628|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4356978|NCT00383071|4184629|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4356979|NCT00383071|4184630|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4356980|NCT00383071|4184631|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4356981|NCT00383071|4184627|B5||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4356982|NCT00383071|4184628|B4||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356983|NCT00383071|4184629|B3||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4356984|NCT00383071|4184630|B2||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4356985|NCT00383071|4184631|B1||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4356986|NCT00383071|4184627|B5||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4356987|NCT00383071|4184628|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4356988|NCT00383071|4184629|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4356989|NCT00383071|4184630|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4356990|NCT00383071|4184631|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4356991|NCT00383071|4184627|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4356992|NCT00383071|4184628|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4356993|NCT00383071|4184629|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4356994|NCT00383071|4184630|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4356995|NCT00383071|4184631|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4356996|NCT00383071|4184627|B5||GTE65|Age||Participants|Count of Participants|0|0.0||||||
4356997|NCT00383071|4184628|B4||GTE65|Age||Participants|Count of Participants|0|0.0||||||
4356998|NCT00383071|4184629|B3||GTE65|Age||Participants|Count of Participants|0|0.0||||||
4356999|NCT00383071|4184630|B2||GTE65|Age||Participants|Count of Participants|0|0.0||||||
4357000|NCT00383071|4184631|B1||GTE65|Age||Participants|Count of Participants|0|0.0||||||
4357001|NCT00383071|4184627|B5||BTWN|Age||Participants|Count of Participants|125|125.0||||||
4357002|NCT00383071|4184628|B4||BTWN|Age||Participants|Count of Participants|25|25.0||||||
4357003|NCT00383071|4184629|B3||BTWN|Age||Participants|Count of Participants|51|51.0||||||
4357004|NCT00383071|4184630|B2||BTWN|Age||Participants|Count of Participants|25|25.0||||||
4357005|NCT00383071|4184631|B1||BTWN|Age||Participants|Count of Participants|24|24.0||||||
4357006|NCT00383071|4184627|B5||LTE18|Age||Participants|Count of Participants|1|1.0||||||
4357007|NCT00383071|4184628|B4||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4357008|NCT00383071|4184629|B3||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4357009|NCT00383071|4184630|B2||LTE18|Age||Participants|Count of Participants|0|0.0||||||
4357010|NCT00383071|4184631|B1||LTE18|Age||Participants|Count of Participants|1|1.0||||||
4357011|NCT00383019|4184644|B3|Japan||Region of Enrollment||participants|Number|289|289.0||||||
4357012|NCT00383019|4184645|B2|Japan||Region of Enrollment||participants|Number|145|145.0||||||
4357013|NCT00383019|4184646|B1|Japan||Region of Enrollment||participants|Number|144|144.0||||||
4357014|NCT00383019|4184644|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4357015|NCT00383019|4184645|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4357016|NCT00383019|4184646|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4357017|NCT00383019|4184644|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4357018|NCT00383019|4184645|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4357019|NCT00383019|4184646|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4357020|NCT00383019|4184644|B3||>=65 years|Age||Participants|Count of Participants|134|134.0||||||
4357021|NCT00383019|4184645|B2||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
4357022|NCT00383019|4184646|B1||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4357023|NCT00383019|4184644|B3||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4357024|NCT00383019|4184645|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4357025|NCT00383019|4184646|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4357026|NCT00383019|4184644|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357027|NCT00383019|4184645|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357028|NCT00383019|4184646|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357029|NCT00382993|4184669|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4357030|NCT00382993|4184669|B1|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4357031|NCT00382993|4184669|B1|White/Caucasian/European American||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4357032|NCT00382993|4184669|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
4357033|NCT00382993|4184669|B1||Female|Gender||Participants|Count of Participants|129|129.0||||||
4357034|NCT00382993|4184669|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|11.11|11.11|||
4357035|NCT00382967|4184712|B3|United Kingdom||Region of Enrollment||participants|Number|79|79.0||||||
4357036|NCT00382967|4184713|B2|United Kingdom||Region of Enrollment||participants|Number|41|41.0||||||
4357037|NCT00382967|4184714|B1|United Kingdom||Region of Enrollment||participants|Number|38|38.0||||||
4357038|NCT00382967|4184712|B3|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4357039|NCT00382967|4184713|B2|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4357040|NCT00382967|4184714|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4357041|NCT00382967|4184712|B3|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4357042|NCT00382967|4184713|B2|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4357043|NCT00382967|4184714|B1|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4357044|NCT00382967|4184712|B3|Norway||Region of Enrollment||participants|Number|16|16.0||||||
4357045|NCT00382967|4184713|B2|Norway||Region of Enrollment||participants|Number|8|8.0||||||
4357046|NCT00382967|4184714|B1|Norway||Region of Enrollment||participants|Number|8|8.0||||||
4357047|NCT00382967|4184712|B3|Italy||Region of Enrollment||participants|Number|26|26.0||||||
4357048|NCT00382967|4184713|B2|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4357049|NCT00382967|4184714|B1|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4357050|NCT00382967|4184712|B3|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4357051|NCT00382967|4184713|B2|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4357052|NCT00382967|4184714|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4357053|NCT00382967|4184712|B3|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4357054|NCT00382967|4184713|B2|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4357055|NCT00382967|4184714|B1|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4357056|NCT00382967|4184712|B3|France||Region of Enrollment||participants|Number|4|4.0||||||
4357057|NCT00382967|4184713|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4357058|NCT00382967|4184714|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4357059|NCT00382967|4184712|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4357060|NCT00382967|4184713|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4357061|NCT00382967|4184714|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4357062|NCT00382967|4184712|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4357063|NCT00382967|4184713|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4357064|NCT00382967|4184714|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4357065|NCT00382967|4184712|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4357066|NCT00382967|4184713|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4357067|NCT00382967|4184714|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4357068|NCT00382967|4184712|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|11.9|11.9|||
4357069|NCT00382967|4184713|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|11.8|11.8|||
4357070|NCT00382967|4184714|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|12.1|12.1|||
4357071|NCT00382967|4184712|B3||>=65 years|Age||Participants|Count of Participants|157|157.0||||||
4357072|NCT00382967|4184713|B2||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4357073|NCT00382967|4184714|B1||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4357074|NCT00382967|4184712|B3||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4357075|NCT00382967|4184713|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4357076|NCT00382967|4184714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4357077|NCT00382967|4184712|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357078|NCT00382967|4184713|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357079|NCT00382967|4184714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357080|NCT00382928|4184723|B3|Other||EKG on admission||participants|Number|5|5.0||||||
4357081|NCT00382928|4184724|B2|Other||EKG on admission||participants|Number|2|2.0||||||
4357082|NCT00382928|4184725|B1|Other||EKG on admission||participants|Number|3|3.0||||||
4357083|NCT00382928|4184723|B3|supraventricular tachycardia||EKG on admission||participants|Number|2|2.0||||||
4357084|NCT00382928|4184724|B2|supraventricular tachycardia||EKG on admission||participants|Number|0|0.0||||||
4357085|NCT00382928|4184725|B1|supraventricular tachycardia||EKG on admission||participants|Number|2|2.0||||||
4357086|NCT00382928|4184723|B3|Atrial fibrillation/flutter||EKG on admission||participants|Number|20|20.0||||||
4357087|NCT00382928|4184724|B2|Atrial fibrillation/flutter||EKG on admission||participants|Number|9|9.0||||||
4357088|NCT00382928|4184725|B1|Atrial fibrillation/flutter||EKG on admission||participants|Number|11|11.0||||||
4357089|NCT00382928|4184723|B3|normal sinus rhythm||EKG on admission||participants|Number|165|165.0||||||
4357090|NCT00382928|4184724|B2|normal sinus rhythm||EKG on admission||participants|Number|84|84.0||||||
4357091|NCT00382928|4184725|B1|normal sinus rhythm||EKG on admission||participants|Number|81|81.0||||||
4357092|NCT00382928|4184723|B3|Hyperlipidemia||Clinical Characteristics of Study Subjects||participants|Number|108|108.0||||||
4357093|NCT00382928|4184724|B2|Hyperlipidemia||Clinical Characteristics of Study Subjects||participants|Number|55|55.0||||||
4357094|NCT00382928|4184725|B1|Hyperlipidemia||Clinical Characteristics of Study Subjects||participants|Number|53|53.0||||||
4357095|NCT00382928|4184723|B3|Hypertension||Clinical Characteristics of Study Subjects||participants|Number|153|153.0||||||
4357096|NCT00382928|4184724|B2|Hypertension||Clinical Characteristics of Study Subjects||participants|Number|79|79.0||||||
4357097|NCT00382928|4184725|B1|Hypertension||Clinical Characteristics of Study Subjects||participants|Number|74|74.0||||||
4357098|NCT00382928|4184723|B3|History of Coronary Artery Disease||Clinical Characteristics of Study Subjects||participants|Number|77|77.0||||||
4357099|NCT00382928|4184724|B2|History of Coronary Artery Disease||Clinical Characteristics of Study Subjects||participants|Number|35|35.0||||||
4357100|NCT00382928|4184725|B1|History of Coronary Artery Disease||Clinical Characteristics of Study Subjects||participants|Number|42|42.0||||||
4357101|NCT00382928|4184723|B3|Diabetes mellitus||Clinical Characteristics of Study Subjects||participants|Number|81|81.0||||||
4357102|NCT00382928|4184724|B2|Diabetes mellitus||Clinical Characteristics of Study Subjects||participants|Number|46|46.0||||||
4357103|NCT00382928|4184725|B1|Diabetes mellitus||Clinical Characteristics of Study Subjects||participants|Number|35|35.0||||||
4357104|NCT00382928|4184723|B3|New Diagnosis of Heart Failure||Clinical Characteristics of Study Subjects||participants|Number|10|10.0||||||
4357105|NCT00382928|4184724|B2|New Diagnosis of Heart Failure||Clinical Characteristics of Study Subjects||participants|Number|6|6.0||||||
4357106|NCT00382928|4184725|B1|New Diagnosis of Heart Failure||Clinical Characteristics of Study Subjects||participants|Number|4|4.0||||||
4357107|NCT00382928|4184723|B3|History of Heart Failure||Clinical Characteristics of Study Subjects||participants|Number|45|45.0||||||
4357108|NCT00382928|4184724|B2|History of Heart Failure||Clinical Characteristics of Study Subjects||participants|Number|25|25.0||||||
4357109|NCT00382928|4184725|B1|History of Heart Failure||Clinical Characteristics of Study Subjects||participants|Number|20|20.0||||||
4357110|NCT00382928|4184723|B3|Black||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4357111|NCT00382928|4184724|B2|Black||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4357112|NCT00382928|4184725|B1|Black||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4357113|NCT00382928|4184723|B3|White||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4357114|NCT00382928|4184724|B2|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4357115|NCT00382928|4184725|B1|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4357116|NCT00382928|4184723|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4357117|NCT00382928|4184724|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4357118|NCT00382928|4184725|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4357119|NCT00382928|4184723|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4357120|NCT00382928|4184724|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4357121|NCT00382928|4184725|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4357122|NCT00382928|4184723|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4357123|NCT00382928|4184724|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4357124|NCT00382928|4184725|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4357125|NCT00382928|4184723|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|3.4|3.4|||
4357126|NCT00382928|4184724|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|3.4|3.4|||
4357127|NCT00382928|4184725|B1|||Age||years|Mean|62|62.0|Standard Deviation|3.4|3.4|||
4357128|NCT00382928|4184723|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357129|NCT00382928|4184724|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357130|NCT00382928|4184725|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357131|NCT00382928|4184723|B3||Between 18 and 65 years|Age||Participants|Count of Participants|192|192.0||||||
4357132|NCT00382928|4184724|B2||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4357133|NCT00382928|4184725|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4357134|NCT00382928|4184723|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357135|NCT00382928|4184724|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357136|NCT00382928|4184725|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357137|NCT00382863|4184738|B3|ICD with Bradycardia Pacing Capability||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|2|2.0||||||
4357138|NCT00382863|4184739|B2|ICD with Bradycardia Pacing Capability||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|2|2.0||||||
4357139|NCT00382863|4184740|B1|ICD with Bradycardia Pacing Capability||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|0|0.0||||||
4357140|NCT00382863|4184738|B3|ICD alone||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|87|87.0||||||
4357141|NCT00382863|4184739|B2|ICD alone||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|45|45.0||||||
4357142|NCT00382863|4184740|B1|ICD alone||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|42|42.0||||||
4357143|NCT00382863|4184738|B3|Pacemaker alone||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|1|1.0||||||
4357144|NCT00382863|4184739|B2|Pacemaker alone||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|1|1.0||||||
4357145|NCT00382863|4184740|B1|Pacemaker alone||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|0|0.0||||||
4357146|NCT00382863|4184738|B3|Biventricular ICD||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|98|98.0||||||
4357147|NCT00382863|4184739|B2|Biventricular ICD||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|57|57.0||||||
4357262|NCT00382785|4184797|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4357148|NCT00382863|4184740|B1|Biventricular ICD||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|41|41.0||||||
4357149|NCT00382863|4184738|B3|Biventricular Pacemaker||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|6|6.0||||||
4357150|NCT00382863|4184739|B2|Biventricular Pacemaker||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|3|3.0||||||
4357151|NCT00382863|4184740|B1|Biventricular Pacemaker||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|3|3.0||||||
4357152|NCT00382863|4184738|B3|Atrial Fibrillation||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|50|50.0||||||
4357153|NCT00382863|4184739|B2|Atrial Fibrillation||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|28|28.0||||||
4357154|NCT00382863|4184740|B1|Atrial Fibrillation||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|22|22.0||||||
4357155|NCT00382863|4184738|B3|Ventricular Tachycardia||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|68|68.0||||||
4357156|NCT00382863|4184739|B2|Ventricular Tachycardia||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|40|40.0||||||
4357157|NCT00382863|4184740|B1|Ventricular Tachycardia||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|28|28.0||||||
4357158|NCT00382863|4184738|B3|Myocardial Infarction||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|68|68.0||||||
4357159|NCT00382863|4184739|B2|Myocardial Infarction||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|33|33.0||||||
4357160|NCT00382863|4184740|B1|Myocardial Infarction||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|35|35.0||||||
4357161|NCT00382863|4184738|B3|Peripheral Vascular Disease||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|4|4.0||||||
4357162|NCT00382863|4184739|B2|Peripheral Vascular Disease||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|1|1.0||||||
4357163|NCT00382863|4184740|B1|Peripheral Vascular Disease||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|3|3.0||||||
4357164|NCT00382863|4184738|B3|Stroke TIA/Other Thromboembolic Events||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|21|21.0||||||
4357165|NCT00382863|4184739|B2|Stroke TIA/Other Thromboembolic Events||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|9|9.0||||||
4357166|NCT00382863|4184740|B1|Stroke TIA/Other Thromboembolic Events||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|12|12.0||||||
4357167|NCT00382863|4184738|B3|Coronary Artery Disease with Angioplasty/Stent||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|61|61.0||||||
4357168|NCT00382863|4184739|B2|Coronary Artery Disease with Angioplasty/Stent||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|30|30.0||||||
4357169|NCT00382863|4184740|B1|Coronary Artery Disease with Angioplasty/Stent||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|31|31.0||||||
4357263|NCT00382785|4184795|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4357170|NCT00382863|4184738|B3|Asthma||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|22|22.0||||||
4357171|NCT00382863|4184739|B2|Asthma||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|11|11.0||||||
4357172|NCT00382863|4184740|B1|Asthma||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|11|11.0||||||
4357173|NCT00382863|4184738|B3|Sleep Apnea||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|58|58.0||||||
4357174|NCT00382863|4184739|B2|Sleep Apnea||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|30|30.0||||||
4357175|NCT00382863|4184740|B1|Sleep Apnea||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|28|28.0||||||
4357176|NCT00382863|4184738|B3|Chronic Obstructive Pulmonary Disease (COPD)||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|21|21.0||||||
4357177|NCT00382863|4184739|B2|Chronic Obstructive Pulmonary Disease (COPD)||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|13|13.0||||||
4357178|NCT00382863|4184740|B1|Chronic Obstructive Pulmonary Disease (COPD)||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|8|8.0||||||
4357179|NCT00382863|4184738|B3|Diabetes Mellitus||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|72|72.0||||||
4357180|NCT00382863|4184739|B2|Diabetes Mellitus||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|42|42.0||||||
4357181|NCT00382863|4184740|B1|Diabetes Mellitus||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|30|30.0||||||
4357182|NCT00382863|4184738|B3|Pulmonary Hypertension||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|30|30.0||||||
4357183|NCT00382863|4184739|B2|Pulmonary Hypertension||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|14|14.0||||||
4357184|NCT00382863|4184740|B1|Pulmonary Hypertension||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|16|16.0||||||
4357185|NCT00382863|4184738|B3|Systemic Hypertension||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|102|102.0||||||
4357186|NCT00382863|4184739|B2|Systemic Hypertension||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|53|53.0||||||
4357187|NCT00382863|4184740|B1|Systemic Hypertension||Medical History and Co-Morbidities|Baseline information on specific co-morbities was requested. Since many participants had more than one co-morbidity, the sum of co-morbidities are greater than the number of participants in each group.|participants|Number|49|49.0||||||
4357188|NCT00382863|4184738|B3|Digoxin||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|98|98.0||||||
4357189|NCT00382863|4184739|B2|Digoxin||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|53|53.0||||||
4357190|NCT00382863|4184740|B1|Digoxin||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|45|45.0||||||
4357191|NCT00382863|4184738|B3|Aldosterone Inhibitors||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|129|129.0||||||
4357192|NCT00382863|4184739|B2|Aldosterone Inhibitors||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|76|76.0||||||
4357193|NCT00382863|4184740|B1|Aldosterone Inhibitors||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|53|53.0||||||
4357194|NCT00382863|4184738|B3|Diuretics (other than Spironolactone)||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|181|181.0||||||
4357195|NCT00382863|4184739|B2|Diuretics (other than Spironolactone)||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|100|100.0||||||
4357196|NCT00382863|4184740|B1|Diuretics (other than Spironolactone)||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|81|81.0||||||
4357197|NCT00382863|4184738|B3|Beta Blockers||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|208|208.0||||||
4357198|NCT00382863|4184739|B2|Beta Blockers||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|114|114.0||||||
4357199|NCT00382863|4184740|B1|Beta Blockers||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|94|94.0||||||
4357200|NCT00382863|4184738|B3|Antiogensin Receptor Blockers||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|51|51.0||||||
4357201|NCT00382863|4184739|B2|Antiogensin Receptor Blockers||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|24|24.0||||||
4357202|NCT00382863|4184740|B1|Antiogensin Receptor Blockers||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|27|27.0||||||
4357203|NCT00382863|4184738|B3|ACE Inhibitors||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|158|158.0||||||
4357204|NCT00382863|4184739|B2|ACE Inhibitors||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|86|86.0||||||
4357205|NCT00382863|4184740|B1|ACE Inhibitors||Cardiac Medications|Baseline information for specific cardiac medications was requested. Since most participants were on more than one medication, the sum of medications are greater than the number of participants in each group.|participants|Number|72|72.0||||||
4357206|NCT00382863|4184738|B3|||Duration of Heart Failure (time)||years|Mean|7.1|7.1|Standard Deviation|5.6|5.6|||
4357207|NCT00382863|4184739|B2|||Duration of Heart Failure (time)||years|Mean|6.5|6.5|Standard Deviation|5.0|5.0|||
4357208|NCT00382863|4184740|B1|||Duration of Heart Failure (time)||years|Mean|7.7|7.7|Standard Deviation|6.2|6.2|||
4357209|NCT00382863|4184738|B3|Unknown||Heart Failure Etiology||participants|Number|0|0.0||||||
4357210|NCT00382863|4184739|B2|Unknown||Heart Failure Etiology||participants|Number|0|0.0||||||
4357211|NCT00382863|4184740|B1|Unknown||Heart Failure Etiology||participants|Number|0|0.0||||||
4357212|NCT00382863|4184738|B3|Ischemic||Heart Failure Etiology||participants|Number|68|68.0||||||
4357213|NCT00382863|4184739|B2|Ischemic||Heart Failure Etiology||participants|Number|34|34.0||||||
4357214|NCT00382863|4184740|B1|Ischemic||Heart Failure Etiology||participants|Number|34|34.0||||||
4357215|NCT00382863|4184738|B3|Non-ischemic||Heart Failure Etiology||participants|Number|142|142.0||||||
4357216|NCT00382863|4184739|B2|Non-ischemic||Heart Failure Etiology||participants|Number|80|80.0||||||
4357217|NCT00382863|4184740|B1|Non-ischemic||Heart Failure Etiology||participants|Number|62|62.0||||||
4357218|NCT00382863|4184738|B3|NYHA IV; inability to have activity w/o discomfort||New York Heart Association (NYHA) Classification||participants|Number|1|1.0||||||
4357219|NCT00382863|4184739|B2|NYHA IV; inability to have activity w/o discomfort||New York Heart Association (NYHA) Classification||participants|Number|0|0.0||||||
4357220|NCT00382863|4184740|B1|NYHA IV; inability to have activity w/o discomfort||New York Heart Association (NYHA) Classification||participants|Number|1|1.0||||||
4357221|NCT00382863|4184738|B3|NYHA III; Marked limit to physical activity||New York Heart Association (NYHA) Classification||participants|Number|100|100.0||||||
4357222|NCT00382863|4184739|B2|NYHA III; Marked limit to physical activity||New York Heart Association (NYHA) Classification||participants|Number|57|57.0||||||
4357223|NCT00382863|4184740|B1|NYHA III; Marked limit to physical activity||New York Heart Association (NYHA) Classification||participants|Number|43|43.0||||||
4357224|NCT00382863|4184738|B3|NYHA II; Pts w/cardiac disease, slight limits||New York Heart Association (NYHA) Classification||participants|Number|102|102.0||||||
4357225|NCT00382863|4184739|B2|NYHA II; Pts w/cardiac disease, slight limits||New York Heart Association (NYHA) Classification||participants|Number|53|53.0||||||
4357226|NCT00382863|4184740|B1|NYHA II; Pts w/cardiac disease, slight limits||New York Heart Association (NYHA) Classification||participants|Number|49|49.0||||||
4357227|NCT00382863|4184738|B3|NYHA I: Pts w/cardiac disease, w/o activity limit||New York Heart Association (NYHA) Classification||participants|Number|7|7.0||||||
4357264|NCT00382785|4184796|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4357228|NCT00382863|4184739|B2|NYHA I: Pts w/cardiac disease, w/o activity limit||New York Heart Association (NYHA) Classification||participants|Number|4|4.0||||||
4357229|NCT00382863|4184740|B1|NYHA I: Pts w/cardiac disease, w/o activity limit||New York Heart Association (NYHA) Classification||participants|Number|3|3.0||||||
4357230|NCT00382863|4184738|B3|Unknown or Not Reported||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|1|1.0||||||
4357231|NCT00382863|4184739|B2|Unknown or Not Reported||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|0|0.0||||||
4357232|NCT00382863|4184740|B1|Unknown or Not Reported||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|1|1.0||||||
4357233|NCT00382863|4184738|B3|More than one race||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|0|0.0||||||
4357234|NCT00382863|4184739|B2|More than one race||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|0|0.0||||||
4357235|NCT00382863|4184740|B1|More than one race||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|0|0.0||||||
4357236|NCT00382863|4184738|B3|White||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|169|169.0||||||
4357237|NCT00382863|4184739|B2|White||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|93|93.0||||||
4357238|NCT00382863|4184740|B1|White||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|76|76.0||||||
4357239|NCT00382863|4184738|B3|Black or African American||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|36|36.0||||||
4357240|NCT00382863|4184739|B2|Black or African American||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|20|20.0||||||
4357241|NCT00382863|4184740|B1|Black or African American||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|16|16.0||||||
4357242|NCT00382863|4184738|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|0|0.0||||||
4357243|NCT00382863|4184739|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|0|0.0||||||
4357244|NCT00382863|4184740|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|0|0.0||||||
4357245|NCT00382863|4184738|B3|Asian||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|5|5.0||||||
4357246|NCT00382863|4184739|B2|Asian||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|3|3.0||||||
4357247|NCT00382863|4184740|B1|Asian||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|2|2.0||||||
4357248|NCT00382863|4184738|B3|American Indian or Alaska Native||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|1|1.0||||||
4357249|NCT00382863|4184739|B2|American Indian or Alaska Native||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|0|0.0||||||
4357250|NCT00382863|4184740|B1|American Indian or Alaska Native||Race (NIH/OMB)|Self-reported race. Since the participants were allowed to select more than one race, the sum of races is greater than the number of participants in each group.|participants|Number|1|1.0||||||
4357251|NCT00382863|4184738|B3||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4357252|NCT00382863|4184739|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4357253|NCT00382863|4184740|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4357254|NCT00382863|4184738|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4357255|NCT00382863|4184739|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4357256|NCT00382863|4184740|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4357257|NCT00382863|4184738|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|10.5|10.5|||
4357258|NCT00382863|4184739|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|10.8|10.8|||
4357259|NCT00382863|4184740|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|10.2|10.2|||
4357260|NCT00382785|4184795|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4357261|NCT00382785|4184796|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4357265|NCT00382785|4184797|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4357266|NCT00382785|4184795|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4357267|NCT00382785|4184796|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4357268|NCT00382785|4184797|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4357269|NCT00382785|4184795|B3|||Age||years|Mean|52.25|52.25|Standard Deviation|9.95|9.95|||
4357270|NCT00382785|4184796|B2|||Age||years|Mean|51.52|51.52|Standard Deviation|8.92|8.92|||
4357271|NCT00382785|4184797|B1|||Age||years|Mean|52.97|52.97|Standard Deviation|10.75|10.75|||
4357272|NCT00382785|4184795|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4357273|NCT00382785|4184796|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4357274|NCT00382785|4184797|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4357275|NCT00382785|4184795|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4357276|NCT00382785|4184796|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4357277|NCT00382785|4184797|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4357278|NCT00382785|4184795|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357279|NCT00382785|4184796|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357280|NCT00382785|4184797|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357281|NCT00382733|4184808|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4357282|NCT00382733|4184808|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4357283|NCT00382733|4184808|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4357284|NCT00382733|4184808|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|8.99|8.99|||
4357285|NCT00382720|4184830|B4|Missing||Weight loss during last 3 months||participants|Number|2|2.0||||||
4357286|NCT00382720|4184831|B3|Missing||Weight loss during last 3 months||participants|Number|1|1.0||||||
4357287|NCT00382720|4184832|B2|Missing||Weight loss during last 3 months||participants|Number|0|0.0||||||
4357288|NCT00382720|4184833|B1|Missing||Weight loss during last 3 months||participants|Number|1|1.0||||||
4357289|NCT00382720|4184830|B4|greater than 5%||Weight loss during last 3 months||participants|Number|122|122.0||||||
4357290|NCT00382720|4184831|B3|greater than 5%||Weight loss during last 3 months||participants|Number|41|41.0||||||
4357291|NCT00382720|4184832|B2|greater than 5%||Weight loss during last 3 months||participants|Number|42|42.0||||||
4357292|NCT00382720|4184833|B1|greater than 5%||Weight loss during last 3 months||participants|Number|39|39.0||||||
4357293|NCT00382720|4184830|B4|less than or equal to 5%||Weight loss during last 3 months||participants|Number|130|130.0||||||
4357294|NCT00382720|4184831|B3|less than or equal to 5%||Weight loss during last 3 months||participants|Number|44|44.0||||||
4357295|NCT00382720|4184832|B2|less than or equal to 5%||Weight loss during last 3 months||participants|Number|47|47.0||||||
4357296|NCT00382720|4184833|B1|less than or equal to 5%||Weight loss during last 3 months||participants|Number|39|39.0||||||
4357297|NCT00382720|4184830|B4|Missing||Karnofsky Performance Status (KPS)||participants|Number|1|1.0||||||
4357298|NCT00382720|4184831|B3|Missing||Karnofsky Performance Status (KPS)||participants|Number|0|0.0||||||
4357299|NCT00382720|4184832|B2|Missing||Karnofsky Performance Status (KPS)||participants|Number|0|0.0||||||
4357300|NCT00382720|4184833|B1|Missing||Karnofsky Performance Status (KPS)||participants|Number|1|1.0||||||
4357301|NCT00382720|4184830|B4|<70% Requires assistance||Karnofsky Performance Status (KPS)||participants|Number|1|1.0||||||
4357302|NCT00382720|4184831|B3|<70% Requires assistance||Karnofsky Performance Status (KPS)||participants|Number|0|0.0||||||
4357303|NCT00382720|4184832|B2|<70% Requires assistance||Karnofsky Performance Status (KPS)||participants|Number|0|0.0||||||
4357304|NCT00382720|4184833|B1|<70% Requires assistance||Karnofsky Performance Status (KPS)||participants|Number|1|1.0||||||
4357305|NCT00382720|4184830|B4|70% Cares for self but unable to work||Karnofsky Performance Status (KPS)||participants|Number|6|6.0||||||
4357306|NCT00382720|4184831|B3|70% Cares for self but unable to work||Karnofsky Performance Status (KPS)||participants|Number|3|3.0||||||
4357307|NCT00382720|4184832|B2|70% Cares for self but unable to work||Karnofsky Performance Status (KPS)||participants|Number|2|2.0||||||
4357308|NCT00382720|4184833|B1|70% Cares for self but unable to work||Karnofsky Performance Status (KPS)||participants|Number|1|1.0||||||
4357309|NCT00382720|4184830|B4|80% Normal activity with effort, some signs||Karnofsky Performance Status (KPS)||participants|Number|88|88.0||||||
4357310|NCT00382720|4184831|B3|80% Normal activity with effort, some signs||Karnofsky Performance Status (KPS)||participants|Number|33|33.0||||||
4357311|NCT00382720|4184832|B2|80% Normal activity with effort, some signs||Karnofsky Performance Status (KPS)||participants|Number|24|24.0||||||
4357312|NCT00382720|4184833|B1|80% Normal activity with effort, some signs||Karnofsky Performance Status (KPS)||participants|Number|31|31.0||||||
4357313|NCT00382720|4184830|B4|90% Able to carry on normal activity; minor signs||Karnofsky Performance Status (KPS)||participants|Number|92|92.0||||||
4357314|NCT00382720|4184831|B3|90% Able to carry on normal activity; minor signs||Karnofsky Performance Status (KPS)||participants|Number|31|31.0||||||
4357315|NCT00382720|4184832|B2|90% Able to carry on normal activity; minor signs||Karnofsky Performance Status (KPS)||participants|Number|35|35.0||||||
4357316|NCT00382720|4184833|B1|90% Able to carry on normal activity; minor signs||Karnofsky Performance Status (KPS)||participants|Number|26|26.0||||||
4357317|NCT00382720|4184830|B4|100% Normal, no complaints: no evidence of disease||Karnofsky Performance Status (KPS)||participants|Number|66|66.0||||||
4357318|NCT00382720|4184831|B3|100% Normal, no complaints: no evidence of disease||Karnofsky Performance Status (KPS)||participants|Number|19|19.0||||||
4357319|NCT00382720|4184832|B2|100% Normal, no complaints: no evidence of disease||Karnofsky Performance Status (KPS)||participants|Number|28|28.0||||||
4357320|NCT00382720|4184833|B1|100% Normal, no complaints: no evidence of disease||Karnofsky Performance Status (KPS)||participants|Number|19|19.0||||||
4357321|NCT00382720|4184830|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4357322|NCT00382720|4184831|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4357323|NCT00382720|4184832|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4357324|NCT00382720|4184833|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4357325|NCT00382720|4184830|B4|White||Race/Ethnicity, Customized||participants|Number|248|248.0||||||
4357326|NCT00382720|4184831|B3|White||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4357327|NCT00382720|4184832|B2|White||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4357328|NCT00382720|4184833|B1|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4357329|NCT00382720|4184830|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4357330|NCT00382720|4184831|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4357331|NCT00382720|4184832|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4357332|NCT00382720|4184833|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4357333|NCT00382720|4184830|B4|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4357334|NCT00382720|4184831|B3|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4357335|NCT00382720|4184832|B2|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4357336|NCT00382720|4184833|B1|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4357337|NCT00382720|4184830|B4||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4357338|NCT00382720|4184831|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4357339|NCT00382720|4184832|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4357340|NCT00382720|4184833|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4357341|NCT00382720|4184830|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4357342|NCT00382720|4184831|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4357343|NCT00382720|4184832|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4357344|NCT00382720|4184833|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4357345|NCT00382720|4184830|B4|||Age||years|Mean|58.7|58.7|Standard Deviation|11.1|11.1|||
4357346|NCT00382720|4184831|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|11.0|11.0|||
4357347|NCT00382720|4184832|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|11.1|11.1|||
4357348|NCT00382720|4184833|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|11.4|11.4|||
4357349|NCT00382590|4184849|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4357350|NCT00382590|4184850|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4357351|NCT00382590|4184851|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4357352|NCT00382590|4184849|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4357353|NCT00382590|4184850|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4357354|NCT00382590|4184851|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4357355|NCT00382590|4184849|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4357356|NCT00382590|4184850|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4357357|NCT00382590|4184851|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4357358|NCT00382590|4184849|B3|||Age||years|Median|75.5|75.5|Full Range|||70.0|86.0|
4357359|NCT00382590|4184850|B2|||Age||years|Median|76.5|76.5|Full Range|||71.0|86.0|
4357360|NCT00382590|4184851|B1|||Age||years|Median|75|75.0|Full Range|||70.0|79.0|
4357361|NCT00382408|4184858|B3|Unknown||Type-7 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|2|2.0||||||
4357362|NCT00382408|4184859|B2|Unknown||Type-7 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|0|0.0||||||
4357363|NCT00382408|4184860|B1|Unknown||Type-7 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|2|2.0||||||
4357364|NCT00382408|4184858|B3|Positive||Type-7 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|2502|2502.0||||||
4357365|NCT00382408|4184859|B2|Positive||Type-7 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|632|632.0||||||
4357366|NCT00382408|4184860|B1|Positive||Type-7 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|1870|1870.0||||||
4357367|NCT00382408|4184858|B3|Negative||Type-7 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|1536|1536.0||||||
4357368|NCT00382408|4184859|B2|Negative||Type-7 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|377|377.0||||||
4357369|NCT00382408|4184860|B1|Negative||Type-7 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|1159|1159.0||||||
4357370|NCT00382408|4184858|B3|Unknown||Type-4 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|2|2.0||||||
4357371|NCT00382408|4184859|B2|Unknown||Type-4 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|0|0.0||||||
4357372|NCT00382408|4184860|B1|Unknown||Type-4 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|2|2.0||||||
4357373|NCT00382408|4184858|B3|Positive||Type-4 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|1454|1454.0||||||
4357374|NCT00382408|4184859|B2|Positive||Type-4 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|331|331.0||||||
4357375|NCT00382408|4184860|B1|Positive||Type-4 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|1123|1123.0||||||
4357376|NCT00382408|4184858|B3|Negative||Type-4 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|2584|2584.0||||||
4357377|NCT00382408|4184859|B2|Negative||Type-4 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|678|678.0||||||
4357378|NCT00382408|4184860|B1|Negative||Type-4 Titer|Negative = titer value <1:4 Positive = titer value >=1:4|participants|Number|1906|1906.0||||||
4357379|NCT00382408|4184858|B3|United States||Region of Enrollment||participants|Number|4040|4040.0||||||
4357380|NCT00382408|4184859|B2|United States||Region of Enrollment||participants|Number|1009|1009.0||||||
4357381|NCT00382408|4184860|B1|United States||Region of Enrollment||participants|Number|3031|3031.0||||||
4357382|NCT00382408|4184858|B3|Other||Race/Ethnicity, Customized||participants|Number|235|235.0||||||
4357383|NCT00382408|4184859|B2|Other||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4357384|NCT00382408|4184860|B1|Other||Race/Ethnicity, Customized||participants|Number|186|186.0||||||
4357385|NCT00382408|4184858|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|429|429.0||||||
4357386|NCT00382408|4184859|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4357387|NCT00382408|4184860|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|326|326.0||||||
4357388|NCT00382408|4184858|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|2513|2513.0||||||
4357389|NCT00382408|4184859|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|642|642.0||||||
4357390|NCT00382408|4184860|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|1871|1871.0||||||
4357391|NCT00382408|4184858|B3|Asian||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4357392|NCT00382408|4184859|B2|Asian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4357393|NCT00382408|4184860|B1|Asian||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4357394|NCT00382408|4184858|B3|African-American||Race/Ethnicity, Customized||participants|Number|740|740.0||||||
4357395|NCT00382408|4184859|B2|African-American||Race/Ethnicity, Customized||participants|Number|186|186.0||||||
4357396|NCT00382408|4184860|B1|African-American||Race/Ethnicity, Customized||participants|Number|554|554.0||||||
4357397|NCT00382408|4184858|B3||Male|Sex: Female, Male||Participants|Count of Participants|2552|2552.0||||||
4357398|NCT00382408|4184859|B2||Male|Sex: Female, Male||Participants|Count of Participants|642|642.0||||||
4357399|NCT00382408|4184860|B1||Male|Sex: Female, Male||Participants|Count of Participants|1910|1910.0||||||
4357400|NCT00382408|4184858|B3||Female|Sex: Female, Male||Participants|Count of Participants|1488|1488.0||||||
4357401|NCT00382408|4184859|B2||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4357402|NCT00382408|4184860|B1||Female|Sex: Female, Male||Participants|Count of Participants|1121|1121.0||||||
4357403|NCT00382408|4184858|B3|||Age, Customized||years|Median|19.8|19.8|Full Range|||17.1|42.2|
4357404|NCT00382408|4184859|B2|||Age, Customized||years|Median|19.7|19.7|Full Range|||17.1|42.2|
4357405|NCT00382408|4184860|B1|||Age, Customized||years|Median|19.8|19.8|Full Range|||17.1|42.0|
4357406|NCT00382408|4184858|B3|||Age||years|Mean|21.2|21.2|Standard Deviation|4.0|4.0|||
4357407|NCT00382408|4184859|B2|||Age||years|Mean|21.1|21.1|Standard Deviation|4.1|4.1|||
4357408|NCT00382408|4184860|B1|||Age||years|Mean|21.3|21.3|Standard Deviation|4.0|4.0|||
4357409|NCT00382291|4184885|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4357410|NCT00382291|4184886|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4357411|NCT00382291|4184887|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4357412|NCT00382291|4184888|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4357413|NCT00382291|4184885|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4357414|NCT00382291|4184886|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4357415|NCT00382291|4184887|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4357416|NCT00382291|4184888|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4357417|NCT00382291|4184885|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357418|NCT00382291|4184886|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357419|NCT00382291|4184887|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357420|NCT00382291|4184888|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357421|NCT00382291|4184885|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4357422|NCT00382291|4184886|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4357423|NCT00382291|4184887|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4357424|NCT00382291|4184888|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4357425|NCT00382291|4184885|B4||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
4357426|NCT00382291|4184886|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4357427|NCT00382291|4184887|B2||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4357428|NCT00382291|4184888|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4357429|NCT00382265|4184901|B3|United States||Region of Enrollment||participants|Number|512|512.0||||||
4357430|NCT00382265|4184902|B2|United States||Region of Enrollment||participants|Number|245|245.0||||||
4357431|NCT00382265|4184903|B1|United States||Region of Enrollment||participants|Number|267|267.0||||||
4357432|NCT00382265|4184901|B3|Non-White Race||Race/Ethnicity, Customized||Participants|Count of Participants|110|110.0||||||
4357433|NCT00382265|4184902|B2|Non-White Race||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
4357434|NCT00382265|4184903|B1|Non-White Race||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
4357435|NCT00382265|4184901|B3||Male|Sex: Female, Male||Participants|Count of Participants|373|373.0||||||
4357436|NCT00382265|4184902|B2||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4357437|NCT00382265|4184903|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4357438|NCT00382265|4184901|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4357439|NCT00382265|4184902|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4357440|NCT00382265|4184903|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4357441|NCT00382265|4184901|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|13.3|13.3|||
4357442|NCT00382265|4184902|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|12.9|12.9|||
4357443|NCT00382265|4184903|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|13.6|13.6|||
4357444|NCT00382174|4184920|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4357445|NCT00382174|4184921|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4357446|NCT00382174|4184922|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4357447|NCT00382174|4184920|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4357448|NCT00382174|4184921|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4357449|NCT00382174|4184922|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4357450|NCT00382174|4184920|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4357451|NCT00382174|4184921|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4357452|NCT00382174|4184922|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4357453|NCT00382174|4184920|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4357454|NCT00382174|4184921|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4357455|NCT00382174|4184922|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4357456|NCT00382174|4184920|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4357457|NCT00382174|4184921|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4357458|NCT00382174|4184922|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4357459|NCT00382174|4184920|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357460|NCT00382174|4184921|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357461|NCT00382174|4184922|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357462|NCT00382148|4184935|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4357463|NCT00382148|4184936|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4357464|NCT00382148|4184937|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4357465|NCT00382148|4184935|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4357466|NCT00382148|4184936|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4357467|NCT00382148|4184937|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4357468|NCT00382148|4184935|B3|||Age||years|Mean|22.6|22.6|Standard Deviation|16.4|16.4|||
4357469|NCT00382148|4184936|B2|||Age||years|Mean|17.3|17.3|Standard Deviation|8.9|8.9|||
4357470|NCT00382148|4184937|B1|||Age||years|Mean|32.0|32.0|Standard Deviation|23.5|23.5|||
4357471|NCT00382148|4184935|B3|>= 12||Age, Customized|Safety-analysis population|participants|Number|9|9.0||||||
4357472|NCT00382148|4184936|B2|>= 12||Age, Customized|Safety-analysis population|participants|Number|5|5.0||||||
4357473|NCT00382148|4184937|B1|>= 12||Age, Customized|Safety-analysis population|participants|Number|4|4.0||||||
4357474|NCT00382148|4184935|B3|6 to < 12||Age, Customized|Safety-analysis population|participants|Number|2|2.0||||||
4357475|NCT00382148|4184936|B2|6 to < 12||Age, Customized|Safety-analysis population|participants|Number|2|2.0||||||
4357476|NCT00382148|4184937|B1|6 to < 12||Age, Customized|Safety-analysis population|participants|Number|0|0.0||||||
4357477|NCT00382109|4184950|B3|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4357478|NCT00382109|4184951|B2|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4357479|NCT00382109|4184952|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4357480|NCT00382109|4184950|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4357481|NCT00382109|4184951|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4357482|NCT00382109|4184952|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4357483|NCT00382109|4184950|B3|United States||Region of Enrollment||participants|Number|133|133.0||||||
4357484|NCT00382109|4184951|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
4357485|NCT00382109|4184952|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4357486|NCT00382109|4184950|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4357487|NCT00382109|4184951|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4357488|NCT00382109|4184952|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4357489|NCT00382109|4184950|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4357490|NCT00382109|4184951|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4357491|NCT00382109|4184952|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4357492|NCT00382109|4184950|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4357493|NCT00382109|4184951|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4357494|NCT00382109|4184952|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4357495|NCT00382109|4184950|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4357496|NCT00382109|4184951|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4357497|NCT00382109|4184952|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4357498|NCT00382109|4184950|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357499|NCT00382109|4184951|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357500|NCT00382109|4184952|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357501|NCT00382109|4184950|B3||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4357502|NCT00382109|4184951|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4357503|NCT00382109|4184952|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4357504|NCT00382109|4184950|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4357505|NCT00382109|4184951|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4357506|NCT00382109|4184952|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4357507|NCT00382109|4184950|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357508|NCT00382109|4184951|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357509|NCT00382109|4184952|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357510|NCT00382109|4184950|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4357511|NCT00382109|4184951|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4357512|NCT00382109|4184952|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4357513|NCT00382109|4184950|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357514|NCT00382109|4184951|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357515|NCT00382109|4184952|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357516|NCT00382109|4184950|B3||Male|Gender||Participants|Count of Participants|87|87.0||||||
4357517|NCT00382109|4184951|B2||Male|Gender||Participants|Count of Participants|41|41.0||||||
4357518|NCT00382109|4184952|B1||Male|Gender||Participants|Count of Participants|46|46.0||||||
4357519|NCT00382109|4184950|B3||Female|Gender||Participants|Count of Participants|59|59.0||||||
4357520|NCT00382109|4184951|B2||Female|Gender||Participants|Count of Participants|29|29.0||||||
4357521|NCT00382109|4184952|B1||Female|Gender||Participants|Count of Participants|30|30.0||||||
4357522|NCT00382109|4184950|B3|||Age||Year|Median|9|9.0|Full Range|||1.0|21.0|
4357523|NCT00382109|4184951|B2|||Age||Year|Median|10|10.0|Full Range|||1.0|21.0|
4357524|NCT00382109|4184952|B1|||Age||Year|Median|9|9.0|Full Range|||1.0|20.0|
4357525|NCT00382031|4184973|B3|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4357526|NCT00382031|4184974|B2|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4357527|NCT00382031|4184975|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4357528|NCT00382031|4184973|B3|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4357529|NCT00382031|4184974|B2|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4357530|NCT00382031|4184975|B1|Poland||Region of Enrollment||participants|Number|14|14.0||||||
4357531|NCT00382031|4184973|B3|Belgium||Region of Enrollment||participants|Number|51|51.0||||||
4357532|NCT00382031|4184974|B2|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
4357533|NCT00382031|4184975|B1|Belgium||Region of Enrollment||participants|Number|31|31.0||||||
4357534|NCT00382031|4184973|B3|Brazil||Region of Enrollment||participants|Number|11|11.0||||||
4357535|NCT00382031|4184974|B2|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4357536|NCT00382031|4184975|B1|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4357537|NCT00382031|4184973|B3|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4357538|NCT00382031|4184974|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4357539|NCT00382031|4184975|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4357540|NCT00382031|4184973|B3|Hungary||Region of Enrollment||participants|Number|57|57.0||||||
4357541|NCT00382031|4184974|B2|Hungary||Region of Enrollment||participants|Number|20|20.0||||||
4357542|NCT00382031|4184975|B1|Hungary||Region of Enrollment||participants|Number|37|37.0||||||
4357543|NCT00382031|4184973|B3|France||Region of Enrollment||participants|Number|16|16.0||||||
4357544|NCT00382031|4184974|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4357545|NCT00382031|4184975|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4357546|NCT00382031|4184973|B3|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
4357547|NCT00382031|4184974|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4357548|NCT00382031|4184975|B1|United Kingdom||Region of Enrollment||participants|Number|22|22.0||||||
4357549|NCT00382031|4184973|B3|Russian Federation||Region of Enrollment||participants|Number|64|64.0||||||
4357550|NCT00382031|4184974|B2|Russian Federation||Region of Enrollment||participants|Number|22|22.0||||||
4357551|NCT00382031|4184975|B1|Russian Federation||Region of Enrollment||participants|Number|42|42.0||||||
4357552|NCT00382031|4184973|B3|Lithuania||Region of Enrollment||participants|Number|2|2.0||||||
4357553|NCT00382031|4184974|B2|Lithuania||Region of Enrollment||participants|Number|0|0.0||||||
4357554|NCT00382031|4184975|B1|Lithuania||Region of Enrollment||participants|Number|2|2.0||||||
4357555|NCT00382031|4184973|B3|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4357556|NCT00382031|4184974|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4357557|NCT00382031|4184975|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4357558|NCT00382031|4184973|B3|Estonia||Region of Enrollment||participants|Number|4|4.0||||||
4357559|NCT00382031|4184974|B2|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
4357560|NCT00382031|4184975|B1|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
4357561|NCT00382031|4184973|B3|Serbia||Region of Enrollment||participants|Number|6|6.0||||||
4357562|NCT00382031|4184974|B2|Serbia||Region of Enrollment||participants|Number|1|1.0||||||
4357563|NCT00382031|4184975|B1|Serbia||Region of Enrollment||participants|Number|5|5.0||||||
4357564|NCT00382031|4184973|B3||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4357565|NCT00382031|4184974|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4357566|NCT00382031|4184975|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4357567|NCT00382031|4184973|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4357568|NCT00382031|4184974|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4357569|NCT00382031|4184975|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4357570|NCT00382031|4184973|B3|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
4357571|NCT00382031|4184974|B2|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
4357572|NCT00382031|4184975|B1|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
4357573|NCT00382031|4184973|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4357574|NCT00382031|4184974|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4357575|NCT00382031|4184975|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4357576|NCT00382031|4184973|B3||Between 18 and 65 years|Age||Participants|Count of Participants|238|238.0||||||
4357577|NCT00382031|4184974|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4357578|NCT00382031|4184975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|161|161.0||||||
4357579|NCT00382031|4184973|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357580|NCT00382031|4184974|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357581|NCT00382031|4184975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357582|NCT00382018|4184988|B5|||HER2 positive||Participants|Count of Participants|96|96.0||||||
4357583|NCT00382018|4184989|B4|||HER2 positive||Participants|Count of Participants|4|4.0||||||
4357584|NCT00382018|4184990|B3|||HER2 positive||Participants|Count of Participants|3|3.0||||||
4357585|NCT00382018|4184991|B2|||HER2 positive||Participants|Count of Participants|36|36.0||||||
4357586|NCT00382018|4184992|B1|||HER2 positive||Participants|Count of Participants|53|53.0||||||
4357587|NCT00382018|4184988|B5|||Triple negative||Participants|Count of Participants|134|134.0||||||
4357588|NCT00382018|4184989|B4|||Triple negative||Participants|Count of Participants|16|16.0||||||
4357589|NCT00382018|4184990|B3|||Triple negative||Participants|Count of Participants|11|11.0||||||
4357590|NCT00382018|4184991|B2|||Triple negative||Participants|Count of Participants|33|33.0||||||
4357591|NCT00382018|4184992|B1|||Triple negative||Participants|Count of Participants|74|74.0||||||
4357592|NCT00382018|4184988|B5|||Homo receptor positive, HER2 negative||Participants|Count of Participants|330|330.0||||||
4357593|NCT00382018|4184989|B4|||Homo receptor positive, HER2 negative||Participants|Count of Participants|39|39.0||||||
4357594|NCT00382018|4184990|B3|||Homo receptor positive, HER2 negative||Participants|Count of Participants|50|50.0||||||
4357595|NCT00382018|4184991|B2|||Homo receptor positive, HER2 negative||Participants|Count of Participants|93|93.0||||||
4357596|NCT00382018|4184992|B1|||Homo receptor positive, HER2 negative||Participants|Count of Participants|148|148.0||||||
4357597|NCT00382018|4184988|B5|||No. of patients classified by disease subtype||Participants|Count of Participants|560|560.0||||||
4357598|NCT00382018|4184989|B4|||No. of patients classified by disease subtype||Participants|Count of Participants|59|59.0||||||
4357599|NCT00382018|4184990|B3|||No. of patients classified by disease subtype||Participants|Count of Participants|64|64.0||||||
4357600|NCT00382018|4184991|B2|||No. of patients classified by disease subtype||Participants|Count of Participants|162|162.0||||||
4357601|NCT00382018|4184992|B1|||No. of patients classified by disease subtype||Participants|Count of Participants|275|275.0||||||
4357602|NCT00382018|4184988|B5|||Measurable disease|Measurable disease: Lesions that can be accurately measured in at least one dimension by 1) medical photograph (skin or oral lesion), palpation, plain x-ray, CT, MRI or other conventional technique with longest diameter 2 cm or greater in the axial plane (bone lesions not included), or 2) spiral CT with longest diameter 1 cm or greater. Ultrasound is suitable only for superficial disease (superficial palpable nodes, subcutaneous lesions, thyroid nodules).|Participants|Count of Participants|455|455.0||||||
4357603|NCT00382018|4184989|B4|||Measurable disease|Measurable disease: Lesions that can be accurately measured in at least one dimension by 1) medical photograph (skin or oral lesion), palpation, plain x-ray, CT, MRI or other conventional technique with longest diameter 2 cm or greater in the axial plane (bone lesions not included), or 2) spiral CT with longest diameter 1 cm or greater. Ultrasound is suitable only for superficial disease (superficial palpable nodes, subcutaneous lesions, thyroid nodules).|Participants|Count of Participants|50|50.0||||||
4357604|NCT00382018|4184990|B3|||Measurable disease|Measurable disease: Lesions that can be accurately measured in at least one dimension by 1) medical photograph (skin or oral lesion), palpation, plain x-ray, CT, MRI or other conventional technique with longest diameter 2 cm or greater in the axial plane (bone lesions not included), or 2) spiral CT with longest diameter 1 cm or greater. Ultrasound is suitable only for superficial disease (superficial palpable nodes, subcutaneous lesions, thyroid nodules).|Participants|Count of Participants|47|47.0||||||
4357605|NCT00382018|4184991|B2|||Measurable disease|Measurable disease: Lesions that can be accurately measured in at least one dimension by 1) medical photograph (skin or oral lesion), palpation, plain x-ray, CT, MRI or other conventional technique with longest diameter 2 cm or greater in the axial plane (bone lesions not included), or 2) spiral CT with longest diameter 1 cm or greater. Ultrasound is suitable only for superficial disease (superficial palpable nodes, subcutaneous lesions, thyroid nodules).|Participants|Count of Participants|137|137.0||||||
4357663|NCT00381862|4185027|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4357606|NCT00382018|4184992|B1|||Measurable disease|Measurable disease: Lesions that can be accurately measured in at least one dimension by 1) medical photograph (skin or oral lesion), palpation, plain x-ray, CT, MRI or other conventional technique with longest diameter 2 cm or greater in the axial plane (bone lesions not included), or 2) spiral CT with longest diameter 1 cm or greater. Ultrasound is suitable only for superficial disease (superficial palpable nodes, subcutaneous lesions, thyroid nodules).|Participants|Count of Participants|221|221.0||||||
4357607|NCT00382018|4184988|B5|||Black Race||Participants|Count of Participants|95|95.0||||||
4357608|NCT00382018|4184989|B4|||Black Race||Participants|Count of Participants|7|7.0||||||
4357609|NCT00382018|4184990|B3|||Black Race||Participants|Count of Participants|15|15.0||||||
4357610|NCT00382018|4184991|B2|||Black Race||Participants|Count of Participants|23|23.0||||||
4357611|NCT00382018|4184992|B1|||Black Race||Participants|Count of Participants|50|50.0||||||
4357612|NCT00382018|4184988|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4357613|NCT00382018|4184989|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4357614|NCT00382018|4184990|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4357615|NCT00382018|4184991|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4357616|NCT00382018|4184992|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4357617|NCT00382018|4184988|B5||Female|Sex: Female, Male||Participants|Count of Participants|564|564.0||||||
4357618|NCT00382018|4184989|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4357619|NCT00382018|4184990|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4357620|NCT00382018|4184991|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4357621|NCT00382018|4184992|B1||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4357622|NCT00382018|4184988|B5|Age 55 years or older||Age, Customized||Participants|Count of Participants|334|334.0||||||
4357623|NCT00382018|4184989|B4|Age 55 years or older||Age, Customized||Participants|Count of Participants|39|39.0||||||
4357624|NCT00382018|4184990|B3|Age 55 years or older||Age, Customized||Participants|Count of Participants|38|38.0||||||
4357625|NCT00382018|4184991|B2|Age 55 years or older||Age, Customized||Participants|Count of Participants|94|94.0||||||
4357626|NCT00382018|4184992|B1|Age 55 years or older||Age, Customized||Participants|Count of Participants|163|163.0||||||
4357627|NCT00381966|4185013|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4357628|NCT00381966|4185013|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4357629|NCT00381966|4185013|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4357630|NCT00381966|4185013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4357631|NCT00381966|4185013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357632|NCT00381940|4185018|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4357633|NCT00381940|4185018|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4357634|NCT00381940|4185018|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4357635|NCT00381940|4185018|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357636|NCT00381940|4185018|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4357637|NCT00381940|4185018|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4357638|NCT00381940|4185018|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4357639|NCT00381940|4185018|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357640|NCT00381940|4185018|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4357641|NCT00381940|4185018|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4357642|NCT00381940|4185018|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357643|NCT00381940|4185018|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4357644|NCT00381940|4185018|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357645|NCT00381940|4185018|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4357646|NCT00381940|4185018|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4357647|NCT00381940|4185018|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357648|NCT00381940|4185018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4357649|NCT00381940|4185018|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4357650|NCT00381940|4185018|B1|||Age||years|Mean|15.9|15.9|Standard Deviation|2.6|2.6|||
4357651|NCT00381888|4185022|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4357652|NCT00381888|4185022|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4357653|NCT00381888|4185022|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4357654|NCT00381888|4185022|B1|||Age||Years|Mean|55.7|55.7|Full Range|||28.0|70.0|
4357655|NCT00381888|4185022|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4357656|NCT00381888|4185022|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4357657|NCT00381888|4185022|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357658|NCT00381862|4185027|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4357659|NCT00381862|4185027|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4357660|NCT00381862|4185027|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4357661|NCT00381862|4185027|B1|||Age||years|Mean|55|55.0|Standard Deviation|11.728|11.728|||
4357662|NCT00381862|4185027|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4357664|NCT00381862|4185027|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357665|NCT00381849|4185031|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4357666|NCT00381849|4185032|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4357667|NCT00381849|4185033|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4357668|NCT00381849|4185031|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4357669|NCT00381849|4185032|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4357670|NCT00381849|4185033|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4357671|NCT00381849|4185031|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4357672|NCT00381849|4185032|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4357673|NCT00381849|4185033|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4357674|NCT00381849|4185031|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4357675|NCT00381849|4185032|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4357676|NCT00381849|4185033|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4357677|NCT00381849|4185031|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4357678|NCT00381849|4185032|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4357679|NCT00381849|4185033|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4357680|NCT00381849|4185031|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357681|NCT00381849|4185032|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357682|NCT00381849|4185033|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357683|NCT00381810|4185052|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4357684|NCT00381810|4185052|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4357685|NCT00381810|4185052|B1|20-64 years||Age, Customized||participants|Number|31|31.0||||||
4357686|NCT00381810|4185052|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|12.3|12.3|||
4357687|NCT00381797|4185056|B6|United States||Region of Enrollment||participants|Number|97|97.0||||||
4357688|NCT00381797|4185057|B5|United States||Region of Enrollment||participants|Number|37|37.0||||||
4357689|NCT00381797|4185058|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4357690|NCT00381797|4185059|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4357691|NCT00381797|4185060|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4357692|NCT00381797|4185061|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4357693|NCT00381797|4185056|B6||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4357694|NCT00381797|4185057|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4357695|NCT00381797|4185058|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4357696|NCT00381797|4185059|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4357697|NCT00381797|4185060|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4357698|NCT00381797|4185061|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4357699|NCT00381797|4185056|B6||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4357700|NCT00381797|4185057|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4357701|NCT00381797|4185058|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4357702|NCT00381797|4185059|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4357703|NCT00381797|4185060|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4357704|NCT00381797|4185061|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4357705|NCT00381797|4185056|B6|||Age||years|Mean|10.21|10.21|Standard Deviation|4.82|4.82|||
4357706|NCT00381797|4185057|B5|||Age||years|Mean|8.58|8.58|Standard Deviation|4.09|4.09|||
4357707|NCT00381797|4185058|B4|||Age||years|Mean|10.16|10.16|Standard Deviation|5.17|5.17|||
4357708|NCT00381797|4185059|B3|||Age||years|Mean|10.56|10.56|Standard Deviation|5.28|5.28|||
4357709|NCT00381797|4185060|B2|||Age||years|Mean|8.45|8.45|Standard Deviation|3.35|3.35|||
4357710|NCT00381797|4185061|B1|||Age||years|Mean|15.07|15.07|Standard Deviation|3.82|3.82|||
4357711|NCT00381797|4185056|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357712|NCT00381797|4185057|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357713|NCT00381797|4185058|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357714|NCT00381797|4185059|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357715|NCT00381797|4185060|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357716|NCT00381797|4185061|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357717|NCT00381797|4185056|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4357718|NCT00381797|4185057|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4357719|NCT00381797|4185058|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4357720|NCT00381797|4185059|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4357721|NCT00381797|4185060|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4357722|NCT00381797|4185061|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4357723|NCT00381797|4185056|B6||<=18 years|Age||Participants|Count of Participants|91|91.0||||||
4357724|NCT00381797|4185057|B5||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4357725|NCT00381797|4185058|B4||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4357726|NCT00381797|4185059|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4357727|NCT00381797|4185060|B2||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4357728|NCT00381797|4185061|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4357729|NCT00381706|4185134|B7|United States||Region of Enrollment||participants|Number|235|235.0||||||
4357730|NCT00381706|4185135|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
4357731|NCT00381706|4185136|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
4357732|NCT00381706|4185137|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4357733|NCT00381706|4185138|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4357734|NCT00381706|4185139|B2|United States||Region of Enrollment||participants|Number|73|73.0||||||
4357735|NCT00381706|4185140|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4357736|NCT00381706|4185134|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4357737|NCT00381706|4185135|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357738|NCT00381706|4185136|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357739|NCT00381706|4185137|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357740|NCT00381706|4185138|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357741|NCT00381706|4185139|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4357742|NCT00381706|4185140|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4357743|NCT00381706|4185134|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357744|NCT00381706|4185135|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357745|NCT00381706|4185136|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357746|NCT00381706|4185137|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357747|NCT00381706|4185138|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357748|NCT00381706|4185139|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357749|NCT00381706|4185140|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357750|NCT00381706|4185134|B7||White|Race (NIH/OMB)||Participants|Count of Participants|223|223.0||||||
4357751|NCT00381706|4185135|B6||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4357752|NCT00381706|4185136|B5||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4357753|NCT00381706|4185137|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4357754|NCT00381706|4185138|B3||White|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4357755|NCT00381706|4185139|B2||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4357756|NCT00381706|4185140|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4357757|NCT00381706|4185134|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4357758|NCT00381706|4185135|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357759|NCT00381706|4185136|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4357760|NCT00381706|4185137|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4357761|NCT00381706|4185138|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4357762|NCT00381706|4185139|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4357763|NCT00381706|4185140|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4357764|NCT00381706|4185134|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357765|NCT00381706|4185135|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357766|NCT00381706|4185136|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357767|NCT00381706|4185137|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357768|NCT00381706|4185138|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357769|NCT00381706|4185139|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357770|NCT00381706|4185140|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357771|NCT00381706|4185134|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4357772|NCT00381706|4185135|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357773|NCT00381706|4185136|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357774|NCT00381706|4185137|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357775|NCT00381706|4185138|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357776|NCT00381706|4185139|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4357777|NCT00381706|4185140|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357778|NCT00381706|4185134|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357779|NCT00381706|4185135|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357780|NCT00381706|4185136|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357781|NCT00381706|4185137|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357782|NCT00381706|4185138|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357783|NCT00381706|4185139|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357784|NCT00381706|4185140|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357785|NCT00381706|4185134|B7||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4357786|NCT00381706|4185135|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4357787|NCT00381706|4185136|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4357788|NCT00381706|4185137|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4357789|NCT00381706|4185138|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4357790|NCT00381706|4185139|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4357791|NCT00381706|4185140|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4357792|NCT00381706|4185134|B7||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4357793|NCT00381706|4185135|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4357794|NCT00381706|4185136|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4357795|NCT00381706|4185137|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4357796|NCT00381706|4185138|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4357797|NCT00381706|4185139|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4357798|NCT00381706|4185140|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4357799|NCT00381706|4185134|B7|||Age||years|Median|59.3|59.3|Full Range|||30.0|87.0|
4357800|NCT00381706|4185135|B6|||Age||years|Median|61.2|61.2|Full Range|||50.0|76.0|
4357801|NCT00381706|4185136|B5|||Age||years|Median|61.8|61.8|Full Range|||52.0|69.0|
4357802|NCT00381706|4185137|B4|||Age||years|Median|61.6|61.6|Full Range|||52.0|84.0|
4357803|NCT00381706|4185138|B3|||Age||years|Median|59.2|59.2|Full Range|||30.0|83.0|
4357804|NCT00381706|4185139|B2|||Age||years|Median|60.3|60.3|Full Range|||34.0|81.0|
4357805|NCT00381706|4185140|B1|||Age||years|Median|57.7|57.7|Full Range|||33.0|87.0|
4357806|NCT00381693|4185165|B1|No||Prior Therapy for Myelofibrosis||participants|Number|3|3.0||||||
4357807|NCT00381693|4185165|B1|Yes||Prior Therapy for Myelofibrosis||participants|Number|7|7.0||||||
4357808|NCT00381693|4185165|B1|No||Prior Thrombosis or Hemorrhage||participants|Number|10|10.0||||||
4357809|NCT00381693|4185165|B1|Yes||Prior Thrombosis or Hemorrhage||participants|Number|0|0.0||||||
4357810|NCT00381693|4185165|B1|No||Red Cell Transfusion-dependent||participants|Number|3|3.0||||||
4357811|NCT00381693|4185165|B1|Yes||Red Cell Transfusion-dependent||participants|Number|7|7.0||||||
4357812|NCT00381693|4185165|B1|2 (High Risk)||Lilie Score at Diagnosis (Myelofibrosis only)|A scoring system reported by Dupriez et al, which was constructed with the two adverse prognostic factors, namely Hb < 10 g/dL and WBC < 4 or > 30 x 10(9)/L, used to separate patients in three groups with low (0 factor), intermediate (1 factor), and high (2 factors) risks, associated with a median survival of 93, 26, and 13 months, respectively.|participants|Number|3|3.0||||||
4357813|NCT00381693|4185165|B1|1 (Intermediate Risk)||Lilie Score at Diagnosis (Myelofibrosis only)|A scoring system reported by Dupriez et al, which was constructed with the two adverse prognostic factors, namely Hb < 10 g/dL and WBC < 4 or > 30 x 10(9)/L, used to separate patients in three groups with low (0 factor), intermediate (1 factor), and high (2 factors) risks, associated with a median survival of 93, 26, and 13 months, respectively.|participants|Number|5|5.0||||||
4357814|NCT00381693|4185165|B1|0 (Low Risk)||Lilie Score at Diagnosis (Myelofibrosis only)|A scoring system reported by Dupriez et al, which was constructed with the two adverse prognostic factors, namely Hb < 10 g/dL and WBC < 4 or > 30 x 10(9)/L, used to separate patients in three groups with low (0 factor), intermediate (1 factor), and high (2 factors) risks, associated with a median survival of 93, 26, and 13 months, respectively.|participants|Number|2|2.0||||||
4357815|NCT00381693|4185165|B1|Post-essential Thrombocythemia Myelofibrosis||Disease||participants|Number|1|1.0||||||
4357816|NCT00381693|4185165|B1|Post-polycythemia Vera Myelofibrosis||Disease||participants|Number|1|1.0||||||
4357817|NCT00381693|4185165|B1|Primary Myelofibrosis||Disease||participants|Number|8|8.0||||||
4357818|NCT00381693|4185165|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4357819|NCT00381693|4185165|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4357820|NCT00381693|4185165|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4357821|NCT00381693|4185165|B1|||Age||years|Median|72|72.0|Full Range|||57.0|76.0|
4357822|NCT00381680|4185172|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4357823|NCT00381680|4185173|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4357824|NCT00381680|4185174|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4357825|NCT00381680|4185172|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357826|NCT00381680|4185173|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357827|NCT00381680|4185174|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357828|NCT00381680|4185172|B3||White|Race (NIH/OMB)||Participants|Count of Participants|212|212.0||||||
4357829|NCT00381680|4185173|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4357830|NCT00381680|4185174|B1||White|Race (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
4357831|NCT00381680|4185172|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4357832|NCT00381680|4185173|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4357833|NCT00381680|4185174|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4357834|NCT00381680|4185172|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4357835|NCT00381680|4185173|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357836|NCT00381680|4185174|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4357837|NCT00381680|4185172|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4357838|NCT00381680|4185173|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4357839|NCT00381680|4185174|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4357840|NCT00381680|4185172|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4357841|NCT00381680|4185173|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357842|NCT00381680|4185174|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4357843|NCT00381680|4185172|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4357844|NCT00381680|4185173|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4357845|NCT00381680|4185174|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4357846|NCT00381680|4185172|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
4357847|NCT00381680|4185173|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4357848|NCT00381680|4185174|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
4357849|NCT00381680|4185172|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4357850|NCT00381680|4185173|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4357851|NCT00381680|4185174|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4357852|NCT00381680|4185172|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4357853|NCT00381680|4185173|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4357854|NCT00381680|4185174|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4357855|NCT00381680|4185172|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4357856|NCT00381680|4185173|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4357857|NCT00381680|4185174|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4357858|NCT00381680|4185172|B3|||Age||years|Mean|17.82|17.82|Standard Deviation|5.21|5.21|||
4357859|NCT00381680|4185173|B2|||Age||years|Mean|19.62|19.62|Standard Deviation|4.84|4.84|||
4357860|NCT00381680|4185174|B1|||Age||years|Mean|17.21|17.21|Standard Deviation|5.20|5.2|||
4357861|NCT00381641|4185190|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
4357862|NCT00381641|4185191|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4357863|NCT00381641|4185192|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4357864|NCT00381641|4185190|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357865|NCT00381641|4185191|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357866|NCT00381641|4185192|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357867|NCT00381641|4185190|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357868|NCT00381641|4185191|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357869|NCT00381641|4185192|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357870|NCT00381641|4185190|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4357871|NCT00381641|4185191|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4357872|NCT00381641|4185192|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4357873|NCT00381641|4185190|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4357874|NCT00381641|4185191|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4357875|NCT00381641|4185192|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4357876|NCT00381641|4185190|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357877|NCT00381641|4185191|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357878|NCT00381641|4185192|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357879|NCT00381641|4185190|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4357880|NCT00381641|4185191|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4357881|NCT00381641|4185192|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357882|NCT00381641|4185190|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357883|NCT00381641|4185191|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357884|NCT00381641|4185192|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357885|NCT00381641|4185190|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4357886|NCT00381641|4185191|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4357887|NCT00381641|4185192|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4357888|NCT00381641|4185190|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4357889|NCT00381641|4185191|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4357890|NCT00381641|4185192|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4357891|NCT00381641|4185190|B3|||Age||years|Mean|55.8|55.8|Full Range|||23.0|76.0|
4357892|NCT00381641|4185191|B2|||Age||years|Mean|50.9|50.9|Full Range|||23.0|73.0|
4357893|NCT00381641|4185192|B1|||Age||years|Mean|59.1|59.1|Full Range|||37.0|76.0|
4357894|NCT00381628|4185205|B5|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4357895|NCT00381628|4185206|B4|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4357896|NCT00381628|4185207|B3|United States||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4357897|NCT00381628|4185208|B2|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4357898|NCT00381628|4185209|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4357899|NCT00381628|4185205|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4357900|NCT00381628|4185206|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4357901|NCT00381628|4185208|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4357902|NCT00381628|4185209|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4357903|NCT00381628|4185205|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4357904|NCT00381628|4185206|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4357905|NCT00381628|4185208|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4357906|NCT00381628|4185209|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4357907|NCT00381628|4185205|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4357908|NCT00381628|4185206|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357909|NCT00381628|4185208|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4357910|NCT00381628|4185209|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4357911|NCT00381628|4185205|B5||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4357912|NCT00381628|4185206|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4357913|NCT00381628|4185208|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4357914|NCT00381628|4185209|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4357915|NCT00381628|4185205|B5||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4357916|NCT00381628|4185206|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357917|NCT00381628|4185208|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4357918|NCT00381628|4185209|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4357919|NCT00381615|4185222|B5||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4357920|NCT00381615|4185223|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4357921|NCT00381615|4185224|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4357922|NCT00381615|4185225|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4357923|NCT00381615|4185226|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4357924|NCT00381615|4185222|B5||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4357925|NCT00381615|4185223|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4357926|NCT00381615|4185224|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4357927|NCT00381615|4185225|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4357928|NCT00381615|4185226|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4357929|NCT00381615|4185222|B5|||Age||Days|Mean|60.2|60.2|Standard Deviation|5.3|5.3|||
4357930|NCT00381615|4185223|B4|||Age||Days|Mean|60.9|60.9|Standard Deviation|6.1|6.1|||
4357931|NCT00381615|4185224|B3|||Age||Days|Mean|60.4|60.4|Standard Deviation|5.9|5.9|||
4357932|NCT00381615|4185225|B2|||Age||Days|Mean|60.9|60.9|Standard Deviation|5.9|5.9|||
4357933|NCT00381615|4185226|B1|||Age||Days|Mean|59.0|59.0|Standard Deviation|3.4|3.4|||
4357934|NCT00381563|4185279|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4357935|NCT00381563|4185280|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4357936|NCT00381563|4185281|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4357937|NCT00381563|4185279|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4357938|NCT00381563|4185280|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4357939|NCT00381563|4185281|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4357940|NCT00381563|4185279|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4357941|NCT00381563|4185280|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4357942|NCT00381563|4185281|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4357943|NCT00381563|4185279|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|9.3|9.3|||
4357944|NCT00381563|4185280|B2|||Age||years|Mean|61|61.0|Standard Deviation|9.1|9.1|||
4357945|NCT00381563|4185281|B1|||Age||years|Mean|60|60.0|Standard Deviation|9.7|9.7|||
4357946|NCT00381563|4185279|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4357947|NCT00381563|4185280|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4357948|NCT00381563|4185281|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4357949|NCT00381563|4185279|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4357950|NCT00381563|4185280|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4357951|NCT00381563|4185281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4357952|NCT00381563|4185279|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357953|NCT00381563|4185280|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357954|NCT00381563|4185281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357955|NCT00381550|4185289|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4357956|NCT00381550|4185289|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4357957|NCT00381550|4185289|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4357958|NCT00381550|4185289|B1|||Age||years|Mean|65|65.0|Standard Deviation|40|40.0|||
4357959|NCT00381550|4185289|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4357960|NCT00381550|4185289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4357961|NCT00381550|4185289|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4357962|NCT00381485|4185294|B4||Male|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
4357963|NCT00381485|4185295|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4357964|NCT00381485|4185296|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4357965|NCT00381485|4185297|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4357966|NCT00381485|4185294|B4||Female|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
4357967|NCT00381485|4185295|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4357968|NCT00381485|4185296|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4357969|NCT00381485|4185297|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4357970|NCT00381485|4185294|B4||>=65 years|Age||Participants|Count of Participants|87|87.0||||||
4357971|NCT00381485|4185295|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4357972|NCT00381485|4185296|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4357973|NCT00381485|4185297|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4357974|NCT00381485|4185294|B4||Between 18 and 65 years|Age||Participants|Count of Participants|578|578.0||||||
4357975|NCT00381485|4185295|B3||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4357976|NCT00381485|4185296|B2||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4357977|NCT00381485|4185297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
4357978|NCT00381485|4185294|B4||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
4357979|NCT00381485|4185295|B3||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4357980|NCT00381485|4185296|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4357981|NCT00381485|4185297|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4357982|NCT00381381|4185318|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357983|NCT00381381|4185318|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357984|NCT00381381|4185318|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357985|NCT00381381|4185318|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357986|NCT00381381|4185318|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357987|NCT00381381|4185318|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|199|199.0||||||
4357988|NCT00381381|4185318|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4357989|NCT00381381|4185318|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4357990|NCT00381381|4185318|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4357991|NCT00381381|4185318|B1|||Age||years|Mean|74.6|74.6|Standard Deviation|6.5|6.5|||
4357992|NCT00381303|4185325|B3|||Time since HIV-infection diagnosis||years|Median|11.3|11.3|Full Range|||0.29|27.62|
4357993|NCT00381303|4185326|B2|||Time since HIV-infection diagnosis||years|Median|11.91|11.91|Full Range|||1.21|23.76|
4357994|NCT00381303|4185327|B1|||Time since HIV-infection diagnosis||years|Median|10.78|10.78|Full Range|||0.29|27.62|
4357995|NCT00381303|4185325|B3|||Plasma log10 copies/mL VL HIV-1 RNA||copies/mL|Mean|4.67|4.67|Standard Deviation|0.874|0.874|||
4357996|NCT00381303|4185326|B2|||Plasma log10 copies/mL VL HIV-1 RNA||copies/mL|Mean|4.73|4.73|Standard Deviation|0.856|0.856|||
4357997|NCT00381303|4185327|B1|||Plasma log10 copies/mL VL HIV-1 RNA||copies/mL|Mean|4.65|4.65|Standard Deviation|0.883|0.883|||
4357998|NCT00381303|4185325|B3|||CD4+ cell count||cells/L|Median|200|200.0|Full Range|||1.0|1125.0|
4357999|NCT00381303|4185326|B2|||CD4+ cell count||cells/L|Median|175|175.0|Full Range|||2.0|1125.0|
4358000|NCT00381303|4185327|B1|||CD4+ cell count||cells/L|Median|210|210.0|Full Range|||1.0|868.0|
4358001|NCT00381303|4185325|B3|PI: >=2||Previous ARV experience: Protease inhibitor (PI)||participants|Number|260|260.0||||||
4358002|NCT00381303|4185326|B2|PI: >=2||Previous ARV experience: Protease inhibitor (PI)||participants|Number|92|92.0||||||
4358003|NCT00381303|4185327|B1|PI: >=2||Previous ARV experience: Protease inhibitor (PI)||participants|Number|168|168.0||||||
4358004|NCT00381303|4185325|B3|PI: <2||Previous ARV experience: Protease inhibitor (PI)||participants|Number|169|169.0||||||
4358005|NCT00381303|4185326|B2|PI: <2||Previous ARV experience: Protease inhibitor (PI)||participants|Number|50|50.0||||||
4358006|NCT00381303|4185327|B1|PI: <2||Previous ARV experience: Protease inhibitor (PI)||participants|Number|119|119.0||||||
4358007|NCT00381303|4185325|B3|NNRTI: >= 1 drug count||Previous Antiretroviral (ARV) Experience: Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)||participants|Number|314|314.0||||||
4358008|NCT00381303|4185326|B2|NNRTI: >= 1 drug count||Previous Antiretroviral (ARV) Experience: Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)||participants|Number|110|110.0||||||
4358009|NCT00381303|4185327|B1|NNRTI: >= 1 drug count||Previous Antiretroviral (ARV) Experience: Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)||participants|Number|204|204.0||||||
4358010|NCT00381303|4185325|B3|NNRTI: < 1 drug count||Previous Antiretroviral (ARV) Experience: Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)||participants|Number|115|115.0||||||
4358011|NCT00381303|4185326|B2|NNRTI: < 1 drug count||Previous Antiretroviral (ARV) Experience: Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)||participants|Number|32|32.0||||||
4358012|NCT00381303|4185327|B1|NNRTI: < 1 drug count||Previous Antiretroviral (ARV) Experience: Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)||participants|Number|83|83.0||||||
4358013|NCT00381303|4185325|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4358014|NCT00381303|4185326|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358015|NCT00381303|4185327|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4358016|NCT00381303|4185325|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4358017|NCT00381303|4185326|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4358018|NCT00381303|4185327|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358019|NCT00381303|4185325|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4358020|NCT00381303|4185326|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4358021|NCT00381303|4185327|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4358022|NCT00381303|4185325|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4358023|NCT00381303|4185326|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4358024|NCT00381303|4185327|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4358025|NCT00381303|4185325|B3|Black||Race/Ethnicity, Customized||participants|Number|264|264.0||||||
4358026|NCT00381303|4185326|B2|Black||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4358027|NCT00381303|4185327|B1|Black||Race/Ethnicity, Customized||participants|Number|191|191.0||||||
4358028|NCT00381303|4185325|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4358029|NCT00381303|4185326|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4358030|NCT00381303|4185327|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4358031|NCT00381303|4185325|B3||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4358032|NCT00381303|4185326|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4358033|NCT00381303|4185327|B1||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4358034|NCT00381303|4185325|B3|||Age||years|Median|43|43.0|Full Range|||19.0|78.0|
4358035|NCT00381303|4185326|B2|||Age||years|Median|45|45.0|Full Range|||21.0|78.0|
4358036|NCT00381303|4185327|B1|||Age||years|Median|43|43.0|Full Range|||19.0|78.0|
4358037|NCT00381238|4185388|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358038|NCT00381238|4185388|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4358039|NCT00381238|4185388|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358040|NCT00381238|4185388|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4358041|NCT00381238|4185388|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4358042|NCT00381238|4185388|B1|||Age||Years|Mean|71.9|71.9|Standard Deviation|9.75|9.75|||
4358043|NCT00381095|4185402|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4358044|NCT00381095|4185403|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4358045|NCT00381095|4185404|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4358046|NCT00381095|4185402|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4358047|NCT00381095|4185403|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4358048|NCT00381095|4185404|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4358049|NCT00381095|4185402|B3|>=65 Years||Age||Participants|Number|48|48.0||||||
4358050|NCT00381095|4185403|B2|>=65 Years||Age||Participants|Number|26|26.0||||||
4358051|NCT00381095|4185404|B1|>=65 Years||Age||Participants|Number|22|22.0||||||
4358052|NCT00381095|4185402|B3|45-64 years||Age||Participants|Number|90|90.0||||||
4358053|NCT00381095|4185403|B2|45-64 years||Age||Participants|Number|47|47.0||||||
4358054|NCT00381095|4185404|B1|45-64 years||Age||Participants|Number|43|43.0||||||
4358055|NCT00381095|4185402|B3|18-44 years||Age||Participants|Number|14|14.0||||||
4358056|NCT00381095|4185403|B2|18-44 years||Age||Participants|Number|7|7.0||||||
4358057|NCT00381095|4185404|B1|18-44 years||Age||Participants|Number|7|7.0||||||
4358058|NCT00381043|4185435|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4358059|NCT00381043|4185436|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4358060|NCT00381043|4185437|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4358061|NCT00381043|4185435|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4358062|NCT00381043|4185436|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4358063|NCT00381043|4185437|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4358064|NCT00381043|4185435|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4358065|NCT00381043|4185436|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4358066|NCT00381043|4185437|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4358067|NCT00381043|4185435|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|8.1|8.1|||
4358068|NCT00381043|4185436|B2|||Age||years|Mean|47.7|47.7|Standard Deviation|8.5|8.5|||
4358069|NCT00381043|4185437|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|7.7|7.7|||
4358070|NCT00381004|4185456|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4358071|NCT00381004|4185456|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4358072|NCT00381004|4185456|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4358073|NCT00381004|4185456|B1|||Age||years|Median|55|55.0|Full Range|||35.0|77.0|
4358074|NCT00380978|4185462|B3|United States||Region of Enrollment||participants|Number|818|818.0||||||
4358075|NCT00380978|4185463|B2|United States||Region of Enrollment||participants|Number|410|410.0||||||
4358076|NCT00380978|4185464|B1|United States||Region of Enrollment||participants|Number|408|408.0||||||
4358077|NCT00380978|4185462|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4358078|NCT00380978|4185463|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4358079|NCT00380978|4185464|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4358080|NCT00380978|4185462|B3||Female|Sex: Female, Male||Participants|Count of Participants|818|818.0||||||
4358081|NCT00380978|4185463|B2||Female|Sex: Female, Male||Participants|Count of Participants|410|410.0||||||
4358082|NCT00380978|4185464|B1||Female|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
4358083|NCT00380978|4185462|B3|||Age||years|Mean|31|31.0|Standard Deviation|6|6.0|||
4358084|NCT00380978|4185463|B2|||Age||years|Mean|31|31.0|Standard Deviation|5|5.0|||
4358085|NCT00380978|4185464|B1|||Age||years|Mean|31|31.0|Standard Deviation|6|6.0|||
4358086|NCT00380978|4185462|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358087|NCT00380978|4185463|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358088|NCT00380978|4185464|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358089|NCT00380978|4185462|B3||Between 18 and 65 years|Age||Participants|Count of Participants|818|818.0||||||
4358090|NCT00380978|4185463|B2||Between 18 and 65 years|Age||Participants|Count of Participants|410|410.0||||||
4358091|NCT00380978|4185464|B1||Between 18 and 65 years|Age||Participants|Count of Participants|408|408.0||||||
4358092|NCT00380978|4185462|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358093|NCT00380978|4185463|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358094|NCT00380978|4185464|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358095|NCT00380874|4185485|B3||Male|Sex: Female, Male||Participants|Count of Participants|42.0|42.0||||||
4358096|NCT00380874|4185486|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4358097|NCT00380874|4185487|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4358098|NCT00380874|4185485|B3||Female|Sex: Female, Male||Participants|Count of Participants|19.0|19.0||||||
4358099|NCT00380874|4185486|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4358100|NCT00380874|4185487|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4358101|NCT00380874|4185485|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|12.0|12.0|||
4358102|NCT00380874|4185486|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|12.9|12.9|||
4358103|NCT00380874|4185487|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|11.3|11.3|||
4358104|NCT00380861|4185504|B3|United States||Region of Enrollment||participants|Number|184|184.0||||||
4358105|NCT00380861|4185505|B2|United States||Region of Enrollment||participants|Number|91|91.0||||||
4358106|NCT00380861|4185506|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
4358107|NCT00380861|4185504|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4358108|NCT00380861|4185505|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4358109|NCT00380861|4185506|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4358110|NCT00380861|4185504|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4358111|NCT00380861|4185505|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4358112|NCT00380861|4185506|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4358113|NCT00380861|4185504|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|5.8|5.8|||
4358114|NCT00380861|4185505|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|5.7|5.7|||
4358115|NCT00380861|4185506|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|5.6|5.6|||
4358116|NCT00380718|4185513|B1|||Weight||kilograms|Mean|63.08|63.08|Standard Deviation|9.912|9.912|||
4358117|NCT00380718|4185513|B1|||Homocysteine||micromoles per Liter (μmol/L)|Mean|7.521|7.521|Standard Deviation|2.6229|2.6229|||
4358118|NCT00380718|4185513|B1|||Height||centimeters|Mean|162.0|162.0|Standard Deviation|8.59|8.59|||
4358119|NCT00380718|4185513|B1|||Heart Rate||beats per minute (bpm)|Mean|87.5|87.5|Standard Deviation|15.00|15.0|||
4358120|NCT00380718|4185513|B1|||Disease Characteristic: Time from Prior Chemotherapy Failure to Study Entry|N=25 (Data not available for 8 patients)|months|Mean|1.00|1.0|Standard Deviation|0.486|0.486|||
4358121|NCT00380718|4185513|B1|||Disease Characteristic: Time from Initial Diagnosis to Study Entry||months|Mean|11.54|11.54|Standard Deviation|20.829|20.829|||
4358122|NCT00380718|4185513|B1|||Disease Characteristic: Time from Initial Diagnosis to Prior Chemotherapy Failure|N=25 (Data not available for 8 patients)|months|Mean|12.04|12.04|Standard Deviation|23.764|23.764|||
4358123|NCT00380718|4185513|B1|||Body Temperature||degrees Celcius (°C)|Mean|36.25|36.25|Standard Deviation|0.336|0.336|||
4358124|NCT00380718|4185513|B1|||24 Hour Creatinine Clearance|N=32 (Data not available for 1 participant).|milliliters per minute (ml/min)|Mean|81.142|81.142|Standard Deviation|24.9265|24.9265|||
4358125|NCT00380718|4185513|B1|Never Smoking||Smoking Status||participants|Number|13|13.0||||||
4358126|NCT00380718|4185513|B1|Ever Smoking||Smoking Status||participants|Number|20|20.0||||||
4358127|NCT00380718|4185513|B1|East/Southeast Asian||Race/Ethnicity||participants|Number|33|33.0||||||
4358128|NCT00380718|4185513|B1|Non-Small Cell Lung Carcinoma||Disease Characterstic: Pathological Diagnosis Code||participants|Number|1|1.0||||||
4358129|NCT00380718|4185513|B1|Squamous Cell Carcinoma of Lung||Disease Characterstic: Pathological Diagnosis Code||participants|Number|8|8.0||||||
4358130|NCT00380718|4185513|B1|Mixed Cell||Disease Characterstic: Pathological Diagnosis Code||participants|Number|0|0.0||||||
4358131|NCT00380718|4185513|B1|Large Cell Carcinoma of Lung||Disease Characterstic: Pathological Diagnosis Code||participants|Number|1|1.0||||||
4358132|NCT00380718|4185513|B1|Adenocarcinoma of Lung||Disease Characterstic: Pathological Diagnosis Code||participants|Number|23|23.0||||||
4358133|NCT00380718|4185513|B1|1 - Ambulatory, Restricted Strenuous Activity||Disease Characteristic: Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|24|24.0||||||
4358134|NCT00380718|4185513|B1|0 - Fully Active||Disease Characteristic: Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|9|9.0||||||
4358135|NCT00380718|4185513|B1|Stage IV||Disease Characteristic: Disease Stage at Study Entry|Stage means how big the tumor is and how far it's spread. Stages range from 0 (the cancer has not spread beyond the inner lining of the lung) to IV (the cancer has spread to other organs of the body such as the other lung, brain, or liver).|participants|Number|30|30.0||||||
4358136|NCT00380718|4185513|B1|Stage IIIB||Disease Characteristic: Disease Stage at Study Entry|Stage means how big the tumor is and how far it's spread. Stages range from 0 (the cancer has not spread beyond the inner lining of the lung) to IV (the cancer has spread to other organs of the body such as the other lung, brain, or liver).|participants|Number|3|3.0||||||
4358137|NCT00380718|4185513|B1|Cytological||Disease Characteristic: Basis for Diagnosis||participants|Number|16|16.0||||||
4358138|NCT00380718|4185513|B1|Histopathological||Disease Characteristic: Basis for Diagnosis||participants|Number|17|17.0||||||
4358139|NCT00380718|4185513|B1|Taiwan||Region of Enrollment||participants|Number|33|33.0||||||
4358140|NCT00380718|4185513|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4358141|NCT00380718|4185513|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4358142|NCT00380718|4185513|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|11.27|11.27|||
4358143|NCT00380692|4185523|B3|||Weight||kilograms|Mean|41.2|41.2|Standard Deviation|15.46|15.46|||
4358144|NCT00380692|4185524|B2|||Weight||kilograms|Mean|41.5|41.5|Standard Deviation|16.12|16.12|||
4358145|NCT00380692|4185525|B1|||Weight||kilograms|Mean|41.0|41.0|Standard Deviation|14.92|14.92|||
4358146|NCT00380692|4185523|B3|||Score for the Overall Scale Intelligence|Overall scale intelligence was assessed with the Wechsler Intelligence Scales (WISC-III). The mean score is 100.|units on a scale|Mean|92.9|92.9|Standard Deviation|17.08|17.08|||
4358147|NCT00380692|4185524|B2|||Score for the Overall Scale Intelligence|Overall scale intelligence was assessed with the Wechsler Intelligence Scales (WISC-III). The mean score is 100.|units on a scale|Mean|94.6|94.6|Standard Deviation|17.71|17.71|||
4358148|NCT00380692|4185525|B1|||Score for the Overall Scale Intelligence|Overall scale intelligence was assessed with the Wechsler Intelligence Scales (WISC-III). The mean score is 100.|units on a scale|Mean|91.0|91.0|Standard Deviation|16.41|16.41|||
4358149|NCT00380692|4185523|B3|||Score for Verbal IQ|Verbal IQ was assessed with the Wechsler Intelligence Scales (WISC-III). There are 5 verbal subtests consisting of oral questions without time limits except for Arithmetic. The mean score is 100.|units on a scale|Mean|93.8|93.8|Standard Deviation|18.29|18.29|||
4358150|NCT00380692|4185524|B2|||Score for Verbal IQ|Verbal IQ was assessed with the Wechsler Intelligence Scales (WISC-III). There are 5 verbal subtests consisting of oral questions without time limits except for Arithmetic. The mean score is 100.|units on a scale|Mean|94.4|94.4|Standard Deviation|18.26|18.26|||
4358151|NCT00380692|4185525|B1|||Score for Verbal IQ|Verbal IQ was assessed with the Wechsler Intelligence Scales (WISC-III). There are 5 verbal subtests consisting of oral questions without time limits except for Arithmetic. The mean score is 100.|units on a scale|Mean|93.2|93.2|Standard Deviation|18.49|18.49|||
4358152|NCT00380692|4185523|B3|||Score for Performance IQ|Performance IQ was assessed with the Wechsler Intelligence Scales (WISC-III). There are 5 performal subtests consisting of nonverbal problems, all of which are timed and some of which allow bonus points for extra fast work. The mean score is 100.|units on a scale|Mean|92.4|92.4|Standard Deviation|17.14|17.14|||
4358153|NCT00380692|4185524|B2|||Score for Performance IQ|Performance IQ was assessed with the Wechsler Intelligence Scales (WISC-III). There are 5 performal subtests consisting of nonverbal problems, all of which are timed and some of which allow bonus points for extra fast work. The mean score is 100.|units on a scale|Mean|94.9|94.9|Standard Deviation|17.46|17.46|||
4358154|NCT00380692|4185525|B1|||Score for Performance IQ|Performance IQ was assessed with the Wechsler Intelligence Scales (WISC-III). There are 5 performal subtests consisting of nonverbal problems, all of which are timed and some of which allow bonus points for extra fast work. The mean score is 100.|units on a scale|Mean|89.9|89.9|Standard Deviation|16.59|16.59|||
4358155|NCT00380692|4185523|B3|||Height||centimeters|Mean|147.0|147.0|Standard Deviation|17.84|17.84|||
4358156|NCT00380692|4185524|B2|||Height||centimeters|Mean|148.0|148.0|Standard Deviation|19.11|19.11|||
4358157|NCT00380692|4185525|B1|||Height||centimeters|Mean|146.0|146.0|Standard Deviation|16.57|16.57|||
4358158|NCT00380692|4185523|B3|||Clinical Global Impression-Attention Deficit Hyperactivity Disorder-Severity Scale|Measures severity of the patient's overall severity of ADHD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|5.1|5.1|Standard Deviation|0.83|0.83|||
4358159|NCT00380692|4185524|B2|||Clinical Global Impression-Attention Deficit Hyperactivity Disorder-Severity Scale|Measures severity of the patient's overall severity of ADHD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|5.1|5.1|Standard Deviation|0.90|0.9|||
4358160|NCT00380692|4185525|B1|||Clinical Global Impression-Attention Deficit Hyperactivity Disorder-Severity Scale|Measures severity of the patient's overall severity of ADHD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|5.0|5.0|Standard Deviation|0.74|0.74|||
4358161|NCT00380692|4185523|B3|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilogram/meter squared|Mean|18.3|18.3|Standard Deviation|3.37|3.37|||
4358162|NCT00380692|4185524|B2|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilogram/meter squared|Mean|18.1|18.1|Standard Deviation|3.36|3.36|||
4358163|NCT00380692|4185525|B1|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilogram/meter squared|Mean|18.5|18.5|Standard Deviation|3.40|3.4|||
4358164|NCT00380692|4185523|B3|||Autism Diagnostic Interview-Revised (ADI-R)|ADI-R is a highly structured method of eliciting information from a parent to confirm clinical impression of autism. To meet criteria for autism, child must meet criteria in each of 3 content areas (communication [cutoff score=8 for verbal, 7 for nonverbal], social interaction [cutoff score=10], restricted/repetitive behavior [cutoff score=3]).|units on a scale|Mean|37.3|37.3|Standard Deviation|11.09|11.09|||
4358165|NCT00380692|4185524|B2|||Autism Diagnostic Interview-Revised (ADI-R)|ADI-R is a highly structured method of eliciting information from a parent to confirm clinical impression of autism. To meet criteria for autism, child must meet criteria in each of 3 content areas (communication [cutoff score=8 for verbal, 7 for nonverbal], social interaction [cutoff score=10], restricted/repetitive behavior [cutoff score=3]).|units on a scale|Mean|37.2|37.2|Standard Deviation|9.68|9.68|||
4358166|NCT00380692|4185525|B1|||Autism Diagnostic Interview-Revised (ADI-R)|ADI-R is a highly structured method of eliciting information from a parent to confirm clinical impression of autism. To meet criteria for autism, child must meet criteria in each of 3 content areas (communication [cutoff score=8 for verbal, 7 for nonverbal], social interaction [cutoff score=10], restricted/repetitive behavior [cutoff score=3]).|units on a scale|Mean|37.4|37.4|Standard Deviation|12.45|12.45|||
4358167|NCT00380692|4185523|B3|||Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version- Total Score|Measures the 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders, Version IV (DSM-IV) diagnosis of Attention-Deficit/Hyperactivity Disorder. Individual item scores range from 0 (none/never or rarely) to 3 (severe/very often). Total scores range from 0 to 54.|units on a scale|Mean|39.6|39.6|Standard Deviation|8.00|8.0|||
4358168|NCT00380692|4185524|B2|||Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version- Total Score|Measures the 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders, Version IV (DSM-IV) diagnosis of Attention-Deficit/Hyperactivity Disorder. Individual item scores range from 0 (none/never or rarely) to 3 (severe/very often). Total scores range from 0 to 54.|units on a scale|Mean|38.6|38.6|Standard Deviation|8.43|8.43|||
4358169|NCT00380692|4185525|B1|||Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version- Total Score|Measures the 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders, Version IV (DSM-IV) diagnosis of Attention-Deficit/Hyperactivity Disorder. Individual item scores range from 0 (none/never or rarely) to 3 (severe/very often). Total scores range from 0 to 54.|units on a scale|Mean|40.7|40.7|Standard Deviation|7.47|7.47|||
4358170|NCT00380692|4185523|B3|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4358171|NCT00380692|4185524|B2|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4358172|NCT00380692|4185525|B1|Hispanic||Race/Ethnicity||participants|Number|0|0.0||||||
4358173|NCT00380692|4185523|B3|African||Race/Ethnicity||participants|Number|1|1.0||||||
4358174|NCT00380692|4185524|B2|African||Race/Ethnicity||participants|Number|1|1.0||||||
4358175|NCT00380692|4185525|B1|African||Race/Ethnicity||participants|Number|0|0.0||||||
4358176|NCT00380692|4185523|B3|Caucasian||Race/Ethnicity||participants|Number|95|95.0||||||
4358177|NCT00380692|4185524|B2|Caucasian||Race/Ethnicity||participants|Number|47|47.0||||||
4358178|NCT00380692|4185525|B1|Caucasian||Race/Ethnicity||participants|Number|48|48.0||||||
4358179|NCT00380692|4185523|B3|Netherlands||Region of Enrollment||participants|Number|97|97.0||||||
4358180|NCT00380692|4185524|B2|Netherlands||Region of Enrollment||participants|Number|49|49.0||||||
4358181|NCT00380692|4185525|B1|Netherlands||Region of Enrollment||participants|Number|48|48.0||||||
4358182|NCT00380692|4185523|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4358183|NCT00380692|4185524|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4358184|NCT00380692|4185525|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4358185|NCT00380692|4185523|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4358186|NCT00380692|4185524|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4358187|NCT00380692|4185525|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4358188|NCT00380692|4185523|B3|||Age||years|Mean|9.9|9.9|Standard Deviation|2.80|2.8|||
4358189|NCT00380692|4185524|B2|||Age||years|Mean|10.0|10.0|Standard Deviation|2.90|2.9|||
4358190|NCT00380692|4185525|B1|||Age||years|Mean|9.9|9.9|Standard Deviation|2.72|2.72|||
4358191|NCT00380588|4185572|B3|||Weight||kilograms (kg)|Mean|54.43|54.43|Standard Deviation|10.92|10.92|||
4358192|NCT00380588|4185573|B2|||Weight||kilograms (kg)|Mean|53.91|53.91|Standard Deviation|9.50|9.5|||
4358193|NCT00380588|4185574|B1|||Weight||kilograms (kg)|Mean|54.97|54.97|Standard Deviation|12.31|12.31|||
4358194|NCT00380588|4185572|B3|||Height||centimeters (cm)|Mean|158.21|158.21|Standard Deviation|8.77|8.77|||
4358195|NCT00380588|4185573|B2|||Height||centimeters (cm)|Mean|156.67|156.67|Standard Deviation|8.62|8.62|||
4358196|NCT00380588|4185574|B1|||Height||centimeters (cm)|Mean|159.80|159.8|Standard Deviation|8.75|8.75|||
4358197|NCT00380588|4185572|B3|||Body Surface Area||square meter (m^2)|Mean|1.539|1.539|Standard Deviation|0.177|0.177|||
4358198|NCT00380588|4185573|B2|||Body Surface Area||square meter (m^2)|Mean|1.523|1.523|Standard Deviation|0.158|0.158|||
4358199|NCT00380588|4185574|B1|||Body Surface Area||square meter (m^2)|Mean|1.555|1.555|Standard Deviation|0.195|0.195|||
4358200|NCT00380588|4185572|B3|Adenosquamous Cancer||Tumor Histological Type||participants|Number|3|3.0||||||
4358201|NCT00380588|4185573|B2|Adenosquamous Cancer||Tumor Histological Type||participants|Number|1|1.0||||||
4358202|NCT00380588|4185574|B1|Adenosquamous Cancer||Tumor Histological Type||participants|Number|2|2.0||||||
4358203|NCT00380588|4185572|B3|Adenocarcinoma||Tumor Histological Type||participants|Number|80|80.0||||||
4358204|NCT00380588|4185573|B2|Adenocarcinoma||Tumor Histological Type||participants|Number|41|41.0||||||
4358205|NCT00380588|4185574|B1|Adenocarcinoma||Tumor Histological Type||participants|Number|39|39.0||||||
4358206|NCT00380588|4185572|B3|Papilla||Primary Tumor||participants|Number|4|4.0||||||
4358207|NCT00380588|4185573|B2|Papilla||Primary Tumor||participants|Number|0|0.0||||||
4358208|NCT00380588|4185574|B1|Papilla||Primary Tumor||participants|Number|4|4.0||||||
4358209|NCT00380588|4185572|B3|Gallbladder||Primary Tumor||participants|Number|32|32.0||||||
4358210|NCT00380588|4185573|B2|Gallbladder||Primary Tumor||participants|Number|17|17.0||||||
4358211|NCT00380588|4185574|B1|Gallbladder||Primary Tumor||participants|Number|15|15.0||||||
4358212|NCT00380588|4185572|B3|Intrahepatic Bile Duct||Primary Tumor||participants|Number|28|28.0||||||
4358213|NCT00380588|4185573|B2|Intrahepatic Bile Duct||Primary Tumor||participants|Number|14|14.0||||||
4358214|NCT00380588|4185574|B1|Intrahepatic Bile Duct||Primary Tumor||participants|Number|14|14.0||||||
4358215|NCT00380588|4185572|B3|Extrahepatic Bile Duct||Primary Tumor||participants|Number|19|19.0||||||
4358216|NCT00380588|4185573|B2|Extrahepatic Bile Duct||Primary Tumor||participants|Number|11|11.0||||||
4358217|NCT00380588|4185574|B1|Extrahepatic Bile Duct||Primary Tumor||participants|Number|8|8.0||||||
4358218|NCT00380588|4185572|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|21|21.0||||||
4358219|NCT00380588|4185573|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|14|14.0||||||
4358220|NCT00380588|4185574|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|7|7.0||||||
4358221|NCT00380588|4185572|B3|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|62|62.0||||||
4358222|NCT00380588|4185573|B2|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|28|28.0||||||
4358223|NCT00380588|4185574|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|34|34.0||||||
4358224|NCT00380588|4185572|B3|Japan||Region of Enrollment||participants|Number|83|83.0||||||
4358225|NCT00380588|4185573|B2|Japan||Region of Enrollment||participants|Number|42|42.0||||||
4358226|NCT00380588|4185574|B1|Japan||Region of Enrollment||participants|Number|41|41.0||||||
4358227|NCT00380588|4185572|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4358228|NCT00380588|4185573|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4358229|NCT00380588|4185574|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4358230|NCT00380588|4185572|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4358231|NCT00380588|4185573|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4358232|NCT00380588|4185574|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4358233|NCT00380588|4185572|B3|||Age||years|Mean|65.4|65.4|Standard Deviation|8.7|8.7|||
4358234|NCT00380588|4185573|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|6.9|6.9|||
4358235|NCT00380588|4185574|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|10.1|10.1|||
4358236|NCT00380393|4185587|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4358237|NCT00380393|4185587|B3||Male|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
4358238|NCT00380393|4185588|B2||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4358239|NCT00380393|4185589|B1||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4358240|NCT00380393|4185587|B3||Female|Sex: Female, Male||Participants|Count of Participants|451|451.0||||||
4358241|NCT00380393|4185588|B2||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4358242|NCT00380393|4185589|B1||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4358243|NCT00380393|4185587|B3|||Age||Months|Mean|11.4|11.4|Standard Deviation|3.5|3.5|||
4358244|NCT00380393|4185588|B2|||Age||Months|Mean|11.4|11.4|Standard Deviation|3.4|3.4|||
4358245|NCT00380393|4185589|B1|||Age||Months|Mean|11.4|11.4|Standard Deviation|3.6|3.6|||
4358246|NCT00380367|4185638|B1|||Weight||Kg|Median|34.90|34.9|Standard Deviation|8.81|8.81|||
4358247|NCT00380367|4185638|B1|||Height||Cm|Mean|143.32|143.32|Standard Deviation|9.58|9.58|||
4358248|NCT00380367|4185638|B1|||Body Mass Index (BMI)||Kg/m2|Mean|16.76|16.76|Standard Deviation|2.79|2.79|||
4358249|NCT00380367|4185638|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4358250|NCT00380367|4185638|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4358251|NCT00380367|4185638|B1|||Age||years|Mean|11.54|11.54|Standard Deviation|1.67|1.67|||
4358252|NCT00380250|4185643|B3|||Height||Inches|Mean|64.9|64.9|Standard Deviation|2.96|2.96|||
4358253|NCT00380250|4185644|B2|||Height||Inches|Mean|64.8|64.8|Standard Deviation|3.09|3.09|||
4358254|NCT00380250|4185645|B1|||Height||Inches|Mean|64.9|64.9|Standard Deviation|2.9|2.9|||
4358255|NCT00380250|4185643|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4358256|NCT00380250|4185644|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4358257|NCT00380250|4185645|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358258|NCT00380250|4185643|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358259|NCT00380250|4185644|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358260|NCT00380250|4185645|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358261|NCT00380250|4185643|B3||White|Race (NIH/OMB)||Participants|Count of Participants|496|496.0||||||
4358262|NCT00380250|4185644|B2||White|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
4358263|NCT00380250|4185645|B1||White|Race (NIH/OMB)||Participants|Count of Participants|336|336.0||||||
4358264|NCT00380250|4185643|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4358265|NCT00380250|4185644|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4358266|NCT00380250|4185645|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4358267|NCT00380250|4185643|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358268|NCT00380250|4185644|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358269|NCT00380250|4185645|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358270|NCT00380250|4185643|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4358271|NCT00380250|4185644|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4358272|NCT00380250|4185645|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358273|NCT00380250|4185643|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4358274|NCT00380250|4185644|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358275|NCT00380250|4185645|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4358276|NCT00380250|4185643|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4358277|NCT00380250|4185644|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4358278|NCT00380250|4185645|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4358279|NCT00380250|4185643|B3||Female|Sex: Female, Male||Participants|Count of Participants|535|535.0||||||
4358280|NCT00380250|4185644|B2||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4358281|NCT00380250|4185645|B1||Female|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4358282|NCT00380250|4185643|B3|||Age||years|Mean|47.2|47.2|Full Range|||19.0|85.0|
4358283|NCT00380250|4185644|B2|||Age||years|Mean|48.1|48.1|Full Range|||20.0|85.0|
4358284|NCT00380250|4185645|B1|||Age||years|Mean|46.7|46.7|Full Range|||19.0|83.0|
4358285|NCT00380081|4185708|B7|||Weight||kilograms|Mean|78.25|78.25|Standard Deviation|14.249|14.249|||
4358286|NCT00380081|4185709|B6|||Weight||kilograms|Mean|77.50|77.5|Standard Deviation|10.331|10.331|||
4358287|NCT00380081|4185710|B5|||Weight||kilograms|Mean|72.91|72.91|Standard Deviation|14.421|14.421|||
4358288|NCT00380081|4185711|B4|||Weight||kilograms|Mean|77.46|77.46|Standard Deviation|16.739|16.739|||
4358289|NCT00380081|4185712|B3|||Weight||kilograms|Mean|81.83|81.83|Standard Deviation|17.816|17.816|||
4358290|NCT00380081|4185713|B2|||Weight||kilograms|Mean|75.10|75.1|Standard Deviation|12.665|12.665|||
4358291|NCT00380081|4185714|B1|||Weight||kilograms|Mean|84.41|84.41|Standard Deviation|11.409|11.409|||
4358292|NCT00380081|4185708|B7|||Number of Nights with Middle of the Night Awakening|Number of nights with Middle of the Night (MOTN) Awakenings is based upon self-reports on more than or equal to 3 nights and completion of at least 7 days of the 10-day Screening Morning Sleep Diary.|number of nights|Mean|9.1|9.1|Standard Deviation|1.20|1.2|||
4358293|NCT00380081|4185709|B6|||Number of Nights with Middle of the Night Awakening|Number of nights with Middle of the Night (MOTN) Awakenings is based upon self-reports on more than or equal to 3 nights and completion of at least 7 days of the 10-day Screening Morning Sleep Diary.|number of nights|Mean|8.6|8.6|Standard Deviation|1.50|1.5|||
4358294|NCT00380081|4185710|B5|||Number of Nights with Middle of the Night Awakening|Number of nights with Middle of the Night (MOTN) Awakenings is based upon self-reports on more than or equal to 3 nights and completion of at least 7 days of the 10-day Screening Morning Sleep Diary.|number of nights|Mean|9.3|9.3|Standard Deviation|1.11|1.11|||
4358295|NCT00380081|4185711|B4|||Number of Nights with Middle of the Night Awakening|Number of nights with Middle of the Night (MOTN) Awakenings is based upon self-reports on more than or equal to 3 nights and completion of at least 7 days of the 10-day Screening Morning Sleep Diary.|number of nights|Mean|9.3|9.3|Standard Deviation|0.98|0.98|||
4358296|NCT00380081|4185712|B3|||Number of Nights with Middle of the Night Awakening|Number of nights with Middle of the Night (MOTN) Awakenings is based upon self-reports on more than or equal to 3 nights and completion of at least 7 days of the 10-day Screening Morning Sleep Diary.|number of nights|Mean|8.9|8.9|Standard Deviation|1.38|1.38|||
4358297|NCT00380081|4185713|B2|||Number of Nights with Middle of the Night Awakening|Number of nights with Middle of the Night (MOTN) Awakenings is based upon self-reports on more than or equal to 3 nights and completion of at least 7 days of the 10-day Screening Morning Sleep Diary.|number of nights|Mean|9.4|9.4|Standard Deviation|1.19|1.19|||
4358298|NCT00380081|4185714|B1|||Number of Nights with Middle of the Night Awakening|Number of nights with Middle of the Night (MOTN) Awakenings is based upon self-reports on more than or equal to 3 nights and completion of at least 7 days of the 10-day Screening Morning Sleep Diary.|number of nights|Mean|9.3|9.3|Standard Deviation|0.99|0.99|||
4358299|NCT00380081|4185708|B7|||Height||centimeters|Mean|169.6|169.6|Standard Deviation|9.700|9.7|||
4358300|NCT00380081|4185709|B6|||Height||centimeters|Mean|169.8|169.8|Standard Deviation|9.955|9.955|||
4358301|NCT00380081|4185710|B5|||Height||centimeters|Mean|167.4|167.4|Standard Deviation|8.775|8.775|||
4358302|NCT00380081|4185711|B4|||Height||centimeters|Mean|167.2|167.2|Standard Deviation|10.246|10.246|||
4358303|NCT00380081|4185712|B3|||Height||centimeters|Mean|172.4|172.4|Standard Deviation|10.740|10.74|||
4358304|NCT00380081|4185713|B2|||Height||centimeters|Mean|166.4|166.4|Standard Deviation|7.574|7.574|||
4358305|NCT00380081|4185714|B1|||Height||centimeters|Mean|174.6|174.6|Standard Deviation|9.353|9.353|||
4358306|NCT00380081|4185708|B7|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters|Mean|27.06|27.06|Standard Deviation|3.718|3.718|||
4358307|NCT00380081|4185709|B6|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters|Mean|26.84|26.84|Standard Deviation|2.681|2.681|||
4358308|NCT00380081|4185710|B5|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters|Mean|25.92|25.92|Standard Deviation|4.393|4.393|||
4358309|NCT00380081|4185711|B4|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters|Mean|27.43|27.43|Standard Deviation|3.717|3.717|||
4358310|NCT00380081|4185712|B3|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters|Mean|27.27|27.27|Standard Deviation|4.164|4.164|||
4358311|NCT00380081|4185713|B2|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters|Mean|27.10|27.1|Standard Deviation|4.164|4.164|||
4358312|NCT00380081|4185714|B1|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters|Mean|27.72|27.72|Standard Deviation|3.494|3.494|||
4358313|NCT00380081|4185708|B7|United States||Region of Enrollment||participants|Number|82|82.0||||||
4358314|NCT00380081|4185709|B6|United States||Region of Enrollment||participants|Number|14|14.0||||||
4358315|NCT00380081|4185710|B5|United States||Region of Enrollment||participants|Number|13|13.0||||||
4358316|NCT00380081|4185711|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4358317|NCT00380081|4185712|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4358318|NCT00380081|4185713|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4358319|NCT00380081|4185714|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4358320|NCT00380081|4185708|B7|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4358321|NCT00380081|4185709|B6|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358322|NCT00380081|4185710|B5|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358323|NCT00380081|4185711|B4|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358324|NCT00380081|4185712|B3|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358325|NCT00380081|4185713|B2|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358326|NCT00380081|4185714|B1|Asian/Pacific||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358327|NCT00380081|4185708|B7|Black||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4358328|NCT00380081|4185709|B6|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4358329|NCT00380081|4185710|B5|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4358330|NCT00380081|4185711|B4|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4358331|NCT00380081|4185712|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4358332|NCT00380081|4185713|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4358333|NCT00380081|4185714|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4358334|NCT00380081|4185708|B7|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4358335|NCT00380081|4185709|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358336|NCT00380081|4185710|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358337|NCT00380081|4185711|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358338|NCT00380081|4185712|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358339|NCT00380081|4185713|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358340|NCT00380081|4185714|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358341|NCT00380081|4185708|B7|Caucasian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4358342|NCT00380081|4185709|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4358343|NCT00380081|4185710|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4358344|NCT00380081|4185711|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4358345|NCT00380081|4185712|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4358346|NCT00380081|4185713|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4358347|NCT00380081|4185714|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4358348|NCT00380081|4185708|B7||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4358349|NCT00380081|4185709|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4358350|NCT00380081|4185710|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4358351|NCT00380081|4185711|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4358352|NCT00380081|4185712|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4358353|NCT00380081|4185713|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4358354|NCT00380081|4185714|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4358355|NCT00380081|4185708|B7||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4358356|NCT00380081|4185709|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4358357|NCT00380081|4185710|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4358358|NCT00380081|4185711|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4358359|NCT00380081|4185712|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4358360|NCT00380081|4185713|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4358361|NCT00380081|4185714|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4358362|NCT00380081|4185708|B7|||Age||years|Mean|45.9|45.9|Standard Deviation|11.97|11.97|||
4358363|NCT00380081|4185709|B6|||Age||years|Mean|43.5|43.5|Standard Deviation|12.99|12.99|||
4358364|NCT00380081|4185710|B5|||Age||years|Mean|41.8|41.8|Standard Deviation|13.33|13.33|||
4358365|NCT00380081|4185711|B4|||Age||years|Mean|45.0|45.0|Standard Deviation|9.64|9.64|||
4358366|NCT00380081|4185712|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|10.74|10.74|||
4358367|NCT00380081|4185713|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|14.90|14.9|||
4358368|NCT00380081|4185714|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|10.21|10.21|||
4358369|NCT00380081|4185708|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358370|NCT00380081|4185709|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358371|NCT00380081|4185710|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358372|NCT00380081|4185711|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358373|NCT00380081|4185712|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358374|NCT00380081|4185713|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358375|NCT00380081|4185714|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358376|NCT00380081|4185708|B7||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4358377|NCT00380081|4185709|B6||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4358378|NCT00380081|4185710|B5||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4358379|NCT00380081|4185711|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4358380|NCT00380081|4185712|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4358381|NCT00380081|4185713|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4358382|NCT00380081|4185714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4358383|NCT00380081|4185708|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358384|NCT00380081|4185709|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358385|NCT00380081|4185710|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358386|NCT00380081|4185711|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358387|NCT00380081|4185712|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358388|NCT00380081|4185713|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358389|NCT00380081|4185714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358390|NCT00380068|4185769|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4358391|NCT00380068|4185769|B1||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4358392|NCT00380068|4185769|B1|||Age||years|Mean|55|55.0|Standard Deviation|16|16.0|||
4358393|NCT00380029|4185789|B1|Never||Smoking Status||Participants|Count of Participants|3|3.0||||||
4358394|NCT00380029|4185789|B1|Former||Smoking Status||Participants|Count of Participants|10|10.0||||||
4358395|NCT00380029|4185789|B1|Current||Smoking Status||Participants|Count of Participants|7|7.0||||||
4358396|NCT00380029|4185789|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4358397|NCT00380029|4185789|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4358398|NCT00380029|4185789|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4358399|NCT00380029|4185789|B1|||Age||years|Mean|67.1|67.1|Full Range|||61.0|95.0|
4358400|NCT00379912|4185799|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4358401|NCT00379912|4185800|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4358402|NCT00379912|4185801|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4358403|NCT00379912|4185799|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358404|NCT00379912|4185800|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358405|NCT00379912|4185801|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358406|NCT00379912|4185799|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358407|NCT00379912|4185800|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358408|NCT00379912|4185801|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358409|NCT00379912|4185799|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4358410|NCT00379912|4185800|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4358411|NCT00379912|4185801|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4358412|NCT00379912|4185799|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358413|NCT00379912|4185800|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358414|NCT00379912|4185801|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358415|NCT00379912|4185799|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358416|NCT00379912|4185800|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358417|NCT00379912|4185801|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358418|NCT00379912|4185799|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358419|NCT00379912|4185800|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358420|NCT00379912|4185801|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358421|NCT00379912|4185799|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358422|NCT00379912|4185800|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358423|NCT00379912|4185801|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358424|NCT00379912|4185799|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358425|NCT00379912|4185800|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358426|NCT00379912|4185801|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358427|NCT00379912|4185799|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4358428|NCT00379912|4185800|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4358429|NCT00379912|4185801|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4358430|NCT00379912|4185799|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358431|NCT00379912|4185800|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358432|NCT00379912|4185801|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358433|NCT00379912|4185799|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4358434|NCT00379912|4185800|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4358435|NCT00379912|4185801|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4358436|NCT00379912|4185799|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4358437|NCT00379912|4185800|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4358438|NCT00379912|4185801|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4358439|NCT00379912|4185799|B3|||Age||years|Median|69|69.0|Full Range|||59.0|85.0|
4358440|NCT00379912|4185800|B2|||Age||years|Median|67.50|67.5|Full Range|||59.0|83.0|
4358441|NCT00379912|4185801|B1|||Age||years|Median|69|69.0|Full Range|||63.0|85.0|
4358442|NCT00379899|4185822|B3|≥1000||Coronary Artery Calcification Score Stratification Factor||Participants|Number|132|132.0||||||
4358443|NCT00379899|4185823|B2|≥1000||Coronary Artery Calcification Score Stratification Factor||Participants|Number|66|66.0||||||
4358444|NCT00379899|4185824|B1|≥1000||Coronary Artery Calcification Score Stratification Factor||Participants|Number|66|66.0||||||
4358445|NCT00379899|4185822|B3|≥400 to 999||Coronary Artery Calcification Score Stratification Factor||Participants|Number|94|94.0||||||
4358446|NCT00379899|4185823|B2|≥400 to 999||Coronary Artery Calcification Score Stratification Factor||Participants|Number|47|47.0||||||
4358447|NCT00379899|4185824|B1|≥400 to 999||Coronary Artery Calcification Score Stratification Factor||Participants|Number|47|47.0||||||
4358448|NCT00379899|4185822|B3|≥30 to 399||Coronary Artery Calcification Score Stratification Factor||Participants|Number|134|134.0||||||
4358449|NCT00379899|4185823|B2|≥30 to 399||Coronary Artery Calcification Score Stratification Factor||Participants|Number|67|67.0||||||
4358450|NCT00379899|4185824|B1|≥30 to 399||Coronary Artery Calcification Score Stratification Factor||Participants|Number|67|67.0||||||
4358451|NCT00379899|4185822|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4358452|NCT00379899|4185823|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4358453|NCT00379899|4185824|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4358454|NCT00379899|4185822|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|236|236.0||||||
4358455|NCT00379899|4185823|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|120|120.0||||||
4358456|NCT00379899|4185824|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|116|116.0||||||
4358457|NCT00379899|4185822|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4358458|NCT00379899|4185823|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4358459|NCT00379899|4185824|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4358460|NCT00379899|4185822|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4358461|NCT00379899|4185823|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4358462|NCT00379899|4185824|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4358463|NCT00379899|4185822|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|85|85.0||||||
4358464|NCT00379899|4185823|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4358465|NCT00379899|4185824|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4358466|NCT00379899|4185822|B3|Asian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4358467|NCT00379899|4185823|B2|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4358468|NCT00379899|4185824|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4358469|NCT00379899|4185822|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4358470|NCT00379899|4185823|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4358471|NCT00379899|4185824|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4358472|NCT00379899|4185822|B3||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4358473|NCT00379899|4185823|B2||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4358474|NCT00379899|4185824|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4358475|NCT00379899|4185822|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4358476|NCT00379899|4185823|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4358477|NCT00379899|4185824|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4358478|NCT00379899|4185822|B3|||Age||Years|Mean|61.5|61.5|Standard Deviation|12.7|12.7|||
4358479|NCT00379899|4185823|B2|||Age||Years|Mean|61.8|61.8|Standard Deviation|12.8|12.8|||
4358480|NCT00379899|4185824|B1|||Age||Years|Mean|61.2|61.2|Standard Deviation|12.6|12.6|||
4358481|NCT00379834|4185853|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4358482|NCT00379834|4185853|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4358483|NCT00379834|4185853|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4358484|NCT00379834|4185853|B1|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
4358485|NCT00379834|4185853|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4358486|NCT00379834|4185853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4358487|NCT00379834|4185853|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358488|NCT00379821|4185857|B5|Malawi||Region of Enrollment||participants|Number|640|640.0||||||
4358489|NCT00379821|4185858|B4|Malawi||Region of Enrollment||participants|Number|160|160.0||||||
4358490|NCT00379821|4185859|B3|Malawi||Region of Enrollment||participants|Number|160|160.0||||||
4358491|NCT00379821|4185860|B2|Malawi||Region of Enrollment||participants|Number|160|160.0||||||
4358492|NCT00379821|4185861|B1|Malawi||Region of Enrollment||participants|Number|160|160.0||||||
4358493|NCT00379821|4185857|B5||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4358494|NCT00379821|4185858|B4||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4358495|NCT00379821|4185859|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4358496|NCT00379821|4185860|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4358497|NCT00379821|4185861|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4358498|NCT00379821|4185857|B5||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4358499|NCT00379821|4185858|B4||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4358500|NCT00379821|4185859|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4358501|NCT00379821|4185860|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4358502|NCT00379821|4185861|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4358503|NCT00379821|4185857|B5|||Age||years|Mean|2.7|2.7|Standard Deviation|1.2|1.2|||
4358504|NCT00379821|4185858|B4|||Age||years|Mean|2.7|2.7|Standard Deviation|1.2|1.2|||
4358505|NCT00379821|4185859|B3|||Age||years|Mean|2.8|2.8|Standard Deviation|1.1|1.1|||
4358506|NCT00379821|4185860|B2|||Age||years|Mean|2.7|2.7|Standard Deviation|1.2|1.2|||
4358507|NCT00379821|4185861|B1|||Age||years|Mean|2.7|2.7|Standard Deviation|1.2|1.2|||
4358508|NCT00379821|4185857|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358509|NCT00379821|4185858|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358510|NCT00379821|4185859|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358511|NCT00379821|4185860|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358512|NCT00379821|4185861|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358513|NCT00379821|4185857|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4358514|NCT00379821|4185858|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4358515|NCT00379821|4185859|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4358516|NCT00379821|4185860|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4358517|NCT00379821|4185861|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4358518|NCT00379821|4185857|B5||<=18 years|Age||Participants|Count of Participants|640|640.0||||||
4358519|NCT00379821|4185858|B4||<=18 years|Age||Participants|Count of Participants|160|160.0||||||
4358520|NCT00379821|4185859|B3||<=18 years|Age||Participants|Count of Participants|160|160.0||||||
4358521|NCT00379821|4185860|B2||<=18 years|Age||Participants|Count of Participants|160|160.0||||||
4358522|NCT00379821|4185861|B1||<=18 years|Age||Participants|Count of Participants|160|160.0||||||
4358523|NCT00379808|4186005|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4358524|NCT00379808|4186005|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4358525|NCT00379808|4186005|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4358526|NCT00379808|4186005|B1|All study participants||Age||years|Mean|50.8|50.8|Standard Deviation|12.5|12.5|||
4358527|NCT00379808|4186005|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358528|NCT00379808|4186005|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4358529|NCT00379808|4186005|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358530|NCT00379795|4186022|B6||Male|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4358531|NCT00379795|4186023|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4358532|NCT00379795|4186024|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4358533|NCT00379795|4186025|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4358534|NCT00379795|4186026|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4358535|NCT00379795|4186027|B1||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4358536|NCT00379795|4186022|B6||Female|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
4358537|NCT00379795|4186023|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4358538|NCT00379795|4186024|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4358539|NCT00379795|4186025|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4358540|NCT00379795|4186026|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4358541|NCT00379795|4186027|B1||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4358542|NCT00379795|4186022|B6|>= 85||Age, Customized||participants|Number|164|164.0||||||
4358543|NCT00379795|4186023|B5|>= 85||Age, Customized||participants|Number|20|20.0||||||
4358544|NCT00379795|4186024|B4|>= 85||Age, Customized||participants|Number|10|10.0||||||
4358545|NCT00379795|4186025|B3|>= 85||Age, Customized||participants|Number|23|23.0||||||
4358546|NCT00379795|4186026|B2|>= 85||Age, Customized||participants|Number|8|8.0||||||
4358547|NCT00379795|4186027|B1|>= 85||Age, Customized||participants|Number|103|103.0||||||
4358548|NCT00379795|4186022|B6|75 to < 85||Age, Customized||participants|Number|444|444.0||||||
4358549|NCT00379795|4186023|B5|75 to < 85||Age, Customized||participants|Number|29|29.0||||||
4358550|NCT00379795|4186024|B4|75 to < 85||Age, Customized||participants|Number|35|35.0||||||
4358551|NCT00379795|4186025|B3|75 to < 85||Age, Customized||participants|Number|61|61.0||||||
4358552|NCT00379795|4186026|B2|75 to < 85||Age, Customized||participants|Number|42|42.0||||||
4358553|NCT00379795|4186027|B1|75 to < 85||Age, Customized||participants|Number|277|277.0||||||
4358554|NCT00379795|4186022|B6|65 to < 75||Age, Customized||participants|Number|194|194.0||||||
4358555|NCT00379795|4186023|B5|65 to < 75||Age, Customized||participants|Number|10|10.0||||||
4358556|NCT00379795|4186024|B4|65 to < 75||Age, Customized||participants|Number|21|21.0||||||
4358557|NCT00379795|4186025|B3|65 to < 75||Age, Customized||participants|Number|27|27.0||||||
4358558|NCT00379795|4186026|B2|65 to < 75||Age, Customized||participants|Number|19|19.0||||||
4358559|NCT00379795|4186027|B1|65 to < 75||Age, Customized||participants|Number|117|117.0||||||
4358560|NCT00379795|4186022|B6|50 to < 65||Age, Customized||participants|Number|51|51.0||||||
4358561|NCT00379795|4186023|B5|50 to < 65||Age, Customized||participants|Number|4|4.0||||||
4358562|NCT00379795|4186024|B4|50 to < 65||Age, Customized||participants|Number|8|8.0||||||
4358563|NCT00379795|4186025|B3|50 to < 65||Age, Customized||participants|Number|5|5.0||||||
4358564|NCT00379795|4186026|B2|50 to < 65||Age, Customized||participants|Number|5|5.0||||||
4358565|NCT00379795|4186027|B1|50 to < 65||Age, Customized||participants|Number|29|29.0||||||
4358566|NCT00379769|4186057|B5|Tahitian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358567|NCT00379769|4186058|B4|Tahitian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358568|NCT00379769|4186059|B3|Tahitian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358569|NCT00379769|4186060|B2|Tahitian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358570|NCT00379769|4186061|B1|Tahitian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358571|NCT00379769|4186057|B5|Sri Lankan||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4358572|NCT00379769|4186058|B4|Sri Lankan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358573|NCT00379769|4186059|B3|Sri Lankan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358574|NCT00379769|4186060|B2|Sri Lankan||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4358575|NCT00379769|4186061|B1|Sri Lankan||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358576|NCT00379769|4186057|B5|Polynesian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358577|NCT00379769|4186058|B4|Polynesian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358578|NCT00379769|4186059|B3|Polynesian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358579|NCT00379769|4186060|B2|Polynesian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358580|NCT00379769|4186061|B1|Polynesian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358581|NCT00379769|4186057|B5|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358582|NCT00379769|4186058|B4|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358583|NCT00379769|4186059|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358584|NCT00379769|4186060|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358585|NCT00379769|4186061|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358586|NCT00379769|4186057|B5|Middle East Hible||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358587|NCT00379769|4186058|B4|Middle East Hible||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358588|NCT00379769|4186059|B3|Middle East Hible||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358589|NCT00379769|4186060|B2|Middle East Hible||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358590|NCT00379769|4186061|B1|Middle East Hible||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358591|NCT00379769|4186057|B5|Maori||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358592|NCT00379769|4186058|B4|Maori||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358593|NCT00379769|4186059|B3|Maori||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358594|NCT00379769|4186060|B2|Maori||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358595|NCT00379769|4186061|B1|Maori||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358596|NCT00379769|4186057|B5|Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358597|NCT00379769|4186058|B4|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358598|NCT00379769|4186059|B3|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358599|NCT00379769|4186060|B2|Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358600|NCT00379769|4186061|B1|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358601|NCT00379769|4186057|B5|Gipsy||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358602|NCT00379769|4186058|B4|Gipsy||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358603|NCT00379769|4186059|B3|Gipsy||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358604|NCT00379769|4186060|B2|Gipsy||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358605|NCT00379769|4186061|B1|Gipsy||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358606|NCT00379769|4186057|B5|Egyptian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358607|NCT00379769|4186058|B4|Egyptian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358608|NCT00379769|4186059|B3|Egyptian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358609|NCT00379769|4186060|B2|Egyptian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358610|NCT00379769|4186061|B1|Egyptian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358611|NCT00379769|4186057|B5|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4358612|NCT00379769|4186058|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358613|NCT00379769|4186059|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358614|NCT00379769|4186060|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4358615|NCT00379769|4186061|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358616|NCT00379769|4186057|B5|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358617|NCT00379769|4186058|B4|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358618|NCT00379769|4186059|B3|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358619|NCT00379769|4186060|B2|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358620|NCT00379769|4186061|B1|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358621|NCT00379769|4186057|B5|Aboriginal||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358622|NCT00379769|4186058|B4|Aboriginal||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358623|NCT00379769|4186059|B3|Aboriginal||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358624|NCT00379769|4186060|B2|Aboriginal||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358625|NCT00379769|4186061|B1|Aboriginal||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358626|NCT00379769|4186057|B5|Oriental||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4358627|NCT00379769|4186058|B4|Oriental||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4358628|NCT00379769|4186059|B3|Oriental||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4358629|NCT00379769|4186060|B2|Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4358630|NCT00379769|4186061|B1|Oriental||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4358631|NCT00379769|4186057|B5|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4358632|NCT00379769|4186058|B4|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4358633|NCT00379769|4186059|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4358634|NCT00379769|4186060|B2|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4358635|NCT00379769|4186061|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4358636|NCT00379769|4186057|B5|White||Race/Ethnicity, Customized||participants|Number|4399|4399.0||||||
4358637|NCT00379769|4186058|B4|White||Race/Ethnicity, Customized||participants|Number|1112|1112.0||||||
4358638|NCT00379769|4186059|B3|White||Race/Ethnicity, Customized||participants|Number|1095|1095.0||||||
4358639|NCT00379769|4186060|B2|White||Race/Ethnicity, Customized||participants|Number|1087|1087.0||||||
4358640|NCT00379769|4186061|B1|White||Race/Ethnicity, Customized||participants|Number|1105|1105.0||||||
4358641|NCT00379769|4186057|B5||Male|Sex: Female, Male||Participants|Count of Participants|2294|2294.0||||||
4358642|NCT00379769|4186058|B4||Male|Sex: Female, Male||Participants|Count of Participants|568|568.0||||||
4358643|NCT00379769|4186059|B3||Male|Sex: Female, Male||Participants|Count of Participants|541|541.0||||||
4358644|NCT00379769|4186060|B2||Male|Sex: Female, Male||Participants|Count of Participants|584|584.0||||||
4358645|NCT00379769|4186061|B1||Male|Sex: Female, Male||Participants|Count of Participants|601|601.0||||||
4358646|NCT00379769|4186057|B5||Female|Sex: Female, Male||Participants|Count of Participants|2153|2153.0||||||
4358647|NCT00379769|4186058|B4||Female|Sex: Female, Male||Participants|Count of Participants|554|554.0||||||
4358648|NCT00379769|4186059|B3||Female|Sex: Female, Male||Participants|Count of Participants|562|562.0||||||
4358649|NCT00379769|4186060|B2||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
4358650|NCT00379769|4186061|B1||Female|Sex: Female, Male||Participants|Count of Participants|516|516.0||||||
4358651|NCT00379769|4186057|B5|||Age||years|Mean|58.4|58.4|Standard Deviation|8.27|8.27|||
4358652|NCT00379769|4186058|B4|||Age||years|Mean|59.7|59.7|Standard Deviation|8.23|8.23|||
4358653|NCT00379769|4186059|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|8.26|8.26|||
4358654|NCT00379769|4186060|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|8.14|8.14|||
4358655|NCT00379769|4186061|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|8.02|8.02|||
4358656|NCT00379639|4186220|B6|||Body Surface Area (BSA)||m^2|Mean|1.8|1.8|Standard Deviation|0.27|0.27|||
4358657|NCT00379639|4186221|B5|||Body Surface Area (BSA)||m^2|Mean|1.7|1.7|Standard Deviation|0.35|0.35|||
4358658|NCT00379639|4186222|B4|||Body Surface Area (BSA)||m^2|Mean|1.7|1.7|Standard Deviation|0.23|0.23|||
4358659|NCT00379639|4186223|B3|||Body Surface Area (BSA)||m^2|Mean|1.8|1.8|Standard Deviation|0.19|0.19|||
4358660|NCT00379639|4186224|B2|||Body Surface Area (BSA)||m^2|Mean|1.8|1.8|Standard Deviation|0.29|0.29|||
4358661|NCT00379639|4186225|B1|||Body Surface Area (BSA)||m^2|Mean|1.9|1.9|Standard Deviation|0.28|0.28|||
4358662|NCT00379639|4186220|B6|||Weight||kg|Mean|72.7|72.7|Standard Deviation|21.70|21.7|||
4358663|NCT00379639|4186221|B5|||Weight||kg|Mean|61.7|61.7|Standard Deviation|27.56|27.56|||
4358664|NCT00379639|4186222|B4|||Weight||kg|Mean|69.0|69.0|Standard Deviation|26.84|26.84|||
4358665|NCT00379639|4186223|B3|||Weight||kg|Mean|73.1|73.1|Standard Deviation|12.58|12.58|||
4358666|NCT00379639|4186224|B2|||Weight||kg|Mean|77.6|77.6|Standard Deviation|25.21|25.21|||
4358667|NCT00379639|4186225|B1|||Weight||kg|Mean|79.8|79.8|Standard Deviation|20.54|20.54|||
4358668|NCT00379639|4186220|B6|||Height||cm|Mean|166.3|166.3|Standard Deviation|9.21|9.21|||
4358669|NCT00379639|4186221|B5|||Height||cm|Mean|164.9|164.9|Standard Deviation|8.71|8.71|||
4358670|NCT00379639|4186222|B4|||Height||cm|Mean|159.6|159.6|Standard Deviation|4.09|4.09|||
4358671|NCT00379639|4186223|B3|||Height||cm|Mean|170.9|170.9|Standard Deviation|10.33|10.33|||
4358672|NCT00379639|4186224|B2|||Height||cm|Mean|163.7|163.7|Standard Deviation|8.13|8.13|||
4358673|NCT00379639|4186225|B1|||Height||cm|Mean|169.3|169.3|Standard Deviation|9.52|9.52|||
4358674|NCT00379639|4186220|B6|United States||Region of Enrollment||participants|Number|36|36.0||||||
4358675|NCT00379639|4186221|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4358676|NCT00379639|4186222|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4358677|NCT00379639|4186223|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4358678|NCT00379639|4186224|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4358679|NCT00379639|4186225|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4358680|NCT00379639|4186220|B6|Pakistani||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358681|NCT00379639|4186221|B5|Pakistani||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358682|NCT00379639|4186222|B4|Pakistani||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358683|NCT00379639|4186223|B3|Pakistani||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358684|NCT00379639|4186224|B2|Pakistani||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358685|NCT00379639|4186225|B1|Pakistani||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358686|NCT00379639|4186220|B6|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358687|NCT00379639|4186221|B5|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358688|NCT00379639|4186222|B4|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358689|NCT00379639|4186223|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358690|NCT00379639|4186224|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4358691|NCT00379639|4186225|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4358692|NCT00379639|4186220|B6|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4358693|NCT00379639|4186221|B5|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4358694|NCT00379639|4186222|B4|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4358695|NCT00379639|4186223|B3|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4358696|NCT00379639|4186224|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4358697|NCT00379639|4186225|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4358698|NCT00379639|4186220|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358699|NCT00379639|4186221|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358700|NCT00379639|4186222|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358701|NCT00379639|4186223|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358702|NCT00379639|4186224|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358703|NCT00379639|4186225|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358704|NCT00379639|4186220|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4358705|NCT00379639|4186221|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4358706|NCT00379639|4186222|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4358707|NCT00379639|4186223|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4358708|NCT00379639|4186224|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4358709|NCT00379639|4186225|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4358710|NCT00379639|4186220|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358711|NCT00379639|4186221|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358712|NCT00379639|4186222|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358713|NCT00379639|4186223|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358714|NCT00379639|4186224|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358715|NCT00379639|4186225|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358716|NCT00379639|4186220|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4358717|NCT00379639|4186221|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4358718|NCT00379639|4186222|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4358719|NCT00379639|4186223|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4358720|NCT00379639|4186224|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4358721|NCT00379639|4186225|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4358722|NCT00379639|4186220|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4358723|NCT00379639|4186221|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4358724|NCT00379639|4186222|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4358725|NCT00379639|4186223|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4358726|NCT00379639|4186224|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4358727|NCT00379639|4186225|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4358728|NCT00379639|4186220|B6|||Age||years|Mean|58.3|58.3|Standard Deviation|11.98|11.98|||
4358729|NCT00379639|4186221|B5|||Age||years|Mean|57.0|57.0|Standard Deviation|13.37|13.37|||
4358730|NCT00379639|4186222|B4|||Age||years|Mean|57.3|57.3|Standard Deviation|15.54|15.54|||
4358731|NCT00379639|4186223|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|10.86|10.86|||
4358732|NCT00379639|4186224|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|11.04|11.04|||
4358733|NCT00379639|4186225|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|11.25|11.25|||
4358734|NCT00379587|4186251|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4358735|NCT00379587|4186251|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4358736|NCT00379587|4186251|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4358737|NCT00379587|4186251|B1|||Age||years|Median|54|54.0|Full Range|||19.0|74.0|
4358738|NCT00379587|4186251|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4358739|NCT00379587|4186251|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4358740|NCT00379587|4186251|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358741|NCT00379574|4186258|B1|Korea, Republic of||Region of Enrollment||participants|Number|49|49.0||||||
4358742|NCT00379574|4186258|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4358743|NCT00379574|4186258|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4358744|NCT00379574|4186258|B1|||Age||years|Mean|52|52.0|Standard Deviation|10|10.0|||
4358745|NCT00379574|4186258|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4358746|NCT00379574|4186258|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4358747|NCT00379574|4186258|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358748|NCT00379353|4186263|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4358749|NCT00379353|4186264|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4358750|NCT00379353|4186265|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4358751|NCT00379353|4186263|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4358752|NCT00379353|4186264|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4358753|NCT00379353|4186265|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4358754|NCT00379353|4186263|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4358755|NCT00379353|4186264|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4358756|NCT00379353|4186265|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4358757|NCT00379353|4186263|B3|||Age||years|Median|60|60.0|Full Range|||24.0|81.0|
4358758|NCT00379353|4186264|B2|||Age||years|Median|65|65.0|Full Range|||49.0|81.0|
4358759|NCT00379353|4186265|B1|||Age||years|Median|60|60.0|Full Range|||24.0|81.0|
4358760|NCT00379353|4186263|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4358761|NCT00379353|4186264|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4358762|NCT00379353|4186265|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4358763|NCT00379353|4186263|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4358764|NCT00379353|4186264|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4358765|NCT00379353|4186265|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4358766|NCT00379353|4186263|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358767|NCT00379353|4186264|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358768|NCT00379353|4186265|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358769|NCT00379340|4186296|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4358770|NCT00379340|4186297|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4358771|NCT00379340|4186298|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4358772|NCT00379340|4186299|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4358773|NCT00379340|4186300|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4358774|NCT00379340|4186301|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4358775|NCT00379340|4186296|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358776|NCT00379340|4186297|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358777|NCT00379340|4186298|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358778|NCT00379340|4186299|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358779|NCT00379340|4186300|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358780|NCT00379340|4186301|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358781|NCT00379340|4186296|B6||White|Race (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
4358782|NCT00379340|4186297|B5||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4358783|NCT00379340|4186298|B4||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4358784|NCT00379340|4186299|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4358785|NCT00379340|4186300|B2||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4358786|NCT00379340|4186301|B1||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4358787|NCT00379340|4186296|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4358788|NCT00379340|4186297|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4358789|NCT00379340|4186298|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4358790|NCT00379340|4186299|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4358791|NCT00379340|4186300|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4358792|NCT00379340|4186301|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4358793|NCT00379340|4186296|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358794|NCT00379340|4186297|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358795|NCT00379340|4186298|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358796|NCT00379340|4186299|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358797|NCT00379340|4186300|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358798|NCT00379340|4186301|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358799|NCT00379340|4186296|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4358800|NCT00379340|4186297|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4358801|NCT00379340|4186298|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4358802|NCT00379340|4186299|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358803|NCT00379340|4186300|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4358804|NCT00379340|4186301|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4358805|NCT00379340|4186296|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4358806|NCT00379340|4186297|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358807|NCT00379340|4186298|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358808|NCT00379340|4186299|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358809|NCT00379340|4186300|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358810|NCT00379340|4186301|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4358811|NCT00379340|4186296|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4358812|NCT00379340|4186297|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4358813|NCT00379340|4186298|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4358814|NCT00379340|4186299|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4358815|NCT00379340|4186300|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4358816|NCT00379340|4186301|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4358817|NCT00379340|4186296|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|308|308.0||||||
4358818|NCT00379340|4186297|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4358819|NCT00379340|4186298|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4358820|NCT00379340|4186299|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4358821|NCT00379340|4186300|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4358822|NCT00379340|4186301|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4358823|NCT00379340|4186296|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4358824|NCT00379340|4186297|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4358825|NCT00379340|4186298|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4358826|NCT00379340|4186299|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4358827|NCT00379340|4186300|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4358828|NCT00379340|4186301|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4358829|NCT00379340|4186296|B6||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4358830|NCT00379340|4186297|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4358831|NCT00379340|4186298|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4358832|NCT00379340|4186299|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4358833|NCT00379340|4186300|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4358834|NCT00379340|4186301|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4358835|NCT00379340|4186296|B6||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4358836|NCT00379340|4186297|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4358837|NCT00379340|4186298|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4358838|NCT00379340|4186299|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4358839|NCT00379340|4186300|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4358840|NCT00379340|4186301|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4358841|NCT00379340|4186296|B6|||Age||Months|Mean|56.60|56.6|Standard Deviation|32.29|32.29|||
4358842|NCT00379340|4186297|B5|||Age||Months|Mean|56.06|56.06|Standard Deviation|23.71|23.71|||
4358843|NCT00379340|4186298|B4|||Age||Months|Mean|69.58|69.58|Standard Deviation|39.24|39.24|||
4358844|NCT00379340|4186299|B3|||Age||Months|Mean|52.16|52.16|Standard Deviation|28.64|28.64|||
4358845|NCT00379340|4186300|B2|||Age||Months|Mean|55.07|55.07|Standard Deviation|27.16|27.16|||
4358846|NCT00379340|4186301|B1|||Age||Months|Mean|54.94|54.94|Standard Deviation|36.27|36.27|||
4358847|NCT00379288|4186318|B5||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4358848|NCT00379288|4186319|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4358849|NCT00379288|4186320|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4358850|NCT00379288|4186321|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4358851|NCT00379288|4186322|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4358852|NCT00379288|4186318|B5||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4358853|NCT00379288|4186319|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4358854|NCT00379288|4186320|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4358855|NCT00379288|4186321|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4358856|NCT00379288|4186322|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4358857|NCT00379288|4186318|B5|||Age||years|Mean|35.5|35.5|Standard Deviation|15.2|15.2|||
4358858|NCT00379288|4186319|B4|||Age||years|Mean|37.1|37.1|Standard Deviation|15.0|15.0|||
4358859|NCT00379288|4186320|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|14.9|14.9|||
4358860|NCT00379288|4186321|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|14.5|14.5|||
4358861|NCT00379288|4186322|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|15.2|15.2|||
4358862|NCT00379236|4186335|B3|||Weight|Mean body weight of study participants in kilograms|kilograms|Mean|91.9|91.9|Standard Deviation|21.81|21.81|||
4358863|NCT00379236|4186336|B2|||Weight|Mean body weight of study participants in kilograms|kilograms|Mean|92.8|92.8|Standard Deviation|21.68|21.68|||
4358864|NCT00379236|4186337|B1|||Weight|Mean body weight of study participants in kilograms|kilograms|Mean|91.0|91.0|Standard Deviation|21.95|21.95|||
4358865|NCT00379236|4186335|B3|||Body Mass Index (BMI)|Body mass index (BMI) is a measure of body fat based on height and weight that applies to both adult men and women. Body mass index is calculated as weight / (height times height).|kilograms/meters square|Mean|32.70|32.7|Standard Deviation|7.446|7.446|||
4358866|NCT00379236|4186336|B2|||Body Mass Index (BMI)|Body mass index (BMI) is a measure of body fat based on height and weight that applies to both adult men and women. Body mass index is calculated as weight / (height times height).|kilograms/meters square|Mean|33.03|33.03|Standard Deviation|7.444|7.444|||
4358867|NCT00379236|4186337|B1|||Body Mass Index (BMI)|Body mass index (BMI) is a measure of body fat based on height and weight that applies to both adult men and women. Body mass index is calculated as weight / (height times height).|kilograms/meters square|Mean|32.36|32.36|Standard Deviation|7.446|7.446|||
4358868|NCT00379236|4186335|B3|United States||Region of Enrollment||participants|Number|588|588.0||||||
4358869|NCT00379236|4186336|B2|United States||Region of Enrollment||participants|Number|295|295.0||||||
4358870|NCT00379236|4186337|B1|United States||Region of Enrollment||participants|Number|293|293.0||||||
4358871|NCT00379236|4186335|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4358872|NCT00379236|4186336|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4358873|NCT00379236|4186337|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4358874|NCT00379236|4186335|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4358875|NCT00379236|4186336|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4358876|NCT00379236|4186337|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4358877|NCT00379236|4186335|B3|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4358878|NCT00379236|4186336|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4358879|NCT00379236|4186337|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4358880|NCT00379236|4186335|B3|African American||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4358881|NCT00379236|4186336|B2|African American||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4358882|NCT00379236|4186337|B1|African American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4358883|NCT00379236|4186335|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|459|459.0||||||
4358884|NCT00379236|4186336|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|228|228.0||||||
4358885|NCT00379236|4186337|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|231|231.0||||||
4358886|NCT00379236|4186335|B3||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4358887|NCT00379236|4186336|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4358888|NCT00379236|4186337|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4358889|NCT00379236|4186335|B3||Female|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4358890|NCT00379236|4186336|B2||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4358891|NCT00379236|4186337|B1||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4358892|NCT00379236|4186335|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|10.50|10.5|||
4358893|NCT00379236|4186336|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|10.31|10.31|||
4358894|NCT00379236|4186337|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|10.62|10.62|||
4358895|NCT00379210|4186382|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4358896|NCT00379210|4186383|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4358897|NCT00379210|4186384|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4358898|NCT00379210|4186382|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4358899|NCT00379210|4186383|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4358900|NCT00379210|4186384|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4358901|NCT00379210|4186382|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4358902|NCT00379210|4186383|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4358903|NCT00379210|4186384|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4358904|NCT00379210|4186382|B3|||Age||years|Mean|46|46.0|Standard Deviation|12|12.0|||
4358905|NCT00379210|4186383|B2|||Age||years|Mean|46|46.0|Standard Deviation|12|12.0|||
4358906|NCT00379210|4186384|B1|||Age||years|Mean|45|45.0|Standard Deviation|11|11.0|||
4358907|NCT00379210|4186382|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358908|NCT00379210|4186383|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358909|NCT00379210|4186384|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4358910|NCT00379210|4186382|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4358911|NCT00379210|4186383|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4358912|NCT00379210|4186384|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4358913|NCT00379210|4186382|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358914|NCT00379210|4186383|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358915|NCT00379210|4186384|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358916|NCT00379197|4186391|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4358917|NCT00379197|4186391|B1|Female only||Sex/Gender, Customized||participants|Number|8|8.0||||||
4358918|NCT00379197|4186391|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4358919|NCT00379197|4186391|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4358920|NCT00379197|4186391|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4358921|NCT00379145|4186396|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358922|NCT00379145|4186396|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358923|NCT00379145|4186396|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4358924|NCT00379145|4186396|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4358925|NCT00379145|4186396|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358926|NCT00379145|4186396|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4358927|NCT00379145|4186396|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4358928|NCT00379145|4186396|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4358929|NCT00379145|4186396|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4358930|NCT00379145|4186396|B1||>79 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
4358931|NCT00379145|4186396|B1||70-79 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
4358932|NCT00379145|4186396|B1||60-69 years|Age, Customized||Participants|Count of Participants|7|7.0||||||
4358933|NCT00379145|4186396|B1||50-59 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
4358934|NCT00379145|4186396|B1||40-49 years|Age, Customized||Participants|Count of Participants|3|3.0||||||
4358935|NCT00379145|4186396|B1||<40 years|Age, Customized||Participants|Count of Participants|1|1.0||||||
4358936|NCT00379080|4186405|B4|No||Steroids||participants|Number|33|33.0||||||
4358937|NCT00379080|4186406|B3|No||Steroids||participants|Number|23|23.0||||||
4358938|NCT00379080|4186407|B2|No||Steroids||participants|Number|9|9.0||||||
4358939|NCT00379080|4186408|B1|No||Steroids||participants|Number|1|1.0||||||
4358940|NCT00379080|4186405|B4|Yes||Steroids||participants|Number|23|23.0||||||
4358941|NCT00379080|4186406|B3|Yes||Steroids||participants|Number|8|8.0||||||
4358942|NCT00379080|4186407|B2|Yes||Steroids||participants|Number|10|10.0||||||
4358943|NCT00379080|4186408|B1|Yes||Steroids||participants|Number|5|5.0||||||
4358944|NCT00379080|4186405|B4|||Mini Mental Score|The mini–mental state examination (MMSE) is a 30-point questionnaire test used to screen for cognitive impairment. Commonly used to screen for dementia. It is also used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time. The MMSE test includes simple questions and problems in a number of areas: the time and place of the test, repeating lists of words, arithmetic such as the serial sevens, language use and comprehension, and basic motor skills. The Higher your score, the higher your function. Scale Ranges from 1-30|units on a scale|Median|29|29.0|Full Range|||15.0|30.0|
4358945|NCT00379080|4186406|B3|||Mini Mental Score|The mini–mental state examination (MMSE) is a 30-point questionnaire test used to screen for cognitive impairment. Commonly used to screen for dementia. It is also used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time. The MMSE test includes simple questions and problems in a number of areas: the time and place of the test, repeating lists of words, arithmetic such as the serial sevens, language use and comprehension, and basic motor skills. The Higher your score, the higher your function. Scale Ranges from 1-30|units on a scale|Median|29|29.0|Full Range|||15.0|30.0|
4358946|NCT00379080|4186407|B2|||Mini Mental Score|The mini–mental state examination (MMSE) is a 30-point questionnaire test used to screen for cognitive impairment. Commonly used to screen for dementia. It is also used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time. The MMSE test includes simple questions and problems in a number of areas: the time and place of the test, repeating lists of words, arithmetic such as the serial sevens, language use and comprehension, and basic motor skills. The Higher your score, the higher your function. Scale Ranges from 1-30|units on a scale|Median|30|30.0|Full Range|||22.0|30.0|
4358947|NCT00379080|4186408|B1|||Mini Mental Score|The mini–mental state examination (MMSE) is a 30-point questionnaire test used to screen for cognitive impairment. Commonly used to screen for dementia. It is also used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time. The MMSE test includes simple questions and problems in a number of areas: the time and place of the test, repeating lists of words, arithmetic such as the serial sevens, language use and comprehension, and basic motor skills. The Higher your score, the higher your function. Scale Ranges from 1-30|units on a scale|Median|29|29.0|Full Range|||20.0|30.0|
4358948|NCT00379080|4186405|B4|||Karnofsky Performance Status|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|Percentage|Median|90|90.0|Full Range|||60.0|100.0|
4358949|NCT00379080|4186406|B3|||Karnofsky Performance Status|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|Percentage|Median|90|90.0|Full Range|||60.0|100.0|
4358950|NCT00379080|4186407|B2|||Karnofsky Performance Status|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|Percentage|Median|90|90.0|Full Range|||60.0|100.0|
4358951|NCT00379080|4186408|B1|||Karnofsky Performance Status|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|Percentage|Median|80|80.0|Full Range|||60.0|100.0|
4358952|NCT00379080|4186405|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4358953|NCT00379080|4186406|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4358954|NCT00379080|4186407|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4358955|NCT00379080|4186408|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4358956|NCT00379080|4186405|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4358957|NCT00379080|4186406|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4358958|NCT00379080|4186407|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4358959|NCT00379080|4186408|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4358960|NCT00379080|4186405|B4|||Age||years|Median|56|56.0|Full Range|||24.0|77.0|
4358961|NCT00379080|4186406|B3|||Age||years|Median|54|54.0|Full Range|||24.0|69.0|
4358962|NCT00379080|4186407|B2|||Age||years|Median|56|56.0|Full Range|||42.0|77.0|
4358963|NCT00379080|4186408|B1|||Age||years|Median|61|61.0|Full Range|||48.0|72.0|
4358964|NCT00378898|4186453|B3|United States||Region of Enrollment|based on participants that completed the study|participants|Number|22|22.0||||||
4358965|NCT00378898|4186454|B2|United States||Region of Enrollment|based on participants that completed the study|participants|Number|11|11.0||||||
4358966|NCT00378898|4186455|B1|United States||Region of Enrollment|based on participants that completed the study|participants|Number|11|11.0||||||
4358967|NCT00378898|4186453|B3|Male||Sex/Gender, Customized|based on participants that completed the study|participants|Number|13|13.0||||||
4358968|NCT00378898|4186454|B2|Male||Sex/Gender, Customized|based on participants that completed the study|participants|Number|6|6.0||||||
4358969|NCT00378898|4186455|B1|Male||Sex/Gender, Customized|based on participants that completed the study|participants|Number|7|7.0||||||
4358970|NCT00378898|4186453|B3|Female||Sex/Gender, Customized|based on participants that completed the study|participants|Number|9|9.0||||||
4358971|NCT00378898|4186454|B2|Female||Sex/Gender, Customized|based on participants that completed the study|participants|Number|5|5.0||||||
4358972|NCT00378898|4186455|B1|Female||Sex/Gender, Customized|based on participants that completed the study|participants|Number|4|4.0||||||
4358973|NCT00378898|4186453|B3|||Age||years|Median|51|51.0|Full Range|||19.0|77.0|
4358974|NCT00378898|4186454|B2|||Age||years|Median|50|50.0|Full Range|||19.0|66.0|
4358975|NCT00378898|4186455|B1|||Age||years|Median|51|51.0|Full Range|||30.0|77.0|
4358976|NCT00378703|4186464|B5|United States||Region of Enrollment||participants|Number|331|331.0||||||
4358977|NCT00378703|4186465|B4|United States||Region of Enrollment||participants|Number|84|84.0||||||
4358978|NCT00378703|4186466|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
4358979|NCT00378703|4186467|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
4358980|NCT00378703|4186468|B1|United States||Region of Enrollment||participants|Number|84|84.0||||||
4358981|NCT00378703|4186464|B5||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4358982|NCT00378703|4186465|B4||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4358983|NCT00378703|4186466|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4358984|NCT00378703|4186467|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4358985|NCT00378703|4186468|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4358986|NCT00378703|4186464|B5||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4358987|NCT00378703|4186465|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4358988|NCT00378703|4186466|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4358989|NCT00378703|4186467|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4358990|NCT00378703|4186468|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4358991|NCT00378703|4186464|B5||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
4358992|NCT00378703|4186465|B4||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4358993|NCT00378703|4186466|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4358994|NCT00378703|4186467|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4358995|NCT00378703|4186468|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4358996|NCT00378703|4186464|B5||Between 18 and 65 years|Age||Participants|Count of Participants|213|213.0||||||
4358997|NCT00378703|4186465|B4||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4358998|NCT00378703|4186466|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4358999|NCT00378703|4186467|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4359000|NCT00378703|4186468|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4359001|NCT00378703|4186464|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359002|NCT00378703|4186465|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359003|NCT00378703|4186466|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359004|NCT00378703|4186467|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359005|NCT00378703|4186468|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359006|NCT00378599|4186493|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4359007|NCT00378599|4186493|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4359008|NCT00378599|4186493|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|5.7|5.7|||
4359009|NCT00378573|4186497|B1|||Weight||kg|Mean|68.22|68.22|Standard Deviation|12.648|12.648|||
4359010|NCT00378573|4186497|B1|||Body Surface Area (BSA)||m²|Mean|1.766|1.766|Standard Deviation|0.1737|0.1737|||
4359011|NCT00378573|4186497|B1|Large Cell||Tumor Histology||Participants|Number|1|1.0||||||
4359012|NCT00378573|4186497|B1|Bronchoalveolar Cell||Tumor Histology||Participants|Number|1|1.0||||||
4359013|NCT00378573|4186497|B1|Adenocarcinoma||Tumor Histology||Participants|Number|15|15.0||||||
4359014|NCT00378573|4186497|B1|Unknown||Histopathological Grade||Participants|Number|9|9.0||||||
4359015|NCT00378573|4186497|B1|G4 (undifferentiated)||Histopathological Grade||Participants|Number|1|1.0||||||
4359016|NCT00378573|4186497|B1|G3 (poorly differentiated)||Histopathological Grade||Participants|Number|3|3.0||||||
4359017|NCT00378573|4186497|B1|G2 (moderately differentiated)||Histopathological Grade||Participants|Number|3|3.0||||||
4359018|NCT00378573|4186497|B1|G1 (well differentiated)||Histopathological Grade||Participants|Number|1|1.0||||||
4359019|NCT00378573|4186497|B1|4 - Completely Disabled, No Self Care||Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Number|0|0.0||||||
4359020|NCT00378573|4186497|B1|3 - Limited Self Care, Partly Confined To Bed||Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Number|0|0.0||||||
4359021|NCT00378573|4186497|B1|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Number|2|2.0||||||
4359022|NCT00378573|4186497|B1|1 - Ambulatory, Restricted Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Number|8|8.0||||||
4359023|NCT00378573|4186497|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Number|7|7.0||||||
4359024|NCT00378573|4186497|B1|IV||Disease Stage at 1st diagnosis||Participants|Number|14|14.0||||||
4359025|NCT00378573|4186497|B1|IIIB||Disease Stage at 1st diagnosis||Participants|Number|2|2.0||||||
4359026|NCT00378573|4186497|B1|IIIA||Disease Stage at 1st diagnosis||Participants|Number|0|0.0||||||
4359027|NCT00378573|4186497|B1|IIB||Disease Stage at 1st diagnosis||Participants|Number|1|1.0||||||
4359028|NCT00378573|4186497|B1|IIA||Disease Stage at 1st diagnosis||Participants|Number|0|0.0||||||
4359029|NCT00378573|4186497|B1|IB||Disease Stage at 1st diagnosis||Participants|Number|0|0.0||||||
4359030|NCT00378573|4186497|B1|IA||Disease Stage at 1st diagnosis||Participants|Number|0|0.0||||||
4359031|NCT00378573|4186497|B1|USA||Region of Enrollment||Participants|Number|17|17.0||||||
4359032|NCT00378573|4186497|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4359033|NCT00378573|4186497|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4359034|NCT00378573|4186497|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|11.74|11.74|||
4359035|NCT00378573|4186497|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4359036|NCT00378573|4186497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4359037|NCT00378573|4186497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359038|NCT00378560|4186503|B3|||Body Weight||Kilograms|Mean|51.9|51.9|Standard Deviation|7.8|7.8|||
4359039|NCT00378560|4186504|B2|||Body Weight||Kilograms|Mean|51.7|51.7|Standard Deviation|7.3|7.3|||
4359040|NCT00378560|4186505|B1|||Body Weight||Kilograms|Mean|52.1|52.1|Standard Deviation|8.2|8.2|||
4359041|NCT00378560|4186503|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359042|NCT00378560|4186504|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359043|NCT00378560|4186505|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359044|NCT00378560|4186503|B3||Female|Sex: Female, Male||Participants|Count of Participants|1021|1021.0||||||
4359045|NCT00378560|4186504|B2||Female|Sex: Female, Male||Participants|Count of Participants|512|512.0||||||
4359046|NCT00378560|4186505|B1||Female|Sex: Female, Male||Participants|Count of Participants|509|509.0||||||
4359047|NCT00378560|4186503|B3|||Age||years|Mean|22.8|22.8|Standard Deviation|2.1|2.1|||
4359048|NCT00378560|4186504|B2|||Age||years|Mean|22.9|22.9|Standard Deviation|2.1|2.1|||
4359049|NCT00378560|4186505|B1|||Age||years|Mean|22.7|22.7|Standard Deviation|2.1|2.1|||
4359050|NCT00378534|4186520|B1|United States||Region of Enrollment||participants|Number|115|115.0||||||
4359051|NCT00378534|4186520|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4359052|NCT00378534|4186520|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4359053|NCT00378534|4186520|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4359054|NCT00378534|4186520|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4359055|NCT00378534|4186520|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4359056|NCT00378508|4186524|B3|Male||Sex/Gender, Customized||participants|Number|33|33.0||||||
4359057|NCT00378508|4186525|B2|Male||Sex/Gender, Customized||participants|Number|16|16.0||||||
4359058|NCT00378508|4186526|B1|Male||Sex/Gender, Customized||participants|Number|17|17.0||||||
4359059|NCT00378508|4186524|B3|Female||Sex/Gender, Customized||participants|Number|25|25.0||||||
4359060|NCT00378508|4186525|B2|Female||Sex/Gender, Customized||participants|Number|15|15.0||||||
4359061|NCT00378508|4186526|B1|Female||Sex/Gender, Customized||participants|Number|10|10.0||||||
4359062|NCT00378508|4186524|B3|>=15 years||Age, Customized||participants|Number|20|20.0||||||
4359063|NCT00378508|4186525|B2|>=15 years||Age, Customized||participants|Number|13|13.0||||||
4359064|NCT00378508|4186526|B1|>=15 years||Age, Customized||participants|Number|7|7.0||||||
4359065|NCT00378508|4186524|B3|<15 years||Age, Customized||participants|Number|38|38.0||||||
4359066|NCT00378508|4186525|B2|<15 years||Age, Customized||participants|Number|18|18.0||||||
4359067|NCT00378508|4186526|B1|<15 years||Age, Customized||participants|Number|20|20.0||||||
4359068|NCT00378378|4186543|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4359069|NCT00378378|4186544|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4359070|NCT00378378|4186545|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4359071|NCT00378378|4186546|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4359072|NCT00378378|4186543|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4359073|NCT00378378|4186544|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4359074|NCT00378378|4186545|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4359075|NCT00378378|4186546|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4359076|NCT00378378|4186543|B4|12 to < 18 years||Age, Customized||participants|Number|81|81.0||||||
4359077|NCT00378378|4186544|B3|12 to < 18 years||Age, Customized||participants|Number|16|16.0||||||
4359078|NCT00378378|4186545|B2|12 to < 18 years||Age, Customized||participants|Number|32|32.0||||||
4359079|NCT00378378|4186546|B1|12 to < 18 years||Age, Customized||participants|Number|33|33.0||||||
4359080|NCT00378378|4186543|B4|6 to < 12 years||Age, Customized||participants|Number|46|46.0||||||
4359081|NCT00378378|4186544|B3|6 to < 12 years||Age, Customized||participants|Number|10|10.0||||||
4359082|NCT00378378|4186545|B2|6 to < 12 years||Age, Customized||participants|Number|18|18.0||||||
4359083|NCT00378378|4186546|B1|6 to < 12 years||Age, Customized||participants|Number|18|18.0||||||
4359084|NCT00378378|4186543|B4|||Age||years|Mean|12.7|12.7|Standard Deviation|2.9|2.9|||
4359085|NCT00378378|4186544|B3|||Age||years|Mean|12.7|12.7|Standard Deviation|3.2|3.2|||
4359086|NCT00378378|4186545|B2|||Age||years|Mean|14.4|14.4|Standard Deviation|1.8|1.8|||
4359087|NCT00378378|4186546|B1|||Age||years|Mean|9.6|9.6|Standard Deviation|1.4|1.4|||
4359088|NCT00378352|4186559|B3|United States||Region of Enrollment||participants|Number|222|222.0||||||
4359089|NCT00378352|4186560|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
4359090|NCT00378352|4186561|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
4359091|NCT00378352|4186559|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4359092|NCT00378352|4186560|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4359093|NCT00378352|4186561|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4359094|NCT00378352|4186559|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4359095|NCT00378352|4186560|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4359096|NCT00378352|4186561|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4359097|NCT00378352|4186559|B3|Greater than or equal to 70 years||Age, Customized||Participants|Count of Participants|38|38.0||||||
4359098|NCT00378352|4186560|B2|Greater than or equal to 70 years||Age, Customized||Participants|Count of Participants|18|18.0||||||
4359099|NCT00378352|4186561|B1|Greater than or equal to 70 years||Age, Customized||Participants|Count of Participants|20|20.0||||||
4359100|NCT00378352|4186559|B3|Less than 70 years||Age, Customized||Participants|Count of Participants|184|184.0||||||
4359101|NCT00378352|4186560|B2|Less than 70 years||Age, Customized||Participants|Count of Participants|81|81.0||||||
4359102|NCT00378352|4186561|B1|Less than 70 years||Age, Customized||Participants|Count of Participants|103|103.0||||||
4359103|NCT00378352|4186559|B3|||Age||years|Mean|56|56.0|Standard Deviation|12|12.0|||
4359104|NCT00378352|4186560|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|12.5|12.5|||
4359105|NCT00378352|4186561|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|12.4|12.4|||
4359106|NCT00378326|4186588|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4359107|NCT00378326|4186588|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4359108|NCT00378326|4186588|B1|||Age||years|Median|59.5|59.5|Full Range|||31.0|78.0|
4359109|NCT00378209|4186594|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4359110|NCT00378209|4186594|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4359111|NCT00378209|4186594|B1|||Age||years|Median|65|65.0|Full Range|||32.0|83.0|
4359112|NCT00378105|4186602|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4359113|NCT00378105|4186603|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4359114|NCT00378105|4186604|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4359115|NCT00378105|4186602|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4359116|NCT00378105|4186603|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4359117|NCT00378105|4186604|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4359118|NCT00378105|4186602|B3|||Age||years|Median|58|58.0|Full Range|||22.0|86.0|
4359119|NCT00378105|4186603|B2|||Age||years|Median|59|59.0|Full Range|||22.0|86.0|
4359120|NCT00378105|4186604|B1|||Age||years|Median|57|57.0|Full Range|||36.0|73.0|
4359121|NCT00378079|4186614|B4|United States||Region of Enrollment||participants|Number|211|211.0||||||
4359122|NCT00378079|4186615|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
4359123|NCT00378079|4186616|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4359124|NCT00378079|4186617|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4359125|NCT00378079|4186614|B4||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4359126|NCT00378079|4186615|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4359127|NCT00378079|4186616|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4359128|NCT00378079|4186617|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4359129|NCT00378079|4186614|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359130|NCT00378079|4186615|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359131|NCT00378079|4186616|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359132|NCT00378079|4186617|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359133|NCT00378079|4186614|B4|||Age||years|Mean|40.3|40.3|Standard Deviation|7.1|7.1|||
4359134|NCT00378079|4186615|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|7.0|7.0|||
4359135|NCT00378079|4186616|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|6.7|6.7|||
4359136|NCT00378079|4186617|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|7.5|7.5|||
4359137|NCT00378079|4186614|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359138|NCT00378079|4186615|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359139|NCT00378079|4186616|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359140|NCT00378079|4186617|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359141|NCT00378079|4186614|B4||Between 18 and 65 years|Age||Participants|Count of Participants|211|211.0||||||
4359142|NCT00378079|4186615|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4359143|NCT00378079|4186616|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4359144|NCT00378079|4186617|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4359145|NCT00378079|4186614|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359146|NCT00378079|4186615|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359147|NCT00378079|4186616|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359148|NCT00378079|4186617|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359149|NCT00378014|4186639|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4359150|NCT00378014|4186640|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4359151|NCT00378014|4186641|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4359152|NCT00378014|4186639|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4359153|NCT00378014|4186640|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4359154|NCT00378014|4186641|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4359155|NCT00378014|4186639|B3|||Age||Years|Mean|52.6|52.6|Standard Deviation|1|1.0|||
4359156|NCT00378014|4186640|B2|||Age||Years|Mean|52.9|52.9|Standard Deviation|10.1|10.1|||
4359157|NCT00378014|4186641|B1|||Age||Years|Mean|52.3|52.3|Standard Deviation|9.9|9.9|||
4359158|NCT00377962|4186666|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4359159|NCT00377962|4186667|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4359160|NCT00377962|4186668|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4359161|NCT00377962|4186666|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4359162|NCT00377962|4186667|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4359163|NCT00377962|4186668|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4359164|NCT00377962|4186666|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|9.96|9.96|||
4359165|NCT00377962|4186667|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|10.7|10.7|||
4359166|NCT00377962|4186668|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|9.5|9.5|||
4359167|NCT00377858|4186703|B3|||Hemoglobin A1c (HbA1c)||percent HbA1c|Mean|9.47|9.47|Standard Deviation|1.18|1.18|||
4359168|NCT00377858|4186704|B2|||Hemoglobin A1c (HbA1c)||percent HbA1c|Mean|9.39|9.39|Standard Deviation|1.17|1.17|||
4359169|NCT00377858|4186705|B1|||Hemoglobin A1c (HbA1c)||percent HbA1c|Mean|9.55|9.55|Standard Deviation|1.18|1.18|||
4359170|NCT00377858|4186703|B3|||Duration of Diabetes||years|Mean|11.33|11.33|Standard Deviation|6.48|6.48|||
4359171|NCT00377858|4186704|B2|||Duration of Diabetes||years|Mean|11.79|11.79|Standard Deviation|7.29|7.29|||
4359172|NCT00377858|4186705|B1|||Duration of Diabetes||years|Mean|10.86|10.86|Standard Deviation|5.54|5.54|||
4359173|NCT00377858|4186703|B3|||Body Weight||kilograms (kg)|Mean|78.86|78.86|Standard Deviation|15.28|15.28|||
4359174|NCT00377858|4186704|B2|||Body Weight||kilograms (kg)|Mean|78.87|78.87|Standard Deviation|15.10|15.1|||
4359175|NCT00377858|4186705|B1|||Body Weight||kilograms (kg)|Mean|78.85|78.85|Standard Deviation|15.50|15.5|||
4359176|NCT00377858|4186703|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|29.25|29.25|Standard Deviation|4.66|4.66|||
4359177|NCT00377858|4186704|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|29.00|29.0|Standard Deviation|4.55|4.55|||
4359178|NCT00377858|4186705|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|29.51|29.51|Standard Deviation|4.76|4.76|||
4359179|NCT00377858|4186703|B3|||Body Height||centimeters (cm)|Mean|163.98|163.98|Standard Deviation|9.39|9.39|||
4359180|NCT00377858|4186704|B2|||Body Height||centimeters (cm)|Mean|164.68|164.68|Standard Deviation|9.48|9.48|||
4359181|NCT00377858|4186705|B1|||Body Height||centimeters (cm)|Mean|163.27|163.27|Standard Deviation|9.27|9.27|||
4359182|NCT00377858|4186703|B3|West Asian (Indian sub-continent)||Race/Ethnicity||participants|Number|57|57.0||||||
4359183|NCT00377858|4186704|B2|West Asian (Indian sub-continent)||Race/Ethnicity||participants|Number|30|30.0||||||
4359184|NCT00377858|4186705|B1|West Asian (Indian sub-continent)||Race/Ethnicity||participants|Number|27|27.0||||||
4359185|NCT00377858|4186703|B3|Hispanic||Race/Ethnicity||participants|Number|97|97.0||||||
4359186|NCT00377858|4186704|B2|Hispanic||Race/Ethnicity||participants|Number|46|46.0||||||
4359187|NCT00377858|4186705|B1|Hispanic||Race/Ethnicity||participants|Number|51|51.0||||||
4359188|NCT00377858|4186703|B3|East Asian||Race/Ethnicity||participants|Number|52|52.0||||||
4359189|NCT00377858|4186704|B2|East Asian||Race/Ethnicity||participants|Number|27|27.0||||||
4359190|NCT00377858|4186705|B1|East Asian||Race/Ethnicity||participants|Number|25|25.0||||||
4359191|NCT00377858|4186703|B3|Caucasian||Race/Ethnicity||participants|Number|270|270.0||||||
4359192|NCT00377858|4186704|B2|Caucasian||Race/Ethnicity||participants|Number|136|136.0||||||
4359193|NCT00377858|4186705|B1|Caucasian||Race/Ethnicity||participants|Number|134|134.0||||||
4359194|NCT00377858|4186703|B3|African||Race/Ethnicity||participants|Number|3|3.0||||||
4359195|NCT00377858|4186704|B2|African||Race/Ethnicity||participants|Number|1|1.0||||||
4359196|NCT00377858|4186705|B1|African||Race/Ethnicity||participants|Number|2|2.0||||||
4359197|NCT00377858|4186703|B3|>8.5% HbA1c||Hemoglobin A1c (HbA1c) Group||participants|Number|352|352.0||||||
4359198|NCT00377858|4186704|B2|>8.5% HbA1c||Hemoglobin A1c (HbA1c) Group||participants|Number|173|173.0||||||
4359199|NCT00377858|4186705|B1|>8.5% HbA1c||Hemoglobin A1c (HbA1c) Group||participants|Number|179|179.0||||||
4359200|NCT00377858|4186703|B3|≤8.5% HbA1c||Hemoglobin A1c (HbA1c) Group||participants|Number|127|127.0||||||
4359201|NCT00377858|4186704|B2|≤8.5% HbA1c||Hemoglobin A1c (HbA1c) Group||participants|Number|67|67.0||||||
4359202|NCT00377858|4186705|B1|≤8.5% HbA1c||Hemoglobin A1c (HbA1c) Group||participants|Number|60|60.0||||||
4359203|NCT00377858|4186703|B3|>10 years||Duration of Diabetes Group||participants|Number|229|229.0||||||
4359204|NCT00377858|4186704|B2|>10 years||Duration of Diabetes Group||participants|Number|113|113.0||||||
4359205|NCT00377858|4186705|B1|>10 years||Duration of Diabetes Group||participants|Number|116|116.0||||||
4359206|NCT00377858|4186703|B3|≥5 years and ≤10 years||Duration of Diabetes Group||participants|Number|195|195.0||||||
4359207|NCT00377858|4186704|B2|≥5 years and ≤10 years||Duration of Diabetes Group||participants|Number|100|100.0||||||
4359208|NCT00377858|4186705|B1|≥5 years and ≤10 years||Duration of Diabetes Group||participants|Number|95|95.0||||||
4359209|NCT00377858|4186703|B3|<5 years||Duration of Diabetes Group||participants|Number|55|55.0||||||
4359210|NCT00377858|4186704|B2|<5 years||Duration of Diabetes Group||participants|Number|27|27.0||||||
4359211|NCT00377858|4186705|B1|<5 years||Duration of Diabetes Group||participants|Number|28|28.0||||||
4359212|NCT00377858|4186703|B3|BMI ≥30 kg/m^2||Body Mass Index (BMI) Group|Body mass index is an estimate of body fat based on body weight divided by height squared.|participants|Number|188|188.0||||||
4359213|NCT00377858|4186704|B2|BMI ≥30 kg/m^2||Body Mass Index (BMI) Group|Body mass index is an estimate of body fat based on body weight divided by height squared.|participants|Number|89|89.0||||||
4359214|NCT00377858|4186705|B1|BMI ≥30 kg/m^2||Body Mass Index (BMI) Group|Body mass index is an estimate of body fat based on body weight divided by height squared.|participants|Number|99|99.0||||||
4359215|NCT00377858|4186703|B3|BMI ≥25 kg/m^2 and <30 kg/m^2||Body Mass Index (BMI) Group|Body mass index is an estimate of body fat based on body weight divided by height squared.|participants|Number|209|209.0||||||
4359216|NCT00377858|4186704|B2|BMI ≥25 kg/m^2 and <30 kg/m^2||Body Mass Index (BMI) Group|Body mass index is an estimate of body fat based on body weight divided by height squared.|participants|Number|103|103.0||||||
4359217|NCT00377858|4186705|B1|BMI ≥25 kg/m^2 and <30 kg/m^2||Body Mass Index (BMI) Group|Body mass index is an estimate of body fat based on body weight divided by height squared.|participants|Number|106|106.0||||||
4359218|NCT00377858|4186703|B3|BMI <25 kg/m^2||Body Mass Index (BMI) Group|Body mass index is an estimate of body fat based on body weight divided by height squared.|participants|Number|82|82.0||||||
4359219|NCT00377858|4186704|B2|BMI <25 kg/m^2||Body Mass Index (BMI) Group|Body mass index is an estimate of body fat based on body weight divided by height squared.|participants|Number|48|48.0||||||
4359220|NCT00377858|4186705|B1|BMI <25 kg/m^2||Body Mass Index (BMI) Group|Body mass index is an estimate of body fat based on body weight divided by height squared.|participants|Number|34|34.0||||||
4359221|NCT00377858|4186703|B3|Spain||Region of Enrollment||participants|Number|60|60.0||||||
4359222|NCT00377858|4186704|B2|Spain||Region of Enrollment||participants|Number|31|31.0||||||
4359223|NCT00377858|4186705|B1|Spain||Region of Enrollment||participants|Number|29|29.0||||||
4359224|NCT00377858|4186703|B3|Russian Federation||Region of Enrollment||participants|Number|50|50.0||||||
4359225|NCT00377858|4186704|B2|Russian Federation||Region of Enrollment||participants|Number|26|26.0||||||
4359226|NCT00377858|4186705|B1|Russian Federation||Region of Enrollment||participants|Number|24|24.0||||||
4359227|NCT00377858|4186703|B3|Mexico||Region of Enrollment||participants|Number|98|98.0||||||
4359228|NCT00377858|4186704|B2|Mexico||Region of Enrollment||participants|Number|47|47.0||||||
4359229|NCT00377858|4186705|B1|Mexico||Region of Enrollment||participants|Number|51|51.0||||||
4359230|NCT00377858|4186703|B3|Korea, Republic of||Region of Enrollment||participants|Number|49|49.0||||||
4359231|NCT00377858|4186704|B2|Korea, Republic of||Region of Enrollment||participants|Number|25|25.0||||||
4359232|NCT00377858|4186705|B1|Korea, Republic of||Region of Enrollment||participants|Number|24|24.0||||||
4359233|NCT00377858|4186703|B3|India||Region of Enrollment||participants|Number|55|55.0||||||
4359234|NCT00377858|4186704|B2|India||Region of Enrollment||participants|Number|29|29.0||||||
4359235|NCT00377858|4186705|B1|India||Region of Enrollment||participants|Number|26|26.0||||||
4359236|NCT00377858|4186703|B3|Greece||Region of Enrollment||participants|Number|39|39.0||||||
4359237|NCT00377858|4186704|B2|Greece||Region of Enrollment||participants|Number|20|20.0||||||
4359238|NCT00377858|4186705|B1|Greece||Region of Enrollment||participants|Number|19|19.0||||||
4359239|NCT00377858|4186703|B3|France||Region of Enrollment||participants|Number|40|40.0||||||
4359240|NCT00377858|4186704|B2|France||Region of Enrollment||participants|Number|19|19.0||||||
4359241|NCT00377858|4186705|B1|France||Region of Enrollment||participants|Number|21|21.0||||||
4359242|NCT00377858|4186703|B3|Canada||Region of Enrollment||participants|Number|51|51.0||||||
4359243|NCT00377858|4186704|B2|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4359244|NCT00377858|4186705|B1|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4359245|NCT00377858|4186703|B3|Australia||Region of Enrollment||participants|Number|37|37.0||||||
4359246|NCT00377858|4186704|B2|Australia||Region of Enrollment||participants|Number|19|19.0||||||
4359247|NCT00377858|4186705|B1|Australia||Region of Enrollment||participants|Number|18|18.0||||||
4359248|NCT00377858|4186703|B3||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4359249|NCT00377858|4186704|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4359250|NCT00377858|4186705|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4359251|NCT00377858|4186703|B3||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4359252|NCT00377858|4186704|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4359253|NCT00377858|4186705|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4359254|NCT00377858|4186703|B3|||Age||years|Mean|58.92|58.92|Standard Deviation|9.55|9.55|||
4359255|NCT00377858|4186704|B2|||Age||years|Mean|59.45|59.45|Standard Deviation|9.87|9.87|||
4359256|NCT00377858|4186705|B1|||Age||years|Mean|58.40|58.4|Standard Deviation|9.21|9.21|||
4359257|NCT00377832|4186734|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4359258|NCT00377832|4186735|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4359259|NCT00377832|4186736|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4359260|NCT00377832|4186734|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359261|NCT00377832|4186735|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359262|NCT00377832|4186736|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359263|NCT00377832|4186734|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4359264|NCT00377832|4186735|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4359265|NCT00377832|4186736|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4359266|NCT00377832|4186734|B3|||Age||years|Mean|26.3|26.3|Standard Deviation|3.8|3.8|||
4359267|NCT00377832|4186735|B2|||Age||years|Mean|26.1|26.1|Standard Deviation|4.6|4.6|||
4359268|NCT00377832|4186736|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|3.4|3.4|||
4359269|NCT00377832|4186734|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359270|NCT00377832|4186735|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359271|NCT00377832|4186736|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359272|NCT00377832|4186734|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4359273|NCT00377832|4186735|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4359274|NCT00377832|4186736|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4359275|NCT00377832|4186734|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359276|NCT00377832|4186735|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359277|NCT00377832|4186736|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359278|NCT00377819|4186757|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4359279|NCT00377819|4186758|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4359280|NCT00377819|4186759|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4359281|NCT00377819|4186757|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4359282|NCT00377819|4186758|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4359283|NCT00377819|4186759|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4359284|NCT00377819|4186757|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4359285|NCT00377819|4186758|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4359286|NCT00377819|4186759|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4359287|NCT00377819|4186757|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4359288|NCT00377819|4186758|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4359289|NCT00377819|4186759|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4359290|NCT00377819|4186757|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4359291|NCT00377819|4186758|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4359292|NCT00377819|4186759|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4359293|NCT00377819|4186757|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4359294|NCT00377819|4186758|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4359295|NCT00377819|4186759|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4359296|NCT00377819|4186757|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4359297|NCT00377819|4186758|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4359298|NCT00377819|4186759|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4359299|NCT00377819|4186757|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|470|470.0||||||
4359300|NCT00377819|4186758|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|238|238.0||||||
4359301|NCT00377819|4186759|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|232|232.0||||||
4359302|NCT00377819|4186757|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359303|NCT00377819|4186758|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359304|NCT00377819|4186759|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359305|NCT00377819|4186757|B3||Female|Sex: Female, Male||Participants|Count of Participants|504|504.0||||||
4359306|NCT00377819|4186758|B2||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4359307|NCT00377819|4186759|B1||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4359308|NCT00377819|4186757|B3|||Age||Years|Mean|67.6|67.6|Standard Deviation|7.8|7.8|||
4359309|NCT00377819|4186758|B2|||Age||Years|Mean|66.9|66.9|Standard Deviation|7.8|7.8|||
4359310|NCT00377819|4186759|B1|||Age||Years|Mean|68.2|68.2|Standard Deviation|7.7|7.7|||
4359311|NCT00377741|4186770|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4359312|NCT00377741|4186771|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4359313|NCT00377741|4186772|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4359314|NCT00377741|4186770|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4359315|NCT00377741|4186771|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4359316|NCT00377741|4186772|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4359317|NCT00377741|4186770|B3|||Age||Years|Mean|40.4|40.4|Standard Deviation|14.34|14.34|||
4359318|NCT00377741|4186771|B2|||Age||Years|Mean|51.6|51.6|Standard Deviation|8.66|8.66|||
4359319|NCT00377741|4186772|B1|||Age||Years|Mean|29.8|29.8|Standard Deviation|9.82|9.82|||
4359320|NCT00377676|4186787|B3|United States||Region of Enrollment||participants|Number|3070|3070.0||||||
4359321|NCT00377676|4186788|B2|United States||Region of Enrollment||participants|Number|1016|1016.0||||||
4359322|NCT00377676|4186789|B1|United States||Region of Enrollment||participants|Number|2054|2054.0||||||
4359323|NCT00377676|4186787|B3||Male|Sex: Female, Male||Participants|Count of Participants|1739|1739.0||||||
4359324|NCT00377676|4186788|B2||Male|Sex: Female, Male||Participants|Count of Participants|598|598.0||||||
4359325|NCT00377676|4186789|B1||Male|Sex: Female, Male||Participants|Count of Participants|1141|1141.0||||||
4359326|NCT00377676|4186787|B3||Female|Sex: Female, Male||Participants|Count of Participants|1331|1331.0||||||
4359327|NCT00377676|4186788|B2||Female|Sex: Female, Male||Participants|Count of Participants|418|418.0||||||
4359328|NCT00377676|4186789|B1||Female|Sex: Female, Male||Participants|Count of Participants|913|913.0||||||
4359329|NCT00377676|4186787|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|10|10.0|||
4359330|NCT00377676|4186788|B2|||Age||years|Mean|59.5|59.5|Standard Deviation|10|10.0|||
4359331|NCT00377676|4186789|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|10|10.0|||
4359332|NCT00377676|4186787|B3||>=65 years|Age||Participants|Count of Participants|916|916.0||||||
4359333|NCT00377676|4186788|B2||>=65 years|Age||Participants|Count of Participants|315|315.0||||||
4359334|NCT00377676|4186789|B1||>=65 years|Age||Participants|Count of Participants|601|601.0||||||
4359335|NCT00377676|4186787|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2154|2154.0||||||
4359336|NCT00377676|4186788|B2||Between 18 and 65 years|Age||Participants|Count of Participants|701|701.0||||||
4359337|NCT00377676|4186789|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1453|1453.0||||||
4359338|NCT00377676|4186787|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359339|NCT00377676|4186788|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359340|NCT00377676|4186789|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359341|NCT00377637|4186802|B5|Maintenance Phase - Male||Sex/Gender, Customized||Participants|Number|32|32.0||||||
4359342|NCT00377637|4186803|B4|Maintenance Phase - Male||Sex/Gender, Customized||Participants|Number|15|15.0||||||
4359343|NCT00377637|4186804|B3|Maintenance Phase - Male||Sex/Gender, Customized||Participants|Number|17|17.0||||||
4359344|NCT00377637|4186805|B2|Maintenance Phase - Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4359345|NCT00377637|4186806|B1|Maintenance Phase - Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4359346|NCT00377637|4186802|B5|Maintenance Phase - Female||Sex/Gender, Customized||Participants|Number|195|195.0||||||
4359347|NCT00377637|4186803|B4|Maintenance Phase - Female||Sex/Gender, Customized||Participants|Number|96|96.0||||||
4359348|NCT00377637|4186804|B3|Maintenance Phase - Female||Sex/Gender, Customized||Participants|Number|99|99.0||||||
4359349|NCT00377637|4186805|B2|Maintenance Phase - Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4359350|NCT00377637|4186806|B1|Maintenance Phase - Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4359351|NCT00377637|4186802|B5|Induction Phase - Male||Sex/Gender, Customized||Participants|Number|57|57.0||||||
4359352|NCT00377637|4186803|B4|Induction Phase - Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4359353|NCT00377637|4186804|B3|Induction Phase - Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4359354|NCT00377637|4186805|B2|Induction Phase - Male||Sex/Gender, Customized||Participants|Number|28|28.0||||||
4359355|NCT00377637|4186806|B1|Induction Phase - Male||Sex/Gender, Customized||Participants|Number|29|29.0||||||
4359356|NCT00377637|4186802|B5|Induction Phase - Female||Sex/Gender, Customized||Participants|Number|313|313.0||||||
4359357|NCT00377637|4186803|B4|Induction Phase - Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4359358|NCT00377637|4186804|B3|Induction Phase - Female||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4359359|NCT00377637|4186805|B2|Induction Phase - Female||Sex/Gender, Customized||Participants|Number|157|157.0||||||
4359360|NCT00377637|4186806|B1|Induction Phase - Female||Sex/Gender, Customized||Participants|Number|156|156.0||||||
4359361|NCT00377637|4186802|B5|Maintenance Phase||Age, Customized||years|Mean|31.4|31.4|Standard Deviation|10.65|10.65|||
4359362|NCT00377637|4186803|B4|Maintenance Phase||Age, Customized||years|Mean|31.0|31.0|Standard Deviation|10.77|10.77|||
4359363|NCT00377637|4186804|B3|Maintenance Phase||Age, Customized||years|Mean|31.8|31.8|Standard Deviation|10.59|10.59|||
4359364|NCT00377637|4186805|B2|Maintenance Phase||Age, Customized||years|Mean|NA||Standard Deviation|NA||||Did not participate in the Maintenance Phase. Please see Induction Phase.
4359365|NCT00377637|4186806|B1|Maintenance Phase||Age, Customized||years|Mean|NA||Standard Deviation|NA||||Did not participate in the Maintenance Phase. Please see Induction Phase.
4359366|NCT00377637|4186802|B5|Induction Phase||Age, Customized||years|Mean|31.9|31.9|Standard Deviation|10.72|10.72|||
4359367|NCT00377637|4186803|B4|Induction Phase||Age, Customized||years|Mean|NA||Standard Deviation|NA||||Did not participate in the Induction Phase. Please see Maintenance Phase.
4359368|NCT00377637|4186804|B3|Induction Phase||Age, Customized||years|Mean|NA||Standard Deviation|NA||||Did not participate in the Induction Phase. Please see Maintenance Phase.
4359369|NCT00377637|4186805|B2|Induction Phase||Age, Customized||years|Mean|32.4|32.4|Standard Deviation|11.7|11.7|||
4359370|NCT00377637|4186806|B1|Induction Phase||Age, Customized||years|Mean|31.3|31.3|Standard Deviation|10.25|10.25|||
4359371|NCT00377611|4186843|B3||Male|Sex: Female, Male||Participants|Count of Participants|1361|1361.0||||||
4359372|NCT00377611|4186844|B2||Male|Sex: Female, Male||Participants|Count of Participants|913|913.0||||||
4359373|NCT00377611|4186845|B1||Male|Sex: Female, Male||Participants|Count of Participants|448|448.0||||||
4359374|NCT00377611|4186843|B3||Female|Sex: Female, Male||Participants|Count of Participants|1693|1693.0||||||
4359375|NCT00377611|4186844|B2||Female|Sex: Female, Male||Participants|Count of Participants|1094|1094.0||||||
4359376|NCT00377611|4186845|B1||Female|Sex: Female, Male||Participants|Count of Participants|599|599.0||||||
4359377|NCT00377611|4186843|B3|||Age||Years|Mean|65.92|65.92|Standard Deviation|7.40|7.4|||
4359378|NCT00377611|4186844|B2|||Age||Years|Mean|70.3|70.3|Standard Deviation|4.42|4.42|||
4359379|NCT00377611|4186845|B1|||Age||Years|Mean|57.6|57.6|Standard Deviation|4.11|4.11|||
4359380|NCT00377572|4186907|B3|||FEV1/FVC Ratio|"The FEV1 (forced expiratory volume 1))/ FVC (forced vital capacity) ratio is used to evaluate airways obstructions since pure restrictive ventilatory defects cause an equal reduction in the FEV1 and the FVC. An FEV1/FVC ratio below 80% indicates airflow obstruction. Normal FEV1/FVC: 8 – 19 years of age=85%.~Baseline FEV1/FVC ratio and FEV1 percent predicted data were available in 398 of the 419 participants. Of the 398, 204 were enrolled in the Omalizumab (Xolair) + Conventional Therapy arm."|ratio (x 100)|Mean|77.4|77.4|Standard Deviation|9.7|9.7|||
4359381|NCT00377572|4186908|B2|||FEV1/FVC Ratio|"The FEV1 (forced expiratory volume 1))/ FVC (forced vital capacity) ratio is used to evaluate airways obstructions since pure restrictive ventilatory defects cause an equal reduction in the FEV1 and the FVC. An FEV1/FVC ratio below 80% indicates airflow obstruction. Normal FEV1/FVC: 8 – 19 years of age=85%.~Baseline FEV1/FVC ratio and FEV1 percent predicted data were available in 398 of the 419 participants. Of the 398, 204 were enrolled in the Omalizumab (Xolair) + Conventional Therapy arm."|ratio (x 100)|Mean|77.6|77.6|Standard Deviation|9.4|9.4|||
4359382|NCT00377572|4186909|B1|||FEV1/FVC Ratio|"The FEV1 (forced expiratory volume 1))/ FVC (forced vital capacity) ratio is used to evaluate airways obstructions since pure restrictive ventilatory defects cause an equal reduction in the FEV1 and the FVC. An FEV1/FVC ratio below 80% indicates airflow obstruction. Normal FEV1/FVC: 8 – 19 years of age=85%.~Baseline FEV1/FVC ratio and FEV1 percent predicted data were available in 398 of the 419 participants. Of the 398, 204 were enrolled in the Omalizumab (Xolair) + Conventional Therapy arm."|ratio (x 100)|Mean|77.3|77.3|Standard Deviation|10.0|10.0|||
4359383|NCT00377572|4186907|B3|||Forced Expiratory Volume in 1 Second (FEV1) % Predicted|FEV1 is air volume exhaled in 1 second during spirometry. For the trial, mild asthma is defined as pre-bronchodilator FEV1 ≥80% predicted, requiring no/low-moderate dose of inhaled glucocorticoids; moderate asthma and severe asthma, respectively, as pre-bronchodilator FEV1 <80% predicted requiring the same glucocorticoids as mild asthma and FEV1 <80% predicted requiring high-dose inhaled glucocorticoids (with/without continuous oral glucocorticoids) or uncontrolled despite treatment. FEV1 % of predicted is FEV1 converted to a percentage of normal, based on height, weight, and race.|Percent|Mean|93|93.0|Standard Deviation|18|18.0|||
4359397|NCT00377572|4186909|B1|||Childhood Asthma Control Test (C-ACT) Score|The Childhood Asthma Control Test (C-ACT) is a validated tool to assess overall asthma control (over the last 4 weeks) in patients ages 4 to 11 years. Scores can range from 0 to 27. A score of 19 or less is indicative of asthma that is not well controlled. The minimally important difference in C-ACT scores is not defined. C-ACT scores were available and relevant for 253 of 419 (60%) study participants. Of the 253, 123 were from the Omalizumab (Xolair) + Conventional Therapy arm.|C-ACT score|Mean|20.5|20.5|Standard Deviation|3.8|3.8|||
4359384|NCT00377572|4186908|B2|||Forced Expiratory Volume in 1 Second (FEV1) % Predicted|FEV1 is air volume exhaled in 1 second during spirometry. For the trial, mild asthma is defined as pre-bronchodilator FEV1 ≥80% predicted, requiring no/low-moderate dose of inhaled glucocorticoids; moderate asthma and severe asthma, respectively, as pre-bronchodilator FEV1 <80% predicted requiring the same glucocorticoids as mild asthma and FEV1 <80% predicted requiring high-dose inhaled glucocorticoids (with/without continuous oral glucocorticoids) or uncontrolled despite treatment. FEV1 % of predicted is FEV1 converted to a percentage of normal, based on height, weight, and race.|Percent|Mean|92|92.0|Standard Deviation|18|18.0|||
4359385|NCT00377572|4186909|B1|||Forced Expiratory Volume in 1 Second (FEV1) % Predicted|FEV1 is air volume exhaled in 1 second during spirometry. For the trial, mild asthma is defined as pre-bronchodilator FEV1 ≥80% predicted, requiring no/low-moderate dose of inhaled glucocorticoids; moderate asthma and severe asthma, respectively, as pre-bronchodilator FEV1 <80% predicted requiring the same glucocorticoids as mild asthma and FEV1 <80% predicted requiring high-dose inhaled glucocorticoids (with/without continuous oral glucocorticoids) or uncontrolled despite treatment. FEV1 % of predicted is FEV1 converted to a percentage of normal, based on height, weight, and race.|Percent|Mean|93|93.0|Standard Deviation|19|19.0|||
4359386|NCT00377572|4186907|B3|||Missed Number of School Days (Previous 2 Weeks)|The number of school days missed reported by the participant’s caretaker was available for 339 of the 419 (81%) study participants. Of the 339, 164 were enrolled in the Omalizumab (Xolair) + Conventional Therapy arm.|Days|Mean|0.24|0.24|Standard Deviation|0.70|0.7|||
4359387|NCT00377572|4186908|B2|||Missed Number of School Days (Previous 2 Weeks)|The number of school days missed reported by the participant’s caretaker was available for 339 of the 419 (81%) study participants. Of the 339, 164 were enrolled in the Omalizumab (Xolair) + Conventional Therapy arm.|Days|Mean|0.25|0.25|Standard Deviation|0.63|0.63|||
4359388|NCT00377572|4186909|B1|||Missed Number of School Days (Previous 2 Weeks)|The number of school days missed reported by the participant’s caretaker was available for 339 of the 419 (81%) study participants. Of the 339, 164 were enrolled in the Omalizumab (Xolair) + Conventional Therapy arm.|Days|Mean|0.23|0.23|Standard Deviation|0.76|0.76|||
4359389|NCT00377572|4186907|B3|||Maximum Number of Asthma Symptom Days (Previous 2 Weeks)|Maximum symptom days was calculated as the largest of the following variables at the baseline visit: number of days with wheezing, chest tightness, or cough; number of nights of sleep disturbance; and number of days when activities were affected. This symptom scale ranges from 0 to 14 days per a 2-week look-back period. A higher score reflected a greater number of asthma symptoms.|Days|Mean|3.0|3.0|Standard Deviation|3.5|3.5|||
4359390|NCT00377572|4186908|B2|||Maximum Number of Asthma Symptom Days (Previous 2 Weeks)|Maximum symptom days was calculated as the largest of the following variables at the baseline visit: number of days with wheezing, chest tightness, or cough; number of nights of sleep disturbance; and number of days when activities were affected. This symptom scale ranges from 0 to 14 days per a 2-week look-back period. A higher score reflected a greater number of asthma symptoms.|Days|Mean|3.1|3.1|Standard Deviation|3.6|3.6|||
4359391|NCT00377572|4186909|B1|||Maximum Number of Asthma Symptom Days (Previous 2 Weeks)|Maximum symptom days was calculated as the largest of the following variables at the baseline visit: number of days with wheezing, chest tightness, or cough; number of nights of sleep disturbance; and number of days when activities were affected. This symptom scale ranges from 0 to 14 days per a 2-week look-back period. A higher score reflected a greater number of asthma symptoms.|Days|Mean|3.0|3.0|Standard Deviation|3.5|3.5|||
4359392|NCT00377572|4186907|B3|||Asthma Control Test (ACT) Score|The Asthma Control Test (ACT) is a validated tool to assess asthma control (over the last 4 weeks) in patients >= 12 yrs old. It is comprised of 5 questions assessing symptoms, use of rescue medications, and the impact of asthma on everyday functioning. All questions are scored on a 5-point Likert scale (higher score indicating better control). Total scores can range from 5-25. A score of <= 19 is indicative of not well-controlled asthma. The minimally important difference is 3 points. Scores were available for 166 of 419 participants (85 from the Omalizumab + Conventional Therapy arm).|ACT score|Mean|20.3|20.3|Standard Deviation|3.5|3.5|||
4359393|NCT00377572|4186908|B2|||Asthma Control Test (ACT) Score|The Asthma Control Test (ACT) is a validated tool to assess asthma control (over the last 4 weeks) in patients >= 12 yrs old. It is comprised of 5 questions assessing symptoms, use of rescue medications, and the impact of asthma on everyday functioning. All questions are scored on a 5-point Likert scale (higher score indicating better control). Total scores can range from 5-25. A score of <= 19 is indicative of not well-controlled asthma. The minimally important difference is 3 points. Scores were available for 166 of 419 participants (85 from the Omalizumab + Conventional Therapy arm).|ACT score|Mean|20.3|20.3|Standard Deviation|3.1|3.1|||
4359394|NCT00377572|4186909|B1|||Asthma Control Test (ACT) Score|The Asthma Control Test (ACT) is a validated tool to assess asthma control (over the last 4 weeks) in patients >= 12 yrs old. It is comprised of 5 questions assessing symptoms, use of rescue medications, and the impact of asthma on everyday functioning. All questions are scored on a 5-point Likert scale (higher score indicating better control). Total scores can range from 5-25. A score of <= 19 is indicative of not well-controlled asthma. The minimally important difference is 3 points. Scores were available for 166 of 419 participants (85 from the Omalizumab + Conventional Therapy arm).|ACT score|Mean|20.3|20.3|Standard Deviation|3.8|3.8|||
4359395|NCT00377572|4186907|B3|||Childhood Asthma Control Test (C-ACT) Score|The Childhood Asthma Control Test (C-ACT) is a validated tool to assess overall asthma control (over the last 4 weeks) in patients ages 4 to 11 years. Scores can range from 0 to 27. A score of 19 or less is indicative of asthma that is not well controlled. The minimally important difference in C-ACT scores is not defined. C-ACT scores were available and relevant for 253 of 419 (60%) study participants. Of the 253, 123 were from the Omalizumab (Xolair) + Conventional Therapy arm.|C-ACT score|Mean|20.6|20.6|Standard Deviation|3.8|3.8|||
4359396|NCT00377572|4186908|B2|||Childhood Asthma Control Test (C-ACT) Score|The Childhood Asthma Control Test (C-ACT) is a validated tool to assess overall asthma control (over the last 4 weeks) in patients ages 4 to 11 years. Scores can range from 0 to 27. A score of 19 or less is indicative of asthma that is not well controlled. The minimally important difference in C-ACT scores is not defined. C-ACT scores were available and relevant for 253 of 419 (60%) study participants. Of the 253, 123 were from the Omalizumab (Xolair) + Conventional Therapy arm.|C-ACT score|Mean|20.7|20.7|Standard Deviation|3.9|3.9|||
4359442|NCT00377429|4186961|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4359398|NCT00377572|4186907|B3|||Duration of Asthma at Baseline|Asthma duration is the number of years since the participant was told by a physician that he/she has asthma, based upon the caretaker’s response as reported at the baseline visit. This data was available for 332 of 419 (79%) study participants. Of the 332, 169 were from the Omalizumab (Xolair) + Conventional Therapy arm.|Years|Mean|7.3|7.3|Standard Deviation|3.9|3.9|||
4359399|NCT00377572|4186908|B2|||Duration of Asthma at Baseline|Asthma duration is the number of years since the participant was told by a physician that he/she has asthma, based upon the caretaker’s response as reported at the baseline visit. This data was available for 332 of 419 (79%) study participants. Of the 332, 169 were from the Omalizumab (Xolair) + Conventional Therapy arm.|Years|Mean|7.0|7.0|Standard Deviation|3.8|3.8|||
4359400|NCT00377572|4186909|B1|||Duration of Asthma at Baseline|Asthma duration is the number of years since the participant was told by a physician that he/she has asthma, based upon the caretaker’s response as reported at the baseline visit. This data was available for 332 of 419 (79%) study participants. Of the 332, 169 were from the Omalizumab (Xolair) + Conventional Therapy arm.|Years|Mean|7.5|7.5|Standard Deviation|4.0|4.0|||
4359401|NCT00377572|4186907|B3|United States||Region of Enrollment||participants|Number|419|419.0||||||
4359402|NCT00377572|4186908|B2|United States||Region of Enrollment||participants|Number|211|211.0||||||
4359403|NCT00377572|4186909|B1|United States||Region of Enrollment||participants|Number|208|208.0||||||
4359404|NCT00377572|4186907|B3||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4359405|NCT00377572|4186908|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4359406|NCT00377572|4186909|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4359407|NCT00377572|4186907|B3||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4359408|NCT00377572|4186908|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4359409|NCT00377572|4186909|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4359410|NCT00377572|4186907|B3|||Age||years|Mean|10.8|10.8|Standard Deviation|3.5|3.5|||
4359411|NCT00377572|4186908|B2|||Age||years|Mean|10.8|10.8|Standard Deviation|3.4|3.4|||
4359412|NCT00377572|4186909|B1|||Age||years|Mean|10.9|10.9|Standard Deviation|3.6|3.6|||
4359413|NCT00377520|4186948|B1|No Prior Radiotherapy||Prior Treatment|Participants could have more than one type of prior treatment (radiotherapy and/or chemotherapy).|participants|Number|14|14.0||||||
4359414|NCT00377520|4186948|B1|Prior Radiotherapy||Prior Treatment|Participants could have more than one type of prior treatment (radiotherapy and/or chemotherapy).|participants|Number|12|12.0||||||
4359415|NCT00377520|4186948|B1|No Prior Chemotherapy||Prior Treatment|Participants could have more than one type of prior treatment (radiotherapy and/or chemotherapy).|participants|Number|0|0.0||||||
4359416|NCT00377520|4186948|B1|Prior Chemotherapy||Prior Treatment|Participants could have more than one type of prior treatment (radiotherapy and/or chemotherapy).|participants|Number|26|26.0||||||
4359417|NCT00377520|4186948|B1|1 - Ambulatory, Restricted Strenuous Activity||Gynecologic Oncology Group (GOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|12|12.0||||||
4359418|NCT00377520|4186948|B1|0 - Fully active||Gynecologic Oncology Group (GOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|14|14.0||||||
4359419|NCT00377520|4186948|B1|G3 - Poorly Differentiated||Grade (Histology)|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|13|13.0||||||
4359420|NCT00377520|4186948|B1|G2 - Moderately Differentiated||Grade (Histology)|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|8|8.0||||||
4359421|NCT00377520|4186948|B1|G1 - Well-Differentiated||Grade (Histology)|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|5|5.0||||||
4359422|NCT00377520|4186948|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4359423|NCT00377520|4186948|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4359424|NCT00377520|4186948|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4359425|NCT00377520|4186948|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4359426|NCT00377520|4186948|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359427|NCT00377520|4186948|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4359428|NCT00377520|4186948|B1|>69 years||Age, Customized||participants|Number|7|7.0||||||
4359429|NCT00377520|4186948|B1|60-69 years||Age, Customized||participants|Number|10|10.0||||||
4359430|NCT00377520|4186948|B1|50-59 years||Age, Customized||participants|Number|6|6.0||||||
4359431|NCT00377520|4186948|B1|40-49 years||Age, Customized||participants|Number|3|3.0||||||
4359432|NCT00377455|4186953|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359433|NCT00377455|4186953|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4359434|NCT00377455|4186953|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359435|NCT00377455|4186953|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4359436|NCT00377455|4186953|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359437|NCT00377429|4186961|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4359438|NCT00377429|4186961|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359439|NCT00377429|4186961|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4359440|NCT00377429|4186961|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|9.36|9.36|||
4359441|NCT00377429|4186961|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4359443|NCT00377429|4186961|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359444|NCT00377403|4186970|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4359445|NCT00377403|4186971|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4359446|NCT00377403|4186972|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4359447|NCT00377403|4186970|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4359448|NCT00377403|4186971|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4359449|NCT00377403|4186972|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4359450|NCT00377403|4186970|B3|||Age||years|Median|32|32.0|Full Range|||18.0|69.0|
4359451|NCT00377403|4186971|B2|||Age||years|Median|31|31.0|Full Range|||18.0|66.0|
4359452|NCT00377403|4186972|B1|||Age||years|Median|32|32.0|Full Range|||18.0|69.0|
4359453|NCT00377364|4186979|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4359454|NCT00377364|4186980|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4359455|NCT00377364|4186981|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4359456|NCT00377364|4186979|B3||Unknown or Not Reported|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|4|4.0||||||
4359457|NCT00377364|4186980|B2||Unknown or Not Reported|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|3|3.0||||||
4359458|NCT00377364|4186981|B1||Unknown or Not Reported|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|1|1.0||||||
4359459|NCT00377364|4186979|B3||More than one race|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|0|0.0||||||
4359460|NCT00377364|4186980|B2||More than one race|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|0|0.0||||||
4359461|NCT00377364|4186981|B1||More than one race|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|0|0.0||||||
4359462|NCT00377364|4186979|B3||White|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|7|7.0||||||
4359463|NCT00377364|4186980|B2||White|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|3|3.0||||||
4359464|NCT00377364|4186981|B1||White|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|4|4.0||||||
4359465|NCT00377364|4186979|B3||Black or African American|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|18|18.0||||||
4359466|NCT00377364|4186980|B2||Black or African American|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|8|8.0||||||
4359467|NCT00377364|4186981|B1||Black or African American|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|10|10.0||||||
4359468|NCT00377364|4186979|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|0|0.0||||||
4359469|NCT00377364|4186980|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|0|0.0||||||
4359470|NCT00377364|4186981|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|0|0.0||||||
4359471|NCT00377364|4186979|B3||Asian|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|0|0.0||||||
4359472|NCT00377364|4186980|B2||Asian|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|0|0.0||||||
4359473|NCT00377364|4186981|B1||Asian|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|0|0.0||||||
4359474|NCT00377364|4186979|B3||American Indian or Alaska Native|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|1|1.0||||||
4359475|NCT00377364|4186980|B2||American Indian or Alaska Native|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|0|0.0||||||
4359476|NCT00377364|4186981|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race as self reported by participants|Participants|Count of Participants|1|1.0||||||
4359477|NCT00377364|4186979|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4359478|NCT00377364|4186980|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4359479|NCT00377364|4186981|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4359480|NCT00377364|4186979|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4359481|NCT00377364|4186980|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4359482|NCT00377364|4186981|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4359483|NCT00377364|4186979|B3|||Age||years|Mean|43.3|43.3|Standard Deviation|11.3|11.3|||
4359484|NCT00377364|4186980|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|11.6|11.6|||
4359485|NCT00377364|4186981|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|10.4|10.4|||
4359486|NCT00377312|4187006|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4359487|NCT00377312|4187007|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4359488|NCT00377312|4187008|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4359489|NCT00377312|4187006|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4359490|NCT00377312|4187007|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4359491|NCT00377312|4187008|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4359492|NCT00377312|4187006|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359493|NCT00377312|4187007|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359494|NCT00377312|4187008|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359495|NCT00377312|4187006|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4359496|NCT00377312|4187007|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4359497|NCT00377312|4187008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4359498|NCT00377312|4187006|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359499|NCT00377312|4187007|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359500|NCT00377312|4187008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359501|NCT00377299|4187039|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4359502|NCT00377299|4187040|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4359503|NCT00377299|4187041|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4359504|NCT00377299|4187039|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4359505|NCT00377299|4187040|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4359506|NCT00377299|4187041|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4359507|NCT00377299|4187039|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359508|NCT00377299|4187040|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359509|NCT00377299|4187041|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359510|NCT00377299|4187039|B3||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4359511|NCT00377299|4187040|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4359512|NCT00377299|4187041|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4359513|NCT00377299|4187039|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359514|NCT00377299|4187040|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359515|NCT00377299|4187041|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359516|NCT00377299|4187039|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359517|NCT00377299|4187040|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359518|NCT00377299|4187041|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359519|NCT00377299|4187039|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359520|NCT00377299|4187040|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359521|NCT00377299|4187041|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359522|NCT00377299|4187039|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4359523|NCT00377299|4187040|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4359524|NCT00377299|4187041|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359525|NCT00377299|4187039|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4359526|NCT00377299|4187040|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4359527|NCT00377299|4187041|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4359528|NCT00377299|4187039|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4359529|NCT00377299|4187040|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4359530|NCT00377299|4187041|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4359531|NCT00377299|4187039|B3|||Age||years|Mean|37.8|37.8|Standard Deviation|9.3|9.3|||
4359532|NCT00377299|4187040|B2|||Age||years|Mean|34.0|34.0|Standard Deviation|7.4|7.4|||
4359533|NCT00377299|4187041|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|9.6|9.6|||
4359534|NCT00377260|4187056|B3|||Mean score of AOM-SOS|"This is the mean score for each arm. Parents completed the Acute Otitis Media -Severity of Symptoms (AOM-SOS) scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|AOM-SOS score|Mean|7.80|7.8|Standard Deviation|2.86|2.86|||
4359535|NCT00377260|4187057|B2|||Mean score of AOM-SOS|"This is the mean score for each arm. Parents completed the Acute Otitis Media -Severity of Symptoms (AOM-SOS) scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|AOM-SOS score|Mean|7.90|7.9|Standard Deviation|2.87|2.87|||
4359536|NCT00377260|4187058|B1|||Mean score of AOM-SOS|"This is the mean score for each arm. Parents completed the Acute Otitis Media -Severity of Symptoms (AOM-SOS) scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|AOM-SOS score|Mean|7.69|7.69|Standard Deviation|2.85|2.85|||
4359537|NCT00377260|4187056|B3|Left ear||Mean Estimated Probability of Middle Ear Effusion|For tympanograms with values for height, middle-ear air pressure, and gradient width, the probability of Middle Ear Effusion (MEE) was estimated by applying an algorithm developed by Smith et al. If the tympanogram was flat and had no printed values for the 3 fields, the probability of MEE was estimated to be .802 based on the proportion of ears with flat graphs that were found otoscopically, by Smith et al, to have MEE.|probability of effusion|Mean|.40|0.4|Standard Deviation|.30|0.3|||
4359573|NCT00377260|4187056|B3|College graduate||Maternal Education|Parents were asked about the highest level of maternal education.|participants|Number|65|65.0||||||
4359688|NCT00376961|4187147|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4359538|NCT00377260|4187057|B2|Left ear||Mean Estimated Probability of Middle Ear Effusion|For tympanograms with values for height, middle-ear air pressure, and gradient width, the probability of Middle Ear Effusion (MEE) was estimated by applying an algorithm developed by Smith et al. If the tympanogram was flat and had no printed values for the 3 fields, the probability of MEE was estimated to be .802 based on the proportion of ears with flat graphs that were found otoscopically, by Smith et al, to have MEE.|probability of effusion|Mean|.44|0.44|Standard Deviation|.29|0.29|||
4359539|NCT00377260|4187058|B1|Left ear||Mean Estimated Probability of Middle Ear Effusion|For tympanograms with values for height, middle-ear air pressure, and gradient width, the probability of Middle Ear Effusion (MEE) was estimated by applying an algorithm developed by Smith et al. If the tympanogram was flat and had no printed values for the 3 fields, the probability of MEE was estimated to be .802 based on the proportion of ears with flat graphs that were found otoscopically, by Smith et al, to have MEE.|probability of effusion|Mean|.35|0.35|Standard Deviation|.30|0.3|||
4359540|NCT00377260|4187056|B3|Right ear||Mean Estimated Probability of Middle Ear Effusion|For tympanograms with values for height, middle-ear air pressure, and gradient width, the probability of Middle Ear Effusion (MEE) was estimated by applying an algorithm developed by Smith et al. If the tympanogram was flat and had no printed values for the 3 fields, the probability of MEE was estimated to be .802 based on the proportion of ears with flat graphs that were found otoscopically, by Smith et al, to have MEE.|probability of effusion|Mean|.41|0.41|Standard Deviation|.29|0.29|||
4359541|NCT00377260|4187057|B2|Right ear||Mean Estimated Probability of Middle Ear Effusion|For tympanograms with values for height, middle-ear air pressure, and gradient width, the probability of Middle Ear Effusion (MEE) was estimated by applying an algorithm developed by Smith et al. If the tympanogram was flat and had no printed values for the 3 fields, the probability of MEE was estimated to be .802 based on the proportion of ears with flat graphs that were found otoscopically, by Smith et al, to have MEE.|probability of effusion|Mean|.39|0.39|Standard Deviation|.27|0.27|||
4359542|NCT00377260|4187058|B1|Right ear||Mean Estimated Probability of Middle Ear Effusion|For tympanograms with values for height, middle-ear air pressure, and gradient width, the probability of Middle Ear Effusion (MEE) was estimated by applying an algorithm developed by Smith et al. If the tympanogram was flat and had no printed values for the 3 fields, the probability of MEE was estimated to be .802 based on the proportion of ears with flat graphs that were found otoscopically, by Smith et al, to have MEE.|probability of effusion|Mean|.42|0.42|Standard Deviation|.31|0.31|||
4359543|NCT00377260|4187056|B3|Armstrong Pediatrics (Kittanning, PA)||Study Site|Children's Hospital of Pittsburgh (CHP) is the Primary Care Center of CHP. Armstrong Pediatrics is a large community practice in Kittanning, PA.|participants|Number|61|61.0||||||
4359544|NCT00377260|4187057|B2|Armstrong Pediatrics (Kittanning, PA)||Study Site|Children's Hospital of Pittsburgh (CHP) is the Primary Care Center of CHP. Armstrong Pediatrics is a large community practice in Kittanning, PA.|participants|Number|30|30.0||||||
4359545|NCT00377260|4187058|B1|Armstrong Pediatrics (Kittanning, PA)||Study Site|Children's Hospital of Pittsburgh (CHP) is the Primary Care Center of CHP. Armstrong Pediatrics is a large community practice in Kittanning, PA.|participants|Number|31|31.0||||||
4359546|NCT00377260|4187056|B3|Children's Hospital of Pittsburgh (Pittsburgh, PA)||Study Site|Children's Hospital of Pittsburgh (CHP) is the Primary Care Center of CHP. Armstrong Pediatrics is a large community practice in Kittanning, PA.|participants|Number|230|230.0||||||
4359547|NCT00377260|4187057|B2|Children's Hospital of Pittsburgh (Pittsburgh, PA)||Study Site|Children's Hospital of Pittsburgh (CHP) is the Primary Care Center of CHP. Armstrong Pediatrics is a large community practice in Kittanning, PA.|participants|Number|117|117.0||||||
4359548|NCT00377260|4187058|B1|Children's Hospital of Pittsburgh (Pittsburgh, PA)||Study Site|Children's Hospital of Pittsburgh (CHP) is the Primary Care Center of CHP. Armstrong Pediatrics is a large community practice in Kittanning, PA.|participants|Number|113|113.0||||||
4359549|NCT00377260|4187056|B3|Score of 12-14||Severity of symptoms score|"Parents completed the Acute Otitis-Media-Severity of Symptoms (AOM-SOS)scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|participants|Number|34|34.0||||||
4359550|NCT00377260|4187057|B2|Score of 12-14||Severity of symptoms score|"Parents completed the Acute Otitis-Media-Severity of Symptoms (AOM-SOS)scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|participants|Number|19|19.0||||||
4359551|NCT00377260|4187058|B1|Score of 12-14||Severity of symptoms score|"Parents completed the Acute Otitis-Media-Severity of Symptoms (AOM-SOS)scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|participants|Number|15|15.0||||||
4359552|NCT00377260|4187056|B3|Score of 9-11||Severity of symptoms score|"Parents completed the Acute Otitis-Media-Severity of Symptoms (AOM-SOS)scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|participants|Number|90|90.0||||||
4359553|NCT00377260|4187057|B2|Score of 9-11||Severity of symptoms score|"Parents completed the Acute Otitis-Media-Severity of Symptoms (AOM-SOS)scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|participants|Number|44|44.0||||||
4359554|NCT00377260|4187058|B1|Score of 9-11||Severity of symptoms score|"Parents completed the Acute Otitis-Media-Severity of Symptoms (AOM-SOS)scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|participants|Number|46|46.0||||||
4359555|NCT00377260|4187056|B3|Score of 6-8||Severity of symptoms score|"Parents completed the Acute Otitis-Media-Severity of Symptoms (AOM-SOS)scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|participants|Number|97|97.0||||||
4359556|NCT00377260|4187057|B2|Score of 6-8||Severity of symptoms score|"Parents completed the Acute Otitis-Media-Severity of Symptoms (AOM-SOS)scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|participants|Number|51|51.0||||||
4359557|NCT00377260|4187058|B1|Score of 6-8||Severity of symptoms score|"Parents completed the Acute Otitis-Media-Severity of Symptoms (AOM-SOS)scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|participants|Number|46|46.0||||||
4359558|NCT00377260|4187056|B3|Score of 3-5||Severity of symptoms score|"Parents completed the Acute Otitis-Media-Severity of Symptoms (AOM-SOS)scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|participants|Number|70|70.0||||||
4359559|NCT00377260|4187057|B2|Score of 3-5||Severity of symptoms score|"Parents completed the Acute Otitis-Media-Severity of Symptoms (AOM-SOS)scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|participants|Number|33|33.0||||||
4359560|NCT00377260|4187058|B1|Score of 3-5||Severity of symptoms score|"Parents completed the Acute Otitis-Media-Severity of Symptoms (AOM-SOS)scale prior to their child's ear exam. It's a list of 7 symptoms associated with Acute Otitis-media.~[tugging/rubbing/holding ears; crying more; irritable/fussy; difficulty sleeping; less playful/active; eating less; fever or warm to touch. The parent rates these symptoms as No (0 points), A little (1 point) or A lot (2 points). Children must have at least 3 points to qualify, so the minimum score is 3, the maximum is 14."|participants|Number|37|37.0||||||
4359561|NCT00377260|4187056|B3|Other||Race|Parents were asked what race or races they would use to describe their child. Caucasian and African-American are listed when only one race was given. Other includes other races as well as any who gave more than one race.|participants|Number|40|40.0||||||
4359562|NCT00377260|4187057|B2|Other||Race|Parents were asked what race or races they would use to describe their child. Caucasian and African-American are listed when only one race was given. Other includes other races as well as any who gave more than one race.|participants|Number|24|24.0||||||
4359563|NCT00377260|4187058|B1|Other||Race|Parents were asked what race or races they would use to describe their child. Caucasian and African-American are listed when only one race was given. Other includes other races as well as any who gave more than one race.|participants|Number|16|16.0||||||
4359564|NCT00377260|4187056|B3|African-American||Race|Parents were asked what race or races they would use to describe their child. Caucasian and African-American are listed when only one race was given. Other includes other races as well as any who gave more than one race.|participants|Number|120|120.0||||||
4359565|NCT00377260|4187057|B2|African-American||Race|Parents were asked what race or races they would use to describe their child. Caucasian and African-American are listed when only one race was given. Other includes other races as well as any who gave more than one race.|participants|Number|58|58.0||||||
4359566|NCT00377260|4187058|B1|African-American||Race|Parents were asked what race or races they would use to describe their child. Caucasian and African-American are listed when only one race was given. Other includes other races as well as any who gave more than one race.|participants|Number|62|62.0||||||
4359567|NCT00377260|4187056|B3|Caucasian||Race|Parents were asked what race or races they would use to describe their child. Caucasian and African-American are listed when only one race was given. Other includes other races as well as any who gave more than one race.|participants|Number|131|131.0||||||
4359568|NCT00377260|4187057|B2|Caucasian||Race|Parents were asked what race or races they would use to describe their child. Caucasian and African-American are listed when only one race was given. Other includes other races as well as any who gave more than one race.|participants|Number|65|65.0||||||
4359569|NCT00377260|4187058|B1|Caucasian||Race|Parents were asked what race or races they would use to describe their child. Caucasian and African-American are listed when only one race was given. Other includes other races as well as any who gave more than one race.|participants|Number|66|66.0||||||
4359570|NCT00377260|4187056|B3|Unknown||Maternal Education|Parents were asked about the highest level of maternal education.|participants|Number|1|1.0||||||
4359571|NCT00377260|4187057|B2|Unknown||Maternal Education|Parents were asked about the highest level of maternal education.|participants|Number|1|1.0||||||
4359572|NCT00377260|4187058|B1|Unknown||Maternal Education|Parents were asked about the highest level of maternal education.|participants|Number|0|0.0||||||
4359751|NCT00376935|4187165|B2|||CD4 count||cell/mm^3|Median|155|155.0|Inter-Quartile Range|||126.0|194.0|
4359574|NCT00377260|4187057|B2|College graduate||Maternal Education|Parents were asked about the highest level of maternal education.|participants|Number|35|35.0||||||
4359575|NCT00377260|4187058|B1|College graduate||Maternal Education|Parents were asked about the highest level of maternal education.|participants|Number|30|30.0||||||
4359576|NCT00377260|4187056|B3|High school graduate||Maternal Education|Parents were asked about the highest level of maternal education.|participants|Number|185|185.0||||||
4359577|NCT00377260|4187057|B2|High school graduate||Maternal Education|Parents were asked about the highest level of maternal education.|participants|Number|95|95.0||||||
4359578|NCT00377260|4187058|B1|High school graduate||Maternal Education|Parents were asked about the highest level of maternal education.|participants|Number|90|90.0||||||
4359579|NCT00377260|4187056|B3|Less than high school||Maternal Education|Parents were asked about the highest level of maternal education.|participants|Number|40|40.0||||||
4359580|NCT00377260|4187057|B2|Less than high school||Maternal Education|Parents were asked about the highest level of maternal education.|participants|Number|16|16.0||||||
4359581|NCT00377260|4187058|B1|Less than high school||Maternal Education|Parents were asked about the highest level of maternal education.|participants|Number|24|24.0||||||
4359582|NCT00377260|4187056|B3|Unilateral||Laterality of Acute Otitis Media|Bilateral means that both ears were found to be acute. Unilateral means that only one ear was found to be acute, the other ear could have had middle ear effusion or have been free of middle ear effusion.|participants|Number|139|139.0||||||
4359583|NCT00377260|4187057|B2|Unilateral||Laterality of Acute Otitis Media|Bilateral means that both ears were found to be acute. Unilateral means that only one ear was found to be acute, the other ear could have had middle ear effusion or have been free of middle ear effusion.|participants|Number|70|70.0||||||
4359584|NCT00377260|4187058|B1|Unilateral||Laterality of Acute Otitis Media|Bilateral means that both ears were found to be acute. Unilateral means that only one ear was found to be acute, the other ear could have had middle ear effusion or have been free of middle ear effusion.|participants|Number|69|69.0||||||
4359585|NCT00377260|4187056|B3|Bilateral||Laterality of Acute Otitis Media|Bilateral means that both ears were found to be acute. Unilateral means that only one ear was found to be acute, the other ear could have had middle ear effusion or have been free of middle ear effusion.|participants|Number|152|152.0||||||
4359586|NCT00377260|4187057|B2|Bilateral||Laterality of Acute Otitis Media|Bilateral means that both ears were found to be acute. Unilateral means that only one ear was found to be acute, the other ear could have had middle ear effusion or have been free of middle ear effusion.|participants|Number|77|77.0||||||
4359587|NCT00377260|4187058|B1|Bilateral||Laterality of Acute Otitis Media|Bilateral means that both ears were found to be acute. Unilateral means that only one ear was found to be acute, the other ear could have had middle ear effusion or have been free of middle ear effusion.|participants|Number|75|75.0||||||
4359588|NCT00377260|4187056|B3|No||History of recurrent acute otitis media|"Records were obtained and reviewed for a history of recurrent acute otitis media.~Yes indicates that the child had a documented history of at least 3 acute otitis media episodes in the past 6 months or at least 4 episodes in the past year.~No indicates that the child did not meet the criteria for Yes."|participants|Number|241|241.0||||||
4359589|NCT00377260|4187057|B2|No||History of recurrent acute otitis media|"Records were obtained and reviewed for a history of recurrent acute otitis media.~Yes indicates that the child had a documented history of at least 3 acute otitis media episodes in the past 6 months or at least 4 episodes in the past year.~No indicates that the child did not meet the criteria for Yes."|participants|Number|118|118.0||||||
4359590|NCT00377260|4187058|B1|No||History of recurrent acute otitis media|"Records were obtained and reviewed for a history of recurrent acute otitis media.~Yes indicates that the child had a documented history of at least 3 acute otitis media episodes in the past 6 months or at least 4 episodes in the past year.~No indicates that the child did not meet the criteria for Yes."|participants|Number|123|123.0||||||
4359591|NCT00377260|4187056|B3|Yes||History of recurrent acute otitis media|"Records were obtained and reviewed for a history of recurrent acute otitis media.~Yes indicates that the child had a documented history of at least 3 acute otitis media episodes in the past 6 months or at least 4 episodes in the past year.~No indicates that the child did not meet the criteria for Yes."|participants|Number|50|50.0||||||
4359592|NCT00377260|4187057|B2|Yes||History of recurrent acute otitis media|"Records were obtained and reviewed for a history of recurrent acute otitis media.~Yes indicates that the child had a documented history of at least 3 acute otitis media episodes in the past 6 months or at least 4 episodes in the past year.~No indicates that the child did not meet the criteria for Yes."|participants|Number|29|29.0||||||
4359593|NCT00377260|4187058|B1|Yes||History of recurrent acute otitis media|"Records were obtained and reviewed for a history of recurrent acute otitis media.~Yes indicates that the child had a documented history of at least 3 acute otitis media episodes in the past 6 months or at least 4 episodes in the past year.~No indicates that the child did not meet the criteria for Yes."|participants|Number|21|21.0||||||
4359594|NCT00377260|4187056|B3|None||Health insurance status|Parents were asked the child's health insurance status|participants|Number|5|5.0||||||
4359595|NCT00377260|4187057|B2|None||Health insurance status|Parents were asked the child's health insurance status|participants|Number|2|2.0||||||
4359596|NCT00377260|4187058|B1|None||Health insurance status|Parents were asked the child's health insurance status|participants|Number|3|3.0||||||
4359597|NCT00377260|4187056|B3|Medicaid||Health insurance status|Parents were asked the child's health insurance status|participants|Number|201|201.0||||||
4359598|NCT00377260|4187057|B2|Medicaid||Health insurance status|Parents were asked the child's health insurance status|participants|Number|103|103.0||||||
4359599|NCT00377260|4187058|B1|Medicaid||Health insurance status|Parents were asked the child's health insurance status|participants|Number|98|98.0||||||
4359600|NCT00377260|4187056|B3|Private||Health insurance status|Parents were asked the child's health insurance status|participants|Number|85|85.0||||||
4359601|NCT00377260|4187057|B2|Private||Health insurance status|Parents were asked the child's health insurance status|participants|Number|42|42.0||||||
4359602|NCT00377260|4187058|B1|Private||Health insurance status|Parents were asked the child's health insurance status|participants|Number|43|43.0||||||
4359752|NCT00376935|4187166|B1|||CD4 count||cell/mm^3|Median|147|147.0|Inter-Quartile Range|||110.0|180.0|
4359603|NCT00377260|4187056|B3|Not exposed||Exposed to other children|"Exposed to other children is defined as a child being exposed to 3 or more children, including siblings, for at least 10 hours per week.~Not exposed is defined as any child who does not meet this criteria."|participants|Number|150|150.0||||||
4359604|NCT00377260|4187057|B2|Not exposed||Exposed to other children|"Exposed to other children is defined as a child being exposed to 3 or more children, including siblings, for at least 10 hours per week.~Not exposed is defined as any child who does not meet this criteria."|participants|Number|75|75.0||||||
4359605|NCT00377260|4187058|B1|Not exposed||Exposed to other children|"Exposed to other children is defined as a child being exposed to 3 or more children, including siblings, for at least 10 hours per week.~Not exposed is defined as any child who does not meet this criteria."|participants|Number|75|75.0||||||
4359606|NCT00377260|4187056|B3|Exposed||Exposed to other children|"Exposed to other children is defined as a child being exposed to 3 or more children, including siblings, for at least 10 hours per week.~Not exposed is defined as any child who does not meet this criteria."|participants|Number|141|141.0||||||
4359607|NCT00377260|4187057|B2|Exposed||Exposed to other children|"Exposed to other children is defined as a child being exposed to 3 or more children, including siblings, for at least 10 hours per week.~Not exposed is defined as any child who does not meet this criteria."|participants|Number|72|72.0||||||
4359608|NCT00377260|4187058|B1|Exposed||Exposed to other children|"Exposed to other children is defined as a child being exposed to 3 or more children, including siblings, for at least 10 hours per week.~Not exposed is defined as any child who does not meet this criteria."|participants|Number|69|69.0||||||
4359609|NCT00377260|4187056|B3|Non-Hispanic||Ethnicity|Parents were asked if their child is Hispanic.|participants|Number|251|251.0||||||
4359610|NCT00377260|4187057|B2|Non-Hispanic||Ethnicity|Parents were asked if their child is Hispanic.|participants|Number|128|128.0||||||
4359611|NCT00377260|4187058|B1|Non-Hispanic||Ethnicity|Parents were asked if their child is Hispanic.|participants|Number|123|123.0||||||
4359612|NCT00377260|4187056|B3|Hispanic||Ethnicity|Parents were asked if their child is Hispanic.|participants|Number|40|40.0||||||
4359613|NCT00377260|4187057|B2|Hispanic||Ethnicity|Parents were asked if their child is Hispanic.|participants|Number|19|19.0||||||
4359614|NCT00377260|4187058|B1|Hispanic||Ethnicity|Parents were asked if their child is Hispanic.|participants|Number|21|21.0||||||
4359615|NCT00377260|4187056|B3|Marked||Degree of tympanic membrane bulging|The degree of bulging for the ear with the greater level of bulging at entry is summarized. The otoscopists rated this as slight bulging, moderate bulging or marked bulging. The otoscopists have all been validated for inter-observer reliability.|participants|Number|77|77.0||||||
4359616|NCT00377260|4187057|B2|Marked||Degree of tympanic membrane bulging|The degree of bulging for the ear with the greater level of bulging at entry is summarized. The otoscopists rated this as slight bulging, moderate bulging or marked bulging. The otoscopists have all been validated for inter-observer reliability.|participants|Number|38|38.0||||||
4359617|NCT00377260|4187058|B1|Marked||Degree of tympanic membrane bulging|The degree of bulging for the ear with the greater level of bulging at entry is summarized. The otoscopists rated this as slight bulging, moderate bulging or marked bulging. The otoscopists have all been validated for inter-observer reliability.|participants|Number|39|39.0||||||
4359618|NCT00377260|4187056|B3|Moderate||Degree of tympanic membrane bulging|The degree of bulging for the ear with the greater level of bulging at entry is summarized. The otoscopists rated this as slight bulging, moderate bulging or marked bulging. The otoscopists have all been validated for inter-observer reliability.|participants|Number|133|133.0||||||
4359619|NCT00377260|4187057|B2|Moderate||Degree of tympanic membrane bulging|The degree of bulging for the ear with the greater level of bulging at entry is summarized. The otoscopists rated this as slight bulging, moderate bulging or marked bulging. The otoscopists have all been validated for inter-observer reliability.|participants|Number|70|70.0||||||
4359620|NCT00377260|4187058|B1|Moderate||Degree of tympanic membrane bulging|The degree of bulging for the ear with the greater level of bulging at entry is summarized. The otoscopists rated this as slight bulging, moderate bulging or marked bulging. The otoscopists have all been validated for inter-observer reliability.|participants|Number|63|63.0||||||
4359621|NCT00377260|4187056|B3|Slight||Degree of tympanic membrane bulging|The degree of bulging for the ear with the greater level of bulging at entry is summarized. The otoscopists rated this as slight bulging, moderate bulging or marked bulging. The otoscopists have all been validated for inter-observer reliability.|participants|Number|81|81.0||||||
4359622|NCT00377260|4187057|B2|Slight||Degree of tympanic membrane bulging|The degree of bulging for the ear with the greater level of bulging at entry is summarized. The otoscopists rated this as slight bulging, moderate bulging or marked bulging. The otoscopists have all been validated for inter-observer reliability.|participants|Number|39|39.0||||||
4359623|NCT00377260|4187058|B1|Slight||Degree of tympanic membrane bulging|The degree of bulging for the ear with the greater level of bulging at entry is summarized. The otoscopists rated this as slight bulging, moderate bulging or marked bulging. The otoscopists have all been validated for inter-observer reliability.|participants|Number|42|42.0||||||
4359624|NCT00377260|4187056|B3|No culture result||Colonization With AOM Pathogens|AOM pathogens refer to Streptococcus Pneumoniae, Haemophilus Influenzae, Moraxella Catarrhalis or Streptococcus Pyogenes|participants|Number|9|9.0||||||
4359625|NCT00377260|4187057|B2|No culture result||Colonization With AOM Pathogens|AOM pathogens refer to Streptococcus Pneumoniae, Haemophilus Influenzae, Moraxella Catarrhalis or Streptococcus Pyogenes|participants|Number|4|4.0||||||
4359626|NCT00377260|4187058|B1|No culture result||Colonization With AOM Pathogens|AOM pathogens refer to Streptococcus Pneumoniae, Haemophilus Influenzae, Moraxella Catarrhalis or Streptococcus Pyogenes|participants|Number|5|5.0||||||
4359627|NCT00377260|4187056|B3|Absence of any AOM pathogen||Colonization With AOM Pathogens|AOM pathogens refer to Streptococcus Pneumoniae, Haemophilus Influenzae, Moraxella Catarrhalis or Streptococcus Pyogenes|participants|Number|40|40.0||||||
4359628|NCT00377260|4187057|B2|Absence of any AOM pathogen||Colonization With AOM Pathogens|AOM pathogens refer to Streptococcus Pneumoniae, Haemophilus Influenzae, Moraxella Catarrhalis or Streptococcus Pyogenes|participants|Number|24|24.0||||||
4359629|NCT00377260|4187058|B1|Absence of any AOM pathogen||Colonization With AOM Pathogens|AOM pathogens refer to Streptococcus Pneumoniae, Haemophilus Influenzae, Moraxella Catarrhalis or Streptococcus Pyogenes|participants|Number|16|16.0||||||
4359630|NCT00377260|4187056|B3|Presence of at least one AOM pathogen||Colonization With AOM Pathogens|AOM pathogens refer to Streptococcus Pneumoniae, Haemophilus Influenzae, Moraxella Catarrhalis or Streptococcus Pyogenes|participants|Number|242|242.0||||||
4359631|NCT00377260|4187057|B2|Presence of at least one AOM pathogen||Colonization With AOM Pathogens|AOM pathogens refer to Streptococcus Pneumoniae, Haemophilus Influenzae, Moraxella Catarrhalis or Streptococcus Pyogenes|participants|Number|119|119.0||||||
4359632|NCT00377260|4187058|B1|Presence of at least one AOM pathogen||Colonization With AOM Pathogens|AOM pathogens refer to Streptococcus Pneumoniae, Haemophilus Influenzae, Moraxella Catarrhalis or Streptococcus Pyogenes|participants|Number|123|123.0||||||
4359633|NCT00377260|4187056|B3||Male|Gender||Participants|Count of Participants|155|155.0||||||
4359634|NCT00377260|4187057|B2||Male|Gender||Participants|Count of Participants|80|80.0||||||
4359635|NCT00377260|4187058|B1||Male|Gender||Participants|Count of Participants|75|75.0||||||
4359636|NCT00377260|4187056|B3||Female|Gender||Participants|Count of Participants|136|136.0||||||
4359637|NCT00377260|4187057|B2||Female|Gender||Participants|Count of Participants|67|67.0||||||
4359638|NCT00377260|4187058|B1||Female|Gender||Participants|Count of Participants|69|69.0||||||
4359639|NCT00377260|4187056|B3|18-23 months||Age, Customized||participants|Number|53|53.0||||||
4359640|NCT00377260|4187057|B2|18-23 months||Age, Customized||participants|Number|27|27.0||||||
4359641|NCT00377260|4187058|B1|18-23 months||Age, Customized||participants|Number|26|26.0||||||
4359642|NCT00377260|4187056|B3|12-17 months||Age, Customized||participants|Number|77|77.0||||||
4359643|NCT00377260|4187057|B2|12-17 months||Age, Customized||participants|Number|42|42.0||||||
4359644|NCT00377260|4187058|B1|12-17 months||Age, Customized||participants|Number|35|35.0||||||
4359645|NCT00377260|4187056|B3|6-11 months||Age, Customized||participants|Number|161|161.0||||||
4359646|NCT00377260|4187057|B2|6-11 months||Age, Customized||participants|Number|78|78.0||||||
4359647|NCT00377260|4187058|B1|6-11 months||Age, Customized||participants|Number|83|83.0||||||
4359648|NCT00377234|4187111|B3|United States||Region of Enrollment||participants|Number|351|351.0||||||
4359649|NCT00377234|4187112|B2|United States||Region of Enrollment||participants|Number|174|174.0||||||
4359650|NCT00377234|4187113|B1|United States||Region of Enrollment||participants|Number|177|177.0||||||
4359651|NCT00377234|4187111|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359652|NCT00377234|4187112|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359653|NCT00377234|4187113|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359654|NCT00377234|4187111|B3||Female|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4359655|NCT00377234|4187112|B2||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4359656|NCT00377234|4187113|B1||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4359657|NCT00377234|4187111|B3|||Age||Years|Mean|64.3|64.3|Standard Deviation|6.9|6.9|||
4359658|NCT00377234|4187112|B2|||Age||Years|Mean|64.0|64.0|Standard Deviation|6.7|6.7|||
4359659|NCT00377234|4187113|B1|||Age||Years|Mean|64.6|64.6|Standard Deviation|7.0|7.0|||
4359660|NCT00377156|4187130|B3|United States||Region of Enrollment||participants|Number|168|168.0||||||
4359661|NCT00377156|4187131|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
4359662|NCT00377156|4187132|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
4359663|NCT00377156|4187130|B3|Canada||Region of Enrollment||participants|Number|45|45.0||||||
4359664|NCT00377156|4187131|B2|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4359665|NCT00377156|4187132|B1|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4359666|NCT00377156|4187130|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4359667|NCT00377156|4187131|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4359668|NCT00377156|4187132|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4359669|NCT00377156|4187130|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4359670|NCT00377156|4187131|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4359671|NCT00377156|4187132|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4359672|NCT00377156|4187130|B3|>= 60||Age, Customized||Participants|Count of Participants|116|116.0||||||
4359673|NCT00377156|4187131|B2|>= 60||Age, Customized||Participants|Count of Participants|58|58.0||||||
4359674|NCT00377156|4187132|B1|>= 60||Age, Customized||Participants|Count of Participants|58|58.0||||||
4359675|NCT00377156|4187130|B3|18 to 59||Age, Customized||Participants|Count of Participants|97|97.0||||||
4359676|NCT00377156|4187131|B2|18 to 59||Age, Customized||Participants|Count of Participants|44|44.0||||||
4359677|NCT00377156|4187132|B1|18 to 59||Age, Customized||Participants|Count of Participants|53|53.0||||||
4359678|NCT00377156|4187130|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|10.5|10.5|||
4359679|NCT00377156|4187131|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|10.6|10.6|||
4359680|NCT00377156|4187132|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|10.4|10.4|||
4359681|NCT00376961|4187147|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359682|NCT00376961|4187147|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359683|NCT00376961|4187147|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4359684|NCT00376961|4187147|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4359685|NCT00376961|4187147|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4359686|NCT00376961|4187147|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4359687|NCT00376961|4187147|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359753|NCT00376935|4187162|B5|Previously||IV drug use||participants|Number|18|18.0||||||
4359689|NCT00376961|4187147|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4359690|NCT00376961|4187147|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4359691|NCT00376961|4187147|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4359692|NCT00376961|4187147|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4359693|NCT00376961|4187147|B1|||Age||years|Median|61|61.0|Full Range|||36.5|85.1|
4359694|NCT00376948|4187157|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4359695|NCT00376948|4187157|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4359696|NCT00376948|4187157|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4359697|NCT00376948|4187157|B1|||Age||years|Median|58.5|58.5|Full Range|||39.0|75.0|
4359698|NCT00376935|4187162|B5|Missing||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359699|NCT00376935|4187163|B4|Missing||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359700|NCT00376935|4187164|B3|Missing||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359701|NCT00376935|4187165|B2|Missing||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359702|NCT00376935|4187166|B1|Missing||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359703|NCT00376935|4187162|B5|= 69440 copies/mL||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359704|NCT00376935|4187163|B4|= 69440 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359705|NCT00376935|4187164|B3|= 69440 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359706|NCT00376935|4187165|B2|= 69440 copies/mL||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359707|NCT00376935|4187166|B1|= 69440 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359708|NCT00376935|4187162|B5|= 97 copies/mL||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359709|NCT00376935|4187163|B4|= 97 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359710|NCT00376935|4187164|B3|= 97 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359711|NCT00376935|4187165|B2|= 97 copies/mL||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359712|NCT00376935|4187166|B1|= 97 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359713|NCT00376935|4187162|B5|= 88 copies/mL||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359714|NCT00376935|4187163|B4|= 88 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359715|NCT00376935|4187164|B3|= 88 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359716|NCT00376935|4187165|B2|= 88 copies/mL||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359717|NCT00376935|4187166|B1|= 88 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359718|NCT00376935|4187162|B5|= 84 copies/mL||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359719|NCT00376935|4187163|B4|= 84 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359720|NCT00376935|4187164|B3|= 84 copies/mL||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359721|NCT00376935|4187165|B2|= 84 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359722|NCT00376935|4187166|B1|= 84 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359723|NCT00376935|4187162|B5|= 81 copies/mL||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359724|NCT00376935|4187163|B4|= 81 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359725|NCT00376935|4187164|B3|= 81 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359726|NCT00376935|4187165|B2|= 81 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359727|NCT00376935|4187166|B1|= 81 copies/mL||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359728|NCT00376935|4187162|B5|= 77 copies/mL||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359729|NCT00376935|4187163|B4|= 77 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359730|NCT00376935|4187164|B3|= 77 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359731|NCT00376935|4187165|B2|= 77 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359732|NCT00376935|4187166|B1|= 77 copies/mL||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359733|NCT00376935|4187162|B5|= 52 copies/mL||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359734|NCT00376935|4187163|B4|= 52 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359735|NCT00376935|4187164|B3|= 52 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359736|NCT00376935|4187165|B2|= 52 copies/mL||HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4359737|NCT00376935|4187166|B1|= 52 copies/mL||HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4359738|NCT00376935|4187162|B5|< 50 copies/mL||HIV-1 RNA Categorical||participants|Number|91|91.0||||||
4359739|NCT00376935|4187163|B4|< 50 copies/mL||HIV-1 RNA Categorical||participants|Number|24|24.0||||||
4359740|NCT00376935|4187164|B3|< 50 copies/mL||HIV-1 RNA Categorical||participants|Number|23|23.0||||||
4359741|NCT00376935|4187165|B2|< 50 copies/mL||HIV-1 RNA Categorical||participants|Number|22|22.0||||||
4359742|NCT00376935|4187166|B1|< 50 copies/mL||HIV-1 RNA Categorical||participants|Number|22|22.0||||||
4359743|NCT00376935|4187162|B5|||CD8 count||cell/mm^3|Median|665|665.0|Inter-Quartile Range|||467.0|954.0|
4359744|NCT00376935|4187163|B4|||CD8 count||cell/mm^3|Median|761|761.0|Inter-Quartile Range|||502.0|1099.0|
4359745|NCT00376935|4187164|B3|||CD8 count||cell/mm^3|Median|716|716.0|Inter-Quartile Range|||575.0|999.0|
4359746|NCT00376935|4187165|B2|||CD8 count||cell/mm^3|Median|615|615.0|Inter-Quartile Range|||464.0|722.0|
4359747|NCT00376935|4187166|B1|||CD8 count||cell/mm^3|Median|638|638.0|Inter-Quartile Range|||394.0|887.0|
4359748|NCT00376935|4187162|B5|||CD4 count||cell/mm^3|Median|153|153.0|Inter-Quartile Range|||116.0|194.0|
4359749|NCT00376935|4187163|B4|||CD4 count||cell/mm^3|Median|152|152.0|Inter-Quartile Range|||112.0|192.0|
4359750|NCT00376935|4187164|B3|||CD4 count||cell/mm^3|Median|156|156.0|Inter-Quartile Range|||116.0|197.0|
4359754|NCT00376935|4187163|B4|Previously||IV drug use||participants|Number|4|4.0||||||
4359755|NCT00376935|4187164|B3|Previously||IV drug use||participants|Number|6|6.0||||||
4359756|NCT00376935|4187165|B2|Previously||IV drug use||participants|Number|3|3.0||||||
4359757|NCT00376935|4187166|B1|Previously||IV drug use||participants|Number|5|5.0||||||
4359758|NCT00376935|4187162|B5|Never||IV drug use||participants|Number|81|81.0||||||
4359759|NCT00376935|4187163|B4|Never||IV drug use||participants|Number|20|20.0||||||
4359760|NCT00376935|4187164|B3|Never||IV drug use||participants|Number|19|19.0||||||
4359761|NCT00376935|4187165|B2|Never||IV drug use||participants|Number|22|22.0||||||
4359762|NCT00376935|4187166|B1|Never||IV drug use||participants|Number|20|20.0||||||
4359763|NCT00376935|4187162|B5|United States||Region of Enrollment||participants|Number|99|99.0||||||
4359764|NCT00376935|4187163|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4359765|NCT00376935|4187164|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4359766|NCT00376935|4187165|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4359767|NCT00376935|4187166|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4359768|NCT00376935|4187162|B5|Missing/ Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4359769|NCT00376935|4187163|B4|Missing/ Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4359770|NCT00376935|4187164|B3|Missing/ Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4359771|NCT00376935|4187165|B2|Missing/ Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4359772|NCT00376935|4187166|B1|Missing/ Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4359773|NCT00376935|4187162|B5|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4359774|NCT00376935|4187163|B4|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4359775|NCT00376935|4187164|B3|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4359776|NCT00376935|4187165|B2|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4359777|NCT00376935|4187166|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4359778|NCT00376935|4187162|B5|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4359779|NCT00376935|4187163|B4|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4359780|NCT00376935|4187164|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4359781|NCT00376935|4187165|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4359782|NCT00376935|4187166|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4359783|NCT00376935|4187162|B5|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4359784|NCT00376935|4187163|B4|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4359785|NCT00376935|4187164|B3|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4359786|NCT00376935|4187165|B2|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4359787|NCT00376935|4187166|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4359788|NCT00376935|4187162|B5|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4359789|NCT00376935|4187163|B4|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4359790|NCT00376935|4187164|B3|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4359791|NCT00376935|4187165|B2|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4359792|NCT00376935|4187166|B1|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4359793|NCT00376935|4187162|B5||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4359794|NCT00376935|4187163|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4359795|NCT00376935|4187164|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4359796|NCT00376935|4187165|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4359797|NCT00376935|4187166|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4359798|NCT00376935|4187162|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4359799|NCT00376935|4187163|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4359800|NCT00376935|4187164|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4359801|NCT00376935|4187165|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4359802|NCT00376935|4187166|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4359803|NCT00376935|4187162|B5|Over 60 years||Age, Customized||participants|Number|16|16.0||||||
4359804|NCT00376935|4187163|B4|Over 60 years||Age, Customized||participants|Number|5|5.0||||||
4359805|NCT00376935|4187164|B3|Over 60 years||Age, Customized||participants|Number|3|3.0||||||
4359806|NCT00376935|4187165|B2|Over 60 years||Age, Customized||participants|Number|4|4.0||||||
4359807|NCT00376935|4187166|B1|Over 60 years||Age, Customized||participants|Number|4|4.0||||||
4359808|NCT00376935|4187162|B5|Between 50 and 59 years||Age, Customized||participants|Number|27|27.0||||||
4359809|NCT00376935|4187163|B4|Between 50 and 59 years||Age, Customized||participants|Number|8|8.0||||||
4359810|NCT00376935|4187164|B3|Between 50 and 59 years||Age, Customized||participants|Number|7|7.0||||||
4359811|NCT00376935|4187165|B2|Between 50 and 59 years||Age, Customized||participants|Number|8|8.0||||||
4359812|NCT00376935|4187166|B1|Between 50 and 59 years||Age, Customized||participants|Number|4|4.0||||||
4359813|NCT00376935|4187162|B5|Between 40 and 49 years||Age, Customized||participants|Number|42|42.0||||||
4359814|NCT00376935|4187163|B4|Between 40 and 49 years||Age, Customized||participants|Number|9|9.0||||||
4359815|NCT00376935|4187164|B3|Between 40 and 49 years||Age, Customized||participants|Number|8|8.0||||||
4359816|NCT00376935|4187165|B2|Between 40 and 49 years||Age, Customized||participants|Number|12|12.0||||||
4359817|NCT00376935|4187166|B1|Between 40 and 49 years||Age, Customized||participants|Number|13|13.0||||||
4359818|NCT00376935|4187162|B5|Between 30 and 39 years||Age, Customized||participants|Number|13|13.0||||||
4359819|NCT00376935|4187163|B4|Between 30 and 39 years||Age, Customized||participants|Number|2|2.0||||||
4359820|NCT00376935|4187164|B3|Between 30 and 39 years||Age, Customized||participants|Number|6|6.0||||||
4359821|NCT00376935|4187165|B2|Between 30 and 39 years||Age, Customized||participants|Number|1|1.0||||||
4359822|NCT00376935|4187166|B1|Between 30 and 39 years||Age, Customized||participants|Number|4|4.0||||||
4359823|NCT00376935|4187162|B5|Between 18 and 29 years||Age, Customized||participants|Number|1|1.0||||||
4359824|NCT00376935|4187163|B4|Between 18 and 29 years||Age, Customized||participants|Number|0|0.0||||||
4359825|NCT00376935|4187164|B3|Between 18 and 29 years||Age, Customized||participants|Number|1|1.0||||||
4359826|NCT00376935|4187165|B2|Between 18 and 29 years||Age, Customized||participants|Number|0|0.0||||||
4359827|NCT00376935|4187166|B1|Between 18 and 29 years||Age, Customized||participants|Number|0|0.0||||||
4359828|NCT00376935|4187162|B5|||Age||years|Median|49|49.0|Inter-Quartile Range|8.9|8.9|42.0|55.0|
4359829|NCT00376935|4187163|B4|||Age||years|Median|50|50.0|Inter-Quartile Range|8.9|8.9|46.0|57.0|
4359830|NCT00376935|4187164|B3|||Age||years|Median|45|45.0|Inter-Quartile Range|9.7|9.7|39.0|54.0|
4359831|NCT00376935|4187165|B2|||Age||years|Median|49|49.0|Inter-Quartile Range|8.8|8.8|43.0|54.0|
4359832|NCT00376935|4187166|B1|||Age||years|Median|47|47.0|Inter-Quartile Range|7.8|7.8|42.0|50.0|
4359833|NCT00376805|4187207|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4359834|NCT00376805|4187207|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359835|NCT00376805|4187207|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4359836|NCT00376805|4187207|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|7.7|7.7|||
4359837|NCT00376805|4187207|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359838|NCT00376805|4187207|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4359839|NCT00376805|4187207|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359840|NCT00376688|4187214|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359841|NCT00376688|4187214|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4359842|NCT00376688|4187214|B1|||Age||years|Median|58|58.0|Full Range|||37.0|79.0|
4359843|NCT00376675|4187218|B3|||Average pain over the last 24 hours|Pain was measured in a scale of 0 to 100 with 0 (poor quality of life or bad symptoms) and 100 (best quality of life or no symptoms).|units on a scale|Mean|86.3|86.3|Standard Deviation|13.20|13.2|||
4359844|NCT00376675|4187219|B2|||Average pain over the last 24 hours|Pain was measured in a scale of 0 to 100 with 0 (poor quality of life or bad symptoms) and 100 (best quality of life or no symptoms).|units on a scale|Mean|86|86.0|Standard Deviation|12.58|12.58|||
4359845|NCT00376675|4187220|B1|||Average pain over the last 24 hours|Pain was measured in a scale of 0 to 100 with 0 (poor quality of life or bad symptoms) and 100 (best quality of life or no symptoms).|units on a scale|Mean|87|87.0|Standard Deviation|13.88|13.88|||
4359846|NCT00376675|4187218|B3|||Average fatigue over the last week|Fatigue was measured in a scale of 0 to 100 with 0 (poor quality of life or bad symptoms) and 100 (best quality of life or no symptoms).|units on a scale|Mean|33.8|33.8|Standard Deviation|16.30|16.3|||
4359847|NCT00376675|4187219|B2|||Average fatigue over the last week|Fatigue was measured in a scale of 0 to 100 with 0 (poor quality of life or bad symptoms) and 100 (best quality of life or no symptoms).|units on a scale|Mean|34.0|34.0|Standard Deviation|17.23|17.23|||
4359848|NCT00376675|4187220|B1|||Average fatigue over the last week|Fatigue was measured in a scale of 0 to 100 with 0 (poor quality of life or bad symptoms) and 100 (best quality of life or no symptoms).|units on a scale|Mean|33.6|33.6|Standard Deviation|15.43|15.43|||
4359849|NCT00376675|4187218|B3|Combination/Unknown/Other||Type of cancer||participants|Number|59|59.0||||||
4359850|NCT00376675|4187219|B2|Combination/Unknown/Other||Type of cancer||participants|Number|32|32.0||||||
4359851|NCT00376675|4187220|B1|Combination/Unknown/Other||Type of cancer||participants|Number|27|27.0||||||
4359852|NCT00376675|4187218|B3|Lung||Type of cancer||participants|Number|18|18.0||||||
4359853|NCT00376675|4187219|B2|Lung||Type of cancer||participants|Number|8|8.0||||||
4359854|NCT00376675|4187220|B1|Lung||Type of cancer||participants|Number|10|10.0||||||
4359855|NCT00376675|4187218|B3|Prostate||Type of cancer||participants|Number|8|8.0||||||
4359856|NCT00376675|4187219|B2|Prostate||Type of cancer||participants|Number|6|6.0||||||
4359857|NCT00376675|4187220|B1|Prostate||Type of cancer||participants|Number|2|2.0||||||
4359858|NCT00376675|4187218|B3|Colon||Type of cancer||participants|Number|8|8.0||||||
4359859|NCT00376675|4187219|B2|Colon||Type of cancer||participants|Number|4|4.0||||||
4359860|NCT00376675|4187220|B1|Colon||Type of cancer||participants|Number|4|4.0||||||
4359861|NCT00376675|4187218|B3|Breast||Type of cancer||participants|Number|46|46.0||||||
4359862|NCT00376675|4187219|B2|Breast||Type of cancer||participants|Number|20|20.0||||||
4359863|NCT00376675|4187220|B1|Breast||Type of cancer||participants|Number|26|26.0||||||
4359864|NCT00376675|4187218|B3|III/IV||Stage|Stage 0: Carcinoma in situ; Stage I, II and III: Higher numbers indicate more extensive disease: larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor; Stage IV: The cancer has spread to distant tissues or organs|participants|Number|95|95.0||||||
4359865|NCT00376675|4187219|B2|III/IV||Stage|Stage 0: Carcinoma in situ; Stage I, II and III: Higher numbers indicate more extensive disease: larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor; Stage IV: The cancer has spread to distant tissues or organs|participants|Number|48|48.0||||||
4359866|NCT00376675|4187220|B1|III/IV||Stage|Stage 0: Carcinoma in situ; Stage I, II and III: Higher numbers indicate more extensive disease: larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor; Stage IV: The cancer has spread to distant tissues or organs|participants|Number|47|47.0||||||
4359867|NCT00376675|4187218|B3|0/I/II||Stage|Stage 0: Carcinoma in situ; Stage I, II and III: Higher numbers indicate more extensive disease: larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor; Stage IV: The cancer has spread to distant tissues or organs|participants|Number|44|44.0||||||
4359868|NCT00376675|4187219|B2|0/I/II||Stage|Stage 0: Carcinoma in situ; Stage I, II and III: Higher numbers indicate more extensive disease: larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor; Stage IV: The cancer has spread to distant tissues or organs|participants|Number|22|22.0||||||
4359869|NCT00376675|4187220|B1|0/I/II||Stage|Stage 0: Carcinoma in situ; Stage I, II and III: Higher numbers indicate more extensive disease: larger tumor size and/or spread of the cancer beyond the organ in which it first developed to nearby lymph nodes and/or tissues or organs adjacent to the location of the primary tumor; Stage IV: The cancer has spread to distant tissues or organs|participants|Number|22|22.0||||||
4359870|NCT00376675|4187218|B3|8-10||Fatigue scale|Fatigue was measured using a scale of 0 to 10, with 0 (No fatigue) and 10 (Fatigue as bad as you can imagine).|participants|Number|44|44.0||||||
4359871|NCT00376675|4187219|B2|8-10||Fatigue scale|Fatigue was measured using a scale of 0 to 10, with 0 (No fatigue) and 10 (Fatigue as bad as you can imagine).|participants|Number|22|22.0||||||
4359872|NCT00376675|4187220|B1|8-10||Fatigue scale|Fatigue was measured using a scale of 0 to 10, with 0 (No fatigue) and 10 (Fatigue as bad as you can imagine).|participants|Number|22|22.0||||||
4359873|NCT00376675|4187218|B3|4-7||Fatigue scale|Fatigue was measured using a scale of 0 to 10, with 0 (No fatigue) and 10 (Fatigue as bad as you can imagine).|participants|Number|95|95.0||||||
4359874|NCT00376675|4187219|B2|4-7||Fatigue scale|Fatigue was measured using a scale of 0 to 10, with 0 (No fatigue) and 10 (Fatigue as bad as you can imagine).|participants|Number|48|48.0||||||
4359875|NCT00376675|4187220|B1|4-7||Fatigue scale|Fatigue was measured using a scale of 0 to 10, with 0 (No fatigue) and 10 (Fatigue as bad as you can imagine).|participants|Number|47|47.0||||||
4359876|NCT00376675|4187218|B3|No||Concurrent biological therapy||participants|Number|105|105.0||||||
4359877|NCT00376675|4187219|B2|No||Concurrent biological therapy||participants|Number|53|53.0||||||
4359878|NCT00376675|4187220|B1|No||Concurrent biological therapy||participants|Number|52|52.0||||||
4359879|NCT00376675|4187218|B3|Yes||Concurrent biological therapy||participants|Number|34|34.0||||||
4359880|NCT00376675|4187219|B2|Yes||Concurrent biological therapy||participants|Number|17|17.0||||||
4359881|NCT00376675|4187220|B1|Yes||Concurrent biological therapy||participants|Number|17|17.0||||||
4359882|NCT00376675|4187218|B3|No||Concurrent radiation||participants|Number|123|123.0||||||
4359883|NCT00376675|4187219|B2|No||Concurrent radiation||participants|Number|63|63.0||||||
4359884|NCT00376675|4187220|B1|No||Concurrent radiation||participants|Number|60|60.0||||||
4359885|NCT00376675|4187218|B3|Yes||Concurrent radiation||participants|Number|16|16.0||||||
4359886|NCT00376675|4187219|B2|Yes||Concurrent radiation||participants|Number|7|7.0||||||
4359887|NCT00376675|4187220|B1|Yes||Concurrent radiation||participants|Number|9|9.0||||||
4359888|NCT00376675|4187218|B3|No||Curative intent treatment||participants|Number|73|73.0||||||
4359889|NCT00376675|4187219|B2|No||Curative intent treatment||participants|Number|38|38.0||||||
4359890|NCT00376675|4187220|B1|No||Curative intent treatment||participants|Number|35|35.0||||||
4359891|NCT00376675|4187218|B3|Yes||Curative intent treatment||participants|Number|64|64.0||||||
4359892|NCT00376675|4187219|B2|Yes||Curative intent treatment||participants|Number|30|30.0||||||
4359893|NCT00376675|4187220|B1|Yes||Curative intent treatment||participants|Number|34|34.0||||||
4359894|NCT00376675|4187218|B3|Missing||Curative intent treatment||participants|Number|2|2.0||||||
4359895|NCT00376675|4187219|B2|Missing||Curative intent treatment||participants|Number|2|2.0||||||
4359896|NCT00376675|4187220|B1|Missing||Curative intent treatment||participants|Number|0|0.0||||||
4359897|NCT00376675|4187218|B3|No||Current chemotherapy||participants|Number|50|50.0||||||
4359898|NCT00376675|4187219|B2|No||Current chemotherapy||participants|Number|25|25.0||||||
4359899|NCT00376675|4187220|B1|No||Current chemotherapy||participants|Number|25|25.0||||||
4359900|NCT00376675|4187218|B3|Yes||Current chemotherapy||participants|Number|89|89.0||||||
4359901|NCT00376675|4187219|B2|Yes||Current chemotherapy||participants|Number|45|45.0||||||
4359902|NCT00376675|4187220|B1|Yes||Current chemotherapy||participants|Number|44|44.0||||||
4359903|NCT00376675|4187218|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
4359904|NCT00376675|4187219|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4359905|NCT00376675|4187220|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4359906|NCT00376675|4187218|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4359907|NCT00376675|4187219|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4359908|NCT00376675|4187220|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359909|NCT00376675|4187218|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359910|NCT00376675|4187219|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359911|NCT00376675|4187220|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359912|NCT00376675|4187218|B3||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4359913|NCT00376675|4187219|B2||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4359914|NCT00376675|4187220|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4359915|NCT00376675|4187218|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4359916|NCT00376675|4187219|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4359917|NCT00376675|4187220|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4359918|NCT00376675|4187218|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359919|NCT00376675|4187219|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359920|NCT00376675|4187220|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359921|NCT00376675|4187218|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359922|NCT00376675|4187219|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359923|NCT00376675|4187220|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359924|NCT00376675|4187218|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359925|NCT00376675|4187219|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359926|NCT00376675|4187220|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4359927|NCT00376675|4187218|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4359928|NCT00376675|4187219|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4359929|NCT00376675|4187220|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4359930|NCT00376675|4187218|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4359931|NCT00376675|4187219|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4359932|NCT00376675|4187220|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4359933|NCT00376675|4187218|B3|>=50 years||Age, Customized||participants|Number|111|111.0||||||
4359934|NCT00376675|4187219|B2|>=50 years||Age, Customized||participants|Number|56|56.0||||||
4359935|NCT00376675|4187220|B1|>=50 years||Age, Customized||participants|Number|55|55.0||||||
4359936|NCT00376675|4187218|B3|<50 years||Age, Customized||participants|Number|28|28.0||||||
4359937|NCT00376675|4187219|B2|<50 years||Age, Customized||participants|Number|14|14.0||||||
4359938|NCT00376675|4187220|B1|<50 years||Age, Customized||participants|Number|14|14.0||||||
4359939|NCT00376675|4187218|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|12.58|12.58|||
4359940|NCT00376675|4187219|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|13.82|13.82|||
4359941|NCT00376675|4187220|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|11.23|11.23|||
4359942|NCT00376597|4187243|B3|United States||Region of Enrollment||participants|Number|554|554.0||||||
4359943|NCT00376597|4187244|B2|United States||Region of Enrollment||participants|Number|312|312.0||||||
4359944|NCT00376597|4187245|B1|United States||Region of Enrollment||participants|Number|242|242.0||||||
4359945|NCT00376597|4187243|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359946|NCT00376597|4187244|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359947|NCT00376597|4187245|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4359948|NCT00376597|4187243|B3||Female|Sex: Female, Male||Participants|Count of Participants|554|554.0||||||
4359949|NCT00376597|4187244|B2||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4359950|NCT00376597|4187245|B1||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4359951|NCT00376597|4187243|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|11.3|11.3|||
4359952|NCT00376597|4187244|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|11.2|11.2|||
4359953|NCT00376597|4187245|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|11.4|11.4|||
4359954|NCT00376558|4187258|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4359955|NCT00376558|4187259|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4359956|NCT00376558|4187260|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4359957|NCT00376558|4187258|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4359958|NCT00376558|4187259|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4359959|NCT00376558|4187260|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4359960|NCT00376558|4187258|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4359961|NCT00376558|4187259|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4359962|NCT00376558|4187260|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4359963|NCT00376558|4187258|B3|||Age||years|Mean|37|37.0|Standard Deviation|7|7.0|||
4359964|NCT00376558|4187259|B2|||Age||years|Mean|38|38.0|Standard Deviation|6|6.0|||
4359965|NCT00376558|4187260|B1|||Age||years|Mean|37|37.0|Standard Deviation|7|7.0|||
4359966|NCT00376558|4187258|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359967|NCT00376558|4187259|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359968|NCT00376558|4187260|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4359969|NCT00376558|4187258|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4359970|NCT00376558|4187259|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4359971|NCT00376558|4187260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4359972|NCT00376558|4187258|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359973|NCT00376558|4187259|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359974|NCT00376558|4187260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359975|NCT00376532|4187268|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4359976|NCT00376532|4187269|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4359977|NCT00376532|4187270|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4359978|NCT00376532|4187268|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4359979|NCT00376532|4187269|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4359980|NCT00376532|4187270|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4359981|NCT00376532|4187268|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4359982|NCT00376532|4187269|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4359983|NCT00376532|4187270|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4359984|NCT00376532|4187268|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4359985|NCT00376532|4187269|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4359986|NCT00376532|4187270|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4359987|NCT00376532|4187268|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359988|NCT00376532|4187269|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359989|NCT00376532|4187270|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4359990|NCT00376506|4187279|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4359991|NCT00376506|4187280|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4359992|NCT00376506|4187281|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4359993|NCT00376506|4187279|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4359994|NCT00376506|4187280|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4359995|NCT00376506|4187281|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4359996|NCT00376506|4187279|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|15.94|15.94|||
4359997|NCT00376506|4187280|B2|||Age||years|Mean|61.16|61.16|Standard Deviation|17.702|17.702|||
4359998|NCT00376506|4187281|B1|||Age||years|Mean|70.25|70.25|Standard Deviation|13.2003|13.2003|||
4359999|NCT00376506|4187279|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4360000|NCT00376506|4187280|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4360001|NCT00376506|4187281|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4360002|NCT00376506|4187279|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4360003|NCT00376506|4187280|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4360004|NCT00376506|4187281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4360005|NCT00376506|4187279|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360006|NCT00376506|4187280|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360007|NCT00376506|4187281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360008|NCT00376363|4187298|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4360009|NCT00376363|4187299|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4360010|NCT00376363|4187300|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4360011|NCT00376363|4187298|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4360012|NCT00376363|4187299|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4360013|NCT00376363|4187300|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4360014|NCT00376363|4187298|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|13.6|13.6|||
4360015|NCT00376363|4187299|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|14.2|14.2|||
4360016|NCT00376363|4187300|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|12.8|12.8|||
4360017|NCT00376259|4187311|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4360018|NCT00376259|4187312|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4360019|NCT00376259|4187313|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4360020|NCT00376259|4187311|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4360021|NCT00376259|4187312|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4360022|NCT00376259|4187313|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4360023|NCT00376259|4187311|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|11.32|11.32|||
4360024|NCT00376259|4187312|B2|||Age||years|Mean|39.0|39.0|Standard Deviation|10.93|10.93|||
4360025|NCT00376259|4187313|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|11.82|11.82|||
4360026|NCT00376220|4187326|B3|||Montgomery Asberg Depression Rating scale (MADRS)|The Montgomery Asberg Depression Rating Scale measures symptoms of depression. The scale is composed of 10 questions with a fixed 7 point scale (0-6). Total score ranges from 0-60. A higher score indicates more depressive symptoms.|units on a scale|Mean|31.4|31.4|Standard Deviation|6.4|6.4|||
4360027|NCT00376220|4187327|B2|||Montgomery Asberg Depression Rating scale (MADRS)|The Montgomery Asberg Depression Rating Scale measures symptoms of depression. The scale is composed of 10 questions with a fixed 7 point scale (0-6). Total score ranges from 0-60. A higher score indicates more depressive symptoms.|units on a scale|Mean|30.4|30.4|Standard Deviation|6.0|6.0|||
4360028|NCT00376220|4187328|B1|||Montgomery Asberg Depression Rating scale (MADRS)|The Montgomery Asberg Depression Rating Scale measures symptoms of depression. The scale is composed of 10 questions with a fixed 7 point scale (0-6). Total score ranges from 0-60. A higher score indicates more depressive symptoms.|units on a scale|Mean|32.4|32.4|Standard Deviation|6.7|6.7|||
4360029|NCT00376220|4187326|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4360030|NCT00376220|4187327|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4360031|NCT00376220|4187328|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4360032|NCT00376220|4187326|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360033|NCT00376220|4187327|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360034|NCT00376220|4187328|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360035|NCT00376220|4187326|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4360036|NCT00376220|4187327|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4360037|NCT00376220|4187328|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4360038|NCT00376220|4187326|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4360039|NCT00376220|4187327|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4360040|NCT00376220|4187328|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4360041|NCT00376220|4187326|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4360042|NCT00376220|4187327|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4360043|NCT00376220|4187328|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4360044|NCT00376220|4187326|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360045|NCT00376220|4187327|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360046|NCT00376220|4187328|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360047|NCT00376220|4187326|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4360048|NCT00376220|4187327|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360049|NCT00376220|4187328|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4360050|NCT00376220|4187326|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360051|NCT00376220|4187327|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360052|NCT00376220|4187328|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360053|NCT00376220|4187326|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4360054|NCT00376220|4187327|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360055|NCT00376220|4187328|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4360056|NCT00376220|4187326|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4360057|NCT00376220|4187327|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4360058|NCT00376220|4187328|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4360059|NCT00376220|4187326|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4360060|NCT00376220|4187327|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4360061|NCT00376220|4187328|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4360062|NCT00376220|4187326|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4360063|NCT00376220|4187327|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4360064|NCT00376220|4187328|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4360065|NCT00376220|4187326|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4360066|NCT00376220|4187327|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4360067|NCT00376220|4187328|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4360068|NCT00376220|4187326|B3|||Age||years|Mean|43|43.0|Standard Deviation|10|10.0|||
4360069|NCT00376220|4187327|B2|||Age||years|Mean|43|43.0|Standard Deviation|11|11.0|||
4360070|NCT00376220|4187328|B1|||Age||years|Mean|43|43.0|Standard Deviation|10|10.0|||
4360071|NCT00376220|4187326|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4360072|NCT00376220|4187327|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4360073|NCT00376220|4187328|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4360074|NCT00376220|4187326|B3||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4360075|NCT00376220|4187327|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4360076|NCT00376220|4187328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4360077|NCT00376220|4187326|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360078|NCT00376220|4187327|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360079|NCT00376220|4187328|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360080|NCT00376168|4187335|B3|||Chitotriosidase|Gaucher disease biomarker|nmol/ml/hr|Mean|26000|26000.0|Standard Deviation|14000|14000.0|||
4360081|NCT00376168|4187336|B2|||Chitotriosidase|Gaucher disease biomarker|nmol/ml/hr|Mean|24702|24702.0|Standard Deviation|17428|17428.0|||
4360082|NCT00376168|4187337|B1|||Chitotriosidase|Gaucher disease biomarker|nmol/ml/hr|Mean|28158|28158.0|Standard Deviation|11686|11686.0|||
4360083|NCT00376168|4187335|B3|||Platelet Count|Measured in local laboratory|count/mm^3|Mean|70,000|70.0|Standard Deviation|32,000|32.0|||
4360084|NCT00376168|4187336|B2|||Platelet Count|Measured in local laboratory|count/mm^3|Mean|65,038|65.0|Standard Deviation|28,668|28.0|||
4360085|NCT00376168|4187337|B1|||Platelet Count|Measured in local laboratory|count/mm^3|Mean|75,320|75.0|Standard Deviation|40,861|40.0|||
4360086|NCT00376168|4187335|B3|||Hemoglobin|Measured in central laboratory|g/dL|Mean|12|12.0|Standard Deviation|2|2.0|||
4360087|NCT00376168|4187336|B2|||Hemoglobin|Measured in central laboratory|g/dL|Mean|11.4|11.4|Standard Deviation|2.6|2.6|||
4360088|NCT00376168|4187337|B1|||Hemoglobin|Measured in central laboratory|g/dL|Mean|12.2|12.2|Standard Deviation|1.7|1.7|||
4360089|NCT00376168|4187335|B3|||Liver Volume|Measured by MRI|mL|Mean|2600|2600.0|Standard Deviation|600|600.0|||
4360090|NCT00376168|4187336|B2|||Liver Volume|Measured by MRI|mL|Mean|2481.31|2481.31|Standard Deviation|452.74|452.74|||
4360091|NCT00376168|4187337|B1|||Liver Volume|Measured by MRI|mL|Mean|2880.60|2880.6|Standard Deviation|736.12|736.12|||
4360092|NCT00376168|4187335|B3|||Spleen Volume|Measured by MRI|mL|Mean|2120|2120.0|Standard Deviation|1200|1200.0|||
4360093|NCT00376168|4187336|B2|||Spleen Volume|Measured by MRI|mL|Mean|2117.38|2117.38|Standard Deviation|1356.17|1356.17|||
4360094|NCT00376168|4187337|B1|||Spleen Volume|Measured by MRI|mL|Mean|2130.94|2130.94|Standard Deviation|1154.72|1154.72|||
4360095|NCT00376168|4187335|B3|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
4360096|NCT00376168|4187336|B2|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4360097|NCT00376168|4187337|B1|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4360098|NCT00376168|4187335|B3|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4360099|NCT00376168|4187336|B2|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4360100|NCT00376168|4187337|B1|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4360101|NCT00376168|4187335|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4360102|NCT00376168|4187336|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4360103|NCT00376168|4187337|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4360104|NCT00376168|4187335|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4360105|NCT00376168|4187336|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4360106|NCT00376168|4187337|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4360107|NCT00376168|4187335|B3|Israel||Region of Enrollment||participants|Number|12|12.0||||||
4360108|NCT00376168|4187336|B2|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4360109|NCT00376168|4187337|B1|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4360110|NCT00376168|4187335|B3|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4360111|NCT00376168|4187336|B2|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4360112|NCT00376168|4187337|B1|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4360113|NCT00376168|4187335|B3|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4360114|NCT00376168|4187336|B2|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4360115|NCT00376168|4187337|B1|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4360116|NCT00376168|4187335|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4360117|NCT00376168|4187336|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4360118|NCT00376168|4187337|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4360119|NCT00376168|4187335|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4360120|NCT00376168|4187336|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4360121|NCT00376168|4187337|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4360122|NCT00376168|4187335|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4360123|NCT00376168|4187336|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4360124|NCT00376168|4187337|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4360125|NCT00376168|4187335|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4360126|NCT00376168|4187336|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4360127|NCT00376168|4187337|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4360128|NCT00376168|4187335|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|11.8|11.8|||
4360129|NCT00376168|4187336|B2|||Age||years|Mean|36.0|36.0|Standard Deviation|12.2|12.2|||
4360130|NCT00376168|4187337|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|11.8|11.8|||
4360131|NCT00376168|4187335|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4360132|NCT00376168|4187336|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4360133|NCT00376168|4187337|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4360134|NCT00376168|4187335|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4360135|NCT00376168|4187336|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4360136|NCT00376168|4187337|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4360137|NCT00376168|4187335|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360138|NCT00376168|4187336|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360139|NCT00376168|4187337|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360140|NCT00375999|4187352|B1|Korea, Republic of||Region of Enrollment||participants|Number|34|34.0||||||
4360141|NCT00375999|4187352|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4360142|NCT00375999|4187352|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4360143|NCT00375999|4187352|B1|||Age||years|Median|53|53.0|Full Range|||34.0|73.0|
4360144|NCT00375973|4187356|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4360145|NCT00375973|4187357|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4360146|NCT00375973|4187358|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4360147|NCT00375973|4187356|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4360148|NCT00375973|4187357|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4360149|NCT00375973|4187358|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4360150|NCT00375973|4187356|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4360151|NCT00375973|4187357|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4360152|NCT00375973|4187358|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4360153|NCT00375973|4187356|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|11.4|11.4|||
4360154|NCT00375973|4187357|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|11.0|11.0|||
4360155|NCT00375973|4187358|B1|||Age||years|Mean|43.0|43.0|Standard Deviation|11.8|11.8|||
4360156|NCT00375973|4187356|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4360157|NCT00375973|4187357|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4360158|NCT00375973|4187358|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4360159|NCT00375973|4187356|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4360160|NCT00375973|4187357|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4360161|NCT00375973|4187358|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4360162|NCT00375973|4187356|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360163|NCT00375973|4187357|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360164|NCT00375973|4187358|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360165|NCT00375934|4187377|B3|||Baseline Pain Score|Pain intensity scores were measured using an 11-point numerical pain rating scale (NPRS) with 0=no pain to 10=worst possible pain|units on a scale|Mean|7.5|7.5|Standard Deviation|1.5|1.5|||
4360166|NCT00375934|4187378|B2|||Baseline Pain Score|Pain intensity scores were measured using an 11-point numerical pain rating scale (NPRS) with 0=no pain to 10=worst possible pain|units on a scale|Mean|7.4|7.4|Standard Deviation|1.4|1.4|||
4360167|NCT00375934|4187379|B1|||Baseline Pain Score|Pain intensity scores were measured using an 11-point numerical pain rating scale (NPRS) with 0=no pain to 10=worst possible pain|units on a scale|Mean|7.5|7.5|Standard Deviation|1.6|1.6|||
4360168|NCT00375934|4187377|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
4360169|NCT00375934|4187378|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4360170|NCT00375934|4187379|B1|United States||Region of Enrollment||participants|Number|99|99.0||||||
4360171|NCT00375934|4187377|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4360172|NCT00375934|4187378|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4360173|NCT00375934|4187379|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4360174|NCT00375934|4187377|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4360175|NCT00375934|4187378|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4360176|NCT00375934|4187379|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4360177|NCT00375934|4187377|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4360178|NCT00375934|4187378|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4360179|NCT00375934|4187379|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4360180|NCT00375934|4187377|B3|Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4360181|NCT00375934|4187378|B2|Black||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4360182|NCT00375934|4187379|B1|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4360183|NCT00375934|4187377|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4360184|NCT00375934|4187378|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4360185|NCT00375934|4187379|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4360186|NCT00375934|4187377|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4360187|NCT00375934|4187378|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4360188|NCT00375934|4187379|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4360189|NCT00375934|4187377|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4360190|NCT00375934|4187378|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4360191|NCT00375934|4187379|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4360192|NCT00375934|4187377|B3|||Age||years|Mean|40|40.0|Standard Deviation|12|12.0|||
4360193|NCT00375934|4187378|B2|||Age||years|Mean|40|40.0|Standard Deviation|12|12.0|||
4360194|NCT00375934|4187379|B1|||Age||years|Mean|41|41.0|Standard Deviation|13|13.0|||
4360195|NCT00375752|4187406|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4360196|NCT00375752|4187407|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4360197|NCT00375752|4187408|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4360198|NCT00375752|4187406|B3||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4360199|NCT00375752|4187407|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4360200|NCT00375752|4187408|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4360201|NCT00375752|4187406|B3|||Age||years|Mean|70.9|70.9|Standard Deviation|8.8|8.8|||
4360202|NCT00375752|4187407|B2|||Age||years|Mean|71.3|71.3|Standard Deviation|9.2|9.2|||
4360203|NCT00375752|4187408|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|8.4|8.4|||
4360204|NCT00375713|4187423|B3|Korea, Republic of||Region of Enrollment||participants|Number|340|340.0||||||
4360205|NCT00375713|4187424|B2|Korea, Republic of||Region of Enrollment||participants|Number|172|172.0||||||
4360206|NCT00375713|4187425|B1|Korea, Republic of||Region of Enrollment||participants|Number|168|168.0||||||
4360207|NCT00375713|4187423|B3||Male|Sex: Female, Male||Participants|Count of Participants|107.0|107.0||||||
4360208|NCT00375713|4187424|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4360209|NCT00375713|4187425|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4360210|NCT00375713|4187423|B3||Female|Sex: Female, Male||Participants|Count of Participants|233.0|233.0||||||
4360211|NCT00375713|4187424|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4360212|NCT00375713|4187425|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4360213|NCT00375713|4187423|B3|||Age||years|Mean|30.14|30.14|Standard Deviation|10.34|10.34|||
4360214|NCT00375713|4187424|B2|||Age||years|Mean|30.11|30.11|Standard Deviation|10.60|10.6|||
4360215|NCT00375713|4187425|B1|||Age||years|Mean|30.17|30.17|Standard Deviation|10.09|10.09|||
4360216|NCT00375674|4187438|B3|Male||Sex/Gender, Customized||Participants|Number|451|451.0||||||
4360217|NCT00375674|4187439|B2|Male||Sex/Gender, Customized||Participants|Number|229|229.0||||||
4360218|NCT00375674|4187440|B1|Male||Sex/Gender, Customized||Participants|Number|222|222.0||||||
4360219|NCT00375674|4187438|B3|Female||Sex/Gender, Customized||Participants|Number|164|164.0||||||
4360220|NCT00375674|4187439|B2|Female||Sex/Gender, Customized||Participants|Number|77|77.0||||||
4360221|NCT00375674|4187440|B1|Female||Sex/Gender, Customized||Participants|Number|87|87.0||||||
4360222|NCT00375674|4187438|B3|>=65 years||Age, Customized||Participants|Number|158|158.0||||||
4360223|NCT00375674|4187439|B2|>=65 years||Age, Customized||Participants|Number|82|82.0||||||
4360224|NCT00375674|4187440|B1|>=65 years||Age, Customized||Participants|Number|76|76.0||||||
4360225|NCT00375674|4187438|B3|Between 18 and 65 years||Age, Customized||Participants|Number|457|457.0||||||
4360226|NCT00375674|4187439|B2|Between 18 and 65 years||Age, Customized||Participants|Number|224|224.0||||||
4360227|NCT00375674|4187440|B1|Between 18 and 65 years||Age, Customized||Participants|Number|233|233.0||||||
4360228|NCT00375674|4187438|B3|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
4360229|NCT00375674|4187439|B2|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
4360230|NCT00375674|4187440|B1|<=18 years||Age, Customized||Participants|Number|0|0.0||||||
4360231|NCT00375674|4187438|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|10.6|10.6|||
4360232|NCT00375674|4187439|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|10.6|10.6|||
4360233|NCT00375674|4187440|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|10.6|10.6|||
4360234|NCT00375609|4187467|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4360235|NCT00375609|4187468|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4360236|NCT00375609|4187469|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4360237|NCT00375609|4187470|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4360238|NCT00375609|4187467|B4||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4360239|NCT00375609|4187468|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4360240|NCT00375609|4187469|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4360241|NCT00375609|4187470|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4360242|NCT00375609|4187467|B4|||Age||years|Mean|63.7|63.7|Standard Deviation|8.1|8.1|||
4360243|NCT00375609|4187468|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|9.6|9.6|||
4360244|NCT00375609|4187469|B2|||Age||years|Mean|65.0|65.0|Standard Deviation|7.9|7.9|||
4360245|NCT00375609|4187470|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|7.2|7.2|||
4360246|NCT00375518|4187486|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4360247|NCT00375518|4187487|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4360248|NCT00375518|4187488|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4360249|NCT00375518|4187486|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4360250|NCT00375518|4187487|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4360251|NCT00375518|4187488|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4360252|NCT00375518|4187486|B3||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
4360253|NCT00375518|4187487|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4360254|NCT00375518|4187488|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4360255|NCT00375518|4187486|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4360256|NCT00375518|4187487|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4360257|NCT00375518|4187488|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4360258|NCT00375518|4187486|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360259|NCT00375518|4187487|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360260|NCT00375518|4187488|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360261|NCT00375505|4187495|B3||Male|Sex: Female, Male|All participants were females|Participants|Count of Participants|0|0.0||||||
4360262|NCT00375505|4187496|B2||Male|Sex: Female, Male|All participants were females|Participants|Count of Participants|0|0.0||||||
4360263|NCT00375505|4187497|B1||Male|Sex: Female, Male|All participants were females|Participants|Count of Participants|0|0.0||||||
4360264|NCT00375505|4187495|B3||Female|Sex: Female, Male|All participants were females|Participants|Count of Participants|70|70.0||||||
4360265|NCT00375505|4187496|B2||Female|Sex: Female, Male|All participants were females|Participants|Count of Participants|34|34.0||||||
4360266|NCT00375505|4187497|B1||Female|Sex: Female, Male|All participants were females|Participants|Count of Participants|36|36.0||||||
4360267|NCT00375505|4187495|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|6.1|6.1|||
4360268|NCT00375505|4187496|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|6.0|6.0|||
4360269|NCT00375505|4187497|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|6.3|6.3|||
4360270|NCT00375492|4187540|B3|||Baseline Waist Circumference||cm|Mean|109.24|109.24|Standard Deviation|11.60|11.6|||
4360271|NCT00375492|4187541|B2|||Baseline Waist Circumference||cm|Mean|108.85|108.85|Standard Deviation|12.10|12.1|||
4360272|NCT00375492|4187542|B1|||Baseline Waist Circumference||cm|Mean|109.64|109.64|Standard Deviation|11.12|11.12|||
4360273|NCT00375492|4187540|B3|||Baseline Triglycerides||mmol/L|Mean|2.14|2.14|Standard Deviation|0.97|0.97|||
4360274|NCT00375492|4187541|B2|||Baseline Triglycerides||mmol/L|Mean|2.13|2.13|Standard Deviation|1.00|1.0|||
4360275|NCT00375492|4187542|B1|||Baseline Triglycerides||mmol/L|Mean|2.15|2.15|Standard Deviation|0.94|0.94|||
4360276|NCT00375492|4187540|B3|||Baseline Low Density Lipoprotein (LDL) Cholesterol||mmol/L|Mean|2.76|2.76|Standard Deviation|0.85|0.85|||
4360277|NCT00375492|4187541|B2|||Baseline Low Density Lipoprotein (LDL) Cholesterol||mmol/L|Mean|2.78|2.78|Standard Deviation|0.82|0.82|||
4360278|NCT00375492|4187542|B1|||Baseline Low Density Lipoprotein (LDL) Cholesterol||mmol/L|Mean|2.74|2.74|Standard Deviation|0.88|0.88|||
4360279|NCT00375492|4187540|B3|||Baseline Homeostatic Model Assessment-Insulin Sensitivity (HOMA-S)||Percent insulin sensitivity|Mean|56.68|56.68|Standard Deviation|37.57|37.57|||
4360280|NCT00375492|4187541|B2|||Baseline Homeostatic Model Assessment-Insulin Sensitivity (HOMA-S)||Percent insulin sensitivity|Mean|62.90|62.9|Standard Deviation|41.07|41.07|||
4360281|NCT00375492|4187542|B1|||Baseline Homeostatic Model Assessment-Insulin Sensitivity (HOMA-S)||Percent insulin sensitivity|Mean|49.72|49.72|Standard Deviation|32.12|32.12|||
4360282|NCT00375492|4187540|B3|||Baseline Homeostatic Model Assessment-Beta Cell (HOMA-B)||Percent beta-cell function|Mean|72.81|72.81|Standard Deviation|67.65|67.65|||
4360283|NCT00375492|4187541|B2|||Baseline Homeostatic Model Assessment-Beta Cell (HOMA-B)||Percent beta-cell function|Mean|70.72|70.72|Standard Deviation|53.16|53.16|||
4360284|NCT00375492|4187542|B1|||Baseline Homeostatic Model Assessment-Beta Cell (HOMA-B)||Percent beta-cell function|Mean|75.15|75.15|Standard Deviation|81.20|81.2|||
4360285|NCT00375492|4187540|B3|||Baseline High Density Lipoprotein (HDL) Cholesterol||mmol/L|Mean|1.20|1.2|Standard Deviation|0.31|0.31|||
4360286|NCT00375492|4187541|B2|||Baseline High Density Lipoprotein (HDL) Cholesterol||mmol/L|Mean|1.21|1.21|Standard Deviation|0.31|0.31|||
4360287|NCT00375492|4187542|B1|||Baseline High Density Lipoprotein (HDL) Cholesterol||mmol/L|Mean|1.18|1.18|Standard Deviation|0.32|0.32|||
4360288|NCT00375492|4187540|B3|||Baseline Glycosylated Hemoglobin (HbA1c)||percent hemoglobin|Mean|7.62|7.62|Standard Deviation|0.85|0.85|||
4360289|NCT00375492|4187541|B2|||Baseline Glycosylated Hemoglobin (HbA1c)||percent hemoglobin|Mean|7.51|7.51|Standard Deviation|0.82|0.82|||
4360290|NCT00375492|4187542|B1|||Baseline Glycosylated Hemoglobin (HbA1c)||percent hemoglobin|Mean|7.74|7.74|Standard Deviation|0.87|0.87|||
4360291|NCT00375492|4187540|B3|||Baseline Cholesterol||mmol/L|Mean|4.68|4.68|Standard Deviation|0.96|0.96|||
4360292|NCT00375492|4187541|B2|||Baseline Cholesterol||mmol/L|Mean|4.68|4.68|Standard Deviation|0.90|0.9|||
4360293|NCT00375492|4187542|B1|||Baseline Cholesterol||mmol/L|Mean|4.67|4.67|Standard Deviation|1.03|1.03|||
4360294|NCT00375492|4187540|B3|||Baseline Body Weight||kg|Mean|95.53|95.53|Standard Deviation|16.05|16.05|||
4360295|NCT00375492|4187541|B2|||Baseline Body Weight||kg|Mean|96.16|96.16|Standard Deviation|16.53|16.53|||
4360296|NCT00375492|4187542|B1|||Baseline Body Weight||kg|Mean|94.90|94.9|Standard Deviation|16.52|16.52|||
4360297|NCT00375492|4187540|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4360298|NCT00375492|4187541|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4360299|NCT00375492|4187542|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4360300|NCT00375492|4187540|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4360301|NCT00375492|4187541|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4360302|NCT00375492|4187542|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4360303|NCT00375492|4187540|B3|||Age||years|Mean|54.81|54.81|Standard Deviation|9.48|9.48|||
4360304|NCT00375492|4187541|B2|||Age||years|Mean|55.08|55.08|Standard Deviation|8.97|8.97|||
4360305|NCT00375492|4187542|B1|||Age||years|Mean|54.52|54.52|Standard Deviation|10.02|10.02|||
4360306|NCT00375492|4187540|B3||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4360307|NCT00375492|4187541|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4360308|NCT00375492|4187542|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4360309|NCT00375492|4187540|B3||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
4360310|NCT00375492|4187541|B2||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4360311|NCT00375492|4187542|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4360312|NCT00375492|4187540|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360313|NCT00375492|4187541|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360314|NCT00375492|4187542|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360315|NCT00375427|4187571|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4360316|NCT00375427|4187572|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4360317|NCT00375427|4187573|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4360318|NCT00375427|4187571|B3||Female|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4360319|NCT00375427|4187572|B2||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4360320|NCT00375427|4187573|B1||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4360321|NCT00375427|4187571|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|11.9|11.9|||
4360322|NCT00375427|4187572|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|11.8|11.8|||
4360323|NCT00375427|4187573|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|11.9|11.9|||
4360324|NCT00375219|4187596|B4|||Time from Initial Chronic Myeloid Leukemia (CML) Diagnosis||months|Median|59.6|59.6|Full Range|||5.2|285.6|
4360325|NCT00375219|4187597|B3|||Time from Initial Chronic Myeloid Leukemia (CML) Diagnosis||months|Median|46.6|46.6|Full Range|||5.2|139.8|
4360326|NCT00375219|4187598|B2|||Time from Initial Chronic Myeloid Leukemia (CML) Diagnosis||months|Median|98.0|98.0|Full Range|||34.3|285.6|
4360327|NCT00375219|4187599|B1|||Time from Initial Chronic Myeloid Leukemia (CML) Diagnosis||months|Median|50.0|50.0|Full Range|||10.9|234.3|
4360328|NCT00375219|4187596|B4|Grade 3||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|2|2.0||||||
4360329|NCT00375219|4187597|B3|Grade 3||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|1|1.0||||||
4360330|NCT00375219|4187598|B2|Grade 3||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|1|1.0||||||
4360331|NCT00375219|4187599|B1|Grade 3||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|0|0.0||||||
4360332|NCT00375219|4187596|B4|Grade 2||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|8|8.0||||||
4360333|NCT00375219|4187597|B3|Grade 2||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|5|5.0||||||
4360334|NCT00375219|4187598|B2|Grade 2||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|2|2.0||||||
4360335|NCT00375219|4187599|B1|Grade 2||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|1|1.0||||||
4360336|NCT00375219|4187596|B4|Grade 1||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|40|40.0||||||
4360337|NCT00375219|4187597|B3|Grade 1||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|9|9.0||||||
4360338|NCT00375219|4187598|B2|Grade 1||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|11|11.0||||||
4360339|NCT00375219|4187599|B1|Grade 1||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|20|20.0||||||
4360340|NCT00375219|4187596|B4|Grade 0||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|53|53.0||||||
4360341|NCT00375219|4187597|B3|Grade 0||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|6|6.0||||||
4360342|NCT00375219|4187598|B2|Grade 0||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|6|6.0||||||
4360343|NCT00375219|4187599|B1|Grade 0||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease activities without restriction;~Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature;~Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours;~Grade 3: Capable of only limited self-care, confined to bed or chair > 50% of waking hours;~Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or chair."|participants|Number|41|41.0||||||
4360344|NCT00375219|4187596|B4|Class IV||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4360345|NCT00375219|4187597|B3|Class IV||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4360346|NCT00375219|4187598|B2|Class IV||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4360347|NCT00375219|4187599|B1|Class IV||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4360348|NCT00375219|4187596|B4|Class III||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4360349|NCT00375219|4187597|B3|Class III||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4360350|NCT00375219|4187598|B2|Class III||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4360351|NCT00375219|4187599|B1|Class III||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|0|0.0||||||
4360352|NCT00375219|4187596|B4|Class II||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|6|6.0||||||
4360353|NCT00375219|4187597|B3|Class II||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|3|3.0||||||
4360354|NCT00375219|4187598|B2|Class II||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|2|2.0||||||
4360355|NCT00375219|4187599|B1|Class II||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|1|1.0||||||
4360356|NCT00375219|4187596|B4|Class I||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|97|97.0||||||
4360357|NCT00375219|4187597|B3|Class I||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|18|18.0||||||
4360358|NCT00375219|4187598|B2|Class I||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|18|18.0||||||
4360359|NCT00375219|4187599|B1|Class I||New York Heart Association (NYHA) Classification|"Class I: Cardiac disease, but no symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~Class II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~Class III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~Class IV: Severe limitations. Experiences symptoms even while at rest. Mostly bed-bound patients."|participants|Number|61|61.0||||||
4360360|NCT00375219|4187596|B4|||Body Surface Area (BSA)||meters^2|Median|1.9|1.9|Full Range|||1.2|2.4|
4360361|NCT00375219|4187597|B3|||Body Surface Area (BSA)||meters^2|Median|1.8|1.8|Full Range|||1.4|2.4|
4360362|NCT00375219|4187598|B2|||Body Surface Area (BSA)||meters^2|Median|1.8|1.8|Full Range|||1.3|2.3|
4360363|NCT00375219|4187599|B1|||Body Surface Area (BSA)||meters^2|Median|1.9|1.9|Full Range|||1.2|2.3|
4360364|NCT00375219|4187596|B4|||Weight||kilograms|Median|76.0|76.0|Full Range|||34.0|118.8|
4360365|NCT00375219|4187597|B3|||Weight||kilograms|Median|68.8|68.8|Full Range|||43.0|117.7|
4360366|NCT00375219|4187598|B2|||Weight||kilograms|Median|69.1|69.1|Full Range|||40.0|118.8|
4360367|NCT00375219|4187599|B1|||Weight||kilograms|Median|77.7|77.7|Full Range|||34.0|115.0|
4360368|NCT00375219|4187596|B4|||Height||centimeter|Median|171.0|171.0|Full Range|||146.0|196.0|
4360369|NCT00375219|4187597|B3|||Height||centimeter|Median|170.2|170.2|Full Range|||157.0|196.0|
4360370|NCT00375219|4187598|B2|||Height||centimeter|Median|172.0|172.0|Full Range|||155.0|185.0|
4360371|NCT00375219|4187599|B1|||Height||centimeter|Median|171.5|171.5|Full Range|||146.0|192.0|
4360372|NCT00375219|4187596|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4360373|NCT00375219|4187597|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360374|NCT00375219|4187598|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360375|NCT00375219|4187599|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4360376|NCT00375219|4187596|B4|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4360377|NCT00375219|4187597|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4360378|NCT00375219|4187598|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4360379|NCT00375219|4187599|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4360380|NCT00375219|4187596|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360381|NCT00375219|4187597|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360382|NCT00375219|4187598|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360383|NCT00375219|4187599|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360384|NCT00375219|4187596|B4|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4360385|NCT00375219|4187597|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4360386|NCT00375219|4187598|B2|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4360387|NCT00375219|4187599|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4360388|NCT00375219|4187596|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4360389|NCT00375219|4187597|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4360390|NCT00375219|4187598|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4360391|NCT00375219|4187599|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4360392|NCT00375219|4187596|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4360393|NCT00375219|4187597|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4360394|NCT00375219|4187598|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4360395|NCT00375219|4187599|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4360396|NCT00375219|4187596|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4360397|NCT00375219|4187597|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4360398|NCT00375219|4187598|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4360399|NCT00375219|4187599|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4360400|NCT00375219|4187596|B4|||Age||years|Median|57|57.0|Full Range|||19.0|83.0|
4360401|NCT00375219|4187597|B3|||Age||years|Median|50|50.0|Full Range|||19.0|64.0|
4360402|NCT00375219|4187598|B2|||Age||years|Median|59|59.0|Full Range|||30.0|83.0|
4360403|NCT00375219|4187599|B1|||Age||years|Median|59|59.0|Full Range|||26.0|83.0|
4360404|NCT00374907|4187667|B3|||Body Mass Index (BMI)||kg/m^2|Median|33.01|33.01|Full Range|||24.67|39.35|
4360405|NCT00374907|4187668|B2|||Body Mass Index (BMI)||kg/m^2|Median|32.31|32.31|Full Range|||25.56|38.55|
4360406|NCT00374907|4187669|B1|||Body Mass Index (BMI)||kg/m^2|Median|33.36|33.36|Full Range|||24.67|39.35|
4360407|NCT00374907|4187667|B3|North America||Region of Enrollment||participants|Number|36|36.0||||||
4360408|NCT00374907|4187668|B2|North America||Region of Enrollment||participants|Number|16|16.0||||||
4360409|NCT00374907|4187669|B1|North America||Region of Enrollment||participants|Number|20|20.0||||||
4360410|NCT00374907|4187667|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4360411|NCT00374907|4187668|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360412|NCT00374907|4187669|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4360413|NCT00374907|4187667|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4360414|NCT00374907|4187668|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4360415|NCT00374907|4187669|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4360416|NCT00374907|4187667|B3|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4360417|NCT00374907|4187668|B2|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4360418|NCT00374907|4187669|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4360419|NCT00374907|4187667|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4360420|NCT00374907|4187668|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4360421|NCT00374907|4187669|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4360422|NCT00374907|4187667|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4360423|NCT00374907|4187668|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4360424|NCT00374907|4187669|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4360425|NCT00374907|4187667|B3|||Age||years|Median|55.5|55.5|Full Range|||43.0|69.0|
4360426|NCT00374907|4187668|B2|||Age||years|Median|55|55.0|Full Range|||45.0|69.0|
4360427|NCT00374907|4187669|B1|||Age||years|Median|58|58.0|Full Range|||43.0|69.0|
4360428|NCT00374868|4187682|B1|||Weight||kilograms|Mean|77.4|77.4|Standard Deviation|13.2|13.2|||
4360429|NCT00374868|4187682|B1|||Height||centimeters|Mean|166|166.0|Standard Deviation|7.5|7.5|||
4360430|NCT00374868|4187682|B1|Renal Pelvis||Location of Primary Tumor||participants|Number|4|4.0||||||
4360431|NCT00374868|4187682|B1|Urethra||Location of Primary Tumor||participants|Number|1|1.0||||||
4360432|NCT00374868|4187682|B1|Ureter||Location of Primary Tumor||participants|Number|1|1.0||||||
4360433|NCT00374868|4187682|B1|Bladder||Location of Primary Tumor||participants|Number|32|32.0||||||
4360434|NCT00374868|4187682|B1|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|2|2.0||||||
4360435|NCT00374868|4187682|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|15|15.0||||||
4360436|NCT00374868|4187682|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|21|21.0||||||
4360437|NCT00374868|4187682|B1|Spain||Region of Enrollment||participants|Number|38|38.0||||||
4360438|NCT00374868|4187682|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4360439|NCT00374868|4187682|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4360440|NCT00374868|4187682|B1|||Age||years|Mean|67.1|67.1|Standard Deviation|8.7|8.7|||
4360441|NCT00374842|4187693|B4||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4360442|NCT00374842|4187694|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4360443|NCT00374842|4187695|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4360444|NCT00374842|4187696|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4360445|NCT00374842|4187693|B4||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4360446|NCT00374842|4187694|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4360447|NCT00374842|4187695|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4360448|NCT00374842|4187696|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4360449|NCT00374842|4187693|B4|||Age||Years|Mean|36.7|36.7|Standard Deviation|13.65|13.65|||
4360450|NCT00374842|4187694|B3|||Age||Years|Mean|37.7|37.7|Standard Deviation|13.75|13.75|||
4360451|NCT00374842|4187695|B2|||Age||Years|Mean|35.0|35.0|Standard Deviation|13.26|13.26|||
4360452|NCT00374842|4187696|B1|||Age||Years|Mean|37.3|37.3|Standard Deviation|13.94|13.94|||
4360453|NCT00374803|4187727|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4360454|NCT00374803|4187728|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4360455|NCT00374803|4187729|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4360456|NCT00374803|4187727|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4360457|NCT00374803|4187728|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4360458|NCT00374803|4187729|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4360459|NCT00374803|4187727|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4360460|NCT00374803|4187728|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4360461|NCT00374803|4187729|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4360462|NCT00374803|4187727|B3|||Age||years|Mean|52|52.0|Standard Deviation|14|14.0|||
4360463|NCT00374803|4187728|B2|||Age||years|Mean|55|55.0|Standard Deviation|13|13.0|||
4360464|NCT00374803|4187729|B1|||Age||years|Mean|49|49.0|Standard Deviation|14|14.0|||
4360465|NCT00374803|4187727|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4360466|NCT00374803|4187728|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4360467|NCT00374803|4187729|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4360468|NCT00374803|4187727|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4360469|NCT00374803|4187728|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4360470|NCT00374803|4187729|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4360471|NCT00374803|4187727|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360472|NCT00374803|4187728|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360473|NCT00374803|4187729|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360474|NCT00374556|4187744|B3|||Duration of OA||months|Mean|95.6|95.6|Standard Deviation|95.69|95.69|||
4360475|NCT00374556|4187745|B2|||Duration of OA||months|Mean|108.5|108.5|Standard Deviation|95.11|95.11|||
4360476|NCT00374556|4187746|B1|||Duration of OA||months|Mean|87.7|87.7|Standard Deviation|98.06|98.06|||
4360477|NCT00374556|4187744|B3|||BMI||kg/m^2|Mean|30.42|30.42|Standard Deviation|5.91|5.91|||
4360478|NCT00374556|4187745|B2|||BMI||kg/m^2|Mean|31.36|31.36|Standard Deviation|6.53|6.53|||
4360479|NCT00374556|4187746|B1|||BMI||kg/m^2|Mean|29.41|29.41|Standard Deviation|5.21|5.21|||
4360480|NCT00374556|4187744|B3|||Kellgren Lawrence OA grade >=3 in either knee|grade 0: no radiographic features of OA are present grade 1: doubtful joint space narrowing (JSN) and possible osteophytic lipping grade 2: definite osteophytes and possible JSN on anteroposterior weight-bearing radiograph grade 3: multiple osteophytes, definite JSN, sclerosis, possible bony deformity grade 4: large osteophytes, marked JSN, severe sclerosis and definite bony deformity|participants|Number|10|10.0||||||
4360481|NCT00374556|4187745|B2|||Kellgren Lawrence OA grade >=3 in either knee|grade 0: no radiographic features of OA are present grade 1: doubtful joint space narrowing (JSN) and possible osteophytic lipping grade 2: definite osteophytes and possible JSN on anteroposterior weight-bearing radiograph grade 3: multiple osteophytes, definite JSN, sclerosis, possible bony deformity grade 4: large osteophytes, marked JSN, severe sclerosis and definite bony deformity|participants|Number|4|4.0||||||
4360482|NCT00374556|4187746|B1|||Kellgren Lawrence OA grade >=3 in either knee|grade 0: no radiographic features of OA are present grade 1: doubtful joint space narrowing (JSN) and possible osteophytic lipping grade 2: definite osteophytes and possible JSN on anteroposterior weight-bearing radiograph grade 3: multiple osteophytes, definite JSN, sclerosis, possible bony deformity grade 4: large osteophytes, marked JSN, severe sclerosis and definite bony deformity|participants|Number|6|6.0||||||
4360483|NCT00374556|4187744|B3|Left Knee||Kellgren Lawrence OA grade|grade 0: no radiographic features of osteoarthritis (OA) are present grade 1: doubtful joint space narrowing (JSN) and possible osteophytic lipping grade 2: definite osteophytes and possible JSN on anteroposterior weight-bearing radiograph grade 3: multiple osteophytes, definite JSN, sclerosis, possible bony deformity grade 4: large osteophytes, marked JSN, severe sclerosis and definite bony deformity|units on a scale|Mean|1.93|1.93|Standard Deviation|1.05|1.05|||
4360484|NCT00374556|4187745|B2|Left Knee||Kellgren Lawrence OA grade|grade 0: no radiographic features of osteoarthritis (OA) are present grade 1: doubtful joint space narrowing (JSN) and possible osteophytic lipping grade 2: definite osteophytes and possible JSN on anteroposterior weight-bearing radiograph grade 3: multiple osteophytes, definite JSN, sclerosis, possible bony deformity grade 4: large osteophytes, marked JSN, severe sclerosis and definite bony deformity|units on a scale|Mean|1.79|1.79|Standard Deviation|1.05|1.05|||
4360530|NCT00374335|4187815|B1|||Age||years|Mean|0.3|0.3|Standard Deviation|0.1|0.1|||
4360531|NCT00374335|4187815|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4360485|NCT00374556|4187746|B1|Left Knee||Kellgren Lawrence OA grade|grade 0: no radiographic features of osteoarthritis (OA) are present grade 1: doubtful joint space narrowing (JSN) and possible osteophytic lipping grade 2: definite osteophytes and possible JSN on anteroposterior weight-bearing radiograph grade 3: multiple osteophytes, definite JSN, sclerosis, possible bony deformity grade 4: large osteophytes, marked JSN, severe sclerosis and definite bony deformity|units on a scale|Mean|2.07|2.07|Standard Deviation|1.07|1.07|||
4360486|NCT00374556|4187744|B3|Right knee||Kellgren Lawrence OA grade|grade 0: no radiographic features of osteoarthritis (OA) are present grade 1: doubtful joint space narrowing (JSN) and possible osteophytic lipping grade 2: definite osteophytes and possible JSN on anteroposterior weight-bearing radiograph grade 3: multiple osteophytes, definite JSN, sclerosis, possible bony deformity grade 4: large osteophytes, marked JSN, severe sclerosis and definite bony deformity|units on a scale|Mean|1.79|1.79|Standard Deviation|0.92|0.92|||
4360487|NCT00374556|4187745|B2|Right knee||Kellgren Lawrence OA grade|grade 0: no radiographic features of osteoarthritis (OA) are present grade 1: doubtful joint space narrowing (JSN) and possible osteophytic lipping grade 2: definite osteophytes and possible JSN on anteroposterior weight-bearing radiograph grade 3: multiple osteophytes, definite JSN, sclerosis, possible bony deformity grade 4: large osteophytes, marked JSN, severe sclerosis and definite bony deformity|units on a scale|Mean|1.53|1.53|Standard Deviation|0.91|0.91|||
4360488|NCT00374556|4187746|B1|Right knee||Kellgren Lawrence OA grade|grade 0: no radiographic features of osteoarthritis (OA) are present grade 1: doubtful joint space narrowing (JSN) and possible osteophytic lipping grade 2: definite osteophytes and possible JSN on anteroposterior weight-bearing radiograph grade 3: multiple osteophytes, definite JSN, sclerosis, possible bony deformity grade 4: large osteophytes, marked JSN, severe sclerosis and definite bony deformity|units on a scale|Mean|2.08|2.08|Standard Deviation|0.86|0.86|||
4360489|NCT00374556|4187744|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4360490|NCT00374556|4187745|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4360491|NCT00374556|4187746|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4360492|NCT00374556|4187744|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4360493|NCT00374556|4187745|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4360494|NCT00374556|4187746|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4360495|NCT00374556|4187744|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4360496|NCT00374556|4187745|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4360497|NCT00374556|4187746|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4360498|NCT00374556|4187744|B3|||Age||years|Mean|53.76|53.76|Standard Deviation|5.94|5.94|||
4360499|NCT00374556|4187745|B2|||Age||years|Mean|52.93|52.93|Standard Deviation|6.64|6.64|||
4360500|NCT00374556|4187746|B1|||Age||years|Mean|54.64|54.64|Standard Deviation|5.18|5.18|||
4360501|NCT00374543|4187797|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4360502|NCT00374543|4187798|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4360503|NCT00374543|4187799|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4360504|NCT00374543|4187797|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4360505|NCT00374543|4187798|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4360506|NCT00374543|4187799|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4360507|NCT00374543|4187797|B3|>75 years||Age, Customized||Participants|Number|0|0.0||||||
4360508|NCT00374543|4187798|B2|>75 years||Age, Customized||Participants|Number|0|0.0||||||
4360509|NCT00374543|4187799|B1|>75 years||Age, Customized||Participants|Number|0|0.0||||||
4360510|NCT00374543|4187797|B3|>= 18 to 75 years||Age, Customized||Participants|Number|3|3.0||||||
4360511|NCT00374543|4187798|B2|>= 18 to 75 years||Age, Customized||Participants|Number|1|1.0||||||
4360512|NCT00374543|4187799|B1|>= 18 to 75 years||Age, Customized||Participants|Number|2|2.0||||||
4360513|NCT00374543|4187797|B3|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4360514|NCT00374543|4187798|B2|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4360515|NCT00374543|4187799|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4360516|NCT00374452|4187806|B3|United States||Region of Enrollment||Participants|Count of Participants|76|76.0||||||
4360517|NCT00374452|4187807|B2|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
4360518|NCT00374452|4187808|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4360519|NCT00374452|4187806|B3|Mean percentage male participants per clinic||Sex/Gender, Customized|Measured percentage of male participants per clinic site, then mean of these percentages for study arm.|percentage of male participants|Number|30.1|30.1||||||
4360520|NCT00374452|4187807|B2|Mean percentage male participants per clinic||Sex/Gender, Customized|Measured percentage of male participants per clinic site, then mean of these percentages for study arm.|percentage of male participants|Number|24.6|24.6||||||
4360521|NCT00374452|4187808|B1|Mean percentage male participants per clinic||Sex/Gender, Customized|Measured percentage of male participants per clinic site, then mean of these percentages for study arm.|percentage of male participants|Number|35.5|35.5||||||
4360522|NCT00374452|4187806|B3|Age >= 18 years||Age, Customized||Participants|Count of Participants|76|76.0||||||
4360523|NCT00374452|4187807|B2|Age >= 18 years||Age, Customized||Participants|Count of Participants|46|46.0||||||
4360524|NCT00374452|4187808|B1|Age >= 18 years||Age, Customized||Participants|Count of Participants|30|30.0||||||
4360525|NCT00374335|4187815|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4360526|NCT00374335|4187815|B1|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4360527|NCT00374335|4187815|B1|United States||Region of Enrollment||participants|Number|232|232.0||||||
4360528|NCT00374335|4187815|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4360529|NCT00374335|4187815|B1||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4360532|NCT00374335|4187815|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4360533|NCT00374335|4187815|B1||<=18 years|Age||Participants|Count of Participants|261|261.0||||||
4360534|NCT00374322|4187820|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|2247|2247.0||||||
4360535|NCT00374322|4187821|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|1121|1121.0||||||
4360536|NCT00374322|4187822|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|1126|1126.0||||||
4360537|NCT00374322|4187820|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|14|14.0||||||
4360538|NCT00374322|4187821|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|11|11.0||||||
4360539|NCT00374322|4187822|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|3|3.0||||||
4360540|NCT00374322|4187820|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|16|16.0||||||
4360541|NCT00374322|4187821|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|11|11.0||||||
4360542|NCT00374322|4187822|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|5|5.0||||||
4360543|NCT00374322|4187820|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|162|162.0||||||
4360544|NCT00374322|4187821|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|81|81.0||||||
4360545|NCT00374322|4187822|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|81|81.0||||||
4360546|NCT00374322|4187820|B3|Asian - Japanese Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|3|3.0||||||
4360547|NCT00374322|4187821|B2|Asian - Japanese Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|2|2.0||||||
4360548|NCT00374322|4187822|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|1|1.0||||||
4360549|NCT00374322|4187820|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|465|465.0||||||
4360550|NCT00374322|4187821|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|229|229.0||||||
4360551|NCT00374322|4187822|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|236|236.0||||||
4360552|NCT00374322|4187820|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|39|39.0||||||
4360553|NCT00374322|4187821|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|19|19.0||||||
4360554|NCT00374322|4187822|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|20|20.0||||||
4360555|NCT00374322|4187820|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|132|132.0||||||
4360556|NCT00374322|4187821|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|67|67.0||||||
4360557|NCT00374322|4187822|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|65|65.0||||||
4360558|NCT00374322|4187820|B3|African American/ African Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|115|115.0||||||
4360559|NCT00374322|4187821|B2|African American/ African Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|62|62.0||||||
4360560|NCT00374322|4187822|B1|African American/ African Heritage||Race/Ethnicity, Customized|Participants can appear in more than one race category.|Participants|Number|53|53.0||||||
4360561|NCT00374322|4187820|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4360562|NCT00374322|4187821|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4360563|NCT00374322|4187822|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4360564|NCT00374322|4187820|B3||Female|Sex: Female, Male||Participants|Count of Participants|3147|3147.0||||||
4360565|NCT00374322|4187821|B2||Female|Sex: Female, Male||Participants|Count of Participants|1576|1576.0||||||
4360566|NCT00374322|4187822|B1||Female|Sex: Female, Male||Participants|Count of Participants|1571|1571.0||||||
4360567|NCT00374322|4187820|B3|||Age||Years|Mean|52.0|52.0|Standard Deviation|9.92|9.92|||
4360568|NCT00374322|4187821|B2|||Age||Years|Mean|52.3|52.3|Standard Deviation|9.94|9.94|||
4360569|NCT00374322|4187822|B1|||Age||Years|Mean|51.7|51.7|Standard Deviation|9.89|9.89|||
4360570|NCT00374244|4187859|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4360571|NCT00374244|4187860|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4360572|NCT00374244|4187861|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4360573|NCT00374244|4187859|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4360574|NCT00374244|4187860|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4360575|NCT00374244|4187861|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4360576|NCT00374244|4187859|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|9.0|9.0|||
4360577|NCT00374244|4187860|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|2.0|2.0|||
4360578|NCT00374244|4187861|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|2.8|2.8|||
4360579|NCT00374231|4187908|B1|Other||Cause of Liver Disease||participants|Number|4|4.0||||||
4360580|NCT00374231|4187908|B1|Autoimmune Hepatitis||Cause of Liver Disease||participants|Number|1|1.0||||||
4360581|NCT00374231|4187908|B1|Non-alcholic Steatohepatitis||Cause of Liver Disease||participants|Number|2|2.0||||||
4360582|NCT00374231|4187908|B1|Cryptogenic Cirrhosis||Cause of Liver Disease||participants|Number|6|6.0||||||
4360583|NCT00374231|4187908|B1|Hepatocellular Carcinoma||Cause of Liver Disease||participants|Number|6|6.0||||||
4360584|NCT00374231|4187908|B1|Primary Schlerosing Cholangitis||Cause of Liver Disease||participants|Number|6|6.0||||||
4360585|NCT00374231|4187908|B1|Viral Hepatitis C||Cause of Liver Disease||participants|Number|6|6.0||||||
4360586|NCT00374231|4187908|B1|Alcoholic Liver Disease||Cause of Liver Disease||participants|Number|9|9.0||||||
4360587|NCT00374231|4187908|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360588|NCT00374231|4187908|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360589|NCT00374231|4187908|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4360590|NCT00374231|4187908|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4360591|NCT00374231|4187908|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360592|NCT00374231|4187908|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360593|NCT00374231|4187908|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360594|NCT00374231|4187908|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4360595|NCT00374231|4187908|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4360596|NCT00374231|4187908|B1|||Age||years|Mean|51|51.0|Standard Deviation|12|12.0|||
4360597|NCT00374231|4187908|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4360598|NCT00374231|4187908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4360599|NCT00374231|4187908|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360600|NCT00374140|4187914|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4360601|NCT00374140|4187914|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4360602|NCT00374140|4187914|B1|||Age, Customized||years|Median|64|64.0|Full Range|||44.0|80.0|
4360603|NCT00374127|4187921|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4360604|NCT00374127|4187921|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4360605|NCT00374127|4187921|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4360606|NCT00374127|4187921|B1|||Age||years|Mean|25.5|25.5|Full Range|||21.0|45.0|
4360607|NCT00374127|4187921|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4360608|NCT00374127|4187921|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4360609|NCT00374127|4187921|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360610|NCT00374088|4187955|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4360611|NCT00374088|4187956|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4360612|NCT00374088|4187957|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4360613|NCT00374088|4187955|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4360614|NCT00374088|4187956|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4360615|NCT00374088|4187957|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4360616|NCT00374088|4187955|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4360617|NCT00374088|4187956|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4360618|NCT00374088|4187957|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4360619|NCT00374088|4187955|B3|||Age||years|Mean|0.02|0.02|Standard Deviation|0.007|0.007|||
4360620|NCT00374088|4187956|B2|||Age||years|Mean|0.02|0.02|Standard Deviation|0.006|0.006|||
4360621|NCT00374088|4187957|B1|||Age||years|Mean|0.02|0.02|Standard Deviation|0.007|0.007|||
4360622|NCT00373958|4187968|B3||Male|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4360623|NCT00373958|4187969|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4360624|NCT00373958|4187970|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4360625|NCT00373958|4187968|B3||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4360626|NCT00373958|4187969|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4360627|NCT00373958|4187970|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4360628|NCT00373958|4187968|B3|||Age||months|Mean|2.1|2.1|Standard Deviation|0.3|0.3|||
4360629|NCT00373958|4187969|B2|||Age||months|Mean|2.1|2.1|Standard Deviation|0.3|0.3|||
4360630|NCT00373958|4187970|B1|||Age||months|Mean|2.1|2.1|Standard Deviation|0.3|0.3|||
4360631|NCT00373880|4188019|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4360632|NCT00373880|4188019|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360633|NCT00373880|4188019|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360634|NCT00373880|4188019|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4360635|NCT00373880|4188019|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4360636|NCT00373880|4188019|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360637|NCT00373880|4188019|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360638|NCT00373880|4188019|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4360639|NCT00373880|4188019|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4360640|NCT00373880|4188019|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4360641|NCT00373880|4188019|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|3.9|3.9|||
4360642|NCT00373880|4188019|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4360643|NCT00373880|4188019|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4360644|NCT00373880|4188019|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4360645|NCT00373698|4188047|B3|||SF-36 Physical Component|SF-36 Physical Component is measured as part of SF-36 Health Survey. Scores can range from 0 (poorest possible health ) to 100 (highest possible health).|units on a scale|Mean|NA||Standard Deviation|NA||||The data are locked and can not be calculated.
4360646|NCT00373698|4188048|B2|||SF-36 Physical Component|SF-36 Physical Component is measured as part of SF-36 Health Survey. Scores can range from 0 (poorest possible health ) to 100 (highest possible health).|units on a scale|Mean|43.4|43.4|Standard Deviation|12.6|12.6|||
4360647|NCT00373698|4188049|B1|||SF-36 Physical Component|SF-36 Physical Component is measured as part of SF-36 Health Survey. Scores can range from 0 (poorest possible health ) to 100 (highest possible health).|units on a scale|Mean|42.2|42.2|Standard Deviation|13.0|13.0|||
4360648|NCT00373698|4188047|B3|||SF-36 Mental Component|SF-36 Mental Component is measured as part of SF-36 Health Survey. Scores can range from 0 (poorest possible health ) to 100 (highest possible health).|units on a scale|Mean|NA||Standard Deviation|NA||||The data are locked and can not be calculated.
4360649|NCT00373698|4188048|B2|||SF-36 Mental Component|SF-36 Mental Component is measured as part of SF-36 Health Survey. Scores can range from 0 (poorest possible health ) to 100 (highest possible health).|units on a scale|Mean|32.7|32.7|Standard Deviation|8.1|8.1|||
4360650|NCT00373698|4188049|B1|||SF-36 Mental Component|SF-36 Mental Component is measured as part of SF-36 Health Survey. Scores can range from 0 (poorest possible health ) to 100 (highest possible health).|units on a scale|Mean|33.8|33.8|Standard Deviation|8.8|8.8|||
4360651|NCT00373698|4188047|B3|||Depression (Hopkins Symptom Checklist-20)|Depression severity (ranging 0-4) was measured with the Hopkins Symptom Checklist-20. This self-assessment measure consists of 20 questions with possible scores ranging from 0 to 4, with higher scores indicating worse symptoms. Means and the standard deviations of the 20 questions are presented with higher scores indicating worse depression.|units on a scale|Mean|NA||Standard Deviation|NA||||The data are locked and can not be calculated
4360652|NCT00373698|4188048|B2|||Depression (Hopkins Symptom Checklist-20)|Depression severity (ranging 0-4) was measured with the Hopkins Symptom Checklist-20. This self-assessment measure consists of 20 questions with possible scores ranging from 0 to 4, with higher scores indicating worse symptoms. Means and the standard deviations of the 20 questions are presented with higher scores indicating worse depression.|units on a scale|Mean|2.06|2.06|Standard Deviation|0.78|0.78|||
4360653|NCT00373698|4188049|B1|||Depression (Hopkins Symptom Checklist-20)|Depression severity (ranging 0-4) was measured with the Hopkins Symptom Checklist-20. This self-assessment measure consists of 20 questions with possible scores ranging from 0 to 4, with higher scores indicating worse symptoms. Means and the standard deviations of the 20 questions are presented with higher scores indicating worse depression.|units on a scale|Mean|1.98|1.98|Standard Deviation|0.69|0.69|||
4360654|NCT00373698|4188047|B3|||PTSD symptom severity (used Posttraumatic Diagnostic Scale (PDS))|The PDS yields a total severity score (ranging from 0 to 51, where 0 is the best and 51 is the worst) that largely reflects the frequency of the 17 symptoms of PTSD. 17 symptoms of PTSD are rated individually on a scale from 0 to 3, with 3 being the highest. Total severity score is calculated by adding the number from each individual symptom. A PDS Profile Report also provides a preliminary determination of DSM-IV PTSD diagnostic status, a count of the number of symptoms endorsed, a rating of symptom severity, and a rating of the level of impairment of functioning.|units on a scale|Mean|NA||Standard Deviation|NA||||The data are locked and can not be calculated
4360655|NCT00373698|4188048|B2|||PTSD symptom severity (used Posttraumatic Diagnostic Scale (PDS))|The PDS yields a total severity score (ranging from 0 to 51, where 0 is the best and 51 is the worst) that largely reflects the frequency of the 17 symptoms of PTSD. 17 symptoms of PTSD are rated individually on a scale from 0 to 3, with 3 being the highest. Total severity score is calculated by adding the number from each individual symptom. A PDS Profile Report also provides a preliminary determination of DSM-IV PTSD diagnostic status, a count of the number of symptoms endorsed, a rating of symptom severity, and a rating of the level of impairment of functioning.|units on a scale|Mean|34.0|34.0|Standard Deviation|9.7|9.7|||
4360656|NCT00373698|4188049|B1|||PTSD symptom severity (used Posttraumatic Diagnostic Scale (PDS))|The PDS yields a total severity score (ranging from 0 to 51, where 0 is the best and 51 is the worst) that largely reflects the frequency of the 17 symptoms of PTSD. 17 symptoms of PTSD are rated individually on a scale from 0 to 3, with 3 being the highest. Total severity score is calculated by adding the number from each individual symptom. A PDS Profile Report also provides a preliminary determination of DSM-IV PTSD diagnostic status, a count of the number of symptoms endorsed, a rating of symptom severity, and a rating of the level of impairment of functioning.|units on a scale|Mean|33.2|33.2|Standard Deviation|8.3|8.3|||
4360657|NCT00373698|4188047|B3|United States||Region of Enrollment||participants|Number|195|195.0||||||
4360658|NCT00373698|4188048|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
4360659|NCT00373698|4188049|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
4360660|NCT00373698|4188047|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4360661|NCT00373698|4188048|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4360662|NCT00373698|4188049|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4360663|NCT00373698|4188047|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4360664|NCT00373698|4188048|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4360665|NCT00373698|4188049|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4360666|NCT00373698|4188047|B3|Age, >=18||Age, Customized||years|Mean|NA||Full Range|||0.0|0.0|The data are locked and the total can not be calculated.
4360667|NCT00373698|4188048|B2|Age, >=18||Age, Customized||years|Mean|44.4|44.4|Full Range|||0.0|0.0|41.3-47.5 (95% confidence interval)
4360668|NCT00373698|4188049|B1|Age, >=18||Age, Customized||years|Mean|46.1|46.1|Full Range|||0.0|0.0|43.1-49.1 (95% confidence interval)
4360669|NCT00373685|4188062|B3|Unspecified||Sex/Gender, Customized||Participants|Number|12|12.0||||||
4360670|NCT00373685|4188063|B2|Unspecified||Sex/Gender, Customized||Participants|Number|6|6.0||||||
4360671|NCT00373685|4188064|B1|Unspecified||Sex/Gender, Customized||Participants|Number|6|6.0||||||
4360672|NCT00373685|4188062|B3|Female||Sex/Gender, Customized||Participants|Number|6113|6113.0||||||
4360673|NCT00373685|4188063|B2|Female||Sex/Gender, Customized||Participants|Number|3064|3064.0||||||
4360674|NCT00373685|4188064|B1|Female||Sex/Gender, Customized||Participants|Number|3049|3049.0||||||
4360675|NCT00373685|4188062|B3|Male||Sex/Gender, Customized||Participants|Number|1942|1942.0||||||
4360676|NCT00373685|4188063|B2|Male||Sex/Gender, Customized||Participants|Number|962|962.0||||||
4360677|NCT00373685|4188064|B1|Male||Sex/Gender, Customized||Participants|Number|980|980.0||||||
4360678|NCT00373685|4188062|B3|Unspecified||Age, Customized||Participants|Number|12|12.0||||||
4360679|NCT00373685|4188063|B2|Unspecified||Age, Customized||Participants|Number|6|6.0||||||
4360680|NCT00373685|4188064|B1|Unspecified||Age, Customized||Participants|Number|6|6.0||||||
4360681|NCT00373685|4188062|B3|>=75 years||Age, Customized||Participants|Number|381|381.0||||||
4360682|NCT00373685|4188063|B2|>=75 years||Age, Customized||Participants|Number|197|197.0||||||
4360683|NCT00373685|4188064|B1|>=75 years||Age, Customized||Participants|Number|184|184.0||||||
4360684|NCT00373685|4188062|B3|70-74 years||Age, Customized||Participants|Number|1021|1021.0||||||
4360685|NCT00373685|4188063|B2|70-74 years||Age, Customized||Participants|Number|517|517.0||||||
4360686|NCT00373685|4188064|B1|70-74 years||Age, Customized||Participants|Number|504|504.0||||||
4360687|NCT00373685|4188062|B3|65-69 years||Age, Customized||Participants|Number|1670|1670.0||||||
4360688|NCT00373685|4188063|B2|65-69 years||Age, Customized||Participants|Number|822|822.0||||||
4360689|NCT00373685|4188064|B1|65-69 years||Age, Customized||Participants|Number|848|848.0||||||
4360690|NCT00373685|4188062|B3|60-64 years||Age, Customized||Participants|Number|2276|2276.0||||||
4360691|NCT00373685|4188063|B2|60-64 years||Age, Customized||Participants|Number|1127|1127.0||||||
4360692|NCT00373685|4188064|B1|60-64 years||Age, Customized||Participants|Number|1149|1149.0||||||
4360693|NCT00373685|4188062|B3|55-59 years||Age, Customized||Participants|Number|2700|2700.0||||||
4360694|NCT00373685|4188063|B2|55-59 years||Age, Customized||Participants|Number|1361|1361.0||||||
4360695|NCT00373685|4188064|B1|55-59 years||Age, Customized||Participants|Number|1339|1339.0||||||
4360696|NCT00373685|4188062|B3|<55 years||Age, Customized||Participants|Number|7|7.0||||||
4360697|NCT00373685|4188063|B2|<55 years||Age, Customized||Participants|Number|2|2.0||||||
4360698|NCT00373685|4188064|B1|<55 years||Age, Customized||Participants|Number|5|5.0||||||
4360699|NCT00373529|4188099|B1|No||Secondary acute myeloid leukemia (AML) at baseline|The diagnosis of secondary AML is based upon investigator judgment regarding prior ionizing radiation and/or chemotherapy.|participants|Number|101|101.0||||||
4360700|NCT00373529|4188099|B1|Yes||Secondary acute myeloid leukemia (AML) at baseline|The diagnosis of secondary AML is based upon investigator judgment regarding prior ionizing radiation and/or chemotherapy.|participants|Number|11|11.0||||||
4360701|NCT00373529|4188099|B1|4 Adverse Prognostic Factors||Participants Summarized by Number of Adverse Prognostic Factors Excluding Intermediate Karyotype|Participant counts by the number of adverse prognostic factors, which include age >= 70 years, antecedent hematologic disorder = Yes, ECOG = 2, and karyotype = unfavorable.|participants|Number|1|1.0||||||
4360702|NCT00373529|4188099|B1|3 Adverse Prognostic Factors||Participants Summarized by Number of Adverse Prognostic Factors Excluding Intermediate Karyotype|Participant counts by the number of adverse prognostic factors, which include age >= 70 years, antecedent hematologic disorder = Yes, ECOG = 2, and karyotype = unfavorable.|participants|Number|27|27.0||||||
4360703|NCT00373529|4188099|B1|2 Adverse Prognostic Factors||Participants Summarized by Number of Adverse Prognostic Factors Excluding Intermediate Karyotype|Participant counts by the number of adverse prognostic factors, which include age >= 70 years, antecedent hematologic disorder = Yes, ECOG = 2, and karyotype = unfavorable.|participants|Number|35|35.0||||||
4360704|NCT00373529|4188099|B1|1 Adverse Prognostic Factor||Participants Summarized by Number of Adverse Prognostic Factors Excluding Intermediate Karyotype|Participant counts by the number of adverse prognostic factors, which include age >= 70 years, antecedent hematologic disorder = Yes, ECOG = 2, and karyotype = unfavorable.|participants|Number|42|42.0||||||
4360705|NCT00373529|4188099|B1|0 Adverse Prognostic Factors||Participants Summarized by Number of Adverse Prognostic Factors Excluding Intermediate Karyotype|Participant counts by the number of adverse prognostic factors, which include age >= 70 years, antecedent hematologic disorder = Yes, ECOG = 2, and karyotype = unfavorable.|participants|Number|7|7.0||||||
4360706|NCT00373529|4188099|B1|4 Adverse Prognostic Factors||Participants Summarized by Number of Adverse Prognostic Factors|Participant counts by the number of adverse prognostic factors, which include age >= 70 years, antecedent hematologic disorder = Yes, ECOG = 2, and karyotype = intermediate or unfavorable.|participants|Number|2|2.0||||||
4360707|NCT00373529|4188099|B1|3 Adverse Prognostic Factors||Participants Summarized by Number of Adverse Prognostic Factors|Participant counts by the number of adverse prognostic factors, which include age >= 70 years, antecedent hematologic disorder = Yes, ECOG = 2, and karyotype = intermediate or unfavorable.|participants|Number|40|40.0||||||
4360708|NCT00373529|4188099|B1|2 Adverse Prognostic Factors||Participants Summarized by Number of Adverse Prognostic Factors|Participant counts by the number of adverse prognostic factors, which include age >= 70 years, antecedent hematologic disorder = Yes, ECOG = 2, and karyotype = intermediate or unfavorable.|participants|Number|45|45.0||||||
4360709|NCT00373529|4188099|B1|1 Adverse Prognostic Factor||Participants Summarized by Number of Adverse Prognostic Factors|Participant counts by the number of adverse prognostic factors, which include age >= 70 years, antecedent hematologic disorder = Yes, ECOG = 2, and karyotype = intermediate or unfavorable.|participants|Number|25|25.0||||||
4360710|NCT00373529|4188099|B1|0 Adverse Prognostic Factors||Participants Summarized by Number of Adverse Prognostic Factors|Participant counts by the number of adverse prognostic factors, which include age >= 70 years, antecedent hematologic disorder = Yes, ECOG = 2, and karyotype = intermediate or unfavorable.|participants|Number|0|0.0||||||
4360711|NCT00373529|4188099|B1|Not reported||Karyotype|A favorable cytogenetic karyotype is associated with a positive prognostic outcome; an unfavorable cytogenetic karyotype is associated with a negative prognostic outcome. An intermediate karyotype is typically associated with a better outcome than a favorable karyotype, but also associated with a worse outcome compared to a favorable karyotype.|participants|Number|4|4.0||||||
4360712|NCT00373529|4188099|B1|Favorable||Karyotype|A favorable cytogenetic karyotype is associated with a positive prognostic outcome; an unfavorable cytogenetic karyotype is associated with a negative prognostic outcome. An intermediate karyotype is typically associated with a better outcome than a favorable karyotype, but also associated with a worse outcome compared to a favorable karyotype.|participants|Number|0|0.0||||||
4360713|NCT00373529|4188099|B1|Unfavorable||Karyotype|A favorable cytogenetic karyotype is associated with a positive prognostic outcome; an unfavorable cytogenetic karyotype is associated with a negative prognostic outcome. An intermediate karyotype is typically associated with a better outcome than a favorable karyotype, but also associated with a worse outcome compared to a favorable karyotype.|participants|Number|62|62.0||||||
4360714|NCT00373529|4188099|B1|Intermediate||Karyotype|A favorable cytogenetic karyotype is associated with a positive prognostic outcome; an unfavorable cytogenetic karyotype is associated with a negative prognostic outcome. An intermediate karyotype is typically associated with a better outcome than a favorable karyotype, but also associated with a worse outcome compared to a favorable karyotype.|participants|Number|46|46.0||||||
4360715|NCT00373529|4188099|B1|ECOG 0||Eastern Cooperative Oncology Group Performance Status|Another prognostic factor. Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0=fully active, 1=capable of light work, 2=no work but all self-care, 3=limited self-care, 4=completely disabled, 5=dead.|participants|Number|21|21.0||||||
4360716|NCT00373529|4188099|B1|ECOG 1||Eastern Cooperative Oncology Group Performance Status|Another prognostic factor. Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0=fully active, 1=capable of light work, 2=no work but all self-care, 3=limited self-care, 4=completely disabled, 5=dead.|participants|Number|66|66.0||||||
4360717|NCT00373529|4188099|B1|ECOG 2||Eastern Cooperative Oncology Group Performance Status|Another prognostic factor. Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0=fully active, 1=capable of light work, 2=no work but all self-care, 3=limited self-care, 4=completely disabled, 5=dead.|participants|Number|25|25.0||||||
4360718|NCT00373529|4188099|B1|ECOG 3||Eastern Cooperative Oncology Group Performance Status|Another prognostic factor. Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0=fully active, 1=capable of light work, 2=no work but all self-care, 3=limited self-care, 4=completely disabled, 5=dead.|participants|Number|0|0.0||||||
4360719|NCT00373529|4188099|B1|ECOG 4||Eastern Cooperative Oncology Group Performance Status|Another prognostic factor. Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0=fully active, 1=capable of light work, 2=no work but all self-care, 3=limited self-care, 4=completely disabled, 5=dead.|participants|Number|0|0.0||||||
4360720|NCT00373529|4188099|B1|ECOG 5||Eastern Cooperative Oncology Group Performance Status|Another prognostic factor. Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0=fully active, 1=capable of light work, 2=no work but all self-care, 3=limited self-care, 4=completely disabled, 5=dead.|participants|Number|0|0.0||||||
4360721|NCT00373529|4188099|B1|Not reported||Antecedent Hematologic Disorder|The most common risk factor for acute myelogenous leukemia (AML) is the presence of an antecedent hematologic disorder.|participants|Number|4|4.0||||||
4360722|NCT00373529|4188099|B1|No||Antecedent Hematologic Disorder|The most common risk factor for acute myelogenous leukemia (AML) is the presence of an antecedent hematologic disorder.|participants|Number|67|67.0||||||
4360723|NCT00373529|4188099|B1|Yes||Antecedent Hematologic Disorder|The most common risk factor for acute myelogenous leukemia (AML) is the presence of an antecedent hematologic disorder.|participants|Number|41|41.0||||||
4360724|NCT00373529|4188099|B1|< 70 years||Age at Enrollment|Being 70 years old or older is considered an adverse prognostic factor.|participants|Number|43|43.0||||||
4360725|NCT00373529|4188099|B1|>= 70 years||Age at Enrollment|Being 70 years old or older is considered an adverse prognostic factor.|participants|Number|69|69.0||||||
4360726|NCT00373529|4188099|B1|||Weight||kg|Mean|78.45|78.45|Standard Deviation|18.191|18.191|||
4360727|NCT00373529|4188099|B1|||Height||cm|Mean|166.50|166.5|Standard Deviation|10.366|10.366|||
4360728|NCT00373529|4188099|B1|Not Hispanic or Latino||Ethnicity||participants|Number|108|108.0||||||
4360729|NCT00373529|4188099|B1|Hispanic or Latino||Ethnicity||participants|Number|4|4.0||||||
4360730|NCT00373529|4188099|B1|Other||Race||participants|Number|2|2.0||||||
4360731|NCT00373529|4188099|B1|White||Race||participants|Number|98|98.0||||||
4360732|NCT00373529|4188099|B1|Black or African American||Race||participants|Number|7|7.0||||||
4360733|NCT00373529|4188099|B1|Native Hawaiian or Other Pacific Islander||Race||participants|Number|0|0.0||||||
4360734|NCT00373529|4188099|B1|Asian||Race||participants|Number|4|4.0||||||
4360735|NCT00373529|4188099|B1|American Indian or Alaska Native||Race||participants|Number|1|1.0||||||
4360736|NCT00373529|4188099|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4360737|NCT00373529|4188099|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4360738|NCT00373529|4188099|B1|||Age||years|Median|71.0|71.0|Full Range|||60.0|88.0|
4360739|NCT00373529|4188099|B1|||Age||years|Mean|71.4|71.4|Standard Deviation|5.92|5.92|||
4360740|NCT00373490|4188109|B3|||Prior chemotherapy regimens||Number of prior chemotherapy regimens|Median|4|4.0|Full Range|||2.0|6.0|
4360741|NCT00373490|4188110|B2|||Prior chemotherapy regimens||Number of prior chemotherapy regimens|Median|4.5|4.5|Full Range|||3.0|6.0|
4360742|NCT00373490|4188111|B1|||Prior chemotherapy regimens||Number of prior chemotherapy regimens|Median|3.5|3.5|Full Range|||2.0|6.0|
4360743|NCT00373490|4188109|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4360744|NCT00373490|4188110|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4360745|NCT00373490|4188111|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4360746|NCT00373490|4188109|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4360747|NCT00373490|4188110|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4360748|NCT00373490|4188111|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4360749|NCT00373490|4188109|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|10.1|10.1|||
4360750|NCT00373490|4188110|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|12|12.0|||
4360751|NCT00373490|4188111|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|8.4|8.4|||
4360752|NCT00373425|4188130|B6|Undetermined||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|20|20.0||||||
4360753|NCT00373425|4188131|B5|Undetermined||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|0|0.0||||||
4360754|NCT00373425|4188132|B4|Undetermined||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|0|0.0||||||
4360755|NCT00373425|4188133|B3|Undetermined||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|1|1.0||||||
4360756|NCT00373425|4188134|B2|Undetermined||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|8|8.0||||||
4360757|NCT00373425|4188135|B1|Undetermined||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|11|11.0||||||
4360758|NCT00373425|4188130|B6|Negative||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|338|338.0||||||
4360759|NCT00373425|4188131|B5|Negative||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|32|32.0||||||
4360760|NCT00373425|4188132|B4|Negative||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|3|3.0||||||
4360761|NCT00373425|4188133|B3|Negative||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|49|49.0||||||
4360762|NCT00373425|4188134|B2|Negative||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|87|87.0||||||
4360763|NCT00373425|4188135|B1|Negative||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|167|167.0||||||
4360764|NCT00373425|4188130|B6|Positive||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|892|892.0||||||
4360765|NCT00373425|4188131|B5|Positive||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|100|100.0||||||
4360766|NCT00373425|4188132|B4|Positive||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|8|8.0||||||
4360767|NCT00373425|4188133|B3|Positive||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|84|84.0||||||
4360768|NCT00373425|4188134|B2|Positive||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|255|255.0||||||
4360769|NCT00373425|4188135|B1|Positive||EGFR Gene Amplification|Analysis of tumor tissue by fluorescent in situ hybridization (FISH), positivity was defined as amplification (EGFR gene to chromosome ratio of ≥ 2 or ≥ 15 EGFR gene copies in ≥ 10% of tumor cells) or high polysomy (≥ 4 EGFR gene copies in ≥ 40% of tumor cells) .|participants|Number|445|445.0||||||
4360770|NCT00373425|4188130|B6|Not Available||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|11|11.0||||||
4360771|NCT00373425|4188131|B5|Not Available||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|2|2.0||||||
4360772|NCT00373425|4188132|B4|Not Available||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|0|0.0||||||
4360773|NCT00373425|4188133|B3|Not Available||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|2|2.0||||||
4360774|NCT00373425|4188134|B2|Not Available||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|3|3.0||||||
4360775|NCT00373425|4188135|B1|Not Available||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|4|4.0||||||
4360776|NCT00373425|4188130|B6|Activating mutation not positive||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|68|68.0||||||
4360777|NCT00373425|4188131|B5|Activating mutation not positive||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|6|6.0||||||
4360778|NCT00373425|4188132|B4|Activating mutation not positive||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|0|0.0||||||
4360779|NCT00373425|4188133|B3|Activating mutation not positive||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|5|5.0||||||
4360780|NCT00373425|4188134|B2|Activating mutation not positive||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|27|27.0||||||
4360881|NCT00373425|4188133|B3|Adenocarcinoma||Histology||participants|Number|73|73.0||||||
4360882|NCT00373425|4188134|B2|Adenocarcinoma||Histology||participants|Number|211|211.0||||||
4360781|NCT00373425|4188135|B1|Activating mutation not positive||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|30|30.0||||||
4360782|NCT00373425|4188130|B6|Undetermined||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|47|47.0||||||
4360783|NCT00373425|4188131|B5|Undetermined||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|1|1.0||||||
4360784|NCT00373425|4188132|B4|Undetermined||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|0|0.0||||||
4360785|NCT00373425|4188133|B3|Undetermined||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|1|1.0||||||
4360786|NCT00373425|4188134|B2|Undetermined||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|16|16.0||||||
4360787|NCT00373425|4188135|B1|Undetermined||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|29|29.0||||||
4360788|NCT00373425|4188130|B6|Wild-type||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|937|937.0||||||
4360789|NCT00373425|4188131|B5|Wild-type||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|107|107.0||||||
4360790|NCT00373425|4188132|B4|Wild-type||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|11|11.0||||||
4360791|NCT00373425|4188133|B3|Wild-type||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|116|116.0||||||
4360792|NCT00373425|4188134|B2|Wild-type||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|245|245.0||||||
4360883|NCT00373425|4188135|B1|Adenocarcinoma||Histology||participants|Number|367|367.0||||||
4360793|NCT00373425|4188135|B1|Wild-type||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|458|458.0||||||
4360794|NCT00373425|4188130|B6|Activating mutation-positive||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|187|187.0||||||
4360795|NCT00373425|4188131|B5|Activating mutation-positive||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|16|16.0||||||
4360796|NCT00373425|4188132|B4|Activating mutation-positive||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|0|0.0||||||
4360797|NCT00373425|4188133|B3|Activating mutation-positive||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|10|10.0||||||
4360798|NCT00373425|4188134|B2|Activating mutation-positive||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|59|59.0||||||
4360799|NCT00373425|4188135|B1|Activating mutation-positive||Epidermal Growth Factor Receptor (EGFR) Mutation Status|"EGFR mutation status:~Activating mutation-positive: exon 19 deletion or exon 21 L858R (or both) detected.~Wild-type: neither exon 19 deletion nor exon 21 L858R or any other mutation (exon 18, 19, 20 and 21) detected or undetermined.~Undetermined: exon 19 deletion or exon 21 L858R (or both) mutation status undetermined.~Activating mutation not positive: neither exon 19 deletion nor exon 21 L858R detected or undetermined (includes other mutation positive and other mutation status undetermined)."|participants|Number|102|102.0||||||
4360800|NCT00373425|4188130|B6|No||Adjuvant Chemotherapy||participants|Number|599|599.0||||||
4360801|NCT00373425|4188131|B5|No||Adjuvant Chemotherapy||participants|Number|64|64.0||||||
4360802|NCT00373425|4188132|B4|No||Adjuvant Chemotherapy||participants|Number|6|6.0||||||
4360803|NCT00373425|4188133|B3|No||Adjuvant Chemotherapy||participants|Number|71|71.0||||||
4360804|NCT00373425|4188134|B2|No||Adjuvant Chemotherapy||participants|Number|150|150.0||||||
4360805|NCT00373425|4188135|B1|No||Adjuvant Chemotherapy||participants|Number|308|308.0||||||
4360806|NCT00373425|4188130|B6|Yes||Adjuvant Chemotherapy||participants|Number|651|651.0||||||
4360807|NCT00373425|4188131|B5|Yes||Adjuvant Chemotherapy||participants|Number|68|68.0||||||
4360808|NCT00373425|4188132|B4|Yes||Adjuvant Chemotherapy||participants|Number|5|5.0||||||
4360809|NCT00373425|4188133|B3|Yes||Adjuvant Chemotherapy||participants|Number|63|63.0||||||
4360810|NCT00373425|4188134|B2|Yes||Adjuvant Chemotherapy||participants|Number|200|200.0||||||
4360811|NCT00373425|4188135|B1|Yes||Adjuvant Chemotherapy||participants|Number|315|315.0||||||
4360812|NCT00373425|4188130|B6|Stage IV||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|2|2.0||||||
4360813|NCT00373425|4188131|B5|Stage IV||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|0|0.0||||||
4360814|NCT00373425|4188132|B4|Stage IV||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|1|1.0||||||
4360815|NCT00373425|4188133|B3|Stage IV||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|0|0.0||||||
4360816|NCT00373425|4188134|B2|Stage IV||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|0|0.0||||||
4360884|NCT00373425|4188130|B6|Current smoker||Cigarette Smoking History||participants|Number|133|133.0||||||
4360817|NCT00373425|4188135|B1|Stage IV||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|1|1.0||||||
4360818|NCT00373425|4188130|B6|Stage IIIB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|7|7.0||||||
4360819|NCT00373425|4188131|B5|Stage IIIB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|3|3.0||||||
4360820|NCT00373425|4188132|B4|Stage IIIB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|0|0.0||||||
4360821|NCT00373425|4188133|B3|Stage IIIB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|2|2.0||||||
4360822|NCT00373425|4188134|B2|Stage IIIB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|0|0.0||||||
4360823|NCT00373425|4188135|B1|Stage IIIB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|2|2.0||||||
4360824|NCT00373425|4188130|B6|Stage IIIA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|190|190.0||||||
4360825|NCT00373425|4188131|B5|Stage IIIA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|17|17.0||||||
4360826|NCT00373425|4188132|B4|Stage IIIA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|1|1.0||||||
4360827|NCT00373425|4188133|B3|Stage IIIA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|21|21.0||||||
4360828|NCT00373425|4188134|B2|Stage IIIA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|58|58.0||||||
4360829|NCT00373425|4188135|B1|Stage IIIA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|93|93.0||||||
4360830|NCT00373425|4188130|B6|Stage IIB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|317|317.0||||||
4360831|NCT00373425|4188131|B5|Stage IIB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|23|23.0||||||
4360832|NCT00373425|4188132|B4|Stage IIB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|4|4.0||||||
4360833|NCT00373425|4188133|B3|Stage IIB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|36|36.0||||||
4360834|NCT00373425|4188134|B2|Stage IIB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|99|99.0||||||
4360835|NCT00373425|4188135|B1|Stage IIB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|155|155.0||||||
4360836|NCT00373425|4188130|B6|Stage IIA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|86|86.0||||||
4360837|NCT00373425|4188131|B5|Stage IIA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|9|9.0||||||
4360838|NCT00373425|4188132|B4|Stage IIA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|1|1.0||||||
4360839|NCT00373425|4188133|B3|Stage IIA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|10|10.0||||||
4360840|NCT00373425|4188134|B2|Stage IIA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|24|24.0||||||
4360841|NCT00373425|4188135|B1|Stage IIA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|42|42.0||||||
4360842|NCT00373425|4188130|B6|Stage IB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|644|644.0||||||
4360843|NCT00373425|4188131|B5|Stage IB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|80|80.0||||||
4360844|NCT00373425|4188132|B4|Stage IB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|4|4.0||||||
4360845|NCT00373425|4188133|B3|Stage IB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|64|64.0||||||
4360846|NCT00373425|4188134|B2|Stage IB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|167|167.0||||||
4360847|NCT00373425|4188135|B1|Stage IB||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|329|329.0||||||
4360848|NCT00373425|4188130|B6|Stage IA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|4|4.0||||||
4360849|NCT00373425|4188131|B5|Stage IA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|0|0.0||||||
4360850|NCT00373425|4188132|B4|Stage IA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|0|0.0||||||
4360851|NCT00373425|4188133|B3|Stage IA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|1|1.0||||||
4360852|NCT00373425|4188134|B2|Stage IA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|2|2.0||||||
4360853|NCT00373425|4188135|B1|Stage IA||Extent of Disease at Diagnosis|Staging is based on the size of the main tumor and whether it has grown into nearby areas, the spread of cancer to nearby lymph nodes and whether the cancer has spread (metastasized) to other organs of the body.|participants|Number|1|1.0||||||
4360854|NCT00373425|4188130|B6|Other||Histology||participants|Number|15|15.0||||||
4360855|NCT00373425|4188131|B5|Other||Histology||participants|Number|2|2.0||||||
4360856|NCT00373425|4188132|B4|Other||Histology||participants|Number|0|0.0||||||
4360857|NCT00373425|4188133|B3|Other||Histology||participants|Number|2|2.0||||||
4360858|NCT00373425|4188134|B2|Other||Histology||participants|Number|2|2.0||||||
4360859|NCT00373425|4188135|B1|Other||Histology||participants|Number|9|9.0||||||
4360860|NCT00373425|4188130|B6|Mixed NSCLC||Histology||participants|Number|53|53.0||||||
4360861|NCT00373425|4188131|B5|Mixed NSCLC||Histology||participants|Number|1|1.0||||||
4360862|NCT00373425|4188132|B4|Mixed NSCLC||Histology||participants|Number|0|0.0||||||
4360863|NCT00373425|4188133|B3|Mixed NSCLC||Histology||participants|Number|5|5.0||||||
4360864|NCT00373425|4188134|B2|Mixed NSCLC||Histology||participants|Number|18|18.0||||||
4360865|NCT00373425|4188135|B1|Mixed NSCLC||Histology||participants|Number|29|29.0||||||
4360866|NCT00373425|4188130|B6|Undifferentiated large cell||Histology||participants|Number|40|40.0||||||
4360867|NCT00373425|4188131|B5|Undifferentiated large cell||Histology||participants|Number|4|4.0||||||
4360868|NCT00373425|4188132|B4|Undifferentiated large cell||Histology||participants|Number|0|0.0||||||
4360869|NCT00373425|4188133|B3|Undifferentiated large cell||Histology||participants|Number|6|6.0||||||
4360870|NCT00373425|4188134|B2|Undifferentiated large cell||Histology||participants|Number|8|8.0||||||
4360871|NCT00373425|4188135|B1|Undifferentiated large cell||Histology||participants|Number|22|22.0||||||
4360872|NCT00373425|4188130|B6|Squamous cell carcinoma||Histology||participants|Number|412|412.0||||||
4360873|NCT00373425|4188131|B5|Squamous cell carcinoma||Histology||participants|Number|49|49.0||||||
4360874|NCT00373425|4188132|B4|Squamous cell carcinoma||Histology||participants|Number|8|8.0||||||
4360875|NCT00373425|4188133|B3|Squamous cell carcinoma||Histology||participants|Number|48|48.0||||||
4360876|NCT00373425|4188134|B2|Squamous cell carcinoma||Histology||participants|Number|111|111.0||||||
4360877|NCT00373425|4188135|B1|Squamous cell carcinoma||Histology||participants|Number|196|196.0||||||
4360878|NCT00373425|4188130|B6|Adenocarcinoma||Histology||participants|Number|730|730.0||||||
4360879|NCT00373425|4188131|B5|Adenocarcinoma||Histology||participants|Number|76|76.0||||||
4360880|NCT00373425|4188132|B4|Adenocarcinoma||Histology||participants|Number|3|3.0||||||
4360885|NCT00373425|4188131|B5|Current smoker||Cigarette Smoking History||participants|Number|9|9.0||||||
4360886|NCT00373425|4188132|B4|Current smoker||Cigarette Smoking History||participants|Number|1|1.0||||||
4360887|NCT00373425|4188133|B3|Current smoker||Cigarette Smoking History||participants|Number|12|12.0||||||
4360888|NCT00373425|4188134|B2|Current smoker||Cigarette Smoking History||participants|Number|40|40.0||||||
4360889|NCT00373425|4188135|B1|Current smoker||Cigarette Smoking History||participants|Number|71|71.0||||||
4360890|NCT00373425|4188130|B6|Former smoker||Cigarette Smoking History||participants|Number|879|879.0||||||
4360891|NCT00373425|4188131|B5|Former smoker||Cigarette Smoking History||participants|Number|104|104.0||||||
4360892|NCT00373425|4188132|B4|Former smoker||Cigarette Smoking History||participants|Number|9|9.0||||||
4360893|NCT00373425|4188133|B3|Former smoker||Cigarette Smoking History||participants|Number|103|103.0||||||
4360894|NCT00373425|4188134|B2|Former smoker||Cigarette Smoking History||participants|Number|240|240.0||||||
4360895|NCT00373425|4188135|B1|Former smoker||Cigarette Smoking History||participants|Number|423|423.0||||||
4360896|NCT00373425|4188130|B6|Never smoked or ≤ 100 cigarettes in lifetime||Cigarette Smoking History||participants|Number|238|238.0||||||
4360897|NCT00373425|4188131|B5|Never smoked or ≤ 100 cigarettes in lifetime||Cigarette Smoking History||participants|Number|19|19.0||||||
4360898|NCT00373425|4188132|B4|Never smoked or ≤ 100 cigarettes in lifetime||Cigarette Smoking History||participants|Number|1|1.0||||||
4360899|NCT00373425|4188133|B3|Never smoked or ≤ 100 cigarettes in lifetime||Cigarette Smoking History||participants|Number|19|19.0||||||
4360900|NCT00373425|4188134|B2|Never smoked or ≤ 100 cigarettes in lifetime||Cigarette Smoking History||participants|Number|70|70.0||||||
4360901|NCT00373425|4188135|B1|Never smoked or ≤ 100 cigarettes in lifetime||Cigarette Smoking History||participants|Number|129|129.0||||||
4360902|NCT00373425|4188130|B6|Not measured||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|3|3.0||||||
4360903|NCT00373425|4188131|B5|Not measured||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|0|0.0||||||
4360904|NCT00373425|4188132|B4|Not measured||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|0|0.0||||||
4360905|NCT00373425|4188133|B3|Not measured||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|1|1.0||||||
4360906|NCT00373425|4188134|B2|Not measured||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|0|0.0||||||
4360907|NCT00373425|4188135|B1|Not measured||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|2|2.0||||||
4360908|NCT00373425|4188130|B6|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|15|15.0||||||
4360909|NCT00373425|4188131|B5|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|1|1.0||||||
4360910|NCT00373425|4188132|B4|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|0|0.0||||||
4360911|NCT00373425|4188133|B3|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|3|3.0||||||
4360912|NCT00373425|4188134|B2|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|5|5.0||||||
4360913|NCT00373425|4188135|B1|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|6|6.0||||||
4360914|NCT00373425|4188130|B6|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|479|479.0||||||
4360915|NCT00373425|4188131|B5|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|54|54.0||||||
4360916|NCT00373425|4188132|B4|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|6|6.0||||||
4360917|NCT00373425|4188133|B3|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|55|55.0||||||
4360918|NCT00373425|4188134|B2|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|134|134.0||||||
4360919|NCT00373425|4188135|B1|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|230|230.0||||||
4360920|NCT00373425|4188130|B6|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|753|753.0||||||
4360921|NCT00373425|4188131|B5|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|77|77.0||||||
4360922|NCT00373425|4188132|B4|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|5|5.0||||||
4360923|NCT00373425|4188133|B3|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|75|75.0||||||
4360924|NCT00373425|4188134|B2|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|211|211.0||||||
4360925|NCT00373425|4188135|B1|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG criteria: 0: Fully active. 1: Ambulatory, carry out work of a light or sedentary nature. 2: Ambulatory, capable of all selfcare. 3: Capable of limited selfcare, confined to bed or chair more than 50% of waking hours. 4: Completely disabled, no selfcare, totally confined to bed or chair. 5: Dead.|participants|Number|385|385.0||||||
4360926|NCT00373425|4188130|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4360927|NCT00373425|4188131|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4360928|NCT00373425|4188132|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360929|NCT00373425|4188133|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4360930|NCT00373425|4188134|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4360931|NCT00373425|4188135|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4360932|NCT00373425|4188130|B6|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1163|1163.0||||||
4360933|NCT00373425|4188131|B5|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
4360934|NCT00373425|4188132|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4360935|NCT00373425|4188133|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4360936|NCT00373425|4188134|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|322|322.0||||||
4360937|NCT00373425|4188135|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|583|583.0||||||
4360938|NCT00373425|4188130|B6|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4360939|NCT00373425|4188131|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360940|NCT00373425|4188132|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360941|NCT00373425|4188133|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360942|NCT00373425|4188134|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360943|NCT00373425|4188135|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4360944|NCT00373425|4188130|B6|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4360945|NCT00373425|4188131|B5|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360946|NCT00373425|4188132|B4|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360947|NCT00373425|4188133|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4360948|NCT00373425|4188134|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360949|NCT00373425|4188135|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4360950|NCT00373425|4188130|B6|Asian||Race/Ethnicity, Customized||participants|Number|200|200.0||||||
4360951|NCT00373425|4188131|B5|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4360952|NCT00373425|4188132|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4360953|NCT00373425|4188133|B3|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4360954|NCT00373425|4188134|B2|Asian||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4360955|NCT00373425|4188135|B1|Asian||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
4360956|NCT00373425|4188130|B6|Black||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4360957|NCT00373425|4188131|B5|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4360958|NCT00373425|4188132|B4|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4360959|NCT00373425|4188133|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4360960|NCT00373425|4188134|B2|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4360961|NCT00373425|4188135|B1|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4360962|NCT00373425|4188130|B6|White||Race/Ethnicity, Customized||participants|Number|1014|1014.0||||||
4360963|NCT00373425|4188131|B5|White||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4360964|NCT00373425|4188132|B4|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4360965|NCT00373425|4188133|B3|White||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
4360966|NCT00373425|4188134|B2|White||Race/Ethnicity, Customized||participants|Number|279|279.0||||||
4360967|NCT00373425|4188135|B1|White||Race/Ethnicity, Customized||participants|Number|500|500.0||||||
4360968|NCT00373425|4188130|B6||Male|Sex: Female, Male||Participants|Count of Participants|746|746.0||||||
4360969|NCT00373425|4188131|B5||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4360970|NCT00373425|4188132|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4360971|NCT00373425|4188133|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4360972|NCT00373425|4188134|B2||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4360973|NCT00373425|4188135|B1||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4360974|NCT00373425|4188130|B6||Female|Sex: Female, Male||Participants|Count of Participants|504|504.0||||||
4360975|NCT00373425|4188131|B5||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4360976|NCT00373425|4188132|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4360977|NCT00373425|4188133|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4360978|NCT00373425|4188134|B2||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4360979|NCT00373425|4188135|B1||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4360980|NCT00373425|4188130|B6|Breached Protocol Cohort, Open label||Age||years|Mean|61.8|61.8|Standard Deviation|9.35|9.35|||
4360981|NCT00373425|4188131|B5|Breached Protocol Cohort, Open label||Age||years|Mean|61.8|61.8|Standard Deviation|9.35|9.35|||
4360982|NCT00373425|4188132|B4|Breached Protocol Cohort, Open label||Age||years|Mean|NA||Standard Deviation|NA||||Breached Protocol Cohort - Open Label only
4360983|NCT00373425|4188133|B3|Breached Protocol Cohort, Open label||Age||years|Mean|NA||Standard Deviation|NA||||Breached Protocol Cohort - Open Label only
4360984|NCT00373425|4188134|B2|Breached Protocol Cohort, Open label||Age||years|Mean|NA||Standard Deviation|NA||||Breached Protocol Cohort - Open Label only
4360985|NCT00373425|4188135|B1|Breached Protocol Cohort, Open label||Age||years|Mean|NA||Standard Deviation|NA||||Breached Protocol Cohort - Open Label only
4360986|NCT00373425|4188130|B6|Breached Protocol Cohort, No Open label||Age||years|Mean|64.3|64.3|Standard Deviation|9.13|9.13|||
4360987|NCT00373425|4188131|B5|Breached Protocol Cohort, No Open label||Age||years|Mean|NA||Standard Deviation|NA||||Breached Protocol Cohort - No Open Label only
4360988|NCT00373425|4188132|B4|Breached Protocol Cohort, No Open label||Age||years|Mean|62.7|62.7|Standard Deviation|6.23|6.23|||
4360989|NCT00373425|4188133|B3|Breached Protocol Cohort, No Open label||Age||years|Mean|64.4|64.4|Standard Deviation|9.33|9.33|||
4360990|NCT00373425|4188134|B2|Breached Protocol Cohort, No Open label||Age||years|Mean|NA||Standard Deviation|NA||||Breached Protocol Cohort - No Open Label only
4360991|NCT00373425|4188135|B1|Breached Protocol Cohort, No Open label||Age||years|Mean|NA||Standard Deviation|NA||||Breached Protocol Cohort - No Open Label only
4360992|NCT00373425|4188130|B6|Randomized Cohort||Age||years|Mean|61.9|61.9|Standard Deviation|9.30|9.3|||
4360993|NCT00373425|4188131|B5|Randomized Cohort||Age||years|Mean|NA||Standard Deviation|NA||||Randomized Cohort only
4360994|NCT00373425|4188132|B4|Randomized Cohort||Age||years|Mean|NA||Standard Deviation|NA||||Randomized Cohort only
4360995|NCT00373425|4188133|B3|Randomized Cohort||Age||years|Mean|NA||Standard Deviation|NA||||Randomized Cohort only
4360996|NCT00373425|4188134|B2|Randomized Cohort||Age||years|Mean|61.8|61.8|Standard Deviation|9.34|9.34|||
4360997|NCT00373425|4188135|B1|Randomized Cohort||Age||years|Mean|62.0|62.0|Standard Deviation|9.28|9.28|||
4360998|NCT00373399|4188164|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4360999|NCT00373399|4188164|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361000|NCT00373399|4188164|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4361001|NCT00373399|4188164|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4361002|NCT00373399|4188164|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4361003|NCT00373399|4188164|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361004|NCT00373399|4188164|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361005|NCT00373399|4188164|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361006|NCT00373399|4188164|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4361007|NCT00373399|4188164|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4361008|NCT00373399|4188164|B1|||Age||years|Mean|25.4|25.4|Standard Deviation|4.0|4.0|||
4361009|NCT00373399|4188164|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361010|NCT00373399|4188164|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4361011|NCT00373399|4188164|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361012|NCT00373386|4188177|B1|||DBP||mmHg|Mean|47|47.0|Standard Deviation|9|9.0|||
4361013|NCT00373386|4188177|B1|||SBP||mmHg|Mean|96|96.0|Standard Deviation|9|9.0|||
4361014|NCT00373386|4188177|B1|||HDL||mg/dl|Mean|44|44.0|Standard Deviation|6|6.0|||
4361015|NCT00373386|4188177|B1|||ldl||mg/dl|Mean|127|127.0|Standard Deviation|51|51.0|||
4361016|NCT00373386|4188177|B1|||triglycerides||mg/dl|Mean|115|115.0|Standard Deviation|150|150.0|||
4361017|NCT00373386|4188177|B1|||Homa||mg*uU/dl*ml|Mean|21|21.0|Standard Deviation|21|21.0|||
4361018|NCT00373386|4188177|B1|||insulin||uU/ml|Mean|5.7|5.7|Standard Deviation|4.8|4.8|||
4361019|NCT00373386|4188177|B1|||Glucose||mg/dl|Mean|82|82.0|Standard Deviation|9|9.0|||
4361020|NCT00373386|4188177|B1|||Post occlusion forearm blood flow||ml/dl*min|Mean|22.8|22.8|Standard Deviation|9.9|9.9|||
4361021|NCT00373386|4188177|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4361022|NCT00373386|4188177|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4361023|NCT00373386|4188177|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4361024|NCT00373386|4188177|B1|||Age||years|Mean|11.9|11.9|Standard Deviation|2.4|2.4|||
4361025|NCT00373360|4188187|B1|||Epoprostenol dose||ng/kg/min|Mean|27.15|27.15|Full Range|||15.0|58.0|
4361026|NCT00373360|4188187|B1|||Six minute walk distance||meters|Mean|447.7|447.7|Full Range|||195.0|663.0|
4361027|NCT00373360|4188187|B1|Class III||World Health Organization (WHO) Functional Classification for PAH|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|4|4.0||||||
4361028|NCT00373360|4188187|B1|Class II||World Health Organization (WHO) Functional Classification for PAH|Class I: No limitation of physical activity. Class II: Slight limitation of physical activity. Class III: Marked limitation of physical activity. Class IV: Inability to carry out any physical activity without symptoms.|participants|Number|6|6.0||||||
4361029|NCT00373360|4188187|B1|Other||PAH Etiology||participants|Number|1|1.0||||||
4361030|NCT00373360|4188187|B1|Connective Tissue Disease (CTD)||PAH Etiology||participants|Number|2|2.0||||||
4361031|NCT00373360|4188187|B1|Idiopathic PAH||PAH Etiology||participants|Number|7|7.0||||||
4361032|NCT00373360|4188187|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4361033|NCT00373360|4188187|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361034|NCT00373360|4188187|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361035|NCT00373360|4188187|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4361036|NCT00373360|4188187|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4361037|NCT00373360|4188187|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361038|NCT00373360|4188187|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361039|NCT00373360|4188187|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361040|NCT00373360|4188187|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361041|NCT00373360|4188187|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4361042|NCT00373360|4188187|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361043|NCT00373360|4188187|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4361044|NCT00373360|4188187|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4361045|NCT00373360|4188187|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4361046|NCT00373360|4188187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4361047|NCT00373360|4188187|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361048|NCT00373334|4188215|B4|United States||Region of Enrollment||participants|Number|138|138.0||||||
4361049|NCT00373334|4188216|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4361050|NCT00373334|4188217|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4361051|NCT00373334|4188218|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4361052|NCT00373334|4188215|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4361053|NCT00373334|4188216|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4361054|NCT00373334|4188217|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4361055|NCT00373334|4188218|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4361056|NCT00373334|4188215|B4||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4361057|NCT00373334|4188216|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4361058|NCT00373334|4188217|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4361059|NCT00373334|4188218|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4361060|NCT00373334|4188215|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361061|NCT00373334|4188216|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361062|NCT00373334|4188217|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361063|NCT00373334|4188218|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361064|NCT00373334|4188215|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4361065|NCT00373334|4188216|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4361066|NCT00373334|4188217|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4361067|NCT00373334|4188218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4361068|NCT00373334|4188215|B4||<=18 years|Age||Participants|Count of Participants|138|138.0||||||
4361069|NCT00373334|4188216|B3||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
4361070|NCT00373334|4188217|B2||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4361071|NCT00373334|4188218|B1||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
4361072|NCT00373295|4188234|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4361073|NCT00373295|4188234|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4361074|NCT00373295|4188234|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4361075|NCT00373295|4188234|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361076|NCT00373295|4188234|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4361077|NCT00373295|4188234|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361078|NCT00373269|4188247|B3|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4361079|NCT00373269|4188248|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4361080|NCT00373269|4188249|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4361081|NCT00373269|4188247|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
4361082|NCT00373269|4188248|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
4361083|NCT00373269|4188249|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4361084|NCT00373269|4188247|B3||Female|Gender||Participants|Count of Participants|12|12.0||||||
4361085|NCT00373269|4188248|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
4361086|NCT00373269|4188249|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4361087|NCT00373269|4188247|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|18.4|18.4|||
4361088|NCT00373269|4188248|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|9.2|9.2|||
4361089|NCT00373269|4188249|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|17.7|17.7|||
4361090|NCT00373269|4188247|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4361091|NCT00373269|4188248|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4361092|NCT00373269|4188249|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4361093|NCT00373269|4188247|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4361094|NCT00373269|4188248|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4361095|NCT00373269|4188249|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4361096|NCT00373269|4188247|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361097|NCT00373269|4188248|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361098|NCT00373269|4188249|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361099|NCT00373256|4188258|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4361100|NCT00373256|4188259|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4361101|NCT00373256|4188260|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4361102|NCT00373256|4188258|B3||Female|Sex: Female, Male||Participants|Count of Participants|487|487.0||||||
4361103|NCT00373256|4188259|B2||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4361104|NCT00373256|4188260|B1||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4361105|NCT00373256|4188258|B3|more than 65 years||Age, Customized||Participants|Number|129|129.0||||||
4361106|NCT00373256|4188259|B2|more than 65 years||Age, Customized||Participants|Number|70|70.0||||||
4361107|NCT00373256|4188260|B1|more than 65 years||Age, Customized||Participants|Number|59|59.0||||||
4361108|NCT00373256|4188258|B3|45 to 64 years||Age, Customized||Participants|Number|281|281.0||||||
4361109|NCT00373256|4188259|B2|45 to 64 years||Age, Customized||Participants|Number|137|137.0||||||
4361110|NCT00373256|4188260|B1|45 to 64 years||Age, Customized||Participants|Number|144|144.0||||||
4361111|NCT00373256|4188258|B3|18 to 44 years||Age, Customized||Participants|Number|78|78.0||||||
4361112|NCT00373256|4188259|B2|18 to 44 years||Age, Customized||Participants|Number|40|40.0||||||
4361113|NCT00373256|4188260|B1|18 to 44 years||Age, Customized||Participants|Number|38|38.0||||||
4361114|NCT00373113|4188285|B3|Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4361115|NCT00373113|4188286|B2|Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4361116|NCT00373113|4188287|B1|Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4361117|NCT00373113|4188285|B3|Female||Sex/Gender, Customized||Participants|Number|482|482.0||||||
4361118|NCT00373113|4188286|B2|Female||Sex/Gender, Customized||Participants|Number|244|244.0||||||
4361119|NCT00373113|4188287|B1|Female||Sex/Gender, Customized||Participants|Number|238|238.0||||||
4361120|NCT00373113|4188285|B3|> = 65 years||Age, Customized||Participants|Number|74|74.0||||||
4361121|NCT00373113|4188286|B2|> = 65 years||Age, Customized||Participants|Number|45|45.0||||||
4361122|NCT00373113|4188287|B1|> = 65 years||Age, Customized||Participants|Number|29|29.0||||||
4361123|NCT00373113|4188285|B3|45 to 64 years||Age, Customized||Participants|Number|288|288.0||||||
4361124|NCT00373113|4188286|B2|45 to 64 years||Age, Customized||Participants|Number|129|129.0||||||
4361125|NCT00373113|4188287|B1|45 to 64 years||Age, Customized||Participants|Number|159|159.0||||||
4361126|NCT00373113|4188285|B3|18 to 44 years||Age, Customized||Participants|Number|120|120.0||||||
4361127|NCT00373113|4188286|B2|18 to 44 years||Age, Customized||Participants|Number|70|70.0||||||
4361128|NCT00373113|4188287|B1|18 to 44 years||Age, Customized||Participants|Number|50|50.0||||||
4361129|NCT00372996|4188308|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4361130|NCT00372996|4188309|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4361131|NCT00372996|4188310|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4361132|NCT00372996|4188308|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4361133|NCT00372996|4188309|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4361134|NCT00372996|4188310|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4361135|NCT00372996|4188308|B3|||Age||Years|Mean|61.9|61.9|Standard Deviation|10.82|10.82|||
4361136|NCT00372996|4188309|B2|||Age||Years|Mean|62.7|62.7|Standard Deviation|10.86|10.86|||
4361137|NCT00372996|4188310|B1|||Age||Years|Mean|61.2|61.2|Standard Deviation|10.77|10.77|||
4361138|NCT00372970|4188337|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4361139|NCT00372970|4188338|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4361140|NCT00372970|4188339|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4361141|NCT00372970|4188337|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4361142|NCT00372970|4188338|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4361143|NCT00372970|4188339|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4361144|NCT00372970|4188337|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4361145|NCT00372970|4188338|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4361146|NCT00372970|4188339|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4361147|NCT00372970|4188337|B3|||Age||years|Mean|41.1|41.1|Standard Deviation|12.2|12.2|||
4361148|NCT00372970|4188338|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|13.0|13.0|||
4361149|NCT00372970|4188339|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|11.6|11.6|||
4361150|NCT00372970|4188337|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361151|NCT00372970|4188338|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361152|NCT00372970|4188339|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361153|NCT00372970|4188337|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4361154|NCT00372970|4188338|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4361155|NCT00372970|4188339|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4361156|NCT00372970|4188337|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361157|NCT00372970|4188338|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361158|NCT00372970|4188339|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361159|NCT00372957|4188346|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361160|NCT00372957|4188347|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361161|NCT00372957|4188348|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361162|NCT00372957|4188349|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361163|NCT00372957|4188346|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361164|NCT00372957|4188347|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361165|NCT00372957|4188348|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361166|NCT00372957|4188349|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361167|NCT00372957|4188346|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361168|NCT00372957|4188347|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361169|NCT00372957|4188348|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361170|NCT00372957|4188349|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361171|NCT00372957|4188346|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361172|NCT00372957|4188347|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361173|NCT00372957|4188348|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361174|NCT00372957|4188349|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361175|NCT00372957|4188346|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361176|NCT00372957|4188347|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361177|NCT00372957|4188348|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361178|NCT00372957|4188349|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361179|NCT00372957|4188346|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4361180|NCT00372957|4188347|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4361181|NCT00372957|4188348|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4361182|NCT00372957|4188349|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4361183|NCT00372957|4188346|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361184|NCT00372957|4188347|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361185|NCT00372957|4188348|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361186|NCT00372957|4188349|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361187|NCT00372957|4188346|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4361188|NCT00372957|4188347|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4361189|NCT00372957|4188348|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4361190|NCT00372957|4188349|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4361191|NCT00372957|4188346|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4361192|NCT00372957|4188347|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4361193|NCT00372957|4188348|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4361194|NCT00372957|4188349|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4361195|NCT00372957|4188346|B4|20 to 64 Years||Age, Customized||Participants|Count of Participants|30|30.0||||||
4361196|NCT00372957|4188347|B3|20 to 64 Years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4361197|NCT00372957|4188348|B2|20 to 64 Years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4361198|NCT00372957|4188349|B1|20 to 64 Years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4361199|NCT00372905|4188398|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4361200|NCT00372905|4188398|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361201|NCT00372905|4188398|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361202|NCT00372905|4188398|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4361203|NCT00372905|4188398|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361204|NCT00372905|4188398|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361205|NCT00372905|4188398|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361206|NCT00372905|4188398|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361207|NCT00372905|4188398|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361208|NCT00372905|4188398|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4361209|NCT00372905|4188398|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361210|NCT00372905|4188398|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4361211|NCT00372905|4188398|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4361212|NCT00372905|4188398|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4361213|NCT00372905|4188398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4361214|NCT00372905|4188398|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361215|NCT00372775|4188413|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4361216|NCT00372775|4188413|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4361217|NCT00372775|4188413|B1|>= 65 years||Age, Customized||Participants|Number|20|20.0||||||
4361218|NCT00372775|4188413|B1|Between 45 and 64 years||Age, Customized||Participants|Number|40|40.0||||||
4361219|NCT00372775|4188413|B1|Between 18 and 44 years||Age, Customized||Participants|Number|4|4.0||||||
4361220|NCT00372697|4188433|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4361221|NCT00372697|4188434|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4361222|NCT00372697|4188435|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4361223|NCT00372697|4188433|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4361224|NCT00372697|4188434|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4361225|NCT00372697|4188435|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4361226|NCT00372697|4188433|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|13.9|13.9|||
4361227|NCT00372697|4188434|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|15.7|15.7|||
4361228|NCT00372697|4188435|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|12.1|12.1|||
4361229|NCT00372619|4188454|B8|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4361230|NCT00372619|4188455|B7|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4361231|NCT00372619|4188456|B6|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4361232|NCT00372619|4188457|B5|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4361233|NCT00372619|4188458|B4|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4361234|NCT00372619|4188459|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4361235|NCT00372619|4188460|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4361236|NCT00372619|4188461|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4361237|NCT00372619|4188454|B8|United States||Region of Enrollment||participants|Number|65|65.0||||||
4361238|NCT00372619|4188455|B7|United States||Region of Enrollment||participants|Number|2|2.0||||||
4361239|NCT00372619|4188456|B6|United States||Region of Enrollment||participants|Number|37|37.0||||||
4361240|NCT00372619|4188457|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
4361241|NCT00372619|4188458|B4|United States||Region of Enrollment||participants|Number|8|8.0||||||
4361242|NCT00372619|4188459|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4361243|NCT00372619|4188460|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4361244|NCT00372619|4188461|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4361245|NCT00372619|4188454|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4361246|NCT00372619|4188455|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361247|NCT00372619|4188456|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4361248|NCT00372619|4188457|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361249|NCT00372619|4188458|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361250|NCT00372619|4188459|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361251|NCT00372619|4188460|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361252|NCT00372619|4188461|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361253|NCT00372619|4188454|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361254|NCT00372619|4188455|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361255|NCT00372619|4188456|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361256|NCT00372619|4188457|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361257|NCT00372619|4188458|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361258|NCT00372619|4188459|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361259|NCT00372619|4188460|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361260|NCT00372619|4188461|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361261|NCT00372619|4188454|B8||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4361262|NCT00372619|4188455|B7||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4361263|NCT00372619|4188456|B6||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4361264|NCT00372619|4188457|B5||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4361265|NCT00372619|4188458|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4361266|NCT00372619|4188459|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4361267|NCT00372619|4188460|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361268|NCT00372619|4188461|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4361269|NCT00372619|4188454|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4361270|NCT00372619|4188455|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361271|NCT00372619|4188456|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4361272|NCT00372619|4188457|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361273|NCT00372619|4188458|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361274|NCT00372619|4188459|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361275|NCT00372619|4188460|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361276|NCT00372619|4188461|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361277|NCT00372619|4188454|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361278|NCT00372619|4188455|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361279|NCT00372619|4188456|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361280|NCT00372619|4188457|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361281|NCT00372619|4188458|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361282|NCT00372619|4188459|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361283|NCT00372619|4188460|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361284|NCT00372619|4188461|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361285|NCT00372619|4188454|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4361286|NCT00372619|4188455|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361287|NCT00372619|4188456|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4361288|NCT00372619|4188457|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361289|NCT00372619|4188458|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361290|NCT00372619|4188459|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361291|NCT00372619|4188460|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361292|NCT00372619|4188461|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361293|NCT00372619|4188454|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361294|NCT00372619|4188455|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361295|NCT00372619|4188456|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361296|NCT00372619|4188457|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361355|NCT00372619|4188460|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361297|NCT00372619|4188458|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361298|NCT00372619|4188459|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361299|NCT00372619|4188460|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361300|NCT00372619|4188461|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361301|NCT00372619|4188454|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4361302|NCT00372619|4188455|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361303|NCT00372619|4188456|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361304|NCT00372619|4188457|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361305|NCT00372619|4188458|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361306|NCT00372619|4188459|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361307|NCT00372619|4188460|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361308|NCT00372619|4188461|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361309|NCT00372619|4188454|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4361310|NCT00372619|4188455|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4361311|NCT00372619|4188456|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4361312|NCT00372619|4188457|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4361313|NCT00372619|4188458|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4361314|NCT00372619|4188459|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361315|NCT00372619|4188460|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4361316|NCT00372619|4188461|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4361317|NCT00372619|4188454|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4361318|NCT00372619|4188455|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361319|NCT00372619|4188456|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4361320|NCT00372619|4188457|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361321|NCT00372619|4188458|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361322|NCT00372619|4188459|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4361323|NCT00372619|4188460|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361324|NCT00372619|4188461|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361325|NCT00372619|4188454|B8||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4361326|NCT00372619|4188455|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4361327|NCT00372619|4188456|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4361328|NCT00372619|4188457|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4361329|NCT00372619|4188458|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4361330|NCT00372619|4188459|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4361331|NCT00372619|4188460|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4361332|NCT00372619|4188461|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4361333|NCT00372619|4188454|B8||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4361334|NCT00372619|4188455|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4361335|NCT00372619|4188456|B6||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4361336|NCT00372619|4188457|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4361337|NCT00372619|4188458|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4361338|NCT00372619|4188459|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4361339|NCT00372619|4188460|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4361340|NCT00372619|4188461|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4361341|NCT00372619|4188454|B8|||Age||years|Mean|15.13|15.13|Standard Deviation|5.94|5.94|||
4361342|NCT00372619|4188455|B7|||Age||years|Mean|19.65|19.65|Standard Deviation|1.80|1.8|||
4361343|NCT00372619|4188456|B6|||Age||years|Mean|12.01|12.01|Standard Deviation|7.12|7.12|||
4361344|NCT00372619|4188457|B5|||Age||years|Mean|9.01|9.01|Standard Deviation|5.79|5.79|||
4361345|NCT00372619|4188458|B4|||Age||years|Mean|9.16|9.16|Standard Deviation|6.69|6.69|||
4361346|NCT00372619|4188459|B3|||Age||years|Mean|13.09|13.09|Standard Deviation|1.54|1.54|||
4361347|NCT00372619|4188460|B2|||Age||years|Mean|15.09|15.09|Standard Deviation|6.33|6.33|||
4361348|NCT00372619|4188461|B1|||Age||years|Mean|12.75|12.75|Standard Deviation|6.37|6.37|||
4361349|NCT00372619|4188454|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361350|NCT00372619|4188455|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361351|NCT00372619|4188456|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361352|NCT00372619|4188457|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361353|NCT00372619|4188458|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361354|NCT00372619|4188459|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361356|NCT00372619|4188461|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361357|NCT00372619|4188454|B8||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4361358|NCT00372619|4188455|B7||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4361359|NCT00372619|4188456|B6||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4361360|NCT00372619|4188457|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4361361|NCT00372619|4188458|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4361362|NCT00372619|4188459|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4361363|NCT00372619|4188460|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4361364|NCT00372619|4188461|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4361365|NCT00372619|4188454|B8||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
4361366|NCT00372619|4188455|B7||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4361367|NCT00372619|4188456|B6||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4361368|NCT00372619|4188457|B5||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4361369|NCT00372619|4188458|B4||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4361370|NCT00372619|4188459|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4361371|NCT00372619|4188460|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4361372|NCT00372619|4188461|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4361373|NCT00372593|4188497|B4|New Zealand||Region of Enrollment||participants|Number|9|9.0||||||
4361374|NCT00372593|4188498|B3|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4361375|NCT00372593|4188499|B2|New Zealand||Region of Enrollment||participants|Number|5|5.0||||||
4361376|NCT00372593|4188500|B1|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
4361377|NCT00372593|4188497|B4|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4361378|NCT00372593|4188498|B3|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4361379|NCT00372593|4188499|B2|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4361380|NCT00372593|4188500|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4361381|NCT00372593|4188497|B4|Australia||Region of Enrollment||participants|Number|34|34.0||||||
4361382|NCT00372593|4188498|B3|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4361383|NCT00372593|4188499|B2|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4361384|NCT00372593|4188500|B1|Australia||Region of Enrollment||participants|Number|19|19.0||||||
4361385|NCT00372593|4188497|B4|Canada||Region of Enrollment||participants|Number|68|68.0||||||
4361386|NCT00372593|4188498|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4361387|NCT00372593|4188499|B2|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4361388|NCT00372593|4188500|B1|Canada||Region of Enrollment||participants|Number|34|34.0||||||
4361389|NCT00372593|4188497|B4|United States||Region of Enrollment||participants|Number|958|958.0||||||
4361390|NCT00372593|4188498|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4361391|NCT00372593|4188499|B2|United States||Region of Enrollment||participants|Number|480|480.0||||||
4361392|NCT00372593|4188500|B1|United States||Region of Enrollment||participants|Number|473|473.0||||||
4361393|NCT00372593|4188497|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4361394|NCT00372593|4188498|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361395|NCT00372593|4188499|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4361396|NCT00372593|4188500|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4361397|NCT00372593|4188497|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|834|834.0||||||
4361398|NCT00372593|4188498|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4361399|NCT00372593|4188499|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|416|416.0||||||
4361400|NCT00372593|4188500|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|411|411.0||||||
4361401|NCT00372593|4188497|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|197|197.0||||||
4361402|NCT00372593|4188498|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361403|NCT00372593|4188499|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4361404|NCT00372593|4188500|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4361405|NCT00372593|4188497|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4361406|NCT00372593|4188498|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361407|NCT00372593|4188499|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4361408|NCT00372593|4188500|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4361409|NCT00372593|4188497|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361410|NCT00372593|4188498|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361411|NCT00372593|4188499|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361412|NCT00372593|4188500|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361413|NCT00372593|4188497|B4||White|Race (NIH/OMB)||Participants|Count of Participants|782|782.0||||||
4361414|NCT00372593|4188498|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4361415|NCT00372593|4188499|B2||White|Race (NIH/OMB)||Participants|Count of Participants|394|394.0||||||
4361416|NCT00372593|4188500|B1||White|Race (NIH/OMB)||Participants|Count of Participants|383|383.0||||||
4361417|NCT00372593|4188497|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4361418|NCT00372593|4188498|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4361419|NCT00372593|4188499|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4361420|NCT00372593|4188500|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4361421|NCT00372593|4188497|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4361422|NCT00372593|4188498|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361423|NCT00372593|4188499|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361424|NCT00372593|4188500|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361425|NCT00372593|4188497|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4361426|NCT00372593|4188498|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361427|NCT00372593|4188499|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4361428|NCT00372593|4188500|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4361429|NCT00372593|4188497|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4361430|NCT00372593|4188498|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361431|NCT00372593|4188499|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361432|NCT00372593|4188500|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4361433|NCT00372593|4188497|B4||Male|Sex: Female, Male||Participants|Count of Participants|529|529.0||||||
4361434|NCT00372593|4188498|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4361435|NCT00372593|4188499|B2||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4361436|NCT00372593|4188500|B1||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4361437|NCT00372593|4188497|B4||Female|Sex: Female, Male||Participants|Count of Participants|541|541.0||||||
4361438|NCT00372593|4188498|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4361439|NCT00372593|4188499|B2||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4361440|NCT00372593|4188500|B1||Female|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4361441|NCT00372593|4188497|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361442|NCT00372593|4188498|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361443|NCT00372593|4188499|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361444|NCT00372593|4188500|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361445|NCT00372593|4188497|B4||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4361446|NCT00372593|4188498|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4361447|NCT00372593|4188499|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4361448|NCT00372593|4188500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4361449|NCT00372593|4188497|B4||<=18 years|Age||Participants|Count of Participants|1033|1033.0||||||
4361450|NCT00372593|4188498|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4361451|NCT00372593|4188499|B2||<=18 years|Age||Participants|Count of Participants|510|510.0||||||
4361452|NCT00372593|4188500|B1||<=18 years|Age||Participants|Count of Participants|516|516.0||||||
4361453|NCT00372593|4188497|B4|||Age||days|Mean|3409.43|3409.43|Standard Deviation|2310|2310.0|||
4361454|NCT00372593|4188498|B3|||Age||days|Mean|4206.71|4206.71|Standard Deviation|1979.95|1979.95|||
4361455|NCT00372593|4188499|B2|||Age||days|Mean|3466|3466.0|Standard Deviation|2283.45|2283.45|||
4361456|NCT00372593|4188500|B1|||Age||days|Mean|3352.86|3352.86|Standard Deviation|2336.55|2336.55|||
4361457|NCT00372567|4188528|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4361458|NCT00372567|4188529|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4361459|NCT00372567|4188530|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4361460|NCT00372567|4188531|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4361461|NCT00372567|4188528|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4361462|NCT00372567|4188529|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4361463|NCT00372567|4188530|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4361464|NCT00372567|4188531|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4361465|NCT00372567|4188528|B4|greater than or equal to 65 years||Age, Customized||participants|Number|26|26.0||||||
4361466|NCT00372567|4188529|B3|greater than or equal to 65 years||Age, Customized||participants|Number|5|5.0||||||
4361467|NCT00372567|4188530|B2|greater than or equal to 65 years||Age, Customized||participants|Number|9|9.0||||||
4361468|NCT00372567|4188531|B1|greater than or equal to 65 years||Age, Customized||participants|Number|12|12.0||||||
4361469|NCT00372567|4188528|B4|less than 65 years||Age, Customized||participants|Number|43|43.0||||||
4361470|NCT00372567|4188529|B3|less than 65 years||Age, Customized||participants|Number|7|7.0||||||
4361471|NCT00372567|4188530|B2|less than 65 years||Age, Customized||participants|Number|17|17.0||||||
4361472|NCT00372567|4188531|B1|less than 65 years||Age, Customized||participants|Number|19|19.0||||||
4361503|NCT00372411|4188582|B3|||Time from Index Stroke to Randomization||Years|Mean|6.2|6.2|Standard Deviation|5.0|5.0|||
4361504|NCT00372411|4188583|B2|||Time from Index Stroke to Randomization||Years|Mean|4.8|4.8|Standard Deviation|4.0|4.0|||
4361473|NCT00372528|4188561|B1|||Mean Number of Seizures|Seizures were episodes of disturbed brain activity that cause changes in attention or behavior. The different types of seizures observed were complex partial, secondarily generalized tonic-clonic, simple partial and others. Mean number of seizures were calculated from baseline visit to 1 day before Month 6 visit.|Seizures|Mean|30.70|30.7|Standard Deviation|40.63|40.63|||
4361474|NCT00372528|4188561|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4361475|NCT00372528|4188561|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4361476|NCT00372528|4188561|B1|||Age||Years|Mean|44.0|44.0|Standard Deviation|12.6|12.6|||
4361477|NCT00372489|4188566|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4361478|NCT00372489|4188566|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4361479|NCT00372489|4188566|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|15.01|15.01|||
4361480|NCT00372489|4188566|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4361481|NCT00372489|4188566|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4361482|NCT00372489|4188566|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361483|NCT00372424|4188570|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4361484|NCT00372424|4188570|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4361485|NCT00372424|4188570|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|12.8|12.8|||
4361486|NCT00372411|4188581|B4|≥3 Domains||Comorbidity Disease Index|The Comorbidity Disease Index domains include cardiac, respiratory, neurologic, musculoskeletal, general (mental or emotional problems and sleep or pain disorders), cancer, diabetes, and visual problems. The domain scores are totaled to create an overall comorbidity score (≤1, 2, or ≥3 domains).|participants|Number|66|66.0||||||
4361487|NCT00372411|4188582|B3|≥3 Domains||Comorbidity Disease Index|The Comorbidity Disease Index domains include cardiac, respiratory, neurologic, musculoskeletal, general (mental or emotional problems and sleep or pain disorders), cancer, diabetes, and visual problems. The domain scores are totaled to create an overall comorbidity score (≤1, 2, or ≥3 domains).|participants|Number|18|18.0||||||
4361488|NCT00372411|4188583|B2|≥3 Domains||Comorbidity Disease Index|The Comorbidity Disease Index domains include cardiac, respiratory, neurologic, musculoskeletal, general (mental or emotional problems and sleep or pain disorders), cancer, diabetes, and visual problems. The domain scores are totaled to create an overall comorbidity score (≤1, 2, or ≥3 domains).|participants|Number|19|19.0||||||
4361489|NCT00372411|4188584|B1|≥3 Domains||Comorbidity Disease Index|The Comorbidity Disease Index domains include cardiac, respiratory, neurologic, musculoskeletal, general (mental or emotional problems and sleep or pain disorders), cancer, diabetes, and visual problems. The domain scores are totaled to create an overall comorbidity score (≤1, 2, or ≥3 domains).|participants|Number|29|29.0||||||
4361490|NCT00372411|4188581|B4|2 Domains||Comorbidity Disease Index|The Comorbidity Disease Index domains include cardiac, respiratory, neurologic, musculoskeletal, general (mental or emotional problems and sleep or pain disorders), cancer, diabetes, and visual problems. The domain scores are totaled to create an overall comorbidity score (≤1, 2, or ≥3 domains).|participants|Number|45|45.0||||||
4361491|NCT00372411|4188582|B3|2 Domains||Comorbidity Disease Index|The Comorbidity Disease Index domains include cardiac, respiratory, neurologic, musculoskeletal, general (mental or emotional problems and sleep or pain disorders), cancer, diabetes, and visual problems. The domain scores are totaled to create an overall comorbidity score (≤1, 2, or ≥3 domains).|participants|Number|8|8.0||||||
4361492|NCT00372411|4188583|B2|2 Domains||Comorbidity Disease Index|The Comorbidity Disease Index domains include cardiac, respiratory, neurologic, musculoskeletal, general (mental or emotional problems and sleep or pain disorders), cancer, diabetes, and visual problems. The domain scores are totaled to create an overall comorbidity score (≤1, 2, or ≥3 domains).|participants|Number|24|24.0||||||
4361493|NCT00372411|4188584|B1|2 Domains||Comorbidity Disease Index|The Comorbidity Disease Index domains include cardiac, respiratory, neurologic, musculoskeletal, general (mental or emotional problems and sleep or pain disorders), cancer, diabetes, and visual problems. The domain scores are totaled to create an overall comorbidity score (≤1, 2, or ≥3 domains).|participants|Number|13|13.0||||||
4361494|NCT00372411|4188581|B4|≤1 Domain||Comorbidity Disease Index|The Comorbidity Disease Index domains include cardiac, respiratory, neurologic, musculoskeletal, general (mental or emotional problems and sleep or pain disorders), cancer, diabetes, and visual problems. The domain scores are totaled to create an overall comorbidity score (≤1, 2, or ≥3 domains).|participants|Number|16|16.0||||||
4361495|NCT00372411|4188582|B3|≤1 Domain||Comorbidity Disease Index|The Comorbidity Disease Index domains include cardiac, respiratory, neurologic, musculoskeletal, general (mental or emotional problems and sleep or pain disorders), cancer, diabetes, and visual problems. The domain scores are totaled to create an overall comorbidity score (≤1, 2, or ≥3 domains).|participants|Number|2|2.0||||||
4361496|NCT00372411|4188583|B2|≤1 Domain||Comorbidity Disease Index|The Comorbidity Disease Index domains include cardiac, respiratory, neurologic, musculoskeletal, general (mental or emotional problems and sleep or pain disorders), cancer, diabetes, and visual problems. The domain scores are totaled to create an overall comorbidity score (≤1, 2, or ≥3 domains).|participants|Number|7|7.0||||||
4361497|NCT00372411|4188584|B1|≤1 Domain||Comorbidity Disease Index|The Comorbidity Disease Index domains include cardiac, respiratory, neurologic, musculoskeletal, general (mental or emotional problems and sleep or pain disorders), cancer, diabetes, and visual problems. The domain scores are totaled to create an overall comorbidity score (≤1, 2, or ≥3 domains).|participants|Number|7|7.0||||||
4361498|NCT00372411|4188581|B4|||Fugl-Meyer Assessment|Primary outcome baseline scores|units on a scale|Mean|18.9|18.9|Standard Deviation|9.5|9.5|||
4361499|NCT00372411|4188582|B3|||Fugl-Meyer Assessment|Primary outcome baseline scores|units on a scale|Mean|20.3|20.3|Standard Deviation|9.0|9.0|||
4361500|NCT00372411|4188583|B2|||Fugl-Meyer Assessment|Primary outcome baseline scores|units on a scale|Mean|17.3|17.3|Standard Deviation|8.4|8.4|||
4361501|NCT00372411|4188584|B1|||Fugl-Meyer Assessment|Primary outcome baseline scores|units on a scale|Mean|19.7|19.7|Standard Deviation|10.7|10.7|||
4361502|NCT00372411|4188581|B4|||Time from Index Stroke to Randomization||Years|Mean|4.7|4.7|Standard Deviation|4.2|4.2|||
4361505|NCT00372411|4188584|B1|||Time from Index Stroke to Randomization||Years|Mean|3.6|3.6|Standard Deviation|4.0|4.0|||
4361506|NCT00372411|4188581|B4|Posterior circulation||Index Stroke Location||Participants|Number|15|15.0||||||
4361507|NCT00372411|4188582|B3|Posterior circulation||Index Stroke Location||Participants|Number|6|6.0||||||
4361508|NCT00372411|4188583|B2|Posterior circulation||Index Stroke Location||Participants|Number|0|0.0||||||
4361509|NCT00372411|4188584|B1|Posterior circulation||Index Stroke Location||Participants|Number|9|9.0||||||
4361510|NCT00372411|4188581|B4|Small deep infarct||Index Stroke Location||Participants|Number|38|38.0||||||
4361511|NCT00372411|4188582|B3|Small deep infarct||Index Stroke Location||Participants|Number|6|6.0||||||
4361512|NCT00372411|4188583|B2|Small deep infarct||Index Stroke Location||Participants|Number|15|15.0||||||
4361513|NCT00372411|4188584|B1|Small deep infarct||Index Stroke Location||Participants|Number|17|17.0||||||
4361514|NCT00372411|4188581|B4|Anterior circulation <1/3 of hemisphere||Index Stroke Location||Participants|Number|48|48.0||||||
4361515|NCT00372411|4188582|B3|Anterior circulation <1/3 of hemisphere||Index Stroke Location||Participants|Number|10|10.0||||||
4361516|NCT00372411|4188583|B2|Anterior circulation <1/3 of hemisphere||Index Stroke Location||Participants|Number|21|21.0||||||
4361517|NCT00372411|4188584|B1|Anterior circulation <1/3 of hemisphere||Index Stroke Location||Participants|Number|17|17.0||||||
4361518|NCT00372411|4188581|B4|Anterior circulation ≥1/3 of hemisphere||Index Stroke Location||Participants|Number|26|26.0||||||
4361519|NCT00372411|4188582|B3|Anterior circulation ≥1/3 of hemisphere||Index Stroke Location||Participants|Number|6|6.0||||||
4361520|NCT00372411|4188583|B2|Anterior circulation ≥1/3 of hemisphere||Index Stroke Location||Participants|Number|14|14.0||||||
4361521|NCT00372411|4188584|B1|Anterior circulation ≥1/3 of hemisphere||Index Stroke Location||Participants|Number|6|6.0||||||
4361522|NCT00372411|4188581|B4|Ischemic||Index Stroke Type||participants|Number|108|108.0||||||
4361523|NCT00372411|4188582|B3|Ischemic||Index Stroke Type||participants|Number|22|22.0||||||
4361524|NCT00372411|4188583|B2|Ischemic||Index Stroke Type||participants|Number|44|44.0||||||
4361525|NCT00372411|4188584|B1|Ischemic||Index Stroke Type||participants|Number|42|42.0||||||
4361526|NCT00372411|4188581|B4|Hemorrhagic||Index Stroke Type||participants|Number|19|19.0||||||
4361527|NCT00372411|4188582|B3|Hemorrhagic||Index Stroke Type||participants|Number|6|6.0||||||
4361528|NCT00372411|4188583|B2|Hemorrhagic||Index Stroke Type||participants|Number|6|6.0||||||
4361529|NCT00372411|4188584|B1|Hemorrhagic||Index Stroke Type||participants|Number|7|7.0||||||
4361530|NCT00372411|4188581|B4|United States||Region of Enrollment||participants|Number|127|127.0||||||
4361531|NCT00372411|4188582|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4361532|NCT00372411|4188583|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4361533|NCT00372411|4188584|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4361534|NCT00372411|4188581|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361535|NCT00372411|4188582|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361536|NCT00372411|4188583|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361537|NCT00372411|4188584|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361538|NCT00372411|4188581|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4361539|NCT00372411|4188582|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361540|NCT00372411|4188583|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4361541|NCT00372411|4188584|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361542|NCT00372411|4188581|B4||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4361543|NCT00372411|4188582|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4361544|NCT00372411|4188583|B2||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4361545|NCT00372411|4188584|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4361546|NCT00372411|4188581|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4361547|NCT00372411|4188582|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4361548|NCT00372411|4188583|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4361549|NCT00372411|4188584|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4361550|NCT00372411|4188581|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361551|NCT00372411|4188582|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361552|NCT00372411|4188583|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361553|NCT00372411|4188584|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361554|NCT00372411|4188581|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361555|NCT00372411|4188582|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361556|NCT00372411|4188583|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361557|NCT00372411|4188584|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361558|NCT00372411|4188581|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361559|NCT00372411|4188582|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361560|NCT00372411|4188583|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361561|NCT00372411|4188584|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361562|NCT00372411|4188581|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361563|NCT00372411|4188582|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361564|NCT00372411|4188583|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361565|NCT00372411|4188584|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361566|NCT00372411|4188581|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4361567|NCT00372411|4188582|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4361568|NCT00372411|4188583|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4361569|NCT00372411|4188584|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4361570|NCT00372411|4188581|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4361571|NCT00372411|4188582|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361572|NCT00372411|4188583|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4361573|NCT00372411|4188584|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361574|NCT00372411|4188581|B4||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4361575|NCT00372411|4188582|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4361576|NCT00372411|4188583|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4361577|NCT00372411|4188584|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4361578|NCT00372411|4188581|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4361579|NCT00372411|4188582|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4361580|NCT00372411|4188583|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4361581|NCT00372411|4188584|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4361582|NCT00372411|4188581|B4|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
4361583|NCT00372411|4188582|B3|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
4361584|NCT00372411|4188583|B2|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
4361585|NCT00372411|4188584|B1|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4361586|NCT00372385|4188606|B5|Europe||Region of Enrollment||participants|Number|323|323.0||||||
4361587|NCT00372385|4188607|B4|Europe||Region of Enrollment||participants|Number|78|78.0||||||
4361588|NCT00372385|4188608|B3|Europe||Region of Enrollment||participants|Number|82|82.0||||||
4361589|NCT00372385|4188609|B2|Europe||Region of Enrollment||participants|Number|81|81.0||||||
4361590|NCT00372385|4188610|B1|Europe||Region of Enrollment||participants|Number|82|82.0||||||
4361591|NCT00372385|4188606|B5||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4361592|NCT00372385|4188607|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4361593|NCT00372385|4188608|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4361594|NCT00372385|4188609|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4361595|NCT00372385|4188610|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4361596|NCT00372385|4188606|B5||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4361597|NCT00372385|4188607|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4361598|NCT00372385|4188608|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4361599|NCT00372385|4188609|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4361600|NCT00372385|4188610|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4361601|NCT00372385|4188606|B5|||Age||years|Mean|44.3|44.3|Standard Deviation|10.3|10.3|||
4361602|NCT00372385|4188607|B4|||Age||years|Mean|44.3|44.3|Standard Deviation|10.8|10.8|||
4361603|NCT00372385|4188608|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|10.2|10.2|||
4361604|NCT00372385|4188609|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|10.0|10.0|||
4361605|NCT00372385|4188610|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|10.6|10.6|||
4361606|NCT00372385|4188606|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4361607|NCT00372385|4188607|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361608|NCT00372385|4188608|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4361609|NCT00372385|4188609|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4361610|NCT00372385|4188610|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361611|NCT00372385|4188606|B5||Between 18 and 65 years|Age||Participants|Count of Participants|320|320.0||||||
4361612|NCT00372385|4188607|B4||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4361613|NCT00372385|4188608|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4361614|NCT00372385|4188609|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4361615|NCT00372385|4188610|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4361616|NCT00372385|4188606|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4361617|NCT00372385|4188607|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361618|NCT00372385|4188608|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361619|NCT00372385|4188609|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361620|NCT00372385|4188610|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4361621|NCT00372190|4188640|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4361622|NCT00372190|4188641|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4361623|NCT00372190|4188642|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4361624|NCT00372190|4188640|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4361625|NCT00372190|4188641|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4361626|NCT00372190|4188642|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4361627|NCT00372190|4188640|B3|||Age|age at randomization|years|Mean|64|64.0|Standard Deviation|10.3|10.3|||
4361628|NCT00372190|4188641|B2|||Age|age at randomization|years|Mean|64|64.0|Standard Deviation|10.2|10.2|||
4361629|NCT00372190|4188642|B1|||Age|age at randomization|years|Mean|64|64.0|Standard Deviation|10.5|10.5|||
4361630|NCT00372112|4188655|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361631|NCT00372112|4188656|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361632|NCT00372112|4188657|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361633|NCT00372112|4188658|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361634|NCT00372112|4188659|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361635|NCT00372112|4188655|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361636|NCT00372112|4188656|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361637|NCT00372112|4188657|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361638|NCT00372112|4188658|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361639|NCT00372112|4188659|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361640|NCT00372112|4188655|B5||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4361641|NCT00372112|4188656|B4||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4361642|NCT00372112|4188657|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4361643|NCT00372112|4188658|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4361644|NCT00372112|4188659|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4361645|NCT00372112|4188655|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361646|NCT00372112|4188656|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361647|NCT00372112|4188657|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361648|NCT00372112|4188658|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361649|NCT00372112|4188659|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361650|NCT00372112|4188655|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4361651|NCT00372112|4188656|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361652|NCT00372112|4188657|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361653|NCT00372112|4188658|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361654|NCT00372112|4188659|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361655|NCT00372112|4188655|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361656|NCT00372112|4188656|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361657|NCT00372112|4188657|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361658|NCT00372112|4188658|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361659|NCT00372112|4188659|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361660|NCT00372112|4188655|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361661|NCT00372112|4188656|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361662|NCT00372112|4188657|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361663|NCT00372112|4188658|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361664|NCT00372112|4188659|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361665|NCT00372112|4188655|B5||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4361666|NCT00372112|4188656|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4361667|NCT00372112|4188657|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4361668|NCT00372112|4188658|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4361669|NCT00372112|4188659|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4361670|NCT00372112|4188655|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4361671|NCT00372112|4188656|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4361672|NCT00372112|4188657|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4361673|NCT00372112|4188658|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4361674|NCT00372112|4188659|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4361675|NCT00372112|4188655|B5|||Age||Years|Mean|63.4|63.4|Standard Deviation|8.86|8.86|||
4361676|NCT00372112|4188656|B4|||Age||Years|Mean|60.2|60.2|Standard Deviation|7.37|7.37|||
4361677|NCT00372112|4188657|B3|||Age||Years|Mean|66.6|66.6|Standard Deviation|9.16|9.16|||
4361678|NCT00372112|4188658|B2|||Age||Years|Mean|65.8|65.8|Standard Deviation|9.06|9.06|||
4361679|NCT00372112|4188659|B1|||Age||Years|Mean|61.4|61.4|Standard Deviation|8.79|8.79|||
4361680|NCT00372060|4188791|B3|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.7|7.7|Standard Deviation|0.8|0.8|||
4361681|NCT00372060|4188792|B2|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.6|7.6|Standard Deviation|0.8|0.8|||
4361682|NCT00372060|4188793|B1|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.7|7.7|Standard Deviation|0.9|0.9|||
4361683|NCT00372060|4188791|B3|||Fasting Plasma Glucose||mg/dL|Mean|149.1|149.1|Standard Deviation|33.8|33.8|||
4361684|NCT00372060|4188792|B2|||Fasting Plasma Glucose||mg/dL|Mean|151.3|151.3|Standard Deviation|34.6|34.6|||
4361685|NCT00372060|4188793|B1|||Fasting Plasma Glucose||mg/dL|Mean|146.8|146.8|Standard Deviation|33.1|33.1|||
4361686|NCT00372060|4188791|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4361687|NCT00372060|4188792|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4361688|NCT00372060|4188793|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4361689|NCT00372060|4188791|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4361690|NCT00372060|4188792|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4361691|NCT00372060|4188793|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4361692|NCT00372060|4188791|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|9.5|9.5|||
4361693|NCT00372060|4188792|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|9.2|9.2|||
4361694|NCT00372060|4188793|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|9.9|9.9|||
4361695|NCT00371865|4188807|B3|United States||Region of Enrollment||participants|Number|114|114.0||||||
4361696|NCT00371865|4188808|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4361697|NCT00371865|4188809|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4361698|NCT00371865|4188807|B3|Other||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4361699|NCT00371865|4188808|B2|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4361700|NCT00371865|4188809|B1|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4361701|NCT00371865|4188807|B3|NonHispanic white||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4361702|NCT00371865|4188808|B2|NonHispanic white||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4361703|NCT00371865|4188809|B1|NonHispanic white||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4361704|NCT00371865|4188807|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4361705|NCT00371865|4188808|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4361706|NCT00371865|4188809|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4361707|NCT00371865|4188807|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4361708|NCT00371865|4188808|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4361709|NCT00371865|4188809|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4361710|NCT00371865|4188807|B3|||Age||years|Mean|54.9|54.9|Standard Deviation|12.5|12.5|||
4361711|NCT00371865|4188808|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|12.5|12.5|||
4361712|NCT00371865|4188809|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|12.5|12.5|||
4361713|NCT00371839|4188824|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4361714|NCT00371839|4188825|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4361715|NCT00371839|4188826|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4361716|NCT00371839|4188827|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4361717|NCT00371839|4188824|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4361718|NCT00371839|4188825|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4361719|NCT00371839|4188826|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4361720|NCT00371839|4188827|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4361721|NCT00371839|4188824|B4|||Age||years|Mean|61.7|61.7|Standard Deviation|5.1|5.1|||
4361722|NCT00371839|4188825|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|5.1|5.1|||
4361723|NCT00371839|4188826|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|7.0|7.0|||
4361724|NCT00371839|4188827|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|6.8|6.8|||
4361725|NCT00371826|4188835|B4||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4361726|NCT00371826|4188836|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4361727|NCT00371826|4188837|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4361728|NCT00371826|4188838|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4361729|NCT00371826|4188835|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4361730|NCT00371826|4188836|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4361731|NCT00371826|4188837|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4361732|NCT00371826|4188838|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4361733|NCT00371826|4188835|B4|||Age||years|Mean|46.3|46.3|Standard Deviation|10.63|10.63|||
4361734|NCT00371826|4188836|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|10.66|10.66|||
4361735|NCT00371826|4188837|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|10.83|10.83|||
4361736|NCT00371826|4188838|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|10.17|10.17|||
4361737|NCT00371787|4188962|B3|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4361738|NCT00371787|4188963|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4361739|NCT00371787|4188964|B1|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4361740|NCT00371787|4188962|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4361741|NCT00371787|4188963|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4361742|NCT00371787|4188964|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4361743|NCT00371787|4188962|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4361744|NCT00371787|4188963|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4361745|NCT00371787|4188964|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4361746|NCT00371787|4188962|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|9.9|9.9|||
4361747|NCT00371787|4188963|B2|||Age||years|Mean|33.25|33.25|Standard Deviation|6.9|6.9|||
4361748|NCT00371787|4188964|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|10.75|10.75|||
4361749|NCT00371787|4188962|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361750|NCT00371787|4188963|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361751|NCT00371787|4188964|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361752|NCT00371787|4188962|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4361753|NCT00371787|4188963|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4361754|NCT00371787|4188964|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4361755|NCT00371787|4188962|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361756|NCT00371787|4188963|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361757|NCT00371787|4188964|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361758|NCT00371761|4188977|B3|Taiwan, Province Of China||Region of Enrollment||participants|Number|25|25.0||||||
4361759|NCT00371761|4188978|B2|Taiwan, Province Of China||Region of Enrollment||participants|Number|12|12.0||||||
4361760|NCT00371761|4188979|B1|Taiwan, Province Of China||Region of Enrollment||participants|Number|13|13.0||||||
4361761|NCT00371761|4188977|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4361762|NCT00371761|4188978|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4361763|NCT00371761|4188979|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4361764|NCT00371761|4188977|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4361765|NCT00371761|4188978|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4361766|NCT00371761|4188979|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4361767|NCT00371761|4188977|B3|||Age||years|Mean|36.7|36.7|Standard Deviation|11.0|11.0|||
4361768|NCT00371761|4188978|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|13.6|13.6|||
4361769|NCT00371761|4188979|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|8.5|8.5|||
4361770|NCT00371683|4188986|B3|Norway||Region of Enrollment||participants|Number|38|38.0||||||
4361771|NCT00371683|4188987|B2|Norway||Region of Enrollment||participants|Number|17|17.0||||||
4361772|NCT00371683|4188988|B1|Norway||Region of Enrollment||participants|Number|21|21.0||||||
4361773|NCT00371683|4188986|B3|Australia||Region of Enrollment||participants|Number|104|104.0||||||
4361774|NCT00371683|4188987|B2|Australia||Region of Enrollment||participants|Number|54|54.0||||||
4361775|NCT00371683|4188988|B1|Australia||Region of Enrollment||participants|Number|50|50.0||||||
4361776|NCT00371683|4188986|B3|Israel||Region of Enrollment||participants|Number|86|86.0||||||
4361777|NCT00371683|4188987|B2|Israel||Region of Enrollment||participants|Number|42|42.0||||||
4361778|NCT00371683|4188988|B1|Israel||Region of Enrollment||participants|Number|44|44.0||||||
4361779|NCT00371683|4188986|B3|Mexico||Region of Enrollment||participants|Number|276|276.0||||||
4361780|NCT00371683|4188987|B2|Mexico||Region of Enrollment||participants|Number|138|138.0||||||
4361781|NCT00371683|4188988|B1|Mexico||Region of Enrollment||participants|Number|138|138.0||||||
4361782|NCT00371683|4188986|B3|Poland||Region of Enrollment||participants|Number|70|70.0||||||
4361783|NCT00371683|4188987|B2|Poland||Region of Enrollment||participants|Number|35|35.0||||||
4361784|NCT00371683|4188988|B1|Poland||Region of Enrollment||participants|Number|35|35.0||||||
4361785|NCT00371683|4188986|B3|Brazil||Region of Enrollment||participants|Number|81|81.0||||||
4361786|NCT00371683|4188987|B2|Brazil||Region of Enrollment||participants|Number|39|39.0||||||
4361787|NCT00371683|4188988|B1|Brazil||Region of Enrollment||participants|Number|42|42.0||||||
4361788|NCT00371683|4188986|B3|Denmark||Region of Enrollment||participants|Number|176|176.0||||||
4361789|NCT00371683|4188987|B2|Denmark||Region of Enrollment||participants|Number|89|89.0||||||
4361790|NCT00371683|4188988|B1|Denmark||Region of Enrollment||participants|Number|87|87.0||||||
4361791|NCT00371683|4188986|B3|Turkey||Region of Enrollment||participants|Number|22|22.0||||||
4361792|NCT00371683|4188987|B2|Turkey||Region of Enrollment||participants|Number|10|10.0||||||
4361793|NCT00371683|4188988|B1|Turkey||Region of Enrollment||participants|Number|12|12.0||||||
4361794|NCT00371683|4188986|B3|Sweden||Region of Enrollment||participants|Number|134|134.0||||||
4361795|NCT00371683|4188987|B2|Sweden||Region of Enrollment||participants|Number|68|68.0||||||
4361796|NCT00371683|4188988|B1|Sweden||Region of Enrollment||participants|Number|66|66.0||||||
4361797|NCT00371683|4188986|B3|Canada||Region of Enrollment||participants|Number|1102|1102.0||||||
4361798|NCT00371683|4188987|B2|Canada||Region of Enrollment||participants|Number|548|548.0||||||
4361799|NCT00371683|4188988|B1|Canada||Region of Enrollment||participants|Number|554|554.0||||||
4361800|NCT00371683|4188986|B3|United States||Region of Enrollment||participants|Number|938|938.0||||||
4361801|NCT00371683|4188987|B2|United States||Region of Enrollment||participants|Number|474|474.0||||||
4361802|NCT00371683|4188988|B1|United States||Region of Enrollment||participants|Number|464|464.0||||||
4361803|NCT00371683|4188986|B3|Hungary||Region of Enrollment||participants|Number|54|54.0||||||
4361804|NCT00371683|4188987|B2|Hungary||Region of Enrollment||participants|Number|26|26.0||||||
4361805|NCT00371683|4188988|B1|Hungary||Region of Enrollment||participants|Number|28|28.0||||||
4361806|NCT00371683|4188986|B3|Russian Federation||Region of Enrollment||participants|Number|28|28.0||||||
4361807|NCT00371683|4188987|B2|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
4361808|NCT00371683|4188988|B1|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4361809|NCT00371683|4188986|B3|Argentina||Region of Enrollment||participants|Number|86|86.0||||||
4361810|NCT00371683|4188987|B2|Argentina||Region of Enrollment||participants|Number|43|43.0||||||
4361811|NCT00371683|4188988|B1|Argentina||Region of Enrollment||participants|Number|43|43.0||||||
4361812|NCT00371683|4188986|B3||Male|Sex: Female, Male||Participants|Count of Participants|1212|1212.0||||||
4361813|NCT00371683|4188987|B2||Male|Sex: Female, Male||Participants|Count of Participants|610|610.0||||||
4361814|NCT00371683|4188988|B1||Male|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
4361815|NCT00371683|4188986|B3||Female|Sex: Female, Male||Participants|Count of Participants|1983|1983.0||||||
4361816|NCT00371683|4188987|B2||Female|Sex: Female, Male||Participants|Count of Participants|986|986.0||||||
4361817|NCT00371683|4188988|B1||Female|Sex: Female, Male||Participants|Count of Participants|997|997.0||||||
4361818|NCT00371683|4188986|B3|>=75 years||Age, Customized||participants|Number|604|604.0||||||
4361819|NCT00371683|4188987|B2|>=75 years||Age, Customized||participants|Number|295|295.0||||||
4361820|NCT00371683|4188988|B1|>=75 years||Age, Customized||participants|Number|309|309.0||||||
4361821|NCT00371683|4188986|B3|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|1203|1203.0||||||
4361822|NCT00371683|4188987|B2|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|610|610.0||||||
4361823|NCT00371683|4188988|B1|Greater than, equal to (>=) 65 and < 75 years||Age, Customized||participants|Number|593|593.0||||||
4361824|NCT00371683|4188986|B3|Less than(<) 65 years||Age, Customized||participants|Number|1388|1388.0||||||
4361825|NCT00371683|4188987|B2|Less than(<) 65 years||Age, Customized||participants|Number|691|691.0||||||
4361826|NCT00371683|4188988|B1|Less than(<) 65 years||Age, Customized||participants|Number|697|697.0||||||
4361827|NCT00371683|4188986|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|9.24|9.24|||
4361828|NCT00371683|4188987|B2|||Age||years|Mean|65.7|65.7|Standard Deviation|9.22|9.22|||
4361829|NCT00371683|4188988|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|9.26|9.26|||
4361830|NCT00371644|4189041|B3|||PTSD Checklist|The PCL is a 17-item self-report measure that is commonly used in clinical and research settings. All 17 items are summed to compute a total score of PTSD symptomatology. Scores for the PCL range from 17-85, with 85 indicating severe PTSD symptomatology.The PCL has strong psychometric properties and mirrors the symptomatology of the DSM.|units on a scale|Mean|65.65|65.65|Standard Deviation|11.69|11.69|||
4361831|NCT00371644|4189042|B2|||PTSD Checklist|The PCL is a 17-item self-report measure that is commonly used in clinical and research settings. All 17 items are summed to compute a total score of PTSD symptomatology. Scores for the PCL range from 17-85, with 85 indicating severe PTSD symptomatology.The PCL has strong psychometric properties and mirrors the symptomatology of the DSM.|units on a scale|Mean|65.21|65.21|Standard Deviation|13.25|13.25|||
4361832|NCT00371644|4189043|B1|||PTSD Checklist|The PCL is a 17-item self-report measure that is commonly used in clinical and research settings. All 17 items are summed to compute a total score of PTSD symptomatology. Scores for the PCL range from 17-85, with 85 indicating severe PTSD symptomatology.The PCL has strong psychometric properties and mirrors the symptomatology of the DSM.|units on a scale|Mean|65.96|65.96|Standard Deviation|10.63|10.63|||
4361833|NCT00371644|4189041|B3|United States||Region of Enrollment||participants|Number|86|86.0||||||
4361834|NCT00371644|4189042|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4361835|NCT00371644|4189043|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4361836|NCT00371644|4189041|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4361837|NCT00371644|4189042|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4361838|NCT00371644|4189043|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4361839|NCT00371644|4189041|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4361840|NCT00371644|4189042|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4361841|NCT00371644|4189043|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4361842|NCT00371644|4189041|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4361843|NCT00371644|4189042|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361844|NCT00371644|4189043|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4361845|NCT00371644|4189041|B3||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4361846|NCT00371644|4189042|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4361847|NCT00371644|4189043|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4361848|NCT00371644|4189041|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361849|NCT00371644|4189042|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361850|NCT00371644|4189043|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361851|NCT00371644|4189041|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|10.1|10.1|||
4361852|NCT00371644|4189042|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|10.7|10.7|||
4361853|NCT00371644|4189043|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|10.5|10.5|||
4361854|NCT00371631|4189050|B1|||average time since injury||years|Mean|15|15.0|Full Range|||1.3|35.0|
4361855|NCT00371631|4189050|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361856|NCT00371631|4189050|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361857|NCT00371631|4189050|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4361858|NCT00371631|4189050|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4361859|NCT00371631|4189050|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361860|NCT00371631|4189050|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361861|NCT00371631|4189050|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361862|NCT00371631|4189050|B1|Male||Sex/Gender, Customized||participants|Number|13|13.0||||||
4361863|NCT00371631|4189050|B1|Age||Age, Customized||years|Mean|56|56.0|Full Range|||37.0|73.0|
4361864|NCT00371566|4189055|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4361865|NCT00371566|4189056|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4361866|NCT00371566|4189057|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4361867|NCT00371566|4189055|B3|Asian-Mixed Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4361868|NCT00371566|4189056|B2|Asian-Mixed Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4361869|NCT00371566|4189057|B1|Asian-Mixed Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4361870|NCT00371566|4189055|B3|Asian-Japanese East/South east Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4361871|NCT00371566|4189056|B2|Asian-Japanese East/South east Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4361872|NCT00371566|4189057|B1|Asian-Japanese East/South east Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4361873|NCT00371566|4189055|B3|Asian-Central and South Asian Heritage||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4361874|NCT00371566|4189056|B2|Asian-Central and South Asian Heritage||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4361875|NCT00371566|4189057|B1|Asian-Central and South Asian Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4361876|NCT00371566|4189055|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4361877|NCT00371566|4189056|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4361878|NCT00371566|4189057|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4361879|NCT00371566|4189055|B3|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4361880|NCT00371566|4189056|B2|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4361881|NCT00371566|4189057|B1|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4361882|NCT00371566|4189055|B3|White||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4361883|NCT00371566|4189056|B2|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4361884|NCT00371566|4189057|B1|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4361885|NCT00371566|4189055|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4361886|NCT00371566|4189056|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4361887|NCT00371566|4189057|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4361888|NCT00371566|4189055|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4361889|NCT00371566|4189056|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4361890|NCT00371566|4189057|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4361891|NCT00371566|4189055|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|10.83|10.83|||
4361892|NCT00371566|4189056|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|11.01|11.01|||
4361893|NCT00371566|4189057|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|10.47|10.47|||
4361894|NCT00371540|4189128|B3|Kenya||Region of Enrollment||participants|Number|208|208.0||||||
4361895|NCT00371540|4189129|B2|Kenya||Region of Enrollment||participants|Number|96|96.0||||||
4361896|NCT00371540|4189130|B1|Kenya||Region of Enrollment||participants|Number|112|112.0||||||
4361897|NCT00371540|4189128|B3||Male|Gender||Participants|Count of Participants|56|56.0||||||
4361898|NCT00371540|4189129|B2||Male|Gender||Participants|Count of Participants|25|25.0||||||
4361899|NCT00371540|4189130|B1||Male|Gender||Participants|Count of Participants|31|31.0||||||
4361900|NCT00371540|4189128|B3||Female|Gender||Participants|Count of Participants|152|152.0||||||
4361901|NCT00371540|4189129|B2||Female|Gender||Participants|Count of Participants|71|71.0||||||
4361902|NCT00371540|4189130|B1||Female|Gender||Participants|Count of Participants|81|81.0||||||
4361903|NCT00371540|4189128|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361904|NCT00371540|4189129|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361905|NCT00371540|4189130|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361906|NCT00371540|4189128|B3||Between 18 and 65 years|Age||Participants|Count of Participants|208|208.0||||||
4361907|NCT00371540|4189129|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4361908|NCT00371540|4189130|B1||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4361909|NCT00371540|4189128|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361910|NCT00371540|4189129|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361911|NCT00371540|4189130|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361912|NCT00371462|4189141|B3|||Waist circumference (cm)||cm|Mean|120.4|120.4|Standard Deviation|11.7|11.7|||
4361913|NCT00371462|4189142|B2|||Waist circumference (cm)||cm|Mean|120.4|120.4|Standard Deviation|8.9|8.9|||
4361914|NCT00371462|4189143|B1|||Waist circumference (cm)||cm|Mean|120.4|120.4|Standard Deviation|14.0|14.0|||
4361915|NCT00371462|4189141|B3|||BMI||kg/m2|Mean|36.3|36.3|Standard Deviation|4.6|4.6|||
4361916|NCT00371462|4189142|B2|||BMI||kg/m2|Mean|35.8|35.8|Standard Deviation|3.8|3.8|||
4361917|NCT00371462|4189143|B1|||BMI||kg/m2|Mean|36.9|36.9|Standard Deviation|5.4|5.4|||
4361918|NCT00371462|4189141|B3|||Weight (kg)||kg|Mean|111.1|111.1|Standard Deviation|15.6|15.6|||
4361919|NCT00371462|4189142|B2|||Weight (kg)||kg|Mean|110.1|110.1|Standard Deviation|15.1|15.1|||
4361920|NCT00371462|4189143|B1|||Weight (kg)||kg|Mean|113.7|113.7|Standard Deviation|16.1|16.1|||
4361921|NCT00371462|4189141|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4361922|NCT00371462|4189142|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4361923|NCT00371462|4189143|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4361924|NCT00371462|4189141|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361925|NCT00371462|4189142|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361926|NCT00371462|4189143|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361927|NCT00371462|4189141|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361928|NCT00371462|4189142|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361929|NCT00371462|4189143|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361930|NCT00371462|4189141|B3||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4361931|NCT00371462|4189142|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4361932|NCT00371462|4189143|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4361933|NCT00371462|4189141|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4361934|NCT00371462|4189142|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4361935|NCT00371462|4189143|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4361936|NCT00371462|4189141|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361937|NCT00371462|4189142|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361938|NCT00371462|4189143|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361939|NCT00371462|4189141|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361940|NCT00371462|4189142|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361941|NCT00371462|4189143|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361942|NCT00371462|4189141|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361943|NCT00371462|4189142|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361944|NCT00371462|4189143|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361945|NCT00371462|4189141|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361946|NCT00371462|4189142|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361947|NCT00371462|4189143|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4361948|NCT00371462|4189141|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4361949|NCT00371462|4189142|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4361950|NCT00371462|4189143|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4361951|NCT00371462|4189141|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4361952|NCT00371462|4189142|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4361953|NCT00371462|4189143|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4361954|NCT00371462|4189141|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4361955|NCT00371462|4189142|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4361956|NCT00371462|4189143|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4361957|NCT00371462|4189141|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4361958|NCT00371462|4189142|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4361959|NCT00371462|4189143|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4361960|NCT00371462|4189141|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|11.9|11.9|||
4361961|NCT00371462|4189142|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|10.2|10.2|||
4361962|NCT00371462|4189143|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|13.5|13.5|||
4361963|NCT00371449|4189150|B1|||unaided Acceptable Noise Level test||dB|Mean|15.5|15.5|Standard Deviation|7.2|7.2|||
4361964|NCT00371449|4189150|B1|||unaided Words-In-Noise Test||dB S/N|Mean|14.4|14.4|Standard Deviation|4.5|4.5|||
4361965|NCT00371449|4189150|B1|||degree of hearing loss||dB HL|Mean|36.3|36.3|Standard Deviation|10.8|10.8|||
4361966|NCT00371449|4189150|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4361967|NCT00371449|4189150|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4361968|NCT00371449|4189150|B1|||Age||years|Mean|68.4|68.4|Standard Deviation|8.2|8.2|||
4361969|NCT00371436|4189159|B3|United States||Region of Enrollment||participants|Number|181|181.0||||||
4361970|NCT00371436|4189160|B2|United States||Region of Enrollment||participants|Number|89|89.0||||||
4361971|NCT00371436|4189161|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4361972|NCT00371436|4189159|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4361973|NCT00371436|4189160|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4361974|NCT00371436|4189161|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4361975|NCT00371436|4189159|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4361976|NCT00371436|4189160|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4361977|NCT00371436|4189161|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4361978|NCT00371436|4189159|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|10.8|10.8|||
4361979|NCT00371436|4189160|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|10.5|10.5|||
4361980|NCT00371436|4189161|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|11.2|11.2|||
4361981|NCT00371397|4189168|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4361982|NCT00371397|4189168|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4361983|NCT00371397|4189168|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4361984|NCT00371397|4189168|B1|||Age||years|Mean|41.32|41.32|Standard Deviation|10.33|10.33|||
4361985|NCT00371397|4189168|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4361986|NCT00371397|4189168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4361987|NCT00371397|4189168|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4361988|NCT00371345|4189185|B3|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4361989|NCT00371345|4189186|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4361990|NCT00371345|4189187|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4361991|NCT00371345|4189185|B3|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4361992|NCT00371345|4189186|B2|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4361993|NCT00371345|4189187|B1|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4361994|NCT00371345|4189185|B3|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
4361995|NCT00371345|4189186|B2|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
4361996|NCT00371345|4189187|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4361997|NCT00371345|4189185|B3|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4361998|NCT00371345|4189186|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4361999|NCT00371345|4189187|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4362000|NCT00371345|4189185|B3|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
4362001|NCT00371345|4189186|B2|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
4362002|NCT00371345|4189187|B1|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4362003|NCT00371345|4189185|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4362004|NCT00371345|4189186|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4362005|NCT00371345|4189187|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4362006|NCT00371345|4189185|B3|France||Region of Enrollment||participants|Number|11|11.0||||||
4362007|NCT00371345|4189186|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4362008|NCT00371345|4189187|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4362009|NCT00371345|4189185|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362010|NCT00371345|4189186|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362011|NCT00371345|4189187|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362012|NCT00371345|4189185|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4362013|NCT00371345|4189186|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4362014|NCT00371345|4189187|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4362015|NCT00371345|4189185|B3|>=50 years||Age, Customized||participants|Number|46|46.0||||||
4362016|NCT00371345|4189186|B2|>=50 years||Age, Customized||participants|Number|30|30.0||||||
4362017|NCT00371345|4189187|B1|>=50 years||Age, Customized||participants|Number|16|16.0||||||
4362018|NCT00371345|4189185|B3|<=50 years||Age, Customized||participants|Number|24|24.0||||||
4362019|NCT00371345|4189186|B2|<=50 years||Age, Customized||participants|Number|16|16.0||||||
4362020|NCT00371345|4189187|B1|<=50 years||Age, Customized||participants|Number|8|8.0||||||
4362021|NCT00371345|4189185|B3|||Age||years|Mean|53.6|53.6|Full Range|||32.0|70.0|
4362022|NCT00371345|4189186|B2|||Age||years|Mean|54.3|54.3|Full Range|||33.0|70.0|
4362023|NCT00371345|4189187|B1|||Age||years|Mean|52.2|52.2|Full Range|||32.0|68.0|
4362024|NCT00371293|4189245|B4|United States||Region of Enrollment||participants|Number|181|181.0||||||
4362025|NCT00371293|4189246|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4362026|NCT00371293|4189247|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4362027|NCT00371293|4189248|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4362028|NCT00371293|4189245|B4||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4362029|NCT00371293|4189246|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4362030|NCT00371293|4189247|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4362031|NCT00371293|4189248|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4362032|NCT00371293|4189245|B4||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4362033|NCT00371293|4189246|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4362034|NCT00371293|4189247|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4362035|NCT00371293|4189248|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4362036|NCT00371293|4189245|B4|||Age||years|Mean|49|49.0|Standard Deviation|10|10.0|||
4362037|NCT00371293|4189246|B3|||Age||years|Mean|49|49.0|Standard Deviation|10|10.0|||
4362038|NCT00371293|4189247|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|10|10.0|||
4362039|NCT00371293|4189248|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|10|10.0|||
4362040|NCT00371267|4189270|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362041|NCT00371267|4189271|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362042|NCT00371267|4189272|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362043|NCT00371267|4189270|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4362044|NCT00371267|4189271|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4362045|NCT00371267|4189272|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4362046|NCT00371267|4189270|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4362047|NCT00371267|4189271|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4362048|NCT00371267|4189272|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4362049|NCT00371267|4189270|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4362050|NCT00371267|4189271|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4362051|NCT00371267|4189272|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4362052|NCT00371267|4189270|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4362053|NCT00371267|4189271|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4362054|NCT00371267|4189272|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4362055|NCT00371267|4189270|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|9.5|9.5|||
4362056|NCT00371267|4189271|B2|||Age||years|Mean|69|69.0|Standard Deviation|10|10.0|||
4362057|NCT00371267|4189272|B1|||Age||years|Mean|66|66.0|Standard Deviation|9|9.0|||
4362058|NCT00371254|4189287|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4362059|NCT00371254|4189288|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4362060|NCT00371254|4189289|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4362061|NCT00371254|4189287|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4362062|NCT00371254|4189288|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4362063|NCT00371254|4189289|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4362064|NCT00371254|4189287|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4362065|NCT00371254|4189288|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4362066|NCT00371254|4189289|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4362067|NCT00371254|4189287|B3|White||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4362068|NCT00371254|4189288|B2|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4362069|NCT00371254|4189289|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4362070|NCT00371254|4189287|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4362071|NCT00371254|4189288|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4362072|NCT00371254|4189289|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4362073|NCT00371254|4189287|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4362074|NCT00371254|4189288|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4362075|NCT00371254|4189289|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4362076|NCT00371254|4189287|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4362077|NCT00371254|4189288|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4362078|NCT00371254|4189289|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4362079|NCT00371254|4189287|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362080|NCT00371254|4189288|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362081|NCT00371254|4189289|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362082|NCT00371254|4189287|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4362083|NCT00371254|4189288|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4362084|NCT00371254|4189289|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4362085|NCT00371254|4189287|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|9.38|9.38|||
4362086|NCT00371254|4189288|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|9.34|9.34|||
4362087|NCT00371254|4189289|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|8.98|8.98|||
4362088|NCT00371254|4189287|B3|>=50 years||Age, Customized||participants|Number|31|31.0||||||
4362089|NCT00371254|4189288|B2|>=50 years||Age, Customized||participants|Number|12|12.0||||||
4362090|NCT00371254|4189289|B1|>=50 years||Age, Customized||participants|Number|19|19.0||||||
4362091|NCT00371254|4189287|B3|<50 years||Age, Customized||participants|Number|13|13.0||||||
4362092|NCT00371254|4189288|B2|<50 years||Age, Customized||participants|Number|9|9.0||||||
4362093|NCT00371254|4189289|B1|<50 years||Age, Customized||participants|Number|4|4.0||||||
4362094|NCT00371176|4189340|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4362095|NCT00371176|4189341|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4362096|NCT00371176|4189342|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4362097|NCT00371176|4189340|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4362098|NCT00371176|4189341|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4362099|NCT00371176|4189342|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4362100|NCT00371176|4189340|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362101|NCT00371176|4189341|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362102|NCT00371176|4189342|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362103|NCT00371176|4189340|B3|||Age||years|Mean|32.19|32.19|Standard Deviation|9.31|9.31|||
4362104|NCT00371176|4189341|B2|||Age||years|Mean|31.62|31.62|Standard Deviation|9.10|9.1|||
4362105|NCT00371176|4189342|B1|||Age||years|Mean|32.77|32.77|Standard Deviation|9.85|9.85|||
4362106|NCT00371176|4189340|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362107|NCT00371176|4189341|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362108|NCT00371176|4189342|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362109|NCT00371176|4189340|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4362110|NCT00371176|4189341|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4362111|NCT00371176|4189342|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4362112|NCT00371176|4189340|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362113|NCT00371176|4189341|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362114|NCT00371176|4189342|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362115|NCT00371150|4189371|B3|||Total Bilirubin||mg/dL|Median|0.6|0.6|Full Range|||0.3|2.1|
4362116|NCT00371150|4189372|B2|||Total Bilirubin||mg/dL|Median|0.5|0.5|Full Range|||0.3|1.1|
4362117|NCT00371150|4189373|B1|||Total Bilirubin||mg/dL|Median|0.6|0.6|Full Range|||0.3|2.1|
4362118|NCT00371150|4189371|B3|||Albumin||g/dL|Median|4.3|4.3|Full Range|||3.0|5.1|
4362119|NCT00371150|4189372|B2|||Albumin||g/dL|Median|4.3|4.3|Full Range|||3.5|4.6|
4362120|NCT00371150|4189373|B1|||Albumin||g/dL|Median|4.3|4.3|Full Range|||3.0|5.1|
4362121|NCT00371150|4189371|B3|||Alanine Aminotransferase (ALT)||U/L|Median|107|107.0|Full Range|||30.0|617.0|
4362122|NCT00371150|4189372|B2|||Alanine Aminotransferase (ALT)||U/L|Median|113|113.0|Full Range|||80.0|301.0|
4362123|NCT00371150|4189373|B1|||Alanine Aminotransferase (ALT)||U/L|Median|106|106.0|Full Range|||30.0|617.0|
4362124|NCT00371150|4189371|B3|Negative||Hepatitis B e antibody (HBeAb) at baseline||participants|Number|25|25.0||||||
4362125|NCT00371150|4189372|B2|Negative||Hepatitis B e antibody (HBeAb) at baseline||participants|Number|4|4.0||||||
4362126|NCT00371150|4189373|B1|Negative||Hepatitis B e antibody (HBeAb) at baseline||participants|Number|21|21.0||||||
4362127|NCT00371150|4189371|B3|Positive||Hepatitis B e antibody (HBeAb) at baseline||participants|Number|21|21.0||||||
4362128|NCT00371150|4189372|B2|Positive||Hepatitis B e antibody (HBeAb) at baseline||participants|Number|2|2.0||||||
4362129|NCT00371150|4189373|B1|Positive||Hepatitis B e antibody (HBeAb) at baseline||participants|Number|19|19.0||||||
4362130|NCT00371150|4189371|B3|Negative||Hepatitis B e antigen (HBeAg) status at baseline||participants|Number|20|20.0||||||
4362131|NCT00371150|4189372|B2|Negative||Hepatitis B e antigen (HBeAg) status at baseline||participants|Number|2|2.0||||||
4362132|NCT00371150|4189373|B1|Negative||Hepatitis B e antigen (HBeAg) status at baseline||participants|Number|18|18.0||||||
4362133|NCT00371150|4189371|B3|Positive||Hepatitis B e antigen (HBeAg) status at baseline||participants|Number|26|26.0||||||
4362134|NCT00371150|4189372|B2|Positive||Hepatitis B e antigen (HBeAg) status at baseline||participants|Number|4|4.0||||||
4362135|NCT00371150|4189373|B1|Positive||Hepatitis B e antigen (HBeAg) status at baseline||participants|Number|22|22.0||||||
4362136|NCT00371150|4189371|B3|Missing||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|2|2.0||||||
4362137|NCT00371150|4189372|B2|Missing||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|2|2.0||||||
4362138|NCT00371150|4189373|B1|Missing||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|0|0.0||||||
4362139|NCT00371150|4189371|B3|Negative||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|0|0.0||||||
4362140|NCT00371150|4189372|B2|Negative||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|0|0.0||||||
4362141|NCT00371150|4189373|B1|Negative||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|0|0.0||||||
4362142|NCT00371150|4189371|B3|Positive||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|44|44.0||||||
4362143|NCT00371150|4189372|B2|Positive||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|4|4.0||||||
4362144|NCT00371150|4189373|B1|Positive||Hepatitis B surface antigen (HBsAg) status at baseline||participants|Number|40|40.0||||||
4362145|NCT00371150|4189371|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4362146|NCT00371150|4189372|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4362147|NCT00371150|4189373|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4362148|NCT00371150|4189371|B3|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
4362149|NCT00371150|4189372|B2|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4362150|NCT00371150|4189373|B1|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
4362151|NCT00371150|4189371|B3|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4362152|NCT00371150|4189372|B2|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4362153|NCT00371150|4189373|B1|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4362154|NCT00371150|4189371|B3|Brazil||Region of Enrollment||participants|Number|21|21.0||||||
4362155|NCT00371150|4189372|B2|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
4362156|NCT00371150|4189373|B1|Brazil||Region of Enrollment||participants|Number|21|21.0||||||
4362157|NCT00371150|4189371|B3|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4362158|NCT00371150|4189372|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4362159|NCT00371150|4189373|B1|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4362160|NCT00371150|4189371|B3|Black/ African American||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4362161|NCT00371150|4189372|B2|Black/ African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4362162|NCT00371150|4189373|B1|Black/ African American||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4362163|NCT00371150|4189371|B3|Missing||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4362164|NCT00371150|4189372|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4362165|NCT00371150|4189373|B1|Missing||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4362166|NCT00371150|4189371|B3|Not Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4362167|NCT00371150|4189372|B2|Not Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4362168|NCT00371150|4189373|B1|Not Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4362169|NCT00371150|4189371|B3|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4362170|NCT00371150|4189372|B2|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4362171|NCT00371150|4189373|B1|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4362172|NCT00371150|4189371|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4362173|NCT00371150|4189372|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4362174|NCT00371150|4189373|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4362175|NCT00371150|4189371|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4362176|NCT00371150|4189372|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4362177|NCT00371150|4189373|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4362178|NCT00371150|4189371|B3|||Age||years|Median|40.0|40.0|Full Range|||22.0|69.0|
4362179|NCT00371150|4189372|B2|||Age||years|Median|48.0|48.0|Full Range|||29.0|69.0|
4362180|NCT00371150|4189373|B1|||Age||years|Median|39.0|39.0|Full Range|||22.0|67.0|
4362181|NCT00371137|4189406|B4|United States||Region of Enrollment||participants|Number|548|548.0||||||
4362182|NCT00371137|4189407|B3|United States||Region of Enrollment||participants|Number|183|183.0||||||
4362183|NCT00371137|4189408|B2|United States||Region of Enrollment||participants|Number|182|182.0||||||
4362184|NCT00371137|4189409|B1|United States||Region of Enrollment||participants|Number|183|183.0||||||
4362185|NCT00371137|4189406|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4362186|NCT00371137|4189407|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362187|NCT00371137|4189408|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4362188|NCT00371137|4189409|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362189|NCT00371137|4189406|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4362190|NCT00371137|4189407|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362191|NCT00371137|4189408|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362192|NCT00371137|4189409|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4362193|NCT00371137|4189406|B4||White|Race (NIH/OMB)||Participants|Count of Participants|498|498.0||||||
4362194|NCT00371137|4189407|B3||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4362195|NCT00371137|4189408|B2||White|Race (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4362196|NCT00371137|4189409|B1||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4362197|NCT00371137|4189406|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4362198|NCT00371137|4189407|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4362199|NCT00371137|4189408|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4362200|NCT00371137|4189409|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4362201|NCT00371137|4189406|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362202|NCT00371137|4189407|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362203|NCT00371137|4189408|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362204|NCT00371137|4189409|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362205|NCT00371137|4189406|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4362206|NCT00371137|4189407|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4362207|NCT00371137|4189408|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4362208|NCT00371137|4189409|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4362209|NCT00371137|4189406|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4362210|NCT00371137|4189407|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4362211|NCT00371137|4189408|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4362212|NCT00371137|4189409|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4362213|NCT00371137|4189406|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4362214|NCT00371137|4189407|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4362215|NCT00371137|4189408|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4362216|NCT00371137|4189409|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4362217|NCT00371137|4189406|B4||Female|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4362218|NCT00371137|4189407|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4362219|NCT00371137|4189408|B2||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4362220|NCT00371137|4189409|B1||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4362221|NCT00371137|4189406|B4|>=65 years||Age, Customized||participants|Number|26|26.0||||||
4362222|NCT00371137|4189407|B3|>=65 years||Age, Customized||participants|Number|8|8.0||||||
4362223|NCT00371137|4189408|B2|>=65 years||Age, Customized||participants|Number|9|9.0||||||
4362224|NCT00371137|4189409|B1|>=65 years||Age, Customized||participants|Number|9|9.0||||||
4362225|NCT00371137|4189406|B4|50 - 64 years||Age, Customized||participants|Number|211|211.0||||||
4362226|NCT00371137|4189407|B3|50 - 64 years||Age, Customized||participants|Number|78|78.0||||||
4362227|NCT00371137|4189408|B2|50 - 64 years||Age, Customized||participants|Number|69|69.0||||||
4362228|NCT00371137|4189409|B1|50 - 64 years||Age, Customized||participants|Number|64|64.0||||||
4362229|NCT00371137|4189406|B4|40 - 49 years||Age, Customized||participants|Number|174|174.0||||||
4362230|NCT00371137|4189407|B3|40 - 49 years||Age, Customized||participants|Number|57|57.0||||||
4362231|NCT00371137|4189408|B2|40 - 49 years||Age, Customized||participants|Number|47|47.0||||||
4362232|NCT00371137|4189409|B1|40 - 49 years||Age, Customized||participants|Number|70|70.0||||||
4362233|NCT00371137|4189406|B4|18 - 39 years||Age, Customized||participants|Number|137|137.0||||||
4362234|NCT00371137|4189407|B3|18 - 39 years||Age, Customized||participants|Number|40|40.0||||||
4362235|NCT00371137|4189408|B2|18 - 39 years||Age, Customized||participants|Number|57|57.0||||||
4362236|NCT00371137|4189409|B1|18 - 39 years||Age, Customized||participants|Number|40|40.0||||||
4362237|NCT00371137|4189406|B4|||Age||years|Mean|47.0|47.0|Standard Deviation|11.26|11.26|||
4362238|NCT00371137|4189407|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|10.61|10.61|||
4362239|NCT00371137|4189408|B2|||Age||years|Mean|47.0|47.0|Standard Deviation|11.76|11.76|||
4362240|NCT00371137|4189409|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|11.43|11.43|||
4362241|NCT00370994|4189419|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4362242|NCT00370994|4189420|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4362243|NCT00370994|4189421|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4362244|NCT00370994|4189419|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4362245|NCT00370994|4189420|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4362246|NCT00370994|4189421|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4362247|NCT00370994|4189419|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4362248|NCT00370994|4189420|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4362249|NCT00370994|4189421|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4362250|NCT00370994|4189419|B3|||Age||years|Mean|52|52.0|Standard Deviation|13.2|13.2|||
4362251|NCT00370994|4189420|B2|||Age||years|Mean|52|52.0|Standard Deviation|12.5|12.5|||
4362252|NCT00370994|4189421|B1|||Age||years|Mean|52|52.0|Standard Deviation|13.9|13.9|||
4362253|NCT00370994|4189419|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4362254|NCT00370994|4189420|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4362255|NCT00370994|4189421|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4362256|NCT00370994|4189419|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4362257|NCT00370994|4189420|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4362258|NCT00370994|4189421|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4362259|NCT00370994|4189419|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362260|NCT00370994|4189420|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362261|NCT00370994|4189421|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362262|NCT00370838|4189430|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4362263|NCT00370838|4189431|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4362264|NCT00370838|4189432|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4362265|NCT00370838|4189430|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4362266|NCT00370838|4189431|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4362267|NCT00370838|4189432|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4362268|NCT00370838|4189430|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4362269|NCT00370838|4189431|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4362270|NCT00370838|4189432|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4362271|NCT00370838|4189430|B3|||Age||years|Mean|14.9|14.9|Standard Deviation|5.5|5.5|||
4362272|NCT00370838|4189431|B2|||Age||years|Mean|16.0|16.0|Standard Deviation|4.4|4.4|||
4362273|NCT00370838|4189432|B1|||Age||years|Mean|14.5|14.5|Standard Deviation|6.4|6.4|||
4362274|NCT00370838|4189430|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362275|NCT00370838|4189431|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362276|NCT00370838|4189432|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362277|NCT00370838|4189430|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4362278|NCT00370838|4189431|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4362279|NCT00370838|4189432|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4362280|NCT00370838|4189430|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4362281|NCT00370838|4189431|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4362282|NCT00370838|4189432|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4362283|NCT00370682|4189451|B4|Thailand||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
4362284|NCT00370682|4189452|B3|Thailand||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4362285|NCT00370682|4189453|B2|Thailand||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4362286|NCT00370682|4189454|B1|Thailand||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4362287|NCT00370682|4189451|B4|Asian - Southeast Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|120|120.0||||||
4362288|NCT00370682|4189452|B3|Asian - Southeast Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4362289|NCT00370682|4189453|B2|Asian - Southeast Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4362290|NCT00370682|4189454|B1|Asian - Southeast Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4362291|NCT00370682|4189451|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4362292|NCT00370682|4189452|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4362293|NCT00370682|4189453|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4362294|NCT00370682|4189454|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4362295|NCT00370682|4189451|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4362296|NCT00370682|4189452|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4362297|NCT00370682|4189453|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4362298|NCT00370682|4189454|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4362299|NCT00370682|4189451|B4|||Age||years|Mean|21.6|21.6|Standard Deviation|1.21|1.21|||
4362300|NCT00370682|4189452|B3|||Age||years|Mean|21.9|21.9|Standard Deviation|1.19|1.19|||
4362301|NCT00370682|4189453|B2|||Age||years|Mean|21.7|21.7|Standard Deviation|1.27|1.27|||
4362302|NCT00370682|4189454|B1|||Age||years|Mean|21.2|21.2|Standard Deviation|1.09|1.09|||
4362303|NCT00370552|4189495|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4362304|NCT00370552|4189496|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4362305|NCT00370552|4189497|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362306|NCT00370552|4189498|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4362307|NCT00370552|4189495|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362308|NCT00370552|4189496|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362309|NCT00370552|4189497|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362310|NCT00370552|4189498|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362311|NCT00370552|4189495|B4||White|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4362312|NCT00370552|4189496|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4362313|NCT00370552|4189497|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4362314|NCT00370552|4189498|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4362315|NCT00370552|4189495|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4362316|NCT00370552|4189496|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362317|NCT00370552|4189497|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4362318|NCT00370552|4189498|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362319|NCT00370552|4189495|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362320|NCT00370552|4189496|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362321|NCT00370552|4189497|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362322|NCT00370552|4189498|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362323|NCT00370552|4189495|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4362324|NCT00370552|4189496|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362325|NCT00370552|4189497|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4362326|NCT00370552|4189498|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4362327|NCT00370552|4189495|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362328|NCT00370552|4189496|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362329|NCT00370552|4189497|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362330|NCT00370552|4189498|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362331|NCT00370552|4189495|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362332|NCT00370552|4189496|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362333|NCT00370552|4189497|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362334|NCT00370552|4189498|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362335|NCT00370552|4189495|B4||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4362336|NCT00370552|4189496|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4362337|NCT00370552|4189497|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4362338|NCT00370552|4189498|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4362339|NCT00370552|4189495|B4|>=65 years||Age, Customized||participants|Number|39|39.0||||||
4362340|NCT00370552|4189496|B3|>=65 years||Age, Customized||participants|Number|10|10.0||||||
4362341|NCT00370552|4189497|B2|>=65 years||Age, Customized||participants|Number|16|16.0||||||
4362342|NCT00370552|4189498|B1|>=65 years||Age, Customized||participants|Number|13|13.0||||||
4362343|NCT00370552|4189495|B4|Younger than 65 years||Age, Customized||participants|Number|84|84.0||||||
4362344|NCT00370552|4189496|B3|Younger than 65 years||Age, Customized||participants|Number|22|22.0||||||
4362345|NCT00370552|4189497|B2|Younger than 65 years||Age, Customized||participants|Number|29|29.0||||||
4362346|NCT00370552|4189498|B1|Younger than 65 years||Age, Customized||participants|Number|33|33.0||||||
4362347|NCT00370552|4189495|B4|||Age||years|Median|59.0|59.0|Full Range|||27.0|83.0|
4362348|NCT00370552|4189496|B3|||Age||years|Median|59.0|59.0|Full Range|||37.0|75.0|
4362349|NCT00370552|4189497|B2|||Age||years|Median|59.0|59.0|Full Range|||37.0|83.0|
4362350|NCT00370552|4189498|B1|||Age||years|Median|60.0|60.0|Full Range|||27.0|80.0|
4362351|NCT00370396|4189538|B4||Male|Sex: Female, Male||Participants|Count of Participants|568|568.0||||||
4362352|NCT00370396|4189539|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4362353|NCT00370396|4189540|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4362354|NCT00370396|4189541|B1||Male|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4362355|NCT00370396|4189538|B4||Female|Sex: Female, Male||Participants|Count of Participants|544|544.0||||||
4362356|NCT00370396|4189539|B3||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4362357|NCT00370396|4189540|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4362358|NCT00370396|4189541|B1||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4362359|NCT00370396|4189538|B4|||Age||Months|Mean|14.93|14.93|Standard Deviation|2.19|2.19|||
4362360|NCT00370396|4189539|B3|||Age||Months|Mean|14.2|14.2|Standard Deviation|2.23|2.23|||
4362361|NCT00370396|4189540|B2|||Age||Months|Mean|14.2|14.2|Standard Deviation|2.26|2.26|||
4362362|NCT00370396|4189541|B1|||Age||Months|Mean|15.3|15.3|Standard Deviation|2.08|2.08|||
4362363|NCT00370331|4189595|B3|Platelet count less or equal 15,000 per microliter||Stratification variable|Subjects were stratified at randomization based on current use of idiopathic thrombocytopenic purpura (ITP) medication, splenectomy status, and baseline platelet count|Participants|Number|97|97.0||||||
4362364|NCT00370331|4189596|B2|Platelet count less or equal 15,000 per microliter||Stratification variable|Subjects were stratified at randomization based on current use of idiopathic thrombocytopenic purpura (ITP) medication, splenectomy status, and baseline platelet count|Participants|Number|67|67.0||||||
4362365|NCT00370331|4189597|B1|Platelet count less or equal 15,000 per microliter||Stratification variable|Subjects were stratified at randomization based on current use of idiopathic thrombocytopenic purpura (ITP) medication, splenectomy status, and baseline platelet count|Participants|Number|30|30.0||||||
4362366|NCT00370331|4189595|B3|Splenectomy at randomization||Stratification variable|Subjects were stratified at randomization based on current use of idiopathic thrombocytopenic purpura (ITP) medication, splenectomy status, and baseline platelet count|Participants|Number|71|71.0||||||
4362367|NCT00370331|4189596|B2|Splenectomy at randomization||Stratification variable|Subjects were stratified at randomization based on current use of idiopathic thrombocytopenic purpura (ITP) medication, splenectomy status, and baseline platelet count|Participants|Number|50|50.0||||||
4362368|NCT00370331|4189597|B1|Splenectomy at randomization||Stratification variable|Subjects were stratified at randomization based on current use of idiopathic thrombocytopenic purpura (ITP) medication, splenectomy status, and baseline platelet count|Participants|Number|21|21.0||||||
4362369|NCT00370331|4189595|B3|Use of ITP medication at randomization||Stratification variable|Subjects were stratified at randomization based on current use of idiopathic thrombocytopenic purpura (ITP) medication, splenectomy status, and baseline platelet count|Participants|Number|94|94.0||||||
4362370|NCT00370331|4189596|B2|Use of ITP medication at randomization||Stratification variable|Subjects were stratified at randomization based on current use of idiopathic thrombocytopenic purpura (ITP) medication, splenectomy status, and baseline platelet count|Participants|Number|63|63.0||||||
4362371|NCT00370331|4189597|B1|Use of ITP medication at randomization||Stratification variable|Subjects were stratified at randomization based on current use of idiopathic thrombocytopenic purpura (ITP) medication, splenectomy status, and baseline platelet count|Participants|Number|31|31.0||||||
4362372|NCT00370331|4189595|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4362373|NCT00370331|4189596|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4362374|NCT00370331|4189597|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4362375|NCT00370331|4189595|B3|White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
4362376|NCT00370331|4189596|B2|White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4362377|NCT00370331|4189597|B1|White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4362378|NCT00370331|4189595|B3|White/Arabic/North African||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4362379|NCT00370331|4189596|B2|White/Arabic/North African||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4362380|NCT00370331|4189597|B1|White/Arabic/North African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4362381|NCT00370331|4189595|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4362382|NCT00370331|4189596|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4362383|NCT00370331|4189597|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4362384|NCT00370331|4189595|B3|South-East Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4362385|NCT00370331|4189596|B2|South-East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4362386|NCT00370331|4189597|B1|South-East Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4362387|NCT00370331|4189595|B3|East Asian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4362388|NCT00370331|4189596|B2|East Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4362389|NCT00370331|4189597|B1|East Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4362390|NCT00370331|4189595|B3|American Indian/Alaska native||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4362391|NCT00370331|4189596|B2|American Indian/Alaska native||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4362392|NCT00370331|4189597|B1|American Indian/Alaska native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4362393|NCT00370331|4189595|B3|African American/African||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4362394|NCT00370331|4189596|B2|African American/African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4362395|NCT00370331|4189597|B1|African American/African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4362396|NCT00370331|4189595|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4362397|NCT00370331|4189596|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4362398|NCT00370331|4189597|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4362399|NCT00370331|4189595|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4362400|NCT00370331|4189596|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4362401|NCT00370331|4189597|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4362402|NCT00370331|4189595|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|15.45|15.45|||
4362403|NCT00370331|4189596|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|15.61|15.61|||
4362404|NCT00370331|4189597|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|14.72|14.72|||
4362405|NCT00370292|4189622|B3|||Weight|One participant in the Pemetrexed - Before Amendment group was missing a baseline weight measurement.|kilograms (kg)|Mean|68.7|68.7|Standard Deviation|13.13|13.13|||
4362406|NCT00370292|4189623|B2|||Weight|One participant in the Pemetrexed - Before Amendment group was missing a baseline weight measurement.|kilograms (kg)|Mean|66.3|66.3|Standard Deviation|9.43|9.43|||
4362407|NCT00370292|4189624|B1|||Weight|One participant in the Pemetrexed - Before Amendment group was missing a baseline weight measurement.|kilograms (kg)|Mean|70.2|70.2|Standard Deviation|15.28|15.28|||
4362408|NCT00370292|4189622|B3|||Height|One participant in the Pemetrexed - Before Amendment group was missing a baseline height measurement.|centimeters (cm)|Mean|166.4|166.4|Standard Deviation|10.09|10.09|||
4362409|NCT00370292|4189623|B2|||Height|One participant in the Pemetrexed - Before Amendment group was missing a baseline height measurement.|centimeters (cm)|Mean|162.1|162.1|Standard Deviation|9.04|9.04|||
4362410|NCT00370292|4189624|B1|||Height|One participant in the Pemetrexed - Before Amendment group was missing a baseline height measurement.|centimeters (cm)|Mean|169.2|169.2|Standard Deviation|10.15|10.15|||
4362411|NCT00370292|4189622|B3|||Heart Rate||beats per minute (bpm)|Mean|81.1|81.1|Standard Deviation|12.58|12.58|||
4362412|NCT00370292|4189623|B2|||Heart Rate||beats per minute (bpm)|Mean|78.6|78.6|Standard Deviation|8.52|8.52|||
4362413|NCT00370292|4189624|B1|||Heart Rate||beats per minute (bpm)|Mean|82.9|82.9|Standard Deviation|14.98|14.98|||
4362414|NCT00370292|4189622|B3|||Body Temperature||degrees Celsius (°C)|Mean|36.0|36.0|Standard Deviation|0.49|0.49|||
4362415|NCT00370292|4189623|B2|||Body Temperature||degrees Celsius (°C)|Mean|35.9|35.9|Standard Deviation|0.36|0.36|||
4362416|NCT00370292|4189624|B1|||Body Temperature||degrees Celsius (°C)|Mean|36.1|36.1|Standard Deviation|0.58|0.58|||
4362417|NCT00370292|4189622|B3|||Body Surface Area (BSA)|BSA = 0.007184 x weight(kg)^0.425 x height(cm)^0.725|square meters (m^2)|Mean|1.7|1.7|Standard Deviation|0.16|0.16|||
4362418|NCT00370292|4189623|B2|||Body Surface Area (BSA)|BSA = 0.007184 x weight(kg)^0.425 x height(cm)^0.725|square meters (m^2)|Mean|1.7|1.7|Standard Deviation|0.13|0.13|||
4362419|NCT00370292|4189624|B1|||Body Surface Area (BSA)|BSA = 0.007184 x weight(kg)^0.425 x height(cm)^0.725|square meters (m^2)|Mean|1.7|1.7|Standard Deviation|0.17|0.17|||
4362420|NCT00370292|4189622|B3|Diastolic Blood Pressure (DBP)||Blood Pressure||mmHg|Mean|82.5|82.5|Standard Deviation|8.37|8.37|||
4362421|NCT00370292|4189623|B2|Diastolic Blood Pressure (DBP)||Blood Pressure||mmHg|Mean|83.6|83.6|Standard Deviation|9.45|9.45|||
4362422|NCT00370292|4189624|B1|Diastolic Blood Pressure (DBP)||Blood Pressure||mmHg|Mean|81.8|81.8|Standard Deviation|7.97|7.97|||
4362423|NCT00370292|4189622|B3|Systolic Blood Pressure (SBP)||Blood Pressure||mmHg|Mean|141.6|141.6|Standard Deviation|17.08|17.08|||
4362424|NCT00370292|4189623|B2|Systolic Blood Pressure (SBP)||Blood Pressure||mmHg|Mean|146.9|146.9|Standard Deviation|21.54|21.54|||
4362425|NCT00370292|4189624|B1|Systolic Blood Pressure (SBP)||Blood Pressure||mmHg|Mean|138.0|138.0|Standard Deviation|13.17|13.17|||
4362426|NCT00370292|4189622|B3|Other||Tumor Type||participants|Number|2|2.0||||||
4362427|NCT00370292|4189623|B2|Other||Tumor Type||participants|Number|0|0.0||||||
4362428|NCT00370292|4189624|B1|Other||Tumor Type||participants|Number|2|2.0||||||
4362429|NCT00370292|4189622|B3|Squamous Cell Carcinoma||Tumor Type||participants|Number|6|6.0||||||
4362430|NCT00370292|4189623|B2|Squamous Cell Carcinoma||Tumor Type||participants|Number|1|1.0||||||
4362431|NCT00370292|4189624|B1|Squamous Cell Carcinoma||Tumor Type||participants|Number|5|5.0||||||
4362432|NCT00370292|4189622|B3|Adenocarcinoma||Tumor Type||participants|Number|11|11.0||||||
4362433|NCT00370292|4189623|B2|Adenocarcinoma||Tumor Type||participants|Number|6|6.0||||||
4362434|NCT00370292|4189624|B1|Adenocarcinoma||Tumor Type||participants|Number|5|5.0||||||
4362435|NCT00370292|4189622|B3|Caucasian||Race/Ethnicity||participants|Number|19|19.0||||||
4362436|NCT00370292|4189623|B2|Caucasian||Race/Ethnicity||participants|Number|7|7.0||||||
4362437|NCT00370292|4189624|B1|Caucasian||Race/Ethnicity||participants|Number|12|12.0||||||
4362438|NCT00370292|4189622|B3|Surgery - Yes: Radical||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|9|9.0||||||
4362439|NCT00370292|4189623|B2|Surgery - Yes: Radical||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|4|4.0||||||
4362440|NCT00370292|4189624|B1|Surgery - Yes: Radical||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|5|5.0||||||
4362441|NCT00370292|4189622|B3|Surgery - Yes: Other||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|8|8.0||||||
4362442|NCT00370292|4189623|B2|Surgery - Yes: Other||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|3|3.0||||||
4362443|NCT00370292|4189624|B1|Surgery - Yes: Other||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|5|5.0||||||
4362444|NCT00370292|4189622|B3|Surgery - Yes: Lobectomy||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|6|6.0||||||
4362445|NCT00370292|4189623|B2|Surgery - Yes: Lobectomy||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|3|3.0||||||
4362446|NCT00370292|4189624|B1|Surgery - Yes: Lobectomy||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|3|3.0||||||
4362447|NCT00370292|4189622|B3|Surgery - Yes: Pneumonectomy||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|1|1.0||||||
4362448|NCT00370292|4189623|B2|Surgery - Yes: Pneumonectomy||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|1|1.0||||||
4362449|NCT00370292|4189624|B1|Surgery - Yes: Pneumonectomy||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|0|0.0||||||
4362450|NCT00370292|4189622|B3|Surgery - No||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|5|5.0||||||
4362451|NCT00370292|4189623|B2|Surgery - No||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|1|1.0||||||
4362452|NCT00370292|4189624|B1|Surgery - No||Previous Surgery|Participants having surgery could have more than one type of surgery.|participants|Number|4|4.0||||||
4362453|NCT00370292|4189622|B3|Yes||Previous Anti-Tumor Treatment||participants|Number|13|13.0||||||
4362454|NCT00370292|4189623|B2|Yes||Previous Anti-Tumor Treatment||participants|Number|6|6.0||||||
4362455|NCT00370292|4189624|B1|Yes||Previous Anti-Tumor Treatment||participants|Number|7|7.0||||||
4362456|NCT00370292|4189622|B3|No||Previous Anti-Tumor Treatment||participants|Number|6|6.0||||||
4362457|NCT00370292|4189623|B2|No||Previous Anti-Tumor Treatment||participants|Number|1|1.0||||||
4362458|NCT00370292|4189624|B1|No||Previous Anti-Tumor Treatment||participants|Number|5|5.0||||||
4362459|NCT00370292|4189622|B3|G3 - Poorly Differentiated||Histopathological Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|5|5.0||||||
4362460|NCT00370292|4189623|B2|G3 - Poorly Differentiated||Histopathological Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|3|3.0||||||
4362461|NCT00370292|4189624|B1|G3 - Poorly Differentiated||Histopathological Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|2|2.0||||||
4362462|NCT00370292|4189622|B3|G2 - Moderately Differentiated||Histopathological Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|3|3.0||||||
4362463|NCT00370292|4189623|B2|G2 - Moderately Differentiated||Histopathological Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|1|1.0||||||
4362464|NCT00370292|4189624|B1|G2 - Moderately Differentiated||Histopathological Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|2|2.0||||||
4362465|NCT00370292|4189622|B3|G1 - Well-Differentiated||Histopathological Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|2|2.0||||||
4362466|NCT00370292|4189623|B2|G1 - Well-Differentiated||Histopathological Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|1|1.0||||||
4362467|NCT00370292|4189624|B1|G1 - Well-Differentiated||Histopathological Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|1|1.0||||||
4362468|NCT00370292|4189622|B3|Not Done||Histopathological Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|9|9.0||||||
4362469|NCT00370292|4189623|B2|Not Done||Histopathological Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|2|2.0||||||
4362470|NCT00370292|4189624|B1|Not Done||Histopathological Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|7|7.0||||||
4362471|NCT00370292|4189622|B3|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|3|3.0||||||
4362472|NCT00370292|4189623|B2|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|1|1.0||||||
4362473|NCT00370292|4189624|B1|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|2|2.0||||||
4362474|NCT00370292|4189622|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|11|11.0||||||
4362475|NCT00370292|4189623|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|5|5.0||||||
4362476|NCT00370292|4189624|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|6|6.0||||||
4362477|NCT00370292|4189622|B3|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|5|5.0||||||
4362478|NCT00370292|4189623|B2|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|1|1.0||||||
4362479|NCT00370292|4189624|B1|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|4|4.0||||||
4362480|NCT00370292|4189622|B3|Stage IV||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|7|7.0||||||
4362481|NCT00370292|4189623|B2|Stage IV||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|2|2.0||||||
4362482|NCT00370292|4189624|B1|Stage IV||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|5|5.0||||||
4362483|NCT00370292|4189622|B3|Stage IIIB||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|5|5.0||||||
4362484|NCT00370292|4189623|B2|Stage IIIB||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|2|2.0||||||
4362485|NCT00370292|4189624|B1|Stage IIIB||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|3|3.0||||||
4362486|NCT00370292|4189622|B3|Stage IIIA||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|1|1.0||||||
4362487|NCT00370292|4189623|B2|Stage IIIA||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|1|1.0||||||
4362488|NCT00370292|4189624|B1|Stage IIIA||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|0|0.0||||||
4362489|NCT00370292|4189622|B3|Stage IIB||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|1|1.0||||||
4362490|NCT00370292|4189623|B2|Stage IIB||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|1|1.0||||||
4362491|NCT00370292|4189624|B1|Stage IIB||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|0|0.0||||||
4362492|NCT00370292|4189622|B3|Stage IIA||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|1|1.0||||||
4362493|NCT00370292|4189623|B2|Stage IIA||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|0|0.0||||||
4362494|NCT00370292|4189624|B1|Stage IIA||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|1|1.0||||||
4362495|NCT00370292|4189622|B3|Stage IB||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|1|1.0||||||
4362496|NCT00370292|4189623|B2|Stage IB||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|0|0.0||||||
4362497|NCT00370292|4189624|B1|Stage IB||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|1|1.0||||||
4362498|NCT00370292|4189622|B3|Stage IA||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|2|2.0||||||
4362499|NCT00370292|4189623|B2|Stage IA||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|0|0.0||||||
4362500|NCT00370292|4189624|B1|Stage IA||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|2|2.0||||||
4362501|NCT00370292|4189622|B3|Not Known||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|1|1.0||||||
4362502|NCT00370292|4189623|B2|Not Known||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|1|1.0||||||
4362503|NCT00370292|4189624|B1|Not Known||Disease Stages|Stage means how big the tumor is and how far it's spread. Stages range from 0 (tumor has not spread) to IV (tumor has spread to other organs).|participants|Number|0|0.0||||||
4362504|NCT00370292|4189622|B3|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4362505|NCT00370292|4189623|B2|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4362506|NCT00370292|4189624|B1|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4362507|NCT00370292|4189622|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4362508|NCT00370292|4189623|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4362509|NCT00370292|4189624|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4362510|NCT00370292|4189622|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4362511|NCT00370292|4189623|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4362512|NCT00370292|4189624|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4362513|NCT00370292|4189622|B3|||Age||years|Mean|69.2|69.2|Standard Deviation|8.90|8.9|||
4362514|NCT00370292|4189623|B2|||Age||years|Mean|69.4|69.4|Standard Deviation|6.45|6.45|||
4362515|NCT00370292|4189624|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|10.34|10.34|||
4362516|NCT00370149|4189635|B3|United States||Region of Enrollment||participants|Number|326|326.0||||||
4362517|NCT00370149|4189636|B2|United States||Region of Enrollment||participants|Number|161|161.0||||||
4362518|NCT00370149|4189637|B1|United States||Region of Enrollment||participants|Number|165|165.0||||||
4362519|NCT00370149|4189635|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4362520|NCT00370149|4189636|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4362521|NCT00370149|4189637|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4362522|NCT00370149|4189635|B3||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4362523|NCT00370149|4189636|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4362524|NCT00370149|4189637|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4362525|NCT00370149|4189635|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362526|NCT00370149|4189636|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362527|NCT00370149|4189637|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362528|NCT00370149|4189635|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4362529|NCT00370149|4189636|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4362530|NCT00370149|4189637|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4362531|NCT00370149|4189635|B3||<=18 years|Age||Participants|Count of Participants|326|326.0||||||
4362532|NCT00370149|4189636|B2||<=18 years|Age||Participants|Count of Participants|161|161.0||||||
4362533|NCT00370149|4189637|B1||<=18 years|Age||Participants|Count of Participants|165|165.0||||||
4362534|NCT00370071|4189648|B1|||Time since onset of Multiple Sclerosis||years|Mean|3.5|3.5|Standard Deviation|4.6|4.6|||
4362535|NCT00370071|4189648|B1|||T2 lesions at screening||lesions|Mean|45.1|45.1|Standard Deviation|32.9|32.9|||
4362536|NCT00370071|4189648|B1|||Previous Multiple Sclerosis relapses||relapses|Mean|2.8|2.8|Standard Deviation|1.7|1.7|||
4362537|NCT00370071|4189648|B1|||Newly active lesions during 3-month pre-treatment||lesions|Mean|4.8|4.8|Standard Deviation|7.1|7.1|||
4362538|NCT00370071|4189648|B1|||New or enlarging T2 lesions during 3-month pre-treatment||lesions|Mean|2.2|2.2|Standard Deviation|3.2|3.2|||
4362539|NCT00370071|4189648|B1|||New Gd-enhancing lesions during 3-month pre-treatment||lesions|Mean|2.6|2.6|Standard Deviation|4.1|4.1|||
4362540|NCT00370071|4189648|B1|||Expanded disability status scale at screening (EDSS)|The EDSS is a scale based on the standardized neurological examination which comprised of optic, brain stem/cranial nerves, pyramidal, cerebellar, sensory, vegetative, and cerebral functions, as well as walking ability. The EDSS scores range from 0.0 (normal) to 10.0 (dead). A score of 2 to 3 indicates minimal to moderate disability.|Points on a scale|Mean|2.26|2.26|Full Range|||0.0|5.0|
4362541|NCT00370071|4189648|B1|Secondary progressive (SP)||Type of Multiple Sclerosis||participants|Number|3|3.0||||||
4362542|NCT00370071|4189648|B1|Relapsing-remitting (RR)||Type of Multiple Sclerosis||participants|Number|36|36.0||||||
4362543|NCT00370071|4189648|B1|>= 4 lesions||Gadolinium enhancing lesions (T1) at screening||participants|Number|11|11.0||||||
4362544|NCT00370071|4189648|B1|1-3 lesions||Gadolinium enhancing lesions (T1) at screening||participants|Number|23|23.0||||||
4362545|NCT00370071|4189648|B1|no lesions||Gadolinium enhancing lesions (T1) at screening||participants|Number|5|5.0||||||
4362546|NCT00370071|4189648|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4362547|NCT00370071|4189648|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4362548|NCT00370071|4189648|B1|||Age||years|Mean|31.6|31.6|Full Range|||17.0|58.0|
4362549|NCT00370032|4189663|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4362550|NCT00370032|4189664|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4362551|NCT00370032|4189665|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4362552|NCT00370032|4189663|B3|South East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4362553|NCT00370032|4189664|B2|South East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4362554|NCT00370032|4189665|B1|South East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4362555|NCT00370032|4189663|B3|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4362556|NCT00370032|4189664|B2|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4362557|NCT00370032|4189665|B1|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4362558|NCT00370032|4189663|B3|Central/South Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4362559|NCT00370032|4189664|B2|Central/South Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4362560|NCT00370032|4189665|B1|Central/South Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4362561|NCT00370032|4189663|B3|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4362562|NCT00370032|4189664|B2|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4362563|NCT00370032|4189665|B1|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4362564|NCT00370032|4189663|B3|White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4362565|NCT00370032|4189664|B2|White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4362566|NCT00370032|4189665|B1|White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4362567|NCT00370032|4189663|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362568|NCT00370032|4189664|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362569|NCT00370032|4189665|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362570|NCT00370032|4189663|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4362571|NCT00370032|4189664|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4362572|NCT00370032|4189665|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4362573|NCT00370032|4189663|B3|||Age||years|Mean|29.99|29.99|Standard Deviation|7.42|7.42|||
4362574|NCT00370032|4189664|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|5.8|5.8|||
4362575|NCT00370032|4189665|B1|||Age||years|Mean|33.2|33.2|Standard Deviation|8.8|8.8|||
4362576|NCT00369967|4189684|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4362577|NCT00369967|4189685|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4362578|NCT00369967|4189686|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4362579|NCT00369967|4189684|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4362580|NCT00369967|4189685|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4362581|NCT00369967|4189686|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4362582|NCT00369967|4189684|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362583|NCT00369967|4189685|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362584|NCT00369967|4189686|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362585|NCT00369967|4189684|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4362586|NCT00369967|4189685|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4362587|NCT00369967|4189686|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4362588|NCT00369967|4189684|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4362589|NCT00369967|4189685|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4362590|NCT00369967|4189686|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4362591|NCT00369967|4189684|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362592|NCT00369967|4189685|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362593|NCT00369967|4189686|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362594|NCT00369967|4189684|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362595|NCT00369967|4189685|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362596|NCT00369967|4189686|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362597|NCT00369967|4189684|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362598|NCT00369967|4189685|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362599|NCT00369967|4189686|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362600|NCT00369967|4189684|B3||Male|Sex: Female, Male|all female participants|Participants|Count of Participants|0|0.0||||||
4362601|NCT00369967|4189685|B2||Male|Sex: Female, Male|all female participants|Participants|Count of Participants|0|0.0||||||
4362602|NCT00369967|4189686|B1||Male|Sex: Female, Male|all female participants|Participants|Count of Participants|0|0.0||||||
4362603|NCT00369967|4189684|B3||Female|Sex: Female, Male|all female participants|Participants|Count of Participants|48|48.0||||||
4362604|NCT00369967|4189685|B2||Female|Sex: Female, Male|all female participants|Participants|Count of Participants|17|17.0||||||
4362605|NCT00369967|4189686|B1||Female|Sex: Female, Male|all female participants|Participants|Count of Participants|31|31.0||||||
4362606|NCT00369967|4189684|B3|||Age||years|Mean|18|18.0|Standard Deviation|1.9|1.9|||
4362607|NCT00369967|4189685|B2|||Age||years|Mean|18|18.0|Standard Deviation|2.1|2.1|||
4362608|NCT00369967|4189686|B1|||Age||years|Mean|19|19.0|Standard Deviation|1.7|1.7|||
4362609|NCT00369967|4189684|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362610|NCT00369967|4189685|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362611|NCT00369967|4189686|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362612|NCT00369967|4189684|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4362613|NCT00369967|4189685|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4362614|NCT00369967|4189686|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4362615|NCT00369967|4189684|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4362616|NCT00369967|4189685|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4362617|NCT00369967|4189686|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4362618|NCT00369941|4189703|B3|||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA)||Copies/mL|Geometric Mean|104702|104702.0|Full Range|||400.0|750000.0|
4362619|NCT00369941|4189704|B2|||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA)||Copies/mL|Geometric Mean|106215|106215.0|Full Range|||4410.0|750000.0|
4362620|NCT00369941|4189705|B1|||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA)||Copies/mL|Geometric Mean|103205|103205.0|Full Range|||400.0|750000.0|
4362621|NCT00369941|4189703|B3|||Cluster of Differentiation 4 (CD4) Cell Count||Cells/mm^3|Mean|218|218.0|Full Range|||1.0|807.0|
4362622|NCT00369941|4189704|B2|||Cluster of Differentiation 4 (CD4) Cell Count||Cells/mm^3|Mean|217|217.0|Full Range|||4.0|807.0|
4362623|NCT00369941|4189705|B1|||Cluster of Differentiation 4 (CD4) Cell Count||Cells/mm^3|Mean|219|219.0|Full Range|||1.0|620.0|
4362624|NCT00369941|4189703|B3|Others||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4362625|NCT00369941|4189704|B2|Others||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4362626|NCT00369941|4189705|B1|Others||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4362627|NCT00369941|4189703|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4362628|NCT00369941|4189704|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4362629|NCT00369941|4189705|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4362630|NCT00369941|4189703|B3|Asian||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4362631|NCT00369941|4189704|B2|Asian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4362632|NCT00369941|4189705|B1|Asian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4362633|NCT00369941|4189703|B3|Black||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4362634|NCT00369941|4189704|B2|Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4362635|NCT00369941|4189705|B1|Black||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4362636|NCT00369941|4189703|B3|White||Race/Ethnicity, Customized||participants|Number|239|239.0||||||
4362637|NCT00369941|4189704|B2|White||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4362638|NCT00369941|4189705|B1|White||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
4362639|NCT00369941|4189703|B3||Male|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4362640|NCT00369941|4189704|B2||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4362641|NCT00369941|4189705|B1||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4362642|NCT00369941|4189703|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4362643|NCT00369941|4189704|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4362644|NCT00369941|4189705|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4362645|NCT00369941|4189703|B3|||Age||years|Mean|37|37.0|Full Range|||19.0|71.0|
4362646|NCT00369941|4189704|B2|||Age||years|Mean|37|37.0|Full Range|||19.0|71.0|
4362647|NCT00369941|4189705|B1|||Age||years|Mean|38|38.0|Full Range|||19.0|67.0|
4362648|NCT00369928|4189856|B4|Hungary||Region of Enrollment||participants|Number|31|31.0||||||
4362649|NCT00369928|4189857|B3|Hungary||Region of Enrollment||participants|Number|12|12.0||||||
4362650|NCT00369928|4189858|B2|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4362651|NCT00369928|4189859|B1|Hungary||Region of Enrollment||participants|Number|10|10.0||||||
4362652|NCT00369928|4189856|B4|Czech Republic||Region of Enrollment||participants|Number|57|57.0||||||
4362653|NCT00369928|4189857|B3|Czech Republic||Region of Enrollment||participants|Number|16|16.0||||||
4362654|NCT00369928|4189858|B2|Czech Republic||Region of Enrollment||participants|Number|23|23.0||||||
4362655|NCT00369928|4189859|B1|Czech Republic||Region of Enrollment||participants|Number|18|18.0||||||
4362656|NCT00369928|4189856|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4362657|NCT00369928|4189857|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4362658|NCT00369928|4189858|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4362659|NCT00369928|4189859|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4362660|NCT00369928|4189856|B4|Poland||Region of Enrollment||participants|Number|136|136.0||||||
4362661|NCT00369928|4189857|B3|Poland||Region of Enrollment||participants|Number|49|49.0||||||
4362662|NCT00369928|4189858|B2|Poland||Region of Enrollment||participants|Number|42|42.0||||||
4362663|NCT00369928|4189859|B1|Poland||Region of Enrollment||participants|Number|45|45.0||||||
4362664|NCT00369928|4189856|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
4362665|NCT00369928|4189857|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4362666|NCT00369928|4189858|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4362667|NCT00369928|4189859|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4362668|NCT00369928|4189856|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4362669|NCT00369928|4189857|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4362670|NCT00369928|4189858|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4362671|NCT00369928|4189859|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4362672|NCT00369928|4189856|B4||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4362673|NCT00369928|4189857|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4362674|NCT00369928|4189858|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4362675|NCT00369928|4189859|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4362676|NCT00369928|4189856|B4|||Age||years|Mean|52.21|52.21|Standard Deviation|10.83|10.83|||
4362677|NCT00369928|4189857|B3|||Age||years|Mean|54.70|54.7|Standard Deviation|9.31|9.31|||
4362678|NCT00369928|4189858|B2|||Age||years|Mean|50.39|50.39|Standard Deviation|11.68|11.68|||
4362679|NCT00369928|4189859|B1|||Age||years|Mean|51.52|51.52|Standard Deviation|11.04|11.04|||
4362680|NCT00369928|4189856|B4||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4362681|NCT00369928|4189857|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4362682|NCT00369928|4189858|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4362683|NCT00369928|4189859|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4362684|NCT00369928|4189856|B4||Between 18 and 65 years|Age||Participants|Count of Participants|232|232.0||||||
4362685|NCT00369928|4189857|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4362686|NCT00369928|4189858|B2||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4362687|NCT00369928|4189859|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4362688|NCT00369928|4189856|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362689|NCT00369928|4189857|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362690|NCT00369928|4189858|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362691|NCT00369928|4189859|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362692|NCT00369915|4189869|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4362693|NCT00369915|4189870|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4362694|NCT00369915|4189871|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4362695|NCT00369915|4189869|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4362696|NCT00369915|4189870|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4362697|NCT00369915|4189871|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4362698|NCT00369915|4189869|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362699|NCT00369915|4189870|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362700|NCT00369915|4189871|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362701|NCT00369915|4189869|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4362702|NCT00369915|4189870|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4362703|NCT00369915|4189871|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4362704|NCT00369915|4189869|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362705|NCT00369915|4189870|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362706|NCT00369915|4189871|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362707|NCT00369915|4189869|B3|||Age||years|Mean|31.9|31.9|Standard Deviation|8.2|8.2|||
4362708|NCT00369915|4189870|B2|||Age||years|Mean|33|33.0|Standard Deviation|10.4|10.4|||
4362709|NCT00369915|4189871|B1|||Age||years|Mean|31|31.0|Standard Deviation|6.6|6.6|||
4362710|NCT00369824|4189880|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362711|NCT00369824|4189881|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362712|NCT00369824|4189882|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362713|NCT00369824|4189883|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362714|NCT00369824|4189884|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362715|NCT00369824|4189885|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362716|NCT00369824|4189886|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4362717|NCT00369824|4189880|B7||Female|Sex: Female, Male||Participants|Count of Participants|1283|1283.0||||||
4362718|NCT00369824|4189881|B6||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4362719|NCT00369824|4189882|B5||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4362720|NCT00369824|4189883|B4||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4362721|NCT00369824|4189884|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4362722|NCT00369824|4189885|B2||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4362723|NCT00369824|4189886|B1||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4362724|NCT00369824|4189880|B7|||Age||years|Mean|13.4|13.4|Standard Deviation|2.3|2.3|||
4362725|NCT00369824|4189881|B6|||Age||years|Mean|13.4|13.4|Standard Deviation|2.34|2.34|||
4362726|NCT00369824|4189882|B5|||Age||years|Mean|13.3|13.3|Standard Deviation|2.35|2.35|||
4362727|NCT00369824|4189883|B4|||Age||years|Mean|13.5|13.5|Standard Deviation|2.33|2.33|||
4362728|NCT00369824|4189884|B3|||Age||years|Mean|13.5|13.5|Standard Deviation|2.26|2.26|||
4362729|NCT00369824|4189885|B2|||Age||years|Mean|13.3|13.3|Standard Deviation|2.28|2.28|||
4362730|NCT00369824|4189886|B1|||Age||years|Mean|13.5|13.5|Standard Deviation|2.27|2.27|||
4362731|NCT00369785|4189989|B3|United States||Region of Enrollment||participants|Number|198|198.0||||||
4362732|NCT00369785|4189990|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
4362733|NCT00369785|4189991|B1|United States||Region of Enrollment||participants|Number|99|99.0||||||
4362734|NCT00369785|4189989|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362735|NCT00369785|4189990|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362736|NCT00369785|4189991|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362737|NCT00369785|4189989|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362738|NCT00369785|4189990|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362739|NCT00369785|4189991|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362740|NCT00369785|4189989|B3||White|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4362741|NCT00369785|4189990|B2||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4362742|NCT00369785|4189991|B1||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4362743|NCT00369785|4189989|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4362744|NCT00369785|4189990|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4362745|NCT00369785|4189991|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4362746|NCT00369785|4189989|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362747|NCT00369785|4189990|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362748|NCT00369785|4189991|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362749|NCT00369785|4189989|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4362750|NCT00369785|4189990|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362751|NCT00369785|4189991|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4362752|NCT00369785|4189989|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362753|NCT00369785|4189990|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362754|NCT00369785|4189991|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362755|NCT00369785|4189989|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4362756|NCT00369785|4189990|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4362757|NCT00369785|4189991|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4362758|NCT00369785|4189989|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4362759|NCT00369785|4189990|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4362760|NCT00369785|4189991|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4362761|NCT00369785|4189989|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4362762|NCT00369785|4189990|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362763|NCT00369785|4189991|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4362764|NCT00369785|4189989|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4362765|NCT00369785|4189990|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4362766|NCT00369785|4189991|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4362767|NCT00369785|4189989|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4362768|NCT00369785|4189990|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4362769|NCT00369785|4189991|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4362770|NCT00369785|4189989|B3|||Age||years|Median|55.1|55.1|Full Range|||19.0|84.0|
4362771|NCT00369785|4189990|B2|||Age||years|Median|54.9|54.9|Full Range|||19.0|81.0|
4362772|NCT00369785|4189991|B1|||Age||years|Median|56.1|56.1|Full Range|||19.0|84.0|
4362773|NCT00369785|4189989|B3||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4362774|NCT00369785|4189990|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4362775|NCT00369785|4189991|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4362776|NCT00369785|4189989|B3||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4362777|NCT00369785|4189990|B2||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4362778|NCT00369785|4189991|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4362779|NCT00369785|4189989|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362780|NCT00369785|4189990|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362781|NCT00369785|4189991|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362782|NCT00369746|4190000|B3|United States||Region of Enrollment||participants|Number|674|674.0||||||
4362783|NCT00369746|4190001|B2|United States||Region of Enrollment||participants|Number|536|536.0||||||
4362784|NCT00369746|4190002|B1|United States||Region of Enrollment||participants|Number|138|138.0||||||
4362785|NCT00369746|4190000|B3||Male|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
4362786|NCT00369746|4190001|B2||Male|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
4362787|NCT00369746|4190002|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4362788|NCT00369746|4190000|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4362789|NCT00369746|4190001|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4362790|NCT00369746|4190002|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4362791|NCT00369746|4190000|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|13.2|13.2|||
4362792|NCT00369746|4190001|B2|||Age||years|Mean|39.5|39.5|Standard Deviation|13.4|13.4|||
4362793|NCT00369746|4190002|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|12.3|12.3|||
4362794|NCT00369746|4190000|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362795|NCT00369746|4190001|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362796|NCT00369746|4190002|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362797|NCT00369746|4190000|B3||Between 18 and 65 years|Age||Participants|Count of Participants|674|674.0||||||
4362798|NCT00369746|4190001|B2||Between 18 and 65 years|Age||Participants|Count of Participants|536|536.0||||||
4362799|NCT00369746|4190002|B1||Between 18 and 65 years|Age||Participants|Count of Participants|138|138.0||||||
4362800|NCT00369746|4190000|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362801|NCT00369746|4190001|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362802|NCT00369746|4190002|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362803|NCT00369707|4190013|B1|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4362804|NCT00369707|4190013|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362805|NCT00369707|4190013|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362806|NCT00369707|4190013|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4362807|NCT00369707|4190013|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4362808|NCT00369707|4190013|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4362809|NCT00369707|4190013|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362810|NCT00369707|4190013|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362811|NCT00369707|4190013|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362812|NCT00369707|4190013|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4362813|NCT00369707|4190013|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4362814|NCT00369707|4190013|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4362815|NCT00369707|4190013|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4362816|NCT00369707|4190013|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4362817|NCT00369707|4190013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4362818|NCT00369707|4190013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362819|NCT00369681|4190026|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4362820|NCT00369681|4190026|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4362821|NCT00369681|4190026|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4362822|NCT00369681|4190026|B1|||Age||years|Mean|33|33.0|Full Range|||18.0|66.0|
4362823|NCT00369668|4190033|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4362824|NCT00369668|4190034|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4362825|NCT00369668|4190035|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4362826|NCT00369668|4190036|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4362827|NCT00369668|4190033|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4362828|NCT00369668|4190034|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4362829|NCT00369668|4190035|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4362830|NCT00369668|4190036|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4362831|NCT00369668|4190033|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4362832|NCT00369668|4190034|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4362833|NCT00369668|4190035|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4362834|NCT00369668|4190036|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4362835|NCT00369668|4190033|B4|||Age||years|Mean|65.2|65.2|Standard Deviation|6.6|6.6|||
4362836|NCT00369668|4190034|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|2.6|2.6|||
4362837|NCT00369668|4190035|B2|||Age||years|Mean|67.2|67.2|Standard Deviation|6.8|6.8|||
4362838|NCT00369668|4190036|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|8.1|8.1|||
4362839|NCT00369668|4190033|B4||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4362840|NCT00369668|4190034|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4362841|NCT00369668|4190035|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4362842|NCT00369668|4190036|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4362843|NCT00369668|4190033|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4362844|NCT00369668|4190034|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4362845|NCT00369668|4190035|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4362846|NCT00369668|4190036|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4362847|NCT00369668|4190033|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362848|NCT00369668|4190034|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362849|NCT00369668|4190035|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362850|NCT00369668|4190036|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362851|NCT00369655|4190052|B1|No||Prior Taxanes||Participants|Number|2|2.0||||||
4362852|NCT00369655|4190052|B1|Yes||Prior Taxanes||Participants|Number|19|19.0||||||
4362853|NCT00369655|4190052|B1|No||Prior Anthracyclines||Participants|Number|6|6.0||||||
4362854|NCT00369655|4190052|B1|Yes||Prior Anthracyclines||Participants|Number|15|15.0||||||
4362855|NCT00369655|4190052|B1|No||Previous Trastuzumab||Participants|Number|16|16.0||||||
4362856|NCT00369655|4190052|B1|Yes||Previous Trastuzumab||Participants|Number|5|5.0||||||
4362857|NCT00369655|4190052|B1|No||Previous Hormonal Therapy||Participants|Number|12|12.0||||||
4362858|NCT00369655|4190052|B1|Yes||Previous Hormonal Therapy||Participants|Number|9|9.0||||||
4362859|NCT00369655|4190052|B1|2||Number of Previous Chemotherapy Regimens||Participants|Number|7|7.0||||||
4362860|NCT00369655|4190052|B1|1||Number of Previous Chemotherapy Regimens||Participants|Number|11|11.0||||||
4362861|NCT00369655|4190052|B1|0||Number of Previous Chemotherapy Regimens||Participants|Number|3|3.0||||||
4362862|NCT00369655|4190052|B1|No||Previous (Neo) Adjuvant Chemotherapy||Participants|Number|8|8.0||||||
4362863|NCT00369655|4190052|B1|Yes||Previous (Neo) Adjuvant Chemotherapy||Participants|Number|13|13.0||||||
4362864|NCT00369655|4190052|B1|HER2 testing not done||Human epidermal growth factor receptor 2 (HER2) Result||Participants|Number|3|3.0||||||
4362865|NCT00369655|4190052|B1|Negative||Human epidermal growth factor receptor 2 (HER2) Result||Participants|Number|14|14.0||||||
4362866|NCT00369655|4190052|B1|Positive||Human epidermal growth factor receptor 2 (HER2) Result||Participants|Number|4|4.0||||||
4362867|NCT00369655|4190052|B1|Negative||Progesterone Receptor (PR) Result||Participants|Number|16|16.0||||||
4362868|NCT00369655|4190052|B1|Positive||Progesterone Receptor (PR) Result||Participants|Number|5|5.0||||||
4362869|NCT00369655|4190052|B1|Negative||Estrogen Receptor (ER) Result||Participants|Number|12|12.0||||||
4362870|NCT00369655|4190052|B1|Positive||Estrogen Receptor (ER) Result||Participants|Number|9|9.0||||||
4362871|NCT00369655|4190052|B1|Other||Visceral Disease Site|The presented results are for the 15 participants with visceral disease. The same participant may report more than one disease site.|Participants|Number|2|2.0||||||
4362872|NCT00369655|4190052|B1|Abodomen||Visceral Disease Site|The presented results are for the 15 participants with visceral disease. The same participant may report more than one disease site.|Participants|Number|1|1.0||||||
4362873|NCT00369655|4190052|B1|Lung||Visceral Disease Site|The presented results are for the 15 participants with visceral disease. The same participant may report more than one disease site.|Participants|Number|7|7.0||||||
4362874|NCT00369655|4190052|B1|Liver||Visceral Disease Site|The presented results are for the 15 participants with visceral disease. The same participant may report more than one disease site.|Participants|Number|7|7.0||||||
4362875|NCT00369655|4190052|B1|Nonvisceral||Dominant Disease||Participants|Number|6|6.0||||||
4362876|NCT00369655|4190052|B1|Visceral||Dominant Disease||Participants|Number|15|15.0||||||
4362877|NCT00369655|4190052|B1|Missing||Cell type||Participants|Number|1|1.0||||||
4362878|NCT00369655|4190052|B1|Infiltrating ductal and comedo||Cell type||Participants|Number|1|1.0||||||
4362879|NCT00369655|4190052|B1|Inflammatory||Cell type||Participants|Number|1|1.0||||||
4362880|NCT00369655|4190052|B1|Comedo||Cell type||Participants|Number|1|1.0||||||
4362881|NCT00369655|4190052|B1|Infiltrating lobular||Cell type||Participants|Number|1|1.0||||||
4362882|NCT00369655|4190052|B1|Infiltrating ductal||Cell type||Participants|Number|16|16.0||||||
4362883|NCT00369655|4190052|B1|1-Ambulatory, restricted strenuous activity||ECOG Performance Score|The Eastern Cooperative Oncology Group (ECOG) score classified patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|7|7.0||||||
4362884|NCT00369655|4190052|B1|0-Fully active||ECOG Performance Score|The Eastern Cooperative Oncology Group (ECOG) score classified patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|14|14.0||||||
4362885|NCT00369655|4190052|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4362886|NCT00369655|4190052|B1|Female||Sex/Gender, Customized||participants|Number|21|21.0||||||
4362887|NCT00369655|4190052|B1|||Age||years|Median|58|58.0|Full Range|||34.0|75.0|
4362888|NCT00369629|4190061|B1|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4362889|NCT00369629|4190061|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362890|NCT00369629|4190061|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362891|NCT00369629|4190061|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4362892|NCT00369629|4190061|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4362893|NCT00369629|4190061|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362894|NCT00369629|4190061|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362895|NCT00369629|4190061|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362896|NCT00369629|4190061|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4362897|NCT00369629|4190061|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4362898|NCT00369629|4190061|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4362899|NCT00369629|4190061|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4362900|NCT00369629|4190061|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4362901|NCT00369629|4190061|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4362902|NCT00369629|4190061|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4362903|NCT00369629|4190061|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362904|NCT00369590|4190074|B3|Anaplastic mixed oligoastrocytoma||Pathology||participants|Number|1|1.0||||||
4362905|NCT00369590|4190075|B2|Anaplastic mixed oligoastrocytoma||Pathology||participants|Number|0|0.0||||||
4362906|NCT00369590|4190076|B1|Anaplastic mixed oligoastrocytoma||Pathology||participants|Number|1|1.0||||||
4362907|NCT00369590|4190074|B3|anaplastic oligodendroglioma||Pathology||participants|Number|3|3.0||||||
4362908|NCT00369590|4190075|B2|anaplastic oligodendroglioma||Pathology||participants|Number|0|0.0||||||
4362909|NCT00369590|4190076|B1|anaplastic oligodendroglioma||Pathology||participants|Number|3|3.0||||||
4362910|NCT00369590|4190074|B3|Anaplastic astrocytoma||Pathology||participants|Number|12|12.0||||||
4362911|NCT00369590|4190075|B2|Anaplastic astrocytoma||Pathology||participants|Number|0|0.0||||||
4362912|NCT00369590|4190076|B1|Anaplastic astrocytoma||Pathology||participants|Number|12|12.0||||||
4362913|NCT00369590|4190074|B3|Gliosarcoma||Pathology||participants|Number|3|3.0||||||
4362914|NCT00369590|4190075|B2|Gliosarcoma||Pathology||participants|Number|3|3.0||||||
4362915|NCT00369590|4190076|B1|Gliosarcoma||Pathology||participants|Number|0|0.0||||||
4362916|NCT00369590|4190074|B3|Glioblastoma||Pathology||participants|Number|39|39.0||||||
4362917|NCT00369590|4190075|B2|Glioblastoma||Pathology||participants|Number|39|39.0||||||
4362918|NCT00369590|4190076|B1|Glioblastoma||Pathology||participants|Number|0|0.0||||||
4362919|NCT00369590|4190074|B3|||Karnofsky Performance Status|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100-80: Able to carry on normal activity and to work; No special care needed.~70-50: Unable to work; able to live at home and care for most personal needs; varying amount of assistance needed~40-10: Unable to care for self; Requires equivalent of institutional or hospital care; diseases may be progressing rapidly.~0: Dead"|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4362920|NCT00369590|4190075|B2|||Karnofsky Performance Status|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100-80: Able to carry on normal activity and to work; No special care needed.~70-50: Unable to work; able to live at home and care for most personal needs; varying amount of assistance needed~40-10: Unable to care for self; Requires equivalent of institutional or hospital care; diseases may be progressing rapidly.~0: Dead"|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4362921|NCT00369590|4190076|B1|||Karnofsky Performance Status|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100-80: Able to carry on normal activity and to work; No special care needed.~70-50: Unable to work; able to live at home and care for most personal needs; varying amount of assistance needed~40-10: Unable to care for self; Requires equivalent of institutional or hospital care; diseases may be progressing rapidly.~0: Dead"|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4362922|NCT00369590|4190074|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4362923|NCT00369590|4190075|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4362924|NCT00369590|4190076|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4362925|NCT00369590|4190074|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4362926|NCT00369590|4190075|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4362927|NCT00369590|4190076|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4362928|NCT00369590|4190074|B3|||Age||years|Median|54|54.0|Full Range|||26.0|72.0|
4362929|NCT00369590|4190075|B2|||Age||years|Median|55|55.0|Full Range|||33.0|72.0|
4362930|NCT00369590|4190076|B1|||Age||years|Median|53|53.0|Full Range|||26.0|70.0|
4362931|NCT00369577|4190092|B4|United States||Region of Enrollment||participants|Number|129|129.0||||||
4362932|NCT00369577|4190093|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4362933|NCT00369577|4190094|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4362934|NCT00369577|4190095|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4362935|NCT00369577|4190092|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4362936|NCT00369577|4190093|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4362937|NCT00369577|4190094|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4362938|NCT00369577|4190095|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4362939|NCT00369577|4190092|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4362940|NCT00369577|4190093|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4362941|NCT00369577|4190094|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4362942|NCT00369577|4190095|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4362943|NCT00369577|4190092|B4|||Age||years|Mean|41.2|41.2|Standard Deviation|8.09|8.09|||
4362944|NCT00369577|4190093|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|8.77|8.77|||
4362945|NCT00369577|4190094|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|7.45|7.45|||
4362946|NCT00369577|4190095|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|7.7|7.7|||
4362947|NCT00369577|4190092|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362948|NCT00369577|4190093|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362949|NCT00369577|4190094|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362950|NCT00369577|4190095|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362951|NCT00369577|4190092|B4||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4362952|NCT00369577|4190093|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4362953|NCT00369577|4190094|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4362954|NCT00369577|4190095|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4362955|NCT00369577|4190092|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362956|NCT00369577|4190093|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362957|NCT00369577|4190094|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362958|NCT00369577|4190095|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362959|NCT00369564|4190114|B3|United States||Region of Enrollment||participants|Number|250|250.0||||||
4362960|NCT00369564|4190115|B2|United States||Region of Enrollment||participants|Number|123|123.0||||||
4362961|NCT00369564|4190116|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
4362962|NCT00369564|4190114|B3|Gender Not Reported||Sex/Gender, Customized|One subject did not report gender information.|participants|Number|1|1.0||||||
4363180|NCT00369317|4190245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4362963|NCT00369564|4190115|B2|Gender Not Reported||Sex/Gender, Customized|One subject did not report gender information.|participants|Number|1|1.0||||||
4362964|NCT00369564|4190116|B1|Gender Not Reported||Sex/Gender, Customized|One subject did not report gender information.|participants|Number|0|0.0||||||
4362965|NCT00369564|4190114|B3|Gender- Male||Sex/Gender, Customized|One subject did not report gender information.|participants|Number|150|150.0||||||
4362966|NCT00369564|4190115|B2|Gender- Male||Sex/Gender, Customized|One subject did not report gender information.|participants|Number|69|69.0||||||
4362967|NCT00369564|4190116|B1|Gender- Male||Sex/Gender, Customized|One subject did not report gender information.|participants|Number|81|81.0||||||
4362968|NCT00369564|4190114|B3|Gender- Female||Sex/Gender, Customized|One subject did not report gender information.|participants|Number|99|99.0||||||
4362969|NCT00369564|4190115|B2|Gender- Female||Sex/Gender, Customized|One subject did not report gender information.|participants|Number|53|53.0||||||
4362970|NCT00369564|4190116|B1|Gender- Female||Sex/Gender, Customized|One subject did not report gender information.|participants|Number|46|46.0||||||
4362971|NCT00369564|4190114|B3|||Age||years|Mean|8.6|8.6|Standard Deviation|4.9|4.9|||
4362972|NCT00369564|4190115|B2|||Age||years|Mean|8.6|8.6|Standard Deviation|4.9|4.9|||
4362973|NCT00369564|4190116|B1|||Age||years|Mean|8.5|8.5|Standard Deviation|4.8|4.8|||
4362974|NCT00369564|4190114|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362975|NCT00369564|4190115|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362976|NCT00369564|4190116|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4362977|NCT00369564|4190114|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4362978|NCT00369564|4190115|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4362979|NCT00369564|4190116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4362980|NCT00369564|4190114|B3||<=18 years|Age||Participants|Count of Participants|240|240.0||||||
4362981|NCT00369564|4190115|B2||<=18 years|Age||Participants|Count of Participants|117|117.0||||||
4362982|NCT00369564|4190116|B1||<=18 years|Age||Participants|Count of Participants|123|123.0||||||
4362983|NCT00369512|4190123|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4362984|NCT00369512|4190123|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4362985|NCT00369512|4190123|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4362986|NCT00369512|4190123|B1|||Age||years|Mean|68|68.0|Standard Deviation|11.0|11.0|||
4362987|NCT00369512|4190123|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4362988|NCT00369512|4190123|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4362989|NCT00369512|4190123|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4362990|NCT00369486|4190129|B6|||Total Retinal Volume (mm^3)||mm^3|Mean|8.0|8.0|Standard Deviation|1.0|1.0|||
4362991|NCT00369486|4190130|B5|||Total Retinal Volume (mm^3)||mm^3|Mean|7.9|7.9|Standard Deviation|0.8|0.8|||
4362992|NCT00369486|4190131|B4|||Total Retinal Volume (mm^3)||mm^3|Mean|7.8|7.8|Standard Deviation|0.6|0.6|||
4362993|NCT00369486|4190132|B3|||Total Retinal Volume (mm^3)||mm^3|Mean|8.1|8.1|Standard Deviation|1.2|1.2|||
4362994|NCT00369486|4190133|B2|||Total Retinal Volume (mm^3)||mm^3|Mean|7.6|7.6|Standard Deviation|0.9|0.9|||
4362995|NCT00369486|4190134|B1|||Total Retinal Volume (mm^3)||mm^3|Mean|8.2|8.2|Standard Deviation|1.2|1.2|||
4362996|NCT00369486|4190129|B6|||Mean visual acuity letter score|Baseline Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) Visual Acuity Letter Score: best value = 97; letter score worst value = 0|letter score|Mean|79|79.0|Standard Deviation|5|5.0|||
4362997|NCT00369486|4190130|B5|||Mean visual acuity letter score|Baseline Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) Visual Acuity Letter Score: best value = 97; letter score worst value = 0|letter score|Mean|78|78.0|Standard Deviation|6|6.0|||
4362998|NCT00369486|4190131|B4|||Mean visual acuity letter score|Baseline Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) Visual Acuity Letter Score: best value = 97; letter score worst value = 0|letter score|Mean|79|79.0|Standard Deviation|7|7.0|||
4362999|NCT00369486|4190132|B3|||Mean visual acuity letter score|Baseline Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) Visual Acuity Letter Score: best value = 97; letter score worst value = 0|letter score|Mean|81|81.0|Standard Deviation|5|5.0|||
4363000|NCT00369486|4190133|B2|||Mean visual acuity letter score|Baseline Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) Visual Acuity Letter Score: best value = 97; letter score worst value = 0|letter score|Mean|79|79.0|Standard Deviation|4|4.0|||
4363001|NCT00369486|4190134|B1|||Mean visual acuity letter score|Baseline Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) Visual Acuity Letter Score: best value = 97; letter score worst value = 0|letter score|Mean|80|80.0|Standard Deviation|5|5.0|||
4363002|NCT00369486|4190129|B6|||Intraocular Pressure (mm Hg)|N=129 eyes|mm Hg|Mean|16|16.0|Standard Deviation|3|3.0|||
4363003|NCT00369486|4190130|B5|||Intraocular Pressure (mm Hg)|N=129 eyes|mm Hg|Mean|17|17.0|Standard Deviation|3|3.0|||
4363004|NCT00369486|4190131|B4|||Intraocular Pressure (mm Hg)|N=129 eyes|mm Hg|Mean|16|16.0|Standard Deviation|3|3.0|||
4363005|NCT00369486|4190132|B3|||Intraocular Pressure (mm Hg)|N=129 eyes|mm Hg|Mean|16|16.0|Standard Deviation|4|4.0|||
4363006|NCT00369486|4190133|B2|||Intraocular Pressure (mm Hg)|N=129 eyes|mm Hg|Mean|16|16.0|Standard Deviation|4|4.0|||
4363007|NCT00369486|4190134|B1|||Intraocular Pressure (mm Hg)|N=129 eyes|mm Hg|Mean|16|16.0|Standard Deviation|3|3.0|||
4363008|NCT00369486|4190129|B6|||Hemoglobin A1c||percentage|Mean|7.8|7.8|Standard Deviation|1.6|1.6|||
4363009|NCT00369486|4190130|B5|||Hemoglobin A1c||percentage|Mean|7.5|7.5|Standard Deviation|1.8|1.8|||
4363010|NCT00369486|4190131|B4|||Hemoglobin A1c||percentage|Mean|7.8|7.8|Standard Deviation|1.3|1.3|||
4363011|NCT00369486|4190132|B3|||Hemoglobin A1c||percentage|Mean|8.1|8.1|Standard Deviation|1.7|1.7|||
4363012|NCT00369486|4190133|B2|||Hemoglobin A1c||percentage|Mean|7.3|7.3|Standard Deviation|1.6|1.6|||
4363013|NCT00369486|4190134|B1|||Hemoglobin A1c||percentage|Mean|7.9|7.9|Standard Deviation|1.7|1.7|||
4363014|NCT00369486|4190129|B6|||Duration of Diabetes|N=129 eyes|years|Mean|15|15.0|Standard Deviation|9|9.0|||
4363015|NCT00369486|4190130|B5|||Duration of Diabetes|N=129 eyes|years|Mean|15|15.0|Standard Deviation|9|9.0|||
4363016|NCT00369486|4190131|B4|||Duration of Diabetes|N=129 eyes|years|Mean|16|16.0|Standard Deviation|7|7.0|||
4363017|NCT00369486|4190132|B3|||Duration of Diabetes|N=129 eyes|years|Mean|15|15.0|Standard Deviation|7|7.0|||
4363018|NCT00369486|4190133|B2|||Duration of Diabetes|N=129 eyes|years|Mean|14|14.0|Standard Deviation|9|9.0|||
4363019|NCT00369486|4190134|B1|||Duration of Diabetes|N=129 eyes|years|Mean|14|14.0|Standard Deviation|10|10.0|||
4363020|NCT00369486|4190129|B6|||Central Subfield Thickness|Measured by Ocular Coherence Tomography (OCT). OCT images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|microns|Mean|328|328.0|Standard Deviation|65|65.0|||
4363021|NCT00369486|4190130|B5|||Central Subfield Thickness|Measured by Ocular Coherence Tomography (OCT). OCT images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|microns|Mean|336|336.0|Standard Deviation|58|58.0|||
4363022|NCT00369486|4190131|B4|||Central Subfield Thickness|Measured by Ocular Coherence Tomography (OCT). OCT images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|microns|Mean|319|319.0|Standard Deviation|59|59.0|||
4363023|NCT00369486|4190132|B3|||Central Subfield Thickness|Measured by Ocular Coherence Tomography (OCT). OCT images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|microns|Mean|342|342.0|Standard Deviation|79|79.0|||
4363024|NCT00369486|4190133|B2|||Central Subfield Thickness|Measured by Ocular Coherence Tomography (OCT). OCT images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|microns|Mean|321|321.0|Standard Deviation|53|53.0|||
4363025|NCT00369486|4190134|B1|||Central Subfield Thickness|Measured by Ocular Coherence Tomography (OCT). OCT images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|microns|Mean|324|324.0|Standard Deviation|70|70.0|||
4363026|NCT00369486|4190129|B6|No||Subretinal Fluid on Ocular Coherence Tomography (OCT)|Ocular Coherence Tomography (OCT) images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|eyes|Number|121|121.0||||||
4363027|NCT00369486|4190130|B5|No||Subretinal Fluid on Ocular Coherence Tomography (OCT)|Ocular Coherence Tomography (OCT) images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|eyes|Number|23|23.0||||||
4363028|NCT00369486|4190131|B4|No||Subretinal Fluid on Ocular Coherence Tomography (OCT)|Ocular Coherence Tomography (OCT) images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|eyes|Number|21|21.0||||||
4363029|NCT00369486|4190132|B3|No||Subretinal Fluid on Ocular Coherence Tomography (OCT)|Ocular Coherence Tomography (OCT) images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|eyes|Number|23|23.0||||||
4363030|NCT00369486|4190133|B2|No||Subretinal Fluid on Ocular Coherence Tomography (OCT)|Ocular Coherence Tomography (OCT) images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|eyes|Number|20|20.0||||||
4363031|NCT00369486|4190134|B1|No||Subretinal Fluid on Ocular Coherence Tomography (OCT)|Ocular Coherence Tomography (OCT) images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|eyes|Number|34|34.0||||||
4363032|NCT00369486|4190129|B6|Yes||Subretinal Fluid on Ocular Coherence Tomography (OCT)|Ocular Coherence Tomography (OCT) images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|eyes|Number|8|8.0||||||
4363114|NCT00369486|4190133|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4363115|NCT00369486|4190134|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4363033|NCT00369486|4190130|B5|Yes||Subretinal Fluid on Ocular Coherence Tomography (OCT)|Ocular Coherence Tomography (OCT) images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|eyes|Number|2|2.0||||||
4363034|NCT00369486|4190131|B4|Yes||Subretinal Fluid on Ocular Coherence Tomography (OCT)|Ocular Coherence Tomography (OCT) images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|eyes|Number|1|1.0||||||
4363035|NCT00369486|4190132|B3|Yes||Subretinal Fluid on Ocular Coherence Tomography (OCT)|Ocular Coherence Tomography (OCT) images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|eyes|Number|0|0.0||||||
4363036|NCT00369486|4190133|B2|Yes||Subretinal Fluid on Ocular Coherence Tomography (OCT)|Ocular Coherence Tomography (OCT) images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|eyes|Number|1|1.0||||||
4363037|NCT00369486|4190134|B1|Yes||Subretinal Fluid on Ocular Coherence Tomography (OCT)|Ocular Coherence Tomography (OCT) images were obtained at each visit following pupil dilation by a certified operator using the OCT3 machine (Carl Zeiss Meditec Inc., Dublin, CA). Scans were 6 mm length and included the 6 radial line pattern for quantitative measures and the cross hair pattern (6-12 to 9-3 o'clock) for qualitative assessment of retinal morphology.|eyes|Number|4|4.0||||||
4363038|NCT00369486|4190129|B6|Yes||Received Prior Scatter (Panretinal) Photocoagulation||eyes|Number|14|14.0||||||
4363039|NCT00369486|4190130|B5|Yes||Received Prior Scatter (Panretinal) Photocoagulation||eyes|Number|0|0.0||||||
4363040|NCT00369486|4190131|B4|Yes||Received Prior Scatter (Panretinal) Photocoagulation||eyes|Number|1|1.0||||||
4363041|NCT00369486|4190132|B3|Yes||Received Prior Scatter (Panretinal) Photocoagulation||eyes|Number|4|4.0||||||
4363042|NCT00369486|4190133|B2|Yes||Received Prior Scatter (Panretinal) Photocoagulation||eyes|Number|5|5.0||||||
4363043|NCT00369486|4190134|B1|Yes||Received Prior Scatter (Panretinal) Photocoagulation||eyes|Number|4|4.0||||||
4363044|NCT00369486|4190129|B6|No||Received Prior Scatter (Panretinal) Photocoagulation||eyes|Number|115|115.0||||||
4363045|NCT00369486|4190130|B5|No||Received Prior Scatter (Panretinal) Photocoagulation||eyes|Number|25|25.0||||||
4363046|NCT00369486|4190131|B4|No||Received Prior Scatter (Panretinal) Photocoagulation||eyes|Number|21|21.0||||||
4363047|NCT00369486|4190132|B3|No||Received Prior Scatter (Panretinal) Photocoagulation||eyes|Number|19|19.0||||||
4363048|NCT00369486|4190133|B2|No||Received Prior Scatter (Panretinal) Photocoagulation||eyes|Number|16|16.0||||||
4363049|NCT00369486|4190134|B1|No||Received Prior Scatter (Panretinal) Photocoagulation||eyes|Number|34|34.0||||||
4363050|NCT00369486|4190129|B6|Yes||Received Prior Focal Photocoagulation||eyes|Number|72|72.0||||||
4363051|NCT00369486|4190130|B5|Yes||Received Prior Focal Photocoagulation||eyes|Number|14|14.0||||||
4363052|NCT00369486|4190131|B4|Yes||Received Prior Focal Photocoagulation||eyes|Number|12|12.0||||||
4363053|NCT00369486|4190132|B3|Yes||Received Prior Focal Photocoagulation||eyes|Number|15|15.0||||||
4363054|NCT00369486|4190133|B2|Yes||Received Prior Focal Photocoagulation||eyes|Number|14|14.0||||||
4363055|NCT00369486|4190134|B1|Yes||Received Prior Focal Photocoagulation||eyes|Number|17|17.0||||||
4363056|NCT00369486|4190129|B6|No||Received Prior Focal Photocoagulation||eyes|Number|57|57.0||||||
4363057|NCT00369486|4190130|B5|No||Received Prior Focal Photocoagulation||eyes|Number|11|11.0||||||
4363058|NCT00369486|4190131|B4|No||Received Prior Focal Photocoagulation||eyes|Number|10|10.0||||||
4363059|NCT00369486|4190132|B3|No||Received Prior Focal Photocoagulation||eyes|Number|8|8.0||||||
4363060|NCT00369486|4190133|B2|No||Received Prior Focal Photocoagulation||eyes|Number|7|7.0||||||
4363061|NCT00369486|4190134|B1|No||Received Prior Focal Photocoagulation||eyes|Number|21|21.0||||||
4363062|NCT00369486|4190129|B6|78-69: 20/32-20/40||Electronic Early Treatment Diabetic Retinopathy Study Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic early treatment diabetic retinopathy study (e-ETDRS) method and approximate Snellen equivalent. Best value on the scale is 97, worst value 0.|eyes|Number|54|54.0||||||
4363063|NCT00369486|4190130|B5|78-69: 20/32-20/40||Electronic Early Treatment Diabetic Retinopathy Study Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic early treatment diabetic retinopathy study (e-ETDRS) method and approximate Snellen equivalent. Best value on the scale is 97, worst value 0.|eyes|Number|14|14.0||||||
4363064|NCT00369486|4190131|B4|78-69: 20/32-20/40||Electronic Early Treatment Diabetic Retinopathy Study Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic early treatment diabetic retinopathy study (e-ETDRS) method and approximate Snellen equivalent. Best value on the scale is 97, worst value 0.|eyes|Number|12|12.0||||||
4363065|NCT00369486|4190132|B3|78-69: 20/32-20/40||Electronic Early Treatment Diabetic Retinopathy Study Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic early treatment diabetic retinopathy study (e-ETDRS) method and approximate Snellen equivalent. Best value on the scale is 97, worst value 0.|eyes|Number|6|6.0||||||
4363066|NCT00369486|4190133|B2|78-69: 20/32-20/40||Electronic Early Treatment Diabetic Retinopathy Study Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic early treatment diabetic retinopathy study (e-ETDRS) method and approximate Snellen equivalent. Best value on the scale is 97, worst value 0.|eyes|Number|9|9.0||||||
4363116|NCT00369486|4190129|B6|African-American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4363117|NCT00369486|4190130|B5|African-American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4363067|NCT00369486|4190134|B1|78-69: 20/32-20/40||Electronic Early Treatment Diabetic Retinopathy Study Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic early treatment diabetic retinopathy study (e-ETDRS) method and approximate Snellen equivalent. Best value on the scale is 97, worst value 0.|eyes|Number|13|13.0||||||
4363068|NCT00369486|4190129|B6|>=79: 20/25 or better||Electronic Early Treatment Diabetic Retinopathy Study Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic early treatment diabetic retinopathy study (e-ETDRS) method and approximate Snellen equivalent. Best value on the scale is 97, worst value 0.|eyes|Number|75|75.0||||||
4363069|NCT00369486|4190130|B5|>=79: 20/25 or better||Electronic Early Treatment Diabetic Retinopathy Study Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic early treatment diabetic retinopathy study (e-ETDRS) method and approximate Snellen equivalent. Best value on the scale is 97, worst value 0.|eyes|Number|11|11.0||||||
4363070|NCT00369486|4190131|B4|>=79: 20/25 or better||Electronic Early Treatment Diabetic Retinopathy Study Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic early treatment diabetic retinopathy study (e-ETDRS) method and approximate Snellen equivalent. Best value on the scale is 97, worst value 0.|eyes|Number|10|10.0||||||
4363071|NCT00369486|4190132|B3|>=79: 20/25 or better||Electronic Early Treatment Diabetic Retinopathy Study Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic early treatment diabetic retinopathy study (e-ETDRS) method and approximate Snellen equivalent. Best value on the scale is 97, worst value 0.|eyes|Number|17|17.0||||||
4363072|NCT00369486|4190133|B2|>=79: 20/25 or better||Electronic Early Treatment Diabetic Retinopathy Study Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic early treatment diabetic retinopathy study (e-ETDRS) method and approximate Snellen equivalent. Best value on the scale is 97, worst value 0.|eyes|Number|12|12.0||||||
4363073|NCT00369486|4190134|B1|>=79: 20/25 or better||Electronic Early Treatment Diabetic Retinopathy Study Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic early treatment diabetic retinopathy study (e-ETDRS) method and approximate Snellen equivalent. Best value on the scale is 97, worst value 0.|eyes|Number|25|25.0||||||
4363074|NCT00369486|4190129|B6|Type 2||Diabetes Type||Participants|Number|119|119.0||||||
4363075|NCT00369486|4190130|B5|Type 2||Diabetes Type||Participants|Number|24|24.0||||||
4363076|NCT00369486|4190131|B4|Type 2||Diabetes Type||Participants|Number|22|22.0||||||
4363077|NCT00369486|4190132|B3|Type 2||Diabetes Type||Participants|Number|20|20.0||||||
4363078|NCT00369486|4190133|B2|Type 2||Diabetes Type||Participants|Number|18|18.0||||||
4363079|NCT00369486|4190134|B1|Type 2||Diabetes Type||Participants|Number|35|35.0||||||
4363080|NCT00369486|4190129|B6|Type 1||Diabetes Type||Participants|Number|10|10.0||||||
4363081|NCT00369486|4190130|B5|Type 1||Diabetes Type||Participants|Number|1|1.0||||||
4363082|NCT00369486|4190131|B4|Type 1||Diabetes Type||Participants|Number|0|0.0||||||
4363083|NCT00369486|4190132|B3|Type 1||Diabetes Type||Participants|Number|3|3.0||||||
4363084|NCT00369486|4190133|B2|Type 1||Diabetes Type||Participants|Number|3|3.0||||||
4363085|NCT00369486|4190134|B1|Type 1||Diabetes Type||Participants|Number|3|3.0||||||
4363086|NCT00369486|4190129|B6|No||Cystoid Abnormality on Ocular Coherence Tomography (OCT)||eyes|Number|25|25.0||||||
4363087|NCT00369486|4190130|B5|No||Cystoid Abnormality on Ocular Coherence Tomography (OCT)||eyes|Number|6|6.0||||||
4363088|NCT00369486|4190131|B4|No||Cystoid Abnormality on Ocular Coherence Tomography (OCT)||eyes|Number|4|4.0||||||
4363089|NCT00369486|4190132|B3|No||Cystoid Abnormality on Ocular Coherence Tomography (OCT)||eyes|Number|3|3.0||||||
4363090|NCT00369486|4190133|B2|No||Cystoid Abnormality on Ocular Coherence Tomography (OCT)||eyes|Number|4|4.0||||||
4363091|NCT00369486|4190134|B1|No||Cystoid Abnormality on Ocular Coherence Tomography (OCT)||eyes|Number|8|8.0||||||
4363092|NCT00369486|4190129|B6|Yes||Cystoid Abnormality on Ocular Coherence Tomography (OCT)||eyes|Number|104|104.0||||||
4363093|NCT00369486|4190130|B5|Yes||Cystoid Abnormality on Ocular Coherence Tomography (OCT)||eyes|Number|19|19.0||||||
4363094|NCT00369486|4190131|B4|Yes||Cystoid Abnormality on Ocular Coherence Tomography (OCT)||eyes|Number|18|18.0||||||
4363095|NCT00369486|4190132|B3|Yes||Cystoid Abnormality on Ocular Coherence Tomography (OCT)||eyes|Number|20|20.0||||||
4363096|NCT00369486|4190133|B2|Yes||Cystoid Abnormality on Ocular Coherence Tomography (OCT)||eyes|Number|17|17.0||||||
4363097|NCT00369486|4190134|B1|Yes||Cystoid Abnormality on Ocular Coherence Tomography (OCT)||eyes|Number|30|30.0||||||
4363098|NCT00369486|4190129|B6|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4363099|NCT00369486|4190130|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4363100|NCT00369486|4190131|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4363101|NCT00369486|4190132|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4363102|NCT00369486|4190133|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4363103|NCT00369486|4190134|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4363104|NCT00369486|4190129|B6|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4363105|NCT00369486|4190130|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4363106|NCT00369486|4190131|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4363107|NCT00369486|4190132|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4363108|NCT00369486|4190133|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4363109|NCT00369486|4190134|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4363110|NCT00369486|4190129|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4363111|NCT00369486|4190130|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4363112|NCT00369486|4190131|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4363113|NCT00369486|4190132|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4363118|NCT00369486|4190131|B4|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4363119|NCT00369486|4190132|B3|African-American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4363120|NCT00369486|4190133|B2|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4363121|NCT00369486|4190134|B1|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4363122|NCT00369486|4190129|B6|White||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4363123|NCT00369486|4190130|B5|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4363124|NCT00369486|4190131|B4|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4363125|NCT00369486|4190132|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4363126|NCT00369486|4190133|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4363127|NCT00369486|4190134|B1|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4363128|NCT00369486|4190129|B6||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4363129|NCT00369486|4190130|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4363130|NCT00369486|4190131|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4363131|NCT00369486|4190132|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4363132|NCT00369486|4190133|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4363133|NCT00369486|4190134|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4363134|NCT00369486|4190129|B6||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4363135|NCT00369486|4190130|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4363136|NCT00369486|4190131|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4363137|NCT00369486|4190132|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4363138|NCT00369486|4190133|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4363139|NCT00369486|4190134|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4363140|NCT00369486|4190129|B6|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
4363141|NCT00369486|4190130|B5|||Age||years|Mean|63|63.0|Standard Deviation|13|13.0|||
4363142|NCT00369486|4190131|B4|||Age||years|Mean|64|64.0|Standard Deviation|7|7.0|||
4363143|NCT00369486|4190132|B3|||Age||years|Mean|60|60.0|Standard Deviation|8|8.0|||
4363144|NCT00369486|4190133|B2|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
4363145|NCT00369486|4190134|B1|||Age||years|Mean|58|58.0|Standard Deviation|11|11.0|||
4363146|NCT00369382|4190175|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4363147|NCT00369382|4190176|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4363148|NCT00369382|4190177|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4363149|NCT00369382|4190175|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4363150|NCT00369382|4190176|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4363151|NCT00369382|4190177|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4363152|NCT00369382|4190175|B3|||Age||years|Mean|58.18|58.18|Standard Deviation|8.73|8.73|||
4363153|NCT00369382|4190176|B2|||Age||years|Mean|57.40|57.4|Standard Deviation|9.42|9.42|||
4363154|NCT00369382|4190177|B1|||Age||years|Mean|58.93|58.93|Standard Deviation|8.01|8.01|||
4363155|NCT00369343|4190209|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4363156|NCT00369343|4190210|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4363157|NCT00369343|4190211|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4363158|NCT00369343|4190209|B3||Female|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4363159|NCT00369343|4190210|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4363160|NCT00369343|4190211|B1||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4363161|NCT00369343|4190209|B3|||Age||years|Mean|52.19|52.19|Standard Deviation|6.72|6.72|||
4363162|NCT00369343|4190210|B2|||Age||years|Mean|52.56|52.56|Standard Deviation|7.17|7.17|||
4363163|NCT00369343|4190211|B1|||Age||years|Mean|52.01|52.01|Standard Deviation|6.50|6.5|||
4363164|NCT00369317|4190245|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4363165|NCT00369317|4190245|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4363166|NCT00369317|4190245|B1|United States||Region of Enrollment||participants|Number|187|187.0||||||
4363167|NCT00369317|4190245|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4363168|NCT00369317|4190245|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
4363169|NCT00369317|4190245|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4363170|NCT00369317|4190245|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4363171|NCT00369317|4190245|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363172|NCT00369317|4190245|B1||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4363173|NCT00369317|4190245|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4363174|NCT00369317|4190245|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4363175|NCT00369317|4190245|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4363176|NCT00369317|4190245|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363177|NCT00369317|4190245|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4363178|NCT00369317|4190245|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4363179|NCT00369317|4190245|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363181|NCT00369317|4190245|B1||<=18 years|Age||Participants|Count of Participants|205|205.0||||||
4363182|NCT00369317|4190245|B1|||Age||days|Mean|616.41|616.41|Standard Deviation|265.73|265.73|||
4363183|NCT00369278|4190259|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4363184|NCT00369278|4190260|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4363185|NCT00369278|4190261|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4363186|NCT00369278|4190259|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4363187|NCT00369278|4190260|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4363188|NCT00369278|4190261|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4363189|NCT00369278|4190259|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|13.6|13.6|||
4363190|NCT00369278|4190260|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|14.6|14.6|||
4363191|NCT00369278|4190261|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|12.5|12.5|||
4363192|NCT00369265|4190276|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4363193|NCT00369265|4190277|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4363194|NCT00369265|4190278|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4363195|NCT00369265|4190276|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4363196|NCT00369265|4190277|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4363197|NCT00369265|4190278|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4363198|NCT00369265|4190276|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4363199|NCT00369265|4190277|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4363200|NCT00369265|4190278|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4363201|NCT00369265|4190276|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|15.83|15.83|||
4363202|NCT00369265|4190277|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|17.33|17.33|||
4363203|NCT00369265|4190278|B1|||Age||years|Mean|33.0|33.0|Standard Deviation|11.56|11.56|||
4363204|NCT00369265|4190276|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4363205|NCT00369265|4190277|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4363206|NCT00369265|4190278|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363207|NCT00369265|4190276|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4363208|NCT00369265|4190277|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4363209|NCT00369265|4190278|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4363210|NCT00369265|4190276|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363211|NCT00369265|4190277|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363212|NCT00369265|4190278|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363213|NCT00369226|4190285|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4363214|NCT00369226|4190286|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4363215|NCT00369226|4190287|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4363216|NCT00369226|4190285|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4363217|NCT00369226|4190286|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4363218|NCT00369226|4190287|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4363219|NCT00369226|4190285|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4363220|NCT00369226|4190286|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4363221|NCT00369226|4190287|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4363222|NCT00369226|4190285|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4363223|NCT00369226|4190286|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4363224|NCT00369226|4190287|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363225|NCT00369226|4190285|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4363226|NCT00369226|4190286|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4363227|NCT00369226|4190287|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4363228|NCT00369226|4190285|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363229|NCT00369226|4190286|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363230|NCT00369226|4190287|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363231|NCT00369161|4190298|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4363232|NCT00369161|4190299|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4363233|NCT00369161|4190300|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4363234|NCT00369161|4190298|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4363235|NCT00369161|4190299|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4363236|NCT00369161|4190300|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4363237|NCT00369161|4190298|B3|||Age|Baseline measures are based on intention to treat (ITT) population.|years|Mean|45.8|45.8|Standard Deviation|12.43|12.43|||
4363238|NCT00369161|4190299|B2|||Age|Baseline measures are based on intention to treat (ITT) population.|years|Mean|46.9|46.9|Standard Deviation|12.08|12.08|||
4363239|NCT00369161|4190300|B1|||Age|Baseline measures are based on intention to treat (ITT) population.|years|Mean|44.6|44.6|Standard Deviation|12.75|12.75|||
4363240|NCT00369122|4190311|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4363241|NCT00369122|4190311|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4363242|NCT00369122|4190311|B1|||Age||years|Median|45.5|45.5|Full Range|||20.0|80.0|
4363243|NCT00368992|4190318|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4363244|NCT00368992|4190318|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4363245|NCT00368992|4190318|B1|||Age||years|Median|64|64.0|Full Range|||42.0|78.0|
4363246|NCT00368979|4190325|B3|Asian-Japanese||Race/Ethnicity, Customized||participants|Number|365|365.0||||||
4363247|NCT00368979|4190326|B2|Asian-Japanese||Race/Ethnicity, Customized||participants|Number|184|184.0||||||
4363248|NCT00368979|4190327|B1|Asian-Japanese||Race/Ethnicity, Customized||participants|Number|181|181.0||||||
4363249|NCT00368979|4190325|B3||Male|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4363250|NCT00368979|4190326|B2||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4363251|NCT00368979|4190327|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4363252|NCT00368979|4190325|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4363253|NCT00368979|4190326|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4363254|NCT00368979|4190327|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4363255|NCT00368979|4190325|B3|||Age||years|Mean|67.4|67.4|Standard Deviation|6.44|6.44|||
4363256|NCT00368979|4190326|B2|||Age||years|Mean|68.0|68.0|Standard Deviation|6.07|6.07|||
4363257|NCT00368979|4190327|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|6.76|6.76|||
4363258|NCT00368966|4190342|B3||Male|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
4363259|NCT00368966|4190343|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4363260|NCT00368966|4190344|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4363261|NCT00368966|4190342|B3||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4363262|NCT00368966|4190343|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4363263|NCT00368966|4190344|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4363264|NCT00368966|4190342|B3|||Age||months|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
4363265|NCT00368966|4190343|B2|||Age||months|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
4363266|NCT00368966|4190344|B1|||Age||months|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
4363267|NCT00368940|4190399|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4363268|NCT00368940|4190400|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4363269|NCT00368940|4190401|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4363270|NCT00368940|4190399|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363271|NCT00368940|4190400|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363272|NCT00368940|4190401|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363273|NCT00368940|4190399|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363274|NCT00368940|4190400|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363275|NCT00368940|4190401|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363276|NCT00368940|4190399|B3||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4363277|NCT00368940|4190400|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4363278|NCT00368940|4190401|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4363279|NCT00368940|4190399|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4363280|NCT00368940|4190400|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4363281|NCT00368940|4190401|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4363282|NCT00368940|4190399|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363283|NCT00368940|4190400|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363284|NCT00368940|4190401|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363285|NCT00368940|4190399|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363286|NCT00368940|4190400|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363287|NCT00368940|4190401|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363288|NCT00368940|4190399|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363289|NCT00368940|4190400|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363290|NCT00368940|4190401|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363291|NCT00368940|4190399|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363292|NCT00368940|4190400|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363293|NCT00368940|4190401|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363294|NCT00368940|4190399|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4363295|NCT00368940|4190400|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4363296|NCT00368940|4190401|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4363297|NCT00368940|4190399|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4363298|NCT00368940|4190400|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363299|NCT00368940|4190401|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4363300|NCT00368940|4190399|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4363301|NCT00368940|4190400|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4363302|NCT00368940|4190401|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4363303|NCT00368940|4190399|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4363304|NCT00368940|4190400|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4363305|NCT00368940|4190401|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4363306|NCT00368940|4190399|B3||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4363307|NCT00368940|4190400|B2||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4363308|NCT00368940|4190401|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4363309|NCT00368940|4190399|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4363310|NCT00368940|4190400|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4363311|NCT00368940|4190401|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4363312|NCT00368940|4190399|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363313|NCT00368940|4190400|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363314|NCT00368940|4190401|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363315|NCT00368927|4190414|B3|> 3||Number of baseline dysplastic lesions||Participants|Number|7|7.0||||||
4363316|NCT00368927|4190415|B2|> 3||Number of baseline dysplastic lesions||Participants|Number|4|4.0||||||
4363317|NCT00368927|4190416|B1|> 3||Number of baseline dysplastic lesions||Participants|Number|3|3.0||||||
4363318|NCT00368927|4190414|B3|1 to 3||Number of baseline dysplastic lesions||Participants|Number|54|54.0||||||
4363319|NCT00368927|4190415|B2|1 to 3||Number of baseline dysplastic lesions||Participants|Number|26|26.0||||||
4363320|NCT00368927|4190416|B1|1 to 3||Number of baseline dysplastic lesions||Participants|Number|28|28.0||||||
4363321|NCT00368927|4190414|B3|No||Prior lung cancer||Participants|Number|60|60.0||||||
4363322|NCT00368927|4190415|B2|No||Prior lung cancer||Participants|Number|30|30.0||||||
4363323|NCT00368927|4190416|B1|No||Prior lung cancer||Participants|Number|30|30.0||||||
4363324|NCT00368927|4190414|B3|Yes||Prior lung cancer||Participants|Number|1|1.0||||||
4363325|NCT00368927|4190415|B2|Yes||Prior lung cancer||Participants|Number|0|0.0||||||
4363326|NCT00368927|4190416|B1|Yes||Prior lung cancer||Participants|Number|1|1.0||||||
4363327|NCT00368927|4190414|B3|Former||Smoking status||Participants|Number|21|21.0||||||
4363328|NCT00368927|4190415|B2|Former||Smoking status||Participants|Number|10|10.0||||||
4363329|NCT00368927|4190416|B1|Former||Smoking status||Participants|Number|11|11.0||||||
4363330|NCT00368927|4190414|B3|Current||Smoking status||Participants|Number|40|40.0||||||
4363331|NCT00368927|4190415|B2|Current||Smoking status||Participants|Number|20|20.0||||||
4363332|NCT00368927|4190416|B1|Current||Smoking status||Participants|Number|20|20.0||||||
4363333|NCT00368927|4190414|B3|||Body mass index||kg/m^2|Median|27.9|27.9|Full Range|||19.1|42.5|
4363334|NCT00368927|4190415|B2|||Body mass index||kg/m^2|Median|28.8|28.8|Full Range|||19.5|42.5|
4363335|NCT00368927|4190416|B1|||Body mass index||kg/m^2|Median|27.5|27.5|Full Range|||19.1|38.9|
4363336|NCT00368927|4190414|B3|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4363337|NCT00368927|4190415|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4363338|NCT00368927|4190416|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4363339|NCT00368927|4190414|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4363340|NCT00368927|4190415|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4363341|NCT00368927|4190416|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4363342|NCT00368927|4190414|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4363343|NCT00368927|4190415|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4363344|NCT00368927|4190416|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4363345|NCT00368927|4190414|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4363346|NCT00368927|4190415|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4363347|NCT00368927|4190416|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4363348|NCT00368927|4190414|B3|||Age||years|Median|59|59.0|Full Range|||44.0|77.0|
4363349|NCT00368927|4190415|B2|||Age||years|Median|60|60.0|Full Range|||44.0|77.0|
4363350|NCT00368927|4190416|B1|||Age||years|Median|59|59.0|Full Range|||45.0|77.0|
4363351|NCT00368875|4190425|B1|Unknown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4363352|NCT00368875|4190425|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4363353|NCT00368875|4190425|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4363354|NCT00368875|4190425|B1|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4363355|NCT00368875|4190425|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4363356|NCT00368875|4190425|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4363357|NCT00368875|4190425|B1|||Age||years|Median|54|54.0|Full Range|||27.0|77.0|
4363358|NCT00368849|4190434|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4363359|NCT00368849|4190434|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4363360|NCT00368849|4190434|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4363361|NCT00368849|4190434|B1|||Age||years|Mean|46.20|46.2|Standard Deviation|10.288|10.288|||
4363362|NCT00368849|4190434|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363363|NCT00368849|4190434|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4363364|NCT00368849|4190434|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363365|NCT00368745|4190449|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4363366|NCT00368745|4190450|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4363367|NCT00368745|4190451|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4363368|NCT00368745|4190449|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4363369|NCT00368745|4190450|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4363370|NCT00368745|4190451|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4363371|NCT00368745|4190449|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|11.0|11.0|||
4363372|NCT00368745|4190450|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|11.3|11.3|||
4363373|NCT00368745|4190451|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|10.6|10.6|||
4363374|NCT00368654|4190482|B5|United States||Region of Enrollment||participants|Number|12|12.0||||||
4363375|NCT00368654|4190483|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4363376|NCT00368654|4190484|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4363377|NCT00368654|4190485|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4363378|NCT00368654|4190486|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4363379|NCT00368654|4190482|B5||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4363380|NCT00368654|4190483|B4||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||data not collected
4363381|NCT00368654|4190484|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||data not collected
4363382|NCT00368654|4190485|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||data not collected
4363383|NCT00368654|4190486|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||data not collected
4363384|NCT00368654|4190482|B5||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4363385|NCT00368654|4190483|B4||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||data not collected
4363386|NCT00368654|4190484|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||data not collected
4363387|NCT00368654|4190485|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||data not collected
4363388|NCT00368654|4190486|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||data not collected
4363389|NCT00368654|4190482|B5|||Age||years|Mean|NA||Standard Deviation|NA||||data not collected
4363390|NCT00368654|4190483|B4|||Age||years|Mean|NA||Standard Deviation|NA||||data not collected
4363391|NCT00368654|4190484|B3|||Age||years|Mean|NA||Standard Deviation|NA||||data not collected
4363392|NCT00368654|4190485|B2|||Age||years|Mean|NA||Standard Deviation|NA||||data not collected
4363393|NCT00368654|4190486|B1|||Age||years|Mean|NA||Standard Deviation|NA||||data not collected
4363394|NCT00368641|4190503|B3|Belgium||Region of Enrollment||participants|Number|2.0|2.0||||||
4363395|NCT00368641|4190504|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4363396|NCT00368641|4190505|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4363397|NCT00368641|4190503|B3|Canada||Region of Enrollment||participants|Number|6.0|6.0||||||
4363398|NCT00368641|4190504|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4363399|NCT00368641|4190505|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4363400|NCT00368641|4190503|B3|United States||Region of Enrollment||participants|Number|4.0|4.0||||||
4363401|NCT00368641|4190504|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4363402|NCT00368641|4190505|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4363403|NCT00368641|4190503|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4363404|NCT00368641|4190504|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4363405|NCT00368641|4190505|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4363406|NCT00368641|4190503|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4363407|NCT00368641|4190504|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4363408|NCT00368641|4190505|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4363409|NCT00368641|4190503|B3|||Age||years|Mean|74.3|74.3|Standard Deviation|10.0|10.0|||
4363410|NCT00368641|4190504|B2|||Age||years|Mean|70.7|70.7|Standard Deviation|13.1|13.1|||
4363411|NCT00368641|4190505|B1|||Age||years|Mean|77.8|77.8|Standard Deviation|4.1|4.1|||
4363412|NCT00368641|4190503|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4363413|NCT00368641|4190504|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4363414|NCT00368641|4190505|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4363415|NCT00368641|4190503|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4363416|NCT00368641|4190504|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4363417|NCT00368641|4190505|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4363418|NCT00368641|4190503|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363419|NCT00368641|4190504|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363420|NCT00368641|4190505|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363421|NCT00368550|4190512|B3|United States||Region of Enrollment||participants|Number|134|134.0||||||
4363422|NCT00368550|4190513|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4363423|NCT00368550|4190514|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4363424|NCT00368550|4190512|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4363425|NCT00368550|4190513|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4363426|NCT00368550|4190514|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4363427|NCT00368550|4190512|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4363428|NCT00368550|4190513|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4363429|NCT00368550|4190514|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4363430|NCT00368550|4190512|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|9.8|9.8|||
4363431|NCT00368550|4190513|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|9.5|9.5|||
4363432|NCT00368550|4190514|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|10.1|10.1|||
4363433|NCT00368550|4190512|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4363434|NCT00368550|4190513|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363435|NCT00368550|4190514|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4363436|NCT00368550|4190512|B3||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
4363437|NCT00368550|4190513|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4363438|NCT00368550|4190514|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4363439|NCT00368550|4190512|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363440|NCT00368550|4190513|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363441|NCT00368550|4190514|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363442|NCT00368537|4190525|B3||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4363443|NCT00368537|4190526|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4363444|NCT00368537|4190527|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4363445|NCT00368537|4190525|B3||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4363446|NCT00368537|4190526|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4363447|NCT00368537|4190527|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4363448|NCT00368537|4190525|B3|||Age||years|Mean|51.32|51.32|Standard Deviation|16.49|16.49|||
4363449|NCT00368537|4190526|B2|||Age||years|Mean|51.54|51.54|Standard Deviation|16.90|16.9|||
4363450|NCT00368537|4190527|B1|||Age||years|Mean|51.10|51.1|Standard Deviation|16.11|16.11|||
4363451|NCT00368472|4190542|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4363452|NCT00368472|4190542|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4363453|NCT00368472|4190542|B1|||Age||Years|Mean|40.7|40.7|Standard Deviation|11.87|11.87|||
4363454|NCT00368459|4190548|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4363455|NCT00368459|4190549|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4363456|NCT00368459|4190550|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4363457|NCT00368459|4190548|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363458|NCT00368459|4190549|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363459|NCT00368459|4190550|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363460|NCT00368459|4190548|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363461|NCT00368459|4190549|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363462|NCT00368459|4190550|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363463|NCT00368459|4190548|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4363464|NCT00368459|4190549|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4363465|NCT00368459|4190550|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4363466|NCT00368459|4190548|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4363467|NCT00368459|4190549|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363468|NCT00368459|4190550|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4363469|NCT00368459|4190548|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363470|NCT00368459|4190549|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363471|NCT00368459|4190550|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363472|NCT00368459|4190548|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363473|NCT00368459|4190549|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363474|NCT00368459|4190550|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363475|NCT00368459|4190548|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363476|NCT00368459|4190549|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363477|NCT00368459|4190550|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363478|NCT00368459|4190548|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363479|NCT00368459|4190549|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363480|NCT00368459|4190550|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363481|NCT00368459|4190548|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4363482|NCT00368459|4190549|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4363483|NCT00368459|4190550|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4363484|NCT00368459|4190548|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363485|NCT00368459|4190549|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363486|NCT00368459|4190550|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363487|NCT00368459|4190548|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4363488|NCT00368459|4190549|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4363489|NCT00368459|4190550|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4363490|NCT00368459|4190548|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4363491|NCT00368459|4190549|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4363492|NCT00368459|4190550|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4363493|NCT00368459|4190548|B3|||Age||years|Mean|76|76.0|Standard Deviation|4.8|4.8|||
4363494|NCT00368459|4190549|B2|||Age||years|Mean|74|74.0|Standard Deviation|5.1|5.1|||
4363495|NCT00368459|4190550|B1|||Age||years|Mean|78|78.0|Standard Deviation|4.5|4.5|||
4363496|NCT00368316|4190575|B3|Israel||Region of Enrollment||participants|Number|2799|2799.0||||||
4363497|NCT00368316|4190576|B2|Israel||Region of Enrollment||participants|Number|1365|1365.0||||||
4363498|NCT00368316|4190577|B1|Israel||Region of Enrollment||participants|Number|1434|1434.0||||||
4363499|NCT00368316|4190575|B3||Male|Sex: Female, Male||Participants|Count of Participants|1455|1455.0||||||
4363500|NCT00368316|4190576|B2||Male|Sex: Female, Male||Participants|Count of Participants|723|723.0||||||
4363501|NCT00368316|4190577|B1||Male|Sex: Female, Male||Participants|Count of Participants|732|732.0||||||
4363502|NCT00368316|4190575|B3||Female|Sex: Female, Male||Participants|Count of Participants|1344|1344.0||||||
4363503|NCT00368316|4190576|B2||Female|Sex: Female, Male||Participants|Count of Participants|642|642.0||||||
4363504|NCT00368316|4190577|B1||Female|Sex: Female, Male||Participants|Count of Participants|702|702.0||||||
4363505|NCT00368316|4190575|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363506|NCT00368316|4190576|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363507|NCT00368316|4190577|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363508|NCT00368316|4190575|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4363509|NCT00368316|4190576|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4363510|NCT00368316|4190577|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4363511|NCT00368316|4190575|B3||<=18 years|Age||Participants|Count of Participants|2799|2799.0||||||
4363512|NCT00368316|4190576|B2||<=18 years|Age||Participants|Count of Participants|1365|1365.0||||||
4363513|NCT00368316|4190577|B1||<=18 years|Age||Participants|Count of Participants|1434|1434.0||||||
4363514|NCT00368290|4190588|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4363515|NCT00368290|4190589|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4363516|NCT00368290|4190590|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4363517|NCT00368290|4190588|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4363518|NCT00368290|4190589|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4363519|NCT00368290|4190590|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4363520|NCT00368290|4190588|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4363521|NCT00368290|4190589|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4363522|NCT00368290|4190590|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4363523|NCT00368290|4190588|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363524|NCT00368290|4190589|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363525|NCT00368290|4190590|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363526|NCT00368290|4190588|B3||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4363527|NCT00368290|4190589|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4363528|NCT00368290|4190590|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4363529|NCT00368290|4190588|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363530|NCT00368290|4190589|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363531|NCT00368290|4190590|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363532|NCT00368277|4190599|B3||Male|Sex: Female, Male||Participants|Count of Participants|429|429.0||||||
4363533|NCT00368277|4190600|B2||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4363534|NCT00368277|4190601|B1||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4363535|NCT00368277|4190599|B3||Female|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
4363536|NCT00368277|4190600|B2||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4363537|NCT00368277|4190601|B1||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4363538|NCT00368277|4190599|B3|75 years and older||Age, Customized||participants|Number|293|293.0||||||
4363539|NCT00368277|4190600|B2|75 years and older||Age, Customized||participants|Number|148|148.0||||||
4363540|NCT00368277|4190601|B1|75 years and older||Age, Customized||participants|Number|145|145.0||||||
4363541|NCT00368277|4190599|B3|65 - 74 years||Age, Customized||participants|Number|608|608.0||||||
4363542|NCT00368277|4190600|B2|65 - 74 years||Age, Customized||participants|Number|296|296.0||||||
4363543|NCT00368277|4190601|B1|65 - 74 years||Age, Customized||participants|Number|312|312.0||||||
4363544|NCT00368277|4190599|B3|||Age||years|Mean|72.1|72.1|Standard Deviation|5.58|5.58|||
4363545|NCT00368277|4190600|B2|||Age||years|Mean|72.2|72.2|Standard Deviation|5.62|5.62|||
4363546|NCT00368277|4190601|B1|||Age||years|Mean|72.0|72.0|Standard Deviation|5.56|5.56|||
4363547|NCT00368251|4190614|B4|Tunisia||Region of Enrollment||participants|Number|5|5.0||||||
4363548|NCT00368251|4190615|B3|Tunisia||Region of Enrollment||participants|Number|0|0.0||||||
4363549|NCT00368251|4190616|B2|Tunisia||Region of Enrollment||participants|Number|3|3.0||||||
4363550|NCT00368251|4190617|B1|Tunisia||Region of Enrollment||participants|Number|2|2.0||||||
4363551|NCT00368251|4190614|B4|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4363552|NCT00368251|4190615|B3|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4363553|NCT00368251|4190616|B2|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4363554|NCT00368251|4190617|B1|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4363555|NCT00368251|4190614|B4|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
4363556|NCT00368251|4190615|B3|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4363557|NCT00368251|4190616|B2|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4363558|NCT00368251|4190617|B1|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4363559|NCT00368251|4190614|B4|Finland||Region of Enrollment||participants|Number|9|9.0||||||
4363560|NCT00368251|4190615|B3|Finland||Region of Enrollment||participants|Number|2|2.0||||||
4363561|NCT00368251|4190616|B2|Finland||Region of Enrollment||participants|Number|4|4.0||||||
4363562|NCT00368251|4190617|B1|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4363563|NCT00368251|4190614|B4|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4363564|NCT00368251|4190615|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4363565|NCT00368251|4190616|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4363566|NCT00368251|4190617|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4363567|NCT00368251|4190614|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4363568|NCT00368251|4190615|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4363569|NCT00368251|4190616|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4363570|NCT00368251|4190617|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4363571|NCT00368251|4190614|B4|France||Region of Enrollment||participants|Number|8|8.0||||||
4363572|NCT00368251|4190615|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
4363573|NCT00368251|4190616|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4363574|NCT00368251|4190617|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4363575|NCT00368251|4190614|B4|Serbia||Region of Enrollment||participants|Number|6|6.0||||||
4363576|NCT00368251|4190615|B3|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4363577|NCT00368251|4190616|B2|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4363578|NCT00368251|4190617|B1|Serbia||Region of Enrollment||participants|Number|2|2.0||||||
4363579|NCT00368251|4190614|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4363580|NCT00368251|4190615|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4363581|NCT00368251|4190616|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4363582|NCT00368251|4190617|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4363583|NCT00368251|4190614|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4363584|NCT00368251|4190615|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4363585|NCT00368251|4190616|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4363586|NCT00368251|4190617|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4363587|NCT00368251|4190614|B4|||Age||years|Mean|34.65|34.65|Standard Deviation|10.38|10.38|||
4363588|NCT00368251|4190615|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|11.4|11.4|||
4363589|NCT00368251|4190616|B2|||Age||years|Mean|35.8|35.8|Standard Deviation|10.9|10.9|||
4363590|NCT00368251|4190617|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|9.2|9.2|||
4363591|NCT00368251|4190614|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363592|NCT00368251|4190615|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363593|NCT00368251|4190616|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363594|NCT00368251|4190617|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363595|NCT00368251|4190614|B4||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4363596|NCT00368251|4190615|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4363597|NCT00368251|4190616|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4363598|NCT00368251|4190617|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4363599|NCT00368251|4190614|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4363600|NCT00368251|4190615|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4363601|NCT00368251|4190616|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4363602|NCT00368251|4190617|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363603|NCT00368108|4190639|B4|Other||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4363604|NCT00368108|4190640|B3|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4363605|NCT00368108|4190641|B2|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4363606|NCT00368108|4190642|B1|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4363607|NCT00368108|4190639|B4|Asian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4363608|NCT00368108|4190640|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4363609|NCT00368108|4190641|B2|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4363610|NCT00368108|4190642|B1|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4363611|NCT00368108|4190639|B4|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4363612|NCT00368108|4190640|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4363613|NCT00368108|4190641|B2|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4363614|NCT00368108|4190642|B1|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4363615|NCT00368108|4190639|B4|White||Race/Ethnicity, Customized||Participants|Number|712|712.0||||||
4363616|NCT00368108|4190640|B3|White||Race/Ethnicity, Customized||Participants|Number|240|240.0||||||
4363617|NCT00368108|4190641|B2|White||Race/Ethnicity, Customized||Participants|Number|239|239.0||||||
4363618|NCT00368108|4190642|B1|White||Race/Ethnicity, Customized||Participants|Number|233|233.0||||||
4363619|NCT00368108|4190639|B4||Male|Sex: Female, Male||Participants|Count of Participants|492|492.0||||||
4363620|NCT00368108|4190640|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4363621|NCT00368108|4190641|B2||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4363622|NCT00368108|4190642|B1||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4363623|NCT00368108|4190639|B4||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4363624|NCT00368108|4190640|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4363625|NCT00368108|4190641|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4363626|NCT00368108|4190642|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4363627|NCT00368108|4190639|B4|≥ 65 years||Age, Customized||Participants|Number|311|311.0||||||
4363628|NCT00368108|4190640|B3|≥ 65 years||Age, Customized||Participants|Number|103|103.0||||||
4363629|NCT00368108|4190641|B2|≥ 65 years||Age, Customized||Participants|Number|107|107.0||||||
4363630|NCT00368108|4190642|B1|≥ 65 years||Age, Customized||Participants|Number|101|101.0||||||
4363631|NCT00368108|4190639|B4|<65 years||Age, Customized||Participants|Number|440|440.0||||||
4363632|NCT00368108|4190640|B3|<65 years||Age, Customized||Participants|Number|147|147.0||||||
4363633|NCT00368108|4190641|B2|<65 years||Age, Customized||Participants|Number|144|144.0||||||
4363634|NCT00368108|4190642|B1|<65 years||Age, Customized||Participants|Number|149|149.0||||||
4363635|NCT00368069|4190661|B3|Brazil||Region of Enrollment||participants|Number|1.0|1.0||||||
4363636|NCT00368069|4190662|B2|Brazil||Region of Enrollment||participants|Number|0|0.0||||||
4363637|NCT00368069|4190663|B1|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
4363638|NCT00368069|4190661|B3|India||Region of Enrollment||participants|Number|51.0|51.0||||||
4363639|NCT00368069|4190662|B2|India||Region of Enrollment||participants|Number|26|26.0||||||
4363640|NCT00368069|4190663|B1|India||Region of Enrollment||participants|Number|25|25.0||||||
4363641|NCT00368069|4190661|B3|Russian Federation||Region of Enrollment||participants|Number|38.0|38.0||||||
4363642|NCT00368069|4190662|B2|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
4363643|NCT00368069|4190663|B1|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
4363644|NCT00368069|4190661|B3|South Africa||Region of Enrollment||participants|Number|8.0|8.0||||||
4363645|NCT00368069|4190662|B2|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4363646|NCT00368069|4190663|B1|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4363647|NCT00368069|4190661|B3|Ukraine||Region of Enrollment||participants|Number|25.0|25.0||||||
4363648|NCT00368069|4190662|B2|Ukraine||Region of Enrollment||participants|Number|12|12.0||||||
4363649|NCT00368069|4190663|B1|Ukraine||Region of Enrollment||participants|Number|13|13.0||||||
4363650|NCT00368069|4190661|B3|Finland||Region of Enrollment||participants|Number|4.0|4.0||||||
4363651|NCT00368069|4190662|B2|Finland||Region of Enrollment||participants|Number|2|2.0||||||
4363652|NCT00368069|4190663|B1|Finland||Region of Enrollment||participants|Number|2|2.0||||||
4363653|NCT00368069|4190661|B3|Mexico||Region of Enrollment||participants|Number|31.0|31.0||||||
4363654|NCT00368069|4190662|B2|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
4363655|NCT00368069|4190663|B1|Mexico||Region of Enrollment||participants|Number|15|15.0||||||
4363656|NCT00368069|4190661|B3||Male|Sex: Female, Male||Participants|Count of Participants|99.0|99.0||||||
4363657|NCT00368069|4190662|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4363658|NCT00368069|4190663|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4363659|NCT00368069|4190661|B3||Female|Sex: Female, Male||Participants|Count of Participants|59.0|59.0||||||
4363660|NCT00368069|4190662|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4363661|NCT00368069|4190663|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4363662|NCT00368069|4190661|B3|||Age||years|Mean|33.17|33.17|Standard Deviation|13.00|13.0|||
4363663|NCT00368069|4190662|B2|||Age||years|Mean|32.38|32.38|Standard Deviation|12.60|12.6|||
4363664|NCT00368069|4190663|B1|||Age||years|Mean|33.97|33.97|Standard Deviation|13.41|13.41|||
4363665|NCT00367991|4190680|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4363666|NCT00367991|4190681|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4363667|NCT00367991|4190682|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4363668|NCT00367991|4190680|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4363669|NCT00367991|4190681|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4363670|NCT00367991|4190682|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4363671|NCT00367991|4190680|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4363672|NCT00367991|4190681|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4363673|NCT00367991|4190682|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4363674|NCT00367991|4190680|B3|||Age||years|Mean|56|56.0|Standard Deviation|11|11.0|||
4363675|NCT00367991|4190681|B2|||Age||years|Mean|53|53.0|Standard Deviation|9|9.0|||
4363676|NCT00367991|4190682|B1|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
4363677|NCT00367991|4190680|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4363678|NCT00367991|4190681|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4363679|NCT00367991|4190682|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4363680|NCT00367991|4190680|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4363681|NCT00367991|4190681|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4363682|NCT00367991|4190682|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4363683|NCT00367991|4190680|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363684|NCT00367991|4190681|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363685|NCT00367991|4190682|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363686|NCT00367835|4190699|B3|United States||Region of Enrollment||participants|Number|217|217.0||||||
4363687|NCT00367835|4190700|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
4363688|NCT00367835|4190701|B1|United States||Region of Enrollment||participants|Number|138|138.0||||||
4363689|NCT00367835|4190699|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4363690|NCT00367835|4190700|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4363691|NCT00367835|4190701|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4363692|NCT00367835|4190699|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4363693|NCT00367835|4190700|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4363694|NCT00367835|4190701|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4363695|NCT00367835|4190699|B3|||Age||years|Mean|9.4|9.4|Standard Deviation|1.84|1.84|||
4363696|NCT00367835|4190700|B2|||Age||years|Mean|9.3|9.3|Standard Deviation|2.04|2.04|||
4363697|NCT00367835|4190701|B1|||Age||years|Mean|9.4|9.4|Standard Deviation|1.73|1.73|||
4363698|NCT00367835|4190699|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363699|NCT00367835|4190700|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363700|NCT00367835|4190701|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363701|NCT00367835|4190699|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4363702|NCT00367835|4190700|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4363703|NCT00367835|4190701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4363704|NCT00367835|4190699|B3||<=18 years|Age||Participants|Count of Participants|217|217.0||||||
4363705|NCT00367835|4190700|B2||<=18 years|Age||Participants|Count of Participants|79|79.0||||||
4363706|NCT00367835|4190701|B1||<=18 years|Age||Participants|Count of Participants|138|138.0||||||
4363707|NCT00367770|4190728|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4363708|NCT00367770|4190728|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4363709|NCT00367770|4190728|B1|||Age||Years|Mean|39.8|39.8|Standard Deviation|11.8|11.8|||
4363710|NCT00367744|4190734|B3|||CD4+ cell count||cells/mm3|Median|645.5|645.5|Inter-Quartile Range|||430.0|787.0|
4363711|NCT00367744|4190735|B2|||CD4+ cell count||cells/mm3|Median|691|691.0|Inter-Quartile Range|||423.0|861.0|
4363712|NCT00367744|4190736|B1|||CD4+ cell count||cells/mm3|Median|596|596.0|Inter-Quartile Range|||437.0|706.0|
4363713|NCT00367744|4190734|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
4363714|NCT00367744|4190735|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4363715|NCT00367744|4190736|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4363716|NCT00367744|4190734|B3||Male|Gender||Participants|Count of Participants|59|59.0||||||
4363717|NCT00367744|4190735|B2||Male|Gender||Participants|Count of Participants|30|30.0||||||
4363718|NCT00367744|4190736|B1||Male|Gender||Participants|Count of Participants|29|29.0||||||
4363719|NCT00367744|4190734|B3||Female|Gender||Participants|Count of Participants|12|12.0||||||
4363720|NCT00367744|4190735|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
4363721|NCT00367744|4190736|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4363722|NCT00367744|4190734|B3|||Age||years|Mean|49.04|49.04|Standard Deviation|7|7.0|||
4363723|NCT00367744|4190735|B2|||Age||years|Mean|50|50.0|Standard Deviation|7|7.0|||
4363724|NCT00367744|4190736|B1|||Age||years|Mean|48|48.0|Standard Deviation|7|7.0|||
4363725|NCT00367744|4190734|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363726|NCT00367744|4190735|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363727|NCT00367744|4190736|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363728|NCT00367744|4190734|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4363729|NCT00367744|4190735|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4363730|NCT00367744|4190736|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4363731|NCT00367744|4190734|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363732|NCT00367744|4190735|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363733|NCT00367744|4190736|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363734|NCT00367679|4190745|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4363735|NCT00367679|4190745|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4363736|NCT00367679|4190745|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4363737|NCT00367679|4190745|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4363738|NCT00367679|4190745|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4363739|NCT00367679|4190745|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.84|8.84|||
4363740|NCT00367640|4190762|B5||Male|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
4363741|NCT00367640|4190763|B4||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4363742|NCT00367640|4190764|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4363743|NCT00367640|4190765|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4363744|NCT00367640|4190766|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4363745|NCT00367640|4190762|B5||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4363746|NCT00367640|4190763|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4363747|NCT00367640|4190764|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4363748|NCT00367640|4190765|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4363749|NCT00367640|4190766|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4363750|NCT00367640|4190762|B5|||Age||years|Mean|29.4|29.4|Standard Deviation|7.34|7.34|||
4363751|NCT00367640|4190763|B4|||Age||years|Mean|29.1|29.1|Standard Deviation|7.60|7.6|||
4363752|NCT00367640|4190764|B3|||Age||years|Mean|30.4|30.4|Standard Deviation|7.45|7.45|||
4363753|NCT00367640|4190765|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|7.34|7.34|||
4363754|NCT00367640|4190766|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|6.90|6.9|||
4363755|NCT00367601|4190779|B1|Stage IV||Stage||participants|Number|22|22.0||||||
4363756|NCT00367601|4190779|B1|Stage III-B||Stage||participants|Number|3|3.0||||||
4363757|NCT00367601|4190779|B1|Unknown||Smoking Status||participants|Number|1|1.0||||||
4363758|NCT00367601|4190779|B1|Current smoker||Smoking Status||participants|Number|9|9.0||||||
4363759|NCT00367601|4190779|B1|Quit > 3 months ago but <30 years ago||Smoking Status||participants|Number|10|10.0||||||
4363760|NCT00367601|4190779|B1|Not smoked in > 30 years||Smoking Status||participants|Number|4|4.0||||||
4363761|NCT00367601|4190779|B1|Never Smoked||Smoking Status||participants|Number|1|1.0||||||
4363762|NCT00367601|4190779|B1|Performance Status Missing||Patient-Reported Performance Status||participants|Number|2|2.0||||||
4363763|NCT00367601|4190779|B1|Performance Status 3||Patient-Reported Performance Status||participants|Number|2|2.0||||||
4363764|NCT00367601|4190779|B1|Performance Status 2||Patient-Reported Performance Status||participants|Number|13|13.0||||||
4363765|NCT00367601|4190779|B1|Performance Status 1||Patient-Reported Performance Status||participants|Number|8|8.0||||||
4363766|NCT00367601|4190779|B1|Performance Status 2||Investigator Assigned Performance Status||participants|Number|23|23.0||||||
4363767|NCT00367601|4190779|B1|Performance Status 1||Investigator Assigned Performance Status||participants|Number|2|2.0||||||
4363768|NCT00367601|4190779|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4363769|NCT00367601|4190779|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363770|NCT00367601|4190779|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363771|NCT00367601|4190779|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4363772|NCT00367601|4190779|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4363773|NCT00367601|4190779|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363774|NCT00367601|4190779|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363775|NCT00367601|4190779|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4363776|NCT00367601|4190779|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4363777|NCT00367601|4190779|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4363778|NCT00367601|4190779|B1|Median Age, Years||Age, Customized||years|Median|77|77.0|Full Range|||52.0|90.0|
4363779|NCT00367484|4190785|B1|||Neutralising Antibody (NAb) Status|Participants who did not test positive for NAb at baseline. The NAb+ value was defined as NAb ≥ 20 NU/ml.|Participants not testing NAb positive|Number|458|458.0||||||
4363780|NCT00367484|4190785|B1|Tunisia||Region of Enrollment|ITT population|participants|Number|31|31.0||||||
4363781|NCT00367484|4190785|B1|Serbia||Region of Enrollment|ITT population|participants|Number|80|80.0||||||
4363782|NCT00367484|4190785|B1|Russian Federation||Region of Enrollment|ITT population|participants|Number|43|43.0||||||
4363783|NCT00367484|4190785|B1|Romania||Region of Enrollment|ITT population|participants|Number|87|87.0||||||
4363784|NCT00367484|4190785|B1|Poland||Region of Enrollment|ITT population|participants|Number|69|69.0||||||
4363785|NCT00367484|4190785|B1|Morocco||Region of Enrollment|ITT population|participants|Number|5|5.0||||||
4363786|NCT00367484|4190785|B1|Lithuania||Region of Enrollment|ITT population|participants|Number|69|69.0||||||
4363787|NCT00367484|4190785|B1|Hungary||Region of Enrollment|ITT population|participants|Number|23|23.0||||||
4363788|NCT00367484|4190785|B1|United Kingdom||Region of Enrollment|ITT population|participants|Number|13|13.0||||||
4363789|NCT00367484|4190785|B1|France||Region of Enrollment|ITT population|participants|Number|2|2.0||||||
4363790|NCT00367484|4190785|B1|Estonia||Region of Enrollment|ITT population|participants|Number|36|36.0||||||
4363791|NCT00367484|4190785|B1||Male|Sex: Female, Male|ITT population|Participants|Count of Participants|122|122.0||||||
4363792|NCT00367484|4190785|B1||Female|Sex: Female, Male|ITT population|Participants|Count of Participants|336|336.0||||||
4363793|NCT00367484|4190785|B1|||Age|ITT population|years|Mean|36.0|36.0|Standard Deviation|8.9|8.9|||
4363794|NCT00367484|4190785|B1||>=65 years|Age|ITT population|Participants|Count of Participants|0|0.0||||||
4363795|NCT00367484|4190785|B1||Between 18 and 65 years|Age|ITT population|Participants|Count of Participants|458|458.0||||||
4363796|NCT00367484|4190785|B1||<=18 years|Age|ITT population|Participants|Count of Participants|0|0.0||||||
4363797|NCT00367432|4190789|B1|||Weight||Kilogram (kg)|Mean|60.39|60.39|Standard Deviation|13.64|13.64|||
4363798|NCT00367432|4190789|B1|Japan||Region of Enrollment||participants|Number|398|398.0||||||
4363799|NCT00367432|4190789|B1|Asian (other than Japanese)||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4363800|NCT00367432|4190789|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|396|396.0||||||
4363801|NCT00367432|4190789|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4363802|NCT00367432|4190789|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4363803|NCT00367432|4190789|B1|Between 16 and 65 years||Age, Customized||participants|Number|398|398.0||||||
4363804|NCT00367432|4190789|B1|||Age||years|Mean|33.68|33.68|Standard Deviation|11.18|11.18|||
4363805|NCT00367380|4190802|B4|||Age||years|Mean|27|27.0|Standard Deviation|7|7.0|||
4363806|NCT00367380|4190803|B3|||Age||years|Mean|27|27.0|Standard Deviation|5|5.0|||
4363807|NCT00367380|4190804|B2|||Age||years|Mean|23|23.0|Standard Deviation|2|2.0|||
4363808|NCT00367380|4190805|B1|||Age||years|Mean|31|31.0|Standard Deviation|11|11.0|||
4363809|NCT00367380|4190802|B4|Colombia||Region of Enrollment||participants|Number|18|18.0||||||
4363810|NCT00367380|4190803|B3|Colombia||Region of Enrollment||participants|Number|6|6.0||||||
4363811|NCT00367380|4190804|B2|Colombia||Region of Enrollment||participants|Number|6|6.0||||||
4363812|NCT00367380|4190805|B1|Colombia||Region of Enrollment||participants|Number|6|6.0||||||
4363813|NCT00367380|4190802|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4363814|NCT00367380|4190803|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4363815|NCT00367380|4190804|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4363816|NCT00367380|4190805|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4363817|NCT00367380|4190802|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4363818|NCT00367380|4190803|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4363819|NCT00367380|4190804|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4363820|NCT00367380|4190805|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4363821|NCT00367380|4190802|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363822|NCT00367380|4190803|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363823|NCT00367380|4190804|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363824|NCT00367380|4190805|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363825|NCT00367380|4190802|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4363826|NCT00367380|4190803|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4363827|NCT00367380|4190804|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4363828|NCT00367380|4190805|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4363829|NCT00367380|4190802|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363830|NCT00367380|4190803|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363831|NCT00367380|4190804|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363832|NCT00367380|4190805|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363833|NCT00367341|4190815|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
4363834|NCT00367341|4190816|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4363835|NCT00367341|4190817|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4363836|NCT00367341|4190815|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4363837|NCT00367341|4190816|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4363838|NCT00367341|4190817|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4363839|NCT00367341|4190815|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4363840|NCT00367341|4190816|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4363841|NCT00367341|4190817|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4363842|NCT00367341|4190815|B3|||Age||years|Mean|41.68|41.68|Standard Deviation|8.22|8.22|||
4363843|NCT00367341|4190816|B2|||Age||years|Mean|42.2|42.2|Standard Deviation|9.5|9.5|||
4363844|NCT00367341|4190817|B1|||Age||years|Mean|41.2|41.2|Standard Deviation|6.8|6.8|||
4363845|NCT00367341|4190815|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363846|NCT00367341|4190816|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363847|NCT00367341|4190817|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4363848|NCT00367341|4190815|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4363849|NCT00367341|4190816|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4363850|NCT00367341|4190817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4363851|NCT00367341|4190815|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363852|NCT00367341|4190816|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363853|NCT00367341|4190817|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4363854|NCT00367237|4190826|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4363855|NCT00367237|4190827|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4363856|NCT00367237|4190828|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4363857|NCT00367237|4190826|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4363858|NCT00367237|4190827|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4363859|NCT00367237|4190828|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4363860|NCT00367237|4190826|B3|||Age|ITT population|years|Mean|41.2|41.2|Full Range|||20.0|65.0|
4363861|NCT00367237|4190827|B2|||Age|ITT population|years|Mean|42.3|42.3|Full Range|||21.0|65.0|
4363862|NCT00367237|4190828|B1|||Age|ITT population|years|Mean|40.1|40.1|Full Range|||20.0|65.0|
4363863|NCT00367133|4190835|B4|||e-ETDRS visual acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|Letter Score|Median|62|62.0|Inter-Quartile Range|||52.0|67.0|
4363864|NCT00367133|4190836|B3|||e-ETDRS visual acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|Letter Score|Median|62|62.0|Inter-Quartile Range|||52.0|67.0|
4363865|NCT00367133|4190837|B2|||e-ETDRS visual acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|Letter Score|Median|62|62.0|Inter-Quartile Range|||54.0|67.0|
4363866|NCT00367133|4190838|B1|||e-ETDRS visual acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|Letter Score|Median|62|62.0|Inter-Quartile Range|||53.0|67.0|
4363867|NCT00367133|4190835|B4|||Retinal volume on OCT|Missing/ungradeable optical coherence tomography and fundus photo data for the laser, 1mg, and 4 mg groups respectively: 37, 36, 48.|cubic millimetre|Median|9.0|9.0|Inter-Quartile Range|||7.8|10.6|
4363868|NCT00367133|4190836|B3|||Retinal volume on OCT|Missing/ungradeable optical coherence tomography and fundus photo data for the laser, 1mg, and 4 mg groups respectively: 37, 36, 48.|cubic millimetre|Median|8.9|8.9|Inter-Quartile Range|||7.9|10.0|
4363869|NCT00367133|4190837|B2|||Retinal volume on OCT|Missing/ungradeable optical coherence tomography and fundus photo data for the laser, 1mg, and 4 mg groups respectively: 37, 36, 48.|cubic millimetre|Median|8.9|8.9|Inter-Quartile Range|||7.8|10.5|
4363870|NCT00367133|4190838|B1|||Retinal volume on OCT|Missing/ungradeable optical coherence tomography and fundus photo data for the laser, 1mg, and 4 mg groups respectively: 37, 36, 48.|cubic millimetre|Median|9.2|9.2|Inter-Quartile Range|||7.9|10.6|
4363871|NCT00367133|4190835|B4|||Intraocular pressure||microns|Median|16|16.0|Inter-Quartile Range|||13.0|18.0|
4363872|NCT00367133|4190836|B3|||Intraocular pressure||microns|Median|16|16.0|Inter-Quartile Range|||14.0|18.0|
4363873|NCT00367133|4190837|B2|||Intraocular pressure||microns|Median|16|16.0|Inter-Quartile Range|||13.0|18.0|
4363874|NCT00367133|4190838|B1|||Intraocular pressure||microns|Median|16|16.0|Inter-Quartile Range|||13.0|18.0|
4363875|NCT00367133|4190835|B4|||HbA1c|Missing HbA1c data in 64, 46, and 50 in the laser, 1 mg, and 4 mg groups respectively|Percentage|Median|7.5|7.5|Inter-Quartile Range|||6.6|8.8|
4363876|NCT00367133|4190836|B3|||HbA1c|Missing HbA1c data in 64, 46, and 50 in the laser, 1 mg, and 4 mg groups respectively|Percentage|Median|7.6|7.6|Inter-Quartile Range|||6.8|8.8|
4363877|NCT00367133|4190837|B2|||HbA1c|Missing HbA1c data in 64, 46, and 50 in the laser, 1 mg, and 4 mg groups respectively|Percentage|Median|7.5|7.5|Inter-Quartile Range|||6.8|8.4|
4363878|NCT00367133|4190838|B1|||HbA1c|Missing HbA1c data in 64, 46, and 50 in the laser, 1 mg, and 4 mg groups respectively|Percentage|Median|7.5|7.5|Inter-Quartile Range|||6.6|8.5|
4363879|NCT00367133|4190835|B4|||Duration of Diabetes||Years|Median|15|15.0|Inter-Quartile Range|||9.0|22.0|
4363880|NCT00367133|4190836|B3|||Duration of Diabetes||Years|Median|16|16.0|Inter-Quartile Range|||10.0|22.0|
4363881|NCT00367133|4190837|B2|||Duration of Diabetes||Years|Median|15|15.0|Inter-Quartile Range|||9.0|21.0|
4363882|NCT00367133|4190838|B1|||Duration of Diabetes||Years|Median|15|15.0|Inter-Quartile Range|||9.0|21.0|
4363883|NCT00367133|4190835|B4|||Central subfield thickness on OCT|Mean of two baseline scans. Mean CST <250 microns based on RC grading in 15, 7, and 5 eyes for laser, 1 mg, and 4 mg groups, respectively. Missing/ungradable optical coherence tomography or fundus photo data for 1, 2, and 1 eyes for laser, 1 mg, and 4 mg groups, respectively.|Microns|Median|400|400.0|Inter-Quartile Range|||323.0|514.0|
4363884|NCT00367133|4190836|B3|||Central subfield thickness on OCT|Mean of two baseline scans. Mean CST <250 microns based on RC grading in 15, 7, and 5 eyes for laser, 1 mg, and 4 mg groups, respectively. Missing/ungradable optical coherence tomography or fundus photo data for 1, 2, and 1 eyes for laser, 1 mg, and 4 mg groups, respectively.|Microns|Median|396|396.0|Inter-Quartile Range|||323.0|484.0|
4363885|NCT00367133|4190837|B2|||Central subfield thickness on OCT|Mean of two baseline scans. Mean CST <250 microns based on RC grading in 15, 7, and 5 eyes for laser, 1 mg, and 4 mg groups, respectively. Missing/ungradable optical coherence tomography or fundus photo data for 1, 2, and 1 eyes for laser, 1 mg, and 4 mg groups, respectively.|Microns|Median|405|405.0|Inter-Quartile Range|||327.0|514.0|
4363886|NCT00367133|4190838|B1|||Central subfield thickness on OCT|Mean of two baseline scans. Mean CST <250 microns based on RC grading in 15, 7, and 5 eyes for laser, 1 mg, and 4 mg groups, respectively. Missing/ungradable optical coherence tomography or fundus photo data for 1, 2, and 1 eyes for laser, 1 mg, and 4 mg groups, respectively.|Microns|Median|398|398.0|Inter-Quartile Range|||329.0|505.0|
4363887|NCT00367133|4190835|B4|35-24 (20/200-20/320)||Visual Acuity Categorized by Randomization Strata|Letter score and approximate Snellen equivalent. Best score is 97, worst is 0.|Eyes|Number|38|38.0||||||
4363888|NCT00367133|4190836|B3|35-24 (20/200-20/320)||Visual Acuity Categorized by Randomization Strata|Letter score and approximate Snellen equivalent. Best score is 97, worst is 0.|Eyes|Number|13|13.0||||||
4363889|NCT00367133|4190837|B2|35-24 (20/200-20/320)||Visual Acuity Categorized by Randomization Strata|Letter score and approximate Snellen equivalent. Best score is 97, worst is 0.|Eyes|Number|13|13.0||||||
4363890|NCT00367133|4190838|B1|35-24 (20/200-20/320)||Visual Acuity Categorized by Randomization Strata|Letter score and approximate Snellen equivalent. Best score is 97, worst is 0.|Eyes|Number|12|12.0||||||
4363961|NCT00367133|4190837|B2|OCT cystoid abnormality (questionable or definite)||OCT cystoid abnormality (questionable or definite)||Eyes|Number|243|243.0||||||
4363891|NCT00367133|4190835|B4|59-36 (<20/631-20/200)||Visual Acuity Categorized by Randomization Strata|Letter score and approximate Snellen equivalent. Best score is 97, worst is 0.|Eyes|Number|315|315.0||||||
4363892|NCT00367133|4190836|B3|59-36 (<20/631-20/200)||Visual Acuity Categorized by Randomization Strata|Letter score and approximate Snellen equivalent. Best score is 97, worst is 0.|Eyes|Number|92|92.0||||||
4363893|NCT00367133|4190837|B2|59-36 (<20/631-20/200)||Visual Acuity Categorized by Randomization Strata|Letter score and approximate Snellen equivalent. Best score is 97, worst is 0.|Eyes|Number|94|94.0||||||
4363894|NCT00367133|4190838|B1|59-36 (<20/631-20/200)||Visual Acuity Categorized by Randomization Strata|Letter score and approximate Snellen equivalent. Best score is 97, worst is 0.|Eyes|Number|129|129.0||||||
4363895|NCT00367133|4190835|B4|73-60 (20/32-2-20/62)||Visual Acuity Categorized by Randomization Strata|Letter score and approximate Snellen equivalent. Best score is 97, worst is 0.|Eyes|Number|487|487.0||||||
4363896|NCT00367133|4190836|B3|73-60 (20/32-2-20/62)||Visual Acuity Categorized by Randomization Strata|Letter score and approximate Snellen equivalent. Best score is 97, worst is 0.|Eyes|Number|149|149.0||||||
4363897|NCT00367133|4190837|B2|73-60 (20/32-2-20/62)||Visual Acuity Categorized by Randomization Strata|Letter score and approximate Snellen equivalent. Best score is 97, worst is 0.|Eyes|Number|149|149.0||||||
4363898|NCT00367133|4190838|B1|73-60 (20/32-2-20/62)||Visual Acuity Categorized by Randomization Strata|Letter score and approximate Snellen equivalent. Best score is 97, worst is 0.|Eyes|Number|189|189.0||||||
4363899|NCT00367133|4190835|B4|Missing (ungradeable)||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|30|30.0||||||
4363900|NCT00367133|4190836|B3|Missing (ungradeable)||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|10|10.0||||||
4363901|NCT00367133|4190837|B2|Missing (ungradeable)||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|8|8.0||||||
4363902|NCT00367133|4190838|B1|Missing (ungradeable)||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|12|12.0||||||
4363903|NCT00367133|4190835|B4|High-risk proliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|23|23.0||||||
4363904|NCT00367133|4190836|B3|High-risk proliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|6|6.0||||||
4363905|NCT00367133|4190837|B2|High-risk proliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|8|8.0||||||
4363906|NCT00367133|4190838|B1|High-risk proliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|9|9.0||||||
4363907|NCT00367133|4190835|B4|Mild to moderate proliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|197|197.0||||||
4363908|NCT00367133|4190836|B3|Mild to moderate proliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|62|62.0||||||
4363909|NCT00367133|4190837|B2|Mild to moderate proliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|56|56.0||||||
4363910|NCT00367133|4190838|B1|Mild to moderate proliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|79|79.0||||||
4363911|NCT00367133|4190835|B4|Severe nonproliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|95|95.0||||||
4363912|NCT00367133|4190836|B3|Severe nonproliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|25|25.0||||||
4363913|NCT00367133|4190837|B2|Severe nonproliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|27|27.0||||||
4363914|NCT00367133|4190838|B1|Severe nonproliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|43|43.0||||||
4363915|NCT00367133|4190835|B4|Mild-moderately severe nonproliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|493|493.0||||||
4363916|NCT00367133|4190836|B3|Mild-moderately severe nonproliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|151|151.0||||||
4363917|NCT00367133|4190837|B2|Mild-moderately severe nonproliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|156|156.0||||||
4363918|NCT00367133|4190838|B1|Mild-moderately severe nonproliferative||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|186|186.0||||||
4363919|NCT00367133|4190835|B4|Microaneurysms only||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|2|2.0||||||
4363920|NCT00367133|4190836|B3|Microaneurysms only||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|0|0.0||||||
4363921|NCT00367133|4190837|B2|Microaneurysms only||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|1|1.0||||||
4363922|NCT00367133|4190838|B1|Microaneurysms only||Retinopathy severity (ETDRS severity scale)|Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Retinopathy severity data missing for: 12, 8, 10 eyes in the Laser, 1mg and 4mg treatment groups, respectively.|Eyes|Number|1|1.0||||||
4363923|NCT00367133|4190835|B4|No Prior photocoagulation for DME||Prior photocoagulation for diabetic macular edema||Eyes|Number|330|330.0||||||
4363924|NCT00367133|4190836|B3|No Prior photocoagulation for DME||Prior photocoagulation for diabetic macular edema||Eyes|Number|96|96.0||||||
4363925|NCT00367133|4190837|B2|No Prior photocoagulation for DME||Prior photocoagulation for diabetic macular edema||Eyes|Number|102|102.0||||||
4363926|NCT00367133|4190838|B1|No Prior photocoagulation for DME||Prior photocoagulation for diabetic macular edema||Eyes|Number|132|132.0||||||
4363927|NCT00367133|4190835|B4|Prior photocoagulation for DME||Prior photocoagulation for diabetic macular edema||Eyes|Number|510|510.0||||||
4363928|NCT00367133|4190836|B3|Prior photocoagulation for DME||Prior photocoagulation for diabetic macular edema||Eyes|Number|158|158.0||||||
4363929|NCT00367133|4190837|B2|Prior photocoagulation for DME||Prior photocoagulation for diabetic macular edema||Eyes|Number|154|154.0||||||
4363930|NCT00367133|4190838|B1|Prior photocoagulation for DME||Prior photocoagulation for diabetic macular edema||Eyes|Number|198|198.0||||||
4363931|NCT00367133|4190835|B4|No Prior Panretinal scatter photocoagulation||Prior Panretinal scatter photocoagulation||Eyes|Number|705|705.0||||||
4363932|NCT00367133|4190836|B3|No Prior Panretinal scatter photocoagulation||Prior Panretinal scatter photocoagulation||Eyes|Number|212|212.0||||||
4363933|NCT00367133|4190837|B2|No Prior Panretinal scatter photocoagulation||Prior Panretinal scatter photocoagulation||Eyes|Number|216|216.0||||||
4363934|NCT00367133|4190838|B1|No Prior Panretinal scatter photocoagulation||Prior Panretinal scatter photocoagulation||Eyes|Number|277|277.0||||||
4363935|NCT00367133|4190835|B4|Prior Panretinal scatter photocoagulation||Prior Panretinal scatter photocoagulation||Eyes|Number|135|135.0||||||
4363936|NCT00367133|4190836|B3|Prior Panretinal scatter photocoagulation||Prior Panretinal scatter photocoagulation||Eyes|Number|42|42.0||||||
4363937|NCT00367133|4190837|B2|Prior Panretinal scatter photocoagulation||Prior Panretinal scatter photocoagulation||Eyes|Number|40|40.0||||||
4363938|NCT00367133|4190838|B1|Prior Panretinal scatter photocoagulation||Prior Panretinal scatter photocoagulation||Eyes|Number|53|53.0||||||
4363939|NCT00367133|4190835|B4|No OCT subretinal fluid present||OCT subretinal fluid present (questionable or definite||Eyes|Number|615|615.0||||||
4363940|NCT00367133|4190836|B3|No OCT subretinal fluid present||OCT subretinal fluid present (questionable or definite||Eyes|Number|192|192.0||||||
4363941|NCT00367133|4190837|B2|No OCT subretinal fluid present||OCT subretinal fluid present (questionable or definite||Eyes|Number|188|188.0||||||
4363942|NCT00367133|4190838|B1|No OCT subretinal fluid present||OCT subretinal fluid present (questionable or definite||Eyes|Number|235|235.0||||||
4363943|NCT00367133|4190835|B4|Missing (or ungradeable)||OCT subretinal fluid present (questionable or definite||Eyes|Number|6|6.0||||||
4363944|NCT00367133|4190836|B3|Missing (or ungradeable)||OCT subretinal fluid present (questionable or definite||Eyes|Number|1|1.0||||||
4363945|NCT00367133|4190837|B2|Missing (or ungradeable)||OCT subretinal fluid present (questionable or definite||Eyes|Number|4|4.0||||||
4363946|NCT00367133|4190838|B1|Missing (or ungradeable)||OCT subretinal fluid present (questionable or definite||Eyes|Number|1|1.0||||||
4363947|NCT00367133|4190835|B4|OCT subretinal fluid present||OCT subretinal fluid present (questionable or definite||Eyes|Number|219|219.0||||||
4363948|NCT00367133|4190836|B3|OCT subretinal fluid present||OCT subretinal fluid present (questionable or definite||Eyes|Number|61|61.0||||||
4363949|NCT00367133|4190837|B2|OCT subretinal fluid present||OCT subretinal fluid present (questionable or definite||Eyes|Number|64|64.0||||||
4363950|NCT00367133|4190838|B1|OCT subretinal fluid present||OCT subretinal fluid present (questionable or definite||Eyes|Number|94|94.0||||||
4363951|NCT00367133|4190835|B4|Missing/can not grade||OCT cystoid abnormality (questionable or definite)||Eyes|Number|9|9.0||||||
4363952|NCT00367133|4190836|B3|Missing/can not grade||OCT cystoid abnormality (questionable or definite)||Eyes|Number|2|2.0||||||
4363953|NCT00367133|4190837|B2|Missing/can not grade||OCT cystoid abnormality (questionable or definite)||Eyes|Number|4|4.0||||||
4363954|NCT00367133|4190838|B1|Missing/can not grade||OCT cystoid abnormality (questionable or definite)||Eyes|Number|3|3.0||||||
4363955|NCT00367133|4190835|B4|No Evidence||OCT cystoid abnormality (questionable or definite)||Eyes|Number|27|27.0||||||
4363956|NCT00367133|4190836|B3|No Evidence||OCT cystoid abnormality (questionable or definite)||Eyes|Number|6|6.0||||||
4363957|NCT00367133|4190837|B2|No Evidence||OCT cystoid abnormality (questionable or definite)||Eyes|Number|9|9.0||||||
4363958|NCT00367133|4190838|B1|No Evidence||OCT cystoid abnormality (questionable or definite)||Eyes|Number|12|12.0||||||
4363959|NCT00367133|4190835|B4|OCT cystoid abnormality (questionable or definite)||OCT cystoid abnormality (questionable or definite)||Eyes|Number|804|804.0||||||
4363960|NCT00367133|4190836|B3|OCT cystoid abnormality (questionable or definite)||OCT cystoid abnormality (questionable or definite)||Eyes|Number|246|246.0||||||
4364022|NCT00367133|4190838|B1||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4363962|NCT00367133|4190838|B1|OCT cystoid abnormality (questionable or definite)||OCT cystoid abnormality (questionable or definite)||Eyes|Number|315|315.0||||||
4363963|NCT00367133|4190835|B4|Pseudophakic||Lens status phakic (clinical examination)||Eyes|Number|178|178.0||||||
4363964|NCT00367133|4190836|B3|Pseudophakic||Lens status phakic (clinical examination)||Eyes|Number|57|57.0||||||
4363965|NCT00367133|4190837|B2|Pseudophakic||Lens status phakic (clinical examination)||Eyes|Number|53|53.0||||||
4363966|NCT00367133|4190838|B1|Pseudophakic||Lens status phakic (clinical examination)||Eyes|Number|68|68.0||||||
4363967|NCT00367133|4190835|B4|Phakic||Lens status phakic (clinical examination)||Eyes|Number|662|662.0||||||
4363968|NCT00367133|4190836|B3|Phakic||Lens status phakic (clinical examination)||Eyes|Number|197|197.0||||||
4363969|NCT00367133|4190837|B2|Phakic||Lens status phakic (clinical examination)||Eyes|Number|203|203.0||||||
4363970|NCT00367133|4190838|B1|Phakic||Lens status phakic (clinical examination)||Eyes|Number|262|262.0||||||
4363971|NCT00367133|4190835|B4|No Ocular Hypertension||History of ocular hypertension||Eyes|Number|825|825.0||||||
4363972|NCT00367133|4190836|B3|No Ocular Hypertension||History of ocular hypertension||Eyes|Number|250|250.0||||||
4363973|NCT00367133|4190837|B2|No Ocular Hypertension||History of ocular hypertension||Eyes|Number|248|248.0||||||
4363974|NCT00367133|4190838|B1|No Ocular Hypertension||History of ocular hypertension||Eyes|Number|327|327.0||||||
4363975|NCT00367133|4190835|B4|Ocular Hypertension||History of ocular hypertension||Eyes|Number|15|15.0||||||
4363976|NCT00367133|4190836|B3|Ocular Hypertension||History of ocular hypertension||Eyes|Number|4|4.0||||||
4363977|NCT00367133|4190837|B2|Ocular Hypertension||History of ocular hypertension||Eyes|Number|8|8.0||||||
4363978|NCT00367133|4190838|B1|Ocular Hypertension||History of ocular hypertension||Eyes|Number|3|3.0||||||
4363979|NCT00367133|4190835|B4|Type 2||Diabetes Type||Participants|Number|802|802.0||||||
4363980|NCT00367133|4190836|B3|Type 2||Diabetes Type||Participants|Number|242|242.0||||||
4363981|NCT00367133|4190837|B2|Type 2||Diabetes Type||Participants|Number|244|244.0||||||
4363982|NCT00367133|4190838|B1|Type 2||Diabetes Type||Participants|Number|316|316.0||||||
4363983|NCT00367133|4190835|B4|Type 1||Diabetes Type||Participants|Number|38|38.0||||||
4363984|NCT00367133|4190836|B3|Type 1||Diabetes Type||Participants|Number|12|12.0||||||
4363985|NCT00367133|4190837|B2|Type 1||Diabetes Type||Participants|Number|12|12.0||||||
4363986|NCT00367133|4190838|B1|Type 1||Diabetes Type||Participants|Number|14|14.0||||||
4363987|NCT00367133|4190835|B4|Unknown/not reported||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4363988|NCT00367133|4190836|B3|Unknown/not reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4363989|NCT00367133|4190837|B2|Unknown/not reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4363990|NCT00367133|4190838|B1|Unknown/not reported||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4363991|NCT00367133|4190835|B4|More than 1 race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4363992|NCT00367133|4190836|B3|More than 1 race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4363993|NCT00367133|4190837|B2|More than 1 race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4363994|NCT00367133|4190838|B1|More than 1 race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4363995|NCT00367133|4190835|B4|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4363996|NCT00367133|4190836|B3|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4363997|NCT00367133|4190837|B2|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4363998|NCT00367133|4190838|B1|Native Hawaiian/other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4363999|NCT00367133|4190835|B4|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4364000|NCT00367133|4190836|B3|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4364001|NCT00367133|4190837|B2|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4364002|NCT00367133|4190838|B1|American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4364003|NCT00367133|4190835|B4|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4364004|NCT00367133|4190836|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4364005|NCT00367133|4190837|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4364006|NCT00367133|4190838|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4364007|NCT00367133|4190835|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4364008|NCT00367133|4190836|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4364009|NCT00367133|4190837|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4364010|NCT00367133|4190838|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4364011|NCT00367133|4190835|B4|Black||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4364012|NCT00367133|4190836|B3|Black||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4364013|NCT00367133|4190837|B2|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4364014|NCT00367133|4190838|B1|Black||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4364015|NCT00367133|4190835|B4|White||Race/Ethnicity, Customized||participants|Number|612|612.0||||||
4364016|NCT00367133|4190836|B3|White||Race/Ethnicity, Customized||participants|Number|183|183.0||||||
4364017|NCT00367133|4190837|B2|White||Race/Ethnicity, Customized||participants|Number|186|186.0||||||
4364018|NCT00367133|4190838|B1|White||Race/Ethnicity, Customized||participants|Number|243|243.0||||||
4364019|NCT00367133|4190835|B4||Male|Sex: Female, Male||Participants|Count of Participants|429|429.0||||||
4364020|NCT00367133|4190836|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4364021|NCT00367133|4190837|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4364023|NCT00367133|4190835|B4||Female|Sex: Female, Male||Participants|Count of Participants|411|411.0||||||
4364024|NCT00367133|4190836|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4364025|NCT00367133|4190837|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4364026|NCT00367133|4190838|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4364027|NCT00367133|4190835|B4|||Age||years|Median|63|63.0|Inter-Quartile Range|||57.0|70.0|
4364028|NCT00367133|4190836|B3|||Age||years|Median|63|63.0|Inter-Quartile Range|||57.0|69.0|
4364029|NCT00367133|4190837|B2|||Age||years|Median|63|63.0|Inter-Quartile Range|||58.0|70.0|
4364030|NCT00367133|4190838|B1|||Age||years|Median|63|63.0|Inter-Quartile Range|||57.0|69.0|
4364031|NCT00367055|4190890|B3|||HbA1c|Mean hemoglobin A1c (HbA1c) levels were measured by blood draw|percentage|Mean|7.4|7.4|Standard Deviation|0.57|0.57|||
4364032|NCT00367055|4190891|B2|||HbA1c|Mean hemoglobin A1c (HbA1c) levels were measured by blood draw|percentage|Mean|7.3|7.3|Standard Deviation|0.55|0.55|||
4364033|NCT00367055|4190892|B1|||HbA1c|Mean hemoglobin A1c (HbA1c) levels were measured by blood draw|percentage|Mean|7.5|7.5|Standard Deviation|0.55|0.55|||
4364034|NCT00367055|4190890|B3|||FBG|Mean fasting blood glucose (FBG) levels were measured by blood draw|Millimoles/Liter (mmol/L)|Mean|8.70|8.7|Standard Deviation|1.50|1.5|||
4364035|NCT00367055|4190891|B2|||FBG|Mean fasting blood glucose (FBG) levels were measured by blood draw|Millimoles/Liter (mmol/L)|Mean|8.28|8.28|Standard Deviation|1.11|1.11|||
4364036|NCT00367055|4190892|B1|||FBG|Mean fasting blood glucose (FBG) levels were measured by blood draw|Millimoles/Liter (mmol/L)|Mean|9.10|9.1|Standard Deviation|1.72|1.72|||
4364037|NCT00367055|4190890|B3|>30||Body Mass Index (BMI)|Number of participants with the indicated class of BMI at randomization|kilograms per square meter (kg/m2)|Number|40|40.0||||||
4364038|NCT00367055|4190891|B2|>30||Body Mass Index (BMI)|Number of participants with the indicated class of BMI at randomization|kilograms per square meter (kg/m2)|Number|21|21.0||||||
4364039|NCT00367055|4190892|B1|>30||Body Mass Index (BMI)|Number of participants with the indicated class of BMI at randomization|kilograms per square meter (kg/m2)|Number|19|19.0||||||
4364040|NCT00367055|4190890|B3|25-30||Body Mass Index (BMI)|Number of participants with the indicated class of BMI at randomization|kilograms per square meter (kg/m2)|Number|41|41.0||||||
4364041|NCT00367055|4190891|B2|25-30||Body Mass Index (BMI)|Number of participants with the indicated class of BMI at randomization|kilograms per square meter (kg/m2)|Number|20|20.0||||||
4364042|NCT00367055|4190892|B1|25-30||Body Mass Index (BMI)|Number of participants with the indicated class of BMI at randomization|kilograms per square meter (kg/m2)|Number|21|21.0||||||
4364043|NCT00367055|4190890|B3|<25||Body Mass Index (BMI)|Number of participants with the indicated class of BMI at randomization|kilograms per square meter (kg/m2)|Number|3|3.0||||||
4364044|NCT00367055|4190891|B2|<25||Body Mass Index (BMI)|Number of participants with the indicated class of BMI at randomization|kilograms per square meter (kg/m2)|Number|0|0.0||||||
4364045|NCT00367055|4190892|B1|<25||Body Mass Index (BMI)|Number of participants with the indicated class of BMI at randomization|kilograms per square meter (kg/m2)|Number|3|3.0||||||
4364046|NCT00367055|4190890|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4364047|NCT00367055|4190891|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4364048|NCT00367055|4190892|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4364049|NCT00367055|4190890|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4364050|NCT00367055|4190891|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4364051|NCT00367055|4190892|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4364052|NCT00367055|4190890|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|8.2|8.2|||
4364053|NCT00367055|4190891|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|8.0|8.0|||
4364054|NCT00367055|4190892|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|8.4|8.4|||
4364055|NCT00366899|4190907|B3|Male||Gender|1 gender unknown|participants|Number|334|334.0||||||
4364056|NCT00366899|4190908|B2|Male||Gender|1 gender unknown|participants|Number|170|170.0||||||
4364057|NCT00366899|4190909|B1|Male||Gender|1 gender unknown|participants|Number|164|164.0||||||
4364058|NCT00366899|4190907|B3|Female||Gender|1 gender unknown|participants|Number|271|271.0||||||
4364059|NCT00366899|4190908|B2|Female||Gender|1 gender unknown|participants|Number|133|133.0||||||
4364060|NCT00366899|4190909|B1|Female||Gender|1 gender unknown|participants|Number|138|138.0||||||
4364061|NCT00366899|4190907|B3|||Age||months|Mean|2.9|2.9|Standard Deviation|0.3|0.3|||
4364062|NCT00366899|4190908|B2|||Age||months|Mean|2.9|2.9|Standard Deviation|0.3|0.3|||
4364063|NCT00366899|4190909|B1|||Age||months|Mean|2.9|2.9|Standard Deviation|0.3|0.3|||
4364064|NCT00366678|4190968|B3||Male|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4364065|NCT00366678|4190969|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4364066|NCT00366678|4190970|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4364067|NCT00366678|4190968|B3||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4364068|NCT00366678|4190969|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4364069|NCT00366678|4190970|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4364070|NCT00366678|4190968|B3|||Age||months|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
4364071|NCT00366678|4190969|B2|||Age||months|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
4364072|NCT00366678|4190970|B1|||Age||months|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
4364073|NCT00366626|4191037|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
4364074|NCT00366626|4191038|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4364075|NCT00366626|4191039|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4364076|NCT00366626|4191037|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4364077|NCT00366626|4191038|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4364078|NCT00366626|4191039|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4364079|NCT00366626|4191037|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4364080|NCT00366626|4191038|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4364081|NCT00366626|4191039|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4364082|NCT00366626|4191037|B3|||Age||years|Mean|28|28.0|Standard Deviation|10|10.0|||
4364083|NCT00366626|4191038|B2|||Age||years|Mean|26|26.0|Standard Deviation|10|10.0|||
4364084|NCT00366626|4191039|B1|||Age||years|Mean|30|30.0|Standard Deviation|10|10.0|||
4364085|NCT00366626|4191037|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364086|NCT00366626|4191038|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364087|NCT00366626|4191039|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364088|NCT00366626|4191037|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4364089|NCT00366626|4191038|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4364090|NCT00366626|4191039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4364091|NCT00366626|4191037|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364092|NCT00366626|4191038|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364093|NCT00366626|4191039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364094|NCT00366548|4191052|B3||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4364095|NCT00366548|4191053|B2||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4364096|NCT00366548|4191054|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4364097|NCT00366548|4191052|B3||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4364098|NCT00366548|4191053|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4364099|NCT00366548|4191054|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4364100|NCT00366548|4191052|B3|||Age||months|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
4364101|NCT00366548|4191053|B2|||Age||months|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
4364102|NCT00366548|4191054|B1|||Age||months|Mean|2.1|2.1|Standard Deviation|0.5|0.5|||
4364103|NCT00366535|4191089|B3|United States||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
4364104|NCT00366535|4191090|B2|United States||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4364105|NCT00366535|4191091|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4364106|NCT00366535|4191089|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4364107|NCT00366535|4191090|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4364108|NCT00366535|4191091|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364109|NCT00366535|4191089|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4364110|NCT00366535|4191090|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4364111|NCT00366535|4191091|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364112|NCT00366535|4191089|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4364113|NCT00366535|4191090|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4364114|NCT00366535|4191091|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4364115|NCT00366535|4191089|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4364116|NCT00366535|4191090|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4364117|NCT00366535|4191091|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4364118|NCT00366535|4191089|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364119|NCT00366535|4191090|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364120|NCT00366535|4191091|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364121|NCT00366535|4191089|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364122|NCT00366535|4191090|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364123|NCT00366535|4191091|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364124|NCT00366535|4191089|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364125|NCT00366535|4191090|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364126|NCT00366535|4191091|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364127|NCT00366535|4191089|B3||Male|Sex: Female, Male|Because fibromyalgia is much more common in women and because there are significant gender differences in the clinical characteristics of the disorder, only women will be included in the study.|Participants|Count of Participants|0|0.0||||||
4364128|NCT00366535|4191090|B2||Male|Sex: Female, Male|Because fibromyalgia is much more common in women and because there are significant gender differences in the clinical characteristics of the disorder, only women will be included in the study.|Participants|Count of Participants|0|0.0||||||
4364129|NCT00366535|4191091|B1||Male|Sex: Female, Male|Because fibromyalgia is much more common in women and because there are significant gender differences in the clinical characteristics of the disorder, only women will be included in the study.|Participants|Count of Participants|0|0.0||||||
4364130|NCT00366535|4191089|B3||Female|Sex: Female, Male|Because fibromyalgia is much more common in women and because there are significant gender differences in the clinical characteristics of the disorder, only women will be included in the study.|Participants|Count of Participants|56|56.0||||||
4364131|NCT00366535|4191090|B2||Female|Sex: Female, Male|Because fibromyalgia is much more common in women and because there are significant gender differences in the clinical characteristics of the disorder, only women will be included in the study.|Participants|Count of Participants|27|27.0||||||
4364132|NCT00366535|4191091|B1||Female|Sex: Female, Male|Because fibromyalgia is much more common in women and because there are significant gender differences in the clinical characteristics of the disorder, only women will be included in the study.|Participants|Count of Participants|29|29.0||||||
4364133|NCT00366535|4191089|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|12.8|12.8|||
4364134|NCT00366535|4191090|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|12.9|12.9|||
4364135|NCT00366535|4191091|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|12.6|12.6|||
4364136|NCT00366535|4191089|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4364137|NCT00366535|4191090|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364138|NCT00366535|4191091|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4364139|NCT00366535|4191089|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4364140|NCT00366535|4191090|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4364141|NCT00366535|4191091|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4364142|NCT00366535|4191089|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364143|NCT00366535|4191090|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364144|NCT00366535|4191091|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364145|NCT00366457|4191106|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4364146|NCT00366457|4191106|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4364147|NCT00366457|4191106|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364148|NCT00366457|4191106|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4364149|NCT00366457|4191106|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364150|NCT00366457|4191106|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364151|NCT00366457|4191106|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364152|NCT00366457|4191106|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364153|NCT00366457|4191106|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4364154|NCT00366457|4191106|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4364155|NCT00366457|4191106|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364156|NCT00366457|4191106|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4364157|NCT00366457|4191106|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4364158|NCT00366457|4191106|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|9.8|9.8|||
4364159|NCT00366457|4191106|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4364160|NCT00366457|4191106|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4364161|NCT00366457|4191106|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364162|NCT00366444|4191113|B3|||Baseline pain score|Pain intensity scores were measured using an 11-point numerical pain rating scale (NPRS) with 0=no pain to 10=worst possible pain|units on a scale|Mean|7.1|7.1|Standard Deviation|1.8|1.8|||
4364163|NCT00366444|4191114|B2|||Baseline pain score|Pain intensity scores were measured using an 11-point numerical pain rating scale (NPRS) with 0=no pain to 10=worst possible pain|units on a scale|Mean|7.3|7.3|Standard Deviation|1.9|1.9|||
4364164|NCT00366444|4191115|B1|||Baseline pain score|Pain intensity scores were measured using an 11-point numerical pain rating scale (NPRS) with 0=no pain to 10=worst possible pain|units on a scale|Mean|6.9|6.9|Standard Deviation|1.7|1.7|||
4364165|NCT00366444|4191113|B3|United States||Region of Enrollment||participants|Number|201|201.0||||||
4364166|NCT00366444|4191114|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
4364167|NCT00366444|4191115|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4364168|NCT00366444|4191113|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4364169|NCT00366444|4191114|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4364170|NCT00366444|4191115|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4364171|NCT00366444|4191113|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4364172|NCT00366444|4191114|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4364173|NCT00366444|4191115|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4364174|NCT00366444|4191113|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4364175|NCT00366444|4191114|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4364176|NCT00366444|4191115|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4364177|NCT00366444|4191113|B3|Black||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4364178|NCT00366444|4191114|B2|Black||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4364179|NCT00366444|4191115|B1|Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4364180|NCT00366444|4191113|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4364181|NCT00366444|4191114|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4364182|NCT00366444|4191115|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4364183|NCT00366444|4191113|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4364184|NCT00366444|4191114|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4364185|NCT00366444|4191115|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4364186|NCT00366444|4191113|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4364187|NCT00366444|4191114|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4364188|NCT00366444|4191115|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4364189|NCT00366444|4191113|B3|||Age||years|Mean|45|45.0|Standard Deviation|11.5|11.5|||
4364190|NCT00366444|4191114|B2|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
4364191|NCT00366444|4191115|B1|||Age||years|Mean|45|45.0|Standard Deviation|11|11.0|||
4364192|NCT00366340|4191142|B3||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4364193|NCT00366340|4191143|B2||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4364194|NCT00366340|4191144|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4364195|NCT00366340|4191142|B3||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4364196|NCT00366340|4191143|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4364197|NCT00366340|4191144|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4364198|NCT00366340|4191142|B3|||Age||months|Mean|2.5|2.5|Standard Deviation|0.6|0.6|||
4364199|NCT00366340|4191143|B2|||Age||months|Mean|2.5|2.5|Standard Deviation|0.6|0.6|||
4364200|NCT00366340|4191144|B1|||Age||months|Mean|2.5|2.5|Standard Deviation|0.6|0.6|||
4364201|NCT00366301|4191199|B5|Other||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4364202|NCT00366301|4191200|B4|Other||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4364203|NCT00366301|4191201|B3|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4364204|NCT00366301|4191202|B2|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4364205|NCT00366301|4191203|B1|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4364206|NCT00366301|4191199|B5|African American||Race/Ethnicity, Customized||Participants|Number|108|108.0||||||
4364207|NCT00366301|4191200|B4|African American||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4364208|NCT00366301|4191201|B3|African American||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4364209|NCT00366301|4191202|B2|African American||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4364210|NCT00366301|4191203|B1|African American||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4364211|NCT00366301|4191199|B5|White||Race/Ethnicity, Customized||Participants|Number|365|365.0||||||
4364212|NCT00366301|4191200|B4|White||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
4364213|NCT00366301|4191201|B3|White||Race/Ethnicity, Customized||Participants|Number|95|95.0||||||
4364214|NCT00366301|4191202|B2|White||Race/Ethnicity, Customized||Participants|Number|88|88.0||||||
4364215|NCT00366301|4191203|B1|White||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
4364216|NCT00366301|4191199|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4364217|NCT00366301|4191200|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4364218|NCT00366301|4191201|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4364219|NCT00366301|4191202|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4364220|NCT00366301|4191203|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4364221|NCT00366301|4191199|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|438|438.0||||||
4364222|NCT00366301|4191200|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4364223|NCT00366301|4191201|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4364224|NCT00366301|4191202|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4364225|NCT00366301|4191203|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4364226|NCT00366301|4191199|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4364227|NCT00366301|4191200|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4364228|NCT00366301|4191201|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4364229|NCT00366301|4191202|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4364230|NCT00366301|4191203|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4364231|NCT00366301|4191199|B5||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4364232|NCT00366301|4191200|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4364233|NCT00366301|4191201|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4364234|NCT00366301|4191202|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4364235|NCT00366301|4191203|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4364236|NCT00366301|4191199|B5||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4364237|NCT00366301|4191200|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4364238|NCT00366301|4191201|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4364239|NCT00366301|4191202|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4364240|NCT00366301|4191203|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4364241|NCT00366301|4191199|B5|Mean (SD)||Age||years|Mean|53.9|53.9|Standard Deviation|11.4|11.4|||
4364242|NCT00366301|4191200|B4|Mean (SD)||Age||years|Mean|54.0|54.0|Standard Deviation|11.7|11.7|||
4364243|NCT00366301|4191201|B3|Mean (SD)||Age||years|Mean|53.8|53.8|Standard Deviation|11.4|11.4|||
4364244|NCT00366301|4191202|B2|Mean (SD)||Age||years|Mean|53.8|53.8|Standard Deviation|11.5|11.5|||
4364245|NCT00366301|4191203|B1|Mean (SD)||Age||years|Mean|54.0|54.0|Standard Deviation|10.9|10.9|||
4364246|NCT00366275|4191216|B1|Italy||Region of Enrollment||participants|Number|64|64.0||||||
4364247|NCT00366275|4191216|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4364248|NCT00366275|4191216|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4364249|NCT00366275|4191216|B1|||Age||years|Median|50|50.0|Full Range|||44.0|60.0|
4364250|NCT00366275|4191216|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364251|NCT00366275|4191216|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4364252|NCT00366275|4191216|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364253|NCT00366249|4191220|B3||Male|Sex: Female, Male||Participants|Count of Participants|697|697.0||||||
4364254|NCT00366249|4191221|B2||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4364255|NCT00366249|4191222|B1||Male|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4364256|NCT00366249|4191220|B3||Female|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4364257|NCT00366249|4191221|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4364258|NCT00366249|4191222|B1||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4364259|NCT00366249|4191220|B3|||Age||years|Mean|59.07|59.07|Standard Deviation|11.88|11.88|||
4364260|NCT00366249|4191221|B2|||Age||years|Mean|58.75|58.75|Standard Deviation|11.70|11.7|||
4364261|NCT00366249|4191222|B1|||Age||years|Mean|59.36|59.36|Standard Deviation|12.04|12.04|||
4364262|NCT00366106|4191237|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4364263|NCT00366106|4191237|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4364264|NCT00366106|4191237|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4364265|NCT00366106|4191237|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|10.05|10.05|||
4364266|NCT00366106|4191237|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4364267|NCT00366106|4191237|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4364268|NCT00366106|4191237|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364269|NCT00366028|4191244|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4364270|NCT00366028|4191245|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender was not collected as it was not pertinent to the outcome of the study.
4364271|NCT00366028|4191246|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender was not collected as it was not pertinent to the outcome of the study.
4364272|NCT00366028|4191244|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4364273|NCT00366028|4191245|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender was not collected as it was not pertinent to the outcome of the study.
4364274|NCT00366028|4191246|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Gender was not collected as it was not pertinent to the outcome of the study.
4364275|NCT00366028|4191244|B3||>=65 years|Age|Age was not collected as it was not pertinent to the outcome of the study.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4364276|NCT00366028|4191245|B2||>=65 years|Age|Age was not collected as it was not pertinent to the outcome of the study.|Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the outcome of the study.
4364277|NCT00366028|4191246|B1||>=65 years|Age|Age was not collected as it was not pertinent to the outcome of the study.|Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the outcome of the study.
4364278|NCT00366028|4191244|B3||Between 18 and 65 years|Age|Age was not collected as it was not pertinent to the outcome of the study.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4364279|NCT00366028|4191245|B2||Between 18 and 65 years|Age|Age was not collected as it was not pertinent to the outcome of the study.|Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the outcome of the study.
4364280|NCT00366028|4191246|B1||Between 18 and 65 years|Age|Age was not collected as it was not pertinent to the outcome of the study.|Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the outcome of the study.
4364281|NCT00366028|4191244|B3||<=18 years|Age|Age was not collected as it was not pertinent to the outcome of the study.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4364282|NCT00366028|4191245|B2||<=18 years|Age|Age was not collected as it was not pertinent to the outcome of the study.|Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the outcome of the study.
4364283|NCT00366028|4191246|B1||<=18 years|Age|Age was not collected as it was not pertinent to the outcome of the study.|Participants|Count of Participants|NA|||||||Age was not collected as it was not pertinent to the outcome of the study.
4364284|NCT00365976|4191255|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4364285|NCT00365976|4191256|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4364286|NCT00365976|4191257|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4364287|NCT00365976|4191255|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4364288|NCT00365976|4191256|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4364289|NCT00365976|4191257|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4364290|NCT00365976|4191255|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4364291|NCT00365976|4191256|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4364292|NCT00365976|4191257|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4364293|NCT00365976|4191255|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|11.7|11.7|||
4364294|NCT00365976|4191256|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|12.8|12.8|||
4364295|NCT00365976|4191257|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|11.0|11.0|||
4364296|NCT00365976|4191255|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364297|NCT00365976|4191256|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364298|NCT00365976|4191257|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364299|NCT00365976|4191255|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4364300|NCT00365976|4191256|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4364301|NCT00365976|4191257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4364302|NCT00365976|4191255|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364303|NCT00365976|4191256|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364304|NCT00365976|4191257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364305|NCT00365872|4191286|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4364306|NCT00365872|4191287|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4364307|NCT00365872|4191288|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4364308|NCT00365872|4191289|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4364309|NCT00365872|4191286|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4364310|NCT00365872|4191287|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4364311|NCT00365872|4191288|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4364312|NCT00365872|4191289|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4364313|NCT00365872|4191286|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4364314|NCT00365872|4191287|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4364315|NCT00365872|4191288|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4364316|NCT00365872|4191289|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4364317|NCT00365872|4191286|B4|||Age||years|Median|53|53.0|Full Range|||25.0|81.0|
4364318|NCT00365872|4191287|B3|||Age||years|Median|68|68.0|Full Range|||55.0|81.0|
4364319|NCT00365872|4191288|B2|||Age||years|Median|61|61.0|Full Range|||41.0|81.0|
4364320|NCT00365872|4191289|B1|||Age||years|Median|35|35.0|Full Range|||25.0|53.0|
4364321|NCT00365872|4191286|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4364322|NCT00365872|4191287|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4364323|NCT00365872|4191288|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4364324|NCT00365872|4191289|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364325|NCT00365872|4191286|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4364326|NCT00365872|4191287|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4364327|NCT00365872|4191288|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4364328|NCT00365872|4191289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4364329|NCT00365872|4191286|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364330|NCT00365872|4191287|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364331|NCT00365872|4191288|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364332|NCT00365872|4191289|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364333|NCT00365859|4191301|B4||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4364334|NCT00365859|4191302|B3||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4364335|NCT00365859|4191303|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4364336|NCT00365859|4191304|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4364337|NCT00365859|4191301|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4364338|NCT00365859|4191302|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4364339|NCT00365859|4191303|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4364340|NCT00365859|4191304|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4364341|NCT00365859|4191301|B4|||Age||years|Mean|9.6|9.6|Standard Deviation|3.02|3.02|||
4364342|NCT00365859|4191302|B3|||Age||years|Mean|9.5|9.5|Standard Deviation|3.00|3.0|||
4364343|NCT00365859|4191303|B2|||Age||years|Mean|9.6|9.6|Standard Deviation|2.95|2.95|||
4364344|NCT00365859|4191304|B1|||Age||years|Mean|9.7|9.7|Standard Deviation|3.13|3.13|||
4364345|NCT00365859|4191301|B4|13 to 17 years||Age, Customized||participants|Number|67|67.0||||||
4364346|NCT00365859|4191302|B3|13 to 17 years||Age, Customized||participants|Number|36|36.0||||||
4364347|NCT00365859|4191303|B2|13 to 17 years||Age, Customized||participants|Number|14|14.0||||||
4364348|NCT00365859|4191304|B1|13 to 17 years||Age, Customized||participants|Number|17|17.0||||||
4364349|NCT00365859|4191301|B4|6 to 12 years||Age, Customized||participants|Number|263|263.0||||||
4364350|NCT00365859|4191302|B3|6 to 12 years||Age, Customized||participants|Number|138|138.0||||||
4364351|NCT00365859|4191303|B2|6 to 12 years||Age, Customized||participants|Number|56|56.0||||||
4364352|NCT00365859|4191304|B1|6 to 12 years||Age, Customized||participants|Number|69|69.0||||||
4364353|NCT00365846|4191396|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4364354|NCT00365846|4191396|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4364355|NCT00365846|4191396|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4364356|NCT00365846|4191396|B1|||Age||years|Mean|41|41.0|Full Range|||19.0|60.0|
4364357|NCT00365846|4191396|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364358|NCT00365846|4191396|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4364359|NCT00365846|4191396|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364360|NCT00365768|4191405|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4364361|NCT00365768|4191406|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4364362|NCT00365768|4191407|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4364363|NCT00365768|4191405|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4364364|NCT00365768|4191406|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4364365|NCT00365768|4191407|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4364366|NCT00365768|4191405|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4364367|NCT00365768|4191406|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4364368|NCT00365768|4191407|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4364369|NCT00365768|4191405|B3|||Age||years|Median|11|11.0|Full Range|||4.0|19.0|
4364370|NCT00365768|4191406|B2|||Age||years|Median|10|10.0|Full Range|||4.0|17.0|
4364371|NCT00365768|4191407|B1|||Age||years|Median|11|11.0|Full Range|||5.0|19.0|
4364372|NCT00365716|4191416|B6|White||Race/Ethnicity, Customized||participants|Number|910|910.0||||||
4364373|NCT00365716|4191417|B5|White||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
4364374|NCT00365716|4191418|B4|White||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4364375|NCT00365716|4191419|B3|White||Race/Ethnicity, Customized||participants|Number|240|240.0||||||
4364376|NCT00365716|4191420|B2|White||Race/Ethnicity, Customized||participants|Number|213|213.0||||||
4364377|NCT00365716|4191421|B1|White||Race/Ethnicity, Customized||participants|Number|228|228.0||||||
4364378|NCT00365716|4191416|B6|Native American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4364379|NCT00365716|4191417|B5|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4364380|NCT00365716|4191418|B4|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4364381|NCT00365716|4191419|B3|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4364382|NCT00365716|4191420|B2|Native American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4364383|NCT00365716|4191421|B1|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4364384|NCT00365716|4191416|B6|Multi-racial||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4364385|NCT00365716|4191417|B5|Multi-racial||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4364386|NCT00365716|4191418|B4|Multi-racial||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4364387|NCT00365716|4191419|B3|Multi-racial||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4364388|NCT00365716|4191420|B2|Multi-racial||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4364389|NCT00365716|4191421|B1|Multi-racial||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4364390|NCT00365716|4191416|B6|Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4364391|NCT00365716|4191417|B5|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4364392|NCT00365716|4191418|B4|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4364393|NCT00365716|4191419|B3|Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4364394|NCT00365716|4191420|B2|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4364395|NCT00365716|4191421|B1|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4364396|NCT00365716|4191416|B6|Hispanic American||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4364397|NCT00365716|4191417|B5|Hispanic American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4364398|NCT00365716|4191418|B4|Hispanic American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4364399|NCT00365716|4191419|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4364400|NCT00365716|4191420|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4364401|NCT00365716|4191421|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4364402|NCT00365716|4191416|B6|Black||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4364403|NCT00365716|4191417|B5|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4364404|NCT00365716|4191418|B4|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4364405|NCT00365716|4191419|B3|Black||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4364406|NCT00365716|4191420|B2|Black||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4364407|NCT00365716|4191421|B1|Black||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4364408|NCT00365716|4191416|B6|Asian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4364409|NCT00365716|4191417|B5|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4364410|NCT00365716|4191418|B4|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4364411|NCT00365716|4191419|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4364412|NCT00365716|4191420|B2|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4364413|NCT00365716|4191421|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4364414|NCT00365716|4191416|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364415|NCT00365716|4191417|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364416|NCT00365716|4191418|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364417|NCT00365716|4191419|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364418|NCT00365716|4191420|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364419|NCT00365716|4191421|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364420|NCT00365716|4191416|B6||Female|Sex: Female, Male||Participants|Count of Participants|1158|1158.0||||||
4364421|NCT00365716|4191417|B5||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4364422|NCT00365716|4191418|B4||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4364423|NCT00365716|4191419|B3||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4364424|NCT00365716|4191420|B2||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4364425|NCT00365716|4191421|B1||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4364426|NCT00365716|4191416|B6|||Age||years|Mean|20.0|20.0|Full Range|||13.0|24.0|
4364427|NCT00365716|4191417|B5|||Age||years|Mean|20.1|20.1|Full Range|||13.0|23.0|
4364428|NCT00365716|4191418|B4|||Age||years|Mean|20.0|20.0|Full Range|||16.0|23.0|
4364429|NCT00365716|4191419|B3|||Age||years|Mean|20.1|20.1|Full Range|||16.0|23.0|
4364430|NCT00365716|4191420|B2|||Age||years|Mean|20.0|20.0|Full Range|||15.0|24.0|
4364431|NCT00365716|4191421|B1|||Age||years|Mean|20.2|20.2|Full Range|||16.0|23.0|
4364432|NCT00365599|4191442|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4364433|NCT00365599|4191442|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364434|NCT00365599|4191442|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4364435|NCT00365599|4191442|B1|||Age, Customized||years|Median|56|56.0|Full Range|||33.0|71.0|
4364436|NCT00365599|4191442|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4364437|NCT00365599|4191442|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4364438|NCT00365599|4191442|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364439|NCT00365547|4191448|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4364440|NCT00365547|4191448|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4364441|NCT00365547|4191448|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4364442|NCT00365547|4191448|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|11.8|11.8|||
4364443|NCT00365547|4191448|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4364444|NCT00365547|4191448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4364445|NCT00365547|4191448|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364446|NCT00365508|4191456|B3||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4364447|NCT00365508|4191457|B2||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4364448|NCT00365508|4191458|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4364449|NCT00365508|4191456|B3||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4364450|NCT00365508|4191457|B2||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4364451|NCT00365508|4191458|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4364452|NCT00365508|4191456|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|12.3|12.3|||
4364453|NCT00365508|4191457|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|11.9|11.9|||
4364454|NCT00365508|4191458|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|12.7|12.7|||
4364455|NCT00365456|4191467|B1|Trial Period III / Risedronate||Body Mass Index||kg/m^2|Mean|24.21|24.21|Standard Deviation|3.933|3.933|||
4364456|NCT00365456|4191467|B1|Trial Period III / PTH(1-84)||Body Mass Index||kg/m^2|Mean|24.06|24.06|Standard Deviation|3.618|3.618|||
4364457|NCT00365456|4191467|B1|Trial Period II / Risedronate||Body Mass Index||kg/m^2|Mean|24.11|24.11|Standard Deviation|3.788|3.788|||
4364458|NCT00365456|4191467|B1|Trial Period I / PTH(1-84)||Body Mass Index||kg/m^2|Mean|24.06|24.06|Standard Deviation|3.861|3.861|||
4364459|NCT00365456|4191467|B1|Trial Period III / Risedronate||Serum Calcium||mmol/L|Mean|2.339|2.339|Standard Deviation|0.1041|0.1041|||
4364460|NCT00365456|4191467|B1|Trial Period III / PTH(1-84)||Serum Calcium||mmol/L|Mean|2.337|2.337|Standard Deviation|0.0961|0.0961|||
4364461|NCT00365456|4191467|B1|Trial Period II / Risedronate||Serum Calcium||mmol/L|Mean|2.337|2.337|Standard Deviation|0.0999|0.0999|||
4364462|NCT00365456|4191467|B1|Trial Period I / PTH(1-84)||Serum Calcium||mmol/L|Mean|2.338|2.338|Standard Deviation|0.1022|0.1022|||
4364463|NCT00365456|4191467|B1|Trial Period III / Risedronate||Height||cm|Mean|157.4|157.4|Standard Deviation|6.86|6.86|||
4364464|NCT00365456|4191467|B1|Trial Period III / PTH(1-84)||Height||cm|Mean|157.6|157.6|Standard Deviation|6.21|6.21|||
4364465|NCT00365456|4191467|B1|Trial Period II / Risedronate||Height||cm|Mean|157.5|157.5|Standard Deviation|6.48|6.48|||
4364466|NCT00365456|4191467|B1|Trial Period I / PTH(1-84)||Height||cm|Mean|157.4|157.4|Standard Deviation|6.40|6.4|||
4364467|NCT00365456|4191467|B1|Trial Period III / Risedronate||Weight||kg|Mean|59.8|59.8|Standard Deviation|9.57|9.57|||
4364468|NCT00365456|4191467|B1|Trial Period III / PTH(1-84)||Weight||kg|Mean|59.6|59.6|Standard Deviation|8.66|8.66|||
4364469|NCT00365456|4191467|B1|Trial Period II / Risedronate||Weight||kg|Mean|59.7|59.7|Standard Deviation|9.17|9.17|||
4364470|NCT00365456|4191467|B1|Trial Period I / PTH(1-84)||Weight||kg|Mean|59.5|59.5|Standard Deviation|9.39|9.39|||
4364471|NCT00365456|4191467|B1|Trial Period III / Risedronate: others||Prevalent non-vertebral fragility fractures||participants|Number|27|27.0||||||
4364472|NCT00365456|4191467|B1|Trial Period III / PTH(1-84): others||Prevalent non-vertebral fragility fractures||participants|Number|28|28.0||||||
4364473|NCT00365456|4191467|B1|Trial Period II / Risedronate: others||Prevalent non-vertebral fragility fractures||participants|Number|59|59.0||||||
4364474|NCT00365456|4191467|B1|Trial Period I / PTH(1-84): others||Prevalent non-vertebral fragility fractures||participants|Number|93|93.0||||||
4364475|NCT00365456|4191467|B1|Trial Period III / Risedronate: wrist fractures||Prevalent non-vertebral fragility fractures||participants|Number|25|25.0||||||
4364476|NCT00365456|4191467|B1|Trial Period III / PTH(1-84): wrist fractures||Prevalent non-vertebral fragility fractures||participants|Number|22|22.0||||||
4364477|NCT00365456|4191467|B1|Trial Period II / Risedronate: wrist fractures||Prevalent non-vertebral fragility fractures||participants|Number|50|50.0||||||
4364478|NCT00365456|4191467|B1|Trial Period I / PTH(1-84): wrist fractures||Prevalent non-vertebral fragility fractures||participants|Number|78|78.0||||||
4364479|NCT00365456|4191467|B1|Trial Period III / Risedronate: hip fractures||Prevalent non-vertebral fragility fractures||participants|Number|3|3.0||||||
4364480|NCT00365456|4191467|B1|Trial Period III / PTH(1-84): hip fractures||Prevalent non-vertebral fragility fractures||participants|Number|1|1.0||||||
4364481|NCT00365456|4191467|B1|Trial Period II / Risedronate: hip fractures||Prevalent non-vertebral fragility fractures||participants|Number|5|5.0||||||
4364482|NCT00365456|4191467|B1|Trial Period I / PTH(1-84): hip fractures||Prevalent non-vertebral fragility fractures||participants|Number|9|9.0||||||
4364483|NCT00365456|4191467|B1|Trial Period III / Risedronate||Prevalent vertebral fractures|Number of patients with at least one vertebral fracture at baseline|participants|Number|29|29.0||||||
4364484|NCT00365456|4191467|B1|Trial Period III / PTH(1-84)||Prevalent vertebral fractures|Number of patients with at least one vertebral fracture at baseline|participants|Number|37|37.0||||||
4364485|NCT00365456|4191467|B1|Trial Period II / Risedronate||Prevalent vertebral fractures|Number of patients with at least one vertebral fracture at baseline|participants|Number|71|71.0||||||
4364486|NCT00365456|4191467|B1|Trial Period I / PTH(1-84)||Prevalent vertebral fractures|Number of patients with at least one vertebral fracture at baseline|participants|Number|105|105.0||||||
4364487|NCT00365456|4191467|B1|Trial Period III / Risedronate||Lumbar spine T-score|The T-score represents the lumbar spine bone mineral density as compared to a young normal reference mean (healthy 30-year-old woman). A score ≥ -1.0 is considered Normal, while a score between -1.0 and -2.5 is defined as Osteopenia and a score ≤ -2.5 is defined as Osteoporosis.|score|Mean|-3.63|-3.63|Standard Deviation|0.518|0.518|||
4364488|NCT00365456|4191467|B1|Trial Period III / PTH(1-84)||Lumbar spine T-score|The T-score represents the lumbar spine bone mineral density as compared to a young normal reference mean (healthy 30-year-old woman). A score ≥ -1.0 is considered Normal, while a score between -1.0 and -2.5 is defined as Osteopenia and a score ≤ -2.5 is defined as Osteoporosis.|score|Mean|-3.60|-3.6|Standard Deviation|0.427|0.427|||
4364489|NCT00365456|4191467|B1|Trial Period II / Risedronate||Lumbar spine T-score|The T-score represents the lumbar spine bone mineral density as compared to a young normal reference mean (healthy 30-year-old woman). A score ≥ -1.0 is considered Normal, while a score between -1.0 and -2.5 is defined as Osteopenia and a score ≤ -2.5 is defined as Osteoporosis.|score|Mean|-3.62|-3.62|Standard Deviation|0.472|0.472|||
4364490|NCT00365456|4191467|B1|Trial Period I / PTH(1-84)||Lumbar spine T-score|The T-score represents the lumbar spine bone mineral density as compared to a young normal reference mean (healthy 30-year-old woman). A score ≥ -1.0 is considered Normal, while a score between -1.0 and -2.5 is defined as Osteopenia and a score ≤ -2.5 is defined as Osteoporosis.|score|Mean|-3.61|-3.61|Standard Deviation|0.490|0.49|||
4364491|NCT00365456|4191467|B1|female||Sex/Gender, Customized||participants|Number|405|405.0||||||
4364492|NCT00365456|4191467|B1|Trial Period III / Risedronate||Age, Customized||years|Mean|64.7|64.7|Standard Deviation|7.91|7.91|||
4364493|NCT00365456|4191467|B1|Trial Period III / PTH(1-84)||Age, Customized||years|Mean|63.4|63.4|Standard Deviation|6.94|6.94|||
4364494|NCT00365456|4191467|B1|Trial Period II / Risedronate||Age, Customized||years|Mean|64.2|64.2|Standard Deviation|7.43|7.43|||
4364495|NCT00365456|4191467|B1|Trial Period I / PTH(1-84)||Age, Customized||years|Mean|64.6|64.6|Standard Deviation|7.46|7.46|||
4364496|NCT00365417|4191474|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4364497|NCT00365417|4191474|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4364498|NCT00365417|4191474|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4364499|NCT00365417|4191474|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4364500|NCT00365417|4191474|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4364501|NCT00365417|4191474|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4364502|NCT00365417|4191474|B1|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4364503|NCT00365417|4191474|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364504|NCT00365417|4191474|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4364505|NCT00365417|4191474|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|10.8|10.8|||
4364506|NCT00365417|4191474|B1|Greater than 59 years||Age, Customized||participants|Number|13|13.0||||||
4364507|NCT00365417|4191474|B1|Between 50 and 59 years||Age, Customized||participants|Number|13|13.0||||||
4364508|NCT00365417|4191474|B1|18 to less than 50 years||Age, Customized||participants|Number|19|19.0||||||
4364509|NCT00365391|4191480|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4364510|NCT00365391|4191480|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4364511|NCT00365391|4191480|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4364512|NCT00365391|4191480|B1|All Patients||Age||years|Median|60|60.0|Full Range|||36.0|79.0|
4364513|NCT00365378|4191488|B3|Other||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4364514|NCT00365378|4191489|B2|Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4364515|NCT00365378|4191490|B1|Other||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4364516|NCT00365378|4191488|B3|White||Race/Ethnicity, Customized||participants|Number|1807|1807.0||||||
4364517|NCT00365378|4191489|B2|White||Race/Ethnicity, Customized||participants|Number|889|889.0||||||
4364518|NCT00365378|4191490|B1|White||Race/Ethnicity, Customized||participants|Number|918|918.0||||||
4364519|NCT00365378|4191488|B3|Native American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4364520|NCT00365378|4191489|B2|Native American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4364521|NCT00365378|4191490|B1|Native American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4364522|NCT00365378|4191488|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
4364523|NCT00365378|4191489|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4364524|NCT00365378|4191490|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4364525|NCT00365378|4191488|B3|Black||Race/Ethnicity, Customized||participants|Number|208|208.0||||||
4364526|NCT00365378|4191489|B2|Black||Race/Ethnicity, Customized||participants|Number|114|114.0||||||
4364527|NCT00365378|4191490|B1|Black||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4364528|NCT00365378|4191488|B3|Asian||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
4364529|NCT00365378|4191489|B2|Asian||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4364530|NCT00365378|4191490|B1|Asian||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4364531|NCT00365378|4191488|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364532|NCT00365378|4191489|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364533|NCT00365378|4191490|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364534|NCT00365378|4191488|B3||Female|Sex: Female, Male||Participants|Count of Participants|2409|2409.0||||||
4364535|NCT00365378|4191489|B2||Female|Sex: Female, Male||Participants|Count of Participants|1205|1205.0||||||
4364536|NCT00365378|4191490|B1||Female|Sex: Female, Male||Participants|Count of Participants|1204|1204.0||||||
4364537|NCT00365378|4191488|B3|||Age||years|Mean|20.1|20.1|Full Range|||16.0|25.0|
4364538|NCT00365378|4191489|B2|||Age||years|Mean|20.1|20.1|Full Range|||16.0|23.0|
4364539|NCT00365378|4191490|B1|||Age||years|Mean|20.0|20.0|Full Range|||16.0|25.0|
4364540|NCT00365365|4191503|B4|Not done/missing||Electrocardiogram (ECG)|Electrocardiogram (ECG) findings were reported.|participants|Number|18|18.0||||||
4364541|NCT00365365|4191504|B3|Not done/missing||Electrocardiogram (ECG)|Electrocardiogram (ECG) findings were reported.|participants|Number|4|4.0||||||
4364542|NCT00365365|4191505|B2|Not done/missing||Electrocardiogram (ECG)|Electrocardiogram (ECG) findings were reported.|participants|Number|3|3.0||||||
4364543|NCT00365365|4191506|B1|Not done/missing||Electrocardiogram (ECG)|Electrocardiogram (ECG) findings were reported.|participants|Number|11|11.0||||||
4364544|NCT00365365|4191503|B4|Abnormal||Electrocardiogram (ECG)|Electrocardiogram (ECG) findings were reported.|participants|Number|60|60.0||||||
4364545|NCT00365365|4191504|B3|Abnormal||Electrocardiogram (ECG)|Electrocardiogram (ECG) findings were reported.|participants|Number|19|19.0||||||
4364546|NCT00365365|4191505|B2|Abnormal||Electrocardiogram (ECG)|Electrocardiogram (ECG) findings were reported.|participants|Number|19|19.0||||||
4364547|NCT00365365|4191506|B1|Abnormal||Electrocardiogram (ECG)|Electrocardiogram (ECG) findings were reported.|participants|Number|22|22.0||||||
4364548|NCT00365365|4191503|B4|Normal||Electrocardiogram (ECG)|Electrocardiogram (ECG) findings were reported.|participants|Number|134|134.0||||||
4364549|NCT00365365|4191504|B3|Normal||Electrocardiogram (ECG)|Electrocardiogram (ECG) findings were reported.|participants|Number|36|36.0||||||
4364550|NCT00365365|4191505|B2|Normal||Electrocardiogram (ECG)|Electrocardiogram (ECG) findings were reported.|participants|Number|53|53.0||||||
4364551|NCT00365365|4191506|B1|Normal||Electrocardiogram (ECG)|Electrocardiogram (ECG) findings were reported.|participants|Number|45|45.0||||||
4364552|NCT00365365|4191503|B4|ECOG Score = 1||Eastern Cooperative Oncology Group Score (ECOG)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|participants|Number|17|17.0||||||
4364553|NCT00365365|4191504|B3|ECOG Score = 1||Eastern Cooperative Oncology Group Score (ECOG)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|participants|Number|4|4.0||||||
4364554|NCT00365365|4191505|B2|ECOG Score = 1||Eastern Cooperative Oncology Group Score (ECOG)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|participants|Number|8|8.0||||||
4364555|NCT00365365|4191506|B1|ECOG Score = 1||Eastern Cooperative Oncology Group Score (ECOG)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|participants|Number|5|5.0||||||
4364556|NCT00365365|4191503|B4|ECOG Score = 0||Eastern Cooperative Oncology Group Score (ECOG)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|participants|Number|195|195.0||||||
4364557|NCT00365365|4191504|B3|ECOG Score = 0||Eastern Cooperative Oncology Group Score (ECOG)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|participants|Number|55|55.0||||||
4364612|NCT00365300|4191610|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4364613|NCT00365300|4191611|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4364558|NCT00365365|4191505|B2|ECOG Score = 0||Eastern Cooperative Oncology Group Score (ECOG)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|participants|Number|67|67.0||||||
4364559|NCT00365365|4191506|B1|ECOG Score = 0||Eastern Cooperative Oncology Group Score (ECOG)|"The ECOG score assesses how the disease affects a participant's daily living abilities. It ranges from 0-5, with 0 being the best and 5 being the worst outcome. 0 reflects a fully active participant, able to carry on all pre-disease performance without restriction. 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|participants|Number|73|73.0||||||
4364560|NCT00365365|4191503|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364561|NCT00365365|4191504|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364562|NCT00365365|4191505|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364563|NCT00365365|4191506|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364564|NCT00365365|4191503|B4||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4364565|NCT00365365|4191504|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4364566|NCT00365365|4191505|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4364567|NCT00365365|4191506|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4364568|NCT00365365|4191503|B4|||Age||years|Mean|53.1|53.1|Standard Deviation|10.12|10.12|||
4364569|NCT00365365|4191504|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|9.61|9.61|||
4364570|NCT00365365|4191505|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|9.89|9.89|||
4364571|NCT00365365|4191506|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|10.45|10.45|||
4364572|NCT00365352|4191522|B4|Unknown||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|4|4.0||||||
4364573|NCT00365352|4191523|B3|Unknown||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|2|2.0||||||
4364574|NCT00365352|4191524|B2|Unknown||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|2|2.0||||||
4364575|NCT00365352|4191525|B1|Unknown||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|0|0.0||||||
4364576|NCT00365352|4191522|B4|White or Caucasian||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|305|305.0||||||
4364577|NCT00365352|4191523|B3|White or Caucasian||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|107|107.0||||||
4364578|NCT00365352|4191524|B2|White or Caucasian||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|106|106.0||||||
4364579|NCT00365352|4191525|B1|White or Caucasian||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|92|92.0||||||
4364580|NCT00365352|4191522|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|1|1.0||||||
4364581|NCT00365352|4191523|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|0|0.0||||||
4364582|NCT00365352|4191524|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|0|0.0||||||
4364583|NCT00365352|4191525|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|1|1.0||||||
4364584|NCT00365352|4191522|B4|Black or African American||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|7|7.0||||||
4364585|NCT00365352|4191523|B3|Black or African American||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|1|1.0||||||
4364586|NCT00365352|4191524|B2|Black or African American||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|5|5.0||||||
4364587|NCT00365352|4191525|B1|Black or African American||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|1|1.0||||||
4364588|NCT00365352|4191522|B4|Asian||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|3|3.0||||||
4364589|NCT00365352|4191523|B3|Asian||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|1|1.0||||||
4364590|NCT00365352|4191524|B2|Asian||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|0|0.0||||||
4364591|NCT00365352|4191525|B1|Asian||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|2|2.0||||||
4364592|NCT00365352|4191522|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|4|4.0||||||
4364593|NCT00365352|4191523|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|0|0.0||||||
4364614|NCT00365300|4191609|B3|||Age||months|Mean|5.09|5.09|Standard Deviation|2.80|2.8|||
4364615|NCT00365300|4191610|B2|||Age||months|Mean|5.04|5.04|Standard Deviation|2.81|2.81|||
4364594|NCT00365352|4191524|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|3|3.0||||||
4364595|NCT00365352|4191525|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|Baseline Characteristics were collected in members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period. Patients were allowed to categorize to more than one race.|participants|Number|1|1.0||||||
4364596|NCT00365352|4191522|B4||Male|Sex: Female, Male|Baseline Characteristics were collected for members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period.|Participants|Count of Participants|133|133.0||||||
4364597|NCT00365352|4191523|B3||Male|Sex: Female, Male|Baseline Characteristics were collected for members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period.|Participants|Count of Participants|46|46.0||||||
4364598|NCT00365352|4191524|B2||Male|Sex: Female, Male|Baseline Characteristics were collected for members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period.|Participants|Count of Participants|48|48.0||||||
4364599|NCT00365352|4191525|B1||Male|Sex: Female, Male|Baseline Characteristics were collected for members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period.|Participants|Count of Participants|39|39.0||||||
4364600|NCT00365352|4191522|B4||Female|Sex: Female, Male|Baseline Characteristics were collected for members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period.|Participants|Count of Participants|188|188.0||||||
4364601|NCT00365352|4191523|B3||Female|Sex: Female, Male|Baseline Characteristics were collected for members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period.|Participants|Count of Participants|65|65.0||||||
4364602|NCT00365352|4191524|B2||Female|Sex: Female, Male|Baseline Characteristics were collected for members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period.|Participants|Count of Participants|66|66.0||||||
4364603|NCT00365352|4191525|B1||Female|Sex: Female, Male|Baseline Characteristics were collected for members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period.|Participants|Count of Participants|57|57.0||||||
4364604|NCT00365352|4191522|B4|||Age|Baseline Characteristics were collected from members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period.|Years|Mean|48.9|48.9|Standard Deviation|12.58|12.58|||
4364605|NCT00365352|4191523|B3|||Age|Baseline Characteristics were collected from members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period.|Years|Mean|49.5|49.5|Standard Deviation|12.67|12.67|||
4364606|NCT00365352|4191524|B2|||Age|Baseline Characteristics were collected from members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period.|Years|Mean|48.3|48.3|Standard Deviation|12.88|12.88|||
4364607|NCT00365352|4191525|B1|||Age|Baseline Characteristics were collected from members of the Modified Intent-to-Treat (MITT) Population, comprised of all participants in the Safety Population who also satisfied both of the following conditions: (1) completed the International Restless Legs Syndrome (IRLS) Rating Scale at Baseline; and (2) completed at least one on-treatment IRLS Rating Scale score during the treatment period.|Years|Mean|49.1|49.1|Standard Deviation|12.19|12.19|||
4364608|NCT00365300|4191609|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4364609|NCT00365300|4191610|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4364610|NCT00365300|4191611|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4364611|NCT00365300|4191609|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4364616|NCT00365300|4191611|B1|||Age||months|Mean|5.15|5.15|Standard Deviation|2.81|2.81|||
4364617|NCT00365274|4191621|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4364618|NCT00365274|4191621|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4364619|NCT00365274|4191621|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4364620|NCT00365274|4191621|B1|||Age||years|Median|36|36.0|Full Range|||20.0|57.0|
4364621|NCT00365261|4191625|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4364622|NCT00365261|4191626|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4364623|NCT00365261|4191627|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4364624|NCT00365261|4191625|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4364625|NCT00365261|4191626|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4364626|NCT00365261|4191627|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4364627|NCT00365261|4191625|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4364628|NCT00365261|4191626|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4364629|NCT00365261|4191627|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4364630|NCT00365261|4191625|B3|||Age||years|Mean|45.76|45.76|Standard Deviation|14.33|14.33|||
4364631|NCT00365261|4191626|B2|||Age||years|Mean|46|46.0|Standard Deviation|15.86|15.86|||
4364632|NCT00365261|4191627|B1|||Age||years|Mean|45.52|45.52|Standard Deviation|13.06|13.06|||
4364633|NCT00365261|4191625|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4364634|NCT00365261|4191626|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4364635|NCT00365261|4191627|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364636|NCT00365261|4191625|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4364637|NCT00365261|4191626|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4364638|NCT00365261|4191627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4364639|NCT00365261|4191625|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364640|NCT00365261|4191626|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364641|NCT00365261|4191627|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364642|NCT00365209|4191638|B1|Stage2 4 g (curcumin): Male||Sex/Gender, Customized||participants|Number|9|9.0||||||
4364643|NCT00365209|4191638|B1|Stage2 4 g (curcumin): Female||Sex/Gender, Customized||participants|Number|12|12.0||||||
4364644|NCT00365209|4191638|B1|Stage1 2 g (curcumin): Male||Sex/Gender, Customized||participants|Number|9|9.0||||||
4364645|NCT00365209|4191638|B1|Stage1 2 g (curcumin): Female||Sex/Gender, Customized||participants|Number|13|13.0||||||
4364646|NCT00365209|4191638|B1|Stage2 4 g (curcumin) N=21||Age||years|Mean|52.2|52.2|Standard Deviation|6.8|6.8|||
4364647|NCT00365209|4191638|B1|Stage1 2 g (curcumin) N=22||Age||years|Mean|57.1|57.1|Standard Deviation|5.0|5.0|||
4364648|NCT00365144|4191667|B1|3 Prior Lines of Therapy||Number of prior lines of systemic therapy|Patients must have received at least one, but no more than three, prior systemic therapies for advanced disease, at least one of which was gemcitabine based|Participants|Number|3|3.0||||||
4364649|NCT00365144|4191667|B1|2 Prior Lines of Therapy||Number of prior lines of systemic therapy|Patients must have received at least one, but no more than three, prior systemic therapies for advanced disease, at least one of which was gemcitabine based|Participants|Number|9|9.0||||||
4364650|NCT00365144|4191667|B1|1 Prior Line of Therapy||Number of prior lines of systemic therapy|Patients must have received at least one, but no more than three, prior systemic therapies for advanced disease, at least one of which was gemcitabine based|Participants|Number|24|24.0||||||
4364651|NCT00365144|4191667|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4364652|NCT00365144|4191667|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4364653|NCT00365144|4191667|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4364654|NCT00365144|4191667|B1|||Age||years|Median|60|60.0|Full Range|||36.0|82.0|
4364655|NCT00365105|4191675|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4364656|NCT00365105|4191676|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4364657|NCT00365105|4191677|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4364658|NCT00365105|4191675|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4364659|NCT00365105|4191676|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4364660|NCT00365105|4191677|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4364661|NCT00365105|4191675|B3|||Age||years|Median|68|68.0|Full Range|||25.0|90.0|
4364662|NCT00365105|4191676|B2|||Age||years|Median|68|68.0|Full Range|||32.0|90.0|
4364663|NCT00365105|4191677|B1|||Age||years|Median|68|68.0|Full Range|||25.0|88.0|
4364664|NCT00365053|4191684|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4364665|NCT00365053|4191684|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4364666|NCT00365053|4191684|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4364667|NCT00365053|4191684|B1|||Age||years|Median|73|73.0|Full Range|||27.0|82.0|
4364668|NCT00364949|4191693|B3|||Maternal age at delivery||yr|Mean|31.1|31.1|Standard Deviation|4|4.0|||
4364669|NCT00364949|4191694|B2|||Maternal age at delivery||yr|Mean|30.1|30.1|Standard Deviation|3.9|3.9|||
4364670|NCT00364949|4191695|B1|||Maternal age at delivery||yr|Mean|32.4|32.4|Standard Deviation|4.4|4.4|||
4364671|NCT00364949|4191693|B3|||Pre-pregnancy BMI||"kg/m^2"|Mean|28.3|28.3|Standard Deviation|7.5|7.5|||
4364672|NCT00364949|4191694|B2|||Pre-pregnancy BMI||"kg/m^2"|Mean|30.8|30.8|Standard Deviation|8.9|8.9|||
4364673|NCT00364949|4191695|B1|||Pre-pregnancy BMI||"kg/m^2"|Mean|25.1|25.1|Standard Deviation|5.7|5.7|||
4364674|NCT00364949|4191693|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4364675|NCT00364949|4191694|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4364676|NCT00364949|4191695|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4364677|NCT00364949|4191693|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364678|NCT00364949|4191694|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364679|NCT00364949|4191695|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364680|NCT00364949|4191693|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4364681|NCT00364949|4191694|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4364682|NCT00364949|4191695|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4364683|NCT00364949|4191693|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364684|NCT00364949|4191694|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364685|NCT00364949|4191695|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364686|NCT00364949|4191693|B3||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4364687|NCT00364949|4191694|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4364688|NCT00364949|4191695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4364689|NCT00364949|4191693|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364690|NCT00364949|4191694|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364691|NCT00364949|4191695|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364692|NCT00364923|4191714|B1|Europe||Region of Enrollment||participants|Number|26|26.0||||||
4364693|NCT00364923|4191714|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4364694|NCT00364923|4191714|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4364695|NCT00364923|4191714|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4364696|NCT00364923|4191714|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4364697|NCT00364923|4191714|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|15|15.0|||
4364698|NCT00364923|4191714|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4364699|NCT00364923|4191714|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4364700|NCT00364923|4191714|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364701|NCT00364858|4191721|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4364702|NCT00364858|4191722|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4364703|NCT00364858|4191723|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4364704|NCT00364858|4191721|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4364705|NCT00364858|4191722|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4364706|NCT00364858|4191723|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4364707|NCT00364858|4191721|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|15.53|15.53|||
4364708|NCT00364858|4191722|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|14.47|14.47|||
4364709|NCT00364858|4191723|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|17.40|17.4|||
4364710|NCT00364845|4191737|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4364711|NCT00364845|4191738|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4364712|NCT00364845|4191739|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4364713|NCT00364845|4191737|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
4364714|NCT00364845|4191738|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4364715|NCT00364845|4191739|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4364716|NCT00364845|4191737|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4364717|NCT00364845|4191738|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4364718|NCT00364845|4191739|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4364719|NCT00364845|4191737|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4364720|NCT00364845|4191738|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4364721|NCT00364845|4191739|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4364722|NCT00364845|4191737|B3|||Age||Years|Mean|80.0|80.0|Standard Deviation|5.0|5.0|||
4364723|NCT00364845|4191738|B2|||Age||Years|Mean|81.0|81.0|Standard Deviation|5.1|5.1|||
4364724|NCT00364845|4191739|B1|||Age||Years|Mean|79.2|79.2|Standard Deviation|4.9|4.9|||
4364725|NCT00364832|4191752|B10||Male|Gender||Participants|Count of Participants|85|85.0||||||
4364726|NCT00364832|4191753|B9||Male|Gender||Participants|Count of Participants|9|9.0||||||
4364727|NCT00364832|4191754|B8||Male|Gender||Participants|Count of Participants|10|10.0||||||
4364728|NCT00364832|4191755|B7||Male|Gender||Participants|Count of Participants|12|12.0||||||
4364729|NCT00364832|4191756|B6||Male|Gender||Participants|Count of Participants|5|5.0||||||
4364730|NCT00364832|4191757|B5||Male|Gender||Participants|Count of Participants|11|11.0||||||
4364731|NCT00364832|4191758|B4||Male|Gender||Participants|Count of Participants|10|10.0||||||
4364732|NCT00364832|4191759|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
4364733|NCT00364832|4191760|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
4364734|NCT00364832|4191761|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
4364735|NCT00364832|4191752|B10||Female|Gender||Participants|Count of Participants|52|52.0||||||
4364736|NCT00364832|4191753|B9||Female|Gender||Participants|Count of Participants|7|7.0||||||
4364737|NCT00364832|4191754|B8||Female|Gender||Participants|Count of Participants|5|5.0||||||
4364738|NCT00364832|4191755|B7||Female|Gender||Participants|Count of Participants|4|4.0||||||
4364739|NCT00364832|4191756|B6||Female|Gender||Participants|Count of Participants|7|7.0||||||
4364740|NCT00364832|4191757|B5||Female|Gender||Participants|Count of Participants|5|5.0||||||
4364741|NCT00364832|4191758|B4||Female|Gender||Participants|Count of Participants|6|6.0||||||
4364742|NCT00364832|4191759|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
4364743|NCT00364832|4191760|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
4364744|NCT00364832|4191761|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4364745|NCT00364832|4191752|B10|||Age||years|Mean|63.9|63.9|Standard Deviation|12.63|12.63|||
4364746|NCT00364832|4191753|B9|||Age||years|Mean|64.1|64.1|Standard Deviation|13.34|13.34|||
4364747|NCT00364832|4191754|B8|||Age||years|Mean|58.9|58.9|Standard Deviation|13.12|13.12|||
4364748|NCT00364832|4191755|B7|||Age||years|Mean|62.7|62.7|Standard Deviation|13.74|13.74|||
4364749|NCT00364832|4191756|B6|||Age||years|Mean|67.3|67.3|Standard Deviation|13.30|13.3|||
4364750|NCT00364832|4191757|B5|||Age||years|Mean|64.1|64.1|Standard Deviation|12.83|12.83|||
4364751|NCT00364832|4191758|B4|||Age||years|Mean|61.8|61.8|Standard Deviation|13.51|13.51|||
4364752|NCT00364832|4191759|B3|||Age||years|Mean|64.8|64.8|Standard Deviation|10.28|10.28|||
4364753|NCT00364832|4191760|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|11.29|11.29|||
4364754|NCT00364832|4191761|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|13.03|13.03|||
4364755|NCT00364819|4191825|B1||Ludwig Stage IV|Liver Biopsy Stage|Staging of liver histology by Ludwig from earliest stage (I) to latest stage (IV). Stage I: Portal inflammation, bile duct abnormalities, or both are present; Stage II: Periportal fibrosis is present, with or without periportal inflammation or prominent enlargement of the portal tracts with seemingly intact, newly formed limiting plates; Stage III: Septal fibrosis with active inflammatory, passive paucicellular septa, or both are present; Stage IV: Nodules with various degrees of inflammation are present|Participants|Count of Participants|0|0.0||||||
4364756|NCT00364819|4191825|B1||Ludwig Stage III|Liver Biopsy Stage|Staging of liver histology by Ludwig from earliest stage (I) to latest stage (IV). Stage I: Portal inflammation, bile duct abnormalities, or both are present; Stage II: Periportal fibrosis is present, with or without periportal inflammation or prominent enlargement of the portal tracts with seemingly intact, newly formed limiting plates; Stage III: Septal fibrosis with active inflammatory, passive paucicellular septa, or both are present; Stage IV: Nodules with various degrees of inflammation are present|Participants|Count of Participants|1|1.0||||||
4364757|NCT00364819|4191825|B1||Ludwig Stage II|Liver Biopsy Stage|Staging of liver histology by Ludwig from earliest stage (I) to latest stage (IV). Stage I: Portal inflammation, bile duct abnormalities, or both are present; Stage II: Periportal fibrosis is present, with or without periportal inflammation or prominent enlargement of the portal tracts with seemingly intact, newly formed limiting plates; Stage III: Septal fibrosis with active inflammatory, passive paucicellular septa, or both are present; Stage IV: Nodules with various degrees of inflammation are present|Participants|Count of Participants|4|4.0||||||
4364758|NCT00364819|4191825|B1||Ludwig Stage I|Liver Biopsy Stage|Staging of liver histology by Ludwig from earliest stage (I) to latest stage (IV). Stage I: Portal inflammation, bile duct abnormalities, or both are present; Stage II: Periportal fibrosis is present, with or without periportal inflammation or prominent enlargement of the portal tracts with seemingly intact, newly formed limiting plates; Stage III: Septal fibrosis with active inflammatory, passive paucicellular septa, or both are present; Stage IV: Nodules with various degrees of inflammation are present|Participants|Count of Participants|1|1.0||||||
4364759|NCT00364819|4191825|B1||Anti-mitochondrial Antibody Negative|Anti-mitochondrial Antibody|Serum anti-mitochondrial antibodies (AMA) are present in 90% of cases of PBC.|Participants|Count of Participants|0|0.0||||||
4364760|NCT00364819|4191825|B1||Anti-mitochondrial Antibody Positive|Anti-mitochondrial Antibody|Serum anti-mitochondrial antibodies (AMA) are present in 90% of cases of PBC.|Participants|Count of Participants|6|6.0||||||
4364761|NCT00364819|4191825|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364762|NCT00364819|4191825|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364763|NCT00364819|4191825|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4364764|NCT00364819|4191825|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364765|NCT00364819|4191825|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364766|NCT00364819|4191825|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364767|NCT00364819|4191825|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364768|NCT00364819|4191825|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4364769|NCT00364819|4191825|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4364770|NCT00364819|4191825|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4364771|NCT00364819|4191825|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364772|NCT00364819|4191825|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4364773|NCT00364819|4191825|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364774|NCT00364819|4191825|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4364775|NCT00364819|4191825|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364833|NCT00364793|4191835|B3|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4364834|NCT00364793|4191836|B2|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4364835|NCT00364793|4191837|B1|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4364836|NCT00364793|4191833|B5|Panama||Region of Enrollment||participants|Number|4|4.0||||||
4364776|NCT00364793|4191833|B5|||CD4 Cell Count (n=13, 9, 3, 7, 32)|A CD4 cell is an antigenic marker of helper/inducer T cells. These cells were counted during the hematology cell counts performed during a Complete Blood Cell count (CBC) performed by the Central Laboratory. CD4 are measured as number of cells per millimeter to the third power (cells/mm^3). Not all treated participants provided a measurement for this baseline parameter (n=number of participants with this baseline measurement).|cells/mm^3|Median|1144|1144.0|Full Range|||11.0|3584.0|
4364777|NCT00364793|4191834|B4|||CD4 Cell Count (n=13, 9, 3, 7, 32)|A CD4 cell is an antigenic marker of helper/inducer T cells. These cells were counted during the hematology cell counts performed during a Complete Blood Cell count (CBC) performed by the Central Laboratory. CD4 are measured as number of cells per millimeter to the third power (cells/mm^3). Not all treated participants provided a measurement for this baseline parameter (n=number of participants with this baseline measurement).|cells/mm^3|Median|540|540.0|Full Range|||11.0|1363.0|
4364778|NCT00364793|4191835|B3|||CD4 Cell Count (n=13, 9, 3, 7, 32)|A CD4 cell is an antigenic marker of helper/inducer T cells. These cells were counted during the hematology cell counts performed during a Complete Blood Cell count (CBC) performed by the Central Laboratory. CD4 are measured as number of cells per millimeter to the third power (cells/mm^3). Not all treated participants provided a measurement for this baseline parameter (n=number of participants with this baseline measurement).|cells/mm^3|Median|517|517.0|Full Range|||129.0|558.0|
4364779|NCT00364793|4191836|B2|||CD4 Cell Count (n=13, 9, 3, 7, 32)|A CD4 cell is an antigenic marker of helper/inducer T cells. These cells were counted during the hematology cell counts performed during a Complete Blood Cell count (CBC) performed by the Central Laboratory. CD4 are measured as number of cells per millimeter to the third power (cells/mm^3). Not all treated participants provided a measurement for this baseline parameter (n=number of participants with this baseline measurement).|cells/mm^3|Median|1569|1569.0|Full Range|||516.0|2879.0|
4364780|NCT00364793|4191837|B1|||CD4 Cell Count (n=13, 9, 3, 7, 32)|A CD4 cell is an antigenic marker of helper/inducer T cells. These cells were counted during the hematology cell counts performed during a Complete Blood Cell count (CBC) performed by the Central Laboratory. CD4 are measured as number of cells per millimeter to the third power (cells/mm^3). Not all treated participants provided a measurement for this baseline parameter (n=number of participants with this baseline measurement).|cells/mm^3|Median|1785|1785.0|Full Range|||200.0|3584.0|
4364781|NCT00364793|4191833|B5|>750,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|20|20.0||||||
4364782|NCT00364793|4191834|B4|>750,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|2|2.0||||||
4364783|NCT00364793|4191835|B3|>750,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|3|3.0||||||
4364784|NCT00364793|4191836|B2|>750,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|6|6.0||||||
4364785|NCT00364793|4191837|B1|>750,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|9|9.0||||||
4364786|NCT00364793|4191833|B5|500,000 to <=750,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|3|3.0||||||
4364787|NCT00364793|4191834|B4|500,000 to <=750,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|1|1.0||||||
4364788|NCT00364793|4191835|B3|500,000 to <=750,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|0|0.0||||||
4364837|NCT00364793|4191834|B4|Panama||Region of Enrollment||participants|Number|1|1.0||||||
4364838|NCT00364793|4191835|B3|Panama||Region of Enrollment||participants|Number|0|0.0||||||
4364839|NCT00364793|4191836|B2|Panama||Region of Enrollment||participants|Number|0|0.0||||||
4364789|NCT00364793|4191836|B2|500,000 to <=750,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|1|1.0||||||
4364790|NCT00364793|4191837|B1|500,000 to <=750,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|1|1.0||||||
4364791|NCT00364793|4191833|B5|100,000 to <500,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|5|5.0||||||
4364792|NCT00364793|4191834|B4|100,000 to <500,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|2|2.0||||||
4364793|NCT00364793|4191835|B3|100,000 to <500,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|0|0.0||||||
4364794|NCT00364793|4191836|B2|100,000 to <500,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|1|1.0||||||
4364795|NCT00364793|4191837|B1|100,000 to <500,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|2|2.0||||||
4364796|NCT00364793|4191833|B5|30,000 to <100,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|4|4.0||||||
4364797|NCT00364793|4191834|B4|30,000 to <100,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|2|2.0||||||
4364798|NCT00364793|4191835|B3|30,000 to <100,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|1|1.0||||||
4364799|NCT00364793|4191836|B2|30,000 to <100,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|1|1.0||||||
4364800|NCT00364793|4191837|B1|30,000 to <100,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|0|0.0||||||
4364801|NCT00364793|4191833|B5|< 30,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|5|5.0||||||
4364840|NCT00364793|4191837|B1|Panama||Region of Enrollment||participants|Number|3|3.0||||||
4364926|NCT00364377|4192028|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4364802|NCT00364793|4191834|B4|< 30,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|1|1.0||||||
4364803|NCT00364793|4191835|B3|< 30,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|0|0.0||||||
4364804|NCT00364793|4191836|B2|< 30,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|1|1.0||||||
4364805|NCT00364793|4191837|B1|< 30,000 copies/mL||HIV RNA Viral Load Category|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values greater than, equal to (≥) 1,000 copies per milliliter (c/mL) were considered evidence of infection. Categories listed indicate the plasma viral load prior to study treatment (Baseline). HIV RNA was first measured using the ultrasensitive and standard Roche Amplicor PCR, version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|participants|Number|3|3.0||||||
4364806|NCT00364793|4191833|B5|||Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA) Viral Load (log10 c/mL)|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values ≥ 1,000 copies per milliliter (c/mL) were considered evidence of infection. HIV RNA measures the viral load and was first measured using the ultrasensitive and standard Roche Amplicor Polymerase Chain Reaction (PCR), version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|log10 c/mL|Median|5.88|5.88|Full Range|||2.12|6.74|
4364807|NCT00364793|4191834|B4|||Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA) Viral Load (log10 c/mL)|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values ≥ 1,000 copies per milliliter (c/mL) were considered evidence of infection. HIV RNA measures the viral load and was first measured using the ultrasensitive and standard Roche Amplicor Polymerase Chain Reaction (PCR), version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|log10 c/mL|Median|5.26|5.26|Full Range|||3.38|5.88|
4364808|NCT00364793|4191835|B3|||Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA) Viral Load (log10 c/mL)|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values ≥ 1,000 copies per milliliter (c/mL) were considered evidence of infection. HIV RNA measures the viral load and was first measured using the ultrasensitive and standard Roche Amplicor Polymerase Chain Reaction (PCR), version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|log10 c/mL|Median|5.88|5.88|Full Range|||4.88|5.88|
4364809|NCT00364793|4191836|B2|||Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA) Viral Load (log10 c/mL)|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values ≥ 1,000 copies per milliliter (c/mL) were considered evidence of infection. HIV RNA measures the viral load and was first measured using the ultrasensitive and standard Roche Amplicor Polymerase Chain Reaction (PCR), version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|log10 c/mL|Median|5.88|5.88|Full Range|||2.12|5.88|
4364810|NCT00364793|4191837|B1|||Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA) Viral Load (log10 c/mL)|Human immunodeficiency virus (HIV) ribonucleic acid (RNA) values ≥ 1,000 copies per milliliter (c/mL) were considered evidence of infection. HIV RNA measures the viral load and was first measured using the ultrasensitive and standard Roche Amplicor Polymerase Chain Reaction (PCR), version 1.5, and then the method of measurement was switched to the COBAS AmpliPrep/COBAS TaqMan HIV IVD method.|log10 c/mL|Median|5.88|5.88|Full Range|||3.34|6.74|
4364811|NCT00364793|4191833|B5|Colombia||Region of Enrollment||participants|Number|1|1.0||||||
4364812|NCT00364793|4191834|B4|Colombia||Region of Enrollment||participants|Number|0|0.0||||||
4364813|NCT00364793|4191835|B3|Colombia||Region of Enrollment||participants|Number|0|0.0||||||
4364814|NCT00364793|4191836|B2|Colombia||Region of Enrollment||participants|Number|0|0.0||||||
4364815|NCT00364793|4191837|B1|Colombia||Region of Enrollment||participants|Number|1|1.0||||||
4364816|NCT00364793|4191833|B5|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
4364817|NCT00364793|4191834|B4|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4364818|NCT00364793|4191835|B3|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4364819|NCT00364793|4191836|B2|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4364820|NCT00364793|4191837|B1|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
4364821|NCT00364793|4191833|B5|Thailand||Region of Enrollment||participants|Number|2|2.0||||||
4364822|NCT00364793|4191834|B4|Thailand||Region of Enrollment||participants|Number|0|0.0||||||
4364823|NCT00364793|4191835|B3|Thailand||Region of Enrollment||participants|Number|0|0.0||||||
4364824|NCT00364793|4191836|B2|Thailand||Region of Enrollment||participants|Number|0|0.0||||||
4364825|NCT00364793|4191837|B1|Thailand||Region of Enrollment||participants|Number|2|2.0||||||
4364826|NCT00364793|4191833|B5|Argentina||Region of Enrollment||participants|Number|4|4.0||||||
4364827|NCT00364793|4191834|B4|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4364828|NCT00364793|4191835|B3|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4364829|NCT00364793|4191836|B2|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4364830|NCT00364793|4191837|B1|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4364831|NCT00364793|4191833|B5|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
4364832|NCT00364793|4191834|B4|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4364841|NCT00364793|4191833|B5|Other||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|4|4.0||||||
4364842|NCT00364793|4191834|B4|Other||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|0|0.0||||||
4364843|NCT00364793|4191835|B3|Other||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|0|0.0||||||
4364844|NCT00364793|4191836|B2|Other||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|1|1.0||||||
4364845|NCT00364793|4191837|B1|Other||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|3|3.0||||||
4364846|NCT00364793|4191833|B5|Asian||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|2|2.0||||||
4364847|NCT00364793|4191834|B4|Asian||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|0|0.0||||||
4364848|NCT00364793|4191835|B3|Asian||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|0|0.0||||||
4364849|NCT00364793|4191836|B2|Asian||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|0|0.0||||||
4364850|NCT00364793|4191837|B1|Asian||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|2|2.0||||||
4364851|NCT00364793|4191833|B5|Black or African American||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|7|7.0||||||
4364852|NCT00364793|4191834|B4|Black or African American||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|0|0.0||||||
4364853|NCT00364793|4191835|B3|Black or African American||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|0|0.0||||||
4364854|NCT00364793|4191836|B2|Black or African American||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|0|0.0||||||
4364855|NCT00364793|4191837|B1|Black or African American||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|7|7.0||||||
4364856|NCT00364793|4191833|B5|White||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|24|24.0||||||
4364857|NCT00364793|4191834|B4|White||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|8|8.0||||||
4364858|NCT00364793|4191835|B3|White||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|4|4.0||||||
4364859|NCT00364793|4191836|B2|White||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|9|9.0||||||
4364860|NCT00364793|4191837|B1|White||Race/Ethnicity, Customized|Ethnicity was not collected because the study was conducted outside of the United States.|participants|Number|3|3.0||||||
4364861|NCT00364793|4191833|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4364862|NCT00364793|4191834|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4364863|NCT00364793|4191835|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4364864|NCT00364793|4191836|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4364865|NCT00364793|4191837|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4364866|NCT00364793|4191833|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4364867|NCT00364793|4191834|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4364868|NCT00364793|4191835|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4364869|NCT00364793|4191836|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364870|NCT00364793|4191837|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4364871|NCT00364793|4191833|B5|||Age||years|Median|0.663|0.663|Full Range|||0.296|6.976|
4364872|NCT00364793|4191834|B4|||Age||years|Median|3.922|3.922|Full Range|||2.998|6.976|
4364873|NCT00364793|4191835|B3|||Age||years|Median|2.313|2.313|Full Range|||2.094|2.995|
4364874|NCT00364793|4191836|B2|||Age||years|Median|0.825|0.825|Full Range|||0.586|1.906|
4364875|NCT00364793|4191837|B1|||Age||years|Median|0.392|0.392|Full Range|||0.296|0.501|
4364876|NCT00364611|4191974|B3|ECOG Performance Score is 1||Eastern Cooperative Oncology|"The ECOG performance status score is used to assess how a patient's disease is progressing and to assess how the disease affects the patient's daily living abilities. The ECOG score ranges from 0-5, with 0 indicating the best outcome and a score of 5 indicating the worst outcome. An ECOG score 0 reflects a fully active patient, able to carry on all pre-disease performance without restriction. An ECOG score 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|participants|Number|29|29.0||||||
4364877|NCT00364611|4191975|B2|ECOG Performance Score is 1||Eastern Cooperative Oncology|"The ECOG performance status score is used to assess how a patient's disease is progressing and to assess how the disease affects the patient's daily living abilities. The ECOG score ranges from 0-5, with 0 indicating the best outcome and a score of 5 indicating the worst outcome. An ECOG score 0 reflects a fully active patient, able to carry on all pre-disease performance without restriction. An ECOG score 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|participants|Number|5|5.0||||||
4364923|NCT00364377|4192028|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4364924|NCT00364377|4192026|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4364925|NCT00364377|4192027|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4364878|NCT00364611|4191976|B1|ECOG Performance Score is 1||Eastern Cooperative Oncology|"The ECOG performance status score is used to assess how a patient's disease is progressing and to assess how the disease affects the patient's daily living abilities. The ECOG score ranges from 0-5, with 0 indicating the best outcome and a score of 5 indicating the worst outcome. An ECOG score 0 reflects a fully active patient, able to carry on all pre-disease performance without restriction. An ECOG score 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|participants|Number|24|24.0||||||
4364879|NCT00364611|4191974|B3|ECOG Performance Score is 0||Eastern Cooperative Oncology|"The ECOG performance status score is used to assess how a patient's disease is progressing and to assess how the disease affects the patient's daily living abilities. The ECOG score ranges from 0-5, with 0 indicating the best outcome and a score of 5 indicating the worst outcome. An ECOG score 0 reflects a fully active patient, able to carry on all pre-disease performance without restriction. An ECOG score 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|participants|Number|44|44.0||||||
4364880|NCT00364611|4191975|B2|ECOG Performance Score is 0||Eastern Cooperative Oncology|"The ECOG performance status score is used to assess how a patient's disease is progressing and to assess how the disease affects the patient's daily living abilities. The ECOG score ranges from 0-5, with 0 indicating the best outcome and a score of 5 indicating the worst outcome. An ECOG score 0 reflects a fully active patient, able to carry on all pre-disease performance without restriction. An ECOG score 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|participants|Number|16|16.0||||||
4364881|NCT00364611|4191976|B1|ECOG Performance Score is 0||Eastern Cooperative Oncology|"The ECOG performance status score is used to assess how a patient's disease is progressing and to assess how the disease affects the patient's daily living abilities. The ECOG score ranges from 0-5, with 0 indicating the best outcome and a score of 5 indicating the worst outcome. An ECOG score 0 reflects a fully active patient, able to carry on all pre-disease performance without restriction. An ECOG score 1 reflects a participant restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature."|participants|Number|28|28.0||||||
4364882|NCT00364611|4191974|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364883|NCT00364611|4191975|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364884|NCT00364611|4191976|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364885|NCT00364611|4191974|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4364886|NCT00364611|4191975|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4364887|NCT00364611|4191976|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4364888|NCT00364611|4191974|B3|>=75 years||Age, Customized||participants|Number|4|4.0||||||
4364889|NCT00364611|4191975|B2|>=75 years||Age, Customized||participants|Number|1|1.0||||||
4364890|NCT00364611|4191976|B1|>=75 years||Age, Customized||participants|Number|3|3.0||||||
4364891|NCT00364611|4191974|B3|Between 65 and 75 years||Age, Customized||participants|Number|11|11.0||||||
4364892|NCT00364611|4191975|B2|Between 65 and 75 years||Age, Customized||participants|Number|3|3.0||||||
4364893|NCT00364611|4191976|B1|Between 65 and 75 years||Age, Customized||participants|Number|8|8.0||||||
4364894|NCT00364611|4191974|B3|<=65 years||Age, Customized||participants|Number|58|58.0||||||
4364895|NCT00364611|4191975|B2|<=65 years||Age, Customized||participants|Number|17|17.0||||||
4364896|NCT00364611|4191976|B1|<=65 years||Age, Customized||participants|Number|41|41.0||||||
4364897|NCT00364611|4191974|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|11.37|11.37|||
4364898|NCT00364611|4191975|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|12.65|12.65|||
4364899|NCT00364611|4191976|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|10.78|10.78|||
4364900|NCT00364533|4191995|B6||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4364901|NCT00364533|4191996|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4364902|NCT00364533|4191997|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4364903|NCT00364533|4191998|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4364904|NCT00364533|4191999|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4364905|NCT00364533|4192000|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4364906|NCT00364533|4191995|B6||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4364907|NCT00364533|4191996|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4364908|NCT00364533|4191997|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4364909|NCT00364533|4191998|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4364910|NCT00364533|4191999|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4364911|NCT00364533|4192000|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4364912|NCT00364533|4191995|B6|||Age||years|Mean|62.7|62.7|Standard Deviation|11.11|11.11|||
4364913|NCT00364533|4191996|B5|||Age||years|Mean|64.0|64.0|Standard Deviation|11.23|11.23|||
4364914|NCT00364533|4191997|B4|||Age||years|Mean|61.3|61.3|Standard Deviation|12.39|12.39|||
4364915|NCT00364533|4191998|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|10.3|10.3|||
4364916|NCT00364533|4191999|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|9.24|9.24|||
4364917|NCT00364533|4192000|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|12.20|12.2|||
4364918|NCT00364377|4192026|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4364919|NCT00364377|4192027|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4364920|NCT00364377|4192028|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4364921|NCT00364377|4192026|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4364922|NCT00364377|4192027|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4364927|NCT00364377|4192026|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|1.8|1.8|||
4364928|NCT00364377|4192027|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|2.4|2.4|||
4364929|NCT00364377|4192028|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|2.5|2.5|||
4364930|NCT00364351|4192035|B3||Male|Sex: Female, Male||Participants|Count of Participants|774|774.0||||||
4364931|NCT00364351|4192036|B2||Male|Sex: Female, Male||Participants|Count of Participants|393|393.0||||||
4364932|NCT00364351|4192037|B1||Male|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4364933|NCT00364351|4192035|B3||Female|Sex: Female, Male||Participants|Count of Participants|466|466.0||||||
4364934|NCT00364351|4192036|B2||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4364935|NCT00364351|4192037|B1||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4364936|NCT00364351|4192035|B3|||Age||years|Mean|60|60.0|Full Range|||26.0|92.0|
4364937|NCT00364351|4192036|B2|||Age||years|Mean|61|61.0|Full Range|||26.0|85.0|
4364938|NCT00364351|4192037|B1|||Age||years|Mean|60|60.0|Full Range|||26.0|92.0|
4364939|NCT00364286|4192056|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4364940|NCT00364286|4192056|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4364941|NCT00364286|4192056|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4364942|NCT00364286|4192056|B1|||Age||years|Median|67|67.0|Full Range|||42.0|83.0|
4364943|NCT00364182|4192060|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4364944|NCT00364182|4192061|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4364945|NCT00364182|4192062|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4364946|NCT00364182|4192063|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4364947|NCT00364182|4192060|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364948|NCT00364182|4192061|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364949|NCT00364182|4192062|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364950|NCT00364182|4192063|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4364951|NCT00364182|4192060|B4|||Age||years|Mean|27.7|27.7|Standard Deviation|13.9|13.9|||
4364952|NCT00364182|4192061|B3|||Age||years|Mean|25.1|25.1|Standard Deviation|14.4|14.4|||
4364953|NCT00364182|4192062|B2|||Age||years|Mean|31.7|31.7|Standard Deviation|13.4|13.4|||
4364954|NCT00364182|4192063|B1|||Age||years|Mean|19.3|19.3|Standard Deviation|4.5|4.5|||
4364955|NCT00364156|4192097|B3|United States||Region of Enrollment||participants|Number|568|568.0||||||
4364956|NCT00364156|4192098|B2|United States||Region of Enrollment||participants|Number|286|286.0||||||
4364957|NCT00364156|4192099|B1|United States||Region of Enrollment||participants|Number|282|282.0||||||
4364958|NCT00364156|4192097|B3||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4364959|NCT00364156|4192098|B2||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4364960|NCT00364156|4192099|B1||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4364961|NCT00364156|4192097|B3||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4364962|NCT00364156|4192098|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4364963|NCT00364156|4192099|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4364964|NCT00364156|4192097|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|10.3|10.3|||
4364965|NCT00364156|4192098|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|10.4|10.4|||
4364966|NCT00364156|4192099|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|10.2|10.2|||
4364967|NCT00364156|4192097|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4364968|NCT00364156|4192098|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364969|NCT00364156|4192099|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4364970|NCT00364156|4192097|B3||Between 18 and 65 years|Age||Participants|Count of Participants|567|567.0||||||
4364971|NCT00364156|4192098|B2||Between 18 and 65 years|Age||Participants|Count of Participants|286|286.0||||||
4364972|NCT00364156|4192099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|281|281.0||||||
4364973|NCT00364156|4192097|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364974|NCT00364156|4192098|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364975|NCT00364156|4192099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4364976|NCT00364130|4192106|B3|United States||Region of Enrollment||participants|Number|138|138.0||||||
4364977|NCT00364130|4192107|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
4364978|NCT00364130|4192108|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4364979|NCT00364130|4192106|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4364980|NCT00364130|4192107|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4364981|NCT00364130|4192108|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4364982|NCT00364130|4192106|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4364983|NCT00364130|4192107|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4364984|NCT00364130|4192108|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4364985|NCT00364130|4192106|B3|||Age||years|Mean|14.3134|14.3134|Standard Deviation|2.816848|2.816848|||
4364986|NCT00364130|4192107|B2|||Age||years|Mean|14.51452|14.51452|Standard Deviation|2.720447|2.720447|||
4364987|NCT00364130|4192108|B1|||Age||years|Mean|14.11475|14.11475|Standard Deviation|2.900821|2.900821|||
4364988|NCT00364130|4192106|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364989|NCT00364130|4192107|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364990|NCT00364130|4192108|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4364991|NCT00364130|4192106|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4364992|NCT00364130|4192107|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4364993|NCT00364130|4192108|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4364994|NCT00364130|4192106|B3||<=18 years|Age||Participants|Count of Participants|126|126.0||||||
4364995|NCT00364130|4192107|B2||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
4364996|NCT00364130|4192108|B1||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
4364997|NCT00364013|4192129|B3|Rectal cancer||Primary tumor type||participants|Number|391|391.0||||||
4364998|NCT00364013|4192130|B2|Rectal cancer||Primary tumor type||participants|Number|192|192.0||||||
4364999|NCT00364013|4192131|B1|Rectal cancer||Primary tumor type||participants|Number|199|199.0||||||
4365000|NCT00364013|4192129|B3|Colon cancer||Primary tumor type||participants|Number|792|792.0||||||
4365001|NCT00364013|4192130|B2|Colon cancer||Primary tumor type||participants|Number|398|398.0||||||
4365002|NCT00364013|4192131|B1|Colon cancer||Primary tumor type||participants|Number|394|394.0||||||
4365003|NCT00364013|4192129|B3|Mising/Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|2|2.0||||||
4365004|NCT00364013|4192130|B2|Mising/Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|2|2.0||||||
4365005|NCT00364013|4192131|B1|Mising/Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|0|0.0||||||
4365006|NCT00364013|4192129|B3|Grade 4||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|1|1.0||||||
4365007|NCT00364013|4192130|B2|Grade 4||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|1|1.0||||||
4365008|NCT00364013|4192131|B1|Grade 4||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|0|0.0||||||
4365009|NCT00364013|4192129|B3|Grade 3||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|0|0.0||||||
4365010|NCT00364013|4192130|B2|Grade 3||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|0|0.0||||||
4365011|NCT00364013|4192131|B1|Grade 3||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|0|0.0||||||
4365012|NCT00364013|4192129|B3|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|60|60.0||||||
4365013|NCT00364013|4192130|B2|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|29|29.0||||||
4365014|NCT00364013|4192131|B1|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|31|31.0||||||
4365015|NCT00364013|4192129|B3|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|468|468.0||||||
4365016|NCT00364013|4192130|B2|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|238|238.0||||||
4365017|NCT00364013|4192131|B1|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|230|230.0||||||
4365018|NCT00364013|4192129|B3|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|652|652.0||||||
4365019|NCT00364013|4192130|B2|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|320|320.0||||||
4365020|NCT00364013|4192131|B1|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|332|332.0||||||
4365021|NCT00364013|4192129|B3|Unevaluable KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|87|87.0||||||
4365022|NCT00364013|4192130|B2|Unevaluable KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|40|40.0||||||
4365023|NCT00364013|4192131|B1|Unevaluable KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|47|47.0||||||
4365024|NCT00364013|4192129|B3|Mutant KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|440|440.0||||||
4365025|NCT00364013|4192130|B2|Mutant KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|219|219.0||||||
4365026|NCT00364013|4192131|B1|Mutant KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|221|221.0||||||
4365027|NCT00364013|4192129|B3|Wild-type KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|656|656.0||||||
4365028|NCT00364013|4192130|B2|Wild-type KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|331|331.0||||||
4365029|NCT00364013|4192131|B1|Wild-type KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|325|325.0||||||
4365030|NCT00364013|4192129|B3|Rest of world||Geographic Region|Stratification factor. Rest of world includes South America, eastern Europe, South Africa and Mexico|participants|Number|522|522.0||||||
4365031|NCT00364013|4192130|B2|Rest of world||Geographic Region|Stratification factor. Rest of world includes South America, eastern Europe, South Africa and Mexico|participants|Number|261|261.0||||||
4365032|NCT00364013|4192131|B1|Rest of world||Geographic Region|Stratification factor. Rest of world includes South America, eastern Europe, South Africa and Mexico|participants|Number|261|261.0||||||
4365033|NCT00364013|4192129|B3|Western Europe, Canada and Australia||Geographic Region|Stratification factor. Rest of world includes South America, eastern Europe, South Africa and Mexico|participants|Number|661|661.0||||||
4365034|NCT00364013|4192130|B2|Western Europe, Canada and Australia||Geographic Region|Stratification factor. Rest of world includes South America, eastern Europe, South Africa and Mexico|participants|Number|329|329.0||||||
4365035|NCT00364013|4192131|B1|Western Europe, Canada and Australia||Geographic Region|Stratification factor. Rest of world includes South America, eastern Europe, South Africa and Mexico|participants|Number|332|332.0||||||
4365036|NCT00364013|4192129|B3|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4365037|NCT00364013|4192130|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4365038|NCT00364013|4192131|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4365039|NCT00364013|4192129|B3|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4365040|NCT00364013|4192130|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4365041|NCT00364013|4192131|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4365042|NCT00364013|4192129|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4365043|NCT00364013|4192130|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4365044|NCT00364013|4192131|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4365045|NCT00364013|4192129|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4365046|NCT00364013|4192130|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4365047|NCT00364013|4192131|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4365048|NCT00364013|4192129|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|1070|1070.0||||||
4365049|NCT00364013|4192130|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|540|540.0||||||
4365050|NCT00364013|4192131|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|530|530.0||||||
4365051|NCT00364013|4192129|B3||Male|Sex: Female, Male||Participants|Count of Participants|744|744.0||||||
4365052|NCT00364013|4192130|B2||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4365053|NCT00364013|4192131|B1||Male|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
4365054|NCT00364013|4192129|B3||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4365055|NCT00364013|4192130|B2||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4365056|NCT00364013|4192131|B1||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4365057|NCT00364013|4192129|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|10.6|10.6|||
4365058|NCT00364013|4192130|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|11.0|11.0|||
4365059|NCT00364013|4192131|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|10.1|10.1|||
4365060|NCT00363896|4192158|B3|Russian Federation||Region of Enrollment||participants|Number|205|205.0||||||
4365061|NCT00363896|4192159|B2|Russian Federation||Region of Enrollment||participants|Number|55|55.0||||||
4365062|NCT00363896|4192160|B1|Russian Federation||Region of Enrollment||participants|Number|150|150.0||||||
4365063|NCT00363896|4192158|B3|Romania||Region of Enrollment||participants|Number|50|50.0||||||
4365064|NCT00363896|4192159|B2|Romania||Region of Enrollment||participants|Number|13|13.0||||||
4365065|NCT00363896|4192160|B1|Romania||Region of Enrollment||participants|Number|37|37.0||||||
4365066|NCT00363896|4192158|B3|Poland||Region of Enrollment||participants|Number|86|86.0||||||
4365067|NCT00363896|4192159|B2|Poland||Region of Enrollment||participants|Number|22|22.0||||||
4365068|NCT00363896|4192160|B1|Poland||Region of Enrollment||participants|Number|64|64.0||||||
4365069|NCT00363896|4192158|B3|Netherlands||Region of Enrollment||participants|Number|23|23.0||||||
4365070|NCT00363896|4192159|B2|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4365071|NCT00363896|4192160|B1|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
4365072|NCT00363896|4192158|B3|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4365073|NCT00363896|4192159|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4365074|NCT00363896|4192160|B1|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4365075|NCT00363896|4192158|B3|Hungary||Region of Enrollment||participants|Number|54|54.0||||||
4365076|NCT00363896|4192159|B2|Hungary||Region of Enrollment||participants|Number|15|15.0||||||
4365077|NCT00363896|4192160|B1|Hungary||Region of Enrollment||participants|Number|39|39.0||||||
4365078|NCT00363896|4192158|B3|United Kingdom||Region of Enrollment||participants|Number|59|59.0||||||
4365079|NCT00363896|4192159|B2|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
4365080|NCT00363896|4192160|B1|United Kingdom||Region of Enrollment||participants|Number|46|46.0||||||
4365081|NCT00363896|4192158|B3|France||Region of Enrollment||participants|Number|50|50.0||||||
4365082|NCT00363896|4192159|B2|France||Region of Enrollment||participants|Number|14|14.0||||||
4365083|NCT00363896|4192160|B1|France||Region of Enrollment||participants|Number|36|36.0||||||
4365084|NCT00363896|4192158|B3|Spain||Region of Enrollment||participants|Number|41|41.0||||||
4365085|NCT00363896|4192159|B2|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4365086|NCT00363896|4192160|B1|Spain||Region of Enrollment||participants|Number|31|31.0||||||
4365087|NCT00363896|4192158|B3|Denmark||Region of Enrollment||participants|Number|12|12.0||||||
4365088|NCT00363896|4192159|B2|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4365089|NCT00363896|4192160|B1|Denmark||Region of Enrollment||participants|Number|9|9.0||||||
4365090|NCT00363896|4192158|B3|Germany||Region of Enrollment||participants|Number|74|74.0||||||
4365091|NCT00363896|4192159|B2|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4365092|NCT00363896|4192160|B1|Germany||Region of Enrollment||participants|Number|56|56.0||||||
4365093|NCT00363896|4192158|B3|Czech Republic||Region of Enrollment||participants|Number|58|58.0||||||
4365094|NCT00363896|4192159|B2|Czech Republic||Region of Enrollment||participants|Number|15|15.0||||||
4365095|NCT00363896|4192160|B1|Czech Republic||Region of Enrollment||participants|Number|43|43.0||||||
4365096|NCT00363896|4192158|B3|Bulgaria||Region of Enrollment||participants|Number|81|81.0||||||
4365097|NCT00363896|4192159|B2|Bulgaria||Region of Enrollment||participants|Number|20|20.0||||||
4365098|NCT00363896|4192160|B1|Bulgaria||Region of Enrollment||participants|Number|61|61.0||||||
4365099|NCT00363896|4192158|B3|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
4365100|NCT00363896|4192159|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4365101|NCT00363896|4192160|B1|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4365102|NCT00363896|4192158|B3|Austria||Region of Enrollment||participants|Number|18|18.0||||||
4365103|NCT00363896|4192159|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4365104|NCT00363896|4192160|B1|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4365105|NCT00363896|4192158|B3|Andorra||Region of Enrollment||participants|Number|4|4.0||||||
4365106|NCT00363896|4192159|B2|Andorra||Region of Enrollment||participants|Number|1|1.0||||||
4365107|NCT00363896|4192160|B1|Andorra||Region of Enrollment||participants|Number|3|3.0||||||
4365108|NCT00363896|4192158|B3||Male|Gender||Participants|Count of Participants|663|663.0||||||
4365109|NCT00363896|4192159|B2||Male|Gender||Participants|Count of Participants|175|175.0||||||
4365110|NCT00363896|4192160|B1||Male|Gender||Participants|Count of Participants|488|488.0||||||
4365111|NCT00363896|4192158|B3||Female|Gender||Participants|Count of Participants|180|180.0||||||
4365112|NCT00363896|4192159|B2||Female|Gender||Participants|Count of Participants|41|41.0||||||
4365113|NCT00363896|4192160|B1||Female|Gender||Participants|Count of Participants|139|139.0||||||
4365114|NCT00363896|4192158|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|8.2|8.2|||
4365115|NCT00363896|4192159|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|8.3|8.3|||
4365116|NCT00363896|4192160|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|8.2|8.2|||
4365117|NCT00363896|4192158|B3||>=65 years|Age||Participants|Count of Participants|331|331.0||||||
4365118|NCT00363896|4192159|B2||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4365119|NCT00363896|4192160|B1||>=65 years|Age||Participants|Count of Participants|249|249.0||||||
4365120|NCT00363896|4192158|B3||Between 18 and 65 years|Age||Participants|Count of Participants|512|512.0||||||
4365121|NCT00363896|4192159|B2||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
4365122|NCT00363896|4192160|B1||Between 18 and 65 years|Age||Participants|Count of Participants|378|378.0||||||
4365123|NCT00363896|4192158|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365124|NCT00363896|4192159|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365125|NCT00363896|4192160|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365126|NCT00363883|4192173|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4365127|NCT00363883|4192173|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4365128|NCT00363883|4192173|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4365129|NCT00363883|4192173|B1|||Age||years|Median|65|65.0|Full Range|||43.0|84.0|
4365130|NCT00363805|4192179|B4|United States||Region of Enrollment||participants|Number|178|178.0||||||
4365131|NCT00363805|4192180|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4365132|NCT00363805|4192181|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4365133|NCT00363805|4192182|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4365134|NCT00363805|4192179|B4||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4365135|NCT00363805|4192180|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4365136|NCT00363805|4192181|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4365137|NCT00363805|4192182|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4365138|NCT00363805|4192179|B4||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4365139|NCT00363805|4192180|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4365140|NCT00363805|4192181|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4365141|NCT00363805|4192182|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4365142|NCT00363805|4192179|B4|||Age||years|Mean|64.7|64.7|Standard Deviation|8.5|8.5|||
4365143|NCT00363805|4192180|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|7.8|7.8|||
4365144|NCT00363805|4192181|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|8.5|8.5|||
4365145|NCT00363805|4192182|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|9.2|9.2|||
4365146|NCT00363805|4192179|B4||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
4365147|NCT00363805|4192180|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4365148|NCT00363805|4192181|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4365149|NCT00363805|4192182|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4365150|NCT00363805|4192179|B4||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4365151|NCT00363805|4192180|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4365152|NCT00363805|4192181|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4365153|NCT00363805|4192182|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4365154|NCT00363805|4192179|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365155|NCT00363805|4192180|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365156|NCT00363805|4192181|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365157|NCT00363805|4192182|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365158|NCT00363779|4192195|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4365159|NCT00363779|4192195|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365160|NCT00363779|4192195|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365161|NCT00363779|4192195|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4365162|NCT00363779|4192195|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365163|NCT00363779|4192195|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365164|NCT00363779|4192195|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4365165|NCT00363779|4192195|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365166|NCT00363779|4192195|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365167|NCT00363779|4192195|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4365168|NCT00363779|4192195|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365169|NCT00363779|4192195|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4365170|NCT00363779|4192195|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4365171|NCT00363779|4192195|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|6.09|6.09|||
4365172|NCT00363779|4192195|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4365173|NCT00363779|4192195|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4365174|NCT00363779|4192195|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365175|NCT00363766|4192200|B3|Bronchoalveolar Carcinoma||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4365176|NCT00363766|4192201|B2|Bronchoalveolar Carcinoma||Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4365177|NCT00363766|4192202|B1|Bronchoalveolar Carcinoma||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4365178|NCT00363766|4192200|B3|Lung, Squamous Cell||Pathological Diagnosis||Participants|Count of Participants|18|18.0||||||
4365179|NCT00363766|4192201|B2|Lung, Squamous Cell||Pathological Diagnosis||Participants|Count of Participants|7|7.0||||||
4365180|NCT00363766|4192202|B1|Lung, Squamous Cell||Pathological Diagnosis||Participants|Count of Participants|11|11.0||||||
4365181|NCT00363766|4192200|B3|Lung, Adenocarcinoma||Pathological Diagnosis||Participants|Count of Participants|24|24.0||||||
4365182|NCT00363766|4192201|B2|Lung, Adenocarcinoma||Pathological Diagnosis||Participants|Count of Participants|12|12.0||||||
4365183|NCT00363766|4192202|B1|Lung, Adenocarcinoma||Pathological Diagnosis||Participants|Count of Participants|12|12.0||||||
4365184|NCT00363766|4192200|B3|Poorly Differentiated Non-Small-Cell Lung Cancer||Pathological Diagnosis||Participants|Count of Participants|7|7.0||||||
4365185|NCT00363766|4192201|B2|Poorly Differentiated Non-Small-Cell Lung Cancer||Pathological Diagnosis||Participants|Count of Participants|1|1.0||||||
4365186|NCT00363766|4192202|B1|Poorly Differentiated Non-Small-Cell Lung Cancer||Pathological Diagnosis||Participants|Count of Participants|6|6.0||||||
4365187|NCT00363766|4192200|B3|Lung, Large Cell||Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4365188|NCT00363766|4192201|B2|Lung, Large Cell||Pathological Diagnosis||Participants|Count of Participants|0|0.0||||||
4365189|NCT00363766|4192202|B1|Lung, Large Cell||Pathological Diagnosis||Participants|Count of Participants|2|2.0||||||
4365190|NCT00363766|4192200|B3|Italy||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4365191|NCT00363766|4192201|B2|Italy||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4365192|NCT00363766|4192202|B1|Italy||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4365193|NCT00363766|4192200|B3|Germany||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4365194|NCT00363766|4192201|B2|Germany||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4365195|NCT00363766|4192202|B1|Germany||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4365196|NCT00363766|4192200|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
4365197|NCT00363766|4192201|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4365198|NCT00363766|4192202|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4365199|NCT00363766|4192200|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4365200|NCT00363766|4192201|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4365201|NCT00363766|4192202|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4365202|NCT00363766|4192200|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4365203|NCT00363766|4192201|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4365204|NCT00363766|4192202|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4365205|NCT00363766|4192200|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|8.63|8.63|||
4365206|NCT00363766|4192201|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|7.90|7.9|||
4365207|NCT00363766|4192202|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|9.14|9.14|||
4365208|NCT00363675|4192223|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4365209|NCT00363675|4192223|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4365210|NCT00363675|4192223|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4365211|NCT00363675|4192223|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4365212|NCT00363675|4192223|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4365213|NCT00363675|4192223|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4365214|NCT00363649|4192230|B3|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4365215|NCT00363649|4192231|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4365216|NCT00363649|4192232|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4365217|NCT00363649|4192230|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4365218|NCT00363649|4192231|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4365219|NCT00363649|4192232|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4365220|NCT00363649|4192230|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365221|NCT00363649|4192231|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365222|NCT00363649|4192232|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365223|NCT00363649|4192230|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4365224|NCT00363649|4192231|B2||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4365225|NCT00363649|4192232|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4365226|NCT00363649|4192230|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4365227|NCT00363649|4192231|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4365228|NCT00363649|4192232|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4365229|NCT00363649|4192230|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365230|NCT00363649|4192231|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365231|NCT00363649|4192232|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365232|NCT00363649|4192230|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365233|NCT00363649|4192231|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365234|NCT00363649|4192232|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365235|NCT00363649|4192230|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365236|NCT00363649|4192231|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365237|NCT00363649|4192232|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365238|NCT00363649|4192230|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4365239|NCT00363649|4192231|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4365240|NCT00363649|4192232|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4365241|NCT00363649|4192230|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4365242|NCT00363649|4192231|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4365243|NCT00363649|4192232|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4365244|NCT00363649|4192230|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365245|NCT00363649|4192231|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365246|NCT00363649|4192232|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365247|NCT00363649|4192230|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4365248|NCT00363649|4192231|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4365249|NCT00363649|4192232|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4365250|NCT00363649|4192230|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4365251|NCT00363649|4192231|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4365252|NCT00363649|4192232|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4365253|NCT00363649|4192230|B3|||Age||years|Median|40.5|40.5|Full Range|||23.0|64.0|
4365254|NCT00363649|4192231|B2|||Age||years|Median|40|40.0|Full Range|||27.0|64.0|
4365255|NCT00363649|4192232|B1|||Age||years|Median|43|43.0|Full Range|||23.0|64.0|
4365256|NCT00363649|4192230|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4365257|NCT00363649|4192231|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4365258|NCT00363649|4192232|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4365259|NCT00363649|4192230|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4365260|NCT00363649|4192231|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4365261|NCT00363649|4192232|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4365262|NCT00363649|4192230|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365263|NCT00363649|4192231|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365264|NCT00363649|4192232|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365265|NCT00363545|4192247|B3||Male|Sex: Female, Male||Participants|Count of Participants|664|664.0||||||
4365266|NCT00363545|4192248|B2||Male|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4365267|NCT00363545|4192249|B1||Male|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4365268|NCT00363545|4192247|B3||Female|Sex: Female, Male||Participants|Count of Participants|610|610.0||||||
4365269|NCT00363545|4192248|B2||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4365270|NCT00363545|4192249|B1||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4365271|NCT00363545|4192247|B3|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|0.86|0.86|||
4365272|NCT00363545|4192248|B2|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|0.86|0.86|||
4365273|NCT00363545|4192249|B1|||Age||Weeks|Mean|8.6|8.6|Standard Deviation|0.87|0.87|||
4365274|NCT00363480|4192268|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4365275|NCT00363480|4192268|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4365276|NCT00363480|4192268|B1|||Age||Years|Mean|49.5|49.5|Standard Deviation|15.5|15.5|||
4365277|NCT00363467|4192288|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4365278|NCT00363467|4192288|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4365279|NCT00363467|4192288|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4365280|NCT00363467|4192288|B1|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4365281|NCT00363467|4192288|B1|Between 18 and 65 years||Age, Customized||participants|Number|2|2.0||||||
4365282|NCT00363467|4192288|B1|||Age||years|Mean|64|64.0|Standard Deviation|2.828427|2.828427|||
4365283|NCT00363415|4192296|B3|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4365284|NCT00363415|4192297|B2|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4365285|NCT00363415|4192298|B1|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4365286|NCT00363415|4192296|B3|Aboriginal and/or Torres Strait Islander||Race/Ethnicity||participants|Number|2|2.0||||||
4365287|NCT00363415|4192297|B2|Aboriginal and/or Torres Strait Islander||Race/Ethnicity||participants|Number|2|2.0||||||
4365288|NCT00363415|4192298|B1|Aboriginal and/or Torres Strait Islander||Race/Ethnicity||participants|Number|0|0.0||||||
4365289|NCT00363415|4192296|B3|Hispanic||Race/Ethnicity||participants|Number|6|6.0||||||
4365290|NCT00363415|4192297|B2|Hispanic||Race/Ethnicity||participants|Number|5|5.0||||||
4365291|NCT00363415|4192298|B1|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4365292|NCT00363415|4192296|B3|African||Race/Ethnicity||participants|Number|13|13.0||||||
4365293|NCT00363415|4192297|B2|African||Race/Ethnicity||participants|Number|8|8.0||||||
4365294|NCT00363415|4192298|B1|African||Race/Ethnicity||participants|Number|5|5.0||||||
4365295|NCT00363415|4192296|B3|West Asian||Race/Ethnicity||participants|Number|24|24.0||||||
4365296|NCT00363415|4192297|B2|West Asian||Race/Ethnicity||participants|Number|12|12.0||||||
4365297|NCT00363415|4192298|B1|West Asian||Race/Ethnicity||participants|Number|12|12.0||||||
4365298|NCT00363415|4192296|B3|East Asian||Race/Ethnicity||participants|Number|92|92.0||||||
4365299|NCT00363415|4192297|B2|East Asian||Race/Ethnicity||participants|Number|49|49.0||||||
4365300|NCT00363415|4192298|B1|East Asian||Race/Ethnicity||participants|Number|43|43.0||||||
4365301|NCT00363415|4192296|B3|Caucasian||Race/Ethnicity||participants|Number|770|770.0||||||
4365302|NCT00363415|4192297|B2|Caucasian||Race/Ethnicity||participants|Number|379|379.0||||||
4365303|NCT00363415|4192298|B1|Caucasian||Race/Ethnicity||participants|Number|391|391.0||||||
4365304|NCT00363415|4192296|B3|Not Reported||History of Brain Metastases||participants|Number|2|2.0||||||
4365305|NCT00363415|4192297|B2|Not Reported||History of Brain Metastases||participants|Number|2|2.0||||||
4365306|NCT00363415|4192298|B1|Not Reported||History of Brain Metastases||participants|Number|0|0.0||||||
4365307|NCT00363415|4192296|B3|Yes||History of Brain Metastases||participants|Number|84|84.0||||||
4365308|NCT00363415|4192297|B2|Yes||History of Brain Metastases||participants|Number|41|41.0||||||
4365309|NCT00363415|4192298|B1|Yes||History of Brain Metastases||participants|Number|43|43.0||||||
4365310|NCT00363415|4192296|B3|No||History of Brain Metastases||participants|Number|822|822.0||||||
4365311|NCT00363415|4192297|B2|No||History of Brain Metastases||participants|Number|412|412.0||||||
4365312|NCT00363415|4192298|B1|No||History of Brain Metastases||participants|Number|410|410.0||||||
4365313|NCT00363415|4192296|B3|Not Reported||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|2|2.0||||||
4365314|NCT00363415|4192297|B2|Not Reported||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|2|2.0||||||
4365315|NCT00363415|4192298|B1|Not Reported||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|0|0.0||||||
4365316|NCT00363415|4192296|B3|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|1|1.0||||||
4365317|NCT00363415|4192297|B2|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|0|0.0||||||
4365318|NCT00363415|4192298|B1|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|1|1.0||||||
4365319|NCT00363415|4192296|B3|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|109|109.0||||||
4365320|NCT00363415|4192297|B2|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|55|55.0||||||
4365321|NCT00363415|4192298|B1|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|54|54.0||||||
4365322|NCT00363415|4192296|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|542|542.0||||||
4365323|NCT00363415|4192297|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|277|277.0||||||
4365324|NCT00363415|4192298|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|265|265.0||||||
4365325|NCT00363415|4192296|B3|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|254|254.0||||||
4365326|NCT00363415|4192297|B2|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|121|121.0||||||
4365327|NCT00363415|4192298|B1|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|133|133.0||||||
4365328|NCT00363415|4192296|B3|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4365329|NCT00363415|4192297|B2|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4365330|NCT00363415|4192298|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4365331|NCT00363415|4192296|B3|Germany||Region of Enrollment||participants|Number|117|117.0||||||
4365332|NCT00363415|4192297|B2|Germany||Region of Enrollment||participants|Number|59|59.0||||||
4365333|NCT00363415|4192298|B1|Germany||Region of Enrollment||participants|Number|58|58.0||||||
4365334|NCT00363415|4192296|B3|Romania||Region of Enrollment||participants|Number|43|43.0||||||
4365335|NCT00363415|4192297|B2|Romania||Region of Enrollment||participants|Number|23|23.0||||||
4365336|NCT00363415|4192298|B1|Romania||Region of Enrollment||participants|Number|20|20.0||||||
4365337|NCT00363415|4192296|B3|Poland||Region of Enrollment||participants|Number|63|63.0||||||
4365338|NCT00363415|4192297|B2|Poland||Region of Enrollment||participants|Number|34|34.0||||||
4365339|NCT00363415|4192298|B1|Poland||Region of Enrollment||participants|Number|29|29.0||||||
4365340|NCT00363415|4192296|B3|Brazil||Region of Enrollment||participants|Number|11|11.0||||||
4365341|NCT00363415|4192297|B2|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4365342|NCT00363415|4192298|B1|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4365343|NCT00363415|4192296|B3|Belgium||Region of Enrollment||participants|Number|29|29.0||||||
4365344|NCT00363415|4192297|B2|Belgium||Region of Enrollment||participants|Number|17|17.0||||||
4365345|NCT00363415|4192298|B1|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4365346|NCT00363415|4192296|B3|Argentina||Region of Enrollment||participants|Number|8|8.0||||||
4365347|NCT00363415|4192297|B2|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
4365348|NCT00363415|4192298|B1|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4365349|NCT00363415|4192296|B3|Hungary||Region of Enrollment||participants|Number|32|32.0||||||
4365350|NCT00363415|4192297|B2|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
4365351|NCT00363415|4192298|B1|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
4365352|NCT00363415|4192296|B3|United Kingdom||Region of Enrollment||participants|Number|34|34.0||||||
4365353|NCT00363415|4192297|B2|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4365354|NCT00363415|4192298|B1|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
4365355|NCT00363415|4192296|B3|Austria||Region of Enrollment||participants|Number|19|19.0||||||
4365356|NCT00363415|4192297|B2|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4365357|NCT00363415|4192298|B1|Austria||Region of Enrollment||participants|Number|5|5.0||||||
4365358|NCT00363415|4192296|B3|Turkey||Region of Enrollment||participants|Number|28|28.0||||||
4365359|NCT00363415|4192297|B2|Turkey||Region of Enrollment||participants|Number|13|13.0||||||
4365360|NCT00363415|4192298|B1|Turkey||Region of Enrollment||participants|Number|15|15.0||||||
4365361|NCT00363415|4192296|B3|Korea, Republic of||Region of Enrollment||participants|Number|32|32.0||||||
4365362|NCT00363415|4192297|B2|Korea, Republic of||Region of Enrollment||participants|Number|15|15.0||||||
4365363|NCT00363415|4192298|B1|Korea, Republic of||Region of Enrollment||participants|Number|17|17.0||||||
4365364|NCT00363415|4192296|B3|China||Region of Enrollment||participants|Number|32|32.0||||||
4365365|NCT00363415|4192297|B2|China||Region of Enrollment||participants|Number|18|18.0||||||
4365366|NCT00363415|4192298|B1|China||Region of Enrollment||participants|Number|14|14.0||||||
4365367|NCT00363415|4192296|B3|Netherlands||Region of Enrollment||participants|Number|34|34.0||||||
4365368|NCT00363415|4192297|B2|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
4365369|NCT00363415|4192298|B1|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
4365370|NCT00363415|4192296|B3|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4365371|NCT00363415|4192297|B2|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4365372|NCT00363415|4192298|B1|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4365373|NCT00363415|4192296|B3|Australia||Region of Enrollment||participants|Number|40|40.0||||||
4365374|NCT00363415|4192297|B2|Australia||Region of Enrollment||participants|Number|19|19.0||||||
4365375|NCT00363415|4192298|B1|Australia||Region of Enrollment||participants|Number|21|21.0||||||
4365376|NCT00363415|4192296|B3|France||Region of Enrollment||participants|Number|29|29.0||||||
4365377|NCT00363415|4192297|B2|France||Region of Enrollment||participants|Number|10|10.0||||||
4365378|NCT00363415|4192298|B1|France||Region of Enrollment||participants|Number|19|19.0||||||
4365379|NCT00363415|4192296|B3|India||Region of Enrollment||participants|Number|26|26.0||||||
4365380|NCT00363415|4192297|B2|India||Region of Enrollment||participants|Number|14|14.0||||||
4365381|NCT00363415|4192298|B1|India||Region of Enrollment||participants|Number|12|12.0||||||
4365382|NCT00363415|4192296|B3|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4365383|NCT00363415|4192297|B2|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4365384|NCT00363415|4192298|B1|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4365385|NCT00363415|4192296|B3|Russian Federation||Region of Enrollment||participants|Number|46|46.0||||||
4365386|NCT00363415|4192297|B2|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
4365387|NCT00363415|4192298|B1|Russian Federation||Region of Enrollment||participants|Number|30|30.0||||||
4365388|NCT00363415|4192296|B3|Spain||Region of Enrollment||participants|Number|37|37.0||||||
4365389|NCT00363415|4192297|B2|Spain||Region of Enrollment||participants|Number|21|21.0||||||
4365390|NCT00363415|4192298|B1|Spain||Region of Enrollment||participants|Number|16|16.0||||||
4365391|NCT00363415|4192296|B3|Greece||Region of Enrollment||participants|Number|15|15.0||||||
4365392|NCT00363415|4192297|B2|Greece||Region of Enrollment||participants|Number|8|8.0||||||
4365393|NCT00363415|4192298|B1|Greece||Region of Enrollment||participants|Number|7|7.0||||||
4365394|NCT00363415|4192296|B3|Taiwan||Region of Enrollment||participants|Number|23|23.0||||||
4365395|NCT00363415|4192297|B2|Taiwan||Region of Enrollment||participants|Number|12|12.0||||||
4365396|NCT00363415|4192298|B1|Taiwan||Region of Enrollment||participants|Number|11|11.0||||||
4365397|NCT00363415|4192296|B3|Portugal||Region of Enrollment||participants|Number|16|16.0||||||
4365398|NCT00363415|4192297|B2|Portugal||Region of Enrollment||participants|Number|7|7.0||||||
4365399|NCT00363415|4192298|B1|Portugal||Region of Enrollment||participants|Number|9|9.0||||||
4365400|NCT00363415|4192296|B3|United States||Region of Enrollment||participants|Number|175|175.0||||||
4365401|NCT00363415|4192297|B2|United States||Region of Enrollment||participants|Number|83|83.0||||||
4365402|NCT00363415|4192298|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4365403|NCT00363415|4192296|B3||Male|Sex: Female, Male||Participants|Count of Participants|655|655.0||||||
4365404|NCT00363415|4192297|B2||Male|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
4365405|NCT00363415|4192298|B1||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4365406|NCT00363415|4192296|B3||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4365407|NCT00363415|4192297|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4365408|NCT00363415|4192298|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4365409|NCT00363415|4192296|B3|>65 years||Age, Customized||participants|Number|366|366.0||||||
4365410|NCT00363415|4192297|B2|>65 years||Age, Customized||participants|Number|180|180.0||||||
4365411|NCT00363415|4192298|B1|>65 years||Age, Customized||participants|Number|186|186.0||||||
4365412|NCT00363415|4192296|B3|<=65 years||Age, Customized||participants|Number|542|542.0||||||
4365413|NCT00363415|4192297|B2|<=65 years||Age, Customized||participants|Number|275|275.0||||||
4365414|NCT00363415|4192298|B1|<=65 years||Age, Customized||participants|Number|267|267.0||||||
4365415|NCT00363311|4192315|B3|White and American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365416|NCT00363311|4192316|B2|White and American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365417|NCT00363311|4192317|B1|White and American Indian/Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365418|NCT00363311|4192315|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4365419|NCT00363311|4192316|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365420|NCT00363311|4192317|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365421|NCT00363311|4192315|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365422|NCT00363311|4192316|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365423|NCT00363311|4192317|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365424|NCT00363311|4192315|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4365425|NCT00363311|4192316|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4365426|NCT00363311|4192317|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365427|NCT00363311|4192315|B3|African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4365428|NCT00363311|4192316|B2|African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4365429|NCT00363311|4192317|B1|African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4365430|NCT00363311|4192315|B3|White||Race/Ethnicity, Customized||participants|Number|273|273.0||||||
4365431|NCT00363311|4192316|B2|White||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4365432|NCT00363311|4192317|B1|White||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
4365433|NCT00363311|4192315|B3||Male|Gender||Participants|Count of Participants|302|302.0||||||
4365434|NCT00363311|4192316|B2||Male|Gender||Participants|Count of Participants|147|147.0||||||
4365435|NCT00363311|4192317|B1||Male|Gender||Participants|Count of Participants|155|155.0||||||
4365436|NCT00363311|4192315|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4365437|NCT00363311|4192316|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4365438|NCT00363311|4192317|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4365439|NCT00363311|4192315|B3|||Age||Years|Mean|65.0|65.0|Standard Deviation|7.34|7.34|||
4365440|NCT00363311|4192316|B2|||Age||Years|Mean|65.1|65.1|Standard Deviation|7.13|7.13|||
4365441|NCT00363311|4192317|B1|||Age||Years|Mean|65.0|65.0|Standard Deviation|7.56|7.56|||
4365442|NCT00363298|4192382|B3|||Atypical antipsychotic drug augmentation trials||trials|Mean|2.5|2.5|Standard Deviation|NA||||Standard deviation was not calculated and the raw data is no longer available.
4365443|NCT00363298|4192383|B2|||Atypical antipsychotic drug augmentation trials||trials|Mean|2.5|2.5|Standard Deviation|NA||||Standard deviation was not calculated and the raw data is no longer available.
4365444|NCT00363298|4192384|B1|||Atypical antipsychotic drug augmentation trials||trials|Mean|2.4|2.4|Standard Deviation|NA||||Standard deviation was not calculated and the raw data is no longer available.
4365445|NCT00363298|4192382|B3|||Prior Selective Serotonin Reuptake or Serotonin Norepinephrine Reuptake Inhibitor trials||trials|Mean|3.4|3.4|Standard Deviation|NA||||Standard deviation was not calculated and the raw data are no longer available.
4365446|NCT00363298|4192383|B2|||Prior Selective Serotonin Reuptake or Serotonin Norepinephrine Reuptake Inhibitor trials||trials|Mean|3.7|3.7|Standard Deviation|NA||||Standard deviation was not calculated and the raw data are no longer available.
4365447|NCT00363298|4192384|B1|||Prior Selective Serotonin Reuptake or Serotonin Norepinephrine Reuptake Inhibitor trials||trials|Mean|3.0|3.0|Standard Deviation|NA||||Standard deviation was not calculated and the raw data are no longer available
4365448|NCT00363298|4192382|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4365449|NCT00363298|4192383|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4365450|NCT00363298|4192384|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4365451|NCT00363298|4192382|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4365452|NCT00363298|4192383|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4365453|NCT00363298|4192384|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4365454|NCT00363298|4192382|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4365455|NCT00363298|4192383|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4365456|NCT00363298|4192384|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4365457|NCT00363298|4192382|B3|Baseline Age||Age|Mean Age, and standard deviation, in years|years|Mean|40.05|40.05|Standard Deviation|13.25|13.25|||
4365458|NCT00363298|4192383|B2|Baseline Age||Age|Mean Age, and standard deviation, in years|years|Mean|37.8|37.8|Standard Deviation|13.7|13.7|||
4365459|NCT00363298|4192384|B1|Baseline Age||Age|Mean Age, and standard deviation, in years|years|Mean|42.3|42.3|Standard Deviation|12.8|12.8|||
4365460|NCT00363246|4192393|B1|||Energy levels|Scale range 4.0-20. Highest energy level = 20.0.|units on a scale|Mean|11.9|11.9|Standard Deviation|4.5|4.5|||
4365461|NCT00363246|4192393|B1|Insufficient data to analyze||Pain when transfer||participants|Number|56|56.0||||||
4365462|NCT00363246|4192393|B1|Missing||Pain when transfer||participants|Number|2|2.0||||||
4365463|NCT00363246|4192393|B1|Severe||Pain when transfer||participants|Number|213|213.0||||||
4365464|NCT00363246|4192393|B1|Moderate||Pain when transfer||participants|Number|180|180.0||||||
4365465|NCT00363246|4192393|B1|Mild||Pain when transfer||participants|Number|315|315.0||||||
4365466|NCT00363246|4192393|B1|Insufficient data to analyze||Pain in last 4 weeks (interference with daily activities)|Pain in last 4 weeks and its interference with daily activities|participants|Number|56|56.0||||||
4365467|NCT00363246|4192393|B1|Missing||Pain in last 4 weeks (interference with daily activities)|Pain in last 4 weeks and its interference with daily activities|participants|Number|1|1.0||||||
4365468|NCT00363246|4192393|B1|Moderate/Severe||Pain in last 4 weeks (interference with daily activities)|Pain in last 4 weeks and its interference with daily activities|participants|Number|499|499.0||||||
4365469|NCT00363246|4192393|B1|None/Mild||Pain in last 4 weeks (interference with daily activities)|Pain in last 4 weeks and its interference with daily activities|participants|Number|210|210.0||||||
4365470|NCT00363246|4192393|B1|Insufficient data to analyze||Health|Participants were asked to characterize their health: Excellent, Very good, good, fair, poor.|participants|Number|56|56.0||||||
4365471|NCT00363246|4192393|B1|Fair/Poor||Health|Participants were asked to characterize their health: Excellent, Very good, good, fair, poor.|participants|Number|427|427.0||||||
4365472|NCT00363246|4192393|B1|Excellent/Very Good/Good||Health|Participants were asked to characterize their health: Excellent, Very good, good, fair, poor.|participants|Number|283|283.0||||||
4365473|NCT00363246|4192393|B1|United States||Region of Enrollment||participants|Number|766|766.0||||||
4365474|NCT00363246|4192393|B1|Unknown or Not Reported||Race/Ethnicity, Customized|The data below was subject self-report on baseline survey: “What category best represents your race/ethnicity? (check one) White, Black/African American, Hispanic, etc.” Therefore, the racial and ethnic categories must be summed and the totals of racial and ethnic categories will not be equal.|participants|Number|2|2.0||||||
4365475|NCT00363246|4192393|B1|White||Race/Ethnicity, Customized|The data below was subject self-report on baseline survey: “What category best represents your race/ethnicity? (check one) White, Black/African American, Hispanic, etc.” Therefore, the racial and ethnic categories must be summed and the totals of racial and ethnic categories will not be equal.|participants|Number|492|492.0||||||
4365476|NCT00363246|4192393|B1|Black or African American||Race/Ethnicity, Customized|The data below was subject self-report on baseline survey: “What category best represents your race/ethnicity? (check one) White, Black/African American, Hispanic, etc.” Therefore, the racial and ethnic categories must be summed and the totals of racial and ethnic categories will not be equal.|participants|Number|40|40.0||||||
4365477|NCT00363246|4192393|B1|American Indian||Race/Ethnicity, Customized|The data below was subject self-report on baseline survey: “What category best represents your race/ethnicity? (check one) White, Black/African American, Hispanic, etc.” Therefore, the racial and ethnic categories must be summed and the totals of racial and ethnic categories will not be equal.|participants|Number|1|1.0||||||
4365478|NCT00363246|4192393|B1|Hispanic||Race/Ethnicity, Customized|The data below was subject self-report on baseline survey: “What category best represents your race/ethnicity? (check one) White, Black/African American, Hispanic, etc.” Therefore, the racial and ethnic categories must be summed and the totals of racial and ethnic categories will not be equal.|participants|Number|231|231.0||||||
4365479|NCT00363246|4192393|B1||Male|Sex: Female, Male||Participants|Count of Participants|738|738.0||||||
4365480|NCT00363246|4192393|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4365481|NCT00363246|4192393|B1||>=65 years|Age||Participants|Count of Participants|674|674.0||||||
4365482|NCT00363246|4192393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4365483|NCT00363246|4192393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365484|NCT00363168|4192398|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4365485|NCT00363168|4192399|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4365486|NCT00363168|4192400|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4365487|NCT00363168|4192398|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4365488|NCT00363168|4192399|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4365489|NCT00363168|4192400|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4365490|NCT00363168|4192398|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4365491|NCT00363168|4192399|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4365492|NCT00363168|4192400|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4365493|NCT00363168|4192398|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4365494|NCT00363168|4192399|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4365495|NCT00363168|4192400|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4365496|NCT00363168|4192398|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4365497|NCT00363168|4192399|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4365498|NCT00363168|4192400|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4365499|NCT00363168|4192398|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365500|NCT00363168|4192399|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365501|NCT00363168|4192400|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365502|NCT00363142|4192409|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365503|NCT00363142|4192410|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365504|NCT00363142|4192411|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365505|NCT00363142|4192409|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4365506|NCT00363142|4192410|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4365507|NCT00363142|4192411|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4365508|NCT00363142|4192409|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4365509|NCT00363142|4192410|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4365510|NCT00363142|4192411|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4365511|NCT00363142|4192409|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365512|NCT00363142|4192410|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365513|NCT00363142|4192411|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365514|NCT00363142|4192409|B3|Mixed race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365515|NCT00363142|4192410|B2|Mixed race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365516|NCT00363142|4192411|B1|Mixed race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365517|NCT00363142|4192409|B3|White - White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
4365518|NCT00363142|4192410|B2|White - White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4365519|NCT00363142|4192411|B1|White - White/Caucasian/European||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4365520|NCT00363142|4192409|B3|White - Arabic/North African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4365521|NCT00363142|4192410|B2|White - Arabic/North African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4365522|NCT00363142|4192411|B1|White - Arabic/North African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365523|NCT00363142|4192409|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365524|NCT00363142|4192410|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365525|NCT00363142|4192411|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365526|NCT00363142|4192409|B3|Asian - South East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4365527|NCT00363142|4192410|B2|Asian - South East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4365528|NCT00363142|4192411|B1|Asian - South East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365529|NCT00363142|4192409|B3|American Indian/Alaskan native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365530|NCT00363142|4192410|B2|American Indian/Alaskan native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365531|NCT00363142|4192411|B1|American Indian/Alaskan native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365532|NCT00363142|4192409|B3|African American/African heritage||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4365533|NCT00363142|4192410|B2|African American/African heritage||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4365534|NCT00363142|4192411|B1|African American/African heritage||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4365535|NCT00363142|4192409|B3||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4365536|NCT00363142|4192410|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4365537|NCT00363142|4192411|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4365538|NCT00363142|4192409|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4365539|NCT00363142|4192410|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4365540|NCT00363142|4192411|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4365541|NCT00363142|4192409|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|10.00|10.0|||
4365542|NCT00363142|4192410|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|8.9|8.9|||
4365543|NCT00363142|4192411|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|10.52|10.52|||
4365544|NCT00363129|4192439|B3|Combination||Type of chemotherapy||participants|Number|20|20.0||||||
4365545|NCT00363129|4192440|B2|Combination||Type of chemotherapy||participants|Number|10|10.0||||||
4365546|NCT00363129|4192441|B1|Combination||Type of chemotherapy||participants|Number|10|10.0||||||
4365547|NCT00363129|4192439|B3|Oxaliplatin||Type of chemotherapy||participants|Number|50|50.0||||||
4365548|NCT00363129|4192440|B2|Oxaliplatin||Type of chemotherapy||participants|Number|26|26.0||||||
4365549|NCT00363129|4192441|B1|Oxaliplatin||Type of chemotherapy||participants|Number|24|24.0||||||
4365550|NCT00363129|4192439|B3|Carboplatin||Type of chemotherapy||participants|Number|2|2.0||||||
4365551|NCT00363129|4192440|B2|Carboplatin||Type of chemotherapy||participants|Number|1|1.0||||||
4365552|NCT00363129|4192441|B1|Carboplatin||Type of chemotherapy||participants|Number|1|1.0||||||
4365553|NCT00363129|4192439|B3|Cisplatin||Type of chemotherapy||participants|Number|8|8.0||||||
4365554|NCT00363129|4192440|B2|Cisplatin||Type of chemotherapy||participants|Number|4|4.0||||||
4365555|NCT00363129|4192441|B1|Cisplatin||Type of chemotherapy||participants|Number|4|4.0||||||
4365556|NCT00363129|4192439|B3|Taxane||Type of chemotherapy||participants|Number|109|109.0||||||
4365557|NCT00363129|4192440|B2|Taxane||Type of chemotherapy||participants|Number|52|52.0||||||
4365558|NCT00363129|4192441|B1|Taxane||Type of chemotherapy||participants|Number|57|57.0||||||
4365559|NCT00363129|4192439|B3|>4||Planned number of chemotherapy cycles||participants|Number|92|92.0||||||
4365560|NCT00363129|4192440|B2|>4||Planned number of chemotherapy cycles||participants|Number|44|44.0||||||
4365561|NCT00363129|4192441|B1|>4||Planned number of chemotherapy cycles||participants|Number|48|48.0||||||
4365562|NCT00363129|4192439|B3|<=4||Planned number of chemotherapy cycles||participants|Number|97|97.0||||||
4365563|NCT00363129|4192440|B2|<=4||Planned number of chemotherapy cycles||participants|Number|49|49.0||||||
4365564|NCT00363129|4192441|B1|<=4||Planned number of chemotherapy cycles||participants|Number|48|48.0||||||
4365565|NCT00363129|4192439|B3|Other Cancer||Type of cancer||participants|Number|69|69.0||||||
4365566|NCT00363129|4192440|B2|Other Cancer||Type of cancer||participants|Number|32|32.0||||||
4365567|NCT00363129|4192441|B1|Other Cancer||Type of cancer||participants|Number|37|37.0||||||
4365568|NCT00363129|4192439|B3|Lung||Type of cancer||participants|Number|5|5.0||||||
4365569|NCT00363129|4192440|B2|Lung||Type of cancer||participants|Number|4|4.0||||||
4365570|NCT00363129|4192441|B1|Lung||Type of cancer||participants|Number|1|1.0||||||
4365571|NCT00363129|4192439|B3|Breast||Type of cancer||participants|Number|115|115.0||||||
4365572|NCT00363129|4192440|B2|Breast||Type of cancer||participants|Number|57|57.0||||||
4365573|NCT00363129|4192441|B1|Breast||Type of cancer||participants|Number|58|58.0||||||
4365574|NCT00363129|4192439|B3|United States||Region of Enrollment||participants|Number|189|189.0||||||
4365575|NCT00363129|4192440|B2|United States||Region of Enrollment||participants|Number|93|93.0||||||
4365576|NCT00363129|4192441|B1|United States||Region of Enrollment||participants|Number|96|96.0||||||
4365577|NCT00363129|4192439|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4365578|NCT00363129|4192440|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4365579|NCT00363129|4192441|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4365580|NCT00363129|4192439|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365581|NCT00363129|4192440|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365582|NCT00363129|4192441|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365583|NCT00363129|4192439|B3||White|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4365584|NCT00363129|4192440|B2||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4365585|NCT00363129|4192441|B1||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4365586|NCT00363129|4192439|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4365587|NCT00363129|4192440|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4365588|NCT00363129|4192441|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4365589|NCT00363129|4192439|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365590|NCT00363129|4192440|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365591|NCT00363129|4192441|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365592|NCT00363129|4192439|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4365593|NCT00363129|4192440|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365594|NCT00363129|4192441|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4365595|NCT00363129|4192439|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365596|NCT00363129|4192440|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365597|NCT00363129|4192441|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365598|NCT00363129|4192439|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4365599|NCT00363129|4192440|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4365600|NCT00363129|4192441|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4365601|NCT00363129|4192439|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4365602|NCT00363129|4192440|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4365603|NCT00363129|4192441|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4365604|NCT00363129|4192439|B3|>50 years||Age, Customized||participants|Number|115|115.0||||||
4365605|NCT00363129|4192440|B2|>50 years||Age, Customized||participants|Number|59|59.0||||||
4365606|NCT00363129|4192441|B1|>50 years||Age, Customized||participants|Number|56|56.0||||||
4365607|NCT00363129|4192439|B3|<=50 years||Age, Customized||participants|Number|74|74.0||||||
4365608|NCT00363129|4192440|B2|<=50 years||Age, Customized||participants|Number|34|34.0||||||
4365609|NCT00363129|4192441|B1|<=50 years||Age, Customized||participants|Number|40|40.0||||||
4365610|NCT00363077|4192456|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4365611|NCT00363077|4192457|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4365612|NCT00363077|4192458|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4365613|NCT00363077|4192456|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4365614|NCT00363077|4192457|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4365615|NCT00363077|4192458|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4365616|NCT00363077|4192456|B3|||Age||Years|Mean|64.4|64.4|Standard Deviation|4.20|4.2|||
4365617|NCT00363077|4192457|B2|||Age||Years|Mean|64.5|64.5|Standard Deviation|4.18|4.18|||
4365618|NCT00363077|4192458|B1|||Age||Years|Mean|64.4|64.4|Standard Deviation|4.22|4.22|||
4365619|NCT00363051|4192483|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4365620|NCT00363051|4192484|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4365621|NCT00363051|4192485|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4365622|NCT00363051|4192483|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4365623|NCT00363051|4192484|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4365624|NCT00363051|4192485|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4365625|NCT00363051|4192483|B3|||Age||years|Mean|54.33|54.33|Standard Deviation|11.98|11.98|||
4365626|NCT00363051|4192484|B2|||Age||years|Mean|53.64|53.64|Standard Deviation|12.478|12.478|||
4365627|NCT00363051|4192485|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|11.8|11.8|||
4365628|NCT00363038|4192503|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4365629|NCT00363038|4192503|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4365630|NCT00363038|4192503|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4365631|NCT00363038|4192503|B1|||Age||years|Mean|26|26.0|Full Range|||21.0|65.0|
4365632|NCT00362882|4192507|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4365633|NCT00362882|4192508|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4365634|NCT00362882|4192509|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4365635|NCT00362882|4192507|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365636|NCT00362882|4192508|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365637|NCT00362882|4192509|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365638|NCT00362882|4192507|B3|African Americian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4365639|NCT00362882|4192508|B2|African Americian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365640|NCT00362882|4192509|B1|African Americian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4365641|NCT00362882|4192507|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4365642|NCT00362882|4192508|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4365643|NCT00362882|4192509|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4365644|NCT00362882|4192507|B3|Caucasion||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4365645|NCT00362882|4192508|B2|Caucasion||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4365646|NCT00362882|4192509|B1|Caucasion||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4365647|NCT00362882|4192507|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4365648|NCT00362882|4192508|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4365649|NCT00362882|4192509|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4365650|NCT00362882|4192507|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4365651|NCT00362882|4192508|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4365652|NCT00362882|4192509|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4365653|NCT00362882|4192507|B3|||Age||years|Median|61|61.0|Full Range|||32.0|82.0|
4365654|NCT00362882|4192508|B2|||Age||years|Median|61|61.0|Full Range|||32.0|82.0|
4365655|NCT00362882|4192509|B1|||Age||years|Median|61|61.0|Full Range|||45.0|79.0|
4365656|NCT00362817|4192522|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4365657|NCT00362817|4192522|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4365658|NCT00362817|4192522|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4365659|NCT00362817|4192522|B1|||Age||years|Mean|52|52.0|Full Range|||34.0|66.0|
4365660|NCT00362648|4192531|B5|Multi-Racial||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4365661|NCT00362648|4192532|B4|Multi-Racial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4365662|NCT00362648|4192533|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365663|NCT00362648|4192534|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365664|NCT00362648|4192535|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365665|NCT00362648|4192531|B5|Asian||Race/Ethnicity, Customized||participants|Number|2033|2033.0||||||
4365666|NCT00362648|4192532|B4|Asian||Race/Ethnicity, Customized||participants|Number|1016|1016.0||||||
4365667|NCT00362648|4192533|B3|Asian||Race/Ethnicity, Customized||participants|Number|1017|1017.0||||||
4365668|NCT00362648|4192534|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365669|NCT00362648|4192535|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365670|NCT00362648|4192531|B5|Black||Race/Ethnicity, Customized||participants|Number|5468|5468.0||||||
4365671|NCT00362648|4192532|B4|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365672|NCT00362648|4192533|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365673|NCT00362648|4192534|B2|Black||Race/Ethnicity, Customized||participants|Number|2735|2735.0||||||
4365674|NCT00362648|4192535|B1|Black||Race/Ethnicity, Customized||participants|Number|2733|2733.0||||||
4365675|NCT00362648|4192531|B5||Male|Sex: Female, Male||Participants|Count of Participants|3819|3819.0||||||
4365676|NCT00362648|4192532|B4||Male|Sex: Female, Male||Participants|Count of Participants|526|526.0||||||
4365677|NCT00362648|4192533|B3||Male|Sex: Female, Male||Participants|Count of Participants|554|554.0||||||
4365678|NCT00362648|4192534|B2||Male|Sex: Female, Male||Participants|Count of Participants|1365|1365.0||||||
4365679|NCT00362648|4192535|B1||Male|Sex: Female, Male||Participants|Count of Participants|1374|1374.0||||||
4365680|NCT00362648|4192531|B5||Female|Sex: Female, Male||Participants|Count of Participants|3685|3685.0||||||
4365681|NCT00362648|4192532|B4||Female|Sex: Female, Male||Participants|Count of Participants|492|492.0||||||
4365682|NCT00362648|4192533|B3||Female|Sex: Female, Male||Participants|Count of Participants|464|464.0||||||
4365683|NCT00362648|4192534|B2||Female|Sex: Female, Male||Participants|Count of Participants|1370|1370.0||||||
4365684|NCT00362648|4192535|B1||Female|Sex: Female, Male||Participants|Count of Participants|1359|1359.0||||||
4365685|NCT00362648|4192531|B5|42 to 84 Days||Age, Customized||participants|Number|6388|6388.0||||||
4365686|NCT00362648|4192532|B4|42 to 84 Days||Age, Customized||participants|Number|1011|1011.0||||||
4365687|NCT00362648|4192533|B3|42 to 84 Days||Age, Customized||participants|Number|1015|1015.0||||||
4365688|NCT00362648|4192534|B2|42 to 84 Days||Age, Customized||participants|Number|2165|2165.0||||||
4365689|NCT00362648|4192535|B1|42 to 84 Days||Age, Customized||participants|Number|2197|2197.0||||||
4365690|NCT00362648|4192531|B5|27 to 41 Days||Age, Customized||participants|Number|1115|1115.0||||||
4365691|NCT00362648|4192532|B4|27 to 41 Days||Age, Customized||participants|Number|7|7.0||||||
4365692|NCT00362648|4192533|B3|27 to 41 Days||Age, Customized||participants|Number|3|3.0||||||
4365693|NCT00362648|4192534|B2|27 to 41 Days||Age, Customized||participants|Number|569|569.0||||||
4365694|NCT00362648|4192535|B1|27 to 41 Days||Age, Customized||participants|Number|536|536.0||||||
4365695|NCT00362648|4192531|B5|<27 Days||Age, Customized||participants|Number|1|1.0||||||
4365696|NCT00362648|4192532|B4|<27 Days||Age, Customized||participants|Number|0|0.0||||||
4365697|NCT00362648|4192533|B3|<27 Days||Age, Customized||participants|Number|0|0.0||||||
4365698|NCT00362648|4192534|B2|<27 Days||Age, Customized||participants|Number|1|1.0||||||
4365699|NCT00362648|4192535|B1|<27 Days||Age, Customized||participants|Number|0|0.0||||||
4365700|NCT00362609|4192554|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4365701|NCT00362609|4192555|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4365702|NCT00362609|4192556|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4365703|NCT00362609|4192554|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4365704|NCT00362609|4192555|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4365705|NCT00362609|4192556|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4365706|NCT00362609|4192554|B3|||Age||weeks (postnatal age)|Mean|8.00|8.0|Standard Deviation|4.40|4.4|||
4365707|NCT00362609|4192555|B2|||Age||weeks (postnatal age)|Mean|7.70|7.7|Standard Deviation|4.20|4.2|||
4365708|NCT00362609|4192556|B1|||Age||weeks (postnatal age)|Mean|8.63|8.63|Standard Deviation|4.86|4.86|||
4365709|NCT00362466|4192569|B3|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4365710|NCT00362466|4192570|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365711|NCT00362466|4192571|B1|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4365712|NCT00362466|4192569|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4365713|NCT00362466|4192570|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4365714|NCT00362466|4192571|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4365715|NCT00362466|4192569|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4365716|NCT00362466|4192570|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4365717|NCT00362466|4192571|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4365718|NCT00362466|4192569|B3|50- to 59-years-old||Age||Participants|Number|1|1.0||||||
4365719|NCT00362466|4192570|B2|50- to 59-years-old||Age||Participants|Number|1|1.0||||||
4365720|NCT00362466|4192571|B1|50- to 59-years-old||Age||Participants|Number|0|0.0||||||
4365721|NCT00362466|4192569|B3|40- to 49-years-old||Age||Participants|Number|1|1.0||||||
4365722|NCT00362466|4192570|B2|40- to 49-years-old||Age||Participants|Number|0|0.0||||||
4365723|NCT00362466|4192571|B1|40- to 49-years-old||Age||Participants|Number|1|1.0||||||
4365724|NCT00362466|4192569|B3|30- to 39-years-old||Age||Participants|Number|1|1.0||||||
4365725|NCT00362466|4192570|B2|30- to 39-years-old||Age||Participants|Number|0|0.0||||||
4365726|NCT00362466|4192571|B1|30- to 39-years-old||Age||Participants|Number|1|1.0||||||
4365727|NCT00362453|4192592|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4365728|NCT00362453|4192593|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4365729|NCT00362453|4192594|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4365730|NCT00362453|4192592|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4365731|NCT00362453|4192593|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4365732|NCT00362453|4192594|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4365733|NCT00362453|4192592|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4365734|NCT00362453|4192593|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4365735|NCT00362453|4192594|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4365736|NCT00362453|4192592|B3|||Age||years|Mean|65|65.0|Standard Deviation|7.8|7.8|||
4365737|NCT00362453|4192593|B2|||Age||years|Mean|68|68.0|Standard Deviation|7.0|7.0|||
4365738|NCT00362453|4192594|B1|||Age||years|Mean|63|63.0|Standard Deviation|8.1|8.1|||
4365739|NCT00362440|4192625|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4365740|NCT00362440|4192626|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4365741|NCT00362440|4192627|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4365742|NCT00362440|4192625|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4365743|NCT00362440|4192626|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4365744|NCT00362440|4192627|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4365745|NCT00362440|4192625|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4365746|NCT00362440|4192626|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4365747|NCT00362440|4192627|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4365748|NCT00362440|4192625|B3|||Age||years|Mean|50|50.0|Full Range|||43.0|57.0|
4365749|NCT00362440|4192626|B2|||Age||years|Mean|50|50.0|Full Range|||43.0|57.0|
4365750|NCT00362440|4192627|B1|||Age||years|Mean|50|50.0|Full Range|||43.0|57.0|
4365751|NCT00362440|4192625|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4365752|NCT00362440|4192626|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4365753|NCT00362440|4192627|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4365754|NCT00362440|4192625|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4365755|NCT00362440|4192626|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4365756|NCT00362440|4192627|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4365757|NCT00362440|4192625|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365758|NCT00362440|4192626|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365759|NCT00362440|4192627|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365760|NCT00362414|4192638|B1|No||History of Atrial Fibrillation||participants|Number|11|11.0||||||
4365761|NCT00362414|4192638|B1|Yes||History of Atrial Fibrillation||participants|Number|4|4.0||||||
4365762|NCT00362414|4192638|B1|No||History of Prior Stroke||participants|Number|10|10.0||||||
4365763|NCT00362414|4192638|B1|Yes||History of Prior Stroke||participants|Number|5|5.0||||||
4365764|NCT00362414|4192638|B1|No||History of Diabetes Mellitus||participants|Number|9|9.0||||||
4365765|NCT00362414|4192638|B1|Yes||History of Diabetes Mellitus||participants|Number|6|6.0||||||
4365766|NCT00362414|4192638|B1|No||History of Hyperlipidemia||participants|Number|6|6.0||||||
4365767|NCT00362414|4192638|B1|Yes||History of Hyperlipidemia||participants|Number|9|9.0||||||
4365768|NCT00362414|4192638|B1|No||History of Hypertension||participants|Number|3|3.0||||||
4365769|NCT00362414|4192638|B1|Yes||History of Hypertension||participants|Number|12|12.0||||||
4365770|NCT00362414|4192638|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4365771|NCT00362414|4192638|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4365772|NCT00362414|4192638|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365773|NCT00362414|4192638|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4365774|NCT00362414|4192638|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4365775|NCT00362414|4192638|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4365776|NCT00362414|4192638|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4365777|NCT00362414|4192638|B1|||Age||years|Median|72|72.0|Full Range|||23.0|87.0|
4365778|NCT00362401|4192655|B4|Germany||Region of Enrollment||participants|Number|84.0|84.0||||||
4365779|NCT00362401|4192656|B3|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4365780|NCT00362401|4192657|B2|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4365781|NCT00362401|4192658|B1|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4365782|NCT00362401|4192655|B4||Male|Sex: Female, Male||Participants|Count of Participants|63.0|63.0||||||
4365783|NCT00362401|4192656|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4365784|NCT00362401|4192657|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4365785|NCT00362401|4192658|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4365786|NCT00362401|4192655|B4||Female|Sex: Female, Male||Participants|Count of Participants|21.0|21.0||||||
4365787|NCT00362401|4192656|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4365788|NCT00362401|4192657|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4365789|NCT00362401|4192658|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4365790|NCT00362401|4192655|B4|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
4365791|NCT00362401|4192656|B3|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
4365792|NCT00362401|4192657|B2|||Age||years|Mean|64|64.0|Standard Deviation|9|9.0|||
4365793|NCT00362401|4192658|B1|||Age||years|Mean|65|65.0|Standard Deviation|7|7.0|||
4365794|NCT00362401|4192655|B4||>=65 years|Age||Participants|Count of Participants|48.0|48.0||||||
4365795|NCT00362401|4192656|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4365796|NCT00362401|4192657|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4365797|NCT00362401|4192658|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4365798|NCT00362401|4192655|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36.0|36.0||||||
4365799|NCT00362401|4192656|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4365800|NCT00362401|4192657|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4365801|NCT00362401|4192658|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4365802|NCT00362401|4192655|B4||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4365803|NCT00362401|4192656|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365804|NCT00362401|4192657|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365805|NCT00362401|4192658|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365806|NCT00362375|4192665|B3|United States||Region of Enrollment||participants|Number|313|313.0||||||
4365807|NCT00362375|4192666|B2|United States||Region of Enrollment||participants|Number|152|152.0||||||
4365808|NCT00362375|4192667|B1|United States||Region of Enrollment||participants|Number|161|161.0||||||
4365809|NCT00362375|4192665|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4365810|NCT00362375|4192666|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4365811|NCT00362375|4192667|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4365812|NCT00362375|4192665|B3||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4365813|NCT00362375|4192666|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4365814|NCT00362375|4192667|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4365815|NCT00362375|4192665|B3|||Age||years|Mean|31.3|31.3|Standard Deviation|11.6|11.6|||
4365816|NCT00362375|4192666|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|12.7|12.7|||
4365817|NCT00362375|4192667|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|10.1|10.1|||
4365818|NCT00362336|4192682|B4|South Africa||Region of Enrollment||Participants|Number|622|622.0||||||
4365819|NCT00362336|4192683|B3|South Africa||Region of Enrollment||Participants|Number|137|137.0||||||
4365820|NCT00362336|4192684|B2|South Africa||Region of Enrollment||Participants|Number|242|242.0||||||
4365821|NCT00362336|4192685|B1|South Africa||Region of Enrollment||Participants|Number|243|243.0||||||
4365822|NCT00362336|4192682|B4||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4365823|NCT00362336|4192683|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4365824|NCT00362336|4192684|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4365825|NCT00362336|4192685|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4365826|NCT00362336|4192682|B4||Female|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
4365827|NCT00362336|4192683|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4365828|NCT00362336|4192684|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4365829|NCT00362336|4192685|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4365830|NCT00362336|4192682|B4|||Age||Days|Mean|1.07|1.07|Standard Deviation|0.751|0.751|||
4365831|NCT00362336|4192683|B3|||Age||Days|Mean|1.11|1.11|Standard Deviation|0.773|0.773|||
4365832|NCT00362336|4192684|B2|||Age||Days|Mean|1.07|1.07|Standard Deviation|0.762|0.762|||
4365833|NCT00362336|4192685|B1|||Age||Days|Mean|1.04|1.04|Standard Deviation|0.729|0.729|||
4365834|NCT00362336|4192682|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4365835|NCT00362336|4192683|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4365836|NCT00362336|4192684|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4365837|NCT00362336|4192685|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4365838|NCT00362336|4192682|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4365839|NCT00362336|4192683|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4365840|NCT00362336|4192684|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4365841|NCT00362336|4192685|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4365842|NCT00362336|4192682|B4||<=18 years|Age||Participants|Count of Participants|622|622.0||||||
4365843|NCT00362336|4192683|B3||<=18 years|Age||Participants|Count of Participants|137|137.0||||||
4365844|NCT00362336|4192684|B2||<=18 years|Age||Participants|Count of Participants|242|242.0||||||
4365845|NCT00362336|4192685|B1||<=18 years|Age||Participants|Count of Participants|243|243.0||||||
4365846|NCT00362297|4192713|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4365847|NCT00362297|4192714|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4365848|NCT00362297|4192715|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365849|NCT00362297|4192713|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4365850|NCT00362297|4192714|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365851|NCT00362297|4192715|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4365852|NCT00362297|4192713|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4365853|NCT00362297|4192714|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4365854|NCT00362297|4192715|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4365855|NCT00362297|4192713|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4365856|NCT00362297|4192714|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4365857|NCT00362297|4192715|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4365858|NCT00362297|4192713|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365859|NCT00362297|4192714|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365860|NCT00362297|4192715|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365861|NCT00362297|4192713|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4365862|NCT00362297|4192714|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4365863|NCT00362297|4192715|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365864|NCT00362297|4192713|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365865|NCT00362297|4192714|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365866|NCT00362297|4192715|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4365867|NCT00362297|4192713|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4365868|NCT00362297|4192714|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4365869|NCT00362297|4192715|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4365870|NCT00362297|4192713|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4365871|NCT00362297|4192714|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4365872|NCT00362297|4192715|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4365873|NCT00362297|4192713|B3|||Age||years|Mean|40.5|40.5|Standard Deviation|12.6|12.6|||
4365874|NCT00362297|4192714|B2|||Age||years|Mean|39.1|39.1|Standard Deviation|12.2|12.2|||
4365875|NCT00362297|4192715|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|13.2|13.2|||
4365876|NCT00362232|4192722|B3|> 110 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|347|347.0||||||
4365877|NCT00362232|4192723|B2|> 110 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|162|162.0||||||
4365878|NCT00362232|4192724|B1|> 110 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|185|185.0||||||
4365879|NCT00362232|4192722|B3|> 90 - 110 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|665|665.0||||||
4365880|NCT00362232|4192723|B2|> 90 - 110 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|343|343.0||||||
4365881|NCT00362232|4192724|B1|> 90 - 110 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|322|322.0||||||
4365882|NCT00362232|4192722|B3|> 70 - 90 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|1245|1245.0||||||
4365883|NCT00362232|4192723|B2|> 70 - 90 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|616|616.0||||||
4365884|NCT00362232|4192724|B1|> 70 - 90 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|629|629.0||||||
4365885|NCT00362232|4192722|B3|> 50 - 70 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|725|725.0||||||
4365886|NCT00362232|4192723|B2|> 50 - 70 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|358|358.0||||||
4365887|NCT00362232|4192724|B1|> 50 - 70 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|367|367.0||||||
4365888|NCT00362232|4192722|B3|=< 50 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|50|50.0||||||
4365889|NCT00362232|4192723|B2|=< 50 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|28|28.0||||||
4365890|NCT00362232|4192724|B1|=< 50 kg||Weight|One subject in each treatment group was missing baseline weight.|participants|Number|22|22.0||||||
4365891|NCT00362232|4192722|B3|Uncodable||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|4|4.0||||||
4365892|NCT00362232|4192723|B2|Uncodable||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|2|2.0||||||
4365893|NCT00362232|4192724|B1|Uncodable||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|2|2.0||||||
4365894|NCT00362232|4192722|B3|Hispanic||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|253|253.0||||||
4365895|NCT00362232|4192723|B2|Hispanic||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|116|116.0||||||
4365896|NCT00362232|4192724|B1|Hispanic||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|137|137.0||||||
4365897|NCT00362232|4192722|B3|American Indian||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|5|5.0||||||
4365898|NCT00362232|4192723|B2|American Indian||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|4|4.0||||||
4365899|NCT00362232|4192724|B1|American Indian||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|1|1.0||||||
4365900|NCT00362232|4192722|B3|Asian||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|578|578.0||||||
4365901|NCT00362232|4192723|B2|Asian||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|289|289.0||||||
4365902|NCT00362232|4192724|B1|Asian||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|289|289.0||||||
4365903|NCT00362232|4192722|B3|Black||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|153|153.0||||||
4365904|NCT00362232|4192723|B2|Black||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|65|65.0||||||
4365905|NCT00362232|4192724|B1|Black||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|88|88.0||||||
4365906|NCT00362232|4192722|B3|White||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|2040|2040.0||||||
4365907|NCT00362232|4192723|B2|White||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|1032|1032.0||||||
4365908|NCT00362232|4192724|B1|White||Race/Ethnicity, Customized|One subject in the rivaroxaban 10 mg OD treatment group was missing race.|participants|Number|1008|1008.0||||||
4365909|NCT00362232|4192722|B3||Male|Sex: Female, Male||Participants|Count of Participants|1060|1060.0||||||
4365910|NCT00362232|4192723|B2||Male|Sex: Female, Male||Participants|Count of Participants|541|541.0||||||
4365911|NCT00362232|4192724|B1||Male|Sex: Female, Male||Participants|Count of Participants|519|519.0||||||
4365912|NCT00362232|4192722|B3||Female|Sex: Female, Male||Participants|Count of Participants|1974|1974.0||||||
4365913|NCT00362232|4192723|B2||Female|Sex: Female, Male||Participants|Count of Participants|967|967.0||||||
4365914|NCT00362232|4192724|B1||Female|Sex: Female, Male||Participants|Count of Participants|1007|1007.0||||||
4365915|NCT00362232|4192722|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|9.7|9.7|||
4365916|NCT00362232|4192723|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|9.7|9.7|||
4365917|NCT00362232|4192724|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|9.7|9.7|||
4365918|NCT00362180|4192761|B10|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365919|NCT00362180|4192762|B9|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365920|NCT00362180|4192763|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365921|NCT00362180|4192764|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365922|NCT00362180|4192765|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365923|NCT00362180|4192766|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365924|NCT00362180|4192768|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365925|NCT00362180|4192769|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365926|NCT00362180|4192770|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4365927|NCT00362180|4192761|B10|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4365928|NCT00362180|4192762|B9|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365929|NCT00362180|4192763|B8|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4365930|NCT00362180|4192764|B7|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4365931|NCT00362180|4192765|B6|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4365932|NCT00362180|4192766|B5|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4365933|NCT00362180|4192768|B3|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365934|NCT00362180|4192769|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4365935|NCT00362180|4192770|B1|White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4365936|NCT00362180|4192761|B10|Male||Gender||participants|Number|18|18.0||||||
4365937|NCT00362180|4192762|B9|Male||Gender||participants|Number|0|0.0||||||
4365938|NCT00362180|4192763|B8|Male||Gender||participants|Number|1|1.0||||||
4365939|NCT00362180|4192764|B7|Male||Gender||participants|Number|5|5.0||||||
4365940|NCT00362180|4192765|B6|Male||Gender||participants|Number|6|6.0||||||
4365941|NCT00362180|4192766|B5|Male||Gender||participants|Number|3|3.0||||||
4365942|NCT00362180|4192768|B3|Male||Gender||participants|Number|0|0.0||||||
4365943|NCT00362180|4192769|B2|Male||Gender||participants|Number|1|1.0||||||
4365944|NCT00362180|4192770|B1|Male||Gender||participants|Number|2|2.0||||||
4365945|NCT00362180|4192761|B10|Female||Gender||participants|Number|20|20.0||||||
4365946|NCT00362180|4192762|B9|Female||Gender||participants|Number|1|1.0||||||
4365947|NCT00362180|4192763|B8|Female||Gender||participants|Number|2|2.0||||||
4365948|NCT00362180|4192764|B7|Female||Gender||participants|Number|1|1.0||||||
4365949|NCT00362180|4192765|B6|Female||Gender||participants|Number|4|4.0||||||
4365950|NCT00362180|4192766|B5|Female||Gender||participants|Number|8|8.0||||||
4365951|NCT00362180|4192768|B3|Female||Gender||participants|Number|1|1.0||||||
4365952|NCT00362180|4192769|B2|Female||Gender||participants|Number|1|1.0||||||
4365953|NCT00362180|4192770|B1|Female||Gender||participants|Number|2|2.0||||||
4365954|NCT00362180|4192761|B10|||Age||years|Median|53.5|53.5|Full Range|||23.0|71.0|
4365955|NCT00362180|4192762|B9|||Age||years|Median|58.0|58.0|Full Range|||58.0|58.0|
4365956|NCT00362180|4192763|B8|||Age||years|Median|62.0|62.0|Full Range|||49.0|64.0|
4365957|NCT00362180|4192764|B7|||Age||years|Median|49.5|49.5|Full Range|||29.0|71.0|
4365958|NCT00362180|4192765|B6|||Age||years|Median|50.0|50.0|Full Range|||23.0|63.0|
4365959|NCT00362180|4192766|B5|||Age||years|Median|46.0|46.0|Full Range|||28.0|59.0|
4365960|NCT00362180|4192768|B3|||Age||years|Median|59.0|59.0|Full Range|||59.0|59.0|
4365961|NCT00362180|4192769|B2|||Age||years|Median|40.5|40.5|Full Range|||24.0|57.0|
4365962|NCT00362180|4192770|B1|||Age||years|Median|58.5|58.5|Full Range|||57.0|65.0|
4365963|NCT00362128|4192839|B1|United States||Region of Enrollment||participants|Number|2072|2072.0||||||
4365964|NCT00362128|4192839|B1||Male|Sex: Female, Male||Participants|Count of Participants|979|979.0||||||
4365965|NCT00362128|4192839|B1||Female|Sex: Female, Male||Participants|Count of Participants|1093|1093.0||||||
4365966|NCT00362128|4192839|B1|||Age||years|Median|53|53.0|Full Range|||21.0|89.0|
4365967|NCT00362128|4192839|B1||>=65 years|Age||Participants|Count of Participants|390|390.0||||||
4365968|NCT00362128|4192839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1682|1682.0||||||
4365969|NCT00362128|4192839|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4365970|NCT00362115|4192843|B8||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4365971|NCT00362115|4192844|B7||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4365972|NCT00362115|4192845|B6||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4365973|NCT00362115|4192846|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4365974|NCT00362115|4192847|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4365975|NCT00362115|4192848|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4365976|NCT00362115|4192849|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4365977|NCT00362115|4192850|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4365978|NCT00362115|4192843|B8||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4365979|NCT00362115|4192844|B7||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4365980|NCT00362115|4192845|B6||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4365981|NCT00362115|4192846|B5||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4365982|NCT00362115|4192847|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4365983|NCT00362115|4192848|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4365984|NCT00362115|4192849|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4365985|NCT00362115|4192850|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4365986|NCT00362115|4192843|B8|≥65 years||Age||participants|Number|64|64.0||||||
4365987|NCT00362115|4192844|B7|≥65 years||Age||participants|Number|14|14.0||||||
4365988|NCT00362115|4192845|B6|≥65 years||Age||participants|Number|7|7.0||||||
4365989|NCT00362115|4192846|B5|≥65 years||Age||participants|Number|11|11.0||||||
4365990|NCT00362115|4192847|B4|≥65 years||Age||participants|Number|10|10.0||||||
4365991|NCT00362115|4192848|B3|≥65 years||Age||participants|Number|8|8.0||||||
4365992|NCT00362115|4192849|B2|≥65 years||Age||participants|Number|6|6.0||||||
4365993|NCT00362115|4192850|B1|≥65 years||Age||participants|Number|8|8.0||||||
4365994|NCT00362115|4192843|B8|Between 45 and 64 years||Age||participants|Number|309|309.0||||||
4365995|NCT00362115|4192844|B7|Between 45 and 64 years||Age||participants|Number|36|36.0||||||
4365996|NCT00362115|4192845|B6|Between 45 and 64 years||Age||participants|Number|46|46.0||||||
4365997|NCT00362115|4192846|B5|Between 45 and 64 years||Age||participants|Number|41|41.0||||||
4365998|NCT00362115|4192847|B4|Between 45 and 64 years||Age||participants|Number|43|43.0||||||
4365999|NCT00362115|4192848|B3|Between 45 and 64 years||Age||participants|Number|46|46.0||||||
4366000|NCT00362115|4192849|B2|Between 45 and 64 years||Age||participants|Number|52|52.0||||||
4366001|NCT00362115|4192850|B1|Between 45 and 64 years||Age||participants|Number|45|45.0||||||
4366002|NCT00362115|4192843|B8|<45 years||Age||participants|Number|69|69.0||||||
4366003|NCT00362115|4192844|B7|<45 years||Age||participants|Number|11|11.0||||||
4366004|NCT00362115|4192845|B6|<45 years||Age||participants|Number|10|10.0||||||
4366005|NCT00362115|4192846|B5|<45 years||Age||participants|Number|12|12.0||||||
4366006|NCT00362115|4192847|B4|<45 years||Age||participants|Number|9|9.0||||||
4366007|NCT00362115|4192848|B3|<45 years||Age||participants|Number|10|10.0||||||
4366008|NCT00362115|4192849|B2|<45 years||Age||participants|Number|5|5.0||||||
4366009|NCT00362115|4192850|B1|<45 years||Age||participants|Number|12|12.0||||||
4366010|NCT00361972|4193005|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4366011|NCT00361972|4193006|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4366012|NCT00361972|4193007|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4366013|NCT00361972|4193005|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4366014|NCT00361972|4193006|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4366015|NCT00361972|4193007|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4366016|NCT00361972|4193005|B3|||Age||years|Mean|41|41.0|Full Range|||20.0|62.0|
4366017|NCT00361972|4193006|B2|||Age||years|Mean|43|43.0|Full Range|||26.0|62.0|
4366018|NCT00361972|4193007|B1|||Age||years|Mean|40|40.0|Full Range|||20.0|57.0|
4366019|NCT00361712|4193016|B3|Israel||Region of Enrollment||Participants|Count of Participants|41|41.0||||||
4366020|NCT00361712|4193017|B2|Israel||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4366021|NCT00361712|4193018|B1|Israel||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4366022|NCT00361712|4193016|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366023|NCT00361712|4193017|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366024|NCT00361712|4193018|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366025|NCT00361712|4193016|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4366026|NCT00361712|4193017|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4366027|NCT00361712|4193018|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4366028|NCT00361712|4193016|B3|||Age||years|Mean|30.5|30.5|Standard Deviation|4.9|4.9|||
4366029|NCT00361712|4193017|B2|||Age||years|Mean|29.1|29.1|Standard Deviation|4.9|4.9|||
4366030|NCT00361712|4193018|B1|||Age||years|Mean|30.5|30.5|Standard Deviation|3.6|3.6|||
4366031|NCT00361634|4193029|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4366032|NCT00361634|4193029|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4366033|NCT00361634|4193029|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4366034|NCT00361634|4193029|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4366035|NCT00361634|4193029|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4366036|NCT00361634|4193029|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4366037|NCT00361634|4193029|B1|||Age||Years|Mean|50.6|50.6|Standard Deviation|14.3|14.3|||
4366038|NCT00361595|4193047|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4366039|NCT00361595|4193047|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366040|NCT00361595|4193047|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4366041|NCT00361595|4193047|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|11.2|11.2|||
4366042|NCT00361595|4193047|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4366043|NCT00361595|4193047|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4366044|NCT00361595|4193047|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366045|NCT00361569|4193054|B5|United States||Region of Enrollment||participants|Number|622.0|622.0||||||
4366046|NCT00361569|4193055|B4|United States||Region of Enrollment||participants|Number|156|156.0||||||
4366047|NCT00361569|4193056|B3|United States||Region of Enrollment||participants|Number|155|155.0||||||
4366048|NCT00361569|4193057|B2|United States||Region of Enrollment||participants|Number|161|161.0||||||
4366049|NCT00361569|4193058|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
4366050|NCT00361569|4193054|B5||Male|Sex: Female, Male||Participants|Count of Participants|0.0|0.0||||||
4366051|NCT00361569|4193055|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366052|NCT00361569|4193056|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366053|NCT00361569|4193057|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366054|NCT00361569|4193058|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366055|NCT00361569|4193054|B5||Female|Sex: Female, Male||Participants|Count of Participants|622.0|622.0||||||
4366056|NCT00361569|4193055|B4||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4366057|NCT00361569|4193056|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4366058|NCT00361569|4193057|B2||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4366059|NCT00361569|4193058|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4366060|NCT00361569|4193054|B5|Between 30 and 80 years||Age, Customized||participants|Number|622.0|622.0||||||
4366061|NCT00361569|4193055|B4|Between 30 and 80 years||Age, Customized||participants|Number|156|156.0||||||
4366062|NCT00361569|4193056|B3|Between 30 and 80 years||Age, Customized||participants|Number|155|155.0||||||
4366063|NCT00361569|4193057|B2|Between 30 and 80 years||Age, Customized||participants|Number|161|161.0||||||
4366064|NCT00361569|4193058|B1|Between 30 and 80 years||Age, Customized||participants|Number|150|150.0||||||
4366065|NCT00361569|4193054|B5|||Age||years|Mean|59.4|59.4|Standard Deviation|6.36|6.36|||
4366066|NCT00361569|4193055|B4|||Age||years|Mean|58.4|58.4|Standard Deviation|6.28|6.28|||
4366067|NCT00361569|4193056|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|6.60|6.6|||
4366068|NCT00361569|4193057|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|6.10|6.1|||
4366069|NCT00361569|4193058|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|6.48|6.48|||
4366070|NCT00361504|4193083|B3|Europe||Region of Enrollment||participants|Number|263|263.0||||||
4366071|NCT00361504|4193084|B2|Europe||Region of Enrollment||participants|Number|53|53.0||||||
4366072|NCT00361504|4193085|B1|Europe||Region of Enrollment||participants|Number|210|210.0||||||
4366073|NCT00361504|4193083|B3|North America||Region of Enrollment||participants|Number|854|854.0||||||
4366074|NCT00361504|4193084|B2|North America||Region of Enrollment||participants|Number|170|170.0||||||
4366075|NCT00361504|4193085|B1|North America||Region of Enrollment||participants|Number|684|684.0||||||
4366076|NCT00361504|4193083|B3||Male|Sex: Female, Male||Participants|Count of Participants|477|477.0||||||
4366077|NCT00361504|4193084|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4366078|NCT00361504|4193085|B1||Male|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4366079|NCT00361504|4193083|B3||Female|Sex: Female, Male||Participants|Count of Participants|640|640.0||||||
4366080|NCT00361504|4193084|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4366081|NCT00361504|4193085|B1||Female|Sex: Female, Male||Participants|Count of Participants|515|515.0||||||
4366082|NCT00361504|4193083|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|12.38|12.38|||
4366083|NCT00361504|4193084|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|11.83|11.83|||
4366084|NCT00361504|4193085|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|12.51|12.51|||
4366085|NCT00361504|4193083|B3||>=65 years|Age||Participants|Count of Participants|312|312.0||||||
4366086|NCT00361504|4193084|B2||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4366087|NCT00361504|4193085|B1||>=65 years|Age||Participants|Count of Participants|245|245.0||||||
4366088|NCT00361504|4193083|B3||Between 18 and 65 years|Age||Participants|Count of Participants|805|805.0||||||
4366089|NCT00361504|4193084|B2||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4366090|NCT00361504|4193085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|649|649.0||||||
4366091|NCT00361504|4193083|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366092|NCT00361504|4193084|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366093|NCT00361504|4193085|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366094|NCT00361439|4193094|B3|Grass||Allergen sensitivity||participants|Number|6|6.0||||||
4366095|NCT00361439|4193095|B2|Grass||Allergen sensitivity||participants|Number|3|3.0||||||
4366096|NCT00361439|4193096|B1|Grass||Allergen sensitivity||participants|Number|3|3.0||||||
4366097|NCT00361439|4193094|B3|Ragweed||Allergen sensitivity||participants|Number|11|11.0||||||
4366098|NCT00361439|4193095|B2|Ragweed||Allergen sensitivity||participants|Number|6|6.0||||||
4366099|NCT00361439|4193096|B1|Ragweed||Allergen sensitivity||participants|Number|5|5.0||||||
4366100|NCT00361439|4193094|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4366101|NCT00361439|4193095|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4366102|NCT00361439|4193096|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4366103|NCT00361439|4193094|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4366104|NCT00361439|4193095|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4366105|NCT00361439|4193096|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4366106|NCT00361439|4193094|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4366107|NCT00361439|4193095|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4366108|NCT00361439|4193096|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4366109|NCT00361439|4193094|B3|||Age||years|Mean|39|39.0|Full Range|||23.0|52.0|
4366110|NCT00361439|4193095|B2|||Age||years|Mean|38|38.0|Full Range|||23.0|52.0|
4366111|NCT00361439|4193096|B1|||Age||years|Mean|40|40.0|Full Range|||24.0|49.0|
4366112|NCT00361374|4193109|B4|United States||Region of Enrollment||participants|Number|177|177.0||||||
4366113|NCT00361374|4193110|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4366114|NCT00361374|4193111|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4366115|NCT00361374|4193112|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4366116|NCT00361374|4193109|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4366117|NCT00361374|4193110|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4366118|NCT00361374|4193111|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4366119|NCT00361374|4193112|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4366120|NCT00361374|4193109|B4||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4366121|NCT00361374|4193110|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4366122|NCT00361374|4193111|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4366123|NCT00361374|4193112|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4366124|NCT00361374|4193109|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4366125|NCT00361374|4193110|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4366126|NCT00361374|4193111|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4366127|NCT00361374|4193112|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4366128|NCT00361374|4193109|B4||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
4366129|NCT00361374|4193110|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4366130|NCT00361374|4193111|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4366131|NCT00361374|4193112|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4366132|NCT00361374|4193109|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366133|NCT00361374|4193110|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366134|NCT00361374|4193111|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366135|NCT00361374|4193112|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366136|NCT00361374|4193109|B4|||Age||years|Mean|45.8|45.8|Standard Deviation|12.5|12.5|||
4366137|NCT00361374|4193110|B3|||Age||years|Mean|45.0|45.0|Standard Deviation|12.1|12.1|||
4366138|NCT00361374|4193111|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|11.8|11.8|||
4366139|NCT00361374|4193112|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|12.5|12.5|||
4366140|NCT00361335|4193122|B6||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4366141|NCT00361335|4193123|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4366142|NCT00361335|4193124|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4366143|NCT00361335|4193125|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4366144|NCT00361335|4193126|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4366145|NCT00361335|4193127|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4366146|NCT00361335|4193122|B6||Female|Sex: Female, Male||Participants|Count of Participants|517|517.0||||||
4366147|NCT00361335|4193123|B5||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4366148|NCT00361335|4193124|B4||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4366149|NCT00361335|4193125|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4366150|NCT00361335|4193126|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4366151|NCT00361335|4193127|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4366152|NCT00361335|4193122|B6|||Age||years|Mean|49.4|49.4|Standard Deviation|11.65|11.65|||
4366153|NCT00361335|4193123|B5|||Age||years|Mean|50.2|50.2|Standard Deviation|11.28|11.28|||
4366154|NCT00361335|4193124|B4|||Age||years|Mean|48.4|48.4|Standard Deviation|12.66|12.66|||
4366155|NCT00361335|4193125|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|10.96|10.96|||
4366156|NCT00361335|4193126|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|11.86|11.86|||
4366157|NCT00361335|4193127|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|11.10|11.1|||
4366158|NCT00361296|4193177|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4366159|NCT00361296|4193177|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4366160|NCT00361296|4193177|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4366161|NCT00361296|4193177|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4366162|NCT00361296|4193177|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4366163|NCT00361296|4193177|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4366164|NCT00361296|4193177|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4366165|NCT00361296|4193177|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4366166|NCT00361296|4193177|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4366167|NCT00361296|4193177|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4366168|NCT00361296|4193177|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4366169|NCT00361296|4193177|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4366170|NCT00361296|4193177|B1|||Age||years|Median|64|64.0|Full Range|||55.0|75.0|
4366171|NCT00361296|4193177|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4366172|NCT00361296|4193177|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4366173|NCT00361296|4193177|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366174|NCT00361283|4193184|B1|United States||Region of Enrollment||participants|Number|108|108.0||||||
4366175|NCT00361283|4193184|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4366176|NCT00361283|4193184|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4366177|NCT00361283|4193184|B1|||Age||years|Mean|31.6|31.6|Standard Deviation|12.6|12.6|||
4366178|NCT00361283|4193184|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4366179|NCT00361283|4193184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4366180|NCT00361283|4193184|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366181|NCT00361270|4193188|B5|||PSQI|The Pittsburgh Sleep Quality Index (PSQI) contains19 items with 7 component scores ranging from 0 no difficulty falling asleep to 3 severe difficulty. Component scores are then added to create a global score ranging from 0 no difficulty falling asleep to 21 severe difficulty falling asleep.|units on a scale|Mean|11.16|11.16|Standard Deviation|4.17|4.17|||
4366182|NCT00361270|4193189|B4|||PSQI|The Pittsburgh Sleep Quality Index (PSQI) contains19 items with 7 component scores ranging from 0 no difficulty falling asleep to 3 severe difficulty. Component scores are then added to create a global score ranging from 0 no difficulty falling asleep to 21 severe difficulty falling asleep.|units on a scale|Mean|10.24|10.24|Standard Deviation|4.02|4.02|||
4366183|NCT00361270|4193190|B3|||PSQI|The Pittsburgh Sleep Quality Index (PSQI) contains19 items with 7 component scores ranging from 0 no difficulty falling asleep to 3 severe difficulty. Component scores are then added to create a global score ranging from 0 no difficulty falling asleep to 21 severe difficulty falling asleep.|units on a scale|Mean|9.68|9.68|Standard Deviation|4.15|4.15|||
4366184|NCT00361270|4193191|B2|||PSQI|The Pittsburgh Sleep Quality Index (PSQI) contains19 items with 7 component scores ranging from 0 no difficulty falling asleep to 3 severe difficulty. Component scores are then added to create a global score ranging from 0 no difficulty falling asleep to 21 severe difficulty falling asleep.|units on a scale|Mean|11.80|11.8|Standard Deviation|4.08|4.08|||
4366185|NCT00361270|4193192|B1|||PSQI|The Pittsburgh Sleep Quality Index (PSQI) contains19 items with 7 component scores ranging from 0 no difficulty falling asleep to 3 severe difficulty. Component scores are then added to create a global score ranging from 0 no difficulty falling asleep to 21 severe difficulty falling asleep.|units on a scale|Mean|11.36|11.36|Standard Deviation|3.55|3.55|||
4366186|NCT00361270|4193188|B5|||BPI Interference|This is a 10 item scale. Each item measures pain on a 0-10 No pain - Worst pain. The overall scale values range from 0 to 100.|units on a scale|Mean|56.15|56.15|Standard Deviation|20.15|20.15|||
4366187|NCT00361270|4193189|B4|||BPI Interference|This is a 10 item scale. Each item measures pain on a 0-10 No pain - Worst pain. The overall scale values range from 0 to 100.|units on a scale|Mean|11.36|11.36|Standard Deviation|3.55|3.55|||
4366188|NCT00361270|4193190|B3|||BPI Interference|This is a 10 item scale. Each item measures pain on a 0-10 No pain - Worst pain. The overall scale values range from 0 to 100.|units on a scale|Mean|49.60|49.6|Standard Deviation|20.65|20.65|||
4366189|NCT00361270|4193191|B2|||BPI Interference|This is a 10 item scale. Each item measures pain on a 0-10 No pain - Worst pain. The overall scale values range from 0 to 100.|units on a scale|Mean|52.06|52.06|Standard Deviation|19.62|19.62|||
4366190|NCT00361270|4193192|B1|||BPI Interference|This is a 10 item scale. Each item measures pain on a 0-10 No pain - Worst pain. The overall scale values range from 0 to 100.|units on a scale|Mean|61.20|61.2|Standard Deviation|17.55|17.55|||
4366191|NCT00361270|4193188|B5|||BPI Pain Intensity|This is a 4 item scale. Each item measures pain on a 0-10 No pain - Worst pain scale. The overall measure ranges from 0 to 40.|units on a scale|Mean|24.37|24.37|Standard Deviation|6.26|6.26|||
4366192|NCT00361270|4193189|B4|||BPI Pain Intensity|This is a 4 item scale. Each item measures pain on a 0-10 No pain - Worst pain scale. The overall measure ranges from 0 to 40.|units on a scale|Mean|25.50|25.5|Standard Deviation|6.05|6.05|||
4366193|NCT00361270|4193190|B3|||BPI Pain Intensity|This is a 4 item scale. Each item measures pain on a 0-10 No pain - Worst pain scale. The overall measure ranges from 0 to 40.|units on a scale|Mean|21.08|21.08|Standard Deviation|5.14|5.14|||
4366194|NCT00361270|4193191|B2|||BPI Pain Intensity|This is a 4 item scale. Each item measures pain on a 0-10 No pain - Worst pain scale. The overall measure ranges from 0 to 40.|units on a scale|Mean|24.50|24.5|Standard Deviation|5.52|5.52|||
4366195|NCT00361270|4193192|B1|||BPI Pain Intensity|This is a 4 item scale. Each item measures pain on a 0-10 No pain - Worst pain scale. The overall measure ranges from 0 to 40.|units on a scale|Mean|24.28|24.28|Standard Deviation|5.44|5.44|||
4366196|NCT00361270|4193188|B5||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4366197|NCT00361270|4193189|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4366198|NCT00361270|4193190|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4366199|NCT00361270|4193191|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4366200|NCT00361270|4193192|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4366201|NCT00361270|4193188|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4366202|NCT00361270|4193189|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4366203|NCT00361270|4193190|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4366204|NCT00361270|4193191|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4366205|NCT00361270|4193192|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4366206|NCT00361270|4193188|B5||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4366207|NCT00361270|4193189|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4366208|NCT00361270|4193190|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4366209|NCT00361270|4193191|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4366210|NCT00361270|4193192|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4366211|NCT00361270|4193188|B5||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4366212|NCT00361270|4193189|B4||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4366213|NCT00361270|4193190|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4366214|NCT00361270|4193191|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4366215|NCT00361270|4193192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4366216|NCT00361270|4193188|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366217|NCT00361270|4193189|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366218|NCT00361270|4193190|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366219|NCT00361270|4193191|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366220|NCT00361270|4193192|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366221|NCT00361257|4193213|B3|||Alternate Frontal Systems Z-Score|This is average of z scores of standardized interference task and trailmaking part b tests. The interference task z score was adjusted for age and education. The trailmaking part b z score was adjusted for age, sex, education, and African-American ethnicity.|z-score|Mean|-0.09|-0.09|Standard Deviation|0.98|0.98|||
4366222|NCT00361257|4193214|B2|||Alternate Frontal Systems Z-Score|This is average of z scores of standardized interference task and trailmaking part b tests. The interference task z score was adjusted for age and education. The trailmaking part b z score was adjusted for age, sex, education, and African-American ethnicity.|z-score|Mean|-0.13|-0.13|Standard Deviation|1.09|1.09|||
4366223|NCT00361257|4193215|B1|||Alternate Frontal Systems Z-Score|This is average of z scores of standardized interference task and trailmaking part b tests. The interference task z score was adjusted for age and education. The trailmaking part b z score was adjusted for age, sex, education, and African-American ethnicity.|z-score|Mean|-0.04|-0.04|Standard Deviation|0.86|0.86|||
4366224|NCT00361257|4193213|B3|||Alternate Verbal Memory Z-Score|This is the average of age and education adjusted z scores of standardized trials 1 to 3 and delayed recall tests.|z-score|Mean|-1.37|-1.37|Standard Deviation|1.14|1.14|||
4366225|NCT00361257|4193214|B2|||Alternate Verbal Memory Z-Score|This is the average of age and education adjusted z scores of standardized trials 1 to 3 and delayed recall tests.|z-score|Mean|-1.41|-1.41|Standard Deviation|1.12|1.12|||
4366226|NCT00361257|4193215|B1|||Alternate Verbal Memory Z-Score|This is the average of age and education adjusted z scores of standardized trials 1 to 3 and delayed recall tests.|z-score|Mean|-1.33|-1.33|Standard Deviation|1.16|1.16|||
4366227|NCT00361257|4193213|B3|||Alternate Psychomotor Function Z-Score|This is the average of z scores of Trail Making Part A and Symbol Digit Tests. Trail Making Part A z score was adjusted for age, sex, education, and African-Ametrican ethnicity. Symbol Digit z score was adjusted for age and education.|z-score|Mean|-0.58|-0.58|Standard Deviation|0.87|0.87|||
4366228|NCT00361257|4193214|B2|||Alternate Psychomotor Function Z-Score|This is the average of z scores of Trail Making Part A and Symbol Digit Tests. Trail Making Part A z score was adjusted for age, sex, education, and African-Ametrican ethnicity. Symbol Digit z score was adjusted for age and education.|z-score|Mean|-0.63|-0.63|Standard Deviation|0.92|0.92|||
4366229|NCT00361257|4193215|B1|||Alternate Psychomotor Function Z-Score|This is the average of z scores of Trail Making Part A and Symbol Digit Tests. Trail Making Part A z score was adjusted for age, sex, education, and African-Ametrican ethnicity. Symbol Digit z score was adjusted for age and education.|z-score|Mean|-0.54|-0.54|Standard Deviation|0.82|0.82|||
4366257|NCT00361257|4193213|B3|CSF RNA VL <30 copies/mL||HIV-1 CerebroSpinal Fluid (CSF) RNA Viral Loads (VL)|HIV CSF RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|38|38.0||||||
4366230|NCT00361257|4193213|B3|||Medication Management Test (MMT) Score|The medication management test (modified) is designed to assess participants' medication management ability and their own medications and management. It’s the number of how many times participants correctly answered 16 questions.|Scores on a scale|Mean|14.39|14.39|Standard Deviation|2.08|2.08|||
4366231|NCT00361257|4193214|B2|||Medication Management Test (MMT) Score|The medication management test (modified) is designed to assess participants' medication management ability and their own medications and management. It’s the number of how many times participants correctly answered 16 questions.|Scores on a scale|Mean|14.09|14.09|Standard Deviation|2.52|2.52|||
4366232|NCT00361257|4193215|B1|||Medication Management Test (MMT) Score|The medication management test (modified) is designed to assess participants' medication management ability and their own medications and management. It’s the number of how many times participants correctly answered 16 questions.|Scores on a scale|Mean|14.72|14.72|Standard Deviation|1.41|1.41|||
4366233|NCT00361257|4193213|B3|||Instrumental Activities of Daily Living (IADL) Summary Score|The IADL questionnaire has 16 common tasks: 1. Housekeeping; 2.Managing Finances; 3. Buying Groceries; 4.Cooking; 5. Planning Social Activities; 6.Understanding Reading Materials/TV; 7.Transportation; 8.Using the Telephone; 9.Home Repairs; 10.Bathing; 11.Dressing; 12.Shopping; 13.Laundry; 14.Taking/Keeping Track of Medication; 15.Child Care; 16.Work. For each task, if the score at the time of evaluation is worse than the best in the past, an indicator of 1 is given; otherwise 0. The IADL score is a sum of 16 indicators divided by 16. The lower score indicates better. The range is from 0 to 1.|Scores on a scale|Mean|0.12|0.12|Standard Deviation|0.15|0.15|||
4366234|NCT00361257|4193214|B2|||Instrumental Activities of Daily Living (IADL) Summary Score|The IADL questionnaire has 16 common tasks: 1. Housekeeping; 2.Managing Finances; 3. Buying Groceries; 4.Cooking; 5. Planning Social Activities; 6.Understanding Reading Materials/TV; 7.Transportation; 8.Using the Telephone; 9.Home Repairs; 10.Bathing; 11.Dressing; 12.Shopping; 13.Laundry; 14.Taking/Keeping Track of Medication; 15.Child Care; 16.Work. For each task, if the score at the time of evaluation is worse than the best in the past, an indicator of 1 is given; otherwise 0. The IADL score is a sum of 16 indicators divided by 16. The lower score indicates better. The range is from 0 to 1.|Scores on a scale|Mean|0.13|0.13|Standard Deviation|0.16|0.16|||
4366235|NCT00361257|4193215|B1|||Instrumental Activities of Daily Living (IADL) Summary Score|The IADL questionnaire has 16 common tasks: 1. Housekeeping; 2.Managing Finances; 3. Buying Groceries; 4.Cooking; 5. Planning Social Activities; 6.Understanding Reading Materials/TV; 7.Transportation; 8.Using the Telephone; 9.Home Repairs; 10.Bathing; 11.Dressing; 12.Shopping; 13.Laundry; 14.Taking/Keeping Track of Medication; 15.Child Care; 16.Work. For each task, if the score at the time of evaluation is worse than the best in the past, an indicator of 1 is given; otherwise 0. The IADL score is a sum of 16 indicators divided by 16. The lower score indicates better. The range is from 0 to 1.|Scores on a scale|Mean|0.12|0.12|Standard Deviation|0.15|0.15|||
4366236|NCT00361257|4193213|B3|Subjective NP Test||Stratification Variable 2 - Objective or subjective Neuropsychological test - Pre-baseline|The 2nd stratification factor is progressive neurocognitive decline defined by objective or subjective criteria at pre-baseline. A decline of at least 1.0 standard deviation below age-matched and education-matched controls on two or more independent tests or 2.0 standard deviations below age-matched and education-matched controls on one test within 1 year before entry is defined as objective decline. Otherwise, subjective neurocognitive decline is defined by the participant or family member or caregiver AND a Center for Epidemiological Studies Depression score <16 within 45 days before entry.|participants|Number|95|95.0||||||
4366237|NCT00361257|4193214|B2|Subjective NP Test||Stratification Variable 2 - Objective or subjective Neuropsychological test - Pre-baseline|The 2nd stratification factor is progressive neurocognitive decline defined by objective or subjective criteria at pre-baseline. A decline of at least 1.0 standard deviation below age-matched and education-matched controls on two or more independent tests or 2.0 standard deviations below age-matched and education-matched controls on one test within 1 year before entry is defined as objective decline. Otherwise, subjective neurocognitive decline is defined by the participant or family member or caregiver AND a Center for Epidemiological Studies Depression score <16 within 45 days before entry.|participants|Number|48|48.0||||||
4366238|NCT00361257|4193215|B1|Subjective NP Test||Stratification Variable 2 - Objective or subjective Neuropsychological test - Pre-baseline|The 2nd stratification factor is progressive neurocognitive decline defined by objective or subjective criteria at pre-baseline. A decline of at least 1.0 standard deviation below age-matched and education-matched controls on two or more independent tests or 2.0 standard deviations below age-matched and education-matched controls on one test within 1 year before entry is defined as objective decline. Otherwise, subjective neurocognitive decline is defined by the participant or family member or caregiver AND a Center for Epidemiological Studies Depression score <16 within 45 days before entry.|participants|Number|47|47.0||||||
4366239|NCT00361257|4193213|B3|Objective Neuropsychological (NP) Test||Stratification Variable 2 - Objective or subjective Neuropsychological test - Pre-baseline|The 2nd stratification factor is progressive neurocognitive decline defined by objective or subjective criteria at pre-baseline. A decline of at least 1.0 standard deviation below age-matched and education-matched controls on two or more independent tests or 2.0 standard deviations below age-matched and education-matched controls on one test within 1 year before entry is defined as objective decline. Otherwise, subjective neurocognitive decline is defined by the participant or family member or caregiver AND a Center for Epidemiological Studies Depression score <16 within 45 days before entry.|participants|Number|12|12.0||||||
4366240|NCT00361257|4193214|B2|Objective Neuropsychological (NP) Test||Stratification Variable 2 - Objective or subjective Neuropsychological test - Pre-baseline|The 2nd stratification factor is progressive neurocognitive decline defined by objective or subjective criteria at pre-baseline. A decline of at least 1.0 standard deviation below age-matched and education-matched controls on two or more independent tests or 2.0 standard deviations below age-matched and education-matched controls on one test within 1 year before entry is defined as objective decline. Otherwise, subjective neurocognitive decline is defined by the participant or family member or caregiver AND a Center for Epidemiological Studies Depression score <16 within 45 days before entry.|participants|Number|7|7.0||||||
4366258|NCT00361257|4193214|B2|CSF RNA VL <30 copies/mL||HIV-1 CerebroSpinal Fluid (CSF) RNA Viral Loads (VL)|HIV CSF RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|18|18.0||||||
4366336|NCT00361257|4193214|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366241|NCT00361257|4193215|B1|Objective Neuropsychological (NP) Test||Stratification Variable 2 - Objective or subjective Neuropsychological test - Pre-baseline|The 2nd stratification factor is progressive neurocognitive decline defined by objective or subjective criteria at pre-baseline. A decline of at least 1.0 standard deviation below age-matched and education-matched controls on two or more independent tests or 2.0 standard deviations below age-matched and education-matched controls on one test within 1 year before entry is defined as objective decline. Otherwise, subjective neurocognitive decline is defined by the participant or family member or caregiver AND a Center for Epidemiological Studies Depression score <16 within 45 days before entry.|participants|Number|5|5.0||||||
4366242|NCT00361257|4193213|B3|No Lumbar Punctures (LPs)||Stratification Variable 1 - CSF Viral Load (VL) - Pre-baseline|Participants were stratified based on two factors. One is CSF HIV-1 RNA. This variable has three levels using the TaqMan assay in CSF: (1) HIV CSF RNA VLs ≥30 copies/mL (detectable), <30 copies/mL (Undetectable), or no lumbar punctures (LPs). The assessment was conducted BEFORE the baseline in order to use this information for randomization.|participants|Number|57|57.0||||||
4366243|NCT00361257|4193214|B2|No Lumbar Punctures (LPs)||Stratification Variable 1 - CSF Viral Load (VL) - Pre-baseline|Participants were stratified based on two factors. One is CSF HIV-1 RNA. This variable has three levels using the TaqMan assay in CSF: (1) HIV CSF RNA VLs ≥30 copies/mL (detectable), <30 copies/mL (Undetectable), or no lumbar punctures (LPs). The assessment was conducted BEFORE the baseline in order to use this information for randomization.|participants|Number|29|29.0||||||
4366244|NCT00361257|4193215|B1|No Lumbar Punctures (LPs)||Stratification Variable 1 - CSF Viral Load (VL) - Pre-baseline|Participants were stratified based on two factors. One is CSF HIV-1 RNA. This variable has three levels using the TaqMan assay in CSF: (1) HIV CSF RNA VLs ≥30 copies/mL (detectable), <30 copies/mL (Undetectable), or no lumbar punctures (LPs). The assessment was conducted BEFORE the baseline in order to use this information for randomization.|participants|Number|28|28.0||||||
4366245|NCT00361257|4193213|B3|CSF RNA VL >= 30 copies/mL||Stratification Variable 1 - CSF Viral Load (VL) - Pre-baseline|Participants were stratified based on two factors. One is CSF HIV-1 RNA. This variable has three levels using the TaqMan assay in CSF: (1) HIV CSF RNA VLs ≥30 copies/mL (detectable), <30 copies/mL (Undetectable), or no lumbar punctures (LPs). The assessment was conducted BEFORE the baseline in order to use this information for randomization.|participants|Number|7|7.0||||||
4366246|NCT00361257|4193214|B2|CSF RNA VL >= 30 copies/mL||Stratification Variable 1 - CSF Viral Load (VL) - Pre-baseline|Participants were stratified based on two factors. One is CSF HIV-1 RNA. This variable has three levels using the TaqMan assay in CSF: (1) HIV CSF RNA VLs ≥30 copies/mL (detectable), <30 copies/mL (Undetectable), or no lumbar punctures (LPs). The assessment was conducted BEFORE the baseline in order to use this information for randomization.|participants|Number|4|4.0||||||
4366247|NCT00361257|4193215|B1|CSF RNA VL >= 30 copies/mL||Stratification Variable 1 - CSF Viral Load (VL) - Pre-baseline|Participants were stratified based on two factors. One is CSF HIV-1 RNA. This variable has three levels using the TaqMan assay in CSF: (1) HIV CSF RNA VLs ≥30 copies/mL (detectable), <30 copies/mL (Undetectable), or no lumbar punctures (LPs). The assessment was conducted BEFORE the baseline in order to use this information for randomization.|participants|Number|3|3.0||||||
4366248|NCT00361257|4193213|B3|CSF RNA VL < 30 copies/mL||Stratification Variable 1 - CSF Viral Load (VL) - Pre-baseline|Participants were stratified based on two factors. One is CSF HIV-1 RNA. This variable has three levels using the TaqMan assay in CSF: (1) HIV CSF RNA VLs ≥30 copies/mL (detectable), <30 copies/mL (Undetectable), or no lumbar punctures (LPs). The assessment was conducted BEFORE the baseline in order to use this information for randomization.|participants|Number|43|43.0||||||
4366249|NCT00361257|4193214|B2|CSF RNA VL < 30 copies/mL||Stratification Variable 1 - CSF Viral Load (VL) - Pre-baseline|Participants were stratified based on two factors. One is CSF HIV-1 RNA. This variable has three levels using the TaqMan assay in CSF: (1) HIV CSF RNA VLs ≥30 copies/mL (detectable), <30 copies/mL (Undetectable), or no lumbar punctures (LPs). The assessment was conducted BEFORE the baseline in order to use this information for randomization.|participants|Number|22|22.0||||||
4366250|NCT00361257|4193215|B1|CSF RNA VL < 30 copies/mL||Stratification Variable 1 - CSF Viral Load (VL) - Pre-baseline|Participants were stratified based on two factors. One is CSF HIV-1 RNA. This variable has three levels using the TaqMan assay in CSF: (1) HIV CSF RNA VLs ≥30 copies/mL (detectable), <30 copies/mL (Undetectable), or no lumbar punctures (LPs). The assessment was conducted BEFORE the baseline in order to use this information for randomization.|participants|Number|21|21.0||||||
4366251|NCT00361257|4193213|B3|||Central Nervous System (CNS) Penetration Score|The baseline CNS penetration score is calculated based on the revised CNS penetration-effectiveness ranks (provided by Dr. Scott Letendre). The score is simply a sum of the ranks of all drugs which participants took at baseline. The better the drug penetrates, the higher the score. The range of ranks are 1 to 4, so the CNS penetration score is integer numbers greater than 1.|Scores on a scale|Mean|7|7.0|Standard Deviation|3|3.0|||
4366252|NCT00361257|4193214|B2|||Central Nervous System (CNS) Penetration Score|The baseline CNS penetration score is calculated based on the revised CNS penetration-effectiveness ranks (provided by Dr. Scott Letendre). The score is simply a sum of the ranks of all drugs which participants took at baseline. The better the drug penetrates, the higher the score. The range of ranks are 1 to 4, so the CNS penetration score is integer numbers greater than 1.|Scores on a scale|Mean|7|7.0|Standard Deviation|3|3.0|||
4366253|NCT00361257|4193215|B1|||Central Nervous System (CNS) Penetration Score|The baseline CNS penetration score is calculated based on the revised CNS penetration-effectiveness ranks (provided by Dr. Scott Letendre). The score is simply a sum of the ranks of all drugs which participants took at baseline. The better the drug penetrates, the higher the score. The range of ranks are 1 to 4, so the CNS penetration score is integer numbers greater than 1.|Scores on a scale|Mean|7|7.0|Standard Deviation|3|3.0|||
4366254|NCT00361257|4193213|B3|missing||HIV-1 CerebroSpinal Fluid (CSF) RNA Viral Loads (VL)|HIV CSF RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|66|66.0||||||
4366255|NCT00361257|4193214|B2|missing||HIV-1 CerebroSpinal Fluid (CSF) RNA Viral Loads (VL)|HIV CSF RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|35|35.0||||||
4366256|NCT00361257|4193215|B1|missing||HIV-1 CerebroSpinal Fluid (CSF) RNA Viral Loads (VL)|HIV CSF RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|31|31.0||||||
4366259|NCT00361257|4193215|B1|CSF RNA VL <30 copies/mL||HIV-1 CerebroSpinal Fluid (CSF) RNA Viral Loads (VL)|HIV CSF RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|20|20.0||||||
4366260|NCT00361257|4193213|B3|CSF RNA VL >=30 copies/mL||HIV-1 CerebroSpinal Fluid (CSF) RNA Viral Loads (VL)|HIV CSF RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|3|3.0||||||
4366261|NCT00361257|4193214|B2|CSF RNA VL >=30 copies/mL||HIV-1 CerebroSpinal Fluid (CSF) RNA Viral Loads (VL)|HIV CSF RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|2|2.0||||||
4366262|NCT00361257|4193215|B1|CSF RNA VL >=30 copies/mL||HIV-1 CerebroSpinal Fluid (CSF) RNA Viral Loads (VL)|HIV CSF RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|1|1.0||||||
4366263|NCT00361257|4193213|B3|missing||HIV-1 Plasma RiboNucleic Acid (RNA) Viral Loads|HIV Plasma RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|11|11.0||||||
4366264|NCT00361257|4193214|B2|missing||HIV-1 Plasma RiboNucleic Acid (RNA) Viral Loads|HIV Plasma RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|8|8.0||||||
4366265|NCT00361257|4193215|B1|missing||HIV-1 Plasma RiboNucleic Acid (RNA) Viral Loads|HIV Plasma RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|3|3.0||||||
4366266|NCT00361257|4193213|B3|Plasma RNA VL < 30 copies/mL||HIV-1 Plasma RiboNucleic Acid (RNA) Viral Loads|HIV Plasma RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|83|83.0||||||
4366267|NCT00361257|4193214|B2|Plasma RNA VL < 30 copies/mL||HIV-1 Plasma RiboNucleic Acid (RNA) Viral Loads|HIV Plasma RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|41|41.0||||||
4366268|NCT00361257|4193215|B1|Plasma RNA VL < 30 copies/mL||HIV-1 Plasma RiboNucleic Acid (RNA) Viral Loads|HIV Plasma RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|42|42.0||||||
4366269|NCT00361257|4193213|B3|Plasma RNA VL >=30 copies/mL||HIV-1 Plasma RiboNucleic Acid (RNA) Viral Loads|HIV Plasma RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|13|13.0||||||
4366270|NCT00361257|4193214|B2|Plasma RNA VL >=30 copies/mL||HIV-1 Plasma RiboNucleic Acid (RNA) Viral Loads|HIV Plasma RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|6|6.0||||||
4366271|NCT00361257|4193215|B1|Plasma RNA VL >=30 copies/mL||HIV-1 Plasma RiboNucleic Acid (RNA) Viral Loads|HIV Plasma RNA viral load less than 30 copies/mL is undetectable, the values will be imputed as 30 copies/mL.|participants|Number|7|7.0||||||
4366272|NCT00361257|4193213|B3|||Cluster of Differentiation 8 (CD8)|CD8 counts by group at baseline|copies/mm^3|Mean|880.96|880.96|Standard Deviation|362.88|362.88|||
4366273|NCT00361257|4193214|B2|||Cluster of Differentiation 8 (CD8)|CD8 counts by group at baseline|copies/mm^3|Mean|838.78|838.78|Standard Deviation|353.73|353.73|||
4366274|NCT00361257|4193215|B1|||Cluster of Differentiation 8 (CD8)|CD8 counts by group at baseline|copies/mm^3|Mean|925.58|925.58|Standard Deviation|370.48|370.48|||
4366275|NCT00361257|4193213|B3|||Cluster of Differentiation 4 (CD4)|CD4 counts by group at baseline|copies/mm^3|Mean|543.35|543.35|Standard Deviation|282.53|282.53|||
4366276|NCT00361257|4193214|B2|||Cluster of Differentiation 4 (CD4)|CD4 counts by group at baseline|copies/mm^3|Mean|535.49|535.49|Standard Deviation|253.11|253.11|||
4366277|NCT00361257|4193215|B1|||Cluster of Differentiation 4 (CD4)|CD4 counts by group at baseline|copies/mm^3|Mean|551.65|551.65|Standard Deviation|312.96|312.96|||
4366278|NCT00361257|4193213|B3|missing||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|5|5.0||||||
4366279|NCT00361257|4193214|B2|missing||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|0|0.0||||||
4366280|NCT00361257|4193215|B1|missing||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|5|5.0||||||
4366281|NCT00361257|4193213|B3|100||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|13|13.0||||||
4366330|NCT00361257|4193214|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4366331|NCT00361257|4193215|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366332|NCT00361257|4193213|B3||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4366333|NCT00361257|4193214|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4366282|NCT00361257|4193214|B2|100||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|5|5.0||||||
4366283|NCT00361257|4193215|B1|100||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|8|8.0||||||
4366284|NCT00361257|4193213|B3|90||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|55|55.0||||||
4366285|NCT00361257|4193214|B2|90||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|34|34.0||||||
4366286|NCT00361257|4193215|B1|90||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|21|21.0||||||
4366287|NCT00361257|4193213|B3|80||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|29|29.0||||||
4366288|NCT00361257|4193214|B2|80||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|16|16.0||||||
4366289|NCT00361257|4193215|B1|80||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|13|13.0||||||
4366290|NCT00361257|4193213|B3|70||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|5|5.0||||||
4366291|NCT00361257|4193214|B2|70||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|0|0.0||||||
4366292|NCT00361257|4193215|B1|70||Karnofsky Score|"Karnofsky performance score is ranged from 100 to 0:~100: Normal; 90: Able to Carry on normal Activity; 80: Normal Activity with Effort; Some Signs or Symptoms of Disease; 70: Cares for Self, Unable to Carry on Normal Activity or to Do Active Work; 60: Requires Occasional Assistance but is Able to Care for Most of Needs; 50: Requires Considerable Assistance and Frequent Medical Care; 40: Disabled, Requires Special Care and Assistance; 30: Severely Disabled; Hospitalization Indicated Although Death is Not Imminent; 20: Very Sick; 10: Morbibund, Fatal Processes Progressing Rapidly; 0: Death"|participants|Number|5|5.0||||||
4366334|NCT00361257|4193215|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4366335|NCT00361257|4193213|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366293|NCT00361257|4193213|B3|||Frontal Systems Function Domain Z-Score|This is the average age and education adjusted z-scores of Stroop Color Interference Test (CTP) and interference task (STP). The Stroop Task is a measure of divided attentional abilities. Performance is measured by the amount of time required to read each of three cards: (1) blocks of colors, (2) names of colors, and (3) colored words. For each task, the time (in seconds) is the score that should be recorded on the form. A task that cannot be completed in 240 seconds is scored as incomplete.|z-score|Mean|-0.92|-0.92|Standard Deviation|1.32|1.32|||
4366294|NCT00361257|4193214|B2|||Frontal Systems Function Domain Z-Score|This is the average age and education adjusted z-scores of Stroop Color Interference Test (CTP) and interference task (STP). The Stroop Task is a measure of divided attentional abilities. Performance is measured by the amount of time required to read each of three cards: (1) blocks of colors, (2) names of colors, and (3) colored words. For each task, the time (in seconds) is the score that should be recorded on the form. A task that cannot be completed in 240 seconds is scored as incomplete.|z-score|Mean|-1.05|-1.05|Standard Deviation|1.57|1.57|||
4366295|NCT00361257|4193215|B1|||Frontal Systems Function Domain Z-Score|This is the average age and education adjusted z-scores of Stroop Color Interference Test (CTP) and interference task (STP). The Stroop Task is a measure of divided attentional abilities. Performance is measured by the amount of time required to read each of three cards: (1) blocks of colors, (2) names of colors, and (3) colored words. For each task, the time (in seconds) is the score that should be recorded on the form. A task that cannot be completed in 240 seconds is scored as incomplete.|z-score|Mean|-0.79|-0.79|Standard Deviation|0.98|0.98|||
4366296|NCT00361257|4193213|B3|||Verbal Memory Domain Z-Score|"This is the average of z-scores of Hopkins Verbal Learning Test- Revised, Learning and Delayed Recall Tests adjusted for age and education. The recognition test list comprises 24 words, consisting of 12 words from the original list and 12 distracters. The subject must answer yes if the word was from the list and no otherwise. Twenty minutes after the third list from verbal learning and immediate recall, delayed recall is assessed by asking the subject to recall as many words as possible from the list. The score is the number of words that are correctly recalled from the original list."|z-score|Mean|-1.37|-1.37|Standard Deviation|1.14|1.14|||
4366297|NCT00361257|4193214|B2|||Verbal Memory Domain Z-Score|"This is the average of z-scores of Hopkins Verbal Learning Test- Revised, Learning and Delayed Recall Tests adjusted for age and education. The recognition test list comprises 24 words, consisting of 12 words from the original list and 12 distracters. The subject must answer yes if the word was from the list and no otherwise. Twenty minutes after the third list from verbal learning and immediate recall, delayed recall is assessed by asking the subject to recall as many words as possible from the list. The score is the number of words that are correctly recalled from the original list."|z-score|Mean|-1.41|-1.41|Standard Deviation|1.12|1.12|||
4366298|NCT00361257|4193215|B1|||Verbal Memory Domain Z-Score|"This is the average of z-scores of Hopkins Verbal Learning Test- Revised, Learning and Delayed Recall Tests adjusted for age and education. The recognition test list comprises 24 words, consisting of 12 words from the original list and 12 distracters. The subject must answer yes if the word was from the list and no otherwise. Twenty minutes after the third list from verbal learning and immediate recall, delayed recall is assessed by asking the subject to recall as many words as possible from the list. The score is the number of words that are correctly recalled from the original list."|z-score|Mean|-1.33|-1.33|Standard Deviation|1.16|1.16|||
4366299|NCT00361257|4193213|B3|||Information Processing Function Domain Z-Score|This is the average age and education adjusted z-scores of simple and sequential reaction time tests adjusted for age and education.|z-score|Mean|-1.04|-1.04|Standard Deviation|1.50|1.5|||
4366300|NCT00361257|4193214|B2|||Information Processing Function Domain Z-Score|This is the average age and education adjusted z-scores of simple and sequential reaction time tests adjusted for age and education.|z-score|Mean|-1.03|-1.03|Standard Deviation|1.49|1.49|||
4366301|NCT00361257|4193215|B1|||Information Processing Function Domain Z-Score|This is the average age and education adjusted z-scores of simple and sequential reaction time tests adjusted for age and education.|z-score|Mean|-1.05|-1.05|Standard Deviation|1.52|1.52|||
4366302|NCT00361257|4193213|B3|||Fine Motor/Nonverbal Function Domain Z-Score|This score is a age and education adjusted z score of Symbol Digit Test (SYD). This test assesses the participant's ability to maintain rapid visual-motor sequencing in a timed test. The score is the total number of correctly transcribed numbers in the time limit (90 seconds). Participants receive 1 point for each item filled in correctly.|z-score|Mean|-1.18|-1.18|Standard Deviation|1.16|1.16|||
4366303|NCT00361257|4193214|B2|||Fine Motor/Nonverbal Function Domain Z-Score|This score is a age and education adjusted z score of Symbol Digit Test (SYD). This test assesses the participant's ability to maintain rapid visual-motor sequencing in a timed test. The score is the total number of correctly transcribed numbers in the time limit (90 seconds). Participants receive 1 point for each item filled in correctly.|z-score|Mean|-1.24|-1.24|Standard Deviation|1.18|1.18|||
4366304|NCT00361257|4193215|B1|||Fine Motor/Nonverbal Function Domain Z-Score|This score is a age and education adjusted z score of Symbol Digit Test (SYD). This test assesses the participant's ability to maintain rapid visual-motor sequencing in a timed test. The score is the total number of correctly transcribed numbers in the time limit (90 seconds). Participants receive 1 point for each item filled in correctly.|z-score|Mean|-1.11|-1.11|Standard Deviation|1.15|1.15|||
4366305|NCT00361257|4193213|B3|||Psychomotor Function Domain Z-Score|This is an average of z-scores of Trail Making Part A (TMA) and Trail Making Part B (TMB) tests adjusted for age, sex, education, and African-American ethnicity. The TMA and TMB tests are measures of planning ability, visual-motor speed and concentration. Subjects are required to connect randomly placed numbers in sequence (1-25 for TMA) or to sequentially connect both numbers and letters while alternating back and forth (1-A-2-B-3-C-4-D etc. for TMB). Scores are the time in seconds required to complete the tasks.|z-score|Mean|0.10|0.1|Standard Deviation|1.01|1.01|||
4366306|NCT00361257|4193214|B2|||Psychomotor Function Domain Z-Score|This is an average of z-scores of Trail Making Part A (TMA) and Trail Making Part B (TMB) tests adjusted for age, sex, education, and African-American ethnicity. The TMA and TMB tests are measures of planning ability, visual-motor speed and concentration. Subjects are required to connect randomly placed numbers in sequence (1-25 for TMA) or to sequentially connect both numbers and letters while alternating back and forth (1-A-2-B-3-C-4-D etc. for TMB). Scores are the time in seconds required to complete the tasks.|z-score|Mean|0.04|0.04|Standard Deviation|1.03|1.03|||
4366307|NCT00361257|4193215|B1|||Psychomotor Function Domain Z-Score|This is an average of z-scores of Trail Making Part A (TMA) and Trail Making Part B (TMB) tests adjusted for age, sex, education, and African-American ethnicity. The TMA and TMB tests are measures of planning ability, visual-motor speed and concentration. Subjects are required to connect randomly placed numbers in sequence (1-25 for TMA) or to sequentially connect both numbers and letters while alternating back and forth (1-A-2-B-3-C-4-D etc. for TMB). Scores are the time in seconds required to complete the tasks.|z-score|Mean|0.15|0.15|Standard Deviation|1.00|1.0|||
4366308|NCT00361257|4193213|B3|||Fine Motor Function Domain Z-Score|This is an average z-scores of Grooved Pegboard Dominant and Non-Dominant Hand Tests adjusted for age, sex, education, and African-American ethnicity. The grooved pegboard is a manipulative dexterity test requiring rapid visual-motor coordination. The test is completed using the dominant hand (GPD) and then using the non-dominant hand (GPN). The score for each hand is the time in seconds that the participant takes to complete the entire board.|z-score|Mean|-0.55|-0.55|Standard Deviation|0.99|0.99|||
4366309|NCT00361257|4193214|B2|||Fine Motor Function Domain Z-Score|This is an average z-scores of Grooved Pegboard Dominant and Non-Dominant Hand Tests adjusted for age, sex, education, and African-American ethnicity. The grooved pegboard is a manipulative dexterity test requiring rapid visual-motor coordination. The test is completed using the dominant hand (GPD) and then using the non-dominant hand (GPN). The score for each hand is the time in seconds that the participant takes to complete the entire board.|z-score|Mean|-0.73|-0.73|Standard Deviation|0.99|0.99|||
4366310|NCT00361257|4193215|B1|||Fine Motor Function Domain Z-Score|This is an average z-scores of Grooved Pegboard Dominant and Non-Dominant Hand Tests adjusted for age, sex, education, and African-American ethnicity. The grooved pegboard is a manipulative dexterity test requiring rapid visual-motor coordination. The test is completed using the dominant hand (GPD) and then using the non-dominant hand (GPN). The score for each hand is the time in seconds that the participant takes to complete the entire board.|z-score|Mean|-0.35|-0.35|Standard Deviation|0.96|0.96|||
4366311|NCT00361257|4193213|B3|||Cognitive Gross Motor Function Domain Z-Score|The cognitive gross motor function is age and education adjusted z-score of Timed Gait.|z-score|Mean|-3.06|-3.06|Standard Deviation|3.71|3.71|||
4366312|NCT00361257|4193214|B2|||Cognitive Gross Motor Function Domain Z-Score|The cognitive gross motor function is age and education adjusted z-score of Timed Gait.|z-score|Mean|-3.66|-3.66|Standard Deviation|4.16|4.16|||
4366313|NCT00361257|4193215|B1|||Cognitive Gross Motor Function Domain Z-Score|The cognitive gross motor function is age and education adjusted z-score of Timed Gait.|z-score|Mean|-2.44|-2.44|Standard Deviation|3.10|3.1|||
4366314|NCT00361257|4193213|B3|||Global Deficit Z-Score (GDS)|GDS is defined as the average of age and education adjusted z-scores of 14 individual deficit scores in the test battery, including Time Gait, Grooved Pegboard Test for the dominant and non-dominant hands, Trail Making Test parts A and B, Symbol Digit Test, simple and sequential reaction time - CalCAP, Hopkins Verbal Learning Test (Revised)- Learning, Delayed Recall and Recognition trials, and Stroop Color Interference Test-color, word, and interference tasks.|z-score|Mean|-0.97|-0.97|Standard Deviation|0.82|0.82|||
4366315|NCT00361257|4193214|B2|||Global Deficit Z-Score (GDS)|GDS is defined as the average of age and education adjusted z-scores of 14 individual deficit scores in the test battery, including Time Gait, Grooved Pegboard Test for the dominant and non-dominant hands, Trail Making Test parts A and B, Symbol Digit Test, simple and sequential reaction time - CalCAP, Hopkins Verbal Learning Test (Revised)- Learning, Delayed Recall and Recognition trials, and Stroop Color Interference Test-color, word, and interference tasks.|z-score|Mean|-1.08|-1.08|Standard Deviation|0.90|0.9|||
4366316|NCT00361257|4193215|B1|||Global Deficit Z-Score (GDS)|GDS is defined as the average of age and education adjusted z-scores of 14 individual deficit scores in the test battery, including Time Gait, Grooved Pegboard Test for the dominant and non-dominant hands, Trail Making Test parts A and B, Symbol Digit Test, simple and sequential reaction time - CalCAP, Hopkins Verbal Learning Test (Revised)- Learning, Delayed Recall and Recognition trials, and Stroop Color Interference Test-color, word, and interference tasks.|z-score|Mean|-0.86|-0.86|Standard Deviation|0.72|0.72|||
4366317|NCT00361257|4193213|B3|||Cognitive Performance Score NPZ-8|"Cognitive performance is measured by NPZ-8. The NPZ-8 is defined as the average of age and education adjusted z-scores of eight neuropsychological tests subcomponents in the neuropsychological test battery:~Grooved Pegboard Dominant Hand (GPD)~Grooved Pegboard Non-dominant hand (GPN)~Choice Reaction Time (CRT)~Sequential Reaction Time (QRT)~Timed Gait (TIG)~Trail Making Part A (TMA)~Trail Making Part B (TMB)~Symbol Digit (SYD)"|z-score|Mean|-0.90|-0.9|Standard Deviation|0.95|0.95|||
4366318|NCT00361257|4193214|B2|||Cognitive Performance Score NPZ-8|"Cognitive performance is measured by NPZ-8. The NPZ-8 is defined as the average of age and education adjusted z-scores of eight neuropsychological tests subcomponents in the neuropsychological test battery:~Grooved Pegboard Dominant Hand (GPD)~Grooved Pegboard Non-dominant hand (GPN)~Choice Reaction Time (CRT)~Sequential Reaction Time (QRT)~Timed Gait (TIG)~Trail Making Part A (TMA)~Trail Making Part B (TMB)~Symbol Digit (SYD)"|z-score|Mean|-1.03|-1.03|Standard Deviation|0.98|0.98|||
4366319|NCT00361257|4193215|B1|||Cognitive Performance Score NPZ-8|"Cognitive performance is measured by NPZ-8. The NPZ-8 is defined as the average of age and education adjusted z-scores of eight neuropsychological tests subcomponents in the neuropsychological test battery:~Grooved Pegboard Dominant Hand (GPD)~Grooved Pegboard Non-dominant hand (GPN)~Choice Reaction Time (CRT)~Sequential Reaction Time (QRT)~Timed Gait (TIG)~Trail Making Part A (TMA)~Trail Making Part B (TMB)~Symbol Digit (SYD)"|z-score|Mean|-0.75|-0.75|Standard Deviation|0.90|0.9|||
4366320|NCT00361257|4193213|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4366321|NCT00361257|4193214|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4366322|NCT00361257|4193215|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4366323|NCT00361257|4193213|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4366324|NCT00361257|4193214|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4366325|NCT00361257|4193215|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4366326|NCT00361257|4193213|B3|||Age||years|Mean|51|51.0|Standard Deviation|7|7.0|||
4366327|NCT00361257|4193214|B2|||Age||years|Mean|52|52.0|Standard Deviation|7|7.0|||
4366328|NCT00361257|4193215|B1|||Age||years|Mean|50|50.0|Standard Deviation|7|7.0|||
4366329|NCT00361257|4193213|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4366337|NCT00361257|4193215|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366338|NCT00361231|4193268|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4366339|NCT00361231|4193268|B1||Male|Gender||Participants|Count of Participants|21|21.0||||||
4366340|NCT00361231|4193268|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
4366341|NCT00361231|4193268|B1|||Age||years|Median|60|60.0|Full Range|||25.0|82.0|
4366342|NCT00361231|4193268|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4366343|NCT00361231|4193268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4366344|NCT00361231|4193268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366345|NCT00361218|4193273|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4366346|NCT00361218|4193273|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4366347|NCT00361218|4193273|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4366348|NCT00361218|4193273|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|13.3|13.3|||
4366349|NCT00361218|4193273|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4366350|NCT00361218|4193273|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4366351|NCT00361218|4193273|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366352|NCT00361140|4193278|B4|United States||Region of Enrollment||participants|Number|72|72.0||||||
4366353|NCT00361140|4193279|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4366354|NCT00361140|4193280|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4366355|NCT00361140|4193281|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4366356|NCT00361140|4193278|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4366357|NCT00361140|4193279|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366358|NCT00361140|4193280|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4366359|NCT00361140|4193281|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4366360|NCT00361140|4193278|B4||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4366361|NCT00361140|4193279|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4366362|NCT00361140|4193280|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4366363|NCT00361140|4193281|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4366364|NCT00361140|4193278|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366365|NCT00361140|4193279|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366366|NCT00361140|4193280|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366367|NCT00361140|4193281|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366368|NCT00361140|4193278|B4||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4366369|NCT00361140|4193279|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4366370|NCT00361140|4193280|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4366371|NCT00361140|4193281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4366372|NCT00361140|4193278|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366373|NCT00361140|4193279|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366374|NCT00361140|4193280|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366375|NCT00361140|4193281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366376|NCT00360971|4193294|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4366377|NCT00360971|4193295|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4366378|NCT00360971|4193296|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4366379|NCT00360971|4193294|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4366380|NCT00360971|4193295|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4366381|NCT00360971|4193296|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366382|NCT00360971|4193294|B3|||Age||years|Median|55|55.0|Full Range|||35.0|82.0|
4366383|NCT00360971|4193295|B2|||Age||years|Median|55|55.0|Full Range|||48.0|67.0|
4366384|NCT00360971|4193296|B1|||Age||years|Median|52|52.0|Full Range|||35.0|82.0|
4366385|NCT00360828|4193313|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4366386|NCT00360828|4193313|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4366387|NCT00360828|4193313|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4366388|NCT00360828|4193313|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366389|NCT00360828|4193313|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4366390|NCT00360828|4193313|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366391|NCT00360724|4193321|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4366392|NCT00360724|4193322|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4366393|NCT00360724|4193323|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4366394|NCT00360724|4193321|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4366395|NCT00360724|4193322|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4366396|NCT00360724|4193323|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4366397|NCT00360724|4193321|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4366398|NCT00360724|4193322|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4366399|NCT00360724|4193323|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4366400|NCT00360724|4193321|B3|||Age||years|Mean|41.6|41.6|Standard Deviation|11.2|11.2|||
4366401|NCT00360724|4193322|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|11.4|11.4|||
4366402|NCT00360724|4193323|B1|||Age||years|Mean|41|41.0|Standard Deviation|11.7|11.7|||
4366403|NCT00360724|4193321|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4366404|NCT00360724|4193322|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366405|NCT00360724|4193323|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4366406|NCT00360724|4193321|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4366407|NCT00360724|4193322|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4366408|NCT00360724|4193323|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4366409|NCT00360724|4193321|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366410|NCT00360724|4193322|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366411|NCT00360724|4193323|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366412|NCT00360698|4193350|B3|||Weight|"Total patients analyzed n=105 due to one missing data in the insulin glulisine+insulin glargine+metformin+glimepiride group"|kg|Mean|92.3|92.3|Standard Deviation|16.83|16.83|||
4366413|NCT00360698|4193351|B2|||Weight|"Total patients analyzed n=105 due to one missing data in the insulin glulisine+insulin glargine+metformin+glimepiride group"|kg|Mean|92.9|92.9|Standard Deviation|17.15|17.15|||
4366414|NCT00360698|4193352|B1|||Weight|"Total patients analyzed n=105 due to one missing data in the insulin glulisine+insulin glargine+metformin+glimepiride group"|kg|Mean|91.5|91.5|Standard Deviation|16.60|16.6|||
4366415|NCT00360698|4193350|B3|||Glycosylated Haemoglobin (HbA1c)||percent|Mean|7.9|7.9|Standard Deviation|0.64|0.64|||
4366416|NCT00360698|4193351|B2|||Glycosylated Haemoglobin (HbA1c)||percent|Mean|8.0|8.0|Standard Deviation|0.67|0.67|||
4366417|NCT00360698|4193352|B1|||Glycosylated Haemoglobin (HbA1c)||percent|Mean|7.8|7.8|Standard Deviation|0.60|0.6|||
4366418|NCT00360698|4193350|B3|||Duration of diabetes||years|Mean|11.5|11.5|Standard Deviation|7.13|7.13|||
4366419|NCT00360698|4193351|B2|||Duration of diabetes||years|Mean|11.0|11.0|Standard Deviation|7.02|7.02|||
4366420|NCT00360698|4193352|B1|||Duration of diabetes||years|Mean|12.1|12.1|Standard Deviation|7.29|7.29|||
4366421|NCT00360698|4193350|B3|||Daily Mean Plasma Glucose|"Patients having a baseline value and a value on treatment:~insulin glulisine+insulin glargine+metformin+glimepiride group n=47 patients, insulin glargine+metformin+glimepiride group n=55 patients"|mg/dL|Mean|169|169.0|Standard Deviation|34.33|34.33|||
4366422|NCT00360698|4193351|B2|||Daily Mean Plasma Glucose|"Patients having a baseline value and a value on treatment:~insulin glulisine+insulin glargine+metformin+glimepiride group n=47 patients, insulin glargine+metformin+glimepiride group n=55 patients"|mg/dL|Mean|167.4|167.4|Standard Deviation|39.41|39.41|||
4366423|NCT00360698|4193352|B1|||Daily Mean Plasma Glucose|"Patients having a baseline value and a value on treatment:~insulin glulisine+insulin glargine+metformin+glimepiride group n=47 patients, insulin glargine+metformin+glimepiride group n=55 patients"|mg/dL|Mean|170.2|170.2|Standard Deviation|27.86|27.86|||
4366424|NCT00360698|4193350|B3|||Body Mass Index (BMI)|"Total patients analyzed n=105 due to one missing data in the insulin glulisine+insulin glargine+metformin+glimepiride group"|kg/m²|Mean|33.3|33.3|Standard Deviation|4.80|4.8|||
4366425|NCT00360698|4193351|B2|||Body Mass Index (BMI)|"Total patients analyzed n=105 due to one missing data in the insulin glulisine+insulin glargine+metformin+glimepiride group"|kg/m²|Mean|33.3|33.3|Standard Deviation|4.39|4.39|||
4366426|NCT00360698|4193352|B1|||Body Mass Index (BMI)|"Total patients analyzed n=105 due to one missing data in the insulin glulisine+insulin glargine+metformin+glimepiride group"|kg/m²|Mean|33.2|33.2|Standard Deviation|5.30|5.3|||
4366427|NCT00360698|4193350|B3|Russian Federation||Region of Enrollment||participants|Number|31|31.0||||||
4366428|NCT00360698|4193351|B2|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
4366429|NCT00360698|4193352|B1|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4366430|NCT00360698|4193350|B3|United Kingdom||Region of Enrollment||participants|Number|25|25.0||||||
4366431|NCT00360698|4193351|B2|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4366432|NCT00360698|4193352|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4366433|NCT00360698|4193350|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4366434|NCT00360698|4193351|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4366435|NCT00360698|4193352|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4366436|NCT00360698|4193350|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4366437|NCT00360698|4193351|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4366438|NCT00360698|4193352|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4366439|NCT00360698|4193350|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4366440|NCT00360698|4193351|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4366441|NCT00360698|4193352|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4366442|NCT00360698|4193350|B3|||Age||years|Mean|59.9|59.9|Standard Deviation|7.92|7.92|||
4366443|NCT00360698|4193351|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|8.84|8.84|||
4366444|NCT00360698|4193352|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|6.73|6.73|||
4366445|NCT00360685|4193379|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
4366446|NCT00360685|4193380|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4366447|NCT00360685|4193381|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4366448|NCT00360685|4193379|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4366449|NCT00360685|4193380|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4366450|NCT00360685|4193381|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4366451|NCT00360685|4193379|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4366452|NCT00360685|4193380|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4366453|NCT00360685|4193381|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4366454|NCT00360685|4193379|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4366455|NCT00360685|4193380|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4366456|NCT00360685|4193381|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4366457|NCT00360685|4193379|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4366458|NCT00360685|4193380|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4366459|NCT00360685|4193381|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4366460|NCT00360685|4193379|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366461|NCT00360685|4193380|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366462|NCT00360685|4193381|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366463|NCT00360672|4193392|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4366464|NCT00360672|4193392|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4366465|NCT00360672|4193392|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4366466|NCT00360672|4193392|B1|||Age||years|Median|64|64.0|Full Range|||39.0|88.0|
4366467|NCT00360568|4193396|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4366468|NCT00360568|4193397|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4366469|NCT00360568|4193398|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4366470|NCT00360568|4193396|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4366471|NCT00360568|4193397|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4366472|NCT00360568|4193398|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4366473|NCT00360568|4193396|B3|>=65 years||Age, Customized||participants|Number|30|30.0||||||
4366474|NCT00360568|4193397|B2|>=65 years||Age, Customized||participants|Number|16|16.0||||||
4366475|NCT00360568|4193398|B1|>=65 years||Age, Customized||participants|Number|14|14.0||||||
4366476|NCT00360568|4193396|B3|<65 years||Age, Customized||participants|Number|32|32.0||||||
4366477|NCT00360568|4193397|B2|<65 years||Age, Customized||participants|Number|13|13.0||||||
4366478|NCT00360568|4193398|B1|<65 years||Age, Customized||participants|Number|19|19.0||||||
4366479|NCT00360568|4193396|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|7.9|7.9|||
4366480|NCT00360568|4193397|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|6.6|6.6|||
4366481|NCT00360568|4193398|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|9.0|9.0|||
4366482|NCT00360555|4193506|B5|Canada||Region of Enrollment||participants|Number|190|190.0||||||
4366483|NCT00360555|4193507|B4|Canada||Region of Enrollment||participants|Number|46|46.0||||||
4366484|NCT00360555|4193508|B3|Canada||Region of Enrollment||participants|Number|46|46.0||||||
4366485|NCT00360555|4193509|B2|Canada||Region of Enrollment||participants|Number|48|48.0||||||
4366486|NCT00360555|4193510|B1|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4366487|NCT00360555|4193506|B5|United States||Region of Enrollment||participants|Number|1391|1391.0||||||
4366488|NCT00360555|4193507|B4|United States||Region of Enrollment||participants|Number|352|352.0||||||
4366489|NCT00360555|4193508|B3|United States||Region of Enrollment||participants|Number|349|349.0||||||
4366490|NCT00360555|4193509|B2|United States||Region of Enrollment||participants|Number|344|344.0||||||
4366491|NCT00360555|4193510|B1|United States||Region of Enrollment||participants|Number|346|346.0||||||
4366492|NCT00360555|4193506|B5|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366493|NCT00360555|4193507|B4|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366494|NCT00360555|4193508|B3|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366495|NCT00360555|4193509|B2|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366496|NCT00360555|4193510|B1|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366497|NCT00360555|4193506|B5|Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4366498|NCT00360555|4193507|B4|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4366499|NCT00360555|4193508|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4366500|NCT00360555|4193509|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4366501|NCT00360555|4193510|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4366502|NCT00360555|4193506|B5|Black||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
4366503|NCT00360555|4193507|B4|Black||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4366504|NCT00360555|4193508|B3|Black||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4366505|NCT00360555|4193509|B2|Black||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4366506|NCT00360555|4193510|B1|Black||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4366507|NCT00360555|4193506|B5|Black Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4366508|NCT00360555|4193507|B4|Black Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4366509|NCT00360555|4193508|B3|Black Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366510|NCT00360555|4193509|B2|Black Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366511|NCT00360555|4193510|B1|Black Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4366512|NCT00360555|4193506|B5|White Hispanic||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4366513|NCT00360555|4193507|B4|White Hispanic||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4366514|NCT00360555|4193508|B3|White Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4366515|NCT00360555|4193509|B2|White Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4366516|NCT00360555|4193510|B1|White Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4366517|NCT00360555|4193506|B5|White||Race/Ethnicity, Customized||participants|Number|1363|1363.0||||||
4366518|NCT00360555|4193507|B4|White||Race/Ethnicity, Customized||participants|Number|343|343.0||||||
4366519|NCT00360555|4193508|B3|White||Race/Ethnicity, Customized||participants|Number|334|334.0||||||
4366520|NCT00360555|4193509|B2|White||Race/Ethnicity, Customized||participants|Number|345|345.0||||||
4366521|NCT00360555|4193510|B1|White||Race/Ethnicity, Customized||participants|Number|341|341.0||||||
4366522|NCT00360555|4193506|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366523|NCT00360555|4193507|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366524|NCT00360555|4193508|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366525|NCT00360555|4193509|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366526|NCT00360555|4193510|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366527|NCT00360555|4193506|B5||Female|Sex: Female, Male||Participants|Count of Participants|1581|1581.0||||||
4366528|NCT00360555|4193507|B4||Female|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4366529|NCT00360555|4193508|B3||Female|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4366530|NCT00360555|4193509|B2||Female|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
4366531|NCT00360555|4193510|B1||Female|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
4366532|NCT00360555|4193506|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366533|NCT00360555|4193507|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366534|NCT00360555|4193508|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366535|NCT00360555|4193509|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366536|NCT00360555|4193510|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366537|NCT00360555|4193506|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1581|1581.0||||||
4366538|NCT00360555|4193507|B4||Between 18 and 65 years|Age||Participants|Count of Participants|398|398.0||||||
4366539|NCT00360555|4193508|B3||Between 18 and 65 years|Age||Participants|Count of Participants|395|395.0||||||
4366540|NCT00360555|4193509|B2||Between 18 and 65 years|Age||Participants|Count of Participants|392|392.0||||||
4366541|NCT00360555|4193510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|396|396.0||||||
4366542|NCT00360555|4193506|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366543|NCT00360555|4193507|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366544|NCT00360555|4193508|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366545|NCT00360555|4193509|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366546|NCT00360555|4193510|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366547|NCT00360529|4193527|B4|||Body mass index||kilogram/square meter|Mean|26.76|26.76|Standard Deviation|6.02|6.02|||
4366548|NCT00360529|4193528|B3|||Body mass index||kilogram/square meter|Mean|27.04|27.04|Standard Deviation|5.85|5.85|||
4366549|NCT00360529|4193529|B2|||Body mass index||kilogram/square meter|Mean|26.90|26.9|Standard Deviation|6.13|6.13|||
4366550|NCT00360529|4193530|B1|||Body mass index||kilogram/square meter|Mean|26.35|26.35|Standard Deviation|6.07|6.07|||
4366551|NCT00360529|4193527|B4|||Weight||kilograms|Mean|72.68|72.68|Standard Deviation|16.68|16.68|||
4366552|NCT00360529|4193528|B3|||Weight||kilograms|Mean|74.19|74.19|Standard Deviation|17.53|17.53|||
4366553|NCT00360529|4193529|B2|||Weight||kilograms|Mean|72.78|72.78|Standard Deviation|17.05|17.05|||
4366554|NCT00360529|4193530|B1|||Weight||kilograms|Mean|71.09|71.09|Standard Deviation|15.31|15.31|||
4366555|NCT00360529|4193527|B4|||Smoking history - pack years||pack years|Mean|6.43|6.43|Standard Deviation|7.20|7.2|||
4366556|NCT00360529|4193528|B3|||Smoking history - pack years||pack years|Mean|6.07|6.07|Standard Deviation|8.26|8.26|||
4366557|NCT00360529|4193529|B2|||Smoking history - pack years||pack years|Mean|6.46|6.46|Standard Deviation|6.09|6.09|||
4366558|NCT00360529|4193530|B1|||Smoking history - pack years||pack years|Mean|6.72|6.72|Standard Deviation|7.27|7.27|||
4366559|NCT00360529|4193527|B4|Currently smokes||Smoking history||participants|Number|101|101.0||||||
4366560|NCT00360529|4193528|B3|Currently smokes||Smoking history||participants|Number|29|29.0||||||
4366561|NCT00360529|4193529|B2|Currently smokes||Smoking history||participants|Number|37|37.0||||||
4366562|NCT00360529|4193530|B1|Currently smokes||Smoking history||participants|Number|35|35.0||||||
4366563|NCT00360529|4193527|B4|Ex-smoker||Smoking history||participants|Number|171|171.0||||||
4366564|NCT00360529|4193528|B3|Ex-smoker||Smoking history||participants|Number|55|55.0||||||
4366565|NCT00360529|4193529|B2|Ex-smoker||Smoking history||participants|Number|56|56.0||||||
4366566|NCT00360529|4193530|B1|Ex-smoker||Smoking history||participants|Number|60|60.0||||||
4366567|NCT00360529|4193527|B4|Never smoked||Smoking history||participants|Number|608|608.0||||||
4366568|NCT00360529|4193528|B3|Never smoked||Smoking history||participants|Number|206|206.0||||||
4366569|NCT00360529|4193529|B2|Never smoked||Smoking history||participants|Number|202|202.0||||||
4366570|NCT00360529|4193530|B1|Never smoked||Smoking history||participants|Number|200|200.0||||||
4366571|NCT00360529|4193527|B4|Drinks - possible interference||Alcohol status||participants|Number|0|0.0||||||
4366572|NCT00360529|4193528|B3|Drinks - possible interference||Alcohol status||participants|Number|0|0.0||||||
4366573|NCT00360529|4193529|B2|Drinks - possible interference||Alcohol status||participants|Number|0|0.0||||||
4366574|NCT00360529|4193530|B1|Drinks - possible interference||Alcohol status||participants|Number|0|0.0||||||
4366575|NCT00360529|4193527|B4|Drinks - no interference||Alcohol status||participants|Number|651|651.0||||||
4366576|NCT00360529|4193528|B3|Drinks - no interference||Alcohol status||participants|Number|212|212.0||||||
4366577|NCT00360529|4193529|B2|Drinks - no interference||Alcohol status||participants|Number|212|212.0||||||
4366578|NCT00360529|4193530|B1|Drinks - no interference||Alcohol status||participants|Number|227|227.0||||||
4366579|NCT00360529|4193527|B4|Non drinker||Alcohol status||participants|Number|229|229.0||||||
4366580|NCT00360529|4193528|B3|Non drinker||Alcohol status||participants|Number|78|78.0||||||
4366581|NCT00360529|4193529|B2|Non drinker||Alcohol status||participants|Number|83|83.0||||||
4366582|NCT00360529|4193530|B1|Non drinker||Alcohol status||participants|Number|68|68.0||||||
4366583|NCT00360529|4193527|B4|||How long in present relationship||years|Mean|10.64|10.64|Standard Deviation|6.61|6.61|||
4366584|NCT00360529|4193528|B3|||How long in present relationship||years|Mean|10.48|10.48|Standard Deviation|6.38|6.38|||
4366585|NCT00360529|4193529|B2|||How long in present relationship||years|Mean|11.05|11.05|Standard Deviation|6.94|6.94|||
4366586|NCT00360529|4193530|B1|||How long in present relationship||years|Mean|10.39|10.39|Standard Deviation|6.50|6.5|||
4366587|NCT00360529|4193527|B4|Missing||Employment status||participants|Number|0|0.0||||||
4366588|NCT00360529|4193528|B3|Missing||Employment status||participants|Number|0|0.0||||||
4366589|NCT00360529|4193529|B2|Missing||Employment status||participants|Number|0|0.0||||||
4366590|NCT00360529|4193530|B1|Missing||Employment status||participants|Number|0|0.0||||||
4366591|NCT00360529|4193527|B4|Unemployed||Employment status||participants|Number|31|31.0||||||
4366592|NCT00360529|4193528|B3|Unemployed||Employment status||participants|Number|16|16.0||||||
4366593|NCT00360529|4193529|B2|Unemployed||Employment status||participants|Number|7|7.0||||||
4366594|NCT00360529|4193530|B1|Unemployed||Employment status||participants|Number|8|8.0||||||
4366595|NCT00360529|4193527|B4|Full time homemaker||Employment status||participants|Number|92|92.0||||||
4366596|NCT00360529|4193528|B3|Full time homemaker||Employment status||participants|Number|31|31.0||||||
4366597|NCT00360529|4193529|B2|Full time homemaker||Employment status||participants|Number|28|28.0||||||
4366598|NCT00360529|4193530|B1|Full time homemaker||Employment status||participants|Number|33|33.0||||||
4366599|NCT00360529|4193527|B4|Occassional (1-16 hours/week)||Employment status||participants|Number|28|28.0||||||
4366600|NCT00360529|4193528|B3|Occassional (1-16 hours/week)||Employment status||participants|Number|15|15.0||||||
4366601|NCT00360529|4193529|B2|Occassional (1-16 hours/week)||Employment status||participants|Number|8|8.0||||||
4366602|NCT00360529|4193530|B1|Occassional (1-16 hours/week)||Employment status||participants|Number|5|5.0||||||
4366603|NCT00360529|4193527|B4|Part time (17-39 hours/week)||Employment status||participants|Number|160|160.0||||||
4366604|NCT00360529|4193528|B3|Part time (17-39 hours/week)||Employment status||participants|Number|48|48.0||||||
4366605|NCT00360529|4193529|B2|Part time (17-39 hours/week)||Employment status||participants|Number|58|58.0||||||
4366606|NCT00360529|4193530|B1|Part time (17-39 hours/week)||Employment status||participants|Number|54|54.0||||||
4366607|NCT00360529|4193527|B4|Full time (>= 40 hours/week)||Employment status||participants|Number|569|569.0||||||
4366608|NCT00360529|4193528|B3|Full time (>= 40 hours/week)||Employment status||participants|Number|180|180.0||||||
4366609|NCT00360529|4193529|B2|Full time (>= 40 hours/week)||Employment status||participants|Number|194|194.0||||||
4366610|NCT00360529|4193530|B1|Full time (>= 40 hours/week)||Employment status||participants|Number|195|195.0||||||
4366611|NCT00360529|4193527|B4|Missing||Education level||participants|Number|0|0.0||||||
4366612|NCT00360529|4193528|B3|Missing||Education level||participants|Number|0|0.0||||||
4366613|NCT00360529|4193529|B2|Missing||Education level||participants|Number|0|0.0||||||
4366614|NCT00360529|4193530|B1|Missing||Education level||participants|Number|0|0.0||||||
4366615|NCT00360529|4193527|B4|Post-graduate/professional degree||Education level||participants|Number|133|133.0||||||
4366616|NCT00360529|4193528|B3|Post-graduate/professional degree||Education level||participants|Number|46|46.0||||||
4366617|NCT00360529|4193529|B2|Post-graduate/professional degree||Education level||participants|Number|45|45.0||||||
4366618|NCT00360529|4193530|B1|Post-graduate/professional degree||Education level||participants|Number|42|42.0||||||
4366619|NCT00360529|4193527|B4|College/university graduate||Education level||participants|Number|400|400.0||||||
4366620|NCT00360529|4193528|B3|College/university graduate||Education level||participants|Number|130|130.0||||||
4366621|NCT00360529|4193529|B2|College/university graduate||Education level||participants|Number|131|131.0||||||
4366622|NCT00360529|4193530|B1|College/university graduate||Education level||participants|Number|139|139.0||||||
4366623|NCT00360529|4193527|B4|Partial college/university||Education level||participants|Number|243|243.0||||||
4366624|NCT00360529|4193528|B3|Partial college/university||Education level||participants|Number|85|85.0||||||
4366625|NCT00360529|4193529|B2|Partial college/university||Education level||participants|Number|80|80.0||||||
4366626|NCT00360529|4193530|B1|Partial college/university||Education level||participants|Number|78|78.0||||||
4366627|NCT00360529|4193527|B4|High school graduate or equivalent||Education level||participants|Number|94|94.0||||||
4366628|NCT00360529|4193528|B3|High school graduate or equivalent||Education level||participants|Number|26|26.0||||||
4366629|NCT00360529|4193529|B2|High school graduate or equivalent||Education level||participants|Number|33|33.0||||||
4366630|NCT00360529|4193530|B1|High school graduate or equivalent||Education level||participants|Number|35|35.0||||||
4366631|NCT00360529|4193527|B4|Partial high school||Education level||participants|Number|10|10.0||||||
4366632|NCT00360529|4193528|B3|Partial high school||Education level||participants|Number|3|3.0||||||
4366633|NCT00360529|4193529|B2|Partial high school||Education level||participants|Number|6|6.0||||||
4366634|NCT00360529|4193530|B1|Partial high school||Education level||participants|Number|1|1.0||||||
4366635|NCT00360529|4193527|B4|Married||Marital Status||participants|Number|680|680.0||||||
4366636|NCT00360529|4193528|B3|Married||Marital Status||participants|Number|229|229.0||||||
4366637|NCT00360529|4193529|B2|Married||Marital Status||participants|Number|214|214.0||||||
4366638|NCT00360529|4193530|B1|Married||Marital Status||participants|Number|237|237.0||||||
4366639|NCT00360529|4193527|B4|Unmarried||Marital Status||participants|Number|200|200.0||||||
4366640|NCT00360529|4193528|B3|Unmarried||Marital Status||participants|Number|61|61.0||||||
4366641|NCT00360529|4193529|B2|Unmarried||Marital Status||participants|Number|81|81.0||||||
4366642|NCT00360529|4193530|B1|Unmarried||Marital Status||participants|Number|58|58.0||||||
4366643|NCT00360529|4193527|B4|United States||Region of Enrollment||participants|Number|679|679.0||||||
4366644|NCT00360529|4193528|B3|United States||Region of Enrollment||participants|Number|224|224.0||||||
4366645|NCT00360529|4193529|B2|United States||Region of Enrollment||participants|Number|226|226.0||||||
4366646|NCT00360529|4193530|B1|United States||Region of Enrollment||participants|Number|229|229.0||||||
4366647|NCT00360529|4193527|B4|Canada||Region of Enrollment||participants|Number|201|201.0||||||
4366648|NCT00360529|4193528|B3|Canada||Region of Enrollment||participants|Number|66|66.0||||||
4366649|NCT00360529|4193529|B2|Canada||Region of Enrollment||participants|Number|69|69.0||||||
4366650|NCT00360529|4193530|B1|Canada||Region of Enrollment||participants|Number|66|66.0||||||
4366651|NCT00360529|4193527|B4|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4366652|NCT00360529|4193528|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4366653|NCT00360529|4193529|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366654|NCT00360529|4193530|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366655|NCT00360529|4193527|B4|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4366656|NCT00360529|4193528|B3|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4366657|NCT00360529|4193529|B2|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366658|NCT00360529|4193530|B1|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366659|NCT00360529|4193527|B4|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4366660|NCT00360529|4193528|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4366661|NCT00360529|4193529|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4366662|NCT00360529|4193530|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4366663|NCT00360529|4193527|B4|Black||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4366664|NCT00360529|4193528|B3|Black||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4366665|NCT00360529|4193529|B2|Black||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4366666|NCT00360529|4193530|B1|Black||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4366667|NCT00360529|4193527|B4|Black Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4366668|NCT00360529|4193528|B3|Black Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4366669|NCT00360529|4193529|B2|Black Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4366670|NCT00360529|4193530|B1|Black Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4366671|NCT00360529|4193527|B4|White Hispanic||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4366672|NCT00360529|4193528|B3|White Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4366673|NCT00360529|4193529|B2|White Hispanic||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4366674|NCT00360529|4193530|B1|White Hispanic||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4366675|NCT00360529|4193527|B4|White||Race/Ethnicity, Customized||participants|Number|701|701.0||||||
4366676|NCT00360529|4193528|B3|White||Race/Ethnicity, Customized||participants|Number|229|229.0||||||
4366677|NCT00360529|4193529|B2|White||Race/Ethnicity, Customized||participants|Number|237|237.0||||||
4366678|NCT00360529|4193530|B1|White||Race/Ethnicity, Customized||participants|Number|235|235.0||||||
4366679|NCT00360529|4193527|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366680|NCT00360529|4193528|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366681|NCT00360529|4193529|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366682|NCT00360529|4193530|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366683|NCT00360529|4193527|B4||Female|Sex: Female, Male||Participants|Count of Participants|880|880.0||||||
4366684|NCT00360529|4193528|B3||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4366685|NCT00360529|4193529|B2||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4366686|NCT00360529|4193530|B1||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4366687|NCT00360529|4193527|B4|>= 45 years||Age, Customized||participants|Number|114|114.0||||||
4366688|NCT00360529|4193528|B3|>= 45 years||Age, Customized||participants|Number|38|38.0||||||
4366689|NCT00360529|4193529|B2|>= 45 years||Age, Customized||participants|Number|43|43.0||||||
4366690|NCT00360529|4193530|B1|>= 45 years||Age, Customized||participants|Number|33|33.0||||||
4366691|NCT00360529|4193527|B4|35 - 44 years||Age, Customized||participants|Number|379|379.0||||||
4366692|NCT00360529|4193528|B3|35 - 44 years||Age, Customized||participants|Number|118|118.0||||||
4366693|NCT00360529|4193529|B2|35 - 44 years||Age, Customized||participants|Number|125|125.0||||||
4366694|NCT00360529|4193530|B1|35 - 44 years||Age, Customized||participants|Number|136|136.0||||||
4366695|NCT00360529|4193527|B4|18 - 34 years||Age, Customized||participants|Number|387|387.0||||||
4366696|NCT00360529|4193528|B3|18 - 34 years||Age, Customized||participants|Number|134|134.0||||||
4366697|NCT00360529|4193529|B2|18 - 34 years||Age, Customized||participants|Number|127|127.0||||||
4366698|NCT00360529|4193530|B1|18 - 34 years||Age, Customized||participants|Number|126|126.0||||||
4366699|NCT00360529|4193527|B4|||Age||years|Mean|35.8|35.8|Standard Deviation|7.2|7.2|||
4366700|NCT00360529|4193528|B3|||Age||years|Mean|35.6|35.6|Standard Deviation|7.2|7.2|||
4366701|NCT00360529|4193529|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|7.5|7.5|||
4366702|NCT00360529|4193530|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|7.0|7.0|||
4366703|NCT00360490|4193558|B3|||Body mass index|There is one participant [patient identifier (pid) =11407] missing in Levonorgestrel Intrauterine System group.|kg/m²|Mean|27.28|27.28|Standard Deviation|4.263|4.263|||
4366704|NCT00360490|4193559|B2|||Body mass index|There is one participant [patient identifier (pid) =11407] missing in Levonorgestrel Intrauterine System group.|kg/m²|Mean|27.36|27.36|Standard Deviation|4.610|4.61|||
4366705|NCT00360490|4193560|B1|||Body mass index|There is one participant [patient identifier (pid) =11407] missing in Levonorgestrel Intrauterine System group.|kg/m²|Mean|27.19|27.19|Standard Deviation|3.903|3.903|||
4366706|NCT00360490|4193558|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366707|NCT00360490|4193559|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366708|NCT00360490|4193560|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366709|NCT00360490|4193558|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4366710|NCT00360490|4193559|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4366711|NCT00360490|4193560|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4366712|NCT00360490|4193558|B3|||Age||years|Mean|38.8|38.8|Full Range|||26.0|53.0|
4366713|NCT00360490|4193559|B2|||Age||years|Mean|39.3|39.3|Full Range|||26.0|53.0|
4366714|NCT00360490|4193560|B1|||Age||years|Mean|38.3|38.3|Full Range|||26.0|50.0|
4366715|NCT00360412|4193594|B3|Other||Race/Ethnicity, Customized|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety population.|Participants|Number|21|21.0||||||
4366716|NCT00360412|4193595|B2|Other||Race/Ethnicity, Customized|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety population.|Participants|Number|15|15.0||||||
4366717|NCT00360412|4193596|B1|Other||Race/Ethnicity, Customized|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety population.|Participants|Number|6|6.0||||||
4366718|NCT00360412|4193594|B3|Asian||Race/Ethnicity, Customized|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety population.|Participants|Number|6|6.0||||||
4366719|NCT00360412|4193595|B2|Asian||Race/Ethnicity, Customized|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety population.|Participants|Number|2|2.0||||||
4366720|NCT00360412|4193596|B1|Asian||Race/Ethnicity, Customized|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety population.|Participants|Number|4|4.0||||||
4366721|NCT00360412|4193594|B3|Black||Race/Ethnicity, Customized|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety population.|Participants|Number|7|7.0||||||
4366722|NCT00360412|4193595|B2|Black||Race/Ethnicity, Customized|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety population.|Participants|Number|4|4.0||||||
4366723|NCT00360412|4193596|B1|Black||Race/Ethnicity, Customized|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety population.|Participants|Number|3|3.0||||||
4366724|NCT00360412|4193594|B3|White||Race/Ethnicity, Customized|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety population.|Participants|Number|963|963.0||||||
4366725|NCT00360412|4193595|B2|White||Race/Ethnicity, Customized|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety population.|Participants|Number|643|643.0||||||
4366726|NCT00360412|4193596|B1|White||Race/Ethnicity, Customized|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety population.|Participants|Number|320|320.0||||||
4366727|NCT00360412|4193594|B3||Male|Sex: Female, Male|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety Population - All subjects entering the open-label extension study who took at least 1 dose of perampanel|Participants|Count of Participants|644|644.0||||||
4366728|NCT00360412|4193595|B2||Male|Sex: Female, Male|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety Population - All subjects entering the open-label extension study who took at least 1 dose of perampanel|Participants|Count of Participants|428|428.0||||||
4366729|NCT00360412|4193596|B1||Male|Sex: Female, Male|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety Population - All subjects entering the open-label extension study who took at least 1 dose of perampanel|Participants|Count of Participants|216|216.0||||||
4366730|NCT00360412|4193594|B3||Female|Sex: Female, Male|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety Population - All subjects entering the open-label extension study who took at least 1 dose of perampanel|Participants|Count of Participants|353|353.0||||||
4366731|NCT00360412|4193595|B2||Female|Sex: Female, Male|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety Population - All subjects entering the open-label extension study who took at least 1 dose of perampanel|Participants|Count of Participants|236|236.0||||||
4366732|NCT00360412|4193596|B1||Female|Sex: Female, Male|Data comes from previous double-blind core studies (E2007-E044-301 and E2007-A001-302). Safety Population - All subjects entering the open-label extension study who took at least 1 dose of perampanel|Participants|Count of Participants|117|117.0||||||
4366733|NCT00360412|4193594|B3|>=65 years||Age, Customized|Data comes from previous double-blind core studies (E2007-E044-301) and (E2007-A001-302).|Participants|Number|453|453.0||||||
4366734|NCT00360412|4193595|B2|>=65 years||Age, Customized|Data comes from previous double-blind core studies (E2007-E044-301) and (E2007-A001-302).|Participants|Number|307|307.0||||||
4366735|NCT00360412|4193596|B1|>=65 years||Age, Customized|Data comes from previous double-blind core studies (E2007-E044-301) and (E2007-A001-302).|Participants|Number|146|146.0||||||
4366773|NCT00360399|4193611|B2|No||Current Anxiety Disorder||participants|Number|48|48.0||||||
4366736|NCT00360412|4193594|B3|<65 years||Age, Customized|Data comes from previous double-blind core studies (E2007-E044-301) and (E2007-A001-302).|Participants|Number|544|544.0||||||
4366737|NCT00360412|4193595|B2|<65 years||Age, Customized|Data comes from previous double-blind core studies (E2007-E044-301) and (E2007-A001-302).|Participants|Number|357|357.0||||||
4366738|NCT00360412|4193596|B1|<65 years||Age, Customized|Data comes from previous double-blind core studies (E2007-E044-301) and (E2007-A001-302).|Participants|Number|187|187.0||||||
4366739|NCT00360399|4193609|B4|No||History of Suicide Attempt|The number of participants who have a prior history of suicide attempt.|participants|Number|319|319.0||||||
4366740|NCT00360399|4193610|B3|No||History of Suicide Attempt|The number of participants who have a prior history of suicide attempt.|participants|Number|107|107.0||||||
4366741|NCT00360399|4193611|B2|No||History of Suicide Attempt|The number of participants who have a prior history of suicide attempt.|participants|Number|102|102.0||||||
4366742|NCT00360399|4193612|B1|No||History of Suicide Attempt|The number of participants who have a prior history of suicide attempt.|participants|Number|110|110.0||||||
4366743|NCT00360399|4193609|B4|Yes||History of Suicide Attempt|The number of participants who have a prior history of suicide attempt.|participants|Number|25|25.0||||||
4366744|NCT00360399|4193610|B3|Yes||History of Suicide Attempt|The number of participants who have a prior history of suicide attempt.|participants|Number|8|8.0||||||
4366745|NCT00360399|4193611|B2|Yes||History of Suicide Attempt|The number of participants who have a prior history of suicide attempt.|participants|Number|13|13.0||||||
4366746|NCT00360399|4193612|B1|Yes||History of Suicide Attempt|The number of participants who have a prior history of suicide attempt.|participants|Number|4|4.0||||||
4366747|NCT00360399|4193609|B4|No||Chronic Episode of Depression (2 or More Years)|The number of participants who are experiencing a chronic episode of depression (2 or more years in duration).|participants|Number|238|238.0||||||
4366748|NCT00360399|4193610|B3|No||Chronic Episode of Depression (2 or More Years)|The number of participants who are experiencing a chronic episode of depression (2 or more years in duration).|participants|Number|77|77.0||||||
4366749|NCT00360399|4193611|B2|No||Chronic Episode of Depression (2 or More Years)|The number of participants who are experiencing a chronic episode of depression (2 or more years in duration).|participants|Number|78|78.0||||||
4366750|NCT00360399|4193612|B1|No||Chronic Episode of Depression (2 or More Years)|The number of participants who are experiencing a chronic episode of depression (2 or more years in duration).|participants|Number|83|83.0||||||
4366751|NCT00360399|4193609|B4|Yes||Chronic Episode of Depression (2 or More Years)|The number of participants who are experiencing a chronic episode of depression (2 or more years in duration).|participants|Number|106|106.0||||||
4366752|NCT00360399|4193610|B3|Yes||Chronic Episode of Depression (2 or More Years)|The number of participants who are experiencing a chronic episode of depression (2 or more years in duration).|participants|Number|38|38.0||||||
4366753|NCT00360399|4193611|B2|Yes||Chronic Episode of Depression (2 or More Years)|The number of participants who are experiencing a chronic episode of depression (2 or more years in duration).|participants|Number|37|37.0||||||
4366754|NCT00360399|4193612|B1|Yes||Chronic Episode of Depression (2 or More Years)|The number of participants who are experiencing a chronic episode of depression (2 or more years in duration).|participants|Number|31|31.0||||||
4366755|NCT00360399|4193609|B4|None||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|5|5.0||||||
4366756|NCT00360399|4193610|B3|None||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|3|3.0||||||
4366757|NCT00360399|4193611|B2|None||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|0|0.0||||||
4366758|NCT00360399|4193612|B1|None||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|2|2.0||||||
4366759|NCT00360399|4193609|B4|Three or more||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|99|99.0||||||
4366760|NCT00360399|4193610|B3|Three or more||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|28|28.0||||||
4366761|NCT00360399|4193611|B2|Three or more||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|38|38.0||||||
4366762|NCT00360399|4193612|B1|Three or more||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|33|33.0||||||
4366763|NCT00360399|4193609|B4|Two||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|63|63.0||||||
4366764|NCT00360399|4193610|B3|Two||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|17|17.0||||||
4366765|NCT00360399|4193611|B2|Two||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|26|26.0||||||
4366766|NCT00360399|4193612|B1|Two||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|20|20.0||||||
4366767|NCT00360399|4193609|B4|One||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|177|177.0||||||
4366768|NCT00360399|4193610|B3|One||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|67|67.0||||||
4366769|NCT00360399|4193611|B2|One||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|51|51.0||||||
4366770|NCT00360399|4193612|B1|One||Previous Episode(s) of Depression|The number of participants who have had 1, 2, or 3 or more prior episodes of depression|participants|Number|59|59.0||||||
4366771|NCT00360399|4193609|B4|No||Current Anxiety Disorder||participants|Number|139|139.0||||||
4366772|NCT00360399|4193610|B3|No||Current Anxiety Disorder||participants|Number|44|44.0||||||
4366774|NCT00360399|4193612|B1|No||Current Anxiety Disorder||participants|Number|47|47.0||||||
4366775|NCT00360399|4193609|B4|Yes||Current Anxiety Disorder||participants|Number|205|205.0||||||
4366776|NCT00360399|4193610|B3|Yes||Current Anxiety Disorder||participants|Number|71|71.0||||||
4366777|NCT00360399|4193611|B2|Yes||Current Anxiety Disorder||participants|Number|67|67.0||||||
4366778|NCT00360399|4193612|B1|Yes||Current Anxiety Disorder||participants|Number|67|67.0||||||
4366779|NCT00360399|4193609|B4|United States||Region of Enrollment||participants|Number|344|344.0||||||
4366780|NCT00360399|4193610|B3|United States||Region of Enrollment||participants|Number|115|115.0||||||
4366781|NCT00360399|4193611|B2|United States||Region of Enrollment||participants|Number|115|115.0||||||
4366782|NCT00360399|4193612|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4366783|NCT00360399|4193609|B4||Unknown or Not Reported|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|116|116.0||||||
4366784|NCT00360399|4193610|B3||Unknown or Not Reported|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|41|41.0||||||
4366785|NCT00360399|4193611|B2||Unknown or Not Reported|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|36|36.0||||||
4366786|NCT00360399|4193612|B1||Unknown or Not Reported|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|39|39.0||||||
4366787|NCT00360399|4193609|B4||More than one race|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366788|NCT00360399|4193610|B3||More than one race|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366789|NCT00360399|4193611|B2||More than one race|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366790|NCT00360399|4193612|B1||More than one race|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366791|NCT00360399|4193609|B4||White|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|164|164.0||||||
4366792|NCT00360399|4193610|B3||White|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|61|61.0||||||
4366793|NCT00360399|4193611|B2||White|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|56|56.0||||||
4366794|NCT00360399|4193612|B1||White|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|47|47.0||||||
4366795|NCT00360399|4193609|B4||Black or African American|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|64|64.0||||||
4366796|NCT00360399|4193610|B3||Black or African American|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|13|13.0||||||
4366797|NCT00360399|4193611|B2||Black or African American|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|23|23.0||||||
4366798|NCT00360399|4193612|B1||Black or African American|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|28|28.0||||||
4366799|NCT00360399|4193609|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366800|NCT00360399|4193610|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366801|NCT00360399|4193611|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366802|NCT00360399|4193612|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366803|NCT00360399|4193609|B4||Asian|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366804|NCT00360399|4193610|B3||Asian|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366805|NCT00360399|4193611|B2||Asian|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366806|NCT00360399|4193612|B1||Asian|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366807|NCT00360399|4193609|B4||American Indian or Alaska Native|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366808|NCT00360399|4193610|B3||American Indian or Alaska Native|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366809|NCT00360399|4193611|B2||American Indian or Alaska Native|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366810|NCT00360399|4193612|B1||American Indian or Alaska Native|Race (NIH/OMB)|"The race of participants was categorized as Caucasian, Black, and Other."|Participants|Count of Participants|0|0.0||||||
4366811|NCT00360399|4193609|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4366812|NCT00360399|4193610|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4366813|NCT00360399|4193611|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4366814|NCT00360399|4193612|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4366973|NCT00360243|4193760|B2|Black Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366815|NCT00360399|4193609|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
4366816|NCT00360399|4193610|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4366817|NCT00360399|4193611|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4366818|NCT00360399|4193612|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4366819|NCT00360399|4193609|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4366820|NCT00360399|4193610|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4366821|NCT00360399|4193611|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4366822|NCT00360399|4193612|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4366823|NCT00360399|4193609|B4||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4366824|NCT00360399|4193610|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4366825|NCT00360399|4193611|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4366826|NCT00360399|4193612|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4366827|NCT00360399|4193609|B4||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4366828|NCT00360399|4193610|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4366829|NCT00360399|4193611|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4366830|NCT00360399|4193612|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4366831|NCT00360399|4193609|B4|||Age||years|Mean|40.0|40.0|Standard Deviation|11.7|11.7|||
4366832|NCT00360399|4193610|B3|||Age||years|Mean|40.0|40.0|Standard Deviation|11.3|11.3|||
4366833|NCT00360399|4193611|B2|||Age||years|Mean|38.3|38.3|Standard Deviation|11.4|11.4|||
4366834|NCT00360399|4193612|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|12.1|12.1|||
4366835|NCT00360399|4193609|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366836|NCT00360399|4193610|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366837|NCT00360399|4193611|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366838|NCT00360399|4193612|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366839|NCT00360399|4193609|B4||Between 18 and 65 years|Age||Participants|Count of Participants|344|344.0||||||
4366840|NCT00360399|4193610|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4366841|NCT00360399|4193611|B2||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4366842|NCT00360399|4193612|B1||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4366843|NCT00360399|4193609|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366844|NCT00360399|4193610|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366845|NCT00360399|4193611|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366846|NCT00360399|4193612|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366847|NCT00360360|4193637|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4366848|NCT00360360|4193637|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4366849|NCT00360360|4193637|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4366850|NCT00360360|4193637|B1|||Age||years|Median|50|50.0|Full Range|||23.0|81.0|
4366851|NCT00360334|4193642|B3|||Baseline total cholesterol to high density lipoprotein cholesterol ratio||ratio|Mean|4.15|4.15|Standard Deviation|1.72|1.72|||
4366852|NCT00360334|4193643|B2|||Baseline total cholesterol to high density lipoprotein cholesterol ratio||ratio|Mean|4.29|4.29|Standard Deviation|2.15|2.15|||
4366853|NCT00360334|4193644|B1|||Baseline total cholesterol to high density lipoprotein cholesterol ratio||ratio|Mean|4.00|4.0|Standard Deviation|1.10|1.1|||
4366854|NCT00360334|4193642|B3|||Baseline low density lipoprotein (LDL) cholesterol||mmol/L|Mean|2.43|2.43|Standard Deviation|0.93|0.93|||
4366855|NCT00360334|4193643|B2|||Baseline low density lipoprotein (LDL) cholesterol||mmol/L|Mean|2.49|2.49|Standard Deviation|1.02|1.02|||
4366856|NCT00360334|4193644|B1|||Baseline low density lipoprotein (LDL) cholesterol||mmol/L|Mean|2.38|2.38|Standard Deviation|0.82|0.82|||
4366857|NCT00360334|4193642|B3|||Baseline high density lipoprotein (HDL) cholesterol||mmol/L|Mean|1.15|1.15|Standard Deviation|0.27|0.27|||
4366858|NCT00360334|4193643|B2|||Baseline high density lipoprotein (HDL) cholesterol||mmol/L|Mean|1.15|1.15|Standard Deviation|0.29|0.29|||
4366859|NCT00360334|4193644|B1|||Baseline high density lipoprotein (HDL) cholesterol||mmol/L|Mean|1.14|1.14|Standard Deviation|0.24|0.24|||
4366860|NCT00360334|4193642|B3|||Baseline fasting serum triglycerides||mmol/L|Mean|2.13|2.13|Standard Deviation|1.75|1.75|||
4366861|NCT00360334|4193643|B2|||Baseline fasting serum triglycerides||mmol/L|Mean|2.31|2.31|Standard Deviation|2.24|2.24|||
4366862|NCT00360334|4193644|B1|||Baseline fasting serum triglycerides||mmol/L|Mean|1.94|1.94|Standard Deviation|1.01|1.01|||
4366863|NCT00360334|4193642|B3|||Baseline fasting serum total cholesterol (TC)||mmol/L|Mean|4.54|4.54|Standard Deviation|1.13|1.13|||
4366864|NCT00360334|4193643|B2|||Baseline fasting serum total cholesterol (TC)||mmol/L|Mean|4.63|4.63|Standard Deviation|1.20|1.2|||
4366865|NCT00360334|4193644|B1|||Baseline fasting serum total cholesterol (TC)||mmol/L|Mean|4.45|4.45|Standard Deviation|1.05|1.05|||
4366866|NCT00360334|4193642|B3|||Baseline fasting serum glucose||mmol/L|Mean|10.48|10.48|Standard Deviation|2.25|2.25|||
4366867|NCT00360334|4193643|B2|||Baseline fasting serum glucose||mmol/L|Mean|10.12|10.12|Standard Deviation|2.22|2.22|||
4366868|NCT00360334|4193644|B1|||Baseline fasting serum glucose||mmol/L|Mean|10.84|10.84|Standard Deviation|2.23|2.23|||
4366869|NCT00360334|4193642|B3|||Baseline apolipoprotein-B||g/L|Mean|0.86|0.86|Standard Deviation|0.24|0.24|||
4366870|NCT00360334|4193643|B2|||Baseline apolipoprotein-B||g/L|Mean|0.88|0.88|Standard Deviation|0.24|0.24|||
4366871|NCT00360334|4193644|B1|||Baseline apolipoprotein-B||g/L|Mean|0.84|0.84|Standard Deviation|0.24|0.24|||
4366872|NCT00360334|4193642|B3|other||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|2|2.0||||||
4366873|NCT00360334|4193643|B2|other||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|1|1.0||||||
4366874|NCT00360334|4193644|B1|other||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|1|1.0||||||
4366875|NCT00360334|4193642|B3|metformin, sulfonylurea, and thiazolidinedione||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|95|95.0||||||
4366876|NCT00360334|4193643|B2|metformin, sulfonylurea, and thiazolidinedione||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|47|47.0||||||
4366877|NCT00360334|4193644|B1|metformin, sulfonylurea, and thiazolidinedione||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|48|48.0||||||
4366878|NCT00360334|4193642|B3|sulfonylurea and thiazolidinedione||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|6|6.0||||||
4366879|NCT00360334|4193643|B2|sulfonylurea and thiazolidinedione||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|4|4.0||||||
4366880|NCT00360334|4193644|B1|sulfonylurea and thiazolidinedione||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|2|2.0||||||
4366881|NCT00360334|4193642|B3|metformin and thiazolidinedione||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|32|32.0||||||
4366882|NCT00360334|4193643|B2|metformin and thiazolidinedione||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|15|15.0||||||
4366883|NCT00360334|4193644|B1|metformin and thiazolidinedione||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|17|17.0||||||
4366884|NCT00360334|4193642|B3|metformin and sulfonylurea||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|99|99.0||||||
4366885|NCT00360334|4193643|B2|metformin and sulfonylurea||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|49|49.0||||||
4366886|NCT00360334|4193644|B1|metformin and sulfonylurea||Types of oral antidiabetic medication combinations administered at baseline||participants|Number|50|50.0||||||
4366887|NCT00360334|4193642|B3|United Kingdom||Region of Enrollment||participants|Number|234|234.0||||||
4366888|NCT00360334|4193643|B2|United Kingdom||Region of Enrollment||participants|Number|116|116.0||||||
4366889|NCT00360334|4193644|B1|United Kingdom||Region of Enrollment||participants|Number|118|118.0||||||
4366890|NCT00360334|4193642|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4366891|NCT00360334|4193643|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4366892|NCT00360334|4193644|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4366893|NCT00360334|4193642|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4366894|NCT00360334|4193643|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4366895|NCT00360334|4193644|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4366896|NCT00360334|4193642|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|9.1|9.1|||
4366897|NCT00360334|4193643|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|7.9|7.9|||
4366898|NCT00360334|4193644|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|10.2|10.2|||
4366899|NCT00360308|4193705|B4|Other||Race/Ethnicity, Customized|Race.|participants|Number|2|2.0||||||
4366900|NCT00360308|4193706|B3|Other||Race/Ethnicity, Customized|Race.|participants|Number|0|0.0||||||
4366901|NCT00360308|4193707|B2|Other||Race/Ethnicity, Customized|Race.|participants|Number|1|1.0||||||
4366902|NCT00360308|4193708|B1|Other||Race/Ethnicity, Customized|Race.|participants|Number|1|1.0||||||
4366903|NCT00360308|4193705|B4|Asian||Race/Ethnicity, Customized|Race.|participants|Number|169|169.0||||||
4366904|NCT00360308|4193706|B3|Asian||Race/Ethnicity, Customized|Race.|participants|Number|57|57.0||||||
4366905|NCT00360308|4193707|B2|Asian||Race/Ethnicity, Customized|Race.|participants|Number|57|57.0||||||
4366906|NCT00360308|4193708|B1|Asian||Race/Ethnicity, Customized|Race.|participants|Number|55|55.0||||||
4366907|NCT00360308|4193705|B4|White||Race/Ethnicity, Customized|Race.|participants|Number|552|552.0||||||
4366908|NCT00360308|4193706|B3|White||Race/Ethnicity, Customized|Race.|participants|Number|185|185.0||||||
4366909|NCT00360308|4193707|B2|White||Race/Ethnicity, Customized|Race.|participants|Number|176|176.0||||||
4366910|NCT00360308|4193708|B1|White||Race/Ethnicity, Customized|Race.|participants|Number|191|191.0||||||
4366911|NCT00360308|4193705|B4||Male|Sex: Female, Male|Safety Population was used. The safety population includes the same number of subjects as the Randomized Population except 1 additional subject in the placebo group who was not randomized, but completed the study.|Participants|Count of Participants|433|433.0||||||
4366912|NCT00360308|4193706|B3||Male|Sex: Female, Male|Safety Population was used. The safety population includes the same number of subjects as the Randomized Population except 1 additional subject in the placebo group who was not randomized, but completed the study.|Participants|Count of Participants|148|148.0||||||
4366913|NCT00360308|4193707|B2||Male|Sex: Female, Male|Safety Population was used. The safety population includes the same number of subjects as the Randomized Population except 1 additional subject in the placebo group who was not randomized, but completed the study.|Participants|Count of Participants|136|136.0||||||
4366914|NCT00360308|4193708|B1||Male|Sex: Female, Male|Safety Population was used. The safety population includes the same number of subjects as the Randomized Population except 1 additional subject in the placebo group who was not randomized, but completed the study.|Participants|Count of Participants|149|149.0||||||
4366915|NCT00360308|4193705|B4||Female|Sex: Female, Male|Safety Population was used. The safety population includes the same number of subjects as the Randomized Population except 1 additional subject in the placebo group who was not randomized, but completed the study.|Participants|Count of Participants|290|290.0||||||
4366974|NCT00360243|4193761|B1|Black Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4366916|NCT00360308|4193706|B3||Female|Sex: Female, Male|Safety Population was used. The safety population includes the same number of subjects as the Randomized Population except 1 additional subject in the placebo group who was not randomized, but completed the study.|Participants|Count of Participants|94|94.0||||||
4366917|NCT00360308|4193707|B2||Female|Sex: Female, Male|Safety Population was used. The safety population includes the same number of subjects as the Randomized Population except 1 additional subject in the placebo group who was not randomized, but completed the study.|Participants|Count of Participants|98|98.0||||||
4366918|NCT00360308|4193708|B1||Female|Sex: Female, Male|Safety Population was used. The safety population includes the same number of subjects as the Randomized Population except 1 additional subject in the placebo group who was not randomized, but completed the study.|Participants|Count of Participants|98|98.0||||||
4366919|NCT00360308|4193705|B4|≥65 years||Age, Customized||participants|Number|355|355.0||||||
4366920|NCT00360308|4193706|B3|≥65 years||Age, Customized||participants|Number|119|119.0||||||
4366921|NCT00360308|4193707|B2|≥65 years||Age, Customized||participants|Number|120|120.0||||||
4366922|NCT00360308|4193708|B1|≥65 years||Age, Customized||participants|Number|116|116.0||||||
4366923|NCT00360308|4193705|B4|<65 years||Age, Customized||participants|Number|368|368.0||||||
4366924|NCT00360308|4193706|B3|<65 years||Age, Customized||participants|Number|123|123.0||||||
4366925|NCT00360308|4193707|B2|<65 years||Age, Customized||participants|Number|114|114.0||||||
4366926|NCT00360308|4193708|B1|<65 years||Age, Customized||participants|Number|131|131.0||||||
4366927|NCT00360282|4193727|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4366928|NCT00360282|4193727|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4366929|NCT00360282|4193727|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4366930|NCT00360282|4193727|B1|||Age||years|Mean|32|32.0|Standard Deviation|8.0|8.0|||
4366931|NCT00360282|4193727|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366932|NCT00360282|4193727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4366933|NCT00360282|4193727|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366934|NCT00360269|4193740|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4366935|NCT00360269|4193741|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4366936|NCT00360269|4193742|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4366937|NCT00360269|4193740|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4366938|NCT00360269|4193741|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4366939|NCT00360269|4193742|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4366940|NCT00360269|4193740|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4366941|NCT00360269|4193741|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4366942|NCT00360269|4193742|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4366943|NCT00360269|4193740|B3|||Age||years|Mean|29.9|29.9|Standard Deviation|11.5|11.5|||
4366944|NCT00360269|4193741|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|13.0|13.0|||
4366945|NCT00360269|4193742|B1|||Age||years|Mean|29.4|29.4|Standard Deviation|10.0|10.0|||
4366946|NCT00360269|4193740|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366947|NCT00360269|4193741|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366948|NCT00360269|4193742|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4366949|NCT00360269|4193740|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4366950|NCT00360269|4193741|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4366951|NCT00360269|4193742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4366952|NCT00360269|4193740|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366953|NCT00360269|4193741|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366954|NCT00360269|4193742|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4366955|NCT00360243|4193757|B5|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4366956|NCT00360243|4193758|B4|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366957|NCT00360243|4193759|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4366958|NCT00360243|4193760|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366959|NCT00360243|4193761|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366960|NCT00360243|4193757|B5|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366961|NCT00360243|4193758|B4|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366962|NCT00360243|4193759|B3|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366963|NCT00360243|4193760|B2|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366964|NCT00360243|4193761|B1|Asian Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4366965|NCT00360243|4193757|B5|Asian Non Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4366966|NCT00360243|4193758|B4|Asian Non Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4366967|NCT00360243|4193759|B3|Asian Non Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4366968|NCT00360243|4193760|B2|Asian Non Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4366969|NCT00360243|4193761|B1|Asian Non Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4366970|NCT00360243|4193757|B5|Black Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4366971|NCT00360243|4193758|B4|Black Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4366972|NCT00360243|4193759|B3|Black Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4366975|NCT00360243|4193757|B5|Black Non Hispanic||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
4366976|NCT00360243|4193758|B4|Black Non Hispanic||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4366977|NCT00360243|4193759|B3|Black Non Hispanic||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4366978|NCT00360243|4193760|B2|Black Non Hispanic||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4366979|NCT00360243|4193761|B1|Black Non Hispanic||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4366980|NCT00360243|4193757|B5|White Hispanic||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4366981|NCT00360243|4193758|B4|White Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4366982|NCT00360243|4193759|B3|White Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4366983|NCT00360243|4193760|B2|White Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4366984|NCT00360243|4193761|B1|White Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4366985|NCT00360243|4193757|B5|White Non Hispanic||Race/Ethnicity, Customized||participants|Number|1126|1126.0||||||
4366986|NCT00360243|4193758|B4|White Non Hispanic||Race/Ethnicity, Customized||participants|Number|278|278.0||||||
4366987|NCT00360243|4193759|B3|White Non Hispanic||Race/Ethnicity, Customized||participants|Number|276|276.0||||||
4366988|NCT00360243|4193760|B2|White Non Hispanic||Race/Ethnicity, Customized||participants|Number|306|306.0||||||
4366989|NCT00360243|4193761|B1|White Non Hispanic||Race/Ethnicity, Customized||participants|Number|266|266.0||||||
4366990|NCT00360243|4193757|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366991|NCT00360243|4193758|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366992|NCT00360243|4193759|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366993|NCT00360243|4193760|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366994|NCT00360243|4193761|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4366995|NCT00360243|4193757|B5||Female|Sex: Female, Male||Participants|Count of Participants|1385|1385.0||||||
4366996|NCT00360243|4193758|B4||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4366997|NCT00360243|4193759|B3||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4366998|NCT00360243|4193760|B2||Female|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
4366999|NCT00360243|4193761|B1||Female|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
4367000|NCT00360243|4193757|B5|45 years and older||Age, Customized||participants|Number|124|124.0||||||
4367001|NCT00360243|4193758|B4|45 years and older||Age, Customized||participants|Number|27|27.0||||||
4367002|NCT00360243|4193759|B3|45 years and older||Age, Customized||participants|Number|30|30.0||||||
4367003|NCT00360243|4193760|B2|45 years and older||Age, Customized||participants|Number|37|37.0||||||
4367004|NCT00360243|4193761|B1|45 years and older||Age, Customized||participants|Number|30|30.0||||||
4367005|NCT00360243|4193757|B5|35-44 years||Age, Customized||participants|Number|635|635.0||||||
4367006|NCT00360243|4193758|B4|35-44 years||Age, Customized||participants|Number|164|164.0||||||
4367007|NCT00360243|4193759|B3|35-44 years||Age, Customized||participants|Number|161|161.0||||||
4367008|NCT00360243|4193760|B2|35-44 years||Age, Customized||participants|Number|157|157.0||||||
4367009|NCT00360243|4193761|B1|35-44 years||Age, Customized||participants|Number|153|153.0||||||
4367010|NCT00360243|4193757|B5|18-34 years||Age, Customized||participants|Number|626|626.0||||||
4367011|NCT00360243|4193758|B4|18-34 years||Age, Customized||participants|Number|158|158.0||||||
4367012|NCT00360243|4193759|B3|18-34 years||Age, Customized||participants|Number|145|145.0||||||
4367013|NCT00360243|4193760|B2|18-34 years||Age, Customized||participants|Number|169|169.0||||||
4367014|NCT00360243|4193761|B1|18-34 years||Age, Customized||participants|Number|154|154.0||||||
4367015|NCT00360230|4193778|B8|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4367016|NCT00360230|4193778|B8||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4367017|NCT00360230|4193779|B7||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4367018|NCT00360230|4193780|B6||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4367019|NCT00360230|4193781|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4367020|NCT00360230|4193782|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4367021|NCT00360230|4193783|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4367022|NCT00360230|4193784|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4367023|NCT00360230|4193785|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4367024|NCT00360230|4193778|B8||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4367025|NCT00360230|4193779|B7||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4367026|NCT00360230|4193780|B6||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4367027|NCT00360230|4193781|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4367028|NCT00360230|4193782|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4367029|NCT00360230|4193783|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4367030|NCT00360230|4193784|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4367031|NCT00360230|4193785|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4367032|NCT00360230|4193778|B8|||Age||Months|Mean|10.7|10.7|Standard Deviation|3.5|3.5|||
4367033|NCT00360230|4193779|B7|||Age||Months|Mean|10.7|10.7|Standard Deviation|3.3|3.3|||
4367034|NCT00360230|4193780|B6|||Age||Months|Mean|10.4|10.4|Standard Deviation|3.6|3.6|||
4367035|NCT00360230|4193781|B5|||Age||Months|Mean|10.9|10.9|Standard Deviation|3.5|3.5|||
4367036|NCT00360230|4193782|B4|||Age||Months|Mean|10.9|10.9|Standard Deviation|3.7|3.7|||
4367037|NCT00360230|4193783|B3|||Age||Months|Mean|11.2|11.2|Standard Deviation|3.3|3.3|||
4367038|NCT00360230|4193784|B2|||Age||Months|Mean|10.4|10.4|Standard Deviation|3.4|3.4|||
4367039|NCT00360230|4193785|B1|||Age||Months|Mean|10.5|10.5|Standard Deviation|3.4|3.4|||
4367040|NCT00360126|4193842|B1|Australia||Region of Enrollment||Participants|Number|11|11.0||||||
4367041|NCT00360126|4193842|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4367042|NCT00360126|4193842|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4367043|NCT00360126|4193842|B1|||Age||Years|Mean|45.64|45.64|Standard Deviation|3.28|3.28|||
4367044|NCT00360009|4193846|B4|United States||Region of Enrollment||participants|Number|62|62.0||||||
4367045|NCT00360009|4193847|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4367046|NCT00360009|4193848|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4367047|NCT00360009|4193849|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4367048|NCT00360009|4193846|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4367049|NCT00360009|4193847|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4367050|NCT00360009|4193848|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4367051|NCT00360009|4193849|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4367052|NCT00360009|4193846|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4367053|NCT00360009|4193847|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4367054|NCT00360009|4193848|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4367055|NCT00360009|4193849|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4367056|NCT00360009|4193846|B4||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4367057|NCT00360009|4193847|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4367058|NCT00360009|4193848|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4367059|NCT00360009|4193849|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4367060|NCT00360009|4193846|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4367061|NCT00360009|4193847|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4367062|NCT00360009|4193848|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4367063|NCT00360009|4193849|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4367064|NCT00360009|4193846|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367065|NCT00360009|4193847|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367066|NCT00360009|4193848|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367067|NCT00360009|4193849|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367068|NCT00359983|4193889|B4||Male|Gender||Participants|Count of Participants|135|135.0||||||
4367069|NCT00359983|4193890|B3||Male|Gender||Participants|Count of Participants|29|29.0||||||
4367070|NCT00359983|4193891|B2||Male|Gender||Participants|Count of Participants|35|35.0||||||
4367071|NCT00359983|4193892|B1||Male|Gender||Participants|Count of Participants|71|71.0||||||
4367072|NCT00359983|4193889|B4||Female|Gender||Participants|Count of Participants|135|135.0||||||
4367073|NCT00359983|4193890|B3||Female|Gender||Participants|Count of Participants|33|33.0||||||
4367074|NCT00359983|4193891|B2||Female|Gender||Participants|Count of Participants|35|35.0||||||
4367075|NCT00359983|4193892|B1||Female|Gender||Participants|Count of Participants|67|67.0||||||
4367076|NCT00359983|4193889|B4|Months||Age||Months|Mean|27.8|27.8|Standard Deviation|3.64|3.64|||
4367077|NCT00359983|4193890|B3|Months||Age||Months|Mean|28.4|28.4|Standard Deviation|3.69|3.69|||
4367078|NCT00359983|4193891|B2|Months||Age||Months|Mean|28.2|28.2|Standard Deviation|4.05|4.05|||
4367079|NCT00359983|4193892|B1|Months||Age||Months|Mean|27.4|27.4|Standard Deviation|3.37|3.37|||
4367080|NCT00359944|4193926|B4|United States||Region of Enrollment||participants|Number|132|132.0||||||
4367081|NCT00359944|4193927|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4367082|NCT00359944|4193928|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4367083|NCT00359944|4193929|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4367084|NCT00359944|4193926|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4367085|NCT00359944|4193927|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4367086|NCT00359944|4193928|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4367087|NCT00359944|4193929|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4367088|NCT00359944|4193926|B4||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4367089|NCT00359944|4193927|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4367090|NCT00359944|4193928|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4367091|NCT00359944|4193929|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4367092|NCT00359944|4193926|B4|||Age||years|Mean|75.6|75.6|Standard Deviation|8.88|8.88|||
4367093|NCT00359944|4193927|B3|||Age||years|Mean|76.3|76.3|Standard Deviation|8.73|8.73|||
4367094|NCT00359944|4193928|B2|||Age||years|Mean|74.8|74.8|Standard Deviation|9.54|9.54|||
4367095|NCT00359944|4193929|B1|||Age||years|Mean|75.5|75.5|Standard Deviation|8.57|8.57|||
4367096|NCT00359944|4193926|B4||>=65 years|Age||Participants|Count of Participants|132|132.0||||||
4367097|NCT00359944|4193927|B3||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4367098|NCT00359944|4193928|B2||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4367099|NCT00359944|4193929|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4367100|NCT00359944|4193926|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4367101|NCT00359944|4193927|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4367102|NCT00359944|4193928|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4367103|NCT00359944|4193929|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4367104|NCT00359944|4193926|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367105|NCT00359944|4193927|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367106|NCT00359944|4193928|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367107|NCT00359944|4193929|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367108|NCT00359801|4193945|B3||Male|Sex: Female, Male||Participants|Count of Participants|1103|1103.0||||||
4367109|NCT00359801|4193946|B2||Male|Sex: Female, Male||Participants|Count of Participants|555|555.0||||||
4367110|NCT00359801|4193947|B1||Male|Sex: Female, Male||Participants|Count of Participants|548|548.0||||||
4367111|NCT00359801|4193945|B3||Female|Sex: Female, Male||Participants|Count of Participants|873|873.0||||||
4367112|NCT00359801|4193946|B2||Female|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
4367113|NCT00359801|4193947|B1||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4367114|NCT00359801|4193945|B3|>= 85 years||Age, Customized||participants|Number|5|5.0||||||
4367115|NCT00359801|4193946|B2|>= 85 years||Age, Customized||participants|Number|2|2.0||||||
4367116|NCT00359801|4193947|B1|>= 85 years||Age, Customized||participants|Number|3|3.0||||||
4367117|NCT00359801|4193945|B3|75-84 years||Age, Customized||participants|Number|109|109.0||||||
4367118|NCT00359801|4193946|B2|75-84 years||Age, Customized||participants|Number|57|57.0||||||
4367119|NCT00359801|4193947|B1|75-84 years||Age, Customized||participants|Number|52|52.0||||||
4367120|NCT00359801|4193945|B3|65-74 years||Age, Customized||participants|Number|487|487.0||||||
4367121|NCT00359801|4193946|B2|65-74 years||Age, Customized||participants|Number|245|245.0||||||
4367122|NCT00359801|4193947|B1|65-74 years||Age, Customized||participants|Number|242|242.0||||||
4367123|NCT00359801|4193945|B3|45-64 years||Age, Customized||participants|Number|1128|1128.0||||||
4367124|NCT00359801|4193946|B2|45-64 years||Age, Customized||participants|Number|552|552.0||||||
4367125|NCT00359801|4193947|B1|45-64 years||Age, Customized||participants|Number|576|576.0||||||
4367126|NCT00359801|4193945|B3|18-44 years||Age, Customized||participants|Number|247|247.0||||||
4367127|NCT00359801|4193946|B2|18-44 years||Age, Customized||participants|Number|133|133.0||||||
4367128|NCT00359801|4193947|B1|18-44 years||Age, Customized||participants|Number|114|114.0||||||
4367129|NCT00359788|4193980|B3||Male|Sex: Female, Male||Participants|Count of Participants|316.0|316.0||||||
4367130|NCT00359788|4193981|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4367131|NCT00359788|4193982|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4367132|NCT00359788|4193980|B3||Female|Sex: Female, Male||Participants|Count of Participants|33.0|33.0||||||
4367133|NCT00359788|4193981|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4367134|NCT00359788|4193982|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4367135|NCT00359788|4193980|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|7.8|7.8|||
4367136|NCT00359788|4193981|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|8|8.0|||
4367137|NCT00359788|4193982|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|7.7|7.7|||
4367138|NCT00359762|4194215|B3|||Weight||kg|Mean|92.0|92.0|Standard Deviation|15.78|15.78|||
4367139|NCT00359762|4194216|B2|||Weight||kg|Mean|91.1|91.1|Standard Deviation|14.78|14.78|||
4367140|NCT00359762|4194217|B1|||Weight||kg|Mean|92.8|92.8|Standard Deviation|16.70|16.7|||
4367141|NCT00359762|4194215|B3|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|7.4|7.4|Standard Deviation|0.70|0.7|||
4367142|NCT00359762|4194216|B2|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|7.4|7.4|Standard Deviation|0.71|0.71|||
4367143|NCT00359762|4194217|B1|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|7.4|7.4|Standard Deviation|0.69|0.69|||
4367144|NCT00359762|4194215|B3||Male|Sex: Female, Male||Participants|Count of Participants|524|524.0||||||
4367145|NCT00359762|4194216|B2||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4367146|NCT00359762|4194217|B1||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4367147|NCT00359762|4194215|B3||Female|Sex: Female, Male||Participants|Count of Participants|453|453.0||||||
4367148|NCT00359762|4194216|B2||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4367149|NCT00359762|4194217|B1||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4367150|NCT00359762|4194215|B3|||Age||years|Mean|56.4|56.4|Standard Deviation|9.60|9.6|||
4367151|NCT00359762|4194216|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|9.14|9.14|||
4367152|NCT00359762|4194217|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|10.03|10.03|||
4367153|NCT00359762|4194215|B3||>=65 years|Age||Participants|Count of Participants|200|200.0||||||
4367154|NCT00359762|4194216|B2||>=65 years|Age||Participants|Count of Participants|98|98.0||||||
4367155|NCT00359762|4194217|B1||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
4367156|NCT00359762|4194215|B3||Between 18 and 65 years|Age||Participants|Count of Participants|777|777.0||||||
4367157|NCT00359762|4194216|B2||Between 18 and 65 years|Age||Participants|Count of Participants|389|389.0||||||
4367158|NCT00359762|4194217|B1||Between 18 and 65 years|Age||Participants|Count of Participants|388|388.0||||||
4367159|NCT00359762|4194215|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367160|NCT00359762|4194216|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367161|NCT00359762|4194217|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367162|NCT00359736|4194282|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4367163|NCT00359736|4194283|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4367164|NCT00359736|4194284|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4367165|NCT00359736|4194282|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4367166|NCT00359736|4194283|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4367167|NCT00359736|4194284|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4367168|NCT00359736|4194282|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4367169|NCT00359736|4194283|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4367170|NCT00359736|4194284|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4367171|NCT00359736|4194282|B3|||Age||years|Mean|70.4|70.4|Standard Deviation|9.3|9.3|||
4367172|NCT00359736|4194283|B2|||Age||years|Mean|71.0|71.0|Standard Deviation|6.2|6.2|||
4367173|NCT00359736|4194284|B1|||Age||years|Mean|69.9|69.9|Standard Deviation|12.0|12.0|||
4367174|NCT00359736|4194282|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4367175|NCT00359736|4194283|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4367176|NCT00359736|4194284|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4367177|NCT00359736|4194282|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4367178|NCT00359736|4194283|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4367179|NCT00359736|4194284|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4367180|NCT00359736|4194282|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367181|NCT00359736|4194283|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367182|NCT00359736|4194284|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367183|NCT00359632|4194293|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4367184|NCT00359632|4194294|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4367185|NCT00359632|4194295|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4367186|NCT00359632|4194293|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4367187|NCT00359632|4194294|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4367188|NCT00359632|4194295|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4367189|NCT00359632|4194293|B3|||Age||Years|Mean|52.5|52.5|Standard Deviation|12.89|12.89|||
4367190|NCT00359632|4194294|B2|||Age||Years|Mean|50.1|50.1|Standard Deviation|11.86|11.86|||
4367191|NCT00359632|4194295|B1|||Age||Years|Mean|53.4|53.4|Standard Deviation|13.38|13.38|||
4367192|NCT00359619|4194303|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4367193|NCT00359619|4194304|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4367194|NCT00359619|4194305|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4367195|NCT00359619|4194306|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4367196|NCT00359619|4194307|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4367197|NCT00359619|4194308|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4367198|NCT00359619|4194309|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4367199|NCT00359619|4194310|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4367200|NCT00359619|4194303|B8||Female|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4367201|NCT00359619|4194304|B7||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4367202|NCT00359619|4194305|B6||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4367203|NCT00359619|4194306|B5||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4367204|NCT00359619|4194307|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4367205|NCT00359619|4194308|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4367206|NCT00359619|4194309|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4367207|NCT00359619|4194310|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4367208|NCT00359619|4194303|B8|||Age||Years|Mean|21.1|21.1|Standard Deviation|2.11|2.11|||
4367209|NCT00359619|4194304|B7|||Age||Years|Mean|20.7|20.7|Standard Deviation|1.91|1.91|||
4367210|NCT00359619|4194305|B6|||Age||Years|Mean|21.2|21.2|Standard Deviation|2.26|2.26|||
4367211|NCT00359619|4194306|B5|||Age||Years|Mean|21.4|21.4|Standard Deviation|2.27|2.27|||
4367212|NCT00359619|4194307|B4|||Age||Years|Mean|21.1|21.1|Standard Deviation|2.09|2.09|||
4367213|NCT00359619|4194308|B3|||Age||Years|Mean|21.2|21.2|Standard Deviation|2.07|2.07|||
4367214|NCT00359619|4194309|B2|||Age||Years|Mean|21.5|21.5|Standard Deviation|2.18|2.18|||
4367215|NCT00359619|4194310|B1|||Age||Years|Mean|20.9|20.9|Standard Deviation|2.03|2.03|||
4367216|NCT00359424|4194444|B3|NIHSS Score > = 20||NIHSS Score Strata||participants|Number|204|204.0||||||
4367217|NCT00359424|4194445|B2|NIHSS Score > = 20||NIHSS Score Strata||participants|Number|72|72.0||||||
4367218|NCT00359424|4194446|B1|NIHSS Score > = 20||NIHSS Score Strata||participants|Number|132|132.0||||||
4367219|NCT00359424|4194444|B3|NIHSS Score <20||NIHSS Score Strata||participants|Number|452|452.0||||||
4367220|NCT00359424|4194445|B2|NIHSS Score <20||NIHSS Score Strata||participants|Number|150|150.0||||||
4367221|NCT00359424|4194446|B1|NIHSS Score <20||NIHSS Score Strata||participants|Number|302|302.0||||||
4367222|NCT00359424|4194444|B3|||Time from stroke onset to initiation of IV rt-PA|Time from stroke onset to initiation of intravenous (IV) rt-PA in minutes.|minutes|Mean|122.0|122.0|Standard Deviation|33.7|33.7|||
4367223|NCT00359424|4194445|B2|||Time from stroke onset to initiation of IV rt-PA|Time from stroke onset to initiation of intravenous (IV) rt-PA in minutes.|minutes|Mean|121.2|121.2|Standard Deviation|33.8|33.8|||
4367224|NCT00359424|4194446|B1|||Time from stroke onset to initiation of IV rt-PA|Time from stroke onset to initiation of intravenous (IV) rt-PA in minutes.|minutes|Mean|122.4|122.4|Standard Deviation|33.7|33.7|||
4367225|NCT00359424|4194444|B3|||NIHSS Score|"The National Institutes of Health Stroke Scale (NIHSS), a serial measure of neurologic deficit, is a 42-point scale that >> quantifies neurologic deficits in 11 categories, with 0 indicating normal function without neurologic deficit and higher~>> scores indicating greater severity of deficit."|Score on a scale|Median|17|17.0|Full Range|||7.0|40.0|
4367226|NCT00359424|4194445|B2|||NIHSS Score|"The National Institutes of Health Stroke Scale (NIHSS), a serial measure of neurologic deficit, is a 42-point scale that >> quantifies neurologic deficits in 11 categories, with 0 indicating normal function without neurologic deficit and higher~>> scores indicating greater severity of deficit."|Score on a scale|Median|16|16.0|Full Range|||8.0|30.0|
4367227|NCT00359424|4194446|B1|||NIHSS Score|"The National Institutes of Health Stroke Scale (NIHSS), a serial measure of neurologic deficit, is a 42-point scale that >> quantifies neurologic deficits in 11 categories, with 0 indicating normal function without neurologic deficit and higher~>> scores indicating greater severity of deficit."|Score on a scale|Median|17|17.0|Full Range|||7.0|40.0|
4367228|NCT00359424|4194444|B3||Male|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4367229|NCT00359424|4194445|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4367230|NCT00359424|4194446|B1||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4367231|NCT00359424|4194444|B3||Female|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4367232|NCT00359424|4194445|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4367233|NCT00359424|4194446|B1||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4367234|NCT00359424|4194444|B3|||Age||years|Median|69|69.0|Full Range|||23.0|89.0|
4367235|NCT00359424|4194445|B2|||Age||years|Median|68|68.0|Full Range|||23.0|84.0|
4367236|NCT00359424|4194446|B1|||Age||years|Median|69|69.0|Full Range|||23.0|89.0|
4367237|NCT00359281|4194477|B10|United States||Region of Enrollment||participants|Number|129|129.0||||||
4367238|NCT00359281|4194478|B9|United States||Region of Enrollment||participants|Number|20|20.0||||||
4367239|NCT00359281|4194479|B8|United States||Region of Enrollment||participants|Number|15|15.0||||||
4367240|NCT00359281|4194480|B7|United States||Region of Enrollment||participants|Number|18|18.0||||||
4367241|NCT00359281|4194481|B6|United States||Region of Enrollment||participants|Number|15|15.0||||||
4367242|NCT00359281|4194482|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
4367243|NCT00359281|4194483|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4367244|NCT00359281|4194484|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4367245|NCT00359281|4194485|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4367246|NCT00359281|4194486|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4367247|NCT00359281|4194477|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4367248|NCT00359281|4194478|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4367249|NCT00359281|4194479|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367250|NCT00359281|4194480|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4367251|NCT00359281|4194481|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4367252|NCT00359281|4194482|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367253|NCT00359281|4194483|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4367254|NCT00359281|4194484|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367255|NCT00359281|4194485|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367256|NCT00359281|4194486|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367257|NCT00359281|4194477|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4367258|NCT00359281|4194478|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367259|NCT00359281|4194479|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367260|NCT00359281|4194480|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367261|NCT00359281|4194481|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367262|NCT00359281|4194482|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367263|NCT00359281|4194483|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367264|NCT00359281|4194484|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4367265|NCT00359281|4194485|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367266|NCT00359281|4194486|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367267|NCT00359281|4194477|B10||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4367268|NCT00359281|4194478|B9||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4367269|NCT00359281|4194479|B8||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4367270|NCT00359281|4194480|B7||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4367271|NCT00359281|4194481|B6||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4367272|NCT00359281|4194482|B5||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4367273|NCT00359281|4194483|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4367274|NCT00359281|4194484|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4367275|NCT00359281|4194485|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4367276|NCT00359281|4194486|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4367277|NCT00359281|4194477|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4367278|NCT00359281|4194478|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4367279|NCT00359281|4194479|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4367280|NCT00359281|4194480|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4367281|NCT00359281|4194481|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4367282|NCT00359281|4194482|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4367283|NCT00359281|4194483|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4367284|NCT00359281|4194484|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4367285|NCT00359281|4194485|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4367286|NCT00359281|4194486|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4367287|NCT00359281|4194477|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367288|NCT00359281|4194478|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367289|NCT00359281|4194479|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367290|NCT00359281|4194480|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367291|NCT00359281|4194481|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367292|NCT00359281|4194482|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367293|NCT00359281|4194483|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367294|NCT00359281|4194484|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367295|NCT00359281|4194485|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367296|NCT00359281|4194486|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367297|NCT00359281|4194477|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4367298|NCT00359281|4194478|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4367299|NCT00359281|4194479|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4367300|NCT00359281|4194480|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4367301|NCT00359281|4194481|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4367302|NCT00359281|4194482|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4367303|NCT00359281|4194483|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367304|NCT00359281|4194484|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367305|NCT00359281|4194485|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4367306|NCT00359281|4194486|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4367307|NCT00359281|4194477|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367308|NCT00359281|4194478|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367309|NCT00359281|4194479|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367310|NCT00359281|4194480|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367311|NCT00359281|4194481|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367312|NCT00359281|4194482|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367313|NCT00359281|4194483|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367314|NCT00359281|4194484|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367315|NCT00359281|4194485|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367316|NCT00359281|4194486|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367317|NCT00359281|4194477|B10||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4367318|NCT00359281|4194478|B9||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4367319|NCT00359281|4194479|B8||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4367320|NCT00359281|4194480|B7||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4367321|NCT00359281|4194481|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4367322|NCT00359281|4194482|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4367323|NCT00359281|4194483|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4367324|NCT00359281|4194484|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4367325|NCT00359281|4194485|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4367326|NCT00359281|4194486|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4367327|NCT00359281|4194477|B10||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4367328|NCT00359281|4194478|B9||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4367329|NCT00359281|4194479|B8||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4367330|NCT00359281|4194480|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4367331|NCT00359281|4194481|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4367332|NCT00359281|4194482|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4367333|NCT00359281|4194483|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4367334|NCT00359281|4194484|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4367335|NCT00359281|4194485|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4367336|NCT00359281|4194486|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4367337|NCT00359281|4194477|B10|||Age||years|Mean|28|28.0|Standard Deviation|10|10.0|||
4367338|NCT00359281|4194478|B9|||Age||years|Mean|29|29.0|Standard Deviation|11|11.0|||
4367339|NCT00359281|4194479|B8|||Age||years|Mean|27|27.0|Standard Deviation|9|9.0|||
4367340|NCT00359281|4194480|B7|||Age||years|Mean|31|31.0|Standard Deviation|13|13.0|||
4367341|NCT00359281|4194481|B6|||Age||years|Mean|27|27.0|Standard Deviation|8|8.0|||
4367342|NCT00359281|4194482|B5|||Age||years|Mean|24|24.0|Standard Deviation|3|3.0|||
4367343|NCT00359281|4194483|B4|||Age||years|Mean|31|31.0|Standard Deviation|13|13.0|||
4367344|NCT00359281|4194484|B3|||Age||years|Mean|29|29.0|Standard Deviation|9|9.0|||
4367345|NCT00359281|4194485|B2|||Age||years|Mean|29|29.0|Standard Deviation|12|12.0|||
4367346|NCT00359281|4194486|B1|||Age||years|Mean|26|26.0|Standard Deviation|7|7.0|||
4367347|NCT00359216|4194524|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4367348|NCT00359216|4194525|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4367349|NCT00359216|4194526|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4367350|NCT00359216|4194524|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4367351|NCT00359216|4194525|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4367352|NCT00359216|4194526|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4367353|NCT00359216|4194524|B3|||Age||years|Mean|34.27|34.27|Standard Deviation|9.36|9.36|||
4367354|NCT00359216|4194525|B2|||Age||years|Mean|33.70|33.7|Standard Deviation|8.11|8.11|||
4367355|NCT00359216|4194526|B1|||Age||years|Mean|34.55|34.55|Standard Deviation|10.11|10.11|||
4367356|NCT00359216|4194524|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4367357|NCT00359216|4194525|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4367358|NCT00359216|4194526|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4367359|NCT00359216|4194524|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4367360|NCT00359216|4194525|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4367361|NCT00359216|4194526|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4367362|NCT00359216|4194524|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367363|NCT00359216|4194525|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367364|NCT00359216|4194526|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367365|NCT00359203|4194533|B3|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4367366|NCT00359203|4194534|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4367367|NCT00359203|4194535|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4367368|NCT00359203|4194533|B3|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4367369|NCT00359203|4194534|B2|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4367370|NCT00359203|4194535|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4367371|NCT00359203|4194533|B3|France||Region of Enrollment||participants|Number|5|5.0||||||
4367372|NCT00359203|4194534|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4367373|NCT00359203|4194535|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4367374|NCT00359203|4194533|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4367375|NCT00359203|4194534|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4367376|NCT00359203|4194535|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4367377|NCT00359203|4194533|B3|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4367378|NCT00359203|4194534|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4367379|NCT00359203|4194535|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4367380|NCT00359203|4194533|B3|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4367381|NCT00359203|4194534|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4367382|NCT00359203|4194535|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4367383|NCT00359203|4194533|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4367384|NCT00359203|4194534|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4367385|NCT00359203|4194535|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4367386|NCT00359203|4194533|B3|Spain||Region of Enrollment||participants|Number|16|16.0||||||
4367387|NCT00359203|4194534|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4367388|NCT00359203|4194535|B1|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4367389|NCT00359203|4194533|B3|Italy||Region of Enrollment||participants|Number|36|36.0||||||
4367390|NCT00359203|4194534|B2|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4367391|NCT00359203|4194535|B1|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4367392|NCT00359203|4194533|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4367393|NCT00359203|4194534|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4367394|NCT00359203|4194535|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4367395|NCT00359203|4194533|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4367396|NCT00359203|4194534|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4367397|NCT00359203|4194535|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4367398|NCT00359203|4194533|B3|||Age||years|Mean|63|63.0|Standard Deviation|13|13.0|||
4367399|NCT00359203|4194534|B2|||Age||years|Mean|63|63.0|Standard Deviation|14|14.0|||
4367400|NCT00359203|4194535|B1|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
4367401|NCT00359203|4194533|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4367402|NCT00359203|4194534|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4367403|NCT00359203|4194535|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4367404|NCT00359203|4194533|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4367405|NCT00359203|4194534|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4367406|NCT00359203|4194535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4367407|NCT00359203|4194533|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367408|NCT00359203|4194534|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367409|NCT00359203|4194535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367410|NCT00359138|4194542|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4367411|NCT00359138|4194543|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4367412|NCT00359138|4194544|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4367413|NCT00359138|4194545|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4367414|NCT00359138|4194542|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4367415|NCT00359138|4194543|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4367416|NCT00359138|4194544|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4367417|NCT00359138|4194545|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4367418|NCT00359138|4194542|B4|||Age||years|Mean|26.86|26.86|Standard Deviation|8.91|8.91|||
4367419|NCT00359138|4194543|B3|||Age||years|Mean|28.83|28.83|Standard Deviation|11.55|11.55|||
4367420|NCT00359138|4194544|B2|||Age||years|Mean|28.33|28.33|Standard Deviation|8.69|8.69|||
4367421|NCT00359138|4194545|B1|||Age||years|Mean|23.42|23.42|Standard Deviation|4.91|4.91|||
4367422|NCT00359073|4194555|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4367423|NCT00359073|4194556|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4367424|NCT00359073|4194557|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4367425|NCT00359073|4194555|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4367426|NCT00359073|4194556|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4367427|NCT00359073|4194557|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4367428|NCT00359073|4194555|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4367429|NCT00359073|4194556|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4367430|NCT00359073|4194557|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4367431|NCT00359073|4194555|B3|||Age||years|Mean|20|20.0|Standard Deviation|4|4.0|||
4367432|NCT00359073|4194556|B2|||Age||years|Mean|21|21.0|Standard Deviation|3|3.0|||
4367433|NCT00359073|4194557|B1|||Age||years|Mean|20|20.0|Standard Deviation|2|2.0|||
4367434|NCT00359021|4194568|B3||Male|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4367435|NCT00359021|4194569|B2||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4367436|NCT00359021|4194570|B1||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4367437|NCT00359021|4194568|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4367438|NCT00359021|4194569|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4367439|NCT00359021|4194570|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4367440|NCT00359021|4194568|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|7.68|7.68|||
4367441|NCT00359021|4194569|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|7.01|7.01|||
4367442|NCT00359021|4194570|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|8.28|8.28|||
4367443|NCT00359021|4194568|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4367444|NCT00359021|4194569|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4367445|NCT00359021|4194570|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4367446|NCT00359021|4194568|B3||Between 18 and 65 years|Age||Participants|Count of Participants|497|497.0||||||
4367447|NCT00359021|4194569|B2||Between 18 and 65 years|Age||Participants|Count of Participants|245|245.0||||||
4367448|NCT00359021|4194570|B1||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
4367449|NCT00359021|4194568|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367450|NCT00359021|4194569|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367451|NCT00359021|4194570|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367452|NCT00358956|4194583|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4367453|NCT00358956|4194583|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4367454|NCT00358956|4194583|B1|||Age||years|Mean|44.7|44.7|Full Range|||22.0|79.0|
4367455|NCT00358917|4194593|B3|||Plasma Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid (RNA) Level||log10 copies/milliliter (mL)|Mean|4.26|4.26|Standard Deviation|0.817|0.817|||
4367456|NCT00358917|4194594|B2|||Plasma Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid (RNA) Level||log10 copies/milliliter (mL)|Mean|4.26|4.26|Standard Deviation|0.809|0.809|||
4367457|NCT00358917|4194595|B1|||Plasma Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid (RNA) Level||log10 copies/milliliter (mL)|Mean|4.26|4.26|Standard Deviation|0.826|0.826|||
4367458|NCT00358917|4194593|B3|||Cluster of Differentiation 4 Single-Positive Thymocyte (CD4+ T) Cell Count||cells/microliter|Mean|253.9|253.9|Standard Deviation|171.98|171.98|||
4367459|NCT00358917|4194594|B2|||Cluster of Differentiation 4 Single-Positive Thymocyte (CD4+ T) Cell Count||cells/microliter|Mean|268.3|268.3|Standard Deviation|183.55|183.55|||
4367460|NCT00358917|4194595|B1|||Cluster of Differentiation 4 Single-Positive Thymocyte (CD4+ T) Cell Count||cells/microliter|Mean|239.3|239.3|Standard Deviation|158.39|158.39|||
4367461|NCT00358917|4194593|B3|Did Not Receive Prior PI||Received Prior Protease Inhibitor (PI)||participants|Number|323|323.0||||||
4367462|NCT00358917|4194594|B2|Did Not Receive Prior PI||Received Prior Protease Inhibitor (PI)||participants|Number|163|163.0||||||
4367463|NCT00358917|4194595|B1|Did Not Receive Prior PI||Received Prior Protease Inhibitor (PI)||participants|Number|160|160.0||||||
4367464|NCT00358917|4194593|B3|Received Prior PI||Received Prior Protease Inhibitor (PI)||participants|Number|276|276.0||||||
4367465|NCT00358917|4194594|B2|Received Prior PI||Received Prior Protease Inhibitor (PI)||participants|Number|136|136.0||||||
4367466|NCT00358917|4194595|B1|Received Prior PI||Received Prior Protease Inhibitor (PI)||participants|Number|140|140.0||||||
4367467|NCT00358917|4194593|B3|Did Not Receive Prior NRTI||Received Prior Nucleoside/nucleotide Reverse Transcriptase Inhibitor (NRTI)||participants|Number|3|3.0||||||
4367468|NCT00358917|4194594|B2|Did Not Receive Prior NRTI||Received Prior Nucleoside/nucleotide Reverse Transcriptase Inhibitor (NRTI)||participants|Number|2|2.0||||||
4367469|NCT00358917|4194595|B1|Did Not Receive Prior NRTI||Received Prior Nucleoside/nucleotide Reverse Transcriptase Inhibitor (NRTI)||participants|Number|1|1.0||||||
4367470|NCT00358917|4194593|B3|Received Prior NRTI||Received Prior Nucleoside/nucleotide Reverse Transcriptase Inhibitor (NRTI)||participants|Number|596|596.0||||||
4367471|NCT00358917|4194594|B2|Received Prior NRTI||Received Prior Nucleoside/nucleotide Reverse Transcriptase Inhibitor (NRTI)||participants|Number|297|297.0||||||
4367472|NCT00358917|4194595|B1|Received Prior NRTI||Received Prior Nucleoside/nucleotide Reverse Transcriptase Inhibitor (NRTI)||participants|Number|299|299.0||||||
4367473|NCT00358917|4194593|B3|Did Not Receive Prior NNRTI||Received Prior Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI)||participants|Number|94|94.0||||||
4367474|NCT00358917|4194594|B2|Did Not Receive Prior NNRTI||Received Prior Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI)||participants|Number|58|58.0||||||
4367475|NCT00358917|4194595|B1|Did Not Receive Prior NNRTI||Received Prior Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI)||participants|Number|36|36.0||||||
4367476|NCT00358917|4194593|B3|Received Prior NNRTI||Received Prior Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI)||participants|Number|505|505.0||||||
4367477|NCT00358917|4194594|B2|Received Prior NNRTI||Received Prior Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI)||participants|Number|241|241.0||||||
4367478|NCT00358917|4194595|B1|Received Prior NNRTI||Received Prior Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI)||participants|Number|264|264.0||||||
4367479|NCT00358917|4194593|B3||Male|Sex: Female, Male||Participants|Count of Participants|393|393.0||||||
4367480|NCT00358917|4194594|B2||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4367481|NCT00358917|4194595|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4367482|NCT00358917|4194593|B3||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4367483|NCT00358917|4194594|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4367484|NCT00358917|4194595|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4367485|NCT00358917|4194593|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|8.92|8.92|||
4367486|NCT00358917|4194594|B2|||Age||years|Mean|40.8|40.8|Standard Deviation|8.63|8.63|||
4367487|NCT00358917|4194595|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|9.22|9.22|||
4367488|NCT00358826|4194610|B5|United States||Region of Enrollment||participants|Number|59|59.0||||||
4367489|NCT00358826|4194611|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4367490|NCT00358826|4194612|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4367491|NCT00358826|4194613|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4367492|NCT00358826|4194614|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4367493|NCT00358826|4194610|B5|Canada||Region of Enrollment||participants|Number|132|132.0||||||
4367494|NCT00358826|4194611|B4|Canada||Region of Enrollment||participants|Number|34|34.0||||||
4367495|NCT00358826|4194612|B3|Canada||Region of Enrollment||participants|Number|31|31.0||||||
4367496|NCT00358826|4194613|B2|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4367497|NCT00358826|4194614|B1|Canada||Region of Enrollment||participants|Number|34|34.0||||||
4367498|NCT00358826|4194610|B5||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4367499|NCT00358826|4194611|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4367500|NCT00358826|4194612|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4367501|NCT00358826|4194613|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4367502|NCT00358826|4194614|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4367503|NCT00358826|4194610|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4367504|NCT00358826|4194611|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4367505|NCT00358826|4194612|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4367506|NCT00358826|4194613|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4367507|NCT00358826|4194614|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4367508|NCT00358826|4194610|B5|||Age||years|Mean|57.0|57.0|Standard Deviation|9.63|9.63|||
4367509|NCT00358826|4194611|B4|||Age||years|Mean|56.6|56.6|Standard Deviation|9.78|9.78|||
4367510|NCT00358826|4194612|B3|||Age||years|Mean|57.6|57.6|Standard Deviation|9.44|9.44|||
4367511|NCT00358826|4194613|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|10.01|10.01|||
4367512|NCT00358826|4194614|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|9.54|9.54|||
4367513|NCT00358826|4194610|B5||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4367514|NCT00358826|4194611|B4||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4367515|NCT00358826|4194612|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4367516|NCT00358826|4194613|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4367517|NCT00358826|4194614|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4367518|NCT00358826|4194610|B5||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
4367519|NCT00358826|4194611|B4||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4367520|NCT00358826|4194612|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4367521|NCT00358826|4194613|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4367522|NCT00358826|4194614|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4367523|NCT00358826|4194610|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367524|NCT00358826|4194611|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367525|NCT00358826|4194612|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367526|NCT00358826|4194613|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367527|NCT00358826|4194614|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367528|NCT00358735|4194655|B3|||length of hospital stay (days)||days|Mean|3.2|3.2|Full Range|||2.0|10.0|
4367529|NCT00358735|4194656|B2|||length of hospital stay (days)||days|Mean|3.2|3.2|Full Range|||2.0|10.0|
4367530|NCT00358735|4194657|B1|||length of hospital stay (days)||days|Mean|3.2|3.2|Full Range|||2.0|8.0|
4367531|NCT00358735|4194655|B3|||Duration of surgery (minutes)||Minutes|Mean|93.5|93.5|Full Range|||41.0|190.0|
4367532|NCT00358735|4194656|B2|||Duration of surgery (minutes)||Minutes|Mean|96|96.0|Full Range|||41.0|190.0|
4367533|NCT00358735|4194657|B1|||Duration of surgery (minutes)||Minutes|Mean|91|91.0|Full Range|||44.0|168.0|
4367534|NCT00358735|4194655|B3|No Diagnosis||Diagnosis of osteoarthritis (n)||participants|Number|22|22.0||||||
4367535|NCT00358735|4194656|B2|No Diagnosis||Diagnosis of osteoarthritis (n)||participants|Number|10|10.0||||||
4367536|NCT00358735|4194657|B1|No Diagnosis||Diagnosis of osteoarthritis (n)||participants|Number|12|12.0||||||
4367537|NCT00358735|4194655|B3|Diagnosis||Diagnosis of osteoarthritis (n)||participants|Number|370|370.0||||||
4367538|NCT00358735|4194656|B2|Diagnosis||Diagnosis of osteoarthritis (n)||participants|Number|184|184.0||||||
4367539|NCT00358735|4194657|B1|Diagnosis||Diagnosis of osteoarthritis (n)||participants|Number|186|186.0||||||
4367540|NCT00358735|4194655|B3|||body-mass index (Kg/m2)||Kg/m^2|Mean|28.5|28.5|Full Range|||16.0|49.0|
4367541|NCT00358735|4194656|B2|||body-mass index (Kg/m2)||Kg/m^2|Mean|29|29.0|Full Range|||16.0|49.0|
4367542|NCT00358735|4194657|B1|||body-mass index (Kg/m2)||Kg/m^2|Mean|28|28.0|Full Range|||17.0|43.0|
4367543|NCT00358735|4194655|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4367544|NCT00358735|4194656|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4367545|NCT00358735|4194657|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4367546|NCT00358735|4194655|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4367547|NCT00358735|4194656|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4367548|NCT00358735|4194657|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4367549|NCT00358735|4194655|B3|||Age||years|Mean|62.5|62.5|Full Range|||20.0|88.0|
4367550|NCT00358735|4194656|B2|||Age||years|Mean|62|62.0|Full Range|||32.0|88.0|
4367551|NCT00358735|4194657|B1|||Age||years|Mean|63|63.0|Full Range|||20.0|84.0|
4367552|NCT00358670|4194686|B3||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4367553|NCT00358670|4194687|B2||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4367554|NCT00358670|4194688|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4367555|NCT00358670|4194686|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4367556|NCT00358670|4194687|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4367557|NCT00358670|4194688|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4367558|NCT00358670|4194686|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|12.2|12.2|||
4367559|NCT00358670|4194687|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|12.2|12.2|||
4367560|NCT00358670|4194688|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|12.1|12.1|||
4367561|NCT00358644|4194703|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4367562|NCT00358644|4194703|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367563|NCT00358644|4194703|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367564|NCT00358644|4194703|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4367565|NCT00358644|4194703|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4367566|NCT00358644|4194703|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367567|NCT00358644|4194703|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367568|NCT00358644|4194703|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367569|NCT00358644|4194703|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4367570|NCT00358644|4194703|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4367571|NCT00358644|4194703|B1|||Age||years|Mean|73.0|73.0|Standard Deviation|6.84|6.84|||
4367572|NCT00358644|4194703|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4367573|NCT00358644|4194703|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4367574|NCT00358644|4194703|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367575|NCT00358579|4194707|B3|Singapore||Region of Enrollment||participants|Number|727|727.0||||||
4367576|NCT00358579|4194708|B2|Singapore||Region of Enrollment||participants|Number|374|374.0||||||
4367577|NCT00358579|4194709|B1|Singapore||Region of Enrollment||participants|Number|353|353.0||||||
4367578|NCT00358579|4194707|B3||Male|Sex: Female, Male||Participants|Count of Participants|505|505.0||||||
4367579|NCT00358579|4194708|B2||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4367580|NCT00358579|4194709|B1||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4367581|NCT00358579|4194707|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4367582|NCT00358579|4194708|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4367583|NCT00358579|4194709|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4367584|NCT00358579|4194707|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|14.8|14.8|||
4367585|NCT00358579|4194708|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|14.2|14.2|||
4367586|NCT00358579|4194709|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|15.4|15.4|||
4367587|NCT00358579|4194707|B3||>=65 years|Age||Participants|Count of Participants|370|370.0||||||
4367588|NCT00358579|4194708|B2||>=65 years|Age||Participants|Count of Participants|188|188.0||||||
4367589|NCT00358579|4194709|B1||>=65 years|Age||Participants|Count of Participants|182|182.0||||||
4367590|NCT00358579|4194707|B3||Between 18 and 65 years|Age||Participants|Count of Participants|356|356.0||||||
4367591|NCT00358579|4194708|B2||Between 18 and 65 years|Age||Participants|Count of Participants|186|186.0||||||
4367592|NCT00358579|4194709|B1||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
4367593|NCT00358579|4194707|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4367594|NCT00358579|4194708|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367595|NCT00358579|4194709|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4367596|NCT00358527|4194724|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4367597|NCT00358527|4194725|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4367598|NCT00358527|4194726|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4367599|NCT00358527|4194724|B3||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4367600|NCT00358527|4194725|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4367601|NCT00358527|4194726|B1||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4367602|NCT00358527|4194724|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|12.5|12.5|||
4367603|NCT00358527|4194725|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|11.8|11.8|||
4367604|NCT00358527|4194726|B1|||Age||years|Mean|36.1|36.1|Standard Deviation|12.8|12.8|||
4367605|NCT00358527|4194724|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4367606|NCT00358527|4194725|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4367607|NCT00358527|4194726|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4367608|NCT00358527|4194724|B3||Between 18 and 65 years|Age||Participants|Count of Participants|391|391.0||||||
4367609|NCT00358527|4194725|B2||Between 18 and 65 years|Age||Participants|Count of Participants|132|132.0||||||
4367610|NCT00358527|4194726|B1||Between 18 and 65 years|Age||Participants|Count of Participants|259|259.0||||||
4367611|NCT00358527|4194724|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367612|NCT00358527|4194725|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367613|NCT00358527|4194726|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367614|NCT00358501|4194735|B3|||Weight||kg|Mean|53.4|53.4|Standard Deviation|32.89|32.89|||
4367615|NCT00358501|4194736|B2|||Weight||kg|Mean|52.6|52.6|Standard Deviation|30.55|30.55|||
4367616|NCT00358501|4194737|B1|||Weight||kg|Mean|53.7|53.7|Standard Deviation|33.73|33.73|||
4367617|NCT00358501|4194735|B3|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4367618|NCT00358501|4194736|B2|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4367619|NCT00358501|4194737|B1|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4367620|NCT00358501|4194735|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4367621|NCT00358501|4194736|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4367622|NCT00358501|4194737|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
4367623|NCT00358501|4194735|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4367624|NCT00358501|4194736|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4367625|NCT00358501|4194737|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4367626|NCT00358501|4194735|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4367627|NCT00358501|4194736|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4367628|NCT00358501|4194737|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4367629|NCT00358501|4194735|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4367630|NCT00358501|4194736|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4367631|NCT00358501|4194737|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4367632|NCT00358501|4194735|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4367633|NCT00358501|4194736|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4367634|NCT00358501|4194737|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4367635|NCT00358501|4194735|B3|African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4367636|NCT00358501|4194736|B2|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4367637|NCT00358501|4194737|B1|African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4367638|NCT00358501|4194735|B3|Latino/Latina||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4367639|NCT00358501|4194736|B2|Latino/Latina||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4367640|NCT00358501|4194737|B1|Latino/Latina||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4367641|NCT00358501|4194735|B3|White||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4367642|NCT00358501|4194736|B2|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4367643|NCT00358501|4194737|B1|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4367644|NCT00358501|4194735|B3||Male|Gender||Participants|Count of Participants|82|82.0||||||
4367645|NCT00358501|4194736|B2||Male|Gender||Participants|Count of Participants|18|18.0||||||
4367646|NCT00358501|4194737|B1||Male|Gender||Participants|Count of Participants|64|64.0||||||
4367647|NCT00358501|4194735|B3||Female|Gender||Participants|Count of Participants|52|52.0||||||
4367648|NCT00358501|4194736|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
4367649|NCT00358501|4194737|B1||Female|Gender||Participants|Count of Participants|38|38.0||||||
4367650|NCT00358501|4194735|B3|>16 years old||Age, Customized||participants|Number|76|76.0||||||
4367651|NCT00358501|4194736|B2|>16 years old||Age, Customized||participants|Number|18|18.0||||||
4367652|NCT00358501|4194737|B1|>16 years old||Age, Customized||participants|Number|58|58.0||||||
4367653|NCT00358501|4194735|B3|≤16 years old||Age, Customized||participants|Number|58|58.0||||||
4367654|NCT00358501|4194736|B2|≤16 years old||Age, Customized||participants|Number|14|14.0||||||
4367655|NCT00358501|4194737|B1|≤16 years old||Age, Customized||participants|Number|44|44.0||||||
4367656|NCT00358501|4194735|B3|||Age||years|Mean|25.7|25.7|Standard Deviation|21.03|21.03|||
4367657|NCT00358501|4194736|B2|||Age||years|Mean|25.1|25.1|Standard Deviation|20.23|20.23|||
4367658|NCT00358501|4194737|B1|||Age||years|Mean|26.0|26.0|Standard Deviation|21.37|21.37|||
4367659|NCT00358462|4194751|B3|United States||Region of Enrollment||participants|Number|606|606.0||||||
4367660|NCT00358462|4194752|B2|United States||Region of Enrollment||participants|Number|302|302.0||||||
4367661|NCT00358462|4194753|B1|United States||Region of Enrollment||participants|Number|304|304.0||||||
4367662|NCT00358462|4194751|B3||Male|Sex: Female, Male||Participants|Count of Participants|606|606.0||||||
4367663|NCT00358462|4194752|B2||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4367664|NCT00358462|4194753|B1||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4367665|NCT00358462|4194751|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4367666|NCT00358462|4194752|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4367667|NCT00358462|4194753|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4367668|NCT00358462|4194751|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|10.0|10.0|||
4367669|NCT00358462|4194752|B2|||Age||years|Mean|33.3|33.3|Standard Deviation|10.1|10.1|||
4367670|NCT00358462|4194753|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|9.8|9.8|||
4367671|NCT00358449|4194774|B4|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4367672|NCT00358449|4194775|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4367673|NCT00358449|4194776|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4367674|NCT00358449|4194777|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4367675|NCT00358449|4194774|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
4367676|NCT00358449|4194775|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4367677|NCT00358449|4194776|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4367678|NCT00358449|4194777|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4367679|NCT00358449|4194774|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4367680|NCT00358449|4194775|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4367681|NCT00358449|4194776|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4367682|NCT00358449|4194777|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4367683|NCT00358449|4194774|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4367684|NCT00358449|4194775|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4367685|NCT00358449|4194776|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4367686|NCT00358449|4194777|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4367687|NCT00358449|4194774|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4367688|NCT00358449|4194775|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4367689|NCT00358449|4194776|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4367690|NCT00358449|4194777|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4367691|NCT00358449|4194774|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4367692|NCT00358449|4194775|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4367693|NCT00358449|4194776|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4367694|NCT00358449|4194777|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4367695|NCT00358449|4194774|B4|||Age||Years|Mean|10.4|10.4|Standard Deviation|4.64|4.64|||
4367696|NCT00358449|4194775|B3|||Age||Years|Mean|10.4|10.4|Standard Deviation|4.66|4.66|||
4367697|NCT00358449|4194776|B2|||Age||Years|Mean|10.5|10.5|Standard Deviation|5.15|5.15|||
4367698|NCT00358449|4194777|B1|||Age||Years|Mean|10.4|10.4|Standard Deviation|4.28|4.28|||
4367699|NCT00358436|4194880|B3|United States||Region of Enrollment||participants|Number|396|396.0||||||
4367700|NCT00358436|4194881|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4367701|NCT00358436|4194882|B1|United States||Region of Enrollment||participants|Number|295|295.0||||||
4367702|NCT00358436|4194880|B3|South Africa||Region of Enrollment||participants|Number|81|81.0||||||
4367703|NCT00358436|4194881|B2|South Africa||Region of Enrollment||participants|Number|20|20.0||||||
4367704|NCT00358436|4194882|B1|South Africa||Region of Enrollment||participants|Number|61|61.0||||||
4367705|NCT00358436|4194880|B3|New Zealand||Region of Enrollment||participants|Number|16|16.0||||||
4367706|NCT00358436|4194881|B2|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
4367707|NCT00358436|4194882|B1|New Zealand||Region of Enrollment||participants|Number|12|12.0||||||
4367708|NCT00358436|4194880|B3|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4367709|NCT00358436|4194881|B2|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4367710|NCT00358436|4194882|B1|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4367711|NCT00358436|4194880|B3|Canada||Region of Enrollment||participants|Number|43|43.0||||||
4367712|NCT00358436|4194881|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4367713|NCT00358436|4194882|B1|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4367714|NCT00358436|4194880|B3|Australia||Region of Enrollment||participants|Number|95|95.0||||||
4367715|NCT00358436|4194881|B2|Australia||Region of Enrollment||participants|Number|25|25.0||||||
4367716|NCT00358436|4194882|B1|Australia||Region of Enrollment||participants|Number|70|70.0||||||
4367717|NCT00358436|4194880|B3|Argentina||Region of Enrollment||participants|Number|164|164.0||||||
4367718|NCT00358436|4194881|B2|Argentina||Region of Enrollment||participants|Number|42|42.0||||||
4367719|NCT00358436|4194882|B1|Argentina||Region of Enrollment||participants|Number|122|122.0||||||
4367720|NCT00358436|4194880|B3||Male|Gender||Participants|Count of Participants|507|507.0||||||
4367721|NCT00358436|4194881|B2||Male|Gender||Participants|Count of Participants|124|124.0||||||
4367722|NCT00358436|4194882|B1||Male|Gender||Participants|Count of Participants|383|383.0||||||
4367723|NCT00358436|4194880|B3||Female|Gender||Participants|Count of Participants|297|297.0||||||
4367724|NCT00358436|4194881|B2||Female|Gender||Participants|Count of Participants|80|80.0||||||
4367725|NCT00358436|4194882|B1||Female|Gender||Participants|Count of Participants|217|217.0||||||
4367726|NCT00358436|4194880|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|8.6|8.6|||
4367727|NCT00358436|4194881|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|8.6|8.6|||
4367728|NCT00358436|4194882|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|8.6|8.6|||
4367729|NCT00358436|4194880|B3||>=65 years|Age||Participants|Count of Participants|427|427.0||||||
4367730|NCT00358436|4194881|B2||>=65 years|Age||Participants|Count of Participants|119|119.0||||||
4367731|NCT00358436|4194882|B1||>=65 years|Age||Participants|Count of Participants|308|308.0||||||
4367732|NCT00358436|4194880|B3||Between 18 and 65 years|Age||Participants|Count of Participants|377|377.0||||||
4367733|NCT00358436|4194881|B2||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4367734|NCT00358436|4194882|B1||Between 18 and 65 years|Age||Participants|Count of Participants|292|292.0||||||
4367735|NCT00358436|4194880|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367736|NCT00358436|4194881|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367737|NCT00358436|4194882|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367738|NCT00358332|4194895|B5|Mali||Region of Enrollment||participants|Number|100|100.0||||||
4367739|NCT00358332|4194896|B4|Mali||Region of Enrollment||participants|Number|25|25.0||||||
4367740|NCT00358332|4194897|B3|Mali||Region of Enrollment||participants|Number|30|30.0||||||
4367741|NCT00358332|4194898|B2|Mali||Region of Enrollment||participants|Number|30|30.0||||||
4367742|NCT00358332|4194899|B1|Mali||Region of Enrollment||participants|Number|15|15.0||||||
4367743|NCT00358332|4194895|B5||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4367744|NCT00358332|4194896|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4367745|NCT00358332|4194897|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4367746|NCT00358332|4194898|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4367747|NCT00358332|4194899|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4367748|NCT00358332|4194895|B5||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4367749|NCT00358332|4194896|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4367750|NCT00358332|4194897|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4367751|NCT00358332|4194898|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4367752|NCT00358332|4194899|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4367753|NCT00358332|4194895|B5|||Age||years|Mean|3.4|3.4|Standard Deviation|1.8|1.8|||
4367754|NCT00358332|4194896|B4|||Age||years|Mean|3.2|3.2|Standard Deviation|1.9|1.9|||
4367755|NCT00358332|4194897|B3|||Age||years|Mean|3.6|3.6|Standard Deviation|1.7|1.7|||
4367756|NCT00358332|4194898|B2|||Age||years|Mean|3.5|3.5|Standard Deviation|1.7|1.7|||
4367757|NCT00358332|4194899|B1|||Age||years|Mean|3.5|3.5|Standard Deviation|1.8|1.8|||
4367758|NCT00358332|4194895|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4367759|NCT00358332|4194896|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4367760|NCT00358332|4194897|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4367761|NCT00358332|4194898|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4367762|NCT00358332|4194899|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4367763|NCT00358332|4194895|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4367764|NCT00358332|4194896|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4367765|NCT00358332|4194897|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4367766|NCT00358332|4194898|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4367767|NCT00358332|4194899|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4367768|NCT00358332|4194895|B5||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4367769|NCT00358332|4194896|B4||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4367770|NCT00358332|4194897|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4367771|NCT00358332|4194898|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4367772|NCT00358332|4194899|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4367773|NCT00358215|4194952|B3|||Study Specific Characteristic [Kansas City Cardiomyopathy Questionnaire: Symptom Frequency Scale|The KCCQ is a patient-reported measure for patients with heart failure. It consists of 23 items, is comprised of 7 clinically relevant scales (Symptom Frequency, Burden and Stability, Physical and Social Limitation, Quality of Life, and Self-Efficacy), and yields 3 summary scores (Clinical Summary, Total Symptom, and Overall Summary Scores). Scores range between 0 and 100, with higher scores indicating better health status (eg, better functioning, quality of life, fewer symptoms). Number of participants with available data = 1106 and 1104 for each treatment group respectively, total = 2210.|units on a scale|Mean|63.2|63.2|Standard Deviation|25.4|25.4|||
4367774|NCT00358215|4194953|B2|||Study Specific Characteristic [Kansas City Cardiomyopathy Questionnaire: Symptom Frequency Scale|The KCCQ is a patient-reported measure for patients with heart failure. It consists of 23 items, is comprised of 7 clinically relevant scales (Symptom Frequency, Burden and Stability, Physical and Social Limitation, Quality of Life, and Self-Efficacy), and yields 3 summary scores (Clinical Summary, Total Symptom, and Overall Summary Scores). Scores range between 0 and 100, with higher scores indicating better health status (eg, better functioning, quality of life, fewer symptoms). Number of participants with available data = 1106 and 1104 for each treatment group respectively, total = 2210.|units on a scale|Mean|63.1|63.1|Standard Deviation|25.6|25.6|||
4367775|NCT00358215|4194954|B1|||Study Specific Characteristic [Kansas City Cardiomyopathy Questionnaire: Symptom Frequency Scale|The KCCQ is a patient-reported measure for patients with heart failure. It consists of 23 items, is comprised of 7 clinically relevant scales (Symptom Frequency, Burden and Stability, Physical and Social Limitation, Quality of Life, and Self-Efficacy), and yields 3 summary scores (Clinical Summary, Total Symptom, and Overall Summary Scores). Scores range between 0 and 100, with higher scores indicating better health status (eg, better functioning, quality of life, fewer symptoms). Number of participants with available data = 1106 and 1104 for each treatment group respectively, total = 2210.|units on a scale|Mean|63.3|63.3|Standard Deviation|25.2|25.2|||
4367776|NCT00358215|4194952|B3|||Kansas City Cardiomyopathy Questionnaire: Overall Summary Score|The KCCQ is a patient-reported measure for patients with heart failure. It consists of 23 items, is comprised of 7 clinically relevant scales (Symptom Frequency, Burden and Stability, Physical and Social Limitation, Quality of Life, and Self-Efficacy), and yields 3 summary scores (Clinical Summary, Total Symptom, and Overall Summary Scores). Scores range between 0 and 100, with higher scores indicating better health status (eg, better functioning, quality of life, fewer symptoms). Number of participants with available data = 1106 and 1104 for each treatment group respectively, total = 2210.|units on a scale|Mean|56.2|56.2|Standard Deviation|22.5|22.5|||
4367777|NCT00358215|4194953|B2|||Kansas City Cardiomyopathy Questionnaire: Overall Summary Score|The KCCQ is a patient-reported measure for patients with heart failure. It consists of 23 items, is comprised of 7 clinically relevant scales (Symptom Frequency, Burden and Stability, Physical and Social Limitation, Quality of Life, and Self-Efficacy), and yields 3 summary scores (Clinical Summary, Total Symptom, and Overall Summary Scores). Scores range between 0 and 100, with higher scores indicating better health status (eg, better functioning, quality of life, fewer symptoms). Number of participants with available data = 1106 and 1104 for each treatment group respectively, total = 2210.|units on a scale|Mean|55.8|55.8|Standard Deviation|22.6|22.6|||
4367778|NCT00358215|4194954|B1|||Kansas City Cardiomyopathy Questionnaire: Overall Summary Score|The KCCQ is a patient-reported measure for patients with heart failure. It consists of 23 items, is comprised of 7 clinically relevant scales (Symptom Frequency, Burden and Stability, Physical and Social Limitation, Quality of Life, and Self-Efficacy), and yields 3 summary scores (Clinical Summary, Total Symptom, and Overall Summary Scores). Scores range between 0 and 100, with higher scores indicating better health status (eg, better functioning, quality of life, fewer symptoms). Number of participants with available data = 1106 and 1104 for each treatment group respectively, total = 2210.|units on a scale|Mean|56.5|56.5|Standard Deviation|22.5|22.5|||
4367779|NCT00358215|4194952|B3|None||Device Usage|Usage of implantable cardioverter defibrillator / cardiac resynchronization therapy (ICD/CRT)|participants|Number|1746|1746.0||||||
4367780|NCT00358215|4194953|B2|None||Device Usage|Usage of implantable cardioverter defibrillator / cardiac resynchronization therapy (ICD/CRT)|participants|Number|871|871.0||||||
4367781|NCT00358215|4194954|B1|None||Device Usage|Usage of implantable cardioverter defibrillator / cardiac resynchronization therapy (ICD/CRT)|participants|Number|875|875.0||||||
4367782|NCT00358215|4194952|B3|ICD without CRT||Device Usage|Usage of implantable cardioverter defibrillator / cardiac resynchronization therapy (ICD/CRT)|participants|Number|246|246.0||||||
4367783|NCT00358215|4194953|B2|ICD without CRT||Device Usage|Usage of implantable cardioverter defibrillator / cardiac resynchronization therapy (ICD/CRT)|participants|Number|122|122.0||||||
4367784|NCT00358215|4194954|B1|ICD without CRT||Device Usage|Usage of implantable cardioverter defibrillator / cardiac resynchronization therapy (ICD/CRT)|participants|Number|124|124.0||||||
4367785|NCT00358215|4194952|B3|CRT with or without ICD||Device Usage|Usage of implantable cardioverter defibrillator / cardiac resynchronization therapy (ICD/CRT)|participants|Number|286|286.0||||||
4367786|NCT00358215|4194953|B2|CRT with or without ICD||Device Usage|Usage of implantable cardioverter defibrillator / cardiac resynchronization therapy (ICD/CRT)|participants|Number|143|143.0||||||
4367787|NCT00358215|4194954|B1|CRT with or without ICD||Device Usage|Usage of implantable cardioverter defibrillator / cardiac resynchronization therapy (ICD/CRT)|participants|Number|143|143.0||||||
4367788|NCT00358215|4194952|B3|Eastern Europe and Russia||Region||participants|Number|454|454.0||||||
4367789|NCT00358215|4194953|B2|Eastern Europe and Russia||Region||participants|Number|227|227.0||||||
4367790|NCT00358215|4194954|B1|Eastern Europe and Russia||Region||participants|Number|227|227.0||||||
4367791|NCT00358215|4194952|B3|Western Europe, Israel, South Africa, Australia||Region||participants|Number|609|609.0||||||
4367792|NCT00358215|4194953|B2|Western Europe, Israel, South Africa, Australia||Region||participants|Number|303|303.0||||||
4367793|NCT00358215|4194954|B1|Western Europe, Israel, South Africa, Australia||Region||participants|Number|306|306.0||||||
4367794|NCT00358215|4194952|B3|Latin America and Asia||Region||participants|Number|571|571.0||||||
4367795|NCT00358215|4194953|B2|Latin America and Asia||Region||participants|Number|285|285.0||||||
4367796|NCT00358215|4194954|B1|Latin America and Asia||Region||participants|Number|286|286.0||||||
4367797|NCT00358215|4194952|B3|North America||Region||participants|Number|644|644.0||||||
4367798|NCT00358215|4194953|B2|North America||Region||participants|Number|321|321.0||||||
4367799|NCT00358215|4194954|B1|North America||Region||participants|Number|323|323.0||||||
4367800|NCT00358215|4194952|B3|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4367801|NCT00358215|4194953|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4367802|NCT00358215|4194954|B1|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4367803|NCT00358215|4194952|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4367804|NCT00358215|4194953|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4367805|NCT00358215|4194954|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4367806|NCT00358215|4194952|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4367807|NCT00358215|4194953|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4367808|NCT00358215|4194954|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4367809|NCT00358215|4194952|B3|Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4367810|NCT00358215|4194953|B2|Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4367811|NCT00358215|4194954|B1|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4367812|NCT00358215|4194952|B3|Asian||Race/Ethnicity, Customized||participants|Number|324|324.0||||||
4367813|NCT00358215|4194953|B2|Asian||Race/Ethnicity, Customized||participants|Number|162|162.0||||||
4367814|NCT00358215|4194954|B1|Asian||Race/Ethnicity, Customized||participants|Number|162|162.0||||||
4367815|NCT00358215|4194952|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
4367816|NCT00358215|4194953|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4367817|NCT00358215|4194954|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4367818|NCT00358215|4194952|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|202|202.0||||||
4367819|NCT00358215|4194953|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4367820|NCT00358215|4194954|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
4367821|NCT00358215|4194952|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|1549|1549.0||||||
4367822|NCT00358215|4194953|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|781|781.0||||||
4367823|NCT00358215|4194954|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|768|768.0||||||
4367824|NCT00358215|4194952|B3||Male|Sex: Female, Male||Participants|Count of Participants|1334|1334.0||||||
4367825|NCT00358215|4194953|B2||Male|Sex: Female, Male||Participants|Count of Participants|678|678.0||||||
4367826|NCT00358215|4194954|B1||Male|Sex: Female, Male||Participants|Count of Participants|656|656.0||||||
4367827|NCT00358215|4194952|B3||Female|Sex: Female, Male||Participants|Count of Participants|944|944.0||||||
4367828|NCT00358215|4194953|B2||Female|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4367829|NCT00358215|4194954|B1||Female|Sex: Female, Male||Participants|Count of Participants|486|486.0||||||
4367830|NCT00358215|4194952|B3|||Age||years|Mean|69.8|69.8|Standard Deviation|11.4|11.4|||
4367831|NCT00358215|4194953|B2|||Age||years|Mean|70.0|70.0|Standard Deviation|11.6|11.6|||
4367832|NCT00358215|4194954|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|11.3|11.3|||
4367833|NCT00358150|4194969|B1|||Spleen Volume||Multiples of normal|Mean|20.04|20.04|Standard Deviation|12.798|12.798|||
4367834|NCT00358150|4194969|B1|||Platelet Count||10^9 cells per liter|Mean|66.423|66.423|Standard Deviation|20.1413|20.1413|||
4367835|NCT00358150|4194969|B1|||Hemoglobin||gram per deciliter (g/dL)|Mean|11.10|11.1|Standard Deviation|1.674|1.674|||
4367836|NCT00358150|4194969|B1|||Height||centimeter (cm)|Mean|165.12|165.12|Standard Deviation|9.747|9.747|||
4367837|NCT00358150|4194969|B1|||Weight||kilogram (kg)|Mean|61.47|61.47|Standard Deviation|11.018|11.018|||
4367838|NCT00358150|4194969|B1|||Body Mass Index (BMI)|BMI was calculated as ([weight in kg] divided by [height in cm multiplied by 0.01]^2).|kilogram per square meter (kg/m^2)|Mean|22.56|22.56|Standard Deviation|3.529|3.529|||
4367839|NCT00358150|4194969|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4367840|NCT00358150|4194969|B1|Non-Jewish Caucasian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4367841|NCT00358150|4194969|B1|Ashkenazi Jewish||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4367842|NCT00358150|4194969|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
4367843|NCT00358150|4194969|B1||Female|Gender||Participants|Count of Participants|16|16.0||||||
4367844|NCT00358150|4194969|B1|||Age||years|Mean|34.47|34.47|Standard Deviation|12.960|12.96|||
4367845|NCT00358007|4194991|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4367846|NCT00358007|4194991|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4367847|NCT00358007|4194991|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4367848|NCT00358007|4194991|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367849|NCT00358007|4194991|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367850|NCT00358007|4194991|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367851|NCT00358007|4194991|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4367852|NCT00358007|4194991|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4367853|NCT00358007|4194991|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367854|NCT00358007|4194991|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4367855|NCT00358007|4194991|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4367856|NCT00358007|4194991|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4367857|NCT00358007|4194991|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4367858|NCT00358007|4194991|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4367859|NCT00358007|4194991|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4367860|NCT00358007|4194991|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367861|NCT00358007|4194991|B1|||Age||years|Mean|58.19|58.19|Standard Deviation|12.21|12.21|||
4367862|NCT00357994|4194996|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4367863|NCT00357994|4194997|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4367864|NCT00357994|4194998|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4367865|NCT00357994|4194996|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4367866|NCT00357994|4194997|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4367867|NCT00357994|4194998|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4367868|NCT00357994|4194996|B3|>=65 years||Age, Customized||participants|Number|35|35.0||||||
4367869|NCT00357994|4194997|B2|>=65 years||Age, Customized||participants|Number|19|19.0||||||
4367870|NCT00357994|4194998|B1|>=65 years||Age, Customized||participants|Number|16|16.0||||||
4367871|NCT00357994|4194996|B3|<65 years||Age, Customized||participants|Number|36|36.0||||||
4367872|NCT00357994|4194997|B2|<65 years||Age, Customized||participants|Number|15|15.0||||||
4367873|NCT00357994|4194998|B1|<65 years||Age, Customized||participants|Number|21|21.0||||||
4367874|NCT00357994|4194996|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|8.3|8.3|||
4367875|NCT00357994|4194997|B2|||Age||years|Mean|65.1|65.1|Standard Deviation|6.8|6.8|||
4367876|NCT00357994|4194998|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|9.5|9.5|||
4367877|NCT00357968|4195051|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4367878|NCT00357968|4195052|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4367879|NCT00357968|4195053|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4367880|NCT00357968|4195051|B3|Israel||Region of Enrollment||participants|Number|28|28.0||||||
4367881|NCT00357968|4195052|B2|Israel||Region of Enrollment||participants|Number|13|13.0||||||
4367882|NCT00357968|4195053|B1|Israel||Region of Enrollment||participants|Number|15|15.0||||||
4367883|NCT00357968|4195051|B3|Germany||Region of Enrollment||participants|Number|108|108.0||||||
4367884|NCT00357968|4195052|B2|Germany||Region of Enrollment||participants|Number|53|53.0||||||
4367885|NCT00357968|4195053|B1|Germany||Region of Enrollment||participants|Number|55|55.0||||||
4367886|NCT00357968|4195051|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
4367887|NCT00357968|4195052|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4367888|NCT00357968|4195053|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4367889|NCT00357968|4195051|B3|West Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4367890|NCT00357968|4195052|B2|West Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4367891|NCT00357968|4195053|B1|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4367892|NCT00357968|4195051|B3|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4367893|NCT00357968|4195052|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4367894|NCT00357968|4195053|B1|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4367895|NCT00357968|4195051|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|191|191.0||||||
4367896|NCT00357968|4195052|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4367897|NCT00357968|4195053|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4367898|NCT00357968|4195051|B3|African||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4367899|NCT00357968|4195052|B2|African||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4367900|NCT00357968|4195053|B1|African||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4367901|NCT00357968|4195051|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4367902|NCT00357968|4195052|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4367903|NCT00357968|4195053|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4367904|NCT00357968|4195051|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4367905|NCT00357968|4195052|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4367906|NCT00357968|4195053|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4367907|NCT00357968|4195051|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|10.06|10.06|||
4367908|NCT00357968|4195052|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|9.38|9.38|||
4367909|NCT00357968|4195053|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|10.73|10.73|||
4367910|NCT00357968|4195051|B3||>=65 years|Age||Participants|Count of Participants|108|108.0||||||
4367911|NCT00357968|4195052|B2||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4367912|NCT00357968|4195053|B1||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4367913|NCT00357968|4195051|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4367914|NCT00357968|4195052|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4367915|NCT00357968|4195053|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4367916|NCT00357968|4195051|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367917|NCT00357968|4195052|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367918|NCT00357968|4195053|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367919|NCT00357955|4195096|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
4367920|NCT00357955|4195097|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4367921|NCT00357955|4195098|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4367922|NCT00357955|4195096|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4367923|NCT00357955|4195097|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4367924|NCT00357955|4195098|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4367925|NCT00357955|4195096|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4367926|NCT00357955|4195097|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4367927|NCT00357955|4195098|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4367928|NCT00357955|4195096|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|10.5|10.5|||
4367929|NCT00357955|4195097|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|10.2|10.2|||
4367930|NCT00357955|4195098|B1|||Age||years|Mean|62|62.0|Standard Deviation|10.3|10.3|||
4367931|NCT00357955|4195096|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4367932|NCT00357955|4195097|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4367933|NCT00357955|4195098|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4367934|NCT00357955|4195096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4367935|NCT00357955|4195097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4367936|NCT00357955|4195098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4367937|NCT00357955|4195096|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367938|NCT00357955|4195097|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367939|NCT00357955|4195098|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367940|NCT00357903|4195105|B3|Other||Race/Ethnicity, Customized||Participant|Number|2|2.0||||||
4367941|NCT00357903|4195106|B2|Other||Race/Ethnicity, Customized||Participant|Number|2|2.0||||||
4367942|NCT00357903|4195107|B1|Other||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4367943|NCT00357903|4195105|B3|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|565|565.0||||||
4367944|NCT00357903|4195106|B2|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|522|522.0||||||
4367945|NCT00357903|4195107|B1|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|43|43.0||||||
4367946|NCT00357903|4195105|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|34|34.0||||||
4367947|NCT00357903|4195106|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|25|25.0||||||
4367948|NCT00357903|4195107|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|9|9.0||||||
4367949|NCT00357903|4195105|B3|Black or African American||Race/Ethnicity, Customized||Participant|Number|22|22.0||||||
4367950|NCT00357903|4195106|B2|Black or African American||Race/Ethnicity, Customized||Participant|Number|18|18.0||||||
4367951|NCT00357903|4195107|B1|Black or African American||Race/Ethnicity, Customized||Participant|Number|4|4.0||||||
4367952|NCT00357903|4195105|B3|Asian||Race/Ethnicity, Customized||Participant|Number|11|11.0||||||
4367953|NCT00357903|4195106|B2|Asian||Race/Ethnicity, Customized||Participant|Number|10|10.0||||||
4367954|NCT00357903|4195107|B1|Asian||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4367955|NCT00357903|4195105|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|5|5.0||||||
4367956|NCT00357903|4195106|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|4|4.0||||||
4367957|NCT00357903|4195107|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4367958|NCT00357903|4195105|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4367959|NCT00357903|4195106|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4367960|NCT00357903|4195107|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4367961|NCT00357903|4195105|B3||Female|Sex: Female, Male||Participants|Count of Participants|504|504.0||||||
4367962|NCT00357903|4195106|B2||Female|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
4367963|NCT00357903|4195107|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4367964|NCT00357903|4195105|B3|||Age||Years|Mean|49.07|49.07|Standard Deviation|16.66|16.66|||
4367965|NCT00357903|4195106|B2|||Age||Years|Mean|52.87|52.87|Standard Deviation|12.03|12.03|||
4367966|NCT00357903|4195107|B1|||Age||Years|Mean|11.02|11.02|Standard Deviation|3.80|3.8|||
4367967|NCT00357877|4195146|B3|United States||Region of Enrollment||participants|Number|983|983.0||||||
4367968|NCT00357877|4195147|B2|United States||Region of Enrollment||participants|Number|490|490.0||||||
4367969|NCT00357877|4195148|B1|United States||Region of Enrollment||participants|Number|493|493.0||||||
4367970|NCT00357877|4195146|B3||Male|Sex: Female, Male||Participants|Count of Participants|491|491.0||||||
4367971|NCT00357877|4195147|B2||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4367972|NCT00357877|4195148|B1||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4367973|NCT00357877|4195146|B3||Female|Sex: Female, Male||Participants|Count of Participants|492|492.0||||||
4367974|NCT00357877|4195147|B2||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4367975|NCT00357877|4195148|B1||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4367976|NCT00357877|4195146|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|14.3|14.3|||
4367977|NCT00357877|4195147|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|14.3|14.3|||
4367978|NCT00357877|4195148|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|14.3|14.3|||
4367979|NCT00357877|4195146|B3||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4367980|NCT00357877|4195147|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4367981|NCT00357877|4195148|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4367982|NCT00357877|4195146|B3||Between 18 and 65 years|Age||Participants|Count of Participants|922|922.0||||||
4367983|NCT00357877|4195147|B2||Between 18 and 65 years|Age||Participants|Count of Participants|459|459.0||||||
4367984|NCT00357877|4195148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|463|463.0||||||
4367985|NCT00357877|4195146|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367986|NCT00357877|4195147|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367987|NCT00357877|4195148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4367988|NCT00357760|4195161|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4367989|NCT00357760|4195162|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4367990|NCT00357760|4195163|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4367991|NCT00357760|4195161|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4367992|NCT00357760|4195162|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4367993|NCT00357760|4195163|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4367994|NCT00357760|4195161|B3|||Age||years|Median|61|61.0|Full Range|||33.0|80.0|
4367995|NCT00357760|4195162|B2|||Age||years|Median|62|62.0|Full Range|||33.0|73.0|
4367996|NCT00357760|4195163|B1|||Age||years|Median|60|60.0|Full Range|||35.0|80.0|
4367997|NCT00357734|4195174|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4367998|NCT00357734|4195174|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4367999|NCT00357734|4195174|B1|||Age||Years|Mean|66|66.0|Full Range|||52.0|81.0|
4368000|NCT00357656|4195183|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4368001|NCT00357656|4195184|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4368002|NCT00357656|4195185|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4368003|NCT00357656|4195183|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368004|NCT00357656|4195184|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368005|NCT00357656|4195185|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368006|NCT00357656|4195183|B3|||Age||Years|Mean|38.8|38.8|Standard Deviation|10.61|10.61|||
4368007|NCT00357656|4195184|B2|||Age||Years|Mean|39.0|39.0|Standard Deviation|11.52|11.52|||
4368008|NCT00357656|4195185|B1|||Age||Years|Mean|38.6|38.6|Standard Deviation|9.76|9.76|||
4368009|NCT00357656|4195183|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368010|NCT00357656|4195184|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368011|NCT00357656|4195185|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368012|NCT00357656|4195183|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4368013|NCT00357656|4195184|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4368014|NCT00357656|4195185|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4368015|NCT00357656|4195183|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368016|NCT00357656|4195184|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368017|NCT00357656|4195185|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368018|NCT00357552|4195237|B1|Tanzania||Region of Enrollment||participants|Number|25|25.0||||||
4368019|NCT00357552|4195237|B1|Malawi||Region of Enrollment||participants|Number|40|40.0||||||
4368020|NCT00357552|4195237|B1|India||Region of Enrollment||participants|Number|12|12.0||||||
4368021|NCT00357552|4195237|B1|Thailand||Region of Enrollment||participants|Number|24|24.0||||||
4368022|NCT00357552|4195237|B1|South Africa||Region of Enrollment||participants|Number|22|22.0||||||
4368023|NCT00357552|4195237|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4368024|NCT00357552|4195237|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4368025|NCT00357552|4195237|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|8.2|8.2|||
4368026|NCT00357552|4195237|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368027|NCT00357552|4195237|B1||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4368028|NCT00357552|4195237|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368029|NCT00357500|4195252|B1|Miscellaneous non-CNS Tumors||Disease Group|Patients were stratified within 7 disease strata and an 8th 'miscellaneous' stratum.|participants|Number|9|9.0||||||
4368030|NCT00357500|4195252|B1|Miscellaneous CNS Tumors||Disease Group|Patients were stratified within 7 disease strata and an 8th 'miscellaneous' stratum.|participants|Number|9|9.0||||||
4368031|NCT00357500|4195252|B1|Leukemia/Lymphoma||Disease Group|Patients were stratified within 7 disease strata and an 8th 'miscellaneous' stratum.|participants|Number|4|4.0||||||
4368032|NCT00357500|4195252|B1|Neuroblastoma||Disease Group|Patients were stratified within 7 disease strata and an 8th 'miscellaneous' stratum.|participants|Number|3|3.0||||||
4368033|NCT00357500|4195252|B1|Medulloblastoma/PNET||Disease Group|Patients were stratified within 7 disease strata and an 8th 'miscellaneous' stratum.|participants|Number|8|8.0||||||
4368034|NCT00357500|4195252|B1|Bone Tumors||Disease Group|Patients were stratified within 7 disease strata and an 8th 'miscellaneous' stratum.|participants|Number|12|12.0||||||
4368035|NCT00357500|4195252|B1|Low Grade Glioma||Disease Group|Patients were stratified within 7 disease strata and an 8th 'miscellaneous' stratum.|participants|Number|12|12.0||||||
4368036|NCT00357500|4195252|B1|Ependymoma||Disease Group|Patients were stratified within 7 disease strata and an 8th 'miscellaneous' stratum.|participants|Number|19|19.0||||||
4368037|NCT00357500|4195252|B1|High Grade Glioma||Disease Group|Patients were stratified within 7 disease strata and an 8th 'miscellaneous' stratum.|participants|Number|21|21.0||||||
4368038|NCT00357500|4195252|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
4368039|NCT00357500|4195252|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4368040|NCT00357500|4195252|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4368041|NCT00357500|4195252|B1|||Age||years|Median|10|10.0|Full Range|||0.52|21.0|
4368042|NCT00357500|4195252|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368043|NCT00357500|4195252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4368044|NCT00357500|4195252|B1||<=18 years|Age||Participants|Count of Participants|91|91.0||||||
4368045|NCT00357396|4195259|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4368046|NCT00357396|4195260|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4368047|NCT00357396|4195261|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4368048|NCT00357396|4195259|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4368049|NCT00357396|4195260|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368050|NCT00357396|4195261|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4368051|NCT00357396|4195259|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368052|NCT00357396|4195260|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368053|NCT00357396|4195261|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368054|NCT00357396|4195259|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4368055|NCT00357396|4195260|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4368056|NCT00357396|4195261|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4368057|NCT00357396|4195259|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4368058|NCT00357396|4195260|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4368059|NCT00357396|4195261|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4368060|NCT00357370|4195267|B4|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4368061|NCT00357370|4195268|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4368062|NCT00357370|4195269|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4368063|NCT00357370|4195270|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4368064|NCT00357370|4195267|B4|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4368065|NCT00357370|4195268|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4368066|NCT00357370|4195269|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4368067|NCT00357370|4195270|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4368068|NCT00357370|4195267|B4|Back/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4368069|NCT00357370|4195268|B3|Back/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4368070|NCT00357370|4195269|B2|Back/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4368071|NCT00357370|4195270|B1|Back/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4368072|NCT00357370|4195267|B4|White||Race/Ethnicity, Customized||Participants|Number|67|67.0||||||
4368073|NCT00357370|4195268|B3|White||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4368074|NCT00357370|4195269|B2|White||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4368075|NCT00357370|4195270|B1|White||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4368076|NCT00357370|4195267|B4|Female||Sex/Gender, Customized||Participants|Number|29|29.0||||||
4368077|NCT00357370|4195268|B3|Female||Sex/Gender, Customized||Participants|Number|11|11.0||||||
4368078|NCT00357370|4195269|B2|Female||Sex/Gender, Customized||Participants|Number|7|7.0||||||
4368079|NCT00357370|4195270|B1|Female||Sex/Gender, Customized||Participants|Number|11|11.0||||||
4368080|NCT00357370|4195267|B4|Male||Sex/Gender, Customized||Participants|Number|42|42.0||||||
4368081|NCT00357370|4195268|B3|Male||Sex/Gender, Customized||Participants|Number|13|13.0||||||
4368082|NCT00357370|4195269|B2|Male||Sex/Gender, Customized||Participants|Number|16|16.0||||||
4368083|NCT00357370|4195270|B1|Male||Sex/Gender, Customized||Participants|Number|13|13.0||||||
4368084|NCT00357370|4195267|B4|65 years or older||Age, Customized||Participants|Number|12|12.0||||||
4368085|NCT00357370|4195268|B3|65 years or older||Age, Customized||Participants|Number|4|4.0||||||
4368086|NCT00357370|4195269|B2|65 years or older||Age, Customized||Participants|Number|4|4.0||||||
4368087|NCT00357370|4195270|B1|65 years or older||Age, Customized||Participants|Number|4|4.0||||||
4368088|NCT00357370|4195267|B4|Younger than 65 years||Age, Customized||Participants|Number|59|59.0||||||
4368089|NCT00357370|4195268|B3|Younger than 65 years||Age, Customized||Participants|Number|20|20.0||||||
4368090|NCT00357370|4195269|B2|Younger than 65 years||Age, Customized||Participants|Number|19|19.0||||||
4368091|NCT00357370|4195270|B1|Younger than 65 years||Age, Customized||Participants|Number|20|20.0||||||
4368092|NCT00357370|4195267|B4|||Age||Years|Mean|56.7|56.7|Standard Deviation|8.92|8.92|||
4368093|NCT00357370|4195268|B3|||Age||Years|Mean|55.7|55.7|Standard Deviation|9.20|9.2|||
4368094|NCT00357370|4195269|B2|||Age||Years|Mean|58.4|58.4|Standard Deviation|6.49|6.49|||
4368095|NCT00357370|4195270|B1|||Age||Years|Mean|56.1|56.1|Standard Deviation|10.63|10.63|||
4368096|NCT00357331|4195295|B3|||25-OH Vitamin D||ng/mL|Median|33.3|33.3|Standard Deviation|13|13.0|||
4368097|NCT00357331|4195296|B2|||25-OH Vitamin D||ng/mL|Median|31.3|31.3|Standard Deviation|13.3|13.3|||
4368098|NCT00357331|4195297|B1|||25-OH Vitamin D||ng/mL|Median|35.3|35.3|Standard Deviation|12.7|12.7|||
4368099|NCT00357331|4195295|B3|||PTH||pg/mL|Median|57.2|57.2|Standard Deviation|28|28.0|||
4368100|NCT00357331|4195296|B2|||PTH||pg/mL|Median|56.9|56.9|Standard Deviation|33.4|33.4|||
4368101|NCT00357331|4195297|B1|||PTH||pg/mL|Median|58.8|58.8|Standard Deviation|25|25.0|||
4368102|NCT00357331|4195295|B3|||BMI||kg/m2|Median|23|23.0|Standard Deviation|3.0|3.0|||
4368103|NCT00357331|4195296|B2|||BMI||kg/m2|Median|24|24.0|Standard Deviation|3.3|3.3|||
4368104|NCT00357331|4195297|B1|||BMI||kg/m2|Median|23|23.0|Standard Deviation|2.5|2.5|||
4368105|NCT00357331|4195295|B3|United States||Region of Enrollment|New York City & Surrounding Environs|participants|Number|83|83.0||||||
4368106|NCT00357331|4195296|B2|United States||Region of Enrollment|New York City & Surrounding Environs|participants|Number|42|42.0||||||
4368107|NCT00357331|4195297|B1|United States||Region of Enrollment|New York City & Surrounding Environs|participants|Number|41|41.0||||||
4368108|NCT00357331|4195295|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368109|NCT00357331|4195296|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368110|NCT00357331|4195297|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368111|NCT00357331|4195295|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4368112|NCT00357331|4195296|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4368113|NCT00357331|4195297|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4368114|NCT00357331|4195295|B3|||Age||years|Median|65.8|65.8|Standard Deviation|6.2|6.2|||
4368115|NCT00357331|4195296|B2|||Age||years|Median|65.1|65.1|Standard Deviation|5.9|5.9|||
4368116|NCT00357331|4195297|B1|||Age||years|Median|66.1|66.1|Standard Deviation|7.1|7.1|||
4368117|NCT00357331|4195295|B3|Age|>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4368118|NCT00357331|4195296|B2|Age|>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4368119|NCT00357331|4195297|B1|Age|>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4368120|NCT00357331|4195295|B3|Age|Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4368121|NCT00357331|4195296|B2|Age|Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4368122|NCT00357331|4195297|B1|Age|Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4368123|NCT00357331|4195295|B3|Age|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368124|NCT00357331|4195296|B2|Age|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368125|NCT00357331|4195297|B1|Age|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368126|NCT00357162|4195308|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4368127|NCT00357162|4195308|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4368128|NCT00357162|4195308|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4368129|NCT00357162|4195308|B1|||Age||years|Median|67|67.0|Full Range|||48.0|79.0|
4368130|NCT00357110|4195316|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368131|NCT00357110|4195317|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368132|NCT00357110|4195318|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368133|NCT00357110|4195316|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4368134|NCT00357110|4195317|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4368135|NCT00357110|4195318|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4368136|NCT00357110|4195316|B3|||Age||age in years at baseline|Mean|62.1|62.1|Standard Deviation|4.5|4.5|||
4368137|NCT00357110|4195317|B2|||Age||age in years at baseline|Mean|63.4|63.4|Standard Deviation|3.5|3.5|||
4368138|NCT00357110|4195318|B1|||Age||age in years at baseline|Mean|60.5|60.5|Standard Deviation|5.4|5.4|||
4368139|NCT00357097|4195325|B3||Male|Sex: Female, Male||Participants|Count of Participants|76.0|76.0||||||
4368140|NCT00357097|4195326|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4368141|NCT00357097|4195327|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4368142|NCT00357097|4195325|B3||Female|Sex: Female, Male||Participants|Count of Participants|189.0|189.0||||||
4368143|NCT00357097|4195326|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4368144|NCT00357097|4195327|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4368145|NCT00357097|4195325|B3|||Age||Years|Mean|58.5|58.5|Standard Deviation|11.4|11.4|||
4368146|NCT00357097|4195326|B2|||Age||Years|Mean|59.5|59.5|Standard Deviation|11.3|11.3|||
4368147|NCT00357097|4195327|B1|||Age||Years|Mean|58.2|58.2|Standard Deviation|11.4|11.4|||
4368148|NCT00357032|4195372|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4368149|NCT00357032|4195372|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4368150|NCT00357032|4195372|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4368151|NCT00357032|4195372|B1|||Age||years|Median|78|78.0|Full Range|||43.0|84.0|
4368152|NCT00357006|4195379|B4|Australia||Region of Enrollment||participants|Number|180|180.0||||||
4368153|NCT00357006|4195380|B3|Australia||Region of Enrollment||participants|Number|62|62.0||||||
4368154|NCT00357006|4195381|B2|Australia||Region of Enrollment||participants|Number|56|56.0||||||
4368155|NCT00357006|4195382|B1|Australia||Region of Enrollment||participants|Number|62|62.0||||||
4368156|NCT00357006|4195379|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368157|NCT00357006|4195380|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368158|NCT00357006|4195381|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368159|NCT00357006|4195382|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368160|NCT00357006|4195379|B4||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4368161|NCT00357006|4195380|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4368162|NCT00357006|4195381|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4368163|NCT00357006|4195382|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4368164|NCT00357006|4195379|B4|||Age||years|Mean|35.18|35.18|Standard Deviation|7.96|7.96|||
4368165|NCT00357006|4195380|B3|||Age||years|Mean|35.44|35.44|Standard Deviation|8.46|8.46|||
4368166|NCT00357006|4195381|B2|||Age||years|Mean|34.77|34.77|Standard Deviation|7.28|7.28|||
4368167|NCT00357006|4195382|B1|||Age||years|Mean|35.29|35.29|Standard Deviation|8.14|8.14|||
4368168|NCT00357006|4195379|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368169|NCT00357006|4195380|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368170|NCT00357006|4195381|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368171|NCT00357006|4195382|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368172|NCT00357006|4195379|B4||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
4368173|NCT00357006|4195380|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4368174|NCT00357006|4195381|B2||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4368175|NCT00357006|4195382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4368176|NCT00357006|4195379|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368177|NCT00357006|4195380|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368178|NCT00357006|4195381|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368179|NCT00357006|4195382|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368180|NCT00356915|4195392|B4|South Africa||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|26|26.0||||||
4368181|NCT00356915|4195393|B3|South Africa||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|3|3.0||||||
4368182|NCT00356915|4195394|B2|South Africa||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|11|11.0||||||
4368183|NCT00356915|4195395|B1|South Africa||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|12|12.0||||||
4368184|NCT00356915|4195392|B4|Dominican Republic||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|18|18.0||||||
4368185|NCT00356915|4195393|B3|Dominican Republic||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|2|2.0||||||
4368186|NCT00356915|4195394|B2|Dominican Republic||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|9|9.0||||||
4368187|NCT00356915|4195395|B1|Dominican Republic||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|7|7.0||||||
4368402|NCT00356525|4195533|B3|>65 years||Age, Customized||participants|Number|5|5.0||||||
4368188|NCT00356915|4195392|B4|Honduras||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|21|21.0||||||
4368189|NCT00356915|4195393|B3|Honduras||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|3|3.0||||||
4368190|NCT00356915|4195394|B2|Honduras||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|9|9.0||||||
4368191|NCT00356915|4195395|B1|Honduras||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|9|9.0||||||
4368192|NCT00356915|4195392|B4|Ecuador||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|17|17.0||||||
4368193|NCT00356915|4195393|B3|Ecuador||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|3|3.0||||||
4368194|NCT00356915|4195394|B2|Ecuador||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|8|8.0||||||
4368195|NCT00356915|4195395|B1|Ecuador||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|6|6.0||||||
4368196|NCT00356915|4195392|B4|Canada||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|52|52.0||||||
4368197|NCT00356915|4195393|B3|Canada||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|8|8.0||||||
4368198|NCT00356915|4195394|B2|Canada||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|21|21.0||||||
4368199|NCT00356915|4195395|B1|Canada||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|23|23.0||||||
4368200|NCT00356915|4195392|B4|United States||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|1226|1226.0||||||
4368201|NCT00356915|4195393|B3|United States||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|176|176.0||||||
4368202|NCT00356915|4195394|B2|United States||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|523|523.0||||||
4368203|NCT00356915|4195395|B1|United States||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|527|527.0||||||
4368204|NCT00356915|4195392|B4|Panama||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|21|21.0||||||
4368205|NCT00356915|4195393|B3|Panama||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|3|3.0||||||
4368403|NCT00356525|4195534|B2|>65 years||Age, Customized||participants|Number|8|8.0||||||
4368404|NCT00356525|4195535|B1|>65 years||Age, Customized||participants|Number|8|8.0||||||
4368206|NCT00356915|4195394|B2|Panama||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|9|9.0||||||
4368207|NCT00356915|4195395|B1|Panama||Region of Enrollment|Participants were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial participants would have checked more than one box and it would have been reported as such. Therefore the total number of participants reported for race is greater than the number enrolled.|participants|Number|9|9.0||||||
4368208|NCT00356915|4195392|B4|Unknown or Not Reported||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|73|73.0||||||
4368209|NCT00356915|4195393|B3|Unknown or Not Reported||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|7|7.0||||||
4368210|NCT00356915|4195394|B2|Unknown or Not Reported||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|41|41.0||||||
4368211|NCT00356915|4195395|B1|Unknown or Not Reported||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|25|25.0||||||
4368212|NCT00356915|4195392|B4|White||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|1174|1174.0||||||
4368213|NCT00356915|4195393|B3|White||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|169|169.0||||||
4368214|NCT00356915|4195394|B2|White||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|493|493.0||||||
4368215|NCT00356915|4195395|B1|White||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|512|512.0||||||
4368216|NCT00356915|4195392|B4|Black or African American||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|114|114.0||||||
4368217|NCT00356915|4195393|B3|Black or African American||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|18|18.0||||||
4368218|NCT00356915|4195394|B2|Black or African American||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|48|48.0||||||
4368219|NCT00356915|4195395|B1|Black or African American||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|48|48.0||||||
4368220|NCT00356915|4195392|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|1|1.0||||||
4368221|NCT00356915|4195393|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|0|0.0||||||
4368222|NCT00356915|4195394|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|1|1.0||||||
4368223|NCT00356915|4195395|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|0|0.0||||||
4368405|NCT00356525|4195531|B5|<=65 years||Age, Customized||participants|Number|15|15.0||||||
4368224|NCT00356915|4195392|B4|Asian||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|11|11.0||||||
4368225|NCT00356915|4195393|B3|Asian||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|2|2.0||||||
4368226|NCT00356915|4195394|B2|Asian||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|4|4.0||||||
4368227|NCT00356915|4195395|B1|Asian||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|5|5.0||||||
4368228|NCT00356915|4195392|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|18|18.0||||||
4368229|NCT00356915|4195393|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|4|4.0||||||
4368230|NCT00356915|4195394|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|7|7.0||||||
4368231|NCT00356915|4195395|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|Subjects were permitted to select all choices from the list that apply to them with regard to race; ie, multiracial subjects would have checked more than one box and it would have been reported as such. Therefore the total number of subjects reported for race is greater than the number enrolled.|Participants|Number|7|7.0||||||
4368232|NCT00356915|4195392|B4||Male|Gender||Participants|Count of Participants|347|347.0||||||
4368233|NCT00356915|4195393|B3||Male|Gender||Participants|Count of Participants|45|45.0||||||
4368234|NCT00356915|4195394|B2||Male|Gender||Participants|Count of Participants|150|150.0||||||
4368235|NCT00356915|4195395|B1||Male|Gender||Participants|Count of Participants|152|152.0||||||
4368236|NCT00356915|4195392|B4||Female|Gender||Participants|Count of Participants|1034|1034.0||||||
4368237|NCT00356915|4195393|B3||Female|Gender||Participants|Count of Participants|153|153.0||||||
4368238|NCT00356915|4195394|B2||Female|Gender||Participants|Count of Participants|440|440.0||||||
4368239|NCT00356915|4195395|B1||Female|Gender||Participants|Count of Participants|441|441.0||||||
4368240|NCT00356915|4195392|B4|||Age||years|Mean|47.4|47.4|Standard Deviation|12.13|12.13|||
4368241|NCT00356915|4195393|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|11.12|11.12|||
4368242|NCT00356915|4195394|B2|||Age||years|Mean|47|47.0|Standard Deviation|12.67|12.67|||
4368243|NCT00356915|4195395|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|11.86|11.86|||
4368244|NCT00356889|4195414|B1|Singapore||Region of Enrollment||participants|Number|4|4.0||||||
4368245|NCT00356889|4195414|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4368246|NCT00356889|4195414|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4368247|NCT00356889|4195414|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4368248|NCT00356889|4195414|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4368249|NCT00356889|4195414|B1|||Age||years|Median|63.5|63.5|Full Range|||31.0|87.0|
4368250|NCT00356863|4195421|B3|Israel||Region of Enrollment||participants|Number|1024|1024.0||||||
4368251|NCT00356863|4195422|B2|Israel||Region of Enrollment||participants|Number|520|520.0||||||
4368252|NCT00356863|4195423|B1|Israel||Region of Enrollment||participants|Number|504|504.0||||||
4368253|NCT00356863|4195421|B3||Male|Sex: Female, Male||Participants|Count of Participants|780|780.0||||||
4368254|NCT00356863|4195422|B2||Male|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
4368255|NCT00356863|4195423|B1||Male|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
4368256|NCT00356863|4195421|B3||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4368257|NCT00356863|4195422|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4368258|NCT00356863|4195423|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4368259|NCT00356863|4195421|B3|||Age||years|Mean|65.902|65.902|Standard Deviation|10.01|10.01|||
4368260|NCT00356863|4195422|B2|||Age||years|Mean|66.146|66.146|Standard Deviation|10.789|10.789|||
4368261|NCT00356863|4195423|B1|||Age||years|Mean|65.644|65.644|Standard Deviation|9.904|9.904|||
4368262|NCT00356811|4195450|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4368263|NCT00356811|4195450|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368264|NCT00356811|4195450|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4368265|NCT00356811|4195450|B1|||Age||Years|Mean|52.3|52.3|Standard Deviation|9.30|9.3|||
4368406|NCT00356525|4195532|B4|<=65 years||Age, Customized||participants|Number|4|4.0||||||
4368407|NCT00356525|4195533|B3|<=65 years||Age, Customized||participants|Number|2|2.0||||||
4368266|NCT00356759|4195463|B3|INR range 2.5-3.5||Therapeutic INR range|International normalized ratio (INR) is a standardized expression of the prothrombin time. Normal is 0.9-1.2. Therapeutic range is 2.0-3-0 for most patients, 2.5-3.5 for those with mechanical mitral valve or with mechanical aortic valve plus atrial fibrillation|participants|Number|30|30.0||||||
4368267|NCT00356759|4195464|B2|INR range 2.5-3.5||Therapeutic INR range|International normalized ratio (INR) is a standardized expression of the prothrombin time. Normal is 0.9-1.2. Therapeutic range is 2.0-3-0 for most patients, 2.5-3.5 for those with mechanical mitral valve or with mechanical aortic valve plus atrial fibrillation|participants|Number|15|15.0||||||
4368268|NCT00356759|4195465|B1|INR range 2.5-3.5||Therapeutic INR range|International normalized ratio (INR) is a standardized expression of the prothrombin time. Normal is 0.9-1.2. Therapeutic range is 2.0-3-0 for most patients, 2.5-3.5 for those with mechanical mitral valve or with mechanical aortic valve plus atrial fibrillation|participants|Number|15|15.0||||||
4368269|NCT00356759|4195463|B3|INR range 2.0-3.0||Therapeutic INR range|International normalized ratio (INR) is a standardized expression of the prothrombin time. Normal is 0.9-1.2. Therapeutic range is 2.0-3-0 for most patients, 2.5-3.5 for those with mechanical mitral valve or with mechanical aortic valve plus atrial fibrillation|participants|Number|220|220.0||||||
4368270|NCT00356759|4195464|B2|INR range 2.0-3.0||Therapeutic INR range|International normalized ratio (INR) is a standardized expression of the prothrombin time. Normal is 0.9-1.2. Therapeutic range is 2.0-3-0 for most patients, 2.5-3.5 for those with mechanical mitral valve or with mechanical aortic valve plus atrial fibrillation|participants|Number|109|109.0||||||
4368271|NCT00356759|4195465|B1|INR range 2.0-3.0||Therapeutic INR range|International normalized ratio (INR) is a standardized expression of the prothrombin time. Normal is 0.9-1.2. Therapeutic range is 2.0-3-0 for most patients, 2.5-3.5 for those with mechanical mitral valve or with mechanical aortic valve plus atrial fibrillation|participants|Number|111|111.0||||||
4368272|NCT00356759|4195463|B3||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4368273|NCT00356759|4195464|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4368274|NCT00356759|4195465|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4368275|NCT00356759|4195463|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4368276|NCT00356759|4195464|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4368277|NCT00356759|4195465|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4368278|NCT00356759|4195463|B3|Age||Age||years|Median|71|71.0|Full Range|||23.0|93.0|
4368279|NCT00356759|4195464|B2|Age||Age||years|Median|70|70.0|Full Range|||23.0|92.0|
4368280|NCT00356759|4195465|B1|Age||Age||years|Median|72|72.0|Full Range|||29.0|93.0|
4368281|NCT00356603|4195482|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368282|NCT00356603|4195483|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368283|NCT00356603|4195484|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368284|NCT00356603|4195482|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368285|NCT00356603|4195483|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368286|NCT00356603|4195484|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368287|NCT00356603|4195482|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368288|NCT00356603|4195483|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368289|NCT00356603|4195484|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368290|NCT00356603|4195482|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368291|NCT00356603|4195483|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368292|NCT00356603|4195484|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368293|NCT00356603|4195482|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368294|NCT00356603|4195483|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368295|NCT00356603|4195484|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368296|NCT00356603|4195482|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4368297|NCT00356603|4195483|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4368298|NCT00356603|4195484|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4368299|NCT00356603|4195482|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368300|NCT00356603|4195483|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368301|NCT00356603|4195484|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368302|NCT00356603|4195482|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4368303|NCT00356603|4195483|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4368304|NCT00356603|4195484|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4368305|NCT00356603|4195482|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4368306|NCT00356603|4195483|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4368307|NCT00356603|4195484|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4368308|NCT00356603|4195482|B3|||Age||Years|Mean|39.3|39.3|Standard Deviation|9.6|9.6|||
4368309|NCT00356603|4195483|B2|||Age||Years|Mean|37.4|37.4|Standard Deviation|9.0|9.0|||
4368310|NCT00356603|4195484|B1|||Age||Years|Mean|41.2|41.2|Standard Deviation|9.9|9.9|||
4368311|NCT00356590|4195499|B1|||Duration of Morning Stiffness||Minutes|Mean|182.24|182.24|Standard Deviation|286.63|286.63|||
4368312|NCT00356590|4195499|B1|||C-Reactive Protein||mg/dL|Mean|3.28|3.28|Standard Deviation|4.90|4.9|||
4368408|NCT00356525|4195534|B2|<=65 years||Age, Customized||participants|Number|3|3.0||||||
4368313|NCT00356590|4195499|B1|||Mental Component Summary Score from SF-36|Mental Component Summary Score from the Short Form-36 Health Survey. This score has a range of 0 to 100, with higher scores indicating better health.|Units on a scale|Mean|48.28|48.28|Standard Deviation|11.52|11.52|||
4368314|NCT00356590|4195499|B1|||Physical Component Summary Score from SF-36|Physical Component Summary Score from the Short Form-36 Health Survey. This score has a range of 0 to 100, with higher scores indicating better health.|Units on a scale|Mean|30.42|30.42|Standard Deviation|9.69|9.69|||
4368315|NCT00356590|4195499|B1|||Health Assessment Questionnaire Disability Index|This index is a weighted average of 24 items, each scored 0 (no difficulty) to 3 (unable to function).|Units on a scale|Mean|1.30|1.3|Standard Deviation|0.67|0.67|||
4368316|NCT00356590|4195499|B1|||Swollen Joint Count|Based on up to 68 joints|Joints|Mean|20.30|20.3|Standard Deviation|12.60|12.6|||
4368317|NCT00356590|4195499|B1|||Tender Joint Count|Based on up to 71 joints|Joints|Mean|25.81|25.81|Standard Deviation|16.71|16.71|||
4368318|NCT00356590|4195499|B1|||Participant Pain Visual Analog Scale|"Assessed using a 10 cm scale ranging from no pain (0 cm) to severe pain (10 cm)."|Units on a scale|Mean|5.01|5.01|Standard Deviation|2.62|2.62|||
4368319|NCT00356590|4195499|B1|||Participant Global Assessment of Disease Status|Assessed using a 0 - 10 Likert scale, where 0 = asymptomatic and 10 = severe symptoms|Units on a scale|Mean|5.51|5.51|Standard Deviation|2.27|2.27|||
4368320|NCT00356590|4195499|B1|||Physician Global Assessment of Disease Status|Assessed using a 0 - 10 Likert scale, where 0 = asymptomatic and 10 = severe symptoms|Units on a scale|Mean|5.32|5.32|Standard Deviation|2.30|2.3|||
4368321|NCT00356590|4195499|B1|Black or African American||Race/Ethnicity, Customized||Participant|Number|23|23.0||||||
4368322|NCT00356590|4195499|B1|Asian||Race/Ethnicity, Customized||Participant|Number|5|5.0||||||
4368323|NCT00356590|4195499|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|4|4.0||||||
4368324|NCT00356590|4195499|B1|Other||Race/Ethnicity, Customized||Participant|Number|4|4.0||||||
4368325|NCT00356590|4195499|B1|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|407|407.0||||||
4368326|NCT00356590|4195499|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|25|25.0||||||
4368327|NCT00356590|4195499|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4368328|NCT00356590|4195499|B1||Female|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4368329|NCT00356590|4195499|B1|||Age||Year|Mean|51.38|51.38|Standard Deviation|12.38|12.38|||
4368330|NCT00356525|4195531|B5|Caucasian||Race/Ethnicity||participants|Number|37|37.0||||||
4368331|NCT00356525|4195532|B4|Caucasian||Race/Ethnicity||participants|Number|7|7.0||||||
4368332|NCT00356525|4195533|B3|Caucasian||Race/Ethnicity||participants|Number|5|5.0||||||
4368333|NCT00356525|4195534|B2|Caucasian||Race/Ethnicity||participants|Number|11|11.0||||||
4368334|NCT00356525|4195535|B1|Caucasian||Race/Ethnicity||participants|Number|14|14.0||||||
4368335|NCT00356525|4195531|B5|West Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4368336|NCT00356525|4195532|B4|West Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4368337|NCT00356525|4195533|B3|West Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4368338|NCT00356525|4195534|B2|West Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4368339|NCT00356525|4195535|B1|West Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4368340|NCT00356525|4195531|B5|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4368341|NCT00356525|4195532|B4|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4368342|NCT00356525|4195533|B3|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4368343|NCT00356525|4195534|B2|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4368344|NCT00356525|4195535|B1|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4368345|NCT00356525|4195531|B5|Black or African American||Race/Ethnicity||participants|Number|2|2.0||||||
4368346|NCT00356525|4195532|B4|Black or African American||Race/Ethnicity||participants|Number|0|0.0||||||
4368347|NCT00356525|4195533|B3|Black or African American||Race/Ethnicity||participants|Number|2|2.0||||||
4368348|NCT00356525|4195534|B2|Black or African American||Race/Ethnicity||participants|Number|0|0.0||||||
4368349|NCT00356525|4195535|B1|Black or African American||Race/Ethnicity||participants|Number|0|0.0||||||
4368350|NCT00356525|4195531|B5|Neoadjuvant||Prior Systemic Therapy|Participants could have more than one type of prior systemic therapy which may result in the total numbers per arm being larger than the overall number of participants per arm.|participants|Number|5|5.0||||||
4368351|NCT00356525|4195532|B4|Neoadjuvant||Prior Systemic Therapy|Participants could have more than one type of prior systemic therapy which may result in the total numbers per arm being larger than the overall number of participants per arm.|participants|Number|1|1.0||||||
4368352|NCT00356525|4195533|B3|Neoadjuvant||Prior Systemic Therapy|Participants could have more than one type of prior systemic therapy which may result in the total numbers per arm being larger than the overall number of participants per arm.|participants|Number|1|1.0||||||
4368353|NCT00356525|4195534|B2|Neoadjuvant||Prior Systemic Therapy|Participants could have more than one type of prior systemic therapy which may result in the total numbers per arm being larger than the overall number of participants per arm.|participants|Number|0|0.0||||||
4368354|NCT00356525|4195535|B1|Neoadjuvant||Prior Systemic Therapy|Participants could have more than one type of prior systemic therapy which may result in the total numbers per arm being larger than the overall number of participants per arm.|participants|Number|3|3.0||||||
4368355|NCT00356525|4195531|B5|Adjuvant||Prior Systemic Therapy|Participants could have more than one type of prior systemic therapy which may result in the total numbers per arm being larger than the overall number of participants per arm.|participants|Number|38|38.0||||||
4368356|NCT00356525|4195532|B4|Adjuvant||Prior Systemic Therapy|Participants could have more than one type of prior systemic therapy which may result in the total numbers per arm being larger than the overall number of participants per arm.|participants|Number|9|9.0||||||
4368357|NCT00356525|4195533|B3|Adjuvant||Prior Systemic Therapy|Participants could have more than one type of prior systemic therapy which may result in the total numbers per arm being larger than the overall number of participants per arm.|participants|Number|6|6.0||||||
4368358|NCT00356525|4195534|B2|Adjuvant||Prior Systemic Therapy|Participants could have more than one type of prior systemic therapy which may result in the total numbers per arm being larger than the overall number of participants per arm.|participants|Number|11|11.0||||||
4368359|NCT00356525|4195535|B1|Adjuvant||Prior Systemic Therapy|Participants could have more than one type of prior systemic therapy which may result in the total numbers per arm being larger than the overall number of participants per arm.|participants|Number|12|12.0||||||
4368360|NCT00356525|4195531|B5|Yes||History of Brain Metastates||participants|Number|2|2.0||||||
4368361|NCT00356525|4195532|B4|Yes||History of Brain Metastates||participants|Number|0|0.0||||||
4368362|NCT00356525|4195533|B3|Yes||History of Brain Metastates||participants|Number|0|0.0||||||
4368363|NCT00356525|4195534|B2|Yes||History of Brain Metastates||participants|Number|0|0.0||||||
4368364|NCT00356525|4195535|B1|Yes||History of Brain Metastates||participants|Number|2|2.0||||||
4368365|NCT00356525|4195531|B5|No||History of Brain Metastates||participants|Number|39|39.0||||||
4368366|NCT00356525|4195532|B4|No||History of Brain Metastates||participants|Number|9|9.0||||||
4368367|NCT00356525|4195533|B3|No||History of Brain Metastates||participants|Number|7|7.0||||||
4368368|NCT00356525|4195534|B2|No||History of Brain Metastates||participants|Number|11|11.0||||||
4368369|NCT00356525|4195535|B1|No||History of Brain Metastates||participants|Number|12|12.0||||||
4368370|NCT00356525|4195531|B5|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|24|24.0||||||
4368371|NCT00356525|4195532|B4|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|3|3.0||||||
4368372|NCT00356525|4195533|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|5|5.0||||||
4368373|NCT00356525|4195534|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|8|8.0||||||
4368374|NCT00356525|4195535|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|8|8.0||||||
4368375|NCT00356525|4195531|B5|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|17|17.0||||||
4368376|NCT00356525|4195532|B4|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|6|6.0||||||
4368377|NCT00356525|4195533|B3|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|2|2.0||||||
4368378|NCT00356525|4195534|B2|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|3|3.0||||||
4368379|NCT00356525|4195535|B1|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|6|6.0||||||
4368380|NCT00356525|4195531|B5|Stage IV||Disease Stage at Initial Diagnosis|Stages of disease range from 0 (no evidence of primary tumor) to IV (tumor in multiple locations).|participants|Number|41|41.0||||||
4368381|NCT00356525|4195532|B4|Stage IV||Disease Stage at Initial Diagnosis|Stages of disease range from 0 (no evidence of primary tumor) to IV (tumor in multiple locations).|participants|Number|9|9.0||||||
4368382|NCT00356525|4195533|B3|Stage IV||Disease Stage at Initial Diagnosis|Stages of disease range from 0 (no evidence of primary tumor) to IV (tumor in multiple locations).|participants|Number|7|7.0||||||
4368383|NCT00356525|4195534|B2|Stage IV||Disease Stage at Initial Diagnosis|Stages of disease range from 0 (no evidence of primary tumor) to IV (tumor in multiple locations).|participants|Number|11|11.0||||||
4368384|NCT00356525|4195535|B1|Stage IV||Disease Stage at Initial Diagnosis|Stages of disease range from 0 (no evidence of primary tumor) to IV (tumor in multiple locations).|participants|Number|14|14.0||||||
4368385|NCT00356525|4195531|B5|United States||Region of Enrollment||participants|Number|41|41.0||||||
4368386|NCT00356525|4195532|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4368387|NCT00356525|4195533|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4368388|NCT00356525|4195534|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4368389|NCT00356525|4195535|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4368390|NCT00356525|4195531|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4368391|NCT00356525|4195532|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4368392|NCT00356525|4195533|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4368393|NCT00356525|4195534|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4368394|NCT00356525|4195535|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4368395|NCT00356525|4195531|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4368396|NCT00356525|4195532|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4368397|NCT00356525|4195533|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368398|NCT00356525|4195534|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4368399|NCT00356525|4195535|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4368400|NCT00356525|4195531|B5|>65 years||Age, Customized||participants|Number|26|26.0||||||
4368401|NCT00356525|4195532|B4|>65 years||Age, Customized||participants|Number|5|5.0||||||
4368409|NCT00356525|4195535|B1|<=65 years||Age, Customized||participants|Number|6|6.0||||||
4368410|NCT00356434|4195564|B3|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4368411|NCT00356434|4195565|B2|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4368412|NCT00356434|4195566|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4368413|NCT00356434|4195564|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368414|NCT00356434|4195565|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368415|NCT00356434|4195566|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368416|NCT00356434|4195564|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4368417|NCT00356434|4195565|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4368418|NCT00356434|4195566|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4368419|NCT00356434|4195564|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368420|NCT00356434|4195565|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368421|NCT00356434|4195566|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368422|NCT00356434|4195564|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4368423|NCT00356434|4195565|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4368424|NCT00356434|4195566|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4368425|NCT00356434|4195564|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368426|NCT00356434|4195565|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368427|NCT00356434|4195566|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368428|NCT00356421|4195577|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4368429|NCT00356421|4195578|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4368430|NCT00356421|4195579|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4368431|NCT00356421|4195577|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4368432|NCT00356421|4195578|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4368433|NCT00356421|4195579|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4368434|NCT00356421|4195577|B3|>=65 years||Age, Customized|Safety population.|participants|Number|3|3.0||||||
4368435|NCT00356421|4195578|B2|>=65 years||Age, Customized|Safety population.|participants|Number|1|1.0||||||
4368436|NCT00356421|4195579|B1|>=65 years||Age, Customized|Safety population.|participants|Number|2|2.0||||||
4368437|NCT00356421|4195577|B3|45 - 64 years||Age, Customized|Safety population.|participants|Number|20|20.0||||||
4368438|NCT00356421|4195578|B2|45 - 64 years||Age, Customized|Safety population.|participants|Number|6|6.0||||||
4368439|NCT00356421|4195579|B1|45 - 64 years||Age, Customized|Safety population.|participants|Number|14|14.0||||||
4368440|NCT00356421|4195577|B3|18 - 44 years||Age, Customized|Safety population.|participants|Number|35|35.0||||||
4368441|NCT00356421|4195578|B2|18 - 44 years||Age, Customized|Safety population.|participants|Number|13|13.0||||||
4368442|NCT00356421|4195579|B1|18 - 44 years||Age, Customized|Safety population.|participants|Number|22|22.0||||||
4368443|NCT00356408|4195616|B5|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4368444|NCT00356408|4195617|B4|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4368445|NCT00356408|4195618|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4368446|NCT00356408|4195619|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4368447|NCT00356408|4195620|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4368448|NCT00356408|4195616|B5|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4368449|NCT00356408|4195617|B4|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4368450|NCT00356408|4195618|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4368451|NCT00356408|4195619|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4368452|NCT00356408|4195620|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4368453|NCT00356408|4195616|B5|United States||Region of Enrollment||participants|Number|70|70.0||||||
4368454|NCT00356408|4195617|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4368455|NCT00356408|4195618|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4368456|NCT00356408|4195619|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4368457|NCT00356408|4195620|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4368458|NCT00356408|4195616|B5||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4368459|NCT00356408|4195617|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4368460|NCT00356408|4195618|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4368461|NCT00356408|4195619|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4368462|NCT00356408|4195620|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4368463|NCT00356408|4195616|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4368464|NCT00356408|4195617|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4368465|NCT00356408|4195618|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4368466|NCT00356408|4195619|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4368467|NCT00356408|4195620|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4368468|NCT00356408|4195616|B5|||Age||years|Mean|40.27|40.27|Standard Deviation|13.39|13.39|||
4368469|NCT00356408|4195617|B4|||Age||years|Mean|41.38|41.38|Standard Deviation|13.75|13.75|||
4368470|NCT00356408|4195618|B3|||Age||years|Mean|38.44|38.44|Standard Deviation|13.73|13.73|||
4368471|NCT00356408|4195619|B2|||Age||years|Mean|39.31|39.31|Standard Deviation|12.83|12.83|||
4368472|NCT00356408|4195620|B1|||Age||years|Mean|44.00|44.0|Standard Deviation|12.53|12.53|||
4368473|NCT00356408|4195616|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4368474|NCT00356408|4195617|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4368475|NCT00356408|4195618|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4368476|NCT00356408|4195619|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368477|NCT00356408|4195620|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368478|NCT00356408|4195616|B5||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4368479|NCT00356408|4195617|B4||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4368480|NCT00356408|4195618|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4368481|NCT00356408|4195619|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4368482|NCT00356408|4195620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4368483|NCT00356408|4195616|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368484|NCT00356408|4195617|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368485|NCT00356408|4195618|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368486|NCT00356408|4195619|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368487|NCT00356408|4195620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368488|NCT00356369|4195635|B3|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
4368489|NCT00356369|4195636|B2|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4368490|NCT00356369|4195637|B1|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
4368491|NCT00356369|4195635|B3|Geographic ancestry|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|399|399.0||||||
4368492|NCT00356369|4195636|B2|Geographic ancestry|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
4368493|NCT00356369|4195637|B1|Geographic ancestry|Asian-South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|298|298.0||||||
4368494|NCT00356369|4195635|B3|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4368495|NCT00356369|4195636|B2|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4368496|NCT00356369|4195637|B1|Geographic ancestry|Asian-East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4368497|NCT00356369|4195635|B3||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4368498|NCT00356369|4195636|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4368499|NCT00356369|4195637|B1||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4368500|NCT00356369|4195635|B3||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4368501|NCT00356369|4195636|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4368502|NCT00356369|4195637|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4368503|NCT00356369|4195635|B3|||Age||Years|Mean|18.78|18.78|Standard Deviation|7.86|7.86|||
4368504|NCT00356369|4195636|B2|||Age||Years|Mean|19.3|19.3|Standard Deviation|8.58|8.58|||
4368505|NCT00356369|4195637|B1|||Age||Years|Mean|18.6|18.6|Standard Deviation|7.62|7.62|||
4368506|NCT00356304|4195706|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4368507|NCT00356304|4195707|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4368508|NCT00356304|4195708|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4368509|NCT00356304|4195706|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4368510|NCT00356304|4195707|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4368511|NCT00356304|4195708|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4368512|NCT00356304|4195706|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4368513|NCT00356304|4195707|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4368514|NCT00356304|4195708|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4368515|NCT00356304|4195706|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|11.8|11.8|||
4368516|NCT00356304|4195707|B2|||Age||years|Mean|41|41.0|Standard Deviation|13|13.0|||
4368517|NCT00356304|4195708|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|10.8|10.8|||
4368518|NCT00356278|4195717|B4|United States||Region of Enrollment||participants|Number|156|156.0||||||
4368519|NCT00356278|4195718|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4368520|NCT00356278|4195719|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4368521|NCT00356278|4195720|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4368522|NCT00356278|4195717|B4||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4368523|NCT00356278|4195718|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4368524|NCT00356278|4195719|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4368525|NCT00356278|4195720|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4368526|NCT00356278|4195717|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4368527|NCT00356278|4195718|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4368528|NCT00356278|4195719|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4368529|NCT00356278|4195720|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4368530|NCT00356278|4195717|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368531|NCT00356278|4195718|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368532|NCT00356278|4195719|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368533|NCT00356278|4195720|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368534|NCT00356278|4195717|B4||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4368535|NCT00356278|4195718|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4368536|NCT00356278|4195719|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4368537|NCT00356278|4195720|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4368538|NCT00356278|4195717|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368539|NCT00356278|4195718|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368540|NCT00356278|4195719|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368541|NCT00356278|4195720|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368542|NCT00356265|4195757|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4368543|NCT00356265|4195758|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4368544|NCT00356265|4195759|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4368545|NCT00356265|4195760|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4368546|NCT00356265|4195757|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368547|NCT00356265|4195758|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368548|NCT00356265|4195759|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368549|NCT00356265|4195760|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368550|NCT00356265|4195757|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368551|NCT00356265|4195758|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368552|NCT00356265|4195759|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368553|NCT00356265|4195760|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368554|NCT00356265|4195757|B4||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4368555|NCT00356265|4195758|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4368556|NCT00356265|4195759|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4368557|NCT00356265|4195760|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4368558|NCT00356265|4195757|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368559|NCT00356265|4195758|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368560|NCT00356265|4195759|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368561|NCT00356265|4195760|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368562|NCT00356265|4195757|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368563|NCT00356265|4195758|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368564|NCT00356265|4195759|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368565|NCT00356265|4195760|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368566|NCT00356265|4195757|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4368567|NCT00356265|4195758|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4368568|NCT00356265|4195759|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368569|NCT00356265|4195760|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368570|NCT00356265|4195757|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368571|NCT00356265|4195758|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368572|NCT00356265|4195759|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368573|NCT00356265|4195760|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368574|NCT00356265|4195757|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368575|NCT00356265|4195758|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368576|NCT00356265|4195759|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368577|NCT00356265|4195760|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368578|NCT00356265|4195757|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4368579|NCT00356265|4195758|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4368580|NCT00356265|4195759|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4368581|NCT00356265|4195760|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4368582|NCT00356265|4195757|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4368583|NCT00356265|4195758|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368584|NCT00356265|4195759|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368585|NCT00356265|4195760|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4368586|NCT00356265|4195757|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4368587|NCT00356265|4195758|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4368588|NCT00356265|4195759|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4368589|NCT00356265|4195760|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4368590|NCT00356265|4195757|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4368591|NCT00356265|4195758|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4368592|NCT00356265|4195759|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4368593|NCT00356265|4195760|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4368594|NCT00356265|4195757|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368595|NCT00356265|4195758|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368596|NCT00356265|4195759|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368597|NCT00356265|4195760|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368598|NCT00356265|4195757|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4368599|NCT00356265|4195758|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4368600|NCT00356265|4195759|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4368601|NCT00356265|4195760|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4368602|NCT00356265|4195757|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368603|NCT00356265|4195758|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368604|NCT00356265|4195759|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368605|NCT00356265|4195760|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368606|NCT00356200|4195772|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4368607|NCT00356200|4195773|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4368608|NCT00356200|4195774|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4368609|NCT00356200|4195772|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4368610|NCT00356200|4195773|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4368611|NCT00356200|4195774|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4368612|NCT00356200|4195772|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4368613|NCT00356200|4195773|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4368614|NCT00356200|4195774|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4368615|NCT00356200|4195772|B3|||Age||years|Mean|39.1|39.1|Standard Deviation|8.99|8.99|||
4368616|NCT00356200|4195773|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|6.69|6.69|||
4368617|NCT00356200|4195774|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|11.70|11.7|||
4368618|NCT00356200|4195772|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368619|NCT00356200|4195773|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368620|NCT00356200|4195774|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368621|NCT00356200|4195772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4368622|NCT00356200|4195773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4368623|NCT00356200|4195774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4368624|NCT00356200|4195772|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368625|NCT00356200|4195773|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368626|NCT00356200|4195774|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368627|NCT00356148|4195802|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368628|NCT00356148|4195803|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368629|NCT00356148|4195804|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4368630|NCT00356148|4195802|B3||Female|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
4368631|NCT00356148|4195803|B2||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4368632|NCT00356148|4195804|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4368633|NCT00356148|4195802|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|13.3|13.3|||
4368634|NCT00356148|4195803|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|14.1|14.1|||
4368635|NCT00356148|4195804|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|11.1|11.1|||
4368636|NCT00356135|4195813|B4|United States||Region of Enrollment||participants|Number|139|139.0||||||
4368637|NCT00356135|4195814|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4368638|NCT00356135|4195815|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4368639|NCT00356135|4195816|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4368640|NCT00356135|4195813|B4|Other||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|7|7.0||||||
4368641|NCT00356135|4195814|B3|Other||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|1|1.0||||||
4368642|NCT00356135|4195815|B2|Other||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|5|5.0||||||
4368643|NCT00356135|4195816|B1|Other||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|1|1.0||||||
4368644|NCT00356135|4195813|B4|Asian||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|0|0.0||||||
4368645|NCT00356135|4195814|B3|Asian||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|0|0.0||||||
4368646|NCT00356135|4195815|B2|Asian||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|0|0.0||||||
4368647|NCT00356135|4195816|B1|Asian||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|0|0.0||||||
4368648|NCT00356135|4195813|B4|African||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|26|26.0||||||
4368649|NCT00356135|4195814|B3|African||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|6|6.0||||||
4368650|NCT00356135|4195815|B2|African||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|13|13.0||||||
4368651|NCT00356135|4195816|B1|African||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|7|7.0||||||
4368652|NCT00356135|4195813|B4|Caucasian||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|106|106.0||||||
4368653|NCT00356135|4195814|B3|Caucasian||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|37|37.0||||||
4368654|NCT00356135|4195815|B2|Caucasian||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|30|30.0||||||
4368655|NCT00356135|4195816|B1|Caucasian||Race/Ethnicity, Customized|breakdown of participants by race/ethnicity|participants|Number|39|39.0||||||
4368656|NCT00356135|4195813|B4||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4368657|NCT00356135|4195814|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4368658|NCT00356135|4195815|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4368659|NCT00356135|4195816|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4368660|NCT00356135|4195813|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4368661|NCT00356135|4195814|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4368662|NCT00356135|4195815|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4368663|NCT00356135|4195816|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4368664|NCT00356135|4195813|B4|||Age||years|Mean|57.7|57.7|Standard Deviation|8.73|8.73|||
4368665|NCT00356135|4195814|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|9.16|9.16|||
4368666|NCT00356135|4195815|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|8.93|8.93|||
4368667|NCT00356135|4195816|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|8.18|8.18|||
4368668|NCT00356122|4195840|B1|||Body Surface Area (BSA)|BSA was calculated using the Mosteller formula if it was missing|Square meters|Mean|1.875|1.875|Standard Deviation|0.252|0.252|||
4368669|NCT00356122|4195840|B1|||Height||Centimeters|Mean|169.80|169.8|Standard Deviation|9.57|9.57|||
4368670|NCT00356122|4195840|B1|||Weight||kilograms|Mean|76.530|76.53|Standard Deviation|17.793|17.793|||
4368671|NCT00356122|4195840|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4368672|NCT00356122|4195840|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4368673|NCT00356122|4195840|B1|>=65 years||Age, Customized||participants|Number|25|25.0||||||
4368674|NCT00356122|4195840|B1|<65 years||Age, Customized||participants|Number|28|28.0||||||
4368675|NCT00356122|4195840|B1|||Age||years|Mean|61.10|61.1|Standard Deviation|11.07|11.07|||
4368676|NCT00356057|4195848|B4|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4368677|NCT00356057|4195849|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4368678|NCT00356057|4195850|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4368679|NCT00356057|4195851|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4368680|NCT00356057|4195848|B4|United States||Region of Enrollment||participants|Number|149|149.0||||||
4368681|NCT00356057|4195849|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4368682|NCT00356057|4195850|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4368683|NCT00356057|4195851|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4368684|NCT00356057|4195848|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4368685|NCT00356057|4195849|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4368686|NCT00356057|4195850|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4368687|NCT00356057|4195851|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4368688|NCT00356057|4195848|B4||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4368689|NCT00356057|4195849|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4368690|NCT00356057|4195850|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4368691|NCT00356057|4195851|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4368692|NCT00356057|4195848|B4|||Age||years|Mean|73.1|73.1|Standard Deviation|8.1|8.1|||
4368693|NCT00356057|4195849|B3|||Age||years|Mean|72.3|72.3|Standard Deviation|8.2|8.2|||
4368694|NCT00356057|4195850|B2|||Age||years|Mean|72.7|72.7|Standard Deviation|7.8|7.8|||
4368695|NCT00356057|4195851|B1|||Age||years|Mean|74.1|74.1|Standard Deviation|8.4|8.4|||
4368696|NCT00356031|4195891|B1|retroperitoneal/pelvis tumors||Sarcoma Location||Participants|Count of Participants|6|6.0||||||
4368697|NCT00356031|4195891|B1|Trunk||Sarcoma Location||Participants|Count of Participants|1|1.0||||||
4368698|NCT00356031|4195891|B1|Extremity||Sarcoma Location||Participants|Count of Participants|13|13.0||||||
4368699|NCT00356031|4195891|B1|||Median Sarcoma Size||Centimeters (cm)|Median|8.25|8.25|Full Range|||5.0|20.2|
4368700|NCT00356031|4195891|B1|High||Sarcoma Grade||Participants|Count of Participants|10|10.0||||||
4368701|NCT00356031|4195891|B1|Intermediate||Sarcoma Grade||Participants|Count of Participants|8|8.0||||||
4368702|NCT00356031|4195891|B1|Low||Sarcoma Grade||Participants|Count of Participants|2|2.0||||||
4368703|NCT00356031|4195891|B1|Not Otherwise Specified||Sarcoma Histology||Participants|Count of Participants|1|1.0||||||
4368704|NCT00356031|4195891|B1|Fibroblastic Osteosarcoma||Sarcoma Histology||Participants|Count of Participants|1|1.0||||||
4368705|NCT00356031|4195891|B1|Leiomyosarcoma||Sarcoma Histology||Participants|Count of Participants|4|4.0||||||
4368706|NCT00356031|4195891|B1|Liposarcoma||Sarcoma Histology||Participants|Count of Participants|6|6.0||||||
4368707|NCT00356031|4195891|B1|Fibroblastic||Sarcoma Histology||Participants|Count of Participants|8|8.0||||||
4368708|NCT00356031|4195891|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4368709|NCT00356031|4195891|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4368710|NCT00356031|4195891|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4368711|NCT00356031|4195891|B1|||Age||years|Mean|54|54.0|Standard Deviation|13|13.0|||
4368712|NCT00356031|4195891|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4368713|NCT00356031|4195891|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4368714|NCT00356031|4195891|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368715|NCT00355914|4195900|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4368716|NCT00355914|4195901|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4368717|NCT00355914|4195902|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4368718|NCT00355914|4195900|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4368719|NCT00355914|4195901|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4368720|NCT00355914|4195902|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4368721|NCT00355914|4195900|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4368722|NCT00355914|4195901|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4368723|NCT00355914|4195902|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4368724|NCT00355914|4195900|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|15.3|15.3|||
4368725|NCT00355914|4195901|B2|||Age||years|Mean|46|46.0|Standard Deviation|17|17.0|||
4368726|NCT00355914|4195902|B1|||Age||years|Mean|47|47.0|Standard Deviation|15|15.0|||
4368727|NCT00355914|4195900|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4368728|NCT00355914|4195901|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4368729|NCT00355914|4195902|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4368730|NCT00355914|4195900|B3||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4368731|NCT00355914|4195901|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4368732|NCT00355914|4195902|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4368733|NCT00355914|4195900|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368734|NCT00355914|4195901|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368735|NCT00355914|4195902|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368736|NCT00355797|4195911|B4||Male|Sex: Female, Male||Participants|Count of Participants|815|815.0||||||
4368737|NCT00355797|4195912|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4368738|NCT00355797|4195913|B2||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4368739|NCT00355797|4195914|B1||Male|Sex: Female, Male||Participants|Count of Participants|433|433.0||||||
4368740|NCT00355797|4195911|B4||Female|Sex: Female, Male||Participants|Count of Participants|676|676.0||||||
4368741|NCT00355797|4195912|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4368742|NCT00355797|4195913|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4368743|NCT00355797|4195914|B1||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4368744|NCT00355797|4195911|B4|||Age||years|Mean|73.1|73.1|Standard Deviation|12.0|12.0|||
4368745|NCT00355797|4195912|B3|||Age||years|Mean|72.7|72.7|Standard Deviation|12.4|12.4|||
4368746|NCT00355797|4195913|B2|||Age||years|Mean|72.5|72.5|Standard Deviation|12.0|12.0|||
4368747|NCT00355797|4195914|B1|||Age||years|Mean|73.5|73.5|Standard Deviation|11.7|11.7|||
4368748|NCT00355784|4195945|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
4368749|NCT00355784|4195946|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4368750|NCT00355784|4195947|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4368751|NCT00355784|4195948|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4368752|NCT00355784|4195945|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4368753|NCT00355784|4195946|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4368754|NCT00355784|4195947|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4368755|NCT00355784|4195948|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4368756|NCT00355784|4195945|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4368757|NCT00355784|4195946|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4368758|NCT00355784|4195947|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4368759|NCT00355784|4195948|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4368760|NCT00355784|4195945|B4|||Age||years|Mean|24.4|24.4|Standard Deviation|0.8|0.8|||
4368761|NCT00355784|4195946|B3|||Age||years|Mean|24.9|24.9|Standard Deviation|1.9|1.9|||
4368762|NCT00355784|4195947|B2|||Age||years|Mean|23.1|23.1|Standard Deviation|1.0|1.0|||
4368763|NCT00355784|4195948|B1|||Age||years|Mean|24.5|24.5|Standard Deviation|1.2|1.2|||
4368764|NCT00355784|4195945|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368765|NCT00355784|4195946|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368766|NCT00355784|4195947|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368767|NCT00355784|4195948|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368768|NCT00355784|4195945|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4368769|NCT00355784|4195946|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4368770|NCT00355784|4195947|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4368771|NCT00355784|4195948|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4368772|NCT00355784|4195945|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368773|NCT00355784|4195946|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368774|NCT00355784|4195947|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368775|NCT00355784|4195948|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368776|NCT00355706|4195982|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4368777|NCT00355706|4195983|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4368778|NCT00355706|4195984|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4368779|NCT00355706|4195982|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4368780|NCT00355706|4195983|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4368781|NCT00355706|4195984|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4368782|NCT00355706|4195982|B3|||Age||years|Mean|43.8|43.8|Standard Deviation|12.0|12.0|||
4368783|NCT00355706|4195983|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|12.3|12.3|||
4368784|NCT00355706|4195984|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|11.7|11.7|||
4368785|NCT00355706|4195982|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4368786|NCT00355706|4195983|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368787|NCT00355706|4195984|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4368788|NCT00355706|4195982|B3||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4368789|NCT00355706|4195983|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4368790|NCT00355706|4195984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4368791|NCT00355706|4195982|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368792|NCT00355706|4195983|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368793|NCT00355706|4195984|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368794|NCT00355615|4195995|B5|||Baseline low-density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|233.3|233.3|Standard Deviation|10.0|10.0|||
4368795|NCT00355615|4195996|B4|||Baseline low-density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|229.00|229.0|Standard Deviation|43.13|43.13|||
4368796|NCT00355615|4195997|B3|||Baseline low-density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|237.40|237.4|Standard Deviation|47.80|47.8|||
4368797|NCT00355615|4195998|B2|||Baseline low-density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|229.10|229.1|Standard Deviation|44.70|44.7|||
4368798|NCT00355615|4195999|B1|||Baseline low-density lipoprotein cholesterol (LDL-C)||mg/dL|Mean|237.70|237.7|Standard Deviation|55.06|55.06|||
4368799|NCT00355615|4195995|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4368800|NCT00355615|4195996|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4368801|NCT00355615|4195997|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4368802|NCT00355615|4195998|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4368803|NCT00355615|4195999|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4368804|NCT00355615|4195995|B5||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4368805|NCT00355615|4195996|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4368806|NCT00355615|4195997|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4368807|NCT00355615|4195998|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4368808|NCT00355615|4195999|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4368809|NCT00355615|4195995|B5|||Age||years|Mean|14.3|14.3|Full Range|||10.0|17.0|
4368810|NCT00355615|4195996|B4|||Age||years|Mean|14.3|14.3|Full Range|||10.0|17.0|
4368811|NCT00355615|4195997|B3|||Age||years|Mean|14.2|14.2|Full Range|||11.0|17.0|
4368812|NCT00355615|4195998|B2|||Age||years|Mean|14.5|14.5|Full Range|||11.0|17.0|
4368813|NCT00355615|4195999|B1|||Age||years|Mean|14.1|14.1|Full Range|||10.0|17.0|
4368814|NCT00355472|4196062|B1|PTCL||Diagnosis||participants|Number|3|3.0||||||
4368815|NCT00355472|4196062|B1|ATL||Diagnosis||participants|Number|13|13.0||||||
4368816|NCT00355472|4196062|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4368817|NCT00355472|4196062|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4368818|NCT00355472|4196062|B1|||Age||years|Median|62|62.0|Full Range|||46.0|69.0|
4368819|NCT00355394|4196087|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4368820|NCT00355394|4196088|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4368821|NCT00355394|4196089|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4368822|NCT00355394|4196087|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4368823|NCT00355394|4196088|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4368824|NCT00355394|4196089|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4368825|NCT00355394|4196087|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4368826|NCT00355394|4196088|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4368827|NCT00355394|4196089|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4368828|NCT00355394|4196087|B3|||Age||years|Mean|11.9|11.9|Standard Deviation|2.9|2.9|||
4368829|NCT00355394|4196088|B2|||Age||years|Mean|12.9|12.9|Standard Deviation|2.4|2.4|||
4368830|NCT00355394|4196089|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|3.1|3.1|||
4368831|NCT00355394|4196087|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368832|NCT00355394|4196088|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368833|NCT00355394|4196089|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368834|NCT00355394|4196087|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4368835|NCT00355394|4196088|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4368836|NCT00355394|4196089|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4368837|NCT00355394|4196087|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4368838|NCT00355394|4196088|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4368839|NCT00355394|4196089|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4368840|NCT00355368|4196106|B3|Switzerland||Region of Enrollment||participants|Number|420|420.0||||||
4368841|NCT00355368|4196107|B2|Switzerland||Region of Enrollment||participants|Number|210|210.0||||||
4368842|NCT00355368|4196108|B1|Switzerland||Region of Enrollment||participants|Number|210|210.0||||||
4368843|NCT00355368|4196106|B3||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4368844|NCT00355368|4196107|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4368845|NCT00355368|4196108|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4368846|NCT00355368|4196106|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4368847|NCT00355368|4196107|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4368848|NCT00355368|4196108|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4368849|NCT00355368|4196106|B3|||Age||years|Mean|61|61.0|Standard Deviation|15|15.0|||
4368850|NCT00355368|4196107|B2|||Age||years|Mean|63|63.0|Standard Deviation|14|14.0|||
4368851|NCT00355368|4196108|B1|||Age||years|Mean|60|60.0|Standard Deviation|16|16.0|||
4368852|NCT00355368|4196106|B3||>=65 years|Age||Participants|Count of Participants|189|189.0||||||
4368853|NCT00355368|4196107|B2||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
4368854|NCT00355368|4196108|B1||>=65 years|Age||Participants|Count of Participants|87|87.0||||||
4368855|NCT00355368|4196106|B3||Between 18 and 65 years|Age||Participants|Count of Participants|231|231.0||||||
4368856|NCT00355368|4196107|B2||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4368857|NCT00355368|4196108|B1||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4368858|NCT00355368|4196106|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368859|NCT00355368|4196107|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368860|NCT00355368|4196108|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368861|NCT00355342|4196121|B3|Race|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|179|179.0||||||
4368862|NCT00355342|4196122|B2|Race|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|87|87.0||||||
4368863|NCT00355342|4196123|B1|Race|White/Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|92|92.0||||||
4368864|NCT00355342|4196121|B3|Race|South Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4368865|NCT00355342|4196122|B2|Race|South Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4368866|NCT00355342|4196123|B1|Race|South Asian|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4368867|NCT00355342|4196121|B3|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4368868|NCT00355342|4196122|B2|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4368869|NCT00355342|4196123|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4368870|NCT00355342|4196121|B3|Race|American Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4368871|NCT00355342|4196122|B2|Race|American Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4368872|NCT00355342|4196123|B1|Race|American Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4368873|NCT00355342|4196121|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4368874|NCT00355342|4196122|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4368875|NCT00355342|4196123|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4368876|NCT00355342|4196121|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4368877|NCT00355342|4196122|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4368878|NCT00355342|4196123|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4368879|NCT00355342|4196121|B3|||Age||Years|Mean|65.6|65.6|Standard Deviation|8.94|8.94|||
4368880|NCT00355342|4196122|B2|||Age||Years|Mean|65.4|65.4|Standard Deviation|8.36|8.36|||
4368881|NCT00355342|4196123|B1|||Age||Years|Mean|65.9|65.9|Standard Deviation|9.52|9.52|||
4368882|NCT00355199|4196132|B3|Italy||Region of Enrollment||participants|Number|235|235.0||||||
4368883|NCT00355199|4196133|B2|Italy||Region of Enrollment||participants|Number|122|122.0||||||
4368884|NCT00355199|4196134|B1|Italy||Region of Enrollment||participants|Number|113|113.0||||||
4368885|NCT00355199|4196132|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4368886|NCT00355199|4196133|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4368887|NCT00355199|4196134|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4368888|NCT00355199|4196132|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4368889|NCT00355199|4196133|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4368890|NCT00355199|4196134|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4368891|NCT00355199|4196132|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4368892|NCT00355199|4196133|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4368893|NCT00355199|4196134|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4368894|NCT00355199|4196132|B3||Between 18 and 65 years|Age||Participants|Count of Participants|233|233.0||||||
4368895|NCT00355199|4196133|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4368896|NCT00355199|4196134|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4368897|NCT00355199|4196132|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4368898|NCT00355199|4196133|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4368899|NCT00355199|4196134|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4368900|NCT00355147|4196149|B3|||Patient Health Questionnaire (PHQ)9 Depressive Symptoms|"PHQ9 is a commonly used scale to measure the degree by which a respondent was bothered by depressive symptoms during the past 2 weeks by Spitzer, Williams, and Kroenke. Each of the 9 items use a 0-3 item response where 0 = not at all and 3 =nearly every day. Total score is the sum of the 9 items."|units on a scale|Mean|7.00|7.0|Standard Deviation|6.34|6.34|||
4368901|NCT00355147|4196150|B2|||Patient Health Questionnaire (PHQ)9 Depressive Symptoms|"PHQ9 is a commonly used scale to measure the degree by which a respondent was bothered by depressive symptoms during the past 2 weeks by Spitzer, Williams, and Kroenke. Each of the 9 items use a 0-3 item response where 0 = not at all and 3 =nearly every day. Total score is the sum of the 9 items."|units on a scale|Mean|6.82|6.82|Standard Deviation|6.68|6.68|||
4368902|NCT00355147|4196151|B1|||Patient Health Questionnaire (PHQ)9 Depressive Symptoms|"PHQ9 is a commonly used scale to measure the degree by which a respondent was bothered by depressive symptoms during the past 2 weeks by Spitzer, Williams, and Kroenke. Each of the 9 items use a 0-3 item response where 0 = not at all and 3 =nearly every day. Total score is the sum of the 9 items."|units on a scale|Mean|7.72|7.72|Standard Deviation|6.16|6.16|||
4368903|NCT00355147|4196149|B3|||Stroke Specific Health Related Quality of Life Perceived Energy|Perceived Energy Subdomain of the Stroke Specific Quality of Life measures perceived energy after stroke. Item response is on a 5 point Likert scale where 1 denotes worse functioning and 5 denotes best functioning. Domain score was calculated as an unweighted average of item scores in the Energy subdomain.|units on a scale|Mean|3.04|3.04|Standard Deviation|1.36|1.36|||
4368904|NCT00355147|4196150|B2|||Stroke Specific Health Related Quality of Life Perceived Energy|Perceived Energy Subdomain of the Stroke Specific Quality of Life measures perceived energy after stroke. Item response is on a 5 point Likert scale where 1 denotes worse functioning and 5 denotes best functioning. Domain score was calculated as an unweighted average of item scores in the Energy subdomain.|units on a scale|Mean|3.30|3.3|Standard Deviation|1.36|1.36|||
4368905|NCT00355147|4196151|B1|||Stroke Specific Health Related Quality of Life Perceived Energy|Perceived Energy Subdomain of the Stroke Specific Quality of Life measures perceived energy after stroke. Item response is on a 5 point Likert scale where 1 denotes worse functioning and 5 denotes best functioning. Domain score was calculated as an unweighted average of item scores in the Energy subdomain.|units on a scale|Mean|2.62|2.62|Standard Deviation|1.24|1.24|||
4368906|NCT00355147|4196149|B3|||Self-Efficacy to Communicate with Physician|The scale designed by K Lorig measures the confidence to communicate with a physician about the patient's health. The response items range from 1-10 where 10 denotes a lot of confidence and a 1 denotes no confidence. The score equals the average of the items.|units on a scale|Mean|2.32|2.32|Standard Deviation|1.16|1.16|||
4368907|NCT00355147|4196150|B2|||Self-Efficacy to Communicate with Physician|The scale designed by K Lorig measures the confidence to communicate with a physician about the patient's health. The response items range from 1-10 where 10 denotes a lot of confidence and a 1 denotes no confidence. The score equals the average of the items.|units on a scale|Mean|2.56|2.56|Standard Deviation|1.28|1.28|||
4368908|NCT00355147|4196151|B1|||Self-Efficacy to Communicate with Physician|The scale designed by K Lorig measures the confidence to communicate with a physician about the patient's health. The response items range from 1-10 where 10 denotes a lot of confidence and a 1 denotes no confidence. The score equals the average of the items.|units on a scale|Mean|2.08|2.08|Standard Deviation|0.96|0.96|||
4368909|NCT00355147|4196149|B3|||Self-Efficacy to Manage Stroke|This scale is modified from the Arthitis Self-Efficacy scale and is designed to measure Confidence to Manage Stroke Symptoms. The items measure the confidence to manage symptoms and health post stroke on a 1-10 scale where 10 denotes a lot of confidence and a 1 denotes no confidence. The scale score is the average score of the items.|units on a scale|Mean|8.14|8.14|Standard Deviation|1.60|1.6|||
4368910|NCT00355147|4196150|B2|||Self-Efficacy to Manage Stroke|This scale is modified from the Arthitis Self-Efficacy scale and is designed to measure Confidence to Manage Stroke Symptoms. The items measure the confidence to manage symptoms and health post stroke on a 1-10 scale where 10 denotes a lot of confidence and a 1 denotes no confidence. The scale score is the average score of the items.|units on a scale|Mean|8.30|8.3|Standard Deviation|1.60|1.6|||
4368911|NCT00355147|4196151|B1|||Self-Efficacy to Manage Stroke|This scale is modified from the Arthitis Self-Efficacy scale and is designed to measure Confidence to Manage Stroke Symptoms. The items measure the confidence to manage symptoms and health post stroke on a 1-10 scale where 10 denotes a lot of confidence and a 1 denotes no confidence. The scale score is the average score of the items.|units on a scale|Mean|7.72|7.72|Standard Deviation|1.68|1.68|||
4368912|NCT00355147|4196149|B3|||Stroke Specific, Health-Related Quality of Life|Stroke, specific, health-related quality of life (SSQoL) is a self-reported survey by LS Williams et al Stroke. 1999;30:1362-1369. Includes 12 domains and 49 items which are scored on a 5pt Likert response format with lower score indicating worse function/lower ability on that item or domain. Domain scores were calculated as an unweighted average of item scores in that domain. Overall Total Score was calculated as an unweighted average of domain scores. Each Domain Score and the Overall Total Score all range from 1-5 with 1 being worst and 5 best best.|units on a scale|Mean|3.84|3.84|Standard Deviation|0.72|0.72|||
4368956|NCT00355134|4196168|B4|Male||Gender|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|participants|Number|17|17.0||||||
4368913|NCT00355147|4196150|B2|||Stroke Specific, Health-Related Quality of Life|Stroke, specific, health-related quality of life (SSQoL) is a self-reported survey by LS Williams et al Stroke. 1999;30:1362-1369. Includes 12 domains and 49 items which are scored on a 5pt Likert response format with lower score indicating worse function/lower ability on that item or domain. Domain scores were calculated as an unweighted average of item scores in that domain. Overall Total Score was calculated as an unweighted average of domain scores. Each Domain Score and the Overall Total Score all range from 1-5 with 1 being worst and 5 best best.|units on a scale|Mean|3.92|3.92|Standard Deviation|0.72|0.72|||
4368914|NCT00355147|4196151|B1|||Stroke Specific, Health-Related Quality of Life|Stroke, specific, health-related quality of life (SSQoL) is a self-reported survey by LS Williams et al Stroke. 1999;30:1362-1369. Includes 12 domains and 49 items which are scored on a 5pt Likert response format with lower score indicating worse function/lower ability on that item or domain. Domain scores were calculated as an unweighted average of item scores in that domain. Overall Total Score was calculated as an unweighted average of domain scores. Each Domain Score and the Overall Total Score all range from 1-5 with 1 being worst and 5 best best.|units on a scale|Mean|3.72|3.72|Standard Deviation|0.68|0.68|||
4368915|NCT00355147|4196149|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4368916|NCT00355147|4196150|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4368917|NCT00355147|4196151|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4368918|NCT00355147|4196149|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4368919|NCT00355147|4196150|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368920|NCT00355147|4196151|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4368921|NCT00355147|4196149|B3||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4368922|NCT00355147|4196150|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4368923|NCT00355147|4196151|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4368924|NCT00355147|4196149|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4368925|NCT00355147|4196150|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4368926|NCT00355147|4196151|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4368927|NCT00355147|4196149|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4368928|NCT00355147|4196150|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4368929|NCT00355147|4196151|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368930|NCT00355147|4196149|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368931|NCT00355147|4196150|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368932|NCT00355147|4196151|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368933|NCT00355147|4196149|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4368934|NCT00355147|4196150|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4368935|NCT00355147|4196151|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4368936|NCT00355147|4196149|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368937|NCT00355147|4196150|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368938|NCT00355147|4196151|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4368939|NCT00355147|4196149|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|159|159.0||||||
4368940|NCT00355147|4196150|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4368941|NCT00355147|4196151|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4368942|NCT00355147|4196149|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4368943|NCT00355147|4196150|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4368944|NCT00355147|4196151|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4368945|NCT00355147|4196149|B3||Male|Sex: Female, Male|Self reported description of respondent's sex|Participants|Count of Participants|169|169.0||||||
4368946|NCT00355147|4196150|B2||Male|Sex: Female, Male|Self reported description of respondent's sex|Participants|Count of Participants|85|85.0||||||
4368947|NCT00355147|4196151|B1||Male|Sex: Female, Male|Self reported description of respondent's sex|Participants|Count of Participants|84|84.0||||||
4368948|NCT00355147|4196149|B3||Female|Sex: Female, Male|Self reported description of respondent's sex|Participants|Count of Participants|5|5.0||||||
4368949|NCT00355147|4196150|B2||Female|Sex: Female, Male|Self reported description of respondent's sex|Participants|Count of Participants|2|2.0||||||
4368950|NCT00355147|4196151|B1||Female|Sex: Female, Male|Self reported description of respondent's sex|Participants|Count of Participants|3|3.0||||||
4368951|NCT00355147|4196149|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|9.5|9.5|||
4368952|NCT00355147|4196150|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|9.4|9.4|||
4368953|NCT00355147|4196151|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|9.5|9.5|||
4368954|NCT00355134|4196166|B6|Male||Gender|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|participants|Number|151|151.0||||||
4368955|NCT00355134|4196167|B5|Male||Gender|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|participants|Number|22|22.0||||||
4368993|NCT00355121|4196218|B1|United States||Region of Enrollment||participants|Number|353|353.0||||||
4368957|NCT00355134|4196169|B3|Male||Gender|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|participants|Number|0|0.0||||||
4368958|NCT00355134|4196170|B2|Male||Gender|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|participants|Number|57|57.0||||||
4368959|NCT00355134|4196171|B1|Male||Gender|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|participants|Number|55|55.0||||||
4368960|NCT00355134|4196166|B6|Female||Gender|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|participants|Number|481|481.0||||||
4368961|NCT00355134|4196167|B5|Female||Gender|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|participants|Number|85|85.0||||||
4368962|NCT00355134|4196168|B4|Female||Gender|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|participants|Number|88|88.0||||||
4368963|NCT00355134|4196169|B3|Female||Gender|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|participants|Number|0|0.0||||||
4368964|NCT00355134|4196170|B2|Female||Gender|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|participants|Number|160|160.0||||||
4368965|NCT00355134|4196171|B1|Female||Gender|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|participants|Number|148|148.0||||||
4368966|NCT00355134|4196166|B6|Male||Gender|Demographic data for the Core phase participant population.|participants|Number|239|239.0||||||
4368967|NCT00355134|4196167|B5|Male||Gender|Demographic data for the Core phase participant population.|participants|Number|0|0.0||||||
4368968|NCT00355134|4196168|B4|Male||Gender|Demographic data for the Core phase participant population.|participants|Number|0|0.0||||||
4368969|NCT00355134|4196169|B3|Male||Gender|Demographic data for the Core phase participant population.|participants|Number|67|67.0||||||
4368970|NCT00355134|4196170|B2|Male||Gender|Demographic data for the Core phase participant population.|participants|Number|83|83.0||||||
4368971|NCT00355134|4196171|B1|Male||Gender|Demographic data for the Core phase participant population.|participants|Number|89|89.0||||||
4368972|NCT00355134|4196166|B6|Female||Gender|Demographic data for the Core phase participant population.|participants|Number|844|844.0||||||
4368973|NCT00355134|4196167|B5|Female||Gender|Demographic data for the Core phase participant population.|participants|Number|0|0.0||||||
4368974|NCT00355134|4196168|B4|Female||Gender|Demographic data for the Core phase participant population.|participants|Number|0|0.0||||||
4368975|NCT00355134|4196169|B3|Female||Gender|Demographic data for the Core phase participant population.|participants|Number|288|288.0||||||
4368976|NCT00355134|4196170|B2|Female||Gender|Demographic data for the Core phase participant population.|participants|Number|275|275.0||||||
4368977|NCT00355134|4196171|B1|Female||Gender|Demographic data for the Core phase participant population.|participants|Number|281|281.0||||||
4368978|NCT00355134|4196166|B6|||Age|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|years|Mean|40.6|40.6|Standard Deviation|8.28|8.28|||
4368979|NCT00355134|4196167|B5|||Age|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|years|Mean|41.1|41.1|Standard Deviation|8.11|8.11|||
4368980|NCT00355134|4196168|B4|||Age|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|years|Mean|39.8|39.8|Standard Deviation|8.32|8.32|||
4368981|NCT00355134|4196169|B3|||Age|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|years|Mean|NA||Standard Deviation|NA||||Age demographic data presented for the Extension phase population only.
4368982|NCT00355134|4196170|B2|||Age|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|years|Mean|40.8|40.8|Standard Deviation|7.96|7.96|||
4368983|NCT00355134|4196171|B1|||Age|Demographic data for the Extension phase population. The number of participants in each treatment group in the Extension phase was 203, 217, 0, 105 and 107; Total participants 632.|years|Mean|40.6|40.6|Standard Deviation|8.71|8.71|||
4368984|NCT00355134|4196166|B6|||Age|Demographic data for the Core phase participant population.|years|Mean|40.5|40.5|Standard Deviation|8.58|8.58|||
4368985|NCT00355134|4196167|B5|||Age|Demographic data for the Core phase participant population.|years|Mean|NA||Standard Deviation|NA||||Age demographic data presented for Core phase population only.
4368986|NCT00355134|4196168|B4|||Age|Demographic data for the Core phase participant population.|years|Mean|NA||Standard Deviation|NA||||Age demographic data presented for Core phase population only.
4368987|NCT00355134|4196169|B3|||Age|Demographic data for the Core phase participant population.|years|Mean|40.1|40.1|Standard Deviation|8.42|8.42|||
4368988|NCT00355134|4196170|B2|||Age|Demographic data for the Core phase participant population.|years|Mean|40.6|40.6|Standard Deviation|8.39|8.39|||
4368989|NCT00355134|4196171|B1|||Age|Demographic data for the Core phase participant population.|years|Mean|40.9|40.9|Standard Deviation|8.90|8.9|||
4368990|NCT00355121|4196215|B4|United States||Region of Enrollment||participants|Number|881|881.0||||||
4368991|NCT00355121|4196216|B3|United States||Region of Enrollment||participants|Number|175|175.0||||||
4368992|NCT00355121|4196217|B2|United States||Region of Enrollment||participants|Number|353|353.0||||||
4368994|NCT00355121|4196215|B4||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
4368995|NCT00355121|4196216|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4368996|NCT00355121|4196217|B2||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4368997|NCT00355121|4196218|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4368998|NCT00355121|4196215|B4||Female|Sex: Female, Male||Participants|Count of Participants|427|427.0||||||
4368999|NCT00355121|4196216|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4369000|NCT00355121|4196217|B2||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4369001|NCT00355121|4196218|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4369002|NCT00355121|4196215|B4|||Age||Years|Mean|4.5|4.5|Standard Deviation|0.50|0.5|||
4369003|NCT00355121|4196216|B3|||Age||Years|Mean|4.5|4.5|Standard Deviation|0.49|0.49|||
4369004|NCT00355121|4196217|B2|||Age||Years|Mean|4.5|4.5|Standard Deviation|0.51|0.51|||
4369005|NCT00355121|4196218|B1|||Age||Years|Mean|4.5|4.5|Standard Deviation|0.48|0.48|||
4369006|NCT00355121|4196215|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369007|NCT00355121|4196216|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369008|NCT00355121|4196217|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369009|NCT00355121|4196218|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369010|NCT00355121|4196215|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4369011|NCT00355121|4196216|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4369012|NCT00355121|4196217|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4369013|NCT00355121|4196218|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4369014|NCT00355121|4196215|B4||<=18 years|Age||Participants|Count of Participants|881|881.0||||||
4369015|NCT00355121|4196216|B3||<=18 years|Age||Participants|Count of Participants|175|175.0||||||
4369016|NCT00355121|4196217|B2||<=18 years|Age||Participants|Count of Participants|353|353.0||||||
4369017|NCT00355121|4196218|B1||<=18 years|Age||Participants|Count of Participants|353|353.0||||||
4369018|NCT00355082|4196249|B3|Pregabalin||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|2|2.0||||||
4369019|NCT00355082|4196250|B2|Pregabalin||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|1|1.0||||||
4369020|NCT00355082|4196251|B1|Pregabalin||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|1|1.0||||||
4369021|NCT00355082|4196249|B3|Zonisamide||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|8|8.0||||||
4369022|NCT00355082|4196250|B2|Zonisamide||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|5|5.0||||||
4369023|NCT00355082|4196251|B1|Zonisamide||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|3|3.0||||||
4369024|NCT00355082|4196249|B3|Topiramate||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|22|22.0||||||
4369025|NCT00355082|4196250|B2|Topiramate||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|10|10.0||||||
4369026|NCT00355082|4196251|B1|Topiramate||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|12|12.0||||||
4369027|NCT00355082|4196249|B3|Oxcarbazepine||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|24|24.0||||||
4369028|NCT00355082|4196250|B2|Oxcarbazepine||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|12|12.0||||||
4369029|NCT00355082|4196251|B1|Oxcarbazepine||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|12|12.0||||||
4369030|NCT00355082|4196249|B3|Levetiracetam||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|24|24.0||||||
4369031|NCT00355082|4196250|B2|Levetiracetam||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|13|13.0||||||
4369032|NCT00355082|4196251|B1|Levetiracetam||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|11|11.0||||||
4369088|NCT00355030|4196274|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369033|NCT00355082|4196249|B3|Valproate||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|143|143.0||||||
4369034|NCT00355082|4196250|B2|Valproate||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|70|70.0||||||
4369035|NCT00355082|4196251|B1|Valproate||Number of participants taking indicated concurrent antiepileptic drug at study entry|Antiepileptic drug (AED) being taken by participant at study entry; this characteristic is not applicable for the Continuation phase|participants|Number|73|73.0||||||
4369036|NCT00355082|4196249|B3|Asian - East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4369037|NCT00355082|4196250|B2|Asian - East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4369038|NCT00355082|4196251|B1|Asian - East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4369039|NCT00355082|4196249|B3|Asian - Central/South Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4369040|NCT00355082|4196250|B2|Asian - Central/South Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4369041|NCT00355082|4196251|B1|Asian - Central/South Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4369042|NCT00355082|4196249|B3|White||Race/Ethnicity, Customized||participants|Number|190|190.0||||||
4369043|NCT00355082|4196250|B2|White||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4369044|NCT00355082|4196251|B1|White||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4369045|NCT00355082|4196249|B3|Arabic/North African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4369046|NCT00355082|4196250|B2|Arabic/North African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4369047|NCT00355082|4196251|B1|Arabic/North African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4369048|NCT00355082|4196249|B3|Asian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4369049|NCT00355082|4196250|B2|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4369050|NCT00355082|4196251|B1|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4369051|NCT00355082|4196249|B3|African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4369052|NCT00355082|4196250|B2|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4369053|NCT00355082|4196251|B1|African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4369054|NCT00355082|4196249|B3||Male|Gender||Participants|Count of Participants|101|101.0||||||
4369055|NCT00355082|4196250|B2||Male|Gender||Participants|Count of Participants|45|45.0||||||
4369056|NCT00355082|4196251|B1||Male|Gender||Participants|Count of Participants|56|56.0||||||
4369057|NCT00355082|4196249|B3||Female|Gender||Participants|Count of Participants|122|122.0||||||
4369058|NCT00355082|4196250|B2||Female|Gender||Participants|Count of Participants|66|66.0||||||
4369059|NCT00355082|4196251|B1||Female|Gender||Participants|Count of Participants|56|56.0||||||
4369060|NCT00355082|4196249|B3|||Age||years|Mean|33.4|33.4|Standard Deviation|13.5|13.5|||
4369061|NCT00355082|4196250|B2|||Age||years|Mean|32.9|32.9|Standard Deviation|12.6|12.6|||
4369062|NCT00355082|4196251|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|14.3|14.3|||
4369063|NCT00355030|4196273|B3|||Standing Height||centimeters|Mean|131.6|131.6|Standard Deviation|6.24|6.24|||
4369064|NCT00355030|4196274|B2|||Standing Height||centimeters|Mean|131.6|131.6|Standard Deviation|5.78|5.78|||
4369065|NCT00355030|4196275|B1|||Standing Height||centimeters|Mean|131.6|131.6|Standard Deviation|6.72|6.72|||
4369066|NCT00355030|4196273|B3|||Standing Height SDS||Standard Deviation Score|Mean|-2.5|-2.5|Standard Deviation|.045|0.045|||
4369067|NCT00355030|4196274|B2|||Standing Height SDS||Standard Deviation Score|Mean|-2.5|-2.5|Standard Deviation|0.46|0.46|||
4369068|NCT00355030|4196275|B1|||Standing Height SDS||Standard Deviation Score|Mean|-2.5|-2.5|Standard Deviation|0.45|0.45|||
4369069|NCT00355030|4196273|B3|France||Region of Enrollment||participants|Number|77|77.0||||||
4369070|NCT00355030|4196274|B2|France||Region of Enrollment||participants|Number|38|38.0||||||
4369071|NCT00355030|4196275|B1|France||Region of Enrollment||participants|Number|39|39.0||||||
4369072|NCT00355030|4196273|B3|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4369073|NCT00355030|4196274|B2|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4369074|NCT00355030|4196275|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4369075|NCT00355030|4196273|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4369076|NCT00355030|4196274|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4369077|NCT00355030|4196275|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4369078|NCT00355030|4196273|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369079|NCT00355030|4196274|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369080|NCT00355030|4196275|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369081|NCT00355030|4196273|B3||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4369082|NCT00355030|4196274|B2||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4369083|NCT00355030|4196275|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4369084|NCT00355030|4196273|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4369085|NCT00355030|4196274|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369086|NCT00355030|4196275|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4369087|NCT00355030|4196273|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369089|NCT00355030|4196275|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369090|NCT00355030|4196273|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4369091|NCT00355030|4196274|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4369092|NCT00355030|4196275|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4369093|NCT00355030|4196273|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369094|NCT00355030|4196274|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369095|NCT00355030|4196275|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369096|NCT00355030|4196273|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4369097|NCT00355030|4196274|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4369098|NCT00355030|4196275|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4369099|NCT00355030|4196273|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4369100|NCT00355030|4196274|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4369101|NCT00355030|4196275|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4369102|NCT00355030|4196273|B3|||Age||years|Mean|12.1|12.1|Standard Deviation|1.36|1.36|||
4369103|NCT00355030|4196274|B2|||Age||years|Mean|12.1|12.1|Standard Deviation|1.33|1.33|||
4369104|NCT00355030|4196275|B1|||Age||years|Mean|12.1|12.1|Standard Deviation|1.41|1.41|||
4369105|NCT00354978|4196298|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4369106|NCT00354978|4196298|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4369107|NCT00354978|4196298|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4369108|NCT00354978|4196298|B1|||Age||years|Median|57|57.0|Full Range|||26.0|78.0|
4369109|NCT00354913|4196302|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4369110|NCT00354913|4196302|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4369111|NCT00354913|4196302|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|13.9|13.9|||
4369112|NCT00354887|4196309|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4369113|NCT00354887|4196309|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4369114|NCT00354887|4196309|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4369115|NCT00354887|4196309|B1|||Age||years|Median|62|62.0|Full Range|||41.0|79.0|
4369116|NCT00354835|4196313|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4369117|NCT00354835|4196314|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4369118|NCT00354835|4196315|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4369119|NCT00354835|4196313|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369120|NCT00354835|4196314|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369121|NCT00354835|4196315|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369122|NCT00354835|4196313|B3||White|Race (NIH/OMB)||Participants|Count of Participants|346|346.0||||||
4369123|NCT00354835|4196314|B2||White|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4369124|NCT00354835|4196315|B1||White|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4369125|NCT00354835|4196313|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4369126|NCT00354835|4196314|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4369127|NCT00354835|4196315|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4369128|NCT00354835|4196313|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369129|NCT00354835|4196314|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369130|NCT00354835|4196315|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369131|NCT00354835|4196313|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4369132|NCT00354835|4196314|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4369133|NCT00354835|4196315|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4369134|NCT00354835|4196313|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4369135|NCT00354835|4196314|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4369136|NCT00354835|4196315|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4369137|NCT00354835|4196313|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4369138|NCT00354835|4196314|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4369139|NCT00354835|4196315|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4369140|NCT00354835|4196313|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|395|395.0||||||
4369141|NCT00354835|4196314|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|204|204.0||||||
4369142|NCT00354835|4196315|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
4369143|NCT00354835|4196313|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4369144|NCT00354835|4196314|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4369145|NCT00354835|4196315|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4369146|NCT00354835|4196313|B3||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4369147|NCT00354835|4196314|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4369148|NCT00354835|4196315|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4369149|NCT00354835|4196313|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4369150|NCT00354835|4196314|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4369151|NCT00354835|4196315|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4369152|NCT00354835|4196313|B3|||Age||months|Mean|93.88|93.88|Standard Deviation|78.21|78.21|||
4369153|NCT00354835|4196314|B2|||Age||months|Mean|97.86|97.86|Standard Deviation|82.66|82.66|||
4369154|NCT00354835|4196315|B1|||Age||months|Mean|89.85|89.85|Standard Deviation|73.39|73.39|||
4369155|NCT00354770|4196346|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4369156|NCT00354770|4196347|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4369157|NCT00354770|4196348|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4369158|NCT00354770|4196346|B3||Male|Gender||Participants|Count of Participants|5|5.0||||||
4369159|NCT00354770|4196347|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
4369160|NCT00354770|4196348|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4369161|NCT00354770|4196346|B3||Female|Gender||Participants|Count of Participants|45|45.0||||||
4369162|NCT00354770|4196347|B2||Female|Gender||Participants|Count of Participants|21|21.0||||||
4369163|NCT00354770|4196348|B1||Female|Gender||Participants|Count of Participants|24|24.0||||||
4369164|NCT00354770|4196346|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|11.5|11.5|||
4369165|NCT00354770|4196347|B2|||Age||years|Mean|32.7|32.7|Standard Deviation|10.5|10.5|||
4369166|NCT00354770|4196348|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|13.6|13.6|||
4369167|NCT00354770|4196346|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369168|NCT00354770|4196347|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369169|NCT00354770|4196348|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369170|NCT00354770|4196346|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4369171|NCT00354770|4196347|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4369172|NCT00354770|4196348|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4369173|NCT00354770|4196346|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369174|NCT00354770|4196347|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369175|NCT00354770|4196348|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369176|NCT00354744|4196355|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4369177|NCT00354744|4196355|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4369178|NCT00354744|4196355|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4369179|NCT00354744|4196355|B1|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4369180|NCT00354744|4196355|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4369181|NCT00354744|4196355|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4369182|NCT00354744|4196355|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369183|NCT00354744|4196355|B1||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4369184|NCT00354744|4196355|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4369185|NCT00354744|4196355|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369186|NCT00354744|4196355|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4369187|NCT00354744|4196355|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4369188|NCT00354744|4196355|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4369189|NCT00354744|4196355|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4369190|NCT00354744|4196355|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4369191|NCT00354744|4196355|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4369192|NCT00354744|4196355|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4369193|NCT00354744|4196355|B1|||Age||years|Mean|11.85|11.85|Standard Deviation|6.55|6.55|||
4369194|NCT00354744|4196355|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369195|NCT00354744|4196355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4369196|NCT00354744|4196355|B1||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
4369197|NCT00354679|4196360|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4369198|NCT00354679|4196360|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4369199|NCT00354679|4196360|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4369200|NCT00354679|4196360|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4369201|NCT00354679|4196360|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369202|NCT00354640|4196364|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4369203|NCT00354640|4196364|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4369204|NCT00354640|4196364|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4369205|NCT00354640|4196364|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4369206|NCT00354640|4196364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4369207|NCT00354640|4196364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369208|NCT00354614|4196369|B1|||Body Mass Index||kg/m2|Mean|35.9|35.9|Standard Deviation|9.1|9.1|||
4369209|NCT00354614|4196369|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4369210|NCT00354614|4196369|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4369211|NCT00354614|4196369|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|11.3|11.3|||
4369212|NCT00354601|4196373|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4369213|NCT00354601|4196373|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4369214|NCT00354601|4196373|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4369215|NCT00354601|4196373|B1|||Age||years|Mean|60.15|60.15|Standard Deviation|8.84|8.84|||
4369216|NCT00354601|4196373|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4369217|NCT00354601|4196373|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4369218|NCT00354601|4196373|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369219|NCT00354484|4196380|B3|United States||Region of Enrollment||participants|Number|289|289.0||||||
4369220|NCT00354484|4196381|B2|United States||Region of Enrollment||participants|Number|147|147.0||||||
4369221|NCT00354484|4196382|B1|United States||Region of Enrollment||participants|Number|142|142.0||||||
4369222|NCT00354484|4196380|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4369223|NCT00354484|4196381|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4369224|NCT00354484|4196382|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4369225|NCT00354484|4196380|B3||Female|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4369226|NCT00354484|4196381|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4369227|NCT00354484|4196382|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4369228|NCT00354484|4196380|B3|||Age||years|Mean|26.45|26.45|Standard Deviation|5.86|5.86|||
4369229|NCT00354484|4196381|B2|||Age||years|Mean|26.49|26.49|Standard Deviation|5.55|5.55|||
4369230|NCT00354484|4196382|B1|||Age||years|Mean|26.43|26.43|Standard Deviation|6.02|6.02|||
4369231|NCT00354484|4196380|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369232|NCT00354484|4196381|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369233|NCT00354484|4196382|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369234|NCT00354484|4196380|B3||Between 18 and 65 years|Age||Participants|Count of Participants|268|268.0||||||
4369235|NCT00354484|4196381|B2||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
4369236|NCT00354484|4196382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4369237|NCT00354484|4196380|B3||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4369238|NCT00354484|4196381|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4369239|NCT00354484|4196382|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4369240|NCT00354432|4196389|B5|United States||Region of Enrollment||participants|Number|120|120.0||||||
4369241|NCT00354432|4196390|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4369242|NCT00354432|4196391|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4369243|NCT00354432|4196392|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4369244|NCT00354432|4196393|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4369245|NCT00354432|4196389|B5||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4369246|NCT00354432|4196390|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4369247|NCT00354432|4196391|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4369248|NCT00354432|4196392|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4369249|NCT00354432|4196393|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4369250|NCT00354432|4196389|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4369251|NCT00354432|4196390|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4369252|NCT00354432|4196391|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4369253|NCT00354432|4196392|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4369254|NCT00354432|4196393|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4369255|NCT00354432|4196389|B5|||Age||years|Mean|68.5|68.5|Standard Deviation|9.0|9.0|||
4369256|NCT00354432|4196390|B4|||Age||years|Mean|67.5|67.5|Standard Deviation|9.1|9.1|||
4369257|NCT00354432|4196391|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|9.9|9.9|||
4369258|NCT00354432|4196392|B2|||Age||years|Mean|71.0|71.0|Standard Deviation|8.2|8.2|||
4369259|NCT00354432|4196393|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|8.8|8.8|||
4369260|NCT00354432|4196389|B5||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
4369261|NCT00354432|4196390|B4||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4369262|NCT00354432|4196391|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4369263|NCT00354432|4196392|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4369264|NCT00354432|4196393|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4369265|NCT00354432|4196389|B5||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4369266|NCT00354432|4196390|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4369267|NCT00354432|4196391|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4369268|NCT00354432|4196392|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4369269|NCT00354432|4196393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4369270|NCT00354432|4196389|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369271|NCT00354432|4196390|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369272|NCT00354432|4196391|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369273|NCT00354432|4196392|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369274|NCT00354432|4196393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369275|NCT00354341|4196410|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4369276|NCT00354341|4196411|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4369277|NCT00354341|4196412|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4369278|NCT00354341|4196410|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4369279|NCT00354341|4196411|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4369280|NCT00354341|4196412|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4369281|NCT00354341|4196410|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|13.24|13.24|||
4369282|NCT00354341|4196411|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|12.64|12.64|||
4369283|NCT00354341|4196412|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|13.82|13.82|||
4369284|NCT00354224|4196429|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4369285|NCT00354224|4196429|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369286|NCT00354224|4196429|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369287|NCT00354224|4196429|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4369288|NCT00354224|4196429|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4369289|NCT00354224|4196429|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369290|NCT00354224|4196429|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369291|NCT00354224|4196429|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369292|NCT00354224|4196429|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4369293|NCT00354224|4196429|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4369294|NCT00354224|4196429|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4369295|NCT00354224|4196429|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4369296|NCT00354224|4196429|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369297|NCT00354172|4196435|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4369298|NCT00354172|4196435|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4369299|NCT00354172|4196435|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4369300|NCT00354172|4196435|B1|||Age||years|Median|22|22.0|Full Range|||3.0|43.0|
4369301|NCT00354172|4196435|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369302|NCT00354172|4196435|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4369303|NCT00354172|4196435|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4369304|NCT00354159|4196453|B3|NYHA Class III||NYHA (New York Heart Association) Classification|"Class II and Class III NYHA classification~Class II Subjects with cardiac disease resulting in slight limitation of physical activity.They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or angina.~Class III Subjects with cardiac disease resulting in marked limitation of physical activity.They are comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea, or angina."|participants|Number|203|203.0||||||
4369305|NCT00354159|4196454|B2|NYHA Class III||NYHA (New York Heart Association) Classification|"Class II and Class III NYHA classification~Class II Subjects with cardiac disease resulting in slight limitation of physical activity.They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or angina.~Class III Subjects with cardiac disease resulting in marked limitation of physical activity.They are comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea, or angina."|participants|Number|108|108.0||||||
4369306|NCT00354159|4196455|B1|NYHA Class III||NYHA (New York Heart Association) Classification|"Class II and Class III NYHA classification~Class II Subjects with cardiac disease resulting in slight limitation of physical activity.They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or angina.~Class III Subjects with cardiac disease resulting in marked limitation of physical activity.They are comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea, or angina."|participants|Number|95|95.0||||||
4369307|NCT00354159|4196453|B3|NYHA Class II||NYHA (New York Heart Association) Classification|"Class II and Class III NYHA classification~Class II Subjects with cardiac disease resulting in slight limitation of physical activity.They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or angina.~Class III Subjects with cardiac disease resulting in marked limitation of physical activity.They are comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea, or angina."|participants|Number|197|197.0||||||
4369308|NCT00354159|4196454|B2|NYHA Class II||NYHA (New York Heart Association) Classification|"Class II and Class III NYHA classification~Class II Subjects with cardiac disease resulting in slight limitation of physical activity.They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or angina.~Class III Subjects with cardiac disease resulting in marked limitation of physical activity.They are comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea, or angina."|participants|Number|90|90.0||||||
4369309|NCT00354159|4196455|B1|NYHA Class II||NYHA (New York Heart Association) Classification|"Class II and Class III NYHA classification~Class II Subjects with cardiac disease resulting in slight limitation of physical activity.They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or angina.~Class III Subjects with cardiac disease resulting in marked limitation of physical activity.They are comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea, or angina."|participants|Number|107|107.0||||||
4369310|NCT00354159|4196453|B3|United States||Region of Enrollment||participants|Number|400|400.0||||||
4369311|NCT00354159|4196454|B2|United States||Region of Enrollment||participants|Number|198|198.0||||||
4369312|NCT00354159|4196455|B1|United States||Region of Enrollment||participants|Number|202|202.0||||||
4369313|NCT00354159|4196453|B3||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4369314|NCT00354159|4196454|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4369315|NCT00354159|4196455|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4369316|NCT00354159|4196453|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4369317|NCT00354159|4196454|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4369318|NCT00354159|4196455|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4369319|NCT00354159|4196453|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|14.7|14.7|||
4369320|NCT00354159|4196454|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|14.8|14.8|||
4369321|NCT00354159|4196455|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|14.7|14.7|||
4369322|NCT00354159|4196453|B3||>=65 years|Age||Participants|Count of Participants|105|105.0||||||
4369323|NCT00354159|4196454|B2||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4369324|NCT00354159|4196455|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4369325|NCT00354159|4196453|B3||Between 18 and 65 years|Age||Participants|Count of Participants|295|295.0||||||
4369326|NCT00354159|4196454|B2||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4369327|NCT00354159|4196455|B1||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
4369328|NCT00354159|4196453|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369329|NCT00354159|4196454|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369330|NCT00354159|4196455|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369331|NCT00354107|4196499|B1|Jordan||Region of Enrollment||participants|Number|1|1.0||||||
4369332|NCT00354107|4196499|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4369333|NCT00354107|4196499|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4369334|NCT00354107|4196499|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369335|NCT00354107|4196499|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4369336|NCT00354107|4196499|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4369337|NCT00354107|4196499|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369338|NCT00354107|4196499|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369339|NCT00354107|4196499|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369340|NCT00354107|4196499|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369341|NCT00354107|4196499|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4369342|NCT00354107|4196499|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369343|NCT00354107|4196499|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4369344|NCT00354107|4196499|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4369345|NCT00354107|4196499|B1|||Age||days|Median|5655|5655.0|Inter-Quartile Range|||3157.0|5786.0|
4369346|NCT00354107|4196499|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369347|NCT00354107|4196499|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4369348|NCT00354107|4196499|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4369349|NCT00354029|4196507|B3|Norway||Region of Enrollment||participants|Number|83|83.0||||||
4369350|NCT00354029|4196508|B2|Norway||Region of Enrollment||participants|Number|40|40.0||||||
4369351|NCT00354029|4196509|B1|Norway||Region of Enrollment||participants|Number|43|43.0||||||
4369352|NCT00354029|4196507|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4369353|NCT00354029|4196508|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4369354|NCT00354029|4196509|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4369355|NCT00354029|4196507|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4369356|NCT00354029|4196508|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4369357|NCT00354029|4196509|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4369358|NCT00354029|4196507|B3|||Age||years|Mean|48|48.0|Standard Deviation|11.5|11.5|||
4369359|NCT00354029|4196508|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|11.4|11.4|||
4369360|NCT00354029|4196509|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|11.6|11.6|||
4369361|NCT00354029|4196507|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369362|NCT00354029|4196508|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369363|NCT00354029|4196509|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369364|NCT00354029|4196507|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4369365|NCT00354029|4196508|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4369366|NCT00354029|4196509|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4369367|NCT00354029|4196507|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369368|NCT00354029|4196508|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369369|NCT00354029|4196509|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369370|NCT00353977|4196516|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4369371|NCT00353977|4196516|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4369372|NCT00353977|4196516|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4369373|NCT00353977|4196516|B1|||Age||years|Mean|39|39.0|Standard Deviation|13|13.0|||
4369374|NCT00353977|4196516|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4369375|NCT00353977|4196516|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4369376|NCT00353977|4196516|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369377|NCT00353873|4196520|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|290|290.0||||||
4369378|NCT00353873|4196521|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|144|144.0||||||
4369379|NCT00353873|4196522|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|146|146.0||||||
4369380|NCT00353873|4196520|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4369381|NCT00353873|4196521|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4369382|NCT00353873|4196522|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4369383|NCT00353873|4196520|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4369384|NCT00353873|4196521|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4369385|NCT00353873|4196522|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4369386|NCT00353873|4196520|B3||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4369387|NCT00353873|4196521|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4369388|NCT00353873|4196522|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4369389|NCT00353873|4196520|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4369390|NCT00353873|4196521|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4369391|NCT00353873|4196522|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4369392|NCT00353873|4196520|B3|||Age||Years|Mean|8.0|8.0|Standard Deviation|2.00|2.0|||
4369393|NCT00353873|4196521|B2|||Age||Years|Mean|8.1|8.1|Standard Deviation|2.00|2.0|||
4369394|NCT00353873|4196522|B1|||Age||Years|Mean|8.0|8.0|Standard Deviation|2.01|2.01|||
4369395|NCT00353834|4196535|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4369396|NCT00353834|4196536|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4369397|NCT00353834|4196537|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4369398|NCT00353834|4196535|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4369399|NCT00353834|4196536|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4369400|NCT00353834|4196537|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4369401|NCT00353834|4196535|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4369402|NCT00353834|4196536|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4369403|NCT00353834|4196537|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4369404|NCT00353834|4196535|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|10.0|10.0|||
4369405|NCT00353834|4196536|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|11.6|11.6|||
4369406|NCT00353834|4196537|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|8.5|8.5|||
4369407|NCT00353834|4196535|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369408|NCT00353834|4196536|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369409|NCT00353834|4196537|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369410|NCT00353834|4196535|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4369411|NCT00353834|4196536|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4369412|NCT00353834|4196537|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4369413|NCT00353834|4196535|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369414|NCT00353834|4196536|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369415|NCT00353834|4196537|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369416|NCT00353795|4196546|B1|United States||Region of Enrollment||participants|Number|179|179.0||||||
4369417|NCT00353795|4196546|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4369418|NCT00353795|4196546|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4369419|NCT00353795|4196546|B1|||Age||years|Mean|61|61.0|Standard Deviation|9|9.0|||
4369420|NCT00353795|4196546|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369421|NCT00353795|4196546|B1||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
4369422|NCT00353795|4196546|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369423|NCT00353704|4196550|B3|Norway||Region of Enrollment||participants|Number|50|50.0||||||
4369424|NCT00353704|4196551|B2|Norway||Region of Enrollment||participants|Number|25|25.0||||||
4369425|NCT00353704|4196552|B1|Norway||Region of Enrollment||participants|Number|25|25.0||||||
4369426|NCT00353704|4196550|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4369427|NCT00353704|4196551|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4369428|NCT00353704|4196552|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4369429|NCT00353704|4196550|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4369430|NCT00353704|4196551|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4369431|NCT00353704|4196552|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4369432|NCT00353704|4196550|B3|||Age||years|Mean|43|43.0|Standard Deviation|10|10.0|||
4369433|NCT00353704|4196551|B2|||Age||years|Mean|43|43.0|Standard Deviation|8|8.0|||
4369434|NCT00353704|4196552|B1|||Age||years|Mean|44|44.0|Standard Deviation|11|11.0|||
4369435|NCT00353704|4196550|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369436|NCT00353704|4196551|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369437|NCT00353704|4196552|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369438|NCT00353704|4196550|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4369439|NCT00353704|4196551|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4369440|NCT00353704|4196552|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4369441|NCT00353704|4196550|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369442|NCT00353704|4196551|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369443|NCT00353704|4196552|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369444|NCT00353652|4196561|B7|United States||Region of Enrollment||participants|Number|104|104.0||||||
4369445|NCT00353652|4196562|B6|United States||Region of Enrollment||participants|Number|23|23.0||||||
4369446|NCT00353652|4196563|B5|United States||Region of Enrollment||participants|Number|23|23.0||||||
4369447|NCT00353652|4196564|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4369448|NCT00353652|4196565|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4369449|NCT00353652|4196566|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4369450|NCT00353652|4196567|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4369451|NCT00353652|4196561|B7||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4369452|NCT00353652|4196562|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4369453|NCT00353652|4196563|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4369454|NCT00353652|4196564|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4369455|NCT00353652|4196565|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4369456|NCT00353652|4196566|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4369457|NCT00353652|4196567|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4369458|NCT00353652|4196561|B7||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4369459|NCT00353652|4196562|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4369460|NCT00353652|4196563|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4369461|NCT00353652|4196564|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4369462|NCT00353652|4196565|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4369463|NCT00353652|4196566|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4369464|NCT00353652|4196567|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4369465|NCT00353652|4196561|B7|||Age||years|Mean|50.5|50.5|Standard Deviation|2.3|2.3|||
4369466|NCT00353652|4196562|B6|||Age||years|Mean|51|51.0|Standard Deviation|2|2.0|||
4369467|NCT00353652|4196563|B5|||Age||years|Mean|51|51.0|Standard Deviation|2|2.0|||
4369468|NCT00353652|4196564|B4|||Age||years|Mean|47|47.0|Standard Deviation|3|3.0|||
4369469|NCT00353652|4196565|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|2.3|2.3|||
4369470|NCT00353652|4196566|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|2.3|2.3|||
4369471|NCT00353652|4196567|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|2.3|2.3|||
4369472|NCT00353496|4196586|B3|Unknown||Chromogranin A|Chromogranin A is an NET marker. ULN: upper limit of normal.|participants|Number|5|5.0||||||
4369473|NCT00353496|4196587|B2|Unknown||Chromogranin A|Chromogranin A is an NET marker. ULN: upper limit of normal.|participants|Number|3|3.0||||||
4369474|NCT00353496|4196588|B1|Unknown||Chromogranin A|Chromogranin A is an NET marker. ULN: upper limit of normal.|participants|Number|2|2.0||||||
4369475|NCT00353496|4196586|B3|>2 × ULN||Chromogranin A|Chromogranin A is an NET marker. ULN: upper limit of normal.|participants|Number|89|89.0||||||
4369476|NCT00353496|4196587|B2|>2 × ULN||Chromogranin A|Chromogranin A is an NET marker. ULN: upper limit of normal.|participants|Number|48|48.0||||||
4369477|NCT00353496|4196588|B1|>2 × ULN||Chromogranin A|Chromogranin A is an NET marker. ULN: upper limit of normal.|participants|Number|41|41.0||||||
4369478|NCT00353496|4196586|B3|1–2 × ULN||Chromogranin A|Chromogranin A is an NET marker. ULN: upper limit of normal.|participants|Number|43|43.0||||||
4369479|NCT00353496|4196587|B2|1–2 × ULN||Chromogranin A|Chromogranin A is an NET marker. ULN: upper limit of normal.|participants|Number|18|18.0||||||
4369480|NCT00353496|4196588|B1|1–2 × ULN||Chromogranin A|Chromogranin A is an NET marker. ULN: upper limit of normal.|participants|Number|25|25.0||||||
4369481|NCT00353496|4196586|B3|≤1 × ULN||Chromogranin A|Chromogranin A is an NET marker. ULN: upper limit of normal.|participants|Number|67|67.0||||||
4369482|NCT00353496|4196587|B2|≤1 × ULN||Chromogranin A|Chromogranin A is an NET marker. ULN: upper limit of normal.|participants|Number|34|34.0||||||
4369483|NCT00353496|4196588|B1|≤1 × ULN||Chromogranin A|Chromogranin A is an NET marker. ULN: upper limit of normal.|participants|Number|33|33.0||||||
4369484|NCT00353496|4196586|B3|Unknown/Other||Neuroendocrine tumour (NET) origin|Primary tumour characteristics.|participants|Number|26|26.0||||||
4369485|NCT00353496|4196587|B2|Unknown/Other||Neuroendocrine tumour (NET) origin|Primary tumour characteristics.|participants|Number|11|11.0||||||
4369486|NCT00353496|4196588|B1|Unknown/Other||Neuroendocrine tumour (NET) origin|Primary tumour characteristics.|participants|Number|15|15.0||||||
4369487|NCT00353496|4196586|B3|Hindgut||Neuroendocrine tumour (NET) origin|Primary tumour characteristics.|participants|Number|14|14.0||||||
4369488|NCT00353496|4196587|B2|Hindgut||Neuroendocrine tumour (NET) origin|Primary tumour characteristics.|participants|Number|3|3.0||||||
4369579|NCT00353301|4196649|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4369489|NCT00353496|4196588|B1|Hindgut||Neuroendocrine tumour (NET) origin|Primary tumour characteristics.|participants|Number|11|11.0||||||
4369490|NCT00353496|4196586|B3|Midgut||Neuroendocrine tumour (NET) origin|Primary tumour characteristics.|participants|Number|73|73.0||||||
4369491|NCT00353496|4196587|B2|Midgut||Neuroendocrine tumour (NET) origin|Primary tumour characteristics.|participants|Number|40|40.0||||||
4369492|NCT00353496|4196588|B1|Midgut||Neuroendocrine tumour (NET) origin|Primary tumour characteristics.|participants|Number|33|33.0||||||
4369493|NCT00353496|4196586|B3|Pancreas||Neuroendocrine tumour (NET) origin|Primary tumour characteristics.|participants|Number|91|91.0||||||
4369494|NCT00353496|4196587|B2|Pancreas||Neuroendocrine tumour (NET) origin|Primary tumour characteristics.|participants|Number|49|49.0||||||
4369495|NCT00353496|4196588|B1|Pancreas||Neuroendocrine tumour (NET) origin|Primary tumour characteristics.|participants|Number|42|42.0||||||
4369496|NCT00353496|4196586|B3|||Time since diagnosis|Time relative to baseline visit (Week 1).|months|Mean|33.5|33.5|Standard Deviation|43.7|43.7|||
4369497|NCT00353496|4196587|B2|||Time since diagnosis|Time relative to baseline visit (Week 1).|months|Mean|34.4|34.4|Standard Deviation|41.4|41.4|||
4369498|NCT00353496|4196588|B1|||Time since diagnosis|Time relative to baseline visit (Week 1).|months|Mean|32.6|32.6|Standard Deviation|46.1|46.1|||
4369499|NCT00353496|4196586|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369500|NCT00353496|4196587|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369501|NCT00353496|4196588|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369502|NCT00353496|4196586|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369503|NCT00353496|4196587|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369504|NCT00353496|4196588|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369505|NCT00353496|4196586|B3||White|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4369506|NCT00353496|4196587|B2||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4369507|NCT00353496|4196588|B1||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4369508|NCT00353496|4196586|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4369509|NCT00353496|4196587|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4369510|NCT00353496|4196588|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4369511|NCT00353496|4196586|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369512|NCT00353496|4196587|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369513|NCT00353496|4196588|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369514|NCT00353496|4196586|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4369515|NCT00353496|4196587|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4369516|NCT00353496|4196588|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4369517|NCT00353496|4196586|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369518|NCT00353496|4196587|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369519|NCT00353496|4196588|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369520|NCT00353496|4196586|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4369521|NCT00353496|4196587|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4369522|NCT00353496|4196588|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4369523|NCT00353496|4196586|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4369524|NCT00353496|4196587|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4369525|NCT00353496|4196588|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4369526|NCT00353496|4196586|B3|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
4369527|NCT00353496|4196587|B2|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
4369528|NCT00353496|4196588|B1|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
4369529|NCT00353431|4196604|B3|Switzerland||Region of Enrollment||participants|Number|130|130.0||||||
4369530|NCT00353431|4196605|B2|Switzerland||Region of Enrollment||participants|Number|67|67.0||||||
4369531|NCT00353431|4196606|B1|Switzerland||Region of Enrollment||participants|Number|63|63.0||||||
4369532|NCT00353431|4196604|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4369533|NCT00353431|4196605|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4369534|NCT00353431|4196606|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4369535|NCT00353431|4196604|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4369536|NCT00353431|4196605|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4369537|NCT00353431|4196606|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4369538|NCT00353431|4196604|B3|||Age||years|Mean|73.30|73.3|Standard Deviation|10.33|10.33|||
4369539|NCT00353431|4196605|B2|||Age||years|Mean|72.43|72.43|Standard Deviation|11.67|11.67|||
4369540|NCT00353431|4196606|B1|||Age||years|Mean|74.22|74.22|Standard Deviation|8.77|8.77|||
4369541|NCT00353431|4196604|B3||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
4369542|NCT00353431|4196605|B2||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4369543|NCT00353431|4196606|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4369544|NCT00353431|4196604|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4369545|NCT00353431|4196605|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4369546|NCT00353431|4196606|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4369547|NCT00353431|4196604|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369548|NCT00353431|4196605|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369549|NCT00353431|4196606|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369550|NCT00353418|4196621|B3|Male||Gender|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Participants|Number|330|330.0||||||
4369551|NCT00353418|4196622|B2|Male||Gender|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Participants|Number|224|224.0||||||
4369552|NCT00353418|4196623|B1|Male||Gender|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Participants|Number|106|106.0||||||
4369553|NCT00353418|4196621|B3|Female||Gender|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Participants|Number|80|80.0||||||
4369554|NCT00353418|4196622|B2|Female||Gender|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Participants|Number|51|51.0||||||
4369555|NCT00353418|4196623|B1|Female||Gender|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Participants|Number|29|29.0||||||
4369556|NCT00353418|4196621|B3|||Age|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Years|Mean|45.4|45.4|Standard Deviation|8.24|8.24|||
4369557|NCT00353418|4196622|B2|||Age|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Years|Mean|45.5|45.5|Standard Deviation|8.16|8.16|||
4369558|NCT00353418|4196623|B1|||Age|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Years|Mean|45.2|45.2|Standard Deviation|8.39|8.39|||
4369559|NCT00353418|4196621|B3|>=65 years||Age, Customized|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Participants|Number|3|3.0||||||
4369560|NCT00353418|4196622|B2|>=65 years||Age, Customized|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Participants|Number|2|2.0||||||
4369561|NCT00353418|4196623|B1|>=65 years||Age, Customized|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Participants|Number|1|1.0||||||
4369562|NCT00353418|4196621|B3|< 65 years||Age, Customized|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Participants|Number|407|407.0||||||
4369563|NCT00353418|4196622|B2|< 65 years||Age, Customized|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Participants|Number|273|273.0||||||
4369564|NCT00353418|4196623|B1|< 65 years||Age, Customized|The All Patients Treated population included all patients randomized who had received at least one dose of study medication: PEG-IFN alfa 2-a 180 μg + ribavirin 800 mg = 135 patients; PEG-IFN alfa 2-a 180 μg + ribavirin 1000 or 1200 mg = 275 patients.|Participants|Number|134|134.0||||||
4369565|NCT00353366|4196642|B1||Male|Sex: Female, Male||Participants|Count of Participants|742|742.0||||||
4369566|NCT00353366|4196642|B1||Female|Sex: Female, Male||Participants|Count of Participants|690|690.0||||||
4369567|NCT00353366|4196642|B1|||Age||Weeks|Mean|11.2|11.2|Standard Deviation|3.87|3.87|||
4369568|NCT00353301|4196649|B1|United States||Region of Enrollment||Participants|Number|25|25.0||||||
4369569|NCT00353301|4196649|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4369570|NCT00353301|4196649|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4369571|NCT00353301|4196649|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4369572|NCT00353301|4196649|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369573|NCT00353301|4196649|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369574|NCT00353301|4196649|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4369575|NCT00353301|4196649|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369576|NCT00353301|4196649|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369577|NCT00353301|4196649|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369578|NCT00353301|4196649|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369580|NCT00353301|4196649|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4369581|NCT00353301|4196649|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4369582|NCT00353301|4196649|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4369583|NCT00353301|4196649|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369584|NCT00353301|4196649|B1|||Age||years|Median|60|60.0|Full Range|||47.0|73.0|
4369585|NCT00353275|4196654|B3|||Height||inches|Mean|66|66.0|Full Range|||63.0|68.0|
4369586|NCT00353275|4196655|B2|||Height||inches|Mean|65|65.0|Full Range|||63.0|68.0|
4369587|NCT00353275|4196656|B1|||Height||inches|Mean|66|66.0|Full Range|||65.0|67.0|
4369588|NCT00353275|4196654|B3|||Weight||pounds|Mean|212|212.0|Full Range|||158.0|272.0|
4369589|NCT00353275|4196655|B2|||Weight||pounds|Mean|240|240.0|Full Range|||215.0|272.0|
4369590|NCT00353275|4196656|B1|||Weight||pounds|Mean|169|169.0|Full Range|||158.0|180.0|
4369591|NCT00353275|4196654|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4369592|NCT00353275|4196655|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4369593|NCT00353275|4196656|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4369594|NCT00353275|4196654|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369595|NCT00353275|4196655|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369596|NCT00353275|4196656|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369597|NCT00353275|4196654|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369598|NCT00353275|4196655|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369599|NCT00353275|4196656|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369600|NCT00353275|4196654|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4369601|NCT00353275|4196655|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4369602|NCT00353275|4196656|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4369603|NCT00353275|4196654|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4369604|NCT00353275|4196655|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4369605|NCT00353275|4196656|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369606|NCT00353275|4196654|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369607|NCT00353275|4196655|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369608|NCT00353275|4196656|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369609|NCT00353275|4196654|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369610|NCT00353275|4196655|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369611|NCT00353275|4196656|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369612|NCT00353275|4196654|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369613|NCT00353275|4196655|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369614|NCT00353275|4196656|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369615|NCT00353275|4196654|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4369616|NCT00353275|4196655|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4369617|NCT00353275|4196656|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4369618|NCT00353275|4196654|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4369619|NCT00353275|4196655|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4369620|NCT00353275|4196656|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4369621|NCT00353275|4196654|B3|||Age||years|Mean|59|59.0|Standard Deviation|7|7.0|||
4369622|NCT00353275|4196655|B2|||Age||years|Mean|59|59.0|Standard Deviation|5|5.0|||
4369623|NCT00353275|4196656|B1|||Age||years|Mean|59|59.0|Standard Deviation|11|11.0|||
4369624|NCT00353262|4196669|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4369625|NCT00353262|4196669|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4369626|NCT00353262|4196669|B1|||Age||Years|Mean|57.3|57.3|Standard Deviation|13.03|13.03|||
4369627|NCT00353119|4196686|B3|||PPPASI - Palmoplantar Pustulosis Area and Severity Index|"PPPASI = (E + I + D)Area X 0.2 (R palm) + (E + I + D) Area X 0.2 (L palm) + (E + I + D) Area X 0.3 (R sole) + (E + I + D) Area X 0.3 (L sole).~Erythema, induration and desquamation are evaluated on a scale of 0 to 4 while area is evaluated on a scale of 0 to 6. The m-PPPASI score can vary from 0 (absence of disease) to 72 (most severe palmoplantar psoriasis possible)."|Units on a scale|Mean|18.0|18.0|Standard Deviation|7.3|7.3|||
4369628|NCT00353119|4196687|B2|||PPPASI - Palmoplantar Pustulosis Area and Severity Index|"PPPASI = (E + I + D)Area X 0.2 (R palm) + (E + I + D) Area X 0.2 (L palm) + (E + I + D) Area X 0.3 (R sole) + (E + I + D) Area X 0.3 (L sole).~Erythema, induration and desquamation are evaluated on a scale of 0 to 4 while area is evaluated on a scale of 0 to 6. The m-PPPASI score can vary from 0 (absence of disease) to 72 (most severe palmoplantar psoriasis possible)."|Units on a scale|Mean|16.3|16.3|Standard Deviation|5.0|5.0|||
4369629|NCT00353119|4196688|B1|||PPPASI - Palmoplantar Pustulosis Area and Severity Index|"PPPASI = (E + I + D)Area X 0.2 (R palm) + (E + I + D) Area X 0.2 (L palm) + (E + I + D) Area X 0.3 (R sole) + (E + I + D) Area X 0.3 (L sole).~Erythema, induration and desquamation are evaluated on a scale of 0 to 4 while area is evaluated on a scale of 0 to 6. The m-PPPASI score can vary from 0 (absence of disease) to 72 (most severe palmoplantar psoriasis possible)."|Units on a scale|Mean|21.3|21.3|Standard Deviation|10.3|10.3|||
4369630|NCT00353119|4196686|B3|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4369631|NCT00353119|4196687|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4369632|NCT00353119|4196688|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4369633|NCT00353119|4196686|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4369634|NCT00353119|4196687|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4369635|NCT00353119|4196688|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4369636|NCT00353119|4196686|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4369637|NCT00353119|4196687|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4369638|NCT00353119|4196688|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4369639|NCT00353119|4196686|B3|||Age||years|Mean|49.33|49.33|Standard Deviation|11.56|11.56|||
4369640|NCT00353119|4196687|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|13.3|13.3|||
4369641|NCT00353119|4196688|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|4.76|4.76|||
4369642|NCT00353119|4196686|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369643|NCT00353119|4196687|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369644|NCT00353119|4196688|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369645|NCT00353119|4196686|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4369646|NCT00353119|4196687|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4369647|NCT00353119|4196688|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4369648|NCT00353119|4196686|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369649|NCT00353119|4196687|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369650|NCT00353119|4196688|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369651|NCT00352911|4196699|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4369652|NCT00352911|4196700|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4369653|NCT00352911|4196701|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4369654|NCT00352911|4196699|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4369655|NCT00352911|4196700|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4369656|NCT00352911|4196701|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4369657|NCT00352911|4196699|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4369658|NCT00352911|4196700|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4369659|NCT00352911|4196701|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4369660|NCT00352911|4196699|B3|||Age||years|Mean|41.6|41.6|Standard Deviation|7.9|7.9|||
4369661|NCT00352911|4196700|B2|||Age||years|Mean|37.7|37.7|Standard Deviation|7.4|7.4|||
4369662|NCT00352911|4196701|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|8.0|8.0|||
4369663|NCT00352885|4196708|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4369664|NCT00352885|4196709|B2|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4369665|NCT00352885|4196710|B1|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4369666|NCT00352885|4196708|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4369667|NCT00352885|4196709|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4369668|NCT00352885|4196710|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4369669|NCT00352885|4196708|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4369670|NCT00352885|4196709|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4369671|NCT00352885|4196710|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4369672|NCT00352885|4196708|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|13.3|13.3|||
4369673|NCT00352885|4196709|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|16.1|16.1|||
4369674|NCT00352885|4196710|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|8.4|8.4|||
4369675|NCT00352846|4196727|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4369676|NCT00352846|4196728|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4369677|NCT00352846|4196729|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4369678|NCT00352846|4196727|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4369679|NCT00352846|4196728|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4369680|NCT00352846|4196729|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4369681|NCT00352846|4196727|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4369682|NCT00352846|4196728|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4369683|NCT00352846|4196729|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4369684|NCT00352846|4196727|B3|||Age||years|Median|57|57.0|Full Range|||19.0|80.0|
4369685|NCT00352846|4196728|B2|||Age||years|Median|61|61.0|Full Range|||24.0|80.0|
4369686|NCT00352846|4196729|B1|||Age||years|Median|57|57.0|Full Range|||19.0|75.0|
4369687|NCT00352781|4196736|B1|Canada||Region of Enrollment||participants|Number|1767|1767.0||||||
4369688|NCT00352781|4196736|B1||Male|Sex: Female, Male||Participants|Count of Participants|770|770.0||||||
4369689|NCT00352781|4196736|B1||Female|Sex: Female, Male||Participants|Count of Participants|997|997.0||||||
4369690|NCT00352781|4196736|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|12.7|12.7|||
4369691|NCT00352781|4196736|B1||>=65 years|Age||Participants|Count of Participants|106|106.0||||||
4369692|NCT00352781|4196736|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1654|1654.0||||||
4369693|NCT00352781|4196736|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4369694|NCT00352755|4196741|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4369695|NCT00352755|4196741|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4369696|NCT00352755|4196741|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4369697|NCT00352755|4196741|B1|||Age||years|Median|58|58.0|Full Range|||32.0|83.0|
4369698|NCT00352690|4196749|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4369699|NCT00352690|4196751|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4369700|NCT00352690|4196751|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
4369701|NCT00352690|4196751|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4369702|NCT00352690|4196749|B3|||Age||years|Median|69|69.0|Full Range|||53.0|77.0|
4369703|NCT00352690|4196751|B1|||Age||years|Median|69|69.0|Full Range|||53.0|77.0|
4369704|NCT00352664|4196770|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4369705|NCT00352664|4196772|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4369706|NCT00352664|4196770|B3|Male||Gender||participants|Number|9|9.0||||||
4369707|NCT00352664|4196772|B1|Male||Gender||participants|Number|9|9.0||||||
4369708|NCT00352664|4196770|B3|Female||Gender||participants|Number|18|18.0||||||
4369709|NCT00352664|4196772|B1|Female||Gender||participants|Number|18|18.0||||||
4369710|NCT00352664|4196770|B3|||Age||years|Median|56|56.0|Full Range|||22.0|64.0|
4369711|NCT00352664|4196772|B1|||Age||years|Median|56|56.0|Full Range|||22.0|64.0|
4369712|NCT00352612|4196779|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4369713|NCT00352612|4196780|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4369714|NCT00352612|4196781|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4369715|NCT00352612|4196779|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4369716|NCT00352612|4196780|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4369717|NCT00352612|4196781|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4369718|NCT00352612|4196779|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369719|NCT00352612|4196780|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369720|NCT00352612|4196781|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369721|NCT00352612|4196779|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4369722|NCT00352612|4196780|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4369723|NCT00352612|4196781|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4369724|NCT00352612|4196779|B3||<=18 years|Age||Participants|Count of Participants|200|200.0||||||
4369725|NCT00352612|4196780|B2||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4369726|NCT00352612|4196781|B1||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4369727|NCT00352534|4196788|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4369728|NCT00352534|4196789|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4369729|NCT00352534|4196790|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4369730|NCT00352534|4196788|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369731|NCT00352534|4196789|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369732|NCT00352534|4196790|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369733|NCT00352534|4196788|B3||White|Race (NIH/OMB)||Participants|Count of Participants|558|558.0||||||
4369734|NCT00352534|4196789|B2||White|Race (NIH/OMB)||Participants|Count of Participants|417|417.0||||||
4369735|NCT00352534|4196790|B1||White|Race (NIH/OMB)||Participants|Count of Participants|141|141.0||||||
4369736|NCT00352534|4196788|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4369737|NCT00352534|4196789|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4369738|NCT00352534|4196790|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4369739|NCT00352534|4196788|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369740|NCT00352534|4196789|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369741|NCT00352534|4196790|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369742|NCT00352534|4196788|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4369743|NCT00352534|4196789|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4369744|NCT00352534|4196790|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4369745|NCT00352534|4196788|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4369746|NCT00352534|4196789|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4369747|NCT00352534|4196790|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4369748|NCT00352534|4196788|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4369749|NCT00352534|4196789|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4369750|NCT00352534|4196790|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4369751|NCT00352534|4196788|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|647|647.0||||||
4369752|NCT00352534|4196789|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|482|482.0||||||
4369753|NCT00352534|4196790|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4369754|NCT00352534|4196788|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4369755|NCT00352534|4196789|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4369756|NCT00352534|4196790|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4369757|NCT00352534|4196788|B3||Male|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
4369758|NCT00352534|4196789|B2||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4369759|NCT00352534|4196790|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4369760|NCT00352534|4196788|B3||Female|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
4369761|NCT00352534|4196789|B2||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4369762|NCT00352534|4196790|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4369763|NCT00352534|4196788|B3|||Age||Months|Mean|43.64|43.64|Standard Deviation|31.83|31.83|||
4369764|NCT00352534|4196789|B2|||Age||Months|Mean|50.62|50.62|Standard Deviation|30.89|30.89|||
4369765|NCT00352534|4196790|B1|||Age||Months|Mean|23.91|23.91|Standard Deviation|24.37|24.37|||
4369766|NCT00352417|4196811|B3|Italy||Region of Enrollment||participants|Number|50|50.0||||||
4369767|NCT00352417|4196812|B2|Italy||Region of Enrollment||participants|Number|26|26.0||||||
4369768|NCT00352417|4196813|B1|Italy||Region of Enrollment||participants|Number|24|24.0||||||
4369769|NCT00352417|4196811|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4369770|NCT00352417|4196812|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4369771|NCT00352417|4196813|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4369772|NCT00352417|4196811|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4369773|NCT00352417|4196812|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4369774|NCT00352417|4196813|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4369775|NCT00352417|4196811|B3|||Age||years|Mean|68.2|68.2|Standard Deviation|8.81|8.81|||
4369776|NCT00352417|4196812|B2|||Age||years|Mean|69.5|69.5|Standard Deviation|8.73|8.73|||
4369777|NCT00352417|4196813|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|8.86|8.86|||
4369778|NCT00352417|4196811|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4369779|NCT00352417|4196812|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4369780|NCT00352417|4196813|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4369781|NCT00352417|4196811|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4369782|NCT00352417|4196812|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4369783|NCT00352417|4196813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4369784|NCT00352417|4196811|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369785|NCT00352417|4196812|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369786|NCT00352417|4196813|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369787|NCT00352365|4196828|B1|1||Performance Status|Performance status is graded according to the Zubrod Performance Status Scale. Patients with a performance status of 0 are fully active, able to carry on all pre-disease performance without restriction. Patients with a performance status of 1 are restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.|participants|Number|30|30.0||||||
4369788|NCT00352365|4196828|B1|0||Performance Status|Performance status is graded according to the Zubrod Performance Status Scale. Patients with a performance status of 0 are fully active, able to carry on all pre-disease performance without restriction. Patients with a performance status of 1 are restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.|participants|Number|7|7.0||||||
4369789|NCT00352365|4196828|B1|MDS related||Disease Onset||participants|Number|19|19.0||||||
4369790|NCT00352365|4196828|B1|Treatment related||Disease Onset||participants|Number|2|2.0||||||
4369791|NCT00352365|4196828|B1|De Novo||Disease Onset||participants|Number|16|16.0||||||
4369792|NCT00352365|4196828|B1|Unknown||Hispanic||participants|Number|4|4.0||||||
4369793|NCT00352365|4196828|B1|No||Hispanic||participants|Number|32|32.0||||||
4369794|NCT00352365|4196828|B1|Yes||Hispanic||participants|Number|1|1.0||||||
4369795|NCT00352365|4196828|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4369796|NCT00352365|4196828|B1|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4369797|NCT00352365|4196828|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4369798|NCT00352365|4196828|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4369799|NCT00352365|4196828|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4369800|NCT00352365|4196828|B1|||Age||years|Median|73.7|73.7|Full Range|||60.1|94.0|
4369801|NCT00352118|4196838|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4369802|NCT00352118|4196838|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4369803|NCT00352118|4196838|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4369804|NCT00352118|4196838|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|7.4|7.4|||
4369805|NCT00352118|4196838|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4369806|NCT00352118|4196838|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4369807|NCT00352118|4196838|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4369808|NCT00352105|4196848|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4369809|NCT00352105|4196848|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369810|NCT00352105|4196848|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369811|NCT00352105|4196848|B1||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4369812|NCT00352105|4196848|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4369813|NCT00352105|4196848|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369814|NCT00352105|4196848|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369815|NCT00352105|4196848|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369816|NCT00352105|4196848|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4369817|NCT00352105|4196848|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4369818|NCT00352105|4196848|B1|||Age||years|Mean|57|57.0|Standard Deviation|8|8.0|||
4369819|NCT00352053|4196857|B3|||Weight||kg|Mean|47.41|47.41|Standard Deviation|10.561|10.561|||
4369820|NCT00352053|4196858|B2|||Weight||kg|Mean|49.09|49.09|Standard Deviation|11.342|11.342|||
4369821|NCT00352053|4196859|B1|||Weight||kg|Mean|45.84|45.84|Standard Deviation|9.639|9.639|||
4369822|NCT00352053|4196857|B3|||Human Immunodeficiency virus type 1 (HIV-1) ribonucleic acid (RNA)||log10 copies/mL|Mean|4.64|4.64|Standard Deviation|0.734|0.734|||
4369823|NCT00352053|4196858|B2|||Human Immunodeficiency virus type 1 (HIV-1) ribonucleic acid (RNA)||log10 copies/mL|Mean|4.56|4.56|Standard Deviation|0.746|0.746|||
4369824|NCT00352053|4196859|B1|||Human Immunodeficiency virus type 1 (HIV-1) ribonucleic acid (RNA)||log10 copies/mL|Mean|4.71|4.71|Standard Deviation|0.723|0.723|||
4369825|NCT00352053|4196857|B3|||Height||cm|Mean|155.94|155.94|Standard Deviation|9.322|9.322|||
4369826|NCT00352053|4196858|B2|||Height||cm|Mean|156.05|156.05|Standard Deviation|8.569|8.569|||
4369827|NCT00352053|4196859|B1|||Height||cm|Mean|155.84|155.84|Standard Deviation|10.071|10.071|||
4369828|NCT00352053|4196857|B3|||CD4 Percentage|CD4 percentage is the percentage of total lymphocytes that are CD4 cells.|Percentage of CD4 lymphocytes|Mean|17.7|17.7|Standard Deviation|9.00|9.0|||
4369829|NCT00352053|4196858|B2|||CD4 Percentage|CD4 percentage is the percentage of total lymphocytes that are CD4 cells.|Percentage of CD4 lymphocytes|Mean|17.6|17.6|Standard Deviation|8.31|8.31|||
4369830|NCT00352053|4196859|B1|||CD4 Percentage|CD4 percentage is the percentage of total lymphocytes that are CD4 cells.|Percentage of CD4 lymphocytes|Mean|17.8|17.8|Standard Deviation|9.70|9.7|||
4369831|NCT00352053|4196857|B3|||CD4 Cell Count||cells/mm^3|Mean|374|374.0|Standard Deviation|223.5|223.5|||
4369832|NCT00352053|4196858|B2|||CD4 Cell Count||cells/mm^3|Mean|357|357.0|Standard Deviation|200.8|200.8|||
4369833|NCT00352053|4196859|B1|||CD4 Cell Count||cells/mm^3|Mean|390|390.0|Standard Deviation|244.0|244.0|||
4369834|NCT00352053|4196857|B3|||Body Mass Index||kg/m^2|Mean|19.33|19.33|Standard Deviation|2.849|2.849|||
4369835|NCT00352053|4196858|B2|||Body Mass Index||kg/m^2|Mean|19.99|19.99|Standard Deviation|3.238|3.238|||
4369836|NCT00352053|4196859|B1|||Body Mass Index||kg/m^2|Mean|18.72|18.72|Standard Deviation|2.304|2.304|||
4369837|NCT00352053|4196857|B3|Brazil||Region of Enrollment||participants|Number|83|83.0||||||
4369838|NCT00352053|4196858|B2|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
4369839|NCT00352053|4196859|B1|Brazil||Region of Enrollment||participants|Number|43|43.0||||||
4369840|NCT00352053|4196857|B3|Panama||Region of Enrollment||participants|Number|4|4.0||||||
4369841|NCT00352053|4196858|B2|Panama||Region of Enrollment||participants|Number|2|2.0||||||
4369842|NCT00352053|4196859|B1|Panama||Region of Enrollment||participants|Number|2|2.0||||||
4369843|NCT00352053|4196857|B3|South American Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4369844|NCT00352053|4196858|B2|South American Indian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4369845|NCT00352053|4196859|B1|South American Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4369846|NCT00352053|4196857|B3|Black and White Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4369847|NCT00352053|4196858|B2|Black and White Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4369848|NCT00352053|4196859|B1|Black and White Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4369849|NCT00352053|4196857|B3|Mestizo||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4369850|NCT00352053|4196858|B2|Mestizo||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4369851|NCT00352053|4196859|B1|Mestizo||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4369852|NCT00352053|4196857|B3|Indian Descendant||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4369853|NCT00352053|4196858|B2|Indian Descendant||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4369854|NCT00352053|4196859|B1|Indian Descendant||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4369855|NCT00352053|4196857|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4369856|NCT00352053|4196858|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4369857|NCT00352053|4196859|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4369858|NCT00352053|4196857|B3|Mulatto||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4369859|NCT00352053|4196858|B2|Mulatto||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4369860|NCT00352053|4196859|B1|Mulatto||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4369861|NCT00352053|4196857|B3|Black or African Heritage||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4369862|NCT00352053|4196858|B2|Black or African Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4369863|NCT00352053|4196859|B1|Black or African Heritage||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4369864|NCT00352053|4196857|B3|White||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4369865|NCT00352053|4196858|B2|White||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4369866|NCT00352053|4196859|B1|White||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4369867|NCT00352053|4196857|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369868|NCT00352053|4196858|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369869|NCT00352053|4196859|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369870|NCT00352053|4196857|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369871|NCT00352053|4196858|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369872|NCT00352053|4196859|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369873|NCT00352053|4196857|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4369874|NCT00352053|4196858|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4369875|NCT00352053|4196859|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4369876|NCT00352053|4196857|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4369877|NCT00352053|4196858|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4369878|NCT00352053|4196859|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4369879|NCT00352053|4196857|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4369880|NCT00352053|4196858|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4369881|NCT00352053|4196859|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4369882|NCT00352053|4196857|B3|||Age||years|Mean|14|14.0|Standard Deviation|1.5|1.5|||
4369883|NCT00352053|4196858|B2|||Age||years|Mean|14|14.0|Standard Deviation|1.5|1.5|||
4369884|NCT00352053|4196859|B1|||Age||years|Mean|14|14.0|Standard Deviation|1.5|1.5|||
4369885|NCT00352053|4196857|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369886|NCT00352053|4196858|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369887|NCT00352053|4196859|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369888|NCT00352053|4196857|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4369889|NCT00352053|4196858|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4369890|NCT00352053|4196859|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4369891|NCT00352053|4196857|B3||<=18 years|Age||Participants|Count of Participants|87|87.0||||||
4369892|NCT00352053|4196858|B2||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4369893|NCT00352053|4196859|B1||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
4369894|NCT00352027|4197027|B1|Stanford University Medical Center, Palo Alto, CA||Participating Site Location||participants|Number|22|22.0||||||
4369895|NCT00352027|4197027|B1|St. Jude Children's Research Hospital, Memphis, TN||Participating Site Location||participants|Number|33|33.0||||||
4369896|NCT00352027|4197027|B1|Rady Children's Hospital, San Diego, CA||Participating Site Location||participants|Number|1|1.0||||||
4369897|NCT00352027|4197027|B1|Massachusetts General Hospital, Boston, MA||Participating Site Location||participants|Number|1|1.0||||||
4369898|NCT00352027|4197027|B1|Main Medical Center, Portland, ME||Participating Site Location||participants|Number|2|2.0||||||
4369899|NCT00352027|4197027|B1|Dana Farber Cancer Institute, Boston, MA||Participating Site Location||participants|Number|21|21.0||||||
4369900|NCT00352027|4197027|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4369901|NCT00352027|4197027|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4369902|NCT00352027|4197027|B1|||Age||years|Mean|15.10|15.1|Standard Deviation|3.15|3.15|||
4369903|NCT00352001|4197296|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4369904|NCT00352001|4197296|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369905|NCT00352001|4197296|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369906|NCT00352001|4197296|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4369907|NCT00352001|4197296|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4369908|NCT00352001|4197296|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369909|NCT00352001|4197296|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369910|NCT00352001|4197296|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4369911|NCT00352001|4197296|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4369912|NCT00352001|4197296|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4369913|NCT00352001|4197296|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4369914|NCT00352001|4197296|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4369915|NCT00352001|4197296|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4369916|NCT00352001|4197296|B1|||Age||years|Median|76.5|76.5|Full Range|||54.0|88.0|
4369917|NCT00351936|4197307|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4369918|NCT00351936|4197307|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4369919|NCT00351936|4197307|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4369920|NCT00351936|4197307|B1|||Age||years|Mean|49.87|49.87|Standard Deviation|7.96|7.96|||
4369921|NCT00351936|4197307|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4369922|NCT00351936|4197307|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4369923|NCT00351936|4197307|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370097|NCT00351819|4197326|B1|||Time on opioids||months|Mean|54|54.0|Standard Deviation|48|48.0|||
4369924|NCT00351819|4197324|B3|||Insomnia severity index (ISI)|ISI is comprised of 7 items assesses a participant's perception of insomnia that specifically address the symptoms and consequences of insomnia, as well as the degree of distress caused by sleep quality. Each item is rated on a 5-point scale from 0 (none) to 4 (very severe). Scores from the questions are summed to assign a total score ranging from 0 to 28, where higher score represents worse insomnia problem.|units on a scale|Mean|11.8|11.8|Standard Deviation|4.5|4.5|||
4369925|NCT00351819|4197325|B2|||Insomnia severity index (ISI)|ISI is comprised of 7 items assesses a participant's perception of insomnia that specifically address the symptoms and consequences of insomnia, as well as the degree of distress caused by sleep quality. Each item is rated on a 5-point scale from 0 (none) to 4 (very severe). Scores from the questions are summed to assign a total score ranging from 0 to 28, where higher score represents worse insomnia problem.|units on a scale|Mean|11.6|11.6|Standard Deviation|4.4|4.4|||
4369926|NCT00351819|4197326|B1|||Insomnia severity index (ISI)|ISI is comprised of 7 items assesses a participant's perception of insomnia that specifically address the symptoms and consequences of insomnia, as well as the degree of distress caused by sleep quality. Each item is rated on a 5-point scale from 0 (none) to 4 (very severe). Scores from the questions are summed to assign a total score ranging from 0 to 28, where higher score represents worse insomnia problem.|units on a scale|Mean|11.9|11.9|Standard Deviation|4.7|4.7|||
4369927|NCT00351819|4197324|B3|Helplessness score||Pain catastrophizing scale (PCS)|PCS questionnaire measures self-assessment of pain catastrophizing. This questionnaire consists of 13 items on past painful experiences and rate on 5-point scales ranging from 0 (not at all) to 4 (all the time). The PCS yields three subscale scores assessing rumination (range 0-16), magnification (range 0-12), helplessness (range 0-24), and a composite score (sum of three domains, ranging 0-52). Higher score represents worse painful experiences.|units on a scale|Mean|11.6|11.6|Standard Deviation|5.2|5.2|||
4369928|NCT00351819|4197325|B2|Helplessness score||Pain catastrophizing scale (PCS)|PCS questionnaire measures self-assessment of pain catastrophizing. This questionnaire consists of 13 items on past painful experiences and rate on 5-point scales ranging from 0 (not at all) to 4 (all the time). The PCS yields three subscale scores assessing rumination (range 0-16), magnification (range 0-12), helplessness (range 0-24), and a composite score (sum of three domains, ranging 0-52). Higher score represents worse painful experiences.|units on a scale|Mean|11.6|11.6|Standard Deviation|5.1|5.1|||
4369929|NCT00351819|4197326|B1|Helplessness score||Pain catastrophizing scale (PCS)|PCS questionnaire measures self-assessment of pain catastrophizing. This questionnaire consists of 13 items on past painful experiences and rate on 5-point scales ranging from 0 (not at all) to 4 (all the time). The PCS yields three subscale scores assessing rumination (range 0-16), magnification (range 0-12), helplessness (range 0-24), and a composite score (sum of three domains, ranging 0-52). Higher score represents worse painful experiences.|units on a scale|Mean|11.5|11.5|Standard Deviation|5.3|5.3|||
4369930|NCT00351819|4197324|B3|Magnification score||Pain catastrophizing scale (PCS)|PCS questionnaire measures self-assessment of pain catastrophizing. This questionnaire consists of 13 items on past painful experiences and rate on 5-point scales ranging from 0 (not at all) to 4 (all the time). The PCS yields three subscale scores assessing rumination (range 0-16), magnification (range 0-12), helplessness (range 0-24), and a composite score (sum of three domains, ranging 0-52). Higher score represents worse painful experiences.|units on a scale|Mean|4.9|4.9|Standard Deviation|3.1|3.1|||
4369931|NCT00351819|4197325|B2|Magnification score||Pain catastrophizing scale (PCS)|PCS questionnaire measures self-assessment of pain catastrophizing. This questionnaire consists of 13 items on past painful experiences and rate on 5-point scales ranging from 0 (not at all) to 4 (all the time). The PCS yields three subscale scores assessing rumination (range 0-16), magnification (range 0-12), helplessness (range 0-24), and a composite score (sum of three domains, ranging 0-52). Higher score represents worse painful experiences.|units on a scale|Mean|5.1|5.1|Standard Deviation|2.9|2.9|||
4369932|NCT00351819|4197326|B1|Magnification score||Pain catastrophizing scale (PCS)|PCS questionnaire measures self-assessment of pain catastrophizing. This questionnaire consists of 13 items on past painful experiences and rate on 5-point scales ranging from 0 (not at all) to 4 (all the time). The PCS yields three subscale scores assessing rumination (range 0-16), magnification (range 0-12), helplessness (range 0-24), and a composite score (sum of three domains, ranging 0-52). Higher score represents worse painful experiences.|units on a scale|Mean|4.7|4.7|Standard Deviation|3.2|3.2|||
4369933|NCT00351819|4197324|B3|Rumination score||Pain catastrophizing scale (PCS)|PCS questionnaire measures self-assessment of pain catastrophizing. This questionnaire consists of 13 items on past painful experiences and rate on 5-point scales ranging from 0 (not at all) to 4 (all the time). The PCS yields three subscale scores assessing rumination (range 0-16), magnification (range 0-12), helplessness (range 0-24), and a composite score (sum of three domains, ranging 0-52). Higher score represents worse painful experiences.|units on a scale|Mean|9.5|9.5|Standard Deviation|3.6|3.6|||
4369934|NCT00351819|4197325|B2|Rumination score||Pain catastrophizing scale (PCS)|PCS questionnaire measures self-assessment of pain catastrophizing. This questionnaire consists of 13 items on past painful experiences and rate on 5-point scales ranging from 0 (not at all) to 4 (all the time). The PCS yields three subscale scores assessing rumination (range 0-16), magnification (range 0-12), helplessness (range 0-24), and a composite score (sum of three domains, ranging 0-52). Higher score represents worse painful experiences.|units on a scale|Mean|9.6|9.6|Standard Deviation|3.0|3.0|||
4369935|NCT00351819|4197326|B1|Rumination score||Pain catastrophizing scale (PCS)|PCS questionnaire measures self-assessment of pain catastrophizing. This questionnaire consists of 13 items on past painful experiences and rate on 5-point scales ranging from 0 (not at all) to 4 (all the time). The PCS yields three subscale scores assessing rumination (range 0-16), magnification (range 0-12), helplessness (range 0-24), and a composite score (sum of three domains, ranging 0-52). Higher score represents worse painful experiences.|units on a scale|Mean|9.5|9.5|Standard Deviation|4.0|4.0|||
4369936|NCT00351819|4197324|B3|Composite score||Pain catastrophizing scale (PCS)|PCS questionnaire measures self-assessment of pain catastrophizing. This questionnaire consists of 13 items on past painful experiences and rate on 5-point scales ranging from 0 (not at all) to 4 (all the time). The PCS yields three subscale scores assessing rumination (range 0-16), magnification (range 0-12), helplessness (range 0-24), and a composite score (sum of three domains, ranging 0-52). Higher score represents worse painful experiences.|units on a scale|Mean|27|27.0|Standard Deviation|11|11.0|||
4369937|NCT00351819|4197325|B2|Composite score||Pain catastrophizing scale (PCS)|PCS questionnaire measures self-assessment of pain catastrophizing. This questionnaire consists of 13 items on past painful experiences and rate on 5-point scales ranging from 0 (not at all) to 4 (all the time). The PCS yields three subscale scores assessing rumination (range 0-16), magnification (range 0-12), helplessness (range 0-24), and a composite score (sum of three domains, ranging 0-52). Higher score represents worse painful experiences.|units on a scale|Mean|27|27.0|Standard Deviation|11|11.0|||
4369938|NCT00351819|4197326|B1|Composite score||Pain catastrophizing scale (PCS)|PCS questionnaire measures self-assessment of pain catastrophizing. This questionnaire consists of 13 items on past painful experiences and rate on 5-point scales ranging from 0 (not at all) to 4 (all the time). The PCS yields three subscale scores assessing rumination (range 0-16), magnification (range 0-12), helplessness (range 0-24), and a composite score (sum of three domains, ranging 0-52). Higher score represents worse painful experiences.|units on a scale|Mean|26|26.0|Standard Deviation|11|11.0|||
4369939|NCT00351819|4197324|B3|||C-reactive protein||mg/L|Mean|2.9|2.9|Standard Deviation|3.0|3.0|||
4369940|NCT00351819|4197325|B2|||C-reactive protein||mg/L|Mean|2.7|2.7|Standard Deviation|2.3|2.3|||
4369941|NCT00351819|4197326|B1|||C-reactive protein||mg/L|Mean|3.1|3.1|Standard Deviation|3.5|3.5|||
4369942|NCT00351819|4197324|B3|||Leptin||ug/L|Mean|17|17.0|Standard Deviation|14|14.0|||
4369943|NCT00351819|4197325|B2|||Leptin||ug/L|Mean|18|18.0|Standard Deviation|17|17.0|||
4369944|NCT00351819|4197326|B1|||Leptin||ug/L|Mean|16|16.0|Standard Deviation|12|12.0|||
4369945|NCT00351819|4197324|B3|||Adiponectin||ug/mL|Mean|4.7|4.7|Standard Deviation|2.3|2.3|||
4369946|NCT00351819|4197325|B2|||Adiponectin||ug/mL|Mean|4.5|4.5|Standard Deviation|1.7|1.7|||
4369947|NCT00351819|4197326|B1|||Adiponectin||ug/mL|Mean|4.9|4.9|Standard Deviation|2.7|2.7|||
4369948|NCT00351819|4197324|B3|||HOMA IR|Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin. HOMA IR was calculated using the formula: glucose * insulin / 22.5|HOMA IR score|Mean|2.6|2.6|Standard Deviation|4.2|4.2|||
4369949|NCT00351819|4197325|B2|||HOMA IR|Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin. HOMA IR was calculated using the formula: glucose * insulin / 22.5|HOMA IR score|Mean|3.3|3.3|Standard Deviation|5.8|5.8|||
4369950|NCT00351819|4197326|B1|||HOMA IR|Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin. HOMA IR was calculated using the formula: glucose * insulin / 22.5|HOMA IR score|Mean|2.1|2.1|Standard Deviation|2.1|2.1|||
4369951|NCT00351819|4197324|B3|OGTT 2-h insulin||Insulin levels in OGTT||pmol/L|Mean|275|275.0|Standard Deviation|266|266.0|||
4369952|NCT00351819|4197325|B2|OGTT 2-h insulin||Insulin levels in OGTT||pmol/L|Mean|311|311.0|Standard Deviation|293|293.0|||
4369953|NCT00351819|4197326|B1|OGTT 2-h insulin||Insulin levels in OGTT||pmol/L|Mean|246|246.0|Standard Deviation|242|242.0|||
4369954|NCT00351819|4197324|B3|OGTT 1-h insulin||Insulin levels in OGTT||pmol/L|Mean|351|351.0|Standard Deviation|317|317.0|||
4369955|NCT00351819|4197325|B2|OGTT 1-h insulin||Insulin levels in OGTT||pmol/L|Mean|416|416.0|Standard Deviation|325|325.0|||
4369956|NCT00351819|4197326|B1|OGTT 1-h insulin||Insulin levels in OGTT||pmol/L|Mean|300|300.0|Standard Deviation|306|306.0|||
4369957|NCT00351819|4197324|B3|Fasting insulin||Insulin levels in OGTT||pmol/L|Mean|80|80.0|Standard Deviation|126|126.0|||
4369958|NCT00351819|4197325|B2|Fasting insulin||Insulin levels in OGTT||pmol/L|Mean|100|100.0|Standard Deviation|174|174.0|||
4369959|NCT00351819|4197326|B1|Fasting insulin||Insulin levels in OGTT||pmol/L|Mean|64|64.0|Standard Deviation|66|66.0|||
4369960|NCT00351819|4197324|B3|OGTT 2-h glucose||Glucose levels in OGTT||mmol/L|Mean|6.3|6.3|Standard Deviation|1.9|1.9|||
4369961|NCT00351819|4197325|B2|OGTT 2-h glucose||Glucose levels in OGTT||mmol/L|Mean|6.0|6.0|Standard Deviation|2.0|2.0|||
4369962|NCT00351819|4197326|B1|OGTT 2-h glucose||Glucose levels in OGTT||mmol/L|Mean|6.5|6.5|Standard Deviation|1.9|1.9|||
4369963|NCT00351819|4197324|B3|OGTT 1-h glucose||Glucose levels in OGTT||mmol/L|Mean|8.2|8.2|Standard Deviation|2.8|2.8|||
4369964|NCT00351819|4197325|B2|OGTT 1-h glucose||Glucose levels in OGTT||mmol/L|Mean|8.0|8.0|Standard Deviation|2.8|2.8|||
4369965|NCT00351819|4197326|B1|OGTT 1-h glucose||Glucose levels in OGTT||mmol/L|Mean|8.4|8.4|Standard Deviation|2.9|2.9|||
4369966|NCT00351819|4197324|B3|Fasting glucose||Glucose levels in OGTT||mmol/L|Mean|5.3|5.3|Standard Deviation|1.8|1.8|||
4369967|NCT00351819|4197325|B2|Fasting glucose||Glucose levels in OGTT||mmol/L|Mean|5.6|5.6|Standard Deviation|2.6|2.6|||
4369968|NCT00351819|4197326|B1|Fasting glucose||Glucose levels in OGTT||mmol/L|Mean|5.2|5.2|Standard Deviation|0.7|0.7|||
4369969|NCT00351819|4197324|B3|||HbA1c||percentage of glycossylated hemoglobin|Mean|5.9|5.9|Standard Deviation|0.01|0.01|||
4369970|NCT00351819|4197325|B2|||HbA1c||percentage of glycossylated hemoglobin|Mean|6.2|6.2|Standard Deviation|0.02|0.02|||
4369971|NCT00351819|4197326|B1|||HbA1c||percentage of glycossylated hemoglobin|Mean|5.7|5.7|Standard Deviation|0.01|0.01|||
4369972|NCT00351819|4197324|B3|Triglycerides||Lipid profile||mmol/L|Mean|2.0|2.0|Standard Deviation|1.4|1.4|||
4369973|NCT00351819|4197325|B2|Triglycerides||Lipid profile||mmol/L|Mean|2.0|2.0|Standard Deviation|1.2|1.2|||
4369974|NCT00351819|4197326|B1|Triglycerides||Lipid profile||mmol/L|Mean|2.0|2.0|Standard Deviation|1.6|1.6|||
4369975|NCT00351819|4197324|B3|HDL||Lipid profile||mmol/L|Mean|1.0|1.0|Standard Deviation|0.3|0.3|||
4369976|NCT00351819|4197325|B2|HDL||Lipid profile||mmol/L|Mean|1.1|1.1|Standard Deviation|0.4|0.4|||
4369977|NCT00351819|4197326|B1|HDL||Lipid profile||mmol/L|Mean|1.0|1.0|Standard Deviation|0.3|0.3|||
4369978|NCT00351819|4197324|B3|LDL||Lipid profile||mmol/L|Mean|3.0|3.0|Standard Deviation|1.0|1.0|||
4369979|NCT00351819|4197325|B2|LDL||Lipid profile||mmol/L|Mean|3.2|3.2|Standard Deviation|0.9|0.9|||
4369980|NCT00351819|4197326|B1|LDL||Lipid profile||mmol/L|Mean|2.8|2.8|Standard Deviation|1.0|1.0|||
4369981|NCT00351819|4197324|B3|Total cholesterol||Lipid profile||mmol/L|Mean|4.9|4.9|Standard Deviation|1.2|1.2|||
4369982|NCT00351819|4197325|B2|Total cholesterol||Lipid profile||mmol/L|Mean|5.2|5.2|Standard Deviation|1.2|1.2|||
4369983|NCT00351819|4197326|B1|Total cholesterol||Lipid profile||mmol/L|Mean|4.6|4.6|Standard Deviation|1.1|1.1|||
4369984|NCT00351819|4197324|B3|Appendicular total mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|38.8|38.8|Standard Deviation|7.4|7.4|||
4369985|NCT00351819|4197325|B2|Appendicular total mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|39.4|39.4|Standard Deviation|7.0|7.0|||
4369986|NCT00351819|4197326|B1|Appendicular total mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|38.3|38.3|Standard Deviation|7.8|7.8|||
4369987|NCT00351819|4197324|B3|Appendicular fat mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|11.8|11.8|Standard Deviation|5.0|5.0|||
4369988|NCT00351819|4197325|B2|Appendicular fat mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|11.9|11.9|Standard Deviation|5.1|5.1|||
4369989|NCT00351819|4197326|B1|Appendicular fat mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|11.7|11.7|Standard Deviation|4.9|4.9|||
4369990|NCT00351819|4197324|B3|Appendicular lean mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|27.9|27.9|Standard Deviation|4.1|4.1|||
4369991|NCT00351819|4197325|B2|Appendicular lean mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|28.6|28.6|Standard Deviation|4.2|4.2|||
4369992|NCT00351819|4197326|B1|Appendicular lean mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|27.4|27.4|Standard Deviation|4.0|4.0|||
4369993|NCT00351819|4197324|B3|Total mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|85.5|85.5|Standard Deviation|15.0|15.0|||
4369994|NCT00351819|4197325|B2|Total mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|86.8|86.8|Standard Deviation|13.8|13.8|||
4369995|NCT00351819|4197326|B1|Total mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|84.4|84.4|Standard Deviation|16.1|16.1|||
4369996|NCT00351819|4197324|B3|Fat mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|26.9|26.9|Standard Deviation|9.5|9.5|||
4369997|NCT00351819|4197325|B2|Fat mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|26.8|26.8|Standard Deviation|9.5|9.5|||
4369998|NCT00351819|4197326|B1|Fat mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|27.0|27.0|Standard Deviation|9.7|9.7|||
4369999|NCT00351819|4197324|B3|Lean mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|58.6|58.6|Standard Deviation|7.5|7.5|||
4370000|NCT00351819|4197325|B2|Lean mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|60.1|60.1|Standard Deviation|6.9|6.9|||
4370001|NCT00351819|4197326|B1|Lean mass||Body composition measured by dual energy x-ray absorptiometry||kg|Mean|57.4|57.4|Standard Deviation|7.8|7.8|||
4370002|NCT00351819|4197324|B3|General health perceptions||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|52|52.0|Standard Deviation|14|14.0|||
4370003|NCT00351819|4197325|B2|General health perceptions||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|51|51.0|Standard Deviation|14|14.0|||
4370004|NCT00351819|4197326|B1|General health perceptions||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|54|54.0|Standard Deviation|14|14.0|||
4370005|NCT00351819|4197324|B3|Energry/fatigue||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|37|37.0|Standard Deviation|18|18.0|||
4370006|NCT00351819|4197325|B2|Energry/fatigue||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|37|37.0|Standard Deviation|18|18.0|||
4370007|NCT00351819|4197326|B1|Energry/fatigue||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|37|37.0|Standard Deviation|18|18.0|||
4370008|NCT00351819|4197324|B3|Social functioning||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|54|54.0|Standard Deviation|14|14.0|||
4370098|NCT00351819|4197324|B3|||Opioid dose (morphine equivalent)||mg|Mean|97|97.0|Standard Deviation|161|161.0|||
4370099|NCT00351819|4197325|B2|||Opioid dose (morphine equivalent)||mg|Mean|76|76.0|Standard Deviation|139|139.0|||
4370100|NCT00351819|4197326|B1|||Opioid dose (morphine equivalent)||mg|Mean|114|114.0|Standard Deviation|176|176.0|||
4370009|NCT00351819|4197325|B2|Social functioning||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|54|54.0|Standard Deviation|15|15.0|||
4370010|NCT00351819|4197326|B1|Social functioning||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|53|53.0|Standard Deviation|13|13.0|||
4370011|NCT00351819|4197324|B3|Emotional well-being||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|60|60.0|Standard Deviation|16|16.0|||
4370012|NCT00351819|4197325|B2|Emotional well-being||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|59|59.0|Standard Deviation|17|17.0|||
4370013|NCT00351819|4197326|B1|Emotional well-being||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|60|60.0|Standard Deviation|16|16.0|||
4370014|NCT00351819|4197324|B3|Role limitations due to emotional problems||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|39|39.0|Standard Deviation|44|44.0|||
4370015|NCT00351819|4197325|B2|Role limitations due to emotional problems||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|40|40.0|Standard Deviation|45|45.0|||
4370016|NCT00351819|4197326|B1|Role limitations due to emotional problems||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|39|39.0|Standard Deviation|45|45.0|||
4370017|NCT00351819|4197324|B3|Role limitations due to physical health problems||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|13|13.0|Standard Deviation|27|27.0|||
4370018|NCT00351819|4197325|B2|Role limitations due to physical health problems||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|18|18.0|Standard Deviation|31|31.0|||
4370019|NCT00351819|4197326|B1|Role limitations due to physical health problems||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|10|10.0|Standard Deviation|24|24.0|||
4370020|NCT00351819|4197324|B3|Bodily pain||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|56|56.0|Standard Deviation|16|16.0|||
4370021|NCT00351819|4197325|B2|Bodily pain||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|55|55.0|Standard Deviation|17|17.0|||
4370022|NCT00351819|4197326|B1|Bodily pain||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|56|56.0|Standard Deviation|15|15.0|||
4370101|NCT00351819|4197324|B3|||Body Mass Index (BMI)||kg/m2|Mean|32.6|32.6|Standard Deviation|7.4|7.4|||
4370023|NCT00351819|4197324|B3|Physical functioning||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|39|39.0|Standard Deviation|23|23.0|||
4370024|NCT00351819|4197325|B2|Physical functioning||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|38|38.0|Standard Deviation|25|25.0|||
4370025|NCT00351819|4197326|B1|Physical functioning||Health Quality of Life (QoL) as assessed by Short Form 36 (SF-36)|The SF-36 measures 8 domains of the QoL: physical function, bodily pain, vitality, role limitations due to physical problems, general health perceptions, emotional well-being, social function, and role limitations due to emotional problems. Each domain is scored separately from 0 to 100 with higher scores representing better health-related QoL.|units on a scale|Mean|41|41.0|Standard Deviation|22|22.0|||
4370026|NCT00351819|4197324|B3|Overall satisfaction||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|4.9|4.9|Standard Deviation|2.7|2.7|||
4370027|NCT00351819|4197325|B2|Overall satisfaction||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|5.0|5.0|Standard Deviation|2.9|2.9|||
4370028|NCT00351819|4197326|B1|Overall satisfaction||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|4.9|4.9|Standard Deviation|2.5|2.5|||
4370029|NCT00351819|4197324|B3|Intercourse satisfaction||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|7.7|7.7|Standard Deviation|5.1|5.1|||
4370030|NCT00351819|4197325|B2|Intercourse satisfaction||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|7.1|7.1|Standard Deviation|5.6|5.6|||
4370031|NCT00351819|4197326|B1|Intercourse satisfaction||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|8.2|8.2|Standard Deviation|4.6|4.6|||
4370032|NCT00351819|4197324|B3|Sexual desire||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|5.8|5.8|Standard Deviation|2.3|2.3|||
4370033|NCT00351819|4197325|B2|Sexual desire||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|6.2|6.2|Standard Deviation|2.1|2.1|||
4370034|NCT00351819|4197326|B1|Sexual desire||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|5.5|5.5|Standard Deviation|2.5|2.5|||
4370102|NCT00351819|4197325|B2|||Body Mass Index (BMI)||kg/m2|Mean|33.4|33.4|Standard Deviation|8.0|8.0|||
4370103|NCT00351819|4197326|B1|||Body Mass Index (BMI)||kg/m2|Mean|32.0|32.0|Standard Deviation|7.0|7.0|||
4370035|NCT00351819|4197324|B3|Orgasmic function||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|6.3|6.3|Standard Deviation|3.6|3.6|||
4370036|NCT00351819|4197325|B2|Orgasmic function||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|6.1|6.1|Standard Deviation|3.6|3.6|||
4370037|NCT00351819|4197326|B1|Orgasmic function||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|6.5|6.5|Standard Deviation|3.5|3.5|||
4370038|NCT00351819|4197324|B3|Erectile function||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|17.9|17.9|Standard Deviation|9.8|9.8|||
4370039|NCT00351819|4197325|B2|Erectile function||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|16.8|16.8|Standard Deviation|10.6|10.6|||
4370040|NCT00351819|4197326|B1|Erectile function||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|18.8|18.8|Standard Deviation|9.2|9.2|||
4370041|NCT00351819|4197324|B3|Total score||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|43.0|43.0|Standard Deviation|20.2|20.2|||
4370042|NCT00351819|4197325|B2|Total score||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|41.1|41.1|Standard Deviation|21.7|21.7|||
4370043|NCT00351819|4197326|B1|Total score||Sexual Function as assessed by International Index of Erectile Function (IIEF)|IIEF is a validated, 15-item questionnaire that assesses 5 domains of sexual function: erectile function (range 1-30), orgasmic function (range 0-10), sexual desire (range 2-10), intercourse satisfaction (range 0-15), and overall sexual satisfaction (range 2-10). Each question was answered on a 6-point or 5-point scale from 0/1 to 5 (best) with a total possible score (sum of 5 domains) range of 5 to 75 with higher scores representing better function.|units on a scale|Mean|44.6|44.6|Standard Deviation|19.0|19.0|||
4370044|NCT00351819|4197324|B3|Cold pain after sensation: 30s||Ice water-induced cold pain and its after-sensation|Cold-pressor tests measure cold-induced pain and its sensation. Time was measured when a participant reached pain tolerance in cold water and after sensation. Higher values of time in Cold pain tolerance and lower values of time in Cold pain after-sensation (30 seconds) represent better tolerance of pain.|seconds|Mean|15.4|15.4|Standard Deviation|18.5|18.5|||
4370045|NCT00351819|4197325|B2|Cold pain after sensation: 30s||Ice water-induced cold pain and its after-sensation|Cold-pressor tests measure cold-induced pain and its sensation. Time was measured when a participant reached pain tolerance in cold water and after sensation. Higher values of time in Cold pain tolerance and lower values of time in Cold pain after-sensation (30 seconds) represent better tolerance of pain.|seconds|Mean|13.8|13.8|Standard Deviation|18.0|18.0|||
4370046|NCT00351819|4197326|B1|Cold pain after sensation: 30s||Ice water-induced cold pain and its after-sensation|Cold-pressor tests measure cold-induced pain and its sensation. Time was measured when a participant reached pain tolerance in cold water and after sensation. Higher values of time in Cold pain tolerance and lower values of time in Cold pain after-sensation (30 seconds) represent better tolerance of pain.|seconds|Mean|16.7|16.7|Standard Deviation|19.2|19.2|||
4370104|NCT00351819|4197324|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4370105|NCT00351819|4197325|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4370106|NCT00351819|4197326|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4370047|NCT00351819|4197324|B3|Cold pain tolerance||Ice water-induced cold pain and its after-sensation|Cold-pressor tests measure cold-induced pain and its sensation. Time was measured when a participant reached pain tolerance in cold water and after sensation. Higher values of time in Cold pain tolerance and lower values of time in Cold pain after-sensation (30 seconds) represent better tolerance of pain.|seconds|Mean|46.1|46.1|Standard Deviation|42.7|42.7|||
4370048|NCT00351819|4197325|B2|Cold pain tolerance||Ice water-induced cold pain and its after-sensation|Cold-pressor tests measure cold-induced pain and its sensation. Time was measured when a participant reached pain tolerance in cold water and after sensation. Higher values of time in Cold pain tolerance and lower values of time in Cold pain after-sensation (30 seconds) represent better tolerance of pain.|seconds|Mean|53.3|53.3|Standard Deviation|51.3|51.3|||
4370049|NCT00351819|4197326|B1|Cold pain tolerance||Ice water-induced cold pain and its after-sensation|Cold-pressor tests measure cold-induced pain and its sensation. Time was measured when a participant reached pain tolerance in cold water and after sensation. Higher values of time in Cold pain tolerance and lower values of time in Cold pain after-sensation (30 seconds) represent better tolerance of pain.|seconds|Mean|40.1|40.1|Standard Deviation|33.4|33.4|||
4370050|NCT00351819|4197324|B3|10th stimulus||Weighted pinprick stimulator-induced mechanical pain|Weighted pinprick stimulators are used to assess mechanical pain. Lower values represent better tolerance of pain.|watt|Mean|23.2|23.2|Standard Deviation|20.4|20.4|||
4370051|NCT00351819|4197325|B2|10th stimulus||Weighted pinprick stimulator-induced mechanical pain|Weighted pinprick stimulators are used to assess mechanical pain. Lower values represent better tolerance of pain.|watt|Mean|18.6|18.6|Standard Deviation|19.5|19.5|||
4370052|NCT00351819|4197326|B1|10th stimulus||Weighted pinprick stimulator-induced mechanical pain|Weighted pinprick stimulators are used to assess mechanical pain. Lower values represent better tolerance of pain.|watt|Mean|27.0|27.0|Standard Deviation|20.6|20.6|||
4370053|NCT00351819|4197324|B3|First stimulus||Weighted pinprick stimulator-induced mechanical pain|Weighted pinprick stimulators are used to assess mechanical pain. Lower values represent better tolerance of pain.|watt|Mean|10.2|10.2|Standard Deviation|11.0|11.0|||
4370054|NCT00351819|4197325|B2|First stimulus||Weighted pinprick stimulator-induced mechanical pain|Weighted pinprick stimulators are used to assess mechanical pain. Lower values represent better tolerance of pain.|watt|Mean|8.0|8.0|Standard Deviation|7.4|7.4|||
4370055|NCT00351819|4197326|B1|First stimulus||Weighted pinprick stimulator-induced mechanical pain|Weighted pinprick stimulators are used to assess mechanical pain. Lower values represent better tolerance of pain.|watt|Mean|12.0|12.0|Standard Deviation|13.0|13.0|||
4370056|NCT00351819|4197324|B3|Thumb||Algometer-induced pressure pain|A digital pressure algometer at the trapezius muscle and the metacarpophalangeal joint of the thumb was used to measure pressure pain thresholds. Higher values represent a better tolerance of pressure pain.|kPa/cm2|Mean|375|375.0|Standard Deviation|155|155.0|||
4370057|NCT00351819|4197325|B2|Thumb||Algometer-induced pressure pain|A digital pressure algometer at the trapezius muscle and the metacarpophalangeal joint of the thumb was used to measure pressure pain thresholds. Higher values represent a better tolerance of pressure pain.|kPa/cm2|Mean|383|383.0|Standard Deviation|185|185.0|||
4370058|NCT00351819|4197326|B1|Thumb||Algometer-induced pressure pain|A digital pressure algometer at the trapezius muscle and the metacarpophalangeal joint of the thumb was used to measure pressure pain thresholds. Higher values represent a better tolerance of pressure pain.|kPa/cm2|Mean|369|369.0|Standard Deviation|125|125.0|||
4370059|NCT00351819|4197324|B3|Trapezius||Algometer-induced pressure pain|A digital pressure algometer at the trapezius muscle and the metacarpophalangeal joint of the thumb was used to measure pressure pain thresholds. Higher values represent a better tolerance of pressure pain.|kPa/cm2|Mean|347|347.0|Standard Deviation|157|157.0|||
4370060|NCT00351819|4197325|B2|Trapezius||Algometer-induced pressure pain|A digital pressure algometer at the trapezius muscle and the metacarpophalangeal joint of the thumb was used to measure pressure pain thresholds. Higher values represent a better tolerance of pressure pain.|kPa/cm2|Mean|353|353.0|Standard Deviation|197|197.0|||
4370061|NCT00351819|4197326|B1|Trapezius||Algometer-induced pressure pain|A digital pressure algometer at the trapezius muscle and the metacarpophalangeal joint of the thumb was used to measure pressure pain thresholds. Higher values represent a better tolerance of pressure pain.|kPa/cm2|Mean|341|341.0|Standard Deviation|116|116.0|||
4370062|NCT00351819|4197324|B3|Interference||Brief Pain Inventory (BPI) questionnaire|The Brief Pain Inventory (BPI) is a self-administered questionnaire that measuring chronic pain. The BPI gives two main scores: a pain severity score and a pain interference score. The pain severity score assesses the severity of pain on a continuous scale from 0 (no pain) to 10 (severe pain). The pain interference score corresponds to the item on pain interference, ranging from 0 (does not interfere) to 10(completely interferes). The total score (ranging from 0-20) is the sum of the pain severity score and pain interference score. Higher scores represents severer and more interfering pain.|units on a scale|Mean|5.4|5.4|Standard Deviation|2.1|2.1|||
4370063|NCT00351819|4197325|B2|Interference||Brief Pain Inventory (BPI) questionnaire|The Brief Pain Inventory (BPI) is a self-administered questionnaire that measuring chronic pain. The BPI gives two main scores: a pain severity score and a pain interference score. The pain severity score assesses the severity of pain on a continuous scale from 0 (no pain) to 10 (severe pain). The pain interference score corresponds to the item on pain interference, ranging from 0 (does not interfere) to 10(completely interferes). The total score (ranging from 0-20) is the sum of the pain severity score and pain interference score. Higher scores represents severer and more interfering pain.|units on a scale|Mean|4.9|4.9|Standard Deviation|1.8|1.8|||
4370064|NCT00351819|4197326|B1|Interference||Brief Pain Inventory (BPI) questionnaire|The Brief Pain Inventory (BPI) is a self-administered questionnaire that measuring chronic pain. The BPI gives two main scores: a pain severity score and a pain interference score. The pain severity score assesses the severity of pain on a continuous scale from 0 (no pain) to 10 (severe pain). The pain interference score corresponds to the item on pain interference, ranging from 0 (does not interfere) to 10(completely interferes). The total score (ranging from 0-20) is the sum of the pain severity score and pain interference score. Higher scores represents severer and more interfering pain.|units on a scale|Mean|5.8|5.8|Standard Deviation|2.2|2.2|||
4370107|NCT00351819|4197324|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4370108|NCT00351819|4197325|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4370065|NCT00351819|4197324|B3|Severity||Brief Pain Inventory (BPI) questionnaire|The Brief Pain Inventory (BPI) is a self-administered questionnaire that measuring chronic pain. The BPI gives two main scores: a pain severity score and a pain interference score. The pain severity score assesses the severity of pain on a continuous scale from 0 (no pain) to 10 (severe pain). The pain interference score corresponds to the item on pain interference, ranging from 0 (does not interfere) to 10(completely interferes). The total score (ranging from 0-20) is the sum of the pain severity score and pain interference score. Higher scores represents severer and more interfering pain.|units on a scale|Mean|5.6|5.6|Standard Deviation|1.6|1.6|||
4370066|NCT00351819|4197325|B2|Severity||Brief Pain Inventory (BPI) questionnaire|The Brief Pain Inventory (BPI) is a self-administered questionnaire that measuring chronic pain. The BPI gives two main scores: a pain severity score and a pain interference score. The pain severity score assesses the severity of pain on a continuous scale from 0 (no pain) to 10 (severe pain). The pain interference score corresponds to the item on pain interference, ranging from 0 (does not interfere) to 10(completely interferes). The total score (ranging from 0-20) is the sum of the pain severity score and pain interference score. Higher scores represents severer and more interfering pain.|units on a scale|Mean|5.5|5.5|Standard Deviation|1.7|1.7|||
4370067|NCT00351819|4197326|B1|Severity||Brief Pain Inventory (BPI) questionnaire|The Brief Pain Inventory (BPI) is a self-administered questionnaire that measuring chronic pain. The BPI gives two main scores: a pain severity score and a pain interference score. The pain severity score assesses the severity of pain on a continuous scale from 0 (no pain) to 10 (severe pain). The pain interference score corresponds to the item on pain interference, ranging from 0 (does not interfere) to 10(completely interferes). The total score (ranging from 0-20) is the sum of the pain severity score and pain interference score. Higher scores represents severer and more interfering pain.|units on a scale|Mean|5.7|5.7|Standard Deviation|1.5|1.5|||
4370068|NCT00351819|4197324|B3|Total||Brief Pain Inventory (BPI) questionnaire|The Brief Pain Inventory (BPI) is a self-administered questionnaire that measuring chronic pain. The BPI gives two main scores: a pain severity score and a pain interference score. The pain severity score assesses the severity of pain on a continuous scale from 0 (no pain) to 10 (severe pain). The pain interference score corresponds to the item on pain interference, ranging from 0 (does not interfere) to 10(completely interferes). The total score (ranging from 0-20) is the sum of the pain severity score and pain interference score. Higher scores represents severer and more interfering pain.|units on a scale|Mean|11.0|11.0|Standard Deviation|3.2|3.2|||
4370069|NCT00351819|4197325|B2|Total||Brief Pain Inventory (BPI) questionnaire|The Brief Pain Inventory (BPI) is a self-administered questionnaire that measuring chronic pain. The BPI gives two main scores: a pain severity score and a pain interference score. The pain severity score assesses the severity of pain on a continuous scale from 0 (no pain) to 10 (severe pain). The pain interference score corresponds to the item on pain interference, ranging from 0 (does not interfere) to 10(completely interferes). The total score (ranging from 0-20) is the sum of the pain severity score and pain interference score. Higher scores represents severer and more interfering pain.|units on a scale|Mean|10.4|10.4|Standard Deviation|3.1|3.1|||
4370070|NCT00351819|4197326|B1|Total||Brief Pain Inventory (BPI) questionnaire|The Brief Pain Inventory (BPI) is a self-administered questionnaire that measuring chronic pain. The BPI gives two main scores: a pain severity score and a pain interference score. The pain severity score assesses the severity of pain on a continuous scale from 0 (no pain) to 10 (severe pain). The pain interference score corresponds to the item on pain interference, ranging from 0 (does not interfere) to 10(completely interferes). The total score (ranging from 0-20) is the sum of the pain severity score and pain interference score. Higher scores represents severer and more interfering pain.|units on a scale|Mean|11.5|11.5|Standard Deviation|3.2|3.2|||
4370071|NCT00351819|4197324|B3|||Hematocrit||%|Median|43|43.0|Inter-Quartile Range|||40.0|45.0|
4370072|NCT00351819|4197325|B2|||Hematocrit||%|Median|43|43.0|Inter-Quartile Range|||39.0|45.0|
4370073|NCT00351819|4197326|B1|||Hematocrit||%|Median|44|44.0|Inter-Quartile Range|||40.0|46.0|
4370074|NCT00351819|4197324|B3|||Hemoglobin||g/dL|Median|15|15.0|Inter-Quartile Range|||13.0|15.0|
4370075|NCT00351819|4197325|B2|||Hemoglobin||g/dL|Median|14|14.0|Inter-Quartile Range|||13.0|15.0|
4370076|NCT00351819|4197326|B1|||Hemoglobin||g/dL|Median|15|15.0|Inter-Quartile Range|||13.0|16.0|
4370077|NCT00351819|4197324|B3|||IL-6||pg/mL|Mean|2.7|2.7|Standard Deviation|2.8|2.8|||
4370078|NCT00351819|4197325|B2|||IL-6||pg/mL|Mean|2.8|2.8|Standard Deviation|2.9|2.9|||
4370079|NCT00351819|4197326|B1|||IL-6||pg/mL|Mean|2.6|2.6|Standard Deviation|2.8|2.8|||
4370080|NCT00351819|4197324|B3|||TNF-Alpha||pg/mL|Mean|2.0|2.0|Standard Deviation|1.9|1.9|||
4370081|NCT00351819|4197325|B2|||TNF-Alpha||pg/mL|Mean|2.2|2.2|Standard Deviation|2.7|2.7|||
4370082|NCT00351819|4197326|B1|||TNF-Alpha||pg/mL|Mean|1.8|1.8|Standard Deviation|0.6|0.6|||
4370083|NCT00351819|4197324|B3|||Luteinizing hormone||U/L|Mean|3.2|3.2|Standard Deviation|2.2|2.2|||
4370084|NCT00351819|4197325|B2|||Luteinizing hormone||U/L|Mean|3.8|3.8|Standard Deviation|2.4|2.4|||
4370085|NCT00351819|4197326|B1|||Luteinizing hormone||U/L|Mean|2.8|2.8|Standard Deviation|1.9|1.9|||
4370086|NCT00351819|4197324|B3|||Sex hormone binding globulin||nmol/L|Mean|38.6|38.6|Standard Deviation|25.2|25.2|||
4370087|NCT00351819|4197325|B2|||Sex hormone binding globulin||nmol/L|Mean|37.7|37.7|Standard Deviation|14.5|14.5|||
4370088|NCT00351819|4197326|B1|||Sex hormone binding globulin||nmol/L|Mean|39.3|39.3|Standard Deviation|31.4|31.4|||
4370089|NCT00351819|4197324|B3|||Free testosterone||pg/mL|Mean|43.9|43.9|Standard Deviation|21.0|21.0|||
4370090|NCT00351819|4197325|B2|||Free testosterone||pg/mL|Mean|43.6|43.6|Standard Deviation|19.3|19.3|||
4370091|NCT00351819|4197326|B1|||Free testosterone||pg/mL|Mean|44.1|44.1|Standard Deviation|22.6|22.6|||
4370092|NCT00351819|4197324|B3|||Total testosterone||ng/dL|Mean|228|228.0|Standard Deviation|91|91.0|||
4370093|NCT00351819|4197325|B2|||Total testosterone||ng/dL|Mean|237|237.0|Standard Deviation|97|97.0|||
4370094|NCT00351819|4197326|B1|||Total testosterone||ng/dL|Mean|221|221.0|Standard Deviation|87|87.0|||
4370095|NCT00351819|4197324|B3|||Time on opioids||months|Mean|48|48.0|Standard Deviation|50|50.0|||
4370096|NCT00351819|4197325|B2|||Time on opioids||months|Mean|40|40.0|Standard Deviation|54|54.0|||
4370109|NCT00351819|4197326|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4370110|NCT00351819|4197324|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4370111|NCT00351819|4197325|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4370112|NCT00351819|4197326|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4370113|NCT00351819|4197324|B3|||Age||years|Mean|49|49.0|Standard Deviation|8|8.0|||
4370114|NCT00351819|4197325|B2|||Age||years|Mean|50|50.0|Standard Deviation|6|6.0|||
4370115|NCT00351819|4197326|B1|||Age||years|Mean|48|48.0|Standard Deviation|9|9.0|||
4370116|NCT00351741|4197375|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4370117|NCT00351741|4197376|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4370118|NCT00351741|4197377|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4370119|NCT00351741|4197375|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4370120|NCT00351741|4197376|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4370121|NCT00351741|4197377|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4370122|NCT00351741|4197375|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4370123|NCT00351741|4197376|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4370124|NCT00351741|4197377|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4370125|NCT00351741|4197375|B3|||Age||years|Mean|36|36.0|Standard Deviation|18|18.0|||
4370126|NCT00351741|4197376|B2|||Age||years|Mean|37|37.0|Standard Deviation|18|18.0|||
4370127|NCT00351741|4197377|B1|||Age||years|Mean|35|35.0|Standard Deviation|18|18.0|||
4370128|NCT00351741|4197375|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4370129|NCT00351741|4197376|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4370130|NCT00351741|4197377|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4370131|NCT00351741|4197375|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4370132|NCT00351741|4197376|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4370133|NCT00351741|4197377|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4370134|NCT00351741|4197375|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370135|NCT00351741|4197376|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370136|NCT00351741|4197377|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370137|NCT00351533|4197396|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4370138|NCT00351533|4197397|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4370139|NCT00351533|4197398|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4370140|NCT00351533|4197396|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4370141|NCT00351533|4197397|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4370142|NCT00351533|4197398|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4370143|NCT00351533|4197396|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|16.4|16.4|||
4370144|NCT00351533|4197397|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|16.5|16.5|||
4370145|NCT00351533|4197398|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|16.5|16.5|||
4370146|NCT00351468|4197459|B1|> 50 Gi/L||Baseline Platelet Count||Participants|Number|39|39.0||||||
4370147|NCT00351468|4197459|B1|30 - 50 Gi/L||Baseline Platelet Count||Participants|Number|52|52.0||||||
4370148|NCT00351468|4197459|B1|<30 Gi/L||Baseline Platelet Count||Participants|Number|211|211.0||||||
4370149|NCT00351468|4197459|B1|No||Splenectomy Status at Baseline||Participants|Number|187|187.0||||||
4370150|NCT00351468|4197459|B1|Yes||Splenectomy Status at Baseline||Participants|Number|115|115.0||||||
4370151|NCT00351468|4197459|B1|No||Concomitant ITP Medication at Baseline||Participant|Number|201|201.0||||||
4370152|NCT00351468|4197459|B1|Yes||Concomitant ITP Medication at Baseline||Participant|Number|101|101.0||||||
4370153|NCT00351468|4197459|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4370154|NCT00351468|4197459|B1||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4370155|NCT00351468|4197459|B1|||Age||Years|Mean|48.9|48.9|Standard Deviation|15.61|15.61|||
4370156|NCT00351416|4197474|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4370157|NCT00351416|4197475|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4370158|NCT00351416|4197476|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4370159|NCT00351416|4197474|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370160|NCT00351416|4197475|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370161|NCT00351416|4197476|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370162|NCT00351416|4197474|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370163|NCT00351416|4197475|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370164|NCT00351416|4197476|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370165|NCT00351416|4197474|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4370166|NCT00351416|4197475|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4370167|NCT00351416|4197476|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4370168|NCT00351416|4197474|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370169|NCT00351416|4197475|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370170|NCT00351416|4197476|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370171|NCT00351416|4197474|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370172|NCT00351416|4197475|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370173|NCT00351416|4197476|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370174|NCT00351416|4197474|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370175|NCT00351416|4197475|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370176|NCT00351416|4197476|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370177|NCT00351416|4197474|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370178|NCT00351416|4197475|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370179|NCT00351416|4197476|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370180|NCT00351416|4197474|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370181|NCT00351416|4197475|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370182|NCT00351416|4197476|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370183|NCT00351416|4197474|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4370184|NCT00351416|4197475|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4370185|NCT00351416|4197476|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4370186|NCT00351416|4197474|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4370187|NCT00351416|4197475|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370188|NCT00351416|4197476|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370189|NCT00351416|4197474|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4370190|NCT00351416|4197475|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4370191|NCT00351416|4197476|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4370192|NCT00351416|4197474|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4370193|NCT00351416|4197475|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4370194|NCT00351416|4197476|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4370195|NCT00351416|4197474|B3|||Age||years|Mean|27.9|27.9|Standard Deviation|4.4|4.4|||
4370196|NCT00351416|4197475|B2|||Age||years|Mean|28.5|28.5|Standard Deviation|4.2|4.2|||
4370197|NCT00351416|4197476|B1|||Age||years|Mean|27.2|27.2|Standard Deviation|5|5.0|||
4370198|NCT00351377|4197483|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4370199|NCT00351377|4197483|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4370200|NCT00351377|4197483|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|14.1|14.1|||
4370201|NCT00351351|4197495|B3|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4370202|NCT00351351|4197496|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4370203|NCT00351351|4197497|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4370204|NCT00351351|4197495|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4370205|NCT00351351|4197496|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4370206|NCT00351351|4197497|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4370207|NCT00351351|4197495|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4370208|NCT00351351|4197496|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4370209|NCT00351351|4197497|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4370210|NCT00351351|4197495|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4370211|NCT00351351|4197496|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4370212|NCT00351351|4197497|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4370213|NCT00351351|4197495|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4370214|NCT00351351|4197496|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4370215|NCT00351351|4197497|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4370216|NCT00351351|4197495|B3||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4370217|NCT00351351|4197496|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4370218|NCT00351351|4197497|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4370219|NCT00351351|4197495|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370220|NCT00351351|4197496|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370221|NCT00351351|4197497|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370222|NCT00351299|4197504|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4370223|NCT00351299|4197505|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4370224|NCT00351299|4197506|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4370225|NCT00351299|4197504|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4370226|NCT00351299|4197505|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4370227|NCT00351299|4197506|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4370228|NCT00351299|4197504|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4370229|NCT00351299|4197505|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4370230|NCT00351299|4197506|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4370231|NCT00351299|4197504|B3|||Age||years|Mean|63.96|63.96|Standard Deviation|10.90|10.9|||
4370232|NCT00351299|4197505|B2|||Age||years|Mean|63.93|63.93|Standard Deviation|11.55|11.55|||
4370233|NCT00351299|4197506|B1|||Age||years|Mean|64.00|64.0|Standard Deviation|10.36|10.36|||
4370234|NCT00351273|4197521|B4|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4370235|NCT00351273|4197522|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4370236|NCT00351273|4197523|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4370237|NCT00351273|4197524|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4370238|NCT00351273|4197521|B4|United States||Region of Enrollment||participants|Number|41|41.0||||||
4370239|NCT00351273|4197522|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4370240|NCT00351273|4197523|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4370241|NCT00351273|4197524|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4370242|NCT00351273|4197521|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4370243|NCT00351273|4197522|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4370244|NCT00351273|4197523|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4370245|NCT00351273|4197524|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4370246|NCT00351273|4197521|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4370247|NCT00351273|4197522|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4370248|NCT00351273|4197523|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4370249|NCT00351273|4197524|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4370250|NCT00351273|4197521|B4|||Age||years|Mean|45.8|45.8|Standard Deviation|11.5|11.5|||
4370251|NCT00351273|4197522|B3|||Age||years|Mean|49|49.0|Standard Deviation|16.3|16.3|||
4370252|NCT00351273|4197523|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|12.3|12.3|||
4370253|NCT00351273|4197524|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|12|12.0|||
4370254|NCT00351273|4197521|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4370255|NCT00351273|4197522|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4370256|NCT00351273|4197523|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370257|NCT00351273|4197524|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370258|NCT00351273|4197521|B4||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4370259|NCT00351273|4197522|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4370260|NCT00351273|4197523|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4370261|NCT00351273|4197524|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4370262|NCT00351273|4197521|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370263|NCT00351273|4197522|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370264|NCT00351273|4197523|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370265|NCT00351273|4197524|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370266|NCT00351039|4197549|B1|||Number of Participants who received treatment on this protocol|All patients accrued sought and received treatment at the Moffitt Cancer Center.|Participants|Number|8|8.0||||||
4370267|NCT00351039|4197549|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4370268|NCT00351039|4197549|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4370269|NCT00351039|4197549|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4370270|NCT00351039|4197549|B1|||Age||years|Mean|75|75.0|Standard Deviation|5|5.0|||
4370271|NCT00351039|4197549|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4370272|NCT00351039|4197549|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4370273|NCT00351039|4197549|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370274|NCT00351000|4197558|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4370275|NCT00351000|4197558|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
4370276|NCT00351000|4197558|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4370277|NCT00351000|4197558|B1|||Age||years|Mean|49|49.0|Standard Deviation|8|8.0|||
4370278|NCT00351000|4197558|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370279|NCT00351000|4197558|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4370280|NCT00351000|4197558|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370281|NCT00350870|4197565|B5|Multiracial/Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4370282|NCT00350870|4197566|B4|Multiracial/Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4370283|NCT00350870|4197567|B3|Multiracial/Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4370284|NCT00350870|4197568|B2|Multiracial/Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4370285|NCT00350870|4197569|B1|Multiracial/Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4370286|NCT00350870|4197565|B5|Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4370287|NCT00350870|4197566|B4|Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4370288|NCT00350870|4197567|B3|Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4370289|NCT00350870|4197568|B2|Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4370290|NCT00350870|4197569|B1|Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4370291|NCT00350870|4197565|B5|African-American||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4370292|NCT00350870|4197566|B4|African-American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4370293|NCT00350870|4197567|B3|African-American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4370294|NCT00350870|4197568|B2|African-American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4370295|NCT00350870|4197569|B1|African-American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4370296|NCT00350870|4197565|B5|Cuacasian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4370297|NCT00350870|4197566|B4|Cuacasian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4370298|NCT00350870|4197567|B3|Cuacasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4370299|NCT00350870|4197568|B2|Cuacasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4370300|NCT00350870|4197569|B1|Cuacasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4370301|NCT00350870|4197565|B5||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4370302|NCT00350870|4197566|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4370303|NCT00350870|4197567|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4370304|NCT00350870|4197568|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4370305|NCT00350870|4197569|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4370306|NCT00350870|4197565|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4370307|NCT00350870|4197566|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4370308|NCT00350870|4197567|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4370309|NCT00350870|4197568|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4370310|NCT00350870|4197569|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4370311|NCT00350870|4197565|B5|||Age||years|Mean|39.3|39.3|Standard Deviation|7.5|7.5|||
4370312|NCT00350870|4197566|B4|||Age||years|Mean|39.3|39.3|Standard Deviation|6.3|6.3|||
4370313|NCT00350870|4197567|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|7.4|7.4|||
4370314|NCT00350870|4197568|B2|||Age||years|Mean|39.8|39.8|Standard Deviation|7.5|7.5|||
4370315|NCT00350870|4197569|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|8.8|8.8|||
4370316|NCT00350844|4197586|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4370317|NCT00350844|4197586|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4370318|NCT00350844|4197586|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4370319|NCT00350844|4197586|B1|||Age||years|Mean|NA||Standard Deviation|NA||||Study was terminated due to low enrollment.
4370320|NCT00350844|4197586|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370321|NCT00350844|4197586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4370322|NCT00350844|4197586|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4370323|NCT00350792|4197590|B1|Other: Undifferentiated||Pathological Diagnosis||participants|Number|1|1.0||||||
4370324|NCT00350792|4197590|B1|Other: Indifferencied Non-Small Cell Lung Cancer||Pathological Diagnosis||participants|Number|1|1.0||||||
4370325|NCT00350792|4197590|B1|Other: Carcinoma||Pathological Diagnosis||participants|Number|1|1.0||||||
4370326|NCT00350792|4197590|B1|Other: Carcinoma-Infiltrant Indifferencie||Pathological Diagnosis||participants|Number|1|1.0||||||
4370327|NCT00350792|4197590|B1|Squamous Cell Carcinoma of Lung||Pathological Diagnosis||participants|Number|21|21.0||||||
4370328|NCT00350792|4197590|B1|Adenocarcinoma of Lung||Pathological Diagnosis||participants|Number|32|32.0||||||
4370329|NCT00350792|4197590|B1|Large Cell Lung Cancer||Pathological Diagnosis||participants|Number|5|5.0||||||
4370330|NCT00350792|4197590|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|52|52.0||||||
4370331|NCT00350792|4197590|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|10|10.0||||||
4370332|NCT00350792|4197590|B1|Stage IV||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).|participants|Number|49|49.0||||||
4370333|NCT00350792|4197590|B1|Stage IIIB||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).|participants|Number|13|13.0||||||
4370334|NCT00350792|4197590|B1|France||Region of Enrollment||participants|Number|62|62.0||||||
4370335|NCT00350792|4197590|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4370336|NCT00350792|4197590|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4370337|NCT00350792|4197590|B1|||Age||years|Mean|76.5|76.5|Standard Deviation|3.6|3.6|||
4370338|NCT00350779|4197598|B3|||HbA1c (Hemoglobin A1c)||Percent|Mean|8.8|8.8|Standard Deviation|1.0|1.0|||
4370339|NCT00350779|4197599|B2|||HbA1c (Hemoglobin A1c)||Percent|Mean|8.7|8.7|Standard Deviation|1.0|1.0|||
4370340|NCT00350779|4197600|B1|||HbA1c (Hemoglobin A1c)||Percent|Mean|8.8|8.8|Standard Deviation|1.0|1.0|||
4370341|NCT00350779|4197598|B3|Other||Race/Ethnicity||participants|Number|14|14.0||||||
4370342|NCT00350779|4197599|B2|Other||Race/Ethnicity||participants|Number|4|4.0||||||
4370343|NCT00350779|4197600|B1|Other||Race/Ethnicity||participants|Number|10|10.0||||||
4370344|NCT00350779|4197598|B3|Asian||Race/Ethnicity||participants|Number|82|82.0||||||
4370345|NCT00350779|4197599|B2|Asian||Race/Ethnicity||participants|Number|24|24.0||||||
4370346|NCT00350779|4197600|B1|Asian||Race/Ethnicity||participants|Number|58|58.0||||||
4370347|NCT00350779|4197598|B3|Hispanic||Race/Ethnicity||participants|Number|23|23.0||||||
4370348|NCT00350779|4197599|B2|Hispanic||Race/Ethnicity||participants|Number|10|10.0||||||
4370349|NCT00350779|4197600|B1|Hispanic||Race/Ethnicity||participants|Number|13|13.0||||||
4370350|NCT00350779|4197598|B3|Black||Race/Ethnicity||participants|Number|10|10.0||||||
4370351|NCT00350779|4197599|B2|Black||Race/Ethnicity||participants|Number|3|3.0||||||
4370352|NCT00350779|4197600|B1|Black||Race/Ethnicity||participants|Number|7|7.0||||||
4370353|NCT00350779|4197598|B3|White||Race/Ethnicity||participants|Number|133|133.0||||||
4370354|NCT00350779|4197599|B2|White||Race/Ethnicity||participants|Number|51|51.0||||||
4370355|NCT00350779|4197600|B1|White||Race/Ethnicity||participants|Number|82|82.0||||||
4370356|NCT00350779|4197598|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4370357|NCT00350779|4197599|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4370358|NCT00350779|4197600|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4370359|NCT00350779|4197598|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4370360|NCT00350779|4197599|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4370361|NCT00350779|4197600|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4370362|NCT00350779|4197598|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|9.0|9.0|||
4370363|NCT00350779|4197599|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|9.5|9.5|||
4370364|NCT00350779|4197600|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|8.8|8.8|||
4370365|NCT00350727|4197619|B4|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4370366|NCT00350727|4197620|B3|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4370367|NCT00350727|4197621|B2|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4370368|NCT00350727|4197622|B1|White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4370369|NCT00350727|4197619|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4370370|NCT00350727|4197620|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4370371|NCT00350727|4197621|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4370372|NCT00350727|4197622|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4370373|NCT00350727|4197619|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4370374|NCT00350727|4197620|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4370375|NCT00350727|4197621|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4370376|NCT00350727|4197622|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4370377|NCT00350727|4197619|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4370378|NCT00350727|4197620|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4370379|NCT00350727|4197621|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4370380|NCT00350727|4197622|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4370381|NCT00350727|4197619|B4|>=70 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|3|3.0||||||
4370382|NCT00350727|4197620|B3|>=70 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|1|1.0||||||
4370383|NCT00350727|4197621|B2|>=70 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|1|1.0||||||
4370384|NCT00350727|4197622|B1|>=70 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|1|1.0||||||
4370385|NCT00350727|4197619|B4|60-69 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|12|12.0||||||
4370386|NCT00350727|4197620|B3|60-69 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|2|2.0||||||
4370387|NCT00350727|4197621|B2|60-69 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|7|7.0||||||
4370388|NCT00350727|4197622|B1|60-69 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|3|3.0||||||
4370389|NCT00350727|4197619|B4|50-59 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|23|23.0||||||
4370390|NCT00350727|4197620|B3|50-59 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|8|8.0||||||
4370391|NCT00350727|4197621|B2|50-59 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|5|5.0||||||
4370392|NCT00350727|4197622|B1|50-59 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|10|10.0||||||
4370393|NCT00350727|4197619|B4|40-49 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|23|23.0||||||
4370394|NCT00350727|4197620|B3|40-49 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|6|6.0||||||
4370395|NCT00350727|4197621|B2|40-49 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|6|6.0||||||
4370396|NCT00350727|4197622|B1|40-49 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|11|11.0||||||
4370397|NCT00350727|4197619|B4|30-39 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|11|11.0||||||
4370398|NCT00350727|4197620|B3|30-39 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|3|3.0||||||
4370399|NCT00350727|4197621|B2|30-39 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|0|0.0||||||
4370400|NCT00350727|4197622|B1|30-39 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|8|8.0||||||
4370401|NCT00350727|4197619|B4|20-29 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|3|3.0||||||
4370466|NCT00350545|4197798|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4370402|NCT00350727|4197620|B3|20-29 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|2|2.0||||||
4370403|NCT00350727|4197621|B2|20-29 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|0|0.0||||||
4370404|NCT00350727|4197622|B1|20-29 years old||Age, Customized|Number of participants falling into the indicated age groups.|participants|Number|1|1.0||||||
4370405|NCT00350636|4197766|B3|United States||Region of Enrollment||participants|Number|789|789.0||||||
4370406|NCT00350636|4197767|B2|United States||Region of Enrollment||participants|Number|400|400.0||||||
4370407|NCT00350636|4197768|B1|United States||Region of Enrollment||participants|Number|389|389.0||||||
4370408|NCT00350636|4197766|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4370409|NCT00350636|4197767|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4370410|NCT00350636|4197768|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4370411|NCT00350636|4197766|B3||Female|Sex: Female, Male||Participants|Count of Participants|704|704.0||||||
4370412|NCT00350636|4197767|B2||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4370413|NCT00350636|4197768|B1||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4370414|NCT00350636|4197766|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|12.17|12.17|||
4370415|NCT00350636|4197767|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|12.17|12.17|||
4370416|NCT00350636|4197768|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|12.50|12.5|||
4370417|NCT00350636|4197766|B3||>=65 years|Age||Participants|Count of Participants|283|283.0||||||
4370418|NCT00350636|4197767|B2||>=65 years|Age||Participants|Count of Participants|140|140.0||||||
4370419|NCT00350636|4197768|B1||>=65 years|Age||Participants|Count of Participants|143|143.0||||||
4370420|NCT00350636|4197766|B3||Between 18 and 65 years|Age||Participants|Count of Participants|506|506.0||||||
4370421|NCT00350636|4197767|B2||Between 18 and 65 years|Age||Participants|Count of Participants|260|260.0||||||
4370422|NCT00350636|4197768|B1||Between 18 and 65 years|Age||Participants|Count of Participants|246|246.0||||||
4370423|NCT00350636|4197766|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370424|NCT00350636|4197767|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370425|NCT00350636|4197768|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370426|NCT00350623|4197785|B4|White||Race||participants|Number|166|166.0||||||
4370427|NCT00350623|4197786|B3|White||Race||participants|Number|52|52.0||||||
4370428|NCT00350623|4197787|B2|White||Race||participants|Number|57|57.0||||||
4370429|NCT00350623|4197788|B1|White||Race||participants|Number|57|57.0||||||
4370430|NCT00350623|4197785|B4|Other (Unknown)||Race||participants|Number|1|1.0||||||
4370431|NCT00350623|4197786|B3|Other (Unknown)||Race||participants|Number|1|1.0||||||
4370432|NCT00350623|4197787|B2|Other (Unknown)||Race||participants|Number|0|0.0||||||
4370433|NCT00350623|4197788|B1|Other (Unknown)||Race||participants|Number|0|0.0||||||
4370434|NCT00350623|4197785|B4|Multi-Racial||Race||participants|Number|8|8.0||||||
4370435|NCT00350623|4197786|B3|Multi-Racial||Race||participants|Number|1|1.0||||||
4370436|NCT00350623|4197787|B2|Multi-Racial||Race||participants|Number|3|3.0||||||
4370437|NCT00350623|4197788|B1|Multi-Racial||Race||participants|Number|4|4.0||||||
4370438|NCT00350623|4197785|B4|Black or African American||Race||participants|Number|28|28.0||||||
4370439|NCT00350623|4197786|B3|Black or African American||Race||participants|Number|10|10.0||||||
4370440|NCT00350623|4197787|B2|Black or African American||Race||participants|Number|9|9.0||||||
4370441|NCT00350623|4197788|B1|Black or African American||Race||participants|Number|9|9.0||||||
4370442|NCT00350623|4197785|B4|Asian||Race||participants|Number|7|7.0||||||
4370443|NCT00350623|4197786|B3|Asian||Race||participants|Number|4|4.0||||||
4370444|NCT00350623|4197787|B2|Asian||Race||participants|Number|2|2.0||||||
4370445|NCT00350623|4197788|B1|Asian||Race||participants|Number|1|1.0||||||
4370446|NCT00350623|4197785|B4|Not Hispanic or Latino||Ethnicity||Participants|Number|180|180.0||||||
4370447|NCT00350623|4197786|B3|Not Hispanic or Latino||Ethnicity||Participants|Number|56|56.0||||||
4370448|NCT00350623|4197787|B2|Not Hispanic or Latino||Ethnicity||Participants|Number|62|62.0||||||
4370449|NCT00350623|4197788|B1|Not Hispanic or Latino||Ethnicity||Participants|Number|62|62.0||||||
4370450|NCT00350623|4197785|B4|Hispanic or Latino||Ethnicity||Participants|Number|30|30.0||||||
4370451|NCT00350623|4197786|B3|Hispanic or Latino||Ethnicity||Participants|Number|12|12.0||||||
4370452|NCT00350623|4197787|B2|Hispanic or Latino||Ethnicity||Participants|Number|9|9.0||||||
4370453|NCT00350623|4197788|B1|Hispanic or Latino||Ethnicity||Participants|Number|9|9.0||||||
4370454|NCT00350623|4197785|B4||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4370455|NCT00350623|4197786|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4370456|NCT00350623|4197787|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4370457|NCT00350623|4197788|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4370458|NCT00350623|4197785|B4||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4370459|NCT00350623|4197786|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4370460|NCT00350623|4197787|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4370461|NCT00350623|4197788|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4370462|NCT00350623|4197785|B4|||Age||years|Mean|31.4|31.4|Full Range|||18.0|50.0|
4370463|NCT00350623|4197786|B3|||Age||years|Mean|32.0|32.0|Full Range|||19.0|50.0|
4370464|NCT00350623|4197787|B2|||Age||years|Mean|31.5|31.5|Full Range|||18.0|50.0|
4370465|NCT00350623|4197788|B1|||Age||years|Mean|30.6|30.6|Full Range|||18.0|50.0|
4370467|NCT00350545|4197798|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370468|NCT00350545|4197798|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4370469|NCT00350545|4197798|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370470|NCT00350545|4197798|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370471|NCT00350545|4197798|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4370472|NCT00350545|4197798|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370473|NCT00350545|4197798|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370474|NCT00350545|4197798|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4370475|NCT00350545|4197798|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4370476|NCT00350545|4197798|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4370477|NCT00350545|4197798|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4370478|NCT00350545|4197798|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4370479|NCT00350545|4197798|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4370480|NCT00350545|4197798|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370481|NCT00350532|4197806|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4370482|NCT00350532|4197807|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4370483|NCT00350532|4197808|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4370484|NCT00350532|4197806|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4370485|NCT00350532|4197807|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4370486|NCT00350532|4197808|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4370487|NCT00350532|4197806|B3|||Age||years|Mean|40.86|40.86|Standard Deviation|12.91|12.91|||
4370488|NCT00350532|4197807|B2|||Age||years|Mean|32|32.0|Standard Deviation|8.51|8.51|||
4370489|NCT00350532|4197808|B1|||Age||years|Mean|47.875|47.875|Standard Deviation|11.48|11.48|||
4370490|NCT00350532|4197806|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370491|NCT00350532|4197807|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370492|NCT00350532|4197808|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370493|NCT00350532|4197806|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4370494|NCT00350532|4197807|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4370495|NCT00350532|4197808|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4370496|NCT00350532|4197806|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370497|NCT00350532|4197807|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370498|NCT00350532|4197808|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370499|NCT00350519|4197815|B3|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4370500|NCT00350519|4197816|B2|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4370501|NCT00350519|4197817|B1|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4370502|NCT00350519|4197815|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4370503|NCT00350519|4197816|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4370504|NCT00350519|4197817|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4370505|NCT00350519|4197815|B3|Black or Aftrican American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4370506|NCT00350519|4197816|B2|Black or Aftrican American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4370507|NCT00350519|4197817|B1|Black or Aftrican American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4370508|NCT00350519|4197815|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4370509|NCT00350519|4197816|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4370510|NCT00350519|4197817|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4370511|NCT00350519|4197815|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4370512|NCT00350519|4197816|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4370513|NCT00350519|4197817|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4370514|NCT00350519|4197815|B3|||Age||years|Mean|62.22|62.22|Standard Deviation|17.08|17.08|||
4370515|NCT00350519|4197816|B2|||Age||years|Mean|61.42|61.42|Standard Deviation|18.32|18.32|||
4370516|NCT00350519|4197817|B1|||Age||years|Mean|63.06|63.06|Standard Deviation|16.17|16.17|||
4370517|NCT00350519|4197815|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4370518|NCT00350519|4197816|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4370519|NCT00350519|4197817|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4370520|NCT00350519|4197815|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4370521|NCT00350519|4197816|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4370522|NCT00350519|4197817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4370523|NCT00350519|4197815|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370524|NCT00350519|4197816|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370525|NCT00350519|4197817|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370526|NCT00350402|4197830|B3|||Hoehn-Yahr Scale|This scale is used to stage the severity of Parkinson disease symptoms. The scale ranges from Stages 0 to 5. Higher scores (i.e., 5) reflect more severe stage of Parkinson disease.|units on a scale|Mean|2.19|2.19|Standard Deviation|.397|0.397|||
4370527|NCT00350402|4197831|B2|||Hoehn-Yahr Scale|This scale is used to stage the severity of Parkinson disease symptoms. The scale ranges from Stages 0 to 5. Higher scores (i.e., 5) reflect more severe stage of Parkinson disease.|units on a scale|Mean|2.29|2.29|Standard Deviation|.463|0.463|||
4370528|NCT00350402|4197832|B1|||Hoehn-Yahr Scale|This scale is used to stage the severity of Parkinson disease symptoms. The scale ranges from Stages 0 to 5. Higher scores (i.e., 5) reflect more severe stage of Parkinson disease.|units on a scale|Mean|2.1|2.1|Standard Deviation|.301|0.301|||
4370529|NCT00350402|4197830|B3|||Dementia Rating Scale-2|The DRS-2 is a cognitive screening measure for ruling out dementia. Raw scores range from 0 to 144, where higher scores reflect better performance. Scores below 130 are associated with significant cognitive disturbance.|Units on a scale|Mean|139|139.0|Standard Deviation|4.07|4.07|||
4370530|NCT00350402|4197831|B2|||Dementia Rating Scale-2|The DRS-2 is a cognitive screening measure for ruling out dementia. Raw scores range from 0 to 144, where higher scores reflect better performance. Scores below 130 are associated with significant cognitive disturbance.|Units on a scale|Mean|138|138.0|Standard Deviation|4.44|4.44|||
4370531|NCT00350402|4197832|B1|||Dementia Rating Scale-2|The DRS-2 is a cognitive screening measure for ruling out dementia. Raw scores range from 0 to 144, where higher scores reflect better performance. Scores below 130 are associated with significant cognitive disturbance.|Units on a scale|Mean|140|140.0|Standard Deviation|3.49|3.49|||
4370532|NCT00350402|4197830|B3|||Education|Education refers to total years in school, up to a maxium of 20 years|years|Mean|16.14|16.14|Standard Deviation|2.88|2.88|||
4370533|NCT00350402|4197831|B2|||Education|Education refers to total years in school, up to a maxium of 20 years|years|Mean|15.52|15.52|Standard Deviation|3.1|3.1|||
4370534|NCT00350402|4197832|B1|||Education|Education refers to total years in school, up to a maxium of 20 years|years|Mean|16.76|16.76|Standard Deviation|2.57|2.57|||
4370535|NCT00350402|4197830|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4370536|NCT00350402|4197831|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4370537|NCT00350402|4197832|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4370538|NCT00350402|4197830|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4370539|NCT00350402|4197831|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4370540|NCT00350402|4197832|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4370541|NCT00350402|4197830|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4370542|NCT00350402|4197831|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4370543|NCT00350402|4197832|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4370544|NCT00350402|4197830|B3|||Age||years|Mean|67.3|67.3|Standard Deviation|6.7|6.7|||
4370545|NCT00350402|4197831|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|6.9|6.9|||
4370546|NCT00350402|4197832|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|7.3|7.3|||
4370547|NCT00350363|4197845|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4370548|NCT00350363|4197845|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4370549|NCT00350363|4197845|B1|||Age||years|Mean|68|68.0|Full Range|||50.0|85.0|
4370550|NCT00350337|4197849|B5|United States||Region of Enrollment||participants|Number|86|86.0||||||
4370551|NCT00350337|4197850|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4370552|NCT00350337|4197851|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4370553|NCT00350337|4197852|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4370554|NCT00350337|4197853|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4370555|NCT00350337|4197849|B5||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4370556|NCT00350337|4197850|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4370557|NCT00350337|4197851|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4370558|NCT00350337|4197852|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4370559|NCT00350337|4197853|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4370560|NCT00350337|4197849|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4370561|NCT00350337|4197850|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4370562|NCT00350337|4197851|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4370563|NCT00350337|4197852|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4370564|NCT00350337|4197853|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4370565|NCT00350337|4197849|B5|||Age||years|Mean|34.3|34.3|Standard Deviation|7.54|7.54|||
4370566|NCT00350337|4197850|B4|||Age||years|Mean|35.8|35.8|Standard Deviation|6.7|6.7|||
4370567|NCT00350337|4197851|B3|||Age||years|Mean|33|33.0|Standard Deviation|8.6|8.6|||
4370568|NCT00350337|4197852|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|6.93|6.93|||
4370569|NCT00350337|4197853|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|7.75|7.75|||
4370570|NCT00350337|4197849|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370571|NCT00350337|4197850|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370572|NCT00350337|4197851|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370573|NCT00350337|4197852|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370574|NCT00350337|4197853|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370575|NCT00350337|4197849|B5||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4370576|NCT00350337|4197850|B4||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4370577|NCT00350337|4197851|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4370578|NCT00350337|4197852|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4370579|NCT00350337|4197853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4370580|NCT00350337|4197849|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370581|NCT00350337|4197850|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370582|NCT00350337|4197851|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370583|NCT00350337|4197852|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370584|NCT00350337|4197853|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370585|NCT00350272|4197904|B3|||Weight||pounds|Mean|166.58|166.58|Standard Deviation|47.035|47.035|||
4370586|NCT00350272|4197905|B2|||Weight||pounds|Mean|162.03|162.03|Standard Deviation|41.272|41.272|||
4370587|NCT00350272|4197906|B1|||Weight||pounds|Mean|171.37|171.37|Standard Deviation|52.582|52.582|||
4370588|NCT00350272|4197904|B3|||Height||inches|Mean|67.77|67.77|Standard Deviation|4.373|4.373|||
4370589|NCT00350272|4197905|B2|||Height||inches|Mean|68.18|68.18|Standard Deviation|4.433|4.433|||
4370590|NCT00350272|4197906|B1|||Height||inches|Mean|67.33|67.33|Standard Deviation|4.325|4.325|||
4370591|NCT00350272|4197904|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370592|NCT00350272|4197905|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370593|NCT00350272|4197906|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370594|NCT00350272|4197904|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370595|NCT00350272|4197905|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370596|NCT00350272|4197906|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370597|NCT00350272|4197904|B3||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4370598|NCT00350272|4197905|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4370599|NCT00350272|4197906|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4370600|NCT00350272|4197904|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4370601|NCT00350272|4197905|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4370602|NCT00350272|4197906|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4370603|NCT00350272|4197904|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370604|NCT00350272|4197905|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370605|NCT00350272|4197906|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370606|NCT00350272|4197904|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4370607|NCT00350272|4197905|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4370608|NCT00350272|4197906|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4370609|NCT00350272|4197904|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370610|NCT00350272|4197905|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370611|NCT00350272|4197906|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370612|NCT00350272|4197904|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370613|NCT00350272|4197905|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370614|NCT00350272|4197906|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370615|NCT00350272|4197904|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4370616|NCT00350272|4197905|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4370617|NCT00350272|4197906|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4370618|NCT00350272|4197904|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4370619|NCT00350272|4197905|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4370620|NCT00350272|4197906|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4370621|NCT00350272|4197904|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4370622|NCT00350272|4197905|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4370623|NCT00350272|4197906|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4370624|NCT00350272|4197904|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4370625|NCT00350272|4197905|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4370626|NCT00350272|4197906|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4370627|NCT00350272|4197904|B3|||Age||years|Mean|36.6|36.6|Standard Deviation|10.71|10.71|||
4370628|NCT00350272|4197905|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|10.20|10.2|||
4370629|NCT00350272|4197906|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|11.34|11.34|||
4370630|NCT00350220|4197915|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4370631|NCT00350220|4197916|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4370632|NCT00350220|4197917|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4370633|NCT00350220|4197915|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4370634|NCT00350220|4197916|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4370635|NCT00350220|4197917|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4370636|NCT00350220|4197915|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4370637|NCT00350220|4197916|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4370638|NCT00350220|4197917|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4370639|NCT00350220|4197915|B3|||Age||years|Mean|2.5|2.5|Standard Deviation|1.8|1.8|||
4370640|NCT00350220|4197916|B2|||Age||years|Mean|2.25|2.25|Standard Deviation|1.8|1.8|||
4370641|NCT00350220|4197917|B1|||Age||years|Mean|2.75|2.75|Standard Deviation|1.9|1.9|||
4370642|NCT00350220|4197915|B3||>=65 years|Age|subjects under 8 years of age included|Participants|Count of Participants|0|0.0||||||
4370643|NCT00350220|4197916|B2||>=65 years|Age|subjects under 8 years of age included|Participants|Count of Participants|0|0.0||||||
4370644|NCT00350220|4197917|B1||>=65 years|Age|subjects under 8 years of age included|Participants|Count of Participants|0|0.0||||||
4370645|NCT00350220|4197915|B3||Between 18 and 65 years|Age|subjects under 8 years of age included|Participants|Count of Participants|0|0.0||||||
4370646|NCT00350220|4197916|B2||Between 18 and 65 years|Age|subjects under 8 years of age included|Participants|Count of Participants|0|0.0||||||
4370647|NCT00350220|4197917|B1||Between 18 and 65 years|Age|subjects under 8 years of age included|Participants|Count of Participants|0|0.0||||||
4370648|NCT00350220|4197915|B3||<=18 years|Age|subjects under 8 years of age included|Participants|Count of Participants|60|60.0||||||
4370649|NCT00350220|4197916|B2||<=18 years|Age|subjects under 8 years of age included|Participants|Count of Participants|30|30.0||||||
4370650|NCT00350220|4197917|B1||<=18 years|Age|subjects under 8 years of age included|Participants|Count of Participants|30|30.0||||||
4370651|NCT00350207|4197926|B4||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4370652|NCT00350207|4197927|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4370653|NCT00350207|4197928|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4370654|NCT00350207|4197929|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4370655|NCT00350207|4197926|B4||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4370656|NCT00350207|4197927|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4370657|NCT00350207|4197928|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4370658|NCT00350207|4197929|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4370659|NCT00350207|4197926|B4|||Age||years|Mean|43.3|43.3|Standard Deviation|12.6|12.6|||
4370660|NCT00350207|4197927|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|11.9|11.9|||
4370661|NCT00350207|4197928|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|13.4|13.4|||
4370662|NCT00350207|4197929|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|12.6|12.6|||
4370663|NCT00350142|4198125|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4370664|NCT00350142|4198125|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4370665|NCT00350142|4198125|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
4370666|NCT00350142|4198125|B1|||Age||years|Median|63|63.0|Full Range|||45.0|85.0|
4370667|NCT00350142|4198125|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4370668|NCT00350142|4198125|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4370669|NCT00350142|4198125|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370670|NCT00350025|4198130|B3|MVAC||Previous Chemotherapy, No. of Patients||Participants|Count of Participants|2|2.0||||||
4370671|NCT00350025|4198131|B2|MVAC||Previous Chemotherapy, No. of Patients||Participants|Count of Participants|2|2.0||||||
4370672|NCT00350025|4198132|B1|MVAC||Previous Chemotherapy, No. of Patients||Participants|Count of Participants|0|0.0||||||
4370673|NCT00350025|4198130|B3|Gemcitabine and Platinum||Previous Chemotherapy, No. of Patients||Participants|Count of Participants|37|37.0||||||
4370674|NCT00350025|4198131|B2|Gemcitabine and Platinum||Previous Chemotherapy, No. of Patients||Participants|Count of Participants|26|26.0||||||
4370675|NCT00350025|4198132|B1|Gemcitabine and Platinum||Previous Chemotherapy, No. of Patients||Participants|Count of Participants|11|11.0||||||
4370676|NCT00350025|4198130|B3|Renal Pelvis||Primary site, No. of patients||Participants|Count of Participants|4|4.0||||||
4370677|NCT00350025|4198131|B2|Renal Pelvis||Primary site, No. of patients||Participants|Count of Participants|2|2.0||||||
4370678|NCT00350025|4198132|B1|Renal Pelvis||Primary site, No. of patients||Participants|Count of Participants|2|2.0||||||
4370679|NCT00350025|4198130|B3|Bladder||Primary site, No. of patients||Participants|Count of Participants|35|35.0||||||
4370680|NCT00350025|4198131|B2|Bladder||Primary site, No. of patients||Participants|Count of Participants|26|26.0||||||
4370681|NCT00350025|4198132|B1|Bladder||Primary site, No. of patients||Participants|Count of Participants|9|9.0||||||
4370682|NCT00350025|4198130|B3|2||Performance Status|"ECOG scale of performance status was used to determine the ability of the patients to perform their daily functions.~Grade(0)- Fully active Grade (1)- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature Grade (2)- Ambulatory and capable of all selfcare but unable to carry out any work activities Grade (3)- Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours Grade (4) -Completely disabled Grade (5)- Dead"|participants|Number|3|3.0||||||
4370683|NCT00350025|4198131|B2|2||Performance Status|"ECOG scale of performance status was used to determine the ability of the patients to perform their daily functions.~Grade(0)- Fully active Grade (1)- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature Grade (2)- Ambulatory and capable of all selfcare but unable to carry out any work activities Grade (3)- Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours Grade (4) -Completely disabled Grade (5)- Dead"|participants|Number|3|3.0||||||
4370728|NCT00349973|4198142|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4370729|NCT00349973|4198143|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4370730|NCT00349973|4198141|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370684|NCT00350025|4198132|B1|2||Performance Status|"ECOG scale of performance status was used to determine the ability of the patients to perform their daily functions.~Grade(0)- Fully active Grade (1)- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature Grade (2)- Ambulatory and capable of all selfcare but unable to carry out any work activities Grade (3)- Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours Grade (4) -Completely disabled Grade (5)- Dead"|participants|Number|0|0.0||||||
4370685|NCT00350025|4198130|B3|0-1||Performance Status|"ECOG scale of performance status was used to determine the ability of the patients to perform their daily functions.~Grade(0)- Fully active Grade (1)- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature Grade (2)- Ambulatory and capable of all selfcare but unable to carry out any work activities Grade (3)- Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours Grade (4) -Completely disabled Grade (5)- Dead"|participants|Number|36|36.0||||||
4370686|NCT00350025|4198131|B2|0-1||Performance Status|"ECOG scale of performance status was used to determine the ability of the patients to perform their daily functions.~Grade(0)- Fully active Grade (1)- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature Grade (2)- Ambulatory and capable of all selfcare but unable to carry out any work activities Grade (3)- Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours Grade (4) -Completely disabled Grade (5)- Dead"|participants|Number|25|25.0||||||
4370687|NCT00350025|4198132|B1|0-1||Performance Status|"ECOG scale of performance status was used to determine the ability of the patients to perform their daily functions.~Grade(0)- Fully active Grade (1)- Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature Grade (2)- Ambulatory and capable of all selfcare but unable to carry out any work activities Grade (3)- Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours Grade (4) -Completely disabled Grade (5)- Dead"|participants|Number|11|11.0||||||
4370688|NCT00350025|4198130|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370689|NCT00350025|4198131|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370690|NCT00350025|4198132|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370691|NCT00350025|4198130|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370692|NCT00350025|4198131|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370693|NCT00350025|4198132|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370694|NCT00350025|4198130|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4370695|NCT00350025|4198131|B2||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4370696|NCT00350025|4198132|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4370697|NCT00350025|4198130|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4370698|NCT00350025|4198131|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4370699|NCT00350025|4198132|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4370700|NCT00350025|4198130|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370701|NCT00350025|4198131|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370702|NCT00350025|4198132|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370703|NCT00350025|4198130|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370704|NCT00350025|4198131|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370705|NCT00350025|4198132|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370706|NCT00350025|4198130|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370707|NCT00350025|4198131|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370708|NCT00350025|4198132|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370709|NCT00350025|4198130|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4370710|NCT00350025|4198131|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4370711|NCT00350025|4198132|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4370712|NCT00350025|4198130|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4370713|NCT00350025|4198131|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4370714|NCT00350025|4198132|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4370715|NCT00350025|4198130|B3|||Age||years|Median|69|69.0|Full Range|||46.0|83.0|
4370716|NCT00350025|4198131|B2|||Age||years|Median|69|69.0|Full Range|||46.0|82.0|
4370717|NCT00350025|4198132|B1|||Age||years|Median|70|70.0|Full Range|||49.0|83.0|
4370718|NCT00349973|4198141|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370719|NCT00349973|4198142|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370720|NCT00349973|4198143|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370721|NCT00349973|4198141|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370722|NCT00349973|4198142|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370723|NCT00349973|4198143|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370724|NCT00349973|4198141|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4370725|NCT00349973|4198142|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4370726|NCT00349973|4198143|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4370727|NCT00349973|4198141|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4370731|NCT00349973|4198142|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370732|NCT00349973|4198143|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370733|NCT00349973|4198141|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370734|NCT00349973|4198142|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370735|NCT00349973|4198143|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370736|NCT00349973|4198141|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370737|NCT00349973|4198142|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370738|NCT00349973|4198143|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370739|NCT00349973|4198141|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4370740|NCT00349973|4198142|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4370741|NCT00349973|4198143|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4370742|NCT00349973|4198141|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4370743|NCT00349973|4198142|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4370744|NCT00349973|4198143|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4370745|NCT00349973|4198141|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370746|NCT00349973|4198142|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370747|NCT00349973|4198143|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370748|NCT00349973|4198141|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4370749|NCT00349973|4198142|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4370750|NCT00349973|4198143|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4370751|NCT00349973|4198141|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370752|NCT00349973|4198142|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370753|NCT00349973|4198143|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370754|NCT00349921|4198154|B5|United States||Region of Enrollment||participants|Number|22|22.0||||||
4370755|NCT00349921|4198155|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4370756|NCT00349921|4198156|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4370757|NCT00349921|4198157|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4370758|NCT00349921|4198158|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4370759|NCT00349921|4198154|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4370760|NCT00349921|4198155|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4370761|NCT00349921|4198156|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4370762|NCT00349921|4198157|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4370763|NCT00349921|4198158|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4370764|NCT00349921|4198154|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4370765|NCT00349921|4198155|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4370766|NCT00349921|4198156|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4370767|NCT00349921|4198157|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4370768|NCT00349921|4198158|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4370769|NCT00349921|4198154|B5|||Age||years|Mean|43.7|43.7|Standard Deviation|10.1|10.1|||
4370770|NCT00349921|4198155|B4|||Age||years|Mean|54|54.0|Standard Deviation|0|0.0|||
4370771|NCT00349921|4198156|B3|||Age||years|Mean|19|19.0|Standard Deviation|0|0.0|||
4370772|NCT00349921|4198157|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|10.8|10.8|||
4370773|NCT00349921|4198158|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|6.4|6.4|||
4370774|NCT00349921|4198154|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370775|NCT00349921|4198155|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370776|NCT00349921|4198156|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370777|NCT00349921|4198157|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370778|NCT00349921|4198158|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370779|NCT00349921|4198154|B5||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4370780|NCT00349921|4198155|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4370781|NCT00349921|4198156|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4370782|NCT00349921|4198157|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4370783|NCT00349921|4198158|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4370784|NCT00349921|4198154|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370785|NCT00349921|4198155|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370786|NCT00349921|4198156|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370787|NCT00349921|4198157|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370788|NCT00349921|4198158|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370789|NCT00349908|4198170|B3|Argentina||Region of Enrollment||participants|Number|20|20.0||||||
4370790|NCT00349908|4198171|B2|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
4370791|NCT00349908|4198172|B1|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
4370792|NCT00349908|4198170|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4370793|NCT00349908|4198171|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4370794|NCT00349908|4198172|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4370795|NCT00349908|4198170|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4370796|NCT00349908|4198171|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4370797|NCT00349908|4198172|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4370798|NCT00349908|4198170|B3|||Age||years|Mean|63.85|63.85|Standard Deviation|9|9.0|||
4370799|NCT00349908|4198171|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|9|9.0|||
4370800|NCT00349908|4198172|B1|||Age||years|Mean|64|64.0|Standard Deviation|9.0|9.0|||
4370801|NCT00349908|4198170|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4370802|NCT00349908|4198171|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4370803|NCT00349908|4198172|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370804|NCT00349908|4198170|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4370805|NCT00349908|4198171|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4370806|NCT00349908|4198172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4370807|NCT00349908|4198170|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370808|NCT00349908|4198171|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370809|NCT00349908|4198172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370810|NCT00349778|4198191|B1|Ethnicity|Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4370811|NCT00349778|4198191|B1|Ethnicity|Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4370812|NCT00349778|4198191|B1|Ethnicity|Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4370813|NCT00349778|4198191|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4370814|NCT00349778|4198191|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4370815|NCT00349778|4198191|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4370816|NCT00349778|4198191|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4370817|NCT00349778|4198191|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370818|NCT00349752|4198197|B3|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4370819|NCT00349752|4198198|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4370820|NCT00349752|4198199|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4370821|NCT00349752|4198197|B3|Canada||Region of Enrollment||participants|Number|29|29.0||||||
4370822|NCT00349752|4198198|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4370823|NCT00349752|4198199|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4370824|NCT00349752|4198197|B3|United States||Region of Enrollment||participants|Number|133|133.0||||||
4370825|NCT00349752|4198198|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
4370826|NCT00349752|4198199|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4370827|NCT00349752|4198197|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4370828|NCT00349752|4198198|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4370829|NCT00349752|4198199|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4370830|NCT00349752|4198197|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4370831|NCT00349752|4198198|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4370832|NCT00349752|4198199|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4370833|NCT00349752|4198197|B3|||Age||years|Mean|40.25|40.25|Standard Deviation|13.23|13.23|||
4370834|NCT00349752|4198198|B2|||Age||years|Mean|39.73|39.73|Standard Deviation|13.31|13.31|||
4370835|NCT00349752|4198199|B1|||Age||years|Mean|40.77|40.77|Standard Deviation|13.20|13.2|||
4370836|NCT00349752|4198197|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4370837|NCT00349752|4198198|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4370838|NCT00349752|4198199|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4370839|NCT00349752|4198197|B3||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
4370840|NCT00349752|4198198|B2||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4370841|NCT00349752|4198199|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4370842|NCT00349752|4198197|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370843|NCT00349752|4198198|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370844|NCT00349752|4198199|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370845|NCT00349713|4198226|B4|Mali||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4370846|NCT00349713|4198227|B3|Mali||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4370847|NCT00349713|4198228|B2|Mali||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4370848|NCT00349713|4198229|B1|Mali||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4370849|NCT00349713|4198226|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4370850|NCT00349713|4198227|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4370851|NCT00349713|4198228|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4370852|NCT00349713|4198229|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4370853|NCT00349713|4198226|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4370854|NCT00349713|4198227|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4370855|NCT00349713|4198228|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4370856|NCT00349713|4198229|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4370857|NCT00349713|4198226|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370858|NCT00349713|4198227|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370859|NCT00349713|4198228|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370860|NCT00349713|4198229|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4370861|NCT00349713|4198226|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4370862|NCT00349713|4198227|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4370863|NCT00349713|4198228|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4370864|NCT00349713|4198229|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4370865|NCT00349713|4198226|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370866|NCT00349713|4198227|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370867|NCT00349713|4198228|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370868|NCT00349713|4198229|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4370869|NCT00349622|4198251|B3|Years from Symptom Onset to Diagnosis||Time to Screening||years|Mean|0.92|0.92|Standard Deviation|0.56|0.56|||
4370870|NCT00349622|4198252|B2|Years from Symptom Onset to Diagnosis||Time to Screening||years|Mean|0.92|0.92|Standard Deviation|0.58|0.58|||
4370871|NCT00349622|4198253|B1|Years from Symptom Onset to Diagnosis||Time to Screening||years|Mean|0.93|0.93|Standard Deviation|0.55|0.55|||
4370872|NCT00349622|4198251|B3|Years from Diagnosis to Screening||Time to Screening||years|Mean|0.57|0.57|Standard Deviation|0.49|0.49|||
4370873|NCT00349622|4198252|B2|Years from Diagnosis to Screening||Time to Screening||years|Mean|0.58|0.58|Standard Deviation|0.49|0.49|||
4370874|NCT00349622|4198253|B1|Years from Diagnosis to Screening||Time to Screening||years|Mean|0.56|0.56|Standard Deviation|0.49|0.49|||
4370875|NCT00349622|4198251|B3|Years from Symptom Onset to Screening||Time to Screening||years|Mean|1.49|1.49|Standard Deviation|0.68|0.68|||
4370876|NCT00349622|4198252|B2|Years from Symptom Onset to Screening||Time to Screening||years|Mean|1.50|1.5|Standard Deviation|0.67|0.67|||
4370877|NCT00349622|4198253|B1|Years from Symptom Onset to Screening||Time to Screening||years|Mean|1.49|1.49|Standard Deviation|0.68|0.68|||
4370878|NCT00349622|4198251|B3|||Vital Capacity Percent Predicted|The vital capacity (lung capacity) for each subject was measured at screening.|percent predicted based on age and heigh|Mean|89.0|89.0|Standard Deviation|17.3|17.3|||
4370879|NCT00349622|4198252|B2|||Vital Capacity Percent Predicted|The vital capacity (lung capacity) for each subject was measured at screening.|percent predicted based on age and heigh|Mean|91.1|91.1|Standard Deviation|18.4|18.4|||
4370880|NCT00349622|4198253|B1|||Vital Capacity Percent Predicted|The vital capacity (lung capacity) for each subject was measured at screening.|percent predicted based on age and heigh|Mean|87.9|87.9|Standard Deviation|16.6|16.6|||
4370881|NCT00349622|4198251|B3|Not on Riluzole||Riluzole Use|At the screening visit, subjects were asked whether or not they were taking a continuous dose of riluzole.|participants|Number|136|136.0||||||
4370882|NCT00349622|4198252|B2|Not on Riluzole||Riluzole Use|At the screening visit, subjects were asked whether or not they were taking a continuous dose of riluzole.|participants|Number|45|45.0||||||
4370883|NCT00349622|4198253|B1|Not on Riluzole||Riluzole Use|At the screening visit, subjects were asked whether or not they were taking a continuous dose of riluzole.|participants|Number|91|91.0||||||
4370884|NCT00349622|4198251|B3|On Riluzole||Riluzole Use|At the screening visit, subjects were asked whether or not they were taking a continuous dose of riluzole.|participants|Number|377|377.0||||||
4370885|NCT00349622|4198252|B2|On Riluzole||Riluzole Use|At the screening visit, subjects were asked whether or not they were taking a continuous dose of riluzole.|participants|Number|128|128.0||||||
4370886|NCT00349622|4198253|B1|On Riluzole||Riluzole Use|At the screening visit, subjects were asked whether or not they were taking a continuous dose of riluzole.|participants|Number|249|249.0||||||
4370887|NCT00349622|4198251|B3|Both||Site of Onset|Indicates region of first symptoms|participants|Number|9|9.0||||||
4370888|NCT00349622|4198252|B2|Both||Site of Onset|Indicates region of first symptoms|participants|Number|1|1.0||||||
4370889|NCT00349622|4198253|B1|Both||Site of Onset|Indicates region of first symptoms|participants|Number|8|8.0||||||
4370890|NCT00349622|4198251|B3|Bulbar||Site of Onset|Indicates region of first symptoms|participants|Number|110|110.0||||||
4370891|NCT00349622|4198252|B2|Bulbar||Site of Onset|Indicates region of first symptoms|participants|Number|35|35.0||||||
4370892|NCT00349622|4198253|B1|Bulbar||Site of Onset|Indicates region of first symptoms|participants|Number|75|75.0||||||
4370893|NCT00349622|4198251|B3|Limb||Site of Onset|Indicates region of first symptoms|participants|Number|394|394.0||||||
4370894|NCT00349622|4198252|B2|Limb||Site of Onset|Indicates region of first symptoms|participants|Number|137|137.0||||||
4370895|NCT00349622|4198253|B1|Limb||Site of Onset|Indicates region of first symptoms|participants|Number|257|257.0||||||
4370896|NCT00349622|4198251|B3|Unknown||ALS Family History|Subjects were asked at screening whether or not they have a familial history of ALS.|participants|Number|11|11.0||||||
4370897|NCT00349622|4198252|B2|Unknown||ALS Family History|Subjects were asked at screening whether or not they have a familial history of ALS.|participants|Number|4|4.0||||||
4370898|NCT00349622|4198253|B1|Unknown||ALS Family History|Subjects were asked at screening whether or not they have a familial history of ALS.|participants|Number|7|7.0||||||
4370899|NCT00349622|4198251|B3|No Known Familial History of ALS||ALS Family History|Subjects were asked at screening whether or not they have a familial history of ALS.|participants|Number|468|468.0||||||
4370900|NCT00349622|4198252|B2|No Known Familial History of ALS||ALS Family History|Subjects were asked at screening whether or not they have a familial history of ALS.|participants|Number|161|161.0||||||
4370901|NCT00349622|4198253|B1|No Known Familial History of ALS||ALS Family History|Subjects were asked at screening whether or not they have a familial history of ALS.|participants|Number|307|307.0||||||
4370902|NCT00349622|4198251|B3|Familial History of ALS||ALS Family History|Subjects were asked at screening whether or not they have a familial history of ALS.|participants|Number|34|34.0||||||
4370903|NCT00349622|4198252|B2|Familial History of ALS||ALS Family History|Subjects were asked at screening whether or not they have a familial history of ALS.|participants|Number|8|8.0||||||
4370904|NCT00349622|4198253|B1|Familial History of ALS||ALS Family History|Subjects were asked at screening whether or not they have a familial history of ALS.|participants|Number|26|26.0||||||
4370905|NCT00349622|4198251|B3|Canada||Region of Enrollment||participants|Number|69|69.0||||||
4370906|NCT00349622|4198252|B2|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4370907|NCT00349622|4198253|B1|Canada||Region of Enrollment||participants|Number|47|47.0||||||
4370908|NCT00349622|4198251|B3|United States||Region of Enrollment||participants|Number|444|444.0||||||
4370909|NCT00349622|4198252|B2|United States||Region of Enrollment||participants|Number|151|151.0||||||
4370910|NCT00349622|4198253|B1|United States||Region of Enrollment||participants|Number|293|293.0||||||
4370911|NCT00349622|4198251|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4370912|NCT00349622|4198252|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4370913|NCT00349622|4198253|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370914|NCT00349622|4198251|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4370915|NCT00349622|4198252|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370916|NCT00349622|4198253|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4370917|NCT00349622|4198251|B3||White|Race (NIH/OMB)||Participants|Count of Participants|483|483.0||||||
4370918|NCT00349622|4198252|B2||White|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
4370919|NCT00349622|4198253|B1||White|Race (NIH/OMB)||Participants|Count of Participants|320|320.0||||||
4370920|NCT00349622|4198251|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4370921|NCT00349622|4198252|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4370922|NCT00349622|4198253|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4370923|NCT00349622|4198251|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370924|NCT00349622|4198252|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370925|NCT00349622|4198253|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4370926|NCT00349622|4198251|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4370927|NCT00349622|4198252|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4370928|NCT00349622|4198253|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4370929|NCT00349622|4198251|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4370930|NCT00349622|4198252|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4370931|NCT00349622|4198253|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4370932|NCT00349622|4198251|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4370933|NCT00349622|4198252|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4370934|NCT00349622|4198253|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4370935|NCT00349622|4198251|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|485|485.0||||||
4370936|NCT00349622|4198252|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4370937|NCT00349622|4198253|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|320|320.0||||||
4370938|NCT00349622|4198251|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4370939|NCT00349622|4198252|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4370940|NCT00349622|4198253|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4370941|NCT00349622|4198251|B3||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4370942|NCT00349622|4198252|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4370943|NCT00349622|4198253|B1||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4370944|NCT00349622|4198251|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4370945|NCT00349622|4198252|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4370946|NCT00349622|4198253|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4370947|NCT00349622|4198251|B3|Age at Screening||Age||years|Mean|55.4|55.4|Standard Deviation|10.4|10.4|||
4370948|NCT00349622|4198252|B2|Age at Screening||Age||years|Mean|54.8|54.8|Standard Deviation|10.3|10.3|||
4370949|NCT00349622|4198253|B1|Age at Screening||Age||years|Mean|55.6|55.6|Standard Deviation|10.4|10.4|||
4370950|NCT00349466|4198270|B3|Israel||Region of Enrollment||participants|Number|80|80.0||||||
4370951|NCT00349466|4198271|B2|Israel||Region of Enrollment||participants|Number|38|38.0||||||
4370952|NCT00349466|4198272|B1|Israel||Region of Enrollment||participants|Number|42|42.0||||||
4370953|NCT00349466|4198270|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4370954|NCT00349466|4198271|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4370955|NCT00349466|4198272|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4370956|NCT00349466|4198270|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4370957|NCT00349466|4198271|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4370958|NCT00349466|4198272|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4370959|NCT00349466|4198270|B3|||Age||Years|Mean|58.7|58.7|Standard Deviation|13.4|13.4|||
4370960|NCT00349466|4198271|B2|||Age||Years|Mean|61.4|61.4|Standard Deviation|1311.7|1311.7|||
4370961|NCT00349466|4198272|B1|||Age||Years|Mean|56.2|56.2|Standard Deviation|14.4|14.4|||
4370962|NCT00349388|4198279|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4370963|NCT00349388|4198280|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4370964|NCT00349388|4198279|B3|Male||Gender||participants|Number|1|1.0||||||
4370965|NCT00349388|4198280|B2|Male||Gender||participants|Number|1|1.0||||||
4370966|NCT00349388|4198279|B3|Female||Gender||participants|Number|0|0.0||||||
4370967|NCT00349388|4198280|B2|Female||Gender||participants|Number|0|0.0||||||
4370968|NCT00349388|4198279|B3|>=65 years||Age||participants|Number|0|0.0||||||
4370969|NCT00349388|4198280|B2|>=65 years||Age||participants|Number|0|0.0||||||
4370970|NCT00349388|4198279|B3|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4370971|NCT00349388|4198280|B2|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4370972|NCT00349388|4198279|B3|<=18 years||Age||participants|Number|1|1.0||||||
4370973|NCT00349388|4198280|B2|<=18 years||Age||participants|Number|1|1.0||||||
4370974|NCT00349349|4198288|B4|Middle Eastern||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4370975|NCT00349349|4198289|B3|Middle Eastern||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4370976|NCT00349349|4198290|B2|Middle Eastern||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4370977|NCT00349349|4198291|B1|Middle Eastern||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4370978|NCT00349349|4198288|B4|Yemenite||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4370979|NCT00349349|4198289|B3|Yemenite||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4370980|NCT00349349|4198290|B2|Yemenite||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4370981|NCT00349349|4198291|B1|Yemenite||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4370982|NCT00349349|4198288|B4|Arab||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4370983|NCT00349349|4198289|B3|Arab||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4370984|NCT00349349|4198290|B2|Arab||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4370985|NCT00349349|4198291|B1|Arab||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4370986|NCT00349349|4198288|B4|White||Race/Ethnicity, Customized||participants|Number|214|214.0||||||
4370987|NCT00349349|4198289|B3|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4370988|NCT00349349|4198290|B2|White||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4370989|NCT00349349|4198291|B1|White||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4370990|NCT00349349|4198288|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4370991|NCT00349349|4198289|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4370992|NCT00349349|4198290|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4370993|NCT00349349|4198291|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4370994|NCT00349349|4198288|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4370995|NCT00349349|4198289|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4370996|NCT00349349|4198290|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4370997|NCT00349349|4198291|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4370998|NCT00349349|4198288|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4370999|NCT00349349|4198289|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371000|NCT00349349|4198290|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371001|NCT00349349|4198291|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371002|NCT00349349|4198288|B4||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4371003|NCT00349349|4198289|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4371004|NCT00349349|4198290|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4371005|NCT00349349|4198291|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4371006|NCT00349349|4198288|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4371007|NCT00349349|4198289|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4371008|NCT00349349|4198290|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4371009|NCT00349349|4198291|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4371010|NCT00349349|4198288|B4|||Age||Years|Mean|63.9|63.9|Standard Deviation|8.8|8.8|||
4371011|NCT00349349|4198289|B3|||Age||Years|Mean|64.5|64.5|Standard Deviation|7.4|7.4|||
4371012|NCT00349349|4198290|B2|||Age||Years|Mean|64.4|64.4|Standard Deviation|9.3|9.3|||
4371013|NCT00349349|4198291|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.4|8.4|||
4371014|NCT00349336|4198357|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4371015|NCT00349336|4198358|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4371016|NCT00349336|4198359|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4371017|NCT00349336|4198357|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4371018|NCT00349336|4198358|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4371019|NCT00349336|4198359|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4371020|NCT00349336|4198357|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|11.74|11.74|||
4371021|NCT00349336|4198358|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|10.84|10.84|||
4371022|NCT00349336|4198359|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|12.56|12.56|||
4371023|NCT00348933|4198382|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
4371024|NCT00348933|4198382|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4371025|NCT00348933|4198382|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4371026|NCT00348933|4198382|B1|||Age||years|Mean|2.9|2.9|Standard Deviation|1.2|1.2|||
4371027|NCT00348933|4198382|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371028|NCT00348933|4198382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4371029|NCT00348933|4198382|B1||<=18 years|Age||Participants|Count of Participants|90|90.0||||||
4371030|NCT00348881|4198388|B3|Philippines||Region of Enrollment||Participants|Number|2133|2133.0||||||
4371031|NCT00348881|4198389|B2|Philippines||Region of Enrollment||Participants|Number|709|709.0||||||
4371032|NCT00348881|4198390|B1|Philippines||Region of Enrollment||Participants|Number|1424|1424.0||||||
4371033|NCT00348881|4198388|B3||Male|Sex: Female, Male||Participants|Count of Participants|1059|1059.0||||||
4371034|NCT00348881|4198389|B2||Male|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4371035|NCT00348881|4198390|B1||Male|Sex: Female, Male||Participants|Count of Participants|706|706.0||||||
4371036|NCT00348881|4198388|B3||Female|Sex: Female, Male||Participants|Count of Participants|1074|1074.0||||||
4371037|NCT00348881|4198389|B2||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4371038|NCT00348881|4198390|B1||Female|Sex: Female, Male||Participants|Count of Participants|718|718.0||||||
4371039|NCT00348881|4198388|B3|||Age||Weeks|Mean|6.28|6.28|Standard Deviation|0.291|0.291|||
4371040|NCT00348881|4198389|B2|||Age||Weeks|Mean|6.30|6.3|Standard Deviation|0.310|0.31|||
4371041|NCT00348881|4198390|B1|||Age||Weeks|Mean|6.27|6.27|Standard Deviation|0.280|0.28|||
4371042|NCT00348881|4198388|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371043|NCT00348881|4198389|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371044|NCT00348881|4198390|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371045|NCT00348881|4198388|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4371046|NCT00348881|4198389|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4371047|NCT00348881|4198390|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4371048|NCT00348881|4198388|B3||<=18 years|Age||Participants|Count of Participants|2133|2133.0||||||
4371049|NCT00348881|4198389|B2||<=18 years|Age||Participants|Count of Participants|709|709.0||||||
4371050|NCT00348881|4198390|B1||<=18 years|Age||Participants|Count of Participants|1424|1424.0||||||
4371051|NCT00348816|4198403|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4371052|NCT00348816|4198403|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371053|NCT00348816|4198403|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371054|NCT00348816|4198403|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4371055|NCT00348816|4198403|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4371056|NCT00348816|4198403|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371057|NCT00348816|4198403|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371058|NCT00348816|4198403|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371059|NCT00348816|4198403|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371060|NCT00348816|4198403|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4371061|NCT00348816|4198403|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4371062|NCT00348816|4198403|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4371063|NCT00348816|4198403|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371064|NCT00348816|4198403|B1|||Age||years|Median|65|65.0|Full Range|||48.0|79.0|
4371065|NCT00348816|4198403|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4371066|NCT00348816|4198403|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4371067|NCT00348816|4198403|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4371068|NCT00348790|4198410|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4371069|NCT00348790|4198410|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4371070|NCT00348790|4198410|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4371071|NCT00348790|4198410|B1|81-90||Age, Customized||participants|Number|1|1.0||||||
4371072|NCT00348790|4198410|B1|71-80||Age, Customized||participants|Number|0|0.0||||||
4371073|NCT00348790|4198410|B1|61-70 years||Age, Customized||participants|Number|8|8.0||||||
4371074|NCT00348790|4198410|B1|51-60||Age, Customized||participants|Number|8|8.0||||||
4371075|NCT00348790|4198410|B1|41-50||Age, Customized||participants|Number|6|6.0||||||
4371076|NCT00348790|4198410|B1|31-40||Age, Customized||participants|Number|1|1.0||||||
4371077|NCT00348790|4198410|B1|21-30||Age, Customized||participants|Number|1|1.0||||||
4371078|NCT00348686|4198422|B1||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4371079|NCT00348686|4198422|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4371080|NCT00348686|4198422|B1|Average age of subjects who participated||Age||years|Mean|49.90|49.9|Standard Deviation|11.9|11.9|||
4371081|NCT00348673|4198431|B9||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4371082|NCT00348673|4198432|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4371083|NCT00348673|4198433|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4371084|NCT00348673|4198434|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4371085|NCT00348673|4198435|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4371086|NCT00348673|4198436|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4371087|NCT00348673|4198437|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4371088|NCT00348673|4198438|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4371089|NCT00348673|4198439|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4371090|NCT00348673|4198431|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371091|NCT00348673|4198432|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371092|NCT00348673|4198433|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371093|NCT00348673|4198434|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371094|NCT00348673|4198435|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371095|NCT00348673|4198436|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371096|NCT00348673|4198437|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371097|NCT00348673|4198438|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371098|NCT00348673|4198439|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371099|NCT00348673|4198431|B9|||Age||years|Mean|36.6|36.6|Standard Deviation|8.2|8.2|||
4371100|NCT00348673|4198432|B8|||Age||years|Mean|33.8|33.8|Standard Deviation|8.0|8.0|||
4371101|NCT00348673|4198433|B7|||Age||years|Mean|37.0|37.0|Standard Deviation|8.5|8.5|||
4371102|NCT00348673|4198434|B6|||Age||years|Mean|40.3|40.3|Standard Deviation|7.5|7.5|||
4371103|NCT00348673|4198435|B5|||Age||years|Mean|29.2|29.2|Standard Deviation|7.9|7.9|||
4371104|NCT00348673|4198436|B4|||Age||years|Mean|41.7|41.7|Standard Deviation|4.1|4.1|||
4371105|NCT00348673|4198437|B3|||Age||years|Mean|33.5|33.5|Standard Deviation|8.6|8.6|||
4371106|NCT00348673|4198438|B2|||Age||years|Mean|38.2|38.2|Standard Deviation|8.6|8.6|||
4371107|NCT00348673|4198439|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|8.4|8.4|||
4371108|NCT00348556|4198494|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4371109|NCT00348556|4198494|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4371110|NCT00348556|4198494|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371111|NCT00348556|4198494|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4371112|NCT00348556|4198494|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4371113|NCT00348556|4198494|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4371114|NCT00348374|4198499|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4371115|NCT00348374|4198500|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4371116|NCT00348374|4198501|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4371117|NCT00348374|4198499|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4371118|NCT00348374|4198500|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4371119|NCT00348374|4198501|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4371120|NCT00348374|4198499|B3|>=65 years||Age, Customized||participants|Number|42|42.0||||||
4371121|NCT00348374|4198500|B2|>=65 years||Age, Customized||participants|Number|26|26.0||||||
4371122|NCT00348374|4198501|B1|>=65 years||Age, Customized||participants|Number|16|16.0||||||
4371123|NCT00348374|4198499|B3|45-64 years||Age, Customized||participants|Number|107|107.0||||||
4371124|NCT00348374|4198500|B2|45-64 years||Age, Customized||participants|Number|51|51.0||||||
4371125|NCT00348374|4198501|B1|45-64 years||Age, Customized||participants|Number|56|56.0||||||
4371126|NCT00348374|4198499|B3|18-44 years||Age, Customized||participants|Number|35|35.0||||||
4371127|NCT00348374|4198500|B2|18-44 years||Age, Customized||participants|Number|19|19.0||||||
4371128|NCT00348374|4198501|B1|18-44 years||Age, Customized||participants|Number|16|16.0||||||
4371129|NCT00348348|4198547|B3|Other||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4371130|NCT00348348|4198548|B2|Other||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4371131|NCT00348348|4198549|B1|Other||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4371132|NCT00348348|4198547|B3|White||Race/Ethnicity, Customized||participants|Number|776|776.0||||||
4371133|NCT00348348|4198548|B2|White||Race/Ethnicity, Customized||participants|Number|385|385.0||||||
4371134|NCT00348348|4198549|B1|White||Race/Ethnicity, Customized||participants|Number|391|391.0||||||
4371135|NCT00348348|4198547|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4371136|NCT00348348|4198548|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4371137|NCT00348348|4198549|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4371138|NCT00348348|4198547|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4371139|NCT00348348|4198548|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4371140|NCT00348348|4198549|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4371141|NCT00348348|4198547|B3|Asian||Race/Ethnicity, Customized||participants|Number|176|176.0||||||
4371142|NCT00348348|4198548|B2|Asian||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4371143|NCT00348348|4198549|B1|Asian||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4371144|NCT00348348|4198547|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4371145|NCT00348348|4198548|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4371146|NCT00348348|4198549|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4371147|NCT00348348|4198547|B3||Male|Sex: Female, Male||Participants|Count of Participants|506|506.0||||||
4371148|NCT00348348|4198548|B2||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4371149|NCT00348348|4198549|B1||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4371150|NCT00348348|4198547|B3||Female|Sex: Female, Male||Participants|Count of Participants|655|655.0||||||
4371151|NCT00348348|4198548|B2||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4371152|NCT00348348|4198549|B1||Female|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
4371153|NCT00348348|4198547|B3|>/= 60 years||Age, Customized||participants|Number|219|219.0||||||
4371154|NCT00348348|4198548|B2|>/= 60 years||Age, Customized||participants|Number|99|99.0||||||
4371155|NCT00348348|4198549|B1|>/= 60 years||Age, Customized||participants|Number|120|120.0||||||
4371156|NCT00348348|4198547|B3|50 to 59 years||Age, Customized||participants|Number|128|128.0||||||
4371157|NCT00348348|4198548|B2|50 to 59 years||Age, Customized||participants|Number|63|63.0||||||
4371158|NCT00348348|4198549|B1|50 to 59 years||Age, Customized||participants|Number|65|65.0||||||
4371159|NCT00348348|4198547|B3|40 to 49 years||Age, Customized||participants|Number|127|127.0||||||
4371160|NCT00348348|4198548|B2|40 to 49 years||Age, Customized||participants|Number|68|68.0||||||
4371161|NCT00348348|4198549|B1|40 to 49 years||Age, Customized||participants|Number|59|59.0||||||
4371162|NCT00348348|4198547|B3|30 to 39 years||Age, Customized||participants|Number|147|147.0||||||
4371163|NCT00348348|4198548|B2|30 to 39 years||Age, Customized||participants|Number|71|71.0||||||
4371164|NCT00348348|4198549|B1|30 to 39 years||Age, Customized||participants|Number|76|76.0||||||
4371165|NCT00348348|4198547|B3|20 to 29 years||Age, Customized||participants|Number|166|166.0||||||
4371166|NCT00348348|4198548|B2|20 to 29 years||Age, Customized||participants|Number|93|93.0||||||
4371167|NCT00348348|4198549|B1|20 to 29 years||Age, Customized||participants|Number|73|73.0||||||
4371168|NCT00348348|4198547|B3|10 to 19 years||Age, Customized||participants|Number|156|156.0||||||
4371169|NCT00348348|4198548|B2|10 to 19 years||Age, Customized||participants|Number|75|75.0||||||
4371170|NCT00348348|4198549|B1|10 to 19 years||Age, Customized||participants|Number|81|81.0||||||
4371171|NCT00348348|4198547|B3|2 to 9 years||Age, Customized||participants|Number|181|181.0||||||
4371172|NCT00348348|4198548|B2|2 to 9 years||Age, Customized||participants|Number|91|91.0||||||
4371173|NCT00348348|4198549|B1|2 to 9 years||Age, Customized||participants|Number|90|90.0||||||
4371174|NCT00348348|4198547|B3|<2 years||Age, Customized||participants|Number|37|37.0||||||
4371175|NCT00348348|4198548|B2|<2 years||Age, Customized||participants|Number|22|22.0||||||
4371176|NCT00348348|4198549|B1|<2 years||Age, Customized||participants|Number|15|15.0||||||
4371177|NCT00348309|4198562|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1214|1214.0||||||
4371178|NCT00348309|4198563|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|407|407.0||||||
4371179|NCT00348309|4198564|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|408|408.0||||||
4371180|NCT00348309|4198565|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|399|399.0||||||
4371181|NCT00348309|4198562|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|265|265.0||||||
4371182|NCT00348309|4198563|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|82|82.0||||||
4371183|NCT00348309|4198564|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|86|86.0||||||
4371184|NCT00348309|4198565|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|97|97.0||||||
4371185|NCT00348309|4198562|B4||Male|Sex: Female, Male||Participants|Count of Participants|584|584.0||||||
4371186|NCT00348309|4198563|B3||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4371187|NCT00348309|4198564|B2||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4371188|NCT00348309|4198565|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4371189|NCT00348309|4198562|B4||Female|Sex: Female, Male||Participants|Count of Participants|895|895.0||||||
4371190|NCT00348309|4198563|B3||Female|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4371191|NCT00348309|4198564|B2||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4371192|NCT00348309|4198565|B1||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4371193|NCT00348309|4198562|B4|||Age||Years|Mean|74.4|74.4|Standard Deviation|7.94|7.94|||
4371194|NCT00348309|4198563|B3|||Age||Years|Mean|74.4|74.4|Standard Deviation|7.83|7.83|||
4371195|NCT00348309|4198564|B2|||Age||Years|Mean|74.5|74.5|Standard Deviation|8.06|8.06|||
4371196|NCT00348309|4198565|B1|||Age||Years|Mean|74.2|74.2|Standard Deviation|7.95|7.95|||
4371197|NCT00348283|4198638|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4371198|NCT00348283|4198639|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4371199|NCT00348283|4198640|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4371200|NCT00348283|4198638|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4371201|NCT00348283|4198639|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4371202|NCT00348283|4198640|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4371203|NCT00348283|4198638|B3|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4371204|NCT00348283|4198639|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4371205|NCT00348283|4198640|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4371206|NCT00348283|4198638|B3|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4371207|NCT00348283|4198639|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4371208|NCT00348283|4198640|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4371209|NCT00348283|4198638|B3|Belgium||Region of Enrollment||participants|Number|39|39.0||||||
4371210|NCT00348283|4198639|B2|Belgium||Region of Enrollment||participants|Number|25|25.0||||||
4371211|NCT00348283|4198640|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4371212|NCT00348283|4198638|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4371213|NCT00348283|4198639|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4371214|NCT00348283|4198640|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4371215|NCT00348283|4198638|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4371216|NCT00348283|4198639|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4371217|NCT00348283|4198640|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4371218|NCT00348283|4198638|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
4371219|NCT00348283|4198639|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4371220|NCT00348283|4198640|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4371221|NCT00348283|4198638|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4371222|NCT00348283|4198639|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4371223|NCT00348283|4198640|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4371224|NCT00348283|4198638|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4371225|NCT00348283|4198639|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4371226|NCT00348283|4198640|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4371227|NCT00348283|4198638|B3|||Age||years|Mean|37.1|37.1|Standard Deviation|11.84|11.84|||
4371228|NCT00348283|4198639|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|11.10|11.1|||
4371229|NCT00348283|4198640|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|12.60|12.6|||
4371230|NCT00348283|4198638|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4371231|NCT00348283|4198639|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4371232|NCT00348283|4198640|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4371233|NCT00348283|4198638|B3||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4371234|NCT00348283|4198639|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4371235|NCT00348283|4198640|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4371236|NCT00348283|4198638|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4371237|NCT00348283|4198639|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4371238|NCT00348283|4198640|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4371239|NCT00348140|4198657|B4|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4371240|NCT00348140|4198658|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4371241|NCT00348140|4198659|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4371242|NCT00348140|4198660|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4371243|NCT00348140|4198657|B4|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|1410|1410.0||||||
4371244|NCT00348140|4198658|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|470|470.0||||||
4371245|NCT00348140|4198659|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|473|473.0||||||
4371246|NCT00348140|4198660|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|467|467.0||||||
4371247|NCT00348140|4198657|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
4371248|NCT00348140|4198658|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4371249|NCT00348140|4198659|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4371250|NCT00348140|4198660|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4371251|NCT00348140|4198657|B4||Male|Sex: Female, Male||Participants|Count of Participants|652|652.0||||||
4371252|NCT00348140|4198658|B3||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4371253|NCT00348140|4198659|B2||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4371254|NCT00348140|4198660|B1||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4371255|NCT00348140|4198657|B4||Female|Sex: Female, Male||Participants|Count of Participants|816|816.0||||||
4371256|NCT00348140|4198658|B3||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4371257|NCT00348140|4198659|B2||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4371258|NCT00348140|4198660|B1||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4371259|NCT00348140|4198657|B4|||Age||Years|Mean|73.3|73.3|Standard Deviation|8.26|8.26|||
4371260|NCT00348140|4198658|B3|||Age||Years|Mean|73.6|73.6|Standard Deviation|8.40|8.4|||
4371261|NCT00348140|4198659|B2|||Age||Years|Mean|73.4|73.4|Standard Deviation|8.19|8.19|||
4371262|NCT00348140|4198660|B1|||Age||Years|Mean|72.8|72.8|Standard Deviation|8.19|8.19|||
4371263|NCT00347958|4198760|B1|Canada||Region of Enrollment||participants|Number|350|350.0||||||
4371264|NCT00347958|4198760|B1|United States||Region of Enrollment||participants|Number|194|194.0||||||
4371265|NCT00347958|4198760|B1||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4371266|NCT00347958|4198760|B1||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4371267|NCT00347958|4198760|B1|||Age||Years|Mean|31.7|31.7|Standard Deviation|15.7|15.7|||
4371268|NCT00347958|4198760|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4371269|NCT00347958|4198760|B1||Between 18 and 65 years|Age||Participants|Count of Participants|368|368.0||||||
4371270|NCT00347958|4198760|B1||<=18 years|Age||Participants|Count of Participants|169|169.0||||||
4371271|NCT00347932|4198767|B3|United States||Region of Enrollment||participants|Number|957|957.0||||||
4371272|NCT00347932|4198768|B2|United States||Region of Enrollment||participants|Number|482|482.0||||||
4371273|NCT00347932|4198769|B1|United States||Region of Enrollment||participants|Number|475|475.0||||||
4371274|NCT00347932|4198767|B3|Other||Race/Ethnicity, Customized||Participants|Number|226|226.0||||||
4371275|NCT00347932|4198768|B2|Other||Race/Ethnicity, Customized||Participants|Number|117|117.0||||||
4371276|NCT00347932|4198769|B1|Other||Race/Ethnicity, Customized||Participants|Number|109|109.0||||||
4371277|NCT00347932|4198767|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|90|90.0||||||
4371278|NCT00347932|4198768|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4371279|NCT00347932|4198769|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4371280|NCT00347932|4198767|B3|Asian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4371281|NCT00347932|4198768|B2|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4371282|NCT00347932|4198769|B1|Asian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4371283|NCT00347932|4198767|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|624|624.0||||||
4371284|NCT00347932|4198768|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|312|312.0||||||
4371285|NCT00347932|4198769|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|312|312.0||||||
4371286|NCT00347932|4198767|B3||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4371287|NCT00347932|4198768|B2||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4371288|NCT00347932|4198769|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4371289|NCT00347932|4198767|B3||Female|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
4371290|NCT00347932|4198768|B2||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4371291|NCT00347932|4198769|B1||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4371292|NCT00347932|4198767|B3|>=60 years||Age, Customized||participants|Number|86|86.0||||||
4371293|NCT00347932|4198768|B2|>=60 years||Age, Customized||participants|Number|40|40.0||||||
4371294|NCT00347932|4198769|B1|>=60 years||Age, Customized||participants|Number|46|46.0||||||
4371295|NCT00347932|4198767|B3|20 to 59 years||Age, Customized||participants|Number|438|438.0||||||
4371296|NCT00347932|4198768|B2|20 to 59 years||Age, Customized||participants|Number|226|226.0||||||
4371297|NCT00347932|4198769|B1|20 to 59 years||Age, Customized||participants|Number|212|212.0||||||
4371298|NCT00347932|4198767|B3|2 to 19 years||Age, Customized||participants|Number|392|392.0||||||
4371299|NCT00347932|4198768|B2|2 to 19 years||Age, Customized||participants|Number|196|196.0||||||
4371300|NCT00347932|4198769|B1|2 to 19 years||Age, Customized||participants|Number|196|196.0||||||
4371301|NCT00347932|4198767|B3|<2 years||Age, Customized||participants|Number|41|41.0||||||
4371302|NCT00347932|4198768|B2|<2 years||Age, Customized||participants|Number|20|20.0||||||
4371303|NCT00347932|4198769|B1|<2 years||Age, Customized||participants|Number|21|21.0||||||
4371304|NCT00347919|4198782|B4|Potentially able to bear children||Child-Bearing Potential||participants|Number|50|50.0||||||
4371305|NCT00347919|4198783|B3|Potentially able to bear children||Child-Bearing Potential||participants|Number|9|9.0||||||
4371306|NCT00347919|4198784|B2|Potentially able to bear children||Child-Bearing Potential||participants|Number|21|21.0||||||
4371307|NCT00347919|4198785|B1|Potentially able to bear children||Child-Bearing Potential||participants|Number|20|20.0||||||
4371308|NCT00347919|4198782|B4|Sterile (of child-bearing age)||Child-Bearing Potential||participants|Number|10|10.0||||||
4371309|NCT00347919|4198783|B3|Sterile (of child-bearing age)||Child-Bearing Potential||participants|Number|5|5.0||||||
4371310|NCT00347919|4198784|B2|Sterile (of child-bearing age)||Child-Bearing Potential||participants|Number|2|2.0||||||
4371311|NCT00347919|4198785|B1|Sterile (of child-bearing age)||Child-Bearing Potential||participants|Number|3|3.0||||||
4371312|NCT00347919|4198782|B4|Post-Menopausal||Child-Bearing Potential||participants|Number|117|117.0||||||
4371313|NCT00347919|4198783|B3|Post-Menopausal||Child-Bearing Potential||participants|Number|22|22.0||||||
4371314|NCT00347919|4198784|B2|Post-Menopausal||Child-Bearing Potential||participants|Number|46|46.0||||||
4371315|NCT00347919|4198785|B1|Post-Menopausal||Child-Bearing Potential||participants|Number|49|49.0||||||
4371316|NCT00347919|4198782|B4|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4371317|NCT00347919|4198783|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371318|NCT00347919|4198784|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371319|NCT00347919|4198785|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371320|NCT00347919|4198782|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371321|NCT00347919|4198783|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371322|NCT00347919|4198784|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371323|NCT00347919|4198785|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371324|NCT00347919|4198782|B4|White||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4371325|NCT00347919|4198783|B3|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4371326|NCT00347919|4198784|B2|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4371327|NCT00347919|4198785|B1|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4371328|NCT00347919|4198782|B4|Asian||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4371329|NCT00347919|4198783|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4371330|NCT00347919|4198784|B2|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4371331|NCT00347919|4198785|B1|Asian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4371332|NCT00347919|4198782|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4371333|NCT00347919|4198783|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371334|NCT00347919|4198784|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4371335|NCT00347919|4198785|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4371336|NCT00347919|4198782|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371337|NCT00347919|4198783|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371338|NCT00347919|4198784|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371339|NCT00347919|4198785|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371340|NCT00347919|4198782|B4||Male|Sex: Female, Male|Males were excluded. All participants were female.|Participants|Count of Participants|0|0.0||||||
4371341|NCT00347919|4198783|B3||Male|Sex: Female, Male|Males were excluded. All participants were female.|Participants|Count of Participants|0|0.0||||||
4371342|NCT00347919|4198784|B2||Male|Sex: Female, Male|Males were excluded. All participants were female.|Participants|Count of Participants|0|0.0||||||
4371343|NCT00347919|4198785|B1||Male|Sex: Female, Male|Males were excluded. All participants were female.|Participants|Count of Participants|0|0.0||||||
4371344|NCT00347919|4198782|B4||Female|Sex: Female, Male|Males were excluded. All participants were female.|Participants|Count of Participants|177|177.0||||||
4371345|NCT00347919|4198783|B3||Female|Sex: Female, Male|Males were excluded. All participants were female.|Participants|Count of Participants|36|36.0||||||
4371346|NCT00347919|4198784|B2||Female|Sex: Female, Male|Males were excluded. All participants were female.|Participants|Count of Participants|69|69.0||||||
4371347|NCT00347919|4198785|B1||Female|Sex: Female, Male|Males were excluded. All participants were female.|Participants|Count of Participants|72|72.0||||||
4371348|NCT00347919|4198782|B4|||Age|The data in the Participant Flow module are for the Safety Population, comprised of any participant who had received study drug. All of the Baseline data are from a more limited population: the Modified Intent-to-Treat Population (MITT), comprised of those participants who received study drug and who also were confirmed to be Human Epidermal growth factor Receptor 2 (ErbB2) positive by fluorescent in situ hybridization (FISH) analysis.|years|Mean|52.8|52.8|Standard Deviation|11.97|11.97|||
4371349|NCT00347919|4198783|B3|||Age|The data in the Participant Flow module are for the Safety Population, comprised of any participant who had received study drug. All of the Baseline data are from a more limited population: the Modified Intent-to-Treat Population (MITT), comprised of those participants who received study drug and who also were confirmed to be Human Epidermal growth factor Receptor 2 (ErbB2) positive by fluorescent in situ hybridization (FISH) analysis.|years|Mean|54.1|54.1|Standard Deviation|12.93|12.93|||
4371350|NCT00347919|4198784|B2|||Age|The data in the Participant Flow module are for the Safety Population, comprised of any participant who had received study drug. All of the Baseline data are from a more limited population: the Modified Intent-to-Treat Population (MITT), comprised of those participants who received study drug and who also were confirmed to be Human Epidermal growth factor Receptor 2 (ErbB2) positive by fluorescent in situ hybridization (FISH) analysis.|years|Mean|52.1|52.1|Standard Deviation|12.76|12.76|||
4371351|NCT00347919|4198785|B1|||Age|The data in the Participant Flow module are for the Safety Population, comprised of any participant who had received study drug. All of the Baseline data are from a more limited population: the Modified Intent-to-Treat Population (MITT), comprised of those participants who received study drug and who also were confirmed to be Human Epidermal growth factor Receptor 2 (ErbB2) positive by fluorescent in situ hybridization (FISH) analysis.|years|Mean|53.5|53.5|Standard Deviation|11.20|11.2|||
4371352|NCT00347776|4198807|B4|Ethiopia||Region of Enrollment||Participants|Count of Participants|1452|1452.0||||||
4371353|NCT00347776|4198808|B3|Ethiopia||Region of Enrollment||Participants|Count of Participants|485|485.0||||||
4371354|NCT00347776|4198809|B2|Ethiopia||Region of Enrollment||Participants|Count of Participants|483|483.0||||||
4371355|NCT00347776|4198810|B1|Ethiopia||Region of Enrollment||Participants|Count of Participants|484|484.0||||||
4371356|NCT00347776|4198807|B4||Male|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
4371357|NCT00347776|4198808|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4371358|NCT00347776|4198809|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4371359|NCT00347776|4198810|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4371360|NCT00347776|4198807|B4||Female|Sex: Female, Male||Participants|Count of Participants|1121|1121.0||||||
4371361|NCT00347776|4198808|B3||Female|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4371362|NCT00347776|4198809|B2||Female|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4371363|NCT00347776|4198810|B1||Female|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
4371364|NCT00347776|4198807|B4|||Age||years|Mean|48.9|48.9|Standard Deviation|13.0|13.0|||
4371365|NCT00347776|4198808|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|12.6|12.6|||
4371366|NCT00347776|4198809|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|13.0|13.0|||
4371367|NCT00347776|4198810|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|12.8|12.8|||
4371368|NCT00347438|4198824|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371369|NCT00347438|4198824|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4371370|NCT00347438|4198824|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|11|11.0|||
4371371|NCT00347360|4198831|B16|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4371372|NCT00347360|4198832|B15|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371373|NCT00347360|4198833|B14|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371374|NCT00347360|4198834|B13|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371375|NCT00347360|4198835|B12|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371376|NCT00347360|4198836|B11|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371377|NCT00347360|4198837|B10|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371378|NCT00347360|4198838|B9|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371379|NCT00347360|4198839|B8|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371380|NCT00347360|4198840|B7|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371381|NCT00347360|4198841|B6|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371382|NCT00347360|4198842|B5|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371383|NCT00347360|4198843|B4|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371384|NCT00347360|4198844|B3|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371385|NCT00347360|4198845|B2|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371386|NCT00347360|4198846|B1|Race not provided by patient||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371387|NCT00347360|4198831|B16|White||Race/Ethnicity, Customized||participants|Number|417|417.0||||||
4371388|NCT00347360|4198832|B15|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4371389|NCT00347360|4198833|B14|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4371390|NCT00347360|4198834|B13|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4371391|NCT00347360|4198835|B12|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4371392|NCT00347360|4198836|B11|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4371393|NCT00347360|4198837|B10|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4371394|NCT00347360|4198838|B9|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4371395|NCT00347360|4198839|B8|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4371396|NCT00347360|4198840|B7|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4371397|NCT00347360|4198841|B6|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4371398|NCT00347360|4198842|B5|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4371399|NCT00347360|4198843|B4|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4371400|NCT00347360|4198844|B3|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4371401|NCT00347360|4198845|B2|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4371402|NCT00347360|4198846|B1|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4371403|NCT00347360|4198831|B16|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371404|NCT00347360|4198832|B15|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371405|NCT00347360|4198833|B14|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371406|NCT00347360|4198834|B13|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371407|NCT00347360|4198835|B12|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371408|NCT00347360|4198836|B11|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371409|NCT00347360|4198837|B10|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371410|NCT00347360|4198838|B9|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371411|NCT00347360|4198839|B8|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371412|NCT00347360|4198840|B7|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371413|NCT00347360|4198841|B6|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371414|NCT00347360|4198842|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371415|NCT00347360|4198843|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371416|NCT00347360|4198844|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371417|NCT00347360|4198845|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371418|NCT00347360|4198846|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371419|NCT00347360|4198831|B16|Asian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4371420|NCT00347360|4198832|B15|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4371421|NCT00347360|4198833|B14|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4371422|NCT00347360|4198834|B13|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4371423|NCT00347360|4198835|B12|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371424|NCT00347360|4198836|B11|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4371425|NCT00347360|4198837|B10|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4371426|NCT00347360|4198838|B9|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4371427|NCT00347360|4198839|B8|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371428|NCT00347360|4198840|B7|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4371429|NCT00347360|4198841|B6|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4371430|NCT00347360|4198842|B5|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4371431|NCT00347360|4198843|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371432|NCT00347360|4198844|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4371433|NCT00347360|4198845|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371434|NCT00347360|4198846|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4371435|NCT00347360|4198831|B16|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4371436|NCT00347360|4198832|B15|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371437|NCT00347360|4198833|B14|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371438|NCT00347360|4198834|B13|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371439|NCT00347360|4198835|B12|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4371440|NCT00347360|4198836|B11|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371441|NCT00347360|4198837|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371442|NCT00347360|4198838|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371443|NCT00347360|4198839|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371444|NCT00347360|4198840|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371445|NCT00347360|4198841|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371446|NCT00347360|4198842|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371447|NCT00347360|4198843|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371448|NCT00347360|4198844|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371449|NCT00347360|4198845|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371450|NCT00347360|4198846|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371451|NCT00347360|4198831|B16|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|194|194.0||||||
4371452|NCT00347360|4198832|B15|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4371453|NCT00347360|4198833|B14|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4371454|NCT00347360|4198834|B13|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4371455|NCT00347360|4198835|B12|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4371456|NCT00347360|4198836|B11|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4371457|NCT00347360|4198837|B10|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4371458|NCT00347360|4198838|B9|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4371459|NCT00347360|4198839|B8|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4371460|NCT00347360|4198840|B7|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4371461|NCT00347360|4198841|B6|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4371462|NCT00347360|4198842|B5|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4371463|NCT00347360|4198843|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4371464|NCT00347360|4198844|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4371465|NCT00347360|4198845|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4371466|NCT00347360|4198846|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4371467|NCT00347360|4198831|B16||Male|Gender||Participants|Count of Participants|422|422.0||||||
4371468|NCT00347360|4198832|B15||Male|Gender||Participants|Count of Participants|29|29.0||||||
4371469|NCT00347360|4198833|B14||Male|Gender||Participants|Count of Participants|30|30.0||||||
4371470|NCT00347360|4198834|B13||Male|Gender||Participants|Count of Participants|29|29.0||||||
4371471|NCT00347360|4198835|B12||Male|Gender||Participants|Count of Participants|25|25.0||||||
4371472|NCT00347360|4198836|B11||Male|Gender||Participants|Count of Participants|31|31.0||||||
4371473|NCT00347360|4198837|B10||Male|Gender||Participants|Count of Participants|31|31.0||||||
4371474|NCT00347360|4198838|B9||Male|Gender||Participants|Count of Participants|30|30.0||||||
4371475|NCT00347360|4198839|B8||Male|Gender||Participants|Count of Participants|25|25.0||||||
4371476|NCT00347360|4198840|B7||Male|Gender||Participants|Count of Participants|31|31.0||||||
4371477|NCT00347360|4198841|B6||Male|Gender||Participants|Count of Participants|25|25.0||||||
4371478|NCT00347360|4198842|B5||Male|Gender||Participants|Count of Participants|32|32.0||||||
4371479|NCT00347360|4198843|B4||Male|Gender||Participants|Count of Participants|23|23.0||||||
4371480|NCT00347360|4198844|B3||Male|Gender||Participants|Count of Participants|28|28.0||||||
4371481|NCT00347360|4198845|B2||Male|Gender||Participants|Count of Participants|26|26.0||||||
4371482|NCT00347360|4198846|B1||Male|Gender||Participants|Count of Participants|27|27.0||||||
4371483|NCT00347360|4198831|B16||Female|Gender||Participants|Count of Participants|232|232.0||||||
4371484|NCT00347360|4198832|B15||Female|Gender||Participants|Count of Participants|14|14.0||||||
4371485|NCT00347360|4198833|B14||Female|Gender||Participants|Count of Participants|14|14.0||||||
4371486|NCT00347360|4198834|B13||Female|Gender||Participants|Count of Participants|15|15.0||||||
4371487|NCT00347360|4198835|B12||Female|Gender||Participants|Count of Participants|18|18.0||||||
4371488|NCT00347360|4198836|B11||Female|Gender||Participants|Count of Participants|13|13.0||||||
4371489|NCT00347360|4198837|B10||Female|Gender||Participants|Count of Participants|13|13.0||||||
4371490|NCT00347360|4198838|B9||Female|Gender||Participants|Count of Participants|14|14.0||||||
4371491|NCT00347360|4198839|B8||Female|Gender||Participants|Count of Participants|18|18.0||||||
4371492|NCT00347360|4198840|B7||Female|Gender||Participants|Count of Participants|13|13.0||||||
4371493|NCT00347360|4198841|B6||Female|Gender||Participants|Count of Participants|19|19.0||||||
4371494|NCT00347360|4198842|B5||Female|Gender||Participants|Count of Participants|12|12.0||||||
4371495|NCT00347360|4198843|B4||Female|Gender||Participants|Count of Participants|20|20.0||||||
4371496|NCT00347360|4198844|B3||Female|Gender||Participants|Count of Participants|15|15.0||||||
4371497|NCT00347360|4198845|B2||Female|Gender||Participants|Count of Participants|17|17.0||||||
4371498|NCT00347360|4198846|B1||Female|Gender||Participants|Count of Participants|17|17.0||||||
4371499|NCT00347360|4198831|B16|||Age||years|Mean|53.1|53.1|Standard Deviation|9.86|9.86|||
4371500|NCT00347360|4198832|B15|||Age||years|Mean|51.5|51.5|Standard Deviation|8.69|8.69|||
4371501|NCT00347360|4198833|B14|||Age||years|Mean|50.9|50.9|Standard Deviation|9.51|9.51|||
4371502|NCT00347360|4198834|B13|||Age||years|Mean|52.5|52.5|Standard Deviation|11.11|11.11|||
4371503|NCT00347360|4198835|B12|||Age||years|Mean|57.9|57.9|Standard Deviation|9.27|9.27|||
4371504|NCT00347360|4198836|B11|||Age||years|Mean|51.5|51.5|Standard Deviation|9.32|9.32|||
4371505|NCT00347360|4198837|B10|||Age||years|Mean|51.9|51.9|Standard Deviation|9.08|9.08|||
4371506|NCT00347360|4198838|B9|||Age||years|Mean|53.5|53.5|Standard Deviation|10.51|10.51|||
4371507|NCT00347360|4198839|B8|||Age||years|Mean|55.5|55.5|Standard Deviation|8.39|8.39|||
4371508|NCT00347360|4198840|B7|||Age||years|Mean|53.3|53.3|Standard Deviation|9.60|9.6|||
4371509|NCT00347360|4198841|B6|||Age||years|Mean|54.3|54.3|Standard Deviation|8.64|8.64|||
4371510|NCT00347360|4198842|B5|||Age||years|Mean|54.1|54.1|Standard Deviation|10.94|10.94|||
4371511|NCT00347360|4198843|B4|||Age||years|Mean|53.2|53.2|Standard Deviation|9.41|9.41|||
4371512|NCT00347360|4198844|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|10.70|10.7|||
4371513|NCT00347360|4198845|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|10.69|10.69|||
4371514|NCT00347360|4198846|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|10.53|10.53|||
4371515|NCT00347308|4199042|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4371516|NCT00347308|4199042|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4371517|NCT00347308|4199042|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4371518|NCT00347308|4199042|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|12.5|12.5|||
4371519|NCT00347308|4199042|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371520|NCT00347308|4199042|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4371521|NCT00347308|4199042|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4371522|NCT00347269|4199046|B3|United States||Region of Enrollment||participants|Number|1004|1004.0||||||
4371523|NCT00347269|4199047|B2|United States||Region of Enrollment||participants|Number|501|501.0||||||
4371524|NCT00347269|4199048|B1|United States||Region of Enrollment||participants|Number|503|503.0||||||
4371525|NCT00347269|4199046|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4371526|NCT00347269|4199047|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4371527|NCT00347269|4199048|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4371528|NCT00347269|4199046|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
4371529|NCT00347269|4199047|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4371530|NCT00347269|4199048|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4371531|NCT00347269|4199046|B3||White|Race (NIH/OMB)||Participants|Count of Participants|664|664.0||||||
4371532|NCT00347269|4199047|B2||White|Race (NIH/OMB)||Participants|Count of Participants|331|331.0||||||
4371533|NCT00347269|4199048|B1||White|Race (NIH/OMB)||Participants|Count of Participants|333|333.0||||||
4371534|NCT00347269|4199046|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4371535|NCT00347269|4199047|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4371536|NCT00347269|4199048|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4371537|NCT00347269|4199046|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4371538|NCT00347269|4199047|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4371539|NCT00347269|4199048|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4371540|NCT00347269|4199046|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4371541|NCT00347269|4199047|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4371542|NCT00347269|4199048|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4371543|NCT00347269|4199046|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4371544|NCT00347269|4199047|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4371545|NCT00347269|4199048|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4371546|NCT00347269|4199046|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371547|NCT00347269|4199047|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371548|NCT00347269|4199048|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371549|NCT00347269|4199046|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|808|808.0||||||
4371550|NCT00347269|4199047|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|409|409.0||||||
4371551|NCT00347269|4199048|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|399|399.0||||||
4371552|NCT00347269|4199046|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
4371553|NCT00347269|4199047|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4371554|NCT00347269|4199048|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4371555|NCT00347269|4199046|B3||Male|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4371556|NCT00347269|4199047|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4371557|NCT00347269|4199048|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4371558|NCT00347269|4199046|B3||Female|Sex: Female, Male||Participants|Count of Participants|714|714.0||||||
4371559|NCT00347269|4199047|B2||Female|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4371560|NCT00347269|4199048|B1||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4371561|NCT00347269|4199046|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|13.4|13.4|||
4371562|NCT00347269|4199047|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|13.7|13.7|||
4371563|NCT00347269|4199048|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|13.2|13.2|||
4371564|NCT00347022|4199055|B3|Austria||Region of Enrollment||participants|Number|30|30.0||||||
4371565|NCT00347022|4199056|B2|Austria||Region of Enrollment||participants|Number|15|15.0||||||
4371566|NCT00347022|4199057|B1|Austria||Region of Enrollment||participants|Number|15|15.0||||||
4371567|NCT00347022|4199055|B3|France||Region of Enrollment||participants|Number|115|115.0||||||
4371568|NCT00347022|4199056|B2|France||Region of Enrollment||participants|Number|56|56.0||||||
4371569|NCT00347022|4199057|B1|France||Region of Enrollment||participants|Number|59|59.0||||||
4371570|NCT00347022|4199055|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4371571|NCT00347022|4199056|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4371572|NCT00347022|4199057|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4371573|NCT00347022|4199055|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4371574|NCT00347022|4199056|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4371575|NCT00347022|4199057|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4371576|NCT00347022|4199055|B3|||Age||years|Mean|8.4|8.4|Standard Deviation|4.7|4.7|||
4371577|NCT00347022|4199056|B2|||Age||years|Mean|8.1|8.1|Standard Deviation|4.7|4.7|||
4371578|NCT00347022|4199057|B1|||Age||years|Mean|8.7|8.7|Standard Deviation|4.8|4.8|||
4371579|NCT00347022|4199055|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371580|NCT00347022|4199056|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371581|NCT00347022|4199057|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371582|NCT00347022|4199055|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4371583|NCT00347022|4199056|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4371584|NCT00347022|4199057|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4371585|NCT00347022|4199055|B3||<=18 years|Age||Participants|Count of Participants|145|145.0||||||
4371586|NCT00347022|4199056|B2||<=18 years|Age||Participants|Count of Participants|71|71.0||||||
4371587|NCT00347022|4199057|B1||<=18 years|Age||Participants|Count of Participants|74|74.0||||||
4371588|NCT00347009|4199064|B1|||Time since Diagnosis of Chronic Hepatitis B|Diagnosis of chronic hepatitis B is defined by the presence of serum hepatitis B surface antigen (HBsAg) for at least 6 months (once at least 6 months before screening and at time of screening visit).|years|Mean|11.29|11.29|Standard Deviation|8.40|8.4|||
4371589|NCT00347009|4199064|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4371590|NCT00347009|4199064|B1|Asian||Race/Ethnicity, Customized||participants|Number|155|155.0||||||
4371591|NCT00347009|4199064|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4371592|NCT00347009|4199064|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4371593|NCT00347009|4199064|B1|||Age||Years|Mean|47.7|47.7|Standard Deviation|9.5|9.5|||
4371594|NCT00346905|4199081|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4371595|NCT00346905|4199081|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4371596|NCT00346905|4199081|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4371597|NCT00346905|4199081|B1|||Age||years|Mean|61|61.0|Standard Deviation|13|13.0|||
4371598|NCT00346905|4199081|B1||>=65 years|Age|Participants analyzed are over 18 years of age.|Participants|Count of Participants|6|6.0||||||
4371599|NCT00346905|4199081|B1||Between 18 and 65 years|Age|Participants analyzed are over 18 years of age.|Participants|Count of Participants|10|10.0||||||
4371600|NCT00346905|4199081|B1||<=18 years|Age|Participants analyzed are over 18 years of age.|Participants|Count of Participants|0|0.0||||||
4371601|NCT00346775|4199085|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371602|NCT00346775|4199085|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4371603|NCT00346775|4199085|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4371604|NCT00346775|4199085|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4371605|NCT00346775|4199085|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371606|NCT00346775|4199085|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4371607|NCT00346775|4199085|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4371608|NCT00346775|4199085|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4371609|NCT00346775|4199085|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4371610|NCT00346775|4199085|B1|||Age||Years|Mean|37.1|37.1|Standard Deviation|12.56|12.56|||
4371611|NCT00346697|4199096|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4371612|NCT00346697|4199097|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4371613|NCT00346697|4199098|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4371614|NCT00346697|4199096|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4371615|NCT00346697|4199097|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4371616|NCT00346697|4199098|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4371617|NCT00346697|4199096|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4371618|NCT00346697|4199097|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4371619|NCT00346697|4199098|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4371620|NCT00346697|4199096|B3|||Age||years|Median|49.5|49.5|Inter-Quartile Range|||45.5|52.5|
4371621|NCT00346697|4199097|B2|||Age||years|Median|48|48.0|Inter-Quartile Range|||41.0|52.0|
4371622|NCT00346697|4199098|B1|||Age||years|Median|50|50.0|Inter-Quartile Range|||47.0|52.0|
4371623|NCT00346697|4199096|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|6.8|6.8|||
4371624|NCT00346697|4199097|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|8.0|8.0|||
4371625|NCT00346697|4199098|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|5.2|5.2|||
4371626|NCT00346697|4199096|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371627|NCT00346697|4199097|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371628|NCT00346697|4199098|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371629|NCT00346697|4199096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4371630|NCT00346697|4199097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4371631|NCT00346697|4199098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4371632|NCT00346697|4199096|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4371633|NCT00346697|4199097|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4371634|NCT00346697|4199098|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4371635|NCT00346632|4199133|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4371636|NCT00346632|4199134|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4371637|NCT00346632|4199135|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4371638|NCT00346632|4199133|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371639|NCT00346632|4199134|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371640|NCT00346632|4199135|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371641|NCT00346632|4199133|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371642|NCT00346632|4199134|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371643|NCT00346632|4199135|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371644|NCT00346632|4199133|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4371645|NCT00346632|4199134|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4371646|NCT00346632|4199135|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4371647|NCT00346632|4199133|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4371648|NCT00346632|4199134|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4371649|NCT00346632|4199135|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4371650|NCT00346632|4199133|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371651|NCT00346632|4199134|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371652|NCT00346632|4199135|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371653|NCT00346632|4199133|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4371654|NCT00346632|4199134|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371655|NCT00346632|4199135|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4371656|NCT00346632|4199133|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371657|NCT00346632|4199134|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371658|NCT00346632|4199135|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371659|NCT00346632|4199133|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4371660|NCT00346632|4199134|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4371661|NCT00346632|4199135|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4371662|NCT00346632|4199133|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4371663|NCT00346632|4199134|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4371664|NCT00346632|4199135|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4371665|NCT00346632|4199133|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|12.0|12.0|||
4371666|NCT00346632|4199134|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|17.22|17.22|||
4371667|NCT00346632|4199135|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|15.48|15.48|||
4371668|NCT00346632|4199133|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4371669|NCT00346632|4199134|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4371670|NCT00346632|4199135|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4371671|NCT00346632|4199133|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4371672|NCT00346632|4199134|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4371673|NCT00346632|4199135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4371674|NCT00346632|4199133|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4371675|NCT00346632|4199134|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4371676|NCT00346632|4199135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4371677|NCT00346476|4199287|B1|South Africa||Region of Enrollment||participants|Number|1250|1250.0||||||
4371678|NCT00346476|4199287|B1||Male|Sex: Female, Male||Participants|Count of Participants|648|648.0||||||
4371679|NCT00346476|4199287|B1||Female|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
4371680|NCT00346476|4199287|B1|||Age||years|Mean|28.9|28.9|Standard Deviation|9.5|9.5|||
4371681|NCT00346476|4199287|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4371682|NCT00346476|4199287|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1185|1185.0||||||
4371683|NCT00346476|4199287|B1||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4371684|NCT00346398|4199292|B3|||Severity of Atopic Dermatitis (AD) Using SCORAD Index|Scoring of Atopic Dermatitis (SCORAD) disease-severity scale measures intensity of erythema, edema/papulation, oozing/crusts, excoriations, lichenification and dryness, each on a scale from 0-3 for a maximum total of 18 points. This score is multiplied by 3.5 and added to 1/5 of the affected percent body surface area. The final score is added to the score from a 0-10 point pruritus visual analog scale (VAS) and a 0-10 point loss of sleep VAS. Summary: SCORAD (0-103)=extent (0-100)/5+intensity (0-18)x3.5 + pruritus and sleep (0-20).Interpretation: SCORAD (0 (no disease) to 103 (most severe)).|Units on a Scale|Mean|12.3|12.3|Standard Deviation|8.8|8.8|||
4371685|NCT00346398|4199293|B2|||Severity of Atopic Dermatitis (AD) Using SCORAD Index|Scoring of Atopic Dermatitis (SCORAD) disease-severity scale measures intensity of erythema, edema/papulation, oozing/crusts, excoriations, lichenification and dryness, each on a scale from 0-3 for a maximum total of 18 points. This score is multiplied by 3.5 and added to 1/5 of the affected percent body surface area. The final score is added to the score from a 0-10 point pruritus visual analog scale (VAS) and a 0-10 point loss of sleep VAS. Summary: SCORAD (0-103)=extent (0-100)/5+intensity (0-18)x3.5 + pruritus and sleep (0-20).Interpretation: SCORAD (0 (no disease) to 103 (most severe)).|Units on a Scale|Mean|11.4|11.4|Standard Deviation|9.1|9.1|||
4371686|NCT00346398|4199294|B1|||Severity of Atopic Dermatitis (AD) Using SCORAD Index|Scoring of Atopic Dermatitis (SCORAD) disease-severity scale measures intensity of erythema, edema/papulation, oozing/crusts, excoriations, lichenification and dryness, each on a scale from 0-3 for a maximum total of 18 points. This score is multiplied by 3.5 and added to 1/5 of the affected percent body surface area. The final score is added to the score from a 0-10 point pruritus visual analog scale (VAS) and a 0-10 point loss of sleep VAS. Summary: SCORAD (0-103)=extent (0-100)/5+intensity (0-18)x3.5 + pruritus and sleep (0-20).Interpretation: SCORAD (0 (no disease) to 103 (most severe)).|Units on a Scale|Mean|13.3|13.3|Standard Deviation|8.5|8.5|||
4371687|NCT00346398|4199292|B3|Australia||Region of Enrollment||participants|Number|43|43.0||||||
4371688|NCT00346398|4199293|B2|Australia||Region of Enrollment||participants|Number|22|22.0||||||
4371689|NCT00346398|4199294|B1|Australia||Region of Enrollment||participants|Number|21|21.0||||||
4371690|NCT00346398|4199292|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4371691|NCT00346398|4199293|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4371692|NCT00346398|4199294|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4371693|NCT00346398|4199292|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4371694|NCT00346398|4199293|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4371695|NCT00346398|4199294|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4371696|NCT00346398|4199292|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4371697|NCT00346398|4199293|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4371698|NCT00346398|4199294|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4371699|NCT00346398|4199292|B3|Aged 24-30 Months||Age, Customized||participants|Number|11|11.0||||||
4371700|NCT00346398|4199293|B2|Aged 24-30 Months||Age, Customized||participants|Number|8|8.0||||||
4371701|NCT00346398|4199294|B1|Aged 24-30 Months||Age, Customized||participants|Number|3|3.0||||||
4371702|NCT00346398|4199292|B3|Aged 18-23 Months||Age, Customized||participants|Number|28|28.0||||||
4371703|NCT00346398|4199293|B2|Aged 18-23 Months||Age, Customized||participants|Number|12|12.0||||||
4371704|NCT00346398|4199294|B1|Aged 18-23 Months||Age, Customized||participants|Number|16|16.0||||||
4371705|NCT00346398|4199292|B3|Aged 12-17 Months||Age, Customized||participants|Number|12|12.0||||||
4371706|NCT00346398|4199293|B2|Aged 12-17 Months||Age, Customized||participants|Number|6|6.0||||||
4371707|NCT00346398|4199294|B1|Aged 12-17 Months||Age, Customized||participants|Number|6|6.0||||||
4371708|NCT00346333|4199305|B3|Undetermined||Genetic type||participants|Number|10|10.0||||||
4371709|NCT00346333|4199306|B2|Undetermined||Genetic type||participants|Number|5|5.0||||||
4371710|NCT00346333|4199307|B1|Undetermined||Genetic type||participants|Number|5|5.0||||||
4371711|NCT00346333|4199305|B3|Isolate||Genetic type||participants|Number|118|118.0||||||
4371712|NCT00346333|4199306|B2|Isolate||Genetic type||participants|Number|60|60.0||||||
4371713|NCT00346333|4199307|B1|Isolate||Genetic type||participants|Number|58|58.0||||||
4371714|NCT00346333|4199305|B3|X-Linked||Genetic type||participants|Number|15|15.0||||||
4371715|NCT00346333|4199306|B2|X-Linked||Genetic type||participants|Number|7|7.0||||||
4371716|NCT00346333|4199307|B1|X-Linked||Genetic type||participants|Number|8|8.0||||||
4371717|NCT00346333|4199305|B3|Recessive||Genetic type||participants|Number|39|39.0||||||
4371718|NCT00346333|4199306|B2|Recessive||Genetic type||participants|Number|19|19.0||||||
4371719|NCT00346333|4199307|B1|Recessive||Genetic type||participants|Number|20|20.0||||||
4371720|NCT00346333|4199305|B3|Dominant||Genetic type||participants|Number|58|58.0||||||
4371721|NCT00346333|4199306|B2|Dominant||Genetic type||participants|Number|28|28.0||||||
4371722|NCT00346333|4199307|B1|Dominant||Genetic type||participants|Number|30|30.0||||||
4371723|NCT00346333|4199305|B3|50-60 years of age||Age of participants by 10-year age groups||Participants|Number|43|43.0||||||
4371724|NCT00346333|4199306|B2|50-60 years of age||Age of participants by 10-year age groups||Participants|Number|23|23.0||||||
4371725|NCT00346333|4199307|B1|50-60 years of age||Age of participants by 10-year age groups||Participants|Number|20|20.0||||||
4371726|NCT00346333|4199305|B3|40-49 years of age||Age of participants by 10-year age groups||Participants|Number|77|77.0||||||
4371727|NCT00346333|4199306|B2|40-49 years of age||Age of participants by 10-year age groups||Participants|Number|36|36.0||||||
4371728|NCT00346333|4199307|B1|40-49 years of age||Age of participants by 10-year age groups||Participants|Number|41|41.0||||||
4371729|NCT00346333|4199305|B3|30-39 years of age||Age of participants by 10-year age groups||Participants|Number|61|61.0||||||
4371730|NCT00346333|4199306|B2|30-39 years of age||Age of participants by 10-year age groups||Participants|Number|35|35.0||||||
4371731|NCT00346333|4199307|B1|30-39 years of age||Age of participants by 10-year age groups||Participants|Number|26|26.0||||||
4371732|NCT00346333|4199305|B3|18-29 years of age||Age of participants by 10-year age groups||Participants|Number|59|59.0||||||
4371733|NCT00346333|4199306|B2|18-29 years of age||Age of participants by 10-year age groups||Participants|Number|25|25.0||||||
4371734|NCT00346333|4199307|B1|18-29 years of age||Age of participants by 10-year age groups||Participants|Number|34|34.0||||||
4371735|NCT00346333|4199305|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4371736|NCT00346333|4199306|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4371737|NCT00346333|4199307|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4371738|NCT00346333|4199305|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4371739|NCT00346333|4199306|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4371740|NCT00346333|4199307|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4371741|NCT00346333|4199305|B3|||Age||years|Mean|39|39.0|Standard Deviation|1.0|1.0|||
4371742|NCT00346333|4199306|B2|||Age||years|Mean|40|40.0|Standard Deviation|1.0|1.0|||
4371743|NCT00346333|4199307|B1|||Age||years|Mean|38|38.0|Standard Deviation|1.0|1.0|||
4371744|NCT00346333|4199305|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371745|NCT00346333|4199306|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371746|NCT00346333|4199307|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371747|NCT00346333|4199305|B3||Between 18 and 65 years|Age||Participants|Count of Participants|240|240.0||||||
4371748|NCT00346333|4199306|B2||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4371749|NCT00346333|4199307|B1||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4371750|NCT00346333|4199305|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4371751|NCT00346333|4199306|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4371752|NCT00346333|4199307|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4371753|NCT00346268|4199322|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4371754|NCT00346268|4199323|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4371755|NCT00346268|4199324|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4371756|NCT00346268|4199322|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371757|NCT00346268|4199323|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371758|NCT00346268|4199324|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371759|NCT00346268|4199322|B3|>= 75 years||Age, Customized||participants|Number|4|4.0||||||
4371760|NCT00346268|4199323|B2|>= 75 years||Age, Customized||participants|Number|2|2.0||||||
4371761|NCT00346268|4199324|B1|>= 75 years||Age, Customized||participants|Number|2|2.0||||||
4371762|NCT00346268|4199322|B3|Between 60 and 74 years||Age, Customized||participants|Number|74|74.0||||||
4371763|NCT00346268|4199323|B2|Between 60 and 74 years||Age, Customized||participants|Number|38|38.0||||||
4371764|NCT00346268|4199324|B1|Between 60 and 74 years||Age, Customized||participants|Number|36|36.0||||||
4371765|NCT00346268|4199322|B3|Between 45 and 59 years||Age, Customized||participants|Number|27|27.0||||||
4371766|NCT00346268|4199323|B2|Between 45 and 59 years||Age, Customized||participants|Number|13|13.0||||||
4371767|NCT00346268|4199324|B1|Between 45 and 59 years||Age, Customized||participants|Number|14|14.0||||||
4371768|NCT00346268|4199322|B3|< 45 years||Age, Customized||participants|Number|0|0.0||||||
4371769|NCT00346268|4199323|B2|< 45 years||Age, Customized||participants|Number|0|0.0||||||
4371770|NCT00346268|4199324|B1|< 45 years||Age, Customized||participants|Number|0|0.0||||||
4371771|NCT00346216|4199357|B4||Male|Sex: Female, Male||Participants|Count of Participants|8636|8636.0||||||
4371772|NCT00346216|4199358|B3||Male|Sex: Female, Male||Participants|Count of Participants|2873|2873.0||||||
4371773|NCT00346216|4199359|B2||Male|Sex: Female, Male||Participants|Count of Participants|2866|2866.0||||||
4371774|NCT00346216|4199360|B1||Male|Sex: Female, Male||Participants|Count of Participants|2897|2897.0||||||
4371775|NCT00346216|4199357|B4||Female|Sex: Female, Male||Participants|Count of Participants|15445|15445.0||||||
4371776|NCT00346216|4199358|B3||Female|Sex: Female, Male||Participants|Count of Participants|5096|5096.0||||||
4371777|NCT00346216|4199359|B2||Female|Sex: Female, Male||Participants|Count of Participants|5174|5174.0||||||
4371778|NCT00346216|4199360|B1||Female|Sex: Female, Male||Participants|Count of Participants|5175|5175.0||||||
4371779|NCT00346216|4199357|B4|||Age||Years|Mean|63.2|63.2|Standard Deviation|9.4|9.4|||
4371780|NCT00346216|4199358|B3|||Age||Years|Mean|63.3|63.3|Standard Deviation|9.4|9.4|||
4371781|NCT00346216|4199359|B2|||Age||Years|Mean|63.2|63.2|Standard Deviation|9.4|9.4|||
4371782|NCT00346216|4199360|B1|||Age||Years|Mean|63.0|63.0|Standard Deviation|9.5|9.5|||
4371783|NCT00346164|4199379|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4371784|NCT00346164|4199380|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4371785|NCT00346164|4199381|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4371786|NCT00346164|4199382|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4371787|NCT00346164|4199383|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4371788|NCT00346164|4199379|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371789|NCT00346164|4199380|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371790|NCT00346164|4199381|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371791|NCT00346164|4199382|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371792|NCT00346164|4199383|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371793|NCT00346164|4199379|B5||White|Race (NIH/OMB)||Participants|Count of Participants|412|412.0||||||
4371794|NCT00346164|4199380|B4||White|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4371795|NCT00346164|4199381|B3||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4371796|NCT00346164|4199382|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4371797|NCT00346164|4199383|B1||White|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
4371798|NCT00346164|4199379|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4371799|NCT00346164|4199380|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4371800|NCT00346164|4199381|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4371801|NCT00346164|4199382|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4371802|NCT00346164|4199383|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4371803|NCT00346164|4199379|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4371804|NCT00346164|4199380|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4371805|NCT00346164|4199381|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371806|NCT00346164|4199382|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371807|NCT00346164|4199383|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371808|NCT00346164|4199379|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4371809|NCT00346164|4199380|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4371810|NCT00346164|4199381|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4371811|NCT00346164|4199382|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4371812|NCT00346164|4199383|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4371813|NCT00346164|4199379|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4371814|NCT00346164|4199380|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4371815|NCT00346164|4199381|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4371816|NCT00346164|4199382|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371817|NCT00346164|4199383|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4371818|NCT00346164|4199379|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4371819|NCT00346164|4199380|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4371820|NCT00346164|4199381|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4371821|NCT00346164|4199382|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4371822|NCT00346164|4199383|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4371823|NCT00346164|4199379|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|477|477.0||||||
4371824|NCT00346164|4199380|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4371825|NCT00346164|4199381|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4371826|NCT00346164|4199382|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4371827|NCT00346164|4199383|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|185|185.0||||||
4371828|NCT00346164|4199379|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4371829|NCT00346164|4199380|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4371830|NCT00346164|4199381|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4371831|NCT00346164|4199382|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4371934|NCT00345969|4199482|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371832|NCT00346164|4199383|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4371833|NCT00346164|4199379|B5||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4371834|NCT00346164|4199380|B4||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4371835|NCT00346164|4199381|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4371836|NCT00346164|4199382|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4371837|NCT00346164|4199383|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4371838|NCT00346164|4199379|B5||Female|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4371839|NCT00346164|4199380|B4||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4371840|NCT00346164|4199381|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4371841|NCT00346164|4199382|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4371842|NCT00346164|4199383|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4371843|NCT00346164|4199379|B5|||Age||Months|Mean|154.68|154.68|Standard Deviation|67.10|67.1|||
4371844|NCT00346164|4199380|B4|||Age||Months|Mean|171.31|171.31|Standard Deviation|68.90|68.9|||
4371845|NCT00346164|4199381|B3|||Age||Months|Mean|155.14|155.14|Standard Deviation|69.20|69.2|||
4371846|NCT00346164|4199382|B2|||Age||Months|Mean|142.58|142.58|Standard Deviation|59.46|59.46|||
4371847|NCT00346164|4199383|B1|||Age||Months|Mean|138.87|138.87|Standard Deviation|60.88|60.88|||
4371848|NCT00346151|4199421|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4371849|NCT00346151|4199421|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4371850|NCT00346151|4199421|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4371851|NCT00346151|4199421|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|5.9|5.9|||
4371852|NCT00346151|4199421|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4371853|NCT00346151|4199421|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4371854|NCT00346151|4199421|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4371855|NCT00346073|4199439|B3|Geographic ancestry|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|113|113.0||||||
4371856|NCT00346073|4199440|B2|Geographic ancestry|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4371857|NCT00346073|4199441|B1|Geographic ancestry|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
4371858|NCT00346073|4199439|B3|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1916|1916.0||||||
4371859|NCT00346073|4199440|B2|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|635|635.0||||||
4371860|NCT00346073|4199441|B1|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1281|1281.0||||||
4371861|NCT00346073|4199439|B3|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4371862|NCT00346073|4199440|B2|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4371863|NCT00346073|4199441|B1|Geographic ancestry|White - Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4371864|NCT00346073|4199439|B3|Geographic ancestry|Native Hawaiian or other Pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4371865|NCT00346073|4199440|B2|Geographic ancestry|Native Hawaiian or other Pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4371866|NCT00346073|4199441|B1|Geographic ancestry|Native Hawaiian or other Pacific islander|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4371867|NCT00346073|4199439|B3|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4371868|NCT00346073|4199440|B2|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4371869|NCT00346073|4199441|B1|Geographic ancestry|Asian - South East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4371870|NCT00346073|4199439|B3|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4371871|NCT00346073|4199440|B2|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4371872|NCT00346073|4199441|B1|Geographic ancestry|Asian - Japanese heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4371873|NCT00346073|4199439|B3|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4371874|NCT00346073|4199440|B2|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4371875|NCT00346073|4199441|B1|Geographic ancestry|Asian - East Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4371876|NCT00346073|4199439|B3|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4371877|NCT00346073|4199440|B2|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4371878|NCT00346073|4199441|B1|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4371879|NCT00346073|4199439|B3|Geographic ancestry|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4371880|NCT00346073|4199440|B2|Geographic ancestry|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4371881|NCT00346073|4199441|B1|Geographic ancestry|American Indian or Alaskan native|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4371882|NCT00346073|4199439|B3|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|187|187.0||||||
4371883|NCT00346073|4199440|B2|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|61|61.0||||||
4371884|NCT00346073|4199441|B1|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|126|126.0||||||
4371885|NCT00346073|4199439|B3||Male|Sex: Female, Male||Participants|Count of Participants|859|859.0||||||
4371886|NCT00346073|4199440|B2||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4371887|NCT00346073|4199441|B1||Male|Sex: Female, Male||Participants|Count of Participants|576|576.0||||||
4371888|NCT00346073|4199439|B3||Female|Sex: Female, Male||Participants|Count of Participants|1425|1425.0||||||
4371889|NCT00346073|4199440|B2||Female|Sex: Female, Male||Participants|Count of Participants|479|479.0||||||
4371890|NCT00346073|4199441|B1||Female|Sex: Female, Male||Participants|Count of Participants|946|946.0||||||
4371891|NCT00346073|4199439|B3|||Age||Years|Mean|39.97|39.97|Standard Deviation|13.59|13.59|||
4371892|NCT00346073|4199440|B2|||Age||Years|Mean|40.1|40.1|Standard Deviation|13.51|13.51|||
4371893|NCT00346073|4199441|B1|||Age||Years|Mean|39.9|39.9|Standard Deviation|13.64|13.64|||
4371894|NCT00346034|4199476|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4371895|NCT00346034|4199476|B1||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4371896|NCT00346034|4199476|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|11.1|11.1|||
4371897|NCT00345969|4199481|B3|||Body Weight (lbs.)||lbs.|Mean|194|194.0|Standard Deviation|34|34.0|||
4371898|NCT00345969|4199482|B2|||Body Weight (lbs.)||lbs.|Mean|195|195.0|Standard Deviation|38|38.0|||
4371899|NCT00345969|4199483|B1|||Body Weight (lbs.)||lbs.|Mean|193|193.0|Standard Deviation|30|30.0|||
4371900|NCT00345969|4199481|B3|||BMI (kg/m2)||kg/m2|Mean|29|29.0|Standard Deviation|4|4.0|||
4371901|NCT00345969|4199482|B2|||BMI (kg/m2)||kg/m2|Mean|29|29.0|Standard Deviation|5|5.0|||
4371902|NCT00345969|4199483|B1|||BMI (kg/m2)||kg/m2|Mean|28|28.0|Standard Deviation|3|3.0|||
4371903|NCT00345969|4199481|B3|||Total Testosterone level (ng/dL)||ng/dL|Mean|250|250.0|Standard Deviation|84|84.0|||
4371904|NCT00345969|4199482|B2|||Total Testosterone level (ng/dL)||ng/dL|Mean|248|248.0|Standard Deviation|97|97.0|||
4371905|NCT00345969|4199483|B1|||Total Testosterone level (ng/dL)||ng/dL|Mean|252|252.0|Standard Deviation|71|71.0|||
4371906|NCT00345969|4199481|B3|||Total Modified Physical Performance (mPPT) score|Range 0-36, (min-max); higher scores indicate better physical performance. The Total mPPT score is constructed by summing sub-scores of 9 performance tasks. Sub-scores have a range of 0-4 (min-max); higher sub-scores indicate better performance.|units on a scale|Mean|25|25.0|Standard Deviation|4|4.0|||
4371907|NCT00345969|4199482|B2|||Total Modified Physical Performance (mPPT) score|Range 0-36, (min-max); higher scores indicate better physical performance. The Total mPPT score is constructed by summing sub-scores of 9 performance tasks. Sub-scores have a range of 0-4 (min-max); higher sub-scores indicate better performance.|units on a scale|Mean|26|26.0|Standard Deviation|3|3.0|||
4371908|NCT00345969|4199483|B1|||Total Modified Physical Performance (mPPT) score|Range 0-36, (min-max); higher scores indicate better physical performance. The Total mPPT score is constructed by summing sub-scores of 9 performance tasks. Sub-scores have a range of 0-4 (min-max); higher sub-scores indicate better performance.|units on a scale|Mean|23|23.0|Standard Deviation|4|4.0|||
4371909|NCT00345969|4199481|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371910|NCT00345969|4199482|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371911|NCT00345969|4199483|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371912|NCT00345969|4199481|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371913|NCT00345969|4199482|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371914|NCT00345969|4199483|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371915|NCT00345969|4199481|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4371916|NCT00345969|4199482|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4371917|NCT00345969|4199483|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4371918|NCT00345969|4199481|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4371919|NCT00345969|4199482|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4371920|NCT00345969|4199483|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371921|NCT00345969|4199481|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371922|NCT00345969|4199482|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371923|NCT00345969|4199483|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371924|NCT00345969|4199481|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371925|NCT00345969|4199482|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371926|NCT00345969|4199483|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371927|NCT00345969|4199481|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371928|NCT00345969|4199482|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371929|NCT00345969|4199483|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4371930|NCT00345969|4199481|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4371931|NCT00345969|4199482|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4371932|NCT00345969|4199483|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4371933|NCT00345969|4199481|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371935|NCT00345969|4199483|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371936|NCT00345969|4199481|B3|||Age||years|Mean|80|80.0|Standard Deviation|7|7.0|||
4371937|NCT00345969|4199482|B2|||Age||years|Mean|77|77.0|Standard Deviation|6|6.0|||
4371938|NCT00345969|4199483|B1|||Age||years|Mean|81|81.0|Standard Deviation|4|4.0|||
4371939|NCT00345878|4199514|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371940|NCT00345878|4199515|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371941|NCT00345878|4199516|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4371942|NCT00345878|4199514|B3||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4371943|NCT00345878|4199515|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4371944|NCT00345878|4199516|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4371945|NCT00345878|4199514|B3|||Age||Years|Mean|24.9|24.9|Standard Deviation|4.02|4.02|||
4371946|NCT00345878|4199515|B2|||Age||Years|Mean|25.0|25.0|Standard Deviation|4.14|4.14|||
4371947|NCT00345878|4199516|B1|||Age||Years|Mean|24.8|24.8|Standard Deviation|3.91|3.91|||
4371948|NCT00345839|4199533|B3|United States||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|1430|1430.0||||||
4371949|NCT00345839|4199534|B2|United States||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|715|715.0||||||
4371950|NCT00345839|4199535|B1|United States||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|715|715.0||||||
4371951|NCT00345839|4199533|B3|United Kingdom||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|160|160.0||||||
4371952|NCT00345839|4199534|B2|United Kingdom||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|79|79.0||||||
4371953|NCT00345839|4199535|B1|United Kingdom||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|81|81.0||||||
4371954|NCT00345839|4199533|B3|Switzerland||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|37|37.0||||||
4371955|NCT00345839|4199534|B2|Switzerland||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|19|19.0||||||
4371956|NCT00345839|4199535|B1|Switzerland||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|18|18.0||||||
4371957|NCT00345839|4199533|B3|Sweden||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|23|23.0||||||
4371958|NCT00345839|4199534|B2|Sweden||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|10|10.0||||||
4371959|NCT00345839|4199535|B1|Sweden||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|13|13.0||||||
4371960|NCT00345839|4199533|B3|Spain||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|78|78.0||||||
4371961|NCT00345839|4199534|B2|Spain||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|38|38.0||||||
4371962|NCT00345839|4199535|B1|Spain||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|40|40.0||||||
4371963|NCT00345839|4199533|B3|Russia||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|283|283.0||||||
4371964|NCT00345839|4199534|B2|Russia||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|140|140.0||||||
4371965|NCT00345839|4199535|B1|Russia||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|143|143.0||||||
4371966|NCT00345839|4199533|B3|Portugal||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|43|43.0||||||
4371967|NCT00345839|4199534|B2|Portugal||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|21|21.0||||||
4371968|NCT00345839|4199535|B1|Portugal||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|22|22.0||||||
4371969|NCT00345839|4199533|B3|Poland||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|116|116.0||||||
4371970|NCT00345839|4199534|B2|Poland||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|57|57.0||||||
4371971|NCT00345839|4199535|B1|Poland||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|59|59.0||||||
4371972|NCT00345839|4199533|B3|Netherlands||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|29|29.0||||||
4371973|NCT00345839|4199534|B2|Netherlands||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|14|14.0||||||
4371974|NCT00345839|4199535|B1|Netherlands||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|15|15.0||||||
4371975|NCT00345839|4199533|B3|Mexico||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|45|45.0||||||
4371976|NCT00345839|4199534|B2|Mexico||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|22|22.0||||||
4371977|NCT00345839|4199535|B1|Mexico||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|23|23.0||||||
4371978|NCT00345839|4199533|B3|Italy||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|137|137.0||||||
4371979|NCT00345839|4199534|B2|Italy||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|68|68.0||||||
4371980|NCT00345839|4199535|B1|Italy||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|69|69.0||||||
4371981|NCT00345839|4199533|B3|Ireland||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|11|11.0||||||
4371982|NCT00345839|4199534|B2|Ireland||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|6|6.0||||||
4371983|NCT00345839|4199535|B1|Ireland||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|5|5.0||||||
4371984|NCT00345839|4199533|B3|Hungary||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|133|133.0||||||
4371985|NCT00345839|4199534|B2|Hungary||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|67|67.0||||||
4371986|NCT00345839|4199535|B1|Hungary||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|66|66.0||||||
4371987|NCT00345839|4199533|B3|Germany||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|162|162.0||||||
4371988|NCT00345839|4199534|B2|Germany||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|81|81.0||||||
4371989|NCT00345839|4199535|B1|Germany||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|81|81.0||||||
4371990|NCT00345839|4199533|B3|France||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|80|80.0||||||
4371991|NCT00345839|4199534|B2|France||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|40|40.0||||||
4371992|NCT00345839|4199535|B1|France||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|40|40.0||||||
4371993|NCT00345839|4199533|B3|Denmark||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|19|19.0||||||
4371994|NCT00345839|4199534|B2|Denmark||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|11|11.0||||||
4371995|NCT00345839|4199535|B1|Denmark||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|8|8.0||||||
4371996|NCT00345839|4199533|B3|Canada||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|146|146.0||||||
4371997|NCT00345839|4199534|B2|Canada||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|73|73.0||||||
4371998|NCT00345839|4199535|B1|Canada||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|73|73.0||||||
4371999|NCT00345839|4199533|B3|Brazil||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|301|301.0||||||
4372000|NCT00345839|4199534|B2|Brazil||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|150|150.0||||||
4372001|NCT00345839|4199535|B1|Brazil||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|151|151.0||||||
4372002|NCT00345839|4199533|B3|Belgium||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|100|100.0||||||
4372003|NCT00345839|4199534|B2|Belgium||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|50|50.0||||||
4372004|NCT00345839|4199535|B1|Belgium||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|50|50.0||||||
4372005|NCT00345839|4199533|B3|Austria||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|60|60.0||||||
4372006|NCT00345839|4199534|B2|Austria||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|29|29.0||||||
4372007|NCT00345839|4199535|B1|Austria||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|31|31.0||||||
4372008|NCT00345839|4199533|B3|Australia||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|149|149.0||||||
4372009|NCT00345839|4199534|B2|Australia||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|75|75.0||||||
4372010|NCT00345839|4199535|B1|Australia||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|74|74.0||||||
4372011|NCT00345839|4199533|B3|Argentina||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|341|341.0||||||
4372012|NCT00345839|4199534|B2|Argentina||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|170|170.0||||||
4372013|NCT00345839|4199535|B1|Argentina||Country stratification factor|Country stratification factor from the interactive voice response system. Denmark and Sweden were combined to create Nordic stratum.|Participants|Number|171|171.0||||||
4372014|NCT00345839|4199533|B3|No Diabetes||History of Diabetes Stratification Factor|History of diabetes stratification factor from the interactive voice response system.|Participants|Number|2650|2650.0||||||
4372015|NCT00345839|4199534|B2|No Diabetes||History of Diabetes Stratification Factor|History of diabetes stratification factor from the interactive voice response system.|Participants|Number|1321|1321.0||||||
4372016|NCT00345839|4199535|B1|No Diabetes||History of Diabetes Stratification Factor|History of diabetes stratification factor from the interactive voice response system.|Participants|Number|1329|1329.0||||||
4372017|NCT00345839|4199533|B3|Diabetes||History of Diabetes Stratification Factor|History of diabetes stratification factor from the interactive voice response system.|Participants|Number|1233|1233.0||||||
4372018|NCT00345839|4199534|B2|Diabetes||History of Diabetes Stratification Factor|History of diabetes stratification factor from the interactive voice response system.|Participants|Number|614|614.0||||||
4372019|NCT00345839|4199535|B1|Diabetes||History of Diabetes Stratification Factor|History of diabetes stratification factor from the interactive voice response system.|Participants|Number|619|619.0||||||
4372020|NCT00345839|4199533|B3|Other||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4372021|NCT00345839|4199534|B2|Other||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4372022|NCT00345839|4199535|B1|Other||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4372023|NCT00345839|4199533|B3|Aborigine||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4372024|NCT00345839|4199534|B2|Aborigine||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4372025|NCT00345839|4199535|B1|Aborigine||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4372026|NCT00345839|4199533|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4372027|NCT00345839|4199534|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4372028|NCT00345839|4199535|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4372029|NCT00345839|4199533|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4372030|NCT00345839|4199534|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4372031|NCT00345839|4199535|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4372032|NCT00345839|4199533|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4372033|NCT00345839|4199534|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4372034|NCT00345839|4199535|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4372035|NCT00345839|4199533|B3|Asian||Race/Ethnicity, Customized||Participants|Number|85|85.0||||||
4372036|NCT00345839|4199534|B2|Asian||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4372037|NCT00345839|4199535|B1|Asian||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4372038|NCT00345839|4199533|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|627|627.0||||||
4372039|NCT00345839|4199534|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|310|310.0||||||
4372040|NCT00345839|4199535|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|317|317.0||||||
4372041|NCT00345839|4199533|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|837|837.0||||||
4372042|NCT00345839|4199534|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|428|428.0||||||
4372043|NCT00345839|4199535|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|409|409.0||||||
4372044|NCT00345839|4199533|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|2240|2240.0||||||
4372045|NCT00345839|4199534|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|1116|1116.0||||||
4372046|NCT00345839|4199535|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|1124|1124.0||||||
4372047|NCT00345839|4199533|B3||Male|Sex: Female, Male||Participants|Count of Participants|2305|2305.0||||||
4372048|NCT00345839|4199534|B2||Male|Sex: Female, Male||Participants|Count of Participants|1166|1166.0||||||
4372049|NCT00345839|4199535|B1||Male|Sex: Female, Male||Participants|Count of Participants|1139|1139.0||||||
4372050|NCT00345839|4199533|B3||Female|Sex: Female, Male||Participants|Count of Participants|1578|1578.0||||||
4372051|NCT00345839|4199534|B2||Female|Sex: Female, Male||Participants|Count of Participants|769|769.0||||||
4372052|NCT00345839|4199535|B1||Female|Sex: Female, Male||Participants|Count of Participants|809|809.0||||||
4372053|NCT00345839|4199533|B3|||Age||Years|Mean|54.4|54.4|Standard Deviation|14.4|14.4|||
4372054|NCT00345839|4199534|B2|||Age||Years|Mean|54.0|54.0|Standard Deviation|14.2|14.2|||
4372055|NCT00345839|4199535|B1|||Age||Years|Mean|54.8|54.8|Standard Deviation|14.5|14.5|||
4372056|NCT00345683|4199560|B3||Male|Sex: Female, Male||Participants|Count of Participants|2065|2065.0||||||
4372057|NCT00345683|4199561|B2||Male|Sex: Female, Male||Participants|Count of Participants|505|505.0||||||
4372058|NCT00345683|4199562|B1||Male|Sex: Female, Male||Participants|Count of Participants|1560|1560.0||||||
4372059|NCT00345683|4199560|B3||Female|Sex: Female, Male||Participants|Count of Participants|1955|1955.0||||||
4372060|NCT00345683|4199561|B2||Female|Sex: Female, Male||Participants|Count of Participants|505|505.0||||||
4372061|NCT00345683|4199562|B1||Female|Sex: Female, Male||Participants|Count of Participants|1450|1450.0||||||
4372062|NCT00345683|4199560|B3|||Age||Days|Mean|12.1|12.1|Standard Deviation|0.34|0.34|||
4372063|NCT00345683|4199561|B2|||Age||Days|Mean|12.1|12.1|Standard Deviation|0.33|0.33|||
4372064|NCT00345683|4199562|B1|||Age||Days|Mean|12.1|12.1|Standard Deviation|0.34|0.34|||
4372065|NCT00345631|4199583|B4|United States||Region of Enrollment||participants|Number|488|488.0||||||
4372066|NCT00345631|4199584|B3|United States||Region of Enrollment||participants|Number|134|134.0||||||
4372067|NCT00345631|4199585|B2|United States||Region of Enrollment||participants|Number|267|267.0||||||
4372068|NCT00345631|4199586|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4372069|NCT00345631|4199583|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372070|NCT00345631|4199584|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372071|NCT00345631|4199585|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372072|NCT00345631|4199586|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372073|NCT00345631|4199583|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372074|NCT00345631|4199584|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372075|NCT00345631|4199585|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372076|NCT00345631|4199586|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372077|NCT00345631|4199583|B4||White|Race (NIH/OMB)||Participants|Count of Participants|427|427.0||||||
4372078|NCT00345631|4199584|B3||White|Race (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4372079|NCT00345631|4199585|B2||White|Race (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
4372080|NCT00345631|4199586|B1||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4372081|NCT00345631|4199583|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4372082|NCT00345631|4199584|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4372083|NCT00345631|4199585|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4372084|NCT00345631|4199586|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4372085|NCT00345631|4199583|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372086|NCT00345631|4199584|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372087|NCT00345631|4199585|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372088|NCT00345631|4199586|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372089|NCT00345631|4199583|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4372090|NCT00345631|4199584|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4372091|NCT00345631|4199585|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4372092|NCT00345631|4199586|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372093|NCT00345631|4199583|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372094|NCT00345631|4199584|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372095|NCT00345631|4199585|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372096|NCT00345631|4199586|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372097|NCT00345631|4199583|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372098|NCT00345631|4199584|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372099|NCT00345631|4199585|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372100|NCT00345631|4199586|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372101|NCT00345631|4199583|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|470|470.0||||||
4372102|NCT00345631|4199584|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4372103|NCT00345631|4199585|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|260|260.0||||||
4372104|NCT00345631|4199586|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4372105|NCT00345631|4199583|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4372106|NCT00345631|4199584|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4372107|NCT00345631|4199585|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4372108|NCT00345631|4199586|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4372109|NCT00345631|4199583|B4||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
4372110|NCT00345631|4199584|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4372111|NCT00345631|4199585|B2||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4372112|NCT00345631|4199586|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4372113|NCT00345631|4199583|B4||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4372114|NCT00345631|4199584|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4372115|NCT00345631|4199585|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4372116|NCT00345631|4199586|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4372117|NCT00345631|4199583|B4|||Age||years|Mean|62.8|62.8|Standard Deviation|11.05|11.05|||
4372118|NCT00345631|4199584|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|10.47|10.47|||
4372119|NCT00345631|4199585|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|11.13|11.13|||
4372120|NCT00345631|4199586|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|11.61|11.61|||
4372121|NCT00345631|4199583|B4||>=65 years|Age||Participants|Count of Participants|214|214.0||||||
4372122|NCT00345631|4199584|B3||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4372123|NCT00345631|4199585|B2||>=65 years|Age||Participants|Count of Participants|123|123.0||||||
4372124|NCT00345631|4199586|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4372125|NCT00345631|4199583|B4||Between 18 and 65 years|Age||Participants|Count of Participants|274|274.0||||||
4372126|NCT00345631|4199584|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4372127|NCT00345631|4199585|B2||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4372128|NCT00345631|4199586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4372129|NCT00345631|4199583|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372130|NCT00345631|4199584|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372131|NCT00345631|4199585|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372132|NCT00345631|4199586|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372133|NCT00345605|4199620|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4372134|NCT00345605|4199620|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4372135|NCT00345605|4199620|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4372136|NCT00345605|4199620|B1|||Age||years|Mean|15.4|15.4|Standard Deviation|7.2|7.2|||
4372137|NCT00345605|4199620|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372138|NCT00345605|4199620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4372139|NCT00345605|4199620|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4372140|NCT00345592|4199639|B3|Italy||Region of Enrollment||participants|Number|396|396.0||||||
4372141|NCT00345592|4199640|B2|Italy||Region of Enrollment||participants|Number|197|197.0||||||
4372142|NCT00345592|4199641|B1|Italy||Region of Enrollment||participants|Number|199|199.0||||||
4372143|NCT00345592|4199639|B3||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4372144|NCT00345592|4199640|B2||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4372145|NCT00345592|4199641|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4372146|NCT00345592|4199639|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4372147|NCT00345592|4199640|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4372148|NCT00345592|4199641|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4372149|NCT00345592|4199639|B3|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
4372150|NCT00345592|4199640|B2|||Age||years|Mean|68|68.0|Standard Deviation|10|10.0|||
4372151|NCT00345592|4199641|B1|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
4372152|NCT00345579|4199648|B3||Male|Gender||Participants|Count of Participants|2258|2258.0||||||
4372153|NCT00345579|4199649|B2||Male|Gender||Participants|Count of Participants|556|556.0||||||
4372154|NCT00345579|4199650|B1||Male|Gender||Participants|Count of Participants|1702|1702.0||||||
4372155|NCT00345579|4199648|B3||Female|Gender||Participants|Count of Participants|2133|2133.0||||||
4372156|NCT00345579|4199649|B2||Female|Gender||Participants|Count of Participants|557|557.0||||||
4372157|NCT00345579|4199650|B1||Female|Gender||Participants|Count of Participants|1576|1576.0||||||
4372158|NCT00345579|4199648|B3|||Age||Days|Mean|58.8|58.8|Standard Deviation|10.42|10.42|||
4372159|NCT00345579|4199649|B2|||Age||Days|Mean|59.0|59.0|Standard Deviation|10.39|10.39|||
4372160|NCT00345579|4199650|B1|||Age||Days|Mean|58.6|58.6|Standard Deviation|10.45|10.45|||
4372161|NCT00345540|4199671|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4372162|NCT00345540|4199671|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372163|NCT00345540|4199671|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4372164|NCT00345540|4199671|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372165|NCT00345540|4199671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4372166|NCT00345540|4199671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372167|NCT00345397|4199677|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4372168|NCT00345397|4199677|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372169|NCT00345397|4199677|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372170|NCT00345397|4199677|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4372171|NCT00345397|4199677|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372172|NCT00345397|4199677|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372173|NCT00345397|4199677|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372174|NCT00345397|4199677|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372175|NCT00345397|4199677|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4372176|NCT00345397|4199677|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4372177|NCT00345397|4199677|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4372178|NCT00345397|4199677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4372179|NCT00345397|4199677|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372180|NCT00345384|4199682|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4372181|NCT00345384|4199683|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4372182|NCT00345384|4199684|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4372183|NCT00345384|4199682|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4372184|NCT00345384|4199683|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4372185|NCT00345384|4199684|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4372186|NCT00345384|4199682|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4372187|NCT00345384|4199683|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4372188|NCT00345384|4199684|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4372189|NCT00345384|4199682|B3|||Age||years|Mean|60|60.0|Standard Deviation|11.75|11.75|||
4372190|NCT00345384|4199683|B2|||Age||years|Mean|61|61.0|Standard Deviation|10.75|10.75|||
4372191|NCT00345384|4199684|B1|||Age||years|Mean|58|58.0|Standard Deviation|12.8|12.8|||
4372192|NCT00345384|4199682|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4372193|NCT00345384|4199683|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4372194|NCT00345384|4199684|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4372195|NCT00345384|4199682|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4372196|NCT00345384|4199683|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4372197|NCT00345384|4199684|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4372198|NCT00345384|4199682|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372199|NCT00345384|4199683|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372200|NCT00345384|4199684|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372201|NCT00345371|4199693|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
4372202|NCT00345371|4199694|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4372203|NCT00345371|4199695|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4372204|NCT00345371|4199693|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4372205|NCT00345371|4199694|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4372206|NCT00345371|4199695|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4372207|NCT00345371|4199693|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4372208|NCT00345371|4199694|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4372209|NCT00345371|4199695|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4372210|NCT00345371|4199693|B3|||Age||years|Mean|38|38.0|Standard Deviation|8.62|8.62|||
4372211|NCT00345371|4199694|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|8.47|8.47|||
4372212|NCT00345371|4199695|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|8.83|8.83|||
4372213|NCT00345332|4199704|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4372214|NCT00345332|4199705|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4372215|NCT00345332|4199706|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4372216|NCT00345332|4199704|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372217|NCT00345332|4199705|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372218|NCT00345332|4199706|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372219|NCT00345332|4199704|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4372220|NCT00345332|4199705|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4372221|NCT00345332|4199706|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4372222|NCT00345332|4199704|B3|||Age||years|Mean|65.97|65.97|Standard Deviation|11.55|11.55|||
4372223|NCT00345332|4199705|B2|||Age||years|Mean|65.15|65.15|Standard Deviation|10.83|10.83|||
4372224|NCT00345332|4199706|B1|||Age||years|Mean|67.45|67.45|Standard Deviation|12.85|12.85|||
4372225|NCT00345293|4199715|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372226|NCT00345293|4199715|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372227|NCT00345293|4199715|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4372228|NCT00345293|4199715|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372229|NCT00345293|4199715|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372230|NCT00345293|4199715|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372231|NCT00345293|4199715|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372232|NCT00345293|4199715|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372233|NCT00345293|4199715|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4372234|NCT00345293|4199715|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372235|NCT00345293|4199715|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4372236|NCT00345293|4199715|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372237|NCT00345293|4199715|B1|||Age||years|Mean|64|64.0|Full Range|||53.0|76.0|
4372238|NCT00345254|4199723|B3|Israel||Region of Enrollment||participants|Number|60|60.0||||||
4372239|NCT00345254|4199724|B2|Israel||Region of Enrollment||participants|Number|30|30.0||||||
4372240|NCT00345254|4199725|B1|Israel||Region of Enrollment||participants|Number|30|30.0||||||
4372241|NCT00345254|4199723|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372242|NCT00345254|4199724|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372243|NCT00345254|4199725|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372244|NCT00345254|4199723|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4372245|NCT00345254|4199724|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4372246|NCT00345254|4199725|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4372247|NCT00345254|4199723|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372248|NCT00345254|4199724|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372249|NCT00345254|4199725|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372250|NCT00345254|4199723|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4372251|NCT00345254|4199724|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4372252|NCT00345254|4199725|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4372253|NCT00345254|4199723|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372254|NCT00345254|4199724|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372255|NCT00345254|4199725|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372256|NCT00345176|4199732|B5||Male|Sex: Female, Male||Participants|Count of Participants|1815|1815.0||||||
4372257|NCT00345176|4199733|B4||Male|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
4372258|NCT00345176|4199734|B3||Male|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
4372259|NCT00345176|4199735|B2||Male|Sex: Female, Male||Participants|Count of Participants|448|448.0||||||
4372260|NCT00345176|4199736|B1||Male|Sex: Female, Male||Participants|Count of Participants|464|464.0||||||
4372261|NCT00345176|4199732|B5||Female|Sex: Female, Male||Participants|Count of Participants|2388|2388.0||||||
4372262|NCT00345176|4199733|B4||Female|Sex: Female, Male||Participants|Count of Participants|641|641.0||||||
4372263|NCT00345176|4199734|B3||Female|Sex: Female, Male||Participants|Count of Participants|603|603.0||||||
4372264|NCT00345176|4199735|B2||Female|Sex: Female, Male||Participants|Count of Participants|596|596.0||||||
4372265|NCT00345176|4199736|B1||Female|Sex: Female, Male||Participants|Count of Participants|548|548.0||||||
4372266|NCT00345176|4199732|B5|||Age||Participants|Median|74|74.0|Inter-Quartile Range|||68.0|79.0|
4372267|NCT00345176|4199733|B4|||Age||Participants|Median|75|75.0|Inter-Quartile Range|||68.0|79.0|
4372268|NCT00345176|4199734|B3|||Age||Participants|Median|74|74.0|Inter-Quartile Range|||68.0|79.0|
4372269|NCT00345176|4199735|B2|||Age||Participants|Median|74|74.0|Inter-Quartile Range|||68.0|79.0|
4372270|NCT00345176|4199736|B1|||Age||Participants|Median|74|74.0|Inter-Quartile Range|||68.0|79.0|
4372271|NCT00345046|4199759|B4||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4372272|NCT00345046|4199760|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4372273|NCT00345046|4199761|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4372274|NCT00345046|4199762|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4372275|NCT00345046|4199759|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4372276|NCT00345046|4199760|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4372277|NCT00345046|4199761|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4372278|NCT00345046|4199762|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4372279|NCT00345046|4199759|B4|||Age||years|Mean|66.5|66.5|Standard Deviation|14.5|14.5|||
4372280|NCT00345046|4199760|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|16.6|16.6|||
4372281|NCT00345046|4199761|B2|||Age||years|Mean|68.3|68.3|Standard Deviation|13.0|13.0|||
4372282|NCT00345046|4199762|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|15.2|15.2|||
4372283|NCT00345033|4199772|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4372284|NCT00345033|4199773|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4372285|NCT00345033|4199774|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4372286|NCT00345033|4199772|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4372287|NCT00345033|4199773|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4372288|NCT00345033|4199774|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4372289|NCT00345033|4199772|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4372290|NCT00345033|4199773|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4372291|NCT00345033|4199774|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4372292|NCT00345033|4199772|B3|||Age||years|Mean|44.25|44.25|Standard Deviation|8.6|8.6|||
4372293|NCT00345033|4199773|B2|||Age||years|Mean|44.2|44.2|Standard Deviation|8.9|8.9|||
4372294|NCT00345033|4199774|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|8.2|8.2|||
4372295|NCT00345033|4199772|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372296|NCT00345033|4199773|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372297|NCT00345033|4199774|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372298|NCT00345033|4199772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4372299|NCT00345033|4199773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4372300|NCT00345033|4199774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4372301|NCT00345033|4199772|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372302|NCT00345033|4199773|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372303|NCT00345033|4199774|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372304|NCT00344968|4199791|B4|Europe||Region of Enrollment|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|93|93.0||||||
4372305|NCT00344968|4199792|B3|Europe||Region of Enrollment|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|39|39.0||||||
4372306|NCT00344968|4199793|B2|Europe||Region of Enrollment|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|37|37.0||||||
4372307|NCT00344968|4199794|B1|Europe||Region of Enrollment|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|17|17.0||||||
4372308|NCT00344968|4199791|B4|India||Region of Enrollment|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|201|201.0||||||
4372309|NCT00344968|4199792|B3|India||Region of Enrollment|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|82|82.0||||||
4372310|NCT00344968|4199793|B2|India||Region of Enrollment|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|80|80.0||||||
4372311|NCT00344968|4199794|B1|India||Region of Enrollment|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|39|39.0||||||
4372312|NCT00344968|4199791|B4|North America||Region of Enrollment|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|662|662.0||||||
4372313|NCT00344968|4199792|B3|North America||Region of Enrollment|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|274|274.0||||||
4372314|NCT00344968|4199793|B2|North America||Region of Enrollment|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|259|259.0||||||
4372315|NCT00344968|4199794|B1|North America||Region of Enrollment|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|129|129.0||||||
4372316|NCT00344968|4199791|B4|Male||Gender|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|566|566.0||||||
4372317|NCT00344968|4199792|B3|Male||Gender|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|243|243.0||||||
4372318|NCT00344968|4199793|B2|Male||Gender|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|215|215.0||||||
4372319|NCT00344968|4199794|B1|Male||Gender|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|108|108.0||||||
4372320|NCT00344968|4199791|B4|Female||Gender|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|387|387.0||||||
4372321|NCT00344968|4199792|B3|Female||Gender|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|150|150.0||||||
4372322|NCT00344968|4199793|B2|Female||Gender|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|160|160.0||||||
4372323|NCT00344968|4199794|B1|Female||Gender|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|77|77.0||||||
4372324|NCT00344968|4199791|B4|||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|years|Mean|62.5|62.5|Standard Deviation|9.4|9.4|||
4372325|NCT00344968|4199792|B3|||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|years|Mean|62.2|62.2|Standard Deviation|9.3|9.3|||
4372326|NCT00344968|4199793|B2|||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|years|Mean|63.0|63.0|Standard Deviation|9.3|9.3|||
4372327|NCT00344968|4199794|B1|||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|years|Mean|61.9|61.9|Standard Deviation|9.6|9.6|||
4372328|NCT00344968|4199791|B4|>=65 years||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|389|389.0||||||
4372329|NCT00344968|4199792|B3|>=65 years||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|161|161.0||||||
4372330|NCT00344968|4199793|B2|>=65 years||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|162|162.0||||||
4372331|NCT00344968|4199794|B1|>=65 years||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|66|66.0||||||
4372332|NCT00344968|4199791|B4|Between 18 and 65 years||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|564|564.0||||||
4372333|NCT00344968|4199792|B3|Between 18 and 65 years||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|232|232.0||||||
4372334|NCT00344968|4199793|B2|Between 18 and 65 years||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|213|213.0||||||
4372335|NCT00344968|4199794|B1|Between 18 and 65 years||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|119|119.0||||||
4372336|NCT00344968|4199791|B4|<=18 years||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|0|0.0||||||
4372337|NCT00344968|4199792|B3|<=18 years||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|0|0.0||||||
4372338|NCT00344968|4199793|B2|<=18 years||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|0|0.0||||||
4372339|NCT00344968|4199794|B1|<=18 years||Age|Three subjects were randomized but did not receive treatment. These subjects were not included in the safety analysis, which accounts for the discrepancy in the overall number of participants.|participants|Number|0|0.0||||||
4372340|NCT00344773|4199807|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4372341|NCT00344773|4199807|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4372342|NCT00344773|4199807|B1|||Age||years|Mean|60|60.0|Standard Deviation|12|12.0|||
4372343|NCT00344682|4199813|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4372344|NCT00344682|4199814|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4372345|NCT00344682|4199815|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4372346|NCT00344682|4199813|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4372347|NCT00344682|4199814|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4372348|NCT00344682|4199815|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4372349|NCT00344682|4199813|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4372350|NCT00344682|4199814|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4372351|NCT00344682|4199815|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4372352|NCT00344682|4199813|B3|||Age||years|Mean|52.28|52.28|Standard Deviation|8.2|8.2|||
4372353|NCT00344682|4199814|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|6.17|6.17|||
4372354|NCT00344682|4199815|B1|||Age||years|Mean|49.75|49.75|Standard Deviation|11.68|11.68|||
4372355|NCT00344682|4199813|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4372356|NCT00344682|4199814|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4372357|NCT00344682|4199815|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4372358|NCT00344682|4199813|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4372359|NCT00344682|4199814|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4372360|NCT00344682|4199815|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4372361|NCT00344682|4199813|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372362|NCT00344682|4199814|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372363|NCT00344682|4199815|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372364|NCT00344500|4199828|B3|||Microalbumin/Creatinine||mgMA/gCrt|Mean|15.0889|15.0889|Standard Deviation|34.4026|34.4026|||
4372365|NCT00344500|4199829|B2|||Microalbumin/Creatinine||mgMA/gCrt|Mean|16.12|16.12|Standard Deviation|39.7|39.7|||
4372366|NCT00344500|4199830|B1|||Microalbumin/Creatinine||mgMA/gCrt|Mean|13.8|13.8|Standard Deviation|26.7|26.7|||
4372367|NCT00344500|4199828|B3|Total Cholesterol||Laboratory Tests||mm/dL|Mean|181.5667|181.5667|Standard Deviation|40.6457|40.6457|||
4372368|NCT00344500|4199829|B2|Total Cholesterol||Laboratory Tests||mm/dL|Mean|178.9|178.9|Standard Deviation|38.1|38.1|||
4372369|NCT00344500|4199830|B1|Total Cholesterol||Laboratory Tests||mm/dL|Mean|184.9|184.9|Standard Deviation|43.8|43.8|||
4372370|NCT00344500|4199828|B3|LDL Cholesterol||Laboratory Tests||mm/dL|Mean|112.4222|112.4222|Standard Deviation|33.1885|33.1885|||
4372371|NCT00344500|4199829|B2|LDL Cholesterol||Laboratory Tests||mm/dL|Mean|111|111.0|Standard Deviation|30.9|30.9|||
4372372|NCT00344500|4199830|B1|LDL Cholesterol||Laboratory Tests||mm/dL|Mean|114.2|114.2|Standard Deviation|36.1|36.1|||
4372373|NCT00344500|4199828|B3|Triglycerides||Laboratory Tests||mm/dL|Mean|161.3889|161.3889|Standard Deviation|110.368|110.368|||
4372374|NCT00344500|4199829|B2|Triglycerides||Laboratory Tests||mm/dL|Mean|161.3|161.3|Standard Deviation|117.9|117.9|||
4372375|NCT00344500|4199830|B1|Triglycerides||Laboratory Tests||mm/dL|Mean|161.5|161.5|Standard Deviation|101.4|101.4|||
4372376|NCT00344500|4199828|B3|HDL Cholesterol||Laboratory Tests||mm/dL|Mean|37.3889|37.3889|Standard Deviation|8.9477|8.9477|||
4372377|NCT00344500|4199829|B2|HDL Cholesterol||Laboratory Tests||mm/dL|Mean|37.3|37.3|Standard Deviation|8.9|8.9|||
4372378|NCT00344500|4199830|B1|HDL Cholesterol||Laboratory Tests||mm/dL|Mean|37.5|37.5|Standard Deviation|9.1|9.1|||
4372379|NCT00344500|4199828|B3|Glucose||Laboratory Tests||mm/dL|Mean|108.6556|108.6556|Standard Deviation|49.3093|49.3093|||
4372380|NCT00344500|4199829|B2|Glucose||Laboratory Tests||mm/dL|Mean|103.9|103.9|Standard Deviation|38.6|38.6|||
4372381|NCT00344500|4199830|B1|Glucose||Laboratory Tests||mm/dL|Mean|114.6|114.6|Standard Deviation|60|60.0|||
4372382|NCT00344500|4199828|B3|Diastolic||Blood Pressure||mmHg|Mean|82.7889|82.7889|Standard Deviation|10.4459|10.4459|||
4372383|NCT00344500|4199829|B2|Diastolic||Blood Pressure||mmHg|Mean|83.1|83.1|Standard Deviation|10.4|10.4|||
4372384|NCT00344500|4199830|B1|Diastolic||Blood Pressure||mmHg|Mean|82.4|82.4|Standard Deviation|10.6|10.6|||
4372385|NCT00344500|4199828|B3|Systolic||Blood Pressure||mmHg|Mean|125.2778|125.2778|Standard Deviation|12.7394|12.7394|||
4372386|NCT00344500|4199829|B2|Systolic||Blood Pressure||mmHg|Mean|126.7|126.7|Standard Deviation|13.3|13.3|||
4372387|NCT00344500|4199830|B1|Systolic||Blood Pressure||mmHg|Mean|123.5|123.5|Standard Deviation|11.9|11.9|||
4372388|NCT00344500|4199828|B3|||Framingham Hard Coronary Heart Disease|10-year risk estimate of developing hard coronary heart disease|Percent|Mean|11.0222|11.0222|Standard Deviation|6.5301|6.5301|||
4372389|NCT00344500|4199829|B2|||Framingham Hard Coronary Heart Disease|10-year risk estimate of developing hard coronary heart disease|Percent|Mean|11.2|11.2|Standard Deviation|5.8|5.8|||
4372390|NCT00344500|4199830|B1|||Framingham Hard Coronary Heart Disease|10-year risk estimate of developing hard coronary heart disease|Percent|Mean|10.8|10.8|Standard Deviation|7.4|7.4|||
4372391|NCT00344500|4199828|B3|||Percent Body Fat||percentage|Mean|30.5333|30.5333|Standard Deviation|6.0941|6.0941|||
4372392|NCT00344500|4199829|B2|||Percent Body Fat||percentage|Mean|30.8|30.8|Standard Deviation|5.7|5.7|||
4372393|NCT00344500|4199830|B1|||Percent Body Fat||percentage|Mean|30.2|30.2|Standard Deviation|6.6|6.6|||
4372394|NCT00344500|4199828|B3|||Waist Circumference||cm|Mean|117.9889|117.9889|Standard Deviation|13.19|13.19|||
4372395|NCT00344500|4199829|B2|||Waist Circumference||cm|Mean|117.1|117.1|Standard Deviation|14.5|14.5|||
4372396|NCT00344500|4199830|B1|||Waist Circumference||cm|Mean|119.1|119.1|Standard Deviation|11.4|11.4|||
4372397|NCT00344500|4199828|B3|||Body Mass Index||kg/m^2|Mean|34.1889|34.1889|Standard Deviation|5.0615|5.0615|||
4372398|NCT00344500|4199829|B2|||Body Mass Index||kg/m^2|Mean|34.1|34.1|Standard Deviation|5.3|5.3|||
4372399|NCT00344500|4199830|B1|||Body Mass Index||kg/m^2|Mean|34.3|34.3|Standard Deviation|4.8|4.8|||
4372400|NCT00344500|4199828|B3|||Body Weight||kg|Mean|105.9222|105.9222|Standard Deviation|18.7231|18.7231|||
4372401|NCT00344500|4199829|B2|||Body Weight||kg|Mean|105.3|105.3|Standard Deviation|21.0|21.0|||
4372402|NCT00344500|4199830|B1|||Body Weight||kg|Mean|106.7|106.7|Standard Deviation|15.6|15.6|||
4372403|NCT00344500|4199828|B3|Motivational Interview to Assess Stage of Change||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|2.9|2.9|Standard Deviation|0.6967|0.6967|||
4372404|NCT00344500|4199829|B2|Motivational Interview to Assess Stage of Change||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|2.9|2.9|Standard Deviation|0.7|0.7|||
4372431|NCT00344500|4199829|B2|Multiple||Antipsychotic (Weight Gain Risk)||participants|Number|8|8.0||||||
4372432|NCT00344500|4199830|B1|Multiple||Antipsychotic (Weight Gain Risk)||participants|Number|7|7.0||||||
4372405|NCT00344500|4199830|B1|Motivational Interview to Assess Stage of Change||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|2.9|2.9|Standard Deviation|0.7|0.7|||
4372406|NCT00344500|4199828|B3|Antipsychotics Side-effects Checklist, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|25.8667|25.8667|Standard Deviation|3.6948|3.6948|||
4372407|NCT00344500|4199829|B2|Antipsychotics Side-effects Checklist, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|25.6|25.6|Standard Deviation|3.7|3.7|||
4372408|NCT00344500|4199830|B1|Antipsychotics Side-effects Checklist, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|26.2|26.2|Standard Deviation|3.7|3.7|||
4372409|NCT00344500|4199828|B3|Self-Assessment of Illness Questionnaire, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|77.9889|77.9889|Standard Deviation|9.3433|9.3433|||
4372410|NCT00344500|4199829|B2|Self-Assessment of Illness Questionnaire, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|79.1|79.1|Standard Deviation|9.4|9.4|||
4372411|NCT00344500|4199830|B1|Self-Assessment of Illness Questionnaire, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|76.6|76.6|Standard Deviation|9.18|9.18|||
4372412|NCT00344500|4199828|B3|Heinrichs Quality of Life Scale, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|58.2556|58.2556|Standard Deviation|21.0662|21.0662|||
4372413|NCT00344500|4199829|B2|Heinrichs Quality of Life Scale, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|61.1|61.1|Standard Deviation|22.4|22.4|||
4372414|NCT00344500|4199830|B1|Heinrichs Quality of Life Scale, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|54.7|54.7|Standard Deviation|18.9|18.9|||
4372433|NCT00344500|4199828|B3|Other||Antipsychotic (Weight Gain Risk)||participants|Number|5|5.0||||||
4372415|NCT00344500|4199828|B3|Hamilton Depression Rating Scale, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|11.5|11.5|Standard Deviation|6.8776|6.8776|||
4372416|NCT00344500|4199829|B2|Hamilton Depression Rating Scale, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|12.7|12.7|Standard Deviation|7.4|7.4|||
4372417|NCT00344500|4199830|B1|Hamilton Depression Rating Scale, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|10.0|10.0|Standard Deviation|5.9|5.9|||
4372418|NCT00344500|4199828|B3|Clinical Global Impression Rating||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|3.4|3.4|Standard Deviation|0.7963|0.7963|||
4372419|NCT00344500|4199829|B2|Clinical Global Impression Rating||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|3.4|3.4|Standard Deviation|0.8|0.8|||
4372420|NCT00344500|4199830|B1|Clinical Global Impression Rating||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|3.4|3.4|Standard Deviation|0.8|0.8|||
4372421|NCT00344500|4199828|B3|Brief Psychiatric Rating Scale, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|34.2333|34.2333|Standard Deviation|8.4483|8.4483|||
4372422|NCT00344500|4199829|B2|Brief Psychiatric Rating Scale, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|34.9|34.9|Standard Deviation|8.8|8.8|||
4372423|NCT00344500|4199830|B1|Brief Psychiatric Rating Scale, Total||Baseline Psychopathology Ratings|"Brief Psychiatric Rating Scale: Symptom survey, score range 18 - 126, best to worst.~Clinical Global Impression: Rates overall psychiatric symptom severity, scored 1-6, best to worst.~Hamilton Depression Rating Scale: Score range 0 - 78, best to worst.~Heinrichs Quality of Life Scale: Score range 0-132, worst to best.~Self-Assessment of Illness Questionnaire: Rates mental health and weight, score range 32 - 128, best to worst.~Antipsychotics Side-effects Checklist: Score range 17-34, worst to best.~Motivational Interview to Assess Stage of Change: Scored 0-5, worst to best."|units on a scale|Mean|33.4|33.4|Standard Deviation|8.0|8.0|||
4372424|NCT00344500|4199828|B3|||Age of Onset of Psychiatric Illness||years|Mean|29.4656|29.4656|Standard Deviation|10.917|10.917|||
4372425|NCT00344500|4199829|B2|||Age of Onset of Psychiatric Illness||years|Mean|30.47|30.47|Standard Deviation|11.5|11.5|||
4372426|NCT00344500|4199830|B1|||Age of Onset of Psychiatric Illness||years|Mean|28.21|28.21|Standard Deviation|10.12|10.12|||
4372427|NCT00344500|4199828|B3|||Length of Psychiatric Illness||years|Mean|19.5889|19.5889|Standard Deviation|11.7732|11.7732|||
4372428|NCT00344500|4199829|B2|||Length of Psychiatric Illness||years|Mean|18.86|18.86|Standard Deviation|11.8|11.8|||
4372429|NCT00344500|4199830|B1|||Length of Psychiatric Illness||years|Mean|20.5|20.5|Standard Deviation|11.8|11.8|||
4372430|NCT00344500|4199828|B3|Multiple||Antipsychotic (Weight Gain Risk)||participants|Number|15|15.0||||||
4372434|NCT00344500|4199829|B2|Other||Antipsychotic (Weight Gain Risk)||participants|Number|2|2.0||||||
4372435|NCT00344500|4199830|B1|Other||Antipsychotic (Weight Gain Risk)||participants|Number|3|3.0||||||
4372436|NCT00344500|4199828|B3|Aripiprazole/Ziprasidone (Low)||Antipsychotic (Weight Gain Risk)||participants|Number|28|28.0||||||
4372437|NCT00344500|4199829|B2|Aripiprazole/Ziprasidone (Low)||Antipsychotic (Weight Gain Risk)||participants|Number|21|21.0||||||
4372438|NCT00344500|4199830|B1|Aripiprazole/Ziprasidone (Low)||Antipsychotic (Weight Gain Risk)||participants|Number|7|7.0||||||
4372439|NCT00344500|4199828|B3|Risperidone/Quetiapine (Med)||Antipsychotic (Weight Gain Risk)||participants|Number|44|44.0||||||
4372440|NCT00344500|4199829|B2|Risperidone/Quetiapine (Med)||Antipsychotic (Weight Gain Risk)||participants|Number|24|24.0||||||
4372441|NCT00344500|4199830|B1|Risperidone/Quetiapine (Med)||Antipsychotic (Weight Gain Risk)||participants|Number|20|20.0||||||
4372442|NCT00344500|4199828|B3|Olanzapine/Clozapine (High)||Antipsychotic (Weight Gain Risk)||participants|Number|16|16.0||||||
4372443|NCT00344500|4199829|B2|Olanzapine/Clozapine (High)||Antipsychotic (Weight Gain Risk)||participants|Number|5|5.0||||||
4372444|NCT00344500|4199830|B1|Olanzapine/Clozapine (High)||Antipsychotic (Weight Gain Risk)||participants|Number|11|11.0||||||
4372445|NCT00344500|4199828|B3|Other||Diagnosis per the Structured Clinical Interview for the Diagnostic and Statistical Manual||participants|Number|7|7.0||||||
4372446|NCT00344500|4199829|B2|Other||Diagnosis per the Structured Clinical Interview for the Diagnostic and Statistical Manual||participants|Number|4|4.0||||||
4372447|NCT00344500|4199830|B1|Other||Diagnosis per the Structured Clinical Interview for the Diagnostic and Statistical Manual||participants|Number|3|3.0||||||
4372448|NCT00344500|4199828|B3|Bipolar||Diagnosis per the Structured Clinical Interview for the Diagnostic and Statistical Manual||participants|Number|32|32.0||||||
4372449|NCT00344500|4199829|B2|Bipolar||Diagnosis per the Structured Clinical Interview for the Diagnostic and Statistical Manual||participants|Number|23|23.0||||||
4372450|NCT00344500|4199830|B1|Bipolar||Diagnosis per the Structured Clinical Interview for the Diagnostic and Statistical Manual||participants|Number|9|9.0||||||
4372451|NCT00344500|4199828|B3|Schizoaffective||Diagnosis per the Structured Clinical Interview for the Diagnostic and Statistical Manual||participants|Number|20|20.0||||||
4372452|NCT00344500|4199829|B2|Schizoaffective||Diagnosis per the Structured Clinical Interview for the Diagnostic and Statistical Manual||participants|Number|12|12.0||||||
4372453|NCT00344500|4199830|B1|Schizoaffective||Diagnosis per the Structured Clinical Interview for the Diagnostic and Statistical Manual||participants|Number|8|8.0||||||
4372454|NCT00344500|4199828|B3|Schizophrenia||Diagnosis per the Structured Clinical Interview for the Diagnostic and Statistical Manual||participants|Number|49|49.0||||||
4372455|NCT00344500|4199829|B2|Schizophrenia||Diagnosis per the Structured Clinical Interview for the Diagnostic and Statistical Manual||participants|Number|21|21.0||||||
4372456|NCT00344500|4199830|B1|Schizophrenia||Diagnosis per the Structured Clinical Interview for the Diagnostic and Statistical Manual||participants|Number|28|28.0||||||
4372457|NCT00344500|4199828|B3|Required Exercise Tolerance Test||Medical Comorbidity||participants|Number|12|12.0||||||
4372458|NCT00344500|4199829|B2|Required Exercise Tolerance Test||Medical Comorbidity||participants|Number|7|7.0||||||
4372459|NCT00344500|4199830|B1|Required Exercise Tolerance Test||Medical Comorbidity||participants|Number|5|5.0||||||
4372460|NCT00344500|4199828|B3|Obesity||Medical Comorbidity||participants|Number|72|72.0||||||
4372461|NCT00344500|4199829|B2|Obesity||Medical Comorbidity||participants|Number|40|40.0||||||
4372462|NCT00344500|4199830|B1|Obesity||Medical Comorbidity||participants|Number|32|32.0||||||
4372463|NCT00344500|4199828|B3|Metabolic Syndrome||Medical Comorbidity||participants|Number|65|65.0||||||
4372464|NCT00344500|4199829|B2|Metabolic Syndrome||Medical Comorbidity||participants|Number|40|40.0||||||
4372465|NCT00344500|4199830|B1|Metabolic Syndrome||Medical Comorbidity||participants|Number|25|25.0||||||
4372466|NCT00344500|4199828|B3|Diabetes||Medical Comorbidity||participants|Number|26|26.0||||||
4372467|NCT00344500|4199829|B2|Diabetes||Medical Comorbidity||participants|Number|15|15.0||||||
4372468|NCT00344500|4199830|B1|Diabetes||Medical Comorbidity||participants|Number|11|11.0||||||
4372469|NCT00344500|4199828|B3|Dyslipidemia||Medical Comorbidity||participants|Number|55|55.0||||||
4372470|NCT00344500|4199829|B2|Dyslipidemia||Medical Comorbidity||participants|Number|32|32.0||||||
4372471|NCT00344500|4199830|B1|Dyslipidemia||Medical Comorbidity||participants|Number|23|23.0||||||
4372472|NCT00344500|4199828|B3|Hypertension||Medical Comorbidity||participants|Number|60|60.0||||||
4372473|NCT00344500|4199829|B2|Hypertension||Medical Comorbidity||participants|Number|33|33.0||||||
4372474|NCT00344500|4199830|B1|Hypertension||Medical Comorbidity||participants|Number|27|27.0||||||
4372475|NCT00344500|4199828|B3|None||Occupation||participants|Number|95|95.0||||||
4372476|NCT00344500|4199829|B2|None||Occupation||participants|Number|53|53.0||||||
4372477|NCT00344500|4199830|B1|None||Occupation||participants|Number|42|42.0||||||
4372478|NCT00344500|4199828|B3|Unpaid Work||Occupation||participants|Number|4|4.0||||||
4372479|NCT00344500|4199829|B2|Unpaid Work||Occupation||participants|Number|1|1.0||||||
4372480|NCT00344500|4199830|B1|Unpaid Work||Occupation||participants|Number|3|3.0||||||
4372481|NCT00344500|4199828|B3|Paid Work||Occupation||participants|Number|9|9.0||||||
4372482|NCT00344500|4199829|B2|Paid Work||Occupation||participants|Number|6|6.0||||||
4372483|NCT00344500|4199830|B1|Paid Work||Occupation||participants|Number|3|3.0||||||
4372484|NCT00344500|4199828|B3|Higher Professional Degree||Education Level||participants|Number|2|2.0||||||
4372485|NCT00344500|4199829|B2|Higher Professional Degree||Education Level||participants|Number|2|2.0||||||
4372486|NCT00344500|4199830|B1|Higher Professional Degree||Education Level||participants|Number|0|0.0||||||
4372487|NCT00344500|4199828|B3|Bachelor's or Equivalent Degree||Education Level||participants|Number|15|15.0||||||
4372488|NCT00344500|4199829|B2|Bachelor's or Equivalent Degree||Education Level||participants|Number|6|6.0||||||
4372489|NCT00344500|4199830|B1|Bachelor's or Equivalent Degree||Education Level||participants|Number|9|9.0||||||
4372490|NCT00344500|4199828|B3|HS Diploma/GED||Education Level||participants|Number|83|83.0||||||
4372491|NCT00344500|4199829|B2|HS Diploma/GED||Education Level||participants|Number|47|47.0||||||
4372492|NCT00344500|4199830|B1|HS Diploma/GED||Education Level||participants|Number|36|36.0||||||
4372493|NCT00344500|4199828|B3|No diploma||Education Level||participants|Number|8|8.0||||||
4372494|NCT00344500|4199829|B2|No diploma||Education Level||participants|Number|5|5.0||||||
4372495|NCT00344500|4199830|B1|No diploma||Education Level||participants|Number|3|3.0||||||
4372496|NCT00344500|4199828|B3|Divorced/Widower||Marital Status||participants|Number|45|45.0||||||
4372497|NCT00344500|4199829|B2|Divorced/Widower||Marital Status||participants|Number|29|29.0||||||
4372498|NCT00344500|4199830|B1|Divorced/Widower||Marital Status||participants|Number|16|16.0||||||
4372499|NCT00344500|4199828|B3|Single/Cohabiting||Marital Status||participants|Number|51|51.0||||||
4372500|NCT00344500|4199829|B2|Single/Cohabiting||Marital Status||participants|Number|27|27.0||||||
4372501|NCT00344500|4199830|B1|Single/Cohabiting||Marital Status||participants|Number|24|24.0||||||
4372502|NCT00344500|4199828|B3|Married||Marital Status||participants|Number|12|12.0||||||
4372503|NCT00344500|4199829|B2|Married||Marital Status||participants|Number|4|4.0||||||
4372504|NCT00344500|4199830|B1|Married||Marital Status||participants|Number|8|8.0||||||
4372505|NCT00344500|4199828|B3|Homeless||Living Situation||participants|Number|0|0.0||||||
4372506|NCT00344500|4199829|B2|Homeless||Living Situation||participants|Number|0|0.0||||||
4372507|NCT00344500|4199830|B1|Homeless||Living Situation||participants|Number|0|0.0||||||
4372508|NCT00344500|4199828|B3|Board and Care||Living Situation||participants|Number|82|82.0||||||
4372509|NCT00344500|4199829|B2|Board and Care||Living Situation||participants|Number|42|42.0||||||
4372510|NCT00344500|4199830|B1|Board and Care||Living Situation||participants|Number|40|40.0||||||
4372511|NCT00344500|4199828|B3|With Relatives||Living Situation||participants|Number|3|3.0||||||
4372512|NCT00344500|4199829|B2|With Relatives||Living Situation||participants|Number|1|1.0||||||
4372513|NCT00344500|4199830|B1|With Relatives||Living Situation||participants|Number|2|2.0||||||
4372514|NCT00344500|4199828|B3|Rental Home/Apt||Living Situation||participants|Number|22|22.0||||||
4372515|NCT00344500|4199829|B2|Rental Home/Apt||Living Situation||participants|Number|16|16.0||||||
4372516|NCT00344500|4199830|B1|Rental Home/Apt||Living Situation||participants|Number|6|6.0||||||
4372517|NCT00344500|4199828|B3|Own Home||Living Situation||participants|Number|1|1.0||||||
4372518|NCT00344500|4199829|B2|Own Home||Living Situation||participants|Number|1|1.0||||||
4372519|NCT00344500|4199830|B1|Own Home||Living Situation||participants|Number|0|0.0||||||
4372520|NCT00344500|4199828|B3|United States||Region of Enrollment||participants|Number|108|108.0||||||
4372521|NCT00344500|4199829|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4372522|NCT00344500|4199830|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4372523|NCT00344500|4199828|B3|Mixed Heritage or Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4372524|NCT00344500|4199829|B2|Mixed Heritage or Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4372525|NCT00344500|4199830|B1|Mixed Heritage or Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4372526|NCT00344500|4199828|B3|Native American or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4372527|NCT00344500|4199829|B2|Native American or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4372528|NCT00344500|4199830|B1|Native American or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4372529|NCT00344500|4199828|B3|Hispanic, Latino, or Spanish Origin||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4372530|NCT00344500|4199829|B2|Hispanic, Latino, or Spanish Origin||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4372531|NCT00344500|4199830|B1|Hispanic, Latino, or Spanish Origin||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4372532|NCT00344500|4199828|B3|Caucasian, White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4372533|NCT00344500|4199829|B2|Caucasian, White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4372534|NCT00344500|4199830|B1|Caucasian, White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4372535|NCT00344500|4199828|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4372536|NCT00344500|4199829|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4372537|NCT00344500|4199830|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4372538|NCT00344500|4199828|B3|African American or Black||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4372539|NCT00344500|4199829|B2|African American or Black||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4372540|NCT00344500|4199830|B1|African American or Black||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4372541|NCT00344500|4199828|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4372542|NCT00344500|4199829|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4372543|NCT00344500|4199830|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4372544|NCT00344500|4199828|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4372545|NCT00344500|4199829|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4372546|NCT00344500|4199830|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4372547|NCT00344500|4199828|B3|||Age||years|Mean|49.63|49.63|Standard Deviation|7.9138|7.9138|||
4372548|NCT00344500|4199829|B2|||Age||years|Mean|49.67|49.67|Standard Deviation|6.9|6.9|||
4372549|NCT00344500|4199830|B1|||Age||years|Mean|49.58|49.58|Standard Deviation|9.1|9.1|||
4372550|NCT00344487|4199843|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4372551|NCT00344487|4199843|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4372552|NCT00344487|4199843|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372553|NCT00344487|4199843|B1|||Age||years|Mean|43|43.0|Standard Deviation|3|3.0|||
4372554|NCT00344487|4199843|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372555|NCT00344487|4199843|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4372556|NCT00344487|4199843|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372557|NCT00344461|4199847|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4372558|NCT00344461|4199847|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372559|NCT00344461|4199847|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372560|NCT00344461|4199847|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4372561|NCT00344461|4199847|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4372562|NCT00344461|4199847|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372563|NCT00344461|4199847|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372564|NCT00344461|4199847|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372565|NCT00344461|4199847|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4372566|NCT00344461|4199847|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4372567|NCT00344461|4199847|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372568|NCT00344461|4199847|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4372569|NCT00344461|4199847|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372570|NCT00344448|4199856|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4372571|NCT00344448|4199857|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4372572|NCT00344448|4199858|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4372573|NCT00344448|4199856|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4372574|NCT00344448|4199857|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4372575|NCT00344448|4199858|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372576|NCT00344448|4199856|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4372577|NCT00344448|4199857|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4372578|NCT00344448|4199858|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4372579|NCT00344448|4199856|B3|||Age||years|Mean|53|53.0|Standard Deviation|11.2|11.2|||
4372580|NCT00344448|4199857|B2|||Age||years|Mean|53|53.0|Standard Deviation|4.16|4.16|||
4372581|NCT00344448|4199858|B1|||Age||years|Mean|51|51.0|Standard Deviation|13.3|13.3|||
4372582|NCT00344448|4199856|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372583|NCT00344448|4199857|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372584|NCT00344448|4199858|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372585|NCT00344448|4199856|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4372586|NCT00344448|4199857|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4372587|NCT00344448|4199858|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4372588|NCT00344448|4199856|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372589|NCT00344448|4199857|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372590|NCT00344448|4199858|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372591|NCT00344370|4199865|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4372592|NCT00344370|4199866|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4372593|NCT00344370|4199867|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4372594|NCT00344370|4199865|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4372595|NCT00344370|4199866|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4372596|NCT00344370|4199867|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4372597|NCT00344370|4199865|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|9.61|9.61|||
4372598|NCT00344370|4199866|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|9.21|9.21|||
4372599|NCT00344370|4199867|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|9.83|9.83|||
4372600|NCT00344370|4199865|B3||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4372601|NCT00344370|4199866|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4372602|NCT00344370|4199867|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4372603|NCT00344370|4199865|B3||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
4372604|NCT00344370|4199866|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4372605|NCT00344370|4199867|B1||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4372606|NCT00344370|4199865|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372607|NCT00344370|4199866|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372608|NCT00344370|4199867|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372609|NCT00344318|4199876|B5||Male|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4372610|NCT00344318|4199877|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4372611|NCT00344318|4199878|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4372612|NCT00344318|4199879|B2||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4372613|NCT00344318|4199880|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4372614|NCT00344318|4199876|B5||Female|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4372615|NCT00344318|4199877|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4372616|NCT00344318|4199878|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4372617|NCT00344318|4199879|B2||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4372618|NCT00344318|4199880|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4372619|NCT00344318|4199876|B5|||Age||Weeks|Mean|7.45|7.45|Standard Deviation|1.56|1.56|||
4372620|NCT00344318|4199877|B4|||Age||Weeks|Mean|7.5|7.5|Standard Deviation|1.55|1.55|||
4372621|NCT00344318|4199878|B3|||Age||Weeks|Mean|7.4|7.4|Standard Deviation|1.53|1.53|||
4372622|NCT00344318|4199879|B2|||Age||Weeks|Mean|7.4|7.4|Standard Deviation|1.5|1.5|||
4372623|NCT00344318|4199880|B1|||Age||Weeks|Mean|7.5|7.5|Standard Deviation|1.64|1.64|||
4372624|NCT00344305|4200003|B3|No||History of receiving an influenza vaccine||participants|Number|84|84.0||||||
4372625|NCT00344305|4200004|B2|No||History of receiving an influenza vaccine||participants|Number|27|27.0||||||
4372626|NCT00344305|4200005|B1|No||History of receiving an influenza vaccine||participants|Number|57|57.0||||||
4372627|NCT00344305|4200003|B3|Yes||History of receiving an influenza vaccine||participants|Number|116|116.0||||||
4372628|NCT00344305|4200004|B2|Yes||History of receiving an influenza vaccine||participants|Number|73|73.0||||||
4372629|NCT00344305|4200005|B1|Yes||History of receiving an influenza vaccine||participants|Number|43|43.0||||||
4372630|NCT00344305|4200003|B3|No||History of laboratory-confirmed influenza illness in previous influenza season||participants|Number|197|197.0||||||
4372631|NCT00344305|4200004|B2|No||History of laboratory-confirmed influenza illness in previous influenza season||participants|Number|98|98.0||||||
4372632|NCT00344305|4200005|B1|No||History of laboratory-confirmed influenza illness in previous influenza season||participants|Number|99|99.0||||||
4372633|NCT00344305|4200003|B3|Yes||History of laboratory-confirmed influenza illness in previous influenza season||participants|Number|3|3.0||||||
4372634|NCT00344305|4200004|B2|Yes||History of laboratory-confirmed influenza illness in previous influenza season||participants|Number|2|2.0||||||
4372635|NCT00344305|4200005|B1|Yes||History of laboratory-confirmed influenza illness in previous influenza season||participants|Number|1|1.0||||||
4372636|NCT00344305|4200003|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372637|NCT00344305|4200004|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372638|NCT00344305|4200005|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372639|NCT00344305|4200003|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372640|NCT00344305|4200004|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372641|NCT00344305|4200005|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372642|NCT00344305|4200003|B3||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
4372643|NCT00344305|4200004|B2||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4372644|NCT00344305|4200005|B1||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4372645|NCT00344305|4200003|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4372646|NCT00344305|4200004|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4372647|NCT00344305|4200005|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4372648|NCT00344305|4200003|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372649|NCT00344305|4200004|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372650|NCT00344305|4200005|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372651|NCT00344305|4200003|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4372652|NCT00344305|4200004|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4372653|NCT00344305|4200005|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372654|NCT00344305|4200003|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372655|NCT00344305|4200004|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372656|NCT00344305|4200005|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372657|NCT00344305|4200003|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372658|NCT00344305|4200004|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372659|NCT00344305|4200005|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372660|NCT00344305|4200003|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4372661|NCT00344305|4200004|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4372662|NCT00344305|4200005|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4372663|NCT00344305|4200003|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4372664|NCT00344305|4200004|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4372665|NCT00344305|4200005|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4372666|NCT00344305|4200003|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4372667|NCT00344305|4200004|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4372668|NCT00344305|4200005|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4372669|NCT00344305|4200003|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4372670|NCT00344305|4200004|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4372671|NCT00344305|4200005|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4372672|NCT00344305|4200003|B3|||Age||months|Mean|28.09|28.09|Standard Deviation|15.50|15.5|||
4372673|NCT00344305|4200004|B2|||Age||months|Mean|41.31|41.31|Standard Deviation|9.98|9.98|||
4372674|NCT00344305|4200005|B1|||Age||months|Mean|14.87|14.87|Standard Deviation|5.50|5.5|||
4372675|NCT00344175|4200041|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4372676|NCT00344175|4200042|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4372677|NCT00344175|4200043|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4372678|NCT00344175|4200041|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4372679|NCT00344175|4200042|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4372680|NCT00344175|4200043|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4372681|NCT00344175|4200041|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|6.02|6.02|||
4372682|NCT00344175|4200042|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|6.52|6.52|||
4372683|NCT00344175|4200043|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|5.80|5.8|||
4372684|NCT00344175|4200041|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4372685|NCT00344175|4200042|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4372686|NCT00344175|4200043|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4372687|NCT00344175|4200041|B3||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4372688|NCT00344175|4200042|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4372689|NCT00344175|4200043|B1||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4372690|NCT00344175|4200041|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372691|NCT00344175|4200042|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372692|NCT00344175|4200043|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372693|NCT00344032|4200054|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372694|NCT00344032|4200055|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372695|NCT00344032|4200056|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372696|NCT00344032|4200054|B3||Female|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4372697|NCT00344032|4200055|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4372698|NCT00344032|4200056|B1||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4372699|NCT00344032|4200054|B3|||Age||Years|Mean|28.5|28.5|Standard Deviation|4.83|4.83|||
4372700|NCT00344032|4200055|B2|||Age||Years|Mean|28.5|28.5|Standard Deviation|4.97|4.97|||
4372701|NCT00344032|4200056|B1|||Age||Years|Mean|28.5|28.5|Standard Deviation|4.70|4.7|||
4372702|NCT00344019|4200073|B4|United States||Region of Enrollment||participants|Number|97|97.0||||||
4372703|NCT00344019|4200074|B3|United States||Region of Enrollment||participants|Number|97|97.0||||||
4372704|NCT00344019|4200073|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4372705|NCT00344019|4200074|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4372706|NCT00344019|4200073|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372707|NCT00344019|4200074|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372708|NCT00344019|4200073|B4||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4372709|NCT00344019|4200074|B3||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4372710|NCT00344019|4200073|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4372711|NCT00344019|4200074|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4372712|NCT00344019|4200073|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372713|NCT00344019|4200074|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372714|NCT00344019|4200073|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372715|NCT00344019|4200074|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372716|NCT00344019|4200073|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372717|NCT00344019|4200074|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372718|NCT00344019|4200073|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372719|NCT00344019|4200074|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372720|NCT00344019|4200073|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4372721|NCT00344019|4200074|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4372722|NCT00344019|4200073|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372723|NCT00344019|4200074|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372724|NCT00344019|4200073|B4||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4372725|NCT00344019|4200074|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4372726|NCT00344019|4200073|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4372727|NCT00344019|4200074|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4372728|NCT00344019|4200073|B4|Age >18 yrs||Age, Customized||Participants|Count of Participants|97|97.0||||||
4372729|NCT00344019|4200074|B3|Age >18 yrs||Age, Customized||Participants|Count of Participants|97|97.0||||||
4372730|NCT00344019|4200075|B2|Age >18 yrs||Age, Customized||Participants|Count of Participants|0|0.0||||||
4372731|NCT00344019|4200076|B1|Age >18 yrs||Age, Customized||Participants|Count of Participants|0|0.0||||||
4372732|NCT00343915|4200094|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4372733|NCT00343915|4200095|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4372734|NCT00343915|4200096|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4372735|NCT00343915|4200094|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4372736|NCT00343915|4200095|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4372737|NCT00343915|4200096|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4372738|NCT00343915|4200094|B3|||Age||years|Mean|12.8|12.8|Standard Deviation|1.26|1.26|||
4372739|NCT00343915|4200095|B2|||Age||years|Mean|12.7|12.7|Standard Deviation|1.32|1.32|||
4372740|NCT00343915|4200096|B1|||Age||years|Mean|12.9|12.9|Standard Deviation|1.23|1.23|||
4372741|NCT00343889|4200121|B3|Philippines||Region of Enrollment||Participants|Number|379|379.0||||||
4372742|NCT00343889|4200122|B2|Philippines||Region of Enrollment||Participants|Number|189|189.0||||||
4372743|NCT00343889|4200123|B1|Philippines||Region of Enrollment||Participants|Number|190|190.0||||||
4372744|NCT00343889|4200121|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4372745|NCT00343889|4200122|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4372746|NCT00343889|4200123|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4372747|NCT00343889|4200121|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4372748|NCT00343889|4200122|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4372749|NCT00343889|4200123|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4372750|NCT00343889|4200121|B3|||Age||Weeks|Mean|6.31|6.31|Standard Deviation|0.306|0.306|||
4372751|NCT00343889|4200122|B2|||Age||Weeks|Mean|6.31|6.31|Standard Deviation|0.304|0.304|||
4372752|NCT00343889|4200123|B1|||Age||Weeks|Mean|6.31|6.31|Standard Deviation|0.308|0.308|||
4372753|NCT00343889|4200121|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372754|NCT00343889|4200122|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372755|NCT00343889|4200123|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372756|NCT00343889|4200121|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4372757|NCT00343889|4200122|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4372758|NCT00343889|4200123|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4372759|NCT00343889|4200121|B3||<=18 years|Age||Participants|Count of Participants|379|379.0||||||
4372760|NCT00343889|4200122|B2||<=18 years|Age||Participants|Count of Participants|189|189.0||||||
4372761|NCT00343889|4200123|B1||<=18 years|Age||Participants|Count of Participants|190|190.0||||||
4372762|NCT00343863|4200140|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4372763|NCT00343863|4200141|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4372764|NCT00343863|4200142|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372765|NCT00343863|4200140|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372766|NCT00343863|4200141|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372767|NCT00343863|4200142|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372768|NCT00343863|4200140|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4372769|NCT00343863|4200141|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4372770|NCT00343863|4200142|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4372771|NCT00343863|4200140|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372772|NCT00343863|4200141|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372773|NCT00343863|4200142|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372774|NCT00343863|4200140|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372775|NCT00343863|4200141|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372776|NCT00343863|4200142|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372777|NCT00343863|4200140|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372778|NCT00343863|4200141|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372779|NCT00343863|4200142|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372780|NCT00343863|4200140|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372781|NCT00343863|4200141|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372782|NCT00343863|4200142|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372783|NCT00343863|4200140|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4372784|NCT00343863|4200141|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4372785|NCT00343863|4200142|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372786|NCT00343863|4200140|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4372787|NCT00343863|4200141|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4372788|NCT00343863|4200142|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4372789|NCT00343863|4200140|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4372790|NCT00343863|4200141|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4372791|NCT00343863|4200142|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372792|NCT00343863|4200140|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372793|NCT00343863|4200141|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372794|NCT00343863|4200142|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372795|NCT00343863|4200140|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4372796|NCT00343863|4200141|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4372797|NCT00343863|4200142|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4372798|NCT00343863|4200140|B3|||Age||years|Median|50|50.0|Full Range|||29.0|69.0|
4372799|NCT00343863|4200141|B2|||Age||years|Median|49|49.0|Full Range|||29.0|69.0|
4372800|NCT00343863|4200142|B1|||Age||years|Median|54|54.0|Full Range|||45.0|63.0|
4372801|NCT00343785|4200165|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4372802|NCT00343785|4200165|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4372803|NCT00343785|4200165|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4372804|NCT00343785|4200165|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372805|NCT00343785|4200165|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372806|NCT00343785|4200165|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4372807|NCT00343785|4200165|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372808|NCT00343785|4200165|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4372809|NCT00343785|4200165|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4372810|NCT00343785|4200165|B1|||Age||years|Median|15|15.0|Full Range|||3.0|52.0|
4372811|NCT00343564|4200171|B12|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4372812|NCT00343564|4200172|B11|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4372813|NCT00343564|4200173|B10|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4372814|NCT00343564|4200174|B9|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4372815|NCT00343564|4200175|B8|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4372816|NCT00343564|4200176|B7|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4372817|NCT00343564|4200177|B6|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4372818|NCT00343564|4200178|B5|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4372819|NCT00343564|4200179|B4|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4372820|NCT00343564|4200180|B3|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4372821|NCT00343564|4200181|B2|Russian Federation||Region of Enrollment||participants|Number|3|3.0||||||
4372822|NCT00343564|4200182|B1|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4372823|NCT00343564|4200171|B12|United States||Region of Enrollment||participants|Number|53|53.0||||||
4372824|NCT00343564|4200172|B11|United States||Region of Enrollment||participants|Number|7|7.0||||||
4372825|NCT00343564|4200173|B10|United States||Region of Enrollment||participants|Number|8|8.0||||||
4372826|NCT00343564|4200174|B9|United States||Region of Enrollment||participants|Number|2|2.0||||||
4372827|NCT00343564|4200175|B8|United States||Region of Enrollment||participants|Number|3|3.0||||||
4372828|NCT00343564|4200176|B7|United States||Region of Enrollment||participants|Number|4|4.0||||||
4372829|NCT00343564|4200177|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
4372830|NCT00343564|4200178|B5|United States||Region of Enrollment||participants|Number|7|7.0||||||
4372831|NCT00343564|4200179|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
4372832|NCT00343564|4200180|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4372833|NCT00343564|4200181|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4372834|NCT00343564|4200182|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4372835|NCT00343564|4200171|B12||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4372836|NCT00343564|4200172|B11||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4372837|NCT00343564|4200173|B10||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4372838|NCT00343564|4200174|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4372839|NCT00343564|4200175|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4372840|NCT00343564|4200176|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4372841|NCT00343564|4200177|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4372842|NCT00343564|4200178|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4372843|NCT00343564|4200179|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4372844|NCT00343564|4200180|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4372845|NCT00343564|4200181|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4372846|NCT00343564|4200182|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4372847|NCT00343564|4200171|B12||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4372848|NCT00343564|4200172|B11||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4372849|NCT00343564|4200173|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4372850|NCT00343564|4200174|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4372851|NCT00343564|4200175|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4372852|NCT00343564|4200176|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4372853|NCT00343564|4200177|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4372854|NCT00343564|4200178|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4372855|NCT00343564|4200179|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4372856|NCT00343564|4200180|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4372857|NCT00343564|4200181|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4372858|NCT00343564|4200182|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4372859|NCT00343564|4200171|B12|||Age||years|Mean|52|52.0|Standard Deviation|19|19.0|||
4372860|NCT00343564|4200172|B11|||Age||years|Mean|56|56.0|Standard Deviation|20|20.0|||
4372861|NCT00343564|4200173|B10|||Age||years|Mean|48|48.0|Standard Deviation|22|22.0|||
4372862|NCT00343564|4200174|B9|||Age||years|Mean|63|63.0|Standard Deviation|17|17.0|||
4372863|NCT00343564|4200175|B8|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
4372864|NCT00343564|4200176|B7|||Age||years|Mean|69|69.0|Standard Deviation|12|12.0|||
4372865|NCT00343564|4200177|B6|||Age||years|Mean|42|42.0|Standard Deviation|24|24.0|||
4372866|NCT00343564|4200178|B5|||Age||years|Mean|48|48.0|Standard Deviation|16|16.0|||
4372867|NCT00343564|4200179|B4|||Age||years|Mean|57|57.0|Standard Deviation|22|22.0|||
4372868|NCT00343564|4200180|B3|||Age||years|Mean|33|33.0|Standard Deviation|9|9.0|||
4372869|NCT00343564|4200181|B2|||Age||years|Mean|43|43.0|Standard Deviation|13|13.0|||
4372870|NCT00343564|4200182|B1|||Age||years|Mean|62|62.0|Standard Deviation|9|9.0|||
4372871|NCT00343564|4200171|B12||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4372872|NCT00343564|4200172|B11||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4372873|NCT00343564|4200173|B10||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4372874|NCT00343564|4200174|B9||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4372875|NCT00343564|4200175|B8||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4372876|NCT00343564|4200176|B7||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4372877|NCT00343564|4200177|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4372878|NCT00343564|4200178|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4372879|NCT00343564|4200179|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4372880|NCT00343564|4200180|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372881|NCT00343564|4200181|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372882|NCT00343564|4200182|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4372883|NCT00343564|4200171|B12||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4372884|NCT00343564|4200172|B11||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4372885|NCT00343564|4200173|B10||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4372886|NCT00343564|4200174|B9||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4372887|NCT00343564|4200175|B8||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4372888|NCT00343564|4200176|B7||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4372889|NCT00343564|4200177|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4372890|NCT00343564|4200178|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4372891|NCT00343564|4200179|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4372892|NCT00343564|4200180|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4372893|NCT00343564|4200181|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4372894|NCT00343564|4200182|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4372895|NCT00343564|4200171|B12||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4372896|NCT00343564|4200172|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372897|NCT00343564|4200173|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372898|NCT00343564|4200174|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372899|NCT00343564|4200175|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372900|NCT00343564|4200176|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372901|NCT00343564|4200177|B6||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4372902|NCT00343564|4200178|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372903|NCT00343564|4200179|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372904|NCT00343564|4200180|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372905|NCT00343564|4200181|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372906|NCT00343564|4200182|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372907|NCT00343512|4200207|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4372908|NCT00343512|4200207|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4372909|NCT00343512|4200207|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4372910|NCT00343512|4200207|B1|||Age||years|Mean|47|47.0|Standard Deviation|1|1.0|||
4372911|NCT00343512|4200207|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4372912|NCT00343512|4200207|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4372913|NCT00343512|4200207|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4372914|NCT00343460|4200213|B7||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4372915|NCT00343460|4200214|B6||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4372916|NCT00343460|4200215|B5||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4372917|NCT00343460|4200216|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4372918|NCT00343460|4200217|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4372919|NCT00343460|4200218|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4372920|NCT00343460|4200219|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4372921|NCT00343460|4200213|B7||Female|Sex: Female, Male||Participants|Count of Participants|1006|1006.0||||||
4372922|NCT00343460|4200214|B6||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4372923|NCT00343460|4200215|B5||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4372924|NCT00343460|4200216|B4||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4372925|NCT00343460|4200217|B3||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4372926|NCT00343460|4200218|B2||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4372927|NCT00343460|4200219|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4372928|NCT00343460|4200213|B7|||Age||years|Mean|56.62|56.62|Standard Deviation|13.04|13.04|||
4372929|NCT00343460|4200214|B6|||Age||years|Mean|58.1|58.1|Standard Deviation|13.74|13.74|||
4372930|NCT00343460|4200215|B5|||Age||years|Mean|56.8|56.8|Standard Deviation|13.20|13.2|||
4372931|NCT00343460|4200216|B4|||Age||years|Mean|57.6|57.6|Standard Deviation|13.35|13.35|||
4372932|NCT00343460|4200217|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|12.36|12.36|||
4372933|NCT00343460|4200218|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|12.79|12.79|||
4372934|NCT00343460|4200219|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|12.80|12.8|||
4372935|NCT00343382|4200292|B4|No||Breast cancer history||participants|Number|23|23.0||||||
4372936|NCT00343382|4200293|B3|No||Breast cancer history||participants|Number|8|8.0||||||
4372937|NCT00343382|4200294|B2|No||Breast cancer history||participants|Number|6|6.0||||||
4372938|NCT00343382|4200295|B1|No||Breast cancer history||participants|Number|9|9.0||||||
4372939|NCT00343382|4200292|B4|Yes||Breast cancer history||participants|Number|172|172.0||||||
4372940|NCT00343382|4200293|B3|Yes||Breast cancer history||participants|Number|58|58.0||||||
4372941|NCT00343382|4200294|B2|Yes||Breast cancer history||participants|Number|59|59.0||||||
4372942|NCT00343382|4200295|B1|Yes||Breast cancer history||participants|Number|55|55.0||||||
4372943|NCT00343382|4200292|B4|Severe||Severity of vaginal symptoms||participants|Number|87|87.0||||||
4372944|NCT00343382|4200293|B3|Severe||Severity of vaginal symptoms||participants|Number|30|30.0||||||
4372945|NCT00343382|4200294|B2|Severe||Severity of vaginal symptoms||participants|Number|29|29.0||||||
4372946|NCT00343382|4200295|B1|Severe||Severity of vaginal symptoms||participants|Number|28|28.0||||||
4372947|NCT00343382|4200292|B4|Moderate||Severity of vaginal symptoms||participants|Number|90|90.0||||||
4372948|NCT00343382|4200293|B3|Moderate||Severity of vaginal symptoms||participants|Number|30|30.0||||||
4372949|NCT00343382|4200294|B2|Moderate||Severity of vaginal symptoms||participants|Number|30|30.0||||||
4372950|NCT00343382|4200295|B1|Moderate||Severity of vaginal symptoms||participants|Number|30|30.0||||||
4372951|NCT00343382|4200292|B4|Mild||Severity of vaginal symptoms||participants|Number|18|18.0||||||
4372952|NCT00343382|4200293|B3|Mild||Severity of vaginal symptoms||participants|Number|6|6.0||||||
4372953|NCT00343382|4200294|B2|Mild||Severity of vaginal symptoms||participants|Number|6|6.0||||||
4372954|NCT00343382|4200295|B1|Mild||Severity of vaginal symptoms||participants|Number|6|6.0||||||
4372955|NCT00343382|4200292|B4|Unknown||Current aromatase inhibitor||participants|Number|2|2.0||||||
4372956|NCT00343382|4200293|B3|Unknown||Current aromatase inhibitor||participants|Number|1|1.0||||||
4372957|NCT00343382|4200294|B2|Unknown||Current aromatase inhibitor||participants|Number|1|1.0||||||
4372958|NCT00343382|4200295|B1|Unknown||Current aromatase inhibitor||participants|Number|0|0.0||||||
4372959|NCT00343382|4200292|B4|No||Current aromatase inhibitor||participants|Number|82|82.0||||||
4372960|NCT00343382|4200293|B3|No||Current aromatase inhibitor||participants|Number|27|27.0||||||
4372961|NCT00343382|4200294|B2|No||Current aromatase inhibitor||participants|Number|27|27.0||||||
4372962|NCT00343382|4200295|B1|No||Current aromatase inhibitor||participants|Number|28|28.0||||||
4372963|NCT00343382|4200292|B4|Yes||Current aromatase inhibitor||participants|Number|111|111.0||||||
4372964|NCT00343382|4200293|B3|Yes||Current aromatase inhibitor||participants|Number|38|38.0||||||
4372965|NCT00343382|4200294|B2|Yes||Current aromatase inhibitor||participants|Number|37|37.0||||||
4372966|NCT00343382|4200295|B1|Yes||Current aromatase inhibitor||participants|Number|36|36.0||||||
4372967|NCT00343382|4200292|B4|Unknown||Tamoxifen use||participants|Number|2|2.0||||||
4372968|NCT00343382|4200293|B3|Unknown||Tamoxifen use||participants|Number|1|1.0||||||
4372969|NCT00343382|4200294|B2|Unknown||Tamoxifen use||participants|Number|1|1.0||||||
4372970|NCT00343382|4200295|B1|Unknown||Tamoxifen use||participants|Number|0|0.0||||||
4372971|NCT00343382|4200292|B4|No||Tamoxifen use||participants|Number|164|164.0||||||
4372972|NCT00343382|4200293|B3|No||Tamoxifen use||participants|Number|56|56.0||||||
4372973|NCT00343382|4200294|B2|No||Tamoxifen use||participants|Number|54|54.0||||||
4372974|NCT00343382|4200295|B1|No||Tamoxifen use||participants|Number|54|54.0||||||
4372975|NCT00343382|4200292|B4|Yes||Tamoxifen use||participants|Number|29|29.0||||||
4372976|NCT00343382|4200293|B3|Yes||Tamoxifen use||participants|Number|9|9.0||||||
4372977|NCT00343382|4200294|B2|Yes||Tamoxifen use||participants|Number|10|10.0||||||
4372978|NCT00343382|4200295|B1|Yes||Tamoxifen use||participants|Number|10|10.0||||||
4372979|NCT00343382|4200292|B4|United States||Region of Enrollment||participants|Number|195|195.0||||||
4372980|NCT00343382|4200293|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4372981|NCT00343382|4200294|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4372982|NCT00343382|4200295|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4372983|NCT00343382|4200292|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372984|NCT00343382|4200293|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372985|NCT00343382|4200294|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372986|NCT00343382|4200295|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372987|NCT00343382|4200292|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372988|NCT00343382|4200293|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372989|NCT00343382|4200294|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372990|NCT00343382|4200295|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372991|NCT00343382|4200292|B4||White|Race (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
4372992|NCT00343382|4200293|B3||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4372993|NCT00343382|4200294|B2||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4372994|NCT00343382|4200295|B1||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4372995|NCT00343382|4200292|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4372996|NCT00343382|4200293|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4372997|NCT00343382|4200294|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4372998|NCT00343382|4200295|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4372999|NCT00343382|4200292|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373000|NCT00343382|4200293|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373001|NCT00343382|4200294|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373002|NCT00343382|4200295|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373003|NCT00343382|4200292|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373004|NCT00343382|4200293|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373005|NCT00343382|4200294|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373006|NCT00343382|4200295|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373007|NCT00343382|4200292|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4373008|NCT00343382|4200293|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4373009|NCT00343382|4200294|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373010|NCT00343382|4200295|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4373011|NCT00343382|4200292|B4|Female||Sex/Gender, Customized||participants|Number|195|195.0||||||
4373012|NCT00343382|4200293|B3|Female||Sex/Gender, Customized||participants|Number|66|66.0||||||
4373013|NCT00343382|4200294|B2|Female||Sex/Gender, Customized||participants|Number|65|65.0||||||
4373014|NCT00343382|4200295|B1|Female||Sex/Gender, Customized||participants|Number|64|64.0||||||
4373015|NCT00343382|4200292|B4|||Age||years|Mean|54.8|54.8|Standard Deviation|7.74|7.74|||
4373016|NCT00343382|4200293|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|7.25|7.25|||
4373017|NCT00343382|4200294|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|8.14|8.14|||
4373018|NCT00343382|4200295|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|7.93|7.93|||
4373019|NCT00343291|4200314|B3|Missing/Unknown||Smoking Status||participants|Number|1|1.0||||||
4373020|NCT00343291|4200315|B2|Missing/Unknown||Smoking Status||participants|Number|1|1.0||||||
4373021|NCT00343291|4200316|B1|Missing/Unknown||Smoking Status||participants|Number|0|0.0||||||
4373022|NCT00343291|4200314|B3|Not Exposed to Second-hand Smoke||Smoking Status||participants|Number|8|8.0||||||
4373023|NCT00343291|4200315|B2|Not Exposed to Second-hand Smoke||Smoking Status||participants|Number|4|4.0||||||
4373024|NCT00343291|4200316|B1|Not Exposed to Second-hand Smoke||Smoking Status||participants|Number|4|4.0||||||
4373025|NCT00343291|4200314|B3|Exposed to Second-hand Smoke||Smoking Status||participants|Number|3|3.0||||||
4373026|NCT00343291|4200315|B2|Exposed to Second-hand Smoke||Smoking Status||participants|Number|1|1.0||||||
4373027|NCT00343291|4200316|B1|Exposed to Second-hand Smoke||Smoking Status||participants|Number|2|2.0||||||
4373028|NCT00343291|4200314|B3|Past||Smoking Status||participants|Number|81|81.0||||||
4373029|NCT00343291|4200315|B2|Past||Smoking Status||participants|Number|44|44.0||||||
4373030|NCT00343291|4200316|B1|Past||Smoking Status||participants|Number|37|37.0||||||
4373031|NCT00343291|4200314|B3|Current||Smoking Status||participants|Number|28|28.0||||||
4373032|NCT00343291|4200315|B2|Current||Smoking Status||participants|Number|11|11.0||||||
4373033|NCT00343291|4200316|B1|Current||Smoking Status||participants|Number|17|17.0||||||
4373034|NCT00343291|4200314|B3|Missing/Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|13|13.0||||||
4373035|NCT00343291|4200315|B2|Missing/Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|5|5.0||||||
4373036|NCT00343291|4200316|B1|Missing/Unknown||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|8|8.0||||||
4373037|NCT00343291|4200314|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|55|55.0||||||
4373038|NCT00343291|4200315|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|27|27.0||||||
4373039|NCT00343291|4200316|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|28|28.0||||||
4373040|NCT00343291|4200314|B3|0 - Full Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|53|53.0||||||
4373041|NCT00343291|4200315|B2|0 - Full Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|29|29.0||||||
4373042|NCT00343291|4200316|B1|0 - Full Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|24|24.0||||||
4373043|NCT00343291|4200314|B3|United States||Region of Enrollment||participants|Number|121|121.0||||||
4373044|NCT00343291|4200315|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4373045|NCT00343291|4200316|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4373046|NCT00343291|4200314|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373047|NCT00343291|4200315|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4373048|NCT00343291|4200316|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4373049|NCT00343291|4200314|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373050|NCT00343291|4200315|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4373051|NCT00343291|4200316|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373052|NCT00343291|4200314|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373053|NCT00343291|4200315|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4373054|NCT00343291|4200316|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4373055|NCT00343291|4200314|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4373056|NCT00343291|4200315|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4373057|NCT00343291|4200316|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4373058|NCT00343291|4200314|B3|White||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4373059|NCT00343291|4200315|B2|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4373060|NCT00343291|4200316|B1|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4373061|NCT00343291|4200314|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4373062|NCT00343291|4200315|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4373063|NCT00343291|4200316|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4373064|NCT00343291|4200314|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4373065|NCT00343291|4200315|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4373066|NCT00343291|4200316|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4373067|NCT00343291|4200314|B3|≥ 70 years||Age, Customized||participants|Number|29|29.0||||||
4373068|NCT00343291|4200315|B2|≥ 70 years||Age, Customized||participants|Number|10|10.0||||||
4373069|NCT00343291|4200316|B1|≥ 70 years||Age, Customized||participants|Number|19|19.0||||||
4373070|NCT00343291|4200314|B3|< 70 years||Age, Customized||participants|Number|92|92.0||||||
4373071|NCT00343291|4200315|B2|< 70 years||Age, Customized||participants|Number|51|51.0||||||
4373072|NCT00343291|4200316|B1|< 70 years||Age, Customized||participants|Number|41|41.0||||||
4373073|NCT00343291|4200314|B3|≥ 65 years||Age, Customized||participants|Number|58|58.0||||||
4373074|NCT00343291|4200315|B2|≥ 65 years||Age, Customized||participants|Number|29|29.0||||||
4373075|NCT00343291|4200316|B1|≥ 65 years||Age, Customized||participants|Number|29|29.0||||||
4373076|NCT00343291|4200314|B3|< 65 years||Age, Customized||participants|Number|63|63.0||||||
4373077|NCT00343291|4200315|B2|< 65 years||Age, Customized||participants|Number|32|32.0||||||
4373078|NCT00343291|4200316|B1|< 65 years||Age, Customized||participants|Number|31|31.0||||||
4373079|NCT00343291|4200314|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|10.29|10.29|||
4373080|NCT00343291|4200315|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|8.97|8.97|||
4373081|NCT00343291|4200316|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|11.52|11.52|||
4373082|NCT00343252|4200331|B3|||Weight||kilograms|Mean|62.65|62.65|Standard Deviation|12.63|12.63|||
4373083|NCT00343252|4200332|B2|||Weight||kilograms|Mean|62.27|62.27|Standard Deviation|12.58|12.58|||
4373084|NCT00343252|4200333|B1|||Weight||kilograms|Mean|63.02|63.02|Standard Deviation|12.70|12.7|||
4373085|NCT00343252|4200331|B3|||Roland-Morris Disability Questionnaire Score|Roland-Morris Disability Questionnaire (RMDQ-24) is completed by the participant and measures the degree of disability due to back pain. The questionnaire consists of 24 statements and the participant is instructed to put a mark next to each appropriate statement. The number of statements marked is added up by the clinician and a total score is given. The total score ranges from 0 (no disability) to 24 (severe disability).|units on a scale|Mean|12.00|12.0|Standard Deviation|5.44|5.44|||
4373165|NCT00343252|4200333|B1|Italy||Region of Enrollment||participants|Number|22|22.0||||||
4373086|NCT00343252|4200332|B2|||Roland-Morris Disability Questionnaire Score|Roland-Morris Disability Questionnaire (RMDQ-24) is completed by the participant and measures the degree of disability due to back pain. The questionnaire consists of 24 statements and the participant is instructed to put a mark next to each appropriate statement. The number of statements marked is added up by the clinician and a total score is given. The total score ranges from 0 (no disability) to 24 (severe disability).|units on a scale|Mean|12.12|12.12|Standard Deviation|5.40|5.4|||
4373087|NCT00343252|4200333|B1|||Roland-Morris Disability Questionnaire Score|Roland-Morris Disability Questionnaire (RMDQ-24) is completed by the participant and measures the degree of disability due to back pain. The questionnaire consists of 24 statements and the participant is instructed to put a mark next to each appropriate statement. The number of statements marked is added up by the clinician and a total score is given. The total score ranges from 0 (no disability) to 24 (severe disability).|units on a scale|Mean|11.88|11.88|Standard Deviation|5.47|5.47|||
4373088|NCT00343252|4200331|B3|||Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) Score|QUALEFFO is an osteoporosis-specific health instrument developed specifically for participants with vertebral deformities used to evaluate the effect of back pain and treatment on quality of life. The QUALEFFO questionnaire includes 41 items in 5 domains: pain, physical function, social function, general health perception, and mental function. The total score is calculated according to the scoring algorithm developed by the International Osteoporosis Foundation. Total scores are reported from 0 to 100, with lower scores corresponding to better quality of life.|units on a scale|Mean|47.03|47.03|Standard Deviation|14.49|14.49|||
4373089|NCT00343252|4200332|B2|||Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) Score|QUALEFFO is an osteoporosis-specific health instrument developed specifically for participants with vertebral deformities used to evaluate the effect of back pain and treatment on quality of life. The QUALEFFO questionnaire includes 41 items in 5 domains: pain, physical function, social function, general health perception, and mental function. The total score is calculated according to the scoring algorithm developed by the International Osteoporosis Foundation. Total scores are reported from 0 to 100, with lower scores corresponding to better quality of life.|units on a scale|Mean|46.98|46.98|Standard Deviation|14.39|14.39|||
4373090|NCT00343252|4200333|B1|||Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) Score|QUALEFFO is an osteoporosis-specific health instrument developed specifically for participants with vertebral deformities used to evaluate the effect of back pain and treatment on quality of life. The QUALEFFO questionnaire includes 41 items in 5 domains: pain, physical function, social function, general health perception, and mental function. The total score is calculated according to the scoring algorithm developed by the International Osteoporosis Foundation. Total scores are reported from 0 to 100, with lower scores corresponding to better quality of life.|units on a scale|Mean|47.08|47.08|Standard Deviation|14.61|14.61|||
4373091|NCT00343252|4200331|B3|||Height||centimeters|Mean|154.23|154.23|Standard Deviation|7.66|7.66|||
4373092|NCT00343252|4200332|B2|||Height||centimeters|Mean|153.62|153.62|Standard Deviation|7.86|7.86|||
4373093|NCT00343252|4200333|B1|||Height||centimeters|Mean|154.82|154.82|Standard Deviation|7.41|7.41|||
4373094|NCT00343252|4200331|B3|||Duration of Back Pain||days|Mean|550.58|550.58|Standard Deviation|842.78|842.78|||
4373095|NCT00343252|4200332|B2|||Duration of Back Pain||days|Mean|550.88|550.88|Standard Deviation|750.47|750.47|||
4373096|NCT00343252|4200333|B1|||Duration of Back Pain||days|Mean|550.33|550.33|Standard Deviation|918.18|918.18|||
4373097|NCT00343252|4200331|B3|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/meters squared|Mean|26.33|26.33|Standard Deviation|4.96|4.96|||
4373098|NCT00343252|4200332|B2|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/meters squared|Mean|26.36|26.36|Standard Deviation|4.91|4.91|||
4373099|NCT00343252|4200333|B1|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/meters squared|Mean|26.30|26.3|Standard Deviation|5.01|5.01|||
4373100|NCT00343252|4200331|B3|||24-Hour Worst Back Pain Score|24-hour worst back pain severity scores recorded daily on an 11-point numeric rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point scale is used for assessment of worst back pain in the preceding 24 hours and is evaluated daily in the week prior to each scheduled study visit. Responders are defined as participants with at least a 30% reduction in the severity of worst back pain from baseline to the 6-month last observation carried forward (LOCF) endpoint.|units on a scale|Mean|6.85|6.85|Standard Deviation|1.59|1.59|||
4373101|NCT00343252|4200332|B2|||24-Hour Worst Back Pain Score|24-hour worst back pain severity scores recorded daily on an 11-point numeric rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point scale is used for assessment of worst back pain in the preceding 24 hours and is evaluated daily in the week prior to each scheduled study visit. Responders are defined as participants with at least a 30% reduction in the severity of worst back pain from baseline to the 6-month last observation carried forward (LOCF) endpoint.|units on a scale|Mean|6.91|6.91|Standard Deviation|1.54|1.54|||
4373102|NCT00343252|4200333|B1|||24-Hour Worst Back Pain Score|24-hour worst back pain severity scores recorded daily on an 11-point numeric rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point scale is used for assessment of worst back pain in the preceding 24 hours and is evaluated daily in the week prior to each scheduled study visit. Responders are defined as participants with at least a 30% reduction in the severity of worst back pain from baseline to the 6-month last observation carried forward (LOCF) endpoint.|units on a scale|Mean|6.80|6.8|Standard Deviation|1.63|1.63|||
4373103|NCT00343252|4200331|B3|||24-Hour Average Back Pain Score|24-hour average back pain severity scores recorded daily on an 11-point numeric rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point scale is used for assessment of average back pain in the preceding 24 hours and is evaluated daily in the week prior to each scheduled study visit. Responders are defined as participants with at least a 30% reduction in the severity of average back pain from baseline to the specified last observation carried forward (LOCF) endpoint.|units on a scale|Mean|5.37|5.37|Standard Deviation|1.85|1.85|||
4373134|NCT00343252|4200332|B2|No||Prior Osteoporosis Drug Use|Participants answered yes or no regarding use of osteoporosis drugs prior to this study.|participants|Number|92|92.0||||||
4373104|NCT00343252|4200332|B2|||24-Hour Average Back Pain Score|24-hour average back pain severity scores recorded daily on an 11-point numeric rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point scale is used for assessment of average back pain in the preceding 24 hours and is evaluated daily in the week prior to each scheduled study visit. Responders are defined as participants with at least a 30% reduction in the severity of average back pain from baseline to the specified last observation carried forward (LOCF) endpoint.|units on a scale|Mean|5.40|5.4|Standard Deviation|1.85|1.85|||
4373105|NCT00343252|4200333|B1|||24-Hour Average Back Pain Score|24-hour average back pain severity scores recorded daily on an 11-point numeric rating scale, an ordinal scale ranging from 0 (no pain) to 10 (worst possible pain). The 11-point scale is used for assessment of average back pain in the preceding 24 hours and is evaluated daily in the week prior to each scheduled study visit. Responders are defined as participants with at least a 30% reduction in the severity of average back pain from baseline to the specified last observation carried forward (LOCF) endpoint.|units on a scale|Mean|5.34|5.34|Standard Deviation|1.86|1.86|||
4373106|NCT00343252|4200331|B3|Unknown or Not Reported||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|15|15.0||||||
4373107|NCT00343252|4200332|B2|Unknown or Not Reported||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|7|7.0||||||
4373108|NCT00343252|4200333|B1|Unknown or Not Reported||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|8|8.0||||||
4373109|NCT00343252|4200331|B3|>=3||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|468|468.0||||||
4373110|NCT00343252|4200332|B2|>=3||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|232|232.0||||||
4373111|NCT00343252|4200333|B1|>=3||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|236|236.0||||||
4373112|NCT00343252|4200331|B3|2||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|143|143.0||||||
4373113|NCT00343252|4200332|B2|2||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|67|67.0||||||
4373114|NCT00343252|4200333|B1|2||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|76|76.0||||||
4373115|NCT00343252|4200331|B3|1||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|27|27.0||||||
4373116|NCT00343252|4200332|B2|1||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|16|16.0||||||
4373117|NCT00343252|4200333|B1|1||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|11|11.0||||||
4373118|NCT00343252|4200331|B3|0||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|57|57.0||||||
4373119|NCT00343252|4200332|B2|0||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|28|28.0||||||
4373120|NCT00343252|4200333|B1|0||Spinal Deformity Index|Spinal deformity index is the summation of the severity of the vertebral fracture(s).|units on a scale|Number|29|29.0||||||
4373121|NCT00343252|4200331|B3|Unknown or Not Reported||Severity of Vertebral Fracture|An experienced radiologist graded all vertebrae by visual inspection from normal (grade 0) to severely deformed (grade 3).|participants|Number|15|15.0||||||
4373122|NCT00343252|4200332|B2|Unknown or Not Reported||Severity of Vertebral Fracture|An experienced radiologist graded all vertebrae by visual inspection from normal (grade 0) to severely deformed (grade 3).|participants|Number|7|7.0||||||
4373123|NCT00343252|4200333|B1|Unknown or Not Reported||Severity of Vertebral Fracture|An experienced radiologist graded all vertebrae by visual inspection from normal (grade 0) to severely deformed (grade 3).|participants|Number|8|8.0||||||
4373124|NCT00343252|4200331|B3|Severe (Grade 3)||Severity of Vertebral Fracture|An experienced radiologist graded all vertebrae by visual inspection from normal (grade 0) to severely deformed (grade 3).|participants|Number|273|273.0||||||
4373125|NCT00343252|4200332|B2|Severe (Grade 3)||Severity of Vertebral Fracture|An experienced radiologist graded all vertebrae by visual inspection from normal (grade 0) to severely deformed (grade 3).|participants|Number|131|131.0||||||
4373126|NCT00343252|4200333|B1|Severe (Grade 3)||Severity of Vertebral Fracture|An experienced radiologist graded all vertebrae by visual inspection from normal (grade 0) to severely deformed (grade 3).|participants|Number|142|142.0||||||
4373127|NCT00343252|4200331|B3|Moderate Severity (Grade 2)||Severity of Vertebral Fracture|An experienced radiologist graded all vertebrae by visual inspection from normal (grade 0) to severely deformed (grade 3).|participants|Number|326|326.0||||||
4373128|NCT00343252|4200332|B2|Moderate Severity (Grade 2)||Severity of Vertebral Fracture|An experienced radiologist graded all vertebrae by visual inspection from normal (grade 0) to severely deformed (grade 3).|participants|Number|166|166.0||||||
4373129|NCT00343252|4200333|B1|Moderate Severity (Grade 2)||Severity of Vertebral Fracture|An experienced radiologist graded all vertebrae by visual inspection from normal (grade 0) to severely deformed (grade 3).|participants|Number|160|160.0||||||
4373130|NCT00343252|4200331|B3|Zero or Mild Severity (Grade 0)||Severity of Vertebral Fracture|An experienced radiologist graded all vertebrae by visual inspection from normal (grade 0) to severely deformed (grade 3).|participants|Number|96|96.0||||||
4373131|NCT00343252|4200332|B2|Zero or Mild Severity (Grade 0)||Severity of Vertebral Fracture|An experienced radiologist graded all vertebrae by visual inspection from normal (grade 0) to severely deformed (grade 3).|participants|Number|46|46.0||||||
4373132|NCT00343252|4200333|B1|Zero or Mild Severity (Grade 0)||Severity of Vertebral Fracture|An experienced radiologist graded all vertebrae by visual inspection from normal (grade 0) to severely deformed (grade 3).|participants|Number|50|50.0||||||
4373133|NCT00343252|4200331|B3|No||Prior Osteoporosis Drug Use|Participants answered yes or no regarding use of osteoporosis drugs prior to this study.|participants|Number|185|185.0||||||
4373135|NCT00343252|4200333|B1|No||Prior Osteoporosis Drug Use|Participants answered yes or no regarding use of osteoporosis drugs prior to this study.|participants|Number|93|93.0||||||
4373136|NCT00343252|4200331|B3|Yes||Prior Osteoporosis Drug Use|Participants answered yes or no regarding use of osteoporosis drugs prior to this study.|participants|Number|525|525.0||||||
4373137|NCT00343252|4200332|B2|Yes||Prior Osteoporosis Drug Use|Participants answered yes or no regarding use of osteoporosis drugs prior to this study.|participants|Number|258|258.0||||||
4373138|NCT00343252|4200333|B1|Yes||Prior Osteoporosis Drug Use|Participants answered yes or no regarding use of osteoporosis drugs prior to this study.|participants|Number|267|267.0||||||
4373139|NCT00343252|4200331|B3|>=2 Vertebral Fractures||Number of Vertebral Fractures|A minimum of at least one moderate osteoporotic vertebral fracture was radiologically detected and vertebral fracture status was documented. A moderate vertebral fracture was defined as at least a 25% decrease in anterior, central, or posterior vertebral height (T4 to L4) as compared to the average height of adjacent vertebrae. This measure categorizes the number of vertebral fractures for each participant.|participants|Number|408|408.0||||||
4373140|NCT00343252|4200332|B2|>=2 Vertebral Fractures||Number of Vertebral Fractures|A minimum of at least one moderate osteoporotic vertebral fracture was radiologically detected and vertebral fracture status was documented. A moderate vertebral fracture was defined as at least a 25% decrease in anterior, central, or posterior vertebral height (T4 to L4) as compared to the average height of adjacent vertebrae. This measure categorizes the number of vertebral fractures for each participant.|participants|Number|211|211.0||||||
4373141|NCT00343252|4200333|B1|>=2 Vertebral Fractures||Number of Vertebral Fractures|A minimum of at least one moderate osteoporotic vertebral fracture was radiologically detected and vertebral fracture status was documented. A moderate vertebral fracture was defined as at least a 25% decrease in anterior, central, or posterior vertebral height (T4 to L4) as compared to the average height of adjacent vertebrae. This measure categorizes the number of vertebral fractures for each participant.|participants|Number|197|197.0||||||
4373142|NCT00343252|4200331|B3|1 Vertebral Fracture||Number of Vertebral Fractures|A minimum of at least one moderate osteoporotic vertebral fracture was radiologically detected and vertebral fracture status was documented. A moderate vertebral fracture was defined as at least a 25% decrease in anterior, central, or posterior vertebral height (T4 to L4) as compared to the average height of adjacent vertebrae. This measure categorizes the number of vertebral fractures for each participant.|participants|Number|230|230.0||||||
4373143|NCT00343252|4200332|B2|1 Vertebral Fracture||Number of Vertebral Fractures|A minimum of at least one moderate osteoporotic vertebral fracture was radiologically detected and vertebral fracture status was documented. A moderate vertebral fracture was defined as at least a 25% decrease in anterior, central, or posterior vertebral height (T4 to L4) as compared to the average height of adjacent vertebrae. This measure categorizes the number of vertebral fractures for each participant.|participants|Number|104|104.0||||||
4373144|NCT00343252|4200333|B1|1 Vertebral Fracture||Number of Vertebral Fractures|A minimum of at least one moderate osteoporotic vertebral fracture was radiologically detected and vertebral fracture status was documented. A moderate vertebral fracture was defined as at least a 25% decrease in anterior, central, or posterior vertebral height (T4 to L4) as compared to the average height of adjacent vertebrae. This measure categorizes the number of vertebral fractures for each participant.|participants|Number|126|126.0||||||
4373145|NCT00343252|4200331|B3|Unknown or No Vertebral Fractures||Number of Vertebral Fractures|A minimum of at least one moderate osteoporotic vertebral fracture was radiologically detected and vertebral fracture status was documented. A moderate vertebral fracture was defined as at least a 25% decrease in anterior, central, or posterior vertebral height (T4 to L4) as compared to the average height of adjacent vertebrae. This measure categorizes the number of vertebral fractures for each participant.|participants|Number|72|72.0||||||
4373146|NCT00343252|4200332|B2|Unknown or No Vertebral Fractures||Number of Vertebral Fractures|A minimum of at least one moderate osteoporotic vertebral fracture was radiologically detected and vertebral fracture status was documented. A moderate vertebral fracture was defined as at least a 25% decrease in anterior, central, or posterior vertebral height (T4 to L4) as compared to the average height of adjacent vertebrae. This measure categorizes the number of vertebral fractures for each participant.|participants|Number|35|35.0||||||
4373147|NCT00343252|4200333|B1|Unknown or No Vertebral Fractures||Number of Vertebral Fractures|A minimum of at least one moderate osteoporotic vertebral fracture was radiologically detected and vertebral fracture status was documented. A moderate vertebral fracture was defined as at least a 25% decrease in anterior, central, or posterior vertebral height (T4 to L4) as compared to the average height of adjacent vertebrae. This measure categorizes the number of vertebral fractures for each participant.|participants|Number|37|37.0||||||
4373148|NCT00343252|4200331|B3|Germany||Region of Enrollment||participants|Number|70|70.0||||||
4373149|NCT00343252|4200332|B2|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4373150|NCT00343252|4200333|B1|Germany||Region of Enrollment||participants|Number|36|36.0||||||
4373151|NCT00343252|4200331|B3|Sweden||Region of Enrollment||participants|Number|23|23.0||||||
4373152|NCT00343252|4200332|B2|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4373153|NCT00343252|4200333|B1|Sweden||Region of Enrollment||participants|Number|13|13.0||||||
4373154|NCT00343252|4200331|B3|Spain||Region of Enrollment||participants|Number|64|64.0||||||
4373155|NCT00343252|4200332|B2|Spain||Region of Enrollment||participants|Number|32|32.0||||||
4373156|NCT00343252|4200333|B1|Spain||Region of Enrollment||participants|Number|32|32.0||||||
4373157|NCT00343252|4200331|B3|Puerto Rico||Region of Enrollment||participants|Number|22|22.0||||||
4373158|NCT00343252|4200332|B2|Puerto Rico||Region of Enrollment||participants|Number|10|10.0||||||
4373159|NCT00343252|4200333|B1|Puerto Rico||Region of Enrollment||participants|Number|12|12.0||||||
4373160|NCT00343252|4200331|B3|Mexico||Region of Enrollment||participants|Number|46|46.0||||||
4373161|NCT00343252|4200332|B2|Mexico||Region of Enrollment||participants|Number|23|23.0||||||
4373162|NCT00343252|4200333|B1|Mexico||Region of Enrollment||participants|Number|23|23.0||||||
4373163|NCT00343252|4200331|B3|Italy||Region of Enrollment||participants|Number|42|42.0||||||
4373164|NCT00343252|4200332|B2|Italy||Region of Enrollment||participants|Number|20|20.0||||||
4373166|NCT00343252|4200331|B3|France||Region of Enrollment||participants|Number|23|23.0||||||
4373167|NCT00343252|4200332|B2|France||Region of Enrollment||participants|Number|10|10.0||||||
4373168|NCT00343252|4200333|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4373169|NCT00343252|4200331|B3|Canada||Region of Enrollment||participants|Number|109|109.0||||||
4373170|NCT00343252|4200332|B2|Canada||Region of Enrollment||participants|Number|55|55.0||||||
4373171|NCT00343252|4200333|B1|Canada||Region of Enrollment||participants|Number|54|54.0||||||
4373172|NCT00343252|4200331|B3|Brazil||Region of Enrollment||participants|Number|60|60.0||||||
4373173|NCT00343252|4200332|B2|Brazil||Region of Enrollment||participants|Number|30|30.0||||||
4373174|NCT00343252|4200333|B1|Brazil||Region of Enrollment||participants|Number|30|30.0||||||
4373175|NCT00343252|4200331|B3|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
4373176|NCT00343252|4200332|B2|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4373177|NCT00343252|4200333|B1|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4373178|NCT00343252|4200331|B3|Australia||Region of Enrollment||participants|Number|60|60.0||||||
4373179|NCT00343252|4200332|B2|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4373180|NCT00343252|4200333|B1|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4373181|NCT00343252|4200331|B3|Argentina||Region of Enrollment||participants|Number|80|80.0||||||
4373182|NCT00343252|4200332|B2|Argentina||Region of Enrollment||participants|Number|42|42.0||||||
4373183|NCT00343252|4200333|B1|Argentina||Region of Enrollment||participants|Number|38|38.0||||||
4373184|NCT00343252|4200331|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
4373185|NCT00343252|4200332|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4373186|NCT00343252|4200333|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4373187|NCT00343252|4200331|B3|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373188|NCT00343252|4200332|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4373189|NCT00343252|4200333|B1|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373190|NCT00343252|4200331|B3|East Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373191|NCT00343252|4200332|B2|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4373192|NCT00343252|4200333|B1|East Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373193|NCT00343252|4200331|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|571|571.0||||||
4373194|NCT00343252|4200332|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|286|286.0||||||
4373195|NCT00343252|4200333|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|285|285.0||||||
4373196|NCT00343252|4200331|B3|African Descent||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4373197|NCT00343252|4200332|B2|African Descent||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373198|NCT00343252|4200333|B1|African Descent||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4373199|NCT00343252|4200331|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4373200|NCT00343252|4200332|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4373201|NCT00343252|4200333|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4373202|NCT00343252|4200331|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373203|NCT00343252|4200332|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373204|NCT00343252|4200333|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373205|NCT00343252|4200331|B3||Female|Sex: Female, Male||Participants|Count of Participants|710|710.0||||||
4373206|NCT00343252|4200332|B2||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4373207|NCT00343252|4200333|B1||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4373208|NCT00343252|4200331|B3|||Age||years|Mean|71.04|71.04|Standard Deviation|8.48|8.48|||
4373209|NCT00343252|4200332|B2|||Age||years|Mean|71.55|71.55|Standard Deviation|8.12|8.12|||
4373210|NCT00343252|4200333|B1|||Age||years|Mean|70.54|70.54|Standard Deviation|8.80|8.8|||
4373211|NCT00343083|4200380|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4373212|NCT00343083|4200380|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4373213|NCT00343083|4200380|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4373214|NCT00343083|4200380|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4373215|NCT00343083|4200380|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4373216|NCT00343083|4200380|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4373217|NCT00343044|4200389|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4373218|NCT00343044|4200389|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373219|NCT00343044|4200389|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4373220|NCT00343044|4200389|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|11.31|11.31|||
4373221|NCT00343044|4200389|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4373222|NCT00343044|4200389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4373223|NCT00343044|4200389|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4373224|NCT00342628|4200396|B4||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4373225|NCT00342628|4200397|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4373226|NCT00342628|4200398|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4373227|NCT00342628|4200399|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4373228|NCT00342628|4200396|B4||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4373229|NCT00342628|4200397|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4373230|NCT00342628|4200398|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4373231|NCT00342628|4200399|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4373232|NCT00342628|4200396|B4|Age at 4th injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|382|382.0|Full Range|||365.0|420.0|
4373233|NCT00342628|4200397|B3|Age at 4th injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|NA||Full Range|||0.0|0.0|No injection given
4373234|NCT00342628|4200398|B2|Age at 4th injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|381|381.0|Full Range|||365.0|406.0|
4373235|NCT00342628|4200399|B1|Age at 4th injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|382|382.0|Full Range|||365.0|420.0|
4373236|NCT00342628|4200396|B4|Age at 3rd injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|197|197.0|Full Range|||181.0|212.0|
4373237|NCT00342628|4200397|B3|Age at 3rd injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|197|197.0|Full Range|||181.0|211.0|
4373238|NCT00342628|4200398|B2|Age at 3rd injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|198|198.0|Full Range|||182.0|211.0|
4373239|NCT00342628|4200399|B1|Age at 3rd injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|197|197.0|Full Range|||181.0|212.0|
4373240|NCT00342628|4200396|B4|Age at 2nd injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|137|137.0|Full Range|||120.0|154.0|
4373241|NCT00342628|4200397|B3|Age at 2nd injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|137|137.0|Full Range|||121.0|151.0|
4373242|NCT00342628|4200398|B2|Age at 2nd injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|137|137.0|Full Range|||120.0|154.0|
4373243|NCT00342628|4200399|B1|Age at 2nd injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|137|137.0|Full Range|||121.0|151.0|
4373244|NCT00342628|4200396|B4|Age at 1st injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|77|77.0|Full Range|||61.0|92.0|
4373245|NCT00342628|4200397|B3|Age at 1st injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|76|76.0|Full Range|||61.0|92.0|
4373246|NCT00342628|4200398|B2|Age at 1st injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|76|76.0|Full Range|||61.0|92.0|
4373247|NCT00342628|4200399|B1|Age at 1st injection||Age, Customized|Study participants are infants recruited at birth, injected with experimental and comparison vaccine at 2, 4, 6 and 12 months of age.|Days|Mean|77|77.0|Full Range|||61.0|92.0|
4373248|NCT00342563|4200418|B5|Non-Veteran||Veteran Status||participants|Number|82|82.0||||||
4373249|NCT00342563|4200419|B4|Non-Veteran||Veteran Status||participants|Number|20|20.0||||||
4373250|NCT00342563|4200420|B3|Non-Veteran||Veteran Status||participants|Number|22|22.0||||||
4373251|NCT00342563|4200421|B2|Non-Veteran||Veteran Status||participants|Number|18|18.0||||||
4373252|NCT00342563|4200422|B1|Non-Veteran||Veteran Status||participants|Number|22|22.0||||||
4373253|NCT00342563|4200418|B5|Veteran||Veteran Status||participants|Number|54|54.0||||||
4373254|NCT00342563|4200419|B4|Veteran||Veteran Status||participants|Number|8|8.0||||||
4373255|NCT00342563|4200420|B3|Veteran||Veteran Status||participants|Number|18|18.0||||||
4373256|NCT00342563|4200421|B2|Veteran||Veteran Status||participants|Number|9|9.0||||||
4373257|NCT00342563|4200422|B1|Veteran||Veteran Status||participants|Number|19|19.0||||||
4373258|NCT00342563|4200418|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4373259|NCT00342563|4200419|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4373260|NCT00342563|4200420|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4373261|NCT00342563|4200421|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4373262|NCT00342563|4200422|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4373263|NCT00342563|4200418|B5|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4373264|NCT00342563|4200419|B4|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4373265|NCT00342563|4200420|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4373266|NCT00342563|4200421|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4373267|NCT00342563|4200422|B1|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4373268|NCT00342563|4200418|B5|Black||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4373269|NCT00342563|4200419|B4|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4373270|NCT00342563|4200420|B3|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4373271|NCT00342563|4200421|B2|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4373272|NCT00342563|4200422|B1|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4373273|NCT00342563|4200418|B5||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4373274|NCT00342563|4200419|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4373275|NCT00342563|4200420|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4373276|NCT00342563|4200421|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4373277|NCT00342563|4200422|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4373278|NCT00342563|4200418|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4373279|NCT00342563|4200419|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4373280|NCT00342563|4200420|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4373281|NCT00342563|4200421|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4373282|NCT00342563|4200422|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4373283|NCT00342563|4200418|B5|||Age||years|Mean|48.4|48.4|Standard Deviation|9.3|9.3|||
4373284|NCT00342563|4200419|B4|||Age||years|Mean|51.14|51.14|Standard Deviation|10.28|10.28|||
4373285|NCT00342563|4200420|B3|||Age||years|Mean|47.28|47.28|Standard Deviation|8.69|8.69|||
4373286|NCT00342563|4200421|B2|||Age||years|Mean|50.93|50.93|Standard Deviation|9.55|9.55|||
4373287|NCT00342563|4200422|B1|||Age||years|Mean|45.83|45.83|Standard Deviation|8.42|8.42|||
4373288|NCT00342355|4200441|B5|South Africa||Region of Enrollment||participants|Number|1771.0|1771.0||||||
4373289|NCT00342355|4200442|B4|South Africa||Region of Enrollment||participants|Number|443|443.0||||||
4373290|NCT00342355|4200443|B3|South Africa||Region of Enrollment||participants|Number|444|444.0||||||
4373291|NCT00342355|4200444|B2|South Africa||Region of Enrollment||participants|Number|440|440.0||||||
4373292|NCT00342355|4200445|B1|South Africa||Region of Enrollment||participants|Number|444|444.0||||||
4373293|NCT00342355|4200441|B5||Male|Sex: Female, Male||Participants|Count of Participants|1204.0|1204.0||||||
4373294|NCT00342355|4200442|B4||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4373295|NCT00342355|4200443|B3||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4373296|NCT00342355|4200444|B2||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4373297|NCT00342355|4200445|B1||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4373298|NCT00342355|4200441|B5||Female|Sex: Female, Male||Participants|Count of Participants|567.0|567.0||||||
4373299|NCT00342355|4200442|B4||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4373300|NCT00342355|4200443|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4373301|NCT00342355|4200444|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4373302|NCT00342355|4200445|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4373303|NCT00342355|4200441|B5|||Age||years|Mean|35.4|35.4|Standard Deviation|5.4|5.4|||
4373304|NCT00342355|4200442|B4|||Age||years|Mean|35.6|35.6|Standard Deviation|5.5|5.5|||
4373305|NCT00342355|4200443|B3|||Age||years|Mean|35.5|35.5|Standard Deviation|5.5|5.5|||
4373306|NCT00342355|4200444|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|5.4|5.4|||
4373307|NCT00342355|4200445|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|5.4|5.4|||
4373308|NCT00340834|4200462|B6|Male||Sex/Gender, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|342|342.0||||||
4373309|NCT00340834|4200463|B5|Male||Sex/Gender, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|58|58.0||||||
4373310|NCT00340834|4200464|B4|Male||Sex/Gender, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|60|60.0||||||
4373311|NCT00340834|4200465|B3|Male||Sex/Gender, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|NA|||||||This group did not exist in the extension phase of the study.
4373312|NCT00340834|4200466|B2|Male||Sex/Gender, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|121|121.0||||||
4373313|NCT00340834|4200467|B1|Male||Sex/Gender, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|103|103.0||||||
4373314|NCT00340834|4200462|B6|Female||Sex/Gender, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|685|685.0||||||
4373315|NCT00340834|4200463|B5|Female||Sex/Gender, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|109|109.0||||||
4373316|NCT00340834|4200464|B4|Female||Sex/Gender, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|114|114.0||||||
4373362|NCT00340834|4200462|B6|> 55||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|0|0.0||||||
4373317|NCT00340834|4200465|B3|Female||Sex/Gender, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|NA|||||||This group did not exist in the extension phase of the study.
4373318|NCT00340834|4200466|B2|Female||Sex/Gender, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|235|235.0||||||
4373319|NCT00340834|4200467|B1|Female||Sex/Gender, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|227|227.0||||||
4373320|NCT00340834|4200462|B6||Male|Sex: Female, Male|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4373321|NCT00340834|4200463|B5||Male|Sex: Female, Male|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Count of Participants|NA|||||||This group did not exist in the core phase of the study.
4373322|NCT00340834|4200464|B4||Male|Sex: Female, Male|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Count of Participants|NA|||||||This group did not exist in the core phase of the study.
4373323|NCT00340834|4200465|B3||Male|Sex: Female, Male|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Count of Participants|140|140.0||||||
4373324|NCT00340834|4200466|B2||Male|Sex: Female, Male|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Count of Participants|149|149.0||||||
4373325|NCT00340834|4200467|B1||Male|Sex: Female, Male|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Count of Participants|133|133.0||||||
4373326|NCT00340834|4200462|B6||Female|Sex: Female, Male|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4373327|NCT00340834|4200463|B5||Female|Sex: Female, Male|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Count of Participants|NA|||||||This group did not exist in the core phase of the study.
4373328|NCT00340834|4200464|B4||Female|Sex: Female, Male|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Count of Participants|NA|||||||This group did not exist in the core phase of the study.
4373329|NCT00340834|4200465|B3||Female|Sex: Female, Male|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Count of Participants|295|295.0||||||
4373330|NCT00340834|4200466|B2||Female|Sex: Female, Male|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Count of Participants|282|282.0||||||
4373331|NCT00340834|4200467|B1||Female|Sex: Female, Male|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Count of Participants|293|293.0||||||
4373332|NCT00340834|4200462|B6|>55||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|0|0.0||||||
4373333|NCT00340834|4200463|B5|>55||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|0|0.0||||||
4373334|NCT00340834|4200464|B4|>55||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|0|0.0||||||
4373335|NCT00340834|4200465|B3|>55||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|NA|||||||This group did not exist in the extension phase of the study.
4373336|NCT00340834|4200466|B2|>55||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|0|0.0||||||
4373337|NCT00340834|4200467|B1|>55||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|0|0.0||||||
4373338|NCT00340834|4200462|B6|41-55||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|348|348.0||||||
4373339|NCT00340834|4200463|B5|41-55||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|57|57.0||||||
4373340|NCT00340834|4200464|B4|41-55||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|52|52.0||||||
4373363|NCT00340834|4200463|B5|> 55||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|NA|||||||This group did not exist in the core phase of the study.
4373341|NCT00340834|4200465|B3|41-55||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|NA|||||||This group did not exist in the extension phase of the study.
4373342|NCT00340834|4200466|B2|41-55||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|131|131.0||||||
4373343|NCT00340834|4200467|B1|41-55||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|108|108.0||||||
4373344|NCT00340834|4200462|B6|31-40||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|394|394.0||||||
4373345|NCT00340834|4200463|B5|31-40||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|62|62.0||||||
4373346|NCT00340834|4200464|B4|31-40||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|83|83.0||||||
4373347|NCT00340834|4200465|B3|31-40||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|NA|||||||This group did not exist in the extension phase of the study.
4373348|NCT00340834|4200466|B2|31-40||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|127|127.0||||||
4373349|NCT00340834|4200467|B1|31-40||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|122|122.0||||||
4373350|NCT00340834|4200462|B6|18-30||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|285|285.0||||||
4373351|NCT00340834|4200463|B5|18-30||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|48|48.0||||||
4373352|NCT00340834|4200464|B4|18-30||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|39|39.0||||||
4373353|NCT00340834|4200465|B3|18-30||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|NA|||||||This group did not exist in the extension phase of the study.
4373354|NCT00340834|4200466|B2|18-30||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|98|98.0||||||
4373355|NCT00340834|4200467|B1|18-30||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|100|100.0||||||
4373356|NCT00340834|4200462|B6|< 18||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|0|0.0||||||
4373357|NCT00340834|4200463|B5|< 18||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|0|0.0||||||
4373358|NCT00340834|4200464|B4|< 18||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|0|0.0||||||
4373359|NCT00340834|4200465|B3|< 18||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|NA|||||||This group did not exist in the extension phase of the study.
4373360|NCT00340834|4200466|B2|< 18||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|0|0.0||||||
4373361|NCT00340834|4200467|B1|< 18||Age, Customized|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Participants|Number|0|0.0||||||
4373496|NCT00340379|4200636|B1|India||Region of Enrollment||participants|Number|18|18.0||||||
4373364|NCT00340834|4200464|B4|> 55||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|NA|||||||This group did not exist in the core phase of the study.
4373365|NCT00340834|4200465|B3|> 55||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|0|0.0||||||
4373366|NCT00340834|4200466|B2|> 55||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|0|0.0||||||
4373367|NCT00340834|4200467|B1|> 55||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|0|0.0||||||
4373368|NCT00340834|4200462|B6|41-55||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|442|442.0||||||
4373369|NCT00340834|4200463|B5|41-55||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|NA|||||||This group did not exist in the core phase of the study.
4373370|NCT00340834|4200464|B4|41-55||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|NA|||||||This group did not exist in the core phase of the study.
4373371|NCT00340834|4200465|B3|41-55||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|137|137.0||||||
4373372|NCT00340834|4200466|B2|41-55||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|164|164.0||||||
4373373|NCT00340834|4200467|B1|41-55||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|141|141.0||||||
4373374|NCT00340834|4200462|B6|31-40||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|495|495.0||||||
4373375|NCT00340834|4200463|B5|31-40||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|NA|||||||This group did not exist in the core phase of the study.
4373376|NCT00340834|4200464|B4|31-40||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|NA|||||||This group did not exist in the core phase of the study.
4373377|NCT00340834|4200465|B3|31-40||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|185|185.0||||||
4373378|NCT00340834|4200466|B2|31-40||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|150|150.0||||||
4373379|NCT00340834|4200467|B1|31-40||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|160|160.0||||||
4373380|NCT00340834|4200462|B6|18-30||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|355|355.0||||||
4373381|NCT00340834|4200463|B5|18-30||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|NA|||||||This group did not exist in the core phase of the study.
4373382|NCT00340834|4200464|B4|18-30||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|NA|||||||This group did not exist in the core phase of the study.
4373383|NCT00340834|4200465|B3|18-30||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|113|113.0||||||
4373384|NCT00340834|4200466|B2|18-30||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|117|117.0||||||
4373385|NCT00340834|4200467|B1|18-30||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|125|125.0||||||
4373386|NCT00340834|4200462|B6|< 18||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|0|0.0||||||
4373387|NCT00340834|4200463|B5|< 18||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|NA|||||||This group did not exist in the core phase of the study.
4373388|NCT00340834|4200464|B4|< 18||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|NA|||||||This group did not exist in the core phase of the study.
4373389|NCT00340834|4200465|B3|< 18||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|0|0.0||||||
4373390|NCT00340834|4200466|B2|< 18||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|0|0.0||||||
4373391|NCT00340834|4200467|B1|< 18||Age, Customized|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|Participants|Number|0|0.0||||||
4373392|NCT00340834|4200462|B6|||Age|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Years|Mean|36.0|36.0|Standard Deviation|8.48|8.48|||
4373393|NCT00340834|4200463|B5|||Age|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Years|Mean|36.1|36.1|Standard Deviation|8.59|8.59|||
4373394|NCT00340834|4200464|B4|||Age|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Years|Mean|36.1|36.1|Standard Deviation|8.11|8.11|||
4373442|NCT00340678|4200618|B2|||Glomerular filtration rate (GFR)|Glomerular filtration rate was measured by the urinary clearance of iothalamate.|mL/min|Mean|152|152.0|Standard Deviation|40|40.0|||
4373395|NCT00340834|4200465|B3|||Age|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Years|Mean|NA||Standard Deviation|NA||||This group did not exist in the extension phase of the study.
4373396|NCT00340834|4200466|B2|||Age|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Years|Mean|36.5|36.5|Standard Deviation|8.67|8.67|||
4373397|NCT00340834|4200467|B1|||Age|Extension phase of study. The number of patients in the optional extension phase was less than the overall number of baseline participants who started the study. Total number of patients is 1027. Demographics are based on the intent-to-treat population.|Years|Mean|35.5|35.5|Standard Deviation|8.42|8.42|||
4373398|NCT00340834|4200462|B6|||Age|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|years|Mean|36.2|36.2|Standard Deviation|8.50|8.5|||
4373399|NCT00340834|4200463|B5|||Age|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|years|Mean|NA||Standard Deviation|NA||||This group did not exist in the core phase of the study.
4373400|NCT00340834|4200464|B4|||Age|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|years|Mean|NA||Standard Deviation|NA||||This group did not exist in the core phase of the study.
4373401|NCT00340834|4200465|B3|||Age|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|years|Mean|36.0|36.0|Standard Deviation|8.29|8.29|||
4373402|NCT00340834|4200466|B2|||Age|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|years|Mean|36.7|36.7|Standard Deviation|8.81|8.81|||
4373403|NCT00340834|4200467|B1|||Age|Core phase of study. Total number of patients is 1292. Demographics are based on the randomized population.|years|Mean|35.8|35.8|Standard Deviation|8.39|8.39|||
4373404|NCT00340704|4200496|B10||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4373405|NCT00340704|4200497|B9||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4373406|NCT00340704|4200498|B8||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4373407|NCT00340704|4200499|B7||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4373408|NCT00340704|4200500|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4373409|NCT00340704|4200501|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4373410|NCT00340704|4200502|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4373411|NCT00340704|4200503|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4373412|NCT00340704|4200504|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4373413|NCT00340704|4200505|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4373414|NCT00340704|4200496|B10||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4373415|NCT00340704|4200497|B9||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4373416|NCT00340704|4200498|B8||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4373417|NCT00340704|4200499|B7||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4373418|NCT00340704|4200500|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4373419|NCT00340704|4200501|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4373420|NCT00340704|4200502|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4373421|NCT00340704|4200503|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4373422|NCT00340704|4200504|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4373423|NCT00340704|4200505|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4373424|NCT00340704|4200496|B10|||Age||years|Mean|7.7|7.7|Standard Deviation|3.7|3.7|||
4373425|NCT00340704|4200497|B9|||Age||years|Mean|8.3|8.3|Standard Deviation|4.1|4.1|||
4373426|NCT00340704|4200498|B8|||Age||years|Mean|7.0|7.0|Standard Deviation|3.4|3.4|||
4373427|NCT00340704|4200499|B7|||Age||years|Mean|8.1|8.1|Standard Deviation|3.8|3.8|||
4373428|NCT00340704|4200500|B6|||Age||years|Mean|8.1|8.1|Standard Deviation|3.8|3.8|||
4373429|NCT00340704|4200501|B5|||Age||years|Mean|6.3|6.3|Standard Deviation|3.7|3.7|||
4373430|NCT00340704|4200502|B4|||Age||years|Mean|6.8|6.8|Standard Deviation|3.4|3.4|||
4373431|NCT00340704|4200503|B3|||Age||years|Mean|8.8|8.8|Standard Deviation|3.7|3.7|||
4373432|NCT00340704|4200504|B2|||Age||years|Mean|6.5|6.5|Standard Deviation|2.6|2.6|||
4373433|NCT00340704|4200505|B1|||Age||years|Mean|8.7|8.7|Standard Deviation|4.5|4.5|||
4373434|NCT00340678|4200615|B5|||Urinary albumin to creatinine ratio||mg/g|Median|47|47.0|Inter-Quartile Range|||9.0|205.0|
4373435|NCT00340678|4200616|B4|||Urinary albumin to creatinine ratio||mg/g|Median|80|80.0|Inter-Quartile Range|||46.0|165.0|
4373436|NCT00340678|4200617|B3|||Urinary albumin to creatinine ratio||mg/g|Median|66|66.0|Inter-Quartile Range|||39.0|205.0|
4373437|NCT00340678|4200618|B2|||Urinary albumin to creatinine ratio||mg/g|Median|14|14.0|Inter-Quartile Range|||9.0|26.0|
4373438|NCT00340678|4200619|B1|||Urinary albumin to creatinine ratio||mg/g|Median|15|15.0|Inter-Quartile Range|||10.0|23.0|
4373439|NCT00340678|4200615|B5|||Glomerular filtration rate (GFR)|Glomerular filtration rate was measured by the urinary clearance of iothalamate.|mL/min|Mean|164|164.0|Standard Deviation|41|41.0|||
4373440|NCT00340678|4200616|B4|||Glomerular filtration rate (GFR)|Glomerular filtration rate was measured by the urinary clearance of iothalamate.|mL/min|Mean|168|168.0|Standard Deviation|43|43.0|||
4373441|NCT00340678|4200617|B3|||Glomerular filtration rate (GFR)|Glomerular filtration rate was measured by the urinary clearance of iothalamate.|mL/min|Mean|166|166.0|Standard Deviation|43|43.0|||
4373495|NCT00340379|4200635|B2|India||Region of Enrollment||participants|Number|17|17.0||||||
4373443|NCT00340678|4200619|B1|||Glomerular filtration rate (GFR)|Glomerular filtration rate was measured by the urinary clearance of iothalamate.|mL/min|Mean|171|171.0|Standard Deviation|38|38.0|||
4373444|NCT00340678|4200615|B5|||HbA1c|Glycosylated hemoglobin is an integrated measure of glycemic control that reflects an average glycemic level over the past 3 months.|%|Mean|9.2|9.2|Standard Deviation|2.1|2.1|||
4373445|NCT00340678|4200616|B4|||HbA1c|Glycosylated hemoglobin is an integrated measure of glycemic control that reflects an average glycemic level over the past 3 months.|%|Mean|10.3|10.3|Standard Deviation|2.1|2.1|||
4373446|NCT00340678|4200617|B3|||HbA1c|Glycosylated hemoglobin is an integrated measure of glycemic control that reflects an average glycemic level over the past 3 months.|%|Mean|9.5|9.5|Standard Deviation|2.3|2.3|||
4373447|NCT00340678|4200618|B2|||HbA1c|Glycosylated hemoglobin is an integrated measure of glycemic control that reflects an average glycemic level over the past 3 months.|%|Mean|8.1|8.1|Standard Deviation|2.2|2.2|||
4373448|NCT00340678|4200619|B1|||HbA1c|Glycosylated hemoglobin is an integrated measure of glycemic control that reflects an average glycemic level over the past 3 months.|%|Mean|9.2|9.2|Standard Deviation|2.0|2.0|||
4373449|NCT00340678|4200615|B5|||Blood pressure, mean||mmHg|Mean|90|90.0|Standard Deviation|9|9.0|||
4373450|NCT00340678|4200616|B4|||Blood pressure, mean||mmHg|Mean|92|92.0|Standard Deviation|8|8.0|||
4373451|NCT00340678|4200617|B3|||Blood pressure, mean||mmHg|Mean|90|90.0|Standard Deviation|10|10.0|||
4373452|NCT00340678|4200618|B2|||Blood pressure, mean||mmHg|Mean|89|89.0|Standard Deviation|9|9.0|||
4373453|NCT00340678|4200619|B1|||Blood pressure, mean||mmHg|Mean|88|88.0|Standard Deviation|7|7.0|||
4373454|NCT00340678|4200615|B5|||Blood pressure, diastolic||mmHg|Mean|76|76.0|Standard Deviation|7|7.0|||
4373455|NCT00340678|4200616|B4|||Blood pressure, diastolic||mmHg|Mean|77|77.0|Standard Deviation|7|7.0|||
4373456|NCT00340678|4200617|B3|||Blood pressure, diastolic||mmHg|Mean|77|77.0|Standard Deviation|9|9.0|||
4373457|NCT00340678|4200618|B2|||Blood pressure, diastolic||mmHg|Mean|75|75.0|Standard Deviation|7|7.0|||
4373458|NCT00340678|4200619|B1|||Blood pressure, diastolic||mmHg|Mean|75|75.0|Standard Deviation|7|7.0|||
4373459|NCT00340678|4200615|B5|||Blood pressure, systolic||mmHg|Mean|118|118.0|Standard Deviation|13|13.0|||
4373460|NCT00340678|4200616|B4|||Blood pressure, systolic||mmHg|Mean|123|123.0|Standard Deviation|13|13.0|||
4373461|NCT00340678|4200617|B3|||Blood pressure, systolic||mmHg|Mean|118|118.0|Standard Deviation|15|15.0|||
4373462|NCT00340678|4200618|B2|||Blood pressure, systolic||mmHg|Mean|118|118.0|Standard Deviation|14|14.0|||
4373463|NCT00340678|4200619|B1|||Blood pressure, systolic||mmHg|Mean|115|115.0|Standard Deviation|11|11.0|||
4373464|NCT00340678|4200615|B5|||BMI|Body Mass Index obtained by measuring the participant's height in meters and weight in kilograms.|kg/(m^2)|Mean|35.7|35.7|Standard Deviation|8.3|8.3|||
4373465|NCT00340678|4200616|B4|||BMI|Body Mass Index obtained by measuring the participant's height in meters and weight in kilograms.|kg/(m^2)|Mean|33.8|33.8|Standard Deviation|7.2|7.2|||
4373466|NCT00340678|4200617|B3|||BMI|Body Mass Index obtained by measuring the participant's height in meters and weight in kilograms.|kg/(m^2)|Mean|34.6|34.6|Standard Deviation|9.1|9.1|||
4373467|NCT00340678|4200618|B2|||BMI|Body Mass Index obtained by measuring the participant's height in meters and weight in kilograms.|kg/(m^2)|Mean|36.6|36.6|Standard Deviation|8.0|8.0|||
4373468|NCT00340678|4200619|B1|||BMI|Body Mass Index obtained by measuring the participant's height in meters and weight in kilograms.|kg/(m^2)|Mean|37.4|37.4|Standard Deviation|8.8|8.8|||
4373469|NCT00340678|4200615|B5|||Diabetes duration||years|Mean|10.8|10.8|Standard Deviation|6.2|6.2|||
4373470|NCT00340678|4200616|B4|||Diabetes duration||years|Mean|14.1|14.1|Standard Deviation|8.4|8.4|||
4373471|NCT00340678|4200617|B3|||Diabetes duration||years|Mean|10.3|10.3|Standard Deviation|5.2|5.2|||
4373472|NCT00340678|4200618|B2|||Diabetes duration||years|Mean|10.4|10.4|Standard Deviation|6.0|6.0|||
4373473|NCT00340678|4200619|B1|||Diabetes duration||years|Mean|8.8|8.8|Standard Deviation|4.7|4.7|||
4373474|NCT00340678|4200615|B5|United States||Region of Enrollment||participants|Number|170|170.0||||||
4373475|NCT00340678|4200616|B4|United States||Region of Enrollment||participants|Number|39|39.0||||||
4373476|NCT00340678|4200617|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4373477|NCT00340678|4200618|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4373478|NCT00340678|4200619|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4373479|NCT00340678|4200615|B5||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4373480|NCT00340678|4200616|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4373481|NCT00340678|4200617|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4373482|NCT00340678|4200618|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4373483|NCT00340678|4200619|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4373484|NCT00340678|4200615|B5||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4373485|NCT00340678|4200616|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4373486|NCT00340678|4200617|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4373487|NCT00340678|4200618|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4373488|NCT00340678|4200619|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4373489|NCT00340678|4200615|B5|||Age||years|Mean|41.3|41.3|Standard Deviation|10.6|10.6|||
4373490|NCT00340678|4200616|B4|||Age||years|Mean|42.3|42.3|Standard Deviation|10.9|10.9|||
4373491|NCT00340678|4200617|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|8.9|8.9|||
4373492|NCT00340678|4200618|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|11.7|11.7|||
4373493|NCT00340678|4200619|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|10.6|10.6|||
4373494|NCT00340379|4200634|B3|India||Region of Enrollment||participants|Number|35|35.0||||||
4373497|NCT00340379|4200634|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4373498|NCT00340379|4200635|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4373499|NCT00340379|4200636|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4373500|NCT00340379|4200634|B3|Egypt||Region of Enrollment||participants|Number|29|29.0||||||
4373501|NCT00340379|4200635|B2|Egypt||Region of Enrollment||participants|Number|15|15.0||||||
4373502|NCT00340379|4200636|B1|Egypt||Region of Enrollment||participants|Number|14|14.0||||||
4373503|NCT00340379|4200634|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4373504|NCT00340379|4200635|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4373505|NCT00340379|4200636|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4373506|NCT00340379|4200634|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4373507|NCT00340379|4200635|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4373508|NCT00340379|4200636|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4373509|NCT00340379|4200634|B3|||Age||years|Mean|36.1|36.1|Standard Deviation|10.5|10.5|||
4373510|NCT00340379|4200635|B2|||Age||years|Mean|35.9|35.9|Standard Deviation|12.0|12.0|||
4373511|NCT00340379|4200636|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|8.7|8.7|||
4373512|NCT00340379|4200634|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4373513|NCT00340379|4200635|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4373514|NCT00340379|4200636|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4373515|NCT00340379|4200634|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4373516|NCT00340379|4200635|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4373517|NCT00340379|4200636|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4373518|NCT00340379|4200634|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4373519|NCT00340379|4200635|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4373520|NCT00340379|4200636|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4373521|NCT00339833|4200647|B3|||Clamp R_d||micro-mol/(kg*min)|Median|14|14.0|Full Range|||11.0|20.0|
4373522|NCT00339833|4200648|B2|||Clamp R_d||micro-mol/(kg*min)|Median|16|16.0|Full Range|||13.0|20.0|
4373523|NCT00339833|4200649|B1|||Clamp R_d||micro-mol/(kg*min)|Median|13|13.0|Full Range|||11.0|15.0|
4373524|NCT00339833|4200647|B3|||Basal EGP||micro-mol/(kg*min)|Mean|10.5|10.5|Standard Deviation|2|2.0|||
4373525|NCT00339833|4200648|B2|||Basal EGP||micro-mol/(kg*min)|Mean|11|11.0|Standard Deviation|2|2.0|||
4373526|NCT00339833|4200649|B1|||Basal EGP||micro-mol/(kg*min)|Mean|10|10.0|Standard Deviation|2|2.0|||
4373527|NCT00339833|4200647|B3|||Fasting plasma insulin||pmol/l|Median|76|76.0|Full Range|||49.0|104.0|
4373528|NCT00339833|4200648|B2|||Fasting plasma insulin||pmol/l|Median|63|63.0|Full Range|||49.0|90.0|
4373529|NCT00339833|4200649|B1|||Fasting plasma insulin||pmol/l|Median|80|80.0|Full Range|||56.0|104.0|
4373530|NCT00339833|4200647|B3|||2 hour plasma glucose||mmol/l|Mean|6.64|6.64|Standard Deviation|1.50|1.5|||
4373531|NCT00339833|4200648|B2|||2 hour plasma glucose||mmol/l|Mean|6.61|6.61|Standard Deviation|1.83|1.83|||
4373532|NCT00339833|4200649|B1|||2 hour plasma glucose||mmol/l|Mean|6.67|6.67|Standard Deviation|1.17|1.17|||
4373533|NCT00339833|4200647|B3|||Fasting plasma glucose||mmol/l|Median|5.09|5.09|Standard Deviation|0.33|0.33|||
4373534|NCT00339833|4200648|B2|||Fasting plasma glucose||mmol/l|Median|5.06|5.06|Standard Deviation|0.33|0.33|||
4373535|NCT00339833|4200649|B1|||Fasting plasma glucose||mmol/l|Median|5.11|5.11|Standard Deviation|0.33|0.33|||
4373536|NCT00339833|4200647|B3|||Body Fat||% body fat|Mean|38|38.0|Standard Deviation|6.5|6.5|||
4373537|NCT00339833|4200648|B2|||Body Fat||% body fat|Mean|38|38.0|Standard Deviation|7|7.0|||
4373538|NCT00339833|4200649|B1|||Body Fat||% body fat|Mean|38|38.0|Standard Deviation|6|6.0|||
4373539|NCT00339833|4200647|B3|||BMI||kg/m2|Mean|37.5|37.5|Standard Deviation|5.5|5.5|||
4373540|NCT00339833|4200648|B2|||BMI||kg/m2|Mean|38|38.0|Standard Deviation|6|6.0|||
4373541|NCT00339833|4200649|B1|||BMI||kg/m2|Mean|37|37.0|Standard Deviation|5|5.0|||
4373542|NCT00339833|4200647|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4373543|NCT00339833|4200648|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4373544|NCT00339833|4200649|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4373545|NCT00339833|4200647|B3|Native American||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4373546|NCT00339833|4200648|B2|Native American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4373547|NCT00339833|4200649|B1|Native American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4373548|NCT00339833|4200647|B3|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4373549|NCT00339833|4200648|B2|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373550|NCT00339833|4200649|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373551|NCT00339833|4200647|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4373552|NCT00339833|4200648|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4373553|NCT00339833|4200649|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4373554|NCT00339833|4200647|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4373555|NCT00339833|4200648|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4373556|NCT00339833|4200649|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4373557|NCT00339833|4200647|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4373558|NCT00339833|4200648|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4373559|NCT00339833|4200649|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4373560|NCT00339833|4200647|B3|||Age||years|Mean|31|31.0|Standard Deviation|7.5|7.5|||
4373561|NCT00339833|4200648|B2|||Age||years|Mean|33|33.0|Standard Deviation|8|8.0|||
4373562|NCT00339833|4200649|B1|||Age||years|Mean|29|29.0|Standard Deviation|7|7.0|||
4373563|NCT00339183|4200658|B3|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|57|57.0||||||
4373564|NCT00339183|4200659|B2|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|30|30.0||||||
4373565|NCT00339183|4200660|B1|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|27|27.0||||||
4373566|NCT00339183|4200658|B3|Grade 0 or 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|1129|1129.0||||||
4373567|NCT00339183|4200659|B2|Grade 0 or 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|565|565.0||||||
4373568|NCT00339183|4200660|B1|Grade 0 or 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; Grade 3: Capable of only limited self care, confined to a bed or chair > 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; Grade 5: Dead|participants|Number|564|564.0||||||
4373569|NCT00339183|4200658|B3|Yes||Prior Bevacizumab Exposure for mCRC||participants|Number|223|223.0||||||
4373570|NCT00339183|4200659|B2|Yes||Prior Bevacizumab Exposure for mCRC||participants|Number|112|112.0||||||
4373571|NCT00339183|4200660|B1|Yes||Prior Bevacizumab Exposure for mCRC||participants|Number|111|111.0||||||
4373572|NCT00339183|4200658|B3|No||Prior Bevacizumab Exposure for mCRC||participants|Number|963|963.0||||||
4373573|NCT00339183|4200659|B2|No||Prior Bevacizumab Exposure for mCRC||participants|Number|483|483.0||||||
4373574|NCT00339183|4200660|B1|No||Prior Bevacizumab Exposure for mCRC||participants|Number|480|480.0||||||
4373575|NCT00339183|4200658|B3|Yes||Prior Oxaliplatin Exposure for mCRC|mCRC: metastatic colorectal cancer|participants|Number|825|825.0||||||
4373576|NCT00339183|4200659|B2|Yes||Prior Oxaliplatin Exposure for mCRC|mCRC: metastatic colorectal cancer|participants|Number|413|413.0||||||
4373577|NCT00339183|4200660|B1|Yes||Prior Oxaliplatin Exposure for mCRC|mCRC: metastatic colorectal cancer|participants|Number|412|412.0||||||
4373578|NCT00339183|4200658|B3|No||Prior Oxaliplatin Exposure for mCRC|mCRC: metastatic colorectal cancer|participants|Number|361|361.0||||||
4373579|NCT00339183|4200659|B2|No||Prior Oxaliplatin Exposure for mCRC|mCRC: metastatic colorectal cancer|participants|Number|182|182.0||||||
4373580|NCT00339183|4200660|B1|No||Prior Oxaliplatin Exposure for mCRC|mCRC: metastatic colorectal cancer|participants|Number|179|179.0||||||
4373581|NCT00339183|4200658|B3|Unevaluable KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|103|103.0||||||
4373582|NCT00339183|4200659|B2|Unevaluable KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|53|53.0||||||
4373583|NCT00339183|4200660|B1|Unevaluable KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|50|50.0||||||
4373584|NCT00339183|4200658|B3|Mutant KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|486|486.0||||||
4373585|NCT00339183|4200659|B2|Mutant KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|248|248.0||||||
4373586|NCT00339183|4200660|B1|Mutant KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|238|238.0||||||
4373587|NCT00339183|4200658|B3|Wild-type KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|597|597.0||||||
4373588|NCT00339183|4200659|B2|Wild-type KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|294|294.0||||||
4373589|NCT00339183|4200660|B1|Wild-type KRAS||KRAS Status|KRAS, the human homolog of the Kirsten rat sarcoma-2 virus oncogene|participants|Number|303|303.0||||||
4373590|NCT00339183|4200658|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4373591|NCT00339183|4200659|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4373592|NCT00339183|4200660|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373593|NCT00339183|4200658|B3|Aborigine||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373594|NCT00339183|4200659|B2|Aborigine||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4373595|NCT00339183|4200660|B1|Aborigine||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4373596|NCT00339183|4200658|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4373597|NCT00339183|4200659|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4373598|NCT00339183|4200660|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4373599|NCT00339183|4200658|B3|Japanese||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4373600|NCT00339183|4200659|B2|Japanese||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4373601|NCT00339183|4200660|B1|Japanese||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4373602|NCT00339183|4200658|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4373603|NCT00339183|4200659|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373604|NCT00339183|4200660|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4373605|NCT00339183|4200658|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4373606|NCT00339183|4200659|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373607|NCT00339183|4200660|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4373608|NCT00339183|4200658|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4373609|NCT00339183|4200659|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4373610|NCT00339183|4200660|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4373611|NCT00339183|4200658|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|1137|1137.0||||||
4373612|NCT00339183|4200659|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|569|569.0||||||
4373613|NCT00339183|4200660|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|568|568.0||||||
4373614|NCT00339183|4200658|B3||Male|Sex: Female, Male||Participants|Count of Participants|722|722.0||||||
4373615|NCT00339183|4200659|B2||Male|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
4373616|NCT00339183|4200660|B1||Male|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4373617|NCT00339183|4200658|B3||Female|Sex: Female, Male||Participants|Count of Participants|464|464.0||||||
4373618|NCT00339183|4200659|B2||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4373619|NCT00339183|4200660|B1||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4373620|NCT00339183|4200658|B3|||Age||years|Mean|60.6|60.6|Standard Deviation|10.5|10.5|||
4373621|NCT00339183|4200659|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|10.6|10.6|||
4373622|NCT00339183|4200660|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|10.5|10.5|||
4373623|NCT00339144|4200687|B4|4 = Completely disabled||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|0|0.0||||||
4373624|NCT00339144|4200688|B3|4 = Completely disabled||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|0|0.0||||||
4373625|NCT00339144|4200689|B2|4 = Completely disabled||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|0|0.0||||||
4373626|NCT00339144|4200690|B1|4 = Completely disabled||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|0|0.0||||||
4373669|NCT00339079|4200775|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4373670|NCT00339079|4200776|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4373627|NCT00339144|4200687|B4|3 = Capable of only limited self care||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|0|0.0||||||
4373628|NCT00339144|4200688|B3|3 = Capable of only limited self care||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|0|0.0||||||
4373629|NCT00339144|4200689|B2|3 = Capable of only limited self care||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|0|0.0||||||
4373630|NCT00339144|4200690|B1|3 = Capable of only limited self care||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|0|0.0||||||
4373631|NCT00339144|4200687|B4|2 = Ambulatory but unable to work||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|0|0.0||||||
4373632|NCT00339144|4200688|B3|2 = Ambulatory but unable to work||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|0|0.0||||||
4373633|NCT00339144|4200689|B2|2 = Ambulatory but unable to work||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|0|0.0||||||
4373634|NCT00339144|4200690|B1|2 = Ambulatory but unable to work||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|0|0.0||||||
4373635|NCT00339144|4200687|B4|1 = Ambulatory and able to work||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|6|6.0||||||
4373636|NCT00339144|4200688|B3|1 = Ambulatory and able to work||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|2|2.0||||||
4373671|NCT00339079|4200777|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4373837|NCT00338598|4200956|B3|||Age||years|Mean|48.9|48.9|Standard Deviation|4.8|4.8|||
4373637|NCT00339144|4200689|B2|1 = Ambulatory and able to work||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|2|2.0||||||
4373638|NCT00339144|4200690|B1|1 = Ambulatory and able to work||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|2|2.0||||||
4373639|NCT00339144|4200687|B4|0 = Fully active||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|10|10.0||||||
4373640|NCT00339144|4200688|B3|0 = Fully active||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|2|2.0||||||
4373641|NCT00339144|4200689|B2|0 = Fully active||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|1|1.0||||||
4373642|NCT00339144|4200690|B1|0 = Fully active||Eastern Cooperative Oncology group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. ECOG PS scores are, 0: fully active, able to carry on all pre-disease performance without restriction; 1: restricted physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2: ambulatory and capable of all self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: capable of only limited self care, confined to bed or chair more than 50% of waking hours; 4: completely disabled, cannot carry on any self-care i.e. totally confined to bed or chair.|Units on a scale|Number|7|7.0||||||
4373643|NCT00339144|4200687|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4373644|NCT00339144|4200688|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4373645|NCT00339144|4200689|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4373646|NCT00339144|4200690|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4373647|NCT00339144|4200687|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4373648|NCT00339144|4200688|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4373649|NCT00339144|4200689|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4373650|NCT00339144|4200690|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4373651|NCT00339144|4200687|B4|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4373652|NCT00339144|4200688|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4373653|NCT00339144|4200689|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4373654|NCT00339144|4200690|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4373655|NCT00339144|4200687|B4|< 65 years||Age, Customized||participants|Number|14|14.0||||||
4373656|NCT00339144|4200688|B3|< 65 years||Age, Customized||participants|Number|4|4.0||||||
4373657|NCT00339144|4200689|B2|< 65 years||Age, Customized||participants|Number|3|3.0||||||
4373658|NCT00339144|4200690|B1|< 65 years||Age, Customized||participants|Number|7|7.0||||||
4373659|NCT00339144|4200687|B4|||Age||years|Median|54.0|54.0|Full Range|||33.0|65.0|
4373660|NCT00339144|4200688|B3|||Age||years|Median|47.5|47.5|Full Range|||33.0|53.0|
4373661|NCT00339144|4200689|B2|||Age||years|Median|55.0|55.0|Full Range|||39.0|63.0|
4373662|NCT00339144|4200690|B1|||Age||years|Median|58.0|58.0|Full Range|||33.0|65.0|
4373663|NCT00339079|4200774|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373664|NCT00339079|4200775|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373665|NCT00339079|4200776|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373666|NCT00339079|4200777|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373667|NCT00339079|4200778|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373668|NCT00339079|4200774|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
4373672|NCT00339079|4200778|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4373673|NCT00339079|4200774|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4373674|NCT00339079|4200775|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4373675|NCT00339079|4200776|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4373676|NCT00339079|4200777|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4373677|NCT00339079|4200778|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4373678|NCT00339079|4200774|B5||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4373679|NCT00339079|4200775|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4373680|NCT00339079|4200776|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4373681|NCT00339079|4200777|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4373682|NCT00339079|4200778|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4373683|NCT00339079|4200774|B5||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4373684|NCT00339079|4200775|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4373685|NCT00339079|4200776|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4373686|NCT00339079|4200777|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4373687|NCT00339079|4200778|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4373688|NCT00339079|4200774|B5|||Age||years|Mean|39.7|39.7|Standard Deviation|14.3|14.3|||
4373689|NCT00339079|4200775|B4|||Age||years|Mean|40.0|40.0|Standard Deviation|14.3|14.3|||
4373690|NCT00339079|4200776|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|15.9|15.9|||
4373691|NCT00339079|4200777|B2|||Age||years|Mean|36.4|36.4|Standard Deviation|12.9|12.9|||
4373692|NCT00339079|4200778|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|13.7|13.7|||
4373693|NCT00339040|4200795|B3|>5000 copies/mL||RNA group||participants|Number|18|18.0||||||
4373694|NCT00339040|4200796|B2|>5000 copies/mL||RNA group||participants|Number|3|3.0||||||
4373695|NCT00339040|4200797|B1|>5000 copies/mL||RNA group||participants|Number|15|15.0||||||
4373696|NCT00339040|4200795|B3|401 to ≤5000 copies/mL||RNA group||participants|Number|21|21.0||||||
4373697|NCT00339040|4200796|B2|401 to ≤5000 copies/mL||RNA group||participants|Number|5|5.0||||||
4373698|NCT00339040|4200797|B1|401 to ≤5000 copies/mL||RNA group||participants|Number|16|16.0||||||
4373699|NCT00339040|4200795|B3|≤400 copies/mL||RNA group||participants|Number|87|87.0||||||
4373700|NCT00339040|4200796|B2|≤400 copies/mL||RNA group||participants|Number|22|22.0||||||
4373701|NCT00339040|4200797|B1|≤400 copies/mL||RNA group||participants|Number|65|65.0||||||
4373702|NCT00339040|4200795|B3|||Log10(RNA)||Log10(copies/mL)|Mean|2.7|2.7|Standard Deviation|0.9|0.9|||
4373703|NCT00339040|4200796|B2|||Log10(RNA)||Log10(copies/mL)|Mean|2.6|2.6|Standard Deviation|0.8|0.8|||
4373704|NCT00339040|4200797|B1|||Log10(RNA)||Log10(copies/mL)|Mean|2.7|2.7|Standard Deviation|0.9|0.9|||
4373705|NCT00339040|4200795|B3|||CD4%||percentage of total lymphocytes|Mean|34.3|34.3|Standard Deviation|8.1|8.1|||
4373706|NCT00339040|4200796|B2|||CD4%||percentage of total lymphocytes|Mean|35.8|35.8|Standard Deviation|8.6|8.6|||
4373707|NCT00339040|4200797|B1|||CD4%||percentage of total lymphocytes|Mean|33.9|33.9|Standard Deviation|7.9|7.9|||
4373708|NCT00339040|4200795|B3|||CD4 count||cells/µL|Mean|903|903.0|Standard Deviation|393|393.0|||
4373709|NCT00339040|4200796|B2|||CD4 count||cells/µL|Mean|1013|1013.0|Standard Deviation|455|455.0|||
4373710|NCT00339040|4200797|B1|||CD4 count||cells/µL|Mean|868|868.0|Standard Deviation|367|367.0|||
4373711|NCT00339040|4200795|B3|Stratum C||Stratification groups|"STRATIFICATION: Participant were stratified by CD4% criteria into three strata:~Stratum A: CD4% Nadir < 15 and CD4% ≥ 15 at screening~Stratum B: CD4% Nadir ≥ 15 and < 25 and CD4% ≥ 15 at screening~Stratum C: CD4% Nadir ≥ 25 and CD4% ≥ 25 at screening"|participants|Number|42|42.0||||||
4373712|NCT00339040|4200796|B2|Stratum C||Stratification groups|"STRATIFICATION: Participant were stratified by CD4% criteria into three strata:~Stratum A: CD4% Nadir < 15 and CD4% ≥ 15 at screening~Stratum B: CD4% Nadir ≥ 15 and < 25 and CD4% ≥ 15 at screening~Stratum C: CD4% Nadir ≥ 25 and CD4% ≥ 25 at screening"|participants|Number|9|9.0||||||
4373713|NCT00339040|4200797|B1|Stratum C||Stratification groups|"STRATIFICATION: Participant were stratified by CD4% criteria into three strata:~Stratum A: CD4% Nadir < 15 and CD4% ≥ 15 at screening~Stratum B: CD4% Nadir ≥ 15 and < 25 and CD4% ≥ 15 at screening~Stratum C: CD4% Nadir ≥ 25 and CD4% ≥ 25 at screening"|participants|Number|33|33.0||||||
4373714|NCT00339040|4200795|B3|Stratum B||Stratification groups|"STRATIFICATION: Participant were stratified by CD4% criteria into three strata:~Stratum A: CD4% Nadir < 15 and CD4% ≥ 15 at screening~Stratum B: CD4% Nadir ≥ 15 and < 25 and CD4% ≥ 15 at screening~Stratum C: CD4% Nadir ≥ 25 and CD4% ≥ 25 at screening"|participants|Number|43|43.0||||||
4373715|NCT00339040|4200796|B2|Stratum B||Stratification groups|"STRATIFICATION: Participant were stratified by CD4% criteria into three strata:~Stratum A: CD4% Nadir < 15 and CD4% ≥ 15 at screening~Stratum B: CD4% Nadir ≥ 15 and < 25 and CD4% ≥ 15 at screening~Stratum C: CD4% Nadir ≥ 25 and CD4% ≥ 25 at screening"|participants|Number|11|11.0||||||
4373716|NCT00339040|4200797|B1|Stratum B||Stratification groups|"STRATIFICATION: Participant were stratified by CD4% criteria into three strata:~Stratum A: CD4% Nadir < 15 and CD4% ≥ 15 at screening~Stratum B: CD4% Nadir ≥ 15 and < 25 and CD4% ≥ 15 at screening~Stratum C: CD4% Nadir ≥ 25 and CD4% ≥ 25 at screening"|participants|Number|32|32.0||||||
4373717|NCT00339040|4200795|B3|Stratum A||Stratification groups|"STRATIFICATION: Participant were stratified by CD4% criteria into three strata:~Stratum A: CD4% Nadir < 15 and CD4% ≥ 15 at screening~Stratum B: CD4% Nadir ≥ 15 and < 25 and CD4% ≥ 15 at screening~Stratum C: CD4% Nadir ≥ 25 and CD4% ≥ 25 at screening"|participants|Number|41|41.0||||||
4373776|NCT00338806|4200884|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4373718|NCT00339040|4200796|B2|Stratum A||Stratification groups|"STRATIFICATION: Participant were stratified by CD4% criteria into three strata:~Stratum A: CD4% Nadir < 15 and CD4% ≥ 15 at screening~Stratum B: CD4% Nadir ≥ 15 and < 25 and CD4% ≥ 15 at screening~Stratum C: CD4% Nadir ≥ 25 and CD4% ≥ 25 at screening"|participants|Number|10|10.0||||||
4373719|NCT00339040|4200797|B1|Stratum A||Stratification groups|"STRATIFICATION: Participant were stratified by CD4% criteria into three strata:~Stratum A: CD4% Nadir < 15 and CD4% ≥ 15 at screening~Stratum B: CD4% Nadir ≥ 15 and < 25 and CD4% ≥ 15 at screening~Stratum C: CD4% Nadir ≥ 25 and CD4% ≥ 25 at screening"|participants|Number|31|31.0||||||
4373720|NCT00339040|4200795|B3|Others||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4373721|NCT00339040|4200796|B2|Others||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4373722|NCT00339040|4200797|B1|Others||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4373723|NCT00339040|4200795|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4373724|NCT00339040|4200796|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4373725|NCT00339040|4200797|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4373726|NCT00339040|4200795|B3|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4373727|NCT00339040|4200796|B2|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4373728|NCT00339040|4200797|B1|Black, non-Hispanic||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4373729|NCT00339040|4200795|B3|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4373730|NCT00339040|4200796|B2|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4373731|NCT00339040|4200797|B1|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4373732|NCT00339040|4200795|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4373733|NCT00339040|4200796|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4373734|NCT00339040|4200797|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4373735|NCT00339040|4200795|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4373736|NCT00339040|4200796|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4373737|NCT00339040|4200797|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4373738|NCT00339040|4200795|B3|||Age||years|Mean|9.9|9.9|Standard Deviation|1.4|1.4|||
4373739|NCT00339040|4200796|B2|||Age||years|Mean|9.9|9.9|Standard Deviation|1.3|1.3|||
4373740|NCT00339040|4200797|B1|||Age||years|Mean|10.0|10.0|Standard Deviation|1.4|1.4|||
4373741|NCT00338988|4200816|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4373742|NCT00338988|4200816|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4373743|NCT00338988|4200816|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4373744|NCT00338988|4200816|B1|||Age||years|Median|68|68.0|Full Range|||28.0|77.0|
4373745|NCT00338962|4200821|B5||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4373746|NCT00338962|4200822|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4373747|NCT00338962|4200823|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4373748|NCT00338962|4200824|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4373749|NCT00338962|4200825|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4373750|NCT00338962|4200821|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4373751|NCT00338962|4200822|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4373752|NCT00338962|4200823|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4373753|NCT00338962|4200824|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4373754|NCT00338962|4200825|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373755|NCT00338962|4200821|B5|||Age||years|Mean|47.1|47.1|Standard Deviation|8.90|8.9|||
4373756|NCT00338962|4200822|B4|||Age||years|Mean|47.04|47.04|Standard Deviation|9.72|9.72|||
4373757|NCT00338962|4200823|B3|||Age||years|Mean|47.05|47.05|Standard Deviation|9.96|9.96|||
4373758|NCT00338962|4200824|B2|||Age||years|Mean|49.15|49.15|Standard Deviation|8.95|8.95|||
4373759|NCT00338962|4200825|B1|||Age||years|Mean|45.14|45.14|Standard Deviation|6.71|6.71|||
4373760|NCT00338884|4200850|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4373761|NCT00338884|4200850|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4373762|NCT00338884|4200850|B1|> = 65 years||Age, Customized||participants|Number|36|36.0||||||
4373763|NCT00338884|4200850|B1|45 to 64 years||Age, Customized||participants|Number|69|69.0||||||
4373764|NCT00338884|4200850|B1|18 to 44 years||Age, Customized||participants|Number|14|14.0||||||
4373765|NCT00338806|4200882|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4373766|NCT00338806|4200883|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4373767|NCT00338806|4200884|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4373768|NCT00338806|4200882|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373769|NCT00338806|4200883|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373770|NCT00338806|4200884|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373771|NCT00338806|4200882|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373772|NCT00338806|4200883|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373773|NCT00338806|4200884|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373774|NCT00338806|4200882|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4373775|NCT00338806|4200883|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4373777|NCT00338806|4200882|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373778|NCT00338806|4200883|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373779|NCT00338806|4200884|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373780|NCT00338806|4200882|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373781|NCT00338806|4200883|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373782|NCT00338806|4200884|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373783|NCT00338806|4200882|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373784|NCT00338806|4200883|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373785|NCT00338806|4200884|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373786|NCT00338806|4200882|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373787|NCT00338806|4200883|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373788|NCT00338806|4200884|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4373789|NCT00338806|4200882|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4373790|NCT00338806|4200883|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4373791|NCT00338806|4200884|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4373792|NCT00338806|4200882|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4373793|NCT00338806|4200883|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4373794|NCT00338806|4200884|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4373795|NCT00338806|4200882|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4373796|NCT00338806|4200883|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4373797|NCT00338806|4200884|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4373798|NCT00338806|4200882|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4373799|NCT00338806|4200883|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4373800|NCT00338806|4200884|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4373801|NCT00338806|4200882|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4373802|NCT00338806|4200883|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4373803|NCT00338806|4200884|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4373804|NCT00338741|4200945|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4373805|NCT00338741|4200946|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4373806|NCT00338741|4200947|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4373807|NCT00338741|4200945|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373808|NCT00338741|4200946|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373809|NCT00338741|4200947|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373810|NCT00338741|4200945|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4373811|NCT00338741|4200946|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4373812|NCT00338741|4200947|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4373813|NCT00338741|4200945|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4373814|NCT00338741|4200946|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4373815|NCT00338741|4200947|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4373816|NCT00338741|4200945|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4373817|NCT00338741|4200946|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4373818|NCT00338741|4200947|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4373819|NCT00338741|4200945|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4373820|NCT00338741|4200946|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4373821|NCT00338741|4200947|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4373822|NCT00338598|4200956|B3|||Drinks per day||drinks per day|Mean|7.5|7.5|Standard Deviation|7.1|7.1|||
4373823|NCT00338598|4200957|B2|||Drinks per day||drinks per day|Mean|5.9|5.9|Standard Deviation|5.0|5.0|||
4373824|NCT00338598|4200958|B1|||Drinks per day||drinks per day|Mean|8.9|8.9|Standard Deviation|8.5|8.5|||
4373825|NCT00338598|4200956|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4373826|NCT00338598|4200957|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4373827|NCT00338598|4200958|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4373828|NCT00338598|4200956|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4373829|NCT00338598|4200957|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4373830|NCT00338598|4200958|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4373831|NCT00338598|4200956|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4373832|NCT00338598|4200957|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4373833|NCT00338598|4200958|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4373834|NCT00338598|4200956|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373835|NCT00338598|4200957|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373836|NCT00338598|4200958|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373838|NCT00338598|4200957|B2|||Age||years|Mean|48.6|48.6|Standard Deviation|5.0|5.0|||
4373839|NCT00338598|4200958|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|4.8|4.8|||
4373840|NCT00338455|4200977|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.5|30.5|Standard Deviation|5.57|5.57|||
4373841|NCT00338455|4200978|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.7|31.7|Standard Deviation|5.79|5.79|||
4373842|NCT00338455|4200979|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.4|29.4|Standard Deviation|5.53|5.53|||
4373843|NCT00338455|4200977|B3|GFR > = 60||Glomerular Filtration Rate (GFR)|Estimate of the GFR using serum creatinine and demographic factors.|Participants|Number|8|8.0||||||
4373844|NCT00338455|4200978|B2|GFR > = 60||Glomerular Filtration Rate (GFR)|Estimate of the GFR using serum creatinine and demographic factors.|Participants|Number|3|3.0||||||
4373845|NCT00338455|4200979|B1|GFR > = 60||Glomerular Filtration Rate (GFR)|Estimate of the GFR using serum creatinine and demographic factors.|Participants|Number|5|5.0||||||
4373846|NCT00338455|4200977|B3|GFR < 60||Glomerular Filtration Rate (GFR)|Estimate of the GFR using serum creatinine and demographic factors.|Participants|Number|8|8.0||||||
4373847|NCT00338455|4200978|B2|GFR < 60||Glomerular Filtration Rate (GFR)|Estimate of the GFR using serum creatinine and demographic factors.|Participants|Number|4|4.0||||||
4373848|NCT00338455|4200979|B1|GFR < 60||Glomerular Filtration Rate (GFR)|Estimate of the GFR using serum creatinine and demographic factors.|Participants|Number|4|4.0||||||
4373849|NCT00338455|4200977|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4373850|NCT00338455|4200978|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4373851|NCT00338455|4200979|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4373852|NCT00338455|4200977|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4373853|NCT00338455|4200978|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4373854|NCT00338455|4200979|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4373855|NCT00338455|4200977|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|7.85|7.85|||
4373856|NCT00338455|4200978|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|4.65|4.65|||
4373857|NCT00338455|4200979|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|9.80|9.8|||
4373858|NCT00338286|4200992|B3|UNITED STATES OF AMERICA||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4373859|NCT00338286|4200993|B2|UNITED STATES OF AMERICA||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4373860|NCT00338286|4200994|B1|UNITED STATES OF AMERICA||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4373861|NCT00338286|4200992|B3|UKRAINE||Region of Enrollment||Participants|Count of Participants|646|646.0||||||
4373862|NCT00338286|4200993|B2|UKRAINE||Region of Enrollment||Participants|Count of Participants|318|318.0||||||
4373863|NCT00338286|4200994|B1|UKRAINE||Region of Enrollment||Participants|Count of Participants|328|328.0||||||
4373864|NCT00338286|4200992|B3|TAIWAN||Region of Enrollment||Participants|Count of Participants|49|49.0||||||
4373865|NCT00338286|4200993|B2|TAIWAN||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4373866|NCT00338286|4200994|B1|TAIWAN||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4373867|NCT00338286|4200992|B3|RUSSIA||Region of Enrollment||Participants|Count of Participants|231|231.0||||||
4373868|NCT00338286|4200993|B2|RUSSIA||Region of Enrollment||Participants|Count of Participants|129|129.0||||||
4373869|NCT00338286|4200994|B1|RUSSIA||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
4373870|NCT00338286|4200992|B3|ROMANIA||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4373871|NCT00338286|4200993|B2|ROMANIA||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4373872|NCT00338286|4200994|B1|ROMANIA||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4373873|NCT00338286|4200992|B3|PHILIPPINES||Region of Enrollment||Participants|Count of Participants|114|114.0||||||
4373874|NCT00338286|4200993|B2|PHILIPPINES||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
4373875|NCT00338286|4200994|B1|PHILIPPINES||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4373876|NCT00338286|4200992|B3|MEXICO||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4373877|NCT00338286|4200993|B2|MEXICO||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4373878|NCT00338286|4200994|B1|MEXICO||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4373879|NCT00338286|4200992|B3|MALAYSIA||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4373880|NCT00338286|4200993|B2|MALAYSIA||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4373881|NCT00338286|4200994|B1|MALAYSIA||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4373882|NCT00338286|4200992|B3|MACEDONIA||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4373883|NCT00338286|4200993|B2|MACEDONIA||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4373884|NCT00338286|4200994|B1|MACEDONIA||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4373885|NCT00338286|4200992|B3|INDONESIA||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4373886|NCT00338286|4200993|B2|INDONESIA||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4373887|NCT00338286|4200994|B1|INDONESIA||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4373888|NCT00338286|4200992|B3|INDIA||Region of Enrollment||Participants|Count of Participants|448|448.0||||||
4373889|NCT00338286|4200993|B2|INDIA||Region of Enrollment||Participants|Count of Participants|237|237.0||||||
4373890|NCT00338286|4200994|B1|INDIA||Region of Enrollment||Participants|Count of Participants|211|211.0||||||
4373891|NCT00338286|4200992|B3|HONG KONG||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4373892|NCT00338286|4200993|B2|HONG KONG||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4373893|NCT00338286|4200994|B1|HONG KONG||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4373894|NCT00338286|4200992|B3|GEORGIA||Region of Enrollment||Participants|Count of Participants|441|441.0||||||
4373895|NCT00338286|4200993|B2|GEORGIA||Region of Enrollment||Participants|Count of Participants|200|200.0||||||
4373896|NCT00338286|4200994|B1|GEORGIA||Region of Enrollment||Participants|Count of Participants|241|241.0||||||
4373897|NCT00338286|4200992|B3|ECUADOR||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4373898|NCT00338286|4200993|B2|ECUADOR||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4373899|NCT00338286|4200994|B1|ECUADOR||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4373900|NCT00338286|4200992|B3|COLOMBIA||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4373901|NCT00338286|4200993|B2|COLOMBIA||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4373902|NCT00338286|4200994|B1|COLOMBIA||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4373903|NCT00338286|4200992|B3|CHILE||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4373904|NCT00338286|4200993|B2|CHILE||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4373905|NCT00338286|4200994|B1|CHILE||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4373906|NCT00338286|4200992|B3|BULGARIA||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4373907|NCT00338286|4200993|B2|BULGARIA||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4373908|NCT00338286|4200994|B1|BULGARIA||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4373909|NCT00338286|4200992|B3|BRAZIL||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4373910|NCT00338286|4200993|B2|BRAZIL||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4373911|NCT00338286|4200994|B1|BRAZIL||Region of Enrollment||Participants|Count of Participants|27|27.0||||||
4373912|NCT00338286|4200992|B3|ARGENTINA||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4373913|NCT00338286|4200993|B2|ARGENTINA||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4373914|NCT00338286|4200994|B1|ARGENTINA||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4373915|NCT00338286|4200992|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373916|NCT00338286|4200993|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373917|NCT00338286|4200994|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373918|NCT00338286|4200992|B3||Female|Sex: Female, Male||Participants|Count of Participants|2098|2098.0||||||
4373919|NCT00338286|4200993|B2||Female|Sex: Female, Male||Participants|Count of Participants|1050|1050.0||||||
4373920|NCT00338286|4200994|B1||Female|Sex: Female, Male||Participants|Count of Participants|1048|1048.0||||||
4373921|NCT00338286|4200992|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|10.51|10.51|||
4373922|NCT00338286|4200993|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|10.49|10.49|||
4373923|NCT00338286|4200994|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|10.54|10.54|||
4373924|NCT00338104|4201009|B4|||Body Mass Index||kg/m2|Mean|29.8|29.8|Standard Deviation|6.6|6.6|||
4373925|NCT00338104|4201010|B3|||Body Mass Index||kg/m2|Mean|29.9|29.9|Standard Deviation|8.0|8.0|||
4373926|NCT00338104|4201011|B2|||Body Mass Index||kg/m2|Mean|30.6|30.6|Standard Deviation|6.4|6.4|||
4373927|NCT00338104|4201012|B1|||Body Mass Index||kg/m2|Mean|28.9|28.9|Standard Deviation|5.0|5.0|||
4373928|NCT00338104|4201009|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4373929|NCT00338104|4201010|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4373930|NCT00338104|4201011|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4373931|NCT00338104|4201012|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4373932|NCT00338104|4201009|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4373933|NCT00338104|4201010|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4373934|NCT00338104|4201011|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4373935|NCT00338104|4201012|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4373936|NCT00338104|4201009|B4|||Age||years|Mean|60.2|60.2|Standard Deviation|11.7|11.7|||
4373937|NCT00338104|4201010|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|10.2|10.2|||
4373938|NCT00338104|4201011|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|10.8|10.8|||
4373939|NCT00338104|4201012|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|13.7|13.7|||
4373940|NCT00338039|4201025|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4373941|NCT00338039|4201025|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4373942|NCT00338039|4201025|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4373943|NCT00338039|4201025|B1|||Age||years|Median|62|62.0|Full Range|||39.0|75.0|
4373944|NCT00337987|4201030|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4373945|NCT00337987|4201030|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4373946|NCT00337987|4201030|B1|||Age||years|Median|52|52.0|Full Range|||23.0|80.0|
4373947|NCT00337935|4201035|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4373948|NCT00337935|4201036|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4373949|NCT00337935|4201037|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4373950|NCT00337935|4201035|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4373951|NCT00337935|4201036|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4373952|NCT00337935|4201037|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4373953|NCT00337935|4201035|B3|||Age||Years|Mean|84.1|84.1|Standard Deviation|9.6|9.6|||
4373954|NCT00337935|4201036|B2|||Age||Years|Mean|84.1|84.1|Standard Deviation|9.2|9.2|||
4373955|NCT00337935|4201037|B1|||Age||Years|Mean|84.4|84.4|Standard Deviation|10.9|10.9|||
4373956|NCT00337935|4201035|B3||>=65 years|Age||Participants|Count of Participants|151|151.0||||||
4373957|NCT00337935|4201036|B2||>=65 years|Age||Participants|Count of Participants|114|114.0||||||
4373958|NCT00337935|4201037|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4373959|NCT00337935|4201035|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4373960|NCT00337935|4201036|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4373961|NCT00337935|4201037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4373962|NCT00337935|4201035|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4373963|NCT00337935|4201036|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4373964|NCT00337935|4201037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4373965|NCT00337818|4201048|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373966|NCT00337818|4201049|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373967|NCT00337818|4201050|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373968|NCT00337818|4201051|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4373969|NCT00337818|4201048|B4||Female|Sex: Female, Male||Participants|Count of Participants|770|770.0||||||
4373970|NCT00337818|4201049|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4373971|NCT00337818|4201050|B2||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4373972|NCT00337818|4201051|B1||Female|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4373973|NCT00337818|4201048|B4|||Age||years|Mean|18.6|18.6|Standard Deviation|4.2|4.2|||
4373974|NCT00337818|4201049|B3|||Age||years|Mean|12.4|12.4|Standard Deviation|1.37|1.37|||
4373975|NCT00337818|4201050|B2|||Age||years|Mean|20.3|20.3|Standard Deviation|2.99|2.99|||
4373976|NCT00337818|4201051|B1|||Age||years|Mean|20.2|20.2|Standard Deviation|2.96|2.96|||
4373977|NCT00337779|4201073|B3|United States||Region of Enrollment||participants|Number|263|263.0||||||
4373978|NCT00337779|4201074|B2|United States||Region of Enrollment||participants|Number|128|128.0||||||
4373979|NCT00337779|4201075|B1|United States||Region of Enrollment||participants|Number|135|135.0||||||
4373980|NCT00337779|4201073|B3|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4373981|NCT00337779|4201074|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4373982|NCT00337779|4201075|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4373983|NCT00337779|4201073|B3|Spain||Region of Enrollment||participants|Number|45|45.0||||||
4373984|NCT00337779|4201074|B2|Spain||Region of Enrollment||participants|Number|22|22.0||||||
4373985|NCT00337779|4201075|B1|Spain||Region of Enrollment||participants|Number|23|23.0||||||
4373986|NCT00337779|4201073|B3|Russian Federation||Region of Enrollment||participants|Number|175|175.0||||||
4373987|NCT00337779|4201074|B2|Russian Federation||Region of Enrollment||participants|Number|88|88.0||||||
4373988|NCT00337779|4201075|B1|Russian Federation||Region of Enrollment||participants|Number|87|87.0||||||
4373989|NCT00337779|4201073|B3|Romania||Region of Enrollment||participants|Number|57|57.0||||||
4373990|NCT00337779|4201074|B2|Romania||Region of Enrollment||participants|Number|28|28.0||||||
4373991|NCT00337779|4201075|B1|Romania||Region of Enrollment||participants|Number|29|29.0||||||
4373992|NCT00337779|4201073|B3|Poland||Region of Enrollment||participants|Number|71|71.0||||||
4373993|NCT00337779|4201074|B2|Poland||Region of Enrollment||participants|Number|35|35.0||||||
4373994|NCT00337779|4201075|B1|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4373995|NCT00337779|4201073|B3|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
4373996|NCT00337779|4201074|B2|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4373997|NCT00337779|4201075|B1|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4373998|NCT00337779|4201073|B3|Lithuania||Region of Enrollment||participants|Number|28|28.0||||||
4373999|NCT00337779|4201074|B2|Lithuania||Region of Enrollment||participants|Number|14|14.0||||||
4374000|NCT00337779|4201075|B1|Lithuania||Region of Enrollment||participants|Number|14|14.0||||||
4374001|NCT00337779|4201073|B3|Latvia||Region of Enrollment||participants|Number|28|28.0||||||
4374002|NCT00337779|4201074|B2|Latvia||Region of Enrollment||participants|Number|14|14.0||||||
4374003|NCT00337779|4201075|B1|Latvia||Region of Enrollment||participants|Number|14|14.0||||||
4374004|NCT00337779|4201073|B3|Italy||Region of Enrollment||participants|Number|90|90.0||||||
4374005|NCT00337779|4201074|B2|Italy||Region of Enrollment||participants|Number|43|43.0||||||
4374006|NCT00337779|4201075|B1|Italy||Region of Enrollment||participants|Number|47|47.0||||||
4374007|NCT00337779|4201073|B3|Israel||Region of Enrollment||participants|Number|28|28.0||||||
4374008|NCT00337779|4201074|B2|Israel||Region of Enrollment||participants|Number|14|14.0||||||
4374009|NCT00337779|4201075|B1|Israel||Region of Enrollment||participants|Number|14|14.0||||||
4374010|NCT00337779|4201073|B3|Hungary||Region of Enrollment||participants|Number|54|54.0||||||
4374011|NCT00337779|4201074|B2|Hungary||Region of Enrollment||participants|Number|27|27.0||||||
4374012|NCT00337779|4201075|B1|Hungary||Region of Enrollment||participants|Number|27|27.0||||||
4374013|NCT00337779|4201073|B3|Germany||Region of Enrollment||participants|Number|98|98.0||||||
4374014|NCT00337779|4201074|B2|Germany||Region of Enrollment||participants|Number|48|48.0||||||
4374015|NCT00337779|4201075|B1|Germany||Region of Enrollment||participants|Number|50|50.0||||||
4374016|NCT00337779|4201073|B3|France||Region of Enrollment||participants|Number|21|21.0||||||
4374017|NCT00337779|4201074|B2|France||Region of Enrollment||participants|Number|11|11.0||||||
4374018|NCT00337779|4201075|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
4374019|NCT00337779|4201073|B3|Finland||Region of Enrollment||participants|Number|16|16.0||||||
4374020|NCT00337779|4201074|B2|Finland||Region of Enrollment||participants|Number|7|7.0||||||
4374021|NCT00337779|4201075|B1|Finland||Region of Enrollment||participants|Number|9|9.0||||||
4374022|NCT00337779|4201073|B3|Estonia||Region of Enrollment||participants|Number|23|23.0||||||
4374023|NCT00337779|4201074|B2|Estonia||Region of Enrollment||participants|Number|12|12.0||||||
4374024|NCT00337779|4201075|B1|Estonia||Region of Enrollment||participants|Number|11|11.0||||||
4374025|NCT00337779|4201073|B3|Czech Republic||Region of Enrollment||participants|Number|67|67.0||||||
4374026|NCT00337779|4201074|B2|Czech Republic||Region of Enrollment||participants|Number|34|34.0||||||
4374027|NCT00337779|4201075|B1|Czech Republic||Region of Enrollment||participants|Number|33|33.0||||||
4374028|NCT00337779|4201073|B3|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4374029|NCT00337779|4201074|B2|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4374030|NCT00337779|4201075|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4374031|NCT00337779|4201073|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4374032|NCT00337779|4201074|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4374033|NCT00337779|4201075|B1|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4374034|NCT00337779|4201073|B3|Argentina||Region of Enrollment||participants|Number|28|28.0||||||
4374035|NCT00337779|4201074|B2|Argentina||Region of Enrollment||participants|Number|14|14.0||||||
4374036|NCT00337779|4201075|B1|Argentina||Region of Enrollment||participants|Number|14|14.0||||||
4374037|NCT00337779|4201073|B3||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4374038|NCT00337779|4201074|B2||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4374039|NCT00337779|4201075|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4374040|NCT00337779|4201073|B3||Female|Sex: Female, Male||Participants|Count of Participants|828|828.0||||||
4374041|NCT00337779|4201074|B2||Female|Sex: Female, Male||Participants|Count of Participants|407|407.0||||||
4374042|NCT00337779|4201075|B1||Female|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4374043|NCT00337779|4201073|B3|||Age||years|Mean|36.3|36.3|Standard Deviation|9.0|9.0|||
4374044|NCT00337779|4201074|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|9.0|9.0|||
4374045|NCT00337779|4201075|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|9.0|9.0|||
4374046|NCT00337779|4201073|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374047|NCT00337779|4201074|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374048|NCT00337779|4201075|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374049|NCT00337779|4201073|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1155|1155.0||||||
4374050|NCT00337779|4201074|B2||Between 18 and 65 years|Age||Participants|Count of Participants|569|569.0||||||
4374051|NCT00337779|4201075|B1||Between 18 and 65 years|Age||Participants|Count of Participants|586|586.0||||||
4374052|NCT00337779|4201073|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374053|NCT00337779|4201074|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374054|NCT00337779|4201075|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374055|NCT00337727|4201086|B3|Not Applicable- Male Patients||History of Vomiting with Pregnancy|Measure is specific to the female study population.|Participants|Number|196|196.0||||||
4374056|NCT00337727|4201087|B2|Not Applicable- Male Patients||History of Vomiting with Pregnancy|Measure is specific to the female study population.|Participants|Number|93|93.0||||||
4374057|NCT00337727|4201088|B1|Not Applicable- Male Patients||History of Vomiting with Pregnancy|Measure is specific to the female study population.|Participants|Number|103|103.0||||||
4374058|NCT00337727|4201086|B3|No||History of Vomiting with Pregnancy|Measure is specific to the female study population.|Participants|Number|516|516.0||||||
4374059|NCT00337727|4201087|B2|No||History of Vomiting with Pregnancy|Measure is specific to the female study population.|Participants|Number|250|250.0||||||
4374060|NCT00337727|4201088|B1|No||History of Vomiting with Pregnancy|Measure is specific to the female study population.|Participants|Number|266|266.0||||||
4374061|NCT00337727|4201086|B3|Yes||History of Vomiting with Pregnancy|Measure is specific to the female study population.|Participants|Number|136|136.0||||||
4374062|NCT00337727|4201087|B2|Yes||History of Vomiting with Pregnancy|Measure is specific to the female study population.|Participants|Number|75|75.0||||||
4374063|NCT00337727|4201088|B1|Yes||History of Vomiting with Pregnancy|Measure is specific to the female study population.|Participants|Number|61|61.0||||||
4374064|NCT00337727|4201086|B3|No Data – Assessment Not Completed||History of Motion Sickness||Participants|Number|2|2.0||||||
4374065|NCT00337727|4201087|B2|No Data – Assessment Not Completed||History of Motion Sickness||Participants|Number|1|1.0||||||
4374066|NCT00337727|4201088|B1|No Data – Assessment Not Completed||History of Motion Sickness||Participants|Number|1|1.0||||||
4374067|NCT00337727|4201086|B3|No||History of Motion Sickness||Participants|Number|781|781.0||||||
4374068|NCT00337727|4201087|B2|No||History of Motion Sickness||Participants|Number|376|376.0||||||
4374069|NCT00337727|4201088|B1|No||History of Motion Sickness||Participants|Number|405|405.0||||||
4374070|NCT00337727|4201086|B3|Yes||History of Motion Sickness||Participants|Number|65|65.0||||||
4374071|NCT00337727|4201087|B2|Yes||History of Motion Sickness||Participants|Number|41|41.0||||||
4374072|NCT00337727|4201088|B1|Yes||History of Motion Sickness||Participants|Number|24|24.0||||||
4374073|NCT00337727|4201086|B3|Other||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4374074|NCT00337727|4201087|B2|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4374075|NCT00337727|4201088|B1|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4374076|NCT00337727|4201086|B3|Multi-racial||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4374077|NCT00337727|4201087|B2|Multi-racial||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4374078|NCT00337727|4201088|B1|Multi-racial||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4374079|NCT00337727|4201086|B3|Black||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4374080|NCT00337727|4201087|B2|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4374081|NCT00337727|4201088|B1|Black||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4374082|NCT00337727|4201086|B3|Asian||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4374083|NCT00337727|4201087|B2|Asian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4374084|NCT00337727|4201088|B1|Asian||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4374085|NCT00337727|4201086|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|583|583.0||||||
4374086|NCT00337727|4201087|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|296|296.0||||||
4374087|NCT00337727|4201088|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|287|287.0||||||
4374088|NCT00337727|4201086|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4374089|NCT00337727|4201087|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4374090|NCT00337727|4201088|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4374091|NCT00337727|4201086|B3||Female|Sex: Female, Male||Participants|Count of Participants|652|652.0||||||
4374092|NCT00337727|4201087|B2||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4374093|NCT00337727|4201088|B1||Female|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4374094|NCT00337727|4201086|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|12.2|12.2|||
4374095|NCT00337727|4201087|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|12.6|12.6|||
4374096|NCT00337727|4201088|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|11.8|11.8|||
4374097|NCT00337675|4201097|B4||Male|Sex: Female, Male||Participants|Count of Participants|1068|1068.0||||||
4374098|NCT00337675|4201098|B3||Male|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4374099|NCT00337675|4201099|B2||Male|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4374100|NCT00337675|4201100|B1||Male|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4374101|NCT00337675|4201097|B4||Female|Sex: Female, Male||Participants|Count of Participants|703|703.0||||||
4374102|NCT00337675|4201098|B3||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4374103|NCT00337675|4201099|B2||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4374104|NCT00337675|4201100|B1||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4374105|NCT00337675|4201097|B4|||Age||Months|Mean|39.2|39.2|Full Range|||6.0|71.0|
4374106|NCT00337675|4201098|B3|||Age||Months|Mean|39.3|39.3|Full Range|||7.0|71.0|
4374107|NCT00337675|4201099|B2|||Age||Months|Mean|39.5|39.5|Full Range|||6.0|71.0|
4374108|NCT00337675|4201100|B1|||Age||Months|Mean|39.0|39.0|Full Range|||6.0|71.0|
4374109|NCT00337662|4201116|B4|||Positive and Negative Syndrome Scale (PANSS) - Total Score|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). The sum of the 30 items is defined as the PANSS total score and ranges from 30 to 210.|units on a scale|Mean|78.21|78.21|Standard Deviation|17.24|17.24|||
4374110|NCT00337662|4201117|B3|||Positive and Negative Syndrome Scale (PANSS) - Total Score|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). The sum of the 30 items is defined as the PANSS total score and ranges from 30 to 210.|units on a scale|Mean|61.67|61.67|Standard Deviation|12.85|12.85|||
4374111|NCT00337662|4201118|B2|||Positive and Negative Syndrome Scale (PANSS) - Total Score|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). The sum of the 30 items is defined as the PANSS total score and ranges from 30 to 210.|units on a scale|Mean|84.05|84.05|Standard Deviation|14.81|14.81|||
4374112|NCT00337662|4201119|B1|||Positive and Negative Syndrome Scale (PANSS) - Total Score|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). The sum of the 30 items is defined as the PANSS total score and ranges from 30 to 210.|units on a scale|Mean|84.91|84.91|Standard Deviation|13.81|13.81|||
4374113|NCT00337662|4201116|B4|||Positive and Negative Syndrome Scale (PANSS) - Positive Subscale|Assesses positive symptoms associated with schizophrenia. 7 items make up the Positive scale (ex. delusions, conceptual disorganization, and hallucinatory behavior). Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Total Positive Subscale scores range from 7 to 49.|units on a scale|Mean|19.61|19.61|Standard Deviation|5.13|5.13|||
4374114|NCT00337662|4201117|B3|||Positive and Negative Syndrome Scale (PANSS) - Positive Subscale|Assesses positive symptoms associated with schizophrenia. 7 items make up the Positive scale (ex. delusions, conceptual disorganization, and hallucinatory behavior). Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Total Positive Subscale scores range from 7 to 49.|units on a scale|Mean|15.37|15.37|Standard Deviation|3.97|3.97|||
4374115|NCT00337662|4201118|B2|||Positive and Negative Syndrome Scale (PANSS) - Positive Subscale|Assesses positive symptoms associated with schizophrenia. 7 items make up the Positive scale (ex. delusions, conceptual disorganization, and hallucinatory behavior). Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Total Positive Subscale scores range from 7 to 49.|units on a scale|Mean|20.95|20.95|Standard Deviation|4.65|4.65|||
4374177|NCT00337662|4201116|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4374178|NCT00337662|4201117|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374116|NCT00337662|4201119|B1|||Positive and Negative Syndrome Scale (PANSS) - Positive Subscale|Assesses positive symptoms associated with schizophrenia. 7 items make up the Positive scale (ex. delusions, conceptual disorganization, and hallucinatory behavior). Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Total Positive Subscale scores range from 7 to 49.|units on a scale|Mean|21.50|21.5|Standard Deviation|4.49|4.49|||
4374117|NCT00337662|4201116|B4|||Positive and Negative Syndrome Scale (PANSS) - Negative Subscale|Assesses negative symptoms associated with schizophrenia. 7 items make up the Negative scale (ex. blunted affect, emotional withdrawal, poor rapport, and passive/apathetic social withdrawal). Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Total Negative Subscale scores range from 7 to 49.|units on a scale|Mean|19.62|19.62|Standard Deviation|5.36|5.36|||
4374118|NCT00337662|4201117|B3|||Positive and Negative Syndrome Scale (PANSS) - Negative Subscale|Assesses negative symptoms associated with schizophrenia. 7 items make up the Negative scale (ex. blunted affect, emotional withdrawal, poor rapport, and passive/apathetic social withdrawal). Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Total Negative Subscale scores range from 7 to 49.|units on a scale|Mean|15.83|15.83|Standard Deviation|3.90|3.9|||
4374119|NCT00337662|4201118|B2|||Positive and Negative Syndrome Scale (PANSS) - Negative Subscale|Assesses negative symptoms associated with schizophrenia. 7 items make up the Negative scale (ex. blunted affect, emotional withdrawal, poor rapport, and passive/apathetic social withdrawal). Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Total Negative Subscale scores range from 7 to 49.|units on a scale|Mean|20.94|20.94|Standard Deviation|5.30|5.3|||
4374120|NCT00337662|4201119|B1|||Positive and Negative Syndrome Scale (PANSS) - Negative Subscale|Assesses negative symptoms associated with schizophrenia. 7 items make up the Negative scale (ex. blunted affect, emotional withdrawal, poor rapport, and passive/apathetic social withdrawal). Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Total Negative Subscale scores range from 7 to 49.|units on a scale|Mean|21.18|21.18|Standard Deviation|4.96|4.96|||
4374121|NCT00337662|4201116|B4|||Montgomery-Asberg Depression Rating Scale (MADRS) - Total Score|Measures the overall severity of depressive symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|11.42|11.42|Standard Deviation|8.09|8.09|||
4374122|NCT00337662|4201117|B3|||Montgomery-Asberg Depression Rating Scale (MADRS) - Total Score|Measures the overall severity of depressive symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|7.29|7.29|Standard Deviation|6.07|6.07|||
4374123|NCT00337662|4201118|B2|||Montgomery-Asberg Depression Rating Scale (MADRS) - Total Score|Measures the overall severity of depressive symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|12.49|12.49|Standard Deviation|8.44|8.44|||
4374124|NCT00337662|4201119|B1|||Montgomery-Asberg Depression Rating Scale (MADRS) - Total Score|Measures the overall severity of depressive symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|units on a scale|Mean|13.52|13.52|Standard Deviation|7.98|7.98|||
4374125|NCT00337662|4201116|B4|||Modified Simpson-Angus Scale|Measures neuroleptic-induced parkinsonism. Total score consists of the sum of 10 items: 7 items (items 1, 3, 4, 7, 8, 9, 10) rated on a 4-point severity scale where 0=normal and 4=extreme, and 3 items (items 2, 5, 6) rated on a 2-point severity scale where 0=normal and 2=definitely abnormal/present. The total score ranges from 0 to 34.|units on a scale|Mean|0.13|0.13|Standard Deviation|0.50|0.5|||
4374126|NCT00337662|4201117|B3|||Modified Simpson-Angus Scale|Measures neuroleptic-induced parkinsonism. Total score consists of the sum of 10 items: 7 items (items 1, 3, 4, 7, 8, 9, 10) rated on a 4-point severity scale where 0=normal and 4=extreme, and 3 items (items 2, 5, 6) rated on a 2-point severity scale where 0=normal and 2=definitely abnormal/present. The total score ranges from 0 to 34.|units on a scale|Mean|0.13|0.13|Standard Deviation|0.82|0.82|||
4374127|NCT00337662|4201118|B2|||Modified Simpson-Angus Scale|Measures neuroleptic-induced parkinsonism. Total score consists of the sum of 10 items: 7 items (items 1, 3, 4, 7, 8, 9, 10) rated on a 4-point severity scale where 0=normal and 4=extreme, and 3 items (items 2, 5, 6) rated on a 2-point severity scale where 0=normal and 2=definitely abnormal/present. The total score ranges from 0 to 34.|units on a scale|Mean|0.14|0.14|Standard Deviation|0.29|0.29|||
4374128|NCT00337662|4201119|B1|||Modified Simpson-Angus Scale|Measures neuroleptic-induced parkinsonism. Total score consists of the sum of 10 items: 7 items (items 1, 3, 4, 7, 8, 9, 10) rated on a 4-point severity scale where 0=normal and 4=extreme, and 3 items (items 2, 5, 6) rated on a 2-point severity scale where 0=normal and 2=definitely abnormal/present. The total score ranges from 0 to 34.|units on a scale|Mean|0.12|0.12|Standard Deviation|0.29|0.29|||
4374129|NCT00337662|4201116|B4|||Barnes Akathisia Rating Scale Total Score|Evaluates akathisia associated with use of antipsychotic medications, includes objective and subjective component plus global impression rating for overall disorder. Components rated on scale of 0 to 3 for objective and subjective items and 0 to 5 for global clinical assessment, for total score of 0 (absence of akathisia) to 11 (severe akathisia).|units on a scale|Mean|0.78|0.78|Standard Deviation|1.83|1.83|||
4374130|NCT00337662|4201117|B3|||Barnes Akathisia Rating Scale Total Score|Evaluates akathisia associated with use of antipsychotic medications, includes objective and subjective component plus global impression rating for overall disorder. Components rated on scale of 0 to 3 for objective and subjective items and 0 to 5 for global clinical assessment, for total score of 0 (absence of akathisia) to 11 (severe akathisia).|units on a scale|Mean|0.54|0.54|Standard Deviation|1.64|1.64|||
4374131|NCT00337662|4201118|B2|||Barnes Akathisia Rating Scale Total Score|Evaluates akathisia associated with use of antipsychotic medications, includes objective and subjective component plus global impression rating for overall disorder. Components rated on scale of 0 to 3 for objective and subjective items and 0 to 5 for global clinical assessment, for total score of 0 (absence of akathisia) to 11 (severe akathisia).|units on a scale|Mean|0.95|0.95|Standard Deviation|1.97|1.97|||
4374179|NCT00337662|4201118|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4374132|NCT00337662|4201119|B1|||Barnes Akathisia Rating Scale Total Score|Evaluates akathisia associated with use of antipsychotic medications, includes objective and subjective component plus global impression rating for overall disorder. Components rated on scale of 0 to 3 for objective and subjective items and 0 to 5 for global clinical assessment, for total score of 0 (absence of akathisia) to 11 (severe akathisia).|units on a scale|Mean|0.80|0.8|Standard Deviation|1.81|1.81|||
4374133|NCT00337662|4201116|B4|||Abnormal Involuntary Movement Scale - Non-Global Total Score|A 12-item instrument assesses observed abnormal movements in different parts of body. Ten items are scored in a 5-point scale (0 = none/normal, 4 = severe) which evaluates abnormal movements in three main anatomic areas (orofacial area, extremities, and trunk). Two items are yes/no questions regarding dentures. Total scores range from 0 to 42.|units on a scale|Mean|0.54|0.54|Standard Deviation|1.58|1.58|||
4374134|NCT00337662|4201117|B3|||Abnormal Involuntary Movement Scale - Non-Global Total Score|A 12-item instrument assesses observed abnormal movements in different parts of body. Ten items are scored in a 5-point scale (0 = none/normal, 4 = severe) which evaluates abnormal movements in three main anatomic areas (orofacial area, extremities, and trunk). Two items are yes/no questions regarding dentures. Total scores range from 0 to 42.|units on a scale|Mean|0.44|0.44|Standard Deviation|1.38|1.38|||
4374135|NCT00337662|4201118|B2|||Abnormal Involuntary Movement Scale - Non-Global Total Score|A 12-item instrument assesses observed abnormal movements in different parts of body. Ten items are scored in a 5-point scale (0 = none/normal, 4 = severe) which evaluates abnormal movements in three main anatomic areas (orofacial area, extremities, and trunk). Two items are yes/no questions regarding dentures. Total scores range from 0 to 42.|units on a scale|Mean|0.49|0.49|Standard Deviation|1.48|1.48|||
4374136|NCT00337662|4201119|B1|||Abnormal Involuntary Movement Scale - Non-Global Total Score|A 12-item instrument assesses observed abnormal movements in different parts of body. Ten items are scored in a 5-point scale (0 = none/normal, 4 = severe) which evaluates abnormal movements in three main anatomic areas (orofacial area, extremities, and trunk). Two items are yes/no questions regarding dentures. Total scores range from 0 to 42.|units on a scale|Mean|0.67|0.67|Standard Deviation|1.82|1.82|||
4374137|NCT00337662|4201116|B4|Schizoaffective Depression||Diagnosis||participants|Number|47|47.0||||||
4374138|NCT00337662|4201117|B3|Schizoaffective Depression||Diagnosis||participants|Number|9|9.0||||||
4374139|NCT00337662|4201118|B2|Schizoaffective Depression||Diagnosis||participants|Number|23|23.0||||||
4374140|NCT00337662|4201119|B1|Schizoaffective Depression||Diagnosis||participants|Number|15|15.0||||||
4374141|NCT00337662|4201116|B4|Schizoaffective Bipolar Disorder||Diagnosis||participants|Number|77|77.0||||||
4374142|NCT00337662|4201117|B3|Schizoaffective Bipolar Disorder||Diagnosis||participants|Number|21|21.0||||||
4374143|NCT00337662|4201118|B2|Schizoaffective Bipolar Disorder||Diagnosis||participants|Number|25|25.0||||||
4374144|NCT00337662|4201119|B1|Schizoaffective Bipolar Disorder||Diagnosis||participants|Number|31|31.0||||||
4374145|NCT00337662|4201116|B4|Schizophrenia/Schizophreniform Disorder||Diagnosis||participants|Number|398|398.0||||||
4374146|NCT00337662|4201117|B3|Schizophrenia/Schizophreniform Disorder||Diagnosis||participants|Number|114|114.0||||||
4374147|NCT00337662|4201118|B2|Schizophrenia/Schizophreniform Disorder||Diagnosis||participants|Number|144|144.0||||||
4374148|NCT00337662|4201119|B1|Schizophrenia/Schizophreniform Disorder||Diagnosis||participants|Number|140|140.0||||||
4374149|NCT00337662|4201116|B4|Russian Federation||Region of Enrollment||participants|Number|25|25.0||||||
4374150|NCT00337662|4201117|B3|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
4374151|NCT00337662|4201118|B2|Russian Federation||Region of Enrollment||participants|Number|11|11.0||||||
4374152|NCT00337662|4201119|B1|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4374153|NCT00337662|4201116|B4|Argentina||Region of Enrollment||participants|Number|18|18.0||||||
4374154|NCT00337662|4201117|B3|Argentina||Region of Enrollment||participants|Number|9|9.0||||||
4374155|NCT00337662|4201118|B2|Argentina||Region of Enrollment||participants|Number|5|5.0||||||
4374156|NCT00337662|4201119|B1|Argentina||Region of Enrollment||participants|Number|4|4.0||||||
4374157|NCT00337662|4201116|B4|United States||Region of Enrollment||participants|Number|479|479.0||||||
4374158|NCT00337662|4201117|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4374159|NCT00337662|4201118|B2|United States||Region of Enrollment||participants|Number|176|176.0||||||
4374160|NCT00337662|4201119|B1|United States||Region of Enrollment||participants|Number|173|173.0||||||
4374161|NCT00337662|4201116|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4374162|NCT00337662|4201117|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4374163|NCT00337662|4201118|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4374164|NCT00337662|4201119|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4374165|NCT00337662|4201116|B4|White||Race/Ethnicity, Customized||participants|Number|234|234.0||||||
4374166|NCT00337662|4201117|B3|White||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4374167|NCT00337662|4201118|B2|White||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4374168|NCT00337662|4201119|B1|White||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4374169|NCT00337662|4201116|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|234|234.0||||||
4374170|NCT00337662|4201117|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4374171|NCT00337662|4201118|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4374172|NCT00337662|4201119|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4374173|NCT00337662|4201116|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4374174|NCT00337662|4201117|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374175|NCT00337662|4201118|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374176|NCT00337662|4201119|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4374241|NCT00337571|4201189|B5|≥40 kilograms||Weight Group||Participants|Number|92|92.0||||||
4374180|NCT00337662|4201119|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374181|NCT00337662|4201116|B4||Male|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4374182|NCT00337662|4201117|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4374183|NCT00337662|4201118|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4374184|NCT00337662|4201119|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4374185|NCT00337662|4201116|B4||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4374186|NCT00337662|4201117|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4374187|NCT00337662|4201118|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4374188|NCT00337662|4201119|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4374189|NCT00337662|4201116|B4|||Age||years|Mean|41.85|41.85|Standard Deviation|11.04|11.04|||
4374190|NCT00337662|4201117|B3|||Age||years|Mean|41.83|41.83|Standard Deviation|10.88|10.88|||
4374191|NCT00337662|4201118|B2|||Age||years|Mean|41.87|41.87|Standard Deviation|11.34|11.34|||
4374192|NCT00337662|4201119|B1|||Age||years|Mean|41.84|41.84|Standard Deviation|10.92|10.92|||
4374193|NCT00337610|4201174|B3|||Hemoglobin A1C (A1C)||Percent|Mean|9.2|9.2|Standard Deviation|0.8|0.8|||
4374194|NCT00337610|4201175|B2|||Hemoglobin A1C (A1C)||Percent|Mean|9.1|9.1|Standard Deviation|0.8|0.8|||
4374195|NCT00337610|4201176|B1|||Hemoglobin A1C (A1C)||Percent|Mean|9.3|9.3|Standard Deviation|0.9|0.9|||
4374196|NCT00337610|4201174|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|199.7|199.7|Standard Deviation|45.3|45.3|||
4374197|NCT00337610|4201175|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|198.2|198.2|Standard Deviation|44.6|44.6|||
4374198|NCT00337610|4201176|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|201.1|201.1|Standard Deviation|46.2|46.2|||
4374199|NCT00337610|4201174|B3|||2-Hour Post-Meal Glucose (2 hr PMG)||mg/dL|Mean|287.7|287.7|Standard Deviation|68.5|68.5|||
4374200|NCT00337610|4201175|B2|||2-Hour Post-Meal Glucose (2 hr PMG)||mg/dL|Mean|286.7|286.7|Standard Deviation|61.7|61.7|||
4374201|NCT00337610|4201176|B1|||2-Hour Post-Meal Glucose (2 hr PMG)||mg/dL|Mean|288.7|288.7|Standard Deviation|74.8|74.8|||
4374202|NCT00337610|4201174|B3|Other||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4374203|NCT00337610|4201175|B2|Other||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4374204|NCT00337610|4201176|B1|Other||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4374205|NCT00337610|4201174|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374206|NCT00337610|4201175|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374207|NCT00337610|4201176|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374208|NCT00337610|4201174|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4374209|NCT00337610|4201175|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4374210|NCT00337610|4201176|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4374211|NCT00337610|4201174|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4374212|NCT00337610|4201175|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374213|NCT00337610|4201176|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4374214|NCT00337610|4201174|B3|White||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4374215|NCT00337610|4201175|B2|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4374216|NCT00337610|4201176|B1|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4374217|NCT00337610|4201174|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4374218|NCT00337610|4201175|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4374219|NCT00337610|4201176|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4374220|NCT00337610|4201174|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4374221|NCT00337610|4201175|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4374222|NCT00337610|4201176|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4374223|NCT00337610|4201174|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|9.5|9.5|||
4374224|NCT00337610|4201175|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|9.5|9.5|||
4374225|NCT00337610|4201176|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|9.5|9.5|||
4374226|NCT00337571|4201189|B5|||Weight||kilograms|Mean|42.9|42.9|Standard Deviation|21.07|21.07|||
4374227|NCT00337571|4201190|B4|||Weight||kilograms|Mean|42.2|42.2|Standard Deviation|22.99|22.99|||
4374228|NCT00337571|4201191|B3|||Weight||kilograms|Mean|44.8|44.8|Standard Deviation|22.38|22.38|||
4374229|NCT00337571|4201192|B2|||Weight||kilograms|Mean|38.9|38.9|Standard Deviation|18.26|18.26|||
4374230|NCT00337571|4201193|B1|||Weight||kilograms|Mean|45.6|45.6|Standard Deviation|20.01|20.01|||
4374231|NCT00337571|4201189|B5|||Height||centimeters|Mean|140.8|140.8|Standard Deviation|17.38|17.38|||
4374232|NCT00337571|4201190|B4|||Height||centimeters|Mean|139.3|139.3|Standard Deviation|17.24|17.24|||
4374233|NCT00337571|4201191|B3|||Height||centimeters|Mean|142.3|142.3|Standard Deviation|17.87|17.87|||
4374234|NCT00337571|4201192|B2|||Height||centimeters|Mean|136.5|136.5|Standard Deviation|14.66|14.66|||
4374235|NCT00337571|4201193|B1|||Height||centimeters|Mean|144.9|144.9|Standard Deviation|18.82|18.82|||
4374236|NCT00337571|4201189|B5|||Body Mass Index||kg/m2|Mean|20.41|20.41|Standard Deviation|5.933|5.933|||
4374237|NCT00337571|4201190|B4|||Body Mass Index||kg/m2|Mean|20.14|20.14|Standard Deviation|6.033|6.033|||
4374238|NCT00337571|4201191|B3|||Body Mass Index||kg/m2|Mean|21.06|21.06|Standard Deviation|6.649|6.649|||
4374239|NCT00337571|4201192|B2|||Body Mass Index||kg/m2|Mean|19.91|19.91|Standard Deviation|6.124|6.124|||
4374240|NCT00337571|4201193|B1|||Body Mass Index||kg/m2|Mean|20.49|20.49|Standard Deviation|4.777|4.777|||
4374242|NCT00337571|4201190|B4|≥40 kilograms||Weight Group||Participants|Number|20|20.0||||||
4374243|NCT00337571|4201191|B3|≥40 kilograms||Weight Group||Participants|Number|26|26.0||||||
4374244|NCT00337571|4201192|B2|≥40 kilograms||Weight Group||Participants|Number|18|18.0||||||
4374245|NCT00337571|4201193|B1|≥40 kilograms||Weight Group||Participants|Number|28|28.0||||||
4374246|NCT00337571|4201189|B5|<40 kilograms||Weight Group||Participants|Number|126|126.0||||||
4374247|NCT00337571|4201190|B4|<40 kilograms||Weight Group||Participants|Number|34|34.0||||||
4374248|NCT00337571|4201191|B3|<40 kilograms||Weight Group||Participants|Number|33|33.0||||||
4374249|NCT00337571|4201192|B2|<40 kilograms||Weight Group||Participants|Number|35|35.0||||||
4374250|NCT00337571|4201193|B1|<40 kilograms||Weight Group||Participants|Number|24|24.0||||||
4374251|NCT00337571|4201189|B5|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|193|193.0||||||
4374252|NCT00337571|4201190|B4|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
4374253|NCT00337571|4201191|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4374254|NCT00337571|4201192|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
4374255|NCT00337571|4201193|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4374256|NCT00337571|4201189|B5|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4374257|NCT00337571|4201190|B4|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4374258|NCT00337571|4201191|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4374259|NCT00337571|4201192|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4374260|NCT00337571|4201193|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4374261|NCT00337571|4201189|B5|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4374262|NCT00337571|4201190|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4374263|NCT00337571|4201191|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374264|NCT00337571|4201192|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4374265|NCT00337571|4201193|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374266|NCT00337571|4201189|B5|White||Race/Ethnicity, Customized||participants|Number|155|155.0||||||
4374267|NCT00337571|4201190|B4|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4374268|NCT00337571|4201191|B3|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4374269|NCT00337571|4201192|B2|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4374270|NCT00337571|4201193|B1|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4374271|NCT00337571|4201189|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4374272|NCT00337571|4201190|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4374273|NCT00337571|4201191|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4374274|NCT00337571|4201192|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4374275|NCT00337571|4201193|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4374276|NCT00337571|4201189|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374277|NCT00337571|4201190|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374278|NCT00337571|4201191|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374279|NCT00337571|4201192|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374280|NCT00337571|4201193|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374281|NCT00337571|4201189|B5|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4374282|NCT00337571|4201190|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374283|NCT00337571|4201191|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4374284|NCT00337571|4201192|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374285|NCT00337571|4201193|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4374286|NCT00337571|4201189|B5||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4374287|NCT00337571|4201190|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4374288|NCT00337571|4201191|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4374289|NCT00337571|4201192|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4374290|NCT00337571|4201193|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4374291|NCT00337571|4201189|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4374292|NCT00337571|4201190|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4374293|NCT00337571|4201191|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4374294|NCT00337571|4201192|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4374295|NCT00337571|4201193|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4374296|NCT00337571|4201189|B5|13 to 17 years||Age, Customized||participants|Number|52|52.0||||||
4374297|NCT00337571|4201190|B4|13 to 17 years||Age, Customized||participants|Number|12|12.0||||||
4374298|NCT00337571|4201191|B3|13 to 17 years||Age, Customized||participants|Number|14|14.0||||||
4374299|NCT00337571|4201192|B2|13 to 17 years||Age, Customized||participants|Number|9|9.0||||||
4374300|NCT00337571|4201193|B1|13 to 17 years||Age, Customized||participants|Number|17|17.0||||||
4374301|NCT00337571|4201189|B5|6 to 12 years||Age, Customized||participants|Number|166|166.0||||||
4374302|NCT00337571|4201190|B4|6 to 12 years||Age, Customized||participants|Number|42|42.0||||||
4374303|NCT00337571|4201191|B3|6 to 12 years||Age, Customized||participants|Number|45|45.0||||||
4374304|NCT00337571|4201192|B2|6 to 12 years||Age, Customized||participants|Number|44|44.0||||||
4374305|NCT00337571|4201193|B1|6 to 12 years||Age, Customized||participants|Number|35|35.0||||||
4374306|NCT00337467|4201234|B1|||HIV RNA||log10 c/mL|Mean|1.71|1.71|Standard Deviation|0.152|0.152|||
4374307|NCT00337467|4201234|B1|||Fasting Triglycerides|Population analyzed = 54 (treated participants with baseline measure)|mg/dL|Mean|164|164.0|Standard Deviation|95.7|95.7|||
4374308|NCT00337467|4201234|B1|||Fasting Total Cholesterol|Population analyzed = 54 (treated participants with baseline measure)|mg/dL|Mean|189|189.0|Standard Deviation|57|57.0|||
4374309|NCT00337467|4201234|B1|||Fasting Non-HDL Cholesterol|Population analyzed = 54 (treated participants with baseline measure)|mg/dL|Mean|144|144.0|Standard Deviation|57.9|57.9|||
4374310|NCT00337467|4201234|B1|||Fasting Low-Density Lipoprotein (LDL) Cholesterol|Population analyzed = 54 (treated participants with baseline measure)|mg/dL|Mean|112|112.0|Standard Deviation|52.3|52.3|||
4374311|NCT00337467|4201234|B1|||Fasting High-Density Lipoprotein (HDL) Cholesterol|Population analyzed = 54 (treated participants with baseline measure)|mg/dL|Mean|45|45.0|Standard Deviation|10.4|10.4|||
4374312|NCT00337467|4201234|B1|||CD4 Count||cell/mm3|Mean|559|559.0|Standard Deviation|272.8|272.8|||
4374313|NCT00337467|4201234|B1|HIV RNA >=50 c/mL||Human Immunodeficiency Ribonucleic Acid (HIV RNA) Categories||Participants|Number|1|1.0||||||
4374314|NCT00337467|4201234|B1|HIV RNA <50 c/mL||Human Immunodeficiency Ribonucleic Acid (HIV RNA) Categories||Participants|Number|60|60.0||||||
4374315|NCT00337467|4201234|B1|CD4 Count >=200 cells/mm3||Cluster of Differentiation 4 (CD4) Categories||participants|Number|58|58.0||||||
4374316|NCT00337467|4201234|B1|CD4 Count <200 cells/mm3||Cluster of Differentiation 4 (CD4) Categories||participants|Number|3|3.0||||||
4374317|NCT00337467|4201234|B1|White||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4374318|NCT00337467|4201234|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4374319|NCT00337467|4201234|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4374320|NCT00337467|4201234|B1|||Age||years|Mean|43|43.0|Standard Deviation|9.5|9.5|||
4374321|NCT00337428|4201251|B3|White||Race/Ethnicity, Customized||participants|Number|828|828.0||||||
4374322|NCT00337428|4201252|B2|White||Race/Ethnicity, Customized||participants|Number|415|415.0||||||
4374323|NCT00337428|4201253|B1|White||Race/Ethnicity, Customized||participants|Number|413|413.0||||||
4374324|NCT00337428|4201251|B3|Multi-racial||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4374325|NCT00337428|4201252|B2|Multi-racial||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4374326|NCT00337428|4201253|B1|Multi-racial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4374327|NCT00337428|4201251|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4374328|NCT00337428|4201252|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4374329|NCT00337428|4201253|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4374330|NCT00337428|4201251|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4374331|NCT00337428|4201252|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4374332|NCT00337428|4201253|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374333|NCT00337428|4201251|B3||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4374334|NCT00337428|4201252|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4374335|NCT00337428|4201253|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4374336|NCT00337428|4201251|B3||Female|Sex: Female, Male||Participants|Count of Participants|583|583.0||||||
4374337|NCT00337428|4201252|B2||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4374338|NCT00337428|4201253|B1||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4374339|NCT00337428|4201251|B3|||Age||years|Mean|12.1|12.1|Standard Deviation|1.5|1.5|||
4374340|NCT00337428|4201252|B2|||Age||years|Mean|12.1|12.1|Standard Deviation|1.5|1.5|||
4374341|NCT00337428|4201253|B1|||Age||years|Mean|12.1|12.1|Standard Deviation|1.5|1.5|||
4374342|NCT00337350|4201292|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4374343|NCT00337350|4201293|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4374344|NCT00337350|4201294|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4374345|NCT00337350|4201292|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4374346|NCT00337350|4201293|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4374347|NCT00337350|4201294|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4374348|NCT00337350|4201292|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4374349|NCT00337350|4201293|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4374350|NCT00337350|4201294|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4374351|NCT00337350|4201292|B3|||Age||years|Mean|40.15|40.15|Standard Deviation|8.46|8.46|||
4374352|NCT00337350|4201293|B2|||Age||years|Mean|39.36|39.36|Standard Deviation|7.06|7.06|||
4374353|NCT00337350|4201294|B1|||Age||years|Mean|41.11|41.11|Standard Deviation|10.29|10.29|||
4374354|NCT00337350|4201292|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374355|NCT00337350|4201293|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374356|NCT00337350|4201294|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374357|NCT00337350|4201292|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4374358|NCT00337350|4201293|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4374359|NCT00337350|4201294|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4374360|NCT00337350|4201292|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374361|NCT00337350|4201293|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374362|NCT00337350|4201294|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374363|NCT00337285|4201305|B1|United States||Region of Enrollment||participants|Number|349|349.0||||||
4374364|NCT00337285|4201305|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4374365|NCT00337285|4201305|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4374366|NCT00337285|4201305|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|10.1|10.1|||
4374367|NCT00337285|4201305|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374368|NCT00337285|4201305|B1||Between 18 and 65 years|Age||Participants|Count of Participants|349|349.0||||||
4374369|NCT00337285|4201305|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374370|NCT00337272|4201311|B3|United States||Region of Enrollment||Participants|Number|16|16.0||||||
4374371|NCT00337272|4201312|B2|United States||Region of Enrollment||Participants|Number|9|9.0||||||
4374372|NCT00337272|4201313|B1|United States||Region of Enrollment||Participants|Number|7|7.0||||||
4374373|NCT00337272|4201311|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374374|NCT00337272|4201312|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374375|NCT00337272|4201313|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374376|NCT00337272|4201311|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374377|NCT00337272|4201312|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374378|NCT00337272|4201313|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374379|NCT00337272|4201311|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4374380|NCT00337272|4201312|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4374381|NCT00337272|4201313|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4374382|NCT00337272|4201311|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4374383|NCT00337272|4201312|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4374384|NCT00337272|4201313|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374385|NCT00337272|4201311|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374386|NCT00337272|4201312|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374387|NCT00337272|4201313|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374388|NCT00337272|4201311|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374389|NCT00337272|4201312|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374390|NCT00337272|4201313|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374391|NCT00337272|4201311|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374392|NCT00337272|4201312|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374393|NCT00337272|4201313|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374394|NCT00337272|4201311|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4374395|NCT00337272|4201312|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4374396|NCT00337272|4201313|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4374397|NCT00337272|4201311|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4374398|NCT00337272|4201312|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4374399|NCT00337272|4201313|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4374400|NCT00337272|4201311|B3|||Age||Years|Mean|50.24|50.24|Standard Deviation|6.37|6.37|||
4374401|NCT00337272|4201312|B2|||Age||Years|Mean|49.11|49.11|Standard Deviation|6.78|6.78|||
4374402|NCT00337272|4201313|B1|||Age||Years|Mean|51.69|51.69|Standard Deviation|5.98|5.98|||
4374403|NCT00337272|4201311|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374404|NCT00337272|4201312|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374405|NCT00337272|4201313|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374406|NCT00337272|4201311|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4374407|NCT00337272|4201312|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4374408|NCT00337272|4201313|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4374409|NCT00337272|4201311|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374410|NCT00337272|4201312|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374411|NCT00337272|4201313|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374412|NCT00337207|4201334|B1|Malignant glioma NOS (not otherwise specified)||Diagnosis|Patients with histologically proven malignant gliomas were eligible to be enrolled including the following diagnoses: glioblastoma multiforme (GBM), gliosarcoma, anaplastic astrocytoma (AA), anaplastic oligodendronglioma, anaplastic mixed glioma or malignant glioma NOS (not otherwise specified).|Participants|Number|0|0.0||||||
4374413|NCT00337207|4201334|B1|Anaplastic mixed glioma||Diagnosis|Patients with histologically proven malignant gliomas were eligible to be enrolled including the following diagnoses: glioblastoma multiforme (GBM), gliosarcoma, anaplastic astrocytoma (AA), anaplastic oligodendronglioma, anaplastic mixed glioma or malignant glioma NOS (not otherwise specified).|Participants|Number|0|0.0||||||
4374464|NCT00337194|4201342|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4374465|NCT00337194|4201340|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4374414|NCT00337207|4201334|B1|Anaplastic oligodendronglioma||Diagnosis|Patients with histologically proven malignant gliomas were eligible to be enrolled including the following diagnoses: glioblastoma multiforme (GBM), gliosarcoma, anaplastic astrocytoma (AA), anaplastic oligodendronglioma, anaplastic mixed glioma or malignant glioma NOS (not otherwise specified).|Participants|Number|4|4.0||||||
4374415|NCT00337207|4201334|B1|Gliosarcoma||Diagnosis|Patients with histologically proven malignant gliomas were eligible to be enrolled including the following diagnoses: glioblastoma multiforme (GBM), gliosarcoma, anaplastic astrocytoma (AA), anaplastic oligodendronglioma, anaplastic mixed glioma or malignant glioma NOS (not otherwise specified).|Participants|Number|0|0.0||||||
4374416|NCT00337207|4201334|B1|Anaplastic astrocytoma (AA)||Diagnosis|Patients with histologically proven malignant gliomas were eligible to be enrolled including the following diagnoses: glioblastoma multiforme (GBM), gliosarcoma, anaplastic astrocytoma (AA), anaplastic oligodendronglioma, anaplastic mixed glioma or malignant glioma NOS (not otherwise specified).|Participants|Number|7|7.0||||||
4374417|NCT00337207|4201334|B1|Glioblastoma multiforme (GBM)||Diagnosis|Patients with histologically proven malignant gliomas were eligible to be enrolled including the following diagnoses: glioblastoma multiforme (GBM), gliosarcoma, anaplastic astrocytoma (AA), anaplastic oligodendronglioma, anaplastic mixed glioma or malignant glioma NOS (not otherwise specified).|Participants|Number|44|44.0||||||
4374418|NCT00337207|4201334|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4374419|NCT00337207|4201334|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374420|NCT00337207|4201334|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4374421|NCT00337207|4201334|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4374422|NCT00337207|4201334|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4374423|NCT00337207|4201334|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374424|NCT00337207|4201334|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4374425|NCT00337207|4201334|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374426|NCT00337207|4201334|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4374427|NCT00337207|4201334|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4374428|NCT00337207|4201334|B1|||Age||years|Mean|51.91|51.91|Standard Deviation|12.14|12.14|||
4374429|NCT00337207|4201334|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4374430|NCT00337207|4201334|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4374431|NCT00337207|4201334|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374432|NCT00337194|4201340|B3|No||Prior autologous transplant||participants|Number|19|19.0||||||
4374433|NCT00337194|4201341|B2|No||Prior autologous transplant||participants|Number|4|4.0||||||
4374434|NCT00337194|4201342|B1|No||Prior autologous transplant||participants|Number|15|15.0||||||
4374435|NCT00337194|4201340|B3|Yes||Prior autologous transplant||participants|Number|11|11.0||||||
4374436|NCT00337194|4201341|B2|Yes||Prior autologous transplant||participants|Number|3|3.0||||||
4374437|NCT00337194|4201342|B1|Yes||Prior autologous transplant||participants|Number|8|8.0||||||
4374438|NCT00337194|4201340|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4374439|NCT00337194|4201341|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4374440|NCT00337194|4201342|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4374441|NCT00337194|4201340|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374442|NCT00337194|4201341|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374443|NCT00337194|4201342|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374444|NCT00337194|4201340|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374445|NCT00337194|4201341|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374446|NCT00337194|4201342|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374447|NCT00337194|4201340|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4374448|NCT00337194|4201341|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4374449|NCT00337194|4201342|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4374450|NCT00337194|4201340|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4374451|NCT00337194|4201341|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4374452|NCT00337194|4201342|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4374453|NCT00337194|4201340|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374454|NCT00337194|4201341|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374455|NCT00337194|4201342|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374456|NCT00337194|4201340|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4374457|NCT00337194|4201341|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374458|NCT00337194|4201342|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4374459|NCT00337194|4201340|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374460|NCT00337194|4201341|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374461|NCT00337194|4201342|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374462|NCT00337194|4201340|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4374463|NCT00337194|4201341|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4374466|NCT00337194|4201341|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4374467|NCT00337194|4201342|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4374468|NCT00337194|4201340|B3|||Age||years|Median|35|35.0|Full Range|||19.0|78.0|
4374469|NCT00337194|4201341|B2|||Age||years|Median|38|38.0|Full Range|||25.0|53.0|
4374470|NCT00337194|4201342|B1|||Age||years|Median|35|35.0|Full Range|||19.0|78.0|
4374471|NCT00337181|4201358|B3||2008-2009|Calendar year of infection diagnosis||Participants|Count of Participants|18|18.0||||||
4374472|NCT00337181|4201359|B2||2008-2009|Calendar year of infection diagnosis||Participants|Count of Participants|12|12.0||||||
4374473|NCT00337181|4201360|B1||2008-2009|Calendar year of infection diagnosis||Participants|Count of Participants|6|6.0||||||
4374474|NCT00337181|4201358|B3||2007|Calendar year of infection diagnosis||Participants|Count of Participants|27|27.0||||||
4374475|NCT00337181|4201359|B2||2007|Calendar year of infection diagnosis||Participants|Count of Participants|10|10.0||||||
4374476|NCT00337181|4201360|B1||2007|Calendar year of infection diagnosis||Participants|Count of Participants|17|17.0||||||
4374477|NCT00337181|4201358|B3||2006|Calendar year of infection diagnosis||Participants|Count of Participants|39|39.0||||||
4374478|NCT00337181|4201359|B2||2006|Calendar year of infection diagnosis||Participants|Count of Participants|26|26.0||||||
4374479|NCT00337181|4201360|B1||2006|Calendar year of infection diagnosis||Participants|Count of Participants|13|13.0||||||
4374480|NCT00337181|4201358|B3||2004-2005|Calendar year of infection diagnosis||Participants|Count of Participants|30|30.0||||||
4374481|NCT00337181|4201359|B2||2004-2005|Calendar year of infection diagnosis||Participants|Count of Participants|17|17.0||||||
4374482|NCT00337181|4201360|B1||2004-2005|Calendar year of infection diagnosis||Participants|Count of Participants|13|13.0||||||
4374483|NCT00337181|4201358|B3|Thailand||Region of Enrollment||participants|Number|114|114.0||||||
4374484|NCT00337181|4201359|B2|Thailand||Region of Enrollment||participants|Number|65|65.0||||||
4374485|NCT00337181|4201360|B1|Thailand||Region of Enrollment||participants|Number|49|49.0||||||
4374486|NCT00337181|4201358|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4374487|NCT00337181|4201359|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4374488|NCT00337181|4201360|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4374489|NCT00337181|4201358|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4374490|NCT00337181|4201359|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4374491|NCT00337181|4201360|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4374492|NCT00337181|4201358|B3|>26||Age, Customized||Participants|Count of Participants|41|41.0||||||
4374493|NCT00337181|4201359|B2|>26||Age, Customized||Participants|Count of Participants|22|22.0||||||
4374494|NCT00337181|4201360|B1|>26||Age, Customized||Participants|Count of Participants|19|19.0||||||
4374495|NCT00337181|4201358|B3|21-25||Age, Customized||Participants|Count of Participants|51|51.0||||||
4374496|NCT00337181|4201359|B2|21-25||Age, Customized||Participants|Count of Participants|33|33.0||||||
4374497|NCT00337181|4201360|B1|21-25||Age, Customized||Participants|Count of Participants|18|18.0||||||
4374498|NCT00337181|4201358|B3|<20||Age, Customized||Participants|Count of Participants|22|22.0||||||
4374499|NCT00337181|4201359|B2|<20||Age, Customized||Participants|Count of Participants|10|10.0||||||
4374500|NCT00337181|4201360|B1|<20||Age, Customized||Participants|Count of Participants|12|12.0||||||
4374501|NCT00337168|4201367|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4374502|NCT00337168|4201367|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4374503|NCT00337168|4201367|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4374504|NCT00337168|4201367|B1|||Age||years|Median|41|41.0|Full Range|||20.0|68.0|
4374505|NCT00337129|4201374|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4374506|NCT00337129|4201374|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374507|NCT00337129|4201374|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4374508|NCT00337129|4201374|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4374509|NCT00337129|4201374|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374510|NCT00337129|4201374|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4374511|NCT00337129|4201374|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374512|NCT00337129|4201374|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4374513|NCT00337129|4201374|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4374514|NCT00337129|4201374|B1|||Age||years|Median|61|61.0|Full Range|||44.0|87.0|
4374515|NCT00337103|4201381|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4374516|NCT00337103|4201382|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4374517|NCT00337103|4201383|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4374518|NCT00337103|4201381|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374519|NCT00337103|4201382|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374520|NCT00337103|4201383|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374521|NCT00337103|4201381|B3||White|Race (NIH/OMB)||Participants|Count of Participants|991|991.0||||||
4374522|NCT00337103|4201382|B2||White|Race (NIH/OMB)||Participants|Count of Participants|495|495.0||||||
4374523|NCT00337103|4201383|B1||White|Race (NIH/OMB)||Participants|Count of Participants|496|496.0||||||
4374524|NCT00337103|4201381|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4374525|NCT00337103|4201382|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4374526|NCT00337103|4201383|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4374527|NCT00337103|4201381|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374528|NCT00337103|4201382|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374529|NCT00337103|4201383|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374530|NCT00337103|4201381|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4374531|NCT00337103|4201382|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4374532|NCT00337103|4201383|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4374533|NCT00337103|4201381|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374534|NCT00337103|4201382|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374535|NCT00337103|4201383|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374536|NCT00337103|4201381|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4374537|NCT00337103|4201382|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4374538|NCT00337103|4201383|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4374539|NCT00337103|4201381|B3||Female|Sex: Female, Male||Participants|Count of Participants|1102|1102.0||||||
4374540|NCT00337103|4201382|B2||Female|Sex: Female, Male||Participants|Count of Participants|548|548.0||||||
4374541|NCT00337103|4201383|B1||Female|Sex: Female, Male||Participants|Count of Participants|554|554.0||||||
4374542|NCT00337103|4201381|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|10.29|10.29|||
4374543|NCT00337103|4201382|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|10.20|10.2|||
4374544|NCT00337103|4201383|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|10.37|10.37|||
4374545|NCT00337077|4201392|B4|United States||Region of Enrollment||participants|Number|116|116.0||||||
4374546|NCT00337077|4201393|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4374547|NCT00337077|4201394|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4374548|NCT00337077|4201395|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4374549|NCT00337077|4201392|B4||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4374550|NCT00337077|4201393|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4374551|NCT00337077|4201394|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4374552|NCT00337077|4201395|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4374553|NCT00337077|4201392|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4374554|NCT00337077|4201393|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4374555|NCT00337077|4201394|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4374556|NCT00337077|4201395|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4374557|NCT00337077|4201392|B4|||Age||years|Median|70|70.0|Full Range|||45.0|88.0|
4374558|NCT00337077|4201393|B3|||Age||years|Median|73|73.0|Full Range|||57.0|85.0|
4374559|NCT00337077|4201394|B2|||Age||years|Median|67|67.0|Full Range|||45.0|88.0|
4374560|NCT00337077|4201395|B1|||Age||years|Median|70|70.0|Full Range|||45.0|86.0|
4374561|NCT00336973|4201406|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4374562|NCT00336973|4201406|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4374563|NCT00336973|4201406|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|12.48|12.48|||
4374564|NCT00336895|4201412|B1|||Constipation screening|"The gastrointestinal Symptom Rating Scale (GSRS) is a validated scale, the items range from 1= No discomfort at all to 7= Very severe discomfort.~The scale ranges from a minimal value of 3 ( No discomfort at all) to a maximum of 21 ( Very severe discomfort)"|units on a scale|Mean|7.2000|7.2|Standard Deviation|4.52769|4.52769|||
4374565|NCT00336895|4201412|B1|||Diarrhea screening|"The gastrointestinal Symptom Rating Scale (GSRS) is a validated scale, the items range from 1= No discomfort at all to 7= Very severe discomfort.~The scale ranges from a minimal value of 3 ( No discomfort at all) to a maximum of 21 ( Very severe discomfort)"|units on a scale|Mean|10.3200|10.32|Standard Deviation|5.57315|5.57315|||
4374566|NCT00336895|4201412|B1|||Indigestion screening|"The gastrointestinal Symptom Rating Scale (GSRS) is a validated scale, the items range from 1= No discomfort at all to 7= Very severe discomfort.~The scale ranges from a minimal value of 4 ( No discomfort at all) to a maximum of 28 ( Very severe discomfort)"|units on a scale|Mean|12.6800|12.68|Standard Deviation|7.11056|7.11056|||
4374567|NCT00336895|4201412|B1|||Reflux screening|"The gastrointestinal Symptom Rating Scale (GSRS) is a validated scale, the items range from 1= No discomfort at all to 7= Very severe discomfort.~The scale ranges from a minimal value of 2 ( No discomfort at all) to a maximum of 14 ( Very severe discomfort)"|units on a scale|Mean|5.0000|5.0|Standard Deviation|3.67423|3.67423|||
4374568|NCT00336895|4201412|B1|||Abdominal Pain- screening|"The gastrointestinal Symptom Rating Scale (GSRS) is a validated scale, the items range from 1= No discomfort at all to 7= Very severe discomfort.~The scale ranges from a minimal value of 3 ( No discomfort at all) to a maximum of 21 ( Very severe discomfort)"|units on a scale|Mean|10.7778|10.7778|Standard Deviation|5.09399|5.09399|||
4374569|NCT00336895|4201412|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4374570|NCT00336895|4201412|B1||Male|Gender||Participants|Count of Participants|16|16.0||||||
4374571|NCT00336895|4201412|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
4374572|NCT00336895|4201412|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|13.0|13.0|||
4374573|NCT00336856|4201418|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4374574|NCT00336856|4201418|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4374575|NCT00336856|4201418|B1|||Age||years|Median|61.8|61.8|Full Range|||43.0|83.9|
4374576|NCT00336817|4201424|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4374577|NCT00336817|4201425|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4374578|NCT00336817|4201426|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4374579|NCT00336817|4201424|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4374580|NCT00336817|4201425|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4374581|NCT00336817|4201426|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4374582|NCT00336817|4201424|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4374583|NCT00336817|4201425|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4374584|NCT00336817|4201426|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4374585|NCT00336817|4201424|B3|||Age||years|Mean|56.4333|56.4333|Standard Deviation|10.92824|10.92824|||
4374586|NCT00336817|4201425|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|8.83338|8.83338|||
4374587|NCT00336817|4201426|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|12.75408|12.75408|||
4374588|NCT00336817|4201424|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4374589|NCT00336817|4201425|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4374590|NCT00336817|4201426|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4374591|NCT00336817|4201424|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4374592|NCT00336817|4201425|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4374593|NCT00336817|4201426|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4374594|NCT00336817|4201424|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374595|NCT00336817|4201425|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374596|NCT00336817|4201426|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374597|NCT00336700|4201457|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4374598|NCT00336700|4201457|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4374599|NCT00336700|4201457|B1|||Age||years|Median|66|66.0|Full Range|||34.0|81.0|
4374600|NCT00336583|4201466|B1|Korea, Republic of||Region of Enrollment||participants|Number|27|27.0||||||
4374601|NCT00336583|4201466|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4374602|NCT00336583|4201466|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4374603|NCT00336583|4201466|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|10.8|10.8|||
4374604|NCT00336583|4201466|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4374605|NCT00336583|4201466|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4374606|NCT00336583|4201466|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374607|NCT00336544|4201471|B3||Male|Sex: Female, Male|All subjects who were randomized and dosed.|Participants|Count of Participants|264|264.0||||||
4374608|NCT00336544|4201472|B2||Male|Sex: Female, Male|All subjects who were randomized and dosed.|Participants|Count of Participants|126|126.0||||||
4374609|NCT00336544|4201473|B1||Male|Sex: Female, Male|All subjects who were randomized and dosed.|Participants|Count of Participants|138|138.0||||||
4374610|NCT00336544|4201471|B3||Female|Sex: Female, Male|All subjects who were randomized and dosed.|Participants|Count of Participants|257|257.0||||||
4374611|NCT00336544|4201472|B2||Female|Sex: Female, Male|All subjects who were randomized and dosed.|Participants|Count of Participants|134|134.0||||||
4374612|NCT00336544|4201473|B1||Female|Sex: Female, Male|All subjects who were randomized and dosed.|Participants|Count of Participants|123|123.0||||||
4374613|NCT00336544|4201471|B3|||Age|All subjects who were randomized and dosed.|years|Mean|47.3|47.3|Standard Deviation|17.2|17.2|||
4374614|NCT00336544|4201472|B2|||Age|All subjects who were randomized and dosed.|years|Mean|46.8|46.8|Standard Deviation|17.6|17.6|||
4374615|NCT00336544|4201473|B1|||Age|All subjects who were randomized and dosed.|years|Mean|47.7|47.7|Standard Deviation|16.8|16.8|||
4374616|NCT00336505|4201486|B3||Male|Sex: Female, Male|All subjects who were randomized and dosed.|Participants|Count of Participants|299|299.0||||||
4374617|NCT00336505|4201487|B2||Male|Sex: Female, Male|All subjects who were randomized and dosed.|Participants|Count of Participants|148|148.0||||||
4374618|NCT00336505|4201488|B1||Male|Sex: Female, Male|All subjects who were randomized and dosed.|Participants|Count of Participants|151|151.0||||||
4374619|NCT00336505|4201486|B3||Female|Sex: Female, Male|All subjects who were randomized and dosed.|Participants|Count of Participants|283|283.0||||||
4374620|NCT00336505|4201487|B2||Female|Sex: Female, Male|All subjects who were randomized and dosed.|Participants|Count of Participants|143|143.0||||||
4374621|NCT00336505|4201488|B1||Female|Sex: Female, Male|All subjects who were randomized and dosed.|Participants|Count of Participants|140|140.0||||||
4374622|NCT00336505|4201486|B3|||Age|All subjects who were randomized and dosed.|years|Mean|49.5|49.5|Standard Deviation|15.4|15.4|||
4374623|NCT00336505|4201487|B2|||Age|All subjects who were randomized and dosed.|years|Mean|50.3|50.3|Standard Deviation|16.3|16.3|||
4374624|NCT00336505|4201488|B1|||Age|All subjects who were randomized and dosed.|years|Mean|48.6|48.6|Standard Deviation|14.5|14.5|||
4374625|NCT00336492|4201501|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4374626|NCT00336492|4201502|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4374627|NCT00336492|4201503|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4374628|NCT00336492|4201504|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4374629|NCT00336492|4201501|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4374630|NCT00336492|4201502|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4374631|NCT00336492|4201503|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4374632|NCT00336492|4201504|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4374633|NCT00336492|4201501|B4|||Age||years|Mean|13.4|13.4|Standard Deviation|3.10|3.1|||
4374634|NCT00336492|4201502|B3|||Age||years|Mean|14.2|14.2|Standard Deviation|3.03|3.03|||
4374635|NCT00336492|4201503|B2|||Age||years|Mean|13.7|13.7|Standard Deviation|3.20|3.2|||
4374636|NCT00336492|4201504|B1|||Age||years|Mean|11.9|11.9|Standard Deviation|2.64|2.64|||
4374637|NCT00336479|4201514|B5|North America||Region of Enrollment||participants|Number|250|250.0||||||
4374638|NCT00336479|4201515|B4|North America||Region of Enrollment||participants|Number|17|17.0||||||
4374639|NCT00336479|4201516|B3|North America||Region of Enrollment||participants|Number|79|79.0||||||
4374640|NCT00336479|4201517|B2|North America||Region of Enrollment||participants|Number|79|79.0||||||
4374641|NCT00336479|4201518|B1|North America||Region of Enrollment||participants|Number|75|75.0||||||
4374642|NCT00336479|4201514|B5||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4374643|NCT00336479|4201515|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4374644|NCT00336479|4201516|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4374645|NCT00336479|4201517|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4374646|NCT00336479|4201518|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4374647|NCT00336479|4201514|B5||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4374648|NCT00336479|4201515|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4374649|NCT00336479|4201516|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4374650|NCT00336479|4201517|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4374651|NCT00336479|4201518|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4374652|NCT00336479|4201514|B5|||Age||years|Mean|48.1|48.1|Standard Deviation|7.9|7.9|||
4374653|NCT00336479|4201515|B4|||Age||years|Mean|49.1|49.1|Standard Deviation|8.0|8.0|||
4374654|NCT00336479|4201516|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|7.6|7.6|||
4374655|NCT00336479|4201517|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|7.4|7.4|||
4374656|NCT00336479|4201518|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|8.7|8.7|||
4374657|NCT00336479|4201514|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374658|NCT00336479|4201515|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374659|NCT00336479|4201516|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374660|NCT00336479|4201517|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374661|NCT00336479|4201518|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4374662|NCT00336479|4201514|B5||Between 18 and 65 years|Age||Participants|Count of Participants|250|250.0||||||
4374663|NCT00336479|4201515|B4||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4374664|NCT00336479|4201516|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4374665|NCT00336479|4201517|B2||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4374666|NCT00336479|4201518|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4374667|NCT00336479|4201514|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374668|NCT00336479|4201515|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374669|NCT00336479|4201516|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374670|NCT00336479|4201517|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374671|NCT00336479|4201518|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374672|NCT00336323|4201544|B6|||Optical Coherence Tomography Retinal Volume||mm^3|Median|8.6|8.6|Inter-Quartile Range|||7.8|10.1|
4374673|NCT00336323|4201545|B5|||Optical Coherence Tomography Retinal Volume||mm^3|Median|8.6|8.6|Inter-Quartile Range|||7.7|9.2|
4374674|NCT00336323|4201546|B4|||Optical Coherence Tomography Retinal Volume||mm^3|Median|8.9|8.9|Inter-Quartile Range|||7.7|10.0|
4374675|NCT00336323|4201547|B3|||Optical Coherence Tomography Retinal Volume||mm^3|Median|9.1|9.1|Inter-Quartile Range|||8.0|10.0|
4374676|NCT00336323|4201548|B2|||Optical Coherence Tomography Retinal Volume||mm^3|Median|9.5|9.5|Inter-Quartile Range|||8.0|10.3|
4374677|NCT00336323|4201549|B1|||Optical Coherence Tomography Retinal Volume||mm^3|Median|8.3|8.3|Inter-Quartile Range|||7.3|10.2|
4374678|NCT00336323|4201544|B6|||Optical Coherence Tomography (OCT) Central Subfield Thickness||microns|Median|411|411.0|Inter-Quartile Range|||334.0|505.0|
4374679|NCT00336323|4201545|B5|||Optical Coherence Tomography (OCT) Central Subfield Thickness||microns|Median|389|389.0|Inter-Quartile Range|||308.0|452.0|
4374680|NCT00336323|4201546|B4|||Optical Coherence Tomography (OCT) Central Subfield Thickness||microns|Median|406|406.0|Inter-Quartile Range|||353.0|520.0|
4374681|NCT00336323|4201547|B3|||Optical Coherence Tomography (OCT) Central Subfield Thickness||microns|Median|446|446.0|Inter-Quartile Range|||342.0|543.0|
4374682|NCT00336323|4201548|B2|||Optical Coherence Tomography (OCT) Central Subfield Thickness||microns|Median|397|397.0|Inter-Quartile Range|||320.0|538.0|
4374683|NCT00336323|4201549|B1|||Optical Coherence Tomography (OCT) Central Subfield Thickness||microns|Median|441|441.0|Inter-Quartile Range|||354.0|512.0|
4374684|NCT00336323|4201544|B6|||Hemoglobin A1c|Missing for 8 patients|percent HbA1c|Median|6.9|6.9|Inter-Quartile Range|||6.3|8.1|
4374685|NCT00336323|4201545|B5|||Hemoglobin A1c|Missing for 8 patients|percent HbA1c|Median|7.1|7.1|Inter-Quartile Range|||6.2|7.7|
4374686|NCT00336323|4201546|B4|||Hemoglobin A1c|Missing for 8 patients|percent HbA1c|Median|6.7|6.7|Inter-Quartile Range|||6.3|7.4|
4374687|NCT00336323|4201547|B3|||Hemoglobin A1c|Missing for 8 patients|percent HbA1c|Median|7.3|7.3|Inter-Quartile Range|||6.4|8.4|
4374688|NCT00336323|4201548|B2|||Hemoglobin A1c|Missing for 8 patients|percent HbA1c|Median|7.4|7.4|Inter-Quartile Range|||5.9|7.8|
4374689|NCT00336323|4201549|B1|||Hemoglobin A1c|Missing for 8 patients|percent HbA1c|Median|7.0|7.0|Inter-Quartile Range|||6.5|8.2|
4374690|NCT00336323|4201544|B6|||Duaration of Diabetes||years|Median|17|17.0|Inter-Quartile Range|||11.0|23.0|
4374691|NCT00336323|4201545|B5|||Duaration of Diabetes||years|Median|20|20.0|Inter-Quartile Range|||7.0|30.0|
4374692|NCT00336323|4201546|B4|||Duaration of Diabetes||years|Median|17|17.0|Inter-Quartile Range|||11.0|25.0|
4374693|NCT00336323|4201547|B3|||Duaration of Diabetes||years|Median|18|18.0|Inter-Quartile Range|||12.0|22.0|
4374694|NCT00336323|4201548|B2|||Duaration of Diabetes||years|Median|15|15.0|Inter-Quartile Range|||8.0|22.0|
4374695|NCT00336323|4201549|B1|||Duaration of Diabetes||years|Median|17|17.0|Inter-Quartile Range|||13.0|22.0|
4374696|NCT00336323|4201544|B6|||Baseline Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|letter score|Median|64|64.0|Inter-Quartile Range|||56.0|71.0|
4374697|NCT00336323|4201545|B5|||Baseline Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|letter score|Median|66|66.0|Inter-Quartile Range|||57.0|72.0|
4374698|NCT00336323|4201546|B4|||Baseline Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|letter score|Median|64|64.0|Inter-Quartile Range|||52.0|68.0|
4374699|NCT00336323|4201547|B3|||Baseline Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|letter score|Median|63|63.0|Inter-Quartile Range|||57.0|71.0|
4374700|NCT00336323|4201548|B2|||Baseline Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|letter score|Median|65|65.0|Inter-Quartile Range|||60.0|70.0|
4374701|NCT00336323|4201549|B1|||Baseline Visual Acuity|Best corrected visual acuity letter score as measured by a certified tester using an electronic visual acuity testing machine based on the Early Treatment Diabetic Retinopathy Study (ETDRS) method. Best value on the scale 97, worst 0.|letter score|Median|64|64.0|Inter-Quartile Range|||50.0|70.0|
4374702|NCT00336323|4201544|B6|Missing||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|1|1.0||||||
4374703|NCT00336323|4201545|B5|Missing||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|0|0.0||||||
4374704|NCT00336323|4201546|B4|Missing||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|0|0.0||||||
4374705|NCT00336323|4201547|B3|Missing||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|0|0.0||||||
4374706|NCT00336323|4201548|B2|Missing||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|0|0.0||||||
4374707|NCT00336323|4201549|B1|Missing||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|1|1.0||||||
4374708|NCT00336323|4201544|B6|No evidence||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|85|85.0||||||
4374709|NCT00336323|4201545|B5|No evidence||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|17|17.0||||||
4374710|NCT00336323|4201546|B4|No evidence||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|18|18.0||||||
4374711|NCT00336323|4201547|B3|No evidence||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|16|16.0||||||
4374712|NCT00336323|4201548|B2|No evidence||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|18|18.0||||||
4374713|NCT00336323|4201549|B1|No evidence||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|16|16.0||||||
4374714|NCT00336323|4201544|B6|Questionable||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|3|3.0||||||
4374715|NCT00336323|4201545|B5|Questionable||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|0|0.0||||||
4374716|NCT00336323|4201546|B4|Questionable||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|2|2.0||||||
4374717|NCT00336323|4201547|B3|Questionable||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|0|0.0||||||
4374718|NCT00336323|4201548|B2|Questionable||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|1|1.0||||||
4374719|NCT00336323|4201549|B1|Questionable||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|0|0.0||||||
4374720|NCT00336323|4201544|B6|Definite, not center||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|3|3.0||||||
4374721|NCT00336323|4201545|B5|Definite, not center||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|1|1.0||||||
4374722|NCT00336323|4201546|B4|Definite, not center||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|0|0.0||||||
4374723|NCT00336323|4201547|B3|Definite, not center||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|1|1.0||||||
4374724|NCT00336323|4201548|B2|Definite, not center||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|1|1.0||||||
4374725|NCT00336323|4201549|B1|Definite, not center||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|0|0.0||||||
4374726|NCT00336323|4201544|B6|Definite, center||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|17|17.0||||||
4374727|NCT00336323|4201545|B5|Definite, center||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|4|4.0||||||
4374728|NCT00336323|4201546|B4|Definite, center||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|2|2.0||||||
4374729|NCT00336323|4201547|B3|Definite, center||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|7|7.0||||||
4374730|NCT00336323|4201548|B2|Definite, center||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|2|2.0||||||
4374731|NCT00336323|4201549|B1|Definite, center||Subretinal Fluid on Optical Coherence Tomography (OCT)||participants|Number|2|2.0||||||
4374732|NCT00336323|4201544|B6|Missing||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|6|6.0||||||
4374733|NCT00336323|4201545|B5|Missing||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|0|0.0||||||
4374734|NCT00336323|4201546|B4|Missing||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|2|2.0||||||
4374735|NCT00336323|4201547|B3|Missing||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|2|2.0||||||
4374736|NCT00336323|4201548|B2|Missing||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|1|1.0||||||
4374737|NCT00336323|4201549|B1|Missing||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|1|1.0||||||
4374738|NCT00336323|4201544|B6|High Risk PDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|2|2.0||||||
4374739|NCT00336323|4201545|B5|High Risk PDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|0|0.0||||||
4374740|NCT00336323|4201546|B4|High Risk PDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|0|0.0||||||
4374741|NCT00336323|4201547|B3|High Risk PDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|0|0.0||||||
4374742|NCT00336323|4201548|B2|High Risk PDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|0|0.0||||||
4374743|NCT00336323|4201549|B1|High Risk PDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|2|2.0||||||
4374744|NCT00336323|4201544|B6|Moderate PDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|4|4.0||||||
4374745|NCT00336323|4201545|B5|Moderate PDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|1|1.0||||||
4374746|NCT00336323|4201546|B4|Moderate PDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|0|0.0||||||
4374747|NCT00336323|4201547|B3|Moderate PDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|2|2.0||||||
4374748|NCT00336323|4201548|B2|Moderate PDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|0|0.0||||||
4374749|NCT00336323|4201549|B1|Moderate PDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|1|1.0||||||
4374750|NCT00336323|4201544|B6|Mild proliferative diabetic retinopathy (PDR)||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|24|24.0||||||
4374751|NCT00336323|4201545|B5|Mild proliferative diabetic retinopathy (PDR)||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|4|4.0||||||
4374752|NCT00336323|4201546|B4|Mild proliferative diabetic retinopathy (PDR)||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|5|5.0||||||
4374753|NCT00336323|4201547|B3|Mild proliferative diabetic retinopathy (PDR)||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|6|6.0||||||
4374754|NCT00336323|4201548|B2|Mild proliferative diabetic retinopathy (PDR)||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|5|5.0||||||
4374755|NCT00336323|4201549|B1|Mild proliferative diabetic retinopathy (PDR)||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|4|4.0||||||
4374756|NCT00336323|4201544|B6|Severe NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|8|8.0||||||
4374757|NCT00336323|4201545|B5|Severe NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|1|1.0||||||
4374758|NCT00336323|4201546|B4|Severe NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|4|4.0||||||
4374759|NCT00336323|4201547|B3|Severe NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|2|2.0||||||
4374760|NCT00336323|4201548|B2|Severe NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|1|1.0||||||
4374761|NCT00336323|4201549|B1|Severe NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|0|0.0||||||
4374762|NCT00336323|4201544|B6|Moderately severe NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|36|36.0||||||
4374763|NCT00336323|4201545|B5|Moderately severe NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|9|9.0||||||
4374764|NCT00336323|4201546|B4|Moderately severe NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|8|8.0||||||
4374765|NCT00336323|4201547|B3|Moderately severe NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|8|8.0||||||
4374766|NCT00336323|4201548|B2|Moderately severe NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|6|6.0||||||
4374767|NCT00336323|4201549|B1|Moderately severe NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|5|5.0||||||
4374768|NCT00336323|4201544|B6|Moderate NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|15|15.0||||||
4374769|NCT00336323|4201545|B5|Moderate NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|3|3.0||||||
4374770|NCT00336323|4201546|B4|Moderate NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|3|3.0||||||
4374771|NCT00336323|4201547|B3|Moderate NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|1|1.0||||||
4374772|NCT00336323|4201548|B2|Moderate NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|3|3.0||||||
4374773|NCT00336323|4201549|B1|Moderate NPDR||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|5|5.0||||||
4374774|NCT00336323|4201544|B6|Mild nonproliferative diabetic retinopathy (NPDR)||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|14|14.0||||||
4374775|NCT00336323|4201545|B5|Mild nonproliferative diabetic retinopathy (NPDR)||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|4|4.0||||||
4374776|NCT00336323|4201546|B4|Mild nonproliferative diabetic retinopathy (NPDR)||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|0|0.0||||||
4374777|NCT00336323|4201547|B3|Mild nonproliferative diabetic retinopathy (NPDR)||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|3|3.0||||||
4374778|NCT00336323|4201548|B2|Mild nonproliferative diabetic retinopathy (NPDR)||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|6|6.0||||||
4374779|NCT00336323|4201549|B1|Mild nonproliferative diabetic retinopathy (NPDR)||Retinopathy Severity|Early Treatment Diabetic Retinopathy Study Severity Scale|participants|Number|1|1.0||||||
4374780|NCT00336323|4201544|B6|Other treatment without focal photocoagulation||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|5|5.0||||||
4374781|NCT00336323|4201545|B5|Other treatment without focal photocoagulation||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|0|0.0||||||
4374782|NCT00336323|4201546|B4|Other treatment without focal photocoagulation||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|0|0.0||||||
4374783|NCT00336323|4201547|B3|Other treatment without focal photocoagulation||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|2|2.0||||||
4374784|NCT00336323|4201548|B2|Other treatment without focal photocoagulation||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|3|3.0||||||
4374785|NCT00336323|4201549|B1|Other treatment without focal photocoagulation||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|0|0.0||||||
4374786|NCT00336323|4201544|B6|Focal photocoagulation plus other treatment||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|31|31.0||||||
4374787|NCT00336323|4201545|B5|Focal photocoagulation plus other treatment||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|6|6.0||||||
4374788|NCT00336323|4201546|B4|Focal photocoagulation plus other treatment||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|11|11.0||||||
4374789|NCT00336323|4201547|B3|Focal photocoagulation plus other treatment||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|3|3.0||||||
4374790|NCT00336323|4201548|B2|Focal photocoagulation plus other treatment||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|3|3.0||||||
4374791|NCT00336323|4201549|B1|Focal photocoagulation plus other treatment||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|8|8.0||||||
4374792|NCT00336323|4201544|B6|Focal photocoagulation alone||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|39|39.0||||||
4374793|NCT00336323|4201545|B5|Focal photocoagulation alone||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|9|9.0||||||
4374794|NCT00336323|4201546|B4|Focal photocoagulation alone||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|6|6.0||||||
4374795|NCT00336323|4201547|B3|Focal photocoagulation alone||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|9|9.0||||||
4374796|NCT00336323|4201548|B2|Focal photocoagulation alone||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|11|11.0||||||
4374797|NCT00336323|4201549|B1|Focal photocoagulation alone||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|4|4.0||||||
4374798|NCT00336323|4201544|B6|None||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|34|34.0||||||
4374799|NCT00336323|4201545|B5|None||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|7|7.0||||||
4374800|NCT00336323|4201546|B4|None||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|5|5.0||||||
4374801|NCT00336323|4201547|B3|None||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|10|10.0||||||
4374802|NCT00336323|4201548|B2|None||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|5|5.0||||||
4374803|NCT00336323|4201549|B1|None||Prior Treatment for Diabetic Macular Edema (DME) in Study Eye||participants|Number|7|7.0||||||
4374804|NCT00336323|4201544|B6|No||Prior Panretinal Scatter Photocoagulation||participants|Number|96|96.0||||||
4374805|NCT00336323|4201545|B5|No||Prior Panretinal Scatter Photocoagulation||participants|Number|18|18.0||||||
4374806|NCT00336323|4201546|B4|No||Prior Panretinal Scatter Photocoagulation||participants|Number|21|21.0||||||
4374807|NCT00336323|4201547|B3|No||Prior Panretinal Scatter Photocoagulation||participants|Number|21|21.0||||||
4374808|NCT00336323|4201548|B2|No||Prior Panretinal Scatter Photocoagulation||participants|Number|20|20.0||||||
4374809|NCT00336323|4201549|B1|No||Prior Panretinal Scatter Photocoagulation||participants|Number|16|16.0||||||
4374810|NCT00336323|4201544|B6|Yes||Prior Panretinal Scatter Photocoagulation||participants|Number|13|13.0||||||
4374811|NCT00336323|4201545|B5|Yes||Prior Panretinal Scatter Photocoagulation||participants|Number|4|4.0||||||
4374812|NCT00336323|4201546|B4|Yes||Prior Panretinal Scatter Photocoagulation||participants|Number|1|1.0||||||
4374813|NCT00336323|4201547|B3|Yes||Prior Panretinal Scatter Photocoagulation||participants|Number|3|3.0||||||
4374814|NCT00336323|4201548|B2|Yes||Prior Panretinal Scatter Photocoagulation||participants|Number|2|2.0||||||
4374815|NCT00336323|4201549|B1|Yes||Prior Panretinal Scatter Photocoagulation||participants|Number|3|3.0||||||
4374816|NCT00336323|4201544|B6|Pseudophakic||Lens status (clinical examination)||participants|Number|43|43.0||||||
4374817|NCT00336323|4201545|B5|Pseudophakic||Lens status (clinical examination)||participants|Number|9|9.0||||||
4374818|NCT00336323|4201546|B4|Pseudophakic||Lens status (clinical examination)||participants|Number|10|10.0||||||
4374819|NCT00336323|4201547|B3|Pseudophakic||Lens status (clinical examination)||participants|Number|10|10.0||||||
4374820|NCT00336323|4201548|B2|Pseudophakic||Lens status (clinical examination)||participants|Number|7|7.0||||||
4374821|NCT00336323|4201549|B1|Pseudophakic||Lens status (clinical examination)||participants|Number|7|7.0||||||
4374822|NCT00336323|4201544|B6|Phakic||Lens status (clinical examination)||participants|Number|66|66.0||||||
4374823|NCT00336323|4201545|B5|Phakic||Lens status (clinical examination)||participants|Number|13|13.0||||||
4374824|NCT00336323|4201546|B4|Phakic||Lens status (clinical examination)||participants|Number|12|12.0||||||
4374825|NCT00336323|4201547|B3|Phakic||Lens status (clinical examination)||participants|Number|14|14.0||||||
4374826|NCT00336323|4201548|B2|Phakic||Lens status (clinical examination)||participants|Number|15|15.0||||||
4374827|NCT00336323|4201549|B1|Phakic||Lens status (clinical examination)||participants|Number|12|12.0||||||
4374828|NCT00336323|4201544|B6|Type 2||Diabetes Type||participants|Number|101|101.0||||||
4374829|NCT00336323|4201545|B5|Type 2||Diabetes Type||participants|Number|21|21.0||||||
4374830|NCT00336323|4201546|B4|Type 2||Diabetes Type||participants|Number|20|20.0||||||
4374831|NCT00336323|4201547|B3|Type 2||Diabetes Type||participants|Number|21|21.0||||||
4374832|NCT00336323|4201548|B2|Type 2||Diabetes Type||participants|Number|21|21.0||||||
4374833|NCT00336323|4201549|B1|Type 2||Diabetes Type||participants|Number|18|18.0||||||
4374834|NCT00336323|4201544|B6|Type 1||Diabetes Type||participants|Number|8|8.0||||||
4374835|NCT00336323|4201545|B5|Type 1||Diabetes Type||participants|Number|1|1.0||||||
4374836|NCT00336323|4201546|B4|Type 1||Diabetes Type||participants|Number|2|2.0||||||
4374837|NCT00336323|4201547|B3|Type 1||Diabetes Type||participants|Number|3|3.0||||||
4374838|NCT00336323|4201548|B2|Type 1||Diabetes Type||participants|Number|1|1.0||||||
4374839|NCT00336323|4201549|B1|Type 1||Diabetes Type||participants|Number|1|1.0||||||
4374840|NCT00336323|4201544|B6|No||Cystoid Abnormalities on Optical Coherence Tomography (OCT)||participants|Number|3|3.0||||||
4374841|NCT00336323|4201545|B5|No||Cystoid Abnormalities on Optical Coherence Tomography (OCT)||participants|Number|1|1.0||||||
4374842|NCT00336323|4201546|B4|No||Cystoid Abnormalities on Optical Coherence Tomography (OCT)||participants|Number|1|1.0||||||
4374843|NCT00336323|4201547|B3|No||Cystoid Abnormalities on Optical Coherence Tomography (OCT)||participants|Number|0|0.0||||||
4374844|NCT00336323|4201548|B2|No||Cystoid Abnormalities on Optical Coherence Tomography (OCT)||participants|Number|0|0.0||||||
4374845|NCT00336323|4201549|B1|No||Cystoid Abnormalities on Optical Coherence Tomography (OCT)||participants|Number|1|1.0||||||
4374846|NCT00336323|4201544|B6|Yes||Cystoid Abnormalities on Optical Coherence Tomography (OCT)||participants|Number|106|106.0||||||
4374847|NCT00336323|4201545|B5|Yes||Cystoid Abnormalities on Optical Coherence Tomography (OCT)||participants|Number|21|21.0||||||
4374848|NCT00336323|4201546|B4|Yes||Cystoid Abnormalities on Optical Coherence Tomography (OCT)||participants|Number|21|21.0||||||
4374849|NCT00336323|4201547|B3|Yes||Cystoid Abnormalities on Optical Coherence Tomography (OCT)||participants|Number|24|24.0||||||
4374850|NCT00336323|4201548|B2|Yes||Cystoid Abnormalities on Optical Coherence Tomography (OCT)||participants|Number|22|22.0||||||
4374851|NCT00336323|4201549|B1|Yes||Cystoid Abnormalities on Optical Coherence Tomography (OCT)||participants|Number|18|18.0||||||
4374852|NCT00336323|4201544|B6|Typical/Predominantly Diffuse||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|63|63.0||||||
4374853|NCT00336323|4201545|B5|Typical/Predominantly Diffuse||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|12|12.0||||||
4374854|NCT00336323|4201546|B4|Typical/Predominantly Diffuse||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|13|13.0||||||
4374855|NCT00336323|4201547|B3|Typical/Predominantly Diffuse||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|17|17.0||||||
4374856|NCT00336323|4201548|B2|Typical/Predominantly Diffuse||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|12|12.0||||||
4374857|NCT00336323|4201549|B1|Typical/Predominantly Diffuse||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|9|9.0||||||
4374858|NCT00336323|4201544|B6|Neither Predominantly Focal or Diffuse||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|26|26.0||||||
4374859|NCT00336323|4201545|B5|Neither Predominantly Focal or Diffuse||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|6|6.0||||||
4374860|NCT00336323|4201546|B4|Neither Predominantly Focal or Diffuse||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|6|6.0||||||
4374861|NCT00336323|4201547|B3|Neither Predominantly Focal or Diffuse||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|5|5.0||||||
4374862|NCT00336323|4201548|B2|Neither Predominantly Focal or Diffuse||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|5|5.0||||||
4374863|NCT00336323|4201549|B1|Neither Predominantly Focal or Diffuse||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|4|4.0||||||
4374864|NCT00336323|4201544|B6|Typical/Predominantly Focal||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|20|20.0||||||
4374865|NCT00336323|4201545|B5|Typical/Predominantly Focal||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|4|4.0||||||
4374866|NCT00336323|4201546|B4|Typical/Predominantly Focal||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|3|3.0||||||
4374867|NCT00336323|4201547|B3|Typical/Predominantly Focal||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|2|2.0||||||
4374868|NCT00336323|4201548|B2|Typical/Predominantly Focal||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|5|5.0||||||
4374869|NCT00336323|4201549|B1|Typical/Predominantly Focal||Character of Diabetic Macular Edema (DME)|Criteria used to define categories was based on investigator discretion.|participants|Number|6|6.0||||||
4374870|NCT00336323|4201544|B6|Unknown/ not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374871|NCT00336323|4201545|B5|Unknown/ not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374872|NCT00336323|4201546|B4|Unknown/ not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374873|NCT00336323|4201547|B3|Unknown/ not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374874|NCT00336323|4201548|B2|Unknown/ not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374875|NCT00336323|4201549|B1|Unknown/ not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374876|NCT00336323|4201544|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374877|NCT00336323|4201545|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374878|NCT00336323|4201546|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374879|NCT00336323|4201547|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374880|NCT00336323|4201548|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374881|NCT00336323|4201549|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374882|NCT00336323|4201544|B6|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4374883|NCT00336323|4201545|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4374884|NCT00336323|4201546|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4374885|NCT00336323|4201547|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4374886|NCT00336323|4201548|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4374887|NCT00336323|4201549|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4374888|NCT00336323|4201544|B6|African-American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4374889|NCT00336323|4201545|B5|African-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4374890|NCT00336323|4201546|B4|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4374891|NCT00336323|4201547|B3|African-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4374892|NCT00336323|4201548|B2|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4374893|NCT00336323|4201549|B1|African-American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4374894|NCT00336323|4201544|B6|White||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4374895|NCT00336323|4201545|B5|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4374896|NCT00336323|4201546|B4|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4374897|NCT00336323|4201547|B3|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4374898|NCT00336323|4201548|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4374899|NCT00336323|4201549|B1|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4374900|NCT00336323|4201544|B6||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4374901|NCT00336323|4201545|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4374902|NCT00336323|4201546|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4374903|NCT00336323|4201547|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4374904|NCT00336323|4201548|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4374905|NCT00336323|4201549|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4374906|NCT00336323|4201544|B6||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4374907|NCT00336323|4201545|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4374908|NCT00336323|4201546|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4374909|NCT00336323|4201547|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4374910|NCT00336323|4201548|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4374911|NCT00336323|4201549|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4374912|NCT00336323|4201544|B6|||Age||years|Median|65|65.0|Inter-Quartile Range|||57.0|73.0|
4374913|NCT00336323|4201545|B5|||Age||years|Median|67|67.0|Inter-Quartile Range|||60.0|71.0|
4374914|NCT00336323|4201546|B4|||Age||years|Median|60|60.0|Inter-Quartile Range|||54.0|75.0|
4374915|NCT00336323|4201547|B3|||Age||years|Median|68|68.0|Inter-Quartile Range|||59.0|75.0|
4374916|NCT00336323|4201548|B2|||Age||years|Median|63|63.0|Inter-Quartile Range|||54.0|73.0|
4374917|NCT00336323|4201549|B1|||Age||years|Median|64|64.0|Inter-Quartile Range|||57.0|72.0|
4374918|NCT00336284|4201608|B3|Canada||Region of Enrollment|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|participants|Number|18|18.0||||||
4374919|NCT00336284|4201609|B2|Canada||Region of Enrollment|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|participants|Number|6|6.0||||||
4374920|NCT00336284|4201610|B1|Canada||Region of Enrollment|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|participants|Number|12|12.0||||||
4374921|NCT00336284|4201608|B3|United States||Region of Enrollment|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|participants|Number|1321|1321.0||||||
4374922|NCT00336284|4201609|B2|United States||Region of Enrollment|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|participants|Number|425|425.0||||||
4374923|NCT00336284|4201610|B1|United States||Region of Enrollment|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|participants|Number|896|896.0||||||
4374924|NCT00336284|4201608|B3||Male|Sex: Female, Male|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|Participants|Count of Participants|969|969.0||||||
4374925|NCT00336284|4201609|B2||Male|Sex: Female, Male|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|Participants|Count of Participants|315|315.0||||||
4374926|NCT00336284|4201610|B1||Male|Sex: Female, Male|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|Participants|Count of Participants|654|654.0||||||
4374927|NCT00336284|4201608|B3||Female|Sex: Female, Male|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|Participants|Count of Participants|370|370.0||||||
4374928|NCT00336284|4201609|B2||Female|Sex: Female, Male|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|Participants|Count of Participants|116|116.0||||||
4374929|NCT00336284|4201610|B1||Female|Sex: Female, Male|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|Participants|Count of Participants|254|254.0||||||
4374930|NCT00336284|4201608|B3|||Age|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|years|Mean|64|64.0|Standard Deviation|13|13.0|||
4374931|NCT00336284|4201609|B2|||Age|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|years|Mean|64|64.0|Standard Deviation|12|12.0|||
4374932|NCT00336284|4201610|B1|||Age|Only participants who completed at least one follow-up visit are included in the analyses. Home Monitoring Arm, N=908; Conventional Arm, N=431.|years|Mean|63|63.0|Standard Deviation|13|13.0|||
4374933|NCT00336232|4201623|B1|||Plasma phylloquinone (nmol/L)||nmol/L|Mean|0.8|0.8|Standard Deviation|1.1|1.1|||
4374934|NCT00336232|4201623|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4374935|NCT00336232|4201623|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374936|NCT00336232|4201623|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4374937|NCT00336232|4201623|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4374938|NCT00336232|4201623|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4374939|NCT00336232|4201623|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374940|NCT00336232|4201623|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4374941|NCT00336232|4201623|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374942|NCT00336232|4201623|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374943|NCT00336232|4201623|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4374944|NCT00336232|4201623|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4374945|NCT00336232|4201623|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4374946|NCT00336232|4201623|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4374947|NCT00336232|4201623|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4374948|NCT00336232|4201623|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4374949|NCT00336232|4201623|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4374950|NCT00336024|4201627|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4374951|NCT00336024|4201628|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4374952|NCT00336024|4201629|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4374953|NCT00336024|4201627|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374954|NCT00336024|4201628|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374955|NCT00336024|4201629|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374956|NCT00336024|4201627|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4374957|NCT00336024|4201628|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4374958|NCT00336024|4201629|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4374959|NCT00336024|4201627|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4374960|NCT00336024|4201628|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4374961|NCT00336024|4201629|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4374962|NCT00336024|4201627|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374963|NCT00336024|4201628|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374964|NCT00336024|4201629|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374965|NCT00336024|4201627|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4374966|NCT00336024|4201628|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4374967|NCT00336024|4201629|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4374968|NCT00336024|4201627|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374969|NCT00336024|4201628|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374970|NCT00336024|4201629|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4374971|NCT00336024|4201627|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4374972|NCT00336024|4201628|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4374973|NCT00336024|4201629|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4374974|NCT00336024|4201627|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4374975|NCT00336024|4201628|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4374976|NCT00336024|4201629|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4374977|NCT00336024|4201627|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4374978|NCT00336024|4201628|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4374979|NCT00336024|4201629|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4374980|NCT00336024|4201627|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4374981|NCT00336024|4201628|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4374982|NCT00336024|4201629|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4374983|NCT00336024|4201627|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4374984|NCT00336024|4201628|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4374985|NCT00336024|4201629|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4374986|NCT00336024|4201627|B3|||Age||years|Mean|1.85|1.85|Standard Deviation|0.82|0.82|||
4374987|NCT00336024|4201628|B2|||Age||years|Mean|1.73|1.73|Standard Deviation|0.87|0.87|||
4374988|NCT00336024|4201629|B1|||Age||years|Mean|1.97|1.97|Standard Deviation|0.75|0.75|||
4374989|NCT00335972|4201662|B3|Race-other||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4374990|NCT00335972|4201663|B2|Race-other||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4374991|NCT00335972|4201664|B1|Race-other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4374992|NCT00335972|4201662|B3|Race-white||Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
4374993|NCT00335972|4201663|B2|Race-white||Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
4374994|NCT00335972|4201664|B1|Race-white||Race/Ethnicity, Customized||Participants|Count of Participants|65|65.0||||||
4374995|NCT00335972|4201662|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4374996|NCT00335972|4201663|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4374997|NCT00335972|4201664|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4374998|NCT00335972|4201662|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4374999|NCT00335972|4201663|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4375000|NCT00335972|4201664|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4375001|NCT00335972|4201662|B3|||Age||years|Mean|55|55.0|Standard Deviation|14|14.0|||
4375002|NCT00335972|4201663|B2|||Age||years|Mean|56|56.0|Standard Deviation|14|14.0|||
4375003|NCT00335972|4201664|B1|||Age||years|Mean|55|55.0|Standard Deviation|14|14.0|||
4375004|NCT00335959|4201675|B1||Unknown or Not Reported|Race (NIH/OMB)|All eligible patients were included in this measure.|Participants|Count of Participants|1|1.0||||||
4375005|NCT00335959|4201675|B1||More than one race|Race (NIH/OMB)|All eligible patients were included in this measure.|Participants|Count of Participants|0|0.0||||||
4375006|NCT00335959|4201675|B1||White|Race (NIH/OMB)|All eligible patients were included in this measure.|Participants|Count of Participants|3|3.0||||||
4375007|NCT00335959|4201675|B1||Black or African American|Race (NIH/OMB)|All eligible patients were included in this measure.|Participants|Count of Participants|2|2.0||||||
4375008|NCT00335959|4201675|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|All eligible patients were included in this measure.|Participants|Count of Participants|0|0.0||||||
4375009|NCT00335959|4201675|B1||Asian|Race (NIH/OMB)|All eligible patients were included in this measure.|Participants|Count of Participants|0|0.0||||||
4375010|NCT00335959|4201675|B1||American Indian or Alaska Native|Race (NIH/OMB)|All eligible patients were included in this measure.|Participants|Count of Participants|0|0.0||||||
4375011|NCT00335959|4201675|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|All eligible patients were included in this measure.|Participants|Count of Participants|2|2.0||||||
4375012|NCT00335959|4201675|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|All eligible patients were included in this measure.|Participants|Count of Participants|3|3.0||||||
4375013|NCT00335959|4201675|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|All eligible patients were included in this measure.|Participants|Count of Participants|1|1.0||||||
4375014|NCT00335959|4201675|B1||Male|Sex: Female, Male|All eligible patients were included in this measure.|Participants|Count of Participants|3|3.0||||||
4375015|NCT00335959|4201675|B1||Female|Sex: Female, Male|All eligible patients were included in this measure.|Participants|Count of Participants|3|3.0||||||
4375016|NCT00335959|4201675|B1|||Age|All eligible patients were included in this measure.|years|Median|72|72.0|Full Range|||29.8|86.9|
4375017|NCT00335829|4201680|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4375018|NCT00335829|4201680|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4375019|NCT00335829|4201680|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4375020|NCT00335829|4201680|B1|||Age||years|Mean|64|64.0|Full Range|||31.0|85.0|
4375021|NCT00335777|4201694|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4375022|NCT00335777|4201694|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4375023|NCT00335777|4201694|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4375024|NCT00335777|4201694|B1|||Age||years|Mean|40.86|40.86|Standard Deviation|10.47|10.47|||
4375025|NCT00335764|4201699|B6|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4375026|NCT00335764|4201700|B5|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4375027|NCT00335764|4201701|B4|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4375028|NCT00335764|4201702|B3|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|85|85.0|Full Range|||60.0|100.0|
4375029|NCT00335764|4201703|B2|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|80|80.0|Full Range|||60.0|100.0|
4375030|NCT00335764|4201704|B1|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|90|90.0|Full Range|||70.0|100.0|
4375031|NCT00335764|4201699|B6||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4375032|NCT00335764|4201700|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4375033|NCT00335764|4201701|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4375034|NCT00335764|4201702|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4375035|NCT00335764|4201703|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4375036|NCT00335764|4201704|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4375037|NCT00335764|4201699|B6||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4375038|NCT00335764|4201700|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4375039|NCT00335764|4201701|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4375040|NCT00335764|4201702|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4375041|NCT00335764|4201703|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4375042|NCT00335764|4201704|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4375043|NCT00335764|4201699|B6|||Age||years|Mean|53|53.0|Full Range|||24.0|76.0|
4375044|NCT00335764|4201700|B5|||Age||years|Mean|50|50.0|Full Range|||24.0|64.0|
4375045|NCT00335764|4201701|B4|||Age||years|Mean|52|52.0|Full Range|||30.0|76.0|
4375046|NCT00335764|4201702|B3|||Age||years|Mean|57|57.0|Full Range|||27.0|76.0|
4375047|NCT00335764|4201703|B2|||Age||years|Mean|50|50.0|Full Range|||32.0|59.0|
4375048|NCT00335764|4201704|B1|||Age||years|Mean|53|53.0|Full Range|||36.0|70.0|
4375049|NCT00335738|4201755|B3|Bangladesh||Region of Enrollment||participants|Number|2|2.0||||||
4375050|NCT00335738|4201756|B2|Bangladesh||Region of Enrollment||participants|Number|2|2.0||||||
4375051|NCT00335738|4201757|B1|Bangladesh||Region of Enrollment||participants|Number|0|0.0||||||
4375052|NCT00335738|4201755|B3|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4375053|NCT00335738|4201756|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4375054|NCT00335738|4201757|B1|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4375055|NCT00335738|4201755|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4375056|NCT00335738|4201756|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4375057|NCT00335738|4201757|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4375058|NCT00335738|4201755|B3|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4375059|NCT00335738|4201756|B2|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4375060|NCT00335738|4201757|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4375061|NCT00335738|4201755|B3|India||Region of Enrollment||participants|Number|87|87.0||||||
4375062|NCT00335738|4201756|B2|India||Region of Enrollment||participants|Number|55|55.0||||||
4375063|NCT00335738|4201757|B1|India||Region of Enrollment||participants|Number|32|32.0||||||
4375064|NCT00335738|4201755|B3|New Zealand||Region of Enrollment||participants|Number|8|8.0||||||
4375065|NCT00335738|4201756|B2|New Zealand||Region of Enrollment||participants|Number|7|7.0||||||
4375066|NCT00335738|4201757|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4375067|NCT00335738|4201755|B3|United States||Region of Enrollment||participants|Number|209|209.0||||||
4375068|NCT00335738|4201756|B2|United States||Region of Enrollment||participants|Number|144|144.0||||||
4375069|NCT00335738|4201757|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4375070|NCT00335738|4201755|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4375071|NCT00335738|4201756|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4375072|NCT00335738|4201757|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4375073|NCT00335738|4201755|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375074|NCT00335738|4201756|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375075|NCT00335738|4201757|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375076|NCT00335738|4201755|B3||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
4375077|NCT00335738|4201756|B2||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4375078|NCT00335738|4201757|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4375079|NCT00335738|4201755|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4375080|NCT00335738|4201756|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4375081|NCT00335738|4201757|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4375082|NCT00335738|4201755|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4375083|NCT00335738|4201756|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4375084|NCT00335738|4201757|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4375085|NCT00335738|4201755|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4375086|NCT00335738|4201756|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4375087|NCT00335738|4201757|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4375088|NCT00335738|4201755|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4375089|NCT00335738|4201756|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375090|NCT00335738|4201757|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4375091|NCT00335738|4201755|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4375092|NCT00335738|4201756|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4375093|NCT00335738|4201757|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4375094|NCT00335738|4201755|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|263|263.0||||||
4375095|NCT00335738|4201756|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4375096|NCT00335738|4201757|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4375097|NCT00335738|4201755|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4375098|NCT00335738|4201756|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4375099|NCT00335738|4201757|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4375100|NCT00335738|4201755|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4375101|NCT00335738|4201756|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4375102|NCT00335738|4201757|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4375103|NCT00335738|4201755|B3||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4375104|NCT00335738|4201756|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4375105|NCT00335738|4201757|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4375106|NCT00335738|4201755|B3|||Age||years|Median|2|2.0|Full Range|||0.0|6.0|
4375107|NCT00335738|4201756|B2|||Age||years|Median|1|1.0|Full Range|||0.0|6.0|
4375108|NCT00335738|4201757|B1|||Age||years|Median|2|2.0|Full Range|||0.0|6.0|
4375109|NCT00335725|4201773|B3|||basal FSH||IU/L|Mean|6.0|6.0|Standard Deviation|2.2|2.2|||
4375110|NCT00335725|4201774|B2|||basal FSH||IU/L|Mean|6.0|6.0|Standard Deviation|1.9|1.9|||
4375111|NCT00335725|4201775|B1|||basal FSH||IU/L|Mean|5.9|5.9|Standard Deviation|2.5|2.5|||
4375112|NCT00335725|4201773|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375113|NCT00335725|4201774|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375114|NCT00335725|4201775|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375115|NCT00335725|4201773|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4375116|NCT00335725|4201774|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4375117|NCT00335725|4201775|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4375118|NCT00335725|4201773|B3|||Age||years|Mean|30.0|30.0|Standard Deviation|3.8|3.8|||
4375119|NCT00335725|4201774|B2|||Age||years|Mean|30.0|30.0|Standard Deviation|3.6|3.6|||
4375120|NCT00335725|4201775|B1|||Age||years|Mean|29.9|29.9|Standard Deviation|4.0|4.0|||
4375121|NCT00335556|4201784|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4375122|NCT00335556|4201785|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4375123|NCT00335556|4201786|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4375124|NCT00335556|4201787|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375125|NCT00335556|4201788|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4375126|NCT00335556|4201789|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4375127|NCT00335556|4201790|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4375128|NCT00335556|4201784|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375129|NCT00335556|4201785|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375130|NCT00335556|4201786|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375131|NCT00335556|4201787|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375132|NCT00335556|4201788|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375133|NCT00335556|4201789|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375134|NCT00335556|4201790|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375135|NCT00335556|4201784|B7||White|Race (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
4375136|NCT00335556|4201785|B6||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4375137|NCT00335556|4201786|B5||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4375138|NCT00335556|4201787|B4||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4375139|NCT00335556|4201788|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4375140|NCT00335556|4201789|B2||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4375141|NCT00335556|4201790|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4375142|NCT00335556|4201784|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4375143|NCT00335556|4201785|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4375144|NCT00335556|4201786|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4375145|NCT00335556|4201787|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4375146|NCT00335556|4201788|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4375147|NCT00335556|4201789|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4375148|NCT00335556|4201790|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4375149|NCT00335556|4201784|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4375150|NCT00335556|4201785|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375151|NCT00335556|4201786|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375152|NCT00335556|4201787|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375153|NCT00335556|4201788|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375154|NCT00335556|4201789|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375155|NCT00335556|4201790|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4375156|NCT00335556|4201784|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4375157|NCT00335556|4201785|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375158|NCT00335556|4201786|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4375159|NCT00335556|4201787|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375160|NCT00335556|4201788|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375161|NCT00335556|4201789|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4375162|NCT00335556|4201790|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4375163|NCT00335556|4201784|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375164|NCT00335556|4201785|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375165|NCT00335556|4201786|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375166|NCT00335556|4201787|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375167|NCT00335556|4201788|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375168|NCT00335556|4201789|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375169|NCT00335556|4201790|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375170|NCT00335556|4201784|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4375171|NCT00335556|4201785|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4375172|NCT00335556|4201786|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375173|NCT00335556|4201787|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375174|NCT00335556|4201788|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4375175|NCT00335556|4201789|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4375176|NCT00335556|4201790|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375177|NCT00335556|4201784|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|253|253.0||||||
4375178|NCT00335556|4201785|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4375179|NCT00335556|4201786|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4375180|NCT00335556|4201787|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4375181|NCT00335556|4201788|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4375182|NCT00335556|4201789|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4375183|NCT00335556|4201790|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4375184|NCT00335556|4201784|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4375185|NCT00335556|4201785|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4375186|NCT00335556|4201786|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4375187|NCT00335556|4201787|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4375188|NCT00335556|4201788|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375189|NCT00335556|4201789|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4375190|NCT00335556|4201790|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4375191|NCT00335556|4201784|B7||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4375192|NCT00335556|4201785|B6||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4375193|NCT00335556|4201786|B5||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4375194|NCT00335556|4201787|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4375195|NCT00335556|4201788|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4375196|NCT00335556|4201789|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4375197|NCT00335556|4201790|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4375198|NCT00335556|4201784|B7||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4375199|NCT00335556|4201785|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4375200|NCT00335556|4201786|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4375201|NCT00335556|4201787|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4375202|NCT00335556|4201788|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4375203|NCT00335556|4201789|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4375204|NCT00335556|4201790|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4375205|NCT00335556|4201784|B7|||Age||Months|Mean|70.60|70.6|Standard Deviation|60.50|60.5|||
4375206|NCT00335556|4201785|B6|||Age||Months|Mean|54.29|54.29|Standard Deviation|32.72|32.72|||
4375207|NCT00335556|4201786|B5|||Age||Months|Mean|34.10|34.1|Standard Deviation|31.10|31.1|||
4375208|NCT00335556|4201787|B4|||Age||Months|Mean|54.04|54.04|Standard Deviation|19.71|19.71|||
4375209|NCT00335556|4201788|B3|||Age||Months|Mean|68.95|68.95|Standard Deviation|97.64|97.64|||
4375210|NCT00335556|4201789|B2|||Age||Months|Mean|52.39|52.39|Standard Deviation|40.09|40.09|||
4375211|NCT00335556|4201790|B1|||Age||Months|Mean|148.53|148.53|Standard Deviation|51.74|51.74|||
4375212|NCT00335517|4201816|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
4375213|NCT00335517|4201816|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4375214|NCT00335517|4201816|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4375215|NCT00335517|4201816|B1|||Age||years|Mean|60|60.0|Standard Deviation|13.7|13.7|||
4375216|NCT00335517|4201816|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4375217|NCT00335517|4201816|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4375218|NCT00335517|4201816|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375219|NCT00335504|4201820|B5|No||History of Surgical Resection|History of prior surgical resection of the colon: Yes vs. No|participants|Number|60|60.0||||||
4375220|NCT00335504|4201821|B4|No||History of Surgical Resection|History of prior surgical resection of the colon: Yes vs. No|participants|Number|16|16.0||||||
4375221|NCT00335504|4201822|B3|No||History of Surgical Resection|History of prior surgical resection of the colon: Yes vs. No|participants|Number|14|14.0||||||
4375222|NCT00335504|4201823|B2|No||History of Surgical Resection|History of prior surgical resection of the colon: Yes vs. No|participants|Number|15|15.0||||||
4375223|NCT00335504|4201824|B1|No||History of Surgical Resection|History of prior surgical resection of the colon: Yes vs. No|participants|Number|15|15.0||||||
4375224|NCT00335504|4201820|B5|Yes||History of Surgical Resection|History of prior surgical resection of the colon: Yes vs. No|participants|Number|25|25.0||||||
4375225|NCT00335504|4201821|B4|Yes||History of Surgical Resection|History of prior surgical resection of the colon: Yes vs. No|participants|Number|6|6.0||||||
4375226|NCT00335504|4201822|B3|Yes||History of Surgical Resection|History of prior surgical resection of the colon: Yes vs. No|participants|Number|6|6.0||||||
4375227|NCT00335504|4201823|B2|Yes||History of Surgical Resection|History of prior surgical resection of the colon: Yes vs. No|participants|Number|6|6.0||||||
4375228|NCT00335504|4201824|B1|Yes||History of Surgical Resection|History of prior surgical resection of the colon: Yes vs. No|participants|Number|7|7.0||||||
4375229|NCT00335504|4201820|B5|United States||Region of Enrollment||participants|Number|85|85.0||||||
4375230|NCT00335504|4201821|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
4375231|NCT00335504|4201822|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4375232|NCT00335504|4201823|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4375233|NCT00335504|4201824|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4375234|NCT00335504|4201820|B5||Male|Gender||Participants|Count of Participants|56|56.0||||||
4375235|NCT00335504|4201821|B4||Male|Gender||Participants|Count of Participants|15|15.0||||||
4375236|NCT00335504|4201822|B3||Male|Gender||Participants|Count of Participants|12|12.0||||||
4375237|NCT00335504|4201823|B2||Male|Gender||Participants|Count of Participants|12|12.0||||||
4375238|NCT00335504|4201824|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
4375239|NCT00335504|4201820|B5||Female|Gender||Participants|Count of Participants|29|29.0||||||
4375240|NCT00335504|4201821|B4||Female|Gender||Participants|Count of Participants|7|7.0||||||
4375241|NCT00335504|4201822|B3||Female|Gender||Participants|Count of Participants|8|8.0||||||
4375242|NCT00335504|4201823|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
4375243|NCT00335504|4201824|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4375244|NCT00335504|4201820|B5|||Age||Years|Median|58|58.0|Full Range|||41.0|78.0|
4375245|NCT00335504|4201821|B4|||Age||Years|Median|57|57.0|Full Range|||44.0|72.0|
4375246|NCT00335504|4201822|B3|||Age||Years|Median|64|64.0|Full Range|||48.0|78.0|
4375247|NCT00335504|4201823|B2|||Age||Years|Median|55|55.0|Full Range|||41.0|74.0|
4375248|NCT00335504|4201824|B1|||Age||Years|Median|61|61.0|Full Range|||44.0|78.0|
4375249|NCT00335478|4201849|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4375250|NCT00335478|4201849|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4375251|NCT00335478|4201849|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4375252|NCT00335478|4201849|B1|||Age||years|Median|50.4|50.4|Standard Deviation|16.730|16.73|||
4375253|NCT00335478|4201849|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4375254|NCT00335478|4201849|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4375255|NCT00335478|4201849|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375256|NCT00335452|4201853|B5|No||Intended PCI performed|The intent to perform a PCI as early as possible and no later than 72 hours of randomization was part of the criteria for inclusion|participants|Number|7823|7823.0||||||
4375257|NCT00335452|4201854|B4|No||Intended PCI performed|The intent to perform a PCI as early as possible and no later than 72 hours of randomization was part of the criteria for inclusion|participants|Number|1955|1955.0||||||
4375258|NCT00335452|4201855|B3|No||Intended PCI performed|The intent to perform a PCI as early as possible and no later than 72 hours of randomization was part of the criteria for inclusion|participants|Number|2005|2005.0||||||
4375259|NCT00335452|4201856|B2|No||Intended PCI performed|The intent to perform a PCI as early as possible and no later than 72 hours of randomization was part of the criteria for inclusion|participants|Number|1928|1928.0||||||
4375260|NCT00335452|4201857|B1|No||Intended PCI performed|The intent to perform a PCI as early as possible and no later than 72 hours of randomization was part of the criteria for inclusion|participants|Number|1935|1935.0||||||
4375261|NCT00335452|4201853|B5|Yes||Intended PCI performed|The intent to perform a PCI as early as possible and no later than 72 hours of randomization was part of the criteria for inclusion|participants|Number|17263|17263.0||||||
4375262|NCT00335452|4201854|B4|Yes||Intended PCI performed|The intent to perform a PCI as early as possible and no later than 72 hours of randomization was part of the criteria for inclusion|participants|Number|4298|4298.0||||||
4375263|NCT00335452|4201855|B3|Yes||Intended PCI performed|The intent to perform a PCI as early as possible and no later than 72 hours of randomization was part of the criteria for inclusion|participants|Number|4262|4262.0||||||
4375264|NCT00335452|4201856|B2|Yes||Intended PCI performed|The intent to perform a PCI as early as possible and no later than 72 hours of randomization was part of the criteria for inclusion|participants|Number|4326|4326.0||||||
4375265|NCT00335452|4201857|B1|Yes||Intended PCI performed|The intent to perform a PCI as early as possible and no later than 72 hours of randomization was part of the criteria for inclusion|participants|Number|4377|4377.0||||||
4375266|NCT00335452|4201853|B5|Missing||Qualifying condition||participants|Number|14|14.0||||||
4375267|NCT00335452|4201854|B4|Missing||Qualifying condition||participants|Number|5|5.0||||||
4375268|NCT00335452|4201855|B3|Missing||Qualifying condition||participants|Number|3|3.0||||||
4375269|NCT00335452|4201856|B2|Missing||Qualifying condition||participants|Number|4|4.0||||||
4375270|NCT00335452|4201857|B1|Missing||Qualifying condition||participants|Number|2|2.0||||||
4375271|NCT00335452|4201853|B5|MI with ST elevation (STEMI)||Qualifying condition||participants|Number|7327|7327.0||||||
4375272|NCT00335452|4201854|B4|MI with ST elevation (STEMI)||Qualifying condition||participants|Number|1832|1832.0||||||
4375273|NCT00335452|4201855|B3|MI with ST elevation (STEMI)||Qualifying condition||participants|Number|1839|1839.0||||||
4375274|NCT00335452|4201856|B2|MI with ST elevation (STEMI)||Qualifying condition||participants|Number|1817|1817.0||||||
4375275|NCT00335452|4201857|B1|MI with ST elevation (STEMI)||Qualifying condition||participants|Number|1839|1839.0||||||
4375276|NCT00335452|4201853|B5|Suspected MI without ST elevation (NSTEMI)||Qualifying condition||participants|Number|10531|10531.0||||||
4375277|NCT00335452|4201854|B4|Suspected MI without ST elevation (NSTEMI)||Qualifying condition||participants|Number|2539|2539.0||||||
4375278|NCT00335452|4201855|B3|Suspected MI without ST elevation (NSTEMI)||Qualifying condition||participants|Number|2668|2668.0||||||
4375279|NCT00335452|4201856|B2|Suspected MI without ST elevation (NSTEMI)||Qualifying condition||participants|Number|2662|2662.0||||||
4375280|NCT00335452|4201857|B1|Suspected MI without ST elevation (NSTEMI)||Qualifying condition||participants|Number|2662|2662.0||||||
4375281|NCT00335452|4201853|B5|Suspected Unstable Angina (UA)||Qualifying condition||participants|Number|7214|7214.0||||||
4375282|NCT00335452|4201854|B4|Suspected Unstable Angina (UA)||Qualifying condition||participants|Number|1877|1877.0||||||
4375283|NCT00335452|4201855|B3|Suspected Unstable Angina (UA)||Qualifying condition||participants|Number|1757|1757.0||||||
4375284|NCT00335452|4201856|B2|Suspected Unstable Angina (UA)||Qualifying condition||participants|Number|1771|1771.0||||||
4375285|NCT00335452|4201857|B1|Suspected Unstable Angina (UA)||Qualifying condition||participants|Number|1809|1809.0||||||
4375286|NCT00335452|4201853|B5|United States||Region of Enrollment||participants|Number|3062|3062.0||||||
4375287|NCT00335452|4201854|B4|United States||Region of Enrollment||participants|Number|765|765.0||||||
4375288|NCT00335452|4201855|B3|United States||Region of Enrollment||participants|Number|759|759.0||||||
4375289|NCT00335452|4201856|B2|United States||Region of Enrollment||participants|Number|763|763.0||||||
4375290|NCT00335452|4201857|B1|United States||Region of Enrollment||participants|Number|775|775.0||||||
4375291|NCT00335452|4201853|B5|United Kingdom||Region of Enrollment||participants|Number|119|119.0||||||
4375292|NCT00335452|4201854|B4|United Kingdom||Region of Enrollment||participants|Number|28|28.0||||||
4375293|NCT00335452|4201855|B3|United Kingdom||Region of Enrollment||participants|Number|34|34.0||||||
4375294|NCT00335452|4201856|B2|United Kingdom||Region of Enrollment||participants|Number|29|29.0||||||
4375295|NCT00335452|4201857|B1|United Kingdom||Region of Enrollment||participants|Number|28|28.0||||||
4375296|NCT00335452|4201853|B5|Turkey||Region of Enrollment||participants|Number|347|347.0||||||
4375297|NCT00335452|4201854|B4|Turkey||Region of Enrollment||participants|Number|78|78.0||||||
4375298|NCT00335452|4201855|B3|Turkey||Region of Enrollment||participants|Number|94|94.0||||||
4375299|NCT00335452|4201856|B2|Turkey||Region of Enrollment||participants|Number|96|96.0||||||
4375300|NCT00335452|4201857|B1|Turkey||Region of Enrollment||participants|Number|79|79.0||||||
4375301|NCT00335452|4201853|B5|Switzerland||Region of Enrollment||participants|Number|227|227.0||||||
4375302|NCT00335452|4201854|B4|Switzerland||Region of Enrollment||participants|Number|48|48.0||||||
4375303|NCT00335452|4201855|B3|Switzerland||Region of Enrollment||participants|Number|64|64.0||||||
4375304|NCT00335452|4201856|B2|Switzerland||Region of Enrollment||participants|Number|64|64.0||||||
4375305|NCT00335452|4201857|B1|Switzerland||Region of Enrollment||participants|Number|51|51.0||||||
4375306|NCT00335452|4201853|B5|Sweden||Region of Enrollment||participants|Number|40|40.0||||||
4375307|NCT00335452|4201854|B4|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4375308|NCT00335452|4201855|B3|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
4375309|NCT00335452|4201856|B2|Sweden||Region of Enrollment||participants|Number|11|11.0||||||
4375310|NCT00335452|4201857|B1|Sweden||Region of Enrollment||participants|Number|10|10.0||||||
4375311|NCT00335452|4201853|B5|Spain||Region of Enrollment||participants|Number|1086|1086.0||||||
4375312|NCT00335452|4201854|B4|Spain||Region of Enrollment||participants|Number|263|263.0||||||
4375313|NCT00335452|4201855|B3|Spain||Region of Enrollment||participants|Number|283|283.0||||||
4375314|NCT00335452|4201856|B2|Spain||Region of Enrollment||participants|Number|276|276.0||||||
4375315|NCT00335452|4201857|B1|Spain||Region of Enrollment||participants|Number|264|264.0||||||
4375316|NCT00335452|4201853|B5|South Africa||Region of Enrollment||participants|Number|75|75.0||||||
4375317|NCT00335452|4201854|B4|South Africa||Region of Enrollment||participants|Number|23|23.0||||||
4375318|NCT00335452|4201855|B3|South Africa||Region of Enrollment||participants|Number|14|14.0||||||
4375319|NCT00335452|4201856|B2|South Africa||Region of Enrollment||participants|Number|14|14.0||||||
4375320|NCT00335452|4201857|B1|South Africa||Region of Enrollment||participants|Number|24|24.0||||||
4375321|NCT00335452|4201853|B5|Slovakia||Region of Enrollment||participants|Number|352|352.0||||||
4375322|NCT00335452|4201854|B4|Slovakia||Region of Enrollment||participants|Number|92|92.0||||||
4375323|NCT00335452|4201855|B3|Slovakia||Region of Enrollment||participants|Number|83|83.0||||||
4375324|NCT00335452|4201856|B2|Slovakia||Region of Enrollment||participants|Number|84|84.0||||||
4375325|NCT00335452|4201857|B1|Slovakia||Region of Enrollment||participants|Number|93|93.0||||||
4375326|NCT00335452|4201853|B5|Singapore||Region of Enrollment||participants|Number|48|48.0||||||
4375327|NCT00335452|4201854|B4|Singapore||Region of Enrollment||participants|Number|10|10.0||||||
4375328|NCT00335452|4201855|B3|Singapore||Region of Enrollment||participants|Number|15|15.0||||||
4375329|NCT00335452|4201856|B2|Singapore||Region of Enrollment||participants|Number|13|13.0||||||
4375330|NCT00335452|4201857|B1|Singapore||Region of Enrollment||participants|Number|10|10.0||||||
4375331|NCT00335452|4201853|B5|Russian Federation||Region of Enrollment||participants|Number|538|538.0||||||
4375332|NCT00335452|4201854|B4|Russian Federation||Region of Enrollment||participants|Number|131|131.0||||||
4375333|NCT00335452|4201855|B3|Russian Federation||Region of Enrollment||participants|Number|138|138.0||||||
4375334|NCT00335452|4201856|B2|Russian Federation||Region of Enrollment||participants|Number|137|137.0||||||
4375335|NCT00335452|4201857|B1|Russian Federation||Region of Enrollment||participants|Number|132|132.0||||||
4375336|NCT00335452|4201853|B5|Romania||Region of Enrollment||participants|Number|158|158.0||||||
4375337|NCT00335452|4201854|B4|Romania||Region of Enrollment||participants|Number|48|48.0||||||
4375338|NCT00335452|4201855|B3|Romania||Region of Enrollment||participants|Number|33|33.0||||||
4375339|NCT00335452|4201856|B2|Romania||Region of Enrollment||participants|Number|30|30.0||||||
4375340|NCT00335452|4201857|B1|Romania||Region of Enrollment||participants|Number|47|47.0||||||
4375341|NCT00335452|4201853|B5|Poland||Region of Enrollment||participants|Number|1374|1374.0||||||
4375342|NCT00335452|4201854|B4|Poland||Region of Enrollment||participants|Number|362|362.0||||||
4375343|NCT00335452|4201855|B3|Poland||Region of Enrollment||participants|Number|325|325.0||||||
4375344|NCT00335452|4201856|B2|Poland||Region of Enrollment||participants|Number|322|322.0||||||
4375345|NCT00335452|4201857|B1|Poland||Region of Enrollment||participants|Number|365|365.0||||||
4375346|NCT00335452|4201853|B5|New Zealand||Region of Enrollment||participants|Number|125|125.0||||||
4375347|NCT00335452|4201854|B4|New Zealand||Region of Enrollment||participants|Number|29|29.0||||||
4375348|NCT00335452|4201855|B3|New Zealand||Region of Enrollment||participants|Number|29|29.0||||||
4375349|NCT00335452|4201856|B2|New Zealand||Region of Enrollment||participants|Number|31|31.0||||||
4375350|NCT00335452|4201857|B1|New Zealand||Region of Enrollment||participants|Number|36|36.0||||||
4375351|NCT00335452|4201853|B5|Netherlands||Region of Enrollment||participants|Number|188|188.0||||||
4375352|NCT00335452|4201854|B4|Netherlands||Region of Enrollment||participants|Number|46|46.0||||||
4375353|NCT00335452|4201855|B3|Netherlands||Region of Enrollment||participants|Number|48|48.0||||||
4375354|NCT00335452|4201856|B2|Netherlands||Region of Enrollment||participants|Number|48|48.0||||||
4375355|NCT00335452|4201857|B1|Netherlands||Region of Enrollment||participants|Number|46|46.0||||||
4375356|NCT00335452|4201853|B5|Mexico||Region of Enrollment||participants|Number|69|69.0||||||
4375357|NCT00335452|4201854|B4|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4375358|NCT00335452|4201855|B3|Mexico||Region of Enrollment||participants|Number|19|19.0||||||
4375359|NCT00335452|4201856|B2|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4375360|NCT00335452|4201857|B1|Mexico||Region of Enrollment||participants|Number|16|16.0||||||
4375361|NCT00335452|4201853|B5|Malaysia||Region of Enrollment||participants|Number|135|135.0||||||
4375362|NCT00335452|4201854|B4|Malaysia||Region of Enrollment||participants|Number|28|28.0||||||
4375363|NCT00335452|4201855|B3|Malaysia||Region of Enrollment||participants|Number|39|39.0||||||
4375364|NCT00335452|4201856|B2|Malaysia||Region of Enrollment||participants|Number|39|39.0||||||
4375365|NCT00335452|4201857|B1|Malaysia||Region of Enrollment||participants|Number|29|29.0||||||
4375366|NCT00335452|4201853|B5|Lithuania||Region of Enrollment||participants|Number|115|115.0||||||
4375367|NCT00335452|4201854|B4|Lithuania||Region of Enrollment||participants|Number|28|28.0||||||
4375368|NCT00335452|4201855|B3|Lithuania||Region of Enrollment||participants|Number|30|30.0||||||
4375369|NCT00335452|4201856|B2|Lithuania||Region of Enrollment||participants|Number|31|31.0||||||
4375370|NCT00335452|4201857|B1|Lithuania||Region of Enrollment||participants|Number|26|26.0||||||
4375371|NCT00335452|4201853|B5|Latvia||Region of Enrollment||participants|Number|62|62.0||||||
4375372|NCT00335452|4201854|B4|Latvia||Region of Enrollment||participants|Number|15|15.0||||||
4375373|NCT00335452|4201855|B3|Latvia||Region of Enrollment||participants|Number|15|15.0||||||
4375374|NCT00335452|4201856|B2|Latvia||Region of Enrollment||participants|Number|16|16.0||||||
4375375|NCT00335452|4201857|B1|Latvia||Region of Enrollment||participants|Number|16|16.0||||||
4375376|NCT00335452|4201853|B5|Korea, Republic of||Region of Enrollment||participants|Number|627|627.0||||||
4375377|NCT00335452|4201854|B4|Korea, Republic of||Region of Enrollment||participants|Number|165|165.0||||||
4375378|NCT00335452|4201855|B3|Korea, Republic of||Region of Enrollment||participants|Number|152|152.0||||||
4375379|NCT00335452|4201856|B2|Korea, Republic of||Region of Enrollment||participants|Number|149|149.0||||||
4375380|NCT00335452|4201857|B1|Korea, Republic of||Region of Enrollment||participants|Number|161|161.0||||||
4375381|NCT00335452|4201853|B5|Italy||Region of Enrollment||participants|Number|981|981.0||||||
4375382|NCT00335452|4201854|B4|Italy||Region of Enrollment||participants|Number|231|231.0||||||
4375383|NCT00335452|4201855|B3|Italy||Region of Enrollment||participants|Number|258|258.0||||||
4375384|NCT00335452|4201856|B2|Italy||Region of Enrollment||participants|Number|260|260.0||||||
4375385|NCT00335452|4201857|B1|Italy||Region of Enrollment||participants|Number|232|232.0||||||
4375386|NCT00335452|4201853|B5|Israel||Region of Enrollment||participants|Number|1115|1115.0||||||
4375387|NCT00335452|4201854|B4|Israel||Region of Enrollment||participants|Number|282|282.0||||||
4375388|NCT00335452|4201855|B3|Israel||Region of Enrollment||participants|Number|275|275.0||||||
4375389|NCT00335452|4201856|B2|Israel||Region of Enrollment||participants|Number|272|272.0||||||
4375390|NCT00335452|4201857|B1|Israel||Region of Enrollment||participants|Number|286|286.0||||||
4375391|NCT00335452|4201853|B5|Ireland||Region of Enrollment||participants|Number|75|75.0||||||
4375392|NCT00335452|4201854|B4|Ireland||Region of Enrollment||participants|Number|23|23.0||||||
4375393|NCT00335452|4201855|B3|Ireland||Region of Enrollment||participants|Number|15|15.0||||||
4375394|NCT00335452|4201856|B2|Ireland||Region of Enrollment||participants|Number|13|13.0||||||
4375395|NCT00335452|4201857|B1|Ireland||Region of Enrollment||participants|Number|24|24.0||||||
4375396|NCT00335452|4201853|B5|India||Region of Enrollment||participants|Number|2599|2599.0||||||
4375397|NCT00335452|4201854|B4|India||Region of Enrollment||participants|Number|646|646.0||||||
4375398|NCT00335452|4201855|B3|India||Region of Enrollment||participants|Number|645|645.0||||||
4375399|NCT00335452|4201856|B2|India||Region of Enrollment||participants|Number|650|650.0||||||
4375400|NCT00335452|4201857|B1|India||Region of Enrollment||participants|Number|658|658.0||||||
4375401|NCT00335452|4201853|B5|Greece||Region of Enrollment||participants|Number|85|85.0||||||
4375402|NCT00335452|4201854|B4|Greece||Region of Enrollment||participants|Number|21|21.0||||||
4375403|NCT00335452|4201855|B3|Greece||Region of Enrollment||participants|Number|23|23.0||||||
4375404|NCT00335452|4201856|B2|Greece||Region of Enrollment||participants|Number|21|21.0||||||
4375405|NCT00335452|4201857|B1|Greece||Region of Enrollment||participants|Number|20|20.0||||||
4375406|NCT00335452|4201853|B5|Germany||Region of Enrollment||participants|Number|1844|1844.0||||||
4375407|NCT00335452|4201854|B4|Germany||Region of Enrollment||participants|Number|470|470.0||||||
4375408|NCT00335452|4201855|B3|Germany||Region of Enrollment||participants|Number|453|453.0||||||
4375409|NCT00335452|4201856|B2|Germany||Region of Enrollment||participants|Number|450|450.0||||||
4375410|NCT00335452|4201857|B1|Germany||Region of Enrollment||participants|Number|471|471.0||||||
4375411|NCT00335452|4201853|B5|France||Region of Enrollment||participants|Number|680|680.0||||||
4375412|NCT00335452|4201854|B4|France||Region of Enrollment||participants|Number|175|175.0||||||
4375413|NCT00335452|4201855|B3|France||Region of Enrollment||participants|Number|165|165.0||||||
4375414|NCT00335452|4201856|B2|France||Region of Enrollment||participants|Number|163|163.0||||||
4375415|NCT00335452|4201857|B1|France||Region of Enrollment||participants|Number|177|177.0||||||
4375416|NCT00335452|4201853|B5|Finland||Region of Enrollment||participants|Number|518|518.0||||||
4375417|NCT00335452|4201854|B4|Finland||Region of Enrollment||participants|Number|132|132.0||||||
4375418|NCT00335452|4201855|B3|Finland||Region of Enrollment||participants|Number|127|127.0||||||
4375419|NCT00335452|4201856|B2|Finland||Region of Enrollment||participants|Number|127|127.0||||||
4375420|NCT00335452|4201857|B1|Finland||Region of Enrollment||participants|Number|132|132.0||||||
4375421|NCT00335452|4201853|B5|Estonia||Region of Enrollment||participants|Number|2|2.0||||||
4375422|NCT00335452|4201854|B4|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
4375423|NCT00335452|4201855|B3|Estonia||Region of Enrollment||participants|Number|0|0.0||||||
4375424|NCT00335452|4201856|B2|Estonia||Region of Enrollment||participants|Number|0|0.0||||||
4375425|NCT00335452|4201857|B1|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
4375426|NCT00335452|4201853|B5|Czech Republic||Region of Enrollment||participants|Number|1067|1067.0||||||
4375427|NCT00335452|4201854|B4|Czech Republic||Region of Enrollment||participants|Number|258|258.0||||||
4375428|NCT00335452|4201855|B3|Czech Republic||Region of Enrollment||participants|Number|277|277.0||||||
4375429|NCT00335452|4201856|B2|Czech Republic||Region of Enrollment||participants|Number|275|275.0||||||
4375430|NCT00335452|4201857|B1|Czech Republic||Region of Enrollment||participants|Number|257|257.0||||||
4375431|NCT00335452|4201853|B5|Croatia||Region of Enrollment||participants|Number|517|517.0||||||
4375432|NCT00335452|4201854|B4|Croatia||Region of Enrollment||participants|Number|114|114.0||||||
4375433|NCT00335452|4201855|B3|Croatia||Region of Enrollment||participants|Number|144|144.0||||||
4375434|NCT00335452|4201856|B2|Croatia||Region of Enrollment||participants|Number|145|145.0||||||
4375435|NCT00335452|4201857|B1|Croatia||Region of Enrollment||participants|Number|114|114.0||||||
4375436|NCT00335452|4201853|B5|China||Region of Enrollment||participants|Number|2017|2017.0||||||
4375437|NCT00335452|4201854|B4|China||Region of Enrollment||participants|Number|515|515.0||||||
4375438|NCT00335452|4201855|B3|China||Region of Enrollment||participants|Number|500|500.0||||||
4375439|NCT00335452|4201856|B2|China||Region of Enrollment||participants|Number|492|492.0||||||
4375440|NCT00335452|4201857|B1|China||Region of Enrollment||participants|Number|510|510.0||||||
4375441|NCT00335452|4201853|B5|Chile||Region of Enrollment||participants|Number|352|352.0||||||
4375442|NCT00335452|4201854|B4|Chile||Region of Enrollment||participants|Number|90|90.0||||||
4375443|NCT00335452|4201855|B3|Chile||Region of Enrollment||participants|Number|82|82.0||||||
4375444|NCT00335452|4201856|B2|Chile||Region of Enrollment||participants|Number|85|85.0||||||
4375445|NCT00335452|4201857|B1|Chile||Region of Enrollment||participants|Number|95|95.0||||||
4375446|NCT00335452|4201853|B5|Canada||Region of Enrollment||participants|Number|1448|1448.0||||||
4375447|NCT00335452|4201854|B4|Canada||Region of Enrollment||participants|Number|347|347.0||||||
4375448|NCT00335452|4201855|B3|Canada||Region of Enrollment||participants|Number|373|373.0||||||
4375449|NCT00335452|4201856|B2|Canada||Region of Enrollment||participants|Number|379|379.0||||||
4375450|NCT00335452|4201857|B1|Canada||Region of Enrollment||participants|Number|349|349.0||||||
4375451|NCT00335452|4201853|B5|Bulgaria||Region of Enrollment||participants|Number|470|470.0||||||
4375452|NCT00335452|4201854|B4|Bulgaria||Region of Enrollment||participants|Number|112|112.0||||||
4375453|NCT00335452|4201855|B3|Bulgaria||Region of Enrollment||participants|Number|125|125.0||||||
4375454|NCT00335452|4201856|B2|Bulgaria||Region of Enrollment||participants|Number|122|122.0||||||
4375455|NCT00335452|4201857|B1|Bulgaria||Region of Enrollment||participants|Number|111|111.0||||||
4375456|NCT00335452|4201853|B5|Brazil||Region of Enrollment||participants|Number|1125|1125.0||||||
4375457|NCT00335452|4201854|B4|Brazil||Region of Enrollment||participants|Number|288|288.0||||||
4375458|NCT00335452|4201855|B3|Brazil||Region of Enrollment||participants|Number|270|270.0||||||
4375459|NCT00335452|4201856|B2|Brazil||Region of Enrollment||participants|Number|275|275.0||||||
4375460|NCT00335452|4201857|B1|Brazil||Region of Enrollment||participants|Number|292|292.0||||||
4375461|NCT00335452|4201853|B5|Belgium||Region of Enrollment||participants|Number|228|228.0||||||
4375462|NCT00335452|4201854|B4|Belgium||Region of Enrollment||participants|Number|53|53.0||||||
4375463|NCT00335452|4201855|B3|Belgium||Region of Enrollment||participants|Number|59|59.0||||||
4375464|NCT00335452|4201856|B2|Belgium||Region of Enrollment||participants|Number|61|61.0||||||
4375465|NCT00335452|4201857|B1|Belgium||Region of Enrollment||participants|Number|55|55.0||||||
4375466|NCT00335452|4201853|B5|Austria||Region of Enrollment||participants|Number|151|151.0||||||
4375467|NCT00335452|4201854|B4|Austria||Region of Enrollment||participants|Number|40|40.0||||||
4375468|NCT00335452|4201855|B3|Austria||Region of Enrollment||participants|Number|35|35.0||||||
4375469|NCT00335452|4201856|B2|Austria||Region of Enrollment||participants|Number|35|35.0||||||
4375470|NCT00335452|4201857|B1|Austria||Region of Enrollment||participants|Number|41|41.0||||||
4375471|NCT00335452|4201853|B5|Australia||Region of Enrollment||participants|Number|388|388.0||||||
4375472|NCT00335452|4201854|B4|Australia||Region of Enrollment||participants|Number|95|95.0||||||
4375473|NCT00335452|4201855|B3|Australia||Region of Enrollment||participants|Number|96|96.0||||||
4375474|NCT00335452|4201856|B2|Australia||Region of Enrollment||participants|Number|100|100.0||||||
4375475|NCT00335452|4201857|B1|Australia||Region of Enrollment||participants|Number|97|97.0||||||
4375476|NCT00335452|4201853|B5|Argentina||Region of Enrollment||participants|Number|677|677.0||||||
4375477|NCT00335452|4201854|B4|Argentina||Region of Enrollment||participants|Number|174|174.0||||||
4375478|NCT00335452|4201855|B3|Argentina||Region of Enrollment||participants|Number|162|162.0||||||
4375479|NCT00335452|4201856|B2|Argentina||Region of Enrollment||participants|Number|159|159.0||||||
4375480|NCT00335452|4201857|B1|Argentina||Region of Enrollment||participants|Number|182|182.0||||||
4375481|NCT00335452|4201853|B5||Male|Sex: Female, Male||Participants|Count of Participants|18215|18215.0||||||
4375482|NCT00335452|4201854|B4||Male|Sex: Female, Male||Participants|Count of Participants|4511|4511.0||||||
4375483|NCT00335452|4201855|B3||Male|Sex: Female, Male||Participants|Count of Participants|4596|4596.0||||||
4375484|NCT00335452|4201856|B2||Male|Sex: Female, Male||Participants|Count of Participants|4498|4498.0||||||
4375485|NCT00335452|4201857|B1||Male|Sex: Female, Male||Participants|Count of Participants|4610|4610.0||||||
4375486|NCT00335452|4201853|B5||Female|Sex: Female, Male||Participants|Count of Participants|6871|6871.0||||||
4375487|NCT00335452|4201854|B4||Female|Sex: Female, Male||Participants|Count of Participants|1742|1742.0||||||
4375488|NCT00335452|4201855|B3||Female|Sex: Female, Male||Participants|Count of Participants|1671|1671.0||||||
4375489|NCT00335452|4201856|B2||Female|Sex: Female, Male||Participants|Count of Participants|1756|1756.0||||||
4375490|NCT00335452|4201857|B1||Female|Sex: Female, Male||Participants|Count of Participants|1702|1702.0||||||
4375491|NCT00335452|4201853|B5|Missing||Age, Customized||participants|Number|1|1.0||||||
4375492|NCT00335452|4201854|B4|Missing||Age, Customized||participants|Number|0|0.0||||||
4375493|NCT00335452|4201855|B3|Missing||Age, Customized||participants|Number|0|0.0||||||
4375494|NCT00335452|4201856|B2|Missing||Age, Customized||participants|Number|1|1.0||||||
4375495|NCT00335452|4201857|B1|Missing||Age, Customized||participants|Number|0|0.0||||||
4375496|NCT00335452|4201853|B5|≥ 75 years||Age, Customized||participants|Number|3796|3796.0||||||
4375497|NCT00335452|4201854|B4|≥ 75 years||Age, Customized||participants|Number|975|975.0||||||
4375498|NCT00335452|4201855|B3|≥ 75 years||Age, Customized||participants|Number|937|937.0||||||
4375499|NCT00335452|4201856|B2|≥ 75 years||Age, Customized||participants|Number|937|937.0||||||
4375500|NCT00335452|4201857|B1|≥ 75 years||Age, Customized||participants|Number|947|947.0||||||
4375501|NCT00335452|4201853|B5|65 - 74 years||Age, Customized||participants|Number|6235|6235.0||||||
4375502|NCT00335452|4201854|B4|65 - 74 years||Age, Customized||participants|Number|1543|1543.0||||||
4375503|NCT00335452|4201855|B3|65 - 74 years||Age, Customized||participants|Number|1543|1543.0||||||
4375504|NCT00335452|4201856|B2|65 - 74 years||Age, Customized||participants|Number|1576|1576.0||||||
4375505|NCT00335452|4201857|B1|65 - 74 years||Age, Customized||participants|Number|1573|1573.0||||||
4375506|NCT00335452|4201853|B5|< 65 years||Age, Customized||participants|Number|15054|15054.0||||||
4375507|NCT00335452|4201854|B4|< 65 years||Age, Customized||participants|Number|3735|3735.0||||||
4375508|NCT00335452|4201855|B3|< 65 years||Age, Customized||participants|Number|3787|3787.0||||||
4375509|NCT00335452|4201856|B2|< 65 years||Age, Customized||participants|Number|3740|3740.0||||||
4375510|NCT00335452|4201857|B1|< 65 years||Age, Customized||participants|Number|3792|3792.0||||||
4375511|NCT00335452|4201853|B5|||Age||years|Mean|61.3|61.3|Standard Deviation|11.8|11.8|||
4375512|NCT00335452|4201854|B4|||Age||years|Mean|61.4|61.4|Standard Deviation|11.9|11.9|||
4375513|NCT00335452|4201855|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|11.8|11.8|||
4375514|NCT00335452|4201856|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|11.7|11.7|||
4375515|NCT00335452|4201857|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|11.7|11.7|||
4375516|NCT00335322|4201882|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375517|NCT00335322|4201883|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375518|NCT00335322|4201884|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375519|NCT00335322|4201885|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375520|NCT00335322|4201882|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4375521|NCT00335322|4201883|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4375522|NCT00335322|4201884|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4375523|NCT00335322|4201885|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4375524|NCT00335322|4201882|B4||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4375525|NCT00335322|4201883|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4375526|NCT00335322|4201884|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4375527|NCT00335322|4201885|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4375528|NCT00335322|4201882|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4375529|NCT00335322|4201883|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4375530|NCT00335322|4201884|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4375531|NCT00335322|4201885|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4375532|NCT00335322|4201882|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375533|NCT00335322|4201883|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375534|NCT00335322|4201884|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375535|NCT00335322|4201885|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375536|NCT00335322|4201882|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4375537|NCT00335322|4201883|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4375538|NCT00335322|4201884|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4375539|NCT00335322|4201885|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4375540|NCT00335322|4201882|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375541|NCT00335322|4201883|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375542|NCT00335322|4201884|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375543|NCT00335322|4201885|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375544|NCT00335322|4201882|B4||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4375545|NCT00335322|4201883|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4375546|NCT00335322|4201884|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4375547|NCT00335322|4201885|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4375548|NCT00335322|4201882|B4||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4375549|NCT00335322|4201883|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4375550|NCT00335322|4201884|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4375551|NCT00335322|4201885|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4375552|NCT00335322|4201882|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4375553|NCT00335322|4201883|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4375554|NCT00335322|4201884|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4375555|NCT00335322|4201885|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4375556|NCT00335322|4201882|B4||Between 18 and 65 years|Age||Participants|Count of Participants|327|327.0||||||
4375557|NCT00335322|4201883|B3||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4375558|NCT00335322|4201884|B2||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4375559|NCT00335322|4201885|B1||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4375560|NCT00335322|4201882|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375561|NCT00335322|4201883|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375562|NCT00335322|4201884|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375563|NCT00335322|4201885|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375564|NCT00335283|4201895|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4375565|NCT00335283|4201896|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4375566|NCT00335283|4201897|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4375567|NCT00335283|4201895|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4375568|NCT00335283|4201896|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4375569|NCT00335283|4201897|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4375570|NCT00335283|4201895|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4375571|NCT00335283|4201896|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4375572|NCT00335283|4201897|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4375573|NCT00335283|4201895|B3|||Age||years|Mean|45|45.0|Standard Deviation|14|14.0|||
4375574|NCT00335283|4201896|B2|||Age||years|Mean|45|45.0|Standard Deviation|13|13.0|||
4375575|NCT00335283|4201897|B1|||Age||years|Mean|46|46.0|Standard Deviation|15|15.0|||
4375576|NCT00335283|4201895|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4375577|NCT00335283|4201896|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4375578|NCT00335283|4201897|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4375579|NCT00335283|4201895|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4375580|NCT00335283|4201896|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4375581|NCT00335283|4201897|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4375582|NCT00335283|4201895|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375583|NCT00335283|4201896|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375584|NCT00335283|4201897|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375585|NCT00335257|4201910|B4|Sweden||Region of Enrollment||participants|Number|2113|2113.0||||||
4375586|NCT00335257|4201911|B3|Sweden||Region of Enrollment||participants|Number|1454|1454.0||||||
4375587|NCT00335257|4201912|B2|Sweden||Region of Enrollment||participants|Number|398|398.0||||||
4375588|NCT00335257|4201913|B1|Sweden||Region of Enrollment||participants|Number|261|261.0||||||
4375589|NCT00335257|4201910|B4|Poland||Region of Enrollment||participants|Number|6290|6290.0||||||
4375590|NCT00335257|4201911|B3|Poland||Region of Enrollment||participants|Number|3664|3664.0||||||
4375591|NCT00335257|4201912|B2|Poland||Region of Enrollment||participants|Number|1457|1457.0||||||
4375592|NCT00335257|4201913|B1|Poland||Region of Enrollment||participants|Number|1169|1169.0||||||
4375593|NCT00335257|4201910|B4|Italy||Region of Enrollment||participants|Number|5728|5728.0||||||
4375594|NCT00335257|4201911|B3|Italy||Region of Enrollment||participants|Number|2657|2657.0||||||
4375595|NCT00335257|4201912|B2|Italy||Region of Enrollment||participants|Number|1427|1427.0||||||
4375596|NCT00335257|4201913|B1|Italy||Region of Enrollment||participants|Number|1644|1644.0||||||
4375597|NCT00335257|4201910|B4|Croatia||Region of Enrollment||participants|Number|948|948.0||||||
4375598|NCT00335257|4201911|B3|Croatia||Region of Enrollment||participants|Number|371|371.0||||||
4375599|NCT00335257|4201912|B2|Croatia||Region of Enrollment||participants|Number|68|68.0||||||
4375600|NCT00335257|4201913|B1|Croatia||Region of Enrollment||participants|Number|509|509.0||||||
4375601|NCT00335257|4201910|B4|Austria||Region of Enrollment||participants|Number|4294|4294.0||||||
4375602|NCT00335257|4201911|B3|Austria||Region of Enrollment||participants|Number|2945|2945.0||||||
4375603|NCT00335257|4201912|B2|Austria||Region of Enrollment||participants|Number|611|611.0||||||
4375604|NCT00335257|4201913|B1|Austria||Region of Enrollment||participants|Number|738|738.0||||||
4375605|NCT00335257|4201910|B4|United States||Region of Enrollment||participants|Number|52169|52169.0||||||
4375606|NCT00335257|4201911|B3|United States||Region of Enrollment||participants|Number|37892|37892.0||||||
4375607|NCT00335257|4201912|B2|United States||Region of Enrollment||participants|Number|3978|3978.0||||||
4375608|NCT00335257|4201913|B1|United States||Region of Enrollment||participants|Number|10299|10299.0||||||
4375609|NCT00335257|4201910|B4|Germany||Region of Enrollment||participants|Number|13567|13567.0||||||
4375610|NCT00335257|4201911|B3|Germany||Region of Enrollment||participants|Number|11207|11207.0||||||
4375611|NCT00335257|4201912|B2|Germany||Region of Enrollment||participants|Number|1438|1438.0||||||
4375612|NCT00335257|4201913|B1|Germany||Region of Enrollment||participants|Number|922|922.0||||||
4375613|NCT00335257|4201910|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375614|NCT00335257|4201911|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375615|NCT00335257|4201912|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375616|NCT00335257|4201913|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375617|NCT00335257|4201910|B4||Female|Sex: Female, Male||Participants|Count of Participants|85109|85109.0||||||
4375618|NCT00335257|4201911|B3||Female|Sex: Female, Male||Participants|Count of Participants|60190|60190.0||||||
4375619|NCT00335257|4201912|B2||Female|Sex: Female, Male||Participants|Count of Participants|9377|9377.0||||||
4375620|NCT00335257|4201913|B1||Female|Sex: Female, Male||Participants|Count of Participants|15542|15542.0||||||
4375621|NCT00335257|4201910|B4|||Age||years|Mean|26.29|26.29|Standard Deviation|7.69|7.69|||
4375622|NCT00335257|4201911|B3|||Age||years|Mean|26.34|26.34|Standard Deviation|7.73|7.73|||
4375623|NCT00335257|4201912|B2|||Age||years|Mean|26.14|26.14|Standard Deviation|7.48|7.48|||
4375624|NCT00335257|4201913|B1|||Age||years|Mean|26.21|26.21|Standard Deviation|7.64|7.64|||
4375625|NCT00335257|4201910|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4375626|NCT00335257|4201911|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4375627|NCT00335257|4201912|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4375628|NCT00335257|4201913|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4375629|NCT00335257|4201910|B4||Between 18 and 65 years|Age||Participants|Count of Participants|74323|74323.0||||||
4375630|NCT00335257|4201911|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52608|52608.0||||||
4375631|NCT00335257|4201912|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8227|8227.0||||||
4375632|NCT00335257|4201913|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13488|13488.0||||||
4375633|NCT00335257|4201910|B4||<=18 years|Age||Participants|Count of Participants|10785|10785.0||||||
4375634|NCT00335257|4201911|B3||<=18 years|Age||Participants|Count of Participants|7582|7582.0||||||
4375635|NCT00335257|4201912|B2||<=18 years|Age||Participants|Count of Participants|1149|1149.0||||||
4375636|NCT00335257|4201913|B1||<=18 years|Age||Participants|Count of Participants|2054|2054.0||||||
4375637|NCT00335153|4201932|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4375638|NCT00335153|4201932|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4375639|NCT00335153|4201932|B1|>=65 years||Age, Customized||participants|Number|183|183.0||||||
4375640|NCT00335153|4201932|B1|<65 years||Age, Customized||participants|Number|171|171.0||||||
4375641|NCT00335153|4201932|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|9.1|9.1|||
4375642|NCT00335140|4201969|B1||Missing/unknown|Other Medical Problems at Baseline||Participants|Count of Participants|2|2.0||||||
4375643|NCT00335140|4201969|B1||Past history of|Other Medical Problems at Baseline||Participants|Count of Participants|7|7.0||||||
4375644|NCT00335140|4201969|B1||Symptomatic or on medication|Other Medical Problems at Baseline||Participants|Count of Participants|7|7.0||||||
4375645|NCT00335140|4201969|B1||Never|Other Medical Problems at Baseline||Participants|Count of Participants|9|9.0||||||
4375646|NCT00335140|4201969|B1||Symptomatic or on medication|Cerebrovascular Disease||Participants|Count of Participants|4|4.0||||||
4375647|NCT00335140|4201969|B1||Never|Cerebrovascular Disease||Participants|Count of Participants|21|21.0||||||
4375648|NCT00335140|4201969|B1||Severe neurologic symptoms|Neurologic Function Status||Participants|Count of Participants|2|2.0||||||
4375649|NCT00335140|4201969|B1||Moderate symptoms/less than fully active|Neurologic Function Status||Participants|Count of Participants|7|7.0||||||
4375650|NCT00335140|4201969|B1||Moderate symptoms/fully active|Neurologic Function Status||Participants|Count of Participants|5|5.0||||||
4375651|NCT00335140|4201969|B1||Minor symptoms|Neurologic Function Status||Participants|Count of Participants|11|11.0||||||
4375652|NCT00335140|4201969|B1||No symptoms|Neurologic Function Status||Participants|Count of Participants|0|0.0||||||
4375653|NCT00335140|4201969|B1||3|ECOG Performance Status|"0 = Fully active, able to carry on all pre-disease performance without restriction~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~= Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~= Completely disabled; cannot carry on any selfcare; totally confined to bed or chair"|Participants|Count of Participants|4|4.0||||||
4375654|NCT00335140|4201969|B1||2|ECOG Performance Status|"0 = Fully active, able to carry on all pre-disease performance without restriction~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~= Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~= Completely disabled; cannot carry on any selfcare; totally confined to bed or chair"|Participants|Count of Participants|5|5.0||||||
4375655|NCT00335140|4201969|B1||1|ECOG Performance Status|"0 = Fully active, able to carry on all pre-disease performance without restriction~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~= Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~= Completely disabled; cannot carry on any selfcare; totally confined to bed or chair"|Participants|Count of Participants|15|15.0||||||
4375656|NCT00335140|4201969|B1||0|ECOG Performance Status|"0 = Fully active, able to carry on all pre-disease performance without restriction~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~= Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~= Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~= Completely disabled; cannot carry on any selfcare; totally confined to bed or chair"|Participants|Count of Participants|1|1.0||||||
4375657|NCT00335140|4201969|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4375658|NCT00335140|4201969|B1|Race|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4375659|NCT00335140|4201969|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4375660|NCT00335140|4201969|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4375661|NCT00335140|4201969|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4375662|NCT00335140|4201969|B1|Age|Age ≥ 60 years|Age, Customized|Older or younger than 60|Participants|Count of Participants|10|10.0||||||
4375663|NCT00335140|4201969|B1|Age|Age < 60 years|Age, Customized|Older or younger than 60|Participants|Count of Participants|15|15.0||||||
4375664|NCT00334958|4201973|B3|Other||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|3|3.0||||||
4375665|NCT00334958|4201974|B2|Other||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|3|3.0||||||
4375666|NCT00334958|4201975|B1|Other||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|0|0.0||||||
4375667|NCT00334958|4201973|B3|Asian/Pacific Islander||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|6|6.0||||||
4375668|NCT00334958|4201974|B2|Asian/Pacific Islander||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|2|2.0||||||
4375669|NCT00334958|4201975|B1|Asian/Pacific Islander||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|4|4.0||||||
4375670|NCT00334958|4201973|B3|Native American||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|2|2.0||||||
4375671|NCT00334958|4201974|B2|Native American||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|2|2.0||||||
4375672|NCT00334958|4201975|B1|Native American||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|0|0.0||||||
4375673|NCT00334958|4201973|B3|Hispanic||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|27|27.0||||||
4375674|NCT00334958|4201974|B2|Hispanic||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|14|14.0||||||
4375675|NCT00334958|4201975|B1|Hispanic||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|13|13.0||||||
4375676|NCT00334958|4201973|B3|White||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|285|285.0||||||
4375677|NCT00334958|4201974|B2|White||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|140|140.0||||||
4375678|NCT00334958|4201975|B1|White||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|145|145.0||||||
4375679|NCT00334958|4201973|B3|Black||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|33|33.0||||||
4375680|NCT00334958|4201974|B2|Black||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|19|19.0||||||
4375681|NCT00334958|4201975|B1|Black||Race/Ethnicity, Customized|Race (Safety population)|participants|Number|14|14.0||||||
4375682|NCT00334958|4201973|B3||Male|Sex: Female, Male|Safety population: All randomized subjects who received at least 1 dose of study medication|Participants|Count of Participants|167|167.0||||||
4375683|NCT00334958|4201974|B2||Male|Sex: Female, Male|Safety population: All randomized subjects who received at least 1 dose of study medication|Participants|Count of Participants|83|83.0||||||
4375684|NCT00334958|4201975|B1||Male|Sex: Female, Male|Safety population: All randomized subjects who received at least 1 dose of study medication|Participants|Count of Participants|84|84.0||||||
4375685|NCT00334958|4201973|B3||Female|Sex: Female, Male|Safety population: All randomized subjects who received at least 1 dose of study medication|Participants|Count of Participants|189|189.0||||||
4375686|NCT00334958|4201974|B2||Female|Sex: Female, Male|Safety population: All randomized subjects who received at least 1 dose of study medication|Participants|Count of Participants|97|97.0||||||
4375687|NCT00334958|4201975|B1||Female|Sex: Female, Male|Safety population: All randomized subjects who received at least 1 dose of study medication|Participants|Count of Participants|92|92.0||||||
4375688|NCT00334958|4201973|B3|>=65 years||Age, Customized|Safety population|participants|Number|12|12.0||||||
4375689|NCT00334958|4201974|B2|>=65 years||Age, Customized|Safety population|participants|Number|6|6.0||||||
4375690|NCT00334958|4201975|B1|>=65 years||Age, Customized|Safety population|participants|Number|6|6.0||||||
4375691|NCT00334958|4201973|B3|18 to <65 years||Age, Customized|Safety population|participants|Number|308|308.0||||||
4375692|NCT00334958|4201974|B2|18 to <65 years||Age, Customized|Safety population|participants|Number|153|153.0||||||
4375693|NCT00334958|4201975|B1|18 to <65 years||Age, Customized|Safety population|participants|Number|155|155.0||||||
4375694|NCT00334958|4201973|B3|12 to < 18 years||Age, Customized|Safety population|participants|Number|36|36.0||||||
4375695|NCT00334958|4201974|B2|12 to < 18 years||Age, Customized|Safety population|participants|Number|21|21.0||||||
4375696|NCT00334958|4201975|B1|12 to < 18 years||Age, Customized|Safety population|participants|Number|15|15.0||||||
4375697|NCT00334893|4201988|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4375698|NCT00334893|4201989|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4375699|NCT00334893|4201990|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4375700|NCT00334893|4201988|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375701|NCT00334893|4201989|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375702|NCT00334893|4201990|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375703|NCT00334893|4201988|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4375704|NCT00334893|4201989|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4375705|NCT00334893|4201990|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4375706|NCT00334893|4201988|B3|||Age||years|Median|60|60.0|Full Range|||38.0|80.0|
4375707|NCT00334893|4201989|B2|||Age||years|Median|60|60.0|Full Range|||45.0|77.0|
4375708|NCT00334893|4201990|B1|||Age||years|Median|61|61.0|Full Range|||38.0|80.0|
4375709|NCT00334893|4201988|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4375710|NCT00334893|4201989|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4375711|NCT00334893|4201990|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4375712|NCT00334893|4201988|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4375713|NCT00334893|4201989|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4375714|NCT00334893|4201990|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4375715|NCT00334893|4201988|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375716|NCT00334893|4201989|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375717|NCT00334893|4201990|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375718|NCT00334815|4201999|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4375719|NCT00334815|4202000|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4375720|NCT00334815|4202001|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4375721|NCT00334815|4201999|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375722|NCT00334815|4202000|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375723|NCT00334815|4202001|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375724|NCT00334815|4201999|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375725|NCT00334815|4202000|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375726|NCT00334815|4202001|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375727|NCT00334815|4201999|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4375728|NCT00334815|4202000|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4375729|NCT00334815|4202001|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4375730|NCT00334815|4201999|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4375731|NCT00334815|4202000|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4375732|NCT00334815|4202001|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4375733|NCT00334815|4201999|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375734|NCT00334815|4202000|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375735|NCT00334815|4202001|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375736|NCT00334815|4201999|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375737|NCT00334815|4202000|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375738|NCT00334815|4202001|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375739|NCT00334815|4201999|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375740|NCT00334815|4202000|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375741|NCT00334815|4202001|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375742|NCT00334815|4201999|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4375743|NCT00334815|4202000|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375744|NCT00334815|4202001|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4375745|NCT00334815|4201999|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4375746|NCT00334815|4202000|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4375747|NCT00334815|4202001|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4375748|NCT00334815|4201999|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375749|NCT00334815|4202000|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375750|NCT00334815|4202001|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4375751|NCT00334815|4201999|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4375752|NCT00334815|4202000|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4375753|NCT00334815|4202001|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4375754|NCT00334815|4201999|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4375755|NCT00334815|4202000|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4375756|NCT00334815|4202001|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4375757|NCT00334815|4201999|B3|||Age||years|Median|60.5|60.5|Full Range|||32.4|77.2|
4375758|NCT00334815|4202000|B2|||Age||years|Median|63.4|63.4|Full Range|||51.1|77.2|
4375759|NCT00334815|4202001|B1|||Age||years|Median|54.5|54.5|Full Range|||32.4|70.3|
4375760|NCT00334802|4202014|B3|||Height||centimeters|Mean|154.60|154.6|Standard Deviation|6.312|6.312|||
4375761|NCT00334802|4202015|B2|||Height||centimeters|Mean|154.71|154.71|Standard Deviation|6.184|6.184|||
4375762|NCT00334802|4202016|B1|||Height||centimeters|Mean|153.53|153.53|Standard Deviation|7.987|7.987|||
4375763|NCT00334802|4202014|B3|||Body Weight||kilograms|Mean|55.90|55.9|Standard Deviation|9.375|9.375|||
4375764|NCT00334802|4202015|B2|||Body Weight||kilograms|Mean|55.76|55.76|Standard Deviation|8.715|8.715|||
4375765|NCT00334802|4202016|B1|||Body Weight||kilograms|Mean|57.18|57.18|Standard Deviation|15.313|15.313|||
4375766|NCT00334802|4202014|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|8|8.0||||||
4375767|NCT00334802|4202015|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|6|6.0||||||
4375768|NCT00334802|4202016|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|2|2.0||||||
4375769|NCT00334802|4202014|B3|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|54|54.0||||||
4375770|NCT00334802|4202015|B2|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|50|50.0||||||
4375771|NCT00334802|4202016|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|4|4.0||||||
4375772|NCT00334802|4202014|B3|≥70 years old||Age at Primary Diagnosis||participants|Number|1|1.0||||||
4375773|NCT00334802|4202015|B2|≥70 years old||Age at Primary Diagnosis||participants|Number|1|1.0||||||
4375774|NCT00334802|4202016|B1|≥70 years old||Age at Primary Diagnosis||participants|Number|0|0.0||||||
4375775|NCT00334802|4202014|B3|60 to <70 years old||Age at Primary Diagnosis||participants|Number|10|10.0||||||
4375776|NCT00334802|4202015|B2|60 to <70 years old||Age at Primary Diagnosis||participants|Number|8|8.0||||||
4375777|NCT00334802|4202016|B1|60 to <70 years old||Age at Primary Diagnosis||participants|Number|2|2.0||||||
4375778|NCT00334802|4202014|B3|50 to <60 years old||Age at Primary Diagnosis||participants|Number|27|27.0||||||
4375779|NCT00334802|4202015|B2|50 to <60 years old||Age at Primary Diagnosis||participants|Number|24|24.0||||||
4375780|NCT00334802|4202016|B1|50 to <60 years old||Age at Primary Diagnosis||participants|Number|3|3.0||||||
4375781|NCT00334802|4202014|B3|40 to <50 years old||Age at Primary Diagnosis||participants|Number|21|21.0||||||
4375782|NCT00334802|4202015|B2|40 to <50 years old||Age at Primary Diagnosis||participants|Number|20|20.0||||||
4375783|NCT00334802|4202016|B1|40 to <50 years old||Age at Primary Diagnosis||participants|Number|1|1.0||||||
4375784|NCT00334802|4202014|B3|30 to <40 years old||Age at Primary Diagnosis||participants|Number|3|3.0||||||
4375785|NCT00334802|4202015|B2|30 to <40 years old||Age at Primary Diagnosis||participants|Number|3|3.0||||||
4375786|NCT00334802|4202016|B1|30 to <40 years old||Age at Primary Diagnosis||participants|Number|0|0.0||||||
4375787|NCT00334802|4202014|B3|<30 years old||Age at Primary Diagnosis||participants|Number|0|0.0||||||
4375788|NCT00334802|4202015|B2|<30 years old||Age at Primary Diagnosis||participants|Number|0|0.0||||||
4375789|NCT00334802|4202016|B1|<30 years old||Age at Primary Diagnosis||participants|Number|0|0.0||||||
4375790|NCT00334802|4202014|B3|Japan||Region of Enrollment||participants|Number|62|62.0||||||
4375791|NCT00334802|4202015|B2|Japan||Region of Enrollment||participants|Number|56|56.0||||||
4375792|NCT00334802|4202016|B1|Japan||Region of Enrollment||participants|Number|6|6.0||||||
4375793|NCT00334802|4202014|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375794|NCT00334802|4202015|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375795|NCT00334802|4202016|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375796|NCT00334802|4202014|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4375797|NCT00334802|4202015|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4375798|NCT00334802|4202016|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4375799|NCT00334802|4202014|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|8.46|8.46|||
4375800|NCT00334802|4202015|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|8.73|8.73|||
4375801|NCT00334802|4202016|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|4.49|4.49|||
4375802|NCT00334633|4202034|B4|United States||Region of Enrollment||participants|Number|593|593.0||||||
4375803|NCT00334633|4202035|B3|United States||Region of Enrollment||participants|Number|196|196.0||||||
4375804|NCT00334633|4202036|B2|United States||Region of Enrollment||participants|Number|200|200.0||||||
4375805|NCT00334633|4202037|B1|United States||Region of Enrollment||participants|Number|197|197.0||||||
4375806|NCT00334633|4202034|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375807|NCT00334633|4202035|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375808|NCT00334633|4202036|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375809|NCT00334633|4202037|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375810|NCT00334633|4202034|B4||Female|Sex: Female, Male||Participants|Count of Participants|593|593.0||||||
4375811|NCT00334633|4202035|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4375812|NCT00334633|4202036|B2||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4375813|NCT00334633|4202037|B1||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4375814|NCT00334633|4202034|B4|||Age||years|Mean|28.3|28.3|Standard Deviation|6.7|6.7|||
4375815|NCT00334633|4202035|B3|||Age||years|Mean|28.5|28.5|Standard Deviation|6.8|6.8|||
4375816|NCT00334633|4202036|B2|||Age||years|Mean|28.3|28.3|Standard Deviation|6.6|6.6|||
4375817|NCT00334633|4202037|B1|||Age||years|Mean|28|28.0|Standard Deviation|6.2|6.2|||
4375818|NCT00334633|4202034|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4375819|NCT00334633|4202035|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4375820|NCT00334633|4202036|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4375821|NCT00334633|4202037|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4375822|NCT00334633|4202034|B4||Between 18 and 65 years|Age||Participants|Count of Participants|593|593.0||||||
4375823|NCT00334633|4202035|B3||Between 18 and 65 years|Age||Participants|Count of Participants|196|196.0||||||
4375824|NCT00334633|4202036|B2||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
4375825|NCT00334633|4202037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|197|197.0||||||
4375826|NCT00334633|4202034|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375827|NCT00334633|4202035|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375828|NCT00334633|4202036|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375829|NCT00334633|4202037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375830|NCT00334542|4202050|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4375831|NCT00334542|4202050|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375832|NCT00334542|4202050|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4375833|NCT00334542|4202050|B1|||Age||years|Median|53|53.0|Full Range|||38.0|74.0|
4375834|NCT00334295|4202055|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4375835|NCT00334295|4202055|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4375836|NCT00334295|4202055|B1|||Age, Customized|post-menopausal|years|Median|69.5|69.5|Full Range|||45.0|83.0|
4375837|NCT00334282|4202063|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4375838|NCT00334282|4202064|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4375839|NCT00334282|4202065|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4375840|NCT00334282|4202063|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4375841|NCT00334282|4202064|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4375842|NCT00334282|4202065|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4375843|NCT00334282|4202063|B3|Asian||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4375844|NCT00334282|4202064|B2|Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4375845|NCT00334282|4202065|B1|Asian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4375846|NCT00334282|4202063|B3|White||Race/Ethnicity, Customized||participants|Number|374|374.0||||||
4375847|NCT00334282|4202064|B2|White||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
4375848|NCT00334282|4202065|B1|White||Race/Ethnicity, Customized||participants|Number|252|252.0||||||
4375849|NCT00334282|4202063|B3||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4375850|NCT00334282|4202064|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4375851|NCT00334282|4202065|B1||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4375852|NCT00334282|4202063|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4375853|NCT00334282|4202064|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4375854|NCT00334282|4202065|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4375855|NCT00334282|4202063|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|10.38|10.38|||
4375856|NCT00334282|4202064|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|11.04|11.04|||
4375857|NCT00334282|4202065|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|10.06|10.06|||
4375858|NCT00334204|4202089|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4375859|NCT00334204|4202089|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4375860|NCT00334204|4202089|B1|||Age||years|Mean|43.68|43.68|Standard Deviation|15|15.0|||
4375861|NCT00334113|4202095|B3|||7 Day Physical Activity Recall||minutes of physical activity in a week|Mean|355|355.0|Standard Deviation|339|339.0|||
4375862|NCT00334113|4202096|B2|||7 Day Physical Activity Recall||minutes of physical activity in a week|Mean|341|341.0|Standard Deviation|329|329.0|||
4375863|NCT00334113|4202097|B1|||7 Day Physical Activity Recall||minutes of physical activity in a week|Mean|370|370.0|Standard Deviation|251|251.0|||
4375864|NCT00334113|4202095|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4375865|NCT00334113|4202096|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4375866|NCT00334113|4202097|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4375867|NCT00334113|4202095|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4375868|NCT00334113|4202096|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4375869|NCT00334113|4202097|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4375870|NCT00334113|4202095|B3|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
4375871|NCT00334113|4202096|B2|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
4375872|NCT00334113|4202097|B1|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
4375873|NCT00334074|4202104|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4375874|NCT00334074|4202104|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4375875|NCT00334074|4202104|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4375876|NCT00334074|4202104|B1|||Age||years|Mean|64|64.0|Standard Deviation|21|21.0|||
4375877|NCT00334074|4202104|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4375878|NCT00334074|4202104|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4375879|NCT00334074|4202104|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375880|NCT00334061|4202109|B1|Europe||Region of Enrollment||participants|Number|49|49.0||||||
4375881|NCT00334061|4202109|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4375882|NCT00334061|4202109|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4375883|NCT00334061|4202109|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4375884|NCT00334061|4202109|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|13.5|13.5|||
4375885|NCT00334061|4202109|B1||>=65 years|Age||Participants|Count of Participants|71|71.0||||||
4375886|NCT00334061|4202109|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4375887|NCT00334061|4202109|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4375888|NCT00333983|4202118|B4|||Fugl-Meyer Upper Extremity Motor Assessment|The upper extremity portion of the Fugl-Meyer Motor Assessment has a range of 0 to 66 with 0 being the minimum score and 66 the maximum. A higher score indicates a better outcome.|units on a scale|Mean|18.0|18.0|Standard Deviation|12.5|12.5|||
4375889|NCT00333983|4202119|B3|||Fugl-Meyer Upper Extremity Motor Assessment|The upper extremity portion of the Fugl-Meyer Motor Assessment has a range of 0 to 66 with 0 being the minimum score and 66 the maximum. A higher score indicates a better outcome.|units on a scale|Mean|18.2|18.2|Standard Deviation|12.5|12.5|||
4375890|NCT00333983|4202120|B2|||Fugl-Meyer Upper Extremity Motor Assessment|The upper extremity portion of the Fugl-Meyer Motor Assessment has a range of 0 to 66 with 0 being the minimum score and 66 the maximum. A higher score indicates a better outcome.|units on a scale|Mean|16.5|16.5|Standard Deviation|10.6|10.6|||
4375891|NCT00333983|4202121|B1|||Fugl-Meyer Upper Extremity Motor Assessment|The upper extremity portion of the Fugl-Meyer Motor Assessment has a range of 0 to 66 with 0 being the minimum score and 66 the maximum. A higher score indicates a better outcome.|units on a scale|Mean|20.3|20.3|Standard Deviation|14.7|14.7|||
4375892|NCT00333983|4202118|B4|United States||Region of Enrollment||participants|Number|62|62.0||||||
4375893|NCT00333983|4202119|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4375894|NCT00333983|4202120|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4375895|NCT00333983|4202121|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4375896|NCT00333983|4202118|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4375897|NCT00333983|4202119|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4375898|NCT00333983|4202120|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4375899|NCT00333983|4202121|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4375900|NCT00333983|4202118|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4375901|NCT00333983|4202119|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4375902|NCT00333983|4202120|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4375903|NCT00333983|4202121|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4375904|NCT00333983|4202118|B4|||Age||years|Mean|57|57.0|Standard Deviation|11|11.0|||
4375905|NCT00333983|4202119|B3|||Age||years|Mean|56|56.0|Standard Deviation|6.3|6.3|||
4375906|NCT00333983|4202120|B2|||Age||years|Mean|60|60.0|Standard Deviation|13|13.0|||
4375907|NCT00333983|4202121|B1|||Age||years|Mean|57|57.0|Standard Deviation|12|12.0|||
4375908|NCT00333983|4202118|B4||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4375909|NCT00333983|4202119|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4375910|NCT00333983|4202120|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4375911|NCT00333983|4202121|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4375912|NCT00333983|4202118|B4||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4375913|NCT00333983|4202119|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4375914|NCT00333983|4202120|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4375915|NCT00333983|4202121|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4375916|NCT00333983|4202118|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375917|NCT00333983|4202119|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375918|NCT00333983|4202120|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375919|NCT00333983|4202121|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375920|NCT00333970|4202131|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4375921|NCT00333970|4202132|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4375922|NCT00333970|4202133|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4375923|NCT00333970|4202131|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4375924|NCT00333970|4202132|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4375925|NCT00333970|4202133|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4375926|NCT00333970|4202131|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4375927|NCT00333970|4202132|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4375928|NCT00333970|4202133|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4375929|NCT00333970|4202131|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4375930|NCT00333970|4202132|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4375931|NCT00333970|4202133|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4375932|NCT00333970|4202131|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375933|NCT00333970|4202132|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375934|NCT00333970|4202133|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375935|NCT00333879|4202140|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4375936|NCT00333879|4202140|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4375937|NCT00333879|4202140|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4375938|NCT00333879|4202140|B1|||Age||years|Mean|43|43.0|Standard Deviation|14.7|14.7|||
4375939|NCT00333879|4202140|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4375940|NCT00333879|4202140|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4375941|NCT00333879|4202140|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4375942|NCT00333866|4202145|B5|||Pain Visual Analogue Scale (VAS) Scores|Pain visual analog scale (VAS): Participants assessed the severity of their pain using a 100 mm visual analog scale (VAS). The scale ranged from 0 (no pain) to 100 (worst possible pain), measurement on a scale corresponds to the magnitude of their pain. Number of participants evaluable=184,184,181,186.|millimeter (mm)|Mean|71.88|71.88|Standard Deviation|13.72|13.72|||
4375943|NCT00333866|4202146|B4|||Pain Visual Analogue Scale (VAS) Scores|Pain visual analog scale (VAS): Participants assessed the severity of their pain using a 100 mm visual analog scale (VAS). The scale ranged from 0 (no pain) to 100 (worst possible pain), measurement on a scale corresponds to the magnitude of their pain. Number of participants evaluable=184,184,181,186.|millimeter (mm)|Mean|71.43|71.43|Standard Deviation|13.51|13.51|||
4375944|NCT00333866|4202147|B3|||Pain Visual Analogue Scale (VAS) Scores|Pain visual analog scale (VAS): Participants assessed the severity of their pain using a 100 mm visual analog scale (VAS). The scale ranged from 0 (no pain) to 100 (worst possible pain), measurement on a scale corresponds to the magnitude of their pain. Number of participants evaluable=184,184,181,186.|millimeter (mm)|Mean|70.92|70.92|Standard Deviation|13.69|13.69|||
4375945|NCT00333866|4202148|B2|||Pain Visual Analogue Scale (VAS) Scores|Pain visual analog scale (VAS): Participants assessed the severity of their pain using a 100 mm visual analog scale (VAS). The scale ranged from 0 (no pain) to 100 (worst possible pain), measurement on a scale corresponds to the magnitude of their pain. Number of participants evaluable=184,184,181,186.|millimeter (mm)|Mean|72.43|72.43|Standard Deviation|13.61|13.61|||
4375946|NCT00333866|4202149|B1|||Pain Visual Analogue Scale (VAS) Scores|Pain visual analog scale (VAS): Participants assessed the severity of their pain using a 100 mm visual analog scale (VAS). The scale ranged from 0 (no pain) to 100 (worst possible pain), measurement on a scale corresponds to the magnitude of their pain. Number of participants evaluable=184,184,181,186.|millimeter (mm)|Mean|72.72|72.72|Standard Deviation|14.09|14.09|||
4375947|NCT00333866|4202145|B5|HADS Depression (HADS-D) Total||Hospital Anxiety and Depression Scale (HADS)|HADS: participant rated questionnaire with 2 subscales. HADS-A assesses state of generalized anxiety (anxious mood, restlessness, anxious thoughts, panic attacks); HADS-D assesses state of lost interest and diminished pleasure response (lowering of hedonic tone). Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms. Number of participants evaluable=182,181,176,185.|Units on a scale|Mean|7.51|7.51|Standard Deviation|4.20|4.2|||
4375948|NCT00333866|4202146|B4|HADS Depression (HADS-D) Total||Hospital Anxiety and Depression Scale (HADS)|HADS: participant rated questionnaire with 2 subscales. HADS-A assesses state of generalized anxiety (anxious mood, restlessness, anxious thoughts, panic attacks); HADS-D assesses state of lost interest and diminished pleasure response (lowering of hedonic tone). Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms. Number of participants evaluable=182,181,176,185.|Units on a scale|Mean|7.39|7.39|Standard Deviation|4.28|4.28|||
4375949|NCT00333866|4202147|B3|HADS Depression (HADS-D) Total||Hospital Anxiety and Depression Scale (HADS)|HADS: participant rated questionnaire with 2 subscales. HADS-A assesses state of generalized anxiety (anxious mood, restlessness, anxious thoughts, panic attacks); HADS-D assesses state of lost interest and diminished pleasure response (lowering of hedonic tone). Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms. Number of participants evaluable=182,181,176,185.|Units on a scale|Mean|7.66|7.66|Standard Deviation|4.32|4.32|||
4375950|NCT00333866|4202148|B2|HADS Depression (HADS-D) Total||Hospital Anxiety and Depression Scale (HADS)|HADS: participant rated questionnaire with 2 subscales. HADS-A assesses state of generalized anxiety (anxious mood, restlessness, anxious thoughts, panic attacks); HADS-D assesses state of lost interest and diminished pleasure response (lowering of hedonic tone). Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms. Number of participants evaluable=182,181,176,185.|Units on a scale|Mean|7.16|7.16|Standard Deviation|4.03|4.03|||
4375951|NCT00333866|4202149|B1|HADS Depression (HADS-D) Total||Hospital Anxiety and Depression Scale (HADS)|HADS: participant rated questionnaire with 2 subscales. HADS-A assesses state of generalized anxiety (anxious mood, restlessness, anxious thoughts, panic attacks); HADS-D assesses state of lost interest and diminished pleasure response (lowering of hedonic tone). Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms. Number of participants evaluable=182,181,176,185.|Units on a scale|Mean|7.83|7.83|Standard Deviation|4.17|4.17|||
4375952|NCT00333866|4202145|B5|HADS Anxiety (HADS-A) Total||Hospital Anxiety and Depression Scale (HADS)|HADS: participant rated questionnaire with 2 subscales. HADS-A assesses state of generalized anxiety (anxious mood, restlessness, anxious thoughts, panic attacks); HADS-D assesses state of lost interest and diminished pleasure response (lowering of hedonic tone). Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms. Number of participants evaluable=182,181,176,185.|Units on a scale|Mean|8.88|8.88|Standard Deviation|4.51|4.51|||
4375953|NCT00333866|4202146|B4|HADS Anxiety (HADS-A) Total||Hospital Anxiety and Depression Scale (HADS)|HADS: participant rated questionnaire with 2 subscales. HADS-A assesses state of generalized anxiety (anxious mood, restlessness, anxious thoughts, panic attacks); HADS-D assesses state of lost interest and diminished pleasure response (lowering of hedonic tone). Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms. Number of participants evaluable=182,181,176,185.|Units on a scale|Mean|8.85|8.85|Standard Deviation|4.58|4.58|||
4375954|NCT00333866|4202147|B3|HADS Anxiety (HADS-A) Total||Hospital Anxiety and Depression Scale (HADS)|HADS: participant rated questionnaire with 2 subscales. HADS-A assesses state of generalized anxiety (anxious mood, restlessness, anxious thoughts, panic attacks); HADS-D assesses state of lost interest and diminished pleasure response (lowering of hedonic tone). Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms. Number of participants evaluable=182,181,176,185.|Units on a scale|Mean|8.75|8.75|Standard Deviation|4.44|4.44|||
4375955|NCT00333866|4202148|B2|HADS Anxiety (HADS-A) Total||Hospital Anxiety and Depression Scale (HADS)|HADS: participant rated questionnaire with 2 subscales. HADS-A assesses state of generalized anxiety (anxious mood, restlessness, anxious thoughts, panic attacks); HADS-D assesses state of lost interest and diminished pleasure response (lowering of hedonic tone). Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms. Number of participants evaluable=182,181,176,185.|Units on a scale|Mean|8.96|8.96|Standard Deviation|4.50|4.5|||
4375956|NCT00333866|4202149|B1|HADS Anxiety (HADS-A) Total||Hospital Anxiety and Depression Scale (HADS)|HADS: participant rated questionnaire with 2 subscales. HADS-A assesses state of generalized anxiety (anxious mood, restlessness, anxious thoughts, panic attacks); HADS-D assesses state of lost interest and diminished pleasure response (lowering of hedonic tone). Each subscale comprised of 7 items with range 0 (no presence of anxiety or depression) to 3 (severe feeling of anxiety or depression). Total score 0 to 21 for each subscale; higher score indicates greater severity of anxiety and depression symptoms. Number of participants evaluable=182,181,176,185.|Units on a scale|Mean|8.95|8.95|Standard Deviation|4.52|4.52|||
4375957|NCT00333866|4202145|B5|||Multidimensional Assessment of Fatigue (MAF)|MAF is a 16-item self-administered questionnaire that yields a Global Fatigue Index (GFI), measures 4 dimensions of fatigue: degree and severity, amount of distress it causes, its timing and degree to which fatigue interferes with activities of daily living. Only 15 items are used to calculate the GFI. GFI score range from 1 (no fatigue) to 50 (severe fatigue). Number of participants evaluable=183,176,175,181.|Units on a scale|Mean|34.68|34.68|Standard Deviation|7.80|7.8|||
4375958|NCT00333866|4202146|B4|||Multidimensional Assessment of Fatigue (MAF)|MAF is a 16-item self-administered questionnaire that yields a Global Fatigue Index (GFI), measures 4 dimensions of fatigue: degree and severity, amount of distress it causes, its timing and degree to which fatigue interferes with activities of daily living. Only 15 items are used to calculate the GFI. GFI score range from 1 (no fatigue) to 50 (severe fatigue). Number of participants evaluable=183,176,175,181.|Units on a scale|Mean|34.87|34.87|Standard Deviation|7.70|7.7|||
4375959|NCT00333866|4202147|B3|||Multidimensional Assessment of Fatigue (MAF)|MAF is a 16-item self-administered questionnaire that yields a Global Fatigue Index (GFI), measures 4 dimensions of fatigue: degree and severity, amount of distress it causes, its timing and degree to which fatigue interferes with activities of daily living. Only 15 items are used to calculate the GFI. GFI score range from 1 (no fatigue) to 50 (severe fatigue). Number of participants evaluable=183,176,175,181.|Units on a scale|Mean|33.98|33.98|Standard Deviation|8.29|8.29|||
4375960|NCT00333866|4202148|B2|||Multidimensional Assessment of Fatigue (MAF)|MAF is a 16-item self-administered questionnaire that yields a Global Fatigue Index (GFI), measures 4 dimensions of fatigue: degree and severity, amount of distress it causes, its timing and degree to which fatigue interferes with activities of daily living. Only 15 items are used to calculate the GFI. GFI score range from 1 (no fatigue) to 50 (severe fatigue). Number of participants evaluable=183,176,175,181.|Units on a scale|Mean|34.97|34.97|Standard Deviation|7.71|7.71|||
4376138|NCT00333840|4202210|B3|||Age||years|Median|51.0|51.0|Full Range|||18.0|70.0|
4376139|NCT00333840|4202211|B2|||Age||years|Median|51.0|51.0|Full Range|||18.0|70.0|
4376140|NCT00333840|4202212|B1|||Age||years|Median|50.0|50.0|Full Range|||18.0|70.0|
4375961|NCT00333866|4202149|B1|||Multidimensional Assessment of Fatigue (MAF)|MAF is a 16-item self-administered questionnaire that yields a Global Fatigue Index (GFI), measures 4 dimensions of fatigue: degree and severity, amount of distress it causes, its timing and degree to which fatigue interferes with activities of daily living. Only 15 items are used to calculate the GFI. GFI score range from 1 (no fatigue) to 50 (severe fatigue). Number of participants evaluable=183,176,175,181.|Units on a scale|Mean|34.89|34.89|Standard Deviation|7.52|7.52|||
4375962|NCT00333866|4202145|B5|Physical Component Score||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|32.35|32.35|Standard Deviation|7.55|7.55|||
4375963|NCT00333866|4202146|B4|Physical Component Score||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|32.42|32.42|Standard Deviation|7.03|7.03|||
4375964|NCT00333866|4202147|B3|Physical Component Score||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|32.51|32.51|Standard Deviation|8.16|8.16|||
4375965|NCT00333866|4202148|B2|Physical Component Score||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|32.60|32.6|Standard Deviation|7.43|7.43|||
4375966|NCT00333866|4202149|B1|Physical Component Score||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|31.87|31.87|Standard Deviation|7.59|7.59|||
4375967|NCT00333866|4202145|B5|Mental Component Score||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|40.43|40.43|Standard Deviation|12.13|12.13|||
4375968|NCT00333866|4202146|B4|Mental Component Score||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|40.37|40.37|Standard Deviation|12.14|12.14|||
4375969|NCT00333866|4202147|B3|Mental Component Score||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|40.79|40.79|Standard Deviation|13.15|13.15|||
4375970|NCT00333866|4202148|B2|Mental Component Score||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|40.45|40.45|Standard Deviation|11.72|11.72|||
4376141|NCT00333814|4202240|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4376142|NCT00333814|4202241|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4375971|NCT00333866|4202149|B1|Mental Component Score||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|40.11|40.11|Standard Deviation|11.57|11.57|||
4375972|NCT00333866|4202145|B5|General Health Perception||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|43.47|43.47|Standard Deviation|18.63|18.63|||
4375973|NCT00333866|4202146|B4|General Health Perception||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|44.58|44.58|Standard Deviation|18.23|18.23|||
4375974|NCT00333866|4202147|B3|General Health Perception||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|45.56|45.56|Standard Deviation|18.56|18.56|||
4375975|NCT00333866|4202148|B2|General Health Perception||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|42.12|42.12|Standard Deviation|19.24|19.24|||
4375976|NCT00333866|4202149|B1|General Health Perception||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|41.65|41.65|Standard Deviation|18.35|18.35|||
4375977|NCT00333866|4202145|B5|Vitality||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|27.63|27.63|Standard Deviation|18.39|18.39|||
4375978|NCT00333866|4202146|B4|Vitality||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|27.42|27.42|Standard Deviation|19.14|19.14|||
4375979|NCT00333866|4202147|B3|Vitality||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|28.78|28.78|Standard Deviation|19.94|19.94|||
4375980|NCT00333866|4202148|B2|Vitality||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|27.88|27.88|Standard Deviation|17.67|17.67|||
4376143|NCT00333814|4202242|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4375981|NCT00333866|4202149|B1|Vitality||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|26.46|26.46|Standard Deviation|16.76|16.76|||
4375982|NCT00333866|4202145|B5|Bodily Pain||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|28.74|28.74|Standard Deviation|14.03|14.03|||
4375983|NCT00333866|4202146|B4|Bodily Pain||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|28.70|28.7|Standard Deviation|13.20|13.2|||
4375984|NCT00333866|4202147|B3|Bodily Pain||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|28.30|28.3|Standard Deviation|13.62|13.62|||
4375985|NCT00333866|4202148|B2|Bodily Pain||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|28.67|28.67|Standard Deviation|13.65|13.65|||
4375986|NCT00333866|4202149|B1|Bodily Pain||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|29.28|29.28|Standard Deviation|15.61|15.61|||
4375987|NCT00333866|4202145|B5|Mental Health||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|56.78|56.78|Standard Deviation|20.77|20.77|||
4375988|NCT00333866|4202146|B4|Mental Health||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|56.71|56.71|Standard Deviation|20.39|20.39|||
4375989|NCT00333866|4202147|B3|Mental Health||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|57.56|57.56|Standard Deviation|21.70|21.7|||
4375990|NCT00333866|4202148|B2|Mental Health||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|56.41|56.41|Standard Deviation|20.49|20.49|||
4376144|NCT00333814|4202243|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4376145|NCT00333814|4202240|B4||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4375991|NCT00333866|4202149|B1|Mental Health||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|56.48|56.48|Standard Deviation|20.68|20.68|||
4375992|NCT00333866|4202145|B5|Social Functioning||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|54.72|54.72|Standard Deviation|26.24|26.24|||
4375993|NCT00333866|4202146|B4|Social Functioning||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|53.70|53.7|Standard Deviation|25.55|25.55|||
4375994|NCT00333866|4202147|B3|Social Functioning||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|53.93|53.93|Standard Deviation|26.55|26.55|||
4375995|NCT00333866|4202148|B2|Social Functioning||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|56.79|56.79|Standard Deviation|26.00|26.0|||
4375996|NCT00333866|4202149|B1|Social Functioning||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|54.44|54.44|Standard Deviation|26.95|26.95|||
4375997|NCT00333866|4202145|B5|Emotional Role Limitations||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|60.76|60.76|Standard Deviation|29.25|29.25|||
4375998|NCT00333866|4202146|B4|Emotional Role Limitations||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|61.31|61.31|Standard Deviation|29.50|29.5|||
4375999|NCT00333866|4202147|B3|Emotional Role Limitations||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|61.54|61.54|Standard Deviation|28.94|28.94|||
4376000|NCT00333866|4202148|B2|Emotional Role Limitations||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|60.61|60.61|Standard Deviation|29.23|29.23|||
4376146|NCT00333814|4202241|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4376001|NCT00333866|4202149|B1|Emotional Role Limitations||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|59.61|59.61|Standard Deviation|29.52|29.52|||
4376002|NCT00333866|4202145|B5|Physical Role Limitations||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|39.69|39.69|Standard Deviation|24.63|24.63|||
4376003|NCT00333866|4202146|B4|Physical Role Limitations||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|39.46|39.46|Standard Deviation|24.71|24.71|||
4376004|NCT00333866|4202147|B3|Physical Role Limitations||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|41.44|41.44|Standard Deviation|25.39|25.39|||
4376005|NCT00333866|4202148|B2|Physical Role Limitations||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|40.79|40.79|Standard Deviation|25.58|25.58|||
4376006|NCT00333866|4202149|B1|Physical Role Limitations||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|37.14|37.14|Standard Deviation|22.75|22.75|||
4376007|NCT00333866|4202145|B5|Physical Functioning||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|43.43|43.43|Standard Deviation|20.94|20.94|||
4376008|NCT00333866|4202146|B4|Physical Functioning||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|43.54|43.54|Standard Deviation|20.39|20.39|||
4376009|NCT00333866|4202147|B3|Physical Functioning||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|42.52|42.52|Standard Deviation|22.17|22.17|||
4376010|NCT00333866|4202148|B2|Physical Functioning||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|44.71|44.71|Standard Deviation|20.29|20.29|||
4376147|NCT00333814|4202242|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4376011|NCT00333866|4202149|B1|Physical Functioning||36-Item Short-Form Health Survey (SF-36)|SF-36 is a standardized survey evaluating 8 aspects of functional health and well being: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional and mental health. The score for a section is an average of the individual question scores, which are scaled 0-100 (100=highest level of functioning) and is reported as 2 summary scores; Physical Component Score and Mental Component Score. Total score range for the summary scores = 0-100, where higher score represents higher level of functioning. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|42.93|42.93|Standard Deviation|21.04|21.04|||
4376012|NCT00333866|4202145|B5|||Fibromyalgia Impact Questionnaire (FIQ) Total Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=184,184,179,186.|Units on a scale|Mean|61.08|61.08|Standard Deviation|14.52|14.52|||
4376013|NCT00333866|4202146|B4|||Fibromyalgia Impact Questionnaire (FIQ) Total Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=184,184,179,186.|Units on a scale|Mean|60.40|60.4|Standard Deviation|13.87|13.87|||
4376014|NCT00333866|4202147|B3|||Fibromyalgia Impact Questionnaire (FIQ) Total Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=184,184,179,186.|Units on a scale|Mean|60.59|60.59|Standard Deviation|14.59|14.59|||
4376015|NCT00333866|4202148|B2|||Fibromyalgia Impact Questionnaire (FIQ) Total Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=184,184,179,186.|Units on a scale|Mean|60.75|60.75|Standard Deviation|14.77|14.77|||
4376016|NCT00333866|4202149|B1|||Fibromyalgia Impact Questionnaire (FIQ) Total Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=184,184,179,186.|Units on a scale|Mean|62.58|62.58|Standard Deviation|14.85|14.85|||
4376017|NCT00333866|4202145|B5|FIQ Depression||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|4.76|4.76|Standard Deviation|3.01|3.01|||
4376018|NCT00333866|4202146|B4|FIQ Depression||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|4.65|4.65|Standard Deviation|3.00|3.0|||
4376019|NCT00333866|4202147|B3|FIQ Depression||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|4.79|4.79|Standard Deviation|3.01|3.01|||
4376020|NCT00333866|4202148|B2|FIQ Depression||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|4.73|4.73|Standard Deviation|2.93|2.93|||
4376115|NCT00333866|4202148|B2|||Mean Pain Score|Daily pain diary consists of 11-point numeric rating scale (NRS) ranging from 0(no pain) to 10(worst possible pain). Participants rated their pain during past 24 hours, self-assessment done daily at awakening. Baseline=Last 7 available pain scores before taking study medication up to and including Day 1. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|6.76|6.76|Standard Deviation|1.29|1.29|||
4376148|NCT00333814|4202243|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4376021|NCT00333866|4202149|B1|FIQ Depression||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|4.85|4.85|Standard Deviation|3.12|3.12|||
4376022|NCT00333866|4202145|B5|FIQ Anxiety||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|5.34|5.34|Standard Deviation|2.97|2.97|||
4376023|NCT00333866|4202146|B4|FIQ Anxiety||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|5.35|5.35|Standard Deviation|2.97|2.97|||
4376024|NCT00333866|4202147|B3|FIQ Anxiety||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|5.35|5.35|Standard Deviation|2.86|2.86|||
4376025|NCT00333866|4202148|B2|FIQ Anxiety||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|5.27|5.27|Standard Deviation|2.96|2.96|||
4376026|NCT00333866|4202149|B1|FIQ Anxiety||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|5.38|5.38|Standard Deviation|3.09|3.09|||
4376027|NCT00333866|4202145|B5|FIQ Stiffness||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.26|7.26|Standard Deviation|2.12|2.12|||
4376028|NCT00333866|4202146|B4|FIQ Stiffness||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.28|7.28|Standard Deviation|2.24|2.24|||
4376029|NCT00333866|4202147|B3|FIQ Stiffness||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.03|7.03|Standard Deviation|2.02|2.02|||
4376030|NCT00333866|4202148|B2|FIQ Stiffness||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.19|7.19|Standard Deviation|2.07|2.07|||
4376116|NCT00333866|4202149|B1|||Mean Pain Score|Daily pain diary consists of 11-point numeric rating scale (NRS) ranging from 0(no pain) to 10(worst possible pain). Participants rated their pain during past 24 hours, self-assessment done daily at awakening. Baseline=Last 7 available pain scores before taking study medication up to and including Day 1. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|6.68|6.68|Standard Deviation|1.48|1.48|||
4376031|NCT00333866|4202149|B1|FIQ Stiffness||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.52|7.52|Standard Deviation|2.13|2.13|||
4376032|NCT00333866|4202145|B5|FIQ Rested||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.58|7.58|Standard Deviation|2.02|2.02|||
4376033|NCT00333866|4202146|B4|FIQ Rested||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.44|7.44|Standard Deviation|2.02|2.02|||
4376034|NCT00333866|4202147|B3|FIQ Rested||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.55|7.55|Standard Deviation|1.96|1.96|||
4376035|NCT00333866|4202148|B2|FIQ Rested||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.61|7.61|Standard Deviation|2.08|2.08|||
4376036|NCT00333866|4202149|B1|FIQ Rested||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.71|7.71|Standard Deviation|2.03|2.03|||
4376037|NCT00333866|4202145|B5|FIQ Fatigue||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.55|7.55|Standard Deviation|2.02|2.02|||
4376038|NCT00333866|4202146|B4|FIQ Fatigue||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.56|7.56|Standard Deviation|2.04|2.04|||
4376039|NCT00333866|4202147|B3|FIQ Fatigue||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.34|7.34|Standard Deviation|2.02|2.02|||
4376040|NCT00333866|4202148|B2|FIQ Fatigue||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.45|7.45|Standard Deviation|2.14|2.14|||
4376117|NCT00333866|4202145|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4376118|NCT00333866|4202146|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4376119|NCT00333866|4202147|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4376120|NCT00333866|4202148|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4376041|NCT00333866|4202149|B1|FIQ Fatigue||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.85|7.85|Standard Deviation|1.84|1.84|||
4376042|NCT00333866|4202145|B5|FIQ Pain||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.21|7.21|Standard Deviation|1.58|1.58|||
4376043|NCT00333866|4202146|B4|FIQ Pain||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.15|7.15|Standard Deviation|1.60|1.6|||
4376044|NCT00333866|4202147|B3|FIQ Pain||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.09|7.09|Standard Deviation|1.62|1.62|||
4376045|NCT00333866|4202148|B2|FIQ Pain||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.24|7.24|Standard Deviation|1.48|1.48|||
4376046|NCT00333866|4202149|B1|FIQ Pain||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.35|7.35|Standard Deviation|1.63|1.63|||
4376047|NCT00333866|4202145|B5|FIQ Do Work||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|6.70|6.7|Standard Deviation|2.12|2.12|||
4376048|NCT00333866|4202146|B4|FIQ Do Work||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|6.62|6.62|Standard Deviation|2.01|2.01|||
4376049|NCT00333866|4202147|B3|FIQ Do Work||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|6.68|6.68|Standard Deviation|1.96|1.96|||
4376050|NCT00333866|4202148|B2|FIQ Do Work||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|6.54|6.54|Standard Deviation|2.23|2.23|||
4376121|NCT00333866|4202149|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4376122|NCT00333866|4202145|B5||Female|Sex: Female, Male||Participants|Count of Participants|673|673.0||||||
4376123|NCT00333866|4202146|B4||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4376124|NCT00333866|4202147|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4376051|NCT00333866|4202149|B1|FIQ Do Work||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|6.96|6.96|Standard Deviation|2.24|2.24|||
4376052|NCT00333866|4202145|B5|FIQ Work Missed||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|3.20|3.2|Standard Deviation|3.22|3.22|||
4376053|NCT00333866|4202146|B4|FIQ Work Missed||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|2.86|2.86|Standard Deviation|2.99|2.99|||
4376054|NCT00333866|4202147|B3|FIQ Work Missed||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|3.22|3.22|Standard Deviation|3.36|3.36|||
4376055|NCT00333866|4202148|B2|FIQ Work Missed||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|3.35|3.35|Standard Deviation|3.18|3.18|||
4376056|NCT00333866|4202149|B1|FIQ Work Missed||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|3.38|3.38|Standard Deviation|3.34|3.34|||
4376057|NCT00333866|4202145|B5|FIQ Feel Good||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.59|7.59|Standard Deviation|2.64|2.64|||
4376058|NCT00333866|4202146|B4|FIQ Feel Good||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.77|7.77|Standard Deviation|2.65|2.65|||
4376059|NCT00333866|4202147|B3|FIQ Feel Good||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.63|7.63|Standard Deviation|2.53|2.53|||
4376060|NCT00333866|4202148|B2|FIQ Feel Good||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.46|7.46|Standard Deviation|2.77|2.77|||
4376125|NCT00333866|4202148|B2||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4376126|NCT00333866|4202149|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4376127|NCT00333866|4202145|B5|||Age||years|Mean|48.5|48.5|Standard Deviation|11.2|11.2|||
4376128|NCT00333866|4202146|B4|||Age||years|Mean|49.6|49.6|Standard Deviation|11.3|11.3|||
4376061|NCT00333866|4202149|B1|FIQ Feel Good||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|7.50|7.5|Standard Deviation|2.61|2.61|||
4376062|NCT00333866|4202145|B5|FIQ Physical Impairment||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|3.88|3.88|Standard Deviation|2.14|2.14|||
4376063|NCT00333866|4202146|B4|FIQ Physical Impairment||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|3.75|3.75|Standard Deviation|2.15|2.15|||
4376064|NCT00333866|4202147|B3|FIQ Physical Impairment||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|3.87|3.87|Standard Deviation|2.12|2.12|||
4376065|NCT00333866|4202148|B2|FIQ Physical Impairment||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|3.88|3.88|Standard Deviation|2.13|2.13|||
4376066|NCT00333866|4202149|B1|FIQ Physical Impairment||Fibromyalgia Impact Questionnaire (FIQ) Subscale Scores|FIQ: 20-item self-administered questionnaire designed to assess areas such as health status, progress, and outcomes in participants with fibromyalgia. 11 items related to physical functioning, other items assess pain, fatigue, stiffness, difficulty working, and symptoms of anxiousness and depression. FIQ contains 10 sub-scales scored from 0 to 10, with higher scores indicating more impairment in the subscale attribute. Total score range from 0 to 100 with higher scores indicating more impairment. Number of participants evaluable=183,184,179,186.|Units on a scale|Mean|4.04|4.04|Standard Deviation|2.18|2.18|||
4376067|NCT00333866|4202145|B5|Overall Sleep Problem Index||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|58.22|58.22|Standard Deviation|18.38|18.38|||
4376068|NCT00333866|4202146|B4|Overall Sleep Problem Index||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|58.05|58.05|Standard Deviation|18.12|18.12|||
4376069|NCT00333866|4202147|B3|Overall Sleep Problem Index||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|58.11|58.11|Standard Deviation|18.94|18.94|||
4376070|NCT00333866|4202148|B2|Overall Sleep Problem Index||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|59.27|59.27|Standard Deviation|19.24|19.24|||
4376129|NCT00333866|4202147|B3|||Age||years|Mean|48.0|48.0|Standard Deviation|11.3|11.3|||
4376130|NCT00333866|4202148|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|10.8|10.8|||
4376131|NCT00333866|4202149|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|11.3|11.3|||
4376071|NCT00333866|4202149|B1|Overall Sleep Problem Index||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|57.46|57.46|Standard Deviation|17.27|17.27|||
4376072|NCT00333866|4202145|B5|Somnolence||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|42.77|42.77|Standard Deviation|23.09|23.09|||
4376073|NCT00333866|4202146|B4|Somnolence||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|42.97|42.97|Standard Deviation|23.92|23.92|||
4376074|NCT00333866|4202147|B3|Somnolence||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|42.37|42.37|Standard Deviation|23.91|23.91|||
4376075|NCT00333866|4202148|B2|Somnolence||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|44.03|44.03|Standard Deviation|22.80|22.8|||
4376076|NCT00333866|4202149|B1|Somnolence||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|41.68|41.68|Standard Deviation|21.78|21.78|||
4376077|NCT00333866|4202145|B5|Sleep Adequacy||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|24.62|24.62|Standard Deviation|23.79|23.79|||
4376078|NCT00333866|4202146|B4|Sleep Adequacy||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|25.03|25.03|Standard Deviation|24.25|24.25|||
4376079|NCT00333866|4202147|B3|Sleep Adequacy||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|24.30|24.3|Standard Deviation|22.83|22.83|||
4376080|NCT00333866|4202148|B2|Sleep Adequacy||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|24.43|24.43|Standard Deviation|24.80|24.8|||
4376132|NCT00333840|4202210|B3||Male|Sex: Female, Male||Participants|Count of Participants|652|652.0||||||
4376133|NCT00333840|4202211|B2||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4376081|NCT00333866|4202149|B1|Sleep Adequacy||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|24.70|24.7|Standard Deviation|23.39|23.39|||
4376082|NCT00333866|4202145|B5|Quantity of Sleep||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|5.53|5.53|Standard Deviation|1.63|1.63|||
4376083|NCT00333866|4202146|B4|Quantity of Sleep||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|5.45|5.45|Standard Deviation|1.65|1.65|||
4376084|NCT00333866|4202147|B3|Quantity of Sleep||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|5.61|5.61|Standard Deviation|1.68|1.68|||
4376085|NCT00333866|4202148|B2|Quantity of Sleep||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|5.59|5.59|Standard Deviation|1.66|1.66|||
4376086|NCT00333866|4202149|B1|Quantity of Sleep||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|5.47|5.47|Standard Deviation|1.54|1.54|||
4376087|NCT00333866|4202145|B5|Shortness of Breath, Headache||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|36.55|36.55|Standard Deviation|31.97|31.97|||
4376088|NCT00333866|4202146|B4|Shortness of Breath, Headache||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|37.07|37.07|Standard Deviation|31.54|31.54|||
4376089|NCT00333866|4202147|B3|Shortness of Breath, Headache||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|38.31|38.31|Standard Deviation|32.46|32.46|||
4376090|NCT00333866|4202148|B2|Shortness of Breath, Headache||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|36.70|36.7|Standard Deviation|31.01|31.01|||
4376134|NCT00333840|4202212|B1||Male|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4376091|NCT00333866|4202149|B1|Shortness of Breath, Headache||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|34.18|34.18|Standard Deviation|32.96|32.96|||
4376092|NCT00333866|4202145|B5|Snoring||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|31.36|31.36|Standard Deviation|31.94|31.94|||
4376093|NCT00333866|4202146|B4|Snoring||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|32.09|32.09|Standard Deviation|32.20|32.2|||
4376094|NCT00333866|4202147|B3|Snoring||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|29.77|29.77|Standard Deviation|32.52|32.52|||
4376095|NCT00333866|4202148|B2|Snoring||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|32.53|32.53|Standard Deviation|30.82|30.82|||
4376096|NCT00333866|4202149|B1|Snoring||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|31.05|31.05|Standard Deviation|32.39|32.39|||
4376097|NCT00333866|4202145|B5|Sleep Disturbance||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|60.47|60.47|Standard Deviation|25.72|25.72|||
4376098|NCT00333866|4202146|B4|Sleep Disturbance||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|60.37|60.37|Standard Deviation|25.09|25.09|||
4376099|NCT00333866|4202147|B3|Sleep Disturbance||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|59.59|59.59|Standard Deviation|26.55|26.55|||
4376100|NCT00333866|4202148|B2|Sleep Disturbance||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|61.86|61.86|Standard Deviation|25.80|25.8|||
4376135|NCT00333840|4202210|B3||Female|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
4376136|NCT00333840|4202211|B2||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4376101|NCT00333866|4202149|B1|Sleep Disturbance||Medical Outcome Study Sleep Scale (MOS-SS)|Participant-rated 12 item questionnaire assess constructs of sleep over past week.7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence (range:0-100); sleep quantity(range:0-24), optimal sleep(yes or no), as well as a 9-item overall sleep problems index. Except Adequacy, Optimal, Quantity of sleep, higher scores=more impairment. Scores transformed(actual raw score minus lowest possible score divided by possible raw score range*100);total score range:0-100,higher score=more intensity of attribute. Number of participants evaluable=183,183,177,185.|Units on a scale|Mean|60.02|60.02|Standard Deviation|25.60|25.6|||
4376102|NCT00333866|4202145|B5|||Percentage of Participants With Optimal Sleep Assessed Using MOS-SS|MOS-SS: participant-rated 12 item questionnaire to assess constructs of sleep over past week. It included 7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence, sleep quantity and optimal sleep. Participants responded whether their sleep was optimal or not by choosing yes or no. Percentage of participants with optimal sleep are reported. Number of participants evaluable=182,182,175,182.|Percentage of Participants|Number|87.2|87.2||||||
4376103|NCT00333866|4202146|B4|||Percentage of Participants With Optimal Sleep Assessed Using MOS-SS|MOS-SS: participant-rated 12 item questionnaire to assess constructs of sleep over past week. It included 7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence, sleep quantity and optimal sleep. Participants responded whether their sleep was optimal or not by choosing yes or no. Percentage of participants with optimal sleep are reported. Number of participants evaluable=182,182,175,182.|Percentage of Participants|Number|17.03|17.03||||||
4376104|NCT00333866|4202147|B3|||Percentage of Participants With Optimal Sleep Assessed Using MOS-SS|MOS-SS: participant-rated 12 item questionnaire to assess constructs of sleep over past week. It included 7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence, sleep quantity and optimal sleep. Participants responded whether their sleep was optimal or not by choosing yes or no. Percentage of participants with optimal sleep are reported. Number of participants evaluable=182,182,175,182.|Percentage of Participants|Number|24.57|24.57||||||
4376105|NCT00333866|4202148|B2|||Percentage of Participants With Optimal Sleep Assessed Using MOS-SS|MOS-SS: participant-rated 12 item questionnaire to assess constructs of sleep over past week. It included 7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence, sleep quantity and optimal sleep. Participants responded whether their sleep was optimal or not by choosing yes or no. Percentage of participants with optimal sleep are reported. Number of participants evaluable=182,182,175,182.|Percentage of Participants|Number|25.27|25.27||||||
4376106|NCT00333866|4202149|B1|||Percentage of Participants With Optimal Sleep Assessed Using MOS-SS|MOS-SS: participant-rated 12 item questionnaire to assess constructs of sleep over past week. It included 7 subscales: sleep disturbance, snoring, awakened short of breath, sleep adequacy, somnolence, sleep quantity and optimal sleep. Participants responded whether their sleep was optimal or not by choosing yes or no. Percentage of participants with optimal sleep are reported. Number of participants evaluable=182,182,175,182.|Percentage of Participants|Number|20.33|20.33||||||
4376107|NCT00333866|4202145|B5|||Mean Sleep Quality Score|Daily quality of sleep diary consists of 11-point NRS ranging from 0(best possible sleep) to 10(worst possible sleep). Participants rated their quality of sleep during past 24 hours, self-assessment done daily upon awakening. Baseline=Last 7 available scores before taking study medication up to and including Day 1. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|5.95|5.95|Standard Deviation|1.77|1.77|||
4376108|NCT00333866|4202146|B4|||Mean Sleep Quality Score|Daily quality of sleep diary consists of 11-point NRS ranging from 0(best possible sleep) to 10(worst possible sleep). Participants rated their quality of sleep during past 24 hours, self-assessment done daily upon awakening. Baseline=Last 7 available scores before taking study medication up to and including Day 1. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|5.91|5.91|Standard Deviation|1.80|1.8|||
4376109|NCT00333866|4202147|B3|||Mean Sleep Quality Score|Daily quality of sleep diary consists of 11-point NRS ranging from 0(best possible sleep) to 10(worst possible sleep). Participants rated their quality of sleep during past 24 hours, self-assessment done daily upon awakening. Baseline=Last 7 available scores before taking study medication up to and including Day 1. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|5.94|5.94|Standard Deviation|1.70|1.7|||
4376110|NCT00333866|4202148|B2|||Mean Sleep Quality Score|Daily quality of sleep diary consists of 11-point NRS ranging from 0(best possible sleep) to 10(worst possible sleep). Participants rated their quality of sleep during past 24 hours, self-assessment done daily upon awakening. Baseline=Last 7 available scores before taking study medication up to and including Day 1. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|5.94|5.94|Standard Deviation|1.70|1.7|||
4376111|NCT00333866|4202149|B1|||Mean Sleep Quality Score|Daily quality of sleep diary consists of 11-point NRS ranging from 0(best possible sleep) to 10(worst possible sleep). Participants rated their quality of sleep during past 24 hours, self-assessment done daily upon awakening. Baseline=Last 7 available scores before taking study medication up to and including Day 1. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|6.01|6.01|Standard Deviation|1.90|1.9|||
4376112|NCT00333866|4202145|B5|||Mean Pain Score|Daily pain diary consists of 11-point numeric rating scale (NRS) ranging from 0(no pain) to 10(worst possible pain). Participants rated their pain during past 24 hours, self-assessment done daily at awakening. Baseline=Last 7 available pain scores before taking study medication up to and including Day 1. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|6.65|6.65|Standard Deviation|1.36|1.36|||
4376113|NCT00333866|4202146|B4|||Mean Pain Score|Daily pain diary consists of 11-point numeric rating scale (NRS) ranging from 0(no pain) to 10(worst possible pain). Participants rated their pain during past 24 hours, self-assessment done daily at awakening. Baseline=Last 7 available pain scores before taking study medication up to and including Day 1. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|6.59|6.59|Standard Deviation|1.37|1.37|||
4376114|NCT00333866|4202147|B3|||Mean Pain Score|Daily pain diary consists of 11-point numeric rating scale (NRS) ranging from 0(no pain) to 10(worst possible pain). Participants rated their pain during past 24 hours, self-assessment done daily at awakening. Baseline=Last 7 available pain scores before taking study medication up to and including Day 1. Number of participants evaluable=184,184,181,186.|Units on a scale|Mean|6.57|6.57|Standard Deviation|1.31|1.31|||
4376137|NCT00333840|4202212|B1||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4376149|NCT00333814|4202240|B4|>65 years||Age, Customized||Participants|Number|19|19.0||||||
4376150|NCT00333814|4202241|B3|>65 years||Age, Customized||Participants|Number|8|8.0||||||
4376151|NCT00333814|4202242|B2|>65 years||Age, Customized||Participants|Number|6|6.0||||||
4376152|NCT00333814|4202243|B1|>65 years||Age, Customized||Participants|Number|5|5.0||||||
4376153|NCT00333814|4202240|B4|Between 45 and 65 years||Age, Customized||Participants|Number|87|87.0||||||
4376154|NCT00333814|4202241|B3|Between 45 and 65 years||Age, Customized||Participants|Number|27|27.0||||||
4376155|NCT00333814|4202242|B2|Between 45 and 65 years||Age, Customized||Participants|Number|28|28.0||||||
4376156|NCT00333814|4202243|B1|Between 45 and 65 years||Age, Customized||Participants|Number|32|32.0||||||
4376157|NCT00333814|4202240|B4|<45 years||Age, Customized||Participants|Number|123|123.0||||||
4376158|NCT00333814|4202241|B3|<45 years||Age, Customized||Participants|Number|41|41.0||||||
4376159|NCT00333814|4202242|B2|<45 years||Age, Customized||Participants|Number|43|43.0||||||
4376160|NCT00333814|4202243|B1|<45 years||Age, Customized||Participants|Number|39|39.0||||||
4376161|NCT00333801|4202259|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4376162|NCT00333801|4202260|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4376163|NCT00333801|4202261|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4376164|NCT00333801|4202259|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4376165|NCT00333801|4202260|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4376166|NCT00333801|4202261|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4376167|NCT00333801|4202259|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|12.2|12.2|||
4376168|NCT00333801|4202260|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|11.9|11.9|||
4376169|NCT00333801|4202261|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|12.5|12.5|||
4376170|NCT00333788|4202280|B1|Sweden||Region of Enrollment|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|participants|Number|2|2.0||||||
4376171|NCT00333788|4202280|B1|Italy||Region of Enrollment|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|participants|Number|24|24.0||||||
4376172|NCT00333788|4202280|B1|Switzerland||Region of Enrollment|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|participants|Number|4|4.0||||||
4376173|NCT00333788|4202280|B1|United Kingdom||Region of Enrollment|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|participants|Number|9|9.0||||||
4376174|NCT00333788|4202280|B1|Germany||Region of Enrollment|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|participants|Number|34|34.0||||||
4376175|NCT00333788|4202280|B1|Netherlands||Region of Enrollment|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|participants|Number|2|2.0||||||
4376176|NCT00333788|4202280|B1|Austria||Region of Enrollment|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|participants|Number|8|8.0||||||
4376177|NCT00333788|4202280|B1|Belgium||Region of Enrollment|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|participants|Number|30|30.0||||||
4376178|NCT00333788|4202280|B1|Spain||Region of Enrollment|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|participants|Number|6|6.0||||||
4376179|NCT00333788|4202280|B1|Canada||Region of Enrollment|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|participants|Number|20|20.0||||||
4376180|NCT00333788|4202280|B1|United States||Region of Enrollment|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|participants|Number|70|70.0||||||
4376181|NCT00333788|4202280|B1|France||Region of Enrollment|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|participants|Number|20|20.0||||||
4376182|NCT00333788|4202280|B1||Male|Sex: Female, Male|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|Participants|Count of Participants|83|83.0||||||
4376183|NCT00333788|4202280|B1||Female|Sex: Female, Male|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|Participants|Count of Participants|146|146.0||||||
4376184|NCT00333788|4202280|B1|||Age|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|years|Mean|31.8|31.8|Standard Deviation|11.6|11.6|||
4376185|NCT00333788|4202280|B1||>=65 years|Age|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|Participants|Count of Participants|4|4.0||||||
4376186|NCT00333788|4202280|B1||Between 18 and 65 years|Age|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|Participants|Count of Participants|224|224.0||||||
4376187|NCT00333788|4202280|B1||<=18 years|Age|Baseline characteristics are based on the ITT population; Participant flow is based on the All Subjects population.|Participants|Count of Participants|1|1.0||||||
4376188|NCT00333775|4202307|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376189|NCT00333775|4202308|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376190|NCT00333775|4202309|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376191|NCT00333775|4202310|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376192|NCT00333775|4202307|B4||Female|Sex: Female, Male||Participants|Count of Participants|736|736.0||||||
4376193|NCT00333775|4202308|B3||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4376194|NCT00333775|4202309|B2||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4376195|NCT00333775|4202310|B1||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4376196|NCT00333775|4202307|B4|||Age||years|Mean|53.7|53.7|Standard Deviation|10.61|10.61|||
4376197|NCT00333775|4202308|B3|||Age||years|Mean|53.6|53.6|Standard Deviation|10.78|10.78|||
4376198|NCT00333775|4202309|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|10.61|10.61|||
4376199|NCT00333775|4202310|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|10.47|10.47|||
4376200|NCT00333762|4202332|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4376201|NCT00333762|4202332|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4376202|NCT00333762|4202332|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376203|NCT00333762|4202332|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4376204|NCT00333762|4202332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4376205|NCT00333762|4202332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376206|NCT00333710|4202336|B4|United States||Region of Enrollment||participants|Number|53|53.0||||||
4376207|NCT00333710|4202337|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4376208|NCT00333710|4202338|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4376209|NCT00333710|4202339|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4376210|NCT00333710|4202336|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4376211|NCT00333710|4202337|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4376212|NCT00333710|4202338|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4376213|NCT00333710|4202339|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4376214|NCT00333710|4202336|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4376215|NCT00333710|4202337|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376216|NCT00333710|4202338|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4376217|NCT00333710|4202339|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4376218|NCT00333710|4202336|B4|||Age||years|Mean|53.85|53.85|Standard Deviation|5.64|5.64|||
4376219|NCT00333710|4202337|B3|||Age||years|Mean|55|55.0|Standard Deviation|6.80|6.8|||
4376220|NCT00333710|4202338|B2|||Age||years|Mean|52.28|52.28|Standard Deviation|5.19|5.19|||
4376221|NCT00333710|4202339|B1|||Age||years|Mean|54.37|54.37|Standard Deviation|4.89|4.89|||
4376222|NCT00333619|4202349|B3|||Sleep efficiency|Average sleep efficiency calculated from 7 days of actigraphy. Sleep efficiency for each night is calculated as the number of hours asleep divided by the number of hours in bed.|Percentage of time asleep while in bed|Mean|68.6|68.6|Standard Deviation|19.3|19.3|||
4376223|NCT00333619|4202350|B2|||Sleep efficiency|Average sleep efficiency calculated from 7 days of actigraphy. Sleep efficiency for each night is calculated as the number of hours asleep divided by the number of hours in bed.|Percentage of time asleep while in bed|Mean|66.7|66.7|Standard Deviation|20.2|20.2|||
4376224|NCT00333619|4202351|B1|||Sleep efficiency|Average sleep efficiency calculated from 7 days of actigraphy. Sleep efficiency for each night is calculated as the number of hours asleep divided by the number of hours in bed.|Percentage of time asleep while in bed|Mean|70.3|70.3|Standard Deviation|18.2|18.2|||
4376225|NCT00333619|4202349|B3|||Pittsburgh Sleep Quality Index|The PSQI is a 18-item questionnaire that measures subjective sleep quality and sleep disturbances (total score ranging from 0 – 21; score > 8 indicates poor sleep quality).|units on a scale; 0-21|Mean|8.4|8.4|Standard Deviation|4.5|4.5|||
4376226|NCT00333619|4202350|B2|||Pittsburgh Sleep Quality Index|The PSQI is a 18-item questionnaire that measures subjective sleep quality and sleep disturbances (total score ranging from 0 – 21; score > 8 indicates poor sleep quality).|units on a scale; 0-21|Mean|9.2|9.2|Standard Deviation|4.3|4.3|||
4376227|NCT00333619|4202351|B1|||Pittsburgh Sleep Quality Index|The PSQI is a 18-item questionnaire that measures subjective sleep quality and sleep disturbances (total score ranging from 0 – 21; score > 8 indicates poor sleep quality).|units on a scale; 0-21|Mean|7.9|7.9|Standard Deviation|4.1|4.1|||
4376228|NCT00333619|4202349|B3||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4376229|NCT00333619|4202350|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4376230|NCT00333619|4202351|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4376231|NCT00333619|4202349|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4376232|NCT00333619|4202350|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4376233|NCT00333619|4202351|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4376234|NCT00333619|4202349|B3|||Age||years|Mean|72.4|72.4|Standard Deviation|9.98|9.98|||
4376235|NCT00333619|4202350|B2|||Age||years|Mean|73.32|73.32|Standard Deviation|10.12|10.12|||
4376236|NCT00333619|4202351|B1|||Age||years|Mean|71.39|71.39|Standard Deviation|9.78|9.78|||
4376237|NCT00333437|4202360|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4376238|NCT00333437|4202360|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4376239|NCT00333437|4202360|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4376240|NCT00333437|4202360|B1|||Age||years|Mean|52.57|52.57|Standard Deviation|7.52|7.52|||
4376241|NCT00333437|4202360|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4376242|NCT00333437|4202360|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4376243|NCT00333437|4202360|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376244|NCT00333359|4202368|B3|Unknown||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|3|3.0||||||
4376303|NCT00332722|4202494|B1|||duration of pain||months|Mean|120|120.0|Standard Deviation|122|122.0|||
4376304|NCT00332722|4202492|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4376245|NCT00333359|4202369|B2|Unknown||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|3|3.0||||||
4376246|NCT00333359|4202370|B1|Unknown||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|0|0.0||||||
4376247|NCT00333359|4202368|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|1|1.0||||||
4376248|NCT00333359|4202369|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|0|0.0||||||
4376249|NCT00333359|4202370|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|1|1.0||||||
4376250|NCT00333359|4202368|B3|Black or African American||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|7|7.0||||||
4376251|NCT00333359|4202369|B2|Black or African American||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|5|5.0||||||
4376252|NCT00333359|4202370|B1|Black or African American||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|2|2.0||||||
4376253|NCT00333359|4202368|B3|Asian||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|4|4.0||||||
4376254|NCT00333359|4202369|B2|Asian||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|3|3.0||||||
4376255|NCT00333359|4202370|B1|Asian||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|1|1.0||||||
4376256|NCT00333359|4202368|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|6|6.0||||||
4376257|NCT00333359|4202369|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|5|5.0||||||
4376258|NCT00333359|4202370|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|1|1.0||||||
4376259|NCT00333359|4202368|B3|White or Caucasian||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|552|552.0||||||
4376260|NCT00333359|4202369|B2|White or Caucasian||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|360|360.0||||||
4376261|NCT00333359|4202370|B1|White or Caucasian||Race/Ethnicity, Customized|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|participants|Number|192|192.0||||||
4376305|NCT00332722|4202493|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4376306|NCT00332722|4202494|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4376307|NCT00332722|4202492|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4376262|NCT00333359|4202368|B3||Male|Sex: Female, Male|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|237|237.0||||||
4376263|NCT00333359|4202369|B2||Male|Sex: Female, Male|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|159|159.0||||||
4376264|NCT00333359|4202370|B1||Male|Sex: Female, Male|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|78|78.0||||||
4376265|NCT00333359|4202368|B3||Female|Sex: Female, Male|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|336|336.0||||||
4376266|NCT00333359|4202369|B2||Female|Sex: Female, Male|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|217|217.0||||||
4376267|NCT00333359|4202370|B1||Female|Sex: Female, Male|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|Participants|Count of Participants|119|119.0||||||
4376268|NCT00333359|4202368|B3|||Age|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|Years|Mean|50.2|50.2|Standard Deviation|11.89|11.89|||
4376269|NCT00333359|4202369|B2|||Age|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|Years|Mean|50.6|50.6|Standard Deviation|11.82|11.82|||
4376270|NCT00333359|4202370|B1|||Age|The Safety Population, consisting of all participants who were enrolled in the study and took at least 1 dose (or any portion of a dose) of study medication, was used for summarizing all baseline characteristics. Eight enrolled participants did not meet the criteria for inclusion in the Safety Population.|Years|Mean|49.5|49.5|Standard Deviation|12.03|12.03|||
4376271|NCT00333229|4202412|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376272|NCT00333229|4202413|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376273|NCT00333229|4202414|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376274|NCT00333229|4202412|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4376275|NCT00333229|4202413|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4376276|NCT00333229|4202414|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4376277|NCT00333229|4202412|B3|||Age||Years|Mean|42.1|42.1|Standard Deviation|4.8|4.8|||
4376278|NCT00333229|4202413|B2|||Age||Years|Mean|43.2|43.2|Standard Deviation|2.6|2.6|||
4376279|NCT00333229|4202414|B1|||Age||Years|Mean|41.2|41.2|Standard Deviation|6.2|6.2|||
4376280|NCT00333138|4202429|B4||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4376281|NCT00333138|4202430|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4376282|NCT00333138|4202431|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4376283|NCT00333138|4202432|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4376284|NCT00333138|4202429|B4||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4376285|NCT00333138|4202430|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4376286|NCT00333138|4202431|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4376287|NCT00333138|4202432|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4376288|NCT00333138|4202429|B4|||Age||Years|Mean|37.8|37.8|Standard Deviation|9.63|9.63|||
4376289|NCT00333138|4202430|B3|||Age||Years|Mean|38.3|38.3|Standard Deviation|10.51|10.51|||
4376290|NCT00333138|4202431|B2|||Age||Years|Mean|38.1|38.1|Standard Deviation|9.54|9.54|||
4376291|NCT00333138|4202432|B1|||Age||Years|Mean|37.0|37.0|Standard Deviation|8.80|8.8|||
4376292|NCT00332839|4202471|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4376293|NCT00332839|4202472|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4376294|NCT00332839|4202473|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4376295|NCT00332839|4202471|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4376296|NCT00332839|4202472|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4376297|NCT00332839|4202473|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4376298|NCT00332839|4202471|B3|||Age||Years|Mean|50.4|50.4|Standard Deviation|10.7|10.7|||
4376299|NCT00332839|4202472|B2|||Age||Years|Mean|51.0|51.0|Standard Deviation|10.3|10.3|||
4376300|NCT00332839|4202473|B1|||Age||Years|Mean|49.8|49.8|Standard Deviation|11.1|11.1|||
4376301|NCT00332722|4202492|B3|||duration of pain||months|Mean|103|103.0|Standard Deviation|174|174.0|||
4376302|NCT00332722|4202493|B2|||duration of pain||months|Mean|87|87.0|Standard Deviation|104|104.0|||
4376308|NCT00332722|4202493|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4376309|NCT00332722|4202494|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4376310|NCT00332722|4202492|B3|||Age||years|Mean|44|44.0|Standard Deviation|13.7|13.7|||
4376311|NCT00332722|4202493|B2|||Age||years|Mean|43|43.0|Standard Deviation|14.1|14.1|||
4376312|NCT00332722|4202494|B1|||Age||years|Mean|46|46.0|Standard Deviation|13.2|13.2|||
4376313|NCT00332722|4202492|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4376314|NCT00332722|4202493|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4376315|NCT00332722|4202494|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4376316|NCT00332722|4202492|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4376317|NCT00332722|4202493|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4376318|NCT00332722|4202494|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4376319|NCT00332722|4202492|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376320|NCT00332722|4202493|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376321|NCT00332722|4202494|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376322|NCT00332709|4202503|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376323|NCT00332709|4202504|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376324|NCT00332709|4202505|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376325|NCT00332709|4202503|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4376326|NCT00332709|4202504|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4376327|NCT00332709|4202505|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4376328|NCT00332709|4202503|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|7.4|7.4|||
4376329|NCT00332709|4202504|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|7.3|7.3|||
4376330|NCT00332709|4202505|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|7.3|7.3|||
4376331|NCT00332709|4202503|B3||>=65 years|Age|Demographic data is provided for the Intent to Treat population.|Participants|Count of Participants|0|0.0||||||
4376332|NCT00332709|4202504|B2||>=65 years|Age|Demographic data is provided for the Intent to Treat population.|Participants|Count of Participants|0|0.0||||||
4376333|NCT00332709|4202505|B1||>=65 years|Age|Demographic data is provided for the Intent to Treat population.|Participants|Count of Participants|0|0.0||||||
4376334|NCT00332709|4202503|B3||Between 18 and 65 years|Age|Demographic data is provided for the Intent to Treat population.|Participants|Count of Participants|76|76.0||||||
4376335|NCT00332709|4202504|B2||Between 18 and 65 years|Age|Demographic data is provided for the Intent to Treat population.|Participants|Count of Participants|39|39.0||||||
4376336|NCT00332709|4202505|B1||Between 18 and 65 years|Age|Demographic data is provided for the Intent to Treat population.|Participants|Count of Participants|37|37.0||||||
4376337|NCT00332709|4202503|B3||<=18 years|Age|Demographic data is provided for the Intent to Treat population.|Participants|Count of Participants|0|0.0||||||
4376338|NCT00332709|4202504|B2||<=18 years|Age|Demographic data is provided for the Intent to Treat population.|Participants|Count of Participants|0|0.0||||||
4376339|NCT00332709|4202505|B1||<=18 years|Age|Demographic data is provided for the Intent to Treat population.|Participants|Count of Participants|0|0.0||||||
4376340|NCT00332696|4202528|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4376341|NCT00332696|4202529|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4376342|NCT00332696|4202530|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4376343|NCT00332696|4202528|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4376344|NCT00332696|4202529|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4376345|NCT00332696|4202530|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4376346|NCT00332696|4202528|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|11.02|11.02|||
4376347|NCT00332696|4202529|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|12.36|12.36|||
4376348|NCT00332696|4202530|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|9.57|9.57|||
4376349|NCT00332644|4202557|B7|United States||Region of Enrollment||participants|Number|1504|1504.0||||||
4376350|NCT00332644|4202558|B6|United States||Region of Enrollment||participants|Number|189|189.0||||||
4376351|NCT00332644|4202559|B5|United States||Region of Enrollment||participants|Number|262|262.0||||||
4376352|NCT00332644|4202560|B4|United States||Region of Enrollment||participants|Number|264|264.0||||||
4376353|NCT00332644|4202561|B3|United States||Region of Enrollment||participants|Number|267|267.0||||||
4376354|NCT00332644|4202562|B2|United States||Region of Enrollment||participants|Number|260|260.0||||||
4376355|NCT00332644|4202563|B1|United States||Region of Enrollment||participants|Number|262|262.0||||||
4376356|NCT00332644|4202557|B7||Male|Sex: Female, Male||Participants|Count of Participants|628|628.0||||||
4376357|NCT00332644|4202558|B6||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4376358|NCT00332644|4202559|B5||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4376359|NCT00332644|4202560|B4||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4376360|NCT00332644|4202561|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4376361|NCT00332644|4202562|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4376362|NCT00332644|4202563|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4376363|NCT00332644|4202557|B7||Female|Sex: Female, Male||Participants|Count of Participants|876|876.0||||||
4376364|NCT00332644|4202558|B6||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4376365|NCT00332644|4202559|B5||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4376366|NCT00332644|4202560|B4||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4376367|NCT00332644|4202561|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4376368|NCT00332644|4202562|B2||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4376369|NCT00332644|4202563|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4376370|NCT00332644|4202557|B7|||Age||years|Mean|44.7|44.7|Standard Deviation|11.1|11.1|||
4376371|NCT00332644|4202558|B6|||Age||years|Mean|43.1|43.1|Standard Deviation|11.4|11.4|||
4376372|NCT00332644|4202559|B5|||Age||years|Mean|45.3|45.3|Standard Deviation|10.4|10.4|||
4376373|NCT00332644|4202560|B4|||Age||years|Mean|43.9|43.9|Standard Deviation|11.7|11.7|||
4376374|NCT00332644|4202561|B3|||Age||years|Mean|44.2|44.2|Standard Deviation|11.1|11.1|||
4376375|NCT00332644|4202562|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|10.4|10.4|||
4376376|NCT00332644|4202563|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|11.6|11.6|||
4376377|NCT00332644|4202557|B7||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4376378|NCT00332644|4202558|B6||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4376379|NCT00332644|4202559|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4376380|NCT00332644|4202560|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4376381|NCT00332644|4202561|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4376382|NCT00332644|4202562|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4376383|NCT00332644|4202563|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4376384|NCT00332644|4202557|B7||Between 18 and 65 years|Age||Participants|Count of Participants|1461|1461.0||||||
4376385|NCT00332644|4202558|B6||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
4376386|NCT00332644|4202559|B5||Between 18 and 65 years|Age||Participants|Count of Participants|256|256.0||||||
4376387|NCT00332644|4202560|B4||Between 18 and 65 years|Age||Participants|Count of Participants|256|256.0||||||
4376388|NCT00332644|4202561|B3||Between 18 and 65 years|Age||Participants|Count of Participants|262|262.0||||||
4376389|NCT00332644|4202562|B2||Between 18 and 65 years|Age||Participants|Count of Participants|256|256.0||||||
4376390|NCT00332644|4202563|B1||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
4376391|NCT00332644|4202557|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376392|NCT00332644|4202558|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376393|NCT00332644|4202559|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376394|NCT00332644|4202560|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376395|NCT00332644|4202561|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376396|NCT00332644|4202562|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376397|NCT00332644|4202563|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376398|NCT00332605|4202582|B4|United States||Region of Enrollment||participants|Number|45|45.0||||||
4376399|NCT00332605|4202583|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4376400|NCT00332605|4202584|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4376401|NCT00332605|4202585|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4376402|NCT00332605|4202582|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4376403|NCT00332605|4202583|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4376404|NCT00332605|4202584|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4376405|NCT00332605|4202585|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4376406|NCT00332605|4202582|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4376407|NCT00332605|4202583|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4376408|NCT00332605|4202584|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4376409|NCT00332605|4202585|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4376410|NCT00332605|4202582|B4|||Age||years|Mean|36.9|36.9|Standard Deviation|7.2|7.2|||
4376411|NCT00332605|4202583|B3|||Age||years|Mean|36.1|36.1|Standard Deviation|6.6|6.6|||
4376412|NCT00332605|4202584|B2|||Age||years|Mean|37.2|37.2|Standard Deviation|8.1|8.1|||
4376413|NCT00332605|4202585|B1|||Age||years|Mean|37|37.0|Standard Deviation|8.2|8.2|||
4376414|NCT00332605|4202582|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4376415|NCT00332605|4202583|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4376416|NCT00332605|4202584|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4376417|NCT00332605|4202585|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4376418|NCT00332605|4202582|B4||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4376419|NCT00332605|4202583|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4376420|NCT00332605|4202584|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4376421|NCT00332605|4202585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4376422|NCT00332605|4202582|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376423|NCT00332605|4202583|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376424|NCT00332605|4202584|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376425|NCT00332605|4202585|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376426|NCT00332579|4202595|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4376427|NCT00332579|4202596|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4376428|NCT00332579|4202597|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4376429|NCT00332579|4202595|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4376430|NCT00332579|4202596|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4376431|NCT00332579|4202597|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4376432|NCT00332579|4202595|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4376433|NCT00332579|4202596|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4376434|NCT00332579|4202597|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4376435|NCT00332579|4202595|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|12.4|12.4|||
4376436|NCT00332579|4202596|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|12.7|12.7|||
4376437|NCT00332579|4202597|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|12.2|12.2|||
4376438|NCT00332579|4202595|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4376439|NCT00332579|4202596|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4376440|NCT00332579|4202597|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4376441|NCT00332579|4202595|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4376442|NCT00332579|4202596|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4376443|NCT00332579|4202597|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4376444|NCT00332579|4202595|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376445|NCT00332579|4202596|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376446|NCT00332579|4202597|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376447|NCT00332488|4202604|B4|||HbA1c|Glycated hemoglobin measurement|percentage|Mean|8.9|8.9|Standard Deviation|0.95|0.95|||
4376448|NCT00332488|4202605|B3|||HbA1c|Glycated hemoglobin measurement|percentage|Mean|9.0|9.0|Standard Deviation|0.97|0.97|||
4376449|NCT00332488|4202606|B2|||HbA1c|Glycated hemoglobin measurement|percentage|Mean|8.9|8.9|Standard Deviation|0.94|0.94|||
4376450|NCT00332488|4202607|B1|||HbA1c|Glycated hemoglobin measurement|percentage|Mean|8.9|8.9|Standard Deviation|0.95|0.95|||
4376451|NCT00332488|4202604|B4|||Fasting Plasma Glucose|Fasting Plasma Glucose|milligrams per deciliter|Mean|192.2|192.2|Standard Deviation|50.23|50.23|||
4376452|NCT00332488|4202605|B3|||Fasting Plasma Glucose|Fasting Plasma Glucose|milligrams per deciliter|Mean|188.6|188.6|Standard Deviation|49.7|49.7|||
4376453|NCT00332488|4202606|B2|||Fasting Plasma Glucose|Fasting Plasma Glucose|milligrams per deciliter|Mean|194.6|194.6|Standard Deviation|48.5|48.5|||
4376454|NCT00332488|4202607|B1|||Fasting Plasma Glucose|Fasting Plasma Glucose|milligrams per deciliter|Mean|193.5|193.5|Standard Deviation|52.4|52.4|||
4376455|NCT00332488|4202604|B4|||Body Weight||kilograms|Mean|84.8|84.8|Standard Deviation|15.27|15.27|||
4376456|NCT00332488|4202605|B3|||Body Weight||kilograms|Mean|83.9|83.9|Standard Deviation|13.9|13.9|||
4376457|NCT00332488|4202606|B2|||Body Weight||kilograms|Mean|84.2|84.2|Standard Deviation|16.2|16.2|||
4376458|NCT00332488|4202607|B1|||Body Weight||kilograms|Mean|86.1|86.1|Standard Deviation|15.6|15.6|||
4376459|NCT00332488|4202604|B4||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4376460|NCT00332488|4202605|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4376461|NCT00332488|4202606|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4376462|NCT00332488|4202607|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4376463|NCT00332488|4202604|B4||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4376464|NCT00332488|4202605|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4376465|NCT00332488|4202606|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4376466|NCT00332488|4202607|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4376467|NCT00332488|4202604|B4|||Age||years|Mean|57.2|57.2|Full Range|||18.0|77.0|
4376468|NCT00332488|4202605|B3|||Age||years|Mean|56.8|56.8|Full Range|||37.0|77.0|
4376469|NCT00332488|4202606|B2|||Age||years|Mean|57.6|57.6|Full Range|||18.0|75.0|
4376470|NCT00332488|4202607|B1|||Age||years|Mean|57.3|57.3|Full Range|||26.0|75.0|
4376471|NCT00332462|4202621|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4376472|NCT00332462|4202621|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4376473|NCT00332462|4202621|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|9.6|9.6|||
4376474|NCT00332332|4202628|B1|||Dermatology Quality of Life Index Total Score|This score ranges from 0 to 30, with 0 = no effect and 30 = large effect|Units on a scale|Mean|13.7|13.7|Standard Deviation|6.1|6.1|||
4376475|NCT00332332|4202628|B1|||Body Surface Area|Body surface area affected by psoriasis|m^2|Mean|27.4|27.4|Standard Deviation|21.3|21.3|||
4376476|NCT00332332|4202628|B1|||Patient Global Assessment|Patient global assessment of psoriasis scores range from 0 (good) to 5 (severe)|Units on a scale|Mean|4.0|4.0|Standard Deviation|0.8|0.8|||
4376477|NCT00332332|4202628|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4376478|NCT00332332|4202628|B1|Aborigine||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4376479|NCT00332332|4202628|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4376480|NCT00332332|4202628|B1|Asian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4376481|NCT00332332|4202628|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4376482|NCT00332332|4202628|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|215|215.0||||||
4376483|NCT00332332|4202628|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4376484|NCT00332332|4202628|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4376485|NCT00332332|4202628|B1|||Age||Years|Mean|45.5|45.5|Standard Deviation|11.5|11.5|||
4376486|NCT00332241|4202635|B3|||Weight||kilograms|Mean|42.2|42.2|Standard Deviation|19.01|19.01|||
4376487|NCT00332241|4202636|B2|||Weight||kilograms|Mean|43.9|43.9|Standard Deviation|19.15|19.15|||
4376488|NCT00332241|4202637|B1|||Weight||kilograms|Mean|40.6|40.6|Standard Deviation|18.92|18.92|||
4376489|NCT00332241|4202635|B3|||Height||centimeters|Mean|139.7|139.7|Standard Deviation|16.74|16.74|||
4376490|NCT00332241|4202636|B2|||Height||centimeters|Mean|140.9|140.9|Standard Deviation|18.80|18.8|||
4376491|NCT00332241|4202637|B1|||Height||centimeters|Mean|138.6|138.6|Standard Deviation|14.7|14.7|||
4376492|NCT00332241|4202635|B3|||Body Mass Index||kg/cm2|Mean|20.50|20.5|Standard Deviation|5.395|5.395|||
4376493|NCT00332241|4202636|B2|||Body Mass Index||kg/cm2|Mean|21.08|21.08|Standard Deviation|5.394|5.394|||
4376494|NCT00332241|4202637|B1|||Body Mass Index||kg/cm2|Mean|19.96|19.96|Standard Deviation|5.392|5.392|||
4376495|NCT00332241|4202635|B3|≥40 kilograms||Weight Group||Participants|Number|40|40.0||||||
4376496|NCT00332241|4202636|B2|≥40 kilograms||Weight Group||Participants|Number|21|21.0||||||
4376497|NCT00332241|4202637|B1|≥40 kilograms||Weight Group||Participants|Number|19|19.0||||||
4376498|NCT00332241|4202635|B3|<40 kilograms||Weight Group||Participants|Number|58|58.0||||||
4376499|NCT00332241|4202636|B2|<40 kilograms||Weight Group||Participants|Number|26|26.0||||||
4376500|NCT00332241|4202637|B1|<40 kilograms||Weight Group||Participants|Number|32|32.0||||||
4376501|NCT00332241|4202635|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4376502|NCT00332241|4202636|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4376503|NCT00332241|4202637|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4376504|NCT00332241|4202635|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4376505|NCT00332241|4202636|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4376506|NCT00332241|4202637|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4376507|NCT00332241|4202635|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4376508|NCT00332241|4202636|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4376509|NCT00332241|4202637|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4376510|NCT00332241|4202635|B3|White||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4376511|NCT00332241|4202636|B2|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4376512|NCT00332241|4202637|B1|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4376513|NCT00332241|4202635|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4376514|NCT00332241|4202636|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4376515|NCT00332241|4202637|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4376516|NCT00332241|4202635|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4376517|NCT00332241|4202636|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4376518|NCT00332241|4202637|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4376519|NCT00332241|4202635|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4376520|NCT00332241|4202636|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4376521|NCT00332241|4202637|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4376522|NCT00332241|4202635|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4376523|NCT00332241|4202636|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4376524|NCT00332241|4202637|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4376525|NCT00332241|4202635|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4376526|NCT00332241|4202636|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4376527|NCT00332241|4202637|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4376528|NCT00332241|4202635|B3|13 to 17 years||Age, Customized||participants|Number|15|15.0||||||
4376529|NCT00332241|4202636|B2|13 to 17 years||Age, Customized||participants|Number|10|10.0||||||
4376530|NCT00332241|4202637|B1|13 to 17 years||Age, Customized||participants|Number|5|5.0||||||
4376531|NCT00332241|4202635|B3|6 to 12 years||Age, Customized||participants|Number|83|83.0||||||
4376532|NCT00332241|4202636|B2|6 to 12 years||Age, Customized||participants|Number|37|37.0||||||
4376533|NCT00332241|4202637|B1|6 to 12 years||Age, Customized||participants|Number|46|46.0||||||
4376534|NCT00332202|4202658|B3|United States||Region of Enrollment||Participants|Count of Participants|186|186.0||||||
4376535|NCT00332202|4202659|B2|United States||Region of Enrollment||Participants|Count of Participants|61|61.0||||||
4376536|NCT00332202|4202660|B1|United States||Region of Enrollment||Participants|Count of Participants|125|125.0||||||
4376537|NCT00332202|4202658|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4376538|NCT00332202|4202659|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4376539|NCT00332202|4202660|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4376540|NCT00332202|4202658|B3|Taiwan||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4376541|NCT00332202|4202659|B2|Taiwan||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4376542|NCT00332202|4202660|B1|Taiwan||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4376543|NCT00332202|4202658|B3|Sweden||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4376544|NCT00332202|4202659|B2|Sweden||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4376545|NCT00332202|4202660|B1|Sweden||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4376546|NCT00332202|4202658|B3|Portugal||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4376547|NCT00332202|4202659|B2|Portugal||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4376548|NCT00332202|4202660|B1|Portugal||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4376549|NCT00332202|4202658|B3|Puerto Rico||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4376550|NCT00332202|4202659|B2|Puerto Rico||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4376551|NCT00332202|4202660|B1|Puerto Rico||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4376552|NCT00332202|4202658|B3|Poland||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4376553|NCT00332202|4202659|B2|Poland||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4376554|NCT00332202|4202660|B1|Poland||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4376555|NCT00332202|4202658|B3|Mexico||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4376556|NCT00332202|4202659|B2|Mexico||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4376557|NCT00332202|4202660|B1|Mexico||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4376558|NCT00332202|4202658|B3|South Korea||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
4376559|NCT00332202|4202659|B2|South Korea||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4376560|NCT00332202|4202660|B1|South Korea||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4376561|NCT00332202|4202658|B3|Japan||Region of Enrollment||Participants|Count of Participants|87|87.0||||||
4376562|NCT00332202|4202659|B2|Japan||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4376563|NCT00332202|4202660|B1|Japan||Region of Enrollment||Participants|Count of Participants|54|54.0||||||
4376564|NCT00332202|4202658|B3|Italy||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4376565|NCT00332202|4202659|B2|Italy||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4376566|NCT00332202|4202660|B1|Italy||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4376567|NCT00332202|4202658|B3|India||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4376568|NCT00332202|4202659|B2|India||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4376569|NCT00332202|4202660|B1|India||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4376570|NCT00332202|4202658|B3|Hungary||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4376571|NCT00332202|4202659|B2|Hungary||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4376572|NCT00332202|4202660|B1|Hungary||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4376573|NCT00332202|4202658|B3|Greece||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4376574|NCT00332202|4202659|B2|Greece||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4376575|NCT00332202|4202660|B1|Greece||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4376576|NCT00332202|4202658|B3|France||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4376577|NCT00332202|4202659|B2|France||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4376578|NCT00332202|4202660|B1|France||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4376579|NCT00332202|4202658|B3|Finland||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4376580|NCT00332202|4202659|B2|Finland||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4376581|NCT00332202|4202660|B1|Finland||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4376582|NCT00332202|4202658|B3|Spain||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4376583|NCT00332202|4202659|B2|Spain||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4376584|NCT00332202|4202660|B1|Spain||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4376585|NCT00332202|4202658|B3|Denmark||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4376586|NCT00332202|4202659|B2|Denmark||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4376587|NCT00332202|4202660|B1|Denmark||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4376588|NCT00332202|4202658|B3|Germany||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4376589|NCT00332202|4202659|B2|Germany||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4376590|NCT00332202|4202660|B1|Germany||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4376591|NCT00332202|4202658|B3|Czechia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4376592|NCT00332202|4202659|B2|Czechia||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4376593|NCT00332202|4202660|B1|Czechia||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4376594|NCT00332202|4202658|B3|China||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4376595|NCT00332202|4202659|B2|China||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4376596|NCT00332202|4202660|B1|China||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4376597|NCT00332202|4202658|B3|Canada||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4376598|NCT00332202|4202659|B2|Canada||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4376599|NCT00332202|4202660|B1|Canada||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4376600|NCT00332202|4202658|B3|Brazil||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4376601|NCT00332202|4202659|B2|Brazil||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4376602|NCT00332202|4202660|B1|Brazil||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4376603|NCT00332202|4202658|B3|Belgium||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4376604|NCT00332202|4202659|B2|Belgium||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4376605|NCT00332202|4202660|B1|Belgium||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4376606|NCT00332202|4202658|B3|Australia||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4376607|NCT00332202|4202659|B2|Australia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4376608|NCT00332202|4202660|B1|Australia||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4376609|NCT00332202|4202658|B3||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|32|32.0||||||
4376610|NCT00332202|4202659|B2||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4376611|NCT00332202|4202660|B1||West Asian (Indian sub-continent)|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4376612|NCT00332202|4202658|B3||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4376613|NCT00332202|4202659|B2||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4376614|NCT00332202|4202660|B1||Native American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4376615|NCT00332202|4202658|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|37|37.0||||||
4376616|NCT00332202|4202659|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4376617|NCT00332202|4202660|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4376618|NCT00332202|4202658|B3||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|217|217.0||||||
4376619|NCT00332202|4202659|B2||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
4376620|NCT00332202|4202660|B1||East Asian|Race/Ethnicity, Customized||Participants|Count of Participants|144|144.0||||||
4376621|NCT00332202|4202658|B3||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|464|464.0||||||
4376622|NCT00332202|4202659|B2||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|155|155.0||||||
4376623|NCT00332202|4202660|B1||Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|309|309.0||||||
4376624|NCT00332202|4202658|B3||African|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4376625|NCT00332202|4202659|B2||African|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4376626|NCT00332202|4202660|B1||African|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4376627|NCT00332202|4202658|B3||Male|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
4376628|NCT00332202|4202659|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4376629|NCT00332202|4202660|B1||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4376630|NCT00332202|4202658|B3||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4376631|NCT00332202|4202659|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4376632|NCT00332202|4202660|B1||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4376633|NCT00332202|4202658|B3|||Age||Years|Mean|62.35|62.35|Standard Deviation|12.78|12.78|||
4376634|NCT00332202|4202659|B2|||Age||Years|Mean|62.65|62.65|Standard Deviation|12.09|12.09|||
4376635|NCT00332202|4202660|B1|||Age||Years|Mean|62.19|62.19|Standard Deviation|13.13|13.13|||
4376636|NCT00332189|4202690|B1|Europe||Region of Enrollment||participants|Number|57|57.0||||||
4376637|NCT00332189|4202690|B1|North America||Region of Enrollment||participants|Number|54|54.0||||||
4376638|NCT00332189|4202690|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4376639|NCT00332189|4202690|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4376640|NCT00332189|4202690|B1|Asian/Asian Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4376641|NCT00332189|4202690|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
4376642|NCT00332189|4202690|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4376643|NCT00332189|4202690|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4376644|NCT00332189|4202690|B1|>=18||Age, Customized||participants|Number|39|39.0||||||
4376645|NCT00332189|4202690|B1|>=12 to <18||Age, Customized||participants|Number|28|28.0||||||
4376646|NCT00332189|4202690|B1|>=8 to <12||Age, Customized||participants|Number|24|24.0||||||
4376647|NCT00332189|4202690|B1|>=4 to <8||Age, Customized||participants|Number|20|20.0||||||
4376648|NCT00332189|4202690|B1|||Age||years|Mean|16.4|16.4|Standard Deviation|10.2|10.2|||
4376649|NCT00332163|4202695|B3|Irinotecan + Panitumumab Q3W||Chemotherapy Stratification||participants|Number|40|40.0||||||
4376650|NCT00332163|4202696|B2|Irinotecan + Panitumumab Q3W||Chemotherapy Stratification||participants|Number|20|20.0||||||
4376651|NCT00332163|4202697|B1|Irinotecan + Panitumumab Q3W||Chemotherapy Stratification||participants|Number|20|20.0||||||
4376652|NCT00332163|4202695|B3|FOLFIRI + Panitumumab Q2W||Chemotherapy Stratification||participants|Number|55|55.0||||||
4376653|NCT00332163|4202696|B2|FOLFIRI + Panitumumab Q2W||Chemotherapy Stratification||participants|Number|27|27.0||||||
4376654|NCT00332163|4202697|B1|FOLFIRI + Panitumumab Q2W||Chemotherapy Stratification||participants|Number|28|28.0||||||
4376655|NCT00332163|4202695|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4376656|NCT00332163|4202696|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4376657|NCT00332163|4202697|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4376658|NCT00332163|4202695|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4376659|NCT00332163|4202696|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4376660|NCT00332163|4202697|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4376661|NCT00332163|4202695|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4376662|NCT00332163|4202696|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4376663|NCT00332163|4202697|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4376664|NCT00332163|4202695|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4376665|NCT00332163|4202696|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4376666|NCT00332163|4202697|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4376667|NCT00332163|4202695|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4376668|NCT00332163|4202696|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4376669|NCT00332163|4202697|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4376670|NCT00332163|4202695|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4376671|NCT00332163|4202696|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4376672|NCT00332163|4202697|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4376673|NCT00332163|4202695|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4376674|NCT00332163|4202696|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4376675|NCT00332163|4202697|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4376676|NCT00332163|4202695|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4376677|NCT00332163|4202696|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4376678|NCT00332163|4202697|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4376679|NCT00332163|4202695|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|11.4|11.4|||
4376680|NCT00332163|4202696|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|9.9|9.9|||
4376681|NCT00332163|4202697|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|12.7|12.7|||
4376682|NCT00331864|4202730|B3||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4376683|NCT00331864|4202731|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4376684|NCT00331864|4202732|B1||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4376685|NCT00331864|4202730|B3||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4376686|NCT00331864|4202731|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4376687|NCT00331864|4202732|B1||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4376688|NCT00331864|4202730|B3|≥ 85 years||Age, Customized||participants|Number|61|61.0||||||
4376689|NCT00331864|4202731|B2|≥ 85 years||Age, Customized||participants|Number|1|1.0||||||
4376690|NCT00331864|4202732|B1|≥ 85 years||Age, Customized||participants|Number|60|60.0||||||
4376691|NCT00331864|4202730|B3|75 to < 85 years||Age, Customized||participants|Number|242|242.0||||||
4376692|NCT00331864|4202731|B2|75 to < 85 years||Age, Customized||participants|Number|12|12.0||||||
4376693|NCT00331864|4202732|B1|75 to < 85 years||Age, Customized||participants|Number|230|230.0||||||
4376694|NCT00331864|4202730|B3|65 to < 75 years||Age, Customized||participants|Number|178|178.0||||||
4376695|NCT00331864|4202731|B2|65 to < 75 years||Age, Customized||participants|Number|5|5.0||||||
4376696|NCT00331864|4202732|B1|65 to < 75 years||Age, Customized||participants|Number|173|173.0||||||
4376697|NCT00331864|4202730|B3|50 to < 65 years||Age, Customized||participants|Number|49|49.0||||||
4376698|NCT00331864|4202731|B2|50 to < 65 years||Age, Customized||participants|Number|0|0.0||||||
4376699|NCT00331864|4202732|B1|50 to < 65 years||Age, Customized||participants|Number|49|49.0||||||
4376700|NCT00331864|4202730|B3|< 50 years||Age, Customized||participants|Number|1|1.0||||||
4376701|NCT00331864|4202731|B2|< 50 years||Age, Customized||participants|Number|0|0.0||||||
4376702|NCT00331864|4202732|B1|< 50 years||Age, Customized||participants|Number|1|1.0||||||
4376703|NCT00331799|4202752|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4376704|NCT00331799|4202752|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4376705|NCT00331799|4202752|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4376706|NCT00331799|4202752|B1|||Age||years|Mean|43.44|43.44|Standard Deviation|9.21|9.21|||
4376707|NCT00331799|4202752|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4376708|NCT00331799|4202752|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4376709|NCT00331799|4202752|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376710|NCT00331773|4202756|B3||Male|Sex: Female, Male||Participants|Count of Participants|1092|1092.0||||||
4376711|NCT00331773|4202757|B2||Male|Sex: Female, Male||Participants|Count of Participants|550|550.0||||||
4376712|NCT00331773|4202758|B1||Male|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
4376713|NCT00331773|4202756|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376714|NCT00331773|4202757|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376715|NCT00331773|4202758|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376716|NCT00331773|4202756|B3|||Age||years|Median|67|67.0|Full Range|||42.0|85.0|
4376717|NCT00331773|4202757|B2|||Age||years|Median|67|67.0|Full Range|||45.0|84.0|
4376718|NCT00331773|4202758|B1|||Age||years|Median|67|67.0|Full Range|||42.0|85.0|
4376719|NCT00331760|4202785|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4376720|NCT00331760|4202786|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4376721|NCT00331760|4202787|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4376722|NCT00331760|4202785|B3||Female|Gender||Participants|Count of Participants|106|106.0||||||
4376723|NCT00331760|4202786|B2||Female|Gender||Participants|Count of Participants|48|48.0||||||
4376724|NCT00331760|4202787|B1||Female|Gender||Participants|Count of Participants|58|58.0||||||
4376725|NCT00331760|4202785|B3|||Age||years|Median|53|53.0|Full Range|||22.0|84.0|
4376726|NCT00331760|4202786|B2|||Age||years|Median|43|43.0|Full Range|||22.0|71.0|
4376727|NCT00331760|4202787|B1|||Age||years|Median|58|58.0|Full Range|||36.0|84.0|
4376728|NCT00331682|4202794|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4376729|NCT00331682|4202794|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4376730|NCT00331682|4202794|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4376731|NCT00331682|4202794|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4376732|NCT00331682|4202794|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4376733|NCT00331682|4202794|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376734|NCT00331682|4202794|B1|||Age||years|Mean|66|66.0|Standard Deviation|21.21320344|21.21320344|||
4376735|NCT00331552|4202800|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376736|NCT00331552|4202801|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376737|NCT00331552|4202802|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376738|NCT00331552|4202800|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4376739|NCT00331552|4202801|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4376740|NCT00331552|4202802|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376741|NCT00331552|4202800|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4376742|NCT00331552|4202801|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4376743|NCT00331552|4202802|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4376744|NCT00331552|4202800|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4376745|NCT00331552|4202801|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4376746|NCT00331552|4202802|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4376747|NCT00331552|4202800|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376748|NCT00331552|4202801|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376749|NCT00331552|4202802|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376750|NCT00331552|4202800|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4376751|NCT00331552|4202801|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4376752|NCT00331552|4202802|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4376753|NCT00331552|4202800|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376754|NCT00331552|4202801|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376755|NCT00331552|4202802|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376756|NCT00331552|4202800|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376757|NCT00331552|4202801|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376758|NCT00331552|4202802|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376759|NCT00331552|4202800|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4376760|NCT00331552|4202801|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4376761|NCT00331552|4202802|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4376762|NCT00331552|4202800|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376763|NCT00331552|4202801|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376764|NCT00331552|4202802|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376765|NCT00331552|4202800|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4376766|NCT00331552|4202801|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4376767|NCT00331552|4202802|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376768|NCT00331552|4202800|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4376769|NCT00331552|4202801|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4376770|NCT00331552|4202802|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4376771|NCT00331552|4202800|B3|||Age||years|Median|56.5|56.5|Full Range|||37.0|77.0|
4376772|NCT00331552|4202801|B2|||Age||years|Median|57|57.0|Full Range|||40.0|77.0|
4376773|NCT00331552|4202802|B1|||Age||years|Median|49.5|49.5|Full Range|||37.0|72.0|
4376774|NCT00331422|4202817|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4376775|NCT00331422|4202817|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376776|NCT00331422|4202817|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4376777|NCT00331422|4202817|B1|||Age||Years|Median|67|67.0|Full Range|||57.0|80.0|
4376778|NCT00331422|4202817|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4376779|NCT00331422|4202817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4376780|NCT00331422|4202817|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376781|NCT00331409|4202826|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4376782|NCT00331409|4202826|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4376783|NCT00331409|4202826|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4376784|NCT00331409|4202826|B1|||Age||years|Mean|65|65.0|Standard Deviation|7.7459|7.7459|||
4376785|NCT00331409|4202826|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4376786|NCT00331409|4202826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4376787|NCT00331409|4202826|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376788|NCT00331344|4202834|B1|United States||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
4376789|NCT00331344|4202834|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4376790|NCT00331344|4202834|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376791|NCT00331344|4202834|B1|||Age||years|Median|66.7|66.7|Full Range|||39.0|83.0|
4376792|NCT00331344|4202834|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4376793|NCT00331344|4202834|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4376794|NCT00331344|4202834|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376795|NCT00331162|4202856|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4376796|NCT00331162|4202857|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4376797|NCT00331162|4202858|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4376798|NCT00331162|4202856|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376799|NCT00331162|4202857|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376800|NCT00331162|4202858|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376801|NCT00331162|4202856|B3||White|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
4376802|NCT00331162|4202857|B2||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4376803|NCT00331162|4202858|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4376804|NCT00331162|4202856|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4376805|NCT00331162|4202857|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4376806|NCT00331162|4202858|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4376807|NCT00331162|4202856|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376808|NCT00331162|4202857|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376809|NCT00331162|4202858|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376810|NCT00331162|4202856|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376811|NCT00331162|4202857|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376812|NCT00331162|4202858|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376813|NCT00331162|4202856|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376814|NCT00331162|4202857|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376815|NCT00331162|4202858|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4376816|NCT00331162|4202856|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4376817|NCT00331162|4202857|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4376818|NCT00331162|4202858|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4376819|NCT00331162|4202856|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4376820|NCT00331162|4202857|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4376821|NCT00331162|4202858|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4376822|NCT00331162|4202856|B3|||Age||years|Mean|50|50.0|Standard Deviation|12|12.0|||
4376823|NCT00331162|4202857|B2|||Age||years|Mean|49|49.0|Standard Deviation|13|13.0|||
4376824|NCT00331162|4202858|B1|||Age||years|Mean|51|51.0|Standard Deviation|12|12.0|||
4376825|NCT00331006|4202879|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4376826|NCT00331006|4202879|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4376827|NCT00331006|4202879|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4376828|NCT00331006|4202879|B1|||Age||years|Mean|15.85|15.85|Standard Deviation|12.02|12.02|||
4376829|NCT00331006|4202879|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4376830|NCT00331006|4202879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4376831|NCT00331006|4202879|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4376832|NCT00330967|4202890|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4376833|NCT00330967|4202891|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4376834|NCT00330967|4202890|B3|Male||Gender||participants|Number|21|21.0||||||
4376835|NCT00330967|4202891|B2|Male||Gender||participants|Number|21|21.0||||||
4376836|NCT00330967|4202890|B3|Female||Gender||participants|Number|4|4.0||||||
4376837|NCT00330967|4202891|B2|Female||Gender||participants|Number|4|4.0||||||
4376838|NCT00330967|4202890|B3|||Age||years|Mean|47.65|47.65|Standard Deviation|11.43|11.43|||
4376839|NCT00330967|4202891|B2|||Age||years|Mean|47.65|47.65|Standard Deviation|11.43|11.43|||
4376840|NCT00330967|4202890|B3|>=65 years||Age||participants|Number|0|0.0||||||
4376841|NCT00330967|4202891|B2|>=65 years||Age||participants|Number|0|0.0||||||
4376842|NCT00330967|4202890|B3|Between 18 and 65 years||Age||participants|Number|25|25.0||||||
4376843|NCT00330967|4202891|B2|Between 18 and 65 years||Age||participants|Number|25|25.0||||||
4376844|NCT00330967|4202890|B3|<=18 years||Age||participants|Number|0|0.0||||||
4376845|NCT00330967|4202891|B2|<=18 years||Age||participants|Number|0|0.0||||||
4376846|NCT00330928|4202904|B1|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4376847|NCT00330928|4202904|B1|United States||Region of Enrollment||participants|Number|79|79.0||||||
4376848|NCT00330928|4202904|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4376849|NCT00330928|4202904|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4376850|NCT00330928|4202904|B1|||Age||years|Mean|61.67|61.67|Standard Deviation|9.96|9.96|||
4376851|NCT00330928|4202904|B1||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4376852|NCT00330928|4202904|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4376853|NCT00330928|4202904|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376854|NCT00330915|4202909|B1|||Time Since Initial Pathological Diagnosis|One patient is excluded because his pathological diagnosis occured 3.6 weeks after the date of informed consent.|weeks|Mean|3.2|3.2|Standard Deviation|1.7|1.7|||
4376855|NCT00330915|4202909|B1|||Heart Rate||beats per minute|Mean|80.4|80.4|Standard Deviation|14.8|14.8|||
4376856|NCT00330915|4202909|B1|||Body Weight||kilograms|Mean|80.4|80.4|Standard Deviation|15.2|15.2|||
4376857|NCT00330915|4202909|B1|||Body Surface Area|BSA is derived as ((height[cm] x weight[kg])/3600)1/2|meter squared|Mean|2.0|2.0|Standard Deviation|0.2|0.2|||
4376858|NCT00330915|4202909|B1|||Body Height||centimeters|Mean|173.4|173.4|Standard Deviation|9.4|9.4|||
4376859|NCT00330915|4202909|B1|Diastolic Blood Pressure||Blood Pressure||mm Hg|Mean|77.6|77.6|Standard Deviation|9.1|9.1|||
4376860|NCT00330915|4202909|B1|Systolic Blood Pressure||Blood Pressure||mm Hg|Mean|136.5|136.5|Standard Deviation|18.4|18.4|||
4376861|NCT00330915|4202909|B1|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4376862|NCT00330915|4202909|B1|Caucasian||Race/Ethnicity||participants|Number|36|36.0||||||
4376863|NCT00330915|4202909|B1|Unspecified||Histopathological Diagnosis|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|2|2.0||||||
4376864|NCT00330915|4202909|B1|Not Applicable||Histopathological Diagnosis|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|4|4.0||||||
4376865|NCT00330915|4202909|B1|G3 - Poorly Differentiated||Histopathological Diagnosis|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|3|3.0||||||
4376866|NCT00330915|4202909|B1|G2 - Moderately Differentiated||Histopathological Diagnosis|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|25|25.0||||||
4376867|NCT00330915|4202909|B1|G1 - Well-Differentiated||Histopathological Diagnosis|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|3|3.0||||||
4376868|NCT00330915|4202909|B1|4 - Completely Disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|0|0.0||||||
4376869|NCT00330915|4202909|B1|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|0|0.0||||||
4376870|NCT00330915|4202909|B1|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|0|0.0||||||
4376871|NCT00330915|4202909|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|0|0.0||||||
4376872|NCT00330915|4202909|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|37|37.0||||||
4376873|NCT00330915|4202909|B1|Sweden||Region of Enrollment||participants|Number|37|37.0||||||
4376874|NCT00330915|4202909|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4376875|NCT00330915|4202909|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4376876|NCT00330915|4202909|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|11.5|11.5|||
4376877|NCT00330876|4202916|B1||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4376878|NCT00330876|4202916|B1||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4376879|NCT00330876|4202916|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|4.73|4.73|||
4376880|NCT00330876|4202916|B1||>=65 years|Age||Participants|Count of Participants|539|539.0||||||
4376881|NCT00330876|4202916|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4376882|NCT00330876|4202916|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4376883|NCT00330863|4202925|B3|||Clinical Global Impressions (CGI) Severity Scale|"The Clinical Global Impressions Severity Scale is one item completed by a clinician rater. Considering your total clinical experience with this patient population, how mentally ill is the patient at this time? The seven possible ratings are as follows.~= Normal, not at all.~= Borderline mentally ill.~= Mildly ill.~= Moderately ill.~= Markedly ill.~= Severely ill~= Among the most extremely ill patients."|units on a scale|Mean|4.04|4.04|Standard Deviation|0.80|0.8|||
4376884|NCT00330863|4202926|B2|||Clinical Global Impressions (CGI) Severity Scale|"The Clinical Global Impressions Severity Scale is one item completed by a clinician rater. Considering your total clinical experience with this patient population, how mentally ill is the patient at this time? The seven possible ratings are as follows.~= Normal, not at all.~= Borderline mentally ill.~= Mildly ill.~= Moderately ill.~= Markedly ill.~= Severely ill~= Among the most extremely ill patients."|units on a scale|Mean|4.0|4.0|Standard Deviation|0.77|0.77|||
4376885|NCT00330863|4202927|B1|||Clinical Global Impressions (CGI) Severity Scale|"The Clinical Global Impressions Severity Scale is one item completed by a clinician rater. Considering your total clinical experience with this patient population, how mentally ill is the patient at this time? The seven possible ratings are as follows.~= Normal, not at all.~= Borderline mentally ill.~= Mildly ill.~= Moderately ill.~= Markedly ill.~= Severely ill~= Among the most extremely ill patients."|units on a scale|Mean|4.1|4.1|Standard Deviation|0.84|0.84|||
4376886|NCT00330863|4202925|B3|United States||Region of Enrollment||participants|Number|305|305.0||||||
4376887|NCT00330863|4202926|B2|United States||Region of Enrollment||participants|Number|152|152.0||||||
4376888|NCT00330863|4202927|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
4376889|NCT00330863|4202925|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4376890|NCT00330863|4202926|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4376891|NCT00330863|4202927|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4376892|NCT00330863|4202925|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4376893|NCT00330863|4202926|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4376894|NCT00330863|4202927|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4376895|NCT00330863|4202925|B3|African American||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4376896|NCT00330863|4202926|B2|African American||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4376897|NCT00330863|4202927|B1|African American||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4376898|NCT00330863|4202925|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
4376899|NCT00330863|4202926|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4376900|NCT00330863|4202927|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4376901|NCT00330863|4202925|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4376902|NCT00330863|4202926|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4376903|NCT00330863|4202927|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4376904|NCT00330863|4202925|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4376905|NCT00330863|4202926|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4376906|NCT00330863|4202927|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4376907|NCT00330863|4202925|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|12.1|12.1|||
4376908|NCT00330863|4202926|B2|||Age||years|Mean|38.23|38.23|Standard Deviation|12.3|12.3|||
4376909|NCT00330863|4202927|B1|||Age||years|Mean|38.18|38.18|Standard Deviation|11.8|11.8|||
4376910|NCT00330759|4202944|B3|No||Systematic Anti-Cancer Therapy Stratification Factor||Participants|Number|283|283.0||||||
4376911|NCT00330759|4202945|B2|No||Systematic Anti-Cancer Therapy Stratification Factor||Participants|Number|140|140.0||||||
4376912|NCT00330759|4202946|B1|No||Systematic Anti-Cancer Therapy Stratification Factor||Participants|Number|143|143.0||||||
4376913|NCT00330759|4202944|B3|Yes||Systematic Anti-Cancer Therapy Stratification Factor||Participants|Number|1493|1493.0||||||
4376914|NCT00330759|4202945|B2|Yes||Systematic Anti-Cancer Therapy Stratification Factor||Participants|Number|746|746.0||||||
4376915|NCT00330759|4202946|B1|Yes||Systematic Anti-Cancer Therapy Stratification Factor||Participants|Number|747|747.0||||||
4376916|NCT00330759|4202944|B3|No||Previous Skeletal-Related Event Stratification Factor||Participants|Number|890|890.0||||||
4376917|NCT00330759|4202945|B2|No||Previous Skeletal-Related Event Stratification Factor||Participants|Number|446|446.0||||||
4376918|NCT00330759|4202946|B1|No||Previous Skeletal-Related Event Stratification Factor||Participants|Number|444|444.0||||||
4376919|NCT00330759|4202944|B3|Yes||Previous Skeletal-Related Event Stratification Factor||Participants|Number|886|886.0||||||
4376920|NCT00330759|4202945|B2|Yes||Previous Skeletal-Related Event Stratification Factor||Participants|Number|440|440.0||||||
4376921|NCT00330759|4202946|B1|Yes||Previous Skeletal-Related Event Stratification Factor||Participants|Number|446|446.0||||||
4376922|NCT00330759|4202944|B3|Non-small cell lung cancer||Tumor Type Stratification Factor||Participants|Number|688|688.0||||||
4376923|NCT00330759|4202945|B2|Non-small cell lung cancer||Tumor Type Stratification Factor||Participants|Number|343|343.0||||||
4376924|NCT00330759|4202946|B1|Non-small cell lung cancer||Tumor Type Stratification Factor||Participants|Number|345|345.0||||||
4376925|NCT00330759|4202944|B3|Other||Tumor Type Stratification Factor||Participants|Number|909|909.0||||||
4376926|NCT00330759|4202945|B2|Other||Tumor Type Stratification Factor||Participants|Number|457|457.0||||||
4376927|NCT00330759|4202946|B1|Other||Tumor Type Stratification Factor||Participants|Number|452|452.0||||||
4376928|NCT00330759|4202944|B3|Multiple myeloma||Tumor Type Stratification Factor||Participants|Number|179|179.0||||||
4376929|NCT00330759|4202945|B2|Multiple myeloma||Tumor Type Stratification Factor||Participants|Number|86|86.0||||||
4376930|NCT00330759|4202946|B1|Multiple myeloma||Tumor Type Stratification Factor||Participants|Number|93|93.0||||||
4376931|NCT00330759|4202944|B3|Other||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4376932|NCT00330759|4202945|B2|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4376933|NCT00330759|4202946|B1|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4376934|NCT00330759|4202944|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4376935|NCT00330759|4202945|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4376936|NCT00330759|4202946|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4376937|NCT00330759|4202944|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4376938|NCT00330759|4202945|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4376939|NCT00330759|4202946|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4376940|NCT00330759|4202944|B3|Asian||Race/Ethnicity, Customized||Participants|Number|80|80.0||||||
4376941|NCT00330759|4202945|B2|Asian||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4376942|NCT00330759|4202946|B1|Asian||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4376943|NCT00330759|4202944|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|85|85.0||||||
4376944|NCT00330759|4202945|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
4376945|NCT00330759|4202946|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4376946|NCT00330759|4202944|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
4376947|NCT00330759|4202945|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4376948|NCT00330759|4202946|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4376949|NCT00330759|4202944|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|1540|1540.0||||||
4376950|NCT00330759|4202945|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|770|770.0||||||
4376951|NCT00330759|4202946|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|770|770.0||||||
4376952|NCT00330759|4202944|B3||Male|Sex: Female, Male||Participants|Count of Participants|1140|1140.0||||||
4376953|NCT00330759|4202945|B2||Male|Sex: Female, Male||Participants|Count of Participants|588|588.0||||||
4376954|NCT00330759|4202946|B1||Male|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
4376955|NCT00330759|4202944|B3||Female|Sex: Female, Male||Participants|Count of Participants|636|636.0||||||
4376956|NCT00330759|4202945|B2||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4376957|NCT00330759|4202946|B1||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4376958|NCT00330759|4202944|B3|||Age||Years|Mean|59.9|59.9|Standard Deviation|11.1|11.1|||
4376959|NCT00330759|4202945|B2|||Age||Years|Mean|59.3|59.3|Standard Deviation|11.4|11.4|||
4376960|NCT00330759|4202946|B1|||Age||Years|Mean|60.6|60.6|Standard Deviation|10.7|10.7|||
4376961|NCT00330733|4202957|B3|||Fasting glucose||mg/dl|Mean|104|104.0|Standard Deviation|11|11.0|||
4376962|NCT00330733|4202958|B2|||Fasting glucose||mg/dl|Mean|103|103.0|Standard Deviation|10|10.0|||
4376963|NCT00330733|4202959|B1|||Fasting glucose||mg/dl|Mean|105|105.0|Standard Deviation|12|12.0|||
4376964|NCT00330733|4202957|B3|||Oral Glucose Tolerance Test|Area Under the Curve Measurement|mg/dl. min|Mean|166|166.0|Standard Deviation|19|19.0|||
4376965|NCT00330733|4202958|B2|||Oral Glucose Tolerance Test|Area Under the Curve Measurement|mg/dl. min|Mean|165|165.0|Standard Deviation|17|17.0|||
4376966|NCT00330733|4202959|B1|||Oral Glucose Tolerance Test|Area Under the Curve Measurement|mg/dl. min|Mean|167|167.0|Standard Deviation|21|21.0|||
4376967|NCT00330733|4202957|B3|||Euglycemic clamps|glucose disposal|mg/ kg . min|Mean|3.93|3.93|Standard Deviation|1.27|1.27|||
4376968|NCT00330733|4202958|B2|||Euglycemic clamps|glucose disposal|mg/ kg . min|Mean|3.8|3.8|Standard Deviation|1.0|1.0|||
4376969|NCT00330733|4202959|B1|||Euglycemic clamps|glucose disposal|mg/ kg . min|Mean|4.08|4.08|Standard Deviation|1.46|1.46|||
4376970|NCT00330733|4202957|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4376971|NCT00330733|4202958|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4376972|NCT00330733|4202959|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4376973|NCT00330733|4202957|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4376974|NCT00330733|4202958|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4376975|NCT00330733|4202959|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4376976|NCT00330733|4202957|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4376977|NCT00330733|4202958|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4376978|NCT00330733|4202959|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4376979|NCT00330733|4202957|B3|||Age||years|Mean|58|58.0|Standard Deviation|8|8.0|||
4376980|NCT00330733|4202958|B2|||Age||years|Mean|60|60.0|Standard Deviation|6|6.0|||
4376981|NCT00330733|4202959|B1|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
4376982|NCT00330681|4202966|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4376983|NCT00330681|4202967|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4376984|NCT00330681|4202968|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4376985|NCT00330681|4202966|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4376986|NCT00330681|4202967|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4376987|NCT00330681|4202968|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4376988|NCT00330681|4202966|B3|>=65 years||Age, Customized||Participants|Count of Participants|61|61.0||||||
4376989|NCT00330681|4202967|B2|>=65 years||Age, Customized||Participants|Count of Participants|33|33.0||||||
4376990|NCT00330681|4202968|B1|>=65 years||Age, Customized||Participants|Count of Participants|28|28.0||||||
4376991|NCT00330681|4202966|B3|Between 19 and 64 years||Age, Customized||Participants|Count of Participants|145|145.0||||||
4376992|NCT00330681|4202967|B2|Between 19 and 64 years||Age, Customized||Participants|Count of Participants|71|71.0||||||
4376993|NCT00330681|4202968|B1|Between 19 and 64 years||Age, Customized||Participants|Count of Participants|74|74.0||||||
4376994|NCT00330681|4202966|B3|<=18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4376995|NCT00330681|4202967|B2|<=18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4376996|NCT00330681|4202968|B1|<=18 years||Age, Customized||Participants|Count of Participants|0|0.0||||||
4376997|NCT00330668|4202991|B1|||Weight||Kg|Mean|21.8|21.8|Standard Deviation|6.2|6.2|||
4376998|NCT00330668|4202991|B1|||Maximum Stimulated Growth Hormone|Growth Hormone Stimulation Test results expressed in ng/mL.|ng/mL|Mean|19.2|19.2|Standard Deviation|12.9|12.9|||
4376999|NCT00330668|4202991|B1|||IGF-1 Standard Deviation (SD) Score|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|SD score|Mean|-0.9|-0.9|Standard Deviation|1.4|1.4|||
4377000|NCT00330668|4202991|B1|||Height Standard Deviation (SD) Score|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|SD score|Mean|-2.4|-2.4|Standard Deviation|0.7|0.7|||
4377001|NCT00330668|4202991|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4377002|NCT00330668|4202991|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4377003|NCT00330668|4202991|B1|Native Hawaiian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4377004|NCT00330668|4202991|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4377005|NCT00330668|4202991|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4377006|NCT00330668|4202991|B1|White||Race/Ethnicity, Customized||Participants|Number|100|100.0||||||
4377007|NCT00330668|4202991|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4377008|NCT00330668|4202991|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4377009|NCT00330668|4202991|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4377010|NCT00330668|4202991|B1|||Age||years|Mean|8.5|8.5|Standard Deviation|2.4|2.4|||
4377011|NCT00330616|4202998|B1|Asian - Japanese Heritage||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4377012|NCT00330616|4202998|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4377013|NCT00330616|4202998|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4377014|NCT00330616|4202998|B1|||Age||Years|Mean|73.5|73.5|Standard Deviation|5.08|5.08|||
4377015|NCT00330564|4203017|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4377016|NCT00330564|4203017|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4377017|NCT00330564|4203017|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4377018|NCT00330564|4203017|B1|||Age||participants|Median|36|36.0|Full Range|||22.0|57.0|
4377019|NCT00330564|4203017|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377020|NCT00330564|4203017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4377021|NCT00330564|4203017|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377022|NCT00330460|4203022|B3|Other||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4377023|NCT00330460|4203023|B2|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4377024|NCT00330460|4203024|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4377025|NCT00330460|4203022|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4377026|NCT00330460|4203023|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4377027|NCT00330460|4203024|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4377028|NCT00330460|4203022|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4377029|NCT00330460|4203023|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4377030|NCT00330460|4203024|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4377031|NCT00330460|4203022|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4377032|NCT00330460|4203023|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4377033|NCT00330460|4203024|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4377034|NCT00330460|4203022|B3|Asian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4377035|NCT00330460|4203023|B2|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4377036|NCT00330460|4203024|B1|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4377037|NCT00330460|4203022|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|135|135.0||||||
4377038|NCT00330460|4203023|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
4377039|NCT00330460|4203024|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
4377040|NCT00330460|4203022|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4377041|NCT00330460|4203023|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4377042|NCT00330460|4203024|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4377043|NCT00330460|4203022|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|1004|1004.0||||||
4377044|NCT00330460|4203023|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|502|502.0||||||
4377045|NCT00330460|4203024|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|502|502.0||||||
4377046|NCT00330460|4203022|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377047|NCT00330460|4203023|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377048|NCT00330460|4203024|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377049|NCT00330460|4203022|B3||Female|Sex: Female, Male||Participants|Count of Participants|1189|1189.0||||||
4377050|NCT00330460|4203023|B2||Female|Sex: Female, Male||Participants|Count of Participants|594|594.0||||||
4377051|NCT00330460|4203024|B1||Female|Sex: Female, Male||Participants|Count of Participants|595|595.0||||||
4377052|NCT00330460|4203022|B3|||Age||Years|Mean|64.4|64.4|Standard Deviation|8.5|8.5|||
4377053|NCT00330460|4203023|B2|||Age||Years|Mean|64.1|64.1|Standard Deviation|8.6|8.6|||
4377054|NCT00330460|4203024|B1|||Age||Years|Mean|64.6|64.6|Standard Deviation|8.3|8.3|||
4377055|NCT00330421|4203039|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4377056|NCT00330421|4203039|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4377057|NCT00330421|4203039|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4377058|NCT00330421|4203039|B1|||Age||years|Mean|59|59.0|Standard Deviation|15|15.0|||
4377059|NCT00330421|4203039|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4377060|NCT00330421|4203039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4377061|NCT00330421|4203039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377062|NCT00330382|4203044|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4377063|NCT00330382|4203045|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4377064|NCT00330382|4203046|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4377065|NCT00330382|4203044|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4377066|NCT00330382|4203045|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4377067|NCT00330382|4203046|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4377068|NCT00330382|4203044|B3|||Age||years|Mean|59.42|59.42|Standard Deviation|12.87|12.87|||
4377069|NCT00330382|4203045|B2|||Age||years|Mean|60.64|60.64|Standard Deviation|12.01|12.01|||
4377070|NCT00330382|4203046|B1|||Age||years|Mean|58.25|58.25|Standard Deviation|13.63|13.63|||
4377071|NCT00330343|4203068|B1|United States||Region of Enrollment||Participants|Count of Participants|64|64.0||||||
4377072|NCT00330343|4203068|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4377073|NCT00330343|4203068|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4377074|NCT00330343|4203068|B1|||Age||years|Mean|12|12.0|Standard Deviation|6|6.0|||
4377075|NCT00330343|4203068|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377076|NCT00330343|4203068|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4377077|NCT00330343|4203068|B1||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
4377078|NCT00330187|4203072|B5||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4377079|NCT00330187|4203073|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4377080|NCT00330187|4203074|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4377081|NCT00330187|4203075|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4377082|NCT00330187|4203076|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4377083|NCT00330187|4203072|B5||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4377084|NCT00330187|4203073|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4377085|NCT00330187|4203074|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4377086|NCT00330187|4203075|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4377087|NCT00330187|4203076|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4377088|NCT00330187|4203072|B5|||Age||years|Mean|18.5|18.5|Standard Deviation|1.9|1.9|||
4377089|NCT00330187|4203073|B4|||Age||years|Mean|19|19.0|Standard Deviation|1.8|1.8|||
4377090|NCT00330187|4203074|B3|||Age||years|Mean|18.1|18.1|Standard Deviation|1.9|1.9|||
4377091|NCT00330187|4203075|B2|||Age||years|Mean|18.4|18.4|Standard Deviation|1.9|1.9|||
4377092|NCT00330187|4203076|B1|||Age||years|Mean|18.4|18.4|Standard Deviation|1.9|1.9|||
4377093|NCT00330187|4203072|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377094|NCT00330187|4203073|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377095|NCT00330187|4203074|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377096|NCT00330187|4203075|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377097|NCT00330187|4203076|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377098|NCT00330187|4203072|B5||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4377099|NCT00330187|4203073|B4||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4377100|NCT00330187|4203074|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4377101|NCT00330187|4203075|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4377102|NCT00330187|4203076|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4377103|NCT00330187|4203072|B5||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
4377104|NCT00330187|4203073|B4||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4377105|NCT00330187|4203074|B3||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4377106|NCT00330187|4203075|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4377107|NCT00330187|4203076|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4377108|NCT00330174|4203089|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
4377109|NCT00330174|4203090|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4377110|NCT00330174|4203091|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4377111|NCT00330174|4203089|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4377112|NCT00330174|4203090|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4377113|NCT00330174|4203091|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4377114|NCT00330174|4203089|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4377115|NCT00330174|4203090|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4377116|NCT00330174|4203091|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4377117|NCT00330174|4203089|B3|||Age||years|Mean|44.1|44.1|Standard Deviation|9.3|9.3|||
4377118|NCT00330174|4203090|B2|||Age||years|Mean|44.6|44.6|Standard Deviation|8.7|8.7|||
4377119|NCT00330174|4203091|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|9.9|9.9|||
4377120|NCT00330174|4203089|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377121|NCT00330174|4203090|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377122|NCT00330174|4203091|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377123|NCT00330174|4203089|B3||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4377124|NCT00330174|4203090|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4377125|NCT00330174|4203091|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4377126|NCT00330174|4203089|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377127|NCT00330174|4203090|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377128|NCT00330174|4203091|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377129|NCT00330161|4203104|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4377130|NCT00330161|4203104|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4377131|NCT00330161|4203104|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377132|NCT00330161|4203104|B1|Age||Age||years|Median|68|68.0|Full Range|||54.0|80.0|
4377133|NCT00329901|4203113|B4||Male|Sex: Female, Male||Participants|Count of Participants|554|554.0||||||
4377134|NCT00329901|4203114|B3||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4377135|NCT00329901|4203115|B2||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4377136|NCT00329901|4203116|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4377137|NCT00329901|4203113|B4||Female|Sex: Female, Male||Participants|Count of Participants|518|518.0||||||
4377138|NCT00329901|4203114|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4377139|NCT00329901|4203115|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4377140|NCT00329901|4203116|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4377141|NCT00329901|4203113|B4|||Age||years|Mean|14.3|14.3|Standard Deviation|3.3|3.3|||
4377142|NCT00329901|4203114|B3|||Age||years|Mean|14.3|14.3|Standard Deviation|3.2|3.2|||
4377143|NCT00329901|4203115|B2|||Age||years|Mean|14.1|14.1|Standard Deviation|3.2|3.2|||
4377144|NCT00329901|4203116|B1|||Age||years|Mean|14.4|14.4|Standard Deviation|3.4|3.4|||
4377145|NCT00329849|4203146|B3||Male|Sex: Female, Male||Participants|Count of Participants|730|730.0||||||
4377146|NCT00329849|4203147|B2||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4377147|NCT00329849|4203148|B1||Male|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
4377148|NCT00329849|4203146|B3||Female|Sex: Female, Male||Participants|Count of Participants|770|770.0||||||
4377149|NCT00329849|4203147|B2||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4377150|NCT00329849|4203148|B1||Female|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
4377151|NCT00329849|4203146|B3|||Age||Years|Mean|5.8|5.8|Standard Deviation|2.5|2.5|||
4377152|NCT00329849|4203147|B2|||Age||Years|Mean|5.7|5.7|Standard Deviation|2.5|2.5|||
4377153|NCT00329849|4203148|B1|||Age||Years|Mean|5.8|5.8|Standard Deviation|2.5|2.5|||
4377154|NCT00329836|4203169|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4377155|NCT00329836|4203169|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4377156|NCT00329836|4203169|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4377157|NCT00329836|4203169|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|10.5|10.5|||
4377158|NCT00329836|4203169|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377159|NCT00329836|4203169|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4377160|NCT00329836|4203169|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377161|NCT00329797|4203173|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4377162|NCT00329797|4203174|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4377163|NCT00329797|4203175|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4377164|NCT00329797|4203173|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377165|NCT00329797|4203174|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377166|NCT00329797|4203175|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377167|NCT00329797|4203173|B3|||Age||years|Median|71|71.0|Full Range|||51.0|87.0|
4377168|NCT00329797|4203174|B2|||Age||years|Median|71|71.0|Full Range|||56.0|84.0|
4377169|NCT00329797|4203175|B1|||Age||years|Median|70|70.0|Full Range|||51.0|87.0|
4377170|NCT00329784|4203188|B5|||Peanut-specific IgE|Immunoglobulin E (IgE) is an antibody produced by the immune system. If you have an allergy, your immune system overreacts to an allergen by producing antibodies called IgE. These antibodies travel to cells that release chemicals, causing an allergic reaction. Peanut-specific IgE is measured in a serum sample following a peanut skin prick test. Results <0.35 kUA/L is considered low level allergic reaction to peanut. Results from >= 0.35 to <15 kUA/L are considered mid-level allergic reaction to peanut. Results >=15 kUA/L are considered high level allergic reaction to peanut.|kUA/L|Median|0.0|0.0|Inter-Quartile Range|||0.0|0.3|
4377171|NCT00329784|4203189|B4|||Peanut-specific IgE|Immunoglobulin E (IgE) is an antibody produced by the immune system. If you have an allergy, your immune system overreacts to an allergen by producing antibodies called IgE. These antibodies travel to cells that release chemicals, causing an allergic reaction. Peanut-specific IgE is measured in a serum sample following a peanut skin prick test. Results <0.35 kUA/L is considered low level allergic reaction to peanut. Results from >= 0.35 to <15 kUA/L are considered mid-level allergic reaction to peanut. Results >=15 kUA/L are considered high level allergic reaction to peanut.|kUA/L|Median|1.3|1.3|Inter-Quartile Range|||0.2|5.5|
4377172|NCT00329784|4203190|B3|||Peanut-specific IgE|Immunoglobulin E (IgE) is an antibody produced by the immune system. If you have an allergy, your immune system overreacts to an allergen by producing antibodies called IgE. These antibodies travel to cells that release chemicals, causing an allergic reaction. Peanut-specific IgE is measured in a serum sample following a peanut skin prick test. Results <0.35 kUA/L is considered low level allergic reaction to peanut. Results from >= 0.35 to <15 kUA/L are considered mid-level allergic reaction to peanut. Results >=15 kUA/L are considered high level allergic reaction to peanut.|kUA/L|Median|0.4|0.4|Inter-Quartile Range|||0.1|3.0|
4377173|NCT00329784|4203191|B2|||Peanut-specific IgE|Immunoglobulin E (IgE) is an antibody produced by the immune system. If you have an allergy, your immune system overreacts to an allergen by producing antibodies called IgE. These antibodies travel to cells that release chemicals, causing an allergic reaction. Peanut-specific IgE is measured in a serum sample following a peanut skin prick test. Results <0.35 kUA/L is considered low level allergic reaction to peanut. Results from >= 0.35 to <15 kUA/L are considered mid-level allergic reaction to peanut. Results >=15 kUA/L are considered high level allergic reaction to peanut.|kUA/L|Median|0.0|0.0|Inter-Quartile Range|||0.0|0.1|
4377174|NCT00329784|4203192|B1|||Peanut-specific IgE|Immunoglobulin E (IgE) is an antibody produced by the immune system. If you have an allergy, your immune system overreacts to an allergen by producing antibodies called IgE. These antibodies travel to cells that release chemicals, causing an allergic reaction. Peanut-specific IgE is measured in a serum sample following a peanut skin prick test. Results <0.35 kUA/L is considered low level allergic reaction to peanut. Results from >= 0.35 to <15 kUA/L are considered mid-level allergic reaction to peanut. Results >=15 kUA/L are considered high level allergic reaction to peanut.|kUA/L|Median|0.0|0.0|Inter-Quartile Range|||0.0|0.2|
4377175|NCT00329784|4203188|B5|||Total IgE|Total Immunoglobulin E (IgE) includes the following potential allergens: peanut, hen’s egg white, cow’s milk, sesame, brazil nut, hazel nut, cashew, almond, walnut, house dust mite, cat dander, dog dander, timothy grass pollen, alternaria mold, and birch tree pollen. IgE is measured in a serum sample. Results <75 kUA/L suggests that the participant is not allergic to any of the potential allergens. A result >75 kUA/L suggests at least a mild clinical allergy. The higher the total IgE present in the serum sample, the more likely it is to be a presence of an allergy to at least one allergen|kUA/L|Mean|104.8|104.8|Standard Deviation|307.9|307.9|||
4377176|NCT00329784|4203189|B4|||Total IgE|Total Immunoglobulin E (IgE) includes the following potential allergens: peanut, hen’s egg white, cow’s milk, sesame, brazil nut, hazel nut, cashew, almond, walnut, house dust mite, cat dander, dog dander, timothy grass pollen, alternaria mold, and birch tree pollen. IgE is measured in a serum sample. Results <75 kUA/L suggests that the participant is not allergic to any of the potential allergens. A result >75 kUA/L suggests at least a mild clinical allergy. The higher the total IgE present in the serum sample, the more likely it is to be a presence of an allergy to at least one allergen|kUA/L|Mean|306.4|306.4|Standard Deviation|666.5|666.5|||
4377177|NCT00329784|4203190|B3|||Total IgE|Total Immunoglobulin E (IgE) includes the following potential allergens: peanut, hen’s egg white, cow’s milk, sesame, brazil nut, hazel nut, cashew, almond, walnut, house dust mite, cat dander, dog dander, timothy grass pollen, alternaria mold, and birch tree pollen. IgE is measured in a serum sample. Results <75 kUA/L suggests that the participant is not allergic to any of the potential allergens. A result >75 kUA/L suggests at least a mild clinical allergy. The higher the total IgE present in the serum sample, the more likely it is to be a presence of an allergy to at least one allergen|kUA/L|Mean|125.7|125.7|Standard Deviation|174.8|174.8|||
4377178|NCT00329784|4203191|B2|||Total IgE|Total Immunoglobulin E (IgE) includes the following potential allergens: peanut, hen’s egg white, cow’s milk, sesame, brazil nut, hazel nut, cashew, almond, walnut, house dust mite, cat dander, dog dander, timothy grass pollen, alternaria mold, and birch tree pollen. IgE is measured in a serum sample. Results <75 kUA/L suggests that the participant is not allergic to any of the potential allergens. A result >75 kUA/L suggests at least a mild clinical allergy. The higher the total IgE present in the serum sample, the more likely it is to be a presence of an allergy to at least one allergen|kUA/L|Mean|76.4|76.4|Standard Deviation|181.4|181.4|||
4377179|NCT00329784|4203192|B1|||Total IgE|Total Immunoglobulin E (IgE) includes the following potential allergens: peanut, hen’s egg white, cow’s milk, sesame, brazil nut, hazel nut, cashew, almond, walnut, house dust mite, cat dander, dog dander, timothy grass pollen, alternaria mold, and birch tree pollen. IgE is measured in a serum sample. Results <75 kUA/L suggests that the participant is not allergic to any of the potential allergens. A result >75 kUA/L suggests at least a mild clinical allergy. The higher the total IgE present in the serum sample, the more likely it is to be a presence of an allergy to at least one allergen|kUA/L|Mean|95.1|95.1|Standard Deviation|321.8|321.8|||
4377180|NCT00329784|4203188|B5|||SCORAD|A modified Scoring Atopic Dermatitis System (SCORAD) was used to detect eczema in children who may not have had access to topical anti-inflammatory medications or whose parents cannot recall or report the severity of their child’s eczema. Eczema is any type of dermatitis or inflammation of the skin. Atopic dermatitis is the most severe and chronic of all types of eczema. The range of the SCORAD is 0-103. Scores less than 15 indicate mild eczema, scores between 15 and 40 indicate moderate eczema, and scores greater than 40 indicate severe eczema.|units on a scale|Mean|34.4|34.4|Standard Deviation|18.9|18.9|||
4377181|NCT00329784|4203189|B4|||SCORAD|A modified Scoring Atopic Dermatitis System (SCORAD) was used to detect eczema in children who may not have had access to topical anti-inflammatory medications or whose parents cannot recall or report the severity of their child’s eczema. Eczema is any type of dermatitis or inflammation of the skin. Atopic dermatitis is the most severe and chronic of all types of eczema. The range of the SCORAD is 0-103. Scores less than 15 indicate mild eczema, scores between 15 and 40 indicate moderate eczema, and scores greater than 40 indicate severe eczema.|units on a scale|Mean|37.8|37.8|Standard Deviation|18.6|18.6|||
4377182|NCT00329784|4203190|B3|||SCORAD|A modified Scoring Atopic Dermatitis System (SCORAD) was used to detect eczema in children who may not have had access to topical anti-inflammatory medications or whose parents cannot recall or report the severity of their child’s eczema. Eczema is any type of dermatitis or inflammation of the skin. Atopic dermatitis is the most severe and chronic of all types of eczema. The range of the SCORAD is 0-103. Scores less than 15 indicate mild eczema, scores between 15 and 40 indicate moderate eczema, and scores greater than 40 indicate severe eczema.|units on a scale|Mean|33.7|33.7|Standard Deviation|16.2|16.2|||
4377252|NCT00329719|4203240|B5||White|Race (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4377183|NCT00329784|4203191|B2|||SCORAD|A modified Scoring Atopic Dermatitis System (SCORAD) was used to detect eczema in children who may not have had access to topical anti-inflammatory medications or whose parents cannot recall or report the severity of their child’s eczema. Eczema is any type of dermatitis or inflammation of the skin. Atopic dermatitis is the most severe and chronic of all types of eczema. The range of the SCORAD is 0-103. Scores less than 15 indicate mild eczema, scores between 15 and 40 indicate moderate eczema, and scores greater than 40 indicate severe eczema.|units on a scale|Mean|33.3|33.3|Standard Deviation|18.4|18.4|||
4377184|NCT00329784|4203192|B1|||SCORAD|A modified Scoring Atopic Dermatitis System (SCORAD) was used to detect eczema in children who may not have had access to topical anti-inflammatory medications or whose parents cannot recall or report the severity of their child’s eczema. Eczema is any type of dermatitis or inflammation of the skin. Atopic dermatitis is the most severe and chronic of all types of eczema. The range of the SCORAD is 0-103. Scores less than 15 indicate mild eczema, scores between 15 and 40 indicate moderate eczema, and scores greater than 40 indicate severe eczema.|units on a scale|Mean|35.0|35.0|Standard Deviation|19.9|19.9|||
4377185|NCT00329784|4203188|B5|||Age at Onset of Eczema|Age in months at which eczema symptoms began. Eczema is any type of dermatitis or inflammation of the skin. Severe eczema for this trial is based on three criteria. The first criterion was the parent or guardians’ description of their child’s eczema severity. The second criterion was the use of topical creams or ointments containing corticosteroids or calcineurin inhibitors. The third criterion will be a modified Scoring Atopic Dermatitis System (SCORAD). Infants with severe eczema are at a high risk of developing a peanut allergy|Months|Mean|2.3|2.3|Standard Deviation|1.6|1.6|||
4377186|NCT00329784|4203189|B4|||Age at Onset of Eczema|Age in months at which eczema symptoms began. Eczema is any type of dermatitis or inflammation of the skin. Severe eczema for this trial is based on three criteria. The first criterion was the parent or guardians’ description of their child’s eczema severity. The second criterion was the use of topical creams or ointments containing corticosteroids or calcineurin inhibitors. The third criterion will be a modified Scoring Atopic Dermatitis System (SCORAD). Infants with severe eczema are at a high risk of developing a peanut allergy|Months|Mean|2.4|2.4|Standard Deviation|1.5|1.5|||
4377187|NCT00329784|4203190|B3|||Age at Onset of Eczema|Age in months at which eczema symptoms began. Eczema is any type of dermatitis or inflammation of the skin. Severe eczema for this trial is based on three criteria. The first criterion was the parent or guardians’ description of their child’s eczema severity. The second criterion was the use of topical creams or ointments containing corticosteroids or calcineurin inhibitors. The third criterion will be a modified Scoring Atopic Dermatitis System (SCORAD). Infants with severe eczema are at a high risk of developing a peanut allergy|Months|Mean|2.1|2.1|Standard Deviation|1.6|1.6|||
4377188|NCT00329784|4203191|B2|||Age at Onset of Eczema|Age in months at which eczema symptoms began. Eczema is any type of dermatitis or inflammation of the skin. Severe eczema for this trial is based on three criteria. The first criterion was the parent or guardians’ description of their child’s eczema severity. The second criterion was the use of topical creams or ointments containing corticosteroids or calcineurin inhibitors. The third criterion will be a modified Scoring Atopic Dermatitis System (SCORAD). Infants with severe eczema are at a high risk of developing a peanut allergy|Months|Mean|2.3|2.3|Standard Deviation|1.6|1.6|||
4377189|NCT00329784|4203192|B1|||Age at Onset of Eczema|Age in months at which eczema symptoms began. Eczema is any type of dermatitis or inflammation of the skin. Severe eczema for this trial is based on three criteria. The first criterion was the parent or guardians’ description of their child’s eczema severity. The second criterion was the use of topical creams or ointments containing corticosteroids or calcineurin inhibitors. The third criterion will be a modified Scoring Atopic Dermatitis System (SCORAD). Infants with severe eczema are at a high risk of developing a peanut allergy|Months|Mean|2.2|2.2|Standard Deviation|1.7|1.7|||
4377190|NCT00329784|4203188|B5|||Severe Eczema|Number of participants with severe eczema at baseline. Eczema is any type of dermatitis or inflammation of the skin. Severe eczema for this trial is based on three criteria. The first criterion was the parent or guardians’ description of their child’s eczema severity. The second criterion was the use of topical creams or ointments containing corticosteroids or calcineurin inhibitors. The third criterion will be a modified Scoring Atopic Dermatitis System (SCORAD). Infants with severe eczema are at a high risk of developing a peanut allergy|Participants|Count of Participants|571|571.0||||||
4377191|NCT00329784|4203189|B4|||Severe Eczema|Number of participants with severe eczema at baseline. Eczema is any type of dermatitis or inflammation of the skin. Severe eczema for this trial is based on three criteria. The first criterion was the parent or guardians’ description of their child’s eczema severity. The second criterion was the use of topical creams or ointments containing corticosteroids or calcineurin inhibitors. The third criterion will be a modified Scoring Atopic Dermatitis System (SCORAD). Infants with severe eczema are at a high risk of developing a peanut allergy|Participants|Count of Participants|41|41.0||||||
4377192|NCT00329784|4203190|B3|||Severe Eczema|Number of participants with severe eczema at baseline. Eczema is any type of dermatitis or inflammation of the skin. Severe eczema for this trial is based on three criteria. The first criterion was the parent or guardians’ description of their child’s eczema severity. The second criterion was the use of topical creams or ointments containing corticosteroids or calcineurin inhibitors. The third criterion will be a modified Scoring Atopic Dermatitis System (SCORAD). Infants with severe eczema are at a high risk of developing a peanut allergy|Participants|Count of Participants|48|48.0||||||
4377193|NCT00329784|4203191|B2|||Severe Eczema|Number of participants with severe eczema at baseline. Eczema is any type of dermatitis or inflammation of the skin. Severe eczema for this trial is based on three criteria. The first criterion was the parent or guardians’ description of their child’s eczema severity. The second criterion was the use of topical creams or ointments containing corticosteroids or calcineurin inhibitors. The third criterion will be a modified Scoring Atopic Dermatitis System (SCORAD). Infants with severe eczema are at a high risk of developing a peanut allergy|Participants|Count of Participants|246|246.0||||||
4377253|NCT00329719|4203241|B4||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4377254|NCT00329719|4203242|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4377255|NCT00329719|4203243|B2||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4377256|NCT00329719|4203244|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4377358|NCT00329433|4203573|B3|||Age||years|Mean|61|61.0|Standard Deviation|11|11.0|||
4377194|NCT00329784|4203192|B1|||Severe Eczema|Number of participants with severe eczema at baseline. Eczema is any type of dermatitis or inflammation of the skin. Severe eczema for this trial is based on three criteria. The first criterion was the parent or guardians’ description of their child’s eczema severity. The second criterion was the use of topical creams or ointments containing corticosteroids or calcineurin inhibitors. The third criterion will be a modified Scoring Atopic Dermatitis System (SCORAD). Infants with severe eczema are at a high risk of developing a peanut allergy|Participants|Count of Participants|236|236.0||||||
4377195|NCT00329784|4203188|B5|United Kingdom||Region of Enrollment||Participants|Count of Participants|640|640.0||||||
4377196|NCT00329784|4203189|B4|United Kingdom||Region of Enrollment||Participants|Count of Participants|47|47.0||||||
4377197|NCT00329784|4203190|B3|United Kingdom||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
4377198|NCT00329784|4203191|B2|United Kingdom||Region of Enrollment||Participants|Count of Participants|272|272.0||||||
4377199|NCT00329784|4203192|B1|United Kingdom||Region of Enrollment||Participants|Count of Participants|270|270.0||||||
4377200|NCT00329784|4203188|B5||Male|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
4377201|NCT00329784|4203189|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4377202|NCT00329784|4203190|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4377203|NCT00329784|4203191|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4377204|NCT00329784|4203192|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4377205|NCT00329784|4203188|B5||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4377206|NCT00329784|4203189|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4377207|NCT00329784|4203190|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4377208|NCT00329784|4203191|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4377209|NCT00329784|4203192|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4377210|NCT00329784|4203188|B5|||Age||Months|Mean|7.8|7.8|Standard Deviation|1.7|1.7|||
4377211|NCT00329784|4203189|B4|||Age||Months|Mean|7.9|7.9|Standard Deviation|1.6|1.6|||
4377212|NCT00329784|4203190|B3|||Age||Months|Mean|8.4|8.4|Standard Deviation|1.7|1.7|||
4377213|NCT00329784|4203191|B2|||Age||Months|Mean|7.7|7.7|Standard Deviation|1.8|1.8|||
4377214|NCT00329784|4203192|B1|||Age||Months|Mean|7.7|7.7|Standard Deviation|1.7|1.7|||
4377215|NCT00329771|4203217|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4377216|NCT00329771|4203217|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4377217|NCT00329771|4203217|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4377218|NCT00329771|4203217|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377219|NCT00329771|4203217|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4377220|NCT00329771|4203217|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377221|NCT00329745|4203221|B3||Male|Gender||Participants|Count of Participants|4482|4482.0||||||
4377222|NCT00329745|4203222|B2||Male|Gender||Participants|Count of Participants|2231|2231.0||||||
4377223|NCT00329745|4203223|B1||Male|Gender||Participants|Count of Participants|2251|2251.0||||||
4377224|NCT00329745|4203221|B3||Female|Gender||Participants|Count of Participants|4205|4205.0||||||
4377225|NCT00329745|4203222|B2||Female|Gender||Participants|Count of Participants|2097|2097.0||||||
4377226|NCT00329745|4203223|B1||Female|Gender||Participants|Count of Participants|2108|2108.0||||||
4377227|NCT00329745|4203221|B3|||Age||months|Mean|35.4|35.4|Standard Deviation|1.22|1.22|||
4377228|NCT00329745|4203222|B2|||Age||months|Mean|35.4|35.4|Standard Deviation|1.26|1.26|||
4377229|NCT00329745|4203223|B1|||Age||months|Mean|35.4|35.4|Standard Deviation|1.18|1.18|||
4377230|NCT00329732|4203232|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4377231|NCT00329732|4203234|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4377232|NCT00329732|4203232|B3|Male||Gender||participants|Number|0|0.0||||||
4377233|NCT00329732|4203234|B1|Male||Gender||participants|Number|0|0.0||||||
4377234|NCT00329732|4203232|B3|Female||Gender||participants|Number|2|2.0||||||
4377235|NCT00329732|4203234|B1|Female||Gender||participants|Number|2|2.0||||||
4377236|NCT00329732|4203232|B3|>=65 years||Age||participants|Number|0|0.0||||||
4377237|NCT00329732|4203234|B1|>=65 years||Age||participants|Number|0|0.0||||||
4377238|NCT00329732|4203232|B3|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4377239|NCT00329732|4203234|B1|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4377240|NCT00329732|4203232|B3|<=18 years||Age||participants|Number|0|0.0||||||
4377241|NCT00329732|4203234|B1|<=18 years||Age||participants|Number|0|0.0||||||
4377242|NCT00329719|4203240|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4377243|NCT00329719|4203241|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377244|NCT00329719|4203242|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377245|NCT00329719|4203243|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4377246|NCT00329719|4203244|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377247|NCT00329719|4203240|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377248|NCT00329719|4203241|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377249|NCT00329719|4203242|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377250|NCT00329719|4203243|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377251|NCT00329719|4203244|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377257|NCT00329719|4203240|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4377258|NCT00329719|4203241|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377259|NCT00329719|4203242|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4377260|NCT00329719|4203243|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4377261|NCT00329719|4203244|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377262|NCT00329719|4203240|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377263|NCT00329719|4203241|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377264|NCT00329719|4203242|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377265|NCT00329719|4203243|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377266|NCT00329719|4203244|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377267|NCT00329719|4203240|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4377268|NCT00329719|4203241|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377269|NCT00329719|4203242|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377270|NCT00329719|4203243|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4377271|NCT00329719|4203244|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377272|NCT00329719|4203240|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377273|NCT00329719|4203241|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377274|NCT00329719|4203242|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377275|NCT00329719|4203243|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377276|NCT00329719|4203244|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377277|NCT00329719|4203240|B5||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4377278|NCT00329719|4203241|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4377279|NCT00329719|4203242|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4377280|NCT00329719|4203243|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4377281|NCT00329719|4203244|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4377282|NCT00329719|4203240|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4377283|NCT00329719|4203241|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4377284|NCT00329719|4203242|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4377285|NCT00329719|4203243|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4377286|NCT00329719|4203244|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4377287|NCT00329719|4203240|B5|||Age||years|Mean|56.0|56.0|Full Range|||24.0|76.0|
4377288|NCT00329719|4203241|B4|||Age||years|Mean|56.8|56.8|Full Range|||29.0|75.0|
4377289|NCT00329719|4203242|B3|||Age||years|Mean|58.4|58.4|Full Range|||51.0|63.0|
4377290|NCT00329719|4203243|B2|||Age||years|Mean|55.5|55.5|Full Range|||24.0|74.0|
4377291|NCT00329719|4203244|B1|||Age||years|Mean|53.8|53.8|Full Range|||24.0|76.0|
4377292|NCT00329641|4203269|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4377293|NCT00329641|4203269|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4377294|NCT00329641|4203269|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4377295|NCT00329641|4203269|B1|||Age||Years|Median|61|61.0|Full Range|||48.0|73.0|
4377296|NCT00329602|4203276|B3|Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|participants|Number|1|1.0||||||
4377297|NCT00329602|4203277|B2|Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|participants|Number|0|0.0||||||
4377298|NCT00329602|4203278|B1|Hawaiian or other Pacific Islander||Race/Ethnicity, Customized|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|participants|Number|1|1.0||||||
4377299|NCT00329602|4203276|B3|Asian||Race/Ethnicity, Customized|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|participants|Number|2|2.0||||||
4377300|NCT00329602|4203277|B2|Asian||Race/Ethnicity, Customized|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|participants|Number|0|0.0||||||
4377301|NCT00329602|4203278|B1|Asian||Race/Ethnicity, Customized|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|participants|Number|2|2.0||||||
4377302|NCT00329602|4203276|B3|White||Race/Ethnicity, Customized|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|participants|Number|401|401.0||||||
4377303|NCT00329602|4203277|B2|White||Race/Ethnicity, Customized|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|participants|Number|197|197.0||||||
4377304|NCT00329602|4203278|B1|White||Race/Ethnicity, Customized|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|participants|Number|204|204.0||||||
4377357|NCT00329433|4203575|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4377305|NCT00329602|4203276|B3||Male|Sex: Female, Male|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|Participants|Count of Participants|148|148.0||||||
4377306|NCT00329602|4203277|B2||Male|Sex: Female, Male|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|Participants|Count of Participants|73|73.0||||||
4377307|NCT00329602|4203278|B1||Male|Sex: Female, Male|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|Participants|Count of Participants|75|75.0||||||
4377308|NCT00329602|4203276|B3||Female|Sex: Female, Male|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|Participants|Count of Participants|256|256.0||||||
4377309|NCT00329602|4203277|B2||Female|Sex: Female, Male|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|Participants|Count of Participants|124|124.0||||||
4377310|NCT00329602|4203278|B1||Female|Sex: Female, Male|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|Participants|Count of Participants|132|132.0||||||
4377311|NCT00329602|4203276|B3|||Age|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|years|Mean|56.2|56.2|Standard Deviation|11.73|11.73|||
4377312|NCT00329602|4203277|B2|||Age|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|years|Mean|56.5|56.5|Standard Deviation|11.97|11.97|||
4377313|NCT00329602|4203278|B1|||Age|The Safety Population, comprised of all participants who received at least one dose of study medication, was used for all demographic characteristics.|years|Mean|55.9|55.9|Standard Deviation|11.53|11.53|||
4377314|NCT00329550|4203315|B4|Japan||Region of Enrollment||participants|Number|40.0|40.0||||||
4377315|NCT00329550|4203316|B3|Japan||Region of Enrollment||participants|Number|16|16.0||||||
4377316|NCT00329550|4203317|B2|Japan||Region of Enrollment||participants|Number|15|15.0||||||
4377317|NCT00329550|4203318|B1|Japan||Region of Enrollment||participants|Number|9|9.0||||||
4377318|NCT00329550|4203315|B4||Male|Sex: Female, Male||Participants|Count of Participants|31.0|31.0||||||
4377319|NCT00329550|4203316|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4377320|NCT00329550|4203317|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4377321|NCT00329550|4203318|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4377322|NCT00329550|4203315|B4||Female|Sex: Female, Male||Participants|Count of Participants|9.0|9.0||||||
4377323|NCT00329550|4203316|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4377324|NCT00329550|4203317|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4377325|NCT00329550|4203318|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4377326|NCT00329550|4203315|B4|||Age||years|Mean|31.7|31.7|Standard Deviation|9.7|9.7|||
4377327|NCT00329550|4203316|B3|||Age||years|Mean|33.3|33.3|Standard Deviation|10.0|10.0|||
4377328|NCT00329550|4203317|B2|||Age||years|Mean|29.3|29.3|Standard Deviation|9.1|9.1|||
4377329|NCT00329550|4203318|B1|||Age||years|Mean|32.7|32.7|Standard Deviation|10.4|10.4|||
4377330|NCT00329550|4203315|B4||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4377331|NCT00329550|4203316|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377332|NCT00329550|4203317|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377333|NCT00329550|4203318|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377334|NCT00329550|4203315|B4||Between 18 and 65 years|Age||Participants|Count of Participants|34.0|34.0||||||
4377335|NCT00329550|4203316|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4377336|NCT00329550|4203317|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4377337|NCT00329550|4203318|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4377338|NCT00329550|4203315|B4||<=18 years|Age||Participants|Count of Participants|6.0|6.0||||||
4377339|NCT00329550|4203316|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4377340|NCT00329550|4203317|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4377341|NCT00329550|4203318|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4377342|NCT00329524|4203567|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4377343|NCT00329524|4203567|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4377344|NCT00329524|4203567|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377345|NCT00329524|4203567|B1|||Age||years|Mean|50|50.0|Standard Deviation|5.5|5.5|||
4377346|NCT00329524|4203567|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377347|NCT00329524|4203567|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4377348|NCT00329524|4203567|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377349|NCT00329433|4203573|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4377350|NCT00329433|4203574|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4377351|NCT00329433|4203575|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4377352|NCT00329433|4203573|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4377353|NCT00329433|4203574|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4377354|NCT00329433|4203575|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4377355|NCT00329433|4203573|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4377356|NCT00329433|4203574|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4377359|NCT00329433|4203574|B2|||Age||years|Mean|61|61.0|Standard Deviation|12|12.0|||
4377360|NCT00329433|4203575|B1|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
4377361|NCT00329433|4203573|B3||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4377362|NCT00329433|4203574|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4377363|NCT00329433|4203575|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4377364|NCT00329433|4203573|B3||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4377365|NCT00329433|4203574|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4377366|NCT00329433|4203575|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4377367|NCT00329433|4203573|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377368|NCT00329433|4203574|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377369|NCT00329433|4203575|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377370|NCT00329420|4203582|B4|Japan||Region of Enrollment||participants|Number|46|46.0||||||
4377371|NCT00329420|4203583|B3|Japan||Region of Enrollment||participants|Number|15|15.0||||||
4377372|NCT00329420|4203584|B2|Japan||Region of Enrollment||participants|Number|13|13.0||||||
4377373|NCT00329420|4203585|B1|Japan||Region of Enrollment||participants|Number|18|18.0||||||
4377374|NCT00329420|4203582|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4377375|NCT00329420|4203583|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4377376|NCT00329420|4203584|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4377377|NCT00329420|4203585|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4377378|NCT00329420|4203582|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4377379|NCT00329420|4203583|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4377380|NCT00329420|4203584|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4377381|NCT00329420|4203585|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4377382|NCT00329420|4203582|B4|||Age||years|Mean|32.2|32.2|Standard Deviation|7.8|7.8|||
4377383|NCT00329420|4203583|B3|||Age||years|Mean|29.9|29.9|Standard Deviation|5.9|5.9|||
4377384|NCT00329420|4203584|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|8.2|8.2|||
4377385|NCT00329420|4203585|B1|||Age||years|Mean|30.4|30.4|Standard Deviation|7.5|7.5|||
4377386|NCT00329420|4203582|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377387|NCT00329420|4203583|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377388|NCT00329420|4203584|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377389|NCT00329420|4203585|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377390|NCT00329420|4203582|B4||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4377391|NCT00329420|4203583|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4377392|NCT00329420|4203584|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4377393|NCT00329420|4203585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4377394|NCT00329420|4203582|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4377395|NCT00329420|4203583|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377396|NCT00329420|4203584|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377397|NCT00329420|4203585|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4377398|NCT00329407|4203966|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4377399|NCT00329407|4203966|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4377400|NCT00329407|4203966|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4377401|NCT00329407|4203966|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|8.9|8.9|||
4377402|NCT00329407|4203966|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377403|NCT00329407|4203966|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4377404|NCT00329407|4203966|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377405|NCT00329238|4203971|B3|Missing||Serum creatinine clearance category||Participants|Number|28|28.0||||||
4377406|NCT00329238|4203972|B2|Missing||Serum creatinine clearance category||Participants|Number|16|16.0||||||
4377407|NCT00329238|4203973|B1|Missing||Serum creatinine clearance category||Participants|Number|12|12.0||||||
4377408|NCT00329238|4203971|B3|>= 80 mL/min||Serum creatinine clearance category||Participants|Number|2103|2103.0||||||
4377409|NCT00329238|4203972|B2|>= 80 mL/min||Serum creatinine clearance category||Participants|Number|1072|1072.0||||||
4377410|NCT00329238|4203973|B1|>= 80 mL/min||Serum creatinine clearance category||Participants|Number|1031|1031.0||||||
4377411|NCT00329238|4203971|B3|>=50 to <80 mL/min||Serum creatinine clearance category||Participants|Number|617|617.0||||||
4377412|NCT00329238|4203972|B2|>=50 to <80 mL/min||Serum creatinine clearance category||Participants|Number|289|289.0||||||
4377413|NCT00329238|4203973|B1|>=50 to <80 mL/min||Serum creatinine clearance category||Participants|Number|328|328.0||||||
4377414|NCT00329238|4203971|B3|>=30 to <50 mL/min||Serum creatinine clearance category||Participants|Number|104|104.0||||||
4377415|NCT00329238|4203972|B2|>=30 to <50 mL/min||Serum creatinine clearance category||Participants|Number|45|45.0||||||
4377416|NCT00329238|4203973|B1|>=30 to <50 mL/min||Serum creatinine clearance category||Participants|Number|59|59.0||||||
4377417|NCT00329238|4203971|B3|>=0 to <30 mL/min||Serum creatinine clearance category||Participants|Number|4|4.0||||||
4377418|NCT00329238|4203972|B2|>=0 to <30 mL/min||Serum creatinine clearance category||Participants|Number|4|4.0||||||
4377419|NCT00329238|4203973|B1|>=0 to <30 mL/min||Serum creatinine clearance category||Participants|Number|0|0.0||||||
4377420|NCT00329238|4203971|B3|||Serum creatinine clearance|N = 1418, 1410, 2828|mL/min|Mean|105.4|105.4|Standard Deviation|38.3|38.3|||
4377421|NCT00329238|4203972|B2|||Serum creatinine clearance|N = 1418, 1410, 2828|mL/min|Mean|106.6|106.6|Standard Deviation|37.9|37.9|||
4377422|NCT00329238|4203973|B1|||Serum creatinine clearance|N = 1418, 1410, 2828|mL/min|Mean|104.2|104.2|Standard Deviation|38.6|38.6|||
4377423|NCT00329238|4203971|B3|Current smoker||Smoking history||Participants|Number|454|454.0||||||
4377424|NCT00329238|4203972|B2|Current smoker||Smoking history||Participants|Number|231|231.0||||||
4377425|NCT00329238|4203973|B1|Current smoker||Smoking history||Participants|Number|223|223.0||||||
4377426|NCT00329238|4203971|B3|Ex-smoker||Smoking history||Participants|Number|759|759.0||||||
4377427|NCT00329238|4203972|B2|Ex-smoker||Smoking history||Participants|Number|366|366.0||||||
4377428|NCT00329238|4203973|B1|Ex-smoker||Smoking history||Participants|Number|393|393.0||||||
4377429|NCT00329238|4203971|B3|Non-smoker||Smoking history||Participants|Number|1643|1643.0||||||
4377430|NCT00329238|4203972|B2|Non-smoker||Smoking history||Participants|Number|829|829.0||||||
4377431|NCT00329238|4203973|B1|Non-smoker||Smoking history||Participants|Number|814|814.0||||||
4377432|NCT00329238|4203971|B3|Missing||Body Mass Index (BMI) category||Participants|Number|6|6.0||||||
4377433|NCT00329238|4203972|B2|Missing||Body Mass Index (BMI) category||Participants|Number|4|4.0||||||
4377434|NCT00329238|4203973|B1|Missing||Body Mass Index (BMI) category||Participants|Number|2|2.0||||||
4377435|NCT00329238|4203971|B3|>= 35 kg/square meter||Body Mass Index (BMI) category||Participants|Number|360|360.0||||||
4377436|NCT00329238|4203972|B2|>= 35 kg/square meter||Body Mass Index (BMI) category||Participants|Number|174|174.0||||||
4377437|NCT00329238|4203973|B1|>= 35 kg/square meter||Body Mass Index (BMI) category||Participants|Number|186|186.0||||||
4377438|NCT00329238|4203971|B3|>=30 to <35 kg/square meter||Body Mass Index (BMI) category||Participants|Number|686|686.0||||||
4377439|NCT00329238|4203972|B2|>=30 to <35 kg/square meter||Body Mass Index (BMI) category||Participants|Number|330|330.0||||||
4377440|NCT00329238|4203973|B1|>=30 to <35 kg/square meter||Body Mass Index (BMI) category||Participants|Number|356|356.0||||||
4377441|NCT00329238|4203971|B3|>=25 to <30 kg/square meter||Body Mass Index (BMI) category||Participants|Number|1155|1155.0||||||
4377442|NCT00329238|4203972|B2|>=25 to <30 kg/square meter||Body Mass Index (BMI) category||Participants|Number|584|584.0||||||
4377443|NCT00329238|4203973|B1|>=25 to <30 kg/square meter||Body Mass Index (BMI) category||Participants|Number|571|571.0||||||
4377444|NCT00329238|4203971|B3|<25 kg/square meter||Body Mass Index (BMI) category||Participants|Number|649|649.0||||||
4377445|NCT00329238|4203972|B2|<25 kg/square meter||Body Mass Index (BMI) category||Participants|Number|334|334.0||||||
4377446|NCT00329238|4203973|B1|<25 kg/square meter||Body Mass Index (BMI) category||Participants|Number|315|315.0||||||
4377447|NCT00329238|4203971|B3|||Body Mass Index (BMI)|N = 1428, 1422, 2850|kg/square meter|Mean|29.08|29.08|Standard Deviation|5.70|5.7|||
4377448|NCT00329238|4203972|B2|||Body Mass Index (BMI)|N = 1428, 1422, 2850|kg/square meter|Mean|29.01|29.01|Standard Deviation|5.75|5.75|||
4377449|NCT00329238|4203973|B1|||Body Mass Index (BMI)|N = 1428, 1422, 2850|kg/square meter|Mean|29.15|29.15|Standard Deviation|5.65|5.65|||
4377450|NCT00329238|4203971|B3|Missing||Weight category||Participants|Number|5|5.0||||||
4377451|NCT00329238|4203972|B2|Missing||Weight category||Participants|Number|4|4.0||||||
4377452|NCT00329238|4203973|B1|Missing||Weight category||Participants|Number|1|1.0||||||
4377453|NCT00329238|4203971|B3|>= 100 kg||Weight category||Participants|Number|599|599.0||||||
4377454|NCT00329238|4203972|B2|>= 100 kg||Weight category||Participants|Number|300|300.0||||||
4377455|NCT00329238|4203973|B1|>= 100 kg||Weight category||Participants|Number|299|299.0||||||
4377456|NCT00329238|4203971|B3|>= 50 to < 100 kg||Weight category||Participants|Number|2237|2237.0||||||
4377457|NCT00329238|4203972|B2|>= 50 to < 100 kg||Weight category||Participants|Number|1117|1117.0||||||
4377458|NCT00329238|4203973|B1|>= 50 to < 100 kg||Weight category||Participants|Number|1120|1120.0||||||
4377459|NCT00329238|4203971|B3|< 50 kg||Weight category||Participants|Number|15|15.0||||||
4377460|NCT00329238|4203972|B2|< 50 kg||Weight category||Participants|Number|5|5.0||||||
4377461|NCT00329238|4203973|B1|< 50 kg||Weight category||Participants|Number|10|10.0||||||
4377462|NCT00329238|4203971|B3|||Weight|N = 1429, 1422, 2851|kg|Mean|86.02|86.02|Standard Deviation|19.06|19.06|||
4377463|NCT00329238|4203972|B2|||Weight|N = 1429, 1422, 2851|kg|Mean|85.95|85.95|Standard Deviation|18.87|18.87|||
4377464|NCT00329238|4203973|B1|||Weight|N = 1429, 1422, 2851|kg|Mean|86.09|86.09|Standard Deviation|19.26|19.26|||
4377465|NCT00329238|4203971|B3|||Height|N = 1429, 1424, 2853|cm|Mean|171.75|171.75|Standard Deviation|9.90|9.9|||
4377466|NCT00329238|4203972|B2|||Height|N = 1429, 1424, 2853|cm|Mean|171.95|171.95|Standard Deviation|10.08|10.08|||
4377467|NCT00329238|4203973|B1|||Height|N = 1429, 1424, 2853|cm|Mean|171.55|171.55|Standard Deviation|9.73|9.73|||
4377468|NCT00329238|4203971|B3|Asian||Race/Ethnicity, Customized||Participants|Number|227|227.0||||||
4377469|NCT00329238|4203972|B2|Asian||Race/Ethnicity, Customized||Participants|Number|114|114.0||||||
4377470|NCT00329238|4203973|B1|Asian||Race/Ethnicity, Customized||Participants|Number|113|113.0||||||
4377471|NCT00329238|4203971|B3|Black||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4377472|NCT00329238|4203972|B2|Black||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4377473|NCT00329238|4203973|B1|Black||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4377474|NCT00329238|4203971|B3|White||Race/Ethnicity, Customized||Participants|Number|2572|2572.0||||||
4377475|NCT00329238|4203972|B2|White||Race/Ethnicity, Customized||Participants|Number|1284|1284.0||||||
4377476|NCT00329238|4203973|B1|White||Race/Ethnicity, Customized||Participants|Number|1288|1288.0||||||
4377477|NCT00329238|4203971|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|214|214.0||||||
4377478|NCT00329238|4203972|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|109|109.0||||||
4377479|NCT00329238|4203973|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|105|105.0||||||
4377480|NCT00329238|4203971|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|2642|2642.0||||||
4377481|NCT00329238|4203972|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|1317|1317.0||||||
4377482|NCT00329238|4203973|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|1325|1325.0||||||
4377483|NCT00329238|4203971|B3||Male|Sex: Female, Male||Participants|Count of Participants|1742|1742.0||||||
4377484|NCT00329238|4203972|B2||Male|Sex: Female, Male||Participants|Count of Participants|871|871.0||||||
4377485|NCT00329238|4203973|B1||Male|Sex: Female, Male||Participants|Count of Participants|871|871.0||||||
4377486|NCT00329238|4203971|B3||Female|Sex: Female, Male||Participants|Count of Participants|1114|1114.0||||||
4377487|NCT00329238|4203972|B2||Female|Sex: Female, Male||Participants|Count of Participants|555|555.0||||||
4377488|NCT00329238|4203973|B1||Female|Sex: Female, Male||Participants|Count of Participants|559|559.0||||||
4377489|NCT00329238|4203971|B3|>= 75 years||Age, Customized||participants|Number|259|259.0||||||
4377490|NCT00329238|4203972|B2|>= 75 years||Age, Customized||participants|Number|119|119.0||||||
4377491|NCT00329238|4203973|B1|>= 75 years||Age, Customized||participants|Number|140|140.0||||||
4377492|NCT00329238|4203971|B3|>=65 to <75 years||Age, Customized||participants|Number|591|591.0||||||
4377493|NCT00329238|4203972|B2|>=65 to <75 years||Age, Customized||participants|Number|288|288.0||||||
4377494|NCT00329238|4203973|B1|>=65 to <75 years||Age, Customized||participants|Number|303|303.0||||||
4377495|NCT00329238|4203971|B3|>=50 to <65 years||Age, Customized||participants|Number|959|959.0||||||
4377496|NCT00329238|4203972|B2|>=50 to <65 years||Age, Customized||participants|Number|459|459.0||||||
4377497|NCT00329238|4203973|B1|>=50 to <65 years||Age, Customized||participants|Number|500|500.0||||||
4377498|NCT00329238|4203971|B3|>=40 to <50 years||Age, Customized||participants|Number|541|541.0||||||
4377499|NCT00329238|4203972|B2|>=40 to <50 years||Age, Customized||participants|Number|291|291.0||||||
4377500|NCT00329238|4203973|B1|>=40 to <50 years||Age, Customized||participants|Number|250|250.0||||||
4377501|NCT00329238|4203971|B3|>=18 to <40 years||Age, Customized||participants|Number|506|506.0||||||
4377502|NCT00329238|4203972|B2|>=18 to <40 years||Age, Customized||participants|Number|269|269.0||||||
4377503|NCT00329238|4203973|B1|>=18 to <40 years||Age, Customized||participants|Number|237|237.0||||||
4377504|NCT00329238|4203971|B3|||Age||years|Mean|54.64|54.64|Standard Deviation|15.18|15.18|||
4377505|NCT00329238|4203972|B2|||Age||years|Mean|53.90|53.9|Standard Deviation|15.34|15.34|||
4377506|NCT00329238|4203973|B1|||Age||years|Mean|55.38|55.38|Standard Deviation|14.99|14.99|||
4377507|NCT00329160|4204010|B1||Male|Sex: Female, Male|1 participant did not receive drug and is not captured in these figures|Participants|Count of Participants|96|96.0||||||
4377508|NCT00329160|4204010|B1||Female|Sex: Female, Male|1 participant did not receive drug and is not captured in these figures|Participants|Count of Participants|30|30.0||||||
4377509|NCT00329160|4204010|B1|Years||Age||years|Mean|62.6|62.6|Standard Deviation|7.7|7.7|||
4377510|NCT00329108|4204017|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4377511|NCT00329108|4204018|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4377512|NCT00329108|4204019|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4377513|NCT00329108|4204017|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4377514|NCT00329108|4204018|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4377515|NCT00329108|4204019|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4377516|NCT00329108|4204017|B3|45-64 years||Age, Customized||participants|Number|13|13.0||||||
4377517|NCT00329108|4204018|B2|45-64 years||Age, Customized||participants|Number|7|7.0||||||
4377518|NCT00329108|4204019|B1|45-64 years||Age, Customized||participants|Number|6|6.0||||||
4377519|NCT00329108|4204017|B3|18-44 years||Age, Customized||participants|Number|16|16.0||||||
4377520|NCT00329108|4204018|B2|18-44 years||Age, Customized||participants|Number|7|7.0||||||
4377521|NCT00329108|4204019|B1|18-44 years||Age, Customized||participants|Number|9|9.0||||||
4377522|NCT00329030|4204026|B3|3||Number of Prior Therapies||participants|Number|39|39.0||||||
4377523|NCT00329030|4204027|B2|3||Number of Prior Therapies||participants|Number|23|23.0||||||
4377524|NCT00329030|4204028|B1|3||Number of Prior Therapies||participants|Number|16|16.0||||||
4377525|NCT00329030|4204026|B3|2||Number of Prior Therapies||participants|Number|176|176.0||||||
4377526|NCT00329030|4204027|B2|2||Number of Prior Therapies||participants|Number|83|83.0||||||
4377527|NCT00329030|4204028|B1|2||Number of Prior Therapies||participants|Number|93|93.0||||||
4377528|NCT00329030|4204026|B3|1||Number of Prior Therapies||participants|Number|9|9.0||||||
4377529|NCT00329030|4204027|B2|1||Number of Prior Therapies||participants|Number|7|7.0||||||
4377530|NCT00329030|4204028|B1|1||Number of Prior Therapies||participants|Number|2|2.0||||||
4377531|NCT00329030|4204026|B3|Second Complete Remission||Disease Status at Transplantation||participants|Number|108|108.0||||||
4377532|NCT00329030|4204027|B2|Second Complete Remission||Disease Status at Transplantation||participants|Number|53|53.0||||||
4377533|NCT00329030|4204028|B1|Second Complete Remission||Disease Status at Transplantation||participants|Number|55|55.0||||||
4377534|NCT00329030|4204026|B3|First Relapse||Disease Status at Transplantation||participants|Number|80|80.0||||||
4377535|NCT00329030|4204027|B2|First Relapse||Disease Status at Transplantation||participants|Number|45|45.0||||||
4377536|NCT00329030|4204028|B1|First Relapse||Disease Status at Transplantation||participants|Number|35|35.0||||||
4377537|NCT00329030|4204026|B3|First Partial Response||Disease Status at Transplantation||participants|Number|36|36.0||||||
4377538|NCT00329030|4204027|B2|First Partial Response||Disease Status at Transplantation||participants|Number|15|15.0||||||
4377539|NCT00329030|4204028|B1|First Partial Response||Disease Status at Transplantation||participants|Number|21|21.0||||||
4377540|NCT00329030|4204026|B3|70%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|8|8.0||||||
4377541|NCT00329030|4204027|B2|70%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|5|5.0||||||
4377542|NCT00329030|4204028|B1|70%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|3|3.0||||||
4377543|NCT00329030|4204026|B3|80%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|31|31.0||||||
4377544|NCT00329030|4204027|B2|80%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|19|19.0||||||
4377545|NCT00329030|4204028|B1|80%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|12|12.0||||||
4377546|NCT00329030|4204026|B3|90%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|130|130.0||||||
4377547|NCT00329030|4204027|B2|90%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|63|63.0||||||
4377548|NCT00329030|4204028|B1|90%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|67|67.0||||||
4377549|NCT00329030|4204026|B3|100%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|55|55.0||||||
4377550|NCT00329030|4204027|B2|100%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|26|26.0||||||
4377551|NCT00329030|4204028|B1|100%||Karnofsky Performance-status Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|29|29.0||||||
4377552|NCT00329030|4204026|B3|Second Complete Remission||Primary Disease Stage||participants|Number|107|107.0||||||
4377553|NCT00329030|4204027|B2|Second Complete Remission||Primary Disease Stage||participants|Number|52|52.0||||||
4377554|NCT00329030|4204028|B1|Second Complete Remission||Primary Disease Stage||participants|Number|55|55.0||||||
4377555|NCT00329030|4204026|B3|First Relapse||Primary Disease Stage||participants|Number|81|81.0||||||
4377556|NCT00329030|4204027|B2|First Relapse||Primary Disease Stage||participants|Number|46|46.0||||||
4377557|NCT00329030|4204028|B1|First Relapse||Primary Disease Stage||participants|Number|35|35.0||||||
4377558|NCT00329030|4204026|B3|Primary Induction Failure||Primary Disease Stage||participants|Number|36|36.0||||||
4377559|NCT00329030|4204027|B2|Primary Induction Failure||Primary Disease Stage||participants|Number|15|15.0||||||
4377560|NCT00329030|4204028|B1|Primary Induction Failure||Primary Disease Stage||participants|Number|21|21.0||||||
4377561|NCT00329030|4204026|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4377562|NCT00329030|4204027|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4377563|NCT00329030|4204028|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4377564|NCT00329030|4204026|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4377565|NCT00329030|4204027|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377566|NCT00329030|4204028|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4377567|NCT00329030|4204026|B3||White|Race (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
4377568|NCT00329030|4204027|B2||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4377569|NCT00329030|4204028|B1||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4377570|NCT00329030|4204026|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4377571|NCT00329030|4204027|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4377572|NCT00329030|4204028|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4377573|NCT00329030|4204026|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377574|NCT00329030|4204027|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377575|NCT00329030|4204028|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377576|NCT00329030|4204026|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4377577|NCT00329030|4204027|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4377578|NCT00329030|4204028|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4377579|NCT00329030|4204026|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4377580|NCT00329030|4204027|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4377581|NCT00329030|4204028|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377582|NCT00329030|4204026|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4377583|NCT00329030|4204027|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4377584|NCT00329030|4204028|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4377585|NCT00329030|4204026|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
4377586|NCT00329030|4204027|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4377587|NCT00329030|4204028|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4377588|NCT00329030|4204026|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4377589|NCT00329030|4204027|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4377590|NCT00329030|4204028|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4377591|NCT00329030|4204026|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4377592|NCT00329030|4204027|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4377593|NCT00329030|4204028|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4377594|NCT00329030|4204026|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4377595|NCT00329030|4204027|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4377596|NCT00329030|4204028|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4377597|NCT00329030|4204026|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|13.0|13.0|||
4377598|NCT00329030|4204027|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|12.5|12.5|||
4377599|NCT00329030|4204028|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|13.5|13.5|||
4377600|NCT00328926|4204057|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377601|NCT00328926|4204058|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377602|NCT00328926|4204059|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377603|NCT00328926|4204060|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377604|NCT00328926|4204057|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4377605|NCT00328926|4204058|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4377606|NCT00328926|4204059|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4377607|NCT00328926|4204060|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4377608|NCT00328926|4204057|B4|||Age||years|Mean|30.4|30.4|Standard Deviation|4.1|4.1|||
4377609|NCT00328926|4204058|B3|||Age||years|Mean|29.3|29.3|Standard Deviation|3.8|3.8|||
4377610|NCT00328926|4204059|B2|||Age||years|Mean|34.3|34.3|Standard Deviation|5.0|5.0|||
4377611|NCT00328926|4204060|B1|||Age||years|Mean|28.6|28.6|Standard Deviation|2.5|2.5|||
4377612|NCT00328861|4204076|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4377613|NCT00328861|4204077|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4377614|NCT00328861|4204078|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4377615|NCT00328861|4204076|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377616|NCT00328861|4204077|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377617|NCT00328861|4204078|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377618|NCT00328861|4204076|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377619|NCT00328861|4204077|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377620|NCT00328861|4204078|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377621|NCT00328861|4204076|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4377622|NCT00328861|4204077|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4377623|NCT00328861|4204078|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4377624|NCT00328861|4204076|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377625|NCT00328861|4204077|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377626|NCT00328861|4204078|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377627|NCT00328861|4204076|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377628|NCT00328861|4204077|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377629|NCT00328861|4204078|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377630|NCT00328861|4204076|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377631|NCT00328861|4204077|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377632|NCT00328861|4204078|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377633|NCT00328861|4204076|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377634|NCT00328861|4204077|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377635|NCT00328861|4204078|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377636|NCT00328861|4204076|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377637|NCT00328861|4204077|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377638|NCT00328861|4204078|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377639|NCT00328861|4204076|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4377640|NCT00328861|4204077|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4377641|NCT00328861|4204078|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4377642|NCT00328861|4204076|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377643|NCT00328861|4204077|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377644|NCT00328861|4204078|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377645|NCT00328861|4204076|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4377646|NCT00328861|4204077|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4377647|NCT00328861|4204078|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4377648|NCT00328861|4204076|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4377649|NCT00328861|4204077|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377650|NCT00328861|4204078|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4377651|NCT00328861|4204076|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|11.3|11.3|||
4377652|NCT00328861|4204077|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|0|0.0|||
4377653|NCT00328861|4204078|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|11.0|11.0|||
4377654|NCT00328861|4204076|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377655|NCT00328861|4204077|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377656|NCT00328861|4204078|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377657|NCT00328861|4204076|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4377658|NCT00328861|4204077|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4377659|NCT00328861|4204078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4377660|NCT00328861|4204076|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377661|NCT00328861|4204077|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377662|NCT00328861|4204078|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377663|NCT00328783|4204087|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
4377664|NCT00328783|4204087|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377665|NCT00328783|4204087|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4377666|NCT00328783|4204087|B1|||Age||years|Mean|54.19|54.19|Standard Deviation|10.82|10.82|||
4377667|NCT00328783|4204087|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4377668|NCT00328783|4204087|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4377669|NCT00328783|4204087|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377670|NCT00328770|4204095|B1|Canada||Region of Enrollment||participants|Number|70|70.0||||||
4377671|NCT00328770|4204095|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4377672|NCT00328770|4204095|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4377673|NCT00328770|4204095|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|7.3|7.3|||
4377674|NCT00328770|4204095|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4377675|NCT00328770|4204095|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4377676|NCT00328770|4204095|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377677|NCT00328627|4204101|B13|||Baseline metformin dose||mg|Mean|1886.5|1886.5|Standard Deviation|429.08|429.08|||
4377678|NCT00328627|4204102|B12|||Baseline metformin dose||mg|Mean|1884.6|1884.6|Standard Deviation|439.47|439.47|||
4377679|NCT00328627|4204103|B11|||Baseline metformin dose||mg|Mean|1919.6|1919.6|Standard Deviation|421.22|421.22|||
4377680|NCT00328627|4204104|B10|||Baseline metformin dose||mg|Mean|1918.6|1918.6|Standard Deviation|417.91|417.91|||
4377681|NCT00328627|4204105|B9|||Baseline metformin dose||mg|Mean|1867.1|1867.1|Standard Deviation|455.48|455.48|||
4377682|NCT00328627|4204106|B8|||Baseline metformin dose||mg|Mean|1822.3|1822.3|Standard Deviation|444.22|444.22|||
4377683|NCT00328627|4204107|B7|||Baseline metformin dose||mg|Mean|1853.5|1853.5|Standard Deviation|435.72|435.72|||
4377684|NCT00328627|4204108|B6|||Baseline metformin dose||mg|Mean|1880.0|1880.0|Standard Deviation|413.65|413.65|||
4377685|NCT00328627|4204109|B5|||Baseline metformin dose||mg|Mean|1909.6|1909.6|Standard Deviation|418.98|418.98|||
4377686|NCT00328627|4204110|B4|||Baseline metformin dose||mg|Mean|1892.6|1892.6|Standard Deviation|410.70|410.7|||
4377687|NCT00328627|4204111|B3|||Baseline metformin dose||mg|Mean|1851.2|1851.2|Standard Deviation|413.85|413.85|||
4377688|NCT00328627|4204112|B2|||Baseline metformin dose||mg|Mean|1902.0|1902.0|Standard Deviation|450.17|450.17|||
4377689|NCT00328627|4204113|B1|||Baseline metformin dose||mg|Mean|1936.8|1936.8|Standard Deviation|428.41|428.41|||
4377690|NCT00328627|4204101|B13|||Diabetes Duration||years|Mean|6.24|6.24|Standard Deviation|5.375|5.375|||
4377691|NCT00328627|4204102|B12|||Diabetes Duration||years|Mean|6.22|6.22|Standard Deviation|5.014|5.014|||
4377692|NCT00328627|4204103|B11|||Diabetes Duration||years|Mean|6.59|6.59|Standard Deviation|5.273|5.273|||
4377693|NCT00328627|4204104|B10|||Diabetes Duration||years|Mean|5.68|5.68|Standard Deviation|4.232|4.232|||
4377694|NCT00328627|4204105|B9|||Diabetes Duration||years|Mean|6.63|6.63|Standard Deviation|6.005|6.005|||
4377695|NCT00328627|4204106|B8|||Diabetes Duration||years|Mean|5.81|5.81|Standard Deviation|5.054|5.054|||
4377696|NCT00328627|4204107|B7|||Diabetes Duration||years|Mean|7.63|7.63|Standard Deviation|7.069|7.069|||
4377697|NCT00328627|4204108|B6|||Diabetes Duration||years|Mean|6.86|6.86|Standard Deviation|5.489|5.489|||
4377698|NCT00328627|4204109|B5|||Diabetes Duration||years|Mean|6.08|6.08|Standard Deviation|5.485|5.485|||
4377699|NCT00328627|4204110|B4|||Diabetes Duration||years|Mean|5.70|5.7|Standard Deviation|4.767|4.767|||
4377700|NCT00328627|4204111|B3|||Diabetes Duration||years|Mean|5.55|5.55|Standard Deviation|4.879|4.879|||
4377701|NCT00328627|4204112|B2|||Diabetes Duration||years|Mean|6.17|6.17|Standard Deviation|5.614|5.614|||
4377702|NCT00328627|4204113|B1|||Diabetes Duration||years|Mean|6.01|6.01|Standard Deviation|4.958|4.958|||
4377703|NCT00328627|4204101|B13|||Body Mass Index (BMI)||kg/m^2|Mean|31.15|31.15|Standard Deviation|5.122|5.122|||
4377704|NCT00328627|4204102|B12|||Body Mass Index (BMI)||kg/m^2|Mean|30.62|30.62|Standard Deviation|4.751|4.751|||
4377705|NCT00328627|4204103|B11|||Body Mass Index (BMI)||kg/m^2|Mean|31.51|31.51|Standard Deviation|5.206|5.206|||
4377706|NCT00328627|4204104|B10|||Body Mass Index (BMI)||kg/m^2|Mean|30.69|30.69|Standard Deviation|4.721|4.721|||
4377707|NCT00328627|4204105|B9|||Body Mass Index (BMI)||kg/m^2|Mean|31.86|31.86|Standard Deviation|5.585|5.585|||
4377708|NCT00328627|4204106|B8|||Body Mass Index (BMI)||kg/m^2|Mean|31.09|31.09|Standard Deviation|5.054|5.054|||
4377709|NCT00328627|4204107|B7|||Body Mass Index (BMI)||kg/m^2|Mean|31.41|31.41|Standard Deviation|5.391|5.391|||
4377710|NCT00328627|4204108|B6|||Body Mass Index (BMI)||kg/m^2|Mean|30.78|30.78|Standard Deviation|4.723|4.723|||
4377711|NCT00328627|4204109|B5|||Body Mass Index (BMI)||kg/m^2|Mean|31.53|31.53|Standard Deviation|4.979|4.979|||
4377712|NCT00328627|4204110|B4|||Body Mass Index (BMI)||kg/m^2|Mean|31.25|31.25|Standard Deviation|5.280|5.28|||
4377713|NCT00328627|4204111|B3|||Body Mass Index (BMI)||kg/m^2|Mean|31.48|31.48|Standard Deviation|5.733|5.733|||
4377714|NCT00328627|4204112|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.96|30.96|Standard Deviation|5.133|5.133|||
4377715|NCT00328627|4204113|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30.59|30.59|Standard Deviation|4.808|4.808|||
4377716|NCT00328627|4204101|B13|||Height||cm|Mean|163.88|163.88|Standard Deviation|10.522|10.522|||
4377717|NCT00328627|4204102|B12|||Height||cm|Mean|163.73|163.73|Standard Deviation|11.432|11.432|||
4377718|NCT00328627|4204103|B11|||Height||cm|Mean|163.82|163.82|Standard Deviation|10.708|10.708|||
4377719|NCT00328627|4204104|B10|||Height||cm|Mean|163.14|163.14|Standard Deviation|10.961|10.961|||
4377720|NCT00328627|4204105|B9|||Height||cm|Mean|163.64|163.64|Standard Deviation|9.548|9.548|||
4377721|NCT00328627|4204106|B8|||Height||cm|Mean|163.63|163.63|Standard Deviation|11.036|11.036|||
4377722|NCT00328627|4204107|B7|||Height||cm|Mean|164.59|164.59|Standard Deviation|9.724|9.724|||
4377723|NCT00328627|4204108|B6|||Height||cm|Mean|163.74|163.74|Standard Deviation|10.456|10.456|||
4377724|NCT00328627|4204109|B5|||Height||cm|Mean|164.59|164.59|Standard Deviation|10.841|10.841|||
4377725|NCT00328627|4204110|B4|||Height||cm|Mean|164.25|164.25|Standard Deviation|11.007|11.007|||
4377726|NCT00328627|4204111|B3|||Height||cm|Mean|162.38|162.38|Standard Deviation|9.790|9.79|||
4377727|NCT00328627|4204112|B2|||Height||cm|Mean|164.61|164.61|Standard Deviation|10.614|10.614|||
4377728|NCT00328627|4204113|B1|||Height||cm|Mean|164.48|164.48|Standard Deviation|10.157|10.157|||
4377729|NCT00328627|4204101|B13|||Weight||kg|Mean|84.17|84.17|Standard Deviation|18.470|18.47|||
4377730|NCT00328627|4204102|B12|||Weight||kg|Mean|82.79|82.79|Standard Deviation|18.768|18.768|||
4377731|NCT00328627|4204103|B11|||Weight||kg|Mean|85.01|85.01|Standard Deviation|18.536|18.536|||
4377732|NCT00328627|4204104|B10|||Weight||kg|Mean|82.10|82.1|Standard Deviation|17.019|17.019|||
4377733|NCT00328627|4204105|B9|||Weight||kg|Mean|85.77|85.77|Standard Deviation|18.844|18.844|||
4377734|NCT00328627|4204106|B8|||Weight||kg|Mean|83.68|83.68|Standard Deviation|18.340|18.34|||
4377735|NCT00328627|4204107|B7|||Weight||kg|Mean|85.86|85.86|Standard Deviation|20.347|20.347|||
4377736|NCT00328627|4204108|B6|||Weight||kg|Mean|82.90|82.9|Standard Deviation|16.570|16.57|||
4377737|NCT00328627|4204109|B5|||Weight||kg|Mean|85.95|85.95|Standard Deviation|18.498|18.498|||
4377738|NCT00328627|4204110|B4|||Weight||kg|Mean|84.68|84.68|Standard Deviation|18.634|18.634|||
4377739|NCT00328627|4204111|B3|||Weight||kg|Mean|83.25|83.25|Standard Deviation|18.326|18.326|||
4377740|NCT00328627|4204112|B2|||Weight||kg|Mean|84.63|84.63|Standard Deviation|19.378|19.378|||
4377741|NCT00328627|4204113|B1|||Weight||kg|Mean|83.38|83.38|Standard Deviation|18.378|18.378|||
4377742|NCT00328627|4204101|B13||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|265|265.0||||||
4377743|NCT00328627|4204102|B12||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4377744|NCT00328627|4204103|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4377745|NCT00328627|4204104|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4377746|NCT00328627|4204105|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4377747|NCT00328627|4204106|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4377748|NCT00328627|4204107|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4377749|NCT00328627|4204108|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4377750|NCT00328627|4204109|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4377751|NCT00328627|4204110|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4377752|NCT00328627|4204111|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4377753|NCT00328627|4204112|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4377754|NCT00328627|4204113|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4377755|NCT00328627|4204101|B13||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377756|NCT00328627|4204102|B12||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377757|NCT00328627|4204103|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377758|NCT00328627|4204104|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377759|NCT00328627|4204105|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377760|NCT00328627|4204106|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377761|NCT00328627|4204107|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377762|NCT00328627|4204108|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377763|NCT00328627|4204109|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377764|NCT00328627|4204110|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377765|NCT00328627|4204111|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377766|NCT00328627|4204112|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377767|NCT00328627|4204113|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377768|NCT00328627|4204101|B13||White|Race (NIH/OMB)||Participants|Count of Participants|1096|1096.0||||||
4377769|NCT00328627|4204102|B12||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4377770|NCT00328627|4204103|B11||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4377771|NCT00328627|4204104|B10||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4377772|NCT00328627|4204105|B9||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4377773|NCT00328627|4204106|B8||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4377774|NCT00328627|4204107|B7||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4377775|NCT00328627|4204108|B6||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4377776|NCT00328627|4204109|B5||White|Race (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4377777|NCT00328627|4204110|B4||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4377778|NCT00328627|4204111|B3||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4377779|NCT00328627|4204112|B2||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4377780|NCT00328627|4204113|B1||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4377781|NCT00328627|4204101|B13||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4377782|NCT00328627|4204102|B12||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4377783|NCT00328627|4204103|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4377784|NCT00328627|4204104|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4377785|NCT00328627|4204105|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4377786|NCT00328627|4204106|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4377787|NCT00328627|4204107|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4377788|NCT00328627|4204108|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4377789|NCT00328627|4204109|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4377790|NCT00328627|4204110|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4377791|NCT00328627|4204111|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4377792|NCT00328627|4204112|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4377793|NCT00328627|4204113|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4377794|NCT00328627|4204101|B13||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377795|NCT00328627|4204102|B12||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377796|NCT00328627|4204103|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377797|NCT00328627|4204104|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377798|NCT00328627|4204105|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377799|NCT00328627|4204106|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377800|NCT00328627|4204107|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377801|NCT00328627|4204108|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377802|NCT00328627|4204109|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377803|NCT00328627|4204110|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377804|NCT00328627|4204111|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377805|NCT00328627|4204112|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377806|NCT00328627|4204113|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377807|NCT00328627|4204101|B13||Asian|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4377808|NCT00328627|4204102|B12||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4377809|NCT00328627|4204103|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4377810|NCT00328627|4204104|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4377811|NCT00328627|4204105|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4377812|NCT00328627|4204106|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4377813|NCT00328627|4204107|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4377814|NCT00328627|4204108|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4377815|NCT00328627|4204109|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4377816|NCT00328627|4204110|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4377817|NCT00328627|4204111|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4377818|NCT00328627|4204112|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4377819|NCT00328627|4204113|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4377820|NCT00328627|4204101|B13||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4377821|NCT00328627|4204102|B12||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377822|NCT00328627|4204103|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377823|NCT00328627|4204104|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377824|NCT00328627|4204105|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377825|NCT00328627|4204106|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4377826|NCT00328627|4204107|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377827|NCT00328627|4204108|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4377828|NCT00328627|4204109|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4377829|NCT00328627|4204110|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377830|NCT00328627|4204111|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377831|NCT00328627|4204112|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377832|NCT00328627|4204113|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377833|NCT00328627|4204101|B13||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377834|NCT00328627|4204102|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377835|NCT00328627|4204103|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377836|NCT00328627|4204104|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377837|NCT00328627|4204105|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377838|NCT00328627|4204106|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377839|NCT00328627|4204107|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377840|NCT00328627|4204108|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377841|NCT00328627|4204109|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377842|NCT00328627|4204110|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377843|NCT00328627|4204111|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377844|NCT00328627|4204112|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377845|NCT00328627|4204113|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377846|NCT00328627|4204101|B13||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|809|809.0||||||
4377847|NCT00328627|4204102|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4377848|NCT00328627|4204103|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4377849|NCT00328627|4204104|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4377850|NCT00328627|4204105|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4377851|NCT00328627|4204106|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4377852|NCT00328627|4204107|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4377853|NCT00328627|4204108|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4377854|NCT00328627|4204109|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4377855|NCT00328627|4204110|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4377856|NCT00328627|4204111|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4377857|NCT00328627|4204112|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4377858|NCT00328627|4204113|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4377859|NCT00328627|4204101|B13||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|745|745.0||||||
4377860|NCT00328627|4204102|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4377861|NCT00328627|4204103|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4377862|NCT00328627|4204104|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4377863|NCT00328627|4204105|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4377864|NCT00328627|4204106|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4377865|NCT00328627|4204107|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4377866|NCT00328627|4204108|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4377867|NCT00328627|4204109|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4377868|NCT00328627|4204110|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4377869|NCT00328627|4204111|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4377870|NCT00328627|4204112|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4377871|NCT00328627|4204113|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4377872|NCT00328627|4204101|B13||Male|Sex: Female, Male||Participants|Count of Participants|697|697.0||||||
4377873|NCT00328627|4204102|B12||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4377874|NCT00328627|4204103|B11||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4377875|NCT00328627|4204104|B10||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4377876|NCT00328627|4204105|B9||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4377877|NCT00328627|4204106|B8||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4377878|NCT00328627|4204107|B7||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4377879|NCT00328627|4204108|B6||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4377880|NCT00328627|4204109|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4377881|NCT00328627|4204110|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4377882|NCT00328627|4204111|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4377883|NCT00328627|4204112|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4377884|NCT00328627|4204113|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4377885|NCT00328627|4204101|B13||Female|Sex: Female, Male||Participants|Count of Participants|857|857.0||||||
4377886|NCT00328627|4204102|B12||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4377887|NCT00328627|4204103|B11||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4377888|NCT00328627|4204104|B10||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4377889|NCT00328627|4204105|B9||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4377890|NCT00328627|4204106|B8||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4377891|NCT00328627|4204107|B7||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4377892|NCT00328627|4204108|B6||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4377893|NCT00328627|4204109|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4377894|NCT00328627|4204110|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4377895|NCT00328627|4204111|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4377896|NCT00328627|4204112|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4377897|NCT00328627|4204113|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4377898|NCT00328627|4204101|B13|≥65 years||Age, Customized||participants|Number|232|232.0||||||
4377899|NCT00328627|4204102|B12|≥65 years||Age, Customized||participants|Number|18|18.0||||||
4377900|NCT00328627|4204103|B11|≥65 years||Age, Customized||participants|Number|19|19.0||||||
4377901|NCT00328627|4204104|B10|≥65 years||Age, Customized||participants|Number|17|17.0||||||
4377902|NCT00328627|4204105|B9|≥65 years||Age, Customized||participants|Number|23|23.0||||||
4377903|NCT00328627|4204106|B8|≥65 years||Age, Customized||participants|Number|19|19.0||||||
4377904|NCT00328627|4204107|B7|≥65 years||Age, Customized||participants|Number|28|28.0||||||
4377905|NCT00328627|4204108|B6|≥65 years||Age, Customized||participants|Number|18|18.0||||||
4377906|NCT00328627|4204109|B5|≥65 years||Age, Customized||participants|Number|21|21.0||||||
4377907|NCT00328627|4204110|B4|≥65 years||Age, Customized||participants|Number|17|17.0||||||
4377908|NCT00328627|4204111|B3|≥65 years||Age, Customized||participants|Number|17|17.0||||||
4377909|NCT00328627|4204112|B2|≥65 years||Age, Customized||participants|Number|12|12.0||||||
4377910|NCT00328627|4204113|B1|≥65 years||Age, Customized||participants|Number|23|23.0||||||
4377911|NCT00328627|4204101|B13|<65 years||Age, Customized||participants|Number|1322|1322.0||||||
4377912|NCT00328627|4204102|B12|<65 years||Age, Customized||participants|Number|112|112.0||||||
4377913|NCT00328627|4204103|B11|<65 years||Age, Customized||participants|Number|111|111.0||||||
4377914|NCT00328627|4204104|B10|<65 years||Age, Customized||participants|Number|112|112.0||||||
4377915|NCT00328627|4204105|B9|<65 years||Age, Customized||participants|Number|107|107.0||||||
4377916|NCT00328627|4204106|B8|<65 years||Age, Customized||participants|Number|111|111.0||||||
4377917|NCT00328627|4204107|B7|<65 years||Age, Customized||participants|Number|101|101.0||||||
4377918|NCT00328627|4204108|B6|<65 years||Age, Customized||participants|Number|112|112.0||||||
4377919|NCT00328627|4204109|B5|<65 years||Age, Customized||participants|Number|109|109.0||||||
4377920|NCT00328627|4204110|B4|<65 years||Age, Customized||participants|Number|113|113.0||||||
4377921|NCT00328627|4204111|B3|<65 years||Age, Customized||participants|Number|112|112.0||||||
4377922|NCT00328627|4204112|B2|<65 years||Age, Customized||participants|Number|116|116.0||||||
4377923|NCT00328627|4204113|B1|<65 years||Age, Customized||participants|Number|106|106.0||||||
4377924|NCT00328627|4204101|B13|||Age||years|Mean|54.4|54.4|Standard Deviation|9.50|9.5|||
4377925|NCT00328627|4204102|B12|||Age||years|Mean|54.2|54.2|Standard Deviation|8.86|8.86|||
4377926|NCT00328627|4204103|B11|||Age||years|Mean|54.0|54.0|Standard Deviation|9.82|9.82|||
4377927|NCT00328627|4204104|B10|||Age||years|Mean|54.5|54.5|Standard Deviation|9.70|9.7|||
4377928|NCT00328627|4204105|B9|||Age||years|Mean|54.4|54.4|Standard Deviation|9.69|9.69|||
4377929|NCT00328627|4204106|B8|||Age||years|Mean|55.0|55.0|Standard Deviation|9.07|9.07|||
4377930|NCT00328627|4204107|B7|||Age||years|Mean|56.1|56.1|Standard Deviation|9.43|9.43|||
4377931|NCT00328627|4204108|B6|||Age||years|Mean|54.9|54.9|Standard Deviation|9.18|9.18|||
4377932|NCT00328627|4204109|B5|||Age||years|Mean|53.6|53.6|Standard Deviation|9.91|9.91|||
4377933|NCT00328627|4204110|B4|||Age||years|Mean|54.1|54.1|Standard Deviation|9.54|9.54|||
4377934|NCT00328627|4204111|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|9.31|9.31|||
4377935|NCT00328627|4204112|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|9.59|9.59|||
4377936|NCT00328627|4204113|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|9.89|9.89|||
4377937|NCT00328614|4205641|B7|United States||Region of Enrollment||participants|Number|32|32.0||||||
4377938|NCT00328614|4205642|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
4377939|NCT00328614|4205643|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4377940|NCT00328614|4205644|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4377941|NCT00328614|4205645|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4377942|NCT00328614|4205646|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4377943|NCT00328614|4205647|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4377944|NCT00328614|4205641|B7||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4377945|NCT00328614|4205642|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4377946|NCT00328614|4205643|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4377947|NCT00328614|4205644|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4377948|NCT00328614|4205645|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4377949|NCT00328614|4205646|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4377950|NCT00328614|4205647|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4377951|NCT00328614|4205641|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377952|NCT00328614|4205642|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377953|NCT00328614|4205643|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377954|NCT00328614|4205644|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377955|NCT00328614|4205645|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377956|NCT00328614|4205646|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377957|NCT00328614|4205647|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4377958|NCT00328614|4205641|B7|||Age||years|Mean|66.99|66.99|Standard Deviation|8.75|8.75|||
4377959|NCT00328614|4205642|B6|||Age||years|Mean|66.19|66.19|Standard Deviation|8.02|8.02|||
4377960|NCT00328614|4205643|B5|||Age||years|Mean|68.00|68.0|Standard Deviation|13.13|13.13|||
4377961|NCT00328614|4205644|B4|||Age||years|Mean|69.46|69.46|Standard Deviation|8.04|8.04|||
4377962|NCT00328614|4205645|B3|||Age||years|Mean|65.58|65.58|Standard Deviation|10.00|10.0|||
4377963|NCT00328614|4205646|B2|||Age||years|Mean|65.10|65.1|Standard Deviation|9.78|9.78|||
4377964|NCT00328614|4205647|B1|||Age||years|Mean|66.97|66.97|Standard Deviation|1.37|1.37|||
4377965|NCT00328614|4205641|B7||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4377966|NCT00328614|4205642|B6||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4377967|NCT00328614|4205643|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4377968|NCT00328614|4205644|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4377969|NCT00328614|4205645|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4377970|NCT00328614|4205646|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4377971|NCT00328614|4205647|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4377972|NCT00328614|4205641|B7||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4377973|NCT00328614|4205642|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4377974|NCT00328614|4205643|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4377975|NCT00328614|4205644|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4377976|NCT00328614|4205645|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4377977|NCT00328614|4205646|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4377978|NCT00328614|4205647|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4377979|NCT00328614|4205641|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377980|NCT00328614|4205642|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377981|NCT00328614|4205643|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377982|NCT00328614|4205644|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377983|NCT00328614|4205645|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377984|NCT00328614|4205646|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377985|NCT00328614|4205647|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4377986|NCT00328562|4205661|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4377987|NCT00328562|4205661|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4377988|NCT00328562|4205661|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4377989|NCT00328562|4205661|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377990|NCT00328562|4205661|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377991|NCT00328562|4205661|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377992|NCT00328562|4205661|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4377993|NCT00328562|4205661|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4377994|NCT00328562|4205661|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377995|NCT00328562|4205661|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4377996|NCT00328562|4205661|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4377997|NCT00328562|4205661|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4377998|NCT00328562|4205661|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4377999|NCT00328562|4205661|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4378000|NCT00328562|4205661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4378001|NCT00328562|4205661|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378002|NCT00328562|4205661|B1|||Age||years|Mean|68.75|68.75|Standard Deviation|13.24|13.24|||
4378003|NCT00328510|4205668|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
4378004|NCT00328510|4205669|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4378005|NCT00328510|4205670|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4378006|NCT00328510|4205668|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4378007|NCT00328510|4205669|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4378008|NCT00328510|4205670|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4378009|NCT00328510|4205668|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4378010|NCT00328510|4205669|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4378011|NCT00328510|4205670|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4378012|NCT00328510|4205668|B3|||Age||years|Mean|56.18|56.18|Standard Deviation|14.44|14.44|||
4378013|NCT00328510|4205669|B2|||Age||years|Mean|56.94|56.94|Standard Deviation|14.07|14.07|||
4378014|NCT00328510|4205670|B1|||Age||years|Mean|55.43|55.43|Standard Deviation|14.93|14.93|||
4378015|NCT00328510|4205668|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4378016|NCT00328510|4205669|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4378017|NCT00328510|4205670|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4378018|NCT00328510|4205668|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4378019|NCT00328510|4205669|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4378020|NCT00328510|4205670|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4378021|NCT00328510|4205668|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378022|NCT00328510|4205669|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378023|NCT00328510|4205670|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378024|NCT00328263|4205677|B3|Canada||Region of Enrollment||participants|Number|437|437.0||||||
4378025|NCT00328263|4205678|B2|Canada||Region of Enrollment||participants|Number|221|221.0||||||
4378026|NCT00328263|4205679|B1|Canada||Region of Enrollment||participants|Number|216|216.0||||||
4378027|NCT00328263|4205677|B3||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4378028|NCT00328263|4205678|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4378029|NCT00328263|4205679|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4378030|NCT00328263|4205677|B3||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4378031|NCT00328263|4205678|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4378032|NCT00328263|4205679|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4378033|NCT00328263|4205677|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|18.6|18.6|||
4378034|NCT00328263|4205678|B2|||Age||years|Mean|58.1|58.1|Standard Deviation|19.1|19.1|||
4378035|NCT00328263|4205679|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|18.1|18.1|||
4378036|NCT00328198|4205686|B1|2||World Health Organization (WHO) Performance|"The WHO performance status classification categorises patients as:~0: able to carry out all normal activity without restriction~restricted in strenuous activity but ambulatory and able to carry out light work~ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours"|participants|Number|3|3.0||||||
4378037|NCT00328198|4205686|B1|1||World Health Organization (WHO) Performance|"The WHO performance status classification categorises patients as:~0: able to carry out all normal activity without restriction~restricted in strenuous activity but ambulatory and able to carry out light work~ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours"|participants|Number|28|28.0||||||
4378038|NCT00328198|4205686|B1|0||World Health Organization (WHO) Performance|"The WHO performance status classification categorises patients as:~0: able to carry out all normal activity without restriction~restricted in strenuous activity but ambulatory and able to carry out light work~ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours"|participants|Number|55|55.0||||||
4378039|NCT00328198|4205686|B1|Stage C||Current Binet Stage|"Binet staging is another way to categorize chronic lymphocytic leukemia (CLL). Data represents the Binet Stage when the participant entered the study.~Stage A CLL is characterized by no anemia or thrombocytopenia and fewer than three areas of lymphoid involvement (Rai stages 0, I, and II).~Stage B CLL is characterized by no anemia or thrombocytopenia with three or more areas of lymphoid involvement (Rai stages I and II).~Stage C CLL is characterized by anemia and/or thrombocytopenia regardless of the number of areas of lymphoid enlargement (Rai stages III and IV)."|participants|Number|44|44.0||||||
4378040|NCT00328198|4205686|B1|Stage B||Current Binet Stage|"Binet staging is another way to categorize chronic lymphocytic leukemia (CLL). Data represents the Binet Stage when the participant entered the study.~Stage A CLL is characterized by no anemia or thrombocytopenia and fewer than three areas of lymphoid involvement (Rai stages 0, I, and II).~Stage B CLL is characterized by no anemia or thrombocytopenia with three or more areas of lymphoid involvement (Rai stages I and II).~Stage C CLL is characterized by anemia and/or thrombocytopenia regardless of the number of areas of lymphoid enlargement (Rai stages III and IV)."|participants|Number|22|22.0||||||
4378041|NCT00328198|4205686|B1|Stage A||Current Binet Stage|"Binet staging is another way to categorize chronic lymphocytic leukemia (CLL). Data represents the Binet Stage when the participant entered the study.~Stage A CLL is characterized by no anemia or thrombocytopenia and fewer than three areas of lymphoid involvement (Rai stages 0, I, and II).~Stage B CLL is characterized by no anemia or thrombocytopenia with three or more areas of lymphoid involvement (Rai stages I and II).~Stage C CLL is characterized by anemia and/or thrombocytopenia regardless of the number of areas of lymphoid enlargement (Rai stages III and IV)."|participants|Number|20|20.0||||||
4378042|NCT00328198|4205686|B1|Rai Stage IV||Current Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity. Data represents the Rai Stage when the participant entered the study.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly, Rai Stage III Lymphocytosis with anemia, Rai Stage IV Lymphocytosis with thrombocytopenia"|participants|Number|40|40.0||||||
4378043|NCT00328198|4205686|B1|Rai Stage III||Current Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity. Data represents the Rai Stage when the participant entered the study.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly, Rai Stage III Lymphocytosis with anemia, Rai Stage IV Lymphocytosis with thrombocytopenia"|participants|Number|7|7.0||||||
4378044|NCT00328198|4205686|B1|Rai Stage II||Current Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity. Data represents the Rai Stage when the participant entered the study.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly, Rai Stage III Lymphocytosis with anemia, Rai Stage IV Lymphocytosis with thrombocytopenia"|participants|Number|22|22.0||||||
4378045|NCT00328198|4205686|B1|Rai Stage I||Current Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity. Data represents the Rai Stage when the participant entered the study.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly, Rai Stage III Lymphocytosis with anemia, Rai Stage IV Lymphocytosis with thrombocytopenia"|participants|Number|10|10.0||||||
4378046|NCT00328198|4205686|B1|Rai Stage 0||Current Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity. Data represents the Rai Stage when the participant entered the study.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly, Rai Stage III Lymphocytosis with anemia, Rai Stage IV Lymphocytosis with thrombocytopenia"|participants|Number|7|7.0||||||
4378047|NCT00328198|4205686|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378048|NCT00328198|4205686|B1|White||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4378049|NCT00328198|4205686|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4378050|NCT00328198|4205686|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4378051|NCT00328198|4205686|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378052|NCT00328198|4205686|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4378053|NCT00328198|4205686|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4378054|NCT00328198|4205686|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4378055|NCT00328198|4205686|B1|||Age||years|Mean|65.32|65.32|Standard Deviation|9.035|9.035|||
4378056|NCT00328172|4205696|B6|||Fasting blood plasma glucose (FPG)||milligram/deciliter (mg/dL)|Mean|188.4|188.4|Standard Deviation|38.8|38.8|||
4378057|NCT00328172|4205697|B5|||Fasting blood plasma glucose (FPG)||milligram/deciliter (mg/dL)|Mean|193.9|193.9|Standard Deviation|45.9|45.9|||
4378058|NCT00328172|4205698|B4|||Fasting blood plasma glucose (FPG)||milligram/deciliter (mg/dL)|Mean|188.7|188.7|Standard Deviation|40.1|40.1|||
4378059|NCT00328172|4205699|B3|||Fasting blood plasma glucose (FPG)||milligram/deciliter (mg/dL)|Mean|191.9|191.9|Standard Deviation|37.8|37.8|||
4378060|NCT00328172|4205700|B2|||Fasting blood plasma glucose (FPG)||milligram/deciliter (mg/dL)|Mean|185.2|185.2|Standard Deviation|34.0|34.0|||
4378061|NCT00328172|4205701|B1|||Fasting blood plasma glucose (FPG)||milligram/deciliter (mg/dL)|Mean|183.0|183.0|Standard Deviation|34.9|34.9|||
4378062|NCT00328172|4205696|B6|||Baseline glycosylated hemoglobin (HbA1c)||percentage|Mean|8.3|8.3|Standard Deviation|0.69|0.69|||
4378063|NCT00328172|4205697|B5|||Baseline glycosylated hemoglobin (HbA1c)||percentage|Mean|8.3|8.3|Standard Deviation|0.64|0.64|||
4378064|NCT00328172|4205698|B4|||Baseline glycosylated hemoglobin (HbA1c)||percentage|Mean|8.4|8.4|Standard Deviation|0.80|0.8|||
4378065|NCT00328172|4205699|B3|||Baseline glycosylated hemoglobin (HbA1c)||percentage|Mean|8.4|8.4|Standard Deviation|0.80|0.8|||
4378066|NCT00328172|4205700|B2|||Baseline glycosylated hemoglobin (HbA1c)||percentage|Mean|8.2|8.2|Standard Deviation|0.62|0.62|||
4378067|NCT00328172|4205701|B1|||Baseline glycosylated hemoglobin (HbA1c)||percentage|Mean|8.3|8.3|Standard Deviation|0.63|0.63|||
4378068|NCT00328172|4205696|B6|||Body Mass Index (BMI)||kilogram/square meter|Mean|31.1|31.1|Standard Deviation|4.3|4.3|||
4378069|NCT00328172|4205697|B5|||Body Mass Index (BMI)||kilogram/square meter|Mean|31.2|31.2|Standard Deviation|4.8|4.8|||
4378070|NCT00328172|4205698|B4|||Body Mass Index (BMI)||kilogram/square meter|Mean|31.2|31.2|Standard Deviation|4.3|4.3|||
4378071|NCT00328172|4205699|B3|||Body Mass Index (BMI)||kilogram/square meter|Mean|31.5|31.5|Standard Deviation|4.5|4.5|||
4378072|NCT00328172|4205700|B2|||Body Mass Index (BMI)||kilogram/square meter|Mean|30.9|30.9|Standard Deviation|3.8|3.8|||
4378073|NCT00328172|4205701|B1|||Body Mass Index (BMI)||kilogram/square meter|Mean|30.8|30.8|Standard Deviation|4.1|4.1|||
4378074|NCT00328172|4205696|B6|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378075|NCT00328172|4205697|B5|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378076|NCT00328172|4205698|B4|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4378077|NCT00328172|4205699|B3|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4378078|NCT00328172|4205700|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4378079|NCT00328172|4205701|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4378080|NCT00328172|4205696|B6|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4378081|NCT00328172|4205697|B5|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4378082|NCT00328172|4205698|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4378083|NCT00328172|4205699|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378084|NCT00328172|4205700|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4378085|NCT00328172|4205701|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4378086|NCT00328172|4205696|B6|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4378087|NCT00328172|4205697|B5|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4378088|NCT00328172|4205698|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378089|NCT00328172|4205699|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4378090|NCT00328172|4205700|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4378091|NCT00328172|4205701|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4378092|NCT00328172|4205696|B6|White||Race/Ethnicity, Customized||participants|Number|272|272.0||||||
4378093|NCT00328172|4205697|B5|White||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4378094|NCT00328172|4205698|B4|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4378095|NCT00328172|4205699|B3|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4378096|NCT00328172|4205700|B2|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4378097|NCT00328172|4205701|B1|White||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4378098|NCT00328172|4205696|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4378099|NCT00328172|4205697|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4378100|NCT00328172|4205698|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4378101|NCT00328172|4205699|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4378102|NCT00328172|4205700|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4378103|NCT00328172|4205701|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4378104|NCT00328172|4205696|B6|Not Hispanic||Race/Ethnicity, Customized||participants|Number|278|278.0||||||
4378105|NCT00328172|4205697|B5|Not Hispanic||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4378106|NCT00328172|4205698|B4|Not Hispanic||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4378107|NCT00328172|4205699|B3|Not Hispanic||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4378108|NCT00328172|4205700|B2|Not Hispanic||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4378109|NCT00328172|4205701|B1|Not Hispanic||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4378110|NCT00328172|4205696|B6||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4378111|NCT00328172|4205697|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4378112|NCT00328172|4205698|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4378113|NCT00328172|4205699|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4378114|NCT00328172|4205700|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4378115|NCT00328172|4205701|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4378116|NCT00328172|4205696|B6||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4378117|NCT00328172|4205697|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4378118|NCT00328172|4205698|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4378119|NCT00328172|4205699|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4378120|NCT00328172|4205700|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4378121|NCT00328172|4205701|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4378122|NCT00328172|4205696|B6|||Age||years|Mean|57.3|57.3|Standard Deviation|9.9|9.9|||
4378123|NCT00328172|4205697|B5|||Age||years|Mean|53.7|53.7|Standard Deviation|10.7|10.7|||
4378124|NCT00328172|4205698|B4|||Age||years|Mean|56.6|56.6|Standard Deviation|9.6|9.6|||
4378125|NCT00328172|4205699|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|10.3|10.3|||
4378126|NCT00328172|4205700|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|9.4|9.4|||
4378127|NCT00328172|4205701|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|8.9|8.9|||
4378128|NCT00328094|4205727|B3|United States||Region of Enrollment||participants|Number|236|236.0||||||
4378129|NCT00328094|4205728|B2|United States||Region of Enrollment||participants|Number|122|122.0||||||
4378130|NCT00328094|4205729|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4378131|NCT00328094|4205727|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4378132|NCT00328094|4205728|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4378133|NCT00328094|4205729|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4378134|NCT00328094|4205727|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4378135|NCT00328094|4205728|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4378136|NCT00328094|4205729|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4378137|NCT00328094|4205727|B3|||Age||years|Mean|69|69.0|Standard Deviation|11|11.0|||
4378138|NCT00328094|4205728|B2|||Age||years|Mean|71|71.0|Standard Deviation|11|11.0|||
4378139|NCT00328094|4205729|B1|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
4378140|NCT00328094|4205727|B3||>=65 years|Age||Participants|Count of Participants|144|144.0||||||
4378141|NCT00328094|4205728|B2||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
4378142|NCT00328094|4205729|B1||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
4378143|NCT00328094|4205727|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4378144|NCT00328094|4205728|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4378145|NCT00328094|4205729|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4378146|NCT00328094|4205727|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378147|NCT00328094|4205728|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378148|NCT00328094|4205729|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378149|NCT00328042|4205738|B3|United States||Region of Enrollment||participants|Number|134|134.0||||||
4378150|NCT00328042|4205739|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4378151|NCT00328042|4205740|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4378152|NCT00328042|4205738|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378153|NCT00328042|4205739|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378154|NCT00328042|4205740|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378155|NCT00328042|4205738|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4378156|NCT00328042|4205739|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4378157|NCT00328042|4205740|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4378158|NCT00328042|4205738|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4378159|NCT00328042|4205739|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4378160|NCT00328042|4205740|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4378161|NCT00328042|4205738|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378162|NCT00328042|4205739|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378163|NCT00328042|4205740|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378164|NCT00328042|4205738|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4378165|NCT00328042|4205739|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4378166|NCT00328042|4205740|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4378167|NCT00328042|4205738|B3||White|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4378168|NCT00328042|4205739|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4378169|NCT00328042|4205740|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4378170|NCT00328042|4205738|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4378171|NCT00328042|4205739|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4378172|NCT00328042|4205740|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4378173|NCT00328042|4205738|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378174|NCT00328042|4205739|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378175|NCT00328042|4205740|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378176|NCT00328042|4205738|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4378177|NCT00328042|4205739|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4378178|NCT00328042|4205740|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4378179|NCT00328042|4205738|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4378180|NCT00328042|4205739|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4378181|NCT00328042|4205740|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378182|NCT00328042|4205738|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4378183|NCT00328042|4205739|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4378184|NCT00328042|4205740|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4378185|NCT00328042|4205738|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4378186|NCT00328042|4205739|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4378187|NCT00328042|4205740|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4378188|NCT00328042|4205738|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|6.2|6.2|||
4378189|NCT00328042|4205739|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|7.2|7.2|||
4378190|NCT00328042|4205740|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|5.2|5.2|||
4378191|NCT00328016|4205749|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4378192|NCT00328016|4205750|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4378193|NCT00328016|4205751|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4378194|NCT00328016|4205749|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4378195|NCT00328016|4205750|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4378196|NCT00328016|4205751|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4378197|NCT00328016|4205749|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4378198|NCT00328016|4205750|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4378199|NCT00328016|4205751|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4378200|NCT00328016|4205749|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|9.8|9.8|||
4378201|NCT00328016|4205750|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|8.0|8.0|||
4378202|NCT00328016|4205751|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|11.6|11.6|||
4378203|NCT00328016|4205749|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4378204|NCT00328016|4205750|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4378205|NCT00328016|4205751|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4378206|NCT00328016|4205749|B3||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4378207|NCT00328016|4205750|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4378208|NCT00328016|4205751|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4378209|NCT00328016|4205749|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378210|NCT00328016|4205750|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378211|NCT00328016|4205751|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378212|NCT00327717|4205762|B3|China||Region of Enrollment||participants|Number|217|217.0||||||
4378213|NCT00327717|4205763|B2|China||Region of Enrollment||participants|Number|106|106.0||||||
4378214|NCT00327717|4205764|B1|China||Region of Enrollment||participants|Number|111|111.0||||||
4378215|NCT00327717|4205762|B3|Asian||Race/Ethnicity, Customized||participants|Number|217|217.0||||||
4378216|NCT00327717|4205763|B2|Asian||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4378217|NCT00327717|4205764|B1|Asian||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4378218|NCT00327717|4205762|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4378219|NCT00327717|4205763|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4378220|NCT00327717|4205764|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4378221|NCT00327717|4205762|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4378222|NCT00327717|4205763|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4378223|NCT00327717|4205764|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4378224|NCT00327717|4205762|B3|||Age||years|Mean|31.73|31.73|Standard Deviation|11.89|11.89|||
4378225|NCT00327717|4205763|B2|||Age||years|Mean|30.69|30.69|Standard Deviation|11.59|11.59|||
4378226|NCT00327717|4205764|B1|||Age||years|Mean|32.72|32.72|Standard Deviation|12.18|12.18|||
4378227|NCT00327470|4205789|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4378228|NCT00327470|4205790|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4378229|NCT00327470|4205791|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4378230|NCT00327470|4205789|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4378231|NCT00327470|4205790|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4378232|NCT00327470|4205791|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4378233|NCT00327470|4205789|B3|>= 65 years||Age, Customized||Participants|Number|250|250.0||||||
4378234|NCT00327470|4205790|B2|>= 65 years||Age, Customized||Participants|Number|155|155.0||||||
4378235|NCT00327470|4205791|B1|>= 65 years||Age, Customized||Participants|Number|95|95.0||||||
4378236|NCT00327470|4205789|B3|45 through 64 years||Age, Customized||Participants|Number|36|36.0||||||
4378237|NCT00327470|4205790|B2|45 through 64 years||Age, Customized||Participants|Number|24|24.0||||||
4378238|NCT00327470|4205791|B1|45 through 64 years||Age, Customized||Participants|Number|12|12.0||||||
4378239|NCT00327444|4205810|B3|Asian, Oriental||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4378240|NCT00327444|4205811|B2|Asian, Oriental||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4378241|NCT00327444|4205812|B1|Asian, Oriental||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4378242|NCT00327444|4205810|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378243|NCT00327444|4205811|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4378244|NCT00327444|4205812|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378245|NCT00327444|4205810|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4378246|NCT00327444|4205811|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4378247|NCT00327444|4205812|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4378248|NCT00327444|4205810|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378249|NCT00327444|4205811|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378250|NCT00327444|4205812|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378251|NCT00327444|4205810|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4378252|NCT00327444|4205811|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4378253|NCT00327444|4205812|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4378254|NCT00327444|4205810|B3|>=75 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|3|3.0||||||
4378255|NCT00327444|4205811|B2|>=75 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|2|2.0||||||
4378256|NCT00327444|4205812|B1|>=75 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|1|1.0||||||
4378257|NCT00327444|4205810|B3|>=65 to <75 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|13|13.0||||||
4378339|NCT00327171|4205844|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4378258|NCT00327444|4205811|B2|>=65 to <75 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|7|7.0||||||
4378259|NCT00327444|4205812|B1|>=65 to <75 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|6|6.0||||||
4378260|NCT00327444|4205810|B3|>=55 to <65 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|15|15.0||||||
4378261|NCT00327444|4205811|B2|>=55 to <65 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|11|11.0||||||
4378262|NCT00327444|4205812|B1|>=55 to <65 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|4|4.0||||||
4378263|NCT00327444|4205810|B3|>=45 to <55 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|17|17.0||||||
4378264|NCT00327444|4205811|B2|>=45 to <55 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|7|7.0||||||
4378265|NCT00327444|4205812|B1|>=45 to <55 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|10|10.0||||||
4378266|NCT00327444|4205810|B3|>=35 to <45 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|6|6.0||||||
4378267|NCT00327444|4205811|B2|>=35 to <45 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|1|1.0||||||
4378268|NCT00327444|4205812|B1|>=35 to <45 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|5|5.0||||||
4378269|NCT00327444|4205810|B3|< 35 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|1|1.0||||||
4378270|NCT00327444|4205811|B2|< 35 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|1|1.0||||||
4378271|NCT00327444|4205812|B1|< 35 years||Age, Customized|Baseline characteristics are reported for the randomized population|participants|Number|0|0.0||||||
4378272|NCT00327392|4205825|B1|P4 (High risk, severely compromised by disease)||American Society of Anesthesiologists (ASA) status||participants|Number|1|1.0||||||
4378273|NCT00327392|4205825|B1|P3 ( A patient with severe systemic disease )||American Society of Anesthesiologists (ASA) status||participants|Number|22|22.0||||||
4378274|NCT00327392|4205825|B1|P2 ( A patient with mild systemic disease )||American Society of Anesthesiologists (ASA) status||participants|Number|67|67.0||||||
4378275|NCT00327392|4205825|B1|P1 ( A normal healthy patient )||American Society of Anesthesiologists (ASA) status||participants|Number|33|33.0||||||
4378276|NCT00327392|4205825|B1|>90||Weight (kg)||participants|Number|36|36.0||||||
4378277|NCT00327392|4205825|B1|>60 to <90||Weight (kg)||participants|Number|69|69.0||||||
4378278|NCT00327392|4205825|B1|<60||Weight (kg)||participants|Number|18|18.0||||||
4378279|NCT00327392|4205825|B1|Other||Race/Ethnicity, Customized||particpants|Number|1|1.0||||||
4378280|NCT00327392|4205825|B1|Hispanic/Latino||Race/Ethnicity, Customized||particpants|Number|3|3.0||||||
4378281|NCT00327392|4205825|B1|Unknown or Not Reported||Race/Ethnicity, Customized||particpants|Number|0|0.0||||||
4378282|NCT00327392|4205825|B1|More than one race||Race/Ethnicity, Customized||particpants|Number|0|0.0||||||
4378283|NCT00327392|4205825|B1|White||Race/Ethnicity, Customized||particpants|Number|109|109.0||||||
4378284|NCT00327392|4205825|B1|Black or African American||Race/Ethnicity, Customized||particpants|Number|9|9.0||||||
4378285|NCT00327392|4205825|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||particpants|Number|0|0.0||||||
4378286|NCT00327392|4205825|B1|Asian||Race/Ethnicity, Customized||particpants|Number|1|1.0||||||
4378287|NCT00327392|4205825|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||particpants|Number|0|0.0||||||
4378288|NCT00327392|4205825|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4378289|NCT00327392|4205825|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4378290|NCT00327392|4205825|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|15.3|15.3|||
4378291|NCT00327340|4205829|B3|100%||Karnofsky Score|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100%=Normal no complaints; no evidence of disease 90%=Able to carry on normal activity; minor signs or symptoms of disease 80%=Normal activity with effort;some signs or symptoms of disease 60-70%=Able to care for self;unable to do active work"|participants|Number|12|12.0||||||
4378292|NCT00327340|4205830|B2|100%||Karnofsky Score|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100%=Normal no complaints; no evidence of disease 90%=Able to carry on normal activity; minor signs or symptoms of disease 80%=Normal activity with effort;some signs or symptoms of disease 60-70%=Able to care for self;unable to do active work"|participants|Number|5|5.0||||||
4378293|NCT00327340|4205831|B1|100%||Karnofsky Score|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100%=Normal no complaints; no evidence of disease 90%=Able to carry on normal activity; minor signs or symptoms of disease 80%=Normal activity with effort;some signs or symptoms of disease 60-70%=Able to care for self;unable to do active work"|participants|Number|7|7.0||||||
4378294|NCT00327340|4205829|B3|90%||Karnofsky Score|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100%=Normal no complaints; no evidence of disease 90%=Able to carry on normal activity; minor signs or symptoms of disease 80%=Normal activity with effort;some signs or symptoms of disease 60-70%=Able to care for self;unable to do active work"|participants|Number|29|29.0||||||
4378295|NCT00327340|4205830|B2|90%||Karnofsky Score|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100%=Normal no complaints; no evidence of disease 90%=Able to carry on normal activity; minor signs or symptoms of disease 80%=Normal activity with effort;some signs or symptoms of disease 60-70%=Able to care for self;unable to do active work"|participants|Number|22|22.0||||||
4378337|NCT00327171|4205845|B2|Asian, Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378338|NCT00327171|4205846|B1|Asian, Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378296|NCT00327340|4205831|B1|90%||Karnofsky Score|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100%=Normal no complaints; no evidence of disease 90%=Able to carry on normal activity; minor signs or symptoms of disease 80%=Normal activity with effort;some signs or symptoms of disease 60-70%=Able to care for self;unable to do active work"|participants|Number|7|7.0||||||
4378297|NCT00327340|4205829|B3|80%||Karnofsky Score|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100%=Normal no complaints; no evidence of disease 90%=Able to carry on normal activity; minor signs or symptoms of disease 80%=Normal activity with effort;some signs or symptoms of disease 60-70%=Able to care for self;unable to do active work"|participants|Number|20|20.0||||||
4378298|NCT00327340|4205830|B2|80%||Karnofsky Score|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100%=Normal no complaints; no evidence of disease 90%=Able to carry on normal activity; minor signs or symptoms of disease 80%=Normal activity with effort;some signs or symptoms of disease 60-70%=Able to care for self;unable to do active work"|participants|Number|13|13.0||||||
4378299|NCT00327340|4205831|B1|80%||Karnofsky Score|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100%=Normal no complaints; no evidence of disease 90%=Able to carry on normal activity; minor signs or symptoms of disease 80%=Normal activity with effort;some signs or symptoms of disease 60-70%=Able to care for self;unable to do active work"|participants|Number|7|7.0||||||
4378300|NCT00327340|4205829|B3|60-70%||Karnofsky Score|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100%=Normal no complaints; no evidence of disease 90%=Able to carry on normal activity; minor signs or symptoms of disease 80%=Normal activity with effort;some signs or symptoms of disease 60-70%=Able to care for self;unable to do active work"|participants|Number|8|8.0||||||
4378301|NCT00327340|4205830|B2|60-70%||Karnofsky Score|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100%=Normal no complaints; no evidence of disease 90%=Able to carry on normal activity; minor signs or symptoms of disease 80%=Normal activity with effort;some signs or symptoms of disease 60-70%=Able to care for self;unable to do active work"|participants|Number|6|6.0||||||
4378302|NCT00327340|4205831|B1|60-70%||Karnofsky Score|"The Karnofsky Performance Scale Index allows patients to be classified as to their functional impairment.~100%=Normal no complaints; no evidence of disease 90%=Able to carry on normal activity; minor signs or symptoms of disease 80%=Normal activity with effort;some signs or symptoms of disease 60-70%=Able to care for self;unable to do active work"|participants|Number|2|2.0||||||
4378303|NCT00327340|4205829|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4378304|NCT00327340|4205830|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378305|NCT00327340|4205831|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4378306|NCT00327340|4205829|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378307|NCT00327340|4205830|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378308|NCT00327340|4205831|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378309|NCT00327340|4205829|B3||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4378310|NCT00327340|4205830|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4378311|NCT00327340|4205831|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4378312|NCT00327340|4205829|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4378313|NCT00327340|4205830|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4378314|NCT00327340|4205831|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378315|NCT00327340|4205829|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378316|NCT00327340|4205830|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378317|NCT00327340|4205831|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378318|NCT00327340|4205829|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4378319|NCT00327340|4205830|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4378320|NCT00327340|4205831|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378321|NCT00327340|4205829|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378322|NCT00327340|4205830|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378323|NCT00327340|4205831|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378324|NCT00327340|4205829|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4378325|NCT00327340|4205830|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4378326|NCT00327340|4205831|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4378327|NCT00327340|4205829|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378328|NCT00327340|4205830|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378329|NCT00327340|4205831|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378330|NCT00327340|4205829|B3|||Age||years|Median|63|63.0|Full Range|||48.0|81.0|
4378331|NCT00327340|4205830|B2|||Age||years|Median|64|64.0|Full Range|||48.0|80.0|
4378332|NCT00327340|4205831|B1|||Age||years|Median|61|61.0|Full Range|||49.0|81.0|
4378333|NCT00327171|4205844|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378334|NCT00327171|4205845|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4378335|NCT00327171|4205846|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378336|NCT00327171|4205844|B3|Asian, Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4378340|NCT00327171|4205845|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378341|NCT00327171|4205846|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4378342|NCT00327171|4205844|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|211|211.0||||||
4378343|NCT00327171|4205845|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
4378344|NCT00327171|4205846|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4378345|NCT00327171|4205844|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378346|NCT00327171|4205845|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378347|NCT00327171|4205846|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378348|NCT00327171|4205844|B3||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4378349|NCT00327171|4205845|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4378350|NCT00327171|4205846|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4378351|NCT00327171|4205844|B3|>=75 years||Age, Customized||participants|Number|13|13.0||||||
4378352|NCT00327171|4205845|B2|>=75 years||Age, Customized||participants|Number|7|7.0||||||
4378353|NCT00327171|4205846|B1|>=75 years||Age, Customized||participants|Number|6|6.0||||||
4378354|NCT00327171|4205844|B3|>=65 to <75 years||Age, Customized||participants|Number|57|57.0||||||
4378355|NCT00327171|4205845|B2|>=65 to <75 years||Age, Customized||participants|Number|25|25.0||||||
4378356|NCT00327171|4205846|B1|>=65 to <75 years||Age, Customized||participants|Number|32|32.0||||||
4378357|NCT00327171|4205844|B3|>=55 to <65 years||Age, Customized||participants|Number|80|80.0||||||
4378358|NCT00327171|4205845|B2|>=55 to <65 years||Age, Customized||participants|Number|43|43.0||||||
4378359|NCT00327171|4205846|B1|>=55 to <65 years||Age, Customized||participants|Number|37|37.0||||||
4378360|NCT00327171|4205844|B3|>=45 to <55 years||Age, Customized||participants|Number|46|46.0||||||
4378361|NCT00327171|4205845|B2|>=45 to <55 years||Age, Customized||participants|Number|25|25.0||||||
4378362|NCT00327171|4205846|B1|>=45 to <55 years||Age, Customized||participants|Number|21|21.0||||||
4378363|NCT00327171|4205844|B3|>=35 to <45 years||Age, Customized||participants|Number|16|16.0||||||
4378364|NCT00327171|4205845|B2|>=35 to <45 years||Age, Customized||participants|Number|6|6.0||||||
4378365|NCT00327171|4205846|B1|>=35 to <45 years||Age, Customized||participants|Number|10|10.0||||||
4378366|NCT00327171|4205844|B3|<35 years||Age, Customized||participants|Number|6|6.0||||||
4378367|NCT00327171|4205845|B2|<35 years||Age, Customized||participants|Number|3|3.0||||||
4378368|NCT00327171|4205846|B1|<35 years||Age, Customized||participants|Number|3|3.0||||||
4378369|NCT00327015|4205875|B5||Male|Sex: Female, Male||Participants|Count of Participants|643|643.0||||||
4378370|NCT00327015|4205876|B4||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4378371|NCT00327015|4205877|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4378372|NCT00327015|4205878|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4378373|NCT00327015|4205879|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4378374|NCT00327015|4205875|B5||Female|Sex: Female, Male||Participants|Count of Participants|663|663.0||||||
4378375|NCT00327015|4205876|B4||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4378376|NCT00327015|4205877|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4378377|NCT00327015|4205878|B2||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4378378|NCT00327015|4205879|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4378379|NCT00327015|4205875|B5|||Age||years|Mean|51.99|51.99|Standard Deviation|10.73|10.73|||
4378380|NCT00327015|4205876|B4|||Age||years|Mean|51.83|51.83|Standard Deviation|10.74|10.74|||
4378381|NCT00327015|4205877|B3|||Age||years|Mean|52.09|52.09|Standard Deviation|10.17|10.17|||
4378382|NCT00327015|4205878|B2|||Age||years|Mean|52.08|52.08|Standard Deviation|11.59|11.59|||
4378383|NCT00327015|4205879|B1|||Age||years|Mean|51.95|51.95|Standard Deviation|10.43|10.43|||
4378384|NCT00326963|4205924|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4378385|NCT00326963|4205924|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4378386|NCT00326963|4205924|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|7.68|7.68|||
4378387|NCT00326950|4205944|B1|Japan||Region of Enrollment||participants|Number|15|15.0||||||
4378388|NCT00326950|4205944|B1||Unknown or Not Reported|Race (NIH/OMB)|Subjects were Japanese|Participants|Count of Participants|0|0.0||||||
4378389|NCT00326950|4205944|B1||More than one race|Race (NIH/OMB)|Subjects were Japanese|Participants|Count of Participants|0|0.0||||||
4378390|NCT00326950|4205944|B1||White|Race (NIH/OMB)|Subjects were Japanese|Participants|Count of Participants|0|0.0||||||
4378391|NCT00326950|4205944|B1||Black or African American|Race (NIH/OMB)|Subjects were Japanese|Participants|Count of Participants|0|0.0||||||
4378392|NCT00326950|4205944|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Subjects were Japanese|Participants|Count of Participants|0|0.0||||||
4378393|NCT00326950|4205944|B1||Asian|Race (NIH/OMB)|Subjects were Japanese|Participants|Count of Participants|15|15.0||||||
4378394|NCT00326950|4205944|B1||American Indian or Alaska Native|Race (NIH/OMB)|Subjects were Japanese|Participants|Count of Participants|0|0.0||||||
4378395|NCT00326950|4205944|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4378396|NCT00326950|4205944|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4378397|NCT00326950|4205944|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|7.9|7.9|||
4378398|NCT00326924|4205949|B3|Canada||Region of Enrollment||participants|Number|377|377.0||||||
4378399|NCT00326924|4205950|B2|Canada||Region of Enrollment||participants|Number|189|189.0||||||
4378400|NCT00326924|4205951|B1|Canada||Region of Enrollment||participants|Number|188|188.0||||||
4378401|NCT00326924|4205949|B3|Mothers' characteristics|Other or unknown|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4378402|NCT00326924|4205950|B2|Mothers' characteristics|Other or unknown|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4378403|NCT00326924|4205951|B1|Mothers' characteristics|Other or unknown|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4378404|NCT00326924|4205949|B3|Mothers' characteristics|Arab|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4378405|NCT00326924|4205950|B2|Mothers' characteristics|Arab|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4378406|NCT00326924|4205951|B1|Mothers' characteristics|Arab|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4378407|NCT00326924|4205949|B3|Mothers' characteristics|Filipino|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4378408|NCT00326924|4205950|B2|Mothers' characteristics|Filipino|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4378409|NCT00326924|4205951|B1|Mothers' characteristics|Filipino|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4378410|NCT00326924|4205949|B3|Mothers' characteristics|Aboriginal|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4378411|NCT00326924|4205950|B2|Mothers' characteristics|Aboriginal|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4378412|NCT00326924|4205951|B1|Mothers' characteristics|Aboriginal|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4378413|NCT00326924|4205949|B3|Mothers' characteristics|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4378414|NCT00326924|4205950|B2|Mothers' characteristics|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4378415|NCT00326924|4205951|B1|Mothers' characteristics|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4378416|NCT00326924|4205949|B3|Mothers' characteristics|Latin American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4378417|NCT00326924|4205950|B2|Mothers' characteristics|Latin American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4378418|NCT00326924|4205951|B1|Mothers' characteristics|Latin American|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4378419|NCT00326924|4205949|B3|Mothers' characteristics|Black|Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4378420|NCT00326924|4205950|B2|Mothers' characteristics|Black|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4378421|NCT00326924|4205951|B1|Mothers' characteristics|Black|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4378422|NCT00326924|4205949|B3|Mothers' characteristics|White|Race/Ethnicity, Customized||Participants|Count of Participants|261|261.0||||||
4378423|NCT00326924|4205950|B2|Mothers' characteristics|White|Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
4378424|NCT00326924|4205951|B1|Mothers' characteristics|White|Race/Ethnicity, Customized||Participants|Count of Participants|138|138.0||||||
4378425|NCT00326924|4205949|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4378426|NCT00326924|4205950|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4378427|NCT00326924|4205951|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4378428|NCT00326924|4205949|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4378429|NCT00326924|4205950|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4378430|NCT00326924|4205951|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4378431|NCT00326924|4205949|B3|||Age||days|Mean|10|10.0|Standard Deviation|9.6|9.6|||
4378432|NCT00326924|4205950|B2|||Age||days|Mean|9.9|9.9|Standard Deviation|9.5|9.5|||
4378433|NCT00326924|4205951|B1|||Age||days|Mean|10.0|10.0|Standard Deviation|9.7|9.7|||
4378434|NCT00326911|4205964|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4378435|NCT00326911|4205965|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4378436|NCT00326911|4205966|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4378437|NCT00326911|4205964|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4378438|NCT00326911|4205965|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4378439|NCT00326911|4205966|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4378440|NCT00326911|4205964|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4378441|NCT00326911|4205965|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4378442|NCT00326911|4205966|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4378443|NCT00326911|4205964|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|11.4|11.4|||
4378444|NCT00326911|4205965|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|11.4|11.4|||
4378445|NCT00326911|4205966|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|11.6|11.6|||
4378446|NCT00326911|4205964|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4378447|NCT00326911|4205965|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4378448|NCT00326911|4205966|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4378449|NCT00326911|4205964|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4378450|NCT00326911|4205965|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4378451|NCT00326911|4205966|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4378452|NCT00326911|4205964|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378453|NCT00326911|4205965|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378454|NCT00326911|4205966|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378455|NCT00326898|4206017|B4||Male|Gender||Participants|Count of Participants|1309|1309.0||||||
4378456|NCT00326898|4206018|B3||Male|Gender||Participants|Count of Participants|443|443.0||||||
4378457|NCT00326898|4206019|B2||Male|Gender||Participants|Count of Participants|437|437.0||||||
4378458|NCT00326898|4206020|B1||Male|Gender||Participants|Count of Participants|429|429.0||||||
4378459|NCT00326898|4206017|B4||Female|Gender||Participants|Count of Participants|634|634.0||||||
4378460|NCT00326898|4206018|B3||Female|Gender||Participants|Count of Participants|204|204.0||||||
4378461|NCT00326898|4206019|B2||Female|Gender||Participants|Count of Participants|212|212.0||||||
4378462|NCT00326898|4206020|B1||Female|Gender||Participants|Count of Participants|218|218.0||||||
4378463|NCT00326898|4206017|B4||>=65 years|Age||Participants|Count of Participants|447|447.0||||||
4378464|NCT00326898|4206018|B3||>=65 years|Age||Participants|Count of Participants|147|147.0||||||
4378465|NCT00326898|4206019|B2||>=65 years|Age||Participants|Count of Participants|142|142.0||||||
4378466|NCT00326898|4206020|B1||>=65 years|Age||Participants|Count of Participants|158|158.0||||||
4378467|NCT00326898|4206017|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1496|1496.0||||||
4378468|NCT00326898|4206018|B3||Between 18 and 65 years|Age||Participants|Count of Participants|500|500.0||||||
4378469|NCT00326898|4206019|B2||Between 18 and 65 years|Age||Participants|Count of Participants|507|507.0||||||
4378470|NCT00326898|4206020|B1||Between 18 and 65 years|Age||Participants|Count of Participants|489|489.0||||||
4378471|NCT00326898|4206017|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378472|NCT00326898|4206018|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378473|NCT00326898|4206019|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378474|NCT00326898|4206020|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378475|NCT00326885|4206039|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4378476|NCT00326885|4206039|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378477|NCT00326885|4206039|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4378478|NCT00326885|4206039|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|10.84|10.84|||
4378479|NCT00326885|4206039|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4378480|NCT00326885|4206039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4378481|NCT00326885|4206039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378482|NCT00326872|4206048|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4378483|NCT00326872|4206048|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4378484|NCT00326872|4206048|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4378485|NCT00326872|4206048|B1|||Age||years|Median|34|34.0|Full Range|||19.0|52.0|
4378486|NCT00326781|4206057|B3|United States||Region of Enrollment||participants|Number|674|674.0||||||
4378487|NCT00326781|4206058|B2|United States||Region of Enrollment||participants|Number|330|330.0||||||
4378488|NCT00326781|4206059|B1|United States||Region of Enrollment||participants|Number|344|344.0||||||
4378489|NCT00326781|4206057|B3||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4378490|NCT00326781|4206058|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4378491|NCT00326781|4206059|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4378492|NCT00326781|4206057|B3||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4378493|NCT00326781|4206058|B2||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4378494|NCT00326781|4206059|B1||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4378495|NCT00326781|4206057|B3|||Age||years|Mean|45.53|45.53|Standard Deviation|10.63|10.63|||
4378496|NCT00326781|4206058|B2|||Age||years|Mean|45.41|45.41|Standard Deviation|10.37|10.37|||
4378497|NCT00326781|4206059|B1|||Age||years|Mean|45.63|45.63|Standard Deviation|10.88|10.88|||
4378498|NCT00326781|4206057|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4378499|NCT00326781|4206058|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4378500|NCT00326781|4206059|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4378501|NCT00326781|4206057|B3||Between 18 and 65 years|Age||Participants|Count of Participants|650|650.0||||||
4378502|NCT00326781|4206058|B2||Between 18 and 65 years|Age||Participants|Count of Participants|321|321.0||||||
4378503|NCT00326781|4206059|B1||Between 18 and 65 years|Age||Participants|Count of Participants|329|329.0||||||
4378504|NCT00326781|4206057|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378505|NCT00326781|4206058|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378506|NCT00326781|4206059|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378507|NCT00326716|4206068|B3|||Infant Gestational Age at Delivery||Weeks|Median|38|38.0|Full Range|||35.0|41.0|
4378508|NCT00326716|4206069|B2|||Infant Gestational Age at Delivery||Weeks|Median|38|38.0|Full Range|||35.0|41.0|
4378509|NCT00326716|4206070|B1|||Infant Gestational Age at Delivery||Weeks|Median|38|38.0|Full Range|||35.0|40.0|
4378510|NCT00326716|4206068|B3|>= 100,000||HIV RNA Distribution at Baseline||c/mL|Number|2|2.0||||||
4378511|NCT00326716|4206069|B2|>= 100,000||HIV RNA Distribution at Baseline||c/mL|Number|1|1.0||||||
4378512|NCT00326716|4206070|B1|>= 100,000||HIV RNA Distribution at Baseline||c/mL|Number|1|1.0||||||
4378513|NCT00326716|4206068|B3|30,000 to < 100,000||HIV RNA Distribution at Baseline||c/mL|Number|9|9.0||||||
4378514|NCT00326716|4206069|B2|30,000 to < 100,000||HIV RNA Distribution at Baseline||c/mL|Number|6|6.0||||||
4378515|NCT00326716|4206070|B1|30,000 to < 100,000||HIV RNA Distribution at Baseline||c/mL|Number|3|3.0||||||
4378516|NCT00326716|4206068|B3|50 to < 30,000||HIV RNA Distribution at Baseline||c/mL|Number|26|26.0||||||
4378517|NCT00326716|4206069|B2|50 to < 30,000||HIV RNA Distribution at Baseline||c/mL|Number|13|13.0||||||
4378518|NCT00326716|4206070|B1|50 to < 30,000||HIV RNA Distribution at Baseline||c/mL|Number|13|13.0||||||
4378519|NCT00326716|4206068|B3|<50||HIV RNA Distribution at Baseline||c/mL|Number|4|4.0||||||
4378520|NCT00326716|4206069|B2|<50||HIV RNA Distribution at Baseline||c/mL|Number|1|1.0||||||
4378521|NCT00326716|4206070|B1|<50||HIV RNA Distribution at Baseline||c/mL|Number|3|3.0||||||
4378522|NCT00326716|4206068|B3|Africa||Region of Enrollment||participants|Number|29|29.0||||||
4378523|NCT00326716|4206069|B2|Africa||Region of Enrollment||participants|Number|15|15.0||||||
4378524|NCT00326716|4206070|B1|Africa||Region of Enrollment||participants|Number|14|14.0||||||
4378525|NCT00326716|4206068|B3|North America||Region of Enrollment||participants|Number|12|12.0||||||
4378526|NCT00326716|4206069|B2|North America||Region of Enrollment||participants|Number|6|6.0||||||
4378527|NCT00326716|4206070|B1|North America||Region of Enrollment||participants|Number|6|6.0||||||
4378528|NCT00326716|4206068|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378529|NCT00326716|4206069|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378530|NCT00326716|4206070|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378531|NCT00326716|4206068|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4378532|NCT00326716|4206069|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4378533|NCT00326716|4206070|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378534|NCT00326716|4206068|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4378535|NCT00326716|4206069|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4378536|NCT00326716|4206070|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4378537|NCT00326716|4206068|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4378538|NCT00326716|4206069|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4378539|NCT00326716|4206070|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4378540|NCT00326716|4206068|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378541|NCT00326716|4206069|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378542|NCT00326716|4206070|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378543|NCT00326716|4206068|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378544|NCT00326716|4206069|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378545|NCT00326716|4206070|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378546|NCT00326716|4206068|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378547|NCT00326716|4206069|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378548|NCT00326716|4206070|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378549|NCT00326716|4206068|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378550|NCT00326716|4206069|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378551|NCT00326716|4206070|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378552|NCT00326716|4206068|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4378553|NCT00326716|4206069|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4378554|NCT00326716|4206070|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4378555|NCT00326716|4206068|B3|||Age||Years|Median|28|28.0|Full Range|||19.0|38.0|
4378556|NCT00326716|4206069|B2|||Age||Years|Median|28|28.0|Full Range|||19.0|37.0|
4378557|NCT00326716|4206070|B1|||Age||Years|Median|29|29.0|Full Range|||21.0|38.0|
4378558|NCT00326716|4206068|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4378559|NCT00326716|4206069|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4378560|NCT00326716|4206070|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4378561|NCT00326716|4206068|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4378562|NCT00326716|4206069|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4378563|NCT00326716|4206070|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4378564|NCT00326716|4206068|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378565|NCT00326716|4206069|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378566|NCT00326716|4206070|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378567|NCT00326612|4206143|B3|United States||Region of Enrollment||participants|Number|92|92.0||||||
4378568|NCT00326612|4206144|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4378569|NCT00326612|4206145|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4378570|NCT00326612|4206143|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4378571|NCT00326612|4206144|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4378572|NCT00326612|4206145|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4378573|NCT00326612|4206143|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4378574|NCT00326612|4206144|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4378575|NCT00326612|4206145|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4378576|NCT00326612|4206143|B3|||Age||years|Mean|7.0|7.0|Standard Deviation|4.8|4.8|||
4378577|NCT00326612|4206144|B2|||Age||years|Mean|7.3|7.3|Standard Deviation|4.5|4.5|||
4378578|NCT00326612|4206145|B1|||Age||years|Mean|6.8|6.8|Standard Deviation|5.0|5.0|||
4378579|NCT00326612|4206143|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4378580|NCT00326612|4206144|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4378581|NCT00326612|4206145|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4378582|NCT00326612|4206143|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4378583|NCT00326612|4206144|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4378584|NCT00326612|4206145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4378585|NCT00326612|4206143|B3||<=18 years|Age||Participants|Count of Participants|92|92.0||||||
4378586|NCT00326612|4206144|B2||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4378587|NCT00326612|4206145|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4378588|NCT00326599|4206164|B5||All other|Cell type||Participants|Count of Participants|35|35.0||||||
4378589|NCT00326599|4206165|B4||All other|Cell type||Participants|Count of Participants|5|5.0||||||
4378590|NCT00326599|4206166|B3||All other|Cell type||Participants|Count of Participants|27|27.0||||||
4378591|NCT00326599|4206167|B2||All other|Cell type||Participants|Count of Participants|1|1.0||||||
4378592|NCT00326599|4206168|B1||All other|Cell type||Participants|Count of Participants|2|2.0||||||
4378593|NCT00326599|4206164|B5||Adenocarcinoma|Cell type||Participants|Count of Participants|43|43.0||||||
4378594|NCT00326599|4206165|B4||Adenocarcinoma|Cell type||Participants|Count of Participants|16|16.0||||||
4378595|NCT00326599|4206166|B3||Adenocarcinoma|Cell type||Participants|Count of Participants|22|22.0||||||
4378596|NCT00326599|4206167|B2||Adenocarcinoma|Cell type||Participants|Count of Participants|1|1.0||||||
4378597|NCT00326599|4206168|B1||Adenocarcinoma|Cell type||Participants|Count of Participants|4|4.0||||||
4378598|NCT00326599|4206164|B5||Squamous|Cell type||Participants|Count of Participants|18|18.0||||||
4378599|NCT00326599|4206165|B4||Squamous|Cell type||Participants|Count of Participants|8|8.0||||||
4378600|NCT00326599|4206166|B3||Squamous|Cell type||Participants|Count of Participants|9|9.0||||||
4378601|NCT00326599|4206167|B2||Squamous|Cell type||Participants|Count of Participants|1|1.0||||||
4378602|NCT00326599|4206168|B1||Squamous|Cell type||Participants|Count of Participants|0|0.0||||||
4378603|NCT00326599|4206164|B5||No|Before adjuvant treatment||Participants|Count of Participants|92|92.0||||||
4378604|NCT00326599|4206165|B4||No|Before adjuvant treatment||Participants|Count of Participants|28|28.0||||||
4378605|NCT00326599|4206166|B3||No|Before adjuvant treatment||Participants|Count of Participants|56|56.0||||||
4378606|NCT00326599|4206167|B2||No|Before adjuvant treatment||Participants|Count of Participants|3|3.0||||||
4378607|NCT00326599|4206168|B1||No|Before adjuvant treatment||Participants|Count of Participants|5|5.0||||||
4378608|NCT00326599|4206164|B5||Yes|Before adjuvant treatment||Participants|Count of Participants|4|4.0||||||
4378609|NCT00326599|4206165|B4||Yes|Before adjuvant treatment||Participants|Count of Participants|1|1.0||||||
4378610|NCT00326599|4206166|B3||Yes|Before adjuvant treatment||Participants|Count of Participants|2|2.0||||||
4378611|NCT00326599|4206167|B2||Yes|Before adjuvant treatment||Participants|Count of Participants|0|0.0||||||
4378612|NCT00326599|4206168|B1||Yes|Before adjuvant treatment||Participants|Count of Participants|1|1.0||||||
4378613|NCT00326599|4206164|B5||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|42|42.0||||||
4378614|NCT00326599|4206165|B4||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|12|12.0||||||
4378615|NCT00326599|4206166|B3||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|25|25.0||||||
4378616|NCT00326599|4206167|B2||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|2|2.0||||||
4378617|NCT00326599|4206168|B1||1=Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|3|3.0||||||
4378618|NCT00326599|4206164|B5||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|54|54.0||||||
4378619|NCT00326599|4206165|B4||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|17|17.0||||||
4378620|NCT00326599|4206166|B3||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|33|33.0||||||
4378621|NCT00326599|4206167|B2||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|1|1.0||||||
4378622|NCT00326599|4206168|B1||0=Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG) Performance Status||Participants|Count of Participants|3|3.0||||||
4378623|NCT00326599|4206164|B5|United States||Region of Enrollment||participants|Number|96|96.0||||||
4378624|NCT00326599|4206165|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
4378625|NCT00326599|4206166|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4378626|NCT00326599|4206167|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4378627|NCT00326599|4206168|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4378628|NCT00326599|4206164|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4378629|NCT00326599|4206165|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4378630|NCT00326599|4206166|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378631|NCT00326599|4206167|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378632|NCT00326599|4206168|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378633|NCT00326599|4206164|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378634|NCT00326599|4206165|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378635|NCT00326599|4206166|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378636|NCT00326599|4206167|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378637|NCT00326599|4206168|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378638|NCT00326599|4206164|B5||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4378639|NCT00326599|4206165|B4||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4378640|NCT00326599|4206166|B3||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4378641|NCT00326599|4206167|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4378642|NCT00326599|4206168|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4378643|NCT00326599|4206164|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4378644|NCT00326599|4206165|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4378645|NCT00326599|4206166|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4378646|NCT00326599|4206167|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378647|NCT00326599|4206168|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378648|NCT00326599|4206164|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378649|NCT00326599|4206165|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378650|NCT00326599|4206166|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378651|NCT00326599|4206167|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378652|NCT00326599|4206168|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378653|NCT00326599|4206164|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378654|NCT00326599|4206165|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378655|NCT00326599|4206166|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378656|NCT00326599|4206167|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378657|NCT00326599|4206168|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378658|NCT00326599|4206164|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378659|NCT00326599|4206165|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378660|NCT00326599|4206166|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378661|NCT00326599|4206167|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378662|NCT00326599|4206168|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378663|NCT00326599|4206164|B5||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4378664|NCT00326599|4206165|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4378665|NCT00326599|4206166|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4378666|NCT00326599|4206167|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378667|NCT00326599|4206168|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4378668|NCT00326599|4206164|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4378669|NCT00326599|4206165|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4378670|NCT00326599|4206166|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4378671|NCT00326599|4206167|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4378672|NCT00326599|4206168|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4378673|NCT00326599|4206164|B5|||Age||years|Median|64|64.0|Full Range|||45.0|82.0|
4378674|NCT00326599|4206165|B4|||Age||years|Median|64|64.0|Full Range|||45.0|82.0|
4378675|NCT00326599|4206166|B3|||Age||years|Median|65|65.0|Full Range|||46.0|81.0|
4378676|NCT00326599|4206167|B2|||Age||years|Median|74|74.0|Full Range|||64.0|76.0|
4378677|NCT00326599|4206168|B1|||Age||years|Median|65.5|65.5|Full Range|||62.0|75.0|
4378678|NCT00326495|4206190|B1|||Median Number of Previous Treatments||Treatments|Median|3|3.0|Full Range|||1.0|5.0|
4378679|NCT00326495|4206190|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4378680|NCT00326495|4206190|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4378681|NCT00326495|4206190|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378682|NCT00326495|4206190|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4378683|NCT00326495|4206190|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4378684|NCT00326495|4206190|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378685|NCT00326495|4206190|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4378686|NCT00326495|4206190|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4378687|NCT00326495|4206190|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4378688|NCT00326495|4206190|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4378689|NCT00326495|4206190|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4378690|NCT00326495|4206190|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4378691|NCT00326495|4206190|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4378692|NCT00326495|4206190|B1|||Age||years|Mean|53.65|53.65|Standard Deviation|13.16|13.16|||
4378693|NCT00326495|4206190|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4378694|NCT00326495|4206190|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4378695|NCT00326495|4206190|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378696|NCT00326417|4206195|B3|None||Type of anti-thymocyte globulin administered||participants|Number|1|1.0||||||
4378697|NCT00326417|4206196|B2|None||Type of anti-thymocyte globulin administered||participants|Number|0|0.0||||||
4378698|NCT00326417|4206197|B1|None||Type of anti-thymocyte globulin administered||participants|Number|1|1.0||||||
4378699|NCT00326417|4206195|B3|Horse-derived||Type of anti-thymocyte globulin administered||participants|Number|16|16.0||||||
4378700|NCT00326417|4206196|B2|Horse-derived||Type of anti-thymocyte globulin administered||participants|Number|9|9.0||||||
4378701|NCT00326417|4206197|B1|Horse-derived||Type of anti-thymocyte globulin administered||participants|Number|7|7.0||||||
4378702|NCT00326417|4206195|B3|Rabbit-derived||Type of anti-thymocyte globulin administered||participants|Number|62|62.0||||||
4378703|NCT00326417|4206196|B2|Rabbit-derived||Type of anti-thymocyte globulin administered||participants|Number|29|29.0||||||
4378704|NCT00326417|4206197|B1|Rabbit-derived||Type of anti-thymocyte globulin administered||participants|Number|33|33.0||||||
4378705|NCT00326417|4206195|B3|Single HLA-locus mismatch||Donor-recipient HLA match||participants|Number|21|21.0||||||
4378706|NCT00326417|4206196|B2|Single HLA-locus mismatch||Donor-recipient HLA match||participants|Number|7|7.0||||||
4378707|NCT00326417|4206197|B1|Single HLA-locus mismatch||Donor-recipient HLA match||participants|Number|14|14.0||||||
4378708|NCT00326417|4206195|B3|HLA-A, -B, -C,-DRB1 matched||Donor-recipient HLA match||participants|Number|58|58.0||||||
4378709|NCT00326417|4206196|B2|HLA-A, -B, -C,-DRB1 matched||Donor-recipient HLA match||participants|Number|31|31.0||||||
4378710|NCT00326417|4206197|B1|HLA-A, -B, -C,-DRB1 matched||Donor-recipient HLA match||participants|Number|27|27.0||||||
4378711|NCT00326417|4206195|B3|No||Immunosuppressive therapy prior to transplant||participants|Number|3|3.0||||||
4378712|NCT00326417|4206196|B2|No||Immunosuppressive therapy prior to transplant||participants|Number|3|3.0||||||
4378713|NCT00326417|4206197|B1|No||Immunosuppressive therapy prior to transplant||participants|Number|0|0.0||||||
4378714|NCT00326417|4206195|B3|Yes||Immunosuppressive therapy prior to transplant||participants|Number|76|76.0||||||
4378715|NCT00326417|4206196|B2|Yes||Immunosuppressive therapy prior to transplant||participants|Number|35|35.0||||||
4378716|NCT00326417|4206197|B1|Yes||Immunosuppressive therapy prior to transplant||participants|Number|41|41.0||||||
4378717|NCT00326417|4206195|B3|60||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|1|1.0||||||
4378718|NCT00326417|4206196|B2|60||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|0|0.0||||||
4378719|NCT00326417|4206197|B1|60||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|1|1.0||||||
4378720|NCT00326417|4206195|B3|70||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|6|6.0||||||
4378721|NCT00326417|4206196|B2|70||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|2|2.0||||||
4378722|NCT00326417|4206197|B1|70||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|4|4.0||||||
4378723|NCT00326417|4206195|B3|80||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|10|10.0||||||
4378724|NCT00326417|4206196|B2|80||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|7|7.0||||||
4378725|NCT00326417|4206197|B1|80||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|3|3.0||||||
4378726|NCT00326417|4206195|B3|90||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|32|32.0||||||
4378727|NCT00326417|4206196|B2|90||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|17|17.0||||||
4378728|NCT00326417|4206197|B1|90||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|15|15.0||||||
4378729|NCT00326417|4206195|B3|100||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|30|30.0||||||
4378730|NCT00326417|4206196|B2|100||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|12|12.0||||||
4378731|NCT00326417|4206197|B1|100||Karnofsky Score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|18|18.0||||||
4378732|NCT00326417|4206195|B3|Negative||Recipient Cytomegalovirus Status||participants|Number|36|36.0||||||
4378733|NCT00326417|4206196|B2|Negative||Recipient Cytomegalovirus Status||participants|Number|21|21.0||||||
4378734|NCT00326417|4206197|B1|Negative||Recipient Cytomegalovirus Status||participants|Number|15|15.0||||||
4378735|NCT00326417|4206195|B3|Positive||Recipient Cytomegalovirus Status||participants|Number|43|43.0||||||
4378736|NCT00326417|4206196|B2|Positive||Recipient Cytomegalovirus Status||participants|Number|17|17.0||||||
4378737|NCT00326417|4206197|B1|Positive||Recipient Cytomegalovirus Status||participants|Number|26|26.0||||||
4378738|NCT00326417|4206195|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378739|NCT00326417|4206196|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4378740|NCT00326417|4206197|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4378741|NCT00326417|4206195|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4378742|NCT00326417|4206196|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4378743|NCT00326417|4206197|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4378744|NCT00326417|4206195|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4378745|NCT00326417|4206196|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4378746|NCT00326417|4206197|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4378747|NCT00326417|4206195|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4378748|NCT00326417|4206196|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4378749|NCT00326417|4206197|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4378750|NCT00326417|4206195|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4378751|NCT00326417|4206196|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4378752|NCT00326417|4206197|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4378753|NCT00326417|4206195|B3|> 40||Age, Customized||participants|Number|15|15.0||||||
4378754|NCT00326417|4206196|B2|> 40||Age, Customized||participants|Number|9|9.0||||||
4378755|NCT00326417|4206197|B1|> 40||Age, Customized||participants|Number|6|6.0||||||
4378756|NCT00326417|4206195|B3|18 - 40||Age, Customized||participants|Number|32|32.0||||||
4378757|NCT00326417|4206196|B2|18 - 40||Age, Customized||participants|Number|18|18.0||||||
4378758|NCT00326417|4206197|B1|18 - 40||Age, Customized||participants|Number|14|14.0||||||
4378759|NCT00326417|4206195|B3|< 18||Age, Customized||participants|Number|32|32.0||||||
4378760|NCT00326417|4206196|B2|< 18||Age, Customized||participants|Number|11|11.0||||||
4378761|NCT00326417|4206197|B1|< 18||Age, Customized||participants|Number|21|21.0||||||
4378762|NCT00326417|4206195|B3|||Age||years|Median|20.6|20.6|Full Range|||0.5|65.9|
4378763|NCT00326417|4206196|B2|||Age||years|Median|24.5|24.5|Full Range|||0.5|65.9|
4378764|NCT00326417|4206197|B1|||Age||years|Median|17.6|17.6|Full Range|||1.9|63.3|
4378765|NCT00326196|4206216|B3|United States||Region of Enrollment||participants|Number|198|198.0||||||
4378766|NCT00326196|4206217|B2|United States||Region of Enrollment||participants|Number|97|97.0||||||
4378767|NCT00326196|4206218|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
4378768|NCT00326196|4206216|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4378769|NCT00326196|4206217|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4378770|NCT00326196|4206218|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4378771|NCT00326196|4206216|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4378772|NCT00326196|4206217|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4378773|NCT00326196|4206218|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4378774|NCT00326196|4206216|B3|||Age||years|Mean|62.4|62.4|Standard Deviation|7.2|7.2|||
4378775|NCT00326196|4206217|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|7.4|7.4|||
4378776|NCT00326196|4206218|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|7.1|7.1|||
4378777|NCT00326183|4206225|B3||Male|Sex: Female, Male||Participants|Count of Participants|921|921.0||||||
4378778|NCT00326183|4206226|B2||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4378779|NCT00326183|4206227|B1||Male|Sex: Female, Male||Participants|Count of Participants|750|750.0||||||
4378780|NCT00326183|4206225|B3||Female|Sex: Female, Male||Participants|Count of Participants|879|879.0||||||
4378781|NCT00326183|4206226|B2||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4378782|NCT00326183|4206227|B1||Female|Sex: Female, Male||Participants|Count of Participants|703|703.0||||||
4378783|NCT00326183|4206225|B3|||Age||months|Mean|13.2|13.2|Standard Deviation|1.43|1.43|||
4378784|NCT00326183|4206226|B2|||Age||months|Mean|12.5|12.5|Standard Deviation|0.90|0.9|||
4378785|NCT00326183|4206227|B1|||Age||months|Mean|13.3|13.3|Standard Deviation|1.49|1.49|||
4378786|NCT00326170|4206254|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4378787|NCT00326170|4206254|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4378788|NCT00326170|4206254|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4378789|NCT00326170|4206254|B1|||Age||years|Median|70|70.0|Full Range|||49.0|84.0|
4378790|NCT00326118|4206258|B3||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4378791|NCT00326118|4206259|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4378792|NCT00326118|4206260|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4378793|NCT00326118|4206258|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4378794|NCT00326118|4206259|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4378795|NCT00326118|4206260|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4378796|NCT00326118|4206258|B3|||Age||Months|Mean|12.5|12.5|Standard Deviation|0.90|0.9|||
4378797|NCT00326118|4206259|B2|||Age||Months|Mean|12.5|12.5|Standard Deviation|0.75|0.75|||
4378798|NCT00326118|4206260|B1|||Age||Months|Mean|12.5|12.5|Standard Deviation|0.94|0.94|||
4378799|NCT00326001|4206295|B3|Germany||Region of Enrollment||participants|Number|446|446.0||||||
4378800|NCT00326001|4206296|B2|Germany||Region of Enrollment||participants|Number|219|219.0||||||
4378801|NCT00326001|4206297|B1|Germany||Region of Enrollment||participants|Number|227|227.0||||||
4378802|NCT00326001|4206295|B3|Czech Republic||Region of Enrollment||participants|Number|17|17.0||||||
4378803|NCT00326001|4206296|B2|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
4378804|NCT00326001|4206297|B1|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
4378805|NCT00326001|4206295|B3||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4378806|NCT00326001|4206296|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4378807|NCT00326001|4206297|B1||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4378808|NCT00326001|4206295|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4378809|NCT00326001|4206296|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4378810|NCT00326001|4206297|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4378811|NCT00326001|4206295|B3|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4378812|NCT00326001|4206296|B2|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4378813|NCT00326001|4206297|B1|||Age||years|Mean|66|66.0|Standard Deviation|10|10.0|||
4378814|NCT00326001|4206295|B3||>=65 years|Age||Participants|Count of Participants|274|274.0||||||
4378815|NCT00326001|4206296|B2||>=65 years|Age||Participants|Count of Participants|135|135.0||||||
4378816|NCT00326001|4206297|B1||>=65 years|Age||Participants|Count of Participants|139|139.0||||||
4378817|NCT00326001|4206295|B3||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4378818|NCT00326001|4206296|B2||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4378819|NCT00326001|4206297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4378820|NCT00326001|4206295|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378821|NCT00326001|4206296|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378822|NCT00326001|4206297|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378823|NCT00325897|4206310|B3|United States||Region of Enrollment||participants|Number|1142|1142.0||||||
4378824|NCT00325897|4206311|B2|United States||Region of Enrollment||participants|Number|572|572.0||||||
4378825|NCT00325897|4206312|B1|United States||Region of Enrollment||participants|Number|570|570.0||||||
4378826|NCT00325897|4206310|B3||Unknown or Not Reported|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|0|0.0||||||
4378827|NCT00325897|4206311|B2||Unknown or Not Reported|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|0|0.0||||||
4378828|NCT00325897|4206312|B1||Unknown or Not Reported|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|0|0.0||||||
4378829|NCT00325897|4206310|B3||More than one race|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|38|38.0||||||
4378830|NCT00325897|4206311|B2||More than one race|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|18|18.0||||||
4378831|NCT00325897|4206312|B1||More than one race|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|20|20.0||||||
4378832|NCT00325897|4206310|B3||White|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|920|920.0||||||
4378833|NCT00325897|4206311|B2||White|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|457|457.0||||||
4378834|NCT00325897|4206312|B1||White|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|463|463.0||||||
4378835|NCT00325897|4206310|B3||Black or African American|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|168|168.0||||||
4378836|NCT00325897|4206311|B2||Black or African American|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|89|89.0||||||
4378837|NCT00325897|4206312|B1||Black or African American|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|79|79.0||||||
4378838|NCT00325897|4206310|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|2|2.0||||||
4378839|NCT00325897|4206311|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|2|2.0||||||
4378840|NCT00325897|4206312|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|0|0.0||||||
4378841|NCT00325897|4206310|B3||Asian|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|10|10.0||||||
4378842|NCT00325897|4206311|B2||Asian|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|4|4.0||||||
4378843|NCT00325897|4206312|B1||Asian|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|6|6.0||||||
4378844|NCT00325897|4206310|B3||American Indian or Alaska Native|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|4|4.0||||||
4378845|NCT00325897|4206311|B2||American Indian or Alaska Native|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|2|2.0||||||
4378846|NCT00325897|4206312|B1||American Indian or Alaska Native|Race (NIH/OMB)|All applicable categories were checked for each participant.|Participants|Count of Participants|2|2.0||||||
4378847|NCT00325897|4206310|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378848|NCT00325897|4206311|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378849|NCT00325897|4206312|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378850|NCT00325897|4206310|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1117|1117.0||||||
4378851|NCT00325897|4206311|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|558|558.0||||||
4378852|NCT00325897|4206312|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|559|559.0||||||
4378853|NCT00325897|4206310|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4378854|NCT00325897|4206311|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4378855|NCT00325897|4206312|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4378856|NCT00325897|4206310|B3||Male|Sex: Female, Male||Participants|Count of Participants|679|679.0||||||
4378857|NCT00325897|4206311|B2||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4378858|NCT00325897|4206312|B1||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4378859|NCT00325897|4206310|B3||Female|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
4378860|NCT00325897|4206311|B2||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4378861|NCT00325897|4206312|B1||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4378862|NCT00325897|4206310|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|8.6|8.6|||
4378863|NCT00325897|4206311|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|8.4|8.4|||
4378864|NCT00325897|4206312|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|8.7|8.7|||
4378865|NCT00325897|4206310|B3||>=65 years|Age||Participants|Count of Participants|604|604.0||||||
4378866|NCT00325897|4206311|B2||>=65 years|Age||Participants|Count of Participants|311|311.0||||||
4378867|NCT00325897|4206312|B1||>=65 years|Age||Participants|Count of Participants|293|293.0||||||
4378868|NCT00325897|4206310|B3||Between 18 and 65 years|Age||Participants|Count of Participants|538|538.0||||||
4378869|NCT00325897|4206311|B2||Between 18 and 65 years|Age||Participants|Count of Participants|261|261.0||||||
4378870|NCT00325897|4206312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|277|277.0||||||
4378871|NCT00325897|4206310|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378872|NCT00325897|4206311|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378873|NCT00325897|4206312|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378874|NCT00325819|4206331|B3|United States||Region of Enrollment||participants|Number|352|352.0||||||
4378875|NCT00325819|4206332|B2|United States||Region of Enrollment||participants|Number|176|176.0||||||
4378876|NCT00325819|4206333|B1|United States||Region of Enrollment||participants|Number|176|176.0||||||
4378877|NCT00325819|4206331|B3||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4378878|NCT00325819|4206332|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4378879|NCT00325819|4206333|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4378880|NCT00325819|4206331|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4378881|NCT00325819|4206332|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4378882|NCT00325819|4206333|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4378883|NCT00325819|4206331|B3|||Age||Weeks|Mean|24.5|24.5|Standard Deviation|4.7|4.7|||
4378884|NCT00325819|4206332|B2|||Age||Weeks|Mean|24.2|24.2|Standard Deviation|4.7|4.7|||
4378885|NCT00325819|4206333|B1|||Age||Weeks|Mean|24.8|24.8|Standard Deviation|4.7|4.7|||
4378886|NCT00325819|4206331|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4378887|NCT00325819|4206332|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4378888|NCT00325819|4206333|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4378889|NCT00325819|4206331|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4378890|NCT00325819|4206332|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4378891|NCT00325819|4206333|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4378892|NCT00325819|4206331|B3||<=18 years|Age||Participants|Count of Participants|352|352.0||||||
4378893|NCT00325819|4206332|B2||<=18 years|Age||Participants|Count of Participants|176|176.0||||||
4378894|NCT00325819|4206333|B1||<=18 years|Age||Participants|Count of Participants|176|176.0||||||
4378895|NCT00325780|4206354|B1||Male|Sex: Female, Male||Participants|Count of Participants|575|575.0||||||
4378896|NCT00325780|4206354|B1||Female|Sex: Female, Male||Participants|Count of Participants|778|778.0||||||
4378897|NCT00325780|4206354|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|9.08|9.08|||
4378898|NCT00325780|4206354|B1||>=65 years|Age||Participants|Count of Participants|412|412.0||||||
4378899|NCT00325780|4206354|B1||Between 18 and 65 years|Age||Participants|Count of Participants|941|941.0||||||
4378900|NCT00325780|4206354|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4378901|NCT00325754|4206359|B3|||Negative logarithm of hydrogen Ion concentration in arterial blood (pHa)||pH units|Mean|7.42|7.42|Standard Deviation|0.03|0.03|||
4378902|NCT00325754|4206360|B2|||Negative logarithm of hydrogen Ion concentration in arterial blood (pHa)||pH units|Mean|7.42|7.42|Standard Deviation|0.03|0.03|||
4378903|NCT00325754|4206361|B1|||Negative logarithm of hydrogen Ion concentration in arterial blood (pHa)||pH units|Mean|7.42|7.42|Standard Deviation|0.03|0.03|||
4378904|NCT00325754|4206359|B3|||Partial pressure of carbon dioxide (PaCO2)||torr|Mean|46.5|46.5|Standard Deviation|7.3|7.3|||
4378905|NCT00325754|4206360|B2|||Partial pressure of carbon dioxide (PaCO2)||torr|Mean|45.4|45.4|Standard Deviation|7.5|7.5|||
4378906|NCT00325754|4206361|B1|||Partial pressure of carbon dioxide (PaCO2)||torr|Mean|47.5|47.5|Standard Deviation|7.2|7.2|||
4378907|NCT00325754|4206359|B3|||Partial pressure of O2 (PaO2)||torr|Mean|51.7|51.7|Standard Deviation|6.4|6.4|||
4378908|NCT00325754|4206360|B2|||Partial pressure of O2 (PaO2)||torr|Mean|49.5|49.5|Standard Deviation|6.5|6.5|||
4378909|NCT00325754|4206361|B1|||Partial pressure of O2 (PaO2)||torr|Mean|53.7|53.7|Standard Deviation|6.0|6.0|||
4378910|NCT00325754|4206359|B3|||Forced expiratory volume in 1 second (FEV1) % Predicted||Percent predicted|Mean|31.3|31.3|Standard Deviation|10.0|10.0|||
4378911|NCT00325754|4206360|B2|||Forced expiratory volume in 1 second (FEV1) % Predicted||Percent predicted|Mean|37.1|37.1|Standard Deviation|13.0|13.0|||
4378912|NCT00325754|4206361|B1|||Forced expiratory volume in 1 second (FEV1) % Predicted||Percent predicted|Mean|30.1|30.1|Standard Deviation|7.7|7.7|||
4378913|NCT00325754|4206359|B3|||Cigarette Pack Years||pack-years|Mean|53.3|53.3|Standard Deviation|26.0|26.0|||
4378914|NCT00325754|4206360|B2|||Cigarette Pack Years||pack-years|Mean|50.2|50.2|Standard Deviation|20.1|20.1|||
4378915|NCT00325754|4206361|B1|||Cigarette Pack Years||pack-years|Mean|56.5|56.5|Standard Deviation|31.2|31.2|||
4378916|NCT00325754|4206359|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378917|NCT00325754|4206360|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378918|NCT00325754|4206361|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378919|NCT00325754|4206359|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4378920|NCT00325754|4206360|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378921|NCT00325754|4206361|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4378922|NCT00325754|4206359|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4378923|NCT00325754|4206360|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4378924|NCT00325754|4206361|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4378925|NCT00325754|4206359|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4378926|NCT00325754|4206360|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4378927|NCT00325754|4206361|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4378928|NCT00325754|4206359|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378929|NCT00325754|4206360|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378930|NCT00325754|4206361|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378931|NCT00325754|4206359|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378932|NCT00325754|4206360|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378933|NCT00325754|4206361|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378934|NCT00325754|4206359|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378935|NCT00325754|4206360|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378936|NCT00325754|4206361|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378937|NCT00325754|4206359|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378938|NCT00325754|4206360|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378939|NCT00325754|4206361|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378940|NCT00325754|4206359|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4378941|NCT00325754|4206360|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4378942|NCT00325754|4206361|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4378943|NCT00325754|4206359|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378944|NCT00325754|4206360|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378945|NCT00325754|4206361|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4378946|NCT00325754|4206359|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4378947|NCT00325754|4206360|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4378948|NCT00325754|4206361|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4378949|NCT00325754|4206359|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4378950|NCT00325754|4206360|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4378951|NCT00325754|4206361|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4378952|NCT00325754|4206359|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|9.2|9.2|||
4378953|NCT00325754|4206360|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|8.1|8.1|||
4378954|NCT00325754|4206361|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|10.0|10.0|||
4378955|NCT00325598|4206376|B3|United States||Region of Enrollment||Participants|Count of Participants|100|100.0||||||
4378956|NCT00325598|4206377|B2|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4378957|NCT00325598|4206378|B1|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4378958|NCT00325598|4206376|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378959|NCT00325598|4206377|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378960|NCT00325598|4206378|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378961|NCT00325598|4206376|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4378962|NCT00325598|4206377|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4378963|NCT00325598|4206378|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4378964|NCT00325598|4206376|B3|||Age||years|Median|58|58.0|Full Range|||36.0|83.0|
4378965|NCT00325598|4206377|B2|||Age||years|Median|59|59.0|Full Range|||46.0|76.0|
4378966|NCT00325598|4206378|B1|||Age||years|Median|56.5|56.5|Full Range|||36.0|83.0|
4378967|NCT00325468|4206403|B6|Distal 1/3 radius T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.35|-1.35|Standard Deviation|1.19|1.19|||
4378968|NCT00325468|4206404|B5|Distal 1/3 radius T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.57|-1.57|Standard Deviation|0.98|0.98|||
4378969|NCT00325468|4206405|B4|Distal 1/3 radius T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.23|-1.23|Standard Deviation|1.21|1.21|||
4378970|NCT00325468|4206406|B3|Distal 1/3 radius T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.14|-1.14|Standard Deviation|1.29|1.29|||
4378971|NCT00325468|4206407|B2|Distal 1/3 radius T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.45|-1.45|Standard Deviation|0.98|0.98|||
4378972|NCT00325468|4206408|B1|Distal 1/3 radius T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.91|-1.91|Standard Deviation|1.25|1.25|||
4378973|NCT00325468|4206403|B6|Total hip BMD T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.21|-1.21|Standard Deviation|0.73|0.73|||
4378974|NCT00325468|4206404|B5|Total hip BMD T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.50|-1.5|Standard Deviation|0.81|0.81|||
4378975|NCT00325468|4206405|B4|Total hip BMD T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.08|-1.08|Standard Deviation|0.68|0.68|||
4378976|NCT00325468|4206406|B3|Total hip BMD T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.05|-1.05|Standard Deviation|0.75|0.75|||
4378977|NCT00325468|4206407|B2|Total hip BMD T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.39|-1.39|Standard Deviation|0.67|0.67|||
4378978|NCT00325468|4206408|B1|Total hip BMD T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.63|-1.63|Standard Deviation|0.75|0.75|||
4378979|NCT00325468|4206403|B6|Lumbar spine BMD T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.55|-1.55|Standard Deviation|0.96|0.96|||
4378980|NCT00325468|4206404|B5|Lumbar spine BMD T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.64|-1.64|Standard Deviation|1.09|1.09|||
4378981|NCT00325468|4206405|B4|Lumbar spine BMD T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.35|-1.35|Standard Deviation|0.87|0.87|||
4378982|NCT00325468|4206406|B3|Lumbar spine BMD T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-1.29|-1.29|Standard Deviation|0.94|0.94|||
4378983|NCT00325468|4206407|B2|Lumbar spine BMD T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-2.02|-2.02|Standard Deviation|1.16|1.16|||
4379040|NCT00325468|4206404|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4378984|NCT00325468|4206408|B1|Lumbar spine BMD T-score||Baseline Bone Mineral Density T-score of Each Anatomic Site|A bone mineral density (BMD) T-score is unit-less and represents the difference, in terms of number of standard deviations, between a subject’s BMD value and the average BMD value of a gender-specific young normal reference.|T-score|Mean|-2.36|-2.36|Standard Deviation|0.62|0.62|||
4378985|NCT00325468|4206403|B6|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4378986|NCT00325468|4206404|B5|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4378987|NCT00325468|4206405|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4378988|NCT00325468|4206406|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4378989|NCT00325468|4206407|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4378990|NCT00325468|4206408|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4378991|NCT00325468|4206403|B6|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4378992|NCT00325468|4206404|B5|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4378993|NCT00325468|4206405|B4|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4378994|NCT00325468|4206406|B3|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4378995|NCT00325468|4206407|B2|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4378996|NCT00325468|4206408|B1|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4378997|NCT00325468|4206403|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4378998|NCT00325468|4206404|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4378999|NCT00325468|4206405|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379000|NCT00325468|4206406|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379001|NCT00325468|4206407|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379002|NCT00325468|4206408|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379003|NCT00325468|4206403|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379004|NCT00325468|4206404|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379005|NCT00325468|4206405|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379006|NCT00325468|4206406|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379007|NCT00325468|4206407|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379008|NCT00325468|4206408|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379009|NCT00325468|4206403|B6|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4379010|NCT00325468|4206404|B5|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379011|NCT00325468|4206405|B4|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4379012|NCT00325468|4206406|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379013|NCT00325468|4206407|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379014|NCT00325468|4206408|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379015|NCT00325468|4206403|B6|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4379016|NCT00325468|4206404|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379017|NCT00325468|4206405|B4|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4379018|NCT00325468|4206406|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379019|NCT00325468|4206407|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379020|NCT00325468|4206408|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379021|NCT00325468|4206403|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4379022|NCT00325468|4206404|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4379023|NCT00325468|4206405|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4379024|NCT00325468|4206406|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4379025|NCT00325468|4206407|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4379026|NCT00325468|4206408|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4379027|NCT00325468|4206403|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4379028|NCT00325468|4206404|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379029|NCT00325468|4206405|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4379030|NCT00325468|4206406|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4379031|NCT00325468|4206407|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379032|NCT00325468|4206408|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379033|NCT00325468|4206403|B6|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|178|178.0||||||
4379034|NCT00325468|4206404|B5|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4379035|NCT00325468|4206405|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|112|112.0||||||
4379036|NCT00325468|4206406|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4379037|NCT00325468|4206407|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4379038|NCT00325468|4206408|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4379039|NCT00325468|4206403|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379041|NCT00325468|4206405|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379042|NCT00325468|4206406|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379043|NCT00325468|4206407|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379044|NCT00325468|4206408|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379045|NCT00325468|4206403|B6||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4379046|NCT00325468|4206404|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4379047|NCT00325468|4206405|B4||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4379048|NCT00325468|4206406|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4379049|NCT00325468|4206407|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4379050|NCT00325468|4206408|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4379051|NCT00325468|4206403|B6|||Age||Years|Mean|66.1|66.1|Standard Deviation|7.7|7.7|||
4379052|NCT00325468|4206404|B5|||Age||Years|Mean|66.6|66.6|Standard Deviation|8.9|8.9|||
4379053|NCT00325468|4206405|B4|||Age||Years|Mean|65.8|65.8|Standard Deviation|7.0|7.0|||
4379054|NCT00325468|4206406|B3|||Age||Years|Mean|68.0|68.0|Standard Deviation|7.2|7.2|||
4379055|NCT00325468|4206407|B2|||Age||Years|Mean|65.8|65.8|Standard Deviation|9.4|9.4|||
4379056|NCT00325468|4206408|B1|||Age||Years|Mean|65.8|65.8|Standard Deviation|9.1|9.1|||
4379057|NCT00325442|4206445|B3|ERA and PDE5-I||Background PAH Therapy||participants|Number|156|156.0||||||
4379058|NCT00325442|4206446|B2|ERA and PDE5-I||Background PAH Therapy||participants|Number|74|74.0||||||
4379059|NCT00325442|4206447|B1|ERA and PDE5-I||Background PAH Therapy||participants|Number|82|82.0||||||
4379060|NCT00325442|4206445|B3|PDE5-I||Background PAH Therapy||participants|Number|88|88.0||||||
4379061|NCT00325442|4206446|B2|PDE5-I||Background PAH Therapy||participants|Number|45|45.0||||||
4379062|NCT00325442|4206447|B1|PDE5-I||Background PAH Therapy||participants|Number|43|43.0||||||
4379063|NCT00325442|4206445|B3|ERA||Background PAH Therapy||participants|Number|106|106.0||||||
4379064|NCT00325442|4206446|B2|ERA||Background PAH Therapy||participants|Number|55|55.0||||||
4379065|NCT00325442|4206447|B1|ERA||Background PAH Therapy||participants|Number|51|51.0||||||
4379066|NCT00325442|4206445|B3|PAH associated with HIV infection||PAH Etiology||participants|Number|4|4.0||||||
4379067|NCT00325442|4206446|B2|PAH associated with HIV infection||PAH Etiology||participants|Number|1|1.0||||||
4379068|NCT00325442|4206447|B1|PAH associated with HIV infection||PAH Etiology||participants|Number|3|3.0||||||
4379069|NCT00325442|4206445|B3|PAH associated wtih congenital heart defect||PAH Etiology||participants|Number|22|22.0||||||
4379070|NCT00325442|4206446|B2|PAH associated wtih congenital heart defect||PAH Etiology||participants|Number|11|11.0||||||
4379071|NCT00325442|4206447|B1|PAH associated wtih congenital heart defect||PAH Etiology||participants|Number|11|11.0||||||
4379072|NCT00325442|4206445|B3|PAH associated with collagen vasular disease||PAH Etiology||participants|Number|92|92.0||||||
4379073|NCT00325442|4206446|B2|PAH associated with collagen vasular disease||PAH Etiology||participants|Number|49|49.0||||||
4379074|NCT00325442|4206447|B1|PAH associated with collagen vasular disease||PAH Etiology||participants|Number|43|43.0||||||
4379075|NCT00325442|4206445|B3|Idiopathic / familial PAH||PAH Etiology||participants|Number|232|232.0||||||
4379076|NCT00325442|4206446|B2|Idiopathic / familial PAH||PAH Etiology||participants|Number|113|113.0||||||
4379077|NCT00325442|4206447|B1|Idiopathic / familial PAH||PAH Etiology||participants|Number|119|119.0||||||
4379078|NCT00325442|4206445|B3|WHO Functional Class IV||Baseline WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|9|9.0||||||
4379079|NCT00325442|4206446|B2|WHO Functional Class IV||Baseline WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|4|4.0||||||
4379080|NCT00325442|4206447|B1|WHO Functional Class IV||Baseline WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|5|5.0||||||
4379081|NCT00325442|4206445|B3|WHO Functional Class III||Baseline WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|266|266.0||||||
4379105|NCT00325442|4206445|B3||Between 18 and 65 years|Age||Participants|Count of Participants|300|300.0||||||
4379082|NCT00325442|4206446|B2|WHO Functional Class III||Baseline WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|127|127.0||||||
4379083|NCT00325442|4206447|B1|WHO Functional Class III||Baseline WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|139|139.0||||||
4379084|NCT00325442|4206445|B3|WHO Functional Class II||Baseline WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|72|72.0||||||
4379085|NCT00325442|4206446|B2|WHO Functional Class II||Baseline WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|41|41.0||||||
4379086|NCT00325442|4206447|B1|WHO Functional Class II||Baseline WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|31|31.0||||||
4379087|NCT00325442|4206445|B3|WHO Functional Class I||Baseline WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|3|3.0||||||
4379088|NCT00325442|4206446|B2|WHO Functional Class I||Baseline WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|2|2.0||||||
4379089|NCT00325442|4206447|B1|WHO Functional Class I||Baseline WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|1|1.0||||||
4379090|NCT00325442|4206445|B3|||Distance Traversed (meters) During Six Minute Walk Test at Baseline||meters|Mean|345.7|345.7|Standard Deviation|73.4|73.4|||
4379091|NCT00325442|4206446|B2|||Distance Traversed (meters) During Six Minute Walk Test at Baseline||meters|Mean|346.1|346.1|Standard Deviation|71.4|71.4|||
4379092|NCT00325442|4206447|B1|||Distance Traversed (meters) During Six Minute Walk Test at Baseline||meters|Mean|345.4|345.4|Standard Deviation|75.5|75.5|||
4379093|NCT00325442|4206445|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4379094|NCT00325442|4206446|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4379095|NCT00325442|4206447|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4379096|NCT00325442|4206445|B3||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4379097|NCT00325442|4206446|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4379098|NCT00325442|4206447|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4379099|NCT00325442|4206445|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|12.8|12.8|||
4379100|NCT00325442|4206446|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|12.3|12.3|||
4379101|NCT00325442|4206447|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|13.3|13.3|||
4379102|NCT00325442|4206445|B3||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4379103|NCT00325442|4206446|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4379104|NCT00325442|4206447|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4379106|NCT00325442|4206446|B2||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
4379107|NCT00325442|4206447|B1||Between 18 and 65 years|Age||Participants|Count of Participants|149|149.0||||||
4379108|NCT00325442|4206445|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4379109|NCT00325442|4206446|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4379110|NCT00325442|4206447|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4379111|NCT00325416|4206493|B3|United States||Region of Enrollment||participants|Number|177|177.0||||||
4379112|NCT00325416|4206494|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
4379113|NCT00325416|4206495|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4379114|NCT00325416|4206493|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4379115|NCT00325416|4206494|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4379116|NCT00325416|4206495|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4379117|NCT00325416|4206493|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4379118|NCT00325416|4206494|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4379119|NCT00325416|4206495|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4379120|NCT00325416|4206493|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4379121|NCT00325416|4206494|B2||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4379122|NCT00325416|4206495|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4379123|NCT00325416|4206493|B3||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4379124|NCT00325416|4206494|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4379125|NCT00325416|4206495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4379126|NCT00325416|4206493|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379127|NCT00325416|4206494|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379128|NCT00325416|4206495|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379129|NCT00325416|4206493|B3|||Age||years|Median|54|54.0|Full Range|||32.0|76.0|
4379130|NCT00325416|4206494|B2|||Age||years|Median|68.5|68.5|Full Range|||61.0|76.0|
4379131|NCT00325416|4206495|B1|||Age||years|Median|46|46.0|Full Range|||32.0|60.0|
4379132|NCT00325403|4206508|B3|WHO Class III||WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|150|150.0||||||
4379133|NCT00325403|4206509|B2|WHO Class III||WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|98|98.0||||||
4379134|NCT00325403|4206510|B1|WHO Class III||WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|52|52.0||||||
4379135|NCT00325403|4206508|B3|WHO Class II||WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|76|76.0||||||
4379136|NCT00325403|4206509|B2|WHO Class II||WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|52|52.0||||||
4379137|NCT00325403|4206510|B1|WHO Class II||WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|24|24.0||||||
4379180|NCT00325234|4206547|B3|Carcinoma, Inflammatory, Breast||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|4|4.0||||||
4379276|NCT00325195|4206566|B4|Mexico||Region of Enrollment||participants|Number|20|20.0||||||
4379138|NCT00325403|4206508|B3|WHO Class I||WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|2|2.0||||||
4379139|NCT00325403|4206509|B2|WHO Class I||WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|1|1.0||||||
4379140|NCT00325403|4206510|B1|WHO Class I||WHO Functional Classification|"Class I: PH without limitation of physical activity (PA); no undue dyspnea or fatigue, chest pain, or near syncope.~Class II: PH resulting in slight limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain or near syncope.~Class III: PH resulting in marked limitation of PA; comfortable at rest; ordinary PA causes undue dyspnea or fatigue, chest pain, or near syncope.~Class IV: PH with inability to carry out any PA without symptoms and signs of right heart failure. Dyspnea and/or fatigue may be present at rest. Discomfort is increased by any PA."|participants|Number|1|1.0||||||
4379141|NCT00325403|4206508|B3|||Baseline Six Minute Walk Distance||meters|Mean|330.0|330.0|Standard Deviation|66.8|66.8|||
4379142|NCT00325403|4206509|B2|||Baseline Six Minute Walk Distance||meters|Mean|331.3|331.3|Standard Deviation|64.9|64.9|||
4379143|NCT00325403|4206510|B1|||Baseline Six Minute Walk Distance||meters|Mean|327.6|327.6|Standard Deviation|70.7|70.7|||
4379144|NCT00325403|4206508|B3|PAH associated w HIV infection||PAH Etiology||participants|Number|2|2.0||||||
4379145|NCT00325403|4206509|B2|PAH associated w HIV infection||PAH Etiology||participants|Number|1|1.0||||||
4379146|NCT00325403|4206510|B1|PAH associated w HIV infection||PAH Etiology||participants|Number|1|1.0||||||
4379147|NCT00325403|4206508|B3|PAH associated w repaired congenital heart defect||PAH Etiology||participants|Number|13|13.0||||||
4379148|NCT00325403|4206509|B2|PAH associated w repaired congenital heart defect||PAH Etiology||participants|Number|10|10.0||||||
4379149|NCT00325403|4206510|B1|PAH associated w repaired congenital heart defect||PAH Etiology||participants|Number|3|3.0||||||
4379150|NCT00325403|4206508|B3|PAH associated w collagen vascular disease||PAH Etiology||participants|Number|43|43.0||||||
4379151|NCT00325403|4206509|B2|PAH associated w collagen vascular disease||PAH Etiology||participants|Number|26|26.0||||||
4379152|NCT00325403|4206510|B1|PAH associated w collagen vascular disease||PAH Etiology||participants|Number|17|17.0||||||
4379153|NCT00325403|4206508|B3|Idiopathic or heritable PAH||PAH Etiology||participants|Number|170|170.0||||||
4379154|NCT00325403|4206509|B2|Idiopathic or heritable PAH||PAH Etiology||participants|Number|114|114.0||||||
4379155|NCT00325403|4206510|B1|Idiopathic or heritable PAH||PAH Etiology||participants|Number|56|56.0||||||
4379156|NCT00325403|4206508|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4379157|NCT00325403|4206509|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4379158|NCT00325403|4206510|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4379159|NCT00325403|4206508|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4379160|NCT00325403|4206509|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4379161|NCT00325403|4206510|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4379162|NCT00325403|4206508|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|13.7|13.7|||
4379163|NCT00325403|4206509|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|13.5|13.5|||
4379164|NCT00325403|4206510|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|13.5|13.5|||
4379165|NCT00325403|4206508|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4379166|NCT00325403|4206509|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4379167|NCT00325403|4206510|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4379168|NCT00325403|4206508|B3||Between 18 and 65 years|Age||Participants|Count of Participants|210|210.0||||||
4379169|NCT00325403|4206509|B2||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
4379170|NCT00325403|4206510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4379171|NCT00325403|4206508|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4379172|NCT00325403|4206509|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4379173|NCT00325403|4206510|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4379174|NCT00325234|4206547|B3|Other||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|3|3.0||||||
4379175|NCT00325234|4206548|B2|Other||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|3|3.0||||||
4379176|NCT00325234|4206549|B1|Other||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|0|0.0||||||
4379177|NCT00325234|4206547|B3|Carcinoma, Mixed Cell, Breast||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|1|1.0||||||
4379178|NCT00325234|4206548|B2|Carcinoma, Mixed Cell, Breast||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|1|1.0||||||
4379179|NCT00325234|4206549|B1|Carcinoma, Mixed Cell, Breast||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|0|0.0||||||
4379181|NCT00325234|4206548|B2|Carcinoma, Inflammatory, Breast||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|3|3.0||||||
4379182|NCT00325234|4206549|B1|Carcinoma, Inflammatory, Breast||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|1|1.0||||||
4379183|NCT00325234|4206547|B3|Carcinoma, Lobular, Breast||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|9|9.0||||||
4379184|NCT00325234|4206548|B2|Carcinoma, Lobular, Breast||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|5|5.0||||||
4379185|NCT00325234|4206549|B1|Carcinoma, Lobular, Breast||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|4|4.0||||||
4379186|NCT00325234|4206547|B3|Carcinoma, Ductal, Breast||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|118|118.0||||||
4379187|NCT00325234|4206548|B2|Carcinoma, Ductal, Breast||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|54|54.0||||||
4379188|NCT00325234|4206549|B1|Carcinoma, Ductal, Breast||Pathological Diagnosis|This measure is the specific diagnosis of breast cancer based upon pathological diagnosis.|participants|Number|64|64.0||||||
4379189|NCT00325234|4206547|B3|Unknown||Tumor Differentiation Grade|"Classification of tumors into one of four grades based upon how similar in appearance the tumor cells are to normal cells, and by how many tumor cells are dividing. The more tumor cells that are dividing, the greater likelihood of tumor growth and the higher the tumor grade. A lower tumor grade is associated with a better prognosis.~Grade 1 - Well-Differentiated, Low cell division Grade 2 - Moderately Differentiated, Moderate cell division Grade 3 - Poorly Differentiated, High cell division Grade 4 - Undifferentiated, High cell division"|participants|Number|12|12.0||||||
4379190|NCT00325234|4206548|B2|Unknown||Tumor Differentiation Grade|"Classification of tumors into one of four grades based upon how similar in appearance the tumor cells are to normal cells, and by how many tumor cells are dividing. The more tumor cells that are dividing, the greater likelihood of tumor growth and the higher the tumor grade. A lower tumor grade is associated with a better prognosis.~Grade 1 - Well-Differentiated, Low cell division Grade 2 - Moderately Differentiated, Moderate cell division Grade 3 - Poorly Differentiated, High cell division Grade 4 - Undifferentiated, High cell division"|participants|Number|6|6.0||||||
4379191|NCT00325234|4206549|B1|Unknown||Tumor Differentiation Grade|"Classification of tumors into one of four grades based upon how similar in appearance the tumor cells are to normal cells, and by how many tumor cells are dividing. The more tumor cells that are dividing, the greater likelihood of tumor growth and the higher the tumor grade. A lower tumor grade is associated with a better prognosis.~Grade 1 - Well-Differentiated, Low cell division Grade 2 - Moderately Differentiated, Moderate cell division Grade 3 - Poorly Differentiated, High cell division Grade 4 - Undifferentiated, High cell division"|participants|Number|6|6.0||||||
4379192|NCT00325234|4206547|B3|Grade III||Tumor Differentiation Grade|"Classification of tumors into one of four grades based upon how similar in appearance the tumor cells are to normal cells, and by how many tumor cells are dividing. The more tumor cells that are dividing, the greater likelihood of tumor growth and the higher the tumor grade. A lower tumor grade is associated with a better prognosis.~Grade 1 - Well-Differentiated, Low cell division Grade 2 - Moderately Differentiated, Moderate cell division Grade 3 - Poorly Differentiated, High cell division Grade 4 - Undifferentiated, High cell division"|participants|Number|62|62.0||||||
4379193|NCT00325234|4206548|B2|Grade III||Tumor Differentiation Grade|"Classification of tumors into one of four grades based upon how similar in appearance the tumor cells are to normal cells, and by how many tumor cells are dividing. The more tumor cells that are dividing, the greater likelihood of tumor growth and the higher the tumor grade. A lower tumor grade is associated with a better prognosis.~Grade 1 - Well-Differentiated, Low cell division Grade 2 - Moderately Differentiated, Moderate cell division Grade 3 - Poorly Differentiated, High cell division Grade 4 - Undifferentiated, High cell division"|participants|Number|30|30.0||||||
4379194|NCT00325234|4206549|B1|Grade III||Tumor Differentiation Grade|"Classification of tumors into one of four grades based upon how similar in appearance the tumor cells are to normal cells, and by how many tumor cells are dividing. The more tumor cells that are dividing, the greater likelihood of tumor growth and the higher the tumor grade. A lower tumor grade is associated with a better prognosis.~Grade 1 - Well-Differentiated, Low cell division Grade 2 - Moderately Differentiated, Moderate cell division Grade 3 - Poorly Differentiated, High cell division Grade 4 - Undifferentiated, High cell division"|participants|Number|32|32.0||||||
4379195|NCT00325234|4206547|B3|Grade II||Tumor Differentiation Grade|"Classification of tumors into one of four grades based upon how similar in appearance the tumor cells are to normal cells, and by how many tumor cells are dividing. The more tumor cells that are dividing, the greater likelihood of tumor growth and the higher the tumor grade. A lower tumor grade is associated with a better prognosis.~Grade 1 - Well-Differentiated, Low cell division Grade 2 - Moderately Differentiated, Moderate cell division Grade 3 - Poorly Differentiated, High cell division Grade 4 - Undifferentiated, High cell division"|participants|Number|52|52.0||||||
4379196|NCT00325234|4206548|B2|Grade II||Tumor Differentiation Grade|"Classification of tumors into one of four grades based upon how similar in appearance the tumor cells are to normal cells, and by how many tumor cells are dividing. The more tumor cells that are dividing, the greater likelihood of tumor growth and the higher the tumor grade. A lower tumor grade is associated with a better prognosis.~Grade 1 - Well-Differentiated, Low cell division Grade 2 - Moderately Differentiated, Moderate cell division Grade 3 - Poorly Differentiated, High cell division Grade 4 - Undifferentiated, High cell division"|participants|Number|27|27.0||||||
4379197|NCT00325234|4206549|B1|Grade II||Tumor Differentiation Grade|"Classification of tumors into one of four grades based upon how similar in appearance the tumor cells are to normal cells, and by how many tumor cells are dividing. The more tumor cells that are dividing, the greater likelihood of tumor growth and the higher the tumor grade. A lower tumor grade is associated with a better prognosis.~Grade 1 - Well-Differentiated, Low cell division Grade 2 - Moderately Differentiated, Moderate cell division Grade 3 - Poorly Differentiated, High cell division Grade 4 - Undifferentiated, High cell division"|participants|Number|25|25.0||||||
4379271|NCT00325234|4206548|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4379198|NCT00325234|4206547|B3|Grade I||Tumor Differentiation Grade|"Classification of tumors into one of four grades based upon how similar in appearance the tumor cells are to normal cells, and by how many tumor cells are dividing. The more tumor cells that are dividing, the greater likelihood of tumor growth and the higher the tumor grade. A lower tumor grade is associated with a better prognosis.~Grade 1 - Well-Differentiated, Low cell division Grade 2 - Moderately Differentiated, Moderate cell division Grade 3 - Poorly Differentiated, High cell division Grade 4 - Undifferentiated, High cell division"|participants|Number|9|9.0||||||
4379199|NCT00325234|4206548|B2|Grade I||Tumor Differentiation Grade|"Classification of tumors into one of four grades based upon how similar in appearance the tumor cells are to normal cells, and by how many tumor cells are dividing. The more tumor cells that are dividing, the greater likelihood of tumor growth and the higher the tumor grade. A lower tumor grade is associated with a better prognosis.~Grade 1 - Well-Differentiated, Low cell division Grade 2 - Moderately Differentiated, Moderate cell division Grade 3 - Poorly Differentiated, High cell division Grade 4 - Undifferentiated, High cell division"|participants|Number|3|3.0||||||
4379200|NCT00325234|4206549|B1|Grade I||Tumor Differentiation Grade|"Classification of tumors into one of four grades based upon how similar in appearance the tumor cells are to normal cells, and by how many tumor cells are dividing. The more tumor cells that are dividing, the greater likelihood of tumor growth and the higher the tumor grade. A lower tumor grade is associated with a better prognosis.~Grade 1 - Well-Differentiated, Low cell division Grade 2 - Moderately Differentiated, Moderate cell division Grade 3 - Poorly Differentiated, High cell division Grade 4 - Undifferentiated, High cell division"|participants|Number|6|6.0||||||
4379201|NCT00325234|4206547|B3|Unknown||Human Epidermal Growth Factor Receptor 2 (HER-2/Neu)|The Human Epidermal Growth Factor Receptor 2 plays an important role in cell growth and development. HER-2/Neu status is determined by an assay. A positive HER-2/Neu result indicates that HER-2 gene receptors are present; negative HER-2/Neu indicates the absence of HER-2 gene receptors.|participants|Number|7|7.0||||||
4379202|NCT00325234|4206548|B2|Unknown||Human Epidermal Growth Factor Receptor 2 (HER-2/Neu)|The Human Epidermal Growth Factor Receptor 2 plays an important role in cell growth and development. HER-2/Neu status is determined by an assay. A positive HER-2/Neu result indicates that HER-2 gene receptors are present; negative HER-2/Neu indicates the absence of HER-2 gene receptors.|participants|Number|3|3.0||||||
4379203|NCT00325234|4206549|B1|Unknown||Human Epidermal Growth Factor Receptor 2 (HER-2/Neu)|The Human Epidermal Growth Factor Receptor 2 plays an important role in cell growth and development. HER-2/Neu status is determined by an assay. A positive HER-2/Neu result indicates that HER-2 gene receptors are present; negative HER-2/Neu indicates the absence of HER-2 gene receptors.|participants|Number|4|4.0||||||
4379204|NCT00325234|4206547|B3|Not Performed||Human Epidermal Growth Factor Receptor 2 (HER-2/Neu)|The Human Epidermal Growth Factor Receptor 2 plays an important role in cell growth and development. HER-2/Neu status is determined by an assay. A positive HER-2/Neu result indicates that HER-2 gene receptors are present; negative HER-2/Neu indicates the absence of HER-2 gene receptors.|participants|Number|1|1.0||||||
4379205|NCT00325234|4206548|B2|Not Performed||Human Epidermal Growth Factor Receptor 2 (HER-2/Neu)|The Human Epidermal Growth Factor Receptor 2 plays an important role in cell growth and development. HER-2/Neu status is determined by an assay. A positive HER-2/Neu result indicates that HER-2 gene receptors are present; negative HER-2/Neu indicates the absence of HER-2 gene receptors.|participants|Number|1|1.0||||||
4379206|NCT00325234|4206549|B1|Not Performed||Human Epidermal Growth Factor Receptor 2 (HER-2/Neu)|The Human Epidermal Growth Factor Receptor 2 plays an important role in cell growth and development. HER-2/Neu status is determined by an assay. A positive HER-2/Neu result indicates that HER-2 gene receptors are present; negative HER-2/Neu indicates the absence of HER-2 gene receptors.|participants|Number|0|0.0||||||
4379207|NCT00325234|4206547|B3|Negative||Human Epidermal Growth Factor Receptor 2 (HER-2/Neu)|The Human Epidermal Growth Factor Receptor 2 plays an important role in cell growth and development. HER-2/Neu status is determined by an assay. A positive HER-2/Neu result indicates that HER-2 gene receptors are present; negative HER-2/Neu indicates the absence of HER-2 gene receptors.|participants|Number|102|102.0||||||
4379208|NCT00325234|4206548|B2|Negative||Human Epidermal Growth Factor Receptor 2 (HER-2/Neu)|The Human Epidermal Growth Factor Receptor 2 plays an important role in cell growth and development. HER-2/Neu status is determined by an assay. A positive HER-2/Neu result indicates that HER-2 gene receptors are present; negative HER-2/Neu indicates the absence of HER-2 gene receptors.|participants|Number|49|49.0||||||
4379209|NCT00325234|4206549|B1|Negative||Human Epidermal Growth Factor Receptor 2 (HER-2/Neu)|The Human Epidermal Growth Factor Receptor 2 plays an important role in cell growth and development. HER-2/Neu status is determined by an assay. A positive HER-2/Neu result indicates that HER-2 gene receptors are present; negative HER-2/Neu indicates the absence of HER-2 gene receptors.|participants|Number|53|53.0||||||
4379210|NCT00325234|4206547|B3|Positive||Human Epidermal Growth Factor Receptor 2 (HER-2/Neu)|The Human Epidermal Growth Factor Receptor 2 plays an important role in cell growth and development. HER-2/Neu status is determined by an assay. A positive HER-2/Neu result indicates that HER-2 gene receptors are present; negative HER-2/Neu indicates the absence of HER-2 gene receptors.|participants|Number|25|25.0||||||
4379211|NCT00325234|4206548|B2|Positive||Human Epidermal Growth Factor Receptor 2 (HER-2/Neu)|The Human Epidermal Growth Factor Receptor 2 plays an important role in cell growth and development. HER-2/Neu status is determined by an assay. A positive HER-2/Neu result indicates that HER-2 gene receptors are present; negative HER-2/Neu indicates the absence of HER-2 gene receptors.|participants|Number|13|13.0||||||
4379212|NCT00325234|4206549|B1|Positive||Human Epidermal Growth Factor Receptor 2 (HER-2/Neu)|The Human Epidermal Growth Factor Receptor 2 plays an important role in cell growth and development. HER-2/Neu status is determined by an assay. A positive HER-2/Neu result indicates that HER-2 gene receptors are present; negative HER-2/Neu indicates the absence of HER-2 gene receptors.|participants|Number|12|12.0||||||
4379213|NCT00325234|4206547|B3|Unknown||Hormonal Receptor Status|Hormone receptor status is a positive or negative measure of estrogen (ER) or progesterone (PR) hormone receptors found in cancer cells. In hormone receptor negative tumors, estrogen and/or progesterone are not present in cancer cells. In hormone receptor positive tumors, estrogen and/or progesterone hormone receptors are present in the cancer cells.|participants|Number|2|2.0||||||
4379272|NCT00325234|4206549|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4379273|NCT00325234|4206547|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|10.87|10.87|||
4379214|NCT00325234|4206548|B2|Unknown||Hormonal Receptor Status|Hormone receptor status is a positive or negative measure of estrogen (ER) or progesterone (PR) hormone receptors found in cancer cells. In hormone receptor negative tumors, estrogen and/or progesterone are not present in cancer cells. In hormone receptor positive tumors, estrogen and/or progesterone hormone receptors are present in the cancer cells.|participants|Number|1|1.0||||||
4379215|NCT00325234|4206549|B1|Unknown||Hormonal Receptor Status|Hormone receptor status is a positive or negative measure of estrogen (ER) or progesterone (PR) hormone receptors found in cancer cells. In hormone receptor negative tumors, estrogen and/or progesterone are not present in cancer cells. In hormone receptor positive tumors, estrogen and/or progesterone hormone receptors are present in the cancer cells.|participants|Number|1|1.0||||||
4379216|NCT00325234|4206547|B3|Estrogen and/or Progesterone Positive||Hormonal Receptor Status|Hormone receptor status is a positive or negative measure of estrogen (ER) or progesterone (PR) hormone receptors found in cancer cells. In hormone receptor negative tumors, estrogen and/or progesterone are not present in cancer cells. In hormone receptor positive tumors, estrogen and/or progesterone hormone receptors are present in the cancer cells.|participants|Number|93|93.0||||||
4379217|NCT00325234|4206548|B2|Estrogen and/or Progesterone Positive||Hormonal Receptor Status|Hormone receptor status is a positive or negative measure of estrogen (ER) or progesterone (PR) hormone receptors found in cancer cells. In hormone receptor negative tumors, estrogen and/or progesterone are not present in cancer cells. In hormone receptor positive tumors, estrogen and/or progesterone hormone receptors are present in the cancer cells.|participants|Number|44|44.0||||||
4379218|NCT00325234|4206549|B1|Estrogen and/or Progesterone Positive||Hormonal Receptor Status|Hormone receptor status is a positive or negative measure of estrogen (ER) or progesterone (PR) hormone receptors found in cancer cells. In hormone receptor negative tumors, estrogen and/or progesterone are not present in cancer cells. In hormone receptor positive tumors, estrogen and/or progesterone hormone receptors are present in the cancer cells.|participants|Number|49|49.0||||||
4379219|NCT00325234|4206547|B3|Estrogen and Progesterone Negative||Hormonal Receptor Status|Hormone receptor status is a positive or negative measure of estrogen (ER) or progesterone (PR) hormone receptors found in cancer cells. In hormone receptor negative tumors, estrogen and/or progesterone are not present in cancer cells. In hormone receptor positive tumors, estrogen and/or progesterone hormone receptors are present in the cancer cells.|participants|Number|40|40.0||||||
4379220|NCT00325234|4206548|B2|Estrogen and Progesterone Negative||Hormonal Receptor Status|Hormone receptor status is a positive or negative measure of estrogen (ER) or progesterone (PR) hormone receptors found in cancer cells. In hormone receptor negative tumors, estrogen and/or progesterone are not present in cancer cells. In hormone receptor positive tumors, estrogen and/or progesterone hormone receptors are present in the cancer cells.|participants|Number|21|21.0||||||
4379221|NCT00325234|4206549|B1|Estrogen and Progesterone Negative||Hormonal Receptor Status|Hormone receptor status is a positive or negative measure of estrogen (ER) or progesterone (PR) hormone receptors found in cancer cells. In hormone receptor negative tumors, estrogen and/or progesterone are not present in cancer cells. In hormone receptor positive tumors, estrogen and/or progesterone hormone receptors are present in the cancer cells.|participants|Number|19|19.0||||||
4379222|NCT00325234|4206547|B3|ECOG 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"The Eastern Cooperative Oncology Group (ECOG) scales and criteria are used by doctors to assess disease progression, assess the patient’s living ability, and determine prognosis. The scale is as follows:~0-Fully active, able to carry on all pre-disease performance without restriction. 1-Restricted in activity but ambulatory and able to perform sedentary work. 2-Ambulatory but unable to work. Up and about > 50% of waking hours. 3-Capable of only limited selfcare, confined to bed or chair > 50% of waking hours. 4-Completely disabled. Cannot self care. Totally confined to bed or chair. 5-Dead"|participants|Number|2|2.0||||||
4379223|NCT00325234|4206548|B2|ECOG 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"The Eastern Cooperative Oncology Group (ECOG) scales and criteria are used by doctors to assess disease progression, assess the patient’s living ability, and determine prognosis. The scale is as follows:~0-Fully active, able to carry on all pre-disease performance without restriction. 1-Restricted in activity but ambulatory and able to perform sedentary work. 2-Ambulatory but unable to work. Up and about > 50% of waking hours. 3-Capable of only limited selfcare, confined to bed or chair > 50% of waking hours. 4-Completely disabled. Cannot self care. Totally confined to bed or chair. 5-Dead"|participants|Number|0|0.0||||||
4379224|NCT00325234|4206549|B1|ECOG 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"The Eastern Cooperative Oncology Group (ECOG) scales and criteria are used by doctors to assess disease progression, assess the patient’s living ability, and determine prognosis. The scale is as follows:~0-Fully active, able to carry on all pre-disease performance without restriction. 1-Restricted in activity but ambulatory and able to perform sedentary work. 2-Ambulatory but unable to work. Up and about > 50% of waking hours. 3-Capable of only limited selfcare, confined to bed or chair > 50% of waking hours. 4-Completely disabled. Cannot self care. Totally confined to bed or chair. 5-Dead"|participants|Number|2|2.0||||||
4379225|NCT00325234|4206547|B3|ECOG 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"The Eastern Cooperative Oncology Group (ECOG) scales and criteria are used by doctors to assess disease progression, assess the patient’s living ability, and determine prognosis. The scale is as follows:~0-Fully active, able to carry on all pre-disease performance without restriction. 1-Restricted in activity but ambulatory and able to perform sedentary work. 2-Ambulatory but unable to work. Up and about > 50% of waking hours. 3-Capable of only limited selfcare, confined to bed or chair > 50% of waking hours. 4-Completely disabled. Cannot self care. Totally confined to bed or chair. 5-Dead"|participants|Number|55|55.0||||||
4379226|NCT00325234|4206548|B2|ECOG 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"The Eastern Cooperative Oncology Group (ECOG) scales and criteria are used by doctors to assess disease progression, assess the patient’s living ability, and determine prognosis. The scale is as follows:~0-Fully active, able to carry on all pre-disease performance without restriction. 1-Restricted in activity but ambulatory and able to perform sedentary work. 2-Ambulatory but unable to work. Up and about > 50% of waking hours. 3-Capable of only limited selfcare, confined to bed or chair > 50% of waking hours. 4-Completely disabled. Cannot self care. Totally confined to bed or chair. 5-Dead"|participants|Number|27|27.0||||||
4379274|NCT00325234|4206548|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|10.40|10.4|||
4379275|NCT00325234|4206549|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|11.38|11.38|||
4379227|NCT00325234|4206549|B1|ECOG 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"The Eastern Cooperative Oncology Group (ECOG) scales and criteria are used by doctors to assess disease progression, assess the patient’s living ability, and determine prognosis. The scale is as follows:~0-Fully active, able to carry on all pre-disease performance without restriction. 1-Restricted in activity but ambulatory and able to perform sedentary work. 2-Ambulatory but unable to work. Up and about > 50% of waking hours. 3-Capable of only limited selfcare, confined to bed or chair > 50% of waking hours. 4-Completely disabled. Cannot self care. Totally confined to bed or chair. 5-Dead"|participants|Number|28|28.0||||||
4379228|NCT00325234|4206547|B3|ECOG 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"The Eastern Cooperative Oncology Group (ECOG) scales and criteria are used by doctors to assess disease progression, assess the patient’s living ability, and determine prognosis. The scale is as follows:~0-Fully active, able to carry on all pre-disease performance without restriction. 1-Restricted in activity but ambulatory and able to perform sedentary work. 2-Ambulatory but unable to work. Up and about > 50% of waking hours. 3-Capable of only limited selfcare, confined to bed or chair > 50% of waking hours. 4-Completely disabled. Cannot self care. Totally confined to bed or chair. 5-Dead"|participants|Number|78|78.0||||||
4379229|NCT00325234|4206548|B2|ECOG 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"The Eastern Cooperative Oncology Group (ECOG) scales and criteria are used by doctors to assess disease progression, assess the patient’s living ability, and determine prognosis. The scale is as follows:~0-Fully active, able to carry on all pre-disease performance without restriction. 1-Restricted in activity but ambulatory and able to perform sedentary work. 2-Ambulatory but unable to work. Up and about > 50% of waking hours. 3-Capable of only limited selfcare, confined to bed or chair > 50% of waking hours. 4-Completely disabled. Cannot self care. Totally confined to bed or chair. 5-Dead"|participants|Number|39|39.0||||||
4379230|NCT00325234|4206549|B1|ECOG 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"The Eastern Cooperative Oncology Group (ECOG) scales and criteria are used by doctors to assess disease progression, assess the patient’s living ability, and determine prognosis. The scale is as follows:~0-Fully active, able to carry on all pre-disease performance without restriction. 1-Restricted in activity but ambulatory and able to perform sedentary work. 2-Ambulatory but unable to work. Up and about > 50% of waking hours. 3-Capable of only limited selfcare, confined to bed or chair > 50% of waking hours. 4-Completely disabled. Cannot self care. Totally confined to bed or chair. 5-Dead"|participants|Number|39|39.0||||||
4379231|NCT00325234|4206547|B3|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
4379232|NCT00325234|4206548|B2|South Africa||Region of Enrollment||participants|Number|6|6.0||||||
4379233|NCT00325234|4206549|B1|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
4379234|NCT00325234|4206547|B3|Turkey||Region of Enrollment||participants|Number|8|8.0||||||
4379235|NCT00325234|4206548|B2|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
4379236|NCT00325234|4206549|B1|Turkey||Region of Enrollment||participants|Number|5|5.0||||||
4379237|NCT00325234|4206547|B3|Italy||Region of Enrollment||participants|Number|30|30.0||||||
4379238|NCT00325234|4206548|B2|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4379239|NCT00325234|4206549|B1|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4379240|NCT00325234|4206547|B3|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4379241|NCT00325234|4206548|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4379242|NCT00325234|4206549|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4379243|NCT00325234|4206547|B3|Israel||Region of Enrollment||participants|Number|18|18.0||||||
4379244|NCT00325234|4206548|B2|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4379245|NCT00325234|4206549|B1|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4379246|NCT00325234|4206547|B3|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
4379247|NCT00325234|4206548|B2|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4379248|NCT00325234|4206549|B1|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4379249|NCT00325234|4206547|B3|Spain||Region of Enrollment||participants|Number|36|36.0||||||
4379250|NCT00325234|4206548|B2|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4379251|NCT00325234|4206549|B1|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4379252|NCT00325234|4206547|B3|West Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4379253|NCT00325234|4206548|B2|West Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4379254|NCT00325234|4206549|B1|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4379255|NCT00325234|4206547|B3|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4379256|NCT00325234|4206548|B2|East Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4379257|NCT00325234|4206549|B1|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4379258|NCT00325234|4206547|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4379259|NCT00325234|4206548|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4379260|NCT00325234|4206549|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4379261|NCT00325234|4206547|B3|African||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4379262|NCT00325234|4206548|B2|African||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4379263|NCT00325234|4206549|B1|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4379264|NCT00325234|4206547|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4379265|NCT00325234|4206548|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4379266|NCT00325234|4206549|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4379267|NCT00325234|4206547|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379268|NCT00325234|4206548|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379269|NCT00325234|4206549|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379270|NCT00325234|4206547|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4379277|NCT00325195|4206567|B3|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4379278|NCT00325195|4206568|B2|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4379279|NCT00325195|4206569|B1|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
4379280|NCT00325195|4206566|B4|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4379281|NCT00325195|4206567|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4379282|NCT00325195|4206568|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4379283|NCT00325195|4206569|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4379284|NCT00325195|4206566|B4|United States||Region of Enrollment||participants|Number|189|189.0||||||
4379285|NCT00325195|4206567|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4379286|NCT00325195|4206568|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4379287|NCT00325195|4206569|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4379288|NCT00325195|4206566|B4||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4379289|NCT00325195|4206567|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4379290|NCT00325195|4206568|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4379291|NCT00325195|4206569|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4379292|NCT00325195|4206566|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4379293|NCT00325195|4206567|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4379294|NCT00325195|4206568|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4379295|NCT00325195|4206569|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4379296|NCT00325195|4206566|B4|||Age||years|Mean|55.4|55.4|Standard Deviation|14.01|14.01|||
4379297|NCT00325195|4206567|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|12.21|12.21|||
4379298|NCT00325195|4206568|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|13.34|13.34|||
4379299|NCT00325195|4206569|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|15.53|15.53|||
4379300|NCT00325195|4206566|B4||>=65 years|Age||Participants|Count of Participants|60|60.0||||||
4379301|NCT00325195|4206567|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4379302|NCT00325195|4206568|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4379303|NCT00325195|4206569|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4379304|NCT00325195|4206566|B4||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
4379305|NCT00325195|4206567|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4379306|NCT00325195|4206568|B2||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4379307|NCT00325195|4206569|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4379308|NCT00325195|4206566|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379309|NCT00325195|4206567|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379310|NCT00325195|4206568|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379311|NCT00325195|4206569|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379312|NCT00325156|4206594|B1||Male|Sex: Female, Male||Participants|Count of Participants|1345|1345.0||||||
4379313|NCT00325156|4206594|B1||Female|Sex: Female, Male||Participants|Count of Participants|1245|1245.0||||||
4379314|NCT00325156|4206594|B1|||Age||Weeks|Mean|13.3|13.3|Standard Deviation|0.87|0.87|||
4379315|NCT00325143|4206601|B1|Indian||Race/Ethnicity, Customized||Participants|Count of Participants|38|38.0||||||
4379316|NCT00325143|4206601|B1|Malay||Race/Ethnicity, Customized||Participants|Count of Participants|269|269.0||||||
4379317|NCT00325143|4206601|B1|Chinese||Race/Ethnicity, Customized||Participants|Count of Participants|366|366.0||||||
4379318|NCT00325143|4206601|B1|Not specified||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4379319|NCT00325143|4206601|B1|Japanese||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4379320|NCT00325143|4206601|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4379321|NCT00325143|4206601|B1||Male|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4379322|NCT00325143|4206601|B1||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4379323|NCT00325143|4206601|B1|||Age||Weeks|Mean|13.5|13.5|Standard Deviation|0.99|0.99|||
4379324|NCT00325130|4206609|B3|White||Race/Ethnicity||participants|Number|810|810.0||||||
4379325|NCT00325130|4206610|B2|White||Race/Ethnicity||participants|Number|404|404.0||||||
4379326|NCT00325130|4206611|B1|White||Race/Ethnicity||participants|Number|406|406.0||||||
4379327|NCT00325130|4206609|B3|Native American||Race/Ethnicity||participants|Number|4|4.0||||||
4379328|NCT00325130|4206610|B2|Native American||Race/Ethnicity||participants|Number|3|3.0||||||
4379329|NCT00325130|4206611|B1|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4379330|NCT00325130|4206609|B3|Multi-Racial||Race/Ethnicity||participants|Number|15|15.0||||||
4379331|NCT00325130|4206610|B2|Multi-Racial||Race/Ethnicity||participants|Number|6|6.0||||||
4379332|NCT00325130|4206611|B1|Multi-Racial||Race/Ethnicity||participants|Number|9|9.0||||||
4379333|NCT00325130|4206609|B3|Indian||Race/Ethnicity||participants|Number|2|2.0||||||
4379334|NCT00325130|4206610|B2|Indian||Race/Ethnicity||participants|Number|1|1.0||||||
4379335|NCT00325130|4206611|B1|Indian||Race/Ethnicity||participants|Number|1|1.0||||||
4379336|NCT00325130|4206609|B3|Hispanic American||Race/Ethnicity||participants|Number|71|71.0||||||
4379337|NCT00325130|4206610|B2|Hispanic American||Race/Ethnicity||participants|Number|29|29.0||||||
4379338|NCT00325130|4206611|B1|Hispanic American||Race/Ethnicity||participants|Number|42|42.0||||||
4379339|NCT00325130|4206609|B3|Black||Race/Ethnicity||participants|Number|128|128.0||||||
4379340|NCT00325130|4206610|B2|Black||Race/Ethnicity||participants|Number|74|74.0||||||
4379341|NCT00325130|4206611|B1|Black||Race/Ethnicity||participants|Number|54|54.0||||||
4379342|NCT00325130|4206609|B3|Asian||Race/Ethnicity||participants|Number|12|12.0||||||
4379343|NCT00325130|4206610|B2|Asian||Race/Ethnicity||participants|Number|7|7.0||||||
4379344|NCT00325130|4206611|B1|Asian||Race/Ethnicity||participants|Number|5|5.0||||||
4379345|NCT00325130|4206609|B3||Male|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
4379346|NCT00325130|4206610|B2||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4379347|NCT00325130|4206611|B1||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4379348|NCT00325130|4206609|B3||Female|Sex: Female, Male||Participants|Count of Participants|648|648.0||||||
4379349|NCT00325130|4206610|B2||Female|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4379350|NCT00325130|4206611|B1||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4379351|NCT00325130|4206609|B3|Over 17 Years of Age||Age, Customized||participants|Number|0|0.0||||||
4379352|NCT00325130|4206610|B2|Over 17 Years of Age||Age, Customized||participants|Number|0|0.0||||||
4379353|NCT00325130|4206611|B1|Over 17 Years of Age||Age, Customized||participants|Number|0|0.0||||||
4379354|NCT00325130|4206609|B3|10 to 17 Years of Age||Age, Customized||participants|Number|1042|1042.0||||||
4379355|NCT00325130|4206610|B2|10 to 17 Years of Age||Age, Customized||participants|Number|524|524.0||||||
4379356|NCT00325130|4206611|B1|10 to 17 Years of Age||Age, Customized||participants|Number|518|518.0||||||
4379357|NCT00325130|4206609|B3|9 Years of Age and Under||Age, Customized||participants|Number|0|0.0||||||
4379358|NCT00325130|4206610|B2|9 Years of Age and Under||Age, Customized||participants|Number|0|0.0||||||
4379359|NCT00325130|4206611|B1|9 Years of Age and Under||Age, Customized||participants|Number|0|0.0||||||
4379360|NCT00325130|4206609|B3|||Age||years|Mean|12.6|12.6|Standard Deviation|1.88|1.88|||
4379361|NCT00325130|4206610|B2|||Age||years|Mean|12.7|12.7|Standard Deviation|1.90|1.9|||
4379362|NCT00325130|4206611|B1|||Age||years|Mean|12.5|12.5|Standard Deviation|1.84|1.84|||
4379363|NCT00325078|4206652|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4379364|NCT00325078|4206653|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4379365|NCT00325078|4206654|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379366|NCT00325078|4206655|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379367|NCT00325078|4206652|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379368|NCT00325078|4206653|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379369|NCT00325078|4206654|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379370|NCT00325078|4206655|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379371|NCT00325078|4206652|B4||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4379372|NCT00325078|4206653|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4379373|NCT00325078|4206654|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4379374|NCT00325078|4206655|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4379375|NCT00325078|4206652|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4379376|NCT00325078|4206653|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4379377|NCT00325078|4206654|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379378|NCT00325078|4206655|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379379|NCT00325078|4206652|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379380|NCT00325078|4206653|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379381|NCT00325078|4206654|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379382|NCT00325078|4206655|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379383|NCT00325078|4206652|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379384|NCT00325078|4206653|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379385|NCT00325078|4206654|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379386|NCT00325078|4206655|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379387|NCT00325078|4206652|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379388|NCT00325078|4206653|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379389|NCT00325078|4206654|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379390|NCT00325078|4206655|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379391|NCT00325078|4206652|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379392|NCT00325078|4206653|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379393|NCT00325078|4206654|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379394|NCT00325078|4206655|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379395|NCT00325078|4206652|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4379396|NCT00325078|4206653|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4379397|NCT00325078|4206654|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4379398|NCT00325078|4206655|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4379399|NCT00325078|4206652|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4379400|NCT00325078|4206653|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4379401|NCT00325078|4206654|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379402|NCT00325078|4206655|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379403|NCT00325078|4206652|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4379404|NCT00325078|4206653|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4379405|NCT00325078|4206654|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4379406|NCT00325078|4206655|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4379407|NCT00325078|4206652|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4379408|NCT00325078|4206653|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4379409|NCT00325078|4206654|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379410|NCT00325078|4206655|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4379411|NCT00325078|4206652|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4379412|NCT00325078|4206653|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4379413|NCT00325078|4206654|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4379414|NCT00325078|4206655|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4379415|NCT00325078|4206652|B4||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4379416|NCT00325078|4206653|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4379417|NCT00325078|4206654|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4379418|NCT00325078|4206655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4379419|NCT00325078|4206652|B4||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4379420|NCT00325078|4206653|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379421|NCT00325078|4206654|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4379422|NCT00325078|4206655|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4379423|NCT00325039|4206667|B3|United States||Region of Enrollment||participants|Number|597|597.0||||||
4379424|NCT00325039|4206668|B2|United States||Region of Enrollment||participants|Number|299|299.0||||||
4379425|NCT00325039|4206669|B1|United States||Region of Enrollment||participants|Number|298|298.0||||||
4379426|NCT00325039|4206667|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379427|NCT00325039|4206668|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379428|NCT00325039|4206669|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379429|NCT00325039|4206667|B3||Female|Sex: Female, Male||Participants|Count of Participants|597|597.0||||||
4379430|NCT00325039|4206668|B2||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4379431|NCT00325039|4206669|B1||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4379432|NCT00325039|4206667|B3|||Age||Yrs|Mean|52.9|52.9|Standard Deviation|11.0|11.0|||
4379433|NCT00325039|4206668|B2|||Age||Yrs|Mean|53.1|53.1|Standard Deviation|11.5|11.5|||
4379434|NCT00325039|4206669|B1|||Age||Yrs|Mean|52.7|52.7|Standard Deviation|10.5|10.5|||
4379435|NCT00324987|4206684|B3|Non-measurable||Disease Status||participants|Number|2|2.0||||||
4379436|NCT00324987|4206685|B2|Non-measurable||Disease Status||participants|Number|1|1.0||||||
4379437|NCT00324987|4206686|B1|Non-measurable||Disease Status||participants|Number|1|1.0||||||
4379438|NCT00324987|4206684|B3|Measurable||Disease Status||participants|Number|10|10.0||||||
4379439|NCT00324987|4206685|B2|Measurable||Disease Status||participants|Number|5|5.0||||||
4379440|NCT00324987|4206686|B1|Measurable||Disease Status||participants|Number|5|5.0||||||
4379441|NCT00324987|4206684|B3|>=1||Performance Status|"Patients graded according to the Zubrod Perfromance Status Scale:~0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light sedentary nature; 2: Ambulatory and capable of self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours; 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair."|participants|Number|3|3.0||||||
4379442|NCT00324987|4206685|B2|>=1||Performance Status|"Patients graded according to the Zubrod Perfromance Status Scale:~0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light sedentary nature; 2: Ambulatory and capable of self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours; 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair."|participants|Number|2|2.0||||||
4379443|NCT00324987|4206686|B1|>=1||Performance Status|"Patients graded according to the Zubrod Perfromance Status Scale:~0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light sedentary nature; 2: Ambulatory and capable of self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours; 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair."|participants|Number|1|1.0||||||
4379490|NCT00324896|4206714|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4379491|NCT00324896|4206715|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4379492|NCT00324896|4206716|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4379444|NCT00324987|4206684|B3|0||Performance Status|"Patients graded according to the Zubrod Perfromance Status Scale:~0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light sedentary nature; 2: Ambulatory and capable of self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours; 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair."|participants|Number|9|9.0||||||
4379445|NCT00324987|4206685|B2|0||Performance Status|"Patients graded according to the Zubrod Perfromance Status Scale:~0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light sedentary nature; 2: Ambulatory and capable of self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours; 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair."|participants|Number|4|4.0||||||
4379446|NCT00324987|4206686|B1|0||Performance Status|"Patients graded according to the Zubrod Perfromance Status Scale:~0: Fully active, able to carry on all pre-disease performance without restriction; 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light sedentary nature; 2: Ambulatory and capable of self-care but unable to carry out any work activities, up and about more than 50% of waking hours; 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours; 4: Completely disabled, cannot carry on any self-care, totally confined to bed or chair."|participants|Number|5|5.0||||||
4379447|NCT00324987|4206684|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379448|NCT00324987|4206685|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379449|NCT00324987|4206686|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379450|NCT00324987|4206684|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379451|NCT00324987|4206685|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379452|NCT00324987|4206686|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379453|NCT00324987|4206684|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4379454|NCT00324987|4206685|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4379455|NCT00324987|4206686|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4379456|NCT00324987|4206684|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379457|NCT00324987|4206685|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379458|NCT00324987|4206686|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379459|NCT00324987|4206684|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379460|NCT00324987|4206685|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379461|NCT00324987|4206686|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379462|NCT00324987|4206684|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4379463|NCT00324987|4206685|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379464|NCT00324987|4206686|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379465|NCT00324987|4206684|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379466|NCT00324987|4206685|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379467|NCT00324987|4206686|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379468|NCT00324987|4206684|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4379469|NCT00324987|4206685|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379470|NCT00324987|4206686|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379471|NCT00324987|4206684|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4379472|NCT00324987|4206685|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4379473|NCT00324987|4206686|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4379474|NCT00324987|4206684|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379475|NCT00324987|4206685|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379476|NCT00324987|4206686|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379477|NCT00324987|4206684|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4379478|NCT00324987|4206685|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4379479|NCT00324987|4206686|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4379480|NCT00324987|4206684|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4379481|NCT00324987|4206685|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4379482|NCT00324987|4206686|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4379483|NCT00324987|4206684|B3|||Age||years|Median|59.9|59.9|Full Range|||44.0|82.9|
4379484|NCT00324987|4206685|B2|||Age||years|Median|57.9|57.9|Full Range|||44.0|68.5|
4379485|NCT00324987|4206686|B1|||Age||years|Median|64.7|64.7|Full Range|||49.4|82.9|
4379486|NCT00324961|4206701|B1|Asian||Race/Ethnicity, Customized||participants|Number|533|533.0||||||
4379487|NCT00324961|4206701|B1||Male|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
4379488|NCT00324961|4206701|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4379489|NCT00324961|4206701|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|10.4|10.4|||
4379493|NCT00324896|4206714|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4379494|NCT00324896|4206715|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4379495|NCT00324896|4206716|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4379496|NCT00324896|4206714|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4379497|NCT00324896|4206715|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4379498|NCT00324896|4206716|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4379499|NCT00324896|4206714|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|8.3|8.3|||
4379500|NCT00324896|4206715|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|10.5|10.5|||
4379501|NCT00324896|4206716|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|7.9|7.9|||
4379502|NCT00324896|4206714|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4379503|NCT00324896|4206715|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4379504|NCT00324896|4206716|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4379505|NCT00324896|4206714|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4379506|NCT00324896|4206715|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4379507|NCT00324896|4206716|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4379508|NCT00324896|4206714|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379509|NCT00324896|4206715|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379510|NCT00324896|4206716|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379511|NCT00324870|4206725|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4379512|NCT00324870|4206725|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4379513|NCT00324870|4206725|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4379514|NCT00324870|4206725|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4379515|NCT00324870|4206725|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4379516|NCT00324870|4206725|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379517|NCT00324870|4206725|B1|||Age||years|Median|64|64.0|Full Range|||34.0|82.0|
4379518|NCT00324857|4206729|B5|United States||Region of Enrollment||participants|Number|639|639.0||||||
4379519|NCT00324857|4206730|B4|United States||Region of Enrollment||participants|Number|158|158.0||||||
4379520|NCT00324857|4206731|B3|United States||Region of Enrollment||participants|Number|158|158.0||||||
4379521|NCT00324857|4206732|B2|United States||Region of Enrollment||participants|Number|162|162.0||||||
4379522|NCT00324857|4206733|B1|United States||Region of Enrollment||participants|Number|161|161.0||||||
4379523|NCT00324857|4206729|B5||Male|Sex: Female, Male||Participants|Count of Participants|639|639.0||||||
4379524|NCT00324857|4206730|B4||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4379525|NCT00324857|4206731|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4379526|NCT00324857|4206732|B2||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4379527|NCT00324857|4206733|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4379528|NCT00324857|4206729|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379529|NCT00324857|4206730|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379530|NCT00324857|4206731|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379531|NCT00324857|4206732|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379532|NCT00324857|4206733|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379533|NCT00324857|4206729|B5|||Age||years|Mean|61|61.0|Standard Deviation|8|8.0|||
4379534|NCT00324857|4206730|B4|||Age||years|Mean|61|61.0|Standard Deviation|8|8.0|||
4379535|NCT00324857|4206731|B3|||Age||years|Mean|61|61.0|Standard Deviation|9|9.0|||
4379536|NCT00324857|4206732|B2|||Age||years|Mean|61|61.0|Standard Deviation|9|9.0|||
4379537|NCT00324857|4206733|B1|||Age||years|Mean|61|61.0|Standard Deviation|8|8.0|||
4379538|NCT00324805|4206750|B3|||Urine protein||mg/dL|Mean|97.79|97.79|Standard Deviation|41.86|41.86|||
4379539|NCT00324805|4206751|B2|||Urine protein||mg/dL|Mean|100.25|100.25|Standard Deviation|32.28|32.28|||
4379540|NCT00324805|4206752|B1|||Urine protein||mg/dL|Mean|95.26|95.26|Standard Deviation|32.28|32.28|||
4379541|NCT00324805|4206750|B3|||Urine protein:creatinine (UPC) ratio||ratio|Mean|0.25|0.25|Standard Deviation|2.28|2.28|||
4379542|NCT00324805|4206751|B2|||Urine protein:creatinine (UPC) ratio||ratio|Mean|0.18|0.18|Standard Deviation|0.92|0.92|||
4379543|NCT00324805|4206752|B1|||Urine protein:creatinine (UPC) ratio||ratio|Mean|0.31|0.31|Standard Deviation|3.10|3.1|||
4379544|NCT00324805|4206750|B3||Unknown/missing|Performance Status||Participants|Count of Participants|2|2.0||||||
4379545|NCT00324805|4206751|B2||Unknown/missing|Performance Status||Participants|Count of Participants|2|2.0||||||
4379546|NCT00324805|4206752|B1||Unknown/missing|Performance Status||Participants|Count of Participants|0|0.0||||||
4379547|NCT00324805|4206750|B3||Ambulatory|Performance Status||Participants|Count of Participants|620|620.0||||||
4379548|NCT00324805|4206751|B2||Ambulatory|Performance Status||Participants|Count of Participants|310|310.0||||||
4379549|NCT00324805|4206752|B1||Ambulatory|Performance Status||Participants|Count of Participants|310|310.0||||||
4379550|NCT00324805|4206750|B3||Fully active|Performance Status||Participants|Count of Participants|879|879.0||||||
4379551|NCT00324805|4206751|B2||Fully active|Performance Status||Participants|Count of Participants|440|440.0||||||
4379552|NCT00324805|4206752|B1||Fully active|Performance Status||Participants|Count of Participants|439|439.0||||||
4379553|NCT00324805|4206750|B3||Unknown/missing|Histology||Participants|Count of Participants|1|1.0||||||
4379554|NCT00324805|4206751|B2||Unknown/missing|Histology||Participants|Count of Participants|1|1.0||||||
4379555|NCT00324805|4206752|B1||Unknown/missing|Histology||Participants|Count of Participants|0|0.0||||||
4379556|NCT00324805|4206750|B3||Other|Histology||Participants|Count of Participants|20|20.0||||||
4379557|NCT00324805|4206751|B2||Other|Histology||Participants|Count of Participants|10|10.0||||||
4379558|NCT00324805|4206752|B1||Other|Histology||Participants|Count of Participants|10|10.0||||||
4379559|NCT00324805|4206750|B3||Combined/mixed|Histology||Participants|Count of Participants|93|93.0||||||
4379560|NCT00324805|4206751|B2||Combined/mixed|Histology||Participants|Count of Participants|48|48.0||||||
4379561|NCT00324805|4206752|B1||Combined/mixed|Histology||Participants|Count of Participants|45|45.0||||||
4379562|NCT00324805|4206750|B3||Not otherwise specified (NOS)|Histology||Participants|Count of Participants|40|40.0||||||
4379563|NCT00324805|4206751|B2||Not otherwise specified (NOS)|Histology||Participants|Count of Participants|16|16.0||||||
4379564|NCT00324805|4206752|B1||Not otherwise specified (NOS)|Histology||Participants|Count of Participants|24|24.0||||||
4379565|NCT00324805|4206750|B3||Bronchioloalveolar carcinoma (BAC)|Histology||Participants|Count of Participants|13|13.0||||||
4379566|NCT00324805|4206751|B2||Bronchioloalveolar carcinoma (BAC)|Histology||Participants|Count of Participants|5|5.0||||||
4379567|NCT00324805|4206752|B1||Bronchioloalveolar carcinoma (BAC)|Histology||Participants|Count of Participants|8|8.0||||||
4379568|NCT00324805|4206750|B3||Large cell|Histology||Participants|Count of Participants|38|38.0||||||
4379569|NCT00324805|4206751|B2||Large cell|Histology||Participants|Count of Participants|16|16.0||||||
4379570|NCT00324805|4206752|B1||Large cell|Histology||Participants|Count of Participants|22|22.0||||||
4379571|NCT00324805|4206750|B3||Adenocarcinoma|Histology||Participants|Count of Participants|874|874.0||||||
4379572|NCT00324805|4206751|B2||Adenocarcinoma|Histology||Participants|Count of Participants|450|450.0||||||
4379573|NCT00324805|4206752|B1||Adenocarcinoma|Histology||Participants|Count of Participants|424|424.0||||||
4379574|NCT00324805|4206750|B3||Squamous|Histology||Participants|Count of Participants|422|422.0||||||
4379575|NCT00324805|4206751|B2||Squamous|Histology||Participants|Count of Participants|206|206.0||||||
4379576|NCT00324805|4206752|B1||Squamous|Histology||Participants|Count of Participants|216|216.0||||||
4379577|NCT00324805|4206750|B3||Unknown/Missing|Chemotherapy||Participants|Count of Participants|1|1.0||||||
4379578|NCT00324805|4206751|B2||Unknown/Missing|Chemotherapy||Participants|Count of Participants|1|1.0||||||
4379579|NCT00324805|4206752|B1||Unknown/Missing|Chemotherapy||Participants|Count of Participants|0|0.0||||||
4379580|NCT00324805|4206750|B3||Cisplatin/Pemetrexed|Chemotherapy||Participants|Count of Participants|497|497.0||||||
4379581|NCT00324805|4206751|B2||Cisplatin/Pemetrexed|Chemotherapy||Participants|Count of Participants|249|249.0||||||
4379582|NCT00324805|4206752|B1||Cisplatin/Pemetrexed|Chemotherapy||Participants|Count of Participants|248|248.0||||||
4379583|NCT00324805|4206750|B3||Cisplatin/Gemcitabine|Chemotherapy||Participants|Count of Participants|283|283.0||||||
4379584|NCT00324805|4206751|B2||Cisplatin/Gemcitabine|Chemotherapy||Participants|Count of Participants|141|141.0||||||
4379585|NCT00324805|4206752|B1||Cisplatin/Gemcitabine|Chemotherapy||Participants|Count of Participants|142|142.0||||||
4379586|NCT00324805|4206750|B3||Cisplatin/Docetaxel|Chemotherapy||Participants|Count of Participants|343|343.0||||||
4379587|NCT00324805|4206751|B2||Cisplatin/Docetaxel|Chemotherapy||Participants|Count of Participants|171|171.0||||||
4379588|NCT00324805|4206752|B1||Cisplatin/Docetaxel|Chemotherapy||Participants|Count of Participants|172|172.0||||||
4379589|NCT00324805|4206750|B3||Cisplatin/Vinorelbine|Chemotherapy||Participants|Count of Participants|377|377.0||||||
4379590|NCT00324805|4206751|B2||Cisplatin/Vinorelbine|Chemotherapy||Participants|Count of Participants|190|190.0||||||
4379591|NCT00324805|4206752|B1||Cisplatin/Vinorelbine|Chemotherapy||Participants|Count of Participants|187|187.0||||||
4379592|NCT00324805|4206750|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4379593|NCT00324805|4206751|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4379594|NCT00324805|4206752|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4379595|NCT00324805|4206750|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379596|NCT00324805|4206751|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379597|NCT00324805|4206752|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379598|NCT00324805|4206750|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1302|1302.0||||||
4379599|NCT00324805|4206751|B2||White|Race (NIH/OMB)||Participants|Count of Participants|660|660.0||||||
4379600|NCT00324805|4206752|B1||White|Race (NIH/OMB)||Participants|Count of Participants|642|642.0||||||
4379601|NCT00324805|4206750|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4379602|NCT00324805|4206751|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4379603|NCT00324805|4206752|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4379604|NCT00324805|4206750|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4379605|NCT00324805|4206751|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4379606|NCT00324805|4206752|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4379607|NCT00324805|4206750|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4379608|NCT00324805|4206751|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4379609|NCT00324805|4206752|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4379610|NCT00324805|4206750|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4379611|NCT00324805|4206751|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4379612|NCT00324805|4206752|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379613|NCT00324805|4206750|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4379614|NCT00324805|4206751|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4379615|NCT00324805|4206752|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4379616|NCT00324805|4206750|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1368|1368.0||||||
4379617|NCT00324805|4206751|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|688|688.0||||||
4379618|NCT00324805|4206752|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|680|680.0||||||
4379619|NCT00324805|4206750|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4379620|NCT00324805|4206751|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4379621|NCT00324805|4206752|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4379622|NCT00324805|4206750|B3||Male|Sex: Female, Male||Participants|Count of Participants|746|746.0||||||
4379623|NCT00324805|4206751|B2||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4379624|NCT00324805|4206752|B1||Male|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
4379625|NCT00324805|4206750|B3||Female|Sex: Female, Male||Participants|Count of Participants|755|755.0||||||
4379626|NCT00324805|4206751|B2||Female|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4379627|NCT00324805|4206752|B1||Female|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
4379628|NCT00324805|4206750|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|8.8|8.8|||
4379629|NCT00324805|4206751|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|8.7|8.7|||
4379630|NCT00324805|4206752|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|9.0|9.0|||
4379631|NCT00324753|4206765|B3||Pittsburgh|Site||Participants|Count of Participants|156|156.0||||||
4379632|NCT00324753|4206766|B2||Pittsburgh|Site||Participants|Count of Participants|87|87.0||||||
4379633|NCT00324753|4206767|B1||Pittsburgh|Site||Participants|Count of Participants|69|69.0||||||
4379634|NCT00324753|4206765|B3||Houston|Site||Participants|Count of Participants|110|110.0||||||
4379635|NCT00324753|4206766|B2||Houston|Site||Participants|Count of Participants|61|61.0||||||
4379636|NCT00324753|4206767|B1||Houston|Site||Participants|Count of Participants|49|49.0||||||
4379637|NCT00324753|4206765|B3||Chicago|Site||Participants|Count of Participants|188|188.0||||||
4379638|NCT00324753|4206766|B2||Chicago|Site||Participants|Count of Participants|116|116.0||||||
4379639|NCT00324753|4206767|B1||Chicago|Site||Participants|Count of Participants|72|72.0||||||
4379640|NCT00324753|4206765|B3||Not Answered|Education||Participants|Count of Participants|2|2.0||||||
4379641|NCT00324753|4206766|B2||Not Answered|Education||Participants|Count of Participants|0|0.0||||||
4379642|NCT00324753|4206767|B1||Not Answered|Education||Participants|Count of Participants|2|2.0||||||
4379643|NCT00324753|4206765|B3||Post High School|Education||Participants|Count of Participants|128|128.0||||||
4379644|NCT00324753|4206766|B2||Post High School|Education||Participants|Count of Participants|8|8.0||||||
4379645|NCT00324753|4206767|B1||Post High School|Education||Participants|Count of Participants|120|120.0||||||
4379646|NCT00324753|4206765|B3||High School Graduate|Education||Participants|Count of Participants|148|148.0||||||
4379647|NCT00324753|4206766|B2||High School Graduate|Education||Participants|Count of Participants|96|96.0||||||
4379648|NCT00324753|4206767|B1||High School Graduate|Education||Participants|Count of Participants|52|52.0||||||
4379649|NCT00324753|4206765|B3||< High School Graduate|Education||Participants|Count of Participants|176|176.0||||||
4379650|NCT00324753|4206766|B2||< High School Graduate|Education||Participants|Count of Participants|160|160.0||||||
4379651|NCT00324753|4206767|B1||< High School Graduate|Education||Participants|Count of Participants|16|16.0||||||
4379652|NCT00324753|4206765|B3||History of Neither|Family History of Colorectal Cancer or Polyps||Participants|Count of Participants|374|374.0||||||
4379653|NCT00324753|4206766|B2||History of Neither|Family History of Colorectal Cancer or Polyps||Participants|Count of Participants|220|220.0||||||
4379654|NCT00324753|4206767|B1||History of Neither|Family History of Colorectal Cancer or Polyps||Participants|Count of Participants|154|154.0||||||
4379655|NCT00324753|4206765|B3||History of Polyps only|Family History of Colorectal Cancer or Polyps||Participants|Count of Participants|34|34.0||||||
4379656|NCT00324753|4206766|B2||History of Polyps only|Family History of Colorectal Cancer or Polyps||Participants|Count of Participants|18|18.0||||||
4379657|NCT00324753|4206767|B1||History of Polyps only|Family History of Colorectal Cancer or Polyps||Participants|Count of Participants|16|16.0||||||
4379658|NCT00324753|4206765|B3||History of Colorectal Cancer|Family History of Colorectal Cancer or Polyps||Participants|Count of Participants|46|46.0||||||
4379659|NCT00324753|4206766|B2||History of Colorectal Cancer|Family History of Colorectal Cancer or Polyps||Participants|Count of Participants|26|26.0||||||
4379660|NCT00324753|4206767|B1||History of Colorectal Cancer|Family History of Colorectal Cancer or Polyps||Participants|Count of Participants|20|20.0||||||
4379661|NCT00324753|4206765|B3||2 or more|Charlson Comorbidity Index|The Charlson Comorbidity Index is a measure of comorbid burden. The index is a weighted sum of the presence of up to 22 comorbid conditions, which are each provided a weight of 1, 2, 3, or 6 as originally derived based on the contribution of each comorbid condition to one-year mortality. A score of 0, indicates the absence of the measured comorbidities, and higher scores indicate a higher level of comorbid burden, with a higher predicted risk of death.|Participants|Count of Participants|119|119.0||||||
4379691|NCT00324753|4206765|B3||Male|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4379692|NCT00324753|4206766|B2||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4379662|NCT00324753|4206766|B2||2 or more|Charlson Comorbidity Index|The Charlson Comorbidity Index is a measure of comorbid burden. The index is a weighted sum of the presence of up to 22 comorbid conditions, which are each provided a weight of 1, 2, 3, or 6 as originally derived based on the contribution of each comorbid condition to one-year mortality. A score of 0, indicates the absence of the measured comorbidities, and higher scores indicate a higher level of comorbid burden, with a higher predicted risk of death.|Participants|Count of Participants|66|66.0||||||
4379663|NCT00324753|4206767|B1||2 or more|Charlson Comorbidity Index|The Charlson Comorbidity Index is a measure of comorbid burden. The index is a weighted sum of the presence of up to 22 comorbid conditions, which are each provided a weight of 1, 2, 3, or 6 as originally derived based on the contribution of each comorbid condition to one-year mortality. A score of 0, indicates the absence of the measured comorbidities, and higher scores indicate a higher level of comorbid burden, with a higher predicted risk of death.|Participants|Count of Participants|53|53.0||||||
4379664|NCT00324753|4206765|B3||1|Charlson Comorbidity Index|The Charlson Comorbidity Index is a measure of comorbid burden. The index is a weighted sum of the presence of up to 22 comorbid conditions, which are each provided a weight of 1, 2, 3, or 6 as originally derived based on the contribution of each comorbid condition to one-year mortality. A score of 0, indicates the absence of the measured comorbidities, and higher scores indicate a higher level of comorbid burden, with a higher predicted risk of death.|Participants|Count of Participants|123|123.0||||||
4379665|NCT00324753|4206766|B2||1|Charlson Comorbidity Index|The Charlson Comorbidity Index is a measure of comorbid burden. The index is a weighted sum of the presence of up to 22 comorbid conditions, which are each provided a weight of 1, 2, 3, or 6 as originally derived based on the contribution of each comorbid condition to one-year mortality. A score of 0, indicates the absence of the measured comorbidities, and higher scores indicate a higher level of comorbid burden, with a higher predicted risk of death.|Participants|Count of Participants|61|61.0||||||
4379666|NCT00324753|4206767|B1||1|Charlson Comorbidity Index|The Charlson Comorbidity Index is a measure of comorbid burden. The index is a weighted sum of the presence of up to 22 comorbid conditions, which are each provided a weight of 1, 2, 3, or 6 as originally derived based on the contribution of each comorbid condition to one-year mortality. A score of 0, indicates the absence of the measured comorbidities, and higher scores indicate a higher level of comorbid burden, with a higher predicted risk of death.|Participants|Count of Participants|62|62.0||||||
4379667|NCT00324753|4206765|B3||0|Charlson Comorbidity Index|The Charlson Comorbidity Index is a measure of comorbid burden. The index is a weighted sum of the presence of up to 22 comorbid conditions, which are each provided a weight of 1, 2, 3, or 6 as originally derived based on the contribution of each comorbid condition to one-year mortality. A score of 0, indicates the absence of the measured comorbidities, and higher scores indicate a higher level of comorbid burden, with a higher predicted risk of death.|Participants|Count of Participants|212|212.0||||||
4379668|NCT00324753|4206766|B2||0|Charlson Comorbidity Index|The Charlson Comorbidity Index is a measure of comorbid burden. The index is a weighted sum of the presence of up to 22 comorbid conditions, which are each provided a weight of 1, 2, 3, or 6 as originally derived based on the contribution of each comorbid condition to one-year mortality. A score of 0, indicates the absence of the measured comorbidities, and higher scores indicate a higher level of comorbid burden, with a higher predicted risk of death.|Participants|Count of Participants|137|137.0||||||
4379669|NCT00324753|4206767|B1||0|Charlson Comorbidity Index|The Charlson Comorbidity Index is a measure of comorbid burden. The index is a weighted sum of the presence of up to 22 comorbid conditions, which are each provided a weight of 1, 2, 3, or 6 as originally derived based on the contribution of each comorbid condition to one-year mortality. A score of 0, indicates the absence of the measured comorbidities, and higher scores indicate a higher level of comorbid burden, with a higher predicted risk of death.|Participants|Count of Participants|75|75.0||||||
4379670|NCT00324753|4206765|B3|Race|Not Answered|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4379671|NCT00324753|4206766|B2|Race|Not Answered|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4379672|NCT00324753|4206767|B1|Race|Not Answered|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4379673|NCT00324753|4206765|B3|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4379674|NCT00324753|4206766|B2|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4379675|NCT00324753|4206767|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4379676|NCT00324753|4206765|B3|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|269|269.0||||||
4379677|NCT00324753|4206766|B2|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|166|166.0||||||
4379678|NCT00324753|4206767|B1|Race|African American|Race/Ethnicity, Customized||Participants|Count of Participants|103|103.0||||||
4379679|NCT00324753|4206765|B3|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|150|150.0||||||
4379680|NCT00324753|4206766|B2|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|82|82.0||||||
4379681|NCT00324753|4206767|B1|Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|68|68.0||||||
4379682|NCT00324753|4206765|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4379683|NCT00324753|4206766|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4379684|NCT00324753|4206767|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4379685|NCT00324753|4206765|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|413|413.0||||||
4379686|NCT00324753|4206766|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|241|241.0||||||
4379687|NCT00324753|4206767|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
4379688|NCT00324753|4206765|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4379689|NCT00324753|4206766|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4379690|NCT00324753|4206767|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4379693|NCT00324753|4206767|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4379694|NCT00324753|4206765|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4379695|NCT00324753|4206766|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4379696|NCT00324753|4206767|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4379697|NCT00324753|4206765|B3|Age (years)|70 and older|Age, Customized||Participants|Count of Participants|17|17.0||||||
4379698|NCT00324753|4206766|B2|Age (years)|70 and older|Age, Customized||Participants|Count of Participants|8|8.0||||||
4379699|NCT00324753|4206767|B1|Age (years)|70 and older|Age, Customized||Participants|Count of Participants|9|9.0||||||
4379700|NCT00324753|4206765|B3|Age (years)|60-69|Age, Customized||Participants|Count of Participants|163|163.0||||||
4379701|NCT00324753|4206766|B2|Age (years)|60-69|Age, Customized||Participants|Count of Participants|96|96.0||||||
4379702|NCT00324753|4206767|B1|Age (years)|60-69|Age, Customized||Participants|Count of Participants|67|67.0||||||
4379703|NCT00324753|4206765|B3|Age (years)|50-59|Age, Customized||Participants|Count of Participants|274|274.0||||||
4379704|NCT00324753|4206766|B2|Age (years)|50-59|Age, Customized||Participants|Count of Participants|160|160.0||||||
4379705|NCT00324753|4206767|B1|Age (years)|50-59|Age, Customized||Participants|Count of Participants|114|114.0||||||
4379706|NCT00324740|4206778|B1|Unknown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4379707|NCT00324740|4206778|B1|Native Hawaiin or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4379708|NCT00324740|4206778|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4379709|NCT00324740|4206778|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4379710|NCT00324740|4206778|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4379711|NCT00324740|4206778|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4379712|NCT00324740|4206778|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4379713|NCT00324740|4206778|B1|||Age||years|Median|55|55.0|Full Range|||33.0|71.0|
4379714|NCT00324701|4206787|B3|$50,000 or more||Income|Not all participants answered the question, which explains the discrepancy in total number|participants|Number|40|40.0||||||
4379715|NCT00324701|4206788|B2|$50,000 or more||Income|Not all participants answered the question, which explains the discrepancy in total number|participants|Number|20|20.0||||||
4379716|NCT00324701|4206789|B1|$50,000 or more||Income|Not all participants answered the question, which explains the discrepancy in total number|participants|Number|20|20.0||||||
4379717|NCT00324701|4206787|B3|$25,000 - < $$50,000||Income|Not all participants answered the question, which explains the discrepancy in total number|participants|Number|93|93.0||||||
4379718|NCT00324701|4206788|B2|$25,000 - < $$50,000||Income|Not all participants answered the question, which explains the discrepancy in total number|participants|Number|44|44.0||||||
4379719|NCT00324701|4206789|B1|$25,000 - < $$50,000||Income|Not all participants answered the question, which explains the discrepancy in total number|participants|Number|49|49.0||||||
4379720|NCT00324701|4206787|B3|$15,000 - < $25,000||Income|Not all participants answered the question, which explains the discrepancy in total number|participants|Number|56|56.0||||||
4379721|NCT00324701|4206788|B2|$15,000 - < $25,000||Income|Not all participants answered the question, which explains the discrepancy in total number|participants|Number|32|32.0||||||
4379722|NCT00324701|4206789|B1|$15,000 - < $25,000||Income|Not all participants answered the question, which explains the discrepancy in total number|participants|Number|24|24.0||||||
4379723|NCT00324701|4206787|B3|$0 - < $15,000||Income|Not all participants answered the question, which explains the discrepancy in total number|participants|Number|49|49.0||||||
4379724|NCT00324701|4206788|B2|$0 - < $15,000||Income|Not all participants answered the question, which explains the discrepancy in total number|participants|Number|24|24.0||||||
4379725|NCT00324701|4206789|B1|$0 - < $15,000||Income|Not all participants answered the question, which explains the discrepancy in total number|participants|Number|25|25.0||||||
4379726|NCT00324701|4206787|B3|||Education||years|Mean|13.7|13.7|Standard Deviation|2.6|2.6|||
4379727|NCT00324701|4206788|B2|||Education||years|Mean|13.8|13.8|Standard Deviation|2.9|2.9|||
4379728|NCT00324701|4206789|B1|||Education||years|Mean|13.5|13.5|Standard Deviation|2.3|2.3|||
4379729|NCT00324701|4206787|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4379730|NCT00324701|4206788|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379731|NCT00324701|4206789|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4379732|NCT00324701|4206787|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379733|NCT00324701|4206788|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379734|NCT00324701|4206789|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379735|NCT00324701|4206787|B3||White|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
4379736|NCT00324701|4206788|B2||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4379737|NCT00324701|4206789|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4379738|NCT00324701|4206787|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4379739|NCT00324701|4206788|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4379740|NCT00324701|4206789|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4379741|NCT00324701|4206787|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379742|NCT00324701|4206788|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379743|NCT00324701|4206789|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379744|NCT00324701|4206787|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379745|NCT00324701|4206788|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379746|NCT00324701|4206789|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379747|NCT00324701|4206787|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379748|NCT00324701|4206788|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379749|NCT00324701|4206789|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379750|NCT00324701|4206787|B3||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4379751|NCT00324701|4206788|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4379752|NCT00324701|4206789|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4379753|NCT00324701|4206787|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4379754|NCT00324701|4206788|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4379755|NCT00324701|4206789|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4379756|NCT00324701|4206787|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|5.1|5.1|||
4379757|NCT00324701|4206788|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|5.6|5.6|||
4379758|NCT00324701|4206789|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|4.4|4.4|||
4379759|NCT00324675|4206798|B3|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4379760|NCT00324675|4206799|B2|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4379761|NCT00324675|4206800|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4379762|NCT00324675|4206798|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4379763|NCT00324675|4206799|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4379764|NCT00324675|4206800|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4379765|NCT00324675|4206798|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4379766|NCT00324675|4206799|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4379767|NCT00324675|4206800|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4379768|NCT00324675|4206798|B3|||Age||years|Mean|66.1|66.1|Standard Deviation|9.1|9.1|||
4379769|NCT00324675|4206799|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|8.5|8.5|||
4379770|NCT00324675|4206800|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|9.6|9.6|||
4379771|NCT00324675|4206798|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4379772|NCT00324675|4206799|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4379773|NCT00324675|4206800|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4379774|NCT00324675|4206798|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4379775|NCT00324675|4206799|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4379776|NCT00324675|4206800|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4379777|NCT00324675|4206798|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379778|NCT00324675|4206799|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379779|NCT00324675|4206800|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379780|NCT00324649|4206807|B3|||Years on zidovudine (AZT)/lamivudine (3TC)||Years|Median|5.9|5.9|Inter-Quartile Range|||4.6|7.2|
4379781|NCT00324649|4206808|B2|||Years on zidovudine (AZT)/lamivudine (3TC)||Years|Median|6.2|6.2|Inter-Quartile Range|||4.7|7.2|
4379782|NCT00324649|4206809|B1|||Years on zidovudine (AZT)/lamivudine (3TC)||Years|Median|5.8|5.8|Inter-Quartile Range|||4.2|7.2|
4379783|NCT00324649|4206807|B3|||Total limb fat|Measured using dual-energy x-ray absorptiometry (DEXA). Total limb fat is the sum of the left arm, right arm, left leg, and right leg.|grams (g)|Median|3589|3589.0|Full Range|||511.0|28155.0|
4379784|NCT00324649|4206808|B2|||Total limb fat|Measured using dual-energy x-ray absorptiometry (DEXA). Total limb fat is the sum of the left arm, right arm, left leg, and right leg.|grams (g)|Median|3589|3589.0|Full Range|||903.0|28155.0|
4379785|NCT00324649|4206809|B1|||Total limb fat|Measured using dual-energy x-ray absorptiometry (DEXA). Total limb fat is the sum of the left arm, right arm, left leg, and right leg.|grams (g)|Median|3565|3565.0|Full Range|||511.0|15932.0|
4379786|NCT00324649|4206807|B3|||Cluster determinant 4 (CD4) cell count||cells/mm^3|Median|600.5|600.5|Inter-Quartile Range|||420.0|760.5|
4379787|NCT00324649|4206808|B2|||Cluster determinant 4 (CD4) cell count||cells/mm^3|Median|504.0|504.0|Inter-Quartile Range|||363.0|756.0|
4379788|NCT00324649|4206809|B1|||Cluster determinant 4 (CD4) cell count||cells/mm^3|Median|655.0|655.0|Inter-Quartile Range|||505.0|789.0|
4379789|NCT00324649|4206807|B3|50 to < 400 copies/mL||HIV-1 RNA Level||Participants|Number|3.0|3.0||||||
4379790|NCT00324649|4206808|B2|50 to < 400 copies/mL||HIV-1 RNA Level||Participants|Number|2|2.0||||||
4379791|NCT00324649|4206809|B1|50 to < 400 copies/mL||HIV-1 RNA Level||Participants|Number|1|1.0||||||
4379792|NCT00324649|4206807|B3|< 50 copies/mL||HIV-1 RNA Level||Participants|Number|77.0|77.0||||||
4379793|NCT00324649|4206808|B2|< 50 copies/mL||HIV-1 RNA Level||Participants|Number|39|39.0||||||
4379794|NCT00324649|4206809|B1|< 50 copies/mL||HIV-1 RNA Level||Participants|Number|38|38.0||||||
4379795|NCT00324649|4206807|B3|Spain||Region of Enrollment||participants|Number|80.0|80.0||||||
4379796|NCT00324649|4206808|B2|Spain||Region of Enrollment||participants|Number|41|41.0||||||
4379797|NCT00324649|4206809|B1|Spain||Region of Enrollment||participants|Number|39|39.0||||||
4379798|NCT00324649|4206807|B3|Other||Race/Ethnicity, Customized||Participants|Number|2.0|2.0||||||
4379799|NCT00324649|4206808|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4379800|NCT00324649|4206809|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4379801|NCT00324649|4206807|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1.0|1.0||||||
4379802|NCT00324649|4206808|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4379803|NCT00324649|4206809|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4379804|NCT00324649|4206807|B3|Black, of African heritage||Race/Ethnicity, Customized||Participants|Number|3.0|3.0||||||
4379805|NCT00324649|4206808|B2|Black, of African heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4379806|NCT00324649|4206809|B1|Black, of African heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4379807|NCT00324649|4206807|B3|White||Race/Ethnicity, Customized||Participants|Number|74.0|74.0||||||
4379808|NCT00324649|4206808|B2|White||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4379809|NCT00324649|4206809|B1|White||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4379810|NCT00324649|4206807|B3||Male|Sex: Female, Male||Participants|Count of Participants|65.0|65.0||||||
4379811|NCT00324649|4206808|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4379812|NCT00324649|4206809|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4379813|NCT00324649|4206807|B3||Female|Sex: Female, Male||Participants|Count of Participants|15.0|15.0||||||
4379814|NCT00324649|4206808|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4379815|NCT00324649|4206809|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4379816|NCT00324649|4206807|B3|||Age||years|Mean|44|44.0|Standard Deviation|9.0|9.0|||
4379817|NCT00324649|4206808|B2|||Age||years|Mean|44|44.0|Standard Deviation|7.4|7.4|||
4379818|NCT00324649|4206809|B1|||Age||years|Mean|44|44.0|Standard Deviation|10.6|10.6|||
4379819|NCT00324415|4206850|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4379820|NCT00324415|4206850|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4379821|NCT00324415|4206850|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379822|NCT00324415|4206850|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4379823|NCT00324415|4206850|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4379824|NCT00324415|4206850|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379825|NCT00324415|4206850|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379826|NCT00324415|4206850|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4379827|NCT00324415|4206850|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4379828|NCT00324415|4206850|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4379829|NCT00324415|4206850|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4379830|NCT00324415|4206850|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4379831|NCT00324415|4206850|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4379832|NCT00324415|4206850|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|6.7|6.7|||
4379833|NCT00324350|4206863|B3|Canada||Region of Enrollment||participants|Number|1508|1508.0||||||
4379834|NCT00324350|4206864|B2|Canada||Region of Enrollment||participants|Number|756|756.0||||||
4379835|NCT00324350|4206865|B1|Canada||Region of Enrollment||participants|Number|752|752.0||||||
4379836|NCT00324350|4206863|B3|United States||Region of Enrollment||participants|Number|5779|5779.0||||||
4379837|NCT00324350|4206864|B2|United States||Region of Enrollment||participants|Number|2876|2876.0||||||
4379838|NCT00324350|4206865|B1|United States||Region of Enrollment||participants|Number|2903|2903.0||||||
4379839|NCT00324350|4206863|B3||Male|Sex: Female, Male||Participants|Count of Participants|4769|4769.0||||||
4379840|NCT00324350|4206864|B2||Male|Sex: Female, Male||Participants|Count of Participants|2381|2381.0||||||
4379841|NCT00324350|4206865|B1||Male|Sex: Female, Male||Participants|Count of Participants|2388|2388.0||||||
4379842|NCT00324350|4206863|B3||Female|Sex: Female, Male||Participants|Count of Participants|2518|2518.0||||||
4379843|NCT00324350|4206864|B2||Female|Sex: Female, Male||Participants|Count of Participants|1251|1251.0||||||
4379844|NCT00324350|4206865|B1||Female|Sex: Female, Male||Participants|Count of Participants|1267|1267.0||||||
4379845|NCT00324350|4206863|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|6.7|6.7|||
4379846|NCT00324350|4206864|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|6.7|6.7|||
4379847|NCT00324350|4206865|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|6.7|6.7|||
4379848|NCT00324350|4206863|B3||>=65 years|Age||Participants|Count of Participants|2546|2546.0||||||
4379849|NCT00324350|4206864|B2||>=65 years|Age||Participants|Count of Participants|1271|1271.0||||||
4379850|NCT00324350|4206865|B1||>=65 years|Age||Participants|Count of Participants|1275|1275.0||||||
4379851|NCT00324350|4206863|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4741|4741.0||||||
4379852|NCT00324350|4206864|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2361|2361.0||||||
4379853|NCT00324350|4206865|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2380|2380.0||||||
4379854|NCT00324350|4206863|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379855|NCT00324350|4206864|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379856|NCT00324350|4206865|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379857|NCT00324272|4206876|B5|United Kingdom||Region of Enrollment||participants|Number|74|74.0||||||
4379858|NCT00324272|4206877|B4|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4379859|NCT00324272|4206878|B3|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4379860|NCT00324272|4206879|B2|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4379861|NCT00324272|4206880|B1|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4379862|NCT00324272|4206876|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4379863|NCT00324272|4206877|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4379864|NCT00324272|4206878|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4379865|NCT00324272|4206879|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4379866|NCT00324272|4206880|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4379867|NCT00324272|4206876|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4379868|NCT00324272|4206877|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4379869|NCT00324272|4206878|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4379870|NCT00324272|4206879|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4379871|NCT00324272|4206880|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4379872|NCT00324272|4206876|B5|||Age||years|Mean|58.1|58.1|Standard Deviation|17.1|17.1|||
4379873|NCT00324272|4206877|B4|||Age||years|Mean|57.3|57.3|Standard Deviation|14.2|14.2|||
4379874|NCT00324272|4206878|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|18.4|18.4|||
4379875|NCT00324272|4206879|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|18.1|18.1|||
4379876|NCT00324272|4206880|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|17.9|17.9|||
4379877|NCT00324272|4206876|B5||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4379878|NCT00324272|4206877|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4379879|NCT00324272|4206878|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4379880|NCT00324272|4206879|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4379881|NCT00324272|4206880|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4379882|NCT00324272|4206876|B5||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4379883|NCT00324272|4206877|B4||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4379884|NCT00324272|4206878|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4379885|NCT00324272|4206879|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4379886|NCT00324272|4206880|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4379887|NCT00324272|4206876|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379888|NCT00324272|4206877|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379889|NCT00324272|4206878|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379890|NCT00324272|4206879|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379891|NCT00324272|4206880|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379892|NCT00324259|4206917|B3|Positive||Progesterone receptor status||participants|Number|52|52.0||||||
4379893|NCT00324259|4206918|B2|Positive||Progesterone receptor status||participants|Number|26|26.0||||||
4379894|NCT00324259|4206919|B1|Positive||Progesterone receptor status||participants|Number|26|26.0||||||
4379895|NCT00324259|4206917|B3|Negative||Progesterone receptor status||participants|Number|14|14.0||||||
4379896|NCT00324259|4206918|B2|Negative||Progesterone receptor status||participants|Number|6|6.0||||||
4379897|NCT00324259|4206919|B1|Negative||Progesterone receptor status||participants|Number|8|8.0||||||
4379898|NCT00324259|4206917|B3|Positive||Estrogen receptor status||participants|Number|65|65.0||||||
4379899|NCT00324259|4206918|B2|Positive||Estrogen receptor status||participants|Number|32|32.0||||||
4379900|NCT00324259|4206919|B1|Positive||Estrogen receptor status||participants|Number|33|33.0||||||
4379901|NCT00324259|4206917|B3|Negative||Estrogen receptor status||participants|Number|1|1.0||||||
4379902|NCT00324259|4206918|B2|Negative||Estrogen receptor status||participants|Number|0|0.0||||||
4379903|NCT00324259|4206919|B1|Negative||Estrogen receptor status||participants|Number|1|1.0||||||
4379904|NCT00324259|4206917|B3|Both||Site||participants|Number|25|25.0||||||
4379905|NCT00324259|4206918|B2|Both||Site||participants|Number|14|14.0||||||
4379906|NCT00324259|4206919|B1|Both||Site||participants|Number|11|11.0||||||
4379907|NCT00324259|4206917|B3|Visceral||Site||participants|Number|10|10.0||||||
4379908|NCT00324259|4206918|B2|Visceral||Site||participants|Number|5|5.0||||||
4379909|NCT00324259|4206919|B1|Visceral||Site||participants|Number|5|5.0||||||
4379910|NCT00324259|4206917|B3|Bone/soft tissue||Site||participants|Number|31|31.0||||||
4379911|NCT00324259|4206918|B2|Bone/soft tissue||Site||participants|Number|13|13.0||||||
4379912|NCT00324259|4206919|B1|Bone/soft tissue||Site||participants|Number|18|18.0||||||
4379913|NCT00324259|4206917|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4379914|NCT00324259|4206918|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4379915|NCT00324259|4206919|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4379916|NCT00324259|4206917|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379917|NCT00324259|4206918|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379918|NCT00324259|4206919|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379919|NCT00324259|4206917|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4379920|NCT00324259|4206918|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4379921|NCT00324259|4206919|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4379922|NCT00324259|4206917|B3|||Age||years|Median|57.1|57.1|Full Range|||36.3|83.8|
4379923|NCT00324259|4206918|B2|||Age||years|Median|59.5|59.5|Full Range|||39.4|77.7|
4379924|NCT00324259|4206919|B1|||Age||years|Median|54.7|54.7|Full Range|||36.3|83.8|
4379925|NCT00324233|4206939|B3|Denmark||Region of Enrollment||participants|Number|36|36.0||||||
4379926|NCT00324233|4206940|B2|Denmark||Region of Enrollment||participants|Number|18|18.0||||||
4379927|NCT00324233|4206941|B1|Denmark||Region of Enrollment||participants|Number|18|18.0||||||
4379928|NCT00324233|4206939|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4379929|NCT00324233|4206940|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4379930|NCT00324233|4206941|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4379931|NCT00324233|4206939|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379932|NCT00324233|4206940|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379933|NCT00324233|4206941|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4379934|NCT00324233|4206939|B3|||Age||years|Mean|23.7|23.7|Standard Deviation|2.9|2.9|||
4379935|NCT00324233|4206940|B2|||Age||years|Mean|23.9|23.9|Standard Deviation|2.9|2.9|||
4379936|NCT00324233|4206941|B1|||Age||years|Mean|23.6|23.6|Standard Deviation|3.0|3.0|||
4379937|NCT00324233|4206939|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4379938|NCT00324233|4206940|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4379939|NCT00324233|4206941|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4379940|NCT00324233|4206939|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4379941|NCT00324233|4206940|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4379942|NCT00324233|4206941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4379943|NCT00324233|4206939|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379944|NCT00324233|4206940|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379945|NCT00324233|4206941|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4379946|NCT00324168|4206948|B3|India||Region of Enrollment||participants|Number|485|485.0||||||
4379947|NCT00324168|4206949|B2|India||Region of Enrollment||participants|Number|242|242.0||||||
4379948|NCT00324168|4206950|B1|India||Region of Enrollment||participants|Number|243|243.0||||||
4379949|NCT00324168|4206948|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4379950|NCT00324168|4206949|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4379951|NCT00324168|4206950|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4379952|NCT00324168|4206948|B3||Male|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4379953|NCT00324168|4206949|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4379954|NCT00324168|4206950|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4379955|NCT00324168|4206948|B3||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4379956|NCT00324168|4206949|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4379957|NCT00324168|4206950|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4379958|NCT00324168|4206948|B3|||Age||years|Median|53.0|53.0|Inter-Quartile Range|||40.0|61.0|
4379959|NCT00324168|4206949|B2|||Age||years|Median|54.5|54.5|Inter-Quartile Range|||40.0|61.0|
4379960|NCT00324168|4206950|B1|||Age||years|Median|52.0|52.0|Inter-Quartile Range|||40.0|62.0|
4379961|NCT00324168|4206948|B3||>=65 years|Age||Participants|Count of Participants|105|105.0||||||
4379962|NCT00324168|4206949|B2||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4379963|NCT00324168|4206950|B1||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4379964|NCT00324168|4206948|B3||Between 18 and 65 years|Age||Participants|Count of Participants|388|388.0||||||
4379965|NCT00324168|4206949|B2||Between 18 and 65 years|Age||Participants|Count of Participants|198|198.0||||||
4379966|NCT00324168|4206950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
4379967|NCT00324168|4206948|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4379968|NCT00324168|4206949|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4379969|NCT00324168|4206950|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4379970|NCT00324155|4206977|B3|Category 1||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status. Measured from 0 to 5 with 0=fully active; 1=restricted in physically strenuous activity; 2=ambulatory; 3=limited self care; 4= completely disabled; 5=dead. Lower score=better performance.|Participants|Number|146|146.0||||||
4379971|NCT00324155|4206978|B2|Category 1||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status. Measured from 0 to 5 with 0=fully active; 1=restricted in physically strenuous activity; 2=ambulatory; 3=limited self care; 4= completely disabled; 5=dead. Lower score=better performance.|Participants|Number|73|73.0||||||
4379972|NCT00324155|4206979|B1|Category 1||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status. Measured from 0 to 5 with 0=fully active; 1=restricted in physically strenuous activity; 2=ambulatory; 3=limited self care; 4= completely disabled; 5=dead. Lower score=better performance.|Participants|Number|73|73.0||||||
4379973|NCT00324155|4206977|B3|Category 0||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status. Measured from 0 to 5 with 0=fully active; 1=restricted in physically strenuous activity; 2=ambulatory; 3=limited self care; 4= completely disabled; 5=dead. Lower score=better performance.|Participants|Number|356|356.0||||||
4379974|NCT00324155|4206978|B2|Category 0||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status. Measured from 0 to 5 with 0=fully active; 1=restricted in physically strenuous activity; 2=ambulatory; 3=limited self care; 4= completely disabled; 5=dead. Lower score=better performance.|Participants|Number|179|179.0||||||
4379975|NCT00324155|4206979|B1|Category 0||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status. Measured from 0 to 5 with 0=fully active; 1=restricted in physically strenuous activity; 2=ambulatory; 3=limited self care; 4= completely disabled; 5=dead. Lower score=better performance.|Participants|Number|177|177.0||||||
4379994|NCT00324155|4206977|B3|North America||Region of Enrollment||participants|Number|92|92.0||||||
4379976|NCT00324155|4206977|B3|M1c||Melanoma Tumor Stage; Metastasis Classification at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification. M0=No distant metastases; M1a=Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b=Lung metastases with normal LDH; M1c=All other visceral metastases with normal LDH or any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;19 (16):3635-3648.|Participants|Number|282|282.0||||||
4379977|NCT00324155|4206978|B2|M1c||Melanoma Tumor Stage; Metastasis Classification at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification. M0=No distant metastases; M1a=Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b=Lung metastases with normal LDH; M1c=All other visceral metastases with normal LDH or any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;19 (16):3635-3648.|Participants|Number|139|139.0||||||
4379978|NCT00324155|4206979|B1|M1c||Melanoma Tumor Stage; Metastasis Classification at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification. M0=No distant metastases; M1a=Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b=Lung metastases with normal LDH; M1c=All other visceral metastases with normal LDH or any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;19 (16):3635-3648.|Participants|Number|143|143.0||||||
4379979|NCT00324155|4206977|B3|M1b||Melanoma Tumor Stage; Metastasis Classification at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification. M0=No distant metastases; M1a=Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b=Lung metastases with normal LDH; M1c=All other visceral metastases with normal LDH or any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;19 (16):3635-3648.|Participants|Number|126|126.0||||||
4379980|NCT00324155|4206978|B2|M1b||Melanoma Tumor Stage; Metastasis Classification at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification. M0=No distant metastases; M1a=Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b=Lung metastases with normal LDH; M1c=All other visceral metastases with normal LDH or any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;19 (16):3635-3648.|Participants|Number|62|62.0||||||
4379981|NCT00324155|4206979|B1|M1b||Melanoma Tumor Stage; Metastasis Classification at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification. M0=No distant metastases; M1a=Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b=Lung metastases with normal LDH; M1c=All other visceral metastases with normal LDH or any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;19 (16):3635-3648.|Participants|Number|64|64.0||||||
4379982|NCT00324155|4206977|B3|M1a||Melanoma Tumor Stage; Metastasis Classification at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification. M0=No distant metastases; M1a=Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b=Lung metastases with normal LDH; M1c=All other visceral metastases with normal LDH or any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;19 (16):3635-3648.|Participants|Number|80|80.0||||||
4379983|NCT00324155|4206978|B2|M1a||Melanoma Tumor Stage; Metastasis Classification at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification. M0=No distant metastases; M1a=Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b=Lung metastases with normal LDH; M1c=All other visceral metastases with normal LDH or any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;19 (16):3635-3648.|Participants|Number|43|43.0||||||
4379984|NCT00324155|4206979|B1|M1a||Melanoma Tumor Stage; Metastasis Classification at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification. M0=No distant metastases; M1a=Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b=Lung metastases with normal LDH; M1c=All other visceral metastases with normal LDH or any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;19 (16):3635-3648.|Participants|Number|37|37.0||||||
4379985|NCT00324155|4206977|B3|M0||Melanoma Tumor Stage; Metastasis Classification at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification. M0=No distant metastases; M1a=Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b=Lung metastases with normal LDH; M1c=All other visceral metastases with normal LDH or any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;19 (16):3635-3648.|Participants|Number|14|14.0||||||
4379986|NCT00324155|4206978|B2|M0||Melanoma Tumor Stage; Metastasis Classification at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification. M0=No distant metastases; M1a=Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b=Lung metastases with normal LDH; M1c=All other visceral metastases with normal LDH or any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;19 (16):3635-3648.|Participants|Number|8|8.0||||||
4379987|NCT00324155|4206979|B1|M0||Melanoma Tumor Stage; Metastasis Classification at Study Entry|Melanoma Tumor Staging: Metastasis (M) classification. M0=No distant metastases; M1a=Distant skin, subcutaneous tissue, or nodal metastases with normal lactic dehydrogenase (LDH); M1b=Lung metastases with normal LDH; M1c=All other visceral metastases with normal LDH or any distant metastasis with elevated LDH. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;19 (16):3635-3648.|Participants|Number|6|6.0||||||
4379988|NCT00324155|4206977|B3|Europe||Region of Enrollment||participants|Number|351|351.0||||||
4379989|NCT00324155|4206978|B2|Europe||Region of Enrollment||participants|Number|175|175.0||||||
4379990|NCT00324155|4206979|B1|Europe||Region of Enrollment||participants|Number|176|176.0||||||
4379991|NCT00324155|4206977|B3|South America||Region of Enrollment||participants|Number|22|22.0||||||
4379992|NCT00324155|4206978|B2|South America||Region of Enrollment||participants|Number|9|9.0||||||
4379993|NCT00324155|4206979|B1|South America||Region of Enrollment||participants|Number|13|13.0||||||
4379995|NCT00324155|4206978|B2|North America||Region of Enrollment||participants|Number|46|46.0||||||
4379996|NCT00324155|4206979|B1|North America||Region of Enrollment||participants|Number|46|46.0||||||
4379997|NCT00324155|4206977|B3|South Africa||Region of Enrollment||participants|Number|22|22.0||||||
4379998|NCT00324155|4206978|B2|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
4379999|NCT00324155|4206979|B1|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4380000|NCT00324155|4206977|B3|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4380001|NCT00324155|4206978|B2|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4380002|NCT00324155|4206979|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4380003|NCT00324155|4206977|B3||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4380004|NCT00324155|4206978|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4380005|NCT00324155|4206979|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4380006|NCT00324155|4206977|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4380007|NCT00324155|4206978|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4380008|NCT00324155|4206979|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4380009|NCT00324155|4206977|B3|||Age||years|Mean|57.0|57.0|Standard Deviation|13.61|13.61|||
4380010|NCT00324155|4206978|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|13.71|13.71|||
4380011|NCT00324155|4206979|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|13.51|13.51|||
4380012|NCT00324155|4206977|B3||>=65 years|Age||Participants|Count of Participants|160|160.0||||||
4380013|NCT00324155|4206978|B2||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4380014|NCT00324155|4206979|B1||>=65 years|Age||Participants|Count of Participants|85|85.0||||||
4380015|NCT00324155|4206977|B3||Between 18 and 65 years|Age||Participants|Count of Participants|342|342.0||||||
4380016|NCT00324155|4206978|B2||Between 18 and 65 years|Age||Participants|Count of Participants|177|177.0||||||
4380017|NCT00324155|4206979|B1||Between 18 and 65 years|Age||Participants|Count of Participants|165|165.0||||||
4380018|NCT00324155|4206977|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380019|NCT00324155|4206978|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380020|NCT00324155|4206979|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380021|NCT00324116|4207010|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4380022|NCT00324116|4207010|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4380023|NCT00324116|4207010|B1|||Age||years|Mean|76.3|76.3|Standard Deviation|6.7|6.7|||
4380024|NCT00324038|4207020|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4380025|NCT00324038|4207021|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4380026|NCT00324038|4207022|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4380027|NCT00324038|4207020|B3||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4380028|NCT00324038|4207021|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4380029|NCT00324038|4207022|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4380030|NCT00324038|4207020|B3||>=65 years|Age|Subjects over 60 years of age were recruited into the study. Initially study started with recruitment age of 65 but this was lowered by protocol amendment to 60 years of age.|Participants|Count of Participants|176|176.0||||||
4380031|NCT00324038|4207021|B2||>=65 years|Age|Subjects over 60 years of age were recruited into the study. Initially study started with recruitment age of 65 but this was lowered by protocol amendment to 60 years of age.|Participants|Count of Participants|86|86.0||||||
4380032|NCT00324038|4207022|B1||>=65 years|Age|Subjects over 60 years of age were recruited into the study. Initially study started with recruitment age of 65 but this was lowered by protocol amendment to 60 years of age.|Participants|Count of Participants|90|90.0||||||
4380033|NCT00324038|4207020|B3||Between 18 and 65 years|Age|Subjects over 60 years of age were recruited into the study. Initially study started with recruitment age of 65 but this was lowered by protocol amendment to 60 years of age.|Participants|Count of Participants|43|43.0||||||
4380034|NCT00324038|4207021|B2||Between 18 and 65 years|Age|Subjects over 60 years of age were recruited into the study. Initially study started with recruitment age of 65 but this was lowered by protocol amendment to 60 years of age.|Participants|Count of Participants|23|23.0||||||
4380035|NCT00324038|4207022|B1||Between 18 and 65 years|Age|Subjects over 60 years of age were recruited into the study. Initially study started with recruitment age of 65 but this was lowered by protocol amendment to 60 years of age.|Participants|Count of Participants|20|20.0||||||
4380036|NCT00324038|4207020|B3||<=18 years|Age|Subjects over 60 years of age were recruited into the study. Initially study started with recruitment age of 65 but this was lowered by protocol amendment to 60 years of age.|Participants|Count of Participants|0|0.0||||||
4380037|NCT00324038|4207021|B2||<=18 years|Age|Subjects over 60 years of age were recruited into the study. Initially study started with recruitment age of 65 but this was lowered by protocol amendment to 60 years of age.|Participants|Count of Participants|0|0.0||||||
4380038|NCT00324038|4207022|B1||<=18 years|Age|Subjects over 60 years of age were recruited into the study. Initially study started with recruitment age of 65 but this was lowered by protocol amendment to 60 years of age.|Participants|Count of Participants|0|0.0||||||
4380039|NCT00323882|4207029|B6|ECOG PS Not Reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|3|3.0||||||
4380165|NCT00323622|4207160|B6||Male|Gender||Participants|Count of Participants|276|276.0||||||
4380040|NCT00323882|4207030|B5|ECOG PS Not Reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|3|3.0||||||
4380041|NCT00323882|4207031|B4|ECOG PS Not Reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4380042|NCT00323882|4207032|B3|ECOG PS Not Reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4380043|NCT00323882|4207033|B2|ECOG PS Not Reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4380044|NCT00323882|4207034|B1|ECOG PS Not Reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4380045|NCT00323882|4207029|B6|ECOG PS 2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|1|1.0||||||
4380046|NCT00323882|4207030|B5|ECOG PS 2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4380047|NCT00323882|4207031|B4|ECOG PS 2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|1|1.0||||||
4380048|NCT00323882|4207032|B3|ECOG PS 2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4380049|NCT00323882|4207033|B2|ECOG PS 2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4380050|NCT00323882|4207034|B1|ECOG PS 2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|0|0.0||||||
4380158|NCT00323635|4207128|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4380159|NCT00323635|4207126|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380051|NCT00323882|4207029|B6|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|34|34.0||||||
4380052|NCT00323882|4207030|B5|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|22|22.0||||||
4380053|NCT00323882|4207031|B4|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|2|2.0||||||
4380054|NCT00323882|4207032|B3|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|6|6.0||||||
4380055|NCT00323882|4207033|B2|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|1|1.0||||||
4380056|NCT00323882|4207034|B1|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|3|3.0||||||
4380057|NCT00323882|4207029|B6|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|33|33.0||||||
4380058|NCT00323882|4207030|B5|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|9|9.0||||||
4380059|NCT00323882|4207031|B4|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|4|4.0||||||
4380060|NCT00323882|4207032|B3|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|10|10.0||||||
4380061|NCT00323882|4207033|B2|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|5|5.0||||||
4380160|NCT00323635|4207127|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380161|NCT00323635|4207128|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380162|NCT00323622|4207157|B9||Male|Gender||Participants|Count of Participants|901|901.0||||||
4380062|NCT00323882|4207034|B1|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG performance: 0= Fully active, able to carry on all pre-disease performance without restriction;1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4=Completely disabled. Cannot carry on any self-care. Totally confined to bed or Chair; 5=Dead|participants|Number|5|5.0||||||
4380063|NCT00323882|4207029|B6|||Mean Prostate-Specific Antigen (PSA) in ng/mL|PSA is measured in nanograms per milliliter (ng/mL).|ng/mL|Mean|212.9|212.9|Standard Deviation|346.5|346.5|||
4380064|NCT00323882|4207030|B5|||Mean Prostate-Specific Antigen (PSA) in ng/mL|PSA is measured in nanograms per milliliter (ng/mL).|ng/mL|Mean|250.1|250.1|Standard Deviation|324.1|324.1|||
4380065|NCT00323882|4207031|B4|||Mean Prostate-Specific Antigen (PSA) in ng/mL|PSA is measured in nanograms per milliliter (ng/mL).|ng/mL|Mean|66.6|66.6|Standard Deviation|68.1|68.1|||
4380066|NCT00323882|4207032|B3|||Mean Prostate-Specific Antigen (PSA) in ng/mL|PSA is measured in nanograms per milliliter (ng/mL).|ng/mL|Mean|302.7|302.7|Standard Deviation|521.2|521.2|||
4380067|NCT00323882|4207033|B2|||Mean Prostate-Specific Antigen (PSA) in ng/mL|PSA is measured in nanograms per milliliter (ng/mL).|ng/mL|Mean|48.8|48.8|Standard Deviation|43.9|43.9|||
4380068|NCT00323882|4207034|B1|||Mean Prostate-Specific Antigen (PSA) in ng/mL|PSA is measured in nanograms per milliliter (ng/mL).|ng/mL|Mean|121.6|121.6|Standard Deviation|140.2|140.2|||
4380069|NCT00323882|4207029|B6|United States||Region of Enrollment||participants|Number|71|71.0||||||
4380070|NCT00323882|4207030|B5|United States||Region of Enrollment||participants|Number|34|34.0||||||
4380071|NCT00323882|4207031|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4380072|NCT00323882|4207032|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4380073|NCT00323882|4207033|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4380074|NCT00323882|4207034|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4380075|NCT00323882|4207029|B6|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4380076|NCT00323882|4207030|B5|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4380077|NCT00323882|4207031|B4|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4380078|NCT00323882|4207032|B3|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4380079|NCT00323882|4207033|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4380080|NCT00323882|4207034|B1|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4380081|NCT00323882|4207029|B6|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4380082|NCT00323882|4207030|B5|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4380083|NCT00323882|4207031|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380084|NCT00323882|4207032|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4380085|NCT00323882|4207033|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4380086|NCT00323882|4207034|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4380087|NCT00323882|4207029|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380088|NCT00323882|4207030|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380089|NCT00323882|4207031|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4380090|NCT00323882|4207032|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4380091|NCT00323882|4207033|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4380092|NCT00323882|4207034|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4380093|NCT00323882|4207029|B6||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4380094|NCT00323882|4207030|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4380095|NCT00323882|4207031|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4380096|NCT00323882|4207032|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4380097|NCT00323882|4207033|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4380098|NCT00323882|4207034|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4380099|NCT00323882|4207029|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380100|NCT00323882|4207030|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380101|NCT00323882|4207031|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380102|NCT00323882|4207032|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380103|NCT00323882|4207033|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380104|NCT00323882|4207034|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380105|NCT00323882|4207029|B6|||Age||years|Mean|65.4|65.4|Standard Deviation|8.5|8.5|||
4380106|NCT00323882|4207030|B5|||Age||years|Mean|65.7|65.7|Standard Deviation|9.1|9.1|||
4380107|NCT00323882|4207031|B4|||Age||years|Mean|67.6|67.6|Standard Deviation|8.5|8.5|||
4380108|NCT00323882|4207032|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|7.7|7.7|||
4380109|NCT00323882|4207033|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|5.6|5.6|||
4380110|NCT00323882|4207034|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|8.1|8.1|||
4380111|NCT00323869|4207109|B1|NSCLC Stage IV||Non-small Cell Lung Cancer Stage|During the time of the trial patients with a malignant pleural effusion as only site of metastases were considered stage III-B (AJCC 6th edition). They were treated the same as stage IV (metastatic). Thus all patients included in this trial had advanced stage NSCLC and if staged under current staging criteria (AJCC 7th edition) all would be considered stage IV (metastatic).|participants|Number|39|39.0||||||
4380163|NCT00323622|4207158|B8||Male|Gender||Participants|Count of Participants|62|62.0||||||
4380164|NCT00323622|4207159|B7||Male|Gender||Participants|Count of Participants|27|27.0||||||
4380112|NCT00323869|4207109|B1|NSCLC Stage III-B||Non-small Cell Lung Cancer Stage|During the time of the trial patients with a malignant pleural effusion as only site of metastases were considered stage III-B (AJCC 6th edition). They were treated the same as stage IV (metastatic). Thus all patients included in this trial had advanced stage NSCLC and if staged under current staging criteria (AJCC 7th edition) all would be considered stage IV (metastatic).|participants|Number|8|8.0||||||
4380113|NCT00323869|4207109|B1|NSCLC not otherwise specified||Non-small Cell Lung Cancer (NSCLC) Histology||participants|Number|13|13.0||||||
4380114|NCT00323869|4207109|B1|Bronchioloalveolar carcinoma (BAC)||Non-small Cell Lung Cancer (NSCLC) Histology||participants|Number|4|4.0||||||
4380115|NCT00323869|4207109|B1|Adenocarcinoma||Non-small Cell Lung Cancer (NSCLC) Histology||participants|Number|30|30.0||||||
4380116|NCT00323869|4207109|B1|Currently a smoker||Smoking Status|"Smoking status based on self-declaration between:~Never a smoker (< 100 cigarettes in lifetime)~Quit and not currently a smoker~Currently a smoker."|participants|Number|21|21.0||||||
4380117|NCT00323869|4207109|B1|Has stopped smoking (ex-smoker)||Smoking Status|"Smoking status based on self-declaration between:~Never a smoker (< 100 cigarettes in lifetime)~Quit and not currently a smoker~Currently a smoker."|participants|Number|7|7.0||||||
4380118|NCT00323869|4207109|B1|Never a smoker||Smoking Status|"Smoking status based on self-declaration between:~Never a smoker (< 100 cigarettes in lifetime)~Quit and not currently a smoker~Currently a smoker."|participants|Number|19|19.0||||||
4380119|NCT00323869|4207109|B1|ECOG 1||Eastern Cooperative Oncology Group (ECOG) performance status|"ECOG performance status~0 = Fully active, able to carry on all pre-disease performance without restriction~1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work~2 = Unable to work, must sit or lie > 50% waking hours~3 = Capable of limited selfcare; confined to bed or chair > 50% waking hours~4 = Completely disabled; cannot carry on any selfcare; totally confined to bed/chair~5 = Deceased"|participants|Number|44|44.0||||||
4380120|NCT00323869|4207109|B1|ECOG 0||Eastern Cooperative Oncology Group (ECOG) performance status|"ECOG performance status~0 = Fully active, able to carry on all pre-disease performance without restriction~1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work~2 = Unable to work, must sit or lie > 50% waking hours~3 = Capable of limited selfcare; confined to bed or chair > 50% waking hours~4 = Completely disabled; cannot carry on any selfcare; totally confined to bed/chair~5 = Deceased"|participants|Number|3|3.0||||||
4380121|NCT00323869|4207109|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4380122|NCT00323869|4207109|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380123|NCT00323869|4207109|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4380124|NCT00323869|4207109|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4380125|NCT00323869|4207109|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380126|NCT00323869|4207109|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4380127|NCT00323869|4207109|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4380128|NCT00323869|4207109|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4380129|NCT00323869|4207109|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4380130|NCT00323869|4207109|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4380131|NCT00323869|4207109|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4380132|NCT00323869|4207109|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4380133|NCT00323869|4207109|B1|||Age||years|Mean|59|59.0|Full Range|||35.0|81.0|
4380134|NCT00323739|4207121|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4380135|NCT00323739|4207121|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4380136|NCT00323739|4207121|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4380137|NCT00323739|4207121|B1|||Age||years|Mean|64|64.0|Standard Deviation|10.4|10.4|||
4380138|NCT00323739|4207121|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4380139|NCT00323739|4207121|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4380140|NCT00323739|4207121|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380141|NCT00323635|4207126|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4380142|NCT00323635|4207127|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4380143|NCT00323635|4207128|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4380144|NCT00323635|4207126|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380145|NCT00323635|4207127|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380146|NCT00323635|4207128|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380147|NCT00323635|4207126|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4380148|NCT00323635|4207127|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4380149|NCT00323635|4207128|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4380150|NCT00323635|4207126|B3|||Age||years|Mean|52|52.0|Standard Deviation|5.2|5.2|||
4380151|NCT00323635|4207127|B2|||Age||years|Mean|53|53.0|Standard Deviation|5.2|5.2|||
4380152|NCT00323635|4207128|B1|||Age||years|Mean|52|52.0|Standard Deviation|5.2|5.2|||
4380153|NCT00323635|4207126|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380154|NCT00323635|4207127|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380155|NCT00323635|4207128|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380156|NCT00323635|4207126|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4380157|NCT00323635|4207127|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4380166|NCT00323622|4207161|B5||Male|Gender||Participants|Count of Participants|80|80.0||||||
4380167|NCT00323622|4207162|B4||Male|Gender||Participants|Count of Participants|67|67.0||||||
4380168|NCT00323622|4207163|B3||Male|Gender||Participants|Count of Participants|23|23.0||||||
4380169|NCT00323622|4207164|B2||Male|Gender||Participants|Count of Participants|275|275.0||||||
4380170|NCT00323622|4207165|B1||Male|Gender||Participants|Count of Participants|91|91.0||||||
4380171|NCT00323622|4207157|B9||Female|Gender||Participants|Count of Participants|836|836.0||||||
4380172|NCT00323622|4207158|B8||Female|Gender||Participants|Count of Participants|78|78.0||||||
4380173|NCT00323622|4207159|B7||Female|Gender||Participants|Count of Participants|16|16.0||||||
4380174|NCT00323622|4207160|B6||Female|Gender||Participants|Count of Participants|252|252.0||||||
4380175|NCT00323622|4207161|B5||Female|Gender||Participants|Count of Participants|79|79.0||||||
4380176|NCT00323622|4207162|B4||Female|Gender||Participants|Count of Participants|67|67.0||||||
4380177|NCT00323622|4207163|B3||Female|Gender||Participants|Count of Participants|19|19.0||||||
4380178|NCT00323622|4207164|B2||Female|Gender||Participants|Count of Participants|240|240.0||||||
4380179|NCT00323622|4207165|B1||Female|Gender||Participants|Count of Participants|85|85.0||||||
4380180|NCT00323622|4207157|B9|||Age||Months|Mean|50.0|50.0|Standard Deviation|6.6|6.6|||
4380181|NCT00323622|4207158|B8|||Age||Months|Mean|61|61.0|Standard Deviation|9.0|9.0|||
4380182|NCT00323622|4207159|B7|||Age||Months|Mean|38|38.0|Standard Deviation|3.0|3.0|||
4380183|NCT00323622|4207160|B6|||Age||Months|Mean|62|62.0|Standard Deviation|10.0|10.0|||
4380184|NCT00323622|4207161|B5|||Age||Months|Mean|38|38.0|Standard Deviation|3.0|3.0|||
4380185|NCT00323622|4207162|B4|||Age||Months|Mean|62|62.0|Standard Deviation|9.0|9.0|||
4380186|NCT00323622|4207163|B3|||Age||Months|Mean|39|39.0|Standard Deviation|4.0|4.0|||
4380187|NCT00323622|4207164|B2|||Age||Months|Mean|62|62.0|Standard Deviation|11.0|11.0|||
4380188|NCT00323622|4207165|B1|||Age||Months|Mean|38|38.0|Standard Deviation|4.0|4.0|||
4380189|NCT00323609|4207212|B3|Three levels of VCFs intend to treat||Number of patients with intend to treat VCFs||participants|Number|17|17.0||||||
4380190|NCT00323609|4207213|B2|Three levels of VCFs intend to treat||Number of patients with intend to treat VCFs||participants|Number|8|8.0||||||
4380191|NCT00323609|4207214|B1|Three levels of VCFs intend to treat||Number of patients with intend to treat VCFs||participants|Number|9|9.0||||||
4380192|NCT00323609|4207212|B3|Two levels of VCFs intend to treat||Number of patients with intend to treat VCFs||participants|Number|65|65.0||||||
4380193|NCT00323609|4207213|B2|Two levels of VCFs intend to treat||Number of patients with intend to treat VCFs||participants|Number|32|32.0||||||
4380194|NCT00323609|4207214|B1|Two levels of VCFs intend to treat||Number of patients with intend to treat VCFs||participants|Number|33|33.0||||||
4380195|NCT00323609|4207212|B3|One level of VCFs intend to treat||Number of patients with intend to treat VCFs||participants|Number|299|299.0||||||
4380196|NCT00323609|4207213|B2|One level of VCFs intend to treat||Number of patients with intend to treat VCFs||participants|Number|150|150.0||||||
4380197|NCT00323609|4207214|B1|One level of VCFs intend to treat||Number of patients with intend to treat VCFs||participants|Number|149|149.0||||||
4380198|NCT00323609|4207212|B3|Suspected or confirmed secondary osteoporosis||Osteoporosis Cause||participants|Number|30|30.0||||||
4380199|NCT00323609|4207213|B2|Suspected or confirmed secondary osteoporosis||Osteoporosis Cause||participants|Number|18|18.0||||||
4380200|NCT00323609|4207214|B1|Suspected or confirmed secondary osteoporosis||Osteoporosis Cause||participants|Number|12|12.0||||||
4380201|NCT00323609|4207212|B3|Suspected or confirmed primary osteoporosis||Osteoporosis Cause||participants|Number|351|351.0||||||
4380202|NCT00323609|4207213|B2|Suspected or confirmed primary osteoporosis||Osteoporosis Cause||participants|Number|172|172.0||||||
4380203|NCT00323609|4207214|B1|Suspected or confirmed primary osteoporosis||Osteoporosis Cause||participants|Number|179|179.0||||||
4380204|NCT00323609|4207212|B3|Current Smoker||Smoking Habit||participants|Number|53|53.0||||||
4380205|NCT00323609|4207213|B2|Current Smoker||Smoking Habit||participants|Number|22|22.0||||||
4380206|NCT00323609|4207214|B1|Current Smoker||Smoking Habit||participants|Number|31|31.0||||||
4380207|NCT00323609|4207212|B3|Former Smoker||Smoking Habit||participants|Number|152|152.0||||||
4380208|NCT00323609|4207213|B2|Former Smoker||Smoking Habit||participants|Number|84|84.0||||||
4380209|NCT00323609|4207214|B1|Former Smoker||Smoking Habit||participants|Number|68|68.0||||||
4380210|NCT00323609|4207212|B3|Never Smoked||Smoking Habit||participants|Number|176|176.0||||||
4380211|NCT00323609|4207213|B2|Never Smoked||Smoking Habit||participants|Number|84|84.0||||||
4380212|NCT00323609|4207214|B1|Never Smoked||Smoking Habit||participants|Number|92|92.0||||||
4380213|NCT00323609|4207212|B3|||Current Height||inches|Mean|64.1|64.1|Standard Deviation|4.2|4.2|||
4380214|NCT00323609|4207213|B2|||Current Height||inches|Mean|64.5|64.5|Standard Deviation|4.0|4.0|||
4380215|NCT00323609|4207214|B1|||Current Height||inches|Mean|63.8|63.8|Standard Deviation|4.3|4.3|||
4380216|NCT00323609|4207212|B3|||Current Weight||lbs|Mean|157.1|157.1|Standard Deviation|41.6|41.6|||
4380217|NCT00323609|4207213|B2|||Current Weight||lbs|Mean|160.2|160.2|Standard Deviation|42.9|42.9|||
4380218|NCT00323609|4207214|B1|||Current Weight||lbs|Mean|154.0|154.0|Standard Deviation|40.2|40.2|||
4380219|NCT00323609|4207212|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380220|NCT00323609|4207213|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4380221|NCT00323609|4207214|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380222|NCT00323609|4207212|B3|White||Race/Ethnicity, Customized||participants|Number|359|359.0||||||
4380223|NCT00323609|4207213|B2|White||Race/Ethnicity, Customized||participants|Number|181|181.0||||||
4380224|NCT00323609|4207214|B1|White||Race/Ethnicity, Customized||participants|Number|178|178.0||||||
4380225|NCT00323609|4207212|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4380226|NCT00323609|4207213|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4380227|NCT00323609|4207214|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4380228|NCT00323609|4207212|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4380229|NCT00323609|4207213|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4380230|NCT00323609|4207214|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4380231|NCT00323609|4207212|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4380232|NCT00323609|4207213|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4380233|NCT00323609|4207214|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380234|NCT00323609|4207212|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380235|NCT00323609|4207213|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380236|NCT00323609|4207214|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4380237|NCT00323609|4207212|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4380238|NCT00323609|4207213|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4380239|NCT00323609|4207214|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4380240|NCT00323609|4207212|B3||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4380241|NCT00323609|4207213|B2||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4380242|NCT00323609|4207214|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4380243|NCT00323609|4207212|B3|||Age||years|Mean|75.6|75.6|Standard Deviation|10.4|10.4|||
4380244|NCT00323609|4207213|B2|||Age||years|Mean|75.7|75.7|Standard Deviation|10.5|10.5|||
4380245|NCT00323609|4207214|B1|||Age||years|Mean|75.5|75.5|Standard Deviation|10.3|10.3|||
4380246|NCT00323557|4207251|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4380247|NCT00323557|4207252|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4380248|NCT00323557|4207253|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4380249|NCT00323557|4207251|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4380250|NCT00323557|4207252|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4380251|NCT00323557|4207253|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4380252|NCT00323557|4207251|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4380253|NCT00323557|4207252|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4380254|NCT00323557|4207253|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4380255|NCT00323557|4207251|B3|||Age||years|Median|68|68.0|Full Range|10|10.0|51.0|91.0|
4380256|NCT00323557|4207252|B2|||Age||years|Median|61|61.0|Full Range|||57.0|77.0|
4380257|NCT00323557|4207253|B1|||Age||years|Median|70|70.0|Full Range|||51.0|91.0|
4380258|NCT00323492|4207261|B3|||Triglycerides|Centralized laboratory assessment|mmol/L|Median|2.4|2.4|Inter-Quartile Range|||1.9|3.7|
4380259|NCT00323492|4207262|B2|||Triglycerides|Centralized laboratory assessment|mmol/L|Median|2.7|2.7|Inter-Quartile Range|||1.9|3.6|
4380260|NCT00323492|4207263|B1|||Triglycerides|Centralized laboratory assessment|mmol/L|Median|2.3|2.3|Inter-Quartile Range|||1.9|4.0|
4380261|NCT00323492|4207261|B3|||Low density lipoprotein cholesterol (LDL-CHO)|Centralized laboratory assessment|mmol/L|Median|4.0|4.0|Inter-Quartile Range|||3.4|4.7|
4380262|NCT00323492|4207262|B2|||Low density lipoprotein cholesterol (LDL-CHO)|Centralized laboratory assessment|mmol/L|Median|4.0|4.0|Inter-Quartile Range|||3.6|4.8|
4380263|NCT00323492|4207263|B1|||Low density lipoprotein cholesterol (LDL-CHO)|Centralized laboratory assessment|mmol/L|Median|4.0|4.0|Inter-Quartile Range|||3.2|4.7|
4380264|NCT00323492|4207261|B3|||Cluster determinant 4 (CD4) cell count|At screening|cells/mm^3|Median|528|528.0|Inter-Quartile Range|||318.0|709.0|
4380265|NCT00323492|4207262|B2|||Cluster determinant 4 (CD4) cell count|At screening|cells/mm^3|Median|559|559.0|Inter-Quartile Range|||337.0|714.0|
4380266|NCT00323492|4207263|B1|||Cluster determinant 4 (CD4) cell count|At screening|cells/mm^3|Median|467|467.0|Inter-Quartile Range|||314.0|698.0|
4380267|NCT00323492|4207261|B3|||Participants with plasma HIV-1 RNA < 400 copies/mL|At screening|participants|Number|92|92.0||||||
4380268|NCT00323492|4207262|B2|||Participants with plasma HIV-1 RNA < 400 copies/mL|At screening|participants|Number|45|45.0||||||
4380269|NCT00323492|4207263|B1|||Participants with plasma HIV-1 RNA < 400 copies/mL|At screening|participants|Number|47|47.0||||||
4380270|NCT00323492|4207261|B3|France||Region of Enrollment||participants|Number|92|92.0||||||
4380271|NCT00323492|4207262|B2|France||Region of Enrollment||participants|Number|45|45.0||||||
4380272|NCT00323492|4207263|B1|France||Region of Enrollment||participants|Number|47|47.0||||||
4380273|NCT00323492|4207261|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4380274|NCT00323492|4207262|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4380275|NCT00323492|4207263|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4380276|NCT00323492|4207261|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4380277|NCT00323492|4207262|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4380278|NCT00323492|4207263|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4380279|NCT00323492|4207261|B3|||Age||years|Median|47.0|47.0|Inter-Quartile Range|9.8|9.8|41.0|55.0|
4380280|NCT00323492|4207262|B2|||Age||years|Median|43.0|43.0|Inter-Quartile Range|7.7|7.7|39.0|50.0|
4380281|NCT00323492|4207263|B1|||Age||years|Median|49.0|49.0|Inter-Quartile Range|10.7|10.7|42.0|58.0|
4380282|NCT00323479|4207296|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380283|NCT00323479|4207296|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4380284|NCT00323479|4207296|B1|||Age||year|Mean|62.87|62.87|Standard Deviation|6.87|6.87|||
4380285|NCT00323453|4207305|B3|||Number of Participants with physical barrier to protect the wound||Participants|Count of Participants|109|109.0||||||
4380286|NCT00323453|4207306|B2|||Number of Participants with physical barrier to protect the wound||Participants|Count of Participants|48|48.0||||||
4380287|NCT00323453|4207307|B1|||Number of Participants with physical barrier to protect the wound||Participants|Count of Participants|61|61.0||||||
4380288|NCT00323453|4207305|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
4380289|NCT00323453|4207306|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4380290|NCT00323453|4207307|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4380291|NCT00323453|4207305|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4380292|NCT00323453|4207305|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4380293|NCT00323453|4207306|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4380294|NCT00323453|4207307|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4380295|NCT00323453|4207305|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4380296|NCT00323453|4207306|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4380297|NCT00323453|4207307|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4380298|NCT00323453|4207305|B3|||Age||years|Mean|34.4|34.4|Standard Deviation|17.7|17.7|||
4380299|NCT00323453|4207306|B2|||Age||years|Mean|33.1|33.1|Standard Deviation|16.1|16.1|||
4380300|NCT00323453|4207307|B1|||Age||years|Mean|35.4|35.4|Standard Deviation|18.9|18.9|||
4380301|NCT00323427|4207314|B3|United States||Region of Enrollment||participants|Number|135|135.0||||||
4380302|NCT00323427|4207315|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4380303|NCT00323427|4207316|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4380304|NCT00323427|4207314|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4380305|NCT00323427|4207315|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4380306|NCT00323427|4207316|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4380307|NCT00323427|4207314|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4380308|NCT00323427|4207315|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4380309|NCT00323427|4207316|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380310|NCT00323427|4207314|B3|||Age||years|Mean|69.0|69.0|Standard Deviation|9.3|9.3|||
4380311|NCT00323427|4207315|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|8.4|8.4|||
4380312|NCT00323427|4207316|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|9.8|9.8|||
4380313|NCT00323427|4207314|B3||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4380314|NCT00323427|4207315|B2||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4380315|NCT00323427|4207316|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4380316|NCT00323427|4207314|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4380317|NCT00323427|4207315|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4380318|NCT00323427|4207316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4380319|NCT00323427|4207314|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380320|NCT00323427|4207315|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380321|NCT00323427|4207316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380322|NCT00323414|4207327|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4380323|NCT00323414|4207328|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4380324|NCT00323414|4207329|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4380325|NCT00323414|4207327|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4380326|NCT00323414|4207328|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4380327|NCT00323414|4207329|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4380328|NCT00323414|4207327|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380329|NCT00323414|4207328|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380330|NCT00323414|4207329|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380331|NCT00323414|4207327|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4380332|NCT00323414|4207328|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4380333|NCT00323414|4207329|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4380334|NCT00323414|4207327|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380335|NCT00323414|4207328|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380336|NCT00323414|4207329|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380337|NCT00323362|4207346|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4380338|NCT00323362|4207346|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4380339|NCT00323362|4207346|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4380340|NCT00323362|4207346|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|8.5|8.5|||
4380341|NCT00323362|4207346|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4380342|NCT00323362|4207346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4380343|NCT00323362|4207346|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380344|NCT00323310|4207352|B1|China||Region of Enrollment||participants|Number|9|9.0||||||
4380345|NCT00323310|4207352|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4380346|NCT00323310|4207352|B1|Europe||Region of Enrollment||participants|Number|47|47.0||||||
4380347|NCT00323310|4207352|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4380348|NCT00323310|4207352|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4380349|NCT00323310|4207352|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4380350|NCT00323310|4207352|B1|||Age||years|Mean|10.59|10.59|Standard Deviation|4.017|4.017|||
4380351|NCT00323310|4207352|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380352|NCT00323310|4207352|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4380353|NCT00323310|4207352|B1||<=18 years|Age||Participants|Count of Participants|92|92.0||||||
4380354|NCT00323297|4207365|B3|Class IV||World Health Organization Functional Class in Participants with Pulmonary Arterial Hypertension|Pulmonary Arterial Hypertension criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|1|1.0||||||
4380355|NCT00323297|4207366|B2|Class IV||World Health Organization Functional Class in Participants with Pulmonary Arterial Hypertension|Pulmonary Arterial Hypertension criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|1|1.0||||||
4380356|NCT00323297|4207367|B1|Class IV||World Health Organization Functional Class in Participants with Pulmonary Arterial Hypertension|Pulmonary Arterial Hypertension criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|0|0.0||||||
4380357|NCT00323297|4207365|B3|Class III||World Health Organization Functional Class in Participants with Pulmonary Arterial Hypertension|Pulmonary Arterial Hypertension criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|67|67.0||||||
4380358|NCT00323297|4207366|B2|Class III||World Health Organization Functional Class in Participants with Pulmonary Arterial Hypertension|Pulmonary Arterial Hypertension criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|29|29.0||||||
4380359|NCT00323297|4207367|B1|Class III||World Health Organization Functional Class in Participants with Pulmonary Arterial Hypertension|Pulmonary Arterial Hypertension criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|38|38.0||||||
4380360|NCT00323297|4207365|B3|Class II||World Health Organization Functional Class in Participants with Pulmonary Arterial Hypertension|Pulmonary Arterial Hypertension criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|35|35.0||||||
4380361|NCT00323297|4207366|B2|Class II||World Health Organization Functional Class in Participants with Pulmonary Arterial Hypertension|Pulmonary Arterial Hypertension criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|20|20.0||||||
4380362|NCT00323297|4207367|B1|Class II||World Health Organization Functional Class in Participants with Pulmonary Arterial Hypertension|Pulmonary Arterial Hypertension criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|15|15.0||||||
4380363|NCT00323297|4207365|B3|Class I||World Health Organization Functional Class in Participants with Pulmonary Arterial Hypertension|Pulmonary Arterial Hypertension criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|0|0.0||||||
4380364|NCT00323297|4207366|B2|Class I||World Health Organization Functional Class in Participants with Pulmonary Arterial Hypertension|Pulmonary Arterial Hypertension criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|0|0.0||||||
4380365|NCT00323297|4207367|B1|Class I||World Health Organization Functional Class in Participants with Pulmonary Arterial Hypertension|Pulmonary Arterial Hypertension criteria for WHO Class: Class I (Participants with no limitation of physical activity); Class II (Participants with slight limitation of physical activity); Class III (Participants with marked limitation of physical activity); Class IV (Participants with inability to carry out any physical activity).|Participants|Number|0|0.0||||||
4380366|NCT00323297|4207365|B3|||Mean Pulmonary Artery Pressure (mPAP)||Millimeter(mm) of mercury(Hg)|Mean|45.8|45.8|Standard Deviation|12.89|12.89|||
4380367|NCT00323297|4207366|B2|||Mean Pulmonary Artery Pressure (mPAP)||Millimeter(mm) of mercury(Hg)|Mean|46.9|46.9|Standard Deviation|12.47|12.47|||
4380368|NCT00323297|4207367|B1|||Mean Pulmonary Artery Pressure (mPAP)||Millimeter(mm) of mercury(Hg)|Mean|44.9|44.9|Standard Deviation|13.33|13.33|||
4380369|NCT00323297|4207365|B3|||Six Minute Walk Test (6MWT)|6MWT is the distance that a participant could walk in 6 minutes. Participants were asked to perform the test at a pace that was comfortable to them, with as many breaks as they needed. Continuous pulse oximetry was conducted during the test for safety.|Meters|Mean|352.35|352.35|Standard Deviation|80.520|80.52|||
4380370|NCT00323297|4207366|B2|||Six Minute Walk Test (6MWT)|6MWT is the distance that a participant could walk in 6 minutes. Participants were asked to perform the test at a pace that was comfortable to them, with as many breaks as they needed. Continuous pulse oximetry was conducted during the test for safety.|Meters|Mean|354.44|354.44|Standard Deviation|73.121|73.121|||
4380371|NCT00323297|4207367|B1|||Six Minute Walk Test (6MWT)|6MWT is the distance that a participant could walk in 6 minutes. Participants were asked to perform the test at a pace that was comfortable to them, with as many breaks as they needed. Continuous pulse oximetry was conducted during the test for safety.|Meters|Mean|350.38|350.38|Standard Deviation|87.587|87.587|||
4380372|NCT00323297|4207365|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4380373|NCT00323297|4207366|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4380374|NCT00323297|4207367|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4380375|NCT00323297|4207365|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4380376|NCT00323297|4207366|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4380377|NCT00323297|4207367|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4380378|NCT00323297|4207365|B3|||Age||Years|Mean|56.0|56.0|Standard Deviation|14.57|14.57|||
4380379|NCT00323297|4207366|B2|||Age||Years|Mean|55.2|55.2|Standard Deviation|15.10|15.1|||
4380380|NCT00323297|4207367|B1|||Age||Years|Mean|56.9|56.9|Standard Deviation|14.14|14.14|||
4380381|NCT00323284|4207384|B3|United States||Region of Enrollment||participants|Number|239|239.0||||||
4380382|NCT00323284|4207385|B2|United States||Region of Enrollment||participants|Number|123|123.0||||||
4380383|NCT00323284|4207386|B1|United States||Region of Enrollment||participants|Number|116|116.0||||||
4380384|NCT00323284|4207384|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4380385|NCT00323284|4207385|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4380386|NCT00323284|4207386|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4380387|NCT00323284|4207384|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4380388|NCT00323284|4207385|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4380389|NCT00323284|4207386|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4380390|NCT00323284|4207384|B3|||Age||years|Mean|73.42|73.42|Standard Deviation|8.11|8.11|||
4380391|NCT00323284|4207385|B2|||Age||years|Mean|72.88|72.88|Standard Deviation|8.66|8.66|||
4380392|NCT00323284|4207386|B1|||Age||years|Mean|73.96|73.96|Standard Deviation|7.66|7.66|||
4380393|NCT00323284|4207384|B3||>=65 years|Age||Participants|Count of Participants|201|201.0||||||
4380394|NCT00323284|4207385|B2||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
4380395|NCT00323284|4207386|B1||>=65 years|Age||Participants|Count of Participants|97|97.0||||||
4380396|NCT00323284|4207384|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4380397|NCT00323284|4207385|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4380398|NCT00323284|4207386|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4380399|NCT00323284|4207384|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380400|NCT00323284|4207385|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380401|NCT00323284|4207386|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380402|NCT00323271|4207395|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4380403|NCT00323271|4207396|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380404|NCT00323271|4207397|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4380405|NCT00323271|4207395|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4380406|NCT00323271|4207396|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4380407|NCT00323271|4207397|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4380408|NCT00323271|4207395|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4380409|NCT00323271|4207396|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4380410|NCT00323271|4207397|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4380411|NCT00323271|4207395|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4380412|NCT00323271|4207396|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4380413|NCT00323271|4207397|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4380414|NCT00323271|4207395|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380415|NCT00323271|4207396|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380416|NCT00323271|4207397|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380417|NCT00323271|4207395|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380418|NCT00323271|4207396|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380419|NCT00323271|4207397|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380420|NCT00323271|4207395|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380421|NCT00323271|4207396|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380422|NCT00323271|4207397|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380423|NCT00323271|4207395|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4380424|NCT00323271|4207396|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4380425|NCT00323271|4207397|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4380426|NCT00323271|4207395|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4380427|NCT00323271|4207396|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4380428|NCT00323271|4207397|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4380429|NCT00323271|4207395|B3|||Age||Years|Mean|53.95|53.95|Standard Deviation|10.408|10.408|||
4380430|NCT00323271|4207396|B2|||Age||Years|Mean|54.67|54.67|Standard Deviation|12.361|12.361|||
4380431|NCT00323271|4207397|B1|||Age||Years|Mean|53.23|53.23|Standard Deviation|8.691|8.691|||
4380432|NCT00323258|4207406|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4380433|NCT00323258|4207407|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4380434|NCT00323258|4207408|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4380435|NCT00323258|4207406|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4380436|NCT00323258|4207407|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4380437|NCT00323258|4207408|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4380438|NCT00323258|4207406|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|11.7|11.7|||
4380439|NCT00323258|4207407|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|12.0|12.0|||
4380440|NCT00323258|4207408|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|11.5|11.5|||
4380441|NCT00323258|4207406|B3|||Age||years|Median|62|62.0|Inter-Quartile Range|||53.0|70.0|
4380442|NCT00323258|4207407|B2|||Age||years|Median|62|62.0|Inter-Quartile Range|||52.0|70.0|
4380443|NCT00323258|4207408|B1|||Age||years|Median|63|63.0|Inter-Quartile Range|||54.0|71.0|
4380444|NCT00323193|4207423|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
4380445|NCT00323193|4207424|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4380446|NCT00323193|4207425|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4380447|NCT00323193|4207423|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380448|NCT00323193|4207424|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380449|NCT00323193|4207425|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380450|NCT00323193|4207423|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4380451|NCT00323193|4207424|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4380452|NCT00323193|4207425|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4380453|NCT00323193|4207423|B3||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4380454|NCT00323193|4207424|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4380455|NCT00323193|4207425|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4380456|NCT00323193|4207423|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4380457|NCT00323193|4207424|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4380458|NCT00323193|4207425|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4380459|NCT00323193|4207423|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380460|NCT00323193|4207424|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380461|NCT00323193|4207425|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380462|NCT00323193|4207423|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4380463|NCT00323193|4207424|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4380464|NCT00323193|4207425|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380465|NCT00323193|4207423|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4380466|NCT00323193|4207424|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4380467|NCT00323193|4207425|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380468|NCT00323193|4207423|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4380469|NCT00323193|4207424|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4380470|NCT00323193|4207425|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4380471|NCT00323193|4207423|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4380472|NCT00323193|4207424|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4380473|NCT00323193|4207425|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4380474|NCT00323193|4207423|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4380475|NCT00323193|4207424|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4380476|NCT00323193|4207425|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380477|NCT00323193|4207423|B3||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4380478|NCT00323193|4207424|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4380479|NCT00323193|4207425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4380480|NCT00323193|4207423|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380481|NCT00323193|4207424|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380482|NCT00323193|4207425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380483|NCT00323115|4207434|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4380484|NCT00323115|4207434|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4380485|NCT00323115|4207434|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4380486|NCT00323115|4207434|B1|||Age||years|Mean|63.273|63.273|Standard Deviation|9.53|9.53|||
4380487|NCT00323115|4207434|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4380488|NCT00323115|4207434|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4380489|NCT00323115|4207434|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380490|NCT00323063|4207459|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4380491|NCT00323063|4207460|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4380492|NCT00323063|4207461|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4380493|NCT00323063|4207459|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380494|NCT00323063|4207460|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380495|NCT00323063|4207461|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380496|NCT00323063|4207459|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380497|NCT00323063|4207460|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380498|NCT00323063|4207461|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380499|NCT00323063|4207459|B3||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4380500|NCT00323063|4207460|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4380501|NCT00323063|4207461|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4380502|NCT00323063|4207459|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4380503|NCT00323063|4207460|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4380504|NCT00323063|4207461|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4380505|NCT00323063|4207459|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380506|NCT00323063|4207460|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380507|NCT00323063|4207461|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380508|NCT00323063|4207459|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4380509|NCT00323063|4207460|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4380510|NCT00323063|4207461|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4380511|NCT00323063|4207459|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380512|NCT00323063|4207460|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380513|NCT00323063|4207461|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380514|NCT00323063|4207459|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380515|NCT00323063|4207460|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380516|NCT00323063|4207461|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380517|NCT00323063|4207459|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4380518|NCT00323063|4207460|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4380519|NCT00323063|4207461|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4380520|NCT00323063|4207459|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4380521|NCT00323063|4207460|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4380522|NCT00323063|4207461|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4380523|NCT00323063|4207459|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380524|NCT00323063|4207460|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380525|NCT00323063|4207461|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380526|NCT00323063|4207459|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4380527|NCT00323063|4207460|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4380528|NCT00323063|4207461|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4380529|NCT00323063|4207459|B3|||Age||years|Median|61.5|61.5|Full Range|||39.0|81.0|
4380530|NCT00323063|4207460|B2|||Age||years|Median|62.4|62.4|Full Range|||45.0|81.0|
4380531|NCT00323063|4207461|B1|||Age||years|Median|60.7|60.7|Full Range|||39.0|78.0|
4380532|NCT00323063|4207459|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4380533|NCT00323063|4207460|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4380534|NCT00323063|4207461|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4380535|NCT00323063|4207459|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4380536|NCT00323063|4207460|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4380537|NCT00323063|4207461|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4380538|NCT00323063|4207459|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380539|NCT00323063|4207460|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380540|NCT00323063|4207461|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380541|NCT00323037|4207472|B3||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4380542|NCT00323037|4207473|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4380543|NCT00323037|4207474|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4380544|NCT00323037|4207472|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4380545|NCT00323037|4207473|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4380546|NCT00323037|4207474|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4380547|NCT00323037|4207472|B3|Age>=75 years||Age, Customized||participants|Number|43|43.0||||||
4380548|NCT00323037|4207473|B2|Age>=75 years||Age, Customized||participants|Number|22|22.0||||||
4380549|NCT00323037|4207474|B1|Age>=75 years||Age, Customized||participants|Number|21|21.0||||||
4380550|NCT00323037|4207472|B3|65<=Age<75||Age, Customized||participants|Number|48|48.0||||||
4380551|NCT00323037|4207473|B2|65<=Age<75||Age, Customized||participants|Number|21|21.0||||||
4380552|NCT00323037|4207474|B1|65<=Age<75||Age, Customized||participants|Number|27|27.0||||||
4380553|NCT00323037|4207472|B3|< 65 years||Age, Customized||participants|Number|227|227.0||||||
4380554|NCT00323037|4207473|B2|< 65 years||Age, Customized||participants|Number|110|110.0||||||
4380555|NCT00323037|4207474|B1|< 65 years||Age, Customized||participants|Number|117|117.0||||||
4380556|NCT00322881|4207479|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4380557|NCT00322881|4207479|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380558|NCT00322881|4207479|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4380559|NCT00322881|4207479|B1|||Age||years|Mean|78.3|78.3|Full Range|||70.0|86.0|
4380560|NCT00322881|4207479|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4380561|NCT00322881|4207479|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4380562|NCT00322881|4207479|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380563|NCT00322868|4207483|B1|||percent neutrophils||percent of white blood cells|Mean|82.47|82.47|Standard Deviation|11.88|11.88|||
4380564|NCT00322868|4207483|B1|||Total neutrophil count||Log 10 (PMN/mL)|Mean|6.88|6.88|Standard Deviation|0.39|0.39|||
4380565|NCT00322868|4207483|B1|||Total white cell count||log 10 (cells/mL)|Mean|6.93|6.93|Standard Deviation|0.40|0.4|||
4380566|NCT00322868|4207483|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4380567|NCT00322868|4207483|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380568|NCT00322868|4207483|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380569|NCT00322868|4207483|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4380570|NCT00322868|4207483|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4380571|NCT00322868|4207483|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380572|NCT00322868|4207483|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380573|NCT00322868|4207483|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380574|NCT00322868|4207483|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380575|NCT00322868|4207483|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4380576|NCT00322868|4207483|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380577|NCT00322868|4207483|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4380578|NCT00322868|4207483|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4380579|NCT00322868|4207483|B1|||Age|great or equal to 18 years of age|years|Mean|30|30.0|Standard Deviation|9.28|9.28|||
4380580|NCT00322855|4207502|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380581|NCT00322855|4207502|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4380582|NCT00322855|4207502|B1|||Age||years|Median|17|17.0|Full Range|||17.0|17.0|
4380583|NCT00322842|4207506|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380584|NCT00322842|4207507|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380585|NCT00322842|4207508|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4380586|NCT00322842|4207506|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4380587|NCT00322842|4207507|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4380588|NCT00322842|4207508|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4380589|NCT00322842|4207506|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4380590|NCT00322842|4207507|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4380591|NCT00322842|4207508|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4380592|NCT00322842|4207506|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4380593|NCT00322842|4207507|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4380594|NCT00322842|4207508|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4380595|NCT00322842|4207506|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|7.3|7.3|||
4380596|NCT00322842|4207507|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|7.3|7.3|||
4380597|NCT00322842|4207508|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|8.1|8.1|||
4380598|NCT00322777|4207534|B3|Very interested||Interest in spirituality||participants|Number|54|54.0||||||
4380599|NCT00322777|4207535|B2|Very interested||Interest in spirituality||participants|Number|30|30.0||||||
4380600|NCT00322777|4207536|B1|Very interested||Interest in spirituality||participants|Number|24|24.0||||||
4380601|NCT00322777|4207534|B3|Quite interested||Interest in spirituality||participants|Number|23|23.0||||||
4380602|NCT00322777|4207535|B2|Quite interested||Interest in spirituality||participants|Number|12|12.0||||||
4380603|NCT00322777|4207536|B1|Quite interested||Interest in spirituality||participants|Number|11|11.0||||||
4380604|NCT00322777|4207534|B3|A little interested||Interest in spirituality||participants|Number|7|7.0||||||
4380605|NCT00322777|4207535|B2|A little interested||Interest in spirituality||participants|Number|3|3.0||||||
4380606|NCT00322777|4207536|B1|A little interested||Interest in spirituality||participants|Number|4|4.0||||||
4380607|NCT00322777|4207534|B3|Other||Religious denomination||participants|Number|7|7.0||||||
4380608|NCT00322777|4207535|B2|Other||Religious denomination||participants|Number|4|4.0||||||
4380609|NCT00322777|4207536|B1|Other||Religious denomination||participants|Number|3|3.0||||||
4380610|NCT00322777|4207534|B3|Christian||Religious denomination||participants|Number|47|47.0||||||
4380611|NCT00322777|4207535|B2|Christian||Religious denomination||participants|Number|25|25.0||||||
4380612|NCT00322777|4207536|B1|Christian||Religious denomination||participants|Number|22|22.0||||||
4380613|NCT00322777|4207534|B3|No religion||Religious denomination||participants|Number|30|30.0||||||
4380614|NCT00322777|4207535|B2|No religion||Religious denomination||participants|Number|16|16.0||||||
4380615|NCT00322777|4207536|B1|No religion||Religious denomination||participants|Number|14|14.0||||||
4380616|NCT00322777|4207534|B3|No paid work||Employment status||participants|Number|20|20.0||||||
4380617|NCT00322777|4207535|B2|No paid work||Employment status||participants|Number|12|12.0||||||
4380618|NCT00322777|4207536|B1|No paid work||Employment status||participants|Number|8|8.0||||||
4380619|NCT00322777|4207534|B3|Paid work||Employment status||participants|Number|64|64.0||||||
4380620|NCT00322777|4207535|B2|Paid work||Employment status||participants|Number|33|33.0||||||
4380621|NCT00322777|4207536|B1|Paid work||Employment status||participants|Number|31|31.0||||||
4380622|NCT00322777|4207534|B3|Not available||Education||participants|Number|1|1.0||||||
4380623|NCT00322777|4207535|B2|Not available||Education||participants|Number|0|0.0||||||
4380624|NCT00322777|4207536|B1|Not available||Education||participants|Number|1|1.0||||||
4380625|NCT00322777|4207534|B3|Postgraduate or professional degree||Education||participants|Number|8|8.0||||||
4380626|NCT00322777|4207535|B2|Postgraduate or professional degree||Education||participants|Number|6|6.0||||||
4380627|NCT00322777|4207536|B1|Postgraduate or professional degree||Education||participants|Number|2|2.0||||||
4380628|NCT00322777|4207534|B3|graduated from college or university||Education||participants|Number|46|46.0||||||
4380629|NCT00322777|4207535|B2|graduated from college or university||Education||participants|Number|24|24.0||||||
4380630|NCT00322777|4207536|B1|graduated from college or university||Education||participants|Number|22|22.0||||||
4380631|NCT00322777|4207534|B3|Some college or university||Education||participants|Number|17|17.0||||||
4380632|NCT00322777|4207535|B2|Some college or university||Education||participants|Number|8|8.0||||||
4380633|NCT00322777|4207536|B1|Some college or university||Education||participants|Number|9|9.0||||||
4380634|NCT00322777|4207534|B3|less than or equal to Highschool||Education||participants|Number|12|12.0||||||
4380635|NCT00322777|4207535|B2|less than or equal to Highschool||Education||participants|Number|7|7.0||||||
4380636|NCT00322777|4207536|B1|less than or equal to Highschool||Education||participants|Number|5|5.0||||||
4380637|NCT00322777|4207534|B3|Not married||Marital Status||participants|Number|35|35.0||||||
4380638|NCT00322777|4207535|B2|Not married||Marital Status||participants|Number|23|23.0||||||
4380639|NCT00322777|4207536|B1|Not married||Marital Status||participants|Number|12|12.0||||||
4380640|NCT00322777|4207534|B3|Married/common law||Marital Status||participants|Number|49|49.0||||||
4380641|NCT00322777|4207535|B2|Married/common law||Marital Status||participants|Number|22|22.0||||||
4380642|NCT00322777|4207536|B1|Married/common law||Marital Status||participants|Number|27|27.0||||||
4380643|NCT00322777|4207534|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4380644|NCT00322777|4207535|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4380645|NCT00322777|4207536|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4380646|NCT00322777|4207534|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4380647|NCT00322777|4207535|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4380648|NCT00322777|4207536|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4380649|NCT00322777|4207534|B3|||Age||years|Mean|44.02|44.02|Standard Deviation|9.92|9.92|||
4380650|NCT00322777|4207535|B2|||Age||years|Mean|44.0|44.0|Standard Deviation|9.14|9.14|||
4380651|NCT00322777|4207536|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|10.86|10.86|||
4380652|NCT00322712|4207547|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4380653|NCT00322712|4207547|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4380654|NCT00322712|4207547|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4380655|NCT00322712|4207547|B1|||Age||Years|Median|70|70.0|Full Range|||50.0|82.0|
4380656|NCT00322712|4207547|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4380657|NCT00322712|4207547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4380658|NCT00322712|4207547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380659|NCT00322621|4207551|B1|||Weight at Visit 2 (Week 0)||kilograms (kg)|Mean|84.0|84.0|Standard Deviation|18.36|18.36|||
4380660|NCT00322621|4207551|B1|||Height at Visit 1 (Week -1)||centimeters (cm)|Mean|166.7|166.7|Standard Deviation|10.39|10.39|||
4380661|NCT00322621|4207551|B1|||Brief Pain Inventory 24-Hour Average Pain Severity|A self-reported scale that measures the severity of pain based on the average pain over the past 24-hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).|units on a scale|Mean|5.88|5.88|Standard Deviation|1.45|1.45|||
4380662|NCT00322621|4207551|B1|Type 2||Type of Diabetes Mellitus||participants|Number|204|204.0||||||
4380663|NCT00322621|4207551|B1|Type 1||Type of Diabetes Mellitus||participants|Number|12|12.0||||||
4380664|NCT00322621|4207551|B1|Hispanic||Race/Ethnicity||participants|Number|4|4.0||||||
4380665|NCT00322621|4207551|B1|African||Race/Ethnicity||participants|Number|6|6.0||||||
4380666|NCT00322621|4207551|B1|West Asian||Race/Ethnicity||participants|Number|33|33.0||||||
4380667|NCT00322621|4207551|B1|Caucasian||Race/Ethnicity||participants|Number|173|173.0||||||
4380668|NCT00322621|4207551|B1|>1 year||Duration of Neuropathic Pain||participants|Number|178|178.0||||||
4380669|NCT00322621|4207551|B1|<=1 year||Duration of Neuropathic Pain||participants|Number|38|38.0||||||
4380670|NCT00322621|4207551|B1|>2 years||Duration of Diabetes||participants|Number|138|138.0||||||
4380671|NCT00322621|4207551|B1|<=2 years||Duration of Diabetes||participants|Number|78|78.0||||||
4380672|NCT00322621|4207551|B1|Italy||Region of Enrollment||participants|Number|41|41.0||||||
4380673|NCT00322621|4207551|B1|Germany||Region of Enrollment||participants|Number|66|66.0||||||
4380674|NCT00322621|4207551|B1|Brazil||Region of Enrollment||participants|Number|66|66.0||||||
4380675|NCT00322621|4207551|B1|France||Region of Enrollment||participants|Number|43|43.0||||||
4380676|NCT00322621|4207551|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4380677|NCT00322621|4207551|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4380678|NCT00322621|4207551|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|9.45|9.45|||
4380679|NCT00322556|4207605|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4380680|NCT00322556|4207605|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4380681|NCT00322556|4207605|B1|>= 65 years||Age, Customized||participants|Number|4|4.0||||||
4380682|NCT00322556|4207605|B1|16 to < 65 years||Age, Customized||participants|Number|30|30.0||||||
4380683|NCT00322556|4207605|B1|12 to < 16 years||Age, Customized||participants|Number|8|8.0||||||
4380684|NCT00322556|4207605|B1|3 to < 12 years||Age, Customized||participants|Number|13|13.0||||||
4380685|NCT00322556|4207605|B1|||Age||years|Mean|30|30.0|Standard Deviation|21|21.0|||
4380686|NCT00322491|4207619|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380687|NCT00322491|4207620|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380688|NCT00322491|4207621|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4380689|NCT00322491|4207619|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380690|NCT00322491|4207620|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380691|NCT00322491|4207621|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4380692|NCT00322491|4207619|B3|African-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380693|NCT00322491|4207620|B2|African-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380694|NCT00322491|4207621|B1|African-American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4380695|NCT00322491|4207619|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4380696|NCT00322491|4207620|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4380697|NCT00322491|4207621|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4380698|NCT00322491|4207619|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4380699|NCT00322491|4207620|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4380700|NCT00322491|4207621|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4380701|NCT00322491|4207619|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4380702|NCT00322491|4207620|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4380703|NCT00322491|4207621|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4380704|NCT00322491|4207619|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|8.3|8.3|||
4380705|NCT00322491|4207620|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|8.1|8.1|||
4380706|NCT00322491|4207621|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|8.7|8.7|||
4380707|NCT00322465|4207644|B5|United States||Region of Enrollment||participants|Number|305|305.0||||||
4380708|NCT00322465|4207645|B4|United States||Region of Enrollment||participants|Number|79|79.0||||||
4380709|NCT00322465|4207646|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4380710|NCT00322465|4207647|B2|United States||Region of Enrollment||participants|Number|73|73.0||||||
4380711|NCT00322465|4207648|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4380712|NCT00322465|4207644|B5||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4380713|NCT00322465|4207645|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4380714|NCT00322465|4207646|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4380715|NCT00322465|4207647|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4380716|NCT00322465|4207648|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4380717|NCT00322465|4207644|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380718|NCT00322465|4207645|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380719|NCT00322465|4207646|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380720|NCT00322465|4207647|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380721|NCT00322465|4207648|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380722|NCT00322465|4207644|B5|||Age||years|Mean|26.8|26.8|Standard Deviation|6.9|6.9|||
4380723|NCT00322465|4207645|B4|||Age||years|Mean|25.7|25.7|Standard Deviation|7.2|7.2|||
4380724|NCT00322465|4207646|B3|||Age||years|Mean|26.4|26.4|Standard Deviation|6.7|6.7|||
4380725|NCT00322465|4207647|B2|||Age||years|Mean|27.8|27.8|Standard Deviation|6.8|6.8|||
4380726|NCT00322465|4207648|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|7.0|7.0|||
4380727|NCT00322465|4207644|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380728|NCT00322465|4207645|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380729|NCT00322465|4207646|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380730|NCT00322465|4207647|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380731|NCT00322465|4207648|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380732|NCT00322465|4207644|B5||Between 18 and 65 years|Age||Participants|Count of Participants|298|298.0||||||
4380733|NCT00322465|4207645|B4||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4380734|NCT00322465|4207646|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4380735|NCT00322465|4207647|B2||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4380736|NCT00322465|4207648|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4380737|NCT00322465|4207644|B5||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4380738|NCT00322465|4207645|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4380739|NCT00322465|4207646|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4380740|NCT00322465|4207647|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4380741|NCT00322465|4207648|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4380742|NCT00322452|4207710|B3|2 (in bed =< 50% of the time)||WHO performance status||Participants|Number|126|126.0||||||
4380743|NCT00322452|4207711|B2|2 (in bed =< 50% of the time)||WHO performance status||Participants|Number|65|65.0||||||
4380744|NCT00322452|4207712|B1|2 (in bed =< 50% of the time)||WHO performance status||Participants|Number|61|61.0||||||
4380745|NCT00322452|4207710|B3|1 (restricted activity)||WHO performance status||Participants|Number|773|773.0||||||
4380746|NCT00322452|4207711|B2|1 (restricted activity)||WHO performance status||Participants|Number|382|382.0||||||
4380747|NCT00322452|4207712|B1|1 (restricted activity)||WHO performance status||Participants|Number|391|391.0||||||
4380748|NCT00322452|4207710|B3|0 (normal activity)||WHO performance status||Participants|Number|318|318.0||||||
4380749|NCT00322452|4207711|B2|0 (normal activity)||WHO performance status||Participants|Number|161|161.0||||||
4380750|NCT00322452|4207712|B1|0 (normal activity)||WHO performance status||Participants|Number|157|157.0||||||
4380751|NCT00322452|4207710|B3|Ex-smoker (non-light)||Smoking history||Participants|Number|2|2.0||||||
4380752|NCT00322452|4207711|B2|Ex-smoker (non-light)||Smoking history||Participants|Number|1|1.0||||||
4380753|NCT00322452|4207712|B1|Ex-smoker (non-light)||Smoking history||Participants|Number|1|1.0||||||
4380754|NCT00322452|4207710|B3|Light ex-smoker||Smoking history||Participants|Number|75|75.0||||||
4380755|NCT00322452|4207711|B2|Light ex-smoker||Smoking history||Participants|Number|38|38.0||||||
4380756|NCT00322452|4207712|B1|Light ex-smoker||Smoking history||Participants|Number|37|37.0||||||
4380757|NCT00322452|4207710|B3|Never Smoker||Smoking history||Participants|Number|1140|1140.0||||||
4380758|NCT00322452|4207711|B2|Never Smoker||Smoking history||Participants|Number|569|569.0||||||
4380759|NCT00322452|4207712|B1|Never Smoker||Smoking history||Participants|Number|571|571.0||||||
4380760|NCT00322452|4207710|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4380761|NCT00322452|4207711|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4380762|NCT00322452|4207712|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4380763|NCT00322452|4207710|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|233|233.0||||||
4380764|NCT00322452|4207711|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|119|119.0||||||
4380765|NCT00322452|4207712|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|114|114.0||||||
4380766|NCT00322452|4207710|B3|Chinese||Race/Ethnicity, Customized||Participants|Number|618|618.0||||||
4380767|NCT00322452|4207711|B2|Chinese||Race/Ethnicity, Customized||Participants|Number|304|304.0||||||
4380768|NCT00322452|4207712|B1|Chinese||Race/Ethnicity, Customized||Participants|Number|314|314.0||||||
4380769|NCT00322452|4207710|B3|Asian (other than Chinese or Japanese)||Race/Ethnicity, Customized||Participants|Number|363|363.0||||||
4380770|NCT00322452|4207711|B2|Asian (other than Chinese or Japanese)||Race/Ethnicity, Customized||Participants|Number|184|184.0||||||
4380771|NCT00322452|4207712|B1|Asian (other than Chinese or Japanese)||Race/Ethnicity, Customized||Participants|Number|179|179.0||||||
4380772|NCT00322452|4207710|B3|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4380773|NCT00322452|4207711|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4380774|NCT00322452|4207712|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4380775|NCT00322452|4207710|B3|Oriental||Race/Ethnicity, Customized||Participants|Number|1209|1209.0||||||
4380776|NCT00322452|4207711|B2|Oriental||Race/Ethnicity, Customized||Participants|Number|606|606.0||||||
4380777|NCT00322452|4207712|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|603|603.0||||||
4380778|NCT00322452|4207710|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4380779|NCT00322452|4207711|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4380780|NCT00322452|4207712|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4380781|NCT00322452|4207710|B3||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4380782|NCT00322452|4207711|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4380783|NCT00322452|4207712|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4380784|NCT00322452|4207710|B3||Female|Sex: Female, Male||Participants|Count of Participants|965|965.0||||||
4380785|NCT00322452|4207711|B2||Female|Sex: Female, Male||Participants|Count of Participants|481|481.0||||||
4380786|NCT00322452|4207712|B1||Female|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
4380787|NCT00322452|4207710|B3|||Age||Years|Median|57|57.0|Full Range|||24.0|84.0|
4380788|NCT00322452|4207711|B2|||Age||Years|Median|57|57.0|Full Range|||25.0|84.0|
4380789|NCT00322452|4207712|B1|||Age||Years|Median|57|57.0|Full Range|||24.0|84.0|
4380790|NCT00322439|4207749|B1|Other||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4380791|NCT00322439|4207749|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4380792|NCT00322439|4207749|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4380793|NCT00322439|4207749|B1|Japanese||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4380794|NCT00322439|4207749|B1|Asian||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
4380795|NCT00322439|4207749|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|164|164.0||||||
4380796|NCT00322439|4207749|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
4380797|NCT00322439|4207749|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|2052|2052.0||||||
4380798|NCT00322439|4207749|B1||Male|Sex: Female, Male||Participants|Count of Participants|1317|1317.0||||||
4380799|NCT00322439|4207749|B1||Female|Sex: Female, Male||Participants|Count of Participants|1193|1193.0||||||
4380800|NCT00322439|4207749|B1|||Age||years|Mean|46.32|46.32|Standard Deviation|13.59|13.59|||
4380801|NCT00322387|4207762|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380802|NCT00322387|4207763|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380803|NCT00322387|4207764|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380804|NCT00322387|4207762|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4380805|NCT00322387|4207763|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4380806|NCT00322387|4207764|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4380807|NCT00322387|4207762|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4380808|NCT00322387|4207763|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4380809|NCT00322387|4207764|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4380810|NCT00322387|4207762|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4380811|NCT00322387|4207763|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4380812|NCT00322387|4207764|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4380813|NCT00322387|4207762|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4380814|NCT00322387|4207763|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4380815|NCT00322387|4207764|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4380816|NCT00322387|4207762|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|8.7|8.7|||
4380817|NCT00322387|4207763|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|7.6|7.6|||
4380818|NCT00322387|4207764|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|10.8|10.8|||
4380819|NCT00322374|4207796|B4|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4380820|NCT00322374|4207797|B3|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4380821|NCT00322374|4207798|B2|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4380822|NCT00322374|4207799|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4380823|NCT00322374|4207796|B4|France||Region of Enrollment||participants|Number|24|24.0||||||
4380824|NCT00322374|4207797|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
4380825|NCT00322374|4207798|B2|France||Region of Enrollment||participants|Number|16|16.0||||||
4380826|NCT00322374|4207799|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
4380827|NCT00322374|4207796|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380828|NCT00322374|4207797|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380829|NCT00322374|4207798|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380830|NCT00322374|4207799|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380831|NCT00322374|4207796|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4380832|NCT00322374|4207797|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4380833|NCT00322374|4207798|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4380834|NCT00322374|4207799|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4380835|NCT00322374|4207796|B4|||Age||years|Median|57|57.0|Full Range|||33.0|69.0|
4380836|NCT00322374|4207797|B3|||Age||years|Median|53.5|53.5|Full Range|||33.0|68.0|
4380837|NCT00322374|4207798|B2|||Age||years|Median|57.5|57.5|Full Range|||38.0|69.0|
4380838|NCT00322374|4207799|B1|||Age||years|Median|57.5|57.5|Full Range|||48.0|61.0|
4380839|NCT00322374|4207796|B4|>=65 years||Age, Customized||participants|Number|7|7.0||||||
4380840|NCT00322374|4207797|B3|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4380841|NCT00322374|4207798|B2|>=65 years||Age, Customized||participants|Number|6|6.0||||||
4380842|NCT00322374|4207799|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4380843|NCT00322374|4207796|B4|Between 18 and 65 years||Age, Customized||participants|Number|35|35.0||||||
4380844|NCT00322374|4207797|B3|Between 18 and 65 years||Age, Customized||participants|Number|5|5.0||||||
4380845|NCT00322374|4207798|B2|Between 18 and 65 years||Age, Customized||participants|Number|24|24.0||||||
4380846|NCT00322374|4207799|B1|Between 18 and 65 years||Age, Customized||participants|Number|6|6.0||||||
4380847|NCT00322348|4207850|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4380848|NCT00322348|4207851|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4380849|NCT00322348|4207852|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4380850|NCT00322348|4207850|B3|Oriental||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4380851|NCT00322348|4207851|B2|Oriental||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4380852|NCT00322348|4207852|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4380853|NCT00322348|4207850|B3|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4380854|NCT00322348|4207851|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4380855|NCT00322348|4207852|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4380856|NCT00322348|4207850|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
4380857|NCT00322348|4207851|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4380858|NCT00322348|4207852|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4380859|NCT00322348|4207850|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380860|NCT00322348|4207851|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380861|NCT00322348|4207852|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4380862|NCT00322348|4207850|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4380863|NCT00322348|4207851|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4380864|NCT00322348|4207852|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4380865|NCT00322348|4207850|B3|||Age||Years|Mean|42.3|42.3|Standard Deviation|6.24|6.24|||
4380866|NCT00322348|4207851|B2|||Age||Years|Mean|42.6|42.6|Standard Deviation|6.07|6.07|||
4380867|NCT00322348|4207852|B1|||Age||Years|Mean|42.0|42.0|Standard Deviation|6.45|6.45|||
4380868|NCT00322335|4207869|B4||Male|Sex: Female, Male|"Baseline characteristics for Menitorix/Pediarix Group and Infanrix Hexa (or IPV/Hib)/NeisVac-C/Engerix-B/Menitorix Group are given for subjects included in the Month 18 follow-up timepoint.~For Infanrix Hexa/Meningitec Group, baseline characteristics are given for all subjects included in the Month 30 follow-up timepoint, as most subjects were eliminated from the Month 18 timepoint in this group."|Participants|Count of Participants|129|129.0||||||
4380869|NCT00322335|4207870|B3||Male|Sex: Female, Male|"Baseline characteristics for Menitorix/Pediarix Group and Infanrix Hexa (or IPV/Hib)/NeisVac-C/Engerix-B/Menitorix Group are given for subjects included in the Month 18 follow-up timepoint.~For Infanrix Hexa/Meningitec Group, baseline characteristics are given for all subjects included in the Month 30 follow-up timepoint, as most subjects were eliminated from the Month 18 timepoint in this group."|Participants|Count of Participants|30|30.0||||||
4380870|NCT00322335|4207871|B2||Male|Sex: Female, Male|"Baseline characteristics for Menitorix/Pediarix Group and Infanrix Hexa (or IPV/Hib)/NeisVac-C/Engerix-B/Menitorix Group are given for subjects included in the Month 18 follow-up timepoint.~For Infanrix Hexa/Meningitec Group, baseline characteristics are given for all subjects included in the Month 30 follow-up timepoint, as most subjects were eliminated from the Month 18 timepoint in this group."|Participants|Count of Participants|68|68.0||||||
4380871|NCT00322335|4207872|B1||Male|Sex: Female, Male|"Baseline characteristics for Menitorix/Pediarix Group and Infanrix Hexa (or IPV/Hib)/NeisVac-C/Engerix-B/Menitorix Group are given for subjects included in the Month 18 follow-up timepoint.~For Infanrix Hexa/Meningitec Group, baseline characteristics are given for all subjects included in the Month 30 follow-up timepoint, as most subjects were eliminated from the Month 18 timepoint in this group."|Participants|Count of Participants|31|31.0||||||
4380872|NCT00322335|4207869|B4||Female|Sex: Female, Male|"Baseline characteristics for Menitorix/Pediarix Group and Infanrix Hexa (or IPV/Hib)/NeisVac-C/Engerix-B/Menitorix Group are given for subjects included in the Month 18 follow-up timepoint.~For Infanrix Hexa/Meningitec Group, baseline characteristics are given for all subjects included in the Month 30 follow-up timepoint, as most subjects were eliminated from the Month 18 timepoint in this group."|Participants|Count of Participants|109|109.0||||||
4380873|NCT00322335|4207870|B3||Female|Sex: Female, Male|"Baseline characteristics for Menitorix/Pediarix Group and Infanrix Hexa (or IPV/Hib)/NeisVac-C/Engerix-B/Menitorix Group are given for subjects included in the Month 18 follow-up timepoint.~For Infanrix Hexa/Meningitec Group, baseline characteristics are given for all subjects included in the Month 30 follow-up timepoint, as most subjects were eliminated from the Month 18 timepoint in this group."|Participants|Count of Participants|27|27.0||||||
4380874|NCT00322335|4207871|B2||Female|Sex: Female, Male|"Baseline characteristics for Menitorix/Pediarix Group and Infanrix Hexa (or IPV/Hib)/NeisVac-C/Engerix-B/Menitorix Group are given for subjects included in the Month 18 follow-up timepoint.~For Infanrix Hexa/Meningitec Group, baseline characteristics are given for all subjects included in the Month 30 follow-up timepoint, as most subjects were eliminated from the Month 18 timepoint in this group."|Participants|Count of Participants|55|55.0||||||
4380875|NCT00322335|4207872|B1||Female|Sex: Female, Male|"Baseline characteristics for Menitorix/Pediarix Group and Infanrix Hexa (or IPV/Hib)/NeisVac-C/Engerix-B/Menitorix Group are given for subjects included in the Month 18 follow-up timepoint.~For Infanrix Hexa/Meningitec Group, baseline characteristics are given for all subjects included in the Month 30 follow-up timepoint, as most subjects were eliminated from the Month 18 timepoint in this group."|Participants|Count of Participants|27|27.0||||||
4380876|NCT00322335|4207869|B4|||Age|"Baseline characteristics for Menitorix/Pediarix Group and Infanrix Hexa (or IPV/Hib)/NeisVac-C/Engerix-B/Menitorix Group are given for subjects included in the Month 18 follow-up timepoint.~For Infanrix Hexa/Meningitec Group, baseline characteristics are given for all subjects included in the Month 30 follow-up timepoint, as most subjects were eliminated from the Month 18 timepoint in this group."|Months|Mean|31.4|31.4|Standard Deviation|0.68|0.68|||
4380877|NCT00322335|4207870|B3|||Age|"Baseline characteristics for Menitorix/Pediarix Group and Infanrix Hexa (or IPV/Hib)/NeisVac-C/Engerix-B/Menitorix Group are given for subjects included in the Month 18 follow-up timepoint.~For Infanrix Hexa/Meningitec Group, baseline characteristics are given for all subjects included in the Month 30 follow-up timepoint, as most subjects were eliminated from the Month 18 timepoint in this group."|Months|Mean|31.5|31.5|Standard Deviation|0.87|0.87|||
4380932|NCT00322153|4207943|B2|Chile||Region of Enrollment||participants|Number|46|46.0||||||
4380878|NCT00322335|4207871|B2|||Age|"Baseline characteristics for Menitorix/Pediarix Group and Infanrix Hexa (or IPV/Hib)/NeisVac-C/Engerix-B/Menitorix Group are given for subjects included in the Month 18 follow-up timepoint.~For Infanrix Hexa/Meningitec Group, baseline characteristics are given for all subjects included in the Month 30 follow-up timepoint, as most subjects were eliminated from the Month 18 timepoint in this group."|Months|Mean|31.4|31.4|Standard Deviation|0.64|0.64|||
4380879|NCT00322335|4207872|B1|||Age|"Baseline characteristics for Menitorix/Pediarix Group and Infanrix Hexa (or IPV/Hib)/NeisVac-C/Engerix-B/Menitorix Group are given for subjects included in the Month 18 follow-up timepoint.~For Infanrix Hexa/Meningitec Group, baseline characteristics are given for all subjects included in the Month 30 follow-up timepoint, as most subjects were eliminated from the Month 18 timepoint in this group."|Months|Mean|31.3|31.3|Standard Deviation|0.54|0.54|||
4380880|NCT00322309|4207912|B3|||Ln Urine Benzoylecgonine Conc|Baseline urine LB BE concentrations were obtained during the screening sessions.|ln (ng/ml)|Mean|9.2|9.2|Standard Deviation|2.1|2.1|||
4380881|NCT00322309|4207913|B2|||Ln Urine Benzoylecgonine Conc|Baseline urine LB BE concentrations were obtained during the screening sessions.|ln (ng/ml)|Mean|9.1|9.1|Standard Deviation|2.4|2.4|||
4380882|NCT00322309|4207914|B1|||Ln Urine Benzoylecgonine Conc|Baseline urine LB BE concentrations were obtained during the screening sessions.|ln (ng/ml)|Mean|9.3|9.3|Standard Deviation|1.7|1.7|||
4380883|NCT00322309|4207912|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4380884|NCT00322309|4207913|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4380885|NCT00322309|4207914|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4380886|NCT00322309|4207912|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4380887|NCT00322309|4207913|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4380888|NCT00322309|4207914|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4380889|NCT00322309|4207912|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4380890|NCT00322309|4207913|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4380891|NCT00322309|4207914|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4380892|NCT00322309|4207912|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|6.4|6.4|||
4380893|NCT00322309|4207913|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|6.7|6.7|||
4380894|NCT00322309|4207914|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|5.6|5.6|||
4380895|NCT00322309|4207912|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380896|NCT00322309|4207913|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380897|NCT00322309|4207914|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380898|NCT00322309|4207912|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4380899|NCT00322309|4207913|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4380900|NCT00322309|4207914|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4380901|NCT00322309|4207912|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380902|NCT00322309|4207913|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380903|NCT00322309|4207914|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380904|NCT00322231|4207929|B3|White||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4380905|NCT00322231|4207930|B2|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4380906|NCT00322231|4207931|B1|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4380907|NCT00322231|4207929|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4380908|NCT00322231|4207930|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4380909|NCT00322231|4207931|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4380910|NCT00322231|4207929|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4380911|NCT00322231|4207930|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4380912|NCT00322231|4207931|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4380913|NCT00322231|4207929|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4380914|NCT00322231|4207930|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4380915|NCT00322231|4207931|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4380916|NCT00322231|4207929|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4380917|NCT00322231|4207930|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4380918|NCT00322231|4207931|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4380919|NCT00322231|4207929|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4380920|NCT00322231|4207930|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4380921|NCT00322231|4207931|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4380922|NCT00322231|4207929|B3|≥ 60 Years of age||Age, Customized||participants|Number|81|81.0||||||
4380923|NCT00322231|4207930|B2|≥ 60 Years of age||Age, Customized||participants|Number|40|40.0||||||
4380924|NCT00322231|4207931|B1|≥ 60 Years of age||Age, Customized||participants|Number|41|41.0||||||
4380925|NCT00322231|4207929|B3|50 to 59 Years of age||Age, Customized||participants|Number|20|20.0||||||
4380926|NCT00322231|4207930|B2|50 to 59 Years of age||Age, Customized||participants|Number|10|10.0||||||
4380927|NCT00322231|4207931|B1|50 to 59 Years of age||Age, Customized||participants|Number|10|10.0||||||
4380928|NCT00322153|4207942|B3|Mexico||Region of Enrollment||participants|Number|97|97.0||||||
4380929|NCT00322153|4207943|B2|Mexico||Region of Enrollment||participants|Number|49|49.0||||||
4380930|NCT00322153|4207944|B1|Mexico||Region of Enrollment||participants|Number|48|48.0||||||
4380931|NCT00322153|4207942|B3|Chile||Region of Enrollment||participants|Number|90|90.0||||||
4380933|NCT00322153|4207944|B1|Chile||Region of Enrollment||participants|Number|44|44.0||||||
4380934|NCT00322153|4207942|B3|Argentina||Region of Enrollment||participants|Number|311|311.0||||||
4380935|NCT00322153|4207943|B2|Argentina||Region of Enrollment||participants|Number|153|153.0||||||
4380936|NCT00322153|4207944|B1|Argentina||Region of Enrollment||participants|Number|158|158.0||||||
4380937|NCT00322153|4207942|B3|United States||Region of Enrollment||participants|Number|178|178.0||||||
4380938|NCT00322153|4207943|B2|United States||Region of Enrollment||participants|Number|93|93.0||||||
4380939|NCT00322153|4207944|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
4380940|NCT00322153|4207942|B3||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4380941|NCT00322153|4207943|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4380942|NCT00322153|4207944|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4380943|NCT00322153|4207942|B3||Female|Sex: Female, Male||Participants|Count of Participants|487|487.0||||||
4380944|NCT00322153|4207943|B2||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4380945|NCT00322153|4207944|B1||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4380946|NCT00322153|4207942|B3|||Age||years|Mean|76.5|76.5|Standard Deviation|8.07|8.07|||
4380947|NCT00322153|4207943|B2|||Age||years|Mean|76.2|76.2|Standard Deviation|8.35|8.35|||
4380948|NCT00322153|4207944|B1|||Age||years|Mean|76.8|76.8|Standard Deviation|7.76|7.76|||
4380949|NCT00322153|4207942|B3|>= 85 years||Age, Customized||participants|Number|97|97.0||||||
4380950|NCT00322153|4207943|B2|>= 85 years||Age, Customized||participants|Number|46|46.0||||||
4380951|NCT00322153|4207944|B1|>= 85 years||Age, Customized||participants|Number|51|51.0||||||
4380952|NCT00322153|4207942|B3|75-84 years||Age, Customized||participants|Number|355|355.0||||||
4380953|NCT00322153|4207943|B2|75-84 years||Age, Customized||participants|Number|176|176.0||||||
4380954|NCT00322153|4207944|B1|75-84 years||Age, Customized||participants|Number|179|179.0||||||
4380955|NCT00322153|4207942|B3|65-74 years||Age, Customized||participants|Number|164|164.0||||||
4380956|NCT00322153|4207943|B2|65-74 years||Age, Customized||participants|Number|85|85.0||||||
4380957|NCT00322153|4207944|B1|65-74 years||Age, Customized||participants|Number|79|79.0||||||
4380958|NCT00322153|4207942|B3|<= 64 years||Age, Customized||participants|Number|60|60.0||||||
4380959|NCT00322153|4207943|B2|<= 64 years||Age, Customized||participants|Number|34|34.0||||||
4380960|NCT00322153|4207944|B1|<= 64 years||Age, Customized||participants|Number|26|26.0||||||
4380961|NCT00322101|4207955|B3|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4380962|NCT00322101|4207956|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4380963|NCT00322101|4207957|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4380964|NCT00322101|4207955|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4380965|NCT00322101|4207956|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4380966|NCT00322101|4207957|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4380967|NCT00322101|4207955|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4380968|NCT00322101|4207956|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4380969|NCT00322101|4207957|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4380970|NCT00322101|4207955|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4380971|NCT00322101|4207956|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4380972|NCT00322101|4207957|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4380973|NCT00322101|4207955|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|7.94|7.94|||
4380974|NCT00322101|4207956|B2|||Age||years|Mean|52.82|52.82|Standard Deviation|5.78|5.78|||
4380975|NCT00322101|4207957|B1|||Age||years|Mean|51.47|51.47|Standard Deviation|9.49|9.49|||
4380976|NCT00322101|4207955|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380977|NCT00322101|4207956|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380978|NCT00322101|4207957|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4380979|NCT00322101|4207955|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4380980|NCT00322101|4207956|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4380981|NCT00322101|4207957|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4380982|NCT00322101|4207955|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380983|NCT00322101|4207956|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380984|NCT00322101|4207957|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4380985|NCT00322049|4207974|B5|Thailand||Region of Enrollment||participants|Number|51|51.0||||||
4380986|NCT00322049|4207975|B4|Thailand||Region of Enrollment||participants|Number|17|17.0||||||
4380987|NCT00322049|4207976|B3|Thailand||Region of Enrollment||participants|Number|20|20.0||||||
4380988|NCT00322049|4207977|B2|Thailand||Region of Enrollment||participants|Number|10|10.0||||||
4380989|NCT00322049|4207978|B1|Thailand||Region of Enrollment||participants|Number|4|4.0||||||
4380990|NCT00322049|4207974|B5|Southeast Asian||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4380991|NCT00322049|4207975|B4|Southeast Asian||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4380992|NCT00322049|4207976|B3|Southeast Asian||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4380993|NCT00322049|4207977|B2|Southeast Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4380994|NCT00322049|4207978|B1|Southeast Asian||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4380995|NCT00322049|4207974|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4380996|NCT00322049|4207975|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4380997|NCT00322049|4207976|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4380998|NCT00322049|4207977|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4380999|NCT00322049|4207978|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4381000|NCT00322049|4207974|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4381001|NCT00322049|4207975|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4381002|NCT00322049|4207976|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4381003|NCT00322049|4207977|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4381004|NCT00322049|4207978|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4381005|NCT00322049|4207974|B5|||Age||months|Mean|13.6|13.6|Standard Deviation|0.80|0.8|||
4381006|NCT00322049|4207975|B4|||Age||months|Mean|13.6|13.6|Standard Deviation|0.79|0.79|||
4381007|NCT00322049|4207976|B3|||Age||months|Mean|13.6|13.6|Standard Deviation|0.88|0.88|||
4381008|NCT00322049|4207977|B2|||Age||months|Mean|13.3|13.3|Standard Deviation|0.82|0.82|||
4381009|NCT00322049|4207978|B1|||Age||months|Mean|14.0|14.0|Standard Deviation|0.00|0.0|||
4381010|NCT00321984|4208011|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381011|NCT00321984|4208012|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381012|NCT00321984|4208013|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381013|NCT00321984|4208014|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381014|NCT00321984|4208011|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|765|765.0||||||
4381015|NCT00321984|4208012|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|262|262.0||||||
4381016|NCT00321984|4208013|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
4381017|NCT00321984|4208014|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|255|255.0||||||
4381018|NCT00321984|4208011|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
4381019|NCT00321984|4208012|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4381020|NCT00321984|4208013|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4381021|NCT00321984|4208014|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4381022|NCT00321984|4208011|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4381023|NCT00321984|4208012|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4381024|NCT00321984|4208013|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4381025|NCT00321984|4208014|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4381026|NCT00321984|4208011|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4381027|NCT00321984|4208012|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4381028|NCT00321984|4208013|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4381029|NCT00321984|4208014|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4381030|NCT00321984|4208011|B4||White|Race (NIH/OMB)||Participants|Count of Participants|773|773.0||||||
4381031|NCT00321984|4208012|B3||White|Race (NIH/OMB)||Participants|Count of Participants|251|251.0||||||
4381032|NCT00321984|4208013|B2||White|Race (NIH/OMB)||Participants|Count of Participants|267|267.0||||||
4381033|NCT00321984|4208014|B1||White|Race (NIH/OMB)||Participants|Count of Participants|255|255.0||||||
4381034|NCT00321984|4208011|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4381035|NCT00321984|4208012|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4381036|NCT00321984|4208013|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4381037|NCT00321984|4208014|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4381038|NCT00321984|4208011|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4381039|NCT00321984|4208012|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381040|NCT00321984|4208013|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4381041|NCT00321984|4208014|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4381042|NCT00321984|4208011|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4381043|NCT00321984|4208012|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4381044|NCT00321984|4208013|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4381045|NCT00321984|4208014|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4381046|NCT00321984|4208011|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4381047|NCT00321984|4208012|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4381048|NCT00321984|4208013|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381049|NCT00321984|4208014|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4381050|NCT00321984|4208011|B4||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4381051|NCT00321984|4208012|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4381052|NCT00321984|4208013|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4381053|NCT00321984|4208014|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4381054|NCT00321984|4208011|B4||Female|Sex: Female, Male||Participants|Count of Participants|673|673.0||||||
4381055|NCT00321984|4208012|B3||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4381056|NCT00321984|4208013|B2||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4381057|NCT00321984|4208014|B1||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4381058|NCT00321984|4208011|B4|≥65 years||Age, Customized||participants|Number|114|114.0||||||
4381059|NCT00321984|4208012|B3|≥65 years||Age, Customized||participants|Number|40|40.0||||||
4381060|NCT00321984|4208013|B2|≥65 years||Age, Customized||participants|Number|35|35.0||||||
4381061|NCT00321984|4208014|B1|≥65 years||Age, Customized||participants|Number|39|39.0||||||
4381062|NCT00321984|4208011|B4|45 to <65 years||Age, Customized||participants|Number|433|433.0||||||
4381063|NCT00321984|4208012|B3|45 to <65 years||Age, Customized||participants|Number|136|136.0||||||
4381064|NCT00321984|4208013|B2|45 to <65 years||Age, Customized||participants|Number|149|149.0||||||
4381065|NCT00321984|4208014|B1|45 to <65 years||Age, Customized||participants|Number|148|148.0||||||
4381066|NCT00321984|4208011|B4|<45 years||Age, Customized||participants|Number|400|400.0||||||
4381067|NCT00321984|4208012|B3|<45 years||Age, Customized||participants|Number|139|139.0||||||
4381068|NCT00321984|4208013|B2|<45 years||Age, Customized||participants|Number|131|131.0||||||
4381069|NCT00321984|4208014|B1|<45 years||Age, Customized||participants|Number|130|130.0||||||
4381070|NCT00321984|4208011|B4|||Age||years|Mean|47.5|47.5|Standard Deviation|13.90|13.9|||
4381071|NCT00321984|4208012|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|13.77|13.77|||
4381072|NCT00321984|4208013|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|13.55|13.55|||
4381073|NCT00321984|4208014|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|14.40|14.4|||
4381074|NCT00321971|4208033|B3|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
4381075|NCT00321971|4208034|B2|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4381076|NCT00321971|4208035|B1|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4381077|NCT00321971|4208033|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381078|NCT00321971|4208034|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381079|NCT00321971|4208035|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381080|NCT00321971|4208033|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381081|NCT00321971|4208034|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381082|NCT00321971|4208035|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381083|NCT00321971|4208033|B3||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4381084|NCT00321971|4208034|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4381085|NCT00321971|4208035|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4381086|NCT00321971|4208033|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4381087|NCT00321971|4208034|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381088|NCT00321971|4208035|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4381089|NCT00321971|4208033|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381090|NCT00321971|4208034|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381091|NCT00321971|4208035|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381092|NCT00321971|4208033|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381093|NCT00321971|4208034|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381094|NCT00321971|4208035|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381095|NCT00321971|4208033|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381096|NCT00321971|4208034|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381097|NCT00321971|4208035|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381098|NCT00321971|4208033|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381099|NCT00321971|4208034|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381100|NCT00321971|4208035|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381101|NCT00321971|4208033|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4381102|NCT00321971|4208034|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4381103|NCT00321971|4208035|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4381104|NCT00321971|4208033|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381105|NCT00321971|4208034|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381106|NCT00321971|4208035|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381107|NCT00321971|4208033|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4381108|NCT00321971|4208034|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4381109|NCT00321971|4208035|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4381110|NCT00321971|4208033|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4381111|NCT00321971|4208034|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4381112|NCT00321971|4208035|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4381113|NCT00321971|4208033|B3|||Age||Years|Mean|64.98|64.98|Standard Deviation|11.3|11.3|||
4381114|NCT00321971|4208034|B2|||Age||Years|Mean|63.4|63.4|Standard Deviation|13.7|13.7|||
4381115|NCT00321971|4208035|B1|||Age||Years|Mean|66.4|66.4|Standard Deviation|8.0|8.0|||
4381116|NCT00321932|4208042|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4381117|NCT00321932|4208043|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4381118|NCT00321932|4208044|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4381119|NCT00321932|4208042|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4381120|NCT00321932|4208043|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4381121|NCT00321932|4208044|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4381122|NCT00321932|4208042|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4381123|NCT00321932|4208043|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4381124|NCT00321932|4208044|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4381125|NCT00321932|4208042|B3|||Age||years|Mean|51|51.0|Standard Deviation|11|11.0|||
4381126|NCT00321932|4208043|B2|||Age||years|Mean|51|51.0|Standard Deviation|12|12.0|||
4381127|NCT00321932|4208044|B1|||Age||years|Mean|51|51.0|Standard Deviation|10|10.0|||
4381128|NCT00321932|4208042|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4381129|NCT00321932|4208043|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4381130|NCT00321932|4208044|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4381131|NCT00321932|4208042|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4381132|NCT00321932|4208043|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4381133|NCT00321932|4208044|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4381134|NCT00321932|4208042|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4381135|NCT00321932|4208043|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4381136|NCT00321932|4208044|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4381137|NCT00321919|4208067|B3||Male|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4381138|NCT00321919|4208068|B2||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4381139|NCT00321919|4208069|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4381140|NCT00321919|4208067|B3||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4381141|NCT00321919|4208068|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4381142|NCT00321919|4208069|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4381143|NCT00321919|4208067|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|14.14|14.14|||
4381144|NCT00321919|4208068|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|13.73|13.73|||
4381145|NCT00321919|4208069|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|14.57|14.57|||
4381146|NCT00321906|4208110|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4381147|NCT00321906|4208111|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4381148|NCT00321906|4208112|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4381149|NCT00321906|4208110|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4381150|NCT00321906|4208111|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4381151|NCT00321906|4208112|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4381152|NCT00321906|4208110|B3|||Age||years|Median|57|57.0|Inter-Quartile Range|||50.0|61.0|
4381153|NCT00321906|4208111|B2|||Age||years|Median|57|57.0|Inter-Quartile Range|||48.0|60.0|
4381154|NCT00321906|4208112|B1|||Age||years|Median|58|58.0|Inter-Quartile Range|||52.0|62.0|
4381155|NCT00321893|4208133|B3|Italy||Region of Enrollment||participants|Number|202|202.0||||||
4381156|NCT00321893|4208134|B2|Italy||Region of Enrollment||participants|Number|101|101.0||||||
4381157|NCT00321893|4208135|B1|Italy||Region of Enrollment||participants|Number|101|101.0||||||
4381158|NCT00321893|4208133|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4381159|NCT00321893|4208134|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4381160|NCT00321893|4208135|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4381161|NCT00321893|4208133|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4381162|NCT00321893|4208134|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4381163|NCT00321893|4208135|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4381164|NCT00321893|4208133|B3|||Age||years|Median|59|59.0|Full Range|||51.0|75.0|
4381165|NCT00321893|4208134|B2|||Age||years|Median|59|59.0|Full Range|||51.0|75.0|
4381166|NCT00321893|4208135|B1|||Age||years|Median|59|59.0|Full Range|||52.0|72.0|
4381167|NCT00321893|4208133|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4381168|NCT00321893|4208134|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4381169|NCT00321893|4208135|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4381170|NCT00321893|4208133|B3||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
4381171|NCT00321893|4208134|B2||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4381172|NCT00321893|4208135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4381173|NCT00321893|4208133|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4381174|NCT00321893|4208134|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4381175|NCT00321893|4208135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4381176|NCT00321854|4208148|B3||Male|Sex: Female, Male|Treated set (TS)|Participants|Count of Participants|343|343.0||||||
4381177|NCT00321854|4208149|B2||Male|Sex: Female, Male|Treated set (TS)|Participants|Count of Participants|166|166.0||||||
4381178|NCT00321854|4208150|B1||Male|Sex: Female, Male|Treated set (TS)|Participants|Count of Participants|177|177.0||||||
4381179|NCT00321854|4208148|B3||Female|Sex: Female, Male|Treated set (TS)|Participants|Count of Participants|192|192.0||||||
4381180|NCT00321854|4208149|B2||Female|Sex: Female, Male|Treated set (TS)|Participants|Count of Participants|108|108.0||||||
4381181|NCT00321854|4208150|B1||Female|Sex: Female, Male|Treated set (TS)|Participants|Count of Participants|84|84.0||||||
4381182|NCT00321854|4208148|B3|||Age|Treated set (TS)|Years|Mean|62.5|62.5|Standard Deviation|10|10.0|||
4381183|NCT00321854|4208149|B2|||Age|Treated set (TS)|Years|Mean|62.9|62.9|Standard Deviation|9.9|9.9|||
4381184|NCT00321854|4208150|B1|||Age|Treated set (TS)|Years|Mean|62.1|62.1|Standard Deviation|10.1|10.1|||
4381185|NCT00321828|4208269|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4381186|NCT00321828|4208269|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4381187|NCT00321828|4208269|B1|||Age||years|Mean|59|59.0|Standard Deviation|11.2|11.2|||
4381188|NCT00321789|4208273|B3|not relevant (not taking medication)||Missed at least one dose of cholesterol medication in previous 30 days at baseline|Based on self-report to a single item querying whether participants missed doses in the previous 30 days.|participants|Number|136|136.0||||||
4381189|NCT00321789|4208274|B2|not relevant (not taking medication)||Missed at least one dose of cholesterol medication in previous 30 days at baseline|Based on self-report to a single item querying whether participants missed doses in the previous 30 days.|participants|Number|71|71.0||||||
4381190|NCT00321789|4208275|B1|not relevant (not taking medication)||Missed at least one dose of cholesterol medication in previous 30 days at baseline|Based on self-report to a single item querying whether participants missed doses in the previous 30 days.|participants|Number|65|65.0||||||
4381191|NCT00321789|4208273|B3|did not miss at least one dose||Missed at least one dose of cholesterol medication in previous 30 days at baseline|Based on self-report to a single item querying whether participants missed doses in the previous 30 days.|participants|Number|60|60.0||||||
4381192|NCT00321789|4208274|B2|did not miss at least one dose||Missed at least one dose of cholesterol medication in previous 30 days at baseline|Based on self-report to a single item querying whether participants missed doses in the previous 30 days.|participants|Number|29|29.0||||||
4381193|NCT00321789|4208275|B1|did not miss at least one dose||Missed at least one dose of cholesterol medication in previous 30 days at baseline|Based on self-report to a single item querying whether participants missed doses in the previous 30 days.|participants|Number|31|31.0||||||
4381194|NCT00321789|4208273|B3|missed at least one dose||Missed at least one dose of cholesterol medication in previous 30 days at baseline|Based on self-report to a single item querying whether participants missed doses in the previous 30 days.|participants|Number|59|59.0||||||
4381195|NCT00321789|4208274|B2|missed at least one dose||Missed at least one dose of cholesterol medication in previous 30 days at baseline|Based on self-report to a single item querying whether participants missed doses in the previous 30 days.|participants|Number|28|28.0||||||
4381196|NCT00321789|4208275|B1|missed at least one dose||Missed at least one dose of cholesterol medication in previous 30 days at baseline|Based on self-report to a single item querying whether participants missed doses in the previous 30 days.|participants|Number|31|31.0||||||
4381197|NCT00321789|4208273|B3|not taking cholesterol medication||number of participants prescribed cholesterol medication at baseline||participants|Number|136|136.0||||||
4381198|NCT00321789|4208274|B2|not taking cholesterol medication||number of participants prescribed cholesterol medication at baseline||participants|Number|71|71.0||||||
4381199|NCT00321789|4208275|B1|not taking cholesterol medication||number of participants prescribed cholesterol medication at baseline||participants|Number|65|65.0||||||
4381200|NCT00321789|4208273|B3|taking cholesterol medication||number of participants prescribed cholesterol medication at baseline||participants|Number|119|119.0||||||
4381201|NCT00321789|4208274|B2|taking cholesterol medication||number of participants prescribed cholesterol medication at baseline||participants|Number|57|57.0||||||
4381202|NCT00321789|4208275|B1|taking cholesterol medication||number of participants prescribed cholesterol medication at baseline||participants|Number|62|62.0||||||
4381203|NCT00321789|4208273|B3|did not meet goal||number of participants who met goal for low-density lipoprotein cholesterol at baseline|Goal is determined by 2003 National Cholesterol Education Program guidelines. Goal could be 160mg/dL for low risk (no coronary heart disease (CHD), 0-1 risk factor); 130 mg/dL for medium risk (no CHD, at least 2 risk factors); or 100 mg/dL for high risk (CHD and risk equivalents including diabetes, atherosclerotic disease, and multiple risk factors that confer a 10-year risk for CHD >20% per Framingham score).|participants|Number|148|148.0||||||
4381204|NCT00321789|4208274|B2|did not meet goal||number of participants who met goal for low-density lipoprotein cholesterol at baseline|Goal is determined by 2003 National Cholesterol Education Program guidelines. Goal could be 160mg/dL for low risk (no coronary heart disease (CHD), 0-1 risk factor); 130 mg/dL for medium risk (no CHD, at least 2 risk factors); or 100 mg/dL for high risk (CHD and risk equivalents including diabetes, atherosclerotic disease, and multiple risk factors that confer a 10-year risk for CHD >20% per Framingham score).|participants|Number|66|66.0||||||
4381205|NCT00321789|4208275|B1|did not meet goal||number of participants who met goal for low-density lipoprotein cholesterol at baseline|Goal is determined by 2003 National Cholesterol Education Program guidelines. Goal could be 160mg/dL for low risk (no coronary heart disease (CHD), 0-1 risk factor); 130 mg/dL for medium risk (no CHD, at least 2 risk factors); or 100 mg/dL for high risk (CHD and risk equivalents including diabetes, atherosclerotic disease, and multiple risk factors that confer a 10-year risk for CHD >20% per Framingham score).|participants|Number|82|82.0||||||
4381255|NCT00321789|4208274|B2|some high school||Education||participants|Number|6|6.0||||||
4381256|NCT00321789|4208275|B1|some high school||Education||participants|Number|4|4.0||||||
4381257|NCT00321789|4208273|B3|8th grade or less||Education||participants|Number|4|4.0||||||
4381206|NCT00321789|4208273|B3|met goal||number of participants who met goal for low-density lipoprotein cholesterol at baseline|Goal is determined by 2003 National Cholesterol Education Program guidelines. Goal could be 160mg/dL for low risk (no coronary heart disease (CHD), 0-1 risk factor); 130 mg/dL for medium risk (no CHD, at least 2 risk factors); or 100 mg/dL for high risk (CHD and risk equivalents including diabetes, atherosclerotic disease, and multiple risk factors that confer a 10-year risk for CHD >20% per Framingham score).|participants|Number|107|107.0||||||
4381207|NCT00321789|4208274|B2|met goal||number of participants who met goal for low-density lipoprotein cholesterol at baseline|Goal is determined by 2003 National Cholesterol Education Program guidelines. Goal could be 160mg/dL for low risk (no coronary heart disease (CHD), 0-1 risk factor); 130 mg/dL for medium risk (no CHD, at least 2 risk factors); or 100 mg/dL for high risk (CHD and risk equivalents including diabetes, atherosclerotic disease, and multiple risk factors that confer a 10-year risk for CHD >20% per Framingham score).|participants|Number|62|62.0||||||
4381208|NCT00321789|4208275|B1|met goal||number of participants who met goal for low-density lipoprotein cholesterol at baseline|Goal is determined by 2003 National Cholesterol Education Program guidelines. Goal could be 160mg/dL for low risk (no coronary heart disease (CHD), 0-1 risk factor); 130 mg/dL for medium risk (no CHD, at least 2 risk factors); or 100 mg/dL for high risk (CHD and risk equivalents including diabetes, atherosclerotic disease, and multiple risk factors that confer a 10-year risk for CHD >20% per Framingham score).|participants|Number|45|45.0||||||
4381209|NCT00321789|4208273|B3|low or moderate risk||High risk for cardiovascular event based on Framingham score||participants|Number|211|211.0||||||
4381210|NCT00321789|4208274|B2|low or moderate risk||High risk for cardiovascular event based on Framingham score||participants|Number|109|109.0||||||
4381211|NCT00321789|4208275|B1|low or moderate risk||High risk for cardiovascular event based on Framingham score||participants|Number|102|102.0||||||
4381212|NCT00321789|4208273|B3|high risk||High risk for cardiovascular event based on Framingham score||participants|Number|44|44.0||||||
4381213|NCT00321789|4208274|B2|high risk||High risk for cardiovascular event based on Framingham score||participants|Number|19|19.0||||||
4381214|NCT00321789|4208275|B1|high risk||High risk for cardiovascular event based on Framingham score||participants|Number|25|25.0||||||
4381215|NCT00321789|4208273|B3|not reported||Employment status||participants|Number|4|4.0||||||
4381216|NCT00321789|4208274|B2|not reported||Employment status||participants|Number|1|1.0||||||
4381217|NCT00321789|4208275|B1|not reported||Employment status||participants|Number|3|3.0||||||
4381218|NCT00321789|4208273|B3|disabled||Employment status||participants|Number|13|13.0||||||
4381219|NCT00321789|4208274|B2|disabled||Employment status||participants|Number|5|5.0||||||
4381220|NCT00321789|4208275|B1|disabled||Employment status||participants|Number|8|8.0||||||
4381221|NCT00321789|4208273|B3|retired||Employment status||participants|Number|90|90.0||||||
4381222|NCT00321789|4208274|B2|retired||Employment status||participants|Number|47|47.0||||||
4381223|NCT00321789|4208275|B1|retired||Employment status||participants|Number|43|43.0||||||
4381224|NCT00321789|4208273|B3|unemployed, not searching for work||Employment status||participants|Number|5|5.0||||||
4381225|NCT00321789|4208274|B2|unemployed, not searching for work||Employment status||participants|Number|2|2.0||||||
4381226|NCT00321789|4208275|B1|unemployed, not searching for work||Employment status||participants|Number|3|3.0||||||
4381227|NCT00321789|4208273|B3|unemployed, searching for work||Employment status||participants|Number|10|10.0||||||
4381228|NCT00321789|4208274|B2|unemployed, searching for work||Employment status||participants|Number|5|5.0||||||
4381229|NCT00321789|4208275|B1|unemployed, searching for work||Employment status||participants|Number|5|5.0||||||
4381230|NCT00321789|4208273|B3|working part time||Employment status||participants|Number|29|29.0||||||
4381231|NCT00321789|4208274|B2|working part time||Employment status||participants|Number|10|10.0||||||
4381232|NCT00321789|4208275|B1|working part time||Employment status||participants|Number|19|19.0||||||
4381233|NCT00321789|4208273|B3|working full time||Employment status||participants|Number|104|104.0||||||
4381234|NCT00321789|4208274|B2|working full time||Employment status||participants|Number|58|58.0||||||
4381235|NCT00321789|4208275|B1|working full time||Employment status||participants|Number|46|46.0||||||
4381236|NCT00321789|4208273|B3|not reported||Education||participants|Number|4|4.0||||||
4381237|NCT00321789|4208274|B2|not reported||Education||participants|Number|1|1.0||||||
4381238|NCT00321789|4208275|B1|not reported||Education||participants|Number|3|3.0||||||
4381239|NCT00321789|4208273|B3|Graduate or professional degree||Education||participants|Number|31|31.0||||||
4381240|NCT00321789|4208274|B2|Graduate or professional degree||Education||participants|Number|15|15.0||||||
4381241|NCT00321789|4208275|B1|Graduate or professional degree||Education||participants|Number|16|16.0||||||
4381242|NCT00321789|4208273|B3|Bachelor's degree||Education||participants|Number|47|47.0||||||
4381243|NCT00321789|4208274|B2|Bachelor's degree||Education||participants|Number|28|28.0||||||
4381244|NCT00321789|4208275|B1|Bachelor's degree||Education||participants|Number|19|19.0||||||
4381245|NCT00321789|4208273|B3|Associate's degree||Education||participants|Number|44|44.0||||||
4381246|NCT00321789|4208274|B2|Associate's degree||Education||participants|Number|21|21.0||||||
4381247|NCT00321789|4208275|B1|Associate's degree||Education||participants|Number|23|23.0||||||
4381248|NCT00321789|4208273|B3|some college or vocational training, no degree||Education||participants|Number|69|69.0||||||
4381249|NCT00321789|4208274|B2|some college or vocational training, no degree||Education||participants|Number|35|35.0||||||
4381250|NCT00321789|4208275|B1|some college or vocational training, no degree||Education||participants|Number|34|34.0||||||
4381251|NCT00321789|4208273|B3|high school degree or equivalent||Education||participants|Number|46|46.0||||||
4381252|NCT00321789|4208274|B2|high school degree or equivalent||Education||participants|Number|20|20.0||||||
4381253|NCT00321789|4208275|B1|high school degree or equivalent||Education||participants|Number|26|26.0||||||
4381254|NCT00321789|4208273|B3|some high school||Education||participants|Number|10|10.0||||||
4381258|NCT00321789|4208274|B2|8th grade or less||Education||participants|Number|2|2.0||||||
4381259|NCT00321789|4208275|B1|8th grade or less||Education||participants|Number|2|2.0||||||
4381260|NCT00321789|4208273|B3|United States||Region of Enrollment||participants|Number|255|255.0||||||
4381261|NCT00321789|4208274|B2|United States||Region of Enrollment||participants|Number|128|128.0||||||
4381262|NCT00321789|4208275|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
4381263|NCT00321789|4208273|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4381264|NCT00321789|4208274|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4381265|NCT00321789|4208275|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4381266|NCT00321789|4208273|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381267|NCT00321789|4208274|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381268|NCT00321789|4208275|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381269|NCT00321789|4208273|B3||White|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
4381270|NCT00321789|4208274|B2||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4381271|NCT00321789|4208275|B1||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4381272|NCT00321789|4208273|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4381273|NCT00321789|4208274|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4381274|NCT00321789|4208275|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4381275|NCT00321789|4208273|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381276|NCT00321789|4208274|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381277|NCT00321789|4208275|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381278|NCT00321789|4208273|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381279|NCT00321789|4208274|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381280|NCT00321789|4208275|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381281|NCT00321789|4208273|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4381282|NCT00321789|4208274|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4381283|NCT00321789|4208275|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4381284|NCT00321789|4208273|B3||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4381285|NCT00321789|4208274|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4381286|NCT00321789|4208275|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4381287|NCT00321789|4208273|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4381288|NCT00321789|4208274|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4381289|NCT00321789|4208275|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4381290|NCT00321789|4208273|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|12.3|12.3|||
4381291|NCT00321789|4208274|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|12.2|12.2|||
4381292|NCT00321789|4208275|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|12.3|12.3|||
4381293|NCT00321763|4208304|B5||Male|Sex: Female, Male||Participants|Count of Participants|1379|1379.0||||||
4381294|NCT00321763|4208305|B4||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4381295|NCT00321763|4208306|B3||Male|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
4381296|NCT00321763|4208307|B2||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
4381297|NCT00321763|4208308|B1||Male|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
4381298|NCT00321763|4208304|B5||Female|Sex: Female, Male||Participants|Count of Participants|1745|1745.0||||||
4381299|NCT00321763|4208305|B4||Female|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4381300|NCT00321763|4208306|B3||Female|Sex: Female, Male||Participants|Count of Participants|479|479.0||||||
4381301|NCT00321763|4208307|B2||Female|Sex: Female, Male||Participants|Count of Participants|451|451.0||||||
4381302|NCT00321763|4208308|B1||Female|Sex: Female, Male||Participants|Count of Participants|475|475.0||||||
4381303|NCT00321763|4208304|B5|||Age||Years|Mean|68.6|68.6|Standard Deviation|6.33|6.33|||
4381304|NCT00321763|4208305|B4|||Age||Years|Mean|68.3|68.3|Standard Deviation|6.15|6.15|||
4381305|NCT00321763|4208306|B3|||Age||Years|Mean|68.7|68.7|Standard Deviation|6.54|6.54|||
4381306|NCT00321763|4208307|B2|||Age||Years|Mean|68.8|68.8|Standard Deviation|6.43|6.43|||
4381307|NCT00321763|4208308|B1|||Age||Years|Mean|68.4|68.4|Standard Deviation|6.17|6.17|||
4381308|NCT00321737|4208368|B4|D: ≥1 mucosal break ≥75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|21|21.0||||||
4381309|NCT00321737|4208369|B3|D: ≥1 mucosal break ≥75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|6|6.0||||||
4381310|NCT00321737|4208370|B2|D: ≥1 mucosal break ≥75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|10|10.0||||||
4381349|NCT00321737|4208369|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4381473|NCT00321685|4208455|B1|T3||Clinical T stage||participants|Number|49|49.0||||||
4381311|NCT00321737|4208371|B1|D: ≥1 mucosal break ≥75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|5|5.0||||||
4381312|NCT00321737|4208368|B4|C: ≥1 mucosal break <75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|104|104.0||||||
4381313|NCT00321737|4208369|B3|C: ≥1 mucosal break <75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|39|39.0||||||
4381314|NCT00321737|4208370|B2|C: ≥1 mucosal break <75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|31|31.0||||||
4381315|NCT00321737|4208371|B1|C: ≥1 mucosal break <75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|34|34.0||||||
4381316|NCT00321737|4208368|B4|B: ≥1 mucosal break ≥5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|160|160.0||||||
4381317|NCT00321737|4208369|B3|B: ≥1 mucosal break ≥5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|57|57.0||||||
4381318|NCT00321737|4208370|B2|B: ≥1 mucosal break ≥5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|46|46.0||||||
4381319|NCT00321737|4208371|B1|B: ≥1 mucosal break ≥5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|57|57.0||||||
4381320|NCT00321737|4208368|B4|A: ≥1 mucosal break <5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|160|160.0||||||
4381321|NCT00321737|4208369|B3|A: ≥1 mucosal break <5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|56|56.0||||||
4381322|NCT00321737|4208370|B2|A: ≥1 mucosal break <5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|53|53.0||||||
4381323|NCT00321737|4208371|B1|A: ≥1 mucosal break <5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693) and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|51|51.0||||||
4381324|NCT00321737|4208368|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381325|NCT00321737|4208369|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381326|NCT00321737|4208370|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381327|NCT00321737|4208371|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381328|NCT00321737|4208368|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|385|385.0||||||
4381329|NCT00321737|4208369|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
4381330|NCT00321737|4208370|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4381331|NCT00321737|4208371|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4381332|NCT00321737|4208368|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4381333|NCT00321737|4208369|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4381334|NCT00321737|4208370|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4381335|NCT00321737|4208371|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4381336|NCT00321737|4208368|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4381337|NCT00321737|4208369|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381338|NCT00321737|4208370|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381339|NCT00321737|4208371|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4381340|NCT00321737|4208368|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4381341|NCT00321737|4208369|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4381342|NCT00321737|4208370|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4381343|NCT00321737|4208371|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4381344|NCT00321737|4208368|B4||White|Race (NIH/OMB)||Participants|Count of Participants|400|400.0||||||
4381345|NCT00321737|4208369|B3||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
4381346|NCT00321737|4208370|B2||White|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4381347|NCT00321737|4208371|B1||White|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4381348|NCT00321737|4208368|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4381350|NCT00321737|4208370|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4381351|NCT00321737|4208371|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4381352|NCT00321737|4208368|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4381353|NCT00321737|4208369|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4381354|NCT00321737|4208370|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381355|NCT00321737|4208371|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381356|NCT00321737|4208368|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4381357|NCT00321737|4208369|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4381358|NCT00321737|4208370|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4381359|NCT00321737|4208371|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4381360|NCT00321737|4208368|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4381361|NCT00321737|4208369|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4381362|NCT00321737|4208370|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381363|NCT00321737|4208371|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381364|NCT00321737|4208368|B4||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4381365|NCT00321737|4208369|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4381366|NCT00321737|4208370|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4381367|NCT00321737|4208371|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4381368|NCT00321737|4208368|B4||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4381369|NCT00321737|4208369|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4381370|NCT00321737|4208370|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4381371|NCT00321737|4208371|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4381372|NCT00321737|4208368|B4|≥65 years||Age, Customized||participants|Number|36|36.0||||||
4381373|NCT00321737|4208369|B3|≥65 years||Age, Customized||participants|Number|11|11.0||||||
4381374|NCT00321737|4208370|B2|≥65 years||Age, Customized||participants|Number|11|11.0||||||
4381375|NCT00321737|4208371|B1|≥65 years||Age, Customized||participants|Number|14|14.0||||||
4381376|NCT00321737|4208368|B4|45 - <65 years||Age, Customized||participants|Number|247|247.0||||||
4381377|NCT00321737|4208369|B3|45 - <65 years||Age, Customized||participants|Number|89|89.0||||||
4381378|NCT00321737|4208370|B2|45 - <65 years||Age, Customized||participants|Number|75|75.0||||||
4381379|NCT00321737|4208371|B1|45 - <65 years||Age, Customized||participants|Number|83|83.0||||||
4381380|NCT00321737|4208368|B4|<45 years||Age, Customized||participants|Number|162|162.0||||||
4381381|NCT00321737|4208369|B3|<45 years||Age, Customized||participants|Number|58|58.0||||||
4381382|NCT00321737|4208370|B2|<45 years||Age, Customized||participants|Number|54|54.0||||||
4381383|NCT00321737|4208371|B1|<45 years||Age, Customized||participants|Number|50|50.0||||||
4381384|NCT00321737|4208368|B4|||Age||years|Mean|48.2|48.2|Standard Deviation|12.60|12.6|||
4381385|NCT00321737|4208369|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|11.72|11.72|||
4381386|NCT00321737|4208370|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|13.15|13.15|||
4381387|NCT00321737|4208371|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|12.94|12.94|||
4381388|NCT00321711|4208396|B6|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4381389|NCT00321711|4208397|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4381390|NCT00321711|4208398|B4|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4381391|NCT00321711|4208399|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4381392|NCT00321711|4208400|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4381393|NCT00321711|4208401|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4381394|NCT00321711|4208396|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4381395|NCT00321711|4208397|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4381396|NCT00321711|4208398|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4381397|NCT00321711|4208399|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4381398|NCT00321711|4208400|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4381399|NCT00321711|4208401|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4381400|NCT00321711|4208396|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4381401|NCT00321711|4208397|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4381402|NCT00321711|4208398|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4381403|NCT00321711|4208399|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4381404|NCT00321711|4208400|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4381405|NCT00321711|4208401|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4381406|NCT00321711|4208396|B6|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4381407|NCT00321711|4208397|B5|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4381408|NCT00321711|4208398|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4381472|NCT00321685|4208455|B1|T4||Clinical T stage||participants|Number|4|4.0||||||
4381409|NCT00321711|4208399|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4381410|NCT00321711|4208400|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4381411|NCT00321711|4208401|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4381412|NCT00321711|4208396|B6||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4381413|NCT00321711|4208397|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4381414|NCT00321711|4208398|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4381415|NCT00321711|4208399|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4381416|NCT00321711|4208400|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4381417|NCT00321711|4208401|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4381418|NCT00321711|4208396|B6||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4381419|NCT00321711|4208397|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4381420|NCT00321711|4208398|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4381421|NCT00321711|4208399|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4381422|NCT00321711|4208400|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4381423|NCT00321711|4208401|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4381424|NCT00321711|4208396|B6|||Age||Years|Mean|69.8|69.8|Full Range|||52.0|86.0|
4381425|NCT00321711|4208397|B5|||Age||Years|Mean|68.2|68.2|Full Range|||55.0|81.0|
4381426|NCT00321711|4208398|B4|||Age||Years|Mean|70.5|70.5|Full Range|||52.0|84.0|
4381427|NCT00321711|4208399|B3|||Age||Years|Mean|71.4|71.4|Full Range|||61.0|81.0|
4381428|NCT00321711|4208400|B2|||Age||Years|Mean|71.9|71.9|Full Range|||56.0|86.0|
4381429|NCT00321711|4208401|B1|||Age||Years|Mean|67.3|67.3|Full Range|||58.0|86.0|
4381430|NCT00321698|4208432|B6|United States||Region of Enrollment||participants|Number|25|25.0||||||
4381431|NCT00321698|4208433|B5|United States||Region of Enrollment||participants|Number|13|13.0||||||
4381432|NCT00321698|4208434|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4381433|NCT00321698|4208435|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4381434|NCT00321698|4208436|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4381435|NCT00321698|4208437|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4381436|NCT00321698|4208432|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4381437|NCT00321698|4208433|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4381438|NCT00321698|4208434|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4381439|NCT00321698|4208435|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4381440|NCT00321698|4208436|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4381441|NCT00321698|4208437|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4381442|NCT00321698|4208432|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4381443|NCT00321698|4208433|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4381444|NCT00321698|4208434|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4381445|NCT00321698|4208435|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4381446|NCT00321698|4208436|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4381447|NCT00321698|4208437|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4381448|NCT00321698|4208432|B6|||Age||years|Mean|61.92|61.92|Standard Deviation|5.89|5.89|||
4381449|NCT00321698|4208433|B5|||Age||years|Mean|60.54|60.54|Standard Deviation|4.58|4.58|||
4381450|NCT00321698|4208434|B4|||Age||years|Mean|58.00|58.0|Standard Deviation|6.56|6.56|||
4381451|NCT00321698|4208435|B3|||Age||years|Mean|66.33|66.33|Standard Deviation|4.93|4.93|||
4381452|NCT00321698|4208436|B2|||Age||years|Mean|62.67|62.67|Standard Deviation|7.64|7.64|||
4381453|NCT00321698|4208437|B1|||Age||years|Mean|66.67|66.67|Standard Deviation|8.14|8.14|||
4381454|NCT00321698|4208432|B6||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4381455|NCT00321698|4208433|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4381456|NCT00321698|4208434|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4381457|NCT00321698|4208435|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4381458|NCT00321698|4208436|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4381459|NCT00321698|4208437|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4381460|NCT00321698|4208432|B6||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4381461|NCT00321698|4208433|B5||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4381462|NCT00321698|4208434|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4381463|NCT00321698|4208435|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4381464|NCT00321698|4208436|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4381465|NCT00321698|4208437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4381466|NCT00321698|4208432|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4381467|NCT00321698|4208433|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4381468|NCT00321698|4208434|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4381469|NCT00321698|4208435|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4381470|NCT00321698|4208436|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4381471|NCT00321698|4208437|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4381474|NCT00321685|4208455|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4381475|NCT00321685|4208455|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4381476|NCT00321685|4208455|B1|||Age||years|Median|54|54.0|Full Range|||25.0|83.0|
4381477|NCT00321672|4208463|B5||Male|Sex: Female, Male|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|Participants|Count of Participants|432|432.0||||||
4381478|NCT00321672|4208464|B4||Male|Sex: Female, Male|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|Participants|Count of Participants|63|63.0||||||
4381479|NCT00321672|4208465|B3||Male|Sex: Female, Male|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|Participants|Count of Participants|142|142.0||||||
4381480|NCT00321672|4208466|B2||Male|Sex: Female, Male|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|Participants|Count of Participants|79|79.0||||||
4381481|NCT00321672|4208467|B1||Male|Sex: Female, Male|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|Participants|Count of Participants|148|148.0||||||
4381482|NCT00321672|4208463|B5||Female|Sex: Female, Male|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|Participants|Count of Participants|62|62.0||||||
4381483|NCT00321672|4208464|B4||Female|Sex: Female, Male|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|Participants|Count of Participants|9|9.0||||||
4381484|NCT00321672|4208465|B3||Female|Sex: Female, Male|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|Participants|Count of Participants|25|25.0||||||
4381485|NCT00321672|4208466|B2||Female|Sex: Female, Male|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|Participants|Count of Participants|11|11.0||||||
4381486|NCT00321672|4208467|B1||Female|Sex: Female, Male|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|Participants|Count of Participants|17|17.0||||||
4381487|NCT00321672|4208463|B5|||Age|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|years|Mean|49.7|49.7|Standard Deviation|8.5|8.5|||
4381488|NCT00321672|4208464|B4|||Age|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|years|Mean|49.3|49.3|Standard Deviation|7.78|7.78|||
4381489|NCT00321672|4208465|B3|||Age|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|years|Mean|50.5|50.5|Standard Deviation|8.34|8.34|||
4381490|NCT00321672|4208466|B2|||Age|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|years|Mean|50.1|50.1|Standard Deviation|9.33|9.33|||
4381491|NCT00321672|4208467|B1|||Age|"60 minutes control group - one randomized 30 minutes received 60 minutes. Under 30 for efficacy and under 60~30 minutes control goup, one randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety."|years|Mean|49.0|49.0|Standard Deviation|8.52|8.52|||
4381492|NCT00321646|4208496|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4381493|NCT00321646|4208496|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4381494|NCT00321646|4208496|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4381495|NCT00321646|4208496|B1|Between 18 and 65 years||Age||year|Median|55|55.0|Full Range|||41.0|67.0|
4381496|NCT00321620|4208501|B3|No||Current Prostate Cancer Chemotherapy Stratification Factor|Defined as within 6 weeks before randomization|Participants|Number|1637|1637.0||||||
4381497|NCT00321620|4208502|B2|No||Current Prostate Cancer Chemotherapy Stratification Factor|Defined as within 6 weeks before randomization|Participants|Number|818|818.0||||||
4381498|NCT00321620|4208503|B1|No||Current Prostate Cancer Chemotherapy Stratification Factor|Defined as within 6 weeks before randomization|Participants|Number|819|819.0||||||
4381499|NCT00321620|4208501|B3|Yes||Current Prostate Cancer Chemotherapy Stratification Factor|Defined as within 6 weeks before randomization|Participants|Number|264|264.0||||||
4381500|NCT00321620|4208502|B2|Yes||Current Prostate Cancer Chemotherapy Stratification Factor|Defined as within 6 weeks before randomization|Participants|Number|132|132.0||||||
4381501|NCT00321620|4208503|B1|Yes||Current Prostate Cancer Chemotherapy Stratification Factor|Defined as within 6 weeks before randomization|Participants|Number|132|132.0||||||
4381502|NCT00321620|4208501|B3|No||Previous Skeletal-Related Event (SRE) Stratification Factor||Participants|Number|1438|1438.0||||||
4381503|NCT00321620|4208502|B2|No||Previous Skeletal-Related Event (SRE) Stratification Factor||Participants|Number|718|718.0||||||
4381504|NCT00321620|4208503|B1|No||Previous Skeletal-Related Event (SRE) Stratification Factor||Participants|Number|720|720.0||||||
4381505|NCT00321620|4208501|B3|Yes||Previous Skeletal-Related Event (SRE) Stratification Factor||Participants|Number|463|463.0||||||
4381506|NCT00321620|4208502|B2|Yes||Previous Skeletal-Related Event (SRE) Stratification Factor||Participants|Number|232|232.0||||||
4381507|NCT00321620|4208503|B1|Yes||Previous Skeletal-Related Event (SRE) Stratification Factor||Participants|Number|231|231.0||||||
4381508|NCT00321620|4208501|B3|PSA level ≥ 10 ng/mL||Prostate-Specific Antigen (PSA) Stratification Factor||Participants|Number|1611|1611.0||||||
4381509|NCT00321620|4208502|B2|PSA level ≥ 10 ng/mL||Prostate-Specific Antigen (PSA) Stratification Factor||Participants|Number|805|805.0||||||
4381510|NCT00321620|4208503|B1|PSA level ≥ 10 ng/mL||Prostate-Specific Antigen (PSA) Stratification Factor||Participants|Number|806|806.0||||||
4381511|NCT00321620|4208501|B3|PSA level < 10 ng/mL||Prostate-Specific Antigen (PSA) Stratification Factor||Participants|Number|290|290.0||||||
4381512|NCT00321620|4208502|B2|PSA level < 10 ng/mL||Prostate-Specific Antigen (PSA) Stratification Factor||Participants|Number|145|145.0||||||
4381513|NCT00321620|4208503|B1|PSA level < 10 ng/mL||Prostate-Specific Antigen (PSA) Stratification Factor||Participants|Number|145|145.0||||||
4381514|NCT00321620|4208501|B3|Other||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4381515|NCT00321620|4208502|B2|Other||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4381516|NCT00321620|4208503|B1|Other||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4381517|NCT00321620|4208501|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4381518|NCT00321620|4208502|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4381519|NCT00321620|4208503|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4381520|NCT00321620|4208501|B3|Asian||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
4381521|NCT00321620|4208502|B2|Asian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4381522|NCT00321620|4208503|B1|Asian||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4381523|NCT00321620|4208501|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
4381524|NCT00321620|4208502|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4381525|NCT00321620|4208503|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4381526|NCT00321620|4208501|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|73|73.0||||||
4381527|NCT00321620|4208502|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4381528|NCT00321620|4208503|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4381529|NCT00321620|4208501|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|1639|1639.0||||||
4381530|NCT00321620|4208502|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|829|829.0||||||
4381531|NCT00321620|4208503|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|810|810.0||||||
4381532|NCT00321620|4208501|B3||Male|Sex: Female, Male||Participants|Count of Participants|1901|1901.0||||||
4381533|NCT00321620|4208502|B2||Male|Sex: Female, Male||Participants|Count of Participants|950|950.0||||||
4381534|NCT00321620|4208503|B1||Male|Sex: Female, Male||Participants|Count of Participants|951|951.0||||||
4381535|NCT00321620|4208501|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4381536|NCT00321620|4208502|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4381537|NCT00321620|4208503|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4381538|NCT00321620|4208501|B3|||Age||Years|Mean|70.8|70.8|Standard Deviation|8.6|8.6|||
4381539|NCT00321620|4208502|B2|||Age||Years|Mean|70.5|70.5|Standard Deviation|8.7|8.7|||
4381540|NCT00321620|4208503|B1|||Age||Years|Mean|71.0|71.0|Standard Deviation|8.4|8.4|||
4381541|NCT00321594|4208514|B3|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4381542|NCT00321594|4208515|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4381543|NCT00321594|4208516|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4381544|NCT00321594|4208514|B3|South Korea||Region of Enrollment||participants|Number|5|5.0||||||
4381545|NCT00321594|4208515|B2|South Korea||Region of Enrollment||participants|Number|5|5.0||||||
4381546|NCT00321594|4208516|B1|South Korea||Region of Enrollment||participants|Number|0|0.0||||||
4381547|NCT00321594|4208514|B3|Hong Kong||Region of Enrollment||participants|Number|44|44.0||||||
4381548|NCT00321594|4208515|B2|Hong Kong||Region of Enrollment||participants|Number|34|34.0||||||
4381549|NCT00321594|4208516|B1|Hong Kong||Region of Enrollment||participants|Number|10|10.0||||||
4381550|NCT00321594|4208514|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4381551|NCT00321594|4208515|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4381552|NCT00321594|4208516|B1|United States||Region of Enrollment||participants|Number|0|0.0||||||
4381553|NCT00321594|4208514|B3|Singapore||Region of Enrollment||participants|Number|3|3.0||||||
4381554|NCT00321594|4208515|B2|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4381555|NCT00321594|4208516|B1|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4381556|NCT00321594|4208514|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381557|NCT00321594|4208515|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381558|NCT00321594|4208516|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381559|NCT00321594|4208514|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381560|NCT00321594|4208515|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381561|NCT00321594|4208516|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381562|NCT00321594|4208514|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381563|NCT00321594|4208515|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381564|NCT00321594|4208516|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381565|NCT00321594|4208514|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381566|NCT00321594|4208515|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381567|NCT00321594|4208516|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381568|NCT00321594|4208514|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381569|NCT00321594|4208515|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381570|NCT00321594|4208516|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381571|NCT00321594|4208514|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4381572|NCT00321594|4208515|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4381573|NCT00321594|4208516|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4381574|NCT00321594|4208514|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381575|NCT00321594|4208515|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381576|NCT00321594|4208516|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381577|NCT00321594|4208514|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4381578|NCT00321594|4208515|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4381579|NCT00321594|4208516|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4381580|NCT00321594|4208514|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4381581|NCT00321594|4208515|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4381582|NCT00321594|4208516|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4381583|NCT00321594|4208514|B3|||Age||year|Median|56.5|56.5|Full Range|||35.0|76.0|
4381584|NCT00321594|4208515|B2|||Age||year|Median|57.5|57.5|Full Range|||35.0|76.0|
4381585|NCT00321594|4208516|B1|||Age||year|Median|54|54.0|Full Range|||38.0|68.0|
4381586|NCT00321464|4208532|B3|No||Japan Stratification Factor|Participant located in Japan|Participants|Number|1910|1910.0||||||
4381587|NCT00321464|4208533|B2|No||Japan Stratification Factor|Participant located in Japan|Participants|Number|957|957.0||||||
4381588|NCT00321464|4208534|B1|No||Japan Stratification Factor|Participant located in Japan|Participants|Number|953|953.0||||||
4381589|NCT00321464|4208532|B3|Yes||Japan Stratification Factor|Participant located in Japan|Participants|Number|136|136.0||||||
4381590|NCT00321464|4208533|B2|Yes||Japan Stratification Factor|Participant located in Japan|Participants|Number|69|69.0||||||
4381591|NCT00321464|4208534|B1|Yes||Japan Stratification Factor|Participant located in Japan|Participants|Number|67|67.0||||||
4381592|NCT00321464|4208532|B3|No||Current Chemotherapy Stratification Factor|Defined as within 6 weeks before randomization|Participants|Number|1228|1228.0||||||
4381593|NCT00321464|4208533|B2|No||Current Chemotherapy Stratification Factor|Defined as within 6 weeks before randomization|Participants|Number|616|616.0||||||
4381594|NCT00321464|4208534|B1|No||Current Chemotherapy Stratification Factor|Defined as within 6 weeks before randomization|Participants|Number|612|612.0||||||
4381595|NCT00321464|4208532|B3|Yes||Current Chemotherapy Stratification Factor|Defined as within 6 weeks before randomization|Participants|Number|818|818.0||||||
4381596|NCT00321464|4208533|B2|Yes||Current Chemotherapy Stratification Factor|Defined as within 6 weeks before randomization|Participants|Number|410|410.0||||||
4381597|NCT00321464|4208534|B1|Yes||Current Chemotherapy Stratification Factor|Defined as within 6 weeks before randomization|Participants|Number|408|408.0||||||
4381598|NCT00321464|4208532|B3|No||Prior Oral Bisphosphonate Use Stratification Factor||Participants|Number|1966|1966.0||||||
4381599|NCT00321464|4208533|B2|No||Prior Oral Bisphosphonate Use Stratification Factor||Participants|Number|984|984.0||||||
4381600|NCT00321464|4208534|B1|No||Prior Oral Bisphosphonate Use Stratification Factor||Participants|Number|982|982.0||||||
4381601|NCT00321464|4208532|B3|Yes||Prior Oral Bisphosphonate Use Stratification Factor||Participants|Number|80|80.0||||||
4381602|NCT00321464|4208533|B2|Yes||Prior Oral Bisphosphonate Use Stratification Factor||Participants|Number|42|42.0||||||
4381603|NCT00321464|4208534|B1|Yes||Prior Oral Bisphosphonate Use Stratification Factor||Participants|Number|38|38.0||||||
4381604|NCT00321464|4208532|B3|No||Previous Skeletal-Related Event Stratification Factor||Participants|Number|1295|1295.0||||||
4381605|NCT00321464|4208533|B2|No||Previous Skeletal-Related Event Stratification Factor||Participants|Number|648|648.0||||||
4381606|NCT00321464|4208534|B1|No||Previous Skeletal-Related Event Stratification Factor||Participants|Number|647|647.0||||||
4381607|NCT00321464|4208532|B3|Yes||Previous Skeletal-Related Event Stratification Factor||Participants|Number|751|751.0||||||
4381608|NCT00321464|4208533|B2|Yes||Previous Skeletal-Related Event Stratification Factor||Participants|Number|378|378.0||||||
4381609|NCT00321464|4208534|B1|Yes||Previous Skeletal-Related Event Stratification Factor||Participants|Number|373|373.0||||||
4381610|NCT00321464|4208532|B3|Other||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4381611|NCT00321464|4208533|B2|Other||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4381612|NCT00321464|4208534|B1|Other||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4381613|NCT00321464|4208532|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4381614|NCT00321464|4208533|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4381615|NCT00321464|4208534|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4381616|NCT00321464|4208532|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|139|139.0||||||
4381617|NCT00321464|4208533|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|70|70.0||||||
4381618|NCT00321464|4208534|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
4381619|NCT00321464|4208532|B3|Asian||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
4381620|NCT00321464|4208533|B2|Asian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4381621|NCT00321464|4208534|B1|Asian||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4381622|NCT00321464|4208532|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|118|118.0||||||
4381623|NCT00321464|4208533|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
4381624|NCT00321464|4208534|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
4381625|NCT00321464|4208532|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4381626|NCT00321464|4208533|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4381627|NCT00321464|4208534|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4381628|NCT00321464|4208532|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|1635|1635.0||||||
4381629|NCT00321464|4208533|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|822|822.0||||||
4381630|NCT00321464|4208534|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|813|813.0||||||
4381631|NCT00321464|4208532|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4381632|NCT00321464|4208533|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4381633|NCT00321464|4208534|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4381634|NCT00321464|4208532|B3||Female|Sex: Female, Male||Participants|Count of Participants|2029|2029.0||||||
4381635|NCT00321464|4208533|B2||Female|Sex: Female, Male||Participants|Count of Participants|1018|1018.0||||||
4381636|NCT00321464|4208534|B1||Female|Sex: Female, Male||Participants|Count of Participants|1011|1011.0||||||
4381637|NCT00321464|4208532|B3|||Age||Years|Mean|56.7|56.7|Standard Deviation|11.5|11.5|||
4381638|NCT00321464|4208533|B2|||Age||Years|Mean|56.8|56.8|Standard Deviation|11.5|11.5|||
4381639|NCT00321464|4208534|B1|||Age||Years|Mean|56.6|56.6|Standard Deviation|11.6|11.6|||
4381640|NCT00321373|4208545|B4||Male|Sex: Female, Male||Participants|Count of Participants|598|598.0||||||
4381641|NCT00321373|4208546|B3||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4381642|NCT00321373|4208547|B2||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4381643|NCT00321373|4208548|B1||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4381644|NCT00321373|4208545|B4||Female|Sex: Female, Male||Participants|Count of Participants|622|622.0||||||
4381645|NCT00321373|4208546|B3||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4381646|NCT00321373|4208547|B2||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4381647|NCT00321373|4208548|B1||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4381648|NCT00321373|4208545|B4|||Age||Years|Mean|64.1|64.1|Standard Deviation|5.15|5.15|||
4381649|NCT00321373|4208546|B3|||Age||Years|Mean|64.2|64.2|Standard Deviation|5.38|5.38|||
4381650|NCT00321373|4208547|B2|||Age||Years|Mean|64.1|64.1|Standard Deviation|4.95|4.95|||
4381651|NCT00321373|4208548|B1|||Age||Years|Mean|64.0|64.0|Standard Deviation|5.12|5.12|||
4381652|NCT00321321|4208573|B1|Denmark||Region of Enrollment||participants|Number|12|12.0||||||
4381653|NCT00321321|4208573|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4381654|NCT00321321|4208573|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4381655|NCT00321321|4208573|B1|||Age||years|Mean|55|55.0|Standard Deviation|7.6|7.6|||
4381656|NCT00321321|4208573|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4381657|NCT00321321|4208573|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4381658|NCT00321321|4208573|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4381659|NCT00321269|4208577|B3|United States||Region of Enrollment||participants|Number|134|134.0||||||
4381660|NCT00321269|4208578|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
4381661|NCT00321269|4208579|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4381662|NCT00321269|4208577|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4381663|NCT00321269|4208578|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4381664|NCT00321269|4208579|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4381665|NCT00321269|4208577|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4381666|NCT00321269|4208578|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4381667|NCT00321269|4208579|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4381668|NCT00321269|4208577|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|9.0|9.0|||
4381669|NCT00321269|4208578|B2|||Age||years|Mean|67.8|67.8|Standard Deviation|9.1|9.1|||
4381670|NCT00321269|4208579|B1|||Age||years|Mean|72.4|72.4|Standard Deviation|8.9|8.9|||
4381671|NCT00320801|4208588|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4381672|NCT00320801|4208589|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4381673|NCT00320801|4208590|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4381674|NCT00320801|4208588|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4381675|NCT00320801|4208589|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4381676|NCT00320801|4208590|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4381677|NCT00320801|4208588|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|11.72|11.72|||
4381678|NCT00320801|4208589|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|11.72|11.72|||
4381679|NCT00320801|4208590|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|11.65|11.65|||
4381680|NCT00320788|4208603|B6|||Best Corrected Visual Acuity (BCVA)|BCVA as Measured by 4 Meter Early Treatment Diabetic Retinopathy Study (ETDRS)eye charts/measures|letters read|Mean|55.5|55.5|Standard Deviation|12.57|12.57|0.0|0.0|
4381681|NCT00320788|4208604|B5|||Best Corrected Visual Acuity (BCVA)|BCVA as Measured by 4 Meter Early Treatment Diabetic Retinopathy Study (ETDRS)eye charts/measures|letters read|Mean|53.0|53.0|Standard Deviation|14.52|14.52|0.0|0.0|
4381682|NCT00320788|4208605|B4|||Best Corrected Visual Acuity (BCVA)|BCVA as Measured by 4 Meter Early Treatment Diabetic Retinopathy Study (ETDRS)eye charts/measures|letters read|Mean|57.2|57.2|Standard Deviation|10.47|10.47|0.0|0.0|
4381683|NCT00320788|4208606|B3|||Best Corrected Visual Acuity (BCVA)|BCVA as Measured by 4 Meter Early Treatment Diabetic Retinopathy Study (ETDRS)eye charts/measures|letters read|Mean|57.9|57.9|Standard Deviation|12.02|12.02|0.0|0.0|
4381684|NCT00320788|4208607|B2|||Best Corrected Visual Acuity (BCVA)|BCVA as Measured by 4 Meter Early Treatment Diabetic Retinopathy Study (ETDRS)eye charts/measures|letters read|Mean|55.6|55.6|Standard Deviation|11.75|11.75|0.0|0.0|
4381685|NCT00320788|4208608|B1|||Best Corrected Visual Acuity (BCVA)|BCVA as Measured by 4 Meter Early Treatment Diabetic Retinopathy Study (ETDRS)eye charts/measures|letters read|Mean|54.1|54.1|Standard Deviation|13.77|13.77|0.0|0.0|
4381686|NCT00320788|4208603|B6|||Central Retinal/Lesion Thickness (CR/LT)||µm|Mean|456.4|456.4|Standard Deviation|142.41|142.41|0.0|0.0|
4381687|NCT00320788|4208604|B5|||Central Retinal/Lesion Thickness (CR/LT)||µm|Mean|497.5|497.5|Standard Deviation|191.17|191.17|0.0|0.0|
4381688|NCT00320788|4208605|B4|||Central Retinal/Lesion Thickness (CR/LT)||µm|Mean|447.0|447.0|Standard Deviation|119.11|119.11|0.0|0.0|
4381689|NCT00320788|4208606|B3|||Central Retinal/Lesion Thickness (CR/LT)||µm|Mean|453.3|453.3|Standard Deviation|143.93|143.93|0.0|0.0|
4381690|NCT00320788|4208607|B2|||Central Retinal/Lesion Thickness (CR/LT)||µm|Mean|442.6|442.6|Standard Deviation|136.60|136.6|0.0|0.0|
4381691|NCT00320788|4208608|B1|||Central Retinal/Lesion Thickness (CR/LT)||µm|Mean|442.2|442.2|Standard Deviation|109.81|109.81|0.0|0.0|
4381692|NCT00320788|4208603|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381693|NCT00320788|4208604|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381694|NCT00320788|4208605|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381695|NCT00320788|4208606|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381696|NCT00320788|4208607|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381697|NCT00320788|4208608|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381698|NCT00320788|4208603|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381699|NCT00320788|4208604|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381700|NCT00320788|4208605|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381701|NCT00320788|4208606|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381702|NCT00320788|4208607|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381703|NCT00320788|4208608|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381704|NCT00320788|4208603|B6||White|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
4381705|NCT00320788|4208604|B5||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||0|0.0|0.0|0.0|
4381706|NCT00320788|4208605|B4||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||0|0.0|0.0|0.0|
4381707|NCT00320788|4208606|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||0|0.0|0.0|0.0|
4381708|NCT00320788|4208607|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||0|0.0|0.0|0.0|
4381709|NCT00320788|4208608|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||0|0.0|0.0|0.0|
4381710|NCT00320788|4208603|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381711|NCT00320788|4208604|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381712|NCT00320788|4208605|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381713|NCT00320788|4208606|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381714|NCT00320788|4208607|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381715|NCT00320788|4208608|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381716|NCT00320788|4208603|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381717|NCT00320788|4208604|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381718|NCT00320788|4208605|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381719|NCT00320788|4208606|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381720|NCT00320788|4208607|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381721|NCT00320788|4208608|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381722|NCT00320788|4208603|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381723|NCT00320788|4208604|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381724|NCT00320788|4208605|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381725|NCT00320788|4208606|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381726|NCT00320788|4208607|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381727|NCT00320788|4208608|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381728|NCT00320788|4208603|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4381729|NCT00320788|4208604|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381730|NCT00320788|4208605|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381731|NCT00320788|4208606|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4381732|NCT00320788|4208607|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381733|NCT00320788|4208608|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381734|NCT00320788|4208603|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381735|NCT00320788|4208604|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381736|NCT00320788|4208605|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381737|NCT00320788|4208606|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381738|NCT00320788|4208607|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381739|NCT00320788|4208608|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381740|NCT00320788|4208603|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4381741|NCT00320788|4208604|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||0|0.0|0.0|0.0|
4381742|NCT00320788|4208605|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||0|0.0|0.0|0.0|
4381743|NCT00320788|4208606|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||0|0.0|0.0|0.0|
4381744|NCT00320788|4208607|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||0|0.0|0.0|0.0|
4381745|NCT00320788|4208608|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||0|0.0|0.0|0.0|
4381746|NCT00320788|4208603|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4381747|NCT00320788|4208604|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381748|NCT00320788|4208605|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4381749|NCT00320788|4208606|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||0|0.0|0.0|0.0|
4381750|NCT00320788|4208607|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||0|0.0|0.0|0.0|
4381751|NCT00320788|4208608|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||0|0.0|0.0|0.0|
4381752|NCT00320788|4208603|B6||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4381753|NCT00320788|4208604|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||0|0.0|0.0|0.0|
4381754|NCT00320788|4208605|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||0|0.0|0.0|0.0|
4381755|NCT00320788|4208606|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||0|0.0|0.0|0.0|
4381756|NCT00320788|4208607|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||0|0.0|0.0|0.0|
4381757|NCT00320788|4208608|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||0|0.0|0.0|0.0|
4381758|NCT00320788|4208603|B6||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4381759|NCT00320788|4208604|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||0|0.0|0.0|0.0|
4381760|NCT00320788|4208605|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||0|0.0|0.0|0.0|
4381761|NCT00320788|4208606|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||0|0.0|0.0|0.0|
4381762|NCT00320788|4208607|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||0|0.0|0.0|0.0|
4381763|NCT00320788|4208608|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||0|0.0|0.0|0.0|
4381764|NCT00320788|4208603|B6|||Age||years|Mean|78.2|78.2|Standard Deviation|8.25|8.25|0.0|0.0|
4381765|NCT00320788|4208604|B5|||Age||years|Mean|78.3|78.3|Standard Deviation|5.97|5.97|0.0|0.0|
4381766|NCT00320788|4208605|B4|||Age||years|Mean|79.6|79.6|Standard Deviation|8.91|8.91|0.0|0.0|
4381767|NCT00320788|4208606|B3|||Age||years|Mean|74.9|74.9|Standard Deviation|7.63|7.63|0.0|0.0|
4381768|NCT00320788|4208607|B2|||Age||years|Mean|78.5|78.5|Standard Deviation|10.12|10.12|0.0|0.0|
4381769|NCT00320788|4208608|B1|||Age||years|Mean|79.6|79.6|Standard Deviation|7.56|7.56|0.0|0.0|
4381770|NCT00320749|4208655|B1|ECOG 1 (Restricted physical activity)||Eastern Cooperative Oncology Group (ECOG)||patients|Number|17|17.0||||||
4381771|NCT00320749|4208655|B1|ECOG 0 (Fully Active)||Eastern Cooperative Oncology Group (ECOG)||patients|Number|4|4.0||||||
4381772|NCT00320749|4208655|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4381773|NCT00320749|4208655|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4381774|NCT00320749|4208655|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4381775|NCT00320749|4208655|B1|||Age||years|Mean|59|59.0|Full Range|||48.0|72.0|
4381776|NCT00320710|4208663|B4|||Sex/Gender, Customized|All participants were female.|participants|Number|416|416.0||||||
4381777|NCT00320710|4208664|B3|||Sex/Gender, Customized|All participants were female.|participants|Number|13|13.0||||||
4381778|NCT00320710|4208665|B2|||Sex/Gender, Customized|All participants were female.|participants|Number|203|203.0||||||
4381779|NCT00320710|4208666|B1|||Sex/Gender, Customized|All participants were female.|participants|Number|200|200.0||||||
4381780|NCT00320710|4208663|B4|||Age||years|Mean|58.9|58.9|Standard Deviation|11.14|11.14|||
4381781|NCT00320710|4208664|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|12.19|12.19|||
4381782|NCT00320710|4208665|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|11.15|11.15|||
4381783|NCT00320710|4208666|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|11.10|11.1|||
4381784|NCT00320671|4208689|B3|||Prolactin Level Male|The measure of dispersion selected is standard deviation; however, the actual number entered below is the STANDARD ERROR|ng/ml|Least Squares Mean|30.11|30.11|Standard Deviation|3.145|3.145|||
4381875|NCT00320671|4208690|B2|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4381785|NCT00320671|4208690|B2|||Prolactin Level Male|The measure of dispersion selected is standard deviation; however, the actual number entered below is the STANDARD ERROR|ng/ml|Least Squares Mean|31.50|31.5|Standard Deviation|3.24|3.24|||
4381786|NCT00320671|4208691|B1|||Prolactin Level Male|The measure of dispersion selected is standard deviation; however, the actual number entered below is the STANDARD ERROR|ng/ml|Least Squares Mean|28.72|28.72|Standard Deviation|3.05|3.05|||
4381787|NCT00320671|4208689|B3|||Prolactin Level Female|The measure of dispersion selected is standard deviation; however, the actual number entered below is the STANDARD ERROR.|ng/ml|Least Squares Mean|63.68|63.68|Standard Deviation|10.24|10.24|||
4381788|NCT00320671|4208690|B2|||Prolactin Level Female|The measure of dispersion selected is standard deviation; however, the actual number entered below is the STANDARD ERROR.|ng/ml|Least Squares Mean|65.52|65.52|Standard Deviation|12.88|12.88|||
4381789|NCT00320671|4208691|B1|||Prolactin Level Female|The measure of dispersion selected is standard deviation; however, the actual number entered below is the STANDARD ERROR.|ng/ml|Least Squares Mean|61.84|61.84|Standard Deviation|7.61|7.61|||
4381790|NCT00320671|4208689|B3|||Fasting insulin||uU/ml|Least Squares Mean|12.745|12.745|Standard Deviation|1.24|1.24|||
4381791|NCT00320671|4208690|B2|||Fasting insulin||uU/ml|Least Squares Mean|13.10|13.1|Standard Deviation|1.38|1.38|||
4381792|NCT00320671|4208691|B1|||Fasting insulin||uU/ml|Least Squares Mean|12.39|12.39|Standard Deviation|1.10|1.1|||
4381793|NCT00320671|4208689|B3|Unknown||Marital Status||participants|Number|2|2.0||||||
4381794|NCT00320671|4208690|B2|Unknown||Marital Status||participants|Number|0|0.0||||||
4381795|NCT00320671|4208691|B1|Unknown||Marital Status||participants|Number|2|2.0||||||
4381796|NCT00320671|4208689|B3|Divorced||Marital Status||participants|Number|9|9.0||||||
4381797|NCT00320671|4208690|B2|Divorced||Marital Status||participants|Number|3|3.0||||||
4381798|NCT00320671|4208691|B1|Divorced||Marital Status||participants|Number|6|6.0||||||
4381799|NCT00320671|4208689|B3|Remarried||Marital Status||participants|Number|1|1.0||||||
4381800|NCT00320671|4208690|B2|Remarried||Marital Status||participants|Number|0|0.0||||||
4381801|NCT00320671|4208691|B1|Remarried||Marital Status||participants|Number|1|1.0||||||
4381802|NCT00320671|4208689|B3|Married||Marital Status||participants|Number|4|4.0||||||
4381803|NCT00320671|4208690|B2|Married||Marital Status||participants|Number|3|3.0||||||
4381804|NCT00320671|4208691|B1|Married||Marital Status||participants|Number|1|1.0||||||
4381805|NCT00320671|4208689|B3|Never Married||Marital Status||participants|Number|182|182.0||||||
4381806|NCT00320671|4208690|B2|Never Married||Marital Status||participants|Number|90|90.0||||||
4381807|NCT00320671|4208691|B1|Never Married||Marital Status||participants|Number|92|92.0||||||
4381808|NCT00320671|4208689|B3|social class for parent||hollingshead- index of social position|"The Hollingshead is designed to measure social status of an individual based on educational and occupation. Scores for educational status range from 1 (Grad/Professional School) to a score of 7 ( < than 7 yrs of formal education). For occupation scores range from 1 (high execs, major professionals) to 7 (unskilled employees). Social class scores are obtained for subjects and their self-reported head of household.~Social Status is based on the formula (Occupation score x 7)+(Education score x 4)-The lower the # the > the social status. Social status scores range from 11 to 77."|units on a scale|Mean|3.4|3.4|Standard Deviation|2.7|2.7|||
4381809|NCT00320671|4208690|B2|social class for parent||hollingshead- index of social position|"The Hollingshead is designed to measure social status of an individual based on educational and occupation. Scores for educational status range from 1 (Grad/Professional School) to a score of 7 ( < than 7 yrs of formal education). For occupation scores range from 1 (high execs, major professionals) to 7 (unskilled employees). Social class scores are obtained for subjects and their self-reported head of household.~Social Status is based on the formula (Occupation score x 7)+(Education score x 4)-The lower the # the > the social status. Social status scores range from 11 to 77."|units on a scale|Mean|3.5|3.5|Standard Deviation|3.6|3.6|||
4381810|NCT00320671|4208691|B1|social class for parent||hollingshead- index of social position|"The Hollingshead is designed to measure social status of an individual based on educational and occupation. Scores for educational status range from 1 (Grad/Professional School) to a score of 7 ( < than 7 yrs of formal education). For occupation scores range from 1 (high execs, major professionals) to 7 (unskilled employees). Social class scores are obtained for subjects and their self-reported head of household.~Social Status is based on the formula (Occupation score x 7)+(Education score x 4)-The lower the # the > the social status. Social status scores range from 11 to 77."|units on a scale|Mean|3.3|3.3|Standard Deviation|1.3|1.3|||
4381811|NCT00320671|4208689|B3|Social Class for subject||hollingshead- index of social position|"The Hollingshead is designed to measure social status of an individual based on educational and occupation. Scores for educational status range from 1 (Grad/Professional School) to a score of 7 ( < than 7 yrs of formal education). For occupation scores range from 1 (high execs, major professionals) to 7 (unskilled employees). Social class scores are obtained for subjects and their self-reported head of household.~Social Status is based on the formula (Occupation score x 7)+(Education score x 4)-The lower the # the > the social status. Social status scores range from 11 to 77."|units on a scale|Mean|4.4|4.4|Standard Deviation|2.5|2.5|||
4381812|NCT00320671|4208690|B2|Social Class for subject||hollingshead- index of social position|"The Hollingshead is designed to measure social status of an individual based on educational and occupation. Scores for educational status range from 1 (Grad/Professional School) to a score of 7 ( < than 7 yrs of formal education). For occupation scores range from 1 (high execs, major professionals) to 7 (unskilled employees). Social class scores are obtained for subjects and their self-reported head of household.~Social Status is based on the formula (Occupation score x 7)+(Education score x 4)-The lower the # the > the social status. Social status scores range from 11 to 77."|units on a scale|Mean|4.6|4.6|Standard Deviation|3.4|3.4|||
4381837|NCT00320671|4208691|B1|avolition-apathy||Scale for the Assessment of Negative|The Scale for the Assessment of Negative Symptoms (SANS) This scale has 4 subscales Affective flattening, Alogia, Avolition Apathy, and Asociality-anhedonia. Score on these subscales range from 1 normal to 5 severe|units on a scale|Mean|2.16|2.16|Standard Deviation|.10|0.1|||
4381876|NCT00320671|4208691|B1|Asian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4381813|NCT00320671|4208691|B1|Social Class for subject||hollingshead- index of social position|"The Hollingshead is designed to measure social status of an individual based on educational and occupation. Scores for educational status range from 1 (Grad/Professional School) to a score of 7 ( < than 7 yrs of formal education). For occupation scores range from 1 (high execs, major professionals) to 7 (unskilled employees). Social class scores are obtained for subjects and their self-reported head of household.~Social Status is based on the formula (Occupation score x 7)+(Education score x 4)-The lower the # the > the social status. Social status scores range from 11 to 77."|units on a scale|Mean|4.2|4.2|Standard Deviation|.8|0.8|||
4381814|NCT00320671|4208689|B3|Highest Educational Level||hollingshead- index of social position|"The Hollingshead is designed to measure social status of an individual based on educational and occupation. Scores for educational status range from 1 (Grad/Professional School) to a score of 7 ( < than 7 yrs of formal education). For occupation scores range from 1 (high execs, major professionals) to 7 (unskilled employees). Social class scores are obtained for subjects and their self-reported head of household.~Social Status is based on the formula (Occupation score x 7)+(Education score x 4)-The lower the # the > the social status. Social status scores range from 11 to 77."|units on a scale|Mean|3.9|3.9|Standard Deviation|1.2|1.2|||
4381815|NCT00320671|4208690|B2|Highest Educational Level||hollingshead- index of social position|"The Hollingshead is designed to measure social status of an individual based on educational and occupation. Scores for educational status range from 1 (Grad/Professional School) to a score of 7 ( < than 7 yrs of formal education). For occupation scores range from 1 (high execs, major professionals) to 7 (unskilled employees). Social class scores are obtained for subjects and their self-reported head of household.~Social Status is based on the formula (Occupation score x 7)+(Education score x 4)-The lower the # the > the social status. Social status scores range from 11 to 77."|units on a scale|Mean|3.8|3.8|Standard Deviation|1.1|1.1|||
4381816|NCT00320671|4208691|B1|Highest Educational Level||hollingshead- index of social position|"The Hollingshead is designed to measure social status of an individual based on educational and occupation. Scores for educational status range from 1 (Grad/Professional School) to a score of 7 ( < than 7 yrs of formal education). For occupation scores range from 1 (high execs, major professionals) to 7 (unskilled employees). Social class scores are obtained for subjects and their self-reported head of household.~Social Status is based on the formula (Occupation score x 7)+(Education score x 4)-The lower the # the > the social status. Social status scores range from 11 to 77."|units on a scale|Mean|4.0|4.0|Standard Deviation|1.4|1.4|||
4381817|NCT00320671|4208689|B3|Fasting glucose baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|84.83|84.83|Standard Deviation|.79|0.79|||
4381818|NCT00320671|4208690|B2|Fasting glucose baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|84.60|84.6|Standard Deviation|0.89|0.89|||
4381819|NCT00320671|4208691|B1|Fasting glucose baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|85.06|85.06|Standard Deviation|0.69|0.69|||
4381820|NCT00320671|4208689|B3|Triglycerides baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|78.705|78.705|Standard Deviation|4.49|4.49|||
4381821|NCT00320671|4208690|B2|Triglycerides baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|77.41|77.41|Standard Deviation|4.50|4.5|||
4381822|NCT00320671|4208691|B1|Triglycerides baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|80.00|80.0|Standard Deviation|4.48|4.48|||
4381823|NCT00320671|4208689|B3|HDL Cholesterol baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|54.61|54.61|Standard Deviation|1.385|1.385|||
4381824|NCT00320671|4208690|B2|HDL Cholesterol baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|53.23|53.23|Standard Deviation|1.40|1.4|||
4381825|NCT00320671|4208691|B1|HDL Cholesterol baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|55.99|55.99|Standard Deviation|1.37|1.37|||
4381826|NCT00320671|4208689|B3|LDL cholesterol Baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|87.31|87.31|Standard Deviation|2.685|2.685|||
4381827|NCT00320671|4208690|B2|LDL cholesterol Baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|88.25|88.25|Standard Deviation|2.77|2.77|||
4381828|NCT00320671|4208691|B1|LDL cholesterol Baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|86.37|86.37|Standard Deviation|2.60|2.6|||
4381829|NCT00320671|4208689|B3|Total Cholesterol Baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|157.63|157.63|Standard Deviation|3.225|3.225|||
4381830|NCT00320671|4208690|B2|Total Cholesterol Baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|157.01|157.01|Standard Deviation|3.30|3.3|||
4381831|NCT00320671|4208691|B1|Total Cholesterol Baseline||Metabolic Outcomes||mg/dl|Least Squares Mean|158.25|158.25|Standard Deviation|3.15|3.15|||
4381832|NCT00320671|4208689|B3|asociality-anhedonia||Scale for the Assessment of Negative|The Scale for the Assessment of Negative Symptoms (SANS) This scale has 4 subscales Affective flattening, Alogia, Avolition Apathy, and Asociality-anhedonia. Score on these subscales range from 1 normal to 5 severe|units on a scale|Mean|2.12|2.12|Standard Deviation|.85|0.85|||
4381833|NCT00320671|4208690|B2|asociality-anhedonia||Scale for the Assessment of Negative|The Scale for the Assessment of Negative Symptoms (SANS) This scale has 4 subscales Affective flattening, Alogia, Avolition Apathy, and Asociality-anhedonia. Score on these subscales range from 1 normal to 5 severe|units on a scale|Mean|2.07|2.07|Standard Deviation|.09|0.09|||
4381834|NCT00320671|4208691|B1|asociality-anhedonia||Scale for the Assessment of Negative|The Scale for the Assessment of Negative Symptoms (SANS) This scale has 4 subscales Affective flattening, Alogia, Avolition Apathy, and Asociality-anhedonia. Score on these subscales range from 1 normal to 5 severe|units on a scale|Mean|2.19|2.19|Standard Deviation|.08|0.08|||
4381835|NCT00320671|4208689|B3|avolition-apathy||Scale for the Assessment of Negative|The Scale for the Assessment of Negative Symptoms (SANS) This scale has 4 subscales Affective flattening, Alogia, Avolition Apathy, and Asociality-anhedonia. Score on these subscales range from 1 normal to 5 severe|units on a scale|Mean|2.09|2.09|Standard Deviation|.10|0.1|||
4381836|NCT00320671|4208690|B2|avolition-apathy||Scale for the Assessment of Negative|The Scale for the Assessment of Negative Symptoms (SANS) This scale has 4 subscales Affective flattening, Alogia, Avolition Apathy, and Asociality-anhedonia. Score on these subscales range from 1 normal to 5 severe|units on a scale|Mean|2.02|2.02|Standard Deviation|.10|0.1|||
4381873|NCT00320671|4208691|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4381874|NCT00320671|4208689|B3|Asian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4381838|NCT00320671|4208689|B3|Alogia||Scale for the Assessment of Negative|The Scale for the Assessment of Negative Symptoms (SANS) This scale has 4 subscales Affective flattening, Alogia, Avolition Apathy, and Asociality-anhedonia. Score on these subscales range from 1 normal to 5 severe|units on a scale|Mean|2.02|2.02|Standard Deviation|.85|0.85|||
4381839|NCT00320671|4208690|B2|Alogia||Scale for the Assessment of Negative|The Scale for the Assessment of Negative Symptoms (SANS) This scale has 4 subscales Affective flattening, Alogia, Avolition Apathy, and Asociality-anhedonia. Score on these subscales range from 1 normal to 5 severe|units on a scale|Mean|1.96|1.96|Standard Deviation|.09|0.09|||
4381840|NCT00320671|4208691|B1|Alogia||Scale for the Assessment of Negative|The Scale for the Assessment of Negative Symptoms (SANS) This scale has 4 subscales Affective flattening, Alogia, Avolition Apathy, and Asociality-anhedonia. Score on these subscales range from 1 normal to 5 severe|units on a scale|Mean|2.08|2.08|Standard Deviation|.08|0.08|||
4381841|NCT00320671|4208689|B3|Affective flattening||Scale for the Assessment of Negative|The Scale for the Assessment of Negative Symptoms (SANS) This scale has 4 subscales Affective flattening, Alogia, Avolition Apathy, and Asociality-anhedonia. Score on these subscales range from 1 normal to 5 severe|units on a scale|Mean|1.795|1.795|Standard Deviation|.09|0.09|||
4381842|NCT00320671|4208690|B2|Affective flattening||Scale for the Assessment of Negative|The Scale for the Assessment of Negative Symptoms (SANS) This scale has 4 subscales Affective flattening, Alogia, Avolition Apathy, and Asociality-anhedonia. Score on these subscales range from 1 normal to 5 severe|units on a scale|Mean|1.74|1.74|Standard Deviation|.09|0.09|||
4381843|NCT00320671|4208691|B1|Affective flattening||Scale for the Assessment of Negative|The Scale for the Assessment of Negative Symptoms (SANS) This scale has 4 subscales Affective flattening, Alogia, Avolition Apathy, and Asociality-anhedonia. Score on these subscales range from 1 normal to 5 severe|units on a scale|Mean|1.85|1.85|Standard Deviation|0.09|0.09|||
4381844|NCT00320671|4208689|B3|||BPRS-A|"Brief Psychiatric Rating Scale-Anchored (BPRS-A) 4 items on this scale were examined to determine subjects responder status: Items 4. Conceptual Disorganization 8. Grandiosity 12. Hallucinations and 15. Unusual Thought Content.~Only subjects who responded with a 4 or greater on one at least one of theses items were eligible to participate in the study. The scores can range from 0-28 with 28 being the most psychotic and 0 being absolutely no signs of psychosis."|units on a scale|Mean|14.54|14.54|Full Range|||4.0|28.0|
4381845|NCT00320671|4208690|B2|||BPRS-A|"Brief Psychiatric Rating Scale-Anchored (BPRS-A) 4 items on this scale were examined to determine subjects responder status: Items 4. Conceptual Disorganization 8. Grandiosity 12. Hallucinations and 15. Unusual Thought Content.~Only subjects who responded with a 4 or greater on one at least one of theses items were eligible to participate in the study. The scores can range from 0-28 with 28 being the most psychotic and 0 being absolutely no signs of psychosis."|units on a scale|Mean|14.42|14.42|Full Range|||4.0|28.0|
4381846|NCT00320671|4208691|B1|||BPRS-A|"Brief Psychiatric Rating Scale-Anchored (BPRS-A) 4 items on this scale were examined to determine subjects responder status: Items 4. Conceptual Disorganization 8. Grandiosity 12. Hallucinations and 15. Unusual Thought Content.~Only subjects who responded with a 4 or greater on one at least one of theses items were eligible to participate in the study. The scores can range from 0-28 with 28 being the most psychotic and 0 being absolutely no signs of psychosis."|units on a scale|Mean|14.66|14.66|Full Range|||4.0|28.0|
4381847|NCT00320671|4208689|B3|Schizophreniform Disorder||Structured Clinical Interview for DSM-IV Axis I Disorders||participants|Number|44|44.0||||||
4381848|NCT00320671|4208690|B2|Schizophreniform Disorder||Structured Clinical Interview for DSM-IV Axis I Disorders||participants|Number|22|22.0||||||
4381849|NCT00320671|4208691|B1|Schizophreniform Disorder||Structured Clinical Interview for DSM-IV Axis I Disorders||participants|Number|22|22.0||||||
4381850|NCT00320671|4208689|B3|Schizophrenia||Structured Clinical Interview for DSM-IV Axis I Disorders||participants|Number|131|131.0||||||
4381851|NCT00320671|4208690|B2|Schizophrenia||Structured Clinical Interview for DSM-IV Axis I Disorders||participants|Number|59|59.0||||||
4381852|NCT00320671|4208691|B1|Schizophrenia||Structured Clinical Interview for DSM-IV Axis I Disorders||participants|Number|72|72.0||||||
4381853|NCT00320671|4208689|B3|Schizoaffective Disorder||Structured Clinical Interview for DSM-IV Axis I Disorders||participants|Number|6|6.0||||||
4381854|NCT00320671|4208690|B2|Schizoaffective Disorder||Structured Clinical Interview for DSM-IV Axis I Disorders||participants|Number|4|4.0||||||
4381855|NCT00320671|4208691|B1|Schizoaffective Disorder||Structured Clinical Interview for DSM-IV Axis I Disorders||participants|Number|2|2.0||||||
4381856|NCT00320671|4208689|B3|psychosis NOS||Structured Clinical Interview for DSM-IV Axis I Disorders||participants|Number|17|17.0||||||
4381857|NCT00320671|4208690|B2|psychosis NOS||Structured Clinical Interview for DSM-IV Axis I Disorders||participants|Number|11|11.0||||||
4381858|NCT00320671|4208691|B1|psychosis NOS||Structured Clinical Interview for DSM-IV Axis I Disorders||participants|Number|6|6.0||||||
4381859|NCT00320671|4208689|B3|United States||Region of Enrollment||participants|Number|198|198.0||||||
4381860|NCT00320671|4208690|B2|United States||Region of Enrollment||participants|Number|96|96.0||||||
4381861|NCT00320671|4208691|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4381862|NCT00320671|4208689|B3|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4381863|NCT00320671|4208690|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4381864|NCT00320671|4208691|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4381865|NCT00320671|4208689|B3|Other/Mixed||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4381866|NCT00320671|4208690|B2|Other/Mixed||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4381867|NCT00320671|4208691|B1|Other/Mixed||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4381868|NCT00320671|4208689|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4381869|NCT00320671|4208690|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4381870|NCT00320671|4208691|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4381871|NCT00320671|4208689|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4381872|NCT00320671|4208690|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4381877|NCT00320671|4208689|B3|African-American||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4381878|NCT00320671|4208690|B2|African-American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4381879|NCT00320671|4208691|B1|African-American||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4381880|NCT00320671|4208689|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4381881|NCT00320671|4208690|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4381882|NCT00320671|4208691|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4381883|NCT00320671|4208689|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4381884|NCT00320671|4208690|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4381885|NCT00320671|4208691|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4381886|NCT00320671|4208689|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4381887|NCT00320671|4208690|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4381888|NCT00320671|4208691|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4381889|NCT00320671|4208689|B3||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4381890|NCT00320671|4208690|B2||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4381891|NCT00320671|4208691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4381892|NCT00320671|4208689|B3||<=18 years|Age||Participants|Count of Participants|56|56.0||||||
4381893|NCT00320671|4208690|B2||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4381894|NCT00320671|4208691|B1||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4381895|NCT00320606|4208698|B1|||Baseline Diastolic Blood Pressure|Diastolic blood pressure measured at the start of IS tapering. Diastolic blood pressure measures the pressure in the arteries when the heart is a rest and is thus filled with blood. For pediatric participants, normal systolic blood pressure is defined as being below the 90th percentile for the participant’s age, sex, and height on at least 3 separate occasions. High blood pressure, also known as hypertension, is a risk factor for coronary artery disease, stroke, heart failure, and other complications if left unmanaged.|mmHg|Median|64.5|64.5|Inter-Quartile Range|||58.0|73.5|
4381896|NCT00320606|4208698|B1|||Baseline Systolic Blood Pressure|Systolic blood pressure measured at the start of IS tapering. Systolic blood pressure measures the pressure on the blood vessels when the heart beats and thus is pushing blood to the rest of the body. For pediatric participants, normal systolic blood pressure is defined as being below the 90th percentile for the participant’s age, sex, and height on at least 3 separate occasions. High blood pressure, also known as hypertension, is a risk factor for coronary artery disease, stroke, heart failure, and other complications if left unmanaged.|mmHg|Median|109.5|109.5|Inter-Quartile Range|||100.0|117.5|
4381897|NCT00320606|4208698|B1|||Baseline Glucose|"Glucose collected at the start of tapering. This is a measure of glucose found in the blood. Glucose, a sugar, is an energy source that the body relies on to properly function. If levels are too high for a long period of time, diabetes can develop. Diabetes can result in many long-term complications such as eye, kidney, and nerve damage, stroke, and cardiovascular complications.~Target range for fasting glucose: 60-106 mg/dL."|mg/dL|Median|89.5|89.5|Inter-Quartile Range|||84.0|94.0|
4381898|NCT00320606|4208698|B1|||Baseline Total Cholesterol|"Total serum cholesterol collected at the start of IS tapering.~Target range for total cholesterol: 75-169 mg/dL if age ≤20; high values indicate risk of cardiovascular disease"|mg/dL|Median|147|147.0|Inter-Quartile Range|||132.0|162.0|
4381899|NCT00320606|4208698|B1|||Baseline Glomerular Filtration Rate (GFR)|Glomerular filtration rate (GFR) is a measure of kidney function. The bedside Schwartz equation was used to estimate GFR from serum creatinine and height in children. Baseline serum creatinine was utilized in this equation, defined as the creatinine value at the start of immunosuppressive (IS) treatment tapering. Baseline height was utilized in the equation, defined as the last height recorded prior to the start of IS treatment tapering. Estimate of normal GFR: ≥90 mL/min per 1.73 m^2.|mL/min/1.73 m^2|Median|113.2|113.2|Inter-Quartile Range|||93.4|121.13|
4381900|NCT00320606|4208698|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4381901|NCT00320606|4208698|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381902|NCT00320606|4208698|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381903|NCT00320606|4208698|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4381904|NCT00320606|4208698|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381905|NCT00320606|4208698|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381906|NCT00320606|4208698|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381907|NCT00320606|4208698|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381908|NCT00320606|4208698|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4381909|NCT00320606|4208698|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4381910|NCT00320606|4208698|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4381911|NCT00320606|4208698|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4381912|NCT00320606|4208698|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4381913|NCT00320606|4208698|B1|||Age||Years|Mean|8.7|8.7|Standard Deviation|2.96|2.96|||
4381914|NCT00320606|4208698|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4381915|NCT00320606|4208698|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4381916|NCT00320606|4208698|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4381917|NCT00320593|4208712|B3|Missing/unknown||Parental History of Myopia||participants|Number|39|39.0||||||
4381918|NCT00320593|4208713|B2|Missing/unknown||Parental History of Myopia||participants|Number|24|24.0||||||
4381919|NCT00320593|4208714|B1|Missing/unknown||Parental History of Myopia||participants|Number|15|15.0||||||
4381920|NCT00320593|4208712|B3|Both parents||Parental History of Myopia||participants|Number|38|38.0||||||
4381921|NCT00320593|4208713|B2|Both parents||Parental History of Myopia||participants|Number|20|20.0||||||
4381922|NCT00320593|4208714|B1|Both parents||Parental History of Myopia||participants|Number|18|18.0||||||
4381923|NCT00320593|4208712|B3|One parent||Parental History of Myopia||participants|Number|26|26.0||||||
4381924|NCT00320593|4208713|B2|One parent||Parental History of Myopia||participants|Number|10|10.0||||||
4381925|NCT00320593|4208714|B1|One parent||Parental History of Myopia||participants|Number|16|16.0||||||
4381926|NCT00320593|4208712|B3|Neither parent||Parental History of Myopia||participants|Number|15|15.0||||||
4381927|NCT00320593|4208713|B2|Neither parent||Parental History of Myopia||participants|Number|5|5.0||||||
4381928|NCT00320593|4208714|B1|Neither parent||Parental History of Myopia||participants|Number|10|10.0||||||
4381929|NCT00320593|4208712|B3|||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|diopters|Mean|1.44|1.44|Standard Deviation|0.50|0.5|||
4381930|NCT00320593|4208713|B2|||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|diopters|Mean|1.40|1.4|Standard Deviation|0.48|0.48|||
4381931|NCT00320593|4208714|B1|||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|diopters|Mean|1.47|1.47|Standard Deviation|0.53|0.53|||
4381932|NCT00320593|4208712|B3|2.00 D or more||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|participants|Number|16|16.0||||||
4381933|NCT00320593|4208713|B2|2.00 D or more||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|participants|Number|4|4.0||||||
4381934|NCT00320593|4208714|B1|2.00 D or more||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|participants|Number|12|12.0||||||
4381935|NCT00320593|4208712|B3|1.50 to 1.99 D||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|participants|Number|29|29.0||||||
4381936|NCT00320593|4208713|B2|1.50 to 1.99 D||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|participants|Number|16|16.0||||||
4381937|NCT00320593|4208714|B1|1.50 to 1.99 D||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|participants|Number|13|13.0||||||
4381954|NCT00320593|4208713|B2|6 to 10 PD||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|participants|Number|21|21.0||||||
4381938|NCT00320593|4208712|B3|1.00 to 1.49 D||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|participants|Number|59|59.0||||||
4381939|NCT00320593|4208713|B2|1.00 to 1.49 D||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|participants|Number|33|33.0||||||
4381940|NCT00320593|4208714|B1|1.00 to 1.49 D||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|participants|Number|26|26.0||||||
4381941|NCT00320593|4208712|B3|0.50 to 0.99 diopters (D)||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|participants|Number|14|14.0||||||
4381942|NCT00320593|4208713|B2|0.50 to 0.99 diopters (D)||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|participants|Number|6|6.0||||||
4381943|NCT00320593|4208714|B1|0.50 to 0.99 diopters (D)||Accommodative Lag|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle (axis). Accommodative lag is the average of the median accommodative lag of the five trials of the right eye. To determine the accommodative lag or accommodative lead, the accommodative measurement was added to the 3.00-D demand to result in the accommodative lag or lead. If the value was positive, it indicated accommodative lag; if the number was negative, it indicated accommodative lead.|participants|Number|8|8.0||||||
4381944|NCT00320593|4208712|B3|||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|prism diopters|Mean|5.9|5.9|Standard Deviation|3.3|3.3|||
4381945|NCT00320593|4208713|B2|||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|prism diopters|Mean|5.9|5.9|Standard Deviation|3.4|3.4|||
4381946|NCT00320593|4208714|B1|||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|prism diopters|Mean|5.8|5.8|Standard Deviation|3.2|3.2|||
4381947|NCT00320593|4208712|B3|16 to 20 PD||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|participants|Number|2|2.0||||||
4381948|NCT00320593|4208713|B2|16 to 20 PD||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|participants|Number|1|1.0||||||
4381949|NCT00320593|4208714|B1|16 to 20 PD||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|participants|Number|1|1.0||||||
4381950|NCT00320593|4208712|B3|11 to 15 PD||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|participants|Number|6|6.0||||||
4381951|NCT00320593|4208713|B2|11 to 15 PD||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|participants|Number|3|3.0||||||
4381952|NCT00320593|4208714|B1|11 to 15 PD||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|participants|Number|3|3.0||||||
4381953|NCT00320593|4208712|B3|6 to 10 PD||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|participants|Number|43|43.0||||||
4381955|NCT00320593|4208714|B1|6 to 10 PD||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|participants|Number|22|22.0||||||
4381956|NCT00320593|4208712|B3|2 to 5 prism diopters (PD)||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|participants|Number|67|67.0||||||
4381957|NCT00320593|4208713|B2|2 to 5 prism diopters (PD)||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|participants|Number|34|34.0||||||
4381958|NCT00320593|4208714|B1|2 to 5 prism diopters (PD)||Near Esophoria|Measured in prism diopters (PD) using the Prism and Alternate Cover Test (PACT) at 33 cm. Esophoria is the tendency of the eyes to deviate inwards when fusion between the eyes is suspended. Near esophoria is an esophoria when viewing close objects.|participants|Number|33|33.0||||||
4381959|NCT00320593|4208712|B3|||Anisometropia|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Anisometropia is defined as spherical equivalent in the right eye subtracted by spherical equivalent in the left eye.|diopters|Mean|0.22|0.22|Standard Deviation|0.18|0.18|||
4381960|NCT00320593|4208713|B2|||Anisometropia|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Anisometropia is defined as spherical equivalent in the right eye subtracted by spherical equivalent in the left eye.|diopters|Mean|0.21|0.21|Standard Deviation|0.16|0.16|||
4381961|NCT00320593|4208714|B1|||Anisometropia|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Anisometropia is defined as spherical equivalent in the right eye subtracted by spherical equivalent in the left eye.|diopters|Mean|0.22|0.22|Standard Deviation|0.20|0.2|||
4381962|NCT00320593|4208712|B3|||Average J45 Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). The dioptric power of a Jackson cross cylinder with axis at 45 degrees (J45) is calculated using the power vector approach. A J45 was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the J45 used for analysis.|diopters|Mean|0.11|0.11|Standard Deviation|0.07|0.07|||
4381963|NCT00320593|4208713|B2|||Average J45 Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). The dioptric power of a Jackson cross cylinder with axis at 45 degrees (J45) is calculated using the power vector approach. A J45 was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the J45 used for analysis.|diopters|Mean|0.10|0.1|Standard Deviation|0.07|0.07|||
4381964|NCT00320593|4208714|B1|||Average J45 Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). The dioptric power of a Jackson cross cylinder with axis at 45 degrees (J45) is calculated using the power vector approach. A J45 was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the J45 used for analysis.|diopters|Mean|0.11|0.11|Standard Deviation|0.07|0.07|||
4381965|NCT00320593|4208712|B3|||Average J0 Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). The dioptric power of a Jackson cross cylinder with axis at 0 degrees (J0) is calculated using the power vector approach. A J0 was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the J0 used for analysis.|diopters|Mean|-0.02|-0.02|Standard Deviation|0.16|0.16|||
4381966|NCT00320593|4208713|B2|||Average J0 Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). The dioptric power of a Jackson cross cylinder with axis at 0 degrees (J0) is calculated using the power vector approach. A J0 was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the J0 used for analysis.|diopters|Mean|-0.02|-0.02|Standard Deviation|0.15|0.15|||
4381967|NCT00320593|4208714|B1|||Average J0 Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). The dioptric power of a Jackson cross cylinder with axis at 0 degrees (J0) is calculated using the power vector approach. A J0 was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the J0 used for analysis.|diopters|Mean|-0.02|-0.02|Standard Deviation|0.18|0.18|||
4381968|NCT00320593|4208712|B3|||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|diopters|Mean|-1.48|-1.48|Standard Deviation|0.46|0.46|||
4382032|NCT00320541|4208738|B2|||Body Surface Area (BSA) at Day 1 of Visit 1||square meters (m2)|Mean|1.8|1.8|Standard Deviation|0.21|0.21|||
4381969|NCT00320593|4208713|B2|||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|diopters|Mean|-1.45|-1.45|Standard Deviation|0.47|0.47|||
4381970|NCT00320593|4208714|B1|||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|diopters|Mean|-1.50|-1.5|Standard Deviation|0.45|0.45|||
4381971|NCT00320593|4208712|B3|-2.00 to -2.50 D||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|participants|Number|21|21.0||||||
4381972|NCT00320593|4208713|B2|-2.00 to -2.50 D||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|participants|Number|10|10.0||||||
4381973|NCT00320593|4208714|B1|-2.00 to -2.50 D||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|participants|Number|11|11.0||||||
4381974|NCT00320593|4208712|B3|-1.50 to -1.99 D||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|participants|Number|32|32.0||||||
4381975|NCT00320593|4208713|B2|-1.50 to -1.99 D||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|participants|Number|14|14.0||||||
4381976|NCT00320593|4208714|B1|-1.50 to -1.99 D||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|participants|Number|18|18.0||||||
4381977|NCT00320593|4208712|B3|-1.00 to -1.49 D||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|participants|Number|45|45.0||||||
4381978|NCT00320593|4208713|B2|-1.00 to -1.49 D||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|participants|Number|23|23.0||||||
4381979|NCT00320593|4208714|B1|-1.00 to -1.49 D||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|participants|Number|22|22.0||||||
4381980|NCT00320593|4208712|B3|-0.75 to -0.99 diopters (D)||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|participants|Number|20|20.0||||||
4381981|NCT00320593|4208713|B2|-0.75 to -0.99 diopters (D)||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|participants|Number|12|12.0||||||
4381982|NCT00320593|4208714|B1|-0.75 to -0.99 diopters (D)||Average Spherical Equivalent Between the Eyes|Measured in diopters (D) using cycloplegic refraction sphere, cylinder and axis. In this study, sphere refers to the amount of myopia (nearsightedness) and cylinder the amount of astigmatism at a particular angle from 0 to 180 degrees (axis). Spherical equivalent is defined as the sphere plus 1/2 the cylinder. A spherical equivalent was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the spherical equivalent used for analysis.|participants|Number|8|8.0||||||
4381983|NCT00320593|4208712|B3|Never||Spectacle wear (single vision lenses)||participants|Number|46|46.0||||||
4381984|NCT00320593|4208713|B2|Never||Spectacle wear (single vision lenses)||participants|Number|24|24.0||||||
4381985|NCT00320593|4208714|B1|Never||Spectacle wear (single vision lenses)||participants|Number|22|22.0||||||
4381986|NCT00320593|4208712|B3|In past but not currently||Spectacle wear (single vision lenses)||participants|Number|6|6.0||||||
4381987|NCT00320593|4208713|B2|In past but not currently||Spectacle wear (single vision lenses)||participants|Number|2|2.0||||||
4381988|NCT00320593|4208714|B1|In past but not currently||Spectacle wear (single vision lenses)||participants|Number|4|4.0||||||
4381989|NCT00320593|4208712|B3|Currently||Spectacle wear (single vision lenses)||participants|Number|66|66.0||||||
4381990|NCT00320593|4208713|B2|Currently||Spectacle wear (single vision lenses)||participants|Number|33|33.0||||||
4381991|NCT00320593|4208714|B1|Currently||Spectacle wear (single vision lenses)||participants|Number|33|33.0||||||
4381992|NCT00320593|4208712|B3|United States||Region of Enrollment||participants|Number|118|118.0||||||
4381993|NCT00320593|4208713|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4381994|NCT00320593|4208714|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4381995|NCT00320593|4208712|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4381996|NCT00320593|4208713|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4381997|NCT00320593|4208714|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4381998|NCT00320593|4208712|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4381999|NCT00320593|4208713|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4382000|NCT00320593|4208714|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4382001|NCT00320593|4208712|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4382002|NCT00320593|4208713|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4382003|NCT00320593|4208714|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4382004|NCT00320593|4208712|B3|African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4382005|NCT00320593|4208713|B2|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4382006|NCT00320593|4208714|B1|African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4382007|NCT00320593|4208712|B3|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4382008|NCT00320593|4208713|B2|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4382009|NCT00320593|4208714|B1|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4382010|NCT00320593|4208712|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4382011|NCT00320593|4208713|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4382012|NCT00320593|4208714|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4382013|NCT00320593|4208712|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4382014|NCT00320593|4208713|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4382015|NCT00320593|4208714|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4382016|NCT00320593|4208712|B3|11 to <12 years||Age, Customized|Age at enrollment|participants|Number|32|32.0||||||
4382017|NCT00320593|4208713|B2|11 to <12 years||Age, Customized|Age at enrollment|participants|Number|14|14.0||||||
4382018|NCT00320593|4208714|B1|11 to <12 years||Age, Customized|Age at enrollment|participants|Number|18|18.0||||||
4382019|NCT00320593|4208712|B3|10 to <11 years||Age, Customized|Age at enrollment|participants|Number|32|32.0||||||
4382020|NCT00320593|4208713|B2|10 to <11 years||Age, Customized|Age at enrollment|participants|Number|14|14.0||||||
4382021|NCT00320593|4208714|B1|10 to <11 years||Age, Customized|Age at enrollment|participants|Number|18|18.0||||||
4382022|NCT00320593|4208712|B3|9 to <10 years||Age, Customized|Age at enrollment|participants|Number|32|32.0||||||
4382023|NCT00320593|4208713|B2|9 to <10 years||Age, Customized|Age at enrollment|participants|Number|17|17.0||||||
4382024|NCT00320593|4208714|B1|9 to <10 years||Age, Customized|Age at enrollment|participants|Number|15|15.0||||||
4382025|NCT00320593|4208712|B3|8 to <9 years||Age, Customized|Age at enrollment|participants|Number|22|22.0||||||
4382026|NCT00320593|4208713|B2|8 to <9 years||Age, Customized|Age at enrollment|participants|Number|14|14.0||||||
4382027|NCT00320593|4208714|B1|8 to <9 years||Age, Customized|Age at enrollment|participants|Number|8|8.0||||||
4382028|NCT00320593|4208712|B3|||Age|Age at enrollment|years|Mean|10.1|10.1|Standard Deviation|1.1|1.1|||
4382029|NCT00320593|4208713|B2|||Age|Age at enrollment|years|Mean|10.0|10.0|Standard Deviation|1.1|1.1|||
4382030|NCT00320593|4208714|B1|||Age|Age at enrollment|years|Mean|10.2|10.2|Standard Deviation|1.1|1.1|||
4382031|NCT00320541|4208737|B3|||Body Surface Area (BSA) at Day 1 of Visit 1||square meters (m2)|Mean|1.8|1.8|Standard Deviation|0.20|0.2|||
4382033|NCT00320541|4208739|B1|||Body Surface Area (BSA) at Day 1 of Visit 1||square meters (m2)|Mean|1.8|1.8|Standard Deviation|0.18|0.18|||
4382034|NCT00320541|4208737|B3|||Prior Radiotherapy|Number of participants, by treatment arm, who received prior radiotherapy. NOTE: The total number of participants who received prior radiotherapy does not equal the total number of participants in the trial because not all participants received prior radiotherapy.|participants|Number|105|105.0||||||
4382035|NCT00320541|4208738|B2|||Prior Radiotherapy|Number of participants, by treatment arm, who received prior radiotherapy. NOTE: The total number of participants who received prior radiotherapy does not equal the total number of participants in the trial because not all participants received prior radiotherapy.|participants|Number|55|55.0||||||
4382036|NCT00320541|4208739|B1|||Prior Radiotherapy|Number of participants, by treatment arm, who received prior radiotherapy. NOTE: The total number of participants who received prior radiotherapy does not equal the total number of participants in the trial because not all participants received prior radiotherapy.|participants|Number|50|50.0||||||
4382037|NCT00320541|4208737|B3|||Prior Immunological Treatment for This Cancer|Number of participants, by treatment arm, who received prior immunological treatment for this cancer. NOTE: The total number of participants who received prior immunnological treatment does not equal the total number of participants in the trial because not all participants received prior immunological treatment.|participants|Number|2|2.0||||||
4382038|NCT00320541|4208738|B2|||Prior Immunological Treatment for This Cancer|Number of participants, by treatment arm, who received prior immunological treatment for this cancer. NOTE: The total number of participants who received prior immunnological treatment does not equal the total number of participants in the trial because not all participants received prior immunological treatment.|participants|Number|0|0.0||||||
4382039|NCT00320541|4208739|B1|||Prior Immunological Treatment for This Cancer|Number of participants, by treatment arm, who received prior immunological treatment for this cancer. NOTE: The total number of participants who received prior immunnological treatment does not equal the total number of participants in the trial because not all participants received prior immunological treatment.|participants|Number|2|2.0||||||
4382040|NCT00320541|4208737|B3|||Prior Hormonal Treatment for This Cancer|Number of participants, by treatment arm, who received prior hormonal treatment for this cancer. NOTE: The total number of participants who received prior hormonal treatment does not equal the total number of participants in the trial because not all participants received prior hormonal treatment.|participants|Number|104|104.0||||||
4382041|NCT00320541|4208738|B2|||Prior Hormonal Treatment for This Cancer|Number of participants, by treatment arm, who received prior hormonal treatment for this cancer. NOTE: The total number of participants who received prior hormonal treatment does not equal the total number of participants in the trial because not all participants received prior hormonal treatment.|participants|Number|53|53.0||||||
4382042|NCT00320541|4208739|B1|||Prior Hormonal Treatment for This Cancer|Number of participants, by treatment arm, who received prior hormonal treatment for this cancer. NOTE: The total number of participants who received prior hormonal treatment does not equal the total number of participants in the trial because not all participants received prior hormonal treatment.|participants|Number|51|51.0||||||
4382043|NCT00320541|4208737|B3|No||Prior Exposure to Taxanes|Number of participants previously treated with taxane chemotherapy including: Taxol (paclitaxel), Topotecan (docetaxel), or Abraxane (albumin-bound paclitaxel).|participants|Number|122|122.0||||||
4382044|NCT00320541|4208738|B2|No||Prior Exposure to Taxanes|Number of participants previously treated with taxane chemotherapy including: Taxol (paclitaxel), Topotecan (docetaxel), or Abraxane (albumin-bound paclitaxel).|participants|Number|61|61.0||||||
4382045|NCT00320541|4208739|B1|No||Prior Exposure to Taxanes|Number of participants previously treated with taxane chemotherapy including: Taxol (paclitaxel), Topotecan (docetaxel), or Abraxane (albumin-bound paclitaxel).|participants|Number|61|61.0||||||
4382046|NCT00320541|4208737|B3|Yes||Prior Exposure to Taxanes|Number of participants previously treated with taxane chemotherapy including: Taxol (paclitaxel), Topotecan (docetaxel), or Abraxane (albumin-bound paclitaxel).|participants|Number|65|65.0||||||
4382047|NCT00320541|4208738|B2|Yes||Prior Exposure to Taxanes|Number of participants previously treated with taxane chemotherapy including: Taxol (paclitaxel), Topotecan (docetaxel), or Abraxane (albumin-bound paclitaxel).|participants|Number|32|32.0||||||
4382048|NCT00320541|4208739|B1|Yes||Prior Exposure to Taxanes|Number of participants previously treated with taxane chemotherapy including: Taxol (paclitaxel), Topotecan (docetaxel), or Abraxane (albumin-bound paclitaxel).|participants|Number|33|33.0||||||
4382049|NCT00320541|4208737|B3|||Prior Chemotherapy for This Cancer|Number of participants, by treatment arm, who received prior chemotherapy for this cancer. NOTE: The total number of participants who received prior chemotherapy does not equal the total number of participants in the trial because not all participants received prior chemotherapy.|participants|Number|112|112.0||||||
4382050|NCT00320541|4208738|B2|||Prior Chemotherapy for This Cancer|Number of participants, by treatment arm, who received prior chemotherapy for this cancer. NOTE: The total number of participants who received prior chemotherapy does not equal the total number of participants in the trial because not all participants received prior chemotherapy.|participants|Number|57|57.0||||||
4382051|NCT00320541|4208739|B1|||Prior Chemotherapy for This Cancer|Number of participants, by treatment arm, who received prior chemotherapy for this cancer. NOTE: The total number of participants who received prior chemotherapy does not equal the total number of participants in the trial because not all participants received prior chemotherapy.|participants|Number|55|55.0||||||
4382052|NCT00320541|4208737|B3|||Prior Cancer Surgery|Number of participants, by treatment arm, who underwent prior surgery. NOTE: The total number of participants who underwent prior surgery does not equal the total number of participants in the trial because not all participants underwent prior surgery.|participants|Number|161|161.0||||||
4382053|NCT00320541|4208738|B2|||Prior Cancer Surgery|Number of participants, by treatment arm, who underwent prior surgery. NOTE: The total number of participants who underwent prior surgery does not equal the total number of participants in the trial because not all participants underwent prior surgery.|participants|Number|82|82.0||||||
4382054|NCT00320541|4208739|B1|||Prior Cancer Surgery|Number of participants, by treatment arm, who underwent prior surgery. NOTE: The total number of participants who underwent prior surgery does not equal the total number of participants in the trial because not all participants underwent prior surgery.|participants|Number|79|79.0||||||
4382055|NCT00320541|4208737|B3|||Prior Biological Treatment for This Cancer|Number of participants, by treatment arm, who had received prior biological treatment for this cancer. NOTE: The total number of participants who received prior biological treatment does not equal the total number of participants in the trial because not all participants received prior biological treatment.|participants|Number|2|2.0||||||
4382056|NCT00320541|4208738|B2|||Prior Biological Treatment for This Cancer|Number of participants, by treatment arm, who had received prior biological treatment for this cancer. NOTE: The total number of participants who received prior biological treatment does not equal the total number of participants in the trial because not all participants received prior biological treatment.|participants|Number|2|2.0||||||
4382057|NCT00320541|4208739|B1|||Prior Biological Treatment for This Cancer|Number of participants, by treatment arm, who had received prior biological treatment for this cancer. NOTE: The total number of participants who received prior biological treatment does not equal the total number of participants in the trial because not all participants received prior biological treatment.|participants|Number|0|0.0||||||
4382058|NCT00320541|4208737|B3|Missing||Presence of Visceral Metastases|Presence of visceral metastases at baseline visit|participants|Number|4|4.0||||||
4382059|NCT00320541|4208738|B2|Missing||Presence of Visceral Metastases|Presence of visceral metastases at baseline visit|participants|Number|3|3.0||||||
4382060|NCT00320541|4208739|B1|Missing||Presence of Visceral Metastases|Presence of visceral metastases at baseline visit|participants|Number|1|1.0||||||
4382061|NCT00320541|4208737|B3|No||Presence of Visceral Metastases|Presence of visceral metastases at baseline visit|participants|Number|49|49.0||||||
4382062|NCT00320541|4208738|B2|No||Presence of Visceral Metastases|Presence of visceral metastases at baseline visit|participants|Number|24|24.0||||||
4382063|NCT00320541|4208739|B1|No||Presence of Visceral Metastases|Presence of visceral metastases at baseline visit|participants|Number|25|25.0||||||
4382064|NCT00320541|4208737|B3|Yes||Presence of Visceral Metastases|Presence of visceral metastases at baseline visit|participants|Number|134|134.0||||||
4382065|NCT00320541|4208738|B2|Yes||Presence of Visceral Metastases|Presence of visceral metastases at baseline visit|participants|Number|66|66.0||||||
4382066|NCT00320541|4208739|B1|Yes||Presence of Visceral Metastases|Presence of visceral metastases at baseline visit|participants|Number|68|68.0||||||
4382067|NCT00320541|4208737|B3|Unknown||Menopausal Status|Breakdown of menopausal status|participants|Number|1|1.0||||||
4382068|NCT00320541|4208738|B2|Unknown||Menopausal Status|Breakdown of menopausal status|participants|Number|1|1.0||||||
4382069|NCT00320541|4208739|B1|Unknown||Menopausal Status|Breakdown of menopausal status|participants|Number|0|0.0||||||
4382070|NCT00320541|4208737|B3|Post-menopausal||Menopausal Status|Breakdown of menopausal status|participants|Number|143|143.0||||||
4382071|NCT00320541|4208738|B2|Post-menopausal||Menopausal Status|Breakdown of menopausal status|participants|Number|70|70.0||||||
4382072|NCT00320541|4208739|B1|Post-menopausal||Menopausal Status|Breakdown of menopausal status|participants|Number|73|73.0||||||
4382073|NCT00320541|4208737|B3|Peri-menopausal||Menopausal Status|Breakdown of menopausal status|participants|Number|5|5.0||||||
4382074|NCT00320541|4208738|B2|Peri-menopausal||Menopausal Status|Breakdown of menopausal status|participants|Number|3|3.0||||||
4382075|NCT00320541|4208739|B1|Peri-menopausal||Menopausal Status|Breakdown of menopausal status|participants|Number|2|2.0||||||
4382076|NCT00320541|4208737|B3|Pre-menopausal||Menopausal Status|Breakdown of menopausal status|participants|Number|36|36.0||||||
4382077|NCT00320541|4208738|B2|Pre-menopausal||Menopausal Status|Breakdown of menopausal status|participants|Number|18|18.0||||||
4382078|NCT00320541|4208739|B1|Pre-menopausal||Menopausal Status|Breakdown of menopausal status|participants|Number|18|18.0||||||
4382079|NCT00320541|4208737|B3|Not done||Menopausal Status|Breakdown of menopausal status|participants|Number|2|2.0||||||
4382080|NCT00320541|4208738|B2|Not done||Menopausal Status|Breakdown of menopausal status|participants|Number|1|1.0||||||
4382081|NCT00320541|4208739|B1|Not done||Menopausal Status|Breakdown of menopausal status|participants|Number|1|1.0||||||
4382082|NCT00320541|4208737|B3|Other||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|8|8.0||||||
4382083|NCT00320541|4208738|B2|Other||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|5|5.0||||||
4382084|NCT00320541|4208739|B1|Other||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|3|3.0||||||
4382085|NCT00320541|4208737|B3|Breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|9|9.0||||||
4382086|NCT00320541|4208738|B2|Breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|3|3.0||||||
4382087|NCT00320541|4208739|B1|Breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|6|6.0||||||
4382088|NCT00320541|4208737|B3|Papillar breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|0|0.0||||||
4382089|NCT00320541|4208738|B2|Papillar breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|0|0.0||||||
4382090|NCT00320541|4208739|B1|Papillar breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|0|0.0||||||
4382091|NCT00320541|4208737|B3|Adenocystic breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|0|0.0||||||
4382092|NCT00320541|4208738|B2|Adenocystic breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|0|0.0||||||
4382093|NCT00320541|4208739|B1|Adenocystic breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|0|0.0||||||
4382094|NCT00320541|4208737|B3|Medullary breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|0|0.0||||||
4382095|NCT00320541|4208738|B2|Medullary breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|0|0.0||||||
4382096|NCT00320541|4208739|B1|Medullary breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|0|0.0||||||
4382097|NCT00320541|4208737|B3|Tubal breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|0|0.0||||||
4382351|NCT00320489|4208812|B2|Slovakia||Region of Enrollment||participants|Number|15|15.0||||||
4382098|NCT00320541|4208738|B2|Tubal breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|0|0.0||||||
4382099|NCT00320541|4208739|B1|Tubal breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|0|0.0||||||
4382100|NCT00320541|4208737|B3|Lobal breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|15|15.0||||||
4382101|NCT00320541|4208738|B2|Lobal breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|6|6.0||||||
4382102|NCT00320541|4208739|B1|Lobal breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|9|9.0||||||
4382103|NCT00320541|4208737|B3|Ductal breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|155|155.0||||||
4382104|NCT00320541|4208738|B2|Ductal breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|79|79.0||||||
4382105|NCT00320541|4208739|B1|Ductal breast carcinoma||Diagnosis by pathology|Pathology of breast cancer diagnosis|participants|Number|76|76.0||||||
4382106|NCT00320541|4208737|B3|Not applicable||Breakdown of Disease-free Interval|Breakdown by treatment arm of disease-free interval which was defined as the duration between prior adjuvant chemotherapy stop date and disease recurrence date for applicable participants who received adjuvant chemotherapy.|participants|Number|164|164.0||||||
4382107|NCT00320541|4208738|B2|Not applicable||Breakdown of Disease-free Interval|Breakdown by treatment arm of disease-free interval which was defined as the duration between prior adjuvant chemotherapy stop date and disease recurrence date for applicable participants who received adjuvant chemotherapy.|participants|Number|81|81.0||||||
4382108|NCT00320541|4208739|B1|Not applicable||Breakdown of Disease-free Interval|Breakdown by treatment arm of disease-free interval which was defined as the duration between prior adjuvant chemotherapy stop date and disease recurrence date for applicable participants who received adjuvant chemotherapy.|participants|Number|83|83.0||||||
4382109|NCT00320541|4208737|B3|Greater than 24 months||Breakdown of Disease-free Interval|Breakdown by treatment arm of disease-free interval which was defined as the duration between prior adjuvant chemotherapy stop date and disease recurrence date for applicable participants who received adjuvant chemotherapy.|participants|Number|8|8.0||||||
4382110|NCT00320541|4208738|B2|Greater than 24 months||Breakdown of Disease-free Interval|Breakdown by treatment arm of disease-free interval which was defined as the duration between prior adjuvant chemotherapy stop date and disease recurrence date for applicable participants who received adjuvant chemotherapy.|participants|Number|2|2.0||||||
4382111|NCT00320541|4208739|B1|Greater than 24 months||Breakdown of Disease-free Interval|Breakdown by treatment arm of disease-free interval which was defined as the duration between prior adjuvant chemotherapy stop date and disease recurrence date for applicable participants who received adjuvant chemotherapy.|participants|Number|6|6.0||||||
4382112|NCT00320541|4208737|B3|Less than or equal to 24 months||Breakdown of Disease-free Interval|Breakdown by treatment arm of disease-free interval which was defined as the duration between prior adjuvant chemotherapy stop date and disease recurrence date for applicable participants who received adjuvant chemotherapy.|participants|Number|15|15.0||||||
4382113|NCT00320541|4208738|B2|Less than or equal to 24 months||Breakdown of Disease-free Interval|Breakdown by treatment arm of disease-free interval which was defined as the duration between prior adjuvant chemotherapy stop date and disease recurrence date for applicable participants who received adjuvant chemotherapy.|participants|Number|10|10.0||||||
4382114|NCT00320541|4208739|B1|Less than or equal to 24 months||Breakdown of Disease-free Interval|Breakdown by treatment arm of disease-free interval which was defined as the duration between prior adjuvant chemotherapy stop date and disease recurrence date for applicable participants who received adjuvant chemotherapy.|participants|Number|5|5.0||||||
4382115|NCT00320541|4208737|B3|Unknown||Breakdown by Progesterone Receptor (PR) Status|Breakdown of participants by PR status|participants|Number|2|2.0||||||
4382116|NCT00320541|4208738|B2|Unknown||Breakdown by Progesterone Receptor (PR) Status|Breakdown of participants by PR status|participants|Number|1|1.0||||||
4382117|NCT00320541|4208739|B1|Unknown||Breakdown by Progesterone Receptor (PR) Status|Breakdown of participants by PR status|participants|Number|1|1.0||||||
4382118|NCT00320541|4208737|B3|Negative||Breakdown by Progesterone Receptor (PR) Status|Breakdown of participants by PR status|participants|Number|85|85.0||||||
4382119|NCT00320541|4208738|B2|Negative||Breakdown by Progesterone Receptor (PR) Status|Breakdown of participants by PR status|participants|Number|35|35.0||||||
4382120|NCT00320541|4208739|B1|Negative||Breakdown by Progesterone Receptor (PR) Status|Breakdown of participants by PR status|participants|Number|50|50.0||||||
4382121|NCT00320541|4208737|B3|Positive||Breakdown by Progesterone Receptor (PR) Status|Breakdown of participants by PR status|participants|Number|99|99.0||||||
4382122|NCT00320541|4208738|B2|Positive||Breakdown by Progesterone Receptor (PR) Status|Breakdown of participants by PR status|participants|Number|57|57.0||||||
4382123|NCT00320541|4208739|B1|Positive||Breakdown by Progesterone Receptor (PR) Status|Breakdown of participants by PR status|participants|Number|42|42.0||||||
4382124|NCT00320541|4208737|B3|Not done||Breakdown by Progesterone Receptor (PR) Status|Breakdown of participants by PR status|participants|Number|1|1.0||||||
4382125|NCT00320541|4208738|B2|Not done||Breakdown by Progesterone Receptor (PR) Status|Breakdown of participants by PR status|participants|Number|0|0.0||||||
4382126|NCT00320541|4208739|B1|Not done||Breakdown by Progesterone Receptor (PR) Status|Breakdown of participants by PR status|participants|Number|1|1.0||||||
4382127|NCT00320541|4208737|B3|Missing||Breakdown by Human Epidermal Growth Factor (HER-2 NEU) Status|Breakdown of participants by HER-2 NEU status|participants|Number|1|1.0||||||
4382128|NCT00320541|4208738|B2|Missing||Breakdown by Human Epidermal Growth Factor (HER-2 NEU) Status|Breakdown of participants by HER-2 NEU status|participants|Number|1|1.0||||||
4382129|NCT00320541|4208739|B1|Missing||Breakdown by Human Epidermal Growth Factor (HER-2 NEU) Status|Breakdown of participants by HER-2 NEU status|participants|Number|0|0.0||||||
4382130|NCT00320541|4208737|B3|Negative||Breakdown by Human Epidermal Growth Factor (HER-2 NEU) Status|Breakdown of participants by HER-2 NEU status|participants|Number|173|173.0||||||
4382131|NCT00320541|4208738|B2|Negative||Breakdown by Human Epidermal Growth Factor (HER-2 NEU) Status|Breakdown of participants by HER-2 NEU status|participants|Number|86|86.0||||||
4382132|NCT00320541|4208739|B1|Negative||Breakdown by Human Epidermal Growth Factor (HER-2 NEU) Status|Breakdown of participants by HER-2 NEU status|participants|Number|87|87.0||||||
4382133|NCT00320541|4208737|B3|Positive||Breakdown by Human Epidermal Growth Factor (HER-2 NEU) Status|Breakdown of participants by HER-2 NEU status|participants|Number|6|6.0||||||
4382134|NCT00320541|4208738|B2|Positive||Breakdown by Human Epidermal Growth Factor (HER-2 NEU) Status|Breakdown of participants by HER-2 NEU status|participants|Number|2|2.0||||||
4382135|NCT00320541|4208739|B1|Positive||Breakdown by Human Epidermal Growth Factor (HER-2 NEU) Status|Breakdown of participants by HER-2 NEU status|participants|Number|4|4.0||||||
4382136|NCT00320541|4208737|B3|Not done||Breakdown by Human Epidermal Growth Factor (HER-2 NEU) Status|Breakdown of participants by HER-2 NEU status|participants|Number|7|7.0||||||
4382137|NCT00320541|4208738|B2|Not done||Breakdown by Human Epidermal Growth Factor (HER-2 NEU) Status|Breakdown of participants by HER-2 NEU status|participants|Number|4|4.0||||||
4382138|NCT00320541|4208739|B1|Not done||Breakdown by Human Epidermal Growth Factor (HER-2 NEU) Status|Breakdown of participants by HER-2 NEU status|participants|Number|3|3.0||||||
4382139|NCT00320541|4208737|B3|Unknown||Breakdown by Estrogen Receptor (ER) Status|Breakdown of participants by ER status|participants|Number|2|2.0||||||
4382140|NCT00320541|4208738|B2|Unknown||Breakdown by Estrogen Receptor (ER) Status|Breakdown of participants by ER status|participants|Number|1|1.0||||||
4382141|NCT00320541|4208739|B1|Unknown||Breakdown by Estrogen Receptor (ER) Status|Breakdown of participants by ER status|participants|Number|1|1.0||||||
4382142|NCT00320541|4208737|B3|Negative||Breakdown by Estrogen Receptor (ER) Status|Breakdown of participants by ER status|participants|Number|58|58.0||||||
4382143|NCT00320541|4208738|B2|Negative||Breakdown by Estrogen Receptor (ER) Status|Breakdown of participants by ER status|participants|Number|25|25.0||||||
4382144|NCT00320541|4208739|B1|Negative||Breakdown by Estrogen Receptor (ER) Status|Breakdown of participants by ER status|participants|Number|33|33.0||||||
4382145|NCT00320541|4208737|B3|Positive||Breakdown by Estrogen Receptor (ER) Status|Breakdown of participants by ER status|participants|Number|127|127.0||||||
4382146|NCT00320541|4208738|B2|Positive||Breakdown by Estrogen Receptor (ER) Status|Breakdown of participants by ER status|participants|Number|67|67.0||||||
4382147|NCT00320541|4208739|B1|Positive||Breakdown by Estrogen Receptor (ER) Status|Breakdown of participants by ER status|participants|Number|60|60.0||||||
4382148|NCT00320541|4208737|B3|Missing||Breakdown According to Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). In this study, ECOG performance status was assessed within 14 days of Visit 1. Patients were required to have a baseline ECOG Performance Status of 0 or 1 for study participation.|participants|Number|2|2.0||||||
4382149|NCT00320541|4208738|B2|Missing||Breakdown According to Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). In this study, ECOG performance status was assessed within 14 days of Visit 1. Patients were required to have a baseline ECOG Performance Status of 0 or 1 for study participation.|participants|Number|2|2.0||||||
4382150|NCT00320541|4208739|B1|Missing||Breakdown According to Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). In this study, ECOG performance status was assessed within 14 days of Visit 1. Patients were required to have a baseline ECOG Performance Status of 0 or 1 for study participation.|participants|Number|0|0.0||||||
4382151|NCT00320541|4208737|B3|Ambulatory, Restricted Strenuous Activity- 1||Breakdown According to Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). In this study, ECOG performance status was assessed within 14 days of Visit 1. Patients were required to have a baseline ECOG Performance Status of 0 or 1 for study participation.|participants|Number|68|68.0||||||
4382152|NCT00320541|4208738|B2|Ambulatory, Restricted Strenuous Activity- 1||Breakdown According to Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). In this study, ECOG performance status was assessed within 14 days of Visit 1. Patients were required to have a baseline ECOG Performance Status of 0 or 1 for study participation.|participants|Number|31|31.0||||||
4382153|NCT00320541|4208739|B1|Ambulatory, Restricted Strenuous Activity- 1||Breakdown According to Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). In this study, ECOG performance status was assessed within 14 days of Visit 1. Patients were required to have a baseline ECOG Performance Status of 0 or 1 for study participation.|participants|Number|37|37.0||||||
4382154|NCT00320541|4208737|B3|Fully Active- 0||Breakdown According to Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). In this study, ECOG performance status was assessed within 14 days of Visit 1. Patients were required to have a baseline ECOG Performance Status of 0 or 1 for study participation.|participants|Number|117|117.0||||||
4382155|NCT00320541|4208738|B2|Fully Active- 0||Breakdown According to Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). In this study, ECOG performance status was assessed within 14 days of Visit 1. Patients were required to have a baseline ECOG Performance Status of 0 or 1 for study participation.|participants|Number|60|60.0||||||
4382156|NCT00320541|4208739|B1|Fully Active- 0||Breakdown According to Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG Performance Status classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death). In this study, ECOG performance status was assessed within 14 days of Visit 1. Patients were required to have a baseline ECOG Performance Status of 0 or 1 for study participation.|participants|Number|57|57.0||||||
4382157|NCT00320541|4208737|B3|Missing||Basis for Pathological Diagnosis|Methodology used for obtaining pathological diagnosis|participants|Number|1|1.0||||||
4382352|NCT00320489|4208813|B1|Slovakia||Region of Enrollment||participants|Number|14|14.0||||||
4382158|NCT00320541|4208738|B2|Missing||Basis for Pathological Diagnosis|Methodology used for obtaining pathological diagnosis|participants|Number|1|1.0||||||
4382159|NCT00320541|4208739|B1|Missing||Basis for Pathological Diagnosis|Methodology used for obtaining pathological diagnosis|participants|Number|0|0.0||||||
4382160|NCT00320541|4208737|B3|Cytological||Basis for Pathological Diagnosis|Methodology used for obtaining pathological diagnosis|participants|Number|18|18.0||||||
4382161|NCT00320541|4208738|B2|Cytological||Basis for Pathological Diagnosis|Methodology used for obtaining pathological diagnosis|participants|Number|8|8.0||||||
4382162|NCT00320541|4208739|B1|Cytological||Basis for Pathological Diagnosis|Methodology used for obtaining pathological diagnosis|participants|Number|10|10.0||||||
4382163|NCT00320541|4208737|B3|Histopathological||Basis for Pathological Diagnosis|Methodology used for obtaining pathological diagnosis|participants|Number|168|168.0||||||
4382164|NCT00320541|4208738|B2|Histopathological||Basis for Pathological Diagnosis|Methodology used for obtaining pathological diagnosis|participants|Number|84|84.0||||||
4382165|NCT00320541|4208739|B1|Histopathological||Basis for Pathological Diagnosis|Methodology used for obtaining pathological diagnosis|participants|Number|84|84.0||||||
4382166|NCT00320541|4208737|B3|United States||Region of Enrollment||participants|Number|187|187.0||||||
4382167|NCT00320541|4208738|B2|United States||Region of Enrollment||participants|Number|93|93.0||||||
4382168|NCT00320541|4208739|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
4382169|NCT00320541|4208737|B3|East Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4382170|NCT00320541|4208738|B2|East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4382171|NCT00320541|4208739|B1|East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4382172|NCT00320541|4208737|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4382173|NCT00320541|4208738|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4382174|NCT00320541|4208739|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4382175|NCT00320541|4208737|B3|African||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4382176|NCT00320541|4208738|B2|African||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4382177|NCT00320541|4208739|B1|African||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4382178|NCT00320541|4208737|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|157|157.0||||||
4382179|NCT00320541|4208738|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4382180|NCT00320541|4208739|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4382181|NCT00320541|4208737|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4382182|NCT00320541|4208738|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4382183|NCT00320541|4208739|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4382184|NCT00320541|4208737|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4382185|NCT00320541|4208738|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4382186|NCT00320541|4208739|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4382187|NCT00320541|4208737|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|10.12|10.12|||
4382188|NCT00320541|4208738|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|9.56|9.56|||
4382189|NCT00320541|4208739|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|10.68|10.68|||
4382190|NCT00320528|4208764|B4|Oppositional Subscale (N=97, N=38, N=127)||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|14.27|14.27|Standard Deviation|5.51|5.51|||
4382191|NCT00320528|4208765|B3|Oppositional Subscale (N=97, N=38, N=127)||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|17.99|17.99|Standard Deviation|3.57|3.57|||
4382192|NCT00320528|4208766|B2|Oppositional Subscale (N=97, N=38, N=127)||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|12.32|12.32|Standard Deviation|4.67|4.67|||
4382193|NCT00320528|4208767|B1|Oppositional Subscale (N=97, N=38, N=127)||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|10.15|10.15|Standard Deviation|4.54|4.54|||
4382194|NCT00320528|4208764|B4|Combined Type Subscale (N=97, N=38, N=127)||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|40.58|40.58|Standard Deviation|7.20|7.2|||
4382195|NCT00320528|4208765|B3|Combined Type Subscale (N=97, N=38, N=127)||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|42.91|42.91|Standard Deviation|5.51|5.51|||
4382196|NCT00320528|4208766|B2|Combined Type Subscale (N=97, N=38, N=127)||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|40.68|40.68|Standard Deviation|7.87|7.87|||
4382197|NCT00320528|4208767|B1|Combined Type Subscale (N=97, N=38, N=127)||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|37.48|37.48|Standard Deviation|7.78|7.78|||
4382198|NCT00320528|4208764|B4|Hyperactivity/Impulsivity Subscale (N=97, N=38, N=||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|19.42|19.42|Standard Deviation|5.19|5.19|||
4382199|NCT00320528|4208765|B3|Hyperactivity/Impulsivity Subscale (N=97, N=38, N=||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|21.04|21.04|Standard Deviation|3.48|3.48|||
4382200|NCT00320528|4208766|B2|Hyperactivity/Impulsivity Subscale (N=97, N=38, N=||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|19.66|19.66|Standard Deviation|5.54|5.54|||
4382201|NCT00320528|4208767|B1|Hyperactivity/Impulsivity Subscale (N=97, N=38, N=||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|17.21|17.21|Standard Deviation|6.10|6.1|||
4382202|NCT00320528|4208764|B4|Inattention Subscale (N=97, N=38, N=127)||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|21.16|21.16|Standard Deviation|3.85|3.85|||
4382302|NCT00320489|4208811|B3|||Clinical Global Impressions of Severity (CGI-S)|CGI-S measures severity of illness at baseline. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|Units on a scale|Mean|3.25|3.25|Standard Deviation|0.72|0.72|||
4382353|NCT00320489|4208811|B3|Taiwan||Region of Enrollment||participants|Number|39|39.0||||||
4382203|NCT00320528|4208765|B3|Inattention Subscale (N=97, N=38, N=127)||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|21.87|21.87|Standard Deviation|3.48|3.48|||
4382204|NCT00320528|4208766|B2|Inattention Subscale (N=97, N=38, N=127)||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|21.03|21.03|Standard Deviation|3.72|3.72|||
4382205|NCT00320528|4208767|B1|Inattention Subscale (N=97, N=38, N=127)||Swanson, Nolan, and Pelham Rating Scale Revised (SNAP-IV)|The SNAP-IV is a 26-item scale that includes 1 item for each of the 18 symptoms contained in the DSM-IV diagnosis of ADHD and 1 item for each of the 8 symptoms contained in the DSM-IV diagnosis of ODD. Each item is score on 0 to 3 scale (0 = “Not at All”, 1 = “Just a Little”, 2 = “Pretty Much”, 3 = “Very Much”). The SNAP-IV yields scores in three domains: Inattention (items 1-9: subscore range=0-27), Hyperactivity/impulsivity (items 10-18: subscale range=0-27), and Oppositional (items 19-26: subscale range=0-24). Combined type (inattention + hyperactivity/impulsivity) scores range from 0-54.|units on a scale|Mean|20.28|20.28|Standard Deviation|4.19|4.19|||
4382206|NCT00320528|4208764|B4|||Pediatric Anxiety Rating Scale (PARS)|The Pediatric Anxiety Rating Scale (PARS) is used to rate the severity of anxiety in children and adolescents, ages 6 to 17 years. The total score for the PARS is derived by summing 5 of the 7 severity/impairment/interference items (2,3,5,6,7). The total score ranges from 0 (none) to 25 (extreme severity). Items 1 (overall number of anxiety symptoms) and 4 (overall severity of physical symptoms) are not included in the total score calculation.|units on a scale|Mean|4.28|4.28|Standard Deviation|4.76|4.76|||
4382207|NCT00320528|4208765|B3|||Pediatric Anxiety Rating Scale (PARS)|The Pediatric Anxiety Rating Scale (PARS) is used to rate the severity of anxiety in children and adolescents, ages 6 to 17 years. The total score for the PARS is derived by summing 5 of the 7 severity/impairment/interference items (2,3,5,6,7). The total score ranges from 0 (none) to 25 (extreme severity). Items 1 (overall number of anxiety symptoms) and 4 (overall severity of physical symptoms) are not included in the total score calculation.|units on a scale|Mean|4.67|4.67|Standard Deviation|5.12|5.12|||
4382208|NCT00320528|4208766|B2|||Pediatric Anxiety Rating Scale (PARS)|The Pediatric Anxiety Rating Scale (PARS) is used to rate the severity of anxiety in children and adolescents, ages 6 to 17 years. The total score for the PARS is derived by summing 5 of the 7 severity/impairment/interference items (2,3,5,6,7). The total score ranges from 0 (none) to 25 (extreme severity). Items 1 (overall number of anxiety symptoms) and 4 (overall severity of physical symptoms) are not included in the total score calculation.|units on a scale|Mean|7.50|7.5|Standard Deviation|5.68|5.68|||
4382209|NCT00320528|4208767|B1|||Pediatric Anxiety Rating Scale (PARS)|The Pediatric Anxiety Rating Scale (PARS) is used to rate the severity of anxiety in children and adolescents, ages 6 to 17 years. The total score for the PARS is derived by summing 5 of the 7 severity/impairment/interference items (2,3,5,6,7). The total score ranges from 0 (none) to 25 (extreme severity). Items 1 (overall number of anxiety symptoms) and 4 (overall severity of physical symptoms) are not included in the total score calculation.|units on a scale|Mean|2.50|2.5|Standard Deviation|2.67|2.67|||
4382210|NCT00320528|4208764|B4|ADHD Index||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|23.70|23.7|Standard Deviation|6.52|6.52|||
4382211|NCT00320528|4208765|B3|ADHD Index||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|25.18|25.18|Standard Deviation|6.07|6.07|||
4382212|NCT00320528|4208766|B2|ADHD Index||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|22.94|22.94|Standard Deviation|6.01|6.01|||
4382213|NCT00320528|4208767|B1|ADHD Index||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|22.14|22.14|Standard Deviation|6.86|6.86|||
4382214|NCT00320528|4208764|B4|Hyperactivity||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|13.05|13.05|Standard Deviation|5.74|5.74|||
4382215|NCT00320528|4208765|B3|Hyperactivity||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|14.67|14.67|Standard Deviation|5.15|5.15|||
4382354|NCT00320489|4208812|B2|Taiwan||Region of Enrollment||participants|Number|19|19.0||||||
4382216|NCT00320528|4208766|B2|Hyperactivity||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|12.03|12.03|Standard Deviation|5.21|5.21|||
4382217|NCT00320528|4208767|B1|Hyperactivity||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|11.38|11.38|Standard Deviation|6.09|6.09|||
4382218|NCT00320528|4208764|B4|Cognitive Problems||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|7.88|7.88|Standard Deviation|3.67|3.67|||
4382219|NCT00320528|4208765|B3|Cognitive Problems||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|7.96|7.96|Standard Deviation|3.61|3.61|||
4382220|NCT00320528|4208766|B2|Cognitive Problems||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|7.68|7.68|Standard Deviation|3.80|3.8|||
4382221|NCT00320528|4208767|B1|Cognitive Problems||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|7.86|7.86|Standard Deviation|3.73|3.73|||
4382222|NCT00320528|4208764|B4|Oppositional||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|7.10|7.1|Standard Deviation|5.05|5.05|||
4382223|NCT00320528|4208765|B3|Oppositional||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|8.62|8.62|Standard Deviation|4.83|4.83|||
4382224|NCT00320528|4208766|B2|Oppositional||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|4.97|4.97|Standard Deviation|4.66|4.66|||
4382225|NCT00320528|4208767|B1|Oppositional||Conners' Teacher Rating Scale-Revised:Short Form (CTRS-R:S)|A 28-item rating scale (0 [not at all/never] to 3 [very much true/very often]) completed by the teacher to assess problem behaviors related to ADHD. Subscale total scores range from 0 to 15 for Oppositional and Cognitive Problems, 0 to 21 for Hyperactivity, and 0 to 36 for ADHD Index.|units on a scale|Mean|5.97|5.97|Standard Deviation|4.93|4.93|||
4382226|NCT00320528|4208764|B4|||Clinical Global Impression-Attention Deficit Hyperactivity Disorder-Severity Scale (CGI-ADHD-S)|Measures severity of the patient's overall severity of ADHD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|4.85|4.85|Standard Deviation|0.80|0.8|||
4382227|NCT00320528|4208765|B3|||Clinical Global Impression-Attention Deficit Hyperactivity Disorder-Severity Scale (CGI-ADHD-S)|Measures severity of the patient's overall severity of ADHD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|4.98|4.98|Standard Deviation|0.78|0.78|||
4382228|NCT00320528|4208766|B2|||Clinical Global Impression-Attention Deficit Hyperactivity Disorder-Severity Scale (CGI-ADHD-S)|Measures severity of the patient's overall severity of ADHD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|4.97|4.97|Standard Deviation|0.79|0.79|||
4382229|NCT00320528|4208767|B1|||Clinical Global Impression-Attention Deficit Hyperactivity Disorder-Severity Scale (CGI-ADHD-S)|Measures severity of the patient's overall severity of ADHD symptoms (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|4.64|4.64|Standard Deviation|0.79|0.79|||
4382230|NCT00320528|4208764|B4|||Children's Depression Rating Scale-Revised (CDRS-R)|Measures presence and severity of depression. Consists of 17 items scored on a 1-5 or 1-7 scale. A rating of 1 indicates normal, thus the minimum score is 17. The maximum score is 113. In general, scores below 20 indicate an absence of depression; scores of 20 or 30 indicate borderline depression; scores of 40 to 60 indicate moderate depression.|units on a scale|Mean|41.26|41.26|Standard Deviation|13.35|13.35|||
4382231|NCT00320528|4208765|B3|||Children's Depression Rating Scale-Revised (CDRS-R)|Measures presence and severity of depression. Consists of 17 items scored on a 1-5 or 1-7 scale. A rating of 1 indicates normal, thus the minimum score is 17. The maximum score is 113. In general, scores below 20 indicate an absence of depression; scores of 20 or 30 indicate borderline depression; scores of 40 to 60 indicate moderate depression.|units on a scale|Mean|43.06|43.06|Standard Deviation|13.69|13.69|||
4382232|NCT00320528|4208766|B2|||Children's Depression Rating Scale-Revised (CDRS-R)|Measures presence and severity of depression. Consists of 17 items scored on a 1-5 or 1-7 scale. A rating of 1 indicates normal, thus the minimum score is 17. The maximum score is 113. In general, scores below 20 indicate an absence of depression; scores of 20 or 30 indicate borderline depression; scores of 40 to 60 indicate moderate depression.|units on a scale|Mean|43.76|43.76|Standard Deviation|13.48|13.48|||
4382233|NCT00320528|4208767|B1|||Children's Depression Rating Scale-Revised (CDRS-R)|Measures presence and severity of depression. Consists of 17 items scored on a 1-5 or 1-7 scale. A rating of 1 indicates normal, thus the minimum score is 17. The maximum score is 113. In general, scores below 20 indicate an absence of depression; scores of 20 or 30 indicate borderline depression; scores of 40 to 60 indicate moderate depression.|units on a scale|Mean|37.93|37.93|Standard Deviation|12.26|12.26|||
4382234|NCT00320528|4208764|B4|Risk Avoidance (N=96, N=33, N=121)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|27.38|27.38|Standard Deviation|12.01|12.01|||
4382235|NCT00320528|4208765|B3|Risk Avoidance (N=96, N=33, N=121)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|22.85|22.85|Standard Deviation|12.00|12.0|||
4382236|NCT00320528|4208766|B2|Risk Avoidance (N=96, N=33, N=121)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|30.48|30.48|Standard Deviation|12.29|12.29|||
4382237|NCT00320528|4208767|B1|Risk Avoidance (N=96, N=33, N=121)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|32.03|32.03|Standard Deviation|9.7|9.7|||
4382238|NCT00320528|4208764|B4|Resilience Domain (N=96, N=34, N=123)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|34.89|34.89|Standard Deviation|11.65|11.65|||
4382239|NCT00320528|4208765|B3|Resilience Domain (N=96, N=34, N=123)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|31.40|31.4|Standard Deviation|11.85|11.85|||
4382240|NCT00320528|4208766|B2|Resilience Domain (N=96, N=34, N=123)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|34.96|34.96|Standard Deviation|10.89|10.89|||
4382241|NCT00320528|4208767|B1|Resilience Domain (N=96, N=34, N=123)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|39.34|39.34|Standard Deviation|10.15|10.15|||
4382242|NCT00320528|4208764|B4|Comfort Domain (N=96, N=35, N=122)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|47.51|47.51|Standard Deviation|10.26|10.26|||
4382243|NCT00320528|4208765|B3|Comfort Domain (N=96, N=35, N=122)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|44.74|44.74|Standard Deviation|9.38|9.38|||
4382244|NCT00320528|4208766|B2|Comfort Domain (N=96, N=35, N=122)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|46.76|46.76|Standard Deviation|12.28|12.28|||
4382245|NCT00320528|4208767|B1|Comfort Domain (N=96, N=35, N=122)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|51.31|51.31|Standard Deviation|9.40|9.4|||
4382246|NCT00320528|4208764|B4|Satisfaction Domain (N=96, N=24, N=122)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|34.34|34.34|Standard Deviation|14.91|14.91|||
4382247|NCT00320528|4208765|B3|Satisfaction Domain (N=96, N=24, N=122)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|31.69|31.69|Standard Deviation|14.78|14.78|||
4382248|NCT00320528|4208766|B2|Satisfaction Domain (N=96, N=24, N=122)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|30.11|30.11|Standard Deviation|14.83|14.83|||
4382249|NCT00320528|4208767|B1|Satisfaction Domain (N=96, N=24, N=122)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|39.26|39.26|Standard Deviation|13.89|13.89|||
4382250|NCT00320528|4208764|B4|Achievement Domain (N=96, N=33, N=121)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|27.40|27.4|Standard Deviation|7.86|7.86|||
4382251|NCT00320528|4208765|B3|Achievement Domain (N=96, N=33, N=121)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|25.83|25.83|Standard Deviation|7.60|7.6|||
4382303|NCT00320489|4208812|B2|||Clinical Global Impressions of Severity (CGI-S)|CGI-S measures severity of illness at baseline. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|Units on a scale|Mean|3.26|3.26|Standard Deviation|0.66|0.66|||
4382355|NCT00320489|4208813|B1|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
4382356|NCT00320489|4208811|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
4382252|NCT00320528|4208766|B2|Achievement Domain (N=96, N=33, N=121)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|27.72|27.72|Standard Deviation|7.73|7.73|||
4382253|NCT00320528|4208767|B1|Achievement Domain (N=96, N=33, N=121)||Child Health and Illness Profile - Child Edition (CHIP-CE) - Achievement Domain|Parent-rated assessment of a child’s health status and level of functioning. It consists of 76 items. The majority of items assess frequency of activities or feelings using a five-point response format (for example, ‘how good is your child at making friends?’ 1=never, 5=always). Standard scores (t-value) were established, with all domains and subdomains having a mean score of 50 and standard deviation of 10. Standard scores are expressed in standard deviation units. Achievement Domain Range = -3.1 to 67.7. Higher scores mean greater health or level of functioning in achievement.|T-Score|Mean|29.27|29.27|Standard Deviation|7.89|7.89|||
4382254|NCT00320528|4208764|B4|East Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4382255|NCT00320528|4208765|B3|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4382256|NCT00320528|4208766|B2|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4382257|NCT00320528|4208767|B1|East Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4382258|NCT00320528|4208764|B4|Native American||Race/Ethnicity||participants|Number|3|3.0||||||
4382259|NCT00320528|4208765|B3|Native American||Race/Ethnicity||participants|Number|2|2.0||||||
4382260|NCT00320528|4208766|B2|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4382261|NCT00320528|4208767|B1|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4382262|NCT00320528|4208764|B4|African||Race/Ethnicity||participants|Number|3|3.0||||||
4382263|NCT00320528|4208765|B3|African||Race/Ethnicity||participants|Number|0|0.0||||||
4382264|NCT00320528|4208766|B2|African||Race/Ethnicity||participants|Number|0|0.0||||||
4382265|NCT00320528|4208767|B1|African||Race/Ethnicity||participants|Number|3|3.0||||||
4382266|NCT00320528|4208764|B4|Hispanic||Race/Ethnicity||participants|Number|5|5.0||||||
4382267|NCT00320528|4208765|B3|Hispanic||Race/Ethnicity||participants|Number|2|2.0||||||
4382268|NCT00320528|4208766|B2|Hispanic||Race/Ethnicity||participants|Number|2|2.0||||||
4382269|NCT00320528|4208767|B1|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4382270|NCT00320528|4208764|B4|Caucasian||Race/Ethnicity||participants|Number|250|250.0||||||
4382271|NCT00320528|4208765|B3|Caucasian||Race/Ethnicity||participants|Number|124|124.0||||||
4382272|NCT00320528|4208766|B2|Caucasian||Race/Ethnicity||participants|Number|36|36.0||||||
4382273|NCT00320528|4208767|B1|Caucasian||Race/Ethnicity||participants|Number|90|90.0||||||
4382274|NCT00320528|4208764|B4|Italy||Region of Enrollment||participants|Number|263|263.0||||||
4382275|NCT00320528|4208765|B3|Italy||Region of Enrollment||participants|Number|128|128.0||||||
4382276|NCT00320528|4208766|B2|Italy||Region of Enrollment||participants|Number|38|38.0||||||
4382277|NCT00320528|4208767|B1|Italy||Region of Enrollment||participants|Number|97|97.0||||||
4382278|NCT00320528|4208764|B4||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4382279|NCT00320528|4208765|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4382280|NCT00320528|4208766|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4382281|NCT00320528|4208767|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4382282|NCT00320528|4208764|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4382283|NCT00320528|4208765|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4382284|NCT00320528|4208766|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4382285|NCT00320528|4208767|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4382286|NCT00320528|4208764|B4|||Age||years|Mean|10.11|10.11|Standard Deviation|2.51|2.51|||
4382287|NCT00320528|4208765|B3|||Age||years|Mean|10.00|10.0|Standard Deviation|2.57|2.57|||
4382288|NCT00320528|4208766|B2|||Age||years|Mean|10.42|10.42|Standard Deviation|2.41|2.41|||
4382289|NCT00320528|4208767|B1|||Age||years|Mean|10.12|10.12|Standard Deviation|2.51|2.51|||
4382290|NCT00320515|4208804|B1|Hispanic||Race/Ethnicity||participants|Number|21|21.0||||||
4382291|NCT00320515|4208804|B1|East Asian||Race/Ethnicity||participants|Number|47|47.0||||||
4382292|NCT00320515|4208804|B1|Caucasian||Race/Ethnicity||participants|Number|1|1.0||||||
4382293|NCT00320515|4208804|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|27|27.0||||||
4382294|NCT00320515|4208804|B1|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|42|42.0||||||
4382295|NCT00320515|4208804|B1|Korea, Republic of||Region of Enrollment||participants|Number|25|25.0||||||
4382296|NCT00320515|4208804|B1|Argentina||Region of Enrollment||participants|Number|18|18.0||||||
4382297|NCT00320515|4208804|B1|Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4382298|NCT00320515|4208804|B1|Taiwan||Region of Enrollment||participants|Number|22|22.0||||||
4382299|NCT00320515|4208804|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4382300|NCT00320515|4208804|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4382301|NCT00320515|4208804|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|10.20|10.2|||
4382345|NCT00320489|4208812|B2|Puerto Rico||Region of Enrollment||participants|Number|8|8.0||||||
4382346|NCT00320489|4208813|B1|Puerto Rico||Region of Enrollment||participants|Number|8|8.0||||||
4382304|NCT00320489|4208813|B1|||Clinical Global Impressions of Severity (CGI-S)|CGI-S measures severity of illness at baseline. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|Units on a scale|Mean|3.24|3.24|Standard Deviation|0.77|0.77|||
4382305|NCT00320489|4208811|B3|PANSS General Pathology||Positivie and Negative Syndrome Scale (PANSS) Scores|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Scores for PANSS positive and negative each range from 7 to 49. Scores for General Psychopathology range from 16 to 112. The sum of all 30 items is defined as the PANSS total score and ranges from 30 to 210.|Units on a scale|Mean|27.91|27.91|Standard Deviation|5.19|5.19|||
4382306|NCT00320489|4208812|B2|PANSS General Pathology||Positivie and Negative Syndrome Scale (PANSS) Scores|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Scores for PANSS positive and negative each range from 7 to 49. Scores for General Psychopathology range from 16 to 112. The sum of all 30 items is defined as the PANSS total score and ranges from 30 to 210.|Units on a scale|Mean|27.81|27.81|Standard Deviation|4.92|4.92|||
4382307|NCT00320489|4208813|B1|PANSS General Pathology||Positivie and Negative Syndrome Scale (PANSS) Scores|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Scores for PANSS positive and negative each range from 7 to 49. Scores for General Psychopathology range from 16 to 112. The sum of all 30 items is defined as the PANSS total score and ranges from 30 to 210.|Units on a scale|Mean|28.00|28.0|Standard Deviation|5.45|5.45|||
4382308|NCT00320489|4208811|B3|PANSS Negative||Positivie and Negative Syndrome Scale (PANSS) Scores|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Scores for PANSS positive and negative each range from 7 to 49. Scores for General Psychopathology range from 16 to 112. The sum of all 30 items is defined as the PANSS total score and ranges from 30 to 210.|Units on a scale|Mean|16.06|16.06|Standard Deviation|4.08|4.08|||
4382309|NCT00320489|4208812|B2|PANSS Negative||Positivie and Negative Syndrome Scale (PANSS) Scores|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Scores for PANSS positive and negative each range from 7 to 49. Scores for General Psychopathology range from 16 to 112. The sum of all 30 items is defined as the PANSS total score and ranges from 30 to 210.|Units on a scale|Mean|16.28|16.28|Standard Deviation|3.93|3.93|||
4382310|NCT00320489|4208813|B1|PANSS Negative||Positivie and Negative Syndrome Scale (PANSS) Scores|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Scores for PANSS positive and negative each range from 7 to 49. Scores for General Psychopathology range from 16 to 112. The sum of all 30 items is defined as the PANSS total score and ranges from 30 to 210.|Units on a scale|Mean|15.84|15.84|Standard Deviation|4.23|4.23|||
4382311|NCT00320489|4208811|B3|PANSS Positive||Positivie and Negative Syndrome Scale (PANSS) Scores|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Scores for PANSS positive and negative each range from 7 to 49. Scores for General Psychopathology range from 16 to 112. The sum of all 30 items is defined as the PANSS total score and ranges from 30 to 210.|Units on a scale|Mean|12.67|12.67|Standard Deviation|3.49|3.49|||
4382312|NCT00320489|4208812|B2|PANSS Positive||Positivie and Negative Syndrome Scale (PANSS) Scores|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Scores for PANSS positive and negative each range from 7 to 49. Scores for General Psychopathology range from 16 to 112. The sum of all 30 items is defined as the PANSS total score and ranges from 30 to 210.|Units on a scale|Mean|12.40|12.4|Standard Deviation|3.33|3.33|||
4382313|NCT00320489|4208813|B1|PANSS Positive||Positivie and Negative Syndrome Scale (PANSS) Scores|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Scores for PANSS positive and negative each range from 7 to 49. Scores for General Psychopathology range from 16 to 112. The sum of all 30 items is defined as the PANSS total score and ranges from 30 to 210.|Units on a scale|Mean|12.93|12.93|Standard Deviation|3.62|3.62|||
4382314|NCT00320489|4208811|B3|PANSS Total||Positivie and Negative Syndrome Scale (PANSS) Scores|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Scores for PANSS positive and negative each range from 7 to 49. Scores for General Psychopathology range from 16 to 112. The sum of all 30 items is defined as the PANSS total score and ranges from 30 to 210.|Units on a scale|Mean|56.64|56.64|Standard Deviation|9.24|9.24|||
4382315|NCT00320489|4208812|B2|PANSS Total||Positivie and Negative Syndrome Scale (PANSS) Scores|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Scores for PANSS positive and negative each range from 7 to 49. Scores for General Psychopathology range from 16 to 112. The sum of all 30 items is defined as the PANSS total score and ranges from 30 to 210.|Units on a scale|Mean|56.50|56.5|Standard Deviation|8.70|8.7|||
4382347|NCT00320489|4208811|B3|Greece||Region of Enrollment||participants|Number|40|40.0||||||
4382348|NCT00320489|4208812|B2|Greece||Region of Enrollment||participants|Number|20|20.0||||||
4382349|NCT00320489|4208813|B1|Greece||Region of Enrollment||participants|Number|20|20.0||||||
4382350|NCT00320489|4208811|B3|Slovakia||Region of Enrollment||participants|Number|29|29.0||||||
4382316|NCT00320489|4208813|B1|PANSS Total||Positivie and Negative Syndrome Scale (PANSS) Scores|Assesses the positive symptoms, negative symptoms, and general psychopathology specifically associated with schizophrenia. The scale consists of 30 items. Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Scores for PANSS positive and negative each range from 7 to 49. Scores for General Psychopathology range from 16 to 112. The sum of all 30 items is defined as the PANSS total score and ranges from 30 to 210.|Units on a scale|Mean|56.78|56.78|Standard Deviation|9.76|9.76|||
4382317|NCT00320489|4208811|B3|||Number of Schizophrenic Episodes or Exacerbations in the Previous 24 Months|Number of episodes of clinical worsening of schizophrenia symptoms such that hospitalization or an increased level of care surrounding the episode was required. Increased level of care could include the addition of or change to any of the following from a lower level of care: day hospital program; outpatient crisis management; short-term psychiatric treatment in an emergency room; or an addition, increase, or switch of medication.|Episodes|Mean|2.73|2.73|Standard Deviation|1.63|1.63|||
4382318|NCT00320489|4208812|B2|||Number of Schizophrenic Episodes or Exacerbations in the Previous 24 Months|Number of episodes of clinical worsening of schizophrenia symptoms such that hospitalization or an increased level of care surrounding the episode was required. Increased level of care could include the addition of or change to any of the following from a lower level of care: day hospital program; outpatient crisis management; short-term psychiatric treatment in an emergency room; or an addition, increase, or switch of medication.|Episodes|Mean|2.67|2.67|Standard Deviation|1.43|1.43|||
4382319|NCT00320489|4208813|B1|||Number of Schizophrenic Episodes or Exacerbations in the Previous 24 Months|Number of episodes of clinical worsening of schizophrenia symptoms such that hospitalization or an increased level of care surrounding the episode was required. Increased level of care could include the addition of or change to any of the following from a lower level of care: day hospital program; outpatient crisis management; short-term psychiatric treatment in an emergency room; or an addition, increase, or switch of medication.|Episodes|Mean|2.78|2.78|Standard Deviation|1.81|1.81|||
4382320|NCT00320489|4208811|B3|||Age of Onset of Illness||Years|Mean|26.24|26.24|Standard Deviation|8.93|8.93|||
4382321|NCT00320489|4208812|B2|||Age of Onset of Illness||Years|Mean|26.52|26.52|Standard Deviation|8.65|8.65|||
4382322|NCT00320489|4208813|B1|||Age of Onset of Illness||Years|Mean|25.95|25.95|Standard Deviation|9.21|9.21|||
4382323|NCT00320489|4208811|B3|||Length of Current Schizophrenic Episode|Length of episodes of clinical worsening of schizophrenia symptoms such that hospitalization or an increased level of care surrounding the episode was required. Increased level of care could include the addition of or change to any of the following from a lower level of care: day hospital program; outpatient crisis management; short-term psychiatric treatment in an emergency room; or an addition, increase, or switch of medication.|Days|Mean|174.98|174.98|Standard Deviation|147.98|147.98|||
4382324|NCT00320489|4208812|B2|||Length of Current Schizophrenic Episode|Length of episodes of clinical worsening of schizophrenia symptoms such that hospitalization or an increased level of care surrounding the episode was required. Increased level of care could include the addition of or change to any of the following from a lower level of care: day hospital program; outpatient crisis management; short-term psychiatric treatment in an emergency room; or an addition, increase, or switch of medication.|Days|Mean|170.73|170.73|Standard Deviation|143.34|143.34|||
4382325|NCT00320489|4208813|B1|||Length of Current Schizophrenic Episode|Length of episodes of clinical worsening of schizophrenia symptoms such that hospitalization or an increased level of care surrounding the episode was required. Increased level of care could include the addition of or change to any of the following from a lower level of care: day hospital program; outpatient crisis management; short-term psychiatric treatment in an emergency room; or an addition, increase, or switch of medication.|Days|Mean|179.16|179.16|Standard Deviation|152.58|152.58|||
4382326|NCT00320489|4208811|B3|||Brief Psychiatric Rating Scale (BPRS) Total Score|BPRS is an 18-item clinician-administered scale used to assess the degree of severity of a subject's general psychopathological symptoms. Item scores range from 0 (not assessed) to 7 (extremely severe). Total Scores range from 0 to 126.|Units on a scale|Mean|13.36|13.36|Standard Deviation|5.56|5.56|||
4382327|NCT00320489|4208812|B2|||Brief Psychiatric Rating Scale (BPRS) Total Score|BPRS is an 18-item clinician-administered scale used to assess the degree of severity of a subject's general psychopathological symptoms. Item scores range from 0 (not assessed) to 7 (extremely severe). Total Scores range from 0 to 126.|Units on a scale|Mean|13.11|13.11|Standard Deviation|5.29|5.29|||
4382328|NCT00320489|4208813|B1|||Brief Psychiatric Rating Scale (BPRS) Total Score|BPRS is an 18-item clinician-administered scale used to assess the degree of severity of a subject's general psychopathological symptoms. Item scores range from 0 (not assessed) to 7 (extremely severe). Total Scores range from 0 to 126.|Units on a scale|Mean|13.61|13.61|Standard Deviation|5.82|5.82|||
4382329|NCT00320489|4208811|B3|Romania||Region of Enrollment||participants|Number|34|34.0||||||
4382330|NCT00320489|4208812|B2|Romania||Region of Enrollment||participants|Number|17|17.0||||||
4382331|NCT00320489|4208813|B1|Romania||Region of Enrollment||participants|Number|17|17.0||||||
4382332|NCT00320489|4208811|B3|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4382333|NCT00320489|4208812|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4382334|NCT00320489|4208813|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4382335|NCT00320489|4208811|B3|Brazil||Region of Enrollment||participants|Number|87|87.0||||||
4382336|NCT00320489|4208812|B2|Brazil||Region of Enrollment||participants|Number|44|44.0||||||
4382337|NCT00320489|4208813|B1|Brazil||Region of Enrollment||participants|Number|43|43.0||||||
4382338|NCT00320489|4208811|B3|Argentina||Region of Enrollment||participants|Number|62|62.0||||||
4382339|NCT00320489|4208812|B2|Argentina||Region of Enrollment||participants|Number|30|30.0||||||
4382340|NCT00320489|4208813|B1|Argentina||Region of Enrollment||participants|Number|32|32.0||||||
4382341|NCT00320489|4208811|B3|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4382342|NCT00320489|4208812|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4382343|NCT00320489|4208813|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4382344|NCT00320489|4208811|B3|Puerto Rico||Region of Enrollment||participants|Number|16|16.0||||||
4382357|NCT00320489|4208812|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4382358|NCT00320489|4208813|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4382359|NCT00320489|4208811|B3|France||Region of Enrollment||participants|Number|27|27.0||||||
4382360|NCT00320489|4208812|B2|France||Region of Enrollment||participants|Number|14|14.0||||||
4382361|NCT00320489|4208813|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4382362|NCT00320489|4208811|B3|Portugal||Region of Enrollment||participants|Number|20|20.0||||||
4382363|NCT00320489|4208812|B2|Portugal||Region of Enrollment||participants|Number|11|11.0||||||
4382364|NCT00320489|4208813|B1|Portugal||Region of Enrollment||participants|Number|9|9.0||||||
4382365|NCT00320489|4208811|B3|Unspecified||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4382366|NCT00320489|4208812|B2|Unspecified||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4382367|NCT00320489|4208813|B1|Unspecified||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4382368|NCT00320489|4208811|B3|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4382369|NCT00320489|4208812|B2|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4382370|NCT00320489|4208813|B1|West Asian (Indian sub-continent)||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4382371|NCT00320489|4208811|B3|Native American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4382372|NCT00320489|4208812|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4382373|NCT00320489|4208813|B1|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4382374|NCT00320489|4208811|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4382375|NCT00320489|4208812|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4382376|NCT00320489|4208813|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4382377|NCT00320489|4208811|B3|East Asian||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4382378|NCT00320489|4208812|B2|East Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4382379|NCT00320489|4208813|B1|East Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4382380|NCT00320489|4208811|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|325|325.0||||||
4382381|NCT00320489|4208812|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|164|164.0||||||
4382382|NCT00320489|4208813|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
4382383|NCT00320489|4208811|B3|African||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4382384|NCT00320489|4208812|B2|African||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4382385|NCT00320489|4208813|B1|African||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4382386|NCT00320489|4208811|B3||Male|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4382387|NCT00320489|4208812|B2||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4382388|NCT00320489|4208813|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4382389|NCT00320489|4208811|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4382390|NCT00320489|4208812|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4382391|NCT00320489|4208813|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4382392|NCT00320489|4208811|B3|||Age||years|Mean|40.92|40.92|Standard Deviation|10.90|10.9|||
4382393|NCT00320489|4208812|B2|||Age||years|Mean|40.12|40.12|Standard Deviation|10.84|10.84|||
4382394|NCT00320489|4208813|B1|||Age||years|Mean|41.70|41.7|Standard Deviation|10.92|10.92|||
4382395|NCT00320424|4208870|B1|Japan||Region of Enrollment||Participants|Count of Participants|48|48.0||||||
4382396|NCT00320424|4208870|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4382397|NCT00320424|4208870|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4382398|NCT00320424|4208870|B1|||Age||Years|Mean|76.6|76.6|Standard Deviation|14.4|14.4|||
4382399|NCT00320411|4208884|B1|Asian||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4382400|NCT00320411|4208884|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4382401|NCT00320411|4208884|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4382402|NCT00320411|4208884|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|8.52|8.52|||
4382403|NCT00320398|4208905|B3|Japan||Region of Enrollment||Participants|Count of Participants|114|114.0||||||
4382404|NCT00320398|4208906|B2|Japan||Region of Enrollment||Participants|Count of Participants|56|56.0||||||
4382405|NCT00320398|4208907|B1|Japan||Region of Enrollment||Participants|Count of Participants|58|58.0||||||
4382406|NCT00320398|4208905|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4382407|NCT00320398|4208906|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4382408|NCT00320398|4208907|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4382409|NCT00320398|4208905|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4382410|NCT00320398|4208906|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4382411|NCT00320398|4208907|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4382412|NCT00320398|4208905|B3|>=20 years||Age, Customized||Participants|Count of Participants|114|114.0||||||
4382413|NCT00320398|4208906|B2|>=20 years||Age, Customized||Participants|Count of Participants|56|56.0||||||
4382414|NCT00320398|4208907|B1|>=20 years||Age, Customized||Participants|Count of Participants|58|58.0||||||
4382415|NCT00320385|4208934|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4382416|NCT00320385|4208935|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4382417|NCT00320385|4208936|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4382418|NCT00320385|4208934|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4382419|NCT00320385|4208935|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4382420|NCT00320385|4208936|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4382421|NCT00320385|4208934|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4382422|NCT00320385|4208935|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4382423|NCT00320385|4208936|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4382424|NCT00320385|4208934|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4382425|NCT00320385|4208935|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4382426|NCT00320385|4208936|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4382427|NCT00320385|4208934|B3|White||Race/Ethnicity, Customized||participants|Number|277|277.0||||||
4382428|NCT00320385|4208935|B2|White||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4382429|NCT00320385|4208936|B1|White||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
4382430|NCT00320385|4208934|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4382431|NCT00320385|4208935|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4382432|NCT00320385|4208936|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4382433|NCT00320385|4208934|B3||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4382434|NCT00320385|4208935|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4382435|NCT00320385|4208936|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4382436|NCT00320385|4208934|B3|||Age||Years|Mean|51.5|51.5|Standard Deviation|11.01|11.01|||
4382437|NCT00320385|4208935|B2|||Age||Years|Mean|51.0|51.0|Standard Deviation|10.40|10.4|||
4382438|NCT00320385|4208936|B1|||Age||Years|Mean|52.1|52.1|Standard Deviation|11.60|11.6|||
4382439|NCT00320372|4208957|B4|BPD II, MRE Depressed||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|85|85.0||||||
4382440|NCT00320372|4208958|B3|BPD II, MRE Depressed||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|38|38.0||||||
4382441|NCT00320372|4208959|B2|BPD II, MRE Depressed||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|15|15.0||||||
4382442|NCT00320372|4208960|B1|BPD II, MRE Depressed||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|32|32.0||||||
4382443|NCT00320372|4208957|B4|BPD I, MRE Depressed,Severe w/o Psychotic Features||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|74|74.0||||||
4382444|NCT00320372|4208958|B3|BPD I, MRE Depressed,Severe w/o Psychotic Features||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|12|12.0||||||
4382445|NCT00320372|4208959|B2|BPD I, MRE Depressed,Severe w/o Psychotic Features||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|16|16.0||||||
4382446|NCT00320372|4208960|B1|BPD I, MRE Depressed,Severe w/o Psychotic Features||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|46|46.0||||||
4382447|NCT00320372|4208957|B4|BPD I, MRE Depressed, Moderate Severity||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|46|46.0||||||
4382448|NCT00320372|4208958|B3|BPD I, MRE Depressed, Moderate Severity||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|21|21.0||||||
4382449|NCT00320372|4208959|B2|BPD I, MRE Depressed, Moderate Severity||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|6|6.0||||||
4382450|NCT00320372|4208960|B1|BPD I, MRE Depressed, Moderate Severity||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|19|19.0||||||
4382451|NCT00320372|4208957|B4|MDD, Single Episode, Severe w/o Psychotic Features||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|92|92.0||||||
4382452|NCT00320372|4208958|B3|MDD, Single Episode, Severe w/o Psychotic Features||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|36|36.0||||||
4382453|NCT00320372|4208959|B2|MDD, Single Episode, Severe w/o Psychotic Features||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|7|7.0||||||
4382454|NCT00320372|4208960|B1|MDD, Single Episode, Severe w/o Psychotic Features||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|49|49.0||||||
4382455|NCT00320372|4208957|B4|MDD, Single Episode, Moderate Severity||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|46|46.0||||||
4382456|NCT00320372|4208958|B3|MDD, Single Episode, Moderate Severity||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|30|30.0||||||
4382457|NCT00320372|4208959|B2|MDD, Single Episode, Moderate Severity||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|4|4.0||||||
4382458|NCT00320372|4208960|B1|MDD, Single Episode, Moderate Severity||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|12|12.0||||||
4382459|NCT00320372|4208957|B4|MDD, Recurrent, Severe w/o Psychotic Features||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|320|320.0||||||
4382460|NCT00320372|4208958|B3|MDD, Recurrent, Severe w/o Psychotic Features||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|95|95.0||||||
4382461|NCT00320372|4208959|B2|MDD, Recurrent, Severe w/o Psychotic Features||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|90|90.0||||||
4382462|NCT00320372|4208960|B1|MDD, Recurrent, Severe w/o Psychotic Features||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|135|135.0||||||
4382463|NCT00320372|4208957|B4|MDD, Recurrent, Moderate Severity||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|132|132.0||||||
4382464|NCT00320372|4208958|B3|MDD, Recurrent, Moderate Severity||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|69|69.0||||||
4382465|NCT00320372|4208959|B2|MDD, Recurrent, Moderate Severity||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|21|21.0||||||
4382466|NCT00320372|4208960|B1|MDD, Recurrent, Moderate Severity||Diagnosis Disorder (Major Depressive Disorder (MDD) or Bipolar Disorder (BPD)||Participants|Number|42|42.0||||||
4382467|NCT00320372|4208957|B4|||Suicide Attempts in Lifetime (n=335, n=159, n=301)||Number of Suicide Attempts in a Lifetime|Mean|1.6|1.6|Standard Deviation|3.49|3.49|||
4382468|NCT00320372|4208958|B3|||Suicide Attempts in Lifetime (n=335, n=159, n=301)||Number of Suicide Attempts in a Lifetime|Mean|1.2|1.2|Standard Deviation|2.41|2.41|||
4382469|NCT00320372|4208959|B2|||Suicide Attempts in Lifetime (n=335, n=159, n=301)||Number of Suicide Attempts in a Lifetime|Mean|1.2|1.2|Standard Deviation|2.95|2.95|||
4382470|NCT00320372|4208960|B1|||Suicide Attempts in Lifetime (n=335, n=159, n=301)||Number of Suicide Attempts in a Lifetime|Mean|2.1|2.1|Standard Deviation|4.38|4.38|||
4382471|NCT00320372|4208957|B4|||Number of Failed Treatments (n=335, n=159, n=301)||Number of Failed Treatments|Mean|7.9|7.9|Standard Deviation|3.19|3.19|||
4382472|NCT00320372|4208958|B3|||Number of Failed Treatments (n=335, n=159, n=301)||Number of Failed Treatments|Mean|7.3|7.3|Standard Deviation|2.92|2.92|||
4382473|NCT00320372|4208959|B2|||Number of Failed Treatments (n=335, n=159, n=301)||Number of Failed Treatments|Mean|8.6|8.6|Standard Deviation|3.74|3.74|||
4382474|NCT00320372|4208960|B1|||Number of Failed Treatments (n=335, n=159, n=301)||Number of Failed Treatments|Mean|8.0|8.0|Standard Deviation|3.05|3.05|||
4382475|NCT00320372|4208957|B4|||Lifetime Episodes of Depression Diagnosed (n=335, n=0, n=301)||Lifetime Episodes of Depression|Mean|13.5|13.5|Standard Deviation|24.03|24.03|||
4382476|NCT00320372|4208958|B3|||Lifetime Episodes of Depression Diagnosed (n=335, n=0, n=301)||Lifetime Episodes of Depression|Mean|12.0|12.0|Standard Deviation|23.86|23.86|||
4382477|NCT00320372|4208959|B2|||Lifetime Episodes of Depression Diagnosed (n=335, n=0, n=301)||Lifetime Episodes of Depression|Mean|NA||Standard Deviation|NA||||This Variable was captured as categorical variable as part of D-21 study
4382478|NCT00320372|4208960|B1|||Lifetime Episodes of Depression Diagnosed (n=335, n=0, n=301)||Lifetime Episodes of Depression|Mean|14.9|14.9|Standard Deviation|24.14|24.14|||
4382479|NCT00320372|4208957|B4|Other||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|4|4.0||||||
4382480|NCT00320372|4208958|B3|Other||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|1|1.0||||||
4382481|NCT00320372|4208959|B2|Other||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|0|0.0||||||
4382482|NCT00320372|4208960|B1|Other||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|3|3.0||||||
4382483|NCT00320372|4208957|B4|Asian||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|3|3.0||||||
4382484|NCT00320372|4208958|B3|Asian||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|1|1.0||||||
4382485|NCT00320372|4208959|B2|Asian||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|0|0.0||||||
4382486|NCT00320372|4208960|B1|Asian||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|2|2.0||||||
4382487|NCT00320372|4208957|B4|Hispanic||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|22|22.0||||||
4382488|NCT00320372|4208958|B3|Hispanic||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|19|19.0||||||
4382489|NCT00320372|4208959|B2|Hispanic||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|0|0.0||||||
4382490|NCT00320372|4208960|B1|Hispanic||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|3|3.0||||||
4382491|NCT00320372|4208957|B4|African-American||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|14|14.0||||||
4382492|NCT00320372|4208958|B3|African-American||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|6|6.0||||||
4382493|NCT00320372|4208959|B2|African-American||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|4|4.0||||||
4382494|NCT00320372|4208960|B1|African-American||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|4|4.0||||||
4382495|NCT00320372|4208957|B4|Caucasian||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|752|752.0||||||
4382496|NCT00320372|4208958|B3|Caucasian||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|274|274.0||||||
4382497|NCT00320372|4208959|B2|Caucasian||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|155|155.0||||||
4382498|NCT00320372|4208960|B1|Caucasian||Race/Ethnicity, Customized|Ethnic Orgin of participants in the study|Participants|Number|323|323.0||||||
4382499|NCT00320372|4208957|B4||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4382500|NCT00320372|4208958|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4382501|NCT00320372|4208959|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4382502|NCT00320372|4208960|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4382503|NCT00320372|4208957|B4||Female|Sex: Female, Male||Participants|Count of Participants|561|561.0||||||
4382504|NCT00320372|4208958|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4382505|NCT00320372|4208959|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4382506|NCT00320372|4208960|B1||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4382507|NCT00320372|4208957|B4|Age-Initial Dx. of Depression(n=334,n=159,n=301)||Age, Customized||Years|Mean|29.1|29.1|Standard Deviation|11.22|11.22|||
4382508|NCT00320372|4208958|B3|Age-Initial Dx. of Depression(n=334,n=159,n=301)||Age, Customized||Years|Mean|29.5|29.5|Standard Deviation|11.89|11.89|||
4382509|NCT00320372|4208959|B2|Age-Initial Dx. of Depression(n=334,n=159,n=301)||Age, Customized||Years|Mean|28.6|28.6|Standard Deviation|10.50|10.5|||
4382510|NCT00320372|4208960|B1|Age-Initial Dx. of Depression(n=334,n=159,n=301)||Age, Customized||Years|Mean|29.0|29.0|Standard Deviation|10.95|10.95|||
4382511|NCT00320372|4208957|B4|Age-Initial Onset of Depression(n=334,n=159,n=301)||Age, Customized||Years|Mean|21.0|21.0|Standard Deviation|11.64|11.64|||
4382512|NCT00320372|4208958|B3|Age-Initial Onset of Depression(n=334,n=159,n=301)||Age, Customized||Years|Mean|21.1|21.1|Standard Deviation|11.40|11.4|||
4382513|NCT00320372|4208959|B2|Age-Initial Onset of Depression(n=334,n=159,n=301)||Age, Customized||Years|Mean|21.1|21.1|Standard Deviation|11.11|11.11|||
4382514|NCT00320372|4208960|B1|Age-Initial Onset of Depression(n=334,n=159,n=301)||Age, Customized||Years|Mean|20.8|20.8|Standard Deviation|12.13|12.13|||
4382515|NCT00320372|4208957|B4|Age at Baseline (n=335, n=159, n=301)||Age, Customized||Years|Mean|49.3|49.3|Standard Deviation|10.49|10.49|||
4382516|NCT00320372|4208958|B3|Age at Baseline (n=335, n=159, n=301)||Age, Customized||Years|Mean|49.9|49.9|Standard Deviation|11.07|11.07|||
4382517|NCT00320372|4208959|B2|Age at Baseline (n=335, n=159, n=301)||Age, Customized||Years|Mean|48.9|48.9|Standard Deviation|9.51|9.51|||
4382518|NCT00320372|4208960|B1|Age at Baseline (n=335, n=159, n=301)||Age, Customized||Years|Mean|48.9|48.9|Standard Deviation|10.41|10.41|||
4382519|NCT00320281|4208986|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4382520|NCT00320281|4208987|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4382521|NCT00320281|4208988|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4382522|NCT00320281|4208986|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4382523|NCT00320281|4208987|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4382524|NCT00320281|4208988|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4382525|NCT00320281|4208986|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4382526|NCT00320281|4208987|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4382527|NCT00320281|4208988|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4382528|NCT00320281|4208986|B3|||Age||years|Mean|36.15|36.15|Standard Deviation|12|12.0|||
4382529|NCT00320281|4208987|B2|||Age||years|Mean|35.91|35.91|Standard Deviation|11|11.0|||
4382530|NCT00320281|4208988|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|14.44|14.44|||
4382531|NCT00320281|4208986|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382532|NCT00320281|4208987|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382533|NCT00320281|4208988|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382534|NCT00320281|4208986|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4382535|NCT00320281|4208987|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4382536|NCT00320281|4208988|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4382537|NCT00320281|4208986|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4382538|NCT00320281|4208987|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4382539|NCT00320281|4208988|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4382540|NCT00320255|4208995|B7|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4382541|NCT00320255|4208996|B6|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382542|NCT00320255|4208997|B5|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382543|NCT00320255|4208998|B4|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4382544|NCT00320255|4208999|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4382545|NCT00320255|4209000|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382546|NCT00320255|4209001|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4382547|NCT00320255|4208995|B7|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4382548|NCT00320255|4208996|B6|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382549|NCT00320255|4208997|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382550|NCT00320255|4208998|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382551|NCT00320255|4208999|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382552|NCT00320255|4209000|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4382553|NCT00320255|4209001|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382554|NCT00320255|4208995|B7|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4382555|NCT00320255|4208996|B6|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382556|NCT00320255|4208997|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382557|NCT00320255|4208998|B4|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4382558|NCT00320255|4208999|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4382559|NCT00320255|4209000|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4382560|NCT00320255|4209001|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4382561|NCT00320255|4208995|B7|Black/African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4382562|NCT00320255|4208996|B6|Black/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382563|NCT00320255|4208997|B5|Black/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382564|NCT00320255|4208998|B4|Black/African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4382565|NCT00320255|4208999|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4382566|NCT00320255|4209000|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4382567|NCT00320255|4209001|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382568|NCT00320255|4208995|B7|White||Race/Ethnicity, Customized||Participants|Number|110|110.0||||||
4382569|NCT00320255|4208996|B6|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4382570|NCT00320255|4208997|B5|White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4382571|NCT00320255|4208998|B4|White||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4382572|NCT00320255|4208999|B3|White||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4382573|NCT00320255|4209000|B2|White||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4382574|NCT00320255|4209001|B1|White||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4382575|NCT00320255|4208995|B7||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4382576|NCT00320255|4208996|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4382577|NCT00320255|4208997|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4382578|NCT00320255|4208998|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4382579|NCT00320255|4208999|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4382580|NCT00320255|4209000|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4382581|NCT00320255|4209001|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4382582|NCT00320255|4208995|B7||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4382583|NCT00320255|4208996|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4382584|NCT00320255|4208997|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4382585|NCT00320255|4208998|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4382586|NCT00320255|4208999|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4382587|NCT00320255|4209000|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4382588|NCT00320255|4209001|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4382589|NCT00320255|4208995|B7|75 years and older||Age, Customized||Participants|Number|15|15.0||||||
4382590|NCT00320255|4208996|B6|75 years and older||Age, Customized||Participants|Number|0|0.0||||||
4382591|NCT00320255|4208997|B5|75 years and older||Age, Customized||Participants|Number|0|0.0||||||
4382592|NCT00320255|4208998|B4|75 years and older||Age, Customized||Participants|Number|8|8.0||||||
4382593|NCT00320255|4208999|B3|75 years and older||Age, Customized||Participants|Number|2|2.0||||||
4382594|NCT00320255|4209000|B2|75 years and older||Age, Customized||Participants|Number|0|0.0||||||
4382595|NCT00320255|4209001|B1|75 years and older||Age, Customized||Participants|Number|5|5.0||||||
4382596|NCT00320255|4208995|B7|65 years and older but younger than 75 years||Age, Customized||Participants|Number|30|30.0||||||
4382597|NCT00320255|4208996|B6|65 years and older but younger than 75 years||Age, Customized||Participants|Number|0|0.0||||||
4382598|NCT00320255|4208997|B5|65 years and older but younger than 75 years||Age, Customized||Participants|Number|1|1.0||||||
4382599|NCT00320255|4208998|B4|65 years and older but younger than 75 years||Age, Customized||Participants|Number|8|8.0||||||
4382600|NCT00320255|4208999|B3|65 years and older but younger than 75 years||Age, Customized||Participants|Number|9|9.0||||||
4382601|NCT00320255|4209000|B2|65 years and older but younger than 75 years||Age, Customized||Participants|Number|4|4.0||||||
4382602|NCT00320255|4209001|B1|65 years and older but younger than 75 years||Age, Customized||Participants|Number|8|8.0||||||
4382603|NCT00320255|4208995|B7|Younger than 65 years||Age, Customized||Participants|Number|85|85.0||||||
4382604|NCT00320255|4208996|B6|Younger than 65 years||Age, Customized||Participants|Number|3|3.0||||||
4382605|NCT00320255|4208997|B5|Younger than 65 years||Age, Customized||Participants|Number|1|1.0||||||
4382606|NCT00320255|4208998|B4|Younger than 65 years||Age, Customized||Participants|Number|17|17.0||||||
4382607|NCT00320255|4208999|B3|Younger than 65 years||Age, Customized||Participants|Number|19|19.0||||||
4382608|NCT00320255|4209000|B2|Younger than 65 years||Age, Customized||Participants|Number|28|28.0||||||
4382609|NCT00320255|4209001|B1|Younger than 65 years||Age, Customized||Participants|Number|17|17.0||||||
4382610|NCT00320242|4209086|B1|United States||Region of Enrollment|Regions of subject enrollment|participants|Number|26|26.0||||||
4382611|NCT00320242|4209086|B1||Male|Sex: Female, Male|Gender distribution: male versus female|Participants|Count of Participants|21|21.0||||||
4382612|NCT00320242|4209086|B1||Female|Sex: Female, Male|Gender distribution: male versus female|Participants|Count of Participants|5|5.0||||||
4382613|NCT00320242|4209086|B1|||Age||years|Mean|71|71.0|Full Range|||58.0|92.0|
4382614|NCT00320242|4209086|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4382615|NCT00320242|4209086|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4382616|NCT00320242|4209086|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4382617|NCT00320216|4209094|B6||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4382618|NCT00320216|4209095|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4382619|NCT00320216|4209096|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4382620|NCT00320216|4209097|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4382621|NCT00320216|4209098|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4382622|NCT00320216|4209099|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4382623|NCT00320216|4209094|B6||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4382624|NCT00320216|4209095|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4382625|NCT00320216|4209096|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4382626|NCT00320216|4209097|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4382627|NCT00320216|4209098|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4382628|NCT00320216|4209099|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4382629|NCT00320216|4209094|B6|Years||Age||Years|Mean|44.9|44.9|Standard Deviation|13.2|13.2|||
4382630|NCT00320216|4209095|B5|Years||Age||Years|Mean|44.3|44.3|Standard Deviation|13.3|13.3|||
4382631|NCT00320216|4209096|B4|Years||Age||Years|Mean|44.5|44.5|Standard Deviation|12.2|12.2|||
4382632|NCT00320216|4209097|B3|Years||Age||Years|Mean|45.5|45.5|Standard Deviation|12.7|12.7|||
4382633|NCT00320216|4209098|B2|Years||Age||Years|Mean|46.4|46.4|Standard Deviation|14.2|14.2|||
4382634|NCT00320216|4209099|B1|Years||Age||Years|Mean|44.0|44.0|Standard Deviation|13.7|13.7|||
4382635|NCT00320190|4209135|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382636|NCT00320190|4209136|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382637|NCT00320190|4209137|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382638|NCT00320190|4209135|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382639|NCT00320190|4209136|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382640|NCT00320190|4209137|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382641|NCT00320190|4209135|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4382642|NCT00320190|4209136|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4382643|NCT00320190|4209137|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4382644|NCT00320190|4209135|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4382645|NCT00320190|4209136|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382646|NCT00320190|4209137|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4382647|NCT00320190|4209135|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382648|NCT00320190|4209136|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382649|NCT00320190|4209137|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382650|NCT00320190|4209135|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382651|NCT00320190|4209136|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382652|NCT00320190|4209137|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382653|NCT00320190|4209135|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382654|NCT00320190|4209136|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382655|NCT00320190|4209137|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382656|NCT00320190|4209135|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4382657|NCT00320190|4209136|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4382658|NCT00320190|4209137|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4382659|NCT00320190|4209135|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4382660|NCT00320190|4209136|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4382661|NCT00320190|4209137|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4382662|NCT00320190|4209135|B3|||Age, Customized||Years|Mean|48.6|48.6|Standard Deviation|14.85|14.85|||
4382663|NCT00320190|4209136|B2|||Age, Customized||Years|Mean|53.2|53.2|Standard Deviation|14.24|14.24|||
4382664|NCT00320190|4209137|B1|||Age, Customized||Years|Mean|45.5|45.5|Standard Deviation|14.83|14.83|||
4382665|NCT00320112|4209156|B3|||Diastolic Blood Pressure||mmHg|Mean|76.5|76.5|Standard Deviation|11.1|11.1|||
4382666|NCT00320112|4209157|B2|||Diastolic Blood Pressure||mmHg|Mean|75.8|75.8|Standard Deviation|10.7|10.7|||
4382667|NCT00320112|4209158|B1|||Diastolic Blood Pressure||mmHg|Mean|77.1|77.1|Standard Deviation|11.5|11.5|||
4382668|NCT00320112|4209156|B3|||Systolic Blood Pressure||mmHg|Mean|138.4|138.4|Standard Deviation|17.9|17.9|||
4382669|NCT00320112|4209157|B2|||Systolic Blood Pressure||mmHg|Mean|136.4|136.4|Standard Deviation|16.9|16.9|||
4382670|NCT00320112|4209158|B1|||Systolic Blood Pressure||mmHg|Mean|140.3|140.3|Standard Deviation|18.6|18.6|||
4382671|NCT00320112|4209156|B3|||HbA1c||percent HbA1c|Mean|7.98|7.98|Standard Deviation|1.40|1.4|||
4382672|NCT00320112|4209157|B2|||HbA1c||percent HbA1c|Mean|7.93|7.93|Standard Deviation|1.40|1.4|||
4382673|NCT00320112|4209158|B1|||HbA1c||percent HbA1c|Mean|8.02|8.02|Standard Deviation|1.32|1.32|||
4382674|NCT00320112|4209156|B3|||Self-Rated General Health Status - Fair or Poor Health||participants|Number|123|123.0||||||
4382675|NCT00320112|4209157|B2|||Self-Rated General Health Status - Fair or Poor Health||participants|Number|64|64.0||||||
4382676|NCT00320112|4209158|B1|||Self-Rated General Health Status - Fair or Poor Health||participants|Number|59|59.0||||||
4382677|NCT00320112|4209156|B3|Insulin, + or - oral medication||Anti-hyperglycemic Medications||participants|Number|136|136.0||||||
4382678|NCT00320112|4209157|B2|Insulin, + or - oral medication||Anti-hyperglycemic Medications||participants|Number|66|66.0||||||
4382679|NCT00320112|4209158|B1|Insulin, + or - oral medication||Anti-hyperglycemic Medications||participants|Number|70|70.0||||||
4382680|NCT00320112|4209156|B3|Only oral diabetes medication||Anti-hyperglycemic Medications||participants|Number|108|108.0||||||
4382681|NCT00320112|4209157|B2|Only oral diabetes medication||Anti-hyperglycemic Medications||participants|Number|53|53.0||||||
4382682|NCT00320112|4209158|B1|Only oral diabetes medication||Anti-hyperglycemic Medications||participants|Number|55|55.0||||||
4382683|NCT00320112|4209156|B3|Other||Social Support||participants|Number|27|27.0||||||
4382684|NCT00320112|4209157|B2|Other||Social Support||participants|Number|13|13.0||||||
4382685|NCT00320112|4209158|B1|Other||Social Support||participants|Number|14|14.0||||||
4382686|NCT00320112|4209156|B3|Lives alone||Social Support||participants|Number|51|51.0||||||
4382687|NCT00320112|4209157|B2|Lives alone||Social Support||participants|Number|22|22.0||||||
4382688|NCT00320112|4209158|B1|Lives alone||Social Support||participants|Number|29|29.0||||||
4382689|NCT00320112|4209156|B3|Lives with a spouse||Social Support||participants|Number|166|166.0||||||
4382690|NCT00320112|4209157|B2|Lives with a spouse||Social Support||participants|Number|84|84.0||||||
4382691|NCT00320112|4209158|B1|Lives with a spouse||Social Support||participants|Number|82|82.0||||||
4382692|NCT00320112|4209156|B3|other or unknown||Annual Income||participants|Number|8|8.0||||||
4382693|NCT00320112|4209157|B2|other or unknown||Annual Income||participants|Number|7|7.0||||||
4382694|NCT00320112|4209158|B1|other or unknown||Annual Income||participants|Number|1|1.0||||||
4382695|NCT00320112|4209156|B3|greater than or equal to $31,000||Annual Income||participants|Number|87|87.0||||||
4382696|NCT00320112|4209157|B2|greater than or equal to $31,000||Annual Income||participants|Number|41|41.0||||||
4382697|NCT00320112|4209158|B1|greater than or equal to $31,000||Annual Income||participants|Number|46|46.0||||||
4382698|NCT00320112|4209156|B3|less than or equal to $30,000||Annual Income||participants|Number|149|149.0||||||
4382699|NCT00320112|4209157|B2|less than or equal to $30,000||Annual Income||participants|Number|71|71.0||||||
4382700|NCT00320112|4209158|B1|less than or equal to $30,000||Annual Income||participants|Number|78|78.0||||||
4382701|NCT00320112|4209156|B3|unknown||Education||participants|Number|1|1.0||||||
4382702|NCT00320112|4209157|B2|unknown||Education||participants|Number|1|1.0||||||
4382703|NCT00320112|4209158|B1|unknown||Education||participants|Number|0|0.0||||||
4382704|NCT00320112|4209156|B3|at least some college, technical\vocational school||Education||participants|Number|174|174.0||||||
4382705|NCT00320112|4209157|B2|at least some college, technical\vocational school||Education||participants|Number|83|83.0||||||
4382706|NCT00320112|4209158|B1|at least some college, technical\vocational school||Education||participants|Number|91|91.0||||||
4382707|NCT00320112|4209156|B3|Some High School, High School||Education||participants|Number|69|69.0||||||
4382708|NCT00320112|4209157|B2|Some High School, High School||Education||participants|Number|35|35.0||||||
4382709|NCT00320112|4209158|B1|Some High School, High School||Education||participants|Number|34|34.0||||||
4382710|NCT00320112|4209156|B3|unkwown||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4382711|NCT00320112|4209157|B2|unkwown||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4382712|NCT00320112|4209158|B1|unkwown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4382713|NCT00320112|4209156|B3|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4382714|NCT00320112|4209157|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4382715|NCT00320112|4209158|B1|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4382716|NCT00320112|4209156|B3|African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4382717|NCT00320112|4209157|B2|African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4382718|NCT00320112|4209158|B1|African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4382719|NCT00320112|4209156|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4382720|NCT00320112|4209157|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4382721|NCT00320112|4209158|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4382722|NCT00320112|4209156|B3|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|197|197.0||||||
4382723|NCT00320112|4209157|B2|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4382724|NCT00320112|4209158|B1|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
4382725|NCT00320112|4209156|B3||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4382726|NCT00320112|4209157|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4382727|NCT00320112|4209158|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4382728|NCT00320112|4209156|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4382729|NCT00320112|4209157|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4382730|NCT00320112|4209158|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4382731|NCT00320112|4209156|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|6.3|6.3|||
4382732|NCT00320112|4209157|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|6.6|6.6|||
4382733|NCT00320112|4209158|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|6.1|6.1|||
4382734|NCT00319982|4209171|B3|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4382735|NCT00319982|4209172|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4382736|NCT00319982|4209173|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4382737|NCT00319982|4209171|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4382738|NCT00319982|4209172|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4382739|NCT00319982|4209173|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4382740|NCT00319982|4209171|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4382741|NCT00319982|4209172|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4382742|NCT00319982|4209173|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4382743|NCT00319982|4209171|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4382744|NCT00319982|4209172|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4382745|NCT00319982|4209173|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4382746|NCT00319982|4209171|B3|||Age||years|Mean|15.8|15.8|Standard Deviation|8.6|8.6|||
4382747|NCT00319982|4209172|B2|||Age||years|Mean|17.3|17.3|Standard Deviation|2.1|2.1|||
4382748|NCT00319982|4209173|B1|||Age||years|Mean|14.1|14.1|Standard Deviation|1.7|1.7|||
4382749|NCT00319956|4209192|B3|United States||Region of Enrollment||participants|Number|220|220.0||||||
4382750|NCT00319956|4209193|B2|United States||Region of Enrollment||participants|Number|109|109.0||||||
4382751|NCT00319956|4209194|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
4382752|NCT00319956|4209192|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4382753|NCT00319956|4209193|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4382754|NCT00319956|4209194|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4382755|NCT00319956|4209192|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4382756|NCT00319956|4209193|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4382757|NCT00319956|4209194|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4382758|NCT00319956|4209192|B3|||Age||gestational age, weeks|Mean|25.85|25.85|Standard Deviation|1.55|1.55|||
4382759|NCT00319956|4209193|B2|||Age||gestational age, weeks|Mean|26|26.0|Standard Deviation|1.6|1.6|||
4382760|NCT00319956|4209194|B1|||Age||gestational age, weeks|Mean|25.7|25.7|Standard Deviation|1.5|1.5|||
4382761|NCT00319956|4209192|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382762|NCT00319956|4209193|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382763|NCT00319956|4209194|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382764|NCT00319956|4209192|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4382765|NCT00319956|4209193|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4382766|NCT00319956|4209194|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4382767|NCT00319956|4209192|B3||<=18 years|Age||Participants|Count of Participants|220|220.0||||||
4382768|NCT00319956|4209193|B2||<=18 years|Age||Participants|Count of Participants|109|109.0||||||
4382769|NCT00319956|4209194|B1||<=18 years|Age||Participants|Count of Participants|111|111.0||||||
4382770|NCT00319839|4209207|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4382771|NCT00319839|4209207|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382772|NCT00319839|4209207|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4382773|NCT00319839|4209207|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4382774|NCT00319839|4209207|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382775|NCT00319839|4209207|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382776|NCT00319839|4209207|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382777|NCT00319839|4209207|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382778|NCT00319839|4209207|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382779|NCT00319839|4209207|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4382780|NCT00319839|4209207|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382781|NCT00319839|4209207|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4382782|NCT00319839|4209207|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4382783|NCT00319839|4209207|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4382784|NCT00319839|4209207|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4382785|NCT00319839|4209207|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4382786|NCT00319748|4209213|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4382787|NCT00319748|4209213|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4382788|NCT00319748|4209213|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4382789|NCT00319748|4209213|B1|||Age||years|Median|52|52.0|Full Range|9.6|9.6|24.0|63.0|
4382790|NCT00319748|4209213|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382791|NCT00319748|4209213|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4382792|NCT00319748|4209213|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4382793|NCT00319735|4209223|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|2|2.0||||||
4382794|NCT00319735|4209223|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|13|13.0||||||
4382795|NCT00319735|4209223|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|26|26.0||||||
4382796|NCT00319735|4209223|B1|Adenocarcinoma||Histology||participants|Number|32|32.0||||||
4382797|NCT00319735|4209223|B1|Squamous cell carcinoma||Histology||participants|Number|9|9.0||||||
4382798|NCT00319735|4209223|B1|IVA||Disease Stage|"Stage I, Stage II, and Stage III Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.~Stage IV The cancer has spread to distant parts of the body."|participants|Number|2|2.0||||||
4382799|NCT00319735|4209223|B1|III||Disease Stage|"Stage I, Stage II, and Stage III Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.~Stage IV The cancer has spread to distant parts of the body."|participants|Number|22|22.0||||||
4382800|NCT00319735|4209223|B1|IIB||Disease Stage|"Stage I, Stage II, and Stage III Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.~Stage IV The cancer has spread to distant parts of the body."|participants|Number|7|7.0||||||
4382801|NCT00319735|4209223|B1|IIA||Disease Stage|"Stage I, Stage II, and Stage III Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.~Stage IV The cancer has spread to distant parts of the body."|participants|Number|10|10.0||||||
4382802|NCT00319735|4209223|B1|Gastroesophageal Junction||Tumor Site||participants|Number|15|15.0||||||
4382803|NCT00319735|4209223|B1|Esophagus||Tumor Site||participants|Number|26|26.0||||||
4382804|NCT00319735|4209223|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4382805|NCT00319735|4209223|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382806|NCT00319735|4209223|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4382807|NCT00319735|4209223|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4382808|NCT00319735|4209223|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382809|NCT00319735|4209223|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382810|NCT00319735|4209223|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382811|NCT00319735|4209223|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4382812|NCT00319735|4209223|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4382813|NCT00319735|4209223|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4382814|NCT00319735|4209223|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4382815|NCT00319735|4209223|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4382816|NCT00319735|4209223|B1|Median||Age, Customized||years|Median|64|64.0|Full Range|||50.0|82.0|
4382817|NCT00319696|4209236|B1|||United Kingdom Scleroderma Functional Score (UKFS)|UKFS relates to upper and lower extremity function and muscle weakness. For each item, the patient indicated the responses that best described their current ability: “able to perform in a normal manner,” “able to perform with alteration in style,” “can only manage with difficulty,” and “impossible to achieve.” Each response was given an integer from 0 (able to perform in a normal manner) to 3 (impossible to achieve), and the sum of individual responses provided an overall score of 0 to 33. Missing values were replaced with the worst value the patient reported on the other items at that visit.|score on a scale|Mean|11.06|11.06|Standard Deviation|7.50|7.5|||
4382818|NCT00319696|4209236|B1|||Overall hand pain|Overall hand pain related to finger ulcers was assessed by the patient using a Visual Analogue Scale. Patients were instructed to score their pain by marking on the continuous 10-cm scale, where 0 (left) was no pain and 100 (right) very severe pain, in response to the question, “How much pain have you had because of your finger ulcers in the past week?” The investigator measured the distance in millimeters between 0 and the patient mark with the ruler provided and recorded the distance.|mm|Mean|58.62|58.62|Standard Deviation|29.80|29.8|||
4382819|NCT00319696|4209236|B1|Activity||Scleroderma Health Assessment Questionnaire (SHAQ) Individual Domain Score|SHAQ evaluates physical disability. Patients were instructed to rate their capacity to perform activities of daily living within the previous 7 days by checking one of the following descriptors: “without any difficulty”, “with some difficulty,” “with much difficulty,” or “unable to do,” equivalent to scores of 0, 1, 2, and 3, respectively. Items were categorized into 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and activities.|score on a scale|Mean|1.0|1.0|Standard Deviation|0.9|0.9|||
4382820|NCT00319696|4209236|B1|Grip||Scleroderma Health Assessment Questionnaire (SHAQ) Individual Domain Score|SHAQ evaluates physical disability. Patients were instructed to rate their capacity to perform activities of daily living within the previous 7 days by checking one of the following descriptors: “without any difficulty”, “with some difficulty,” “with much difficulty,” or “unable to do,” equivalent to scores of 0, 1, 2, and 3, respectively. Items were categorized into 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and activities.|score on a scale|Mean|1.1|1.1|Standard Deviation|0.8|0.8|||
4382821|NCT00319696|4209236|B1|Reach||Scleroderma Health Assessment Questionnaire (SHAQ) Individual Domain Score|SHAQ evaluates physical disability. Patients were instructed to rate their capacity to perform activities of daily living within the previous 7 days by checking one of the following descriptors: “without any difficulty”, “with some difficulty,” “with much difficulty,” or “unable to do,” equivalent to scores of 0, 1, 2, and 3, respectively. Items were categorized into 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and activities.|score on a scale|Mean|1.1|1.1|Standard Deviation|0.9|0.9|||
4382822|NCT00319696|4209236|B1|Hygiene||Scleroderma Health Assessment Questionnaire (SHAQ) Individual Domain Score|SHAQ evaluates physical disability. Patients were instructed to rate their capacity to perform activities of daily living within the previous 7 days by checking one of the following descriptors: “without any difficulty”, “with some difficulty,” “with much difficulty,” or “unable to do,” equivalent to scores of 0, 1, 2, and 3, respectively. Items were categorized into 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and activities.|score on a scale|Mean|0.9|0.9|Standard Deviation|1.0|1.0|||
4382823|NCT00319696|4209236|B1|Walking||Scleroderma Health Assessment Questionnaire (SHAQ) Individual Domain Score|SHAQ evaluates physical disability. Patients were instructed to rate their capacity to perform activities of daily living within the previous 7 days by checking one of the following descriptors: “without any difficulty”, “with some difficulty,” “with much difficulty,” or “unable to do,” equivalent to scores of 0, 1, 2, and 3, respectively. Items were categorized into 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and activities.|score on a scale|Mean|0.5|0.5|Standard Deviation|0.7|0.7|||
4382874|NCT00319592|4209270|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4382824|NCT00319696|4209236|B1|Eating||Scleroderma Health Assessment Questionnaire (SHAQ) Individual Domain Score|SHAQ evaluates physical disability. Patients were instructed to rate their capacity to perform activities of daily living within the previous 7 days by checking one of the following descriptors: “without any difficulty”, “with some difficulty,” “with much difficulty,” or “unable to do,” equivalent to scores of 0, 1, 2, and 3, respectively. Items were categorized into 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and activities.|score on a scale|Mean|1.5|1.5|Standard Deviation|1.0|1.0|||
4382825|NCT00319696|4209236|B1|Arising||Scleroderma Health Assessment Questionnaire (SHAQ) Individual Domain Score|SHAQ evaluates physical disability. Patients were instructed to rate their capacity to perform activities of daily living within the previous 7 days by checking one of the following descriptors: “without any difficulty”, “with some difficulty,” “with much difficulty,” or “unable to do,” equivalent to scores of 0, 1, 2, and 3, respectively. Items were categorized into 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and activities.|score on a scale|Mean|0.5|0.5|Standard Deviation|0.8|0.8|||
4382826|NCT00319696|4209236|B1|Dressing||Scleroderma Health Assessment Questionnaire (SHAQ) Individual Domain Score|SHAQ evaluates physical disability. Patients were instructed to rate their capacity to perform activities of daily living within the previous 7 days by checking one of the following descriptors: “without any difficulty”, “with some difficulty,” “with much difficulty,” or “unable to do,” equivalent to scores of 0, 1, 2, and 3, respectively. Items were categorized into 8 domains: dressing/grooming, arising, eating, walking, hygiene, reach, grip, and activities.|score on a scale|Mean|1.3|1.3|Standard Deviation|0.9|0.9|||
4382827|NCT00319696|4209236|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4382828|NCT00319696|4209236|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4382829|NCT00319696|4209236|B1|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4382830|NCT00319696|4209236|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4382831|NCT00319696|4209236|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4382832|NCT00319696|4209236|B1|France||Region of Enrollment||participants|Number|10|10.0||||||
4382833|NCT00319696|4209236|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4382834|NCT00319696|4209236|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4382835|NCT00319696|4209236|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4382836|NCT00319696|4209236|B1|Between 24 and 79 years||Age, Customized||participants|Number|116|116.0||||||
4382837|NCT00319696|4209236|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|12.0|12.0|||
4382838|NCT00319644|4209259|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4382839|NCT00319644|4209260|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4382840|NCT00319644|4209261|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4382841|NCT00319644|4209259|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4382842|NCT00319644|4209260|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4382843|NCT00319644|4209261|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4382844|NCT00319644|4209259|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4382845|NCT00319644|4209260|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4382846|NCT00319644|4209261|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4382847|NCT00319644|4209259|B3|||Age||years|Mean|51.09|51.09|Standard Deviation|27.45|27.45|||
4382848|NCT00319644|4209260|B2|||Age||years|Mean|52.81|52.81|Standard Deviation|19.3|19.3|||
4382849|NCT00319644|4209261|B1|||Age||years|Mean|49.38|49.38|Standard Deviation|16.3|16.3|||
4382850|NCT00319644|4209259|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382851|NCT00319644|4209260|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382852|NCT00319644|4209261|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382853|NCT00319644|4209259|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4382854|NCT00319644|4209260|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4382855|NCT00319644|4209261|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4382856|NCT00319644|4209259|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4382857|NCT00319644|4209260|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4382858|NCT00319644|4209261|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4382859|NCT00319592|4209270|B3|United States||Region of Enrollment||Participants|Number|60|60.0||||||
4382860|NCT00319592|4209271|B2|United States||Region of Enrollment||Participants|Number|30|30.0||||||
4382861|NCT00319592|4209272|B1|United States||Region of Enrollment||Participants|Number|30|30.0||||||
4382862|NCT00319592|4209270|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4382863|NCT00319592|4209271|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4382864|NCT00319592|4209272|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4382865|NCT00319592|4209270|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4382866|NCT00319592|4209271|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4382867|NCT00319592|4209272|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4382868|NCT00319592|4209270|B3|||Age||Years|Mean|31|31.0|Standard Deviation|8.98|8.98|||
4382869|NCT00319592|4209271|B2|||Age||Years|Mean|29.2|29.2|Standard Deviation|9.14|9.14|||
4382870|NCT00319592|4209272|B1|||Age||Years|Mean|32.7|32.7|Standard Deviation|8.82|8.82|||
4382871|NCT00319592|4209270|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382872|NCT00319592|4209271|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382873|NCT00319592|4209272|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382875|NCT00319592|4209271|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4382876|NCT00319592|4209272|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4382877|NCT00319592|4209270|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4382878|NCT00319592|4209271|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4382879|NCT00319592|4209272|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4382880|NCT00319553|4209287|B3|United States||Region of Enrollment||participants|Number|644|644.0||||||
4382881|NCT00319553|4209288|B2|United States||Region of Enrollment||participants|Number|321|321.0||||||
4382882|NCT00319553|4209289|B1|United States||Region of Enrollment||participants|Number|323|323.0||||||
4382883|NCT00319553|4209287|B3||Male|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4382884|NCT00319553|4209288|B2||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4382885|NCT00319553|4209289|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4382886|NCT00319553|4209287|B3||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4382887|NCT00319553|4209288|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4382888|NCT00319553|4209289|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4382889|NCT00319553|4209287|B3|||Age||years|Mean|14.6|14.6|Standard Deviation|2.33|2.33|||
4382890|NCT00319553|4209288|B2|||Age||years|Mean|14.7|14.7|Standard Deviation|2.33|2.33|||
4382891|NCT00319553|4209289|B1|||Age||years|Mean|14.5|14.5|Standard Deviation|2.33|2.33|||
4382892|NCT00319553|4209287|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382893|NCT00319553|4209288|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382894|NCT00319553|4209289|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4382895|NCT00319553|4209287|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4382896|NCT00319553|4209288|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4382897|NCT00319553|4209289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4382898|NCT00319553|4209287|B3||<=18 years|Age||Participants|Count of Participants|582|582.0||||||
4382899|NCT00319553|4209288|B2||<=18 years|Age||Participants|Count of Participants|291|291.0||||||
4382900|NCT00319553|4209289|B1||<=18 years|Age||Participants|Count of Participants|291|291.0||||||
4382901|NCT00319501|4209302|B3|||Weight||Kilograms|Mean|60.0|60.0|Standard Deviation|28.79|28.79|||
4382902|NCT00319501|4209303|B2|||Weight||Kilograms|Mean|58.9|58.9|Standard Deviation|28.47|28.47|||
4382903|NCT00319501|4209304|B1|||Weight||Kilograms|Mean|61.0|61.0|Standard Deviation|29.15|29.15|||
4382904|NCT00319501|4209302|B3|||Height||Centimeters|Mean|154.4|154.4|Standard Deviation|23.91|23.91|||
4382905|NCT00319501|4209303|B2|||Height||Centimeters|Mean|154.5|154.5|Standard Deviation|22.61|22.61|||
4382906|NCT00319501|4209304|B1|||Height||Centimeters|Mean|154.2|154.2|Standard Deviation|25.08|25.08|||
4382907|NCT00319501|4209302|B3|Other||Place of Residence||Participants|Number|0|0.0||||||
4382908|NCT00319501|4209303|B2|Other||Place of Residence||Participants|Number|0|0.0||||||
4382909|NCT00319501|4209304|B1|Other||Place of Residence||Participants|Number|0|0.0||||||
4382910|NCT00319501|4209302|B3|Residential facility||Place of Residence||Participants|Number|1|1.0||||||
4382911|NCT00319501|4209303|B2|Residential facility||Place of Residence||Participants|Number|1|1.0||||||
4382912|NCT00319501|4209304|B1|Residential facility||Place of Residence||Participants|Number|0|0.0||||||
4382913|NCT00319501|4209302|B3|Group home||Place of Residence||Participants|Number|2|2.0||||||
4382914|NCT00319501|4209303|B2|Group home||Place of Residence||Participants|Number|1|1.0||||||
4382915|NCT00319501|4209304|B1|Group home||Place of Residence||Participants|Number|1|1.0||||||
4382916|NCT00319501|4209302|B3|Foster home||Place of Residence||Participants|Number|1|1.0||||||
4382917|NCT00319501|4209303|B2|Foster home||Place of Residence||Participants|Number|1|1.0||||||
4382918|NCT00319501|4209304|B1|Foster home||Place of Residence||Participants|Number|0|0.0||||||
4382919|NCT00319501|4209302|B3|Home||Place of Residence||Participants|Number|230|230.0||||||
4382920|NCT00319501|4209303|B2|Home||Place of Residence||Participants|Number|107|107.0||||||
4382921|NCT00319501|4209304|B1|Home||Place of Residence||Participants|Number|123|123.0||||||
4382922|NCT00319501|4209302|B3|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382923|NCT00319501|4209303|B2|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382924|NCT00319501|4209304|B1|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382925|NCT00319501|4209302|B3|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4382926|NCT00319501|4209303|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4382927|NCT00319501|4209304|B1|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4382928|NCT00319501|4209302|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382929|NCT00319501|4209303|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382930|NCT00319501|4209304|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382931|NCT00319501|4209302|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382932|NCT00319501|4209303|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382933|NCT00319501|4209304|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4382934|NCT00319501|4209302|B3|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4382935|NCT00319501|4209303|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4382936|NCT00319501|4209304|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4382937|NCT00319501|4209302|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4382938|NCT00319501|4209303|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4382939|NCT00319501|4209304|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4382940|NCT00319501|4209302|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|193|193.0||||||
4382941|NCT00319501|4209303|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|89|89.0||||||
4382942|NCT00319501|4209304|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|104|104.0||||||
4382943|NCT00319501|4209302|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382944|NCT00319501|4209303|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382945|NCT00319501|4209304|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4382946|NCT00319501|4209302|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
4382947|NCT00319501|4209303|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4382948|NCT00319501|4209304|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4382949|NCT00319501|4209302|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4382950|NCT00319501|4209303|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4382951|NCT00319501|4209304|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4382952|NCT00319501|4209302|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4382953|NCT00319501|4209303|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4382954|NCT00319501|4209304|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4382955|NCT00319501|4209302|B3||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4382956|NCT00319501|4209303|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4382957|NCT00319501|4209304|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4382958|NCT00319501|4209302|B3|12 years and older||Age, Customized||participants|Number|184|184.0||||||
4382959|NCT00319501|4209303|B2|12 years and older||Age, Customized||participants|Number|90|90.0||||||
4382960|NCT00319501|4209304|B1|12 years and older||Age, Customized||participants|Number|94|94.0||||||
4382961|NCT00319501|4209302|B3|6 to 11 years||Age, Customized||participants|Number|32|32.0||||||
4382962|NCT00319501|4209303|B2|6 to 11 years||Age, Customized||participants|Number|14|14.0||||||
4382963|NCT00319501|4209304|B1|6 to 11 years||Age, Customized||participants|Number|18|18.0||||||
4382964|NCT00319501|4209302|B3|2 to 5 years||Age, Customized||participants|Number|18|18.0||||||
4382965|NCT00319501|4209303|B2|2 to 5 years||Age, Customized||participants|Number|6|6.0||||||
4382966|NCT00319501|4209304|B1|2 to 5 years||Age, Customized||participants|Number|12|12.0||||||
4382967|NCT00319501|4209302|B3|||Age||years|Mean|22.1|22.1|Standard Deviation|14.61|14.61|||
4382968|NCT00319501|4209303|B2|||Age||years|Mean|21.3|21.3|Standard Deviation|12.92|12.92|||
4382969|NCT00319501|4209304|B1|||Age||years|Mean|22.8|22.8|Standard Deviation|15.98|15.98|||
4382970|NCT00319449|4209329|B3|Indonesia||Region of Enrollment||participants|Number|22|22.0||||||
4382971|NCT00319449|4209330|B2|Indonesia||Region of Enrollment||participants|Number|12|12.0||||||
4382972|NCT00319449|4209331|B1|Indonesia||Region of Enrollment||participants|Number|10|10.0||||||
4382973|NCT00319449|4209329|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4382974|NCT00319449|4209330|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4382975|NCT00319449|4209331|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4382976|NCT00319449|4209329|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4382977|NCT00319449|4209330|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4382978|NCT00319449|4209331|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4382979|NCT00319449|4209329|B3|65 or older||Age, Customized||Participants|Number|4|4.0||||||
4382980|NCT00319449|4209330|B2|65 or older||Age, Customized||Participants|Number|1|1.0||||||
4382981|NCT00319449|4209331|B1|65 or older||Age, Customized||Participants|Number|3|3.0||||||
4382982|NCT00319449|4209329|B3|18 to <65 years||Age, Customized||Participants|Number|18|18.0||||||
4382983|NCT00319449|4209330|B2|18 to <65 years||Age, Customized||Participants|Number|11|11.0||||||
4382984|NCT00319449|4209331|B1|18 to <65 years||Age, Customized||Participants|Number|7|7.0||||||
4382985|NCT00319449|4209329|B3|||Age||Years|Mean|54.5|54.5|Standard Deviation|11.3|11.3|||
4382986|NCT00319449|4209330|B2|||Age||Years|Mean|52.2|52.2|Standard Deviation|10.4|10.4|||
4382987|NCT00319449|4209331|B1|||Age||Years|Mean|57.4|57.4|Standard Deviation|12.1|12.1|||
4382988|NCT00319436|4209342|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4382989|NCT00319436|4209343|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4382990|NCT00319436|4209344|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4382991|NCT00319436|4209342|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4382992|NCT00319436|4209343|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4382993|NCT00319436|4209344|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4382994|NCT00319436|4209342|B3||Female|Gender||Participants|Count of Participants|47|47.0||||||
4382995|NCT00319436|4209343|B2||Female|Gender||Participants|Count of Participants|24|24.0||||||
4382996|NCT00319436|4209344|B1||Female|Gender||Participants|Count of Participants|23|23.0||||||
4382997|NCT00319436|4209342|B3|||Age||years|Mean|30.16|30.16|Standard Deviation|6.48|6.48|||
4382998|NCT00319436|4209343|B2|||Age||years|Mean|28.88|28.88|Standard Deviation|6.50|6.5|||
4382999|NCT00319436|4209344|B1|||Age||years|Mean|31.43|31.43|Standard Deviation|6.46|6.46|||
4383000|NCT00319254|4209363|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383001|NCT00319254|4209363|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4383002|NCT00319254|4209363|B1|||Age||years|Mean|54.27|54.27|Standard Deviation|9.81|9.81|||
4383003|NCT00319111|4209376|B1|Unassessed||World Health Organisation (WHO) functional class|"Disease severity assessed using WHO classification of pulmonary hypertension: Class I: no limitation of physical activity etc.~Class II: slight limitation of physical activity etc. Class III: marked limitation of physical activity etc. Class IV: inability to carry out physical activity without symptoms. Signs of right heart failure etc.~WHO functional class was assessed in 139 patients"|participants|Number|12|12.0||||||
4383004|NCT00319111|4209376|B1|Class IV||World Health Organisation (WHO) functional class|"Disease severity assessed using WHO classification of pulmonary hypertension: Class I: no limitation of physical activity etc.~Class II: slight limitation of physical activity etc. Class III: marked limitation of physical activity etc. Class IV: inability to carry out physical activity without symptoms. Signs of right heart failure etc.~WHO functional class was assessed in 139 patients"|participants|Number|4|4.0||||||
4383005|NCT00319111|4209376|B1|Class III||World Health Organisation (WHO) functional class|"Disease severity assessed using WHO classification of pulmonary hypertension: Class I: no limitation of physical activity etc.~Class II: slight limitation of physical activity etc. Class III: marked limitation of physical activity etc. Class IV: inability to carry out physical activity without symptoms. Signs of right heart failure etc.~WHO functional class was assessed in 139 patients"|participants|Number|91|91.0||||||
4383006|NCT00319111|4209376|B1|Class II||World Health Organisation (WHO) functional class|"Disease severity assessed using WHO classification of pulmonary hypertension: Class I: no limitation of physical activity etc.~Class II: slight limitation of physical activity etc. Class III: marked limitation of physical activity etc. Class IV: inability to carry out physical activity without symptoms. Signs of right heart failure etc.~WHO functional class was assessed in 139 patients"|participants|Number|41|41.0||||||
4383007|NCT00319111|4209376|B1|Class I||World Health Organisation (WHO) functional class|"Disease severity assessed using WHO classification of pulmonary hypertension: Class I: no limitation of physical activity etc.~Class II: slight limitation of physical activity etc. Class III: marked limitation of physical activity etc. Class IV: inability to carry out physical activity without symptoms. Signs of right heart failure etc.~WHO functional class was assessed in 139 patients"|participants|Number|3|3.0||||||
4383008|NCT00319111|4209376|B1|||Borg dyspnea index|The Borg dyspnea index was assessed in 136 out of the 151 participants. Maximal dyspnea during the walk test was assessed by the patient using the Borg dyspnea index. Immediately following each walk test, patients rated perceived maximal breathlessness during the walk test on a 12-point scale (0 [nothing at all], 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 [maximum ever experienced]).|points on a scale|Mean|4.2|4.2|Standard Deviation|2.2|2.2|||
4383009|NCT00319111|4209376|B1|||Six-minute walk test (6MWT)|Exercise capacity was determined for 137 of the 151 participants using the 6MWT. Area used for testing was a minimum of 30m in length and 2-3m in width, with 3m gradations. Areas were well ventilated with air temperature controlled. The test was administered at the same time of day and by the same tester throughout the study. The tester measured the distance walked by non-encouraged patients during the timed 6min period. If the test was stopped before 6 minutes, the main reason for stopping the test was recorded. The tester measured the distance walked by patients during the timed 6min period.|walk distance (m)|Mean|345.2|345.2|Standard Deviation|93.4|93.4|||
4383010|NCT00319111|4209376|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4383011|NCT00319111|4209376|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4383012|NCT00319111|4209376|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4383013|NCT00319111|4209376|B1|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4383014|NCT00319111|4209376|B1|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4383015|NCT00319111|4209376|B1|Italy||Region of Enrollment||participants|Number|28|28.0||||||
4383016|NCT00319111|4209376|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4383017|NCT00319111|4209376|B1|France||Region of Enrollment||participants|Number|18|18.0||||||
4383018|NCT00319111|4209376|B1|Czech Republic||Region of Enrollment||participants|Number|20|20.0||||||
4383019|NCT00319111|4209376|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4383020|NCT00319111|4209376|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4383021|NCT00319111|4209376|B1|Austria||Region of Enrollment||participants|Number|10|10.0||||||
4383022|NCT00319111|4209376|B1|Australia||Region of Enrollment||participants|Number|17|17.0||||||
4383023|NCT00319111|4209376|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4383024|NCT00319111|4209376|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4383025|NCT00319111|4209376|B1|25-81 years||Age, Customized||participants|Number|151|151.0||||||
4383026|NCT00319111|4209376|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|11.7|11.7|||
4383027|NCT00319098|4209386|B5||Male|Sex: Female, Male||Participants|Count of Participants|2119|2119.0||||||
4383028|NCT00319098|4209387|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4383029|NCT00319098|4209388|B3||Male|Sex: Female, Male||Participants|Count of Participants|445|445.0||||||
4383030|NCT00319098|4209389|B2||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4383031|NCT00319098|4209390|B1||Male|Sex: Female, Male||Participants|Count of Participants|1379|1379.0||||||
4383032|NCT00319098|4209386|B5||Female|Sex: Female, Male||Participants|Count of Participants|2952|2952.0||||||
4383033|NCT00319098|4209387|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4383034|NCT00319098|4209388|B3||Female|Sex: Female, Male||Participants|Count of Participants|691|691.0||||||
4383035|NCT00319098|4209389|B2||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4383036|NCT00319098|4209390|B1||Female|Sex: Female, Male||Participants|Count of Participants|2018|2018.0||||||
4383037|NCT00319098|4209386|B5|||Age||Years|Mean|38.36|38.36|Standard Deviation|15.40|15.4|||
4383038|NCT00319098|4209387|B4|||Age||Years|Mean|66.6|66.6|Standard Deviation|5.20|5.2|||
4383039|NCT00319098|4209388|B3|||Age||Years|Mean|35.4|35.4|Standard Deviation|12.51|12.51|||
4383040|NCT00319098|4209389|B2|||Age||Years|Mean|67.3|67.3|Standard Deviation|6.01|6.01|||
4383041|NCT00319098|4209390|B1|||Age||Years|Mean|34.8|34.8|Standard Deviation|12.24|12.24|||
4383042|NCT00319046|4209449|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4383043|NCT00319046|4209449|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4383044|NCT00319046|4209449|B1|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
4383045|NCT00319046|4209449|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4383046|NCT00319046|4209449|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4383047|NCT00319046|4209449|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4383048|NCT00319046|4209449|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4383049|NCT00319046|4209449|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4383050|NCT00319046|4209449|B1|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
4383051|NCT00319046|4209449|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4383052|NCT00319046|4209449|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4383053|NCT00319046|4209449|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4383054|NCT00319046|4209449|B1|Between 22 and 70 years||Age, Customized||participants|Number|42|42.0||||||
4383055|NCT00319046|4209449|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|12.7|12.7|||
4383056|NCT00319020|4209456|B3|||Duration of pulmonary arterial hypertension (PAH)||Months|Median|25.8|25.8|Full Range|||0.0|133.5|
4383057|NCT00319020|4209457|B2|||Duration of pulmonary arterial hypertension (PAH)||Months|Median|14|14.0|Full Range|||0.0|133.5|
4383058|NCT00319020|4209458|B1|||Duration of pulmonary arterial hypertension (PAH)||Months|Median|37.6|37.6|Full Range|||1.2|82.6|
4383059|NCT00319020|4209456|B3|Familial PAH||Etiology of pulmonary arterial hypertension (PAH)|Children included in the study had a diagnosis of pulmonary arterial hypertension (PAH) belonging to one of the following two categories: 1- Idiopathic PAH, 2- Familal PAH|Participants|Number|5|5.0||||||
4383060|NCT00319020|4209457|B2|Familial PAH||Etiology of pulmonary arterial hypertension (PAH)|Children included in the study had a diagnosis of pulmonary arterial hypertension (PAH) belonging to one of the following two categories: 1- Idiopathic PAH, 2- Familal PAH|Participants|Number|2|2.0||||||
4383061|NCT00319020|4209458|B1|Familial PAH||Etiology of pulmonary arterial hypertension (PAH)|Children included in the study had a diagnosis of pulmonary arterial hypertension (PAH) belonging to one of the following two categories: 1- Idiopathic PAH, 2- Familal PAH|Participants|Number|3|3.0||||||
4383062|NCT00319020|4209456|B3|Idiopathic PAH||Etiology of pulmonary arterial hypertension (PAH)|Children included in the study had a diagnosis of pulmonary arterial hypertension (PAH) belonging to one of the following two categories: 1- Idiopathic PAH, 2- Familal PAH|Participants|Number|31|31.0||||||
4383063|NCT00319020|4209457|B2|Idiopathic PAH||Etiology of pulmonary arterial hypertension (PAH)|Children included in the study had a diagnosis of pulmonary arterial hypertension (PAH) belonging to one of the following two categories: 1- Idiopathic PAH, 2- Familal PAH|Participants|Number|19|19.0||||||
4383064|NCT00319020|4209458|B1|Idiopathic PAH||Etiology of pulmonary arterial hypertension (PAH)|Children included in the study had a diagnosis of pulmonary arterial hypertension (PAH) belonging to one of the following two categories: 1- Idiopathic PAH, 2- Familal PAH|Participants|Number|12|12.0||||||
4383065|NCT00319020|4209456|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4383066|NCT00319020|4209457|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4383067|NCT00319020|4209458|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4383068|NCT00319020|4209456|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4383069|NCT00319020|4209457|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4383070|NCT00319020|4209458|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4383071|NCT00319020|4209456|B3|6-11 years old||Age, Customized||Participants|Number|23|23.0||||||
4383072|NCT00319020|4209457|B2|6-11 years old||Age, Customized||Participants|Number|12|12.0||||||
4383073|NCT00319020|4209458|B1|6-11 years old||Age, Customized||Participants|Number|11|11.0||||||
4383074|NCT00319020|4209456|B3|4-5 years old||Age, Customized||Participants|Number|9|9.0||||||
4383075|NCT00319020|4209457|B2|4-5 years old||Age, Customized||Participants|Number|6|6.0||||||
4383076|NCT00319020|4209458|B1|4-5 years old||Age, Customized||Participants|Number|3|3.0||||||
4383077|NCT00319020|4209456|B3|2-3 years old||Age, Customized||Participants|Number|4|4.0||||||
4383078|NCT00319020|4209457|B2|2-3 years old||Age, Customized||Participants|Number|3|3.0||||||
4383079|NCT00319020|4209458|B1|2-3 years old||Age, Customized||Participants|Number|1|1.0||||||
4383080|NCT00319020|4209456|B3|||Age||Years|Median|7|7.0|Full Range|||2.0|11.0|
4383081|NCT00319020|4209457|B2|||Age||Years|Median|7|7.0|Full Range|||2.0|11.0|
4383082|NCT00319020|4209458|B1|||Age||Years|Median|7|7.0|Full Range|||3.0|10.0|
4383083|NCT00318929|4209488|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4383084|NCT00318929|4209488|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4383085|NCT00318929|4209488|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4383086|NCT00318929|4209488|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|9.5|9.5|||
4383087|NCT00318929|4209488|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4383088|NCT00318929|4209488|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4383089|NCT00318929|4209488|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383090|NCT00318812|4209495|B3|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4383091|NCT00318812|4209496|B2|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4383092|NCT00318812|4209497|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4383093|NCT00318812|4209495|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4383094|NCT00318812|4209496|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4383095|NCT00318812|4209497|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4383096|NCT00318812|4209495|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4383097|NCT00318812|4209496|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4383098|NCT00318812|4209497|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4383099|NCT00318812|4209495|B3|||Age||years|Median|68|68.0|Inter-Quartile Range|||63.0|77.0|
4383100|NCT00318812|4209496|B2|||Age||years|Median|66|66.0|Inter-Quartile Range|||58.0|76.0|
4383101|NCT00318812|4209497|B1|||Age||years|Median|76|76.0|Inter-Quartile Range|||66.0|83.0|
4383102|NCT00318708|4209508|B3|United States||Region of Enrollment||participants|Number|92|92.0||||||
4383103|NCT00318708|4209509|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4383104|NCT00318708|4209510|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4383105|NCT00318708|4209508|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4383106|NCT00318708|4209509|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4383107|NCT00318708|4209510|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4383108|NCT00318708|4209508|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4383109|NCT00318708|4209509|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4383110|NCT00318708|4209510|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4383111|NCT00318708|4209508|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|11.5|11.5|||
4383112|NCT00318708|4209509|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|10.5|10.5|||
4383113|NCT00318708|4209510|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|12.5|12.5|||
4383114|NCT00318708|4209508|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4383115|NCT00318708|4209509|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4383116|NCT00318708|4209510|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4383117|NCT00318708|4209508|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4383118|NCT00318708|4209509|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4383119|NCT00318708|4209510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4383120|NCT00318708|4209508|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383121|NCT00318708|4209509|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383122|NCT00318708|4209510|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383123|NCT00318656|4209529|B3|||HbA1c|HbA1c reflects the mean level of glycaemia over time.|percentage|Mean|7.8|7.8|Standard Deviation|0.50|0.5|||
4383124|NCT00318656|4209530|B2|||HbA1c|HbA1c reflects the mean level of glycaemia over time.|percentage|Mean|7.8|7.8|Standard Deviation|0.52|0.52|||
4383125|NCT00318656|4209531|B1|||HbA1c|HbA1c reflects the mean level of glycaemia over time.|percentage|Mean|7.8|7.8|Standard Deviation|0.51|0.51|||
4383126|NCT00318656|4209529|B3|||Body Mass Index (BMI)|BMI: A key index for relating a person's body weight to their height. The body mass index (BMI) is a person's weight in kilograms (kg) divided by their height in meters (m) squared.|kg/m²|Mean|31.2|31.2|Standard Deviation|5.8|5.8|||
4383127|NCT00318656|4209530|B2|||Body Mass Index (BMI)|BMI: A key index for relating a person's body weight to their height. The body mass index (BMI) is a person's weight in kilograms (kg) divided by their height in meters (m) squared.|kg/m²|Mean|30.1|30.1|Standard Deviation|4.8|4.8|||
4383128|NCT00318656|4209531|B1|||Body Mass Index (BMI)|BMI: A key index for relating a person's body weight to their height. The body mass index (BMI) is a person's weight in kilograms (kg) divided by their height in meters (m) squared.|kg/m²|Mean|32.2|32.2|Standard Deviation|6.6|6.6|||
4383129|NCT00318656|4209529|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4383130|NCT00318656|4209530|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4383131|NCT00318656|4209531|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4383132|NCT00318656|4209529|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4383133|NCT00318656|4209530|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4383134|NCT00318656|4209531|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4383135|NCT00318656|4209529|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|8.7|8.7|||
4383136|NCT00318656|4209530|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|6.6|6.6|||
4383137|NCT00318656|4209531|B1|||Age||years|Mean|59|59.0|Standard Deviation|10.3|10.3|||
4383138|NCT00318591|4209568|B3|Canada||Region of Enrollment||participants|Number|53|53.0||||||
4383139|NCT00318591|4209569|B2|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4383140|NCT00318591|4209570|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4383141|NCT00318591|4209568|B3|United States||Region of Enrollment||participants|Number|166|166.0||||||
4383142|NCT00318591|4209569|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
4383143|NCT00318591|4209570|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4383144|NCT00318591|4209568|B3|Male||Gender|Gender is unknown for one participant|participants|Number|176|176.0||||||
4383145|NCT00318591|4209569|B2|Male||Gender|Gender is unknown for one participant|participants|Number|93|93.0||||||
4383146|NCT00318591|4209570|B1|Male||Gender|Gender is unknown for one participant|participants|Number|83|83.0||||||
4383147|NCT00318591|4209568|B3|Female||Gender|Gender is unknown for one participant|participants|Number|42|42.0||||||
4383563|NCT00317226|4210007|B1||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4383148|NCT00318591|4209569|B2|Female||Gender|Gender is unknown for one participant|participants|Number|20|20.0||||||
4383149|NCT00318591|4209570|B1|Female||Gender|Gender is unknown for one participant|participants|Number|22|22.0||||||
4383150|NCT00318591|4209568|B3|||Age||years|Mean|36.1|36.1|Standard Deviation|13.8|13.8|||
4383151|NCT00318591|4209569|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|13.2|13.2|||
4383152|NCT00318591|4209570|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|14.4|14.4|||
4383153|NCT00318565|4209589|B1|United States||Region of Enrollment||participants|Number|291|291.0||||||
4383154|NCT00318565|4209589|B1||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4383155|NCT00318565|4209589|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4383156|NCT00318565|4209589|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|12.1|12.1|||
4383157|NCT00318565|4209589|B1||>=65 years|Age||Participants|Count of Participants|155|155.0||||||
4383158|NCT00318565|4209589|B1||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4383159|NCT00318565|4209589|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383160|NCT00318474|4209594|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4383161|NCT00318474|4209595|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4383162|NCT00318474|4209596|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4383163|NCT00318474|4209594|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4383164|NCT00318474|4209595|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4383165|NCT00318474|4209596|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4383166|NCT00318474|4209594|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4383167|NCT00318474|4209595|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4383168|NCT00318474|4209596|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4383169|NCT00318474|4209594|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4383170|NCT00318474|4209595|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4383171|NCT00318474|4209596|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4383172|NCT00318474|4209594|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4383173|NCT00318474|4209595|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4383174|NCT00318474|4209596|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4383175|NCT00318474|4209594|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4383176|NCT00318474|4209595|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4383177|NCT00318474|4209596|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4383178|NCT00318474|4209594|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4383179|NCT00318474|4209595|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4383180|NCT00318474|4209596|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4383181|NCT00318474|4209594|B3|||Age||years|Mean|32.0|32.0|Standard Deviation|12.2|12.2|||
4383182|NCT00318474|4209595|B2|||Age||years|Mean|32.2|32.2|Standard Deviation|13.2|13.2|||
4383183|NCT00318474|4209596|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|11.7|11.7|||
4383184|NCT00318461|4209603|B6|||Height||m|Mean|1.69|1.69|Standard Deviation|0.10|0.1|||
4383185|NCT00318461|4209604|B5|||Height||m|Mean|1.69|1.69|Standard Deviation|0.11|0.11|||
4383186|NCT00318461|4209605|B4|||Height||m|Mean|1.69|1.69|Standard Deviation|0.10|0.1|||
4383187|NCT00318461|4209606|B3|||Height||m|Mean|1.69|1.69|Standard Deviation|0.10|0.1|||
4383188|NCT00318461|4209607|B2|||Height||m|Mean|1.68|1.68|Standard Deviation|0.11|0.11|||
4383189|NCT00318461|4209608|B1|||Height||m|Mean|1.69|1.69|Standard Deviation|0.10|0.1|||
4383190|NCT00318461|4209603|B6|||HbA1c|Glycosylated Haemoglobin at screening|percentage of total haemoglobin|Mean|8.4|8.4|Standard Deviation|0.9|0.9|||
4383191|NCT00318461|4209604|B5|||HbA1c|Glycosylated Haemoglobin at screening|percentage of total haemoglobin|Mean|8.4|8.4|Standard Deviation|0.9|0.9|||
4383192|NCT00318461|4209605|B4|||HbA1c|Glycosylated Haemoglobin at screening|percentage of total haemoglobin|Mean|8.4|8.4|Standard Deviation|1.0|1.0|||
4383193|NCT00318461|4209606|B3|||HbA1c|Glycosylated Haemoglobin at screening|percentage of total haemoglobin|Mean|8.3|8.3|Standard Deviation|0.9|0.9|||
4383194|NCT00318461|4209607|B2|||HbA1c|Glycosylated Haemoglobin at screening|percentage of total haemoglobin|Mean|8.3|8.3|Standard Deviation|0.9|0.9|||
4383195|NCT00318461|4209608|B1|||HbA1c|Glycosylated Haemoglobin at screening|percentage of total haemoglobin|Mean|8.4|8.4|Standard Deviation|0.9|0.9|||
4383196|NCT00318461|4209603|B6|||Duration of diabetes|Number of years since diagnosis of diabetes|years|Mean|7.4|7.4|Standard Deviation|5.2|5.2|||
4383197|NCT00318461|4209604|B5|||Duration of diabetes|Number of years since diagnosis of diabetes|years|Mean|7.7|7.7|Standard Deviation|5.3|5.3|||
4383198|NCT00318461|4209605|B4|||Duration of diabetes|Number of years since diagnosis of diabetes|years|Mean|7.9|7.9|Standard Deviation|6.0|6.0|||
4383199|NCT00318461|4209606|B3|||Duration of diabetes|Number of years since diagnosis of diabetes|years|Mean|7.8|7.8|Standard Deviation|5.2|5.2|||
4383200|NCT00318461|4209607|B2|||Duration of diabetes|Number of years since diagnosis of diabetes|years|Mean|6.8|6.8|Standard Deviation|4.9|4.9|||
4383201|NCT00318461|4209608|B1|||Duration of diabetes|Number of years since diagnosis of diabetes|years|Mean|7.0|7.0|Standard Deviation|4.8|4.8|||
4383202|NCT00318461|4209603|B6|||BMI|Body Mass Index|kg/m2|Mean|31.0|31.0|Standard Deviation|4.7|4.7|||
4383203|NCT00318461|4209604|B5|||BMI|Body Mass Index|kg/m2|Mean|31.2|31.2|Standard Deviation|4.6|4.6|||
4383204|NCT00318461|4209605|B4|||BMI|Body Mass Index|kg/m2|Mean|31.6|31.6|Standard Deviation|4.4|4.4|||
4383205|NCT00318461|4209606|B3|||BMI|Body Mass Index|kg/m2|Mean|30.9|30.9|Standard Deviation|4.6|4.6|||
4383206|NCT00318461|4209607|B2|||BMI|Body Mass Index|kg/m2|Mean|31.1|31.1|Standard Deviation|4.8|4.8|||
4383207|NCT00318461|4209608|B1|||BMI|Body Mass Index|kg/m2|Mean|30.5|30.5|Standard Deviation|4.8|4.8|||
4383208|NCT00318461|4209603|B6|Combination therapy||Previous anti-diabetic treatment||participants|Number|703|703.0||||||
4383209|NCT00318461|4209604|B5|Combination therapy||Previous anti-diabetic treatment||participants|Number|152|152.0||||||
4383210|NCT00318461|4209605|B4|Combination therapy||Previous anti-diabetic treatment||participants|Number|80|80.0||||||
4383211|NCT00318461|4209606|B3|Combination therapy||Previous anti-diabetic treatment||participants|Number|160|160.0||||||
4383212|NCT00318461|4209607|B2|Combination therapy||Previous anti-diabetic treatment||participants|Number|150|150.0||||||
4383213|NCT00318461|4209608|B1|Combination therapy||Previous anti-diabetic treatment||participants|Number|161|161.0||||||
4383214|NCT00318461|4209603|B6|Mono-therapy||Previous anti-diabetic treatment||participants|Number|384|384.0||||||
4383215|NCT00318461|4209604|B5|Mono-therapy||Previous anti-diabetic treatment||participants|Number|90|90.0||||||
4383216|NCT00318461|4209605|B4|Mono-therapy||Previous anti-diabetic treatment||participants|Number|41|41.0||||||
4383217|NCT00318461|4209606|B3|Mono-therapy||Previous anti-diabetic treatment||participants|Number|82|82.0||||||
4383218|NCT00318461|4209607|B2|Mono-therapy||Previous anti-diabetic treatment||participants|Number|90|90.0||||||
4383219|NCT00318461|4209608|B1|Mono-therapy||Previous anti-diabetic treatment||participants|Number|81|81.0||||||
4383220|NCT00318461|4209603|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4383221|NCT00318461|4209604|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4383222|NCT00318461|4209605|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4383223|NCT00318461|4209606|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4383224|NCT00318461|4209607|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4383225|NCT00318461|4209608|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4383226|NCT00318461|4209603|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383227|NCT00318461|4209604|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383228|NCT00318461|4209605|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383229|NCT00318461|4209606|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383230|NCT00318461|4209607|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383231|NCT00318461|4209608|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383232|NCT00318461|4209603|B6||White|Race (NIH/OMB)||Participants|Count of Participants|946|946.0||||||
4383233|NCT00318461|4209604|B5||White|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
4383234|NCT00318461|4209605|B4||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4383235|NCT00318461|4209606|B3||White|Race (NIH/OMB)||Participants|Count of Participants|214|214.0||||||
4383236|NCT00318461|4209607|B2||White|Race (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
4383237|NCT00318461|4209608|B1||White|Race (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
4383238|NCT00318461|4209603|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4383239|NCT00318461|4209604|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4383240|NCT00318461|4209605|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4383241|NCT00318461|4209606|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4383242|NCT00318461|4209607|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4383243|NCT00318461|4209608|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4383244|NCT00318461|4209603|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383245|NCT00318461|4209604|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383246|NCT00318461|4209605|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383247|NCT00318461|4209606|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383248|NCT00318461|4209607|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383249|NCT00318461|4209608|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383250|NCT00318461|4209603|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4383251|NCT00318461|4209604|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4383252|NCT00318461|4209605|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4383253|NCT00318461|4209606|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4383254|NCT00318461|4209607|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4383255|NCT00318461|4209608|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4383256|NCT00318461|4209603|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383257|NCT00318461|4209604|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383258|NCT00318461|4209605|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383259|NCT00318461|4209606|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383260|NCT00318461|4209607|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383261|NCT00318461|4209608|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383262|NCT00318461|4209603|B6||Male|Sex: Female, Male||Participants|Count of Participants|633|633.0||||||
4383263|NCT00318461|4209604|B5||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4383264|NCT00318461|4209605|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4383265|NCT00318461|4209606|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4383266|NCT00318461|4209607|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4383267|NCT00318461|4209608|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4383268|NCT00318461|4209603|B6||Female|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
4383269|NCT00318461|4209604|B5||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4383270|NCT00318461|4209605|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4383271|NCT00318461|4209606|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4383272|NCT00318461|4209607|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4383273|NCT00318461|4209608|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4383274|NCT00318461|4209603|B6|||Age||years|Mean|56.7|56.7|Standard Deviation|9.5|9.5|||
4383275|NCT00318461|4209604|B5|||Age||years|Mean|57.3|57.3|Standard Deviation|8.8|8.8|||
4383276|NCT00318461|4209605|B4|||Age||years|Mean|56.0|56.0|Standard Deviation|9.4|9.4|||
4383277|NCT00318461|4209606|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|9.4|9.4|||
4383278|NCT00318461|4209607|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|9.2|9.2|||
4383279|NCT00318461|4209608|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|10.5|10.5|||
4383280|NCT00318409|4209689|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4383281|NCT00318409|4209690|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4383282|NCT00318409|4209691|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4383283|NCT00318409|4209689|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383284|NCT00318409|4209690|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383285|NCT00318409|4209691|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383286|NCT00318409|4209689|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4383287|NCT00318409|4209690|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4383288|NCT00318409|4209691|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4383289|NCT00318409|4209689|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4383290|NCT00318409|4209690|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4383291|NCT00318409|4209691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4383292|NCT00318409|4209689|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383293|NCT00318409|4209690|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383294|NCT00318409|4209691|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383295|NCT00318370|4209711|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4383296|NCT00318370|4209711|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4383297|NCT00318370|4209711|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4383298|NCT00318370|4209711|B1|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4383299|NCT00318370|4209711|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4383300|NCT00318370|4209711|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4383301|NCT00318370|4209711|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4383302|NCT00318370|4209711|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4383303|NCT00318370|4209711|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383304|NCT00318370|4209711|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4383305|NCT00318370|4209711|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|11.66|11.66|||
4383306|NCT00318292|4209723|B3|||BMI|Body Mass Index|kg/m^2|Mean|25.8|25.8|Standard Deviation|4.8|4.8|||
4383307|NCT00318292|4209724|B2|||BMI|Body Mass Index|kg/m^2|Mean|25.4|25.4|Standard Deviation|4.0|4.0|||
4383308|NCT00318292|4209725|B1|||BMI|Body Mass Index|kg/m^2|Mean|26.2|26.2|Standard Deviation|5.4|5.4|||
4383309|NCT00318292|4209723|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383310|NCT00318292|4209724|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383311|NCT00318292|4209725|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383312|NCT00318292|4209723|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4383313|NCT00318292|4209724|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4383314|NCT00318292|4209725|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4383315|NCT00318292|4209723|B3|||Age||years|Mean|56|56.0|Standard Deviation|18|18.0|||
4383316|NCT00318292|4209724|B2|||Age||years|Mean|54|54.0|Standard Deviation|20|20.0|||
4383317|NCT00318292|4209725|B1|||Age||years|Mean|57|57.0|Standard Deviation|15|15.0|||
4383318|NCT00318149|4209732|B7|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4383319|NCT00318149|4209733|B6|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4383320|NCT00318149|4209734|B5|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4383321|NCT00318149|4209735|B4|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4383322|NCT00318149|4209736|B3|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4383323|NCT00318149|4209737|B2|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4383324|NCT00318149|4209738|B1|Geographic ancestry|Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4383325|NCT00318149|4209732|B7|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|422|422.0||||||
4383326|NCT00318149|4209733|B6|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
4383327|NCT00318149|4209734|B5|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
4383328|NCT00318149|4209735|B4|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
4383329|NCT00318149|4209736|B3|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
4383330|NCT00318149|4209737|B2|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4383331|NCT00318149|4209738|B1|Geographic ancestry|White - Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
4383332|NCT00318149|4209732|B7|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4383333|NCT00318149|4209733|B6|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4383334|NCT00318149|4209734|B5|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4383335|NCT00318149|4209735|B4|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4383336|NCT00318149|4209736|B3|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4383337|NCT00318149|4209737|B2|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4383338|NCT00318149|4209738|B1|Geographic ancestry|Asian - Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4383339|NCT00318149|4209732|B7||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4383340|NCT00318149|4209733|B6||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4383341|NCT00318149|4209734|B5||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4383342|NCT00318149|4209735|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4383343|NCT00318149|4209736|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4383344|NCT00318149|4209737|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4383345|NCT00318149|4209738|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4383346|NCT00318149|4209732|B7||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4383347|NCT00318149|4209733|B6||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4383348|NCT00318149|4209734|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4383349|NCT00318149|4209735|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4383350|NCT00318149|4209736|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4383351|NCT00318149|4209737|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4383352|NCT00318149|4209738|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4383353|NCT00318149|4209732|B7|||Age||Years|Mean|61.66|61.66|Standard Deviation|17.02|17.02|||
4383354|NCT00318149|4209733|B6|||Age||Years|Mean|69.5|69.5|Standard Deviation|4.06|4.06|||
4383355|NCT00318149|4209734|B5|||Age||Years|Mean|69.5|69.5|Standard Deviation|3.3|3.3|||
4383356|NCT00318149|4209735|B4|||Age||Years|Mean|69.1|69.1|Standard Deviation|3.51|3.51|||
4383357|NCT00318149|4209736|B3|||Age||Years|Mean|69.2|69.2|Standard Deviation|2.98|2.98|||
4383358|NCT00318149|4209737|B2|||Age||Years|Mean|69.3|69.3|Standard Deviation|3.31|3.31|||
4383359|NCT00318149|4209738|B1|||Age||Years|Mean|25.9|25.9|Standard Deviation|5.47|5.47|||
4383360|NCT00318136|4209829|B1||Male|Sex: Female, Male|Of the 47 enrolled subjects, 31 met the protocol-specified criteria and received bevacizumab.|Participants|Count of Participants|21|21.0||||||
4383361|NCT00318136|4209829|B1||Female|Sex: Female, Male|Of the 47 enrolled subjects, 31 met the protocol-specified criteria and received bevacizumab.|Participants|Count of Participants|10|10.0||||||
4383362|NCT00318136|4209829|B1|||Age|Of the 47 enrolled subjects, 31 met the protocol-specified criteria and received bevacizumab.|years|Mean|65.0|65.0|Standard Deviation|7.9|7.9|||
4383363|NCT00317941|4209836|B3|||Time since diagnosis||Years|Mean|3.3|3.3|Standard Deviation|6.4|6.4|||
4383364|NCT00317941|4209837|B2|||Time since diagnosis||Years|Mean|3.3|3.3|Standard Deviation|6.7|6.7|||
4383365|NCT00317941|4209838|B1|||Time since diagnosis||Years|Mean|3.3|3.3|Standard Deviation|5.7|5.7|||
4383366|NCT00317941|4209836|B3|||Expanded disability status scale at screening (EDSS)|The EDSS scores range from 0.0 (normal) to 10.0 (dead). A score of 2 to 3 indicates minimal to moderate disability.|Scores on a scale|Mean|1.8|1.8|Standard Deviation|1.3|1.3|||
4383367|NCT00317941|4209837|B2|||Expanded disability status scale at screening (EDSS)|The EDSS scores range from 0.0 (normal) to 10.0 (dead). A score of 2 to 3 indicates minimal to moderate disability.|Scores on a scale|Mean|1.9|1.9|Standard Deviation|1.4|1.4|||
4383368|NCT00317941|4209838|B1|||Expanded disability status scale at screening (EDSS)|The EDSS scores range from 0.0 (normal) to 10.0 (dead). A score of 2 to 3 indicates minimal to moderate disability.|Scores on a scale|Mean|1.7|1.7|Standard Deviation|1.2|1.2|||
4383369|NCT00317941|4209836|B3|||Number of relapses||Relapses|Mean|2.1|2.1|Standard Deviation|1.1|1.1|||
4383370|NCT00317941|4209837|B2|||Number of relapses||Relapses|Mean|2.1|2.1|Standard Deviation|1.0|1.0|||
4383371|NCT00317941|4209838|B1|||Number of relapses||Relapses|Mean|2.2|2.2|Standard Deviation|1.2|1.2|||
4383372|NCT00317941|4209836|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4383373|NCT00317941|4209837|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4383374|NCT00317941|4209838|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4383375|NCT00317941|4209836|B3||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4383376|NCT00317941|4209837|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4383377|NCT00317941|4209838|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4383378|NCT00317941|4209836|B3|||Age||Years|Mean|38.7|38.7|Standard Deviation|10.4|10.4|||
4383379|NCT00317941|4209837|B2|||Age||Years|Mean|38.4|38.4|Standard Deviation|10.5|10.5|||
4383380|NCT00317941|4209838|B1|||Age||Years|Mean|39.2|39.2|Standard Deviation|10.3|10.3|||
4383381|NCT00317720|4209881|B1|2||Prior lines of trastuzumab-containing chemotherapy for metastatic breast cancer (MBC)|Number of trastuzumab-containing chemotherapy regimens participants had for MBC before starting study|Participants|Number|8|8.0||||||
4383382|NCT00317720|4209881|B1|1||Prior lines of trastuzumab-containing chemotherapy for metastatic breast cancer (MBC)|Number of trastuzumab-containing chemotherapy regimens participants had for MBC before starting study|Participants|Number|29|29.0||||||
4383383|NCT00317720|4209881|B1|0||Prior lines of trastuzumab-containing chemotherapy for metastatic breast cancer (MBC)|Number of trastuzumab-containing chemotherapy regimens participants had for MBC before starting study|Participants|Number|10|10.0||||||
4383384|NCT00317720|4209881|B1|ER and PR Negative||Hormone receptor status|Pathological determination of hormone receptor status, Hormone receptor-positive (estrogen receptor-positive (ER+)/progesterone receptor-positive (PR+)) breast cancers have many hormone receptors. Hormone receptor-negative (estrogen receptor-negative (ER-)/progesterone receptor-negative (PR-)) breast cancers have few or no hormone receptors.|Participants|Number|19|19.0||||||
4383385|NCT00317720|4209881|B1|ER or PR positive||Hormone receptor status|Pathological determination of hormone receptor status, Hormone receptor-positive (estrogen receptor-positive (ER+)/progesterone receptor-positive (PR+)) breast cancers have many hormone receptors. Hormone receptor-negative (estrogen receptor-negative (ER-)/progesterone receptor-negative (PR-)) breast cancers have few or no hormone receptors.|Participants|Number|28|28.0||||||
4383386|NCT00317720|4209881|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383387|NCT00317720|4209881|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4383388|NCT00317720|4209881|B1|||Age||years|Median|50|50.0|Full Range|||28.0|66.0|
4383389|NCT00317642|4209887|B3|unknown||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|3|3.0||||||
4383390|NCT00317642|4209888|B2|unknown||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|1|1.0||||||
4383391|NCT00317642|4209889|B1|unknown||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|2|2.0||||||
4383392|NCT00317642|4209887|B3|Not Assessed||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|11|11.0||||||
4383393|NCT00317642|4209888|B2|Not Assessed||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|3|3.0||||||
4383394|NCT00317642|4209889|B1|Not Assessed||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|8|8.0||||||
4383395|NCT00317642|4209887|B3|Unfavorable||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|156|156.0||||||
4383396|NCT00317642|4209888|B2|Unfavorable||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|70|70.0||||||
4383397|NCT00317642|4209889|B1|Unfavorable||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|86|86.0||||||
4383398|NCT00317642|4209887|B3|Intermediate||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|149|149.0||||||
4383399|NCT00317642|4209888|B2|Intermediate||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|84|84.0||||||
4383400|NCT00317642|4209889|B1|Intermediate||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|65|65.0||||||
4383401|NCT00317642|4209887|B3|Favorable||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|1|1.0||||||
4383402|NCT00317642|4209888|B2|Favorable||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|0|0.0||||||
4383443|NCT00317642|4209887|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383622|NCT00316914|4210099|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4383403|NCT00317642|4209889|B1|Favorable||Karyotype|Favorable karyotype was defined as any abnormality of chromosome 16; Intermediate karyotype was defined as normal (no abnormalities); Unfavorable karyotype was defined as any other abnormality|participants|Number|1|1.0||||||
4383404|NCT00317642|4209887|B3|ECOG 2||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0 (fully active); 1 (capable of light work); 2 (no work but all self-care); 3 (limited self-care); 4 (completely disabled); 5 (dead).|Participants|Number|44|44.0||||||
4383405|NCT00317642|4209888|B2|ECOG 2||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0 (fully active); 1 (capable of light work); 2 (no work but all self-care); 3 (limited self-care); 4 (completely disabled); 5 (dead).|Participants|Number|18|18.0||||||
4383406|NCT00317642|4209889|B1|ECOG 2||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0 (fully active); 1 (capable of light work); 2 (no work but all self-care); 3 (limited self-care); 4 (completely disabled); 5 (dead).|Participants|Number|26|26.0||||||
4383407|NCT00317642|4209887|B3|ECOG 1||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0 (fully active); 1 (capable of light work); 2 (no work but all self-care); 3 (limited self-care); 4 (completely disabled); 5 (dead).|Participants|Number|171|171.0||||||
4383408|NCT00317642|4209888|B2|ECOG 1||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0 (fully active); 1 (capable of light work); 2 (no work but all self-care); 3 (limited self-care); 4 (completely disabled); 5 (dead).|Participants|Number|92|92.0||||||
4383409|NCT00317642|4209889|B1|ECOG 1||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0 (fully active); 1 (capable of light work); 2 (no work but all self-care); 3 (limited self-care); 4 (completely disabled); 5 (dead).|Participants|Number|79|79.0||||||
4383410|NCT00317642|4209887|B3|ECOG 0||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0 (fully active); 1 (capable of light work); 2 (no work but all self-care); 3 (limited self-care); 4 (completely disabled); 5 (dead).|Participants|Number|105|105.0||||||
4383411|NCT00317642|4209888|B2|ECOG 0||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0 (fully active); 1 (capable of light work); 2 (no work but all self-care); 3 (limited self-care); 4 (completely disabled); 5 (dead).|Participants|Number|48|48.0||||||
4383412|NCT00317642|4209889|B1|ECOG 0||Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a scale ranging from 0-5, with 0 (fully active); 1 (capable of light work); 2 (no work but all self-care); 3 (limited self-care); 4 (completely disabled); 5 (dead).|Participants|Number|57|57.0||||||
4383413|NCT00317642|4209887|B3|||Body Surface Area (BSA)||m^2|Mean|1.950|1.95|Standard Deviation|0.2359|0.2359|||
4383414|NCT00317642|4209888|B2|||Body Surface Area (BSA)||m^2|Mean|1.959|1.959|Standard Deviation|0.2338|0.2338|||
4383415|NCT00317642|4209889|B1|||Body Surface Area (BSA)||m^2|Mean|1.941|1.941|Standard Deviation|0.2383|0.2383|||
4383416|NCT00317642|4209887|B3|||Weight(kg)||kg|Mean|82.11|82.11|Standard Deviation|17.574|17.574|||
4383417|NCT00317642|4209888|B2|||Weight(kg)||kg|Mean|83.03|83.03|Standard Deviation|17.281|17.281|||
4383418|NCT00317642|4209889|B1|||Weight(kg)||kg|Mean|81.21|81.21|Standard Deviation|17.862|17.862|||
4383419|NCT00317642|4209887|B3|||Height (cm)||centimeter|Mean|171.0|171.0|Standard Deviation|9.62|9.62|||
4383420|NCT00317642|4209888|B2|||Height (cm)||centimeter|Mean|170.5|170.5|Standard Deviation|8.92|8.92|||
4383421|NCT00317642|4209889|B1|||Height (cm)||centimeter|Mean|171.5|171.5|Standard Deviation|10.27|10.27|||
4383422|NCT00317642|4209887|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4383423|NCT00317642|4209888|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4383424|NCT00317642|4209889|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4383425|NCT00317642|4209887|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383426|NCT00317642|4209888|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383427|NCT00317642|4209889|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383428|NCT00317642|4209887|B3||White|Race (NIH/OMB)||Participants|Count of Participants|292|292.0||||||
4383429|NCT00317642|4209888|B2||White|Race (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
4383430|NCT00317642|4209889|B1||White|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
4383431|NCT00317642|4209887|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4383432|NCT00317642|4209888|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4383433|NCT00317642|4209889|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4383434|NCT00317642|4209887|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383435|NCT00317642|4209888|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383436|NCT00317642|4209889|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383437|NCT00317642|4209887|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4383438|NCT00317642|4209888|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4383439|NCT00317642|4209889|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4383440|NCT00317642|4209887|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383441|NCT00317642|4209888|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383442|NCT00317642|4209889|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383444|NCT00317642|4209888|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383445|NCT00317642|4209889|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383446|NCT00317642|4209887|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|305|305.0||||||
4383447|NCT00317642|4209888|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
4383448|NCT00317642|4209889|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4383449|NCT00317642|4209887|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4383450|NCT00317642|4209888|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4383451|NCT00317642|4209889|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4383452|NCT00317642|4209887|B3||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4383453|NCT00317642|4209888|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4383454|NCT00317642|4209889|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4383455|NCT00317642|4209887|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4383456|NCT00317642|4209888|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4383457|NCT00317642|4209889|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4383458|NCT00317642|4209887|B3|||Age||years|Mean|67.0|67.0|Standard Deviation|6.09|6.09|||
4383459|NCT00317642|4209888|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|5.82|5.82|||
4383460|NCT00317642|4209889|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|6.36|6.36|||
4383461|NCT00317473|4209963|B7|||Weight (kg)||kg|Mean|12.00|12.0|Standard Deviation|2.14|2.14|||
4383462|NCT00317473|4209964|B6|||Weight (kg)||kg|Mean|11.04|11.04|Standard Deviation|2.17|2.17|||
4383463|NCT00317473|4209965|B5|||Weight (kg)||kg|Mean|11.73|11.73|Standard Deviation|1.93|1.93|||
4383464|NCT00317473|4209966|B4|||Weight (kg)||kg|Mean|12.51|12.51|Standard Deviation|3.11|3.11|||
4383465|NCT00317473|4209967|B3|||Weight (kg)||kg|Mean|12.04|12.04|Standard Deviation|2.52|2.52|||
4383466|NCT00317473|4209968|B2|||Weight (kg)||kg|Mean|11.97|11.97|Standard Deviation|2.10|2.1|||
4383467|NCT00317473|4209969|B1|||Weight (kg)||kg|Mean|12.23|12.23|Standard Deviation|1.97|1.97|||
4383468|NCT00317473|4209963|B7|||Height (cm)||cm|Mean|84.2|84.2|Standard Deviation|7.6|7.6|||
4383469|NCT00317473|4209964|B6|||Height (cm)||cm|Mean|81.2|81.2|Standard Deviation|8.3|8.3|||
4383470|NCT00317473|4209965|B5|||Height (cm)||cm|Mean|83.1|83.1|Standard Deviation|6.9|6.9|||
4383471|NCT00317473|4209966|B4|||Height (cm)||cm|Mean|85.7|85.7|Standard Deviation|9.2|9.2|||
4383472|NCT00317473|4209967|B3|||Height (cm)||cm|Mean|84.8|84.8|Standard Deviation|9.0|9.0|||
4383473|NCT00317473|4209968|B2|||Height (cm)||cm|Mean|84.3|84.3|Standard Deviation|6.7|6.7|||
4383474|NCT00317473|4209969|B1|||Height (cm)||cm|Mean|84.7|84.7|Standard Deviation|7.0|7.0|||
4383475|NCT00317473|4209963|B7|||Diastolic blood pressure (mmHg)||mmHg|Mean|53.5|53.5|Standard Deviation|9.7|9.7|||
4383476|NCT00317473|4209964|B6|||Diastolic blood pressure (mmHg)||mmHg|Mean|52.0|52.0|Standard Deviation|8.0|8.0|||
4383477|NCT00317473|4209965|B5|||Diastolic blood pressure (mmHg)||mmHg|Mean|53.5|53.5|Standard Deviation|10.2|10.2|||
4383478|NCT00317473|4209966|B4|||Diastolic blood pressure (mmHg)||mmHg|Mean|53.3|53.3|Standard Deviation|10.1|10.1|||
4383479|NCT00317473|4209967|B3|||Diastolic blood pressure (mmHg)||mmHg|Mean|51.3|51.3|Standard Deviation|7.5|7.5|||
4383480|NCT00317473|4209968|B2|||Diastolic blood pressure (mmHg)||mmHg|Mean|54.5|54.5|Standard Deviation|11.5|11.5|||
4383481|NCT00317473|4209969|B1|||Diastolic blood pressure (mmHg)||mmHg|Mean|55.8|55.8|Standard Deviation|11.0|11.0|||
4383482|NCT00317473|4209963|B7|||Systolic blood pressure (mmHg)||mmHg|Mean|96.4|96.4|Standard Deviation|10.1|10.1|||
4383483|NCT00317473|4209964|B6|||Systolic blood pressure (mmHg)||mmHg|Mean|94.4|94.4|Standard Deviation|14.1|14.1|||
4383484|NCT00317473|4209965|B5|||Systolic blood pressure (mmHg)||mmHg|Mean|97.3|97.3|Standard Deviation|11.7|11.7|||
4383485|NCT00317473|4209966|B4|||Systolic blood pressure (mmHg)||mmHg|Mean|96.1|96.1|Standard Deviation|11.8|11.8|||
4383486|NCT00317473|4209967|B3|||Systolic blood pressure (mmHg)||mmHg|Mean|95.2|95.2|Standard Deviation|9.6|9.6|||
4383487|NCT00317473|4209968|B2|||Systolic blood pressure (mmHg)||mmHg|Mean|96.4|96.4|Standard Deviation|14.5|14.5|||
4383488|NCT00317473|4209969|B1|||Systolic blood pressure (mmHg)||mmHg|Mean|96.6|96.6|Standard Deviation|9.2|9.2|||
4383489|NCT00317473|4209963|B7|||Respiratory rate (bpm)||breaths per minute (bpm)|Mean|31.4|31.4|Standard Deviation|5.2|5.2|||
4383490|NCT00317473|4209964|B6|||Respiratory rate (bpm)||breaths per minute (bpm)|Mean|32.8|32.8|Standard Deviation|5.4|5.4|||
4383491|NCT00317473|4209965|B5|||Respiratory rate (bpm)||breaths per minute (bpm)|Mean|31.6|31.6|Standard Deviation|5.2|5.2|||
4383492|NCT00317473|4209966|B4|||Respiratory rate (bpm)||breaths per minute (bpm)|Mean|29.9|29.9|Standard Deviation|2.8|2.8|||
4383493|NCT00317473|4209967|B3|||Respiratory rate (bpm)||breaths per minute (bpm)|Mean|31.1|31.1|Standard Deviation|5.3|5.3|||
4383494|NCT00317473|4209968|B2|||Respiratory rate (bpm)||breaths per minute (bpm)|Mean|30.9|30.9|Standard Deviation|5.5|5.5|||
4383495|NCT00317473|4209969|B1|||Respiratory rate (bpm)||breaths per minute (bpm)|Mean|31.5|31.5|Standard Deviation|5.3|5.3|||
4383496|NCT00317473|4209963|B7|||Pulse (bpm)||beats per minute (bpm)|Mean|107.8|107.8|Standard Deviation|18.0|18.0|||
4383497|NCT00317473|4209964|B6|||Pulse (bpm)||beats per minute (bpm)|Mean|119.7|119.7|Standard Deviation|19.0|19.0|||
4383498|NCT00317473|4209965|B5|||Pulse (bpm)||beats per minute (bpm)|Mean|102.9|102.9|Standard Deviation|17.3|17.3|||
4383499|NCT00317473|4209966|B4|||Pulse (bpm)||beats per minute (bpm)|Mean|116.5|116.5|Standard Deviation|18.0|18.0|||
4383500|NCT00317473|4209967|B3|||Pulse (bpm)||beats per minute (bpm)|Mean|108.8|108.8|Standard Deviation|14.1|14.1|||
4383501|NCT00317473|4209968|B2|||Pulse (bpm)||beats per minute (bpm)|Mean|102.7|102.7|Standard Deviation|24.4|24.4|||
4383502|NCT00317473|4209969|B1|||Pulse (bpm)||beats per minute (bpm)|Mean|111.8|111.8|Standard Deviation|21.4|21.4|||
4383503|NCT00317473|4209963|B7|||Temperature (celcius)||Celcius|Mean|36.45|36.45|Standard Deviation|0.54|0.54|||
4383504|NCT00317473|4209964|B6|||Temperature (celcius)||Celcius|Mean|36.85|36.85|Standard Deviation|0.65|0.65|||
4383505|NCT00317473|4209965|B5|||Temperature (celcius)||Celcius|Mean|36.50|36.5|Standard Deviation|0.62|0.62|||
4383506|NCT00317473|4209966|B4|||Temperature (celcius)||Celcius|Mean|36.46|36.46|Standard Deviation|0.51|0.51|||
4383507|NCT00317473|4209967|B3|||Temperature (celcius)||Celcius|Mean|36.49|36.49|Standard Deviation|0.57|0.57|||
4383508|NCT00317473|4209968|B2|||Temperature (celcius)||Celcius|Mean|36.30|36.3|Standard Deviation|36.49|36.49|||
4383509|NCT00317473|4209969|B1|||Temperature (celcius)||Celcius|Mean|36.36|36.36|Standard Deviation|0.42|0.42|||
4383510|NCT00317473|4209963|B7|Kenya||Region of Enrollment||participants|Number|134|134.0||||||
4383511|NCT00317473|4209964|B6|Kenya||Region of Enrollment||participants|Number|15|15.0||||||
4383512|NCT00317473|4209965|B5|Kenya||Region of Enrollment||participants|Number|30|30.0||||||
4383513|NCT00317473|4209966|B4|Kenya||Region of Enrollment||participants|Number|15|15.0||||||
4383514|NCT00317473|4209967|B3|Kenya||Region of Enrollment||participants|Number|30|30.0||||||
4383515|NCT00317473|4209968|B2|Kenya||Region of Enrollment||participants|Number|15|15.0||||||
4383516|NCT00317473|4209969|B1|Kenya||Region of Enrollment||participants|Number|29|29.0||||||
4383517|NCT00317473|4209963|B7||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4383518|NCT00317473|4209964|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4383519|NCT00317473|4209965|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4383520|NCT00317473|4209966|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4383521|NCT00317473|4209967|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4383522|NCT00317473|4209968|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4383523|NCT00317473|4209969|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4383524|NCT00317473|4209963|B7||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4383525|NCT00317473|4209964|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4383526|NCT00317473|4209965|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4383527|NCT00317473|4209966|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4383528|NCT00317473|4209967|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4383529|NCT00317473|4209968|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4383530|NCT00317473|4209969|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4383531|NCT00317473|4209963|B7|||Age||Months|Mean|29.0|29.0|Standard Deviation|10.1|10.1|||
4383532|NCT00317473|4209964|B6|||Age||Months|Mean|29.2|29.2|Standard Deviation|10.9|10.9|||
4383533|NCT00317473|4209965|B5|||Age||Months|Mean|29.0|29.0|Standard Deviation|9.9|9.9|||
4383534|NCT00317473|4209966|B4|||Age||Months|Mean|29.9|29.9|Standard Deviation|11.2|11.2|||
4383535|NCT00317473|4209967|B3|||Age||Months|Mean|29.5|29.5|Standard Deviation|10.9|10.9|||
4383536|NCT00317473|4209968|B2|||Age||Months|Mean|28.8|28.8|Standard Deviation|9.7|9.7|||
4383537|NCT00317473|4209969|B1|||Age||Months|Mean|28.5|28.5|Standard Deviation|9.6|9.6|||
4383538|NCT00317239|4209998|B3|United States||Region of Enrollment||participants|Number|250|250.0||||||
4383539|NCT00317239|4209999|B2|United States||Region of Enrollment||participants|Number|103|103.0||||||
4383540|NCT00317239|4210000|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
4383541|NCT00317239|4209998|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4383542|NCT00317239|4209999|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4383543|NCT00317239|4210000|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4383544|NCT00317239|4209998|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4383545|NCT00317239|4209999|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4383546|NCT00317239|4210000|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4383547|NCT00317239|4209998|B3|||Age||years|Mean|65.94|65.94|Standard Deviation|12.94|12.94|||
4383548|NCT00317239|4209999|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|13.48|13.48|||
4383549|NCT00317239|4210000|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|12.56|12.56|||
4383550|NCT00317239|4209998|B3||>=65 years|Age||Participants|Count of Participants|143|143.0||||||
4383551|NCT00317239|4209999|B2||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4383552|NCT00317239|4210000|B1||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4383553|NCT00317239|4209998|B3||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4383554|NCT00317239|4209999|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4383555|NCT00317239|4210000|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4383556|NCT00317239|4209998|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383557|NCT00317239|4209999|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383558|NCT00317239|4210000|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383559|NCT00317226|4210007|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
4383560|NCT00317226|4210007|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4383561|NCT00317226|4210007|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4383562|NCT00317226|4210007|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|13.39|13.39|||
4383564|NCT00317226|4210007|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4383565|NCT00317226|4210007|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383566|NCT00317109|4210011|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4383567|NCT00317109|4210012|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4383568|NCT00317109|4210013|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4383569|NCT00317109|4210011|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4383570|NCT00317109|4210012|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4383571|NCT00317109|4210013|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4383572|NCT00317109|4210011|B3|Months at MENCEVAX™ booster||Age||Months|Mean|24.55|24.55|Standard Deviation|0.98|0.98|||
4383573|NCT00317109|4210012|B2|Months at MENCEVAX™ booster||Age||Months|Mean|24.6|24.6|Standard Deviation|1.04|1.04|||
4383574|NCT00317109|4210013|B1|Months at MENCEVAX™ booster||Age||Months|Mean|24.5|24.5|Standard Deviation|0.92|0.92|||
4383575|NCT00317109|4210011|B3|Months at TRITANRIX™-HEPB/HIBERIX™ booster||Age||Months|Mean|16.5|16.5|Standard Deviation|1.02|1.02|||
4383576|NCT00317109|4210012|B2|Months at TRITANRIX™-HEPB/HIBERIX™ booster||Age||Months|Mean|16.5|16.5|Standard Deviation|1.02|1.02|||
4383577|NCT00317109|4210013|B1|Months at TRITANRIX™-HEPB/HIBERIX™ booster||Age||Months|Mean|16.5|16.5|Standard Deviation|1.02|1.02|||
4383578|NCT00317044|4210048|B4||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4383579|NCT00317044|4210049|B3||Male|Sex: Female, Male||Participants|Count of Participants|81.00|81.0||||||
4383580|NCT00317044|4210050|B2||Male|Sex: Female, Male||Participants|Count of Participants|73.00|73.0||||||
4383581|NCT00317044|4210051|B1||Male|Sex: Female, Male||Participants|Count of Participants|79.00|79.0||||||
4383582|NCT00317044|4210048|B4||Female|Sex: Female, Male||Participants|Count of Participants|727|727.0||||||
4383583|NCT00317044|4210049|B3||Female|Sex: Female, Male||Participants|Count of Participants|247.00|247.0||||||
4383584|NCT00317044|4210050|B2||Female|Sex: Female, Male||Participants|Count of Participants|240.00|240.0||||||
4383585|NCT00317044|4210051|B1||Female|Sex: Female, Male||Participants|Count of Participants|240.00|240.0||||||
4383586|NCT00317044|4210048|B4|||Age||Years|Mean|44.667|44.667|Full Range|||18.0|70.0|
4383587|NCT00317044|4210049|B3|||Age||Years|Mean|45.0|45.0|Full Range|||18.0|70.0|
4383588|NCT00317044|4210050|B2|||Age||Years|Mean|45.0|45.0|Full Range|||19.0|70.0|
4383589|NCT00317044|4210051|B1|||Age||Years|Mean|44.0|44.0|Full Range|||18.0|69.0|
4383590|NCT00316914|4210097|B3|Modified FOLFOX6||Regimen||Participants|Number|96|96.0||||||
4383591|NCT00316914|4210098|B2|Modified FOLFOX6||Regimen||Participants|Number|49|49.0||||||
4383592|NCT00316914|4210099|B1|Modified FOLFOX6||Regimen||Participants|Number|47|47.0||||||
4383593|NCT00316914|4210097|B3|FOLFOX4 (Oxaliplatin, Leucovorin, and Fluorouracil||Regimen||Participants|Number|6|6.0||||||
4383594|NCT00316914|4210098|B2|FOLFOX4 (Oxaliplatin, Leucovorin, and Fluorouracil||Regimen||Participants|Number|3|3.0||||||
4383595|NCT00316914|4210099|B1|FOLFOX4 (Oxaliplatin, Leucovorin, and Fluorouracil||Regimen||Participants|Number|3|3.0||||||
4383596|NCT00316914|4210097|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4383597|NCT00316914|4210098|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4383598|NCT00316914|4210099|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4383599|NCT00316914|4210097|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4383600|NCT00316914|4210098|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383601|NCT00316914|4210099|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4383602|NCT00316914|4210097|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383603|NCT00316914|4210098|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383604|NCT00316914|4210099|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383605|NCT00316914|4210097|B3||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4383606|NCT00316914|4210098|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4383607|NCT00316914|4210099|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4383608|NCT00316914|4210097|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4383609|NCT00316914|4210098|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4383610|NCT00316914|4210099|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4383611|NCT00316914|4210097|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383612|NCT00316914|4210098|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383613|NCT00316914|4210099|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383614|NCT00316914|4210097|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383615|NCT00316914|4210098|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383616|NCT00316914|4210099|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383617|NCT00316914|4210097|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4383618|NCT00316914|4210098|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4383619|NCT00316914|4210099|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383620|NCT00316914|4210097|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4383621|NCT00316914|4210098|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4383623|NCT00316914|4210097|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4383624|NCT00316914|4210098|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4383625|NCT00316914|4210099|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4383626|NCT00316914|4210097|B3|>=65||Age, Customized||Participants|Number|36|36.0||||||
4383627|NCT00316914|4210098|B2|>=65||Age, Customized||Participants|Number|19|19.0||||||
4383628|NCT00316914|4210099|B1|>=65||Age, Customized||Participants|Number|17|17.0||||||
4383629|NCT00316914|4210097|B3|<65||Age, Customized||Participants|Number|66|66.0||||||
4383630|NCT00316914|4210098|B2|<65||Age, Customized||Participants|Number|33|33.0||||||
4383631|NCT00316914|4210099|B1|<65||Age, Customized||Participants|Number|33|33.0||||||
4383632|NCT00316888|4210128|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4383633|NCT00316888|4210129|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4383634|NCT00316888|4210130|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4383635|NCT00316888|4210128|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4383636|NCT00316888|4210129|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4383637|NCT00316888|4210130|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4383638|NCT00316888|4210128|B3|||Age||years|Median|56|56.0|Full Range|||37.0|78.0|
4383639|NCT00316888|4210129|B2|||Age||years|Median|56|56.0|Full Range|||37.0|78.0|
4383640|NCT00316888|4210130|B1|||Age||years|Median|56|56.0|Full Range|||42.0|77.0|
4383641|NCT00316862|4210145|B1|United States||Region of Enrollment||participants|Number|82|82.0||||||
4383642|NCT00316862|4210145|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4383643|NCT00316862|4210145|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4383644|NCT00316862|4210145|B1||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4383645|NCT00316862|4210145|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4383646|NCT00316862|4210145|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383647|NCT00316862|4210145|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383648|NCT00316862|4210145|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383649|NCT00316862|4210145|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4383650|NCT00316862|4210145|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4383651|NCT00316862|4210145|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383652|NCT00316862|4210145|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4383653|NCT00316862|4210145|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4383654|NCT00316862|4210145|B1|||Age||years|Median|62.2|62.2|Full Range|||37.3|85.2|
4383655|NCT00316719|4210151|B3|Japan||Region of Enrollment||participants|Number|102|102.0||||||
4383656|NCT00316719|4210152|B2|Japan||Region of Enrollment||participants|Number|52|52.0||||||
4383657|NCT00316719|4210153|B1|Japan||Region of Enrollment||participants|Number|50|50.0||||||
4383658|NCT00316719|4210151|B3|Asian||Race/Ethnicity, Customized||Number of participants|Number|102|102.0||||||
4383659|NCT00316719|4210152|B2|Asian||Race/Ethnicity, Customized||Number of participants|Number|52|52.0||||||
4383660|NCT00316719|4210153|B1|Asian||Race/Ethnicity, Customized||Number of participants|Number|50|50.0||||||
4383661|NCT00316719|4210151|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4383662|NCT00316719|4210152|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4383663|NCT00316719|4210153|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4383664|NCT00316719|4210151|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4383665|NCT00316719|4210152|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4383666|NCT00316719|4210153|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4383667|NCT00316719|4210151|B3|||Age||years|Mean|44|44.0|Standard Deviation|9.79|9.79|||
4383668|NCT00316719|4210152|B2|||Age||years|Mean|43.9|43.9|Standard Deviation|9.95|9.95|||
4383669|NCT00316719|4210153|B1|||Age||years|Mean|44|44.0|Standard Deviation|9.73|9.73|||
4383670|NCT00316706|4210178|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383671|NCT00316706|4210179|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383672|NCT00316706|4210180|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383673|NCT00316706|4210178|B3||Female|Sex: Female, Male||Participants|Count of Participants|1245|1245.0||||||
4383674|NCT00316706|4210179|B2||Female|Sex: Female, Male||Participants|Count of Participants|619|619.0||||||
4383675|NCT00316706|4210180|B1||Female|Sex: Female, Male||Participants|Count of Participants|626|626.0||||||
4383676|NCT00316706|4210178|B3|||Age||years|Mean|12.1|12.1|Standard Deviation|1.4|1.4|||
4383677|NCT00316706|4210179|B2|||Age||years|Mean|12.1|12.1|Standard Deviation|1.4|1.4|||
4383678|NCT00316706|4210180|B1|||Age||years|Mean|12.1|12.1|Standard Deviation|1.4|1.4|||
4383679|NCT00316693|4210195|B3|Asian - Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1040|1040.0||||||
4383680|NCT00316693|4210196|B2|Asian - Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|521|521.0||||||
4383681|NCT00316693|4210197|B1|Asian - Japanese heritage||Race/Ethnicity, Customized||Participants|Count of Participants|519|519.0||||||
4383682|NCT00316693|4210195|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383683|NCT00316693|4210196|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383684|NCT00316693|4210197|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383685|NCT00316693|4210195|B3||Female|Sex: Female, Male||Participants|Count of Participants|1040|1040.0||||||
4383686|NCT00316693|4210196|B2||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
4383687|NCT00316693|4210197|B1||Female|Sex: Female, Male||Participants|Count of Participants|519|519.0||||||
4383688|NCT00316693|4210195|B3|||Age||years|Mean|22.5|22.5|Standard Deviation|1.6|1.6|||
4383689|NCT00316693|4210196|B2|||Age||years|Mean|22.5|22.5|Standard Deviation|1.6|1.6|||
4383690|NCT00316693|4210197|B1|||Age||years|Mean|22.4|22.4|Standard Deviation|1.7|1.7|||
4383691|NCT00316355|4210238|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4383692|NCT00316355|4210239|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4383693|NCT00316355|4210240|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4383694|NCT00316355|4210238|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4383695|NCT00316355|4210239|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4383696|NCT00316355|4210240|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4383697|NCT00316355|4210238|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4383698|NCT00316355|4210239|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4383699|NCT00316355|4210240|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4383700|NCT00316355|4210238|B3|||Age||years|Mean|33.74|33.74|Standard Deviation|13.10|13.1|||
4383701|NCT00316355|4210239|B2|||Age||years|Mean|35.95|35.95|Standard Deviation|16.16|16.16|||
4383702|NCT00316355|4210240|B1|||Age||years|Mean|31.33|31.33|Standard Deviation|10.50|10.5|||
4383703|NCT00316303|4210249|B3|United States||Region of Enrollment||participants|Number|236|236.0||||||
4383704|NCT00316303|4210250|B2|United States||Region of Enrollment||participants|Number|118|118.0||||||
4383705|NCT00316303|4210251|B1|United States||Region of Enrollment||participants|Number|118|118.0||||||
4383706|NCT00316303|4210249|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4383707|NCT00316303|4210250|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4383708|NCT00316303|4210251|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4383709|NCT00316303|4210249|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383710|NCT00316303|4210250|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383711|NCT00316303|4210251|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383712|NCT00316303|4210249|B3||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4383713|NCT00316303|4210250|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4383714|NCT00316303|4210251|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4383715|NCT00316303|4210249|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
4383716|NCT00316303|4210250|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4383717|NCT00316303|4210251|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4383718|NCT00316303|4210249|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383719|NCT00316303|4210250|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383720|NCT00316303|4210251|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383721|NCT00316303|4210249|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383722|NCT00316303|4210250|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383723|NCT00316303|4210251|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383724|NCT00316303|4210249|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383725|NCT00316303|4210250|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383726|NCT00316303|4210251|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383727|NCT00316303|4210249|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4383728|NCT00316303|4210250|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4383729|NCT00316303|4210251|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4383730|NCT00316303|4210249|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4383731|NCT00316303|4210250|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4383732|NCT00316303|4210251|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4383733|NCT00316303|4210249|B3|||Age||years|Mean|46.5|46.5|Standard Deviation|8.9|8.9|||
4383734|NCT00316303|4210250|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|9.3|9.3|||
4383735|NCT00316303|4210251|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|8.5|8.5|||
4383736|NCT00316277|4210266|B3|United States||Region of Enrollment||participants|Number|653|653.0||||||
4383737|NCT00316277|4210267|B2|United States||Region of Enrollment||participants|Number|324|324.0||||||
4383738|NCT00316277|4210268|B1|United States||Region of Enrollment||participants|Number|329|329.0||||||
4383739|NCT00316277|4210266|B3||Male|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
4383740|NCT00316277|4210267|B2||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4383741|NCT00316277|4210268|B1||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4383742|NCT00316277|4210266|B3||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4383743|NCT00316277|4210267|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4383744|NCT00316277|4210268|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4383745|NCT00316277|4210266|B3|||Age||years|Mean|33.2|33.2|Standard Deviation|10.2|10.2|||
4383746|NCT00316277|4210267|B2|||Age||years|Mean|33.5|33.5|Standard Deviation|10.3|10.3|||
4383747|NCT00316277|4210268|B1|||Age||years|Mean|32.9|32.9|Standard Deviation|10.1|10.1|||
4383748|NCT00316277|4210266|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4383749|NCT00316277|4210267|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4383750|NCT00316277|4210268|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4383751|NCT00316277|4210266|B3||Between 18 and 65 years|Age||Participants|Count of Participants|653|653.0||||||
4383752|NCT00316277|4210267|B2||Between 18 and 65 years|Age||Participants|Count of Participants|324|324.0||||||
4383753|NCT00316277|4210268|B1||Between 18 and 65 years|Age||Participants|Count of Participants|329|329.0||||||
4383754|NCT00316277|4210266|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383755|NCT00316277|4210267|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383756|NCT00316277|4210268|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4383757|NCT00316264|4210287|B4||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4383758|NCT00316264|4210288|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4383759|NCT00316264|4210289|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4383760|NCT00316264|4210290|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4383761|NCT00316264|4210287|B4||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4383762|NCT00316264|4210288|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4383763|NCT00316264|4210289|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4383764|NCT00316264|4210290|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4383765|NCT00316264|4210287|B4|||Age||months|Mean|3.66|3.66|Standard Deviation|2.62|2.62|||
4383766|NCT00316264|4210288|B3|||Age||months|Mean|3.92|3.92|Standard Deviation|2.43|2.43|||
4383767|NCT00316264|4210289|B2|||Age||months|Mean|3.35|3.35|Standard Deviation|2.25|2.25|||
4383768|NCT00316264|4210290|B1|||Age||months|Mean|3.68|3.68|Standard Deviation|3.13|3.13|||
4383769|NCT00316225|4210360|B1|||Weight||kilograms (kg)|Median|68.0|68.0|Full Range|||47.9|100.0|
4383770|NCT00316225|4210360|B1|||Height||centimeters (cm)|Median|171.0|171.0|Full Range|||147.0|189.0|
4383771|NCT00316225|4210360|B1|||Body Surface Area||meters squared (m^2)|Median|1.8|1.8|Full Range|||1.4|2.3|
4383772|NCT00316225|4210360|B1|Ascites||Type of Third-Space Fluid||participants|Number|1|1.0||||||
4383773|NCT00316225|4210360|B1|Pleural Effusion||Type of Third-Space Fluid||participants|Number|30|30.0||||||
4383774|NCT00316225|4210360|B1|Histopathological||Primary Basis for Diagnosis||participants|Number|25|25.0||||||
4383775|NCT00316225|4210360|B1|Cytological||Primary Basis for Diagnosis||participants|Number|6|6.0||||||
4383776|NCT00316225|4210360|B1|Severe||Fluid Severity|"Mild = (1) pleural effusion detectable on radiological imaging, but less than moderate; (2) ascites detectable only by radiological imaging. Moderate = (1) pleural effusion less than 1/3 of the way up the thorax on 1 side on imaging and obscuring the entire hemidiaphragm on that side; (2) ascites detectable on physical exam (that is, fluid wave is palpable). Severe = (1) pleural effusion more than 1/3 of the way up the thorax on imaging; (2) ascites visibly detectable.~For Moderate Fluid Severity, there were 13 patients with pleural effusion and 1 patient with ascites."|participants|Number|2|2.0||||||
4383777|NCT00316225|4210360|B1|Moderate||Fluid Severity|"Mild = (1) pleural effusion detectable on radiological imaging, but less than moderate; (2) ascites detectable only by radiological imaging. Moderate = (1) pleural effusion less than 1/3 of the way up the thorax on 1 side on imaging and obscuring the entire hemidiaphragm on that side; (2) ascites detectable on physical exam (that is, fluid wave is palpable). Severe = (1) pleural effusion more than 1/3 of the way up the thorax on imaging; (2) ascites visibly detectable.~For Moderate Fluid Severity, there were 13 patients with pleural effusion and 1 patient with ascites."|participants|Number|14|14.0||||||
4383778|NCT00316225|4210360|B1|Mild||Fluid Severity|"Mild = (1) pleural effusion detectable on radiological imaging, but less than moderate; (2) ascites detectable only by radiological imaging. Moderate = (1) pleural effusion less than 1/3 of the way up the thorax on 1 side on imaging and obscuring the entire hemidiaphragm on that side; (2) ascites detectable on physical exam (that is, fluid wave is palpable). Severe = (1) pleural effusion more than 1/3 of the way up the thorax on imaging; (2) ascites visibly detectable.~For Moderate Fluid Severity, there were 13 patients with pleural effusion and 1 patient with ascites."|participants|Number|15|15.0||||||
4383779|NCT00316225|4210360|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|17|17.0||||||
4383780|NCT00316225|4210360|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|14|14.0||||||
4383781|NCT00316225|4210360|B1|Unknown||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).|participants|Number|1|1.0||||||
4383782|NCT00316225|4210360|B1|Stage IV (metastatic disease)||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).|participants|Number|18|18.0||||||
4383783|NCT00316225|4210360|B1|Stage III (locally advanced disease)||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).|participants|Number|12|12.0||||||
4383784|NCT00316225|4210360|B1|Mesothelioma||Diagnosis|Diagnosis of Non-Small Cell Lung Cancer (NSCLC) and mesothelioma were determined by each individual investigator.|participants|Number|8|8.0||||||
4383785|NCT00316225|4210360|B1|Non-Small Cell Lung Cancer (NSCLC)||Diagnosis|Diagnosis of Non-Small Cell Lung Cancer (NSCLC) and mesothelioma were determined by each individual investigator.|participants|Number|23|23.0||||||
4383786|NCT00316225|4210360|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4383787|NCT00316225|4210360|B1|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
4383788|NCT00316225|4210360|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4383789|NCT00316225|4210360|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4383790|NCT00316225|4210360|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4383791|NCT00316225|4210360|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4383792|NCT00316225|4210360|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4383793|NCT00316225|4210360|B1|||Age||years|Median|62.7|62.7|Full Range|||35.7|77.5|
4383794|NCT00316199|4210369|B1|||Weight||kilograms|Mean|62.68|62.68|Standard Deviation|9.518|9.518|||
4383795|NCT00316199|4210369|B1|||Height||centimeters|Mean|160.3|160.3|Standard Deviation|4.35|4.35|||
4383796|NCT00316199|4210369|B1|East Asian (Chinese)||Race/Ethnicity||participants|Number|60|60.0||||||
4383797|NCT00316199|4210369|B1|Missing||Pathological Diagnosis||participants|Number|1|1.0||||||
4383798|NCT00316199|4210369|B1|Comedocarcinoma||Pathological Diagnosis||participants|Number|0|0.0||||||
4383799|NCT00316199|4210369|B1|Adenocarcinoma||Pathological Diagnosis||participants|Number|3|3.0||||||
4383800|NCT00316199|4210369|B1|Infiltrating Ductal Breast Carcinoma||Pathological Diagnosis||participants|Number|55|55.0||||||
4383801|NCT00316199|4210369|B1|Infiltrating Lobular Carcinoma||Pathological Diagnosis||participants|Number|0|0.0||||||
4383802|NCT00316199|4210369|B1|Undifferentiated Breast Carcinoma||Pathological Diagnosis||participants|Number|1|1.0||||||
4383803|NCT00316199|4210369|B1|Missing||Menopausal Status||participants|Number|2|2.0||||||
4383804|NCT00316199|4210369|B1|Post Menopausal||Menopausal Status||participants|Number|22|22.0||||||
4383805|NCT00316199|4210369|B1|Peri-Menopausal||Menopausal Status||participants|Number|7|7.0||||||
4383806|NCT00316199|4210369|B1|Pre-Menopausal||Menopausal Status||participants|Number|29|29.0||||||
4383807|NCT00316199|4210369|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|30|30.0||||||
4383808|NCT00316199|4210369|B1|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|30|30.0||||||
4383809|NCT00316199|4210369|B1|Stage IV||Disease Stage at Study Entry|Stage of disease was determined using American Joint Committee on Cancer Staging Criteria for Breast Cancer. Stages range from Stage 0 to Stage IV. The higher the stage, the more severe the disease.|participants|Number|54|54.0||||||
4383810|NCT00316199|4210369|B1|Stage IIIB||Disease Stage at Study Entry|Stage of disease was determined using American Joint Committee on Cancer Staging Criteria for Breast Cancer. Stages range from Stage 0 to Stage IV. The higher the stage, the more severe the disease.|participants|Number|6|6.0||||||
4383811|NCT00316199|4210369|B1|China||Region of Enrollment||participants|Number|60|60.0||||||
4383812|NCT00316199|4210369|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383813|NCT00316199|4210369|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4383814|NCT00316199|4210369|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|8.96|8.96|||
4383815|NCT00316186|4210377|B1|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4383816|NCT00316186|4210377|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4383817|NCT00316186|4210377|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4383818|NCT00316186|4210377|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|9.45|9.45|||
4383819|NCT00316173|4210389|B3|Grade 2||Number of participants with the indicated ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) performance status assesses the effect of disease on daily living abilities, graded as: Grade 0: fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity; Grade 2: Capable of all selfcare, but unable to carry out any work activities.|participants|Number|4|4.0||||||
4383820|NCT00316173|4210390|B2|Grade 2||Number of participants with the indicated ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) performance status assesses the effect of disease on daily living abilities, graded as: Grade 0: fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity; Grade 2: Capable of all selfcare, but unable to carry out any work activities.|participants|Number|4|4.0||||||
4383821|NCT00316173|4210391|B1|Grade 2||Number of participants with the indicated ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) performance status assesses the effect of disease on daily living abilities, graded as: Grade 0: fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity; Grade 2: Capable of all selfcare, but unable to carry out any work activities.|participants|Number|0|0.0||||||
4383822|NCT00316173|4210389|B3|Grade 1||Number of participants with the indicated ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) performance status assesses the effect of disease on daily living abilities, graded as: Grade 0: fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity; Grade 2: Capable of all selfcare, but unable to carry out any work activities.|participants|Number|16|16.0||||||
4383823|NCT00316173|4210390|B2|Grade 1||Number of participants with the indicated ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) performance status assesses the effect of disease on daily living abilities, graded as: Grade 0: fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity; Grade 2: Capable of all selfcare, but unable to carry out any work activities.|participants|Number|9|9.0||||||
4383873|NCT00316082|4210412|B6|||Age||years|Mean|54.98|54.98|Standard Deviation|10.31|10.31|||
4383874|NCT00316082|4210413|B5|||Age||years|Mean|55.57|55.57|Standard Deviation|10.32|10.32|||
4383875|NCT00316082|4210414|B4|||Age||years|Mean|55.11|55.11|Standard Deviation|10.35|10.35|||
4383876|NCT00316082|4210415|B3|||Age||years|Mean|54.28|54.28|Standard Deviation|10.93|10.93|||
4383824|NCT00316173|4210391|B1|Grade 1||Number of participants with the indicated ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) performance status assesses the effect of disease on daily living abilities, graded as: Grade 0: fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity; Grade 2: Capable of all selfcare, but unable to carry out any work activities.|participants|Number|7|7.0||||||
4383825|NCT00316173|4210389|B3|Grade 0||Number of participants with the indicated ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) performance status assesses the effect of disease on daily living abilities, graded as: Grade 0: fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity; Grade 2: Capable of all selfcare, but unable to carry out any work activities.|participants|Number|57|57.0||||||
4383826|NCT00316173|4210390|B2|Grade 0||Number of participants with the indicated ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) performance status assesses the effect of disease on daily living abilities, graded as: Grade 0: fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity; Grade 2: Capable of all selfcare, but unable to carry out any work activities.|participants|Number|42|42.0||||||
4383827|NCT00316173|4210391|B1|Grade 0||Number of participants with the indicated ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) performance status assesses the effect of disease on daily living abilities, graded as: Grade 0: fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity; Grade 2: Capable of all selfcare, but unable to carry out any work activities.|participants|Number|15|15.0||||||
4383828|NCT00316173|4210389|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4383829|NCT00316173|4210390|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4383830|NCT00316173|4210391|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4383831|NCT00316173|4210389|B3|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4383832|NCT00316173|4210390|B2|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4383833|NCT00316173|4210391|B1|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4383834|NCT00316173|4210389|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4383835|NCT00316173|4210390|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4383836|NCT00316173|4210391|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4383837|NCT00316173|4210389|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4383838|NCT00316173|4210390|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4383839|NCT00316173|4210391|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4383840|NCT00316173|4210389|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4383841|NCT00316173|4210390|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4383842|NCT00316173|4210391|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4383843|NCT00316173|4210389|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383844|NCT00316173|4210390|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383845|NCT00316173|4210391|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4383846|NCT00316173|4210389|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4383847|NCT00316173|4210390|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4383848|NCT00316173|4210391|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4383849|NCT00316173|4210389|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|11.03|11.03|||
4383850|NCT00316173|4210390|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|11.13|11.13|||
4383851|NCT00316173|4210391|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|10.94|10.94|||
4383852|NCT00316121|4210403|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4383853|NCT00316121|4210404|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4383854|NCT00316121|4210405|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4383855|NCT00316121|4210403|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4383856|NCT00316121|4210404|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4383857|NCT00316121|4210405|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4383858|NCT00316121|4210403|B3|||Age|Between 18-70 years old|Years|Mean|48.45|48.45|Full Range|||21.0|70.0|
4383859|NCT00316121|4210404|B2|||Age|Between 18-70 years old|Years|Mean|49.5|49.5|Full Range|||22.0|70.0|
4383860|NCT00316121|4210405|B1|||Age|Between 18-70 years old|Years|Mean|47.4|47.4|Full Range|||21.0|68.0|
4383861|NCT00316082|4210412|B6||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4383862|NCT00316082|4210413|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4383863|NCT00316082|4210414|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4383864|NCT00316082|4210415|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4383865|NCT00316082|4210416|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4383866|NCT00316082|4210417|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4383867|NCT00316082|4210412|B6||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4383868|NCT00316082|4210413|B5||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4383869|NCT00316082|4210414|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4383870|NCT00316082|4210415|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4383871|NCT00316082|4210416|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4383872|NCT00316082|4210417|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4383877|NCT00316082|4210416|B2|||Age||years|Mean|54.66|54.66|Standard Deviation|9.71|9.71|||
4383878|NCT00316082|4210417|B1|||Age||years|Mean|55.24|55.24|Standard Deviation|10.44|10.44|||
4383879|NCT00316017|4210449|B4|Canada||Region of Enrollment||participants|Number|180|180.0||||||
4383880|NCT00316017|4210450|B3|Canada||Region of Enrollment||participants|Number|93|93.0||||||
4383881|NCT00316017|4210451|B2|Canada||Region of Enrollment||participants|Number|44|44.0||||||
4383882|NCT00316017|4210452|B1|Canada||Region of Enrollment||participants|Number|43|43.0||||||
4383883|NCT00316017|4210449|B4|United States||Region of Enrollment||participants|Number|672|672.0||||||
4383884|NCT00316017|4210450|B3|United States||Region of Enrollment||participants|Number|283|283.0||||||
4383885|NCT00316017|4210451|B2|United States||Region of Enrollment||participants|Number|212|212.0||||||
4383886|NCT00316017|4210452|B1|United States||Region of Enrollment||participants|Number|177|177.0||||||
4383887|NCT00316017|4210449|B4||Male|Sex: Female, Male|Description only includes those subjects who received the study fluid.|Participants|Count of Participants|666|666.0||||||
4383888|NCT00316017|4210450|B3||Male|Sex: Female, Male|Description only includes those subjects who received the study fluid.|Participants|Count of Participants|291|291.0||||||
4383889|NCT00316017|4210451|B2||Male|Sex: Female, Male|Description only includes those subjects who received the study fluid.|Participants|Count of Participants|205|205.0||||||
4383890|NCT00316017|4210452|B1||Male|Sex: Female, Male|Description only includes those subjects who received the study fluid.|Participants|Count of Participants|170|170.0||||||
4383891|NCT00316017|4210449|B4||Female|Sex: Female, Male|Description only includes those subjects who received the study fluid.|Participants|Count of Participants|186|186.0||||||
4383892|NCT00316017|4210450|B3||Female|Sex: Female, Male|Description only includes those subjects who received the study fluid.|Participants|Count of Participants|85|85.0||||||
4383893|NCT00316017|4210451|B2||Female|Sex: Female, Male|Description only includes those subjects who received the study fluid.|Participants|Count of Participants|51|51.0||||||
4383894|NCT00316017|4210452|B1||Female|Sex: Female, Male|Description only includes those subjects who received the study fluid.|Participants|Count of Participants|50|50.0||||||
4383895|NCT00316017|4210449|B4|||Age|The HSD group included one subject with no age data available.|years|Mean|36.7|36.7|Standard Deviation|16.5|16.5|||
4383896|NCT00316017|4210450|B3|||Age|The HSD group included one subject with no age data available.|years|Mean|36.2|36.2|Standard Deviation|16.4|16.4|||
4383897|NCT00316017|4210451|B2|||Age|The HSD group included one subject with no age data available.|years|Mean|36.8|36.8|Standard Deviation|16.1|16.1|||
4383898|NCT00316017|4210452|B1|||Age|The HSD group included one subject with no age data available.|years|Mean|37.7|37.7|Standard Deviation|17.3|17.3|||
4383899|NCT00316017|4210449|B4|>=65 years||Age|The HSD group included one subject with no age data available.|participants|Number|57|57.0||||||
4383900|NCT00316017|4210450|B3|>=65 years||Age|The HSD group included one subject with no age data available.|participants|Number|21|21.0||||||
4383901|NCT00316017|4210451|B2|>=65 years||Age|The HSD group included one subject with no age data available.|participants|Number|18|18.0||||||
4383902|NCT00316017|4210452|B1|>=65 years||Age|The HSD group included one subject with no age data available.|participants|Number|18|18.0||||||
4383903|NCT00316017|4210449|B4|Between 18 and 65 years||Age|The HSD group included one subject with no age data available.|participants|Number|745|745.0||||||
4383904|NCT00316017|4210450|B3|Between 18 and 65 years||Age|The HSD group included one subject with no age data available.|participants|Number|332|332.0||||||
4383905|NCT00316017|4210451|B2|Between 18 and 65 years||Age|The HSD group included one subject with no age data available.|participants|Number|225|225.0||||||
4383906|NCT00316017|4210452|B1|Between 18 and 65 years||Age|The HSD group included one subject with no age data available.|participants|Number|188|188.0||||||
4383907|NCT00316017|4210449|B4|<=18 years||Age|The HSD group included one subject with no age data available.|participants|Number|49|49.0||||||
4383908|NCT00316017|4210450|B3|<=18 years||Age|The HSD group included one subject with no age data available.|participants|Number|23|23.0||||||
4383909|NCT00316017|4210451|B2|<=18 years||Age|The HSD group included one subject with no age data available.|participants|Number|13|13.0||||||
4383910|NCT00316017|4210452|B1|<=18 years||Age|The HSD group included one subject with no age data available.|participants|Number|13|13.0||||||
4383911|NCT00316004|4210525|B4|Canada||Region of Enrollment||participants|Number|340|340.0||||||
4383912|NCT00316004|4210526|B3|Canada||Region of Enrollment||participants|Number|162|162.0||||||
4383913|NCT00316004|4210527|B2|Canada||Region of Enrollment||participants|Number|96|96.0||||||
4383914|NCT00316004|4210528|B1|Canada||Region of Enrollment||participants|Number|82|82.0||||||
4383915|NCT00316004|4210525|B4|United States||Region of Enrollment||participants|Number|991|991.0||||||
4383916|NCT00316004|4210526|B3|United States||Region of Enrollment||participants|Number|441|441.0||||||
4383917|NCT00316004|4210527|B2|United States||Region of Enrollment||participants|Number|259|259.0||||||
4383918|NCT00316004|4210528|B1|United States||Region of Enrollment||participants|Number|291|291.0||||||
4383919|NCT00316004|4210525|B4|Male||Gender|The HSD group included 3 subjects with no gender data available. The HS group included 1 subject with no gender data available. The NS group included 2 subjects with no gender data available.|participants|Number|1008|1008.0||||||
4383920|NCT00316004|4210526|B3|Male||Gender|The HSD group included 3 subjects with no gender data available. The HS group included 1 subject with no gender data available. The NS group included 2 subjects with no gender data available.|participants|Number|438|438.0||||||
4383921|NCT00316004|4210527|B2|Male||Gender|The HSD group included 3 subjects with no gender data available. The HS group included 1 subject with no gender data available. The NS group included 2 subjects with no gender data available.|participants|Number|286|286.0||||||
4383922|NCT00316004|4210528|B1|Male||Gender|The HSD group included 3 subjects with no gender data available. The HS group included 1 subject with no gender data available. The NS group included 2 subjects with no gender data available.|participants|Number|284|284.0||||||
4383958|NCT00315822|4210592|B3|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
4383923|NCT00316004|4210525|B4|Female||Gender|The HSD group included 3 subjects with no gender data available. The HS group included 1 subject with no gender data available. The NS group included 2 subjects with no gender data available.|participants|Number|317|317.0||||||
4383924|NCT00316004|4210526|B3|Female||Gender|The HSD group included 3 subjects with no gender data available. The HS group included 1 subject with no gender data available. The NS group included 2 subjects with no gender data available.|participants|Number|163|163.0||||||
4383925|NCT00316004|4210527|B2|Female||Gender|The HSD group included 3 subjects with no gender data available. The HS group included 1 subject with no gender data available. The NS group included 2 subjects with no gender data available.|participants|Number|68|68.0||||||
4383926|NCT00316004|4210528|B1|Female||Gender|The HSD group included 3 subjects with no gender data available. The HS group included 1 subject with no gender data available. The NS group included 2 subjects with no gender data available.|participants|Number|86|86.0||||||
4383927|NCT00316004|4210525|B4|||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|years|Mean|39.0|39.0|Standard Deviation|18.4|18.4|||
4383928|NCT00316004|4210526|B3|||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|years|Mean|39.5|39.5|Standard Deviation|19.2|19.2|||
4383929|NCT00316004|4210527|B2|||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|years|Mean|38.6|38.6|Standard Deviation|17.3|17.3|||
4383930|NCT00316004|4210528|B1|||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|years|Mean|38.5|38.5|Standard Deviation|18.6|18.6|||
4383931|NCT00316004|4210525|B4|>=65 years||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|participants|Number|144|144.0||||||
4383932|NCT00316004|4210526|B3|>=65 years||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|participants|Number|74|74.0||||||
4383933|NCT00316004|4210527|B2|>=65 years||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|participants|Number|29|29.0||||||
4383934|NCT00316004|4210528|B1|>=65 years||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|participants|Number|41|41.0||||||
4383935|NCT00316004|4210525|B4|Between 18 and 65 years||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|participants|Number|1085|1085.0||||||
4383936|NCT00316004|4210526|B3|Between 18 and 65 years||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|participants|Number|484|484.0||||||
4383937|NCT00316004|4210527|B2|Between 18 and 65 years||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|participants|Number|305|305.0||||||
4383938|NCT00316004|4210528|B1|Between 18 and 65 years||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|participants|Number|296|296.0||||||
4383939|NCT00316004|4210525|B4|<=18 years||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|participants|Number|95|95.0||||||
4383940|NCT00316004|4210526|B3|<=18 years||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|participants|Number|43|43.0||||||
4383941|NCT00316004|4210527|B2|<=18 years||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|participants|Number|19|19.0||||||
4383942|NCT00316004|4210528|B1|<=18 years||Age|The HSD group included 3 subjects with no age data available. The HS group included 2 subjects with no age data available. The NS group included 2 subjects with no age data available.|participants|Number|33|33.0||||||
4383943|NCT00315939|4210583|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4383944|NCT00315939|4210584|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4383945|NCT00315939|4210585|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4383946|NCT00315939|4210583|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4383947|NCT00315939|4210584|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4383948|NCT00315939|4210585|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4383949|NCT00315939|4210583|B3|||Age||years|Mean|39.15|39.15|Standard Deviation|14.35|14.35|||
4383950|NCT00315939|4210584|B2|||Age||years|Mean|37.61|37.61|Standard Deviation|13.78|13.78|||
4383951|NCT00315939|4210585|B1|||Age||years|Mean|40.65|40.65|Standard Deviation|14.84|14.84|||
4383952|NCT00315822|4210592|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4383953|NCT00315822|4210593|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4383954|NCT00315822|4210594|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4383955|NCT00315822|4210592|B3||Female|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4383956|NCT00315822|4210593|B2||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4383957|NCT00315822|4210594|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4383959|NCT00315822|4210593|B2|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
4383960|NCT00315822|4210594|B1|||Age||years|Mean|43|43.0|Standard Deviation|12|12.0|||
4383961|NCT00315731|4210601|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4383962|NCT00315731|4210601|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4383963|NCT00315731|4210601|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4383964|NCT00315731|4210601|B1|||Age||Years|Mean|58.1|58.1|Standard Deviation|12.9|12.9|||
4383965|NCT00315705|4210627|B3|100||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|22|22.0||||||
4383966|NCT00315705|4210628|B2|100||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|10|10.0||||||
4383967|NCT00315705|4210629|B1|100||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|12|12.0||||||
4383968|NCT00315705|4210627|B3|90||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|13|13.0||||||
4383969|NCT00315705|4210628|B2|90||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|6|6.0||||||
4383970|NCT00315705|4210629|B1|90||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|7|7.0||||||
4383971|NCT00315705|4210627|B3|80||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|8|8.0||||||
4383972|NCT00315705|4210628|B2|80||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|3|3.0||||||
4383973|NCT00315705|4210629|B1|80||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|5|5.0||||||
4383974|NCT00315705|4210627|B3|70||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|3|3.0||||||
4383975|NCT00315705|4210628|B2|70||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|2|2.0||||||
4383976|NCT00315705|4210629|B1|70||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|1|1.0||||||
4383977|NCT00315705|4210627|B3|60||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|2|2.0||||||
4384000|NCT00315705|4210629|B1|2 regimens||Count of Previous Anti-Leukemic (non-transplant) Treatment Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|18|18.0||||||
4384070|NCT00315627|4210666|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4383978|NCT00315705|4210628|B2|60||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|2|2.0||||||
4383979|NCT00315705|4210629|B1|60||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|0|0.0||||||
4383980|NCT00315705|4210627|B3|50||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|2|2.0||||||
4383981|NCT00315705|4210628|B2|50||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|2|2.0||||||
4383982|NCT00315705|4210629|B1|50||Participant Rating Using the Karnofsky/Lansky Performance Status Scale|Baseline performance was rating using either the Karnofsky Performance Scale for participants greater than 10 years old, or the Lansky Performance Scale for participants 10 years or younger. Both scales range from 0-100 with 0 indicating dead or unresponsive and 100 indicating normal performance. The two study phases were not designed to be reported in the aggregate.|participants|Number|0|0.0||||||
4383983|NCT00315705|4210627|B3|No||Participants Who Were Refractory to the Most Recent Previous Anti-Leukemic Treatment|"The answer Yes indicates the number of participants who were refractory (unresponsive) to the most recent anti-leukemic treatment. The answer No represents participants who were not refractory. The two study phases were not designed to be reported in the aggregate."|participants|Number|28|28.0||||||
4383984|NCT00315705|4210628|B2|No||Participants Who Were Refractory to the Most Recent Previous Anti-Leukemic Treatment|"The answer Yes indicates the number of participants who were refractory (unresponsive) to the most recent anti-leukemic treatment. The answer No represents participants who were not refractory. The two study phases were not designed to be reported in the aggregate."|participants|Number|10|10.0||||||
4383985|NCT00315705|4210629|B1|No||Participants Who Were Refractory to the Most Recent Previous Anti-Leukemic Treatment|"The answer Yes indicates the number of participants who were refractory (unresponsive) to the most recent anti-leukemic treatment. The answer No represents participants who were not refractory. The two study phases were not designed to be reported in the aggregate."|participants|Number|18|18.0||||||
4383986|NCT00315705|4210627|B3|Yes||Participants Who Were Refractory to the Most Recent Previous Anti-Leukemic Treatment|"The answer Yes indicates the number of participants who were refractory (unresponsive) to the most recent anti-leukemic treatment. The answer No represents participants who were not refractory. The two study phases were not designed to be reported in the aggregate."|participants|Number|22|22.0||||||
4383987|NCT00315705|4210628|B2|Yes||Participants Who Were Refractory to the Most Recent Previous Anti-Leukemic Treatment|"The answer Yes indicates the number of participants who were refractory (unresponsive) to the most recent anti-leukemic treatment. The answer No represents participants who were not refractory. The two study phases were not designed to be reported in the aggregate."|participants|Number|15|15.0||||||
4383988|NCT00315705|4210629|B1|Yes||Participants Who Were Refractory to the Most Recent Previous Anti-Leukemic Treatment|"The answer Yes indicates the number of participants who were refractory (unresponsive) to the most recent anti-leukemic treatment. The answer No represents participants who were not refractory. The two study phases were not designed to be reported in the aggregate."|participants|Number|7|7.0||||||
4383989|NCT00315705|4210627|B3|No transplants||Participants with Previous Anti-Leukemic Transplant Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|42|42.0||||||
4383990|NCT00315705|4210628|B2|No transplants||Participants with Previous Anti-Leukemic Transplant Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|21|21.0||||||
4383991|NCT00315705|4210629|B1|No transplants||Participants with Previous Anti-Leukemic Transplant Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|21|21.0||||||
4383992|NCT00315705|4210627|B3|Transplants||Participants with Previous Anti-Leukemic Transplant Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|8|8.0||||||
4383993|NCT00315705|4210628|B2|Transplants||Participants with Previous Anti-Leukemic Transplant Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|4|4.0||||||
4383994|NCT00315705|4210629|B1|Transplants||Participants with Previous Anti-Leukemic Transplant Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|4|4.0||||||
4383995|NCT00315705|4210627|B3|3 regimens||Count of Previous Anti-Leukemic (non-transplant) Treatment Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|10|10.0||||||
4383996|NCT00315705|4210628|B2|3 regimens||Count of Previous Anti-Leukemic (non-transplant) Treatment Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|7|7.0||||||
4383997|NCT00315705|4210629|B1|3 regimens||Count of Previous Anti-Leukemic (non-transplant) Treatment Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|3|3.0||||||
4383998|NCT00315705|4210627|B3|2 regimens||Count of Previous Anti-Leukemic (non-transplant) Treatment Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|32|32.0||||||
4383999|NCT00315705|4210628|B2|2 regimens||Count of Previous Anti-Leukemic (non-transplant) Treatment Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|14|14.0||||||
4384001|NCT00315705|4210627|B3|1 regimen||Count of Previous Anti-Leukemic (non-transplant) Treatment Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|8|8.0||||||
4384002|NCT00315705|4210628|B2|1 regimen||Count of Previous Anti-Leukemic (non-transplant) Treatment Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|4|4.0||||||
4384003|NCT00315705|4210629|B1|1 regimen||Count of Previous Anti-Leukemic (non-transplant) Treatment Regimens|The two study phases were not designed to be reported in the aggregate.|participants|Number|4|4.0||||||
4384004|NCT00315705|4210627|B3|not included (AML participants)||Immunophenotype|Applies to acute lymphoblastic leukemic (ALL) participants only. Acute myelogenous leukemic (AML) participants are not included. The two study phases were not designed to be reported in the aggregate.|participants|Number|5|5.0||||||
4384005|NCT00315705|4210628|B2|not included (AML participants)||Immunophenotype|Applies to acute lymphoblastic leukemic (ALL) participants only. Acute myelogenous leukemic (AML) participants are not included. The two study phases were not designed to be reported in the aggregate.|participants|Number|0|0.0||||||
4384006|NCT00315705|4210629|B1|not included (AML participants)||Immunophenotype|Applies to acute lymphoblastic leukemic (ALL) participants only. Acute myelogenous leukemic (AML) participants are not included. The two study phases were not designed to be reported in the aggregate.|participants|Number|5|5.0||||||
4384007|NCT00315705|4210627|B3|Unknown||Immunophenotype|Applies to acute lymphoblastic leukemic (ALL) participants only. Acute myelogenous leukemic (AML) participants are not included. The two study phases were not designed to be reported in the aggregate.|participants|Number|5|5.0||||||
4384008|NCT00315705|4210628|B2|Unknown||Immunophenotype|Applies to acute lymphoblastic leukemic (ALL) participants only. Acute myelogenous leukemic (AML) participants are not included. The two study phases were not designed to be reported in the aggregate.|participants|Number|3|3.0||||||
4384009|NCT00315705|4210629|B1|Unknown||Immunophenotype|Applies to acute lymphoblastic leukemic (ALL) participants only. Acute myelogenous leukemic (AML) participants are not included. The two study phases were not designed to be reported in the aggregate.|participants|Number|2|2.0||||||
4384010|NCT00315705|4210627|B3|T cell||Immunophenotype|Applies to acute lymphoblastic leukemic (ALL) participants only. Acute myelogenous leukemic (AML) participants are not included. The two study phases were not designed to be reported in the aggregate.|participants|Number|6|6.0||||||
4384011|NCT00315705|4210628|B2|T cell||Immunophenotype|Applies to acute lymphoblastic leukemic (ALL) participants only. Acute myelogenous leukemic (AML) participants are not included. The two study phases were not designed to be reported in the aggregate.|participants|Number|1|1.0||||||
4384012|NCT00315705|4210629|B1|T cell||Immunophenotype|Applies to acute lymphoblastic leukemic (ALL) participants only. Acute myelogenous leukemic (AML) participants are not included. The two study phases were not designed to be reported in the aggregate.|participants|Number|5|5.0||||||
4384013|NCT00315705|4210627|B3|B cell||Immunophenotype|Applies to acute lymphoblastic leukemic (ALL) participants only. Acute myelogenous leukemic (AML) participants are not included. The two study phases were not designed to be reported in the aggregate.|participants|Number|34|34.0||||||
4384014|NCT00315705|4210628|B2|B cell||Immunophenotype|Applies to acute lymphoblastic leukemic (ALL) participants only. Acute myelogenous leukemic (AML) participants are not included. The two study phases were not designed to be reported in the aggregate.|participants|Number|21|21.0||||||
4384015|NCT00315705|4210629|B1|B cell||Immunophenotype|Applies to acute lymphoblastic leukemic (ALL) participants only. Acute myelogenous leukemic (AML) participants are not included. The two study phases were not designed to be reported in the aggregate.|participants|Number|13|13.0||||||
4384016|NCT00315705|4210627|B3|||White Blood Cell Counts|The two study phases were not designed to be reported in the aggregate.|10^9/L|Mean|10.247|10.247|Standard Deviation|17.4370|17.437|||
4384017|NCT00315705|4210628|B2|||White Blood Cell Counts|The two study phases were not designed to be reported in the aggregate.|10^9/L|Mean|12.171|12.171|Standard Deviation|23.0150|23.015|||
4384018|NCT00315705|4210629|B1|||White Blood Cell Counts|The two study phases were not designed to be reported in the aggregate.|10^9/L|Mean|8.323|8.323|Standard Deviation|9.1305|9.1305|||
4384019|NCT00315705|4210627|B3|||Absolute Neutrophil Counts|The two study phases were not designed to be reported in the aggregate.|10^9/L|Mean|1.93325|1.93325|Standard Deviation|2.459536|2.459536|||
4384020|NCT00315705|4210628|B2|||Absolute Neutrophil Counts|The two study phases were not designed to be reported in the aggregate.|10^9/L|Mean|1.9280|1.928|Standard Deviation|1.708126|1.708126|||
4384021|NCT00315705|4210629|B1|||Absolute Neutrophil Counts|The two study phases were not designed to be reported in the aggregate.|10^9/L|Mean|1.93828|1.93828|Standard Deviation|3.049992|3.049992|||
4384022|NCT00315705|4210627|B3|||Percent Leukemic Blast Cells|Percent of leukemic blast cells based on bone marrow aspirate. The two study phases were not designed to be reported in the aggregate.|percentage of total blast cells|Mean|68.16|68.16|Standard Deviation|24.008|24.008|||
4384023|NCT00315705|4210628|B2|||Percent Leukemic Blast Cells|Percent of leukemic blast cells based on bone marrow aspirate. The two study phases were not designed to be reported in the aggregate.|percentage of total blast cells|Mean|69.52|69.52|Standard Deviation|23.566|23.566|||
4384024|NCT00315705|4210629|B1|||Percent Leukemic Blast Cells|Percent of leukemic blast cells based on bone marrow aspirate. The two study phases were not designed to be reported in the aggregate.|percentage of total blast cells|Mean|66.8|66.8|Standard Deviation|24.85|24.85|||
4384025|NCT00315705|4210627|B3||Unknown or Not Reported|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|10|10.0||||||
4384026|NCT00315705|4210628|B2||Unknown or Not Reported|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|8|8.0||||||
4384027|NCT00315705|4210629|B1||Unknown or Not Reported|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|2|2.0||||||
4384028|NCT00315705|4210627|B3||More than one race|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|0|0.0||||||
4384029|NCT00315705|4210628|B2||More than one race|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|0|0.0||||||
4384030|NCT00315705|4210629|B1||More than one race|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|0|0.0||||||
4384031|NCT00315705|4210627|B3||White|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|28|28.0||||||
4384032|NCT00315705|4210628|B2||White|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|12|12.0||||||
4384033|NCT00315705|4210629|B1||White|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|16|16.0||||||
4384034|NCT00315705|4210627|B3||Black or African American|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|6|6.0||||||
4384035|NCT00315705|4210628|B2||Black or African American|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|2|2.0||||||
4384036|NCT00315705|4210629|B1||Black or African American|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|4|4.0||||||
4384037|NCT00315705|4210627|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|0|0.0||||||
4384038|NCT00315705|4210628|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|0|0.0||||||
4384039|NCT00315705|4210629|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|0|0.0||||||
4384040|NCT00315705|4210627|B3||Asian|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|5|5.0||||||
4384041|NCT00315705|4210628|B2||Asian|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|2|2.0||||||
4384042|NCT00315705|4210629|B1||Asian|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|3|3.0||||||
4384043|NCT00315705|4210627|B3||American Indian or Alaska Native|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|1|1.0||||||
4384044|NCT00315705|4210628|B2||American Indian or Alaska Native|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|1|1.0||||||
4384045|NCT00315705|4210629|B1||American Indian or Alaska Native|Race (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|0|0.0||||||
4384046|NCT00315705|4210627|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|0|0.0||||||
4384047|NCT00315705|4210628|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|0|0.0||||||
4384048|NCT00315705|4210629|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|0|0.0||||||
4384049|NCT00315705|4210627|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|35|35.0||||||
4384050|NCT00315705|4210628|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|15|15.0||||||
4384051|NCT00315705|4210629|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|20|20.0||||||
4384052|NCT00315705|4210627|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|15|15.0||||||
4384053|NCT00315705|4210628|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|10|10.0||||||
4384054|NCT00315705|4210629|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|5|5.0||||||
4384055|NCT00315705|4210627|B3||Male|Sex: Female, Male|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|31|31.0||||||
4384056|NCT00315705|4210628|B2||Male|Sex: Female, Male|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|16|16.0||||||
4384057|NCT00315705|4210629|B1||Male|Sex: Female, Male|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|15|15.0||||||
4384058|NCT00315705|4210627|B3||Female|Sex: Female, Male|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|19|19.0||||||
4384059|NCT00315705|4210628|B2||Female|Sex: Female, Male|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|9|9.0||||||
4384060|NCT00315705|4210629|B1||Female|Sex: Female, Male|The two study phases were not designed to be reported in the aggregate.|Participants|Count of Participants|10|10.0||||||
4384061|NCT00315705|4210627|B3|||Age|The two study phases were not designed to be reported in the aggregate.|years|Mean|11.2|11.2|Standard Deviation|5.49|5.49|||
4384062|NCT00315705|4210628|B2|||Age|The two study phases were not designed to be reported in the aggregate.|years|Mean|13.2|13.2|Standard Deviation|5.25|5.25|||
4384063|NCT00315705|4210629|B1|||Age|The two study phases were not designed to be reported in the aggregate.|years|Mean|9.1|9.1|Standard Deviation|5.03|5.03|||
4384064|NCT00315627|4210666|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4384065|NCT00315627|4210666|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384066|NCT00315627|4210666|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384067|NCT00315627|4210666|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4384068|NCT00315627|4210666|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384069|NCT00315627|4210666|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384071|NCT00315627|4210666|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384072|NCT00315627|4210666|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384073|NCT00315627|4210666|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4384074|NCT00315627|4210666|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384075|NCT00315627|4210666|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4384076|NCT00315627|4210666|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4384077|NCT00315627|4210666|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384078|NCT00315627|4210666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4384079|NCT00315627|4210666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384080|NCT00315614|4210674|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4384081|NCT00315614|4210674|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4384082|NCT00315614|4210674|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4384083|NCT00315614|4210674|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384084|NCT00315614|4210674|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4384085|NCT00315614|4210674|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384086|NCT00315588|4210681|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4384087|NCT00315588|4210681|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384088|NCT00315588|4210681|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384089|NCT00315588|4210681|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4384090|NCT00315588|4210681|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384091|NCT00315588|4210681|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384092|NCT00315588|4210681|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384093|NCT00315588|4210681|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384094|NCT00315588|4210681|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384095|NCT00315588|4210681|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4384096|NCT00315588|4210681|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4384097|NCT00315588|4210681|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4384098|NCT00315588|4210681|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4384099|NCT00315588|4210681|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384100|NCT00315588|4210681|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4384101|NCT00315588|4210681|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384102|NCT00315458|4210688|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4384103|NCT00315458|4210689|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4384104|NCT00315458|4210690|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4384105|NCT00315458|4210688|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4384106|NCT00315458|4210689|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4384107|NCT00315458|4210690|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4384108|NCT00315458|4210688|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|10.45|10.45|||
4384109|NCT00315458|4210689|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|9.56|9.56|||
4384110|NCT00315458|4210690|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|11.36|11.36|||
4384111|NCT00315445|4210703|B4|Opioid experienced||Opioid Experience|"Subjects were either classified as opioid naive (those not currently receiving an opioid-containing analgesic or those receiving 2 or fewer short-acting opioid tablets or capsules per day) or opioid experienced (those receiving a controlled-release opioid analgesic at a dose of ≤ 90 mg of morphine equivalents per day or those receiving 3 to 12 capsules or tablets of short-acting opioid analgesics per day)"|participants|Number|27|27.0||||||
4384112|NCT00315445|4210704|B3|Opioid experienced||Opioid Experience|"Subjects were either classified as opioid naive (those not currently receiving an opioid-containing analgesic or those receiving 2 or fewer short-acting opioid tablets or capsules per day) or opioid experienced (those receiving a controlled-release opioid analgesic at a dose of ≤ 90 mg of morphine equivalents per day or those receiving 3 to 12 capsules or tablets of short-acting opioid analgesics per day)"|participants|Number|12|12.0||||||
4384113|NCT00315445|4210705|B2|Opioid experienced||Opioid Experience|"Subjects were either classified as opioid naive (those not currently receiving an opioid-containing analgesic or those receiving 2 or fewer short-acting opioid tablets or capsules per day) or opioid experienced (those receiving a controlled-release opioid analgesic at a dose of ≤ 90 mg of morphine equivalents per day or those receiving 3 to 12 capsules or tablets of short-acting opioid analgesics per day)"|participants|Number|9|9.0||||||
4384114|NCT00315445|4210706|B1|Opioid experienced||Opioid Experience|"Subjects were either classified as opioid naive (those not currently receiving an opioid-containing analgesic or those receiving 2 or fewer short-acting opioid tablets or capsules per day) or opioid experienced (those receiving a controlled-release opioid analgesic at a dose of ≤ 90 mg of morphine equivalents per day or those receiving 3 to 12 capsules or tablets of short-acting opioid analgesics per day)"|participants|Number|6|6.0||||||
4384150|NCT00315328|4210788|B5|||Intereye Acuity Difference|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Intereye difference defined as the difference between ETDRS letter scores (amblyopic eye minus sound eye).|ETDRS letter score|Mean|28.0|28.0|Standard Deviation|11.7|11.7|||
4384115|NCT00315445|4210703|B4|Opioid naive||Opioid Experience|"Subjects were either classified as opioid naive (those not currently receiving an opioid-containing analgesic or those receiving 2 or fewer short-acting opioid tablets or capsules per day) or opioid experienced (those receiving a controlled-release opioid analgesic at a dose of ≤ 90 mg of morphine equivalents per day or those receiving 3 to 12 capsules or tablets of short-acting opioid analgesics per day)"|participants|Number|107|107.0||||||
4384116|NCT00315445|4210704|B3|Opioid naive||Opioid Experience|"Subjects were either classified as opioid naive (those not currently receiving an opioid-containing analgesic or those receiving 2 or fewer short-acting opioid tablets or capsules per day) or opioid experienced (those receiving a controlled-release opioid analgesic at a dose of ≤ 90 mg of morphine equivalents per day or those receiving 3 to 12 capsules or tablets of short-acting opioid analgesics per day)"|participants|Number|34|34.0||||||
4384117|NCT00315445|4210705|B2|Opioid naive||Opioid Experience|"Subjects were either classified as opioid naive (those not currently receiving an opioid-containing analgesic or those receiving 2 or fewer short-acting opioid tablets or capsules per day) or opioid experienced (those receiving a controlled-release opioid analgesic at a dose of ≤ 90 mg of morphine equivalents per day or those receiving 3 to 12 capsules or tablets of short-acting opioid analgesics per day)"|participants|Number|34|34.0||||||
4384118|NCT00315445|4210706|B1|Opioid naive||Opioid Experience|"Subjects were either classified as opioid naive (those not currently receiving an opioid-containing analgesic or those receiving 2 or fewer short-acting opioid tablets or capsules per day) or opioid experienced (those receiving a controlled-release opioid analgesic at a dose of ≤ 90 mg of morphine equivalents per day or those receiving 3 to 12 capsules or tablets of short-acting opioid analgesics per day)"|participants|Number|39|39.0||||||
4384119|NCT00315445|4210703|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4384120|NCT00315445|4210704|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4384121|NCT00315445|4210705|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4384122|NCT00315445|4210706|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4384123|NCT00315445|4210703|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4384124|NCT00315445|4210704|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4384125|NCT00315445|4210705|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4384126|NCT00315445|4210706|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4384127|NCT00315445|4210703|B4|||Age||years|Mean|52|52.0|Standard Deviation|1.31|1.31|||
4384128|NCT00315445|4210704|B3|||Age||years|Mean|54|54.0|Standard Deviation|2.2|2.2|||
4384129|NCT00315445|4210705|B2|||Age||years|Mean|49|49.0|Standard Deviation|2.5|2.5|||
4384130|NCT00315445|4210706|B1|||Age||years|Mean|52|52.0|Standard Deviation|2.2|2.2|||
4384131|NCT00315341|4210779|B3||Male|Gender||Participants|Count of Participants|861|861.0||||||
4384132|NCT00315341|4210780|B2||Male|Gender||Participants|Count of Participants|359|359.0||||||
4384133|NCT00315341|4210781|B1||Male|Gender||Participants|Count of Participants|502|502.0||||||
4384134|NCT00315341|4210779|B3||Female|Gender||Participants|Count of Participants|408|408.0||||||
4384135|NCT00315341|4210780|B2||Female|Gender||Participants|Count of Participants|170|170.0||||||
4384136|NCT00315341|4210781|B1||Female|Gender||Participants|Count of Participants|238|238.0||||||
4384137|NCT00315341|4210779|B3|||Age||years|Mean|37.4|37.4|Standard Deviation|11.1|11.1|||
4384138|NCT00315341|4210780|B2|||Age||years|Mean|37.3|37.3|Standard Deviation|10.9|10.9|||
4384139|NCT00315341|4210781|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|11.2|11.2|||
4384140|NCT00315328|4210788|B5|||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopter|Mean|2.17|2.17|Standard Deviation|2.00|2.0|||
4384141|NCT00315328|4210789|B4|||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopter|Mean|1.98|1.98|Standard Deviation|2.11|2.11|||
4384142|NCT00315328|4210790|B3|||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopter|Mean|2.12|2.12|Standard Deviation|1.76|1.76|||
4384143|NCT00315328|4210791|B2|||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopter|Mean|2.56|2.56|Standard Deviation|2.22|2.22|||
4384144|NCT00315328|4210792|B1|||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopter|Mean|1.84|1.84|Standard Deviation|1.74|1.74|||
4384145|NCT00315328|4210788|B5|||Refractive Error in Amblyopic Eye (spherical equivalent|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopter|Mean|3.95|3.95|Standard Deviation|2.16|2.16|||
4384146|NCT00315328|4210789|B4|||Refractive Error in Amblyopic Eye (spherical equivalent|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopter|Mean|4.18|4.18|Standard Deviation|1.99|1.99|||
4384147|NCT00315328|4210790|B3|||Refractive Error in Amblyopic Eye (spherical equivalent|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopter|Mean|4.97|4.97|Standard Deviation|2.50|2.5|||
4384148|NCT00315328|4210791|B2|||Refractive Error in Amblyopic Eye (spherical equivalent|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopter|Mean|4.10|4.1|Standard Deviation|2.19|2.19|||
4384149|NCT00315328|4210792|B1|||Refractive Error in Amblyopic Eye (spherical equivalent|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopter|Mean|3.57|3.57|Standard Deviation|2.07|2.07|||
4384151|NCT00315328|4210789|B4|||Intereye Acuity Difference|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Intereye difference defined as the difference between ETDRS letter scores (amblyopic eye minus sound eye).|ETDRS letter score|Mean|47.5|47.5|Standard Deviation|9.5|9.5|||
4384152|NCT00315328|4210790|B3|||Intereye Acuity Difference|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Intereye difference defined as the difference between ETDRS letter scores (amblyopic eye minus sound eye).|ETDRS letter score|Mean|49.5|49.5|Standard Deviation|5.5|5.5|||
4384153|NCT00315328|4210791|B2|||Intereye Acuity Difference|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Intereye difference defined as the difference between ETDRS letter scores (amblyopic eye minus sound eye).|ETDRS letter score|Mean|24.0|24.0|Standard Deviation|7.0|7.0|||
4384154|NCT00315328|4210792|B1|||Intereye Acuity Difference|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best. Intereye difference defined as the difference between ETDRS letter scores (amblyopic eye minus sound eye).|ETDRS letter score|Mean|23.5|23.5|Standard Deviation|6.8|6.8|||
4384155|NCT00315328|4210788|B5|||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|ETDRS letter score|Mean|85.9|85.9|Standard Deviation|3.6|3.6|||
4384156|NCT00315328|4210789|B4|||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|ETDRS letter score|Mean|85.5|85.5|Standard Deviation|4.0|4.0|||
4384157|NCT00315328|4210790|B3|||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|ETDRS letter score|Mean|87.0|87.0|Standard Deviation|3.5|3.5|||
4384158|NCT00315328|4210791|B2|||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|ETDRS letter score|Mean|85.7|85.7|Standard Deviation|3.4|3.4|||
4384159|NCT00315328|4210792|B1|||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|ETDRS letter score|Mean|86.0|86.0|Standard Deviation|3.6|3.6|||
4384160|NCT00315328|4210788|B5|||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|ETDRS letter score|Mean|57.9|57.9|Standard Deviation|11.1|11.1|||
4384161|NCT00315328|4210789|B4|||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|ETDRS letter score|Mean|37.5|37.5|Standard Deviation|7.5|7.5|||
4384162|NCT00315328|4210790|B3|||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|ETDRS letter score|Mean|37.5|37.5|Standard Deviation|5.0|5.0|||
4384163|NCT00315328|4210791|B2|||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|ETDRS letter score|Mean|61.7|61.7|Standard Deviation|6.6|6.6|||
4384164|NCT00315328|4210792|B1|||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|ETDRS letter score|Mean|62.4|62.4|Standard Deviation|5.7|5.7|||
4384165|NCT00315328|4210788|B5|>= +4.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|51|51.0||||||
4384166|NCT00315328|4210789|B4|>= +4.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|4|4.0||||||
4384167|NCT00315328|4210790|B3|>= +4.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|3|3.0||||||
4384168|NCT00315328|4210791|B2|>= +4.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|32|32.0||||||
4384169|NCT00315328|4210792|B1|>= +4.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|12|12.0||||||
4384170|NCT00315328|4210788|B5|+3.00 to < +4.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|17|17.0||||||
4384353|NCT00315328|4210791|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4384171|NCT00315328|4210789|B4|+3.00 to < +4.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|2|2.0||||||
4384172|NCT00315328|4210790|B3|+3.00 to < +4.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|2|2.0||||||
4384173|NCT00315328|4210791|B2|+3.00 to < +4.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|6|6.0||||||
4384174|NCT00315328|4210792|B1|+3.00 to < +4.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|7|7.0||||||
4384175|NCT00315328|4210788|B5|+2.00 to < +3.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|25|25.0||||||
4384176|NCT00315328|4210789|B4|+2.00 to < +3.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|2|2.0||||||
4384177|NCT00315328|4210790|B3|+2.00 to < +3.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|1|1.0||||||
4384178|NCT00315328|4210791|B2|+2.00 to < +3.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|9|9.0||||||
4384179|NCT00315328|4210792|B1|+2.00 to < +3.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|13|13.0||||||
4384180|NCT00315328|4210788|B5|+1.00 to < +2.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|63|63.0||||||
4384181|NCT00315328|4210789|B4|+1.00 to < +2.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|5|5.0||||||
4384182|NCT00315328|4210790|B3|+1.00 to < +2.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|8|8.0||||||
4384183|NCT00315328|4210791|B2|+1.00 to < +2.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|17|17.0||||||
4384184|NCT00315328|4210792|B1|+1.00 to < +2.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|33|33.0||||||
4384185|NCT00315328|4210788|B5|0 to < +1.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|74|74.0||||||
4384186|NCT00315328|4210789|B4|0 to < +1.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|9|9.0||||||
4384187|NCT00315328|4210790|B3|0 to < +1.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|4|4.0||||||
4384188|NCT00315328|4210791|B2|0 to < +1.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|29|29.0||||||
4384189|NCT00315328|4210792|B1|0 to < +1.00D||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|32|32.0||||||
4384190|NCT00315328|4210788|B5|< 0 Diopters (D)||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|3|3.0||||||
4384191|NCT00315328|4210789|B4|< 0 Diopters (D)||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|0|0.0||||||
4384192|NCT00315328|4210790|B3|< 0 Diopters (D)||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|0|0.0||||||
4384193|NCT00315328|4210791|B2|< 0 Diopters (D)||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|2|2.0||||||
4384194|NCT00315328|4210792|B1|< 0 Diopters (D)||Refractive Error in Fellow Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|1|1.0||||||
4384195|NCT00315328|4210788|B5|>= +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|119|119.0||||||
4384354|NCT00315328|4210792|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4384355|NCT00315328|4210788|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4384196|NCT00315328|4210789|B4|>= +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|12|12.0||||||
4384197|NCT00315328|4210790|B3|>= +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|12|12.0||||||
4384198|NCT00315328|4210791|B2|>= +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|53|53.0||||||
4384199|NCT00315328|4210792|B1|>= +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|42|42.0||||||
4384200|NCT00315328|4210788|B5|+3.00 to < +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|45|45.0||||||
4384201|NCT00315328|4210789|B4|+3.00 to < +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|4|4.0||||||
4384202|NCT00315328|4210790|B3|+3.00 to < +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|2|2.0||||||
4384203|NCT00315328|4210791|B2|+3.00 to < +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|16|16.0||||||
4384204|NCT00315328|4210792|B1|+3.00 to < +4.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|23|23.0||||||
4384205|NCT00315328|4210788|B5|+2.00 to < +3.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|22|22.0||||||
4384206|NCT00315328|4210789|B4|+2.00 to < +3.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|3|3.0||||||
4384207|NCT00315328|4210790|B3|+2.00 to < +3.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|1|1.0||||||
4384208|NCT00315328|4210791|B2|+2.00 to < +3.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|8|8.0||||||
4384209|NCT00315328|4210792|B1|+2.00 to < +3.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|10|10.0||||||
4384210|NCT00315328|4210788|B5|+1.00 to < +2.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|23|23.0||||||
4384211|NCT00315328|4210789|B4|+1.00 to < +2.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|2|2.0||||||
4384212|NCT00315328|4210790|B3|+1.00 to < +2.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|2|2.0||||||
4384213|NCT00315328|4210791|B2|+1.00 to < +2.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|6|6.0||||||
4384214|NCT00315328|4210792|B1|+1.00 to < +2.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|13|13.0||||||
4384215|NCT00315328|4210788|B5|0 to < +1.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|20|20.0||||||
4384216|NCT00315328|4210789|B4|0 to < +1.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|1|1.0||||||
4384217|NCT00315328|4210790|B3|0 to < +1.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|1|1.0||||||
4384218|NCT00315328|4210791|B2|0 to < +1.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|10|10.0||||||
4384219|NCT00315328|4210792|B1|0 to < +1.00D||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|8|8.0||||||
4384220|NCT00315328|4210788|B5|< 0 Diopters (D)||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|4|4.0||||||
4384619|NCT00315302|4210865|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4384221|NCT00315328|4210789|B4|< 0 Diopters (D)||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|0|0.0||||||
4384222|NCT00315328|4210790|B3|< 0 Diopters (D)||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|0|0.0||||||
4384223|NCT00315328|4210791|B2|< 0 Diopters (D)||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|2|2.0||||||
4384224|NCT00315328|4210792|B1|< 0 Diopters (D)||Refractive Error in Amblyopic Eye (spherical equivalent)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|2|2.0||||||
4384225|NCT00315328|4210788|B5|Patching and atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|23|23.0||||||
4384226|NCT00315328|4210789|B4|Patching and atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|1|1.0||||||
4384227|NCT00315328|4210790|B3|Patching and atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|2|2.0||||||
4384228|NCT00315328|4210791|B2|Patching and atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|11|11.0||||||
4384229|NCT00315328|4210792|B1|Patching and atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|9|9.0||||||
4384230|NCT00315328|4210788|B5|Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|3|3.0||||||
4384231|NCT00315328|4210789|B4|Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|0|0.0||||||
4384232|NCT00315328|4210790|B3|Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|1|1.0||||||
4384233|NCT00315328|4210791|B2|Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|0|0.0||||||
4384234|NCT00315328|4210792|B1|Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|2|2.0||||||
4384235|NCT00315328|4210788|B5|Patching||Prior Treatment for Amblyopia at Enrollment||participants|Number|37|37.0||||||
4384236|NCT00315328|4210789|B4|Patching||Prior Treatment for Amblyopia at Enrollment||participants|Number|3|3.0||||||
4384237|NCT00315328|4210790|B3|Patching||Prior Treatment for Amblyopia at Enrollment||participants|Number|2|2.0||||||
4384238|NCT00315328|4210791|B2|Patching||Prior Treatment for Amblyopia at Enrollment||participants|Number|16|16.0||||||
4384239|NCT00315328|4210792|B1|Patching||Prior Treatment for Amblyopia at Enrollment||participants|Number|16|16.0||||||
4384240|NCT00315328|4210788|B5|None||Prior Treatment for Amblyopia at Enrollment||participants|Number|170|170.0||||||
4384241|NCT00315328|4210789|B4|None||Prior Treatment for Amblyopia at Enrollment||participants|Number|18|18.0||||||
4384242|NCT00315328|4210790|B3|None||Prior Treatment for Amblyopia at Enrollment||participants|Number|13|13.0||||||
4384243|NCT00315328|4210791|B2|None||Prior Treatment for Amblyopia at Enrollment||participants|Number|68|68.0||||||
4384244|NCT00315328|4210792|B1|None||Prior Treatment for Amblyopia at Enrollment||participants|Number|71|71.0||||||
4384245|NCT00315328|4210788|B5|20/12 (93 to 97 letters) (best)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|4|4.0||||||
4384246|NCT00315328|4210789|B4|20/12 (93 to 97 letters) (best)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384247|NCT00315328|4210790|B3|20/12 (93 to 97 letters) (best)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384248|NCT00315328|4210791|B2|20/12 (93 to 97 letters) (best)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|2|2.0||||||
4384249|NCT00315328|4210792|B1|20/12 (93 to 97 letters) (best)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|2|2.0||||||
4384250|NCT00315328|4210788|B5|20/16 (88 to 92 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|82|82.0||||||
4384251|NCT00315328|4210789|B4|20/16 (88 to 92 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|11|11.0||||||
4384252|NCT00315328|4210790|B3|20/16 (88 to 92 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|9|9.0||||||
4384253|NCT00315328|4210791|B2|20/16 (88 to 92 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|26|26.0||||||
4384356|NCT00315328|4210789|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4384357|NCT00315328|4210790|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4384254|NCT00315328|4210792|B1|20/16 (88 to 92 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|36|36.0||||||
4384255|NCT00315328|4210788|B5|20/20 (83 to 87 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|103|103.0||||||
4384256|NCT00315328|4210789|B4|20/20 (83 to 87 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|5|5.0||||||
4384257|NCT00315328|4210790|B3|20/20 (83 to 87 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|8|8.0||||||
4384258|NCT00315328|4210791|B2|20/20 (83 to 87 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|47|47.0||||||
4384259|NCT00315328|4210792|B1|20/20 (83 to 87 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|43|43.0||||||
4384260|NCT00315328|4210788|B5|20/25 (78 to 82 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|44|44.0||||||
4384261|NCT00315328|4210789|B4|20/25 (78 to 82 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|6|6.0||||||
4384262|NCT00315328|4210790|B3|20/25 (78 to 82 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|1|1.0||||||
4384263|NCT00315328|4210791|B2|20/25 (78 to 82 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|20|20.0||||||
4384264|NCT00315328|4210792|B1|20/25 (78 to 82 letters)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|17|17.0||||||
4384265|NCT00315328|4210788|B5|20/32 (73 to 77 letters) (worse)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384266|NCT00315328|4210789|B4|20/32 (73 to 77 letters) (worse)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384267|NCT00315328|4210790|B3|20/32 (73 to 77 letters) (worse)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384268|NCT00315328|4210791|B2|20/32 (73 to 77 letters) (worse)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384269|NCT00315328|4210792|B1|20/32 (73 to 77 letters) (worse)||Distance Visual Acuity in Fellow Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384270|NCT00315328|4210788|B5|20/40 (68 to 72 letters) (best)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|39|39.0||||||
4384271|NCT00315328|4210789|B4|20/40 (68 to 72 letters) (best)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384272|NCT00315328|4210790|B3|20/40 (68 to 72 letters) (best)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384273|NCT00315328|4210791|B2|20/40 (68 to 72 letters) (best)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|19|19.0||||||
4384358|NCT00315328|4210791|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4384274|NCT00315328|4210792|B1|20/40 (68 to 72 letters) (best)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|20|20.0||||||
4384275|NCT00315328|4210788|B5|20/50 (63 to 67 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|61|61.0||||||
4384276|NCT00315328|4210789|B4|20/50 (63 to 67 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384277|NCT00315328|4210790|B3|20/50 (63 to 67 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384278|NCT00315328|4210791|B2|20/50 (63 to 67 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|28|28.0||||||
4384279|NCT00315328|4210792|B1|20/50 (63 to 67 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|33|33.0||||||
4384280|NCT00315328|4210788|B5|20/63 (58 to 62 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|46|46.0||||||
4384281|NCT00315328|4210789|B4|20/63 (58 to 62 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384282|NCT00315328|4210790|B3|20/63 (58 to 62 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384283|NCT00315328|4210791|B2|20/63 (58 to 62 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|22|22.0||||||
4384284|NCT00315328|4210792|B1|20/63 (58 to 62 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|24|24.0||||||
4384285|NCT00315328|4210788|B5|20/80 (53 to 57 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|28|28.0||||||
4384286|NCT00315328|4210789|B4|20/80 (53 to 57 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384287|NCT00315328|4210790|B3|20/80 (53 to 57 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384288|NCT00315328|4210791|B2|20/80 (53 to 57 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|13|13.0||||||
4384289|NCT00315328|4210792|B1|20/80 (53 to 57 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|15|15.0||||||
4384290|NCT00315328|4210788|B5|20/100 (48 to 52 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|19|19.0||||||
4384291|NCT00315328|4210789|B4|20/100 (48 to 52 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384292|NCT00315328|4210790|B3|20/100 (48 to 52 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384293|NCT00315328|4210791|B2|20/100 (48 to 52 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|13|13.0||||||
4384686|NCT00315146|4210911|B4||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4384294|NCT00315328|4210792|B1|20/100 (48 to 52 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|6|6.0||||||
4384295|NCT00315328|4210788|B5|20/125 (43 to 47 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|12|12.0||||||
4384296|NCT00315328|4210789|B4|20/125 (43 to 47 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|9|9.0||||||
4384297|NCT00315328|4210790|B3|20/125 (43 to 47 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|3|3.0||||||
4384298|NCT00315328|4210791|B2|20/125 (43 to 47 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384299|NCT00315328|4210792|B1|20/125 (43 to 47 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384300|NCT00315328|4210788|B5|20/160 (38 to 42 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|9|9.0||||||
4384301|NCT00315328|4210789|B4|20/160 (38 to 42 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|4|4.0||||||
4384302|NCT00315328|4210790|B3|20/160 (38 to 42 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|5|5.0||||||
4384303|NCT00315328|4210791|B2|20/160 (38 to 42 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384304|NCT00315328|4210792|B1|20/160 (38 to 42 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384305|NCT00315328|4210788|B5|20/200 (33 to 37 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|11|11.0||||||
4384306|NCT00315328|4210789|B4|20/200 (33 to 37 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|3|3.0||||||
4384307|NCT00315328|4210790|B3|20/200 (33 to 37 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|8|8.0||||||
4384308|NCT00315328|4210791|B2|20/200 (33 to 37 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384309|NCT00315328|4210792|B1|20/200 (33 to 37 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384310|NCT00315328|4210788|B5|20/250 (28 to 32 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|6|6.0||||||
4384311|NCT00315328|4210789|B4|20/250 (28 to 32 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|4|4.0||||||
4384312|NCT00315328|4210790|B3|20/250 (28 to 32 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|2|2.0||||||
4384313|NCT00315328|4210791|B2|20/250 (28 to 32 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384687|NCT00315146|4210912|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4384314|NCT00315328|4210792|B1|20/250 (28 to 32 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384315|NCT00315328|4210788|B5|20/320 (23 to 27 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|1|1.0||||||
4384316|NCT00315328|4210789|B4|20/320 (23 to 27 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|1|1.0||||||
4384317|NCT00315328|4210790|B3|20/320 (23 to 27 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384318|NCT00315328|4210791|B2|20/320 (23 to 27 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384319|NCT00315328|4210792|B1|20/320 (23 to 27 letters)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384320|NCT00315328|4210788|B5|20/400 (18 to 22 letters) (worse)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|1|1.0||||||
4384321|NCT00315328|4210789|B4|20/400 (18 to 22 letters) (worse)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|1|1.0||||||
4384322|NCT00315328|4210790|B3|20/400 (18 to 22 letters) (worse)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384323|NCT00315328|4210791|B2|20/400 (18 to 22 letters) (worse)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384324|NCT00315328|4210792|B1|20/400 (18 to 22 letters) (worse)||Distance Visual Acuity in Amblyopic Eye|Visual acuity was measured in each eye using the electronic early treatment diabetic retinopathy study (E-ETDRS) method which resulted in a letter score that could range from 0 to 97 letters, with 0 being the worst and 97 being the best.|participants|Number|0|0.0||||||
4384325|NCT00315328|4210788|B5|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|72|72.0||||||
4384326|NCT00315328|4210789|B4|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|9|9.0||||||
4384327|NCT00315328|4210790|B3|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|8|8.0||||||
4384328|NCT00315328|4210791|B2|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|31|31.0||||||
4384329|NCT00315328|4210792|B1|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|24|24.0||||||
4384330|NCT00315328|4210788|B5|Anisometropia||Cause of Amblyopia||participants|Number|92|92.0||||||
4384331|NCT00315328|4210789|B4|Anisometropia||Cause of Amblyopia||participants|Number|9|9.0||||||
4384332|NCT00315328|4210790|B3|Anisometropia||Cause of Amblyopia||participants|Number|6|6.0||||||
4384333|NCT00315328|4210791|B2|Anisometropia||Cause of Amblyopia||participants|Number|31|31.0||||||
4384334|NCT00315328|4210792|B1|Anisometropia||Cause of Amblyopia||participants|Number|46|46.0||||||
4384335|NCT00315328|4210788|B5|Strabismus||Cause of Amblyopia||participants|Number|69|69.0||||||
4384336|NCT00315328|4210789|B4|Strabismus||Cause of Amblyopia||participants|Number|4|4.0||||||
4384337|NCT00315328|4210790|B3|Strabismus||Cause of Amblyopia||participants|Number|4|4.0||||||
4384338|NCT00315328|4210791|B2|Strabismus||Cause of Amblyopia||participants|Number|33|33.0||||||
4384339|NCT00315328|4210792|B1|Strabismus||Cause of Amblyopia||participants|Number|28|28.0||||||
4384340|NCT00315328|4210788|B5|Not reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4384341|NCT00315328|4210789|B4|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4384342|NCT00315328|4210790|B3|Not reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4384343|NCT00315328|4210791|B2|Not reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4384344|NCT00315328|4210792|B1|Not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4384345|NCT00315328|4210788|B5|More than one race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4384346|NCT00315328|4210789|B4|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4384347|NCT00315328|4210790|B3|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4384348|NCT00315328|4210791|B2|More than one race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4384349|NCT00315328|4210792|B1|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4384350|NCT00315328|4210788|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4384351|NCT00315328|4210789|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4384352|NCT00315328|4210790|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4384359|NCT00315328|4210792|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4384360|NCT00315328|4210788|B5|African-American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4384361|NCT00315328|4210789|B4|African-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4384362|NCT00315328|4210790|B3|African-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4384363|NCT00315328|4210791|B2|African-American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4384364|NCT00315328|4210792|B1|African-American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4384365|NCT00315328|4210788|B5|White||Race/Ethnicity, Customized||participants|Number|158|158.0||||||
4384366|NCT00315328|4210789|B4|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4384367|NCT00315328|4210790|B3|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4384368|NCT00315328|4210791|B2|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4384369|NCT00315328|4210792|B1|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4384370|NCT00315328|4210788|B5||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4384371|NCT00315328|4210789|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4384372|NCT00315328|4210790|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4384373|NCT00315328|4210791|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4384374|NCT00315328|4210792|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4384375|NCT00315328|4210788|B5||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4384376|NCT00315328|4210789|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4384377|NCT00315328|4210790|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4384378|NCT00315328|4210791|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4384379|NCT00315328|4210792|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4384380|NCT00315328|4210788|B5|12 to <13 years||Age, Customized|Age at enrollment|participants|Number|18|18.0||||||
4384381|NCT00315328|4210789|B4|12 to <13 years||Age, Customized|Age at enrollment|participants|Number|3|3.0||||||
4384382|NCT00315328|4210790|B3|12 to <13 years||Age, Customized|Age at enrollment|participants|Number|1|1.0||||||
4384383|NCT00315328|4210791|B2|12 to <13 years||Age, Customized|Age at enrollment|participants|Number|8|8.0||||||
4384384|NCT00315328|4210792|B1|12 to <13 years||Age, Customized|Age at enrollment|participants|Number|6|6.0||||||
4384385|NCT00315328|4210788|B5|11 to <12 years||Age, Customized|Age at enrollment|participants|Number|18|18.0||||||
4384386|NCT00315328|4210789|B4|11 to <12 years||Age, Customized|Age at enrollment|participants|Number|1|1.0||||||
4384387|NCT00315328|4210790|B3|11 to <12 years||Age, Customized|Age at enrollment|participants|Number|2|2.0||||||
4384388|NCT00315328|4210791|B2|11 to <12 years||Age, Customized|Age at enrollment|participants|Number|7|7.0||||||
4384389|NCT00315328|4210792|B1|11 to <12 years||Age, Customized|Age at enrollment|participants|Number|8|8.0||||||
4384390|NCT00315328|4210788|B5|10 to <11 years||Age, Customized|Age at enrollment|participants|Number|24|24.0||||||
4384391|NCT00315328|4210789|B4|10 to <11 years||Age, Customized|Age at enrollment|participants|Number|2|2.0||||||
4384392|NCT00315328|4210790|B3|10 to <11 years||Age, Customized|Age at enrollment|participants|Number|4|4.0||||||
4384393|NCT00315328|4210791|B2|10 to <11 years||Age, Customized|Age at enrollment|participants|Number|10|10.0||||||
4384394|NCT00315328|4210792|B1|10 to <11 years||Age, Customized|Age at enrollment|participants|Number|8|8.0||||||
4384395|NCT00315328|4210788|B5|9 to <10 years||Age, Customized|Age at enrollment|participants|Number|41|41.0||||||
4384396|NCT00315328|4210789|B4|9 to <10 years||Age, Customized|Age at enrollment|participants|Number|3|3.0||||||
4384397|NCT00315328|4210790|B3|9 to <10 years||Age, Customized|Age at enrollment|participants|Number|5|5.0||||||
4384398|NCT00315328|4210791|B2|9 to <10 years||Age, Customized|Age at enrollment|participants|Number|16|16.0||||||
4384399|NCT00315328|4210792|B1|9 to <10 years||Age, Customized|Age at enrollment|participants|Number|17|17.0||||||
4384400|NCT00315328|4210788|B5|8 to <9 years||Age, Customized|Age at enrollment|participants|Number|54|54.0||||||
4384401|NCT00315328|4210789|B4|8 to <9 years||Age, Customized|Age at enrollment|participants|Number|4|4.0||||||
4384402|NCT00315328|4210790|B3|8 to <9 years||Age, Customized|Age at enrollment|participants|Number|0|0.0||||||
4384403|NCT00315328|4210791|B2|8 to <9 years||Age, Customized|Age at enrollment|participants|Number|26|26.0||||||
4384404|NCT00315328|4210792|B1|8 to <9 years||Age, Customized|Age at enrollment|participants|Number|24|24.0||||||
4384405|NCT00315328|4210788|B5|7 to <8 years||Age, Customized|Age at enrollment|participants|Number|78|78.0||||||
4384406|NCT00315328|4210789|B4|7 to <8 years||Age, Customized|Age at enrollment|participants|Number|9|9.0||||||
4384407|NCT00315328|4210790|B3|7 to <8 years||Age, Customized|Age at enrollment|participants|Number|6|6.0||||||
4384408|NCT00315328|4210791|B2|7 to <8 years||Age, Customized|Age at enrollment|participants|Number|28|28.0||||||
4384409|NCT00315328|4210792|B1|7 to <8 years||Age, Customized|Age at enrollment|participants|Number|35|35.0||||||
4384410|NCT00315328|4210788|B5|||Age|Age at enrollment|years|Mean|9.0|9.0|Standard Deviation|1.6|1.6|||
4384411|NCT00315328|4210789|B4|||Age|Age at enrollment|years|Mean|9.2|9.2|Standard Deviation|1.8|1.8|||
4384412|NCT00315328|4210790|B3|||Age|Age at enrollment|years|Mean|9.5|9.5|Standard Deviation|1.5|1.5|||
4384413|NCT00315328|4210791|B2|||Age|Age at enrollment|years|Mean|9.1|9.1|Standard Deviation|1.6|1.6|||
4384414|NCT00315328|4210792|B1|||Age|Age at enrollment|years|Mean|8.9|8.9|Standard Deviation|1.5|1.5|||
4384415|NCT00315302|4210861|B5|||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopters|Mean|3.63|3.63|Standard Deviation|1.79|1.79|||
4384688|NCT00315146|4210913|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4384416|NCT00315302|4210862|B4|||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopters|Mean|3.71|3.71|Standard Deviation|1.58|1.58|||
4384417|NCT00315302|4210863|B3|||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopters|Mean|3.60|3.6|Standard Deviation|2.18|2.18|||
4384418|NCT00315302|4210864|B2|||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopters|Mean|3.54|3.54|Standard Deviation|1.86|1.86|||
4384419|NCT00315302|4210865|B1|||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopters|Mean|3.71|3.71|Standard Deviation|1.71|1.71|||
4384420|NCT00315302|4210861|B5|||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopters|Mean|5.05|5.05|Standard Deviation|1.72|1.72|||
4384421|NCT00315302|4210862|B4|||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopters|Mean|5.36|5.36|Standard Deviation|1.29|1.29|||
4384422|NCT00315302|4210863|B3|||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopters|Mean|5.25|5.25|Standard Deviation|2.09|2.09|||
4384423|NCT00315302|4210864|B2|||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopters|Mean|4.94|4.94|Standard Deviation|1.81|1.81|||
4384424|NCT00315302|4210865|B1|||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|diopters|Mean|4.99|4.99|Standard Deviation|1.66|1.66|||
4384425|NCT00315302|4210861|B5|||Intereye Acuity Difference|Intereye difference defined as the difference between logMAR scores (amblyopic eye minus sound eye)|logMAR lines|Mean|5.2|5.2|Standard Deviation|2.4|2.4|||
4384426|NCT00315302|4210862|B4|||Intereye Acuity Difference|Intereye difference defined as the difference between logMAR scores (amblyopic eye minus sound eye)|logMAR lines|Mean|8.6|8.6|Standard Deviation|2.2|2.2|||
4384427|NCT00315302|4210863|B3|||Intereye Acuity Difference|Intereye difference defined as the difference between logMAR scores (amblyopic eye minus sound eye)|logMAR lines|Mean|8.3|8.3|Standard Deviation|1.7|1.7|||
4384428|NCT00315302|4210864|B2|||Intereye Acuity Difference|Intereye difference defined as the difference between logMAR scores (amblyopic eye minus sound eye)|logMAR lines|Mean|4.3|4.3|Standard Deviation|1.3|1.3|||
4384429|NCT00315302|4210865|B1|||Intereye Acuity Difference|Intereye difference defined as the difference between logMAR scores (amblyopic eye minus sound eye)|logMAR lines|Mean|4.0|4.0|Standard Deviation|1.2|1.2|||
4384430|NCT00315302|4210861|B5|||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|log of min angle of resolution (logMAR)|Mean|.09|0.09|Standard Deviation|.11|0.11|||
4384431|NCT00315302|4210862|B4|||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|log of min angle of resolution (logMAR)|Mean|0.15|0.15|Standard Deviation|0.11|0.11|||
4384432|NCT00315302|4210863|B3|||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|log of min angle of resolution (logMAR)|Mean|0.16|0.16|Standard Deviation|0.09|0.09|||
4384433|NCT00315302|4210864|B2|||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|log of min angle of resolution (logMAR)|Mean|0.07|0.07|Standard Deviation|0.10|0.1|||
4384434|NCT00315302|4210865|B1|||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|log of min angle of resolution (logMAR)|Mean|0.07|0.07|Standard Deviation|0.10|0.1|||
4384620|NCT00315302|4210861|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4384435|NCT00315302|4210861|B5|||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|log of min angle of resolution (logMAR)|Mean|0.61|0.61|Standard Deviation|0.27|0.27|||
4384436|NCT00315302|4210862|B4|||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|log of min angle of resolution (logMAR)|Mean|1.01|1.01|Standard Deviation|0.20|0.2|||
4384437|NCT00315302|4210863|B3|||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|log of min angle of resolution (logMAR)|Mean|0.99|0.99|Standard Deviation|0.16|0.16|||
4384438|NCT00315302|4210864|B2|||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|log of min angle of resolution (logMAR)|Mean|0.50|0.5|Standard Deviation|0.13|0.13|||
4384439|NCT00315302|4210865|B1|||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|log of min angle of resolution (logMAR)|Mean|0.47|0.47|Standard Deviation|0.12|0.12|||
4384440|NCT00315302|4210861|B5|>= + 4.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|100|100.0||||||
4384441|NCT00315302|4210862|B4|>= + 4.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|15|15.0||||||
4384442|NCT00315302|4210863|B3|>= + 4.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|10|10.0||||||
4384443|NCT00315302|4210864|B2|>= + 4.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|36|36.0||||||
4384444|NCT00315302|4210865|B1|>= + 4.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|39|39.0||||||
4384445|NCT00315302|4210861|B5|+3.00 D to < + 4.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|42|42.0||||||
4384446|NCT00315302|4210862|B4|+3.00 D to < + 4.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|8|8.0||||||
4384447|NCT00315302|4210863|B3|+3.00 D to < + 4.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|2|2.0||||||
4384448|NCT00315302|4210864|B2|+3.00 D to < + 4.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|12|12.0||||||
4384449|NCT00315302|4210865|B1|+3.00 D to < + 4.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|20|20.0||||||
4384450|NCT00315302|4210861|B5|+ 2.00 D to < + 3.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|46|46.0||||||
4384451|NCT00315302|4210862|B4|+ 2.00 D to < + 3.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|5|5.0||||||
4384452|NCT00315302|4210863|B3|+ 2.00 D to < + 3.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|8|8.0||||||
4384621|NCT00315302|4210862|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4384453|NCT00315302|4210864|B2|+ 2.00 D to < + 3.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|19|19.0||||||
4384454|NCT00315302|4210865|B1|+ 2.00 D to < + 3.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|14|14.0||||||
4384455|NCT00315302|4210861|B5|+ 1.50 to < + 2.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|52|52.0||||||
4384456|NCT00315302|4210862|B4|+ 1.50 to < + 2.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|6|6.0||||||
4384457|NCT00315302|4210863|B3|+ 1.50 to < + 2.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|6|6.0||||||
4384458|NCT00315302|4210864|B2|+ 1.50 to < + 2.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|23|23.0||||||
4384459|NCT00315302|4210865|B1|+ 1.50 to < + 2.00 D||Refractive Error in Sound Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|17|17.0||||||
4384460|NCT00315302|4210861|B5|>= +4.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|180|180.0||||||
4384461|NCT00315302|4210862|B4|>= +4.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|30|30.0||||||
4384462|NCT00315302|4210863|B3|>= +4.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|19|19.0||||||
4384463|NCT00315302|4210864|B2|>= +4.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|63|63.0||||||
4384464|NCT00315302|4210865|B1|>= +4.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|68|68.0||||||
4384465|NCT00315302|4210861|B5|+3.00 D to < +4.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|35|35.0||||||
4384466|NCT00315302|4210862|B4|+3.00 D to < +4.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|4|4.0||||||
4384467|NCT00315302|4210863|B3|+3.00 D to < +4.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|3|3.0||||||
4384468|NCT00315302|4210864|B2|+3.00 D to < +4.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|15|15.0||||||
4384469|NCT00315302|4210865|B1|+3.00 D to < +4.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|13|13.0||||||
4384470|NCT00315302|4210861|B5|+2.00 D to < +3.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|17|17.0||||||
4384471|NCT00315302|4210862|B4|+2.00 D to < +3.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|0|0.0||||||
4384472|NCT00315302|4210863|B3|+2.00 D to < +3.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|3|3.0||||||
4384473|NCT00315302|4210864|B2|+2.00 D to < +3.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|6|6.0||||||
4384474|NCT00315302|4210865|B1|+2.00 D to < +3.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|8|8.0||||||
4384475|NCT00315302|4210861|B5|+1.00 to < +2.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|7|7.0||||||
4384476|NCT00315302|4210862|B4|+1.00 to < +2.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|0|0.0||||||
4384622|NCT00315302|4210863|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4384477|NCT00315302|4210863|B3|+1.00 to < +2.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|1|1.0||||||
4384478|NCT00315302|4210864|B2|+1.00 to < +2.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|6|6.0||||||
4384479|NCT00315302|4210865|B1|+1.00 to < +2.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|0|0.0||||||
4384480|NCT00315302|4210861|B5|0 to < +1.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|1|1.0||||||
4384481|NCT00315302|4210862|B4|0 to < +1.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|0|0.0||||||
4384482|NCT00315302|4210863|B3|0 to < +1.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|0|0.0||||||
4384483|NCT00315302|4210864|B2|0 to < +1.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|0|0.0||||||
4384484|NCT00315302|4210865|B1|0 to < +1.00 D||Refractive Error in Amblyopic Eye (spherical equivalent/diopters)|Measured in diopters (D) using cycloplegic refraction sphere, cylinder, and axis. Spherical equivalent is defined as the sphere plus 1/2 the cylinder.|participants|Number|1|1.0||||||
4384485|NCT00315302|4210861|B5|Patching and Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|9|9.0||||||
4384486|NCT00315302|4210862|B4|Patching and Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|0|0.0||||||
4384487|NCT00315302|4210863|B3|Patching and Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|1|1.0||||||
4384488|NCT00315302|4210864|B2|Patching and Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|4|4.0||||||
4384489|NCT00315302|4210865|B1|Patching and Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|4|4.0||||||
4384490|NCT00315302|4210861|B5|Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|3|3.0||||||
4384491|NCT00315302|4210862|B4|Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|0|0.0||||||
4384492|NCT00315302|4210863|B3|Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|0|0.0||||||
4384493|NCT00315302|4210864|B2|Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|2|2.0||||||
4384494|NCT00315302|4210865|B1|Atropine||Prior Treatment for Amblyopia at Enrollment||participants|Number|1|1.0||||||
4384495|NCT00315302|4210861|B5|Patching||Prior Treatment for Amblyopia at Enrollment||participants|Number|28|28.0||||||
4384496|NCT00315302|4210862|B4|Patching||Prior Treatment for Amblyopia at Enrollment||participants|Number|6|6.0||||||
4384497|NCT00315302|4210863|B3|Patching||Prior Treatment for Amblyopia at Enrollment||participants|Number|1|1.0||||||
4384498|NCT00315302|4210864|B2|Patching||Prior Treatment for Amblyopia at Enrollment||participants|Number|12|12.0||||||
4384499|NCT00315302|4210865|B1|Patching||Prior Treatment for Amblyopia at Enrollment||participants|Number|9|9.0||||||
4384500|NCT00315302|4210861|B5|None||Prior Treatment for Amblyopia at Enrollment||participants|Number|200|200.0||||||
4384501|NCT00315302|4210862|B4|None||Prior Treatment for Amblyopia at Enrollment||participants|Number|28|28.0||||||
4384502|NCT00315302|4210863|B3|None||Prior Treatment for Amblyopia at Enrollment||participants|Number|24|24.0||||||
4384503|NCT00315302|4210864|B2|None||Prior Treatment for Amblyopia at Enrollment||participants|Number|72|72.0||||||
4384504|NCT00315302|4210865|B1|None||Prior Treatment for Amblyopia at Enrollment||participants|Number|76|76.0||||||
4384505|NCT00315302|4210861|B5|20/16 (better)||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|19|19.0||||||
4384506|NCT00315302|4210862|B4|20/16 (better)||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384507|NCT00315302|4210863|B3|20/16 (better)||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384623|NCT00315302|4210864|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4384624|NCT00315302|4210865|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4384625|NCT00315302|4210861|B5|African-American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4384508|NCT00315302|4210864|B2|20/16 (better)||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|8|8.0||||||
4384509|NCT00315302|4210865|B1|20/16 (better)||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|11|11.0||||||
4384510|NCT00315302|4210861|B5|20/20||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|75|75.0||||||
4384511|NCT00315302|4210862|B4|20/20||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|8|8.0||||||
4384512|NCT00315302|4210863|B3|20/20||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|3|3.0||||||
4384513|NCT00315302|4210864|B2|20/20||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|33|33.0||||||
4384514|NCT00315302|4210865|B1|20/20||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|31|31.0||||||
4384515|NCT00315302|4210861|B5|20/25||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|70|70.0||||||
4384516|NCT00315302|4210862|B4|20/25||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|7|7.0||||||
4384517|NCT00315302|4210863|B3|20/25||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|8|8.0||||||
4384518|NCT00315302|4210864|B2|20/25||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|28|28.0||||||
4384519|NCT00315302|4210865|B1|20/25||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|27|27.0||||||
4384520|NCT00315302|4210861|B5|20/32||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|59|59.0||||||
4384521|NCT00315302|4210862|B4|20/32||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|12|12.0||||||
4384522|NCT00315302|4210863|B3|20/32||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|11|11.0||||||
4384523|NCT00315302|4210864|B2|20/32||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|18|18.0||||||
4384524|NCT00315302|4210865|B1|20/32||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|18|18.0||||||
4384525|NCT00315302|4210861|B5|20/40 (worse)||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|17|17.0||||||
4384526|NCT00315302|4210862|B4|20/40 (worse)||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|7|7.0||||||
4384527|NCT00315302|4210863|B3|20/40 (worse)||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|4|4.0||||||
4384528|NCT00315302|4210864|B2|20/40 (worse)||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|3|3.0||||||
4384529|NCT00315302|4210865|B1|20/40 (worse)||Distance Visual Acuity in Sound Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|3|3.0||||||
4384530|NCT00315302|4210861|B5|20/40 (better)||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|31|31.0||||||
4384542|NCT00315302|4210863|B3|20/63||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384531|NCT00315302|4210862|B4|20/40 (better)||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384532|NCT00315302|4210863|B3|20/40 (better)||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384533|NCT00315302|4210864|B2|20/40 (better)||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|15|15.0||||||
4384534|NCT00315302|4210865|B1|20/40 (better)||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|16|16.0||||||
4384535|NCT00315302|4210861|B5|20/50||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|41|41.0||||||
4384536|NCT00315302|4210862|B4|20/50||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384537|NCT00315302|4210863|B3|20/50||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384538|NCT00315302|4210864|B2|20/50||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|17|17.0||||||
4384539|NCT00315302|4210865|B1|20/50||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|24|24.0||||||
4384540|NCT00315302|4210861|B5|20/63||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|57|57.0||||||
4384541|NCT00315302|4210862|B4|20/63||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384600|NCT00315302|4210861|B5|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4384601|NCT00315302|4210862|B4|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4384602|NCT00315302|4210863|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4384603|NCT00315302|4210864|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4384604|NCT00315302|4210865|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4384543|NCT00315302|4210864|B2|20/63||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|28|28.0||||||
4384544|NCT00315302|4210865|B1|20/63||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|29|29.0||||||
4384545|NCT00315302|4210861|B5|20/80||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|29|29.0||||||
4384546|NCT00315302|4210862|B4|20/80||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384547|NCT00315302|4210863|B3|20/80||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384548|NCT00315302|4210864|B2|20/80||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|15|15.0||||||
4384549|NCT00315302|4210865|B1|20/80||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|14|14.0||||||
4384550|NCT00315302|4210861|B5|20/100||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|22|22.0||||||
4384551|NCT00315302|4210862|B4|20/100||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384552|NCT00315302|4210863|B3|20/100||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384553|NCT00315302|4210864|B2|20/100||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|15|15.0||||||
4384605|NCT00315302|4210861|B5|United States||Region of Enrollment||participants|Number|239|239.0||||||
4384606|NCT00315302|4210862|B4|United States||Region of Enrollment||participants|Number|34|34.0||||||
4384607|NCT00315302|4210863|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4384608|NCT00315302|4210864|B2|United States||Region of Enrollment||participants|Number|90|90.0||||||
4384609|NCT00315302|4210865|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
4384554|NCT00315302|4210865|B1|20/100||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|7|7.0||||||
4384555|NCT00315302|4210861|B5|20/125||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|18|18.0||||||
4384556|NCT00315302|4210862|B4|20/125||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|11|11.0||||||
4384557|NCT00315302|4210863|B3|20/125||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|7|7.0||||||
4384558|NCT00315302|4210864|B2|20/125||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384559|NCT00315302|4210865|B1|20/125||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384560|NCT00315302|4210861|B5|20/160||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|10|10.0||||||
4384561|NCT00315302|4210862|B4|20/160||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|5|5.0||||||
4384562|NCT00315302|4210863|B3|20/160||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|5|5.0||||||
4384563|NCT00315302|4210864|B2|20/160||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384564|NCT00315302|4210865|B1|20/160||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384610|NCT00315302|4210861|B5|Unknown / Not reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4384611|NCT00315302|4210862|B4|Unknown / Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4384612|NCT00315302|4210863|B3|Unknown / Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4384613|NCT00315302|4210864|B2|Unknown / Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4384565|NCT00315302|4210861|B5|20/200||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|10|10.0||||||
4384566|NCT00315302|4210862|B4|20/200||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|5|5.0||||||
4384567|NCT00315302|4210863|B3|20/200||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|5|5.0||||||
4384568|NCT00315302|4210864|B2|20/200||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384569|NCT00315302|4210865|B1|20/200||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384570|NCT00315302|4210861|B5|20/250||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|4|4.0||||||
4384571|NCT00315302|4210862|B4|20/250||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|3|3.0||||||
4384572|NCT00315302|4210863|B3|20/250||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|1|1.0||||||
4384573|NCT00315302|4210864|B2|20/250||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384574|NCT00315302|4210865|B1|20/250||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384575|NCT00315302|4210861|B5|20/320||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|10|10.0||||||
4384614|NCT00315302|4210865|B1|Unknown / Not reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4384615|NCT00315302|4210861|B5|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4384616|NCT00315302|4210862|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4384617|NCT00315302|4210863|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4384618|NCT00315302|4210864|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4384576|NCT00315302|4210862|B4|20/320||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|2|2.0||||||
4384577|NCT00315302|4210863|B3|20/320||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|8|8.0||||||
4384578|NCT00315302|4210864|B2|20/320||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384579|NCT00315302|4210865|B1|20/320||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384580|NCT00315302|4210861|B5|20/400 (worse)||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|8|8.0||||||
4384581|NCT00315302|4210862|B4|20/400 (worse)||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|8|8.0||||||
4384582|NCT00315302|4210863|B3|20/400 (worse)||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384583|NCT00315302|4210864|B2|20/400 (worse)||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384584|NCT00315302|4210865|B1|20/400 (worse)||Distance Visual Acuity in Amblyopic Eye|"Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis.~20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst"|participants|Number|0|0.0||||||
4384585|NCT00315302|4210861|B5|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|69|69.0||||||
4384586|NCT00315302|4210862|B4|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|15|15.0||||||
4384587|NCT00315302|4210863|B3|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|11|11.0||||||
4384588|NCT00315302|4210864|B2|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|23|23.0||||||
4384589|NCT00315302|4210865|B1|Strabismus and anisometropia||Cause of Amblyopia||participants|Number|20|20.0||||||
4384590|NCT00315302|4210861|B5|Anisometropia||Cause of Amblyopia||participants|Number|75|75.0||||||
4384591|NCT00315302|4210862|B4|Anisometropia||Cause of Amblyopia||participants|Number|8|8.0||||||
4384592|NCT00315302|4210863|B3|Anisometropia||Cause of Amblyopia||participants|Number|5|5.0||||||
4384593|NCT00315302|4210864|B2|Anisometropia||Cause of Amblyopia||participants|Number|30|30.0||||||
4384594|NCT00315302|4210865|B1|Anisometropia||Cause of Amblyopia||participants|Number|32|32.0||||||
4384595|NCT00315302|4210861|B5|Strabismus||Cause of Amblyopia||participants|Number|96|96.0||||||
4384596|NCT00315302|4210862|B4|Strabismus||Cause of Amblyopia||participants|Number|11|11.0||||||
4384597|NCT00315302|4210863|B3|Strabismus||Cause of Amblyopia||participants|Number|10|10.0||||||
4384598|NCT00315302|4210864|B2|Strabismus||Cause of Amblyopia||participants|Number|37|37.0||||||
4384599|NCT00315302|4210865|B1|Strabismus||Cause of Amblyopia||participants|Number|38|38.0||||||
4384626|NCT00315302|4210862|B4|African-American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4384627|NCT00315302|4210863|B3|African-American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4384628|NCT00315302|4210864|B2|African-American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4384629|NCT00315302|4210865|B1|African-American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4384630|NCT00315302|4210861|B5|White||Race/Ethnicity, Customized||Participants|Number|196|196.0||||||
4384631|NCT00315302|4210862|B4|White||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4384632|NCT00315302|4210863|B3|White||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4384633|NCT00315302|4210864|B2|White||Race/Ethnicity, Customized||Participants|Number|70|70.0||||||
4384634|NCT00315302|4210865|B1|White||Race/Ethnicity, Customized||Participants|Number|75|75.0||||||
4384635|NCT00315302|4210861|B5||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4384636|NCT00315302|4210862|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4384637|NCT00315302|4210863|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4384638|NCT00315302|4210864|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4384639|NCT00315302|4210865|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4384640|NCT00315302|4210861|B5||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4384641|NCT00315302|4210862|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4384642|NCT00315302|4210863|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4384643|NCT00315302|4210864|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4384644|NCT00315302|4210865|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4384645|NCT00315302|4210861|B5|||Age|Age at enrollment|years|Mean|5.0|5.0|Standard Deviation|1.1|1.1|||
4384646|NCT00315302|4210862|B4|||Age|Age at enrollment|years|Mean|4.4|4.4|Standard Deviation|1.0|1.0|||
4384647|NCT00315302|4210863|B3|||Age|Age at enrollment|years|Mean|4.5|4.5|Standard Deviation|0.9|0.9|||
4384648|NCT00315302|4210864|B2|||Age|Age at enrollment|years|Mean|5.1|5.1|Standard Deviation|1.0|1.0|||
4384649|NCT00315302|4210865|B1|||Age|Age at enrollment|years|Mean|5.2|5.2|Standard Deviation|1.1|1.1|||
4384650|NCT00315302|4210861|B5||>=65 years|Age|Age at enrollment|Participants|Count of Participants|0|0.0||||||
4384651|NCT00315302|4210862|B4||>=65 years|Age|Age at enrollment|Participants|Count of Participants|0|0.0||||||
4384652|NCT00315302|4210863|B3||>=65 years|Age|Age at enrollment|Participants|Count of Participants|0|0.0||||||
4384653|NCT00315302|4210864|B2||>=65 years|Age|Age at enrollment|Participants|Count of Participants|0|0.0||||||
4384654|NCT00315302|4210865|B1||>=65 years|Age|Age at enrollment|Participants|Count of Participants|0|0.0||||||
4384655|NCT00315302|4210861|B5||Between 18 and 65 years|Age|Age at enrollment|Participants|Count of Participants|0|0.0||||||
4384656|NCT00315302|4210862|B4||Between 18 and 65 years|Age|Age at enrollment|Participants|Count of Participants|0|0.0||||||
4384657|NCT00315302|4210863|B3||Between 18 and 65 years|Age|Age at enrollment|Participants|Count of Participants|0|0.0||||||
4384658|NCT00315302|4210864|B2||Between 18 and 65 years|Age|Age at enrollment|Participants|Count of Participants|0|0.0||||||
4384659|NCT00315302|4210865|B1||Between 18 and 65 years|Age|Age at enrollment|Participants|Count of Participants|0|0.0||||||
4384660|NCT00315302|4210861|B5||<=18 years|Age|Age at enrollment|Participants|Count of Participants|240|240.0||||||
4384661|NCT00315302|4210862|B4||<=18 years|Age|Age at enrollment|Participants|Count of Participants|34|34.0||||||
4384662|NCT00315302|4210863|B3||<=18 years|Age|Age at enrollment|Participants|Count of Participants|26|26.0||||||
4384663|NCT00315302|4210864|B2||<=18 years|Age|Age at enrollment|Participants|Count of Participants|90|90.0||||||
4384664|NCT00315302|4210865|B1||<=18 years|Age|Age at enrollment|Participants|Count of Participants|90|90.0||||||
4384665|NCT00315146|4210910|B5|United States||Region of Enrollment||participants|Number|88|88.0||||||
4384666|NCT00315146|4210911|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
4384667|NCT00315146|4210912|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4384668|NCT00315146|4210913|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4384669|NCT00315146|4210914|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4384670|NCT00315146|4210910|B5||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4384671|NCT00315146|4210911|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4384672|NCT00315146|4210912|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4384673|NCT00315146|4210913|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4384674|NCT00315146|4210914|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4384675|NCT00315146|4210910|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4384676|NCT00315146|4210911|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4384677|NCT00315146|4210912|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4384678|NCT00315146|4210913|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4384679|NCT00315146|4210914|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4384680|NCT00315146|4210910|B5|||Age||years|Mean|70.6|70.6|Standard Deviation|3.6|3.6|||
4384681|NCT00315146|4210911|B4|||Age||years|Mean|69.9|69.9|Standard Deviation|2.7|2.7|||
4384682|NCT00315146|4210912|B3|||Age||years|Mean|71.0|71.0|Standard Deviation|4.3|4.3|||
4384683|NCT00315146|4210913|B2|||Age||years|Mean|70.4|70.4|Standard Deviation|3.5|3.5|||
4384684|NCT00315146|4210914|B1|||Age||years|Mean|71.0|71.0|Standard Deviation|3.9|3.9|||
4384685|NCT00315146|4210910|B5||>=65 years|Age||Participants|Count of Participants|88|88.0||||||
4384689|NCT00315146|4210914|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4384690|NCT00315146|4210910|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4384691|NCT00315146|4210911|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4384692|NCT00315146|4210912|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4384693|NCT00315146|4210913|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4384694|NCT00315146|4210914|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4384695|NCT00315146|4210910|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384696|NCT00315146|4210911|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384697|NCT00315146|4210912|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384698|NCT00315146|4210913|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384699|NCT00315146|4210914|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384700|NCT00315120|4210931|B5|United States||Region of Enrollment||participants|Number|455|455.0||||||
4384701|NCT00315120|4210932|B4|United States||Region of Enrollment||participants|Number|107|107.0||||||
4384702|NCT00315120|4210933|B3|United States||Region of Enrollment||participants|Number|115|115.0||||||
4384703|NCT00315120|4210934|B2|United States||Region of Enrollment||participants|Number|118|118.0||||||
4384704|NCT00315120|4210935|B1|United States||Region of Enrollment||participants|Number|115|115.0||||||
4384705|NCT00315120|4210931|B5||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4384706|NCT00315120|4210932|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4384707|NCT00315120|4210933|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4384708|NCT00315120|4210934|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4384709|NCT00315120|4210935|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4384710|NCT00315120|4210931|B5||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4384711|NCT00315120|4210932|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4384712|NCT00315120|4210933|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4384713|NCT00315120|4210934|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4384714|NCT00315120|4210935|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4384715|NCT00315120|4210931|B5|||Age||years|Mean|40.74|40.74|Standard Deviation|12.63|12.63|||
4384716|NCT00315120|4210932|B4|||Age||years|Mean|41.38|41.38|Standard Deviation|12.99|12.99|||
4384717|NCT00315120|4210933|B3|||Age||years|Mean|41.97|41.97|Standard Deviation|12.58|12.58|||
4384718|NCT00315120|4210934|B2|||Age||years|Mean|39.19|39.19|Standard Deviation|11.90|11.9|||
4384719|NCT00315120|4210935|B1|||Age||years|Mean|40.50|40.5|Standard Deviation|13.05|13.05|||
4384720|NCT00315120|4210931|B5||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4384721|NCT00315120|4210932|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4384722|NCT00315120|4210933|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4384723|NCT00315120|4210934|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4384724|NCT00315120|4210935|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4384725|NCT00315120|4210931|B5||Between 18 and 65 years|Age||Participants|Count of Participants|445|445.0||||||
4384726|NCT00315120|4210932|B4||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4384727|NCT00315120|4210933|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4384728|NCT00315120|4210934|B2||Between 18 and 65 years|Age||Participants|Count of Participants|117|117.0||||||
4384729|NCT00315120|4210935|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4384730|NCT00315120|4210931|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384731|NCT00315120|4210932|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384732|NCT00315120|4210933|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384733|NCT00315120|4210934|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384734|NCT00315120|4210935|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384735|NCT00315055|4210996|B3|Turkey||Region of Enrollment||Participants|Number|310|310.0||||||
4384736|NCT00315055|4210997|B2|Turkey||Region of Enrollment||Participants|Number|155|155.0||||||
4384737|NCT00315055|4210998|B1|Turkey||Region of Enrollment||Participants|Number|155|155.0||||||
4384738|NCT00315055|4210996|B3||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4384739|NCT00315055|4210997|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4384740|NCT00315055|4210998|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4384741|NCT00315055|4210996|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4384742|NCT00315055|4210997|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4384743|NCT00315055|4210998|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4384744|NCT00315055|4210996|B3|||Age||Months|Mean|2.08|2.08|Standard Deviation|0.096|0.096|||
4384745|NCT00315055|4210997|B2|||Age||Months|Mean|2.08|2.08|Standard Deviation|0.102|0.102|||
4384746|NCT00315055|4210998|B1|||Age||Months|Mean|2.08|2.08|Standard Deviation|0.090|0.09|||
4384747|NCT00315055|4210996|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384748|NCT00315055|4210997|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384749|NCT00315055|4210998|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384750|NCT00315055|4210996|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4384751|NCT00315055|4210997|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4384752|NCT00315055|4210998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4384753|NCT00315055|4210996|B3||<=18 years|Age||Participants|Count of Participants|310|310.0||||||
4384754|NCT00315055|4210997|B2||<=18 years|Age||Participants|Count of Participants|155|155.0||||||
4384755|NCT00315055|4210998|B1||<=18 years|Age||Participants|Count of Participants|155|155.0||||||
4384756|NCT00314951|4211015|B3|Canada||Region of Enrollment||participants|Number|245|245.0||||||
4384757|NCT00314951|4211016|B2|Canada||Region of Enrollment||participants|Number|124|124.0||||||
4384758|NCT00314951|4211017|B1|Canada||Region of Enrollment||participants|Number|121|121.0||||||
4384759|NCT00314951|4211015|B3|United States||Region of Enrollment||participants|Number|351|351.0||||||
4384760|NCT00314951|4211016|B2|United States||Region of Enrollment||participants|Number|165|165.0||||||
4384761|NCT00314951|4211017|B1|United States||Region of Enrollment||participants|Number|186|186.0||||||
4384762|NCT00314951|4211015|B3||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4384763|NCT00314951|4211016|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4384764|NCT00314951|4211017|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4384765|NCT00314951|4211015|B3||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4384766|NCT00314951|4211016|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4384767|NCT00314951|4211017|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4384768|NCT00314951|4211015|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|16.9|16.9|||
4384769|NCT00314951|4211016|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|16.9|16.9|||
4384770|NCT00314951|4211017|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|16.9|16.9|||
4384771|NCT00314808|4211028|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4384772|NCT00314808|4211028|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4384773|NCT00314808|4211028|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|12.7|12.7|||
4384774|NCT00314574|4211036|B3||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4384775|NCT00314574|4211037|B2||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4384776|NCT00314574|4211038|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4384777|NCT00314574|4211036|B3||Female|Sex: Female, Male||Participants|Count of Participants|557|557.0||||||
4384778|NCT00314574|4211037|B2||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4384779|NCT00314574|4211038|B1||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4384780|NCT00314574|4211036|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|14.1|14.1|||
4384781|NCT00314574|4211037|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|14.3|14.3|||
4384782|NCT00314574|4211038|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|13.9|13.9|||
4384783|NCT00314574|4211036|B3||>=65 years|Age|All baseline measures were based on all randomized subjects who received at least one dose of study drug (the modified ITT population). The modified ITT population included 848 subjects (427 subjects in the Xolair group and 421 subjects in the placebo group).|Participants|Count of Participants|54|54.0||||||
4384784|NCT00314574|4211037|B2||>=65 years|Age|All baseline measures were based on all randomized subjects who received at least one dose of study drug (the modified ITT population). The modified ITT population included 848 subjects (427 subjects in the Xolair group and 421 subjects in the placebo group).|Participants|Count of Participants|25|25.0||||||
4384785|NCT00314574|4211038|B1||>=65 years|Age|All baseline measures were based on all randomized subjects who received at least one dose of study drug (the modified ITT population). The modified ITT population included 848 subjects (427 subjects in the Xolair group and 421 subjects in the placebo group).|Participants|Count of Participants|29|29.0||||||
4384786|NCT00314574|4211036|B3||Between 18 and 65 years|Age|All baseline measures were based on all randomized subjects who received at least one dose of study drug (the modified ITT population). The modified ITT population included 848 subjects (427 subjects in the Xolair group and 421 subjects in the placebo group).|Participants|Count of Participants|755|755.0||||||
4384787|NCT00314574|4211037|B2||Between 18 and 65 years|Age|All baseline measures were based on all randomized subjects who received at least one dose of study drug (the modified ITT population). The modified ITT population included 848 subjects (427 subjects in the Xolair group and 421 subjects in the placebo group).|Participants|Count of Participants|379|379.0||||||
4384788|NCT00314574|4211038|B1||Between 18 and 65 years|Age|All baseline measures were based on all randomized subjects who received at least one dose of study drug (the modified ITT population). The modified ITT population included 848 subjects (427 subjects in the Xolair group and 421 subjects in the placebo group).|Participants|Count of Participants|376|376.0||||||
4384789|NCT00314574|4211036|B3||<=18 years|Age|All baseline measures were based on all randomized subjects who received at least one dose of study drug (the modified ITT population). The modified ITT population included 848 subjects (427 subjects in the Xolair group and 421 subjects in the placebo group).|Participants|Count of Participants|39|39.0||||||
4384790|NCT00314574|4211037|B2||<=18 years|Age|All baseline measures were based on all randomized subjects who received at least one dose of study drug (the modified ITT population). The modified ITT population included 848 subjects (427 subjects in the Xolair group and 421 subjects in the placebo group).|Participants|Count of Participants|23|23.0||||||
4384791|NCT00314574|4211038|B1||<=18 years|Age|All baseline measures were based on all randomized subjects who received at least one dose of study drug (the modified ITT population). The modified ITT population included 848 subjects (427 subjects in the Xolair group and 421 subjects in the placebo group).|Participants|Count of Participants|16|16.0||||||
4384792|NCT00314366|4211053|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4384793|NCT00314366|4211054|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4384794|NCT00314366|4211055|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4384795|NCT00314366|4211053|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4384796|NCT00314366|4211054|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4384797|NCT00314366|4211055|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4384798|NCT00314366|4211053|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4384799|NCT00314366|4211054|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4384800|NCT00314366|4211055|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4384801|NCT00314366|4211053|B3|Age||Age||years|Mean|58.0|58.0|Standard Deviation|5.8|5.8|||
4384802|NCT00314366|4211054|B2|Age||Age||years|Mean|57.8|57.8|Standard Deviation|5.5|5.5|||
4384803|NCT00314366|4211055|B1|Age||Age||years|Mean|58.2|58.2|Standard Deviation|6.1|6.1|||
4384804|NCT00314366|4211053|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384805|NCT00314366|4211054|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384806|NCT00314366|4211055|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384807|NCT00314366|4211053|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4384808|NCT00314366|4211054|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4384809|NCT00314366|4211055|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4384810|NCT00314366|4211053|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384811|NCT00314366|4211054|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384812|NCT00314366|4211055|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384813|NCT00314353|4211084|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4384814|NCT00314353|4211085|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4384815|NCT00314353|4211086|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4384816|NCT00314353|4211084|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4384817|NCT00314353|4211085|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4384818|NCT00314353|4211086|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4384819|NCT00314353|4211084|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4384820|NCT00314353|4211085|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4384821|NCT00314353|4211086|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4384822|NCT00314353|4211084|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|10.1|10.1|||
4384823|NCT00314353|4211085|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|13.2|13.2|||
4384824|NCT00314353|4211086|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|9.0|9.0|||
4384825|NCT00314353|4211084|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4384826|NCT00314353|4211085|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4384827|NCT00314353|4211086|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4384828|NCT00314353|4211084|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4384829|NCT00314353|4211085|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4384830|NCT00314353|4211086|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4384831|NCT00314353|4211084|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384832|NCT00314353|4211085|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384833|NCT00314353|4211086|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384834|NCT00314340|4211101|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4384835|NCT00314340|4211101|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4384836|NCT00314340|4211101|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4384837|NCT00314340|4211101|B1|||Age||years|Mean|46|46.0|Standard Deviation|4|4.0|||
4384838|NCT00314340|4211101|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384839|NCT00314340|4211101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4384840|NCT00314340|4211101|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384841|NCT00314327|4211107|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4384842|NCT00314327|4211107|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4384843|NCT00314327|4211107|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4384844|NCT00314327|4211107|B1|||Age||years|Mean|19|19.0|Full Range|||||
4384845|NCT00314262|4211112|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4384846|NCT00314262|4211112|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4384847|NCT00314262|4211112|B1|80-89 years old||Age, Customized||participants|Number|1|1.0||||||
4384848|NCT00314262|4211112|B1|70-79 years old||Age, Customized||participants|Number|1|1.0||||||
4384849|NCT00314262|4211112|B1|60-69 years old||Age, Customized||participants|Number|4|4.0||||||
4384850|NCT00314262|4211112|B1|50-59 years old||Age, Customized||participants|Number|2|2.0||||||
4384851|NCT00314262|4211112|B1|40-49 years old||Age, Customized||participants|Number|4|4.0||||||
4384852|NCT00314249|4211118|B3|Canada||Region of Enrollment||participants|Number|93|93.0||||||
4384853|NCT00314249|4211119|B2|Canada||Region of Enrollment||participants|Number|47|47.0||||||
4384854|NCT00314249|4211120|B1|Canada||Region of Enrollment||participants|Number|46|46.0||||||
4384855|NCT00314249|4211118|B3|United States||Region of Enrollment||participants|Number|932|932.0||||||
4384856|NCT00314249|4211119|B2|United States||Region of Enrollment||participants|Number|469|469.0||||||
4384857|NCT00314249|4211120|B1|United States||Region of Enrollment||participants|Number|463|463.0||||||
4384858|NCT00314249|4211118|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4384859|NCT00314249|4211119|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4384860|NCT00314249|4211120|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4384861|NCT00314249|4211118|B3||Female|Sex: Female, Male||Participants|Count of Participants|977|977.0||||||
4384862|NCT00314249|4211119|B2||Female|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4384863|NCT00314249|4211120|B1||Female|Sex: Female, Male||Participants|Count of Participants|477|477.0||||||
4384864|NCT00314249|4211118|B3|>=60 years||Age, Customized||participants|Number|155|155.0||||||
4384865|NCT00314249|4211119|B2|>=60 years||Age, Customized||participants|Number|85|85.0||||||
4384866|NCT00314249|4211120|B1|>=60 years||Age, Customized||participants|Number|70|70.0||||||
4384867|NCT00314249|4211118|B3|Between 20 and 60 years||Age, Customized||participants|Number|866|866.0||||||
4384868|NCT00314249|4211119|B2|Between 20 and 60 years||Age, Customized||participants|Number|429|429.0||||||
4384869|NCT00314249|4211120|B1|Between 20 and 60 years||Age, Customized||participants|Number|437|437.0||||||
4384870|NCT00314249|4211118|B3|<=20 years||Age, Customized||participants|Number|4|4.0||||||
4384871|NCT00314249|4211119|B2|<=20 years||Age, Customized||participants|Number|2|2.0||||||
4384872|NCT00314249|4211120|B1|<=20 years||Age, Customized||participants|Number|2|2.0||||||
4384873|NCT00314249|4211118|B3|||Age||years|Mean|48.90|48.9|Standard Deviation|10.67|10.67|||
4384874|NCT00314249|4211119|B2|||Age||years|Mean|49.07|49.07|Standard Deviation|10.79|10.79|||
4384875|NCT00314249|4211120|B1|||Age||years|Mean|48.73|48.73|Standard Deviation|10.56|10.56|||
4384876|NCT00314236|4211137|B3|Korea, Republic of||Region of Enrollment||participants|Number|2|2.0||||||
4384877|NCT00314236|4211138|B2|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4384878|NCT00314236|4211139|B1|Korea, Republic of||Region of Enrollment||participants|Number|1|1.0||||||
4384879|NCT00314236|4211137|B3|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4384880|NCT00314236|4211138|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4384881|NCT00314236|4211139|B1|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4384882|NCT00314236|4211137|B3|Canada||Region of Enrollment||participants|Number|65|65.0||||||
4384883|NCT00314236|4211138|B2|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4384884|NCT00314236|4211139|B1|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4384885|NCT00314236|4211137|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4384886|NCT00314236|4211138|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4384887|NCT00314236|4211139|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4384888|NCT00314236|4211137|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4384889|NCT00314236|4211138|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4384890|NCT00314236|4211139|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4384891|NCT00314236|4211137|B3|||Age||years|Mean|36.1|36.1|Standard Deviation|10.1|10.1|||
4384892|NCT00314236|4211138|B2|||Age||years|Mean|37.2|37.2|Standard Deviation|10.6|10.6|||
4384893|NCT00314236|4211139|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|9.6|9.6|||
4384894|NCT00314236|4211137|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384895|NCT00314236|4211138|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384896|NCT00314236|4211139|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384897|NCT00314236|4211137|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4384898|NCT00314236|4211138|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4384899|NCT00314236|4211139|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4384900|NCT00314236|4211137|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384901|NCT00314236|4211138|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384902|NCT00314236|4211139|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384903|NCT00314145|4211152|B3|United States||Region of Enrollment||Participants|Number|497|497.0||||||
4384904|NCT00314145|4211153|B2|United States||Region of Enrollment||Participants|Number|290|290.0||||||
4384905|NCT00314145|4211154|B1|United States||Region of Enrollment||Participants|Number|207|207.0||||||
4384906|NCT00314145|4211152|B3|Australia||Region of Enrollment||Participants|Number|323|323.0||||||
4384907|NCT00314145|4211153|B2|Australia||Region of Enrollment||Participants|Number|120|120.0||||||
4384908|NCT00314145|4211154|B1|Australia||Region of Enrollment||Participants|Number|203|203.0||||||
4384909|NCT00314145|4211152|B3||Male|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4384910|NCT00314145|4211153|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4384911|NCT00314145|4211154|B1||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4384912|NCT00314145|4211152|B3||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4384913|NCT00314145|4211153|B2||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4384914|NCT00314145|4211154|B1||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4384915|NCT00314145|4211152|B3|||Age||Years|Mean|37.4|37.4|Standard Deviation|14.96|14.96|||
4384916|NCT00314145|4211153|B2|||Age||Years|Mean|37.7|37.7|Standard Deviation|15.11|15.11|||
4384917|NCT00314145|4211154|B1|||Age||Years|Mean|37.0|37.0|Standard Deviation|14.81|14.81|||
4384918|NCT00314145|4211152|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384919|NCT00314145|4211153|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384920|NCT00314145|4211154|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384921|NCT00314145|4211152|B3||Between 18 and 65 years|Age||Participants|Count of Participants|820|820.0||||||
4384922|NCT00314145|4211153|B2||Between 18 and 65 years|Age||Participants|Count of Participants|410|410.0||||||
4384923|NCT00314145|4211154|B1||Between 18 and 65 years|Age||Participants|Count of Participants|410|410.0||||||
4384924|NCT00314145|4211152|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384925|NCT00314145|4211153|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384926|NCT00314145|4211154|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384927|NCT00314132|4211167|B3|Australia||Region of Enrollment||Participants|Number|540|540.0||||||
4384928|NCT00314132|4211168|B2|Australia||Region of Enrollment||Participants|Number|400|400.0||||||
4384929|NCT00314132|4211169|B1|Australia||Region of Enrollment||Participants|Number|140|140.0||||||
4384930|NCT00314132|4211167|B3|United States||Region of Enrollment||Participants|Number|1464|1464.0||||||
4384931|NCT00314132|4211168|B2|United States||Region of Enrollment||Participants|Number|1201|1201.0||||||
4384932|NCT00314132|4211169|B1|United States||Region of Enrollment||Participants|Number|263|263.0||||||
4384933|NCT00314132|4211167|B3||Male|Sex: Female, Male||Participants|Count of Participants|1118|1118.0||||||
4384934|NCT00314132|4211168|B2||Male|Sex: Female, Male||Participants|Count of Participants|880|880.0||||||
4384935|NCT00314132|4211169|B1||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4384936|NCT00314132|4211167|B3||Female|Sex: Female, Male||Participants|Count of Participants|886|886.0||||||
4384937|NCT00314132|4211168|B2||Female|Sex: Female, Male||Participants|Count of Participants|721|721.0||||||
4384938|NCT00314132|4211169|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4384939|NCT00314132|4211167|B3|||Age||Years|Mean|34.7|34.7|Standard Deviation|14.22|14.22|||
4384940|NCT00314132|4211168|B2|||Age||Years|Mean|34.6|34.6|Standard Deviation|14.25|14.25|||
4384941|NCT00314132|4211169|B1|||Age||Years|Mean|34.8|34.8|Standard Deviation|14.12|14.12|||
4384942|NCT00314132|4211167|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384943|NCT00314132|4211168|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384944|NCT00314132|4211169|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384945|NCT00314132|4211167|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2004|2004.0||||||
4384946|NCT00314132|4211168|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1601|1601.0||||||
4384947|NCT00314132|4211169|B1||Between 18 and 65 years|Age||Participants|Count of Participants|403|403.0||||||
4384948|NCT00314132|4211167|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384949|NCT00314132|4211168|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384950|NCT00314132|4211169|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4384951|NCT00314106|4211178|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4384952|NCT00314106|4211179|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4384953|NCT00314106|4211180|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4384954|NCT00314106|4211178|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384955|NCT00314106|4211179|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384956|NCT00314106|4211180|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384957|NCT00314106|4211178|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384958|NCT00314106|4211179|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384959|NCT00314106|4211180|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384960|NCT00314106|4211178|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4384961|NCT00314106|4211179|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4384962|NCT00314106|4211180|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4384963|NCT00314106|4211178|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384964|NCT00314106|4211179|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384965|NCT00314106|4211180|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384966|NCT00314106|4211178|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384967|NCT00314106|4211179|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384968|NCT00314106|4211180|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384969|NCT00314106|4211178|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384970|NCT00314106|4211179|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384971|NCT00314106|4211180|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384972|NCT00314106|4211178|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384973|NCT00314106|4211179|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384974|NCT00314106|4211180|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384975|NCT00314106|4211178|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384976|NCT00314106|4211179|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384977|NCT00314106|4211180|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384978|NCT00314106|4211178|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4384979|NCT00314106|4211179|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4384980|NCT00314106|4211180|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4384981|NCT00314106|4211178|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4384982|NCT00314106|4211179|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4384983|NCT00314106|4211180|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4384984|NCT00314106|4211178|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4384985|NCT00314106|4211179|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4384986|NCT00314106|4211180|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4384987|NCT00314106|4211178|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4384988|NCT00314106|4211179|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4384989|NCT00314106|4211180|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4384990|NCT00314106|4211178|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|11.6|11.6|||
4384991|NCT00314106|4211179|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|10.6|10.6|||
4384992|NCT00314106|4211180|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|11.4|11.4|||
4384993|NCT00314106|4211178|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384994|NCT00314106|4211179|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384995|NCT00314106|4211180|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4384996|NCT00314106|4211178|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4384997|NCT00314106|4211179|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4384998|NCT00314106|4211180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4384999|NCT00314106|4211178|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4385000|NCT00314106|4211179|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4385001|NCT00314106|4211180|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4385002|NCT00313911|4211189|B3|Peru||Region of Enrollment||Participants|Number|1066|1066.0||||||
4385003|NCT00313911|4211190|B2|Peru||Region of Enrollment||Participants|Number|356|356.0||||||
4385004|NCT00313911|4211191|B1|Peru||Region of Enrollment||Participants|Number|710|710.0||||||
4385005|NCT00313911|4211189|B3|Mexico||Region of Enrollment||Participants|Number|1067|1067.0||||||
4385006|NCT00313911|4211190|B2|Mexico||Region of Enrollment||Participants|Number|355|355.0||||||
4385007|NCT00313911|4211191|B1|Mexico||Region of Enrollment||Participants|Number|712|712.0||||||
4385008|NCT00313911|4211189|B3||Male|Sex: Female, Male||Participants|Count of Participants|1083|1083.0||||||
4385009|NCT00313911|4211190|B2||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4385010|NCT00313911|4211191|B1||Male|Sex: Female, Male||Participants|Count of Participants|716|716.0||||||
4385011|NCT00313911|4211189|B3||Female|Sex: Female, Male||Participants|Count of Participants|1050|1050.0||||||
4385012|NCT00313911|4211190|B2||Female|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4385013|NCT00313911|4211191|B1||Female|Sex: Female, Male||Participants|Count of Participants|706|706.0||||||
4385014|NCT00313911|4211189|B3|Age Continuous||Age||Months|Mean|1.88|1.88|Standard Deviation|0.196|0.196|||
4385015|NCT00313911|4211190|B2|Age Continuous||Age||Months|Mean|1.88|1.88|Standard Deviation|0.197|0.197|||
4385016|NCT00313911|4211191|B1|Age Continuous||Age||Months|Mean|1.89|1.89|Standard Deviation|0.195|0.195|||
4385017|NCT00313911|4211189|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4385018|NCT00313911|4211190|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4385019|NCT00313911|4211191|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4385020|NCT00313911|4211189|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4385021|NCT00313911|4211190|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4385022|NCT00313911|4211191|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4385023|NCT00313911|4211189|B3||<=18 years|Age||Participants|Count of Participants|2133|2133.0||||||
4385024|NCT00313911|4211190|B2||<=18 years|Age||Participants|Count of Participants|711|711.0||||||
4385025|NCT00313911|4211191|B1||<=18 years|Age||Participants|Count of Participants|1422|1422.0||||||
4385026|NCT00313846|4211204|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4385027|NCT00313846|4211205|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4385028|NCT00313846|4211206|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4385029|NCT00313846|4211204|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4385030|NCT00313846|4211205|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4385031|NCT00313846|4211206|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4385032|NCT00313846|4211204|B3|||Age||years|Mean|60.8|60.8|Standard Deviation|9.45|9.45|||
4385033|NCT00313846|4211205|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|9.28|9.28|||
4385034|NCT00313846|4211206|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|9.64|9.64|||
4385035|NCT00313820|4211216|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4385036|NCT00313820|4211217|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4385037|NCT00313820|4211218|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4385038|NCT00313820|4211216|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4385039|NCT00313820|4211217|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4385040|NCT00313820|4211218|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4385041|NCT00313820|4211216|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|10.0|10.0|||
4385042|NCT00313820|4211217|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|10.2|10.2|||
4385043|NCT00313820|4211218|B1|||Age||years|Mean|59.4|59.4|Standard Deviation|9.8|9.8|||
4385044|NCT00313781|4211255|B3||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4385045|NCT00313781|4211256|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4385046|NCT00313781|4211257|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4385047|NCT00313781|4211255|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4385048|NCT00313781|4211256|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4385049|NCT00313781|4211257|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4385050|NCT00313781|4211255|B3|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|145|145.0||||||
4385051|NCT00313781|4211256|B2|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|69|69.0||||||
4385052|NCT00313781|4211257|B1|Greater than or equal to (>=) 65 years||Age, Customized||Participants|Number|76|76.0||||||
4385053|NCT00313781|4211255|B3|45 to 64 years||Age, Customized||Participants|Number|58|58.0||||||
4385054|NCT00313781|4211256|B2|45 to 64 years||Age, Customized||Participants|Number|32|32.0||||||
4385055|NCT00313781|4211257|B1|45 to 64 years||Age, Customized||Participants|Number|26|26.0||||||
4385056|NCT00313781|4211255|B3|18 to 44 years||Age, Customized||Participants|Number|1|1.0||||||
4385057|NCT00313781|4211256|B2|18 to 44 years||Age, Customized||Participants|Number|1|1.0||||||
4385058|NCT00313781|4211257|B1|18 to 44 years||Age, Customized||Participants|Number|0|0.0||||||
4385059|NCT00313781|4211255|B3|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4385060|NCT00313781|4211256|B2|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4385061|NCT00313781|4211257|B1|Less than (<) 18 years||Age, Customized||Participants|Number|0|0.0||||||
4385062|NCT00313716|4211293|B7|No surgery on admission||Surgery on admission||participants|Number|139|139.0||||||
4385063|NCT00313716|4211294|B6|No surgery on admission||Surgery on admission||participants|Number|34|34.0||||||
4385064|NCT00313716|4211295|B5|No surgery on admission||Surgery on admission||participants|Number|18|18.0||||||
4385065|NCT00313716|4211296|B4|No surgery on admission||Surgery on admission||participants|Number|14|14.0||||||
4385066|NCT00313716|4211297|B3|No surgery on admission||Surgery on admission||participants|Number|34|34.0||||||
4385067|NCT00313716|4211298|B2|No surgery on admission||Surgery on admission||participants|Number|24|24.0||||||
4385068|NCT00313716|4211299|B1|No surgery on admission||Surgery on admission||participants|Number|15|15.0||||||
4385069|NCT00313716|4211293|B7|Non-central nervous system injury||Surgery on admission||participants|Number|2|2.0||||||
4385070|NCT00313716|4211294|B6|Non-central nervous system injury||Surgery on admission||participants|Number|1|1.0||||||
4385071|NCT00313716|4211295|B5|Non-central nervous system injury||Surgery on admission||participants|Number|0|0.0||||||
4385072|NCT00313716|4211296|B4|Non-central nervous system injury||Surgery on admission||participants|Number|0|0.0||||||
4385073|NCT00313716|4211297|B3|Non-central nervous system injury||Surgery on admission||participants|Number|1|1.0||||||
4385074|NCT00313716|4211298|B2|Non-central nervous system injury||Surgery on admission||participants|Number|0|0.0||||||
4385075|NCT00313716|4211299|B1|Non-central nervous system injury||Surgery on admission||participants|Number|0|0.0||||||
4385076|NCT00313716|4211293|B7|Evacuation intracerebral hematoma or contusion||Surgery on admission||participants|Number|4|4.0||||||
4385077|NCT00313716|4211294|B6|Evacuation intracerebral hematoma or contusion||Surgery on admission||participants|Number|1|1.0||||||
4385078|NCT00313716|4211295|B5|Evacuation intracerebral hematoma or contusion||Surgery on admission||participants|Number|0|0.0||||||
4385079|NCT00313716|4211296|B4|Evacuation intracerebral hematoma or contusion||Surgery on admission||participants|Number|1|1.0||||||
4385080|NCT00313716|4211297|B3|Evacuation intracerebral hematoma or contusion||Surgery on admission||participants|Number|1|1.0||||||
4385081|NCT00313716|4211298|B2|Evacuation intracerebral hematoma or contusion||Surgery on admission||participants|Number|0|0.0||||||
4385082|NCT00313716|4211299|B1|Evacuation intracerebral hematoma or contusion||Surgery on admission||participants|Number|1|1.0||||||
4385083|NCT00313716|4211293|B7|Evacuation subdural hematoma||Surgery on admission||participants|Number|46|46.0||||||
4385084|NCT00313716|4211294|B6|Evacuation subdural hematoma||Surgery on admission||participants|Number|7|7.0||||||
4385085|NCT00313716|4211295|B5|Evacuation subdural hematoma||Surgery on admission||participants|Number|14|14.0||||||
4385086|NCT00313716|4211296|B4|Evacuation subdural hematoma||Surgery on admission||participants|Number|5|5.0||||||
4385087|NCT00313716|4211297|B3|Evacuation subdural hematoma||Surgery on admission||participants|Number|13|13.0||||||
4385088|NCT00313716|4211298|B2|Evacuation subdural hematoma||Surgery on admission||participants|Number|5|5.0||||||
4385089|NCT00313716|4211299|B1|Evacuation subdural hematoma||Surgery on admission||participants|Number|2|2.0||||||
4385090|NCT00313716|4211293|B7|Evacuation epidural hematoma||Surgery on admission||participants|Number|9|9.0||||||
4385091|NCT00313716|4211294|B6|Evacuation epidural hematoma||Surgery on admission||participants|Number|5|5.0||||||
4385092|NCT00313716|4211295|B5|Evacuation epidural hematoma||Surgery on admission||participants|Number|1|1.0||||||
4385093|NCT00313716|4211296|B4|Evacuation epidural hematoma||Surgery on admission||participants|Number|0|0.0||||||
4385094|NCT00313716|4211297|B3|Evacuation epidural hematoma||Surgery on admission||participants|Number|1|1.0||||||
4385095|NCT00313716|4211298|B2|Evacuation epidural hematoma||Surgery on admission||participants|Number|2|2.0||||||
4385096|NCT00313716|4211299|B1|Evacuation epidural hematoma||Surgery on admission||participants|Number|0|0.0||||||
4385097|NCT00313716|4211293|B7|||Glucose concentration||mmol/L|Median|8.42|8.42|Inter-Quartile Range|||7.11|10.22|
4385098|NCT00313716|4211294|B6|||Glucose concentration||mmol/L|Median|7.7|7.7|Inter-Quartile Range|||6.6|10.0|
4385099|NCT00313716|4211295|B5|||Glucose concentration||mmol/L|Median|8.6|8.6|Inter-Quartile Range|||7.1|9.7|
4385100|NCT00313716|4211296|B4|||Glucose concentration||mmol/L|Median|8.8|8.8|Inter-Quartile Range|||7.4|11.7|
4385101|NCT00313716|4211297|B3|||Glucose concentration||mmol/L|Median|8.9|8.9|Inter-Quartile Range|||7.5|10.4|
4385102|NCT00313716|4211298|B2|||Glucose concentration||mmol/L|Median|9.1|9.1|Inter-Quartile Range|||7.2|10.6|
4385103|NCT00313716|4211299|B1|||Glucose concentration||mmol/L|Median|8.3|8.3|Inter-Quartile Range|||7.2|10.2|
4385104|NCT00313716|4211293|B7|||Hemoglobin concentration||g/dl|Median|14.45|14.45|Inter-Quartile Range|||12.95|15.6|
4385105|NCT00313716|4211294|B6|||Hemoglobin concentration||g/dl|Median|14.7|14.7|Inter-Quartile Range|||13.6|15.6|
4385106|NCT00313716|4211295|B5|||Hemoglobin concentration||g/dl|Median|13.9|13.9|Inter-Quartile Range|||12.7|15.4|
4385107|NCT00313716|4211296|B4|||Hemoglobin concentration||g/dl|Median|14.8|14.8|Inter-Quartile Range|||13.0|15.6|
4385108|NCT00313716|4211297|B3|||Hemoglobin concentration||g/dl|Median|14.0|14.0|Inter-Quartile Range|||12.3|15.6|
4385109|NCT00313716|4211298|B2|||Hemoglobin concentration||g/dl|Median|14.7|14.7|Inter-Quartile Range|||13.2|15.5|
4385110|NCT00313716|4211299|B1|||Hemoglobin concentration||g/dl|Median|14.7|14.7|Inter-Quartile Range|||13.9|16.0|
4385111|NCT00313716|4211293|B7|no||Presence of epidural hematoma||participants|Number|168|168.0||||||
4385112|NCT00313716|4211294|B6|no||Presence of epidural hematoma||participants|Number|37|37.0||||||
4385113|NCT00313716|4211295|B5|no||Presence of epidural hematoma||participants|Number|25|25.0||||||
4385114|NCT00313716|4211296|B4|no||Presence of epidural hematoma||participants|Number|17|17.0||||||
4385115|NCT00313716|4211297|B3|no||Presence of epidural hematoma||participants|Number|47|47.0||||||
4385116|NCT00313716|4211298|B2|no||Presence of epidural hematoma||participants|Number|27|27.0||||||
4385117|NCT00313716|4211299|B1|no||Presence of epidural hematoma||participants|Number|15|15.0||||||
4385118|NCT00313716|4211293|B7|yes||Presence of epidural hematoma||participants|Number|32|32.0||||||
4385119|NCT00313716|4211294|B6|yes||Presence of epidural hematoma||participants|Number|11|11.0||||||
4385120|NCT00313716|4211295|B5|yes||Presence of epidural hematoma||participants|Number|8|8.0||||||
4385121|NCT00313716|4211296|B4|yes||Presence of epidural hematoma||participants|Number|3|3.0||||||
4385122|NCT00313716|4211297|B3|yes||Presence of epidural hematoma||participants|Number|3|3.0||||||
4385123|NCT00313716|4211298|B2|yes||Presence of epidural hematoma||participants|Number|4|4.0||||||
4385124|NCT00313716|4211299|B1|yes||Presence of epidural hematoma||participants|Number|3|3.0||||||
4385125|NCT00313716|4211293|B7|no||Presence of subarachnoid hemorrhage||participants|Number|93|93.0||||||
4385126|NCT00313716|4211294|B6|no||Presence of subarachnoid hemorrhage||participants|Number|37|37.0||||||
4385127|NCT00313716|4211295|B5|no||Presence of subarachnoid hemorrhage||participants|Number|11|11.0||||||
4385128|NCT00313716|4211296|B4|no||Presence of subarachnoid hemorrhage||participants|Number|17|17.0||||||
4385129|NCT00313716|4211297|B3|no||Presence of subarachnoid hemorrhage||participants|Number|13|13.0||||||
4385130|NCT00313716|4211298|B2|no||Presence of subarachnoid hemorrhage||participants|Number|9|9.0||||||
4385131|NCT00313716|4211299|B1|no||Presence of subarachnoid hemorrhage||participants|Number|6|6.0||||||
4385132|NCT00313716|4211293|B7|yes||Presence of subarachnoid hemorrhage||participants|Number|107|107.0||||||
4385133|NCT00313716|4211294|B6|yes||Presence of subarachnoid hemorrhage||participants|Number|11|11.0||||||
4385134|NCT00313716|4211295|B5|yes||Presence of subarachnoid hemorrhage||participants|Number|22|22.0||||||
4385135|NCT00313716|4211296|B4|yes||Presence of subarachnoid hemorrhage||participants|Number|3|3.0||||||
4385136|NCT00313716|4211297|B3|yes||Presence of subarachnoid hemorrhage||participants|Number|37|37.0||||||
4385137|NCT00313716|4211298|B2|yes||Presence of subarachnoid hemorrhage||participants|Number|22|22.0||||||
4385138|NCT00313716|4211299|B1|yes||Presence of subarachnoid hemorrhage||participants|Number|12|12.0||||||
4385139|NCT00313716|4211293|B7|Mass lesion||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|65|65.0||||||
4385140|NCT00313716|4211294|B6|Mass lesion||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|16|16.0||||||
4385141|NCT00313716|4211295|B5|Mass lesion||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|16|16.0||||||
4385142|NCT00313716|4211296|B4|Mass lesion||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|6|6.0||||||
4385143|NCT00313716|4211297|B3|Mass lesion||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|16|16.0||||||
4385195|NCT00313716|4211293|B7|GCS 3-5||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|66|66.0||||||
4385144|NCT00313716|4211298|B2|Mass lesion||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|8|8.0||||||
4385145|NCT00313716|4211299|B1|Mass lesion||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|3|3.0||||||
4385146|NCT00313716|4211293|B7|Diffuse injury 3 or 4||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|46|46.0||||||
4385147|NCT00313716|4211294|B6|Diffuse injury 3 or 4||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|12|12.0||||||
4385148|NCT00313716|4211295|B5|Diffuse injury 3 or 4||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|2|2.0||||||
4385149|NCT00313716|4211296|B4|Diffuse injury 3 or 4||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|9|9.0||||||
4385150|NCT00313716|4211297|B3|Diffuse injury 3 or 4||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|10|10.0||||||
4385151|NCT00313716|4211298|B2|Diffuse injury 3 or 4||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|8|8.0||||||
4385152|NCT00313716|4211299|B1|Diffuse injury 3 or 4||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|5|5.0||||||
4385153|NCT00313716|4211293|B7|Diffuse injury 1 or 2||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|89|89.0||||||
4385154|NCT00313716|4211294|B6|Diffuse injury 1 or 2||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|20|20.0||||||
4385155|NCT00313716|4211295|B5|Diffuse injury 1 or 2||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|15|15.0||||||
4385156|NCT00313716|4211296|B4|Diffuse injury 1 or 2||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|5|5.0||||||
4385157|NCT00313716|4211297|B3|Diffuse injury 1 or 2||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|24|24.0||||||
4385158|NCT00313716|4211298|B2|Diffuse injury 1 or 2||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|15|15.0||||||
4385196|NCT00313716|4211294|B6|GCS 3-5||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|11|11.0||||||
4385272|NCT00313716|4211293|B7|yes||Prehospital hypoxia||participants|Number|39|39.0||||||
4385159|NCT00313716|4211299|B1|Diffuse injury 1 or 2||Marshall CT scan category|Marshall CT scan category is a classification system for traumatic brain injury. Diffuse injury 1 is a normal scan. Diffuse injury 2 has some abnormalities but basal cisterns are present. Diffuse injury 3 has basal cistern compression but no midline shift. Diffuse injury 4 has midline shift. Mass lesions include hematomas and contusions of at least 25 ml in volume.|participants|Number|10|10.0||||||
4385160|NCT00313716|4211293|B7|Neither reactive||Pupil reactivity||participants|Number|56|56.0||||||
4385161|NCT00313716|4211294|B6|Neither reactive||Pupil reactivity||participants|Number|15|15.0||||||
4385162|NCT00313716|4211295|B5|Neither reactive||Pupil reactivity||participants|Number|15|15.0||||||
4385163|NCT00313716|4211296|B4|Neither reactive||Pupil reactivity||participants|Number|4|4.0||||||
4385164|NCT00313716|4211297|B3|Neither reactive||Pupil reactivity||participants|Number|15|15.0||||||
4385165|NCT00313716|4211298|B2|Neither reactive||Pupil reactivity||participants|Number|3|3.0||||||
4385166|NCT00313716|4211299|B1|Neither reactive||Pupil reactivity||participants|Number|4|4.0||||||
4385167|NCT00313716|4211293|B7|One reactive||Pupil reactivity||participants|Number|23|23.0||||||
4385168|NCT00313716|4211294|B6|One reactive||Pupil reactivity||participants|Number|5|5.0||||||
4385169|NCT00313716|4211295|B5|One reactive||Pupil reactivity||participants|Number|1|1.0||||||
4385170|NCT00313716|4211296|B4|One reactive||Pupil reactivity||participants|Number|3|3.0||||||
4385171|NCT00313716|4211297|B3|One reactive||Pupil reactivity||participants|Number|8|8.0||||||
4385172|NCT00313716|4211298|B2|One reactive||Pupil reactivity||participants|Number|4|4.0||||||
4385173|NCT00313716|4211299|B1|One reactive||Pupil reactivity||participants|Number|2|2.0||||||
4385174|NCT00313716|4211293|B7|Both reactive||Pupil reactivity||participants|Number|121|121.0||||||
4385175|NCT00313716|4211294|B6|Both reactive||Pupil reactivity||participants|Number|28|28.0||||||
4385176|NCT00313716|4211295|B5|Both reactive||Pupil reactivity||participants|Number|17|17.0||||||
4385177|NCT00313716|4211296|B4|Both reactive||Pupil reactivity||participants|Number|13|13.0||||||
4385178|NCT00313716|4211297|B3|Both reactive||Pupil reactivity||participants|Number|27|27.0||||||
4385179|NCT00313716|4211298|B2|Both reactive||Pupil reactivity||participants|Number|24|24.0||||||
4385180|NCT00313716|4211299|B1|Both reactive||Pupil reactivity||participants|Number|12|12.0||||||
4385181|NCT00313716|4211293|B7|GCS > 8||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|45|45.0||||||
4385182|NCT00313716|4211294|B6|GCS > 8||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|14|14.0||||||
4385183|NCT00313716|4211295|B5|GCS > 8||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|4|4.0||||||
4385184|NCT00313716|4211296|B4|GCS > 8||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|4|4.0||||||
4385185|NCT00313716|4211297|B3|GCS > 8||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|11|11.0||||||
4385186|NCT00313716|4211298|B2|GCS > 8||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|8|8.0||||||
4385187|NCT00313716|4211299|B1|GCS > 8||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|4|4.0||||||
4385188|NCT00313716|4211293|B7|GCS 6-8||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|89|89.0||||||
4385189|NCT00313716|4211294|B6|GCS 6-8||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|23|23.0||||||
4385190|NCT00313716|4211295|B5|GCS 6-8||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|16|16.0||||||
4385191|NCT00313716|4211296|B4|GCS 6-8||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|8|8.0||||||
4385192|NCT00313716|4211297|B3|GCS 6-8||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|19|19.0||||||
4385193|NCT00313716|4211298|B2|GCS 6-8||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|13|13.0||||||
4385194|NCT00313716|4211299|B1|GCS 6-8||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|10|10.0||||||
4385271|NCT00313716|4211299|B1|no||Prehospital hypoxia||participants|Number|18|18.0||||||
4385197|NCT00313716|4211295|B5|GCS 3-5||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|13|13.0||||||
4385198|NCT00313716|4211296|B4|GCS 3-5||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|8|8.0||||||
4385199|NCT00313716|4211297|B3|GCS 3-5||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|20|20.0||||||
4385200|NCT00313716|4211298|B2|GCS 3-5||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|10|10.0||||||
4385201|NCT00313716|4211299|B1|GCS 3-5||Sum Glasgow Coma Score|The Sum Glasgow Coma Score sums the three components of the neurological examination (eye, verbal, and motor responses). The score ranges from 3 to 15 with 3 indicating no response, and 15 indicating normal response.|participants|Number|4|4.0||||||
4385202|NCT00313716|4211293|B7|mGCS 4-5||Motor component of Glasgow Coma Score|The motor component of the Glasgow Coma Score describes the motor response. The scale ranges from 1-6 (1=no response, 2=decerebrate posturing, 3=decorticate posturing, 4=withdrawal response, 5=localizing response, 6=following commands) with a higher score indicating better performance.|participants|Number|129|129.0||||||
4385203|NCT00313716|4211294|B6|mGCS 4-5||Motor component of Glasgow Coma Score|The motor component of the Glasgow Coma Score describes the motor response. The scale ranges from 1-6 (1=no response, 2=decerebrate posturing, 3=decorticate posturing, 4=withdrawal response, 5=localizing response, 6=following commands) with a higher score indicating better performance.|participants|Number|35|35.0||||||
4385204|NCT00313716|4211295|B5|mGCS 4-5||Motor component of Glasgow Coma Score|The motor component of the Glasgow Coma Score describes the motor response. The scale ranges from 1-6 (1=no response, 2=decerebrate posturing, 3=decorticate posturing, 4=withdrawal response, 5=localizing response, 6=following commands) with a higher score indicating better performance.|participants|Number|19|19.0||||||
4385205|NCT00313716|4211296|B4|mGCS 4-5||Motor component of Glasgow Coma Score|The motor component of the Glasgow Coma Score describes the motor response. The scale ranges from 1-6 (1=no response, 2=decerebrate posturing, 3=decorticate posturing, 4=withdrawal response, 5=localizing response, 6=following commands) with a higher score indicating better performance.|participants|Number|12|12.0||||||
4385206|NCT00313716|4211297|B3|mGCS 4-5||Motor component of Glasgow Coma Score|The motor component of the Glasgow Coma Score describes the motor response. The scale ranges from 1-6 (1=no response, 2=decerebrate posturing, 3=decorticate posturing, 4=withdrawal response, 5=localizing response, 6=following commands) with a higher score indicating better performance.|participants|Number|30|30.0||||||
4385207|NCT00313716|4211298|B2|mGCS 4-5||Motor component of Glasgow Coma Score|The motor component of the Glasgow Coma Score describes the motor response. The scale ranges from 1-6 (1=no response, 2=decerebrate posturing, 3=decorticate posturing, 4=withdrawal response, 5=localizing response, 6=following commands) with a higher score indicating better performance.|participants|Number|19|19.0||||||
4385208|NCT00313716|4211299|B1|mGCS 4-5||Motor component of Glasgow Coma Score|The motor component of the Glasgow Coma Score describes the motor response. The scale ranges from 1-6 (1=no response, 2=decerebrate posturing, 3=decorticate posturing, 4=withdrawal response, 5=localizing response, 6=following commands) with a higher score indicating better performance.|participants|Number|14|14.0||||||
4385209|NCT00313716|4211293|B7|mGCS 1-3||Motor component of Glasgow Coma Score|The motor component of the Glasgow Coma Score describes the motor response. The scale ranges from 1-6 (1=no response, 2=decerebrate posturing, 3=decorticate posturing, 4=withdrawal response, 5=localizing response, 6=following commands) with a higher score indicating better performance.|participants|Number|71|71.0||||||
4385210|NCT00313716|4211294|B6|mGCS 1-3||Motor component of Glasgow Coma Score|The motor component of the Glasgow Coma Score describes the motor response. The scale ranges from 1-6 (1=no response, 2=decerebrate posturing, 3=decorticate posturing, 4=withdrawal response, 5=localizing response, 6=following commands) with a higher score indicating better performance.|participants|Number|13|13.0||||||
4385211|NCT00313716|4211295|B5|mGCS 1-3||Motor component of Glasgow Coma Score|The motor component of the Glasgow Coma Score describes the motor response. The scale ranges from 1-6 (1=no response, 2=decerebrate posturing, 3=decorticate posturing, 4=withdrawal response, 5=localizing response, 6=following commands) with a higher score indicating better performance.|participants|Number|14|14.0||||||
4385212|NCT00313716|4211296|B4|mGCS 1-3||Motor component of Glasgow Coma Score|The motor component of the Glasgow Coma Score describes the motor response. The scale ranges from 1-6 (1=no response, 2=decerebrate posturing, 3=decorticate posturing, 4=withdrawal response, 5=localizing response, 6=following commands) with a higher score indicating better performance.|participants|Number|8|8.0||||||
4385213|NCT00313716|4211297|B3|mGCS 1-3||Motor component of Glasgow Coma Score|The motor component of the Glasgow Coma Score describes the motor response. The scale ranges from 1-6 (1=no response, 2=decerebrate posturing, 3=decorticate posturing, 4=withdrawal response, 5=localizing response, 6=following commands) with a higher score indicating better performance.|participants|Number|20|20.0||||||
4385214|NCT00313716|4211298|B2|mGCS 1-3||Motor component of Glasgow Coma Score|The motor component of the Glasgow Coma Score describes the motor response. The scale ranges from 1-6 (1=no response, 2=decerebrate posturing, 3=decorticate posturing, 4=withdrawal response, 5=localizing response, 6=following commands) with a higher score indicating better performance.|participants|Number|12|12.0||||||
4385215|NCT00313716|4211299|B1|mGCS 1-3||Motor component of Glasgow Coma Score|The motor component of the Glasgow Coma Score describes the motor response. The scale ranges from 1-6 (1=no response, 2=decerebrate posturing, 3=decorticate posturing, 4=withdrawal response, 5=localizing response, 6=following commands) with a higher score indicating better performance.|participants|Number|4|4.0||||||
4385216|NCT00313716|4211293|B7|||IMPACT probability of poor outcome||probability of poor outcome|Mean|.41|0.41|Standard Deviation|.25|0.25|||
4385217|NCT00313716|4211294|B6|||IMPACT probability of poor outcome||probability of poor outcome|Mean|.38|0.38|Standard Deviation|.3|0.3|||
4385218|NCT00313716|4211295|B5|||IMPACT probability of poor outcome||probability of poor outcome|Mean|.46|0.46|Standard Deviation|.3|0.3|||
4385219|NCT00313716|4211296|B4|||IMPACT probability of poor outcome||probability of poor outcome|Mean|.49|0.49|Standard Deviation|.2|0.2|||
4385220|NCT00313716|4211297|B3|||IMPACT probability of poor outcome||probability of poor outcome|Mean|.45|0.45|Standard Deviation|.3|0.3|||
4385221|NCT00313716|4211298|B2|||IMPACT probability of poor outcome||probability of poor outcome|Mean|.35|0.35|Standard Deviation|.2|0.2|||
4385222|NCT00313716|4211299|B1|||IMPACT probability of poor outcome||probability of poor outcome|Mean|.29|0.29|Standard Deviation|.2|0.2|||
4385223|NCT00313716|4211293|B7|||Injury Severity Score|Injury Severity Score describes the severity of all traumatic injuries. The score ranges from 0 to 75, with a higher score indicating a more severe injury.|units on a scale|Median|29|29.0|Inter-Quartile Range|||25.0|36.5|
4385224|NCT00313716|4211294|B6|||Injury Severity Score|Injury Severity Score describes the severity of all traumatic injuries. The score ranges from 0 to 75, with a higher score indicating a more severe injury.|units on a scale|Median|29|29.0|Inter-Quartile Range|||25.0|35.0|
4385225|NCT00313716|4211295|B5|||Injury Severity Score|Injury Severity Score describes the severity of all traumatic injuries. The score ranges from 0 to 75, with a higher score indicating a more severe injury.|units on a scale|Median|29|29.0|Inter-Quartile Range|||25.0|38.0|
4385226|NCT00313716|4211296|B4|||Injury Severity Score|Injury Severity Score describes the severity of all traumatic injuries. The score ranges from 0 to 75, with a higher score indicating a more severe injury.|units on a scale|Median|27|27.0|Inter-Quartile Range|||26.0|36.5|
4385227|NCT00313716|4211297|B3|||Injury Severity Score|Injury Severity Score describes the severity of all traumatic injuries. The score ranges from 0 to 75, with a higher score indicating a more severe injury.|units on a scale|Median|29|29.0|Inter-Quartile Range|||25.0|43.0|
4385228|NCT00313716|4211298|B2|||Injury Severity Score|Injury Severity Score describes the severity of all traumatic injuries. The score ranges from 0 to 75, with a higher score indicating a more severe injury.|units on a scale|Median|30|30.0|Inter-Quartile Range|||25.0|35.0|
4385229|NCT00313716|4211299|B1|||Injury Severity Score|Injury Severity Score describes the severity of all traumatic injuries. The score ranges from 0 to 75, with a higher score indicating a more severe injury.|units on a scale|Median|29|29.0|Inter-Quartile Range|||26.0|34.0|
4385230|NCT00313716|4211293|B7|Other||Mechanism of injury||participants|Number|4|4.0||||||
4385231|NCT00313716|4211294|B6|Other||Mechanism of injury||participants|Number|1|1.0||||||
4385232|NCT00313716|4211295|B5|Other||Mechanism of injury||participants|Number|0|0.0||||||
4385233|NCT00313716|4211296|B4|Other||Mechanism of injury||participants|Number|1|1.0||||||
4385234|NCT00313716|4211297|B3|Other||Mechanism of injury||participants|Number|2|2.0||||||
4385235|NCT00313716|4211298|B2|Other||Mechanism of injury||participants|Number|0|0.0||||||
4385236|NCT00313716|4211299|B1|Other||Mechanism of injury||participants|Number|0|0.0||||||
4385237|NCT00313716|4211293|B7|Motorcycle crash||Mechanism of injury||participants|Number|31|31.0||||||
4385238|NCT00313716|4211294|B6|Motorcycle crash||Mechanism of injury||participants|Number|8|8.0||||||
4385239|NCT00313716|4211295|B5|Motorcycle crash||Mechanism of injury||participants|Number|4|4.0||||||
4385240|NCT00313716|4211296|B4|Motorcycle crash||Mechanism of injury||participants|Number|5|5.0||||||
4385241|NCT00313716|4211297|B3|Motorcycle crash||Mechanism of injury||participants|Number|7|7.0||||||
4385242|NCT00313716|4211298|B2|Motorcycle crash||Mechanism of injury||participants|Number|7|7.0||||||
4385243|NCT00313716|4211299|B1|Motorcycle crash||Mechanism of injury||participants|Number|0|0.0||||||
4385244|NCT00313716|4211293|B7|Automobile crash||Mechanism of injury||participants|Number|116|116.0||||||
4385245|NCT00313716|4211294|B6|Automobile crash||Mechanism of injury||participants|Number|27|27.0||||||
4385246|NCT00313716|4211295|B5|Automobile crash||Mechanism of injury||participants|Number|22|22.0||||||
4385247|NCT00313716|4211296|B4|Automobile crash||Mechanism of injury||participants|Number|9|9.0||||||
4385248|NCT00313716|4211297|B3|Automobile crash||Mechanism of injury||participants|Number|29|29.0||||||
4385249|NCT00313716|4211298|B2|Automobile crash||Mechanism of injury||participants|Number|19|19.0||||||
4385250|NCT00313716|4211299|B1|Automobile crash||Mechanism of injury||participants|Number|10|10.0||||||
4385251|NCT00313716|4211293|B7|Fall or jump||Mechanism of injury||participants|Number|27|27.0||||||
4385252|NCT00313716|4211294|B6|Fall or jump||Mechanism of injury||participants|Number|2|2.0||||||
4385253|NCT00313716|4211295|B5|Fall or jump||Mechanism of injury||participants|Number|4|4.0||||||
4385254|NCT00313716|4211296|B4|Fall or jump||Mechanism of injury||participants|Number|3|3.0||||||
4385255|NCT00313716|4211297|B3|Fall or jump||Mechanism of injury||participants|Number|7|7.0||||||
4385256|NCT00313716|4211298|B2|Fall or jump||Mechanism of injury||participants|Number|3|3.0||||||
4385257|NCT00313716|4211299|B1|Fall or jump||Mechanism of injury||participants|Number|8|8.0||||||
4385258|NCT00313716|4211293|B7|Assault||Mechanism of injury||participants|Number|22|22.0||||||
4385259|NCT00313716|4211294|B6|Assault||Mechanism of injury||participants|Number|10|10.0||||||
4385260|NCT00313716|4211295|B5|Assault||Mechanism of injury||participants|Number|3|3.0||||||
4385261|NCT00313716|4211296|B4|Assault||Mechanism of injury||participants|Number|2|2.0||||||
4385262|NCT00313716|4211297|B3|Assault||Mechanism of injury||participants|Number|5|5.0||||||
4385263|NCT00313716|4211298|B2|Assault||Mechanism of injury||participants|Number|2|2.0||||||
4385264|NCT00313716|4211299|B1|Assault||Mechanism of injury||participants|Number|0|0.0||||||
4385265|NCT00313716|4211293|B7|no||Prehospital hypoxia||participants|Number|161|161.0||||||
4385266|NCT00313716|4211294|B6|no||Prehospital hypoxia||participants|Number|35|35.0||||||
4385267|NCT00313716|4211295|B5|no||Prehospital hypoxia||participants|Number|28|28.0||||||
4385268|NCT00313716|4211296|B4|no||Prehospital hypoxia||participants|Number|17|17.0||||||
4385269|NCT00313716|4211297|B3|no||Prehospital hypoxia||participants|Number|34|34.0||||||
4385270|NCT00313716|4211298|B2|no||Prehospital hypoxia||participants|Number|29|29.0||||||
4385273|NCT00313716|4211294|B6|yes||Prehospital hypoxia||participants|Number|13|13.0||||||
4385274|NCT00313716|4211295|B5|yes||Prehospital hypoxia||participants|Number|5|5.0||||||
4385275|NCT00313716|4211296|B4|yes||Prehospital hypoxia||participants|Number|3|3.0||||||
4385276|NCT00313716|4211297|B3|yes||Prehospital hypoxia||participants|Number|16|16.0||||||
4385277|NCT00313716|4211298|B2|yes||Prehospital hypoxia||participants|Number|2|2.0||||||
4385278|NCT00313716|4211299|B1|yes||Prehospital hypoxia||participants|Number|0|0.0||||||
4385279|NCT00313716|4211293|B7|no||Prehospital hypotension||participants|Number|175|175.0||||||
4385280|NCT00313716|4211294|B6|no||Prehospital hypotension||participants|Number|39|39.0||||||
4385281|NCT00313716|4211295|B5|no||Prehospital hypotension||participants|Number|31|31.0||||||
4385282|NCT00313716|4211296|B4|no||Prehospital hypotension||participants|Number|17|17.0||||||
4385283|NCT00313716|4211297|B3|no||Prehospital hypotension||participants|Number|43|43.0||||||
4385284|NCT00313716|4211298|B2|no||Prehospital hypotension||participants|Number|28|28.0||||||
4385285|NCT00313716|4211299|B1|no||Prehospital hypotension||participants|Number|17|17.0||||||
4385286|NCT00313716|4211293|B7|yes||Prehospital hypotension||participants|Number|25|25.0||||||
4385287|NCT00313716|4211294|B6|yes||Prehospital hypotension||participants|Number|9|9.0||||||
4385288|NCT00313716|4211295|B5|yes||Prehospital hypotension||participants|Number|2|2.0||||||
4385289|NCT00313716|4211296|B4|yes||Prehospital hypotension||participants|Number|3|3.0||||||
4385290|NCT00313716|4211297|B3|yes||Prehospital hypotension||participants|Number|7|7.0||||||
4385291|NCT00313716|4211298|B2|yes||Prehospital hypotension||participants|Number|3|3.0||||||
4385292|NCT00313716|4211299|B1|yes||Prehospital hypotension||participants|Number|1|1.0||||||
4385293|NCT00313716|4211293|B7|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4385294|NCT00313716|4211294|B6|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4385295|NCT00313716|4211295|B5|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4385296|NCT00313716|4211296|B4|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4385297|NCT00313716|4211297|B3|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4385298|NCT00313716|4211298|B2|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4385299|NCT00313716|4211299|B1|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4385300|NCT00313716|4211293|B7|Black||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4385301|NCT00313716|4211294|B6|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4385302|NCT00313716|4211295|B5|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4385303|NCT00313716|4211296|B4|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4385304|NCT00313716|4211297|B3|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4385305|NCT00313716|4211298|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4385306|NCT00313716|4211299|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4385307|NCT00313716|4211293|B7|Hispanic||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4385308|NCT00313716|4211294|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4385309|NCT00313716|4211295|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4385310|NCT00313716|4211296|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4385311|NCT00313716|4211297|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4385312|NCT00313716|4211298|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4385313|NCT00313716|4211299|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4385314|NCT00313716|4211293|B7|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4385315|NCT00313716|4211294|B6|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4385316|NCT00313716|4211295|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4385317|NCT00313716|4211296|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4385318|NCT00313716|4211297|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4385319|NCT00313716|4211298|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4385320|NCT00313716|4211299|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4385321|NCT00313716|4211293|B7||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4385322|NCT00313716|4211294|B6||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4385323|NCT00313716|4211295|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4385324|NCT00313716|4211296|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4385325|NCT00313716|4211297|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4385326|NCT00313716|4211298|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4385327|NCT00313716|4211299|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4385328|NCT00313716|4211293|B7||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4385329|NCT00313716|4211294|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4385330|NCT00313716|4211295|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4385331|NCT00313716|4211296|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4385332|NCT00313716|4211297|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4385333|NCT00313716|4211298|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4385334|NCT00313716|4211299|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4385335|NCT00313716|4211293|B7|||Age||years|Median|30|30.0|Inter-Quartile Range|||23.0|46.0|
4385336|NCT00313716|4211294|B6|||Age||years|Median|30.5|30.5|Inter-Quartile Range|||25.0|45.0|
4385337|NCT00313716|4211295|B5|||Age||years|Median|30|30.0|Inter-Quartile Range|||23.0|46.0|
4385338|NCT00313716|4211296|B4|||Age||years|Median|36.5|36.5|Inter-Quartile Range|||28.5|44.0|
4385339|NCT00313716|4211297|B3|||Age||years|Median|29.5|29.5|Inter-Quartile Range|||20.0|39.0|
4385340|NCT00313716|4211298|B2|||Age||years|Median|28|28.0|Inter-Quartile Range|||23.0|48.0|
4385341|NCT00313716|4211299|B1|||Age||years|Median|25.5|25.5|Inter-Quartile Range|||22.0|52.0|
4385342|NCT00313703|4211327|B5||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4385343|NCT00313703|4211328|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4385344|NCT00313703|4211329|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4385345|NCT00313703|4211330|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4385346|NCT00313703|4211331|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4385347|NCT00313703|4211327|B5||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4385348|NCT00313703|4211328|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4385349|NCT00313703|4211329|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4385350|NCT00313703|4211330|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4385351|NCT00313703|4211331|B1||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4385352|NCT00313703|4211327|B5|||Age||Years|Mean|39|39.0|Standard Deviation|12|12.0|||
4385353|NCT00313703|4211328|B4|||Age||Years|Mean|40|40.0|Standard Deviation|11|11.0|||
4385354|NCT00313703|4211329|B3|||Age||Years|Mean|42|42.0|Standard Deviation|12|12.0|||
4385355|NCT00313703|4211330|B2|||Age||Years|Mean|40|40.0|Standard Deviation|12|12.0|||
4385356|NCT00313703|4211331|B1|||Age||Years|Mean|38|38.0|Standard Deviation|12|12.0|||
4385357|NCT00313612|4211348|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4385358|NCT00313612|4211349|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4385359|NCT00313612|4211350|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4385360|NCT00313612|4211348|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4385361|NCT00313612|4211349|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4385362|NCT00313612|4211350|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4385363|NCT00313612|4211348|B3|||Age||years|Median|60|60.0|Full Range|||38.0|80.0|
4385364|NCT00313612|4211349|B2|||Age||years|Median|59|59.0|Full Range|||40.0|71.0|
4385365|NCT00313612|4211350|B1|||Age||years|Median|61|61.0|Full Range|||38.0|80.0|
4385366|NCT00313586|4211359|B5|United States||Region of Enrollment||participants|Number|196|196.0||||||
4385367|NCT00313586|4211360|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
4385368|NCT00313586|4211361|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4385369|NCT00313586|4211362|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4385370|NCT00313586|4211363|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
4385371|NCT00313586|4211359|B5||Male|Gender||Participants|Count of Participants|123|123.0||||||
4385372|NCT00313586|4211360|B4||Male|Gender||Participants|Count of Participants|12|12.0||||||
4385373|NCT00313586|4211361|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
4385374|NCT00313586|4211362|B2||Male|Gender||Participants|Count of Participants|52|52.0||||||
4385375|NCT00313586|4211363|B1||Male|Gender||Participants|Count of Participants|50|50.0||||||
4385376|NCT00313586|4211359|B5||Female|Gender||Participants|Count of Participants|73|73.0||||||
4385377|NCT00313586|4211360|B4||Female|Gender||Participants|Count of Participants|11|11.0||||||
4385378|NCT00313586|4211361|B3||Female|Gender||Participants|Count of Participants|15|15.0||||||
4385379|NCT00313586|4211362|B2||Female|Gender||Participants|Count of Participants|23|23.0||||||
4385380|NCT00313586|4211363|B1||Female|Gender||Participants|Count of Participants|24|24.0||||||
4385381|NCT00313586|4211359|B5|||Age||years|Median|71|71.0|Full Range|||25.0|87.0|
4385382|NCT00313586|4211360|B4|||Age||years|Median|71|71.0|Full Range|||39.0|81.0|
4385383|NCT00313586|4211361|B3|||Age||years|Median|68|68.0|Full Range|||54.0|83.0|
4385384|NCT00313586|4211362|B2|||Age||years|Median|72|72.0|Full Range|||30.0|86.0|
4385385|NCT00313586|4211363|B1|||Age||years|Median|72|72.0|Full Range|||25.0|87.0|
4385386|NCT00313443|4211374|B1|France||Region of Enrollment||participants|Number|30|30.0||||||
4385387|NCT00313443|4211374|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4385388|NCT00313443|4211374|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4385389|NCT00313443|4211374|B1|||Age||years|Mean|75|75.0|Standard Deviation|14|14.0|||
4385390|NCT00313443|4211374|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4385391|NCT00313443|4211374|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4385392|NCT00313443|4211374|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4385393|NCT00313313|4211382|B4||Male|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4385394|NCT00313313|4211383|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4385395|NCT00313313|4211384|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4385396|NCT00313313|4211385|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4385397|NCT00313313|4211382|B4||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4385398|NCT00313313|4211383|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4385399|NCT00313313|4211384|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4385400|NCT00313313|4211385|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4385401|NCT00313313|4211382|B4|||Age||years|Mean|55.09|55.09|Standard Deviation|10.09|10.09|||
4385402|NCT00313313|4211383|B3|||Age||years|Mean|55.06|55.06|Standard Deviation|10.69|10.69|||
4385403|NCT00313313|4211384|B2|||Age||years|Mean|54.85|54.85|Standard Deviation|9.96|9.96|||
4385404|NCT00313313|4211385|B1|||Age||years|Mean|55.36|55.36|Standard Deviation|9.58|9.58|||
4385405|NCT00313300|4211404|B6|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4385406|NCT00313300|4211405|B5|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4385407|NCT00313300|4211406|B4|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4385408|NCT00313300|4211407|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4385409|NCT00313300|4211408|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4385410|NCT00313300|4211409|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4385411|NCT00313300|4211404|B6|Germany||Region of Enrollment||participants|Number|95|95.0||||||
4385412|NCT00313300|4211405|B5|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4385413|NCT00313300|4211406|B4|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4385414|NCT00313300|4211407|B3|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4385415|NCT00313300|4211408|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4385416|NCT00313300|4211409|B1|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4385417|NCT00313300|4211404|B6|France||Region of Enrollment||participants|Number|56|56.0||||||
4385418|NCT00313300|4211405|B5|France||Region of Enrollment||participants|Number|10|10.0||||||
4385419|NCT00313300|4211406|B4|France||Region of Enrollment||participants|Number|8|8.0||||||
4385420|NCT00313300|4211407|B3|France||Region of Enrollment||participants|Number|8|8.0||||||
4385421|NCT00313300|4211408|B2|France||Region of Enrollment||participants|Number|9|9.0||||||
4385422|NCT00313300|4211409|B1|France||Region of Enrollment||participants|Number|21|21.0||||||
4385423|NCT00313300|4211404|B6|Israel||Region of Enrollment||participants|Number|163|163.0||||||
4385424|NCT00313300|4211405|B5|Israel||Region of Enrollment||participants|Number|21|21.0||||||
4385425|NCT00313300|4211406|B4|Israel||Region of Enrollment||participants|Number|26|26.0||||||
4385426|NCT00313300|4211407|B3|Israel||Region of Enrollment||participants|Number|32|32.0||||||
4385427|NCT00313300|4211408|B2|Israel||Region of Enrollment||participants|Number|29|29.0||||||
4385428|NCT00313300|4211409|B1|Israel||Region of Enrollment||participants|Number|55|55.0||||||
4385429|NCT00313300|4211404|B6|Denmark||Region of Enrollment||participants|Number|54|54.0||||||
4385430|NCT00313300|4211405|B5|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4385431|NCT00313300|4211406|B4|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4385432|NCT00313300|4211407|B3|Denmark||Region of Enrollment||participants|Number|15|15.0||||||
4385433|NCT00313300|4211408|B2|Denmark||Region of Enrollment||participants|Number|14|14.0||||||
4385434|NCT00313300|4211409|B1|Denmark||Region of Enrollment||participants|Number|16|16.0||||||
4385435|NCT00313300|4211404|B6|Poland||Region of Enrollment||participants|Number|166|166.0||||||
4385436|NCT00313300|4211405|B5|Poland||Region of Enrollment||participants|Number|31|31.0||||||
4385437|NCT00313300|4211406|B4|Poland||Region of Enrollment||participants|Number|34|34.0||||||
4385438|NCT00313300|4211407|B3|Poland||Region of Enrollment||participants|Number|19|19.0||||||
4385439|NCT00313300|4211408|B2|Poland||Region of Enrollment||participants|Number|21|21.0||||||
4385440|NCT00313300|4211409|B1|Poland||Region of Enrollment||participants|Number|61|61.0||||||
4385441|NCT00313300|4211404|B6|Belgium||Region of Enrollment||participants|Number|62|62.0||||||
4385442|NCT00313300|4211405|B5|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4385443|NCT00313300|4211406|B4|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
4385444|NCT00313300|4211407|B3|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4385445|NCT00313300|4211408|B2|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
4385446|NCT00313300|4211409|B1|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
4385447|NCT00313300|4211404|B6|Sweden||Region of Enrollment||participants|Number|111|111.0||||||
4385448|NCT00313300|4211405|B5|Sweden||Region of Enrollment||participants|Number|12|12.0||||||
4385449|NCT00313300|4211406|B4|Sweden||Region of Enrollment||participants|Number|12|12.0||||||
4385450|NCT00313300|4211407|B3|Sweden||Region of Enrollment||participants|Number|24|24.0||||||
4385451|NCT00313300|4211408|B2|Sweden||Region of Enrollment||participants|Number|21|21.0||||||
4385452|NCT00313300|4211409|B1|Sweden||Region of Enrollment||participants|Number|42|42.0||||||
4385453|NCT00313300|4211404|B6|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4385454|NCT00313300|4211405|B5|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4385455|NCT00313300|4211406|B4|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4385456|NCT00313300|4211407|B3|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4385457|NCT00313300|4211408|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4385458|NCT00313300|4211409|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4385459|NCT00313300|4211404|B6|Canada||Region of Enrollment||participants|Number|219|219.0||||||
4385460|NCT00313300|4211405|B5|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4385461|NCT00313300|4211406|B4|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4385462|NCT00313300|4211407|B3|Canada||Region of Enrollment||participants|Number|44|44.0||||||
4385463|NCT00313300|4211408|B2|Canada||Region of Enrollment||participants|Number|47|47.0||||||
4385464|NCT00313300|4211409|B1|Canada||Region of Enrollment||participants|Number|81|81.0||||||
4385465|NCT00313300|4211404|B6|Spain||Region of Enrollment||participants|Number|99|99.0||||||
4385466|NCT00313300|4211405|B5|Spain||Region of Enrollment||participants|Number|19|19.0||||||
4385467|NCT00313300|4211406|B4|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4385468|NCT00313300|4211407|B3|Spain||Region of Enrollment||participants|Number|16|16.0||||||
4385469|NCT00313300|4211408|B2|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4385470|NCT00313300|4211409|B1|Spain||Region of Enrollment||participants|Number|36|36.0||||||
4385471|NCT00313300|4211404|B6|United Kingdom||Region of Enrollment||participants|Number|41|41.0||||||
4385472|NCT00313300|4211405|B5|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4385473|NCT00313300|4211406|B4|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4385474|NCT00313300|4211407|B3|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4385475|NCT00313300|4211408|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4385476|NCT00313300|4211409|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4385477|NCT00313300|4211404|B6|United States||Region of Enrollment||participants|Number|191|191.0||||||
4385478|NCT00313300|4211405|B5|United States||Region of Enrollment||participants|Number|14|14.0||||||
4385479|NCT00313300|4211406|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4385480|NCT00313300|4211407|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4385481|NCT00313300|4211408|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4385482|NCT00313300|4211409|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4385483|NCT00313300|4211404|B6|Russian Federation||Region of Enrollment||participants|Number|442|442.0||||||
4385484|NCT00313300|4211405|B5|Russian Federation||Region of Enrollment||participants|Number|52|52.0||||||
4385485|NCT00313300|4211406|B4|Russian Federation||Region of Enrollment||participants|Number|59|59.0||||||
4385486|NCT00313300|4211407|B3|Russian Federation||Region of Enrollment||participants|Number|82|82.0||||||
4385487|NCT00313300|4211408|B2|Russian Federation||Region of Enrollment||participants|Number|93|93.0||||||
4385488|NCT00313300|4211409|B1|Russian Federation||Region of Enrollment||participants|Number|156|156.0||||||
4385489|NCT00313300|4211404|B6||Male|Sex: Female, Male||Participants|Count of Participants|1302|1302.0||||||
4385490|NCT00313300|4211405|B5||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4385491|NCT00313300|4211406|B4||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4385492|NCT00313300|4211407|B3||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4385493|NCT00313300|4211408|B2||Male|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4385494|NCT00313300|4211409|B1||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
4385495|NCT00313300|4211404|B6||Female|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
4385496|NCT00313300|4211405|B5||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4385497|NCT00313300|4211406|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4385498|NCT00313300|4211407|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4385499|NCT00313300|4211408|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4385500|NCT00313300|4211409|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4385501|NCT00313300|4211404|B6|Greater than (>) 75 years||Age, Customized||participants|Number|213|213.0||||||
4385502|NCT00313300|4211405|B5|Greater than (>) 75 years||Age, Customized||participants|Number|32|32.0||||||
4385503|NCT00313300|4211406|B4|Greater than (>) 75 years||Age, Customized||participants|Number|30|30.0||||||
4385504|NCT00313300|4211407|B3|Greater than (>) 75 years||Age, Customized||participants|Number|39|39.0||||||
4385505|NCT00313300|4211408|B2|Greater than (>) 75 years||Age, Customized||participants|Number|45|45.0||||||
4385506|NCT00313300|4211409|B1|Greater than (>) 75 years||Age, Customized||participants|Number|67|67.0||||||
4385507|NCT00313300|4211404|B6|Greater than, equal to 65 and < 75 years||Age, Customized||participants|Number|447|447.0||||||
4385508|NCT00313300|4211405|B5|Greater than, equal to 65 and < 75 years||Age, Customized||participants|Number|57|57.0||||||
4385509|NCT00313300|4211406|B4|Greater than, equal to 65 and < 75 years||Age, Customized||participants|Number|53|53.0||||||
4385510|NCT00313300|4211407|B3|Greater than, equal to 65 and < 75 years||Age, Customized||participants|Number|82|82.0||||||
4385511|NCT00313300|4211408|B2|Greater than, equal to 65 and < 75 years||Age, Customized||participants|Number|85|85.0||||||
4385512|NCT00313300|4211409|B1|Greater than, equal to 65 and < 75 years||Age, Customized||participants|Number|170|170.0||||||
4385513|NCT00313300|4211404|B6|Less than (<) 65 years||Age, Customized||participants|Number|1055|1055.0||||||
4385514|NCT00313300|4211405|B5|Less than (<) 65 years||Age, Customized||participants|Number|132|132.0||||||
4385515|NCT00313300|4211406|B4|Less than (<) 65 years||Age, Customized||participants|Number|165|165.0||||||
4385516|NCT00313300|4211407|B3|Less than (<) 65 years||Age, Customized||participants|Number|197|197.0||||||
4385517|NCT00313300|4211408|B2|Less than (<) 65 years||Age, Customized||participants|Number|187|187.0||||||
4385518|NCT00313300|4211409|B1|Less than (<) 65 years||Age, Customized||participants|Number|374|374.0||||||
4385519|NCT00313300|4211404|B6|||Age||years|Mean|60.7|60.7|Standard Deviation|11.38|11.38|||
4385520|NCT00313300|4211405|B5|||Age||years|Mean|60.9|60.9|Standard Deviation|11.95|11.95|||
4385521|NCT00313300|4211406|B4|||Age||years|Mean|60.3|60.3|Standard Deviation|11.00|11.0|||
4385522|NCT00313300|4211407|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|11.35|11.35|||
4385523|NCT00313300|4211408|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|11.64|11.64|||
4385524|NCT00313300|4211409|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|11.25|11.25|||
4385525|NCT00313209|4211463|B3||Male|Gender||Participants|Count of Participants|618|618.0||||||
4385526|NCT00313209|4211464|B2||Male|Gender||Participants|Count of Participants|299|299.0||||||
4385527|NCT00313209|4211465|B1||Male|Gender||Participants|Count of Participants|319|319.0||||||
4385528|NCT00313209|4211463|B3||Female|Gender||Participants|Count of Participants|315|315.0||||||
4385529|NCT00313209|4211464|B2||Female|Gender||Participants|Count of Participants|168|168.0||||||
4385530|NCT00313209|4211465|B1||Female|Gender||Participants|Count of Participants|147|147.0||||||
4385531|NCT00313209|4211463|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|9.0|9.0|||
4385532|NCT00313209|4211464|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|9.3|9.3|||
4385533|NCT00313209|4211465|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|8.7|8.7|||
4385534|NCT00313170|4211480|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4385535|NCT00313170|4211481|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4385536|NCT00313170|4211482|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4385537|NCT00313170|4211483|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4385538|NCT00313170|4211480|B4||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4385539|NCT00313170|4211481|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4385540|NCT00313170|4211482|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4385541|NCT00313170|4211483|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4385542|NCT00313170|4211480|B4|||Age||years|Mean|65.8|65.8|Standard Deviation|9.8|9.8|||
4385543|NCT00313170|4211481|B3|||Age||years|Mean|65.5|65.5|Standard Deviation|9.0|9.0|||
4385544|NCT00313170|4211482|B2|||Age||years|Mean|68.1|68.1|Standard Deviation|9.9|9.9|||
4385545|NCT00313170|4211483|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|9.9|9.9|||
4385546|NCT00313144|4211501|B1|Mental Component Score (MCS)||Health Related Quality of Life (HRQoL): Baseline Assessment SF-36 Health Domain Scores (n=126)|The SF-36 is a validated instrument measuring health-related quality of life across multiple disease states. It has 36 questions with 8 subscale scores and 2 summary scores (1) physical component summary score (PCS)=physical functioning, role-physical, bodily pain, and general health; (2) mental component summary score (MCS)=vitality, social functioning, role-emotional, and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0 =worst score (or quality of life) and 100=best score.|Scores on a scale|Mean|50.340|50.34|Standard Deviation|11.897|11.897|||
4385547|NCT00313144|4211501|B1|Physical Component Score (PCS)||Health Related Quality of Life (HRQoL): Baseline Assessment SF-36 Health Domain Scores (n=126)|The SF-36 is a validated instrument measuring health-related quality of life across multiple disease states. It has 36 questions with 8 subscale scores and 2 summary scores (1) physical component summary score (PCS)=physical functioning, role-physical, bodily pain, and general health; (2) mental component summary score (MCS)=vitality, social functioning, role-emotional, and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0 =worst score (or quality of life) and 100=best score.|Scores on a scale|Mean|34.150|34.15|Standard Deviation|11.263|11.263|||
4385548|NCT00313144|4211501|B1|Mental Health (MH)||Health Related Quality of Life (HRQoL): Baseline Assessment SF-36 Health Domain Scores (n=126)|The SF-36 is a validated instrument measuring health-related quality of life across multiple disease states. It has 36 questions with 8 subscale scores and 2 summary scores (1) physical component summary score (PCS)=physical functioning, role-physical, bodily pain, and general health; (2) mental component summary score (MCS)=vitality, social functioning, role-emotional, and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0 =worst score (or quality of life) and 100=best score.|Scores on a scale|Mean|47.326|47.326|Standard Deviation|11.358|11.358|||
4385549|NCT00313144|4211501|B1|Role Limitation Due to Emotional Problems (RE)||Health Related Quality of Life (HRQoL): Baseline Assessment SF-36 Health Domain Scores (n=126)|The SF-36 is a validated instrument measuring health-related quality of life across multiple disease states. It has 36 questions with 8 subscale scores and 2 summary scores (1) physical component summary score (PCS)=physical functioning, role-physical, bodily pain, and general health; (2) mental component summary score (MCS)=vitality, social functioning, role-emotional, and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0 =worst score (or quality of life) and 100=best score.|Scores on a scale|Mean|48.474|48.474|Standard Deviation|10.687|10.687|||
4385550|NCT00313144|4211501|B1|Social Functioning (SF)||Health Related Quality of Life (HRQoL): Baseline Assessment SF-36 Health Domain Scores (n=126)|The SF-36 is a validated instrument measuring health-related quality of life across multiple disease states. It has 36 questions with 8 subscale scores and 2 summary scores (1) physical component summary score (PCS)=physical functioning, role-physical, bodily pain, and general health; (2) mental component summary score (MCS)=vitality, social functioning, role-emotional, and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0 =worst score (or quality of life) and 100=best score.|Scores on a scale|Mean|41.699|41.699|Standard Deviation|14.069|14.069|||
4385551|NCT00313144|4211501|B1|Vitality (VT)||Health Related Quality of Life (HRQoL): Baseline Assessment SF-36 Health Domain Scores (n=126)|The SF-36 is a validated instrument measuring health-related quality of life across multiple disease states. It has 36 questions with 8 subscale scores and 2 summary scores (1) physical component summary score (PCS)=physical functioning, role-physical, bodily pain, and general health; (2) mental component summary score (MCS)=vitality, social functioning, role-emotional, and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0 =worst score (or quality of life) and 100=best score.|Scores on a scale|Mean|42.279|42.279|Standard Deviation|11.209|11.209|||
4385552|NCT00313144|4211501|B1|General Health (GH)||Health Related Quality of Life (HRQoL): Baseline Assessment SF-36 Health Domain Scores (n=126)|The SF-36 is a validated instrument measuring health-related quality of life across multiple disease states. It has 36 questions with 8 subscale scores and 2 summary scores (1) physical component summary score (PCS)=physical functioning, role-physical, bodily pain, and general health; (2) mental component summary score (MCS)=vitality, social functioning, role-emotional, and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0 =worst score (or quality of life) and 100=best score.|Scores on a scale|Mean|37.351|37.351|Standard Deviation|10.120|10.12|||
4385553|NCT00313144|4211501|B1|Bodily Pain (BP)||Health Related Quality of Life (HRQoL): Baseline Assessment SF-36 Health Domain Scores (n=126)|The SF-36 is a validated instrument measuring health-related quality of life across multiple disease states. It has 36 questions with 8 subscale scores and 2 summary scores (1) physical component summary score (PCS)=physical functioning, role-physical, bodily pain, and general health; (2) mental component summary score (MCS)=vitality, social functioning, role-emotional, and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0 =worst score (or quality of life) and 100=best score.|Scores on a scale|Mean|46.368|46.368|Standard Deviation|11.116|11.116|||
4385554|NCT00313144|4211501|B1|Role Limitation Due to Physical Health (RP)||Health Related Quality of Life (HRQoL): Baseline Assessment SF-36 Health Domain Scores (n=126)|The SF-36 is a validated instrument measuring health-related quality of life across multiple disease states. It has 36 questions with 8 subscale scores and 2 summary scores (1) physical component summary score (PCS)=physical functioning, role-physical, bodily pain, and general health; (2) mental component summary score (MCS)=vitality, social functioning, role-emotional, and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0 =worst score (or quality of life) and 100=best score.|Scores on a scale|Mean|37.281|37.281|Standard Deviation|11.871|11.871|||
4385555|NCT00313144|4211501|B1|Physical Functioning (PF)||Health Related Quality of Life (HRQoL): Baseline Assessment SF-36 Health Domain Scores (n=126)|The SF-36 is a validated instrument measuring health-related quality of life across multiple disease states. It has 36 questions with 8 subscale scores and 2 summary scores (1) physical component summary score (PCS)=physical functioning, role-physical, bodily pain, and general health; (2) mental component summary score (MCS)=vitality, social functioning, role-emotional, and mental health. There is no total overall score; scoring is done for both subscores and summary scores. For subscores and summary scores, 0 =worst score (or quality of life) and 100=best score.|Scores on a scale|Mean|31.612|31.612|Standard Deviation|11.678|11.678|||
4385556|NCT00313144|4211501|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
4385557|NCT00313144|4211501|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4385558|NCT00313144|4211501|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4385559|NCT00313144|4211501|B1|||Age||years|Median|52.3|52.3|Full Range|||21.2|84.8|
4385560|NCT00313014|4211585|B4||Male|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4385561|NCT00313014|4211586|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4385562|NCT00313014|4211587|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4385563|NCT00313014|4211588|B1||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4385564|NCT00313014|4211585|B4||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4385565|NCT00313014|4211586|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4385566|NCT00313014|4211587|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4385567|NCT00313014|4211588|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4385568|NCT00313014|4211585|B4|||Age||years|Mean|50.0|50.0|Standard Deviation|12.39|12.39|||
4385569|NCT00313014|4211586|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|12.37|12.37|||
4385570|NCT00313014|4211587|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|11.93|11.93|||
4385571|NCT00313014|4211588|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|12.88|12.88|||
4385572|NCT00312923|4211608|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4385573|NCT00312923|4211609|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4385574|NCT00312923|4211610|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4385575|NCT00312923|4211608|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4385576|NCT00312923|4211609|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4385577|NCT00312923|4211610|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4385578|NCT00312923|4211608|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4385579|NCT00312923|4211609|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4385580|NCT00312923|4211610|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4385581|NCT00312923|4211608|B3|||Age||years|Mean|44.67|44.67|Standard Deviation|6.04|6.04|||
4385582|NCT00312923|4211609|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|6.56|6.56|||
4385583|NCT00312923|4211610|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|.54|0.54|||
4385584|NCT00312923|4211608|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4385585|NCT00312923|4211609|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4385586|NCT00312923|4211610|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4385587|NCT00312923|4211608|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4385588|NCT00312923|4211609|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4385589|NCT00312923|4211610|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4385590|NCT00312923|4211608|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4385591|NCT00312923|4211609|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4385592|NCT00312923|4211610|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4385593|NCT00312897|4211619|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4385594|NCT00312897|4211620|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4385595|NCT00312897|4211621|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4385596|NCT00312897|4211619|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4385597|NCT00312897|4211620|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4385598|NCT00312897|4211621|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4385599|NCT00312897|4211619|B3|||Age||years|Mean|16.05|16.05|Standard Deviation|2.079|2.079|||
4385600|NCT00312897|4211620|B2|||Age||years|Mean|15.68|15.68|Standard Deviation|2.19|2.19|||
4385601|NCT00312897|4211621|B1|||Age||years|Mean|16.34|16.34|Standard Deviation|1.981|1.981|||
4385602|NCT00312884|4211630|B3|United Kingdom||Region of Enrollment||participants|Number|182|182.0||||||
4385603|NCT00312884|4211631|B2|United Kingdom||Region of Enrollment||participants|Number|91|91.0||||||
4385604|NCT00312884|4211632|B1|United Kingdom||Region of Enrollment||participants|Number|91|91.0||||||
4385605|NCT00312884|4211630|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4385606|NCT00312884|4211631|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4385607|NCT00312884|4211632|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4385608|NCT00312884|4211630|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4385609|NCT00312884|4211631|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4385610|NCT00312884|4211632|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4385611|NCT00312884|4211630|B3|||Age||years|Mean|71|71.0|Standard Deviation|11|11.0|||
4385612|NCT00312884|4211631|B2|||Age||years|Mean|70|70.0|Standard Deviation|12.8|12.8|||
4385613|NCT00312884|4211632|B1|||Age||years|Mean|72|72.0|Standard Deviation|10.4|10.4|||
4385614|NCT00312884|4211630|B3||>=65 years|Age||Participants|Count of Participants|122|122.0||||||
4385615|NCT00312884|4211631|B2||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4385616|NCT00312884|4211632|B1||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4385617|NCT00312884|4211630|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4385618|NCT00312884|4211631|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4385619|NCT00312884|4211632|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4385620|NCT00312884|4211630|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4385621|NCT00312884|4211631|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4385622|NCT00312884|4211632|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4385623|NCT00312858|4211645|B3||Male|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
4385624|NCT00312858|4211646|B2||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4385625|NCT00312858|4211647|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4385626|NCT00312858|4211645|B3||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4385627|NCT00312858|4211646|B2||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4385628|NCT00312858|4211647|B1||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4385629|NCT00312858|4211645|B3|||Age||months|Mean|12.4|12.4|Standard Deviation|0.85|0.85|||
4385630|NCT00312858|4211646|B2|||Age||months|Mean|12.5|12.5|Standard Deviation|0.89|0.89|||
4385631|NCT00312858|4211647|B1|||Age||months|Mean|12.4|12.4|Standard Deviation|0.80|0.8|||
4385632|NCT00312845|4211700|B3|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4385633|NCT00312845|4211701|B2|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4385634|NCT00312845|4211702|B1|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4385635|NCT00312845|4211700|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4385636|NCT00312845|4211701|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4385637|NCT00312845|4211702|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4385638|NCT00312845|4211700|B3|Romania||Region of Enrollment||participants|Number|8|8.0||||||
4385639|NCT00312845|4211701|B2|Romania||Region of Enrollment||participants|Number|2|2.0||||||
4385640|NCT00312845|4211702|B1|Romania||Region of Enrollment||participants|Number|6|6.0||||||
4385641|NCT00312845|4211700|B3|Poland||Region of Enrollment||participants|Number|45|45.0||||||
4385642|NCT00312845|4211701|B2|Poland||Region of Enrollment||participants|Number|21|21.0||||||
4385643|NCT00312845|4211702|B1|Poland||Region of Enrollment||participants|Number|24|24.0||||||
4385644|NCT00312845|4211700|B3|Belgium||Region of Enrollment||participants|Number|37|37.0||||||
4385645|NCT00312845|4211701|B2|Belgium||Region of Enrollment||participants|Number|19|19.0||||||
4385646|NCT00312845|4211702|B1|Belgium||Region of Enrollment||participants|Number|18|18.0||||||
4385647|NCT00312845|4211700|B3|Brazil||Region of Enrollment||participants|Number|39|39.0||||||
4385648|NCT00312845|4211701|B2|Brazil||Region of Enrollment||participants|Number|21|21.0||||||
4385649|NCT00312845|4211702|B1|Brazil||Region of Enrollment||participants|Number|18|18.0||||||
4385650|NCT00312845|4211700|B3|Argentina||Region of Enrollment||participants|Number|7|7.0||||||
4385651|NCT00312845|4211701|B2|Argentina||Region of Enrollment||participants|Number|5|5.0||||||
4385652|NCT00312845|4211702|B1|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4385653|NCT00312845|4211700|B3|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4385654|NCT00312845|4211701|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4385655|NCT00312845|4211702|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4385656|NCT00312845|4211700|B3|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4385657|NCT00312845|4211701|B2|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4385658|NCT00312845|4211702|B1|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4385659|NCT00312845|4211700|B3|Czech Republic||Region of Enrollment||participants|Number|35|35.0||||||
4385660|NCT00312845|4211701|B2|Czech Republic||Region of Enrollment||participants|Number|17|17.0||||||
4385661|NCT00312845|4211702|B1|Czech Republic||Region of Enrollment||participants|Number|18|18.0||||||
4385662|NCT00312845|4211700|B3|Hungary||Region of Enrollment||participants|Number|9|9.0||||||
4385663|NCT00312845|4211701|B2|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4385664|NCT00312845|4211702|B1|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4385665|NCT00312845|4211700|B3|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4385666|NCT00312845|4211701|B2|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4385667|NCT00312845|4211702|B1|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4385668|NCT00312845|4211700|B3|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4385669|NCT00312845|4211701|B2|Finland||Region of Enrollment||participants|Number|2|2.0||||||
4385670|NCT00312845|4211702|B1|Finland||Region of Enrollment||participants|Number|1|1.0||||||
4385671|NCT00312845|4211700|B3|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
4385672|NCT00312845|4211701|B2|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4385673|NCT00312845|4211702|B1|Korea, Republic of||Region of Enrollment||participants|Number|4|4.0||||||
4385674|NCT00312845|4211700|B3|China||Region of Enrollment||participants|Number|86|86.0||||||
4385675|NCT00312845|4211701|B2|China||Region of Enrollment||participants|Number|40|40.0||||||
4385676|NCT00312845|4211702|B1|China||Region of Enrollment||participants|Number|46|46.0||||||
4385677|NCT00312845|4211700|B3|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4385678|NCT00312845|4211701|B2|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4385679|NCT00312845|4211702|B1|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4385680|NCT00312845|4211700|B3|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4385681|NCT00312845|4211701|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4385682|NCT00312845|4211702|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4385683|NCT00312845|4211700|B3|France||Region of Enrollment||participants|Number|23|23.0||||||
4385684|NCT00312845|4211701|B2|France||Region of Enrollment||participants|Number|10|10.0||||||
4385685|NCT00312845|4211702|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4385686|NCT00312845|4211700|B3|India||Region of Enrollment||participants|Number|41|41.0||||||
4385687|NCT00312845|4211701|B2|India||Region of Enrollment||participants|Number|24|24.0||||||
4385688|NCT00312845|4211702|B1|India||Region of Enrollment||participants|Number|17|17.0||||||
4385689|NCT00312845|4211700|B3|Italy||Region of Enrollment||participants|Number|29|29.0||||||
4385690|NCT00312845|4211701|B2|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4385691|NCT00312845|4211702|B1|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4385692|NCT00312845|4211700|B3|Russian Federation||Region of Enrollment||participants|Number|107|107.0||||||
4385693|NCT00312845|4211701|B2|Russian Federation||Region of Enrollment||participants|Number|55|55.0||||||
4385694|NCT00312845|4211702|B1|Russian Federation||Region of Enrollment||participants|Number|52|52.0||||||
4385695|NCT00312845|4211700|B3|Israel||Region of Enrollment||participants|Number|14|14.0||||||
4385696|NCT00312845|4211701|B2|Israel||Region of Enrollment||participants|Number|7|7.0||||||
4385697|NCT00312845|4211702|B1|Israel||Region of Enrollment||participants|Number|7|7.0||||||
4385698|NCT00312845|4211700|B3|Ukraine||Region of Enrollment||participants|Number|24|24.0||||||
4385699|NCT00312845|4211701|B2|Ukraine||Region of Enrollment||participants|Number|11|11.0||||||
4385700|NCT00312845|4211702|B1|Ukraine||Region of Enrollment||participants|Number|13|13.0||||||
4385701|NCT00312845|4211700|B3|Spain||Region of Enrollment||participants|Number|14|14.0||||||
4385702|NCT00312845|4211701|B2|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4385703|NCT00312845|4211702|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4385704|NCT00312845|4211700|B3|Thailand||Region of Enrollment||participants|Number|3|3.0||||||
4385705|NCT00312845|4211701|B2|Thailand||Region of Enrollment||participants|Number|1|1.0||||||
4385706|NCT00312845|4211702|B1|Thailand||Region of Enrollment||participants|Number|2|2.0||||||
4385707|NCT00312845|4211700|B3|Greece||Region of Enrollment||participants|Number|2|2.0||||||
4385708|NCT00312845|4211701|B2|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4385709|NCT00312845|4211702|B1|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4385710|NCT00312845|4211700|B3|Slovakia||Region of Enrollment||participants|Number|15|15.0||||||
4385711|NCT00312845|4211701|B2|Slovakia||Region of Enrollment||participants|Number|8|8.0||||||
4385712|NCT00312845|4211702|B1|Slovakia||Region of Enrollment||participants|Number|7|7.0||||||
4385713|NCT00312845|4211700|B3|Portugal||Region of Enrollment||participants|Number|23|23.0||||||
4385714|NCT00312845|4211701|B2|Portugal||Region of Enrollment||participants|Number|12|12.0||||||
4385715|NCT00312845|4211702|B1|Portugal||Region of Enrollment||participants|Number|11|11.0||||||
4385716|NCT00312845|4211700|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4385717|NCT00312845|4211701|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4385718|NCT00312845|4211702|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4385719|NCT00312845|4211700|B3||Male|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4385720|NCT00312845|4211701|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4385721|NCT00312845|4211702|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4385722|NCT00312845|4211700|B3||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4385723|NCT00312845|4211701|B2||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4385724|NCT00312845|4211702|B1||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4385725|NCT00312845|4211700|B3|||Age||years|Mean|57|57.0|Standard Deviation|11.56|11.56|||
4385726|NCT00312845|4211701|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|12|12.0|||
4385727|NCT00312845|4211702|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|11.12|11.12|||
4385728|NCT00312845|4211700|B3||>=65 years|Age||Participants|Count of Participants|191|191.0||||||
4385729|NCT00312845|4211701|B2||>=65 years|Age||Participants|Count of Participants|98|98.0||||||
4385730|NCT00312845|4211702|B1||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
4385731|NCT00312845|4211700|B3||Between 18 and 65 years|Age||Participants|Count of Participants|485|485.0||||||
4385732|NCT00312845|4211701|B2||Between 18 and 65 years|Age||Participants|Count of Participants|242|242.0||||||
4385733|NCT00312845|4211702|B1||Between 18 and 65 years|Age||Participants|Count of Participants|243|243.0||||||
4385734|NCT00312845|4211700|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4385735|NCT00312845|4211701|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4385736|NCT00312845|4211702|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4385737|NCT00312728|4211711|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4385738|NCT00312728|4211711|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4385739|NCT00312728|4211711|B1|>=65 years||Age, Customized||patients|Number|32|32.0||||||
4385740|NCT00312728|4211711|B1|41-64 years||Age, Customized||patients|Number|77|77.0||||||
4385741|NCT00312728|4211711|B1|18-40 years||Age, Customized||patients|Number|6|6.0||||||
4385742|NCT00312728|4211711|B1|||Age||years|Mean|58|58.0|Standard Deviation|10.6|10.6|||
4385743|NCT00312702|4211720|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4385744|NCT00312702|4211721|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4385745|NCT00312702|4211722|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4385746|NCT00312702|4211723|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4385747|NCT00312702|4211720|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385748|NCT00312702|4211721|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385749|NCT00312702|4211722|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385750|NCT00312702|4211723|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385751|NCT00312702|4211720|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4385752|NCT00312702|4211721|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385753|NCT00312702|4211722|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4385754|NCT00312702|4211723|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385755|NCT00312702|4211720|B4||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4385756|NCT00312702|4211721|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4385757|NCT00312702|4211722|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4385758|NCT00312702|4211723|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4385759|NCT00312702|4211720|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385760|NCT00312702|4211721|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385761|NCT00312702|4211722|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385762|NCT00312702|4211723|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385763|NCT00312702|4211720|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385764|NCT00312702|4211721|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385765|NCT00312702|4211722|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385766|NCT00312702|4211723|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385767|NCT00312702|4211720|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385768|NCT00312702|4211721|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385769|NCT00312702|4211722|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385770|NCT00312702|4211723|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385771|NCT00312702|4211720|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4385772|NCT00312702|4211721|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385773|NCT00312702|4211722|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4385774|NCT00312702|4211723|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385775|NCT00312702|4211720|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385776|NCT00312702|4211721|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385777|NCT00312702|4211722|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385778|NCT00312702|4211723|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385779|NCT00312702|4211720|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4385780|NCT00312702|4211721|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4385781|NCT00312702|4211722|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4385782|NCT00312702|4211723|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4385783|NCT00312702|4211720|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385784|NCT00312702|4211721|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385785|NCT00312702|4211722|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385786|NCT00312702|4211723|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385787|NCT00312702|4211720|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4385788|NCT00312702|4211721|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4385789|NCT00312702|4211722|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4385790|NCT00312702|4211723|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4385791|NCT00312702|4211720|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4385792|NCT00312702|4211721|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4385793|NCT00312702|4211722|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4385794|NCT00312702|4211723|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4385795|NCT00312702|4211720|B4|||Age||years|Mean|30.7|30.7|Standard Deviation|8.2|8.2|||
4385796|NCT00312702|4211721|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|0.0|0.0|||
4385797|NCT00312702|4211722|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|8.2|8.2|||
4385798|NCT00312702|4211723|B1|||Age||years|Mean|25.4|25.4|Standard Deviation|6.2|6.2|||
4385799|NCT00312663|4211735|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4385800|NCT00312663|4211736|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4385801|NCT00312663|4211737|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4385802|NCT00312663|4211738|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4385803|NCT00312663|4211735|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385804|NCT00312663|4211736|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385805|NCT00312663|4211737|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385806|NCT00312663|4211738|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385807|NCT00312663|4211735|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4385808|NCT00312663|4211736|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385809|NCT00312663|4211737|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4385810|NCT00312663|4211738|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385811|NCT00312663|4211735|B4||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4385812|NCT00312663|4211736|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4385813|NCT00312663|4211737|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4385814|NCT00312663|4211738|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4385815|NCT00312663|4211735|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4385816|NCT00312663|4211736|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4385817|NCT00312663|4211737|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4385818|NCT00312663|4211738|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385819|NCT00312663|4211735|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385820|NCT00312663|4211736|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385821|NCT00312663|4211737|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385822|NCT00312663|4211738|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385823|NCT00312663|4211735|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4385824|NCT00312663|4211736|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385825|NCT00312663|4211737|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4385826|NCT00312663|4211738|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4385827|NCT00312663|4211735|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385828|NCT00312663|4211736|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385829|NCT00312663|4211737|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385830|NCT00312663|4211738|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4385831|NCT00312663|4211735|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4385832|NCT00312663|4211736|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4385833|NCT00312663|4211737|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4385834|NCT00312663|4211738|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4385835|NCT00312663|4211735|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4385836|NCT00312663|4211736|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4385837|NCT00312663|4211737|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4385838|NCT00312663|4211738|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4385839|NCT00312663|4211735|B4|||Age||years|Mean|32.2|32.2|Standard Deviation|7.9|7.9|||
4385840|NCT00312663|4211736|B3|||Age||years|Mean|24.5|24.5|Standard Deviation|4.9|4.9|||
4385841|NCT00312663|4211737|B2|||Age||years|Mean|32.8|32.8|Standard Deviation|8.1|8.1|||
4385842|NCT00312663|4211738|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|7.9|7.9|||
4385843|NCT00312572|4211751|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4385844|NCT00312572|4211752|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4385845|NCT00312572|4211753|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4385846|NCT00312572|4211751|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4385847|NCT00312572|4211752|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4385848|NCT00312572|4211753|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4385849|NCT00312572|4211751|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|10.04|10.04|||
4385850|NCT00312572|4211752|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|9.97|9.97|||
4385851|NCT00312572|4211753|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|10.10|10.1|||
4385852|NCT00312494|4211762|B4||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4385853|NCT00312494|4211763|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4385854|NCT00312494|4211764|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4385855|NCT00312494|4211765|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4385856|NCT00312494|4211762|B4||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4385857|NCT00312494|4211763|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4385858|NCT00312494|4211764|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4385859|NCT00312494|4211765|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4385860|NCT00312494|4211762|B4|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4385861|NCT00312494|4211763|B3|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4385862|NCT00312494|4211764|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4385863|NCT00312494|4211765|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4385864|NCT00312494|4211762|B4|Between 45 and 64 years||Age, Customized||participants|Number|278|278.0||||||
4385865|NCT00312494|4211763|B3|Between 45 and 64 years||Age, Customized||participants|Number|90|90.0||||||
4385866|NCT00312494|4211764|B2|Between 45 and 64 years||Age, Customized||participants|Number|92|92.0||||||
4385867|NCT00312494|4211765|B1|Between 45 and 64 years||Age, Customized||participants|Number|96|96.0||||||
4385868|NCT00312494|4211762|B4|Between 18 and 44 years||Age, Customized||participants|Number|375|375.0||||||
4385869|NCT00312494|4211763|B3|Between 18 and 44 years||Age, Customized||participants|Number|126|126.0||||||
4385870|NCT00312494|4211764|B2|Between 18 and 44 years||Age, Customized||participants|Number|124|124.0||||||
4385871|NCT00312494|4211765|B1|Between 18 and 44 years||Age, Customized||participants|Number|125|125.0||||||
4385872|NCT00312494|4211762|B4|<18 years||Age, Customized||participants|Number|0|0.0||||||
4385873|NCT00312494|4211763|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4385874|NCT00312494|4211764|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4385875|NCT00312494|4211765|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4385876|NCT00312377|4211799|B3||Male|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4385877|NCT00312377|4211800|B2||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4385878|NCT00312377|4211801|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4385879|NCT00312377|4211799|B3||Female|Sex: Female, Male||Participants|Count of Participants|970|970.0||||||
4385880|NCT00312377|4211800|B2||Female|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
4385881|NCT00312377|4211801|B1||Female|Sex: Female, Male||Participants|Count of Participants|497|497.0||||||
4385882|NCT00312377|4211799|B3|||Age||years|Mean|58.45|58.45|Full Range|||20.0|82.0|
4385883|NCT00312377|4211800|B2|||Age||years|Mean|58.4|58.4|Full Range|||20.0|82.0|
4385884|NCT00312377|4211801|B1|||Age||years|Mean|58.5|58.5|Full Range|||28.0|82.0|
4385885|NCT00312338|4211824|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4385886|NCT00312338|4211825|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4385887|NCT00312338|4211826|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4385888|NCT00312338|4211824|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4385889|NCT00312338|4211825|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4385890|NCT00312338|4211826|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4385891|NCT00312338|4211824|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4385892|NCT00312338|4211825|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4385893|NCT00312338|4211826|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4385894|NCT00312338|4211824|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4385895|NCT00312338|4211825|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4385896|NCT00312338|4211826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4385897|NCT00312338|4211824|B3||<=18 years|Age||Participants|Count of Participants|162|162.0||||||
4385898|NCT00312338|4211825|B2||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4385899|NCT00312338|4211826|B1||<=18 years|Age||Participants|Count of Participants|105|105.0||||||
4385900|NCT00312221|4211837|B4||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4385901|NCT00312221|4211838|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4385902|NCT00312221|4211839|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4385903|NCT00312221|4211840|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4385904|NCT00312221|4211837|B4||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4385905|NCT00312221|4211838|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4385906|NCT00312221|4211839|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4385907|NCT00312221|4211840|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4385908|NCT00312221|4211837|B4|||Age||years|Mean|58.3|58.3|Standard Deviation|10.15|10.15|||
4385909|NCT00312221|4211838|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|10.36|10.36|||
4385910|NCT00312221|4211839|B2|||Age||years|Mean|57.9|57.9|Standard Deviation|9.45|9.45|||
4385911|NCT00312221|4211840|B1|||Age||years|Mean|58.7|58.7|Standard Deviation|10.71|10.71|||
4385912|NCT00312208|4211861|B3|pTis: Carcinoma in situ||Primary Tumor||Participants|Number|1|1.0||||||
4385913|NCT00312208|4211862|B2|pTis: Carcinoma in situ||Primary Tumor||Participants|Number|0|0.0||||||
4385914|NCT00312208|4211863|B1|pTis: Carcinoma in situ||Primary Tumor||Participants|Number|1|1.0||||||
4385915|NCT00312208|4211861|B3|pT4: Tumor with extension to chest wall/skin||Primary Tumor||Participants|Number|3|3.0||||||
4385916|NCT00312208|4211862|B2|pT4: Tumor with extension to chest wall/skin||Primary Tumor||Participants|Number|2|2.0||||||
4385917|NCT00312208|4211863|B1|pT4: Tumor with extension to chest wall/skin||Primary Tumor||Participants|Number|1|1.0||||||
4385918|NCT00312208|4211861|B3|pT3: Tumor > 5cm||Primary Tumor||Participants|Number|266|266.0||||||
4385919|NCT00312208|4211862|B2|pT3: Tumor > 5cm||Primary Tumor||Participants|Number|135|135.0||||||
4385920|NCT00312208|4211863|B1|pT3: Tumor > 5cm||Primary Tumor||Participants|Number|131|131.0||||||
4385921|NCT00312208|4211861|B3|pT2: Tumor in [ 2 - 5 ]||Primary Tumor||Participants|Number|1668|1668.0||||||
4385922|NCT00312208|4211862|B2|pT2: Tumor in [ 2 - 5 ]||Primary Tumor||Participants|Number|844|844.0||||||
4385923|NCT00312208|4211863|B1|pT2: Tumor in [ 2 - 5 ]||Primary Tumor||Participants|Number|824|824.0||||||
4385924|NCT00312208|4211861|B3|pT1: Tumor < = 2cm||Primary Tumor||Participants|Number|1360|1360.0||||||
4385925|NCT00312208|4211862|B2|pT1: Tumor < = 2cm||Primary Tumor||Participants|Number|668|668.0||||||
4385926|NCT00312208|4211863|B1|pT1: Tumor < = 2cm||Primary Tumor||Participants|Number|692|692.0||||||
4385927|NCT00312208|4211861|B3|Quadrantectomy/Segmental||Patients with at least one surgery||Participants|Number|811|811.0||||||
4385928|NCT00312208|4211862|B2|Quadrantectomy/Segmental||Patients with at least one surgery||Participants|Number|400|400.0||||||
4385929|NCT00312208|4211863|B1|Quadrantectomy/Segmental||Patients with at least one surgery||Participants|Number|411|411.0||||||
4385930|NCT00312208|4211861|B3|Lumpectomy||Patients with at least one surgery||Participants|Number|559|559.0||||||
4385931|NCT00312208|4211862|B2|Lumpectomy||Patients with at least one surgery||Participants|Number|276|276.0||||||
4385932|NCT00312208|4211863|B1|Lumpectomy||Patients with at least one surgery||Participants|Number|283|283.0||||||
4385933|NCT00312208|4211861|B3|Mastectomy||Patients with at least one surgery||Participants|Number|1928|1928.0||||||
4385934|NCT00312208|4211862|B2|Mastectomy||Patients with at least one surgery||Participants|Number|973|973.0||||||
4385935|NCT00312208|4211863|B1|Mastectomy||Patients with at least one surgery||Participants|Number|955|955.0||||||
4385936|NCT00312208|4211861|B3|> 10||Number of Positive Lymph Nodes||Participants|Number|364|364.0||||||
4385937|NCT00312208|4211862|B2|> 10||Number of Positive Lymph Nodes||Participants|Number|187|187.0||||||
4385938|NCT00312208|4211863|B1|> 10||Number of Positive Lymph Nodes||Participants|Number|177|177.0||||||
4385939|NCT00312208|4211861|B3|[4 to 10]||Number of Positive Lymph Nodes||Participants|Number|918|918.0||||||
4385940|NCT00312208|4211862|B2|[4 to 10]||Number of Positive Lymph Nodes||Participants|Number|456|456.0||||||
4385941|NCT00312208|4211863|B1|[4 to 10]||Number of Positive Lymph Nodes||Participants|Number|462|462.0||||||
4385942|NCT00312208|4211861|B3|[1 to 3]||Number of Positive Lymph Nodes||Participants|Number|2015|2015.0||||||
4385943|NCT00312208|4211862|B2|[1 to 3]||Number of Positive Lymph Nodes||Participants|Number|1005|1005.0||||||
4385944|NCT00312208|4211863|B1|[1 to 3]||Number of Positive Lymph Nodes||Participants|Number|1010|1010.0||||||
4385945|NCT00312208|4211861|B3|[0]||Number of Positive Lymph Nodes||Participants|Number|1|1.0||||||
4385946|NCT00312208|4211862|B2|[0]||Number of Positive Lymph Nodes||Participants|Number|1|1.0||||||
4385947|NCT00312208|4211863|B1|[0]||Number of Positive Lymph Nodes||Participants|Number|0|0.0||||||
4385948|NCT00312208|4211861|B3|Post-Menopausal or Other age > 50 Years||Menopausal status||Participants|Number|1569|1569.0||||||
4385949|NCT00312208|4211862|B2|Post-Menopausal or Other age > 50 Years||Menopausal status||Participants|Number|786|786.0||||||
4385950|NCT00312208|4211863|B1|Post-Menopausal or Other age > 50 Years||Menopausal status||Participants|Number|783|783.0||||||
4385951|NCT00312208|4211861|B3|Pre-Menopausal or Other age < 50 Years||Menopausal status||Participants|Number|1729|1729.0||||||
4385952|NCT00312208|4211862|B2|Pre-Menopausal or Other age < 50 Years||Menopausal status||Participants|Number|863|863.0||||||
4385953|NCT00312208|4211863|B1|Pre-Menopausal or Other age < 50 Years||Menopausal status||Participants|Number|866|866.0||||||
4385954|NCT00312208|4211861|B3|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status at Baseline||Participants|Number|2591|2591.0||||||
4385955|NCT00312208|4211862|B2|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status at Baseline||Participants|Number|1293|1293.0||||||
4385956|NCT00312208|4211863|B1|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status at Baseline||Participants|Number|1298|1298.0||||||
4385957|NCT00312208|4211861|B3|90 - Normal activity; minor signs of disease||Karnofsky Performance Status at Baseline||Participants|Number|638|638.0||||||
4385958|NCT00312208|4211862|B2|90 - Normal activity; minor signs of disease||Karnofsky Performance Status at Baseline||Participants|Number|323|323.0||||||
4385959|NCT00312208|4211863|B1|90 - Normal activity; minor signs of disease||Karnofsky Performance Status at Baseline||Participants|Number|315|315.0||||||
4385960|NCT00312208|4211861|B3|80 - Activity with effort; some signs of disease||Karnofsky Performance Status at Baseline||Participants|Number|69|69.0||||||
4385961|NCT00312208|4211862|B2|80 - Activity with effort; some signs of disease||Karnofsky Performance Status at Baseline||Participants|Number|33|33.0||||||
4386026|NCT00312208|4211861|B3|Hong Kong||Region of Enrollment||participants|Number|9|9.0||||||
4385962|NCT00312208|4211863|B1|80 - Activity with effort; some signs of disease||Karnofsky Performance Status at Baseline||Participants|Number|36|36.0||||||
4385963|NCT00312208|4211861|B3|Negative||Hormonal Receptor Status||Participants|Number|604|604.0||||||
4385964|NCT00312208|4211862|B2|Negative||Hormonal Receptor Status||Participants|Number|303|303.0||||||
4385965|NCT00312208|4211863|B1|Negative||Hormonal Receptor Status||Participants|Number|301|301.0||||||
4385966|NCT00312208|4211861|B3|Positive||Hormonal Receptor Status||Participants|Number|2694|2694.0||||||
4385967|NCT00312208|4211862|B2|Positive||Hormonal Receptor Status||Participants|Number|1346|1346.0||||||
4385968|NCT00312208|4211863|B1|Positive||Hormonal Receptor Status||Participants|Number|1348|1348.0||||||
4385969|NCT00312208|4211861|B3|Venezuela||Region of Enrollment||participants|Number|11|11.0||||||
4385970|NCT00312208|4211862|B2|Venezuela||Region of Enrollment||participants|Number|5|5.0||||||
4385971|NCT00312208|4211863|B1|Venezuela||Region of Enrollment||participants|Number|6|6.0||||||
4385972|NCT00312208|4211861|B3|Uruguay||Region of Enrollment||participants|Number|6|6.0||||||
4385973|NCT00312208|4211862|B2|Uruguay||Region of Enrollment||participants|Number|2|2.0||||||
4385974|NCT00312208|4211863|B1|Uruguay||Region of Enrollment||participants|Number|4|4.0||||||
4385975|NCT00312208|4211861|B3|United States||Region of Enrollment||participants|Number|572|572.0||||||
4385976|NCT00312208|4211862|B2|United States||Region of Enrollment||participants|Number|278|278.0||||||
4385977|NCT00312208|4211863|B1|United States||Region of Enrollment||participants|Number|294|294.0||||||
4385978|NCT00312208|4211861|B3|Taiwan||Region of Enrollment||participants|Number|34|34.0||||||
4385979|NCT00312208|4211862|B2|Taiwan||Region of Enrollment||participants|Number|16|16.0||||||
4385980|NCT00312208|4211863|B1|Taiwan||Region of Enrollment||participants|Number|18|18.0||||||
4385981|NCT00312208|4211861|B3|Spain||Region of Enrollment||participants|Number|67|67.0||||||
4385982|NCT00312208|4211862|B2|Spain||Region of Enrollment||participants|Number|41|41.0||||||
4385983|NCT00312208|4211863|B1|Spain||Region of Enrollment||participants|Number|26|26.0||||||
4385984|NCT00312208|4211861|B3|South Korea||Region of Enrollment||participants|Number|49|49.0||||||
4385985|NCT00312208|4211862|B2|South Korea||Region of Enrollment||participants|Number|27|27.0||||||
4385986|NCT00312208|4211863|B1|South Korea||Region of Enrollment||participants|Number|22|22.0||||||
4385987|NCT00312208|4211861|B3|South Africa||Region of Enrollment||participants|Number|40|40.0||||||
4385988|NCT00312208|4211862|B2|South Africa||Region of Enrollment||participants|Number|21|21.0||||||
4385989|NCT00312208|4211863|B1|South Africa||Region of Enrollment||participants|Number|19|19.0||||||
4385990|NCT00312208|4211861|B3|Slovenia||Region of Enrollment||participants|Number|32|32.0||||||
4385991|NCT00312208|4211862|B2|Slovenia||Region of Enrollment||participants|Number|17|17.0||||||
4385992|NCT00312208|4211863|B1|Slovenia||Region of Enrollment||participants|Number|15|15.0||||||
4385993|NCT00312208|4211861|B3|Saudi Arabia||Region of Enrollment||participants|Number|2|2.0||||||
4385994|NCT00312208|4211862|B2|Saudi Arabia||Region of Enrollment||participants|Number|0|0.0||||||
4385995|NCT00312208|4211863|B1|Saudi Arabia||Region of Enrollment||participants|Number|2|2.0||||||
4385996|NCT00312208|4211861|B3|Romania||Region of Enrollment||participants|Number|36|36.0||||||
4385997|NCT00312208|4211862|B2|Romania||Region of Enrollment||participants|Number|19|19.0||||||
4385998|NCT00312208|4211863|B1|Romania||Region of Enrollment||participants|Number|17|17.0||||||
4385999|NCT00312208|4211861|B3|Russian Federation||Region of Enrollment||participants|Number|67|67.0||||||
4386000|NCT00312208|4211862|B2|Russian Federation||Region of Enrollment||participants|Number|35|35.0||||||
4386001|NCT00312208|4211863|B1|Russian Federation||Region of Enrollment||participants|Number|32|32.0||||||
4386002|NCT00312208|4211861|B3|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4386003|NCT00312208|4211862|B2|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4386004|NCT00312208|4211863|B1|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4386005|NCT00312208|4211861|B3|Poland||Region of Enrollment||participants|Number|335|335.0||||||
4386006|NCT00312208|4211862|B2|Poland||Region of Enrollment||participants|Number|168|168.0||||||
4386007|NCT00312208|4211863|B1|Poland||Region of Enrollment||participants|Number|167|167.0||||||
4386008|NCT00312208|4211861|B3|New Zealand||Region of Enrollment||participants|Number|40|40.0||||||
4386009|NCT00312208|4211862|B2|New Zealand||Region of Enrollment||participants|Number|19|19.0||||||
4386010|NCT00312208|4211863|B1|New Zealand||Region of Enrollment||participants|Number|21|21.0||||||
4386011|NCT00312208|4211861|B3|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4386012|NCT00312208|4211862|B2|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4386013|NCT00312208|4211863|B1|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4386014|NCT00312208|4211861|B3|Lebanon||Region of Enrollment||participants|Number|41|41.0||||||
4386015|NCT00312208|4211862|B2|Lebanon||Region of Enrollment||participants|Number|18|18.0||||||
4386016|NCT00312208|4211863|B1|Lebanon||Region of Enrollment||participants|Number|23|23.0||||||
4386017|NCT00312208|4211861|B3|Israel||Region of Enrollment||participants|Number|130|130.0||||||
4386018|NCT00312208|4211862|B2|Israel||Region of Enrollment||participants|Number|67|67.0||||||
4386019|NCT00312208|4211863|B1|Israel||Region of Enrollment||participants|Number|63|63.0||||||
4386020|NCT00312208|4211861|B3|Ireland||Region of Enrollment||participants|Number|171|171.0||||||
4386021|NCT00312208|4211862|B2|Ireland||Region of Enrollment||participants|Number|88|88.0||||||
4386022|NCT00312208|4211863|B1|Ireland||Region of Enrollment||participants|Number|83|83.0||||||
4386023|NCT00312208|4211861|B3|Hungary||Region of Enrollment||participants|Number|69|69.0||||||
4386024|NCT00312208|4211862|B2|Hungary||Region of Enrollment||participants|Number|35|35.0||||||
4386025|NCT00312208|4211863|B1|Hungary||Region of Enrollment||participants|Number|34|34.0||||||
4386027|NCT00312208|4211862|B2|Hong Kong||Region of Enrollment||participants|Number|6|6.0||||||
4386028|NCT00312208|4211863|B1|Hong Kong||Region of Enrollment||participants|Number|3|3.0||||||
4386029|NCT00312208|4211861|B3|Greece||Region of Enrollment||participants|Number|8|8.0||||||
4386030|NCT00312208|4211862|B2|Greece||Region of Enrollment||participants|Number|3|3.0||||||
4386031|NCT00312208|4211863|B1|Greece||Region of Enrollment||participants|Number|5|5.0||||||
4386032|NCT00312208|4211861|B3|Germany||Region of Enrollment||participants|Number|447|447.0||||||
4386033|NCT00312208|4211862|B2|Germany||Region of Enrollment||participants|Number|223|223.0||||||
4386034|NCT00312208|4211863|B1|Germany||Region of Enrollment||participants|Number|224|224.0||||||
4386035|NCT00312208|4211861|B3|France||Region of Enrollment||participants|Number|117|117.0||||||
4386036|NCT00312208|4211862|B2|France||Region of Enrollment||participants|Number|58|58.0||||||
4386037|NCT00312208|4211863|B1|France||Region of Enrollment||participants|Number|59|59.0||||||
4386038|NCT00312208|4211861|B3|Estonia||Region of Enrollment||participants|Number|5|5.0||||||
4386039|NCT00312208|4211862|B2|Estonia||Region of Enrollment||participants|Number|2|2.0||||||
4386040|NCT00312208|4211863|B1|Estonia||Region of Enrollment||participants|Number|3|3.0||||||
4386041|NCT00312208|4211861|B3|Egypt||Region of Enrollment||participants|Number|8|8.0||||||
4386042|NCT00312208|4211862|B2|Egypt||Region of Enrollment||participants|Number|4|4.0||||||
4386043|NCT00312208|4211863|B1|Egypt||Region of Enrollment||participants|Number|4|4.0||||||
4386044|NCT00312208|4211861|B3|Czech Republic||Region of Enrollment||participants|Number|21|21.0||||||
4386045|NCT00312208|4211862|B2|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
4386046|NCT00312208|4211863|B1|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
4386047|NCT00312208|4211861|B3|Cyprus||Region of Enrollment||participants|Number|7|7.0||||||
4386048|NCT00312208|4211862|B2|Cyprus||Region of Enrollment||participants|Number|5|5.0||||||
4386049|NCT00312208|4211863|B1|Cyprus||Region of Enrollment||participants|Number|2|2.0||||||
4386050|NCT00312208|4211861|B3|Croatia||Region of Enrollment||participants|Number|58|58.0||||||
4386051|NCT00312208|4211862|B2|Croatia||Region of Enrollment||participants|Number|29|29.0||||||
4386052|NCT00312208|4211863|B1|Croatia||Region of Enrollment||participants|Number|29|29.0||||||
4386053|NCT00312208|4211861|B3|Colombia||Region of Enrollment||participants|Number|14|14.0||||||
4386054|NCT00312208|4211862|B2|Colombia||Region of Enrollment||participants|Number|8|8.0||||||
4386055|NCT00312208|4211863|B1|Colombia||Region of Enrollment||participants|Number|6|6.0||||||
4386056|NCT00312208|4211861|B3|China||Region of Enrollment||participants|Number|38|38.0||||||
4386057|NCT00312208|4211862|B2|China||Region of Enrollment||participants|Number|17|17.0||||||
4386058|NCT00312208|4211863|B1|China||Region of Enrollment||participants|Number|21|21.0||||||
4386059|NCT00312208|4211861|B3|Canada||Region of Enrollment||participants|Number|354|354.0||||||
4386060|NCT00312208|4211862|B2|Canada||Region of Enrollment||participants|Number|180|180.0||||||
4386061|NCT00312208|4211863|B1|Canada||Region of Enrollment||participants|Number|174|174.0||||||
4386062|NCT00312208|4211861|B3|Bulgaria||Region of Enrollment||participants|Number|22|22.0||||||
4386063|NCT00312208|4211862|B2|Bulgaria||Region of Enrollment||participants|Number|11|11.0||||||
4386064|NCT00312208|4211863|B1|Bulgaria||Region of Enrollment||participants|Number|11|11.0||||||
4386065|NCT00312208|4211861|B3|Brazil||Region of Enrollment||participants|Number|40|40.0||||||
4386066|NCT00312208|4211862|B2|Brazil||Region of Enrollment||participants|Number|21|21.0||||||
4386067|NCT00312208|4211863|B1|Brazil||Region of Enrollment||participants|Number|19|19.0||||||
4386068|NCT00312208|4211861|B3|Bosnia And Herzegovina||Region of Enrollment||participants|Number|10|10.0||||||
4386069|NCT00312208|4211862|B2|Bosnia And Herzegovina||Region of Enrollment||participants|Number|5|5.0||||||
4386070|NCT00312208|4211863|B1|Bosnia And Herzegovina||Region of Enrollment||participants|Number|5|5.0||||||
4386071|NCT00312208|4211861|B3|Belgium||Region of Enrollment||participants|Number|64|64.0||||||
4386072|NCT00312208|4211862|B2|Belgium||Region of Enrollment||participants|Number|31|31.0||||||
4386073|NCT00312208|4211863|B1|Belgium||Region of Enrollment||participants|Number|33|33.0||||||
4386074|NCT00312208|4211861|B3|Australia||Region of Enrollment||participants|Number|300|300.0||||||
4386075|NCT00312208|4211862|B2|Australia||Region of Enrollment||participants|Number|144|144.0||||||
4386076|NCT00312208|4211863|B1|Australia||Region of Enrollment||participants|Number|156|156.0||||||
4386077|NCT00312208|4211861|B3|Argentina||Region of Enrollment||participants|Number|63|63.0||||||
4386078|NCT00312208|4211862|B2|Argentina||Region of Enrollment||participants|Number|32|32.0||||||
4386079|NCT00312208|4211863|B1|Argentina||Region of Enrollment||participants|Number|31|31.0||||||
4386080|NCT00312208|4211861|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386081|NCT00312208|4211862|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386082|NCT00312208|4211863|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386083|NCT00312208|4211861|B3||Female|Sex: Female, Male||Participants|Count of Participants|3298|3298.0||||||
4386084|NCT00312208|4211862|B2||Female|Sex: Female, Male||Participants|Count of Participants|1649|1649.0||||||
4386085|NCT00312208|4211863|B1||Female|Sex: Female, Male||Participants|Count of Participants|1649|1649.0||||||
4386086|NCT00312208|4211861|B3|||Age||years|Median|50|50.0|Full Range|||22.0|74.0|
4386087|NCT00312208|4211862|B2|||Age||years|Median|50|50.0|Full Range|||24.0|72.0|
4386088|NCT00312208|4211863|B1|||Age||years|Median|50|50.0|Full Range|||22.0|74.0|
4386089|NCT00312208|4211861|B3|< =35 years||Age, Customized||Participants|Number|164|164.0||||||
4386090|NCT00312208|4211862|B2|< =35 years||Age, Customized||Participants|Number|73|73.0||||||
4386091|NCT00312208|4211863|B1|< =35 years||Age, Customized||Participants|Number|91|91.0||||||
4386092|NCT00312208|4211861|B3|Between 49 and 35 years||Age, Customized||Participants|Number|1399|1399.0||||||
4386093|NCT00312208|4211862|B2|Between 49 and 35 years||Age, Customized||Participants|Number|710|710.0||||||
4386094|NCT00312208|4211863|B1|Between 49 and 35 years||Age, Customized||Participants|Number|689|689.0||||||
4386095|NCT00312208|4211861|B3|Between 65 and 50 years||Age, Customized||Participants|Number|1567|1567.0||||||
4386096|NCT00312208|4211862|B2|Between 65 and 50 years||Age, Customized||Participants|Number|783|783.0||||||
4386097|NCT00312208|4211863|B1|Between 65 and 50 years||Age, Customized||Participants|Number|784|784.0||||||
4386098|NCT00312208|4211861|B3|> =65 years||Age, Customized||Participants|Number|168|168.0||||||
4386099|NCT00312208|4211862|B2|> =65 years||Age, Customized||Participants|Number|83|83.0||||||
4386100|NCT00312208|4211863|B1|> =65 years||Age, Customized||Participants|Number|85|85.0||||||
4386101|NCT00312195|4211872|B3|United Kingdom||Region of Enrollment||participants|Number|179|179.0||||||
4386102|NCT00312195|4211873|B2|United Kingdom||Region of Enrollment||participants|Number|87|87.0||||||
4386103|NCT00312195|4211874|B1|United Kingdom||Region of Enrollment||participants|Number|92|92.0||||||
4386104|NCT00312195|4211872|B3|United States||Region of Enrollment||participants|Number|88|88.0||||||
4386105|NCT00312195|4211873|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4386106|NCT00312195|4211874|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4386107|NCT00312195|4211872|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4386108|NCT00312195|4211873|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4386109|NCT00312195|4211874|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4386110|NCT00312195|4211872|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4386111|NCT00312195|4211873|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4386112|NCT00312195|4211874|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4386113|NCT00312195|4211872|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|12.48|12.48|||
4386114|NCT00312195|4211873|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|13.34|13.34|||
4386115|NCT00312195|4211874|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|11.48|11.48|||
4386116|NCT00311766|4211889|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4386117|NCT00311766|4211890|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4386118|NCT00311766|4211891|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4386119|NCT00311766|4211889|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4386120|NCT00311766|4211890|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4386121|NCT00311766|4211891|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4386122|NCT00311766|4211889|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4386123|NCT00311766|4211890|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4386124|NCT00311766|4211891|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4386125|NCT00311766|4211889|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386126|NCT00311766|4211890|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386127|NCT00311766|4211891|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386128|NCT00311766|4211889|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4386129|NCT00311766|4211890|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4386130|NCT00311766|4211891|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4386131|NCT00311766|4211889|B3||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4386132|NCT00311766|4211890|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4386133|NCT00311766|4211891|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4386134|NCT00311584|4211900|B3|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4386135|NCT00311584|4211901|B2|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4386136|NCT00311584|4211902|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4386137|NCT00311584|4211900|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4386138|NCT00311584|4211901|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4386139|NCT00311584|4211902|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4386140|NCT00311584|4211900|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4386141|NCT00311584|4211901|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4386142|NCT00311584|4211902|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4386143|NCT00311584|4211900|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4386144|NCT00311584|4211901|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4386145|NCT00311584|4211902|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4386146|NCT00311584|4211900|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386147|NCT00311584|4211901|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386148|NCT00311584|4211902|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386149|NCT00311584|4211900|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4386150|NCT00311584|4211901|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4386151|NCT00311584|4211902|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4386152|NCT00311584|4211900|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4386153|NCT00311584|4211901|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4386154|NCT00311584|4211902|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4386155|NCT00311584|4211900|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4386156|NCT00311584|4211901|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386157|NCT00311584|4211902|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4386158|NCT00311584|4211900|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4386159|NCT00311584|4211901|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4386160|NCT00311584|4211902|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386161|NCT00311584|4211900|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386162|NCT00311584|4211901|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386163|NCT00311584|4211902|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386164|NCT00311584|4211900|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4386165|NCT00311584|4211901|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4386166|NCT00311584|4211902|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4386167|NCT00311584|4211900|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4386168|NCT00311584|4211901|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4386169|NCT00311584|4211902|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4386170|NCT00311584|4211900|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4386171|NCT00311584|4211901|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4386172|NCT00311584|4211902|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386173|NCT00311584|4211900|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4386174|NCT00311584|4211901|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4386175|NCT00311584|4211902|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4386176|NCT00311584|4211900|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4386177|NCT00311584|4211901|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4386178|NCT00311584|4211902|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4386179|NCT00311584|4211900|B3|||Age||days|Median|1742|1742.0|Inter-Quartile Range|||1420.0|2737.75|
4386180|NCT00311584|4211901|B2|||Age||days|Median|1562|1562.0|Inter-Quartile Range|||1158.0|2648.5|
4386181|NCT00311584|4211902|B1|||Age||days|Median|1922|1922.0|Inter-Quartile Range|||1682.0|2827.0|
4386182|NCT00311584|4211900|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386183|NCT00311584|4211901|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386184|NCT00311584|4211902|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386185|NCT00311584|4211900|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4386186|NCT00311584|4211901|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4386187|NCT00311584|4211902|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4386188|NCT00311584|4211900|B3||<=18 years|Age||Participants|Count of Participants|58|58.0||||||
4386189|NCT00311584|4211901|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4386190|NCT00311584|4211902|B1||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4386191|NCT00311402|4211909|B3||Male|Sex: Female, Male||Participants|Count of Participants|925|925.0||||||
4386192|NCT00311402|4211910|B2||Male|Sex: Female, Male||Participants|Count of Participants|453|453.0||||||
4386193|NCT00311402|4211911|B1||Male|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
4386194|NCT00311402|4211909|B3||Female|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
4386195|NCT00311402|4211910|B2||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4386196|NCT00311402|4211911|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4386197|NCT00311402|4211909|B3|||Age||years|Mean|66.1|66.1|Standard Deviation|8.4|8.4|||
4386198|NCT00311402|4211910|B2|||Age||years|Mean|66.0|66.0|Standard Deviation|8.6|8.6|||
4386199|NCT00311402|4211911|B1|||Age||years|Mean|66.2|66.2|Standard Deviation|8.1|8.1|||
4386200|NCT00311376|4211936|B4||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4386201|NCT00311376|4211937|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4386202|NCT00311376|4211938|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4386203|NCT00311376|4211939|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4386204|NCT00311376|4211936|B4||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4386205|NCT00311376|4211937|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4386206|NCT00311376|4211938|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4386207|NCT00311376|4211939|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4386208|NCT00311376|4211936|B4|>=75 years||Age, Customized||participants|Number|0|0.0||||||
4386209|NCT00311376|4211937|B3|>=75 years||Age, Customized||participants|Number|0|0.0||||||
4386210|NCT00311376|4211938|B2|>=75 years||Age, Customized||participants|Number|0|0.0||||||
4386211|NCT00311376|4211939|B1|>=75 years||Age, Customized||participants|Number|0|0.0||||||
4386212|NCT00311376|4211936|B4|Between 65 and 74 years||Age, Customized||participants|Number|32|32.0||||||
4386213|NCT00311376|4211937|B3|Between 65 and 74 years||Age, Customized||participants|Number|9|9.0||||||
4386214|NCT00311376|4211938|B2|Between 65 and 74 years||Age, Customized||participants|Number|14|14.0||||||
4386215|NCT00311376|4211939|B1|Between 65 and 74 years||Age, Customized||participants|Number|9|9.0||||||
4386216|NCT00311376|4211936|B4|Between 40 and 64 years||Age, Customized||participants|Number|251|251.0||||||
4386217|NCT00311376|4211937|B3|Between 40 and 64 years||Age, Customized||participants|Number|95|95.0||||||
4386218|NCT00311376|4211938|B2|Between 40 and 64 years||Age, Customized||participants|Number|73|73.0||||||
4386219|NCT00311376|4211939|B1|Between 40 and 64 years||Age, Customized||participants|Number|83|83.0||||||
4386220|NCT00311376|4211936|B4|<40 years||Age, Customized||participants|Number|133|133.0||||||
4386221|NCT00311376|4211937|B3|<40 years||Age, Customized||participants|Number|45|45.0||||||
4386222|NCT00311376|4211938|B2|<40 years||Age, Customized||participants|Number|48|48.0||||||
4386223|NCT00311376|4211939|B1|<40 years||Age, Customized||participants|Number|40|40.0||||||
4386224|NCT00311363|4211958|B4|Other, Syrian||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|1|1.0||||||
4386225|NCT00311363|4211959|B3|Other, Syrian||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|0|0.0||||||
4386226|NCT00311363|4211960|B2|Other, Syrian||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|0|0.0||||||
4386227|NCT00311363|4211961|B1|Other, Syrian||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|1|1.0||||||
4386228|NCT00311363|4211958|B4|Hispanic||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|5|5.0||||||
4386229|NCT00311363|4211959|B3|Hispanic||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|1|1.0||||||
4386230|NCT00311363|4211960|B2|Hispanic||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|1|1.0||||||
4386231|NCT00311363|4211961|B1|Hispanic||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|3|3.0||||||
4386232|NCT00311363|4211958|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|1|1.0||||||
4386233|NCT00311363|4211959|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|0|0.0||||||
4386234|NCT00311363|4211960|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|0|0.0||||||
4386235|NCT00311363|4211961|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|1|1.0||||||
4386236|NCT00311363|4211958|B4|Black or African American||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|23|23.0||||||
4386237|NCT00311363|4211959|B3|Black or African American||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|2|2.0||||||
4386238|NCT00311363|4211960|B2|Black or African American||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|5|5.0||||||
4386239|NCT00311363|4211961|B1|Black or African American||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|16|16.0||||||
4386240|NCT00311363|4211958|B4|White or Caucasian||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|490|490.0||||||
4386241|NCT00311363|4211959|B3|White or Caucasian||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|93|93.0||||||
4386242|NCT00311363|4211960|B2|White or Caucasian||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|92|92.0||||||
4386243|NCT00311363|4211961|B1|White or Caucasian||Race/Ethnicity, Customized|The Safety Population (all participants received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|participants|Number|305|305.0||||||
4386244|NCT00311363|4211958|B4||Male|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|Participants|Count of Participants|217|217.0||||||
4386245|NCT00311363|4211959|B3||Male|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|Participants|Count of Participants|34|34.0||||||
4386297|NCT00310856|4212089|B4|||Age||Months|Mean|7.7|7.7|Standard Deviation|2.8|2.8|||
4386246|NCT00311363|4211960|B2||Male|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|Participants|Count of Participants|45|45.0||||||
4386247|NCT00311363|4211961|B1||Male|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|Participants|Count of Participants|138|138.0||||||
4386248|NCT00311363|4211958|B4||Female|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|Participants|Count of Participants|303|303.0||||||
4386249|NCT00311363|4211959|B3||Female|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|Participants|Count of Participants|62|62.0||||||
4386250|NCT00311363|4211960|B2||Female|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|Participants|Count of Participants|53|53.0||||||
4386251|NCT00311363|4211961|B1||Female|Sex: Female, Male|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|Participants|Count of Participants|188|188.0||||||
4386252|NCT00311363|4211958|B4|||Age|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|Years|Mean|51.5|51.5|Standard Deviation|11.87|11.87|||
4386253|NCT00311363|4211959|B3|||Age|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|Years|Mean|50.7|50.7|Standard Deviation|11.68|11.68|||
4386254|NCT00311363|4211960|B2|||Age|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|Years|Mean|52.2|52.2|Standard Deviation|12.07|12.07|||
4386255|NCT00311363|4211961|B1|||Age|The Safety Population (all participants who received at least one dose [or any portion of a dose] of study drug) was used for all baseline characteristics.|Years|Mean|49.8|49.8|Standard Deviation|12.38|12.38|||
4386256|NCT00311311|4212021|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4386257|NCT00311311|4212022|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4386258|NCT00311311|4212023|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4386259|NCT00311311|4212021|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4386260|NCT00311311|4212022|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4386261|NCT00311311|4212023|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4386262|NCT00311311|4212021|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|11.02|11.02|||
4386263|NCT00311311|4212022|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|11.08|11.08|||
4386264|NCT00311311|4212023|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|11.11|11.11|||
4386265|NCT00311181|4212074|B1|United States||Region of Enrollment||participants|Number|217|217.0||||||
4386266|NCT00311181|4212074|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4386267|NCT00311181|4212074|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4386268|NCT00311181|4212074|B1|||Age||years|Mean|67|67.0|Standard Deviation|14|14.0|||
4386269|NCT00311181|4212074|B1||>=65 years|Age||Participants|Count of Participants|129|129.0||||||
4386270|NCT00311181|4212074|B1||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4386271|NCT00311181|4212074|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386272|NCT00311155|4212080|B1|Asian||Ethnicity||Participants|Number|3|3.0||||||
4386273|NCT00311155|4212080|B1|Black||Ethnicity||Participants|Number|13|13.0||||||
4386274|NCT00311155|4212080|B1|Caucasian||Ethnicity||Participants|Number|678|678.0||||||
4386275|NCT00311155|4212080|B1|||Body Mass Index||kg/m^2|Mean|28.86|28.86|Standard Deviation|4.69|4.69|||
4386276|NCT00311155|4212080|B1|||Weight||kg|Mean|82.16|82.16|Standard Deviation|16.09|16.09|||
4386277|NCT00311155|4212080|B1|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
4386278|NCT00311155|4212080|B1|Italy||Region of Enrollment||participants|Number|35|35.0||||||
4386279|NCT00311155|4212080|B1|United Kingdom||Region of Enrollment||participants|Number|141|141.0||||||
4386280|NCT00311155|4212080|B1|Germany||Region of Enrollment||participants|Number|207|207.0||||||
4386281|NCT00311155|4212080|B1|Netherlands||Region of Enrollment||participants|Number|43|43.0||||||
4386282|NCT00311155|4212080|B1|Austria||Region of Enrollment||participants|Number|35|35.0||||||
4386283|NCT00311155|4212080|B1|Belgium||Region of Enrollment||participants|Number|94|94.0||||||
4386284|NCT00311155|4212080|B1|France||Region of Enrollment||participants|Number|121|121.0||||||
4386285|NCT00311155|4212080|B1|Portugal||Region of Enrollment||participants|Number|12|12.0||||||
4386286|NCT00311155|4212080|B1||Male|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
4386287|NCT00311155|4212080|B1||Female|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
4386288|NCT00311155|4212080|B1|||Age||years|Mean|58.16|58.16|Standard Deviation|12.06|12.06|||
4386289|NCT00310856|4212089|B4||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4386290|NCT00310856|4212090|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4386291|NCT00310856|4212091|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4386292|NCT00310856|4212092|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4386293|NCT00310856|4212089|B4||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4386294|NCT00310856|4212090|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4386295|NCT00310856|4212091|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4386296|NCT00310856|4212092|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4386298|NCT00310856|4212090|B3|||Age||Months|Mean|12.1|12.1|Standard Deviation|0.2|0.2|||
4386299|NCT00310856|4212091|B2|||Age||Months|Mean|6.0|6.0|Standard Deviation|0.0|0.0|||
4386300|NCT00310856|4212092|B1|||Age||Months|Mean|6.0|6.0|Standard Deviation|0.2|0.2|||
4386301|NCT00310817|4212114|B5||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4386302|NCT00310817|4212115|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4386303|NCT00310817|4212116|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4386304|NCT00310817|4212117|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4386305|NCT00310817|4212118|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4386306|NCT00310817|4212114|B5||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4386307|NCT00310817|4212115|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4386308|NCT00310817|4212116|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4386309|NCT00310817|4212117|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4386310|NCT00310817|4212118|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4386311|NCT00310817|4212114|B5|||Age||Months|Mean|31.0|31.0|Standard Deviation|11.8|11.8|||
4386312|NCT00310817|4212115|B4|||Age||Months|Mean|44.7|44.7|Standard Deviation|6.4|6.4|||
4386313|NCT00310817|4212116|B3|||Age||Months|Mean|45.1|45.1|Standard Deviation|6.7|6.7|||
4386314|NCT00310817|4212117|B2|||Age||Months|Mean|23.7|23.7|Standard Deviation|6.2|6.2|||
4386315|NCT00310817|4212118|B1|||Age||Months|Mean|24.1|24.1|Standard Deviation|6.4|6.4|||
4386316|NCT00310804|4212207|B3|Lithuania||Region of Enrollment||participants|Number|700|700.0||||||
4386317|NCT00310804|4212208|B2|Lithuania||Region of Enrollment||participants|Number|100|100.0||||||
4386318|NCT00310804|4212209|B1|Lithuania||Region of Enrollment||participants|Number|600|600.0||||||
4386319|NCT00310804|4212207|B3||Male|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4386320|NCT00310804|4212208|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4386321|NCT00310804|4212209|B1||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4386322|NCT00310804|4212207|B3||Female|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4386323|NCT00310804|4212208|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4386324|NCT00310804|4212209|B1||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4386325|NCT00310804|4212207|B3|||Age||years|Mean|27.2|27.2|Standard Deviation|11.1|11.1|||
4386326|NCT00310804|4212208|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|11.5|11.5|||
4386327|NCT00310804|4212209|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|11.1|11.1|||
4386328|NCT00310791|4212243|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4386329|NCT00310791|4212244|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4386330|NCT00310791|4212245|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4386331|NCT00310791|4212243|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386332|NCT00310791|4212244|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386333|NCT00310791|4212245|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386334|NCT00310791|4212243|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4386335|NCT00310791|4212244|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4386336|NCT00310791|4212245|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4386337|NCT00310791|4212243|B3|||Age||years|Mean|22|22.0|Standard Deviation|8|8.0|||
4386338|NCT00310791|4212244|B2|||Age||years|Mean|24|24.0|Standard Deviation|6|6.0|||
4386339|NCT00310791|4212245|B1|||Age||years|Mean|21|21.0|Standard Deviation|4|4.0|||
4386340|NCT00310791|4212243|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386341|NCT00310791|4212244|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386342|NCT00310791|4212245|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386343|NCT00310791|4212243|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4386344|NCT00310791|4212244|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4386345|NCT00310791|4212245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4386346|NCT00310791|4212243|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4386347|NCT00310791|4212244|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4386348|NCT00310791|4212245|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4386349|NCT00310466|4212252|B3|Germany||Region of Enrollment||participants|Number|226.0|226.0||||||
4386350|NCT00310466|4212253|B2|Germany||Region of Enrollment||participants|Number|113|113.0||||||
4386351|NCT00310466|4212254|B1|Germany||Region of Enrollment||participants|Number|113|113.0||||||
4386352|NCT00310466|4212252|B3||Male|Sex: Female, Male||Participants|Count of Participants|86.0|86.0||||||
4386353|NCT00310466|4212253|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4386354|NCT00310466|4212254|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4386355|NCT00310466|4212252|B3||Female|Sex: Female, Male||Participants|Count of Participants|140.0|140.0||||||
4386356|NCT00310466|4212253|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4386357|NCT00310466|4212254|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4386358|NCT00310466|4212252|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|11.2|11.2|||
4386359|NCT00310466|4212253|B2|||Age||years|Mean|39.5|39.5|Standard Deviation|11.5|11.5|||
4386360|NCT00310466|4212254|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|10.9|10.9|||
4386361|NCT00310466|4212252|B3||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4386362|NCT00310466|4212253|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386363|NCT00310466|4212254|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386364|NCT00310466|4212252|B3||Between 18 and 65 years|Age||Participants|Count of Participants|226.0|226.0||||||
4386365|NCT00310466|4212253|B2||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4386366|NCT00310466|4212254|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4386367|NCT00310466|4212252|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4386368|NCT00310466|4212253|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386369|NCT00310466|4212254|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386370|NCT00310440|4212267|B3|United States||Region of Enrollment||participants|Number|264|264.0||||||
4386371|NCT00310440|4212268|B2|United States||Region of Enrollment||participants|Number|128|128.0||||||
4386372|NCT00310440|4212269|B1|United States||Region of Enrollment||participants|Number|136|136.0||||||
4386373|NCT00310440|4212267|B3|Canada||Region of Enrollment||participants|Number|55|55.0||||||
4386374|NCT00310440|4212268|B2|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4386375|NCT00310440|4212269|B1|Canada||Region of Enrollment||participants|Number|29|29.0||||||
4386376|NCT00310440|4212267|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4386377|NCT00310440|4212268|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4386378|NCT00310440|4212269|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4386379|NCT00310440|4212267|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386380|NCT00310440|4212268|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386381|NCT00310440|4212269|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386382|NCT00310440|4212267|B3||White|Race (NIH/OMB)||Participants|Count of Participants|295|295.0||||||
4386383|NCT00310440|4212268|B2||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4386384|NCT00310440|4212269|B1||White|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
4386385|NCT00310440|4212267|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4386386|NCT00310440|4212268|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4386387|NCT00310440|4212269|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4386388|NCT00310440|4212267|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386389|NCT00310440|4212268|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386390|NCT00310440|4212269|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386391|NCT00310440|4212267|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4386392|NCT00310440|4212268|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4386393|NCT00310440|4212269|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4386394|NCT00310440|4212267|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4386395|NCT00310440|4212268|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386396|NCT00310440|4212269|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4386397|NCT00310440|4212267|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4386398|NCT00310440|4212268|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386399|NCT00310440|4212269|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4386400|NCT00310440|4212267|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|307|307.0||||||
4386401|NCT00310440|4212268|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
4386402|NCT00310440|4212269|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|157|157.0||||||
4386403|NCT00310440|4212267|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4386404|NCT00310440|4212268|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4386405|NCT00310440|4212269|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4386406|NCT00310440|4212267|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4386407|NCT00310440|4212268|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4386408|NCT00310440|4212269|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4386409|NCT00310440|4212267|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4386410|NCT00310440|4212268|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4386411|NCT00310440|4212269|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4386412|NCT00310440|4212267|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|9.6|9.6|||
4386413|NCT00310440|4212268|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|9.4|9.4|||
4386414|NCT00310440|4212269|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|9.7|9.7|||
4386415|NCT00310427|4212294|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4386416|NCT00310427|4212295|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4386417|NCT00310427|4212296|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4386418|NCT00310427|4212294|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4386419|NCT00310427|4212295|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4386420|NCT00310427|4212296|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4386421|NCT00310427|4212294|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4386422|NCT00310427|4212295|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4386423|NCT00310427|4212296|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4386424|NCT00310427|4212294|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386425|NCT00310427|4212295|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386426|NCT00310427|4212296|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386427|NCT00310427|4212294|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4386428|NCT00310427|4212295|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4386429|NCT00310427|4212296|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4386430|NCT00310427|4212294|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386431|NCT00310427|4212295|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386432|NCT00310427|4212296|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386433|NCT00310401|4212317|B3|United States||Region of Enrollment||participants|Number|506|506.0||||||
4386434|NCT00310401|4212318|B2|United States||Region of Enrollment||participants|Number|246|246.0||||||
4386435|NCT00310401|4212319|B1|United States||Region of Enrollment||participants|Number|260|260.0||||||
4386436|NCT00310401|4212317|B3||Male|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
4386437|NCT00310401|4212318|B2||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4386438|NCT00310401|4212319|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4386439|NCT00310401|4212317|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4386440|NCT00310401|4212318|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4386441|NCT00310401|4212319|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4386442|NCT00310401|4212317|B3|||Age||years|Mean|42|42.0|Standard Deviation|16|16.0|||
4386443|NCT00310401|4212318|B2|||Age||years|Mean|42|42.0|Standard Deviation|15|15.0|||
4386444|NCT00310401|4212319|B1|||Age||years|Mean|43|43.0|Standard Deviation|16|16.0|||
4386445|NCT00310401|4212317|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4386446|NCT00310401|4212318|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4386447|NCT00310401|4212319|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4386448|NCT00310401|4212317|B3||Between 18 and 65 years|Age||Participants|Count of Participants|441|441.0||||||
4386449|NCT00310401|4212318|B2||Between 18 and 65 years|Age||Participants|Count of Participants|217|217.0||||||
4386450|NCT00310401|4212319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|224|224.0||||||
4386451|NCT00310401|4212317|B3||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
4386452|NCT00310401|4212318|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4386453|NCT00310401|4212319|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4386454|NCT00310388|4212334|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4386455|NCT00310388|4212334|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4386456|NCT00310388|4212334|B1|African-American (Black)||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4386457|NCT00310388|4212334|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|360|360.0||||||
4386458|NCT00310388|4212334|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4386459|NCT00310388|4212334|B1||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4386460|NCT00310388|4212334|B1|||Age||years|Mean|37.0|37.0|Standard Deviation|11.85|11.85|||
4386461|NCT00310375|4212375|B3|Among the Most Extremely Severe||Clinical Global Impression (CGI) at Baseline||Participants|Number|0|0.0||||||
4386462|NCT00310375|4212376|B2|Among the Most Extremely Severe||Clinical Global Impression (CGI) at Baseline||Participants|Number|0|0.0||||||
4386463|NCT00310375|4212377|B1|Among the Most Extremely Severe||Clinical Global Impression (CGI) at Baseline||Participants|Number|0|0.0||||||
4386464|NCT00310375|4212375|B3|Very Severe||Clinical Global Impression (CGI) at Baseline||Participants|Number|11|11.0||||||
4386465|NCT00310375|4212376|B2|Very Severe||Clinical Global Impression (CGI) at Baseline||Participants|Number|5|5.0||||||
4386466|NCT00310375|4212377|B1|Very Severe||Clinical Global Impression (CGI) at Baseline||Participants|Number|6|6.0||||||
4386467|NCT00310375|4212375|B3|Marked Severity||Clinical Global Impression (CGI) at Baseline||Participants|Number|62|62.0||||||
4386468|NCT00310375|4212376|B2|Marked Severity||Clinical Global Impression (CGI) at Baseline||Participants|Number|26|26.0||||||
4386469|NCT00310375|4212377|B1|Marked Severity||Clinical Global Impression (CGI) at Baseline||Participants|Number|36|36.0||||||
4386470|NCT00310375|4212375|B3|Moderate Severity||Clinical Global Impression (CGI) at Baseline||Participants|Number|89|89.0||||||
4386471|NCT00310375|4212376|B2|Moderate Severity||Clinical Global Impression (CGI) at Baseline||Participants|Number|40|40.0||||||
4386472|NCT00310375|4212377|B1|Moderate Severity||Clinical Global Impression (CGI) at Baseline||Participants|Number|49|49.0||||||
4386473|NCT00310375|4212375|B3|Mild Severity||Clinical Global Impression (CGI) at Baseline||Participants|Number|17|17.0||||||
4386474|NCT00310375|4212376|B2|Mild Severity||Clinical Global Impression (CGI) at Baseline||Participants|Number|8|8.0||||||
4386475|NCT00310375|4212377|B1|Mild Severity||Clinical Global Impression (CGI) at Baseline||Participants|Number|9|9.0||||||
4386476|NCT00310375|4212375|B3|Very Mild Severity||Clinical Global Impression (CGI) at Baseline||Participants|Number|2|2.0||||||
4386531|NCT00310362|4212421|B4||Male|Sex: Female, Male||Participants|Count of Participants|3456|3456.0||||||
4386477|NCT00310375|4212376|B2|Very Mild Severity||Clinical Global Impression (CGI) at Baseline||Participants|Number|0|0.0||||||
4386478|NCT00310375|4212377|B1|Very Mild Severity||Clinical Global Impression (CGI) at Baseline||Participants|Number|2|2.0||||||
4386479|NCT00310375|4212375|B3|No Seizures||Clinical Global Impression (CGI) at Baseline||Participants|Number|0|0.0||||||
4386480|NCT00310375|4212376|B2|No Seizures||Clinical Global Impression (CGI) at Baseline||Participants|Number|0|0.0||||||
4386481|NCT00310375|4212377|B1|No Seizures||Clinical Global Impression (CGI) at Baseline||Participants|Number|0|0.0||||||
4386482|NCT00310375|4212375|B3|Not Assessed||Clinical Global Impression (CGI) at Baseline||Participants|Number|0|0.0||||||
4386483|NCT00310375|4212376|B2|Not Assessed||Clinical Global Impression (CGI) at Baseline||Participants|Number|0|0.0||||||
4386484|NCT00310375|4212377|B1|Not Assessed||Clinical Global Impression (CGI) at Baseline||Participants|Number|0|0.0||||||
4386485|NCT00310375|4212375|B3|||Mean Duration of Generalized Seizure|For this study specific outcome measure, Placebo in Parent Study N=12 and Retigabine in parent study N=8|Years|Mean|21.5|21.5|Standard Deviation|12.94|12.94|||
4386486|NCT00310375|4212376|B2|||Mean Duration of Generalized Seizure|For this study specific outcome measure, Placebo in Parent Study N=12 and Retigabine in parent study N=8|Years|Mean|25.8|25.8|Standard Deviation|13.25|13.25|||
4386487|NCT00310375|4212377|B1|||Mean Duration of Generalized Seizure|For this study specific outcome measure, Placebo in Parent Study N=12 and Retigabine in parent study N=8|Years|Mean|18.6|18.6|Standard Deviation|12.45|12.45|||
4386488|NCT00310375|4212375|B3|||Mean Duration of Partial seizures|For this study specific outcome measure, Placebo in Parent Study N=101 and Retigabine in parent study N=79|Years|Mean|23.9|23.9|Standard Deviation|12.95|12.95|||
4386489|NCT00310375|4212376|B2|||Mean Duration of Partial seizures|For this study specific outcome measure, Placebo in Parent Study N=101 and Retigabine in parent study N=79|Years|Mean|23.7|23.7|Standard Deviation|12.88|12.88|||
4386490|NCT00310375|4212377|B1|||Mean Duration of Partial seizures|For this study specific outcome measure, Placebo in Parent Study N=101 and Retigabine in parent study N=79|Years|Mean|24.1|24.1|Standard Deviation|13.06|13.06|||
4386491|NCT00310375|4212375|B3|AED=3||Number of background AEDs||Participants|Number|63|63.0||||||
4386492|NCT00310375|4212376|B2|AED=3||Number of background AEDs||Participants|Number|20|20.0||||||
4386493|NCT00310375|4212377|B1|AED=3||Number of background AEDs||Participants|Number|43|43.0||||||
4386494|NCT00310375|4212375|B3|AED=2||Number of background AEDs||Participants|Number|88|88.0||||||
4386495|NCT00310375|4212376|B2|AED=2||Number of background AEDs||Participants|Number|41|41.0||||||
4386496|NCT00310375|4212377|B1|AED=2||Number of background AEDs||Participants|Number|47|47.0||||||
4386497|NCT00310375|4212375|B3|AED=1||Number of background AEDs||Participants|Number|30|30.0||||||
4386498|NCT00310375|4212376|B2|AED=1||Number of background AEDs||Participants|Number|18|18.0||||||
4386499|NCT00310375|4212377|B1|AED=1||Number of background AEDs||Participants|Number|12|12.0||||||
4386500|NCT00310375|4212375|B3|Yes||Number of Participants with Vagal nerve stimulator (VNS) use||Participants|Number|18|18.0||||||
4386501|NCT00310375|4212376|B2|Yes||Number of Participants with Vagal nerve stimulator (VNS) use||Participants|Number|5|5.0||||||
4386502|NCT00310375|4212377|B1|Yes||Number of Participants with Vagal nerve stimulator (VNS) use||Participants|Number|13|13.0||||||
4386503|NCT00310375|4212375|B3|No||Number of Participants with Vagal nerve stimulator (VNS) use||Participants|Number|163|163.0||||||
4386504|NCT00310375|4212376|B2|No||Number of Participants with Vagal nerve stimulator (VNS) use||Participants|Number|74|74.0||||||
4386505|NCT00310375|4212377|B1|No||Number of Participants with Vagal nerve stimulator (VNS) use||Participants|Number|89|89.0||||||
4386506|NCT00310375|4212375|B3|Other||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4386507|NCT00310375|4212376|B2|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4386508|NCT00310375|4212377|B1|Other||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4386509|NCT00310375|4212375|B3|African-American (black)||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4386510|NCT00310375|4212376|B2|African-American (black)||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4386511|NCT00310375|4212377|B1|African-American (black)||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4386512|NCT00310375|4212375|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4386513|NCT00310375|4212376|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4386514|NCT00310375|4212377|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4386515|NCT00310375|4212375|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|94|94.0||||||
4386516|NCT00310375|4212376|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4386517|NCT00310375|4212377|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
4386518|NCT00310375|4212375|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4386519|NCT00310375|4212376|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4386520|NCT00310375|4212377|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4386521|NCT00310375|4212375|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4386522|NCT00310375|4212376|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4386523|NCT00310375|4212377|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4386524|NCT00310375|4212375|B3|||Age||Years|Mean|37.6|37.6|Standard Deviation|11.92|11.92|||
4386525|NCT00310375|4212376|B2|||Age||Years|Mean|37.1|37.1|Standard Deviation|12.20|12.2|||
4386526|NCT00310375|4212377|B1|||Age||Years|Mean|38.0|38.0|Standard Deviation|11.74|11.74|||
4386527|NCT00310362|4212421|B4|United States||Region of Enrollment||participants|Number|3610|3610.0||||||
4386528|NCT00310362|4212422|B3|United States||Region of Enrollment||participants|Number|1206|1206.0||||||
4386529|NCT00310362|4212423|B2|United States||Region of Enrollment||participants|Number|1205|1205.0||||||
4386530|NCT00310362|4212424|B1|United States||Region of Enrollment||participants|Number|1199|1199.0||||||
4386532|NCT00310362|4212422|B3||Male|Sex: Female, Male||Participants|Count of Participants|1156|1156.0||||||
4386533|NCT00310362|4212423|B2||Male|Sex: Female, Male||Participants|Count of Participants|1151|1151.0||||||
4386534|NCT00310362|4212424|B1||Male|Sex: Female, Male||Participants|Count of Participants|1149|1149.0||||||
4386535|NCT00310362|4212421|B4||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4386536|NCT00310362|4212422|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4386537|NCT00310362|4212423|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4386538|NCT00310362|4212424|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4386539|NCT00310362|4212421|B4|||Age||years|Mean|62.6|62.6|Standard Deviation|10.1|10.1|||
4386540|NCT00310362|4212422|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|10.2|10.2|||
4386541|NCT00310362|4212423|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|10.2|10.2|||
4386542|NCT00310362|4212424|B1|||Age||years|Mean|62.6|62.6|Standard Deviation|9.9|9.9|||
4386543|NCT00310310|4212434|B3|United States||Region of Enrollment||participants|Number|240|240.0||||||
4386544|NCT00310310|4212435|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
4386545|NCT00310310|4212436|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
4386546|NCT00310310|4212434|B3||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4386547|NCT00310310|4212435|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4386548|NCT00310310|4212436|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4386549|NCT00310310|4212434|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4386550|NCT00310310|4212435|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4386551|NCT00310310|4212436|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4386552|NCT00310310|4212434|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|12.2|12.2|||
4386553|NCT00310310|4212435|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|11.9|11.9|||
4386554|NCT00310310|4212436|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|12.5|12.5|||
4386555|NCT00310076|4212461|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4386556|NCT00310076|4212461|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4386557|NCT00310076|4212461|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4386558|NCT00310076|4212461|B1|||Age||years|Mean|51|51.0|Standard Deviation|10|10.0|||
4386559|NCT00310076|4212461|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4386560|NCT00310076|4212461|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4386561|NCT00310076|4212461|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386562|NCT00310050|4212467|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4386563|NCT00310050|4212467|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4386564|NCT00310050|4212467|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|2.645|2.645|||
4386565|NCT00310037|4212476|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4386566|NCT00310037|4212477|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4386567|NCT00310037|4212478|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4386568|NCT00310037|4212476|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4386569|NCT00310037|4212477|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4386570|NCT00310037|4212478|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4386571|NCT00310037|4212476|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386572|NCT00310037|4212477|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386573|NCT00310037|4212478|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386574|NCT00310037|4212476|B3||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4386575|NCT00310037|4212477|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4386576|NCT00310037|4212478|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4386577|NCT00310037|4212476|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4386578|NCT00310037|4212477|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386579|NCT00310037|4212478|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4386580|NCT00310037|4212476|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386581|NCT00310037|4212477|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386582|NCT00310037|4212478|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386583|NCT00310037|4212476|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386584|NCT00310037|4212477|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386585|NCT00310037|4212478|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386586|NCT00310037|4212476|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386587|NCT00310037|4212477|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386588|NCT00310037|4212478|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386589|NCT00310037|4212476|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4386590|NCT00310037|4212477|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4386591|NCT00310037|4212478|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4386592|NCT00310037|4212476|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4386593|NCT00310037|4212477|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4386594|NCT00310037|4212478|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4386595|NCT00310037|4212476|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4386596|NCT00310037|4212477|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4386597|NCT00310037|4212478|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386598|NCT00310037|4212476|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4386599|NCT00310037|4212477|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4386600|NCT00310037|4212478|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4386601|NCT00310037|4212476|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4386602|NCT00310037|4212477|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4386603|NCT00310037|4212478|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4386604|NCT00310037|4212476|B3|||Age||years|Median|58.5|58.5|Full Range|||29.0|69.0|
4386605|NCT00310037|4212477|B2|||Age||years|Median|59|59.0|Full Range|||41.0|68.0|
4386606|NCT00310037|4212478|B1|||Age||years|Median|58|58.0|Full Range|||29.0|69.0|
4386607|NCT00309985|4212491|B3||Male|Sex: Female, Male||Participants|Count of Participants|790|790.0||||||
4386608|NCT00309985|4212492|B2||Male|Sex: Female, Male||Participants|Count of Participants|393|393.0||||||
4386609|NCT00309985|4212493|B1||Male|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
4386610|NCT00309985|4212491|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386611|NCT00309985|4212492|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386612|NCT00309985|4212493|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386613|NCT00309985|4212491|B3|||Age||years|Median|63|63.0|Full Range|||36.0|91.0|
4386614|NCT00309985|4212492|B2|||Age||years|Median|63|63.0|Full Range|||39.0|91.0|
4386615|NCT00309985|4212493|B1|||Age||years|Median|64|64.0|Full Range|||36.0|88.0|
4386616|NCT00309946|4212510|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4386617|NCT00309946|4212510|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4386618|NCT00309946|4212510|B1|||Age||years|Median|64|64.0|Full Range|||44.0|81.0|
4386619|NCT00309907|4212516|B1|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
4386620|NCT00309907|4212516|B1|Sri Lanka||Region of Enrollment||participants|Number|1|1.0||||||
4386621|NCT00309907|4212516|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4386622|NCT00309907|4212516|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4386623|NCT00309907|4212516|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386624|NCT00309907|4212516|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4386625|NCT00309907|4212516|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4386626|NCT00309907|4212516|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4386627|NCT00309907|4212516|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4386628|NCT00309907|4212516|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4386629|NCT00309907|4212516|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4386630|NCT00309907|4212516|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4386631|NCT00309907|4212516|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4386632|NCT00309907|4212516|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4386633|NCT00309907|4212516|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4386634|NCT00309907|4212516|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4386635|NCT00309907|4212516|B1|||Age||years|Median|11|11.0|Full Range|||1.0|17.0|
4386636|NCT00309777|4212525|B5||Male|Sex: Female, Male|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|346|346.0||||||
4386637|NCT00309777|4212526|B4||Male|Sex: Female, Male|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|62|62.0||||||
4386638|NCT00309777|4212527|B3||Male|Sex: Female, Male|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|125|125.0||||||
4386639|NCT00309777|4212528|B2||Male|Sex: Female, Male|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|44|44.0||||||
4386640|NCT00309777|4212529|B1||Male|Sex: Female, Male|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|115|115.0||||||
4386641|NCT00309777|4212525|B5||Female|Sex: Female, Male|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|502|502.0||||||
4386642|NCT00309777|4212526|B4||Female|Sex: Female, Male|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|48|48.0||||||
4386643|NCT00309777|4212527|B3||Female|Sex: Female, Male|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|195|195.0||||||
4386644|NCT00309777|4212528|B2||Female|Sex: Female, Male|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|63|63.0||||||
4386645|NCT00309777|4212529|B1||Female|Sex: Female, Male|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|196|196.0||||||
4386646|NCT00309777|4212525|B5|||Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|years|Mean|58.3|58.3|Standard Deviation|9.08|9.08|||
4386647|NCT00309777|4212526|B4|||Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|years|Mean|58.4|58.4|Standard Deviation|9.54|9.54|||
4386648|NCT00309777|4212527|B3|||Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|years|Mean|57.7|57.7|Standard Deviation|8.97|8.97|||
4386649|NCT00309777|4212528|B2|||Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|years|Mean|58.6|58.6|Standard Deviation|9.64|9.64|||
4386650|NCT00309777|4212529|B1|||Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|years|Mean|58.7|58.7|Standard Deviation|8.83|8.83|||
4386651|NCT00309777|4212525|B5||>=65 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|255|255.0||||||
4386652|NCT00309777|4212526|B4||>=65 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|34|34.0||||||
4386653|NCT00309777|4212527|B3||>=65 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|89|89.0||||||
4386654|NCT00309777|4212528|B2||>=65 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|35|35.0||||||
4386655|NCT00309777|4212529|B1||>=65 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|97|97.0||||||
4386656|NCT00309777|4212525|B5||Between 18 and 65 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|593|593.0||||||
4386657|NCT00309777|4212526|B4||Between 18 and 65 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|76|76.0||||||
4386658|NCT00309777|4212527|B3||Between 18 and 65 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|231|231.0||||||
4386659|NCT00309777|4212528|B2||Between 18 and 65 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|72|72.0||||||
4386660|NCT00309777|4212529|B1||Between 18 and 65 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|214|214.0||||||
4386661|NCT00309777|4212525|B5||<=18 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|0|0.0||||||
4386662|NCT00309777|4212526|B4||<=18 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|0|0.0||||||
4386663|NCT00309777|4212527|B3||<=18 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|0|0.0||||||
4386664|NCT00309777|4212528|B2||<=18 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|0|0.0||||||
4386665|NCT00309777|4212529|B1||<=18 years|Age|Data presented are for the safety population, defined as all randomized patients who receive at least one dose of the study drug.|Participants|Count of Participants|0|0.0||||||
4386666|NCT00309751|4212546|B3||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4386667|NCT00309751|4212547|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4386668|NCT00309751|4212548|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4386669|NCT00309751|4212546|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4386670|NCT00309751|4212547|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4386671|NCT00309751|4212548|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4386672|NCT00309751|4212546|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|9.15|9.15|||
4386673|NCT00309751|4212547|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|9.06|9.06|||
4386674|NCT00309751|4212548|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|9.21|9.21|||
4386675|NCT00309751|4212546|B3||>=65 years|Age||Participants|Count of Participants|128|128.0||||||
4386676|NCT00309751|4212547|B2||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4386677|NCT00309751|4212548|B1||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
4386678|NCT00309751|4212546|B3||Between 18 and 65 years|Age||Participants|Count of Participants|284|284.0||||||
4386679|NCT00309751|4212547|B2||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4386680|NCT00309751|4212548|B1||Between 18 and 65 years|Age||Participants|Count of Participants|191|191.0||||||
4386681|NCT00309751|4212546|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386682|NCT00309751|4212547|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386683|NCT00309751|4212548|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386684|NCT00309738|4212557|B3||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4386685|NCT00309738|4212558|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4386686|NCT00309738|4212559|B1||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4386687|NCT00309738|4212557|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4386688|NCT00309738|4212558|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4386689|NCT00309738|4212559|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4386690|NCT00309738|4212557|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|6.81|6.81|||
4386691|NCT00309738|4212558|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|6.78|6.78|||
4386692|NCT00309738|4212559|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|6.82|6.82|||
4386693|NCT00309738|4212557|B3||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
4386694|NCT00309738|4212558|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4386695|NCT00309738|4212559|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4386696|NCT00309738|4212557|B3||Between 18 and 65 years|Age||Participants|Count of Participants|272|272.0||||||
4386697|NCT00309738|4212558|B2||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4386698|NCT00309738|4212559|B1||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
4386699|NCT00309738|4212557|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386700|NCT00309738|4212558|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386701|NCT00309738|4212559|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386702|NCT00309608|4212568|B6|||Fasting plasma glucose (FPG) continuous||mg/dL|Mean|185.1|185.1|Standard Deviation|41.0|41.0|||
4386703|NCT00309608|4212569|B5|||Fasting plasma glucose (FPG) continuous||mg/dL|Mean|179.9|179.9|Standard Deviation|40.4|40.4|||
4386704|NCT00309608|4212570|B4|||Fasting plasma glucose (FPG) continuous||mg/dL|Mean|188.7|188.7|Standard Deviation|42.4|42.4|||
4386705|NCT00309608|4212571|B3|||Fasting plasma glucose (FPG) continuous||mg/dL|Mean|189.3|189.3|Standard Deviation|42.4|42.4|||
4386706|NCT00309608|4212572|B2|||Fasting plasma glucose (FPG) continuous||mg/dL|Mean|182.3|182.3|Standard Deviation|42.0|42.0|||
4386707|NCT00309608|4212573|B1|||Fasting plasma glucose (FPG) continuous||mg/dL|Mean|185.5|185.5|Standard Deviation|38.8|38.8|||
4386708|NCT00309608|4212568|B6|||Glycosylated Hemoglobin A1 (HbA1C) continuous||Percent|Mean|8.33|8.33|Standard Deviation|0.75|0.75|||
4386709|NCT00309608|4212569|B5|||Glycosylated Hemoglobin A1 (HbA1C) continuous||Percent|Mean|8.22|8.22|Standard Deviation|0.70|0.7|||
4386710|NCT00309608|4212570|B4|||Glycosylated Hemoglobin A1 (HbA1C) continuous||Percent|Mean|8.35|8.35|Standard Deviation|0.73|0.73|||
4386711|NCT00309608|4212571|B3|||Glycosylated Hemoglobin A1 (HbA1C) continuous||Percent|Mean|8.46|8.46|Standard Deviation|0.85|0.85|||
4386712|NCT00309608|4212572|B2|||Glycosylated Hemoglobin A1 (HbA1C) continuous||Percent|Mean|8.24|8.24|Standard Deviation|0.74|0.74|||
4386713|NCT00309608|4212573|B1|||Glycosylated Hemoglobin A1 (HbA1C) continuous||Percent|Mean|8.37|8.37|Standard Deviation|0.74|0.74|||
4386714|NCT00309608|4212568|B6|||Body Mass Index (BMI) continuous||kg/m^2|Mean|31.9|31.9|Standard Deviation|4.3|4.3|||
4386715|NCT00309608|4212569|B5|||Body Mass Index (BMI) continuous||kg/m^2|Mean|31.5|31.5|Standard Deviation|4.2|4.2|||
4386716|NCT00309608|4212570|B4|||Body Mass Index (BMI) continuous||kg/m^2|Mean|31.7|31.7|Standard Deviation|4.5|4.5|||
4386717|NCT00309608|4212571|B3|||Body Mass Index (BMI) continuous||kg/m^2|Mean|31.7|31.7|Standard Deviation|4.5|4.5|||
4386718|NCT00309608|4212572|B2|||Body Mass Index (BMI) continuous||kg/m^2|Mean|32.3|32.3|Standard Deviation|4.3|4.3|||
4386719|NCT00309608|4212573|B1|||Body Mass Index (BMI) continuous||kg/m^2|Mean|32.2|32.2|Standard Deviation|4.2|4.2|||
4386720|NCT00309608|4212568|B6||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4386721|NCT00309608|4212569|B5||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4386722|NCT00309608|4212570|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4386723|NCT00309608|4212571|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4386724|NCT00309608|4212572|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4386725|NCT00309608|4212573|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4386726|NCT00309608|4212568|B6||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4386727|NCT00309608|4212569|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4386728|NCT00309608|4212570|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4386729|NCT00309608|4212571|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4386730|NCT00309608|4212572|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4386731|NCT00309608|4212573|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4386732|NCT00309608|4212568|B6|||Age||Years|Mean|60.0|60.0|Standard Deviation|9.0|9.0|||
4386733|NCT00309608|4212569|B5|||Age||Years|Mean|59.4|59.4|Standard Deviation|9.9|9.9|||
4386734|NCT00309608|4212570|B4|||Age||Years|Mean|61.8|61.8|Standard Deviation|8.8|8.8|||
4386735|NCT00309608|4212571|B3|||Age||Years|Mean|59.6|59.6|Standard Deviation|9.8|9.8|||
4386736|NCT00309608|4212572|B2|||Age||Years|Mean|59.2|59.2|Standard Deviation|8.4|8.4|||
4386737|NCT00309608|4212573|B1|||Age||Years|Mean|60.1|60.1|Standard Deviation|8.1|8.1|||
4386738|NCT00309465|4212598|B7|United States||Region of Enrollment||participants|Number|401|401.0||||||
4386739|NCT00309465|4212599|B6|United States||Region of Enrollment||participants|Number|76|76.0||||||
4386740|NCT00309465|4212600|B5|United States||Region of Enrollment||participants|Number|76|76.0||||||
4386741|NCT00309465|4212601|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
4386742|NCT00309465|4212602|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4386743|NCT00309465|4212603|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4386744|NCT00309465|4212604|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4386745|NCT00309465|4212598|B7||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4386746|NCT00309465|4212599|B6||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4386747|NCT00309465|4212600|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4386748|NCT00309465|4212601|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4386749|NCT00309465|4212602|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4386750|NCT00309465|4212603|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4386751|NCT00309465|4212604|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4386752|NCT00309465|4212598|B7||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4386753|NCT00309465|4212599|B6||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4386754|NCT00309465|4212600|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4386755|NCT00309465|4212601|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4386756|NCT00309465|4212602|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4386757|NCT00309465|4212603|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4386758|NCT00309465|4212604|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4386759|NCT00309465|4212598|B7|||Age||years|Mean|59.1|59.1|Standard Deviation|12.5|12.5|||
4386760|NCT00309465|4212599|B6|||Age||years|Mean|57.3|57.3|Standard Deviation|13.3|13.3|||
4386761|NCT00309465|4212600|B5|||Age||years|Mean|58.4|58.4|Standard Deviation|12.0|12.0|||
4386762|NCT00309465|4212601|B4|||Age||years|Mean|55.8|55.8|Standard Deviation|15.9|15.9|||
4386763|NCT00309465|4212602|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|11.6|11.6|||
4386764|NCT00309465|4212603|B2|||Age||years|Mean|61.5|61.5|Standard Deviation|11.4|11.4|||
4386765|NCT00309465|4212604|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|10.0|10.0|||
4386766|NCT00309465|4212598|B7||>=65 years|Age||Participants|Count of Participants|142|142.0||||||
4386767|NCT00309465|4212599|B6||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4386768|NCT00309465|4212600|B5||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4386769|NCT00309465|4212601|B4||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4386770|NCT00309465|4212602|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4386771|NCT00309465|4212603|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4386772|NCT00309465|4212604|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4386773|NCT00309465|4212598|B7||Between 18 and 65 years|Age||Participants|Count of Participants|259|259.0||||||
4386774|NCT00309465|4212599|B6||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4386775|NCT00309465|4212600|B5||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4386776|NCT00309465|4212601|B4||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4386777|NCT00309465|4212602|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4386778|NCT00309465|4212603|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4386779|NCT00309465|4212604|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4386780|NCT00309465|4212598|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386781|NCT00309465|4212599|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386782|NCT00309465|4212600|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386783|NCT00309465|4212601|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386784|NCT00309465|4212602|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386785|NCT00309465|4212603|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386786|NCT00309465|4212604|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386787|NCT00309452|4212623|B3|Total||PANNS Positive and Negative Symptom Scale|"The Positive scale has7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The Negative scale has 7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The General Psychopathology scale has 16 Items, (minimum score = 16, maximum score = 112). With a higher score indicates more severe symptoms.~The range for the PANSS Total score is minimum = 30, maximum = 210. With a higher score indicates more severe symptoms."|units on a scale|Mean|71.21|71.21|Standard Deviation|16.14|16.14|||
4386788|NCT00309452|4212624|B2|Total||PANNS Positive and Negative Symptom Scale|"The Positive scale has7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The Negative scale has 7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The General Psychopathology scale has 16 Items, (minimum score = 16, maximum score = 112). With a higher score indicates more severe symptoms.~The range for the PANSS Total score is minimum = 30, maximum = 210. With a higher score indicates more severe symptoms."|units on a scale|Mean|72.0|72.0|Standard Deviation|16.76|16.76|||
4386789|NCT00309452|4212625|B1|Total||PANNS Positive and Negative Symptom Scale|"The Positive scale has7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The Negative scale has 7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The General Psychopathology scale has 16 Items, (minimum score = 16, maximum score = 112). With a higher score indicates more severe symptoms.~The range for the PANSS Total score is minimum = 30, maximum = 210. With a higher score indicates more severe symptoms."|units on a scale|Mean|70.33|70.33|Standard Deviation|15.52|15.52|||
4386804|NCT00309452|4212625|B1||Male|Gender||Participants|Count of Participants|46|46.0||||||
4386805|NCT00309452|4212623|B3||Female|Gender||Participants|Count of Participants|22|22.0||||||
4386790|NCT00309452|4212623|B3|General Symptoms||PANNS Positive and Negative Symptom Scale|"The Positive scale has7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The Negative scale has 7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The General Psychopathology scale has 16 Items, (minimum score = 16, maximum score = 112). With a higher score indicates more severe symptoms.~The range for the PANSS Total score is minimum = 30, maximum = 210. With a higher score indicates more severe symptoms."|units on a scale|Mean|33.56|33.56|Standard Deviation|8.56|8.56|||
4386791|NCT00309452|4212624|B2|General Symptoms||PANNS Positive and Negative Symptom Scale|"The Positive scale has7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The Negative scale has 7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The General Psychopathology scale has 16 Items, (minimum score = 16, maximum score = 112). With a higher score indicates more severe symptoms.~The range for the PANSS Total score is minimum = 30, maximum = 210. With a higher score indicates more severe symptoms."|units on a scale|Mean|33.42|33.42|Standard Deviation|8.62|8.62|||
4386792|NCT00309452|4212625|B1|General Symptoms||PANNS Positive and Negative Symptom Scale|"The Positive scale has7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The Negative scale has 7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The General Psychopathology scale has 16 Items, (minimum score = 16, maximum score = 112). With a higher score indicates more severe symptoms.~The range for the PANSS Total score is minimum = 30, maximum = 210. With a higher score indicates more severe symptoms."|units on a scale|Mean|33.70|33.7|Standard Deviation|8.56|8.56|||
4386793|NCT00309452|4212623|B3|Negative Dimension||PANNS Positive and Negative Symptom Scale|"The Positive scale has7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The Negative scale has 7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The General Psychopathology scale has 16 Items, (minimum score = 16, maximum score = 112). With a higher score indicates more severe symptoms.~The range for the PANSS Total score is minimum = 30, maximum = 210. With a higher score indicates more severe symptoms."|units on a scale|Mean|17.44|17.44|Standard Deviation|5.95|5.95|||
4386794|NCT00309452|4212624|B2|Negative Dimension||PANNS Positive and Negative Symptom Scale|"The Positive scale has7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The Negative scale has 7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The General Psychopathology scale has 16 Items, (minimum score = 16, maximum score = 112). With a higher score indicates more severe symptoms.~The range for the PANSS Total score is minimum = 30, maximum = 210. With a higher score indicates more severe symptoms."|units on a scale|Mean|17.82|17.82|Standard Deviation|6.42|6.42|||
4386795|NCT00309452|4212625|B1|Negative Dimension||PANNS Positive and Negative Symptom Scale|"The Positive scale has7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The Negative scale has 7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The General Psychopathology scale has 16 Items, (minimum score = 16, maximum score = 112). With a higher score indicates more severe symptoms.~The range for the PANSS Total score is minimum = 30, maximum = 210. With a higher score indicates more severe symptoms."|units on a scale|Mean|17.01|17.01|Standard Deviation|5.40|5.4|||
4386796|NCT00309452|4212623|B3|Positive Dimension||PANNS Positive and Negative Symptom Scale|"The Positive scale has7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The Negative scale has 7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The General Psychopathology scale has 16 Items, (minimum score = 16, maximum score = 112). With a higher score indicates more severe symptoms.~The range for the PANSS Total score is minimum = 30, maximum = 210. With a higher score indicates more severe symptoms."|units on a scale|Mean|20.21|20.21|Standard Deviation|6.36|6.36|||
4386797|NCT00309452|4212624|B2|Positive Dimension||PANNS Positive and Negative Symptom Scale|"The Positive scale has7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The Negative scale has 7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The General Psychopathology scale has 16 Items, (minimum score = 16, maximum score = 112). With a higher score indicates more severe symptoms.~The range for the PANSS Total score is minimum = 30, maximum = 210. With a higher score indicates more severe symptoms."|units on a scale|Mean|20.75|20.75|Standard Deviation|6.74|6.74|||
4386798|NCT00309452|4212625|B1|Positive Dimension||PANNS Positive and Negative Symptom Scale|"The Positive scale has7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The Negative scale has 7 Items, (minimum score = 7, maximum score = 49). With a higher score indicates more severe symptoms.~The General Psychopathology scale has 16 Items, (minimum score = 16, maximum score = 112). With a higher score indicates more severe symptoms.~The range for the PANSS Total score is minimum = 30, maximum = 210. With a higher score indicates more severe symptoms."|units on a scale|Mean|19.60|19.6|Standard Deviation|5.90|5.9|||
4386799|NCT00309452|4212623|B3|||Global Assessment of Functioning|The Global Assessment of Functioning (GAF) is a numeric scale (1 through 100) used by mental health clinicians and physicians to rate subjectively the social, occupational, and psychological functioning of adults, e.g., how well or adaptively one is meeting various problems-in-living. The higher the score, the better functioning the subject.|units on a scale|Mean|35.88|35.88|Standard Deviation|13.04|13.04|||
4386800|NCT00309452|4212624|B2|||Global Assessment of Functioning|The Global Assessment of Functioning (GAF) is a numeric scale (1 through 100) used by mental health clinicians and physicians to rate subjectively the social, occupational, and psychological functioning of adults, e.g., how well or adaptively one is meeting various problems-in-living. The higher the score, the better functioning the subject.|units on a scale|Mean|36.22|36.22|Standard Deviation|12.89|12.89|||
4386801|NCT00309452|4212625|B1|||Global Assessment of Functioning|The Global Assessment of Functioning (GAF) is a numeric scale (1 through 100) used by mental health clinicians and physicians to rate subjectively the social, occupational, and psychological functioning of adults, e.g., how well or adaptively one is meeting various problems-in-living. The higher the score, the better functioning the subject.|units on a scale|Mean|34.42|34.42|Standard Deviation|10.43|10.43|||
4386802|NCT00309452|4212623|B3||Male|Gender||Participants|Count of Participants|95|95.0||||||
4386803|NCT00309452|4212624|B2||Male|Gender||Participants|Count of Participants|49|49.0||||||
4386806|NCT00309452|4212624|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
4386807|NCT00309452|4212625|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
4386808|NCT00309452|4212623|B3|||Age||years|Mean|22.5|22.5|Standard Deviation|4.9|4.9|||
4386809|NCT00309452|4212624|B2|||Age||years|Mean|22.4|22.4|Standard Deviation|4.5|4.5|||
4386810|NCT00309452|4212625|B1|||Age||years|Mean|22.6|22.6|Standard Deviation|5.3|5.3|||
4386811|NCT00309387|4212652|B3|Italy||Region of Enrollment||participants|Number|1020|1020.0||||||
4386812|NCT00309387|4212653|B2|Italy||Region of Enrollment||participants|Number|510|510.0||||||
4386813|NCT00309387|4212654|B1|Italy||Region of Enrollment||participants|Number|510|510.0||||||
4386814|NCT00309387|4212652|B3||Male|Sex: Female, Male||Participants|Count of Participants|561|561.0||||||
4386815|NCT00309387|4212653|B2||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4386816|NCT00309387|4212654|B1||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4386817|NCT00309387|4212652|B3||Female|Sex: Female, Male||Participants|Count of Participants|459|459.0||||||
4386818|NCT00309387|4212653|B2||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4386819|NCT00309387|4212654|B1||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4386820|NCT00309387|4212652|B3|||Age||years|Mean|67.7|67.7|Standard Deviation|4.89|4.89|||
4386821|NCT00309387|4212653|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|4.97|4.97|||
4386822|NCT00309387|4212654|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|4.82|4.82|||
4386823|NCT00309387|4212652|B3||>=65 years|Age||Participants|Count of Participants|741|741.0||||||
4386824|NCT00309387|4212653|B2||>=65 years|Age||Participants|Count of Participants|370|370.0||||||
4386825|NCT00309387|4212654|B1||>=65 years|Age||Participants|Count of Participants|371|371.0||||||
4386826|NCT00309387|4212652|B3||Between 18 and 65 years|Age||Participants|Count of Participants|279|279.0||||||
4386827|NCT00309387|4212653|B2||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
4386828|NCT00309387|4212654|B1||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
4386829|NCT00309387|4212652|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386830|NCT00309387|4212653|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386831|NCT00309387|4212654|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386832|NCT00309244|4212671|B3|||Weight|Weight in kg TI + Insulin glargine arm, 322 subjects BPR 70/30 arm, 331 subjects|kilogram|Mean|86.9|86.9|Standard Deviation|17.74|17.74|||
4386833|NCT00309244|4212672|B2|||Weight|Weight in kg TI + Insulin glargine arm, 322 subjects BPR 70/30 arm, 331 subjects|kilogram|Mean|85.7|85.7|Standard Deviation|18.07|18.07|||
4386834|NCT00309244|4212673|B1|||Weight|Weight in kg TI + Insulin glargine arm, 322 subjects BPR 70/30 arm, 331 subjects|kilogram|Mean|88.1|88.1|Standard Deviation|17.33|17.33|||
4386835|NCT00309244|4212671|B3|||HbA1c|Glycosylated Hemoglobin|percentage|Mean|8.7|8.7|Standard Deviation|1.12|1.12|||
4386836|NCT00309244|4212672|B2|||HbA1c|Glycosylated Hemoglobin|percentage|Mean|8.7|8.7|Standard Deviation|1.10|1.1|||
4386837|NCT00309244|4212673|B1|||HbA1c|Glycosylated Hemoglobin|percentage|Mean|8.7|8.7|Standard Deviation|1.14|1.14|||
4386838|NCT00309244|4212671|B3|||Fasting Plasma Glucose (FPG)|TI + Insulin glargine arm,302 subjects BPR 70/30 arm, 316 subjects|milligrams per deciliter|Mean|174|174.0|Standard Deviation|67.82|67.82|||
4386839|NCT00309244|4212672|B2|||Fasting Plasma Glucose (FPG)|TI + Insulin glargine arm,302 subjects BPR 70/30 arm, 316 subjects|milligrams per deciliter|Mean|176.2|176.2|Standard Deviation|67.15|67.15|||
4386840|NCT00309244|4212673|B1|||Fasting Plasma Glucose (FPG)|TI + Insulin glargine arm,302 subjects BPR 70/30 arm, 316 subjects|milligrams per deciliter|Mean|171.8|171.8|Standard Deviation|68.53|68.53|||
4386841|NCT00309244|4212671|B3||Male|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4386842|NCT00309244|4212672|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4386843|NCT00309244|4212673|B1||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4386844|NCT00309244|4212671|B3||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4386845|NCT00309244|4212672|B2||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4386846|NCT00309244|4212673|B1||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4386847|NCT00309244|4212671|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|10.29|10.29|19.0|79.0|
4386848|NCT00309244|4212672|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|9.91|9.91|24.0|78.0|
4386849|NCT00309244|4212673|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|10.68|10.68|19.0|79.0|
4386850|NCT00309166|4212694|B3|Geographic ancestry|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4386851|NCT00309166|4212695|B2|Geographic ancestry|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4386852|NCT00309166|4212696|B1|Geographic ancestry|Not specified|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4386853|NCT00309166|4212694|B3|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|265|265.0||||||
4386854|NCT00309166|4212695|B2|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
4386855|NCT00309166|4212696|B1|Geographic ancestry|White-Caucasian/European heritage|Race/Ethnicity, Customized||Participants|Count of Participants|177|177.0||||||
4386856|NCT00309166|4212694|B3|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4386857|NCT00309166|4212695|B2|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4386858|NCT00309166|4212696|B1|Geographic ancestry|White-Arabic/North African heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4386859|NCT00309166|4212694|B3|Geographic ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4386860|NCT00309166|4212695|B2|Geographic ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4386861|NCT00309166|4212696|B1|Geographic ancestry|Asian-Central/South Asian heritage|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4386862|NCT00309166|4212694|B3|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4386863|NCT00309166|4212695|B2|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4386864|NCT00309166|4212696|B1|Geographic ancestry|African heritage/African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4386865|NCT00309166|4212694|B3||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4386866|NCT00309166|4212695|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4386867|NCT00309166|4212696|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4386868|NCT00309166|4212694|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386869|NCT00309166|4212695|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386870|NCT00309166|4212696|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386871|NCT00309166|4212694|B3|||Age||Years|Mean|14.4|14.4|Standard Deviation|2.10|2.1|||
4386872|NCT00309166|4212695|B2|||Age||Years|Mean|14.4|14.4|Standard Deviation|2.02|2.02|||
4386873|NCT00309166|4212696|B1|||Age||Years|Mean|14.4|14.4|Standard Deviation|2.14|2.14|||
4386874|NCT00308997|4212723|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4386875|NCT00308997|4212724|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4386876|NCT00308997|4212725|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4386877|NCT00308997|4212723|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4386878|NCT00308997|4212724|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4386879|NCT00308997|4212725|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4386880|NCT00308997|4212723|B3|||Age||years|Mean|35.8|35.8|Standard Deviation|10.7|10.7|||
4386881|NCT00308997|4212724|B2|||Age||years|Mean|34.0|34.0|Standard Deviation|10.0|10.0|||
4386882|NCT00308997|4212725|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|11.0|11.0|||
4386883|NCT00308737|4212742|B4|||Weight|Weight in kilograms|kilograms|Mean|86.6|86.6|Standard Deviation|18.33|18.33|||
4386884|NCT00308737|4212743|B3|||Weight|Weight in kilograms|kilograms|Mean|74.35|74.35|Standard Deviation|16.204|16.204|||
4386885|NCT00308737|4212744|B2|||Weight|Weight in kilograms|kilograms|Mean|87.53|87.53|Standard Deviation|17.638|17.638|||
4386886|NCT00308737|4212745|B1|||Weight|Weight in kilograms|kilograms|Mean|87.69|87.69|Standard Deviation|18.628|18.628|||
4386887|NCT00308737|4212742|B4|||HbA1c|Glycated hemoglobin|percentage|Mean|8.4|8.4|Standard Deviation|1.61|1.61|||
4386888|NCT00308737|4212743|B3|||HbA1c|Glycated hemoglobin|percentage|Mean|0|0.0|Standard Deviation|0|0.0|||
4386889|NCT00308737|4212744|B2|||HbA1c|Glycated hemoglobin|percentage|Mean|8.7|8.7|Standard Deviation|1.38|1.38|||
4386890|NCT00308737|4212745|B1|||HbA1c|Glycated hemoglobin|percentage|Mean|8.7|8.7|Standard Deviation|1.39|1.39|||
4386891|NCT00308737|4212742|B4|||Body mass index|Body mass index|kilograms per meter squared|Mean|29.5|29.5|Standard Deviation|5.29|5.29|||
4386892|NCT00308737|4212743|B3|||Body mass index|Body mass index|kilograms per meter squared|Mean|25.27|25.27|Standard Deviation|4.494|4.494|||
4386893|NCT00308737|4212744|B2|||Body mass index|Body mass index|kilograms per meter squared|Mean|29.76|29.76|Standard Deviation|5.035|5.035|||
4386894|NCT00308737|4212745|B1|||Body mass index|Body mass index|kilograms per meter squared|Mean|29.87|29.87|Standard Deviation|5.366|5.366|||
4386895|NCT00308737|4212742|B4||Male|Sex: Female, Male||Participants|Count of Participants|1206|1206.0||||||
4386896|NCT00308737|4212743|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4386897|NCT00308737|4212744|B2||Male|Sex: Female, Male||Participants|Count of Participants|578|578.0||||||
4386898|NCT00308737|4212745|B1||Male|Sex: Female, Male||Participants|Count of Participants|557|557.0||||||
4386899|NCT00308737|4212742|B4||Female|Sex: Female, Male||Participants|Count of Participants|829|829.0||||||
4386900|NCT00308737|4212743|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4386901|NCT00308737|4212744|B2||Female|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4386902|NCT00308737|4212745|B1||Female|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4386903|NCT00308737|4212742|B4|||Age||years|Mean|49.6|49.6|Standard Deviation|12.15|12.15|||
4386904|NCT00308737|4212743|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|12.59|12.59|||
4386905|NCT00308737|4212744|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|11.62|11.62|||
4386906|NCT00308737|4212745|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|11.55|11.55|||
4386907|NCT00308711|4212784|B4|||modified Bishop score (mBS)|The mBS measures cervical softness. There are five elements assessed during a vaginal examination. Maximum mBS is 12: 0 to 3 for Dilation, 0 to 3 for Station, 0 to 2 for Consistency, 0 to 1 for Position, and 0 to 3 for Length of Cervix. A score of zero is a long, closed, thick firm cervix; a score of 12 indicates thin, completely soft, 100% effaced cervix.|Units on a scale of 0 (low) to 12 (most)|Mean|2.72|2.72|Standard Deviation|1.1|1.1|||
4386908|NCT00308711|4212785|B3|||modified Bishop score (mBS)|The mBS measures cervical softness. There are five elements assessed during a vaginal examination. Maximum mBS is 12: 0 to 3 for Dilation, 0 to 3 for Station, 0 to 2 for Consistency, 0 to 1 for Position, and 0 to 3 for Length of Cervix. A score of zero is a long, closed, thick firm cervix; a score of 12 indicates thin, completely soft, 100% effaced cervix.|Units on a scale of 0 (low) to 12 (most)|Mean|2.73|2.73|Standard Deviation|1.1|1.1|||
4386958|NCT00308620|4212824|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4386959|NCT00308620|4212821|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4386909|NCT00308711|4212786|B2|||modified Bishop score (mBS)|The mBS measures cervical softness. There are five elements assessed during a vaginal examination. Maximum mBS is 12: 0 to 3 for Dilation, 0 to 3 for Station, 0 to 2 for Consistency, 0 to 1 for Position, and 0 to 3 for Length of Cervix. A score of zero is a long, closed, thick firm cervix; a score of 12 indicates thin, completely soft, 100% effaced cervix.|Units on a scale of 0 (low) to 12 (most)|Mean|2.74|2.74|Standard Deviation|1.1|1.1|||
4386910|NCT00308711|4212787|B1|||modified Bishop score (mBS)|The mBS measures cervical softness. There are five elements assessed during a vaginal examination. Maximum mBS is 12: 0 to 3 for Dilation, 0 to 3 for Station, 0 to 2 for Consistency, 0 to 1 for Position, and 0 to 3 for Length of Cervix. A score of zero is a long, closed, thick firm cervix; a score of 12 indicates thin, completely soft, 100% effaced cervix.|Units on a scale of 0 (low) to 12 (most)|Mean|2.69|2.69|Standard Deviation|1.1|1.1|||
4386911|NCT00308711|4212784|B4|Parous||Parity|Nulliparaous = no previous vaginal delivery prior to 24 wks gestation Parous = at least one previous vaginal delivery after 24 weeks|participants|Number|496|496.0||||||
4386912|NCT00308711|4212785|B3|Parous||Parity|Nulliparaous = no previous vaginal delivery prior to 24 wks gestation Parous = at least one previous vaginal delivery after 24 weeks|participants|Number|166|166.0||||||
4386913|NCT00308711|4212786|B2|Parous||Parity|Nulliparaous = no previous vaginal delivery prior to 24 wks gestation Parous = at least one previous vaginal delivery after 24 weeks|participants|Number|169|169.0||||||
4386914|NCT00308711|4212787|B1|Parous||Parity|Nulliparaous = no previous vaginal delivery prior to 24 wks gestation Parous = at least one previous vaginal delivery after 24 weeks|participants|Number|161|161.0||||||
4386915|NCT00308711|4212784|B4|Nulliparous||Parity|Nulliparaous = no previous vaginal delivery prior to 24 wks gestation Parous = at least one previous vaginal delivery after 24 weeks|participants|Number|812|812.0||||||
4386916|NCT00308711|4212785|B3|Nulliparous||Parity|Nulliparaous = no previous vaginal delivery prior to 24 wks gestation Parous = at least one previous vaginal delivery after 24 weeks|participants|Number|270|270.0||||||
4386917|NCT00308711|4212786|B2|Nulliparous||Parity|Nulliparaous = no previous vaginal delivery prior to 24 wks gestation Parous = at least one previous vaginal delivery after 24 weeks|participants|Number|275|275.0||||||
4386918|NCT00308711|4212787|B1|Nulliparous||Parity|Nulliparaous = no previous vaginal delivery prior to 24 wks gestation Parous = at least one previous vaginal delivery after 24 weeks|participants|Number|267|267.0||||||
4386919|NCT00308711|4212784|B4|Canada||Region of Enrollment||participants|Number|49|49.0||||||
4386920|NCT00308711|4212785|B3|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4386921|NCT00308711|4212786|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4386922|NCT00308711|4212787|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4386923|NCT00308711|4212784|B4|United States||Region of Enrollment||participants|Number|1259|1259.0||||||
4386924|NCT00308711|4212785|B3|United States||Region of Enrollment||participants|Number|419|419.0||||||
4386925|NCT00308711|4212786|B2|United States||Region of Enrollment||participants|Number|427|427.0||||||
4386926|NCT00308711|4212787|B1|United States||Region of Enrollment||participants|Number|413|413.0||||||
4386927|NCT00308711|4212784|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386928|NCT00308711|4212785|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386929|NCT00308711|4212786|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386930|NCT00308711|4212787|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386931|NCT00308711|4212784|B4||Female|Sex: Female, Male||Participants|Count of Participants|1308|1308.0||||||
4386932|NCT00308711|4212785|B3||Female|Sex: Female, Male||Participants|Count of Participants|436|436.0||||||
4386933|NCT00308711|4212786|B2||Female|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
4386934|NCT00308711|4212787|B1||Female|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
4386935|NCT00308711|4212784|B4|||Age||years|Mean|26.4|26.4|Standard Deviation|5.9|5.9|||
4386936|NCT00308711|4212785|B3|||Age||years|Mean|26.0|26.0|Standard Deviation|5.7|5.7|||
4386937|NCT00308711|4212786|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|6.2|6.2|||
4386938|NCT00308711|4212787|B1|||Age||years|Mean|26.2|26.2|Standard Deviation|5.9|5.9|||
4386939|NCT00308711|4212784|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386940|NCT00308711|4212785|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386941|NCT00308711|4212786|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386942|NCT00308711|4212787|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386943|NCT00308711|4212784|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1308|1308.0||||||
4386944|NCT00308711|4212785|B3||Between 18 and 65 years|Age||Participants|Count of Participants|436|436.0||||||
4386945|NCT00308711|4212786|B2||Between 18 and 65 years|Age||Participants|Count of Participants|444|444.0||||||
4386946|NCT00308711|4212787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|428|428.0||||||
4386947|NCT00308711|4212784|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386948|NCT00308711|4212785|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386949|NCT00308711|4212786|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386950|NCT00308711|4212787|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386951|NCT00308620|4212821|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
4386952|NCT00308620|4212822|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4386953|NCT00308620|4212823|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4386954|NCT00308620|4212824|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4386955|NCT00308620|4212821|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4386956|NCT00308620|4212822|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4386957|NCT00308620|4212823|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4386960|NCT00308620|4212822|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386961|NCT00308620|4212823|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4386962|NCT00308620|4212824|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4386963|NCT00308620|4212821|B4|||Age||years|Mean|36.5|36.5|Standard Deviation|8.0|8.0|||
4386964|NCT00308620|4212822|B3|||Age||years|Mean|36|36.0|Standard Deviation|5|5.0|||
4386965|NCT00308620|4212823|B2|||Age||years|Mean|34|34.0|Standard Deviation|5|5.0|||
4386966|NCT00308620|4212824|B1|||Age||years|Mean|40|40.0|Standard Deviation|15|15.0|||
4386967|NCT00308620|4212821|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386968|NCT00308620|4212822|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386969|NCT00308620|4212823|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386970|NCT00308620|4212824|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4386971|NCT00308620|4212821|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4386972|NCT00308620|4212822|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4386973|NCT00308620|4212823|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4386974|NCT00308620|4212824|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4386975|NCT00308620|4212821|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386976|NCT00308620|4212822|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386977|NCT00308620|4212823|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386978|NCT00308620|4212824|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386979|NCT00308581|4212835|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4386980|NCT00308581|4212835|B1|Norway||Region of Enrollment||participants|Number|9|9.0||||||
4386981|NCT00308581|4212835|B1|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
4386982|NCT00308581|4212835|B1|Germany||Region of Enrollment||participants|Number|64|64.0||||||
4386983|NCT00308581|4212835|B1|Denmark||Region of Enrollment||participants|Number|11|11.0||||||
4386984|NCT00308581|4212835|B1|Belgium||Region of Enrollment||participants|Number|88|88.0||||||
4386985|NCT00308581|4212835|B1|Canada||Region of Enrollment||participants|Number|43|43.0||||||
4386986|NCT00308581|4212835|B1|France||Region of Enrollment||participants|Number|45|45.0||||||
4386987|NCT00308581|4212835|B1|Switzerland||Region of Enrollment||participants|Number|8|8.0||||||
4386988|NCT00308581|4212835|B1|Italy||Region of Enrollment||participants|Number|53|53.0||||||
4386989|NCT00308581|4212835|B1|United Kingdom||Region of Enrollment||participants|Number|29|29.0||||||
4386990|NCT00308581|4212835|B1|Austria||Region of Enrollment||participants|Number|16|16.0||||||
4386991|NCT00308581|4212835|B1|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4386992|NCT00308581|4212835|B1|United States||Region of Enrollment||participants|Number|141|141.0||||||
4386993|NCT00308581|4212835|B1||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4386994|NCT00308581|4212835|B1||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4386995|NCT00308581|4212835|B1|||Age||years|Mean|37.67|37.67|Standard Deviation|12.19|12.19|||
4386996|NCT00308581|4212835|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4386997|NCT00308581|4212835|B1||Between 18 and 65 years|Age||Participants|Count of Participants|526|526.0||||||
4386998|NCT00308581|4212835|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4386999|NCT00308555|4212961|B3|||Mean opioid dose, twice daily|Baseline medication use|mg|Mean|58|58.0|Full Range|||10.0|120.0|
4387000|NCT00308555|4212962|B2|||Mean opioid dose, twice daily|Baseline medication use|mg|Mean|53|53.0|Full Range|||10.0|120.0|
4387001|NCT00308555|4212963|B1|||Mean opioid dose, twice daily|Baseline medication use|mg|Mean|62|62.0|Full Range|||10.0|100.0|
4387002|NCT00308555|4212961|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4387003|NCT00308555|4212962|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4387004|NCT00308555|4212963|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4387005|NCT00308555|4212961|B3||Male|Gender||Participants|Count of Participants|12|12.0||||||
4387006|NCT00308555|4212962|B2||Male|Gender||Participants|Count of Participants|5|5.0||||||
4387007|NCT00308555|4212963|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
4387008|NCT00308555|4212961|B3||Female|Gender||Participants|Count of Participants|12|12.0||||||
4387009|NCT00308555|4212962|B2||Female|Gender||Participants|Count of Participants|6|6.0||||||
4387010|NCT00308555|4212963|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4387011|NCT00308555|4212961|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|10.0|10.0|||
4387012|NCT00308555|4212962|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|11.8|11.8|||
4387013|NCT00308555|4212963|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|7.4|7.4|||
4387014|NCT00308555|4212961|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4387015|NCT00308555|4212962|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4387016|NCT00308555|4212963|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4387017|NCT00308555|4212961|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4387018|NCT00308555|4212962|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4387019|NCT00308555|4212963|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4387020|NCT00308555|4212961|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387021|NCT00308555|4212962|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387022|NCT00308555|4212963|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387023|NCT00308516|4212970|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4387024|NCT00308516|4212971|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4387025|NCT00308516|4212972|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4387026|NCT00308516|4212970|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4387027|NCT00308516|4212971|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4387028|NCT00308516|4212972|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4387029|NCT00308516|4212970|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4387030|NCT00308516|4212971|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4387031|NCT00308516|4212972|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4387032|NCT00308516|4212970|B3|||Age||years|Median|57|57.0|Full Range|||26.0|82.0|
4387033|NCT00308516|4212971|B2|||Age||years|Median|56|56.0|Full Range|||31.0|76.0|
4387034|NCT00308516|4212972|B1|||Age||years|Median|57|57.0|Full Range|||26.0|82.0|
4387035|NCT00308308|4212979|B3|||Weight|Weight in kilograms|kilogram|Mean|76.7|76.7|Standard Deviation|15.3|15.3|||
4387036|NCT00308308|4212980|B2|||Weight|Weight in kilograms|kilogram|Mean|76.8|76.8|Standard Deviation|14.95|14.95|||
4387037|NCT00308308|4212981|B1|||Weight|Weight in kilograms|kilogram|Mean|76.7|76.7|Standard Deviation|15.64|15.64|||
4387038|NCT00308308|4212979|B3|||HbA1c|Glycosylated Hemoglobin|percent|Mean|8.5|8.5|Standard Deviation|0.96|0.96|||
4387039|NCT00308308|4212980|B2|||HbA1c|Glycosylated Hemoglobin|percent|Mean|8.5|8.5|Standard Deviation|0.97|0.97|||
4387040|NCT00308308|4212981|B1|||HbA1c|Glycosylated Hemoglobin|percent|Mean|8.4|8.4|Standard Deviation|0.95|0.95|||
4387041|NCT00308308|4212979|B3||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4387042|NCT00308308|4212980|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4387043|NCT00308308|4212981|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4387044|NCT00308308|4212979|B3||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4387045|NCT00308308|4212980|B2||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4387046|NCT00308308|4212981|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4387047|NCT00308308|4212979|B3|||Age||years|Mean|38|38.0|Standard Deviation|13.11|13.11|||
4387048|NCT00308308|4212980|B2|||Age||years|Mean|38.1|38.1|Standard Deviation|13.18|13.18|||
4387049|NCT00308308|4212981|B1|||Age||years|Mean|37.9|37.9|Standard Deviation|13.06|13.06|||
4387050|NCT00308230|4213002|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4387051|NCT00308230|4213003|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4387052|NCT00308230|4213004|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4387053|NCT00308230|4213005|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4387054|NCT00308230|4213002|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4387055|NCT00308230|4213003|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4387056|NCT00308230|4213004|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4387057|NCT00308230|4213005|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4387058|NCT00308230|4213002|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4387059|NCT00308230|4213003|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4387060|NCT00308230|4213004|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4387061|NCT00308230|4213005|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4387062|NCT00308230|4213002|B4||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4387063|NCT00308230|4213003|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4387064|NCT00308230|4213004|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4387065|NCT00308230|4213005|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4387066|NCT00308230|4213002|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387067|NCT00308230|4213003|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387068|NCT00308230|4213004|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387069|NCT00308230|4213005|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387070|NCT00308139|4213015|B3|SU+MET+TZD||Background Oral Antidiabetic Agent||participants|Number|1|1.0||||||
4387071|NCT00308139|4213016|B2|SU+MET+TZD||Background Oral Antidiabetic Agent||participants|Number|0|0.0||||||
4387072|NCT00308139|4213017|B1|SU+MET+TZD||Background Oral Antidiabetic Agent||participants|Number|1|1.0||||||
4387073|NCT00308139|4213015|B3|SU+TZD||Background Oral Antidiabetic Agent||participants|Number|10|10.0||||||
4387074|NCT00308139|4213016|B2|SU+TZD||Background Oral Antidiabetic Agent||participants|Number|5|5.0||||||
4387075|NCT00308139|4213017|B1|SU+TZD||Background Oral Antidiabetic Agent||participants|Number|5|5.0||||||
4387076|NCT00308139|4213015|B3|MET+TZD||Background Oral Antidiabetic Agent||participants|Number|28|28.0||||||
4387077|NCT00308139|4213016|B2|MET+TZD||Background Oral Antidiabetic Agent||participants|Number|14|14.0||||||
4387078|NCT00308139|4213017|B1|MET+TZD||Background Oral Antidiabetic Agent||participants|Number|14|14.0||||||
4387079|NCT00308139|4213015|B3|MET+SU||Background Oral Antidiabetic Agent||participants|Number|82|82.0||||||
4387080|NCT00308139|4213016|B2|MET+SU||Background Oral Antidiabetic Agent||participants|Number|39|39.0||||||
4387081|NCT00308139|4213017|B1|MET+SU||Background Oral Antidiabetic Agent||participants|Number|43|43.0||||||
4387082|NCT00308139|4213015|B3|Thiazolidinediones (TZD)||Background Oral Antidiabetic Agent||participants|Number|9|9.0||||||
4387144|NCT00308087|4213115|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4387083|NCT00308139|4213016|B2|Thiazolidinediones (TZD)||Background Oral Antidiabetic Agent||participants|Number|7|7.0||||||
4387084|NCT00308139|4213017|B1|Thiazolidinediones (TZD)||Background Oral Antidiabetic Agent||participants|Number|2|2.0||||||
4387085|NCT00308139|4213015|B3|Sulfonylurea (SU)||Background Oral Antidiabetic Agent||participants|Number|16|16.0||||||
4387086|NCT00308139|4213016|B2|Sulfonylurea (SU)||Background Oral Antidiabetic Agent||participants|Number|10|10.0||||||
4387087|NCT00308139|4213017|B1|Sulfonylurea (SU)||Background Oral Antidiabetic Agent||participants|Number|6|6.0||||||
4387088|NCT00308139|4213015|B3|Metformin (MET)||Background Oral Antidiabetic Agent||participants|Number|106|106.0||||||
4387089|NCT00308139|4213016|B2|Metformin (MET)||Background Oral Antidiabetic Agent||participants|Number|50|50.0||||||
4387090|NCT00308139|4213017|B1|Metformin (MET)||Background Oral Antidiabetic Agent||participants|Number|56|56.0||||||
4387091|NCT00308139|4213015|B3|Diet and Exercise||Background Oral Antidiabetic Agent||participants|Number|43|43.0||||||
4387092|NCT00308139|4213016|B2|Diet and Exercise||Background Oral Antidiabetic Agent||participants|Number|22|22.0||||||
4387093|NCT00308139|4213017|B1|Diet and Exercise||Background Oral Antidiabetic Agent||participants|Number|21|21.0||||||
4387094|NCT00308139|4213015|B3|||Weight||kg|Mean|101.8|101.8|Standard Deviation|19.90|19.9|||
4387095|NCT00308139|4213016|B2|||Weight||kg|Mean|101.9|101.9|Standard Deviation|21.05|21.05|||
4387096|NCT00308139|4213017|B1|||Weight||kg|Mean|101.7|101.7|Standard Deviation|18.76|18.76|||
4387097|NCT00308139|4213015|B3|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.3|8.3|Standard Deviation|0.99|0.99|||
4387098|NCT00308139|4213016|B2|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.3|8.3|Standard Deviation|1.00|1.0|||
4387099|NCT00308139|4213017|B1|||Glycosylated hemoglobin (HbA1c)||percentage of total hemoglobin|Mean|8.3|8.3|Standard Deviation|0.99|0.99|||
4387100|NCT00308139|4213015|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4387101|NCT00308139|4213016|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4387102|NCT00308139|4213017|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4387103|NCT00308139|4213015|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4387104|NCT00308139|4213016|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4387105|NCT00308139|4213017|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4387106|NCT00308139|4213015|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|9.66|9.66|||
4387107|NCT00308139|4213016|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|9.63|9.63|||
4387108|NCT00308139|4213017|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|9.72|9.72|||
4387109|NCT00308139|4213015|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4387110|NCT00308139|4213016|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4387111|NCT00308139|4213017|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4387112|NCT00308139|4213015|B3||Between 18 and 65 years|Age||Participants|Count of Participants|245|245.0||||||
4387113|NCT00308139|4213016|B2||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4387114|NCT00308139|4213017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4387115|NCT00308139|4213015|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387116|NCT00308139|4213016|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387117|NCT00308139|4213017|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387118|NCT00308113|4213088|B5|Male||Gender||participants|Number|3|3.0||||||
4387119|NCT00308113|4213089|B4|Male||Gender||participants|Number|2|2.0||||||
4387120|NCT00308113|4213090|B3|Male||Gender||participants|Number|1|1.0||||||
4387121|NCT00308113|4213088|B5|Female||Gender||participants|Number|0|0.0||||||
4387122|NCT00308113|4213089|B4|Female||Gender||participants|Number|0|0.0||||||
4387123|NCT00308113|4213090|B3|Female||Gender||participants|Number|0|0.0||||||
4387124|NCT00308113|4213088|B5|10-18 years||Age, Customized||participants|Number|3|3.0||||||
4387125|NCT00308113|4213089|B4|10-18 years||Age, Customized||participants|Number|2|2.0||||||
4387126|NCT00308113|4213090|B3|10-18 years||Age, Customized||participants|Number|1|1.0||||||
4387127|NCT00308087|4213113|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387128|NCT00308087|4213114|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4387129|NCT00308087|4213115|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387130|NCT00308087|4213113|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4387131|NCT00308087|4213114|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4387132|NCT00308087|4213115|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387133|NCT00308087|4213113|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4387134|NCT00308087|4213114|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4387135|NCT00308087|4213115|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4387136|NCT00308087|4213113|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4387137|NCT00308087|4213114|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4387138|NCT00308087|4213115|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4387139|NCT00308087|4213113|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4387140|NCT00308087|4213114|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4387141|NCT00308087|4213115|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4387142|NCT00308087|4213113|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4387143|NCT00308087|4213114|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4387145|NCT00308087|4213113|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4387146|NCT00308087|4213114|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4387147|NCT00308087|4213115|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4387148|NCT00308087|4213113|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|9.47|9.47|||
4387149|NCT00308087|4213114|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|8.68|8.68|||
4387150|NCT00308087|4213115|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|10.23|10.23|||
4387151|NCT00308074|4213132|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4387152|NCT00308074|4213132|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4387153|NCT00308074|4213132|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4387154|NCT00308074|4213132|B1|||Age||years|Mean|13|13.0|Standard Deviation|1.66|1.66|||
4387155|NCT00308074|4213132|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4387156|NCT00308074|4213132|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4387157|NCT00308074|4213132|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4387158|NCT00308061|4213139|B3|Mali||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4387159|NCT00308061|4213140|B2|Mali||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4387160|NCT00308061|4213141|B1|Mali||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4387161|NCT00308061|4213139|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4387162|NCT00308061|4213140|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4387163|NCT00308061|4213141|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4387164|NCT00308061|4213139|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4387165|NCT00308061|4213140|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4387166|NCT00308061|4213141|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4387167|NCT00308061|4213139|B3|||Age||years|Mean|39.4|39.4|Standard Deviation|9.0|9.0|||
4387168|NCT00308061|4213140|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|10.0|10.0|||
4387169|NCT00308061|4213141|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|8.0|8.0|||
4387170|NCT00307931|4213149|B1|||Body Weight||kg|Mean|64.0|64.0|Standard Deviation|19.5|19.5|||
4387171|NCT00307931|4213149|B1|||Body Mass Index||kg/m^2|Mean|22.20|22.2|Standard Deviation|4.98|4.98|||
4387172|NCT00307931|4213149|B1|||Body Height||cm|Mean|168.7|168.7|Standard Deviation|9.2|9.2|||
4387173|NCT00307931|4213149|B1|Greece||Region of Enrollment||participants|Number|16|16.0||||||
4387174|NCT00307931|4213149|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4387175|NCT00307931|4213149|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4387176|NCT00307931|4213149|B1|||Age||years|Mean|42.45|42.45|Standard Deviation|15.40|15.4|||
4387177|NCT00307801|4213164|B3|||prolonged, frequent and excessive bleeding||participants|Number|0|0.0||||||
4387178|NCT00307801|4213165|B2|||prolonged, frequent and excessive bleeding||participants|Number|0|0.0||||||
4387179|NCT00307801|4213166|B1|||prolonged, frequent and excessive bleeding||participants|Number|0|0.0||||||
4387180|NCT00307801|4213164|B3|||frequent and excessive bleeding|Excessive bleeding: 2 or more bleeding episodes each with blood loss volume of 80 mL or more in a 90-day period, as assessed by the alkaline hematin method. Frequent bleeding: greater than 5 bleeding episodes, with a minimum of 20 bleeding days overall.|participants|Number|0|0.0||||||
4387181|NCT00307801|4213165|B2|||frequent and excessive bleeding|Excessive bleeding: 2 or more bleeding episodes each with blood loss volume of 80 mL or more in a 90-day period, as assessed by the alkaline hematin method. Frequent bleeding: greater than 5 bleeding episodes, with a minimum of 20 bleeding days overall.|participants|Number|0|0.0||||||
4387182|NCT00307801|4213166|B1|||frequent and excessive bleeding|Excessive bleeding: 2 or more bleeding episodes each with blood loss volume of 80 mL or more in a 90-day period, as assessed by the alkaline hematin method. Frequent bleeding: greater than 5 bleeding episodes, with a minimum of 20 bleeding days overall.|participants|Number|0|0.0||||||
4387183|NCT00307801|4213164|B3|||prolonged and excessive bleeding|Prolonged bleeding: 2 or more bleeding episodes, each lasting 8 or more days. Excessive bleeding: 2 or more bleeding episodes each with blood loss volume of 80 mL or more in a 90-day period, as assessed by the alkaline hematin method.|participants|Number|24|24.0||||||
4387184|NCT00307801|4213165|B2|||prolonged and excessive bleeding|Prolonged bleeding: 2 or more bleeding episodes, each lasting 8 or more days. Excessive bleeding: 2 or more bleeding episodes each with blood loss volume of 80 mL or more in a 90-day period, as assessed by the alkaline hematin method.|participants|Number|9|9.0||||||
4387185|NCT00307801|4213166|B1|||prolonged and excessive bleeding|Prolonged bleeding: 2 or more bleeding episodes, each lasting 8 or more days. Excessive bleeding: 2 or more bleeding episodes each with blood loss volume of 80 mL or more in a 90-day period, as assessed by the alkaline hematin method.|participants|Number|15|15.0||||||
4387186|NCT00307801|4213164|B3|||prolonged and frequent bleeding|Prolonged bleeding: 2 or more bleeding episodes, each lasting 8 or more days.Frequent bleeding: greater than 5 bleeding episodes, with a minimum of 20 bleeding days overall.|participants|Number|0|0.0||||||
4387187|NCT00307801|4213165|B2|||prolonged and frequent bleeding|Prolonged bleeding: 2 or more bleeding episodes, each lasting 8 or more days.Frequent bleeding: greater than 5 bleeding episodes, with a minimum of 20 bleeding days overall.|participants|Number|0|0.0||||||
4387188|NCT00307801|4213166|B1|||prolonged and frequent bleeding|Prolonged bleeding: 2 or more bleeding episodes, each lasting 8 or more days.Frequent bleeding: greater than 5 bleeding episodes, with a minimum of 20 bleeding days overall.|participants|Number|0|0.0||||||
4387189|NCT00307801|4213164|B3|||frequent bleeding|Frequent bleeding: greater than 5 bleeding episodes, with a minimum of 20 bleeding days overall.|participants|Number|0|0.0||||||
4387190|NCT00307801|4213165|B2|||frequent bleeding|Frequent bleeding: greater than 5 bleeding episodes, with a minimum of 20 bleeding days overall.|participants|Number|0|0.0||||||
4387191|NCT00307801|4213166|B1|||frequent bleeding|Frequent bleeding: greater than 5 bleeding episodes, with a minimum of 20 bleeding days overall.|participants|Number|0|0.0||||||
4387192|NCT00307801|4213164|B3|||prolonged bleeding|Prolonged bleeding: 2 or more bleeding episodes, each lasting 8 or more days.|participants|Number|30|30.0||||||
4387193|NCT00307801|4213165|B2|||prolonged bleeding|Prolonged bleeding: 2 or more bleeding episodes, each lasting 8 or more days.|participants|Number|10|10.0||||||
4387194|NCT00307801|4213166|B1|||prolonged bleeding|Prolonged bleeding: 2 or more bleeding episodes, each lasting 8 or more days.|participants|Number|20|20.0||||||
4387195|NCT00307801|4213164|B3|||excessive bleeding|Excessive bleeding: 2 or more bleeding episodes each with blood loss volume of 80 mL or more in a 90-day period, as assessed by the alkaline hematin method.|participants|Number|212|212.0||||||
4387196|NCT00307801|4213165|B2|||excessive bleeding|Excessive bleeding: 2 or more bleeding episodes each with blood loss volume of 80 mL or more in a 90-day period, as assessed by the alkaline hematin method.|participants|Number|76|76.0||||||
4387197|NCT00307801|4213166|B1|||excessive bleeding|Excessive bleeding: 2 or more bleeding episodes each with blood loss volume of 80 mL or more in a 90-day period, as assessed by the alkaline hematin method.|participants|Number|136|136.0||||||
4387198|NCT00307801|4213164|B3|||Body Mass Index (BMI)|Body mass index was calculated with body weight and height measured at screening (BMI = body weight in kg/ body height in m^2)|kg/m²|Mean|24.9|24.9|Standard Deviation|3.4|3.4|||
4387199|NCT00307801|4213165|B2|||Body Mass Index (BMI)|Body mass index was calculated with body weight and height measured at screening (BMI = body weight in kg/ body height in m^2)|kg/m²|Mean|25.7|25.7|Standard Deviation|3.0|3.0|||
4387200|NCT00307801|4213166|B1|||Body Mass Index (BMI)|Body mass index was calculated with body weight and height measured at screening (BMI = body weight in kg/ body height in m^2)|kg/m²|Mean|24.5|24.5|Standard Deviation|3.5|3.5|||
4387201|NCT00307801|4213164|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4387202|NCT00307801|4213165|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4387203|NCT00307801|4213166|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4387204|NCT00307801|4213164|B3||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4387205|NCT00307801|4213165|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4387206|NCT00307801|4213166|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4387207|NCT00307801|4213164|B3|||Age||Years|Mean|39.2|39.2|Standard Deviation|6.9|6.9|||
4387208|NCT00307801|4213165|B2|||Age||Years|Mean|38.5|38.5|Standard Deviation|7.5|7.5|||
4387209|NCT00307801|4213166|B1|||Age||Years|Mean|39.5|39.5|Standard Deviation|6.6|6.6|||
4387210|NCT00307736|4213279|B1|T4N1||Clinical staging|"MRI or ultrasound determined T stage. Clinical staging is based off of TNM staging (Tumor, Node, Metastasis). The T and the following number (0 to 4) are used to describe how deeply the primary tumor has grown into the bowel lining (Tx: primary tumor cannot be evaluated, Tis: refers to carcinoma in situ). The N stands for lymph nodes: (Nx: regional lymph nodes cannot be evaluated; N0: no spread to regional lymph nodes; N1: tumor cells found in 1-3 regional lymph nodes; N2: tumor cells found in 4-7 regional lymph nodes). M0: the disease has not spread to a distant part of the body."|Participants|Count of Participants|1|1.0||||||
4387211|NCT00307736|4213279|B1|T4N0||Clinical staging|"MRI or ultrasound determined T stage. Clinical staging is based off of TNM staging (Tumor, Node, Metastasis). The T and the following number (0 to 4) are used to describe how deeply the primary tumor has grown into the bowel lining (Tx: primary tumor cannot be evaluated, Tis: refers to carcinoma in situ). The N stands for lymph nodes: (Nx: regional lymph nodes cannot be evaluated; N0: no spread to regional lymph nodes; N1: tumor cells found in 1-3 regional lymph nodes; N2: tumor cells found in 4-7 regional lymph nodes). M0: the disease has not spread to a distant part of the body."|Participants|Count of Participants|2|2.0||||||
4387212|NCT00307736|4213279|B1|T3Nx||Clinical staging|"MRI or ultrasound determined T stage. Clinical staging is based off of TNM staging (Tumor, Node, Metastasis). The T and the following number (0 to 4) are used to describe how deeply the primary tumor has grown into the bowel lining (Tx: primary tumor cannot be evaluated, Tis: refers to carcinoma in situ). The N stands for lymph nodes: (Nx: regional lymph nodes cannot be evaluated; N0: no spread to regional lymph nodes; N1: tumor cells found in 1-3 regional lymph nodes; N2: tumor cells found in 4-7 regional lymph nodes). M0: the disease has not spread to a distant part of the body."|Participants|Count of Participants|4|4.0||||||
4387213|NCT00307736|4213279|B1|T3N2M0||Clinical staging|"MRI or ultrasound determined T stage. Clinical staging is based off of TNM staging (Tumor, Node, Metastasis). The T and the following number (0 to 4) are used to describe how deeply the primary tumor has grown into the bowel lining (Tx: primary tumor cannot be evaluated, Tis: refers to carcinoma in situ). The N stands for lymph nodes: (Nx: regional lymph nodes cannot be evaluated; N0: no spread to regional lymph nodes; N1: tumor cells found in 1-3 regional lymph nodes; N2: tumor cells found in 4-7 regional lymph nodes). M0: the disease has not spread to a distant part of the body."|Participants|Count of Participants|4|4.0||||||
4387214|NCT00307736|4213279|B1|T3N1||Clinical staging|"MRI or ultrasound determined T stage. Clinical staging is based off of TNM staging (Tumor, Node, Metastasis). The T and the following number (0 to 4) are used to describe how deeply the primary tumor has grown into the bowel lining (Tx: primary tumor cannot be evaluated, Tis: refers to carcinoma in situ). The N stands for lymph nodes: (Nx: regional lymph nodes cannot be evaluated; N0: no spread to regional lymph nodes; N1: tumor cells found in 1-3 regional lymph nodes; N2: tumor cells found in 4-7 regional lymph nodes). M0: the disease has not spread to a distant part of the body."|Participants|Count of Participants|15|15.0||||||
4387215|NCT00307736|4213279|B1|T3N0||Clinical staging|"MRI or ultrasound determined T stage. Clinical staging is based off of TNM staging (Tumor, Node, Metastasis). The T and the following number (0 to 4) are used to describe how deeply the primary tumor has grown into the bowel lining (Tx: primary tumor cannot be evaluated, Tis: refers to carcinoma in situ). The N stands for lymph nodes: (Nx: regional lymph nodes cannot be evaluated; N0: no spread to regional lymph nodes; N1: tumor cells found in 1-3 regional lymph nodes; N2: tumor cells found in 4-7 regional lymph nodes). M0: the disease has not spread to a distant part of the body."|Participants|Count of Participants|6|6.0||||||
4387270|NCT00307437|4213367|B3||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4387216|NCT00307736|4213279|B1|III||Stage Grouping|The cancer is referred to as Stage II rectal cancer if the pathology report shows that the cancer has penetrated the wall of the rectum, but does not invade any of the local lymph nodes and cannot be detected in other locations in the body The cancer is referred to as Stage III rectal cancer if the pathology report shows that the cancer has invaded any of the local lymph nodes, but cannot be detected in other locations in the body.|Participants|Count of Participants|21|21.0||||||
4387217|NCT00307736|4213279|B1|II||Stage Grouping|The cancer is referred to as Stage II rectal cancer if the pathology report shows that the cancer has penetrated the wall of the rectum, but does not invade any of the local lymph nodes and cannot be detected in other locations in the body The cancer is referred to as Stage III rectal cancer if the pathology report shows that the cancer has invaded any of the local lymph nodes, but cannot be detected in other locations in the body.|Participants|Count of Participants|11|11.0||||||
4387218|NCT00307736|4213279|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4387219|NCT00307736|4213279|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4387220|NCT00307736|4213279|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|29|29.0||||||
4387221|NCT00307736|4213279|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4387222|NCT00307736|4213279|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4387223|NCT00307736|4213279|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4387224|NCT00307736|4213279|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4387225|NCT00307736|4213279|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4387226|NCT00307736|4213279|B1|||Age||years|Mean|53.5|53.5|Full Range|||35.0|75.0|
4387227|NCT00307736|4213279|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4387228|NCT00307736|4213279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4387229|NCT00307736|4213279|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387230|NCT00307684|4213293|B1|||body mass index (BMI)||kg/m2|Mean|24.8|24.8|Standard Deviation|4.47|4.47|||
4387231|NCT00307684|4213293|B1|||Weight||kg|Mean|75.1|75.1|Standard Deviation|16.46|16.46|||
4387232|NCT00307684|4213293|B1|White||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
4387233|NCT00307684|4213293|B1|Other: Northern-African + Hindustan||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387234|NCT00307684|4213293|B1|Other: Asian white||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387235|NCT00307684|4213293|B1|Black or African heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387236|NCT00307684|4213293|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4387237|NCT00307684|4213293|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4387238|NCT00307684|4213293|B1|||Age||years|Mean|35.0|35.0|Standard Deviation|10.60|10.6|||
4387239|NCT00307489|4213321|B3|||Baseline HBV DNA||log10 copies/mL|Mean|5.97|5.97|Standard Deviation|1.607|1.607|||
4387240|NCT00307489|4213322|B2|||Baseline HBV DNA||log10 copies/mL|Mean|5.87|5.87|Standard Deviation|1.779|1.779|||
4387241|NCT00307489|4213323|B1|||Baseline HBV DNA||log10 copies/mL|Mean|6.06|6.06|Standard Deviation|1.430|1.43|||
4387242|NCT00307489|4213321|B3|No||Previous Lamivudine Experience||participants|Number|44|44.0||||||
4387243|NCT00307489|4213322|B2|No||Previous Lamivudine Experience||participants|Number|21|21.0||||||
4387244|NCT00307489|4213323|B1|No||Previous Lamivudine Experience||participants|Number|23|23.0||||||
4387245|NCT00307489|4213321|B3|Yes||Previous Lamivudine Experience||participants|Number|61|61.0||||||
4387246|NCT00307489|4213322|B2|Yes||Previous Lamivudine Experience||participants|Number|31|31.0||||||
4387247|NCT00307489|4213323|B1|Yes||Previous Lamivudine Experience||participants|Number|30|30.0||||||
4387248|NCT00307489|4213321|B3|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4387249|NCT00307489|4213322|B2|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4387250|NCT00307489|4213323|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4387251|NCT00307489|4213321|B3|White||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4387252|NCT00307489|4213322|B2|White||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4387253|NCT00307489|4213323|B1|White||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4387254|NCT00307489|4213321|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4387255|NCT00307489|4213322|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4387256|NCT00307489|4213323|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4387257|NCT00307489|4213321|B3|Asian||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4387258|NCT00307489|4213322|B2|Asian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4387259|NCT00307489|4213323|B1|Asian||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4387260|NCT00307489|4213321|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4387261|NCT00307489|4213322|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4387262|NCT00307489|4213323|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4387263|NCT00307489|4213321|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4387264|NCT00307489|4213322|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4387265|NCT00307489|4213323|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4387266|NCT00307489|4213321|B3|||Age||years|Mean|39|39.0|Standard Deviation|10.9|10.9|||
4387267|NCT00307489|4213322|B2|||Age||years|Mean|39|39.0|Standard Deviation|10.4|10.4|||
4387268|NCT00307489|4213323|B1|||Age||years|Mean|40|40.0|Standard Deviation|11.4|11.4|||
4387269|NCT00307437|4213366|B4||Male|Sex: Female, Male||Participants|Count of Participants|840|840.0||||||
4387271|NCT00307437|4213368|B2||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4387272|NCT00307437|4213369|B1||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4387273|NCT00307437|4213366|B4||Female|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
4387274|NCT00307437|4213367|B3||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4387275|NCT00307437|4213368|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4387276|NCT00307437|4213369|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4387277|NCT00307437|4213366|B4|||Age||years|Mean|46.2|46.2|Standard Deviation|12.24|12.24|||
4387278|NCT00307437|4213367|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|12.14|12.14|||
4387279|NCT00307437|4213368|B2|||Age||years|Mean|45.1|45.1|Standard Deviation|12.06|12.06|||
4387280|NCT00307437|4213369|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|12.47|12.47|||
4387281|NCT00307333|4213399|B3|United States||Region of Enrollment||participants|Number|3003|3003.0||||||
4387282|NCT00307333|4213400|B2|United States||Region of Enrollment||participants|Number|1492|1492.0||||||
4387283|NCT00307333|4213401|B1|United States||Region of Enrollment||participants|Number|1511|1511.0||||||
4387284|NCT00307333|4213399|B3||Male|Sex: Female, Male||Participants|Count of Participants|1445|1445.0||||||
4387285|NCT00307333|4213400|B2||Male|Sex: Female, Male||Participants|Count of Participants|725|725.0||||||
4387286|NCT00307333|4213401|B1||Male|Sex: Female, Male||Participants|Count of Participants|720|720.0||||||
4387287|NCT00307333|4213399|B3||Female|Sex: Female, Male||Participants|Count of Participants|1558|1558.0||||||
4387288|NCT00307333|4213400|B2||Female|Sex: Female, Male||Participants|Count of Participants|767|767.0||||||
4387289|NCT00307333|4213401|B1||Female|Sex: Female, Male||Participants|Count of Participants|791|791.0||||||
4387290|NCT00307333|4213399|B3|||Age|correct as reported|years|Mean|0.54|0.54|Standard Deviation|0.054|0.054|||
4387291|NCT00307333|4213400|B2|||Age|correct as reported|years|Mean|0.54|0.54|Standard Deviation|0.054|0.054|||
4387292|NCT00307333|4213401|B1|||Age|correct as reported|years|Mean|0.54|0.54|Standard Deviation|0.054|0.054|||
4387293|NCT00307333|4213399|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4387294|NCT00307333|4213400|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4387295|NCT00307333|4213401|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4387296|NCT00307333|4213399|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4387297|NCT00307333|4213400|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4387298|NCT00307333|4213401|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4387299|NCT00307333|4213399|B3||<=18 years|Age||Participants|Count of Participants|3003|3003.0||||||
4387300|NCT00307333|4213400|B2||<=18 years|Age||Participants|Count of Participants|1492|1492.0||||||
4387301|NCT00307333|4213401|B1||<=18 years|Age||Participants|Count of Participants|1511|1511.0||||||
4387302|NCT00307294|4213414|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4387303|NCT00307294|4213414|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4387304|NCT00307294|4213414|B1|||Age||years|Median|70|70.0|Full Range|||55.0|84.0|
4387305|NCT00307164|4213421|B3|||Creatine kinase (NucleomaxX N=80, Placebo N=82)||IU/L|Median|134|134.0|Inter-Quartile Range|||84.0|231.0|
4387306|NCT00307164|4213422|B2|||Creatine kinase (NucleomaxX N=80, Placebo N=82)||IU/L|Median|142|142.0|Inter-Quartile Range|||88.0|247.0|
4387307|NCT00307164|4213423|B1|||Creatine kinase (NucleomaxX N=80, Placebo N=82)||IU/L|Median|125|125.0|Inter-Quartile Range|||79.0|216.0|
4387308|NCT00307164|4213421|B3|||Leukocytes||cells*10^3/L|Median|5.5|5.5|Inter-Quartile Range|||4.5|7.0|
4387309|NCT00307164|4213422|B2|||Leukocytes||cells*10^3/L|Median|5.5|5.5|Inter-Quartile Range|||4.7|7.0|
4387310|NCT00307164|4213423|B1|||Leukocytes||cells*10^3/L|Median|5.6|5.6|Inter-Quartile Range|||4.2|7.1|
4387311|NCT00307164|4213421|B3|||Hemoglobin||g/dL|Median|14.9|14.9|Inter-Quartile Range|||13.8|15.7|
4387312|NCT00307164|4213422|B2|||Hemoglobin||g/dL|Median|15.0|15.0|Inter-Quartile Range|||14.0|15.8|
4387313|NCT00307164|4213423|B1|||Hemoglobin||g/dL|Median|14.9|14.9|Inter-Quartile Range|||13.7|15.6|
4387314|NCT00307164|4213421|B3|||Fasting triglycerides (NucleomaxX N=82, Placebo N=81)||mg/dL|Median|164|164.0|Inter-Quartile Range|||114.0|258.0|
4387315|NCT00307164|4213422|B2|||Fasting triglycerides (NucleomaxX N=82, Placebo N=81)||mg/dL|Median|165|165.0|Inter-Quartile Range|||114.0|262.0|
4387316|NCT00307164|4213423|B1|||Fasting triglycerides (NucleomaxX N=82, Placebo N=81)||mg/dL|Median|161|161.0|Inter-Quartile Range|||112.0|237.0|
4387317|NCT00307164|4213421|B3|||Fasting low-density lipoprotein (LDL) (NucleomaxX N=73, Placebo N=67)||mg/dL|Median|109|109.0|Inter-Quartile Range|||88.0|130.0|
4387318|NCT00307164|4213422|B2|||Fasting low-density lipoprotein (LDL) (NucleomaxX N=73, Placebo N=67)||mg/dL|Median|110|110.0|Inter-Quartile Range|||89.0|127.0|
4387319|NCT00307164|4213423|B1|||Fasting low-density lipoprotein (LDL) (NucleomaxX N=73, Placebo N=67)||mg/dL|Median|107|107.0|Inter-Quartile Range|||88.0|132.0|
4387320|NCT00307164|4213421|B3|||Fasting non-high-density lipoprotein (non-HDL) (NucleomaxX N=77, Placebo N=69)||mg/dL|Median|143|143.0|Inter-Quartile Range|||121.0|167.0|
4387321|NCT00307164|4213422|B2|||Fasting non-high-density lipoprotein (non-HDL) (NucleomaxX N=77, Placebo N=69)||mg/dL|Median|145|145.0|Inter-Quartile Range|||115.0|166.0|
4387322|NCT00307164|4213423|B1|||Fasting non-high-density lipoprotein (non-HDL) (NucleomaxX N=77, Placebo N=69)||mg/dL|Median|139|139.0|Inter-Quartile Range|||123.0|168.0|
4387323|NCT00307164|4213421|B3|||Fasting high-density lipoprotein (HDL) (NucleomaxX N=82, Placebo N=80)||mg/dL|Median|38|38.0|Inter-Quartile Range|||32.0|49.0|
4387324|NCT00307164|4213422|B2|||Fasting high-density lipoprotein (HDL) (NucleomaxX N=82, Placebo N=80)||mg/dL|Median|37|37.0|Inter-Quartile Range|||31.0|47.0|
4387325|NCT00307164|4213423|B1|||Fasting high-density lipoprotein (HDL) (NucleomaxX N=82, Placebo N=80)||mg/dL|Median|39|39.0|Inter-Quartile Range|||33.0|49.0|
4387326|NCT00307164|4213421|B3|||Fasting total cholesterol (NucleomaxX N=82, Placebo N=81)||mg/dL|Median|193|193.0|Inter-Quartile Range|||166.0|215.0|
4387327|NCT00307164|4213422|B2|||Fasting total cholesterol (NucleomaxX N=82, Placebo N=81)||mg/dL|Median|190|190.0|Inter-Quartile Range|||166.0|211.0|
4387328|NCT00307164|4213423|B1|||Fasting total cholesterol (NucleomaxX N=82, Placebo N=81)||mg/dL|Median|194|194.0|Inter-Quartile Range|||163.0|216.0|
4387329|NCT00307164|4213421|B3|||Fasting glucose (NucleomaxX N=82, Placebo N=82)||mg/dL|Median|89|89.0|Inter-Quartile Range|||82.0|97.0|
4387330|NCT00307164|4213422|B2|||Fasting glucose (NucleomaxX N=82, Placebo N=82)||mg/dL|Median|87|87.0|Inter-Quartile Range|||81.0|95.0|
4387331|NCT00307164|4213423|B1|||Fasting glucose (NucleomaxX N=82, Placebo N=82)||mg/dL|Median|90|90.0|Inter-Quartile Range|||84.0|98.0|
4387332|NCT00307164|4213421|B3|||Fasting lactate (NucleomaxX N=76, Placebo N=75)||mmol/L|Median|1.3|1.3|Inter-Quartile Range|||0.9|1.6|
4387333|NCT00307164|4213422|B2|||Fasting lactate (NucleomaxX N=76, Placebo N=75)||mmol/L|Median|1.2|1.2|Inter-Quartile Range|||0.9|1.5|
4387334|NCT00307164|4213423|B1|||Fasting lactate (NucleomaxX N=76, Placebo N=75)||mmol/L|Median|1.3|1.3|Inter-Quartile Range|||1.0|1.7|
4387335|NCT00307164|4213421|B3|||Trunk fat||Grams|Median|8114|8114.0|Inter-Quartile Range|||5397.0|10898.0|
4387336|NCT00307164|4213422|B2|||Trunk fat||Grams|Median|7795|7795.0|Inter-Quartile Range|||5327.0|10825.0|
4387337|NCT00307164|4213423|B1|||Trunk fat||Grams|Median|8175|8175.0|Inter-Quartile Range|||5784.0|10931.0|
4387338|NCT00307164|4213421|B3|||Limb fat||Grams|Median|3037|3037.0|Inter-Quartile Range|||2002.0|4403.0|
4387339|NCT00307164|4213422|B2|||Limb fat||Grams|Median|2995|2995.0|Inter-Quartile Range|||2082.0|4847.0|
4387340|NCT00307164|4213423|B1|||Limb fat||Grams|Median|3149|3149.0|Inter-Quartile Range|||1833.0|4210.0|
4387341|NCT00307164|4213421|B3|||CD4+ Count (NucleomaxX sample size (N)=80, Placebo N=80)||Cells/mm^3|Median|506|506.0|Inter-Quartile Range|||359.0|714.0|
4387342|NCT00307164|4213422|B2|||CD4+ Count (NucleomaxX sample size (N)=80, Placebo N=80)||Cells/mm^3|Median|504|504.0|Inter-Quartile Range|||376.0|710.0|
4387343|NCT00307164|4213423|B1|||CD4+ Count (NucleomaxX sample size (N)=80, Placebo N=80)||Cells/mm^3|Median|506|506.0|Inter-Quartile Range|||353.0|724.0|
4387344|NCT00307164|4213421|B3|>50 Copies||HIV-1 RNA (copies/mL) Category||Participants|Number|31|31.0||||||
4387345|NCT00307164|4213422|B2|>50 Copies||HIV-1 RNA (copies/mL) Category||Participants|Number|18|18.0||||||
4387346|NCT00307164|4213423|B1|>50 Copies||HIV-1 RNA (copies/mL) Category||Participants|Number|13|13.0||||||
4387347|NCT00307164|4213421|B3|<=50 Copies||HIV-1 RNA (copies/mL) Category||Participants|Number|134|134.0||||||
4387348|NCT00307164|4213422|B2|<=50 Copies||HIV-1 RNA (copies/mL) Category||Participants|Number|64|64.0||||||
4387349|NCT00307164|4213423|B1|<=50 Copies||HIV-1 RNA (copies/mL) Category||Participants|Number|70|70.0||||||
4387350|NCT00307164|4213421|B3|d4T-Containing||Antiretroviral Therapy Used (Stratification)||Participants|Number|39|39.0||||||
4387351|NCT00307164|4213422|B2|d4T-Containing||Antiretroviral Therapy Used (Stratification)||Participants|Number|19|19.0||||||
4387352|NCT00307164|4213423|B1|d4T-Containing||Antiretroviral Therapy Used (Stratification)||Participants|Number|20|20.0||||||
4387353|NCT00307164|4213421|B3|AZT-Containing||Antiretroviral Therapy Used (Stratification)||Participants|Number|126|126.0||||||
4387354|NCT00307164|4213422|B2|AZT-Containing||Antiretroviral Therapy Used (Stratification)||Participants|Number|63|63.0||||||
4387355|NCT00307164|4213423|B1|AZT-Containing||Antiretroviral Therapy Used (Stratification)||Participants|Number|63|63.0||||||
4387356|NCT00307164|4213421|B3|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4387357|NCT00307164|4213422|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4387358|NCT00307164|4213423|B1|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4387359|NCT00307164|4213421|B3|United States||Region of Enrollment||participants|Number|162|162.0||||||
4387360|NCT00307164|4213422|B2|United States||Region of Enrollment||participants|Number|81|81.0||||||
4387361|NCT00307164|4213423|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4387362|NCT00307164|4213421|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4387363|NCT00307164|4213422|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4387364|NCT00307164|4213423|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4387365|NCT00307164|4213421|B3|Other (More than One Race)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4387366|NCT00307164|4213422|B2|Other (More than One Race)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4387367|NCT00307164|4213423|B1|Other (More than One Race)||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4387368|NCT00307164|4213421|B3|Native American, Alaskan Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4387369|NCT00307164|4213422|B2|Native American, Alaskan Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4387370|NCT00307164|4213423|B1|Native American, Alaskan Native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4387371|NCT00307164|4213421|B3|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4387372|NCT00307164|4213422|B2|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4387373|NCT00307164|4213423|B1|Asian, Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4387374|NCT00307164|4213421|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4387375|NCT00307164|4213422|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4387376|NCT00307164|4213423|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4387377|NCT00307164|4213421|B3|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4387378|NCT00307164|4213422|B2|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4387379|NCT00307164|4213423|B1|Black Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4387380|NCT00307164|4213421|B3|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|102|102.0||||||
4387381|NCT00307164|4213422|B2|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4387382|NCT00307164|4213423|B1|White Non-Hispanic||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
4387383|NCT00307164|4213421|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4387384|NCT00307164|4213422|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4387385|NCT00307164|4213423|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4387386|NCT00307164|4213421|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4387387|NCT00307164|4213422|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4387388|NCT00307164|4213423|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4387389|NCT00307164|4213421|B3|60-69 Years||Age, Customized||Participants|Number|10|10.0||||||
4387390|NCT00307164|4213422|B2|60-69 Years||Age, Customized||Participants|Number|2|2.0||||||
4387391|NCT00307164|4213423|B1|60-69 Years||Age, Customized||Participants|Number|8|8.0||||||
4387392|NCT00307164|4213421|B3|50-59 Years||Age, Customized||Participants|Number|66|66.0||||||
4387393|NCT00307164|4213422|B2|50-59 Years||Age, Customized||Participants|Number|38|38.0||||||
4387394|NCT00307164|4213423|B1|50-59 Years||Age, Customized||Participants|Number|28|28.0||||||
4387395|NCT00307164|4213421|B3|40-49 Years||Age, Customized||Participants|Number|70|70.0||||||
4387396|NCT00307164|4213422|B2|40-49 Years||Age, Customized||Participants|Number|32|32.0||||||
4387397|NCT00307164|4213423|B1|40-49 Years||Age, Customized||Participants|Number|38|38.0||||||
4387398|NCT00307164|4213421|B3|30-39 Years||Age, Customized||Participants|Number|19|19.0||||||
4387399|NCT00307164|4213422|B2|30-39 Years||Age, Customized||Participants|Number|10|10.0||||||
4387400|NCT00307164|4213423|B1|30-39 Years||Age, Customized||Participants|Number|9|9.0||||||
4387401|NCT00307164|4213421|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|7.13|7.13|||
4387402|NCT00307164|4213422|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|6.46|6.46|||
4387403|NCT00307164|4213423|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|7.78|7.78|||
4387404|NCT00307151|4213460|B5|Not available||NVP resistance||participants|Number|97|97.0||||||
4387405|NCT00307151|4213461|B4|Not available||NVP resistance||participants|Number|45|45.0||||||
4387406|NCT00307151|4213462|B3|Not available||NVP resistance||participants|Number|36|36.0||||||
4387407|NCT00307151|4213463|B2|Not available||NVP resistance||participants|Number|9|9.0||||||
4387408|NCT00307151|4213464|B1|Not available||NVP resistance||participants|Number|7|7.0||||||
4387409|NCT00307151|4213460|B5|No||NVP resistance||participants|Number|331|331.0||||||
4387410|NCT00307151|4213461|B4|No||NVP resistance||participants|Number|91|91.0||||||
4387411|NCT00307151|4213462|B3|No||NVP resistance||participants|Number|110|110.0||||||
4387412|NCT00307151|4213463|B2|No||NVP resistance||participants|Number|62|62.0||||||
4387413|NCT00307151|4213464|B1|No||NVP resistance||participants|Number|68|68.0||||||
4387414|NCT00307151|4213460|B5|Yes||NVP resistance||participants|Number|23|23.0||||||
4387415|NCT00307151|4213461|B4|Yes||NVP resistance||participants|Number|4|4.0||||||
4387416|NCT00307151|4213462|B3|Yes||NVP resistance||participants|Number|1|1.0||||||
4387417|NCT00307151|4213463|B2|Yes||NVP resistance||participants|Number|11|11.0||||||
4387418|NCT00307151|4213464|B1|Yes||NVP resistance||participants|Number|7|7.0||||||
4387419|NCT00307151|4213460|B5|Missing||CD4 Percent||participants|Number|1|1.0||||||
4387420|NCT00307151|4213461|B4|Missing||CD4 Percent||participants|Number|0|0.0||||||
4387421|NCT00307151|4213462|B3|Missing||CD4 Percent||participants|Number|1|1.0||||||
4387422|NCT00307151|4213463|B2|Missing||CD4 Percent||participants|Number|0|0.0||||||
4387423|NCT00307151|4213464|B1|Missing||CD4 Percent||participants|Number|0|0.0||||||
4387424|NCT00307151|4213460|B5|>= 25 Percent||CD4 Percent||participants|Number|75|75.0||||||
4387425|NCT00307151|4213461|B4|>= 25 Percent||CD4 Percent||participants|Number|17|17.0||||||
4387426|NCT00307151|4213462|B3|>= 25 Percent||CD4 Percent||participants|Number|13|13.0||||||
4387427|NCT00307151|4213463|B2|>= 25 Percent||CD4 Percent||participants|Number|24|24.0||||||
4387428|NCT00307151|4213464|B1|>= 25 Percent||CD4 Percent||participants|Number|21|21.0||||||
4387429|NCT00307151|4213460|B5|15 Percent - < 25 Percent||CD4 Percent||participants|Number|188|188.0||||||
4387430|NCT00307151|4213461|B4|15 Percent - < 25 Percent||CD4 Percent||participants|Number|54|54.0||||||
4387431|NCT00307151|4213462|B3|15 Percent - < 25 Percent||CD4 Percent||participants|Number|60|60.0||||||
4387432|NCT00307151|4213463|B2|15 Percent - < 25 Percent||CD4 Percent||participants|Number|37|37.0||||||
4387433|NCT00307151|4213464|B1|15 Percent - < 25 Percent||CD4 Percent||participants|Number|37|37.0||||||
4387434|NCT00307151|4213460|B5|<15 Percent||CD4 Percent||participants|Number|187|187.0||||||
4387435|NCT00307151|4213461|B4|<15 Percent||CD4 Percent||participants|Number|69|69.0||||||
4387436|NCT00307151|4213462|B3|<15 Percent||CD4 Percent||participants|Number|73|73.0||||||
4387437|NCT00307151|4213463|B2|<15 Percent||CD4 Percent||participants|Number|21|21.0||||||
4387438|NCT00307151|4213464|B1|<15 Percent||CD4 Percent||participants|Number|24|24.0||||||
4387439|NCT00307151|4213460|B5|>=750,000 copies/ml||HIV-1 RNA||participants|Number|209|209.0||||||
4387440|NCT00307151|4213461|B4|>=750,000 copies/ml||HIV-1 RNA||participants|Number|60|60.0||||||
4387441|NCT00307151|4213462|B3|>=750,000 copies/ml||HIV-1 RNA||participants|Number|57|57.0||||||
4387442|NCT00307151|4213463|B2|>=750,000 copies/ml||HIV-1 RNA||participants|Number|43|43.0||||||
4387443|NCT00307151|4213464|B1|>=750,000 copies/ml||HIV-1 RNA||participants|Number|49|49.0||||||
4387444|NCT00307151|4213460|B5|100,000 - < 750,000 copies/ml||HIV-1 RNA||participants|Number|184|184.0||||||
4387445|NCT00307151|4213461|B4|100,000 - < 750,000 copies/ml||HIV-1 RNA||participants|Number|53|53.0||||||
4387446|NCT00307151|4213462|B3|100,000 - < 750,000 copies/ml||HIV-1 RNA||participants|Number|70|70.0||||||
4387447|NCT00307151|4213463|B2|100,000 - < 750,000 copies/ml||HIV-1 RNA||participants|Number|34|34.0||||||
4387448|NCT00307151|4213464|B1|100,000 - < 750,000 copies/ml||HIV-1 RNA||participants|Number|27|27.0||||||
4387449|NCT00307151|4213460|B5|<100,000 copies/ml||HIV-1 RNA||participants|Number|58|58.0||||||
4387450|NCT00307151|4213461|B4|<100,000 copies/ml||HIV-1 RNA||participants|Number|27|27.0||||||
4387451|NCT00307151|4213462|B3|<100,000 copies/ml||HIV-1 RNA||participants|Number|20|20.0||||||
4387452|NCT00307151|4213463|B2|<100,000 copies/ml||HIV-1 RNA||participants|Number|5|5.0||||||
4387453|NCT00307151|4213464|B1|<100,000 copies/ml||HIV-1 RNA||participants|Number|6|6.0||||||
4387454|NCT00307151|4213460|B5|IV||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|40|40.0||||||
4387455|NCT00307151|4213461|B4|IV||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|11|11.0||||||
4387456|NCT00307151|4213462|B3|IV||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|12|12.0||||||
4387457|NCT00307151|4213463|B2|IV||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|4|4.0||||||
4387458|NCT00307151|4213464|B1|IV||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|13|13.0||||||
4387459|NCT00307151|4213460|B5|III||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|234|234.0||||||
4387460|NCT00307151|4213461|B4|III||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|77|77.0||||||
4387461|NCT00307151|4213462|B3|III||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|80|80.0||||||
4387462|NCT00307151|4213463|B2|III||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|38|38.0||||||
4387463|NCT00307151|4213464|B1|III||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|39|39.0||||||
4387464|NCT00307151|4213460|B5|II||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|98|98.0||||||
4387465|NCT00307151|4213461|B4|II||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|27|27.0||||||
4387466|NCT00307151|4213462|B3|II||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|26|26.0||||||
4387467|NCT00307151|4213463|B2|II||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|22|22.0||||||
4387468|NCT00307151|4213464|B1|II||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|23|23.0||||||
4387469|NCT00307151|4213460|B5|I||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|79|79.0||||||
4387470|NCT00307151|4213461|B4|I||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|25|25.0||||||
4387471|NCT00307151|4213462|B3|I||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|29|29.0||||||
4387472|NCT00307151|4213463|B2|I||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|18|18.0||||||
4387473|NCT00307151|4213464|B1|I||WHO Stage|World Health Organization (WHO) staging system for HIV infection and disease.|participants|Number|7|7.0||||||
4387474|NCT00307151|4213460|B5|Found to have received SD NVP||Documentation of SD NVP use at birth||participants|Number|4|4.0||||||
4387475|NCT00307151|4213461|B4|Found to have received SD NVP||Documentation of SD NVP use at birth||participants|Number|2|2.0||||||
4387476|NCT00307151|4213462|B3|Found to have received SD NVP||Documentation of SD NVP use at birth||participants|Number|2|2.0||||||
4387477|NCT00307151|4213463|B2|Found to have received SD NVP||Documentation of SD NVP use at birth||participants|Number|0|0.0||||||
4387478|NCT00307151|4213464|B1|Found to have received SD NVP||Documentation of SD NVP use at birth||participants|Number|0|0.0||||||
4387479|NCT00307151|4213460|B5|Verbal evidence only||Documentation of SD NVP use at birth||participants|Number|80|80.0||||||
4387480|NCT00307151|4213461|B4|Verbal evidence only||Documentation of SD NVP use at birth||participants|Number|22|22.0||||||
4387481|NCT00307151|4213462|B3|Verbal evidence only||Documentation of SD NVP use at birth||participants|Number|19|19.0||||||
4387482|NCT00307151|4213463|B2|Verbal evidence only||Documentation of SD NVP use at birth||participants|Number|19|19.0||||||
4387483|NCT00307151|4213464|B1|Verbal evidence only||Documentation of SD NVP use at birth||participants|Number|20|20.0||||||
4387484|NCT00307151|4213460|B5|Medical record review||Documentation of SD NVP use at birth||participants|Number|147|147.0||||||
4387485|NCT00307151|4213461|B4|Medical record review||Documentation of SD NVP use at birth||participants|Number|12|12.0||||||
4387486|NCT00307151|4213462|B3|Medical record review||Documentation of SD NVP use at birth||participants|Number|10|10.0||||||
4387487|NCT00307151|4213463|B2|Medical record review||Documentation of SD NVP use at birth||participants|Number|63|63.0||||||
4387488|NCT00307151|4213464|B1|Medical record review||Documentation of SD NVP use at birth||participants|Number|62|62.0||||||
4387489|NCT00307151|4213460|B5|Born before NVP available/mother known to have HIV||Documentation of SD NVP use at birth||participants|Number|220|220.0||||||
4387490|NCT00307151|4213461|B4|Born before NVP available/mother known to have HIV||Documentation of SD NVP use at birth||participants|Number|104|104.0||||||
4387491|NCT00307151|4213462|B3|Born before NVP available/mother known to have HIV||Documentation of SD NVP use at birth||participants|Number|116|116.0||||||
4387492|NCT00307151|4213463|B2|Born before NVP available/mother known to have HIV||Documentation of SD NVP use at birth||participants|Number|0|0.0||||||
4387493|NCT00307151|4213464|B1|Born before NVP available/mother known to have HIV||Documentation of SD NVP use at birth||participants|Number|0|0.0||||||
4387494|NCT00307151|4213460|B5|No||Ever breastfed||participants|Number|184|184.0||||||
4387495|NCT00307151|4213461|B4|No||Ever breastfed||participants|Number|25|25.0||||||
4387496|NCT00307151|4213462|B3|No||Ever breastfed||participants|Number|29|29.0||||||
4387497|NCT00307151|4213463|B2|No||Ever breastfed||participants|Number|63|63.0||||||
4387498|NCT00307151|4213464|B1|No||Ever breastfed||participants|Number|67|67.0||||||
4387499|NCT00307151|4213460|B5|Yes||Ever breastfed||participants|Number|267|267.0||||||
4387500|NCT00307151|4213461|B4|Yes||Ever breastfed||participants|Number|115|115.0||||||
4387501|NCT00307151|4213462|B3|Yes||Ever breastfed||participants|Number|118|118.0||||||
4387502|NCT00307151|4213463|B2|Yes||Ever breastfed||participants|Number|19|19.0||||||
4387503|NCT00307151|4213464|B1|Yes||Ever breastfed||participants|Number|15|15.0||||||
4387504|NCT00307151|4213460|B5|India||Region of Enrollment||participants|Number|16|16.0||||||
4387505|NCT00307151|4213461|B4|India||Region of Enrollment||participants|Number|4|4.0||||||
4387506|NCT00307151|4213462|B3|India||Region of Enrollment||participants|Number|12|12.0||||||
4387507|NCT00307151|4213463|B2|India||Region of Enrollment||participants|Number|0|0.0||||||
4387508|NCT00307151|4213464|B1|India||Region of Enrollment||participants|Number|0|0.0||||||
4387509|NCT00307151|4213460|B5|Zimbabwe||Region of Enrollment||participants|Number|84|84.0||||||
4387510|NCT00307151|4213461|B4|Zimbabwe||Region of Enrollment||participants|Number|35|35.0||||||
4387511|NCT00307151|4213462|B3|Zimbabwe||Region of Enrollment||participants|Number|36|36.0||||||
4387512|NCT00307151|4213463|B2|Zimbabwe||Region of Enrollment||participants|Number|9|9.0||||||
4387513|NCT00307151|4213464|B1|Zimbabwe||Region of Enrollment||participants|Number|4|4.0||||||
4387514|NCT00307151|4213460|B5|South Africa||Region of Enrollment||participants|Number|213|213.0||||||
4387515|NCT00307151|4213461|B4|South Africa||Region of Enrollment||participants|Number|36|36.0||||||
4387516|NCT00307151|4213462|B3|South Africa||Region of Enrollment||participants|Number|41|41.0||||||
4387517|NCT00307151|4213463|B2|South Africa||Region of Enrollment||participants|Number|65|65.0||||||
4387518|NCT00307151|4213464|B1|South Africa||Region of Enrollment||participants|Number|71|71.0||||||
4387519|NCT00307151|4213460|B5|Malawi||Region of Enrollment||participants|Number|38|38.0||||||
4387520|NCT00307151|4213461|B4|Malawi||Region of Enrollment||participants|Number|20|20.0||||||
4387521|NCT00307151|4213462|B3|Malawi||Region of Enrollment||participants|Number|16|16.0||||||
4387522|NCT00307151|4213463|B2|Malawi||Region of Enrollment||participants|Number|0|0.0||||||
4387523|NCT00307151|4213464|B1|Malawi||Region of Enrollment||participants|Number|2|2.0||||||
4387524|NCT00307151|4213460|B5|Uganda||Region of Enrollment||participants|Number|45|45.0||||||
4387525|NCT00307151|4213461|B4|Uganda||Region of Enrollment||participants|Number|20|20.0||||||
4387526|NCT00307151|4213462|B3|Uganda||Region of Enrollment||participants|Number|20|20.0||||||
4387527|NCT00307151|4213463|B2|Uganda||Region of Enrollment||participants|Number|4|4.0||||||
4387528|NCT00307151|4213464|B1|Uganda||Region of Enrollment||participants|Number|1|1.0||||||
4387529|NCT00307151|4213460|B5|Zambia||Region of Enrollment||participants|Number|38|38.0||||||
4387530|NCT00307151|4213461|B4|Zambia||Region of Enrollment||participants|Number|18|18.0||||||
4387531|NCT00307151|4213462|B3|Zambia||Region of Enrollment||participants|Number|14|14.0||||||
4387532|NCT00307151|4213463|B2|Zambia||Region of Enrollment||participants|Number|4|4.0||||||
4387533|NCT00307151|4213464|B1|Zambia||Region of Enrollment||participants|Number|2|2.0||||||
4387534|NCT00307151|4213460|B5|Tanzania||Region of Enrollment||participants|Number|17|17.0||||||
4387535|NCT00307151|4213461|B4|Tanzania||Region of Enrollment||participants|Number|7|7.0||||||
4387536|NCT00307151|4213462|B3|Tanzania||Region of Enrollment||participants|Number|8|8.0||||||
4387537|NCT00307151|4213463|B2|Tanzania||Region of Enrollment||participants|Number|0|0.0||||||
4387538|NCT00307151|4213464|B1|Tanzania||Region of Enrollment||participants|Number|2|2.0||||||
4387539|NCT00307151|4213460|B5|Not available||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4387540|NCT00307151|4213461|B4|Not available||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4387541|NCT00307151|4213462|B3|Not available||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4387542|NCT00307151|4213463|B2|Not available||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4387543|NCT00307151|4213464|B1|Not available||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4387544|NCT00307151|4213460|B5|Native of India||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4387545|NCT00307151|4213461|B4|Native of India||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4387546|NCT00307151|4213462|B3|Native of India||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4387547|NCT00307151|4213463|B2|Native of India||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4387548|NCT00307151|4213464|B1|Native of India||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4387549|NCT00307151|4213460|B5|Coloured||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4387550|NCT00307151|4213461|B4|Coloured||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4387551|NCT00307151|4213462|B3|Coloured||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387552|NCT00307151|4213463|B2|Coloured||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387553|NCT00307151|4213464|B1|Coloured||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387554|NCT00307151|4213460|B5|Black African||Race/Ethnicity, Customized||participants|Number|428|428.0||||||
4387555|NCT00307151|4213461|B4|Black African||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
4387556|NCT00307151|4213462|B3|Black African||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4387557|NCT00307151|4213463|B2|Black African||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4387558|NCT00307151|4213464|B1|Black African||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4387559|NCT00307151|4213460|B5||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4387560|NCT00307151|4213461|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4387561|NCT00307151|4213462|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4387562|NCT00307151|4213463|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4387563|NCT00307151|4213464|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4387564|NCT00307151|4213460|B5||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4387565|NCT00307151|4213461|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4387566|NCT00307151|4213462|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4387567|NCT00307151|4213463|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4387568|NCT00307151|4213464|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4387569|NCT00307151|4213460|B5|>=12 months||Age, Customized||participants|Number|251|251.0||||||
4387570|NCT00307151|4213461|B4|>=12 months||Age, Customized||participants|Number|104|104.0||||||
4387571|NCT00307151|4213462|B3|>=12 months||Age, Customized||participants|Number|106|106.0||||||
4387572|NCT00307151|4213463|B2|>=12 months||Age, Customized||participants|Number|19|19.0||||||
4387573|NCT00307151|4213464|B1|>=12 months||Age, Customized||participants|Number|22|22.0||||||
4387574|NCT00307151|4213460|B5|<12 months||Age, Customized||participants|Number|200|200.0||||||
4387575|NCT00307151|4213461|B4|<12 months||Age, Customized||participants|Number|36|36.0||||||
4387576|NCT00307151|4213462|B3|<12 months||Age, Customized||participants|Number|41|41.0||||||
4387577|NCT00307151|4213463|B2|<12 months||Age, Customized||participants|Number|63|63.0||||||
4387578|NCT00307151|4213464|B1|<12 months||Age, Customized||participants|Number|60|60.0||||||
4387579|NCT00307125|4213509|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4387580|NCT00307125|4213510|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4387581|NCT00307125|4213511|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4387582|NCT00307125|4213509|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4387583|NCT00307125|4213510|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4387584|NCT00307125|4213511|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4387585|NCT00307125|4213509|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4387586|NCT00307125|4213510|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4387587|NCT00307125|4213511|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4387588|NCT00307125|4213509|B3|||Age||years|Mean|43.8|43.8|Standard Deviation|18.2|18.2|||
4387589|NCT00307125|4213510|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|15.0|15.0|||
4387590|NCT00307125|4213511|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|19.5|19.5|||
4387591|NCT00307125|4213509|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4387592|NCT00307125|4213510|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4387593|NCT00307125|4213511|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4387594|NCT00307125|4213509|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4387595|NCT00307125|4213510|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4387596|NCT00307125|4213511|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4387597|NCT00307125|4213509|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4387598|NCT00307125|4213510|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4387599|NCT00307125|4213511|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4387600|NCT00307086|4213535|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4387601|NCT00307086|4213535|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4387602|NCT00307086|4213535|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4387603|NCT00307086|4213535|B1|||Age||years|Mean|55|55.0|Standard Deviation|9.26|9.26|||
4387604|NCT00307086|4213535|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4387605|NCT00307086|4213535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4387606|NCT00307086|4213535|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387607|NCT00307047|4213539|B3|United States||Region of Enrollment||participants|Number|3687|3687.0||||||
4387608|NCT00307047|4213540|B2|United States||Region of Enrollment||participants|Number|1229|1229.0||||||
4387609|NCT00307047|4213541|B1|United States||Region of Enrollment||participants|Number|2458|2458.0||||||
4387610|NCT00307047|4213539|B3||Male|Sex: Female, Male||Participants|Count of Participants|2498|2498.0||||||
4387611|NCT00307047|4213540|B2||Male|Sex: Female, Male||Participants|Count of Participants|833|833.0||||||
4387612|NCT00307047|4213541|B1||Male|Sex: Female, Male||Participants|Count of Participants|1665|1665.0||||||
4387613|NCT00307047|4213539|B3||Female|Sex: Female, Male||Participants|Count of Participants|1189|1189.0||||||
4387614|NCT00307047|4213540|B2||Female|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
4387615|NCT00307047|4213541|B1||Female|Sex: Female, Male||Participants|Count of Participants|793|793.0||||||
4387616|NCT00307047|4213539|B3|||Age||years|Mean|63.28|63.28|Standard Deviation|10.42|10.42|||
4387617|NCT00307047|4213540|B2|||Age||years|Mean|63.34|63.34|Standard Deviation|10.23|10.23|||
4387618|NCT00307047|4213541|B1|||Age||years|Mean|63.25|63.25|Standard Deviation|10.52|10.52|||
4387619|NCT00307047|4213539|B3||>=65 years|Age||Participants|Count of Participants|1637|1637.0||||||
4387620|NCT00307047|4213540|B2||>=65 years|Age||Participants|Count of Participants|552|552.0||||||
4387621|NCT00307047|4213541|B1||>=65 years|Age||Participants|Count of Participants|1085|1085.0||||||
4387622|NCT00307047|4213539|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2050|2050.0||||||
4387623|NCT00307047|4213540|B2||Between 18 and 65 years|Age||Participants|Count of Participants|677|677.0||||||
4387624|NCT00307047|4213541|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1373|1373.0||||||
4387625|NCT00307047|4213539|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387626|NCT00307047|4213540|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387627|NCT00307047|4213541|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387628|NCT00307034|4213678|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4387629|NCT00307034|4213679|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4387630|NCT00307034|4213680|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4387631|NCT00307034|4213678|B3||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4387632|NCT00307034|4213679|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4387633|NCT00307034|4213680|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4387634|NCT00307034|4213678|B3|||Age||Weeks|Mean|12.05|12.05|Standard Deviation|1.92|1.92|||
4387635|NCT00307034|4213679|B2|||Age||Weeks|Mean|12.1|12.1|Standard Deviation|1.9|1.9|||
4387636|NCT00307034|4213680|B1|||Age||Weeks|Mean|12|12.0|Standard Deviation|1.94|1.94|||
4387637|NCT00306917|4213719|B3|United States||Region of Enrollment||participants|Number|245|245.0||||||
4387638|NCT00306917|4213720|B2|United States||Region of Enrollment||participants|Number|124|124.0||||||
4387639|NCT00306917|4213721|B1|United States||Region of Enrollment||participants|Number|121|121.0||||||
4387640|NCT00306917|4213719|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4387641|NCT00306917|4213720|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4387642|NCT00306917|4213721|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4387643|NCT00306917|4213719|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4387644|NCT00306917|4213720|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4387645|NCT00306917|4213721|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4387646|NCT00306917|4213719|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|8.7|8.7|||
4387647|NCT00306917|4213720|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|9.2|9.2|||
4387648|NCT00306917|4213721|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|8.2|8.2|||
4387649|NCT00306891|4213728|B5|Male, Part B||Sex/Gender, Customized||participants|Number|27|27.0||||||
4387650|NCT00306891|4213729|B4|Male, Part B||Sex/Gender, Customized||participants|Number|19|19.0||||||
4387651|NCT00306891|4213730|B3|Male, Part B||Sex/Gender, Customized||participants|Number|8|8.0||||||
4387652|NCT00306891|4213731|B2|Male, Part B||Sex/Gender, Customized||participants|Number|NA|||||||Cediranib 45 mg Fasted/Fed existed only in Part A.
4387653|NCT00306891|4213732|B1|Male, Part B||Sex/Gender, Customized||participants|Number|NA|||||||Cediranib 45 mg Fed/Fasted only in Part A.
4387654|NCT00306891|4213728|B5|Female, Part B||Sex/Gender, Customized||participants|Number|20|20.0||||||
4387655|NCT00306891|4213729|B4|Female, Part B||Sex/Gender, Customized||participants|Number|12|12.0||||||
4387656|NCT00306891|4213730|B3|Female, Part B||Sex/Gender, Customized||participants|Number|8|8.0||||||
4387657|NCT00306891|4213731|B2|Female, Part B||Sex/Gender, Customized||participants|Number|NA|||||||Cediranib 45 mg Fasted/Fed existed only in Part A.
4387658|NCT00306891|4213732|B1|Female, Part B||Sex/Gender, Customized||participants|Number|NA|||||||Cediranib 45 mg Fed/Fasted existed only in Part A.
4387659|NCT00306891|4213728|B5|Male, Part A||Sex/Gender, Customized||participants|Number|25|25.0||||||
4387660|NCT00306891|4213729|B4|Male, Part A||Sex/Gender, Customized||participants|Number|NA|||||||Cediranib 30 to 90 mg Dose Escalation existed only in Part B.
4387661|NCT00306891|4213730|B3|Male, Part A||Sex/Gender, Customized||participants|Number|NA|||||||Cediranib 45 mg Fixed dose arm existed only in Part B
4387662|NCT00306891|4213731|B2|Male, Part A||Sex/Gender, Customized||participants|Number|12|12.0||||||
4387663|NCT00306891|4213732|B1|Male, Part A||Sex/Gender, Customized||participants|Number|13|13.0||||||
4387664|NCT00306891|4213728|B5|Female, Part A||Sex/Gender, Customized||participants|Number|20|20.0||||||
4387665|NCT00306891|4213729|B4|Female, Part A||Sex/Gender, Customized||participants|Number|NA|||||||Cediranib 30 to 90 mg Dose Escalation existed only in Part B.
4387666|NCT00306891|4213730|B3|Female, Part A||Sex/Gender, Customized||participants|Number|NA|||||||Cediranib 45 mg Fixed dose arm existed only in Part B.
4387667|NCT00306891|4213731|B2|Female, Part A||Sex/Gender, Customized||participants|Number|10|10.0||||||
4387668|NCT00306891|4213732|B1|Female, Part A||Sex/Gender, Customized||participants|Number|10|10.0||||||
4387669|NCT00306891|4213728|B5|||Age||Years|Mean|56.0|56.0|Standard Deviation|13.0|13.0|||
4387670|NCT00306891|4213729|B4|||Age||Years|Mean|56.0|56.0|Standard Deviation|13.5|13.5|||
4387671|NCT00306891|4213730|B3|||Age||Years|Mean|56.4|56.4|Standard Deviation|13.1|13.1|||
4387672|NCT00306891|4213731|B2|||Age||Years|Mean|51.2|51.2|Standard Deviation|14.8|14.8|||
4387673|NCT00306891|4213732|B1|||Age||Years|Mean|58.6|58.6|Standard Deviation|10.6|10.6|||
4387674|NCT00306852|4213756|B3|||ETDRS (Early Treatment Diabetic Retinopathy Study) VISUAL ACUITY|Numbers of letters read correctly on the ETDRS (Early Treatment Diabetic Retinopathy Study) chart.|Letters|Mean|63.6|63.6|Standard Deviation|21.6|21.6|||
4387675|NCT00306852|4213757|B2|||ETDRS (Early Treatment Diabetic Retinopathy Study) VISUAL ACUITY|Numbers of letters read correctly on the ETDRS (Early Treatment Diabetic Retinopathy Study) chart.|Letters|Mean|62.7|62.7|Standard Deviation|24.1|24.1|||
4387676|NCT00306852|4213758|B1|||ETDRS (Early Treatment Diabetic Retinopathy Study) VISUAL ACUITY|Numbers of letters read correctly on the ETDRS (Early Treatment Diabetic Retinopathy Study) chart.|Letters|Mean|64.4|64.4|Standard Deviation|19.6|19.6|||
4387677|NCT00306852|4213756|B3|||GLAUCOMA MEDICATIONS||number of medications used|Mean|3.1|3.1|Standard Deviation|1.2|1.2|||
4387678|NCT00306852|4213757|B2|||GLAUCOMA MEDICATIONS||number of medications used|Mean|3.2|3.2|Standard Deviation|1.1|1.1|||
4387679|NCT00306852|4213758|B1|||GLAUCOMA MEDICATIONS||number of medications used|Mean|3.0|3.0|Standard Deviation|1.2|1.2|||
4387680|NCT00306852|4213756|B3|||Intra-ocular pressure (IOP)||mm Hg|Mean|25.3|25.3|Standard Deviation|5.3|5.3|||
4387681|NCT00306852|4213757|B2|||Intra-ocular pressure (IOP)||mm Hg|Mean|25.1|25.1|Standard Deviation|5.3|5.3|||
4387682|NCT00306852|4213758|B1|||Intra-ocular pressure (IOP)||mm Hg|Mean|25.6|25.6|Standard Deviation|503|503.0|||
4387683|NCT00306852|4213756|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4387684|NCT00306852|4213757|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4387685|NCT00306852|4213758|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4387686|NCT00306852|4213756|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4387687|NCT00306852|4213757|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4387688|NCT00306852|4213758|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4387689|NCT00306852|4213756|B3|||Age||years|Mean|71.0|71.0|Standard Deviation|10.4|10.4|||
4387690|NCT00306852|4213757|B2|||Age||years|Mean|70.9|70.9|Standard Deviation|11.0|11.0|||
4387691|NCT00306852|4213758|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|9.9|9.9|||
4387692|NCT00306787|4213775|B3||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4387693|NCT00306787|4213776|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4387694|NCT00306787|4213777|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4387695|NCT00306787|4213775|B3||Female|Sex: Female, Male||Participants|Count of Participants|488|488.0||||||
4387696|NCT00306787|4213776|B2||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4387697|NCT00306787|4213777|B1||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4387698|NCT00306787|4213775|B3|||Age|Demographic data is provided for the intent to treat (IIT) population, which included all randomized patients who initiated treatment with (i.e. received any dose of) the study drug, with the intention of treating genital herpes recurrences.|years|Mean|40.7|40.7|Standard Deviation|12.2|12.2|||
4387699|NCT00306787|4213776|B2|||Age|Demographic data is provided for the intent to treat (IIT) population, which included all randomized patients who initiated treatment with (i.e. received any dose of) the study drug, with the intention of treating genital herpes recurrences.|years|Mean|41.7|41.7|Standard Deviation|12.6|12.6|||
4387700|NCT00306787|4213777|B1|||Age|Demographic data is provided for the intent to treat (IIT) population, which included all randomized patients who initiated treatment with (i.e. received any dose of) the study drug, with the intention of treating genital herpes recurrences.|years|Mean|39.6|39.6|Standard Deviation|11.6|11.6|||
4387701|NCT00306670|4213794|B3|||factor VIII activity; factor VIII inhibitor titer||units on a scale|Mean|25|25.0|Full Range|||5.0|30.0|
4387702|NCT00306670|4213795|B2|||factor VIII activity; factor VIII inhibitor titer||units on a scale|Mean|25|25.0|Full Range|||5.0|30.0|
4387703|NCT00306670|4213794|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4387704|NCT00306670|4213795|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4387705|NCT00306670|4213794|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
4387706|NCT00306670|4213795|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
4387707|NCT00306670|4213794|B3||Female|Gender||Participants|Count of Participants|1|1.0||||||
4387708|NCT00306670|4213795|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
4387709|NCT00306670|4213794|B3|||Age||years|Mean|60|60.0|Full Range|||52.0|68.0|
4387710|NCT00306670|4213795|B2|||Age||years|Mean|60|60.0|Full Range|||52.0|68.0|
4387711|NCT00306592|4213803|B1||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4387712|NCT00306592|4213803|B1||Female|Sex: Female, Male||Participants|Count of Participants|755|755.0||||||
4387713|NCT00306592|4213803|B1|>/= 60 years||Age, Customized||participants|Number|0|0.0||||||
4387714|NCT00306592|4213803|B1|≥ 50 to < 59 years||Age, Customized||participants|Number|195|195.0||||||
4387715|NCT00306592|4213803|B1|≥ 40 to < 50 years||Age, Customized||participants|Number|454|454.0||||||
4387716|NCT00306592|4213803|B1|≥ 30 to < 40 years||Age, Customized||participants|Number|347|347.0||||||
4387717|NCT00306592|4213803|B1|≥ 20 to < 30 years||Age, Customized||participants|Number|98|98.0||||||
4387718|NCT00306592|4213803|B1|≥ 18 to < 20 years||Age, Customized||participants|Number|0|0.0||||||
4387719|NCT00306592|4213803|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|8.12|8.12|||
4387720|NCT00306527|4213810|B5||Male|Sex: Female, Male||Participants|Count of Participants|957|957.0||||||
4387721|NCT00306527|4213811|B4||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4387722|NCT00306527|4213812|B3||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4387723|NCT00306527|4213813|B2||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4387724|NCT00306527|4213814|B1||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4387725|NCT00306527|4213810|B5||Female|Sex: Female, Male||Participants|Count of Participants|1278|1278.0||||||
4387726|NCT00306527|4213811|B4||Female|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4387727|NCT00306527|4213812|B3||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4387728|NCT00306527|4213813|B2||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4387729|NCT00306527|4213814|B1||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4387730|NCT00306527|4213810|B5|||Age||years|Mean|55.2|55.2|Standard Deviation|17.9|17.9|||
4387731|NCT00306527|4213811|B4|||Age||years|Mean|69.9|69.9|Standard Deviation|5.7|5.7|||
4387732|NCT00306527|4213812|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|12.5|12.5|||
4387733|NCT00306527|4213813|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|5.7|5.7|||
4387734|NCT00306527|4213814|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|12.7|12.7|||
4387735|NCT00306488|4213871|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4387736|NCT00306488|4213871|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4387737|NCT00306488|4213871|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4387738|NCT00306488|4213871|B1|||Age||years|Mean|76.91|76.91|Standard Deviation|7.85|7.85|||
4387739|NCT00306488|4213871|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4387740|NCT00306488|4213871|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4387741|NCT00306488|4213871|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4387742|NCT00306384|4213883|B4|Study 01-06-TL-322OPI-002||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|475|475.0||||||
4387743|NCT00306384|4213884|B3|Study 01-06-TL-322OPI-002||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|43|43.0||||||
4387744|NCT00306384|4213885|B2|Study 01-06-TL-322OPI-002||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|217|217.0||||||
4387745|NCT00306384|4213886|B1|Study 01-06-TL-322OPI-002||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|215|215.0||||||
4387746|NCT00306384|4213883|B4|Study 01-05-TL-322OPI-001||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|1240|1240.0||||||
4387747|NCT00306384|4213884|B3|Study 01-05-TL-322OPI-001||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|146|146.0||||||
4387748|NCT00306384|4213885|B2|Study 01-05-TL-322OPI-001||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|548|548.0||||||
4387749|NCT00306384|4213886|B1|Study 01-05-TL-322OPI-001||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|546|546.0||||||
4387750|NCT00306384|4213883|B4|Alogliptin 25 mg||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|604|604.0||||||
4387751|NCT00306384|4213884|B3|Alogliptin 25 mg||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|99|99.0||||||
4387752|NCT00306384|4213885|B2|Alogliptin 25 mg||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|262|262.0||||||
4387753|NCT00306384|4213886|B1|Alogliptin 25 mg||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|243|243.0||||||
4387754|NCT00306384|4213883|B4|Alogliptin 12.5 mg||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|641|641.0||||||
4387755|NCT00306384|4213884|B3|Alogliptin 12.5 mg||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|105|105.0||||||
4387756|NCT00306384|4213885|B2|Alogliptin 12.5 mg||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|262|262.0||||||
4387757|NCT00306384|4213886|B1|Alogliptin 12.5 mg||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|274|274.0||||||
4387808|NCT00306384|4213885|B2|<65 years||Age, Customized||participants|Number|1134|1134.0||||||
4387758|NCT00306384|4213883|B4|Placebo||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|363|363.0||||||
4387759|NCT00306384|4213884|B3|Placebo||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|135|135.0||||||
4387760|NCT00306384|4213885|B2|Placebo||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|110|110.0||||||
4387761|NCT00306384|4213886|B1|Placebo||Previous double-blind study treatment|Patients from coadministration Studies 01-05-TL-322OPI-001 and 01-06-TL-322OPI-002 are presented separately; due to the complexity of treatment assignments, they were not included in the subgroups of patients previously randomized to placebo, alogliptin 12.5 mg, or alogliptin 25 mg.|participants|Number|118|118.0||||||
4387762|NCT00306384|4213883|B4|||Diabetes duration||years|Mean|6.99|6.99|Standard Deviation|5.784|5.784|||
4387763|NCT00306384|4213884|B3|||Diabetes duration||years|Mean|8.35|8.35|Standard Deviation|6.325|6.325|||
4387764|NCT00306384|4213885|B2|||Diabetes duration||years|Mean|6.92|6.92|Standard Deviation|5.824|5.824|||
4387765|NCT00306384|4213886|B1|||Diabetes duration||years|Mean|6.56|6.56|Standard Deviation|5.446|5.446|||
4387766|NCT00306384|4213883|B4|||Body Mass Index (BMI)||kg/m^2|Mean|31.66|31.66|Standard Deviation|5.386|5.386|||
4387767|NCT00306384|4213884|B3|||Body Mass Index (BMI)||kg/m^2|Mean|32.20|32.2|Standard Deviation|5.704|5.704|||
4387768|NCT00306384|4213885|B2|||Body Mass Index (BMI)||kg/m^2|Mean|31.71|31.71|Standard Deviation|5.266|5.266|||
4387769|NCT00306384|4213886|B1|||Body Mass Index (BMI)||kg/m^2|Mean|31.42|31.42|Standard Deviation|5.370|5.37|||
4387770|NCT00306384|4213883|B4|Other||Race/Ethnicity, Customized||participants|Number|438|438.0||||||
4387771|NCT00306384|4213884|B3|Other||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4387772|NCT00306384|4213885|B2|Other||Race/Ethnicity, Customized||participants|Number|193|193.0||||||
4387773|NCT00306384|4213886|B1|Other||Race/Ethnicity, Customized||participants|Number|176|176.0||||||
4387774|NCT00306384|4213883|B4|White||Race/Ethnicity, Customized||participants|Number|2422|2422.0||||||
4387775|NCT00306384|4213884|B3|White||Race/Ethnicity, Customized||participants|Number|390|390.0||||||
4387776|NCT00306384|4213885|B2|White||Race/Ethnicity, Customized||participants|Number|1007|1007.0||||||
4387777|NCT00306384|4213886|B1|White||Race/Ethnicity, Customized||participants|Number|1025|1025.0||||||
4387778|NCT00306384|4213883|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|187|187.0||||||
4387779|NCT00306384|4213884|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4387780|NCT00306384|4213885|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4387781|NCT00306384|4213886|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4387782|NCT00306384|4213883|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4387783|NCT00306384|4213884|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387784|NCT00306384|4213885|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4387785|NCT00306384|4213886|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4387786|NCT00306384|4213883|B4|Asian||Race/Ethnicity, Customized||participants|Number|260|260.0||||||
4387787|NCT00306384|4213884|B3|Asian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4387788|NCT00306384|4213885|B2|Asian||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
4387789|NCT00306384|4213886|B1|Asian||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4387790|NCT00306384|4213883|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4387791|NCT00306384|4213884|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4387792|NCT00306384|4213885|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4387793|NCT00306384|4213886|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4387794|NCT00306384|4213883|B4||Male|Sex: Female, Male||Participants|Count of Participants|1605|1605.0||||||
4387795|NCT00306384|4213884|B3||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4387796|NCT00306384|4213885|B2||Male|Sex: Female, Male||Participants|Count of Participants|669|669.0||||||
4387797|NCT00306384|4213886|B1||Male|Sex: Female, Male||Participants|Count of Participants|697|697.0||||||
4387798|NCT00306384|4213883|B4||Female|Sex: Female, Male||Participants|Count of Participants|1718|1718.0||||||
4387799|NCT00306384|4213884|B3||Female|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4387800|NCT00306384|4213885|B2||Female|Sex: Female, Male||Participants|Count of Participants|730|730.0||||||
4387801|NCT00306384|4213886|B1||Female|Sex: Female, Male||Participants|Count of Participants|699|699.0||||||
4387802|NCT00306384|4213883|B4|≥65 years||Age, Customized||participants|Number|594|594.0||||||
4387803|NCT00306384|4213884|B3|≥65 years||Age, Customized||participants|Number|67|67.0||||||
4387804|NCT00306384|4213885|B2|≥65 years||Age, Customized||participants|Number|265|265.0||||||
4387805|NCT00306384|4213886|B1|≥65 years||Age, Customized||participants|Number|262|262.0||||||
4387806|NCT00306384|4213883|B4|<65 years||Age, Customized||participants|Number|2729|2729.0||||||
4387807|NCT00306384|4213884|B3|<65 years||Age, Customized||participants|Number|461|461.0||||||
4387809|NCT00306384|4213886|B1|<65 years||Age, Customized||participants|Number|1134|1134.0||||||
4387810|NCT00306384|4213883|B4|||Age||years|Mean|55.0|55.0|Standard Deviation|10.11|10.11|||
4387811|NCT00306384|4213884|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|10.06|10.06|||
4387812|NCT00306384|4213885|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|10.21|10.21|||
4387813|NCT00306384|4213886|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|9.92|9.92|||
4387814|NCT00306293|4213920|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4387815|NCT00306293|4213920|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4387816|NCT00306293|4213920|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4387817|NCT00306293|4213920|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4387818|NCT00306293|4213920|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4387819|NCT00306293|4213920|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4387820|NCT00306293|4213920|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4387821|NCT00306293|4213920|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4387822|NCT00306293|4213920|B1|||Age||Year|Mean|30.9|30.9|Standard Deviation|9.64|9.64|||
4387823|NCT00306202|4213939|B4|Not Reported||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|25|25.0||||||
4387824|NCT00306202|4213940|B3|Not Reported||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|8|8.0||||||
4387825|NCT00306202|4213941|B2|Not Reported||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|8|8.0||||||
4387826|NCT00306202|4213942|B1|Not Reported||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|9|9.0||||||
4387827|NCT00306202|4213939|B4|100||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|15|15.0||||||
4387828|NCT00306202|4213940|B3|100||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|4|4.0||||||
4387829|NCT00306202|4213941|B2|100||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|4|4.0||||||
4387830|NCT00306202|4213942|B1|100||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|7|7.0||||||
4387831|NCT00306202|4213939|B4|80 - 90||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|16|16.0||||||
4387874|NCT00306202|4213942|B1|||Blasts in Peripheral Blood|n = 9, 9, 19; n = number of participants with measures available|percentage of participants|Median|0.0|0.0|Full Range|||0.0|1.0|
4387832|NCT00306202|4213940|B3|80 - 90||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|11|11.0||||||
4387833|NCT00306202|4213941|B2|80 - 90||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|4|4.0||||||
4387834|NCT00306202|4213942|B1|80 - 90||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|1|1.0||||||
4387835|NCT00306202|4213939|B4|60 - 70||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|2|2.0||||||
4387836|NCT00306202|4213940|B3|60 - 70||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|1|1.0||||||
4387837|NCT00306202|4213941|B2|60 - 70||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|1|1.0||||||
4387838|NCT00306202|4213942|B1|60 - 70||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|0|0.0||||||
4387839|NCT00306202|4213939|B4|<60||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|0|0.0||||||
4387840|NCT00306202|4213940|B3|<60||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|0|0.0||||||
4387841|NCT00306202|4213941|B2|<60||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|0|0.0||||||
4387842|NCT00306202|4213942|B1|<60||Karnofsky Performance Score|"Classifies patients according to their functional impairment. Scores range from 0-100 units on a scale, the lower the score, the worse the survival for most serious illnesses.~<=60: Needs increasing assistance up to Death (0). 70: Cares for self. Unable to carry on normal activity or to do active work. 80: Normal activity with effort; some signs or symptoms of disease. 90: Able to carry on normal activities; minor signs or symptoms of disease. 100: Normal, no complaints. Not reported=no Lansky Play Score reported."|participants|Number|0|0.0||||||
4387843|NCT00306202|4213939|B4|Not Reported||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|33|33.0||||||
4387875|NCT00306202|4213939|B4|||Basophils in Bone Marrow|n = 13, 12, 19; n = number of participants with measures available|percentage|Median|0.0|0.0|Full Range|||0.0|2.0|
4387844|NCT00306202|4213940|B3|Not Reported||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|16|16.0||||||
4387845|NCT00306202|4213941|B2|Not Reported||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|9|9.0||||||
4387846|NCT00306202|4213942|B1|Not Reported||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|8|8.0||||||
4387847|NCT00306202|4213939|B4|100||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|13|13.0||||||
4387848|NCT00306202|4213940|B3|100||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|2|2.0||||||
4387849|NCT00306202|4213941|B2|100||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|4|4.0||||||
4387850|NCT00306202|4213942|B1|100||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|7|7.0||||||
4387851|NCT00306202|4213939|B4|80 - 90||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|6|6.0||||||
4387852|NCT00306202|4213940|B3|80 - 90||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|3|3.0||||||
4387853|NCT00306202|4213941|B2|80 - 90||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|2|2.0||||||
4387854|NCT00306202|4213942|B1|80 - 90||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|1|1.0||||||
4387876|NCT00306202|4213940|B3|||Basophils in Bone Marrow|n = 13, 12, 19; n = number of participants with measures available|percentage|Median|0.0|0.0|Full Range|||0.0|0.8|
4387855|NCT00306202|4213939|B4|60 - 70||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|6|6.0||||||
4387856|NCT00306202|4213940|B3|60 - 70||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|3|3.0||||||
4387857|NCT00306202|4213941|B2|60 - 70||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|2|2.0||||||
4387858|NCT00306202|4213942|B1|60 - 70||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|1|1.0||||||
4387859|NCT00306202|4213939|B4|<60||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|0|0.0||||||
4387860|NCT00306202|4213940|B3|<60||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|0|0.0||||||
4387861|NCT00306202|4213941|B2|<60||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|0|0.0||||||
4387862|NCT00306202|4213942|B1|<60||Lansky Play Score|"Used in children between 1 to 16 years of age to measure functional impairment. Scores range from 0-100 units on a scale; lower the score, worse the survival.~10-40:Moderate to severe restriction. 50:Gets dressed but inactive much of day; no active play, able to participate in quiet play. 60:Out of bed, but minimal active play; keeps busy with quiet activities. 70:Substantial restriction of, and less time spent, in play. 80:Active, but tires quickly. 90:Minor restrictions in physically strenuous activity. 100: Fully active, normal. Not reported=no Karnofsky Performance Score reported."|participants|Number|0|0.0||||||
4387863|NCT00306202|4213939|B4|||Promyelocytes in Bone Marrow|n = 12, 12, 19; n = number of participants with measures available|percentage|Median|0.8|0.8|Full Range|||0.0|43.0|
4387864|NCT00306202|4213940|B3|||Promyelocytes in Bone Marrow|n = 12, 12, 19; n = number of participants with measures available|percentage|Median|0.4|0.4|Full Range|||0.0|4.0|
4387865|NCT00306202|4213941|B2|||Promyelocytes in Bone Marrow|n = 12, 12, 19; n = number of participants with measures available|percentage|Median|0.5|0.5|Full Range|||0.0|6.0|
4387866|NCT00306202|4213942|B1|||Promyelocytes in Bone Marrow|n = 12, 12, 19; n = number of participants with measures available|percentage|Median|3.0|3.0|Full Range|||0.0|43.0|
4387867|NCT00306202|4213939|B4|||Blasts in Bone Marrow|n = 15, 16, 24; n = number of participants with measures available.|percentage|Median|52.0|52.0|Full Range|||0.0|98.0|
4387868|NCT00306202|4213940|B3|||Blasts in Bone Marrow|n = 15, 16, 24; n = number of participants with measures available.|percentage|Median|79.9|79.9|Full Range|||24.0|98.0|
4387869|NCT00306202|4213941|B2|||Blasts in Bone Marrow|n = 15, 16, 24; n = number of participants with measures available.|percentage|Median|39.0|39.0|Full Range|||0.0|95.0|
4387870|NCT00306202|4213942|B1|||Blasts in Bone Marrow|n = 15, 16, 24; n = number of participants with measures available.|percentage|Median|0.0|0.0|Full Range|||0.0|4.0|
4387871|NCT00306202|4213939|B4|||Blasts in Peripheral Blood|n = 9, 9, 19; n = number of participants with measures available|percentage of participants|Median|2.5|2.5|Full Range|||0.0|92.0|
4387872|NCT00306202|4213940|B3|||Blasts in Peripheral Blood|n = 9, 9, 19; n = number of participants with measures available|percentage of participants|Median|18.0|18.0|Full Range|||0.0|92.0|
4387873|NCT00306202|4213941|B2|||Blasts in Peripheral Blood|n = 9, 9, 19; n = number of participants with measures available|percentage of participants|Median|0.0|0.0|Full Range|||0.0|88.0|
4387921|NCT00306202|4213941|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4387877|NCT00306202|4213941|B2|||Basophils in Bone Marrow|n = 13, 12, 19; n = number of participants with measures available|percentage|Median|0.0|0.0|Full Range|||0.0|0.2|
4387878|NCT00306202|4213942|B1|||Basophils in Bone Marrow|n = 13, 12, 19; n = number of participants with measures available|percentage|Median|0.6|0.6|Full Range|||0.0|2.0|
4387879|NCT00306202|4213939|B4|||Basophils in Peripheral Blood|n = 9, 10, 19; n = number of participants with measures available|percentage of participants|Median|0.0|0.0|Full Range|||0.0|9.0|
4387880|NCT00306202|4213940|B3|||Basophils in Peripheral Blood|n = 9, 10, 19; n = number of participants with measures available|percentage of participants|Median|0.0|0.0|Full Range|||0.0|2.0|
4387881|NCT00306202|4213941|B2|||Basophils in Peripheral Blood|n = 9, 10, 19; n = number of participants with measures available|percentage of participants|Median|0.2|0.2|Full Range|||0.0|4.5|
4387882|NCT00306202|4213942|B1|||Basophils in Peripheral Blood|n = 9, 10, 19; n = number of participants with measures available|percentage of participants|Median|0.9|0.9|Full Range|||0.0|9.0|
4387883|NCT00306202|4213939|B4|||Platelets in Peripheral Blood||cells/mm^3|Median|86.0|86.0|Full Range|||3.0|1058.0|
4387884|NCT00306202|4213940|B3|||Platelets in Peripheral Blood||cells/mm^3|Median|41.0|41.0|Full Range|||3.0|226.0|
4387885|NCT00306202|4213941|B2|||Platelets in Peripheral Blood||cells/mm^3|Median|82.0|82.0|Full Range|||3.0|312.0|
4387886|NCT00306202|4213942|B1|||Platelets in Peripheral Blood||cells/mm^3|Median|294.0|294.0|Full Range|||139.0|1058.0|
4387887|NCT00306202|4213939|B4|||Hemoglobin in Peripheral Blood||g/dL|Median|11.0|11.0|Full Range|||7.1|16.0|
4387888|NCT00306202|4213940|B3|||Hemoglobin in Peripheral Blood||g/dL|Median|10.2|10.2|Full Range|||7.1|13.6|
4387889|NCT00306202|4213941|B2|||Hemoglobin in Peripheral Blood||g/dL|Median|10.0|10.0|Full Range|||7.7|13.5|
4387890|NCT00306202|4213942|B1|||Hemoglobin in Peripheral Blood||g/dL|Median|12.2|12.2|Full Range|||9.5|16.0|
4387891|NCT00306202|4213939|B4|>=20000/mm^3||White Blood Cells in Peripheral Blood||participants|Number|8|8.0||||||
4387892|NCT00306202|4213940|B3|>=20000/mm^3||White Blood Cells in Peripheral Blood||participants|Number|2|2.0||||||
4387893|NCT00306202|4213941|B2|>=20000/mm^3||White Blood Cells in Peripheral Blood||participants|Number|5|5.0||||||
4387894|NCT00306202|4213942|B1|>=20000/mm^3||White Blood Cells in Peripheral Blood||participants|Number|1|1.0||||||
4387895|NCT00306202|4213939|B4|< 20000/mm^3||White Blood Cells in Peripheral Blood||participants|Number|50|50.0||||||
4387896|NCT00306202|4213940|B3|< 20000/mm^3||White Blood Cells in Peripheral Blood||participants|Number|22|22.0||||||
4387897|NCT00306202|4213941|B2|< 20000/mm^3||White Blood Cells in Peripheral Blood||participants|Number|12|12.0||||||
4387898|NCT00306202|4213942|B1|< 20000/mm^3||White Blood Cells in Peripheral Blood||participants|Number|16|16.0||||||
4387899|NCT00306202|4213939|B4|||White Blood Cells in Peripheral Blood||cells/mm^3|Median|5.8|5.8|Full Range|||0.6|197.0|
4387900|NCT00306202|4213940|B3|||White Blood Cells in Peripheral Blood||cells/mm^3|Median|3.0|3.0|Full Range|||0.7|20.0|
4387901|NCT00306202|4213941|B2|||White Blood Cells in Peripheral Blood||cells/mm^3|Median|6.2|6.2|Full Range|||0.6|197.0|
4387902|NCT00306202|4213942|B1|||White Blood Cells in Peripheral Blood||cells/mm^3|Median|8.7|8.7|Full Range|||3.6|134.6|
4387903|NCT00306202|4213939|B4|Liver (participants with hepatomegaly)||Extramedullary Disease Involvement|Participants could be categorized in more than 1 category. CNS = central nervous system|participants|Number|6|6.0||||||
4387904|NCT00306202|4213940|B3|Liver (participants with hepatomegaly)||Extramedullary Disease Involvement|Participants could be categorized in more than 1 category. CNS = central nervous system|participants|Number|1|1.0||||||
4387905|NCT00306202|4213941|B2|Liver (participants with hepatomegaly)||Extramedullary Disease Involvement|Participants could be categorized in more than 1 category. CNS = central nervous system|participants|Number|4|4.0||||||
4387906|NCT00306202|4213942|B1|Liver (participants with hepatomegaly)||Extramedullary Disease Involvement|Participants could be categorized in more than 1 category. CNS = central nervous system|participants|Number|1|1.0||||||
4387907|NCT00306202|4213939|B4|Spleen (participants with splenomegaly)||Extramedullary Disease Involvement|Participants could be categorized in more than 1 category. CNS = central nervous system|participants|Number|4|4.0||||||
4387908|NCT00306202|4213940|B3|Spleen (participants with splenomegaly)||Extramedullary Disease Involvement|Participants could be categorized in more than 1 category. CNS = central nervous system|participants|Number|2|2.0||||||
4387909|NCT00306202|4213941|B2|Spleen (participants with splenomegaly)||Extramedullary Disease Involvement|Participants could be categorized in more than 1 category. CNS = central nervous system|participants|Number|2|2.0||||||
4387910|NCT00306202|4213942|B1|Spleen (participants with splenomegaly)||Extramedullary Disease Involvement|Participants could be categorized in more than 1 category. CNS = central nervous system|participants|Number|0|0.0||||||
4387911|NCT00306202|4213939|B4|Outside Spleen or Liver (involvement of CNS)||Extramedullary Disease Involvement|Participants could be categorized in more than 1 category. CNS = central nervous system|participants|Number|11|11.0||||||
4387912|NCT00306202|4213940|B3|Outside Spleen or Liver (involvement of CNS)||Extramedullary Disease Involvement|Participants could be categorized in more than 1 category. CNS = central nervous system|participants|Number|6|6.0||||||
4387913|NCT00306202|4213941|B2|Outside Spleen or Liver (involvement of CNS)||Extramedullary Disease Involvement|Participants could be categorized in more than 1 category. CNS = central nervous system|participants|Number|5|5.0||||||
4387914|NCT00306202|4213942|B1|Outside Spleen or Liver (involvement of CNS)||Extramedullary Disease Involvement|Participants could be categorized in more than 1 category. CNS = central nervous system|participants|Number|0|0.0||||||
4387915|NCT00306202|4213939|B4|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4387916|NCT00306202|4213940|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4387917|NCT00306202|4213941|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4387918|NCT00306202|4213942|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4387919|NCT00306202|4213939|B4|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4387920|NCT00306202|4213940|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4387922|NCT00306202|4213942|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4387923|NCT00306202|4213939|B4|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4387924|NCT00306202|4213940|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4387925|NCT00306202|4213941|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4387926|NCT00306202|4213942|B1|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4387927|NCT00306202|4213939|B4|Netherlands||Region of Enrollment||participants|Number|13|13.0||||||
4387928|NCT00306202|4213940|B3|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4387929|NCT00306202|4213941|B2|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4387930|NCT00306202|4213942|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4387931|NCT00306202|4213939|B4|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4387932|NCT00306202|4213940|B3|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4387933|NCT00306202|4213941|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4387934|NCT00306202|4213942|B1|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4387935|NCT00306202|4213939|B4|France||Region of Enrollment||participants|Number|15|15.0||||||
4387936|NCT00306202|4213940|B3|France||Region of Enrollment||participants|Number|5|5.0||||||
4387937|NCT00306202|4213941|B2|France||Region of Enrollment||participants|Number|4|4.0||||||
4387938|NCT00306202|4213942|B1|France||Region of Enrollment||participants|Number|6|6.0||||||
4387939|NCT00306202|4213939|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4387940|NCT00306202|4213940|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4387941|NCT00306202|4213941|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4387942|NCT00306202|4213942|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4387943|NCT00306202|4213939|B4|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387944|NCT00306202|4213940|B3|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4387945|NCT00306202|4213941|B2|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387946|NCT00306202|4213942|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4387947|NCT00306202|4213939|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4387948|NCT00306202|4213940|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387949|NCT00306202|4213941|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387950|NCT00306202|4213942|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4387951|NCT00306202|4213939|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4387952|NCT00306202|4213940|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387953|NCT00306202|4213941|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387954|NCT00306202|4213942|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387955|NCT00306202|4213939|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387956|NCT00306202|4213940|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4387957|NCT00306202|4213941|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4387958|NCT00306202|4213942|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4387959|NCT00306202|4213939|B4|White||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4387960|NCT00306202|4213940|B3|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4387961|NCT00306202|4213941|B2|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4387962|NCT00306202|4213942|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4387963|NCT00306202|4213939|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4387964|NCT00306202|4213940|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4387965|NCT00306202|4213941|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4387966|NCT00306202|4213942|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4387967|NCT00306202|4213939|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4387968|NCT00306202|4213940|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4387969|NCT00306202|4213941|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4387970|NCT00306202|4213942|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4387971|NCT00306202|4213939|B4|> 18||Age, Customized||participants|Number|1|1.0||||||
4387972|NCT00306202|4213940|B3|> 18||Age, Customized||participants|Number|1|1.0||||||
4387973|NCT00306202|4213941|B2|> 18||Age, Customized||participants|Number|0|0.0||||||
4387974|NCT00306202|4213942|B1|> 18||Age, Customized||participants|Number|0|0.0||||||
4387975|NCT00306202|4213939|B4|Between 12 and 18 years||Age, Customized||participants|Number|23|23.0||||||
4387976|NCT00306202|4213940|B3|Between 12 and 18 years||Age, Customized||participants|Number|7|7.0||||||
4387977|NCT00306202|4213941|B2|Between 12 and 18 years||Age, Customized||participants|Number|7|7.0||||||
4387978|NCT00306202|4213942|B1|Between 12 and 18 years||Age, Customized||participants|Number|9|9.0||||||
4387979|NCT00306202|4213939|B4|Between 7 and 11 years||Age, Customized||participants|Number|18|18.0||||||
4387980|NCT00306202|4213940|B3|Between 7 and 11 years||Age, Customized||participants|Number|7|7.0||||||
4387981|NCT00306202|4213941|B2|Between 7 and 11 years||Age, Customized||participants|Number|5|5.0||||||
4387982|NCT00306202|4213942|B1|Between 7 and 11 years||Age, Customized||participants|Number|6|6.0||||||
4387983|NCT00306202|4213939|B4|Between 2 and 6 years||Age, Customized||participants|Number|14|14.0||||||
4387984|NCT00306202|4213940|B3|Between 2 and 6 years||Age, Customized||participants|Number|7|7.0||||||
4387985|NCT00306202|4213941|B2|Between 2 and 6 years||Age, Customized||participants|Number|5|5.0||||||
4387986|NCT00306202|4213942|B1|Between 2 and 6 years||Age, Customized||participants|Number|2|2.0||||||
4387987|NCT00306202|4213939|B4|< 2||Age, Customized||participants|Number|2|2.0||||||
4387988|NCT00306202|4213940|B3|< 2||Age, Customized||participants|Number|2|2.0||||||
4387989|NCT00306202|4213941|B2|< 2||Age, Customized||participants|Number|0|0.0||||||
4387990|NCT00306202|4213942|B1|< 2||Age, Customized||participants|Number|0|0.0||||||
4387991|NCT00306202|4213939|B4|||Age||years|Mean|10.0|10.0|Standard Deviation|5.0|5.0|||
4387992|NCT00306202|4213940|B3|||Age||years|Mean|8.6|8.6|Standard Deviation|5.6|5.6|||
4387993|NCT00306202|4213941|B2|||Age||years|Mean|9.7|9.7|Standard Deviation|4.3|4.3|||
4387994|NCT00306202|4213942|B1|||Age||years|Mean|12.4|12.4|Standard Deviation|4.1|4.1|||
4387995|NCT00306189|4214100|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4387996|NCT00306189|4214101|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4387997|NCT00306189|4214102|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4387998|NCT00306189|4214103|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4387999|NCT00306189|4214104|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388000|NCT00306189|4214100|B5||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4388001|NCT00306189|4214101|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4388002|NCT00306189|4214102|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4388003|NCT00306189|4214103|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4388004|NCT00306189|4214104|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4388005|NCT00306189|4214100|B5|||Age||Years|Mean|65.1|65.1|Standard Deviation|6.8|6.8|||
4388006|NCT00306189|4214101|B4|||Age||Years|Mean|64.6|64.6|Standard Deviation|7|7.0|||
4388007|NCT00306189|4214102|B3|||Age||Years|Mean|64.6|64.6|Standard Deviation|7.1|7.1|||
4388008|NCT00306189|4214103|B2|||Age||Years|Mean|65.1|65.1|Standard Deviation|6.3|6.3|||
4388009|NCT00306189|4214104|B1|||Age||Years|Mean|65.9|65.9|Standard Deviation|7.1|7.1|||
4388010|NCT00306163|4214117|B3||Male|Gender||Participants|Count of Participants|16|16.0||||||
4388011|NCT00306163|4214118|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
4388012|NCT00306163|4214119|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4388013|NCT00306163|4214117|B3||Female|Gender||Participants|Count of Participants|21|21.0||||||
4388014|NCT00306163|4214118|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
4388015|NCT00306163|4214119|B1||Female|Gender||Participants|Count of Participants|13|13.0||||||
4388016|NCT00306163|4214117|B3|||Age|Statistics for the total value were not available. The cited numbers are the results of manual calculations.|years|Median|42.25|42.25|Inter-Quartile Range|10.16|10.16|37.58|51.75|
4388017|NCT00306163|4214118|B2|||Age|Statistics for the total value were not available. The cited numbers are the results of manual calculations.|years|Median|46.02|46.02|Inter-Quartile Range|9.80|9.8|37.85|55.52|
4388018|NCT00306163|4214119|B1|||Age|Statistics for the total value were not available. The cited numbers are the results of manual calculations.|years|Median|39.61|39.61|Inter-Quartile Range|10.50|10.5|32.54|46.64|
4388019|NCT00305942|4214126|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4388020|NCT00305942|4214126|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4388021|NCT00305942|4214126|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4388022|NCT00305942|4214126|B1|||Age||years|Mean|66|66.0|Standard Deviation|9.8|9.8|||
4388023|NCT00305942|4214126|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4388024|NCT00305942|4214126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4388025|NCT00305942|4214126|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388026|NCT00305877|4214132|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4388027|NCT00305877|4214133|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4388028|NCT00305877|4214134|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4388029|NCT00305877|4214132|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4388030|NCT00305877|4214133|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4388031|NCT00305877|4214134|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4388032|NCT00305877|4214132|B3|||Age||years|Median|60|60.0|Full Range|||29.2|92.9|
4388033|NCT00305877|4214133|B2|||Age||years|Median|60|60.0|Full Range|||41.6|79.4|
4388034|NCT00305877|4214134|B1|||Age||years|Median|60|60.0|Full Range|||29.2|92.9|
4388035|NCT00305864|4214145|B5||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4388036|NCT00305864|4214146|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4388037|NCT00305864|4214147|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4388038|NCT00305864|4214148|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4388039|NCT00305864|4214149|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4388040|NCT00305864|4214145|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4388041|NCT00305864|4214146|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4388042|NCT00305864|4214147|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4388043|NCT00305864|4214148|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4388044|NCT00305864|4214149|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4388045|NCT00305864|4214145|B5|||Age||years|Median|57|57.0|Full Range|||20.0|81.0|
4388046|NCT00305864|4214146|B4|||Age||years|Median|57.5|57.5|Full Range|||20.0|81.0|
4388047|NCT00305864|4214147|B3|||Age||years|Median|58|58.0|Full Range|||40.0|65.0|
4388048|NCT00305864|4214148|B2|||Age||years|Median|57.5|57.5|Full Range|||37.0|72.0|
4388049|NCT00305864|4214149|B1|||Age||years|Median|56|56.0|Full Range|||44.0|67.0|
4388050|NCT00305773|4214163|B3|Untreated AML with >= 3 cytogenetic abnnormalities||AML disease classification||participants|Number|0|0.0||||||
4388051|NCT00305773|4214164|B2|Untreated AML with >= 3 cytogenetic abnnormalities||AML disease classification||participants|Number|0|0.0||||||
4388052|NCT00305773|4214165|B1|Untreated AML with >= 3 cytogenetic abnnormalities||AML disease classification||participants|Number|0|0.0||||||
4388053|NCT00305773|4214163|B3|Untreated AML patients with MDS-AML||AML disease classification||participants|Number|3|3.0||||||
4388054|NCT00305773|4214164|B2|Untreated AML patients with MDS-AML||AML disease classification||participants|Number|3|3.0||||||
4388055|NCT00305773|4214165|B1|Untreated AML patients with MDS-AML||AML disease classification||participants|Number|0|0.0||||||
4388056|NCT00305773|4214163|B3|Untreated AML patients >= 65 years old||AML disease classification||participants|Number|6|6.0||||||
4388057|NCT00305773|4214164|B2|Untreated AML patients >= 65 years old||AML disease classification||participants|Number|3|3.0||||||
4388058|NCT00305773|4214165|B1|Untreated AML patients >= 65 years old||AML disease classification||participants|Number|3|3.0||||||
4388059|NCT00305773|4214163|B3|All other relapsed AML||AML disease classification||participants|Number|28|28.0||||||
4388060|NCT00305773|4214164|B2|All other relapsed AML||AML disease classification||participants|Number|16|16.0||||||
4388061|NCT00305773|4214165|B1|All other relapsed AML||AML disease classification||participants|Number|12|12.0||||||
4388062|NCT00305773|4214163|B3|Relapsed AML with good risk cytogenetics||AML disease classification||participants|Number|0|0.0||||||
4388063|NCT00305773|4214164|B2|Relapsed AML with good risk cytogenetics||AML disease classification||participants|Number|0|0.0||||||
4388064|NCT00305773|4214165|B1|Relapsed AML with good risk cytogenetics||AML disease classification||participants|Number|0|0.0||||||
4388065|NCT00305773|4214163|B3|Untreated||Disease status||participants|Number|9|9.0||||||
4388066|NCT00305773|4214164|B2|Untreated||Disease status||participants|Number|6|6.0||||||
4388067|NCT00305773|4214165|B1|Untreated||Disease status||participants|Number|3|3.0||||||
4388068|NCT00305773|4214163|B3|Relapsed||Disease status||participants|Number|28|28.0||||||
4388069|NCT00305773|4214164|B2|Relapsed||Disease status||participants|Number|16|16.0||||||
4388070|NCT00305773|4214165|B1|Relapsed||Disease status||participants|Number|12|12.0||||||
4388071|NCT00305773|4214163|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4388072|NCT00305773|4214164|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4388073|NCT00305773|4214165|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4388074|NCT00305773|4214163|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4388075|NCT00305773|4214164|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4388076|NCT00305773|4214165|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4388077|NCT00305773|4214163|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4388078|NCT00305773|4214164|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4388079|NCT00305773|4214165|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4388080|NCT00305773|4214163|B3|||Age||years|Median|67|67.0|Full Range|||28.0|81.0|
4388081|NCT00305773|4214164|B2|||Age||years|Median|67|67.0|Full Range|||28.0|81.0|
4388082|NCT00305773|4214165|B1|||Age||years|Median|67|67.0|Full Range|||41.0|79.0|
4388083|NCT00305760|4214180|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4388084|NCT00305760|4214180|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4388085|NCT00305760|4214180|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4388086|NCT00305760|4214180|B1|||Age||years|Mean|60|60.0|Standard Deviation|9.56|9.56|||
4388087|NCT00305760|4214180|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4388088|NCT00305760|4214180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4388089|NCT00305760|4214180|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388090|NCT00305643|4214184|B3|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4388091|NCT00305643|4214185|B2|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4388092|NCT00305643|4214186|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4388093|NCT00305643|4214184|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4388094|NCT00305643|4214185|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4388095|NCT00305643|4214186|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4388096|NCT00305643|4214184|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4388097|NCT00305643|4214185|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4388098|NCT00305643|4214186|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4388099|NCT00305643|4214184|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4388100|NCT00305643|4214185|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4388101|NCT00305643|4214186|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4388102|NCT00305643|4214184|B3|||Age||years|Mean|63|63.0|Full Range|||47.0|83.0|
4388103|NCT00305643|4214185|B2|||Age||years|Mean|66|66.0|Full Range|||50.0|83.0|
4388104|NCT00305643|4214186|B1|||Age||years|Mean|61|61.0|Full Range|||47.0|76.0|
4388105|NCT00305604|4214195|B3|||HbA1c (Hemoglobin A1c)||Percent|Mean|7.8|7.8|Standard Deviation|0.7|0.7|||
4388106|NCT00305604|4214196|B2|||HbA1c (Hemoglobin A1c)||Percent|Mean|7.8|7.8|Standard Deviation|0.7|0.7|||
4388107|NCT00305604|4214197|B1|||HbA1c (Hemoglobin A1c)||Percent|Mean|7.8|7.8|Standard Deviation|0.8|0.8|||
4388108|NCT00305604|4214195|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4388109|NCT00305604|4214196|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4388110|NCT00305604|4214197|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4388111|NCT00305604|4214195|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4388112|NCT00305604|4214196|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4388113|NCT00305604|4214197|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4388114|NCT00305604|4214195|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4388115|NCT00305604|4214196|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4388116|NCT00305604|4214197|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4388117|NCT00305604|4214195|B3|Black||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4388118|NCT00305604|4214196|B2|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4388119|NCT00305604|4214197|B1|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4388120|NCT00305604|4214195|B3|White||Race/Ethnicity, Customized||participants|Number|162|162.0||||||
4388121|NCT00305604|4214196|B2|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4388122|NCT00305604|4214197|B1|White||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4388123|NCT00305604|4214195|B3||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4388124|NCT00305604|4214196|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4388125|NCT00305604|4214197|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4388126|NCT00305604|4214195|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4388127|NCT00305604|4214196|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4388128|NCT00305604|4214197|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4388129|NCT00305604|4214195|B3|||Age||years|Mean|71.9|71.9|Standard Deviation|6.0|6.0|||
4388130|NCT00305604|4214196|B2|||Age||years|Mean|72.1|72.1|Standard Deviation|6.0|6.0|||
4388131|NCT00305604|4214197|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|6.1|6.1|||
4388132|NCT00305578|4214210|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4388133|NCT00305578|4214211|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4388134|NCT00305578|4214212|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4388135|NCT00305578|4214210|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4388136|NCT00305578|4214211|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4388137|NCT00305578|4214212|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4388138|NCT00305578|4214210|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4388139|NCT00305578|4214211|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4388140|NCT00305578|4214212|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4388141|NCT00305578|4214210|B3|||Age||years|Mean|40|40.0|Standard Deviation|15|15.0|||
4388142|NCT00305578|4214211|B2|||Age||years|Mean|38|38.0|Standard Deviation|15|15.0|||
4388143|NCT00305578|4214212|B1|||Age||years|Mean|41|41.0|Standard Deviation|14|14.0|||
4388144|NCT00305578|4214210|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388145|NCT00305578|4214211|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388146|NCT00305578|4214212|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388147|NCT00305578|4214210|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4388148|NCT00305578|4214211|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4388149|NCT00305578|4214212|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4388150|NCT00305578|4214210|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388151|NCT00305578|4214211|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388152|NCT00305578|4214212|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388153|NCT00305565|4214219|B4|||Length of Current Major Depressive Episode||Months|Mean|108.1|108.1|Standard Deviation|126.5|126.5|||
4388154|NCT00305565|4214220|B3|||Length of Current Major Depressive Episode||Months|Mean|111.3|111.3|Standard Deviation|146.3|146.3|||
4388155|NCT00305565|4214221|B2|||Length of Current Major Depressive Episode||Months|Mean|106.1|106.1|Standard Deviation|107.3|107.3|||
4388156|NCT00305565|4214222|B1|||Length of Current Major Depressive Episode||Months|Mean|106.7|106.7|Standard Deviation|122.8|122.8|||
4388157|NCT00305565|4214219|B4|||Duration of Illness||Years|Mean|27.7|27.7|Standard Deviation|11.8|11.8|||
4388158|NCT00305565|4214220|B3|||Duration of Illness||Years|Mean|27.0|27.0|Standard Deviation|12.1|12.1|||
4388159|NCT00305565|4214221|B2|||Duration of Illness||Years|Mean|26.3|26.3|Standard Deviation|10.9|10.9|||
4388160|NCT00305565|4214222|B1|||Duration of Illness||Years|Mean|29.8|29.8|Standard Deviation|12.1|12.1|||
4388161|NCT00305565|4214219|B4|>10 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|135|135.0||||||
4388162|NCT00305565|4214220|B3|>10 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|39|39.0||||||
4388163|NCT00305565|4214221|B2|>10 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|46|46.0||||||
4388164|NCT00305565|4214222|B1|>10 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|50|50.0||||||
4388165|NCT00305565|4214219|B4|6-10 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|47|47.0||||||
4388166|NCT00305565|4214220|B3|6-10 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|18|18.0||||||
4388167|NCT00305565|4214221|B2|6-10 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|16|16.0||||||
4388168|NCT00305565|4214222|B1|6-10 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|13|13.0||||||
4388169|NCT00305565|4214219|B4|3-5 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|66|66.0||||||
4388170|NCT00305565|4214220|B3|3-5 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|22|22.0||||||
4388171|NCT00305565|4214221|B2|3-5 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|21|21.0||||||
4388172|NCT00305565|4214222|B1|3-5 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|23|23.0||||||
4388173|NCT00305565|4214219|B4|0-2 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|61|61.0||||||
4388174|NCT00305565|4214220|B3|0-2 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|28|28.0||||||
4388175|NCT00305565|4214221|B2|0-2 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|17|17.0||||||
4388176|NCT00305565|4214222|B1|0-2 Episodes||Lifetime Episodes of Depression|This study specific characteristic data was not available for 1 participant in the Medium Dose Group.|participants|Number|16|16.0||||||
4388177|NCT00305565|4214219|B4|Bipolar Depression||Unipolar or Bipolar Depression||participants|Number|66|66.0||||||
4388178|NCT00305565|4214220|B3|Bipolar Depression||Unipolar or Bipolar Depression||participants|Number|26|26.0||||||
4388179|NCT00305565|4214221|B2|Bipolar Depression||Unipolar or Bipolar Depression||participants|Number|20|20.0||||||
4388180|NCT00305565|4214222|B1|Bipolar Depression||Unipolar or Bipolar Depression||participants|Number|20|20.0||||||
4388181|NCT00305565|4214219|B4|Unipolar Depression (Recurrent)||Unipolar or Bipolar Depression||participants|Number|213|213.0||||||
4388182|NCT00305565|4214220|B3|Unipolar Depression (Recurrent)||Unipolar or Bipolar Depression||participants|Number|66|66.0||||||
4388183|NCT00305565|4214221|B2|Unipolar Depression (Recurrent)||Unipolar or Bipolar Depression||participants|Number|71|71.0||||||
4388184|NCT00305565|4214222|B1|Unipolar Depression (Recurrent)||Unipolar or Bipolar Depression||participants|Number|76|76.0||||||
4388185|NCT00305565|4214219|B4|Unipolar Depression (Single Episode)||Unipolar or Bipolar Depression||participants|Number|31|31.0||||||
4388186|NCT00305565|4214220|B3|Unipolar Depression (Single Episode)||Unipolar or Bipolar Depression||participants|Number|15|15.0||||||
4388187|NCT00305565|4214221|B2|Unipolar Depression (Single Episode)||Unipolar or Bipolar Depression||participants|Number|10|10.0||||||
4388188|NCT00305565|4214222|B1|Unipolar Depression (Single Episode)||Unipolar or Bipolar Depression||participants|Number|6|6.0||||||
4388189|NCT00305565|4214219|B4|United States||Region of Enrollment||participants|Number|310|310.0||||||
4388190|NCT00305565|4214220|B3|United States||Region of Enrollment||participants|Number|107|107.0||||||
4388191|NCT00305565|4214221|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4388192|NCT00305565|4214222|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4388193|NCT00305565|4214219|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4388194|NCT00305565|4214220|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4388195|NCT00305565|4214221|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4388196|NCT00305565|4214222|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4388197|NCT00305565|4214219|B4|African-American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4388198|NCT00305565|4214220|B3|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4388199|NCT00305565|4214221|B2|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4388200|NCT00305565|4214222|B1|African-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4388201|NCT00305565|4214219|B4|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4388202|NCT00305565|4214220|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4388203|NCT00305565|4214221|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4388204|NCT00305565|4214222|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4388205|NCT00305565|4214219|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|297|297.0||||||
4388206|NCT00305565|4214220|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4388207|NCT00305565|4214221|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4388208|NCT00305565|4214222|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4388209|NCT00305565|4214219|B4||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4388210|NCT00305565|4214220|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4388211|NCT00305565|4214221|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4388212|NCT00305565|4214222|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4388213|NCT00305565|4214219|B4||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4388214|NCT00305565|4214220|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4388215|NCT00305565|4214221|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4388216|NCT00305565|4214222|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4388217|NCT00305565|4214219|B4|||Age||years|Mean|47.9|47.9|Standard Deviation|10.8|10.8|||
4388218|NCT00305565|4214220|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|10.8|10.8|||
4388219|NCT00305565|4214221|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|11.0|11.0|||
4388220|NCT00305565|4214222|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|10.5|10.5|||
4388221|NCT00305448|4214339|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388222|NCT00305448|4214340|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388223|NCT00305448|4214341|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388224|NCT00305448|4214342|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388225|NCT00305448|4214339|B4||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4388226|NCT00305448|4214340|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4388227|NCT00305448|4214341|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4388228|NCT00305448|4214342|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4388229|NCT00305448|4214339|B4|||Age||Years|Mean|62.5|62.5|Standard Deviation|8.7|8.7|||
4388230|NCT00305448|4214340|B3|||Age||Years|Mean|62.7|62.7|Standard Deviation|9.1|9.1|||
4388231|NCT00305448|4214341|B2|||Age||Years|Mean|62.4|62.4|Standard Deviation|9.5|9.5|||
4388232|NCT00305448|4214342|B1|||Age||Years|Mean|62.5|62.5|Standard Deviation|7.4|7.4|||
4388233|NCT00305344|4214360|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4388234|NCT00305344|4214360|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4388235|NCT00305344|4214360|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4388236|NCT00305344|4214360|B1|||Age||years|Mean|5.1|5.1|Standard Deviation|1|1.0|||
4388237|NCT00305344|4214360|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388238|NCT00305344|4214360|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4388239|NCT00305344|4214360|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4388240|NCT00305253|4214364|B3|Egypt||Region of Enrollment||participants|Number|990|990.0||||||
4388241|NCT00305253|4214365|B2|Egypt||Region of Enrollment||participants|Number|558|558.0||||||
4388242|NCT00305253|4214366|B1|Egypt||Region of Enrollment||participants|Number|432|432.0||||||
4388243|NCT00305253|4214364|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388244|NCT00305253|4214365|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388245|NCT00305253|4214366|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388246|NCT00305253|4214364|B3||Female|Sex: Female, Male||Participants|Count of Participants|990|990.0||||||
4388247|NCT00305253|4214365|B2||Female|Sex: Female, Male||Participants|Count of Participants|558|558.0||||||
4388248|NCT00305253|4214366|B1||Female|Sex: Female, Male||Participants|Count of Participants|432|432.0||||||
4388249|NCT00305253|4214364|B3|||Age||years|Mean|28.8|28.8|Standard Deviation|6.2|6.2|||
4388250|NCT00305253|4214365|B2|||Age||years|Mean|28.9|28.9|Standard Deviation|6.0|6.0|||
4388251|NCT00305253|4214366|B1|||Age||years|Mean|28.7|28.7|Standard Deviation|6.2|6.2|||
4388252|NCT00305227|4214377|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4388253|NCT00305227|4214378|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4388254|NCT00305227|4214379|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4388255|NCT00305227|4214377|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388256|NCT00305227|4214378|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388257|NCT00305227|4214379|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388258|NCT00305227|4214377|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4388259|NCT00305227|4214378|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4388260|NCT00305227|4214379|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4388261|NCT00305227|4214377|B3|||Age||years|Mean|21|21.0|Full Range|18-36|18.0|18.0|36.0|
4388262|NCT00305227|4214378|B2|||Age||years|Mean|21|21.0|Full Range|18-36|18.0|18.0|36.0|
4388263|NCT00305227|4214379|B1|||Age||years|Mean|21|21.0|Full Range|18-31|18.0|18.0|31.0|
4388264|NCT00305227|4214377|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388265|NCT00305227|4214378|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388266|NCT00305227|4214379|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388267|NCT00305227|4214377|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4388268|NCT00305227|4214378|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4388269|NCT00305227|4214379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4388270|NCT00305227|4214377|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388271|NCT00305227|4214378|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388272|NCT00305227|4214379|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388273|NCT00305162|4214386|B3|Ukraine||Region of Enrollment||participants|Number|78|78.0||||||
4388274|NCT00305162|4214387|B2|Ukraine||Region of Enrollment||participants|Number|39|39.0||||||
4388275|NCT00305162|4214388|B1|Ukraine||Region of Enrollment||participants|Number|39|39.0||||||
4388276|NCT00305162|4214386|B3|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4388277|NCT00305162|4214387|B2|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4388278|NCT00305162|4214388|B1|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4388279|NCT00305162|4214386|B3|Poland||Region of Enrollment||participants|Number|463|463.0||||||
4388280|NCT00305162|4214387|B2|Poland||Region of Enrollment||participants|Number|232|232.0||||||
4388281|NCT00305162|4214388|B1|Poland||Region of Enrollment||participants|Number|231|231.0||||||
4388282|NCT00305162|4214386|B3|New Zealand||Region of Enrollment||participants|Number|226|226.0||||||
4388283|NCT00305162|4214387|B2|New Zealand||Region of Enrollment||participants|Number|116|116.0||||||
4388284|NCT00305162|4214388|B1|New Zealand||Region of Enrollment||participants|Number|110|110.0||||||
4388285|NCT00305162|4214386|B3|Italy||Region of Enrollment||participants|Number|336|336.0||||||
4388286|NCT00305162|4214387|B2|Italy||Region of Enrollment||participants|Number|167|167.0||||||
4388287|NCT00305162|4214388|B1|Italy||Region of Enrollment||participants|Number|169|169.0||||||
4388288|NCT00305162|4214386|B3|India||Region of Enrollment||participants|Number|520|520.0||||||
4388289|NCT00305162|4214387|B2|India||Region of Enrollment||participants|Number|260|260.0||||||
4388290|NCT00305162|4214388|B1|India||Region of Enrollment||participants|Number|260|260.0||||||
4388291|NCT00305162|4214386|B3|Germany||Region of Enrollment||participants|Number|318|318.0||||||
4388292|NCT00305162|4214387|B2|Germany||Region of Enrollment||participants|Number|156|156.0||||||
4388293|NCT00305162|4214388|B1|Germany||Region of Enrollment||participants|Number|162|162.0||||||
4388294|NCT00305162|4214386|B3|Georgia||Region of Enrollment||participants|Number|458|458.0||||||
4388295|NCT00305162|4214387|B2|Georgia||Region of Enrollment||participants|Number|230|230.0||||||
4388296|NCT00305162|4214388|B1|Georgia||Region of Enrollment||participants|Number|228|228.0||||||
4388297|NCT00305162|4214386|B3|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4388298|NCT00305162|4214387|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4388299|NCT00305162|4214388|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4388300|NCT00305162|4214386|B3|Brazil||Region of Enrollment||participants|Number|227|227.0||||||
4388301|NCT00305162|4214387|B2|Brazil||Region of Enrollment||participants|Number|116|116.0||||||
4388302|NCT00305162|4214388|B1|Brazil||Region of Enrollment||participants|Number|111|111.0||||||
4388303|NCT00305162|4214386|B3|Austria||Region of Enrollment||participants|Number|430|430.0||||||
4388304|NCT00305162|4214387|B2|Austria||Region of Enrollment||participants|Number|215|215.0||||||
4388305|NCT00305162|4214388|B1|Austria||Region of Enrollment||participants|Number|215|215.0||||||
4388306|NCT00305162|4214386|B3|Argentina||Region of Enrollment||participants|Number|51|51.0||||||
4388307|NCT00305162|4214387|B2|Argentina||Region of Enrollment||participants|Number|26|26.0||||||
4388308|NCT00305162|4214388|B1|Argentina||Region of Enrollment||participants|Number|25|25.0||||||
4388309|NCT00305162|4214386|B3|Australia||Region of Enrollment||participants|Number|470|470.0||||||
4388310|NCT00305162|4214387|B2|Australia||Region of Enrollment||participants|Number|237|237.0||||||
4388311|NCT00305162|4214388|B1|Australia||Region of Enrollment||participants|Number|233|233.0||||||
4388312|NCT00305162|4214386|B3|United States||Region of Enrollment||participants|Number|5267|5267.0||||||
4388313|NCT00305162|4214387|B2|United States||Region of Enrollment||participants|Number|2638|2638.0||||||
4388314|NCT00305162|4214388|B1|United States||Region of Enrollment||participants|Number|2629|2629.0||||||
4388315|NCT00305162|4214386|B3||Male|Sex: Female, Male||Participants|Count of Participants|6484|6484.0||||||
4388316|NCT00305162|4214387|B2||Male|Sex: Female, Male||Participants|Count of Participants|3209|3209.0||||||
4388317|NCT00305162|4214388|B1||Male|Sex: Female, Male||Participants|Count of Participants|3275|3275.0||||||
4388318|NCT00305162|4214386|B3||Female|Sex: Female, Male||Participants|Count of Participants|2393|2393.0||||||
4388319|NCT00305162|4214387|B2||Female|Sex: Female, Male||Participants|Count of Participants|1235|1235.0||||||
4388320|NCT00305162|4214388|B1||Female|Sex: Female, Male||Participants|Count of Participants|1158|1158.0||||||
4388321|NCT00305162|4214386|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|11.4|11.4|||
4388322|NCT00305162|4214387|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|11.5|11.5|||
4388323|NCT00305162|4214388|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|11.3|11.3|||
4388324|NCT00305110|4214427|B1|Against medical advice||Disposition|Disposition is where the participant goes after the ED. Discharge means they are well enough to leave the hospital. Admit means they were admitted to the hospital for an inpatient stay. Against medical advice means that although the physician recommended they come into the hospital for an inpatient stay, the patient chose to leave the hospital and go against the recommendation of their doctor.|Participants|Count of Participants|3|3.0||||||
4388325|NCT00305110|4214427|B1|Discharged||Disposition|Disposition is where the participant goes after the ED. Discharge means they are well enough to leave the hospital. Admit means they were admitted to the hospital for an inpatient stay. Against medical advice means that although the physician recommended they come into the hospital for an inpatient stay, the patient chose to leave the hospital and go against the recommendation of their doctor.|Participants|Count of Participants|144|144.0||||||
4388326|NCT00305110|4214427|B1|Admitted||Disposition|Disposition is where the participant goes after the ED. Discharge means they are well enough to leave the hospital. Admit means they were admitted to the hospital for an inpatient stay. Against medical advice means that although the physician recommended they come into the hospital for an inpatient stay, the patient chose to leave the hospital and go against the recommendation of their doctor.|Participants|Count of Participants|122|122.0||||||
4388327|NCT00305110|4214427|B1|Other||Final diagnosis||Participants|Count of Participants|68|68.0||||||
4388328|NCT00305110|4214427|B1|Small bowel obstruction||Final diagnosis||Participants|Count of Participants|8|8.0||||||
4388329|NCT00305110|4214427|B1|Pyelonephritis||Final diagnosis||Participants|Count of Participants|6|6.0||||||
4388330|NCT00305110|4214427|B1|Pancreatitis||Final diagnosis||Participants|Count of Participants|9|9.0||||||
4388331|NCT00305110|4214427|B1|Nonspecific abdominal pain||Final diagnosis||Participants|Count of Participants|65|65.0||||||
4388332|NCT00305110|4214427|B1|Low back pain||Final diagnosis||Participants|Count of Participants|7|7.0||||||
4388333|NCT00305110|4214427|B1|Kidney Stone||Final diagnosis||Participants|Count of Participants|38|38.0||||||
4388334|NCT00305110|4214427|B1|Gastritis||Final diagnosis||Participants|Count of Participants|8|8.0||||||
4388335|NCT00305110|4214427|B1|Diverticulitis||Final diagnosis||Participants|Count of Participants|14|14.0||||||
4388336|NCT00305110|4214427|B1|Biliary colic/cholecystitis||Final diagnosis||Participants|Count of Participants|21|21.0||||||
4388337|NCT00305110|4214427|B1|Appendicitis||Final diagnosis||Participants|Count of Participants|18|18.0||||||
4388338|NCT00305110|4214427|B1|Abcess||Final diagnosis||Participants|Count of Participants|7|7.0||||||
4388339|NCT00305110|4214427|B1|||Weight||pounds|Mean|198|198.0|Standard Deviation|38|38.0|||
4388340|NCT00305110|4214427|B1|10||Baseline Pain intensity|Pain intensity is measured on a numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).|Participants|Count of Participants|158|158.0||||||
4388341|NCT00305110|4214427|B1|9||Baseline Pain intensity|Pain intensity is measured on a numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).|Participants|Count of Participants|33|33.0||||||
4388342|NCT00305110|4214427|B1|8||Baseline Pain intensity|Pain intensity is measured on a numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).|Participants|Count of Participants|45|45.0||||||
4388343|NCT00305110|4214427|B1|7||Baseline Pain intensity|Pain intensity is measured on a numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).|Participants|Count of Participants|22|22.0||||||
4388344|NCT00305110|4214427|B1|less than 7||Baseline Pain intensity|Pain intensity is measured on a numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable).|Participants|Count of Participants|10|10.0||||||
4388345|NCT00305110|4214427|B1|Other||Pain Location||Participants|Count of Participants|64|64.0||||||
4388346|NCT00305110|4214427|B1|Abdomen||Pain Location||Participants|Count of Participants|205|205.0||||||
4388347|NCT00305110|4214427|B1|United States||Region of Enrollment||Participants|Count of Participants|269|269.0||||||
4388348|NCT00305110|4214427|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4388349|NCT00305110|4214427|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4388350|NCT00305110|4214427|B1|African-American||Race/Ethnicity, Customized||Participants|Count of Participants|85|85.0||||||
4388351|NCT00305110|4214427|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|163|163.0||||||
4388352|NCT00305110|4214427|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4388353|NCT00305110|4214427|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4388354|NCT00305110|4214427|B1|||Age||years|Mean|41|41.0|Standard Deviation|11|11.0|||
4388355|NCT00305058|4214436|B3|Yes||Number of participants experiencing vomiting since pain began||Participants|Count of Participants|59|59.0||||||
4388356|NCT00305058|4214437|B2|Yes||Number of participants experiencing vomiting since pain began||Participants|Count of Participants|29|29.0||||||
4388357|NCT00305058|4214438|B1|Yes||Number of participants experiencing vomiting since pain began||Participants|Count of Participants|30|30.0||||||
4388358|NCT00305058|4214436|B3|No||Number of participants experiencing vomiting since pain began||Participants|Count of Participants|119|119.0||||||
4388359|NCT00305058|4214437|B2|No||Number of participants experiencing vomiting since pain began||Participants|Count of Participants|60|60.0||||||
4388360|NCT00305058|4214438|B1|No||Number of participants experiencing vomiting since pain began||Participants|Count of Participants|59|59.0||||||
4388361|NCT00305058|4214436|B3|Yes||Number of participants experiencing nausea since pain began||Participants|Count of Participants|79|79.0||||||
4388362|NCT00305058|4214437|B2|Yes||Number of participants experiencing nausea since pain began||Participants|Count of Participants|38|38.0||||||
4388363|NCT00305058|4214438|B1|Yes||Number of participants experiencing nausea since pain began||Participants|Count of Participants|41|41.0||||||
4388364|NCT00305058|4214436|B3|No||Number of participants experiencing nausea since pain began||Participants|Count of Participants|96|96.0||||||
4388365|NCT00305058|4214437|B2|No||Number of participants experiencing nausea since pain began||Participants|Count of Participants|48|48.0||||||
4388366|NCT00305058|4214438|B1|No||Number of participants experiencing nausea since pain began||Participants|Count of Participants|48|48.0||||||
4388367|NCT00305058|4214436|B3|Unknown/missing data||Number of participants who had pain in specific locations||Participants|Count of Participants|1|1.0||||||
4388368|NCT00305058|4214437|B2|Unknown/missing data||Number of participants who had pain in specific locations||Participants|Count of Participants|1|1.0||||||
4388369|NCT00305058|4214438|B1|Unknown/missing data||Number of participants who had pain in specific locations||Participants|Count of Participants|0|0.0||||||
4388370|NCT00305058|4214436|B3|Other||Number of participants who had pain in specific locations||Participants|Count of Participants|33|33.0||||||
4388371|NCT00305058|4214437|B2|Other||Number of participants who had pain in specific locations||Participants|Count of Participants|15|15.0||||||
4388372|NCT00305058|4214438|B1|Other||Number of participants who had pain in specific locations||Participants|Count of Participants|18|18.0||||||
4388373|NCT00305058|4214436|B3|Head/neck||Number of participants who had pain in specific locations||Participants|Count of Participants|4|4.0||||||
4388374|NCT00305058|4214437|B2|Head/neck||Number of participants who had pain in specific locations||Participants|Count of Participants|2|2.0||||||
4388375|NCT00305058|4214438|B1|Head/neck||Number of participants who had pain in specific locations||Participants|Count of Participants|2|2.0||||||
4388376|NCT00305058|4214436|B3|Chest||Number of participants who had pain in specific locations||Participants|Count of Participants|6|6.0||||||
4388377|NCT00305058|4214437|B2|Chest||Number of participants who had pain in specific locations||Participants|Count of Participants|4|4.0||||||
4388378|NCT00305058|4214438|B1|Chest||Number of participants who had pain in specific locations||Participants|Count of Participants|2|2.0||||||
4388379|NCT00305058|4214436|B3|Back||Number of participants who had pain in specific locations||Participants|Count of Participants|25|25.0||||||
4388380|NCT00305058|4214437|B2|Back||Number of participants who had pain in specific locations||Participants|Count of Participants|7|7.0||||||
4388381|NCT00305058|4214438|B1|Back||Number of participants who had pain in specific locations||Participants|Count of Participants|18|18.0||||||
4388382|NCT00305058|4214436|B3|Extremities||Number of participants who had pain in specific locations||Participants|Count of Participants|13|13.0||||||
4388383|NCT00305058|4214437|B2|Extremities||Number of participants who had pain in specific locations||Participants|Count of Participants|8|8.0||||||
4388384|NCT00305058|4214438|B1|Extremities||Number of participants who had pain in specific locations||Participants|Count of Participants|5|5.0||||||
4388385|NCT00305058|4214436|B3|Abdomen/pelvis||Number of participants who had pain in specific locations||Participants|Count of Participants|101|101.0||||||
4388386|NCT00305058|4214437|B2|Abdomen/pelvis||Number of participants who had pain in specific locations||Participants|Count of Participants|56|56.0||||||
4388387|NCT00305058|4214438|B1|Abdomen/pelvis||Number of participants who had pain in specific locations||Participants|Count of Participants|45|45.0||||||
4388388|NCT00305058|4214436|B3|Some||Number of participants who took analgesics before coming to the ED||Participants|Count of Participants|42|42.0||||||
4388389|NCT00305058|4214437|B2|Some||Number of participants who took analgesics before coming to the ED||Participants|Count of Participants|18|18.0||||||
4388390|NCT00305058|4214438|B1|Some||Number of participants who took analgesics before coming to the ED||Participants|Count of Participants|24|24.0||||||
4388391|NCT00305058|4214436|B3|None||Number of participants who took analgesics before coming to the ED||Participants|Count of Participants|141|141.0||||||
4388392|NCT00305058|4214437|B2|None||Number of participants who took analgesics before coming to the ED||Participants|Count of Participants|75|75.0||||||
4388393|NCT00305058|4214438|B1|None||Number of participants who took analgesics before coming to the ED||Participants|Count of Participants|66|66.0||||||
4388394|NCT00305058|4214436|B3|10||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|86|86.0||||||
4388395|NCT00305058|4214437|B2|10||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|46|46.0||||||
4388396|NCT00305058|4214438|B1|10||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|40|40.0||||||
4388397|NCT00305058|4214436|B3|9||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|19|19.0||||||
4388398|NCT00305058|4214437|B2|9||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|10|10.0||||||
4388399|NCT00305058|4214438|B1|9||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|9|9.0||||||
4388400|NCT00305058|4214436|B3|8||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|38|38.0||||||
4388401|NCT00305058|4214437|B2|8||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|18|18.0||||||
4388402|NCT00305058|4214438|B1|8||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|20|20.0||||||
4388403|NCT00305058|4214436|B3|7||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|21|21.0||||||
4388404|NCT00305058|4214437|B2|7||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|9|9.0||||||
4388405|NCT00305058|4214438|B1|7||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|12|12.0||||||
4388406|NCT00305058|4214436|B3|6||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|19|19.0||||||
4388407|NCT00305058|4214437|B2|6||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|10|10.0||||||
4388408|NCT00305058|4214438|B1|6||Baseline Pain Score|"based on a numerical rating scale (NRS) of 0 (no pain) to 10 (worst possible pain)"|Participants|Count of Participants|9|9.0||||||
4388409|NCT00305058|4214436|B3|Unknown||Primary Language||Participants|Count of Participants|3|3.0||||||
4388410|NCT00305058|4214437|B2|Unknown||Primary Language||Participants|Count of Participants|2|2.0||||||
4388411|NCT00305058|4214438|B1|Unknown||Primary Language||Participants|Count of Participants|1|1.0||||||
4388412|NCT00305058|4214436|B3|Other||Primary Language||Participants|Count of Participants|5|5.0||||||
4388413|NCT00305058|4214437|B2|Other||Primary Language||Participants|Count of Participants|0|0.0||||||
4388414|NCT00305058|4214438|B1|Other||Primary Language||Participants|Count of Participants|5|5.0||||||
4388415|NCT00305058|4214436|B3|Spanish||Primary Language||Participants|Count of Participants|73|73.0||||||
4388416|NCT00305058|4214437|B2|Spanish||Primary Language||Participants|Count of Participants|40|40.0||||||
4388417|NCT00305058|4214438|B1|Spanish||Primary Language||Participants|Count of Participants|33|33.0||||||
4388418|NCT00305058|4214436|B3|English||Primary Language||Participants|Count of Participants|102|102.0||||||
4388419|NCT00305058|4214437|B2|English||Primary Language||Participants|Count of Participants|51|51.0||||||
4388420|NCT00305058|4214438|B1|English||Primary Language||Participants|Count of Participants|51|51.0||||||
4388421|NCT00305058|4214436|B3|||Weight||lbs|Mean|153|153.0|Standard Deviation|29|29.0|||
4388422|NCT00305058|4214437|B2|||Weight||lbs|Mean|157|157.0|Standard Deviation|29|29.0|||
4388423|NCT00305058|4214438|B1|||Weight||lbs|Mean|148|148.0|Standard Deviation|29|29.0|||
4388424|NCT00305058|4214436|B3|United States||Region of Enrollment||Participants|Count of Participants|183|183.0||||||
4388425|NCT00305058|4214437|B2|United States||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
4388426|NCT00305058|4214438|B1|United States||Region of Enrollment||Participants|Count of Participants|90|90.0||||||
4388427|NCT00305058|4214436|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4388428|NCT00305058|4214437|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4388429|NCT00305058|4214438|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4388430|NCT00305058|4214436|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
4388431|NCT00305058|4214437|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4388432|NCT00305058|4214438|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4388433|NCT00305058|4214436|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4388434|NCT00305058|4214437|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4388435|NCT00305058|4214438|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4388436|NCT00305058|4214436|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|86|86.0||||||
4388437|NCT00305058|4214437|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4388438|NCT00305058|4214438|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|39|39.0||||||
4388439|NCT00305058|4214436|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4388440|NCT00305058|4214437|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4388441|NCT00305058|4214438|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4388442|NCT00305058|4214436|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4388443|NCT00305058|4214437|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4388444|NCT00305058|4214438|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4388445|NCT00305058|4214436|B3|||Age||years|Mean|75|75.0|Standard Deviation|8|8.0|||
4388446|NCT00305058|4214437|B2|||Age||years|Mean|74|74.0|Standard Deviation|8|8.0|||
4388447|NCT00305058|4214438|B1|||Age||years|Mean|76|76.0|Standard Deviation|8|8.0|||
4388448|NCT00304954|4214451|B5|United States||Region of Enrollment||participants|Number|13|13.0||||||
4388449|NCT00304954|4214452|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4388450|NCT00304954|4214453|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4388451|NCT00304954|4214454|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4388452|NCT00304954|4214455|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4388453|NCT00304954|4214451|B5||Male|Gender||Participants|Count of Participants|1|1.0||||||
4388454|NCT00304954|4214452|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
4388455|NCT00304954|4214453|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4388456|NCT00304954|4214454|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
4388457|NCT00304954|4214455|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4388458|NCT00304954|4214451|B5||Female|Gender||Participants|Count of Participants|12|12.0||||||
4388459|NCT00304954|4214452|B4||Female|Gender||Participants|Count of Participants|3|3.0||||||
4388460|NCT00304954|4214453|B3||Female|Gender||Participants|Count of Participants|3|3.0||||||
4388461|NCT00304954|4214454|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
4388462|NCT00304954|4214455|B1||Female|Gender||Participants|Count of Participants|4|4.0||||||
4388463|NCT00304954|4214451|B5|||Age||years|Mean|80|80.0|Standard Deviation|9|9.0|||
4388464|NCT00304954|4214452|B4|||Age||years|Mean|87|87.0|Standard Deviation|4|4.0|||
4388465|NCT00304954|4214453|B3|||Age||years|Mean|78|78.0|Standard Deviation|7|7.0|||
4388466|NCT00304954|4214454|B2|||Age||years|Mean|77|77.0|Standard Deviation|8|8.0|||
4388467|NCT00304954|4214455|B1|||Age||years|Mean|79|79.0|Standard Deviation|13|13.0|||
4388468|NCT00304954|4214451|B5||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4388469|NCT00304954|4214452|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4388470|NCT00304954|4214453|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4388471|NCT00304954|4214454|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4388472|NCT00304954|4214455|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4388473|NCT00304954|4214451|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4388474|NCT00304954|4214452|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4388475|NCT00304954|4214453|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4388476|NCT00304954|4214454|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4388477|NCT00304954|4214455|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4388478|NCT00304954|4214451|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388479|NCT00304954|4214452|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388480|NCT00304954|4214453|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388481|NCT00304954|4214454|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388482|NCT00304954|4214455|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388483|NCT00304915|4214476|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388484|NCT00304915|4214477|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388485|NCT00304915|4214478|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388486|NCT00304915|4214476|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388487|NCT00304915|4214477|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388488|NCT00304915|4214478|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388489|NCT00304915|4214476|B3||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4388490|NCT00304915|4214477|B2||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4388491|NCT00304915|4214478|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4388492|NCT00304915|4214476|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4388493|NCT00304915|4214477|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4388494|NCT00304915|4214478|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4388495|NCT00304915|4214476|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388496|NCT00304915|4214477|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388497|NCT00304915|4214478|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388498|NCT00304915|4214476|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388499|NCT00304915|4214477|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388500|NCT00304915|4214478|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388501|NCT00304915|4214476|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388502|NCT00304915|4214477|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388503|NCT00304915|4214478|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388504|NCT00304915|4214476|B3||Male|Gender||Participants|Count of Participants|242|242.0||||||
4388505|NCT00304915|4214477|B2||Male|Gender||Participants|Count of Participants|122|122.0||||||
4388506|NCT00304915|4214478|B1||Male|Gender||Participants|Count of Participants|120|120.0||||||
4388507|NCT00304915|4214476|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
4388508|NCT00304915|4214477|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
4388509|NCT00304915|4214478|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4388510|NCT00304915|4214476|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|9.6|9.6|||
4388511|NCT00304915|4214477|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|10.5|10.5|||
4388512|NCT00304915|4214478|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|8.7|8.7|||
4388513|NCT00304746|4214485|B3|Israel||Region of Enrollment||participants|Number|47|47.0||||||
4388514|NCT00304746|4214486|B2|Israel||Region of Enrollment||participants|Number|26|26.0||||||
4388515|NCT00304746|4214487|B1|Israel||Region of Enrollment||participants|Number|21|21.0||||||
4388516|NCT00304746|4214485|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4388517|NCT00304746|4214486|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4388518|NCT00304746|4214487|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4388519|NCT00304746|4214485|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4388520|NCT00304746|4214486|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4388521|NCT00304746|4214487|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4388522|NCT00304746|4214485|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388523|NCT00304746|4214486|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388524|NCT00304746|4214487|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388525|NCT00304746|4214485|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|7.7|7.7|||
4388526|NCT00304746|4214486|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|7.1|7.1|||
4388527|NCT00304746|4214487|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|8.2|8.2|||
4388528|NCT00304746|4214485|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388529|NCT00304746|4214486|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388530|NCT00304746|4214487|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388531|NCT00304746|4214485|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4388532|NCT00304746|4214486|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4388533|NCT00304746|4214487|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4388534|NCT00304746|4214485|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388535|NCT00304746|4214486|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388536|NCT00304746|4214487|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388537|NCT00304707|4214496|B3|United States||Region of Enrollment||participants|Number|143|143.0||||||
4388538|NCT00304707|4214497|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4388539|NCT00304707|4214498|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4388540|NCT00304707|4214496|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388541|NCT00304707|4214497|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388542|NCT00304707|4214498|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388543|NCT00304707|4214496|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388544|NCT00304707|4214497|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388545|NCT00304707|4214498|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388546|NCT00304707|4214496|B3||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4388547|NCT00304707|4214497|B2||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4388548|NCT00304707|4214498|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4388549|NCT00304707|4214496|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4388550|NCT00304707|4214497|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4388551|NCT00304707|4214498|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4388552|NCT00304707|4214496|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388553|NCT00304707|4214497|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388554|NCT00304707|4214498|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388555|NCT00304707|4214496|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388556|NCT00304707|4214497|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388557|NCT00304707|4214498|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388558|NCT00304707|4214496|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388559|NCT00304707|4214497|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388560|NCT00304707|4214498|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388561|NCT00304707|4214496|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4388562|NCT00304707|4214497|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4388563|NCT00304707|4214498|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4388564|NCT00304707|4214496|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4388565|NCT00304707|4214497|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4388566|NCT00304707|4214498|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4388567|NCT00304707|4214496|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|9.0|9.0|||
4388568|NCT00304707|4214497|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|10.5|10.5|||
4388569|NCT00304707|4214498|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|7.5|7.5|||
4388570|NCT00304512|4214505|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388571|NCT00304512|4214506|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388572|NCT00304512|4214507|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388573|NCT00304512|4214508|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388574|NCT00304512|4214505|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4388575|NCT00304512|4214506|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4388576|NCT00304512|4214507|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4388577|NCT00304512|4214508|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4388578|NCT00304512|4214505|B4|||Age||years|Mean|45.4|45.4|Standard Deviation|9.23|9.23|||
4388579|NCT00304512|4214506|B3|||Age||years|Mean|44.0|44.0|Standard Deviation|2.65|2.65|||
4388580|NCT00304512|4214507|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|9.95|9.95|||
4388581|NCT00304512|4214508|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|18.38|18.38|||
4388582|NCT00304356|4214524|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4388583|NCT00304356|4214524|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4388584|NCT00304356|4214524|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388585|NCT00304356|4214524|B1|||Age||years|Mean|27|27.0|Standard Deviation|27|27.0|||
4388586|NCT00304356|4214524|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388587|NCT00304356|4214524|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4388588|NCT00304356|4214524|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388589|NCT00304278|4214528|B1||N2 Stage of tumor|N stage of Tumor at diagnosis|"T3 Tumor > 4cm in greatest dimension~T4a - Moderately advanced local disease~T4b - Very Advanced local disease~N0-no regional lymph node metastasis~N1-metastasis in a single ipsilateral lymph node 3cm or less in greatest dimension~N2-metastasis in a single ipsilateral lymph node > 3cm but not more than 6cm in greatest dimension; or in multiple ipsilateral lymph nodes, none > 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none> 6 cm in greatest dimension~N3 Metastasis in a lymph node > 6cm greatest dimension"|Participants|Count of Participants|13|13.0||||||
4388590|NCT00304278|4214528|B1||N1 stage of tumor|N stage of Tumor at diagnosis|"T3 Tumor > 4cm in greatest dimension~T4a - Moderately advanced local disease~T4b - Very Advanced local disease~N0-no regional lymph node metastasis~N1-metastasis in a single ipsilateral lymph node 3cm or less in greatest dimension~N2-metastasis in a single ipsilateral lymph node > 3cm but not more than 6cm in greatest dimension; or in multiple ipsilateral lymph nodes, none > 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none> 6 cm in greatest dimension~N3 Metastasis in a lymph node > 6cm greatest dimension"|Participants|Count of Participants|4|4.0||||||
4388591|NCT00304278|4214528|B1||N0 stage of tumor|N stage of Tumor at diagnosis|"T3 Tumor > 4cm in greatest dimension~T4a - Moderately advanced local disease~T4b - Very Advanced local disease~N0-no regional lymph node metastasis~N1-metastasis in a single ipsilateral lymph node 3cm or less in greatest dimension~N2-metastasis in a single ipsilateral lymph node > 3cm but not more than 6cm in greatest dimension; or in multiple ipsilateral lymph nodes, none > 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none> 6 cm in greatest dimension~N3 Metastasis in a lymph node > 6cm greatest dimension"|Participants|Count of Participants|4|4.0||||||
4388592|NCT00304278|4214528|B1||T3 stage of tumor|T stage of Tumor at diagnosis||Participants|Count of Participants|8|8.0||||||
4388593|NCT00304278|4214528|B1||T4 stage of tumor|T stage of Tumor at diagnosis||Participants|Count of Participants|13|13.0||||||
4388594|NCT00304278|4214528|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4388595|NCT00304278|4214528|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4388596|NCT00304278|4214528|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4388597|NCT00304278|4214528|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388598|NCT00304278|4214528|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4388599|NCT00304278|4214528|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4388600|NCT00304278|4214528|B1|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
4388601|NCT00304278|4214528|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4388602|NCT00304278|4214528|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4388603|NCT00304278|4214528|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388604|NCT00304265|4214533|B3|Germany||Region of Enrollment||Participants|Number|215|215.0||||||
4388605|NCT00304265|4214534|B2|Germany||Region of Enrollment||Participants|Number|98|98.0||||||
4388606|NCT00304265|4214535|B1|Germany||Region of Enrollment||Participants|Number|117|117.0||||||
4388607|NCT00304265|4214533|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4388608|NCT00304265|4214534|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4388609|NCT00304265|4214535|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4388610|NCT00304265|4214533|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4388611|NCT00304265|4214534|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4388612|NCT00304265|4214535|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4388613|NCT00304265|4214533|B3|||Age||Years|Mean|12.4|12.4|Full Range|0|0.0|10.0|16.0|
4388614|NCT00304265|4214534|B2|||Age||Years|Mean|12.6|12.6|Full Range|0|0.0|10.0|16.0|
4388615|NCT00304265|4214535|B1|||Age||Years|Mean|12.3|12.3|Full Range|0|0.0|11.0|13.0|
4388616|NCT00304265|4214533|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388617|NCT00304265|4214534|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388618|NCT00304265|4214535|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388619|NCT00304265|4214533|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4388620|NCT00304265|4214534|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4388621|NCT00304265|4214535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4388622|NCT00304265|4214533|B3||<=18 years|Age||Participants|Count of Participants|215|215.0||||||
4388623|NCT00304265|4214534|B2||<=18 years|Age||Participants|Count of Participants|98|98.0||||||
4388624|NCT00304265|4214535|B1||<=18 years|Age||Participants|Count of Participants|117|117.0||||||
4388625|NCT00304187|4214542|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4388626|NCT00304187|4214543|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4388627|NCT00304187|4214544|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4388628|NCT00304187|4214542|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388629|NCT00304187|4214543|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388630|NCT00304187|4214544|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388631|NCT00304187|4214542|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4388632|NCT00304187|4214543|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4388633|NCT00304187|4214544|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4388634|NCT00304187|4214542|B3|||Age||years|Mean|24|24.0|Standard Deviation|3|3.0|||
4388635|NCT00304187|4214543|B2|||Age||years|Mean|24|24.0|Standard Deviation|3|3.0|||
4388636|NCT00304187|4214544|B1|||Age||years|Mean|24|24.0|Standard Deviation|3|3.0|||
4388637|NCT00304187|4214542|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388638|NCT00304187|4214543|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388639|NCT00304187|4214544|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388640|NCT00304187|4214542|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4388641|NCT00304187|4214543|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4388642|NCT00304187|4214544|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4388643|NCT00304187|4214542|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388644|NCT00304187|4214543|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388645|NCT00304187|4214544|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388646|NCT00304161|4214553|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4388647|NCT00304161|4214554|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4388648|NCT00304161|4214555|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4388649|NCT00304161|4214553|B3||Male|Gender||Participants|Count of Participants|36|36.0||||||
4388650|NCT00304161|4214554|B2||Male|Gender||Participants|Count of Participants|16|16.0||||||
4388651|NCT00304161|4214555|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
4388652|NCT00304161|4214553|B3||Female|Gender||Participants|Count of Participants|19|19.0||||||
4388653|NCT00304161|4214554|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
4388654|NCT00304161|4214555|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4388655|NCT00304161|4214553|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|10.5|10.5|||
4388656|NCT00304161|4214554|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|11.5|11.5|||
4388657|NCT00304161|4214555|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|9.5|9.5|||
4388658|NCT00304161|4214553|B3||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4388659|NCT00304161|4214554|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4388660|NCT00304161|4214555|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4388661|NCT00304161|4214553|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4388662|NCT00304161|4214554|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4388663|NCT00304161|4214555|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4388664|NCT00304161|4214553|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388665|NCT00304161|4214554|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388666|NCT00304161|4214555|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388667|NCT00304096|4214564|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4388668|NCT00304096|4214565|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4388669|NCT00304096|4214566|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4388670|NCT00304096|4214564|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388671|NCT00304096|4214565|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388672|NCT00304096|4214566|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388673|NCT00304096|4214564|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4388674|NCT00304096|4214565|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4388675|NCT00304096|4214566|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4388676|NCT00304096|4214564|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|10.13|10.13|||
4388677|NCT00304096|4214565|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|14.47|14.47|||
4388678|NCT00304096|4214566|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|5.75|5.75|||
4388679|NCT00304096|4214564|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4388680|NCT00304096|4214565|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4388681|NCT00304096|4214566|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388682|NCT00304096|4214564|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4388683|NCT00304096|4214565|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4388684|NCT00304096|4214566|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4388685|NCT00304096|4214564|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388686|NCT00304096|4214565|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388687|NCT00304096|4214566|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388688|NCT00304083|4214575|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|31|31.0||||||
4388689|NCT00304083|4214576|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|9|9.0||||||
4388690|NCT00304083|4214577|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|22|22.0||||||
4388691|NCT00304083|4214575|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|17|17.0||||||
4388692|NCT00304083|4214576|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
4388693|NCT00304083|4214577|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|12|12.0||||||
4388694|NCT00304083|4214575|B3|||Age||years|Median|36.5|36.5|Full Range|||8.0|72.0|
4388695|NCT00304083|4214576|B2|||Age||years|Median|40|40.0|Full Range|||13.0|72.0|
4388696|NCT00304083|4214577|B1|||Age||years|Median|33|33.0|Full Range|||8.0|66.0|
4388697|NCT00304070|4214594|B4|Brazil||Region of Enrollment||participants|Number|30|30.0||||||
4388698|NCT00304070|4214595|B3|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4388699|NCT00304070|4214596|B2|Brazil||Region of Enrollment||participants|Number|6|6.0||||||
4388700|NCT00304070|4214597|B1|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4388701|NCT00304070|4214594|B4|United States||Region of Enrollment||participants|Number|43|43.0||||||
4388702|NCT00304070|4214595|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4388703|NCT00304070|4214596|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4388704|NCT00304070|4214597|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4388705|NCT00304070|4214594|B4|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4388706|NCT00304070|4214595|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4388707|NCT00304070|4214596|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4388708|NCT00304070|4214597|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4388709|NCT00304070|4214594|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4388710|NCT00304070|4214595|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4388711|NCT00304070|4214596|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388712|NCT00304070|4214597|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4388713|NCT00304070|4214594|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388714|NCT00304070|4214595|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388715|NCT00304070|4214596|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388716|NCT00304070|4214597|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388717|NCT00304070|4214594|B4||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4388718|NCT00304070|4214595|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4388719|NCT00304070|4214596|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4388720|NCT00304070|4214597|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4388721|NCT00304070|4214594|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4388722|NCT00304070|4214595|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4388723|NCT00304070|4214596|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4388724|NCT00304070|4214597|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4388725|NCT00304070|4214594|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388726|NCT00304070|4214595|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388727|NCT00304070|4214596|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388728|NCT00304070|4214597|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388729|NCT00304070|4214594|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4388730|NCT00304070|4214595|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4388731|NCT00304070|4214596|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4388732|NCT00304070|4214597|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4388733|NCT00304070|4214594|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4388734|NCT00304070|4214595|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4388735|NCT00304070|4214596|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388736|NCT00304070|4214597|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4388737|NCT00304070|4214594|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4388738|NCT00304070|4214595|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4388739|NCT00304070|4214596|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388740|NCT00304070|4214597|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4388741|NCT00304070|4214594|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4388742|NCT00304070|4214595|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4388743|NCT00304070|4214596|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4388744|NCT00304070|4214597|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4388745|NCT00304070|4214594|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4388746|NCT00304070|4214595|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4388747|NCT00304070|4214596|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4388748|NCT00304070|4214597|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4388749|NCT00304070|4214594|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4388750|NCT00304070|4214595|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4388751|NCT00304070|4214596|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4388752|NCT00304070|4214597|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4388753|NCT00304070|4214594|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4388754|NCT00304070|4214595|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4388755|NCT00304070|4214596|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4388756|NCT00304070|4214597|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4388757|NCT00304070|4214594|B4|||Age||years|Mean|5|5.0|Full Range|||0.0|20.0|
4388758|NCT00304070|4214595|B3|||Age||years|Mean|7|7.0|Full Range|||0.0|20.0|
4388759|NCT00304070|4214596|B2|||Age||years|Mean|3|3.0|Full Range|||0.0|12.0|
4388760|NCT00304070|4214597|B1|||Age||years|Mean|2|2.0|Full Range|||0.0|12.0|
4388761|NCT00304031|4214611|B4||Male|Gender||Participants|Count of Participants|642|642.0||||||
4388762|NCT00304031|4214612|B3||Male|Gender||Participants|Count of Participants|237|237.0||||||
4388763|NCT00304031|4214613|B2||Male|Gender||Participants|Count of Participants|239|239.0||||||
4388764|NCT00304031|4214614|B1||Male|Gender||Participants|Count of Participants|166|166.0||||||
4388765|NCT00304031|4214611|B4||Female|Gender||Participants|Count of Participants|483|483.0||||||
4388766|NCT00304031|4214612|B3||Female|Gender||Participants|Count of Participants|185|185.0||||||
4388767|NCT00304031|4214613|B2||Female|Gender||Participants|Count of Participants|172|172.0||||||
4388768|NCT00304031|4214614|B1||Female|Gender||Participants|Count of Participants|126|126.0||||||
4388769|NCT00304031|4214611|B4|||Age||years|Median|58|58.0|Full Range|||21.0|87.0|
4388770|NCT00304031|4214612|B3|||Age||years|Median|58|58.0|Full Range|||21.0|84.0|
4388771|NCT00304031|4214613|B2|||Age||years|Median|57|57.0|Full Range|||22.0|84.0|
4388772|NCT00304031|4214614|B1|||Age||years|Median|60.5|60.5|Full Range|||22.0|87.0|
4388773|NCT00303979|4214623|B4|United States||Region of Enrollment||participants|Number|34810|34810.0||||||
4388774|NCT00303979|4214624|B3|United States||Region of Enrollment||participants|Number|9641|9641.0||||||
4388775|NCT00303979|4214625|B2|United States||Region of Enrollment||participants|Number|9992|9992.0||||||
4388776|NCT00303979|4214626|B1|United States||Region of Enrollment||participants|Number|15177|15177.0||||||
4388777|NCT00303979|4214623|B4|Missing||Sex/Gender, Customized||participants|Number|12|12.0||||||
4388778|NCT00303979|4214624|B3|Missing||Sex/Gender, Customized||participants|Number|0|0.0||||||
4388779|NCT00303979|4214625|B2|Missing||Sex/Gender, Customized||participants|Number|5|5.0||||||
4388780|NCT00303979|4214626|B1|Missing||Sex/Gender, Customized||participants|Number|7|7.0||||||
4388781|NCT00303979|4214623|B4|Male||Sex/Gender, Customized||participants|Number|24670|24670.0||||||
4388782|NCT00303979|4214624|B3|Male||Sex/Gender, Customized||participants|Number|6814|6814.0||||||
4388783|NCT00303979|4214625|B2|Male||Sex/Gender, Customized||participants|Number|7069|7069.0||||||
4388784|NCT00303979|4214626|B1|Male||Sex/Gender, Customized||participants|Number|10787|10787.0||||||
4388785|NCT00303979|4214623|B4|Female||Sex/Gender, Customized||participants|Number|10128|10128.0||||||
4388786|NCT00303979|4214624|B3|Female||Sex/Gender, Customized||participants|Number|2827|2827.0||||||
4388787|NCT00303979|4214625|B2|Female||Sex/Gender, Customized||participants|Number|2918|2918.0||||||
4388788|NCT00303979|4214626|B1|Female||Sex/Gender, Customized||participants|Number|4383|4383.0||||||
4388789|NCT00303979|4214623|B4|Missing||Age, Customized||participants|Number|32|32.0||||||
4388790|NCT00303979|4214624|B3|Missing||Age, Customized||participants|Number|3|3.0||||||
4388791|NCT00303979|4214625|B2|Missing||Age, Customized||participants|Number|1|1.0||||||
4388792|NCT00303979|4214626|B1|Missing||Age, Customized||participants|Number|28|28.0||||||
4388793|NCT00303979|4214623|B4|>76 years||Age, Customized||participants|Number|10799|10799.0||||||
4388794|NCT00303979|4214624|B3|>76 years||Age, Customized||participants|Number|3010|3010.0||||||
4388795|NCT00303979|4214625|B2|>76 years||Age, Customized||participants|Number|3041|3041.0||||||
4388796|NCT00303979|4214626|B1|>76 years||Age, Customized||participants|Number|4748|4748.0||||||
4388797|NCT00303979|4214623|B4|Between 64 and 76 years||Age, Customized||participants|Number|11560|11560.0||||||
4388798|NCT00303979|4214624|B3|Between 64 and 76 years||Age, Customized||participants|Number|3089|3089.0||||||
4388799|NCT00303979|4214625|B2|Between 64 and 76 years||Age, Customized||participants|Number|3344|3344.0||||||
4388800|NCT00303979|4214626|B1|Between 64 and 76 years||Age, Customized||participants|Number|5127|5127.0||||||
4388801|NCT00303979|4214623|B4|<=64 years||Age, Customized||participants|Number|12419|12419.0||||||
4388802|NCT00303979|4214624|B3|<=64 years||Age, Customized||participants|Number|3539|3539.0||||||
4388803|NCT00303979|4214625|B2|<=64 years||Age, Customized||participants|Number|3606|3606.0||||||
4388804|NCT00303979|4214626|B1|<=64 years||Age, Customized||participants|Number|5274|5274.0||||||
4388805|NCT00303979|4214623|B4|||Age||years|Mean|68.4|68.4|Standard Deviation|13.3|13.3|||
4388806|NCT00303979|4214624|B3|||Age||years|Mean|68.2|68.2|Standard Deviation|13.6|13.6|||
4388807|NCT00303979|4214625|B2|||Age||years|Mean|68.3|68.3|Standard Deviation|13.2|13.2|||
4388808|NCT00303979|4214626|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|13.2|13.2|||
4388809|NCT00303966|4214638|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4388810|NCT00303966|4214638|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4388811|NCT00303966|4214638|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4388812|NCT00303966|4214638|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|5.9|5.9|||
4388813|NCT00303953|4214647|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388814|NCT00303953|4214647|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388815|NCT00303953|4214647|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4388816|NCT00303953|4214647|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388817|NCT00303953|4214647|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388818|NCT00303953|4214647|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4388819|NCT00303953|4214647|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388820|NCT00303953|4214647|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4388821|NCT00303953|4214647|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4388822|NCT00303953|4214647|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4388823|NCT00303953|4214647|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4388824|NCT00303953|4214647|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4388825|NCT00303953|4214647|B1|||Age||years|Median|68.9|68.9|Full Range|||51.6|82.9|
4388826|NCT00303901|4214653|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4388827|NCT00303901|4214653|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4388828|NCT00303901|4214653|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4388829|NCT00303901|4214653|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4388830|NCT00303901|4214653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4388831|NCT00303901|4214653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388832|NCT00303862|4214658|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4388833|NCT00303862|4214658|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4388834|NCT00303862|4214658|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4388835|NCT00303862|4214658|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|11.0|11.0|||
4388836|NCT00303862|4214658|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4388837|NCT00303862|4214658|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4388838|NCT00303862|4214658|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388839|NCT00303823|4214665|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
4388840|NCT00303823|4214666|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4388841|NCT00303823|4214667|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4388842|NCT00303823|4214665|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388843|NCT00303823|4214666|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388844|NCT00303823|4214667|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4388845|NCT00303823|4214665|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4388846|NCT00303823|4214666|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4388847|NCT00303823|4214667|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4388848|NCT00303823|4214665|B3|||Age||years|Mean|28.28|28.28|Standard Deviation|8.39|8.39|||
4388849|NCT00303823|4214666|B2|||Age||years|Mean|28.27|28.27|Standard Deviation|8.05|8.05|||
4388850|NCT00303823|4214667|B1|||Age||years|Mean|28.48|28.48|Standard Deviation|8.78|8.78|||
4388851|NCT00303823|4214665|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388852|NCT00303823|4214666|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388853|NCT00303823|4214667|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388854|NCT00303823|4214665|B3||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4388855|NCT00303823|4214666|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4388856|NCT00303823|4214667|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4388857|NCT00303823|4214665|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388858|NCT00303823|4214666|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388859|NCT00303823|4214667|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388860|NCT00303667|4214680|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4388861|NCT00303667|4214681|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4388862|NCT00303667|4214682|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4388863|NCT00303667|4214680|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4388864|NCT00303667|4214681|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4388865|NCT00303667|4214682|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4388866|NCT00303667|4214680|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4388867|NCT00303667|4214681|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4388868|NCT00303667|4214682|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4388869|NCT00303667|4214680|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4388870|NCT00303667|4214681|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4388871|NCT00303667|4214682|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4388872|NCT00303667|4214680|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4388873|NCT00303667|4214681|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4388874|NCT00303667|4214682|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4388875|NCT00303667|4214680|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388876|NCT00303667|4214681|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388877|NCT00303667|4214682|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4388878|NCT00303628|4214705|B3||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4388879|NCT00303628|4214706|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4388880|NCT00303628|4214707|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4388881|NCT00303628|4214705|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4388882|NCT00303628|4214706|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4388883|NCT00303628|4214707|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4388884|NCT00303628|4214705|B3|||Age||Years|Median|53|53.0|Full Range|||21.0|80.0|
4388885|NCT00303628|4214706|B2|||Age||Years|Median|53|53.0|Full Range|||21.0|74.0|
4388886|NCT00303628|4214707|B1|||Age||Years|Median|54|54.0|Full Range|||22.0|80.0|
4388887|NCT00303602|4214724|B3|||Weight||kilograms|Mean|81.1|81.1|Standard Deviation|18.10|18.1|||
4388888|NCT00303602|4214725|B2|||Weight||kilograms|Mean|81.2|81.2|Standard Deviation|17.05|17.05|||
4388889|NCT00303602|4214726|B1|||Weight||kilograms|Mean|81.1|81.1|Standard Deviation|18.97|18.97|||
4388890|NCT00303602|4214724|B3|||Waist Circumference||centimeters|Mean|96.6|96.6|Standard Deviation|13.09|13.09|||
4388891|NCT00303602|4214725|B2|||Waist Circumference||centimeters|Mean|97.2|97.2|Standard Deviation|12.97|12.97|||
4388892|NCT00303602|4214726|B1|||Waist Circumference||centimeters|Mean|96.1|96.1|Standard Deviation|13.24|13.24|||
4388893|NCT00303602|4214724|B3|Emotional Regulation Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|17.5|17.5|Standard Deviation|3.95|3.95|||
4388894|NCT00303602|4214725|B2|Emotional Regulation Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|17.4|17.4|Standard Deviation|3.82|3.82|||
4388895|NCT00303602|4214726|B1|Emotional Regulation Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|17.6|17.6|Standard Deviation|4.07|4.07|||
4388896|NCT00303602|4214724|B3|Self-Control Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|17.1|17.1|Standard Deviation|3.76|3.76|||
4388897|NCT00303602|4214725|B2|Self-Control Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|17.3|17.3|Standard Deviation|4.15|4.15|||
4388898|NCT00303602|4214726|B1|Self-Control Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|17.0|17.0|Standard Deviation|3.45|3.45|||
4388899|NCT00303602|4214724|B3|Mental Functioning Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|16.7|16.7|Standard Deviation|4.09|4.09|||
4388900|NCT00303602|4214725|B2|Mental Functioning Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|16.7|16.7|Standard Deviation|4.20|4.2|||
4388901|NCT00303602|4214726|B1|Mental Functioning Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|16.7|16.7|Standard Deviation|4.02|4.02|||
4388902|NCT00303602|4214724|B3|Physical Functioning Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|17.1|17.1|Standard Deviation|3.41|3.41|||
4388903|NCT00303602|4214725|B2|Physical Functioning Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|17.2|17.2|Standard Deviation|3.26|3.26|||
4388904|NCT00303602|4214726|B1|Physical Functioning Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|17.0|17.0|Standard Deviation|3.53|3.53|||
4388905|NCT00303602|4214724|B3|Social Integration Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|17.0|17.0|Standard Deviation|4.19|4.19|||
4388906|NCT00303602|4214725|B2|Social Integration Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|17.0|17.0|Standard Deviation|3.97|3.97|||
4388907|NCT00303602|4214726|B1|Social Integration Subscale||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|17.0|17.0|Standard Deviation|4.38|4.38|||
4388908|NCT00303602|4214724|B3|Total Score||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|85.5|85.5|Standard Deviation|15.28|15.28|||
4389003|NCT00303602|4214726|B1|Mexico||Region of Enrollment||participants|Number|27|27.0||||||
4388909|NCT00303602|4214725|B2|Total Score||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|85.6|85.6|Standard Deviation|15.00|15.0|||
4388910|NCT00303602|4214726|B1|Total Score||Subjective Well-Being Under Neuroleptic Treatment - Short Form|Measures subjective well-being for previous 7 days. 20 items covering 5 health domains (subscales) (4 items each): emotional regulation, self-control, mental functioning, social integration, and physical functioning. Individual scores range from 1 (not at all) to 6 (very much). Subscale scores range from 4 to 24. Total score ranges from 20 to 120.|units on a scale|Mean|85.5|85.5|Standard Deviation|15.59|15.59|||
4388911|NCT00303602|4214724|B3|||Subjective Appetite (Visual Analog Scale)|Participant chooses where they think their appetite lies on a 10 centimeter line between two anchors (0 - very poor appetite and 10 - very strong appetite). The possible range of scores is 0 to 100 and represents millimeters on the 10 centimeter line.|units on a scale|Mean|63.9|63.9|Standard Deviation|20.16|20.16|||
4388912|NCT00303602|4214725|B2|||Subjective Appetite (Visual Analog Scale)|Participant chooses where they think their appetite lies on a 10 centimeter line between two anchors (0 - very poor appetite and 10 - very strong appetite). The possible range of scores is 0 to 100 and represents millimeters on the 10 centimeter line.|units on a scale|Mean|65.7|65.7|Standard Deviation|19.24|19.24|||
4388913|NCT00303602|4214726|B1|||Subjective Appetite (Visual Analog Scale)|Participant chooses where they think their appetite lies on a 10 centimeter line between two anchors (0 - very poor appetite and 10 - very strong appetite). The possible range of scores is 0 to 100 and represents millimeters on the 10 centimeter line.|units on a scale|Mean|62.5|62.5|Standard Deviation|20.85|20.85|||
4388914|NCT00303602|4214724|B3|||Height||centimeters|Mean|169.5|169.5|Standard Deviation|10.18|10.18|||
4388915|NCT00303602|4214725|B2|||Height||centimeters|Mean|168.9|168.9|Standard Deviation|10.23|10.23|||
4388916|NCT00303602|4214726|B1|||Height||centimeters|Mean|170.0|170.0|Standard Deviation|10.18|10.18|||
4388917|NCT00303602|4214724|B3|||Glycosylated Hemoglobin||percent|Mean|5.5|5.5|Standard Deviation|0.42|0.42|||
4388918|NCT00303602|4214725|B2|||Glycosylated Hemoglobin||percent|Mean|5.5|5.5|Standard Deviation|0.38|0.38|||
4388919|NCT00303602|4214726|B1|||Glycosylated Hemoglobin||percent|Mean|5.5|5.5|Standard Deviation|0.45|0.45|||
4388920|NCT00303602|4214724|B3|||Global Assessment of Functioning Scale|Measures physician's judgment of a patient's overall level of functioning. Ratings are based on a scale of 1 to 100, with the following classification range: 1-10 (severely impaired) to 91-100 (superior functioning).|units on a scale|Mean|63.0|63.0|Standard Deviation|12.60|12.6|||
4388921|NCT00303602|4214725|B2|||Global Assessment of Functioning Scale|Measures physician's judgment of a patient's overall level of functioning. Ratings are based on a scale of 1 to 100, with the following classification range: 1-10 (severely impaired) to 91-100 (superior functioning).|units on a scale|Mean|62.5|62.5|Standard Deviation|12.39|12.39|||
4388922|NCT00303602|4214726|B1|||Global Assessment of Functioning Scale|Measures physician's judgment of a patient's overall level of functioning. Ratings are based on a scale of 1 to 100, with the following classification range: 1-10 (severely impaired) to 91-100 (superior functioning).|units on a scale|Mean|63.4|63.4|Standard Deviation|12.82|12.82|||
4388923|NCT00303602|4214724|B3|Triglycerides||Fasting Lipoproteins||millimole/Liter|Mean|1.7|1.7|Standard Deviation|0.83|0.83|||
4388924|NCT00303602|4214725|B2|Triglycerides||Fasting Lipoproteins||millimole/Liter|Mean|1.7|1.7|Standard Deviation|0.90|0.9|||
4388925|NCT00303602|4214726|B1|Triglycerides||Fasting Lipoproteins||millimole/Liter|Mean|1.7|1.7|Standard Deviation|0.77|0.77|||
4388926|NCT00303602|4214724|B3|Low-Density Lipoprotein Cholesterol||Fasting Lipoproteins||millimole/Liter|Mean|3.1|3.1|Standard Deviation|0.84|0.84|||
4388927|NCT00303602|4214725|B2|Low-Density Lipoprotein Cholesterol||Fasting Lipoproteins||millimole/Liter|Mean|3.0|3.0|Standard Deviation|0.88|0.88|||
4388928|NCT00303602|4214726|B1|Low-Density Lipoprotein Cholesterol||Fasting Lipoproteins||millimole/Liter|Mean|3.1|3.1|Standard Deviation|0.81|0.81|||
4388929|NCT00303602|4214724|B3|High-Density Lipoprotein Cholesterol||Fasting Lipoproteins||millimole/Liter|Mean|1.3|1.3|Standard Deviation|0.37|0.37|||
4388930|NCT00303602|4214725|B2|High-Density Lipoprotein Cholesterol||Fasting Lipoproteins||millimole/Liter|Mean|1.3|1.3|Standard Deviation|0.34|0.34|||
4388931|NCT00303602|4214726|B1|High-Density Lipoprotein Cholesterol||Fasting Lipoproteins||millimole/Liter|Mean|1.2|1.2|Standard Deviation|0.40|0.4|||
4388932|NCT00303602|4214724|B3|Total Cholesterol||Fasting Lipoproteins||millimole/Liter|Mean|5.1|5.1|Standard Deviation|1.0|1.0|||
4388933|NCT00303602|4214725|B2|Total Cholesterol||Fasting Lipoproteins||millimole/Liter|Mean|5.1|5.1|Standard Deviation|1.01|1.01|||
4388934|NCT00303602|4214726|B1|Total Cholesterol||Fasting Lipoproteins||millimole/Liter|Mean|5.1|5.1|Standard Deviation|1.01|1.01|||
4388935|NCT00303602|4214724|B3|||Fasting Insulin||micro International Unit/milliliter|Mean|11.9|11.9|Standard Deviation|12.06|12.06|||
4388936|NCT00303602|4214725|B2|||Fasting Insulin||micro International Unit/milliliter|Mean|10.0|10.0|Standard Deviation|7.18|7.18|||
4388937|NCT00303602|4214726|B1|||Fasting Insulin||micro International Unit/milliliter|Mean|13.5|13.5|Standard Deviation|14.65|14.65|||
4388938|NCT00303602|4214724|B3|||Fasting Glucose||millimole/Liter|Mean|5.1|5.1|Standard Deviation|0.65|0.65|||
4388939|NCT00303602|4214725|B2|||Fasting Glucose||millimole/Liter|Mean|5.0|5.0|Standard Deviation|0.46|0.46|||
4388940|NCT00303602|4214726|B1|||Fasting Glucose||millimole/Liter|Mean|5.1|5.1|Standard Deviation|0.77|0.77|||
4388941|NCT00303602|4214724|B3|||Clinical Global Impression-Severity Scale|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients.|units on a scale|Mean|3.1|3.1|Standard Deviation|0.81|0.81|||
4388942|NCT00303602|4214725|B2|||Clinical Global Impression-Severity Scale|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients.|units on a scale|Mean|3.2|3.2|Standard Deviation|0.85|0.85|||
4389004|NCT00303602|4214724|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4388943|NCT00303602|4214726|B1|||Clinical Global Impression-Severity Scale|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients.|units on a scale|Mean|3.0|3.0|Standard Deviation|0.78|0.78|||
4388944|NCT00303602|4214724|B3|||Body Mass Index||kilograms/meters-squared|Mean|28.1|28.1|Standard Deviation|5.26|5.26|||
4388945|NCT00303602|4214725|B2|||Body Mass Index||kilograms/meters-squared|Mean|28.3|28.3|Standard Deviation|4.76|4.76|||
4388946|NCT00303602|4214726|B1|||Body Mass Index||kilograms/meters-squared|Mean|28.0|28.0|Standard Deviation|5.63|5.63|||
4388947|NCT00303602|4214724|B3|Diastolic Blood Pressure||Blood Pressure||mm Hg|Mean|76.8|76.8|Standard Deviation|9.43|9.43|||
4388948|NCT00303602|4214725|B2|Diastolic Blood Pressure||Blood Pressure||mm Hg|Mean|75.8|75.8|Standard Deviation|9.15|9.15|||
4388949|NCT00303602|4214726|B1|Diastolic Blood Pressure||Blood Pressure||mm Hg|Mean|77.6|77.6|Standard Deviation|9.62|9.62|||
4388950|NCT00303602|4214724|B3|Systolic Blood Pressure||Blood Pressure||mm Hg|Mean|119.7|119.7|Standard Deviation|14.82|14.82|||
4388951|NCT00303602|4214725|B2|Systolic Blood Pressure||Blood Pressure||mm Hg|Mean|119.0|119.0|Standard Deviation|12.49|12.49|||
4388952|NCT00303602|4214726|B1|Systolic Blood Pressure||Blood Pressure||mm Hg|Mean|120.3|120.3|Standard Deviation|16.45|16.45|||
4388953|NCT00303602|4214724|B3|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4388954|NCT00303602|4214725|B2|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4388955|NCT00303602|4214726|B1|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4388956|NCT00303602|4214724|B3|Hispanic||Race/Ethnicity||participants|Number|50|50.0||||||
4388957|NCT00303602|4214725|B2|Hispanic||Race/Ethnicity||participants|Number|23|23.0||||||
4388958|NCT00303602|4214726|B1|Hispanic||Race/Ethnicity||participants|Number|27|27.0||||||
4388959|NCT00303602|4214724|B3|First Nations||Race/Ethnicity||participants|Number|2|2.0||||||
4388960|NCT00303602|4214725|B2|First Nations||Race/Ethnicity||participants|Number|0|0.0||||||
4388961|NCT00303602|4214726|B1|First Nations||Race/Ethnicity||participants|Number|2|2.0||||||
4388962|NCT00303602|4214724|B3|East/Southeast Asian||Race/Ethnicity||participants|Number|3|3.0||||||
4388963|NCT00303602|4214725|B2|East/Southeast Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4388964|NCT00303602|4214726|B1|East/Southeast Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4388965|NCT00303602|4214724|B3|Caucasian||Race/Ethnicity||participants|Number|78|78.0||||||
4388966|NCT00303602|4214725|B2|Caucasian||Race/Ethnicity||participants|Number|36|36.0||||||
4388967|NCT00303602|4214726|B1|Caucasian||Race/Ethnicity||participants|Number|42|42.0||||||
4388968|NCT00303602|4214724|B3|African Descent||Race/Ethnicity||participants|Number|15|15.0||||||
4388969|NCT00303602|4214725|B2|African Descent||Race/Ethnicity||participants|Number|4|4.0||||||
4388970|NCT00303602|4214726|B1|African Descent||Race/Ethnicity||participants|Number|11|11.0||||||
4388971|NCT00303602|4214724|B3|Bipolar disorder||Psychiatric Illness||participants|Number|41|41.0||||||
4388972|NCT00303602|4214725|B2|Bipolar disorder||Psychiatric Illness||participants|Number|14|14.0||||||
4388973|NCT00303602|4214726|B1|Bipolar disorder||Psychiatric Illness||participants|Number|27|27.0||||||
4388974|NCT00303602|4214724|B3|Other related psychiatric disorder||Psychiatric Illness||participants|Number|2|2.0||||||
4388975|NCT00303602|4214725|B2|Other related psychiatric disorder||Psychiatric Illness||participants|Number|1|1.0||||||
4388976|NCT00303602|4214726|B1|Other related psychiatric disorder||Psychiatric Illness||participants|Number|1|1.0||||||
4388977|NCT00303602|4214724|B3|Schizoaffective disorder||Psychiatric Illness||participants|Number|15|15.0||||||
4388978|NCT00303602|4214725|B2|Schizoaffective disorder||Psychiatric Illness||participants|Number|12|12.0||||||
4388979|NCT00303602|4214726|B1|Schizoaffective disorder||Psychiatric Illness||participants|Number|3|3.0||||||
4388980|NCT00303602|4214724|B3|Schizophreniform||Psychiatric Illness||participants|Number|9|9.0||||||
4388981|NCT00303602|4214725|B2|Schizophreniform||Psychiatric Illness||participants|Number|2|2.0||||||
4388982|NCT00303602|4214726|B1|Schizophreniform||Psychiatric Illness||participants|Number|7|7.0||||||
4388983|NCT00303602|4214724|B3|Schizophrenia||Psychiatric Illness||participants|Number|82|82.0||||||
4388984|NCT00303602|4214725|B2|Schizophrenia||Psychiatric Illness||participants|Number|36|36.0||||||
4388985|NCT00303602|4214726|B1|Schizophrenia||Psychiatric Illness||participants|Number|46|46.0||||||
4388986|NCT00303602|4214724|B3|Unknown||Presence of Metabolic Syndrome||participants|Number|2|2.0||||||
4388987|NCT00303602|4214725|B2|Unknown||Presence of Metabolic Syndrome||participants|Number|0|0.0||||||
4388988|NCT00303602|4214726|B1|Unknown||Presence of Metabolic Syndrome||participants|Number|2|2.0||||||
4388989|NCT00303602|4214724|B3|Yes||Presence of Metabolic Syndrome||participants|Number|34|34.0||||||
4388990|NCT00303602|4214725|B2|Yes||Presence of Metabolic Syndrome||participants|Number|16|16.0||||||
4388991|NCT00303602|4214726|B1|Yes||Presence of Metabolic Syndrome||participants|Number|18|18.0||||||
4388992|NCT00303602|4214724|B3|No||Presence of Metabolic Syndrome||participants|Number|113|113.0||||||
4388993|NCT00303602|4214725|B2|No||Presence of Metabolic Syndrome||participants|Number|49|49.0||||||
4388994|NCT00303602|4214726|B1|No||Presence of Metabolic Syndrome||participants|Number|64|64.0||||||
4388995|NCT00303602|4214724|B3|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4388996|NCT00303602|4214725|B2|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4388997|NCT00303602|4214726|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4388998|NCT00303602|4214724|B3|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4388999|NCT00303602|4214725|B2|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4389000|NCT00303602|4214726|B1|Canada||Region of Enrollment||participants|Number|29|29.0||||||
4389001|NCT00303602|4214724|B3|Mexico||Region of Enrollment||participants|Number|50|50.0||||||
4389002|NCT00303602|4214725|B2|Mexico||Region of Enrollment||participants|Number|23|23.0||||||
4389005|NCT00303602|4214725|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4389006|NCT00303602|4214726|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4389007|NCT00303602|4214724|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4389008|NCT00303602|4214725|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4389009|NCT00303602|4214726|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4389010|NCT00303602|4214724|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4389011|NCT00303602|4214725|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4389012|NCT00303602|4214726|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4389013|NCT00303602|4214724|B3|||Age||years|Mean|38.6|38.6|Standard Deviation|12.7|12.7|||
4389014|NCT00303602|4214725|B2|||Age||years|Mean|38.7|38.7|Standard Deviation|12.23|12.23|||
4389015|NCT00303602|4214726|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|13.13|13.13|||
4389016|NCT00303511|4214767|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4389017|NCT00303511|4214767|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4389018|NCT00303511|4214767|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4389019|NCT00303511|4214767|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|5|5.0|||
4389020|NCT00303511|4214767|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389021|NCT00303511|4214767|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4389022|NCT00303511|4214767|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389023|NCT00303485|4214771|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389024|NCT00303485|4214772|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389025|NCT00303485|4214773|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389026|NCT00303485|4214771|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4389027|NCT00303485|4214772|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4389028|NCT00303485|4214773|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4389029|NCT00303485|4214771|B3|||Age||Years|Mean|64.0|64.0|Standard Deviation|8.54|8.54|||
4389030|NCT00303485|4214772|B2|||Age||Years|Mean|63.0|63.0|Standard Deviation|8.41|8.41|||
4389031|NCT00303485|4214773|B1|||Age||Years|Mean|64.3|64.3|Standard Deviation|8.64|8.64|||
4389032|NCT00303472|4214798|B8|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4389033|NCT00303472|4214799|B7|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4389034|NCT00303472|4214800|B6|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4389035|NCT00303472|4214801|B5|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4389036|NCT00303472|4214802|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389037|NCT00303472|4214803|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389038|NCT00303472|4214804|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389039|NCT00303472|4214805|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389040|NCT00303472|4214798|B8|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389041|NCT00303472|4214799|B7|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389042|NCT00303472|4214800|B6|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389043|NCT00303472|4214801|B5|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389044|NCT00303472|4214802|B4|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389045|NCT00303472|4214803|B3|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389046|NCT00303472|4214804|B2|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389047|NCT00303472|4214805|B1|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389048|NCT00303472|4214798|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389049|NCT00303472|4214799|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389050|NCT00303472|4214800|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389051|NCT00303472|4214801|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389052|NCT00303472|4214802|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389053|NCT00303472|4214803|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389054|NCT00303472|4214804|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389055|NCT00303472|4214805|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389056|NCT00303472|4214798|B8|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389057|NCT00303472|4214799|B7|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389058|NCT00303472|4214800|B6|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389059|NCT00303472|4214801|B5|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389060|NCT00303472|4214802|B4|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389061|NCT00303472|4214803|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389062|NCT00303472|4214804|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389063|NCT00303472|4214805|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389064|NCT00303472|4214798|B8|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4389065|NCT00303472|4214799|B7|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389066|NCT00303472|4214800|B6|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389067|NCT00303472|4214801|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389068|NCT00303472|4214802|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389069|NCT00303472|4214803|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4389070|NCT00303472|4214804|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389071|NCT00303472|4214805|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389072|NCT00303472|4214798|B8|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4389073|NCT00303472|4214799|B7|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389074|NCT00303472|4214800|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389075|NCT00303472|4214801|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389076|NCT00303472|4214802|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4389077|NCT00303472|4214803|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389078|NCT00303472|4214804|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389079|NCT00303472|4214805|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4389080|NCT00303472|4214798|B8|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4389081|NCT00303472|4214799|B7|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389082|NCT00303472|4214800|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4389083|NCT00303472|4214801|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389084|NCT00303472|4214802|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4389085|NCT00303472|4214803|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389086|NCT00303472|4214804|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389087|NCT00303472|4214805|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4389088|NCT00303472|4214798|B8|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
4389089|NCT00303472|4214799|B7|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4389090|NCT00303472|4214800|B6|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4389091|NCT00303472|4214801|B5|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4389092|NCT00303472|4214802|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4389093|NCT00303472|4214803|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4389094|NCT00303472|4214804|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4389095|NCT00303472|4214805|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4389096|NCT00303472|4214798|B8||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4389097|NCT00303472|4214799|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4389098|NCT00303472|4214800|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4389099|NCT00303472|4214801|B5||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4389100|NCT00303472|4214802|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4389101|NCT00303472|4214803|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4389102|NCT00303472|4214804|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4389103|NCT00303472|4214805|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4389104|NCT00303472|4214798|B8||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4389105|NCT00303472|4214799|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4389106|NCT00303472|4214800|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4389107|NCT00303472|4214801|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4389108|NCT00303472|4214802|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4389109|NCT00303472|4214803|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4389110|NCT00303472|4214804|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4389111|NCT00303472|4214805|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389112|NCT00303472|4214798|B8|||Age||Years|Mean|70.7|70.7|Standard Deviation|10.6|10.6|||
4389113|NCT00303472|4214799|B7|||Age||Years|Mean|72.2|72.2|Standard Deviation|4.3|4.3|||
4389114|NCT00303472|4214800|B6|||Age||Years|Mean|72.1|72.1|Standard Deviation|9.9|9.9|||
4389115|NCT00303472|4214801|B5|||Age||Years|Mean|69.4|69.4|Standard Deviation|6.3|6.3|||
4389116|NCT00303472|4214802|B4|||Age||Years|Mean|68.9|68.9|Standard Deviation|13.8|13.8|||
4389117|NCT00303472|4214803|B3|||Age||Years|Mean|70.9|70.9|Standard Deviation|14.2|14.2|||
4389118|NCT00303472|4214804|B2|||Age||Years|Mean|68.2|68.2|Standard Deviation|10.2|10.2|||
4389119|NCT00303472|4214805|B1|||Age||Years|Mean|77.5|77.5|Standard Deviation|3.3|3.3|||
4389120|NCT00303459|4214869|B3|United States||Region of Enrollment||participants|Number|156|156.0||||||
4389121|NCT00303459|4214870|B2|United States||Region of Enrollment||participants|Number|83|83.0||||||
4389122|NCT00303459|4214871|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4389123|NCT00303459|4214869|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4389124|NCT00303459|4214870|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4389125|NCT00303459|4214871|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4389126|NCT00303459|4214869|B3|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
4389422|NCT00302848|4215078|B3|Male||Gender||participants|Number|0|0.0||||||
4389127|NCT00303459|4214870|B2|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4389128|NCT00303459|4214871|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4389129|NCT00303459|4214869|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4389130|NCT00303459|4214870|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4389131|NCT00303459|4214871|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4389132|NCT00303459|4214869|B3|Slovakia||Region of Enrollment||participants|Number|7|7.0||||||
4389133|NCT00303459|4214870|B2|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
4389134|NCT00303459|4214871|B1|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
4389135|NCT00303459|4214869|B3|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
4389136|NCT00303459|4214870|B2|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
4389137|NCT00303459|4214871|B1|Saudi Arabia||Region of Enrollment||participants|Number|0|0.0||||||
4389138|NCT00303459|4214869|B3|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4389139|NCT00303459|4214870|B2|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
4389140|NCT00303459|4214871|B1|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4389141|NCT00303459|4214869|B3|Greece||Region of Enrollment||participants|Number|9|9.0||||||
4389142|NCT00303459|4214870|B2|Greece||Region of Enrollment||participants|Number|5|5.0||||||
4389143|NCT00303459|4214871|B1|Greece||Region of Enrollment||participants|Number|4|4.0||||||
4389144|NCT00303459|4214869|B3|Germany||Region of Enrollment||participants|Number|41|41.0||||||
4389145|NCT00303459|4214870|B2|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4389146|NCT00303459|4214871|B1|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4389147|NCT00303459|4214869|B3|Denmark||Region of Enrollment||participants|Number|7|7.0||||||
4389148|NCT00303459|4214870|B2|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4389149|NCT00303459|4214871|B1|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4389150|NCT00303459|4214869|B3|Czech Republic||Region of Enrollment||participants|Number|27|27.0||||||
4389151|NCT00303459|4214870|B2|Czech Republic||Region of Enrollment||participants|Number|15|15.0||||||
4389152|NCT00303459|4214871|B1|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4389153|NCT00303459|4214869|B3|Brazil||Region of Enrollment||participants|Number|71|71.0||||||
4389154|NCT00303459|4214870|B2|Brazil||Region of Enrollment||participants|Number|35|35.0||||||
4389155|NCT00303459|4214871|B1|Brazil||Region of Enrollment||participants|Number|36|36.0||||||
4389156|NCT00303459|4214869|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4389157|NCT00303459|4214870|B2|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4389158|NCT00303459|4214871|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4389159|NCT00303459|4214869|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4389160|NCT00303459|4214870|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4389161|NCT00303459|4214871|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4389162|NCT00303459|4214869|B3|Black||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4389163|NCT00303459|4214870|B2|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4389164|NCT00303459|4214871|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4389165|NCT00303459|4214869|B3|Caucasian/White||Race/Ethnicity, Customized||participants|Number|296|296.0||||||
4389166|NCT00303459|4214870|B2|Caucasian/White||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
4389167|NCT00303459|4214871|B1|Caucasian/White||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
4389168|NCT00303459|4214869|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4389169|NCT00303459|4214870|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4389170|NCT00303459|4214871|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4389171|NCT00303459|4214869|B3||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4389172|NCT00303459|4214870|B2||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4389173|NCT00303459|4214871|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4389174|NCT00303459|4214869|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|15.60|15.6|||
4389175|NCT00303459|4214870|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|15.73|15.73|||
4389176|NCT00303459|4214871|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|15.44|15.44|||
4389177|NCT00303446|4214896|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4389178|NCT00303446|4214897|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4389179|NCT00303446|4214898|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4389180|NCT00303446|4214896|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4389181|NCT00303446|4214897|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4389182|NCT00303446|4214898|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4389183|NCT00303446|4214896|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389184|NCT00303446|4214897|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389185|NCT00303446|4214898|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389186|NCT00303446|4214896|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|9.5|9.5|||
4389187|NCT00303446|4214897|B2|||Age||years|Mean|51.9|51.9|Standard Deviation|10.5|10.5|||
4389188|NCT00303446|4214898|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|9.2|9.2|||
4389189|NCT00303446|4214896|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4389190|NCT00303446|4214897|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4389191|NCT00303446|4214898|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4389192|NCT00303446|4214896|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4389193|NCT00303446|4214897|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4389194|NCT00303446|4214898|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4389195|NCT00303446|4214896|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389196|NCT00303446|4214897|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389197|NCT00303446|4214898|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389198|NCT00303329|4214933|B3|Italy||Region of Enrollment||participants|Number|57|57.0||||||
4389199|NCT00303329|4214934|B2|Italy||Region of Enrollment||participants|Number|26|26.0||||||
4389200|NCT00303329|4214935|B1|Italy||Region of Enrollment||participants|Number|31|31.0||||||
4389201|NCT00303329|4214933|B3|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4389202|NCT00303329|4214934|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4389203|NCT00303329|4214935|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4389204|NCT00303329|4214933|B3|Germany||Region of Enrollment||participants|Number|25|25.0||||||
4389205|NCT00303329|4214934|B2|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4389206|NCT00303329|4214935|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4389207|NCT00303329|4214933|B3|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4389208|NCT00303329|4214934|B2|Belgium||Region of Enrollment||participants|Number|12|12.0||||||
4389209|NCT00303329|4214935|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4389210|NCT00303329|4214933|B3|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4389211|NCT00303329|4214934|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4389212|NCT00303329|4214935|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4389213|NCT00303329|4214933|B3|France||Region of Enrollment||participants|Number|20|20.0||||||
4389214|NCT00303329|4214934|B2|France||Region of Enrollment||participants|Number|11|11.0||||||
4389215|NCT00303329|4214935|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4389216|NCT00303329|4214933|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4389217|NCT00303329|4214934|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4389218|NCT00303329|4214935|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4389219|NCT00303329|4214933|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4389220|NCT00303329|4214934|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4389221|NCT00303329|4214935|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4389222|NCT00303329|4214933|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4389223|NCT00303329|4214934|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4389224|NCT00303329|4214935|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4389225|NCT00303329|4214933|B3|>=65 years||Age, Customized||participants|Number|30|30.0||||||
4389226|NCT00303329|4214934|B2|>=65 years||Age, Customized||participants|Number|30|30.0||||||
4389227|NCT00303329|4214935|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4389228|NCT00303329|4214933|B3|Between 50 and 64 years||Age, Customized||participants|Number|20|20.0||||||
4389229|NCT00303329|4214934|B2|Between 50 and 64 years||Age, Customized||participants|Number|19|19.0||||||
4389230|NCT00303329|4214935|B1|Between 50 and 64 years||Age, Customized||participants|Number|1|1.0||||||
4389231|NCT00303329|4214933|B3|Between 16 and 49 years||Age, Customized||participants|Number|99|99.0||||||
4389232|NCT00303329|4214934|B2|Between 16 and 49 years||Age, Customized||participants|Number|30|30.0||||||
4389233|NCT00303329|4214935|B1|Between 16 and 49 years||Age, Customized||participants|Number|69|69.0||||||
4389234|NCT00303329|4214933|B3|Between 12 and 15 years||Age, Customized||participants|Number|13|13.0||||||
4389235|NCT00303329|4214934|B2|Between 12 and 15 years||Age, Customized||participants|Number|5|5.0||||||
4389236|NCT00303329|4214935|B1|Between 12 and 15 years||Age, Customized||participants|Number|8|8.0||||||
4389237|NCT00303329|4214933|B3|Between 6 and 11 years||Age, Customized||participants|Number|11|11.0||||||
4389238|NCT00303329|4214934|B2|Between 6 and 11 years||Age, Customized||participants|Number|6|6.0||||||
4389239|NCT00303329|4214935|B1|Between 6 and 11 years||Age, Customized||participants|Number|5|5.0||||||
4389240|NCT00303329|4214933|B3|<6 years||Age, Customized||participants|Number|11|11.0||||||
4389241|NCT00303329|4214934|B2|<6 years||Age, Customized||participants|Number|9|9.0||||||
4389242|NCT00303329|4214935|B1|<6 years||Age, Customized||participants|Number|2|2.0||||||
4389243|NCT00303329|4214933|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|22.4|22.4|||
4389244|NCT00303329|4214934|B2|||Age||years|Mean|43.7|43.7|Standard Deviation|26.13|26.13|||
4389245|NCT00303329|4214935|B1|||Age||years|Mean|24.7|24.7|Standard Deviation|10.03|10.03|||
4389246|NCT00303316|4214948|B3|Argentina||Region of Enrollment||Participants|Number|458|458.0||||||
4389247|NCT00303316|4214949|B2|Argentina||Region of Enrollment||Participants|Number|226|226.0||||||
4389248|NCT00303316|4214950|B1|Argentina||Region of Enrollment||Participants|Number|232|232.0||||||
4389249|NCT00303316|4214948|B3||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4389250|NCT00303316|4214949|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4389251|NCT00303316|4214950|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4389252|NCT00303316|4214948|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4389253|NCT00303316|4214949|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4389423|NCT00302848|4215079|B2|Male||Gender||participants|Number|0|0.0||||||
4389254|NCT00303316|4214950|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4389255|NCT00303316|4214948|B3|||Age||Months|Mean|17.6|17.6|Standard Deviation|0.465|0.465|||
4389256|NCT00303316|4214949|B2|||Age||Months|Mean|17.7|17.7|Standard Deviation|0.492|0.492|||
4389257|NCT00303316|4214950|B1|||Age||Months|Mean|17.6|17.6|Standard Deviation|0.436|0.436|||
4389258|NCT00303316|4214948|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389259|NCT00303316|4214949|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389260|NCT00303316|4214950|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389261|NCT00303316|4214948|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4389262|NCT00303316|4214949|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4389263|NCT00303316|4214950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4389264|NCT00303316|4214948|B3||<=18 years|Age||Participants|Count of Participants|458|458.0||||||
4389265|NCT00303316|4214949|B2||<=18 years|Age||Participants|Count of Participants|226|226.0||||||
4389266|NCT00303316|4214950|B1||<=18 years|Age||Participants|Count of Participants|232|232.0||||||
4389267|NCT00303186|4214963|B1|Indirect costs||Mean Cost per Participant per Month|Overall cost was evaluated to quantify burden of Refractory PsA and its treatment, resources absorbed by disease and its care into monetary terms. Overall cost = sum of direct costs (pharmacological treatment; hospitalizations; diagnostic examinations, laboratory analysis and specialist visits; transports) and indirect costs (productivity losses).|Euro/participant-month|Mean|96.05|96.05|Standard Deviation|260.85|260.85|||
4389268|NCT00303186|4214963|B1|Transports||Mean Cost per Participant per Month|Overall cost was evaluated to quantify burden of Refractory PsA and its treatment, resources absorbed by disease and its care into monetary terms. Overall cost = sum of direct costs (pharmacological treatment; hospitalizations; diagnostic examinations, laboratory analysis and specialist visits; transports) and indirect costs (productivity losses).|Euro/participant-month|Mean|9.96|9.96|Standard Deviation|16.03|16.03|||
4389269|NCT00303186|4214963|B1|Diagnostic, laboratory, specialist visits||Mean Cost per Participant per Month|Overall cost was evaluated to quantify burden of Refractory PsA and its treatment, resources absorbed by disease and its care into monetary terms. Overall cost = sum of direct costs (pharmacological treatment; hospitalizations; diagnostic examinations, laboratory analysis and specialist visits; transports) and indirect costs (productivity losses).|Euro/participant-month|Mean|14.12|14.12|Standard Deviation|22.70|22.7|||
4389270|NCT00303186|4214963|B1|Hospitalizations||Mean Cost per Participant per Month|Overall cost was evaluated to quantify burden of Refractory PsA and its treatment, resources absorbed by disease and its care into monetary terms. Overall cost = sum of direct costs (pharmacological treatment; hospitalizations; diagnostic examinations, laboratory analysis and specialist visits; transports) and indirect costs (productivity losses).|Euro/participant-month|Mean|27.92|27.92|Standard Deviation|104.56|104.56|||
4389271|NCT00303186|4214963|B1|Pharmacological treatment||Mean Cost per Participant per Month|Overall cost was evaluated to quantify burden of Refractory PsA and its treatment, resources absorbed by disease and its care into monetary terms. Overall cost = sum of direct costs (pharmacological treatment; hospitalizations; diagnostic examinations, laboratory analysis and specialist visits; transports) and indirect costs (productivity losses).|Euro/participant-month|Mean|105.14|105.14|Standard Deviation|160.53|160.53|||
4389272|NCT00303186|4214963|B1|Overall||Mean Cost per Participant per Month|Overall cost was evaluated to quantify burden of Refractory PsA and its treatment, resources absorbed by disease and its care into monetary terms. Overall cost = sum of direct costs (pharmacological treatment; hospitalizations; diagnostic examinations, laboratory analysis and specialist visits; transports) and indirect costs (productivity losses).|Euro/participant-month|Mean|253.20|253.2|Standard Deviation|324.19|324.19|||
4389273|NCT00303186|4214963|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4389274|NCT00303186|4214963|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4389275|NCT00303186|4214963|B1|||Age||years|Mean|49.68|49.68|Standard Deviation|11.7|11.7|||
4389276|NCT00303108|4214994|B4|United States||Region of Enrollment||participants|Number|136|136.0||||||
4389277|NCT00303108|4214995|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4389278|NCT00303108|4214996|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4389279|NCT00303108|4214997|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4389280|NCT00303108|4214994|B4|Hawaiian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4389281|NCT00303108|4214995|B3|Hawaiian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4389282|NCT00303108|4214996|B2|Hawaiian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4389283|NCT00303108|4214997|B1|Hawaiian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4389284|NCT00303108|4214994|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4389285|NCT00303108|4214995|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4389286|NCT00303108|4214996|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4389287|NCT00303108|4214997|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4389288|NCT00303108|4214994|B4|Black||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4389289|NCT00303108|4214995|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4389290|NCT00303108|4214996|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4389291|NCT00303108|4214997|B1|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4389292|NCT00303108|4214994|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4389293|NCT00303108|4214995|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4389294|NCT00303108|4214996|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4389295|NCT00303108|4214997|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4389296|NCT00303108|4214994|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4389424|NCT00302848|4215080|B1|Male||Gender||participants|Number|0|0.0||||||
4389297|NCT00303108|4214995|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389298|NCT00303108|4214996|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389299|NCT00303108|4214997|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4389300|NCT00303108|4214994|B4||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4389301|NCT00303108|4214995|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4389302|NCT00303108|4214996|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4389303|NCT00303108|4214997|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4389304|NCT00303108|4214994|B4|||Age||years|Median|56.4|56.4|Full Range|||28.0|84.9|
4389305|NCT00303108|4214995|B3|||Age||years|Median|54.1|54.1|Full Range|||29.0|77.6|
4389306|NCT00303108|4214996|B2|||Age||years|Median|51.7|51.7|Full Range|||29.8|72.3|
4389307|NCT00303108|4214997|B1|||Age||years|Median|61.0|61.0|Full Range|||28.0|84.9|
4389308|NCT00303069|4215015|B5|White||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4389309|NCT00303069|4215016|B4|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4389310|NCT00303069|4215017|B3|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4389311|NCT00303069|4215018|B2|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4389312|NCT00303069|4215019|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4389313|NCT00303069|4215015|B5|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4389314|NCT00303069|4215016|B4|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4389315|NCT00303069|4215017|B3|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4389316|NCT00303069|4215018|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4389317|NCT00303069|4215019|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4389318|NCT00303069|4215015|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4389319|NCT00303069|4215016|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4389320|NCT00303069|4215017|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4389321|NCT00303069|4215018|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4389322|NCT00303069|4215019|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4389323|NCT00303069|4215015|B5|Hispanic-American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4389324|NCT00303069|4215016|B4|Hispanic-American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4389325|NCT00303069|4215017|B3|Hispanic-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4389326|NCT00303069|4215018|B2|Hispanic-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4389327|NCT00303069|4215019|B1|Hispanic-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4389328|NCT00303069|4215015|B5|Black||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4389329|NCT00303069|4215016|B4|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4389330|NCT00303069|4215017|B3|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4389331|NCT00303069|4215018|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4389332|NCT00303069|4215019|B1|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4389333|NCT00303069|4215015|B5|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4389334|NCT00303069|4215016|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4389335|NCT00303069|4215017|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4389336|NCT00303069|4215018|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4389337|NCT00303069|4215019|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4389338|NCT00303069|4215015|B5||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4389339|NCT00303069|4215016|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4389340|NCT00303069|4215017|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4389341|NCT00303069|4215018|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4389342|NCT00303069|4215019|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4389343|NCT00303069|4215015|B5||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4389344|NCT00303069|4215016|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4389345|NCT00303069|4215017|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4389346|NCT00303069|4215018|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4389347|NCT00303069|4215019|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4389348|NCT00303069|4215015|B5|Over 55 years of age||Age, Customized||participants|Number|0|0.0||||||
4389349|NCT00303069|4215016|B4|Over 55 years of age||Age, Customized||participants|Number|0|0.0||||||
4389350|NCT00303069|4215017|B3|Over 55 years of age||Age, Customized||participants|Number|0|0.0||||||
4389351|NCT00303069|4215018|B2|Over 55 years of age||Age, Customized||participants|Number|0|0.0||||||
4389352|NCT00303069|4215019|B1|Over 55 years of age||Age, Customized||participants|Number|0|0.0||||||
4389353|NCT00303069|4215015|B5|50 to 55 years of age||Age, Customized||participants|Number|18|18.0||||||
4389354|NCT00303069|4215016|B4|50 to 55 years of age||Age, Customized||participants|Number|5|5.0||||||
4389355|NCT00303069|4215017|B3|50 to 55 years of age||Age, Customized||participants|Number|3|3.0||||||
4389356|NCT00303069|4215018|B2|50 to 55 years of age||Age, Customized||participants|Number|7|7.0||||||
4389357|NCT00303069|4215019|B1|50 to 55 years of age||Age, Customized||participants|Number|3|3.0||||||
4389358|NCT00303069|4215015|B5|40 to 49 years of age||Age, Customized||participants|Number|41|41.0||||||
4389359|NCT00303069|4215016|B4|40 to 49 years of age||Age, Customized||participants|Number|11|11.0||||||
4389360|NCT00303069|4215017|B3|40 to 49 years of age||Age, Customized||participants|Number|11|11.0||||||
4389361|NCT00303069|4215018|B2|40 to 49 years of age||Age, Customized||participants|Number|8|8.0||||||
4389362|NCT00303069|4215019|B1|40 to 49 years of age||Age, Customized||participants|Number|11|11.0||||||
4389363|NCT00303069|4215015|B5|30 to 39 years of age||Age, Customized||participants|Number|32|32.0||||||
4389364|NCT00303069|4215016|B4|30 to 39 years of age||Age, Customized||participants|Number|5|5.0||||||
4389365|NCT00303069|4215017|B3|30 to 39 years of age||Age, Customized||participants|Number|12|12.0||||||
4389366|NCT00303069|4215018|B2|30 to 39 years of age||Age, Customized||participants|Number|8|8.0||||||
4389367|NCT00303069|4215019|B1|30 to 39 years of age||Age, Customized||participants|Number|7|7.0||||||
4389368|NCT00303069|4215015|B5|18 to 29 years of age||Age, Customized||participants|Number|33|33.0||||||
4389369|NCT00303069|4215016|B4|18 to 29 years of age||Age, Customized||participants|Number|10|10.0||||||
4389370|NCT00303069|4215017|B3|18 to 29 years of age||Age, Customized||participants|Number|8|8.0||||||
4389371|NCT00303069|4215018|B2|18 to 29 years of age||Age, Customized||participants|Number|5|5.0||||||
4389372|NCT00303069|4215019|B1|18 to 29 years of age||Age, Customized||participants|Number|10|10.0||||||
4389373|NCT00303069|4215015|B5|17 years of age and under||Age, Customized||participants|Number|0|0.0||||||
4389374|NCT00303069|4215016|B4|17 years of age and under||Age, Customized||participants|Number|0|0.0||||||
4389375|NCT00303069|4215017|B3|17 years of age and under||Age, Customized||participants|Number|0|0.0||||||
4389376|NCT00303069|4215018|B2|17 years of age and under||Age, Customized||participants|Number|0|0.0||||||
4389377|NCT00303069|4215019|B1|17 years of age and under||Age, Customized||participants|Number|0|0.0||||||
4389378|NCT00302952|4215040|B3|||Disease Activity Score Using C-reactive Protein (DAS28-CRP)|The DAS28-CRP score is on a scale of 0 to 10 and indicates current activity of rheumatoid arthritis (>5.1=high disease activity; 3.2-<=5.1=moderate disease activity; <=3.2=low disease activity; <2.6=remission). The score uses a combination of four variables: 1) the number of tender joints (of the 28 that are measured); 2) the number of swollen joints (of the 28 that are measured); 3) serum C-reactive protein (CRP) in mg/L , and 4) Patient Global Assessment of Disease Activity. Using a formula, the physician determines the score.|scores on a scale|Mean|4.0|4.0|Standard Deviation|0.6|0.6|||
4389379|NCT00302952|4215041|B2|||Disease Activity Score Using C-reactive Protein (DAS28-CRP)|The DAS28-CRP score is on a scale of 0 to 10 and indicates current activity of rheumatoid arthritis (>5.1=high disease activity; 3.2-<=5.1=moderate disease activity; <=3.2=low disease activity; <2.6=remission). The score uses a combination of four variables: 1) the number of tender joints (of the 28 that are measured); 2) the number of swollen joints (of the 28 that are measured); 3) serum C-reactive protein (CRP) in mg/L , and 4) Patient Global Assessment of Disease Activity. Using a formula, the physician determines the score.|scores on a scale|Mean|4.2|4.2|Standard Deviation|0.4|0.4|||
4389380|NCT00302952|4215042|B1|||Disease Activity Score Using C-reactive Protein (DAS28-CRP)|The DAS28-CRP score is on a scale of 0 to 10 and indicates current activity of rheumatoid arthritis (>5.1=high disease activity; 3.2-<=5.1=moderate disease activity; <=3.2=low disease activity; <2.6=remission). The score uses a combination of four variables: 1) the number of tender joints (of the 28 that are measured); 2) the number of swollen joints (of the 28 that are measured); 3) serum C-reactive protein (CRP) in mg/L , and 4) Patient Global Assessment of Disease Activity. Using a formula, the physician determines the score.|scores on a scale|Mean|3.9|3.9|Standard Deviation|0.7|0.7|||
4389381|NCT00302952|4215040|B3|||Patient Global Assessment of Disease Activity - Visual Analog Scale (VAS)|The Patient Global Assessment of Disease Activity is a self-reported measure of perceived disease activity obtained by responding to the question “considering all the ways that your arthritis affects you, rate how you are doing on the following scale by placing a vertical mark.” A vertical mark on a 10 cm line rated 0 (very well) to 10 (very bad) determines the score. The range is 0 to 10, with 10 as the highest perceived disease activity.|cm|Mean|4.0|4.0|Standard Deviation|2.0|2.0|||
4389382|NCT00302952|4215041|B2|||Patient Global Assessment of Disease Activity - Visual Analog Scale (VAS)|The Patient Global Assessment of Disease Activity is a self-reported measure of perceived disease activity obtained by responding to the question “considering all the ways that your arthritis affects you, rate how you are doing on the following scale by placing a vertical mark.” A vertical mark on a 10 cm line rated 0 (very well) to 10 (very bad) determines the score. The range is 0 to 10, with 10 as the highest perceived disease activity.|cm|Mean|4.5|4.5|Standard Deviation|1.6|1.6|||
4389383|NCT00302952|4215042|B1|||Patient Global Assessment of Disease Activity - Visual Analog Scale (VAS)|The Patient Global Assessment of Disease Activity is a self-reported measure of perceived disease activity obtained by responding to the question “considering all the ways that your arthritis affects you, rate how you are doing on the following scale by placing a vertical mark.” A vertical mark on a 10 cm line rated 0 (very well) to 10 (very bad) determines the score. The range is 0 to 10, with 10 as the highest perceived disease activity.|cm|Mean|3.5|3.5|Standard Deviation|2.3|2.3|||
4389384|NCT00302952|4215040|B3|||Swollen Joint Count at Baseline|The swollen joint count is the number of swollen joints out of the 28 examined.|swollen joints|Mean|3.6|3.6|Standard Deviation|1.5|1.5|||
4389385|NCT00302952|4215041|B2|||Swollen Joint Count at Baseline|The swollen joint count is the number of swollen joints out of the 28 examined.|swollen joints|Mean|3.8|3.8|Standard Deviation|1.6|1.6|||
4389386|NCT00302952|4215042|B1|||Swollen Joint Count at Baseline|The swollen joint count is the number of swollen joints out of the 28 examined.|swollen joints|Mean|3.5|3.5|Standard Deviation|1.4|1.4|||
4389387|NCT00302952|4215040|B3|||Tender Joint Count at Baseline|The tender joint count is the number of tender joints out of the 28 examined.|tender joints|Mean|4.6|4.6|Standard Deviation|2.4|2.4|||
4389388|NCT00302952|4215041|B2|||Tender Joint Count at Baseline|The tender joint count is the number of tender joints out of the 28 examined.|tender joints|Mean|4.8|4.8|Standard Deviation|2.2|2.2|||
4389389|NCT00302952|4215042|B1|||Tender Joint Count at Baseline|The tender joint count is the number of tender joints out of the 28 examined.|tender joints|Mean|4.4|4.4|Standard Deviation|2.5|2.5|||
4389425|NCT00302848|4215077|B4|Female||Gender||participants|Number|58303|58303.0||||||
4389390|NCT00302952|4215040|B3|||C-reactive Protein (CRP) Level at Baseline|Baseline measure description: CRP is an acute phase reactant that is used to identify the presence of nonspecific inflammation. The CRP normal reference range in this study is 0-4 mg/L. An increased CRP level indicates the presence of inflammation. Reduced CRP levels could mean a decrease in inflammation.|mg/L|Mean|12.4|12.4|Standard Deviation|13.8|13.8|||
4389391|NCT00302952|4215041|B2|||C-reactive Protein (CRP) Level at Baseline|Baseline measure description: CRP is an acute phase reactant that is used to identify the presence of nonspecific inflammation. The CRP normal reference range in this study is 0-4 mg/L. An increased CRP level indicates the presence of inflammation. Reduced CRP levels could mean a decrease in inflammation.|mg/L|Mean|12.6|12.6|Standard Deviation|16.4|16.4|||
4389392|NCT00302952|4215042|B1|||C-reactive Protein (CRP) Level at Baseline|Baseline measure description: CRP is an acute phase reactant that is used to identify the presence of nonspecific inflammation. The CRP normal reference range in this study is 0-4 mg/L. An increased CRP level indicates the presence of inflammation. Reduced CRP levels could mean a decrease in inflammation.|mg/L|Mean|12.2|12.2|Standard Deviation|11.4|11.4|||
4389393|NCT00302952|4215040|B3|||Number of Participants at Baseline Who Were Taking a Biologic Drug|A biologic drug for the treatment of rheumatoid arthritis is a product made from a living system, that is used to decrease disease activity and to slow the progression of joint damage and includes drugs such as such as abatacept, adalimumab, or etanercept. This information was gathered from the medical history during the Baseline visit.|Participants|Number|31|31.0||||||
4389394|NCT00302952|4215041|B2|||Number of Participants at Baseline Who Were Taking a Biologic Drug|A biologic drug for the treatment of rheumatoid arthritis is a product made from a living system, that is used to decrease disease activity and to slow the progression of joint damage and includes drugs such as such as abatacept, adalimumab, or etanercept. This information was gathered from the medical history during the Baseline visit.|Participants|Number|11|11.0||||||
4389395|NCT00302952|4215042|B1|||Number of Participants at Baseline Who Were Taking a Biologic Drug|A biologic drug for the treatment of rheumatoid arthritis is a product made from a living system, that is used to decrease disease activity and to slow the progression of joint damage and includes drugs such as such as abatacept, adalimumab, or etanercept. This information was gathered from the medical history during the Baseline visit.|Participants|Number|20|20.0||||||
4389396|NCT00302952|4215040|B3|||Number of Participants at Baseline Who Were Taking an Anti-TNF Drug|Number of participants at Baseline who were taking an anti-tumor necrosis factor (Anti-TNF) drug prescribed by a physician. This information was gathered from the medical history during the Baseline visit.|Participants|Number|26|26.0||||||
4389397|NCT00302952|4215041|B2|||Number of Participants at Baseline Who Were Taking an Anti-TNF Drug|Number of participants at Baseline who were taking an anti-tumor necrosis factor (Anti-TNF) drug prescribed by a physician. This information was gathered from the medical history during the Baseline visit.|Participants|Number|10|10.0||||||
4389398|NCT00302952|4215042|B1|||Number of Participants at Baseline Who Were Taking an Anti-TNF Drug|Number of participants at Baseline who were taking an anti-tumor necrosis factor (Anti-TNF) drug prescribed by a physician. This information was gathered from the medical history during the Baseline visit.|Participants|Number|16|16.0||||||
4389399|NCT00302952|4215040|B3|||Number of Participants at Baseline Who Were Taking Methotrexate|Number of participants at Baseline who were taking methotrexate prescribed by a physician. This information was gathered from the medical history during the Baseline visit.|Participants|Number|36|36.0||||||
4389400|NCT00302952|4215041|B2|||Number of Participants at Baseline Who Were Taking Methotrexate|Number of participants at Baseline who were taking methotrexate prescribed by a physician. This information was gathered from the medical history during the Baseline visit.|Participants|Number|16|16.0||||||
4389401|NCT00302952|4215042|B1|||Number of Participants at Baseline Who Were Taking Methotrexate|Number of participants at Baseline who were taking methotrexate prescribed by a physician. This information was gathered from the medical history during the Baseline visit.|Participants|Number|20|20.0||||||
4389402|NCT00302952|4215040|B3|||Years with Rheumatoid Arthritis at Baseline|Years since rheumatoid arthritis was diagnosed by a physician. This information was gathered from the medical history during the Baseline visit.|years|Mean|12.2|12.2|Standard Deviation|11.0|11.0|||
4389403|NCT00302952|4215041|B2|||Years with Rheumatoid Arthritis at Baseline|Years since rheumatoid arthritis was diagnosed by a physician. This information was gathered from the medical history during the Baseline visit.|years|Mean|11.9|11.9|Standard Deviation|12.6|12.6|||
4389404|NCT00302952|4215042|B1|||Years with Rheumatoid Arthritis at Baseline|Years since rheumatoid arthritis was diagnosed by a physician. This information was gathered from the medical history during the Baseline visit.|years|Mean|12.5|12.5|Standard Deviation|9.6|9.6|||
4389405|NCT00302952|4215040|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
4389406|NCT00302952|4215041|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4389407|NCT00302952|4215042|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4389408|NCT00302952|4215040|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4389409|NCT00302952|4215041|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4389410|NCT00302952|4215042|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4389411|NCT00302952|4215040|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4389412|NCT00302952|4215041|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4389413|NCT00302952|4215042|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4389414|NCT00302952|4215040|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|8.8|8.8|||
4389415|NCT00302952|4215041|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|10.4|10.4|||
4389416|NCT00302952|4215042|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|7.1|7.1|||
4389417|NCT00302848|4215077|B4|Europe||Region of Enrollment||participants|Number|58303|58303.0||||||
4389418|NCT00302848|4215078|B3|Europe||Region of Enrollment||participants|Number|26,341|26.0||||||
4389419|NCT00302848|4215079|B2|Europe||Region of Enrollment||participants|Number|15,428|15.0||||||
4389420|NCT00302848|4215080|B1|Europe||Region of Enrollment||participants|Number|16,534|16.0||||||
4389421|NCT00302848|4215077|B4|Male||Gender||participants|Number|0|0.0||||||
4389426|NCT00302848|4215078|B3|Female||Gender||participants|Number|26,341|26.0||||||
4389427|NCT00302848|4215079|B2|Female||Gender||participants|Number|15,428|15.0||||||
4389428|NCT00302848|4215080|B1|Female||Gender||participants|Number|16,534|16.0||||||
4389429|NCT00302848|4215077|B4|||Age||years|Mean|25.2|25.2|Standard Deviation|8.2|8.2|||
4389430|NCT00302848|4215078|B3|||Age||years|Mean|24.8|24.8|Standard Deviation|7.8|7.8|||
4389431|NCT00302848|4215079|B2|||Age||years|Mean|25.1|25.1|Standard Deviation|8.7|8.7|||
4389432|NCT00302848|4215080|B1|||Age||years|Mean|25.9|25.9|Standard Deviation|8.1|8.1|||
4389433|NCT00302848|4215077|B4|>=65 years||Age||participants|Number|0|0.0||||||
4389434|NCT00302848|4215078|B3|>=65 years||Age||participants|Number|0|0.0||||||
4389435|NCT00302848|4215079|B2|>=65 years||Age||participants|Number|0|0.0||||||
4389436|NCT00302848|4215080|B1|>=65 years||Age||participants|Number|0|0.0||||||
4389437|NCT00302848|4215077|B4|Between 18 and 65 years||Age||participants|Number|44327|44327.0||||||
4389438|NCT00302848|4215078|B3|Between 18 and 65 years||Age||participants|Number|20,034|20.0||||||
4389439|NCT00302848|4215079|B2|Between 18 and 65 years||Age||participants|Number|11,213|11.0||||||
4389440|NCT00302848|4215080|B1|Between 18 and 65 years||Age||participants|Number|13,080|13.0||||||
4389441|NCT00302848|4215077|B4|<=18 years||Age||participants|Number|13976|13976.0||||||
4389442|NCT00302848|4215078|B3|<=18 years||Age||participants|Number|6,307|6.0||||||
4389443|NCT00302848|4215079|B2|<=18 years||Age||participants|Number|4,215|4.0||||||
4389444|NCT00302848|4215080|B1|<=18 years||Age||participants|Number|3,454|3.0||||||
4389445|NCT00302731|4215089|B5|United States||Region of Enrollment||participants|Number|21|21.0||||||
4389446|NCT00302731|4215090|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4389447|NCT00302731|4215091|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4389448|NCT00302731|4215092|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4389449|NCT00302731|4215093|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4389450|NCT00302731|4215089|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389451|NCT00302731|4215090|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389452|NCT00302731|4215091|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389453|NCT00302731|4215092|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389454|NCT00302731|4215093|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389455|NCT00302731|4215089|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4389456|NCT00302731|4215090|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4389457|NCT00302731|4215091|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4389458|NCT00302731|4215092|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4389459|NCT00302731|4215093|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4389460|NCT00302731|4215089|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389461|NCT00302731|4215090|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389462|NCT00302731|4215091|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389463|NCT00302731|4215092|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389464|NCT00302731|4215093|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389465|NCT00302731|4215089|B5||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4389466|NCT00302731|4215090|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4389467|NCT00302731|4215091|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4389468|NCT00302731|4215092|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4389469|NCT00302731|4215093|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4389470|NCT00302731|4215089|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389471|NCT00302731|4215090|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389472|NCT00302731|4215091|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389473|NCT00302731|4215092|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389474|NCT00302731|4215093|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389475|NCT00302718|4215118|B5|United States||Region of Enrollment||participants|Number|77|77.0||||||
4389476|NCT00302718|4215119|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
4389477|NCT00302718|4215120|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4389478|NCT00302718|4215121|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4389479|NCT00302718|4215122|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4389480|NCT00302718|4215118|B5|Other||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|19|19.0||||||
4389481|NCT00302718|4215119|B4|Other||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|6|6.0||||||
4389482|NCT00302718|4215120|B3|Other||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|3|3.0||||||
4389483|NCT00302718|4215121|B2|Other||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|6|6.0||||||
4389484|NCT00302718|4215122|B1|Other||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|4|4.0||||||
4389485|NCT00302718|4215118|B5|Asian Indian||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|21|21.0||||||
4389486|NCT00302718|4215119|B4|Asian Indian||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|5|5.0||||||
4389487|NCT00302718|4215120|B3|Asian Indian||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|6|6.0||||||
4389488|NCT00302718|4215121|B2|Asian Indian||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|5|5.0||||||
4389489|NCT00302718|4215122|B1|Asian Indian||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|5|5.0||||||
4389490|NCT00302718|4215118|B5|Black||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|6|6.0||||||
4389491|NCT00302718|4215119|B4|Black||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|0|0.0||||||
4389492|NCT00302718|4215120|B3|Black||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|1|1.0||||||
4389493|NCT00302718|4215121|B2|Black||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|2|2.0||||||
4389494|NCT00302718|4215122|B1|Black||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|3|3.0||||||
4389495|NCT00302718|4215118|B5|White||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|31|31.0||||||
4389496|NCT00302718|4215119|B4|White||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|8|8.0||||||
4389497|NCT00302718|4215120|B3|White||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|9|9.0||||||
4389498|NCT00302718|4215121|B2|White||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|7|7.0||||||
4389499|NCT00302718|4215122|B1|White||Race/Ethnicity, Customized|These data describe the race of the physician participants.|participants|Number|7|7.0||||||
4389500|NCT00302718|4215118|B5||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4389501|NCT00302718|4215119|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4389502|NCT00302718|4215120|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4389503|NCT00302718|4215121|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4389504|NCT00302718|4215122|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4389505|NCT00302718|4215118|B5||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4389506|NCT00302718|4215119|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4389507|NCT00302718|4215120|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4389508|NCT00302718|4215121|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4389509|NCT00302718|4215122|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4389510|NCT00302718|4215118|B5|||Age|One physician participant in the physician-level incentive arm declined to provide age data.|years|Mean|46|46.0|Standard Deviation|8|8.0|||
4389511|NCT00302718|4215119|B4|||Age|One physician participant in the physician-level incentive arm declined to provide age data.|years|Mean|48|48.0|Standard Deviation|7|7.0|||
4389512|NCT00302718|4215120|B3|||Age|One physician participant in the physician-level incentive arm declined to provide age data.|years|Mean|44|44.0|Standard Deviation|6|6.0|||
4389513|NCT00302718|4215121|B2|||Age|One physician participant in the physician-level incentive arm declined to provide age data.|years|Mean|48|48.0|Standard Deviation|8|8.0|||
4389514|NCT00302718|4215122|B1|||Age|One physician participant in the physician-level incentive arm declined to provide age data.|years|Mean|45|45.0|Standard Deviation|8|8.0|||
4389515|NCT00302458|4215157|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4389516|NCT00302458|4215157|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4389517|NCT00302458|4215157|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4389518|NCT00302458|4215157|B1|||Age||years|Mean|28.86|28.86|Standard Deviation|6.06|6.06|||
4389519|NCT00302458|4215157|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389520|NCT00302458|4215157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4389521|NCT00302458|4215157|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389522|NCT00302328|4215165|B4|Denmark||Region of Enrollment||participants|Number|78|78.0||||||
4389523|NCT00302328|4215166|B3|Denmark||Region of Enrollment||participants|Number|18|18.0||||||
4389524|NCT00302328|4215167|B2|Denmark||Region of Enrollment||participants|Number|35|35.0||||||
4389525|NCT00302328|4215168|B1|Denmark||Region of Enrollment||participants|Number|25|25.0||||||
4389526|NCT00302328|4215165|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4389527|NCT00302328|4215166|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4389528|NCT00302328|4215167|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4389529|NCT00302328|4215168|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4389530|NCT00302328|4215165|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4389531|NCT00302328|4215166|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4389532|NCT00302328|4215167|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4389533|NCT00302328|4215168|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4389534|NCT00302328|4215165|B4|||Age||years|Mean|66.6|66.6|Standard Deviation|5|5.0|||
4389535|NCT00302328|4215166|B3|||Age||years|Mean|66.6|66.6|Standard Deviation|5|5.0|||
4389536|NCT00302328|4215167|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|5|5.0|||
4389537|NCT00302328|4215168|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|5|5.0|||
4389538|NCT00302328|4215165|B4||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4389539|NCT00302328|4215166|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4389540|NCT00302328|4215167|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4389541|NCT00302328|4215168|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4389542|NCT00302328|4215165|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4389543|NCT00302328|4215166|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4389544|NCT00302328|4215167|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4389545|NCT00302328|4215168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4389546|NCT00302328|4215165|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389547|NCT00302328|4215166|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389548|NCT00302328|4215167|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389549|NCT00302328|4215168|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389550|NCT00302211|4215184|B4|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4389551|NCT00302211|4215185|B3|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4389552|NCT00302211|4215186|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4389553|NCT00302211|4215187|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4389554|NCT00302211|4215184|B4|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4389555|NCT00302211|4215185|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4389556|NCT00302211|4215186|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4389557|NCT00302211|4215187|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4389558|NCT00302211|4215184|B4|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4389559|NCT00302211|4215185|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4389560|NCT00302211|4215186|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4389561|NCT00302211|4215187|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4389562|NCT00302211|4215184|B4|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4389563|NCT00302211|4215185|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4389564|NCT00302211|4215186|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4389565|NCT00302211|4215187|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4389566|NCT00302211|4215184|B4|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4389567|NCT00302211|4215185|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4389568|NCT00302211|4215186|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4389569|NCT00302211|4215187|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4389570|NCT00302211|4215184|B4|United States||Region of Enrollment||participants|Number|38|38.0||||||
4389571|NCT00302211|4215185|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4389572|NCT00302211|4215186|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4389573|NCT00302211|4215187|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4389574|NCT00302211|4215184|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4389575|NCT00302211|4215185|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4389576|NCT00302211|4215186|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4389577|NCT00302211|4215187|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4389578|NCT00302211|4215184|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4389579|NCT00302211|4215185|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4389580|NCT00302211|4215186|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4389581|NCT00302211|4215187|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4389582|NCT00302211|4215184|B4|||Age||years|Mean|54.8|54.8|Standard Deviation|13.85|13.85|||
4389583|NCT00302211|4215185|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|11.90|11.9|||
4389584|NCT00302211|4215186|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|16.27|16.27|||
4389585|NCT00302211|4215187|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|11.95|11.95|||
4389586|NCT00302211|4215184|B4||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4389587|NCT00302211|4215185|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4389588|NCT00302211|4215186|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4389589|NCT00302211|4215187|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4389590|NCT00302211|4215184|B4||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4389591|NCT00302211|4215185|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4389592|NCT00302211|4215186|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4389593|NCT00302211|4215187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4389594|NCT00302211|4215184|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389595|NCT00302211|4215185|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389596|NCT00302211|4215186|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389597|NCT00302211|4215187|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389598|NCT00302159|4215203|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4389599|NCT00302159|4215203|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389600|NCT00302159|4215203|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4389601|NCT00302159|4215203|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4389602|NCT00302159|4215203|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4389660|NCT00302107|4215223|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4389603|NCT00302159|4215203|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389604|NCT00302159|4215203|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4389605|NCT00302159|4215203|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4389606|NCT00302159|4215203|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389607|NCT00302159|4215203|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4389608|NCT00302159|4215203|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389609|NCT00302159|4215203|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4389610|NCT00302159|4215203|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4389611|NCT00302159|4215203|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4389612|NCT00302159|4215203|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4389613|NCT00302159|4215203|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389614|NCT00302159|4215203|B1|||Age||years|Mean|52.88|52.88|Standard Deviation|11.33|11.33|||
4389615|NCT00302133|4215212|B3|United States||Region of Enrollment|TimeLine Follow-Back (TLFB)|participants|Number|18|18.0||||||
4389616|NCT00302133|4215213|B2|United States||Region of Enrollment|TimeLine Follow-Back (TLFB)|participants|Number|9|9.0||||||
4389617|NCT00302133|4215214|B1|United States||Region of Enrollment|TimeLine Follow-Back (TLFB)|participants|Number|9|9.0||||||
4389618|NCT00302133|4215212|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389619|NCT00302133|4215213|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389620|NCT00302133|4215214|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389621|NCT00302133|4215212|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4389622|NCT00302133|4215213|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4389623|NCT00302133|4215214|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4389624|NCT00302133|4215212|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4389625|NCT00302133|4215213|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4389626|NCT00302133|4215214|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4389627|NCT00302133|4215212|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389628|NCT00302133|4215213|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389629|NCT00302133|4215214|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389630|NCT00302133|4215212|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389631|NCT00302133|4215213|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389632|NCT00302133|4215214|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389633|NCT00302133|4215212|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4389634|NCT00302133|4215213|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4389635|NCT00302133|4215214|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4389636|NCT00302133|4215212|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4389637|NCT00302133|4215213|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4389638|NCT00302133|4215214|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4389639|NCT00302133|4215212|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389640|NCT00302133|4215213|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389641|NCT00302133|4215214|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389642|NCT00302133|4215212|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389643|NCT00302133|4215213|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389644|NCT00302133|4215214|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389645|NCT00302133|4215212|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389646|NCT00302133|4215213|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389647|NCT00302133|4215214|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389648|NCT00302133|4215212|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4389649|NCT00302133|4215213|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4389650|NCT00302133|4215214|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4389651|NCT00302133|4215212|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4389652|NCT00302133|4215213|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4389653|NCT00302133|4215214|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4389654|NCT00302133|4215212|B3|||Age||years|Mean|41.9|41.9|Standard Deviation|10.9|10.9|||
4389655|NCT00302133|4215213|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|12.7|12.7|||
4389656|NCT00302133|4215214|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|9.5|9.5|||
4389657|NCT00302107|4215223|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
4389658|NCT00302107|4215224|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4389659|NCT00302107|4215225|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4389661|NCT00302107|4215224|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4389662|NCT00302107|4215225|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4389663|NCT00302107|4215223|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4389664|NCT00302107|4215224|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4389665|NCT00302107|4215225|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4389666|NCT00302107|4215223|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|9.9|9.9|||
4389667|NCT00302107|4215224|B2|||Age||years|Mean|38.1|38.1|Standard Deviation|9.5|9.5|||
4389668|NCT00302107|4215225|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|10.3|10.3|||
4389669|NCT00302081|4215232|B4||Male|Sex: Female, Male||Participants|Count of Participants|433|433.0||||||
4389670|NCT00302081|4215233|B3||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4389671|NCT00302081|4215234|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4389672|NCT00302081|4215235|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4389673|NCT00302081|4215232|B4||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4389674|NCT00302081|4215233|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4389675|NCT00302081|4215234|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4389676|NCT00302081|4215235|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4389677|NCT00302081|4215232|B4|||Age||years|Mean|39.5|39.5|Standard Deviation|10.9|10.9|||
4389678|NCT00302081|4215233|B3|||Age||years|Mean|39.7|39.7|Standard Deviation|11.1|11.1|||
4389679|NCT00302081|4215234|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|11.2|11.2|||
4389680|NCT00302081|4215235|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|10.2|10.2|||
4389681|NCT00302068|4215245|B4|United States||Region of Enrollment||participants|Number|101|101.0||||||
4389682|NCT00302068|4215246|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4389683|NCT00302068|4215247|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4389684|NCT00302068|4215248|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4389685|NCT00302068|4215245|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4389686|NCT00302068|4215246|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4389687|NCT00302068|4215247|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4389688|NCT00302068|4215248|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4389689|NCT00302068|4215245|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4389690|NCT00302068|4215246|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4389691|NCT00302068|4215247|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4389692|NCT00302068|4215248|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4389693|NCT00302068|4215245|B4|||Age||years|Mean|63.9|63.9|Standard Deviation|11|11.0|||
4389694|NCT00302068|4215246|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|11.4|11.4|||
4389695|NCT00302068|4215247|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|10.2|10.2|||
4389696|NCT00302068|4215248|B1|||Age||years|Mean|64.7|64.7|Standard Deviation|11.0|11.0|||
4389697|NCT00302068|4215245|B4||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4389698|NCT00302068|4215246|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4389699|NCT00302068|4215247|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4389700|NCT00302068|4215248|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4389701|NCT00302068|4215245|B4||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4389702|NCT00302068|4215246|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4389703|NCT00302068|4215247|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4389704|NCT00302068|4215248|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4389705|NCT00302068|4215245|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389706|NCT00302068|4215246|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389707|NCT00302068|4215247|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389708|NCT00302068|4215248|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389709|NCT00302055|4215276|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4389710|NCT00302055|4215277|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4389711|NCT00302055|4215278|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4389712|NCT00302055|4215276|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4389713|NCT00302055|4215277|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4389714|NCT00302055|4215278|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4389715|NCT00302055|4215276|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4389716|NCT00302055|4215277|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4389717|NCT00302055|4215278|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4389718|NCT00302055|4215276|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|11.9|11.9|||
4389719|NCT00302055|4215277|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|13.1|13.1|||
4389720|NCT00302055|4215278|B1|||Age||years|Mean|53.0|53.0|Standard Deviation|10.7|10.7|||
4389721|NCT00302055|4215276|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389722|NCT00302055|4215277|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389723|NCT00302055|4215278|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389724|NCT00302055|4215276|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4389725|NCT00302055|4215277|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4389726|NCT00302055|4215278|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4389727|NCT00302055|4215276|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389728|NCT00302055|4215277|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389729|NCT00302055|4215278|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389730|NCT00302042|4215285|B3|United States||Region of Enrollment||participants|Number|92|92.0||||||
4389731|NCT00302042|4215286|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4389732|NCT00302042|4215287|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4389733|NCT00302042|4215285|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4389734|NCT00302042|4215286|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4389735|NCT00302042|4215287|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4389736|NCT00302042|4215285|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4389737|NCT00302042|4215286|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4389738|NCT00302042|4215287|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4389739|NCT00302042|4215285|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|10.1|10.1|||
4389740|NCT00302042|4215286|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|10.5|10.5|||
4389741|NCT00302042|4215287|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|9.7|9.7|||
4389742|NCT00302042|4215285|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4389743|NCT00302042|4215286|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4389744|NCT00302042|4215287|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4389745|NCT00302042|4215285|B3||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4389746|NCT00302042|4215286|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4389747|NCT00302042|4215287|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4389748|NCT00302042|4215285|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389749|NCT00302042|4215286|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389750|NCT00302042|4215287|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389751|NCT00302003|4215294|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4389752|NCT00302003|4215294|B1|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4389753|NCT00302003|4215294|B1|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4389754|NCT00302003|4215294|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4389755|NCT00302003|4215294|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4389756|NCT00302003|4215294|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4389757|NCT00302003|4215294|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4389758|NCT00302003|4215294|B1|United States||Region of Enrollment||participants|Number|250|250.0||||||
4389759|NCT00302003|4215294|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4389760|NCT00302003|4215294|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389761|NCT00302003|4215294|B1||White|Race (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
4389762|NCT00302003|4215294|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4389763|NCT00302003|4215294|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389764|NCT00302003|4215294|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4389765|NCT00302003|4215294|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4389766|NCT00302003|4215294|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4389767|NCT00302003|4215294|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
4389768|NCT00302003|4215294|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4389769|NCT00302003|4215294|B1||Male|Gender||Participants|Count of Participants|127|127.0||||||
4389770|NCT00302003|4215294|B1||Female|Gender||Participants|Count of Participants|160|160.0||||||
4389771|NCT00302003|4215294|B1|||Age||Years|Median|15|15.0|Full Range|||3.0|21.0|
4389772|NCT00302003|4215294|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389773|NCT00302003|4215294|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4389774|NCT00302003|4215294|B1||<=18 years|Age||Participants|Count of Participants|272|272.0||||||
4389775|NCT00301964|4215301|B1|Serous Adenocarcinoma||Cell Type||participants|Number|14|14.0||||||
4389776|NCT00301964|4215301|B1|Undifferentiated Carcinoma||Cell Type||participants|Number|1|1.0||||||
4389777|NCT00301964|4215301|B1|Mixed Epithelial Carcinoma||Cell Type||participants|Number|5|5.0||||||
4389778|NCT00301964|4215301|B1|Mucinous Adenocarcinoma||Cell Type||participants|Number|1|1.0||||||
4389779|NCT00301964|4215301|B1|Endometrioid Adenocarcinoma||Cell Type||participants|Number|26|26.0||||||
4389780|NCT00301964|4215301|B1|Clear Cell Carcinoma||Cell Type||participants|Number|4|4.0||||||
4389781|NCT00301964|4215301|B1|Adenocarcinoma, Unspecified||Cell Type||participants|Number|1|1.0||||||
4389782|NCT00301964|4215301|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4389783|NCT00301964|4215301|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389784|NCT00301964|4215301|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4389785|NCT00301964|4215301|B1|80-89 years||Age, Customized||participants|Number|1|1.0||||||
4389786|NCT00301964|4215301|B1|70-79 years||Age, Customized||participants|Number|11|11.0||||||
4389787|NCT00301964|4215301|B1|60-69 years||Age, Customized||participants|Number|22|22.0||||||
4389788|NCT00301964|4215301|B1|50-59 years||Age, Customized||participants|Number|13|13.0||||||
4389789|NCT00301964|4215301|B1|40-49 years||Age, Customized||participants|Number|4|4.0||||||
4389790|NCT00301964|4215301|B1|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4389791|NCT00301964|4215301|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|10.3|10.3|||
4389792|NCT00301873|4215316|B1|no||Steroid use||participants|Number|18|18.0||||||
4389793|NCT00301873|4215316|B1|yes||Steroid use||participants|Number|41|41.0||||||
4389794|NCT00301873|4215316|B1|no||Anticonvulsant use||participants|Number|5|5.0||||||
4389795|NCT00301873|4215316|B1|yes||Anticonvulsant use||participants|Number|54|54.0||||||
4389796|NCT00301873|4215316|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4389797|NCT00301873|4215316|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4389798|NCT00301873|4215316|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|9.4|9.4|||
4389799|NCT00301873|4215316|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4389800|NCT00301873|4215316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4389801|NCT00301873|4215316|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389802|NCT00301834|4215322|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4389803|NCT00301834|4215322|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4389804|NCT00301834|4215322|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4389805|NCT00301834|4215322|B1|||Age||years|Mean|7.58|7.58|Standard Deviation|5.25|5.25|||
4389806|NCT00301834|4215322|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389807|NCT00301834|4215322|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4389808|NCT00301834|4215322|B1||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4389809|NCT00301821|4215331|B1|United States||Region of Enrollment||participants|Number|107|107.0||||||
4389810|NCT00301821|4215331|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4389811|NCT00301821|4215331|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4389812|NCT00301821|4215331|B1|||Age||years|Median|62|62.0|Full Range|||21.0|82.0|
4389813|NCT00301808|4215338|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4389814|NCT00301808|4215338|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4389815|NCT00301808|4215338|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4389816|NCT00301808|4215338|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4389817|NCT00301808|4215338|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4389818|NCT00301808|4215338|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389819|NCT00301808|4215338|B1|||Age||years|Mean|60.76|60.76|Standard Deviation|8.03|8.03|||
4389820|NCT00301756|4215345|B1|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4389821|NCT00301756|4215345|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389822|NCT00301756|4215345|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4389823|NCT00301756|4215345|B1|||Age||years|Median|54|54.0|Full Range|||28.0|82.0|
4389824|NCT00301756|4215345|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4389825|NCT00301756|4215345|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4389826|NCT00301756|4215345|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389827|NCT00301418|4215357|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4389828|NCT00301418|4215357|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4389829|NCT00301418|4215357|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4389830|NCT00301418|4215357|B1|||Age||years|Mean|50|50.0|Standard Deviation|10.7|10.7|||
4389831|NCT00301366|4215363|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4389832|NCT00301366|4215363|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4389833|NCT00301366|4215363|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4389834|NCT00301366|4215363|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4389835|NCT00301366|4215363|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|8.63|8.63|||
4389836|NCT00301366|4215363|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4389837|NCT00301366|4215363|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4389838|NCT00301366|4215363|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389839|NCT00301262|4215367|B3||Male|Sex: Female, Male|DB Viagra/OL Viagra Male/Female=83/0 DB Placebo/OL Viagra Male/Female=69/0|Participants|Count of Participants|176|176.0||||||
4389840|NCT00301262|4215368|B2||Male|Sex: Female, Male|DB Viagra/OL Viagra Male/Female=83/0 DB Placebo/OL Viagra Male/Female=69/0|Participants|Count of Participants|82|82.0||||||
4389841|NCT00301262|4215369|B1||Male|Sex: Female, Male|DB Viagra/OL Viagra Male/Female=83/0 DB Placebo/OL Viagra Male/Female=69/0|Participants|Count of Participants|94|94.0||||||
4389842|NCT00301262|4215367|B3||Female|Sex: Female, Male|DB Viagra/OL Viagra Male/Female=83/0 DB Placebo/OL Viagra Male/Female=69/0|Participants|Count of Participants|0|0.0||||||
4389843|NCT00301262|4215368|B2||Female|Sex: Female, Male|DB Viagra/OL Viagra Male/Female=83/0 DB Placebo/OL Viagra Male/Female=69/0|Participants|Count of Participants|0|0.0||||||
4389844|NCT00301262|4215369|B1||Female|Sex: Female, Male|DB Viagra/OL Viagra Male/Female=83/0 DB Placebo/OL Viagra Male/Female=69/0|Participants|Count of Participants|0|0.0||||||
4389957|NCT00300781|4215608|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389845|NCT00301262|4215367|B3|||Age|DB Viagra/OL Viagra=52.2+/-12.1(n=83) DB Placebo/OL Viagra=48.4+/-12.2(n=69)|years|Mean|49.9|49.9|Standard Deviation|12.3|12.3|||
4389846|NCT00301262|4215368|B2|||Age|DB Viagra/OL Viagra=52.2+/-12.1(n=83) DB Placebo/OL Viagra=48.4+/-12.2(n=69)|years|Mean|48.0|48.0|Standard Deviation|11.9|11.9|||
4389847|NCT00301262|4215369|B1|||Age|DB Viagra/OL Viagra=52.2+/-12.1(n=83) DB Placebo/OL Viagra=48.4+/-12.2(n=69)|years|Mean|51.6|51.6|Standard Deviation|12.5|12.5|||
4389848|NCT00301080|4215528|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4389849|NCT00301080|4215528|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4389850|NCT00301080|4215528|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4389851|NCT00301080|4215528|B1|61-70 years||Age, Customized||participants|Number|4|4.0||||||
4389852|NCT00301080|4215528|B1|51-60 years||Age, Customized||participants|Number|2|2.0||||||
4389853|NCT00301080|4215528|B1|40-50 years||Age, Customized||participants|Number|1|1.0||||||
4389854|NCT00301067|4215561|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4389855|NCT00301067|4215561|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389856|NCT00301067|4215561|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389857|NCT00301067|4215561|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4389858|NCT00301067|4215561|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389859|NCT00301067|4215561|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389860|NCT00301067|4215561|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389861|NCT00301067|4215561|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389862|NCT00301067|4215561|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389863|NCT00301067|4215561|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4389864|NCT00301067|4215561|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389865|NCT00301067|4215561|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4389866|NCT00301067|4215561|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4389867|NCT00301067|4215561|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4389868|NCT00301067|4215561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4389869|NCT00301067|4215561|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389870|NCT00301028|4215583|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4389871|NCT00301028|4215583|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4389872|NCT00301028|4215583|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4389873|NCT00301028|4215583|B1|||Age||years|Median|53|53.0|Full Range|||21.0|78.0|
4389874|NCT00300885|4215587|B3|Stage IV||Stage at Study Entry|Stage IIIB (according to American Joint Committee on Cancer): primary tumor any stage, regional lymph node stage N3, no distant metastasis OR primary tumor stage T4, regional lymph node any stage, no distant metastasis. Stage IV: primary tumor any stage, regional lymph node any stage, distant metastasis present.|Participants|Number|835|835.0||||||
4389875|NCT00300885|4215588|B2|Stage IV||Stage at Study Entry|Stage IIIB (according to American Joint Committee on Cancer): primary tumor any stage, regional lymph node stage N3, no distant metastasis OR primary tumor stage T4, regional lymph node any stage, no distant metastasis. Stage IV: primary tumor any stage, regional lymph node any stage, distant metastasis present.|Participants|Number|415|415.0||||||
4389876|NCT00300885|4215589|B1|Stage IV||Stage at Study Entry|Stage IIIB (according to American Joint Committee on Cancer): primary tumor any stage, regional lymph node stage N3, no distant metastasis OR primary tumor stage T4, regional lymph node any stage, no distant metastasis. Stage IV: primary tumor any stage, regional lymph node any stage, distant metastasis present.|Participants|Number|420|420.0||||||
4389877|NCT00300885|4215587|B3|Stage III B||Stage at Study Entry|Stage IIIB (according to American Joint Committee on Cancer): primary tumor any stage, regional lymph node stage N3, no distant metastasis OR primary tumor stage T4, regional lymph node any stage, no distant metastasis. Stage IV: primary tumor any stage, regional lymph node any stage, distant metastasis present.|Participants|Number|91|91.0||||||
4389878|NCT00300885|4215588|B2|Stage III B||Stage at Study Entry|Stage IIIB (according to American Joint Committee on Cancer): primary tumor any stage, regional lymph node stage N3, no distant metastasis OR primary tumor stage T4, regional lymph node any stage, no distant metastasis. Stage IV: primary tumor any stage, regional lymph node any stage, distant metastasis present.|Participants|Number|47|47.0||||||
4389879|NCT00300885|4215589|B1|Stage III B||Stage at Study Entry|Stage IIIB (according to American Joint Committee on Cancer): primary tumor any stage, regional lymph node stage N3, no distant metastasis OR primary tumor stage T4, regional lymph node any stage, no distant metastasis. Stage IV: primary tumor any stage, regional lymph node any stage, distant metastasis present.|Participants|Number|44|44.0||||||
4389880|NCT00300885|4215587|B3|Unknown or unspecified histology||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|3|3.0||||||
4389881|NCT00300885|4215588|B2|Unknown or unspecified histology||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|1|1.0||||||
4389882|NCT00300885|4215589|B1|Unknown or unspecified histology||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|2|2.0||||||
4389883|NCT00300885|4215587|B3|Low differentiated carcinoma (neuro-endocrine)||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|1|1.0||||||
4389884|NCT00300885|4215588|B2|Low differentiated carcinoma (neuro-endocrine)||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|0|0.0||||||
4389958|NCT00300781|4215606|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4389885|NCT00300885|4215589|B1|Low differentiated carcinoma (neuro-endocrine)||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|1|1.0||||||
4389886|NCT00300885|4215587|B3|Neuro-Endocrine carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|1|1.0||||||
4389887|NCT00300885|4215588|B2|Neuro-Endocrine carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|1|1.0||||||
4389888|NCT00300885|4215589|B1|Neuro-Endocrine carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|0|0.0||||||
4389889|NCT00300885|4215587|B3|Poorly differentiated non-small cell carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|7|7.0||||||
4389890|NCT00300885|4215588|B2|Poorly differentiated non-small cell carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|3|3.0||||||
4389891|NCT00300885|4215589|B1|Poorly differentiated non-small cell carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|4|4.0||||||
4389892|NCT00300885|4215587|B3|Undifferentiated carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|72|72.0||||||
4389893|NCT00300885|4215588|B2|Undifferentiated carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|26|26.0||||||
4389894|NCT00300885|4215589|B1|Undifferentiated carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|46|46.0||||||
4389895|NCT00300885|4215587|B3|Non-Small cell lung cancer carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|20|20.0||||||
4389896|NCT00300885|4215588|B2|Non-Small cell lung cancer carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|10|10.0||||||
4389897|NCT00300885|4215589|B1|Non-Small cell lung cancer carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|10|10.0||||||
4389898|NCT00300885|4215587|B3|Squamous cell carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|223|223.0||||||
4389899|NCT00300885|4215588|B2|Squamous cell carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|114|114.0||||||
4389900|NCT00300885|4215589|B1|Squamous cell carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|109|109.0||||||
4389901|NCT00300885|4215587|B3|Large cell carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|53|53.0||||||
4389902|NCT00300885|4215588|B2|Large cell carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|30|30.0||||||
4389903|NCT00300885|4215589|B1|Large cell carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|23|23.0||||||
4389904|NCT00300885|4215587|B3|Non-Microcellulare carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|1|1.0||||||
4389905|NCT00300885|4215588|B2|Non-Microcellulare carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|1|1.0||||||
4389906|NCT00300885|4215589|B1|Non-Microcellulare carcinoma||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|0|0.0||||||
4389907|NCT00300885|4215587|B3|Bronchoalveolar||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|11|11.0||||||
4389908|NCT00300885|4215588|B2|Bronchoalveolar||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|5|5.0||||||
4389909|NCT00300885|4215589|B1|Bronchoalveolar||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|6|6.0||||||
4389910|NCT00300885|4215587|B3|Adenocarcinoma NSCLC||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|534|534.0||||||
4389911|NCT00300885|4215588|B2|Adenocarcinoma NSCLC||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|271|271.0||||||
4389912|NCT00300885|4215589|B1|Adenocarcinoma NSCLC||NSCLC Classification|Histology (squamous versus non-squamous) was a stratification factor for randomization.|Participants|Number|263|263.0||||||
4389913|NCT00300885|4215587|B3|non-core||Geographic region|Geographic region (core versus non-core) was stratification factor for randomization. Core region comprises North America, Northern/Western Europe, and Australia. Non-core region comprises South America, Eastern Europe, and Asia-Pacific.|Participants|Number|278|278.0||||||
4389914|NCT00300885|4215588|B2|non-core||Geographic region|Geographic region (core versus non-core) was stratification factor for randomization. Core region comprises North America, Northern/Western Europe, and Australia. Non-core region comprises South America, Eastern Europe, and Asia-Pacific.|Participants|Number|139|139.0||||||
4389915|NCT00300885|4215589|B1|non-core||Geographic region|Geographic region (core versus non-core) was stratification factor for randomization. Core region comprises North America, Northern/Western Europe, and Australia. Non-core region comprises South America, Eastern Europe, and Asia-Pacific.|Participants|Number|139|139.0||||||
4389916|NCT00300885|4215587|B3|core||Geographic region|Geographic region (core versus non-core) was stratification factor for randomization. Core region comprises North America, Northern/Western Europe, and Australia. Non-core region comprises South America, Eastern Europe, and Asia-Pacific.|Participants|Number|648|648.0||||||
4389959|NCT00300781|4215607|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4389960|NCT00300781|4215608|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4389917|NCT00300885|4215588|B2|core||Geographic region|Geographic region (core versus non-core) was stratification factor for randomization. Core region comprises North America, Northern/Western Europe, and Australia. Non-core region comprises South America, Eastern Europe, and Asia-Pacific.|Participants|Number|323|323.0||||||
4389918|NCT00300885|4215589|B1|core||Geographic region|Geographic region (core versus non-core) was stratification factor for randomization. Core region comprises North America, Northern/Western Europe, and Australia. Non-core region comprises South America, Eastern Europe, and Asia-Pacific.|Participants|Number|325|325.0||||||
4389919|NCT00300885|4215587|B3|1||ECOG (Eastern Cooperative Oncology Group) Performance Status|ECOG 0 versus 1 was a stratification factor for randomization. ECOG Performance Status is a rating of daily living abilities, from 0 to 5: 0= fully active without restriction. 1= restricted in physically strenuous activity; 2= ambulatory, capable of all selfcare; 3= capable of limited selfcare; 4= completely disabled; 5= dead.|Participants|Number|548|548.0||||||
4389920|NCT00300885|4215588|B2|1||ECOG (Eastern Cooperative Oncology Group) Performance Status|ECOG 0 versus 1 was a stratification factor for randomization. ECOG Performance Status is a rating of daily living abilities, from 0 to 5: 0= fully active without restriction. 1= restricted in physically strenuous activity; 2= ambulatory, capable of all selfcare; 3= capable of limited selfcare; 4= completely disabled; 5= dead.|Participants|Number|274|274.0||||||
4389921|NCT00300885|4215589|B1|1||ECOG (Eastern Cooperative Oncology Group) Performance Status|ECOG 0 versus 1 was a stratification factor for randomization. ECOG Performance Status is a rating of daily living abilities, from 0 to 5: 0= fully active without restriction. 1= restricted in physically strenuous activity; 2= ambulatory, capable of all selfcare; 3= capable of limited selfcare; 4= completely disabled; 5= dead.|Participants|Number|274|274.0||||||
4389922|NCT00300885|4215587|B3|0||ECOG (Eastern Cooperative Oncology Group) Performance Status|ECOG 0 versus 1 was a stratification factor for randomization. ECOG Performance Status is a rating of daily living abilities, from 0 to 5: 0= fully active without restriction. 1= restricted in physically strenuous activity; 2= ambulatory, capable of all selfcare; 3= capable of limited selfcare; 4= completely disabled; 5= dead.|Participants|Number|378|378.0||||||
4389923|NCT00300885|4215588|B2|0||ECOG (Eastern Cooperative Oncology Group) Performance Status|ECOG 0 versus 1 was a stratification factor for randomization. ECOG Performance Status is a rating of daily living abilities, from 0 to 5: 0= fully active without restriction. 1= restricted in physically strenuous activity; 2= ambulatory, capable of all selfcare; 3= capable of limited selfcare; 4= completely disabled; 5= dead.|Participants|Number|188|188.0||||||
4389924|NCT00300885|4215589|B1|0||ECOG (Eastern Cooperative Oncology Group) Performance Status|ECOG 0 versus 1 was a stratification factor for randomization. ECOG Performance Status is a rating of daily living abilities, from 0 to 5: 0= fully active without restriction. 1= restricted in physically strenuous activity; 2= ambulatory, capable of all selfcare; 3= capable of limited selfcare; 4= completely disabled; 5= dead.|Participants|Number|190|190.0||||||
4389925|NCT00300885|4215587|B3||Male|Sex: Female, Male||Participants|Count of Participants|581|581.0||||||
4389926|NCT00300885|4215588|B2||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4389927|NCT00300885|4215589|B1||Male|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
4389928|NCT00300885|4215587|B3||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4389929|NCT00300885|4215588|B2||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4389930|NCT00300885|4215589|B1||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4389931|NCT00300885|4215587|B3|||Age||years|Median|62|62.0|Full Range|||34.0|86.0|
4389932|NCT00300885|4215588|B2|||Age||years|Median|63|63.0|Full Range|||34.0|82.0|
4389933|NCT00300885|4215589|B1|||Age||years|Median|62|62.0|Full Range|||34.0|86.0|
4389934|NCT00300781|4215606|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4389935|NCT00300781|4215607|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4389936|NCT00300781|4215608|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4389937|NCT00300781|4215606|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389938|NCT00300781|4215607|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389939|NCT00300781|4215608|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389940|NCT00300781|4215606|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4389941|NCT00300781|4215607|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4389942|NCT00300781|4215608|B1||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4389943|NCT00300781|4215606|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4389944|NCT00300781|4215607|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389945|NCT00300781|4215608|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4389946|NCT00300781|4215606|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389947|NCT00300781|4215607|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389948|NCT00300781|4215608|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389949|NCT00300781|4215606|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4389950|NCT00300781|4215607|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4389951|NCT00300781|4215608|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4389952|NCT00300781|4215606|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389953|NCT00300781|4215607|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389954|NCT00300781|4215608|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4389955|NCT00300781|4215606|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389956|NCT00300781|4215607|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389961|NCT00300781|4215606|B3|||Age||years|Mean|50.60|50.6|Standard Deviation|10.30|10.3|||
4389962|NCT00300781|4215607|B2|||Age||years|Mean|49.64|49.64|Standard Deviation|9.92|9.92|||
4389963|NCT00300781|4215608|B1|||Age||years|Mean|51.62|51.62|Standard Deviation|10.67|10.67|||
4389964|NCT00300755|4215621|B4||Male|Sex: Female, Male||Participants|Count of Participants|37.0|37.0||||||
4389965|NCT00300755|4215622|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4389966|NCT00300755|4215623|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4389967|NCT00300755|4215624|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4389968|NCT00300755|4215621|B4||Female|Sex: Female, Male||Participants|Count of Participants|23.0|23.0||||||
4389969|NCT00300755|4215622|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4389970|NCT00300755|4215623|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4389971|NCT00300755|4215624|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4389972|NCT00300755|4215621|B4|||Age||years|Mean|2.43|2.43|Standard Deviation|1.41|1.41|||
4389973|NCT00300755|4215622|B3|||Age||years|Mean|2.76|2.76|Standard Deviation|1.34|1.34|||
4389974|NCT00300755|4215623|B2|||Age||years|Mean|1.90|1.9|Standard Deviation|1.18|1.18|||
4389975|NCT00300755|4215624|B1|||Age||years|Mean|2.67|2.67|Standard Deviation|1.61|1.61|||
4389976|NCT00300742|4215643|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4389977|NCT00300742|4215643|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389978|NCT00300742|4215643|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4389979|NCT00300742|4215643|B1|||Age||years|Mean|45|45.0|Standard Deviation|10.46422|10.46422|||
4389980|NCT00300742|4215643|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4389981|NCT00300742|4215643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4389982|NCT00300742|4215643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4389983|NCT00300677|4215651|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4389984|NCT00300677|4215651|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4389985|NCT00300677|4215651|B1|36-45 years||Age, Customized||participants|Number|3|3.0||||||
4389986|NCT00300677|4215651|B1|26-35 years||Age, Customized||participants|Number|6|6.0||||||
4389987|NCT00300677|4215651|B1|18-25 years||Age, Customized||participants|Number|3|3.0||||||
4389988|NCT00300495|4215658|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4389989|NCT00300495|4215659|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4389990|NCT00300495|4215660|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4389991|NCT00300495|4215658|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4389992|NCT00300495|4215658|B3|Male||Sex/Gender, Customized||Participants|Count of Participants|10|10.0||||||
4389993|NCT00300495|4215659|B2|Male||Sex/Gender, Customized||Participants|Count of Participants|4|4.0||||||
4389994|NCT00300495|4215660|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|6|6.0||||||
4389995|NCT00300495|4215658|B3|Age > 18||Age, Customized||Participants|Count of Participants|19|19.0||||||
4389996|NCT00300495|4215659|B2|Age > 18||Age, Customized||Participants|Count of Participants|9|9.0||||||
4389997|NCT00300495|4215660|B1|Age > 18||Age, Customized||Participants|Count of Participants|10|10.0||||||
4389998|NCT00300482|4215669|B7|North America||Region of Enrollment||participants|Number|1439|1439.0||||||
4389999|NCT00300482|4215670|B6|North America||Region of Enrollment||participants|Number|131|131.0||||||
4390000|NCT00300482|4215671|B5|North America||Region of Enrollment||participants|Number|266|266.0||||||
4390001|NCT00300482|4215672|B4|North America||Region of Enrollment||participants|Number|261|261.0||||||
4390002|NCT00300482|4215673|B3|North America||Region of Enrollment||participants|Number|259|259.0||||||
4390003|NCT00300482|4215674|B2|North America||Region of Enrollment||participants|Number|261|261.0||||||
4390004|NCT00300482|4215675|B1|North America||Region of Enrollment||participants|Number|261|261.0||||||
4390005|NCT00300482|4215669|B7||Male|Sex: Female, Male||Participants|Count of Participants|689|689.0||||||
4390006|NCT00300482|4215670|B6||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4390007|NCT00300482|4215671|B5||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4390008|NCT00300482|4215672|B4||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4390009|NCT00300482|4215673|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4390010|NCT00300482|4215674|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4390011|NCT00300482|4215675|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4390012|NCT00300482|4215669|B7||Female|Sex: Female, Male||Participants|Count of Participants|750|750.0||||||
4390013|NCT00300482|4215670|B6||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4390014|NCT00300482|4215671|B5||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4390015|NCT00300482|4215672|B4||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4390016|NCT00300482|4215673|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4390017|NCT00300482|4215674|B2||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4390018|NCT00300482|4215675|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4390019|NCT00300482|4215669|B7||>=65 years|Age||Participants|Count of Participants|273|273.0||||||
4390020|NCT00300482|4215670|B6||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4390021|NCT00300482|4215671|B5||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4390022|NCT00300482|4215672|B4||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4390023|NCT00300482|4215673|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4390024|NCT00300482|4215674|B2||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4390025|NCT00300482|4215675|B1||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4390026|NCT00300482|4215669|B7||Between 18 and 65 years|Age||Participants|Count of Participants|1166|1166.0||||||
4390027|NCT00300482|4215670|B6||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4390028|NCT00300482|4215671|B5||Between 18 and 65 years|Age||Participants|Count of Participants|217|217.0||||||
4390029|NCT00300482|4215672|B4||Between 18 and 65 years|Age||Participants|Count of Participants|222|222.0||||||
4390030|NCT00300482|4215673|B3||Between 18 and 65 years|Age||Participants|Count of Participants|209|209.0||||||
4390031|NCT00300482|4215674|B2||Between 18 and 65 years|Age||Participants|Count of Participants|209|209.0||||||
4390032|NCT00300482|4215675|B1||Between 18 and 65 years|Age||Participants|Count of Participants|206|206.0||||||
4390033|NCT00300482|4215669|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390034|NCT00300482|4215670|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390035|NCT00300482|4215671|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390036|NCT00300482|4215672|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390037|NCT00300482|4215673|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390038|NCT00300482|4215674|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390039|NCT00300482|4215675|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390040|NCT00300469|4215736|B7|North America||Region of Enrollment||participants|Number|609|609.0||||||
4390041|NCT00300469|4215737|B6|North America||Region of Enrollment||participants|Number|55|55.0||||||
4390042|NCT00300469|4215738|B5|North America||Region of Enrollment||participants|Number|109|109.0||||||
4390043|NCT00300469|4215739|B4|North America||Region of Enrollment||participants|Number|113|113.0||||||
4390044|NCT00300469|4215740|B3|North America||Region of Enrollment||participants|Number|112|112.0||||||
4390045|NCT00300469|4215741|B2|North America||Region of Enrollment||participants|Number|110|110.0||||||
4390046|NCT00300469|4215742|B1|North America||Region of Enrollment||participants|Number|110|110.0||||||
4390047|NCT00300469|4215736|B7||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4390048|NCT00300469|4215737|B6||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4390049|NCT00300469|4215738|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4390050|NCT00300469|4215739|B4||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4390051|NCT00300469|4215740|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4390052|NCT00300469|4215741|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4390053|NCT00300469|4215742|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4390054|NCT00300469|4215736|B7||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4390055|NCT00300469|4215737|B6||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4390056|NCT00300469|4215738|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4390057|NCT00300469|4215739|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4390058|NCT00300469|4215740|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4390059|NCT00300469|4215741|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4390060|NCT00300469|4215742|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4390061|NCT00300469|4215736|B7||>=65 years|Age||Participants|Count of Participants|119|119.0||||||
4390062|NCT00300469|4215737|B6||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4390063|NCT00300469|4215738|B5||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4390064|NCT00300469|4215739|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4390065|NCT00300469|4215740|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4390066|NCT00300469|4215741|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4390067|NCT00300469|4215742|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4390068|NCT00300469|4215736|B7||Between 18 and 65 years|Age||Participants|Count of Participants|489|489.0||||||
4390069|NCT00300469|4215737|B6||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4390070|NCT00300469|4215738|B5||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4390071|NCT00300469|4215739|B4||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4390072|NCT00300469|4215740|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4390073|NCT00300469|4215741|B2||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4390074|NCT00300469|4215742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4390075|NCT00300469|4215736|B7||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4390076|NCT00300469|4215737|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390077|NCT00300469|4215738|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390078|NCT00300469|4215739|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390079|NCT00300469|4215740|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390080|NCT00300469|4215741|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4390081|NCT00300469|4215742|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390082|NCT00300456|4215803|B7|North America||Region of Enrollment||participants|Number|650|650.0||||||
4390083|NCT00300456|4215804|B6|North America||Region of Enrollment||participants|Number|59|59.0||||||
4390084|NCT00300456|4215805|B5|North America||Region of Enrollment||participants|Number|116|116.0||||||
4390085|NCT00300456|4215806|B4|North America||Region of Enrollment||participants|Number|119|119.0||||||
4390086|NCT00300456|4215807|B3|North America||Region of Enrollment||participants|Number|119|119.0||||||
4390087|NCT00300456|4215808|B2|North America||Region of Enrollment||participants|Number|118|118.0||||||
4390088|NCT00300456|4215809|B1|North America||Region of Enrollment||participants|Number|119|119.0||||||
4390089|NCT00300456|4215803|B7||Male|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4390090|NCT00300456|4215804|B6||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4390091|NCT00300456|4215805|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4390092|NCT00300456|4215806|B4||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4390093|NCT00300456|4215807|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4390094|NCT00300456|4215808|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4390095|NCT00300456|4215809|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4390096|NCT00300456|4215803|B7||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4390097|NCT00300456|4215804|B6||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4390098|NCT00300456|4215805|B5||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4390099|NCT00300456|4215806|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4390100|NCT00300456|4215807|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4390101|NCT00300456|4215808|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4390102|NCT00300456|4215809|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4390103|NCT00300456|4215803|B7||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
4390104|NCT00300456|4215804|B6||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4390105|NCT00300456|4215805|B5||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4390106|NCT00300456|4215806|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4390107|NCT00300456|4215807|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4390108|NCT00300456|4215808|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4390109|NCT00300456|4215809|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4390110|NCT00300456|4215803|B7||Between 18 and 65 years|Age||Participants|Count of Participants|551|551.0||||||
4390111|NCT00300456|4215804|B6||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4390112|NCT00300456|4215805|B5||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4390113|NCT00300456|4215806|B4||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4390114|NCT00300456|4215807|B3||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4390115|NCT00300456|4215808|B2||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4390116|NCT00300456|4215809|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4390117|NCT00300456|4215803|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390118|NCT00300456|4215804|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390119|NCT00300456|4215805|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390120|NCT00300456|4215806|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390121|NCT00300456|4215807|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390122|NCT00300456|4215808|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390123|NCT00300456|4215809|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390124|NCT00300430|4215870|B4|North America||Region of Enrollment||participants|Number|2201|2201.0||||||
4390125|NCT00300430|4215871|B3|North America||Region of Enrollment||participants|Number|501|501.0||||||
4390126|NCT00300430|4215872|B2|North America||Region of Enrollment||participants|Number|514|514.0||||||
4390127|NCT00300430|4215873|B1|North America||Region of Enrollment||participants|Number|1186|1186.0||||||
4390128|NCT00300430|4215870|B4||Male|Sex: Female, Male||Participants|Count of Participants|1081|1081.0||||||
4390129|NCT00300430|4215871|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4390130|NCT00300430|4215872|B2||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4390131|NCT00300430|4215873|B1||Male|Sex: Female, Male||Participants|Count of Participants|578|578.0||||||
4390132|NCT00300430|4215870|B4||Female|Sex: Female, Male||Participants|Count of Participants|1120|1120.0||||||
4390133|NCT00300430|4215871|B3||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4390134|NCT00300430|4215872|B2||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4390135|NCT00300430|4215873|B1||Female|Sex: Female, Male||Participants|Count of Participants|608|608.0||||||
4390136|NCT00300430|4215870|B4|||Age||years|Mean|55.0|55.0|Standard Deviation|10.69|10.69|||
4390137|NCT00300430|4215871|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|10.86|10.86|||
4390138|NCT00300430|4215872|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|10.25|10.25|||
4390139|NCT00300430|4215873|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|10.79|10.79|||
4390140|NCT00300430|4215870|B4||>=65 years|Age||Participants|Count of Participants|398|398.0||||||
4390141|NCT00300430|4215871|B3||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
4390142|NCT00300430|4215872|B2||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4390143|NCT00300430|4215873|B1||>=65 years|Age||Participants|Count of Participants|221|221.0||||||
4390144|NCT00300430|4215870|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1802|1802.0||||||
4390145|NCT00300430|4215871|B3||Between 18 and 65 years|Age||Participants|Count of Participants|397|397.0||||||
4390146|NCT00300430|4215872|B2||Between 18 and 65 years|Age||Participants|Count of Participants|440|440.0||||||
4390147|NCT00300430|4215873|B1||Between 18 and 65 years|Age||Participants|Count of Participants|965|965.0||||||
4390148|NCT00300430|4215870|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4390149|NCT00300430|4215871|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4390150|NCT00300430|4215872|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390151|NCT00300430|4215873|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390152|NCT00300391|4215907|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4390153|NCT00300391|4215908|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4390154|NCT00300391|4215909|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4390155|NCT00300391|4215907|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4390156|NCT00300391|4215908|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4390157|NCT00300391|4215909|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4390158|NCT00300391|4215907|B3|>=18 Years||Age, Customized||Participants|Count of Participants|30|30.0||||||
4390159|NCT00300391|4215908|B2|>=18 Years||Age, Customized||Participants|Count of Participants|14|14.0||||||
4390160|NCT00300391|4215909|B1|>=18 Years||Age, Customized||Participants|Count of Participants|16|16.0||||||
4390161|NCT00300365|4215926|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4390162|NCT00300365|4215927|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4390163|NCT00300365|4215928|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4390164|NCT00300365|4215926|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4390165|NCT00300365|4215927|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4390166|NCT00300365|4215928|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4390167|NCT00300365|4215926|B3|African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4390168|NCT00300365|4215927|B2|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4390169|NCT00300365|4215928|B1|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4390170|NCT00300365|4215926|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4390171|NCT00300365|4215927|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4390172|NCT00300365|4215928|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4390173|NCT00300365|4215926|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4390174|NCT00300365|4215927|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4390175|NCT00300365|4215928|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4390176|NCT00300365|4215926|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4390177|NCT00300365|4215927|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4390178|NCT00300365|4215928|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4390179|NCT00300365|4215926|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|12.2|12.2|||
4390180|NCT00300365|4215927|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|12.2|12.2|||
4390181|NCT00300365|4215928|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|12.1|12.1|||
4390182|NCT00300274|4215935|B4||Male|Sex: Female, Male||Participants|Count of Participants|574|574.0||||||
4390183|NCT00300274|4215936|B3||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4390184|NCT00300274|4215937|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4390185|NCT00300274|4215938|B1||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4390186|NCT00300274|4215935|B4||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4390187|NCT00300274|4215936|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4390188|NCT00300274|4215937|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4390189|NCT00300274|4215938|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4390190|NCT00300274|4215935|B4|||Age||years|Mean|50.3|50.3|Standard Deviation|11.6|11.6|||
4390191|NCT00300274|4215936|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|11.88|11.88|||
4390192|NCT00300274|4215937|B2|||Age||years|Mean|48.9|48.9|Standard Deviation|12.06|12.06|||
4390193|NCT00300274|4215938|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|10.99|10.99|||
4390194|NCT00300235|4215975|B6|United States||Region of Enrollment||participants|Number|1459.0|1459.0||||||
4390195|NCT00300235|4215976|B5|United States||Region of Enrollment||participants|Number|251|251.0||||||
4390196|NCT00300235|4215977|B4|United States||Region of Enrollment||participants|Number|362|362.0||||||
4390197|NCT00300235|4215978|B3|United States||Region of Enrollment||participants|Number|398|398.0||||||
4390198|NCT00300235|4215979|B2|United States||Region of Enrollment||participants|Number|240|240.0||||||
4390199|NCT00300235|4215980|B1|United States||Region of Enrollment||participants|Number|208|208.0||||||
4390200|NCT00300235|4215975|B6||Male|Sex: Female, Male||Participants|Count of Participants|1459.0|1459.0||||||
4390201|NCT00300235|4215976|B5||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4390202|NCT00300235|4215977|B4||Male|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4390203|NCT00300235|4215978|B3||Male|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4390204|NCT00300235|4215979|B2||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4390205|NCT00300235|4215980|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4390206|NCT00300235|4215975|B6||Female|Sex: Female, Male||Participants|Count of Participants|0.0|0.0||||||
4390207|NCT00300235|4215976|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390208|NCT00300235|4215977|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390209|NCT00300235|4215978|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390210|NCT00300235|4215979|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390211|NCT00300235|4215980|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390212|NCT00300235|4215975|B6|||Age||years|Mean|22.5|22.5|Standard Deviation|12.65|12.65|||
4390213|NCT00300235|4215976|B5|||Age||years|Mean|29.8|29.8|Standard Deviation|13.69|13.69|||
4390214|NCT00300235|4215977|B4|||Age||years|Mean|36.0|36.0|Standard Deviation|8.93|8.93|||
4390215|NCT00300235|4215978|B3|||Age||years|Mean|19.3|19.3|Standard Deviation|2.72|2.72|||
4390216|NCT00300235|4215979|B2|||Age||years|Mean|12.6|12.6|Standard Deviation|1.46|1.46|||
4390217|NCT00300235|4215980|B1|||Age||years|Mean|7.4|7.4|Standard Deviation|1.44|1.44|||
4390218|NCT00300235|4215975|B6||>=65 years|Age||Participants|Count of Participants|3.0|3.0||||||
4390219|NCT00300235|4215976|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4390220|NCT00300235|4215977|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4390221|NCT00300235|4215978|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4390222|NCT00300235|4215979|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4390223|NCT00300235|4215980|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4390224|NCT00300235|4215975|B6||Between 18 and 65 years|Age||Participants|Count of Participants|721.0|721.0||||||
4390225|NCT00300235|4215976|B5||Between 18 and 65 years|Age||Participants|Count of Participants|165|165.0||||||
4390226|NCT00300235|4215977|B4||Between 18 and 65 years|Age||Participants|Count of Participants|361|361.0||||||
4390227|NCT00300235|4215978|B3||Between 18 and 65 years|Age||Participants|Count of Participants|195|195.0||||||
4390228|NCT00300235|4215979|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4390229|NCT00300235|4215980|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4390230|NCT00300235|4215975|B6||<=18 years|Age||Participants|Count of Participants|735.0|735.0||||||
4390231|NCT00300235|4215976|B5||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
4390232|NCT00300235|4215977|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390233|NCT00300235|4215978|B3||<=18 years|Age||Participants|Count of Participants|203|203.0||||||
4390234|NCT00300235|4215979|B2||<=18 years|Age||Participants|Count of Participants|240|240.0||||||
4390235|NCT00300235|4215980|B1||<=18 years|Age||Participants|Count of Participants|208|208.0||||||
4390236|NCT00299975|4215996|B4|||Severity of Constipation|It was a 7-point ordinal scale from 0=not at all to 6=very severe.|Units on a scale|Mean|4.2|4.2|Standard Deviation|1.3|1.3|||
4390237|NCT00299975|4215997|B3|||Severity of Constipation|It was a 7-point ordinal scale from 0=not at all to 6=very severe.|Units on a scale|Mean|4.3|4.3|Standard Deviation|1.5|1.5|||
4390238|NCT00299975|4215998|B2|||Severity of Constipation|It was a 7-point ordinal scale from 0=not at all to 6=very severe.|Units on a scale|Mean|4.1|4.1|Standard Deviation|1.3|1.3|||
4390239|NCT00299975|4215999|B1|||Severity of Constipation|It was a 7-point ordinal scale from 0=not at all to 6=very severe.|Units on a scale|Mean|4.2|4.2|Standard Deviation|1.1|1.1|||
4390240|NCT00299975|4215996|B4|||No. of days taking rescue therapy|Any medications, including laxatives, enemas and Chinese herbal medicine, for facilitating bowel movements.|days per week|Mean|2.1|2.1|Standard Deviation|3.1|3.1|||
4390241|NCT00299975|4215997|B3|||No. of days taking rescue therapy|Any medications, including laxatives, enemas and Chinese herbal medicine, for facilitating bowel movements.|days per week|Mean|2.2|2.2|Standard Deviation|3.2|3.2|||
4390242|NCT00299975|4215998|B2|||No. of days taking rescue therapy|Any medications, including laxatives, enemas and Chinese herbal medicine, for facilitating bowel movements.|days per week|Mean|2.4|2.4|Standard Deviation|3.3|3.3|||
4390243|NCT00299975|4215999|B1|||No. of days taking rescue therapy|Any medications, including laxatives, enemas and Chinese herbal medicine, for facilitating bowel movements.|days per week|Mean|1.7|1.7|Standard Deviation|2.8|2.8|||
4390244|NCT00299975|4215996|B4|||Complete Spontaneous Bowel Movement (CSBM)|CSBM referred to the feeling that defecation led to complete passage of stool rather than partial or incomplete evacuation without the use of any laxative or enema within 24 hours.|movements per week|Mean|0.5|0.5|Standard Deviation|0.7|0.7|||
4390245|NCT00299975|4215997|B3|||Complete Spontaneous Bowel Movement (CSBM)|CSBM referred to the feeling that defecation led to complete passage of stool rather than partial or incomplete evacuation without the use of any laxative or enema within 24 hours.|movements per week|Mean|0.5|0.5|Standard Deviation|0.7|0.7|||
4390246|NCT00299975|4215998|B2|||Complete Spontaneous Bowel Movement (CSBM)|CSBM referred to the feeling that defecation led to complete passage of stool rather than partial or incomplete evacuation without the use of any laxative or enema within 24 hours.|movements per week|Mean|0.5|0.5|Standard Deviation|0.7|0.7|||
4390247|NCT00299975|4215999|B1|||Complete Spontaneous Bowel Movement (CSBM)|CSBM referred to the feeling that defecation led to complete passage of stool rather than partial or incomplete evacuation without the use of any laxative or enema within 24 hours.|movements per week|Mean|0.5|0.5|Standard Deviation|0.6|0.6|||
4390248|NCT00299975|4215996|B4|||Bowel Movement||movements per week|Mean|3.8|3.8|Standard Deviation|2.7|2.7|||
4390249|NCT00299975|4215997|B3|||Bowel Movement||movements per week|Mean|4.7|4.7|Standard Deviation|4.1|4.1|||
4390250|NCT00299975|4215998|B2|||Bowel Movement||movements per week|Mean|3.1|3.1|Standard Deviation|1.4|1.4|||
4390251|NCT00299975|4215999|B1|||Bowel Movement||movements per week|Mean|3.6|3.6|Standard Deviation|1.5|1.5|||
4390252|NCT00299975|4215996|B4|||Duration of constipation||years|Mean|13.2|13.2|Standard Deviation|9.9|9.9|||
4390253|NCT00299975|4215997|B3|||Duration of constipation||years|Mean|15.0|15.0|Standard Deviation|10.9|10.9|||
4390254|NCT00299975|4215998|B2|||Duration of constipation||years|Mean|13.7|13.7|Standard Deviation|10.0|10.0|||
4390255|NCT00299975|4215999|B1|||Duration of constipation||years|Mean|10.9|10.9|Standard Deviation|8.5|8.5|||
4390256|NCT00299975|4215996|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4390257|NCT00299975|4215997|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4390258|NCT00299975|4215998|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4390259|NCT00299975|4215999|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4390260|NCT00299975|4215996|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4390261|NCT00299975|4215997|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4390262|NCT00299975|4215998|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4390263|NCT00299975|4215999|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4390264|NCT00299975|4215996|B4|||Age||years|Mean|36.8|36.8|Standard Deviation|9.6|9.6|||
4390265|NCT00299975|4215997|B3|||Age||years|Mean|36.1|36.1|Standard Deviation|9.2|9.2|||
4390266|NCT00299975|4215998|B2|||Age||years|Mean|38.8|38.8|Standard Deviation|9.9|9.9|||
4390267|NCT00299975|4215999|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|9.8|9.8|||
4390268|NCT00299741|4216051|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4390269|NCT00299741|4216051|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4390270|NCT00299741|4216051|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390271|NCT00299741|4216051|B1|||Age||years|Mean|68|68.0|Standard Deviation|10|10.0|||
4390272|NCT00299741|4216051|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4390273|NCT00299741|4216051|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4390274|NCT00299741|4216051|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390275|NCT00299702|4216056|B3|South America||Region of Enrollment||participants|Number|70|70.0||||||
4390276|NCT00299702|4216057|B2|South America||Region of Enrollment||participants|Number|33|33.0||||||
4390277|NCT00299702|4216058|B1|South America||Region of Enrollment||participants|Number|37|37.0||||||
4390278|NCT00299702|4216056|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
4390279|NCT00299702|4216057|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4390280|NCT00299702|4216058|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4390281|NCT00299702|4216056|B3|India||Region of Enrollment||participants|Number|182|182.0||||||
4390282|NCT00299702|4216057|B2|India||Region of Enrollment||participants|Number|91|91.0||||||
4390283|NCT00299702|4216058|B1|India||Region of Enrollment||participants|Number|91|91.0||||||
4390284|NCT00299702|4216056|B3||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4390285|NCT00299702|4216057|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4390286|NCT00299702|4216058|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4390287|NCT00299702|4216056|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4390288|NCT00299702|4216057|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4390289|NCT00299702|4216058|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4390290|NCT00299702|4216056|B3|||Age||years|Mean|38|38.0|Standard Deviation|11.56|11.56|||
4390291|NCT00299702|4216057|B2|||Age||years|Mean|37.8|37.8|Standard Deviation|11.49|11.49|||
4390292|NCT00299702|4216058|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|11.66|11.66|||
4390293|NCT00299702|4216056|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4390294|NCT00299702|4216057|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4390295|NCT00299702|4216058|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4390296|NCT00299702|4216056|B3||Between 18 and 65 years|Age||Participants|Count of Participants|350|350.0||||||
4390297|NCT00299702|4216057|B2||Between 18 and 65 years|Age||Participants|Count of Participants|173|173.0||||||
4390298|NCT00299702|4216058|B1||Between 18 and 65 years|Age||Participants|Count of Participants|177|177.0||||||
4390299|NCT00299702|4216056|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390300|NCT00299702|4216057|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390301|NCT00299702|4216058|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390302|NCT00299689|4216067|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4390303|NCT00299689|4216067|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4390304|NCT00299689|4216067|B1|>= 18 years||Age, Customized||Participants|Number|69|69.0||||||
4390305|NCT00299546|4216071|B4||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4390306|NCT00299546|4216072|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4390307|NCT00299546|4216073|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4390308|NCT00299546|4216074|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4390309|NCT00299546|4216071|B4||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4390310|NCT00299546|4216072|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4390311|NCT00299546|4216073|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4390312|NCT00299546|4216074|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4390313|NCT00299546|4216071|B4|||Age||years|Mean|54.1|54.1|Standard Deviation|12.27|12.27|||
4390314|NCT00299546|4216072|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|12.26|12.26|||
4390315|NCT00299546|4216073|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|11.47|11.47|||
4390316|NCT00299546|4216074|B1|||Age||years|Mean|54.8|54.8|Standard Deviation|13.07|13.07|||
4390317|NCT00299494|4216101|B7||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4390318|NCT00299494|4216102|B6||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4390319|NCT00299494|4216103|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4390320|NCT00299494|4216104|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4390321|NCT00299494|4216105|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4390322|NCT00299494|4216106|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4390323|NCT00299494|4216107|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4390324|NCT00299494|4216101|B7||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4390325|NCT00299494|4216102|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4390326|NCT00299494|4216103|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4390327|NCT00299494|4216104|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4390328|NCT00299494|4216105|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4390329|NCT00299494|4216106|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4390330|NCT00299494|4216107|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4390331|NCT00299494|4216101|B7|||Age||Years|Mean|62.1|62.1|Standard Deviation|13.7|13.7|||
4390332|NCT00299494|4216102|B6|||Age||Years|Mean|55.5|55.5|Standard Deviation|15.8|15.8|||
4390333|NCT00299494|4216103|B5|||Age||Years|Mean|67.2|67.2|Standard Deviation|13.0|13.0|||
4390334|NCT00299494|4216104|B4|||Age||Years|Mean|61.7|61.7|Standard Deviation|12.2|12.2|||
4390335|NCT00299494|4216105|B3|||Age||Years|Mean|60.7|60.7|Standard Deviation|9.6|9.6|||
4390336|NCT00299494|4216106|B2|||Age||Years|Mean|65.7|65.7|Standard Deviation|0.6|0.6|||
4390337|NCT00299494|4216107|B1|||Age||Years|Mean|63.4|63.4|Standard Deviation|10.9|10.9|||
4390338|NCT00299416|4216215|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4390339|NCT00299416|4216215|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4390340|NCT00299416|4216215|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4390341|NCT00299416|4216215|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|15.6|15.6|||
4390342|NCT00299416|4216215|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4390343|NCT00299416|4216215|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4390344|NCT00299416|4216215|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390345|NCT00299221|4216221|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4390346|NCT00299221|4216222|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4390347|NCT00299221|4216223|B1|United States||Region of Enrollment||participants|Number|79|79.0||||||
4390348|NCT00299221|4216221|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4390349|NCT00299221|4216222|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4390350|NCT00299221|4216223|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4390351|NCT00299221|4216221|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4390352|NCT00299221|4216222|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4390353|NCT00299221|4216223|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4390354|NCT00299221|4216221|B3|||Age||years|Mean|54.65|54.65|Standard Deviation|10|10.0|||
4390355|NCT00299221|4216222|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|11.6|11.6|||
4390356|NCT00299221|4216223|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|10.7|10.7|||
4390357|NCT00299221|4216221|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4390358|NCT00299221|4216222|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4390359|NCT00299221|4216223|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4390360|NCT00299221|4216221|B3||Between 18 and 65 years|Age||Participants|Count of Participants|121|121.0||||||
4390361|NCT00299221|4216222|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4390362|NCT00299221|4216223|B1||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4390363|NCT00299221|4216221|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390364|NCT00299221|4216222|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390365|NCT00299221|4216223|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390366|NCT00299156|4216238|B4|United States||Region of Enrollment||participants|Number|65|65.0||||||
4390367|NCT00299156|4216239|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4390368|NCT00299156|4216240|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4390369|NCT00299156|4216241|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4390370|NCT00299156|4216238|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4390371|NCT00299156|4216239|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4390372|NCT00299156|4216240|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4390373|NCT00299156|4216241|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4390374|NCT00299156|4216238|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4390375|NCT00299156|4216239|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4390376|NCT00299156|4216240|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4390377|NCT00299156|4216241|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4390378|NCT00299156|4216238|B4|||Age||years|Median|70.0|70.0|Full Range|||43.0|87.0|
4390379|NCT00299156|4216239|B3|||Age||years|Median|72.5|72.5|Full Range|||54.0|84.0|
4390380|NCT00299156|4216240|B2|||Age||years|Median|67.5|67.5|Full Range|||43.0|87.0|
4390381|NCT00299156|4216241|B1|||Age||years|Median|70.0|70.0|Full Range|||53.0|86.0|
4390382|NCT00299130|4216251|B4||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4390383|NCT00299130|4216252|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4390384|NCT00299130|4216253|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4390385|NCT00299130|4216254|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4390386|NCT00299130|4216251|B4||Female|Sex: Female, Male||Participants|Count of Participants|418|418.0||||||
4390387|NCT00299130|4216252|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4390388|NCT00299130|4216253|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4390389|NCT00299130|4216254|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4390390|NCT00299130|4216251|B4|||Age||years|Mean|51.80|51.8|Standard Deviation|12.64|12.64|||
4390391|NCT00299130|4216252|B3|||Age||years|Mean|51.30|51.3|Standard Deviation|12.64|12.64|||
4390392|NCT00299130|4216253|B2|||Age||years|Mean|51.91|51.91|Standard Deviation|12.93|12.93|||
4390393|NCT00299130|4216254|B1|||Age||years|Mean|52.16|52.16|Standard Deviation|12.39|12.39|||
4390394|NCT00299104|4216358|B4||Male|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|141|141.0||||||
4390395|NCT00299104|4216359|B3||Male|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|38|38.0||||||
4390396|NCT00299104|4216360|B2||Male|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|46|46.0||||||
4390397|NCT00299104|4216361|B1||Male|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|57|57.0||||||
4390398|NCT00299104|4216358|B4||Female|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|607|607.0||||||
4390399|NCT00299104|4216359|B3||Female|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|212|212.0||||||
4390400|NCT00299104|4216360|B2||Female|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|203|203.0||||||
4390401|NCT00299104|4216361|B1||Female|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|192|192.0||||||
4390402|NCT00299104|4216358|B4|||Age|Intent-to-treat population|years|Mean|47.94|47.94|Standard Deviation|13.136|13.136|||
4390403|NCT00299104|4216359|B3|||Age|Intent-to-treat population|years|Mean|47.89|47.89|Standard Deviation|13.324|13.324|||
4390404|NCT00299104|4216360|B2|||Age|Intent-to-treat population|years|Mean|47.87|47.87|Standard Deviation|13.391|13.391|||
4390405|NCT00299104|4216361|B1|||Age|Intent-to-treat population|years|Mean|48.06|48.06|Standard Deviation|12.692|12.692|||
4390406|NCT00299000|4216458|B3|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4390407|NCT00299000|4216459|B2|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4390408|NCT00299000|4216460|B1|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
4390409|NCT00299000|4216458|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4390410|NCT00299000|4216459|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4390411|NCT00299000|4216460|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4390412|NCT00299000|4216458|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4390413|NCT00299000|4216459|B2|United States||Region of Enrollment||participants|Number|0|0.0||||||
4390414|NCT00299000|4216460|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4390415|NCT00299000|4216458|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4390416|NCT00299000|4216459|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4390417|NCT00299000|4216460|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4390418|NCT00299000|4216458|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4390419|NCT00299000|4216459|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4390420|NCT00299000|4216460|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4390421|NCT00299000|4216458|B3|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4390422|NCT00299000|4216459|B2|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4390423|NCT00299000|4216460|B1|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4390424|NCT00299000|4216458|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4390425|NCT00299000|4216459|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4390426|NCT00299000|4216460|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4390427|NCT00299000|4216458|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390428|NCT00299000|4216459|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390429|NCT00299000|4216460|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390430|NCT00299000|4216458|B3|||Age||months|Mean|9.23|9.23|Standard Deviation|4.31|4.31|||
4390431|NCT00299000|4216459|B2|||Age||months|Mean|12.4|12.4|Standard Deviation|0.42|0.42|||
4390432|NCT00299000|4216460|B1|||Age||months|Mean|6.05|6.05|Standard Deviation|3.89|3.89|||
4390433|NCT00299000|4216458|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4390434|NCT00299000|4216459|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4390435|NCT00299000|4216460|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4390436|NCT00299000|4216458|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4390437|NCT00299000|4216459|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4390438|NCT00299000|4216460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4390439|NCT00299000|4216458|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4390440|NCT00299000|4216459|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4390441|NCT00299000|4216460|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4390442|NCT00298896|4216473|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4390443|NCT00298896|4216473|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4390444|NCT00298896|4216473|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390445|NCT00298896|4216473|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390446|NCT00298896|4216473|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4390447|NCT00298896|4216473|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4390448|NCT00298896|4216473|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390449|NCT00298896|4216473|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390450|NCT00298896|4216473|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390451|NCT00298896|4216473|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4390452|NCT00298896|4216473|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4390453|NCT00298896|4216473|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|9.46|9.46|||
4390454|NCT00298766|4216478|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4390455|NCT00298766|4216478|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4390456|NCT00298766|4216478|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4390457|NCT00298766|4216478|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4390458|NCT00298766|4216478|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4390459|NCT00298766|4216478|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4390460|NCT00298766|4216478|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4390461|NCT00298766|4216478|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4390462|NCT00298766|4216478|B1|||Age||years|Mean|61|61.0|Standard Deviation|10.10|10.1|||
4390463|NCT00298766|4216478|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4390464|NCT00298766|4216478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4390465|NCT00298766|4216478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390466|NCT00298740|4216487|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4390467|NCT00298740|4216487|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4390468|NCT00298740|4216487|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4390469|NCT00298740|4216487|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4390470|NCT00298740|4216487|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4390471|NCT00298740|4216487|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390472|NCT00298610|4216491|B1|Kenya||Region of Enrollment||participants|Number|30|30.0||||||
4390473|NCT00298610|4216491|B1|Tribe = Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4390474|NCT00298610|4216491|B1|Tribe = Luyha||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4390475|NCT00298610|4216491|B1|Tribe = Luo||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4390476|NCT00298610|4216491|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390477|NCT00298610|4216491|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390478|NCT00298610|4216491|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390479|NCT00298610|4216491|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4390480|NCT00298610|4216491|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390481|NCT00298610|4216491|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390482|NCT00298610|4216491|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390483|NCT00298610|4216491|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4390484|NCT00298610|4216491|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4390485|NCT00298610|4216491|B1|||Age||years|Mean|28|28.0|Standard Deviation|9.4|9.4|||
4390486|NCT00298610|4216491|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4390487|NCT00298610|4216491|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4390488|NCT00298610|4216491|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390489|NCT00298558|4216501|B5|United States||Region of Enrollment||participants|Number|2802|2802.0||||||
4390490|NCT00298558|4216502|B4|United States||Region of Enrollment||participants|Number|698|698.0||||||
4390491|NCT00298558|4216503|B3|United States||Region of Enrollment||participants|Number|702|702.0||||||
4390492|NCT00298558|4216504|B2|United States||Region of Enrollment||participants|Number|699|699.0||||||
4390493|NCT00298558|4216505|B1|United States||Region of Enrollment||participants|Number|703|703.0||||||
4390494|NCT00298558|4216501|B5||Male|Sex: Female, Male||Participants|Count of Participants|676|676.0||||||
4390495|NCT00298558|4216502|B4||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4390496|NCT00298558|4216503|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4390497|NCT00298558|4216504|B2||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4390498|NCT00298558|4216505|B1||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4390499|NCT00298558|4216501|B5||Female|Sex: Female, Male||Participants|Count of Participants|2126|2126.0||||||
4390500|NCT00298558|4216502|B4||Female|Sex: Female, Male||Participants|Count of Participants|514|514.0||||||
4390501|NCT00298558|4216503|B3||Female|Sex: Female, Male||Participants|Count of Participants|538|538.0||||||
4390502|NCT00298558|4216504|B2||Female|Sex: Female, Male||Participants|Count of Participants|537|537.0||||||
4390503|NCT00298558|4216505|B1||Female|Sex: Female, Male||Participants|Count of Participants|537|537.0||||||
4390504|NCT00298558|4216501|B5|||Age||years|Mean|73.6|73.6|Standard Deviation|5.91|5.91|||
4390505|NCT00298558|4216502|B4|||Age||years|Mean|74.0|74.0|Standard Deviation|6.05|6.05|||
4390506|NCT00298558|4216503|B3|||Age||years|Mean|73.4|73.4|Standard Deviation|5.78|5.78|||
4390507|NCT00298558|4216504|B2|||Age||years|Mean|73.5|73.5|Standard Deviation|5.76|5.76|||
4390508|NCT00298558|4216505|B1|||Age||years|Mean|73.5|73.5|Standard Deviation|6.02|6.02|||
4390509|NCT00298558|4216501|B5||>=65 years|Age||Participants|Count of Participants|2802|2802.0||||||
4390510|NCT00298558|4216502|B4||>=65 years|Age||Participants|Count of Participants|698|698.0||||||
4390511|NCT00298558|4216503|B3||>=65 years|Age||Participants|Count of Participants|702|702.0||||||
4390512|NCT00298558|4216504|B2||>=65 years|Age||Participants|Count of Participants|699|699.0||||||
4390513|NCT00298558|4216505|B1||>=65 years|Age||Participants|Count of Participants|703|703.0||||||
4390514|NCT00298558|4216501|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4390515|NCT00298558|4216502|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4390516|NCT00298558|4216503|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4390517|NCT00298558|4216504|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4390518|NCT00298558|4216505|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4390519|NCT00298558|4216501|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390520|NCT00298558|4216502|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390521|NCT00298558|4216503|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390522|NCT00298558|4216504|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390523|NCT00298558|4216505|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390524|NCT00298363|4216538|B4|||BMI||kg/m^2|Mean|27.0|27.0|Standard Deviation|5.35|5.35|||
4390525|NCT00298363|4216539|B3|||BMI||kg/m^2|Mean|27.6|27.6|Standard Deviation|5.27|5.27|||
4390526|NCT00298363|4216540|B2|||BMI||kg/m^2|Mean|26.2|26.2|Standard Deviation|5.07|5.07|||
4390527|NCT00298363|4216541|B1|||BMI||kg/m^2|Mean|27.6|27.6|Standard Deviation|5.67|5.67|||
4390528|NCT00298363|4216538|B4|||Height||cm|Mean|168.1|168.1|Standard Deviation|8.20|8.2|||
4390529|NCT00298363|4216539|B3|||Height||cm|Mean|167.1|167.1|Standard Deviation|8.39|8.39|||
4390530|NCT00298363|4216540|B2|||Height||cm|Mean|168.4|168.4|Standard Deviation|8.47|8.47|||
4390531|NCT00298363|4216541|B1|||Height||cm|Mean|168.3|168.3|Standard Deviation|7.98|7.98|||
4390532|NCT00298363|4216538|B4|||Weight||kg|Mean|76.5|76.5|Standard Deviation|16.26|16.26|||
4390533|NCT00298363|4216539|B3|||Weight||kg|Mean|77.3|77.3|Standard Deviation|16.64|16.64|||
4390534|NCT00298363|4216540|B2|||Weight||kg|Mean|74.4|74.4|Standard Deviation|15.41|15.41|||
4390535|NCT00298363|4216541|B1|||Weight||kg|Mean|78.1|78.1|Standard Deviation|17.02|17.02|||
4390536|NCT00298363|4216538|B4|Not Permitted||Ethnicity||participants|Number|10|10.0||||||
4390537|NCT00298363|4216539|B3|Not Permitted||Ethnicity||participants|Number|1|1.0||||||
4390538|NCT00298363|4216540|B2|Not Permitted||Ethnicity||participants|Number|5|5.0||||||
4390539|NCT00298363|4216541|B1|Not Permitted||Ethnicity||participants|Number|4|4.0||||||
4390540|NCT00298363|4216538|B4|Not Hispanic or Latino||Ethnicity||participants|Number|99|99.0||||||
4390541|NCT00298363|4216539|B3|Not Hispanic or Latino||Ethnicity||participants|Number|21|21.0||||||
4390542|NCT00298363|4216540|B2|Not Hispanic or Latino||Ethnicity||participants|Number|39|39.0||||||
4390543|NCT00298363|4216541|B1|Not Hispanic or Latino||Ethnicity||participants|Number|39|39.0||||||
4390544|NCT00298363|4216538|B4|Hispanic or Latino||Ethnicity||participants|Number|3|3.0||||||
4390545|NCT00298363|4216539|B3|Hispanic or Latino||Ethnicity||participants|Number|0|0.0||||||
4390546|NCT00298363|4216540|B2|Hispanic or Latino||Ethnicity||participants|Number|1|1.0||||||
4390547|NCT00298363|4216541|B1|Hispanic or Latino||Ethnicity||participants|Number|2|2.0||||||
4390548|NCT00298363|4216538|B4|White||Race||participants|Number|47|47.0||||||
4390549|NCT00298363|4216539|B3|White||Race||participants|Number|8|8.0||||||
4390550|NCT00298363|4216540|B2|White||Race||participants|Number|20|20.0||||||
4390551|NCT00298363|4216541|B1|White||Race||participants|Number|19|19.0||||||
4390552|NCT00298363|4216538|B4|Other||Race||participants|Number|3|3.0||||||
4390553|NCT00298363|4216539|B3|Other||Race||participants|Number|1|1.0||||||
4390554|NCT00298363|4216540|B2|Other||Race||participants|Number|0|0.0||||||
4390555|NCT00298363|4216541|B1|Other||Race||participants|Number|2|2.0||||||
4390556|NCT00298363|4216538|B4|Black||Race||participants|Number|2|2.0||||||
4390557|NCT00298363|4216539|B3|Black||Race||participants|Number|0|0.0||||||
4390558|NCT00298363|4216540|B2|Black||Race||participants|Number|1|1.0||||||
4390559|NCT00298363|4216541|B1|Black||Race||participants|Number|1|1.0||||||
4390560|NCT00298363|4216538|B4|Asian||Race||participants|Number|60|60.0||||||
4390561|NCT00298363|4216539|B3|Asian||Race||participants|Number|13|13.0||||||
4390562|NCT00298363|4216540|B2|Asian||Race||participants|Number|24|24.0||||||
4390563|NCT00298363|4216541|B1|Asian||Race||participants|Number|23|23.0||||||
4390564|NCT00298363|4216538|B4|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4390565|NCT00298363|4216539|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4390566|NCT00298363|4216540|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4390567|NCT00298363|4216541|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4390568|NCT00298363|4216538|B4|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4390569|NCT00298363|4216539|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4390570|NCT00298363|4216540|B2|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4390571|NCT00298363|4216541|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4390572|NCT00298363|4216538|B4|Turkey||Region of Enrollment||participants|Number|12|12.0||||||
4390573|NCT00298363|4216539|B3|Turkey||Region of Enrollment||participants|Number|2|2.0||||||
4390574|NCT00298363|4216540|B2|Turkey||Region of Enrollment||participants|Number|6|6.0||||||
4390575|NCT00298363|4216541|B1|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
4390576|NCT00298363|4216538|B4|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
4390577|NCT00298363|4216539|B3|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4390578|NCT00298363|4216540|B2|Singapore||Region of Enrollment||participants|Number|3|3.0||||||
4390579|NCT00298363|4216541|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4390580|NCT00298363|4216538|B4|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4390581|NCT00298363|4216539|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4390582|NCT00298363|4216540|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4390583|NCT00298363|4216541|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4390584|NCT00298363|4216538|B4|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4390585|NCT00298363|4216539|B3|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4390586|NCT00298363|4216540|B2|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4390587|NCT00298363|4216541|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4390588|NCT00298363|4216538|B4|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4390589|NCT00298363|4216539|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4390590|NCT00298363|4216540|B2|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4390591|NCT00298363|4216541|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4390592|NCT00298363|4216538|B4|Greece||Region of Enrollment||participants|Number|6|6.0||||||
4390593|NCT00298363|4216539|B3|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4390594|NCT00298363|4216540|B2|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4390595|NCT00298363|4216541|B1|Greece||Region of Enrollment||participants|Number|4|4.0||||||
4390596|NCT00298363|4216538|B4|Taiwan||Region of Enrollment||participants|Number|38|38.0||||||
4390597|NCT00298363|4216539|B3|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4390598|NCT00298363|4216540|B2|Taiwan||Region of Enrollment||participants|Number|16|16.0||||||
4390599|NCT00298363|4216541|B1|Taiwan||Region of Enrollment||participants|Number|13|13.0||||||
4390600|NCT00298363|4216538|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
4390601|NCT00298363|4216539|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4390602|NCT00298363|4216540|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4390603|NCT00298363|4216541|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4390604|NCT00298363|4216538|B4|France||Region of Enrollment||participants|Number|1|1.0||||||
4390605|NCT00298363|4216539|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4390606|NCT00298363|4216540|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4390607|NCT00298363|4216541|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4390608|NCT00298363|4216538|B4||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4390609|NCT00298363|4216539|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4390610|NCT00298363|4216540|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4390611|NCT00298363|4216541|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4390612|NCT00298363|4216538|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4390613|NCT00298363|4216539|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4390614|NCT00298363|4216540|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4390615|NCT00298363|4216541|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4390616|NCT00298363|4216538|B4|||Age||years|Mean|51|51.0|Standard Deviation|10.0|10.0|||
4390617|NCT00298363|4216539|B3|||Age||years|Mean|52|52.0|Standard Deviation|12.0|12.0|||
4390618|NCT00298363|4216540|B2|||Age||years|Mean|49|49.0|Standard Deviation|10.1|10.1|||
4390619|NCT00298363|4216541|B1|||Age||years|Mean|53|53.0|Standard Deviation|8.8|8.8|||
4390620|NCT00298272|4216699|B3|Tender joints||Swollen and Tender Joints|Total number of swollen joints evaluated was 66 and total number of tender joints evaluated was 68.|Joint counts|Mean|24.6|24.6|Full Range|||5.0|63.0|
4390621|NCT00298272|4216700|B2|Tender joints||Swollen and Tender Joints|Total number of swollen joints evaluated was 66 and total number of tender joints evaluated was 68.|Joint counts|Mean|22.8|22.8|Full Range|||9.0|63.0|
4390622|NCT00298272|4216701|B1|Tender joints||Swollen and Tender Joints|Total number of swollen joints evaluated was 66 and total number of tender joints evaluated was 68.|Joint counts|Mean|25.6|25.6|Full Range|||5.0|56.0|
4390623|NCT00298272|4216699|B3|Swollen joints||Swollen and Tender Joints|Total number of swollen joints evaluated was 66 and total number of tender joints evaluated was 68.|Joint counts|Mean|16.0|16.0|Full Range|||5.0|43.0|
4390624|NCT00298272|4216700|B2|Swollen joints||Swollen and Tender Joints|Total number of swollen joints evaluated was 66 and total number of tender joints evaluated was 68.|Joint counts|Mean|14.2|14.2|Full Range|||6.0|30.0|
4390625|NCT00298272|4216701|B1|Swollen joints||Swollen and Tender Joints|Total number of swollen joints evaluated was 66 and total number of tender joints evaluated was 68.|Joint counts|Mean|16.9|16.9|Full Range|||5.0|43.0|
4390626|NCT00298272|4216699|B3|||C-Reactive Protein||mg/dL|Mean|0.92|0.92|Full Range|||0.0|6.3|
4390627|NCT00298272|4216700|B2|||C-Reactive Protein||mg/dL|Mean|0.83|0.83|Full Range|||0.1|3.3|
4390628|NCT00298272|4216701|B1|||C-Reactive Protein||mg/dL|Mean|0.97|0.97|Full Range|||0.0|6.3|
4390629|NCT00298272|4216699|B3|2||Number of Prior Tumor Necrosis Factor (TNF) Inhibitors||participants|Number|1|1.0||||||
4390630|NCT00298272|4216700|B2|2||Number of Prior Tumor Necrosis Factor (TNF) Inhibitors||participants|Number|0|0.0||||||
4390631|NCT00298272|4216701|B1|2||Number of Prior Tumor Necrosis Factor (TNF) Inhibitors||participants|Number|1|1.0||||||
4390632|NCT00298272|4216699|B3|1||Number of Prior Tumor Necrosis Factor (TNF) Inhibitors||participants|Number|50|50.0||||||
4390633|NCT00298272|4216700|B2|1||Number of Prior Tumor Necrosis Factor (TNF) Inhibitors||participants|Number|18|18.0||||||
4390634|NCT00298272|4216701|B1|1||Number of Prior Tumor Necrosis Factor (TNF) Inhibitors||participants|Number|32|32.0||||||
4390635|NCT00298272|4216699|B3|||Years since rheumatoid arthritis (RA) diagnosis||Years|Mean|10.5|10.5|Standard Deviation|6.9|6.9|||
4390636|NCT00298272|4216700|B2|||Years since rheumatoid arthritis (RA) diagnosis||Years|Mean|10.7|10.7|Standard Deviation|7.5|7.5|||
4390637|NCT00298272|4216701|B1|||Years since rheumatoid arthritis (RA) diagnosis||Years|Mean|10.3|10.3|Standard Deviation|6.7|6.7|||
4390638|NCT00298272|4216699|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4390639|NCT00298272|4216700|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4390640|NCT00298272|4216701|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4390641|NCT00298272|4216699|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4390642|NCT00298272|4216700|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4390643|NCT00298272|4216701|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4390644|NCT00298272|4216699|B3|||Age||Years|Mean|50.0|50.0|Standard Deviation|11.7|11.7|||
4390645|NCT00298272|4216700|B2|||Age||Years|Mean|50.4|50.4|Standard Deviation|11.4|11.4|||
4390646|NCT00298272|4216701|B1|||Age||Years|Mean|49.7|49.7|Standard Deviation|12.1|12.1|||
4390647|NCT00298233|4216723|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4390648|NCT00298233|4216724|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4390649|NCT00298233|4216725|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4390650|NCT00298233|4216723|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4390651|NCT00298233|4216724|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4390652|NCT00298233|4216725|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4390653|NCT00298233|4216723|B3|Adult cohort: ≥15 years||Age, Customized||participants|Number|80|80.0||||||
4390654|NCT00298233|4216724|B2|Adult cohort: ≥15 years||Age, Customized||participants|Number|41|41.0||||||
4390655|NCT00298233|4216725|B1|Adult cohort: ≥15 years||Age, Customized||participants|Number|39|39.0||||||
4390656|NCT00298233|4216723|B3|Child cohort: ≥1 to <15 years||Age, Customized||participants|Number|246|246.0||||||
4390657|NCT00298233|4216724|B2|Child cohort: ≥1 to <15 years||Age, Customized||participants|Number|124|124.0||||||
4390658|NCT00298233|4216725|B1|Child cohort: ≥1 to <15 years||Age, Customized||participants|Number|122|122.0||||||
4390659|NCT00298155|4216744|B4|United States||Region of Enrollment||participants|Number|35|35.0||||||
4390660|NCT00298155|4216745|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4390661|NCT00298155|4216746|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4390662|NCT00298155|4216747|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4390663|NCT00298155|4216744|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4390664|NCT00298155|4216745|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4390665|NCT00298155|4216746|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4390666|NCT00298155|4216747|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4390667|NCT00298155|4216744|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390668|NCT00298155|4216745|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390669|NCT00298155|4216746|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390670|NCT00298155|4216747|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390671|NCT00298155|4216744|B4|||Age||years|Median|64|64.0|Full Range|||41.0|82.0|
4390672|NCT00298155|4216745|B3|||Age||years|Median|60|60.0|Full Range|||41.0|82.0|
4390673|NCT00298155|4216746|B2|||Age||years|Median|66|66.0|Full Range|||41.0|82.0|
4390674|NCT00298155|4216747|B1|||Age||years|Median|62|62.0|Full Range|||41.0|82.0|
4390675|NCT00298090|4216760|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4390676|NCT00298090|4216760|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4390677|NCT00298090|4216760|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4390678|NCT00298090|4216760|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4390679|NCT00298090|4216760|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4390680|NCT00298090|4216760|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390681|NCT00297830|4216764|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390682|NCT00297830|4216765|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390683|NCT00297830|4216766|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390684|NCT00297830|4216767|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390685|NCT00297830|4216764|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4390686|NCT00297830|4216765|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4390687|NCT00297830|4216766|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4390688|NCT00297830|4216767|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4390689|NCT00297830|4216764|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4390690|NCT00297830|4216765|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4390691|NCT00297830|4216766|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4390692|NCT00297830|4216767|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4390693|NCT00297830|4216764|B4||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4390694|NCT00297830|4216765|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4390695|NCT00297830|4216766|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4390696|NCT00297830|4216767|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4390697|NCT00297830|4216764|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4390698|NCT00297830|4216765|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4390699|NCT00297830|4216766|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4390700|NCT00297830|4216767|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4390701|NCT00297830|4216764|B4|||Age||years|Mean|52.9|52.9|Standard Deviation|11.1|11.1|||
4390702|NCT00297830|4216765|B3|||Age||years|Mean|48|48.0|Standard Deviation|15|15.0|||
4390703|NCT00297830|4216766|B2|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
4390704|NCT00297830|4216767|B1|||Age||years|Mean|55|55.0|Standard Deviation|8|8.0|||
4390705|NCT00297778|4216786|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4390706|NCT00297778|4216787|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4390707|NCT00297778|4216788|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4390708|NCT00297778|4216786|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4390709|NCT00297778|4216787|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4390710|NCT00297778|4216788|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4390711|NCT00297778|4216786|B3|||Age||Years|Mean|67|67.0|Standard Deviation|9.5|9.5|||
4390712|NCT00297778|4216787|B2|||Age||Years|Mean|67.4|67.4|Standard Deviation|9.0|9.0|||
4390713|NCT00297778|4216788|B1|||Age||Years|Mean|66.6|66.6|Standard Deviation|9.9|9.9|||
4390714|NCT00297648|4216823|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4390715|NCT00297648|4216823|B1|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4390716|NCT00297648|4216823|B1|France||Region of Enrollment||participants|Number|68|68.0||||||
4390717|NCT00297648|4216823|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4390718|NCT00297648|4216823|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4390719|NCT00297648|4216823|B1|||Age||years|Mean|30.19|30.19|Standard Deviation|9.88|9.88|||
4390720|NCT00297648|4216823|B1||>=65 years|Age|Note: The 4 patients in the '<=18 years' category were all 18 years of age at Baseline.|Participants|Count of Participants|0|0.0||||||
4390721|NCT00297648|4216823|B1||Between 18 and 65 years|Age|Note: The 4 patients in the '<=18 years' category were all 18 years of age at Baseline.|Participants|Count of Participants|85|85.0||||||
4390722|NCT00297648|4216823|B1||<=18 years|Age|Note: The 4 patients in the '<=18 years' category were all 18 years of age at Baseline.|Participants|Count of Participants|4|4.0||||||
4390723|NCT00297596|4216862|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4390724|NCT00297596|4216862|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390725|NCT00297596|4216862|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4390726|NCT00297596|4216862|B1|||Age||years|Median|59|59.0|Full Range|||40.0|78.0|
4390727|NCT00297492|4216866|B4|United States||Region of Enrollment||participants|Number|746|746.0||||||
4390728|NCT00297492|4216867|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4390729|NCT00297492|4216868|B2|United States||Region of Enrollment||participants|Number|299|299.0||||||
4390730|NCT00297492|4216869|B1|United States||Region of Enrollment||participants|Number|297|297.0||||||
4390731|NCT00297492|4216866|B4||Male|Sex: Female, Male||Participants|Count of Participants|342|342.0||||||
4390732|NCT00297492|4216867|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4390733|NCT00297492|4216868|B2||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4390734|NCT00297492|4216869|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4390735|NCT00297492|4216866|B4||Female|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
4390736|NCT00297492|4216867|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4390737|NCT00297492|4216868|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4390738|NCT00297492|4216869|B1||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4390739|NCT00297492|4216866|B4|||Age||years|Mean|48|48.0|Standard Deviation|13|13.0|||
4390740|NCT00297492|4216867|B3|||Age||years|Mean|47|47.0|Standard Deviation|13|13.0|||
4390741|NCT00297492|4216868|B2|||Age||years|Mean|48|48.0|Standard Deviation|12|12.0|||
4390742|NCT00297492|4216869|B1|||Age||years|Mean|48|48.0|Standard Deviation|13|13.0|||
4390743|NCT00297492|4216866|B4||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4390744|NCT00297492|4216867|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4390745|NCT00297492|4216868|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4390746|NCT00297492|4216869|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4390747|NCT00297492|4216866|B4||Between 18 and 65 years|Age||Participants|Count of Participants|688|688.0||||||
4390748|NCT00297492|4216867|B3||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
4390749|NCT00297492|4216868|B2||Between 18 and 65 years|Age||Participants|Count of Participants|276|276.0||||||
4390750|NCT00297492|4216869|B1||Between 18 and 65 years|Age||Participants|Count of Participants|273|273.0||||||
4390751|NCT00297492|4216866|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390752|NCT00297492|4216867|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390753|NCT00297492|4216868|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390754|NCT00297492|4216869|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4390755|NCT00297427|4216879|B3|||Incontinence-Specific Quality of Life|Measured by the Incontinence Impact Questionnaire total score. Possible scores range from 0 to 300 with higher scored indicating worse urinary-specific quality of life.|units on a scale|Median|57.78|57.78|Inter-Quartile Range|||25.56|118.78|
4390756|NCT00297427|4216880|B2|||Incontinence-Specific Quality of Life|Measured by the Incontinence Impact Questionnaire total score. Possible scores range from 0 to 300 with higher scored indicating worse urinary-specific quality of life.|units on a scale|Median|61.43|61.43|Inter-Quartile Range|||20.63|118.78|
4390757|NCT00297427|4216881|B1|||Incontinence-Specific Quality of Life|Measured by the Incontinence Impact Questionnaire total score. Possible scores range from 0 to 300 with higher scored indicating worse urinary-specific quality of life.|units on a scale|Median|55.95|55.95|Inter-Quartile Range|||27.94|121.88|
4390758|NCT00297427|4216879|B3|||Physical Health-Related Quality of Life|Measured by the Medical Outcomes Study Short Form-36 (SF-36) where higher scores indicate better quality of life. Possible score range is 0 to 100.|units on a scale|Median|54.17|54.17|Inter-Quartile Range|||48.34|57.08|
4390759|NCT00297427|4216880|B2|||Physical Health-Related Quality of Life|Measured by the Medical Outcomes Study Short Form-36 (SF-36) where higher scores indicate better quality of life. Possible score range is 0 to 100.|units on a scale|Median|53.83|53.83|Inter-Quartile Range|||48.47|56.8|
4390760|NCT00297427|4216881|B1|||Physical Health-Related Quality of Life|Measured by the Medical Outcomes Study Short Form-36 (SF-36) where higher scores indicate better quality of life. Possible score range is 0 to 100.|units on a scale|Median|54.32|54.32|Inter-Quartile Range|||48.03|57.19|
4390761|NCT00297427|4216879|B3|||Mental Health-Related Quality of Life|Measured by the Medical Outcomes Short Form-36 (SF-36) where higher scores indicate better quality of life. The possible score range is 0 to 100.|units on a scale|Median|55.67|55.67|Inter-Quartile Range|||49.22|59.42|
4390762|NCT00297427|4216880|B2|||Mental Health-Related Quality of Life|Measured by the Medical Outcomes Short Form-36 (SF-36) where higher scores indicate better quality of life. The possible score range is 0 to 100.|units on a scale|Median|55.90|55.9|Inter-Quartile Range|||49.22|60.52|
4390763|NCT00297427|4216881|B1|||Mental Health-Related Quality of Life|Measured by the Medical Outcomes Short Form-36 (SF-36) where higher scores indicate better quality of life. The possible score range is 0 to 100.|units on a scale|Median|55.49|55.49|Inter-Quartile Range|||48.03|58.99|
4390764|NCT00297427|4216879|B3|||Duration of urinary incontinence||Years|Mean|9.22|9.22|Standard Deviation|9.52|9.52|||
4390765|NCT00297427|4216880|B2|||Duration of urinary incontinence||Years|Mean|8.61|8.61|Standard Deviation|9.98|9.98|||
4390766|NCT00297427|4216881|B1|||Duration of urinary incontinence||Years|Mean|9.81|9.81|Standard Deviation|9.08|9.08|||
4390767|NCT00297427|4216879|B3|||Incontinent episodes/day|Episodes of urinary incontinence per day as measured by bladder diary|episodes/day|Mean|2.39|2.39|Standard Deviation|1.87|1.87|||
4390768|NCT00297427|4216880|B2|||Incontinent episodes/day|Episodes of urinary incontinence per day as measured by bladder diary|episodes/day|Mean|2.59|2.59|Standard Deviation|2.12|2.12|||
4390769|NCT00297427|4216881|B1|||Incontinent episodes/day|Episodes of urinary incontinence per day as measured by bladder diary|episodes/day|Mean|2.19|2.19|Standard Deviation|1.57|1.57|||
4390770|NCT00297427|4216879|B3|No||Limited mobility|Number of women with self-reported limitations in mobility|participants|Number|110|110.0||||||
4390771|NCT00297427|4216880|B2|No||Limited mobility|Number of women with self-reported limitations in mobility|participants|Number|54|54.0||||||
4390772|NCT00297427|4216881|B1|No||Limited mobility|Number of women with self-reported limitations in mobility|participants|Number|56|56.0||||||
4390773|NCT00297427|4216879|B3|Yes||Limited mobility|Number of women with self-reported limitations in mobility|participants|Number|17|17.0||||||
4390774|NCT00297427|4216880|B2|Yes||Limited mobility|Number of women with self-reported limitations in mobility|participants|Number|9|9.0||||||
4390775|NCT00297427|4216881|B1|Yes||Limited mobility|Number of women with self-reported limitations in mobility|participants|Number|8|8.0||||||
4390776|NCT00297427|4216879|B3|No applicable (premenopausal)||Hormone replacement therapy|Number of women taking hormone replacement therapy|participants|Number|43|43.0||||||
4390777|NCT00297427|4216880|B2|No applicable (premenopausal)||Hormone replacement therapy|Number of women taking hormone replacement therapy|participants|Number|20|20.0||||||
4390778|NCT00297427|4216881|B1|No applicable (premenopausal)||Hormone replacement therapy|Number of women taking hormone replacement therapy|participants|Number|23|23.0||||||
4390779|NCT00297427|4216879|B3|No||Hormone replacement therapy|Number of women taking hormone replacement therapy|participants|Number|70|70.0||||||
4390780|NCT00297427|4216880|B2|No||Hormone replacement therapy|Number of women taking hormone replacement therapy|participants|Number|36|36.0||||||
4390781|NCT00297427|4216881|B1|No||Hormone replacement therapy|Number of women taking hormone replacement therapy|participants|Number|34|34.0||||||
4390782|NCT00297427|4216879|B3|Yes||Hormone replacement therapy|Number of women taking hormone replacement therapy|participants|Number|14|14.0||||||
4390783|NCT00297427|4216880|B2|Yes||Hormone replacement therapy|Number of women taking hormone replacement therapy|participants|Number|7|7.0||||||
4390784|NCT00297427|4216881|B1|Yes||Hormone replacement therapy|Number of women taking hormone replacement therapy|participants|Number|7|7.0||||||
4390785|NCT00297427|4216879|B3|Premenopausal||Menopausal Status|Number of women in each group who self-reported cessation of menses|participants|Number|43|43.0||||||
4390786|NCT00297427|4216880|B2|Premenopausal||Menopausal Status|Number of women in each group who self-reported cessation of menses|participants|Number|20|20.0||||||
4390787|NCT00297427|4216881|B1|Premenopausal||Menopausal Status|Number of women in each group who self-reported cessation of menses|participants|Number|23|23.0||||||
4390788|NCT00297427|4216879|B3|Postmenopausal||Menopausal Status|Number of women in each group who self-reported cessation of menses|participants|Number|84|84.0||||||
4390789|NCT00297427|4216880|B2|Postmenopausal||Menopausal Status|Number of women in each group who self-reported cessation of menses|participants|Number|43|43.0||||||
4390790|NCT00297427|4216881|B1|Postmenopausal||Menopausal Status|Number of women in each group who self-reported cessation of menses|participants|Number|41|41.0||||||
4390791|NCT00297427|4216879|B3|||Vaginal deliveries|Number of vaginal deliveries|Vaginal deliveries|Mean|1.51|1.51|Standard Deviation|1.38|1.38|||
4390792|NCT00297427|4216880|B2|||Vaginal deliveries|Number of vaginal deliveries|Vaginal deliveries|Mean|1.43|1.43|Standard Deviation|1.24|1.24|||
4390793|NCT00297427|4216881|B1|||Vaginal deliveries|Number of vaginal deliveries|Vaginal deliveries|Mean|1.59|1.59|Standard Deviation|1.51|1.51|||
4390794|NCT00297427|4216879|B3|||Number of prescription medications|Number of prescription medications taken on a regular basis|Prescription medications|Mean|2.21|2.21|Standard Deviation|2.26|2.26|||
4390795|NCT00297427|4216880|B2|||Number of prescription medications|Number of prescription medications taken on a regular basis|Prescription medications|Mean|2.22|2.22|Standard Deviation|2.33|2.33|||
4390796|NCT00297427|4216881|B1|||Number of prescription medications|Number of prescription medications taken on a regular basis|Prescription medications|Mean|2.20|2.2|Standard Deviation|2.2|2.2|||
4390797|NCT00297427|4216879|B3|||Co-morbidities|Number of co-morbid health problems|co-morbid health problems|Mean|2.87|2.87|Standard Deviation|2.23|2.23|||
4390798|NCT00297427|4216880|B2|||Co-morbidities|Number of co-morbid health problems|co-morbid health problems|Mean|2.82|2.82|Standard Deviation|2.09|2.09|||
4390799|NCT00297427|4216881|B1|||Co-morbidities|Number of co-morbid health problems|co-morbid health problems|Mean|2.92|2.92|Standard Deviation|2.37|2.37|||
4390800|NCT00297427|4216879|B3|||BMI||Kg/m^2|Mean|29.50|29.5|Standard Deviation|6.64|6.64|||
4390801|NCT00297427|4216880|B2|||BMI||Kg/m^2|Mean|29.54|29.54|Standard Deviation|6.65|6.65|||
4390802|NCT00297427|4216881|B1|||BMI||Kg/m^2|Mean|29.47|29.47|Standard Deviation|6.68|6.68|||
4390803|NCT00297427|4216879|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4390804|NCT00297427|4216880|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390805|NCT00297427|4216881|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4390806|NCT00297427|4216879|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4390807|NCT00297427|4216880|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4390808|NCT00297427|4216881|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4390809|NCT00297427|4216879|B3||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4390810|NCT00297427|4216880|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4390811|NCT00297427|4216881|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4390812|NCT00297427|4216879|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4390813|NCT00297427|4216880|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4390814|NCT00297427|4216881|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4390815|NCT00297427|4216879|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390816|NCT00297427|4216880|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390817|NCT00297427|4216881|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390818|NCT00297427|4216879|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390819|NCT00297427|4216880|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390820|NCT00297427|4216881|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390821|NCT00297427|4216879|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390822|NCT00297427|4216880|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390823|NCT00297427|4216881|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390824|NCT00297427|4216879|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4390825|NCT00297427|4216880|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390826|NCT00297427|4216881|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4390827|NCT00297427|4216879|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4390828|NCT00297427|4216880|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4390829|NCT00297427|4216881|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4390830|NCT00297427|4216879|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390831|NCT00297427|4216880|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390832|NCT00297427|4216881|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4390833|NCT00297427|4216879|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390834|NCT00297427|4216880|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390835|NCT00297427|4216881|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390836|NCT00297427|4216879|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4390837|NCT00297427|4216880|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4390838|NCT00297427|4216881|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4390839|NCT00297427|4216879|B3|||Age||years|Mean|56.86|56.86|Standard Deviation|11.86|11.86|||
4390840|NCT00297427|4216880|B2|||Age||years|Mean|57.41|57.41|Standard Deviation|11.86|11.86|||
4390841|NCT00297427|4216881|B1|||Age||years|Mean|56.31|56.31|Standard Deviation|11.93|11.93|||
4390842|NCT00297258|4216923|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4390843|NCT00297258|4216923|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4390844|NCT00297258|4216923|B1|||Age|Includes all participants enrolled in the study|years|Median|51.0|51.0|Full Range|||18.0|79.0|
4390845|NCT00297232|4216942|B1||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4390846|NCT00297232|4216942|B1||Female|Sex: Female, Male||Participants|Count of Participants|755|755.0||||||
4390847|NCT00297232|4216942|B1|50 to 59 years||Age, Customized||years|Number|195|195.0||||||
4390848|NCT00297232|4216942|B1|40 to 49 years||Age, Customized||years|Number|454|454.0||||||
4390849|NCT00297232|4216942|B1|30 to 39 years||Age, Customized||years|Number|347|347.0||||||
4390850|NCT00297232|4216942|B1|20 to 29 years||Age, Customized||years|Number|98|98.0||||||
4390851|NCT00297232|4216942|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|8.12|8.12|||
4390852|NCT00297167|4216948|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4390853|NCT00297167|4216948|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4390854|NCT00297167|4216948|B1|||Age||years|Mean|14.9|14.9|Standard Deviation|4.75|4.75|||
4390855|NCT00297115|4216974|B3||Male|Sex: Female, Male||Participants|Count of Participants|1258|1258.0||||||
4390856|NCT00297115|4216975|B2||Male|Sex: Female, Male||Participants|Count of Participants|648|648.0||||||
4390857|NCT00297115|4216976|B1||Male|Sex: Female, Male||Participants|Count of Participants|610|610.0||||||
4390858|NCT00297115|4216974|B3||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4390859|NCT00297115|4216975|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4390860|NCT00297115|4216976|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4390861|NCT00297115|4216974|B3|||Age||years|Mean|64.12|64.12|Standard Deviation|9.1|9.1|||
4390862|NCT00297115|4216975|B2|||Age||years|Mean|64.31|64.31|Standard Deviation|9.0|9.0|||
4390863|NCT00297115|4216976|B1|||Age||years|Mean|63.92|63.92|Standard Deviation|9.2|9.2|||
4390864|NCT00297102|4216993|B3||Male|Gender||Participants|Count of Participants|1078|1078.0||||||
4390865|NCT00297102|4216994|B2||Male|Gender||Participants|Count of Participants|538|538.0||||||
4390866|NCT00297102|4216995|B1||Male|Gender||Participants|Count of Participants|540|540.0||||||
4390867|NCT00297102|4216993|B3||Female|Gender||Participants|Count of Participants|445|445.0||||||
4390868|NCT00297102|4216994|B2||Female|Gender||Participants|Count of Participants|220|220.0||||||
4390869|NCT00297102|4216995|B1||Female|Gender||Participants|Count of Participants|225|225.0||||||
4390870|NCT00297102|4216993|B3|||Age||years|Mean|63.45|63.45|Standard Deviation|9.4|9.4|||
4390871|NCT00297102|4216994|B2|||Age||years|Mean|63.36|63.36|Standard Deviation|9.2|9.2|||
4390872|NCT00297102|4216995|B1|||Age||years|Mean|63.53|63.53|Standard Deviation|9.5|9.5|||
4390873|NCT00297037|4217012|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4390874|NCT00297037|4217013|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4390875|NCT00297037|4217014|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4390876|NCT00297037|4217012|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4390877|NCT00297037|4217013|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4390878|NCT00297037|4217014|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4390879|NCT00297037|4217012|B3||>=65 years|Age|This study is designed to assess the efficacy and safety of pimecrolimus cream 1% when applied twice daily with occlusion in the treatment of OLP in a population > 18 years of age.|Participants|Count of Participants|2|2.0||||||
4390880|NCT00297037|4217013|B2||>=65 years|Age|This study is designed to assess the efficacy and safety of pimecrolimus cream 1% when applied twice daily with occlusion in the treatment of OLP in a population > 18 years of age.|Participants|Count of Participants|2|2.0||||||
4390881|NCT00297037|4217014|B1||>=65 years|Age|This study is designed to assess the efficacy and safety of pimecrolimus cream 1% when applied twice daily with occlusion in the treatment of OLP in a population > 18 years of age.|Participants|Count of Participants|0|0.0||||||
4390882|NCT00297037|4217012|B3||Between 18 and 65 years|Age|This study is designed to assess the efficacy and safety of pimecrolimus cream 1% when applied twice daily with occlusion in the treatment of OLP in a population > 18 years of age.|Participants|Count of Participants|19|19.0||||||
4390883|NCT00297037|4217013|B2||Between 18 and 65 years|Age|This study is designed to assess the efficacy and safety of pimecrolimus cream 1% when applied twice daily with occlusion in the treatment of OLP in a population > 18 years of age.|Participants|Count of Participants|9|9.0||||||
4390884|NCT00297037|4217014|B1||Between 18 and 65 years|Age|This study is designed to assess the efficacy and safety of pimecrolimus cream 1% when applied twice daily with occlusion in the treatment of OLP in a population > 18 years of age.|Participants|Count of Participants|10|10.0||||||
4390885|NCT00297037|4217012|B3||<=18 years|Age|This study is designed to assess the efficacy and safety of pimecrolimus cream 1% when applied twice daily with occlusion in the treatment of OLP in a population > 18 years of age.|Participants|Count of Participants|0|0.0||||||
4390886|NCT00297037|4217013|B2||<=18 years|Age|This study is designed to assess the efficacy and safety of pimecrolimus cream 1% when applied twice daily with occlusion in the treatment of OLP in a population > 18 years of age.|Participants|Count of Participants|0|0.0||||||
4390887|NCT00297037|4217014|B1||<=18 years|Age|This study is designed to assess the efficacy and safety of pimecrolimus cream 1% when applied twice daily with occlusion in the treatment of OLP in a population > 18 years of age.|Participants|Count of Participants|0|0.0||||||
4391046|NCT00296504|4217096|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4390888|NCT00296816|4217025|B3|Stage IV||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|20|20.0||||||
4390889|NCT00296816|4217026|B2|Stage IV||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|5|5.0||||||
4390890|NCT00296816|4217027|B1|Stage IV||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|15|15.0||||||
4390891|NCT00296816|4217025|B3|Stage IIIC||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|89|89.0||||||
4390892|NCT00296816|4217026|B2|Stage IIIC||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|32|32.0||||||
4390893|NCT00296816|4217027|B1|Stage IIIC||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|57|57.0||||||
4390894|NCT00296816|4217025|B3|Stage IIIB||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|7|7.0||||||
4390895|NCT00296816|4217026|B2|Stage IIIB||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|5|5.0||||||
4390896|NCT00296816|4217027|B1|Stage IIIB||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|2|2.0||||||
4390897|NCT00296816|4217025|B3|Stage IIIA||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|5|5.0||||||
4390898|NCT00296816|4217026|B2|Stage IIIA||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|2|2.0||||||
4390899|NCT00296816|4217027|B1|Stage IIIA||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|3|3.0||||||
4390900|NCT00296816|4217025|B3|Stage IIC||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|8|8.0||||||
4391047|NCT00296504|4217097|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4390901|NCT00296816|4217026|B2|Stage IIC||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|5|5.0||||||
4390902|NCT00296816|4217027|B1|Stage IIC||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|3|3.0||||||
4390903|NCT00296816|4217025|B3|Stage IIB||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|0|0.0||||||
4390904|NCT00296816|4217026|B2|Stage IIB||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|0|0.0||||||
4390905|NCT00296816|4217027|B1|Stage IIB||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|0|0.0||||||
4390906|NCT00296816|4217025|B3|Stage IIA||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|0|0.0||||||
4390907|NCT00296816|4217026|B2|Stage IIA||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|0|0.0||||||
4390908|NCT00296816|4217027|B1|Stage IIA||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|0|0.0||||||
4390909|NCT00296816|4217025|B3|Stage IC||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|3|3.0||||||
4390910|NCT00296816|4217026|B2|Stage IC||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|3|3.0||||||
4390911|NCT00296816|4217027|B1|Stage IC||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|0|0.0||||||
4390912|NCT00296816|4217025|B3|Stage IB||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|0|0.0||||||
4390913|NCT00296816|4217026|B2|Stage IB||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|0|0.0||||||
4391048|NCT00296504|4217098|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4390914|NCT00296816|4217027|B1|Stage IB||FIGO stage at diagnosis|"Ovarian cancer staging at diagnosis was based on the International Federation of Gynecology and Obstetrics (FIGO).~Stage I is the least severe, where the tumor is restricted to the ovaries.~Stage II involves both ovaries and the pelvis.~Stage III involves the ovaries and has microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node (also includes liver capsule metastasis).~Stage IV involves distant metastasis beyond the peritoneal cavity."|participants|Number|0|0.0||||||
4390915|NCT00296816|4217025|B3|Peritoneum||Primary Tumor Site||participants|Number|11|11.0||||||
4390916|NCT00296816|4217026|B2|Peritoneum||Primary Tumor Site||participants|Number|2|2.0||||||
4390917|NCT00296816|4217027|B1|Peritoneum||Primary Tumor Site||participants|Number|9|9.0||||||
4390918|NCT00296816|4217025|B3|Fallopian tube||Primary Tumor Site||participants|Number|11|11.0||||||
4390919|NCT00296816|4217026|B2|Fallopian tube||Primary Tumor Site||participants|Number|5|5.0||||||
4390920|NCT00296816|4217027|B1|Fallopian tube||Primary Tumor Site||participants|Number|6|6.0||||||
4390921|NCT00296816|4217025|B3|Ovary||Primary Tumor Site||participants|Number|110|110.0||||||
4390922|NCT00296816|4217026|B2|Ovary||Primary Tumor Site||participants|Number|45|45.0||||||
4390923|NCT00296816|4217027|B1|Ovary||Primary Tumor Site||participants|Number|65|65.0||||||
4390924|NCT00296816|4217025|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390925|NCT00296816|4217026|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390926|NCT00296816|4217027|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4390927|NCT00296816|4217025|B3||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4390928|NCT00296816|4217026|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4390929|NCT00296816|4217027|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4390930|NCT00296816|4217025|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|10.19|10.19|||
4390931|NCT00296816|4217026|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|9.54|9.54|||
4390932|NCT00296816|4217027|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|10.43|10.43|||
4390933|NCT00296647|4217039|B6|United States||Region of Enrollment||participants|Number|1346|1346.0||||||
4390934|NCT00296647|4217040|B5|United States||Region of Enrollment||participants|Number|268|268.0||||||
4390935|NCT00296647|4217041|B4|United States||Region of Enrollment||participants|Number|279|279.0||||||
4390936|NCT00296647|4217042|B3|United States||Region of Enrollment||participants|Number|256|256.0||||||
4390937|NCT00296647|4217043|B2|United States||Region of Enrollment||participants|Number|261|261.0||||||
4390938|NCT00296647|4217044|B1|United States||Region of Enrollment||participants|Number|282|282.0||||||
4390939|NCT00296647|4217039|B6||Male|Sex: Female, Male||Participants|Count of Participants|593|593.0||||||
4390940|NCT00296647|4217040|B5||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4390941|NCT00296647|4217041|B4||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4390942|NCT00296647|4217042|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4390943|NCT00296647|4217043|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4390944|NCT00296647|4217044|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4390945|NCT00296647|4217039|B6||Female|Sex: Female, Male||Participants|Count of Participants|753|753.0||||||
4390946|NCT00296647|4217040|B5||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4390947|NCT00296647|4217041|B4||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4390948|NCT00296647|4217042|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4390949|NCT00296647|4217043|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4390950|NCT00296647|4217044|B1||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4390951|NCT00296647|4217039|B6|||Age||years|Mean|44.3|44.3|Standard Deviation|12.1|12.1|||
4390952|NCT00296647|4217040|B5|||Age||years|Mean|45.4|45.4|Standard Deviation|12.2|12.2|||
4390953|NCT00296647|4217041|B4|||Age||years|Mean|44.8|44.8|Standard Deviation|12.4|12.4|||
4390954|NCT00296647|4217042|B3|||Age||years|Mean|44|44.0|Standard Deviation|11.6|11.6|||
4390955|NCT00296647|4217043|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|11.7|11.7|||
4390956|NCT00296647|4217044|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|12.4|12.4|||
4390957|NCT00296517|4217060|B3|Japan||Region of Enrollment|The Full Analysis Set (all subjects who entered the treatment phase, with the exception of those who did not take any investigational products during the treatment phase and those who did not meet the major eligibility criteria of Major Depressive Disorder or those with no valid post baseline assessment) for Baseline Characteristic measures.|participants|Number|322|322.0||0|0.0|0.0|0.0|
4390958|NCT00296517|4217061|B2|Japan||Region of Enrollment|The Full Analysis Set (all subjects who entered the treatment phase, with the exception of those who did not take any investigational products during the treatment phase and those who did not meet the major eligibility criteria of Major Depressive Disorder or those with no valid post baseline assessment) for Baseline Characteristic measures.|participants|Number|165|165.0||||||
4390959|NCT00296517|4217062|B1|Japan||Region of Enrollment|The Full Analysis Set (all subjects who entered the treatment phase, with the exception of those who did not take any investigational products during the treatment phase and those who did not meet the major eligibility criteria of Major Depressive Disorder or those with no valid post baseline assessment) for Baseline Characteristic measures.|participants|Number|157|157.0||||||
4390960|NCT00296517|4217060|B3||Male|Sex: Female, Male|The Full Analysis Set (all subjects who entered the treatment phase, with the exception of those who did not take any investigational products during the treatment phase and those who did not meet the major eligibility criteria of Major Depressive Disorder or those with no valid post baseline assessment) for Baseline Characteristic measures.|Participants|Count of Participants|176|176.0||||||
4391049|NCT00296504|4217099|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4391050|NCT00296504|4217091|B9||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4390961|NCT00296517|4217061|B2||Male|Sex: Female, Male|The Full Analysis Set (all subjects who entered the treatment phase, with the exception of those who did not take any investigational products during the treatment phase and those who did not meet the major eligibility criteria of Major Depressive Disorder or those with no valid post baseline assessment) for Baseline Characteristic measures.|Participants|Count of Participants|88|88.0||||||
4390962|NCT00296517|4217062|B1||Male|Sex: Female, Male|The Full Analysis Set (all subjects who entered the treatment phase, with the exception of those who did not take any investigational products during the treatment phase and those who did not meet the major eligibility criteria of Major Depressive Disorder or those with no valid post baseline assessment) for Baseline Characteristic measures.|Participants|Count of Participants|88|88.0||||||
4390963|NCT00296517|4217060|B3||Female|Sex: Female, Male|The Full Analysis Set (all subjects who entered the treatment phase, with the exception of those who did not take any investigational products during the treatment phase and those who did not meet the major eligibility criteria of Major Depressive Disorder or those with no valid post baseline assessment) for Baseline Characteristic measures.|Participants|Count of Participants|146|146.0||||||
4390964|NCT00296517|4217061|B2||Female|Sex: Female, Male|The Full Analysis Set (all subjects who entered the treatment phase, with the exception of those who did not take any investigational products during the treatment phase and those who did not meet the major eligibility criteria of Major Depressive Disorder or those with no valid post baseline assessment) for Baseline Characteristic measures.|Participants|Count of Participants|77|77.0||||||
4390965|NCT00296517|4217062|B1||Female|Sex: Female, Male|The Full Analysis Set (all subjects who entered the treatment phase, with the exception of those who did not take any investigational products during the treatment phase and those who did not meet the major eligibility criteria of Major Depressive Disorder or those with no valid post baseline assessment) for Baseline Characteristic measures.|Participants|Count of Participants|69|69.0||||||
4390966|NCT00296517|4217060|B3|||Age|The Full Analysis Set (all subjects who entered the treatment phase, with the exception of those who did not take any investigational products during the treatment phase and those who did not meet the major eligibility criteria of Major Depressive Disorder or those with no valid post baseline assessment) for Baseline Characteristic measures.|Years|Mean|36.4|36.4|Standard Deviation|9.10|9.1|||
4390967|NCT00296517|4217061|B2|||Age|The Full Analysis Set (all subjects who entered the treatment phase, with the exception of those who did not take any investigational products during the treatment phase and those who did not meet the major eligibility criteria of Major Depressive Disorder or those with no valid post baseline assessment) for Baseline Characteristic measures.|Years|Mean|36.8|36.8|Standard Deviation|9.28|9.28|||
4390968|NCT00296517|4217062|B1|||Age|The Full Analysis Set (all subjects who entered the treatment phase, with the exception of those who did not take any investigational products during the treatment phase and those who did not meet the major eligibility criteria of Major Depressive Disorder or those with no valid post baseline assessment) for Baseline Characteristic measures.|Years|Mean|36.0|36.0|Standard Deviation|8.91|8.91|||
4390969|NCT00296504|4217091|B9|Acquired Immune Deficiency Syndrome (AIDS)||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|183|183.0||||||
4390970|NCT00296504|4217092|B8|Acquired Immune Deficiency Syndrome (AIDS)||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|39|39.0||||||
4390971|NCT00296504|4217093|B7|Acquired Immune Deficiency Syndrome (AIDS)||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|5|5.0||||||
4390972|NCT00296504|4217094|B6|Acquired Immune Deficiency Syndrome (AIDS)||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|24|24.0||||||
4390973|NCT00296504|4217095|B5|Acquired Immune Deficiency Syndrome (AIDS)||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|26|26.0||||||
4391051|NCT00296504|4217092|B8||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4391052|NCT00296504|4217093|B7||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4391053|NCT00296504|4217094|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4390974|NCT00296504|4217096|B4|Acquired Immune Deficiency Syndrome (AIDS)||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|18|18.0||||||
4390975|NCT00296504|4217097|B3|Acquired Immune Deficiency Syndrome (AIDS)||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|49|49.0||||||
4390976|NCT00296504|4217098|B2|Acquired Immune Deficiency Syndrome (AIDS)||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|1|1.0||||||
4390977|NCT00296504|4217099|B1|Acquired Immune Deficiency Syndrome (AIDS)||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|21|21.0||||||
4390978|NCT00296504|4217091|B9|Symptomatic, not AIDS||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|175|175.0||||||
4390979|NCT00296504|4217092|B8|Symptomatic, not AIDS||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|18|18.0||||||
4390980|NCT00296504|4217093|B7|Symptomatic, not AIDS||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|23|23.0||||||
4390981|NCT00296504|4217094|B6|Symptomatic, not AIDS||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|24|24.0||||||
4390982|NCT00296504|4217095|B5|Symptomatic, not AIDS||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|21|21.0||||||
4390983|NCT00296504|4217096|B4|Symptomatic, not AIDS||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|23|23.0||||||
4391054|NCT00296504|4217095|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4391055|NCT00296504|4217096|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4391056|NCT00296504|4217097|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4391057|NCT00296504|4217098|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4391058|NCT00296504|4217099|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4390984|NCT00296504|4217097|B3|Symptomatic, not AIDS||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|48|48.0||||||
4390985|NCT00296504|4217098|B2|Symptomatic, not AIDS||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|1|1.0||||||
4390986|NCT00296504|4217099|B1|Symptomatic, not AIDS||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|17|17.0||||||
4390987|NCT00296504|4217091|B9|Asymptomatic or lymphadenopathy||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|395|395.0||||||
4390988|NCT00296504|4217092|B8|Asymptomatic or lymphadenopathy||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|29|29.0||||||
4390989|NCT00296504|4217093|B7|Asymptomatic or lymphadenopathy||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|76|76.0||||||
4390990|NCT00296504|4217094|B6|Asymptomatic or lymphadenopathy||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|30|30.0||||||
4390991|NCT00296504|4217095|B5|Asymptomatic or lymphadenopathy||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|26|26.0||||||
4390992|NCT00296504|4217096|B4|Asymptomatic or lymphadenopathy||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|13|13.0||||||
4390993|NCT00296504|4217097|B3|Asymptomatic or lymphadenopathy||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|124|124.0||||||
4391059|NCT00296504|4217091|B9|||Age, Customized||years|Mean|38.7|38.7|Full Range|||17.0|75.0|
4391060|NCT00296504|4217092|B8|||Age, Customized||years|Mean|40.2|40.2|Full Range|||19.0|60.0|
4391061|NCT00296504|4217093|B7|||Age, Customized||years|Mean|39.3|39.3|Full Range|||21.0|75.0|
4391062|NCT00296504|4217094|B6|||Age, Customized||years|Mean|42.3|42.3|Full Range|||24.0|71.0|
4391063|NCT00296504|4217095|B5|||Age, Customized||years|Mean|41.9|41.9|Full Range|||27.0|58.0|
4390994|NCT00296504|4217098|B2|Asymptomatic or lymphadenopathy||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|16|16.0||||||
4390995|NCT00296504|4217099|B1|Asymptomatic or lymphadenopathy||Number of Participants with the Indicated CDC Classification of HIV Infection|The Centers for Disease Control and Prevention (CDC) 1993 classification system for HIV infection was based on three clinical categories (A, B, and C). Category A comprised asymptomatic acute or primary HIV infection or persistent generalized lymphadenopathy (lymphnode disease). Category B comprised symptomatic conditions not included in clinical categories A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Category C comprised AIDS-defining conditions.|participants|Number|81|81.0||||||
4390996|NCT00296504|4217091|B9|Other: Race Not Specified||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4390997|NCT00296504|4217092|B8|Other: Race Not Specified||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4390998|NCT00296504|4217093|B7|Other: Race Not Specified||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4390999|NCT00296504|4217094|B6|Other: Race Not Specified||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4391000|NCT00296504|4217095|B5|Other: Race Not Specified||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4391001|NCT00296504|4217096|B4|Other: Race Not Specified||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4391002|NCT00296504|4217097|B3|Other: Race Not Specified||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4391003|NCT00296504|4217098|B2|Other: Race Not Specified||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4391004|NCT00296504|4217099|B1|Other: Race Not Specified||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4391005|NCT00296504|4217091|B9|American Hispanic||Race/Ethnicity, Customized||participants|Number|113|113.0||||||
4391006|NCT00296504|4217092|B8|American Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4391007|NCT00296504|4217093|B7|American Hispanic||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4391008|NCT00296504|4217094|B6|American Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4391009|NCT00296504|4217095|B5|American Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4391010|NCT00296504|4217096|B4|American Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4391011|NCT00296504|4217097|B3|American Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4391012|NCT00296504|4217098|B2|American Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4391013|NCT00296504|4217099|B1|American Hispanic||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4391014|NCT00296504|4217091|B9|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4391015|NCT00296504|4217092|B8|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4391016|NCT00296504|4217093|B7|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4391017|NCT00296504|4217094|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4391018|NCT00296504|4217095|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4391019|NCT00296504|4217096|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4391020|NCT00296504|4217097|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4391021|NCT00296504|4217098|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4391022|NCT00296504|4217099|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4391023|NCT00296504|4217091|B9|Black||Race/Ethnicity, Customized||participants|Number|226|226.0||||||
4391024|NCT00296504|4217092|B8|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4391025|NCT00296504|4217093|B7|Black||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4391026|NCT00296504|4217094|B6|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4391027|NCT00296504|4217095|B5|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4391028|NCT00296504|4217096|B4|Black||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4391029|NCT00296504|4217097|B3|Black||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4391030|NCT00296504|4217098|B2|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4391031|NCT00296504|4217099|B1|Black||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4391032|NCT00296504|4217091|B9|White||Race/Ethnicity, Customized||participants|Number|394|394.0||||||
4391033|NCT00296504|4217092|B8|White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4391034|NCT00296504|4217093|B7|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4391035|NCT00296504|4217094|B6|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4391036|NCT00296504|4217095|B5|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4391037|NCT00296504|4217096|B4|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4391038|NCT00296504|4217097|B3|White||Race/Ethnicity, Customized||participants|Number|109|109.0||||||
4391039|NCT00296504|4217098|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4391040|NCT00296504|4217099|B1|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4391041|NCT00296504|4217091|B9||Male|Sex: Female, Male||Participants|Count of Participants|555|555.0||||||
4391042|NCT00296504|4217092|B8||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4391043|NCT00296504|4217093|B7||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4391044|NCT00296504|4217094|B6||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4391045|NCT00296504|4217095|B5||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4391064|NCT00296504|4217096|B4|||Age, Customized||years|Mean|36.2|36.2|Full Range|||26.0|63.0|
4391065|NCT00296504|4217097|B3|||Age, Customized||years|Mean|37.7|37.7|Full Range|||19.0|69.0|
4391066|NCT00296504|4217098|B2|||Age, Customized||years|Mean|35.8|35.8|Full Range|||22.0|54.0|
4391067|NCT00296504|4217099|B1|||Age, Customized||years|Mean|36.3|36.3|Full Range|||17.0|70.0|
4391068|NCT00296491|4217196|B5|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4391069|NCT00296491|4217197|B4|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4391070|NCT00296491|4217198|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4391071|NCT00296491|4217199|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4391072|NCT00296491|4217200|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4391073|NCT00296491|4217196|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4391074|NCT00296491|4217197|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4391075|NCT00296491|4217198|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4391076|NCT00296491|4217199|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4391077|NCT00296491|4217200|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4391078|NCT00296491|4217196|B5|Asian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4391079|NCT00296491|4217197|B4|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4391080|NCT00296491|4217198|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4391081|NCT00296491|4217199|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4391082|NCT00296491|4217200|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4391083|NCT00296491|4217196|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4391084|NCT00296491|4217197|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4391085|NCT00296491|4217198|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4391086|NCT00296491|4217199|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4391087|NCT00296491|4217200|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4391088|NCT00296491|4217196|B5|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
4391089|NCT00296491|4217197|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4391090|NCT00296491|4217198|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4391091|NCT00296491|4217199|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4391092|NCT00296491|4217200|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4391093|NCT00296491|4217196|B5|White||Race/Ethnicity, Customized||participants|Number|564|564.0||||||
4391094|NCT00296491|4217197|B4|White||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4391095|NCT00296491|4217198|B3|White||Race/Ethnicity, Customized||participants|Number|143|143.0||||||
4391096|NCT00296491|4217199|B2|White||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
4391097|NCT00296491|4217200|B1|White||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
4391098|NCT00296491|4217196|B5||Male|Gender||Participants|Count of Participants|276|276.0||||||
4391099|NCT00296491|4217197|B4||Male|Gender||Participants|Count of Participants|69|69.0||||||
4391100|NCT00296491|4217198|B3||Male|Gender||Participants|Count of Participants|62|62.0||||||
4391101|NCT00296491|4217199|B2||Male|Gender||Participants|Count of Participants|78|78.0||||||
4391102|NCT00296491|4217200|B1||Male|Gender||Participants|Count of Participants|67|67.0||||||
4391103|NCT00296491|4217196|B5||Female|Gender||Participants|Count of Participants|449|449.0||||||
4391104|NCT00296491|4217197|B4||Female|Gender||Participants|Count of Participants|112|112.0||||||
4391105|NCT00296491|4217198|B3||Female|Gender||Participants|Count of Participants|120|120.0||||||
4391106|NCT00296491|4217199|B2||Female|Gender||Participants|Count of Participants|102|102.0||||||
4391107|NCT00296491|4217200|B1||Female|Gender||Participants|Count of Participants|115|115.0||||||
4391108|NCT00296491|4217196|B5|||Age||years|Mean|34.2|34.2|Standard Deviation|13.34|13.34|||
4391109|NCT00296491|4217197|B4|||Age||years|Mean|34.5|34.5|Standard Deviation|12.47|12.47|||
4391110|NCT00296491|4217198|B3|||Age||years|Mean|34.9|34.9|Standard Deviation|12.62|12.62|||
4391111|NCT00296491|4217199|B2|||Age||years|Mean|34.5|34.5|Standard Deviation|14.64|14.64|||
4391112|NCT00296491|4217200|B1|||Age||years|Mean|33.0|33.0|Standard Deviation|13.54|13.54|||
4391113|NCT00296400|4217229|B4|||Urine protein/creatinine ratio||mg/g|Mean|1416.023|1416.023|Standard Deviation|975.7636|975.7636|0.0|2892.0335|
4391114|NCT00296400|4217230|B3|||Urine protein/creatinine ratio||mg/g|Mean|1439.720|1439.72|Standard Deviation|991.2295|991.2295|1439.72|991.2295|
4391115|NCT00296400|4217231|B2|||Urine protein/creatinine ratio||mg/g|Mean|1487.131|1487.131|Standard Deviation|1068.0642|1068.0642|1487.131|1068.0642|
4391116|NCT00296400|4217232|B1|||Urine protein/creatinine ratio||mg/g|Mean|1301.163|1301.163|Standard Deviation|832.7398|832.7398|1301.163|832.7398|
4391117|NCT00296400|4217229|B4|||Urine albumin/creatinine ratio||mg/g|Mean|1091.263|1091.263|Standard Deviation|775.1889|775.1889|0.0|2306.2846|
4391118|NCT00296400|4217230|B3|||Urine albumin/creatinine ratio||mg/g|Mean|1069.103|1069.103|Standard Deviation|720.8011|720.8011|1069.103|720.8011|
4391119|NCT00296400|4217231|B2|||Urine albumin/creatinine ratio||mg/g|Mean|1167.368|1167.368|Standard Deviation|865.4584|865.4584|1167.368|865.4584|
4391120|NCT00296400|4217232|B1|||Urine albumin/creatinine ratio||mg/g|Mean|1023.165|1023.165|Standard Deviation|720.0251|720.0251|1023.165|720.0251|
4391121|NCT00296400|4217229|B4|||Estimated glomerular filtration rate [eGFR]||mL/min|Mean|75.419|75.419|Standard Deviation|29.6012|29.6012|0.0|88.43993|
4391122|NCT00296400|4217230|B3|||Estimated glomerular filtration rate [eGFR]||mL/min|Mean|71.464|71.464|Standard Deviation|30.0156|30.0156|71.464|30.0156|
4391123|NCT00296400|4217231|B2|||Estimated glomerular filtration rate [eGFR]||mL/min|Mean|76.774|76.774|Standard Deviation|30.3878|30.3878|76.774|30.3878|
4391124|NCT00296400|4217232|B1|||Estimated glomerular filtration rate [eGFR]||mL/min|Mean|78.315|78.315|Standard Deviation|28.0653|28.0653|78.315|28.03653|
4391125|NCT00296400|4217229|B4||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||0.0|0.0|
4391126|NCT00296400|4217230|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||49.0||
4391127|NCT00296400|4217231|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||52.0||
4391128|NCT00296400|4217232|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||42.0||
4391129|NCT00296400|4217229|B4||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||0.0|0.0|
4391130|NCT00296400|4217230|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||31.0||
4391131|NCT00296400|4217231|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||35.0||
4391132|NCT00296400|4217232|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||28.0||
4391133|NCT00296400|4217229|B4|>=65 years||Age, Customized||Participants|Number|25|25.0||||||
4391134|NCT00296400|4217230|B3|>=65 years||Age, Customized||Participants|Number|8|8.0||||||
4391135|NCT00296400|4217231|B2|>=65 years||Age, Customized||Participants|Number|12|12.0||||||
4391136|NCT00296400|4217232|B1|>=65 years||Age, Customized||Participants|Number|5|5.0||||||
4391137|NCT00296400|4217229|B4|50 to 64 years||Age, Customized||Participants|Number|92|92.0||||||
4391138|NCT00296400|4217230|B3|50 to 64 years||Age, Customized||Participants|Number|30|30.0||||||
4391139|NCT00296400|4217231|B2|50 to 64 years||Age, Customized||Participants|Number|31|31.0||||||
4391140|NCT00296400|4217232|B1|50 to 64 years||Age, Customized||Participants|Number|31|31.0||||||
4391141|NCT00296400|4217229|B4|18 to 49 years||Age, Customized||Participants|Number|120|120.0||||||
4391142|NCT00296400|4217230|B3|18 to 49 years||Age, Customized||Participants|Number|42|42.0||||||
4391143|NCT00296400|4217231|B2|18 to 49 years||Age, Customized||Participants|Number|44|44.0||||||
4391144|NCT00296400|4217232|B1|18 to 49 years||Age, Customized||Participants|Number|34|34.0||||||
4391145|NCT00296374|4217455|B4|||Urine protein/creatinine ratio||mg/g|Mean|1467.843|1467.843|Standard Deviation|952.0380|952.038|||
4391146|NCT00296374|4217456|B3|||Urine protein/creatinine ratio||mg/g|Mean|1517.858|1517.858|Standard Deviation|969.7020|969.702|||
4391147|NCT00296374|4217457|B2|||Urine protein/creatinine ratio||mg/g|Mean|1493.574|1493.574|Standard Deviation|996.0972|996.0972|||
4391148|NCT00296374|4217458|B1|||Urine protein/creatinine ratio||mg/g|Mean|1392.26|1392.26|Standard Deviation|888.3215|888.3215|||
4391149|NCT00296374|4217455|B4|||Urine albumin/creatinine ratio||mg/g|Mean|1085.435|1085.435|Standard Deviation|743.5360|743.536|||
4391150|NCT00296374|4217456|B3|||Urine albumin/creatinine ratio||mg/g|Mean|1143.198|1143.198|Standard Deviation|779.5282|779.5282|||
4391151|NCT00296374|4217457|B2|||Urine albumin/creatinine ratio||mg/g|Mean|1079.802|1079.802|Standard Deviation|725.7039|725.7039|||
4391152|NCT00296374|4217458|B1|||Urine albumin/creatinine ratio||mg/g|Mean|1036.478|1036.478|Standard Deviation|730.6185|730.6185|||
4391153|NCT00296374|4217455|B4|||Estimated glomerular filtration rate [eGFR]||mL/min|Mean|71.210|71.21|Standard Deviation|24.9455|24.9455|||
4391154|NCT00296374|4217456|B3|||Estimated glomerular filtration rate [eGFR]||mL/min|Mean|72.149|72.149|Standard Deviation|24.8721|24.8721|||
4391155|NCT00296374|4217457|B2|||Estimated glomerular filtration rate [eGFR]||mL/min|Mean|72.644|72.644|Standard Deviation|25.8018|25.8018|||
4391156|NCT00296374|4217458|B1|||Estimated glomerular filtration rate [eGFR]||mL/min|Mean|68.759|68.759|Standard Deviation|24.1080|24.108|||
4391157|NCT00296374|4217455|B4||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4391158|NCT00296374|4217456|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4391159|NCT00296374|4217457|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4391160|NCT00296374|4217458|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4391161|NCT00296374|4217455|B4||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4391162|NCT00296374|4217456|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4391163|NCT00296374|4217457|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4391164|NCT00296374|4217458|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4391165|NCT00296374|4217455|B4|>=65 years||Age, Customized||Participants|Number|98|98.0||||||
4391166|NCT00296374|4217456|B3|>=65 years||Age, Customized||Participants|Number|29|29.0||||||
4391167|NCT00296374|4217457|B2|>=65 years||Age, Customized||Participants|Number|32|32.0||||||
4391168|NCT00296374|4217458|B1|>=65 years||Age, Customized||Participants|Number|37|37.0||||||
4391169|NCT00296374|4217455|B4|50-64 years||Age, Customized||Participants|Number|175|175.0||||||
4391170|NCT00296374|4217456|B3|50-64 years||Age, Customized||Participants|Number|57|57.0||||||
4391171|NCT00296374|4217457|B2|50-64 years||Age, Customized||Participants|Number|59|59.0||||||
4391172|NCT00296374|4217458|B1|50-64 years||Age, Customized||Participants|Number|59|59.0||||||
4391173|NCT00296374|4217455|B4|18-49 years||Age, Customized||Participants|Number|80|80.0||||||
4391174|NCT00296374|4217456|B3|18-49 years||Age, Customized||Participants|Number|25|25.0||||||
4391175|NCT00296374|4217457|B2|18-49 years||Age, Customized||Participants|Number|33|33.0||||||
4391176|NCT00296374|4217458|B1|18-49 years||Age, Customized||Participants|Number|22|22.0||||||
4391177|NCT00296335|4217681|B3|Korea, Republic of||Region of Enrollment||participants|Number|855|855.0||||||
4391178|NCT00296335|4217682|B2|Korea, Republic of||Region of Enrollment||participants|Number|431|431.0||||||
4391179|NCT00296335|4217683|B1|Korea, Republic of||Region of Enrollment||participants|Number|424|424.0||||||
4391180|NCT00296335|4217681|B3||Male|Sex: Female, Male||Participants|Count of Participants|588|588.0||||||
4391181|NCT00296335|4217682|B2||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4391182|NCT00296335|4217683|B1||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4391183|NCT00296335|4217681|B3||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4391184|NCT00296335|4217682|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4391185|NCT00296335|4217683|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4391186|NCT00296335|4217681|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|10.3|10.3|||
4391187|NCT00296335|4217682|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|10.1|10.1|||
4391188|NCT00296335|4217683|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|10.6|10.6|||
4391189|NCT00296335|4217681|B3||>=65 years|Age||Participants|Count of Participants|114|114.0||||||
4391190|NCT00296335|4217682|B2||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4391191|NCT00296335|4217683|B1||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4391192|NCT00296335|4217681|B3||Between 18 and 65 years|Age||Participants|Count of Participants|741|741.0||||||
4391193|NCT00296335|4217682|B2||Between 18 and 65 years|Age||Participants|Count of Participants|380|380.0||||||
4391194|NCT00296335|4217683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|361|361.0||||||
4391195|NCT00296335|4217681|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391196|NCT00296335|4217682|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391197|NCT00296335|4217683|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391198|NCT00296322|4217694|B3|Korea, Republic of||Region of Enrollment||participants|Number|521|521.0||||||
4391199|NCT00296322|4217695|B2|Korea, Republic of||Region of Enrollment||participants|Number|263|263.0||||||
4391200|NCT00296322|4217696|B1|Korea, Republic of||Region of Enrollment||participants|Number|258|258.0||||||
4391201|NCT00296322|4217694|B3||Male|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4391202|NCT00296322|4217695|B2||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4391203|NCT00296322|4217696|B1||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4391204|NCT00296322|4217694|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4391205|NCT00296322|4217695|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4391206|NCT00296322|4217696|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4391207|NCT00296322|4217694|B3|||Age||years|Mean|53.04|53.04|Standard Deviation|10.591|10.591|||
4391208|NCT00296322|4217695|B2|||Age||years|Mean|52.23|52.23|Standard Deviation|11.016|11.016|||
4391209|NCT00296322|4217696|B1|||Age||years|Mean|53.87|53.87|Standard Deviation|10.093|10.093|||
4391210|NCT00296322|4217694|B3||>=65 years|Age||Participants|Count of Participants|85|85.0||||||
4391211|NCT00296322|4217695|B2||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4391212|NCT00296322|4217696|B1||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4391213|NCT00296322|4217694|B3||Between 18 and 65 years|Age||Participants|Count of Participants|436|436.0||||||
4391214|NCT00296322|4217695|B2||Between 18 and 65 years|Age||Participants|Count of Participants|224|224.0||||||
4391215|NCT00296322|4217696|B1||Between 18 and 65 years|Age||Participants|Count of Participants|212|212.0||||||
4391216|NCT00296322|4217694|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391217|NCT00296322|4217695|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391218|NCT00296322|4217696|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391219|NCT00296296|4217707|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4391220|NCT00296296|4217708|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4391221|NCT00296296|4217709|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4391222|NCT00296296|4217707|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4391223|NCT00296296|4217708|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4391224|NCT00296296|4217709|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4391225|NCT00296296|4217707|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4391226|NCT00296296|4217708|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4391227|NCT00296296|4217709|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4391228|NCT00296296|4217707|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4391229|NCT00296296|4217708|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4391230|NCT00296296|4217709|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4391231|NCT00296296|4217707|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391232|NCT00296296|4217708|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391233|NCT00296296|4217709|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391234|NCT00296244|4217722|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4391235|NCT00296244|4217723|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4391236|NCT00296244|4217724|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4391237|NCT00296244|4217722|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4391238|NCT00296244|4217723|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4391239|NCT00296244|4217724|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4391240|NCT00296244|4217722|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4391241|NCT00296244|4217723|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4391242|NCT00296244|4217724|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4391243|NCT00296244|4217722|B3|||Age||years|Mean|53|53.0|Standard Deviation|9|9.0|||
4391244|NCT00296244|4217723|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|1.1|1.1|||
4391245|NCT00296244|4217724|B1|||Age||years|Mean|50.40|50.4|Standard Deviation|2.6|2.6|||
4391246|NCT00296244|4217722|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4391247|NCT00296244|4217723|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4391248|NCT00296244|4217724|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4391249|NCT00296244|4217722|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4391250|NCT00296244|4217723|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4391251|NCT00296244|4217724|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4391252|NCT00296244|4217722|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391253|NCT00296244|4217723|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391254|NCT00296244|4217724|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391255|NCT00296231|4217741|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4391256|NCT00296231|4217741|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4391257|NCT00296231|4217741|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4391258|NCT00296231|4217741|B1|||Age||days|Median|39.5|39.5|Inter-Quartile Range|||18.0|147.0|
4391259|NCT00296231|4217741|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4391260|NCT00296231|4217741|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4391261|NCT00296231|4217741|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4391262|NCT00296192|4217746|B6|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4391263|NCT00296192|4217747|B5|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4391264|NCT00296192|4217748|B4|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4391265|NCT00296192|4217749|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4391266|NCT00296192|4217750|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4391267|NCT00296192|4217751|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4391268|NCT00296192|4217746|B6|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4391269|NCT00296192|4217747|B5|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4391270|NCT00296192|4217748|B4|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4391271|NCT00296192|4217749|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4391272|NCT00296192|4217750|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4391273|NCT00296192|4217751|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4391274|NCT00296192|4217746|B6|Austria||Region of Enrollment||participants|Number|10|10.0||||||
4391275|NCT00296192|4217747|B5|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4391276|NCT00296192|4217748|B4|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4391277|NCT00296192|4217749|B3|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4391278|NCT00296192|4217750|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4391279|NCT00296192|4217751|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4391280|NCT00296192|4217746|B6|Germany||Region of Enrollment||participants|Number|58|58.0||||||
4391281|NCT00296192|4217747|B5|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4391282|NCT00296192|4217748|B4|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4391283|NCT00296192|4217749|B3|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4391284|NCT00296192|4217750|B2|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4391285|NCT00296192|4217751|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4391286|NCT00296192|4217746|B6||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4391287|NCT00296192|4217747|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4391288|NCT00296192|4217748|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4391289|NCT00296192|4217749|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4391290|NCT00296192|4217750|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4391291|NCT00296192|4217751|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4391292|NCT00296192|4217746|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4391293|NCT00296192|4217747|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4391294|NCT00296192|4217748|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4391295|NCT00296192|4217749|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4391296|NCT00296192|4217750|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4391297|NCT00296192|4217751|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4391298|NCT00296192|4217746|B6|||Age||years|Mean|64.4|64.4|Standard Deviation|8.28|8.28|||
4391299|NCT00296192|4217747|B5|||Age||years|Mean|60.5|60.5|Standard Deviation|8.04|8.04|||
4391300|NCT00296192|4217748|B4|||Age||years|Mean|63.9|63.9|Standard Deviation|8.28|8.28|||
4391301|NCT00296192|4217749|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|9.67|9.67|||
4391302|NCT00296192|4217750|B2|||Age||years|Mean|67.1|67.1|Standard Deviation|7.54|7.54|||
4391303|NCT00296192|4217751|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|6.94|6.94|||
4391304|NCT00296192|4217746|B6||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4391305|NCT00296192|4217747|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4391306|NCT00296192|4217748|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4391307|NCT00296192|4217749|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4391308|NCT00296192|4217750|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4391309|NCT00296192|4217751|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4391310|NCT00296192|4217746|B6||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4391311|NCT00296192|4217747|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4391312|NCT00296192|4217748|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4391313|NCT00296192|4217749|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4391314|NCT00296192|4217750|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4391315|NCT00296192|4217751|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4391316|NCT00296192|4217746|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391317|NCT00296192|4217747|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391318|NCT00296192|4217748|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391319|NCT00296192|4217749|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391320|NCT00296192|4217750|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391321|NCT00296192|4217751|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391322|NCT00296140|4217787|B3|||National Institute of Health Stroke Scale score|Summed score representing clinical stroke severity; ranges from 0-42, lower scores indicate lower clinical severity.|points|Median|2.0|2.0|Full Range|||0.0|11.0|
4391323|NCT00296140|4217788|B2|||National Institute of Health Stroke Scale score|Summed score representing clinical stroke severity; ranges from 0-42, lower scores indicate lower clinical severity.|points|Median|2.0|2.0|Full Range|||0.0|11.0|
4391324|NCT00296140|4217789|B1|||National Institute of Health Stroke Scale score|Summed score representing clinical stroke severity; ranges from 0-42, lower scores indicate lower clinical severity.|points|Median|3.0|3.0|Full Range|||0.0|11.0|
4391325|NCT00296140|4217787|B3||No|Caregiver Present||Participants|Count of Participants|40|40.0||||||
4391326|NCT00296140|4217788|B2||No|Caregiver Present||Participants|Count of Participants|21|21.0||||||
4391327|NCT00296140|4217789|B1||No|Caregiver Present||Participants|Count of Participants|19|19.0||||||
4391328|NCT00296140|4217787|B3||Yes|Caregiver Present||Participants|Count of Participants|23|23.0||||||
4391329|NCT00296140|4217788|B2||Yes|Caregiver Present||Participants|Count of Participants|12|12.0||||||
4391330|NCT00296140|4217789|B1||Yes|Caregiver Present||Participants|Count of Participants|11|11.0||||||
4391331|NCT00296140|4217787|B3||With 2 or more others|Living status||Participants|Count of Participants|13|13.0||||||
4391332|NCT00296140|4217788|B2||With 2 or more others|Living status||Participants|Count of Participants|5|5.0||||||
4391333|NCT00296140|4217789|B1||With 2 or more others|Living status||Participants|Count of Participants|8|8.0||||||
4391334|NCT00296140|4217787|B3||With one other|Living status||Participants|Count of Participants|32|32.0||||||
4391335|NCT00296140|4217788|B2||With one other|Living status||Participants|Count of Participants|17|17.0||||||
4391336|NCT00296140|4217789|B1||With one other|Living status||Participants|Count of Participants|15|15.0||||||
4391337|NCT00296140|4217787|B3||Alone|Living status||Participants|Count of Participants|18|18.0||||||
4391338|NCT00296140|4217788|B2||Alone|Living status||Participants|Count of Participants|11|11.0||||||
4391339|NCT00296140|4217789|B1||Alone|Living status||Participants|Count of Participants|7|7.0||||||
4391340|NCT00296140|4217787|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
4391341|NCT00296140|4217788|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4391342|NCT00296140|4217789|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4391343|NCT00296140|4217787|B3||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4391344|NCT00296140|4217788|B2||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4391345|NCT00296140|4217789|B1||Unknown|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4391346|NCT00296140|4217787|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4391347|NCT00296140|4217788|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4391348|NCT00296140|4217789|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4391349|NCT00296140|4217787|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4391350|NCT00296140|4217788|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4391351|NCT00296140|4217789|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4391352|NCT00296140|4217787|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4391353|NCT00296140|4217788|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4391354|NCT00296140|4217789|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4391355|NCT00296140|4217787|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4391356|NCT00296140|4217788|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4391357|NCT00296140|4217789|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4391358|NCT00296140|4217787|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|10.3|10.3|||
4391359|NCT00296140|4217788|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|8.4|8.4|||
4391360|NCT00296140|4217789|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|12.4|12.4|||
4391361|NCT00296036|4217800|B3|United States||Region of Enrollment||participants|Number|127|127.0||||||
4391362|NCT00296036|4217801|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4391363|NCT00296036|4217802|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4391364|NCT00296036|4217800|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4391365|NCT00296036|4217801|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4391366|NCT00296036|4217802|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4391367|NCT00296036|4217800|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4391368|NCT00296036|4217801|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4391369|NCT00296036|4217802|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4391370|NCT00296036|4217800|B3|> 60||Age, Customized||participants|Number|71|71.0||||||
4391371|NCT00296036|4217801|B2|> 60||Age, Customized||participants|Number|34|34.0||||||
4391372|NCT00296036|4217802|B1|> 60||Age, Customized||participants|Number|37|37.0||||||
4391373|NCT00296036|4217800|B3|50-60||Age, Customized||participants|Number|36|36.0||||||
4391374|NCT00296036|4217801|B2|50-60||Age, Customized||participants|Number|17|17.0||||||
4391375|NCT00296036|4217802|B1|50-60||Age, Customized||participants|Number|19|19.0||||||
4391376|NCT00296036|4217800|B3|<50||Age, Customized||participants|Number|20|20.0||||||
4391377|NCT00296036|4217801|B2|<50||Age, Customized||participants|Number|9|9.0||||||
4391378|NCT00296036|4217802|B1|<50||Age, Customized||participants|Number|11|11.0||||||
4391379|NCT00295932|4217833|B12||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4391380|NCT00295932|4217834|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4391381|NCT00295932|4217835|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391382|NCT00295932|4217836|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391383|NCT00295932|4217837|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391384|NCT00295932|4217838|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391385|NCT00295932|4217839|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391386|NCT00295932|4217840|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4391387|NCT00295932|4217841|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391388|NCT00295932|4217842|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391389|NCT00295932|4217843|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391390|NCT00295932|4217844|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391391|NCT00295932|4217833|B12||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391392|NCT00295932|4217834|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391393|NCT00295932|4217835|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391394|NCT00295932|4217836|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391395|NCT00295932|4217837|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391396|NCT00295932|4217838|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391397|NCT00295932|4217839|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391398|NCT00295932|4217840|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391399|NCT00295932|4217841|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391400|NCT00295932|4217842|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391401|NCT00295932|4217843|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391402|NCT00295932|4217844|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391403|NCT00295932|4217833|B12||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4391404|NCT00295932|4217834|B11||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4391405|NCT00295932|4217835|B10||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4391406|NCT00295932|4217836|B9||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4391407|NCT00295932|4217837|B8||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4391408|NCT00295932|4217838|B7||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4391409|NCT00295932|4217839|B6||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4391410|NCT00295932|4217840|B5||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391411|NCT00295932|4217841|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4391412|NCT00295932|4217842|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4391413|NCT00295932|4217843|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4391414|NCT00295932|4217844|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4391415|NCT00295932|4217833|B12||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4391416|NCT00295932|4217834|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4391417|NCT00295932|4217835|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391418|NCT00295932|4217836|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391419|NCT00295932|4217837|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4391420|NCT00295932|4217838|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391421|NCT00295932|4217839|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4391422|NCT00295932|4217840|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4391423|NCT00295932|4217841|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391424|NCT00295932|4217842|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391425|NCT00295932|4217843|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391426|NCT00295932|4217844|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391427|NCT00295932|4217833|B12||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391428|NCT00295932|4217834|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391429|NCT00295932|4217835|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391430|NCT00295932|4217836|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391431|NCT00295932|4217837|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391432|NCT00295932|4217838|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391433|NCT00295932|4217839|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391434|NCT00295932|4217840|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391435|NCT00295932|4217841|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391436|NCT00295932|4217842|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391437|NCT00295932|4217843|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391438|NCT00295932|4217844|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391439|NCT00295932|4217833|B12||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4391440|NCT00295932|4217834|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391441|NCT00295932|4217835|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4391442|NCT00295932|4217836|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4391443|NCT00295932|4217837|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391444|NCT00295932|4217838|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4391445|NCT00295932|4217839|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391446|NCT00295932|4217840|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391447|NCT00295932|4217841|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4391448|NCT00295932|4217842|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391449|NCT00295932|4217843|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391450|NCT00295932|4217844|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391451|NCT00295932|4217833|B12||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391452|NCT00295932|4217834|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391453|NCT00295932|4217835|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391454|NCT00295932|4217836|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391455|NCT00295932|4217837|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391456|NCT00295932|4217838|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391457|NCT00295932|4217839|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391458|NCT00295932|4217840|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391459|NCT00295932|4217841|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391460|NCT00295932|4217842|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391461|NCT00295932|4217843|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391462|NCT00295932|4217844|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391463|NCT00295932|4217833|B12||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4391464|NCT00295932|4217834|B11||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4391465|NCT00295932|4217835|B10||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4391466|NCT00295932|4217836|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4391467|NCT00295932|4217837|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4391468|NCT00295932|4217838|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4391469|NCT00295932|4217839|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4391470|NCT00295932|4217840|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4391471|NCT00295932|4217841|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4391472|NCT00295932|4217842|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4391473|NCT00295932|4217843|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4391474|NCT00295932|4217844|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4391475|NCT00295932|4217833|B12||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4391476|NCT00295932|4217834|B11||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4391477|NCT00295932|4217835|B10||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4391478|NCT00295932|4217836|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4391479|NCT00295932|4217837|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4391480|NCT00295932|4217838|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4391481|NCT00295932|4217839|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4391482|NCT00295932|4217840|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4391483|NCT00295932|4217841|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4391484|NCT00295932|4217842|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4391485|NCT00295932|4217843|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4391486|NCT00295932|4217844|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4391487|NCT00295932|4217833|B12||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4391488|NCT00295932|4217834|B11||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4391489|NCT00295932|4217835|B10||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4391490|NCT00295932|4217836|B9||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4391491|NCT00295932|4217837|B8||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4391492|NCT00295932|4217838|B7||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4391493|NCT00295932|4217839|B6||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4391494|NCT00295932|4217840|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4391495|NCT00295932|4217841|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4391496|NCT00295932|4217842|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4391497|NCT00295932|4217843|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4391498|NCT00295932|4217844|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4391499|NCT00295932|4217833|B12||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4391500|NCT00295932|4217834|B11||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4391501|NCT00295932|4217835|B10||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4391502|NCT00295932|4217836|B9||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4391503|NCT00295932|4217837|B8||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4391504|NCT00295932|4217838|B7||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4391505|NCT00295932|4217839|B6||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4391506|NCT00295932|4217840|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4391507|NCT00295932|4217841|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4391508|NCT00295932|4217842|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4391509|NCT00295932|4217843|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4391510|NCT00295932|4217844|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4391511|NCT00295932|4217833|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391512|NCT00295932|4217834|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391513|NCT00295932|4217835|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391514|NCT00295932|4217836|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391515|NCT00295932|4217837|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391516|NCT00295932|4217838|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391517|NCT00295932|4217839|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391518|NCT00295932|4217840|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391519|NCT00295932|4217841|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391520|NCT00295932|4217842|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391521|NCT00295932|4217843|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391522|NCT00295932|4217844|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391523|NCT00295880|4217888|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4391524|NCT00295880|4217888|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4391525|NCT00295880|4217888|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4391526|NCT00295880|4217888|B1|||Age||years|Mean|34|34.0|Standard Deviation|8|8.0|||
4391527|NCT00295880|4217888|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4391528|NCT00295880|4217888|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4391529|NCT00295880|4217888|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391530|NCT00295854|4217899|B4|Over 18 years old||diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months|Diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months prior to Baseline, a score of ≥ 15 on the Modified Pelvic Pain and Urgency/Frequency (PUF) Patient Symptom Scale, a score of ≥ 12 on the O’Leary Sant IC Symptom and Problem Index, urinary frequency of ≥ 8 ≤ 30 micturitions within 24 hours while awake, and a history of nocturia ≥ 2 x/night over an 8-hour period prior to screening or Baseline.|participants|Number|305|305.0||||||
4391531|NCT00295854|4217900|B3|Over 18 years old||diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months|Diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months prior to Baseline, a score of ≥ 15 on the Modified Pelvic Pain and Urgency/Frequency (PUF) Patient Symptom Scale, a score of ≥ 12 on the O’Leary Sant IC Symptom and Problem Index, urinary frequency of ≥ 8 ≤ 30 micturitions within 24 hours while awake, and a history of nocturia ≥ 2 x/night over an 8-hour period prior to screening or Baseline.|participants|Number|102|102.0||||||
4391567|NCT00295750|4217916|B3|||Serum Prostate-specific Antigen Levels||nanogram per milliliter|Median|19.0|19.0|Inter-Quartile Range|||8.7|57.0|
4391532|NCT00295854|4217901|B2|Over 18 years old||diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months|Diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months prior to Baseline, a score of ≥ 15 on the Modified Pelvic Pain and Urgency/Frequency (PUF) Patient Symptom Scale, a score of ≥ 12 on the O’Leary Sant IC Symptom and Problem Index, urinary frequency of ≥ 8 ≤ 30 micturitions within 24 hours while awake, and a history of nocturia ≥ 2 x/night over an 8-hour period prior to screening or Baseline.|participants|Number|108|108.0||||||
4391533|NCT00295854|4217902|B1|Over 18 years old||diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months|Diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months prior to Baseline, a score of ≥ 15 on the Modified Pelvic Pain and Urgency/Frequency (PUF) Patient Symptom Scale, a score of ≥ 12 on the O’Leary Sant IC Symptom and Problem Index, urinary frequency of ≥ 8 ≤ 30 micturitions within 24 hours while awake, and a history of nocturia ≥ 2 x/night over an 8-hour period prior to screening or Baseline.|participants|Number|95|95.0||||||
4391534|NCT00295854|4217899|B4|<=18 years||diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months|Diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months prior to Baseline, a score of ≥ 15 on the Modified Pelvic Pain and Urgency/Frequency (PUF) Patient Symptom Scale, a score of ≥ 12 on the O’Leary Sant IC Symptom and Problem Index, urinary frequency of ≥ 8 ≤ 30 micturitions within 24 hours while awake, and a history of nocturia ≥ 2 x/night over an 8-hour period prior to screening or Baseline.|participants|Number|0|0.0||||||
4391535|NCT00295854|4217900|B3|<=18 years||diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months|Diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months prior to Baseline, a score of ≥ 15 on the Modified Pelvic Pain and Urgency/Frequency (PUF) Patient Symptom Scale, a score of ≥ 12 on the O’Leary Sant IC Symptom and Problem Index, urinary frequency of ≥ 8 ≤ 30 micturitions within 24 hours while awake, and a history of nocturia ≥ 2 x/night over an 8-hour period prior to screening or Baseline.|participants|Number|0|0.0||||||
4391536|NCT00295854|4217901|B2|<=18 years||diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months|Diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months prior to Baseline, a score of ≥ 15 on the Modified Pelvic Pain and Urgency/Frequency (PUF) Patient Symptom Scale, a score of ≥ 12 on the O’Leary Sant IC Symptom and Problem Index, urinary frequency of ≥ 8 ≤ 30 micturitions within 24 hours while awake, and a history of nocturia ≥ 2 x/night over an 8-hour period prior to screening or Baseline.|participants|Number|0|0.0||||||
4391537|NCT00295854|4217902|B1|<=18 years||diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months|Diagnosis of moderate to severe interstitial cystitis (IC) with bladder pain for ≥ 6 months prior to Baseline, a score of ≥ 15 on the Modified Pelvic Pain and Urgency/Frequency (PUF) Patient Symptom Scale, a score of ≥ 12 on the O’Leary Sant IC Symptom and Problem Index, urinary frequency of ≥ 8 ≤ 30 micturitions within 24 hours while awake, and a history of nocturia ≥ 2 x/night over an 8-hour period prior to screening or Baseline.|participants|Number|0|0.0||||||
4391538|NCT00295854|4217899|B4|United States||Region of Enrollment||participants|Number|305|305.0||||||
4391539|NCT00295854|4217900|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4391540|NCT00295854|4217901|B2|United States||Region of Enrollment||participants|Number|108|108.0||||||
4391541|NCT00295854|4217902|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
4391542|NCT00295854|4217899|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4391543|NCT00295854|4217900|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4391544|NCT00295854|4217901|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4391545|NCT00295854|4217902|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4391546|NCT00295854|4217899|B4||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4391547|NCT00295854|4217900|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4391548|NCT00295854|4217901|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4391549|NCT00295854|4217902|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4391550|NCT00295854|4217899|B4|||Age||years|Mean|44|44.0|Standard Deviation|13.6|13.6|||
4391551|NCT00295854|4217900|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|13.97|13.97|||
4391552|NCT00295854|4217901|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|13.95|13.95|||
4391553|NCT00295854|4217902|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|12.87|12.87|||
4391554|NCT00295750|4217915|B4|||Weight|ITT population|kilogram|Mean|79.3|79.3|Standard Deviation|13.4|13.4|||
4391555|NCT00295750|4217916|B3|||Weight|ITT population|kilogram|Mean|79.4|79.4|Standard Deviation|12.2|12.2|||
4391556|NCT00295750|4217917|B2|||Weight|ITT population|kilogram|Mean|79.8|79.8|Standard Deviation|14.9|14.9|||
4391557|NCT00295750|4217918|B1|||Weight|ITT population|kilogram|Mean|78.7|78.7|Standard Deviation|13.0|13.0|||
4391558|NCT00295750|4217915|B4|||Time Since Prostate Cancer Diagnosis|ITT population.|days|Mean|491|491.0|Standard Deviation|1063|1063.0|||
4391559|NCT00295750|4217916|B3|||Time Since Prostate Cancer Diagnosis|ITT population.|days|Mean|497|497.0|Standard Deviation|1088|1088.0|||
4391560|NCT00295750|4217917|B2|||Time Since Prostate Cancer Diagnosis|ITT population.|days|Mean|491|491.0|Standard Deviation|994|994.0|||
4391561|NCT00295750|4217918|B1|||Time Since Prostate Cancer Diagnosis|ITT population.|days|Mean|485|485.0|Standard Deviation|1109|1109.0|||
4391562|NCT00295750|4217915|B4|||Serum Testosterone Levels||nanogram per milliliter|Median|3.93|3.93|Inter-Quartile Range|||2.89|5.1|
4391563|NCT00295750|4217916|B3|||Serum Testosterone Levels||nanogram per milliliter|Median|3.84|3.84|Inter-Quartile Range|||2.91|5.01|
4391564|NCT00295750|4217917|B2|||Serum Testosterone Levels||nanogram per milliliter|Median|4.11|4.11|Inter-Quartile Range|||3.05|5.32|
4391565|NCT00295750|4217918|B1|||Serum Testosterone Levels||nanogram per milliliter|Median|3.78|3.78|Inter-Quartile Range|||2.86|5.05|
4391566|NCT00295750|4217915|B4|||Serum Prostate-specific Antigen Levels||nanogram per milliliter|Median|19.0|19.0|Inter-Quartile Range|||8.7|57.0|
4391568|NCT00295750|4217917|B2|||Serum Prostate-specific Antigen Levels||nanogram per milliliter|Median|19.8|19.8|Inter-Quartile Range|||9.4|46.0|
4391569|NCT00295750|4217918|B1|||Serum Prostate-specific Antigen Levels||nanogram per milliliter|Median|19.9|19.9|Inter-Quartile Range|||8.2|68.0|
4391570|NCT00295750|4217915|B4|||Body Mass Index|ITT population|kilogram per square meter|Mean|26.8|26.8|Standard Deviation|3.93|3.93|||
4391571|NCT00295750|4217916|B3|||Body Mass Index|ITT population|kilogram per square meter|Mean|26.9|26.9|Standard Deviation|3.86|3.86|||
4391572|NCT00295750|4217917|B2|||Body Mass Index|ITT population|kilogram per square meter|Mean|26.7|26.7|Standard Deviation|4.21|4.21|||
4391573|NCT00295750|4217918|B1|||Body Mass Index|ITT population|kilogram per square meter|Mean|26.6|26.6|Standard Deviation|3.70|3.7|||
4391574|NCT00295750|4217915|B4|Not classifiable||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|116|116.0||||||
4391575|NCT00295750|4217916|B3|Not classifiable||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|39|39.0||||||
4391576|NCT00295750|4217917|B2|Not classifiable||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|37|37.0||||||
4391577|NCT00295750|4217918|B1|Not classifiable||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|40|40.0||||||
4391578|NCT00295750|4217915|B4|Metastatic||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|125|125.0||||||
4391579|NCT00295750|4217916|B3|Metastatic||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|47|47.0||||||
4391580|NCT00295750|4217917|B2|Metastatic||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|37|37.0||||||
4391581|NCT00295750|4217918|B1|Metastatic||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|41|41.0||||||
4391582|NCT00295750|4217915|B4|Locally advanced||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|178|178.0||||||
4391583|NCT00295750|4217916|B3|Locally advanced||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|52|52.0||||||
4391584|NCT00295750|4217917|B2|Locally advanced||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|64|64.0||||||
4391585|NCT00295750|4217918|B1|Locally advanced||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|62|62.0||||||
4391586|NCT00295750|4217915|B4|Localized||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|191|191.0||||||
4391587|NCT00295750|4217916|B3|Localized||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|63|63.0||||||
4391609|NCT00295750|4217918|B1|No||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|participants|Number|178|178.0||||||
4391588|NCT00295750|4217917|B2|Localized||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|69|69.0||||||
4391589|NCT00295750|4217918|B1|Localized||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis|participants|Number|59|59.0||||||
4391590|NCT00295750|4217915|B4|8-10||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|163|163.0||||||
4391591|NCT00295750|4217916|B3|8-10||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|51|51.0||||||
4391592|NCT00295750|4217917|B2|8-10||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|56|56.0||||||
4391593|NCT00295750|4217918|B1|8-10||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|56|56.0||||||
4391594|NCT00295750|4217915|B4|7||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|181|181.0||||||
4391595|NCT00295750|4217916|B3|7||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|62|62.0||||||
4391596|NCT00295750|4217917|B2|7||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|63|63.0||||||
4391597|NCT00295750|4217918|B1|7||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|56|56.0||||||
4391598|NCT00295750|4217915|B4|5-6||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|198|198.0||||||
4391599|NCT00295750|4217916|B3|5-6||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|63|63.0||||||
4391600|NCT00295750|4217917|B2|5-6||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|68|68.0||||||
4391601|NCT00295750|4217918|B1|5-6||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|67|67.0||||||
4391602|NCT00295750|4217915|B4|2-4||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|65|65.0||||||
4391603|NCT00295750|4217916|B3|2-4||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|24|24.0||||||
4391604|NCT00295750|4217917|B2|2-4||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|20|20.0||||||
4391605|NCT00295750|4217918|B1|2-4||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.|participants|Number|21|21.0||||||
4391606|NCT00295750|4217915|B4|No||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|participants|Number|532|532.0||||||
4391607|NCT00295750|4217916|B3|No||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|participants|Number|177|177.0||||||
4391608|NCT00295750|4217917|B2|No||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|participants|Number|177|177.0||||||
4391662|NCT00295750|4217915|B4||>=65 years|Age|Intent-to-treat (ITT) population.|Participants|Count of Participants|492|492.0||||||
4391610|NCT00295750|4217915|B4|Yes||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|participants|Number|78|78.0||||||
4391611|NCT00295750|4217916|B3|Yes||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|participants|Number|24|24.0||||||
4391612|NCT00295750|4217917|B2|Yes||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|participants|Number|30|30.0||||||
4391613|NCT00295750|4217918|B1|Yes||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|participants|Number|24|24.0||||||
4391614|NCT00295750|4217915|B4|Europe||Region of Enrollment|ITT population|participants|Number|353|353.0||||||
4391615|NCT00295750|4217916|B3|Europe||Region of Enrollment|ITT population|participants|Number|115|115.0||||||
4391616|NCT00295750|4217917|B2|Europe||Region of Enrollment|ITT population|participants|Number|120|120.0||||||
4391617|NCT00295750|4217918|B1|Europe||Region of Enrollment|ITT population|participants|Number|118|118.0||||||
4391618|NCT00295750|4217915|B4|North America||Region of Enrollment|ITT population|participants|Number|257|257.0||||||
4391619|NCT00295750|4217916|B3|North America||Region of Enrollment|ITT population|participants|Number|86|86.0||||||
4391620|NCT00295750|4217917|B2|North America||Region of Enrollment|ITT population|participants|Number|87|87.0||||||
4391621|NCT00295750|4217918|B1|North America||Region of Enrollment|ITT population|participants|Number|84|84.0||||||
4391622|NCT00295750|4217915|B4||Unknown or Not Reported|Race (NIH/OMB)|ITT population|Participants|Count of Participants|0|0.0||||||
4391623|NCT00295750|4217916|B3||Unknown or Not Reported|Race (NIH/OMB)|ITT population|Participants|Count of Participants|0|0.0||||||
4391624|NCT00295750|4217917|B2||Unknown or Not Reported|Race (NIH/OMB)|ITT population|Participants|Count of Participants|0|0.0||||||
4391625|NCT00295750|4217918|B1||Unknown or Not Reported|Race (NIH/OMB)|ITT population|Participants|Count of Participants|0|0.0||||||
4391626|NCT00295750|4217915|B4||More than one race|Race (NIH/OMB)|ITT population|Participants|Count of Participants|0|0.0||||||
4391627|NCT00295750|4217916|B3||More than one race|Race (NIH/OMB)|ITT population|Participants|Count of Participants|0|0.0||||||
4391628|NCT00295750|4217917|B2||More than one race|Race (NIH/OMB)|ITT population|Participants|Count of Participants|0|0.0||||||
4391629|NCT00295750|4217918|B1||More than one race|Race (NIH/OMB)|ITT population|Participants|Count of Participants|0|0.0||||||
4391630|NCT00295750|4217915|B4||White|Race (NIH/OMB)|ITT population|Participants|Count of Participants|511|511.0||||||
4391631|NCT00295750|4217916|B3||White|Race (NIH/OMB)|ITT population|Participants|Count of Participants|172|172.0||||||
4391632|NCT00295750|4217917|B2||White|Race (NIH/OMB)|ITT population|Participants|Count of Participants|171|171.0||||||
4391633|NCT00295750|4217918|B1||White|Race (NIH/OMB)|ITT population|Participants|Count of Participants|168|168.0||||||
4391634|NCT00295750|4217915|B4||Black or African American|Race (NIH/OMB)|ITT population|Participants|Count of Participants|38|38.0||||||
4391635|NCT00295750|4217916|B3||Black or African American|Race (NIH/OMB)|ITT population|Participants|Count of Participants|10|10.0||||||
4391636|NCT00295750|4217917|B2||Black or African American|Race (NIH/OMB)|ITT population|Participants|Count of Participants|17|17.0||||||
4391637|NCT00295750|4217918|B1||Black or African American|Race (NIH/OMB)|ITT population|Participants|Count of Participants|11|11.0||||||
4391638|NCT00295750|4217915|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT population|Participants|Count of Participants|0|0.0||||||
4391639|NCT00295750|4217916|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT population|Participants|Count of Participants|0|0.0||||||
4391640|NCT00295750|4217917|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT population|Participants|Count of Participants|0|0.0||||||
4391641|NCT00295750|4217918|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT population|Participants|Count of Participants|0|0.0||||||
4391642|NCT00295750|4217915|B4||Asian|Race (NIH/OMB)|ITT population|Participants|Count of Participants|2|2.0||||||
4391643|NCT00295750|4217916|B3||Asian|Race (NIH/OMB)|ITT population|Participants|Count of Participants|0|0.0||||||
4391644|NCT00295750|4217917|B2||Asian|Race (NIH/OMB)|ITT population|Participants|Count of Participants|1|1.0||||||
4391645|NCT00295750|4217918|B1||Asian|Race (NIH/OMB)|ITT population|Participants|Count of Participants|1|1.0||||||
4391646|NCT00295750|4217915|B4||American Indian or Alaska Native|Race (NIH/OMB)|ITT population|Participants|Count of Participants|59|59.0||||||
4391647|NCT00295750|4217916|B3||American Indian or Alaska Native|Race (NIH/OMB)|ITT population|Participants|Count of Participants|19|19.0||||||
4391648|NCT00295750|4217917|B2||American Indian or Alaska Native|Race (NIH/OMB)|ITT population|Participants|Count of Participants|18|18.0||||||
4391649|NCT00295750|4217918|B1||American Indian or Alaska Native|Race (NIH/OMB)|ITT population|Participants|Count of Participants|22|22.0||||||
4391650|NCT00295750|4217915|B4||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|610|610.0||||||
4391651|NCT00295750|4217916|B3||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|201|201.0||||||
4391652|NCT00295750|4217917|B2||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|207|207.0||||||
4391653|NCT00295750|4217918|B1||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|202|202.0||||||
4391654|NCT00295750|4217915|B4||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4391655|NCT00295750|4217916|B3||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4391656|NCT00295750|4217917|B2||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4391657|NCT00295750|4217918|B1||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4391658|NCT00295750|4217915|B4|||Age|ITT population.|years|Median|73|73.0|Full Range|8.45|8.45|50.0|98.0|
4391659|NCT00295750|4217916|B3|||Age|ITT population.|years|Median|74|74.0|Full Range|8.77|8.77|52.0|98.0|
4391660|NCT00295750|4217917|B2|||Age|ITT population.|years|Median|72|72.0|Full Range|8.12|8.12|51.0|89.0|
4391661|NCT00295750|4217918|B1|||Age|ITT population.|years|Median|72|72.0|Full Range|8.47|8.47|50.0|88.0|
4391663|NCT00295750|4217916|B3||>=65 years|Age|Intent-to-treat (ITT) population.|Participants|Count of Participants|163|163.0||||||
4391664|NCT00295750|4217917|B2||>=65 years|Age|Intent-to-treat (ITT) population.|Participants|Count of Participants|164|164.0||||||
4391665|NCT00295750|4217918|B1||>=65 years|Age|Intent-to-treat (ITT) population.|Participants|Count of Participants|165|165.0||||||
4391666|NCT00295750|4217915|B4||Between 18 and 65 years|Age|Intent-to-treat (ITT) population.|Participants|Count of Participants|118|118.0||||||
4391667|NCT00295750|4217916|B3||Between 18 and 65 years|Age|Intent-to-treat (ITT) population.|Participants|Count of Participants|38|38.0||||||
4391668|NCT00295750|4217917|B2||Between 18 and 65 years|Age|Intent-to-treat (ITT) population.|Participants|Count of Participants|43|43.0||||||
4391669|NCT00295750|4217918|B1||Between 18 and 65 years|Age|Intent-to-treat (ITT) population.|Participants|Count of Participants|37|37.0||||||
4391670|NCT00295750|4217915|B4||<=18 years|Age|Intent-to-treat (ITT) population.|Participants|Count of Participants|0|0.0||||||
4391671|NCT00295750|4217916|B3||<=18 years|Age|Intent-to-treat (ITT) population.|Participants|Count of Participants|0|0.0||||||
4391672|NCT00295750|4217917|B2||<=18 years|Age|Intent-to-treat (ITT) population.|Participants|Count of Participants|0|0.0||||||
4391673|NCT00295750|4217918|B1||<=18 years|Age|Intent-to-treat (ITT) population.|Participants|Count of Participants|0|0.0||||||
4391674|NCT00295633|4217952|B4||Male|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4391675|NCT00295633|4217953|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4391676|NCT00295633|4217954|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4391677|NCT00295633|4217955|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4391678|NCT00295633|4217952|B4||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4391679|NCT00295633|4217953|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4391680|NCT00295633|4217954|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4391681|NCT00295633|4217955|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4391682|NCT00295633|4217952|B4|||Age||years|Mean|54.04|54.04|Standard Deviation|10.13|10.13|||
4391683|NCT00295633|4217953|B3|||Age||years|Mean|54.01|54.01|Standard Deviation|10.08|10.08|||
4391684|NCT00295633|4217954|B2|||Age||years|Mean|53.22|53.22|Standard Deviation|10.56|10.56|||
4391685|NCT00295633|4217955|B1|||Age||years|Mean|54.85|54.85|Standard Deviation|9.73|9.73|||
4391686|NCT00295503|4217974|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4391687|NCT00295503|4217974|B1||Male|Gender||Participants|Count of Participants|44|44.0||||||
4391688|NCT00295503|4217974|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4391689|NCT00295503|4217974|B1|||Age||years|Median|66|66.0|Full Range|||24.0|81.0|
4391690|NCT00295503|4217974|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4391691|NCT00295503|4217974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4391692|NCT00295503|4217974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391693|NCT00295490|4217980|B5|United Kingdom||Region of Enrollment||participants|Number|67|67.0||||||
4391694|NCT00295490|4217981|B4|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4391695|NCT00295490|4217982|B3|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
4391696|NCT00295490|4217983|B2|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4391697|NCT00295490|4217984|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4391698|NCT00295490|4217980|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4391699|NCT00295490|4217981|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4391700|NCT00295490|4217982|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4391701|NCT00295490|4217983|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4391702|NCT00295490|4217984|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4391703|NCT00295490|4217980|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4391704|NCT00295490|4217981|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4391705|NCT00295490|4217982|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4391706|NCT00295490|4217983|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4391707|NCT00295490|4217984|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4391708|NCT00295490|4217980|B5|||Age||years|Mean|61.8|61.8|Standard Deviation|9.1|9.1|||
4391709|NCT00295490|4217981|B4|||Age||years|Mean|63.2|63.2|Standard Deviation|8.6|8.6|||
4391710|NCT00295490|4217982|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|8.4|8.4|||
4391711|NCT00295490|4217983|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|6.9|6.9|||
4391712|NCT00295490|4217984|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|11.9|11.9|||
4391713|NCT00295490|4217980|B5||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4391714|NCT00295490|4217981|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4391715|NCT00295490|4217982|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4391716|NCT00295490|4217983|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4391717|NCT00295490|4217984|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4391718|NCT00295490|4217980|B5||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4391719|NCT00295490|4217981|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4391720|NCT00295490|4217982|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4391721|NCT00295490|4217983|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4391722|NCT00295490|4217984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4391723|NCT00295490|4217980|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391724|NCT00295490|4217981|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391725|NCT00295490|4217982|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391726|NCT00295490|4217983|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391727|NCT00295490|4217984|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391728|NCT00295061|4218025|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4391729|NCT00295061|4218026|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4391730|NCT00295061|4218027|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4391731|NCT00295061|4218025|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4391732|NCT00295061|4218026|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4391733|NCT00295061|4218027|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4391734|NCT00295061|4218025|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4391735|NCT00295061|4218026|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4391736|NCT00295061|4218027|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4391737|NCT00295061|4218025|B3|||Age||years|Mean|57.7|57.7|Standard Deviation|8.04|8.04|||
4391738|NCT00295061|4218026|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|9.33|9.33|||
4391739|NCT00295061|4218027|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|6.86|6.86|||
4391740|NCT00295061|4218025|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4391741|NCT00295061|4218026|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4391742|NCT00295061|4218027|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4391743|NCT00295061|4218025|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4391744|NCT00295061|4218026|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4391745|NCT00295061|4218027|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4391746|NCT00295061|4218025|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391747|NCT00295061|4218026|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391748|NCT00295061|4218027|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391749|NCT00295022|4218034|B4||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4391750|NCT00295022|4218035|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4391751|NCT00295022|4218036|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4391752|NCT00295022|4218037|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4391753|NCT00295022|4218034|B4||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4391754|NCT00295022|4218035|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4391755|NCT00295022|4218036|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4391756|NCT00295022|4218037|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4391757|NCT00295022|4218034|B4|||Age||years|Mean|34.33|34.33|Standard Deviation|11.85|11.85|||
4391758|NCT00295022|4218035|B3|||Age||years|Mean|32.98|32.98|Standard Deviation|11.72|11.72|||
4391759|NCT00295022|4218036|B2|||Age||years|Mean|34.95|34.95|Standard Deviation|11.98|11.98|||
4391760|NCT00295022|4218037|B1|||Age||years|Mean|35.41|35.41|Standard Deviation|11.74|11.74|||
4391761|NCT00295022|4218034|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4391762|NCT00295022|4218035|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4391763|NCT00295022|4218036|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4391764|NCT00295022|4218037|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4391765|NCT00295022|4218034|B4||Between 18 and 65 years|Age||Participants|Count of Participants|415|415.0||||||
4391766|NCT00295022|4218035|B3||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4391767|NCT00295022|4218036|B2||Between 18 and 65 years|Age||Participants|Count of Participants|155|155.0||||||
4391768|NCT00295022|4218037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4391769|NCT00295022|4218034|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391770|NCT00295022|4218035|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391771|NCT00295022|4218036|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391772|NCT00295022|4218037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391773|NCT00295009|4218122|B7|United States||Region of Enrollment||participants|Number|788|788.0||||||
4391774|NCT00295009|4218123|B6|United States||Region of Enrollment||participants|Number|259|259.0||||||
4391775|NCT00295009|4218124|B5|United States||Region of Enrollment||participants|Number|165|165.0||||||
4391776|NCT00295009|4218125|B4|United States||Region of Enrollment||participants|Number|72|72.0||||||
4391777|NCT00295009|4218126|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4391778|NCT00295009|4218127|B2|United States||Region of Enrollment||participants|Number|162|162.0||||||
4391779|NCT00295009|4218128|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4391780|NCT00295009|4218122|B7||Male|Sex: Female, Male||Participants|Count of Participants|430|430.0||||||
4391781|NCT00295009|4218123|B6||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4391782|NCT00295009|4218124|B5||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4391783|NCT00295009|4218125|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4391784|NCT00295009|4218126|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4391785|NCT00295009|4218127|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4391786|NCT00295009|4218128|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4391787|NCT00295009|4218122|B7||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4391788|NCT00295009|4218123|B6||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4391789|NCT00295009|4218124|B5||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4391790|NCT00295009|4218125|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4391791|NCT00295009|4218126|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4391792|NCT00295009|4218127|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4391793|NCT00295009|4218128|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4391794|NCT00295009|4218122|B7|||Age||years|Mean|40.3|40.3|Standard Deviation|7.8|7.8|||
4391795|NCT00295009|4218123|B6|||Age||years|Mean|40.5|40.5|Standard Deviation|7.4|7.4|||
4391796|NCT00295009|4218124|B5|||Age||years|Mean|41.8|41.8|Standard Deviation|7.7|7.7|||
4391797|NCT00295009|4218125|B4|||Age||years|Mean|41.8|41.8|Standard Deviation|7.8|7.8|||
4391798|NCT00295009|4218126|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|8.0|8.0|||
4391799|NCT00295009|4218127|B2|||Age||years|Mean|39.6|39.6|Standard Deviation|8.0|8.0|||
4391800|NCT00295009|4218128|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|7.6|7.6|||
4391801|NCT00294762|4218153|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4391802|NCT00294762|4218154|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4391803|NCT00294762|4218155|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4391804|NCT00294762|4218153|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4391805|NCT00294762|4218154|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4391806|NCT00294762|4218155|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4391807|NCT00294762|4218153|B3|Asian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4391808|NCT00294762|4218154|B2|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4391809|NCT00294762|4218155|B1|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4391810|NCT00294762|4218153|B3|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4391811|NCT00294762|4218154|B2|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4391812|NCT00294762|4218155|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4391813|NCT00294762|4218153|B3|White||Race/Ethnicity, Customized||Participants|Number|113|113.0||||||
4391814|NCT00294762|4218154|B2|White||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4391815|NCT00294762|4218155|B1|White||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
4391816|NCT00294762|4218153|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4391817|NCT00294762|4218154|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4391818|NCT00294762|4218155|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4391819|NCT00294762|4218153|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4391820|NCT00294762|4218154|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4391821|NCT00294762|4218155|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4391822|NCT00294762|4218153|B3|||Age||years|Median|63|63.0|Full Range|||27.0|90.0|
4391823|NCT00294762|4218154|B2|||Age||years|Median|63|63.0|Full Range|||27.0|90.0|
4391824|NCT00294762|4218155|B1|||Age||years|Median|63|63.0|Full Range|||31.0|81.0|
4391825|NCT00294723|4218172|B4|||HbA1c (Glycosylated Haemoglobin A1c)|HbA1c at screening|percentage of total haemoglobin|Mean|8.3|8.3|Standard Deviation|1.1|1.1|||
4391826|NCT00294723|4218173|B3|||HbA1c (Glycosylated Haemoglobin A1c)|HbA1c at screening|percentage of total haemoglobin|Mean|8.4|8.4|Standard Deviation|1.2|1.2|||
4391827|NCT00294723|4218174|B2|||HbA1c (Glycosylated Haemoglobin A1c)|HbA1c at screening|percentage of total haemoglobin|Mean|8.3|8.3|Standard Deviation|1.0|1.0|||
4391828|NCT00294723|4218175|B1|||HbA1c (Glycosylated Haemoglobin A1c)|HbA1c at screening|percentage of total haemoglobin|Mean|8.3|8.3|Standard Deviation|1.1|1.1|||
4391829|NCT00294723|4218172|B4|||Duration of diabetes|Number of years since diagnosis|years|Mean|5.4|5.4|Standard Deviation|5.3|5.3|||
4391830|NCT00294723|4218173|B3|||Duration of diabetes|Number of years since diagnosis|years|Mean|5.6|5.6|Standard Deviation|5.1|5.1|||
4391831|NCT00294723|4218174|B2|||Duration of diabetes|Number of years since diagnosis|years|Mean|5.2|5.2|Standard Deviation|5.5|5.5|||
4391832|NCT00294723|4218175|B1|||Duration of diabetes|Number of years since diagnosis|years|Mean|5.3|5.3|Standard Deviation|5.1|5.1|||
4391833|NCT00294723|4218172|B4|||Body Mass Index (BMI)||kg/m^2|Mean|33.1|33.1|Standard Deviation|5.8|5.8|||
4391834|NCT00294723|4218173|B3|||Body Mass Index (BMI)||kg/m^2|Mean|33.2|33.2|Standard Deviation|5.6|5.6|||
4391835|NCT00294723|4218174|B2|||Body Mass Index (BMI)||kg/m^2|Mean|33.2|33.2|Standard Deviation|5.6|5.6|||
4391836|NCT00294723|4218175|B1|||Body Mass Index (BMI)||kg/m^2|Mean|32.8|32.8|Standard Deviation|6.3|6.3|||
4391837|NCT00294723|4218172|B4|Monotherapy||Previous anti-diabetic treatment||participants|Number|474|474.0||||||
4391838|NCT00294723|4218173|B3|Monotherapy||Previous anti-diabetic treatment||participants|Number|154|154.0||||||
4391839|NCT00294723|4218174|B2|Monotherapy||Previous anti-diabetic treatment||participants|Number|160|160.0||||||
4391840|NCT00294723|4218175|B1|Monotherapy||Previous anti-diabetic treatment||participants|Number|160|160.0||||||
4391841|NCT00294723|4218172|B4|Diet/Exercise||Previous anti-diabetic treatment||participants|Number|272|272.0||||||
4391842|NCT00294723|4218173|B3|Diet/Exercise||Previous anti-diabetic treatment||participants|Number|94|94.0||||||
4391843|NCT00294723|4218174|B2|Diet/Exercise||Previous anti-diabetic treatment||participants|Number|91|91.0||||||
4391844|NCT00294723|4218175|B1|Diet/Exercise||Previous anti-diabetic treatment||participants|Number|87|87.0||||||
4391845|NCT00294723|4218172|B4|United States||Region of Enrollment||participants|Number|575|575.0||||||
4391846|NCT00294723|4218173|B3|United States||Region of Enrollment||participants|Number|182|182.0||||||
4391847|NCT00294723|4218174|B2|United States||Region of Enrollment||participants|Number|198|198.0||||||
4391848|NCT00294723|4218175|B1|United States||Region of Enrollment||participants|Number|195|195.0||||||
4391849|NCT00294723|4218172|B4|Mexico||Region of Enrollment||participants|Number|171|171.0||||||
4391850|NCT00294723|4218173|B3|Mexico||Region of Enrollment||participants|Number|66|66.0||||||
4391851|NCT00294723|4218174|B2|Mexico||Region of Enrollment||participants|Number|53|53.0||||||
4391852|NCT00294723|4218175|B1|Mexico||Region of Enrollment||participants|Number|52|52.0||||||
4391853|NCT00294723|4218172|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4391854|NCT00294723|4218173|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4391855|NCT00294723|4218174|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4391856|NCT00294723|4218175|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4391857|NCT00294723|4218172|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391858|NCT00294723|4218173|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391859|NCT00294723|4218174|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391860|NCT00294723|4218175|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391861|NCT00294723|4218172|B4||White|Race (NIH/OMB)||Participants|Count of Participants|578|578.0||||||
4391862|NCT00294723|4218173|B3||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4391863|NCT00294723|4218174|B2||White|Race (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
4391864|NCT00294723|4218175|B1||White|Race (NIH/OMB)||Participants|Count of Participants|186|186.0||||||
4391865|NCT00294723|4218172|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4391866|NCT00294723|4218173|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4391867|NCT00294723|4218174|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4391868|NCT00294723|4218175|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4391869|NCT00294723|4218172|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4391870|NCT00294723|4218173|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391871|NCT00294723|4218174|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391872|NCT00294723|4218175|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4391873|NCT00294723|4218172|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4391874|NCT00294723|4218173|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4391875|NCT00294723|4218174|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4391876|NCT00294723|4218175|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4391877|NCT00294723|4218172|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391878|NCT00294723|4218173|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391879|NCT00294723|4218174|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391880|NCT00294723|4218175|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391881|NCT00294723|4218172|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391882|NCT00294723|4218173|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391883|NCT00294723|4218174|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391884|NCT00294723|4218175|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391885|NCT00294723|4218172|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|485|485.0||||||
4391886|NCT00294723|4218173|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4391887|NCT00294723|4218174|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
4391888|NCT00294723|4218175|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
4391889|NCT00294723|4218172|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|261|261.0||||||
4391890|NCT00294723|4218173|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4391891|NCT00294723|4218174|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4391892|NCT00294723|4218175|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4391893|NCT00294723|4218172|B4||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4391894|NCT00294723|4218173|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4391895|NCT00294723|4218174|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4391896|NCT00294723|4218175|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4391897|NCT00294723|4218172|B4||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
4391898|NCT00294723|4218173|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4391899|NCT00294723|4218174|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4391900|NCT00294723|4218175|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4391901|NCT00294723|4218172|B4|||Age||years|Mean|53.0|53.0|Standard Deviation|10.9|10.9|||
4391902|NCT00294723|4218173|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|10.9|10.9|||
4391903|NCT00294723|4218174|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|11.0|11.0|||
4391904|NCT00294723|4218175|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|10.8|10.8|||
4391905|NCT00294723|4218172|B4||>=65 years|Age||Participants|Count of Participants|108|108.0||||||
4391906|NCT00294723|4218173|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4391907|NCT00294723|4218174|B2||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4391908|NCT00294723|4218175|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4391909|NCT00294723|4218172|B4||Between 18 and 65 years|Age||Participants|Count of Participants|638|638.0||||||
4391910|NCT00294723|4218173|B3||Between 18 and 65 years|Age||Participants|Count of Participants|208|208.0||||||
4391911|NCT00294723|4218174|B2||Between 18 and 65 years|Age||Participants|Count of Participants|208|208.0||||||
4391912|NCT00294723|4218175|B1||Between 18 and 65 years|Age||Participants|Count of Participants|222|222.0||||||
4391913|NCT00294723|4218172|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391914|NCT00294723|4218173|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391915|NCT00294723|4218174|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391916|NCT00294723|4218175|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4391917|NCT00294684|4218236|B3|||Weight Z Score||Z-Score|Mean|-0.8|-0.8|Standard Deviation|1.07|1.07|||
4391918|NCT00294684|4218237|B2|||Weight Z Score||Z-Score|Mean|-0.8|-0.8|Standard Deviation|1.06|1.06|||
4391919|NCT00294684|4218238|B1|||Weight Z Score||Z-Score|Mean|-0.8|-0.8|Standard Deviation|1.07|1.07|||
4391920|NCT00294684|4218236|B3|||Length Z Score||Z-Score|Mean|-0.65|-0.65|Standard Deviation|1.35|1.35|||
4391921|NCT00294684|4218237|B2|||Length Z Score||Z-Score|Mean|-0.6|-0.6|Standard Deviation|1.35|1.35|||
4391922|NCT00294684|4218238|B1|||Length Z Score||Z-Score|Mean|-0.7|-0.7|Standard Deviation|1.35|1.35|||
4391923|NCT00294684|4218236|B3|||Total Bilirubin||mg/dL|Mean|7.7|7.7|Standard Deviation|2.7|2.7|||
4391924|NCT00294684|4218237|B2|||Total Bilirubin||mg/dL|Mean|7.9|7.9|Standard Deviation|2.8|2.8|||
4391925|NCT00294684|4218238|B1|||Total Bilirubin||mg/dL|Mean|7.5|7.5|Standard Deviation|2.6|2.6|||
4391926|NCT00294684|4218236|B3|Missing||OHI Main Type|Ohi classifications are provided by the study sites. Type I = atresia of common bile duct, Type II = atresia of hepatic duct and Type III = atresia of porta hepatis.|participants|Number|1|1.0||||||
4391927|NCT00294684|4218237|B2|Missing||OHI Main Type|Ohi classifications are provided by the study sites. Type I = atresia of common bile duct, Type II = atresia of hepatic duct and Type III = atresia of porta hepatis.|participants|Number|1|1.0||||||
4391928|NCT00294684|4218238|B1|Missing||OHI Main Type|Ohi classifications are provided by the study sites. Type I = atresia of common bile duct, Type II = atresia of hepatic duct and Type III = atresia of porta hepatis.|participants|Number|0|0.0||||||
4391929|NCT00294684|4218236|B3|III||OHI Main Type|Ohi classifications are provided by the study sites. Type I = atresia of common bile duct, Type II = atresia of hepatic duct and Type III = atresia of porta hepatis.|participants|Number|121|121.0||||||
4391930|NCT00294684|4218237|B2|III||OHI Main Type|Ohi classifications are provided by the study sites. Type I = atresia of common bile duct, Type II = atresia of hepatic duct and Type III = atresia of porta hepatis.|participants|Number|57|57.0||||||
4391931|NCT00294684|4218238|B1|III||OHI Main Type|Ohi classifications are provided by the study sites. Type I = atresia of common bile duct, Type II = atresia of hepatic duct and Type III = atresia of porta hepatis.|participants|Number|64|64.0||||||
4391932|NCT00294684|4218236|B3|II||OHI Main Type|Ohi classifications are provided by the study sites. Type I = atresia of common bile duct, Type II = atresia of hepatic duct and Type III = atresia of porta hepatis.|participants|Number|5|5.0||||||
4391933|NCT00294684|4218237|B2|II||OHI Main Type|Ohi classifications are provided by the study sites. Type I = atresia of common bile duct, Type II = atresia of hepatic duct and Type III = atresia of porta hepatis.|participants|Number|4|4.0||||||
4391934|NCT00294684|4218238|B1|II||OHI Main Type|Ohi classifications are provided by the study sites. Type I = atresia of common bile duct, Type II = atresia of hepatic duct and Type III = atresia of porta hepatis.|participants|Number|1|1.0||||||
4391935|NCT00294684|4218236|B3|I||OHI Main Type|Ohi classifications are provided by the study sites. Type I = atresia of common bile duct, Type II = atresia of hepatic duct and Type III = atresia of porta hepatis.|participants|Number|13|13.0||||||
4391936|NCT00294684|4218237|B2|I||OHI Main Type|Ohi classifications are provided by the study sites. Type I = atresia of common bile duct, Type II = atresia of hepatic duct and Type III = atresia of porta hepatis.|participants|Number|8|8.0||||||
4391937|NCT00294684|4218238|B1|I||OHI Main Type|Ohi classifications are provided by the study sites. Type I = atresia of common bile duct, Type II = atresia of hepatic duct and Type III = atresia of porta hepatis.|participants|Number|5|5.0||||||
4391938|NCT00294684|4218236|B3|Not BASM||Biliary atresia splenic malformation (BASM)|"BASM (Biliary Atresia Splenic Malformation) categorization as provided by the study sites (absent or present). Patients where BASM is considered present are provided as Number below. Other patients are considered absent of BASM."|participants|Number|135|135.0||||||
4391939|NCT00294684|4218237|B2|Not BASM||Biliary atresia splenic malformation (BASM)|"BASM (Biliary Atresia Splenic Malformation) categorization as provided by the study sites (absent or present). Patients where BASM is considered present are provided as Number below. Other patients are considered absent of BASM."|participants|Number|67|67.0||||||
4391940|NCT00294684|4218238|B1|Not BASM||Biliary atresia splenic malformation (BASM)|"BASM (Biliary Atresia Splenic Malformation) categorization as provided by the study sites (absent or present). Patients where BASM is considered present are provided as Number below. Other patients are considered absent of BASM."|participants|Number|68|68.0||||||
4391941|NCT00294684|4218236|B3|BASM||Biliary atresia splenic malformation (BASM)|"BASM (Biliary Atresia Splenic Malformation) categorization as provided by the study sites (absent or present). Patients where BASM is considered present are provided as Number below. Other patients are considered absent of BASM."|participants|Number|5|5.0||||||
4392041|NCT00294671|4218278|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|12.2|12.2|||
4391942|NCT00294684|4218237|B2|BASM||Biliary atresia splenic malformation (BASM)|"BASM (Biliary Atresia Splenic Malformation) categorization as provided by the study sites (absent or present). Patients where BASM is considered present are provided as Number below. Other patients are considered absent of BASM."|participants|Number|3|3.0||||||
4391943|NCT00294684|4218238|B1|BASM||Biliary atresia splenic malformation (BASM)|"BASM (Biliary Atresia Splenic Malformation) categorization as provided by the study sites (absent or present). Patients where BASM is considered present are provided as Number below. Other patients are considered absent of BASM."|participants|Number|2|2.0||||||
4391944|NCT00294684|4218236|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4391945|NCT00294684|4218237|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4391946|NCT00294684|4218238|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4391947|NCT00294684|4218236|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391948|NCT00294684|4218237|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391949|NCT00294684|4218238|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391950|NCT00294684|4218236|B3||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4391951|NCT00294684|4218237|B2||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4391952|NCT00294684|4218238|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4391953|NCT00294684|4218236|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4391954|NCT00294684|4218237|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4391955|NCT00294684|4218238|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4391956|NCT00294684|4218236|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391957|NCT00294684|4218237|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391958|NCT00294684|4218238|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391959|NCT00294684|4218236|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391960|NCT00294684|4218237|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391961|NCT00294684|4218238|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391962|NCT00294684|4218236|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391963|NCT00294684|4218237|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391964|NCT00294684|4218238|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391965|NCT00294684|4218236|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4391966|NCT00294684|4218237|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4391967|NCT00294684|4218238|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4391968|NCT00294684|4218236|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4391969|NCT00294684|4218237|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4391970|NCT00294684|4218238|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4391971|NCT00294684|4218236|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4391972|NCT00294684|4218237|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4391973|NCT00294684|4218238|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4391974|NCT00294684|4218236|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4391975|NCT00294684|4218237|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4391976|NCT00294684|4218238|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4391977|NCT00294684|4218236|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4391978|NCT00294684|4218237|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4391979|NCT00294684|4218238|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4391980|NCT00294684|4218236|B3|||Age||Months|Mean|2.3|2.3|Standard Deviation|.89|0.89|||
4391981|NCT00294684|4218237|B2|||Age||Months|Mean|2.3|2.3|Standard Deviation|.84|0.84|||
4391982|NCT00294684|4218238|B1|||Age||Months|Mean|2.3|2.3|Standard Deviation|.93|0.93|||
4391983|NCT00294671|4218277|B3|||SF-36 mental component score|Higher scores indicate greater mental quality of life, scale 0-100 points|units on a scale|Mean|46.6|46.6|Standard Deviation|12.9|12.9|||
4391984|NCT00294671|4218278|B2|||SF-36 mental component score|Higher scores indicate greater mental quality of life, scale 0-100 points|units on a scale|Mean|46.5|46.5|Standard Deviation|11.8|11.8|||
4391985|NCT00294671|4218279|B1|||SF-36 mental component score|Higher scores indicate greater mental quality of life, scale 0-100 points|units on a scale|Mean|46.6|46.6|Standard Deviation|14.1|14.1|||
4391986|NCT00294671|4218277|B3|||SF-36 physical component score|Higher scores indicate greater physical quality of life, scale from 0 to 100 points|units on a scale|Mean|35.4|35.4|Standard Deviation|11.3|11.3|||
4391987|NCT00294671|4218278|B2|||SF-36 physical component score|Higher scores indicate greater physical quality of life, scale from 0 to 100 points|units on a scale|Mean|34.8|34.8|Standard Deviation|11|11.0|||
4391988|NCT00294671|4218279|B1|||SF-36 physical component score|Higher scores indicate greater physical quality of life, scale from 0 to 100 points|units on a scale|Mean|35.9|35.9|Standard Deviation|11.6|11.6|||
4391989|NCT00294671|4218277|B3|||Modified BMI|The product of BMI and serum albumin (g/L). Lower scores indicate worse nutritional status.|kg/M2 x g/L|Mean|1021.7|1021.7|Standard Deviation|240.4|240.4|||
4392042|NCT00294671|4218279|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|11.7|11.7|||
4391990|NCT00294671|4218278|B2|||Modified BMI|The product of BMI and serum albumin (g/L). Lower scores indicate worse nutritional status.|kg/M2 x g/L|Mean|1019|1019.0|Standard Deviation|255|255.0|||
4391991|NCT00294671|4218279|B1|||Modified BMI|The product of BMI and serum albumin (g/L). Lower scores indicate worse nutritional status.|kg/M2 x g/L|Mean|1024.4|1024.4|Standard Deviation|226.3|226.3|||
4391992|NCT00294671|4218277|B3|||Kumamoto score|Higher scores indicating greater neurologic and end organ deficits (0=no neurologic deficits, 102=no detectable peripheral neurologic function)|units on a scale|Mean|16.0|16.0|Standard Deviation|12.2|12.2|||
4391993|NCT00294671|4218278|B2|||Kumamoto score|Higher scores indicating greater neurologic and end organ deficits (0=no neurologic deficits, 102=no detectable peripheral neurologic function)|units on a scale|Mean|16.7|16.7|Standard Deviation|13.5|13.5|||
4391994|NCT00294671|4218279|B1|||Kumamoto score|Higher scores indicating greater neurologic and end organ deficits (0=no neurologic deficits, 102=no detectable peripheral neurologic function)|units on a scale|Mean|15.3|15.3|Standard Deviation|10.8|10.8|||
4391995|NCT00294671|4218277|B3|||NIS+7 score|Higher scores indicating greater neurologic deficits (0=no neurologic impairment, 270=no detectable peripheral neurologic function)|units on a scale|Mean|55.3|55.3|Standard Deviation|46.5|46.5|||
4391996|NCT00294671|4218278|B2|||NIS+7 score|Higher scores indicating greater neurologic deficits (0=no neurologic impairment, 270=no detectable peripheral neurologic function)|units on a scale|Mean|59.0|59.0|Standard Deviation|50|50.0|||
4391997|NCT00294671|4218279|B1|||NIS+7 score|Higher scores indicating greater neurologic deficits (0=no neurologic impairment, 270=no detectable peripheral neurologic function)|units on a scale|Mean|51.6|51.6|Standard Deviation|42.8|42.8|||
4391998|NCT00294671|4218277|B3|Sweden||Region of Enrollment||participants|Number|24|24.0||||||
4391999|NCT00294671|4218278|B2|Sweden||Region of Enrollment||participants|Number|12|12.0||||||
4392000|NCT00294671|4218279|B1|Sweden||Region of Enrollment||participants|Number|12|12.0||||||
4392001|NCT00294671|4218277|B3|Japan||Region of Enrollment||participants|Number|9|9.0||||||
4392002|NCT00294671|4218278|B2|Japan||Region of Enrollment||participants|Number|4|4.0||||||
4392003|NCT00294671|4218279|B1|Japan||Region of Enrollment||participants|Number|5|5.0||||||
4392004|NCT00294671|4218277|B3|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4392005|NCT00294671|4218278|B2|Italy||Region of Enrollment||participants|Number|11|11.0||||||
4392006|NCT00294671|4218279|B1|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4392007|NCT00294671|4218277|B3|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4392008|NCT00294671|4218278|B2|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4392009|NCT00294671|4218279|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4392010|NCT00294671|4218277|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4392011|NCT00294671|4218278|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4392012|NCT00294671|4218279|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4392013|NCT00294671|4218277|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4392014|NCT00294671|4218278|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4392015|NCT00294671|4218279|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392016|NCT00294671|4218277|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4392017|NCT00294671|4218278|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4392018|NCT00294671|4218279|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4392019|NCT00294671|4218277|B3||White|Race (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4392020|NCT00294671|4218278|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4392021|NCT00294671|4218279|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4392022|NCT00294671|4218277|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4392023|NCT00294671|4218278|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4392024|NCT00294671|4218279|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4392025|NCT00294671|4218277|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392026|NCT00294671|4218278|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392027|NCT00294671|4218279|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392028|NCT00294671|4218277|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4392029|NCT00294671|4218278|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4392030|NCT00294671|4218279|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4392031|NCT00294671|4218277|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392032|NCT00294671|4218278|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392033|NCT00294671|4218279|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392034|NCT00294671|4218277|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4392035|NCT00294671|4218278|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4392036|NCT00294671|4218279|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4392037|NCT00294671|4218277|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4392038|NCT00294671|4218278|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4392039|NCT00294671|4218279|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4392040|NCT00294671|4218277|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|11.9|11.9|||
4392043|NCT00294658|4218294|B3|||Prednisone Dosage at baseline (mg)|Prednisone dosage unit as mg, patient has been taken prednisone every other day|mg|Mean|42.97|42.97|Standard Deviation|26.28|26.28|||
4392044|NCT00294658|4218295|B2|||Prednisone Dosage at baseline (mg)|Prednisone dosage unit as mg, patient has been taken prednisone every other day|mg|Mean|42.49|42.49|Standard Deviation|23.52|23.52|||
4392045|NCT00294658|4218296|B1|||Prednisone Dosage at baseline (mg)|Prednisone dosage unit as mg, patient has been taken prednisone every other day|mg|Mean|43.43|43.43|Standard Deviation|28.92|28.92|||
4392046|NCT00294658|4218294|B3|Missing||Prednisone use at baseline||participants|Number|4|4.0||||||
4392047|NCT00294658|4218295|B2|Missing||Prednisone use at baseline||participants|Number|3|3.0||||||
4392048|NCT00294658|4218296|B1|Missing||Prednisone use at baseline||participants|Number|1|1.0||||||
4392049|NCT00294658|4218294|B3|No||Prednisone use at baseline||participants|Number|26|26.0||||||
4392050|NCT00294658|4218295|B2|No||Prednisone use at baseline||participants|Number|10|10.0||||||
4392051|NCT00294658|4218296|B1|No||Prednisone use at baseline||participants|Number|16|16.0||||||
4392052|NCT00294658|4218294|B3|Yes||Prednisone use at baseline||participants|Number|96|96.0||||||
4392053|NCT00294658|4218295|B2|Yes||Prednisone use at baseline||participants|Number|47|47.0||||||
4392054|NCT00294658|4218296|B1|Yes||Prednisone use at baseline||participants|Number|49|49.0||||||
4392055|NCT00294658|4218294|B3|||QMG score|Myasthenia Gravis (QMG) test. QMG total scores range from 0 to 39, with higher scores indicating more severe disease.|units on a scale|Mean|11.84|11.84|Standard Deviation|5.02|5.02|||
4392056|NCT00294658|4218295|B2|||QMG score|Myasthenia Gravis (QMG) test. QMG total scores range from 0 to 39, with higher scores indicating more severe disease.|units on a scale|Mean|12.35|12.35|Standard Deviation|4.90|4.9|||
4392057|NCT00294658|4218296|B1|||QMG score|Myasthenia Gravis (QMG) test. QMG total scores range from 0 to 39, with higher scores indicating more severe disease.|units on a scale|Mean|11.40|11.4|Standard Deviation|5.12|5.12|||
4392058|NCT00294658|4218294|B3|||Duration of disease||years|Median|1.11|1.11|Full Range|||0.02|4.41|
4392059|NCT00294658|4218295|B2|||Duration of disease||years|Median|1.14|1.14|Full Range|||0.15|4.38|
4392060|NCT00294658|4218296|B1|||Duration of disease||years|Median|1.08|1.08|Full Range|||0.02|4.41|
4392061|NCT00294658|4218294|B3|IV||MGFA class|"Class IIa. Predominantly affecting limb, axial muscles, or both. May also have lesser involvement of oropharyngeal muscles.~Class IIb. Predominantly affecting oropharyngeal, respiratory muscles, or both. May also have lesser or equal involvement of limb, axial muscles, or both.~Class III. Moderate weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Class IV. Severe weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Higher class was considered worse outcome."|participants|Number|3|3.0||||||
4392062|NCT00294658|4218295|B2|IV||MGFA class|"Class IIa. Predominantly affecting limb, axial muscles, or both. May also have lesser involvement of oropharyngeal muscles.~Class IIb. Predominantly affecting oropharyngeal, respiratory muscles, or both. May also have lesser or equal involvement of limb, axial muscles, or both.~Class III. Moderate weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Class IV. Severe weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Higher class was considered worse outcome."|participants|Number|1|1.0||||||
4392063|NCT00294658|4218296|B1|IV||MGFA class|"Class IIa. Predominantly affecting limb, axial muscles, or both. May also have lesser involvement of oropharyngeal muscles.~Class IIb. Predominantly affecting oropharyngeal, respiratory muscles, or both. May also have lesser or equal involvement of limb, axial muscles, or both.~Class III. Moderate weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Class IV. Severe weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Higher class was considered worse outcome."|participants|Number|2|2.0||||||
4392064|NCT00294658|4218294|B3|III||MGFA class|"Class IIa. Predominantly affecting limb, axial muscles, or both. May also have lesser involvement of oropharyngeal muscles.~Class IIb. Predominantly affecting oropharyngeal, respiratory muscles, or both. May also have lesser or equal involvement of limb, axial muscles, or both.~Class III. Moderate weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Class IV. Severe weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Higher class was considered worse outcome."|participants|Number|41|41.0||||||
4392065|NCT00294658|4218295|B2|III||MGFA class|"Class IIa. Predominantly affecting limb, axial muscles, or both. May also have lesser involvement of oropharyngeal muscles.~Class IIb. Predominantly affecting oropharyngeal, respiratory muscles, or both. May also have lesser or equal involvement of limb, axial muscles, or both.~Class III. Moderate weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Class IV. Severe weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Higher class was considered worse outcome."|participants|Number|20|20.0||||||
4392066|NCT00294658|4218296|B1|III||MGFA class|"Class IIa. Predominantly affecting limb, axial muscles, or both. May also have lesser involvement of oropharyngeal muscles.~Class IIb. Predominantly affecting oropharyngeal, respiratory muscles, or both. May also have lesser or equal involvement of limb, axial muscles, or both.~Class III. Moderate weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Class IV. Severe weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Higher class was considered worse outcome."|participants|Number|21|21.0||||||
4392067|NCT00294658|4218294|B3|IIb||MGFA class|"Class IIa. Predominantly affecting limb, axial muscles, or both. May also have lesser involvement of oropharyngeal muscles.~Class IIb. Predominantly affecting oropharyngeal, respiratory muscles, or both. May also have lesser or equal involvement of limb, axial muscles, or both.~Class III. Moderate weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Class IV. Severe weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Higher class was considered worse outcome."|participants|Number|32|32.0||||||
4392106|NCT00294658|4218294|B3|Yes||Therapy at enrollment - Pyridostigimine||participants|Number|116|116.0||||||
4392107|NCT00294658|4218295|B2|Yes||Therapy at enrollment - Pyridostigimine||participants|Number|56|56.0||||||
4392068|NCT00294658|4218295|B2|IIb||MGFA class|"Class IIa. Predominantly affecting limb, axial muscles, or both. May also have lesser involvement of oropharyngeal muscles.~Class IIb. Predominantly affecting oropharyngeal, respiratory muscles, or both. May also have lesser or equal involvement of limb, axial muscles, or both.~Class III. Moderate weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Class IV. Severe weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Higher class was considered worse outcome."|participants|Number|14|14.0||||||
4392069|NCT00294658|4218296|B1|IIb||MGFA class|"Class IIa. Predominantly affecting limb, axial muscles, or both. May also have lesser involvement of oropharyngeal muscles.~Class IIb. Predominantly affecting oropharyngeal, respiratory muscles, or both. May also have lesser or equal involvement of limb, axial muscles, or both.~Class III. Moderate weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Class IV. Severe weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Higher class was considered worse outcome."|participants|Number|18|18.0||||||
4392070|NCT00294658|4218294|B3|IIa||MGFA class|"Class IIa. Predominantly affecting limb, axial muscles, or both. May also have lesser involvement of oropharyngeal muscles.~Class IIb. Predominantly affecting oropharyngeal, respiratory muscles, or both. May also have lesser or equal involvement of limb, axial muscles, or both.~Class III. Moderate weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Class IV. Severe weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Higher class was considered worse outcome."|participants|Number|50|50.0||||||
4392071|NCT00294658|4218295|B2|IIa||MGFA class|"Class IIa. Predominantly affecting limb, axial muscles, or both. May also have lesser involvement of oropharyngeal muscles.~Class IIb. Predominantly affecting oropharyngeal, respiratory muscles, or both. May also have lesser or equal involvement of limb, axial muscles, or both.~Class III. Moderate weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Class IV. Severe weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Higher class was considered worse outcome."|participants|Number|25|25.0||||||
4392072|NCT00294658|4218296|B1|IIa||MGFA class|"Class IIa. Predominantly affecting limb, axial muscles, or both. May also have lesser involvement of oropharyngeal muscles.~Class IIb. Predominantly affecting oropharyngeal, respiratory muscles, or both. May also have lesser or equal involvement of limb, axial muscles, or both.~Class III. Moderate weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Class IV. Severe weakness affecting muscles other than ocular muscles; may also have ocular muscle weakness of any severity.~Higher class was considered worse outcome."|participants|Number|25|25.0||||||
4392073|NCT00294658|4218294|B3|Missing||Previous therapy - Plasma exchange||participants|Number|4|4.0||||||
4392074|NCT00294658|4218295|B2|Missing||Previous therapy - Plasma exchange||participants|Number|3|3.0||||||
4392075|NCT00294658|4218296|B1|Missing||Previous therapy - Plasma exchange||participants|Number|1|1.0||||||
4392076|NCT00294658|4218294|B3|No||Previous therapy - Plasma exchange||participants|Number|106|106.0||||||
4392077|NCT00294658|4218295|B2|No||Previous therapy - Plasma exchange||participants|Number|50|50.0||||||
4392078|NCT00294658|4218296|B1|No||Previous therapy - Plasma exchange||participants|Number|56|56.0||||||
4392079|NCT00294658|4218294|B3|Yes||Previous therapy - Plasma exchange||participants|Number|16|16.0||||||
4392080|NCT00294658|4218295|B2|Yes||Previous therapy - Plasma exchange||participants|Number|7|7.0||||||
4392081|NCT00294658|4218296|B1|Yes||Previous therapy - Plasma exchange||participants|Number|9|9.0||||||
4392082|NCT00294658|4218294|B3|Missing||Previous therapy - Intravenous immue globulin||participants|Number|4|4.0||||||
4392083|NCT00294658|4218295|B2|Missing||Previous therapy - Intravenous immue globulin||participants|Number|3|3.0||||||
4392084|NCT00294658|4218296|B1|Missing||Previous therapy - Intravenous immue globulin||participants|Number|1|1.0||||||
4392085|NCT00294658|4218294|B3|No||Previous therapy - Intravenous immue globulin||participants|Number|97|97.0||||||
4392086|NCT00294658|4218295|B2|No||Previous therapy - Intravenous immue globulin||participants|Number|44|44.0||||||
4392087|NCT00294658|4218296|B1|No||Previous therapy - Intravenous immue globulin||participants|Number|53|53.0||||||
4392088|NCT00294658|4218294|B3|Yes||Previous therapy - Intravenous immue globulin||participants|Number|25|25.0||||||
4392089|NCT00294658|4218295|B2|Yes||Previous therapy - Intravenous immue globulin||participants|Number|13|13.0||||||
4392090|NCT00294658|4218296|B1|Yes||Previous therapy - Intravenous immue globulin||participants|Number|12|12.0||||||
4392091|NCT00294658|4218294|B3|Missing||Therapy at enrollment - Glucocorticoid||participants|Number|4|4.0||||||
4392092|NCT00294658|4218295|B2|Missing||Therapy at enrollment - Glucocorticoid||participants|Number|3|3.0||||||
4392093|NCT00294658|4218296|B1|Missing||Therapy at enrollment - Glucocorticoid||participants|Number|1|1.0||||||
4392094|NCT00294658|4218294|B3|No||Therapy at enrollment - Glucocorticoid||participants|Number|26|26.0||||||
4392095|NCT00294658|4218295|B2|No||Therapy at enrollment - Glucocorticoid||participants|Number|10|10.0||||||
4392096|NCT00294658|4218296|B1|No||Therapy at enrollment - Glucocorticoid||participants|Number|16|16.0||||||
4392097|NCT00294658|4218294|B3|Yes||Therapy at enrollment - Glucocorticoid||participants|Number|96|96.0||||||
4392098|NCT00294658|4218295|B2|Yes||Therapy at enrollment - Glucocorticoid||participants|Number|47|47.0||||||
4392099|NCT00294658|4218296|B1|Yes||Therapy at enrollment - Glucocorticoid||participants|Number|49|49.0||||||
4392100|NCT00294658|4218294|B3|Missing||Therapy at enrollment - Pyridostigimine||participants|Number|4|4.0||||||
4392101|NCT00294658|4218295|B2|Missing||Therapy at enrollment - Pyridostigimine||participants|Number|3|3.0||||||
4392102|NCT00294658|4218296|B1|Missing||Therapy at enrollment - Pyridostigimine||participants|Number|1|1.0||||||
4392103|NCT00294658|4218294|B3|No||Therapy at enrollment - Pyridostigimine||participants|Number|6|6.0||||||
4392104|NCT00294658|4218295|B2|No||Therapy at enrollment - Pyridostigimine||participants|Number|1|1.0||||||
4392105|NCT00294658|4218296|B1|No||Therapy at enrollment - Pyridostigimine||participants|Number|5|5.0||||||
4392108|NCT00294658|4218296|B1|Yes||Therapy at enrollment - Pyridostigimine||participants|Number|60|60.0||||||
4392109|NCT00294658|4218294|B3|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4392110|NCT00294658|4218295|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4392111|NCT00294658|4218296|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4392112|NCT00294658|4218294|B3|Chile||Region of Enrollment||participants|Number|10|10.0||||||
4392113|NCT00294658|4218295|B2|Chile||Region of Enrollment||participants|Number|5|5.0||||||
4392114|NCT00294658|4218296|B1|Chile||Region of Enrollment||participants|Number|5|5.0||||||
4392115|NCT00294658|4218294|B3|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4392116|NCT00294658|4218295|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4392117|NCT00294658|4218296|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4392118|NCT00294658|4218294|B3|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4392119|NCT00294658|4218295|B2|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4392120|NCT00294658|4218296|B1|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4392121|NCT00294658|4218294|B3|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4392122|NCT00294658|4218295|B2|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4392123|NCT00294658|4218296|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4392124|NCT00294658|4218294|B3|Italy||Region of Enrollment||participants|Number|10|10.0||||||
4392125|NCT00294658|4218295|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4392126|NCT00294658|4218296|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4392127|NCT00294658|4218294|B3|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4392128|NCT00294658|4218295|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4392129|NCT00294658|4218296|B1|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4392130|NCT00294658|4218294|B3|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4392131|NCT00294658|4218295|B2|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4392132|NCT00294658|4218296|B1|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
4392133|NCT00294658|4218294|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4392134|NCT00294658|4218295|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4392135|NCT00294658|4218296|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4392136|NCT00294658|4218294|B3|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4392137|NCT00294658|4218295|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4392138|NCT00294658|4218296|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4392139|NCT00294658|4218294|B3|Thailand||Region of Enrollment||participants|Number|5|5.0||||||
4392140|NCT00294658|4218295|B2|Thailand||Region of Enrollment||participants|Number|2|2.0||||||
4392141|NCT00294658|4218296|B1|Thailand||Region of Enrollment||participants|Number|3|3.0||||||
4392142|NCT00294658|4218294|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4392143|NCT00294658|4218295|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4392144|NCT00294658|4218296|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4392145|NCT00294658|4218294|B3|Japan||Region of Enrollment||participants|Number|2|2.0||||||
4392146|NCT00294658|4218295|B2|Japan||Region of Enrollment||participants|Number|1|1.0||||||
4392147|NCT00294658|4218296|B1|Japan||Region of Enrollment||participants|Number|1|1.0||||||
4392148|NCT00294658|4218294|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4392149|NCT00294658|4218295|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4392150|NCT00294658|4218296|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4392151|NCT00294658|4218294|B3|Argentina||Region of Enrollment||participants|Number|21|21.0||||||
4392152|NCT00294658|4218295|B2|Argentina||Region of Enrollment||participants|Number|11|11.0||||||
4392153|NCT00294658|4218296|B1|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
4392154|NCT00294658|4218294|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4392155|NCT00294658|4218295|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4392156|NCT00294658|4218296|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4392157|NCT00294658|4218294|B3|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4392158|NCT00294658|4218295|B2|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4392159|NCT00294658|4218296|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4392160|NCT00294658|4218294|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4392161|NCT00294658|4218295|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4392162|NCT00294658|4218296|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4392163|NCT00294658|4218294|B3|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4392164|NCT00294658|4218295|B2|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4392165|NCT00294658|4218296|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4392166|NCT00294658|4218294|B3|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4392167|NCT00294658|4218295|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4392168|NCT00294658|4218296|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4392169|NCT00294658|4218294|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4392170|NCT00294658|4218295|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4392171|NCT00294658|4218296|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4392172|NCT00294658|4218294|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4392173|NCT00294658|4218295|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4392174|NCT00294658|4218296|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4392175|NCT00294658|4218294|B3|||Age||years|Median|32|32.0|Full Range|||18.0|64.0|
4392176|NCT00294658|4218295|B2|||Age||years|Median|33|33.0|Full Range|||18.0|64.0|
4392177|NCT00294658|4218296|B1|||Age||years|Median|32|32.0|Full Range|||18.0|63.0|
4392178|NCT00294645|4218359|B3|United States||Region of Enrollment||participants|Number|897.0|897.0||||||
4392179|NCT00294645|4218360|B2|United States||Region of Enrollment||participants|Number|602|602.0||||||
4392180|NCT00294645|4218361|B1|United States||Region of Enrollment||participants|Number|295|295.0||||||
4392181|NCT00294645|4218359|B3||Male|Sex: Female, Male||Participants|Count of Participants|454.0|454.0||||||
4392182|NCT00294645|4218360|B2||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4392183|NCT00294645|4218361|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4392184|NCT00294645|4218359|B3||Female|Sex: Female, Male||Participants|Count of Participants|443.0|443.0||||||
4392185|NCT00294645|4218360|B2||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4392186|NCT00294645|4218361|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4392187|NCT00294645|4218359|B3|||Age||years|Mean|68|68.0|Standard Deviation|16.8|16.8|||
4392188|NCT00294645|4218360|B2|||Age||years|Mean|68|68.0|Standard Deviation|16.7|16.7|||
4392189|NCT00294645|4218361|B1|||Age||years|Mean|69|69.0|Standard Deviation|16.9|16.9|||
4392190|NCT00294645|4218359|B3||>=65 years|Age||Participants|Count of Participants|629.0|629.0||||||
4392191|NCT00294645|4218360|B2||>=65 years|Age||Participants|Count of Participants|417|417.0||||||
4392192|NCT00294645|4218361|B1||>=65 years|Age||Participants|Count of Participants|212|212.0||||||
4392193|NCT00294645|4218359|B3||Between 18 and 65 years|Age||Participants|Count of Participants|243.0|243.0||||||
4392194|NCT00294645|4218360|B2||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
4392195|NCT00294645|4218361|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4392196|NCT00294645|4218359|B3||<=18 years|Age||Participants|Count of Participants|25.0|25.0||||||
4392197|NCT00294645|4218360|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4392198|NCT00294645|4218361|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4392199|NCT00294554|4218394|B3|||NART (Full Scale IQ)|"The National Adult Reading Test (NART) consists of 50 words with irregular phonetic spelling and pronunciation. Score ranges from 0-50, based on the number of words correctly pronounced. The NART score can be used to estimate IQ. Calculating the full scale IQ is done as 127.8-0.78(number of errors on NART). The higher the score, the higher the IQ.~IQ Scores:~Over 140 - Genius or near genius. 120 - 140 - Very superior intelligence. 110 - 119 - Superior intelligence. 90 - 109 - Normal or average intelligence. 80 - 89 - Dullness. 70 - 79 - Borderline deficiency."|units on a scale|Mean|105.5|105.5|Standard Deviation|8.5|8.5|||
4392200|NCT00294554|4218395|B2|||NART (Full Scale IQ)|"The National Adult Reading Test (NART) consists of 50 words with irregular phonetic spelling and pronunciation. Score ranges from 0-50, based on the number of words correctly pronounced. The NART score can be used to estimate IQ. Calculating the full scale IQ is done as 127.8-0.78(number of errors on NART). The higher the score, the higher the IQ.~IQ Scores:~Over 140 - Genius or near genius. 120 - 140 - Very superior intelligence. 110 - 119 - Superior intelligence. 90 - 109 - Normal or average intelligence. 80 - 89 - Dullness. 70 - 79 - Borderline deficiency."|units on a scale|Mean|102.7|102.7|Standard Deviation|6.6|6.6|||
4392201|NCT00294554|4218396|B1|||NART (Full Scale IQ)|"The National Adult Reading Test (NART) consists of 50 words with irregular phonetic spelling and pronunciation. Score ranges from 0-50, based on the number of words correctly pronounced. The NART score can be used to estimate IQ. Calculating the full scale IQ is done as 127.8-0.78(number of errors on NART). The higher the score, the higher the IQ.~IQ Scores:~Over 140 - Genius or near genius. 120 - 140 - Very superior intelligence. 110 - 119 - Superior intelligence. 90 - 109 - Normal or average intelligence. 80 - 89 - Dullness. 70 - 79 - Borderline deficiency."|units on a scale|Mean|108.0|108.0|Standard Deviation|9.5|9.5|||
4392202|NCT00294554|4218394|B3|||Education||years|Mean|17.1|17.1|Standard Deviation|3.7|3.7|||
4392203|NCT00294554|4218395|B2|||Education||years|Mean|16.9|16.9|Standard Deviation|3.0|3.0|||
4392204|NCT00294554|4218396|B1|||Education||years|Mean|17.2|17.2|Standard Deviation|4.5|4.5|||
4392205|NCT00294554|4218394|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4392206|NCT00294554|4218395|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4392207|NCT00294554|4218396|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4392208|NCT00294554|4218394|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392209|NCT00294554|4218395|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392210|NCT00294554|4218396|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392211|NCT00294554|4218394|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392212|NCT00294554|4218395|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392213|NCT00294554|4218396|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392214|NCT00294554|4218394|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4392215|NCT00294554|4218395|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4392216|NCT00294554|4218396|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4392217|NCT00294554|4218394|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392218|NCT00294554|4218395|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392219|NCT00294554|4218396|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392220|NCT00294554|4218394|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392221|NCT00294554|4218395|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392222|NCT00294554|4218396|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392223|NCT00294554|4218394|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392224|NCT00294554|4218395|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392225|NCT00294554|4218396|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392226|NCT00294554|4218394|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392227|NCT00294554|4218395|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392228|NCT00294554|4218396|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392229|NCT00294554|4218394|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4392230|NCT00294554|4218395|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4392231|NCT00294554|4218396|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4392232|NCT00294554|4218394|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4392233|NCT00294554|4218395|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4392234|NCT00294554|4218396|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392235|NCT00294554|4218394|B3|||Age||years|Mean|71.8|71.8|Standard Deviation|7.4|7.4|||
4392236|NCT00294554|4218395|B2|||Age||years|Mean|71.9|71.9|Standard Deviation|7.5|7.5|||
4392237|NCT00294554|4218396|B1|||Age||years|Mean|71.7|71.7|Standard Deviation|7.3|7.3|||
4392238|NCT00294515|4218405|B3||Male|Sex: Female, Male|Safety population|Participants|Count of Participants|235|235.0||||||
4392239|NCT00294515|4218406|B2||Male|Sex: Female, Male|Safety population|Participants|Count of Participants|116|116.0||||||
4392240|NCT00294515|4218407|B1||Male|Sex: Female, Male|Safety population|Participants|Count of Participants|119|119.0||||||
4392241|NCT00294515|4218405|B3||Female|Sex: Female, Male|Safety population|Participants|Count of Participants|85|85.0||||||
4392242|NCT00294515|4218406|B2||Female|Sex: Female, Male|Safety population|Participants|Count of Participants|40|40.0||||||
4392243|NCT00294515|4218407|B1||Female|Sex: Female, Male|Safety population|Participants|Count of Participants|45|45.0||||||
4392244|NCT00294515|4218405|B3|||Age|Safety population|years|Mean|47.8|47.8|Standard Deviation|13.64|13.64|||
4392245|NCT00294515|4218406|B2|||Age|Safety population|years|Mean|47.0|47.0|Standard Deviation|13.51|13.51|||
4392246|NCT00294515|4218407|B1|||Age|Safety population|years|Mean|48.5|48.5|Standard Deviation|13.76|13.76|||
4392247|NCT00294398|4218422|B3|United States||Region of Enrollment||participants|Number|152|152.0||||||
4392248|NCT00294398|4218423|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4392249|NCT00294398|4218424|B1|United States||Region of Enrollment||participants|Number|78|78.0||||||
4392250|NCT00294398|4218422|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4392251|NCT00294398|4218423|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4392252|NCT00294398|4218424|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4392253|NCT00294398|4218422|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4392254|NCT00294398|4218423|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4392255|NCT00294398|4218424|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4392256|NCT00294398|4218422|B3|||Age||years|Mean|5.0|5.0|Standard Deviation|4.0|4.0|||
4392257|NCT00294398|4218423|B2|||Age||years|Mean|5.5|5.5|Standard Deviation|4.8|4.8|||
4392258|NCT00294398|4218424|B1|||Age||years|Mean|4.5|4.5|Standard Deviation|3.1|3.1|||
4392259|NCT00294398|4218422|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4392260|NCT00294398|4218423|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4392261|NCT00294398|4218424|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4392262|NCT00294398|4218422|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4392263|NCT00294398|4218423|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4392264|NCT00294398|4218424|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4392265|NCT00294398|4218422|B3||<=18 years|Age||Participants|Count of Participants|152|152.0||||||
4392266|NCT00294398|4218423|B2||<=18 years|Age||Participants|Count of Participants|74|74.0||||||
4392267|NCT00294398|4218424|B1||<=18 years|Age||Participants|Count of Participants|78|78.0||||||
4392268|NCT00294060|4218433|B1|United States||Region of Enrollment||participants|Number|2013|2013.0||||||
4392269|NCT00294060|4218433|B1||Male|Sex: Female, Male||Participants|Count of Participants|1017|1017.0||||||
4392270|NCT00294060|4218433|B1||Female|Sex: Female, Male||Participants|Count of Participants|996|996.0||||||
4392271|NCT00294060|4218433|B1|||Age||years|Mean|76.3|76.3|Standard Deviation|11.2|11.2|||
4392272|NCT00294060|4218433|B1||>=65 years|Age||Participants|Count of Participants|1747|1747.0||||||
4392273|NCT00294060|4218433|B1||Between 18 and 65 years|Age||Participants|Count of Participants|266|266.0||||||
4392274|NCT00294060|4218433|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392275|NCT00294047|4218439|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392276|NCT00294047|4218440|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392277|NCT00294047|4218441|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392278|NCT00294047|4218439|B3||Female|Sex: Female, Male||Participants|Count of Participants|5752|5752.0||||||
4392279|NCT00294047|4218440|B2||Female|Sex: Female, Male||Participants|Count of Participants|2871|2871.0||||||
4392280|NCT00294047|4218441|B1||Female|Sex: Female, Male||Participants|Count of Participants|2881|2881.0||||||
4392281|NCT00294047|4218439|B3|||Age||Years|Mean|37.0|37.0|Standard Deviation|7.28|7.28|||
4392282|NCT00294047|4218440|B2|||Age||Years|Mean|37.0|37.0|Standard Deviation|7.32|7.32|||
4392283|NCT00294047|4218441|B1|||Age||Years|Mean|37.0|37.0|Standard Deviation|7.24|7.24|||
4392284|NCT00293813|4218544|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392285|NCT00293813|4218545|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392286|NCT00293813|4218546|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392287|NCT00293813|4218547|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392288|NCT00293813|4218544|B4||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4392289|NCT00293813|4218545|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4392290|NCT00293813|4218546|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4392291|NCT00293813|4218547|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4392292|NCT00293813|4218544|B4|||Age||Years|Mean|60.6|60.6|Standard Deviation|5.4|5.4|||
4392293|NCT00293813|4218545|B3|||Age||Years|Mean|60.8|60.8|Standard Deviation|5.2|5.2|||
4392294|NCT00293813|4218546|B2|||Age||Years|Mean|60.3|60.3|Standard Deviation|5.9|5.9|||
4392295|NCT00293813|4218547|B1|||Age||Years|Mean|60.7|60.7|Standard Deviation|5.2|5.2|||
4392296|NCT00293722|4218560|B1|Missing||Sex/Gender, Customized||participants|Number|6|6.0||||||
4392297|NCT00293722|4218560|B1|Male||Sex/Gender, Customized||participants|Number|571|571.0||||||
4392298|NCT00293722|4218560|B1|Female||Sex/Gender, Customized||participants|Number|708|708.0||||||
4392299|NCT00293722|4218560|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|11.4|11.4|||
4392300|NCT00293709|4218574|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4392301|NCT00293709|4218574|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4392302|NCT00293709|4218574|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|12.2|12.2|||
4392303|NCT00293579|4218588|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4392304|NCT00293579|4218588|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4392305|NCT00293579|4218588|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4392306|NCT00293579|4218588|B1|||Age||years|Median|52|52.0|Full Range|||49.0|71.0|
4392307|NCT00293540|4218595|B3|Viscera||Dominant metastatic site||participants|Number|30|30.0||||||
4392308|NCT00293540|4218596|B2|Viscera||Dominant metastatic site||participants|Number|11|11.0||||||
4392309|NCT00293540|4218597|B1|Viscera||Dominant metastatic site||participants|Number|19|19.0||||||
4392310|NCT00293540|4218595|B3|Bone||Dominant metastatic site||participants|Number|45|45.0||||||
4392311|NCT00293540|4218596|B2|Bone||Dominant metastatic site||participants|Number|25|25.0||||||
4392312|NCT00293540|4218597|B1|Bone||Dominant metastatic site||participants|Number|20|20.0||||||
4392313|NCT00293540|4218595|B3|Soft tissue||Dominant metastatic site||participants|Number|159|159.0||||||
4392314|NCT00293540|4218596|B2|Soft tissue||Dominant metastatic site||participants|Number|83|83.0||||||
4392315|NCT00293540|4218597|B1|Soft tissue||Dominant metastatic site||participants|Number|76|76.0||||||
4392316|NCT00293540|4218595|B3|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
4392317|NCT00293540|4218596|B2|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4392318|NCT00293540|4218597|B1|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4392319|NCT00293540|4218595|B3|Indonesia||Region of Enrollment||participants|Number|7|7.0||||||
4392320|NCT00293540|4218596|B2|Indonesia||Region of Enrollment||participants|Number|4|4.0||||||
4392321|NCT00293540|4218597|B1|Indonesia||Region of Enrollment||participants|Number|3|3.0||||||
4392322|NCT00293540|4218595|B3|Nigeria||Region of Enrollment||participants|Number|12|12.0||||||
4392323|NCT00293540|4218596|B2|Nigeria||Region of Enrollment||participants|Number|6|6.0||||||
4392324|NCT00293540|4218597|B1|Nigeria||Region of Enrollment||participants|Number|6|6.0||||||
4392325|NCT00293540|4218595|B3|Malaysia||Region of Enrollment||participants|Number|6|6.0||||||
4392326|NCT00293540|4218596|B2|Malaysia||Region of Enrollment||participants|Number|3|3.0||||||
4392327|NCT00293540|4218597|B1|Malaysia||Region of Enrollment||participants|Number|3|3.0||||||
4392328|NCT00293540|4218595|B3|China||Region of Enrollment||participants|Number|48|48.0||||||
4392329|NCT00293540|4218596|B2|China||Region of Enrollment||participants|Number|27|27.0||||||
4392330|NCT00293540|4218597|B1|China||Region of Enrollment||participants|Number|21|21.0||||||
4392331|NCT00293540|4218595|B3|Philippines||Region of Enrollment||participants|Number|54|54.0||||||
4392332|NCT00293540|4218596|B2|Philippines||Region of Enrollment||participants|Number|26|26.0||||||
4392333|NCT00293540|4218597|B1|Philippines||Region of Enrollment||participants|Number|28|28.0||||||
4392334|NCT00293540|4218595|B3|Morocco||Region of Enrollment||participants|Number|1|1.0||||||
4392335|NCT00293540|4218596|B2|Morocco||Region of Enrollment||participants|Number|1|1.0||||||
4392336|NCT00293540|4218597|B1|Morocco||Region of Enrollment||participants|Number|0|0.0||||||
4392337|NCT00293540|4218595|B3|Bangladesh||Region of Enrollment||participants|Number|98|98.0||||||
4392338|NCT00293540|4218596|B2|Bangladesh||Region of Enrollment||participants|Number|48|48.0||||||
4392339|NCT00293540|4218597|B1|Bangladesh||Region of Enrollment||participants|Number|50|50.0||||||
4392340|NCT00293540|4218595|B3|Vietnam||Region of Enrollment||participants|Number|1|1.0||||||
4392341|NCT00293540|4218596|B2|Vietnam||Region of Enrollment||participants|Number|0|0.0||||||
4392342|NCT00293540|4218597|B1|Vietnam||Region of Enrollment||participants|Number|1|1.0||||||
4392343|NCT00293540|4218595|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392344|NCT00293540|4218596|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392345|NCT00293540|4218597|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392346|NCT00293540|4218595|B3||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4392347|NCT00293540|4218596|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4392348|NCT00293540|4218597|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4392349|NCT00293540|4218595|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|5.6|5.6|||
4392350|NCT00293540|4218596|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|5.7|5.7|||
4392351|NCT00293540|4218597|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|5.4|5.4|||
4392352|NCT00293462|4218604|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4392353|NCT00293462|4218605|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4392354|NCT00293462|4218606|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392355|NCT00293462|4218607|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392356|NCT00293462|4218604|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4392357|NCT00293462|4218605|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392358|NCT00293462|4218606|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4392359|NCT00293462|4218607|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392360|NCT00293462|4218604|B4||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4392361|NCT00293462|4218605|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4392362|NCT00293462|4218606|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4392363|NCT00293462|4218607|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4392364|NCT00293462|4218604|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4392365|NCT00293462|4218605|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392366|NCT00293462|4218606|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4392367|NCT00293462|4218607|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4392368|NCT00293462|4218604|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4392369|NCT00293462|4218605|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4392370|NCT00293462|4218606|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392371|NCT00293462|4218607|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4392372|NCT00293462|4218604|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4392373|NCT00293462|4218605|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4392374|NCT00293462|4218606|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4392375|NCT00293462|4218607|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4392376|NCT00293462|4218604|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392377|NCT00293462|4218605|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392378|NCT00293462|4218606|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392379|NCT00293462|4218607|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392380|NCT00293462|4218604|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4392381|NCT00293462|4218605|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4392382|NCT00293462|4218606|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392383|NCT00293462|4218607|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392384|NCT00293462|4218604|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4392385|NCT00293462|4218605|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4392386|NCT00293462|4218606|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4392387|NCT00293462|4218607|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4392388|NCT00293462|4218604|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4392389|NCT00293462|4218605|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4392390|NCT00293462|4218606|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4392391|NCT00293462|4218607|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4392392|NCT00293462|4218604|B4||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4392393|NCT00293462|4218605|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4392394|NCT00293462|4218606|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4392395|NCT00293462|4218607|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4392396|NCT00293462|4218604|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4392397|NCT00293462|4218605|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4392398|NCT00293462|4218606|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4392399|NCT00293462|4218607|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4392400|NCT00293462|4218604|B4|||Age||years|Mean|54.48|54.48|Standard Deviation|12.43|12.43|||
4392401|NCT00293462|4218605|B3|||Age||years|Mean|56.26|56.26|Standard Deviation|11.29|11.29|||
4392402|NCT00293462|4218606|B2|||Age||years|Mean|54.69|54.69|Standard Deviation|12.22|12.22|||
4392403|NCT00293462|4218607|B1|||Age||years|Mean|53.55|53.55|Standard Deviation|13.73|13.73|||
4392404|NCT00293462|4218604|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4392405|NCT00293462|4218605|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4392406|NCT00293462|4218606|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4392407|NCT00293462|4218607|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4392408|NCT00293462|4218604|B4||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4392409|NCT00293462|4218605|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4392410|NCT00293462|4218606|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4392411|NCT00293462|4218607|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4392412|NCT00293462|4218604|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392413|NCT00293462|4218605|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392414|NCT00293462|4218606|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392415|NCT00293462|4218607|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392416|NCT00293397|4218628|B1|BCLC C||Barcelona Clinic Liver Cancer (BCLC) grade|The Barcelona Clinic Liver Cancer (BCLC) grades are used to assess those with Hepatocellular carcinoma (HCC). Grade A is the least severe, grade B is moderate and grade C is advanced.|Participants|Count of Participants|12|12.0||||||
4392417|NCT00293397|4218628|B1|BCLC B||Barcelona Clinic Liver Cancer (BCLC) grade|The Barcelona Clinic Liver Cancer (BCLC) grades are used to assess those with Hepatocellular carcinoma (HCC). Grade A is the least severe, grade B is moderate and grade C is advanced.|Participants|Count of Participants|2|2.0||||||
4392418|NCT00293397|4218628|B1|BCLC A||Barcelona Clinic Liver Cancer (BCLC) grade|The Barcelona Clinic Liver Cancer (BCLC) grades are used to assess those with Hepatocellular carcinoma (HCC). Grade A is the least severe, grade B is moderate and grade C is advanced.|Participants|Count of Participants|6|6.0||||||
4392419|NCT00293397|4218628|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4392420|NCT00293397|4218628|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4392421|NCT00293397|4218628|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4392422|NCT00293397|4218628|B1|||Age||years|Mean|64|64.0|Full Range|||41.0|85.0|
4392423|NCT00293384|4218638|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4392424|NCT00293384|4218638|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4392425|NCT00293384|4218638|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4392426|NCT00293384|4218638|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4392427|NCT00293384|4218638|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4392428|NCT00293384|4218638|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392429|NCT00293293|4218645|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4392430|NCT00293293|4218646|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4392431|NCT00293293|4218647|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4392432|NCT00293293|4218645|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392433|NCT00293293|4218646|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392434|NCT00293293|4218647|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392435|NCT00293293|4218645|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4392436|NCT00293293|4218646|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4392437|NCT00293293|4218647|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4392438|NCT00293293|4218645|B3|||Age||years|Mean|60.72|60.72|Standard Deviation|11.67|11.67|||
4392439|NCT00293293|4218646|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|11.8|11.8|||
4392440|NCT00293293|4218647|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|11.4|11.4|||
4392441|NCT00293293|4218645|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4392442|NCT00293293|4218646|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4392443|NCT00293293|4218647|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4392444|NCT00293293|4218645|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4392445|NCT00293293|4218646|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4392446|NCT00293293|4218647|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4392447|NCT00293293|4218645|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392448|NCT00293293|4218646|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392449|NCT00293293|4218647|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392450|NCT00293267|4218674|B3|||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA)||copies/mL|Geometric Mean|37352|37352.0|Full Range|||200.0|750000.0|
4392451|NCT00293267|4218675|B2|||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA)||copies/mL|Geometric Mean|31828|31828.0|Full Range|||200.0|750000.0|
4392452|NCT00293267|4218676|B1|||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA)||copies/mL|Geometric Mean|40519|40519.0|Full Range|||441.0|750000.0|
4392453|NCT00293267|4218674|B3|||Cluster of Differentiation 4 (CD4) Cell Count||cells/mm^3|Mean|155|155.0|Full Range|||1.0|792.0|
4392454|NCT00293267|4218675|B2|||Cluster of Differentiation 4 (CD4) Cell Count||cells/mm^3|Mean|153|153.0|Full Range|||3.0|759.0|
4392455|NCT00293267|4218676|B1|||Cluster of Differentiation 4 (CD4) Cell Count||cells/mm^3|Mean|156|156.0|Full Range|||1.0|792.0|
4392456|NCT00293267|4218674|B3|Other||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4392457|NCT00293267|4218675|B2|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4392458|NCT00293267|4218676|B1|Other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4392459|NCT00293267|4218674|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4392460|NCT00293267|4218675|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4392461|NCT00293267|4218676|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4392462|NCT00293267|4218674|B3|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4392463|NCT00293267|4218675|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4392464|NCT00293267|4218676|B1|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4392465|NCT00293267|4218674|B3|Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4392466|NCT00293267|4218675|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4392467|NCT00293267|4218676|B1|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4392468|NCT00293267|4218674|B3|White||Race/Ethnicity, Customized||participants|Number|270|270.0||||||
4392469|NCT00293267|4218675|B2|White||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4392470|NCT00293267|4218676|B1|White||Race/Ethnicity, Customized||participants|Number|174|174.0||||||
4392471|NCT00293267|4218674|B3||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4392472|NCT00293267|4218675|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4392473|NCT00293267|4218676|B1||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4392474|NCT00293267|4218674|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4392475|NCT00293267|4218675|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4392476|NCT00293267|4218676|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4392477|NCT00293267|4218674|B3|||Age||Years|Mean|45.3|45.3|Full Range|||16.0|74.0|
4392478|NCT00293267|4218675|B2|||Age||Years|Mean|43.7|43.7|Full Range|||19.0|64.0|
4392479|NCT00293267|4218676|B1|||Age||Years|Mean|46.1|46.1|Full Range|||16.0|74.0|
4392480|NCT00293254|4218715|B3|||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA)||copies/mL|Geometric Mean|48709|48709.0|Full Range|||200.0|750000.0|
4392481|NCT00293254|4218716|B2|||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA)||copies/mL|Geometric Mean|47850|47850.0|Full Range|||200.0|750000.0|
4392482|NCT00293254|4218717|B1|||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA)||copies/mL|Geometric Mean|49159|49159.0|Full Range|||200.0|750000.0|
4392483|NCT00293254|4218715|B3|||Cluster of Differentiation 4 (CD4) Cell Count||cells/mm^3|Mean|152|152.0|Full Range|||0.0|757.0|
4392484|NCT00293254|4218716|B2|||Cluster of Differentiation 4 (CD4) Cell Count||cells/mm^3|Mean|163|163.0|Full Range|||0.0|674.0|
4392485|NCT00293254|4218717|B1|||Cluster of Differentiation 4 (CD4) Cell Count||cells/mm^3|Mean|146|146.0|Full Range|||1.0|757.0|
4392486|NCT00293254|4218715|B3|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4392487|NCT00293254|4218716|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4392488|NCT00293254|4218717|B1|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4392489|NCT00293254|4218715|B3|Native American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4392490|NCT00293254|4218716|B2|Native American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4392491|NCT00293254|4218717|B1|Native American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4392492|NCT00293254|4218715|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
4392493|NCT00293254|4218716|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4392494|NCT00293254|4218717|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4392495|NCT00293254|4218715|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4392496|NCT00293254|4218716|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4392497|NCT00293254|4218717|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4392498|NCT00293254|4218715|B3|Black||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
4392499|NCT00293254|4218716|B2|Black||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4392500|NCT00293254|4218717|B1|Black||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4392501|NCT00293254|4218715|B3|White||Race/Ethnicity, Customized||Participants|Number|204|204.0||||||
4392502|NCT00293254|4218716|B2|White||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
4392503|NCT00293254|4218717|B1|White||Race/Ethnicity, Customized||Participants|Number|127|127.0||||||
4392504|NCT00293254|4218715|B3||Male|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
4392505|NCT00293254|4218716|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4392506|NCT00293254|4218717|B1||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4392507|NCT00293254|4218715|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4392508|NCT00293254|4218716|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4392509|NCT00293254|4218717|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4392510|NCT00293254|4218715|B3|||Age||Years|Mean|45.7|45.7|Full Range|||16.0|70.0|
4392511|NCT00293254|4218716|B2|||Age||Years|Mean|46.5|46.5|Full Range|||17.0|70.0|
4392512|NCT00293254|4218717|B1|||Age||Years|Mean|45.3|45.3|Full Range|||16.0|67.0|
4392513|NCT00293241|4218756|B3||Male|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4392514|NCT00293241|4218757|B2||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4392515|NCT00293241|4218758|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4392516|NCT00293241|4218756|B3||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4392517|NCT00293241|4218757|B2||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4392518|NCT00293241|4218758|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4392519|NCT00293241|4218756|B3|||Age||years|Mean|74.7|74.7|Standard Deviation|10.8|10.8|||
4392520|NCT00293241|4218757|B2|||Age||years|Mean|74.3|74.3|Standard Deviation|10.8|10.8|||
4392521|NCT00293241|4218758|B1|||Age||years|Mean|75.1|75.1|Standard Deviation|10.9|10.9|||
4392522|NCT00293059|4218801|B3|||prolonged, frequent and excessive bleeding||participants|Number|0|0.0||||||
4392523|NCT00293059|4218802|B2|||prolonged, frequent and excessive bleeding||participants|Number|0|0.0||||||
4392524|NCT00293059|4218803|B1|||prolonged, frequent and excessive bleeding||participants|Number|0|0.0||||||
4392525|NCT00293059|4218801|B3|||frequent and excessive bleeding||participants|Number|1|1.0||||||
4392526|NCT00293059|4218802|B2|||frequent and excessive bleeding||participants|Number|0|0.0||||||
4392527|NCT00293059|4218803|B1|||frequent and excessive bleeding||participants|Number|1|1.0||||||
4392528|NCT00293059|4218801|B3|||prolonged and excessive bleeding||participants|Number|18|18.0||||||
4392529|NCT00293059|4218802|B2|||prolonged and excessive bleeding||participants|Number|9|9.0||||||
4392530|NCT00293059|4218803|B1|||prolonged and excessive bleeding||participants|Number|9|9.0||||||
4392531|NCT00293059|4218801|B3|||prolonged and frequent bleeding||participants|Number|5|5.0||||||
4392532|NCT00293059|4218802|B2|||prolonged and frequent bleeding||participants|Number|2|2.0||||||
4392533|NCT00293059|4218803|B1|||prolonged and frequent bleeding||participants|Number|3|3.0||||||
4392534|NCT00293059|4218801|B3|||frequent bleeding|> 5 bleeding episodes in the 90-day run-in phase, with a minimum of 20 bleeding days overall|participants|Number|6|6.0||||||
4392535|NCT00293059|4218802|B2|||frequent bleeding|> 5 bleeding episodes in the 90-day run-in phase, with a minimum of 20 bleeding days overall|participants|Number|2|2.0||||||
4392536|NCT00293059|4218803|B1|||frequent bleeding|> 5 bleeding episodes in the 90-day run-in phase, with a minimum of 20 bleeding days overall|participants|Number|4|4.0||||||
4392537|NCT00293059|4218801|B3|||prolonged bleeding|2 or more bleeding episodes in the 90-day run-in phase, each lasting 8 or more days|participants|Number|38|38.0||||||
4392538|NCT00293059|4218802|B2|||prolonged bleeding|2 or more bleeding episodes in the 90-day run-in phase, each lasting 8 or more days|participants|Number|12|12.0||||||
4392539|NCT00293059|4218803|B1|||prolonged bleeding|2 or more bleeding episodes in the 90-day run-in phase, each lasting 8 or more days|participants|Number|26|26.0||||||
4392540|NCT00293059|4218801|B3|||excessive bleeding|2 or more bleeding episodes in the 90-day run-in phase, each with blood loss ≥80 mL|participants|Number|151|151.0||||||
4392541|NCT00293059|4218802|B2|||excessive bleeding|2 or more bleeding episodes in the 90-day run-in phase, each with blood loss ≥80 mL|participants|Number|60|60.0||||||
4392542|NCT00293059|4218803|B1|||excessive bleeding|2 or more bleeding episodes in the 90-day run-in phase, each with blood loss ≥80 mL|participants|Number|91|91.0||||||
4392543|NCT00293059|4218801|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.1|26.1|Standard Deviation|3.6|3.6|||
4392544|NCT00293059|4218802|B2|||Body Mass Index (BMI)||kg/m^2|Mean|25.8|25.8|Standard Deviation|3.6|3.6|||
4392545|NCT00293059|4218803|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.3|26.3|Standard Deviation|3.6|3.6|||
4392546|NCT00293059|4218801|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392547|NCT00293059|4218802|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392548|NCT00293059|4218803|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392549|NCT00293059|4218801|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4392550|NCT00293059|4218802|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4392551|NCT00293059|4218803|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4392552|NCT00293059|4218801|B3|||Age||Years|Mean|36.9|36.9|Standard Deviation|7.2|7.2|||
4392553|NCT00293059|4218802|B2|||Age||Years|Mean|37.0|37.0|Standard Deviation|6.7|6.7|||
4392554|NCT00293059|4218803|B1|||Age||Years|Mean|36.9|36.9|Standard Deviation|7.5|7.5|||
4392555|NCT00293020|4218916|B1|United States||Region of Enrollment||participants|Number|243|243.0||||||
4392556|NCT00293020|4218916|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4392557|NCT00293020|4218916|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392558|NCT00293020|4218916|B1||White|Race (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
4392559|NCT00293020|4218916|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4392560|NCT00293020|4218916|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392561|NCT00293020|4218916|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4392562|NCT00293020|4218916|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392563|NCT00293020|4218916|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4392564|NCT00293020|4218916|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4392565|NCT00293020|4218916|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|12.12|12.12|||
4392566|NCT00293020|4218916|B1||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4392567|NCT00293020|4218916|B1||Between 18 and 65 years|Age||Participants|Count of Participants|168|168.0||||||
4392568|NCT00293020|4218916|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392569|NCT00292981|4218920|B1|Unknown||Type of HAE|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-Inhibitor (C1-INH) molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|participants|Number|1|1.0||||||
4392620|NCT00292942|4218927|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4392570|NCT00292981|4218920|B1|Type II HAE||Type of HAE|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-Inhibitor (C1-INH) molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|participants|Number|7|7.0||||||
4392571|NCT00292981|4218920|B1|Type I HAE||Type of HAE|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-Inhibitor (C1-INH) molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|participants|Number|49|49.0||||||
4392572|NCT00292981|4218920|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4392573|NCT00292981|4218920|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4392574|NCT00292981|4218920|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|11.98|11.98|||
4392575|NCT00292942|4218927|B5|||Body Mass Index (kg/m^2)||kg/m^2|Mean|26.09|26.09|Standard Deviation|2.386|2.386|||
4392576|NCT00292942|4218928|B4|||Body Mass Index (kg/m^2)||kg/m^2|Mean|25.30|25.3|Standard Deviation|1.628|1.628|||
4392577|NCT00292942|4218929|B3|||Body Mass Index (kg/m^2)||kg/m^2|Mean|26.89|26.89|Standard Deviation|2.270|2.27|||
4392578|NCT00292942|4218930|B2|||Body Mass Index (kg/m^2)||kg/m^2|Mean|25.50|25.5|Standard Deviation|2.828|2.828|||
4392579|NCT00292942|4218931|B1|||Body Mass Index (kg/m^2)||kg/m^2|Mean|26.68|26.68|Standard Deviation|2.917|2.917|||
4392580|NCT00292942|4218927|B5|||Weight (kg)||kg|Mean|78.96|78.96|Standard Deviation|9.445|9.445|||
4392581|NCT00292942|4218928|B4|||Weight (kg)||kg|Mean|77.80|77.8|Standard Deviation|5.912|5.912|||
4392582|NCT00292942|4218929|B3|||Weight (kg)||kg|Mean|81.03|81.03|Standard Deviation|12.681|12.681|||
4392583|NCT00292942|4218930|B2|||Weight (kg)||kg|Mean|76.53|76.53|Standard Deviation|11.114|11.114|||
4392584|NCT00292942|4218931|B1|||Weight (kg)||kg|Mean|80.33|80.33|Standard Deviation|8.390|8.39|||
4392585|NCT00292942|4218927|B5|||Height (cm)||cm|Mean|173.82|173.82|Standard Deviation|7.348|7.348|||
4392586|NCT00292942|4218928|B4|||Height (cm)||cm|Mean|175.34|175.34|Standard Deviation|2.519|2.519|||
4392587|NCT00292942|4218929|B3|||Height (cm)||cm|Mean|173.14|173.14|Standard Deviation|12.472|12.472|||
4392588|NCT00292942|4218930|B2|||Height (cm)||cm|Mean|172.97|172.97|Standard Deviation|3.634|3.634|||
4392589|NCT00292942|4218931|B1|||Height (cm)||cm|Mean|173.68|173.68|Standard Deviation|7.598|7.598|||
4392590|NCT00292942|4218927|B5|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4392591|NCT00292942|4218928|B4|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4392592|NCT00292942|4218929|B3|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4392593|NCT00292942|4218930|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4392594|NCT00292942|4218931|B1|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4392595|NCT00292942|4218927|B5|Subjects with >1 race||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4392596|NCT00292942|4218928|B4|Subjects with >1 race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392597|NCT00292942|4218929|B3|Subjects with >1 race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4392598|NCT00292942|4218930|B2|Subjects with >1 race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4392599|NCT00292942|4218931|B1|Subjects with >1 race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392600|NCT00292942|4218927|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392601|NCT00292942|4218928|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392602|NCT00292942|4218929|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392603|NCT00292942|4218930|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392604|NCT00292942|4218931|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392605|NCT00292942|4218927|B5|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392606|NCT00292942|4218928|B4|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392607|NCT00292942|4218929|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392608|NCT00292942|4218930|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392609|NCT00292942|4218931|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392610|NCT00292942|4218927|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4392611|NCT00292942|4218928|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392612|NCT00292942|4218929|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4392613|NCT00292942|4218930|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392614|NCT00292942|4218931|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392615|NCT00292942|4218927|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392616|NCT00292942|4218928|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392617|NCT00292942|4218929|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392618|NCT00292942|4218930|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392619|NCT00292942|4218931|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392621|NCT00292942|4218928|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4392622|NCT00292942|4218929|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392623|NCT00292942|4218930|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392624|NCT00292942|4218931|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392625|NCT00292942|4218927|B5|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4392626|NCT00292942|4218928|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4392627|NCT00292942|4218929|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4392628|NCT00292942|4218930|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4392629|NCT00292942|4218931|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4392630|NCT00292942|4218927|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4392631|NCT00292942|4218928|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4392632|NCT00292942|4218929|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4392633|NCT00292942|4218930|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4392634|NCT00292942|4218931|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4392635|NCT00292942|4218927|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4392636|NCT00292942|4218928|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4392637|NCT00292942|4218929|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4392638|NCT00292942|4218930|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4392639|NCT00292942|4218931|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4392640|NCT00292942|4218927|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4392641|NCT00292942|4218928|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392642|NCT00292942|4218929|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4392643|NCT00292942|4218930|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392644|NCT00292942|4218931|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4392645|NCT00292942|4218927|B5|||Age||years|Mean|37.2|37.2|Standard Deviation|10.95|10.95|||
4392646|NCT00292942|4218928|B4|||Age||years|Mean|35.0|35.0|Standard Deviation|11.86|11.86|||
4392647|NCT00292942|4218929|B3|||Age||years|Mean|35.3|35.3|Standard Deviation|9.96|9.96|||
4392648|NCT00292942|4218930|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|12.02|12.02|||
4392649|NCT00292942|4218931|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|10.41|10.41|||
4392650|NCT00292591|4218965|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392651|NCT00292591|4218966|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392652|NCT00292591|4218967|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392653|NCT00292591|4218968|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392654|NCT00292591|4218965|B4||Female|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
4392655|NCT00292591|4218966|B3||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4392656|NCT00292591|4218967|B2||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4392657|NCT00292591|4218968|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4392658|NCT00292591|4218965|B4|||Age||years|Mean|26.5|26.5|Standard Deviation|5.5|5.5|||
4392659|NCT00292591|4218966|B3|||Age||years|Mean|26.4|26.4|Standard Deviation|5.4|5.4|||
4392660|NCT00292591|4218967|B2|||Age||years|Mean|26.7|26.7|Standard Deviation|5.5|5.5|||
4392661|NCT00292591|4218968|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|5.6|5.6|||
4392662|NCT00292461|4218978|B3|Taiwan||Region of Enrollment||participants|Number|64|64.0||||||
4392663|NCT00292461|4218979|B2|Taiwan||Region of Enrollment||participants|Number|30|30.0||||||
4392664|NCT00292461|4218980|B1|Taiwan||Region of Enrollment||participants|Number|34|34.0||||||
4392665|NCT00292461|4218978|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392666|NCT00292461|4218979|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392667|NCT00292461|4218980|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392668|NCT00292461|4218978|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392669|NCT00292461|4218979|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392670|NCT00292461|4218980|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392671|NCT00292461|4218978|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392672|NCT00292461|4218979|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392673|NCT00292461|4218980|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392674|NCT00292461|4218978|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392675|NCT00292461|4218979|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392676|NCT00292461|4218980|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392677|NCT00292461|4218978|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392678|NCT00292461|4218979|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392679|NCT00292461|4218980|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392680|NCT00292461|4218978|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4392681|NCT00292461|4218979|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4392682|NCT00292461|4218980|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4392683|NCT00292461|4218978|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392684|NCT00292461|4218979|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392685|NCT00292461|4218980|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392686|NCT00292461|4218978|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4392687|NCT00292461|4218979|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4392688|NCT00292461|4218980|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4392689|NCT00292461|4218978|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4392690|NCT00292461|4218979|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4392691|NCT00292461|4218980|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4392692|NCT00292461|4218978|B3|||Age||years|Mean|36.8|36.8|Standard Deviation|10.8|10.8|||
4392693|NCT00292461|4218979|B2|||Age||years|Mean|35.0|35.0|Standard Deviation|9.8|9.8|||
4392694|NCT00292461|4218980|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|11.5|11.5|||
4392695|NCT00292370|4218993|B4|Education - Double Blind (DB), Phase II||Years of Education||years|Mean|12.89|12.89|Standard Deviation|2.24|2.24|||
4392696|NCT00292370|4218994|B3|Education - Double Blind (DB), Phase II||Years of Education||years|Mean|12.55|12.55|Standard Deviation|1.53|1.53|||
4392697|NCT00292370|4218995|B2|Education - Double Blind (DB), Phase II||Years of Education||years|Mean|13.22|13.22|Standard Deviation|2.74|2.74|||
4392698|NCT00292370|4218996|B1|Education - Double Blind (DB), Phase II||Years of Education||years|Mean|NA||Standard Deviation|NA||||Only randomized participants counted in DB, phase II.
4392699|NCT00292370|4218993|B4|Education - Open Label (OL) Population||Years of Education||years|Mean|13.12|13.12|Standard Deviation|2.05|2.05|||
4392700|NCT00292370|4218994|B3|Education - Open Label (OL) Population||Years of Education||years|Mean|NA||Standard Deviation|NA||||DB participants not yet randomized in OL, phase I.
4392701|NCT00292370|4218995|B2|Education - Open Label (OL) Population||Years of Education||years|Mean|NA||Standard Deviation|NA||||DB participants not yet randomized in OL, phase I.
4392702|NCT00292370|4218996|B1|Education - Open Label (OL) Population||Years of Education||years|Mean|13.12|13.12|Standard Deviation|2.05|2.05|||
4392703|NCT00292370|4218993|B4|United States||Region of Enrollment||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4392704|NCT00292370|4218994|B3|United States||Region of Enrollment||participants|Number|NA|||||||Same region as in OL phase
4392705|NCT00292370|4218995|B2|United States||Region of Enrollment||participants|Number|NA|||||||Same region as in OL phase
4392706|NCT00292370|4218996|B1|United States||Region of Enrollment||participants|Number|124|124.0||||||
4392707|NCT00292370|4218993|B4|DB Unknown/ Not Reported||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4392708|NCT00292370|4218994|B3|DB Unknown/ Not Reported||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|1|1.0||||||
4392709|NCT00292370|4218995|B2|DB Unknown/ Not Reported||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|1|1.0||||||
4392710|NCT00292370|4218996|B1|DB Unknown/ Not Reported||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|NA|||||||Only randomized participants counted in Phase II (period 2)
4392711|NCT00292370|4218993|B4|DB White||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4392712|NCT00292370|4218994|B3|DB White||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|14|14.0||||||
4392713|NCT00292370|4218995|B2|DB White||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|9|9.0||||||
4392714|NCT00292370|4218996|B1|DB White||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|NA|||||||Only randomized participants counted in Phase II (period 2)
4392715|NCT00292370|4218993|B4|DB African American||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4392716|NCT00292370|4218994|B3|DB African American||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|10|10.0||||||
4392717|NCT00292370|4218995|B2|DB African American||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|15|15.0||||||
4392718|NCT00292370|4218996|B1|DB African American||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|NA|||||||Only randomized participants counted in Phase II (period 2)
4392719|NCT00292370|4218993|B4|DB Amer Indian/ Alaska Native||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4392720|NCT00292370|4218994|B3|DB Amer Indian/ Alaska Native||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|0|0.0||||||
4392721|NCT00292370|4218995|B2|DB Amer Indian/ Alaska Native||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|0|0.0||||||
4392722|NCT00292370|4218996|B1|DB Amer Indian/ Alaska Native||Race/Ethnicity, Customized|Race/Ethnicity for Double-Blind participants|participants|Number|NA|||||||Only randomized participants counted in Phase II (period 2)
4392723|NCT00292370|4218993|B4|OL Unknown or Not Reported||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4392724|NCT00292370|4218994|B3|OL Unknown or Not Reported||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|NA|||||||DB participants not randomized in OL phase I
4392725|NCT00292370|4218995|B2|OL Unknown or Not Reported||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|NA|||||||DB participants not randomized in OL phase I
4392726|NCT00292370|4218996|B1|OL Unknown or Not Reported||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|4|4.0||||||
4392727|NCT00292370|4218993|B4|OL White||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4392728|NCT00292370|4218994|B3|OL White||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|NA|||||||DB participants not randomized in OL phase I
4392729|NCT00292370|4218995|B2|OL White||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|NA|||||||DB participants not randomized in OL phase I
4392730|NCT00292370|4218996|B1|OL White||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|68|68.0||||||
4392731|NCT00292370|4218993|B4|OL African American||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4392732|NCT00292370|4218994|B3|OL African American||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|NA|||||||DB participants not randomized in OL phase I
4392733|NCT00292370|4218995|B2|OL African American||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|NA|||||||DB participants not randomized in OL phase I
4392734|NCT00292370|4218996|B1|OL African American||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|50|50.0||||||
4392735|NCT00292370|4218993|B4|OL Amer Indian/ Alask Native||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4392736|NCT00292370|4218994|B3|OL Amer Indian/ Alask Native||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|NA|||||||DB participants not randomized in OL phase I
4392737|NCT00292370|4218995|B2|OL Amer Indian/ Alask Native||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|NA|||||||DB participants not randomized in OL phase I
4392738|NCT00292370|4218996|B1|OL Amer Indian/ Alask Native||Race/Ethnicity, Customized|Race/Ethnicity for Open-Label Phase participants|participants|Number|2|2.0||||||
4392739|NCT00292370|4218993|B4|Males Double Blind||Sex/Gender, Customized|Gender for Double-Blind phase II|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4392740|NCT00292370|4218994|B3|Males Double Blind||Sex/Gender, Customized|Gender for Double-Blind phase II|participants|Number|24|24.0||||||
4392741|NCT00292370|4218995|B2|Males Double Blind||Sex/Gender, Customized|Gender for Double-Blind phase II|participants|Number|24|24.0||||||
4392742|NCT00292370|4218996|B1|Males Double Blind||Sex/Gender, Customized|Gender for Double-Blind phase II|participants|Number|NA|||||||Only randomized participants counted in Phase II (period 2)
4392743|NCT00292370|4218993|B4|Females Double Blind||Sex/Gender, Customized|Gender for Double-Blind phase II|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4392744|NCT00292370|4218994|B3|Females Double Blind||Sex/Gender, Customized|Gender for Double-Blind phase II|participants|Number|1|1.0||||||
4392745|NCT00292370|4218995|B2|Females Double Blind||Sex/Gender, Customized|Gender for Double-Blind phase II|participants|Number|1|1.0||||||
4392746|NCT00292370|4218996|B1|Females Double Blind||Sex/Gender, Customized|Gender for Double-Blind phase II|participants|Number|NA|||||||Only randomized participants counted in Phase II (period 2)
4392747|NCT00292370|4218993|B4|Gender OL Males||Sex/Gender, Customized|Gender for Open - Label (OL) population.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4392748|NCT00292370|4218994|B3|Gender OL Males||Sex/Gender, Customized|Gender for Open - Label (OL) population.|participants|Number|NA|||||||Double-Blind participants not randomized in OL Phase
4392749|NCT00292370|4218995|B2|Gender OL Males||Sex/Gender, Customized|Gender for Open - Label (OL) population.|participants|Number|NA|||||||Double-Blind participants not randomized in OL Phase
4392750|NCT00292370|4218996|B1|Gender OL Males||Sex/Gender, Customized|Gender for Open - Label (OL) population.|participants|Number|119|119.0||||||
4392751|NCT00292370|4218993|B4|Gender OL Females||Sex/Gender, Customized|Gender for Open - Label (OL) population.|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4392752|NCT00292370|4218994|B3|Gender OL Females||Sex/Gender, Customized|Gender for Open - Label (OL) population.|participants|Number|NA|||||||Double-Blind participants not randomized in OL Phase
4392753|NCT00292370|4218995|B2|Gender OL Females||Sex/Gender, Customized|Gender for Open - Label (OL) population.|participants|Number|NA|||||||Double-Blind participants not randomized in OL Phase
4392754|NCT00292370|4218996|B1|Gender OL Females||Sex/Gender, Customized|Gender for Open - Label (OL) population.|participants|Number|5|5.0||||||
4392755|NCT00292370|4218993|B4|Age - Double Blind||Age, Customized||years|Mean|54.76|54.76|Standard Deviation|11.48|11.48|||
4392756|NCT00292370|4218994|B3|Age - Double Blind||Age, Customized||years|Mean|54.45|54.45|Standard Deviation|13.69|13.69|||
4392757|NCT00292370|4218995|B2|Age - Double Blind||Age, Customized||years|Mean|57.17|57.17|Standard Deviation|8.74|8.74|||
4392758|NCT00292370|4218996|B1|Age - Double Blind||Age, Customized||years|Mean|NA||Standard Deviation|NA||||Only randomized participants counted in phase II (period 2).
4392759|NCT00292370|4218993|B4|Age - OL Paroxetine||Age, Customized||years|Mean|52.32|52.32|Standard Deviation|13.23|13.23|||
4392760|NCT00292370|4218994|B3|Age - OL Paroxetine||Age, Customized||years|Mean|NA||Standard Deviation|NA||||DB participants not randomized in OL phase I (period 1)
4392761|NCT00292370|4218995|B2|Age - OL Paroxetine||Age, Customized||years|Mean|NA||Standard Deviation|NA||||DB participants not randomized in OL phase I (period 1)
4392762|NCT00292370|4218996|B1|Age - OL Paroxetine||Age, Customized||years|Mean|52.32|52.32|Standard Deviation|13.23|13.23|||
4392763|NCT00292318|4219005|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4392764|NCT00292318|4219006|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4392765|NCT00292318|4219007|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4392766|NCT00292318|4219005|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392767|NCT00292318|4219006|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392768|NCT00292318|4219007|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392769|NCT00292318|4219005|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4392770|NCT00292318|4219006|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4392771|NCT00292318|4219007|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4392772|NCT00292318|4219005|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392773|NCT00292318|4219006|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392774|NCT00292318|4219007|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4392775|NCT00292318|4219005|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4392776|NCT00292318|4219006|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4392777|NCT00292318|4219007|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4392778|NCT00292318|4219005|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4392779|NCT00292318|4219006|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392780|NCT00292318|4219007|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4392781|NCT00292318|4219005|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4392782|NCT00292318|4219006|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4392783|NCT00292318|4219007|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4392784|NCT00292318|4219005|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4392785|NCT00292318|4219006|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4392786|NCT00292318|4219007|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4392787|NCT00292318|4219005|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392788|NCT00292318|4219006|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392789|NCT00292318|4219007|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392790|NCT00292227|4219016|B3|South Africa||Region of Enrollment||participants|Number|130|130.0||||||
4392791|NCT00292227|4219017|B2|South Africa||Region of Enrollment||participants|Number|64|64.0||||||
4392792|NCT00292227|4219018|B1|South Africa||Region of Enrollment||participants|Number|66|66.0||||||
4392793|NCT00292227|4219016|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4392794|NCT00292227|4219017|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4392795|NCT00292227|4219018|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4392796|NCT00292227|4219016|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4392797|NCT00292227|4219017|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4392798|NCT00292227|4219018|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4392799|NCT00292227|4219016|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|10.1|10.1|||
4392800|NCT00292227|4219017|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|9.8|9.8|||
4392801|NCT00292227|4219018|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|10.4|10.4|||
4392802|NCT00292227|4219016|B3||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
4392803|NCT00292227|4219017|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4392804|NCT00292227|4219018|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4392805|NCT00292227|4219016|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4392806|NCT00292227|4219017|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4392807|NCT00292227|4219018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4392808|NCT00292227|4219016|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392809|NCT00292227|4219017|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392810|NCT00292227|4219018|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392811|NCT00292188|4219100|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4392812|NCT00292188|4219101|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4392813|NCT00292188|4219102|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4392814|NCT00292188|4219100|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4392815|NCT00292188|4219101|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4392816|NCT00292188|4219102|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4392817|NCT00292188|4219100|B3|≥65 years||Age, Customized||participants|Number|54|54.0||||||
4392818|NCT00292188|4219101|B2|≥65 years||Age, Customized||participants|Number|25|25.0||||||
4392819|NCT00292188|4219102|B1|≥65 years||Age, Customized||participants|Number|29|29.0||||||
4392820|NCT00292188|4219100|B3|45-64 years||Age, Customized||participants|Number|120|120.0||||||
4392821|NCT00292188|4219101|B2|45-64 years||Age, Customized||participants|Number|60|60.0||||||
4392822|NCT00292188|4219102|B1|45-64 years||Age, Customized||participants|Number|60|60.0||||||
4392823|NCT00292188|4219100|B3|18-44 years||Age, Customized||participants|Number|80|80.0||||||
4392824|NCT00292188|4219101|B2|18-44 years||Age, Customized||participants|Number|42|42.0||||||
4392825|NCT00292188|4219102|B1|18-44 years||Age, Customized||participants|Number|38|38.0||||||
4392826|NCT00292162|4219163|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4392827|NCT00292162|4219164|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4392828|NCT00292162|4219165|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4392829|NCT00292162|4219163|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4392830|NCT00292162|4219164|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4392831|NCT00292162|4219165|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4392832|NCT00292162|4219163|B3|||Age||years|Mean|63|63.0|Standard Deviation|7|7.0|||
4392833|NCT00292162|4219164|B2|||Age||years|Mean|62|62.0|Standard Deviation|6.7|6.7|||
4392834|NCT00292162|4219165|B1|||Age||years|Mean|64|64.0|Standard Deviation|8|8.0|||
4392835|NCT00291876|4219182|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Month 246|Participants|Count of Participants|30|30.0||||||
4392836|NCT00291876|4219182|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Month 246|Participants|Count of Participants|86|86.0||||||
4392837|NCT00291876|4219182|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Month 234|Participants|Count of Participants|29|29.0||||||
4392838|NCT00291876|4219182|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Month 234|Participants|Count of Participants|81|81.0||||||
4392839|NCT00291876|4219182|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Month 222|Participants|Count of Participants|31|31.0||||||
4392840|NCT00291876|4219182|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Month 222|Participants|Count of Participants|83|83.0||||||
4392841|NCT00291876|4219182|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Month 210|Participants|Count of Participants|31|31.0||||||
4392842|NCT00291876|4219182|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Month 210|Participants|Count of Participants|93|93.0||||||
4392843|NCT00291876|4219182|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Month 198|Participants|Count of Participants|32|32.0||||||
4392844|NCT00291876|4219182|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Month 198|Participants|Count of Participants|103|103.0||||||
4392845|NCT00291876|4219182|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Month 186|Participants|Count of Participants|31|31.0||||||
4392846|NCT00291876|4219182|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Month 186|Participants|Count of Participants|98|98.0||||||
4392847|NCT00291876|4219182|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Month 174|Participants|Count of Participants|33|33.0||||||
4392848|NCT00291876|4219182|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Month 174|Participants|Count of Participants|94|94.0||||||
4392849|NCT00291876|4219182|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Month 162|Participants|Count of Participants|34|34.0||||||
4392850|NCT00291876|4219182|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Month 162|Participants|Count of Participants|93|93.0||||||
4392851|NCT00291876|4219182|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Month 150|Participants|Count of Participants|30|30.0||||||
4392852|NCT00291876|4219182|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Month 150|Participants|Count of Participants|87|87.0||||||
4392853|NCT00291876|4219182|B1||Male|Sex: Female, Male|The baseline measure data here corresponds to Month 138|Participants|Count of Participants|30|30.0||||||
4392854|NCT00291876|4219182|B1||Female|Sex: Female, Male|The baseline measure data here corresponds to Month 138|Participants|Count of Participants|77|77.0||||||
4392855|NCT00291876|4219182|B1|||Age|The baseline measure data here corresponds to Month 246|Years|Mean|50.8|50.8|Standard Deviation|5.34|5.34|||
4392856|NCT00291876|4219182|B1|||Age|The baseline measure data here corresponds to Month 234|Years|Mean|49.6|49.6|Standard Deviation|5.42|5.42|||
4392857|NCT00291876|4219182|B1|||Age|The baseline measure data here corresponds to Month 222|Years|Mean|48.5|48.5|Standard Deviation|5.39|5.39|||
4392858|NCT00291876|4219182|B1|||Age|The baseline measure data here corresponds to Month 210|Years|Mean|47.6|47.6|Standard Deviation|5.39|5.39|||
4392859|NCT00291876|4219182|B1|||Age|The baseline measure data here corresponds to Month 198|Years|Mean|46.3|46.3|Standard Deviation|5.35|5.35|||
4392860|NCT00291876|4219182|B1|||Age|The baseline measure data here corresponds to Month 186|Years|Mean|45.4|45.4|Standard Deviation|5.39|5.39|||
4392861|NCT00291876|4219182|B1|||Age|The baseline measure data here corresponds to Month 174|Years|Mean|44.5|44.5|Standard Deviation|5.37|5.37|||
4392862|NCT00291876|4219182|B1|||Age|The baseline measure data here corresponds to Month 162|Years|Mean|43.4|43.4|Standard Deviation|5.34|5.34|||
4392863|NCT00291876|4219182|B1|||Age|The baseline measure data here corresponds to Month 150|Years|Mean|42.9|42.9|Standard Deviation|5.35|5.35|||
4392864|NCT00291876|4219182|B1|||Age|The baseline measure data here corresponds to Month 138|Years|Mean|42.2|42.2|Standard Deviation|5.44|5.44|||
4392865|NCT00291694|4219194|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4392866|NCT00291694|4219195|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4392867|NCT00291694|4219196|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4392868|NCT00291694|4219194|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392869|NCT00291694|4219195|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392870|NCT00291694|4219196|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4392871|NCT00291694|4219194|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4392872|NCT00291694|4219195|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4392873|NCT00291694|4219196|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4392874|NCT00291694|4219194|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|7.4|7.4|||
4392875|NCT00291694|4219195|B2|||Age||years|Mean|45.2|45.2|Standard Deviation|8.5|8.5|||
4392876|NCT00291694|4219196|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|6.6|6.6|||
4392877|NCT00291694|4219194|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4392878|NCT00291694|4219195|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4392879|NCT00291694|4219196|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4392880|NCT00291694|4219194|B3||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4392881|NCT00291694|4219195|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4392882|NCT00291694|4219196|B1||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4392883|NCT00291694|4219194|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392884|NCT00291694|4219195|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392885|NCT00291694|4219196|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4392886|NCT00291655|4219211|B1|Switzerland||Region of Enrollment||participants|Number|15|15.0||||||
4392887|NCT00291655|4219211|B1|Bulgaria||Region of Enrollment||participants|Number|31|31.0||||||
4392888|NCT00291655|4219211|B1|Belgium||Region of Enrollment||participants|Number|25|25.0||||||
4392889|NCT00291655|4219211|B1|Poland||Region of Enrollment||participants|Number|32|32.0||||||
4392890|NCT00291655|4219211|B1|Finland||Region of Enrollment||participants|Number|9|9.0||||||
4392891|NCT00291655|4219211|B1|France||Region of Enrollment||participants|Number|18|18.0||||||
4392892|NCT00291655|4219211|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4392893|NCT00291655|4219211|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4392894|NCT00291655|4219211|B1|||Age||years|Mean|40.68|40.68|Standard Deviation|18.35|18.35|||
4392895|NCT00291642|4219216|B6||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4392896|NCT00291642|4219217|B5||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4392897|NCT00291642|4219218|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4392898|NCT00291642|4219219|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4392899|NCT00291642|4219220|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4392900|NCT00291642|4219221|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4392901|NCT00291642|4219216|B6||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4392902|NCT00291642|4219217|B5||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4392903|NCT00291642|4219218|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4392904|NCT00291642|4219219|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4392905|NCT00291642|4219220|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4392906|NCT00291642|4219221|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4392907|NCT00291642|4219216|B6|||Age||years|Mean|33.76|33.76|Standard Deviation|11.86|11.86|||
4392908|NCT00291642|4219217|B5|||Age||years|Mean|34.33|34.33|Standard Deviation|11.65|11.65|||
4392909|NCT00291642|4219218|B4|||Age||years|Mean|32.91|32.91|Standard Deviation|11.30|11.3|||
4392910|NCT00291642|4219219|B3|||Age||years|Mean|34.36|34.36|Standard Deviation|12.84|12.84|||
4392911|NCT00291642|4219220|B2|||Age||years|Mean|33.45|33.45|Standard Deviation|11.28|11.28|||
4392912|NCT00291642|4219221|B1|||Age||years|Mean|33.71|33.71|Standard Deviation|12.46|12.46|||
4392913|NCT00291642|4219216|B6||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4392914|NCT00291642|4219217|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4392915|NCT00291642|4219218|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4392916|NCT00291642|4219219|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4392917|NCT00291642|4219220|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4392918|NCT00291642|4219221|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4392919|NCT00291642|4219216|B6||Between 18 and 65 years|Age||Participants|Count of Participants|530|530.0||||||
4392920|NCT00291642|4219217|B5||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4392921|NCT00291642|4219218|B4||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4392922|NCT00291642|4219219|B3||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4392923|NCT00291642|4219220|B2||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4392924|NCT00291642|4219221|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4392925|NCT00291642|4219216|B6||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4392926|NCT00291642|4219217|B5||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4392927|NCT00291642|4219218|B4||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4392928|NCT00291642|4219219|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4392929|NCT00291642|4219220|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4392930|NCT00291642|4219221|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4392931|NCT00291577|4219277|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4392932|NCT00291577|4219277|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4392933|NCT00291577|4219277|B1|> = 65 years||Age, Customized||participants|Number|6|6.0||||||
4392934|NCT00291577|4219277|B1|45 to 64 years||Age, Customized||participants|Number|13|13.0||||||
4392935|NCT00291577|4219277|B1|18 to 44 years||Age, Customized||participants|Number|3|3.0||||||
4392936|NCT00291551|4219296|B1|||Duration of heart failure||years|Mean|6.9|6.9|Standard Deviation|4.7|4.7|||
4392937|NCT00291551|4219296|B1|Non-ischemic||Etiology||participants|Number|31|31.0||||||
4392938|NCT00291551|4219296|B1|Ischemic||Etiology||participants|Number|8|8.0||||||
4392939|NCT00291551|4219296|B1||Unknown or Not Reported|Race (NIH/OMB)|Measured as Caucasian, Black, of African heritage, and Hispanic|Participants|Count of Participants|1|1.0||||||
4392940|NCT00291551|4219296|B1||More than one race|Race (NIH/OMB)|Measured as Caucasian, Black, of African heritage, and Hispanic|Participants|Count of Participants|0|0.0||||||
4392941|NCT00291551|4219296|B1||White|Race (NIH/OMB)|Measured as Caucasian, Black, of African heritage, and Hispanic|Participants|Count of Participants|35|35.0||||||
4392942|NCT00291551|4219296|B1||Black or African American|Race (NIH/OMB)|Measured as Caucasian, Black, of African heritage, and Hispanic|Participants|Count of Participants|3|3.0||||||
4392943|NCT00291551|4219296|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Measured as Caucasian, Black, of African heritage, and Hispanic|Participants|Count of Participants|0|0.0||||||
4392944|NCT00291551|4219296|B1||Asian|Race (NIH/OMB)|Measured as Caucasian, Black, of African heritage, and Hispanic|Participants|Count of Participants|0|0.0||||||
4392945|NCT00291551|4219296|B1||American Indian or Alaska Native|Race (NIH/OMB)|Measured as Caucasian, Black, of African heritage, and Hispanic|Participants|Count of Participants|0|0.0||||||
4392946|NCT00291551|4219296|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4392947|NCT00291551|4219296|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4392948|NCT00291551|4219296|B1|||Age||years|Mean|53|53.0|Standard Deviation|11.0|11.0|||
4392949|NCT00291343|4219311|B3||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4392950|NCT00291343|4219312|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4392951|NCT00291343|4219313|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4392952|NCT00291343|4219311|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4392953|NCT00291343|4219312|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4392954|NCT00291343|4219313|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4392955|NCT00291343|4219311|B3|||Age||Months|Mean|24.17|24.17|Standard Deviation|0.61|0.61|||
4392956|NCT00291343|4219312|B2|||Age||Months|Mean|24.1|24.1|Standard Deviation|0.40|0.4|||
4392957|NCT00291343|4219313|B1|||Age||Months|Mean|24.2|24.2|Standard Deviation|0.68|0.68|||
4392958|NCT00291330|4219342|B3|No PE and no DVT||Acute symptomatic DVT of the leg and/or PE as assessed by investigator|Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)|participants|Number|4|4.0||||||
4392959|NCT00291330|4219343|B2|No PE and no DVT||Acute symptomatic DVT of the leg and/or PE as assessed by investigator|Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)|participants|Number|2|2.0||||||
4392960|NCT00291330|4219344|B1|No PE and no DVT||Acute symptomatic DVT of the leg and/or PE as assessed by investigator|Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)|participants|Number|2|2.0||||||
4392961|NCT00291330|4219342|B3|Symptomatic DVT||Acute symptomatic DVT of the leg and/or PE as assessed by investigator|Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)|participants|Number|1749|1749.0||||||
4392962|NCT00291330|4219343|B2|Symptomatic DVT||Acute symptomatic DVT of the leg and/or PE as assessed by investigator|Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)|participants|Number|869|869.0||||||
4392963|NCT00291330|4219344|B1|Symptomatic DVT||Acute symptomatic DVT of the leg and/or PE as assessed by investigator|Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)|participants|Number|880|880.0||||||
4392964|NCT00291330|4219342|B3|Symptomatic PE||Acute symptomatic DVT of the leg and/or PE as assessed by investigator|Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)|participants|Number|541|541.0||||||
4392965|NCT00291330|4219343|B2|Symptomatic PE||Acute symptomatic DVT of the leg and/or PE as assessed by investigator|Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)|participants|Number|271|271.0||||||
4392966|NCT00291330|4219344|B1|Symptomatic PE||Acute symptomatic DVT of the leg and/or PE as assessed by investigator|Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)|participants|Number|270|270.0||||||
4392967|NCT00291330|4219342|B3|Symptomatic PE and symptomatic DVT||Acute symptomatic DVT of the leg and/or PE as assessed by investigator|Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)|participants|Number|245|245.0||||||
4392968|NCT00291330|4219343|B2|Symptomatic PE and symptomatic DVT||Acute symptomatic DVT of the leg and/or PE as assessed by investigator|Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)|participants|Number|124|124.0||||||
4392969|NCT00291330|4219344|B1|Symptomatic PE and symptomatic DVT||Acute symptomatic DVT of the leg and/or PE as assessed by investigator|Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)|participants|Number|121|121.0||||||
4392970|NCT00291330|4219342|B3||Male|Sex: Female, Male||Participants|Count of Participants|1484|1484.0||||||
4392971|NCT00291330|4219343|B2||Male|Sex: Female, Male||Participants|Count of Participants|746|746.0||||||
4392972|NCT00291330|4219344|B1||Male|Sex: Female, Male||Participants|Count of Participants|738|738.0||||||
4392973|NCT00291330|4219342|B3||Female|Sex: Female, Male||Participants|Count of Participants|1055|1055.0||||||
4392974|NCT00291330|4219343|B2||Female|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4392975|NCT00291330|4219344|B1||Female|Sex: Female, Male||Participants|Count of Participants|535|535.0||||||
4392976|NCT00291330|4219342|B3|||Age||Year|Mean|54.7|54.7|Standard Deviation|16.0|16.0|||
4392977|NCT00291330|4219343|B2|||Age||Year|Mean|54.4|54.4|Standard Deviation|16.2|16.2|||
4392978|NCT00291330|4219344|B1|||Age||Year|Mean|55.0|55.0|Standard Deviation|15.8|15.8|||
4392979|NCT00291317|4219367|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4392980|NCT00291317|4219367|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4392981|NCT00291317|4219367|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4392982|NCT00291317|4219367|B1|||Age||years|Mean|16.57|16.57|Standard Deviation|4.42|4.42|||
4392983|NCT00291317|4219367|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4392984|NCT00291317|4219367|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4392985|NCT00291317|4219367|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4392986|NCT00291226|4219372|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
4392987|NCT00291226|4219373|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
4392988|NCT00291226|4219374|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
4392989|NCT00291226|4219372|B3||Female|Gender||Participants|Count of Participants|2|2.0||||||
4392990|NCT00291226|4219373|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
4392991|NCT00291226|4219374|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4392992|NCT00291226|4219372|B3|||Age||years|Mean|15.9|15.9|Standard Deviation|1.8|1.8|||
4392993|NCT00291226|4219373|B2|||Age||years|Mean|16.5|16.5|Standard Deviation|2.4|2.4|||
4392994|NCT00291226|4219374|B1|||Age||years|Mean|15.3|15.3|Standard Deviation|0.5|0.5|||
4392995|NCT00291187|4219383|B5||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4392996|NCT00291187|4219384|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4392997|NCT00291187|4219385|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4392998|NCT00291187|4219386|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4392999|NCT00291187|4219387|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4393000|NCT00291187|4219383|B5||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4393001|NCT00291187|4219384|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4393002|NCT00291187|4219385|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4393003|NCT00291187|4219386|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4393004|NCT00291187|4219387|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4393005|NCT00291187|4219383|B5|||Age||years|Mean|31.0|31.0|Standard Deviation|8.08|8.08|||
4393006|NCT00291187|4219384|B4|||Age||years|Mean|31.2|31.2|Standard Deviation|8.19|8.19|||
4393007|NCT00291187|4219385|B3|||Age||years|Mean|31.0|31.0|Standard Deviation|8.51|8.51|||
4393008|NCT00291187|4219386|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|8.41|8.41|||
4393009|NCT00291187|4219387|B1|||Age||years|Mean|30.9|30.9|Standard Deviation|7.28|7.28|||
4393010|NCT00291161|4219412|B5|Caregivers who were not spouses||Number of Caregivers Who were Spouses|Was only collected for Caregiver groups|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4393011|NCT00291161|4219413|B4|Caregivers who were not spouses||Number of Caregivers Who were Spouses|Was only collected for Caregiver groups|participants|Number|38|38.0||||||
4393012|NCT00291161|4219414|B3|Caregivers who were not spouses||Number of Caregivers Who were Spouses|Was only collected for Caregiver groups|participants|Number|95|95.0||||||
4393013|NCT00291161|4219415|B2|Caregivers who were not spouses||Number of Caregivers Who were Spouses|Was only collected for Caregiver groups|participants|Number|NA|||||||Was only collected for Caregiver groups
4393014|NCT00291161|4219416|B1|Caregivers who were not spouses||Number of Caregivers Who were Spouses|Was only collected for Caregiver groups|participants|Number|NA|||||||Was only collected for Caregiver groups
4393015|NCT00291161|4219412|B5|Caregivers who were spouses||Number of Caregivers Who were Spouses|Was only collected for Caregiver groups|participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4393016|NCT00291161|4219413|B4|Caregivers who were spouses||Number of Caregivers Who were Spouses|Was only collected for Caregiver groups|participants|Number|149|149.0||||||
4393017|NCT00291161|4219414|B3|Caregivers who were spouses||Number of Caregivers Who were Spouses|Was only collected for Caregiver groups|participants|Number|204|204.0||||||
4393018|NCT00291161|4219415|B2|Caregivers who were spouses||Number of Caregivers Who were Spouses|Was only collected for Caregiver groups|participants|Number|NA|||||||Was only collected for Caregiver groups
4393019|NCT00291161|4219416|B1|Caregivers who were spouses||Number of Caregivers Who were Spouses|Was only collected for Caregiver groups|participants|Number|NA|||||||Was only collected for Caregiver groups
4393020|NCT00291161|4219412|B5|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4393021|NCT00291161|4219413|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4393022|NCT00291161|4219414|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4393023|NCT00291161|4219415|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4393024|NCT00291161|4219416|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4393025|NCT00291161|4219412|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4393026|NCT00291161|4219413|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4393027|NCT00291161|4219414|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4393028|NCT00291161|4219415|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4393029|NCT00291161|4219416|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4393030|NCT00291161|4219412|B5|Black nonhispanic||Race/Ethnicity, Customized||participants|Number|145|145.0||||||
4393031|NCT00291161|4219413|B4|Black nonhispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4393032|NCT00291161|4219414|B3|Black nonhispanic||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4393033|NCT00291161|4219415|B2|Black nonhispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4393034|NCT00291161|4219416|B1|Black nonhispanic||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4393035|NCT00291161|4219412|B5|White nonhispanic||Race/Ethnicity, Customized||participants|Number|804|804.0||||||
4393036|NCT00291161|4219413|B4|White nonhispanic||Race/Ethnicity, Customized||participants|Number|170|170.0||||||
4393037|NCT00291161|4219414|B3|White nonhispanic||Race/Ethnicity, Customized||participants|Number|222|222.0||||||
4393038|NCT00291161|4219415|B2|White nonhispanic||Race/Ethnicity, Customized||participants|Number|178|178.0||||||
4393039|NCT00291161|4219416|B1|White nonhispanic||Race/Ethnicity, Customized||participants|Number|234|234.0||||||
4393040|NCT00291161|4219412|B5||Male|Sex: Female, Male||Participants|Count of Participants|519|519.0||||||
4393041|NCT00291161|4219413|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4393042|NCT00291161|4219414|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4393043|NCT00291161|4219415|B2||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4393044|NCT00291161|4219416|B1||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4393045|NCT00291161|4219412|B5||Female|Sex: Female, Male||Participants|Count of Participants|475|475.0||||||
4393046|NCT00291161|4219413|B4||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4393047|NCT00291161|4219414|B3||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4393048|NCT00291161|4219415|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4393049|NCT00291161|4219416|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4393050|NCT00291161|4219412|B5|Age of Caregivers||Age||years|Mean|69.1|69.1|Standard Deviation|12.2|12.2|||
4393051|NCT00291161|4219413|B4|Age of Caregivers||Age||years|Mean|70.8|70.8|Standard Deviation|11.4|11.4|||
4393052|NCT00291161|4219414|B3|Age of Caregivers||Age||years|Mean|68.0|68.0|Standard Deviation|12.6|12.6|||
4393053|NCT00291161|4219415|B2|Age of Caregivers||Age||years|Mean|NA||Standard Deviation|NA||||Age of veterans measured separate from age of caregivers
4393054|NCT00291161|4219416|B1|Age of Caregivers||Age||years|Mean|NA||Standard Deviation|NA||||Age of veterans measured separate from age of caregivers
4393055|NCT00291161|4219412|B5|Age of Veterans||Age||years|Mean|79.9|79.9|Standard Deviation|7.6|7.6|||
4393056|NCT00291161|4219413|B4|Age of Veterans||Age||years|Mean|NA||Standard Deviation|NA||||Age of veterans measured separate from age of caregivers
4393057|NCT00291161|4219414|B3|Age of Veterans||Age||years|Mean|NA||Standard Deviation|NA||||Age of veterans measured separate from age of caregivers
4393058|NCT00291161|4219415|B2|Age of Veterans||Age||years|Mean|80.7|80.7|Standard Deviation|6.2|6.2|||
4393059|NCT00291161|4219416|B1|Age of Veterans||Age||years|Mean|79.4|79.4|Standard Deviation|8.2|8.2|||
4393060|NCT00291135|4219427|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4393061|NCT00291135|4219427|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4393062|NCT00291135|4219427|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4393063|NCT00291135|4219427|B1|||Age||years|Mean|50|50.0|Standard Deviation|7|7.0|||
4393064|NCT00291135|4219427|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4393065|NCT00291135|4219427|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4393066|NCT00291135|4219427|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393067|NCT00291018|4219431|B4|> 1 year||Duration of Neck/Arm Pain||Subjects|Number|201|201.0||||||
4393068|NCT00291018|4219432|B3|> 1 year||Duration of Neck/Arm Pain||Subjects|Number|86|86.0||||||
4393069|NCT00291018|4219433|B2|> 1 year||Duration of Neck/Arm Pain||Subjects|Number|59|59.0||||||
4393070|NCT00291018|4219434|B1|> 1 year||Duration of Neck/Arm Pain||Subjects|Number|56|56.0||||||
4393071|NCT00291018|4219431|B4|6 weeks to 1 year||Duration of Neck/Arm Pain||Subjects|Number|137|137.0||||||
4393072|NCT00291018|4219432|B3|6 weeks to 1 year||Duration of Neck/Arm Pain||Subjects|Number|49|49.0||||||
4393073|NCT00291018|4219433|B2|6 weeks to 1 year||Duration of Neck/Arm Pain||Subjects|Number|44|44.0||||||
4393074|NCT00291018|4219434|B1|6 weeks to 1 year||Duration of Neck/Arm Pain||Subjects|Number|44|44.0||||||
4393075|NCT00291018|4219431|B4|< 6 weeks||Duration of Neck/Arm Pain||Subjects|Number|7|7.0||||||
4393076|NCT00291018|4219432|B3|< 6 weeks||Duration of Neck/Arm Pain||Subjects|Number|1|1.0||||||
4393077|NCT00291018|4219433|B2|< 6 weeks||Duration of Neck/Arm Pain||Subjects|Number|3|3.0||||||
4393078|NCT00291018|4219434|B1|< 6 weeks||Duration of Neck/Arm Pain||Subjects|Number|3|3.0||||||
4393079|NCT00291018|4219431|B4|||BMI||kg/m^2|Mean|26.8|26.8|Standard Deviation|5.29|5.29|||
4393080|NCT00291018|4219432|B3|||BMI||kg/m^2|Mean|26.6|26.6|Standard Deviation|5.07|5.07|||
4393081|NCT00291018|4219433|B2|||BMI||kg/m^2|Mean|27.3|27.3|Standard Deviation|5.54|5.54|||
4393082|NCT00291018|4219434|B1|||BMI||kg/m^2|Mean|26.4|26.4|Standard Deviation|5.32|5.32|||
4393083|NCT00291018|4219431|B4|Current||Smoking Status||Subjects|Number|98|98.0||||||
4393084|NCT00291018|4219432|B3|Current||Smoking Status||Subjects|Number|27|27.0||||||
4393085|NCT00291018|4219433|B2|Current||Smoking Status||Subjects|Number|37|37.0||||||
4393086|NCT00291018|4219434|B1|Current||Smoking Status||Subjects|Number|34|34.0||||||
4393087|NCT00291018|4219431|B4|Former||Smoking Status||Subjects|Number|68|68.0||||||
4393088|NCT00291018|4219432|B3|Former||Smoking Status||Subjects|Number|30|30.0||||||
4393089|NCT00291018|4219433|B2|Former||Smoking Status||Subjects|Number|20|20.0||||||
4393090|NCT00291018|4219434|B1|Former||Smoking Status||Subjects|Number|18|18.0||||||
4393091|NCT00291018|4219431|B4|Never||Smoking Status||Subjects|Number|179|179.0||||||
4393092|NCT00291018|4219432|B3|Never||Smoking Status||Subjects|Number|79|79.0||||||
4393093|NCT00291018|4219433|B2|Never||Smoking Status||Subjects|Number|49|49.0||||||
4393094|NCT00291018|4219434|B1|Never||Smoking Status||Subjects|Number|51|51.0||||||
4393095|NCT00291018|4219431|B4|United States||Region of Enrollment||Participants|Number|345|345.0||||||
4393096|NCT00291018|4219432|B3|United States||Region of Enrollment||Participants|Number|136|136.0||||||
4393097|NCT00291018|4219433|B2|United States||Region of Enrollment||Participants|Number|106|106.0||||||
4393098|NCT00291018|4219434|B1|United States||Region of Enrollment||Participants|Number|103|103.0||||||
4393099|NCT00291018|4219431|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4393100|NCT00291018|4219432|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4393101|NCT00291018|4219433|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4393102|NCT00291018|4219434|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4393103|NCT00291018|4219431|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4393104|NCT00291018|4219432|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4393105|NCT00291018|4219433|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4393106|NCT00291018|4219434|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4393107|NCT00291018|4219431|B4||White|Race (NIH/OMB)||Participants|Count of Participants|310|310.0||||||
4393108|NCT00291018|4219432|B3||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4393109|NCT00291018|4219433|B2||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4393110|NCT00291018|4219434|B1||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4393111|NCT00291018|4219431|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4393112|NCT00291018|4219432|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393113|NCT00291018|4219433|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4393114|NCT00291018|4219434|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4393115|NCT00291018|4219431|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393116|NCT00291018|4219432|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393117|NCT00291018|4219433|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393118|NCT00291018|4219434|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393119|NCT00291018|4219431|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4393120|NCT00291018|4219432|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4393121|NCT00291018|4219433|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393122|NCT00291018|4219434|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4393123|NCT00291018|4219431|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393124|NCT00291018|4219432|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393125|NCT00291018|4219433|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393126|NCT00291018|4219434|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393127|NCT00291018|4219431|B4||Male|Sex: Female, Male|number of subjects who are female or male|Participants|Count of Participants|153|153.0||||||
4393128|NCT00291018|4219432|B3||Male|Sex: Female, Male|number of subjects who are female or male|Participants|Count of Participants|58|58.0||||||
4393129|NCT00291018|4219433|B2||Male|Sex: Female, Male|number of subjects who are female or male|Participants|Count of Participants|49|49.0||||||
4393130|NCT00291018|4219434|B1||Male|Sex: Female, Male|number of subjects who are female or male|Participants|Count of Participants|46|46.0||||||
4393131|NCT00291018|4219431|B4||Female|Sex: Female, Male|number of subjects who are female or male|Participants|Count of Participants|192|192.0||||||
4393132|NCT00291018|4219432|B3||Female|Sex: Female, Male|number of subjects who are female or male|Participants|Count of Participants|78|78.0||||||
4393133|NCT00291018|4219433|B2||Female|Sex: Female, Male|number of subjects who are female or male|Participants|Count of Participants|57|57.0||||||
4393134|NCT00291018|4219434|B1||Female|Sex: Female, Male|number of subjects who are female or male|Participants|Count of Participants|57|57.0||||||
4393135|NCT00291018|4219431|B4|||Age||Years|Mean|43.1|43.1|Standard Deviation|7.86|7.86|||
4393136|NCT00291018|4219432|B3|||Age||Years|Mean|43.4|43.4|Standard Deviation|7.95|7.95|||
4393137|NCT00291018|4219433|B2|||Age||Years|Mean|43.5|43.5|Standard Deviation|7.15|7.15|||
4393138|NCT00291018|4219434|B1|||Age||Years|Mean|42.1|42.1|Standard Deviation|8.42|8.42|||
4393139|NCT00290888|4219474|B3|Canada||Region of Enrollment||participants|Number|86|86.0||||||
4393140|NCT00290888|4219475|B2|Canada||Region of Enrollment||participants|Number|45|45.0||||||
4393141|NCT00290888|4219476|B1|Canada||Region of Enrollment||participants|Number|41|41.0||||||
4393142|NCT00290888|4219474|B3|Male||Gender||participants|Number|54|54.0||||||
4393143|NCT00290888|4219475|B2|Male||Gender||participants|Number|24|24.0||||||
4393144|NCT00290888|4219476|B1|Male||Gender||participants|Number|30|30.0||||||
4393145|NCT00290888|4219474|B3|Female||Gender||participants|Number|29|29.0||||||
4393146|NCT00290888|4219475|B2|Female||Gender||participants|Number|14|14.0||||||
4393147|NCT00290888|4219476|B1|Female||Gender||participants|Number|15|15.0||||||
4393148|NCT00290888|4219474|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4393149|NCT00290888|4219475|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4393150|NCT00290888|4219476|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4393151|NCT00290888|4219474|B3||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4393152|NCT00290888|4219475|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4393153|NCT00290888|4219476|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4393154|NCT00290888|4219474|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393155|NCT00290888|4219475|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393156|NCT00290888|4219476|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393157|NCT00290888|4219474|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|8.7|8.7|||
4393158|NCT00290888|4219475|B2|||Age||years|Mean|56.2|56.2|Standard Deviation|7.9|7.9|||
4393159|NCT00290888|4219476|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|9.5|9.5|||
4393160|NCT00290810|4219485|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4393161|NCT00290810|4219485|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4393162|NCT00290810|4219485|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4393163|NCT00290810|4219485|B1|||Age||years|Median|73|73.0|Full Range|||60.0|80.0|
4393164|NCT00290771|4219492|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4393165|NCT00290771|4219493|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4393166|NCT00290771|4219494|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4393167|NCT00290771|4219492|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4393168|NCT00290771|4219493|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4393169|NCT00290771|4219494|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4393170|NCT00290771|4219492|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|11.7|11.7|||
4393171|NCT00290771|4219493|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|11.4|11.4|||
4393172|NCT00290771|4219494|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|11.9|11.9|||
4393173|NCT00290758|4219517|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393174|NCT00290758|4219518|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393175|NCT00290758|4219519|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393176|NCT00290758|4219517|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393177|NCT00290758|4219518|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393178|NCT00290758|4219519|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393179|NCT00290758|4219517|B3||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4393180|NCT00290758|4219518|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4393181|NCT00290758|4219519|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4393182|NCT00290758|4219517|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4393183|NCT00290758|4219518|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4393184|NCT00290758|4219519|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4393185|NCT00290758|4219517|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4393186|NCT00290758|4219518|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393187|NCT00290758|4219519|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4393188|NCT00290758|4219517|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393189|NCT00290758|4219518|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393190|NCT00290758|4219519|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393191|NCT00290758|4219517|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393192|NCT00290758|4219518|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393193|NCT00290758|4219519|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393194|NCT00290758|4219517|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393195|NCT00290758|4219518|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393196|NCT00290758|4219519|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393197|NCT00290758|4219517|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4393198|NCT00290758|4219518|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4393199|NCT00290758|4219519|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4393200|NCT00290758|4219517|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4393201|NCT00290758|4219518|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4393202|NCT00290758|4219519|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4393203|NCT00290758|4219517|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4393204|NCT00290758|4219518|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4393205|NCT00290758|4219519|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4393206|NCT00290758|4219517|B3||Female|Gender||Participants|Count of Participants|126|126.0||||||
4393207|NCT00290758|4219518|B2||Female|Gender||Participants|Count of Participants|64|64.0||||||
4393208|NCT00290758|4219519|B1||Female|Gender||Participants|Count of Participants|62|62.0||||||
4393209|NCT00290758|4219517|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4393210|NCT00290758|4219518|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4393211|NCT00290758|4219519|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4393212|NCT00290758|4219517|B3||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4393213|NCT00290758|4219518|B2||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4393214|NCT00290758|4219519|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4393215|NCT00290758|4219517|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393216|NCT00290758|4219518|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393217|NCT00290758|4219519|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393218|NCT00290732|4219540|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4393219|NCT00290732|4219541|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4393220|NCT00290732|4219542|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4393221|NCT00290732|4219540|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4393222|NCT00290732|4219541|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4393223|NCT00290732|4219542|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4393224|NCT00290732|4219540|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4393225|NCT00290732|4219541|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4393226|NCT00290732|4219542|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4393227|NCT00290732|4219540|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4393228|NCT00290732|4219541|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4393229|NCT00290732|4219542|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4393230|NCT00290732|4219540|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4393231|NCT00290732|4219541|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4393232|NCT00290732|4219542|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4393233|NCT00290732|4219540|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393234|NCT00290732|4219541|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393235|NCT00290732|4219542|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393236|NCT00290693|4219564|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4393237|NCT00290693|4219564|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4393238|NCT00290693|4219564|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4393239|NCT00290693|4219564|B1|||Age||years|Median|64.4|64.4|Full Range|||44.0|83.0|
4393240|NCT00290693|4219564|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4393241|NCT00290693|4219564|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4393242|NCT00290693|4219564|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393243|NCT00290654|4219572|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4393244|NCT00290654|4219572|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4393245|NCT00290654|4219572|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4393246|NCT00290654|4219572|B1|||Age||years|Median|54|54.0|Full Range|||36.0|86.0|
4393247|NCT00290615|4219583|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4393248|NCT00290615|4219583|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4393249|NCT00290615|4219583|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4393250|NCT00290615|4219583|B1|||Age||years|Mean|56|56.0|Standard Deviation|10|10.0|||
4393251|NCT00290615|4219583|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4393252|NCT00290615|4219583|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4393253|NCT00290615|4219583|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393254|NCT00290537|4219590|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4393255|NCT00290537|4219590|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4393256|NCT00290537|4219590|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4393257|NCT00290537|4219590|B1|||Age||years|Median|50|50.0|Full Range|||35.0|58.0|
4393258|NCT00290472|4219596|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4393259|NCT00290472|4219597|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4393260|NCT00290472|4219598|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4393261|NCT00290472|4219599|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4393262|NCT00290472|4219596|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4393263|NCT00290472|4219597|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4393264|NCT00290472|4219598|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4393265|NCT00290472|4219599|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4393266|NCT00290472|4219596|B4|||Age||years|Median|61|61.0|Full Range|||28.0|87.0|
4393267|NCT00290472|4219597|B3|||Age||years|Median|57|57.0|Full Range|||38.0|82.0|
4393268|NCT00290472|4219598|B2|||Age||years|Median|59|59.0|Full Range|||28.0|75.0|
4393269|NCT00290472|4219599|B1|||Age||years|Median|67|67.0|Full Range|||30.0|87.0|
4393270|NCT00290407|4219613|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4393271|NCT00290407|4219613|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4393272|NCT00290407|4219613|B1|Over 18 years of age||Age, Customized||participants|Number|2|2.0||||||
4393273|NCT00290342|4219618|B3||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4393274|NCT00290342|4219619|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4393275|NCT00290342|4219620|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4393276|NCT00290342|4219618|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4393277|NCT00290342|4219619|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4393278|NCT00290342|4219620|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4393279|NCT00290342|4219618|B3|||Age||Weeks|Mean|8.8|8.8|Standard Deviation|0.63|0.63|||
4393280|NCT00290342|4219619|B2|||Age||Weeks|Mean|8.8|8.8|Standard Deviation|0.91|0.91|||
4393281|NCT00290342|4219620|B1|||Age||Weeks|Mean|8.8|8.8|Standard Deviation|0.9|0.9|||
4393282|NCT00290329|4219649|B4|South Asian||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4393283|NCT00290329|4219650|B3|South Asian||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4393284|NCT00290329|4219651|B2|South Asian||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4393285|NCT00290329|4219652|B1|South Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4393286|NCT00290329|4219649|B4|East/ South-east Asian||Race/Ethnicity, Customized||Participants|Count of Participants|223|223.0||||||
4393287|NCT00290329|4219650|B3|East/ South-east Asian||Race/Ethnicity, Customized||Participants|Count of Participants|56|56.0||||||
4393288|NCT00290329|4219651|B2|East/ South-east Asian||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
4393289|NCT00290329|4219652|B1|East/ South-east Asian||Race/Ethnicity, Customized||Participants|Count of Participants|94|94.0||||||
4393290|NCT00290329|4219649|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4393291|NCT00290329|4219650|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4393292|NCT00290329|4219651|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4393293|NCT00290329|4219652|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4393294|NCT00290329|4219649|B4||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4393295|NCT00290329|4219650|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4393296|NCT00290329|4219651|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4393297|NCT00290329|4219652|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4393298|NCT00290329|4219649|B4|||Age||Years|Mean|12.51|12.51|Standard Deviation|13.07|13.07|||
4393299|NCT00290329|4219650|B3|||Age||Years|Mean|32.5|32.5|Standard Deviation|10.98|10.98|||
4393300|NCT00290329|4219651|B2|||Age||Years|Mean|9.6|9.6|Standard Deviation|2.80|2.8|||
4393301|NCT00290329|4219652|B1|||Age||Years|Mean|3.0|3.0|Standard Deviation|1.11|1.11|||
4393302|NCT00290290|4219674|B3|United States||Region of Enrollment||participants|Number|849|849.0||||||
4393303|NCT00290290|4219675|B2|United States||Region of Enrollment||participants|Number|409|409.0||||||
4393304|NCT00290290|4219676|B1|United States||Region of Enrollment||participants|Number|440|440.0||||||
4393305|NCT00290290|4219674|B3||Male|Sex: Female, Male||Participants|Count of Participants|487|487.0||||||
4393306|NCT00290290|4219675|B2||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4393307|NCT00290290|4219676|B1||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4393308|NCT00290290|4219674|B3||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4393309|NCT00290290|4219675|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4393310|NCT00290290|4219676|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4393311|NCT00290290|4219674|B3|>18 years||Age, Customized||participants|Number|849|849.0||||||
4393312|NCT00290290|4219675|B2|>18 years||Age, Customized||participants|Number|409|409.0||||||
4393313|NCT00290290|4219676|B1|>18 years||Age, Customized||participants|Number|440|440.0||||||
4393314|NCT00290290|4219674|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4393315|NCT00290290|4219675|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4393316|NCT00290290|4219676|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4393317|NCT00290290|4219674|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|14.4|14.4|||
4393318|NCT00290290|4219675|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|14.6|14.6|||
4393319|NCT00290290|4219676|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|14.2|14.2|||
4393320|NCT00290251|4219683|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4393321|NCT00290251|4219683|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4393322|NCT00290251|4219683|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4393323|NCT00290251|4219683|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4393324|NCT00290251|4219683|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4393325|NCT00290251|4219683|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393326|NCT00290238|4219695|B3|United States||Region of Enrollment||participants|Number|122|122.0||||||
4393327|NCT00290238|4219696|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4393328|NCT00290238|4219697|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4393329|NCT00290238|4219695|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4393330|NCT00290238|4219696|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4393331|NCT00290238|4219697|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4393332|NCT00290238|4219695|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4393333|NCT00290238|4219696|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4393334|NCT00290238|4219697|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4393335|NCT00290238|4219695|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|13.1|13.1|||
4393336|NCT00290238|4219696|B2|||Age||years|Mean|55.9|55.9|Standard Deviation|11.0|11.0|||
4393337|NCT00290238|4219697|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|15.1|15.1|||
4393338|NCT00290238|4219695|B3|>=65 years||Age|One subject had an invalid birth date and was excluded from the Age Categorical counts.|participants|Number|24|24.0||||||
4393339|NCT00290238|4219696|B2|>=65 years||Age|One subject had an invalid birth date and was excluded from the Age Categorical counts.|participants|Number|10|10.0||||||
4393340|NCT00290238|4219697|B1|>=65 years||Age|One subject had an invalid birth date and was excluded from the Age Categorical counts.|participants|Number|14|14.0||||||
4393388|NCT00290186|4219723|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4393341|NCT00290238|4219695|B3|Between 18 and 65 years||Age|One subject had an invalid birth date and was excluded from the Age Categorical counts.|participants|Number|97|97.0||||||
4393342|NCT00290238|4219696|B2|Between 18 and 65 years||Age|One subject had an invalid birth date and was excluded from the Age Categorical counts.|participants|Number|54|54.0||||||
4393343|NCT00290238|4219697|B1|Between 18 and 65 years||Age|One subject had an invalid birth date and was excluded from the Age Categorical counts.|participants|Number|43|43.0||||||
4393344|NCT00290238|4219695|B3|<=18 years||Age|One subject had an invalid birth date and was excluded from the Age Categorical counts.|participants|Number|0|0.0||||||
4393345|NCT00290238|4219696|B2|<=18 years||Age|One subject had an invalid birth date and was excluded from the Age Categorical counts.|participants|Number|0|0.0||||||
4393346|NCT00290238|4219697|B1|<=18 years||Age|One subject had an invalid birth date and was excluded from the Age Categorical counts.|participants|Number|0|0.0||||||
4393347|NCT00290199|4219706|B3|United States||Region of Enrollment||participants|Number|169|169.0||||||
4393348|NCT00290199|4219707|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
4393349|NCT00290199|4219708|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4393350|NCT00290199|4219706|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4393351|NCT00290199|4219707|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4393352|NCT00290199|4219708|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4393353|NCT00290199|4219706|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4393354|NCT00290199|4219707|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4393355|NCT00290199|4219708|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4393356|NCT00290199|4219706|B3|||Age||years|Mean|25|25.0|Standard Deviation|5.5|5.5|||
4393357|NCT00290199|4219707|B2|||Age||years|Mean|25|25.0|Standard Deviation|6|6.0|||
4393358|NCT00290199|4219708|B1|||Age||years|Mean|25|25.0|Standard Deviation|5|5.0|||
4393359|NCT00290199|4219706|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4393360|NCT00290199|4219707|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4393361|NCT00290199|4219708|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4393362|NCT00290199|4219706|B3||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
4393363|NCT00290199|4219707|B2||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4393364|NCT00290199|4219708|B1||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4393365|NCT00290199|4219706|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393366|NCT00290199|4219707|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393367|NCT00290199|4219708|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393368|NCT00290186|4219721|B3|V||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|22|22.0||||||
4393369|NCT00290186|4219722|B2|V||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|9|9.0||||||
4393370|NCT00290186|4219723|B1|V||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|13|13.0||||||
4393371|NCT00290186|4219721|B3|IV||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|9|9.0||||||
4393372|NCT00290186|4219722|B2|IV||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|6|6.0||||||
4393389|NCT00290186|4219721|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4393390|NCT00290186|4219722|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4393391|NCT00290186|4219723|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4393392|NCT00290186|4219721|B3|||Age||years|Mean|5.8|5.8|Standard Deviation|1.7|1.7|||
4393373|NCT00290186|4219723|B1|IV||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|3|3.0||||||
4393374|NCT00290186|4219721|B3|III||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|6|6.0||||||
4393375|NCT00290186|4219722|B2|III||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|4|4.0||||||
4393376|NCT00290186|4219723|B1|III||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|2|2.0||||||
4393377|NCT00290186|4219721|B3|II||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|2|2.0||||||
4393378|NCT00290186|4219722|B2|II||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|1|1.0||||||
4393379|NCT00290186|4219723|B1|II||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|1|1.0||||||
4393380|NCT00290186|4219721|B3|I||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|10|10.0||||||
4393381|NCT00290186|4219722|B2|I||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|4|4.0||||||
4393382|NCT00290186|4219723|B1|I||Gross Motor Function Classification System (GMFCS) level|"GMFCS© Robert Palisano, Peter Rosenbaum, Stephen Walter, Dianne Russell, Ellen Wood, Barbara Galuppi, 1997. CanChild Centre for Childhood Disability Research, McMaster University. (Reference: Dev Med Child Neurol 1997;39:214-223).~Levels I-V based on self-initiated movement, with emphasis on sitting, transfers, and mobility. Level I is highest functioning, level V is lowest~General:~I: walks without limitations II: walks with limitations III: walks using hand-held mobility device IV: self-mobility with limitations; may use powered mobility V: transported in manual wheelchair"|participants|Number|6|6.0||||||
4393383|NCT00290186|4219721|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4393384|NCT00290186|4219722|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4393385|NCT00290186|4219723|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4393386|NCT00290186|4219721|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4393387|NCT00290186|4219722|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4393393|NCT00290186|4219722|B2|||Age||years|Mean|5.2|5.2|Standard Deviation|2.0|2.0|||
4393394|NCT00290186|4219723|B1|||Age||years|Mean|6.3|6.3|Standard Deviation|1.3|1.3|||
4393395|NCT00290186|4219721|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4393396|NCT00290186|4219722|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4393397|NCT00290186|4219723|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4393398|NCT00290186|4219721|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4393399|NCT00290186|4219722|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4393400|NCT00290186|4219723|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4393401|NCT00290186|4219721|B3||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
4393402|NCT00290186|4219722|B2||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4393403|NCT00290186|4219723|B1||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4393404|NCT00290147|4219762|B3|||Civilian||Participants|Count of Participants|20|20.0||||||
4393405|NCT00290147|4219763|B2|||Civilian||Participants|Count of Participants|10|10.0||||||
4393406|NCT00290147|4219764|B1|||Civilian||Participants|Count of Participants|10|10.0||||||
4393407|NCT00290147|4219762|B3|||Active Duty Military||Participants|Count of Participants|2|2.0||||||
4393408|NCT00290147|4219763|B2|||Active Duty Military||Participants|Count of Participants|2|2.0||||||
4393409|NCT00290147|4219764|B1|||Active Duty Military||Participants|Count of Participants|0|0.0||||||
4393410|NCT00290147|4219762|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4393411|NCT00290147|4219763|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4393412|NCT00290147|4219764|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4393413|NCT00290147|4219762|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4393414|NCT00290147|4219763|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4393415|NCT00290147|4219764|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4393416|NCT00290147|4219762|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4393417|NCT00290147|4219763|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393418|NCT00290147|4219764|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4393419|NCT00290147|4219762|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4393420|NCT00290147|4219763|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4393421|NCT00290147|4219764|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4393422|NCT00290147|4219762|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4393423|NCT00290147|4219763|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4393424|NCT00290147|4219764|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4393425|NCT00290147|4219762|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393426|NCT00290147|4219763|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393427|NCT00290147|4219764|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393428|NCT00290147|4219762|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4393429|NCT00290147|4219763|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4393430|NCT00290147|4219764|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393431|NCT00290147|4219762|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393432|NCT00290147|4219763|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393433|NCT00290147|4219764|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393434|NCT00290147|4219762|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4393435|NCT00290147|4219763|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4393436|NCT00290147|4219764|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4393437|NCT00290147|4219762|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4393438|NCT00290147|4219763|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4393439|NCT00290147|4219764|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4393440|NCT00290147|4219762|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|9.28|9.28|||
4393441|NCT00290147|4219763|B2|||Age||years|Mean|36.9|36.9|Standard Deviation|9.89|9.89|||
4393442|NCT00290147|4219764|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|8.60|8.6|||
4393443|NCT00289991|4219773|B3||Male|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
4393444|NCT00289991|4219774|B2||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4393445|NCT00289991|4219775|B1||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4393446|NCT00289991|4219773|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4393447|NCT00289991|4219774|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4393448|NCT00289991|4219775|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4393449|NCT00289991|4219773|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|14.5|14.5|||
4393450|NCT00289991|4219774|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|14.6|14.6|||
4393451|NCT00289991|4219775|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|14.4|14.4|||
4393452|NCT00289991|4219773|B3|>=65 years||Age, Customized||participants|Number|25|25.0||||||
4393453|NCT00289991|4219774|B2|>=65 years||Age, Customized||participants|Number|10|10.0||||||
4393454|NCT00289991|4219775|B1|>=65 years||Age, Customized||participants|Number|15|15.0||||||
4393455|NCT00289991|4219773|B3|Between 45 and 64 years||Age, Customized||participants|Number|219|219.0||||||
4393456|NCT00289991|4219774|B2|Between 45 and 64 years||Age, Customized||participants|Number|115|115.0||||||
4393457|NCT00289991|4219775|B1|Between 45 and 64 years||Age, Customized||participants|Number|104|104.0||||||
4393458|NCT00289991|4219773|B3|Between 18 and 44 years||Age, Customized||participants|Number|225|225.0||||||
4393459|NCT00289991|4219774|B2|Between 18 and 44 years||Age, Customized||participants|Number|119|119.0||||||
4393460|NCT00289991|4219775|B1|Between 18 and 44 years||Age, Customized||participants|Number|106|106.0||||||
4393461|NCT00289991|4219773|B3|<18 years||Age, Customized||participants|Number|20|20.0||||||
4393462|NCT00289991|4219774|B2|<18 years||Age, Customized||participants|Number|11|11.0||||||
4393463|NCT00289991|4219775|B1|<18 years||Age, Customized||participants|Number|9|9.0||||||
4393464|NCT00289978|4219798|B4|||Expanded Disability Status Scale (EDSS)|The EDSS is a scale for assessing disability in 8 functional systems (visual, brain stem, pyramidal, cerebellar, sensory, bowel & bladder, cerebral, other functions). Based on scores in these 8 functional systems, an overall score ranging from 0 (normal) to 10 (death due to MS) is assigned. Patients with EDSS scores of 0.0 to 4.5 are fully ambulatory; patients with EDSS scores of 5.0 to 9.5 have impaired ambulation. EDSS was assessed by an evaluating physician at each site.|Units on a scale|Mean|2.40|2.4|Standard Deviation|1.32|1.32|0.0|5.5|
4393465|NCT00289978|4219799|B3|||Expanded Disability Status Scale (EDSS)|The EDSS is a scale for assessing disability in 8 functional systems (visual, brain stem, pyramidal, cerebellar, sensory, bowel & bladder, cerebral, other functions). Based on scores in these 8 functional systems, an overall score ranging from 0 (normal) to 10 (death due to MS) is assigned. Patients with EDSS scores of 0.0 to 4.5 are fully ambulatory; patients with EDSS scores of 5.0 to 9.5 have impaired ambulation. EDSS was assessed by an evaluating physician at each site.|Units on a scale|Mean|2.49|2.49|Standard Deviation|1.29|1.29|0.0|5.5|
4393466|NCT00289978|4219800|B2|||Expanded Disability Status Scale (EDSS)|The EDSS is a scale for assessing disability in 8 functional systems (visual, brain stem, pyramidal, cerebellar, sensory, bowel & bladder, cerebral, other functions). Based on scores in these 8 functional systems, an overall score ranging from 0 (normal) to 10 (death due to MS) is assigned. Patients with EDSS scores of 0.0 to 4.5 are fully ambulatory; patients with EDSS scores of 5.0 to 9.5 have impaired ambulation. EDSS was assessed by an evaluating physician at each site.|Units on a scale|Mean|2.30|2.3|Standard Deviation|1.29|1.29|0.0|5.5|
4393467|NCT00289978|4219801|B1|||Expanded Disability Status Scale (EDSS)|The EDSS is a scale for assessing disability in 8 functional systems (visual, brain stem, pyramidal, cerebellar, sensory, bowel & bladder, cerebral, other functions). Based on scores in these 8 functional systems, an overall score ranging from 0 (normal) to 10 (death due to MS) is assigned. Patients with EDSS scores of 0.0 to 4.5 are fully ambulatory; patients with EDSS scores of 5.0 to 9.5 have impaired ambulation. EDSS was assessed by an evaluating physician at each site.|Units on a scale|Mean|2.41|2.41|Standard Deviation|1.36|1.36|0.0|5.5|
4393468|NCT00289978|4219798|B4|||Number of relapses in last 2 years||relapses|Mean|1.5|1.5|Standard Deviation|0.77|0.77|1.0|11.0|
4393469|NCT00289978|4219799|B3|||Number of relapses in last 2 years||relapses|Mean|1.4|1.4|Standard Deviation|0.73|0.73|1.0|10.0|
4393470|NCT00289978|4219800|B2|||Number of relapses in last 2 years||relapses|Mean|1.5|1.5|Standard Deviation|0.76|0.76|1.0|11.0|
4393471|NCT00289978|4219801|B1|||Number of relapses in last 2 years||relapses|Mean|1.5|1.5|Standard Deviation|0.81|0.81|1.0|10.0|
4393472|NCT00289978|4219798|B4|||Duration of multiple sclerosis since first symptoms||Years|Mean|8.2|8.2|Standard Deviation|6.60|6.6|0.0|37.0|
4393473|NCT00289978|4219799|B3|||Duration of multiple sclerosis since first symptoms||Years|Mean|8.1|8.1|Standard Deviation|6.35|6.35|0.0|32.0|
4393474|NCT00289978|4219800|B2|||Duration of multiple sclerosis since first symptoms||Years|Mean|8.0|8.0|Standard Deviation|6.60|6.6|0.0|35.0|
4393475|NCT00289978|4219801|B1|||Duration of multiple sclerosis since first symptoms||Years|Mean|8.4|8.4|Standard Deviation|6.86|6.86|0.0|37.0|
4393476|NCT00289978|4219798|B4||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4393477|NCT00289978|4219799|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4393478|NCT00289978|4219800|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4393479|NCT00289978|4219801|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4393480|NCT00289978|4219798|B4||Female|Sex: Female, Male||Participants|Count of Participants|889|889.0||||||
4393481|NCT00289978|4219799|B3||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4393482|NCT00289978|4219800|B2||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4393483|NCT00289978|4219801|B1||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4393484|NCT00289978|4219798|B4|41-55||Age, Customized||participants|Number|473|473.0||||||
4393485|NCT00289978|4219799|B3|41-55||Age, Customized||participants|Number|156|156.0||||||
4393486|NCT00289978|4219800|B2|41-55||Age, Customized||participants|Number|143|143.0||||||
4393487|NCT00289978|4219801|B1|41-55||Age, Customized||participants|Number|174|174.0||||||
4393488|NCT00289978|4219798|B4|31-40||Age, Customized||participants|Number|474|474.0||||||
4393489|NCT00289978|4219799|B3|31-40||Age, Customized||participants|Number|165|165.0||||||
4393490|NCT00289978|4219800|B2|31-40||Age, Customized||participants|Number|162|162.0||||||
4393491|NCT00289978|4219801|B1|31-40||Age, Customized||participants|Number|147|147.0||||||
4393492|NCT00289978|4219798|B4|18 -30||Age, Customized||participants|Number|324|324.0||||||
4393493|NCT00289978|4219799|B3|18 -30||Age, Customized||participants|Number|97|97.0||||||
4393494|NCT00289978|4219800|B2|18 -30||Age, Customized||participants|Number|120|120.0||||||
4393495|NCT00289978|4219801|B1|18 -30||Age, Customized||participants|Number|107|107.0||||||
4393496|NCT00289978|4219798|B4|<18 years||Age, Customized||participants|Number|1|1.0||||||
4393497|NCT00289978|4219799|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4393498|NCT00289978|4219800|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4393499|NCT00289978|4219801|B1|<18 years||Age, Customized||participants|Number|1|1.0||||||
4393500|NCT00289978|4219798|B4|||Age||years|Mean|37.1|37.1|Standard Deviation|8.76|8.76|||
4393501|NCT00289978|4219799|B3|||Age||years|Mean|37.2|37.2|Standard Deviation|8.60|8.6|||
4393502|NCT00289978|4219800|B2|||Age||years|Mean|36.6|36.6|Standard Deviation|8.77|8.77|||
4393503|NCT00289978|4219801|B1|||Age||years|Mean|37.4|37.4|Standard Deviation|8.91|8.91|||
4393504|NCT00289913|4219817|B6||Male|Sex: Female, Male||Participants|Count of Participants|668|668.0||||||
4393505|NCT00289913|4219818|B5||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4393506|NCT00289913|4219819|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4393507|NCT00289913|4219820|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4393508|NCT00289913|4219821|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4393509|NCT00289913|4219822|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4393510|NCT00289913|4219817|B6||Female|Sex: Female, Male||Participants|Count of Participants|603|603.0||||||
4393511|NCT00289913|4219818|B5||Female|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
4393512|NCT00289913|4219819|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4393513|NCT00289913|4219820|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4393514|NCT00289913|4219821|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4393515|NCT00289913|4219822|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4393516|NCT00289913|4219817|B6|Between 12 and 18 months||Age, Customized|Months between the birthdate and consent date.|participants|Number|1271|1271.0||||||
4393517|NCT00289913|4219818|B5|Between 12 and 18 months||Age, Customized|Months between the birthdate and consent date.|participants|Number|654|654.0||||||
4393518|NCT00289913|4219819|B4|Between 12 and 18 months||Age, Customized|Months between the birthdate and consent date.|participants|Number|152|152.0||||||
4393519|NCT00289913|4219820|B3|Between 12 and 18 months||Age, Customized|Months between the birthdate and consent date.|participants|Number|159|159.0||||||
4393520|NCT00289913|4219821|B2|Between 12 and 18 months||Age, Customized|Months between the birthdate and consent date.|participants|Number|151|151.0||||||
4393521|NCT00289913|4219822|B1|Between 12 and 18 months||Age, Customized|Months between the birthdate and consent date.|participants|Number|155|155.0||||||
4393522|NCT00289900|4219851|B7||Male|Sex: Female, Male||Participants|Count of Participants|1031|1031.0||||||
4393523|NCT00289900|4219852|B6||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4393524|NCT00289900|4219853|B5||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4393525|NCT00289900|4219854|B4||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4393526|NCT00289900|4219855|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4393527|NCT00289900|4219856|B2||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4393528|NCT00289900|4219857|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4393529|NCT00289900|4219851|B7||Female|Sex: Female, Male||Participants|Count of Participants|1309|1309.0||||||
4393530|NCT00289900|4219852|B6||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4393531|NCT00289900|4219853|B5||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4393532|NCT00289900|4219854|B4||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4393533|NCT00289900|4219855|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4393534|NCT00289900|4219856|B2||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4393535|NCT00289900|4219857|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4393536|NCT00289900|4219851|B7|||Age||years|Mean|54.7|54.7|Standard Deviation|10.5|10.5|||
4393537|NCT00289900|4219852|B6|||Age||years|Mean|54.7|54.7|Standard Deviation|10.5|10.5|||
4393538|NCT00289900|4219853|B5|||Age||years|Mean|55.1|55.1|Standard Deviation|10.1|10.1|||
4393539|NCT00289900|4219854|B4|||Age||years|Mean|54.8|54.8|Standard Deviation|10.8|10.8|||
4393540|NCT00289900|4219855|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|10.6|10.6|||
4393541|NCT00289900|4219856|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|10.3|10.3|||
4393542|NCT00289900|4219857|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|10.8|10.8|||
4393543|NCT00289887|4219964|B3|||Sitting Systolic Blood Pressure (SiSBP)||mm Hg|Mean|152.0|152.0|Standard Deviation|8.6|8.6|||
4393544|NCT00289887|4219965|B2|||Sitting Systolic Blood Pressure (SiSBP)||mm Hg|Mean|152.4|152.4|Standard Deviation|9.0|9.0|||
4393545|NCT00289887|4219966|B1|||Sitting Systolic Blood Pressure (SiSBP)||mm Hg|Mean|151.6|151.6|Standard Deviation|8.2|8.2|||
4393546|NCT00289887|4219964|B3|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|99.0|99.0|Standard Deviation|4.1|4.1|||
4393547|NCT00289887|4219965|B2|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|99.0|99.0|Standard Deviation|4.0|4.0|||
4393548|NCT00289887|4219966|B1|||Sitting Diastolic Blood Pressure (SiDBP)||mm Hg|Mean|99.1|99.1|Standard Deviation|4.2|4.2|||
4393549|NCT00289887|4219964|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4393550|NCT00289887|4219965|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4393551|NCT00289887|4219966|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4393552|NCT00289887|4219964|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4393553|NCT00289887|4219965|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4393554|NCT00289887|4219966|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4393555|NCT00289887|4219964|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4393556|NCT00289887|4219965|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4393557|NCT00289887|4219966|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4393558|NCT00289887|4219964|B3|Black||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4393559|NCT00289887|4219965|B2|Black||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4393560|NCT00289887|4219966|B1|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4393561|NCT00289887|4219964|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|171|171.0||||||
4393562|NCT00289887|4219965|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4393563|NCT00289887|4219966|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4393564|NCT00289887|4219964|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4393565|NCT00289887|4219965|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4393566|NCT00289887|4219966|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4393567|NCT00289887|4219964|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4393568|NCT00289887|4219965|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4393569|NCT00289887|4219966|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4393570|NCT00289887|4219964|B3|||Age||years|Mean|50.8|50.8|Standard Deviation|10.0|10.0|||
4393571|NCT00289887|4219965|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|9.7|9.7|||
4393572|NCT00289887|4219966|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|10.4|10.4|||
4393573|NCT00289874|4219983|B3|||Forced expiratory volume in 1 second (FEV1)||Liters|Mean|1.83|1.83|Standard Deviation|0.58|0.58|||
4393574|NCT00289874|4219984|B2|||Forced expiratory volume in 1 second (FEV1)||Liters|Mean|1.84|1.84|Standard Deviation|0.60|0.6|||
4393575|NCT00289874|4219985|B1|||Forced expiratory volume in 1 second (FEV1)||Liters|Mean|1.81|1.81|Standard Deviation|0.57|0.57|||
4393576|NCT00289874|4219983|B3|||Daily β-agonist use||Puffs/Day|Mean|2.86|2.86|Standard Deviation|1.73|1.73|||
4393577|NCT00289874|4219984|B2|||Daily β-agonist use||Puffs/Day|Mean|2.72|2.72|Standard Deviation|1.68|1.68|||
4393578|NCT00289874|4219985|B1|||Daily β-agonist use||Puffs/Day|Mean|3.01|3.01|Standard Deviation|1.77|1.77|||
4393579|NCT00289874|4219983|B3||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4393580|NCT00289874|4219984|B2||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4393581|NCT00289874|4219985|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4393582|NCT00289874|4219983|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4393583|NCT00289874|4219984|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4393584|NCT00289874|4219985|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4393585|NCT00289874|4219983|B3|||Age||years|Mean|10.6|10.6|Standard Deviation|2.4|2.4|||
4393586|NCT00289874|4219984|B2|||Age||years|Mean|10.7|10.7|Standard Deviation|2.4|2.4|||
4393587|NCT00289874|4219985|B1|||Age||years|Mean|10.6|10.6|Standard Deviation|2.4|2.4|||
4393588|NCT00289848|4219994|B3|||Hemoglobin A1C (HbA1C; A1C)||Percent|Mean|8.74|8.74|Standard Deviation|1.03|1.03|||
4393589|NCT00289848|4219995|B2|||Hemoglobin A1C (HbA1C; A1C)||Percent|Mean|8.75|8.75|Standard Deviation|1.06|1.06|||
4393590|NCT00289848|4219996|B1|||Hemoglobin A1C (HbA1C; A1C)||Percent|Mean|8.74|8.74|Standard Deviation|1.01|1.01|||
4393591|NCT00289848|4219994|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|189.4|189.4|Standard Deviation|44.7|44.7|||
4393592|NCT00289848|4219995|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|190.2|190.2|Standard Deviation|46.2|46.2|||
4393593|NCT00289848|4219996|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|189.0|189.0|Standard Deviation|44.0|44.0|||
4393594|NCT00289848|4219994|B3|Korean||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4393595|NCT00289848|4219995|B2|Korean||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4393596|NCT00289848|4219996|B1|Korean||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4393597|NCT00289848|4219994|B3|Indian||Race/Ethnicity, Customized||participants|Number|190|190.0||||||
4393598|NCT00289848|4219995|B2|Indian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4393599|NCT00289848|4219996|B1|Indian||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4393600|NCT00289848|4219994|B3|Chinese||Race/Ethnicity, Customized||participants|Number|245|245.0||||||
4393601|NCT00289848|4219995|B2|Chinese||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4393602|NCT00289848|4219996|B1|Chinese||Race/Ethnicity, Customized||participants|Number|163|163.0||||||
4393603|NCT00289848|4219994|B3||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4393604|NCT00289848|4219995|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4393605|NCT00289848|4219996|B1||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4393606|NCT00289848|4219994|B3||Female|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4393607|NCT00289848|4219995|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4393608|NCT00289848|4219996|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4393609|NCT00289848|4219994|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|9.3|9.3|||
4393610|NCT00289848|4219995|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|9.3|9.3|||
4393611|NCT00289848|4219996|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|9.3|9.3|||
4393612|NCT00289783|4220007|B3||Male|Sex: Female, Male||Participants|Count of Participants|2159|2159.0||||||
4393613|NCT00289783|4220008|B2||Male|Sex: Female, Male||Participants|Count of Participants|546|546.0||||||
4393614|NCT00289783|4220009|B1||Male|Sex: Female, Male||Participants|Count of Participants|1613|1613.0||||||
4393615|NCT00289783|4220007|B3||Female|Sex: Female, Male||Participants|Count of Participants|2021|2021.0||||||
4393616|NCT00289783|4220008|B2||Female|Sex: Female, Male||Participants|Count of Participants|498|498.0||||||
4393617|NCT00289783|4220009|B1||Female|Sex: Female, Male||Participants|Count of Participants|1523|1523.0||||||
4393618|NCT00289783|4220007|B3|||Age||Months|Mean|2.11|2.11|Standard Deviation|0.27|0.27|||
4393619|NCT00289783|4220008|B2|||Age||Months|Mean|2.11|2.11|Standard Deviation|0.27|0.27|||
4393620|NCT00289783|4220009|B1|||Age||Months|Mean|2.11|2.11|Standard Deviation|0.26|0.26|||
4393621|NCT00289770|4220188|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4393622|NCT00289770|4220188|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4393623|NCT00289770|4220188|B1|||Age||Years|Mean|34.4|34.4|Standard Deviation|2.66|2.66|||
4393624|NCT00289757|4220200|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4393625|NCT00289757|4220200|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4393626|NCT00289757|4220200|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|7.00|7.0|||
4393627|NCT00289744|4220211|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4393628|NCT00289744|4220211|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4393629|NCT00289744|4220211|B1|||Age||years|Mean|13.1|13.1|Standard Deviation|2.82|2.82|||
4393630|NCT00289731|4220231|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4393631|NCT00289731|4220232|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4393632|NCT00289731|4220233|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4393633|NCT00289731|4220234|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4393634|NCT00289731|4220231|B4|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|595|595.0||||||
4393635|NCT00289731|4220232|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|196|196.0||||||
4393636|NCT00289731|4220233|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|200|200.0||||||
4393637|NCT00289731|4220234|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|199|199.0||||||
4393638|NCT00289731|4220231|B4||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4393639|NCT00289731|4220232|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4393640|NCT00289731|4220233|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4393641|NCT00289731|4220234|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4393642|NCT00289731|4220231|B4||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4393643|NCT00289731|4220232|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4393644|NCT00289731|4220233|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4393645|NCT00289731|4220234|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4393646|NCT00289731|4220231|B4|||Age||Years|Mean|55.17|55.17|Standard Deviation|9.59|9.59|||
4393647|NCT00289731|4220232|B3|||Age||Years|Mean|55.0|55.0|Standard Deviation|9.64|9.64|||
4393648|NCT00289731|4220233|B2|||Age||Years|Mean|55.3|55.3|Standard Deviation|9.91|9.91|||
4393649|NCT00289731|4220234|B1|||Age||Years|Mean|55.2|55.2|Standard Deviation|9.24|9.24|||
4393650|NCT00289718|4220328|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4393651|NCT00289718|4220328|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4393652|NCT00289718|4220328|B1|||Age||years|Mean|36.4|36.4|Standard Deviation|5.65|5.65|||
4393653|NCT00289653|4220343|B1|||Beck Depression Inventory (BDI) score|This self report scale measures level of depression. the response of each of the 21 items ranges from 0-3. The total score (range 0-63) reflects level of depression. 0-10 (normal) 11-16 (moderate) 17-20 (borderline) 21-30 (moderate) 21-40 (Severe) > 40 (extreme)|units on a scale|Mean|10.0|10.0|Standard Deviation|9.7|9.7|||
4393654|NCT00289653|4220343|B1|||Hamilton Depression Rating Scale (HAM-D)|This measure is used to assess level of depression. There are 21 items and the score is based on the first 17 items. 8 items are scored 0-4. 9 items are scored 0-2. Total score determines level of depression. 0-7 (normal); 8-13 (mild depression); 14-18 (moderate depression); 19-22 (severe depression); => 23 (very severe depression)|units on a scale|Mean|8.9|8.9|Standard Deviation|9.8|9.8|||
4393655|NCT00289653|4220343|B1|||Fagerstrom Test of Nicotine Dependence|"A standard test to assess nicotine dependence completed by the subject. The yes/ no responses are scored 0-1 and multiple choice answers are scored 0-3.~Items are summed to yield a total score of 0-10. Total score indicates level of nicotine dependence. 0-2 (Low); 3-5 (Low-moderate); 5-7 (Moderate); 8-10 (High)."|units on a scale|Mean|6.3|6.3|Standard Deviation|2.3|2.3|||
4393656|NCT00289653|4220343|B1|||No. years smoking||years|Mean|30.1|30.1|Standard Deviation|12.9|12.9|||
4393657|NCT00289653|4220343|B1|||No. of previous serious quit attempts||Quit attempts|Mean|4.7|4.7|Standard Deviation|6.3|6.3|||
4393658|NCT00289653|4220343|B1|||Carbon monoxide gas (CO) reading||ppm|Mean|23.1|23.1|Standard Deviation|11.5|11.5|||
4393659|NCT00289653|4220343|B1|||Mean Cigarettes per day||cigarettes per day|Mean|25.7|25.7|Standard Deviation|13.4|13.4|||
4393660|NCT00289653|4220343|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4393661|NCT00289653|4220343|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4393662|NCT00289653|4220343|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|12.4|12.4|||
4393663|NCT00289536|4220348|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4393664|NCT00289536|4220348|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4393665|NCT00289536|4220348|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4393666|NCT00289536|4220348|B1|||Age||years|Mean|23.8|23.8|Standard Deviation|9.6|9.6|||
4393667|NCT00289536|4220348|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4393668|NCT00289536|4220348|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4393669|NCT00289536|4220348|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4393670|NCT00289471|4220389|B1|United States||Region of Enrollment||participants|Number|630|630.0||||||
4393671|NCT00289471|4220389|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4393672|NCT00289471|4220389|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393673|NCT00289471|4220389|B1||White|Race (NIH/OMB)||Participants|Count of Participants|461|461.0||||||
4393674|NCT00289471|4220389|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4393675|NCT00289471|4220389|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393676|NCT00289471|4220389|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393677|NCT00289471|4220389|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393678|NCT00289471|4220389|B1||Male|Sex: Female, Male||Participants|Count of Participants|585|585.0||||||
4393679|NCT00289471|4220389|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4393680|NCT00289471|4220389|B1|||Age||years|Mean|74.8|74.8|Standard Deviation|6.6|6.6|||
4393681|NCT00289458|4220393|B4|Canada||Region of Enrollment||participants|Number|79|79.0||||||
4393682|NCT00289458|4220394|B3|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4393683|NCT00289458|4220395|B2|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4393684|NCT00289458|4220396|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4393685|NCT00289458|4220393|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4393686|NCT00289458|4220394|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4393687|NCT00289458|4220395|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4393688|NCT00289458|4220396|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4393689|NCT00289458|4220393|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4393690|NCT00289458|4220394|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4393691|NCT00289458|4220395|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4393692|NCT00289458|4220396|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4393693|NCT00289458|4220393|B4|||Age||years|Mean|74.4|74.4|Standard Deviation|6.3|6.3|||
4393694|NCT00289458|4220394|B3|||Age||years|Mean|73.2|73.2|Standard Deviation|4.8|4.8|||
4393695|NCT00289458|4220395|B2|||Age||years|Mean|74.4|74.4|Standard Deviation|7.5|7.5|||
4393696|NCT00289458|4220396|B1|||Age||years|Mean|75.8|75.8|Standard Deviation|6.2|6.2|||
4393697|NCT00289458|4220393|B4||>=65 years|Age||Participants|Count of Participants|79|79.0||||||
4393698|NCT00289458|4220394|B3||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4393699|NCT00289458|4220395|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4393700|NCT00289458|4220396|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4393701|NCT00289458|4220393|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4393702|NCT00289458|4220394|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4393703|NCT00289458|4220395|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4393704|NCT00289458|4220396|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4393705|NCT00289458|4220393|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393706|NCT00289458|4220394|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393707|NCT00289458|4220395|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393708|NCT00289458|4220396|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393709|NCT00289341|4220421|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4393710|NCT00289341|4220422|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4393711|NCT00289341|4220423|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4393712|NCT00289341|4220421|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4393713|NCT00289341|4220422|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4393714|NCT00289341|4220423|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4393715|NCT00289341|4220421|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4393716|NCT00289341|4220422|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4393717|NCT00289341|4220423|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4393718|NCT00289341|4220421|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|7.9|7.9|||
4393719|NCT00289341|4220422|B2|||Age||years|Mean|65.7|65.7|Standard Deviation|9.2|9.2|||
4393720|NCT00289341|4220423|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|6.7|6.7|||
4393721|NCT00289341|4220421|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4393722|NCT00289341|4220422|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4393723|NCT00289341|4220423|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4393724|NCT00289341|4220421|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4393725|NCT00289341|4220422|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4393726|NCT00289341|4220423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4393727|NCT00289341|4220421|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393728|NCT00289341|4220422|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393729|NCT00289341|4220423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393730|NCT00289315|4220434|B4||Male|Sex: Female, Male||Participants|Count of Participants|839|839.0||||||
4393731|NCT00289315|4220435|B3||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4393732|NCT00289315|4220436|B2||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4393733|NCT00289315|4220437|B1||Male|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4393734|NCT00289315|4220434|B4||Female|Sex: Female, Male||Participants|Count of Participants|1176|1176.0||||||
4393735|NCT00289315|4220435|B3||Female|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4393736|NCT00289315|4220436|B2||Female|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
4393737|NCT00289315|4220437|B1||Female|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
4393738|NCT00289315|4220434|B4|||Age||years|Mean|10.5|10.5|Standard Deviation|1.2|1.2|||
4393739|NCT00289315|4220435|B3|||Age||years|Mean|10.6|10.6|Standard Deviation|1.2|1.2|||
4393740|NCT00289315|4220436|B2|||Age||years|Mean|10.5|10.5|Standard Deviation|1.2|1.2|||
4393741|NCT00289315|4220437|B1|||Age||years|Mean|10.5|10.5|Standard Deviation|1.2|1.2|||
4393742|NCT00289289|4220456|B4|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4393743|NCT00289289|4220457|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4393744|NCT00289289|4220458|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4393745|NCT00289289|4220459|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4393746|NCT00289289|4220456|B4|United States||Region of Enrollment||participants|Number|382|382.0||||||
4393747|NCT00289289|4220457|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
4393748|NCT00289289|4220458|B2|United States||Region of Enrollment||participants|Number|118|118.0||||||
4393749|NCT00289289|4220459|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
4393750|NCT00289289|4220456|B4||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4393751|NCT00289289|4220457|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4393752|NCT00289289|4220458|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4393753|NCT00289289|4220459|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4393754|NCT00289289|4220456|B4||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4393755|NCT00289289|4220457|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4393756|NCT00289289|4220458|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4393757|NCT00289289|4220459|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4393758|NCT00289289|4220456|B4|||Age||years|Mean|72.0|72.0|Standard Deviation|9.5|9.5|||
4393759|NCT00289289|4220457|B3|||Age||years|Mean|72.4|72.4|Standard Deviation|9.2|9.2|||
4393760|NCT00289289|4220458|B2|||Age||years|Mean|70.6|70.6|Standard Deviation|9.3|9.3|||
4393761|NCT00289289|4220459|B1|||Age||years|Mean|73.0|73.0|Standard Deviation|9.9|9.9|||
4393762|NCT00289289|4220456|B4||>=65 years|Age||Participants|Count of Participants|318|318.0||||||
4393763|NCT00289289|4220457|B3||>=65 years|Age||Participants|Count of Participants|117|117.0||||||
4393764|NCT00289289|4220458|B2||>=65 years|Age||Participants|Count of Participants|94|94.0||||||
4393765|NCT00289289|4220459|B1||>=65 years|Age||Participants|Count of Participants|107|107.0||||||
4393766|NCT00289289|4220456|B4||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4393767|NCT00289289|4220457|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4393768|NCT00289289|4220458|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4393769|NCT00289289|4220459|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4393770|NCT00289289|4220456|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393771|NCT00289289|4220457|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393772|NCT00289289|4220458|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393773|NCT00289289|4220459|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393774|NCT00289276|4220474|B3|China||Region of Enrollment||participants|Number|14.0|14.0||||||
4393775|NCT00289276|4220475|B2|China||Region of Enrollment||participants|Number|14|14.0||||||
4393776|NCT00289276|4220476|B1|China||Region of Enrollment||participants|Number|0|0.0||||||
4393777|NCT00289276|4220474|B3|Canada||Region of Enrollment||participants|Number|11.0|11.0||||||
4393778|NCT00289276|4220475|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4393779|NCT00289276|4220476|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4393780|NCT00289276|4220474|B3|United States||Region of Enrollment||participants|Number|131.0|131.0||||||
4393781|NCT00289276|4220475|B2|United States||Region of Enrollment||participants|Number|90|90.0||||||
4393782|NCT00289276|4220476|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4393783|NCT00289276|4220474|B3||Male|Sex: Female, Male||Participants|Count of Participants|120.0|120.0||||||
4393784|NCT00289276|4220475|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4393785|NCT00289276|4220476|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4393786|NCT00289276|4220474|B3||Female|Sex: Female, Male||Participants|Count of Participants|36.0|36.0||||||
4393787|NCT00289276|4220475|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4393788|NCT00289276|4220476|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4393789|NCT00289276|4220474|B3|||Age||years|Mean|69.4|69.4|Standard Deviation|10.88|10.88|||
4393790|NCT00289276|4220475|B2|||Age||years|Mean|69.6|69.6|Standard Deviation|11.1|11.1|||
4393791|NCT00289276|4220476|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|10.5|10.5|||
4393792|NCT00289276|4220474|B3||>=65 years|Age||Participants|Count of Participants|112.0|112.0||||||
4393793|NCT00289276|4220475|B2||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
4393794|NCT00289276|4220476|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4393795|NCT00289276|4220474|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44.0|44.0||||||
4393796|NCT00289276|4220475|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4393797|NCT00289276|4220476|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4393798|NCT00289276|4220474|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4393799|NCT00289276|4220475|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393800|NCT00289276|4220476|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393801|NCT00289211|4220489|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4393802|NCT00289211|4220490|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4393803|NCT00289211|4220491|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4393804|NCT00289211|4220492|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4393805|NCT00289211|4220489|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4393806|NCT00289211|4220490|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4393807|NCT00289211|4220491|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4393808|NCT00289211|4220492|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4393809|NCT00289211|4220489|B4|||Age||years|Mean|36.8|36.8|Standard Deviation|16.20|16.2|||
4393810|NCT00289211|4220490|B3|||Age||years|Mean|36.3|36.3|Standard Deviation|19.42|19.42|||
4393811|NCT00289211|4220491|B2|||Age||years|Mean|37.0|37.0|Standard Deviation|13.76|13.76|||
4393812|NCT00289211|4220492|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|17.68|17.68|||
4393813|NCT00289198|4220510|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4393814|NCT00289198|4220511|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4393815|NCT00289198|4220512|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4393816|NCT00289198|4220510|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|274|274.0||||||
4393817|NCT00289198|4220511|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|139|139.0||||||
4393818|NCT00289198|4220512|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|135|135.0||||||
4393819|NCT00289198|4220510|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4393820|NCT00289198|4220511|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4393821|NCT00289198|4220512|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4393822|NCT00289198|4220510|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4393823|NCT00289198|4220511|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4393824|NCT00289198|4220512|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4393825|NCT00289198|4220510|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4393826|NCT00289198|4220511|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4393827|NCT00289198|4220512|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4393828|NCT00289198|4220510|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4393829|NCT00289198|4220511|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4393830|NCT00289198|4220512|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4393831|NCT00289198|4220510|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4393832|NCT00289198|4220511|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4393833|NCT00289198|4220512|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4393834|NCT00289198|4220510|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4393835|NCT00289198|4220511|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4393836|NCT00289198|4220512|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4393837|NCT00289198|4220510|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4393838|NCT00289198|4220511|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4393839|NCT00289198|4220512|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4393840|NCT00289198|4220510|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4393841|NCT00289198|4220511|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4393842|NCT00289198|4220512|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4393843|NCT00289198|4220510|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4393844|NCT00289198|4220511|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4393845|NCT00289198|4220512|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4393846|NCT00289198|4220510|B3|||Age||Years|Mean|37.1|37.1|Standard Deviation|16.36|16.36|||
4393847|NCT00289198|4220511|B2|||Age||Years|Mean|37.2|37.2|Standard Deviation|16.20|16.2|||
4393848|NCT00289198|4220512|B1|||Age||Years|Mean|37.1|37.1|Standard Deviation|16.57|16.57|||
4393849|NCT00289185|4220561|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4393850|NCT00289185|4220562|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4393851|NCT00289185|4220563|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4393852|NCT00289185|4220561|B3||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4393853|NCT00289185|4220562|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4393854|NCT00289185|4220563|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4393855|NCT00289185|4220561|B3|||Age||Weeks|Mean|7.85|7.85|Standard Deviation|0.80|0.8|||
4393856|NCT00289185|4220562|B2|||Age||Weeks|Mean|7.82|7.82|Standard Deviation|0.77|0.77|||
4393857|NCT00289185|4220563|B1|||Age||Weeks|Mean|7.87|7.87|Standard Deviation|0.83|0.83|||
4393858|NCT00289133|4220609|B3|United States||Region of Enrollment||participants|Number|926|926.0||||||
4393859|NCT00289133|4220610|B2|United States||Region of Enrollment||participants|Number|477|477.0||||||
4393860|NCT00289133|4220611|B1|United States||Region of Enrollment||participants|Number|449|449.0||||||
4393861|NCT00289133|4220609|B3||Male|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
4393862|NCT00289133|4220610|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4393863|NCT00289133|4220611|B1||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4393864|NCT00289133|4220609|B3||Female|Sex: Female, Male||Participants|Count of Participants|598|598.0||||||
4393865|NCT00289133|4220610|B2||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4393866|NCT00289133|4220611|B1||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4393867|NCT00289133|4220609|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|8.5|8.5|||
4393868|NCT00289133|4220610|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|8.5|8.5|||
4393869|NCT00289133|4220611|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|8.5|8.5|||
4393870|NCT00289120|4220634|B1|Calcium oxalate stone- formers||Study participants||participants|Number|3|3.0||||||
4393871|NCT00289120|4220634|B1|Normal subjects||Study participants||participants|Number|10|10.0||||||
4393872|NCT00289120|4220634|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4393873|NCT00289120|4220634|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4393874|NCT00289120|4220634|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4393875|NCT00289120|4220634|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4393876|NCT00289120|4220634|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4393877|NCT00289107|4220650|B3|United States||Region of Enrollment||participants|Number|149|149.0||||||
4393878|NCT00289107|4220651|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4393879|NCT00289107|4220652|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
4393880|NCT00289107|4220650|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4393881|NCT00289107|4220651|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4393882|NCT00289107|4220652|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4393883|NCT00289107|4220650|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4393884|NCT00289107|4220651|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4393885|NCT00289107|4220652|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4393886|NCT00289107|4220650|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|6.8|6.8|||
4393887|NCT00289107|4220651|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|7.2|7.2|||
4393888|NCT00289107|4220652|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|6.3|6.3|||
4393889|NCT00289094|4220659|B3|United States||Region of Enrollment||participants|Number|99|99.0||||||
4393890|NCT00289094|4220660|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4393891|NCT00289094|4220661|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4393892|NCT00289094|4220659|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4393893|NCT00289094|4220660|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4393894|NCT00289094|4220661|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4393895|NCT00289094|4220659|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4393896|NCT00289094|4220660|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4393897|NCT00289094|4220661|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4393898|NCT00289094|4220659|B3|||Age||years|Mean|65.3|65.3|Standard Deviation|5.9|5.9|||
4393899|NCT00289094|4220660|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|5.1|5.1|||
4393900|NCT00289094|4220661|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|6.2|6.2|||
4393901|NCT00289016|4220668|B1|Stage IVM1c||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH level; M1c: Spread to all other visceral organs, normal LDH level or any distant disease with elevated LDH level.|participants|Number|19|19.0||||||
4393902|NCT00289016|4220668|B1|Stage IVM1b||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH level; M1c: Spread to all other visceral organs, normal LDH level or any distant disease with elevated LDH level.|participants|Number|5|5.0||||||
4393903|NCT00289016|4220668|B1|Stage IVM1a||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH level; M1c: Spread to all other visceral organs, normal LDH level or any distant disease with elevated LDH level.|participants|Number|13|13.0||||||
4393952|NCT00288860|4220720|B3|Iraq/Afghanistan veteran||Iraq or Afghanistan veteran||participants|Number|228|228.0||||||
4393904|NCT00289016|4220668|B1|Stage IIIC||Tumor, Node, Metastasis (TNM) Disease Stage|Stage IIIC: Ulcerated lesion and 1 lymph node with macrometastasis; 2-3 nodes with macrometastasis or ≥ 4 metastatic lymph nodes, matted lymph nodes, or in-transit met(s)/satellite(s); Stage IV: M1a: Spread to skin, subcutaneous tissue, or lymph nodes; normal lactate dehydrogenase (LDH) level; M1b: Spread to lungs; normal LDH level; M1c: Spread to all other visceral organs, normal LDH level or any distant disease with elevated LDH level.|participants|Number|13|13.0||||||
4393905|NCT00289016|4220668|B1|1 (Restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|19|19.0||||||
4393906|NCT00289016|4220668|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|31|31.0||||||
4393907|NCT00289016|4220668|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4393908|NCT00289016|4220668|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4393909|NCT00289016|4220668|B1|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4393910|NCT00289016|4220668|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4393911|NCT00289016|4220668|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4393912|NCT00289016|4220668|B1|||Age||years|Mean|63|63.0|Standard Deviation|15.2|15.2|||
4393913|NCT00288912|4220677|B4|United States||Region of Enrollment||participants|Number|515|515.0||||||
4393914|NCT00288912|4220678|B3|United States||Region of Enrollment||participants|Number|172|172.0||||||
4393915|NCT00288912|4220679|B2|United States||Region of Enrollment||participants|Number|171|171.0||||||
4393916|NCT00288912|4220680|B1|United States||Region of Enrollment||participants|Number|172|172.0||||||
4393917|NCT00288912|4220677|B4|Non-White||Race/Ethnicity, Customized||participants|Number|237|237.0||||||
4393918|NCT00288912|4220678|B3|Non-White||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4393919|NCT00288912|4220679|B2|Non-White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4393920|NCT00288912|4220680|B1|Non-White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4393921|NCT00288912|4220677|B4|White||Race/Ethnicity, Customized||participants|Number|278|278.0||||||
4393922|NCT00288912|4220678|B3|White||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4393923|NCT00288912|4220679|B2|White||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4393924|NCT00288912|4220680|B1|White||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4393925|NCT00288912|4220677|B4||Male|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
4393926|NCT00288912|4220678|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4393927|NCT00288912|4220679|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4393928|NCT00288912|4220680|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4393929|NCT00288912|4220677|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4393930|NCT00288912|4220678|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4393931|NCT00288912|4220679|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4393932|NCT00288912|4220680|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4393933|NCT00288912|4220677|B4|||Age||years|Mean|60.1|60.1|Standard Deviation|10.4|10.4|||
4393934|NCT00288912|4220678|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|10.3|10.3|||
4393935|NCT00288912|4220679|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|10.1|10.1|||
4393936|NCT00288912|4220680|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|10.8|10.8|||
4393937|NCT00288886|4220699|B3|United States||Region of Enrollment||participants|Number|183|183.0||||||
4393938|NCT00288886|4220700|B2|United States||Region of Enrollment||participants|Number|92|92.0||||||
4393939|NCT00288886|4220701|B1|United States||Region of Enrollment||participants|Number|91|91.0||||||
4393940|NCT00288886|4220699|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4393941|NCT00288886|4220700|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4393942|NCT00288886|4220701|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4393943|NCT00288886|4220699|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4393944|NCT00288886|4220700|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4393945|NCT00288886|4220701|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4393946|NCT00288886|4220699|B3|||Age||years|Mean|50.09|50.09|Standard Deviation|8.26|8.26|||
4393947|NCT00288886|4220700|B2|||Age||years|Mean|49.55|49.55|Standard Deviation|8.63|8.63|||
4393948|NCT00288886|4220701|B1|||Age||years|Mean|50.63|50.63|Standard Deviation|7.88|7.88|||
4393949|NCT00288860|4220720|B3|Served prior to current Iraq/Afghanistan conflicts||Iraq or Afghanistan veteran||participants|Number|609|609.0||||||
4393950|NCT00288860|4220721|B2|Served prior to current Iraq/Afghanistan conflicts||Iraq or Afghanistan veteran||participants|Number|311|311.0||||||
4393951|NCT00288860|4220722|B1|Served prior to current Iraq/Afghanistan conflicts||Iraq or Afghanistan veteran||participants|Number|298|298.0||||||
4393953|NCT00288860|4220721|B2|Iraq/Afghanistan veteran||Iraq or Afghanistan veteran||participants|Number|114|114.0||||||
4393954|NCT00288860|4220722|B1|Iraq/Afghanistan veteran||Iraq or Afghanistan veteran||participants|Number|114|114.0||||||
4393955|NCT00288860|4220720|B3|Race/ethnicity missing||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4393956|NCT00288860|4220721|B2|Race/ethnicity missing||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4393957|NCT00288860|4220722|B1|Race/ethnicity missing||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4393958|NCT00288860|4220720|B3|Other||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4393959|NCT00288860|4220721|B2|Other||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4393960|NCT00288860|4220722|B1|Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4393961|NCT00288860|4220720|B3|Latino||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4393962|NCT00288860|4220721|B2|Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4393963|NCT00288860|4220722|B1|Latino||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4393964|NCT00288860|4220720|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4393965|NCT00288860|4220721|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4393966|NCT00288860|4220722|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4393967|NCT00288860|4220720|B3|Native American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4393968|NCT00288860|4220721|B2|Native American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4393969|NCT00288860|4220722|B1|Native American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4393970|NCT00288860|4220720|B3|Asian American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4393971|NCT00288860|4220721|B2|Asian American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4393972|NCT00288860|4220722|B1|Asian American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4393973|NCT00288860|4220720|B3|African American||Race/Ethnicity, Customized||participants|Number|180|180.0||||||
4393974|NCT00288860|4220721|B2|African American||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4393975|NCT00288860|4220722|B1|African American||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4393976|NCT00288860|4220720|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|519|519.0||||||
4393977|NCT00288860|4220721|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|256|256.0||||||
4393978|NCT00288860|4220722|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|263|263.0||||||
4393979|NCT00288860|4220720|B3||Male|Sex: Female, Male||Participants|Count of Participants|725|725.0||||||
4393980|NCT00288860|4220721|B2||Male|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
4393981|NCT00288860|4220722|B1||Male|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
4393982|NCT00288860|4220720|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4393983|NCT00288860|4220721|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4393984|NCT00288860|4220722|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4393985|NCT00288860|4220720|B3|||Age||Years|Mean|50.0|50.0|Standard Deviation|0.74|0.74|||
4393986|NCT00288860|4220721|B2|||Age||Years|Mean|49.9|49.9|Standard Deviation|0.86|0.86|||
4393987|NCT00288860|4220722|B1|||Age||Years|Mean|50.2|50.2|Standard Deviation|0.62|0.62|||
4393988|NCT00288704|4220733|B4|United States||Region of Enrollment||participants|Number|104|104.0||||||
4393989|NCT00288704|4220734|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4393990|NCT00288704|4220735|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4393991|NCT00288704|4220736|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4393992|NCT00288704|4220733|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393993|NCT00288704|4220734|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393994|NCT00288704|4220735|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393995|NCT00288704|4220736|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393996|NCT00288704|4220733|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393997|NCT00288704|4220734|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393998|NCT00288704|4220735|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4393999|NCT00288704|4220736|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394000|NCT00288704|4220733|B4||White|Race (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4394001|NCT00288704|4220734|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4394002|NCT00288704|4220735|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4394003|NCT00288704|4220736|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4394004|NCT00288704|4220733|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394005|NCT00288704|4220734|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394006|NCT00288704|4220735|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394007|NCT00288704|4220736|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394008|NCT00288704|4220733|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394009|NCT00288704|4220734|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394010|NCT00288704|4220735|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394118|NCT00288574|4220833|B1|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4394011|NCT00288704|4220736|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394012|NCT00288704|4220733|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394013|NCT00288704|4220734|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394014|NCT00288704|4220735|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394015|NCT00288704|4220736|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394016|NCT00288704|4220733|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394017|NCT00288704|4220734|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394018|NCT00288704|4220735|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394019|NCT00288704|4220736|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394020|NCT00288704|4220733|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)|Everyone in Part A and Part B of the study was non hispanic and white.|Participants|Count of Participants|1|1.0||||||
4394021|NCT00288704|4220734|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Everyone in Part A and Part B of the study was non hispanic and white.|Participants|Count of Participants|1|1.0||||||
4394022|NCT00288704|4220735|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Everyone in Part A and Part B of the study was non hispanic and white.|Participants|Count of Participants|0|0.0||||||
4394023|NCT00288704|4220736|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Everyone in Part A and Part B of the study was non hispanic and white.|Participants|Count of Participants|0|0.0||||||
4394024|NCT00288704|4220733|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Everyone in Part A and Part B of the study was non hispanic and white.|Participants|Count of Participants|103|103.0||||||
4394025|NCT00288704|4220734|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Everyone in Part A and Part B of the study was non hispanic and white.|Participants|Count of Participants|56|56.0||||||
4394026|NCT00288704|4220735|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Everyone in Part A and Part B of the study was non hispanic and white.|Participants|Count of Participants|23|23.0||||||
4394027|NCT00288704|4220736|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Everyone in Part A and Part B of the study was non hispanic and white.|Participants|Count of Participants|24|24.0||||||
4394028|NCT00288704|4220733|B4||Hispanic or Latino|Ethnicity (NIH/OMB)|Everyone in Part A and Part B of the study was non hispanic and white.|Participants|Count of Participants|0|0.0||||||
4394029|NCT00288704|4220734|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Everyone in Part A and Part B of the study was non hispanic and white.|Participants|Count of Participants|0|0.0||||||
4394030|NCT00288704|4220735|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Everyone in Part A and Part B of the study was non hispanic and white.|Participants|Count of Participants|0|0.0||||||
4394031|NCT00288704|4220736|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Everyone in Part A and Part B of the study was non hispanic and white.|Participants|Count of Participants|0|0.0||||||
4394032|NCT00288704|4220733|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4394033|NCT00288704|4220734|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4394034|NCT00288704|4220735|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4394035|NCT00288704|4220736|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4394036|NCT00288704|4220733|B4||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4394037|NCT00288704|4220734|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4394038|NCT00288704|4220735|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4394039|NCT00288704|4220736|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4394040|NCT00288704|4220733|B4|||Age||years|Mean|43.6|43.6|Standard Deviation|17.8|17.8|||
4394041|NCT00288704|4220734|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|17.2|17.2|||
4394042|NCT00288704|4220735|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|16|16.0|||
4394043|NCT00288704|4220736|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|14.7|14.7|||
4394044|NCT00288704|4220733|B4||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4394045|NCT00288704|4220734|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4394046|NCT00288704|4220735|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4394047|NCT00288704|4220736|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4394048|NCT00288704|4220733|B4||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4394049|NCT00288704|4220734|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4394050|NCT00288704|4220735|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4394051|NCT00288704|4220736|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4394052|NCT00288704|4220733|B4||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4394053|NCT00288704|4220734|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4394054|NCT00288704|4220735|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394055|NCT00288704|4220736|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394056|NCT00288639|4220765|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4394057|NCT00288639|4220765|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4394058|NCT00288639|4220765|B1|>=65 years||Age, Customized||Participants|Number|4|4.0||||||
4394059|NCT00288639|4220765|B1|45 to 64 years||Age, Customized||Participants|Number|25|25.0||||||
4394060|NCT00288639|4220765|B1|18 to 44 years||Age, Customized||Participants|Number|69|69.0||||||
4394061|NCT00288626|4220782|B1|||Normalized Brain Volume at Screening|Magnetic resonance imaging (MRI) scan techniques measured ventricular volumes and grey and white matter brain volumes|liters|Mean|1.6|1.6|Standard Deviation|0.1|0.1|||
4394062|NCT00288626|4220782|B1|||T2 Lesion Volume at Baseline|A T2-weighted magnetic resonance imaging (MRI) scan assessed the volume of T2 lesions in the brain.|milliliters|Mean|11.1|11.1|Standard Deviation|13.7|13.7|||
4394063|NCT00288626|4220782|B1|||T1 Lesion Volume at Baseline|A T1-weighted magnetic resonance imaging (MRI) scan assessed the volume of T1 lesions.|milliliters|Mean|1.2|1.2|Standard Deviation|2.7|2.7|||
4394064|NCT00288626|4220782|B1|||Number of Gadolinium-Enhanced Lesions at Baseline|Multiple sclerosis disease-related lesions were assessed by gadolinium-enhanced magnetic resonance imaging (MRI). More lesions indicate more severe disease.|Lesions per scan|Mean|2.3|2.3|Standard Deviation|5.8|5.8|||
4394065|NCT00288626|4220782|B1|||Expanded Disability Status Scale (EDSS) at Baseline|Kurtzke’s Expanded Disability Status Scale (EDSS) assesses disability in Multiple Sclerosis patients. Eight functional systems are evaluated: visual, brain stem, pyramidal, cerebellar, sensory, bowel and bladder, cerebral, and ambulation. The overall score ranges from 0 (normal neurological exam) to 10 (death due to MS).|units on a scale|Mean|4.4|4.4|Standard Deviation|.64|0.64|||
4394066|NCT00288626|4220782|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4394067|NCT00288626|4220782|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394068|NCT00288626|4220782|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4394069|NCT00288626|4220782|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4394070|NCT00288626|4220782|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394071|NCT00288626|4220782|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394072|NCT00288626|4220782|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394073|NCT00288626|4220782|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394074|NCT00288626|4220782|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4394075|NCT00288626|4220782|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4394076|NCT00288626|4220782|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394077|NCT00288626|4220782|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4394078|NCT00288626|4220782|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4394079|NCT00288626|4220782|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|7.7|7.7|||
4394080|NCT00288600|4220805|B3|||TSB at birth||mg/dl|Mean|2.64|2.64|Standard Deviation|1.36|1.36|||
4394081|NCT00288600|4220806|B2|||TSB at birth||mg/dl|Mean|2.87|2.87|Standard Deviation|1.49|1.49|||
4394082|NCT00288600|4220807|B1|||TSB at birth||mg/dl|Mean|2.42|2.42|Standard Deviation|1.29|1.29|||
4394083|NCT00288600|4220805|B3|||maternal age||years|Mean|30.2|30.2|Standard Deviation|6.2|6.2|||
4394084|NCT00288600|4220806|B2|||maternal age||years|Mean|30.0|30.0|Standard Deviation|6.2|6.2|||
4394085|NCT00288600|4220807|B1|||maternal age||years|Mean|30.6|30.6|Standard Deviation|6.0|6.0|||
4394086|NCT00288600|4220805|B3|Brazil||Region of Enrollment||participants|Number|92|92.0||||||
4394087|NCT00288600|4220806|B2|Brazil||Region of Enrollment||participants|Number|46|46.0||||||
4394088|NCT00288600|4220807|B1|Brazil||Region of Enrollment||participants|Number|46|46.0||||||
4394089|NCT00288600|4220805|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4394090|NCT00288600|4220806|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4394091|NCT00288600|4220807|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4394092|NCT00288600|4220805|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4394093|NCT00288600|4220806|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4394094|NCT00288600|4220807|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4394095|NCT00288600|4220805|B3|||Age||hours of life|Median|3|3.0|Full Range|||1.0|4.5|
4394096|NCT00288600|4220806|B2|||Age||hours of life|Median|3|3.0|Full Range|||1.0|4.2|
4394097|NCT00288600|4220807|B1|||Age||hours of life|Median|3|3.0|Full Range|||1.0|4.5|
4394098|NCT00288587|4220814|B3|GFR <50 mL/min/1.73m2||Glomerular Filtration Rate (GFR)||Participants|Number|17|17.0||||||
4394099|NCT00288587|4220815|B2|GFR <50 mL/min/1.73m2||Glomerular Filtration Rate (GFR)||Participants|Number|7|7.0||||||
4394100|NCT00288587|4220816|B1|GFR <50 mL/min/1.73m2||Glomerular Filtration Rate (GFR)||Participants|Number|10|10.0||||||
4394101|NCT00288587|4220814|B3|GFR >50 mL/min/1.73m2||Glomerular Filtration Rate (GFR)||Participants|Number|19|19.0||||||
4394102|NCT00288587|4220815|B2|GFR >50 mL/min/1.73m2||Glomerular Filtration Rate (GFR)||Participants|Number|10|10.0||||||
4394103|NCT00288587|4220816|B1|GFR >50 mL/min/1.73m2||Glomerular Filtration Rate (GFR)||Participants|Number|9|9.0||||||
4394104|NCT00288587|4220814|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4394105|NCT00288587|4220815|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4394106|NCT00288587|4220816|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4394107|NCT00288587|4220814|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4394108|NCT00288587|4220815|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4394109|NCT00288587|4220816|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4394110|NCT00288587|4220814|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4394111|NCT00288587|4220815|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4394112|NCT00288587|4220816|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4394113|NCT00288587|4220814|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|12|12.0|||
4394114|NCT00288587|4220815|B2|||Age||years|Mean|59|59.0|Standard Deviation|15.5|15.5|||
4394115|NCT00288587|4220816|B1|||Age||years|Mean|60|60.0|Standard Deviation|9.1|9.1|||
4394116|NCT00288574|4220831|B3|Canada||Region of Enrollment||participants|Number|48|48.0||||||
4394117|NCT00288574|4220832|B2|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4394119|NCT00288574|4220831|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4394120|NCT00288574|4220832|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4394121|NCT00288574|4220833|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4394122|NCT00288574|4220831|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4394123|NCT00288574|4220832|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4394124|NCT00288574|4220833|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4394125|NCT00288574|4220831|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4394126|NCT00288574|4220832|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4394127|NCT00288574|4220833|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4394128|NCT00288574|4220831|B3|||Age||years|Mean|23|23.0|Standard Deviation|4.6|4.6|||
4394129|NCT00288574|4220832|B2|||Age||years|Mean|24.2|24.2|Standard Deviation|4.52|4.52|||
4394130|NCT00288574|4220833|B1|||Age||years|Mean|22.4|22.4|Standard Deviation|4.46|4.46|||
4394131|NCT00288574|4220831|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4394132|NCT00288574|4220832|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4394133|NCT00288574|4220833|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4394134|NCT00288574|4220831|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4394135|NCT00288574|4220832|B2||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4394136|NCT00288574|4220833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4394137|NCT00288574|4220831|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394138|NCT00288574|4220832|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394139|NCT00288574|4220833|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394140|NCT00288509|4220860|B1|Russian Federation||Region of Enrollment||participants|Number|27|27.0||||||
4394141|NCT00288509|4220860|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4394142|NCT00288509|4220860|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4394143|NCT00288509|4220860|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4394144|NCT00288509|4220860|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|13.0|13.0|||
4394145|NCT00288509|4220860|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4394146|NCT00288509|4220860|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4394147|NCT00288509|4220860|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394148|NCT00288080|4220867|B3||Male|Sex: Female, Male||Participants|Count of Participants|563|563.0||||||
4394149|NCT00288080|4220868|B2||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4394150|NCT00288080|4220869|B1||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4394151|NCT00288080|4220867|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4394152|NCT00288080|4220868|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4394153|NCT00288080|4220869|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4394154|NCT00288080|4220867|B3|||Age||years|Median|66|66.0|Full Range|||46.0|83.0|
4394155|NCT00288080|4220868|B2|||Age||years|Median|66|66.0|Full Range|||46.0|83.0|
4394156|NCT00288080|4220869|B1|||Age||years|Median|66|66.0|Full Range|||47.0|83.0|
4394157|NCT00288067|4220886|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4394158|NCT00288067|4220886|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4394159|NCT00288067|4220886|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4394160|NCT00288067|4220886|B1|||Age||years|Mean|62|62.0|Standard Deviation|10|10.0|||
4394161|NCT00288067|4220886|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4394162|NCT00288067|4220886|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4394163|NCT00288067|4220886|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394164|NCT00288054|4220892|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394165|NCT00288054|4220892|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394166|NCT00288054|4220892|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4394167|NCT00288054|4220892|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4394168|NCT00288054|4220892|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394169|NCT00288054|4220892|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4394170|NCT00288054|4220892|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394171|NCT00288054|4220892|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4394172|NCT00288054|4220892|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4394173|NCT00288054|4220892|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394174|NCT00288054|4220892|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4394175|NCT00288054|4220892|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4394176|NCT00288054|4220892|B1|||Age||years|Median|72|72.0|Full Range|||51.0|84.0|
4394177|NCT00288015|4220900|B1||epitheliod hemangioendothelioma|Type of Sarcoma||Participants|Count of Participants|8|8.0||||||
4394178|NCT00288015|4220900|B1||angiosarcoma|Type of Sarcoma||Participants|Count of Participants|24|24.0||||||
4394179|NCT00288015|4220900|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4394180|NCT00288015|4220900|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394181|NCT00288015|4220900|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394182|NCT00288015|4220900|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4394183|NCT00288015|4220900|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4394184|NCT00288015|4220900|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394185|NCT00288015|4220900|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394186|NCT00288015|4220900|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394187|NCT00288015|4220900|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4394188|NCT00288015|4220900|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4394189|NCT00288015|4220900|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394190|NCT00288015|4220900|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4394191|NCT00288015|4220900|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4394192|NCT00288015|4220900|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4394193|NCT00288015|4220900|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4394194|NCT00288015|4220900|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394195|NCT00287989|4220909|B4|United States||Region of Enrollment||Participants|Count of Participants|86|86.0||||||
4394196|NCT00287989|4220910|B3|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4394197|NCT00287989|4220911|B2|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4394198|NCT00287989|4220912|B1|United States||Region of Enrollment||Participants|Count of Participants|28|28.0||||||
4394199|NCT00287989|4220909|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4394200|NCT00287989|4220910|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4394201|NCT00287989|4220911|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4394202|NCT00287989|4220912|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4394203|NCT00287989|4220909|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4394204|NCT00287989|4220910|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4394205|NCT00287989|4220911|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4394206|NCT00287989|4220912|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4394207|NCT00287989|4220909|B4|||Age||years|Median|64|64.0|Full Range|||42.0|81.0|
4394208|NCT00287989|4220910|B3|||Age||years|Median|62|62.0|Full Range|||43.0|81.0|
4394209|NCT00287989|4220911|B2|||Age||years|Median|62|62.0|Full Range|||42.0|78.0|
4394210|NCT00287989|4220912|B1|||Age||years|Median|68|68.0|Full Range|||51.0|81.0|
4394211|NCT00287989|4220909|B4||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4394212|NCT00287989|4220910|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4394213|NCT00287989|4220911|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4394214|NCT00287989|4220912|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4394215|NCT00287989|4220909|B4||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4394216|NCT00287989|4220910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4394217|NCT00287989|4220911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4394218|NCT00287989|4220912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4394219|NCT00287989|4220909|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394220|NCT00287989|4220910|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394221|NCT00287989|4220911|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394222|NCT00287989|4220912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394223|NCT00287872|4220925|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4394224|NCT00287872|4220925|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4394225|NCT00287872|4220925|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4394226|NCT00287872|4220925|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4394227|NCT00287872|4220925|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4394228|NCT00287872|4220925|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394229|NCT00287872|4220925|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|9.9|9.9|||
4394230|NCT00287729|4220933|B3|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4394231|NCT00287729|4220934|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4394232|NCT00287729|4220935|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4394233|NCT00287729|4220933|B3|Europe||Region of Enrollment||participants|Number|45|45.0||||||
4394234|NCT00287729|4220934|B2|Europe||Region of Enrollment||participants|Number|22|22.0||||||
4394235|NCT00287729|4220935|B1|Europe||Region of Enrollment||participants|Number|23|23.0||||||
4394236|NCT00287729|4220933|B3|United States||Region of Enrollment||participants|Number|298|298.0||||||
4394237|NCT00287729|4220934|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
4394238|NCT00287729|4220935|B1|United States||Region of Enrollment||participants|Number|148|148.0||||||
4394239|NCT00287729|4220933|B3||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4394240|NCT00287729|4220934|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4394241|NCT00287729|4220935|B1||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4394242|NCT00287729|4220933|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4394243|NCT00287729|4220934|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4394244|NCT00287729|4220935|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4394245|NCT00287729|4220933|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|7.84|7.84|||
4394246|NCT00287729|4220934|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|7.80|7.8|||
4394247|NCT00287729|4220935|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|7.90|7.9|||
4394248|NCT00287729|4220933|B3||>=65 years|Age||Participants|Count of Participants|213|213.0||||||
4394249|NCT00287729|4220934|B2||>=65 years|Age||Participants|Count of Participants|112|112.0||||||
4394250|NCT00287729|4220935|B1||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
4394251|NCT00287729|4220933|B3||Between 18 and 65 years|Age||Participants|Count of Participants|131|131.0||||||
4394252|NCT00287729|4220934|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4394253|NCT00287729|4220935|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4394254|NCT00287729|4220933|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394255|NCT00287729|4220934|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394256|NCT00287729|4220935|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394257|NCT00287716|4220956|B4|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4394258|NCT00287716|4220957|B3|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4394259|NCT00287716|4220958|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4394260|NCT00287716|4220959|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4394261|NCT00287716|4220956|B4|Canada||Region of Enrollment||participants|Number|47|47.0||||||
4394262|NCT00287716|4220957|B3|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4394263|NCT00287716|4220958|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4394264|NCT00287716|4220959|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4394265|NCT00287716|4220956|B4|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4394266|NCT00287716|4220957|B3|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4394267|NCT00287716|4220958|B2|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4394268|NCT00287716|4220959|B1|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4394269|NCT00287716|4220956|B4|Europe||Region of Enrollment||participants|Number|90|90.0||||||
4394270|NCT00287716|4220957|B3|Europe||Region of Enrollment||participants|Number|38|38.0||||||
4394271|NCT00287716|4220958|B2|Europe||Region of Enrollment||participants|Number|18|18.0||||||
4394272|NCT00287716|4220959|B1|Europe||Region of Enrollment||participants|Number|34|34.0||||||
4394273|NCT00287716|4220956|B4|United States||Region of Enrollment||participants|Number|286|286.0||||||
4394274|NCT00287716|4220957|B3|United States||Region of Enrollment||participants|Number|114|114.0||||||
4394275|NCT00287716|4220958|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4394276|NCT00287716|4220959|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4394277|NCT00287716|4220956|B4||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4394278|NCT00287716|4220957|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4394279|NCT00287716|4220958|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4394280|NCT00287716|4220959|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4394281|NCT00287716|4220956|B4||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4394282|NCT00287716|4220957|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4394283|NCT00287716|4220958|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4394284|NCT00287716|4220959|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4394285|NCT00287716|4220956|B4|||Age||years|Mean|66.4|66.4|Standard Deviation|7.83|7.83|||
4394286|NCT00287716|4220957|B3|||Age||years|Mean|66.3|66.3|Standard Deviation|7.53|7.53|||
4394287|NCT00287716|4220958|B2|||Age||years|Mean|68|68.0|Standard Deviation|7.63|7.63|||
4394288|NCT00287716|4220959|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|8.15|8.15|||
4394289|NCT00287716|4220956|B4||>=65 years|Age||Participants|Count of Participants|259|259.0||||||
4394290|NCT00287716|4220957|B3||>=65 years|Age||Participants|Count of Participants|101|101.0||||||
4394291|NCT00287716|4220958|B2||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4394292|NCT00287716|4220959|B1||>=65 years|Age||Participants|Count of Participants|99|99.0||||||
4394293|NCT00287716|4220956|B4||Between 18 and 65 years|Age||Participants|Count of Participants|176|176.0||||||
4394294|NCT00287716|4220957|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4394295|NCT00287716|4220958|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4394296|NCT00287716|4220959|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4394297|NCT00287716|4220956|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394298|NCT00287716|4220957|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394299|NCT00287716|4220958|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394300|NCT00287716|4220959|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394301|NCT00287586|4220990|B3||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4394302|NCT00287586|4220991|B2||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4394303|NCT00287586|4220992|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4394304|NCT00287586|4220990|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4394305|NCT00287586|4220991|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4394306|NCT00287586|4220992|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4394307|NCT00287586|4220990|B3|||Age||years|Mean|67.6|67.6|Standard Deviation|5.2|5.2|||
4394308|NCT00287586|4220991|B2|||Age||years|Mean|68.3|68.3|Standard Deviation|5.3|5.3|||
4394309|NCT00287586|4220992|B1|||Age||years|Mean|66.9|66.9|Standard Deviation|5.0|5.0|||
4394310|NCT00287365|4221029|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4394311|NCT00287365|4221029|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4394312|NCT00287365|4221029|B1|||Age||years|Mean|25|25.0|Full Range|||18.0|50.0|
4394313|NCT00287339|4221038|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4394314|NCT00287339|4221039|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4394315|NCT00287339|4221040|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4394316|NCT00287339|4221038|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4394317|NCT00287339|4221039|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4394318|NCT00287339|4221040|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4394319|NCT00287339|4221038|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4394320|NCT00287339|4221039|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4394321|NCT00287339|4221040|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4394322|NCT00287339|4221038|B3|||Age||years|Mean|50|50.0|Standard Deviation|11.7|11.7|||
4394323|NCT00287339|4221039|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|11.6|11.6|||
4394324|NCT00287339|4221040|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|12|12.0|||
4394325|NCT00287339|4221038|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4394326|NCT00287339|4221039|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4394327|NCT00287339|4221040|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4394328|NCT00287339|4221038|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4394329|NCT00287339|4221039|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4394330|NCT00287339|4221040|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4394331|NCT00287339|4221038|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394332|NCT00287339|4221039|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394333|NCT00287339|4221040|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394334|NCT00287222|4221047|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4394335|NCT00287222|4221047|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4394336|NCT00287222|4221047|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4394337|NCT00287222|4221047|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4394338|NCT00287222|4221047|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4394339|NCT00287222|4221047|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394340|NCT00287118|4221051|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4394341|NCT00287118|4221051|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4394342|NCT00287118|4221051|B1|||Age||years|Mean|46|46.0|Standard Deviation|12.8|12.8|||
4394343|NCT00287079|4221055|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4394344|NCT00287079|4221056|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4394345|NCT00287079|4221057|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4394346|NCT00287079|4221055|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4394347|NCT00287079|4221056|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4394348|NCT00287079|4221057|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4394349|NCT00287079|4221055|B3|||Age||years|Mean|35.80|35.8|Standard Deviation|11.50|11.5|||
4394350|NCT00287079|4221056|B2|||Age||years|Mean|35.30|35.3|Standard Deviation|13.32|13.32|||
4394351|NCT00287079|4221057|B1|||Age||years|Mean|36.30|36.3|Standard Deviation|9.68|9.68|||
4394352|NCT00287053|4221068|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4394353|NCT00287053|4221069|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4394354|NCT00287053|4221070|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4394355|NCT00287053|4221068|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4394356|NCT00287053|4221069|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4394357|NCT00287053|4221070|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4394358|NCT00287053|4221068|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4394359|NCT00287053|4221069|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4394360|NCT00287053|4221070|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4394361|NCT00287053|4221068|B3|||Age||years|Mean|30.3|30.3|Standard Deviation|9.5|9.5|||
4394362|NCT00287053|4221069|B2|||Age||years|Mean|32|32.0|Standard Deviation|10.2|10.2|||
4394363|NCT00287053|4221070|B1|||Age||years|Mean|28.2|28.2|Standard Deviation|8.6|8.6|||
4394364|NCT00287053|4221068|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4394365|NCT00287053|4221069|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4394366|NCT00287053|4221070|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4394367|NCT00287053|4221068|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4394368|NCT00287053|4221069|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4394369|NCT00287053|4221070|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4394370|NCT00287053|4221068|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394371|NCT00287053|4221069|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394372|NCT00287053|4221070|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394373|NCT00286949|4221077|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4394374|NCT00286949|4221077|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4394375|NCT00286949|4221077|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4394376|NCT00286949|4221077|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|7.2|7.2|||
4394377|NCT00286949|4221077|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4394378|NCT00286949|4221077|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4394379|NCT00286949|4221077|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394380|NCT00286754|4221083|B4|Precontemplation, Contemplation or Preparation||Medication Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.|participants|Number|33|33.0||||||
4394381|NCT00286754|4221084|B3|Precontemplation, Contemplation or Preparation||Medication Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.|participants|Number|14|14.0||||||
4394382|NCT00286754|4221085|B2|Precontemplation, Contemplation or Preparation||Medication Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.|participants|Number|7|7.0||||||
4394383|NCT00286754|4221086|B1|Precontemplation, Contemplation or Preparation||Medication Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.|participants|Number|12|12.0||||||
4394384|NCT00286754|4221083|B4|Action or Maintenance||Medication Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.|participants|Number|500|500.0||||||
4394385|NCT00286754|4221084|B3|Action or Maintenance||Medication Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.|participants|Number|166|166.0||||||
4394386|NCT00286754|4221085|B2|Action or Maintenance||Medication Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.|participants|Number|170|170.0||||||
4394387|NCT00286754|4221086|B1|Action or Maintenance||Medication Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.|participants|Number|164|164.0||||||
4394388|NCT00286754|4221083|B4|Precontemplation, Contemplation, or Preparation||Exercise Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time. We used the lower threshold for exercise adherence19, 20 due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.|participants|Number|190|190.0||||||
4394389|NCT00286754|4221084|B3|Precontemplation, Contemplation, or Preparation||Exercise Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time. We used the lower threshold for exercise adherence19, 20 due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.|participants|Number|72|72.0||||||
4394401|NCT00286754|4221084|B3|Action or Maintenance||Diet stage of change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.|participants|Number|70|70.0||||||
4394390|NCT00286754|4221085|B2|Precontemplation, Contemplation, or Preparation||Exercise Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time. We used the lower threshold for exercise adherence19, 20 due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.|participants|Number|67|67.0||||||
4394391|NCT00286754|4221086|B1|Precontemplation, Contemplation, or Preparation||Exercise Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time. We used the lower threshold for exercise adherence19, 20 due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.|participants|Number|51|51.0||||||
4394392|NCT00286754|4221083|B4|Action or Maintenance||Exercise Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time. We used the lower threshold for exercise adherence19, 20 due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.|participants|Number|343|343.0||||||
4394393|NCT00286754|4221084|B3|Action or Maintenance||Exercise Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time. We used the lower threshold for exercise adherence19, 20 due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.|participants|Number|108|108.0||||||
4394394|NCT00286754|4221085|B2|Action or Maintenance||Exercise Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time. We used the lower threshold for exercise adherence19, 20 due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.|participants|Number|110|110.0||||||
4394395|NCT00286754|4221086|B1|Action or Maintenance||Exercise Stage of Change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time. We used the lower threshold for exercise adherence19, 20 due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.|participants|Number|125|125.0||||||
4394396|NCT00286754|4221083|B4|Precontemplation, Contemplation or Preparation||Diet stage of change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.|participants|Number|327|327.0||||||
4394397|NCT00286754|4221084|B3|Precontemplation, Contemplation or Preparation||Diet stage of change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.|participants|Number|110|110.0||||||
4394398|NCT00286754|4221085|B2|Precontemplation, Contemplation or Preparation||Diet stage of change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.|participants|Number|110|110.0||||||
4394399|NCT00286754|4221086|B1|Precontemplation, Contemplation or Preparation||Diet stage of change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.|participants|Number|107|107.0||||||
4394400|NCT00286754|4221083|B4|Action or Maintenance||Diet stage of change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.|participants|Number|206|206.0||||||
4394440|NCT00286754|4221083|B4|History of revascularization||History of revascularization|self-reported|participants|Number|86|86.0||||||
4394441|NCT00286754|4221084|B3|History of revascularization||History of revascularization|self-reported|participants|Number|31|31.0||||||
4394442|NCT00286754|4221085|B2|History of revascularization||History of revascularization|self-reported|participants|Number|28|28.0||||||
4394402|NCT00286754|4221085|B2|Action or Maintenance||Diet stage of change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.|participants|Number|67|67.0||||||
4394403|NCT00286754|4221086|B1|Action or Maintenance||Diet stage of change|The stages of change were: precontemplation, or no plans to adhere in <6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for <6 months; and maintenance, or adherence for ≥ 6 months. Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.|participants|Number|69|69.0||||||
4394404|NCT00286754|4221083|B4|||Number of antihypertensive medications||medications|Mean|2.7|2.7|Standard Deviation|1.4|1.4|||
4394405|NCT00286754|4221084|B3|||Number of antihypertensive medications||medications|Mean|2.7|2.7|Standard Deviation|1.3|1.3|||
4394406|NCT00286754|4221085|B2|||Number of antihypertensive medications||medications|Mean|2.8|2.8|Standard Deviation|1.3|1.3|||
4394407|NCT00286754|4221086|B1|||Number of antihypertensive medications||medications|Mean|2.7|2.7|Standard Deviation|1.5|1.5|||
4394408|NCT00286754|4221083|B4|||Medication adherence by Morisky scale|Morisky medication-taking scale is a 4-item questionnaire scored from 0-4, with 4 being most adherent and less than 4 being considered nonadherent|units on a scale|Mean|3.3|3.3|Standard Deviation|0.88|0.88|||
4394409|NCT00286754|4221084|B3|||Medication adherence by Morisky scale|Morisky medication-taking scale is a 4-item questionnaire scored from 0-4, with 4 being most adherent and less than 4 being considered nonadherent|units on a scale|Mean|3.3|3.3|Standard Deviation|0.94|0.94|||
4394410|NCT00286754|4221085|B2|||Medication adherence by Morisky scale|Morisky medication-taking scale is a 4-item questionnaire scored from 0-4, with 4 being most adherent and less than 4 being considered nonadherent|units on a scale|Mean|3.2|3.2|Standard Deviation|0.67|0.67|||
4394411|NCT00286754|4221086|B1|||Medication adherence by Morisky scale|Morisky medication-taking scale is a 4-item questionnaire scored from 0-4, with 4 being most adherent and less than 4 being considered nonadherent|units on a scale|Mean|3.4|3.4|Standard Deviation|0.93|0.93|||
4394412|NCT00286754|4221083|B4|||Aerobic exercise||hours per week|Mean|4.9|4.9|Standard Deviation|6.7|6.7|||
4394413|NCT00286754|4221084|B3|||Aerobic exercise||hours per week|Mean|5.0|5.0|Standard Deviation|6.7|6.7|||
4394414|NCT00286754|4221085|B2|||Aerobic exercise||hours per week|Mean|4.5|4.5|Standard Deviation|5.9|5.9|||
4394415|NCT00286754|4221086|B1|||Aerobic exercise||hours per week|Mean|5.3|5.3|Standard Deviation|8.1|8.1|||
4394416|NCT00286754|4221083|B4|||Diastolic blood pressure||mm Hg|Mean|75.5|75.5|Standard Deviation|11.6|11.6|||
4394417|NCT00286754|4221084|B3|||Diastolic blood pressure||mm Hg|Mean|75.0|75.0|Standard Deviation|11.1|11.1|||
4394418|NCT00286754|4221085|B2|||Diastolic blood pressure||mm Hg|Mean|76.1|76.1|Standard Deviation|11.6|11.6|||
4394419|NCT00286754|4221086|B1|||Diastolic blood pressure||mm Hg|Mean|75.5|75.5|Standard Deviation|9.3|9.3|||
4394420|NCT00286754|4221083|B4|||Systolic Blood Pressure, mm Mg||mm Hg|Mean|136.7|136.7|Standard Deviation|15.5|15.5|||
4394421|NCT00286754|4221084|B3|||Systolic Blood Pressure, mm Mg||mm Hg|Mean|137.0|137.0|Standard Deviation|12.9|12.9|||
4394422|NCT00286754|4221085|B2|||Systolic Blood Pressure, mm Mg||mm Hg|Mean|137.2|137.2|Standard Deviation|17.7|17.7|||
4394423|NCT00286754|4221086|B1|||Systolic Blood Pressure, mm Mg||mm Hg|Mean|136.0|136.0|Standard Deviation|11.8|11.8|||
4394424|NCT00286754|4221083|B4|||Estimated glomerular filtration rate (EGFR)||mL/min/1.73m^2|Mean|81.3|81.3|Standard Deviation|35.8|35.8|||
4394425|NCT00286754|4221084|B3|||Estimated glomerular filtration rate (EGFR)||mL/min/1.73m^2|Mean|80.6|80.6|Standard Deviation|28.4|28.4|||
4394426|NCT00286754|4221085|B2|||Estimated glomerular filtration rate (EGFR)||mL/min/1.73m^2|Mean|83.2|83.2|Standard Deviation|46.3|46.3|||
4394427|NCT00286754|4221086|B1|||Estimated glomerular filtration rate (EGFR)||mL/min/1.73m^2|Mean|79.9|79.9|Standard Deviation|25.5|25.5|||
4394428|NCT00286754|4221083|B4|No hyperlipidemia||Hyperlipidemia|Hyperlipidemia was defined as LDL cholesterol of greater than or equal to 100 mg/dL from laboratory results|participants|Number|404|404.0||||||
4394429|NCT00286754|4221084|B3|No hyperlipidemia||Hyperlipidemia|Hyperlipidemia was defined as LDL cholesterol of greater than or equal to 100 mg/dL from laboratory results|participants|Number|128|128.0||||||
4394430|NCT00286754|4221085|B2|No hyperlipidemia||Hyperlipidemia|Hyperlipidemia was defined as LDL cholesterol of greater than or equal to 100 mg/dL from laboratory results|participants|Number|139|139.0||||||
4394431|NCT00286754|4221086|B1|No hyperlipidemia||Hyperlipidemia|Hyperlipidemia was defined as LDL cholesterol of greater than or equal to 100 mg/dL from laboratory results|participants|Number|137|137.0||||||
4394432|NCT00286754|4221083|B4|Hyperlipidemia||Hyperlipidemia|Hyperlipidemia was defined as LDL cholesterol of greater than or equal to 100 mg/dL from laboratory results|participants|Number|129|129.0||||||
4394433|NCT00286754|4221084|B3|Hyperlipidemia||Hyperlipidemia|Hyperlipidemia was defined as LDL cholesterol of greater than or equal to 100 mg/dL from laboratory results|participants|Number|52|52.0||||||
4394434|NCT00286754|4221085|B2|Hyperlipidemia||Hyperlipidemia|Hyperlipidemia was defined as LDL cholesterol of greater than or equal to 100 mg/dL from laboratory results|participants|Number|38|38.0||||||
4394435|NCT00286754|4221086|B1|Hyperlipidemia||Hyperlipidemia|Hyperlipidemia was defined as LDL cholesterol of greater than or equal to 100 mg/dL from laboratory results|participants|Number|39|39.0||||||
4394436|NCT00286754|4221083|B4|No history of revascularization||History of revascularization|self-reported|participants|Number|447|447.0||||||
4394437|NCT00286754|4221084|B3|No history of revascularization||History of revascularization|self-reported|participants|Number|149|149.0||||||
4394438|NCT00286754|4221085|B2|No history of revascularization||History of revascularization|self-reported|participants|Number|149|149.0||||||
4394439|NCT00286754|4221086|B1|No history of revascularization||History of revascularization|self-reported|participants|Number|149|149.0||||||
4394443|NCT00286754|4221086|B1|History of revascularization||History of revascularization|self-reported|participants|Number|27|27.0||||||
4394444|NCT00286754|4221083|B4|No history of IHD||Ischemic Heart Disease (IHD)|self-reported|participants|Number|465|465.0||||||
4394445|NCT00286754|4221084|B3|No history of IHD||Ischemic Heart Disease (IHD)|self-reported|participants|Number|157|157.0||||||
4394446|NCT00286754|4221085|B2|No history of IHD||Ischemic Heart Disease (IHD)|self-reported|participants|Number|155|155.0||||||
4394447|NCT00286754|4221086|B1|No history of IHD||Ischemic Heart Disease (IHD)|self-reported|participants|Number|153|153.0||||||
4394448|NCT00286754|4221083|B4|History of IHD||Ischemic Heart Disease (IHD)|self-reported|participants|Number|68|68.0||||||
4394449|NCT00286754|4221084|B3|History of IHD||Ischemic Heart Disease (IHD)|self-reported|participants|Number|23|23.0||||||
4394450|NCT00286754|4221085|B2|History of IHD||Ischemic Heart Disease (IHD)|self-reported|participants|Number|22|22.0||||||
4394451|NCT00286754|4221086|B1|History of IHD||Ischemic Heart Disease (IHD)|self-reported|participants|Number|23|23.0||||||
4394452|NCT00286754|4221083|B4|No diabetes mellitus||Diabetes Mellitus|From chart review|participants|Number|298|298.0||||||
4394453|NCT00286754|4221084|B3|No diabetes mellitus||Diabetes Mellitus|From chart review|participants|Number|99|99.0||||||
4394454|NCT00286754|4221085|B2|No diabetes mellitus||Diabetes Mellitus|From chart review|participants|Number|94|94.0||||||
4394455|NCT00286754|4221086|B1|No diabetes mellitus||Diabetes Mellitus|From chart review|participants|Number|105|105.0||||||
4394456|NCT00286754|4221083|B4|Diabetes mellitus||Diabetes Mellitus|From chart review|participants|Number|235|235.0||||||
4394457|NCT00286754|4221084|B3|Diabetes mellitus||Diabetes Mellitus|From chart review|participants|Number|81|81.0||||||
4394458|NCT00286754|4221085|B2|Diabetes mellitus||Diabetes Mellitus|From chart review|participants|Number|83|83.0||||||
4394459|NCT00286754|4221086|B1|Diabetes mellitus||Diabetes Mellitus|From chart review|participants|Number|71|71.0||||||
4394460|NCT00286754|4221083|B4|BP not controlled||Blood pressure control|Controlled BP was defined as systolic BP (SBP) less than130 mm Hg or Diastolic BP (DBP) less than 80 mm Hg in diabetes mellitus or chronic kidney disease, or SBP less than140 mm Hg or DBP less than 90 mm Hg in all others as per the BP guidelines at the time of the study.|participants|Number|306|306.0||||||
4394461|NCT00286754|4221084|B3|BP not controlled||Blood pressure control|Controlled BP was defined as systolic BP (SBP) less than130 mm Hg or Diastolic BP (DBP) less than 80 mm Hg in diabetes mellitus or chronic kidney disease, or SBP less than140 mm Hg or DBP less than 90 mm Hg in all others as per the BP guidelines at the time of the study.|participants|Number|100|100.0||||||
4394462|NCT00286754|4221085|B2|BP not controlled||Blood pressure control|Controlled BP was defined as systolic BP (SBP) less than130 mm Hg or Diastolic BP (DBP) less than 80 mm Hg in diabetes mellitus or chronic kidney disease, or SBP less than140 mm Hg or DBP less than 90 mm Hg in all others as per the BP guidelines at the time of the study.|participants|Number|105|105.0||||||
4394463|NCT00286754|4221086|B1|BP not controlled||Blood pressure control|Controlled BP was defined as systolic BP (SBP) less than130 mm Hg or Diastolic BP (DBP) less than 80 mm Hg in diabetes mellitus or chronic kidney disease, or SBP less than140 mm Hg or DBP less than 90 mm Hg in all others as per the BP guidelines at the time of the study.|participants|Number|101|101.0||||||
4394464|NCT00286754|4221083|B4|BP controlled||Blood pressure control|Controlled BP was defined as systolic BP (SBP) less than130 mm Hg or Diastolic BP (DBP) less than 80 mm Hg in diabetes mellitus or chronic kidney disease, or SBP less than140 mm Hg or DBP less than 90 mm Hg in all others as per the BP guidelines at the time of the study.|participants|Number|227|227.0||||||
4394465|NCT00286754|4221084|B3|BP controlled||Blood pressure control|Controlled BP was defined as systolic BP (SBP) less than130 mm Hg or Diastolic BP (DBP) less than 80 mm Hg in diabetes mellitus or chronic kidney disease, or SBP less than140 mm Hg or DBP less than 90 mm Hg in all others as per the BP guidelines at the time of the study.|participants|Number|80|80.0||||||
4394466|NCT00286754|4221085|B2|BP controlled||Blood pressure control|Controlled BP was defined as systolic BP (SBP) less than130 mm Hg or Diastolic BP (DBP) less than 80 mm Hg in diabetes mellitus or chronic kidney disease, or SBP less than140 mm Hg or DBP less than 90 mm Hg in all others as per the BP guidelines at the time of the study.|participants|Number|72|72.0||||||
4394467|NCT00286754|4221086|B1|BP controlled||Blood pressure control|Controlled BP was defined as systolic BP (SBP) less than130 mm Hg or Diastolic BP (DBP) less than 80 mm Hg in diabetes mellitus or chronic kidney disease, or SBP less than140 mm Hg or DBP less than 90 mm Hg in all others as per the BP guidelines at the time of the study.|participants|Number|75|75.0||||||
4394468|NCT00286754|4221083|B4|||Body mass index||kg/m^2|Mean|30.5|30.5|Standard Deviation|5.3|5.3|||
4394469|NCT00286754|4221084|B3|||Body mass index||kg/m^2|Mean|30.0|30.0|Standard Deviation|4.8|4.8|||
4394470|NCT00286754|4221085|B2|||Body mass index||kg/m^2|Mean|31.2|31.2|Standard Deviation|5.8|5.8|||
4394471|NCT00286754|4221086|B1|||Body mass index||kg/m^2|Mean|30.5|30.5|Standard Deviation|5.2|5.2|||
4394472|NCT00286754|4221083|B4|Current non-smoker||Smoking||participants|Number|434|434.0||||||
4394473|NCT00286754|4221084|B3|Current non-smoker||Smoking||participants|Number|148|148.0||||||
4394474|NCT00286754|4221085|B2|Current non-smoker||Smoking||participants|Number|145|145.0||||||
4394475|NCT00286754|4221086|B1|Current non-smoker||Smoking||participants|Number|141|141.0||||||
4394476|NCT00286754|4221083|B4|Current smoker||Smoking||participants|Number|99|99.0||||||
4394477|NCT00286754|4221084|B3|Current smoker||Smoking||participants|Number|32|32.0||||||
4394478|NCT00286754|4221085|B2|Current smoker||Smoking||participants|Number|32|32.0||||||
4394479|NCT00286754|4221086|B1|Current smoker||Smoking||participants|Number|35|35.0||||||
4394480|NCT00286754|4221083|B4|Brooklyn campus||Campus||participants|Number|244|244.0||||||
4394481|NCT00286754|4221084|B3|Brooklyn campus||Campus||participants|Number|83|83.0||||||
4394482|NCT00286754|4221085|B2|Brooklyn campus||Campus||participants|Number|81|81.0||||||
4394483|NCT00286754|4221086|B1|Brooklyn campus||Campus||participants|Number|80|80.0||||||
4394484|NCT00286754|4221083|B4|Manhattan campus||Campus||participants|Number|289|289.0||||||
4394485|NCT00286754|4221084|B3|Manhattan campus||Campus||participants|Number|97|97.0||||||
4394486|NCT00286754|4221085|B2|Manhattan campus||Campus||participants|Number|96|96.0||||||
4394487|NCT00286754|4221086|B1|Manhattan campus||Campus||participants|Number|96|96.0||||||
4394488|NCT00286754|4221083|B4|Not employed||Employment status||participants|Number|422|422.0||||||
4394489|NCT00286754|4221084|B3|Not employed||Employment status||participants|Number|139|139.0||||||
4394490|NCT00286754|4221085|B2|Not employed||Employment status||participants|Number|136|136.0||||||
4394491|NCT00286754|4221086|B1|Not employed||Employment status||participants|Number|147|147.0||||||
4394492|NCT00286754|4221083|B4|Employed||Employment status||participants|Number|111|111.0||||||
4394493|NCT00286754|4221084|B3|Employed||Employment status||participants|Number|41|41.0||||||
4394494|NCT00286754|4221085|B2|Employed||Employment status||participants|Number|41|41.0||||||
4394495|NCT00286754|4221086|B1|Employed||Employment status||participants|Number|29|29.0||||||
4394496|NCT00286754|4221083|B4|Some college or higher||Education||participants|Number|285|285.0||||||
4394497|NCT00286754|4221084|B3|Some college or higher||Education||participants|Number|93|93.0||||||
4394498|NCT00286754|4221085|B2|Some college or higher||Education||participants|Number|88|88.0||||||
4394499|NCT00286754|4221086|B1|Some college or higher||Education||participants|Number|104|104.0||||||
4394500|NCT00286754|4221083|B4|High school graduate or below||Education||participants|Number|248|248.0||||||
4394501|NCT00286754|4221084|B3|High school graduate or below||Education||participants|Number|87|87.0||||||
4394502|NCT00286754|4221085|B2|High school graduate or below||Education||participants|Number|89|89.0||||||
4394503|NCT00286754|4221086|B1|High school graduate or below||Education||participants|Number|72|72.0||||||
4394504|NCT00286754|4221083|B4|Not Married||Marital status||participants|Number|337|337.0||||||
4394505|NCT00286754|4221084|B3|Not Married||Marital status||participants|Number|110|110.0||||||
4394506|NCT00286754|4221085|B2|Not Married||Marital status||participants|Number|110|110.0||||||
4394507|NCT00286754|4221086|B1|Not Married||Marital status||participants|Number|117|117.0||||||
4394508|NCT00286754|4221083|B4|Married||Marital status||participants|Number|196|196.0||||||
4394509|NCT00286754|4221084|B3|Married||Marital status||participants|Number|70|70.0||||||
4394510|NCT00286754|4221085|B2|Married||Marital status||participants|Number|67|67.0||||||
4394511|NCT00286754|4221086|B1|Married||Marital status||participants|Number|59|59.0||||||
4394512|NCT00286754|4221083|B4|Other||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4394513|NCT00286754|4221084|B3|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4394514|NCT00286754|4221085|B2|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4394515|NCT00286754|4221086|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4394516|NCT00286754|4221083|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4394517|NCT00286754|4221084|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4394518|NCT00286754|4221085|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4394519|NCT00286754|4221086|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4394520|NCT00286754|4221083|B4|Black (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|212|212.0||||||
4394521|NCT00286754|4221084|B3|Black (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4394522|NCT00286754|4221085|B2|Black (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4394523|NCT00286754|4221086|B1|Black (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4394524|NCT00286754|4221083|B4|White (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|212|212.0||||||
4394525|NCT00286754|4221084|B3|White (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4394526|NCT00286754|4221085|B2|White (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4394527|NCT00286754|4221086|B1|White (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4394528|NCT00286754|4221083|B4||Male|Sex: Female, Male||Participants|Count of Participants|526|526.0||||||
4394529|NCT00286754|4221084|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4394530|NCT00286754|4221085|B2||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4394531|NCT00286754|4221086|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4394532|NCT00286754|4221083|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4394533|NCT00286754|4221084|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4394534|NCT00286754|4221085|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4394535|NCT00286754|4221086|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4394536|NCT00286754|4221083|B4|Age and Standard Deviation||Age||years|Mean|66.1|66.1|Standard Deviation|18.5|18.5|||
4394537|NCT00286754|4221084|B3|Age and Standard Deviation||Age||years|Mean|65.4|65.4|Standard Deviation|10.2|10.2|||
4394538|NCT00286754|4221085|B2|Age and Standard Deviation||Age||years|Mean|66.5|66.5|Standard Deviation|12.8|12.8|||
4394539|NCT00286754|4221086|B1|Age and Standard Deviation||Age||years|Mean|66.4|66.4|Standard Deviation|8.8|8.8|||
4394540|NCT00286741|4221120|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4394541|NCT00286741|4221121|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4394542|NCT00286741|4221122|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4394543|NCT00286741|4221120|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
4394544|NCT00286741|4221121|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4394545|NCT00286741|4221122|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4394546|NCT00286741|4221120|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4394547|NCT00286741|4221121|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4394548|NCT00286741|4221122|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4394549|NCT00286741|4221120|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4394550|NCT00286741|4221121|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4394551|NCT00286741|4221122|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4394552|NCT00286741|4221120|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394553|NCT00286741|4221121|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394554|NCT00286741|4221122|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394555|NCT00286741|4221120|B3||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4394556|NCT00286741|4221121|B2||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4394557|NCT00286741|4221122|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4394558|NCT00286741|4221120|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
4394559|NCT00286741|4221121|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4394560|NCT00286741|4221122|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4394561|NCT00286741|4221120|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394562|NCT00286741|4221121|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394563|NCT00286741|4221122|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394564|NCT00286741|4221120|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394565|NCT00286741|4221121|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394566|NCT00286741|4221122|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394567|NCT00286741|4221120|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394568|NCT00286741|4221121|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394569|NCT00286741|4221122|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394570|NCT00286741|4221120|B3||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4394571|NCT00286741|4221121|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4394572|NCT00286741|4221122|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4394573|NCT00286741|4221120|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4394574|NCT00286741|4221121|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4394575|NCT00286741|4221122|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4394576|NCT00286741|4221120|B3|||Age||years|Mean|62.0|62.0|Standard Deviation|9.8|9.8|||
4394577|NCT00286741|4221121|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|10|10.0|||
4394578|NCT00286741|4221122|B1|||Age||years|Mean|63|63.0|Standard Deviation|9.4|9.4|||
4394579|NCT00286728|4221131|B3|United States||Region of Enrollment||participants|Number|287|287.0||||||
4394580|NCT00286728|4221132|B2|United States||Region of Enrollment||participants|Number|145|145.0||||||
4394581|NCT00286728|4221133|B1|United States||Region of Enrollment||participants|Number|142|142.0||||||
4394582|NCT00286728|4221131|B3||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4394583|NCT00286728|4221132|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4394584|NCT00286728|4221133|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4394585|NCT00286728|4221131|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4394586|NCT00286728|4221132|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4394587|NCT00286728|4221133|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4394588|NCT00286728|4221131|B3|||Age||years|Mean|51.0|51.0|Standard Deviation|8.9|8.9|||
4394589|NCT00286728|4221132|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|8.8|8.8|||
4394590|NCT00286728|4221133|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|9.0|9.0|||
4394591|NCT00286494|4221140|B4||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4394592|NCT00286494|4221141|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4394593|NCT00286494|4221142|B2||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4394594|NCT00286494|4221143|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4394595|NCT00286494|4221140|B4||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4394596|NCT00286494|4221141|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4394597|NCT00286494|4221142|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4394598|NCT00286494|4221143|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4394599|NCT00286494|4221140|B4|≥75 years||Age, Customized||participants|Number|12|12.0||||||
4394600|NCT00286494|4221141|B3|≥75 years||Age, Customized||participants|Number|5|5.0||||||
4394601|NCT00286494|4221142|B2|≥75 years||Age, Customized||participants|Number|3|3.0||||||
4394602|NCT00286494|4221143|B1|≥75 years||Age, Customized||participants|Number|4|4.0||||||
4394603|NCT00286494|4221140|B4|Between 65 and 74 years||Age, Customized||participants|Number|73|73.0||||||
4394604|NCT00286494|4221141|B3|Between 65 and 74 years||Age, Customized||participants|Number|34|34.0||||||
4394605|NCT00286494|4221142|B2|Between 65 and 74 years||Age, Customized||participants|Number|29|29.0||||||
4394606|NCT00286494|4221143|B1|Between 65 and 74 years||Age, Customized||participants|Number|10|10.0||||||
4394607|NCT00286494|4221140|B4|<65 years||Age, Customized||participants|Number|408|408.0||||||
4394608|NCT00286494|4221141|B3|<65 years||Age, Customized||participants|Number|160|160.0||||||
4394609|NCT00286494|4221142|B2|<65 years||Age, Customized||participants|Number|165|165.0||||||
4394610|NCT00286494|4221143|B1|<65 years||Age, Customized||participants|Number|83|83.0||||||
4394611|NCT00286468|4221303|B4||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4394612|NCT00286468|4221304|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4394613|NCT00286468|4221305|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4394614|NCT00286468|4221306|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4394615|NCT00286468|4221303|B4||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4394616|NCT00286468|4221304|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4394617|NCT00286468|4221305|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4394618|NCT00286468|4221306|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4394619|NCT00286468|4221303|B4|≥75 years||Age, Customized||participants|Number|18|18.0||||||
4394620|NCT00286468|4221304|B3|≥75 years||Age, Customized||participants|Number|6|6.0||||||
4394621|NCT00286468|4221305|B2|≥75 years||Age, Customized||participants|Number|8|8.0||||||
4394622|NCT00286468|4221306|B1|≥75 years||Age, Customized||participants|Number|4|4.0||||||
4394623|NCT00286468|4221303|B4|Between 65 and 74 years||Age, Customized||participants|Number|112|112.0||||||
4394624|NCT00286468|4221304|B3|Between 65 and 74 years||Age, Customized||participants|Number|47|47.0||||||
4394625|NCT00286468|4221305|B2|Between 65 and 74 years||Age, Customized||participants|Number|42|42.0||||||
4394626|NCT00286468|4221306|B1|Between 65 and 74 years||Age, Customized||participants|Number|23|23.0||||||
4394627|NCT00286468|4221303|B4|<65 years||Age, Customized||participants|Number|370|370.0||||||
4394628|NCT00286468|4221304|B3|<65 years||Age, Customized||participants|Number|145|145.0||||||
4394629|NCT00286468|4221305|B2|<65 years||Age, Customized||participants|Number|153|153.0||||||
4394630|NCT00286468|4221306|B1|<65 years||Age, Customized||participants|Number|72|72.0||||||
4394631|NCT00286455|4221466|B4||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4394632|NCT00286455|4221467|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4394633|NCT00286455|4221468|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4394634|NCT00286455|4221469|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4394635|NCT00286455|4221466|B4||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4394636|NCT00286455|4221467|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4394637|NCT00286455|4221468|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4394638|NCT00286455|4221469|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4394639|NCT00286455|4221466|B4|≥75 years||Age, Customized||participants|Number|13|13.0||||||
4394640|NCT00286455|4221467|B3|≥75 years||Age, Customized||participants|Number|4|4.0||||||
4394641|NCT00286455|4221468|B2|≥75 years||Age, Customized||participants|Number|5|5.0||||||
4394642|NCT00286455|4221469|B1|≥75 years||Age, Customized||participants|Number|4|4.0||||||
4394643|NCT00286455|4221466|B4|Between 65 and 74 years||Age, Customized||participants|Number|42|42.0||||||
4394644|NCT00286455|4221467|B3|Between 65 and 74 years||Age, Customized||participants|Number|16|16.0||||||
4394645|NCT00286455|4221468|B2|Between 65 and 74 years||Age, Customized||participants|Number|18|18.0||||||
4394646|NCT00286455|4221469|B1|Between 65 and 74 years||Age, Customized||participants|Number|8|8.0||||||
4394647|NCT00286455|4221466|B4|<65 years||Age, Customized||participants|Number|274|274.0||||||
4394648|NCT00286455|4221467|B3|<65 years||Age, Customized||participants|Number|111|111.0||||||
4394649|NCT00286455|4221468|B2|<65 years||Age, Customized||participants|Number|110|110.0||||||
4394650|NCT00286455|4221469|B1|<65 years||Age, Customized||participants|Number|53|53.0||||||
4394651|NCT00286442|4221647|B4||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4394652|NCT00286442|4221648|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4394653|NCT00286442|4221649|B2||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4394654|NCT00286442|4221650|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4394655|NCT00286442|4221647|B4||Female|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4394656|NCT00286442|4221648|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4394657|NCT00286442|4221649|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4394658|NCT00286442|4221650|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4394659|NCT00286442|4221647|B4|≥65 years||Age, Customized||participants|Number|92|92.0||||||
4394660|NCT00286442|4221648|B3|≥65 years||Age, Customized||participants|Number|21|21.0||||||
4394661|NCT00286442|4221649|B2|≥65 years||Age, Customized||participants|Number|31|31.0||||||
4394662|NCT00286442|4221650|B1|≥65 years||Age, Customized||participants|Number|40|40.0||||||
4394663|NCT00286442|4221647|B4|<65 years||Age, Customized||participants|Number|435|435.0||||||
4394664|NCT00286442|4221648|B3|<65 years||Age, Customized||participants|Number|83|83.0||||||
4394665|NCT00286442|4221649|B2|<65 years||Age, Customized||participants|Number|179|179.0||||||
4394666|NCT00286442|4221650|B1|<65 years||Age, Customized||participants|Number|173|173.0||||||
4394667|NCT00286429|4221810|B4||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4394668|NCT00286429|4221811|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4394669|NCT00286429|4221812|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4394670|NCT00286429|4221813|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4394671|NCT00286429|4221810|B4||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4394672|NCT00286429|4221811|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4394673|NCT00286429|4221812|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4394674|NCT00286429|4221813|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4394675|NCT00286429|4221810|B4|≥65 years||Age, Customized||participants|Number|63|63.0||||||
4394676|NCT00286429|4221811|B3|≥65 years||Age, Customized||participants|Number|23|23.0||||||
4394677|NCT00286429|4221812|B2|≥65 years||Age, Customized||participants|Number|19|19.0||||||
4394678|NCT00286429|4221813|B1|≥65 years||Age, Customized||participants|Number|21|21.0||||||
4394679|NCT00286429|4221810|B4|<65 years||Age, Customized||participants|Number|327|327.0||||||
4394680|NCT00286429|4221811|B3|<65 years||Age, Customized||participants|Number|106|106.0||||||
4394681|NCT00286429|4221812|B2|<65 years||Age, Customized||participants|Number|112|112.0||||||
4394682|NCT00286429|4221813|B1|<65 years||Age, Customized||participants|Number|109|109.0||||||
4394683|NCT00286325|4221919|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4394684|NCT00286325|4221919|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4394685|NCT00286325|4221919|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4394686|NCT00286325|4221919|B1|||Age||years|Mean|61|61.0|Standard Deviation|9.7|9.7|||
4394687|NCT00286325|4221919|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4394688|NCT00286325|4221919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4394689|NCT00286325|4221919|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394690|NCT00286221|4221927|B5|United States||Region of Enrollment||Participants|Count of Participants|129|129.0||||||
4394691|NCT00286221|4221928|B4|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4394692|NCT00286221|4221929|B3|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4394693|NCT00286221|4221930|B2|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4394694|NCT00286221|4221931|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4394695|NCT00286221|4221927|B5||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4394696|NCT00286221|4221928|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4394697|NCT00286221|4221929|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4394698|NCT00286221|4221930|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4394699|NCT00286221|4221931|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4394700|NCT00286221|4221927|B5||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4394701|NCT00286221|4221928|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4394702|NCT00286221|4221929|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4394703|NCT00286221|4221930|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4394704|NCT00286221|4221931|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4394705|NCT00286221|4221927|B5|||Age||years|Mean|45.6|45.6|Standard Deviation|13.2|13.2|||
4394706|NCT00286221|4221928|B4|||Age||years|Mean|41.4|41.4|Standard Deviation|11.1|11.1|||
4394707|NCT00286221|4221929|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|14.6|14.6|||
4394708|NCT00286221|4221930|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|15.0|15.0|||
4394709|NCT00286221|4221931|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|11.9|11.9|||
4394710|NCT00286182|4221948|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4394711|NCT00286182|4221949|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4394712|NCT00286182|4221950|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4394713|NCT00286182|4221948|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4394714|NCT00286182|4221949|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4394715|NCT00286182|4221950|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4394716|NCT00286182|4221948|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4394717|NCT00286182|4221949|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4394718|NCT00286182|4221950|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4394719|NCT00286182|4221948|B3|||Age||years|Mean|76.5|76.5|Standard Deviation|10|10.0|||
4394720|NCT00286182|4221949|B2|||Age||years|Mean|74|74.0|Standard Deviation|9|9.0|||
4394721|NCT00286182|4221950|B1|||Age||years|Mean|79|79.0|Standard Deviation|11|11.0|||
4394722|NCT00286156|4221957|B4|Initial height-adjusted TKV>=600ml/m||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|20|20.0||||||
4394723|NCT00286156|4221958|B3|Initial height-adjusted TKV>=600ml/m||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|6|6.0||||||
4394724|NCT00286156|4221959|B2|Initial height-adjusted TKV>=600ml/m||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|8|8.0||||||
4394752|NCT00286156|4221959|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394725|NCT00286156|4221960|B1|Initial height-adjusted TKV>=600ml/m||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|6|6.0||||||
4394726|NCT00286156|4221957|B4|Initial TKV>1500ml||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|19|19.0||||||
4394727|NCT00286156|4221958|B3|Initial TKV>1500ml||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|6|6.0||||||
4394728|NCT00286156|4221959|B2|Initial TKV>1500ml||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|7|7.0||||||
4394729|NCT00286156|4221960|B1|Initial TKV>1500ml||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|6|6.0||||||
4394730|NCT00286156|4221957|B4|Initial iGFR 25-59 ml/min per 1.73 m^2||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|9|9.0||||||
4394731|NCT00286156|4221958|B3|Initial iGFR 25-59 ml/min per 1.73 m^2||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|2|2.0||||||
4394732|NCT00286156|4221959|B2|Initial iGFR 25-59 ml/min per 1.73 m^2||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|4|4.0||||||
4394733|NCT00286156|4221960|B1|Initial iGFR 25-59 ml/min per 1.73 m^2||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|3|3.0||||||
4394734|NCT00286156|4221957|B4|Family history of ESRD||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|19|19.0||||||
4394735|NCT00286156|4221958|B3|Family history of ESRD||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|7|7.0||||||
4394736|NCT00286156|4221959|B2|Family history of ESRD||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|8|8.0||||||
4394737|NCT00286156|4221960|B1|Family history of ESRD||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|4|4.0||||||
4394738|NCT00286156|4221957|B4|Hypertension||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|11|11.0||||||
4394739|NCT00286156|4221958|B3|Hypertension||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|5|5.0||||||
4394740|NCT00286156|4221959|B2|Hypertension||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|3|3.0||||||
4394741|NCT00286156|4221960|B1|Hypertension||Baseline characteristics and risk factors|ADPKD, autosomal dominant polycystic kidney disease; iGFR, 125I-iothalamate GFR; TKV, total kidney volume; Hypertension is a BP >= 140/90 mmHg before 35 years old; family history of ESRD occurs from ADPKD before 56 years old|participants|Number|3|3.0||||||
4394742|NCT00286156|4221957|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4394743|NCT00286156|4221958|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4394744|NCT00286156|4221959|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4394745|NCT00286156|4221960|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4394746|NCT00286156|4221957|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394747|NCT00286156|4221958|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394748|NCT00286156|4221959|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394749|NCT00286156|4221960|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394750|NCT00286156|4221957|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394751|NCT00286156|4221958|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394753|NCT00286156|4221960|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394754|NCT00286156|4221957|B4||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4394755|NCT00286156|4221958|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4394756|NCT00286156|4221959|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4394757|NCT00286156|4221960|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4394758|NCT00286156|4221957|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4394759|NCT00286156|4221958|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4394760|NCT00286156|4221959|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394761|NCT00286156|4221960|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394762|NCT00286156|4221957|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394763|NCT00286156|4221958|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394764|NCT00286156|4221959|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394765|NCT00286156|4221960|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394766|NCT00286156|4221957|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394767|NCT00286156|4221958|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394768|NCT00286156|4221959|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394769|NCT00286156|4221960|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394770|NCT00286156|4221957|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394771|NCT00286156|4221958|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394772|NCT00286156|4221959|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394773|NCT00286156|4221960|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394774|NCT00286156|4221957|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4394775|NCT00286156|4221958|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4394776|NCT00286156|4221959|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4394777|NCT00286156|4221960|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4394778|NCT00286156|4221957|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4394779|NCT00286156|4221958|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4394780|NCT00286156|4221959|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4394781|NCT00286156|4221960|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4394782|NCT00286156|4221957|B4|||Age||years|Mean|49.3|49.3|Standard Deviation|12.0|12.0|||
4394783|NCT00286156|4221958|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|11.0|11.0|||
4394784|NCT00286156|4221959|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|8.6|8.6|||
4394785|NCT00286156|4221960|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|15.0|15.0|||
4394786|NCT00286091|4221973|B3|No||Prior Chemotherapy Regimens||participants|Number|1315|1315.0||||||
4394787|NCT00286091|4221974|B2|No||Prior Chemotherapy Regimens||participants|Number|653|653.0||||||
4394788|NCT00286091|4221975|B1|No||Prior Chemotherapy Regimens||participants|Number|662|662.0||||||
4394789|NCT00286091|4221973|B3|Yes||Prior Chemotherapy Regimens||participants|Number|117|117.0||||||
4394790|NCT00286091|4221974|B2|Yes||Prior Chemotherapy Regimens||participants|Number|63|63.0||||||
4394791|NCT00286091|4221975|B1|Yes||Prior Chemotherapy Regimens||participants|Number|54|54.0||||||
4394792|NCT00286091|4221973|B3|No||Prostate-Specific Antigen (PSA) ≥ 8.0 ng/mL||participants|Number|488|488.0||||||
4394793|NCT00286091|4221974|B2|No||Prostate-Specific Antigen (PSA) ≥ 8.0 ng/mL||participants|Number|243|243.0||||||
4394794|NCT00286091|4221975|B1|No||Prostate-Specific Antigen (PSA) ≥ 8.0 ng/mL||participants|Number|245|245.0||||||
4394795|NCT00286091|4221973|B3|Yes||Prostate-Specific Antigen (PSA) ≥ 8.0 ng/mL||participants|Number|944|944.0||||||
4394796|NCT00286091|4221974|B2|Yes||Prostate-Specific Antigen (PSA) ≥ 8.0 ng/mL||participants|Number|473|473.0||||||
4394797|NCT00286091|4221975|B1|Yes||Prostate-Specific Antigen (PSA) ≥ 8.0 ng/mL||participants|Number|471|471.0||||||
4394798|NCT00286091|4221973|B3|> 10 months||Prostate-Specific Antigen (PSA) Doubling Time||participants|Number|278|278.0||||||
4394799|NCT00286091|4221974|B2|> 10 months||Prostate-Specific Antigen (PSA) Doubling Time||participants|Number|142|142.0||||||
4394800|NCT00286091|4221975|B1|> 10 months||Prostate-Specific Antigen (PSA) Doubling Time||participants|Number|136|136.0||||||
4394801|NCT00286091|4221973|B3|≤ 10 months||Prostate-Specific Antigen (PSA) Doubling Time||participants|Number|1154|1154.0||||||
4394802|NCT00286091|4221974|B2|≤ 10 months||Prostate-Specific Antigen (PSA) Doubling Time||participants|Number|574|574.0||||||
4394803|NCT00286091|4221975|B1|≤ 10 months||Prostate-Specific Antigen (PSA) Doubling Time||participants|Number|580|580.0||||||
4394804|NCT00286091|4221973|B3|Grade 4||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4394869|NCT00285857|4221999|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4394870|NCT00285857|4221999|B1|||Age||years|Median|45|45.0|Full Range|||25.0|62.0|
4394805|NCT00286091|4221974|B2|Grade 4||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4394806|NCT00286091|4221975|B1|Grade 4||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4394807|NCT00286091|4221973|B3|Grade 3||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4394808|NCT00286091|4221974|B2|Grade 3||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4394809|NCT00286091|4221975|B1|Grade 3||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|0|0.0||||||
4394810|NCT00286091|4221973|B3|Grade 2||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|4|4.0||||||
4394811|NCT00286091|4221974|B2|Grade 2||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1|1.0||||||
4394812|NCT00286091|4221975|B1|Grade 2||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|3|3.0||||||
4394813|NCT00286091|4221973|B3|Grade 1||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|409|409.0||||||
4394814|NCT00286091|4221974|B2|Grade 1||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|210|210.0||||||
4394815|NCT00286091|4221975|B1|Grade 1||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|199|199.0||||||
4394816|NCT00286091|4221973|B3|Grade 0||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|1019|1019.0||||||
4394817|NCT00286091|4221974|B2|Grade 0||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|505|505.0||||||
4394818|NCT00286091|4221975|B1|Grade 0||Eastern Cooperative Oncology Group (ECOG)Pperformance Status|A scale to assess a patient's disease status. 0 = Fully active, able to carry out all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2 = Ambulatory and capable of all self care, unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|514|514.0||||||
4394819|NCT00286091|4221973|B3|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4394820|NCT00286091|4221974|B2|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4394821|NCT00286091|4221975|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4394822|NCT00286091|4221973|B3|Other||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4394823|NCT00286091|4221974|B2|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4394824|NCT00286091|4221975|B1|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4394825|NCT00286091|4221973|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4394826|NCT00286091|4221974|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4394827|NCT00286091|4221975|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4394828|NCT00286091|4221973|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4394829|NCT00286091|4221974|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4394830|NCT00286091|4221975|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4394831|NCT00286091|4221973|B3|Japanese||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4394832|NCT00286091|4221974|B2|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4394833|NCT00286091|4221975|B1|Japanese||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4394834|NCT00286091|4221973|B3|Asian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4394835|NCT00286091|4221974|B2|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4394836|NCT00286091|4221975|B1|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4394837|NCT00286091|4221973|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4394838|NCT00286091|4221974|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4394839|NCT00286091|4221975|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4394840|NCT00286091|4221973|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4394841|NCT00286091|4221974|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4394842|NCT00286091|4221975|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4394843|NCT00286091|4221973|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|1210|1210.0||||||
4394844|NCT00286091|4221974|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|606|606.0||||||
4394845|NCT00286091|4221975|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|604|604.0||||||
4394846|NCT00286091|4221973|B3||Male|Sex: Female, Male||Participants|Count of Participants|1432|1432.0||||||
4394847|NCT00286091|4221974|B2||Male|Sex: Female, Male||Participants|Count of Participants|716|716.0||||||
4394848|NCT00286091|4221975|B1||Male|Sex: Female, Male||Participants|Count of Participants|716|716.0||||||
4394849|NCT00286091|4221973|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4394850|NCT00286091|4221974|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4394851|NCT00286091|4221975|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4394852|NCT00286091|4221973|B3|||Age||years|Mean|73.2|73.2|Standard Deviation|8.6|8.6|||
4394853|NCT00286091|4221974|B2|||Age||years|Mean|73.2|73.2|Standard Deviation|8.8|8.8|||
4394854|NCT00286091|4221975|B1|||Age||years|Mean|73.2|73.2|Standard Deviation|8.3|8.3|||
4394855|NCT00286078|4221988|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
4394856|NCT00286078|4221989|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
4394857|NCT00286078|4221990|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4394858|NCT00286078|4221988|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4394859|NCT00286078|4221989|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4394860|NCT00286078|4221990|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4394861|NCT00286078|4221988|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4394862|NCT00286078|4221989|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4394863|NCT00286078|4221990|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4394864|NCT00286078|4221988|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|11.6|11.6|||
4394865|NCT00286078|4221989|B2|||Age||years|Mean|43.8|43.8|Standard Deviation|11.9|11.9|||
4394866|NCT00286078|4221990|B1|||Age||years|Mean|41.5|41.5|Standard Deviation|11.2|11.2|||
4394867|NCT00285857|4221999|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4394868|NCT00285857|4221999|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4394871|NCT00285857|4221999|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4394872|NCT00285857|4221999|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4394873|NCT00285857|4221999|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394874|NCT00285818|4222010|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4394875|NCT00285818|4222011|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4394876|NCT00285818|4222012|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4394877|NCT00285818|4222010|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394878|NCT00285818|4222011|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394879|NCT00285818|4222012|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394880|NCT00285818|4222010|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394881|NCT00285818|4222011|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394882|NCT00285818|4222012|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394883|NCT00285818|4222010|B3||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4394884|NCT00285818|4222011|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4394885|NCT00285818|4222012|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4394886|NCT00285818|4222010|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4394887|NCT00285818|4222011|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394888|NCT00285818|4222012|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4394889|NCT00285818|4222010|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394890|NCT00285818|4222011|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394891|NCT00285818|4222012|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394892|NCT00285818|4222010|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394893|NCT00285818|4222011|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394894|NCT00285818|4222012|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394895|NCT00285818|4222010|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394896|NCT00285818|4222011|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394897|NCT00285818|4222012|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394898|NCT00285818|4222010|B3||Male|Gender||Participants|Count of Participants|3|3.0||||||
4394899|NCT00285818|4222011|B2||Male|Gender||Participants|Count of Participants|2|2.0||||||
4394900|NCT00285818|4222012|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4394901|NCT00285818|4222010|B3||Female|Gender||Participants|Count of Participants|8|8.0||||||
4394902|NCT00285818|4222011|B2||Female|Gender||Participants|Count of Participants|3|3.0||||||
4394903|NCT00285818|4222012|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4394904|NCT00285818|4222010|B3|||Age||years|Mean|48.3|48.3|Standard Deviation|5.3|5.3|||
4394905|NCT00285818|4222011|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|6.2|6.2|||
4394906|NCT00285818|4222012|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|5.2|5.2|||
4394907|NCT00285818|4222010|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4394908|NCT00285818|4222011|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4394909|NCT00285818|4222012|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4394910|NCT00285818|4222010|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4394911|NCT00285818|4222011|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4394912|NCT00285818|4222012|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4394913|NCT00285818|4222010|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394914|NCT00285818|4222011|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394915|NCT00285818|4222012|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4394916|NCT00285779|4222019|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394917|NCT00285779|4222020|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394918|NCT00285779|4222021|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394919|NCT00285779|4222019|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394920|NCT00285779|4222020|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394921|NCT00285779|4222021|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394922|NCT00285779|4222019|B3||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4394923|NCT00285779|4222020|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4394924|NCT00285779|4222021|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4394925|NCT00285779|4222019|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4394926|NCT00285779|4222020|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4394927|NCT00285779|4222021|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4394928|NCT00285779|4222019|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394929|NCT00285779|4222020|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394930|NCT00285779|4222021|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394931|NCT00285779|4222019|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394932|NCT00285779|4222020|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394933|NCT00285779|4222021|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394934|NCT00285779|4222019|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394935|NCT00285779|4222020|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394936|NCT00285779|4222021|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394937|NCT00285779|4222019|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4394938|NCT00285779|4222020|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4394939|NCT00285779|4222021|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4394940|NCT00285779|4222019|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4394941|NCT00285779|4222020|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4394942|NCT00285779|4222021|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4394943|NCT00285779|4222019|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|16.5|16.5|||
4394944|NCT00285779|4222020|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|16.0|16.0|||
4394945|NCT00285779|4222021|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|16.9|16.9|||
4394946|NCT00285649|4222055|B4|||Roland-Morris Disability Questionnaire (RMDQ)|The RMDQ is a widely used health status measure for low back pain. Scoring of the RMDQ ranges from 0-24, with a higher score indicating an increase in low back pain disability.|units on a scale|Mean|9.7|9.7|Standard Deviation|3.2|3.2|||
4394947|NCT00285649|4222056|B3|||Roland-Morris Disability Questionnaire (RMDQ)|The RMDQ is a widely used health status measure for low back pain. Scoring of the RMDQ ranges from 0-24, with a higher score indicating an increase in low back pain disability.|units on a scale|Mean|9.7|9.7|Standard Deviation|3.0|3.0|||
4394948|NCT00285649|4222057|B2|||Roland-Morris Disability Questionnaire (RMDQ)|The RMDQ is a widely used health status measure for low back pain. Scoring of the RMDQ ranges from 0-24, with a higher score indicating an increase in low back pain disability.|units on a scale|Mean|9.5|9.5|Standard Deviation|3.0|3.0|||
4394949|NCT00285649|4222058|B1|||Roland-Morris Disability Questionnaire (RMDQ)|The RMDQ is a widely used health status measure for low back pain. Scoring of the RMDQ ranges from 0-24, with a higher score indicating an increase in low back pain disability.|units on a scale|Mean|9.8|9.8|Standard Deviation|3.6|3.6|||
4394950|NCT00285649|4222055|B4|Participant Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4394951|NCT00285649|4222056|B3|Participant Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4394952|NCT00285649|4222057|B2|Participant Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4394953|NCT00285649|4222058|B1|Participant Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4394954|NCT00285649|4222055|B4|Participant Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|169|169.0||||||
4394955|NCT00285649|4222056|B3|Participant Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4394956|NCT00285649|4222057|B2|Participant Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
4394957|NCT00285649|4222058|B1|Participant Race|White|Race/Ethnicity, Customized||Participants|Count of Participants|63|63.0||||||
4394958|NCT00285649|4222055|B4||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4394959|NCT00285649|4222056|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4394960|NCT00285649|4222057|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4394961|NCT00285649|4222058|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4394962|NCT00285649|4222055|B4||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4394963|NCT00285649|4222056|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4394964|NCT00285649|4222057|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4394965|NCT00285649|4222058|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4394966|NCT00285649|4222055|B4|||Age||years|Mean|40.0|40.0|Standard Deviation|9.4|9.4|||
4394967|NCT00285649|4222056|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|9.5|9.5|||
4394968|NCT00285649|4222057|B2|||Age||years|Mean|39.3|39.3|Standard Deviation|8.8|8.8|||
4394969|NCT00285649|4222058|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|10.0|10.0|||
4394970|NCT00285584|4222068|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4394971|NCT00285584|4222069|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4394972|NCT00285584|4222070|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4394973|NCT00285584|4222068|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394974|NCT00285584|4222069|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394975|NCT00285584|4222070|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394976|NCT00285584|4222068|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4394977|NCT00285584|4222069|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394978|NCT00285584|4222070|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4394979|NCT00285584|4222068|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4394980|NCT00285584|4222069|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4394981|NCT00285584|4222070|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4394982|NCT00285584|4222068|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4394983|NCT00285584|4222069|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4394984|NCT00285584|4222070|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4394985|NCT00285584|4222068|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394986|NCT00285584|4222069|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394987|NCT00285584|4222070|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394988|NCT00285584|4222068|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4394989|NCT00285584|4222069|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4394990|NCT00285584|4222070|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4394991|NCT00285584|4222068|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394992|NCT00285584|4222069|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394993|NCT00285584|4222070|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394994|NCT00285584|4222068|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394995|NCT00285584|4222069|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394996|NCT00285584|4222070|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4394997|NCT00285584|4222068|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4394998|NCT00285584|4222069|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4394999|NCT00285584|4222070|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4395000|NCT00285584|4222068|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4395001|NCT00285584|4222069|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4395002|NCT00285584|4222070|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4395003|NCT00285584|4222068|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4395004|NCT00285584|4222069|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4395005|NCT00285584|4222070|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4395006|NCT00285584|4222068|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395007|NCT00285584|4222069|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395008|NCT00285584|4222070|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395009|NCT00285584|4222068|B3|||Age||years|Median|32|32.0|Full Range|||20.0|48.0|
4395010|NCT00285584|4222069|B2|||Age||years|Median|32|32.0|Full Range|||20.0|48.0|
4395011|NCT00285584|4222070|B1|||Age||years|Median|32.5|32.5|Full Range|||23.0|48.0|
4395012|NCT00285467|4222083|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4395013|NCT00285467|4222084|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4395014|NCT00285467|4222085|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4395015|NCT00285467|4222083|B3||Male|Sex: Female, Male|55 subjects were consents and underwent qualifying blood tests. 47 subjects were randomized to treatment: 25 to doxercalciferol and 22 to cholecalciferol.|Participants|Count of Participants|26|26.0||||||
4395016|NCT00285467|4222084|B2||Male|Sex: Female, Male|55 subjects were consents and underwent qualifying blood tests. 47 subjects were randomized to treatment: 25 to doxercalciferol and 22 to cholecalciferol.|Participants|Count of Participants|10|10.0||||||
4395017|NCT00285467|4222085|B1||Male|Sex: Female, Male|55 subjects were consents and underwent qualifying blood tests. 47 subjects were randomized to treatment: 25 to doxercalciferol and 22 to cholecalciferol.|Participants|Count of Participants|16|16.0||||||
4395018|NCT00285467|4222083|B3||Female|Sex: Female, Male|55 subjects were consents and underwent qualifying blood tests. 47 subjects were randomized to treatment: 25 to doxercalciferol and 22 to cholecalciferol.|Participants|Count of Participants|21|21.0||||||
4395019|NCT00285467|4222084|B2||Female|Sex: Female, Male|55 subjects were consents and underwent qualifying blood tests. 47 subjects were randomized to treatment: 25 to doxercalciferol and 22 to cholecalciferol.|Participants|Count of Participants|12|12.0||||||
4395020|NCT00285467|4222085|B1||Female|Sex: Female, Male|55 subjects were consents and underwent qualifying blood tests. 47 subjects were randomized to treatment: 25 to doxercalciferol and 22 to cholecalciferol.|Participants|Count of Participants|9|9.0||||||
4395021|NCT00285467|4222083|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|10|10.0|||
4395022|NCT00285467|4222084|B2|||Age||years|Mean|62|62.0|Standard Deviation|10|10.0|||
4395023|NCT00285467|4222085|B1|||Age||years|Mean|65|65.0|Standard Deviation|10|10.0|||
4395024|NCT00285246|4222094|B1|United States||Region of Enrollment||participants|Number|838|838.0||||||
4395025|NCT00285246|4222094|B1|Unknown/Not Provided||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4395026|NCT00285246|4222094|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4395027|NCT00285246|4222094|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4395028|NCT00285246|4222094|B1|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4395029|NCT00285246|4222094|B1|Black/African American/Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4395030|NCT00285246|4222094|B1|Black/African American/Non-Hispanic||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4395031|NCT00285246|4222094|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4395032|NCT00285246|4222094|B1|White/Causasian||Race/Ethnicity, Customized||participants|Number|564|564.0||||||
4395033|NCT00285246|4222094|B1||Male|Sex: Female, Male||Participants|Count of Participants|742|742.0||||||
4395034|NCT00285246|4222094|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4395035|NCT00285246|4222094|B1|||Age||years|Mean|27.9|27.9|Standard Deviation|8.3|8.3|||
4395036|NCT00285207|4222101|B3|United States||Region of Enrollment||participants|Number|147|147.0||||||
4395037|NCT00285207|4222102|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4395038|NCT00285207|4222103|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4395039|NCT00285207|4222101|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395040|NCT00285207|4222102|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395041|NCT00285207|4222103|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395042|NCT00285207|4222101|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4395043|NCT00285207|4222102|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4395044|NCT00285207|4222103|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4395045|NCT00285207|4222101|B3|||Age||years|Mean|28.4|28.4|Standard Deviation|7.1|7.1|||
4395046|NCT00285207|4222102|B2|||Age||years|Mean|28.7|28.7|Standard Deviation|7.9|7.9|||
4395047|NCT00285207|4222103|B1|||Age||years|Mean|28|28.0|Standard Deviation|6|6.0|||
4395048|NCT00285207|4222101|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395049|NCT00285207|4222102|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395050|NCT00285207|4222103|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395051|NCT00285207|4222101|B3||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4395052|NCT00285207|4222102|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4395053|NCT00285207|4222103|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4395054|NCT00285207|4222101|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395055|NCT00285207|4222102|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395056|NCT00285207|4222103|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395057|NCT00285012|4222110|B3||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4395058|NCT00285012|4222111|B2||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4395059|NCT00285012|4222112|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4395060|NCT00285012|4222110|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4395061|NCT00285012|4222111|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4395062|NCT00285012|4222112|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4395063|NCT00285012|4222110|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|9.1|9.1|||
4395064|NCT00285012|4222111|B2|||Age||years|Mean|57.1|57.1|Standard Deviation|9.0|9.0|||
4395065|NCT00285012|4222112|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|9.1|9.1|||
4395066|NCT00284934|4222137|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4395067|NCT00284934|4222138|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4395068|NCT00284934|4222139|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4395069|NCT00284934|4222137|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4395070|NCT00284934|4222138|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4395071|NCT00284934|4222139|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4395072|NCT00284934|4222137|B3|>= 60||Age, Customized||Participants|Number|30|30.0||||||
4395073|NCT00284934|4222138|B2|>= 60||Age, Customized||Participants|Number|12|12.0||||||
4395074|NCT00284934|4222139|B1|>= 60||Age, Customized||Participants|Number|18|18.0||||||
4395075|NCT00284934|4222137|B3|45-60||Age, Customized||Participants|Number|38|38.0||||||
4395076|NCT00284934|4222138|B2|45-60||Age, Customized||Participants|Number|20|20.0||||||
4395077|NCT00284934|4222139|B1|45-60||Age, Customized||Participants|Number|18|18.0||||||
4395078|NCT00284934|4222137|B3|< 45||Age, Customized||Participants|Number|24|24.0||||||
4395079|NCT00284934|4222138|B2|< 45||Age, Customized||Participants|Number|13|13.0||||||
4395080|NCT00284934|4222139|B1|< 45||Age, Customized||Participants|Number|11|11.0||||||
4395081|NCT00284934|4222137|B3|||Age||Years|Mean|52.7|52.7|Standard Deviation|11|11.0|||
4395082|NCT00284934|4222138|B2|||Age||Years|Mean|50.7|50.7|Standard Deviation|12.2|12.2|||
4395083|NCT00284934|4222139|B1|||Age||Years|Mean|54.5|54.5|Standard Deviation|10.4|10.4|||
4395084|NCT00284856|4222152|B4||Male|Sex: Female, Male||Participants|Count of Participants|543|543.0||||||
4395085|NCT00284856|4222153|B3||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4395086|NCT00284856|4222154|B2||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4395087|NCT00284856|4222155|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4395088|NCT00284856|4222152|B4||Female|Sex: Female, Male||Participants|Count of Participants|476|476.0||||||
4395089|NCT00284856|4222153|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4395090|NCT00284856|4222154|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4395091|NCT00284856|4222155|B1||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4395092|NCT00284856|4222152|B4|||Age||years|Mean|38.0|38.0|Standard Deviation|10.3|10.3|||
4395093|NCT00284856|4222153|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|9.9|9.9|||
4395094|NCT00284856|4222154|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|10.7|10.7|||
4395095|NCT00284856|4222155|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|10.4|10.4|||
4395096|NCT00284739|4222171|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4395097|NCT00284739|4222172|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4395098|NCT00284739|4222173|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4395099|NCT00284739|4222171|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4395100|NCT00284739|4222172|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4395101|NCT00284739|4222173|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4395102|NCT00284739|4222171|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4395103|NCT00284739|4222172|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4395104|NCT00284739|4222173|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4395105|NCT00284739|4222171|B3|||Age||years|Mean|52|52.0|Standard Deviation|20|20.0|||
4395106|NCT00284739|4222172|B2|||Age||years|Mean|57|57.0|Standard Deviation|20|20.0|||
4395107|NCT00284739|4222173|B1|||Age||years|Mean|48|48.0|Standard Deviation|19|19.0|||
4395108|NCT00284739|4222171|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4395109|NCT00284739|4222172|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4395110|NCT00284739|4222173|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4395111|NCT00284739|4222171|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4395112|NCT00284739|4222172|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4395113|NCT00284739|4222173|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4395114|NCT00284739|4222171|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395115|NCT00284739|4222172|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395116|NCT00284739|4222173|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395117|NCT00284557|4222184|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4395118|NCT00284557|4222185|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4395119|NCT00284557|4222186|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4395120|NCT00284557|4222184|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395121|NCT00284557|4222185|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395122|NCT00284557|4222186|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395123|NCT00284557|4222184|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395124|NCT00284557|4222185|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395125|NCT00284557|4222186|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395126|NCT00284557|4222184|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395127|NCT00284557|4222185|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395128|NCT00284557|4222186|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395129|NCT00284557|4222184|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4395130|NCT00284557|4222185|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4395131|NCT00284557|4222186|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4395132|NCT00284557|4222184|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395133|NCT00284557|4222185|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395134|NCT00284557|4222186|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395135|NCT00284557|4222184|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395136|NCT00284557|4222185|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395137|NCT00284557|4222186|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395138|NCT00284557|4222184|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395139|NCT00284557|4222185|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395140|NCT00284557|4222186|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395141|NCT00284557|4222184|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4395142|NCT00284557|4222185|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4395143|NCT00284557|4222186|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4395144|NCT00284557|4222184|B3||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4395145|NCT00284557|4222185|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4395146|NCT00284557|4222186|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4395147|NCT00284557|4222184|B3|||Age||years|Mean|9.4|9.4|Standard Deviation|1.5|1.5|||
4395148|NCT00284557|4222185|B2|||Age||years|Mean|9.3|9.3|Standard Deviation|1.4|1.4|||
4395149|NCT00284557|4222186|B1|||Age||years|Mean|9.5|9.5|Standard Deviation|1.7|1.7|||
4395150|NCT00284557|4222184|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395151|NCT00284557|4222185|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395152|NCT00284557|4222186|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395153|NCT00284557|4222184|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4395154|NCT00284557|4222185|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4395155|NCT00284557|4222186|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4395156|NCT00284557|4222184|B3||<=18 years|Age||Participants|Count of Participants|130|130.0||||||
4395157|NCT00284557|4222185|B2||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
4395158|NCT00284557|4222186|B1||<=18 years|Age||Participants|Count of Participants|67|67.0||||||
4395159|NCT00284518|4222195|B5||Male|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
4395160|NCT00284518|4222196|B4||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4395161|NCT00284518|4222197|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4395162|NCT00284518|4222198|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4395163|NCT00284518|4222199|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4395164|NCT00284518|4222195|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395165|NCT00284518|4222196|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395166|NCT00284518|4222197|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395167|NCT00284518|4222198|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395168|NCT00284518|4222199|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395169|NCT00284518|4222195|B5|>65 Years||Age, Customized||Participants|Number|186|186.0||||||
4395170|NCT00284518|4222196|B4|>65 Years||Age, Customized||Participants|Number|50|50.0||||||
4395171|NCT00284518|4222197|B3|>65 Years||Age, Customized||Participants|Number|39|39.0||||||
4395172|NCT00284518|4222198|B2|>65 Years||Age, Customized||Participants|Number|48|48.0||||||
4395173|NCT00284518|4222199|B1|>65 Years||Age, Customized||Participants|Number|49|49.0||||||
4395174|NCT00284518|4222195|B5|45 to 65 Years||Age, Customized||Participants|Number|194|194.0||||||
4395175|NCT00284518|4222196|B4|45 to 65 Years||Age, Customized||Participants|Number|44|44.0||||||
4395176|NCT00284518|4222197|B3|45 to 65 Years||Age, Customized||Participants|Number|56|56.0||||||
4395177|NCT00284518|4222198|B2|45 to 65 Years||Age, Customized||Participants|Number|46|46.0||||||
4395178|NCT00284518|4222199|B1|45 to 65 Years||Age, Customized||Participants|Number|48|48.0||||||
4395179|NCT00284180|4222240|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4395180|NCT00284180|4222241|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4395181|NCT00284180|4222242|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4395182|NCT00284180|4222240|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395183|NCT00284180|4222241|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395184|NCT00284180|4222242|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395185|NCT00284180|4222240|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4395186|NCT00284180|4222241|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4395187|NCT00284180|4222242|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4395188|NCT00284180|4222240|B3|||Age||years|Median|59|59.0|Full Range|||35.0|78.0|
4395189|NCT00284180|4222241|B2|||Age||years|Median|58|58.0|Full Range|||35.0|78.0|
4395190|NCT00284180|4222242|B1|||Age||years|Median|59|59.0|Full Range|||47.0|78.0|
4395191|NCT00284154|4222249|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4395192|NCT00284154|4222249|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4395193|NCT00284154|4222249|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4395194|NCT00284154|4222249|B1|||Age||years|Mean|61|61.0|Standard Deviation|10.1|10.1|||
4395195|NCT00284154|4222249|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4395196|NCT00284154|4222249|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4395197|NCT00284154|4222249|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395198|NCT00284141|4222256|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4395199|NCT00284141|4222256|B1|Asian, Oriental||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4395200|NCT00284141|4222256|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4395201|NCT00284141|4222256|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4395202|NCT00284141|4222256|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4395203|NCT00284141|4222256|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4395204|NCT00284141|4222256|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|11.0|11.0|||
4395205|NCT00284089|4222275|B5|Male||Gender|Gender demographics for those subjects enrolled in the extension phase of the study.|participants|Number|55|55.0||||||
4395206|NCT00284089|4222276|B4|Male||Gender|Gender demographics for those subjects enrolled in the extension phase of the study.|participants|Number|28|28.0||||||
4395207|NCT00284089|4222277|B3|Male||Gender|Gender demographics for those subjects enrolled in the extension phase of the study.|participants|Number|19|19.0||||||
4395208|NCT00284089|4222278|B2|Male||Gender|Gender demographics for those subjects enrolled in the extension phase of the study.|participants|Number|5|5.0||||||
4395209|NCT00284089|4222279|B1|Male||Gender|Gender demographics for those subjects enrolled in the extension phase of the study.|participants|Number|3|3.0||||||
4395210|NCT00284089|4222275|B5|Female||Gender|Gender demographics for those subjects enrolled in the extension phase of the study.|participants|Number|15|15.0||||||
4395211|NCT00284089|4222276|B4|Female||Gender|Gender demographics for those subjects enrolled in the extension phase of the study.|participants|Number|5|5.0||||||
4395212|NCT00284089|4222277|B3|Female||Gender|Gender demographics for those subjects enrolled in the extension phase of the study.|participants|Number|9|9.0||||||
4395213|NCT00284089|4222278|B2|Female||Gender|Gender demographics for those subjects enrolled in the extension phase of the study.|participants|Number|1|1.0||||||
4395214|NCT00284089|4222279|B1|Female||Gender|Gender demographics for those subjects enrolled in the extension phase of the study.|participants|Number|0|0.0||||||
4395305|NCT00283842|4222353|B5||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4395215|NCT00284089|4222275|B5||Male|Sex: Female, Male|Gender demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Count of Participants|69|69.0||||||
4395216|NCT00284089|4222276|B4||Male|Sex: Female, Male|Gender demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Count of Participants|33|33.0||||||
4395217|NCT00284089|4222277|B3||Male|Sex: Female, Male|Gender demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Count of Participants|26|26.0||||||
4395218|NCT00284089|4222278|B2||Male|Sex: Female, Male|Gender demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Count of Participants|5|5.0||||||
4395219|NCT00284089|4222279|B1||Male|Sex: Female, Male|Gender demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Count of Participants|5|5.0||||||
4395220|NCT00284089|4222275|B5||Female|Sex: Female, Male|Gender demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Count of Participants|19|19.0||||||
4395221|NCT00284089|4222276|B4||Female|Sex: Female, Male|Gender demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Count of Participants|8|8.0||||||
4395222|NCT00284089|4222277|B3||Female|Sex: Female, Male|Gender demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Count of Participants|9|9.0||||||
4395223|NCT00284089|4222278|B2||Female|Sex: Female, Male|Gender demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Count of Participants|1|1.0||||||
4395224|NCT00284089|4222279|B1||Female|Sex: Female, Male|Gender demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Count of Participants|1|1.0||||||
4395225|NCT00284089|4222275|B5|>= 85 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|2|2.0||||||
4395226|NCT00284089|4222276|B4|>= 85 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|1|1.0||||||
4395227|NCT00284089|4222277|B3|>= 85 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|1|1.0||||||
4395228|NCT00284089|4222278|B2|>= 85 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|0|0.0||||||
4395229|NCT00284089|4222279|B1|>= 85 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|0|0.0||||||
4395230|NCT00284089|4222275|B5|75 to <85 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|21|21.0||||||
4395231|NCT00284089|4222276|B4|75 to <85 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|12|12.0||||||
4395232|NCT00284089|4222277|B3|75 to <85 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|6|6.0||||||
4395233|NCT00284089|4222278|B2|75 to <85 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|2|2.0||||||
4395234|NCT00284089|4222279|B1|75 to <85 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|1|1.0||||||
4395235|NCT00284089|4222275|B5|65 to <75 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|29|29.0||||||
4395236|NCT00284089|4222276|B4|65 to <75 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|10|10.0||||||
4395237|NCT00284089|4222277|B3|65 to <75 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|14|14.0||||||
4395238|NCT00284089|4222278|B2|65 to <75 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|4|4.0||||||
4395239|NCT00284089|4222279|B1|65 to <75 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|1|1.0||||||
4395240|NCT00284089|4222275|B5|50 to <65 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|18|18.0||||||
4395241|NCT00284089|4222276|B4|50 to <65 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|10|10.0||||||
4395242|NCT00284089|4222277|B3|50 to <65 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|7|7.0||||||
4395243|NCT00284089|4222278|B2|50 to <65 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|0|0.0||||||
4395244|NCT00284089|4222279|B1|50 to <65 years||Age, Customized|Age demographics for those subjects enrolled in the extension phase of the study.|Participants|Number|1|1.0||||||
4395245|NCT00284089|4222275|B5|>= 85 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|4|4.0||||||
4395246|NCT00284089|4222276|B4|>= 85 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|3|3.0||||||
4395247|NCT00284089|4222277|B3|>= 85 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|1|1.0||||||
4395248|NCT00284089|4222278|B2|>= 85 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|0|0.0||||||
4395249|NCT00284089|4222279|B1|>= 85 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|0|0.0||||||
4395250|NCT00284089|4222275|B5|75 to <85 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|29|29.0||||||
4395251|NCT00284089|4222276|B4|75 to <85 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|15|15.0||||||
4395306|NCT00283842|4222354|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4395252|NCT00284089|4222277|B3|75 to <85 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|10|10.0||||||
4395253|NCT00284089|4222278|B2|75 to <85 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|2|2.0||||||
4395254|NCT00284089|4222279|B1|75 to <85 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|2|2.0||||||
4395255|NCT00284089|4222275|B5|65 to <75 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|35|35.0||||||
4395256|NCT00284089|4222276|B4|65 to <75 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|13|13.0||||||
4395257|NCT00284089|4222277|B3|65 to <75 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|16|16.0||||||
4395258|NCT00284089|4222278|B2|65 to <75 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|4|4.0||||||
4395259|NCT00284089|4222279|B1|65 to <75 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|2|2.0||||||
4395260|NCT00284089|4222275|B5|50 to <65 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|20|20.0||||||
4395261|NCT00284089|4222276|B4|50 to <65 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|10|10.0||||||
4395262|NCT00284089|4222277|B3|50 to <65 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|8|8.0||||||
4395263|NCT00284089|4222278|B2|50 to <65 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|0|0.0||||||
4395264|NCT00284089|4222279|B1|50 to <65 years||Age, Customized|Age demographics for those subjects enrolled in the single and multiple dose phases of the study.|Participants|Number|2|2.0||||||
4395265|NCT00284050|4222308|B4||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4395266|NCT00284050|4222309|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4395267|NCT00284050|4222310|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4395268|NCT00284050|4222311|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4395269|NCT00284050|4222308|B4||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4395270|NCT00284050|4222309|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4395271|NCT00284050|4222310|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4395272|NCT00284050|4222311|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4395273|NCT00284050|4222308|B4|||Age||years|Mean|63.6|63.6|Standard Deviation|9.95|9.95|||
4395274|NCT00284050|4222309|B3|||Age||years|Mean|65.0|65.0|Standard Deviation|9.26|9.26|||
4395275|NCT00284050|4222310|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|10.14|10.14|||
4395276|NCT00284050|4222311|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|10.44|10.44|||
4395277|NCT00283959|4222327|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4395278|NCT00283959|4222327|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395279|NCT00283959|4222327|B1|||Age||years|Mean|33.3|33.3|Standard Deviation|21.5|21.5|||
4395280|NCT00283933|4222332|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4395281|NCT00283933|4222332|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395282|NCT00283933|4222332|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|9.5|9.5|||
4395283|NCT00283868|4222337|B3|United States||Region of Enrollment||participants|Number|222.0|222.0||||||
4395284|NCT00283868|4222338|B2|United States||Region of Enrollment||participants|Number|111|111.0||||||
4395285|NCT00283868|4222339|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
4395286|NCT00283868|4222337|B3||Male|Sex: Female, Male||Participants|Count of Participants|108.0|108.0||||||
4395287|NCT00283868|4222338|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4395288|NCT00283868|4222339|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4395289|NCT00283868|4222337|B3||Female|Sex: Female, Male||Participants|Count of Participants|114.0|114.0||||||
4395290|NCT00283868|4222338|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4395291|NCT00283868|4222339|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4395292|NCT00283868|4222337|B3|||Age||years|Mean|69.7|69.7|Standard Deviation|14.7|14.7|||
4395293|NCT00283868|4222338|B2|||Age||years|Mean|69|69.0|Standard Deviation|14.9|14.9|||
4395294|NCT00283868|4222339|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|14.5|14.5|||
4395295|NCT00283868|4222337|B3||>=65 years|Age||Participants|Count of Participants|148.0|148.0||||||
4395296|NCT00283868|4222338|B2||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4395297|NCT00283868|4222339|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4395298|NCT00283868|4222337|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74.0|74.0||||||
4395299|NCT00283868|4222338|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4395300|NCT00283868|4222339|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4395301|NCT00283868|4222337|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4395302|NCT00283868|4222338|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395303|NCT00283868|4222339|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395304|NCT00283842|4222352|B6||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4395307|NCT00283842|4222355|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4395308|NCT00283842|4222356|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4395309|NCT00283842|4222357|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4395310|NCT00283842|4222352|B6||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4395311|NCT00283842|4222353|B5||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4395312|NCT00283842|4222354|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4395313|NCT00283842|4222355|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4395314|NCT00283842|4222356|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4395315|NCT00283842|4222357|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4395316|NCT00283842|4222352|B6|||Age||years|Mean|60.31|60.31|Standard Deviation|9.16|9.16|||
4395317|NCT00283842|4222353|B5|||Age||years|Mean|58.98|58.98|Standard Deviation|8.51|8.51|||
4395318|NCT00283842|4222354|B4|||Age||years|Mean|61.14|61.14|Standard Deviation|10.03|10.03|||
4395319|NCT00283842|4222355|B3|||Age||years|Mean|59.80|59.8|Standard Deviation|9.38|9.38|||
4395320|NCT00283842|4222356|B2|||Age||years|Mean|60.66|60.66|Standard Deviation|9.23|9.23|||
4395321|NCT00283842|4222357|B1|||Age||years|Mean|61.62|61.62|Standard Deviation|8.59|8.59|||
4395322|NCT00283816|4222378|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4395323|NCT00283816|4222379|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4395324|NCT00283816|4222380|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4395325|NCT00283816|4222378|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395326|NCT00283816|4222379|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395327|NCT00283816|4222380|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395328|NCT00283816|4222378|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4395329|NCT00283816|4222379|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4395330|NCT00283816|4222380|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4395331|NCT00283816|4222378|B3|||Age||years|Mean|15.1|15.1|Standard Deviation|1.6|1.6|||
4395332|NCT00283816|4222379|B2|||Age||years|Mean|15.8|15.8|Standard Deviation|1.6|1.6|||
4395333|NCT00283816|4222380|B1|||Age||years|Mean|14.7|14.7|Standard Deviation|1.6|1.6|||
4395334|NCT00283816|4222378|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395335|NCT00283816|4222379|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395336|NCT00283816|4222380|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395337|NCT00283816|4222378|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4395338|NCT00283816|4222379|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4395339|NCT00283816|4222380|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4395340|NCT00283816|4222378|B3||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4395341|NCT00283816|4222379|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4395342|NCT00283816|4222380|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4395343|NCT00283803|4222393|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4395344|NCT00283803|4222393|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395345|NCT00283803|4222393|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395346|NCT00283803|4222393|B1||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4395347|NCT00283803|4222393|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4395348|NCT00283803|4222393|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395349|NCT00283803|4222393|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395350|NCT00283803|4222393|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395351|NCT00283803|4222393|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4395352|NCT00283803|4222393|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395353|NCT00283803|4222393|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4395354|NCT00283803|4222393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4395355|NCT00283803|4222393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395356|NCT00283712|4222399|B3|Any eye, esophageal, laryngeal involvement||Pemphigus Vulgaris Disease Activity Score: Other Organ System|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|1|1.0||||||
4395357|NCT00283712|4222400|B2|Any eye, esophageal, laryngeal involvement||Pemphigus Vulgaris Disease Activity Score: Other Organ System|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|0|0.0||||||
4395358|NCT00283712|4222401|B1|Any eye, esophageal, laryngeal involvement||Pemphigus Vulgaris Disease Activity Score: Other Organ System|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|1|1.0||||||
4395359|NCT00283712|4222399|B3|No eye, esophageal, laryngeal involvement||Pemphigus Vulgaris Disease Activity Score: Other Organ System|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|19|19.0||||||
4395360|NCT00283712|4222400|B2|No eye, esophageal, laryngeal involvement||Pemphigus Vulgaris Disease Activity Score: Other Organ System|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|10|10.0||||||
4395361|NCT00283712|4222401|B1|No eye, esophageal, laryngeal involvement||Pemphigus Vulgaris Disease Activity Score: Other Organ System|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|9|9.0||||||
4395362|NCT00283712|4222399|B3|>40 blisters or >10% BSA||Pemphigus Vulgaris Disease Activity Score: Cutaneous|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|2|2.0||||||
4395363|NCT00283712|4222400|B2|>40 blisters or >10% BSA||Pemphigus Vulgaris Disease Activity Score: Cutaneous|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|1|1.0||||||
4395364|NCT00283712|4222401|B1|>40 blisters or >10% BSA||Pemphigus Vulgaris Disease Activity Score: Cutaneous|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|1|1.0||||||
4395365|NCT00283712|4222399|B3|20 to 40 blisters or 3 to 10% BSA||Pemphigus Vulgaris Disease Activity Score: Cutaneous|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|6|6.0||||||
4395366|NCT00283712|4222400|B2|20 to 40 blisters or 3 to 10% BSA||Pemphigus Vulgaris Disease Activity Score: Cutaneous|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|2|2.0||||||
4395367|NCT00283712|4222401|B1|20 to 40 blisters or 3 to 10% BSA||Pemphigus Vulgaris Disease Activity Score: Cutaneous|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|4|4.0||||||
4395389|NCT00283712|4222399|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4395390|NCT00283712|4222400|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4395368|NCT00283712|4222399|B3|<20 blisters or <1 to 3% BSA||Pemphigus Vulgaris Disease Activity Score: Cutaneous|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|6|6.0||||||
4395369|NCT00283712|4222400|B2|<20 blisters or <1 to 3% BSA||Pemphigus Vulgaris Disease Activity Score: Cutaneous|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|4|4.0||||||
4395370|NCT00283712|4222401|B1|<20 blisters or <1 to 3% BSA||Pemphigus Vulgaris Disease Activity Score: Cutaneous|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|2|2.0||||||
4395371|NCT00283712|4222399|B3|No blisters or erosions||Pemphigus Vulgaris Disease Activity Score: Cutaneous|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|6|6.0||||||
4395372|NCT00283712|4222400|B2|No blisters or erosions||Pemphigus Vulgaris Disease Activity Score: Cutaneous|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|3|3.0||||||
4395373|NCT00283712|4222401|B1|No blisters or erosions||Pemphigus Vulgaris Disease Activity Score: Cutaneous|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|3|3.0||||||
4395374|NCT00283712|4222399|B3|>10 lesions or extension erosions||Pemphigus Vulgaris Disease Activity Score: Mucosal|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|2|2.0||||||
4395375|NCT00283712|4222400|B2|>10 lesions or extension erosions||Pemphigus Vulgaris Disease Activity Score: Mucosal|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|1|1.0||||||
4395376|NCT00283712|4222401|B1|>10 lesions or extension erosions||Pemphigus Vulgaris Disease Activity Score: Mucosal|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|1|1.0||||||
4395377|NCT00283712|4222399|B3|6 to 10 lesions, small ulcers||Pemphigus Vulgaris Disease Activity Score: Mucosal|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|7|7.0||||||
4395391|NCT00283712|4222401|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4395392|NCT00283712|4222399|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4395378|NCT00283712|4222400|B2|6 to 10 lesions, small ulcers||Pemphigus Vulgaris Disease Activity Score: Mucosal|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|5|5.0||||||
4395379|NCT00283712|4222401|B1|6 to 10 lesions, small ulcers||Pemphigus Vulgaris Disease Activity Score: Mucosal|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|2|2.0||||||
4395380|NCT00283712|4222399|B3|1 to 5 lesions, small ulcers||Pemphigus Vulgaris Disease Activity Score: Mucosal|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|8|8.0||||||
4395381|NCT00283712|4222400|B2|1 to 5 lesions, small ulcers||Pemphigus Vulgaris Disease Activity Score: Mucosal|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|2|2.0||||||
4395382|NCT00283712|4222401|B1|1 to 5 lesions, small ulcers||Pemphigus Vulgaris Disease Activity Score: Mucosal|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|6|6.0||||||
4395383|NCT00283712|4222399|B3|No oral ulcers||Pemphigus Vulgaris Disease Activity Score: Mucosal|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|3|3.0||||||
4395384|NCT00283712|4222400|B2|No oral ulcers||Pemphigus Vulgaris Disease Activity Score: Mucosal|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|2|2.0||||||
4395385|NCT00283712|4222401|B1|No oral ulcers||Pemphigus Vulgaris Disease Activity Score: Mucosal|The Pemphigus Vulgaris Disease Activity(PVDA)score was used to grade a participant’s baseline disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area(BSA)involved. Scores were based on the number of lesions and blisters present as well as total body surface area involved. Three types of disease activity were assessed: mucosal, cutaneous, and other organ system. A higher score indicates more severe disease activity. For each of the 3 types of disease activity, the number of participants who met the disease activity condition is shown.|Participants|Number|1|1.0||||||
4395386|NCT00283712|4222399|B3|||PDAI Index Total Score|The Pemphigus Disease Area Index (PDAI) was developed by the International Pemphigus Committee and measures both activity of and damage due to pemphigus on the skin, scalp, and mucous membranes. Total scores can range from 0 to a possible 263 maximum score, with 250 points representing disease activity (120 points for skin activity, 10 points for scalp activity, and 120 points for mucosal activity) and 13 points representing disease damage. Higher scores reflect worse disease.|Total Activity Score|Mean|21.9|21.9|Standard Deviation|12.4|12.4|||
4395387|NCT00283712|4222400|B2|||PDAI Index Total Score|The Pemphigus Disease Area Index (PDAI) was developed by the International Pemphigus Committee and measures both activity of and damage due to pemphigus on the skin, scalp, and mucous membranes. Total scores can range from 0 to a possible 263 maximum score, with 250 points representing disease activity (120 points for skin activity, 10 points for scalp activity, and 120 points for mucosal activity) and 13 points representing disease damage. Higher scores reflect worse disease.|Total Activity Score|Mean|20.8|20.8|Standard Deviation|10.7|10.7|||
4395388|NCT00283712|4222401|B1|||PDAI Index Total Score|The Pemphigus Disease Area Index (PDAI) was developed by the International Pemphigus Committee and measures both activity of and damage due to pemphigus on the skin, scalp, and mucous membranes. Total scores can range from 0 to a possible 263 maximum score, with 250 points representing disease activity (120 points for skin activity, 10 points for scalp activity, and 120 points for mucosal activity) and 13 points representing disease damage. Higher scores reflect worse disease.|Total Activity Score|Mean|23.0|23.0|Standard Deviation|14.6|14.6|||
4395393|NCT00283712|4222400|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4395394|NCT00283712|4222401|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4395395|NCT00283712|4222399|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4395396|NCT00283712|4222400|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4395397|NCT00283712|4222401|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4395398|NCT00283712|4222399|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|14.3|14.3|||
4395399|NCT00283712|4222400|B2|||Age||years|Mean|51.1|51.1|Standard Deviation|13.9|13.9|||
4395400|NCT00283712|4222401|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|15.2|15.2|||
4395401|NCT00283712|4222399|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4395402|NCT00283712|4222400|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4395403|NCT00283712|4222401|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395404|NCT00283712|4222399|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4395405|NCT00283712|4222400|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4395406|NCT00283712|4222401|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4395407|NCT00283712|4222399|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395408|NCT00283712|4222400|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395409|NCT00283712|4222401|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395410|NCT00283686|4222436|B5|No information||PKD Genotype||participants|Number|46|46.0||||||
4395411|NCT00283686|4222437|B4|No information||PKD Genotype||participants|Number|13|13.0||||||
4395412|NCT00283686|4222438|B3|No information||PKD Genotype||participants|Number|12|12.0||||||
4395413|NCT00283686|4222439|B2|No information||PKD Genotype||participants|Number|9|9.0||||||
4395414|NCT00283686|4222440|B1|No information||PKD Genotype||participants|Number|12|12.0||||||
4395415|NCT00283686|4222436|B5|No Mutation Detected||PKD Genotype||participants|Number|46|46.0||||||
4395416|NCT00283686|4222437|B4|No Mutation Detected||PKD Genotype||participants|Number|14|14.0||||||
4395417|NCT00283686|4222438|B3|No Mutation Detected||PKD Genotype||participants|Number|12|12.0||||||
4395418|NCT00283686|4222439|B2|No Mutation Detected||PKD Genotype||participants|Number|10|10.0||||||
4395419|NCT00283686|4222440|B1|No Mutation Detected||PKD Genotype||participants|Number|10|10.0||||||
4395420|NCT00283686|4222436|B5|PKD2||PKD Genotype||participants|Number|84|84.0||||||
4395421|NCT00283686|4222437|B4|PKD2||PKD Genotype||participants|Number|23|23.0||||||
4395422|NCT00283686|4222438|B3|PKD2||PKD Genotype||participants|Number|19|19.0||||||
4395423|NCT00283686|4222439|B2|PKD2||PKD Genotype||participants|Number|27|27.0||||||
4395424|NCT00283686|4222440|B1|PKD2||PKD Genotype||participants|Number|15|15.0||||||
4395425|NCT00283686|4222436|B5|PKD1||PKD Genotype||participants|Number|382|382.0||||||
4395426|NCT00283686|4222437|B4|PKD1||PKD Genotype||participants|Number|91|91.0||||||
4395427|NCT00283686|4222438|B3|PKD1||PKD Genotype||participants|Number|101|101.0||||||
4395428|NCT00283686|4222439|B2|PKD1||PKD Genotype||participants|Number|87|87.0||||||
4395429|NCT00283686|4222440|B1|PKD1||PKD Genotype||participants|Number|103|103.0||||||
4395430|NCT00283686|4222436|B5|||Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) eGFR (ml/min/m2)||ml/min/m2|Mean|88.9|88.9|Standard Deviation|18.5|18.5|||
4395431|NCT00283686|4222437|B4|||Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) eGFR (ml/min/m2)||ml/min/m2|Mean|87.6|87.6|Standard Deviation|17.2|17.2|||
4395432|NCT00283686|4222438|B3|||Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) eGFR (ml/min/m2)||ml/min/m2|Mean|92.9|92.9|Standard Deviation|18.5|18.5|||
4395433|NCT00283686|4222439|B2|||Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) eGFR (ml/min/m2)||ml/min/m2|Mean|86.5|86.5|Standard Deviation|19.3|19.3|||
4395434|NCT00283686|4222440|B1|||Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) eGFR (ml/min/m2)||ml/min/m2|Mean|88.5|88.5|Standard Deviation|18.8|18.8|||
4395435|NCT00283686|4222436|B5|||Serum Creatinine (mg/dl)||mg/dl|Mean|1.0|1.0|Standard Deviation|0.2|0.2|||
4395436|NCT00283686|4222437|B4|||Serum Creatinine (mg/dl)||mg/dl|Mean|1.0|1.0|Standard Deviation|0.2|0.2|||
4395437|NCT00283686|4222438|B3|||Serum Creatinine (mg/dl)||mg/dl|Mean|0.9|0.9|Standard Deviation|0.2|0.2|||
4395438|NCT00283686|4222439|B2|||Serum Creatinine (mg/dl)||mg/dl|Mean|1.0|1.0|Standard Deviation|0.2|0.2|||
4395439|NCT00283686|4222440|B1|||Serum Creatinine (mg/dl)||mg/dl|Mean|1.0|1.0|Standard Deviation|0.3|0.3|||
4395440|NCT00283686|4222436|B5|||Body Mass Index (kg/m2)||kg/m2|Mean|27.2|27.2|Standard Deviation|5.2|5.2|||
4395441|NCT00283686|4222437|B4|||Body Mass Index (kg/m2)||kg/m2|Mean|26.8|26.8|Standard Deviation|4.8|4.8|||
4395442|NCT00283686|4222438|B3|||Body Mass Index (kg/m2)||kg/m2|Mean|27.3|27.3|Standard Deviation|5.5|5.5|||
4395443|NCT00283686|4222439|B2|||Body Mass Index (kg/m2)||kg/m2|Mean|27.4|27.4|Standard Deviation|5.1|5.1|||
4395444|NCT00283686|4222440|B1|||Body Mass Index (kg/m2)||kg/m2|Mean|27.4|27.4|Standard Deviation|5.4|5.4|||
4395445|NCT00283686|4222436|B5|||Age at Diagnosis of autosomal dominant polycystic kidney disease (ADPKD)||years|Mean|27.6|27.6|Standard Deviation|10.0|10.0|||
4395446|NCT00283686|4222437|B4|||Age at Diagnosis of autosomal dominant polycystic kidney disease (ADPKD)||years|Mean|27.6|27.6|Standard Deviation|10.4|10.4|||
4395447|NCT00283686|4222438|B3|||Age at Diagnosis of autosomal dominant polycystic kidney disease (ADPKD)||years|Mean|27.0|27.0|Standard Deviation|9.5|9.5|||
4395448|NCT00283686|4222439|B2|||Age at Diagnosis of autosomal dominant polycystic kidney disease (ADPKD)||years|Mean|28.5|28.5|Standard Deviation|10.0|10.0|||
4395449|NCT00283686|4222440|B1|||Age at Diagnosis of autosomal dominant polycystic kidney disease (ADPKD)||years|Mean|27.2|27.2|Standard Deviation|10.0|10.0|||
4395450|NCT00283686|4222436|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4395451|NCT00283686|4222437|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395452|NCT00283686|4222438|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395453|NCT00283686|4222439|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395454|NCT00283686|4222440|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4395455|NCT00283686|4222436|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4395456|NCT00283686|4222437|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4395457|NCT00283686|4222438|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4395458|NCT00283686|4222439|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4395459|NCT00283686|4222440|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4395460|NCT00283686|4222436|B5||White|Race (NIH/OMB)||Participants|Count of Participants|517|517.0||||||
4395461|NCT00283686|4222437|B4||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4395462|NCT00283686|4222438|B3||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4395463|NCT00283686|4222439|B2||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4395464|NCT00283686|4222440|B1||White|Race (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4395465|NCT00283686|4222436|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4395466|NCT00283686|4222437|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4395467|NCT00283686|4222438|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4395468|NCT00283686|4222439|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4395469|NCT00283686|4222440|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4395470|NCT00283686|4222436|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395471|NCT00283686|4222437|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395472|NCT00283686|4222438|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395473|NCT00283686|4222439|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395474|NCT00283686|4222440|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395475|NCT00283686|4222436|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4395476|NCT00283686|4222437|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4395477|NCT00283686|4222438|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4395478|NCT00283686|4222439|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4395479|NCT00283686|4222440|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4395480|NCT00283686|4222436|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4395481|NCT00283686|4222437|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4395482|NCT00283686|4222438|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4395483|NCT00283686|4222439|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395484|NCT00283686|4222440|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4395485|NCT00283686|4222436|B5||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4395486|NCT00283686|4222437|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4395487|NCT00283686|4222438|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4395488|NCT00283686|4222439|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4395489|NCT00283686|4222440|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4395490|NCT00283686|4222436|B5||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4395491|NCT00283686|4222437|B4||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4395492|NCT00283686|4222438|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4395493|NCT00283686|4222439|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4395494|NCT00283686|4222440|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4395495|NCT00283686|4222436|B5|||Age||years|Mean|36.7|36.7|Standard Deviation|8.3|8.3|||
4395496|NCT00283686|4222437|B4|||Age||years|Mean|36.8|36.8|Standard Deviation|8.0|8.0|||
4395497|NCT00283686|4222438|B3|||Age||years|Mean|35.8|35.8|Standard Deviation|8.6|8.6|||
4395498|NCT00283686|4222439|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|8.4|8.4|||
4395499|NCT00283686|4222440|B1|||Age||years|Mean|37.0|37.0|Standard Deviation|8.3|8.3|||
4395500|NCT00283595|4222485|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4395501|NCT00283595|4222486|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4395502|NCT00283595|4222487|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4395503|NCT00283595|4222485|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395504|NCT00283595|4222486|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395505|NCT00283595|4222487|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395506|NCT00283595|4222485|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4395507|NCT00283595|4222486|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4395508|NCT00283595|4222487|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4395509|NCT00283595|4222485|B3|||Age||years|Mean|28.7|28.7|Standard Deviation|7.5|7.5|||
4395510|NCT00283595|4222486|B2|||Age||years|Mean|29.2|29.2|Standard Deviation|8.6|8.6|||
4395511|NCT00283595|4222487|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|6.7|6.7|||
4395512|NCT00283504|4222496|B3|moderate||asthma severity||Participants|Count of Participants|6|6.0||||||
4395513|NCT00283504|4222497|B2|moderate||asthma severity||Participants|Count of Participants|4|4.0||||||
4395514|NCT00283504|4222498|B1|moderate||asthma severity||Participants|Count of Participants|2|2.0||||||
4395515|NCT00283504|4222496|B3|severe||asthma severity||Participants|Count of Participants|7|7.0||||||
4395516|NCT00283504|4222497|B2|severe||asthma severity||Participants|Count of Participants|2|2.0||||||
4395517|NCT00283504|4222498|B1|severe||asthma severity||Participants|Count of Participants|5|5.0||||||
4395518|NCT00283504|4222496|B3|neutrophilic sputum||number of participants with eosinophilic or non eosinophilic (neutrophilic) sputum|The category of eosinophilic patients were based on their sputum eosinophils of >2.5% of total cells. The non eosinophilic patients on the other hand have >50% of neutrophils and <2.5 % eosinophils in their total sputum cells.|Participants|Count of Participants|6|6.0||||||
4395519|NCT00283504|4222497|B2|neutrophilic sputum||number of participants with eosinophilic or non eosinophilic (neutrophilic) sputum|The category of eosinophilic patients were based on their sputum eosinophils of >2.5% of total cells. The non eosinophilic patients on the other hand have >50% of neutrophils and <2.5 % eosinophils in their total sputum cells.|Participants|Count of Participants|6|6.0||||||
4395520|NCT00283504|4222498|B1|neutrophilic sputum||number of participants with eosinophilic or non eosinophilic (neutrophilic) sputum|The category of eosinophilic patients were based on their sputum eosinophils of >2.5% of total cells. The non eosinophilic patients on the other hand have >50% of neutrophils and <2.5 % eosinophils in their total sputum cells.|Participants|Count of Participants|0|0.0||||||
4395521|NCT00283504|4222496|B3|eosinophilic sputum||number of participants with eosinophilic or non eosinophilic (neutrophilic) sputum|The category of eosinophilic patients were based on their sputum eosinophils of >2.5% of total cells. The non eosinophilic patients on the other hand have >50% of neutrophils and <2.5 % eosinophils in their total sputum cells.|Participants|Count of Participants|7|7.0||||||
4395522|NCT00283504|4222497|B2|eosinophilic sputum||number of participants with eosinophilic or non eosinophilic (neutrophilic) sputum|The category of eosinophilic patients were based on their sputum eosinophils of >2.5% of total cells. The non eosinophilic patients on the other hand have >50% of neutrophils and <2.5 % eosinophils in their total sputum cells.|Participants|Count of Participants|0|0.0||||||
4395523|NCT00283504|4222498|B1|eosinophilic sputum||number of participants with eosinophilic or non eosinophilic (neutrophilic) sputum|The category of eosinophilic patients were based on their sputum eosinophils of >2.5% of total cells. The non eosinophilic patients on the other hand have >50% of neutrophils and <2.5 % eosinophils in their total sputum cells.|Participants|Count of Participants|7|7.0||||||
4395524|NCT00283504|4222496|B3|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4395525|NCT00283504|4222497|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4395526|NCT00283504|4222498|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4395527|NCT00283504|4222496|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395528|NCT00283504|4222497|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395529|NCT00283504|4222498|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395530|NCT00283504|4222496|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395531|NCT00283504|4222497|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395532|NCT00283504|4222498|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395533|NCT00283504|4222496|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4395534|NCT00283504|4222497|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4395535|NCT00283504|4222498|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395536|NCT00283504|4222496|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4395537|NCT00283504|4222497|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4395538|NCT00283504|4222498|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4395539|NCT00283504|4222496|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395540|NCT00283504|4222497|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395541|NCT00283504|4222498|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395542|NCT00283504|4222496|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395543|NCT00283504|4222497|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395544|NCT00283504|4222498|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395545|NCT00283504|4222496|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395546|NCT00283504|4222497|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395547|NCT00283504|4222498|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4395548|NCT00283504|4222496|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4395549|NCT00283504|4222497|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4395550|NCT00283504|4222498|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4395551|NCT00283504|4222496|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4395552|NCT00283504|4222497|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4395553|NCT00283504|4222498|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4395554|NCT00283504|4222496|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395555|NCT00283504|4222497|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395556|NCT00283504|4222498|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395557|NCT00283504|4222496|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4395558|NCT00283504|4222497|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4395559|NCT00283504|4222498|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4395560|NCT00283504|4222496|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4395561|NCT00283504|4222497|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4395562|NCT00283504|4222498|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4395563|NCT00283439|4222509|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|3|3.0||||||
4395564|NCT00283439|4222510|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4395565|NCT00283439|4222511|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4395566|NCT00283439|4222512|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4395567|NCT00283439|4222513|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|2|2.0||||||
4395568|NCT00283439|4222509|B5|Black or African American||Race/Ethnicity, Customized||Participant|Number|2|2.0||||||
4395569|NCT00283439|4222510|B4|Black or African American||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4395570|NCT00283439|4222511|B3|Black or African American||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4395571|NCT00283439|4222512|B2|Black or African American||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4395572|NCT00283439|4222513|B1|Black or African American||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4395573|NCT00283439|4222509|B5|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|34|34.0||||||
4395574|NCT00283439|4222510|B4|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|8|8.0||||||
4395575|NCT00283439|4222511|B3|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|10|10.0||||||
4395576|NCT00283439|4222512|B2|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|10|10.0||||||
4395577|NCT00283439|4222513|B1|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|6|6.0||||||
4395578|NCT00283439|4222509|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4395579|NCT00283439|4222510|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4395580|NCT00283439|4222511|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4395581|NCT00283439|4222512|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4395582|NCT00283439|4222513|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4395583|NCT00283439|4222509|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4395584|NCT00283439|4222510|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4395585|NCT00283439|4222511|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4395586|NCT00283439|4222512|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4395587|NCT00283439|4222513|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4395588|NCT00283439|4222509|B5|||Age||Year|Mean|58.0|58.0|Standard Deviation|11.5|11.5|||
4395589|NCT00283439|4222510|B4|||Age||Year|Mean|59.9|59.9|Standard Deviation|10.6|10.6|||
4395590|NCT00283439|4222511|B3|||Age||Year|Mean|54.0|54.0|Standard Deviation|16.3|16.3|||
4395591|NCT00283439|4222512|B2|||Age||Year|Mean|58.1|58.1|Standard Deviation|9.5|9.5|||
4395592|NCT00283439|4222513|B1|||Age||Year|Mean|61.3|61.3|Standard Deviation|6.2|6.2|||
4395593|NCT00283400|4222538|B5|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4395594|NCT00283400|4222540|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4395595|NCT00283400|4222541|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4395596|NCT00283400|4222542|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4395597|NCT00283400|4222538|B5|United States||Region of Enrollment||participants|Number|31|31.0||||||
4395598|NCT00283400|4222540|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4395599|NCT00283400|4222541|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4395600|NCT00283400|4222542|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4395601|NCT00283400|4222538|B5|Male||Gender||participants|Number|13|13.0||||||
4395602|NCT00283400|4222540|B3|Male||Gender||participants|Number|1|1.0||||||
4395603|NCT00283400|4222541|B2|Male||Gender||participants|Number|7|7.0||||||
4395604|NCT00283400|4222542|B1|Male||Gender||participants|Number|5|5.0||||||
4395605|NCT00283400|4222538|B5|Female||Gender||participants|Number|34|34.0||||||
4395606|NCT00283400|4222540|B3|Female||Gender||participants|Number|6|6.0||||||
4395607|NCT00283400|4222541|B2|Female||Gender||participants|Number|13|13.0||||||
4395608|NCT00283400|4222542|B1|Female||Gender||participants|Number|15|15.0||||||
4395609|NCT00283400|4222538|B5|||Age||years|Mean|51|51.0|Standard Deviation|25|25.0|||
4395610|NCT00283400|4222540|B3|||Age||years|Mean|55|55.0|Standard Deviation|25|25.0|||
4395611|NCT00283400|4222541|B2|||Age||years|Mean|51|51.0|Standard Deviation|24|24.0|||
4395612|NCT00283400|4222542|B1|||Age||years|Mean|51|51.0|Standard Deviation|25|25.0|||
4395613|NCT00283400|4222538|B5|>=65 years||Age||participants|Number|3|3.0||||||
4395614|NCT00283400|4222540|B3|>=65 years||Age||participants|Number|1|1.0||||||
4395615|NCT00283400|4222541|B2|>=65 years||Age||participants|Number|1|1.0||||||
4395616|NCT00283400|4222542|B1|>=65 years||Age||participants|Number|1|1.0||||||
4395617|NCT00283400|4222538|B5|Between 18 and 65 years||Age||participants|Number|44|44.0||||||
4395618|NCT00283400|4222540|B3|Between 18 and 65 years||Age||participants|Number|6|6.0||||||
4395619|NCT00283400|4222541|B2|Between 18 and 65 years||Age||participants|Number|19|19.0||||||
4395620|NCT00283400|4222542|B1|Between 18 and 65 years||Age||participants|Number|19|19.0||||||
4395621|NCT00283400|4222538|B5|<=18 years||Age||participants|Number|0|0.0||||||
4395622|NCT00283400|4222540|B3|<=18 years||Age||participants|Number|0|0.0||||||
4395623|NCT00283400|4222541|B2|<=18 years||Age||participants|Number|0|0.0||||||
4395624|NCT00283400|4222542|B1|<=18 years||Age||participants|Number|0|0.0||||||
4395625|NCT00283387|4222563|B1|Citrate||Number of Subjects on Concomitant Medications|Usual medications for primary hyperoxaluria were continued throughout the study. Subjects could have been prescribed more than one medication, so the sum of participants will be greater than the subject population.|participants|Number|3|3.0||||||
4395626|NCT00283387|4222563|B1|Neutral Phosphate||Number of Subjects on Concomitant Medications|Usual medications for primary hyperoxaluria were continued throughout the study. Subjects could have been prescribed more than one medication, so the sum of participants will be greater than the subject population.|participants|Number|7|7.0||||||
4395627|NCT00283387|4222563|B1|Vitamin B6||Number of Subjects on Concomitant Medications|Usual medications for primary hyperoxaluria were continued throughout the study. Subjects could have been prescribed more than one medication, so the sum of participants will be greater than the subject population.|participants|Number|9|9.0||||||
4395628|NCT00283387|4222563|B1|||Glomerular Filtration Rate (GFR)||ml/min/1.73 m^2|Mean|79|79.0|Full Range|||39.0|134.0|
4395629|NCT00283387|4222563|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4395630|NCT00283387|4222563|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4395631|NCT00283387|4222563|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4395632|NCT00283387|4222563|B1|||Age||years|Mean|20.1|20.1|Full Range|||6.0|43.0|
4395633|NCT00283296|4222570|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4395634|NCT00283296|4222570|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4395635|NCT00283296|4222570|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4395636|NCT00283296|4222570|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|10.8|10.8|||
4395637|NCT00283296|4222570|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395638|NCT00283296|4222570|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4395639|NCT00283296|4222570|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395640|NCT00283244|4222576|B4|||Cumulative Illness Rating scale for Geriatrics (CIRS-G)|"A measure of co-morbidity burden rating the severity of chronic diseases in 14 individual body systems.~Severity ratings:~0=No problems.~Current mild or past significant problem.~Moderate disability or morbidity and/or requires first line therapy.~Severe problem; constant, significant disability and/or hard to control chronic problems.~Extremely severe problem; immediate treatment required; organ failure and/or severe functional impairment.~Total score is a sum of the 14 item scores and may vary from 0 to 56. A higher score represents higher co-morbidity (worse health)."|units on a scale|Median|11|11.0|Full Range|||0.0|25.0|
4395641|NCT00283244|4222577|B3|||Cumulative Illness Rating scale for Geriatrics (CIRS-G)|"A measure of co-morbidity burden rating the severity of chronic diseases in 14 individual body systems.~Severity ratings:~0=No problems.~Current mild or past significant problem.~Moderate disability or morbidity and/or requires first line therapy.~Severe problem; constant, significant disability and/or hard to control chronic problems.~Extremely severe problem; immediate treatment required; organ failure and/or severe functional impairment.~Total score is a sum of the 14 item scores and may vary from 0 to 56. A higher score represents higher co-morbidity (worse health)."|units on a scale|Median|11|11.0|Full Range|||4.0|24.0|
4395642|NCT00283244|4222578|B2|||Cumulative Illness Rating scale for Geriatrics (CIRS-G)|"A measure of co-morbidity burden rating the severity of chronic diseases in 14 individual body systems.~Severity ratings:~0=No problems.~Current mild or past significant problem.~Moderate disability or morbidity and/or requires first line therapy.~Severe problem; constant, significant disability and/or hard to control chronic problems.~Extremely severe problem; immediate treatment required; organ failure and/or severe functional impairment.~Total score is a sum of the 14 item scores and may vary from 0 to 56. A higher score represents higher co-morbidity (worse health)."|units on a scale|Median|10|10.0|Full Range|||2.0|24.0|
4395643|NCT00283244|4222579|B1|||Cumulative Illness Rating scale for Geriatrics (CIRS-G)|"A measure of co-morbidity burden rating the severity of chronic diseases in 14 individual body systems.~Severity ratings:~0=No problems.~Current mild or past significant problem.~Moderate disability or morbidity and/or requires first line therapy.~Severe problem; constant, significant disability and/or hard to control chronic problems.~Extremely severe problem; immediate treatment required; organ failure and/or severe functional impairment.~Total score is a sum of the 14 item scores and may vary from 0 to 56. A higher score represents higher co-morbidity (worse health)."|units on a scale|Median|11.5|11.5|Full Range|||0.0|25.0|
4395644|NCT00283244|4222576|B4|Not otherwise specified||Histology||participants|Number|32|32.0||||||
4395645|NCT00283244|4222577|B3|Not otherwise specified||Histology||participants|Number|12|12.0||||||
4395646|NCT00283244|4222578|B2|Not otherwise specified||Histology||participants|Number|12|12.0||||||
4395647|NCT00283244|4222579|B1|Not otherwise specified||Histology||participants|Number|8|8.0||||||
4395648|NCT00283244|4222576|B4|Large cell carcinoma||Histology||participants|Number|1|1.0||||||
4395649|NCT00283244|4222577|B3|Large cell carcinoma||Histology||participants|Number|0|0.0||||||
4395650|NCT00283244|4222578|B2|Large cell carcinoma||Histology||participants|Number|0|0.0||||||
4395651|NCT00283244|4222579|B1|Large cell carcinoma||Histology||participants|Number|1|1.0||||||
4395652|NCT00283244|4222576|B4|Squamous||Histology||participants|Number|20|20.0||||||
4395653|NCT00283244|4222577|B3|Squamous||Histology||participants|Number|8|8.0||||||
4395654|NCT00283244|4222578|B2|Squamous||Histology||participants|Number|5|5.0||||||
4395655|NCT00283244|4222579|B1|Squamous||Histology||participants|Number|7|7.0||||||
4395656|NCT00283244|4222576|B4|Adenocarcinoma||Histology||participants|Number|93|93.0||||||
4395657|NCT00283244|4222577|B3|Adenocarcinoma||Histology||participants|Number|31|31.0||||||
4395658|NCT00283244|4222578|B2|Adenocarcinoma||Histology||participants|Number|34|34.0||||||
4395659|NCT00283244|4222579|B1|Adenocarcinoma||Histology||participants|Number|28|28.0||||||
4395660|NCT00283244|4222576|B4|Missing||Smoking history||participants|Number|11|11.0||||||
4395661|NCT00283244|4222577|B3|Missing||Smoking history||participants|Number|4|4.0||||||
4395662|NCT00283244|4222578|B2|Missing||Smoking history||participants|Number|2|2.0||||||
4395663|NCT00283244|4222579|B1|Missing||Smoking history||participants|Number|5|5.0||||||
4395664|NCT00283244|4222576|B4|Current or former smoker||Smoking history||participants|Number|120|120.0||||||
4395665|NCT00283244|4222577|B3|Current or former smoker||Smoking history||participants|Number|42|42.0||||||
4395666|NCT00283244|4222578|B2|Current or former smoker||Smoking history||participants|Number|43|43.0||||||
4395667|NCT00283244|4222579|B1|Current or former smoker||Smoking history||participants|Number|35|35.0||||||
4395668|NCT00283244|4222576|B4|Never or light smoker||Smoking history||participants|Number|15|15.0||||||
4395669|NCT00283244|4222577|B3|Never or light smoker||Smoking history||participants|Number|5|5.0||||||
4395670|NCT00283244|4222578|B2|Never or light smoker||Smoking history||participants|Number|6|6.0||||||
4395671|NCT00283244|4222579|B1|Never or light smoker||Smoking history||participants|Number|4|4.0||||||
4395672|NCT00283244|4222576|B4|Missing at baseline||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|3|3.0||||||
4395673|NCT00283244|4222577|B3|Missing at baseline||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|2|2.0||||||
4395674|NCT00283244|4222578|B2|Missing at baseline||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|1|1.0||||||
4395675|NCT00283244|4222579|B1|Missing at baseline||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|0|0.0||||||
4395676|NCT00283244|4222576|B4|2||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|41|41.0||||||
4395677|NCT00283244|4222577|B3|2||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|14|14.0||||||
4395678|NCT00283244|4222578|B2|2||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|14|14.0||||||
4395679|NCT00283244|4222579|B1|2||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|13|13.0||||||
4395680|NCT00283244|4222576|B4|1||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|79|79.0||||||
4395746|NCT00283062|4222615|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4395681|NCT00283244|4222577|B3|1||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|29|29.0||||||
4395682|NCT00283244|4222578|B2|1||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|29|29.0||||||
4395683|NCT00283244|4222579|B1|1||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|21|21.0||||||
4395684|NCT00283244|4222576|B4|0||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|23|23.0||||||
4395685|NCT00283244|4222577|B3|0||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|6|6.0||||||
4395686|NCT00283244|4222578|B2|0||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|7|7.0||||||
4395687|NCT00283244|4222579|B1|0||ECOG Performance Status|"A scale from 0-5 to describe a patient’s level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|participants|Number|10|10.0||||||
4395688|NCT00283244|4222576|B4|IV (Any T, any N, M1a or M1b)||Cancer Stage (TNM)|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) TNM system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Spread (metastasis; M) to other organs of the body. Once the T, N, and M categories have been determined, this information is combined into a prognostic group. Higher numbers (Roman numerals) mean the cancer is more advanced."|participants|Number|120|120.0||||||
4395689|NCT00283244|4222577|B3|IV (Any T, any N, M1a or M1b)||Cancer Stage (TNM)|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) TNM system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Spread (metastasis; M) to other organs of the body. Once the T, N, and M categories have been determined, this information is combined into a prognostic group. Higher numbers (Roman numerals) mean the cancer is more advanced."|participants|Number|41|41.0||||||
4395690|NCT00283244|4222578|B2|IV (Any T, any N, M1a or M1b)||Cancer Stage (TNM)|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) TNM system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Spread (metastasis; M) to other organs of the body. Once the T, N, and M categories have been determined, this information is combined into a prognostic group. Higher numbers (Roman numerals) mean the cancer is more advanced."|participants|Number|46|46.0||||||
4395691|NCT00283244|4222579|B1|IV (Any T, any N, M1a or M1b)||Cancer Stage (TNM)|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) TNM system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Spread (metastasis; M) to other organs of the body. Once the T, N, and M categories have been determined, this information is combined into a prognostic group. Higher numbers (Roman numerals) mean the cancer is more advanced."|participants|Number|33|33.0||||||
4395692|NCT00283244|4222576|B4|IIIB (Any T, N3, M0 or T4, N2, M0)||Cancer Stage (TNM)|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) TNM system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Spread (metastasis; M) to other organs of the body. Once the T, N, and M categories have been determined, this information is combined into a prognostic group. Higher numbers (Roman numerals) mean the cancer is more advanced."|participants|Number|26|26.0||||||
4395747|NCT00283062|4222616|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4395748|NCT00283062|4222617|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4395749|NCT00283062|4222613|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395693|NCT00283244|4222577|B3|IIIB (Any T, N3, M0 or T4, N2, M0)||Cancer Stage (TNM)|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) TNM system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Spread (metastasis; M) to other organs of the body. Once the T, N, and M categories have been determined, this information is combined into a prognostic group. Higher numbers (Roman numerals) mean the cancer is more advanced."|participants|Number|10|10.0||||||
4395694|NCT00283244|4222578|B2|IIIB (Any T, N3, M0 or T4, N2, M0)||Cancer Stage (TNM)|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) TNM system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Spread (metastasis; M) to other organs of the body. Once the T, N, and M categories have been determined, this information is combined into a prognostic group. Higher numbers (Roman numerals) mean the cancer is more advanced."|participants|Number|5|5.0||||||
4395695|NCT00283244|4222579|B1|IIIB (Any T, N3, M0 or T4, N2, M0)||Cancer Stage (TNM)|"Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) TNM system, which is based on:~Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Spread (metastasis; M) to other organs of the body. Once the T, N, and M categories have been determined, this information is combined into a prognostic group. Higher numbers (Roman numerals) mean the cancer is more advanced."|participants|Number|11|11.0||||||
4395696|NCT00283244|4222576|B4|United States||Region of Enrollment||participants|Number|146|146.0||||||
4395697|NCT00283244|4222577|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4395698|NCT00283244|4222578|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4395699|NCT00283244|4222579|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4395700|NCT00283244|4222576|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4395701|NCT00283244|4222577|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4395702|NCT00283244|4222578|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4395703|NCT00283244|4222579|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4395704|NCT00283244|4222576|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4395705|NCT00283244|4222577|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4395706|NCT00283244|4222578|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4395707|NCT00283244|4222579|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4395708|NCT00283244|4222576|B4|||Age||years|Median|76|76.0|Full Range|||69.0|90.0|
4395709|NCT00283244|4222577|B3|||Age||years|Median|78|78.0|Full Range|||70.0|90.0|
4395710|NCT00283244|4222578|B2|||Age||years|Median|76|76.0|Full Range|||69.0|86.0|
4395711|NCT00283244|4222579|B1|||Age||years|Median|74|74.0|Full Range|||70.0|86.0|
4395712|NCT00283075|4222601|B1|Not Available||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4395713|NCT00283075|4222601|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4395714|NCT00283075|4222601|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4395715|NCT00283075|4222601|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4395716|NCT00283075|4222601|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4395717|NCT00283075|4222601|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4395718|NCT00283075|4222601|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|8.53|8.53|||
4395719|NCT00283062|4222613|B5|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4395720|NCT00283062|4222614|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4395721|NCT00283062|4222615|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4395722|NCT00283062|4222616|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4395723|NCT00283062|4222617|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4395724|NCT00283062|4222613|B5|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4395725|NCT00283062|4222614|B4|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4395726|NCT00283062|4222615|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4395727|NCT00283062|4222616|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4395728|NCT00283062|4222617|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4395729|NCT00283062|4222613|B5|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4395730|NCT00283062|4222614|B4|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4395731|NCT00283062|4222615|B3|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4395732|NCT00283062|4222616|B2|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4395733|NCT00283062|4222617|B1|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4395734|NCT00283062|4222613|B5|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4395735|NCT00283062|4222614|B4|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4395736|NCT00283062|4222615|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4395737|NCT00283062|4222616|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4395738|NCT00283062|4222617|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4395739|NCT00283062|4222613|B5|White||Race/Ethnicity, Customized||participants|Number|199|199.0||||||
4395740|NCT00283062|4222614|B4|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4395741|NCT00283062|4222615|B3|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4395742|NCT00283062|4222616|B2|White||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4395743|NCT00283062|4222617|B1|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4395744|NCT00283062|4222613|B5||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4395745|NCT00283062|4222614|B4||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4395750|NCT00283062|4222614|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395751|NCT00283062|4222615|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395752|NCT00283062|4222616|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395753|NCT00283062|4222617|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395754|NCT00283062|4222613|B5|>=65 years||Age, Customized||participants|Number|87|87.0||||||
4395755|NCT00283062|4222614|B4|>=65 years||Age, Customized||participants|Number|27|27.0||||||
4395756|NCT00283062|4222615|B3|>=65 years||Age, Customized||participants|Number|21|21.0||||||
4395757|NCT00283062|4222616|B2|>=65 years||Age, Customized||participants|Number|21|21.0||||||
4395758|NCT00283062|4222617|B1|>=65 years||Age, Customized||participants|Number|18|18.0||||||
4395759|NCT00283062|4222613|B5|<65 years||Age, Customized||participants|Number|141|141.0||||||
4395760|NCT00283062|4222614|B4|<65 years||Age, Customized||participants|Number|35|35.0||||||
4395761|NCT00283062|4222615|B3|<65 years||Age, Customized||participants|Number|35|35.0||||||
4395762|NCT00283062|4222616|B2|<65 years||Age, Customized||participants|Number|34|34.0||||||
4395763|NCT00283062|4222617|B1|<65 years||Age, Customized||participants|Number|37|37.0||||||
4395764|NCT00283062|4222613|B5|||Age||years|Mean|61.9|61.9|Standard Deviation|7.2|7.2|||
4395765|NCT00283062|4222614|B4|||Age||years|Mean|62.9|62.9|Standard Deviation|7.5|7.5|||
4395766|NCT00283062|4222615|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|7|7.0|||
4395767|NCT00283062|4222616|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|7.0|7.0|||
4395768|NCT00283062|4222617|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|7.4|7.4|||
4395769|NCT00283049|4222650|B4|||Weight||kg|Mean|99.6|99.6|Standard Deviation|22.31|22.31|||
4395770|NCT00283049|4222651|B3|||Weight||kg|Mean|101.2|101.2|Standard Deviation|24.98|24.98|||
4395771|NCT00283049|4222652|B2|||Weight||kg|Mean|99.6|99.6|Standard Deviation|20.22|20.22|||
4395772|NCT00283049|4222653|B1|||Weight||kg|Mean|98.1|98.1|Standard Deviation|21.46|21.46|||
4395773|NCT00283049|4222650|B4|||Duration of diabetes||years|Mean|10.2|10.2|Standard Deviation|6.23|6.23|||
4395774|NCT00283049|4222651|B3|||Duration of diabetes||years|Mean|10.5|10.5|Standard Deviation|6.00|6.0|||
4395775|NCT00283049|4222652|B2|||Duration of diabetes||years|Mean|9.7|9.7|Standard Deviation|5.68|5.68|||
4395776|NCT00283049|4222653|B1|||Duration of diabetes||years|Mean|10.5|10.5|Standard Deviation|6.95|6.95|||
4395777|NCT00283049|4222650|B4|||Body Mass Index (BMI)||kg/m²|Mean|34.0|34.0|Standard Deviation|6.69|6.69|||
4395778|NCT00283049|4222651|B3|||Body Mass Index (BMI)||kg/m²|Mean|34.5|34.5|Standard Deviation|7.04|7.04|||
4395779|NCT00283049|4222652|B2|||Body Mass Index (BMI)||kg/m²|Mean|34.3|34.3|Standard Deviation|6.57|6.57|||
4395780|NCT00283049|4222653|B1|||Body Mass Index (BMI)||kg/m²|Mean|33.2|33.2|Standard Deviation|6.41|6.41|||
4395781|NCT00283049|4222650|B4|USA||Region of Enrollment||participants|Number|386|386.0||||||
4395782|NCT00283049|4222651|B3|USA||Region of Enrollment||participants|Number|130|130.0||||||
4395783|NCT00283049|4222652|B2|USA||Region of Enrollment||participants|Number|128|128.0||||||
4395784|NCT00283049|4222653|B1|USA||Region of Enrollment||participants|Number|128|128.0||||||
4395785|NCT00283049|4222650|B4||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4395786|NCT00283049|4222651|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4395787|NCT00283049|4222652|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4395788|NCT00283049|4222653|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4395789|NCT00283049|4222650|B4||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4395790|NCT00283049|4222651|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4395791|NCT00283049|4222652|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4395792|NCT00283049|4222653|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4395793|NCT00283049|4222650|B4|||Age||years|Mean|55.2|55.2|Standard Deviation|9.71|9.71|||
4395794|NCT00283049|4222651|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|9.41|9.41|||
4395795|NCT00283049|4222652|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|10.14|10.14|||
4395796|NCT00283049|4222653|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|9.57|9.57|||
4395797|NCT00282984|4222681|B3||Male|Sex: Female, Male||Participants|Count of Participants|553|553.0||||||
4395798|NCT00282984|4222682|B2||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4395799|NCT00282984|4222683|B1||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4395800|NCT00282984|4222681|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4395801|NCT00282984|4222682|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4395802|NCT00282984|4222683|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4395803|NCT00282984|4222681|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|8.5|8.5|||
4395804|NCT00282984|4222682|B2|||Age||years|Mean|56.0|56.0|Standard Deviation|8.4|8.4|||
4395805|NCT00282984|4222683|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|8.6|8.6|||
4395806|NCT00282971|4222708|B3||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4395807|NCT00282971|4222709|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4395808|NCT00282971|4222710|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4395809|NCT00282971|4222708|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4395810|NCT00282971|4222709|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4395811|NCT00282971|4222710|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4395812|NCT00282971|4222708|B3|>=65 years||Age, Customized||participants|Number|108|108.0||||||
4395813|NCT00282971|4222709|B2|>=65 years||Age, Customized||participants|Number|52|52.0||||||
4395814|NCT00282971|4222710|B1|>=65 years||Age, Customized||participants|Number|56|56.0||||||
4395815|NCT00282971|4222708|B3|Between 45 and 64 years||Age, Customized||participants|Number|225|225.0||||||
4395816|NCT00282971|4222709|B2|Between 45 and 64 years||Age, Customized||participants|Number|113|113.0||||||
4395817|NCT00282971|4222710|B1|Between 45 and 64 years||Age, Customized||participants|Number|112|112.0||||||
4395818|NCT00282971|4222708|B3|Between 18 and 44 years||Age, Customized||participants|Number|18|18.0||||||
4395819|NCT00282971|4222709|B2|Between 18 and 44 years||Age, Customized||participants|Number|6|6.0||||||
4395820|NCT00282971|4222710|B1|Between 18 and 44 years||Age, Customized||participants|Number|12|12.0||||||
4395821|NCT00282971|4222708|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4395822|NCT00282971|4222709|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4395823|NCT00282971|4222710|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4395824|NCT00282919|4222721|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4395825|NCT00282919|4222721|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4395826|NCT00282919|4222721|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|13.0|13.0|||
4395827|NCT00282867|4222733|B4|United States||Region of Enrollment||participants|Number|74|74.0||||||
4395828|NCT00282867|4222734|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4395829|NCT00282867|4222735|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4395830|NCT00282867|4222736|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4395831|NCT00282867|4222733|B4||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4395832|NCT00282867|4222734|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4395833|NCT00282867|4222735|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4395834|NCT00282867|4222736|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4395835|NCT00282867|4222733|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4395836|NCT00282867|4222734|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4395837|NCT00282867|4222735|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4395838|NCT00282867|4222736|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4395839|NCT00282867|4222733|B4||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4395840|NCT00282867|4222734|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4395841|NCT00282867|4222735|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4395842|NCT00282867|4222736|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4395843|NCT00282867|4222733|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4395844|NCT00282867|4222734|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4395845|NCT00282867|4222735|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4395846|NCT00282867|4222736|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4395847|NCT00282867|4222733|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395848|NCT00282867|4222734|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395849|NCT00282867|4222735|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395850|NCT00282867|4222736|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395851|NCT00282828|4222752|B4|Canada||Region of Enrollment||participants|Number|76|76.0||||||
4395852|NCT00282828|4222753|B3|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4395853|NCT00282828|4222754|B2|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4395854|NCT00282828|4222755|B1|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4395855|NCT00282828|4222752|B4|United States||Region of Enrollment||participants|Number|105|105.0||||||
4395856|NCT00282828|4222753|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4395857|NCT00282828|4222754|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4395858|NCT00282828|4222755|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4395859|NCT00282828|4222752|B4||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4395860|NCT00282828|4222753|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4395861|NCT00282828|4222754|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4395862|NCT00282828|4222755|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4395863|NCT00282828|4222752|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4395864|NCT00282828|4222753|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4395865|NCT00282828|4222754|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4395866|NCT00282828|4222755|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4395867|NCT00282828|4222752|B4|||Age||years|Mean|34.6|34.6|Standard Deviation|12.8|12.8|||
4395868|NCT00282828|4222753|B3|||Age||years|Mean|35.3|35.3|Standard Deviation|14.2|14.2|||
4395869|NCT00282828|4222754|B2|||Age||years|Mean|33.7|33.7|Standard Deviation|12.0|12.0|||
4395870|NCT00282828|4222755|B1|||Age||years|Mean|34.7|34.7|Standard Deviation|12.2|12.2|||
4395871|NCT00282815|4222768|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4395872|NCT00282815|4222769|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4395873|NCT00282815|4222770|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4395874|NCT00282815|4222768|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4395875|NCT00282815|4222769|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4395876|NCT00282815|4222770|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4395877|NCT00282815|4222768|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4395878|NCT00282815|4222769|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4395879|NCT00282815|4222770|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4395880|NCT00282815|4222768|B3|||Age||years|Mean|65|65.0|Standard Deviation|16|16.0|||
4395881|NCT00282815|4222769|B2|||Age||years|Mean|74|74.0|Standard Deviation|16|16.0|||
4395882|NCT00282815|4222770|B1|||Age||years|Mean|61|61.0|Standard Deviation|16|16.0|||
4395883|NCT00282815|4222768|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4395884|NCT00282815|4222769|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4395885|NCT00282815|4222770|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4395886|NCT00282815|4222768|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4395887|NCT00282815|4222769|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4395888|NCT00282815|4222770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4395889|NCT00282815|4222768|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395890|NCT00282815|4222769|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395891|NCT00282815|4222770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395892|NCT00282672|4222780|B5|United States||Region of Enrollment||participants|Number|127|127.0||||||
4395893|NCT00282672|4222781|B4|United States||Region of Enrollment||participants|Number|42|42.0||||||
4395894|NCT00282672|4222782|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4395895|NCT00282672|4222783|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4395896|NCT00282672|4222784|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4395897|NCT00282672|4222780|B5||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4395898|NCT00282672|4222781|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4395899|NCT00282672|4222782|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4395900|NCT00282672|4222783|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4395901|NCT00282672|4222784|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4395902|NCT00282672|4222780|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4395903|NCT00282672|4222781|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4395904|NCT00282672|4222782|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395905|NCT00282672|4222783|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4395906|NCT00282672|4222784|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4395907|NCT00282672|4222780|B5|||Age||years|Mean|65.95|65.95|Standard Deviation|8.95|8.95|||
4395908|NCT00282672|4222781|B4|||Age||years|Mean|65.9|65.9|Standard Deviation|1.4|1.4|||
4395909|NCT00282672|4222782|B3|||Age||years|Mean|67.3|67.3|Standard Deviation|1.8|1.8|||
4395910|NCT00282672|4222783|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|1.4|1.4|||
4395911|NCT00282672|4222784|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|1.9|1.9|||
4395912|NCT00282568|4222835|B1|Yes||History of Pre-Study Dialysis||participants|Number|54|54.0||||||
4395913|NCT00282568|4222835|B1|No||History of Pre-Study Dialysis||participants|Number|12|12.0||||||
4395914|NCT00282568|4222835|B1|Yes||Re-transplant||participants|Number|5|5.0||||||
4395915|NCT00282568|4222835|B1|No||Re-transplant||participants|Number|61|61.0||||||
4395916|NCT00282568|4222835|B1|Living Nonrelated Donor||Type of Current Transplant||participants|Number|5|5.0||||||
4395917|NCT00282568|4222835|B1|Living Related Donor||Type of Current Transplant||participants|Number|18|18.0||||||
4395918|NCT00282568|4222835|B1|Cadaver||Type of Current Transplant||participants|Number|43|43.0||||||
4395919|NCT00282568|4222835|B1|Other||Reason for End Stage Renal Disease||participants|Number|10|10.0||||||
4395920|NCT00282568|4222835|B1|Unknown||Reason for End Stage Renal Disease||participants|Number|1|1.0||||||
4395921|NCT00282568|4222835|B1|Tubular and Interstitial Disease||Reason for End Stage Renal Disease||participants|Number|3|3.0||||||
4395922|NCT00282568|4222835|B1|Focal Segmental Glomerulonephritis||Reason for End Stage Renal Disease||participants|Number|5|5.0||||||
4395923|NCT00282568|4222835|B1|Systemic Lupus Erythematosis||Reason for End Stage Renal Disease||participants|Number|5|5.0||||||
4395924|NCT00282568|4222835|B1|Diabetes||Reason for End Stage Renal Disease||participants|Number|6|6.0||||||
4395925|NCT00282568|4222835|B1|Immunoglobulin A Nephropathy||Reason for End Stage Renal Disease||participants|Number|6|6.0||||||
4395926|NCT00282568|4222835|B1|Hypertensive Nephrosclerosis||Reason for End Stage Renal Disease||participants|Number|6|6.0||||||
4395927|NCT00282568|4222835|B1|Polycystic Kidney Disease||Reason for End Stage Renal Disease||participants|Number|8|8.0||||||
4395928|NCT00282568|4222835|B1|Glomerulonephritis||Reason for End Stage Renal Disease||participants|Number|16|16.0||||||
4395929|NCT00282568|4222835|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4395930|NCT00282568|4222835|B1|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4395931|NCT00282568|4222835|B1|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4395932|NCT00282568|4222835|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4395933|NCT00282568|4222835|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4395934|NCT00282568|4222835|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|12.37|12.37|||
4395935|NCT00282464|4222859|B3||Male|Sex: Female, Male||Participants|Count of Participants|162.0|162.0||||||
4395936|NCT00282464|4222860|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4395937|NCT00282464|4222861|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4395938|NCT00282464|4222859|B3||Female|Sex: Female, Male||Participants|Count of Participants|219.0|219.0||||||
4395939|NCT00282464|4222860|B2||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4395940|NCT00282464|4222861|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4395941|NCT00282464|4222859|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|12.1|12.1|||
4395942|NCT00282464|4222860|B2|||Age||years|Mean|40.0|40.0|Standard Deviation|11.7|11.7|||
4395943|NCT00282464|4222861|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|12.5|12.5|||
4395944|NCT00282438|4222910|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4395945|NCT00282438|4222911|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4395946|NCT00282438|4222912|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4395947|NCT00282438|4222910|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4395948|NCT00282438|4222911|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395949|NCT00282438|4222912|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4395950|NCT00282438|4222910|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4395951|NCT00282438|4222911|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4395952|NCT00282438|4222912|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395953|NCT00282438|4222910|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|2.5|2.5|||
4395954|NCT00282438|4222911|B2|||Age||years|Mean|49|49.0|Standard Deviation|NA||||Only one participant was analyzed and then the standard deviation could only be provided for the total column
4395955|NCT00282438|4222912|B1|||Age||years|Mean|54|54.0|Standard Deviation|NA||||Only one participant was analyzed and then the standard deviation could only be provided for the total column.
4395956|NCT00282438|4222910|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395957|NCT00282438|4222911|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395958|NCT00282438|4222912|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395959|NCT00282438|4222910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4395960|NCT00282438|4222911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4395961|NCT00282438|4222912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4395962|NCT00282438|4222910|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395963|NCT00282438|4222911|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395964|NCT00282438|4222912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395965|NCT00282412|4222923|B1|United States||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4395966|NCT00282412|4222923|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4395967|NCT00282412|4222923|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4395968|NCT00282412|4222923|B1|||Age||years|Mean|40.00|40.0|Standard Deviation|12.91|12.91|||
4395969|NCT00282412|4222923|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4395970|NCT00282412|4222923|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4395971|NCT00282412|4222923|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4395972|NCT00282347|4222927|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4395973|NCT00282347|4222928|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4395974|NCT00282347|4222929|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4395975|NCT00282347|4222927|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4395976|NCT00282347|4222928|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4395977|NCT00282347|4222929|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4395978|NCT00282347|4222927|B3|||Age||years|Mean|30.6|30.6|Standard Deviation|9.5|9.5|||
4395979|NCT00282347|4222928|B2|||Age||years|Mean|29.4|29.4|Standard Deviation|9.3|9.3|||
4395980|NCT00282347|4222929|B1|||Age||years|Mean|31.8|31.8|Standard Deviation|9.6|9.6|||
4395981|NCT00282347|4222927|B3|≥ 50 years||Age, Customized||participants|Number|8|8.0||||||
4395982|NCT00282347|4222928|B2|≥ 50 years||Age, Customized||participants|Number|4|4.0||||||
4395983|NCT00282347|4222929|B1|≥ 50 years||Age, Customized||participants|Number|4|4.0||||||
4395984|NCT00282347|4222927|B3|35 to < 50 years||Age, Customized||participants|Number|37|37.0||||||
4395985|NCT00282347|4222928|B2|35 to < 50 years||Age, Customized||participants|Number|19|19.0||||||
4395986|NCT00282347|4222929|B1|35 to < 50 years||Age, Customized||participants|Number|18|18.0||||||
4395987|NCT00282347|4222927|B3|18 to < 35 years||Age, Customized||participants|Number|96|96.0||||||
4395988|NCT00282347|4222928|B2|18 to < 35 years||Age, Customized||participants|Number|48|48.0||||||
4395989|NCT00282347|4222929|B1|18 to < 35 years||Age, Customized||participants|Number|48|48.0||||||
4395990|NCT00282347|4222927|B3|< 18 years||Age, Customized||participants|Number|3|3.0||||||
4395991|NCT00282347|4222928|B2|< 18 years||Age, Customized||participants|Number|1|1.0||||||
4395992|NCT00282347|4222929|B1|< 18 years||Age, Customized||participants|Number|2|2.0||||||
4395993|NCT00282334|4222954|B3|Denmark||Region of Enrollment||participants|Number|236|236.0||||||
4395994|NCT00282334|4222955|B2|Denmark||Region of Enrollment||participants|Number|113|113.0||||||
4395995|NCT00282334|4222956|B1|Denmark||Region of Enrollment||participants|Number|123|123.0||||||
4395996|NCT00282334|4222954|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4395997|NCT00282334|4222955|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4395998|NCT00282334|4222956|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4395999|NCT00282334|4222954|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4396000|NCT00282334|4222955|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4396001|NCT00282334|4222956|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4396002|NCT00282334|4222954|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|11.6|11.6|||
4396003|NCT00282334|4222955|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|11.6|11.6|||
4396004|NCT00282334|4222956|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|11.7|11.7|||
4396005|NCT00282308|4222963|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4396006|NCT00282308|4222964|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4396007|NCT00282308|4222965|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4396008|NCT00282308|4222963|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4396009|NCT00282308|4222964|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4396010|NCT00282308|4222965|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4396011|NCT00282308|4222963|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|9.85|9.85|||
4396012|NCT00282308|4222964|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|10.51|10.51|||
4396013|NCT00282308|4222965|B1|||Age||years|Mean|49.7|49.7|Standard Deviation|9.60|9.6|||
4396014|NCT00282295|4222994|B4||Male|Sex: Female, Male||Participants|Count of Participants|675|675.0||||||
4396015|NCT00282295|4222995|B3||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4396016|NCT00282295|4222996|B2||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4396017|NCT00282295|4222997|B1||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4396018|NCT00282295|4222994|B4||Female|Sex: Female, Male||Participants|Count of Participants|666|666.0||||||
4396019|NCT00282295|4222995|B3||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4396020|NCT00282295|4222996|B2||Female|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4396021|NCT00282295|4222997|B1||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4396022|NCT00282295|4222994|B4|||Age||Years|Mean|13.37|13.37|Standard Deviation|2.22|2.22|||
4396023|NCT00282295|4222995|B3|||Age||Years|Mean|13.4|13.4|Standard Deviation|2.27|2.27|||
4396024|NCT00282295|4222996|B2|||Age||Years|Mean|13.2|13.2|Standard Deviation|2.07|2.07|||
4396025|NCT00282295|4222997|B1|||Age||Years|Mean|13.5|13.5|Standard Deviation|2.31|2.31|||
4396026|NCT00282282|4223048|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4396027|NCT00282282|4223048|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4396028|NCT00282282|4223048|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4396029|NCT00282282|4223048|B1|||Age||years|Median|53|53.0|Full Range|||29.0|64.0|
4396030|NCT00282282|4223048|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396031|NCT00282282|4223048|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4396032|NCT00282282|4223048|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396033|NCT00282256|4223054|B1|Yes||Re-transplant||participants|Number|2|2.0||||||
4396034|NCT00282256|4223054|B1|No||Re-transplant||participants|Number|16|16.0||||||
4396035|NCT00282256|4223054|B1|Living Donor||Type of Current Transplant||participants|Number|4|4.0||||||
4396036|NCT00282256|4223054|B1|Split Cadaver||Type of Current Transplant||participants|Number|4|4.0||||||
4396037|NCT00282256|4223054|B1|Whole Cadaver||Type of Current Transplant||participants|Number|10|10.0||||||
4396038|NCT00282256|4223054|B1|Other||Reason for End Stage Liver Disease||participants|Number|6|6.0||||||
4396039|NCT00282256|4223054|B1|Unknown||Reason for End Stage Liver Disease||participants|Number|1|1.0||||||
4396040|NCT00282256|4223054|B1|Tyrosinemia||Reason for End Stage Liver Disease||participants|Number|2|2.0||||||
4396041|NCT00282256|4223054|B1|Fulminant Hepatitis||Reason for End Stage Liver Disease||participants|Number|2|2.0||||||
4396042|NCT00282256|4223054|B1|Acute Fulminant (Hepatic) Failure||Reason for End Stage Liver Disease||participants|Number|2|2.0||||||
4396043|NCT00282256|4223054|B1|Biliary Atresia||Reason for End Stage Liver Disease||participants|Number|5|5.0||||||
4396044|NCT00282256|4223054|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4396045|NCT00282256|4223054|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4396046|NCT00282256|4223054|B1|||Age||years|Mean|8.6|8.6|Standard Deviation|2.28|2.28|||
4396047|NCT00282243|4223075|B1|Yes||Re-transplant||participants|Number|6|6.0||||||
4396048|NCT00282243|4223075|B1|No||Re-transplant||participants|Number|56|56.0||||||
4396049|NCT00282243|4223075|B1|Split Cadaver||Type of Current Transplant||participants|Number|3|3.0||||||
4396050|NCT00282243|4223075|B1|Living related Donor||Type of Current Transplant||participants|Number|3|3.0||||||
4396051|NCT00282243|4223075|B1|Whole Cadaver||Type of Current Transplant||participants|Number|56|56.0||||||
4396052|NCT00282243|4223075|B1|Other||Reason for End Stage Liver Disease||participants|Number|9|9.0||||||
4396053|NCT00282243|4223075|B1|Unknown||Reason for End Stage Liver Disease||participants|Number|1|1.0||||||
4396054|NCT00282243|4223075|B1|Cryptogenic Cirrhosis||Reason for End Stage Liver Disease||participants|Number|2|2.0||||||
4396055|NCT00282243|4223075|B1|Non-Alcoholic Steatohepatitis||Reason for End Stage Liver Disease||participants|Number|2|2.0||||||
4396056|NCT00282243|4223075|B1|Hepatitis B||Reason for End Stage Liver Disease||participants|Number|2|2.0||||||
4396057|NCT00282243|4223075|B1|Alpha-1 Anti-Trypsin Deficiency||Reason for End Stage Liver Disease||participants|Number|3|3.0||||||
4396058|NCT00282243|4223075|B1|Primary Sclerosing Cholangitis||Reason for End Stage Liver Disease||participants|Number|6|6.0||||||
4396059|NCT00282243|4223075|B1|Primary Biliary Cirrhosis||Reason for End Stage Liver Disease||participants|Number|7|7.0||||||
4396060|NCT00282243|4223075|B1|Autoimmune Disease||Reason for End Stage Liver Disease||participants|Number|4|4.0||||||
4396061|NCT00282243|4223075|B1|Alcoholic Liver Disease||Reason for End Stage Liver Disease||participants|Number|11|11.0||||||
4396062|NCT00282243|4223075|B1|Hepatitis C||Reason for End Stage Liver Disease||participants|Number|15|15.0||||||
4396063|NCT00282243|4223075|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4396064|NCT00282243|4223075|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4396065|NCT00282243|4223075|B1|White||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4396066|NCT00282243|4223075|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4396067|NCT00282243|4223075|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4396068|NCT00282243|4223075|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|8.97|8.97|||
4396069|NCT00282152|4223099|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4396070|NCT00282152|4223100|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4396071|NCT00282152|4223101|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4396072|NCT00282152|4223099|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4396073|NCT00282152|4223100|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4396074|NCT00282152|4223101|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4396075|NCT00282152|4223099|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4396076|NCT00282152|4223100|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4396077|NCT00282152|4223101|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4396078|NCT00282152|4223099|B3|||Age||years|Mean|60|60.0|Full Range|||51.0|74.0|
4396079|NCT00282152|4223100|B2|||Age||years|Mean|60|60.0|Full Range|||52.0|74.0|
4396080|NCT00282152|4223101|B1|||Age||years|Mean|60|60.0|Full Range|||51.0|69.0|
4396081|NCT00282113|4223120|B4|United States||Region of Enrollment||participants|Number|90|90.0||||||
4396082|NCT00282113|4223121|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4396083|NCT00282113|4223122|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4396084|NCT00282113|4223123|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4396085|NCT00282113|4223120|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4396086|NCT00282113|4223121|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4396087|NCT00282113|4223122|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4396088|NCT00282113|4223123|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4396089|NCT00282113|4223120|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4396090|NCT00282113|4223121|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4396091|NCT00282113|4223122|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4396092|NCT00282113|4223123|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4396093|NCT00282113|4223120|B4|||Age||weeks gestation|Mean|29.7|29.7|Standard Deviation|2.5|2.5|||
4396094|NCT00282113|4223121|B3|||Age||weeks gestation|Mean|30.2|30.2|Standard Deviation|2.4|2.4|||
4396095|NCT00282113|4223122|B2|||Age||weeks gestation|Mean|29.5|29.5|Standard Deviation|2.6|2.6|||
4396096|NCT00282113|4223123|B1|||Age||weeks gestation|Mean|29.3|29.3|Standard Deviation|2.6|2.6|||
4396097|NCT00282113|4223120|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396098|NCT00282113|4223121|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396099|NCT00282113|4223122|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396100|NCT00282113|4223123|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396101|NCT00282113|4223120|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4396102|NCT00282113|4223121|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4396103|NCT00282113|4223122|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4396104|NCT00282113|4223123|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4396105|NCT00282113|4223120|B4||<=18 years|Age||Participants|Count of Participants|90|90.0||||||
4396106|NCT00282113|4223121|B3||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
4396107|NCT00282113|4223122|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4396108|NCT00282113|4223123|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4396109|NCT00282087|4223139|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4396110|NCT00282087|4223139|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4396111|NCT00282087|4223139|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4396112|NCT00282087|4223139|B1|||Age||years|Mean|53|53.0|Standard Deviation|16|16.0|||
4396113|NCT00282087|4223139|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4396114|NCT00282087|4223139|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4396115|NCT00282087|4223139|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396116|NCT00282048|4223152|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4396117|NCT00282048|4223152|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4396118|NCT00282048|4223152|B1|||Age||Years|Mean|57.9|57.9|Standard Deviation|9.4|9.4|||
4396119|NCT00281957|4223164|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4396120|NCT00281957|4223165|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4396121|NCT00281957|4223166|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4396122|NCT00281957|4223164|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4396123|NCT00281957|4223165|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4396124|NCT00281957|4223166|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4396125|NCT00281957|4223164|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4396126|NCT00281957|4223165|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4396127|NCT00281957|4223166|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4396128|NCT00281957|4223164|B3|||Age||years|Median|62|62.0|Full Range|||27.0|85.0|
4396129|NCT00281957|4223165|B2|||Age||years|Median|58|58.0|Full Range|||28.0|84.0|
4396130|NCT00281957|4223166|B1|||Age||years|Median|64|64.0|Full Range|||27.0|85.0|
4396131|NCT00281918|4223179|B3||Male|Sex: Female, Male||Participants|Count of Participants|600|600.0||||||
4396132|NCT00281918|4223180|B2||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4396133|NCT00281918|4223181|B1||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4396134|NCT00281918|4223179|B3||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4396135|NCT00281918|4223180|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4396136|NCT00281918|4223181|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4396137|NCT00281918|4223179|B3|||Age||years|Mean|59.5|59.5|Standard Deviation|8.62|8.62|||
4396138|NCT00281918|4223180|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|8.70|8.7|||
4396139|NCT00281918|4223181|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|8.55|8.55|||
4396140|NCT00281879|4223208|B9|United States||Region of Enrollment||participants|Number|200|200.0||||||
4396141|NCT00281879|4223209|B8|United States||Region of Enrollment||participants|Number|1|1.0||||||
4396142|NCT00281879|4223211|B6|United States||Region of Enrollment||participants|Number|9|9.0||||||
4396143|NCT00281879|4223212|B5|United States||Region of Enrollment||participants|Number|6|6.0||||||
4396144|NCT00281879|4223214|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4396145|NCT00281879|4223215|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4396146|NCT00281879|4223216|B1|United States||Region of Enrollment||participants|Number|128|128.0||||||
4396147|NCT00281879|4223208|B9||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4396148|NCT00281879|4223209|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4396149|NCT00281879|4223211|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4396150|NCT00281879|4223212|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4396151|NCT00281879|4223214|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4396152|NCT00281879|4223215|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4396153|NCT00281879|4223216|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4396154|NCT00281879|4223208|B9||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4396155|NCT00281879|4223209|B8||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4396156|NCT00281879|4223211|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4396157|NCT00281879|4223212|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4396158|NCT00281879|4223214|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4396159|NCT00281879|4223215|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4396160|NCT00281879|4223216|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4396161|NCT00281879|4223208|B9|||Age||years|Mean|34.743|34.743|Standard Deviation|16.818|16.818|||
4396162|NCT00281879|4223209|B8|||Age||years|Mean|5.42|5.42|Standard Deviation|0|0.0|||
4396163|NCT00281879|4223211|B6|||Age||years|Mean|11.77|11.77|Standard Deviation|10.725|10.725|||
4396164|NCT00281879|4223212|B5|||Age||years|Mean|12.22|12.22|Standard Deviation|7.90|7.9|||
4396165|NCT00281879|4223214|B3|||Age||years|Mean|46.187|46.187|Standard Deviation|12.87|12.87|||
4396166|NCT00281879|4223215|B2|||Age||years|Mean|48.33|48.33|Standard Deviation|11.67|11.67|||
4396167|NCT00281879|4223216|B1|||Age||years|Mean|32.033|32.033|Standard Deviation|14.923|14.923|||
4396168|NCT00281879|4223208|B9||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4396169|NCT00281879|4223209|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396170|NCT00281879|4223211|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4396171|NCT00281879|4223212|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396172|NCT00281879|4223214|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396173|NCT00281879|4223215|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396174|NCT00281879|4223216|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396175|NCT00281879|4223208|B9||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4396176|NCT00281879|4223209|B8||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4396177|NCT00281879|4223211|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4396178|NCT00281879|4223212|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4396179|NCT00281879|4223214|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4396180|NCT00281879|4223215|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4396181|NCT00281879|4223216|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4396182|NCT00281879|4223208|B9||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4396183|NCT00281879|4223209|B8||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4396184|NCT00281879|4223211|B6||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4396185|NCT00281879|4223212|B5||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4396186|NCT00281879|4223214|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396187|NCT00281879|4223215|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4396188|NCT00281879|4223216|B1||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4396189|NCT00281840|4223241|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4396190|NCT00281840|4223241|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396191|NCT00281840|4223241|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396192|NCT00281840|4223241|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4396193|NCT00281840|4223241|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396194|NCT00281840|4223241|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396195|NCT00281840|4223241|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396196|NCT00281840|4223241|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396197|NCT00281840|4223241|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4396198|NCT00281840|4223241|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4396199|NCT00281840|4223241|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396200|NCT00281840|4223241|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4396201|NCT00281840|4223241|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4396202|NCT00281840|4223241|B1|70-79 years||Age, Customized||participants|Number|1|1.0||||||
4396203|NCT00281840|4223241|B1|60-69 years||Age, Customized||participants|Number|9|9.0||||||
4396204|NCT00281840|4223241|B1|50-59 years||Age, Customized||participants|Number|16|16.0||||||
4396205|NCT00281840|4223241|B1|40-49 years||Age, Customized||participants|Number|4|4.0||||||
4396206|NCT00281827|4223246|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4396207|NCT00281827|4223246|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4396208|NCT00281827|4223246|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4396209|NCT00281827|4223246|B1|||Age||years|Median|53|53.0|Full Range|||32.0|78.0|
4396210|NCT00281827|4223246|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4396211|NCT00281827|4223246|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4396212|NCT00281827|4223246|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396213|NCT00281697|4223255|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4396214|NCT00281697|4223256|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4396215|NCT00281697|4223257|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4396216|NCT00281697|4223255|B3||Female|Sex: Female, Male||Participants|Count of Participants|682|682.0||||||
4396217|NCT00281697|4223256|B2||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4396218|NCT00281697|4223257|B1||Female|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4396219|NCT00281697|4223255|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|11.1|11.1|||
4396220|NCT00281697|4223256|B2|||Age||years|Mean|55.0|55.0|Standard Deviation|11.2|11.2|||
4396221|NCT00281697|4223257|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|11.0|11.0|||
4396222|NCT00281658|4223274|B3|||Mean Time of Disease-Free Interval|The disease-free interval was defined as the time from initial diagnosis to metastases.|months|Mean|28.27|28.27|Standard Deviation|31.174|31.174|||
4396223|NCT00281658|4223275|B2|||Mean Time of Disease-Free Interval|The disease-free interval was defined as the time from initial diagnosis to metastases.|months|Mean|29.04|29.04|Standard Deviation|34.522|34.522|||
4396224|NCT00281658|4223276|B1|||Mean Time of Disease-Free Interval|The disease-free interval was defined as the time from initial diagnosis to metastases.|months|Mean|27.51|27.51|Standard Deviation|27.481|27.481|||
4396225|NCT00281658|4223274|B3|Less than 65 years of age||Number of Participants in the Indicated Age Groups||participants|Number|415|415.0||||||
4396226|NCT00281658|4223275|B2|Less than 65 years of age||Number of Participants in the Indicated Age Groups||participants|Number|209|209.0||||||
4396227|NCT00281658|4223276|B1|Less than 65 years of age||Number of Participants in the Indicated Age Groups||participants|Number|206|206.0||||||
4396228|NCT00281658|4223274|B3|Greater than or equal to 65 years of age||Number of Participants in the Indicated Age Groups||participants|Number|29|29.0||||||
4396229|NCT00281658|4223275|B2|Greater than or equal to 65 years of age||Number of Participants in the Indicated Age Groups||participants|Number|13|13.0||||||
4396230|NCT00281658|4223276|B1|Greater than or equal to 65 years of age||Number of Participants in the Indicated Age Groups||participants|Number|16|16.0||||||
4396231|NCT00281658|4223274|B3|Less than 3||Number of Participants with the Indicated Number of Metastatic Sites|Tumor cells move from the primary site to other sites in the body, where they continue to multiply and eventually form another clinically detectable tumor; thus, the site becomes metastatic.|participants|Number|198|198.0||||||
4396232|NCT00281658|4223275|B2|Less than 3||Number of Participants with the Indicated Number of Metastatic Sites|Tumor cells move from the primary site to other sites in the body, where they continue to multiply and eventually form another clinically detectable tumor; thus, the site becomes metastatic.|participants|Number|107|107.0||||||
4396233|NCT00281658|4223276|B1|Less than 3||Number of Participants with the Indicated Number of Metastatic Sites|Tumor cells move from the primary site to other sites in the body, where they continue to multiply and eventually form another clinically detectable tumor; thus, the site becomes metastatic.|participants|Number|91|91.0||||||
4396319|NCT00281580|4223330|B8||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4396320|NCT00281580|4223331|B7||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4396234|NCT00281658|4223274|B3|Greater than or equal to 3||Number of Participants with the Indicated Number of Metastatic Sites|Tumor cells move from the primary site to other sites in the body, where they continue to multiply and eventually form another clinically detectable tumor; thus, the site becomes metastatic.|participants|Number|246|246.0||||||
4396235|NCT00281658|4223275|B2|Greater than or equal to 3||Number of Participants with the Indicated Number of Metastatic Sites|Tumor cells move from the primary site to other sites in the body, where they continue to multiply and eventually form another clinically detectable tumor; thus, the site becomes metastatic.|participants|Number|115|115.0||||||
4396236|NCT00281658|4223276|B1|Greater than or equal to 3||Number of Participants with the Indicated Number of Metastatic Sites|Tumor cells move from the primary site to other sites in the body, where they continue to multiply and eventually form another clinically detectable tumor; thus, the site becomes metastatic.|participants|Number|131|131.0||||||
4396237|NCT00281658|4223274|B3|1, Ambulatory, Restricted Strenuous Activity||Number of Participants with the Indicated Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment, and scores indicate: 0, fully active; 1, ambulatory, restricted strenuous activity; 2, ambulatory, no work activity; 3, partially confined to bed; 5, death. Participants were required to have a baseline ECOG performance status of 0 or 1 for study participation.|participants|Number|228|228.0||||||
4396238|NCT00281658|4223275|B2|1, Ambulatory, Restricted Strenuous Activity||Number of Participants with the Indicated Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment, and scores indicate: 0, fully active; 1, ambulatory, restricted strenuous activity; 2, ambulatory, no work activity; 3, partially confined to bed; 5, death. Participants were required to have a baseline ECOG performance status of 0 or 1 for study participation.|participants|Number|109|109.0||||||
4396239|NCT00281658|4223276|B1|1, Ambulatory, Restricted Strenuous Activity||Number of Participants with the Indicated Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment, and scores indicate: 0, fully active; 1, ambulatory, restricted strenuous activity; 2, ambulatory, no work activity; 3, partially confined to bed; 5, death. Participants were required to have a baseline ECOG performance status of 0 or 1 for study participation.|participants|Number|119|119.0||||||
4396240|NCT00281658|4223274|B3|0, Fully Active||Number of Participants with the Indicated Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment, and scores indicate: 0, fully active; 1, ambulatory, restricted strenuous activity; 2, ambulatory, no work activity; 3, partially confined to bed; 5, death. Participants were required to have a baseline ECOG performance status of 0 or 1 for study participation.|participants|Number|216|216.0||||||
4396241|NCT00281658|4223275|B2|0, Fully Active||Number of Participants with the Indicated Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment, and scores indicate: 0, fully active; 1, ambulatory, restricted strenuous activity; 2, ambulatory, no work activity; 3, partially confined to bed; 5, death. Participants were required to have a baseline ECOG performance status of 0 or 1 for study participation.|participants|Number|113|113.0||||||
4396242|NCT00281658|4223276|B1|0, Fully Active||Number of Participants with the Indicated Eastern Cooperative Oncology Group Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status classifies participants according to their functional impairment, and scores indicate: 0, fully active; 1, ambulatory, restricted strenuous activity; 2, ambulatory, no work activity; 3, partially confined to bed; 5, death. Participants were required to have a baseline ECOG performance status of 0 or 1 for study participation.|participants|Number|103|103.0||||||
4396243|NCT00281658|4223274|B3|Unknown||Number of Participants with the Indicated Stage of Disease at Initial Diagnosis|The stage of cancer is a description of the extent to which the cancer has spread. Stage I cancer is localized; Stage II cancer has not started to spread into the surrounding tissue, but the tumor is larger than in Stage I; Stage III cancer is locally advanced and/or involves local lymph nodes; Stage IV cancer has spread to other organs.|participants|Number|21|21.0||||||
4396244|NCT00281658|4223275|B2|Unknown||Number of Participants with the Indicated Stage of Disease at Initial Diagnosis|The stage of cancer is a description of the extent to which the cancer has spread. Stage I cancer is localized; Stage II cancer has not started to spread into the surrounding tissue, but the tumor is larger than in Stage I; Stage III cancer is locally advanced and/or involves local lymph nodes; Stage IV cancer has spread to other organs.|participants|Number|11|11.0||||||
4396245|NCT00281658|4223276|B1|Unknown||Number of Participants with the Indicated Stage of Disease at Initial Diagnosis|The stage of cancer is a description of the extent to which the cancer has spread. Stage I cancer is localized; Stage II cancer has not started to spread into the surrounding tissue, but the tumor is larger than in Stage I; Stage III cancer is locally advanced and/or involves local lymph nodes; Stage IV cancer has spread to other organs.|participants|Number|10|10.0||||||
4396246|NCT00281658|4223274|B3|Stage IV||Number of Participants with the Indicated Stage of Disease at Initial Diagnosis|The stage of cancer is a description of the extent to which the cancer has spread. Stage I cancer is localized; Stage II cancer has not started to spread into the surrounding tissue, but the tumor is larger than in Stage I; Stage III cancer is locally advanced and/or involves local lymph nodes; Stage IV cancer has spread to other organs.|participants|Number|54|54.0||||||
4396247|NCT00281658|4223275|B2|Stage IV||Number of Participants with the Indicated Stage of Disease at Initial Diagnosis|The stage of cancer is a description of the extent to which the cancer has spread. Stage I cancer is localized; Stage II cancer has not started to spread into the surrounding tissue, but the tumor is larger than in Stage I; Stage III cancer is locally advanced and/or involves local lymph nodes; Stage IV cancer has spread to other organs.|participants|Number|24|24.0||||||
4396248|NCT00281658|4223276|B1|Stage IV||Number of Participants with the Indicated Stage of Disease at Initial Diagnosis|The stage of cancer is a description of the extent to which the cancer has spread. Stage I cancer is localized; Stage II cancer has not started to spread into the surrounding tissue, but the tumor is larger than in Stage I; Stage III cancer is locally advanced and/or involves local lymph nodes; Stage IV cancer has spread to other organs.|participants|Number|30|30.0||||||
4396321|NCT00281580|4223332|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4396249|NCT00281658|4223274|B3|Stage III||Number of Participants with the Indicated Stage of Disease at Initial Diagnosis|The stage of cancer is a description of the extent to which the cancer has spread. Stage I cancer is localized; Stage II cancer has not started to spread into the surrounding tissue, but the tumor is larger than in Stage I; Stage III cancer is locally advanced and/or involves local lymph nodes; Stage IV cancer has spread to other organs.|participants|Number|143|143.0||||||
4396250|NCT00281658|4223275|B2|Stage III||Number of Participants with the Indicated Stage of Disease at Initial Diagnosis|The stage of cancer is a description of the extent to which the cancer has spread. Stage I cancer is localized; Stage II cancer has not started to spread into the surrounding tissue, but the tumor is larger than in Stage I; Stage III cancer is locally advanced and/or involves local lymph nodes; Stage IV cancer has spread to other organs.|participants|Number|68|68.0||||||
4396251|NCT00281658|4223276|B1|Stage III||Number of Participants with the Indicated Stage of Disease at Initial Diagnosis|The stage of cancer is a description of the extent to which the cancer has spread. Stage I cancer is localized; Stage II cancer has not started to spread into the surrounding tissue, but the tumor is larger than in Stage I; Stage III cancer is locally advanced and/or involves local lymph nodes; Stage IV cancer has spread to other organs.|participants|Number|75|75.0||||||
4396252|NCT00281658|4223274|B3|Stage I to II||Number of Participants with the Indicated Stage of Disease at Initial Diagnosis|The stage of cancer is a description of the extent to which the cancer has spread. Stage I cancer is localized; Stage II cancer has not started to spread into the surrounding tissue, but the tumor is larger than in Stage I; Stage III cancer is locally advanced and/or involves local lymph nodes; Stage IV cancer has spread to other organs.|participants|Number|226|226.0||||||
4396253|NCT00281658|4223275|B2|Stage I to II||Number of Participants with the Indicated Stage of Disease at Initial Diagnosis|The stage of cancer is a description of the extent to which the cancer has spread. Stage I cancer is localized; Stage II cancer has not started to spread into the surrounding tissue, but the tumor is larger than in Stage I; Stage III cancer is locally advanced and/or involves local lymph nodes; Stage IV cancer has spread to other organs.|participants|Number|119|119.0||||||
4396254|NCT00281658|4223276|B1|Stage I to II||Number of Participants with the Indicated Stage of Disease at Initial Diagnosis|The stage of cancer is a description of the extent to which the cancer has spread. Stage I cancer is localized; Stage II cancer has not started to spread into the surrounding tissue, but the tumor is larger than in Stage I; Stage III cancer is locally advanced and/or involves local lymph nodes; Stage IV cancer has spread to other organs.|participants|Number|107|107.0||||||
4396255|NCT00281658|4223274|B3|ER- and PgR-||Number of Participants with the Indicated Hormone Receptor Status|Cancer cells have hormone receptor expression of Estrogen Receptor (ER) and/or Progesterone Receptor (PR) and are thus considered to be ER+ and/or PgR+ cells, respectively.|participants|Number|220|220.0||||||
4396256|NCT00281658|4223275|B2|ER- and PgR-||Number of Participants with the Indicated Hormone Receptor Status|Cancer cells have hormone receptor expression of Estrogen Receptor (ER) and/or Progesterone Receptor (PR) and are thus considered to be ER+ and/or PgR+ cells, respectively.|participants|Number|109|109.0||||||
4396257|NCT00281658|4223276|B1|ER- and PgR-||Number of Participants with the Indicated Hormone Receptor Status|Cancer cells have hormone receptor expression of Estrogen Receptor (ER) and/or Progesterone Receptor (PR) and are thus considered to be ER+ and/or PgR+ cells, respectively.|participants|Number|111|111.0||||||
4396258|NCT00281658|4223274|B3|ER+ and/or PgR+ or Unknown||Number of Participants with the Indicated Hormone Receptor Status|Cancer cells have hormone receptor expression of Estrogen Receptor (ER) and/or Progesterone Receptor (PR) and are thus considered to be ER+ and/or PgR+ cells, respectively.|participants|Number|224|224.0||||||
4396259|NCT00281658|4223275|B2|ER+ and/or PgR+ or Unknown||Number of Participants with the Indicated Hormone Receptor Status|Cancer cells have hormone receptor expression of Estrogen Receptor (ER) and/or Progesterone Receptor (PR) and are thus considered to be ER+ and/or PgR+ cells, respectively.|participants|Number|113|113.0||||||
4396260|NCT00281658|4223276|B1|ER+ and/or PgR+ or Unknown||Number of Participants with the Indicated Hormone Receptor Status|Cancer cells have hormone receptor expression of Estrogen Receptor (ER) and/or Progesterone Receptor (PR) and are thus considered to be ER+ and/or PgR+ cells, respectively.|participants|Number|111|111.0||||||
4396261|NCT00281658|4223274|B3|Non-visceral||Number of participants with any visceral metastatic disease and with only non-visceral disease|Metastasis is defined as the spread of a tumor or cancerous cells from the primary site to one or more sites elsewhere in the body. Visceral metastasis is defined as the spread of cancer to viscera, the internal organs of the body, specifically those within the chest (as the heart or lungs) or abdomen (as the liver, pancreas, or intestines). Non-visceral organs are defined as any organ not considered visceral.|participants|Number|71|71.0||||||
4396262|NCT00281658|4223275|B2|Non-visceral||Number of participants with any visceral metastatic disease and with only non-visceral disease|Metastasis is defined as the spread of a tumor or cancerous cells from the primary site to one or more sites elsewhere in the body. Visceral metastasis is defined as the spread of cancer to viscera, the internal organs of the body, specifically those within the chest (as the heart or lungs) or abdomen (as the liver, pancreas, or intestines). Non-visceral organs are defined as any organ not considered visceral.|participants|Number|36|36.0||||||
4396263|NCT00281658|4223276|B1|Non-visceral||Number of participants with any visceral metastatic disease and with only non-visceral disease|Metastasis is defined as the spread of a tumor or cancerous cells from the primary site to one or more sites elsewhere in the body. Visceral metastasis is defined as the spread of cancer to viscera, the internal organs of the body, specifically those within the chest (as the heart or lungs) or abdomen (as the liver, pancreas, or intestines). Non-visceral organs are defined as any organ not considered visceral.|participants|Number|35|35.0||||||
4396264|NCT00281658|4223274|B3|Visceral||Number of participants with any visceral metastatic disease and with only non-visceral disease|Metastasis is defined as the spread of a tumor or cancerous cells from the primary site to one or more sites elsewhere in the body. Visceral metastasis is defined as the spread of cancer to viscera, the internal organs of the body, specifically those within the chest (as the heart or lungs) or abdomen (as the liver, pancreas, or intestines). Non-visceral organs are defined as any organ not considered visceral.|participants|Number|373|373.0||||||
4396322|NCT00281580|4223333|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4396323|NCT00281580|4223334|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4396265|NCT00281658|4223275|B2|Visceral||Number of participants with any visceral metastatic disease and with only non-visceral disease|Metastasis is defined as the spread of a tumor or cancerous cells from the primary site to one or more sites elsewhere in the body. Visceral metastasis is defined as the spread of cancer to viscera, the internal organs of the body, specifically those within the chest (as the heart or lungs) or abdomen (as the liver, pancreas, or intestines). Non-visceral organs are defined as any organ not considered visceral.|participants|Number|186|186.0||||||
4396266|NCT00281658|4223276|B1|Visceral||Number of participants with any visceral metastatic disease and with only non-visceral disease|Metastasis is defined as the spread of a tumor or cancerous cells from the primary site to one or more sites elsewhere in the body. Visceral metastasis is defined as the spread of cancer to viscera, the internal organs of the body, specifically those within the chest (as the heart or lungs) or abdomen (as the liver, pancreas, or intestines). Non-visceral organs are defined as any organ not considered visceral.|participants|Number|187|187.0||||||
4396267|NCT00281658|4223274|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4396268|NCT00281658|4223275|B2|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4396269|NCT00281658|4223276|B1|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4396270|NCT00281658|4223274|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4396271|NCT00281658|4223275|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4396272|NCT00281658|4223276|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4396273|NCT00281658|4223274|B3|Asian||Race/Ethnicity, Customized||participants|Number|384|384.0||||||
4396274|NCT00281658|4223275|B2|Asian||Race/Ethnicity, Customized||participants|Number|192|192.0||||||
4396275|NCT00281658|4223276|B1|Asian||Race/Ethnicity, Customized||participants|Number|192|192.0||||||
4396276|NCT00281658|4223274|B3|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4396277|NCT00281658|4223275|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4396278|NCT00281658|4223276|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4396279|NCT00281658|4223274|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4396280|NCT00281658|4223275|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4396281|NCT00281658|4223276|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4396282|NCT00281658|4223274|B3||Female|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4396283|NCT00281658|4223275|B2||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4396284|NCT00281658|4223276|B1||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4396285|NCT00281658|4223274|B3|||Age||Years|Mean|49.2|49.2|Standard Deviation|10.25|10.25|||
4396286|NCT00281658|4223275|B2|||Age||Years|Mean|49.3|49.3|Standard Deviation|9.75|9.75|||
4396287|NCT00281658|4223276|B1|||Age||Years|Mean|49.1|49.1|Standard Deviation|10.74|10.74|||
4396288|NCT00281632|4223295|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4396289|NCT00281632|4223295|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4396290|NCT00281632|4223295|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4396291|NCT00281632|4223295|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4396292|NCT00281632|4223295|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|11.24|11.24|||
4396293|NCT00281580|4223321|B17||Male|Sex: Female, Male||Participants|Count of Participants|737|737.0||||||
4396294|NCT00281580|4223322|B16||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4396295|NCT00281580|4223323|B15||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4396296|NCT00281580|4223324|B14||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4396297|NCT00281580|4223325|B13||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4396298|NCT00281580|4223326|B12||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4396299|NCT00281580|4223327|B11||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4396300|NCT00281580|4223328|B10||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4396301|NCT00281580|4223329|B9||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4396302|NCT00281580|4223330|B8||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4396303|NCT00281580|4223331|B7||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4396304|NCT00281580|4223332|B6||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4396305|NCT00281580|4223333|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4396306|NCT00281580|4223334|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4396307|NCT00281580|4223335|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4396308|NCT00281580|4223336|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4396309|NCT00281580|4223337|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4396310|NCT00281580|4223321|B17||Female|Sex: Female, Male||Participants|Count of Participants|724|724.0||||||
4396311|NCT00281580|4223322|B16||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4396312|NCT00281580|4223323|B15||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4396313|NCT00281580|4223324|B14||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4396314|NCT00281580|4223325|B13||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4396315|NCT00281580|4223326|B12||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4396316|NCT00281580|4223327|B11||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4396317|NCT00281580|4223328|B10||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4396318|NCT00281580|4223329|B9||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4396324|NCT00281580|4223335|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4396325|NCT00281580|4223336|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4396326|NCT00281580|4223337|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4396327|NCT00281580|4223321|B17|||Age||Years|Mean|53.1|53.1|Standard Deviation|11.1|11.1|||
4396328|NCT00281580|4223322|B16|||Age||Years|Mean|53.4|53.4|Standard Deviation|10.7|10.7|||
4396329|NCT00281580|4223323|B15|||Age||Years|Mean|53.1|53.1|Standard Deviation|10.6|10.6|||
4396330|NCT00281580|4223324|B14|||Age||Years|Mean|55.3|55.3|Standard Deviation|10.4|10.4|||
4396331|NCT00281580|4223325|B13|||Age||Years|Mean|53.9|53.9|Standard Deviation|11.6|11.6|||
4396332|NCT00281580|4223326|B12|||Age||Years|Mean|52.7|52.7|Standard Deviation|11.9|11.9|||
4396333|NCT00281580|4223327|B11|||Age||Years|Mean|54.8|54.8|Standard Deviation|9.7|9.7|||
4396334|NCT00281580|4223328|B10|||Age||Years|Mean|53.3|53.3|Standard Deviation|11.3|11.3|||
4396335|NCT00281580|4223329|B9|||Age||Years|Mean|52.3|52.3|Standard Deviation|11.9|11.9|||
4396336|NCT00281580|4223330|B8|||Age||Years|Mean|50.7|50.7|Standard Deviation|10.2|10.2|||
4396337|NCT00281580|4223331|B7|||Age||Years|Mean|51|51.0|Standard Deviation|11.2|11.2|||
4396338|NCT00281580|4223332|B6|||Age||Years|Mean|54.4|54.4|Standard Deviation|10.2|10.2|||
4396339|NCT00281580|4223333|B5|||Age||Years|Mean|54|54.0|Standard Deviation|10.8|10.8|||
4396340|NCT00281580|4223334|B4|||Age||Years|Mean|53.1|53.1|Standard Deviation|11.3|11.3|||
4396341|NCT00281580|4223335|B3|||Age||Years|Mean|52|52.0|Standard Deviation|11|11.0|||
4396342|NCT00281580|4223336|B2|||Age||Years|Mean|53.6|53.6|Standard Deviation|10.4|10.4|||
4396343|NCT00281580|4223337|B1|||Age||Years|Mean|52.5|52.5|Standard Deviation|12.3|12.3|||
4396344|NCT00281528|4223696|B4|||Participants with Current Diagnosis at Stage IV|Stage IV characteristics are the cancer can be any size (any T) and may or may not have spread to nearby lymph nodes (any N). It has spread to distant organs or to lymph nodes far from the breast (M1). The most common sites of spread are the bone, liver, brain, or lung,|Participants|Number|208|208.0||||||
4396345|NCT00281528|4223697|B3|||Participants with Current Diagnosis at Stage IV|Stage IV characteristics are the cancer can be any size (any T) and may or may not have spread to nearby lymph nodes (any N). It has spread to distant organs or to lymph nodes far from the breast (M1). The most common sites of spread are the bone, liver, brain, or lung,|Participants|Number|79|79.0||||||
4396346|NCT00281528|4223698|B2|||Participants with Current Diagnosis at Stage IV|Stage IV characteristics are the cancer can be any size (any T) and may or may not have spread to nearby lymph nodes (any N). It has spread to distant organs or to lymph nodes far from the breast (M1). The most common sites of spread are the bone, liver, brain, or lung,|Participants|Number|54|54.0||||||
4396347|NCT00281528|4223699|B1|||Participants with Current Diagnosis at Stage IV|Stage IV characteristics are the cancer can be any size (any T) and may or may not have spread to nearby lymph nodes (any N). It has spread to distant organs or to lymph nodes far from the breast (M1). The most common sites of spread are the bone, liver, brain, or lung,|Participants|Number|75|75.0||||||
4396348|NCT00281528|4223696|B4|||Time from Primary Diagnosis to Study Entry||Years|Median|2.983|2.983|Full Range|||0.022|23.932|
4396349|NCT00281528|4223697|B3|||Time from Primary Diagnosis to Study Entry||Years|Median|2.579|2.579|Full Range|||0.022|21.065|
4396350|NCT00281528|4223698|B2|||Time from Primary Diagnosis to Study Entry||Years|Median|3.127|3.127|Full Range|||0.041|23.932|
4396351|NCT00281528|4223699|B1|||Time from Primary Diagnosis to Study Entry||Years|Median|4.320|4.32|Full Range|||0.025|16.901|
4396352|NCT00281528|4223696|B4|4||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|0|0.0||||||
4396353|NCT00281528|4223697|B3|4||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|0|0.0||||||
4396354|NCT00281528|4223698|B2|4||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|0|0.0||||||
4396355|NCT00281528|4223699|B1|4||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|0|0.0||||||
4396356|NCT00281528|4223696|B4|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|0|0.0||||||
4396357|NCT00281528|4223697|B3|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|0|0.0||||||
4396358|NCT00281528|4223698|B2|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|0|0.0||||||
4396359|NCT00281528|4223699|B1|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|0|0.0||||||
4396360|NCT00281528|4223696|B4|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|11|11.0||||||
4396361|NCT00281528|4223697|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|4|4.0||||||
4396362|NCT00281528|4223698|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|4|4.0||||||
4396363|NCT00281528|4223699|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|3|3.0||||||
4396364|NCT00281528|4223696|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|73|73.0||||||
4396365|NCT00281528|4223697|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|27|27.0||||||
4396366|NCT00281528|4223698|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|17|17.0||||||
4396367|NCT00281528|4223699|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|29|29.0||||||
4396368|NCT00281528|4223696|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|124|124.0||||||
4396369|NCT00281528|4223697|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|48|48.0||||||
4396370|NCT00281528|4223698|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|33|33.0||||||
4396371|NCT00281528|4223699|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"0 – Asymptomatic~– Symptomatic but completely ambulatory~– Symptomatic, <50% in bed during the day~– Symptomatic, >50% in bed, but not bedbound~– Bedbound~– Death"|Participants|Number|43|43.0||||||
4396372|NCT00281528|4223696|B4|Post-menopausal||Menopausal status||Participants|Number|170|170.0||||||
4396373|NCT00281528|4223697|B3|Post-menopausal||Menopausal status||Participants|Number|63|63.0||||||
4396374|NCT00281528|4223698|B2|Post-menopausal||Menopausal status||Participants|Number|43|43.0||||||
4396375|NCT00281528|4223699|B1|Post-menopausal||Menopausal status||Participants|Number|64|64.0||||||
4396376|NCT00281528|4223696|B4|Pre-menopausal||Menopausal status||Participants|Number|38|38.0||||||
4396377|NCT00281528|4223697|B3|Pre-menopausal||Menopausal status||Participants|Number|16|16.0||||||
4396378|NCT00281528|4223698|B2|Pre-menopausal||Menopausal status||Participants|Number|11|11.0||||||
4396379|NCT00281528|4223699|B1|Pre-menopausal||Menopausal status||Participants|Number|11|11.0||||||
4396380|NCT00281528|4223696|B4|||Weight||kilograms|Median|72.2|72.2|Full Range|||41.4|167.8|
4396381|NCT00281528|4223697|B3|||Weight||kilograms|Median|73.1|73.1|Full Range|||46.0|167.8|
4396382|NCT00281528|4223698|B2|||Weight||kilograms|Median|70.2|70.2|Full Range|||41.4|145.0|
4396383|NCT00281528|4223699|B1|||Weight||kilograms|Median|72.9|72.9|Full Range|||41.8|119.5|
4396384|NCT00281528|4223696|B4|Other (not specified)||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4396385|NCT00281528|4223697|B3|Other (not specified)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4396386|NCT00281528|4223698|B2|Other (not specified)||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4396387|NCT00281528|4223699|B1|Other (not specified)||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4396388|NCT00281528|4223696|B4|White, Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4396389|NCT00281528|4223697|B3|White, Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4396390|NCT00281528|4223698|B2|White, Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4396391|NCT00281528|4223699|B1|White, Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4396392|NCT00281528|4223696|B4|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||Participants|Number|128|128.0||||||
4396393|NCT00281528|4223697|B3|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4396394|NCT00281528|4223698|B2|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4396395|NCT00281528|4223699|B1|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4396396|NCT00281528|4223696|B4|Black, of African Heritage||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4396397|NCT00281528|4223697|B3|Black, of African Heritage||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4396398|NCT00281528|4223698|B2|Black, of African Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4396399|NCT00281528|4223699|B1|Black, of African Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4396400|NCT00281528|4223696|B4|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4396401|NCT00281528|4223697|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4396402|NCT00281528|4223698|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4396403|NCT00281528|4223699|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4396404|NCT00281528|4223696|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
4396405|NCT00281528|4223697|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4396406|NCT00281528|4223698|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4396407|NCT00281528|4223699|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4396408|NCT00281528|4223696|B4||Female|Gender||Participants|Count of Participants|208|208.0||||||
4396409|NCT00281528|4223697|B3||Female|Gender||Participants|Count of Participants|79|79.0||||||
4396410|NCT00281528|4223698|B2||Female|Gender||Participants|Count of Participants|54|54.0||||||
4396411|NCT00281528|4223699|B1||Female|Gender||Participants|Count of Participants|75|75.0||||||
4396412|NCT00281528|4223696|B4|||Age, Customized||Years|Median|57.0|57.0|Full Range|||29.0|85.0|
4396413|NCT00281528|4223697|B3|||Age, Customized||Years|Median|56.0|56.0|Full Range|||32.0|85.0|
4396414|NCT00281528|4223698|B2|||Age, Customized||Years|Median|56.0|56.0|Full Range|||36.0|79.0|
4396415|NCT00281528|4223699|B1|||Age, Customized||Years|Median|59.0|59.0|Full Range|||29.0|80.0|
4396416|NCT00281528|4223696|B4||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4396417|NCT00281528|4223697|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4396418|NCT00281528|4223698|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4396419|NCT00281528|4223699|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4396420|NCT00281528|4223696|B4||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
4396421|NCT00281528|4223697|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4396422|NCT00281528|4223698|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4396423|NCT00281528|4223699|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4396424|NCT00281528|4223696|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396425|NCT00281528|4223697|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396426|NCT00281528|4223698|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396427|NCT00281528|4223699|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396428|NCT00281463|4223745|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4396429|NCT00281463|4223745|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4396430|NCT00281463|4223745|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4396431|NCT00281463|4223745|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396432|NCT00281463|4223745|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4396433|NCT00281463|4223745|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396434|NCT00281320|4223750|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4396435|NCT00281320|4223751|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4396436|NCT00281320|4223752|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4396437|NCT00281320|4223750|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4396438|NCT00281320|4223751|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4396439|NCT00281320|4223752|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4396440|NCT00281320|4223750|B3|||Age||years|Mean|71.2|71.2|Standard Deviation|5.2|5.2|||
4396441|NCT00281320|4223751|B2|||Age||years|Mean|72.0|72.0|Standard Deviation|5.8|5.8|||
4396442|NCT00281320|4223752|B1|||Age||years|Mean|70.5|70.5|Standard Deviation|4.6|4.6|||
4396443|NCT00281099|4223773|B3|Italy||Region of Enrollment||participants|Number|23|23.0||||||
4396444|NCT00281099|4223774|B2|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4396445|NCT00281099|4223775|B1|Italy||Region of Enrollment||participants|Number|11|11.0||||||
4396446|NCT00281099|4223773|B3|Switzerland||Region of Enrollment||participants|Number|18|18.0||||||
4396447|NCT00281099|4223774|B2|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
4396448|NCT00281099|4223775|B1|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
4396449|NCT00281099|4223773|B3|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4396450|NCT00281099|4223774|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4396451|NCT00281099|4223775|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4396452|NCT00281099|4223773|B3|Germany||Region of Enrollment||participants|Number|30|30.0||||||
4396453|NCT00281099|4223774|B2|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4396454|NCT00281099|4223775|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4396455|NCT00281099|4223773|B3|Israel||Region of Enrollment||participants|Number|29|29.0||||||
4396456|NCT00281099|4223774|B2|Israel||Region of Enrollment||participants|Number|15|15.0||||||
4396457|NCT00281099|4223775|B1|Israel||Region of Enrollment||participants|Number|14|14.0||||||
4396458|NCT00281099|4223773|B3|Denmark||Region of Enrollment||participants|Number|7|7.0||||||
4396459|NCT00281099|4223774|B2|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4396460|NCT00281099|4223775|B1|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4396461|NCT00281099|4223773|B3|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4396462|NCT00281099|4223774|B2|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4396463|NCT00281099|4223775|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4396464|NCT00281099|4223773|B3|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4396465|NCT00281099|4223774|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4396466|NCT00281099|4223775|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4396467|NCT00281099|4223773|B3|Canada||Region of Enrollment||participants|Number|118|118.0||||||
4396468|NCT00281099|4223774|B2|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4396469|NCT00281099|4223775|B1|Canada||Region of Enrollment||participants|Number|58|58.0||||||
4396470|NCT00281099|4223773|B3|United States||Region of Enrollment||participants|Number|780|780.0||||||
4396471|NCT00281099|4223774|B2|United States||Region of Enrollment||participants|Number|390|390.0||||||
4396472|NCT00281099|4223775|B1|United States||Region of Enrollment||participants|Number|390|390.0||||||
4396473|NCT00281099|4223773|B3|France||Region of Enrollment||participants|Number|6|6.0||||||
4396474|NCT00281099|4223774|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4396475|NCT00281099|4223775|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4396476|NCT00281099|4223773|B3||Male|Sex: Female, Male||Participants|Count of Participants|819|819.0||||||
4396477|NCT00281099|4223774|B2||Male|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
4396478|NCT00281099|4223775|B1||Male|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
4396479|NCT00281099|4223773|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4396480|NCT00281099|4223774|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4396481|NCT00281099|4223775|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4396482|NCT00281099|4223773|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|11.9|11.9|||
4396483|NCT00281099|4223774|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|12.0|12.0|||
4396484|NCT00281099|4223775|B1|||Age||years|Mean|61.7|61.7|Standard Deviation|11.7|11.7|||
4396485|NCT00281099|4223773|B3||>=65 years|Age||Participants|Count of Participants|458|458.0||||||
4396486|NCT00281099|4223774|B2||>=65 years|Age||Participants|Count of Participants|234|234.0||||||
4396487|NCT00281099|4223775|B1||>=65 years|Age||Participants|Count of Participants|224|224.0||||||
4396488|NCT00281099|4223773|B3||Between 18 and 65 years|Age||Participants|Count of Participants|573|573.0||||||
4396489|NCT00281099|4223774|B2||Between 18 and 65 years|Age||Participants|Count of Participants|284|284.0||||||
4396490|NCT00281099|4223775|B1||Between 18 and 65 years|Age||Participants|Count of Participants|289|289.0||||||
4396491|NCT00281099|4223773|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396492|NCT00281099|4223774|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396493|NCT00281099|4223775|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396494|NCT00281021|4223817|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4396495|NCT00281021|4223817|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4396496|NCT00281021|4223817|B1|>18 years||Age, Customized||participants|Number|26|26.0||||||
4396497|NCT00281021|4223817|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4396498|NCT00281021|4223817|B1|||Age||years|Mean|61|61.0|Full Range|||34.0|78.0|
4396499|NCT00280917|4223821|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4396500|NCT00280917|4223822|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4396501|NCT00280917|4223823|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4396502|NCT00280917|4223824|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4396503|NCT00280917|4223825|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4396504|NCT00280917|4223821|B5||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4396505|NCT00280917|4223822|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4396506|NCT00280917|4223823|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4396507|NCT00280917|4223824|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4396508|NCT00280917|4223825|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4396509|NCT00280917|4223821|B5|||Age||years|Mean|54.1|54.1|Standard Deviation|10.73|10.73|||
4396510|NCT00280917|4223822|B4|||Age||years|Mean|53|53.0|Standard Deviation|10.86|10.86|||
4396511|NCT00280917|4223823|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|10.07|10.07|||
4396512|NCT00280917|4223824|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|9.98|9.98|||
4396513|NCT00280917|4223825|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|12.02|12.02|||
4396514|NCT00280904|4223838|B1||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4396515|NCT00280904|4223838|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4396516|NCT00280904|4223838|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|25.49|25.49|||
4396517|NCT00280904|4223838|B1||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4396518|NCT00280904|4223838|B1||Between 18 and 65 years|Age||Participants|Count of Participants|193|193.0||||||
4396519|NCT00280904|4223838|B1||<=18 years|Age||Participants|Count of Participants|183|183.0||||||
4396520|NCT00280826|4223843|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4396521|NCT00280826|4223843|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4396522|NCT00280826|4223843|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4396523|NCT00280826|4223843|B1|||Age||years|Mean|43|43.0|Standard Deviation|23|23.0|||
4396524|NCT00280826|4223843|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4396525|NCT00280826|4223843|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4396526|NCT00280826|4223843|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396527|NCT00280748|4223851|B1||KPS unknown|Karnofsky Performance Status||Participants|Count of Participants|1|1.0||||||
4396528|NCT00280748|4223851|B1||KPS 70-80; unable to carry on all normal activity|Karnofsky Performance Status||Participants|Count of Participants|6|6.0||||||
4396529|NCT00280748|4223851|B1||KPS 80-90; some symptoms of disease|Karnofsky Performance Status||Participants|Count of Participants|0|0.0||||||
4396530|NCT00280748|4223851|B1||KPS 90-100; minor symptoms of disease|Karnofsky Performance Status||Participants|Count of Participants|3|3.0||||||
4396531|NCT00280748|4223851|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4396532|NCT00280748|4223851|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396533|NCT00280748|4223851|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396534|NCT00280748|4223851|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4396535|NCT00280748|4223851|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4396536|NCT00280748|4223851|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396537|NCT00280748|4223851|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396538|NCT00280748|4223851|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4396539|NCT00280748|4223851|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4396540|NCT00280748|4223851|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4396541|NCT00280748|4223851|B1|||Age||years|Median|62.5|62.5|Full Range|||46.0|82.0|
4396542|NCT00280735|4223861|B1|Pneumonectomy||Type of surgery|Type of pre-screening surgical resection undergone by subjects|Participants|Count of Participants|11|11.0||||||
4396543|NCT00280735|4223861|B1|Bi-lobectomy||Type of surgery|Type of pre-screening surgical resection undergone by subjects|Participants|Count of Participants|7|7.0||||||
4396544|NCT00280735|4223861|B1|Lobectomy||Type of surgery|Type of pre-screening surgical resection undergone by subjects|Participants|Count of Participants|52|52.0||||||
4396545|NCT00280735|4223861|B1|Wedge resection||Type of surgery|Type of pre-screening surgical resection undergone by subjects|Participants|Count of Participants|2|2.0||||||
4396546|NCT00280735|4223861|B1|Large cell carcinoma||Histology||Participants|Count of Participants|3|3.0||||||
4396547|NCT00280735|4223861|B1|Non-small cell—not otherwise specified||Histology||Participants|Count of Participants|7|7.0||||||
4396548|NCT00280735|4223861|B1|Squamous cell carcinoma||Histology||Participants|Count of Participants|30|30.0||||||
4396549|NCT00280735|4223861|B1|Adenocarcinoma||Histology||Participants|Count of Participants|32|32.0||||||
4396550|NCT00280735|4223861|B1|Stage IIIB||Stage|Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) tumor node metastatic (TNM) system, which is based on: Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Spread (metastasis; M) to other organs of the body. Once the T, N, and M categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced.|Participants|Count of Participants|1|1.0||||||
4396551|NCT00280735|4223861|B1|Stage IIIA||Stage|Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) tumor node metastatic (TNM) system, which is based on: Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Spread (metastasis; M) to other organs of the body. Once the T, N, and M categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced.|Participants|Count of Participants|16|16.0||||||
4396552|NCT00280735|4223861|B1|Stage II||Stage|Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) tumor node metastatic (TNM) system, which is based on: Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Spread (metastasis; M) to other organs of the body. Once the T, N, and M categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced.|Participants|Count of Participants|26|26.0||||||
4396553|NCT00280735|4223861|B1|Stage I||Stage|Anatomic stage for NSCLC is the American Joint Committee on Cancer (AJCC) tumor node metastatic (TNM) system, which is based on: Size of primary tumor (T) and whether it has grown into nearby areas. Spread to regional lymph nodes (N). Spread (metastasis; M) to other organs of the body. Once the T, N, and M categories have been determined, this information is combined into a prognostic group. Higher numbers mean the cancer is more advanced.|Participants|Count of Participants|29|29.0||||||
4396554|NCT00280735|4223861|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~1, Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature 2. Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours 3. Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours 4. Completely disabled; cannot carry on any selfcare; totally confined to bed or chair 5. Dead"|Participants|Count of Participants|1|1.0||||||
4396555|NCT00280735|4223861|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~1, Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature 2. Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours 3. Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours 4. Completely disabled; cannot carry on any selfcare; totally confined to bed or chair 5. Dead"|Participants|Count of Participants|43|43.0||||||
4396556|NCT00280735|4223861|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~1, Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature 2. Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours 3. Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours 4. Completely disabled; cannot carry on any selfcare; totally confined to bed or chair 5. Dead"|Participants|Count of Participants|28|28.0||||||
4396557|NCT00280735|4223861|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4396558|NCT00280735|4223861|B1|Ethnicity|Unknown or Not Reported|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4396559|NCT00280735|4223861|B1|Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4396560|NCT00280735|4223861|B1|Ethnicity|Latino|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4396561|NCT00280735|4223861|B1|Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4396562|NCT00280735|4223861|B1|Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
4396614|NCT00280384|4223918|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4396563|NCT00280735|4223861|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4396564|NCT00280735|4223861|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4396565|NCT00280735|4223861|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4396566|NCT00280735|4223861|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4396567|NCT00280735|4223861|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4396568|NCT00280735|4223861|B1|||Age||years|Median|65|65.0|Full Range|||47.0|84.0|
4396569|NCT00280683|4223871|B3|||Exhaled Nitric oxide|The secondary clinical endpoints that were measured included the patient symptom diary, daily short acting β-agonist use, St. George’s Respiratory questionnaire, daily PEF diary, forced expiratory volume in one second (FEV1), and forced expiratory volume in one second to forced vital capacity ratio (FEV1/FVC) measurements performed at the monthly visits, exhaled NO concentration and induced sputum eosinophil percent counts|ppb (parts per billion)|Mean|26.3|26.3|Standard Deviation|17|17.0|||
4396570|NCT00280683|4223872|B2|||Exhaled Nitric oxide|The secondary clinical endpoints that were measured included the patient symptom diary, daily short acting β-agonist use, St. George’s Respiratory questionnaire, daily PEF diary, forced expiratory volume in one second (FEV1), and forced expiratory volume in one second to forced vital capacity ratio (FEV1/FVC) measurements performed at the monthly visits, exhaled NO concentration and induced sputum eosinophil percent counts|ppb (parts per billion)|Mean|24.4|24.4|Standard Deviation|17.6|17.6|||
4396571|NCT00280683|4223873|B1|||Exhaled Nitric oxide|The secondary clinical endpoints that were measured included the patient symptom diary, daily short acting β-agonist use, St. George’s Respiratory questionnaire, daily PEF diary, forced expiratory volume in one second (FEV1), and forced expiratory volume in one second to forced vital capacity ratio (FEV1/FVC) measurements performed at the monthly visits, exhaled NO concentration and induced sputum eosinophil percent counts|ppb (parts per billion)|Mean|28.2|28.2|Standard Deviation|16.4|16.4|||
4396572|NCT00280683|4223871|B3|||FEV1 Percent Predicted||Percent|Mean|72.9|72.9|Standard Deviation|18.0|18.0|||
4396573|NCT00280683|4223872|B2|||FEV1 Percent Predicted||Percent|Mean|70.8|70.8|Standard Deviation|18.5|18.5|||
4396574|NCT00280683|4223873|B1|||FEV1 Percent Predicted||Percent|Mean|75|75.0|Standard Deviation|17.5|17.5|||
4396575|NCT00280683|4223871|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4396576|NCT00280683|4223872|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4396577|NCT00280683|4223873|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4396578|NCT00280683|4223871|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4396579|NCT00280683|4223872|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4396580|NCT00280683|4223873|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4396581|NCT00280683|4223871|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|15.2|15.2|||
4396582|NCT00280683|4223872|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|15.1|15.1|||
4396583|NCT00280683|4223873|B1|||Age||years|Mean|53.1|53.1|Standard Deviation|15.4|15.4|||
4396584|NCT00280683|4223871|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4396585|NCT00280683|4223872|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4396586|NCT00280683|4223873|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4396587|NCT00280683|4223871|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4396588|NCT00280683|4223872|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4396589|NCT00280683|4223873|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4396590|NCT00280683|4223871|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396591|NCT00280683|4223872|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396592|NCT00280683|4223873|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396593|NCT00280566|4223882|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4396594|NCT00280566|4223883|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4396595|NCT00280566|4223884|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4396596|NCT00280566|4223882|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4396597|NCT00280566|4223883|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4396598|NCT00280566|4223884|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4396599|NCT00280566|4223882|B3|||Age||years|Mean|38.4|38.4|Standard Deviation|11.8|11.8|||
4396600|NCT00280566|4223883|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|11.6|11.6|||
4396601|NCT00280566|4223884|B1|||Age||years|Mean|39.6|39.6|Standard Deviation|12.3|12.3|||
4396602|NCT00280397|4223911|B1|Female||Sex/Gender, Customized||Participants|Number|17|17.0||||||
4396603|NCT00280397|4223911|B1|Male||Sex/Gender, Customized||Participants|Number|10|10.0||||||
4396604|NCT00280397|4223911|B1|||Age||Years|Mean|50.7|50.7|Standard Deviation|11.1|11.1|||
4396605|NCT00280384|4223918|B9||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4396606|NCT00280384|4223919|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4396607|NCT00280384|4223920|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4396608|NCT00280384|4223921|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4396609|NCT00280384|4223922|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4396610|NCT00280384|4223923|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4396611|NCT00280384|4223924|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4396612|NCT00280384|4223925|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4396613|NCT00280384|4223926|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4396615|NCT00280384|4223919|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4396616|NCT00280384|4223920|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4396617|NCT00280384|4223921|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4396618|NCT00280384|4223922|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4396619|NCT00280384|4223923|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4396620|NCT00280384|4223924|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4396621|NCT00280384|4223925|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4396622|NCT00280384|4223926|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4396623|NCT00280384|4223918|B9|||Age||years|Mean|28.3|28.3|Standard Deviation|5.7|5.7|||
4396624|NCT00280384|4223919|B8|||Age||years|Mean|29.3|29.3|Standard Deviation|2.6|2.6|||
4396625|NCT00280384|4223920|B7|||Age||years|Mean|32.7|32.7|Standard Deviation|2.9|2.9|||
4396626|NCT00280384|4223921|B6|||Age||years|Mean|34.5|34.5|Standard Deviation|3.7|3.7|||
4396627|NCT00280384|4223922|B5|||Age||years|Mean|33.7|33.7|Standard Deviation|2.7|2.7|||
4396628|NCT00280384|4223923|B4|||Age||years|Mean|22.2|22.2|Standard Deviation|2.6|2.6|||
4396629|NCT00280384|4223924|B3|||Age||years|Mean|23.3|23.3|Standard Deviation|2.9|2.9|||
4396630|NCT00280384|4223925|B2|||Age||years|Mean|28.0|28.0|Standard Deviation|5.4|5.4|||
4396631|NCT00280384|4223926|B1|||Age||years|Mean|22.7|22.7|Standard Deviation|2.9|2.9|||
4396632|NCT00280293|4223975|B3|United States||Region of Enrollment||participants|Number|112|112.0||||||
4396633|NCT00280293|4223976|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4396634|NCT00280293|4223977|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4396635|NCT00280293|4223975|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4396636|NCT00280293|4223976|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4396637|NCT00280293|4223977|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4396638|NCT00280293|4223975|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4396639|NCT00280293|4223976|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4396640|NCT00280293|4223977|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4396641|NCT00280293|4223975|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|8.8|8.8|||
4396642|NCT00280293|4223976|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|10.0|10.0|||
4396643|NCT00280293|4223977|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|7.3|7.3|||
4396644|NCT00280293|4223975|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396645|NCT00280293|4223976|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396646|NCT00280293|4223977|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396647|NCT00280293|4223975|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4396648|NCT00280293|4223976|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4396649|NCT00280293|4223977|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4396650|NCT00280293|4223975|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396651|NCT00280293|4223976|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396652|NCT00280293|4223977|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396653|NCT00280241|4223990|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4396654|NCT00280241|4223990|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4396655|NCT00280241|4223990|B1|||Age, Customized||years|Median|58|58.0|Full Range|||36.0|85.0|
4396656|NCT00280150|4223997|B5|United States||Region of Enrollment||participants|Number|46|46.0||||||
4396657|NCT00280150|4223998|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4396658|NCT00280150|4223999|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4396659|NCT00280150|4224000|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4396660|NCT00280150|4224001|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4396661|NCT00280150|4223997|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396662|NCT00280150|4223998|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396663|NCT00280150|4223999|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396664|NCT00280150|4224000|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396665|NCT00280150|4224001|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396666|NCT00280150|4223997|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396667|NCT00280150|4223998|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396668|NCT00280150|4223999|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396669|NCT00280150|4224000|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396670|NCT00280150|4224001|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396671|NCT00280150|4223997|B5||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4396672|NCT00280150|4223998|B4||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4396673|NCT00280150|4223999|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4396674|NCT00280150|4224000|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4396675|NCT00280150|4224001|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4396676|NCT00280150|4223997|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4396677|NCT00280150|4223998|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4396678|NCT00280150|4223999|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4396679|NCT00280150|4224000|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4396680|NCT00280150|4224001|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396681|NCT00280150|4223997|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396682|NCT00280150|4223998|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396683|NCT00280150|4223999|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396684|NCT00280150|4224000|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396685|NCT00280150|4224001|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396686|NCT00280150|4223997|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4396687|NCT00280150|4223998|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4396688|NCT00280150|4223999|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396689|NCT00280150|4224000|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396690|NCT00280150|4224001|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4396691|NCT00280150|4223997|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396692|NCT00280150|4223998|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396693|NCT00280150|4223999|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396694|NCT00280150|4224000|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396695|NCT00280150|4224001|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396696|NCT00280150|4223997|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396697|NCT00280150|4223998|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396698|NCT00280150|4223999|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396699|NCT00280150|4224000|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396700|NCT00280150|4224001|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396701|NCT00280150|4223997|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4396702|NCT00280150|4223998|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4396703|NCT00280150|4223999|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4396704|NCT00280150|4224000|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4396705|NCT00280150|4224001|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4396706|NCT00280150|4223997|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4396707|NCT00280150|4223998|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4396708|NCT00280150|4223999|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396709|NCT00280150|4224000|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396710|NCT00280150|4224001|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4396711|NCT00280150|4223997|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4396712|NCT00280150|4223998|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4396713|NCT00280150|4223999|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4396714|NCT00280150|4224000|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4396715|NCT00280150|4224001|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4396716|NCT00280150|4223997|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4396717|NCT00280150|4223998|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4396718|NCT00280150|4223999|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4396719|NCT00280150|4224000|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4396720|NCT00280150|4224001|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4396721|NCT00280150|4223997|B5||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4396722|NCT00280150|4223998|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4396723|NCT00280150|4223999|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4396724|NCT00280150|4224000|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4396725|NCT00280150|4224001|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4396726|NCT00280150|4223997|B5||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4396727|NCT00280150|4223998|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4396728|NCT00280150|4223999|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4396729|NCT00280150|4224000|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4396730|NCT00280150|4224001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4396731|NCT00280150|4223997|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396732|NCT00280150|4223998|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396733|NCT00280150|4223999|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396734|NCT00280150|4224000|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396735|NCT00280150|4224001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396736|NCT00280059|4224017|B3||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4396737|NCT00280059|4224018|B2||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4396738|NCT00280059|4224019|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4396739|NCT00280059|4224017|B3||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4396740|NCT00280059|4224018|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4396741|NCT00280059|4224019|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4396742|NCT00280059|4224017|B3|>= 65 years||Age, Customized||participants|Number|33|33.0||||||
4396743|NCT00280059|4224018|B2|>= 65 years||Age, Customized||participants|Number|19|19.0||||||
4396744|NCT00280059|4224019|B1|>= 65 years||Age, Customized||participants|Number|14|14.0||||||
4396745|NCT00280059|4224017|B3|Between 45 and 64 years||Age, Customized||participants|Number|153|153.0||||||
4396746|NCT00280059|4224018|B2|Between 45 and 64 years||Age, Customized||participants|Number|74|74.0||||||
4396747|NCT00280059|4224019|B1|Between 45 and 64 years||Age, Customized||participants|Number|79|79.0||||||
4396748|NCT00280059|4224017|B3|Between 18 and 44 years||Age, Customized||participants|Number|456|456.0||||||
4396749|NCT00280059|4224018|B2|Between 18 and 44 years||Age, Customized||participants|Number|228|228.0||||||
4396750|NCT00280059|4224019|B1|Between 18 and 44 years||Age, Customized||participants|Number|228|228.0||||||
4396751|NCT00280059|4224017|B3|< 18 years||Age, Customized||participants|Number|18|18.0||||||
4396752|NCT00280059|4224018|B2|< 18 years||Age, Customized||participants|Number|9|9.0||||||
4396753|NCT00280059|4224019|B1|< 18 years||Age, Customized||participants|Number|9|9.0||||||
4396754|NCT00279955|4224066|B4|United States||Region of Enrollment||participants|Number|1001|1001.0||||||
4396755|NCT00279955|4224067|B3|United States||Region of Enrollment||participants|Number|358|358.0||||||
4396756|NCT00279955|4224068|B2|United States||Region of Enrollment||participants|Number|486|486.0||||||
4396757|NCT00279955|4224069|B1|United States||Region of Enrollment||participants|Number|157|157.0||||||
4396758|NCT00279955|4224066|B4||Male|Sex: Female, Male||Participants|Count of Participants|684|684.0||||||
4396759|NCT00279955|4224067|B3||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4396760|NCT00279955|4224068|B2||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
4396761|NCT00279955|4224069|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4396762|NCT00279955|4224066|B4||Female|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
4396763|NCT00279955|4224067|B3||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4396764|NCT00279955|4224068|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4396765|NCT00279955|4224069|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4396766|NCT00279955|4224066|B4|||Age||years|Mean|68.4|68.4|Standard Deviation|10.8|10.8|||
4396767|NCT00279955|4224067|B3|||Age||years|Mean|68.5|68.5|Standard Deviation|11.0|11.0|||
4396768|NCT00279955|4224068|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|10.6|10.6|||
4396769|NCT00279955|4224069|B1|||Age||years|Mean|68.8|68.8|Standard Deviation|11.0|11.0|||
4396770|NCT00279916|4224082|B3|C; peaked pressure greater than -100 kPa||Tympanogram type in worst ear||participants|Number|58|58.0||||||
4396771|NCT00279916|4224083|B2|C; peaked pressure greater than -100 kPa||Tympanogram type in worst ear||participants|Number|30|30.0||||||
4396772|NCT00279916|4224084|B1|C; peaked pressure greater than -100 kPa||Tympanogram type in worst ear||participants|Number|28|28.0||||||
4396773|NCT00279916|4224082|B3|B; non-peaked or flat pressure||Tympanogram type in worst ear||participants|Number|33|33.0||||||
4396774|NCT00279916|4224083|B2|B; non-peaked or flat pressure||Tympanogram type in worst ear||participants|Number|16|16.0||||||
4396775|NCT00279916|4224084|B1|B; non-peaked or flat pressure||Tympanogram type in worst ear||participants|Number|17|17.0||||||
4396776|NCT00279916|4224082|B3|A; peak pressure under -100 kPa||Tympanogram type in worst ear||participants|Number|0|0.0||||||
4396777|NCT00279916|4224083|B2|A; peak pressure under -100 kPa||Tympanogram type in worst ear||participants|Number|0|0.0||||||
4396778|NCT00279916|4224084|B1|A; peak pressure under -100 kPa||Tympanogram type in worst ear||participants|Number|0|0.0||||||
4396779|NCT00279916|4224082|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4396780|NCT00279916|4224083|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4396781|NCT00279916|4224084|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4396782|NCT00279916|4224082|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4396783|NCT00279916|4224083|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4396784|NCT00279916|4224084|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4396785|NCT00279916|4224082|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|29.5|29.5|||
4396786|NCT00279916|4224083|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|30.8|30.8|||
4396787|NCT00279916|4224084|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|28.4|28.4|||
4396788|NCT00279916|4224082|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4396789|NCT00279916|4224083|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4396790|NCT00279916|4224084|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4396791|NCT00279916|4224082|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4396792|NCT00279916|4224083|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4396793|NCT00279916|4224084|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4396794|NCT00279916|4224082|B3||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4396795|NCT00279916|4224083|B2||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4396796|NCT00279916|4224084|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4396797|NCT00279812|4224105|B7|||BMI||kg/m^2|Mean|26|26.0|Standard Deviation|0.54|0.54|||
4396798|NCT00279812|4224106|B6|||BMI||kg/m^2|Mean|26.1|26.1|Standard Deviation|2.4|2.4|||
4396799|NCT00279812|4224107|B5|||BMI||kg/m^2|Mean|26.6|26.6|Standard Deviation|4.1|4.1|||
4396800|NCT00279812|4224108|B4|||BMI||kg/m^2|Mean|25.9|25.9|Standard Deviation|3.8|3.8|||
4396801|NCT00279812|4224109|B3|||BMI||kg/m^2|Mean|26.3|26.3|Standard Deviation|3.9|3.9|||
4396802|NCT00279812|4224110|B2|||BMI||kg/m^2|Mean|26.1|26.1|Standard Deviation|3|3.0|||
4396803|NCT00279812|4224111|B1|||BMI||kg/m^2|Mean|25|25.0|Standard Deviation|2.7|2.7|||
4396804|NCT00279812|4224105|B7|United Kingdom||Region of Enrollment||participants|Number|119|119.0||||||
4396805|NCT00279812|4224106|B6|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4396806|NCT00279812|4224107|B5|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4396807|NCT00279812|4224108|B4|United Kingdom||Region of Enrollment||participants|Number|23|23.0||||||
4396808|NCT00279812|4224109|B3|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4396809|NCT00279812|4224110|B2|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4396810|NCT00279812|4224111|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4396811|NCT00279812|4224105|B7||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4396812|NCT00279812|4224106|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4396813|NCT00279812|4224107|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4396814|NCT00279812|4224108|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4396815|NCT00279812|4224109|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4396816|NCT00279812|4224110|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4396817|NCT00279812|4224111|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4396818|NCT00279812|4224105|B7||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4396819|NCT00279812|4224106|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4396820|NCT00279812|4224107|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4396821|NCT00279812|4224108|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4396822|NCT00279812|4224109|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4396823|NCT00279812|4224110|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4396824|NCT00279812|4224111|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4396825|NCT00279812|4224105|B7|||Age||years|Mean|57.12|57.12|Standard Deviation|1.12|1.12|||
4396826|NCT00279812|4224106|B6|||Age||years|Mean|57.7|57.7|Standard Deviation|4.2|4.2|||
4396827|NCT00279812|4224107|B5|||Age||years|Mean|58.2|58.2|Standard Deviation|5.1|5.1|||
4396828|NCT00279812|4224108|B4|||Age||years|Mean|56.1|56.1|Standard Deviation|3.9|3.9|||
4396829|NCT00279812|4224109|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|3.9|3.9|||
4396830|NCT00279812|4224110|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|4.6|4.6|||
4396831|NCT00279812|4224111|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|3.9|3.9|||
4396832|NCT00279812|4224105|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396833|NCT00279812|4224106|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396834|NCT00279812|4224107|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396835|NCT00279812|4224108|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396836|NCT00279812|4224109|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396837|NCT00279812|4224110|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396838|NCT00279812|4224111|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396839|NCT00279812|4224105|B7||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4396840|NCT00279812|4224106|B6||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4396841|NCT00279812|4224107|B5||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4396842|NCT00279812|4224108|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4396843|NCT00279812|4224109|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4396844|NCT00279812|4224110|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4396845|NCT00279812|4224111|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4396846|NCT00279812|4224105|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396847|NCT00279812|4224106|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396848|NCT00279812|4224107|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396849|NCT00279812|4224108|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396850|NCT00279812|4224109|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396851|NCT00279812|4224110|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396852|NCT00279812|4224111|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396853|NCT00279708|4224142|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4396854|NCT00279708|4224143|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4396855|NCT00279708|4224144|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4396856|NCT00279708|4224142|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4396857|NCT00279708|4224143|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4396858|NCT00279708|4224144|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4396859|NCT00279708|4224142|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4396860|NCT00279708|4224143|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4396861|NCT00279708|4224144|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4396862|NCT00279708|4224142|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|8.57|8.57|||
4396863|NCT00279708|4224143|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|9.12|9.12|||
4396864|NCT00279708|4224144|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|7.95|7.95|||
4396865|NCT00279708|4224142|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4396866|NCT00279708|4224143|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396867|NCT00279708|4224144|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4396868|NCT00279708|4224142|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4396869|NCT00279708|4224143|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4396870|NCT00279708|4224144|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4396871|NCT00279708|4224142|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396872|NCT00279708|4224143|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396873|NCT00279708|4224144|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4396874|NCT00279591|4224151|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4396875|NCT00279591|4224152|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4396876|NCT00279591|4224153|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4396877|NCT00279591|4224151|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4396878|NCT00279591|4224152|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4396879|NCT00279591|4224153|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4396880|NCT00279591|4224151|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4396881|NCT00279591|4224152|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4396882|NCT00279591|4224153|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4396883|NCT00279591|4224151|B3|||Age||years|Mean|7.5|7.5|Standard Deviation|5.1|5.1|||
4396884|NCT00279591|4224152|B2|||Age||years|Mean|6.5|6.5|Standard Deviation|4.6|4.6|||
4396885|NCT00279591|4224153|B1|||Age||years|Mean|8.5|8.5|Standard Deviation|5.6|5.6|||
4396886|NCT00279591|4224151|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396887|NCT00279591|4224152|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396888|NCT00279591|4224153|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4396889|NCT00279591|4224151|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4396890|NCT00279591|4224152|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4396891|NCT00279591|4224153|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4396892|NCT00279591|4224151|B3||<=18 years|Age||Participants|Count of Participants|94|94.0||||||
4396893|NCT00279591|4224152|B2||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4396894|NCT00279591|4224153|B1||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4396895|NCT00279500|4224168|B1||Bare Light Perception|Visual Acuity||Participants|Count of Participants|4|4.0||||||
4396896|NCT00279500|4224168|B1||No Light Perception|Visual Acuity||Participants|Count of Participants|2|2.0||||||
4396897|NCT00279500|4224168|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4396898|NCT00279500|4224168|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4396899|NCT00279500|4224168|B1|||Age||years|Mean|65|65.0|Standard Deviation|9.2|9.2|||
4396900|NCT00279305|4224172|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4396901|NCT00279305|4224173|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4396902|NCT00279305|4224174|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4396903|NCT00279305|4224172|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4396904|NCT00279305|4224173|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4396905|NCT00279305|4224174|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4396906|NCT00279305|4224172|B3|||Age||years|Mean|18.5|18.5|Standard Deviation|8.3|8.3|||
4396907|NCT00279305|4224173|B2|||Age||years|Mean|17.4|17.4|Standard Deviation|8.0|8.0|||
4396908|NCT00279305|4224174|B1|||Age||years|Mean|19.0|19.0|Standard Deviation|8.6|8.6|||
4396909|NCT00279214|4224181|B3|||Total Sequential Organ Failure Assessment Score|The presence of 5 organ dysfunctions (cardiovascular, respiratory, renal, hepatic, coagulation) was assessed using a Sequential Organ Failure Assessment (SOFA) score. Each organ has a possible dysfunction score of 0 to 4, for a total SOFA score range of 0 (no organ dysfunction) to 20 (all organs with dysfunction).|units on a scale|Mean|8.4|8.4|Standard Deviation|2.6|2.6|6.0|10.0|
4396910|NCT00279214|4224182|B2|||Total Sequential Organ Failure Assessment Score|The presence of 5 organ dysfunctions (cardiovascular, respiratory, renal, hepatic, coagulation) was assessed using a Sequential Organ Failure Assessment (SOFA) score. Each organ has a possible dysfunction score of 0 to 4, for a total SOFA score range of 0 (no organ dysfunction) to 20 (all organs with dysfunction).|units on a scale|Mean|8.3|8.3|Standard Deviation|3.2|3.2|6.0|10.0|
4396948|NCT00279214|4224181|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4396949|NCT00279214|4224182|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4396950|NCT00279214|4224183|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4396911|NCT00279214|4224183|B1|||Total Sequential Organ Failure Assessment Score|The presence of 5 organ dysfunctions (cardiovascular, respiratory, renal, hepatic, coagulation) was assessed using a Sequential Organ Failure Assessment (SOFA) score. Each organ has a possible dysfunction score of 0 to 4, for a total SOFA score range of 0 (no organ dysfunction) to 20 (all organs with dysfunction).|units on a scale|Mean|8.5|8.5|Standard Deviation|2.0|2.0|7.0|10.0|
4396912|NCT00279214|4224181|B3|||Ratio of Arterial Partial Pressure of Oxygen to Fraction of Inspired Oxygen (PaO2/FiO2)||mm Hg / percent inspired oxygen|Mean|222.0|222.0|Inter-Quartile Range|||164.0|303.3|
4396913|NCT00279214|4224182|B2|||Ratio of Arterial Partial Pressure of Oxygen to Fraction of Inspired Oxygen (PaO2/FiO2)||mm Hg / percent inspired oxygen|Mean|248.3|248.3|Inter-Quartile Range|||181.7|330.0|
4396914|NCT00279214|4224183|B1|||Ratio of Arterial Partial Pressure of Oxygen to Fraction of Inspired Oxygen (PaO2/FiO2)||mm Hg / percent inspired oxygen|Mean|191.8|191.8|Inter-Quartile Range|||140.0|260.0|
4396915|NCT00279214|4224181|B3|||Number of Organ Dysfunctions||number of organ dysfunctions|Mean|2.3|2.3|Standard Deviation|0.9|0.9|||
4396916|NCT00279214|4224182|B2|||Number of Organ Dysfunctions||number of organ dysfunctions|Mean|2.0|2.0|Standard Deviation|0.9|0.9|||
4396917|NCT00279214|4224183|B1|||Number of Organ Dysfunctions||number of organ dysfunctions|Mean|2.5|2.5|Standard Deviation|0.8|0.8|||
4396918|NCT00279214|4224181|B3|||Mixed Venous Oxygen Saturation|Cardiovascular performance measures obtained with a pulmonary catheter as assessed by mixed venous oxygen saturation.|percent saturation mixed venous oxygen|Mean|68.9|68.9|Standard Deviation|12.9|12.9|||
4396919|NCT00279214|4224182|B2|||Mixed Venous Oxygen Saturation|Cardiovascular performance measures obtained with a pulmonary catheter as assessed by mixed venous oxygen saturation.|percent saturation mixed venous oxygen|Mean|68.9|68.9|Standard Deviation|10.1|10.1|||
4396920|NCT00279214|4224183|B1|||Mixed Venous Oxygen Saturation|Cardiovascular performance measures obtained with a pulmonary catheter as assessed by mixed venous oxygen saturation.|percent saturation mixed venous oxygen|Mean|68.9|68.9|Standard Deviation|15.6|15.6|||
4396921|NCT00279214|4224181|B3|||Mean Arterial Pressure (MAP)||mm Hg|Mean|72.8|72.8|Standard Deviation|9.5|9.5|||
4396922|NCT00279214|4224182|B2|||Mean Arterial Pressure (MAP)||mm Hg|Mean|72.1|72.1|Standard Deviation|9.4|9.4|||
4396923|NCT00279214|4224183|B1|||Mean Arterial Pressure (MAP)||mm Hg|Mean|73.5|73.5|Standard Deviation|9.9|9.9|||
4396924|NCT00279214|4224181|B3|||Lactate Levels|Measures of global tissue perfusion and oxygenation were assessed via lactate levels.|millimoles per Liter|Mean|2.3|2.3|Standard Deviation|2.1|2.1|||
4396925|NCT00279214|4224182|B2|||Lactate Levels|Measures of global tissue perfusion and oxygenation were assessed via lactate levels.|millimoles per Liter|Mean|2.6|2.6|Standard Deviation|2.8|2.8|||
4396926|NCT00279214|4224183|B1|||Lactate Levels|Measures of global tissue perfusion and oxygenation were assessed via lactate levels.|millimoles per Liter|Mean|2.0|2.0|Standard Deviation|1.1|1.1|||
4396927|NCT00279214|4224181|B3|||Cumulative Vasopressor Index (CVI)|"CVI is sum of rankings for all vasopressors being used by patient at given time.~Based on relative potency and dosing range for each vasopressor, each vasopressor was assigned ranking of 1 (low dosage) to 4 (high dosage). Range of CVI is between~1 and 20."|units on a scale|Mean|4.4|4.4|Standard Deviation|2.2|2.2|||
4396928|NCT00279214|4224182|B2|||Cumulative Vasopressor Index (CVI)|"CVI is sum of rankings for all vasopressors being used by patient at given time.~Based on relative potency and dosing range for each vasopressor, each vasopressor was assigned ranking of 1 (low dosage) to 4 (high dosage). Range of CVI is between~1 and 20."|units on a scale|Mean|4.4|4.4|Standard Deviation|2.4|2.4|||
4396929|NCT00279214|4224183|B1|||Cumulative Vasopressor Index (CVI)|"CVI is sum of rankings for all vasopressors being used by patient at given time.~Based on relative potency and dosing range for each vasopressor, each vasopressor was assigned ranking of 1 (low dosage) to 4 (high dosage). Range of CVI is between~1 and 20."|units on a scale|Mean|4.3|4.3|Standard Deviation|2.1|2.1|||
4396930|NCT00279214|4224181|B3|||Creatinine Clearance|CrCl = (urine creatinine*urine volume)/(plasma creatinine*time period of urine collection). Corrected CrCl = CrCl*1.73/body surface area. Change in CrCl = Endpoint minus baseline.|milliliter per minute|Mean|52.9|52.9|Standard Deviation|64.5|64.5|||
4396931|NCT00279214|4224182|B2|||Creatinine Clearance|CrCl = (urine creatinine*urine volume)/(plasma creatinine*time period of urine collection). Corrected CrCl = CrCl*1.73/body surface area. Change in CrCl = Endpoint minus baseline.|milliliter per minute|Mean|29.9|29.9|Standard Deviation|31.1|31.1|||
4396932|NCT00279214|4224183|B1|||Creatinine Clearance|CrCl = (urine creatinine*urine volume)/(plasma creatinine*time period of urine collection). Corrected CrCl = CrCl*1.73/body surface area. Change in CrCl = Endpoint minus baseline.|milliliter per minute|Mean|69.2|69.2|Standard Deviation|77.0|77.0|||
4396933|NCT00279214|4224181|B3|||Cardiac Index|Cardiac Index = cardiac output divided by body surface area.|liters/minute/meters squared|Mean|3.4|3.4|Standard Deviation|1.6|1.6|||
4396934|NCT00279214|4224182|B2|||Cardiac Index|Cardiac Index = cardiac output divided by body surface area.|liters/minute/meters squared|Mean|3.3|3.3|Standard Deviation|1.4|1.4|||
4396935|NCT00279214|4224183|B1|||Cardiac Index|Cardiac Index = cardiac output divided by body surface area.|liters/minute/meters squared|Mean|3.5|3.5|Standard Deviation|1.7|1.7|||
4396936|NCT00279214|4224181|B3|Hispanic||Race/Ethnicity||participants|Number|4|4.0||||||
4396937|NCT00279214|4224182|B2|Hispanic||Race/Ethnicity||participants|Number|3|3.0||||||
4396938|NCT00279214|4224183|B1|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4396939|NCT00279214|4224181|B3|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4396940|NCT00279214|4224182|B2|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4396941|NCT00279214|4224183|B1|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4396942|NCT00279214|4224181|B3|Caucasian||Race/Ethnicity||participants|Number|31|31.0||||||
4396943|NCT00279214|4224182|B2|Caucasian||Race/Ethnicity||participants|Number|15|15.0||||||
4396944|NCT00279214|4224183|B1|Caucasian||Race/Ethnicity||participants|Number|16|16.0||||||
4396945|NCT00279214|4224181|B3|African||Race/Ethnicity||participants|Number|2|2.0||||||
4396946|NCT00279214|4224182|B2|African||Race/Ethnicity||participants|Number|1|1.0||||||
4396947|NCT00279214|4224183|B1|African||Race/Ethnicity||participants|Number|1|1.0||||||
4396951|NCT00279214|4224181|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4396952|NCT00279214|4224182|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4396953|NCT00279214|4224183|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4396954|NCT00279214|4224181|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4396955|NCT00279214|4224182|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4396956|NCT00279214|4224183|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4396957|NCT00279214|4224181|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|13.3|13.3|||
4396958|NCT00279214|4224182|B2|||Age||years|Mean|65.8|65.8|Standard Deviation|15.0|15.0|||
4396959|NCT00279214|4224183|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|11.8|11.8|||
4396960|NCT00279201|4224212|B3|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|194.53|194.53|Standard Deviation|54.20|54.2|||
4396961|NCT00279201|4224213|B2|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|192.91|192.91|Standard Deviation|53.22|53.22|||
4396962|NCT00279201|4224214|B1|||Fasting Blood Glucose||milligrams per deciliter (mg/dL)|Mean|196.16|196.16|Standard Deviation|55.14|55.14|||
4396963|NCT00279201|4224212|B3|||Average of All Blood Glucose||milligrams per deciliter (mg/dL)|Mean|217.08|217.08|Standard Deviation|55.48|55.48|||
4396964|NCT00279201|4224213|B2|||Average of All Blood Glucose||milligrams per deciliter (mg/dL)|Mean|216.12|216.12|Standard Deviation|54.40|54.4|||
4396965|NCT00279201|4224214|B1|||Average of All Blood Glucose||milligrams per deciliter (mg/dL)|Mean|218.05|218.05|Standard Deviation|56.55|56.55|||
4396966|NCT00279201|4224212|B3|||Mean of Post Meals Blood Glucose (Postprandial)||milligrams per deciliter (mg/dL)|Mean|240.82|240.82|Standard Deviation|59.61|59.61|||
4396967|NCT00279201|4224213|B2|||Mean of Post Meals Blood Glucose (Postprandial)||milligrams per deciliter (mg/dL)|Mean|240.08|240.08|Standard Deviation|58.15|58.15|||
4396968|NCT00279201|4224214|B1|||Mean of Post Meals Blood Glucose (Postprandial)||milligrams per deciliter (mg/dL)|Mean|241.58|241.58|Standard Deviation|61.06|61.06|||
4396969|NCT00279201|4224212|B3|||Mean of Pre-Meals Blood Glucose||milligrams per deciliter (mg/dL)|Mean|200.13|200.13|Standard Deviation|56.14|56.14|||
4396970|NCT00279201|4224213|B2|||Mean of Pre-Meals Blood Glucose||milligrams per deciliter (mg/dL)|Mean|198.97|198.97|Standard Deviation|54.87|54.87|||
4396971|NCT00279201|4224214|B1|||Mean of Pre-Meals Blood Glucose||milligrams per deciliter (mg/dL)|Mean|201.29|201.29|Standard Deviation|57.40|57.4|||
4396972|NCT00279201|4224212|B3|||1,5 Anhydroglucitol (1,5 AG)||micrograms per milliliter (ug/mL)|Mean|4.99|4.99|Standard Deviation|4.09|4.09|||
4396973|NCT00279201|4224213|B2|||1,5 Anhydroglucitol (1,5 AG)||micrograms per milliliter (ug/mL)|Mean|5.02|5.02|Standard Deviation|4.12|4.12|||
4396974|NCT00279201|4224214|B1|||1,5 Anhydroglucitol (1,5 AG)||micrograms per milliliter (ug/mL)|Mean|4.97|4.97|Standard Deviation|4.06|4.06|||
4396975|NCT00279201|4224212|B3|||Glycosylated Hemoglobin (HbA1c)||percent glycosylated hemoglobin|Mean|9.04|9.04|Standard Deviation|1.26|1.26|||
4396976|NCT00279201|4224213|B2|||Glycosylated Hemoglobin (HbA1c)||percent glycosylated hemoglobin|Mean|9.06|9.06|Standard Deviation|1.29|1.29|||
4396977|NCT00279201|4224214|B1|||Glycosylated Hemoglobin (HbA1c)||percent glycosylated hemoglobin|Mean|9.02|9.02|Standard Deviation|1.24|1.24|||
4396978|NCT00279201|4224212|B3|||Duration of Diabetes||years|Mean|9.51|9.51|Standard Deviation|6.11|6.11|||
4396979|NCT00279201|4224213|B2|||Duration of Diabetes||years|Mean|9.73|9.73|Standard Deviation|6.29|6.29|||
4396980|NCT00279201|4224214|B1|||Duration of Diabetes||years|Mean|9.30|9.3|Standard Deviation|5.93|5.93|||
4396981|NCT00279201|4224212|B3|||Body Mass Index (BMI)||kilograms per meters squared (kg/m^2)|Mean|31.68|31.68|Standard Deviation|5.98|5.98|||
4396982|NCT00279201|4224213|B2|||Body Mass Index (BMI)||kilograms per meters squared (kg/m^2)|Mean|31.67|31.67|Standard Deviation|5.96|5.96|||
4396983|NCT00279201|4224214|B1|||Body Mass Index (BMI)||kilograms per meters squared (kg/m^2)|Mean|31.69|31.69|Standard Deviation|6.01|6.01|||
4396984|NCT00279201|4224212|B3|||Weight||kilograms (kg)|Mean|88.53|88.53|Standard Deviation|20.87|20.87|||
4396985|NCT00279201|4224213|B2|||Weight||kilograms (kg)|Mean|88.84|88.84|Standard Deviation|20.97|20.97|||
4396986|NCT00279201|4224214|B1|||Weight||kilograms (kg)|Mean|88.23|88.23|Standard Deviation|20.78|20.78|||
4396987|NCT00279201|4224212|B3|India||Region of Enrollment||participants|Number|259|259.0||||||
4396988|NCT00279201|4224213|B2|India||Region of Enrollment||participants|Number|128|128.0||||||
4396989|NCT00279201|4224214|B1|India||Region of Enrollment||participants|Number|131|131.0||||||
4396990|NCT00279201|4224212|B3|Netherlands||Region of Enrollment||participants|Number|57|57.0||||||
4396991|NCT00279201|4224213|B2|Netherlands||Region of Enrollment||participants|Number|27|27.0||||||
4396992|NCT00279201|4224214|B1|Netherlands||Region of Enrollment||participants|Number|30|30.0||||||
4396993|NCT00279201|4224212|B3|Australia||Region of Enrollment||participants|Number|96|96.0||||||
4396994|NCT00279201|4224213|B2|Australia||Region of Enrollment||participants|Number|48|48.0||||||
4396995|NCT00279201|4224214|B1|Australia||Region of Enrollment||participants|Number|48|48.0||||||
4396996|NCT00279201|4224212|B3|Romania||Region of Enrollment||participants|Number|57|57.0||||||
4396997|NCT00279201|4224213|B2|Romania||Region of Enrollment||participants|Number|28|28.0||||||
4396998|NCT00279201|4224214|B1|Romania||Region of Enrollment||participants|Number|29|29.0||||||
4396999|NCT00279201|4224212|B3|Spain||Region of Enrollment||participants|Number|96|96.0||||||
4397000|NCT00279201|4224213|B2|Spain||Region of Enrollment||participants|Number|49|49.0||||||
4397001|NCT00279201|4224214|B1|Spain||Region of Enrollment||participants|Number|47|47.0||||||
4397002|NCT00279201|4224212|B3|Brazil||Region of Enrollment||participants|Number|91|91.0||||||
4397003|NCT00279201|4224213|B2|Brazil||Region of Enrollment||participants|Number|46|46.0||||||
4397004|NCT00279201|4224214|B1|Brazil||Region of Enrollment||participants|Number|45|45.0||||||
4397005|NCT00279201|4224212|B3|Argentina||Region of Enrollment||participants|Number|193|193.0||||||
4397006|NCT00279201|4224213|B2|Argentina||Region of Enrollment||participants|Number|95|95.0||||||
4397007|NCT00279201|4224214|B1|Argentina||Region of Enrollment||participants|Number|98|98.0||||||
4397008|NCT00279201|4224212|B3|Canada||Region of Enrollment||participants|Number|120|120.0||||||
4397009|NCT00279201|4224213|B2|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4397010|NCT00279201|4224214|B1|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4397011|NCT00279201|4224212|B3|Greece||Region of Enrollment||participants|Number|50|50.0||||||
4397012|NCT00279201|4224213|B2|Greece||Region of Enrollment||participants|Number|25|25.0||||||
4397013|NCT00279201|4224214|B1|Greece||Region of Enrollment||participants|Number|25|25.0||||||
4397014|NCT00279201|4224212|B3|Hungary||Region of Enrollment||participants|Number|50|50.0||||||
4397015|NCT00279201|4224213|B2|Hungary||Region of Enrollment||participants|Number|26|26.0||||||
4397016|NCT00279201|4224214|B1|Hungary||Region of Enrollment||participants|Number|24|24.0||||||
4397017|NCT00279201|4224212|B3|United States||Region of Enrollment||participants|Number|1022|1022.0||||||
4397018|NCT00279201|4224213|B2|United States||Region of Enrollment||participants|Number|513|513.0||||||
4397019|NCT00279201|4224214|B1|United States||Region of Enrollment||participants|Number|509|509.0||||||
4397020|NCT00279201|4224212|B3|Western Asian||Race/Ethnicity, Customized||participants|Number|275|275.0||||||
4397021|NCT00279201|4224213|B2|Western Asian||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
4397022|NCT00279201|4224214|B1|Western Asian||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4397023|NCT00279201|4224212|B3|Other||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4397024|NCT00279201|4224213|B2|Other||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4397025|NCT00279201|4224214|B1|Other||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4397026|NCT00279201|4224212|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|252|252.0||||||
4397027|NCT00279201|4224213|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4397028|NCT00279201|4224214|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|116|116.0||||||
4397029|NCT00279201|4224212|B3|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4397030|NCT00279201|4224213|B2|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4397031|NCT00279201|4224214|B1|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4397032|NCT00279201|4224212|B3|African Descent||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4397033|NCT00279201|4224213|B2|African Descent||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4397034|NCT00279201|4224214|B1|African Descent||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4397035|NCT00279201|4224212|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|1319|1319.0||||||
4397036|NCT00279201|4224213|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|651|651.0||||||
4397037|NCT00279201|4224214|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|668|668.0||||||
4397038|NCT00279201|4224212|B3||Male|Sex: Female, Male||Participants|Count of Participants|1104|1104.0||||||
4397039|NCT00279201|4224213|B2||Male|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
4397040|NCT00279201|4224214|B1||Male|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
4397041|NCT00279201|4224212|B3||Female|Sex: Female, Male||Participants|Count of Participants|987|987.0||||||
4397042|NCT00279201|4224213|B2||Female|Sex: Female, Male||Participants|Count of Participants|493|493.0||||||
4397043|NCT00279201|4224214|B1||Female|Sex: Female, Male||Participants|Count of Participants|494|494.0||||||
4397044|NCT00279201|4224212|B3|||Age||years|Mean|56.82|56.82|Standard Deviation|9.84|9.84|||
4397045|NCT00279201|4224213|B2|||Age||years|Mean|57.05|57.05|Standard Deviation|9.73|9.73|||
4397046|NCT00279201|4224214|B1|||Age||years|Mean|56.59|56.59|Standard Deviation|9.95|9.95|||
4397047|NCT00278993|4224363|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4397048|NCT00278993|4224363|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4397049|NCT00278993|4224363|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4397050|NCT00278993|4224363|B1|White||Race/Ethnicity, Customized||participants|Number|94|94.0||||||
4397051|NCT00278993|4224363|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4397052|NCT00278993|4224363|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4397053|NCT00278993|4224363|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4397054|NCT00278993|4224363|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4397055|NCT00278993|4224363|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4397056|NCT00278993|4224363|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397057|NCT00278993|4224363|B1|||Age|Intent to Treat/Safety Population|years|Mean|71.0|71.0|Standard Deviation|9.36|9.36|||
4397058|NCT00278954|4224371|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4397059|NCT00278954|4224371|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4397060|NCT00278954|4224371|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4397061|NCT00278954|4224371|B1|||Age||years|Mean|44.0|44.0|Standard Deviation|19.10|19.1|||
4397062|NCT00278954|4224371|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4397063|NCT00278954|4224371|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4397064|NCT00278954|4224371|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4397065|NCT00278915|4224379|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397066|NCT00278915|4224379|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4397067|NCT00278915|4224379|B1|||Age||Years|Mean|5.86|5.86|Standard Deviation|1.846|1.846|||
4397068|NCT00278889|4224412|B4||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4397069|NCT00278889|4224413|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4397070|NCT00278889|4224414|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4397071|NCT00278889|4224415|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4397072|NCT00278889|4224412|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4397073|NCT00278889|4224413|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4397074|NCT00278889|4224414|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4397075|NCT00278889|4224415|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4397076|NCT00278889|4224412|B4|Age||Age||Years|Mean|63.07|63.07|Standard Deviation|9.63|9.63|||
4397077|NCT00278889|4224413|B3|Age||Age||Years|Mean|61.8|61.8|Standard Deviation|10.6|10.6|||
4397078|NCT00278889|4224414|B2|Age||Age||Years|Mean|63.5|63.5|Standard Deviation|9.6|9.6|||
4397079|NCT00278889|4224415|B1|Age||Age||Years|Mean|63.9|63.9|Standard Deviation|8.7|8.7|||
4397080|NCT00278876|4224443|B1|Korea, Republic of||Region of Enrollment||participants|Number|47|47.0||||||
4397081|NCT00278876|4224443|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4397082|NCT00278876|4224443|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4397083|NCT00278876|4224443|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|10.0|10.0|||
4397084|NCT00278876|4224443|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4397085|NCT00278876|4224443|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4397086|NCT00278876|4224443|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397087|NCT00278863|4224449|B3|Korea, Republic of||Region of Enrollment||participants|Number|91|91.0||||||
4397088|NCT00278863|4224450|B2|Korea, Republic of||Region of Enrollment||participants|Number|46|46.0||||||
4397089|NCT00278863|4224451|B1|Korea, Republic of||Region of Enrollment||participants|Number|45|45.0||||||
4397090|NCT00278863|4224449|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4397091|NCT00278863|4224450|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4397092|NCT00278863|4224451|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4397093|NCT00278863|4224449|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4397094|NCT00278863|4224450|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4397095|NCT00278863|4224451|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4397096|NCT00278863|4224449|B3|Age_median||Age, Customized||years|Median|71|71.0|Full Range|||65.0|88.0|
4397097|NCT00278863|4224450|B2|Age_median||Age, Customized||years|Median|71|71.0|Full Range|||66.0|88.0|
4397098|NCT00278863|4224451|B1|Age_median||Age, Customized||years|Median|71|71.0|Full Range|||65.0|82.0|
4397099|NCT00278655|4224460|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4397100|NCT00278655|4224460|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4397101|NCT00278655|4224460|B1|||Age||years|Mean|21|21.0|Standard Deviation|2|2.0|||
4397102|NCT00278655|4224460|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397103|NCT00278655|4224460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4397104|NCT00278655|4224460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397105|NCT00278564|4224465|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4397106|NCT00278564|4224465|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397107|NCT00278564|4224465|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4397108|NCT00278564|4224465|B1|||Age||years|Mean|37|37.0|Standard Deviation|8|8.0|||
4397109|NCT00278564|4224465|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397110|NCT00278564|4224465|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4397111|NCT00278564|4224465|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397112|NCT00278525|4224469|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4397113|NCT00278525|4224470|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4397114|NCT00278525|4224471|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4397115|NCT00278525|4224469|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4397116|NCT00278525|4224470|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4397117|NCT00278525|4224471|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397118|NCT00278525|4224469|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4397119|NCT00278525|4224470|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4397120|NCT00278525|4224471|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4397121|NCT00278525|4224469|B3|||Age||years|Mean|44|44.0|Standard Deviation|10|10.0|||
4397122|NCT00278525|4224470|B2|||Age||years|Mean|44|44.0|Standard Deviation|10|10.0|||
4397123|NCT00278525|4224471|B1|||Age||years|Mean|45|45.0|Standard Deviation|13|13.0|||
4397124|NCT00278525|4224469|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397125|NCT00278525|4224470|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397126|NCT00278525|4224471|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397127|NCT00278525|4224469|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4397128|NCT00278525|4224470|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4397129|NCT00278525|4224471|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4397130|NCT00278525|4224469|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397131|NCT00278525|4224470|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397132|NCT00278525|4224471|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397133|NCT00278512|4224480|B3|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4397134|NCT00278512|4224482|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4397135|NCT00278512|4224480|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4397136|NCT00278512|4224481|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397137|NCT00278512|4224482|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4397138|NCT00278512|4224480|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4397139|NCT00278512|4224481|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397140|NCT00278512|4224482|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4397141|NCT00278512|4224480|B3|||Age||years|Mean|40.43|40.43|Standard Deviation|12.03|12.03|||
4397142|NCT00278512|4224482|B1|||Age||years|Mean|40.43|40.43|Standard Deviation|12.03|12.03|||
4397143|NCT00278512|4224480|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397144|NCT00278512|4224481|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397145|NCT00278512|4224482|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397146|NCT00278512|4224480|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4397147|NCT00278512|4224481|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4397148|NCT00278512|4224482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4397149|NCT00278512|4224480|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397150|NCT00278512|4224481|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397151|NCT00278512|4224482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397152|NCT00278473|4224489|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4397153|NCT00278473|4224490|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4397154|NCT00278473|4224491|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4397155|NCT00278473|4224489|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4397156|NCT00278473|4224490|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4397157|NCT00278473|4224491|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4397158|NCT00278473|4224489|B3|||Age||years|Mean|41.69|41.69|Standard Deviation|11.78|11.78|||
4397159|NCT00278473|4224490|B2|||Age||years|Mean|42.37|42.37|Standard Deviation|12.09|12.09|||
4397160|NCT00278473|4224491|B1|||Age||years|Mean|41.04|41.04|Standard Deviation|11.59|11.59|||
4397161|NCT00278395|4224508|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4397162|NCT00278395|4224508|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4397163|NCT00278395|4224508|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4397164|NCT00278395|4224508|B1|||Age||years|Mean|60|60.0|Standard Deviation|2|2.0|||
4397165|NCT00278395|4224508|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4397166|NCT00278395|4224508|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4397167|NCT00278395|4224508|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397168|NCT00278343|4224515|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4397169|NCT00278343|4224515|B1|Canada||Region of Enrollment||participants|Number|52|52.0||||||
4397170|NCT00278343|4224515|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397171|NCT00278343|4224515|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4397172|NCT00278343|4224515|B1|||Age||years|Median|58|58.0|Full Range|||31.0|87.0|
4397173|NCT00278343|4224515|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4397174|NCT00278343|4224515|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4397175|NCT00278343|4224515|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397176|NCT00278161|4224524|B1|Unknown||Sex/Gender, Customized||Participants|Count of Participants|5|5.0||||||
4397177|NCT00278161|4224524|B1|Male||Sex/Gender, Customized||Participants|Count of Participants|59|59.0||||||
4397178|NCT00278161|4224524|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|17|17.0||||||
4397179|NCT00278161|4224524|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4397180|NCT00278161|4224524|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4397181|NCT00278161|4224524|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397182|NCT00277524|4224530|B1|||Number of patients implanted||participants|Number|2882|2882.0||||||
4397183|NCT00277524|4224530|B1|NA||Heart failure (HF) stage|"This is a new classification heart failure (HF) which include four stages:~Stage A - At high risk for HF but without structural heart disease or symptoms of HF; Stage B - Structural heart disease but without signs or symptoms of HF; Stage C - Structural heart disease with prior or current symptoms of HF; Stage D - Refractory HF requiring specialized interventions."|participants|Number|1275|1275.0||||||
4397184|NCT00277524|4224530|B1|No HF||Heart failure (HF) stage|"This is a new classification heart failure (HF) which include four stages:~Stage A - At high risk for HF but without structural heart disease or symptoms of HF; Stage B - Structural heart disease but without signs or symptoms of HF; Stage C - Structural heart disease with prior or current symptoms of HF; Stage D - Refractory HF requiring specialized interventions."|participants|Number|578|578.0||||||
4397222|NCT00277394|4224559|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4397185|NCT00277524|4224530|B1|D||Heart failure (HF) stage|"This is a new classification heart failure (HF) which include four stages:~Stage A - At high risk for HF but without structural heart disease or symptoms of HF; Stage B - Structural heart disease but without signs or symptoms of HF; Stage C - Structural heart disease with prior or current symptoms of HF; Stage D - Refractory HF requiring specialized interventions."|participants|Number|44|44.0||||||
4397186|NCT00277524|4224530|B1|C||Heart failure (HF) stage|"This is a new classification heart failure (HF) which include four stages:~Stage A - At high risk for HF but without structural heart disease or symptoms of HF; Stage B - Structural heart disease but without signs or symptoms of HF; Stage C - Structural heart disease with prior or current symptoms of HF; Stage D - Refractory HF requiring specialized interventions."|participants|Number|713|713.0||||||
4397187|NCT00277524|4224530|B1|B||Heart failure (HF) stage|"This is a new classification heart failure (HF) which include four stages:~Stage A - At high risk for HF but without structural heart disease or symptoms of HF; Stage B - Structural heart disease but without signs or symptoms of HF; Stage C - Structural heart disease with prior or current symptoms of HF; Stage D - Refractory HF requiring specialized interventions."|participants|Number|229|229.0||||||
4397188|NCT00277524|4224530|B1|A||Heart failure (HF) stage|"This is a new classification heart failure (HF) which include four stages:~Stage A - At high risk for HF but without structural heart disease or symptoms of HF; Stage B - Structural heart disease but without signs or symptoms of HF; Stage C - Structural heart disease with prior or current symptoms of HF; Stage D - Refractory HF requiring specialized interventions."|participants|Number|44|44.0||||||
4397189|NCT00277524|4224530|B1|Missing||New York Heart Association (NYHA) classification|New York Heart Association (NYHA) classification is used to classify the extent of heart failure. It has four classes: Class I (Mild), Class II (Mild), Class III (Moderate), and Class IV (Severe).|participants|Number|5|5.0||||||
4397190|NCT00277524|4224530|B1|No Heart Failure||New York Heart Association (NYHA) classification|New York Heart Association (NYHA) classification is used to classify the extent of heart failure. It has four classes: Class I (Mild), Class II (Mild), Class III (Moderate), and Class IV (Severe).|participants|Number|600|600.0||||||
4397191|NCT00277524|4224530|B1|IV||New York Heart Association (NYHA) classification|New York Heart Association (NYHA) classification is used to classify the extent of heart failure. It has four classes: Class I (Mild), Class II (Mild), Class III (Moderate), and Class IV (Severe).|participants|Number|72|72.0||||||
4397192|NCT00277524|4224530|B1|III||New York Heart Association (NYHA) classification|New York Heart Association (NYHA) classification is used to classify the extent of heart failure. It has four classes: Class I (Mild), Class II (Mild), Class III (Moderate), and Class IV (Severe).|participants|Number|857|857.0||||||
4397193|NCT00277524|4224530|B1|II||New York Heart Association (NYHA) classification|New York Heart Association (NYHA) classification is used to classify the extent of heart failure. It has four classes: Class I (Mild), Class II (Mild), Class III (Moderate), and Class IV (Severe).|participants|Number|627|627.0||||||
4397194|NCT00277524|4224530|B1|I||New York Heart Association (NYHA) classification|New York Heart Association (NYHA) classification is used to classify the extent of heart failure. It has four classes: Class I (Mild), Class II (Mild), Class III (Moderate), and Class IV (Severe).|participants|Number|104|104.0||||||
4397195|NCT00277524|4224530|B1|||LVEF(%)|2487 subjects had information on left ventricular ejection fraction (LVEF, %).|participants|Mean|33.4|33.4|Standard Deviation|15.7|15.7|||
4397196|NCT00277524|4224530|B1|||PR interval|1829 subjects had information on PR interval.|ms|Mean|182.6|182.6|Standard Deviation|45.5|45.5|||
4397197|NCT00277524|4224530|B1|||QRS duration|2132 subjects had information on QRS duration.|ms|Mean|119.9|119.9|Standard Deviation|34.0|34.0|||
4397198|NCT00277524|4224530|B1|||Weight|2781 subjects had information on weight.|lbs|Mean|188|188.0|Standard Deviation|45.3|45.3|||
4397199|NCT00277524|4224530|B1|United States||Region of Enrollment||participants|Number|2883|2883.0||||||
4397200|NCT00277524|4224530|B1|Other||Race/Ethnicity, Customized|2817 subjects had information on race or ethnic origin.|participants|Number|6|6.0||||||
4397201|NCT00277524|4224530|B1|White||Race/Ethnicity, Customized|2817 subjects had information on race or ethnic origin.|participants|Number|2217|2217.0||||||
4397202|NCT00277524|4224530|B1|Native Hawaiian||Race/Ethnicity, Customized|2817 subjects had information on race or ethnic origin.|participants|Number|8|8.0||||||
4397203|NCT00277524|4224530|B1|Hispanic||Race/Ethnicity, Customized|2817 subjects had information on race or ethnic origin.|participants|Number|206|206.0||||||
4397204|NCT00277524|4224530|B1|Black||Race/Ethnicity, Customized|2817 subjects had information on race or ethnic origin.|participants|Number|335|335.0||||||
4397205|NCT00277524|4224530|B1|Asian||Race/Ethnicity, Customized|2817 subjects had information on race or ethnic origin.|participants|Number|38|38.0||||||
4397206|NCT00277524|4224530|B1|American Indian||Race/Ethnicity, Customized|2817 subjects had information on race or ethnic origin.|participants|Number|7|7.0||||||
4397207|NCT00277524|4224530|B1||Male|Sex: Female, Male||Participants|Count of Participants|1976|1976.0||||||
4397208|NCT00277524|4224530|B1||Female|Sex: Female, Male||Participants|Count of Participants|907|907.0||||||
4397209|NCT00277524|4224530|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|12.5|12.5|||
4397210|NCT00277524|4224530|B1||>=65 years|Age||Participants|Count of Participants|1895|1895.0||||||
4397211|NCT00277524|4224530|B1||Between 18 and 65 years|Age||Participants|Count of Participants|988|988.0||||||
4397212|NCT00277524|4224530|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397213|NCT00277446|4224551|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4397214|NCT00277446|4224551|B1|Male||Gender||participants|Number|8|8.0||||||
4397215|NCT00277446|4224551|B1|Female||Gender||participants|Number|7|7.0||||||
4397216|NCT00277446|4224551|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|12.1|12.1|||
4397217|NCT00277446|4224551|B1|>=65 years||Age||participants|Number|0|0.0||||||
4397218|NCT00277446|4224551|B1|Between 18 and 65 years||Age||participants|Number|15|15.0||||||
4397219|NCT00277446|4224551|B1|<=18 years||Age||participants|Number|0|0.0||||||
4397220|NCT00277394|4224557|B3|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4397221|NCT00277394|4224558|B2|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4397223|NCT00277394|4224557|B3|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4397224|NCT00277394|4224558|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4397225|NCT00277394|4224559|B1|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4397226|NCT00277394|4224557|B3|Croatia||Region of Enrollment||participants|Number|25|25.0||||||
4397227|NCT00277394|4224558|B2|Croatia||Region of Enrollment||participants|Number|16|16.0||||||
4397228|NCT00277394|4224559|B1|Croatia||Region of Enrollment||participants|Number|9|9.0||||||
4397229|NCT00277394|4224557|B3|Romania||Region of Enrollment||participants|Number|50|50.0||||||
4397230|NCT00277394|4224558|B2|Romania||Region of Enrollment||participants|Number|20|20.0||||||
4397231|NCT00277394|4224559|B1|Romania||Region of Enrollment||participants|Number|30|30.0||||||
4397232|NCT00277394|4224557|B3|Spain||Region of Enrollment||participants|Number|77|77.0||||||
4397233|NCT00277394|4224558|B2|Spain||Region of Enrollment||participants|Number|38|38.0||||||
4397234|NCT00277394|4224559|B1|Spain||Region of Enrollment||participants|Number|39|39.0||||||
4397235|NCT00277394|4224557|B3|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4397236|NCT00277394|4224558|B2|Poland||Region of Enrollment||participants|Number|1|1.0||||||
4397237|NCT00277394|4224559|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4397238|NCT00277394|4224557|B3|France||Region of Enrollment||participants|Number|278|278.0||||||
4397239|NCT00277394|4224558|B2|France||Region of Enrollment||participants|Number|139|139.0||||||
4397240|NCT00277394|4224559|B1|France||Region of Enrollment||participants|Number|139|139.0||||||
4397241|NCT00277394|4224557|B3|Serbia||Region of Enrollment||participants|Number|80|80.0||||||
4397242|NCT00277394|4224558|B2|Serbia||Region of Enrollment||participants|Number|43|43.0||||||
4397243|NCT00277394|4224559|B1|Serbia||Region of Enrollment||participants|Number|37|37.0||||||
4397244|NCT00277394|4224557|B3||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4397245|NCT00277394|4224558|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4397246|NCT00277394|4224559|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4397247|NCT00277394|4224557|B3||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4397248|NCT00277394|4224558|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4397249|NCT00277394|4224559|B1||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4397250|NCT00277394|4224557|B3|||Age||years|Mean|82.8|82.8|Standard Deviation|5.7|5.7|||
4397251|NCT00277394|4224558|B2|||Age||years|Mean|82.6|82.6|Standard Deviation|5.8|5.8|||
4397252|NCT00277394|4224559|B1|||Age||years|Mean|82.9|82.9|Standard Deviation|5.7|5.7|||
4397253|NCT00277394|4224557|B3||>=65 years|Age||Participants|Count of Participants|539|539.0||||||
4397254|NCT00277394|4224558|B2||>=65 years|Age||Participants|Count of Participants|270|270.0||||||
4397255|NCT00277394|4224559|B1||>=65 years|Age||Participants|Count of Participants|269|269.0||||||
4397256|NCT00277394|4224557|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4397257|NCT00277394|4224558|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4397258|NCT00277394|4224559|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4397259|NCT00277394|4224557|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397260|NCT00277394|4224558|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397261|NCT00277394|4224559|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397262|NCT00277355|4224570|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4397263|NCT00277355|4224571|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4397264|NCT00277355|4224572|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4397265|NCT00277355|4224570|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
4397266|NCT00277355|4224571|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4397267|NCT00277355|4224572|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4397268|NCT00277355|4224570|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4397269|NCT00277355|4224571|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4397270|NCT00277355|4224572|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4397271|NCT00277355|4224570|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4397272|NCT00277355|4224571|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4397273|NCT00277355|4224572|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4397274|NCT00277355|4224570|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|10.4|10.4|||
4397275|NCT00277355|4224571|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|10.6|10.6|||
4397276|NCT00277355|4224572|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|10.3|10.3|||
4397277|NCT00277355|4224570|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4397278|NCT00277355|4224571|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4397279|NCT00277355|4224572|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4397280|NCT00277355|4224570|B3||Between 18 and 65 years|Age||Participants|Count of Participants|110|110.0||||||
4397281|NCT00277355|4224571|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4397282|NCT00277355|4224572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4397283|NCT00277355|4224570|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397284|NCT00277355|4224571|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397285|NCT00277355|4224572|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397286|NCT00277212|4224581|B1|Missing||BMI Category||participants|Number|27|27.0||||||
4397287|NCT00277212|4224581|B1|BMI >=30||BMI Category||participants|Number|321|321.0||||||
4397288|NCT00277212|4224581|B1|BMI <18.5||BMI Category||participants|Number|12|12.0||||||
4397289|NCT00277212|4224581|B1|25 <= BMI <30||BMI Category||participants|Number|215|215.0||||||
4397290|NCT00277212|4224581|B1|18.5 <= BMI <25||BMI Category||participants|Number|221|221.0||||||
4397291|NCT00277212|4224581|B1|||Weight||kg|Mean|84.7|84.7|Standard Deviation|22.7|22.7|||
4397292|NCT00277212|4224581|B1|||Body Mass Index (BMI)||kg/m^2|Mean|29.7|29.7|Standard Deviation|7.6|7.6|||
4397293|NCT00277212|4224581|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|703|703.0||||||
4397294|NCT00277212|4224581|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4397295|NCT00277212|4224581|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4397296|NCT00277212|4224581|B1|Native Hawaiian/Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4397297|NCT00277212|4224581|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4397298|NCT00277212|4224581|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4397299|NCT00277212|4224581|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4397300|NCT00277212|4224581|B1|White||Race/Ethnicity, Customized||participants|Number|693|693.0||||||
4397301|NCT00277212|4224581|B1||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4397302|NCT00277212|4224581|B1||Female|Sex: Female, Male||Participants|Count of Participants|505|505.0||||||
4397303|NCT00277212|4224581|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|12.0|12.0|||
4397304|NCT00277095|4224621|B1|New Zealand||Region of Enrollment||participants|Number|12|12.0||||||
4397305|NCT00277095|4224621|B1|Canada||Region of Enrollment||participants|Number|44|44.0||||||
4397306|NCT00277095|4224621|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4397307|NCT00277095|4224621|B1||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4397308|NCT00277095|4224621|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397309|NCT00277095|4224621|B1|||Age||years|Mean|69.7|69.7|Standard Deviation|7.9|7.9|||
4397310|NCT00276861|4224625|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4397311|NCT00276861|4224625|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
4397312|NCT00276861|4224625|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4397313|NCT00276861|4224625|B1|||Age||years|Median|58.5|58.5|Full Range|||47.0|72.0|
4397314|NCT00276861|4224625|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4397315|NCT00276861|4224625|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4397316|NCT00276861|4224625|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397317|NCT00276744|4224630|B1|United States||Region of Enrollment||participants|Number|240|240.0||||||
4397318|NCT00276744|4224630|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4397319|NCT00276744|4224630|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4397320|NCT00276744|4224630|B1||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4397321|NCT00276744|4224630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|187|187.0||||||
4397322|NCT00276744|4224630|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397323|NCT00276614|4224634|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4397324|NCT00276614|4224634|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4397325|NCT00276614|4224634|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4397326|NCT00276614|4224634|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4397327|NCT00276614|4224634|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4397328|NCT00276614|4224634|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4397329|NCT00276614|4224634|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4397330|NCT00276614|4224634|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4397331|NCT00276614|4224634|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4397332|NCT00276614|4224634|B1|||Age||years|Median|42|42.0|Full Range|||26.0|63.0|
4397333|NCT00276549|4224638|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4397334|NCT00276549|4224638|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4397335|NCT00276549|4224638|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397336|NCT00276549|4224638|B1|||Age||years|Median|67|67.0|Full Range|||55.0|84.0|
4397337|NCT00276484|4224643|B3|||Triglycerides||mg/dL|Median|133.5|133.5|Standard Deviation|72.1|72.1|||
4397338|NCT00276484|4224644|B2|||Triglycerides||mg/dL|Median|134.0|134.0|Standard Deviation|72.1|72.1|||
4397339|NCT00276484|4224645|B1|||Triglycerides||mg/dL|Median|132.5|132.5|Standard Deviation|72.1|72.1|||
4397340|NCT00276484|4224643|B3|||Total cholesterol:High-Density Lipoprotein-C ratio||Ratio|Mean|3.6|3.6|Standard Deviation|0.8|0.8|||
4397341|NCT00276484|4224644|B2|||Total cholesterol:High-Density Lipoprotein-C ratio||Ratio|Mean|3.6|3.6|Standard Deviation|0.8|0.8|||
4397342|NCT00276484|4224645|B1|||Total cholesterol:High-Density Lipoprotein-C ratio||Ratio|Mean|3.6|3.6|Standard Deviation|0.8|0.8|||
4397343|NCT00276484|4224643|B3|||Total Cholesterol||mg/dL|Mean|165.2|165.2|Standard Deviation|22.1|22.1|||
4397344|NCT00276484|4224644|B2|||Total Cholesterol||mg/dL|Mean|165.3|165.3|Standard Deviation|22.8|22.8|||
4397345|NCT00276484|4224645|B1|||Total Cholesterol||mg/dL|Mean|165.2|165.2|Standard Deviation|21.4|21.4|||
4397346|NCT00276484|4224643|B3|||Non-High-Density Lipoprotein-C:High-Density Lipoprotein-C ratio||Ratio|Mean|2.6|2.6|Standard Deviation|0.8|0.8|||
4397347|NCT00276484|4224644|B2|||Non-High-Density Lipoprotein-C:High-Density Lipoprotein-C ratio||Ratio|Mean|2.6|2.6|Standard Deviation|0.8|0.8|||
4397348|NCT00276484|4224645|B1|||Non-High-Density Lipoprotein-C:High-Density Lipoprotein-C ratio||Ratio|Mean|2.6|2.6|Standard Deviation|0.8|0.8|||
4397349|NCT00276484|4224643|B3|||Non-High-Density Lipoprotein Cholesterol||mg/dL|Mean|117.9|117.9|Standard Deviation|21.4|21.4|||
4397350|NCT00276484|4224644|B2|||Non-High-Density Lipoprotein Cholesterol||mg/dL|Mean|118.1|118.1|Standard Deviation|21.9|21.9|||
4397351|NCT00276484|4224645|B1|||Non-High-Density Lipoprotein Cholesterol||mg/dL|Mean|117.7|117.7|Standard Deviation|20.8|20.8|||
4397352|NCT00276484|4224643|B3|||Low-Density Lipoprotein-C:High-Density Lipoprotein-C ratio||Ratio|Mean|2.0|2.0|Standard Deviation|0.6|0.6|||
4397353|NCT00276484|4224644|B2|||Low-Density Lipoprotein-C:High-Density Lipoprotein-C ratio||Ratio|Mean|2.0|2.0|Standard Deviation|0.6|0.6|||
4397354|NCT00276484|4224645|B1|||Low-Density Lipoprotein-C:High-Density Lipoprotein-C ratio||Ratio|Mean|2.0|2.0|Standard Deviation|0.6|0.6|||
4397355|NCT00276484|4224643|B3|||Low-Density Lipoprotein||mg/dL|Mean|89.4|89.4|Standard Deviation|16.2|16.2|||
4397356|NCT00276484|4224644|B2|||Low-Density Lipoprotein||mg/dL|Mean|89.8|89.8|Standard Deviation|16.2|16.2|||
4397357|NCT00276484|4224645|B1|||Low-Density Lipoprotein||mg/dL|Mean|88.8|88.8|Standard Deviation|16.2|16.2|||
4397358|NCT00276484|4224643|B3|||High-Density Lipoprotein||mg/dL|Mean|47.3|47.3|Standard Deviation|10.5|10.5|||
4397359|NCT00276484|4224644|B2|||High-Density Lipoprotein||mg/dL|Mean|47.2|47.2|Standard Deviation|10.6|10.6|||
4397360|NCT00276484|4224645|B1|||High-Density Lipoprotein||mg/dL|Mean|47.4|47.4|Standard Deviation|10.5|10.5|||
4397361|NCT00276484|4224643|B3|||C Reactive Protein||mg/dL|Mean|1.6|1.6|Standard Deviation|2.8|2.8|||
4397362|NCT00276484|4224644|B2|||C Reactive Protein||mg/dL|Mean|1.5|1.5|Standard Deviation|3.0|3.0|||
4397363|NCT00276484|4224645|B1|||C Reactive Protein||mg/dL|Mean|1.8|1.8|Standard Deviation|2.7|2.7|||
4397364|NCT00276484|4224643|B3|||Apolipoprotein B:Apolipoprotein A-I ratio||Ratio|Mean|0.7|0.7|Standard Deviation|0.2|0.2|||
4397365|NCT00276484|4224644|B2|||Apolipoprotein B:Apolipoprotein A-I ratio||Ratio|Mean|0.7|0.7|Standard Deviation|0.2|0.2|||
4397366|NCT00276484|4224645|B1|||Apolipoprotein B:Apolipoprotein A-I ratio||Ratio|Mean|0.7|0.7|Standard Deviation|0.2|0.2|||
4397367|NCT00276484|4224643|B3|||Apolipoprotein B||mg/dL|Mean|101.7|101.7|Standard Deviation|18.9|18.9|||
4397368|NCT00276484|4224644|B2|||Apolipoprotein B||mg/dL|Mean|102.0|102.0|Standard Deviation|18.8|18.8|||
4397369|NCT00276484|4224645|B1|||Apolipoprotein B||mg/dL|Mean|101.3|101.3|Standard Deviation|19.0|19.0|||
4397370|NCT00276484|4224643|B3|||Apolipoprotein A-I||mg/dL|Mean|154.3|154.3|Standard Deviation|25.3|25.3|||
4397371|NCT00276484|4224644|B2|||Apolipoprotein A-I||mg/dL|Mean|154.6|154.6|Standard Deviation|25.0|25.0|||
4397372|NCT00276484|4224645|B1|||Apolipoprotein A-I||mg/dL|Mean|154.0|154.0|Standard Deviation|25.5|25.5|||
4397373|NCT00276484|4224643|B3|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4397374|NCT00276484|4224644|B2|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4397375|NCT00276484|4224645|B1|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4397376|NCT00276484|4224643|B3|Black||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
4397377|NCT00276484|4224644|B2|Black||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4397378|NCT00276484|4224645|B1|Black||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4397379|NCT00276484|4224643|B3|Asian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4397380|NCT00276484|4224644|B2|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4397381|NCT00276484|4224645|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4397382|NCT00276484|4224643|B3|White||Race/Ethnicity, Customized||Participants|Number|469|469.0||||||
4397383|NCT00276484|4224644|B2|White||Race/Ethnicity, Customized||Participants|Number|232|232.0||||||
4397384|NCT00276484|4224645|B1|White||Race/Ethnicity, Customized||Participants|Number|237|237.0||||||
4397385|NCT00276484|4224643|B3||Male|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4397386|NCT00276484|4224644|B2||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4397387|NCT00276484|4224645|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4397388|NCT00276484|4224643|B3||Female|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4397389|NCT00276484|4224644|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4397390|NCT00276484|4224645|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4397391|NCT00276484|4224643|B3|||Age||years|Mean|61.3|61.3|Full Range|||31.0|80.0|
4397392|NCT00276484|4224644|B2|||Age||years|Mean|62|62.0|Full Range|||34.0|79.0|
4397393|NCT00276484|4224645|B1|||Age||years|Mean|60.6|60.6|Full Range|||31.0|80.0|
4397394|NCT00276458|4224676|B3|||Triglycerides (TG)||mg/dL|Mean|149.0|149.0|Standard Deviation|75.3|75.3|||
4397395|NCT00276458|4224677|B2|||Triglycerides (TG)||mg/dL|Mean|147.8|147.8|Standard Deviation|75.3|75.3|||
4397396|NCT00276458|4224678|B1|||Triglycerides (TG)||mg/dL|Mean|152.5|152.5|Standard Deviation|68.8|68.8|||
4397397|NCT00276458|4224676|B3|||Total cholesterol:High Density Lipoprotein Cholesterol (HDL-C) ratio||Ratio|Mean|4.1|4.1|Standard Deviation|1.0|1.0|||
4397398|NCT00276458|4224677|B2|||Total cholesterol:High Density Lipoprotein Cholesterol (HDL-C) ratio||Ratio|Mean|4.0|4.0|Standard Deviation|0.9|0.9|||
4397399|NCT00276458|4224678|B1|||Total cholesterol:High Density Lipoprotein Cholesterol (HDL-C) ratio||Ratio|Mean|4.2|4.2|Standard Deviation|1.0|1.0|||
4397400|NCT00276458|4224676|B3|||Total Cholesterol||mg/dL|Mean|201.3|201.3|Standard Deviation|23.4|23.4|||
4397401|NCT00276458|4224677|B2|||Total Cholesterol||mg/dL|Mean|200.0|200.0|Standard Deviation|21.5|21.5|||
4397402|NCT00276458|4224678|B1|||Total Cholesterol||mg/dL|Mean|202.6|202.6|Standard Deviation|25.2|25.2|||
4397403|NCT00276458|4224676|B3|||NonHigh Density Lipoprotein-Cholesterol (NonHDL-C):High Density Lipoprotein-Cholesterol (HDL-C)ratio||Ratio|Mean|3.1|3.1|Standard Deviation|1.0|1.0|||
4397404|NCT00276458|4224677|B2|||NonHigh Density Lipoprotein-Cholesterol (NonHDL-C):High Density Lipoprotein-Cholesterol (HDL-C)ratio||Ratio|Mean|3.0|3.0|Standard Deviation|0.9|0.9|||
4397405|NCT00276458|4224678|B1|||NonHigh Density Lipoprotein-Cholesterol (NonHDL-C):High Density Lipoprotein-Cholesterol (HDL-C)ratio||Ratio|Mean|3.2|3.2|Standard Deviation|1.0|1.0|||
4397406|NCT00276458|4224676|B3|||Non- High Density Lipoprotein (Non-HDL) Cholesterol||mg/dL|Mean|150.0|150.0|Standard Deviation|22.7|22.7|||
4397407|NCT00276458|4224677|B2|||Non- High Density Lipoprotein (Non-HDL) Cholesterol||mg/dL|Mean|148.4|148.4|Standard Deviation|21.1|21.1|||
4397408|NCT00276458|4224678|B1|||Non- High Density Lipoprotein (Non-HDL) Cholesterol||mg/dL|Mean|151.6|151.6|Standard Deviation|24.1|24.1|||
4397409|NCT00276458|4224676|B3|||Low Density Lipoprotein Cholesterol (LDL-C):High Density Lipoprotein Cholesterol (HDL-C) ratio||Ratio|Mean|2.4|2.4|Standard Deviation|0.7|0.7|||
4397410|NCT00276458|4224677|B2|||Low Density Lipoprotein Cholesterol (LDL-C):High Density Lipoprotein Cholesterol (HDL-C) ratio||Ratio|Mean|2.5|2.5|Standard Deviation|0.7|0.7|||
4397411|NCT00276458|4224678|B1|||Low Density Lipoprotein Cholesterol (LDL-C):High Density Lipoprotein Cholesterol (HDL-C) ratio||Ratio|Mean|2.4|2.4|Standard Deviation|0.6|0.6|||
4397412|NCT00276458|4224676|B3|||Low Density Lipoprotein (LDL)||mg/dL|Mean|118.9|118.9|Standard Deviation|18.1|18.1|||
4397413|NCT00276458|4224677|B2|||Low Density Lipoprotein (LDL)||mg/dL|Mean|117.9|117.9|Standard Deviation|16.8|16.8|||
4397414|NCT00276458|4224678|B1|||Low Density Lipoprotein (LDL)||mg/dL|Mean|119.9|119.9|Standard Deviation|19.4|19.4|||
4397415|NCT00276458|4224676|B3|||High Density Lipoprotein (HDL)||mg/dL|Mean|51.4|51.4|Standard Deviation|11.8|11.8|||
4397416|NCT00276458|4224677|B2|||High Density Lipoprotein (HDL)||mg/dL|Mean|51.7|51.7|Standard Deviation|11.5|11.5|||
4397417|NCT00276458|4224678|B1|||High Density Lipoprotein (HDL)||mg/dL|Mean|51.1|51.1|Standard Deviation|12.1|12.1|||
4397418|NCT00276458|4224676|B3|||C Reactive Protein||mg/dL|Mean|1.5|1.5|Standard Deviation|2.1|2.1|||
4397419|NCT00276458|4224677|B2|||C Reactive Protein||mg/dL|Mean|1.2|1.2|Standard Deviation|1.7|1.7|||
4397420|NCT00276458|4224678|B1|||C Reactive Protein||mg/dL|Mean|1.6|1.6|Standard Deviation|2.6|2.6|||
4397421|NCT00276458|4224676|B3|||Apolipoprotein B||mg/dL|Mean|121.4|121.4|Standard Deviation|21.7|21.7|||
4397422|NCT00276458|4224677|B2|||Apolipoprotein B||mg/dL|Mean|119.9|119.9|Standard Deviation|21.0|21.0|||
4397423|NCT00276458|4224678|B1|||Apolipoprotein B||mg/dL|Mean|122.9|122.9|Standard Deviation|22.4|22.4|||
4397424|NCT00276458|4224676|B3|||Apolipoprotein A-I:Apolipoprotein B ratio||Ratio|Mean|0.8|0.8|Standard Deviation|0.2|0.2|||
4397425|NCT00276458|4224677|B2|||Apolipoprotein A-I:Apolipoprotein B ratio||Ratio|Mean|0.7|0.7|Standard Deviation|0.2|0.2|||
4397426|NCT00276458|4224678|B1|||Apolipoprotein A-I:Apolipoprotein B ratio||Ratio|Mean|0.8|0.8|Standard Deviation|0.2|0.2|||
4397427|NCT00276458|4224676|B3|||Apolipoprotein A-I||mg/dL|Mean|162.6|162.6|Standard Deviation|24.8|24.8|||
4397428|NCT00276458|4224677|B2|||Apolipoprotein A-I||mg/dL|Mean|163.4|163.4|Standard Deviation|24.6|24.6|||
4397429|NCT00276458|4224678|B1|||Apolipoprotein A-I||mg/dL|Mean|161.8|161.8|Standard Deviation|25.2|25.2|||
4397430|NCT00276458|4224676|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4397431|NCT00276458|4224677|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4397432|NCT00276458|4224678|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4397433|NCT00276458|4224676|B3|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4397434|NCT00276458|4224677|B2|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4397435|NCT00276458|4224678|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4397436|NCT00276458|4224676|B3|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4397437|NCT00276458|4224677|B2|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4397438|NCT00276458|4224678|B1|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4397439|NCT00276458|4224676|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4397440|NCT00276458|4224677|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4397441|NCT00276458|4224678|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4397442|NCT00276458|4224676|B3|White||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
4397443|NCT00276458|4224677|B2|White||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4397444|NCT00276458|4224678|B1|White||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4397445|NCT00276458|4224676|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4397446|NCT00276458|4224677|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4397447|NCT00276458|4224678|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4397448|NCT00276458|4224676|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4397449|NCT00276458|4224677|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4397450|NCT00276458|4224678|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4397451|NCT00276458|4224676|B3|||Age||years|Mean|57.2|57.2|Full Range|||24.0|78.0|
4397452|NCT00276458|4224677|B2|||Age||years|Mean|58.0|58.0|Full Range|||34.0|76.0|
4397453|NCT00276458|4224678|B1|||Age||years|Mean|56.4|56.4|Full Range|||24.0|78.0|
4397454|NCT00276419|4224711|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4397455|NCT00276419|4224712|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4397456|NCT00276419|4224713|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4397457|NCT00276419|4224711|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397458|NCT00276419|4224712|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397459|NCT00276419|4224713|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397460|NCT00276419|4224711|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4397461|NCT00276419|4224712|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4397462|NCT00276419|4224713|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4397463|NCT00276419|4224711|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397464|NCT00276419|4224712|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397465|NCT00276419|4224713|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397466|NCT00276419|4224711|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4397467|NCT00276419|4224712|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4397468|NCT00276419|4224713|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4397469|NCT00276419|4224711|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397470|NCT00276419|4224712|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397471|NCT00276419|4224713|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397472|NCT00276406|4224724|B3|Geometric Center of Colonic Transit at 48 hr (GC48||Geometric Center (GC) of Colonic transit|The scintigraphic method is used to measure movement of large intestine contents. A radio-labeled isotope is adsorbed on activated charcoal particles and delivered to the colon in a delayed release capsule taken by mouth with a meal. Abdominal anterior and posterior gamma images are taken hourly. The geometric center (GC) is the weighted average of counts in the different colonic regions. The scale ranges from 1 to 5; a high GC implies faster colonic transit, a GC of 1 implies all isotope is in the ascending colon, and a GC of 5 implies all isotope is in the stool.|Units on a scale|Mean|2.94|2.94|Standard Deviation|0.93|0.93|||
4397473|NCT00276406|4224725|B2|Geometric Center of Colonic Transit at 48 hr (GC48||Geometric Center (GC) of Colonic transit|The scintigraphic method is used to measure movement of large intestine contents. A radio-labeled isotope is adsorbed on activated charcoal particles and delivered to the colon in a delayed release capsule taken by mouth with a meal. Abdominal anterior and posterior gamma images are taken hourly. The geometric center (GC) is the weighted average of counts in the different colonic regions. The scale ranges from 1 to 5; a high GC implies faster colonic transit, a GC of 1 implies all isotope is in the ascending colon, and a GC of 5 implies all isotope is in the stool.|Units on a scale|Mean|2.97|2.97|Standard Deviation|1.00|1.0|||
4397474|NCT00276406|4224726|B1|Geometric Center of Colonic Transit at 48 hr (GC48||Geometric Center (GC) of Colonic transit|The scintigraphic method is used to measure movement of large intestine contents. A radio-labeled isotope is adsorbed on activated charcoal particles and delivered to the colon in a delayed release capsule taken by mouth with a meal. Abdominal anterior and posterior gamma images are taken hourly. The geometric center (GC) is the weighted average of counts in the different colonic regions. The scale ranges from 1 to 5; a high GC implies faster colonic transit, a GC of 1 implies all isotope is in the ascending colon, and a GC of 5 implies all isotope is in the stool.|Units on a scale|Mean|2.92|2.92|Standard Deviation|0.89|0.89|||
4397475|NCT00276406|4224724|B3|Geometric Center of Colonic Transit at 24 hr (GC24||Geometric Center (GC) of Colonic transit|The scintigraphic method is used to measure movement of large intestine contents. A radio-labeled isotope is adsorbed on activated charcoal particles and delivered to the colon in a delayed release capsule taken by mouth with a meal. Abdominal anterior and posterior gamma images are taken hourly. The geometric center (GC) is the weighted average of counts in the different colonic regions. The scale ranges from 1 to 5; a high GC implies faster colonic transit, a GC of 1 implies all isotope is in the ascending colon, and a GC of 5 implies all isotope is in the stool.|Units on a scale|Mean|1.97|1.97|Standard Deviation|0.66|0.66|||
4397476|NCT00276406|4224725|B2|Geometric Center of Colonic Transit at 24 hr (GC24||Geometric Center (GC) of Colonic transit|The scintigraphic method is used to measure movement of large intestine contents. A radio-labeled isotope is adsorbed on activated charcoal particles and delivered to the colon in a delayed release capsule taken by mouth with a meal. Abdominal anterior and posterior gamma images are taken hourly. The geometric center (GC) is the weighted average of counts in the different colonic regions. The scale ranges from 1 to 5; a high GC implies faster colonic transit, a GC of 1 implies all isotope is in the ascending colon, and a GC of 5 implies all isotope is in the stool.|Units on a scale|Mean|1.98|1.98|Standard Deviation|0.62|0.62|||
4397477|NCT00276406|4224726|B1|Geometric Center of Colonic Transit at 24 hr (GC24||Geometric Center (GC) of Colonic transit|The scintigraphic method is used to measure movement of large intestine contents. A radio-labeled isotope is adsorbed on activated charcoal particles and delivered to the colon in a delayed release capsule taken by mouth with a meal. Abdominal anterior and posterior gamma images are taken hourly. The geometric center (GC) is the weighted average of counts in the different colonic regions. The scale ranges from 1 to 5; a high GC implies faster colonic transit, a GC of 1 implies all isotope is in the ascending colon, and a GC of 5 implies all isotope is in the stool.|Units on a scale|Mean|1.96|1.96|Standard Deviation|0.71|0.71|||
4397478|NCT00276406|4224724|B3|||Subjects with diabetic retinopathy|"Diabetic retinopathy is a condition of the eye caused by diabetes, caused by abnormal blood vessel growth, which invades the retina and can cause reduced vision and blindness.~Note: because not all subjects had retinopathy, the number of subjects with retinopathy in each arm will not match the overall number of subjects enrolled in each arm."|Participants|Number|16|16.0||||||
4397479|NCT00276406|4224725|B2|||Subjects with diabetic retinopathy|"Diabetic retinopathy is a condition of the eye caused by diabetes, caused by abnormal blood vessel growth, which invades the retina and can cause reduced vision and blindness.~Note: because not all subjects had retinopathy, the number of subjects with retinopathy in each arm will not match the overall number of subjects enrolled in each arm."|Participants|Number|7|7.0||||||
4397480|NCT00276406|4224726|B1|||Subjects with diabetic retinopathy|"Diabetic retinopathy is a condition of the eye caused by diabetes, caused by abnormal blood vessel growth, which invades the retina and can cause reduced vision and blindness.~Note: because not all subjects had retinopathy, the number of subjects with retinopathy in each arm will not match the overall number of subjects enrolled in each arm."|Participants|Number|9|9.0||||||
4397529|NCT00276159|4224813|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|23.32|23.32|||
4397481|NCT00276406|4224724|B3|||Hemoglobin A1c|Hemoglobin A1c (HgA1c) or glycolated hemoglobin is a laboratory test of blood which provides a measure the average blood glucose (sugar) levels for the prior 3 month period.|Percentage|Mean|7.9|7.9|Standard Deviation|0.3|0.3|||
4397482|NCT00276406|4224725|B2|||Hemoglobin A1c|Hemoglobin A1c (HgA1c) or glycolated hemoglobin is a laboratory test of blood which provides a measure the average blood glucose (sugar) levels for the prior 3 month period.|Percentage|Mean|7.7|7.7|Standard Deviation|1.2|1.2|||
4397483|NCT00276406|4224726|B1|||Hemoglobin A1c|Hemoglobin A1c (HgA1c) or glycolated hemoglobin is a laboratory test of blood which provides a measure the average blood glucose (sugar) levels for the prior 3 month period.|Percentage|Mean|8.1|8.1|Standard Deviation|1.7|1.7|||
4397484|NCT00276406|4224724|B3|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kilograms/meter^2|Mean|29.7|29.7|Standard Deviation|5.5|5.5|||
4397485|NCT00276406|4224725|B2|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kilograms/meter^2|Mean|31.6|31.6|Standard Deviation|6.0|6.0|||
4397486|NCT00276406|4224726|B1|||Body Mass Index|Body Mass Index (BMI) is a health index for comparing weight to height. BMI is a person's weight in kilograms (kg) divided by his or her height in meters squared. The body mass index is an indication if a person is at a suitable weight for his height on an approximation of body fat. A body mass index of under 20 is considered to be underweight, while a body mass index between 20 to 25 is considered healthy. A body mass index in the range of 25 to 30 is regarded as overweight. A body mass index over 30 is regarded as obese.|kilograms/meter^2|Mean|27.9|27.9|Standard Deviation|4.4|4.4|||
4397487|NCT00276406|4224724|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4397488|NCT00276406|4224725|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4397489|NCT00276406|4224726|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4397490|NCT00276406|4224724|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4397491|NCT00276406|4224725|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4397492|NCT00276406|4224726|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4397493|NCT00276406|4224724|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4397494|NCT00276406|4224725|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4397495|NCT00276406|4224726|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4397496|NCT00276406|4224724|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|11.3|11.3|||
4397497|NCT00276406|4224725|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|11.3|11.3|||
4397498|NCT00276406|4224726|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|11.4|11.4|||
4397499|NCT00276380|4224755|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4397500|NCT00276380|4224756|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4397501|NCT00276380|4224757|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4397502|NCT00276380|4224755|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4397503|NCT00276380|4224756|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4397504|NCT00276380|4224757|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4397505|NCT00276380|4224755|B3|||Age||years|Median|68|68.0|Full Range|||50.0|90.0|
4397506|NCT00276380|4224756|B2|||Age||years|Median|69|69.0|Full Range|||50.0|90.0|
4397507|NCT00276380|4224757|B1|||Age||years|Median|68|68.0|Full Range|||50.0|83.0|
4397508|NCT00276250|4224776|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
4397509|NCT00276250|4224778|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4397510|NCT00276250|4224779|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4397511|NCT00276250|4224776|B4|Male||Gender||participants|Number|3|3.0||||||
4397512|NCT00276250|4224778|B2|Male||Gender||participants|Number|0|0.0||||||
4397513|NCT00276250|4224779|B1|Male||Gender||participants|Number|3|3.0||||||
4397514|NCT00276250|4224776|B4|Female||Gender||participants|Number|2|2.0||||||
4397515|NCT00276250|4224778|B2|Female||Gender||participants|Number|1|1.0||||||
4397516|NCT00276250|4224779|B1|Female||Gender||participants|Number|1|1.0||||||
4397517|NCT00276250|4224776|B4|>=65 years||Age||participants|Number|0|0.0||||||
4397518|NCT00276250|4224778|B2|>=65 years||Age||participants|Number|0|0.0||||||
4397519|NCT00276250|4224779|B1|>=65 years||Age||participants|Number|0|0.0||||||
4397520|NCT00276250|4224776|B4|Between 18 and 65 years||Age||participants|Number|5|5.0||||||
4397521|NCT00276250|4224778|B2|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4397522|NCT00276250|4224779|B1|Between 18 and 65 years||Age||participants|Number|4|4.0||||||
4397523|NCT00276250|4224776|B4|<=18 years||Age||participants|Number|0|0.0||||||
4397524|NCT00276250|4224778|B2|<=18 years||Age||participants|Number|0|0.0||||||
4397525|NCT00276250|4224779|B1|<=18 years||Age||participants|Number|0|0.0||||||
4397526|NCT00276159|4224813|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4397527|NCT00276159|4224813|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4397528|NCT00276159|4224813|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4397530|NCT00276159|4224813|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4397531|NCT00276159|4224813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4397532|NCT00276159|4224813|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4397533|NCT00276094|4224820|B4|Severe||MBS-Vaginal Bleeding with Sexual Activity at Randomization|Vaginal Bleeding with Sexual Activity was assessed in 1, 5, and 0 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|3|3.0||||||
4397534|NCT00276094|4224821|B3|Severe||MBS-Vaginal Bleeding with Sexual Activity at Randomization|Vaginal Bleeding with Sexual Activity was assessed in 1, 5, and 0 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|0|0.0||||||
4397535|NCT00276094|4224822|B2|Severe||MBS-Vaginal Bleeding with Sexual Activity at Randomization|Vaginal Bleeding with Sexual Activity was assessed in 1, 5, and 0 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|3|3.0||||||
4397536|NCT00276094|4224823|B1|Severe||MBS-Vaginal Bleeding with Sexual Activity at Randomization|Vaginal Bleeding with Sexual Activity was assessed in 1, 5, and 0 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|0|0.0||||||
4397537|NCT00276094|4224820|B4|Moderate||MBS-Vaginal Bleeding with Sexual Activity at Randomization|Vaginal Bleeding with Sexual Activity was assessed in 1, 5, and 0 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|2|2.0||||||
4397538|NCT00276094|4224821|B3|Moderate||MBS-Vaginal Bleeding with Sexual Activity at Randomization|Vaginal Bleeding with Sexual Activity was assessed in 1, 5, and 0 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|0|0.0||||||
4397539|NCT00276094|4224822|B2|Moderate||MBS-Vaginal Bleeding with Sexual Activity at Randomization|Vaginal Bleeding with Sexual Activity was assessed in 1, 5, and 0 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|1|1.0||||||
4397540|NCT00276094|4224823|B1|Moderate||MBS-Vaginal Bleeding with Sexual Activity at Randomization|Vaginal Bleeding with Sexual Activity was assessed in 1, 5, and 0 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|1|1.0||||||
4397541|NCT00276094|4224820|B4|None||MBS-Vaginal Bleeding with Sexual Activity at Randomization|Vaginal Bleeding with Sexual Activity was assessed in 1, 5, and 0 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|1|1.0||||||
4397542|NCT00276094|4224821|B3|None||MBS-Vaginal Bleeding with Sexual Activity at Randomization|Vaginal Bleeding with Sexual Activity was assessed in 1, 5, and 0 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|0|0.0||||||
4397543|NCT00276094|4224822|B2|None||MBS-Vaginal Bleeding with Sexual Activity at Randomization|Vaginal Bleeding with Sexual Activity was assessed in 1, 5, and 0 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|1|1.0||||||
4397544|NCT00276094|4224823|B1|None||MBS-Vaginal Bleeding with Sexual Activity at Randomization|Vaginal Bleeding with Sexual Activity was assessed in 1, 5, and 0 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|0|0.0||||||
4397545|NCT00276094|4224820|B4|Severe||MBS-Difficult/Painful Urination at Randomization|Difficult/Painful Urination was assessed in 3, 2, and 2 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|2|2.0||||||
4397546|NCT00276094|4224821|B3|Severe||MBS-Difficult/Painful Urination at Randomization|Difficult/Painful Urination was assessed in 3, 2, and 2 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|0|0.0||||||
4397547|NCT00276094|4224822|B2|Severe||MBS-Difficult/Painful Urination at Randomization|Difficult/Painful Urination was assessed in 3, 2, and 2 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|1|1.0||||||
4397548|NCT00276094|4224823|B1|Severe||MBS-Difficult/Painful Urination at Randomization|Difficult/Painful Urination was assessed in 3, 2, and 2 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|1|1.0||||||
4397549|NCT00276094|4224820|B4|Moderate||MBS-Difficult/Painful Urination at Randomization|Difficult/Painful Urination was assessed in 3, 2, and 2 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|5|5.0||||||
4397550|NCT00276094|4224821|B3|Moderate||MBS-Difficult/Painful Urination at Randomization|Difficult/Painful Urination was assessed in 3, 2, and 2 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|2|2.0||||||
4397551|NCT00276094|4224822|B2|Moderate||MBS-Difficult/Painful Urination at Randomization|Difficult/Painful Urination was assessed in 3, 2, and 2 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|1|1.0||||||
4397552|NCT00276094|4224823|B1|Moderate||MBS-Difficult/Painful Urination at Randomization|Difficult/Painful Urination was assessed in 3, 2, and 2 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|2|2.0||||||
4397553|NCT00276094|4224820|B4|Severe||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|29|29.0||||||
4397554|NCT00276094|4224821|B3|Severe||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|9|9.0||||||
4397555|NCT00276094|4224822|B2|Severe||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|9|9.0||||||
4397556|NCT00276094|4224823|B1|Severe||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|11|11.0||||||
4397582|NCT00276094|4224821|B3|None||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|2|2.0||||||
4397557|NCT00276094|4224820|B4|Moderate||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|66|66.0||||||
4397558|NCT00276094|4224821|B3|Moderate||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|24|24.0||||||
4397559|NCT00276094|4224822|B2|Moderate||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|17|17.0||||||
4397560|NCT00276094|4224823|B1|Moderate||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|25|25.0||||||
4397561|NCT00276094|4224820|B4|Mild||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|9|9.0||||||
4397562|NCT00276094|4224821|B3|Mild||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|3|3.0||||||
4397563|NCT00276094|4224822|B2|Mild||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|4|4.0||||||
4397564|NCT00276094|4224823|B1|Mild||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|2|2.0||||||
4397565|NCT00276094|4224820|B4|None||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|2|2.0||||||
4397566|NCT00276094|4224821|B3|None||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|1|1.0||||||
4397567|NCT00276094|4224822|B2|None||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|0|0.0||||||
4397568|NCT00276094|4224823|B1|None||MBS-Vaginal and/or Vulvar Irritation or Itching at Randomization|Vaginal and/or Vulvar Irritation or Itching was assessed in 39, 30, and 37 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|1|1.0||||||
4397569|NCT00276094|4224820|B4|Severe||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|254|254.0||||||
4397570|NCT00276094|4224821|B3|Severe||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|86|86.0||||||
4397571|NCT00276094|4224822|B2|Severe||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|84|84.0||||||
4397572|NCT00276094|4224823|B1|Severe||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|84|84.0||||||
4397573|NCT00276094|4224820|B4|Moderate||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|108|108.0||||||
4397574|NCT00276094|4224821|B3|Moderate||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|33|33.0||||||
4397575|NCT00276094|4224822|B2|Moderate||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|29|29.0||||||
4397576|NCT00276094|4224823|B1|Moderate||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|46|46.0||||||
4397577|NCT00276094|4224820|B4|Mild||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|7|7.0||||||
4397578|NCT00276094|4224821|B3|Mild||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|1|1.0||||||
4397579|NCT00276094|4224822|B2|Mild||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|3|3.0||||||
4397580|NCT00276094|4224823|B1|Mild||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|3|3.0||||||
4397581|NCT00276094|4224820|B4|None||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|9|9.0||||||
4397583|NCT00276094|4224822|B2|None||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|4|4.0||||||
4397584|NCT00276094|4224823|B1|None||MBS-Vaginal Pain with Sexual Activity at Randomization|Vaginal Pain with Sexual Activity was assessed in 136, 120, and 122 subjects in the Ospemifeme 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|3|3.0||||||
4397585|NCT00276094|4224820|B4|Severe||MBS-Vaginal Dryness at Randomization|Vaginal Dryness was assessed in 102, 118, and 104 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|146|146.0||||||
4397586|NCT00276094|4224821|B3|Severe||MBS-Vaginal Dryness at Randomization|Vaginal Dryness was assessed in 102, 118, and 104 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|41|41.0||||||
4397587|NCT00276094|4224822|B2|Severe||MBS-Vaginal Dryness at Randomization|Vaginal Dryness was assessed in 102, 118, and 104 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|53|53.0||||||
4397588|NCT00276094|4224823|B1|Severe||MBS-Vaginal Dryness at Randomization|Vaginal Dryness was assessed in 102, 118, and 104 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|52|52.0||||||
4397589|NCT00276094|4224820|B4|Moderate||MBS-Vaginal Dryness at Randomization|Vaginal Dryness was assessed in 102, 118, and 104 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|170|170.0||||||
4397590|NCT00276094|4224821|B3|Moderate||MBS-Vaginal Dryness at Randomization|Vaginal Dryness was assessed in 102, 118, and 104 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|62|62.0||||||
4397591|NCT00276094|4224822|B2|Moderate||MBS-Vaginal Dryness at Randomization|Vaginal Dryness was assessed in 102, 118, and 104 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|61|61.0||||||
4397592|NCT00276094|4224823|B1|Moderate||MBS-Vaginal Dryness at Randomization|Vaginal Dryness was assessed in 102, 118, and 104 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|47|47.0||||||
4397593|NCT00276094|4224820|B4|Mild||MBS-Vaginal Dryness at Randomization|Vaginal Dryness was assessed in 102, 118, and 104 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|8|8.0||||||
4397594|NCT00276094|4224821|B3|Mild||MBS-Vaginal Dryness at Randomization|Vaginal Dryness was assessed in 102, 118, and 104 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|1|1.0||||||
4397595|NCT00276094|4224822|B2|Mild||MBS-Vaginal Dryness at Randomization|Vaginal Dryness was assessed in 102, 118, and 104 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|4|4.0||||||
4397596|NCT00276094|4224823|B1|Mild||MBS-Vaginal Dryness at Randomization|Vaginal Dryness was assessed in 102, 118, and 104 subjects in the Ospemifene 30 mg, Ospemifene 60 mg, and Placebo groups, respectively.|Participants|Number|3|3.0||||||
4397597|NCT00276094|4224820|B4|Severe||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|434|434.0||||||
4397598|NCT00276094|4224821|B3|Severe||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|136|136.0||||||
4397599|NCT00276094|4224822|B2|Severe||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|150|150.0||||||
4397600|NCT00276094|4224823|B1|Severe||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|148|148.0||||||
4397601|NCT00276094|4224820|B4|Moderate||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|351|351.0||||||
4397602|NCT00276094|4224821|B3|Moderate||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|121|121.0||||||
4397603|NCT00276094|4224822|B2|Moderate||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|109|109.0||||||
4397604|NCT00276094|4224823|B1|Moderate||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|121|121.0||||||
4397605|NCT00276094|4224820|B4|Mild||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|24|24.0||||||
4397606|NCT00276094|4224821|B3|Mild||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|5|5.0||||||
4397607|NCT00276094|4224822|B2|Mild||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|11|11.0||||||
4397608|NCT00276094|4224823|B1|Mild||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|8|8.0||||||
4397609|NCT00276094|4224820|B4|None||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|12|12.0||||||
4397610|NCT00276094|4224821|B3|None||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|3|3.0||||||
4397611|NCT00276094|4224822|B2|None||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|5|5.0||||||
4397612|NCT00276094|4224823|B1|None||Most Bothersome Vulvar and Vaginal Atrophy (VVA) Symptom (MBS) by Severity (Overall [Composite])||Participants|Number|4|4.0||||||
4397613|NCT00276094|4224820|B4|||Vaginal pH at Screening||Vaginal pH|Mean|6.35|6.35|Standard Deviation|0.743|0.743|||
4397614|NCT00276094|4224821|B3|||Vaginal pH at Screening||Vaginal pH|Mean|6.34|6.34|Standard Deviation|0.732|0.732|||
4397615|NCT00276094|4224822|B2|||Vaginal pH at Screening||Vaginal pH|Mean|6.37|6.37|Standard Deviation|0.763|0.763|||
4397616|NCT00276094|4224823|B1|||Vaginal pH at Screening||Vaginal pH|Mean|6.35|6.35|Standard Deviation|0.736|0.736|||
4397617|NCT00276094|4224820|B4|||Percentage of Superficial Cells at Screening||Percentage of Superficial Cells|Mean|1.07|1.07|Standard Deviation|2.989|2.989|||
4397618|NCT00276094|4224821|B3|||Percentage of Superficial Cells at Screening||Percentage of Superficial Cells|Mean|0.91|0.91|Standard Deviation|2.635|2.635|||
4397619|NCT00276094|4224822|B2|||Percentage of Superficial Cells at Screening||Percentage of Superficial Cells|Mean|1.04|1.04|Standard Deviation|3.368|3.368|||
4397620|NCT00276094|4224823|B1|||Percentage of Superficial Cells at Screening||Percentage of Superficial Cells|Mean|1.25|1.25|Standard Deviation|2.907|2.907|||
4397621|NCT00276094|4224820|B4|||Percentage of Parabasal Cells at Screening||Percentage of Parabasal Cells|Mean|39.3|39.3|Standard Deviation|38.28|38.28|||
4397622|NCT00276094|4224821|B3|||Percentage of Parabasal Cells at Screening||Percentage of Parabasal Cells|Mean|38.5|38.5|Standard Deviation|37.60|37.6|||
4397623|NCT00276094|4224822|B2|||Percentage of Parabasal Cells at Screening||Percentage of Parabasal Cells|Mean|39.3|39.3|Standard Deviation|38.98|38.98|||
4397624|NCT00276094|4224823|B1|||Percentage of Parabasal Cells at Screening||Percentage of Parabasal Cells|Mean|40.1|40.1|Standard Deviation|38.33|38.33|||
4397625|NCT00276094|4224820|B4|Yes||Previous Hormone Treatment||Partcipants|Number|154|154.0||||||
4397626|NCT00276094|4224821|B3|Yes||Previous Hormone Treatment||Partcipants|Number|50|50.0||||||
4397627|NCT00276094|4224822|B2|Yes||Previous Hormone Treatment||Partcipants|Number|54|54.0||||||
4397628|NCT00276094|4224823|B1|Yes||Previous Hormone Treatment||Partcipants|Number|50|50.0||||||
4397629|NCT00276094|4224820|B4|No||Previous Hormone Treatment||Partcipants|Number|672|672.0||||||
4397630|NCT00276094|4224821|B3|No||Previous Hormone Treatment||Partcipants|Number|218|218.0||||||
4397631|NCT00276094|4224822|B2|No||Previous Hormone Treatment||Partcipants|Number|222|222.0||||||
4397632|NCT00276094|4224823|B1|No||Previous Hormone Treatment||Partcipants|Number|232|232.0||||||
4397633|NCT00276094|4224820|B4|||No. of Days with Hot Flashes (/month)||Days|Mean|19.6|19.6|Standard Deviation|11.41|11.41|||
4397634|NCT00276094|4224821|B3|||No. of Days with Hot Flashes (/month)||Days|Mean|19.6|19.6|Standard Deviation|11.09|11.09|||
4397635|NCT00276094|4224822|B2|||No. of Days with Hot Flashes (/month)||Days|Mean|19.6|19.6|Standard Deviation|11.49|11.49|||
4397636|NCT00276094|4224823|B1|||No. of Days with Hot Flashes (/month)||Days|Mean|19.7|19.7|Standard Deviation|11.68|11.68|||
4397637|NCT00276094|4224820|B4|Yes||Currently Experiencing Hot Flashes?||Participants|Number|501|501.0||||||
4397638|NCT00276094|4224821|B3|Yes||Currently Experiencing Hot Flashes?||Participants|Number|155|155.0||||||
4397639|NCT00276094|4224822|B2|Yes||Currently Experiencing Hot Flashes?||Participants|Number|174|174.0||||||
4397640|NCT00276094|4224823|B1|Yes||Currently Experiencing Hot Flashes?||Participants|Number|172|172.0||||||
4397641|NCT00276094|4224820|B4|No||Currently Experiencing Hot Flashes?||Participants|Number|325|325.0||||||
4397642|NCT00276094|4224821|B3|No||Currently Experiencing Hot Flashes?||Participants|Number|113|113.0||||||
4397643|NCT00276094|4224822|B2|No||Currently Experiencing Hot Flashes?||Participants|Number|102|102.0||||||
4397644|NCT00276094|4224823|B1|No||Currently Experiencing Hot Flashes?||Participants|Number|110|110.0||||||
4397645|NCT00276094|4224820|B4|4 or more||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|2|2.0||||||
4397646|NCT00276094|4224821|B3|4 or more||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|0|0.0||||||
4397647|NCT00276094|4224822|B2|4 or more||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|1|1.0||||||
4397648|NCT00276094|4224823|B1|4 or more||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|1|1.0||||||
4397649|NCT00276094|4224820|B4|3||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|3|3.0||||||
4397650|NCT00276094|4224821|B3|3||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|1|1.0||||||
4397651|NCT00276094|4224822|B2|3||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|2|2.0||||||
4397652|NCT00276094|4224823|B1|3||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|0|0.0||||||
4397653|NCT00276094|4224820|B4|2||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|24|24.0||||||
4397654|NCT00276094|4224821|B3|2||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|8|8.0||||||
4397655|NCT00276094|4224822|B2|2||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|9|9.0||||||
4397656|NCT00276094|4224823|B1|2||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|7|7.0||||||
4397657|NCT00276094|4224820|B4|1||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|68|68.0||||||
4397658|NCT00276094|4224821|B3|1||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|17|17.0||||||
4397659|NCT00276094|4224822|B2|1||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|24|24.0||||||
4397660|NCT00276094|4224823|B1|1||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|27|27.0||||||
4397661|NCT00276094|4224820|B4|0||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|728|728.0||||||
4397662|NCT00276094|4224821|B3|0||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|242|242.0||||||
4397663|NCT00276094|4224822|B2|0||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|239|239.0||||||
4397664|NCT00276094|4224823|B1|0||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|247|247.0||||||
4397665|NCT00276094|4224820|B4|Missing values||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|1|1.0||||||
4397666|NCT00276094|4224821|B3|Missing values||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|0|0.0||||||
4397667|NCT00276094|4224822|B2|Missing values||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|1|1.0||||||
4397668|NCT00276094|4224823|B1|Missing values||No. of Urinary Tract Infections in Past 6 Months||Participants|Number|0|0.0||||||
4397669|NCT00276094|4224820|B4|||No. of Vaginal Births||Vaginal births per participant|Mean|1.68|1.68|Standard Deviation|1.480|1.48|||
4397670|NCT00276094|4224821|B3|||No. of Vaginal Births||Vaginal births per participant|Mean|1.59|1.59|Standard Deviation|1.386|1.386|||
4397671|NCT00276094|4224822|B2|||No. of Vaginal Births||Vaginal births per participant|Mean|1.65|1.65|Standard Deviation|1.478|1.478|||
4397672|NCT00276094|4224823|B1|||No. of Vaginal Births||Vaginal births per participant|Mean|1.78|1.78|Standard Deviation|1.565|1.565|||
4397673|NCT00276094|4224820|B4|||Number (No.) of Pregnancies||Pregnancies per participant|Mean|2.46|2.46|Standard Deviation|1.675|1.675|||
4397674|NCT00276094|4224821|B3|||Number (No.) of Pregnancies||Pregnancies per participant|Mean|2.38|2.38|Standard Deviation|1.525|1.525|||
4397675|NCT00276094|4224822|B2|||Number (No.) of Pregnancies||Pregnancies per participant|Mean|2.39|2.39|Standard Deviation|1.638|1.638|||
4397676|NCT00276094|4224823|B1|||Number (No.) of Pregnancies||Pregnancies per participant|Mean|2.61|2.61|Standard Deviation|1.834|1.834|||
4397677|NCT00276094|4224820|B4|No||Intact Cervix?||Participants|Number|431|431.0||||||
4397678|NCT00276094|4224821|B3|No||Intact Cervix?||Participants|Number|139|139.0||||||
4397679|NCT00276094|4224822|B2|No||Intact Cervix?||Participants|Number|143|143.0||||||
4397680|NCT00276094|4224823|B1|No||Intact Cervix?||Participants|Number|149|149.0||||||
4397681|NCT00276094|4224820|B4|Yes||Intact Cervix?||Participants|Number|395|395.0||||||
4397682|NCT00276094|4224821|B3|Yes||Intact Cervix?||Participants|Number|129|129.0||||||
4397683|NCT00276094|4224822|B2|Yes||Intact Cervix?||Participants|Number|133|133.0||||||
4397684|NCT00276094|4224823|B1|Yes||Intact Cervix?||Participants|Number|133|133.0||||||
4397685|NCT00276094|4224820|B4|No||Intact Uterus?||Participants|Number|447|447.0||||||
4397686|NCT00276094|4224821|B3|No||Intact Uterus?||Participants|Number|146|146.0||||||
4397687|NCT00276094|4224822|B2|No||Intact Uterus?||Participants|Number|148|148.0||||||
4397688|NCT00276094|4224823|B1|No||Intact Uterus?||Participants|Number|153|153.0||||||
4397689|NCT00276094|4224820|B4|Yes||Intact Uterus?||Participants|Number|379|379.0||||||
4397690|NCT00276094|4224821|B3|Yes||Intact Uterus?||Participants|Number|122|122.0||||||
4397691|NCT00276094|4224822|B2|Yes||Intact Uterus?||Participants|Number|128|128.0||||||
4397692|NCT00276094|4224823|B1|Yes||Intact Uterus?||Participants|Number|129|129.0||||||
4397693|NCT00276094|4224820|B4|||Body Mass Index (BMI)||kg/m^2|Mean|26.2|26.2|Standard Deviation|4.43|4.43|||
4397694|NCT00276094|4224821|B3|||Body Mass Index (BMI)||kg/m^2|Mean|26.1|26.1|Standard Deviation|4.37|4.37|||
4397695|NCT00276094|4224822|B2|||Body Mass Index (BMI)||kg/m^2|Mean|26.0|26.0|Standard Deviation|4.44|4.44|||
4397696|NCT00276094|4224823|B1|||Body Mass Index (BMI)||kg/m^2|Mean|26.4|26.4|Standard Deviation|4.51|4.51|||
4397697|NCT00276094|4224820|B4|||Weight||kg|Mean|68.9|68.9|Standard Deviation|12.68|12.68|||
4397698|NCT00276094|4224821|B3|||Weight||kg|Mean|69.0|69.0|Standard Deviation|12.90|12.9|||
4397699|NCT00276094|4224822|B2|||Weight||kg|Mean|68.4|68.4|Standard Deviation|12.08|12.08|||
4397700|NCT00276094|4224823|B1|||Weight||kg|Mean|69.2|69.2|Standard Deviation|13.06|13.06|||
4397701|NCT00276094|4224820|B4|||Height||cm|Mean|162.1|162.1|Standard Deviation|6.62|6.62|||
4397702|NCT00276094|4224821|B3|||Height||cm|Mean|162.3|162.3|Standard Deviation|6.87|6.87|||
4397703|NCT00276094|4224822|B2|||Height||cm|Mean|162.1|162.1|Standard Deviation|6.42|6.42|||
4397704|NCT00276094|4224823|B1|||Height||cm|Mean|161.9|161.9|Standard Deviation|6.60|6.6|||
4397705|NCT00276094|4224820|B4|Not Hispanic or Latino||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|765|765.0||||||
4397706|NCT00276094|4224821|B3|Not Hispanic or Latino||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|244|244.0||||||
4397707|NCT00276094|4224822|B2|Not Hispanic or Latino||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|256|256.0||||||
4397708|NCT00276094|4224823|B1|Not Hispanic or Latino||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|265|265.0||||||
4397709|NCT00276094|4224820|B4|Hispanic or Latino||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|61|61.0||||||
4397710|NCT00276094|4224821|B3|Hispanic or Latino||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|24|24.0||||||
4397711|NCT00276094|4224822|B2|Hispanic or Latino||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|20|20.0||||||
4397712|NCT00276094|4224823|B1|Hispanic or Latino||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|17|17.0||||||
4397713|NCT00276094|4224820|B4|Missing value||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|1|1.0||||||
4397714|NCT00276094|4224821|B3|Missing value||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|1|1.0||||||
4397715|NCT00276094|4224822|B2|Missing value||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|0|0.0||||||
4397716|NCT00276094|4224823|B1|Missing value||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|0|0.0||||||
4397717|NCT00276094|4224820|B4|Other||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|12|12.0||||||
4397718|NCT00276094|4224821|B3|Other||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|4|4.0||||||
4397719|NCT00276094|4224822|B2|Other||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|2|2.0||||||
4397720|NCT00276094|4224823|B1|Other||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|6|6.0||||||
4397721|NCT00276094|4224820|B4|White||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|744|744.0||||||
4397722|NCT00276094|4224821|B3|White||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|242|242.0||||||
4397723|NCT00276094|4224822|B2|White||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|249|249.0||||||
4397724|NCT00276094|4224823|B1|White||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|253|253.0||||||
4397725|NCT00276094|4224820|B4|Black or African American||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|50|50.0||||||
4397726|NCT00276094|4224821|B3|Black or African American||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|14|14.0||||||
4397727|NCT00276094|4224822|B2|Black or African American||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|18|18.0||||||
4397728|NCT00276094|4224823|B1|Black or African American||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|18|18.0||||||
4397729|NCT00276094|4224820|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|1|1.0||||||
4397730|NCT00276094|4224821|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|0|0.0||||||
4397731|NCT00276094|4224822|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|1|1.0||||||
4397732|NCT00276094|4224823|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|0|0.0||||||
4397733|NCT00276094|4224820|B4|Asian||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|15|15.0||||||
4397734|NCT00276094|4224821|B3|Asian||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|6|6.0||||||
4397735|NCT00276094|4224822|B2|Asian||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|4|4.0||||||
4397736|NCT00276094|4224823|B1|Asian||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|5|5.0||||||
4397737|NCT00276094|4224820|B4|American Indian or Alaska Native||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|3|3.0||||||
4397738|NCT00276094|4224821|B3|American Indian or Alaska Native||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|1|1.0||||||
4397739|NCT00276094|4224822|B2|American Indian or Alaska Native||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|2|2.0||||||
4397740|NCT00276094|4224823|B1|American Indian or Alaska Native||Race/Ethnicity, Customized|"Total number of participants in each arm/group do not match the Overall Number of Baseline participants in each Arm/group because Race and Ethnicity parameters have been combined to ensure faithful reproduction of each parameter, as mentioned in the CSR."|Participants|Number|0|0.0||||||
4397741|NCT00276094|4224820|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397742|NCT00276094|4224821|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397743|NCT00276094|4224822|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397744|NCT00276094|4224823|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397745|NCT00276094|4224820|B4||Female|Sex: Female, Male||Participants|Count of Participants|826|826.0||||||
4397746|NCT00276094|4224821|B3||Female|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4397747|NCT00276094|4224822|B2||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4397748|NCT00276094|4224823|B1||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4397749|NCT00276094|4224820|B4|||Age||Years|Mean|58.6|58.6|Standard Deviation|6.23|6.23|||
4397750|NCT00276094|4224821|B3|||Age||Years|Mean|58.9|58.9|Standard Deviation|6.09|6.09|||
4397751|NCT00276094|4224822|B2|||Age||Years|Mean|58.6|58.6|Standard Deviation|6.34|6.34|||
4397752|NCT00276094|4224823|B1|||Age||Years|Mean|58.4|58.4|Standard Deviation|6.27|6.27|||
4397753|NCT00276016|4224872|B7||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4397754|NCT00276016|4224873|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4397755|NCT00276016|4224874|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4397756|NCT00276016|4224875|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4397757|NCT00276016|4224876|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4397758|NCT00276016|4224877|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4397759|NCT00276016|4224878|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4397760|NCT00276016|4224872|B7||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4397761|NCT00276016|4224873|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4397762|NCT00276016|4224874|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4397763|NCT00276016|4224875|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4397764|NCT00276016|4224876|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4397765|NCT00276016|4224877|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4397766|NCT00276016|4224878|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4397767|NCT00276016|4224872|B7|||Age, Customized||years|Mean|27.0|27.0|Standard Deviation|5.1|5.1|||
4397768|NCT00276016|4224873|B6|||Age, Customized||years|Mean|27.3|27.3|Standard Deviation|3.3|3.3|||
4397769|NCT00276016|4224874|B5|||Age, Customized||years|Mean|28.0|28.0|Standard Deviation|7.1|7.1|||
4397770|NCT00276016|4224875|B4|||Age, Customized||years|Mean|26.3|26.3|Standard Deviation|1.6|1.6|||
4397771|NCT00276016|4224876|B3|||Age, Customized||years|Mean|24.9|24.9|Standard Deviation|3.5|3.5|||
4397772|NCT00276016|4224877|B2|||Age, Customized||years|Mean|27.9|27.9|Standard Deviation|3.3|3.3|||
4397773|NCT00276016|4224878|B1|||Age, Customized||years|Mean|27.9|27.9|Standard Deviation|9.0|9.0|||
4397774|NCT00275834|4224892|B4|United States||Region of Enrollment||participants|Number|225|225.0||||||
4397775|NCT00275834|4224893|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4397776|NCT00275834|4224894|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4397777|NCT00275834|4224895|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
4397778|NCT00275834|4224892|B4||Male|Gender||Participants|Count of Participants|91|91.0||||||
4397779|NCT00275834|4224893|B3||Male|Gender||Participants|Count of Participants|30|30.0||||||
4397780|NCT00275834|4224894|B2||Male|Gender||Participants|Count of Participants|31|31.0||||||
4397781|NCT00275834|4224895|B1||Male|Gender||Participants|Count of Participants|30|30.0||||||
4397782|NCT00275834|4224892|B4||Female|Gender||Participants|Count of Participants|134|134.0||||||
4397783|NCT00275834|4224893|B3||Female|Gender||Participants|Count of Participants|45|45.0||||||
4397784|NCT00275834|4224894|B2||Female|Gender||Participants|Count of Participants|45|45.0||||||
4397785|NCT00275834|4224895|B1||Female|Gender||Participants|Count of Participants|44|44.0||||||
4397786|NCT00275834|4224892|B4|||Age||years|Mean|43.4|43.4|Standard Deviation|10.1|10.1|||
4397787|NCT00275834|4224893|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|10.0|10.0|||
4397788|NCT00275834|4224894|B2|||Age||years|Mean|44.2|44.2|Standard Deviation|10.1|10.1|||
4397789|NCT00275834|4224895|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|10.3|10.3|||
4397790|NCT00275834|4224892|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397791|NCT00275834|4224893|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397792|NCT00275834|4224894|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397793|NCT00275834|4224895|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397794|NCT00275834|4224892|B4||Between 18 and 65 years|Age||Participants|Count of Participants|225|225.0||||||
4397795|NCT00275834|4224893|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4397796|NCT00275834|4224894|B2||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4397797|NCT00275834|4224895|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4397798|NCT00275834|4224892|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397799|NCT00275834|4224893|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397800|NCT00275834|4224894|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397801|NCT00275834|4224895|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397802|NCT00275821|4224926|B4||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4397803|NCT00275821|4224927|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4397804|NCT00275821|4224928|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4397805|NCT00275821|4224929|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4397806|NCT00275821|4224926|B4||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4397807|NCT00275821|4224927|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4397808|NCT00275821|4224928|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4397809|NCT00275821|4224929|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4397810|NCT00275821|4224926|B4|≥ 85||Age, Customized||Participants|Number|29|29.0||||||
4397811|NCT00275821|4224927|B3|≥ 85||Age, Customized||Participants|Number|14|14.0||||||
4397812|NCT00275821|4224928|B2|≥ 85||Age, Customized||Participants|Number|6|6.0||||||
4397813|NCT00275821|4224929|B1|≥ 85||Age, Customized||Participants|Number|9|9.0||||||
4397814|NCT00275821|4224926|B4|75 - < 85||Age, Customized||Participants|Number|179|179.0||||||
4397815|NCT00275821|4224927|B3|75 - < 85||Age, Customized||Participants|Number|46|46.0||||||
4397816|NCT00275821|4224928|B2|75 - < 85||Age, Customized||Participants|Number|72|72.0||||||
4397817|NCT00275821|4224929|B1|75 - < 85||Age, Customized||Participants|Number|61|61.0||||||
4397818|NCT00275821|4224926|B4|65 - < 75||Age, Customized||Participants|Number|110|110.0||||||
4397819|NCT00275821|4224927|B3|65 - < 75||Age, Customized||Participants|Number|45|45.0||||||
4397820|NCT00275821|4224928|B2|65 - < 75||Age, Customized||Participants|Number|28|28.0||||||
4397821|NCT00275821|4224929|B1|65 - < 75||Age, Customized||Participants|Number|37|37.0||||||
4397822|NCT00275821|4224926|B4|50 - < 65||Age, Customized||Participants|Number|35|35.0||||||
4397823|NCT00275821|4224927|B3|50 - < 65||Age, Customized||Participants|Number|10|10.0||||||
4397824|NCT00275821|4224928|B2|50 - < 65||Age, Customized||Participants|Number|12|12.0||||||
4397825|NCT00275821|4224929|B1|50 - < 65||Age, Customized||Participants|Number|13|13.0||||||
4397826|NCT00275561|4224948|B3|||Mean Esophageal Eosinophil Count||eosinophils/high powered field|Mean|40|40.0|Full Range|||8.0|100.0|
4397827|NCT00275561|4224949|B2|||Mean Esophageal Eosinophil Count||eosinophils/high powered field|Mean|40|40.0|Full Range|||20.0|80.0|
4397828|NCT00275561|4224950|B1|||Mean Esophageal Eosinophil Count||eosinophils/high powered field|Mean|40|40.0|Full Range|||8.0|100.0|
4397829|NCT00275561|4224948|B3|Participants without Food Impaction||Food Impaction > 5 minutes|Food stuck and unable to swallow liquids for >5 minutes|participants|Number|9|9.0||||||
4397830|NCT00275561|4224949|B2|Participants without Food Impaction||Food Impaction > 5 minutes|Food stuck and unable to swallow liquids for >5 minutes|participants|Number|4|4.0||||||
4397831|NCT00275561|4224950|B1|Participants without Food Impaction||Food Impaction > 5 minutes|Food stuck and unable to swallow liquids for >5 minutes|participants|Number|5|5.0||||||
4397832|NCT00275561|4224948|B3|Participants with Food Impaction||Food Impaction > 5 minutes|Food stuck and unable to swallow liquids for >5 minutes|participants|Number|33|33.0||||||
4397833|NCT00275561|4224949|B2|Participants with Food Impaction||Food Impaction > 5 minutes|Food stuck and unable to swallow liquids for >5 minutes|participants|Number|17|17.0||||||
4397834|NCT00275561|4224950|B1|Participants with Food Impaction||Food Impaction > 5 minutes|Food stuck and unable to swallow liquids for >5 minutes|participants|Number|16|16.0||||||
4397835|NCT00275561|4224948|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4397836|NCT00275561|4224949|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4397837|NCT00275561|4224950|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4397838|NCT00275561|4224948|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4397839|NCT00275561|4224949|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4397840|NCT00275561|4224950|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4397841|NCT00275561|4224948|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4397842|NCT00275561|4224949|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4397843|NCT00275561|4224950|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4397844|NCT00275561|4224948|B3|||Age||years|Mean|37.5|37.5|Full Range|||19.0|59.0|
4397845|NCT00275561|4224949|B2|||Age||years|Mean|35|35.0|Full Range|||20.0|57.0|
4397846|NCT00275561|4224950|B1|||Age||years|Mean|37.5|37.5|Full Range|||19.0|59.0|
4397847|NCT00275509|4224961|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4397848|NCT00275509|4224962|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4397849|NCT00275509|4224963|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4397850|NCT00275509|4224961|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4397851|NCT00275509|4224962|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4397852|NCT00275509|4224963|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4397853|NCT00275509|4224961|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4397854|NCT00275509|4224962|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4397855|NCT00275509|4224963|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4397856|NCT00275509|4224961|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|13.0|13.0|||
4397857|NCT00275509|4224962|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|15.4|15.4|||
4397858|NCT00275509|4224963|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|10.6|10.6|||
4397859|NCT00275392|4224974|B3|||Dynamic Visual Acuity|Visual acuity during head movement (dynamic visual acuity, DVA) was measured using customized computerized software. Participants identified letters while turning the head from side to side between 120 and 180 deg/s. DVA, the difference in acuity between head stationary and moving, is reported as the average of rightward and leftward scores; higher scores indicate worse visual acuity (0.00 LogMAR = 20/20).|LogMAR|Mean|0.16|0.16|Standard Deviation|0.08|0.08|||
4397860|NCT00275392|4224975|B2|||Dynamic Visual Acuity|Visual acuity during head movement (dynamic visual acuity, DVA) was measured using customized computerized software. Participants identified letters while turning the head from side to side between 120 and 180 deg/s. DVA, the difference in acuity between head stationary and moving, is reported as the average of rightward and leftward scores; higher scores indicate worse visual acuity (0.00 LogMAR = 20/20).|LogMAR|Mean|0.14|0.14|Standard Deviation|0.07|0.07|||
4397861|NCT00275392|4224976|B1|||Dynamic Visual Acuity|Visual acuity during head movement (dynamic visual acuity, DVA) was measured using customized computerized software. Participants identified letters while turning the head from side to side between 120 and 180 deg/s. DVA, the difference in acuity between head stationary and moving, is reported as the average of rightward and leftward scores; higher scores indicate worse visual acuity (0.00 LogMAR = 20/20).|LogMAR|Mean|0.20|0.2|Standard Deviation|0.08|0.08|||
4397862|NCT00275392|4224974|B3|||Dynamic Gait Index|The Dynamic Gait Index (DGI) measures the ability to adapt gait to external demands and also is used to assess fall risk while walking. The eight items of the DGI include walking while changing speed and turning the head, walking over and around obstacles, and stair climbing. Scoring of the DGI is based on a 4-point scale from 0 to 3 with 0 indicating severe impairment and 3 indicating normal ability. A maximum total score of 24 is possible and scores of < 20 indicate risk for falling.|units on a scale|Mean|15.1|15.1|Standard Deviation|3.0|3.0|||
4397863|NCT00275392|4224975|B2|||Dynamic Gait Index|The Dynamic Gait Index (DGI) measures the ability to adapt gait to external demands and also is used to assess fall risk while walking. The eight items of the DGI include walking while changing speed and turning the head, walking over and around obstacles, and stair climbing. Scoring of the DGI is based on a 4-point scale from 0 to 3 with 0 indicating severe impairment and 3 indicating normal ability. A maximum total score of 24 is possible and scores of < 20 indicate risk for falling.|units on a scale|Mean|16.1|16.1|Standard Deviation|2.6|2.6|||
4397864|NCT00275392|4224976|B1|||Dynamic Gait Index|The Dynamic Gait Index (DGI) measures the ability to adapt gait to external demands and also is used to assess fall risk while walking. The eight items of the DGI include walking while changing speed and turning the head, walking over and around obstacles, and stair climbing. Scoring of the DGI is based on a 4-point scale from 0 to 3 with 0 indicating severe impairment and 3 indicating normal ability. A maximum total score of 24 is possible and scores of < 20 indicate risk for falling.|units on a scale|Mean|14.2|14.2|Standard Deviation|3.1|3.1|||
4397865|NCT00275392|4224974|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4397866|NCT00275392|4224975|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4397867|NCT00275392|4224976|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4397868|NCT00275392|4224974|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4397869|NCT00275392|4224975|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4397870|NCT00275392|4224976|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4397871|NCT00275392|4224974|B3|||Age||years|Mean|73.8|73.8|Standard Deviation|7.5|7.5|||
4397872|NCT00275392|4224975|B2|||Age||years|Mean|74.5|74.5|Standard Deviation|8.5|8.5|||
4397873|NCT00275392|4224976|B1|||Age||years|Mean|73.6|73.6|Standard Deviation|6.5|6.5|||
4397874|NCT00275340|4224985|B3|Physical Component Score||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|40.6|40.6|Standard Deviation|11.1|11.1|||
4397875|NCT00275340|4224986|B2|Physical Component Score||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|40.5|40.5|Standard Deviation|11.3|11.3|||
4397876|NCT00275340|4224987|B1|Physical Component Score||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|41.2|41.2|Standard Deviation|11.0|11.0|||
4397915|NCT00275340|4224987|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4397877|NCT00275340|4224985|B3|General Health||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|64.6|64.6|Standard Deviation|19.8|19.8|||
4397878|NCT00275340|4224986|B2|General Health||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|64.1|64.1|Standard Deviation|21.5|21.5|||
4397879|NCT00275340|4224987|B1|General Health||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|65.3|65.3|Standard Deviation|18.8|18.8|||
4397880|NCT00275340|4224985|B3|Bodily Pain||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|67.1|67.1|Standard Deviation|27.7|27.7|||
4397881|NCT00275340|4224986|B2|Bodily Pain||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|70.4|70.4|Standard Deviation|25.9|25.9|||
4397882|NCT00275340|4224987|B1|Bodily Pain||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|64.4|64.4|Standard Deviation|29.0|29.0|||
4397883|NCT00275340|4224985|B3|Role-Physical||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|40.3|40.3|Standard Deviation|31.6|31.6|||
4397884|NCT00275340|4224986|B2|Role-Physical||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|37.6|37.6|Standard Deviation|30.8|30.8|||
4397885|NCT00275340|4224987|B1|Role-Physical||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|44.3|44.3|Standard Deviation|32.4|32.4|||
4397886|NCT00275340|4224985|B3|Physical Function||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|54.7|54.7|Standard Deviation|29.8|29.8|||
4397887|NCT00275340|4224986|B2|Physical Function||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|54.4|54.4|Standard Deviation|31.7|31.7|||
4397888|NCT00275340|4224987|B1|Physical Function||Health-Related Quality of Life (SF-36v2-Acute Form)|The SF-36v2 yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state.|units on a scale|Mean|57.0|57.0|Standard Deviation|27.7|27.7|||
4397889|NCT00275340|4224985|B3|No Response||Marital Status||participants|Number|1|1.0||||||
4397890|NCT00275340|4224986|B2|No Response||Marital Status||participants|Number|0|0.0||||||
4397891|NCT00275340|4224987|B1|No Response||Marital Status||participants|Number|1|1.0||||||
4397892|NCT00275340|4224985|B3|Divorced/Widow/Single||Marital Status||participants|Number|20|20.0||||||
4397893|NCT00275340|4224986|B2|Divorced/Widow/Single||Marital Status||participants|Number|7|7.0||||||
4397894|NCT00275340|4224987|B1|Divorced/Widow/Single||Marital Status||participants|Number|13|13.0||||||
4397895|NCT00275340|4224985|B3|Married||Marital Status||participants|Number|80|80.0||||||
4397896|NCT00275340|4224986|B2|Married||Marital Status||participants|Number|42|42.0||||||
4397897|NCT00275340|4224987|B1|Married||Marital Status||participants|Number|38|38.0||||||
4397898|NCT00275340|4224985|B3|No Response||Left Ventricular Function||Participants|Number|1|1.0||||||
4397899|NCT00275340|4224986|B2|No Response||Left Ventricular Function||Participants|Number|0|0.0||||||
4397900|NCT00275340|4224987|B1|No Response||Left Ventricular Function||Participants|Number|1|1.0||||||
4397901|NCT00275340|4224985|B3|Grade 4 (worst)||Left Ventricular Function||Participants|Number|0|0.0||||||
4397902|NCT00275340|4224986|B2|Grade 4 (worst)||Left Ventricular Function||Participants|Number|0|0.0||||||
4397903|NCT00275340|4224987|B1|Grade 4 (worst)||Left Ventricular Function||Participants|Number|0|0.0||||||
4397904|NCT00275340|4224985|B3|Grade 3||Left Ventricular Function||Participants|Number|9|9.0||||||
4397905|NCT00275340|4224986|B2|Grade 3||Left Ventricular Function||Participants|Number|5|5.0||||||
4397906|NCT00275340|4224987|B1|Grade 3||Left Ventricular Function||Participants|Number|4|4.0||||||
4397907|NCT00275340|4224985|B3|Grade 2||Left Ventricular Function||Participants|Number|39|39.0||||||
4397908|NCT00275340|4224986|B2|Grade 2||Left Ventricular Function||Participants|Number|24|24.0||||||
4397909|NCT00275340|4224987|B1|Grade 2||Left Ventricular Function||Participants|Number|15|15.0||||||
4397910|NCT00275340|4224985|B3|Grade 1 (normal)||Left Ventricular Function||Participants|Number|52|52.0||||||
4397911|NCT00275340|4224986|B2|Grade 1 (normal)||Left Ventricular Function||Participants|Number|20|20.0||||||
4397912|NCT00275340|4224987|B1|Grade 1 (normal)||Left Ventricular Function||Participants|Number|32|32.0||||||
4397913|NCT00275340|4224985|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4397914|NCT00275340|4224986|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4397916|NCT00275340|4224985|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4397917|NCT00275340|4224986|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4397918|NCT00275340|4224987|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4397919|NCT00275340|4224985|B3|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4397920|NCT00275340|4224986|B2|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
4397921|NCT00275340|4224987|B1|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4397922|NCT00275301|4224992|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4397923|NCT00275301|4224992|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4397924|NCT00275301|4224992|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4397925|NCT00275301|4224992|B1|||Age||years|Mean|26.4|26.4|Standard Deviation|7.56|7.56|||
4397926|NCT00275301|4224992|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397927|NCT00275301|4224992|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4397928|NCT00275301|4224992|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397929|NCT00275275|4224996|B4|United States||Region of Enrollment||participants|Number|61|61.0||||||
4397930|NCT00275275|4224997|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4397931|NCT00275275|4224998|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4397932|NCT00275275|4224999|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4397933|NCT00275275|4224996|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4397934|NCT00275275|4224997|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4397935|NCT00275275|4224998|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4397936|NCT00275275|4224999|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4397937|NCT00275275|4224996|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4397938|NCT00275275|4224997|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4397939|NCT00275275|4224998|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4397940|NCT00275275|4224999|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4397941|NCT00275275|4224996|B4|||Age||years|Mean|64.7|64.7|Standard Deviation|9.7|9.7|||
4397942|NCT00275275|4224997|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|9.7|9.7|||
4397943|NCT00275275|4224998|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|9.7|9.7|||
4397944|NCT00275275|4224999|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|10.1|10.1|||
4397945|NCT00275262|4225009|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4397946|NCT00275262|4225010|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4397947|NCT00275262|4225011|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4397948|NCT00275262|4225009|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4397949|NCT00275262|4225010|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4397950|NCT00275262|4225011|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4397951|NCT00275262|4225009|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4397952|NCT00275262|4225010|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4397953|NCT00275262|4225011|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4397954|NCT00275262|4225009|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|8.53|8.53|||
4397955|NCT00275262|4225010|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|7.04|7.04|||
4397956|NCT00275262|4225011|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|10.16|10.16|||
4397957|NCT00275262|4225009|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397958|NCT00275262|4225010|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397959|NCT00275262|4225011|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4397960|NCT00275262|4225009|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4397961|NCT00275262|4225010|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4397962|NCT00275262|4225011|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4397963|NCT00275262|4225009|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397964|NCT00275262|4225010|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397965|NCT00275262|4225011|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4397966|NCT00275028|4225026|B1|No||Prior History of Hypertension||participants|Number|40|40.0||||||
4397967|NCT00275028|4225026|B1|Yes||Prior History of Hypertension||participants|Number|6|6.0||||||
4397968|NCT00275028|4225026|B1|2||Number of Prior Therapies for Recurrent Cancer||participants|Number|5|5.0||||||
4397969|NCT00275028|4225026|B1|1||Number of Prior Therapies for Recurrent Cancer||participants|Number|22|22.0||||||
4397970|NCT00275028|4225026|B1|0||Number of Prior Therapies for Recurrent Cancer||participants|Number|19|19.0||||||
4397971|NCT00275028|4225026|B1|CA-125||Response Assessment|Refers to how the participants were followed for progression from baseline onward.|participants|Number|10|10.0||||||
4397972|NCT00275028|4225026|B1|RECIST||Response Assessment|Refers to how the participants were followed for progression from baseline onward.|participants|Number|36|36.0||||||
4397973|NCT00275028|4225026|B1|3||Tumor grade||participants|Number|39|39.0||||||
4397974|NCT00275028|4225026|B1|2-3||Tumor grade||participants|Number|6|6.0||||||
4397975|NCT00275028|4225026|B1|2||Tumor grade||participants|Number|0|0.0||||||
4397976|NCT00275028|4225026|B1|1||Tumor grade||participants|Number|1|1.0||||||
4398035|NCT00274924|4225054|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4397977|NCT00275028|4225026|B1|1||ECOG PS|"Eastern Cooperative Oncology Group Performance Status (ECOG PS)~0 - Normal activity.~- Symptoms, but ambulatory.~- In bed <50% of the time.~- In bed >50% of the time.~- 100% bed ridden.~- Dead."|participants|Number|12|12.0||||||
4397978|NCT00275028|4225026|B1|0||ECOG PS|"Eastern Cooperative Oncology Group Performance Status (ECOG PS)~0 - Normal activity.~- Symptoms, but ambulatory.~- In bed <50% of the time.~- In bed >50% of the time.~- 100% bed ridden.~- Dead."|participants|Number|34|34.0||||||
4397979|NCT00275028|4225026|B1|Mixed type or other||Histologic Subtype||participants|Number|4|4.0||||||
4397980|NCT00275028|4225026|B1|Clear cell||Histologic Subtype||participants|Number|3|3.0||||||
4397981|NCT00275028|4225026|B1|Endometrioid||Histologic Subtype||participants|Number|1|1.0||||||
4397982|NCT00275028|4225026|B1|Papillary serous||Histologic Subtype||participants|Number|38|38.0||||||
4397983|NCT00275028|4225026|B1|Peritoneal cancer||Primary Cancer Diagnosis||participants|Number|5|5.0||||||
4397984|NCT00275028|4225026|B1|Fallopian tube cancer||Primary Cancer Diagnosis||participants|Number|1|1.0||||||
4397985|NCT00275028|4225026|B1|Ovarian cancer||Primary Cancer Diagnosis||participants|Number|40|40.0||||||
4397986|NCT00275028|4225026|B1|Platinum Resistant||Platinum Sensitivity||participants|Number|30|30.0||||||
4397987|NCT00275028|4225026|B1|Platinum Sensitive||Platinum Sensitivity||participants|Number|16|16.0||||||
4397988|NCT00275028|4225026|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4397989|NCT00275028|4225026|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4397990|NCT00275028|4225026|B1|White (non-Hispanic)||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4397991|NCT00275028|4225026|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4397992|NCT00275028|4225026|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4397993|NCT00275028|4225026|B1|||Age||years|Median|56.5|56.5|Full Range|||41.0|78.0|
4397994|NCT00275002|4225031|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4397995|NCT00275002|4225032|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4397996|NCT00275002|4225033|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4397997|NCT00275002|4225031|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4397998|NCT00275002|4225032|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4397999|NCT00275002|4225033|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4398000|NCT00275002|4225031|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4398001|NCT00275002|4225032|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4398002|NCT00275002|4225033|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4398003|NCT00275002|4225031|B3|||Age||years|Mean|11.2|11.2|Standard Deviation|5.4|5.4|||
4398004|NCT00275002|4225032|B2|||Age||years|Mean|7.8|7.8|Standard Deviation|3.9|3.9|||
4398005|NCT00275002|4225033|B1|||Age||years|Mean|13.4|13.4|Standard Deviation|5.1|5.1|||
4398006|NCT00275002|4225031|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398007|NCT00275002|4225032|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398008|NCT00275002|4225033|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398009|NCT00275002|4225031|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4398010|NCT00275002|4225032|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4398011|NCT00275002|4225033|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4398012|NCT00275002|4225031|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4398013|NCT00275002|4225032|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4398014|NCT00275002|4225033|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4398015|NCT00274937|4225042|B1|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
4398016|NCT00274937|4225042|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4398017|NCT00274937|4225042|B1|United States||Region of Enrollment||participants|Number|107|107.0||||||
4398018|NCT00274937|4225042|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4398019|NCT00274937|4225042|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4398020|NCT00274937|4225042|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398021|NCT00274937|4225042|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4398022|NCT00274937|4225042|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4398023|NCT00274937|4225042|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4398024|NCT00274937|4225042|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4398025|NCT00274937|4225042|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4398026|NCT00274937|4225042|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4398027|NCT00274937|4225042|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4398028|NCT00274937|4225042|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4398029|NCT00274937|4225042|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4398030|NCT00274937|4225042|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4398031|NCT00274937|4225042|B1|||Age||Participants|Mean|13.8|13.8|Standard Deviation|2.9|2.9|||
4398032|NCT00274924|4225051|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4398033|NCT00274924|4225052|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4398034|NCT00274924|4225053|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4398036|NCT00274924|4225051|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4398037|NCT00274924|4225052|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4398038|NCT00274924|4225053|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4398039|NCT00274924|4225054|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4398040|NCT00274924|4225051|B4|||Age||years|Median|62|62.0|Full Range|||20.0|74.0|
4398041|NCT00274924|4225052|B3|||Age||years|Median|54|54.0|Full Range|||33.0|60.0|
4398042|NCT00274924|4225053|B2|||Age||years|Median|63|63.0|Full Range|||36.0|74.0|
4398043|NCT00274924|4225054|B1|||Age||years|Median|61|61.0|Full Range|||20.0|70.0|
4398044|NCT00274846|4225065|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4398045|NCT00274846|4225065|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4398046|NCT00274846|4225065|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4398047|NCT00274846|4225065|B1|||Age||years|Mean|40|40.0|Standard Deviation|18.8|18.8|||
4398048|NCT00274846|4225065|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4398049|NCT00274846|4225065|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4398050|NCT00274846|4225065|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4398051|NCT00274781|4225073|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4398052|NCT00274781|4225073|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4398053|NCT00274781|4225073|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4398054|NCT00274781|4225073|B1|||Age||years|Median|69|69.0|Full Range|||44.0|88.0|
4398055|NCT00274768|4225079|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4398056|NCT00274768|4225079|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398057|NCT00274768|4225079|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4398058|NCT00274768|4225079|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4398059|NCT00274768|4225079|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4398060|NCT00274768|4225079|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398061|NCT00274742|4225083|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398062|NCT00274742|4225084|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398063|NCT00274742|4225085|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398064|NCT00274742|4225086|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398065|NCT00274742|4225087|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398066|NCT00274742|4225088|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398067|NCT00274742|4225089|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398068|NCT00274742|4225083|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398069|NCT00274742|4225084|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398070|NCT00274742|4225085|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398071|NCT00274742|4225086|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398072|NCT00274742|4225087|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398073|NCT00274742|4225088|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398074|NCT00274742|4225089|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398075|NCT00274742|4225083|B7||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4398076|NCT00274742|4225084|B6||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4398077|NCT00274742|4225085|B5||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4398078|NCT00274742|4225086|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4398079|NCT00274742|4225087|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4398080|NCT00274742|4225088|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4398081|NCT00274742|4225089|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4398082|NCT00274742|4225083|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398083|NCT00274742|4225084|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398084|NCT00274742|4225085|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398085|NCT00274742|4225086|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398086|NCT00274742|4225087|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398087|NCT00274742|4225088|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398088|NCT00274742|4225089|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398089|NCT00274742|4225083|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398090|NCT00274742|4225084|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398091|NCT00274742|4225085|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398092|NCT00274742|4225086|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398093|NCT00274742|4225087|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398094|NCT00274742|4225088|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398095|NCT00274742|4225089|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398096|NCT00274742|4225083|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398097|NCT00274742|4225084|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398098|NCT00274742|4225085|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398099|NCT00274742|4225086|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398100|NCT00274742|4225087|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398101|NCT00274742|4225088|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398102|NCT00274742|4225089|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398103|NCT00274742|4225083|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398104|NCT00274742|4225084|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398105|NCT00274742|4225085|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398106|NCT00274742|4225086|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398107|NCT00274742|4225087|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398108|NCT00274742|4225088|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398109|NCT00274742|4225089|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398110|NCT00274742|4225083|B7||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4398111|NCT00274742|4225084|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4398112|NCT00274742|4225085|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4398113|NCT00274742|4225086|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4398114|NCT00274742|4225087|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4398115|NCT00274742|4225088|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4398116|NCT00274742|4225089|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4398117|NCT00274742|4225083|B7||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4398118|NCT00274742|4225084|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4398119|NCT00274742|4225085|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4398120|NCT00274742|4225086|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398121|NCT00274742|4225087|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4398122|NCT00274742|4225088|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4398123|NCT00274742|4225089|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4398124|NCT00274742|4225083|B7|||Age||years|Mean|60.3|60.3|Standard Deviation|12.4|12.4|||
4398125|NCT00274742|4225084|B6|||Age||years|Mean|64.8|64.8|Standard Deviation|5.6|5.6|||
4398126|NCT00274742|4225085|B5|||Age||years|Mean|57.1|57.1|Standard Deviation|14.9|14.9|||
4398127|NCT00274742|4225086|B4|||Age||years|Mean|59.7|59.7|Standard Deviation|11.9|11.9|||
4398128|NCT00274742|4225087|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|9.4|9.4|||
4398129|NCT00274742|4225088|B2|||Age||years|Mean|64.8|64.8|Standard Deviation|8.0|8.0|||
4398130|NCT00274742|4225089|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|7.5|7.5|||
4398131|NCT00274716|4225126|B7||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4398132|NCT00274716|4225127|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4398133|NCT00274716|4225128|B5||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4398134|NCT00274716|4225129|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4398135|NCT00274716|4225130|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4398136|NCT00274716|4225131|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4398137|NCT00274716|4225132|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4398138|NCT00274716|4225126|B7||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4398139|NCT00274716|4225127|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4398140|NCT00274716|4225128|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4398141|NCT00274716|4225129|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4398142|NCT00274716|4225130|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4398143|NCT00274716|4225131|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4398144|NCT00274716|4225132|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4398145|NCT00274716|4225126|B7|>70 years||Age, Customized||Participants|Number|2|2.0||||||
4398146|NCT00274716|4225127|B6|>70 years||Age, Customized||Participants|Number|0|0.0||||||
4398147|NCT00274716|4225128|B5|>70 years||Age, Customized||Participants|Number|0|0.0||||||
4398148|NCT00274716|4225129|B4|>70 years||Age, Customized||Participants|Number|0|0.0||||||
4398149|NCT00274716|4225130|B3|>70 years||Age, Customized||Participants|Number|0|0.0||||||
4398150|NCT00274716|4225131|B2|>70 years||Age, Customized||Participants|Number|1|1.0||||||
4398151|NCT00274716|4225132|B1|>70 years||Age, Customized||Participants|Number|1|1.0||||||
4398152|NCT00274716|4225126|B7|61 to 70 years||Age, Customized||Participants|Number|61|61.0||||||
4398153|NCT00274716|4225127|B6|61 to 70 years||Age, Customized||Participants|Number|6|6.0||||||
4398154|NCT00274716|4225128|B5|61 to 70 years||Age, Customized||Participants|Number|4|4.0||||||
4398155|NCT00274716|4225129|B4|61 to 70 years||Age, Customized||Participants|Number|13|13.0||||||
4398156|NCT00274716|4225130|B3|61 to 70 years||Age, Customized||Participants|Number|12|12.0||||||
4398157|NCT00274716|4225131|B2|61 to 70 years||Age, Customized||Participants|Number|12|12.0||||||
4398158|NCT00274716|4225132|B1|61 to 70 years||Age, Customized||Participants|Number|14|14.0||||||
4398159|NCT00274716|4225126|B7|51 to 60 years||Age, Customized||Participants|Number|101|101.0||||||
4398160|NCT00274716|4225127|B6|51 to 60 years||Age, Customized||Participants|Number|9|9.0||||||
4398161|NCT00274716|4225128|B5|51 to 60 years||Age, Customized||Participants|Number|9|9.0||||||
4398162|NCT00274716|4225129|B4|51 to 60 years||Age, Customized||Participants|Number|17|17.0||||||
4398163|NCT00274716|4225130|B3|51 to 60 years||Age, Customized||Participants|Number|20|20.0||||||
4398164|NCT00274716|4225131|B2|51 to 60 years||Age, Customized||Participants|Number|20|20.0||||||
4398165|NCT00274716|4225132|B1|51 to 60 years||Age, Customized||Participants|Number|26|26.0||||||
4398166|NCT00274716|4225126|B7|41 to 50 years||Age, Customized||Participants|Number|71|71.0||||||
4398167|NCT00274716|4225127|B6|41 to 50 years||Age, Customized||Participants|Number|4|4.0||||||
4398168|NCT00274716|4225128|B5|41 to 50 years||Age, Customized||Participants|Number|6|6.0||||||
4398169|NCT00274716|4225129|B4|41 to 50 years||Age, Customized||Participants|Number|14|14.0||||||
4398170|NCT00274716|4225130|B3|41 to 50 years||Age, Customized||Participants|Number|20|20.0||||||
4398171|NCT00274716|4225131|B2|41 to 50 years||Age, Customized||Participants|Number|17|17.0||||||
4398172|NCT00274716|4225132|B1|41 to 50 years||Age, Customized||Participants|Number|10|10.0||||||
4398173|NCT00274716|4225126|B7|31 to 40 years||Age, Customized||Participants|Number|12|12.0||||||
4398174|NCT00274716|4225127|B6|31 to 40 years||Age, Customized||Participants|Number|0|0.0||||||
4398175|NCT00274716|4225128|B5|31 to 40 years||Age, Customized||Participants|Number|0|0.0||||||
4398176|NCT00274716|4225129|B4|31 to 40 years||Age, Customized||Participants|Number|6|6.0||||||
4398177|NCT00274716|4225130|B3|31 to 40 years||Age, Customized||Participants|Number|0|0.0||||||
4398178|NCT00274716|4225131|B2|31 to 40 years||Age, Customized||Participants|Number|3|3.0||||||
4398179|NCT00274716|4225132|B1|31 to 40 years||Age, Customized||Participants|Number|3|3.0||||||
4398180|NCT00274716|4225126|B7|21 to 30 years||Age, Customized||Participants|Number|2|2.0||||||
4398181|NCT00274716|4225127|B6|21 to 30 years||Age, Customized||Participants|Number|0|0.0||||||
4398182|NCT00274716|4225128|B5|21 to 30 years||Age, Customized||Participants|Number|0|0.0||||||
4398183|NCT00274716|4225129|B4|21 to 30 years||Age, Customized||Participants|Number|1|1.0||||||
4398184|NCT00274716|4225130|B3|21 to 30 years||Age, Customized||Participants|Number|0|0.0||||||
4398185|NCT00274716|4225131|B2|21 to 30 years||Age, Customized||Participants|Number|1|1.0||||||
4398186|NCT00274716|4225132|B1|21 to 30 years||Age, Customized||Participants|Number|0|0.0||||||
4398187|NCT00274651|4225197|B3|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4398188|NCT00274651|4225198|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4398189|NCT00274651|4225199|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4398190|NCT00274651|4225197|B3|Thailand||Region of Enrollment||participants|Number|8|8.0||||||
4398191|NCT00274651|4225198|B2|Thailand||Region of Enrollment||participants|Number|6|6.0||||||
4398192|NCT00274651|4225199|B1|Thailand||Region of Enrollment||participants|Number|2|2.0||||||
4398193|NCT00274651|4225197|B3|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4398194|NCT00274651|4225198|B2|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4398195|NCT00274651|4225199|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4398196|NCT00274651|4225197|B3|France||Region of Enrollment||participants|Number|2|2.0||||||
4398197|NCT00274651|4225198|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4398198|NCT00274651|4225199|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4398199|NCT00274651|4225197|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4398200|NCT00274651|4225198|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4398201|NCT00274651|4225199|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4398202|NCT00274651|4225197|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4398203|NCT00274651|4225198|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4398204|NCT00274651|4225199|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4398205|NCT00274651|4225197|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4398206|NCT00274651|4225198|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4398207|NCT00274651|4225199|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4398208|NCT00274651|4225197|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4398209|NCT00274651|4225198|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4398210|NCT00274651|4225199|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4398211|NCT00274651|4225197|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4398212|NCT00274651|4225198|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4398213|NCT00274651|4225199|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4398214|NCT00274651|4225197|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398215|NCT00274651|4225198|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398216|NCT00274651|4225199|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398217|NCT00274651|4225197|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|14.7|14.7|||
4398218|NCT00274651|4225198|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|15.9|15.9|||
4398219|NCT00274651|4225199|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|13.4|13.4|||
4398220|NCT00274625|4225213|B3|||BMI (Body mass index)||kg/m^2|Mean|48.2|48.2|Standard Deviation|7.9|7.9|||
4398221|NCT00274625|4225214|B2|||BMI (Body mass index)||kg/m^2|Mean|48.2|48.2|Standard Deviation|7.7|7.7|||
4398222|NCT00274625|4225215|B1|||BMI (Body mass index)||kg/m^2|Mean|48.2|48.2|Standard Deviation|8.2|8.2|||
4398223|NCT00274625|4225213|B3|||Weight||kg|Mean|140.6|140.6|Standard Deviation|32.2|32.2|||
4398224|NCT00274625|4225214|B2|||Weight||kg|Mean|143|143.0|Standard Deviation|34|34.0|||
4398225|NCT00274625|4225215|B1|||Weight||kg|Mean|138|138.0|Standard Deviation|30|30.0|||
4398226|NCT00274625|4225213|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4398227|NCT00274625|4225214|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4398228|NCT00274625|4225215|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4398229|NCT00274625|4225213|B3||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4398230|NCT00274625|4225214|B2||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4398231|NCT00274625|4225215|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4398232|NCT00274625|4225213|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|11.4|11.4|||
4398233|NCT00274625|4225214|B2|||Age||years|Mean|45.1|45.1|Standard Deviation|12.1|12.1|||
4398234|NCT00274625|4225215|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|10.6|10.6|||
4398235|NCT00274469|4225222|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398236|NCT00274469|4225223|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398237|NCT00274469|4225224|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398238|NCT00274469|4225222|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4398239|NCT00274469|4225223|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4398240|NCT00274469|4225224|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4398241|NCT00274469|4225222|B3|||Age||Years|Mean|67.1|67.1|Standard Deviation|9.1|9.1|||
4398242|NCT00274469|4225223|B2|||Age||Years|Mean|67.6|67.6|Standard Deviation|9.3|9.3|||
4398243|NCT00274469|4225224|B1|||Age||Years|Mean|66.6|66.6|Standard Deviation|9.0|9.0|||
4398244|NCT00274456|4225239|B5|>3 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|252|252.0||||||
4398245|NCT00274456|4225240|B4|>3 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|60|60.0||||||
4398246|NCT00274456|4225241|B3|>3 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|67|67.0||||||
4398247|NCT00274456|4225242|B2|>3 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|62|62.0||||||
4398248|NCT00274456|4225243|B1|>3 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|63|63.0||||||
4398249|NCT00274456|4225239|B5|2-3 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|40|40.0||||||
4398250|NCT00274456|4225240|B4|2-3 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|10|10.0||||||
4398251|NCT00274456|4225241|B3|2-3 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|6|6.0||||||
4398252|NCT00274456|4225242|B2|2-3 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|13|13.0||||||
4398253|NCT00274456|4225243|B1|2-3 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|11|11.0||||||
4398254|NCT00274456|4225239|B5|1 lesion||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|8|8.0||||||
4398255|NCT00274456|4225240|B4|1 lesion||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|4|4.0||||||
4398256|NCT00274456|4225241|B3|1 lesion||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|1|1.0||||||
4398257|NCT00274456|4225242|B2|1 lesion||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|1|1.0||||||
4398258|NCT00274456|4225243|B1|1 lesion||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|2|2.0||||||
4398259|NCT00274456|4225239|B5|0 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|0|0.0||||||
4398260|NCT00274456|4225240|B4|0 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|0|0.0||||||
4398261|NCT00274456|4225241|B3|0 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|0|0.0||||||
4398262|NCT00274456|4225242|B2|0 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|0|0.0||||||
4398263|NCT00274456|4225243|B1|0 lesions||Number of Lesions (Target + Non-Target)|Target lesions were selected on the basis of their size (those with the longest diameter) and their suitability for accurate repeat measurements (either by imaging techniques or clinically).|Participants|Number|0|0.0||||||
4398264|NCT00274456|4225239|B5|Unknown||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|10|10.0||||||
4398265|NCT00274456|4225240|B4|Unknown||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|3|3.0||||||
4398266|NCT00274456|4225241|B3|Unknown||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|3|3.0||||||
4398267|NCT00274456|4225242|B2|Unknown||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|1|1.0||||||
4398268|NCT00274456|4225243|B1|Unknown||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|3|3.0||||||
4398269|NCT00274456|4225239|B5|Stage IV||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|97|97.0||||||
4398270|NCT00274456|4225240|B4|Stage IV||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|21|21.0||||||
4398271|NCT00274456|4225241|B3|Stage IV||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|28|28.0||||||
4398272|NCT00274456|4225242|B2|Stage IV||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|25|25.0||||||
4398273|NCT00274456|4225243|B1|Stage IV||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|23|23.0||||||
4398274|NCT00274456|4225239|B5|Stage IIIc||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|3|3.0||||||
4398275|NCT00274456|4225240|B4|Stage IIIc||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|1|1.0||||||
4398276|NCT00274456|4225241|B3|Stage IIIc||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|0|0.0||||||
4398277|NCT00274456|4225242|B2|Stage IIIc||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|2|2.0||||||
4398278|NCT00274456|4225243|B1|Stage IIIc||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|0|0.0||||||
4398279|NCT00274456|4225239|B5|Stage IIIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|50|50.0||||||
4398280|NCT00274456|4225240|B4|Stage IIIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|13|13.0||||||
4398281|NCT00274456|4225241|B3|Stage IIIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|9|9.0||||||
4398282|NCT00274456|4225242|B2|Stage IIIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|14|14.0||||||
4398283|NCT00274456|4225243|B1|Stage IIIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|14|14.0||||||
4398284|NCT00274456|4225239|B5|Stage IIIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|34|34.0||||||
4398285|NCT00274456|4225240|B4|Stage IIIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|6|6.0||||||
4398329|NCT00274456|4225239|B5|Abdomen/Peritoneal||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|34|34.0||||||
4398330|NCT00274456|4225240|B4|Abdomen/Peritoneal||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|7|7.0||||||
4398286|NCT00274456|4225241|B3|Stage IIIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|7|7.0||||||
4398287|NCT00274456|4225242|B2|Stage IIIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|10|10.0||||||
4398288|NCT00274456|4225243|B1|Stage IIIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|11|11.0||||||
4398289|NCT00274456|4225239|B5|Stage IIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|47|47.0||||||
4398290|NCT00274456|4225240|B4|Stage IIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|15|15.0||||||
4398291|NCT00274456|4225241|B3|Stage IIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|13|13.0||||||
4398292|NCT00274456|4225242|B2|Stage IIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|7|7.0||||||
4398293|NCT00274456|4225243|B1|Stage IIb||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|12|12.0||||||
4398294|NCT00274456|4225239|B5|Stage IIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|48|48.0||||||
4398295|NCT00274456|4225240|B4|Stage IIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|13|13.0||||||
4398296|NCT00274456|4225241|B3|Stage IIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|11|11.0||||||
4398297|NCT00274456|4225242|B2|Stage IIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|13|13.0||||||
4398331|NCT00274456|4225241|B3|Abdomen/Peritoneal||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|4|4.0||||||
4398332|NCT00274456|4225242|B2|Abdomen/Peritoneal||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|11|11.0||||||
4398298|NCT00274456|4225243|B1|Stage IIa||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|11|11.0||||||
4398299|NCT00274456|4225239|B5|Stage I||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|11|11.0||||||
4398300|NCT00274456|4225240|B4|Stage I||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|2|2.0||||||
4398301|NCT00274456|4225241|B3|Stage I||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|3|3.0||||||
4398302|NCT00274456|4225242|B2|Stage I||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|4|4.0||||||
4398303|NCT00274456|4225243|B1|Stage I||Stage at Primary Diagnosis|"Invasive breast cancer stages:~Stage I-cancer cells are breaking through to or invading normal surrounding breast tissue.~Stage IIa-breast tumor about 2cm and involvement of ancillary lymph nodes.~Stage IIb-a larger tumor than earlier phases.~Stage IIIa-axillary lymph nodes clumping together.~Stage IIIb-spread further to the skin, breast bone or chest wall.~Stage IIIc-expanded involvement of lymph nodes.~Stage IV-cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body."|participants|Number|2|2.0||||||
4398304|NCT00274456|4225239|B5|Non-visceral||Dominant Current Site of Metastasis/Relapse||Participants|Number|49|49.0||||||
4398305|NCT00274456|4225240|B4|Non-visceral||Dominant Current Site of Metastasis/Relapse||Participants|Number|7|7.0||||||
4398306|NCT00274456|4225241|B3|Non-visceral||Dominant Current Site of Metastasis/Relapse||Participants|Number|15|15.0||||||
4398307|NCT00274456|4225242|B2|Non-visceral||Dominant Current Site of Metastasis/Relapse||Participants|Number|15|15.0||||||
4398308|NCT00274456|4225243|B1|Non-visceral||Dominant Current Site of Metastasis/Relapse||Participants|Number|12|12.0||||||
4398309|NCT00274456|4225239|B5|Visceral||Dominant Current Site of Metastasis/Relapse||Participants|Number|251|251.0||||||
4398310|NCT00274456|4225240|B4|Visceral||Dominant Current Site of Metastasis/Relapse||Participants|Number|67|67.0||||||
4398311|NCT00274456|4225241|B3|Visceral||Dominant Current Site of Metastasis/Relapse||Participants|Number|59|59.0||||||
4398312|NCT00274456|4225242|B2|Visceral||Dominant Current Site of Metastasis/Relapse||Participants|Number|61|61.0||||||
4398313|NCT00274456|4225243|B1|Visceral||Dominant Current Site of Metastasis/Relapse||Participants|Number|64|64.0||||||
4398314|NCT00274456|4225239|B5|Other||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|7|7.0||||||
4398315|NCT00274456|4225240|B4|Other||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|1|1.0||||||
4398316|NCT00274456|4225241|B3|Other||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|1|1.0||||||
4398317|NCT00274456|4225242|B2|Other||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|4|4.0||||||
4398318|NCT00274456|4225243|B1|Other||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|1|1.0||||||
4398319|NCT00274456|4225239|B5|Bone||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|105|105.0||||||
4398320|NCT00274456|4225240|B4|Bone||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|25|25.0||||||
4398321|NCT00274456|4225241|B3|Bone||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|33|33.0||||||
4398322|NCT00274456|4225242|B2|Bone||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|25|25.0||||||
4398323|NCT00274456|4225243|B1|Bone||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|22|22.0||||||
4398324|NCT00274456|4225239|B5|Pelvis||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|4|4.0||||||
4398325|NCT00274456|4225240|B4|Pelvis||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|1|1.0||||||
4398326|NCT00274456|4225241|B3|Pelvis||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|2|2.0||||||
4398327|NCT00274456|4225242|B2|Pelvis||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|1|1.0||||||
4398328|NCT00274456|4225243|B1|Pelvis||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|0|0.0||||||
4398333|NCT00274456|4225243|B1|Abdomen/Peritoneal||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|12|12.0||||||
4398334|NCT00274456|4225239|B5|Hepatic/Liver||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|97|97.0||||||
4398335|NCT00274456|4225240|B4|Hepatic/Liver||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|25|25.0||||||
4398336|NCT00274456|4225241|B3|Hepatic/Liver||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|23|23.0||||||
4398337|NCT00274456|4225242|B2|Hepatic/Liver||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|28|28.0||||||
4398338|NCT00274456|4225243|B1|Hepatic/Liver||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|21|21.0||||||
4398339|NCT00274456|4225239|B5|Lung/Thoracic||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|211|211.0||||||
4398340|NCT00274456|4225240|B4|Lung/Thoracic||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|58|58.0||||||
4398341|NCT00274456|4225241|B3|Lung/Thoracic||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|51|51.0||||||
4398342|NCT00274456|4225242|B2|Lung/Thoracic||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|49|49.0||||||
4398343|NCT00274456|4225243|B1|Lung/Thoracic||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|53|53.0||||||
4398344|NCT00274456|4225239|B5|Axilla||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|182|182.0||||||
4398345|NCT00274456|4225240|B4|Axilla||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|44|44.0||||||
4398346|NCT00274456|4225241|B3|Axilla||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|47|47.0||||||
4398347|NCT00274456|4225242|B2|Axilla||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|48|48.0||||||
4398348|NCT00274456|4225243|B1|Axilla||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|43|43.0||||||
4398349|NCT00274456|4225239|B5|Supraclavicular||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|93|93.0||||||
4398350|NCT00274456|4225240|B4|Supraclavicular||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|25|25.0||||||
4398351|NCT00274456|4225241|B3|Supraclavicular||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|20|20.0||||||
4398352|NCT00274456|4225242|B2|Supraclavicular||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|25|25.0||||||
4398353|NCT00274456|4225243|B1|Supraclavicular||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|23|23.0||||||
4398354|NCT00274456|4225239|B5|Skin/Soft Tissue||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|68|68.0||||||
4398355|NCT00274456|4225240|B4|Skin/Soft Tissue||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|19|19.0||||||
4398356|NCT00274456|4225241|B3|Skin/Soft Tissue||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|15|15.0||||||
4398357|NCT00274456|4225242|B2|Skin/Soft Tissue||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|18|18.0||||||
4398358|NCT00274456|4225243|B1|Skin/Soft Tissue||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|16|16.0||||||
4398359|NCT00274456|4225239|B5|Breast||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|42|42.0||||||
4398360|NCT00274456|4225240|B4|Breast||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|11|11.0||||||
4398361|NCT00274456|4225241|B3|Breast||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|11|11.0||||||
4398362|NCT00274456|4225242|B2|Breast||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|10|10.0||||||
4398363|NCT00274456|4225243|B1|Breast||Current Site of Metastasis/Relapse|Patients may have multiple sites of metastasis/relapse.|Participants|Number|10|10.0||||||
4398364|NCT00274456|4225239|B5|Time from First Metastasis/Relapse to Study Entry||Time from Primary Diagnosis and from First Metastasis/Relapse to Study Entry||Years|Median|0.04|0.04|Full Range|||0.0|8.2|
4398365|NCT00274456|4225240|B4|Time from First Metastasis/Relapse to Study Entry||Time from Primary Diagnosis and from First Metastasis/Relapse to Study Entry||Years|Median|0.04|0.04|Full Range|||0.0|2.6|
4398366|NCT00274456|4225241|B3|Time from First Metastasis/Relapse to Study Entry||Time from Primary Diagnosis and from First Metastasis/Relapse to Study Entry||Years|Median|0.05|0.05|Full Range|||0.0|2.0|
4398367|NCT00274456|4225242|B2|Time from First Metastasis/Relapse to Study Entry||Time from Primary Diagnosis and from First Metastasis/Relapse to Study Entry||Years|Median|0.04|0.04|Full Range|||0.0|8.1|
4398368|NCT00274456|4225243|B1|Time from First Metastasis/Relapse to Study Entry||Time from Primary Diagnosis and from First Metastasis/Relapse to Study Entry||Years|Median|0.02|0.02|Full Range|||0.0|8.2|
4398369|NCT00274456|4225239|B5|Time from Primary Diagnosis to Study Entry||Time from Primary Diagnosis and from First Metastasis/Relapse to Study Entry||Years|Median|1.23|1.23|Full Range|||0.0|16.9|
4398370|NCT00274456|4225240|B4|Time from Primary Diagnosis to Study Entry||Time from Primary Diagnosis and from First Metastasis/Relapse to Study Entry||Years|Median|1.27|1.27|Full Range|||0.0|14.3|
4398371|NCT00274456|4225241|B3|Time from Primary Diagnosis to Study Entry||Time from Primary Diagnosis and from First Metastasis/Relapse to Study Entry||Years|Median|0.97|0.97|Full Range|||0.0|16.9|
4398430|NCT00274456|4225240|B4|White, Non-Hispanic, Non-Latino||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
4398372|NCT00274456|4225242|B2|Time from Primary Diagnosis to Study Entry||Time from Primary Diagnosis and from First Metastasis/Relapse to Study Entry||Years|Median|1.17|1.17|Full Range|||0.0|14.9|
4398373|NCT00274456|4225243|B1|Time from Primary Diagnosis to Study Entry||Time from Primary Diagnosis and from First Metastasis/Relapse to Study Entry||Years|Median|1.24|1.24|Full Range|||0.0|11.9|
4398374|NCT00274456|4225239|B5|Grade 1||Physician Assessment of Sensory Neuropathy|The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of “Neurology -- Neuropathy – Sensory”. The scale is 0=normal and 1=asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function.|Participants|Number|31|31.0||||||
4398375|NCT00274456|4225240|B4|Grade 1||Physician Assessment of Sensory Neuropathy|The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of “Neurology -- Neuropathy – Sensory”. The scale is 0=normal and 1=asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function.|Participants|Number|7|7.0||||||
4398376|NCT00274456|4225241|B3|Grade 1||Physician Assessment of Sensory Neuropathy|The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of “Neurology -- Neuropathy – Sensory”. The scale is 0=normal and 1=asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function.|Participants|Number|9|9.0||||||
4398377|NCT00274456|4225242|B2|Grade 1||Physician Assessment of Sensory Neuropathy|The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of “Neurology -- Neuropathy – Sensory”. The scale is 0=normal and 1=asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function.|Participants|Number|6|6.0||||||
4398378|NCT00274456|4225243|B1|Grade 1||Physician Assessment of Sensory Neuropathy|The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of “Neurology -- Neuropathy – Sensory”. The scale is 0=normal and 1=asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function.|Participants|Number|9|9.0||||||
4398379|NCT00274456|4225239|B5|Grade 0||Physician Assessment of Sensory Neuropathy|The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of “Neurology -- Neuropathy – Sensory”. The scale is 0=normal and 1=asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function.|Participants|Number|269|269.0||||||
4398380|NCT00274456|4225240|B4|Grade 0||Physician Assessment of Sensory Neuropathy|The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of “Neurology -- Neuropathy – Sensory”. The scale is 0=normal and 1=asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function.|Participants|Number|67|67.0||||||
4398381|NCT00274456|4225241|B3|Grade 0||Physician Assessment of Sensory Neuropathy|The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of “Neurology -- Neuropathy – Sensory”. The scale is 0=normal and 1=asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function.|Participants|Number|65|65.0||||||
4398382|NCT00274456|4225242|B2|Grade 0||Physician Assessment of Sensory Neuropathy|The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of “Neurology -- Neuropathy – Sensory”. The scale is 0=normal and 1=asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function.|Participants|Number|70|70.0||||||
4398383|NCT00274456|4225243|B1|Grade 0||Physician Assessment of Sensory Neuropathy|The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of “Neurology -- Neuropathy – Sensory”. The scale is 0=normal and 1=asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function.|Participants|Number|67|67.0||||||
4398384|NCT00274456|4225239|B5|Unknown||Menopausal Status||Participants|Number|3|3.0||||||
4398385|NCT00274456|4225240|B4|Unknown||Menopausal Status||Participants|Number|2|2.0||||||
4398386|NCT00274456|4225241|B3|Unknown||Menopausal Status||Participants|Number|0|0.0||||||
4398387|NCT00274456|4225242|B2|Unknown||Menopausal Status||Participants|Number|0|0.0||||||
4398388|NCT00274456|4225243|B1|Unknown||Menopausal Status||Participants|Number|1|1.0||||||
4398389|NCT00274456|4225239|B5|Post-menopausal||Menopausal Status||Participants|Number|224|224.0||||||
4398390|NCT00274456|4225240|B4|Post-menopausal||Menopausal Status||Participants|Number|60|60.0||||||
4398391|NCT00274456|4225241|B3|Post-menopausal||Menopausal Status||Participants|Number|53|53.0||||||
4398392|NCT00274456|4225242|B2|Post-menopausal||Menopausal Status||Participants|Number|62|62.0||||||
4398393|NCT00274456|4225243|B1|Post-menopausal||Menopausal Status||Participants|Number|49|49.0||||||
4398394|NCT00274456|4225239|B5|Pre-menopausal||Menopausal Status||Participants|Number|73|73.0||||||
4398395|NCT00274456|4225240|B4|Pre-menopausal||Menopausal Status||Participants|Number|12|12.0||||||
4398396|NCT00274456|4225241|B3|Pre-menopausal||Menopausal Status||Participants|Number|21|21.0||||||
4398397|NCT00274456|4225242|B2|Pre-menopausal||Menopausal Status||Participants|Number|14|14.0||||||
4398398|NCT00274456|4225243|B1|Pre-menopausal||Menopausal Status||Participants|Number|26|26.0||||||
4398399|NCT00274456|4225239|B5|3 (limited self-care) + 4 (completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
4398400|NCT00274456|4225240|B4|3 (limited self-care) + 4 (completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
4398431|NCT00274456|4225241|B3|White, Non-Hispanic, Non-Latino||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
4398432|NCT00274456|4225242|B2|White, Non-Hispanic, Non-Latino||Race/Ethnicity, Customized||Participants|Number|75|75.0||||||
4398401|NCT00274456|4225241|B3|3 (limited self-care) + 4 (completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
4398402|NCT00274456|4225242|B2|3 (limited self-care) + 4 (completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
4398403|NCT00274456|4225243|B1|3 (limited self-care) + 4 (completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|0|0.0||||||
4398404|NCT00274456|4225239|B5|2 (ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|18|18.0||||||
4398405|NCT00274456|4225240|B4|2 (ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|2|2.0||||||
4398406|NCT00274456|4225241|B3|2 (ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|5|5.0||||||
4398407|NCT00274456|4225242|B2|2 (ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|4|4.0||||||
4398408|NCT00274456|4225243|B1|2 (ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|7|7.0||||||
4398409|NCT00274456|4225239|B5|1 (restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|163|163.0||||||
4398410|NCT00274456|4225240|B4|1 (restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|44|44.0||||||
4398411|NCT00274456|4225241|B3|1 (restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|45|45.0||||||
4398412|NCT00274456|4225242|B2|1 (restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|39|39.0||||||
4398413|NCT00274456|4225243|B1|1 (restrictive but ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|35|35.0||||||
4398414|NCT00274456|4225239|B5|0 (fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|119|119.0||||||
4398415|NCT00274456|4225240|B4|0 (fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|28|28.0||||||
4398416|NCT00274456|4225241|B3|0 (fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|24|24.0||||||
4398417|NCT00274456|4225242|B2|0 (fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|33|33.0||||||
4398418|NCT00274456|4225243|B1|0 (fully active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|A scale used to assess the progress of disease in a patient, how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|34|34.0||||||
4398419|NCT00274456|4225239|B5|||Weight||Kg|Mean|74.59|74.59|Standard Deviation|13.742|13.742|||
4398420|NCT00274456|4225240|B4|||Weight||Kg|Mean|75.99|75.99|Standard Deviation|14.034|14.034|||
4398421|NCT00274456|4225241|B3|||Weight||Kg|Mean|76.24|76.24|Standard Deviation|13.437|13.437|||
4398422|NCT00274456|4225242|B2|||Weight||Kg|Mean|73.64|73.64|Standard Deviation|14.670|14.67|||
4398423|NCT00274456|4225243|B1|||Weight||Kg|Mean|72.56|72.56|Standard Deviation|12.668|12.668|||
4398424|NCT00274456|4225239|B5|White, Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4398425|NCT00274456|4225240|B4|White, Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398426|NCT00274456|4225241|B3|White, Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398427|NCT00274456|4225242|B2|White, Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4398428|NCT00274456|4225243|B1|White, Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4398429|NCT00274456|4225239|B5|White, Non-Hispanic, Non-Latino||Race/Ethnicity, Customized||Participants|Number|297|297.0||||||
4398433|NCT00274456|4225243|B1|White, Non-Hispanic, Non-Latino||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
4398434|NCT00274456|4225239|B5||Male|Gender||Participants|Count of Participants|0|0.0||||||
4398435|NCT00274456|4225240|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
4398436|NCT00274456|4225241|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4398437|NCT00274456|4225242|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4398438|NCT00274456|4225243|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4398439|NCT00274456|4225239|B5||Female|Gender||Participants|Count of Participants|300|300.0||||||
4398440|NCT00274456|4225240|B4||Female|Gender||Participants|Count of Participants|74|74.0||||||
4398441|NCT00274456|4225241|B3||Female|Gender||Participants|Count of Participants|74|74.0||||||
4398442|NCT00274456|4225242|B2||Female|Gender||Participants|Count of Participants|76|76.0||||||
4398443|NCT00274456|4225243|B1||Female|Gender||Participants|Count of Participants|76|76.0||||||
4398444|NCT00274456|4225239|B5|<65 years||Age, Customized||Participants|Number|248|248.0||||||
4398445|NCT00274456|4225240|B4|<65 years||Age, Customized||Participants|Number|55|55.0||||||
4398446|NCT00274456|4225241|B3|<65 years||Age, Customized||Participants|Number|64|64.0||||||
4398447|NCT00274456|4225242|B2|<65 years||Age, Customized||Participants|Number|62|62.0||||||
4398448|NCT00274456|4225243|B1|<65 years||Age, Customized||Participants|Number|67|67.0||||||
4398449|NCT00274456|4225239|B5|>=65 years||Age, Customized||Participants|Number|52|52.0||||||
4398450|NCT00274456|4225240|B4|>=65 years||Age, Customized||Participants|Number|19|19.0||||||
4398451|NCT00274456|4225241|B3|>=65 years||Age, Customized||Participants|Number|10|10.0||||||
4398452|NCT00274456|4225242|B2|>=65 years||Age, Customized||Participants|Number|14|14.0||||||
4398453|NCT00274456|4225243|B1|>=65 years||Age, Customized||Participants|Number|9|9.0||||||
4398454|NCT00274456|4225239|B5|||Age||years|Mean|53.9|53.9|Standard Deviation|10.05|10.05|||
4398455|NCT00274456|4225240|B4|||Age||years|Mean|55.4|55.4|Standard Deviation|11.57|11.57|||
4398456|NCT00274456|4225241|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|9.14|9.14|||
4398457|NCT00274456|4225242|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|9.59|9.59|||
4398458|NCT00274456|4225243|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|9.47|9.47|||
4398459|NCT00274287|4225288|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4398460|NCT00274287|4225288|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4398461|NCT00274287|4225288|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398462|NCT00274287|4225288|B1|||Age|Age at protocol entry|years|Median|78|78.0|Full Range|||66.0|96.0|
4398463|NCT00274261|4225292|B3|United States||Region of Enrollment||participants|Number|1565|1565.0||||||
4398464|NCT00274261|4225293|B2|United States||Region of Enrollment||participants|Number|633|633.0||||||
4398465|NCT00274261|4225294|B1|United States||Region of Enrollment||participants|Number|932|932.0||||||
4398466|NCT00274261|4225292|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398467|NCT00274261|4225293|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398468|NCT00274261|4225294|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398469|NCT00274261|4225292|B3||Female|Sex: Female, Male||Participants|Count of Participants|1565|1565.0||||||
4398470|NCT00274261|4225293|B2||Female|Sex: Female, Male||Participants|Count of Participants|633|633.0||||||
4398471|NCT00274261|4225294|B1||Female|Sex: Female, Male||Participants|Count of Participants|932|932.0||||||
4398472|NCT00274261|4225292|B3|||Age||years|Mean|28.2|28.2|Standard Deviation|5.71|5.71|||
4398473|NCT00274261|4225293|B2|||Age||years|Mean|28.3|28.3|Standard Deviation|5.90|5.9|||
4398474|NCT00274261|4225294|B1|||Age||years|Mean|28.1|28.1|Standard Deviation|5.58|5.58|||
4398475|NCT00274261|4225292|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398476|NCT00274261|4225293|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398477|NCT00274261|4225294|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398478|NCT00274261|4225292|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1565|1565.0||||||
4398479|NCT00274261|4225293|B2||Between 18 and 65 years|Age||Participants|Count of Participants|633|633.0||||||
4398480|NCT00274261|4225294|B1||Between 18 and 65 years|Age||Participants|Count of Participants|932|932.0||||||
4398481|NCT00274261|4225292|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398482|NCT00274261|4225293|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398483|NCT00274261|4225294|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398484|NCT00273910|4225303|B7|United States||Region of Enrollment||participants|Number|104|104.0||||||
4398485|NCT00273910|4225304|B6|United States||Region of Enrollment||participants|Number|14|14.0||||||
4398486|NCT00273910|4225305|B5|United States||Region of Enrollment||participants|Number|15|15.0||||||
4398487|NCT00273910|4225306|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
4398488|NCT00273910|4225307|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4398489|NCT00273910|4225308|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4398490|NCT00273910|4225309|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4398491|NCT00273910|4225303|B7|Other or Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398492|NCT00273910|4225304|B6|Other or Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398493|NCT00273910|4225305|B5|Other or Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398494|NCT00273910|4225306|B4|Other or Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398495|NCT00273910|4225307|B3|Other or Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398496|NCT00273910|4225308|B2|Other or Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398497|NCT00273910|4225309|B1|Other or Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398498|NCT00273910|4225303|B7|White of non-Hispanic Origin||Race/Ethnicity, Customized||Participants|Number|103|103.0||||||
4398499|NCT00273910|4225304|B6|White of non-Hispanic Origin||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4398500|NCT00273910|4225305|B5|White of non-Hispanic Origin||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4398501|NCT00273910|4225306|B4|White of non-Hispanic Origin||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4398502|NCT00273910|4225307|B3|White of non-Hispanic Origin||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4398503|NCT00273910|4225308|B2|White of non-Hispanic Origin||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4398504|NCT00273910|4225309|B1|White of non-Hispanic Origin||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4398505|NCT00273910|4225303|B7|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398506|NCT00273910|4225304|B6|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398507|NCT00273910|4225305|B5|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398508|NCT00273910|4225306|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398509|NCT00273910|4225307|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398510|NCT00273910|4225308|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398511|NCT00273910|4225309|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398512|NCT00273910|4225303|B7|Black of non-Hispanic Origin||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398513|NCT00273910|4225304|B6|Black of non-Hispanic Origin||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398514|NCT00273910|4225305|B5|Black of non-Hispanic Origin||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398515|NCT00273910|4225306|B4|Black of non-Hispanic Origin||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398516|NCT00273910|4225307|B3|Black of non-Hispanic Origin||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398517|NCT00273910|4225308|B2|Black of non-Hispanic Origin||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398518|NCT00273910|4225309|B1|Black of non-Hispanic Origin||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398519|NCT00273910|4225303|B7|Native Hawaiian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398520|NCT00273910|4225304|B6|Native Hawaiian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398521|NCT00273910|4225305|B5|Native Hawaiian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398522|NCT00273910|4225306|B4|Native Hawaiian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398523|NCT00273910|4225307|B3|Native Hawaiian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398524|NCT00273910|4225308|B2|Native Hawaiian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398525|NCT00273910|4225309|B1|Native Hawaiian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398526|NCT00273910|4225303|B7|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4398527|NCT00273910|4225304|B6|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398528|NCT00273910|4225305|B5|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398529|NCT00273910|4225306|B4|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398530|NCT00273910|4225307|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398531|NCT00273910|4225308|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398532|NCT00273910|4225309|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4398533|NCT00273910|4225303|B7|American Indian or Alaskan Natives||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398534|NCT00273910|4225304|B6|American Indian or Alaskan Natives||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398535|NCT00273910|4225305|B5|American Indian or Alaskan Natives||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398536|NCT00273910|4225306|B4|American Indian or Alaskan Natives||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398537|NCT00273910|4225307|B3|American Indian or Alaskan Natives||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398538|NCT00273910|4225308|B2|American Indian or Alaskan Natives||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398539|NCT00273910|4225309|B1|American Indian or Alaskan Natives||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398540|NCT00273910|4225303|B7||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4398541|NCT00273910|4225304|B6||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4398542|NCT00273910|4225305|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4398543|NCT00273910|4225306|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4398544|NCT00273910|4225307|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4398545|NCT00273910|4225308|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4398546|NCT00273910|4225309|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4398547|NCT00273910|4225303|B7||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4398548|NCT00273910|4225304|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4398549|NCT00273910|4225305|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4398550|NCT00273910|4225306|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4398551|NCT00273910|4225307|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4398552|NCT00273910|4225308|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4398553|NCT00273910|4225309|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4398554|NCT00273910|4225303|B7|||Age||years|Mean|47.6|47.6|Standard Deviation|10.65|10.65|||
4398555|NCT00273910|4225304|B6|||Age||years|Mean|47.7|47.7|Standard Deviation|8.3|8.3|||
4398556|NCT00273910|4225305|B5|||Age||years|Mean|51.7|51.7|Standard Deviation|13.2|13.2|||
4398557|NCT00273910|4225306|B4|||Age||years|Mean|48.1|48.1|Standard Deviation|10.2|10.2|||
4398558|NCT00273910|4225307|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|12.7|12.7|||
4398559|NCT00273910|4225308|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|10.4|10.4|||
4398560|NCT00273910|4225309|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|9.1|9.1|||
4398561|NCT00273910|4225303|B7||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4398562|NCT00273910|4225304|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398563|NCT00273910|4225305|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4398564|NCT00273910|4225306|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398565|NCT00273910|4225307|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398566|NCT00273910|4225308|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398567|NCT00273910|4225309|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398568|NCT00273910|4225303|B7||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4398569|NCT00273910|4225304|B6||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4398570|NCT00273910|4225305|B5||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4398571|NCT00273910|4225306|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4398572|NCT00273910|4225307|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4398573|NCT00273910|4225308|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4398574|NCT00273910|4225309|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4398575|NCT00273910|4225303|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398576|NCT00273910|4225304|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398577|NCT00273910|4225305|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398578|NCT00273910|4225306|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398579|NCT00273910|4225307|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398580|NCT00273910|4225308|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398581|NCT00273910|4225309|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398582|NCT00273858|4225334|B1||Male|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4398583|NCT00273858|4225334|B1||Female|Sex: Female, Male||Participants|Count of Participants|562|562.0||||||
4398584|NCT00273858|4225334|B1|||Age|Mean age of the participants is based on N=795.|Years|Mean|52.0|52.0|Standard Deviation|13.6|13.6|||
4398585|NCT00273793|4225343|B7|United States||Region of Enrollment||participants|Number|239|239.0||||||
4398586|NCT00273793|4225344|B6|United States||Region of Enrollment||participants|Number|29|29.0||||||
4398587|NCT00273793|4225345|B5|United States||Region of Enrollment||participants|Number|58|58.0||||||
4398588|NCT00273793|4225346|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
4398589|NCT00273793|4225347|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4398590|NCT00273793|4225348|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4398591|NCT00273793|4225349|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4398592|NCT00273793|4225343|B7||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4398593|NCT00273793|4225344|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4398594|NCT00273793|4225345|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4398595|NCT00273793|4225346|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4398596|NCT00273793|4225347|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4398597|NCT00273793|4225348|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4398598|NCT00273793|4225349|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4398599|NCT00273793|4225343|B7||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4398600|NCT00273793|4225344|B6||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4398601|NCT00273793|4225345|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4398602|NCT00273793|4225346|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4398603|NCT00273793|4225347|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4398604|NCT00273793|4225348|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4398605|NCT00273793|4225349|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4398606|NCT00273793|4225343|B7|||Age||years|Mean|42.5|42.5|Standard Deviation|12.0|12.0|||
4398607|NCT00273793|4225344|B6|||Age||years|Mean|40.6|40.6|Standard Deviation|10.0|10.0|||
4398608|NCT00273793|4225345|B5|||Age||years|Mean|41.3|41.3|Standard Deviation|11.8|11.8|||
4398609|NCT00273793|4225346|B4|||Age||years|Mean|41.9|41.9|Standard Deviation|12.9|12.9|||
4398610|NCT00273793|4225347|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|11.2|11.2|||
4398611|NCT00273793|4225348|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|12.8|12.8|||
4398612|NCT00273793|4225349|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|12.2|12.2|||
4398613|NCT00273793|4225343|B7||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4398614|NCT00273793|4225344|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398615|NCT00273793|4225345|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398616|NCT00273793|4225346|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4398617|NCT00273793|4225347|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398618|NCT00273793|4225348|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4398619|NCT00273793|4225349|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398620|NCT00273793|4225343|B7||Between 18 and 65 years|Age||Participants|Count of Participants|237|237.0||||||
4398621|NCT00273793|4225344|B6||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4398622|NCT00273793|4225345|B5||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4398623|NCT00273793|4225346|B4||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4398624|NCT00273793|4225347|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4398625|NCT00273793|4225348|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4398626|NCT00273793|4225349|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4398627|NCT00273793|4225343|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398628|NCT00273793|4225344|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398629|NCT00273793|4225345|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398630|NCT00273793|4225346|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398631|NCT00273793|4225347|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398632|NCT00273793|4225348|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398633|NCT00273793|4225349|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398634|NCT00273754|4225374|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4398635|NCT00273754|4225375|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4398636|NCT00273754|4225376|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4398637|NCT00273754|4225374|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4398638|NCT00273754|4225375|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4398639|NCT00273754|4225376|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4398640|NCT00273754|4225374|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4398641|NCT00273754|4225375|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4398642|NCT00273754|4225376|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4398643|NCT00273754|4225374|B3|||Age||years|Mean|5.3|5.3|Standard Deviation|2.5|2.5|||
4398644|NCT00273754|4225375|B2|||Age||years|Mean|5.3|5.3|Standard Deviation|2.2|2.2|||
4398645|NCT00273754|4225376|B1|||Age||years|Mean|5.3|5.3|Standard Deviation|2.9|2.9|||
4398646|NCT00273754|4225374|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398647|NCT00273754|4225375|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398648|NCT00273754|4225376|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398649|NCT00273754|4225374|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4398650|NCT00273754|4225375|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4398651|NCT00273754|4225376|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4398652|NCT00273754|4225374|B3||<=18 years|Age||Participants|Count of Participants|72|72.0||||||
4398653|NCT00273754|4225375|B2||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4398654|NCT00273754|4225376|B1||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4398655|NCT00273182|4225393|B1|United States||Region of Enrollment||participants|Number|1999|1999.0||||||
4398656|NCT00273182|4225393|B1||Male|Sex: Female, Male||Participants|Count of Participants|1271|1271.0||||||
4398657|NCT00273182|4225393|B1||Female|Sex: Female, Male||Participants|Count of Participants|728|728.0||||||
4398658|NCT00273182|4225393|B1|||Age||years|Mean|67.2|67.2|Standard Deviation|12.7|12.7|||
4398659|NCT00273182|4225393|B1||>=65 years|Age||Participants|Count of Participants|1313|1313.0||||||
4398660|NCT00273182|4225393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|686|686.0||||||
4398661|NCT00273182|4225393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398662|NCT00273052|4225401|B3|Other||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4398663|NCT00273052|4225402|B2|Other||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4398664|NCT00273052|4225403|B1|Other||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4398665|NCT00273052|4225401|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|465|465.0||||||
4398666|NCT00273052|4225402|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|226|226.0||||||
4398667|NCT00273052|4225403|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|239|239.0||||||
4398668|NCT00273052|4225401|B3|Black||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4398669|NCT00273052|4225402|B2|Black||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4398670|NCT00273052|4225403|B1|Black||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4398671|NCT00273052|4225401|B3||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4398672|NCT00273052|4225402|B2||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4398673|NCT00273052|4225403|B1||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4398674|NCT00273052|4225401|B3||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4398675|NCT00273052|4225402|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4398676|NCT00273052|4225403|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4398677|NCT00273052|4225401|B3|>=65 years||Age, Customized||participants|Number|64|64.0||||||
4398678|NCT00273052|4225402|B2|>=65 years||Age, Customized||participants|Number|34|34.0||||||
4398679|NCT00273052|4225403|B1|>=65 years||Age, Customized||participants|Number|30|30.0||||||
4398680|NCT00273052|4225401|B3|< 65 years||Age, Customized||participants|Number|504|504.0||||||
4398681|NCT00273052|4225402|B2|< 65 years||Age, Customized||participants|Number|244|244.0||||||
4398682|NCT00273052|4225403|B1|< 65 years||Age, Customized||participants|Number|260|260.0||||||
4398683|NCT00272987|4225436|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
4398684|NCT00272987|4225437|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4398685|NCT00272987|4225438|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4398686|NCT00272987|4225439|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4398687|NCT00272987|4225436|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4398688|NCT00272987|4225437|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398689|NCT00272987|4225438|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4398690|NCT00272987|4225439|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4398691|NCT00272987|4225436|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4398692|NCT00272987|4225437|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4398693|NCT00272987|4225438|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4398694|NCT00272987|4225439|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4398695|NCT00272987|4225436|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398696|NCT00272987|4225437|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398697|NCT00272987|4225438|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398698|NCT00272987|4225439|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398699|NCT00272987|4225436|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4398700|NCT00272987|4225437|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4398701|NCT00272987|4225438|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4398702|NCT00272987|4225439|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4398703|NCT00272987|4225436|B4|||Age||Years|Mean|52.7|52.7|Standard Deviation|11.84|11.84|||
4398704|NCT00272987|4225437|B3|||Age||Years|Mean|52.2|52.2|Standard Deviation|13.00|13.0|||
4398705|NCT00272987|4225438|B2|||Age||Years|Mean|56.1|56.1|Standard Deviation|11.92|11.92|||
4398706|NCT00272987|4225439|B1|||Age||Years|Mean|51.5|51.5|Standard Deviation|11.08|11.08|||
4398707|NCT00272961|4225500|B6||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4398708|NCT00272961|4225501|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4398709|NCT00272961|4225502|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4398710|NCT00272961|4225503|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4398711|NCT00272961|4225504|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4398712|NCT00272961|4225505|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4398713|NCT00272961|4225500|B6||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4398714|NCT00272961|4225501|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4398715|NCT00272961|4225502|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4398716|NCT00272961|4225503|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4398717|NCT00272961|4225504|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4398718|NCT00272961|4225505|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4398719|NCT00272961|4225500|B6|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|9|9.0||||||
4398720|NCT00272961|4225501|B5|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|2|2.0||||||
4398721|NCT00272961|4225502|B4|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|0|0.0||||||
4398722|NCT00272961|4225503|B3|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|1|1.0||||||
4398723|NCT00272961|4225504|B2|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|2|2.0||||||
4398724|NCT00272961|4225505|B1|Greater Than or Equal to (>=) 65 Years||Age, Customized||participants|Number|4|4.0||||||
4398725|NCT00272961|4225500|B6|45 to 64 Years||Age, Customized||participants|Number|37|37.0||||||
4398726|NCT00272961|4225501|B5|45 to 64 Years||Age, Customized||participants|Number|7|7.0||||||
4398727|NCT00272961|4225502|B4|45 to 64 Years||Age, Customized||participants|Number|9|9.0||||||
4398728|NCT00272961|4225503|B3|45 to 64 Years||Age, Customized||participants|Number|10|10.0||||||
4398729|NCT00272961|4225504|B2|45 to 64 Years||Age, Customized||participants|Number|5|5.0||||||
4398730|NCT00272961|4225505|B1|45 to 64 Years||Age, Customized||participants|Number|6|6.0||||||
4398731|NCT00272961|4225500|B6|18 to 44 Years||Age, Customized||participants|Number|3|3.0||||||
4398732|NCT00272961|4225501|B5|18 to 44 Years||Age, Customized||participants|Number|1|1.0||||||
4398733|NCT00272961|4225502|B4|18 to 44 Years||Age, Customized||participants|Number|1|1.0||||||
4398734|NCT00272961|4225503|B3|18 to 44 Years||Age, Customized||participants|Number|0|0.0||||||
4398735|NCT00272961|4225504|B2|18 to 44 Years||Age, Customized||participants|Number|1|1.0||||||
4398736|NCT00272961|4225505|B1|18 to 44 Years||Age, Customized||participants|Number|0|0.0||||||
4398737|NCT00272844|4225566|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4398738|NCT00272844|4225566|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4398739|NCT00272844|4225566|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4398740|NCT00272844|4225566|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398741|NCT00272844|4225566|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4398742|NCT00272844|4225566|B1||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4398743|NCT00272792|4225572|B3|Hispanic||Race||Participants|Number|1|1.0||||||
4398744|NCT00272792|4225573|B2|Hispanic||Race||Participants|Number|1|1.0||||||
4398745|NCT00272792|4225574|B1|Hispanic||Race||Participants|Number|0|0.0||||||
4398746|NCT00272792|4225572|B3|Caucasian||Race||Participants|Number|44|44.0||||||
4398747|NCT00272792|4225573|B2|Caucasian||Race||Participants|Number|11|11.0||||||
4398748|NCT00272792|4225574|B1|Caucasian||Race||Participants|Number|33|33.0||||||
4398749|NCT00272792|4225572|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4398750|NCT00272792|4225573|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4398751|NCT00272792|4225574|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4398752|NCT00272792|4225572|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4398753|NCT00272792|4225573|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4398754|NCT00272792|4225574|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4398755|NCT00272792|4225572|B3|||Age||years|Mean|7.5|7.5|Standard Deviation|2.6|2.6|||
4398756|NCT00272792|4225573|B2|||Age||years|Mean|7.1|7.1|Standard Deviation|2.0|2.0|||
4398757|NCT00272792|4225574|B1|||Age||years|Mean|7.7|7.7|Standard Deviation|2.8|2.8|||
4398758|NCT00272779|4225583|B3|Mixed race||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4398759|NCT00272779|4225584|B2|Mixed race||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4398760|NCT00272779|4225585|B1|Mixed race||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4398761|NCT00272779|4225583|B3|Mestizo||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
4398762|NCT00272779|4225584|B2|Mestizo||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4398763|NCT00272779|4225585|B1|Mestizo||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4398764|NCT00272779|4225583|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4398765|NCT00272779|4225584|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4398766|NCT00272779|4225585|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4398767|NCT00272779|4225583|B3|White||Race/Ethnicity, Customized||participants|Number|428|428.0||||||
4398768|NCT00272779|4225584|B2|White||Race/Ethnicity, Customized||participants|Number|221|221.0||||||
4398769|NCT00272779|4225585|B1|White||Race/Ethnicity, Customized||participants|Number|207|207.0||||||
4398770|NCT00272779|4225583|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|163|163.0||||||
4398771|NCT00272779|4225584|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4398772|NCT00272779|4225585|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4398773|NCT00272779|4225583|B3|Asian||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4398774|NCT00272779|4225584|B2|Asian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4398775|NCT00272779|4225585|B1|Asian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4398776|NCT00272779|4225583|B3||Male|Sex: Female, Male||Participants|Count of Participants|606|606.0||||||
4398777|NCT00272779|4225584|B2||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4398778|NCT00272779|4225585|B1||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4398779|NCT00272779|4225583|B3||Female|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4398780|NCT00272779|4225584|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4398781|NCT00272779|4225585|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4398782|NCT00272779|4225583|B3|||Age||years|Mean|36|36.0|Standard Deviation|9.6|9.6|||
4398783|NCT00272779|4225584|B2|||Age||years|Mean|37|37.0|Standard Deviation|10.0|10.0|||
4398784|NCT00272779|4225585|B1|||Age||years|Mean|36|36.0|Standard Deviation|9.1|9.1|||
4398785|NCT00272337|4225765|B6|United States||Region of Enrollment||participants|Number|37|37.0||||||
4398786|NCT00272337|4225766|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
4398787|NCT00272337|4225767|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4398788|NCT00272337|4225768|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4398789|NCT00272337|4225769|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4398790|NCT00272337|4225770|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4398791|NCT00272337|4225765|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4398792|NCT00272337|4225766|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4398793|NCT00272337|4225767|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4398794|NCT00272337|4225768|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4398795|NCT00272337|4225769|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4398796|NCT00272337|4225770|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4398797|NCT00272337|4225765|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4398798|NCT00272337|4225766|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4398799|NCT00272337|4225767|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4398800|NCT00272337|4225768|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4398801|NCT00272337|4225769|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4398802|NCT00272337|4225770|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4398803|NCT00272337|4225765|B6|||Age||years|Mean|64.0|64.0|Standard Deviation|8.9|8.9|||
4398804|NCT00272337|4225766|B5|||Age||years|Mean|62.6|62.6|Standard Deviation|10.8|10.8|||
4398805|NCT00272337|4225767|B4|||Age||years|Mean|67.2|67.2|Standard Deviation|6.0|6.0|||
4398806|NCT00272337|4225768|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|9.0|9.0|||
4398807|NCT00272337|4225769|B2|||Age||years|Mean|67.8|67.8|Standard Deviation|8.0|8.0|||
4398808|NCT00272337|4225770|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|9.7|9.7|||
4398809|NCT00272337|4225765|B6||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4398810|NCT00272337|4225766|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4398811|NCT00272337|4225767|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4398812|NCT00272337|4225768|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4398813|NCT00272337|4225769|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4398814|NCT00272337|4225770|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4398815|NCT00272337|4225765|B6||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4398816|NCT00272337|4225766|B5||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4398817|NCT00272337|4225767|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4398818|NCT00272337|4225768|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4398819|NCT00272337|4225769|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4398820|NCT00272337|4225770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4398821|NCT00272337|4225765|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398822|NCT00272337|4225766|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398823|NCT00272337|4225767|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398824|NCT00272337|4225768|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398825|NCT00272337|4225769|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398826|NCT00272337|4225770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398827|NCT00272311|4225796|B6|United States||Region of Enrollment||participants|Number|70|70.0||||||
4398828|NCT00272311|4225797|B5|United States||Region of Enrollment||participants|Number|14|14.0||||||
4398829|NCT00272311|4225798|B4|United States||Region of Enrollment||participants|Number|14|14.0||||||
4398830|NCT00272311|4225799|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4398831|NCT00272311|4225800|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4398832|NCT00272311|4225801|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4398833|NCT00272311|4225796|B6||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4398834|NCT00272311|4225797|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4398835|NCT00272311|4225798|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4398836|NCT00272311|4225799|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4398837|NCT00272311|4225800|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4398838|NCT00272311|4225801|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4398839|NCT00272311|4225796|B6||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4398840|NCT00272311|4225797|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4398841|NCT00272311|4225798|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4398842|NCT00272311|4225799|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4398843|NCT00272311|4225800|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4398844|NCT00272311|4225801|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4398845|NCT00272311|4225796|B6|||Age||years|Mean|57.6|57.6|Standard Deviation|9.9|9.9|||
4398846|NCT00272311|4225797|B5|||Age||years|Mean|59.1|59.1|Standard Deviation|11.4|11.4|||
4398847|NCT00272311|4225798|B4|||Age||years|Mean|58.0|58.0|Standard Deviation|9.6|9.6|||
4398848|NCT00272311|4225799|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|9.2|9.2|||
4398849|NCT00272311|4225800|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|10.0|10.0|||
4398850|NCT00272311|4225801|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|10.3|10.3|||
4398851|NCT00272311|4225796|B6||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4398852|NCT00272311|4225797|B5||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4398853|NCT00272311|4225798|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4398854|NCT00272311|4225799|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4398855|NCT00272311|4225800|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4398856|NCT00272311|4225801|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4398857|NCT00272311|4225796|B6||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4398858|NCT00272311|4225797|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4398859|NCT00272311|4225798|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4398860|NCT00272311|4225799|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4398861|NCT00272311|4225800|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4398862|NCT00272311|4225801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4398863|NCT00272311|4225796|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398864|NCT00272311|4225797|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398865|NCT00272311|4225798|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398866|NCT00272311|4225799|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398867|NCT00272311|4225800|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398868|NCT00272311|4225801|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398869|NCT00272168|4225817|B3|United States||Region of Enrollment||participants|Number|88|88.0||||||
4398870|NCT00272168|4225818|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4398871|NCT00272168|4225819|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4398872|NCT00272168|4225817|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4398873|NCT00272168|4225818|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4398874|NCT00272168|4225819|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4398875|NCT00272168|4225817|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4398876|NCT00272168|4225818|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4398877|NCT00272168|4225819|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4398878|NCT00272168|4225817|B3|||Age||years|Mean|51.49|51.49|Standard Deviation|6.15|6.15|||
4398879|NCT00272168|4225818|B2|||Age||years|Mean|51.51|51.51|Standard Deviation|6.07|6.07|||
4398880|NCT00272168|4225819|B1|||Age||years|Mean|51.47|51.47|Standard Deviation|6.29|6.29|||
4398881|NCT00272038|4225836|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4398882|NCT00272038|4225836|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4398883|NCT00272038|4225836|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398884|NCT00272038|4225836|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4398885|NCT00272038|4225836|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4398886|NCT00272038|4225836|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398887|NCT00271947|4225842|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4398888|NCT00271947|4225842|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4398889|NCT00271947|4225842|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4398890|NCT00271947|4225842|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398891|NCT00271947|4225842|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4398892|NCT00271947|4225842|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398893|NCT00271856|4225846|B3|United States||Region of Enrollment||participants|Number|177|177.0||||||
4398894|NCT00271856|4225847|B2|United States||Region of Enrollment||participants|Number|88|88.0||||||
4398895|NCT00271856|4225848|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
4398896|NCT00271856|4225846|B3||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4398897|NCT00271856|4225847|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4398898|NCT00271856|4225848|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4398899|NCT00271856|4225846|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4398900|NCT00271856|4225847|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4398901|NCT00271856|4225848|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4398902|NCT00271856|4225846|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|9.41|9.41|||
4398903|NCT00271856|4225847|B2|||Age||years|Mean|40.5|40.5|Standard Deviation|9.5|9.5|||
4398904|NCT00271856|4225848|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|9.36|9.36|||
4398905|NCT00271856|4225846|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4398906|NCT00271856|4225847|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4398907|NCT00271856|4225848|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4398908|NCT00271856|4225846|B3||Between 18 and 65 years|Age||Participants|Count of Participants|176|176.0||||||
4398909|NCT00271856|4225847|B2||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4398910|NCT00271856|4225848|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4398911|NCT00271856|4225846|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398912|NCT00271856|4225847|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398913|NCT00271856|4225848|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4398914|NCT00271817|4225865|B4|No BMI Data||Body Mass Index||Participants|Number|6|6.0||||||
4398915|NCT00271817|4225866|B3|No BMI Data||Body Mass Index||Participants|Number|4|4.0||||||
4398916|NCT00271817|4225867|B2|No BMI Data||Body Mass Index||Participants|Number|1|1.0||||||
4398917|NCT00271817|4225868|B1|No BMI Data||Body Mass Index||Participants|Number|1|1.0||||||
4398918|NCT00271817|4225865|B4|≥ 40 kg/m2||Body Mass Index||Participants|Number|69|69.0||||||
4398919|NCT00271817|4225866|B3|≥ 40 kg/m2||Body Mass Index||Participants|Number|34|34.0||||||
4398920|NCT00271817|4225867|B2|≥ 40 kg/m2||Body Mass Index||Participants|Number|19|19.0||||||
4398921|NCT00271817|4225868|B1|≥ 40 kg/m2||Body Mass Index||Participants|Number|16|16.0||||||
4398922|NCT00271817|4225865|B4|30 to <40 kg/m2||Body Mass Index||Participants|Number|442|442.0||||||
4398923|NCT00271817|4225866|B3|30 to <40 kg/m2||Body Mass Index||Participants|Number|251|251.0||||||
4398924|NCT00271817|4225867|B2|30 to <40 kg/m2||Body Mass Index||Participants|Number|94|94.0||||||
4398925|NCT00271817|4225868|B1|30 to <40 kg/m2||Body Mass Index||Participants|Number|97|97.0||||||
4398926|NCT00271817|4225865|B4|25 to <30 kg/m2||Body Mass Index||Participants|Number|481|481.0||||||
4398927|NCT00271817|4225866|B3|25 to <30 kg/m2||Body Mass Index||Participants|Number|252|252.0||||||
4398928|NCT00271817|4225867|B2|25 to <30 kg/m2||Body Mass Index||Participants|Number|119|119.0||||||
4398929|NCT00271817|4225868|B1|25 to <30 kg/m2||Body Mass Index||Participants|Number|110|110.0||||||
4398930|NCT00271817|4225865|B4|<25 kg/m2||Body Mass Index||Participants|Number|222|222.0||||||
4398931|NCT00271817|4225866|B3|<25 kg/m2||Body Mass Index||Participants|Number|135|135.0||||||
4398932|NCT00271817|4225867|B2|<25 kg/m2||Body Mass Index||Participants|Number|39|39.0||||||
4398933|NCT00271817|4225868|B1|<25 kg/m2||Body Mass Index||Participants|Number|48|48.0||||||
4398934|NCT00271817|4225865|B4|White||Race/Ethnicity, Customized||participants|Number|1047|1047.0||||||
4398935|NCT00271817|4225866|B3|White||Race/Ethnicity, Customized||participants|Number|576|576.0||||||
4398936|NCT00271817|4225867|B2|White||Race/Ethnicity, Customized||participants|Number|240|240.0||||||
4398937|NCT00271817|4225868|B1|White||Race/Ethnicity, Customized||participants|Number|231|231.0||||||
4398938|NCT00271817|4225865|B4|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4398939|NCT00271817|4225866|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4398940|NCT00271817|4225867|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4398941|NCT00271817|4225868|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4398942|NCT00271817|4225865|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4398943|NCT00271817|4225866|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4398944|NCT00271817|4225867|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4398945|NCT00271817|4225868|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4398946|NCT00271817|4225865|B4|Black||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4398947|NCT00271817|4225866|B3|Black||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4398948|NCT00271817|4225867|B2|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4398949|NCT00271817|4225868|B1|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4398950|NCT00271817|4225865|B4|Asian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4398951|NCT00271817|4225866|B3|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4398952|NCT00271817|4225867|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4398953|NCT00271817|4225868|B1|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4398954|NCT00271817|4225865|B4||Male|Sex: Female, Male||Participants|Count of Participants|612|612.0||||||
4398955|NCT00271817|4225866|B3||Male|Sex: Female, Male||Participants|Count of Participants|324|324.0||||||
4398956|NCT00271817|4225867|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4398957|NCT00271817|4225868|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4398958|NCT00271817|4225865|B4||Female|Sex: Female, Male||Participants|Count of Participants|608|608.0||||||
4398959|NCT00271817|4225866|B3||Female|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4398960|NCT00271817|4225867|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4398961|NCT00271817|4225868|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4398962|NCT00271817|4225865|B4|||Age||years|Mean|56.9|56.9|Standard Deviation|10.7|10.7|||
4398963|NCT00271817|4225866|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|10.9|10.9|||
4398964|NCT00271817|4225867|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|10.3|10.3|||
4398965|NCT00271817|4225868|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|10.6|10.6|||
4398966|NCT00271739|4225897|B3||Male|Sex: Female, Male||Participants|Count of Participants|619|619.0||||||
4398967|NCT00271739|4225898|B2||Male|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4398968|NCT00271739|4225899|B1||Male|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4398969|NCT00271739|4225897|B3||Female|Sex: Female, Male||Participants|Count of Participants|1046|1046.0||||||
4398970|NCT00271739|4225898|B2||Female|Sex: Female, Male||Participants|Count of Participants|510|510.0||||||
4398971|NCT00271739|4225899|B1||Female|Sex: Female, Male||Participants|Count of Participants|536|536.0||||||
4398972|NCT00271739|4225897|B3|||Age||years|Mean|70.8|70.8|Standard Deviation|6.7|6.7|||
4398973|NCT00271739|4225898|B2|||Age||years|Mean|70.9|70.9|Standard Deviation|6.8|6.8|||
4398974|NCT00271739|4225899|B1|||Age||years|Mean|70.8|70.8|Standard Deviation|6.5|6.5|||
4398975|NCT00271609|4225910|B3|United States||Region of Enrollment||participants|Number|88|88.0||||||
4398976|NCT00271609|4225911|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4398977|NCT00271609|4225912|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4398978|NCT00271609|4225910|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398979|NCT00271609|4225911|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398980|NCT00271609|4225912|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398981|NCT00271609|4225910|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398982|NCT00271609|4225911|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398983|NCT00271609|4225912|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398984|NCT00271609|4225910|B3||White|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4398985|NCT00271609|4225911|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4398986|NCT00271609|4225912|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4398987|NCT00271609|4225910|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4398988|NCT00271609|4225911|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398989|NCT00271609|4225912|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4398990|NCT00271609|4225910|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4398991|NCT00271609|4225911|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398992|NCT00271609|4225912|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4398993|NCT00271609|4225910|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4398994|NCT00271609|4225911|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4398995|NCT00271609|4225912|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4398996|NCT00271609|4225910|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398997|NCT00271609|4225911|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398998|NCT00271609|4225912|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4398999|NCT00271609|4225910|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399000|NCT00271609|4225911|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399001|NCT00271609|4225912|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399002|NCT00271609|4225910|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4399003|NCT00271609|4225911|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4399004|NCT00271609|4225912|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4399005|NCT00271609|4225910|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4399006|NCT00271609|4225911|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4399007|NCT00271609|4225912|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4399008|NCT00271609|4225910|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4399009|NCT00271609|4225911|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4399010|NCT00271609|4225912|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4399011|NCT00271609|4225910|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4399012|NCT00271609|4225911|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4399013|NCT00271609|4225912|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4399014|NCT00271609|4225910|B3|||Age||years|Mean|48.66|48.66|Standard Deviation|11.3|11.3|||
4399015|NCT00271609|4225911|B2|||Age||years|Mean|52.33|52.33|Standard Deviation|10.6|10.6|||
4399016|NCT00271609|4225912|B1|||Age||years|Mean|45|45.0|Standard Deviation|12|12.0|||
4399017|NCT00271609|4225910|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4399018|NCT00271609|4225911|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4399019|NCT00271609|4225912|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4399020|NCT00271609|4225910|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4399021|NCT00271609|4225911|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4399022|NCT00271609|4225912|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4399023|NCT00271609|4225910|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399024|NCT00271609|4225911|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399025|NCT00271609|4225912|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399026|NCT00271596|4225921|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4399027|NCT00271596|4225922|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4399028|NCT00271596|4225923|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4399029|NCT00271596|4225921|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4399030|NCT00271596|4225922|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4399031|NCT00271596|4225923|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4399032|NCT00271596|4225921|B3|Age||Age||years|Mean|46.2|46.2|Standard Deviation|13.9|13.9|||
4399033|NCT00271596|4225922|B2|Age||Age||years|Mean|45.13|45.13|Standard Deviation|13.59|13.59|||
4399034|NCT00271596|4225923|B1|Age||Age||years|Mean|47.33|47.33|Standard Deviation|14.61|14.61|||
4399035|NCT00271570|4225948|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4399036|NCT00271570|4225949|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4399037|NCT00271570|4225950|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4399038|NCT00271570|4225948|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4399039|NCT00271570|4225949|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4399040|NCT00271570|4225950|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4399041|NCT00271570|4225948|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4399042|NCT00271570|4225949|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4399043|NCT00271570|4225950|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4399044|NCT00271570|4225948|B3|||Age||years|Mean|1.75|1.75|Standard Deviation|.3|0.3|||
4399045|NCT00271570|4225949|B2|||Age||years|Mean|1.667|1.667|Standard Deviation|.3|0.3|||
4399046|NCT00271570|4225950|B1|||Age||years|Mean|1.833|1.833|Standard Deviation|.3|0.3|||
4399047|NCT00271570|4225948|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399048|NCT00271570|4225949|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399049|NCT00271570|4225950|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399050|NCT00271570|4225948|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4399051|NCT00271570|4225949|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4399052|NCT00271570|4225950|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4399053|NCT00271570|4225948|B3||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4399054|NCT00271570|4225949|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4399055|NCT00271570|4225950|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4399056|NCT00271544|4225959|B1|||Left Ventricular Ejection Fraction|All subjects who underwent an implant attempt (186) were included in the study population analyses. Some subjects did not report data or data was outside the criteria, this was captured as a protocol deviation. Left ventricular ejection fraction is the fraction of blood pumped out of the left ventricle with each heartbeat. For this measurement, the fraction is presented as a percent.|Percent|Mean|24.2|24.2|Standard Deviation|6.9|6.9|||
4399057|NCT00271544|4225959|B1|||Intrinsic QRS Width|All subjects who underwent an implant attempt (186) were included in the study population analyses. Some subjects did not report data or data was outside the criteria, this was captured as a protocol deviation.|Milliseconds|Mean|153.1|153.1|Standard Deviation|24.1|24.1|||
4399058|NCT00271544|4225959|B1|White||Race / Ethnicity|All subjects who underwent an implant attempt (186) were included in the study population analyses.|Participants|Number|161|161.0||||||
4399059|NCT00271544|4225959|B1|Subject chose not to provide||Race / Ethnicity|All subjects who underwent an implant attempt (186) were included in the study population analyses.|Participants|Number|6|6.0||||||
4399060|NCT00271544|4225959|B1|Sri Lankan||Race / Ethnicity|All subjects who underwent an implant attempt (186) were included in the study population analyses.|Participants|Number|1|1.0||||||
4399061|NCT00271544|4225959|B1|Native Hawaiian or Pacific Islander||Race / Ethnicity|All subjects who underwent an implant attempt (186) were included in the study population analyses.|Participants|Number|1|1.0||||||
4399062|NCT00271544|4225959|B1|Hispanic or Latino||Race / Ethnicity|All subjects who underwent an implant attempt (186) were included in the study population analyses.|Participants|Number|3|3.0||||||
4399063|NCT00271544|4225959|B1|Columbian||Race / Ethnicity|All subjects who underwent an implant attempt (186) were included in the study population analyses.|Participants|Number|1|1.0||||||
4399064|NCT00271544|4225959|B1|Black or African American||Race / Ethnicity|All subjects who underwent an implant attempt (186) were included in the study population analyses.|Participants|Number|10|10.0||||||
4399065|NCT00271544|4225959|B1|Asian||Race / Ethnicity|All subjects who underwent an implant attempt (186) were included in the study population analyses.|Participants|Number|2|2.0||||||
4399066|NCT00271544|4225959|B1|American Indian or Alaska Native||Race / Ethnicity|All subjects who underwent an implant attempt (186) were included in the study population analyses.|Participants|Number|1|1.0||||||
4399067|NCT00271544|4225959|B1|Missing||New York Heart Association|All subjects who underwent an implant attempt (186) were included in the study population analyses. Some subjects did not report data or data was outside the criteria, this was captured as a protocol deviation.|Participants|Number|2|2.0||||||
4399068|NCT00271544|4225959|B1|Class IV||New York Heart Association|All subjects who underwent an implant attempt (186) were included in the study population analyses. Some subjects did not report data or data was outside the criteria, this was captured as a protocol deviation.|Participants|Number|2|2.0||||||
4399069|NCT00271544|4225959|B1|Class III||New York Heart Association|All subjects who underwent an implant attempt (186) were included in the study population analyses. Some subjects did not report data or data was outside the criteria, this was captured as a protocol deviation.|Participants|Number|182|182.0||||||
4399070|NCT00271544|4225959|B1|Canada||Region of Enrollment||participants|Number|43|43.0||||||
4399071|NCT00271544|4225959|B1|United States||Region of Enrollment||participants|Number|143|143.0||||||
4399072|NCT00271544|4225959|B1||Male|Sex: Female, Male|All subjects who underwent an implant attempt (186) were included in the study population analyses.|Participants|Count of Participants|138|138.0||||||
4399073|NCT00271544|4225959|B1||Female|Sex: Female, Male|All subjects who underwent an implant attempt (186) were included in the study population analyses.|Participants|Count of Participants|48|48.0||||||
4399074|NCT00271544|4225959|B1|||Age|All subjects who underwent an implant attempt (186) were included in the study population analyses.|years|Mean|69.1|69.1|Standard Deviation|11.1|11.1|||
4399075|NCT00271544|4225959|B1||>=65 years|Age|All subjects who underwent an implant attempt (186) were included in the study population analyses.|Participants|Count of Participants|129|129.0||||||
4399076|NCT00271544|4225959|B1||Between 18 and 65 years|Age|All subjects who underwent an implant attempt (186) were included in the study population analyses.|Participants|Count of Participants|57|57.0||||||
4399077|NCT00271544|4225959|B1||<=18 years|Age|All subjects who underwent an implant attempt (186) were included in the study population analyses.|Participants|Count of Participants|0|0.0||||||
4399078|NCT00271375|4225980|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4399079|NCT00271375|4225981|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4399080|NCT00271375|4225982|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399081|NCT00271375|4225983|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4399082|NCT00271375|4225980|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399083|NCT00271375|4225981|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399084|NCT00271375|4225982|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399085|NCT00271375|4225983|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399086|NCT00271375|4225980|B4||White|Race (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
4399087|NCT00271375|4225981|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4399088|NCT00271375|4225982|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4399089|NCT00271375|4225983|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4399090|NCT00271375|4225980|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4399091|NCT00271375|4225981|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4399092|NCT00271375|4225982|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4399093|NCT00271375|4225983|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4399094|NCT00271375|4225980|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399095|NCT00271375|4225981|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399096|NCT00271375|4225982|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399097|NCT00271375|4225983|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399098|NCT00271375|4225980|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399099|NCT00271375|4225981|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399100|NCT00271375|4225982|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399101|NCT00271375|4225983|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399102|NCT00271375|4225980|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399103|NCT00271375|4225981|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399104|NCT00271375|4225982|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399105|NCT00271375|4225983|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399106|NCT00271375|4225980|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4399107|NCT00271375|4225981|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4399108|NCT00271375|4225982|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4399109|NCT00271375|4225983|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4399110|NCT00271375|4225980|B4||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4399111|NCT00271375|4225981|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4399112|NCT00271375|4225982|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4399113|NCT00271375|4225983|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4399114|NCT00271375|4225980|B4|||Age|Age|Years|Mean|64.69|64.69|Standard Deviation|11.24|11.24|||
4399115|NCT00271375|4225981|B3|||Age|Age|Years|Mean|61.1|61.1|Standard Deviation|9.8|9.8|||
4399116|NCT00271375|4225982|B2|||Age|Age|Years|Mean|63.4|63.4|Standard Deviation|11.7|11.7|||
4399117|NCT00271375|4225983|B1|||Age|Age|Years|Mean|66.9|66.9|Standard Deviation|11.0|11.0|||
4399118|NCT00271219|4226021|B3|Austria||Region of Enrollment||participants|Number|37|37.0||||||
4399119|NCT00271219|4226022|B2|Austria||Region of Enrollment||participants|Number|18|18.0||||||
4399120|NCT00271219|4226023|B1|Austria||Region of Enrollment||participants|Number|19|19.0||||||
4399121|NCT00271219|4226021|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4399122|NCT00271219|4226022|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4399123|NCT00271219|4226023|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4399124|NCT00271219|4226021|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4399125|NCT00271219|4226022|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4399126|NCT00271219|4226023|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4399127|NCT00271219|4226021|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4399128|NCT00271219|4226022|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4399129|NCT00271219|4226023|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4399130|NCT00271219|4226021|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|0.7|0.7|||
4399131|NCT00271219|4226022|B2|||Age||years|Mean|25.3|25.3|Standard Deviation|0.7|0.7|||
4399132|NCT00271219|4226023|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|0.7|0.7|||
4399133|NCT00271219|4226021|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399134|NCT00271219|4226022|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399135|NCT00271219|4226023|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399136|NCT00271219|4226021|B3||Between 18 and 65 years|Age||Participants|Count of Participants|131|131.0||||||
4399137|NCT00271219|4226022|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4399138|NCT00271219|4226023|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4399139|NCT00271219|4226021|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399140|NCT00271219|4226022|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399141|NCT00271219|4226023|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399142|NCT00271154|4226048|B3|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4399143|NCT00271154|4226049|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4399144|NCT00271154|4226050|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4399145|NCT00271154|4226048|B3|Sweden||Region of Enrollment||participants|Number|24|24.0||||||
4399146|NCT00271154|4226049|B2|Sweden||Region of Enrollment||participants|Number|17|17.0||||||
4399147|NCT00271154|4226050|B1|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
4399148|NCT00271154|4226048|B3|Norway||Region of Enrollment||participants|Number|7|7.0||||||
4399149|NCT00271154|4226049|B2|Norway||Region of Enrollment||participants|Number|4|4.0||||||
4399150|NCT00271154|4226050|B1|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4399151|NCT00271154|4226048|B3|Germany||Region of Enrollment||participants|Number|17|17.0||||||
4399152|NCT00271154|4226049|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4399153|NCT00271154|4226050|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4399154|NCT00271154|4226048|B3|Denmark||Region of Enrollment||participants|Number|65|65.0||||||
4399155|NCT00271154|4226049|B2|Denmark||Region of Enrollment||participants|Number|46|46.0||||||
4399156|NCT00271154|4226050|B1|Denmark||Region of Enrollment||participants|Number|19|19.0||||||
4399157|NCT00271154|4226048|B3|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4399158|NCT00271154|4226049|B2|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4399159|NCT00271154|4226050|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4399160|NCT00271154|4226048|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4399161|NCT00271154|4226049|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4399162|NCT00271154|4226050|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4399163|NCT00271154|4226048|B3|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
4399164|NCT00271154|4226049|B2|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
4399165|NCT00271154|4226050|B1|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4399166|NCT00271154|4226048|B3|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4399167|NCT00271154|4226049|B2|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4399168|NCT00271154|4226050|B1|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4399169|NCT00271154|4226048|B3|France||Region of Enrollment||participants|Number|49|49.0||||||
4399170|NCT00271154|4226049|B2|France||Region of Enrollment||participants|Number|34|34.0||||||
4399171|NCT00271154|4226050|B1|France||Region of Enrollment||participants|Number|15|15.0||||||
4399172|NCT00271154|4226048|B3|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4399173|NCT00271154|4226049|B2|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4399174|NCT00271154|4226050|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4399175|NCT00271154|4226048|B3|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4399176|NCT00271154|4226049|B2|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4399177|NCT00271154|4226050|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4399178|NCT00271154|4226048|B3|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4399179|NCT00271154|4226049|B2|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4399180|NCT00271154|4226050|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4399181|NCT00271154|4226048|B3|Ireland||Region of Enrollment||participants|Number|5|5.0||||||
4399182|NCT00271154|4226049|B2|Ireland||Region of Enrollment||participants|Number|4|4.0||||||
4399183|NCT00271154|4226050|B1|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4399184|NCT00271154|4226048|B3|Spain||Region of Enrollment||participants|Number|27|27.0||||||
4399185|NCT00271154|4226049|B2|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4399186|NCT00271154|4226050|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4399187|NCT00271154|4226048|B3|United States||Region of Enrollment||participants|Number|343|343.0||||||
4399188|NCT00271154|4226049|B2|United States||Region of Enrollment||participants|Number|235|235.0||||||
4399189|NCT00271154|4226050|B1|United States||Region of Enrollment||participants|Number|108|108.0||||||
4399190|NCT00271154|4226048|B3||Male|Sex: Female, Male||Participants|Count of Participants|479|479.0||||||
4399191|NCT00271154|4226049|B2||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4399192|NCT00271154|4226050|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4399193|NCT00271154|4226048|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4399194|NCT00271154|4226049|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4399195|NCT00271154|4226050|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4399196|NCT00271154|4226048|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|11.0|11.0|||
4399197|NCT00271154|4226049|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|10.6|10.6|||
4399198|NCT00271154|4226050|B1|||Age||years|Mean|61.8|61.8|Standard Deviation|11.6|11.6|||
4399199|NCT00271154|4226048|B3||>=65 years|Age||Participants|Count of Participants|273|273.0||||||
4399200|NCT00271154|4226049|B2||>=65 years|Age||Participants|Count of Participants|190|190.0||||||
4399201|NCT00271154|4226050|B1||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
4399202|NCT00271154|4226048|B3||Between 18 and 65 years|Age||Participants|Count of Participants|337|337.0||||||
4399203|NCT00271154|4226049|B2||Between 18 and 65 years|Age||Participants|Count of Participants|229|229.0||||||
4399204|NCT00271154|4226050|B1||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4399205|NCT00271154|4226048|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399206|NCT00271154|4226049|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399207|NCT00271154|4226050|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399208|NCT00271024|4226060|B5|United States||Region of Enrollment||participants|Number|333|333.0||||||
4399209|NCT00271024|4226061|B4|United States||Region of Enrollment||participants|Number|88|88.0||||||
4399210|NCT00271024|4226062|B3|United States||Region of Enrollment||participants|Number|88|88.0||||||
4399211|NCT00271024|4226063|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4399212|NCT00271024|4226064|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4399213|NCT00271024|4226060|B5||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4399214|NCT00271024|4226061|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4399215|NCT00271024|4226062|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4399216|NCT00271024|4226063|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4399217|NCT00271024|4226064|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4399218|NCT00271024|4226060|B5||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4399219|NCT00271024|4226061|B4||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4399220|NCT00271024|4226062|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4399221|NCT00271024|4226063|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4399222|NCT00271024|4226064|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4399223|NCT00271024|4226060|B5|||Age||years|Mean|42.13|42.13|Standard Deviation|11.27|11.27|||
4399224|NCT00271024|4226061|B4|||Age||years|Mean|44.95|44.95|Standard Deviation|10.45|10.45|||
4399225|NCT00271024|4226062|B3|||Age||years|Mean|44.34|44.34|Standard Deviation|11.49|11.49|||
4399226|NCT00271024|4226063|B2|||Age||years|Mean|40.21|40.21|Standard Deviation|10.98|10.98|||
4399227|NCT00271024|4226064|B1|||Age||years|Mean|38.45|38.45|Standard Deviation|10.97|10.97|||
4399228|NCT00271024|4226060|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4399229|NCT00271024|4226061|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399230|NCT00271024|4226062|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4399231|NCT00271024|4226063|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399232|NCT00271024|4226064|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399233|NCT00271024|4226060|B5||Between 18 and 65 years|Age||Participants|Count of Participants|331|331.0||||||
4399234|NCT00271024|4226061|B4||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4399235|NCT00271024|4226062|B3||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4399236|NCT00271024|4226063|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4399237|NCT00271024|4226064|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4399238|NCT00271024|4226060|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399239|NCT00271024|4226061|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399240|NCT00271024|4226062|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399241|NCT00271024|4226063|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399242|NCT00271024|4226064|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399243|NCT00271011|4226109|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4399244|NCT00271011|4226109|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4399245|NCT00271011|4226109|B1|||Age||years|Mean|56|56.0|Full Range|||37.0|78.0|
4399246|NCT00270998|4226114|B4|||Currently Receiving Estrogen Therapy||Participants|Count of Participants|67|67.0||||||
4399247|NCT00270998|4226115|B3|||Currently Receiving Estrogen Therapy||Participants|Count of Participants|16|16.0||||||
4399248|NCT00270998|4226116|B2|||Currently Receiving Estrogen Therapy||Participants|Count of Participants|24|24.0||||||
4399249|NCT00270998|4226117|B1|||Currently Receiving Estrogen Therapy||Participants|Count of Participants|27|27.0||||||
4399250|NCT00270998|4226114|B4|Fewer than 14 episodes per wk||Incontinence Frequency||Participants|Count of Participants|243|243.0||||||
4399251|NCT00270998|4226115|B3|Fewer than 14 episodes per wk||Incontinence Frequency||Participants|Count of Participants|83|83.0||||||
4399252|NCT00270998|4226116|B2|Fewer than 14 episodes per wk||Incontinence Frequency||Participants|Count of Participants|79|79.0||||||
4399253|NCT00270998|4226117|B1|Fewer than 14 episodes per wk||Incontinence Frequency||Participants|Count of Participants|81|81.0||||||
4399254|NCT00270998|4226114|B4|14 or more episodes per wk||Incontinence Frequency||Participants|Count of Participants|202|202.0||||||
4399255|NCT00270998|4226115|B3|14 or more episodes per wk||Incontinence Frequency||Participants|Count of Participants|67|67.0||||||
4399256|NCT00270998|4226116|B2|14 or more episodes per wk||Incontinence Frequency||Participants|Count of Participants|67|67.0||||||
4399257|NCT00270998|4226117|B1|14 or more episodes per wk||Incontinence Frequency||Participants|Count of Participants|68|68.0||||||
4399258|NCT00270998|4226114|B4|Mixed||Incontinence Type||Participants|Count of Participants|241|241.0||||||
4399259|NCT00270998|4226115|B3|Mixed||Incontinence Type||Participants|Count of Participants|80|80.0||||||
4399260|NCT00270998|4226116|B2|Mixed||Incontinence Type||Participants|Count of Participants|81|81.0||||||
4399261|NCT00270998|4226117|B1|Mixed||Incontinence Type||Participants|Count of Participants|80|80.0||||||
4399262|NCT00270998|4226114|B4|Stress Only||Incontinence Type||Participants|Count of Participants|204|204.0||||||
4399263|NCT00270998|4226115|B3|Stress Only||Incontinence Type||Participants|Count of Participants|70|70.0||||||
4399264|NCT00270998|4226116|B2|Stress Only||Incontinence Type||Participants|Count of Participants|65|65.0||||||
4399265|NCT00270998|4226117|B1|Stress Only||Incontinence Type||Participants|Count of Participants|69|69.0||||||
4399266|NCT00270998|4226114|B4|||Hysterectomy||Participants|Count of Participants|110|110.0||||||
4399267|NCT00270998|4226115|B3|||Hysterectomy||Participants|Count of Participants|32|32.0||||||
4399268|NCT00270998|4226116|B2|||Hysterectomy||Participants|Count of Participants|39|39.0||||||
4399269|NCT00270998|4226117|B1|||Hysterectomy||Participants|Count of Participants|39|39.0||||||
4399270|NCT00270998|4226114|B4|||Prior UI Surgery||Participants|Count of Participants|27|27.0||||||
4399271|NCT00270998|4226115|B3|||Prior UI Surgery||Participants|Count of Participants|10|10.0||||||
4399272|NCT00270998|4226116|B2|||Prior UI Surgery||Participants|Count of Participants|7|7.0||||||
4399273|NCT00270998|4226117|B1|||Prior UI Surgery||Participants|Count of Participants|10|10.0||||||
4399274|NCT00270998|4226114|B4|||Prior Nonsurgical UI||Participants|Count of Participants|92|92.0||||||
4399275|NCT00270998|4226115|B3|||Prior Nonsurgical UI||Participants|Count of Participants|27|27.0||||||
4399276|NCT00270998|4226116|B2|||Prior Nonsurgical UI||Participants|Count of Participants|35|35.0||||||
4399277|NCT00270998|4226117|B1|||Prior Nonsurgical UI||Participants|Count of Participants|30|30.0||||||
4399278|NCT00270998|4226114|B4|Not sure||Menstrual Status||Participants|Count of Participants|43|43.0||||||
4399279|NCT00270998|4226115|B3|Not sure||Menstrual Status||Participants|Count of Participants|16|16.0||||||
4399280|NCT00270998|4226116|B2|Not sure||Menstrual Status||Participants|Count of Participants|13|13.0||||||
4399281|NCT00270998|4226117|B1|Not sure||Menstrual Status||Participants|Count of Participants|14|14.0||||||
4399282|NCT00270998|4226114|B4|Post-menopausal||Menstrual Status||Participants|Count of Participants|188|188.0||||||
4399283|NCT00270998|4226115|B3|Post-menopausal||Menstrual Status||Participants|Count of Participants|66|66.0||||||
4399284|NCT00270998|4226116|B2|Post-menopausal||Menstrual Status||Participants|Count of Participants|62|62.0||||||
4399285|NCT00270998|4226117|B1|Post-menopausal||Menstrual Status||Participants|Count of Participants|60|60.0||||||
4399286|NCT00270998|4226114|B4|Pre-menopausal||Menstrual Status||Participants|Count of Participants|214|214.0||||||
4399287|NCT00270998|4226115|B3|Pre-menopausal||Menstrual Status||Participants|Count of Participants|68|68.0||||||
4399288|NCT00270998|4226116|B2|Pre-menopausal||Menstrual Status||Participants|Count of Participants|71|71.0||||||
4399289|NCT00270998|4226117|B1|Pre-menopausal||Menstrual Status||Participants|Count of Participants|75|75.0||||||
4399290|NCT00270998|4226114|B4|||Vaginal Deliveries||deliveries|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
4399291|NCT00270998|4226115|B3|||Vaginal Deliveries||deliveries|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
4399292|NCT00270998|4226116|B2|||Vaginal Deliveries||deliveries|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
4399293|NCT00270998|4226117|B1|||Vaginal Deliveries||deliveries|Median|2|2.0|Inter-Quartile Range|||1.0|3.0|
4399294|NCT00270998|4226114|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4399295|NCT00270998|4226115|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4399296|NCT00270998|4226116|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4399297|NCT00270998|4226117|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4399298|NCT00270998|4226114|B4|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|45|45.0||||||
4399299|NCT00270998|4226115|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4399300|NCT00270998|4226116|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4399301|NCT00270998|4226117|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4399302|NCT00270998|4226114|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|380|380.0||||||
4399303|NCT00270998|4226115|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|122|122.0||||||
4399304|NCT00270998|4226116|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|132|132.0||||||
4399305|NCT00270998|4226117|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|126|126.0||||||
4399306|NCT00270998|4226114|B4|Female||Sex/Gender, Customized||Participants|Count of Participants|445|445.0||||||
4399307|NCT00270998|4226115|B3|Female||Sex/Gender, Customized||Participants|Count of Participants|150|150.0||||||
4399308|NCT00270998|4226116|B2|Female||Sex/Gender, Customized||Participants|Count of Participants|146|146.0||||||
4399309|NCT00270998|4226117|B1|Female||Sex/Gender, Customized||Participants|Count of Participants|149|149.0||||||
4399310|NCT00270998|4226114|B4|||Age||years|Mean|49.8|49.8|Standard Deviation|11.9|11.9|||
4399311|NCT00270998|4226115|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|11.8|11.8|||
4399312|NCT00270998|4226116|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|13.0|13.0|||
4399313|NCT00270998|4226117|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|11.0|11.0|||
4399314|NCT00270894|4226148|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4399315|NCT00270894|4226148|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4399316|NCT00270894|4226148|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4399317|NCT00270894|4226148|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|11.17|11.17|||
4399318|NCT00270894|4226148|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4399319|NCT00270894|4226148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4399320|NCT00270894|4226148|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399321|NCT00270855|4226158|B3|||Bone Mineral Density||g/cm^2|Mean|1.209|1.209|Standard Deviation|0.140|0.14|||
4399322|NCT00270855|4226159|B2|||Bone Mineral Density||g/cm^2|Mean|1.293|1.293|Standard Deviation|0.135|0.135|||
4399323|NCT00270855|4226160|B1|||Bone Mineral Density||g/cm^2|Mean|1.138|1.138|Standard Deviation|0.104|0.104|||
4399324|NCT00270855|4226158|B3|||HDL-Cholesterol||mg/dl|Mean|36.7|36.7|Standard Deviation|7.1|7.1|||
4399325|NCT00270855|4226159|B2|||HDL-Cholesterol||mg/dl|Mean|37.8|37.8|Standard Deviation|8.3|8.3|||
4399326|NCT00270855|4226160|B1|||HDL-Cholesterol||mg/dl|Mean|35.7|35.7|Standard Deviation|6.4|6.4|||
4399327|NCT00270855|4226158|B3|||Total Cholesterol||mg/dl|Mean|172|172.0|Standard Deviation|38|38.0|||
4399328|NCT00270855|4226159|B2|||Total Cholesterol||mg/dl|Mean|167|167.0|Standard Deviation|49|49.0|||
4399329|NCT00270855|4226160|B1|||Total Cholesterol||mg/dl|Mean|176|176.0|Standard Deviation|29|29.0|||
4399330|NCT00270855|4226158|B3|||Resting Metabolic Rate||Kcal/d|Mean|1565|1565.0|Standard Deviation|689|689.0|||
4399331|NCT00270855|4226159|B2|||Resting Metabolic Rate||Kcal/d|Mean|1710|1710.0|Standard Deviation|974|974.0|||
4399332|NCT00270855|4226160|B1|||Resting Metabolic Rate||Kcal/d|Mean|1442|1442.0|Standard Deviation|348|348.0|||
4399333|NCT00270855|4226158|B3|||Exercise Energy Expenditure (Kcal/session)||Kcal/session|Mean|101|101.0|Standard Deviation|34|34.0|||
4399334|NCT00270855|4226159|B2|||Exercise Energy Expenditure (Kcal/session)||Kcal/session|Mean|80.7|80.7|Standard Deviation|32.6|32.6|||
4399335|NCT00270855|4226160|B1|||Exercise Energy Expenditure (Kcal/session)||Kcal/session|Mean|128.3|128.3|Standard Deviation|35.4|35.4|||
4399336|NCT00270855|4226158|B3|||Insulin Sensitivity (Si)||μu/ml|Mean|2.85|2.85|Standard Deviation|2|2.0|||
4399337|NCT00270855|4226159|B2|||Insulin Sensitivity (Si)||μu/ml|Mean|2.7|2.7|Standard Deviation|2.0|2.0|||
4399338|NCT00270855|4226160|B1|||Insulin Sensitivity (Si)||μu/ml|Mean|3.0|3.0|Standard Deviation|2.0|2.0|||
4399339|NCT00270855|4226158|B3|||Glucose Effectiveness (Sg)||min^-1|Mean|0.02|0.02|Standard Deviation|0.01|0.01|||
4399340|NCT00270855|4226159|B2|||Glucose Effectiveness (Sg)||min^-1|Mean|0.017|0.017|Standard Deviation|0.01|0.01|||
4399341|NCT00270855|4226160|B1|||Glucose Effectiveness (Sg)||min^-1|Mean|0.023|0.023|Standard Deviation|0.01|0.01|||
4399342|NCT00270855|4226158|B3|||Fat-Free Mass (kg)||Kg|Mean|49.55|49.55|Standard Deviation|10.15|10.15|||
4399343|NCT00270855|4226159|B2|||Fat-Free Mass (kg)||Kg|Mean|49.5|49.5|Standard Deviation|11.2|11.2|||
4399344|NCT00270855|4226160|B1|||Fat-Free Mass (kg)||Kg|Mean|49.6|49.6|Standard Deviation|9.1|9.1|||
4399345|NCT00270855|4226158|B3|||Fat Mass (Kg)||Kg|Mean|31.5|31.5|Standard Deviation|8.7|8.7|||
4399346|NCT00270855|4226159|B2|||Fat Mass (Kg)||Kg|Mean|33.4|33.4|Standard Deviation|11.0|11.0|||
4399347|NCT00270855|4226160|B1|||Fat Mass (Kg)||Kg|Mean|29.6|29.6|Standard Deviation|6.4|6.4|||
4399348|NCT00270855|4226158|B3|||% Body Fat||Percent Body Fat|Mean|40.75|40.75|Standard Deviation|7.4|7.4|||
4399349|NCT00270855|4226159|B2|||% Body Fat||Percent Body Fat|Mean|41.6|41.6|Standard Deviation|7.1|7.1|||
4399350|NCT00270855|4226160|B1|||% Body Fat||Percent Body Fat|Mean|38.9|38.9|Standard Deviation|6.9|6.9|||
4399351|NCT00270855|4226158|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4399352|NCT00270855|4226159|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4399353|NCT00270855|4226160|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4399354|NCT00270855|4226158|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4399355|NCT00270855|4226159|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4399356|NCT00270855|4226160|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4399357|NCT00270855|4226158|B3|||Age||Years|Mean|40.5|40.5|Standard Deviation|12|12.0|||
4399358|NCT00270855|4226159|B2|||Age||Years|Mean|39|39.0|Standard Deviation|14|14.0|||
4399359|NCT00270855|4226160|B1|||Age||Years|Mean|42|42.0|Standard Deviation|10|10.0|||
4399360|NCT00270842|4226217|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4399361|NCT00270842|4226218|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4399362|NCT00270842|4226219|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4399363|NCT00270842|4226220|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4399364|NCT00270842|4226217|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4399365|NCT00270842|4226218|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4399366|NCT00270842|4226219|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4399367|NCT00270842|4226220|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4399368|NCT00270842|4226217|B4|||Age||years|Mean|67.8|67.8|Standard Deviation|10.6|10.6|||
4399369|NCT00270842|4226218|B3|||Age||years|Mean|68.4|68.4|Standard Deviation|9.3|9.3|||
4399370|NCT00270842|4226219|B2|||Age||years|Mean|67.6|67.6|Standard Deviation|10.6|10.6|||
4399371|NCT00270842|4226220|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|10.2|10.2|||
4399372|NCT00270790|4226233|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4399373|NCT00270790|4226233|B1||Male|Gender||Participants|Count of Participants|18|18.0||||||
4399374|NCT00270790|4226233|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4399375|NCT00270790|4226233|B1|||Age||years|Mean|58.2|58.2|Full Range|||48.0|70.0|
4399376|NCT00270790|4226233|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4399377|NCT00270790|4226233|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4399378|NCT00270790|4226233|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399379|NCT00270634|4226238|B5|Canada||Region of Enrollment||participants|Number|44|44.0||||||
4399380|NCT00270634|4226239|B4|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4399381|NCT00270634|4226240|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4399382|NCT00270634|4226241|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4399383|NCT00270634|4226242|B1|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4399384|NCT00270634|4226238|B5|United States||Region of Enrollment||participants|Number|290|290.0||||||
4399385|NCT00270634|4226239|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
4399386|NCT00270634|4226240|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4399387|NCT00270634|4226241|B2|United States||Region of Enrollment||participants|Number|67|67.0||||||
4399388|NCT00270634|4226242|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
4399389|NCT00270634|4226238|B5||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4399390|NCT00270634|4226239|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4399391|NCT00270634|4226240|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4399392|NCT00270634|4226241|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4399393|NCT00270634|4226242|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4399394|NCT00270634|4226238|B5||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4399395|NCT00270634|4226239|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4399396|NCT00270634|4226240|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4399397|NCT00270634|4226241|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4399398|NCT00270634|4226242|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4399399|NCT00270634|4226238|B5||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4399400|NCT00270634|4226239|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4399401|NCT00270634|4226240|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4399402|NCT00270634|4226241|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4399403|NCT00270634|4226242|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4399404|NCT00270634|4226238|B5||Between 18 and 65 years|Age||Participants|Count of Participants|319|319.0||||||
4399405|NCT00270634|4226239|B4||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4399406|NCT00270634|4226240|B3||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4399407|NCT00270634|4226241|B2||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4399408|NCT00270634|4226242|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4399409|NCT00270634|4226238|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399410|NCT00270634|4226239|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399411|NCT00270634|4226240|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399412|NCT00270634|4226241|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399413|NCT00270634|4226242|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399414|NCT00270296|4226279|B4|Botswana||Region of Enrollment||participants|Number|730|730.0||||||
4399415|NCT00270296|4226280|B3|Botswana||Region of Enrollment||participants|Number|170|170.0||||||
4399416|NCT00270296|4226281|B2|Botswana||Region of Enrollment||participants|Number|275|275.0||||||
4399417|NCT00270296|4226282|B1|Botswana||Region of Enrollment||participants|Number|285|285.0||||||
4399418|NCT00270296|4226279|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399419|NCT00270296|4226280|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399420|NCT00270296|4226281|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399421|NCT00270296|4226282|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399422|NCT00270296|4226279|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399423|NCT00270296|4226280|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399424|NCT00270296|4226281|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399425|NCT00270296|4226282|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399426|NCT00270296|4226279|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399427|NCT00270296|4226280|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399428|NCT00270296|4226281|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399429|NCT00270296|4226282|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399430|NCT00270296|4226279|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|730|730.0||||||
4399431|NCT00270296|4226280|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
4399432|NCT00270296|4226281|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|275|275.0||||||
4399433|NCT00270296|4226282|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|285|285.0||||||
4399434|NCT00270296|4226279|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399435|NCT00270296|4226280|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399436|NCT00270296|4226281|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399437|NCT00270296|4226282|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399438|NCT00270296|4226279|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399439|NCT00270296|4226280|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399440|NCT00270296|4226281|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399441|NCT00270296|4226282|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399442|NCT00270296|4226279|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399443|NCT00270296|4226280|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399444|NCT00270296|4226281|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399445|NCT00270296|4226282|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399446|NCT00270296|4226279|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4399447|NCT00270296|4226280|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4399448|NCT00270296|4226281|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4399449|NCT00270296|4226282|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4399450|NCT00270296|4226279|B4||Female|Sex: Female, Male||Participants|Count of Participants|730|730.0||||||
4399451|NCT00270296|4226280|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4399452|NCT00270296|4226281|B2||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4399453|NCT00270296|4226282|B1||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4399454|NCT00270296|4226279|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399455|NCT00270296|4226280|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399456|NCT00270296|4226281|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399457|NCT00270296|4226282|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399458|NCT00270296|4226279|B4||Between 18 and 65 years|Age||Participants|Count of Participants|730|730.0||||||
4399459|NCT00270296|4226280|B3||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
4399460|NCT00270296|4226281|B2||Between 18 and 65 years|Age||Participants|Count of Participants|275|275.0||||||
4399461|NCT00270296|4226282|B1||Between 18 and 65 years|Age||Participants|Count of Participants|285|285.0||||||
4399462|NCT00270296|4226279|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399463|NCT00270296|4226280|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399464|NCT00270296|4226281|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399465|NCT00270296|4226282|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399466|NCT00270257|4226295|B3|||Years of Injection||Years|Median|7|7.0|Inter-Quartile Range|||3.0|12.0|
4399467|NCT00270257|4226296|B2|||Years of Injection||Years|Median|7|7.0|Inter-Quartile Range|||3.0|12.0|
4399468|NCT00270257|4226297|B1|||Years of Injection||Years|Median|7|7.0|Inter-Quartile Range|||3.0|12.0|
4399469|NCT00270257|4226295|B3|Thailand||Region of Enrollment||participants|Number|201|201.0||||||
4399470|NCT00270257|4226296|B2|Thailand||Region of Enrollment||participants|Number|100|100.0||||||
4399471|NCT00270257|4226297|B1|Thailand||Region of Enrollment||participants|Number|101|101.0||||||
4399472|NCT00270257|4226295|B3|China||Region of Enrollment||participants|Number|1049|1049.0||||||
4399473|NCT00270257|4226296|B2|China||Region of Enrollment||participants|Number|527|527.0||||||
4399474|NCT00270257|4226297|B1|China||Region of Enrollment||participants|Number|522|522.0||||||
4399475|NCT00270257|4226295|B3||Male|Gender||Participants|Count of Participants|1151|1151.0||||||
4399476|NCT00270257|4226296|B2||Male|Gender||Participants|Count of Participants|577|577.0||||||
4399477|NCT00270257|4226297|B1||Male|Gender||Participants|Count of Participants|574|574.0||||||
4399478|NCT00270257|4226295|B3||Female|Gender||Participants|Count of Participants|99|99.0||||||
4399479|NCT00270257|4226296|B2||Female|Gender||Participants|Count of Participants|50|50.0||||||
4399480|NCT00270257|4226297|B1||Female|Gender||Participants|Count of Participants|49|49.0||||||
4399481|NCT00270257|4226295|B3|||Age, Customized||years|Median|34|34.0|Inter-Quartile Range|||28.0|39.0|
4399482|NCT00270257|4226296|B2|||Age, Customized||years|Median|34|34.0|Inter-Quartile Range|||28.0|39.0|
4399483|NCT00270257|4226297|B1|||Age, Customized||years|Median|33|33.0|Inter-Quartile Range|||27.0|39.0|
4399484|NCT00270231|4226316|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4399485|NCT00270231|4226316|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4399486|NCT00270231|4226316|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4399487|NCT00270231|4226316|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|15.0|15.0|||
4399488|NCT00270231|4226316|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4399489|NCT00270231|4226316|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4399490|NCT00270231|4226316|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4399491|NCT00270205|4226323|B5|United States||Region of Enrollment||participants|Number|25|25.0||||||
4399492|NCT00270205|4226324|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4399493|NCT00270205|4226325|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4399494|NCT00270205|4226326|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4399495|NCT00270205|4226327|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4399496|NCT00270205|4226323|B5||Male|Sex: Female, Male|Participants who never started study vaccination were excluded.|Participants|Count of Participants|23|23.0||||||
4399497|NCT00270205|4226324|B4||Male|Sex: Female, Male|Participants who never started study vaccination were excluded.|Participants|Count of Participants|6|6.0||||||
4399498|NCT00270205|4226325|B3||Male|Sex: Female, Male|Participants who never started study vaccination were excluded.|Participants|Count of Participants|6|6.0||||||
4399499|NCT00270205|4226326|B2||Male|Sex: Female, Male|Participants who never started study vaccination were excluded.|Participants|Count of Participants|6|6.0||||||
4399500|NCT00270205|4226327|B1||Male|Sex: Female, Male|Participants who never started study vaccination were excluded.|Participants|Count of Participants|5|5.0||||||
4399501|NCT00270205|4226323|B5||Female|Sex: Female, Male|Participants who never started study vaccination were excluded.|Participants|Count of Participants|2|2.0||||||
4399502|NCT00270205|4226324|B4||Female|Sex: Female, Male|Participants who never started study vaccination were excluded.|Participants|Count of Participants|1|1.0||||||
4399503|NCT00270205|4226325|B3||Female|Sex: Female, Male|Participants who never started study vaccination were excluded.|Participants|Count of Participants|0|0.0||||||
4399504|NCT00270205|4226326|B2||Female|Sex: Female, Male|Participants who never started study vaccination were excluded.|Participants|Count of Participants|0|0.0||||||
4399505|NCT00270205|4226327|B1||Female|Sex: Female, Male|Participants who never started study vaccination were excluded.|Participants|Count of Participants|1|1.0||||||
4399506|NCT00270205|4226323|B5|41-50||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|10|10.0||||||
4399507|NCT00270205|4226324|B4|41-50||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|0|0.0||||||
4399508|NCT00270205|4226325|B3|41-50||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|4|4.0||||||
4399560|NCT00269477|4226474|B5||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4399509|NCT00270205|4226326|B2|41-50||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|3|3.0||||||
4399510|NCT00270205|4226327|B1|41-50||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|3|3.0||||||
4399511|NCT00270205|4226323|B5|31-40||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|10|10.0||||||
4399512|NCT00270205|4226324|B4|31-40||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|5|5.0||||||
4399513|NCT00270205|4226325|B3|31-40||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|1|1.0||||||
4399514|NCT00270205|4226326|B2|31-40||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|2|2.0||||||
4399515|NCT00270205|4226327|B1|31-40||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|2|2.0||||||
4399516|NCT00270205|4226323|B5|18-30||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|5|5.0||||||
4399517|NCT00270205|4226324|B4|18-30||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|2|2.0||||||
4399518|NCT00270205|4226325|B3|18-30||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|1|1.0||||||
4399519|NCT00270205|4226326|B2|18-30||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|1|1.0||||||
4399520|NCT00270205|4226327|B1|18-30||Age, Customized|Age (in years) at study entry. Participants who never started study vaccination were excluded.|participants|Number|1|1.0||||||
4399521|NCT00270205|4226323|B5|||Age|Age (in years) at study entry. Participants who never started study vaccination were excluded.|years|Median|39|39.0|Inter-Quartile Range|||32.0|45.0|
4399522|NCT00270205|4226324|B4|||Age|Age (in years) at study entry. Participants who never started study vaccination were excluded.|years|Median|34|34.0|Inter-Quartile Range|||30.0|35.0|
4399523|NCT00270205|4226325|B3|||Age|Age (in years) at study entry. Participants who never started study vaccination were excluded.|years|Median|46|46.0|Inter-Quartile Range|||34.0|47.0|
4399524|NCT00270205|4226326|B2|||Age|Age (in years) at study entry. Participants who never started study vaccination were excluded.|years|Median|41|41.0|Inter-Quartile Range|||38.0|43.0|
4399525|NCT00270205|4226327|B1|||Age|Age (in years) at study entry. Participants who never started study vaccination were excluded.|years|Median|44|44.0|Inter-Quartile Range|||32.0|48.0|
4399526|NCT00269919|4226448|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4399527|NCT00269919|4226448|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4399528|NCT00269919|4226448|B1|||Age||Years|Mean|35.0|35.0|Standard Deviation|8.3|8.3|||
4399529|NCT00269633|4226465|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4399530|NCT00269633|4226466|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4399531|NCT00269633|4226467|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4399532|NCT00269633|4226465|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4399533|NCT00269633|4226466|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4399534|NCT00269633|4226467|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4399535|NCT00269633|4226465|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4399536|NCT00269633|4226466|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4399537|NCT00269633|4226467|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4399538|NCT00269633|4226465|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|10.3|10.3|||
4399539|NCT00269633|4226466|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|10.8|10.8|||
4399540|NCT00269633|4226467|B1|||Age||years|Mean|40.3|40.3|Standard Deviation|11.8|11.8|||
4399541|NCT00269633|4226465|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399542|NCT00269633|4226466|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399543|NCT00269633|4226467|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399544|NCT00269633|4226465|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4399545|NCT00269633|4226466|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4399546|NCT00269633|4226467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4399547|NCT00269633|4226465|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399548|NCT00269633|4226466|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399549|NCT00269633|4226467|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399550|NCT00269477|4226474|B5|United States||Region of Enrollment||participants|Number|145|145.0||||||
4399551|NCT00269477|4226475|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
4399552|NCT00269477|4226476|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4399553|NCT00269477|4226477|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4399554|NCT00269477|4226478|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4399555|NCT00269477|4226474|B5||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4399556|NCT00269477|4226475|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4399557|NCT00269477|4226476|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4399558|NCT00269477|4226477|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4399559|NCT00269477|4226478|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4399561|NCT00269477|4226475|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4399562|NCT00269477|4226476|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4399563|NCT00269477|4226477|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4399564|NCT00269477|4226478|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4399565|NCT00269477|4226474|B5|||Age||years|Mean|17.9|17.9|Standard Deviation|2.24|2.24|||
4399566|NCT00269477|4226475|B4|||Age||years|Mean|16.6|16.6|Standard Deviation|1.81|1.81|||
4399567|NCT00269477|4226476|B3|||Age||years|Mean|16.4|16.4|Standard Deviation|1.38|1.38|||
4399568|NCT00269477|4226477|B2|||Age||years|Mean|18.8|18.8|Standard Deviation|1.86|1.86|||
4399569|NCT00269477|4226478|B1|||Age||years|Mean|18.1|18.1|Standard Deviation|1.62|1.62|||
4399570|NCT00269477|4226474|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399571|NCT00269477|4226475|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399572|NCT00269477|4226476|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399573|NCT00269477|4226477|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399574|NCT00269477|4226478|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399575|NCT00269477|4226474|B5||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4399576|NCT00269477|4226475|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4399577|NCT00269477|4226476|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4399578|NCT00269477|4226477|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4399579|NCT00269477|4226478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4399580|NCT00269477|4226474|B5||<=18 years|Age||Participants|Count of Participants|122|122.0||||||
4399581|NCT00269477|4226475|B4||<=18 years|Age||Participants|Count of Participants|54|54.0||||||
4399582|NCT00269477|4226476|B3||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
4399583|NCT00269477|4226477|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4399584|NCT00269477|4226478|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4399585|NCT00269152|4226495|B3|Bronchoalveolar Carcinoma||Tumor Type at Initial Pathological Diagnosis||participants|Number|2|2.0||||||
4399586|NCT00269152|4226496|B2|Bronchoalveolar Carcinoma||Tumor Type at Initial Pathological Diagnosis||participants|Number|0|0.0||||||
4399587|NCT00269152|4226497|B1|Bronchoalveolar Carcinoma||Tumor Type at Initial Pathological Diagnosis||participants|Number|2|2.0||||||
4399588|NCT00269152|4226495|B3|Large Cell Carcinoma of Lung||Tumor Type at Initial Pathological Diagnosis||participants|Number|12|12.0||||||
4399589|NCT00269152|4226496|B2|Large Cell Carcinoma of Lung||Tumor Type at Initial Pathological Diagnosis||participants|Number|7|7.0||||||
4399590|NCT00269152|4226497|B1|Large Cell Carcinoma of Lung||Tumor Type at Initial Pathological Diagnosis||participants|Number|5|5.0||||||
4399591|NCT00269152|4226495|B3|Mixed Cell (Squamous/Adeno) Carcinoma of Lung||Tumor Type at Initial Pathological Diagnosis||participants|Number|5|5.0||||||
4399592|NCT00269152|4226496|B2|Mixed Cell (Squamous/Adeno) Carcinoma of Lung||Tumor Type at Initial Pathological Diagnosis||participants|Number|5|5.0||||||
4399593|NCT00269152|4226497|B1|Mixed Cell (Squamous/Adeno) Carcinoma of Lung||Tumor Type at Initial Pathological Diagnosis||participants|Number|0|0.0||||||
4399594|NCT00269152|4226495|B3|Non-Small Cell Lung Cancer||Tumor Type at Initial Pathological Diagnosis||participants|Number|9|9.0||||||
4399595|NCT00269152|4226496|B2|Non-Small Cell Lung Cancer||Tumor Type at Initial Pathological Diagnosis||participants|Number|4|4.0||||||
4399596|NCT00269152|4226497|B1|Non-Small Cell Lung Cancer||Tumor Type at Initial Pathological Diagnosis||participants|Number|5|5.0||||||
4399597|NCT00269152|4226495|B3|Squamous Carcinoma of the Lung||Tumor Type at Initial Pathological Diagnosis||participants|Number|44|44.0||||||
4399598|NCT00269152|4226496|B2|Squamous Carcinoma of the Lung||Tumor Type at Initial Pathological Diagnosis||participants|Number|20|20.0||||||
4399599|NCT00269152|4226497|B1|Squamous Carcinoma of the Lung||Tumor Type at Initial Pathological Diagnosis||participants|Number|24|24.0||||||
4399600|NCT00269152|4226495|B3|Adenocarcinoma of the Lung||Tumor Type at Initial Pathological Diagnosis||participants|Number|50|50.0||||||
4399601|NCT00269152|4226496|B2|Adenocarcinoma of the Lung||Tumor Type at Initial Pathological Diagnosis||participants|Number|23|23.0||||||
4399602|NCT00269152|4226497|B1|Adenocarcinoma of the Lung||Tumor Type at Initial Pathological Diagnosis||participants|Number|27|27.0||||||
4399603|NCT00269152|4226495|B3|Unknown: could have been either Stage IIIb or IV||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|1|1.0||||||
4399604|NCT00269152|4226496|B2|Unknown: could have been either Stage IIIb or IV||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|1|1.0||||||
4399605|NCT00269152|4226497|B1|Unknown: could have been either Stage IIIb or IV||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|0|0.0||||||
4399606|NCT00269152|4226495|B3|Stage IIIa||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|1|1.0||||||
4399607|NCT00269152|4226496|B2|Stage IIIa||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|1|1.0||||||
4399608|NCT00269152|4226497|B1|Stage IIIa||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|0|0.0||||||
4399609|NCT00269152|4226495|B3|Stage IIb||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|55|55.0||||||
4399664|NCT00269113|4226513|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4399610|NCT00269152|4226496|B2|Stage IIb||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|25|25.0||||||
4399611|NCT00269152|4226497|B1|Stage IIb||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|30|30.0||||||
4399612|NCT00269152|4226495|B3|Stage IIa||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|11|11.0||||||
4399613|NCT00269152|4226496|B2|Stage IIa||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|5|5.0||||||
4399614|NCT00269152|4226497|B1|Stage IIa||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|6|6.0||||||
4399615|NCT00269152|4226495|B3|Stage Ib||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|53|53.0||||||
4399616|NCT00269152|4226496|B2|Stage Ib||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|26|26.0||||||
4399617|NCT00269152|4226497|B1|Stage Ib||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|27|27.0||||||
4399618|NCT00269152|4226495|B3|Stage Ia||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|1|1.0||||||
4399619|NCT00269152|4226496|B2|Stage Ia||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|1|1.0||||||
4399620|NCT00269152|4226497|B1|Stage Ia||Stage of Disease Prior to Tumor Resection|Classification based on the American Joint Committee on Cancer Staging Criteria for Lung Cancer.|participants|Number|0|0.0||||||
4399621|NCT00269152|4226495|B3|No||Smoking History||participants|Number|10|10.0||||||
4399622|NCT00269152|4226496|B2|No||Smoking History||participants|Number|3|3.0||||||
4399623|NCT00269152|4226497|B1|No||Smoking History||participants|Number|7|7.0||||||
4399624|NCT00269152|4226495|B3|Yes||Smoking History||participants|Number|112|112.0||||||
4399625|NCT00269152|4226496|B2|Yes||Smoking History||participants|Number|56|56.0||||||
4399626|NCT00269152|4226497|B1|Yes||Smoking History||participants|Number|56|56.0||||||
4399627|NCT00269152|4226495|B3|Bi-lobectomy||Curative Surgery Used||participants|Number|12|12.0||||||
4399628|NCT00269152|4226496|B2|Bi-lobectomy||Curative Surgery Used||participants|Number|4|4.0||||||
4399629|NCT00269152|4226497|B1|Bi-lobectomy||Curative Surgery Used||participants|Number|8|8.0||||||
4399630|NCT00269152|4226495|B3|Lobectomy||Curative Surgery Used||participants|Number|92|92.0||||||
4399631|NCT00269152|4226496|B2|Lobectomy||Curative Surgery Used||participants|Number|46|46.0||||||
4399632|NCT00269152|4226497|B1|Lobectomy||Curative Surgery Used||participants|Number|46|46.0||||||
4399633|NCT00269152|4226495|B3|Pneumonectomy||Curative Surgery Used||participants|Number|18|18.0||||||
4399634|NCT00269152|4226496|B2|Pneumonectomy||Curative Surgery Used||participants|Number|9|9.0||||||
4399635|NCT00269152|4226497|B1|Pneumonectomy||Curative Surgery Used||participants|Number|9|9.0||||||
4399636|NCT00269152|4226495|B3|Germany||Region of Enrollment||participants|Number|87|87.0||||||
4399637|NCT00269152|4226496|B2|Germany||Region of Enrollment||participants|Number|43|43.0||||||
4399638|NCT00269152|4226497|B1|Germany||Region of Enrollment||participants|Number|44|44.0||||||
4399639|NCT00269152|4226495|B3|Spain||Region of Enrollment||participants|Number|15|15.0||||||
4399640|NCT00269152|4226496|B2|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4399641|NCT00269152|4226497|B1|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4399642|NCT00269152|4226495|B3|France||Region of Enrollment||participants|Number|20|20.0||||||
4399643|NCT00269152|4226496|B2|France||Region of Enrollment||participants|Number|8|8.0||||||
4399644|NCT00269152|4226497|B1|France||Region of Enrollment||participants|Number|12|12.0||||||
4399645|NCT00269152|4226495|B3|African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4399646|NCT00269152|4226496|B2|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4399647|NCT00269152|4226497|B1|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4399648|NCT00269152|4226495|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|120|120.0||||||
4399649|NCT00269152|4226496|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4399650|NCT00269152|4226497|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4399651|NCT00269152|4226495|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4399652|NCT00269152|4226496|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4399653|NCT00269152|4226497|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4399654|NCT00269152|4226495|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4399655|NCT00269152|4226496|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4399656|NCT00269152|4226497|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4399657|NCT00269152|4226495|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|7.5|7.5|||
4399658|NCT00269152|4226496|B2|||Age||years|Mean|58.9|58.9|Standard Deviation|7.2|7.2|||
4399659|NCT00269152|4226497|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|7.7|7.7|||
4399660|NCT00269113|4226512|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4399661|NCT00269113|4226513|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4399662|NCT00269113|4226514|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4399663|NCT00269113|4226512|B3||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4399665|NCT00269113|4226514|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4399666|NCT00269113|4226512|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|8.5|8.5|||
4399667|NCT00269113|4226513|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|8.3|8.3|||
4399668|NCT00269113|4226514|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|8.7|8.7|||
4399669|NCT00268996|4226533|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399670|NCT00268996|4226534|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399671|NCT00268996|4226535|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399672|NCT00268996|4226533|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399673|NCT00268996|4226534|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399674|NCT00268996|4226535|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399675|NCT00268996|4226533|B3||White|Race (NIH/OMB)||Participants|Count of Participants|317|317.0||||||
4399676|NCT00268996|4226534|B2||White|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
4399677|NCT00268996|4226535|B1||White|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
4399678|NCT00268996|4226533|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4399679|NCT00268996|4226534|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399680|NCT00268996|4226535|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4399681|NCT00268996|4226533|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399682|NCT00268996|4226534|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399683|NCT00268996|4226535|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399684|NCT00268996|4226533|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4399685|NCT00268996|4226534|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4399686|NCT00268996|4226535|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4399687|NCT00268996|4226533|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399688|NCT00268996|4226534|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399689|NCT00268996|4226535|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399690|NCT00268996|4226533|B3||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4399691|NCT00268996|4226534|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4399692|NCT00268996|4226535|B1||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4399693|NCT00268996|4226533|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4399694|NCT00268996|4226534|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4399695|NCT00268996|4226535|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4399696|NCT00268996|4226533|B3|||Age||Years|Mean|58.4|58.4|Standard Deviation|10.36|10.36|||
4399697|NCT00268996|4226534|B2|||Age||Years|Mean|59.4|59.4|Standard Deviation|9.81|9.81|||
4399698|NCT00268996|4226535|B1|||Age||Years|Mean|57.3|57.3|Standard Deviation|10.86|10.86|||
4399699|NCT00268983|4226578|B3|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4399700|NCT00268983|4226579|B2|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4399701|NCT00268983|4226580|B1|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4399702|NCT00268983|4226578|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
4399703|NCT00268983|4226579|B2||Male|Gender||Participants|Count of Participants|4|4.0||||||
4399704|NCT00268983|4226580|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
4399705|NCT00268983|4226578|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
4399706|NCT00268983|4226579|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
4399707|NCT00268983|4226580|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4399708|NCT00268983|4226578|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|11.0|11.0|||
4399709|NCT00268983|4226579|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|8.0|8.0|||
4399710|NCT00268983|4226580|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|14.4|14.4|||
4399711|NCT00268905|4226621|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4399712|NCT00268905|4226622|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399713|NCT00268905|4226623|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4399714|NCT00268905|4226624|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4399715|NCT00268905|4226621|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399716|NCT00268905|4226622|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399717|NCT00268905|4226623|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399718|NCT00268905|4226624|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399719|NCT00268905|4226621|B4||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4399720|NCT00268905|4226622|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4399721|NCT00268905|4226623|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4399722|NCT00268905|4226624|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4399723|NCT00268905|4226621|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4399724|NCT00268905|4226622|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399725|NCT00268905|4226623|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4399726|NCT00268905|4226624|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4399727|NCT00268905|4226621|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4399728|NCT00268905|4226622|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4399729|NCT00268905|4226623|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399730|NCT00268905|4226624|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399731|NCT00268905|4226621|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4399732|NCT00268905|4226622|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399733|NCT00268905|4226623|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399734|NCT00268905|4226624|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4399735|NCT00268905|4226621|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399736|NCT00268905|4226622|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399737|NCT00268905|4226623|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399738|NCT00268905|4226624|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399739|NCT00268905|4226621|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4399740|NCT00268905|4226622|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4399741|NCT00268905|4226623|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4399742|NCT00268905|4226624|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4399743|NCT00268905|4226621|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4399744|NCT00268905|4226622|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4399745|NCT00268905|4226623|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4399746|NCT00268905|4226624|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4399747|NCT00268905|4226621|B4|||Age||years|Mean|60.4|60.4|Standard Deviation|8.75|8.75|||
4399748|NCT00268905|4226622|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|10.04|10.04|||
4399749|NCT00268905|4226623|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|8.08|8.08|||
4399750|NCT00268905|4226624|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|8.35|8.35|||
4399751|NCT00268892|4226640|B4|||Time since Prostate Cancer Diagnosis|Safety analysis set.|days|Mean|356|356.0|Standard Deviation|852|852.0|||
4399752|NCT00268892|4226641|B3|||Time since Prostate Cancer Diagnosis|Safety analysis set.|days|Mean|255|255.0|Standard Deviation|583|583.0|||
4399753|NCT00268892|4226642|B2|||Time since Prostate Cancer Diagnosis|Safety analysis set.|days|Mean|347|347.0|Standard Deviation|824|824.0|||
4399754|NCT00268892|4226643|B1|||Time since Prostate Cancer Diagnosis|Safety analysis set.|days|Mean|469|469.0|Standard Deviation|1079|1079.0|||
4399755|NCT00268892|4226640|B4|Not Classifiable||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|36|36.0||||||
4399756|NCT00268892|4226641|B3|Not Classifiable||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|9|9.0||||||
4399757|NCT00268892|4226642|B2|Not Classifiable||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|13|13.0||||||
4399758|NCT00268892|4226643|B1|Not Classifiable||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|14|14.0||||||
4399759|NCT00268892|4226640|B4|Metastatic||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|55|55.0||||||
4399760|NCT00268892|4226641|B3|Metastatic||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|20|20.0||||||
4399761|NCT00268892|4226642|B2|Metastatic||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|19|19.0||||||
4399817|NCT00268892|4226642|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399877|NCT00268346|4226688|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4399762|NCT00268892|4226643|B1|Metastatic||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|16|16.0||||||
4399763|NCT00268892|4226640|B4|Locally Advanced||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|80|80.0||||||
4399764|NCT00268892|4226641|B3|Locally Advanced||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|28|28.0||||||
4399765|NCT00268892|4226642|B2|Locally Advanced||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|26|26.0||||||
4399766|NCT00268892|4226643|B1|Locally Advanced||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|26|26.0||||||
4399767|NCT00268892|4226640|B4|Localized||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|107|107.0||||||
4399768|NCT00268892|4226641|B3|Localized||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|36|36.0||||||
4399769|NCT00268892|4226642|B2|Localized||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|37|37.0||||||
4399770|NCT00268892|4226643|B1|Localized||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|34|34.0||||||
4399771|NCT00268892|4226640|B4|7-10||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. A Gleason Score was missing for one participant in the Degarelix 240/240@60(1-3-6-9) group.|participants|Number|148|148.0||||||
4399772|NCT00268892|4226641|B3|7-10||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. A Gleason Score was missing for one participant in the Degarelix 240/240@60(1-3-6-9) group.|participants|Number|46|46.0||||||
4399773|NCT00268892|4226642|B2|7-10||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. A Gleason Score was missing for one participant in the Degarelix 240/240@60(1-3-6-9) group.|participants|Number|58|58.0||||||
4399774|NCT00268892|4226643|B1|7-10||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. A Gleason Score was missing for one participant in the Degarelix 240/240@60(1-3-6-9) group.|participants|Number|44|44.0||||||
4399775|NCT00268892|4226640|B4|5-6||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. A Gleason Score was missing for one participant in the Degarelix 240/240@60(1-3-6-9) group.|participants|Number|97|97.0||||||
4399776|NCT00268892|4226641|B3|5-6||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. A Gleason Score was missing for one participant in the Degarelix 240/240@60(1-3-6-9) group.|participants|Number|34|34.0||||||
4399777|NCT00268892|4226642|B2|5-6||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. A Gleason Score was missing for one participant in the Degarelix 240/240@60(1-3-6-9) group.|participants|Number|30|30.0||||||
4399778|NCT00268892|4226643|B1|5-6||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. A Gleason Score was missing for one participant in the Degarelix 240/240@60(1-3-6-9) group.|participants|Number|33|33.0||||||
4399818|NCT00268892|4226643|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399779|NCT00268892|4226640|B4|2-4||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. A Gleason Score was missing for one participant in the Degarelix 240/240@60(1-3-6-9) group.|participants|Number|32|32.0||||||
4399780|NCT00268892|4226641|B3|2-4||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. A Gleason Score was missing for one participant in the Degarelix 240/240@60(1-3-6-9) group.|participants|Number|13|13.0||||||
4399781|NCT00268892|4226642|B2|2-4||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. A Gleason Score was missing for one participant in the Degarelix 240/240@60(1-3-6-9) group.|participants|Number|6|6.0||||||
4399782|NCT00268892|4226643|B1|2-4||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. A Gleason Score was missing for one participant in the Degarelix 240/240@60(1-3-6-9) group.|participants|Number|13|13.0||||||
4399783|NCT00268892|4226640|B4|No||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|249|249.0||||||
4399784|NCT00268892|4226641|B3|No||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|86|86.0||||||
4399785|NCT00268892|4226642|B2|No||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|83|83.0||||||
4399786|NCT00268892|4226643|B1|No||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|80|80.0||||||
4399787|NCT00268892|4226640|B4|Yes||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|29|29.0||||||
4399788|NCT00268892|4226641|B3|Yes||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|7|7.0||||||
4399789|NCT00268892|4226642|B2|Yes||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|12|12.0||||||
4399790|NCT00268892|4226643|B1|Yes||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|10|10.0||||||
4399791|NCT00268892|4226640|B4|||Body Mass Index|Safety analysis set.|kilogram per square meter|Mean|25.7|25.7|Standard Deviation|4.07|4.07|||
4399792|NCT00268892|4226641|B3|||Body Mass Index|Safety analysis set.|kilogram per square meter|Mean|25.8|25.8|Standard Deviation|4.16|4.16|||
4399793|NCT00268892|4226642|B2|||Body Mass Index|Safety analysis set.|kilogram per square meter|Mean|25.8|25.8|Standard Deviation|3.93|3.93|||
4399794|NCT00268892|4226643|B1|||Body Mass Index|Safety analysis set.|kilogram per square meter|Mean|25.4|25.4|Standard Deviation|4.14|4.14|||
4399795|NCT00268892|4226640|B4|||Body Weight|Safety analysis set.|kilogram|Mean|76.7|76.7|Standard Deviation|12.6|12.6|||
4399796|NCT00268892|4226641|B3|||Body Weight|Safety analysis set.|kilogram|Mean|76.5|76.5|Standard Deviation|12.8|12.8|||
4399797|NCT00268892|4226642|B2|||Body Weight|Safety analysis set.|kilogram|Mean|76.9|76.9|Standard Deviation|12.2|12.2|||
4399798|NCT00268892|4226643|B1|||Body Weight|Safety analysis set.|kilogram|Mean|76.7|76.7|Standard Deviation|13.0|13.0|||
4399799|NCT00268892|4226640|B4||Unknown or Not Reported|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399800|NCT00268892|4226641|B3||Unknown or Not Reported|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399801|NCT00268892|4226642|B2||Unknown or Not Reported|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399802|NCT00268892|4226643|B1||Unknown or Not Reported|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399803|NCT00268892|4226640|B4||More than one race|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399804|NCT00268892|4226641|B3||More than one race|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399805|NCT00268892|4226642|B2||More than one race|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399806|NCT00268892|4226643|B1||More than one race|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399807|NCT00268892|4226640|B4||White|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|264|264.0||||||
4399808|NCT00268892|4226641|B3||White|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|88|88.0||||||
4399809|NCT00268892|4226642|B2||White|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|89|89.0||||||
4399810|NCT00268892|4226643|B1||White|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|87|87.0||||||
4399811|NCT00268892|4226640|B4||Black or African American|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|11|11.0||||||
4399812|NCT00268892|4226641|B3||Black or African American|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|3|3.0||||||
4399813|NCT00268892|4226642|B2||Black or African American|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|5|5.0||||||
4399814|NCT00268892|4226643|B1||Black or African American|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|3|3.0||||||
4399815|NCT00268892|4226640|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399816|NCT00268892|4226641|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399819|NCT00268892|4226640|B4||Asian|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|2|2.0||||||
4399820|NCT00268892|4226641|B3||Asian|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|1|1.0||||||
4399821|NCT00268892|4226642|B2||Asian|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|1|1.0||||||
4399822|NCT00268892|4226643|B1||Asian|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399823|NCT00268892|4226640|B4||American Indian or Alaska Native|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|1|1.0||||||
4399824|NCT00268892|4226641|B3||American Indian or Alaska Native|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|1|1.0||||||
4399825|NCT00268892|4226642|B2||American Indian or Alaska Native|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399826|NCT00268892|4226643|B1||American Indian or Alaska Native|Race (NIH/OMB)|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399827|NCT00268892|4226640|B4||Male|Sex: Female, Male|Safety analysis set.|Participants|Count of Participants|278|278.0||||||
4399828|NCT00268892|4226641|B3||Male|Sex: Female, Male|Safety analysis set.|Participants|Count of Participants|93|93.0||||||
4399829|NCT00268892|4226642|B2||Male|Sex: Female, Male|Safety analysis set.|Participants|Count of Participants|95|95.0||||||
4399830|NCT00268892|4226643|B1||Male|Sex: Female, Male|Safety analysis set.|Participants|Count of Participants|90|90.0||||||
4399831|NCT00268892|4226640|B4||Female|Sex: Female, Male|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399832|NCT00268892|4226641|B3||Female|Sex: Female, Male|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399833|NCT00268892|4226642|B2||Female|Sex: Female, Male|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399834|NCT00268892|4226643|B1||Female|Sex: Female, Male|Safety analysis set.|Participants|Count of Participants|0|0.0||||||
4399835|NCT00268892|4226640|B4|||Age|Safety analysis set.|years|Mean|72.6|72.6|Standard Deviation|6.88|6.88|||
4399836|NCT00268892|4226641|B3|||Age|Safety analysis set.|years|Mean|71.8|71.8|Standard Deviation|7.05|7.05|||
4399837|NCT00268892|4226642|B2|||Age|Safety analysis set.|years|Mean|73.3|73.3|Standard Deviation|7.00|7.0|||
4399838|NCT00268892|4226643|B1|||Age|Safety analysis set.|years|Mean|72.7|72.7|Standard Deviation|6.55|6.55|||
4399839|NCT00268762|4226656|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4399840|NCT00268762|4226656|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4399841|NCT00268762|4226656|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4399842|NCT00268762|4226656|B1|||Age||years|Mean|63|63.0|Standard Deviation|14|14.0|||
4399843|NCT00268762|4226656|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4399844|NCT00268762|4226656|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4399845|NCT00268762|4226656|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399846|NCT00268463|4226662|B3|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4399847|NCT00268463|4226663|B2|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4399848|NCT00268463|4226664|B1|Unknown||Sex/Gender, Customized||participants|Number|0|0.0||||||
4399849|NCT00268463|4226662|B3|Male||Sex/Gender, Customized||participants|Number|14|14.0||||||
4399850|NCT00268463|4226663|B2|Male||Sex/Gender, Customized||participants|Number|7|7.0||||||
4399851|NCT00268463|4226664|B1|Male||Sex/Gender, Customized||participants|Number|7|7.0||||||
4399852|NCT00268463|4226662|B3|Female||Sex/Gender, Customized||participants|Number|7|7.0||||||
4399853|NCT00268463|4226663|B2|Female||Sex/Gender, Customized||participants|Number|4|4.0||||||
4399854|NCT00268463|4226664|B1|Female||Sex/Gender, Customized||participants|Number|3|3.0||||||
4399855|NCT00268463|4226662|B3|||Age||years|Mean|59|59.0|Standard Deviation|9.7|9.7|||
4399856|NCT00268463|4226663|B2|||Age||years|Mean|59|59.0|Standard Deviation|9.4|9.4|||
4399857|NCT00268463|4226664|B1|||Age||years|Mean|60|60.0|Standard Deviation|10.4|10.4|||
4399858|NCT00268450|4226671|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4399859|NCT00268450|4226671|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399860|NCT00268450|4226671|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399861|NCT00268450|4226671|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4399862|NCT00268450|4226671|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4399863|NCT00268450|4226671|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399864|NCT00268450|4226671|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399865|NCT00268450|4226671|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399866|NCT00268450|4226671|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4399867|NCT00268450|4226671|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4399868|NCT00268450|4226671|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4399869|NCT00268450|4226671|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4399870|NCT00268450|4226671|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399871|NCT00268437|4226681|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4399872|NCT00268437|4226681|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4399873|NCT00268437|4226681|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4399874|NCT00268437|4226681|B1|||Age||years|Median|66|66.0|Full Range|||42.0|84.0|
4399875|NCT00268346|4226686|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4399876|NCT00268346|4226687|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4399878|NCT00268346|4226686|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4399879|NCT00268346|4226687|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4399880|NCT00268346|4226688|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4399881|NCT00268346|4226686|B3|||Age||years|Median|60|60.0|Full Range|||33.0|82.0|
4399882|NCT00268346|4226687|B2|||Age||years|Median|58|58.0|Full Range|||33.0|73.0|
4399883|NCT00268346|4226688|B1|||Age||years|Median|66|66.0|Full Range|||45.0|82.0|
4399884|NCT00268242|4226695|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4399885|NCT00268242|4226695|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4399886|NCT00268242|4226695|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4399887|NCT00268242|4226695|B1|||Age||years|Median|51|51.0|Full Range|||28.0|74.0|
4399888|NCT00268203|4226704|B1|Peruvian||Race/Ethnicity, Customized|Race data were not collected; ethnicity data were collected and are presented instead.|participants|Number|1|1.0||||||
4399889|NCT00268203|4226704|B1|Arab||Race/Ethnicity, Customized|Race data were not collected; ethnicity data were collected and are presented instead.|participants|Number|1|1.0||||||
4399890|NCT00268203|4226704|B1|Indian||Race/Ethnicity, Customized|Race data were not collected; ethnicity data were collected and are presented instead.|participants|Number|2|2.0||||||
4399891|NCT00268203|4226704|B1|Iranian||Race/Ethnicity, Customized|Race data were not collected; ethnicity data were collected and are presented instead.|participants|Number|1|1.0||||||
4399892|NCT00268203|4226704|B1|Middle Eastern||Race/Ethnicity, Customized|Race data were not collected; ethnicity data were collected and are presented instead.|participants|Number|1|1.0||||||
4399893|NCT00268203|4226704|B1|Portuguese||Race/Ethnicity, Customized|Race data were not collected; ethnicity data were collected and are presented instead.|participants|Number|1|1.0||||||
4399894|NCT00268203|4226704|B1|Native American||Race/Ethnicity, Customized|Race data were not collected; ethnicity data were collected and are presented instead.|participants|Number|1|1.0||||||
4399895|NCT00268203|4226704|B1|Black||Race/Ethnicity, Customized|Race data were not collected; ethnicity data were collected and are presented instead.|participants|Number|20|20.0||||||
4399896|NCT00268203|4226704|B1|Asian||Race/Ethnicity, Customized|Race data were not collected; ethnicity data were collected and are presented instead.|participants|Number|7|7.0||||||
4399897|NCT00268203|4226704|B1|Hispanic||Race/Ethnicity, Customized|Race data were not collected; ethnicity data were collected and are presented instead.|participants|Number|19|19.0||||||
4399898|NCT00268203|4226704|B1|White||Race/Ethnicity, Customized|Race data were not collected; ethnicity data were collected and are presented instead.|participants|Number|711|711.0||||||
4399899|NCT00268203|4226704|B1||Male|Gender||Participants|Count of Participants|411|411.0||||||
4399900|NCT00268203|4226704|B1||Female|Gender||Participants|Count of Participants|354|354.0||||||
4399901|NCT00268203|4226704|B1|||Age||Years|Mean|58.8|58.8|Standard Deviation|11.5|11.5|||
4399902|NCT00267969|4226715|B4||Male|Sex: Female, Male||Participants|Count of Participants|531|531.0||||||
4399903|NCT00267969|4226716|B3||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4399904|NCT00267969|4226717|B2||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4399905|NCT00267969|4226718|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4399906|NCT00267969|4226715|B4||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4399907|NCT00267969|4226716|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4399908|NCT00267969|4226717|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4399909|NCT00267969|4226718|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4399910|NCT00267969|4226715|B4|||Age||Years|Mean|45.3|45.3|Standard Deviation|11.71|11.71|||
4399911|NCT00267969|4226716|B3|||Age||Years|Mean|46.2|46.2|Standard Deviation|11.27|11.27|||
4399912|NCT00267969|4226717|B2|||Age||Years|Mean|44.8|44.8|Standard Deviation|12.48|12.48|||
4399913|NCT00267969|4226718|B1|||Age||Years|Mean|44.8|44.8|Standard Deviation|11.32|11.32|||
4399914|NCT00267956|4226748|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4399915|NCT00267956|4226749|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4399916|NCT00267956|4226750|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4399917|NCT00267956|4226748|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4399918|NCT00267956|4226749|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4399919|NCT00267956|4226750|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4399920|NCT00267956|4226748|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|10.97|10.97|||
4399921|NCT00267956|4226749|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|11.23|11.23|||
4399922|NCT00267956|4226750|B1|||Age||years|Mean|47.1|47.1|Standard Deviation|10.52|10.52|||
4399923|NCT00267774|4226771|B3||Male|Sex: Female, Male||Participants|Count of Participants|744|744.0||||||
4399924|NCT00267774|4226772|B2||Male|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4399925|NCT00267774|4226773|B1||Male|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
4399926|NCT00267774|4226771|B3||Female|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4399927|NCT00267774|4226772|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4399928|NCT00267774|4226773|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4399929|NCT00267774|4226771|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|10.3|10.3|||
4399930|NCT00267774|4226772|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|10.2|10.2|||
4399931|NCT00267774|4226773|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|10.3|10.3|||
4399932|NCT00267748|4226782|B4||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4399933|NCT00267748|4226783|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4399934|NCT00267748|4226784|B2||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4399935|NCT00267748|4226785|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4399936|NCT00267748|4226782|B4||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4399937|NCT00267748|4226783|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4399938|NCT00267748|4226784|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4399939|NCT00267748|4226785|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4399940|NCT00267748|4226782|B4|||Age||Years|Mean|62.4|62.4|Standard Deviation|9.7|9.7|||
4399941|NCT00267748|4226783|B3|||Age||Years|Mean|64.3|64.3|Standard Deviation|9.7|9.7|||
4399942|NCT00267748|4226784|B2|||Age||Years|Mean|60.4|60.4|Standard Deviation|9.8|9.8|||
4399943|NCT00267748|4226785|B1|||Age||Years|Mean|62.4|62.4|Standard Deviation|7.2|7.2|||
4399944|NCT00267696|4226804|B1|Non-measurable disease (CA125)||Disease status at study enrollment||patients|Number|12|12.0||||||
4399945|NCT00267696|4226804|B1|Measurable disease||Disease status at study enrollment||patients|Number|33|33.0||||||
4399946|NCT00267696|4226804|B1|||Platinum-free interval||months|Median|15|15.0|Full Range|||6.0|125.0|
4399947|NCT00267696|4226804|B1|G3(tissue poorly differentiated/undifferentiated)||Primary disease grade||patients|Number|42|42.0||||||
4399948|NCT00267696|4226804|B1|G2(tissue moderately differentiated)||Primary disease grade||patients|Number|3|3.0||||||
4399949|NCT00267696|4226804|B1|Stage 4 (cancer has spread to distant organs)||Primary disease stage||patients|Number|4|4.0||||||
4399950|NCT00267696|4226804|B1|Stage 3 (cancer in ovaries spread to peritoneum)||Primary disease stage||patients|Number|34|34.0||||||
4399951|NCT00267696|4226804|B1|Stage 1-2 (cancer located in ovaries or pelvis)||Primary disease stage||patients|Number|7|7.0||||||
4399952|NCT00267696|4226804|B1|Tubal||Primary disease site||patients|Number|1|1.0||||||
4399953|NCT00267696|4226804|B1|Primary peritoneal||Primary disease site||patients|Number|4|4.0||||||
4399954|NCT00267696|4226804|B1|Ovarian||Primary disease site||patients|Number|40|40.0||||||
4399955|NCT00267696|4226804|B1|1 (Restricted in physical activity)||ECOG (Eastern Cooperative Oncology Group) Performance Status||patients|Number|11|11.0||||||
4399956|NCT00267696|4226804|B1|0 (Fully active)||ECOG (Eastern Cooperative Oncology Group) Performance Status||patients|Number|34|34.0||||||
4399957|NCT00267696|4226804|B1|United States||Region of Enrollment||patients|Number|45|45.0||||||
4399958|NCT00267696|4226804|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4399959|NCT00267696|4226804|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399960|NCT00267696|4226804|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4399961|NCT00267696|4226804|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4399962|NCT00267696|4226804|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399963|NCT00267696|4226804|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399964|NCT00267696|4226804|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399965|NCT00267696|4226804|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4399966|NCT00267696|4226804|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4399967|NCT00267696|4226804|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4399968|NCT00267696|4226804|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4399969|NCT00267696|4226804|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4399970|NCT00267696|4226804|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|8.6|8.6|||
4399971|NCT00267696|4226804|B1|||Age||years|Median|60.0|60.0|Full Range|||42.0|77.0|
4399972|NCT00267670|4226809|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4399973|NCT00267670|4226810|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4399974|NCT00267670|4226811|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4399975|NCT00267670|4226809|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4399976|NCT00267670|4226810|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4399977|NCT00267670|4226811|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4399978|NCT00267670|4226809|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4399979|NCT00267670|4226810|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4399980|NCT00267670|4226811|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4399981|NCT00267670|4226809|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|10|10.0|||
4399982|NCT00267670|4226810|B2|||Age||years|Mean|53|53.0|Standard Deviation|8|8.0|||
4399983|NCT00267670|4226811|B1|||Age||years|Mean|46|46.0|Standard Deviation|10|10.0|||
4399984|NCT00267670|4226809|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399985|NCT00267670|4226810|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399986|NCT00267670|4226811|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4399987|NCT00267670|4226809|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4399988|NCT00267670|4226810|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4399989|NCT00267670|4226811|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4399990|NCT00267670|4226809|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399991|NCT00267670|4226810|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399992|NCT00267670|4226811|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4399993|NCT00267644|4226824|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
4399994|NCT00267644|4226825|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4399995|NCT00267644|4226826|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4399996|NCT00267644|4226824|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4399997|NCT00267644|4226825|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4399998|NCT00267644|4226826|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4399999|NCT00267644|4226824|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4400000|NCT00267644|4226825|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4400001|NCT00267644|4226826|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4400002|NCT00267644|4226824|B3|||Age||years|Mean|1.5|1.5|Standard Deviation|.83|0.83|||
4400003|NCT00267644|4226825|B2|||Age||years|Mean|1.2|1.2|Standard Deviation|.41|0.41|||
4400004|NCT00267644|4226826|B1|||Age||years|Mean|1.6|1.6|Standard Deviation|.83|0.83|||
4400005|NCT00267644|4226824|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400006|NCT00267644|4226825|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400007|NCT00267644|4226826|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400008|NCT00267644|4226824|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400009|NCT00267644|4226825|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400010|NCT00267644|4226826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400011|NCT00267644|4226824|B3||<=18 years|Age||Participants|Count of Participants|76|76.0||||||
4400012|NCT00267644|4226825|B2||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
4400013|NCT00267644|4226826|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4400014|NCT00267631|4226835|B3|United States||Region of Enrollment||participants|Number|5392|5392.0||||||
4400015|NCT00267631|4226836|B2|United States||Region of Enrollment||participants|Number|2361|2361.0||||||
4400016|NCT00267631|4226837|B1|United States||Region of Enrollment||participants|Number|3031|3031.0||||||
4400017|NCT00267631|4226835|B3||Male|Sex: Female, Male||Participants|Count of Participants|3132|3132.0||||||
4400018|NCT00267631|4226836|B2||Male|Sex: Female, Male||Participants|Count of Participants|1330|1330.0||||||
4400019|NCT00267631|4226837|B1||Male|Sex: Female, Male||Participants|Count of Participants|1802|1802.0||||||
4400020|NCT00267631|4226835|B3||Female|Sex: Female, Male||Participants|Count of Participants|2260|2260.0||||||
4400021|NCT00267631|4226836|B2||Female|Sex: Female, Male||Participants|Count of Participants|1031|1031.0||||||
4400022|NCT00267631|4226837|B1||Female|Sex: Female, Male||Participants|Count of Participants|1229|1229.0||||||
4400023|NCT00267631|4226835|B3|||Age||years|Mean|9.0|9.0|Standard Deviation|4.5|4.5|||
4400024|NCT00267631|4226836|B2|||Age||years|Mean|8.8|8.8|Standard Deviation|4.7|4.7|||
4400025|NCT00267631|4226837|B1|||Age||years|Mean|9.2|9.2|Standard Deviation|4.3|4.3|||
4400026|NCT00267631|4226835|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400027|NCT00267631|4226836|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400028|NCT00267631|4226837|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400029|NCT00267631|4226835|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400030|NCT00267631|4226836|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400031|NCT00267631|4226837|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400032|NCT00267631|4226835|B3||<=18 years|Age||Participants|Count of Participants|5392|5392.0||||||
4400033|NCT00267631|4226836|B2||<=18 years|Age||Participants|Count of Participants|2361|2361.0||||||
4400034|NCT00267631|4226837|B1||<=18 years|Age||Participants|Count of Participants|3031|3031.0||||||
4400035|NCT00267488|4226844|B1|African Heritage/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4400036|NCT00267488|4226844|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4400037|NCT00267488|4226844|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400038|NCT00267488|4226844|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4400039|NCT00267488|4226844|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|9.12|9.12|||
4400040|NCT00267293|4226853|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
4400041|NCT00267293|4226854|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4400042|NCT00267293|4226855|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4400043|NCT00267293|4226856|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4400044|NCT00267293|4226853|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4400045|NCT00267293|4226854|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4400046|NCT00267293|4226855|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4400047|NCT00267293|4226856|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4400048|NCT00267293|4226853|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4400049|NCT00267293|4226854|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4400050|NCT00267293|4226855|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4400051|NCT00267293|4226856|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4400052|NCT00267293|4226853|B4|||Age||years|Mean|3.4|3.4|Standard Deviation|2.2|2.2|||
4400053|NCT00267293|4226854|B3|||Age||years|Mean|4.0|4.0|Standard Deviation|2.8|2.8|||
4400054|NCT00267293|4226855|B2|||Age||years|Mean|3.0|3.0|Standard Deviation|1.9|1.9|||
4400055|NCT00267293|4226856|B1|||Age||years|Mean|3.2|3.2|Standard Deviation|1.9|1.9|||
4400056|NCT00267293|4226853|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400057|NCT00267293|4226854|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400058|NCT00267293|4226855|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400059|NCT00267293|4226856|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400060|NCT00267293|4226853|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400061|NCT00267293|4226854|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400062|NCT00267293|4226855|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400063|NCT00267293|4226856|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400064|NCT00267293|4226853|B4||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4400065|NCT00267293|4226854|B3||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4400066|NCT00267293|4226855|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4400067|NCT00267293|4226856|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4400068|NCT00267202|4226866|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4400069|NCT00267202|4226867|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4400070|NCT00267202|4226868|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4400071|NCT00267202|4226866|B3|White||Race/Ethnicity, Customized||participants|Number|230|230.0||||||
4400072|NCT00267202|4226867|B2|White||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
4400073|NCT00267202|4226868|B1|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
4400074|NCT00267202|4226866|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4400075|NCT00267202|4226867|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4400076|NCT00267202|4226868|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4400077|NCT00267202|4226866|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4400078|NCT00267202|4226867|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4400079|NCT00267202|4226868|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400080|NCT00267202|4226866|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4400081|NCT00267202|4226867|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4400082|NCT00267202|4226868|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4400083|NCT00267202|4226866|B3||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4400084|NCT00267202|4226867|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4400085|NCT00267202|4226868|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4400086|NCT00267202|4226866|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|9.93|9.93|||
4400087|NCT00267202|4226867|B2|||Age||years|Mean|38.2|38.2|Standard Deviation|9.89|9.89|||
4400088|NCT00267202|4226868|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|10.02|10.02|||
4400089|NCT00267189|4226888|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4400090|NCT00267189|4226889|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4400091|NCT00267189|4226890|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4400092|NCT00267189|4226888|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4400093|NCT00267189|4226889|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4400094|NCT00267189|4226890|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4400095|NCT00267189|4226888|B3|>= 60 years||Age, Customized||Paricipants|Number|61|61.0||||||
4400096|NCT00267189|4226889|B2|>= 60 years||Age, Customized||Paricipants|Number|31|31.0||||||
4400097|NCT00267189|4226890|B1|>= 60 years||Age, Customized||Paricipants|Number|30|30.0||||||
4400098|NCT00267189|4226888|B3|>= 50 - < 60 years||Age, Customized||Paricipants|Number|62|62.0||||||
4400099|NCT00267189|4226889|B2|>= 50 - < 60 years||Age, Customized||Paricipants|Number|33|33.0||||||
4400100|NCT00267189|4226890|B1|>= 50 - < 60 years||Age, Customized||Paricipants|Number|29|29.0||||||
4400101|NCT00267189|4226888|B3|>= 40 - < 50 years||Age, Customized||Paricipants|Number|19|19.0||||||
4400102|NCT00267189|4226889|B2|>= 40 - < 50 years||Age, Customized||Paricipants|Number|7|7.0||||||
4400103|NCT00267189|4226890|B1|>= 40 - < 50 years||Age, Customized||Paricipants|Number|12|12.0||||||
4400104|NCT00267189|4226888|B3|< 40 years||Age, Customized||Paricipants|Number|3|3.0||||||
4400105|NCT00267189|4226889|B2|< 40 years||Age, Customized||Paricipants|Number|2|2.0||||||
4400106|NCT00267189|4226890|B1|< 40 years||Age, Customized||Paricipants|Number|1|1.0||||||
4400107|NCT00267189|4226888|B3|||Age||Years|Mean|57.4|57.4|Standard Deviation|7.70|7.7|||
4400108|NCT00267189|4226889|B2|||Age||Years|Mean|57.8|57.8|Standard Deviation|6.93|6.93|||
4400109|NCT00267189|4226890|B1|||Age||Years|Mean|57.0|57.0|Standard Deviation|8.45|8.45|||
4400110|NCT00267150|4226901|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4400111|NCT00267150|4226901|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4400112|NCT00267150|4226901|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|9.5|9.5|||
4400113|NCT00267111|4226906|B3|Canada||Region of Enrollment||participants|Number|110|110.0||||||
4400114|NCT00267111|4226907|B2|Canada||Region of Enrollment||participants|Number|55|55.0||||||
4400115|NCT00267111|4226908|B1|Canada||Region of Enrollment||participants|Number|55|55.0||||||
4400116|NCT00267111|4226906|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4400117|NCT00267111|4226907|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4400118|NCT00267111|4226908|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4400119|NCT00267111|4226906|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4400120|NCT00267111|4226907|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4400121|NCT00267111|4226908|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4400122|NCT00267111|4226906|B3|||Age||years|Mean|39.25|39.25|Standard Deviation|1.05|1.05|||
4400123|NCT00267111|4226907|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|1.0|1.0|||
4400124|NCT00267111|4226908|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|1.1|1.1|||
4400125|NCT00267111|4226906|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400126|NCT00267111|4226907|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400127|NCT00267111|4226908|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400128|NCT00267111|4226906|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400129|NCT00267111|4226907|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400130|NCT00267111|4226908|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400131|NCT00267111|4226906|B3||<=18 years|Age||Participants|Count of Participants|110|110.0||||||
4400132|NCT00267111|4226907|B2||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4400133|NCT00267111|4226908|B1||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4400134|NCT00267098|4226917|B9|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4400135|NCT00267098|4226918|B8|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4400136|NCT00267098|4226919|B7|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4400137|NCT00267098|4226920|B6|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4400138|NCT00267098|4226921|B5|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4400139|NCT00267098|4226922|B4|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4400140|NCT00267098|4226923|B3|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4400141|NCT00267098|4226924|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4400142|NCT00267098|4226925|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4400143|NCT00267098|4226917|B9|United States||Region of Enrollment||participants|Number|886|886.0||||||
4400144|NCT00267098|4226918|B8|United States||Region of Enrollment||participants|Number|19|19.0||||||
4400145|NCT00267098|4226919|B7|United States||Region of Enrollment||participants|Number|98|98.0||||||
4400146|NCT00267098|4226920|B6|United States||Region of Enrollment||participants|Number|104|104.0||||||
4400147|NCT00267098|4226921|B5|United States||Region of Enrollment||participants|Number|47|47.0||||||
4400148|NCT00267098|4226922|B4|United States||Region of Enrollment||participants|Number|231|231.0||||||
4400149|NCT00267098|4226923|B3|United States||Region of Enrollment||participants|Number|232|232.0||||||
4400150|NCT00267098|4226924|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4400151|NCT00267098|4226925|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4400152|NCT00267098|4226917|B9|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4400153|NCT00267098|4226918|B8|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400154|NCT00267098|4226919|B7|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4400155|NCT00267098|4226920|B6|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400156|NCT00267098|4226921|B5|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400157|NCT00267098|4226922|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400158|NCT00267098|4226923|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4400159|NCT00267098|4226924|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4400160|NCT00267098|4226925|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4400161|NCT00267098|4226917|B9|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4400162|NCT00267098|4226918|B8|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400163|NCT00267098|4226919|B7|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400164|NCT00267098|4226920|B6|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400165|NCT00267098|4226921|B5|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400166|NCT00267098|4226922|B4|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4400167|NCT00267098|4226923|B3|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400168|NCT00267098|4226924|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400169|NCT00267098|4226925|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400170|NCT00267098|4226917|B9|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4400171|NCT00267098|4226918|B8|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4400172|NCT00267098|4226919|B7|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4400173|NCT00267098|4226920|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4400174|NCT00267098|4226921|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4400175|NCT00267098|4226922|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4400176|NCT00267098|4226923|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4400177|NCT00267098|4226924|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400178|NCT00267098|4226925|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4400179|NCT00267098|4226917|B9|Caucasian||Race/Ethnicity, Customized||participants|Number|832|832.0||||||
4400180|NCT00267098|4226918|B8|Caucasian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4400181|NCT00267098|4226919|B7|Caucasian||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
4400182|NCT00267098|4226920|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4400183|NCT00267098|4226921|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4400184|NCT00267098|4226922|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|224|224.0||||||
4400185|NCT00267098|4226923|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|225|225.0||||||
4400186|NCT00267098|4226924|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4400187|NCT00267098|4226925|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4400188|NCT00267098|4226917|B9|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4400189|NCT00267098|4226918|B8|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400190|NCT00267098|4226919|B7|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400191|NCT00267098|4226920|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400192|NCT00267098|4226921|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4400193|NCT00267098|4226922|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400194|NCT00267098|4226923|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400195|NCT00267098|4226924|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400196|NCT00267098|4226925|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400197|NCT00267098|4226917|B9|African American||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4400198|NCT00267098|4226918|B8|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4400199|NCT00267098|4226919|B7|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4400200|NCT00267098|4226920|B6|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4400201|NCT00267098|4226921|B5|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400202|NCT00267098|4226922|B4|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4400203|NCT00267098|4226923|B3|African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4400204|NCT00267098|4226924|B2|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4400205|NCT00267098|4226925|B1|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4400206|NCT00267098|4226917|B9|Subject did not offer ethnicity||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4400207|NCT00267098|4226918|B8|Subject did not offer ethnicity||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4400208|NCT00267098|4226919|B7|Subject did not offer ethnicity||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4400209|NCT00267098|4226920|B6|Subject did not offer ethnicity||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4400210|NCT00267098|4226921|B5|Subject did not offer ethnicity||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4400211|NCT00267098|4226922|B4|Subject did not offer ethnicity||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4400212|NCT00267098|4226923|B3|Subject did not offer ethnicity||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4400213|NCT00267098|4226924|B2|Subject did not offer ethnicity||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4400214|NCT00267098|4226925|B1|Subject did not offer ethnicity||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4400215|NCT00267098|4226917|B9||Male|Sex: Female, Male||Participants|Count of Participants|679|679.0||||||
4400216|NCT00267098|4226918|B8||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4400217|NCT00267098|4226919|B7||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4400218|NCT00267098|4226920|B6||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4400219|NCT00267098|4226921|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4400220|NCT00267098|4226922|B4||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4400221|NCT00267098|4226923|B3||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4400222|NCT00267098|4226924|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4400223|NCT00267098|4226925|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4400224|NCT00267098|4226917|B9||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4400225|NCT00267098|4226918|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4400226|NCT00267098|4226919|B7||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4400227|NCT00267098|4226920|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4400228|NCT00267098|4226921|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4400229|NCT00267098|4226922|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4400230|NCT00267098|4226923|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4400231|NCT00267098|4226924|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4400232|NCT00267098|4226925|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4400233|NCT00267098|4226917|B9|||Age||years|Mean|73.2|73.2|Standard Deviation|10.6|10.6|||
4400234|NCT00267098|4226918|B8|||Age||years|Mean|74.0|74.0|Standard Deviation|9.1|9.1|||
4400235|NCT00267098|4226919|B7|||Age||years|Mean|71.0|71.0|Standard Deviation|10.0|10.0|||
4400236|NCT00267098|4226920|B6|||Age||years|Mean|72.0|72.0|Standard Deviation|9.3|9.3|||
4400237|NCT00267098|4226921|B5|||Age||years|Mean|79.3|79.3|Standard Deviation|7.6|7.6|||
4400238|NCT00267098|4226922|B4|||Age||years|Mean|73.8|73.8|Standard Deviation|10.8|10.8|||
4400239|NCT00267098|4226923|B3|||Age||years|Mean|74.4|74.4|Standard Deviation|10.2|10.2|||
4400240|NCT00267098|4226924|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|11.2|11.2|||
4400241|NCT00267098|4226925|B1|||Age||years|Mean|70.2|70.2|Standard Deviation|12.6|12.6|||
4400242|NCT00267085|4227065|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4400243|NCT00267085|4227065|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4400244|NCT00267085|4227065|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4400245|NCT00267085|4227065|B1|||Age||years|Median|45|45.0|Full Range|||28.0|63.0|
4400246|NCT00267085|4227065|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400247|NCT00267085|4227065|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4400248|NCT00267085|4227065|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400249|NCT00267059|4227069|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4400250|NCT00267059|4227069|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4400251|NCT00267059|4227069|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4400252|NCT00267059|4227069|B1|||Age||years|Median|63|63.0|Full Range|||49.0|86.0|
4400253|NCT00267059|4227069|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4400254|NCT00267059|4227069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4400255|NCT00267059|4227069|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400256|NCT00267046|4227073|B3|Not Completed 6 Cycles||Participants' Completion of 6 Blinded Cycles|Number of participants completing six (6) blinded treatment cycles; one cycle equals 3 weeks.|participants|Number|23|23.0||||||
4400257|NCT00267046|4227074|B2|Not Completed 6 Cycles||Participants' Completion of 6 Blinded Cycles|Number of participants completing six (6) blinded treatment cycles; one cycle equals 3 weeks.|participants|Number|11|11.0||||||
4400258|NCT00267046|4227075|B1|Not Completed 6 Cycles||Participants' Completion of 6 Blinded Cycles|Number of participants completing six (6) blinded treatment cycles; one cycle equals 3 weeks.|participants|Number|12|12.0||||||
4400259|NCT00267046|4227073|B3|Completed 6 Cycles||Participants' Completion of 6 Blinded Cycles|Number of participants completing six (6) blinded treatment cycles; one cycle equals 3 weeks.|participants|Number|25|25.0||||||
4400260|NCT00267046|4227074|B2|Completed 6 Cycles||Participants' Completion of 6 Blinded Cycles|Number of participants completing six (6) blinded treatment cycles; one cycle equals 3 weeks.|participants|Number|5|5.0||||||
4400261|NCT00267046|4227075|B1|Completed 6 Cycles||Participants' Completion of 6 Blinded Cycles|Number of participants completing six (6) blinded treatment cycles; one cycle equals 3 weeks.|participants|Number|20|20.0||||||
4400262|NCT00267046|4227073|B3|Number of participants on AP chemotherapy||Number of participants on two different chemotherapy regimens.|Number of participants on two different chemotherapy regimens:AI; AP.|Participant|Number|3|3.0||||||
4400263|NCT00267046|4227074|B2|Number of participants on AP chemotherapy||Number of participants on two different chemotherapy regimens.|Number of participants on two different chemotherapy regimens:AI; AP.|Participant|Number|1|1.0||||||
4400264|NCT00267046|4227075|B1|Number of participants on AP chemotherapy||Number of participants on two different chemotherapy regimens.|Number of participants on two different chemotherapy regimens:AI; AP.|Participant|Number|2|2.0||||||
4400265|NCT00267046|4227073|B3|Number of participants on AI chemotherapy||Number of participants on two different chemotherapy regimens.|Number of participants on two different chemotherapy regimens:AI; AP.|Participant|Number|45|45.0||||||
4400266|NCT00267046|4227074|B2|Number of participants on AI chemotherapy||Number of participants on two different chemotherapy regimens.|Number of participants on two different chemotherapy regimens:AI; AP.|Participant|Number|15|15.0||||||
4400267|NCT00267046|4227075|B1|Number of participants on AI chemotherapy||Number of participants on two different chemotherapy regimens.|Number of participants on two different chemotherapy regimens:AI; AP.|Participant|Number|30|30.0||||||
4400268|NCT00267046|4227073|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4400269|NCT00267046|4227074|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4400270|NCT00267046|4227075|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4400271|NCT00267046|4227073|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4400272|NCT00267046|4227074|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4400273|NCT00267046|4227075|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4400274|NCT00267046|4227073|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4400275|NCT00267046|4227074|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4400276|NCT00267046|4227075|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4400277|NCT00267046|4227073|B3|||Age, Customized||years|Median|42|42.0|Full Range|||15.0|64.0|
4400278|NCT00267046|4227074|B2|||Age, Customized||years|Median|39|39.0|Full Range|||15.0|64.0|
4400279|NCT00267046|4227075|B1|||Age, Customized||years|Median|42|42.0|Full Range|||17.0|63.0|
4400280|NCT00267007|4227084|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400281|NCT00267007|4227085|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400282|NCT00267007|4227086|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400283|NCT00267007|4227084|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4400284|NCT00267007|4227085|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4400285|NCT00267007|4227086|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4400286|NCT00267007|4227084|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|13.62|13.62|||
4400287|NCT00267007|4227085|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|12.98|12.98|||
4400288|NCT00267007|4227086|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|14.18|14.18|||
4400289|NCT00267007|4227084|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4400290|NCT00267007|4227085|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4400291|NCT00267007|4227086|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4400292|NCT00267007|4227084|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4400293|NCT00267007|4227085|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4400294|NCT00267007|4227086|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4400295|NCT00267007|4227084|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400296|NCT00267007|4227085|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400297|NCT00267007|4227086|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400298|NCT00266877|4227095|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4400299|NCT00266877|4227096|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4400300|NCT00266877|4227097|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4400301|NCT00266877|4227098|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4400302|NCT00266877|4227095|B4||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4400303|NCT00266877|4227096|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4400304|NCT00266877|4227097|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4400305|NCT00266877|4227098|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4400306|NCT00266877|4227095|B4||>= 60 years|Age, Customized||Participants|Count of Participants|85|85.0||||||
4400307|NCT00266877|4227096|B3||>= 60 years|Age, Customized||Participants|Count of Participants|15|15.0||||||
4400308|NCT00266877|4227097|B2||>= 60 years|Age, Customized||Participants|Count of Participants|24|24.0||||||
4400309|NCT00266877|4227098|B1||>= 60 years|Age, Customized||Participants|Count of Participants|46|46.0||||||
4400310|NCT00266877|4227095|B4||< 60 years|Age, Customized||Participants|Count of Participants|82|82.0||||||
4400311|NCT00266877|4227096|B3||< 60 years|Age, Customized||Participants|Count of Participants|13|13.0||||||
4400312|NCT00266877|4227097|B2||< 60 years|Age, Customized||Participants|Count of Participants|24|24.0||||||
4400313|NCT00266877|4227098|B1||< 60 years|Age, Customized||Participants|Count of Participants|45|45.0||||||
4400314|NCT00266864|4227117|B3|||Resting Energy Expenditure|Resting Energy Expenditure was obtained by the measurement of exhaled air from fractions of mixed expired oxygen and carbon dioxide by a process known as indirect calorimetry. Data was collected under steady state conditions and was adjusted to account for differences in total body lean tissue mass. Participants arrived at the laboratory for testing between the hours of 8:00 and 10:00 in the morning, following a 12 hour fast, with a minimum of 24 hours free from any type of exercise.|kcal/day|Mean|1324|1324.0|Standard Deviation|197|197.0|||
4400315|NCT00266864|4227118|B2|||Resting Energy Expenditure|Resting Energy Expenditure was obtained by the measurement of exhaled air from fractions of mixed expired oxygen and carbon dioxide by a process known as indirect calorimetry. Data was collected under steady state conditions and was adjusted to account for differences in total body lean tissue mass. Participants arrived at the laboratory for testing between the hours of 8:00 and 10:00 in the morning, following a 12 hour fast, with a minimum of 24 hours free from any type of exercise.|kcal/day|Mean|1319|1319.0|Standard Deviation|112|112.0|||
4400316|NCT00266864|4227119|B1|||Resting Energy Expenditure|Resting Energy Expenditure was obtained by the measurement of exhaled air from fractions of mixed expired oxygen and carbon dioxide by a process known as indirect calorimetry. Data was collected under steady state conditions and was adjusted to account for differences in total body lean tissue mass. Participants arrived at the laboratory for testing between the hours of 8:00 and 10:00 in the morning, following a 12 hour fast, with a minimum of 24 hours free from any type of exercise.|kcal/day|Mean|1328|1328.0|Standard Deviation|262|262.0|||
4400317|NCT00266864|4227117|B3|||Dual energy x-ray absorptiometry (DXA) for lean tissue mass|Body composition measurements for measures of total body lean tissue mass (LTM) were assessed by dual energy X-ray absorptiometry (DXA; General Electric LUNAR Prodigy Advance, software version 11.4 and 12.2, Madison, WI). In accordance with International Society for Clinical Densitometry guidelines, total body scans were repeated on 30 spinal cord injury subjects by the “on-and-off -the-table” method (i. e., subjects were repositioned between scans) and our precision error was equal to 1.2 % for LTM.|kilograms|Mean|50.8|50.8|Standard Deviation|7.8|7.8|||
4400318|NCT00266864|4227118|B2|||Dual energy x-ray absorptiometry (DXA) for lean tissue mass|Body composition measurements for measures of total body lean tissue mass (LTM) were assessed by dual energy X-ray absorptiometry (DXA; General Electric LUNAR Prodigy Advance, software version 11.4 and 12.2, Madison, WI). In accordance with International Society for Clinical Densitometry guidelines, total body scans were repeated on 30 spinal cord injury subjects by the “on-and-off -the-table” method (i. e., subjects were repositioned between scans) and our precision error was equal to 1.2 % for LTM.|kilograms|Mean|51.9|51.9|Standard Deviation|8.1|8.1|||
4400319|NCT00266864|4227119|B1|||Dual energy x-ray absorptiometry (DXA) for lean tissue mass|Body composition measurements for measures of total body lean tissue mass (LTM) were assessed by dual energy X-ray absorptiometry (DXA; General Electric LUNAR Prodigy Advance, software version 11.4 and 12.2, Madison, WI). In accordance with International Society for Clinical Densitometry guidelines, total body scans were repeated on 30 spinal cord injury subjects by the “on-and-off -the-table” method (i. e., subjects were repositioned between scans) and our precision error was equal to 1.2 % for LTM.|kilograms|Mean|49.6|49.6|Standard Deviation|7.6|7.6|||
4400320|NCT00266864|4227117|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4400321|NCT00266864|4227118|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4400322|NCT00266864|4227119|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4400323|NCT00266864|4227117|B3|Male||Sex/Gender, Customized|Hypogonadal (Testosterone Replacement Therapy group, total testosterone < 4 ng/ml) and Eugonadal (No Intervention group total testosterone > 4 ng/ml) subjects|participants|Number|24|24.0||||||
4400324|NCT00266864|4227118|B2|Male||Sex/Gender, Customized|Hypogonadal (Testosterone Replacement Therapy group, total testosterone < 4 ng/ml) and Eugonadal (No Intervention group total testosterone > 4 ng/ml) subjects|participants|Number|11|11.0||||||
4400444|NCT00266630|4227216|B2|Manic||Current Episode - Mixed or Manic|Description of the bipolar episode the participant experienced when enrolling into the study.|participants|Number|39|39.0||||||
4400325|NCT00266864|4227119|B1|Male||Sex/Gender, Customized|Hypogonadal (Testosterone Replacement Therapy group, total testosterone < 4 ng/ml) and Eugonadal (No Intervention group total testosterone > 4 ng/ml) subjects|participants|Number|13|13.0||||||
4400326|NCT00266864|4227117|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400327|NCT00266864|4227118|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400328|NCT00266864|4227119|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400329|NCT00266864|4227117|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4400330|NCT00266864|4227118|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4400331|NCT00266864|4227119|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4400332|NCT00266864|4227117|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400333|NCT00266864|4227118|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400334|NCT00266864|4227119|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400335|NCT00266825|4227127|B3|||Gestation at Enrollment||days|Mean|101.3|101.3|Standard Deviation|25.7|25.7|||
4400336|NCT00266825|4227128|B2|||Gestation at Enrollment||days|Mean|102.9|102.9|Standard Deviation|25.3|25.3|||
4400337|NCT00266825|4227129|B1|||Gestation at Enrollment||days|Mean|99.6|99.6|Standard Deviation|26.1|26.1|||
4400338|NCT00266825|4227127|B3|United States||Region of Enrollment||participants|Number|350|350.0||||||
4400339|NCT00266825|4227128|B2|United States||Region of Enrollment||participants|Number|178|178.0||||||
4400340|NCT00266825|4227129|B1|United States||Region of Enrollment||participants|Number|172|172.0||||||
4400341|NCT00266825|4227127|B3|Not Hispanic||Race/Ethnicity, Customized|Ethnicity of mother|participants|Number|322|322.0||||||
4400342|NCT00266825|4227128|B2|Not Hispanic||Race/Ethnicity, Customized|Ethnicity of mother|participants|Number|164|164.0||||||
4400343|NCT00266825|4227129|B1|Not Hispanic||Race/Ethnicity, Customized|Ethnicity of mother|participants|Number|158|158.0||||||
4400344|NCT00266825|4227127|B3|Hispanic||Race/Ethnicity, Customized|Ethnicity of mother|participants|Number|28|28.0||||||
4400345|NCT00266825|4227128|B2|Hispanic||Race/Ethnicity, Customized|Ethnicity of mother|participants|Number|14|14.0||||||
4400346|NCT00266825|4227129|B1|Hispanic||Race/Ethnicity, Customized|Ethnicity of mother|participants|Number|14|14.0||||||
4400347|NCT00266825|4227127|B3|Not Black||Race/Ethnicity, Customized|Race of mother|participants|Number|205|205.0||||||
4400348|NCT00266825|4227128|B2|Not Black||Race/Ethnicity, Customized|Race of mother|participants|Number|112|112.0||||||
4400349|NCT00266825|4227129|B1|Not Black||Race/Ethnicity, Customized|Race of mother|participants|Number|93|93.0||||||
4400350|NCT00266825|4227127|B3|Black||Race/Ethnicity, Customized|Race of mother|participants|Number|145|145.0||||||
4400351|NCT00266825|4227128|B2|Black||Race/Ethnicity, Customized|Race of mother|participants|Number|66|66.0||||||
4400352|NCT00266825|4227129|B1|Black||Race/Ethnicity, Customized|Race of mother|participants|Number|79|79.0||||||
4400353|NCT00266825|4227127|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400354|NCT00266825|4227128|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400355|NCT00266825|4227129|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400356|NCT00266825|4227127|B3||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4400357|NCT00266825|4227128|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4400358|NCT00266825|4227129|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4400359|NCT00266825|4227127|B3|||Age||years|Mean|25.0|25.0|Standard Deviation|4.8|4.8|||
4400360|NCT00266825|4227128|B2|||Age||years|Mean|25.3|25.3|Standard Deviation|4.9|4.9|||
4400361|NCT00266825|4227129|B1|||Age||years|Mean|24.8|24.8|Standard Deviation|4.7|4.7|||
4400362|NCT00266812|4227154|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4400363|NCT00266812|4227155|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4400364|NCT00266812|4227156|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4400365|NCT00266812|4227154|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4400366|NCT00266812|4227155|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4400367|NCT00266812|4227156|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4400368|NCT00266812|4227154|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|11.3|11.3|||
4400369|NCT00266812|4227155|B2|||Age||years|Mean|63.02|63.02|Standard Deviation|8.76|8.76|||
4400370|NCT00266812|4227156|B1|||Age||years|Mean|65.12|65.12|Standard Deviation|12.72|12.72|||
4400371|NCT00266799|4227163|B3||Male|Sex: Female, Male|For baseline characteristics, all 210 participants who were enrolled and randomized were incorporated , although 7 participants in the PLD group and 3 participants in the Capecitabine group were not treated.|Participants|Count of Participants|0|0.0||||||
4400372|NCT00266799|4227164|B2||Male|Sex: Female, Male|For baseline characteristics, all 210 participants who were enrolled and randomized were incorporated , although 7 participants in the PLD group and 3 participants in the Capecitabine group were not treated.|Participants|Count of Participants|0|0.0||||||
4400373|NCT00266799|4227165|B1||Male|Sex: Female, Male|For baseline characteristics, all 210 participants who were enrolled and randomized were incorporated , although 7 participants in the PLD group and 3 participants in the Capecitabine group were not treated.|Participants|Count of Participants|0|0.0||||||
4400374|NCT00266799|4227163|B3||Female|Sex: Female, Male|For baseline characteristics, all 210 participants who were enrolled and randomized were incorporated , although 7 participants in the PLD group and 3 participants in the Capecitabine group were not treated.|Participants|Count of Participants|210|210.0||||||
4400375|NCT00266799|4227164|B2||Female|Sex: Female, Male|For baseline characteristics, all 210 participants who were enrolled and randomized were incorporated , although 7 participants in the PLD group and 3 participants in the Capecitabine group were not treated.|Participants|Count of Participants|105|105.0||||||
4400376|NCT00266799|4227165|B1||Female|Sex: Female, Male|For baseline characteristics, all 210 participants who were enrolled and randomized were incorporated , although 7 participants in the PLD group and 3 participants in the Capecitabine group were not treated.|Participants|Count of Participants|105|105.0||||||
4400377|NCT00266799|4227163|B3|||Age|For baseline characteristics, all 210 participants who were enrolled and randomized were incorporated , although 7 participants in the PLD group and 3 participants in the Capecitabine group were not treated.|years|Mean|61.5|61.5|Standard Deviation|10.60|10.6|||
4400378|NCT00266799|4227164|B2|||Age|For baseline characteristics, all 210 participants who were enrolled and randomized were incorporated , although 7 participants in the PLD group and 3 participants in the Capecitabine group were not treated.|years|Mean|61.5|61.5|Standard Deviation|10.59|10.59|||
4400379|NCT00266799|4227165|B1|||Age|For baseline characteristics, all 210 participants who were enrolled and randomized were incorporated , although 7 participants in the PLD group and 3 participants in the Capecitabine group were not treated.|years|Mean|61.4|61.4|Standard Deviation|10.66|10.66|||
4400380|NCT00266695|4227180|B1|Diastolic Blood Pressure||Blood Pressure||millimeters of mercury (mm Hg)|Mean|73.29|73.29|Standard Deviation|10.07|10.07|||
4400381|NCT00266695|4227180|B1|Systolic Blood Pressure||Blood Pressure||millimeters of mercury (mm Hg)|Mean|131.48|131.48|Standard Deviation|17.03|17.03|||
4400382|NCT00266695|4227180|B1|||Visual Acuity (VA) Score|Best-corrected Early Treatment of Diabetic Retinopathy Study (ETDRS) VA was measured at 4 meters (m) using an eye chart, 5 letters per row. Participants read chart from top down until reaching row where ≥3 letters not read correctly. If <20 letters read correctly at 4 m, chart was re-read at 1 m. Best-corrected ETDRS VA score was the total number of letters read correctly at 4 m, and if necessary, 1 m. A correction factor of 30 was added to score if total number of letters read correctly at 4 m was ≥20. VA scores ranged from 0 (no letters read correctly) to 100 (all letters read correctly).|letters read correctly|Mean|76.84|76.84|Standard Deviation|13.11|13.11|||
4400383|NCT00266695|4227180|B1|Two||Number of Diabetic Retinopathy (DR) Study Eyes Per Participant||participant|Number|131|131.0||||||
4400384|NCT00266695|4227180|B1|One||Number of Diabetic Retinopathy (DR) Study Eyes Per Participant||participant|Number|72|72.0||||||
4400385|NCT00266695|4227180|B1|||Body Mass Index|Body mass index was an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m^2)|Mean|33.47|33.47|Standard Deviation|7.34|7.34|||
4400386|NCT00266695|4227180|B1|||Duration of Diabetes||years|Mean|16.08|16.08|Standard Deviation|8.40|8.4|||
4400387|NCT00266695|4227180|B1|Type 2||Diabetes Type|Type 1 diabetes results from autoimmune mediated destruction of the beta cells of the pancreas. Participants require insulin treatment to survive. Type 2 diabetes is characterized by resistance to the action of insulin leading to relative insulin deficiency.|participants|Number|179|179.0||||||
4400388|NCT00266695|4227180|B1|Type 1||Diabetes Type|Type 1 diabetes results from autoimmune mediated destruction of the beta cells of the pancreas. Participants require insulin treatment to survive. Type 2 diabetes is characterized by resistance to the action of insulin leading to relative insulin deficiency.|participants|Number|24|24.0||||||
4400389|NCT00266695|4227180|B1|United States||Region of Enrollment||participants|Number|203|203.0||||||
4400390|NCT00266695|4227180|B1|Non-Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4400391|NCT00266695|4227180|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|180|180.0||||||
4400392|NCT00266695|4227180|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4400393|NCT00266695|4227180|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4400394|NCT00266695|4227180|B1|||Age||years|Mean|58.50|58.5|Standard Deviation|9.70|9.7|||
4400395|NCT00266656|4227190|B3|||Bone Age||years|Mean|8.54|8.54|Standard Deviation|1.56|1.56|||
4400396|NCT00266656|4227191|B2|||Bone Age||years|Mean|8.34|8.34|Standard Deviation|1.57|1.57|||
4400397|NCT00266656|4227192|B1|||Bone Age||years|Mean|8.73|8.73|Standard Deviation|1.55|1.55|||
4400398|NCT00266656|4227190|B3|||Height Standard Deviation Score (SDS)||Standard Deviation Score|Mean|-1.15|-1.15|Standard Deviation|1.26|1.26|||
4400399|NCT00266656|4227191|B2|||Height Standard Deviation Score (SDS)||Standard Deviation Score|Mean|-1.48|-1.48|Standard Deviation|1.23|1.23|||
4400400|NCT00266656|4227192|B1|||Height Standard Deviation Score (SDS)||Standard Deviation Score|Mean|-0.84|-0.84|Standard Deviation|1.22|1.22|||
4400401|NCT00266656|4227190|B3|||Height||centimeter|Mean|122.77|122.77|Standard Deviation|9.99|9.99|||
4400402|NCT00266656|4227191|B2|||Height||centimeter|Mean|121.06|121.06|Standard Deviation|9.76|9.76|||
4400403|NCT00266656|4227192|B1|||Height||centimeter|Mean|124.34|124.34|Standard Deviation|10.08|10.08|||
4400404|NCT00266656|4227190|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400405|NCT00266656|4227191|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400406|NCT00266656|4227192|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400407|NCT00266656|4227190|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4400408|NCT00266656|4227191|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4400409|NCT00266656|4227192|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4400410|NCT00266656|4227190|B3|||Age||years|Mean|8.35|8.35|Standard Deviation|1.25|1.25|||
4400411|NCT00266656|4227191|B2|||Age||years|Mean|8.41|8.41|Standard Deviation|1.30|1.3|||
4400412|NCT00266656|4227192|B1|||Age||years|Mean|8.29|8.29|Standard Deviation|1.22|1.22|||
4400413|NCT00266630|4227215|B3|||Young Mania Rating Scale (YMRS) Total Score|The YMRS is an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60.|units on a scale|Mean|13.4|13.4|Standard Deviation|13.9|13.9|||
4400445|NCT00266630|4227217|B1|Manic||Current Episode - Mixed or Manic|Description of the bipolar episode the participant experienced when enrolling into the study.|participants|Number|88|88.0||||||
4400446|NCT00266630|4227215|B3|Japan||Region of Enrollment||participants|Number|139|139.0||||||
4400414|NCT00266630|4227216|B2|||Young Mania Rating Scale (YMRS) Total Score|The YMRS is an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60.|units on a scale|Mean|33.2|33.2|Standard Deviation|6.6|6.6|||
4400415|NCT00266630|4227217|B1|||Young Mania Rating Scale (YMRS) Total Score|The YMRS is an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60.|units on a scale|Mean|5.7|5.7|Standard Deviation|6.4|6.4|||
4400416|NCT00266630|4227215|B3|||Mean Age at Onset of Illness||years|Mean|31.0|31.0|Standard Deviation|10.8|10.8|||
4400417|NCT00266630|4227216|B2|||Mean Age at Onset of Illness||years|Mean|29.8|29.8|Standard Deviation|8.4|8.4|||
4400418|NCT00266630|4227217|B1|||Mean Age at Onset of Illness||years|Mean|31.5|31.5|Standard Deviation|11.6|11.6|||
4400419|NCT00266630|4227215|B3|||Length of Current Episode||days|Mean|33.9|33.9|Standard Deviation|24.6|24.6|||
4400420|NCT00266630|4227216|B2|||Length of Current Episode||days|Mean|35.0|35.0|Standard Deviation|26.7|26.7|||
4400421|NCT00266630|4227217|B1|||Length of Current Episode||days|Mean|33.5|33.5|Standard Deviation|23.9|23.9|||
4400422|NCT00266630|4227215|B3|||Hamilton Depression Scale - 17 item version (HAMD-17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using a 3-point scale (e.g. absent, mild, marked) or a 5-point scale (e.g. absent, mild, moderate, severe, very severe). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|2.5|2.5|Standard Deviation|3.5|3.5|||
4400423|NCT00266630|4227216|B2|||Hamilton Depression Scale - 17 item version (HAMD-17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using a 3-point scale (e.g. absent, mild, marked) or a 5-point scale (e.g. absent, mild, moderate, severe, very severe). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|4.4|4.4|Standard Deviation|3.9|3.9|||
4400424|NCT00266630|4227217|B1|||Hamilton Depression Scale - 17 item version (HAMD-17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using a 3-point scale (e.g. absent, mild, marked) or a 5-point scale (e.g. absent, mild, moderate, severe, very severe). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|1.8|1.8|Standard Deviation|3.1|3.1|||
4400425|NCT00266630|4227215|B3|||Clinical Global Impressions - Bipolar Version, Severity of Illness (CGI-BP) overall|Measures severity of the patient's overall severity of bipolar symptoms (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|2.7|2.7|Standard Deviation|1.6|1.6|||
4400426|NCT00266630|4227216|B2|||Clinical Global Impressions - Bipolar Version, Severity of Illness (CGI-BP) overall|Measures severity of the patient's overall severity of bipolar symptoms (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|4.7|4.7|Standard Deviation|0.8|0.8|||
4400427|NCT00266630|4227217|B1|||Clinical Global Impressions - Bipolar Version, Severity of Illness (CGI-BP) overall|Measures severity of the patient's overall severity of bipolar symptoms (1=normal, not at all ill; 7=among the most extremely ill patients).|units on a scale|Mean|1.9|1.9|Standard Deviation|1.0|1.0|||
4400428|NCT00266630|4227215|B3|Non-Rapid Cyclers||Rapid Cyclers|A rapid cycler is defined as a person who experiences four or more mood swings or episodes in a twelve-month period.|participants|Number|129|129.0||||||
4400429|NCT00266630|4227216|B2|Non-Rapid Cyclers||Rapid Cyclers|A rapid cycler is defined as a person who experiences four or more mood swings or episodes in a twelve-month period.|participants|Number|36|36.0||||||
4400430|NCT00266630|4227217|B1|Non-Rapid Cyclers||Rapid Cyclers|A rapid cycler is defined as a person who experiences four or more mood swings or episodes in a twelve-month period.|participants|Number|93|93.0||||||
4400431|NCT00266630|4227215|B3|Rapid Cyclers||Rapid Cyclers|A rapid cycler is defined as a person who experiences four or more mood swings or episodes in a twelve-month period.|participants|Number|10|10.0||||||
4400432|NCT00266630|4227216|B2|Rapid Cyclers||Rapid Cyclers|A rapid cycler is defined as a person who experiences four or more mood swings or episodes in a twelve-month period.|participants|Number|3|3.0||||||
4400433|NCT00266630|4227217|B1|Rapid Cyclers||Rapid Cyclers|A rapid cycler is defined as a person who experiences four or more mood swings or episodes in a twelve-month period.|participants|Number|7|7.0||||||
4400434|NCT00266630|4227215|B3|Nonpsychotic||Current Episode - Psychotic or Nonpsychotic|Description of the bipolar episode the participant experienced when enrolling into the study.|participants|Number|117|117.0||||||
4400435|NCT00266630|4227216|B2|Nonpsychotic||Current Episode - Psychotic or Nonpsychotic|Description of the bipolar episode the participant experienced when enrolling into the study.|participants|Number|30|30.0||||||
4400436|NCT00266630|4227217|B1|Nonpsychotic||Current Episode - Psychotic or Nonpsychotic|Description of the bipolar episode the participant experienced when enrolling into the study.|participants|Number|87|87.0||||||
4400437|NCT00266630|4227215|B3|Psychotic||Current Episode - Psychotic or Nonpsychotic|Description of the bipolar episode the participant experienced when enrolling into the study.|participants|Number|22|22.0||||||
4400438|NCT00266630|4227216|B2|Psychotic||Current Episode - Psychotic or Nonpsychotic|Description of the bipolar episode the participant experienced when enrolling into the study.|participants|Number|9|9.0||||||
4400439|NCT00266630|4227217|B1|Psychotic||Current Episode - Psychotic or Nonpsychotic|Description of the bipolar episode the participant experienced when enrolling into the study.|participants|Number|13|13.0||||||
4400440|NCT00266630|4227215|B3|Mixed||Current Episode - Mixed or Manic|Description of the bipolar episode the participant experienced when enrolling into the study.|participants|Number|12|12.0||||||
4400441|NCT00266630|4227216|B2|Mixed||Current Episode - Mixed or Manic|Description of the bipolar episode the participant experienced when enrolling into the study.|participants|Number|0|0.0||||||
4400442|NCT00266630|4227217|B1|Mixed||Current Episode - Mixed or Manic|Description of the bipolar episode the participant experienced when enrolling into the study.|participants|Number|12|12.0||||||
4400443|NCT00266630|4227215|B3|Manic||Current Episode - Mixed or Manic|Description of the bipolar episode the participant experienced when enrolling into the study.|participants|Number|127|127.0||||||
4400447|NCT00266630|4227216|B2|Japan||Region of Enrollment||participants|Number|39|39.0||||||
4400448|NCT00266630|4227217|B1|Japan||Region of Enrollment||participants|Number|100|100.0||||||
4400449|NCT00266630|4227215|B3|Japanese||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
4400450|NCT00266630|4227216|B2|Japanese||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4400451|NCT00266630|4227217|B1|Japanese||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4400452|NCT00266630|4227215|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4400453|NCT00266630|4227216|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4400454|NCT00266630|4227217|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4400455|NCT00266630|4227215|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4400456|NCT00266630|4227216|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4400457|NCT00266630|4227217|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4400458|NCT00266630|4227215|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|11.6|11.6|||
4400459|NCT00266630|4227216|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|11.1|11.1|||
4400460|NCT00266630|4227217|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|11.7|11.7|||
4400461|NCT00266409|4227256|B5|United States||Region of Enrollment||participants|Number|374|374.0||||||
4400462|NCT00266409|4227257|B4|United States||Region of Enrollment||participants|Number|62|62.0||||||
4400463|NCT00266409|4227258|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4400464|NCT00266409|4227259|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
4400465|NCT00266409|4227260|B1|United States||Region of Enrollment||participants|Number|125|125.0||||||
4400466|NCT00266409|4227256|B5||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4400467|NCT00266409|4227257|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4400468|NCT00266409|4227258|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4400469|NCT00266409|4227259|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4400470|NCT00266409|4227260|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4400471|NCT00266409|4227256|B5||Female|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4400472|NCT00266409|4227257|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4400473|NCT00266409|4227258|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4400474|NCT00266409|4227259|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4400475|NCT00266409|4227260|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4400476|NCT00266409|4227256|B5|||Age||years|Mean|40|40.0|Standard Deviation|12|12.0|||
4400477|NCT00266409|4227257|B4|||Age||years|Mean|43.6|43.6|Standard Deviation|12.20|12.2|||
4400478|NCT00266409|4227258|B3|||Age||years|Mean|40.1|40.1|Standard Deviation|12.64|12.64|||
4400479|NCT00266409|4227259|B2|||Age||years|Mean|38.1|38.1|Standard Deviation|12.55|12.55|||
4400480|NCT00266409|4227260|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|12.24|12.24|||
4400481|NCT00266409|4227256|B5||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4400482|NCT00266409|4227257|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4400483|NCT00266409|4227258|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4400484|NCT00266409|4227259|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4400485|NCT00266409|4227260|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4400486|NCT00266409|4227256|B5||Between 18 and 65 years|Age||Participants|Count of Participants|366|366.0||||||
4400487|NCT00266409|4227257|B4||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4400488|NCT00266409|4227258|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4400489|NCT00266409|4227259|B2||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4400490|NCT00266409|4227260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4400491|NCT00266409|4227256|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400492|NCT00266409|4227257|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400493|NCT00266409|4227258|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400494|NCT00266409|4227259|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400495|NCT00266409|4227260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400496|NCT00266279|4227545|B1|Femal||Sex/Gender, Customized||Participants|Number|5|5.0||||||
4400497|NCT00266279|4227545|B1|Male||Sex/Gender, Customized||Participants|Number|10|10.0||||||
4400498|NCT00266279|4227545|B1|>=18 years||Age, Customized||Participants|Number|15|15.0||||||
4400499|NCT00266227|4227549|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4400500|NCT00266227|4227550|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4400501|NCT00266227|4227551|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4400502|NCT00266227|4227549|B3||Female|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4400503|NCT00266227|4227550|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4400504|NCT00266227|4227551|B1||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4400505|NCT00266227|4227549|B3|||Age||years|Mean|54.1|54.1|Standard Deviation|10.54|10.54|||
4400506|NCT00266227|4227550|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|10.52|10.52|||
4400507|NCT00266227|4227551|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|10.57|10.57|||
4400508|NCT00266227|4227549|B3||>=65 years|Age|Baseline measures are based on the Intent-to-treat population that includes all participants randomized to Retreatment.|Participants|Count of Participants|76|76.0||||||
4400509|NCT00266227|4227550|B2||>=65 years|Age|Baseline measures are based on the Intent-to-treat population that includes all participants randomized to Retreatment.|Participants|Count of Participants|24|24.0||||||
4400510|NCT00266227|4227551|B1||>=65 years|Age|Baseline measures are based on the Intent-to-treat population that includes all participants randomized to Retreatment.|Participants|Count of Participants|52|52.0||||||
4400511|NCT00266227|4227549|B3||Between 18 and 65 years|Age|Baseline measures are based on the Intent-to-treat population that includes all participants randomized to Retreatment.|Participants|Count of Participants|399|399.0||||||
4400512|NCT00266227|4227550|B2||Between 18 and 65 years|Age|Baseline measures are based on the Intent-to-treat population that includes all participants randomized to Retreatment.|Participants|Count of Participants|133|133.0||||||
4400513|NCT00266227|4227551|B1||Between 18 and 65 years|Age|Baseline measures are based on the Intent-to-treat population that includes all participants randomized to Retreatment.|Participants|Count of Participants|266|266.0||||||
4400514|NCT00266227|4227549|B3||<=18 years|Age|Baseline measures are based on the Intent-to-treat population that includes all participants randomized to Retreatment.|Participants|Count of Participants|0|0.0||||||
4400515|NCT00266227|4227550|B2||<=18 years|Age|Baseline measures are based on the Intent-to-treat population that includes all participants randomized to Retreatment.|Participants|Count of Participants|0|0.0||||||
4400516|NCT00266227|4227551|B1||<=18 years|Age|Baseline measures are based on the Intent-to-treat population that includes all participants randomized to Retreatment.|Participants|Count of Participants|0|0.0||||||
4400517|NCT00266110|4227598|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4400518|NCT00266110|4227598|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400519|NCT00266110|4227598|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400520|NCT00266110|4227598|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4400521|NCT00266110|4227598|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4400522|NCT00266110|4227598|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400523|NCT00266110|4227598|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400524|NCT00266110|4227598|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400525|NCT00266110|4227598|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400526|NCT00266110|4227598|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4400527|NCT00266110|4227598|B1|||Age||years|Mean|65.18|65.18|Full Range|||47.0|80.0|
4400528|NCT00266032|4227604|B4|||Body-Mass-Index (BMI)|"Body mass index was calculated with body weight and height measured at screening (BMI = body weight in kg²/ body height in m³) and had to be 18 Years to 35 Years old (smokers ≤ 30 Years old) at inclusion.~Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)."|kg/m²|Mean|22.546|22.546|Full Range|||17.9|30.5|
4400529|NCT00266032|4227605|B3|||Body-Mass-Index (BMI)|"Body mass index was calculated with body weight and height measured at screening (BMI = body weight in kg²/ body height in m³) and had to be 18 Years to 35 Years old (smokers ≤ 30 Years old) at inclusion.~Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)."|kg/m²|Mean|22.566|22.566|Full Range|||17.9|29.8|
4400530|NCT00266032|4227606|B2|||Body-Mass-Index (BMI)|"Body mass index was calculated with body weight and height measured at screening (BMI = body weight in kg²/ body height in m³) and had to be 18 Years to 35 Years old (smokers ≤ 30 Years old) at inclusion.~Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)."|kg/m²|Mean|22.541|22.541|Full Range|||18.0|29.7|
4400531|NCT00266032|4227607|B1|||Body-Mass-Index (BMI)|"Body mass index was calculated with body weight and height measured at screening (BMI = body weight in kg²/ body height in m³) and had to be 18 Years to 35 Years old (smokers ≤ 30 Years old) at inclusion.~Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)."|kg/m²|Mean|22.541|22.541|Full Range|||17.95|30.5|
4400532|NCT00266032|4227604|B4||Male|Sex: Female, Male|Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)|Participants|Count of Participants|0|0.0||||||
4400533|NCT00266032|4227605|B3||Male|Sex: Female, Male|Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)|Participants|Count of Participants|0|0.0||||||
4400534|NCT00266032|4227606|B2||Male|Sex: Female, Male|Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)|Participants|Count of Participants|0|0.0||||||
4400535|NCT00266032|4227607|B1||Male|Sex: Female, Male|Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)|Participants|Count of Participants|0|0.0||||||
4400536|NCT00266032|4227604|B4||Female|Sex: Female, Male|Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)|Participants|Count of Participants|1067|1067.0||||||
4400537|NCT00266032|4227605|B3||Female|Sex: Female, Male|Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)|Participants|Count of Participants|216|216.0||||||
4400538|NCT00266032|4227606|B2||Female|Sex: Female, Male|Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)|Participants|Count of Participants|209|209.0||||||
4400539|NCT00266032|4227607|B1||Female|Sex: Female, Male|Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)|Participants|Count of Participants|642|642.0||||||
4400540|NCT00266032|4227604|B4|||Age|Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)|years|Mean|24.7|24.7|Full Range|||18.0|35.0|
4400541|NCT00266032|4227605|B3|||Age|Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)|years|Mean|24.3|24.3|Full Range|||18.0|35.0|
4400542|NCT00266032|4227606|B2|||Age|Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)|years|Mean|24.8|24.8|Full Range|||18.0|35.0|
4400543|NCT00266032|4227607|B1|||Age|Number of Participants analyzed for baseline was Full Analysis Set (FAS=safety set)|years|Mean|24.8|24.8|Full Range|||18.0|35.0|
4400544|NCT00265941|4227637|B3||Male|Sex: Female, Male||Participants|Count of Participants|786|786.0||||||
4400545|NCT00265941|4227638|B2||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
4400546|NCT00265941|4227639|B1||Male|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
4400547|NCT00265941|4227637|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4400548|NCT00265941|4227638|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4400549|NCT00265941|4227639|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4400550|NCT00265941|4227637|B3|||Age||years|Median|57|57.0|Full Range|||31.0|79.0|
4400551|NCT00265941|4227638|B2|||Age||years|Median|58|58.0|Full Range|||34.0|76.0|
4400552|NCT00265941|4227639|B1|||Age||years|Median|57|57.0|Full Range|||31.0|79.0|
4400553|NCT00265889|4227672|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4400554|NCT00265889|4227672|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400555|NCT00265889|4227672|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400556|NCT00265889|4227672|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4400557|NCT00265889|4227672|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4400558|NCT00265889|4227672|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400559|NCT00265889|4227672|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400560|NCT00265889|4227672|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400561|NCT00265889|4227672|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400562|NCT00265889|4227672|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4400563|NCT00265889|4227672|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4400564|NCT00265889|4227672|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4400565|NCT00265889|4227672|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4400566|NCT00265889|4227672|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400567|NCT00265889|4227672|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4400568|NCT00265889|4227672|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400569|NCT00265850|4227678|B4|United States||Region of Enrollment||participants|Number|1073|1073.0||||||
4400570|NCT00265850|4227680|B2|United States||Region of Enrollment||participants|Number|546|546.0||||||
4400571|NCT00265850|4227681|B1|United States||Region of Enrollment||participants|Number|527|527.0||||||
4400572|NCT00265850|4227678|B4|Canada||Region of Enrollment||participants|Number|64|64.0||||||
4400573|NCT00265850|4227680|B2|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4400574|NCT00265850|4227681|B1|Canada||Region of Enrollment||participants|Number|32|32.0||||||
4400575|NCT00265850|4227678|B4||Male|Sex: Female, Male||Participants|Count of Participants|697|697.0||||||
4400576|NCT00265850|4227680|B2||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4400577|NCT00265850|4227681|B1||Male|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
4400578|NCT00265850|4227678|B4||Female|Sex: Female, Male||Participants|Count of Participants|440|440.0||||||
4400579|NCT00265850|4227680|B2||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4400580|NCT00265850|4227681|B1||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4400581|NCT00265850|4227678|B4|||Age||years|Median|59.1|59.1|Full Range|||20.8|89.5|
4400582|NCT00265850|4227680|B2|||Age||years|Median|59.2|59.2|Full Range|||20.8|89.5|
4400583|NCT00265850|4227681|B1|||Age||years|Median|59|59.0|Full Range|||21.8|85.0|
4400584|NCT00265798|4227693|B1|2||Performance Status|"Eastern Cooperative Oncology Group (ECOG) performance status scores on a scale of 0-5, higher is worse 0= Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light/sedentary nature~Ambulatory and capable of all selfcare, unable to carry out any work activities. Up and about > 50% of waking hours~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed/chair~Dead"|participants|Number|2|2.0||||||
4400585|NCT00265798|4227693|B1|1||Performance Status|"Eastern Cooperative Oncology Group (ECOG) performance status scores on a scale of 0-5, higher is worse 0= Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light/sedentary nature~Ambulatory and capable of all selfcare, unable to carry out any work activities. Up and about > 50% of waking hours~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed/chair~Dead"|participants|Number|18|18.0||||||
4400586|NCT00265798|4227693|B1|0||Performance Status|"Eastern Cooperative Oncology Group (ECOG) performance status scores on a scale of 0-5, higher is worse 0= Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light/sedentary nature~Ambulatory and capable of all selfcare, unable to carry out any work activities. Up and about > 50% of waking hours~Capable of only limited selfcare, confined to bed/chair > 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed/chair~Dead"|participants|Number|18|18.0||||||
4400587|NCT00265798|4227693|B1|Imatinib- and sunitinib-resistant||Study Cohort|Participants were classified as having either imatinib-resistant disease or imatinib- and sunitinib-resistant disease|participants|Number|32|32.0||||||
4400588|NCT00265798|4227693|B1|Imatinib-resistant||Study Cohort|Participants were classified as having either imatinib-resistant disease or imatinib- and sunitinib-resistant disease|participants|Number|6|6.0||||||
4400589|NCT00265798|4227693|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4400590|NCT00265798|4227693|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4400591|NCT00265798|4227693|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4400592|NCT00265798|4227693|B1|||Age||years|Median|57|57.0|Full Range|||42.0|85.0|
4400593|NCT00265785|4227699|B1|> 20%||Weight Loss Last 6 months||participants|Number|0|0.0||||||
4400594|NCT00265785|4227699|B1|10% to 20%||Weight Loss Last 6 months||participants|Number|1|1.0||||||
4400595|NCT00265785|4227699|B1|5% to < 10%||Weight Loss Last 6 months||participants|Number|3|3.0||||||
4400596|NCT00265785|4227699|B1|< 5%||Weight Loss Last 6 months||participants|Number|20|20.0||||||
4400597|NCT00265785|4227699|B1|Never||Smoking Status||participants|Number|3|3.0||||||
4400598|NCT00265785|4227699|B1|Former||Smoking Status||participants|Number|16|16.0||||||
4400599|NCT00265785|4227699|B1|Current||Smoking Status||participants|Number|5|5.0||||||
4400600|NCT00265785|4227699|B1|1||Zubbrod Performance Status|Performance status is graded according to the Zubrod Performance Status Scale. Patients with a performance status of 0 are fully active, able to carry on all pre-disease performance without restriction. Patients with a performance status of 1 are restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.|participants|Number|12|12.0||||||
4400601|NCT00265785|4227699|B1|0||Zubbrod Performance Status|Performance status is graded according to the Zubrod Performance Status Scale. Patients with a performance status of 0 are fully active, able to carry on all pre-disease performance without restriction. Patients with a performance status of 1 are restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.|participants|Number|12|12.0||||||
4400602|NCT00265785|4227699|B1|No||Prior Surgery||participants|Number|13|13.0||||||
4400603|NCT00265785|4227699|B1|Yes||Prior Surgery||participants|Number|11|11.0||||||
4400604|NCT00265785|4227699|B1|No||Prior Systemic Treatment||participants|Number|14|14.0||||||
4400605|NCT00265785|4227699|B1|Yes||Prior Systemic Treatment||participants|Number|10|10.0||||||
4400606|NCT00265785|4227699|B1|No||Prior Radiation Therapy||participants|Number|21|21.0||||||
4400607|NCT00265785|4227699|B1|Yes||Prior Radiation Therapy||participants|Number|3|3.0||||||
4400608|NCT00265785|4227699|B1|Yes||Prior EGFR-TKI Therapy||participants|Number|5|5.0||||||
4400609|NCT00265785|4227699|B1|No||Prior EGFR-TKI Therapy||participants|Number|19|19.0||||||
4400610|NCT00265785|4227699|B1|IV||Stage||participants|Number|24|24.0||||||
4400611|NCT00265785|4227699|B1|IIIB||Stage||participants|Number|0|0.0||||||
4400612|NCT00265785|4227699|B1|None||Number of Metastatic Sites||participants|Number|5|5.0||||||
4400613|NCT00265785|4227699|B1|Multiple||Number of Metastatic Sites||participants|Number|7|7.0||||||
4400614|NCT00265785|4227699|B1|Single||Number of Metastatic Sites||participants|Number|12|12.0||||||
4400615|NCT00265785|4227699|B1|Bronchioloalveolar||Histology||participants|Number|6|6.0||||||
4400616|NCT00265785|4227699|B1|Adenocarcinoma w/BAC features||Histology||participants|Number|18|18.0||||||
4400617|NCT00265785|4227699|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4400618|NCT00265785|4227699|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4400619|NCT00265785|4227699|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4400620|NCT00265785|4227699|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4400621|NCT00265785|4227699|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400622|NCT00265785|4227699|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4400623|NCT00265785|4227699|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400624|NCT00265785|4227699|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4400625|NCT00265785|4227699|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4400626|NCT00265785|4227699|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4400627|NCT00265785|4227699|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4400628|NCT00265785|4227699|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4400629|NCT00265785|4227699|B1|||Age||years|Median|68.2|68.2|Full Range|||49.6|82.9|
4400630|NCT00265759|4227706|B7|United States||Region of Enrollment||participants|Number|610|610.0||||||
4400631|NCT00265759|4227707|B6|United States||Region of Enrollment||participants|Number|22|22.0||||||
4400632|NCT00265759|4227708|B5|United States||Region of Enrollment||participants|Number|49|49.0||||||
4400633|NCT00265759|4227709|B4|United States||Region of Enrollment||participants|Number|165|165.0||||||
4400634|NCT00265759|4227710|B3|United States||Region of Enrollment||participants|Number|123|123.0||||||
4400635|NCT00265759|4227711|B2|United States||Region of Enrollment||participants|Number|127|127.0||||||
4400636|NCT00265759|4227712|B1|United States||Region of Enrollment||participants|Number|124|124.0||||||
4400637|NCT00265759|4227706|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400638|NCT00265759|4227707|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400639|NCT00265759|4227708|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400640|NCT00265759|4227709|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400641|NCT00265759|4227710|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400642|NCT00265759|4227711|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400643|NCT00265759|4227712|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4400644|NCT00265759|4227706|B7||Female|Sex: Female, Male||Participants|Count of Participants|610|610.0||||||
4400645|NCT00265759|4227707|B6||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4400646|NCT00265759|4227708|B5||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4400647|NCT00265759|4227709|B4||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4400648|NCT00265759|4227710|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4400649|NCT00265759|4227711|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4400650|NCT00265759|4227712|B1||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4400651|NCT00265759|4227706|B7|||Age||years|Median|65|65.0|Full Range|||43.0|90.0|
4400652|NCT00265759|4227707|B6|||Age||years|Median|66|66.0|Full Range|||53.0|84.0|
4400653|NCT00265759|4227708|B5|||Age||years|Median|60|60.0|Full Range|||47.0|76.0|
4400654|NCT00265759|4227709|B4|||Age||years|Median|65|65.0|Full Range|||49.0|86.0|
4400655|NCT00265759|4227710|B3|||Age||years|Median|65|65.0|Full Range|||51.0|87.0|
4400656|NCT00265759|4227711|B2|||Age||years|Median|65|65.0|Full Range|||49.0|90.0|
4400657|NCT00265759|4227712|B1|||Age||years|Median|69|69.0|Full Range|||43.0|90.0|
4400658|NCT00265616|4227744|B3|Switzerland||Region of Enrollment||participants|Number|16|16.0||||||
4400659|NCT00265616|4227745|B2|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
4400660|NCT00265616|4227746|B1|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
4400661|NCT00265616|4227744|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4400662|NCT00265616|4227745|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4400663|NCT00265616|4227746|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4400664|NCT00265616|4227744|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4400665|NCT00265616|4227745|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4400666|NCT00265616|4227746|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4400667|NCT00265616|4227744|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4400668|NCT00265616|4227745|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4400669|NCT00265616|4227746|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4400670|NCT00265616|4227744|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4400671|NCT00265616|4227745|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4400672|NCT00265616|4227746|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4400673|NCT00265616|4227744|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4400674|NCT00265616|4227745|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4400675|NCT00265616|4227746|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4400676|NCT00265616|4227744|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4400677|NCT00265616|4227745|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4400678|NCT00265616|4227746|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400679|NCT00265512|4227763|B3||Male|Sex: Female, Male||Participants|Count of Participants|636|636.0||||||
4400680|NCT00265512|4227764|B2||Male|Sex: Female, Male||Participants|Count of Participants|433|433.0||||||
4400681|NCT00265512|4227765|B1||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4400682|NCT00265512|4227763|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4400683|NCT00265512|4227764|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4400684|NCT00265512|4227765|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4400685|NCT00265512|4227763|B3|||Age||years|Mean|51.3|51.3|Standard Deviation|8.2|8.2|||
4400686|NCT00265512|4227764|B2|||Age||years|Mean|51.0|51.0|Standard Deviation|8.1|8.1|||
4400687|NCT00265512|4227765|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|8.5|8.5|||
4400688|NCT00265473|4227772|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4400689|NCT00265473|4227772|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4400690|NCT00265473|4227772|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4400691|NCT00265473|4227772|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|9.5|9.5|||
4400692|NCT00265473|4227772|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400693|NCT00265473|4227772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4400694|NCT00265473|4227772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400695|NCT00265395|4227780|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4400696|NCT00265395|4227781|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4400697|NCT00265395|4227782|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4400698|NCT00265395|4227780|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4400699|NCT00265395|4227781|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4400700|NCT00265395|4227782|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4400701|NCT00265395|4227780|B3|||Age||years|Mean|45.35|45.35|Standard Deviation|10.79|10.79|||
4400702|NCT00265395|4227781|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|11.6|11.6|||
4400703|NCT00265395|4227782|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|9.9|9.9|||
4400704|NCT00265382|4227788|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4400705|NCT00265382|4227788|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4400706|NCT00265382|4227788|B1|13 to 17 years||Age, Customized|Baseline data are from the preceding Study A1281134 (NCT00257192).|Participants|Number|218|218.0||||||
4400707|NCT00265382|4227788|B1|>12 years and <13 years at start of treatment||Age, Customized|Baseline data are from the preceding Study A1281134 (NCT00257192).|Participants|Number|3|3.0||||||
4400708|NCT00265343|4227806|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4400709|NCT00265343|4227807|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4400710|NCT00265343|4227808|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4400711|NCT00265343|4227806|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4400712|NCT00265343|4227807|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4400713|NCT00265343|4227808|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4400714|NCT00265343|4227806|B3|||Age||years|Mean|40.4|40.4|Standard Deviation|11.9|11.9|||
4400715|NCT00265343|4227807|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|11.7|11.7|||
4400716|NCT00265343|4227808|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|12.2|12.2|||
4400717|NCT00265330|4227817|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4400718|NCT00265330|4227817|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4400719|NCT00265330|4227817|B1|||Age||years|Mean|13.3|13.3|Standard Deviation|2.1|2.1|||
4400720|NCT00265317|4227839|B5|Unknown or Not Collected||Sex/Gender, Customized||participants|Number|1|1.0||||||
4400721|NCT00265317|4227840|B4|Unknown or Not Collected||Sex/Gender, Customized||participants|Number|0|0.0||||||
4400722|NCT00265317|4227841|B3|Unknown or Not Collected||Sex/Gender, Customized||participants|Number|1|1.0||||||
4400723|NCT00265317|4227842|B2|Unknown or Not Collected||Sex/Gender, Customized||participants|Number|0|0.0||||||
4400724|NCT00265317|4227843|B1|Unknown or Not Collected||Sex/Gender, Customized||participants|Number|0|0.0||||||
4400725|NCT00265317|4227839|B5|Male||Sex/Gender, Customized||participants|Number|102|102.0||||||
4400726|NCT00265317|4227840|B4|Male||Sex/Gender, Customized||participants|Number|45|45.0||||||
4400727|NCT00265317|4227841|B3|Male||Sex/Gender, Customized||participants|Number|39|39.0||||||
4400728|NCT00265317|4227842|B2|Male||Sex/Gender, Customized||participants|Number|11|11.0||||||
4400729|NCT00265317|4227843|B1|Male||Sex/Gender, Customized||participants|Number|7|7.0||||||
4400730|NCT00265317|4227839|B5|Female||Sex/Gender, Customized||participants|Number|59|59.0||||||
4400731|NCT00265317|4227840|B4|Female||Sex/Gender, Customized||participants|Number|22|22.0||||||
4400732|NCT00265317|4227841|B3|Female||Sex/Gender, Customized||participants|Number|25|25.0||||||
4400733|NCT00265317|4227842|B2|Female||Sex/Gender, Customized||participants|Number|6|6.0||||||
4400734|NCT00265317|4227843|B1|Female||Sex/Gender, Customized||participants|Number|6|6.0||||||
4400735|NCT00265317|4227839|B5|Unknown or Not Collected||Age, Customized||participants|Number|1|1.0||||||
4400736|NCT00265317|4227840|B4|Unknown or Not Collected||Age, Customized||participants|Number|0|0.0||||||
4400737|NCT00265317|4227841|B3|Unknown or Not Collected||Age, Customized||participants|Number|1|1.0||||||
4400738|NCT00265317|4227842|B2|Unknown or Not Collected||Age, Customized||participants|Number|0|0.0||||||
4400739|NCT00265317|4227843|B1|Unknown or Not Collected||Age, Customized||participants|Number|0|0.0||||||
4400740|NCT00265317|4227839|B5|Greater than or equal to 65 years||Age, Customized||participants|Number|54|54.0||||||
4400741|NCT00265317|4227840|B4|Greater than or equal to 65 years||Age, Customized||participants|Number|24|24.0||||||
4400742|NCT00265317|4227841|B3|Greater than or equal to 65 years||Age, Customized||participants|Number|17|17.0||||||
4400743|NCT00265317|4227842|B2|Greater than or equal to 65 years||Age, Customized||participants|Number|7|7.0||||||
4400744|NCT00265317|4227843|B1|Greater than or equal to 65 years||Age, Customized||participants|Number|6|6.0||||||
4400745|NCT00265317|4227839|B5|Less than 65 years||Age, Customized||participants|Number|107|107.0||||||
4400746|NCT00265317|4227840|B4|Less than 65 years||Age, Customized||participants|Number|43|43.0||||||
4400747|NCT00265317|4227841|B3|Less than 65 years||Age, Customized||participants|Number|47|47.0||||||
4400748|NCT00265317|4227842|B2|Less than 65 years||Age, Customized||participants|Number|10|10.0||||||
4400749|NCT00265317|4227843|B1|Less than 65 years||Age, Customized||participants|Number|7|7.0||||||
4400750|NCT00265239|4227959|B3|Japan||Region of Enrollment||participants|Number|101|101.0||||||
4400751|NCT00265239|4227960|B2|Japan||Region of Enrollment||participants|Number|51|51.0||||||
4400752|NCT00265239|4227961|B1|Japan||Region of Enrollment||participants|Number|50|50.0||||||
4400753|NCT00265239|4227959|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4400754|NCT00265239|4227960|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4400755|NCT00265239|4227961|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4400756|NCT00265239|4227959|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4400757|NCT00265239|4227960|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4400758|NCT00265239|4227961|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4400759|NCT00265239|4227959|B3|||Age||years|Mean|63|63.0|Standard Deviation|2|2.0|||
4400760|NCT00265239|4227960|B2|||Age||years|Mean|63|63.0|Standard Deviation|2|2.0|||
4400761|NCT00265239|4227961|B1|||Age||years|Mean|63|63.0|Standard Deviation|2|2.0|||
4400762|NCT00265200|4227974|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4400763|NCT00265200|4227974|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4400764|NCT00265200|4227974|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4400765|NCT00265200|4227974|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4400766|NCT00265200|4227974|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4400767|NCT00265200|4227974|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400768|NCT00265122|4227978|B7||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4400769|NCT00265122|4227979|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4400770|NCT00265122|4227980|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4400771|NCT00265122|4227981|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4400772|NCT00265122|4227982|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4400773|NCT00265122|4227983|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4400774|NCT00265122|4227984|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4400775|NCT00265122|4227978|B7||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4400776|NCT00265122|4227979|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4400777|NCT00265122|4227980|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4400778|NCT00265122|4227981|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4400779|NCT00265122|4227982|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4400780|NCT00265122|4227983|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4400781|NCT00265122|4227984|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4400782|NCT00265122|4227978|B7|||Age||Years|Mean|40.0|40.0|Standard Deviation|12.97|12.97|||
4400783|NCT00265122|4227979|B6|||Age||Years|Mean|42.7|42.7|Standard Deviation|11.27|11.27|||
4400784|NCT00265122|4227980|B5|||Age||Years|Mean|46.9|46.9|Standard Deviation|13.63|13.63|||
4400785|NCT00265122|4227981|B4|||Age||Years|Mean|43.1|43.1|Standard Deviation|12.23|12.23|||
4400786|NCT00265122|4227982|B3|||Age||Years|Mean|43.5|43.5|Standard Deviation|11.39|11.39|||
4400787|NCT00265122|4227983|B2|||Age||Years|Mean|36.5|36.5|Standard Deviation|13.17|13.17|||
4400788|NCT00265122|4227984|B1|||Age||Years|Mean|36.7|36.7|Standard Deviation|13.99|13.99|||
4400789|NCT00265109|4228011|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4400790|NCT00265109|4228011|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4400791|NCT00265109|4228011|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4400792|NCT00265109|4228011|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|10.2|10.2|||
4400793|NCT00265109|4228011|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400794|NCT00265109|4228011|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4400795|NCT00265109|4228011|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4400796|NCT00265096|4228015|B4||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4400797|NCT00265096|4228016|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4400798|NCT00265096|4228017|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4400799|NCT00265096|4228018|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4400800|NCT00265096|4228015|B4||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4400801|NCT00265096|4228016|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4400802|NCT00265096|4228017|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4400803|NCT00265096|4228018|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4400804|NCT00265096|4228015|B4|||Age||years|Mean|47|47.0|Standard Deviation|10.77|10.77|||
4400805|NCT00265096|4228016|B3|||Age||years|Mean|48.2|48.2|Standard Deviation|10.93|10.93|||
4400806|NCT00265096|4228017|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|10.7|10.7|||
4400807|NCT00265096|4228018|B1|||Age||years|Mean|47|47.0|Standard Deviation|10.56|10.56|||
4400808|NCT00265083|4228049|B4||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4400809|NCT00265083|4228050|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4400810|NCT00265083|4228051|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4400811|NCT00265083|4228052|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4400812|NCT00265083|4228049|B4||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4400813|NCT00265083|4228050|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4400814|NCT00265083|4228051|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4400815|NCT00265083|4228052|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4400816|NCT00265083|4228049|B4|||Age||years|Mean|39.3|39.3|Standard Deviation|12.06|12.06|||
4400817|NCT00265083|4228050|B3|||Age||years|Mean|38.6|38.6|Standard Deviation|11.30|11.3|||
4400818|NCT00265083|4228051|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|12.46|12.46|||
4400819|NCT00265083|4228052|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|12.71|12.71|||
4400820|NCT00264875|4228075|B1||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4400821|NCT00264875|4228075|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4400822|NCT00264875|4228075|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|7.8|7.8|||
4400823|NCT00264849|4228079|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4400824|NCT00264849|4228080|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4400825|NCT00264849|4228081|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4400826|NCT00264849|4228079|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400827|NCT00264849|4228080|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400828|NCT00264849|4228081|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400829|NCT00264849|4228079|B3||White|Race (NIH/OMB)||Participants|Count of Participants|391|391.0||||||
4400830|NCT00264849|4228080|B2||White|Race (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4400831|NCT00264849|4228081|B1||White|Race (NIH/OMB)||Participants|Count of Participants|266|266.0||||||
4400832|NCT00264849|4228079|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400833|NCT00264849|4228080|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400834|NCT00264849|4228081|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400835|NCT00264849|4228079|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400836|NCT00264849|4228080|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400837|NCT00264849|4228081|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400838|NCT00264849|4228079|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4400839|NCT00264849|4228080|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4400840|NCT00264849|4228081|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4400841|NCT00264849|4228079|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4400842|NCT00264849|4228080|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400843|NCT00264849|4228081|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4400844|NCT00264849|4228079|B3||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4400845|NCT00264849|4228080|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4400846|NCT00264849|4228081|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4400847|NCT00264849|4228079|B3||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4400848|NCT00264849|4228080|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4400849|NCT00264849|4228081|B1||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4400850|NCT00264849|4228079|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|12.87|12.87|||
4400851|NCT00264849|4228080|B2|||Age||years|Mean|45.7|45.7|Standard Deviation|12.57|12.57|||
4400852|NCT00264849|4228081|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|13.04|13.04|||
4400853|NCT00264849|4228079|B3||>=65 years|Age|All demographic data is described for the Modified ITT population. The modified ITT population includes all randomized patients with at least one post-baseline efficacy assessment|Participants|Count of Participants|27|27.0||||||
4400854|NCT00264849|4228080|B2||>=65 years|Age|All demographic data is described for the Modified ITT population. The modified ITT population includes all randomized patients with at least one post-baseline efficacy assessment|Participants|Count of Participants|10|10.0||||||
4400855|NCT00264849|4228081|B1||>=65 years|Age|All demographic data is described for the Modified ITT population. The modified ITT population includes all randomized patients with at least one post-baseline efficacy assessment|Participants|Count of Participants|17|17.0||||||
4400856|NCT00264849|4228079|B3||Between 18 and 65 years|Age|All demographic data is described for the Modified ITT population. The modified ITT population includes all randomized patients with at least one post-baseline efficacy assessment|Participants|Count of Participants|368|368.0||||||
4400857|NCT00264849|4228080|B2||Between 18 and 65 years|Age|All demographic data is described for the Modified ITT population. The modified ITT population includes all randomized patients with at least one post-baseline efficacy assessment|Participants|Count of Participants|118|118.0||||||
4400858|NCT00264849|4228081|B1||Between 18 and 65 years|Age|All demographic data is described for the Modified ITT population. The modified ITT population includes all randomized patients with at least one post-baseline efficacy assessment|Participants|Count of Participants|250|250.0||||||
4400859|NCT00264849|4228079|B3||<=18 years|Age|All demographic data is described for the Modified ITT population. The modified ITT population includes all randomized patients with at least one post-baseline efficacy assessment|Participants|Count of Participants|5|5.0||||||
4400860|NCT00264849|4228080|B2||<=18 years|Age|All demographic data is described for the Modified ITT population. The modified ITT population includes all randomized patients with at least one post-baseline efficacy assessment|Participants|Count of Participants|0|0.0||||||
4400861|NCT00264849|4228081|B1||<=18 years|Age|All demographic data is described for the Modified ITT population. The modified ITT population includes all randomized patients with at least one post-baseline efficacy assessment|Participants|Count of Participants|5|5.0||||||
4400862|NCT00264810|4228114|B3|No||Acute benzodiazepine use (does not include daily use)||participants|Number|122|122.0||||||
4400863|NCT00264810|4228115|B2|No||Acute benzodiazepine use (does not include daily use)||participants|Number|55|55.0||||||
4400864|NCT00264810|4228116|B1|No||Acute benzodiazepine use (does not include daily use)||participants|Number|67|67.0||||||
4400865|NCT00264810|4228114|B3|Yes||Acute benzodiazepine use (does not include daily use)||participants|Number|69|69.0||||||
4400866|NCT00264810|4228115|B2|Yes||Acute benzodiazepine use (does not include daily use)||participants|Number|39|39.0||||||
4400867|NCT00264810|4228116|B1|Yes||Acute benzodiazepine use (does not include daily use)||participants|Number|30|30.0||||||
4400868|NCT00264810|4228114|B3|No||Anatomical brain abnormality (by neuroimaging)||participants|Number|64|64.0||||||
4400869|NCT00264810|4228115|B2|No||Anatomical brain abnormality (by neuroimaging)||participants|Number|33|33.0||||||
4400870|NCT00264810|4228116|B1|No||Anatomical brain abnormality (by neuroimaging)||participants|Number|31|31.0||||||
4400871|NCT00264810|4228114|B3|Yes||Anatomical brain abnormality (by neuroimaging)||participants|Number|127|127.0||||||
4400872|NCT00264810|4228115|B2|Yes||Anatomical brain abnormality (by neuroimaging)||participants|Number|61|61.0||||||
4400873|NCT00264810|4228116|B1|Yes||Anatomical brain abnormality (by neuroimaging)||participants|Number|66|66.0||||||
4400874|NCT00264810|4228114|B3|No||Prior vagal nerve stimulator (VNS)||participants|Number|127|127.0||||||
4400875|NCT00264810|4228115|B2|No||Prior vagal nerve stimulator (VNS)||participants|Number|60|60.0||||||
4400876|NCT00264810|4228116|B1|No||Prior vagal nerve stimulator (VNS)||participants|Number|67|67.0||||||
4400877|NCT00264810|4228114|B3|Yes||Prior vagal nerve stimulator (VNS)||participants|Number|64|64.0||||||
4400878|NCT00264810|4228115|B2|Yes||Prior vagal nerve stimulator (VNS)||participants|Number|34|34.0||||||
4400879|NCT00264810|4228116|B1|Yes||Prior vagal nerve stimulator (VNS)||participants|Number|30|30.0||||||
4400880|NCT00264810|4228114|B3|No||Prior EEG monitoring with intracranial electrodes||participants|Number|78|78.0||||||
4400881|NCT00264810|4228115|B2|No||Prior EEG monitoring with intracranial electrodes||participants|Number|44|44.0||||||
4400882|NCT00264810|4228116|B1|No||Prior EEG monitoring with intracranial electrodes||participants|Number|34|34.0||||||
4400883|NCT00264810|4228114|B3|Yes||Prior EEG monitoring with intracranial electrodes||participants|Number|113|113.0||||||
4400884|NCT00264810|4228115|B2|Yes||Prior EEG monitoring with intracranial electrodes||participants|Number|50|50.0||||||
4400885|NCT00264810|4228116|B1|Yes||Prior EEG monitoring with intracranial electrodes||participants|Number|63|63.0||||||
4400886|NCT00264810|4228114|B3|No||Prior therapeutic surgery for epilepsy||participants|Number|129|129.0||||||
4400887|NCT00264810|4228115|B2|No||Prior therapeutic surgery for epilepsy||participants|Number|66|66.0||||||
4400888|NCT00264810|4228116|B1|No||Prior therapeutic surgery for epilepsy||participants|Number|63|63.0||||||
4400889|NCT00264810|4228114|B3|Yes||Prior therapeutic surgery for epilepsy||participants|Number|62|62.0||||||
4400890|NCT00264810|4228115|B2|Yes||Prior therapeutic surgery for epilepsy||participants|Number|28|28.0||||||
4400891|NCT00264810|4228116|B1|Yes||Prior therapeutic surgery for epilepsy||participants|Number|34|34.0||||||
4400892|NCT00264810|4228114|B3|Unifocal||Number of seizure foci||participants|Number|85|85.0||||||
4400893|NCT00264810|4228115|B2|Unifocal||Number of seizure foci||participants|Number|36|36.0||||||
4400894|NCT00264810|4228116|B1|Unifocal||Number of seizure foci||participants|Number|49|49.0||||||
4400895|NCT00264810|4228114|B3|Bifocal||Number of seizure foci||participants|Number|106|106.0||||||
4400896|NCT00264810|4228115|B2|Bifocal||Number of seizure foci||participants|Number|58|58.0||||||
4400897|NCT00264810|4228116|B1|Bifocal||Number of seizure foci||participants|Number|48|48.0||||||
4400898|NCT00264810|4228114|B3|Other||Seizure onset location||participants|Number|96|96.0||||||
4400899|NCT00264810|4228115|B2|Other||Seizure onset location||participants|Number|47|47.0||||||
4400900|NCT00264810|4228116|B1|Other||Seizure onset location||participants|Number|49|49.0||||||
4400901|NCT00264810|4228114|B3|Mesial Temporal lobe ONLY||Seizure onset location||participants|Number|95|95.0||||||
4400902|NCT00264810|4228115|B2|Mesial Temporal lobe ONLY||Seizure onset location||participants|Number|47|47.0||||||
4400903|NCT00264810|4228116|B1|Mesial Temporal lobe ONLY||Seizure onset location||participants|Number|48|48.0||||||
4400904|NCT00264810|4228114|B3|||Mean seizure frequency||seizures/month|Mean|34.2|34.2|Full Range|||3.0|338.0|
4400905|NCT00264810|4228115|B2|||Mean seizure frequency||seizures/month|Mean|34.9|34.9|Full Range|||3.0|338.0|
4400906|NCT00264810|4228116|B1|||Mean seizure frequency||seizures/month|Mean|33.5|33.5|Full Range|||3.0|295.0|
4400907|NCT00264810|4228114|B3|||Number of AEDs at enrollment||number of AEDs|Mean|2.8|2.8|Full Range|||0.0|8.0|
4400908|NCT00264810|4228115|B2|||Number of AEDs at enrollment||number of AEDs|Mean|2.9|2.9|Full Range|||0.0|6.0|
4400909|NCT00264810|4228116|B1|||Number of AEDs at enrollment||number of AEDs|Mean|2.8|2.8|Full Range|||1.0|8.0|
4400910|NCT00264810|4228114|B3|||Duration of epilepsy||years|Mean|20.5|20.5|Full Range|||2.0|57.0|
4400911|NCT00264810|4228115|B2|||Duration of epilepsy||years|Mean|21.0|21.0|Full Range|||2.0|54.0|
4400912|NCT00264810|4228116|B1|||Duration of epilepsy||years|Mean|20.0|20.0|Full Range|||2.0|57.0|
4400913|NCT00264810|4228114|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4400914|NCT00264810|4228115|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4400915|NCT00264810|4228116|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4400916|NCT00264810|4228114|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4400917|NCT00264810|4228115|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4400918|NCT00264810|4228116|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4400919|NCT00264810|4228114|B3|||Age||years|Mean|34.9|34.9|Full Range|||18.0|66.0|
4400920|NCT00264810|4228115|B2|||Age||years|Mean|35.9|35.9|Full Range|||18.0|66.0|
4400921|NCT00264810|4228116|B1|||Age||years|Mean|34.0|34.0|Full Range|||18.0|60.0|
4400922|NCT00264810|4228114|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4400923|NCT00264810|4228115|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4400924|NCT00264810|4228116|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400925|NCT00264810|4228114|B3||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
4400926|NCT00264810|4228115|B2||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4400927|NCT00264810|4228116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4400928|NCT00264810|4228114|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4400929|NCT00264810|4228115|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4400930|NCT00264810|4228116|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4400931|NCT00264797|4228125|B3|United States||Region of Enrollment||participants|Number|303|303.0||||||
4400932|NCT00264797|4228126|B2|United States||Region of Enrollment||participants|Number|152|152.0||||||
4400933|NCT00264797|4228127|B1|United States||Region of Enrollment||participants|Number|151|151.0||||||
4400934|NCT00264797|4228125|B3||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4400935|NCT00264797|4228126|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4400936|NCT00264797|4228127|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4400937|NCT00264797|4228125|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4400938|NCT00264797|4228126|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4400939|NCT00264797|4228127|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4400940|NCT00264797|4228125|B3|||Age||years|Mean|16.5|16.5|Standard Deviation|1.3|1.3|||
4400941|NCT00264797|4228126|B2|||Age||years|Mean|16.6|16.6|Standard Deviation|1.2|1.2|||
4400942|NCT00264797|4228127|B1|||Age||years|Mean|16.4|16.4|Standard Deviation|1.3|1.3|||
4400943|NCT00264797|4228125|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400944|NCT00264797|4228126|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400945|NCT00264797|4228127|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4400946|NCT00264797|4228125|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400947|NCT00264797|4228126|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400948|NCT00264797|4228127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4400949|NCT00264797|4228125|B3||<=18 years|Age||Participants|Count of Participants|303|303.0||||||
4400950|NCT00264797|4228126|B2||<=18 years|Age||Participants|Count of Participants|152|152.0||||||
4400951|NCT00264797|4228127|B1||<=18 years|Age||Participants|Count of Participants|151|151.0||||||
4400952|NCT00264641|4228140|B3|Denmark||Region of Enrollment||participants|Number|20|20.0||||||
4400953|NCT00264641|4228141|B2|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
4400954|NCT00264641|4228142|B1|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
4400955|NCT00264641|4228140|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400956|NCT00264641|4228141|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400957|NCT00264641|4228142|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400958|NCT00264641|4228140|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400959|NCT00264641|4228141|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400960|NCT00264641|4228142|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400961|NCT00264641|4228140|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4400962|NCT00264641|4228141|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4400963|NCT00264641|4228142|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4400964|NCT00264641|4228140|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400965|NCT00264641|4228141|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400966|NCT00264641|4228142|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400967|NCT00264641|4228140|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400968|NCT00264641|4228141|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400969|NCT00264641|4228142|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400970|NCT00264641|4228140|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400971|NCT00264641|4228141|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400972|NCT00264641|4228142|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400973|NCT00264641|4228140|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400974|NCT00264641|4228141|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400975|NCT00264641|4228142|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4400976|NCT00264641|4228140|B3||Male|Sex: Female, Male|Only men were included|Participants|Count of Participants|20|20.0||||||
4400977|NCT00264641|4228141|B2||Male|Sex: Female, Male|Only men were included|Participants|Count of Participants|10|10.0||||||
4400978|NCT00264641|4228142|B1||Male|Sex: Female, Male|Only men were included|Participants|Count of Participants|10|10.0||||||
4400979|NCT00264641|4228140|B3||Female|Sex: Female, Male|Only men were included|Participants|Count of Participants|0|0.0||||||
4400980|NCT00264641|4228141|B2||Female|Sex: Female, Male|Only men were included|Participants|Count of Participants|0|0.0||||||
4400981|NCT00264641|4228142|B1||Female|Sex: Female, Male|Only men were included|Participants|Count of Participants|0|0.0||||||
4400982|NCT00264641|4228140|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|5.2|5.2|||
4400983|NCT00264641|4228141|B2|||Age||years|Mean|27|27.0|Standard Deviation|5.6|5.6|||
4400984|NCT00264641|4228142|B1|||Age||years|Mean|26|26.0|Standard Deviation|4.8|4.8|||
4400985|NCT00264576|4228148|B3||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4400986|NCT00264576|4228149|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4400987|NCT00264576|4228150|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4400988|NCT00264576|4228148|B3||Female|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
4400989|NCT00264576|4228149|B2||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4400990|NCT00264576|4228150|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4400991|NCT00264576|4228148|B3|||Age||years|Mean|34|34.0|Standard Deviation|9|9.0|||
4400992|NCT00264576|4228149|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|9.3|9.3|||
4400993|NCT00264576|4228150|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|8.8|8.8|||
4400994|NCT00264550|4228171|B5||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4400995|NCT00264550|4228172|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4400996|NCT00264550|4228173|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4400997|NCT00264550|4228174|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4400998|NCT00264550|4228175|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4400999|NCT00264550|4228171|B5||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4401000|NCT00264550|4228172|B4||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4401001|NCT00264550|4228173|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4401002|NCT00264550|4228174|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4401003|NCT00264550|4228175|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4401004|NCT00264550|4228171|B5|||Age||years|Mean|50.4|50.4|Standard Deviation|11.36|11.36|||
4401005|NCT00264550|4228172|B4|||Age||years|Mean|50|50.0|Standard Deviation|10.78|10.78|||
4401006|NCT00264550|4228173|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|10.98|10.98|||
4401007|NCT00264550|4228174|B2|||Age||years|Mean|50|50.0|Standard Deviation|11.47|11.47|||
4401008|NCT00264550|4228175|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|11.96|11.96|||
4401009|NCT00264537|4228213|B5||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4401010|NCT00264537|4228214|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4401011|NCT00264537|4228215|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4401012|NCT00264537|4228216|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4401013|NCT00264537|4228217|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4401014|NCT00264537|4228213|B5||Female|Sex: Female, Male||Participants|Count of Participants|528|528.0||||||
4401015|NCT00264537|4228214|B4||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4401016|NCT00264537|4228215|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4401017|NCT00264537|4228216|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4401018|NCT00264537|4228217|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4401019|NCT00264537|4228213|B5|||Age||years|Mean|49.5|49.5|Standard Deviation|12.28|12.28|||
4401020|NCT00264537|4228214|B4|||Age||years|Mean|50.2|50.2|Standard Deviation|11.87|11.87|||
4401021|NCT00264537|4228215|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|11.32|11.32|||
4401022|NCT00264537|4228216|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|12.85|12.85|||
4401023|NCT00264537|4228217|B1|||Age||years|Mean|48.6|48.6|Standard Deviation|12.91|12.91|||
4401024|NCT00264498|4228250|B3|Other||Race/Ethnicity, Customized||Participants|Number|2.0|2.0||||||
4401025|NCT00264498|4228251|B2|Other||Race/Ethnicity, Customized||Participants|Number|2.0|2.0||||||
4401026|NCT00264498|4228252|B1|Other||Race/Ethnicity, Customized||Participants|Number|0.0|0.0||||||
4401027|NCT00264498|4228250|B3|Oriental||Race/Ethnicity, Customized||Participants|Number|4.0|4.0||||||
4401028|NCT00264498|4228251|B2|Oriental||Race/Ethnicity, Customized||Participants|Number|4.0|4.0||||||
4401029|NCT00264498|4228252|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4401030|NCT00264498|4228250|B3|Black||Race/Ethnicity, Customized||Participants|Number|1.0|1.0||||||
4401031|NCT00264498|4228251|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4401032|NCT00264498|4228252|B1|Black||Race/Ethnicity, Customized||Participants|Number|1.0|1.0||||||
4401033|NCT00264498|4228250|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|28.0|28.0||||||
4401034|NCT00264498|4228251|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|12.0|12.0||||||
4401035|NCT00264498|4228252|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|16.0|16.0||||||
4401036|NCT00264498|4228250|B3||Male|Sex: Female, Male||Participants|Count of Participants|21.0|21.0||||||
4401037|NCT00264498|4228251|B2||Male|Sex: Female, Male||Participants|Count of Participants|12.0|12.0||||||
4401038|NCT00264498|4228252|B1||Male|Sex: Female, Male||Participants|Count of Participants|9.0|9.0||||||
4401039|NCT00264498|4228250|B3||Female|Sex: Female, Male||Participants|Count of Participants|14.0|14.0||||||
4401040|NCT00264498|4228251|B2||Female|Sex: Female, Male||Participants|Count of Participants|6.0|6.0||||||
4401041|NCT00264498|4228252|B1||Female|Sex: Female, Male||Participants|Count of Participants|8.0|8.0||||||
4401042|NCT00264498|4228250|B3|Age at screening||Age||Years|Mean|67.0|67.0|Standard Deviation|7.19|7.19|||
4401043|NCT00264498|4228251|B2|Age at screening||Age||Years|Mean|66.2|66.2|Standard Deviation|8.24|8.24|||
4401044|NCT00264498|4228252|B1|Age at screening||Age||Years|Mean|67.8|67.8|Standard Deviation|6.01|6.01|||
4401045|NCT00264381|4228259|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4401046|NCT00264381|4228260|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4401047|NCT00264381|4228261|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4401048|NCT00264381|4228259|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4401049|NCT00264381|4228260|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4401050|NCT00264381|4228261|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4401051|NCT00264381|4228259|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4401052|NCT00264381|4228260|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4401053|NCT00264381|4228261|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4401054|NCT00264381|4228259|B3|||Age||years|Mean|51|51.0|Full Range|||19.0|88.0|
4401055|NCT00264381|4228260|B2|||Age||years|Mean|51|51.0|Full Range|||28.0|88.0|
4401056|NCT00264381|4228261|B1|||Age||years|Mean|52|52.0|Full Range|||19.0|85.0|
4401057|NCT00264303|4228274|B3|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
4401058|NCT00264303|4228275|B2|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4401059|NCT00264303|4228276|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4401060|NCT00264303|4228274|B3|Italy||Region of Enrollment||participants|Number|127|127.0||||||
4401061|NCT00264303|4228275|B2|Italy||Region of Enrollment||participants|Number|65|65.0||||||
4401062|NCT00264303|4228276|B1|Italy||Region of Enrollment||participants|Number|62|62.0||||||
4401063|NCT00264303|4228274|B3|Germany||Region of Enrollment||participants|Number|224|224.0||||||
4401064|NCT00264303|4228275|B2|Germany||Region of Enrollment||participants|Number|115|115.0||||||
4401065|NCT00264303|4228276|B1|Germany||Region of Enrollment||participants|Number|109|109.0||||||
4401066|NCT00264303|4228274|B3|South Africa||Region of Enrollment||participants|Number|60|60.0||||||
4401067|NCT00264303|4228275|B2|South Africa||Region of Enrollment||participants|Number|30|30.0||||||
4401068|NCT00264303|4228276|B1|South Africa||Region of Enrollment||participants|Number|30|30.0||||||
4401069|NCT00264303|4228274|B3|Romania||Region of Enrollment||participants|Number|113|113.0||||||
4401070|NCT00264303|4228275|B2|Romania||Region of Enrollment||participants|Number|56|56.0||||||
4401071|NCT00264303|4228276|B1|Romania||Region of Enrollment||participants|Number|57|57.0||||||
4401072|NCT00264303|4228274|B3|Belgium||Region of Enrollment||participants|Number|24|24.0||||||
4401073|NCT00264303|4228275|B2|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
4401074|NCT00264303|4228276|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4401075|NCT00264303|4228274|B3|Spain||Region of Enrollment||participants|Number|75|75.0||||||
4401076|NCT00264303|4228275|B2|Spain||Region of Enrollment||participants|Number|37|37.0||||||
4401077|NCT00264303|4228276|B1|Spain||Region of Enrollment||participants|Number|38|38.0||||||
4401078|NCT00264303|4228274|B3|Malaysia||Region of Enrollment||participants|Number|89|89.0||||||
4401079|NCT00264303|4228275|B2|Malaysia||Region of Enrollment||participants|Number|44|44.0||||||
4401080|NCT00264303|4228276|B1|Malaysia||Region of Enrollment||participants|Number|45|45.0||||||
4401081|NCT00264303|4228274|B3|France||Region of Enrollment||participants|Number|161|161.0||||||
4401082|NCT00264303|4228275|B2|France||Region of Enrollment||participants|Number|82|82.0||||||
4401083|NCT00264303|4228276|B1|France||Region of Enrollment||participants|Number|79|79.0||||||
4401084|NCT00264303|4228274|B3||Male|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4401085|NCT00264303|4228275|B2||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4401086|NCT00264303|4228276|B1||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4401087|NCT00264303|4228274|B3||Female|Sex: Female, Male||Participants|Count of Participants|590|590.0||||||
4401088|NCT00264303|4228275|B2||Female|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4401089|NCT00264303|4228276|B1||Female|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4401090|NCT00264303|4228274|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|15.1|15.1|||
4401091|NCT00264303|4228275|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|14.9|14.9|||
4401092|NCT00264303|4228276|B1|||Age||years|Mean|43.4|43.4|Standard Deviation|15.3|15.3|||
4401093|NCT00264290|4228293|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4401094|NCT00264290|4228294|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4401095|NCT00264290|4228295|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4401096|NCT00264290|4228293|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4401097|NCT00264290|4228294|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4401098|NCT00264290|4228295|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4401099|NCT00264290|4228293|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4401100|NCT00264290|4228294|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4401101|NCT00264290|4228295|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4401102|NCT00264290|4228293|B3|||Age||years|Mean|49|49.0|Full Range|||43.0|59.0|
4401103|NCT00264290|4228294|B2|||Age||years|Mean|48|48.0|Full Range|||43.0|55.0|
4401104|NCT00264290|4228295|B1|||Age||years|Mean|50|50.0|Full Range|||44.0|59.0|
4401105|NCT00264290|4228293|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4401106|NCT00264290|4228294|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4401107|NCT00264290|4228295|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4401108|NCT00264290|4228293|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4401109|NCT00264290|4228294|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4401110|NCT00264290|4228295|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4401111|NCT00264290|4228293|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401112|NCT00264290|4228294|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401113|NCT00264290|4228295|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401114|NCT00264238|4228302|B1|Participants without comorbid condition||Psychiatric comorbid condition||participants|Number|6|6.0||||||
4401115|NCT00264238|4228302|B1|Participants with comorbid condition||Psychiatric comorbid condition||participants|Number|8|8.0||||||
4401116|NCT00264238|4228302|B1|||Yale-Brown Obsessive Compulsive Scale|The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) is designed to rate the severity and type of symptoms in patients with obsessive compulsive disorder. In general, the items depend on the patient's report; however, the final rating is based on the clinical judgement of the interviewer. The Y-BOCS is designed to rate symptom severity, not to establish a diagnosis.The scale consists of 10 items summed to determine the level of symptom severity. The total score ranges from 0 to 40 with higher scores indicating greater symptom severity|units on a scale|Mean|27.4|27.4|Standard Deviation|5|5.0|||
4401117|NCT00264238|4228302|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4401118|NCT00264238|4228302|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4401119|NCT00264238|4228302|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4401120|NCT00264238|4228302|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4401121|NCT00264238|4228302|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4401122|NCT00264238|4228302|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4401123|NCT00264238|4228302|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4401124|NCT00264238|4228302|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4401125|NCT00264238|4228302|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4401126|NCT00264238|4228302|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4401127|NCT00264238|4228302|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|13.7|13.7|||
4401128|NCT00264147|4228309|B6|||Tender Joint Count (Out of 68 Joints)||Number of Tender Joints|Mean|27.30|27.3|Standard Deviation|15.00|15.0|||
4401129|NCT00264147|4228310|B5|||Tender Joint Count (Out of 68 Joints)||Number of Tender Joints|Mean|27.25|27.25|Standard Deviation|16.11|16.11|||
4401130|NCT00264147|4228311|B4|||Tender Joint Count (Out of 68 Joints)||Number of Tender Joints|Mean|26.76|26.76|Standard Deviation|14.37|14.37|||
4401131|NCT00264147|4228312|B3|||Tender Joint Count (Out of 68 Joints)||Number of Tender Joints|Mean|27.19|27.19|Standard Deviation|14.97|14.97|||
4401132|NCT00264147|4228313|B2|||Tender Joint Count (Out of 68 Joints)||Number of Tender Joints|Mean|28.33|28.33|Standard Deviation|15.42|15.42|||
4401133|NCT00264147|4228314|B1|||Tender Joint Count (Out of 68 Joints)||Number of Tender Joints|Mean|26.91|26.91|Standard Deviation|14.17|14.17|||
4401134|NCT00264147|4228309|B6|||Swollen Joint Count (Out of 66 Joints)||Number of Swollen Joints|Mean|16.53|16.53|Standard Deviation|10.06|10.06|||
4401135|NCT00264147|4228310|B5|||Swollen Joint Count (Out of 66 Joints)||Number of Swollen Joints|Mean|16.30|16.3|Standard Deviation|10.05|10.05|||
4401136|NCT00264147|4228311|B4|||Swollen Joint Count (Out of 66 Joints)||Number of Swollen Joints|Mean|15.79|15.79|Standard Deviation|9.40|9.4|||
4401137|NCT00264147|4228312|B3|||Swollen Joint Count (Out of 66 Joints)||Number of Swollen Joints|Mean|16.74|16.74|Standard Deviation|10.11|10.11|||
4401138|NCT00264147|4228313|B2|||Swollen Joint Count (Out of 66 Joints)||Number of Swollen Joints|Mean|17.75|17.75|Standard Deviation|10.86|10.86|||
4401139|NCT00264147|4228314|B1|||Swollen Joint Count (Out of 66 Joints)||Number of Swollen Joints|Mean|16.05|16.05|Standard Deviation|9.79|9.79|||
4401140|NCT00264147|4228309|B6|||Patient Global Assessment of Pain (0- To- 100-mm Visual Analog Scale)|(0- to 100-mm Visual Analog Scale) 0 mm= No pain, 100 mm= Extreme pain|units on a scale|Mean|71.38|71.38|Standard Deviation|17.14|17.14|||
4401141|NCT00264147|4228310|B5|||Patient Global Assessment of Pain (0- To- 100-mm Visual Analog Scale)|(0- to 100-mm Visual Analog Scale) 0 mm= No pain, 100 mm= Extreme pain|units on a scale|Mean|71.08|71.08|Standard Deviation|17.55|17.55|||
4401142|NCT00264147|4228311|B4|||Patient Global Assessment of Pain (0- To- 100-mm Visual Analog Scale)|(0- to 100-mm Visual Analog Scale) 0 mm= No pain, 100 mm= Extreme pain|units on a scale|Mean|69.54|69.54|Standard Deviation|18.24|18.24|||
4401143|NCT00264147|4228312|B3|||Patient Global Assessment of Pain (0- To- 100-mm Visual Analog Scale)|(0- to 100-mm Visual Analog Scale) 0 mm= No pain, 100 mm= Extreme pain|units on a scale|Mean|70.95|70.95|Standard Deviation|16.67|16.67|||
4401144|NCT00264147|4228313|B2|||Patient Global Assessment of Pain (0- To- 100-mm Visual Analog Scale)|(0- to 100-mm Visual Analog Scale) 0 mm= No pain, 100 mm= Extreme pain|units on a scale|Mean|72.42|72.42|Standard Deviation|17.32|17.32|||
4401145|NCT00264147|4228314|B1|||Patient Global Assessment of Pain (0- To- 100-mm Visual Analog Scale)|(0- to 100-mm Visual Analog Scale) 0 mm= No pain, 100 mm= Extreme pain|units on a scale|Mean|72.66|72.66|Standard Deviation|16.03|16.03|||
4401146|NCT00264147|4228309|B6|||Patient Global Assessment of Disease Activity (0-To- 100 Millimeter Visual Analog Scale)|(0- to 100-mm Visual Analog Scale) 0 mm= No pain, 100 mm= Extreme pain|units on a scale|Mean|66.79|66.79|Standard Deviation|19.30|19.3|||
4401147|NCT00264147|4228310|B5|||Patient Global Assessment of Disease Activity (0-To- 100 Millimeter Visual Analog Scale)|(0- to 100-mm Visual Analog Scale) 0 mm= No pain, 100 mm= Extreme pain|units on a scale|Mean|65.42|65.42|Standard Deviation|18.45|18.45|||
4401148|NCT00264147|4228311|B4|||Patient Global Assessment of Disease Activity (0-To- 100 Millimeter Visual Analog Scale)|(0- to 100-mm Visual Analog Scale) 0 mm= No pain, 100 mm= Extreme pain|units on a scale|Mean|66.60|66.6|Standard Deviation|19.58|19.58|||
4401149|NCT00264147|4228312|B3|||Patient Global Assessment of Disease Activity (0-To- 100 Millimeter Visual Analog Scale)|(0- to 100-mm Visual Analog Scale) 0 mm= No pain, 100 mm= Extreme pain|units on a scale|Mean|66.56|66.56|Standard Deviation|20.47|20.47|||
4401150|NCT00264147|4228313|B2|||Patient Global Assessment of Disease Activity (0-To- 100 Millimeter Visual Analog Scale)|(0- to 100-mm Visual Analog Scale) 0 mm= No pain, 100 mm= Extreme pain|units on a scale|Mean|69.28|69.28|Standard Deviation|19.37|19.37|||
4401151|NCT00264147|4228314|B1|||Patient Global Assessment of Disease Activity (0-To- 100 Millimeter Visual Analog Scale)|(0- to 100-mm Visual Analog Scale) 0 mm= No pain, 100 mm= Extreme pain|units on a scale|Mean|66.08|66.08|Standard Deviation|18.67|18.67|||
4401152|NCT00264147|4228309|B6|||Investigator Global Assessment of Disease Activity (0 to 4 - Likert Scale)|(0 to 4 - Likert Scale) 0=Very Well, 1=Well, 2=Fair, 3=Poor, 4=Very Poor|units on a scale|Mean|2.72|2.72|Standard Deviation|0.64|0.64|||
4401153|NCT00264147|4228310|B5|||Investigator Global Assessment of Disease Activity (0 to 4 - Likert Scale)|(0 to 4 - Likert Scale) 0=Very Well, 1=Well, 2=Fair, 3=Poor, 4=Very Poor|units on a scale|Mean|2.73|2.73|Standard Deviation|0.65|0.65|||
4401154|NCT00264147|4228311|B4|||Investigator Global Assessment of Disease Activity (0 to 4 - Likert Scale)|(0 to 4 - Likert Scale) 0=Very Well, 1=Well, 2=Fair, 3=Poor, 4=Very Poor|units on a scale|Mean|2.69|2.69|Standard Deviation|0.63|0.63|||
4401155|NCT00264147|4228312|B3|||Investigator Global Assessment of Disease Activity (0 to 4 - Likert Scale)|(0 to 4 - Likert Scale) 0=Very Well, 1=Well, 2=Fair, 3=Poor, 4=Very Poor|units on a scale|Mean|2.75|2.75|Standard Deviation|0.66|0.66|||
4401156|NCT00264147|4228313|B2|||Investigator Global Assessment of Disease Activity (0 to 4 - Likert Scale)|(0 to 4 - Likert Scale) 0=Very Well, 1=Well, 2=Fair, 3=Poor, 4=Very Poor|units on a scale|Mean|2.71|2.71|Standard Deviation|0.67|0.67|||
4401157|NCT00264147|4228314|B1|||Investigator Global Assessment of Disease Activity (0 to 4 - Likert Scale)|(0 to 4 - Likert Scale) 0=Very Well, 1=Well, 2=Fair, 3=Poor, 4=Very Poor|units on a scale|Mean|2.71|2.71|Standard Deviation|0.61|0.61|||
4401158|NCT00264147|4228309|B6|||Height||Centimeters|Mean|163.30|163.3|Standard Deviation|9.37|9.37|||
4401159|NCT00264147|4228310|B5|||Height||Centimeters|Mean|163.49|163.49|Standard Deviation|10.04|10.04|||
4401160|NCT00264147|4228311|B4|||Height||Centimeters|Mean|162.96|162.96|Standard Deviation|9.22|9.22|||
4401161|NCT00264147|4228312|B3|||Height||Centimeters|Mean|164.57|164.57|Standard Deviation|9.13|9.13|||
4401162|NCT00264147|4228313|B2|||Height||Centimeters|Mean|163.63|163.63|Standard Deviation|8.55|8.55|||
4401163|NCT00264147|4228314|B1|||Height||Centimeters|Mean|161.93|161.93|Standard Deviation|9.71|9.71|||
4401164|NCT00264147|4228309|B6|||Duration of Rheumatoid Arthritis (Years)||Years|Mean|10.3|10.3|Standard Deviation|9.62|9.62|||
4401165|NCT00264147|4228310|B5|||Duration of Rheumatoid Arthritis (Years)||Years|Mean|9.9|9.9|Standard Deviation|9.98|9.98|||
4401166|NCT00264147|4228311|B4|||Duration of Rheumatoid Arthritis (Years)||Years|Mean|10.3|10.3|Standard Deviation|10.18|10.18|||
4401167|NCT00264147|4228312|B3|||Duration of Rheumatoid Arthritis (Years)||Years|Mean|11.2|11.2|Standard Deviation|8.40|8.4|||
4401168|NCT00264147|4228313|B2|||Duration of Rheumatoid Arthritis (Years)||Years|Mean|10.1|10.1|Standard Deviation|9.76|9.76|||
4401169|NCT00264147|4228314|B1|||Duration of Rheumatoid Arthritis (Years)||Years|Mean|10.0|10.0|Standard Deviation|9.78|9.78|||
4401170|NCT00264147|4228309|B6|||Body Weight||Kilograms|Mean|76.73|76.73|Standard Deviation|18.58|18.58|||
4401171|NCT00264147|4228310|B5|||Body Weight||Kilograms|Mean|77.97|77.97|Standard Deviation|18.61|18.61|||
4401172|NCT00264147|4228311|B4|||Body Weight||Kilograms|Mean|75.72|75.72|Standard Deviation|19.54|19.54|||
4401173|NCT00264147|4228312|B3|||Body Weight||Kilograms|Mean|77.36|77.36|Standard Deviation|20.00|20.0|||
4401174|NCT00264147|4228313|B2|||Body Weight||Kilograms|Mean|76.12|76.12|Standard Deviation|18.48|18.48|||
4401175|NCT00264147|4228314|B1|||Body Weight||Kilograms|Mean|76.42|76.42|Standard Deviation|16.54|16.54|||
4401176|NCT00264147|4228309|B6|Non-User||Smoking Status||Participants|Number|412|412.0||||||
4401177|NCT00264147|4228310|B5|Non-User||Smoking Status||Participants|Number|93|93.0||||||
4401178|NCT00264147|4228311|B4|Non-User||Smoking Status||Participants|Number|78|78.0||||||
4401179|NCT00264147|4228312|B3|Non-User||Smoking Status||Participants|Number|80|80.0||||||
4401180|NCT00264147|4228313|B2|Non-User||Smoking Status||Participants|Number|80|80.0||||||
4401181|NCT00264147|4228314|B1|Non-User||Smoking Status||Participants|Number|81|81.0||||||
4401182|NCT00264147|4228309|B6|Ex-User||Smoking Status||Participants|Number|220|220.0||||||
4401183|NCT00264147|4228310|B5|Ex-User||Smoking Status||Participants|Number|40|40.0||||||
4401184|NCT00264147|4228311|B4|Ex-User||Smoking Status||Participants|Number|39|39.0||||||
4401185|NCT00264147|4228312|B3|Ex-User||Smoking Status||Participants|Number|42|42.0||||||
4401186|NCT00264147|4228313|B2|Ex-User||Smoking Status||Participants|Number|46|46.0||||||
4401187|NCT00264147|4228314|B1|Ex-User||Smoking Status||Participants|Number|53|53.0||||||
4401188|NCT00264147|4228309|B6|Current||Smoking Status||Participants|Number|129|129.0||||||
4401189|NCT00264147|4228310|B5|Current||Smoking Status||Participants|Number|22|22.0||||||
4401190|NCT00264147|4228311|B4|Current||Smoking Status||Participants|Number|23|23.0||||||
4401191|NCT00264147|4228312|B3|Current||Smoking Status||Participants|Number|29|29.0||||||
4401192|NCT00264147|4228313|B2|Current||Smoking Status||Participants|Number|28|28.0||||||
4401193|NCT00264147|4228314|B1|Current||Smoking Status||Participants|Number|27|27.0||||||
4401194|NCT00264147|4228309|B6|Not Reported||Rheumatoid Factor||Participants|Number|1|1.0||||||
4401195|NCT00264147|4228310|B5|Not Reported||Rheumatoid Factor||Participants|Number|0|0.0||||||
4401196|NCT00264147|4228311|B4|Not Reported||Rheumatoid Factor||Participants|Number|0|0.0||||||
4401197|NCT00264147|4228312|B3|Not Reported||Rheumatoid Factor||Participants|Number|0|0.0||||||
4401198|NCT00264147|4228313|B2|Not Reported||Rheumatoid Factor||Participants|Number|0|0.0||||||
4401199|NCT00264147|4228314|B1|Not Reported||Rheumatoid Factor||Participants|Number|1|1.0||||||
4401200|NCT00264147|4228309|B6|Negative||Rheumatoid Factor||Participants|Number|161|161.0||||||
4401201|NCT00264147|4228310|B5|Negative||Rheumatoid Factor||Participants|Number|34|34.0||||||
4401202|NCT00264147|4228311|B4|Negative||Rheumatoid Factor||Participants|Number|20|20.0||||||
4401203|NCT00264147|4228312|B3|Negative||Rheumatoid Factor||Participants|Number|30|30.0||||||
4401204|NCT00264147|4228313|B2|Negative||Rheumatoid Factor||Participants|Number|37|37.0||||||
4401205|NCT00264147|4228314|B1|Negative||Rheumatoid Factor||Participants|Number|40|40.0||||||
4401206|NCT00264147|4228309|B6|Positive||Rheumatoid Factor||Participants|Number|599|599.0||||||
4401207|NCT00264147|4228310|B5|Positive||Rheumatoid Factor||Participants|Number|121|121.0||||||
4401208|NCT00264147|4228311|B4|Positive||Rheumatoid Factor||Participants|Number|120|120.0||||||
4401209|NCT00264147|4228312|B3|Positive||Rheumatoid Factor||Participants|Number|121|121.0||||||
4401210|NCT00264147|4228313|B2|Positive||Rheumatoid Factor||Participants|Number|117|117.0||||||
4401211|NCT00264147|4228314|B1|Positive||Rheumatoid Factor||Participants|Number|120|120.0||||||
4401212|NCT00264147|4228309|B6|Indian||Race/Ethnicity||participants|Number|1|1.0||||||
4401213|NCT00264147|4228310|B5|Indian||Race/Ethnicity||participants|Number|0|0.0||||||
4401214|NCT00264147|4228311|B4|Indian||Race/Ethnicity||participants|Number|0|0.0||||||
4401215|NCT00264147|4228312|B3|Indian||Race/Ethnicity||participants|Number|0|0.0||||||
4401216|NCT00264147|4228313|B2|Indian||Race/Ethnicity||participants|Number|1|1.0||||||
4401217|NCT00264147|4228314|B1|Indian||Race/Ethnicity||participants|Number|0|0.0||||||
4401218|NCT00264147|4228309|B6|Native American||Race/Ethnicity||participants|Number|3|3.0||||||
4401219|NCT00264147|4228310|B5|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4401220|NCT00264147|4228311|B4|Native American||Race/Ethnicity||participants|Number|2|2.0||||||
4401221|NCT00264147|4228312|B3|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4401222|NCT00264147|4228313|B2|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4401223|NCT00264147|4228314|B1|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4401224|NCT00264147|4228309|B6|Hispanic||Race/Ethnicity||participants|Number|175|175.0||||||
4401225|NCT00264147|4228310|B5|Hispanic||Race/Ethnicity||participants|Number|36|36.0||||||
4401226|NCT00264147|4228311|B4|Hispanic||Race/Ethnicity||participants|Number|34|34.0||||||
4401227|NCT00264147|4228312|B3|Hispanic||Race/Ethnicity||participants|Number|25|25.0||||||
4401228|NCT00264147|4228313|B2|Hispanic||Race/Ethnicity||participants|Number|39|39.0||||||
4401229|NCT00264147|4228314|B1|Hispanic||Race/Ethnicity||participants|Number|41|41.0||||||
4401230|NCT00264147|4228309|B6|White||Race/Ethnicity||participants|Number|549|549.0||||||
4401231|NCT00264147|4228310|B5|White||Race/Ethnicity||participants|Number|112|112.0||||||
4401232|NCT00264147|4228311|B4|White||Race/Ethnicity||participants|Number|96|96.0||||||
4401233|NCT00264147|4228312|B3|White||Race/Ethnicity||participants|Number|121|121.0||||||
4401234|NCT00264147|4228313|B2|White||Race/Ethnicity||participants|Number|106|106.0||||||
4401235|NCT00264147|4228314|B1|White||Race/Ethnicity||participants|Number|114|114.0||||||
4401236|NCT00264147|4228309|B6|Black||Race/Ethnicity||participants|Number|29|29.0||||||
4401237|NCT00264147|4228310|B5|Black||Race/Ethnicity||participants|Number|6|6.0||||||
4401238|NCT00264147|4228311|B4|Black||Race/Ethnicity||participants|Number|7|7.0||||||
4401239|NCT00264147|4228312|B3|Black||Race/Ethnicity||participants|Number|3|3.0||||||
4401240|NCT00264147|4228313|B2|Black||Race/Ethnicity||participants|Number|8|8.0||||||
4401241|NCT00264147|4228314|B1|Black||Race/Ethnicity||participants|Number|5|5.0||||||
4401242|NCT00264147|4228309|B6|Asian||Race/Ethnicity||participants|Number|4|4.0||||||
4401243|NCT00264147|4228310|B5|Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4401244|NCT00264147|4228311|B4|Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4401245|NCT00264147|4228312|B3|Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4401246|NCT00264147|4228313|B2|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4401247|NCT00264147|4228314|B1|Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4401248|NCT00264147|4228309|B6|No||Methotrexate User||Participants|Number|289|289.0||||||
4401249|NCT00264147|4228310|B5|No||Methotrexate User||Participants|Number|62|62.0||||||
4401250|NCT00264147|4228311|B4|No||Methotrexate User||Participants|Number|47|47.0||||||
4401251|NCT00264147|4228312|B3|No||Methotrexate User||Participants|Number|55|55.0||||||
4401252|NCT00264147|4228313|B2|No||Methotrexate User||Participants|Number|63|63.0||||||
4401253|NCT00264147|4228314|B1|No||Methotrexate User||Participants|Number|62|62.0||||||
4401254|NCT00264147|4228309|B6|Yes||Methotrexate User||Participants|Number|472|472.0||||||
4401255|NCT00264147|4228310|B5|Yes||Methotrexate User||Participants|Number|93|93.0||||||
4401256|NCT00264147|4228311|B4|Yes||Methotrexate User||Participants|Number|93|93.0||||||
4401257|NCT00264147|4228312|B3|Yes||Methotrexate User||Participants|Number|96|96.0||||||
4401258|NCT00264147|4228313|B2|Yes||Methotrexate User||Participants|Number|91|91.0||||||
4401259|NCT00264147|4228314|B1|Yes||Methotrexate User||Participants|Number|99|99.0||||||
4401260|NCT00264147|4228309|B6|No||Disease Modifying Antirheumatic Drug or Corticosteroid User||Participants|Number|107|107.0||||||
4401261|NCT00264147|4228310|B5|No||Disease Modifying Antirheumatic Drug or Corticosteroid User||Participants|Number|19|19.0||||||
4401262|NCT00264147|4228311|B4|No||Disease Modifying Antirheumatic Drug or Corticosteroid User||Participants|Number|21|21.0||||||
4401263|NCT00264147|4228312|B3|No||Disease Modifying Antirheumatic Drug or Corticosteroid User||Participants|Number|25|25.0||||||
4401264|NCT00264147|4228313|B2|No||Disease Modifying Antirheumatic Drug or Corticosteroid User||Participants|Number|20|20.0||||||
4401265|NCT00264147|4228314|B1|No||Disease Modifying Antirheumatic Drug or Corticosteroid User||Participants|Number|22|22.0||||||
4401266|NCT00264147|4228309|B6|Yes||Disease Modifying Antirheumatic Drug or Corticosteroid User||Participants|Number|654|654.0||||||
4401267|NCT00264147|4228310|B5|Yes||Disease Modifying Antirheumatic Drug or Corticosteroid User||Participants|Number|136|136.0||||||
4401268|NCT00264147|4228311|B4|Yes||Disease Modifying Antirheumatic Drug or Corticosteroid User||Participants|Number|119|119.0||||||
4401269|NCT00264147|4228312|B3|Yes||Disease Modifying Antirheumatic Drug or Corticosteroid User||Participants|Number|126|126.0||||||
4401270|NCT00264147|4228313|B2|Yes||Disease Modifying Antirheumatic Drug or Corticosteroid User||Participants|Number|134|134.0||||||
4401271|NCT00264147|4228314|B1|Yes||Disease Modifying Antirheumatic Drug or Corticosteroid User||Participants|Number|139|139.0||||||
4401272|NCT00264147|4228309|B6|No||Disease Modifying Antirheumatic Drug User||Participants|Number|132|132.0||||||
4401273|NCT00264147|4228310|B5|No||Disease Modifying Antirheumatic Drug User||Participants|Number|24|24.0||||||
4401274|NCT00264147|4228311|B4|No||Disease Modifying Antirheumatic Drug User||Participants|Number|26|26.0||||||
4401275|NCT00264147|4228312|B3|No||Disease Modifying Antirheumatic Drug User||Participants|Number|29|29.0||||||
4401276|NCT00264147|4228313|B2|No||Disease Modifying Antirheumatic Drug User||Participants|Number|25|25.0||||||
4401277|NCT00264147|4228314|B1|No||Disease Modifying Antirheumatic Drug User||Participants|Number|28|28.0||||||
4401278|NCT00264147|4228309|B6|Yes||Disease Modifying Antirheumatic Drug User||Participants|Number|629|629.0||||||
4401279|NCT00264147|4228310|B5|Yes||Disease Modifying Antirheumatic Drug User||Participants|Number|131|131.0||||||
4401280|NCT00264147|4228311|B4|Yes||Disease Modifying Antirheumatic Drug User||Participants|Number|114|114.0||||||
4401281|NCT00264147|4228312|B3|Yes||Disease Modifying Antirheumatic Drug User||Participants|Number|122|122.0||||||
4401282|NCT00264147|4228313|B2|Yes||Disease Modifying Antirheumatic Drug User||Participants|Number|129|129.0||||||
4401283|NCT00264147|4228314|B1|Yes||Disease Modifying Antirheumatic Drug User||Participants|Number|133|133.0||||||
4401284|NCT00264147|4228309|B6|No||Corticosteroid User||Participants|Number|529|529.0||||||
4401285|NCT00264147|4228310|B5|No||Corticosteroid User||Participants|Number|106|106.0||||||
4401286|NCT00264147|4228311|B4|No||Corticosteroid User||Participants|Number|99|99.0||||||
4401287|NCT00264147|4228312|B3|No||Corticosteroid User||Participants|Number|109|109.0||||||
4401288|NCT00264147|4228313|B2|No||Corticosteroid User||Participants|Number|104|104.0||||||
4401289|NCT00264147|4228314|B1|No||Corticosteroid User||Participants|Number|111|111.0||||||
4401290|NCT00264147|4228309|B6|Yes||Corticosteroid User||Participants|Number|232|232.0||||||
4401291|NCT00264147|4228310|B5|Yes||Corticosteroid User||Participants|Number|49|49.0||||||
4401292|NCT00264147|4228311|B4|Yes||Corticosteroid User||Participants|Number|41|41.0||||||
4401293|NCT00264147|4228312|B3|Yes||Corticosteroid User||Participants|Number|42|42.0||||||
4401294|NCT00264147|4228313|B2|Yes||Corticosteroid User||Participants|Number|50|50.0||||||
4401295|NCT00264147|4228314|B1|Yes||Corticosteroid User||Participants|Number|50|50.0||||||
4401296|NCT00264147|4228309|B6|Class III||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|101|101.0||||||
4401297|NCT00264147|4228310|B5|Class III||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|19|19.0||||||
4401298|NCT00264147|4228311|B4|Class III||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|26|26.0||||||
4401299|NCT00264147|4228312|B3|Class III||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|19|19.0||||||
4401300|NCT00264147|4228313|B2|Class III||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|22|22.0||||||
4401301|NCT00264147|4228314|B1|Class III||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|15|15.0||||||
4401302|NCT00264147|4228309|B6|Class II||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|439|439.0||||||
4401303|NCT00264147|4228310|B5|Class II||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|98|98.0||||||
4401304|NCT00264147|4228311|B4|Class II||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|73|73.0||||||
4401305|NCT00264147|4228312|B3|Class II||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|83|83.0||||||
4401306|NCT00264147|4228313|B2|Class II||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|83|83.0||||||
4401307|NCT00264147|4228314|B1|Class II||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|102|102.0||||||
4401308|NCT00264147|4228309|B6|Class I||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|221|221.0||||||
4401309|NCT00264147|4228310|B5|Class I||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|38|38.0||||||
4401310|NCT00264147|4228311|B4|Class I||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|41|41.0||||||
4401311|NCT00264147|4228312|B3|Class I||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|49|49.0||||||
4401312|NCT00264147|4228313|B2|Class I||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|49|49.0||||||
4401313|NCT00264147|4228314|B1|Class I||American Rheumatism Association Functional Class|Class I: Completely able to perform usual activities of daily living (self care, vocational, and avocational), Class II: Able to perform usual self-care and vocational activities, but limited in avocational activities, Class III: Able to perform usual self-care activities, but limited in vocational and avocational activities|Participants|Number|44|44.0||||||
4401314|NCT00264147|4228309|B6||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4401315|NCT00264147|4228310|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4401316|NCT00264147|4228311|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4401317|NCT00264147|4228312|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4401318|NCT00264147|4228313|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4401319|NCT00264147|4228314|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4401320|NCT00264147|4228309|B6||Female|Sex: Female, Male||Participants|Count of Participants|613|613.0||||||
4401321|NCT00264147|4228310|B5||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4401322|NCT00264147|4228311|B4||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4401323|NCT00264147|4228312|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4401324|NCT00264147|4228313|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4401325|NCT00264147|4228314|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4401326|NCT00264147|4228309|B6|||Age||years|Mean|57.0|57.0|Standard Deviation|11.75|11.75|||
4401327|NCT00264147|4228310|B5|||Age||years|Mean|54.9|54.9|Standard Deviation|12.54|12.54|||
4401328|NCT00264147|4228311|B4|||Age||years|Mean|57.7|57.7|Standard Deviation|10.96|10.96|||
4401329|NCT00264147|4228312|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|11.17|11.17|||
4401330|NCT00264147|4228313|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|11.92|11.92|||
4401331|NCT00264147|4228314|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|11.80|11.8|||
4401332|NCT00264004|4228358|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4401333|NCT00264004|4228359|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4401334|NCT00264004|4228360|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4401335|NCT00264004|4228361|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4401336|NCT00264004|4228362|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4401337|NCT00264004|4228358|B5||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4401338|NCT00264004|4228359|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4401339|NCT00264004|4228360|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4401340|NCT00264004|4228361|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4401341|NCT00264004|4228362|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4401342|NCT00264004|4228358|B5|Age||Age||Years|Mean|55.175|55.175|Standard Deviation|11.225|11.225|||
4401343|NCT00264004|4228359|B4|Age||Age||Years|Mean|53.5|53.5|Standard Deviation|11.7|11.7|||
4401344|NCT00264004|4228360|B3|Age||Age||Years|Mean|56.4|56.4|Standard Deviation|11.0|11.0|||
4401345|NCT00264004|4228361|B2|Age||Age||Years|Mean|52.7|52.7|Standard Deviation|12.9|12.9|||
4401346|NCT00264004|4228362|B1|Age||Age||Years|Mean|58.1|58.1|Standard Deviation|9.3|9.3|||
4401347|NCT00263887|4228391|B3|Very Severe||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|13|13.0||||||
4401348|NCT00263887|4228392|B2|Very Severe||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|7|7.0||||||
4401349|NCT00263887|4228393|B1|Very Severe||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|6|6.0||||||
4401350|NCT00263887|4228391|B3|Severe||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|39|39.0||||||
4401351|NCT00263887|4228392|B2|Severe||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|20|20.0||||||
4401352|NCT00263887|4228393|B1|Severe||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|19|19.0||||||
4401405|NCT00263757|4228401|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401353|NCT00263887|4228391|B3|Moderate||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|18|18.0||||||
4401354|NCT00263887|4228392|B2|Moderate||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|8|8.0||||||
4401355|NCT00263887|4228393|B1|Moderate||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|10|10.0||||||
4401356|NCT00263887|4228391|B3|Mild||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|3|3.0||||||
4401357|NCT00263887|4228392|B2|Mild||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|2|2.0||||||
4401358|NCT00263887|4228393|B1|Mild||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|1|1.0||||||
4401359|NCT00263887|4228391|B3|None||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|4|4.0||||||
4401360|NCT00263887|4228392|B2|None||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|2|2.0||||||
4401361|NCT00263887|4228393|B1|None||Severity of COPD at baseline|Severity of Chronic Obstructive pulmonary Disease (COPD) at baseline according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classes|participants|Number|2|2.0||||||
4401362|NCT00263887|4228391|B3|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
4401363|NCT00263887|4228392|B2|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
4401364|NCT00263887|4228393|B1|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
4401365|NCT00263887|4228391|B3|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
4401366|NCT00263887|4228392|B2|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4401367|NCT00263887|4228393|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4401368|NCT00263887|4228391|B3|Denmark||Region of Enrollment||participants|Number|35|35.0||||||
4401369|NCT00263887|4228392|B2|Denmark||Region of Enrollment||participants|Number|17|17.0||||||
4401370|NCT00263887|4228393|B1|Denmark||Region of Enrollment||participants|Number|18|18.0||||||
4401371|NCT00263887|4228391|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4401372|NCT00263887|4228392|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4401373|NCT00263887|4228393|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4401374|NCT00263887|4228391|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4401375|NCT00263887|4228392|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4401376|NCT00263887|4228393|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4401377|NCT00263887|4228391|B3|||Age||years|Mean|54.97|54.97|Standard Deviation|9.03|9.03|||
4401378|NCT00263887|4228392|B2|||Age||years|Mean|55.26|55.26|Standard Deviation|9.68|9.68|||
4401379|NCT00263887|4228393|B1|||Age||years|Mean|54.68|54.68|Standard Deviation|8.29|8.29|||
4401380|NCT00263887|4228391|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4401381|NCT00263887|4228392|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4401382|NCT00263887|4228393|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4401383|NCT00263887|4228391|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4401384|NCT00263887|4228392|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4401385|NCT00263887|4228393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4401386|NCT00263887|4228391|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401387|NCT00263887|4228392|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401388|NCT00263887|4228393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401389|NCT00263757|4228400|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4401390|NCT00263757|4228401|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4401391|NCT00263757|4228402|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4401392|NCT00263757|4228400|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4401393|NCT00263757|4228401|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4401394|NCT00263757|4228402|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4401395|NCT00263757|4228400|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4401396|NCT00263757|4228401|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4401397|NCT00263757|4228402|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4401398|NCT00263757|4228400|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4401399|NCT00263757|4228401|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4401400|NCT00263757|4228402|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4401401|NCT00263757|4228400|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4401402|NCT00263757|4228401|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4401403|NCT00263757|4228402|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4401404|NCT00263757|4228400|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401406|NCT00263757|4228402|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401407|NCT00263666|4228413|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4401408|NCT00263666|4228414|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4401409|NCT00263666|4228415|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4401410|NCT00263666|4228413|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4401411|NCT00263666|4228414|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4401412|NCT00263666|4228415|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4401413|NCT00263666|4228413|B3|||Age||weeks|Mean|7.0|7.0|Standard Deviation|1.06|1.06|||
4401414|NCT00263666|4228414|B2|||Age||weeks|Mean|6.9|6.9|Standard Deviation|1.02|1.02|||
4401415|NCT00263666|4228415|B1|||Age||weeks|Mean|7.1|7.1|Standard Deviation|1.10|1.1|||
4401416|NCT00263328|4228467|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4401417|NCT00263328|4228468|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4401418|NCT00263328|4228469|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4401419|NCT00263328|4228470|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4401420|NCT00263328|4228467|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4401421|NCT00263328|4228468|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4401422|NCT00263328|4228469|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4401423|NCT00263328|4228470|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4401424|NCT00263328|4228467|B4|||Age||Years|Mean|43.6|43.6|Standard Deviation|10.3|10.3|||
4401425|NCT00263328|4228468|B3|||Age||Years|Mean|44.5|44.5|Standard Deviation|12.2|12.2|||
4401426|NCT00263328|4228469|B2|||Age||Years|Mean|48.1|48.1|Standard Deviation|7.9|7.9|||
4401427|NCT00263328|4228470|B1|||Age||Years|Mean|39.6|39.6|Standard Deviation|9.3|9.3|||
4401428|NCT00263211|4228628|B3|||Number of Participants who Smoke||participants|Number|9|9.0||||||
4401429|NCT00263211|4228629|B2|||Number of Participants who Smoke||participants|Number|5|5.0||||||
4401430|NCT00263211|4228630|B1|||Number of Participants who Smoke||participants|Number|4|4.0||||||
4401431|NCT00263211|4228628|B3|||Number of Participants Concurrently using Bisphosphonate||participants|Number|21|21.0||||||
4401432|NCT00263211|4228629|B2|||Number of Participants Concurrently using Bisphosphonate||participants|Number|9|9.0||||||
4401433|NCT00263211|4228630|B1|||Number of Participants Concurrently using Bisphosphonate||participants|Number|12|12.0||||||
4401434|NCT00263211|4228628|B3|||Number of Participants Concurrently using Trastuzumab||participants|Number|14|14.0||||||
4401435|NCT00263211|4228629|B2|||Number of Participants Concurrently using Trastuzumab||participants|Number|9|9.0||||||
4401436|NCT00263211|4228630|B1|||Number of Participants Concurrently using Trastuzumab||participants|Number|5|5.0||||||
4401437|NCT00263211|4228628|B3|≥2||Number of Previous Metastatic Endocrine Therapies||participants|Number|19|19.0||||||
4401438|NCT00263211|4228629|B2|≥2||Number of Previous Metastatic Endocrine Therapies||participants|Number|10|10.0||||||
4401439|NCT00263211|4228630|B1|≥2||Number of Previous Metastatic Endocrine Therapies||participants|Number|9|9.0||||||
4401440|NCT00263211|4228628|B3|1||Number of Previous Metastatic Endocrine Therapies||participants|Number|10|10.0||||||
4401441|NCT00263211|4228629|B2|1||Number of Previous Metastatic Endocrine Therapies||participants|Number|3|3.0||||||
4401442|NCT00263211|4228630|B1|1||Number of Previous Metastatic Endocrine Therapies||participants|Number|7|7.0||||||
4401443|NCT00263211|4228628|B3|0||Number of Previous Metastatic Endocrine Therapies||participants|Number|19|19.0||||||
4401444|NCT00263211|4228629|B2|0||Number of Previous Metastatic Endocrine Therapies||participants|Number|11|11.0||||||
4401445|NCT00263211|4228630|B1|0||Number of Previous Metastatic Endocrine Therapies||participants|Number|8|8.0||||||
4401446|NCT00263211|4228628|B3|≥3||Number of Previous Metastatic Chemotherapy Regimens||participants|Number|15|15.0||||||
4401447|NCT00263211|4228629|B2|≥3||Number of Previous Metastatic Chemotherapy Regimens||participants|Number|6|6.0||||||
4401448|NCT00263211|4228630|B1|≥3||Number of Previous Metastatic Chemotherapy Regimens||participants|Number|9|9.0||||||
4401449|NCT00263211|4228628|B3|2||Number of Previous Metastatic Chemotherapy Regimens||participants|Number|10|10.0||||||
4401450|NCT00263211|4228629|B2|2||Number of Previous Metastatic Chemotherapy Regimens||participants|Number|6|6.0||||||
4401451|NCT00263211|4228630|B1|2||Number of Previous Metastatic Chemotherapy Regimens||participants|Number|4|4.0||||||
4401452|NCT00263211|4228628|B3|1||Number of Previous Metastatic Chemotherapy Regimens||participants|Number|13|13.0||||||
4401453|NCT00263211|4228629|B2|1||Number of Previous Metastatic Chemotherapy Regimens||participants|Number|8|8.0||||||
4401454|NCT00263211|4228630|B1|1||Number of Previous Metastatic Chemotherapy Regimens||participants|Number|5|5.0||||||
4401455|NCT00263211|4228628|B3|0||Number of Previous Metastatic Chemotherapy Regimens||participants|Number|10|10.0||||||
4401456|NCT00263211|4228629|B2|0||Number of Previous Metastatic Chemotherapy Regimens||participants|Number|4|4.0||||||
4401457|NCT00263211|4228630|B1|0||Number of Previous Metastatic Chemotherapy Regimens||participants|Number|6|6.0||||||
4401458|NCT00263211|4228628|B3|≥3||Number of Metastatic Sites||participants|Number|17|17.0||||||
4401459|NCT00263211|4228629|B2|≥3||Number of Metastatic Sites||participants|Number|8|8.0||||||
4401460|NCT00263211|4228630|B1|≥3||Number of Metastatic Sites||participants|Number|9|9.0||||||
4401461|NCT00263211|4228628|B3|2||Number of Metastatic Sites||participants|Number|14|14.0||||||
4401462|NCT00263211|4228629|B2|2||Number of Metastatic Sites||participants|Number|7|7.0||||||
4401463|NCT00263211|4228630|B1|2||Number of Metastatic Sites||participants|Number|7|7.0||||||
4401464|NCT00263211|4228628|B3|1||Number of Metastatic Sites||participants|Number|17|17.0||||||
4401465|NCT00263211|4228629|B2|1||Number of Metastatic Sites||participants|Number|9|9.0||||||
4401466|NCT00263211|4228630|B1|1||Number of Metastatic Sites||participants|Number|8|8.0||||||
4401467|NCT00263211|4228628|B3|||Estrogen Receptor Positivity (ER+)|Estrogen Receptor + means that the breast cancer is considered “hormone-receptor-positive.”|participants|Number|28|28.0||||||
4401468|NCT00263211|4228629|B2|||Estrogen Receptor Positivity (ER+)|Estrogen Receptor + means that the breast cancer is considered “hormone-receptor-positive.”|participants|Number|13|13.0||||||
4401469|NCT00263211|4228630|B1|||Estrogen Receptor Positivity (ER+)|Estrogen Receptor + means that the breast cancer is considered “hormone-receptor-positive.”|participants|Number|15|15.0||||||
4401470|NCT00263211|4228628|B3|||Human Epidermal Growth Factor Receptor 2 Positivity (HER2+)|Some breast cancers have high amounts of a protein called HER2/neu on the surface of the cancer cells (called HER2/neu-positive (HER2-positive) breast cancer). The HER2/neu protein is important for cancer cell growth.|participants|Number|18|18.0||||||
4401471|NCT00263211|4228629|B2|||Human Epidermal Growth Factor Receptor 2 Positivity (HER2+)|Some breast cancers have high amounts of a protein called HER2/neu on the surface of the cancer cells (called HER2/neu-positive (HER2-positive) breast cancer). The HER2/neu protein is important for cancer cell growth.|participants|Number|10|10.0||||||
4401472|NCT00263211|4228630|B1|||Human Epidermal Growth Factor Receptor 2 Positivity (HER2+)|Some breast cancers have high amounts of a protein called HER2/neu on the surface of the cancer cells (called HER2/neu-positive (HER2-positive) breast cancer). The HER2/neu protein is important for cancer cell growth.|participants|Number|8|8.0||||||
4401473|NCT00263211|4228628|B3|||The Number of Participants with Detectable Positive Circulating Tumor Cells (CTCs=>1) at Baseline|The number of participants with detectable CTCs (>= 1 CTC) was calculated at baseline.|participants|Number|30|30.0||||||
4401474|NCT00263211|4228629|B2|||The Number of Participants with Detectable Positive Circulating Tumor Cells (CTCs=>1) at Baseline|The number of participants with detectable CTCs (>= 1 CTC) was calculated at baseline.|participants|Number|18|18.0||||||
4401475|NCT00263211|4228630|B1|||The Number of Participants with Detectable Positive Circulating Tumor Cells (CTCs=>1) at Baseline|The number of participants with detectable CTCs (>= 1 CTC) was calculated at baseline.|participants|Number|12|12.0||||||
4401476|NCT00263211|4228628|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4401477|NCT00263211|4228629|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4401478|NCT00263211|4228630|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4401479|NCT00263211|4228628|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4401480|NCT00263211|4228629|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4401481|NCT00263211|4228630|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4401482|NCT00263211|4228628|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4401483|NCT00263211|4228629|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4401484|NCT00263211|4228630|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4401485|NCT00263211|4228628|B3|||Age||years|Mean|55.79|55.79|Standard Deviation|12.97|12.97|||
4401486|NCT00263211|4228629|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|12.06|12.06|||
4401487|NCT00263211|4228630|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|12.01|12.01|||
4401488|NCT00262964|4228647|B3|||plasma insulin level|fasting plasma insulin|mU/L|Mean|17.9|17.9|Standard Deviation|9.6|9.6|||
4401489|NCT00262964|4228648|B2|||plasma insulin level|fasting plasma insulin|mU/L|Mean|21.2|21.2|Standard Deviation|9.9|9.9|||
4401490|NCT00262964|4228649|B1|||plasma insulin level|fasting plasma insulin|mU/L|Mean|11.4|11.4|Standard Deviation|4.5|4.5|||
4401491|NCT00262964|4228647|B3|||plasma glucose level|fasting plasma glucose level|mg/dl|Mean|95.4|95.4|Standard Deviation|7.8|7.8|||
4401492|NCT00262964|4228648|B2|||plasma glucose level|fasting plasma glucose level|mg/dl|Mean|96.0|96.0|Standard Deviation|8.6|8.6|||
4401493|NCT00262964|4228649|B1|||plasma glucose level|fasting plasma glucose level|mg/dl|Mean|94.2|94.2|Standard Deviation|6.0|6.0|||
4401494|NCT00262964|4228647|B3|||fat as percentage of total body composition|fat as percentage of total body composition as characterized using whole body Dual Energy X-ray Absorptiometry (DEXA).|percentage of total body weight|Mean|40.3|40.3|Standard Deviation|6.4|6.4|||
4401495|NCT00262964|4228648|B2|||fat as percentage of total body composition|fat as percentage of total body composition as characterized using whole body Dual Energy X-ray Absorptiometry (DEXA).|percentage of total body weight|Mean|39.3|39.3|Standard Deviation|6.0|6.0|||
4401496|NCT00262964|4228649|B1|||fat as percentage of total body composition|fat as percentage of total body composition as characterized using whole body Dual Energy X-ray Absorptiometry (DEXA).|percentage of total body weight|Mean|42.1|42.1|Standard Deviation|6.9|6.9|||
4401497|NCT00262964|4228647|B3|||Body Weight||kilograms|Mean|102.7|102.7|Standard Deviation|14.4|14.4|||
4401498|NCT00262964|4228648|B2|||Body Weight||kilograms|Mean|104.1|104.1|Standard Deviation|15.6|15.6|||
4401499|NCT00262964|4228649|B1|||Body Weight||kilograms|Mean|99.8|99.8|Standard Deviation|11.6|11.6|||
4401500|NCT00262964|4228647|B3|||Body Mass Index (BMI)||kg/m^2|Mean|36.19|36.19|Standard Deviation|4.57|4.57|||
4401501|NCT00262964|4228648|B2|||Body Mass Index (BMI)||kg/m^2|Mean|36.73|36.73|Standard Deviation|4.66|4.66|||
4401502|NCT00262964|4228649|B1|||Body Mass Index (BMI)||kg/m^2|Mean|35.11|35.11|Standard Deviation|4.33|4.33|||
4401503|NCT00262964|4228647|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4401504|NCT00262964|4228648|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4401505|NCT00262964|4228649|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4401506|NCT00262964|4228647|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4401507|NCT00262964|4228648|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4401508|NCT00262964|4228649|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4401509|NCT00262964|4228647|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4401510|NCT00262964|4228648|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4401511|NCT00262964|4228649|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4401512|NCT00262964|4228647|B3|||Age||years|Mean|42|42.0|Standard Deviation|3|3.0|||
4401513|NCT00262964|4228648|B2|||Age||years|Mean|45|45.0|Standard Deviation|3|3.0|||
4401514|NCT00262964|4228649|B1|||Age||years|Mean|41|41.0|Standard Deviation|3|3.0|||
4401515|NCT00262964|4228647|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4401516|NCT00262964|4228648|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4401517|NCT00262964|4228649|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4401518|NCT00262964|4228647|B3|Between 18 and 65 years||Age, Customized||participants|Number|51|51.0||||||
4401519|NCT00262964|4228648|B2|Between 18 and 65 years||Age, Customized||participants|Number|34|34.0||||||
4401520|NCT00262964|4228649|B1|Between 18 and 65 years||Age, Customized||participants|Number|17|17.0||||||
4401521|NCT00262964|4228647|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4401522|NCT00262964|4228648|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4401523|NCT00262964|4228649|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4401524|NCT00262951|4228682|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4401525|NCT00262951|4228682|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4401526|NCT00262951|4228682|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4401527|NCT00262951|4228682|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|9.01|9.01|||
4401528|NCT00262951|4228682|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4401529|NCT00262951|4228682|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4401530|NCT00262951|4228682|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401531|NCT00262925|4228687|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4401532|NCT00262925|4228687|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4401533|NCT00262925|4228687|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4401534|NCT00262925|4228687|B1|||Age, Customized||years|Median|35|35.0|Full Range|||19.0|68.0|
4401535|NCT00262873|4228693|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4401536|NCT00262873|4228693|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4401537|NCT00262873|4228693|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4401538|NCT00262873|4228693|B1|||Age||years|Mean|69|69.0|Full Range|||51.0|89.0|
4401539|NCT00262873|4228693|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4401540|NCT00262873|4228693|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4401541|NCT00262873|4228693|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401542|NCT00262860|4228704|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4401543|NCT00262860|4228704|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4401544|NCT00262860|4228704|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4401545|NCT00262860|4228704|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4401546|NCT00262860|4228704|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4401547|NCT00262860|4228704|B1|||Age||years|Median|36|36.0|Full Range|||19.0|62.0|
4401548|NCT00262847|4228710|B4|Not graded||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|136|136.0||||||
4401549|NCT00262847|4228711|B3|Not graded||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|48|48.0||||||
4401550|NCT00262847|4228712|B2|Not graded||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|46|46.0||||||
4401551|NCT00262847|4228713|B1|Not graded||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|42|42.0||||||
4401552|NCT00262847|4228710|B4|1||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|82|82.0||||||
4401553|NCT00262847|4228711|B3|1||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|18|18.0||||||
4401554|NCT00262847|4228712|B2|1||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|28|28.0||||||
4401555|NCT00262847|4228713|B1|1||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|36|36.0||||||
4401556|NCT00262847|4228710|B4|2||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|285|285.0||||||
4401557|NCT00262847|4228711|B3|2||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|97|97.0||||||
4401558|NCT00262847|4228712|B2|2||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|86|86.0||||||
4401559|NCT00262847|4228713|B1|2||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|102|102.0||||||
4401673|NCT00262847|4228711|B3|United States||Region of Enrollment||participants|Number|599|599.0||||||
4401560|NCT00262847|4228710|B4|3||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|1370|1370.0||||||
4401561|NCT00262847|4228711|B3|3||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|460|460.0||||||
4401562|NCT00262847|4228712|B2|3||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|465|465.0||||||
4401563|NCT00262847|4228713|B1|3||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.|participants|Number|445|445.0||||||
4401564|NCT00262847|4228710|B4|Other or not specified||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|156|156.0||||||
4401565|NCT00262847|4228711|B3|Other or not specified||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|47|47.0||||||
4401566|NCT00262847|4228712|B2|Other or not specified||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|64|64.0||||||
4401567|NCT00262847|4228713|B1|Other or not specified||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|45|45.0||||||
4401568|NCT00262847|4228710|B4|Mucinous||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|19|19.0||||||
4401569|NCT00262847|4228711|B3|Mucinous||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|8|8.0||||||
4401570|NCT00262847|4228712|B2|Mucinous||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|5|5.0||||||
4401571|NCT00262847|4228713|B1|Mucinous||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|6|6.0||||||
4401572|NCT00262847|4228710|B4|Clear cell||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|55|55.0||||||
4401573|NCT00262847|4228711|B3|Clear cell||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|20|20.0||||||
4401574|NCT00262847|4228712|B2|Clear cell||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|23|23.0||||||
4401575|NCT00262847|4228713|B1|Clear cell||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|12|12.0||||||
4401576|NCT00262847|4228710|B4|Endometrioid||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|59|59.0||||||
4401577|NCT00262847|4228711|B3|Endometrioid||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|24|24.0||||||
4401578|NCT00262847|4228712|B2|Endometrioid||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|14|14.0||||||
4401579|NCT00262847|4228713|B1|Endometrioid||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|21|21.0||||||
4401580|NCT00262847|4228710|B4|Serous adenocarcinoma||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|1584|1584.0||||||
4401581|NCT00262847|4228711|B3|Serous adenocarcinoma||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|524|524.0||||||
4401582|NCT00262847|4228712|B2|Serous adenocarcinoma||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|519|519.0||||||
4401583|NCT00262847|4228713|B1|Serous adenocarcinoma||Histologic Type|Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.|participants|Number|541|541.0||||||
4401584|NCT00262847|4228710|B4|4-distant metastatis||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|482|482.0||||||
4401585|NCT00262847|4228711|B3|4-distant metastatis||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|165|165.0||||||
4401586|NCT00262847|4228712|B2|4-distant metastatis||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|164|164.0||||||
4401587|NCT00262847|4228713|B1|4-distant metastatis||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|153|153.0||||||
4401588|NCT00262847|4228710|B4|3C-disease w/ abdominal implants >2cm, pos nodes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401589|NCT00262847|4228711|B3|3C-disease w/ abdominal implants >2cm, pos nodes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401590|NCT00262847|4228712|B2|3C-disease w/ abdominal implants >2cm, pos nodes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401674|NCT00262847|4228712|B2|United States||Region of Enrollment||participants|Number|596|596.0||||||
4401591|NCT00262847|4228713|B1|3C-disease w/ abdominal implants >2cm, pos nodes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401592|NCT00262847|4228710|B4|3B-disease w/ abdominal implants <2cm, neg nodes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401593|NCT00262847|4228711|B3|3B-disease w/ abdominal implants <2cm, neg nodes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401594|NCT00262847|4228712|B2|3B-disease w/ abdominal implants <2cm, neg nodes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401595|NCT00262847|4228713|B1|3B-disease w/ abdominal implants <2cm, neg nodes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401596|NCT00262847|4228710|B4|3A-disease w/ microscopic implants, negative nodes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401597|NCT00262847|4228711|B3|3A-disease w/ microscopic implants, negative nodes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401598|NCT00262847|4228712|B2|3A-disease w/ microscopic implants, negative nodes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401599|NCT00262847|4228713|B1|3A-disease w/ microscopic implants, negative nodes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401600|NCT00262847|4228710|B4|3-disease w/ implants > 1 cm outside pelvis||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|752|752.0||||||
4401601|NCT00262847|4228711|B3|3-disease w/ implants > 1 cm outside pelvis||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|242|242.0||||||
4401602|NCT00262847|4228712|B2|3-disease w/ implants > 1 cm outside pelvis||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|256|256.0||||||
4401603|NCT00262847|4228713|B1|3-disease w/ implants > 1 cm outside pelvis||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|254|254.0||||||
4401604|NCT00262847|4228710|B4|3-disease w/ macroscopic implants outside pelvis||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|639|639.0||||||
4401605|NCT00262847|4228711|B3|3-disease w/ macroscopic implants outside pelvis||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|216|216.0||||||
4401606|NCT00262847|4228712|B2|3-disease w/ macroscopic implants outside pelvis||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|205|205.0||||||
4401607|NCT00262847|4228713|B1|3-disease w/ macroscopic implants outside pelvis||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|218|218.0||||||
4401608|NCT00262847|4228710|B4|2C-disease with capsules ruptured or ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401609|NCT00262847|4228711|B3|2C-disease with capsules ruptured or ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401610|NCT00262847|4228712|B2|2C-disease with capsules ruptured or ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401611|NCT00262847|4228713|B1|2C-disease with capsules ruptured or ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401612|NCT00262847|4228710|B4|2B-disease with extension to other pelvic tissues||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401613|NCT00262847|4228711|B3|2B-disease with extension to other pelvic tissues||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401614|NCT00262847|4228712|B2|2B-disease with extension to other pelvic tissues||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401675|NCT00262847|4228713|B1|United States||Region of Enrollment||participants|Number|596|596.0||||||
4401615|NCT00262847|4228713|B1|2B-disease with extension to other pelvic tissues||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401616|NCT00262847|4228710|B4|2A-disease with extension to uterus and or tubes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401617|NCT00262847|4228711|B3|2A-disease with extension to uterus and or tubes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401618|NCT00262847|4228712|B2|2A-disease with extension to uterus and or tubes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401619|NCT00262847|4228713|B1|2A-disease with extension to uterus and or tubes||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401620|NCT00262847|4228710|B4|2-disease with pelvic extension||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401621|NCT00262847|4228711|B3|2-disease with pelvic extension||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401622|NCT00262847|4228712|B2|2-disease with pelvic extension||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401623|NCT00262847|4228713|B1|2-disease with pelvic extension||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401624|NCT00262847|4228710|B4|1C-disease with capsules ruptured or ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401625|NCT00262847|4228711|B3|1C-disease with capsules ruptured or ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401626|NCT00262847|4228712|B2|1C-disease with capsules ruptured or ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401627|NCT00262847|4228713|B1|1C-disease with capsules ruptured or ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401628|NCT00262847|4228710|B4|1B-both ovaries involved, no ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401629|NCT00262847|4228711|B3|1B-both ovaries involved, no ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401630|NCT00262847|4228712|B2|1B-both ovaries involved, no ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401631|NCT00262847|4228713|B1|1B-both ovaries involved, no ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401632|NCT00262847|4228710|B4|1A-1 ovary involved, no ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401633|NCT00262847|4228711|B3|1A-1 ovary involved, no ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401634|NCT00262847|4228712|B2|1A-1 ovary involved, no ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401635|NCT00262847|4228713|B1|1A-1 ovary involved, no ascites||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401636|NCT00262847|4228710|B4|1-limited to ovaries||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401637|NCT00262847|4228711|B3|1-limited to ovaries||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401638|NCT00262847|4228712|B2|1-limited to ovaries||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401639|NCT00262847|4228713|B1|1-limited to ovaries||International Federation of Gynecologic and Obstetrics (FIGO) Stage|Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)|participants|Number|0|0.0||||||
4401640|NCT00262847|4228710|B4|4 - completely disabled, no self-care||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|0|0.0||||||
4401641|NCT00262847|4228711|B3|4 - completely disabled, no self-care||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|0|0.0||||||
4401642|NCT00262847|4228712|B2|4 - completely disabled, no self-care||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|0|0.0||||||
4401643|NCT00262847|4228713|B1|4 - completely disabled, no self-care||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|0|0.0||||||
4401644|NCT00262847|4228710|B4|3 - limited self-care, partly confined to bed||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|0|0.0||||||
4401645|NCT00262847|4228711|B3|3 - limited self-care, partly confined to bed||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|0|0.0||||||
4401646|NCT00262847|4228712|B2|3 - limited self-care, partly confined to bed||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|0|0.0||||||
4401647|NCT00262847|4228713|B1|3 - limited self-care, partly confined to bed||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|0|0.0||||||
4401648|NCT00262847|4228710|B4|2 - ambulatory, difficulty walking||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|133|133.0||||||
4401649|NCT00262847|4228711|B3|2 - ambulatory, difficulty walking||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|51|51.0||||||
4401650|NCT00262847|4228712|B2|2 - ambulatory, difficulty walking||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|40|40.0||||||
4401651|NCT00262847|4228713|B1|2 - ambulatory, difficulty walking||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|42|42.0||||||
4401652|NCT00262847|4228710|B4|1 - restricted strenuous activity, ambulatory||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|809|809.0||||||
4401653|NCT00262847|4228711|B3|1 - restricted strenuous activity, ambulatory||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|267|267.0||||||
4401654|NCT00262847|4228712|B2|1 - restricted strenuous activity, ambulatory||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|270|270.0||||||
4401655|NCT00262847|4228713|B1|1 - restricted strenuous activity, ambulatory||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|272|272.0||||||
4401656|NCT00262847|4228710|B4|0 - fully active||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|931|931.0||||||
4401657|NCT00262847|4228711|B3|0 - fully active||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|305|305.0||||||
4401658|NCT00262847|4228712|B2|0 - fully active||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|315|315.0||||||
4401659|NCT00262847|4228713|B1|0 - fully active||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).|participants|Number|311|311.0||||||
4401660|NCT00262847|4228710|B4|Korea, Republic of||Region of Enrollment||participants|Number|28|28.0||||||
4401661|NCT00262847|4228711|B3|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
4401662|NCT00262847|4228712|B2|Korea, Republic of||Region of Enrollment||participants|Number|12|12.0||||||
4401663|NCT00262847|4228713|B1|Korea, Republic of||Region of Enrollment||participants|Number|7|7.0||||||
4401664|NCT00262847|4228710|B4|Japan||Region of Enrollment||participants|Number|45|45.0||||||
4401665|NCT00262847|4228711|B3|Japan||Region of Enrollment||participants|Number|12|12.0||||||
4401666|NCT00262847|4228712|B2|Japan||Region of Enrollment||participants|Number|12|12.0||||||
4401667|NCT00262847|4228713|B1|Japan||Region of Enrollment||participants|Number|21|21.0||||||
4401668|NCT00262847|4228710|B4|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4401669|NCT00262847|4228711|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4401670|NCT00262847|4228712|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4401671|NCT00262847|4228713|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4401672|NCT00262847|4228710|B4|United States||Region of Enrollment||participants|Number|1791|1791.0||||||
4401676|NCT00262847|4228710|B4|Other or unspecified||Race/Ethnicity, Customized||participant|Number|36|36.0||||||
4401677|NCT00262847|4228711|B3|Other or unspecified||Race/Ethnicity, Customized||participant|Number|11|11.0||||||
4401678|NCT00262847|4228712|B2|Other or unspecified||Race/Ethnicity, Customized||participant|Number|13|13.0||||||
4401679|NCT00262847|4228713|B1|Other or unspecified||Race/Ethnicity, Customized||participant|Number|12|12.0||||||
4401680|NCT00262847|4228710|B4|Hispanic||Race/Ethnicity, Customized||participant|Number|74|74.0||||||
4401681|NCT00262847|4228711|B3|Hispanic||Race/Ethnicity, Customized||participant|Number|25|25.0||||||
4401682|NCT00262847|4228712|B2|Hispanic||Race/Ethnicity, Customized||participant|Number|28|28.0||||||
4401683|NCT00262847|4228713|B1|Hispanic||Race/Ethnicity, Customized||participant|Number|21|21.0||||||
4401684|NCT00262847|4228710|B4|Non-Hispanic black||Race/Ethnicity, Customized||participant|Number|80|80.0||||||
4401685|NCT00262847|4228711|B3|Non-Hispanic black||Race/Ethnicity, Customized||participant|Number|27|27.0||||||
4401686|NCT00262847|4228712|B2|Non-Hispanic black||Race/Ethnicity, Customized||participant|Number|28|28.0||||||
4401687|NCT00262847|4228713|B1|Non-Hispanic black||Race/Ethnicity, Customized||participant|Number|25|25.0||||||
4401688|NCT00262847|4228710|B4|Asian||Race/Ethnicity, Customized||participant|Number|117|117.0||||||
4401689|NCT00262847|4228711|B3|Asian||Race/Ethnicity, Customized||participant|Number|39|39.0||||||
4401690|NCT00262847|4228712|B2|Asian||Race/Ethnicity, Customized||participant|Number|37|37.0||||||
4401691|NCT00262847|4228713|B1|Asian||Race/Ethnicity, Customized||participant|Number|41|41.0||||||
4401692|NCT00262847|4228710|B4|Non-Hispanic white||Race/Ethnicity, Customized||participant|Number|1566|1566.0||||||
4401693|NCT00262847|4228711|B3|Non-Hispanic white||Race/Ethnicity, Customized||participant|Number|521|521.0||||||
4401694|NCT00262847|4228712|B2|Non-Hispanic white||Race/Ethnicity, Customized||participant|Number|519|519.0||||||
4401695|NCT00262847|4228713|B1|Non-Hispanic white||Race/Ethnicity, Customized||participant|Number|526|526.0||||||
4401696|NCT00262847|4228710|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4401697|NCT00262847|4228711|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4401698|NCT00262847|4228712|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4401699|NCT00262847|4228713|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4401700|NCT00262847|4228710|B4||Female|Sex: Female, Male||Participants|Count of Participants|1873|1873.0||||||
4401701|NCT00262847|4228711|B3||Female|Sex: Female, Male||Participants|Count of Participants|623|623.0||||||
4401702|NCT00262847|4228712|B2||Female|Sex: Female, Male||Participants|Count of Participants|625|625.0||||||
4401703|NCT00262847|4228713|B1||Female|Sex: Female, Male||Participants|Count of Participants|625|625.0||||||
4401704|NCT00262847|4228710|B4|||Age||years|Mean|59.7|59.7|Standard Deviation|10.6|10.6|||
4401705|NCT00262847|4228711|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|10.6|10.6|||
4401706|NCT00262847|4228712|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|10.3|10.3|||
4401707|NCT00262847|4228713|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|10.9|10.9|||
4401708|NCT00262834|4228732|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4401709|NCT00262834|4228733|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4401710|NCT00262834|4228734|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4401711|NCT00262834|4228732|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4401712|NCT00262834|4228733|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4401713|NCT00262834|4228734|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4401714|NCT00262834|4228732|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4401715|NCT00262834|4228733|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4401716|NCT00262834|4228734|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4401717|NCT00262834|4228732|B3|>18 years||Age, Customized||years|Number|54|54.0||||||
4401718|NCT00262834|4228733|B2|>18 years||Age, Customized||years|Number|29|29.0||||||
4401719|NCT00262834|4228734|B1|>18 years||Age, Customized||years|Number|25|25.0||||||
4401720|NCT00262834|4228732|B3|<=18 years||Age, Customized||years|Number|0|0.0||||||
4401721|NCT00262834|4228733|B2|<=18 years||Age, Customized||years|Number|0|0.0||||||
4401722|NCT00262834|4228734|B1|<=18 years||Age, Customized||years|Number|0|0.0||||||
4401723|NCT00262834|4228732|B3|||Age||years|Median|54|54.0|Full Range|||34.0|79.0|
4401724|NCT00262834|4228733|B2|||Age||years|Median|52|52.0|Full Range|||34.0|79.0|
4401725|NCT00262834|4228734|B1|||Age||years|Median|55|55.0|Full Range|||34.0|71.0|
4401726|NCT00262821|4228746|B3|Other||Cooperative Group Enrollment||participants|Number|4|4.0||||||
4401727|NCT00262821|4228747|B2|Other||Cooperative Group Enrollment||participants|Number|1|1.0||||||
4401728|NCT00262821|4228748|B1|Other||Cooperative Group Enrollment||participants|Number|3|3.0||||||
4401729|NCT00262821|4228746|B3|National Cancer Institute of Canada (NCIC)||Cooperative Group Enrollment||participants|Number|41|41.0||||||
4401730|NCT00262821|4228747|B2|National Cancer Institute of Canada (NCIC)||Cooperative Group Enrollment||participants|Number|17|17.0||||||
4401731|NCT00262821|4228748|B1|National Cancer Institute of Canada (NCIC)||Cooperative Group Enrollment||participants|Number|24|24.0||||||
4401732|NCT00262821|4228746|B3|Gynecologic Oncology Group (GOG)||Cooperative Group Enrollment||participants|Number|334|334.0||||||
4401733|NCT00262821|4228747|B2|Gynecologic Oncology Group (GOG)||Cooperative Group Enrollment||participants|Number|167|167.0||||||
4401734|NCT00262821|4228748|B1|Gynecologic Oncology Group (GOG)||Cooperative Group Enrollment||participants|Number|167|167.0||||||
4401735|NCT00262821|4228746|B3|High-dose rate||Brachytherapy||participants|Number|267|267.0||||||
4401736|NCT00262821|4228747|B2|High-dose rate||Brachytherapy||participants|Number|129|129.0||||||
4401737|NCT00262821|4228748|B1|High-dose rate||Brachytherapy||participants|Number|138|138.0||||||
4401738|NCT00262821|4228746|B3|Low-dose rate||Brachytherapy||participants|Number|103|103.0||||||
4401739|NCT00262821|4228747|B2|Low-dose rate||Brachytherapy||participants|Number|51|51.0||||||
4401740|NCT00262821|4228748|B1|Low-dose rate||Brachytherapy||participants|Number|52|52.0||||||
4401741|NCT00262821|4228746|B3|None||Brachytherapy||participants|Number|9|9.0||||||
4401742|NCT00262821|4228747|B2|None||Brachytherapy||participants|Number|5|5.0||||||
4401743|NCT00262821|4228748|B1|None||Brachytherapy||participants|Number|4|4.0||||||
4401744|NCT00262821|4228746|B3|Sampled||Para-aortic Lymph Node||participants|Number|321|321.0||||||
4401745|NCT00262821|4228747|B2|Sampled||Para-aortic Lymph Node||participants|Number|152|152.0||||||
4401746|NCT00262821|4228748|B1|Sampled||Para-aortic Lymph Node||participants|Number|169|169.0||||||
4401747|NCT00262821|4228746|B3|Not sampled||Para-aortic Lymph Node||participants|Number|58|58.0||||||
4401748|NCT00262821|4228747|B2|Not sampled||Para-aortic Lymph Node||participants|Number|33|33.0||||||
4401749|NCT00262821|4228748|B1|Not sampled||Para-aortic Lymph Node||participants|Number|25|25.0||||||
4401750|NCT00262821|4228746|B3|Other||Histologic Type|Histologic (cell) type was obtained from the central GOG Pathology Committee review|participants|Number|8|8.0||||||
4401751|NCT00262821|4228747|B2|Other||Histologic Type|Histologic (cell) type was obtained from the central GOG Pathology Committee review|participants|Number|4|4.0||||||
4401752|NCT00262821|4228748|B1|Other||Histologic Type|Histologic (cell) type was obtained from the central GOG Pathology Committee review|participants|Number|4|4.0||||||
4401753|NCT00262821|4228746|B3|Adenosquamous carcinoma||Histologic Type|Histologic (cell) type was obtained from the central GOG Pathology Committee review|participants|Number|16|16.0||||||
4401754|NCT00262821|4228747|B2|Adenosquamous carcinoma||Histologic Type|Histologic (cell) type was obtained from the central GOG Pathology Committee review|participants|Number|5|5.0||||||
4401755|NCT00262821|4228748|B1|Adenosquamous carcinoma||Histologic Type|Histologic (cell) type was obtained from the central GOG Pathology Committee review|participants|Number|11|11.0||||||
4401756|NCT00262821|4228746|B3|Adenocarcinoma, unspecified||Histologic Type|Histologic (cell) type was obtained from the central GOG Pathology Committee review|participants|Number|33|33.0||||||
4401757|NCT00262821|4228747|B2|Adenocarcinoma, unspecified||Histologic Type|Histologic (cell) type was obtained from the central GOG Pathology Committee review|participants|Number|18|18.0||||||
4401758|NCT00262821|4228748|B1|Adenocarcinoma, unspecified||Histologic Type|Histologic (cell) type was obtained from the central GOG Pathology Committee review|participants|Number|15|15.0||||||
4401759|NCT00262821|4228746|B3|Squamous cell carcinoma||Histologic Type|Histologic (cell) type was obtained from the central GOG Pathology Committee review|participants|Number|322|322.0||||||
4401760|NCT00262821|4228747|B2|Squamous cell carcinoma||Histologic Type|Histologic (cell) type was obtained from the central GOG Pathology Committee review|participants|Number|158|158.0||||||
4401761|NCT00262821|4228748|B1|Squamous cell carcinoma||Histologic Type|Histologic (cell) type was obtained from the central GOG Pathology Committee review|participants|Number|164|164.0||||||
4401762|NCT00262821|4228746|B3|IVA||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|13|13.0||||||
4401763|NCT00262821|4228747|B2|IVA||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|7|7.0||||||
4401764|NCT00262821|4228748|B1|IVA||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|6|6.0||||||
4401765|NCT00262821|4228746|B3|IIIB||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|103|103.0||||||
4401766|NCT00262821|4228747|B2|IIIB||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|52|52.0||||||
4401767|NCT00262821|4228748|B1|IIIB||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|51|51.0||||||
4401768|NCT00262821|4228746|B3|IIB||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|175|175.0||||||
4401769|NCT00262821|4228747|B2|IIB||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|82|82.0||||||
4401770|NCT00262821|4228748|B1|IIB||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|93|93.0||||||
4401771|NCT00262821|4228746|B3|IIA||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|23|23.0||||||
4401772|NCT00262821|4228747|B2|IIA||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|12|12.0||||||
4401773|NCT00262821|4228748|B1|IIA||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|11|11.0||||||
4401774|NCT00262821|4228746|B3|IB||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|65|65.0||||||
4401775|NCT00262821|4228747|B2|IB||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|32|32.0||||||
4401776|NCT00262821|4228748|B1|IB||International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcin|International Federation of Gynecologic and Obstetrics (FIGO), Clinical Staging, for Cervical Carcinoma (1995). Stage IB is defined as clinical lesions confined to the cervix or pre-clinical lesions greater than stage 1A. Stage IIA is defined as the carcinoma extends beyond the cervix but has not extended on to the pelvic wall with no obvious parametrial involvement. Stage IIB has obvious parametrial involvement. Stage IIIB includes extension on to the pelvic wall and/or hydro-nephrosis or non-functioning kidney. Stage IVA is the spread of the growth to adjacent organs.|participants|Number|33|33.0||||||
4401777|NCT00262821|4228746|B3|Not graded||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review|participants|Number|6|6.0||||||
4401818|NCT00262821|4228748|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4401778|NCT00262821|4228747|B2|Not graded||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review|participants|Number|3|3.0||||||
4401779|NCT00262821|4228748|B1|Not graded||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review|participants|Number|3|3.0||||||
4401780|NCT00262821|4228746|B3|3 – Poorly differentiated||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review|participants|Number|145|145.0||||||
4401781|NCT00262821|4228747|B2|3 – Poorly differentiated||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review|participants|Number|67|67.0||||||
4401782|NCT00262821|4228748|B1|3 – Poorly differentiated||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review|participants|Number|78|78.0||||||
4401783|NCT00262821|4228746|B3|2 – Moderately differentiated||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review|participants|Number|208|208.0||||||
4401784|NCT00262821|4228747|B2|2 – Moderately differentiated||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review|participants|Number|103|103.0||||||
4401785|NCT00262821|4228748|B1|2 – Moderately differentiated||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review|participants|Number|105|105.0||||||
4401786|NCT00262821|4228746|B3|1 – Well differentiated||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review|participants|Number|20|20.0||||||
4401787|NCT00262821|4228747|B2|1 – Well differentiated||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review|participants|Number|12|12.0||||||
4401788|NCT00262821|4228748|B1|1 – Well differentiated||Tumor Grade|Tumor grade was obtained from the central GOG Pathology Committee review|participants|Number|8|8.0||||||
4401789|NCT00262821|4228746|B3|4 – completely disabled, no self-care||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|0|0.0||||||
4401790|NCT00262821|4228747|B2|4 – completely disabled, no self-care||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|0|0.0||||||
4401791|NCT00262821|4228748|B1|4 – completely disabled, no self-care||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|0|0.0||||||
4401792|NCT00262821|4228746|B3|3 – limited self-care, partly confined to bed||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|1|1.0||||||
4401793|NCT00262821|4228747|B2|3 – limited self-care, partly confined to bed||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|1|1.0||||||
4401794|NCT00262821|4228748|B1|3 – limited self-care, partly confined to bed||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|0|0.0||||||
4401795|NCT00262821|4228746|B3|2 – ambulatory, difficulty walking||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|3|3.0||||||
4401796|NCT00262821|4228747|B2|2 – ambulatory, difficulty walking||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|2|2.0||||||
4401797|NCT00262821|4228748|B1|2 – ambulatory, difficulty walking||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|1|1.0||||||
4401798|NCT00262821|4228746|B3|1 – restricted strenuous activity, ambulatory||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|87|87.0||||||
4401799|NCT00262821|4228747|B2|1 – restricted strenuous activity, ambulatory||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|41|41.0||||||
4401800|NCT00262821|4228748|B1|1 – restricted strenuous activity, ambulatory||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|46|46.0||||||
4401801|NCT00262821|4228746|B3|0 – fully active||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|288|288.0||||||
4401802|NCT00262821|4228747|B2|0 – fully active||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|141|141.0||||||
4401803|NCT00262821|4228748|B1|0 – fully active||Gynecologic Oncology Group (GOG) Performance Status|5-point, ordinal scale specifying patient's ability to perform activities|participants|Number|147|147.0||||||
4401804|NCT00262821|4228746|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4401805|NCT00262821|4228747|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4401806|NCT00262821|4228748|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4401807|NCT00262821|4228746|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4401808|NCT00262821|4228747|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4401809|NCT00262821|4228748|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4401810|NCT00262821|4228746|B3||White|Race (NIH/OMB)||Participants|Count of Participants|263|263.0||||||
4401811|NCT00262821|4228747|B2||White|Race (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4401812|NCT00262821|4228748|B1||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4401813|NCT00262821|4228746|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4401814|NCT00262821|4228747|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4401815|NCT00262821|4228748|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4401816|NCT00262821|4228746|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4401817|NCT00262821|4228747|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4401819|NCT00262821|4228746|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4401820|NCT00262821|4228747|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4401821|NCT00262821|4228748|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4401822|NCT00262821|4228746|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4401823|NCT00262821|4228747|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4401824|NCT00262821|4228748|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4401825|NCT00262821|4228746|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4401826|NCT00262821|4228747|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4401827|NCT00262821|4228748|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4401828|NCT00262821|4228746|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|299|299.0||||||
4401829|NCT00262821|4228747|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4401830|NCT00262821|4228748|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
4401831|NCT00262821|4228746|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4401832|NCT00262821|4228747|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4401833|NCT00262821|4228748|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4401834|NCT00262821|4228746|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4401835|NCT00262821|4228747|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4401836|NCT00262821|4228748|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4401837|NCT00262821|4228746|B3||Female|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4401838|NCT00262821|4228747|B2||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4401839|NCT00262821|4228748|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4401840|NCT00262821|4228746|B3|71-79 years||Age, Customized||participants|Number|14|14.0||||||
4401841|NCT00262821|4228747|B2|71-79 years||Age, Customized||participants|Number|6|6.0||||||
4401842|NCT00262821|4228748|B1|71-79 years||Age, Customized||participants|Number|8|8.0||||||
4401843|NCT00262821|4228746|B3|61-70 years||Age, Customized||participants|Number|43|43.0||||||
4401844|NCT00262821|4228747|B2|61-70 years||Age, Customized||participants|Number|23|23.0||||||
4401845|NCT00262821|4228748|B1|61-70 years||Age, Customized||participants|Number|20|20.0||||||
4401846|NCT00262821|4228746|B3|51-60 years||Age, Customized||participants|Number|101|101.0||||||
4401847|NCT00262821|4228747|B2|51-60 years||Age, Customized||participants|Number|48|48.0||||||
4401848|NCT00262821|4228748|B1|51-60 years||Age, Customized||participants|Number|53|53.0||||||
4401849|NCT00262821|4228746|B3|41-50 years||Age, Customized||participants|Number|126|126.0||||||
4401850|NCT00262821|4228747|B2|41-50 years||Age, Customized||participants|Number|61|61.0||||||
4401851|NCT00262821|4228748|B1|41-50 years||Age, Customized||participants|Number|65|65.0||||||
4401852|NCT00262821|4228746|B3|31-40 years||Age, Customized||participants|Number|78|78.0||||||
4401853|NCT00262821|4228747|B2|31-40 years||Age, Customized||participants|Number|37|37.0||||||
4401854|NCT00262821|4228748|B1|31-40 years||Age, Customized||participants|Number|41|41.0||||||
4401855|NCT00262821|4228746|B3|20-30 years||Age, Customized||participants|Number|17|17.0||||||
4401856|NCT00262821|4228747|B2|20-30 years||Age, Customized||participants|Number|10|10.0||||||
4401857|NCT00262821|4228748|B1|20-30 years||Age, Customized||participants|Number|7|7.0||||||
4401858|NCT00262821|4228746|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|11.3|11.3|||
4401859|NCT00262821|4228747|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|11.3|11.3|||
4401860|NCT00262821|4228748|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|11.3|11.3|||
4401861|NCT00262743|4228759|B3|Unavailable||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|11|11.0||||||
4401862|NCT00262743|4228760|B2|Unavailable||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|9|9.0||||||
4401863|NCT00262743|4228761|B1|Unavailable||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|2|2.0||||||
4401864|NCT00262743|4228759|B3|Mutated (>2%)||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|45|45.0||||||
4401865|NCT00262743|4228760|B2|Mutated (>2%)||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|27|27.0||||||
4401914|NCT00262743|4228761|B1|1400 mg||Dose Level of Polyphenon E||participants|Number|3|3.0||||||
4401915|NCT00262743|4228759|B3|1200 mg||Dose Level of Polyphenon E||participants|Number|6|6.0||||||
4401916|NCT00262743|4228760|B2|1200 mg||Dose Level of Polyphenon E||participants|Number|0|0.0||||||
4401866|NCT00262743|4228761|B1|Mutated (>2%)||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|18|18.0||||||
4401867|NCT00262743|4228759|B3|Unmutated (<=2%)||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|13|13.0||||||
4401868|NCT00262743|4228760|B2|Unmutated (<=2%)||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|6|6.0||||||
4401869|NCT00262743|4228761|B1|Unmutated (<=2%)||Immunoglobulin Variable Heavy Chain (IGVH) Mutation Status|IGVH testing helps predict which patients will experience a more aggressive (if the gene is unmutated, <=2%) or less aggressive (if the gene is mutated, >2%) course of CLL. This technically complex test is only available at select medical institutions.|participants|Number|7|7.0||||||
4401870|NCT00262743|4228759|B3|Negative (<30%)||CD38 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive CD38 (>=30%) tend to experience a more aggressive course of CLL.|participants|Number|58|58.0||||||
4401871|NCT00262743|4228760|B2|Negative (<30%)||CD38 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive CD38 (>=30%) tend to experience a more aggressive course of CLL.|participants|Number|35|35.0||||||
4401872|NCT00262743|4228761|B1|Negative (<30%)||CD38 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive CD38 (>=30%) tend to experience a more aggressive course of CLL.|participants|Number|23|23.0||||||
4401873|NCT00262743|4228759|B3|Positive (>=30%)||CD38 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive CD38 (>=30%) tend to experience a more aggressive course of CLL.|participants|Number|11|11.0||||||
4401874|NCT00262743|4228760|B2|Positive (>=30%)||CD38 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive CD38 (>=30%) tend to experience a more aggressive course of CLL.|participants|Number|7|7.0||||||
4401875|NCT00262743|4228761|B1|Positive (>=30%)||CD38 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive CD38 (>=30%) tend to experience a more aggressive course of CLL.|participants|Number|4|4.0||||||
4401876|NCT00262743|4228759|B3|Negative (<20%)||ZAP-70 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive ZAP-70 (>=20%) tend to experience a more aggressive course of CLL.|participants|Number|51|51.0||||||
4401877|NCT00262743|4228760|B2|Negative (<20%)||ZAP-70 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive ZAP-70 (>=20%) tend to experience a more aggressive course of CLL.|participants|Number|30|30.0||||||
4401878|NCT00262743|4228761|B1|Negative (<20%)||ZAP-70 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive ZAP-70 (>=20%) tend to experience a more aggressive course of CLL.|participants|Number|21|21.0||||||
4401879|NCT00262743|4228759|B3|Positive (>=20%)||ZAP-70 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive ZAP-70 (>=20%) tend to experience a more aggressive course of CLL.|participants|Number|18|18.0||||||
4401880|NCT00262743|4228760|B2|Positive (>=20%)||ZAP-70 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive ZAP-70 (>=20%) tend to experience a more aggressive course of CLL.|participants|Number|12|12.0||||||
4401881|NCT00262743|4228761|B1|Positive (>=20%)||ZAP-70 Status|This test is used to predict the rate of progression from diagnosis to need for treatment in CLL. Participants with positive ZAP-70 (>=20%) tend to experience a more aggressive course of CLL.|participants|Number|6|6.0||||||
4401882|NCT00262743|4228759|B3|Stage II||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly"|participants|Number|9|9.0||||||
4401883|NCT00262743|4228760|B2|Stage II||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly"|participants|Number|5|5.0||||||
4401884|NCT00262743|4228761|B1|Stage II||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly"|participants|Number|4|4.0||||||
4401885|NCT00262743|4228759|B3|Stage I||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly"|participants|Number|32|32.0||||||
4401886|NCT00262743|4228760|B2|Stage I||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly"|participants|Number|24|24.0||||||
4401887|NCT00262743|4228761|B1|Stage I||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly"|participants|Number|8|8.0||||||
4401917|NCT00262743|4228761|B1|1200 mg||Dose Level of Polyphenon E||participants|Number|6|6.0||||||
4401888|NCT00262743|4228759|B3|Stage 0||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly"|participants|Number|28|28.0||||||
4401889|NCT00262743|4228760|B2|Stage 0||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly"|participants|Number|13|13.0||||||
4401890|NCT00262743|4228761|B1|Stage 0||Rai Stage|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly"|participants|Number|15|15.0||||||
4401891|NCT00262743|4228759|B3|deletion (11q23)||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|1|1.0||||||
4401892|NCT00262743|4228760|B2|deletion (11q23)||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|1|1.0||||||
4401893|NCT00262743|4228761|B1|deletion (11q23)||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|0|0.0||||||
4401894|NCT00262743|4228759|B3|Trisomy 12||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|8|8.0||||||
4401895|NCT00262743|4228760|B2|Trisomy 12||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|4|4.0||||||
4401896|NCT00262743|4228761|B1|Trisomy 12||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|4|4.0||||||
4401897|NCT00262743|4228759|B3|deletion (13q14.2)||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|44|44.0||||||
4401898|NCT00262743|4228760|B2|deletion (13q14.2)||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|27|27.0||||||
4401899|NCT00262743|4228761|B1|deletion (13q14.2)||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|17|17.0||||||
4401900|NCT00262743|4228759|B3|Normal||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|16|16.0||||||
4401901|NCT00262743|4228760|B2|Normal||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|10|10.0||||||
4401902|NCT00262743|4228761|B1|Normal||Fluorescence In Situ Hybridization (FISH) Abnormalities|This test determines the presence of abnormalities in specific chromosomes of CLL cells, which are associated with more or less aggressive forms of cancer. Patients with abnormalities of chromosome 11 (deletion 11q23) and 17 (deletion 17p13) experience rapid progression of their CLL.|participants|Number|6|6.0||||||
4401903|NCT00262743|4228759|B3|2000 mg||Dose Level of Polyphenon E||participants|Number|42|42.0||||||
4401904|NCT00262743|4228760|B2|2000 mg||Dose Level of Polyphenon E||participants|Number|42|42.0||||||
4401905|NCT00262743|4228761|B1|2000 mg||Dose Level of Polyphenon E||participants|Number|0|0.0||||||
4401906|NCT00262743|4228759|B3|1800 mg||Dose Level of Polyphenon E||participants|Number|3|3.0||||||
4401907|NCT00262743|4228760|B2|1800 mg||Dose Level of Polyphenon E||participants|Number|0|0.0||||||
4401908|NCT00262743|4228761|B1|1800 mg||Dose Level of Polyphenon E||participants|Number|3|3.0||||||
4401909|NCT00262743|4228759|B3|1600 mg||Dose Level of Polyphenon E||participants|Number|3|3.0||||||
4401910|NCT00262743|4228760|B2|1600 mg||Dose Level of Polyphenon E||participants|Number|0|0.0||||||
4401911|NCT00262743|4228761|B1|1600 mg||Dose Level of Polyphenon E||participants|Number|3|3.0||||||
4401912|NCT00262743|4228759|B3|1400 mg||Dose Level of Polyphenon E||participants|Number|3|3.0||||||
4401913|NCT00262743|4228760|B2|1400 mg||Dose Level of Polyphenon E||participants|Number|0|0.0||||||
4401918|NCT00262743|4228759|B3|1000 mg||Dose Level of Polyphenon E||participants|Number|3|3.0||||||
4401919|NCT00262743|4228760|B2|1000 mg||Dose Level of Polyphenon E||participants|Number|0|0.0||||||
4401920|NCT00262743|4228761|B1|1000 mg||Dose Level of Polyphenon E||participants|Number|3|3.0||||||
4401921|NCT00262743|4228759|B3|800 mg||Dose Level of Polyphenon E||participants|Number|6|6.0||||||
4401922|NCT00262743|4228760|B2|800 mg||Dose Level of Polyphenon E||participants|Number|0|0.0||||||
4401923|NCT00262743|4228761|B1|800 mg||Dose Level of Polyphenon E||participants|Number|6|6.0||||||
4401924|NCT00262743|4228759|B3|400 mg||Dose Level of Polyphenon E||participants|Number|3|3.0||||||
4401925|NCT00262743|4228760|B2|400 mg||Dose Level of Polyphenon E||participants|Number|0|0.0||||||
4401926|NCT00262743|4228761|B1|400 mg||Dose Level of Polyphenon E||participants|Number|3|3.0||||||
4401927|NCT00262743|4228759|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4401928|NCT00262743|4228760|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4401929|NCT00262743|4228761|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4401930|NCT00262743|4228759|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4401931|NCT00262743|4228760|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4401932|NCT00262743|4228761|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4401933|NCT00262743|4228759|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4401934|NCT00262743|4228760|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4401935|NCT00262743|4228761|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4401936|NCT00262743|4228759|B3|||Age||years|Median|60|60.0|Full Range|||41.0|78.0|
4401937|NCT00262743|4228760|B2|||Age||years|Median|60|60.0|Full Range|||41.0|78.0|
4401938|NCT00262743|4228761|B1|||Age||years|Median|62|62.0|Full Range|||44.0|76.0|
4401939|NCT00262730|4228769|B1|Other||Histologic Diagnosis||Patient|Number|2|2.0||||||
4401940|NCT00262730|4228769|B1|Anaplastic Astrocytoma||Histologic Diagnosis||Patient|Number|1|1.0||||||
4401941|NCT00262730|4228769|B1|Glioblastoma||Histologic Diagnosis||Patient|Number|94|94.0||||||
4401942|NCT00262730|4228769|B1|Missing Data||Corticosteroid Therapy||Participant|Number|1|1.0||||||
4401943|NCT00262730|4228769|B1|No||Corticosteroid Therapy||Participant|Number|26|26.0||||||
4401944|NCT00262730|4228769|B1|Yes||Corticosteroid Therapy||Participant|Number|70|70.0||||||
4401945|NCT00262730|4228769|B1|Less than or equal 26||Baseline Mini-Mental State Examiniation (MMSE) Score|The mini–mental state examination (MMSE) is a 30-point questionnaire test used to screen for cognitive impairment. Commonly used to screen for dementia. It is also used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time. The MMSE test includes simple questions and problems in a number of areas: the time and place of the test, repeating lists of words, arithmetic such as the serial sevens, language use and comprehension, and basic motor skills. The Higher your score, the higher your function.|Scores on a Scale|Number|11|11.0||||||
4401946|NCT00262730|4228769|B1|27-29||Baseline Mini-Mental State Examiniation (MMSE) Score|The mini–mental state examination (MMSE) is a 30-point questionnaire test used to screen for cognitive impairment. Commonly used to screen for dementia. It is also used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time. The MMSE test includes simple questions and problems in a number of areas: the time and place of the test, repeating lists of words, arithmetic such as the serial sevens, language use and comprehension, and basic motor skills. The Higher your score, the higher your function.|Scores on a Scale|Number|30|30.0||||||
4401947|NCT00262730|4228769|B1|30||Baseline Mini-Mental State Examiniation (MMSE) Score|The mini–mental state examination (MMSE) is a 30-point questionnaire test used to screen for cognitive impairment. Commonly used to screen for dementia. It is also used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time. The MMSE test includes simple questions and problems in a number of areas: the time and place of the test, repeating lists of words, arithmetic such as the serial sevens, language use and comprehension, and basic motor skills. The Higher your score, the higher your function.|Scores on a Scale|Number|56|56.0||||||
4401948|NCT00262730|4228769|B1|||time from diagnosis to radiotherapy||weeks|Median|4.4|4.4|Full Range|||2.0|12.6|
4401949|NCT00262730|4228769|B1|Craniotomy||Extent of surgery||Patient|Number|79|79.0||||||
4401950|NCT00262730|4228769|B1|Biopsy||Extent of surgery||Patient|Number|18|18.0||||||
4401951|NCT00262730|4228769|B1|60||Karnofsky Performance Status|100 normal no complaints no disease 90 capable of normal activity few symptoms/disease 80 normal activity with some difficulty some symptoms or signs 70 caring for self not capable of normal activity or work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care and help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures or treatment 10 moribund rapidly progressive fatal disease processes 0 death|Units on a scale|Number|3|3.0||||||
4401952|NCT00262730|4228769|B1|70||Karnofsky Performance Status|100 normal no complaints no disease 90 capable of normal activity few symptoms/disease 80 normal activity with some difficulty some symptoms or signs 70 caring for self not capable of normal activity or work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care and help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures or treatment 10 moribund rapidly progressive fatal disease processes 0 death|Units on a scale|Number|3|3.0||||||
4401953|NCT00262730|4228769|B1|80||Karnofsky Performance Status|100 normal no complaints no disease 90 capable of normal activity few symptoms/disease 80 normal activity with some difficulty some symptoms or signs 70 caring for self not capable of normal activity or work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care and help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures or treatment 10 moribund rapidly progressive fatal disease processes 0 death|Units on a scale|Number|12|12.0||||||
4401954|NCT00262730|4228769|B1|90||Karnofsky Performance Status|100 normal no complaints no disease 90 capable of normal activity few symptoms/disease 80 normal activity with some difficulty some symptoms or signs 70 caring for self not capable of normal activity or work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care and help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures or treatment 10 moribund rapidly progressive fatal disease processes 0 death|Units on a scale|Number|45|45.0||||||
4401955|NCT00262730|4228769|B1|100||Karnofsky Performance Status|100 normal no complaints no disease 90 capable of normal activity few symptoms/disease 80 normal activity with some difficulty some symptoms or signs 70 caring for self not capable of normal activity or work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care and help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures or treatment 10 moribund rapidly progressive fatal disease processes 0 death|Units on a scale|Number|34|34.0||||||
4401956|NCT00262730|4228769|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4401957|NCT00262730|4228769|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4401958|NCT00262730|4228769|B1|||Age||years|Median|56.6|56.6|Full Range|||21.0|85.0|
4401959|NCT00262639|4228773|B5|United States||Region of Enrollment||participants|Number|60|60.0||||||
4401960|NCT00262639|4228774|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4401961|NCT00262639|4228775|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4401962|NCT00262639|4228776|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4401963|NCT00262639|4228777|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4401964|NCT00262639|4228773|B5||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4401965|NCT00262639|4228774|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4401966|NCT00262639|4228775|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4401967|NCT00262639|4228776|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4401968|NCT00262639|4228777|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4401969|NCT00262639|4228773|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4401970|NCT00262639|4228774|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4401971|NCT00262639|4228775|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4401972|NCT00262639|4228776|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4401973|NCT00262639|4228777|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4401974|NCT00262639|4228773|B5|||Age||years|Mean|46.1|46.1|Standard Deviation|10.6|10.6|||
4401975|NCT00262639|4228774|B4|||Age||years|Mean|46.7|46.7|Standard Deviation|5.6|5.6|||
4401976|NCT00262639|4228775|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|8.5|8.5|||
4401977|NCT00262639|4228776|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|11.9|11.9|||
4401978|NCT00262639|4228777|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|11.2|11.2|||
4401979|NCT00262639|4228773|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4401980|NCT00262639|4228774|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4401981|NCT00262639|4228775|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4401982|NCT00262639|4228776|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4401983|NCT00262639|4228777|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4401984|NCT00262639|4228773|B5||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4401985|NCT00262639|4228774|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4401986|NCT00262639|4228775|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4401987|NCT00262639|4228776|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4401988|NCT00262639|4228777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4401989|NCT00262639|4228773|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401990|NCT00262639|4228774|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401991|NCT00262639|4228775|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401992|NCT00262639|4228776|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401993|NCT00262639|4228777|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4401994|NCT00262600|4228794|B4|Missing||Regular Alcohol Consumption||participants|Number|3|3.0||||||
4401995|NCT00262600|4228795|B3|Missing||Regular Alcohol Consumption||participants|Number|1|1.0||||||
4401996|NCT00262600|4228796|B2|Missing||Regular Alcohol Consumption||participants|Number|0|0.0||||||
4401997|NCT00262600|4228797|B1|Missing||Regular Alcohol Consumption||participants|Number|2|2.0||||||
4401998|NCT00262600|4228794|B4|Yes||Regular Alcohol Consumption||participants|Number|5976|5976.0||||||
4401999|NCT00262600|4228795|B3|Yes||Regular Alcohol Consumption||participants|Number|1981|1981.0||||||
4402000|NCT00262600|4228796|B2|Yes||Regular Alcohol Consumption||participants|Number|1999|1999.0||||||
4402001|NCT00262600|4228797|B1|Yes||Regular Alcohol Consumption||participants|Number|1996|1996.0||||||
4402002|NCT00262600|4228794|B4|No||Regular Alcohol Consumption||participants|Number|12134|12134.0||||||
4402003|NCT00262600|4228795|B3|No||Regular Alcohol Consumption||participants|Number|4040|4040.0||||||
4402004|NCT00262600|4228796|B2|No||Regular Alcohol Consumption||participants|Number|4077|4077.0||||||
4402005|NCT00262600|4228797|B1|No||Regular Alcohol Consumption||participants|Number|4017|4017.0||||||
4402006|NCT00262600|4228794|B4|Missing||Smoking history||participants|Number|2|2.0||||||
4402007|NCT00262600|4228795|B3|Missing||Smoking history||participants|Number|1|1.0||||||
4402008|NCT00262600|4228796|B2|Missing||Smoking history||participants|Number|0|0.0||||||
4402009|NCT00262600|4228797|B1|Missing||Smoking history||participants|Number|1|1.0||||||
4402010|NCT00262600|4228794|B4|Ex-smoker||Smoking history||participants|Number|7836|7836.0||||||
4402011|NCT00262600|4228795|B3|Ex-smoker||Smoking history||participants|Number|2567|2567.0||||||
4402012|NCT00262600|4228796|B2|Ex-smoker||Smoking history||participants|Number|2636|2636.0||||||
4402013|NCT00262600|4228797|B1|Ex-smoker||Smoking history||participants|Number|2633|2633.0||||||
4402014|NCT00262600|4228794|B4|Smoker||Smoking history||participants|Number|1335|1335.0||||||
4402015|NCT00262600|4228795|B3|Smoker||Smoking history||participants|Number|448|448.0||||||
4402016|NCT00262600|4228796|B2|Smoker||Smoking history||participants|Number|447|447.0||||||
4402017|NCT00262600|4228797|B1|Smoker||Smoking history||participants|Number|440|440.0||||||
4402018|NCT00262600|4228794|B4|Non-smoker||Smoking history||participants|Number|8940|8940.0||||||
4402019|NCT00262600|4228795|B3|Non-smoker||Smoking history||participants|Number|3006|3006.0||||||
4402020|NCT00262600|4228796|B2|Non-smoker||Smoking history||participants|Number|2993|2993.0||||||
4402021|NCT00262600|4228797|B1|Non-smoker||Smoking history||participants|Number|2941|2941.0||||||
4402022|NCT00262600|4228794|B4|Other||Region of Enrollment||participants|Number|1072|1072.0||||||
4402023|NCT00262600|4228795|B3|Other||Region of Enrollment||participants|Number|355|355.0||||||
4402024|NCT00262600|4228796|B2|Other||Region of Enrollment||participants|Number|362|362.0||||||
4402025|NCT00262600|4228797|B1|Other||Region of Enrollment||participants|Number|355|355.0||||||
4402026|NCT00262600|4228794|B4|Asia||Region of Enrollment||participants|Number|2782|2782.0||||||
4402027|NCT00262600|4228795|B3|Asia||Region of Enrollment||participants|Number|926|926.0||||||
4402028|NCT00262600|4228796|B2|Asia||Region of Enrollment||participants|Number|933|933.0||||||
4402029|NCT00262600|4228797|B1|Asia||Region of Enrollment||participants|Number|923|923.0||||||
4402030|NCT00262600|4228794|B4|Latin America||Region of Enrollment||participants|Number|956|956.0||||||
4402031|NCT00262600|4228795|B3|Latin America||Region of Enrollment||participants|Number|316|316.0||||||
4402032|NCT00262600|4228796|B2|Latin America||Region of Enrollment||participants|Number|320|320.0||||||
4402033|NCT00262600|4228797|B1|Latin America||Region of Enrollment||participants|Number|320|320.0||||||
4402034|NCT00262600|4228794|B4|Western Europe||Region of Enrollment||participants|Number|4651|4651.0||||||
4402035|NCT00262600|4228795|B3|Western Europe||Region of Enrollment||participants|Number|1552|1552.0||||||
4402036|NCT00262600|4228796|B2|Western Europe||Region of Enrollment||participants|Number|1555|1555.0||||||
4402037|NCT00262600|4228797|B1|Western Europe||Region of Enrollment||participants|Number|1544|1544.0||||||
4402038|NCT00262600|4228794|B4|Central Europe||Region of Enrollment||participants|Number|2119|2119.0||||||
4402039|NCT00262600|4228795|B3|Central Europe||Region of Enrollment||participants|Number|706|706.0||||||
4402040|NCT00262600|4228796|B2|Central Europe||Region of Enrollment||participants|Number|706|706.0||||||
4402041|NCT00262600|4228797|B1|Central Europe||Region of Enrollment||participants|Number|707|707.0||||||
4402042|NCT00262600|4228794|B4|USA, Canada||Region of Enrollment||participants|Number|6533|6533.0||||||
4402043|NCT00262600|4228795|B3|USA, Canada||Region of Enrollment||participants|Number|2167|2167.0||||||
4402044|NCT00262600|4228796|B2|USA, Canada||Region of Enrollment||participants|Number|2200|2200.0||||||
4402045|NCT00262600|4228797|B1|USA, Canada||Region of Enrollment||participants|Number|2166|2166.0||||||
4402046|NCT00262600|4228794|B4|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4402047|NCT00262600|4228795|B3|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4402048|NCT00262600|4228796|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4402049|NCT00262600|4228797|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4402050|NCT00262600|4228794|B4|Other||Race/Ethnicity, Customized||participants|Number|2382|2382.0||||||
4402051|NCT00262600|4228795|B3|Other||Race/Ethnicity, Customized||participants|Number|797|797.0||||||
4402052|NCT00262600|4228796|B2|Other||Race/Ethnicity, Customized||participants|Number|786|786.0||||||
4402053|NCT00262600|4228797|B1|Other||Race/Ethnicity, Customized||participants|Number|799|799.0||||||
4402054|NCT00262600|4228794|B4|Asian||Race/Ethnicity, Customized||participants|Number|2875|2875.0||||||
4402055|NCT00262600|4228795|B3|Asian||Race/Ethnicity, Customized||participants|Number|955|955.0||||||
4402056|NCT00262600|4228796|B2|Asian||Race/Ethnicity, Customized||participants|Number|965|965.0||||||
4402057|NCT00262600|4228797|B1|Asian||Race/Ethnicity, Customized||participants|Number|955|955.0||||||
4402058|NCT00262600|4228794|B4|Black||Race/Ethnicity, Customized||participants|Number|176|176.0||||||
4402059|NCT00262600|4228795|B3|Black||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4402060|NCT00262600|4228796|B2|Black||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4402061|NCT00262600|4228797|B1|Black||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4402062|NCT00262600|4228794|B4|White||Race/Ethnicity, Customized||participants|Number|12679|12679.0||||||
4402063|NCT00262600|4228795|B3|White||Race/Ethnicity, Customized||participants|Number|4203|4203.0||||||
4402064|NCT00262600|4228796|B2|White||Race/Ethnicity, Customized||participants|Number|4268|4268.0||||||
4402065|NCT00262600|4228797|B1|White||Race/Ethnicity, Customized||participants|Number|4208|4208.0||||||
4402066|NCT00262600|4228794|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4402067|NCT00262600|4228795|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402068|NCT00262600|4228796|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402069|NCT00262600|4228797|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4402070|NCT00262600|4228794|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1244|1244.0||||||
4402071|NCT00262600|4228795|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|407|407.0||||||
4402072|NCT00262600|4228796|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|416|416.0||||||
4402073|NCT00262600|4228797|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|421|421.0||||||
4402074|NCT00262600|4228794|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16868|16868.0||||||
4402075|NCT00262600|4228795|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5615|5615.0||||||
4402076|NCT00262600|4228796|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5660|5660.0||||||
4402077|NCT00262600|4228797|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5593|5593.0||||||
4402078|NCT00262600|4228794|B4|Missing||Sex/Gender, Customized||participants|Number|1|1.0||||||
4402079|NCT00262600|4228795|B3|Missing||Sex/Gender, Customized||participants|Number|0|0.0||||||
4402080|NCT00262600|4228796|B2|Missing||Sex/Gender, Customized||participants|Number|0|0.0||||||
4402081|NCT00262600|4228797|B1|Missing||Sex/Gender, Customized||participants|Number|1|1.0||||||
4402082|NCT00262600|4228794|B4|Female||Sex/Gender, Customized||participants|Number|6598|6598.0||||||
4402083|NCT00262600|4228795|B3|Female||Sex/Gender, Customized||participants|Number|2213|2213.0||||||
4402084|NCT00262600|4228796|B2|Female||Sex/Gender, Customized||participants|Number|2236|2236.0||||||
4402085|NCT00262600|4228797|B1|Female||Sex/Gender, Customized||participants|Number|2149|2149.0||||||
4402086|NCT00262600|4228794|B4|Male||Sex/Gender, Customized||participants|Number|11514|11514.0||||||
4402087|NCT00262600|4228795|B3|Male||Sex/Gender, Customized||participants|Number|3809|3809.0||||||
4402088|NCT00262600|4228796|B2|Male||Sex/Gender, Customized||participants|Number|3840|3840.0||||||
4402089|NCT00262600|4228797|B1|Male||Sex/Gender, Customized||participants|Number|3865|3865.0||||||
4402090|NCT00262600|4228794|B4|>=75||Age, Customized||Participants|Number|7238|7238.0||||||
4402091|NCT00262600|4228795|B3|>=75||Age, Customized||Participants|Number|2423|2423.0||||||
4402092|NCT00262600|4228796|B2|>=75||Age, Customized||Participants|Number|2466|2466.0||||||
4402093|NCT00262600|4228797|B1|>=75||Age, Customized||Participants|Number|2349|2349.0||||||
4402094|NCT00262600|4228794|B4|65<= and <75||Age, Customized||Participants|Number|7894|7894.0||||||
4402095|NCT00262600|4228795|B3|65<= and <75||Age, Customized||Participants|Number|2646|2646.0||||||
4402096|NCT00262600|4228796|B2|65<= and <75||Age, Customized||Participants|Number|2580|2580.0||||||
4402097|NCT00262600|4228797|B1|65<= and <75||Age, Customized||Participants|Number|2668|2668.0||||||
4402098|NCT00262600|4228794|B4|<65||Age, Customized||Participants|Number|2981|2981.0||||||
4402099|NCT00262600|4228795|B3|<65||Age, Customized||Participants|Number|953|953.0||||||
4402100|NCT00262600|4228796|B2|<65||Age, Customized||Participants|Number|1030|1030.0||||||
4402101|NCT00262600|4228797|B1|<65||Age, Customized||Participants|Number|998|998.0||||||
4402102|NCT00262600|4228794|B4|||Age||years|Mean|71.5|71.5|Standard Deviation|8.7|8.7|||
4402103|NCT00262600|4228795|B3|||Age||years|Mean|71.6|71.6|Standard Deviation|8.6|8.6|||
4402104|NCT00262600|4228796|B2|||Age||years|Mean|71.5|71.5|Standard Deviation|8.8|8.8|||
4402105|NCT00262600|4228797|B1|||Age||years|Mean|71.4|71.4|Standard Deviation|8.6|8.6|||
4402106|NCT00262522|4228822|B5|||Plasma HIV-1 RNA Level||log10 copies/mL|Mean|4.99|4.99|Standard Deviation|0.66|0.66|||
4402107|NCT00262522|4228823|B4|||Plasma HIV-1 RNA Level||log10 copies/mL|Mean|5.06|5.06|Standard Deviation|0.64|0.64|||
4402108|NCT00262522|4228824|B3|||Plasma HIV-1 RNA Level||log10 copies/mL|Mean|5.04|5.04|Standard Deviation|0.68|0.68|||
4402109|NCT00262522|4228825|B2|||Plasma HIV-1 RNA Level||log10 copies/mL|Mean|4.94|4.94|Standard Deviation|0.67|0.67|||
4402110|NCT00262522|4228826|B1|||Plasma HIV-1 RNA Level||log10 copies/mL|Mean|4.92|4.92|Standard Deviation|0.64|0.64|||
4402111|NCT00262522|4228822|B5|||CD4+ T Cell Count|For once daily (QD) soft gel capsule (SGC), N=165.|cells/mm3|Mean|215.5|215.5|Standard Deviation|132.34|132.34|||
4402112|NCT00262522|4228823|B4|||CD4+ T Cell Count|For once daily (QD) soft gel capsule (SGC), N=165.|cells/mm3|Mean|202.9|202.9|Standard Deviation|139.57|139.57|||
4402113|NCT00262522|4228824|B3|||CD4+ T Cell Count|For once daily (QD) soft gel capsule (SGC), N=165.|cells/mm3|Mean|226.4|226.4|Standard Deviation|136.64|136.64|||
4402114|NCT00262522|4228825|B2|||CD4+ T Cell Count|For once daily (QD) soft gel capsule (SGC), N=165.|cells/mm3|Mean|222.6|222.6|Standard Deviation|127.37|127.37|||
4402115|NCT00262522|4228826|B1|||CD4+ T Cell Count|For once daily (QD) soft gel capsule (SGC), N=165.|cells/mm3|Mean|209.9|209.9|Standard Deviation|125.10|125.1|||
4402116|NCT00262522|4228822|B5||Male|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4402117|NCT00262522|4228823|B4||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4402118|NCT00262522|4228824|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4402119|NCT00262522|4228825|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4402120|NCT00262522|4228826|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4402121|NCT00262522|4228822|B5||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4402122|NCT00262522|4228823|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4402123|NCT00262522|4228824|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4402124|NCT00262522|4228825|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4402125|NCT00262522|4228826|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4402126|NCT00262522|4228822|B5|||Age||years|Mean|38.7|38.7|Standard Deviation|9.85|9.85|||
4402127|NCT00262522|4228823|B4|||Age||years|Mean|39.5|39.5|Standard Deviation|10.31|10.31|||
4402128|NCT00262522|4228824|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|9.69|9.69|||
4402129|NCT00262522|4228825|B2|||Age||years|Mean|38.2|38.2|Standard Deviation|9.63|9.63|||
4402130|NCT00262522|4228826|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|9.80|9.8|||
4402131|NCT00262509|4228849|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4402132|NCT00262509|4228850|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4402133|NCT00262509|4228851|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4402134|NCT00262509|4228849|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4402135|NCT00262509|4228850|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4402136|NCT00262509|4228851|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4402137|NCT00262509|4228849|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4402138|NCT00262509|4228850|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4402139|NCT00262509|4228851|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4402140|NCT00262509|4228849|B3|||Age||years|Mean|50.12|50.12|Standard Deviation|9.27|9.27|||
4402141|NCT00262509|4228850|B2|||Age||years|Mean|52.75|52.75|Standard Deviation|7.07|7.07|||
4402142|NCT00262509|4228851|B1|||Age||years|Mean|47.78|47.78|Standard Deviation|10.72|10.72|||
4402143|NCT00262509|4228849|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4402144|NCT00262509|4228850|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4402145|NCT00262509|4228851|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402146|NCT00262509|4228849|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4402147|NCT00262509|4228850|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4402148|NCT00262509|4228851|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4402149|NCT00262509|4228849|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402150|NCT00262509|4228850|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402151|NCT00262509|4228851|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402152|NCT00262314|4228858|B1|United States||Region of Enrollment||participants|Number|509|509.0||||||
4402153|NCT00262314|4228858|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4402154|NCT00262314|4228858|B1||Female|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4402155|NCT00262314|4228858|B1|||Age||years|Mean|46|46.0|Full Range|||19.0|68.0|
4402156|NCT00262314|4228858|B1|18 - 70 years||Age, Customized||participants|Number|509|509.0||||||
4402157|NCT00262314|4228858|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4402158|NCT00262301|4228873|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4402159|NCT00262301|4228874|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4402160|NCT00262301|4228875|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4402161|NCT00262301|4228876|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4402162|NCT00262301|4228873|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4402163|NCT00262301|4228874|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4402164|NCT00262301|4228875|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4402165|NCT00262301|4228876|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4402166|NCT00262301|4228873|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4402167|NCT00262301|4228874|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4402168|NCT00262301|4228875|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4402169|NCT00262301|4228876|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4402170|NCT00262301|4228873|B4||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4402171|NCT00262301|4228874|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4402172|NCT00262301|4228875|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4402173|NCT00262301|4228876|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4402174|NCT00262301|4228873|B4||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4402175|NCT00262301|4228874|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4402176|NCT00262301|4228875|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4402177|NCT00262301|4228876|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4402178|NCT00262223|4228889|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4402179|NCT00262223|4228890|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4402180|NCT00262223|4228891|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4402181|NCT00262223|4228889|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4402182|NCT00262223|4228890|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4402183|NCT00262223|4228891|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4402184|NCT00262223|4228889|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|9.0|9.0|||
4402185|NCT00262223|4228890|B2|||Age||years|Mean|42.5|42.5|Standard Deviation|8.5|8.5|||
4402186|NCT00262223|4228891|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|9.8|9.8|||
4402187|NCT00262119|4228900|B4|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
4402188|NCT00262119|4228901|B3|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4402189|NCT00262119|4228902|B2|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
4402190|NCT00262119|4228903|B1|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
4402191|NCT00262119|4228900|B4|Switzerland||Region of Enrollment||participants|Number|23|23.0||||||
4402192|NCT00262119|4228901|B3|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
4402193|NCT00262119|4228902|B2|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
4402194|NCT00262119|4228903|B1|Switzerland||Region of Enrollment||participants|Number|9|9.0||||||
4402195|NCT00262119|4228900|B4|Slovakia||Region of Enrollment||participants|Number|16|16.0||||||
4402196|NCT00262119|4228901|B3|Slovakia||Region of Enrollment||participants|Number|6|6.0||||||
4402197|NCT00262119|4228902|B2|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
4402198|NCT00262119|4228903|B1|Slovakia||Region of Enrollment||participants|Number|5|5.0||||||
4402199|NCT00262119|4228900|B4|Russian Federation||Region of Enrollment||participants|Number|30|30.0||||||
4402200|NCT00262119|4228901|B3|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4402201|NCT00262119|4228902|B2|Russian Federation||Region of Enrollment||participants|Number|11|11.0||||||
4402202|NCT00262119|4228903|B1|Russian Federation||Region of Enrollment||participants|Number|10|10.0||||||
4402203|NCT00262119|4228900|B4|Kuwait||Region of Enrollment||participants|Number|9|9.0||||||
4402204|NCT00262119|4228901|B3|Kuwait||Region of Enrollment||participants|Number|3|3.0||||||
4402205|NCT00262119|4228902|B2|Kuwait||Region of Enrollment||participants|Number|4|4.0||||||
4402206|NCT00262119|4228903|B1|Kuwait||Region of Enrollment||participants|Number|2|2.0||||||
4402207|NCT00262119|4228900|B4|Israel||Region of Enrollment||participants|Number|22|22.0||||||
4402208|NCT00262119|4228901|B3|Israel||Region of Enrollment||participants|Number|8|8.0||||||
4402209|NCT00262119|4228902|B2|Israel||Region of Enrollment||participants|Number|7|7.0||||||
4402210|NCT00262119|4228903|B1|Israel||Region of Enrollment||participants|Number|7|7.0||||||
4402211|NCT00262119|4228900|B4|Hong Kong||Region of Enrollment||participants|Number|3|3.0||||||
4402212|NCT00262119|4228901|B3|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4402213|NCT00262119|4228902|B2|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4402214|NCT00262119|4228903|B1|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4402215|NCT00262119|4228900|B4|Greece||Region of Enrollment||participants|Number|73|73.0||||||
4402216|NCT00262119|4228901|B3|Greece||Region of Enrollment||participants|Number|25|25.0||||||
4402217|NCT00262119|4228902|B2|Greece||Region of Enrollment||participants|Number|25|25.0||||||
4402218|NCT00262119|4228903|B1|Greece||Region of Enrollment||participants|Number|23|23.0||||||
4402219|NCT00262119|4228900|B4|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4402220|NCT00262119|4228901|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4402221|NCT00262119|4228902|B2|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4402222|NCT00262119|4228903|B1|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4402223|NCT00262119|4228900|B4|France||Region of Enrollment||participants|Number|2|2.0||||||
4402224|NCT00262119|4228901|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4402225|NCT00262119|4228902|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4402226|NCT00262119|4228903|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4402227|NCT00262119|4228900|B4|Austria||Region of Enrollment||participants|Number|44|44.0||||||
4402228|NCT00262119|4228901|B3|Austria||Region of Enrollment||participants|Number|15|15.0||||||
4402229|NCT00262119|4228902|B2|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4402230|NCT00262119|4228903|B1|Austria||Region of Enrollment||participants|Number|15|15.0||||||
4402231|NCT00262119|4228900|B4|Portugal||Region of Enrollment||participants|Number|131|131.0||||||
4402232|NCT00262119|4228901|B3|Portugal||Region of Enrollment||participants|Number|44|44.0||||||
4402233|NCT00262119|4228902|B2|Portugal||Region of Enrollment||participants|Number|44|44.0||||||
4402234|NCT00262119|4228903|B1|Portugal||Region of Enrollment||participants|Number|43|43.0||||||
4402235|NCT00262119|4228900|B4|Spain||Region of Enrollment||participants|Number|51|51.0||||||
4402236|NCT00262119|4228901|B3|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4402237|NCT00262119|4228902|B2|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4402238|NCT00262119|4228903|B1|Spain||Region of Enrollment||participants|Number|16|16.0||||||
4402239|NCT00262119|4228900|B4|Netherlands||Region of Enrollment||participants|Number|123|123.0||||||
4402240|NCT00262119|4228901|B3|Netherlands||Region of Enrollment||participants|Number|39|39.0||||||
4402241|NCT00262119|4228902|B2|Netherlands||Region of Enrollment||participants|Number|43|43.0||||||
4402242|NCT00262119|4228903|B1|Netherlands||Region of Enrollment||participants|Number|41|41.0||||||
4402243|NCT00262119|4228900|B4|Italy||Region of Enrollment||participants|Number|616|616.0||||||
4402244|NCT00262119|4228901|B3|Italy||Region of Enrollment||participants|Number|202|202.0||||||
4402245|NCT00262119|4228902|B2|Italy||Region of Enrollment||participants|Number|211|211.0||||||
4402246|NCT00262119|4228903|B1|Italy||Region of Enrollment||participants|Number|203|203.0||||||
4402247|NCT00262119|4228900|B4||Male|Sex: Female, Male||Participants|Count of Participants|588|588.0||||||
4402248|NCT00262119|4228901|B3||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4402249|NCT00262119|4228902|B2||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4402250|NCT00262119|4228903|B1||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4402251|NCT00262119|4228900|B4||Female|Sex: Female, Male||Participants|Count of Participants|578|578.0||||||
4402252|NCT00262119|4228901|B3||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4402253|NCT00262119|4228902|B2||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4402254|NCT00262119|4228903|B1||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4402255|NCT00262119|4228900|B4|||Age||years|Mean|74|74.0|Standard Deviation|9|9.0|||
4402256|NCT00262119|4228901|B3|||Age||years|Mean|74|74.0|Standard Deviation|9|9.0|||
4402257|NCT00262119|4228902|B2|||Age||years|Mean|74|74.0|Standard Deviation|9|9.0|||
4402258|NCT00262119|4228903|B1|||Age||years|Mean|73|73.0|Standard Deviation|9|9.0|||
4402259|NCT00262080|4228922|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4402260|NCT00262080|4228923|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4402261|NCT00262080|4228924|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4402262|NCT00262080|4228925|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4402263|NCT00262080|4228922|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4402264|NCT00262080|4228923|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4402265|NCT00262080|4228924|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4402266|NCT00262080|4228925|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4402267|NCT00262080|4228922|B4|||Age||years|Mean|34.7|34.7|Standard Deviation|14.7|14.7|||
4402268|NCT00262080|4228923|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|14.6|14.6|||
4402269|NCT00262080|4228924|B2|||Age||years|Mean|33.6|33.6|Standard Deviation|14.6|14.6|||
4402270|NCT00262080|4228925|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|14.3|14.3|||
4402271|NCT00262067|4228943|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4402272|NCT00262067|4228944|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4402273|NCT00262067|4228945|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4402274|NCT00262067|4228946|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4402275|NCT00262067|4228947|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4402276|NCT00262067|4228943|B5||Female|Sex: Female, Male||Participants|Count of Participants|1232|1232.0||||||
4402277|NCT00262067|4228944|B4||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4402278|NCT00262067|4228945|B3||Female|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
4402279|NCT00262067|4228946|B2||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4402280|NCT00262067|4228947|B1||Female|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
4402281|NCT00262067|4228943|B5|≥ 65 years||Age, Customized||Participants|Number|277|277.0||||||
4402282|NCT00262067|4228944|B4|≥ 65 years||Age, Customized||Participants|Number|54|54.0||||||
4402283|NCT00262067|4228945|B3|≥ 65 years||Age, Customized||Participants|Number|99|99.0||||||
4402284|NCT00262067|4228946|B2|≥ 65 years||Age, Customized||Participants|Number|33|33.0||||||
4402285|NCT00262067|4228947|B1|≥ 65 years||Age, Customized||Participants|Number|91|91.0||||||
4402286|NCT00262067|4228943|B5|40-64 years||Age, Customized||Participants|Number|881|881.0||||||
4402287|NCT00262067|4228944|B4|40-64 years||Age, Customized||Participants|Number|137|137.0||||||
4402288|NCT00262067|4228945|B3|40-64 years||Age, Customized||Participants|Number|289|289.0||||||
4402289|NCT00262067|4228946|B2|40-64 years||Age, Customized||Participants|Number|160|160.0||||||
4402290|NCT00262067|4228947|B1|40-64 years||Age, Customized||Participants|Number|295|295.0||||||
4402291|NCT00262067|4228943|B5|< 40 years||Age, Customized||Participants|Number|79|79.0||||||
4402292|NCT00262067|4228944|B4|< 40 years||Age, Customized||Participants|Number|15|15.0||||||
4402293|NCT00262067|4228945|B3|< 40 years||Age, Customized||Participants|Number|21|21.0||||||
4402294|NCT00262067|4228946|B2|< 40 years||Age, Customized||Participants|Number|14|14.0||||||
4402295|NCT00262067|4228947|B1|< 40 years||Age, Customized||Participants|Number|29|29.0||||||
4402296|NCT00262041|4228980|B5||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4402297|NCT00262041|4228981|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4402298|NCT00262041|4228982|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4402299|NCT00262041|4228983|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4402300|NCT00262041|4228984|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4402301|NCT00262041|4228980|B5||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4402302|NCT00262041|4228981|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4402303|NCT00262041|4228982|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4402304|NCT00262041|4228983|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4402305|NCT00262041|4228984|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4402306|NCT00262041|4228980|B5|||Age||years|Mean|14.2|14.2|Standard Deviation|1.8|1.8|||
4402307|NCT00262041|4228981|B4|||Age||years|Mean|14.2|14.2|Standard Deviation|2.0|2.0|||
4402308|NCT00262041|4228982|B3|||Age||years|Mean|14.2|14.2|Standard Deviation|1.8|1.8|||
4402309|NCT00262041|4228983|B2|||Age||years|Mean|14.1|14.1|Standard Deviation|1.8|1.8|||
4402310|NCT00262041|4228984|B1|||Age||years|Mean|14.3|14.3|Standard Deviation|1.9|1.9|||
4402311|NCT00262028|4229006|B10||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4402312|NCT00262028|4229007|B9||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4402313|NCT00262028|4229008|B8||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4402314|NCT00262028|4229009|B7||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4402315|NCT00262028|4229010|B6||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4402316|NCT00262028|4229011|B5||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4402317|NCT00262028|4229012|B4||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Data are reported in the previous table
4402318|NCT00262028|4229013|B3||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Data are reported in the previous table
4402319|NCT00262028|4229014|B2||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Data are reported in the previous table
4402376|NCT00262002|4229083|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4402320|NCT00262028|4229015|B1||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Data are reported in the previous table
4402321|NCT00262028|4229006|B10||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4402322|NCT00262028|4229007|B9||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4402323|NCT00262028|4229008|B8||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4402324|NCT00262028|4229009|B7||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4402325|NCT00262028|4229010|B6||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4402326|NCT00262028|4229011|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4402327|NCT00262028|4229012|B4||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Data are reported in the previous table
4402328|NCT00262028|4229013|B3||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Data are reported in the previous table
4402329|NCT00262028|4229014|B2||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Data are reported in the previous table
4402330|NCT00262028|4229015|B1||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Data are reported in the previous table
4402331|NCT00262028|4229006|B10||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4402332|NCT00262028|4229007|B9||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||reported in a separate table
4402333|NCT00262028|4229008|B8||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||reported in a separate table
4402334|NCT00262028|4229009|B7||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||reported in a separate table
4402335|NCT00262028|4229010|B6||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||reported in a separate table
4402336|NCT00262028|4229011|B5||Male|Sex: Female, Male||Participants|Count of Participants|NA|||||||reported in a separate table
4402337|NCT00262028|4229012|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4402338|NCT00262028|4229013|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4402339|NCT00262028|4229014|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4402340|NCT00262028|4229015|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4402341|NCT00262028|4229006|B10||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4402342|NCT00262028|4229007|B9||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||reported in a separate table
4402343|NCT00262028|4229008|B8||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||reported in a separate table
4402344|NCT00262028|4229009|B7||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||reported in a separate table
4402345|NCT00262028|4229010|B6||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||reported in a separate table
4402346|NCT00262028|4229011|B5||Female|Sex: Female, Male||Participants|Count of Participants|NA|||||||Data are reported in a separate table
4402347|NCT00262028|4229012|B4||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4402348|NCT00262028|4229013|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4402349|NCT00262028|4229014|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4402350|NCT00262028|4229015|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4402351|NCT00262028|4229006|B10|||Age||months|Mean|24.7|24.7|Standard Deviation|17.5|17.5|||
4402352|NCT00262028|4229007|B9|||Age||months|Mean|52.6|52.6|Standard Deviation|11.4|11.4|||
4402353|NCT00262028|4229008|B8|||Age||months|Mean|18.2|18.2|Standard Deviation|1.4|1.4|||
4402354|NCT00262028|4229009|B7|||Age||months|Mean|18.2|18.2|Standard Deviation|1.3|1.3|||
4402355|NCT00262028|4229010|B6|||Age||months|Mean|12.2|12.2|Standard Deviation|0.5|0.5|||
4402356|NCT00262028|4229011|B5|||Age||months|Mean|12.2|12.2|Standard Deviation|0.5|0.5|||
4402357|NCT00262028|4229012|B4|||Age||months|Mean|NA||Standard Deviation|NA||||Data are reported in the previous table
4402358|NCT00262028|4229013|B3|||Age||months|Mean|NA||Standard Deviation|NA||||Data are reported in the previous table
4402359|NCT00262028|4229014|B2|||Age||months|Mean|NA||Standard Deviation|NA||||Data are reported in the previous table
4402360|NCT00262028|4229015|B1|||Age||months|Mean|NA||Standard Deviation|NA||||Data are reported in the previous table
4402361|NCT00262028|4229006|B10|||Age||years|Mean|5.7|5.7|Standard Deviation|2.7|2.7|||
4402362|NCT00262028|4229007|B9|||Age||years|Mean|NA||Standard Deviation|NA||||Data are reported in a separate table
4402363|NCT00262028|4229008|B8|||Age||years|Mean|NA||Standard Deviation|NA||||Data are reported in a separate table
4402364|NCT00262028|4229009|B7|||Age||years|Mean|NA||Standard Deviation|NA||||Data are reported in a separate table
4402365|NCT00262028|4229010|B6|||Age||years|Mean|NA||Standard Deviation|NA||||Data are reported in a separate table
4402366|NCT00262028|4229011|B5|||Age||years|Mean|NA||Standard Deviation|NA||||Data are reported in a separate table
4402367|NCT00262028|4229012|B4|||Age||years|Mean|8.0|8.0|Standard Deviation|1.4|1.4|||
4402368|NCT00262028|4229013|B3|||Age||years|Mean|8.0|8.0|Standard Deviation|1.5|1.5|||
4402369|NCT00262028|4229014|B2|||Age||years|Mean|3.3|3.3|Standard Deviation|1.2|1.2|||
4402370|NCT00262028|4229015|B1|||Age||years|Mean|3.3|3.3|Standard Deviation|1.2|1.2|||
4402371|NCT00262002|4229078|B8||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4402372|NCT00262002|4229079|B7||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4402373|NCT00262002|4229080|B6||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4402374|NCT00262002|4229081|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4402375|NCT00262002|4229082|B4||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4402377|NCT00262002|4229084|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4402378|NCT00262002|4229085|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4402379|NCT00262002|4229078|B8||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4402380|NCT00262002|4229079|B7||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4402381|NCT00262002|4229080|B6||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4402382|NCT00262002|4229081|B5||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4402383|NCT00262002|4229082|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4402384|NCT00262002|4229083|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4402385|NCT00262002|4229084|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4402386|NCT00262002|4229085|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4402387|NCT00262002|4229078|B8|||Age||days|Mean|64.6|64.6|Standard Deviation|7.3|7.3|||
4402388|NCT00262002|4229079|B7|||Age||days|Mean|69.4|69.4|Standard Deviation|10.0|10.0|||
4402389|NCT00262002|4229080|B6|||Age||days|Mean|64.1|64.1|Standard Deviation|5.5|5.5|||
4402390|NCT00262002|4229081|B5|||Age||days|Mean|65.8|65.8|Standard Deviation|6.9|6.9|||
4402391|NCT00262002|4229082|B4|||Age||days|Mean|65.6|65.6|Standard Deviation|6.9|6.9|||
4402392|NCT00262002|4229083|B3|||Age||days|Mean|62.6|62.6|Standard Deviation|6.5|6.5|||
4402393|NCT00262002|4229084|B2|||Age||days|Mean|61.3|61.3|Standard Deviation|5.0|5.0|||
4402394|NCT00262002|4229085|B1|||Age||days|Mean|62.1|62.1|Standard Deviation|5.4|5.4|||
4402395|NCT00261950|4229184|B1|Other||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4402396|NCT00261950|4229184|B1|Black||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4402397|NCT00261950|4229184|B1|White||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
4402398|NCT00261950|4229184|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4402399|NCT00261950|4229184|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4402400|NCT00261950|4229184|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|14.2|14.2|||
4402401|NCT00261846|4229200|B10||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4402402|NCT00261846|4229201|B9||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4402403|NCT00261846|4229202|B8||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4402404|NCT00261846|4229203|B7||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4402405|NCT00261846|4229204|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4402406|NCT00261846|4229205|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4402407|NCT00261846|4229206|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4402408|NCT00261846|4229207|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4402409|NCT00261846|4229208|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4402410|NCT00261846|4229209|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4402411|NCT00261846|4229200|B10||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4402412|NCT00261846|4229201|B9||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4402413|NCT00261846|4229202|B8||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4402414|NCT00261846|4229203|B7||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4402415|NCT00261846|4229204|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4402416|NCT00261846|4229205|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4402417|NCT00261846|4229206|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4402418|NCT00261846|4229207|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4402419|NCT00261846|4229208|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4402420|NCT00261846|4229209|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4402421|NCT00261846|4229200|B10|>=65 years||Age, Customized||Participants|Number|119|119.0||||||
4402422|NCT00261846|4229201|B9|>=65 years||Age, Customized||Participants|Number|11|11.0||||||
4402423|NCT00261846|4229202|B8|>=65 years||Age, Customized||Participants|Number|10|10.0||||||
4402424|NCT00261846|4229203|B7|>=65 years||Age, Customized||Participants|Number|8|8.0||||||
4402425|NCT00261846|4229204|B6|>=65 years||Age, Customized||Participants|Number|2|2.0||||||
4402426|NCT00261846|4229205|B5|>=65 years||Age, Customized||Participants|Number|14|14.0||||||
4402427|NCT00261846|4229206|B4|>=65 years||Age, Customized||Participants|Number|10|10.0||||||
4402428|NCT00261846|4229207|B3|>=65 years||Age, Customized||Participants|Number|1|1.0||||||
4402429|NCT00261846|4229208|B2|>=65 years||Age, Customized||Participants|Number|27|27.0||||||
4402430|NCT00261846|4229209|B1|>=65 years||Age, Customized||Participants|Number|36|36.0||||||
4402431|NCT00261846|4229200|B10|Between 45 and 64 years||Age, Customized||Participants|Number|272|272.0||||||
4402432|NCT00261846|4229201|B9|Between 45 and 64 years||Age, Customized||Participants|Number|7|7.0||||||
4402433|NCT00261846|4229202|B8|Between 45 and 64 years||Age, Customized||Participants|Number|25|25.0||||||
4402434|NCT00261846|4229203|B7|Between 45 and 64 years||Age, Customized||Participants|Number|45|45.0||||||
4402435|NCT00261846|4229204|B6|Between 45 and 64 years||Age, Customized||Participants|Number|14|14.0||||||
4402436|NCT00261846|4229205|B5|Between 45 and 64 years||Age, Customized||Participants|Number|29|29.0||||||
4402437|NCT00261846|4229206|B4|Between 45 and 64 years||Age, Customized||Participants|Number|23|23.0||||||
4402438|NCT00261846|4229207|B3|Between 45 and 64 years||Age, Customized||Participants|Number|3|3.0||||||
4402439|NCT00261846|4229208|B2|Between 45 and 64 years||Age, Customized||Participants|Number|40|40.0||||||
4402440|NCT00261846|4229209|B1|Between 45 and 64 years||Age, Customized||Participants|Number|86|86.0||||||
4402441|NCT00261846|4229200|B10|Between 18 and 44 years||Age, Customized||Participants|Number|179|179.0||||||
4402442|NCT00261846|4229201|B9|Between 18 and 44 years||Age, Customized||Participants|Number|6|6.0||||||
4402443|NCT00261846|4229202|B8|Between 18 and 44 years||Age, Customized||Participants|Number|29|29.0||||||
4402444|NCT00261846|4229203|B7|Between 18 and 44 years||Age, Customized||Participants|Number|26|26.0||||||
4402445|NCT00261846|4229204|B6|Between 18 and 44 years||Age, Customized||Participants|Number|10|10.0||||||
4402446|NCT00261846|4229205|B5|Between 18 and 44 years||Age, Customized||Participants|Number|7|7.0||||||
4402447|NCT00261846|4229206|B4|Between 18 and 44 years||Age, Customized||Participants|Number|5|5.0||||||
4402448|NCT00261846|4229207|B3|Between 18 and 44 years||Age, Customized||Participants|Number|1|1.0||||||
4402449|NCT00261846|4229208|B2|Between 18 and 44 years||Age, Customized||Participants|Number|22|22.0||||||
4402450|NCT00261846|4229209|B1|Between 18 and 44 years||Age, Customized||Participants|Number|73|73.0||||||
4402451|NCT00261846|4229200|B10|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4402452|NCT00261846|4229201|B9|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4402453|NCT00261846|4229202|B8|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4402454|NCT00261846|4229203|B7|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4402455|NCT00261846|4229204|B6|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4402456|NCT00261846|4229205|B5|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4402457|NCT00261846|4229206|B4|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4402458|NCT00261846|4229207|B3|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4402459|NCT00261846|4229208|B2|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4402460|NCT00261846|4229209|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4402461|NCT00261833|4229477|B3|Other||Number of participants with ZZ genotype (A1-PI deficiency), or SZ, Z / Null or Other genotype||participants|Number|9|9.0||||||
4402462|NCT00261833|4229478|B2|Other||Number of participants with ZZ genotype (A1-PI deficiency), or SZ, Z / Null or Other genotype||participants|Number|3|3.0||||||
4402463|NCT00261833|4229479|B1|Other||Number of participants with ZZ genotype (A1-PI deficiency), or SZ, Z / Null or Other genotype||participants|Number|6|6.0||||||
4402464|NCT00261833|4229477|B3|Z / Null||Number of participants with ZZ genotype (A1-PI deficiency), or SZ, Z / Null or Other genotype||participants|Number|3|3.0||||||
4402465|NCT00261833|4229478|B2|Z / Null||Number of participants with ZZ genotype (A1-PI deficiency), or SZ, Z / Null or Other genotype||participants|Number|1|1.0||||||
4402466|NCT00261833|4229479|B1|Z / Null||Number of participants with ZZ genotype (A1-PI deficiency), or SZ, Z / Null or Other genotype||participants|Number|2|2.0||||||
4402467|NCT00261833|4229477|B3|SZ||Number of participants with ZZ genotype (A1-PI deficiency), or SZ, Z / Null or Other genotype||participants|Number|2|2.0||||||
4402468|NCT00261833|4229478|B2|SZ||Number of participants with ZZ genotype (A1-PI deficiency), or SZ, Z / Null or Other genotype||participants|Number|0|0.0||||||
4402469|NCT00261833|4229479|B1|SZ||Number of participants with ZZ genotype (A1-PI deficiency), or SZ, Z / Null or Other genotype||participants|Number|2|2.0||||||
4402470|NCT00261833|4229477|B3|ZZ||Number of participants with ZZ genotype (A1-PI deficiency), or SZ, Z / Null or Other genotype||participants|Number|166|166.0||||||
4402471|NCT00261833|4229478|B2|ZZ||Number of participants with ZZ genotype (A1-PI deficiency), or SZ, Z / Null or Other genotype||participants|Number|83|83.0||||||
4402472|NCT00261833|4229479|B1|ZZ||Number of participants with ZZ genotype (A1-PI deficiency), or SZ, Z / Null or Other genotype||participants|Number|83|83.0||||||
4402473|NCT00261833|4229477|B3|||Baseline diffusion capacity of carbon monoxide (DLCO)||mL/min/mmHg|Mean|14.3|14.3|Standard Deviation|5.5|5.5|||
4402474|NCT00261833|4229478|B2|||Baseline diffusion capacity of carbon monoxide (DLCO)||mL/min/mmHg|Mean|15.0|15.0|Standard Deviation|5.6|5.6|||
4402475|NCT00261833|4229479|B1|||Baseline diffusion capacity of carbon monoxide (DLCO)||mL/min/mmHg|Mean|13.6|13.6|Standard Deviation|5.3|5.3|||
4402476|NCT00261833|4229477|B3|||Baseline percent predicted forced expiratory volume in 1 second (FEV1)||percentage|Mean|47.3|47.3|Standard Deviation|11.6|11.6|||
4402477|NCT00261833|4229478|B2|||Baseline percent predicted forced expiratory volume in 1 second (FEV1)||percentage|Mean|47.2|47.2|Standard Deviation|11.1|11.1|||
4402478|NCT00261833|4229479|B1|||Baseline percent predicted forced expiratory volume in 1 second (FEV1)||percentage|Mean|47.4|47.4|Standard Deviation|12.1|12.1|||
4402479|NCT00261833|4229477|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4402480|NCT00261833|4229478|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4402481|NCT00261833|4229479|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4402482|NCT00261833|4229477|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4402483|NCT00261833|4229478|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4402484|NCT00261833|4229479|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4402485|NCT00261833|4229477|B3|||Age||years|Mean|53.13|53.13|Standard Deviation|7.374|7.374|||
4402486|NCT00261833|4229478|B2|||Age||years|Mean|52.40|52.4|Standard Deviation|7.812|7.812|||
4402487|NCT00261833|4229479|B1|||Age||years|Mean|53.81|53.81|Standard Deviation|6.193|6.193|||
4402488|NCT00261716|4229512|B3|missing||Education||participants|Number|1|1.0||||||
4402489|NCT00261716|4229513|B2|missing||Education||participants|Number|0|0.0||||||
4402490|NCT00261716|4229514|B1|missing||Education||participants|Number|1|1.0||||||
4402491|NCT00261716|4229512|B3|College Graduate||Education||participants|Number|5|5.0||||||
4402492|NCT00261716|4229513|B2|College Graduate||Education||participants|Number|2|2.0||||||
4402493|NCT00261716|4229514|B1|College Graduate||Education||participants|Number|3|3.0||||||
4402494|NCT00261716|4229512|B3|Some College||Education||participants|Number|18|18.0||||||
4402495|NCT00261716|4229513|B2|Some College||Education||participants|Number|10|10.0||||||
4402496|NCT00261716|4229514|B1|Some College||Education||participants|Number|8|8.0||||||
4402497|NCT00261716|4229512|B3|12 years or less||Education||participants|Number|14|14.0||||||
4402498|NCT00261716|4229513|B2|12 years or less||Education||participants|Number|9|9.0||||||
4402499|NCT00261716|4229514|B1|12 years or less||Education||participants|Number|5|5.0||||||
4402500|NCT00261716|4229512|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4402501|NCT00261716|4229513|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4402502|NCT00261716|4229514|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4402503|NCT00261716|4229512|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4402504|NCT00261716|4229513|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4402505|NCT00261716|4229514|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4402506|NCT00261716|4229512|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4402507|NCT00261716|4229513|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4402508|NCT00261716|4229514|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4402509|NCT00261716|4229512|B3|African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4402510|NCT00261716|4229513|B2|African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4402511|NCT00261716|4229514|B1|African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4402512|NCT00261716|4229512|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4402513|NCT00261716|4229513|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4402514|NCT00261716|4229514|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4402515|NCT00261716|4229512|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4402516|NCT00261716|4229513|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4402517|NCT00261716|4229514|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4402518|NCT00261716|4229512|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4402519|NCT00261716|4229513|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4402520|NCT00261716|4229514|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4402521|NCT00261716|4229512|B3|||Age||years|Mean|41.26|41.26|Standard Deviation|11.87|11.87|||
4402522|NCT00261716|4229513|B2|||Age||years|Mean|40.71|40.71|Standard Deviation|12.72|12.72|||
4402523|NCT00261716|4229514|B1|||Age||years|Mean|41.94|41.94|Standard Deviation|11.08|11.08|||
4402524|NCT00261495|4229533|B3|Switzerland||Region of Enrollment||participants|Number|11|11.0||||||
4402525|NCT00261495|4229534|B2|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
4402526|NCT00261495|4229535|B1|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4402527|NCT00261495|4229533|B3|Sweden||Region of Enrollment||participants|Number|33|33.0||||||
4402528|NCT00261495|4229534|B2|Sweden||Region of Enrollment||participants|Number|19|19.0||||||
4402529|NCT00261495|4229535|B1|Sweden||Region of Enrollment||participants|Number|14|14.0||||||
4402530|NCT00261495|4229533|B3|Slovenia||Region of Enrollment||participants|Number|8|8.0||||||
4402531|NCT00261495|4229534|B2|Slovenia||Region of Enrollment||participants|Number|5|5.0||||||
4402532|NCT00261495|4229535|B1|Slovenia||Region of Enrollment||participants|Number|3|3.0||||||
4402533|NCT00261495|4229533|B3|Slovakia||Region of Enrollment||participants|Number|22|22.0||||||
4402534|NCT00261495|4229534|B2|Slovakia||Region of Enrollment||participants|Number|11|11.0||||||
4402535|NCT00261495|4229535|B1|Slovakia||Region of Enrollment||participants|Number|11|11.0||||||
4402536|NCT00261495|4229533|B3|Poland||Region of Enrollment||participants|Number|62|62.0||||||
4402537|NCT00261495|4229534|B2|Poland||Region of Enrollment||participants|Number|34|34.0||||||
4402538|NCT00261495|4229535|B1|Poland||Region of Enrollment||participants|Number|28|28.0||||||
4402539|NCT00261495|4229533|B3|Norway||Region of Enrollment||participants|Number|36|36.0||||||
4402540|NCT00261495|4229534|B2|Norway||Region of Enrollment||participants|Number|18|18.0||||||
4402541|NCT00261495|4229535|B1|Norway||Region of Enrollment||participants|Number|18|18.0||||||
4402542|NCT00261495|4229533|B3|Italy||Region of Enrollment||participants|Number|38|38.0||||||
4402543|NCT00261495|4229534|B2|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4402544|NCT00261495|4229535|B1|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4402545|NCT00261495|4229533|B3|Germany||Region of Enrollment||participants|Number|163|163.0||||||
4402546|NCT00261495|4229534|B2|Germany||Region of Enrollment||participants|Number|80|80.0||||||
4402547|NCT00261495|4229535|B1|Germany||Region of Enrollment||participants|Number|83|83.0||||||
4402548|NCT00261495|4229533|B3|France||Region of Enrollment||participants|Number|40|40.0||||||
4402549|NCT00261495|4229534|B2|France||Region of Enrollment||participants|Number|18|18.0||||||
4402550|NCT00261495|4229535|B1|France||Region of Enrollment||participants|Number|22|22.0||||||
4402551|NCT00261495|4229533|B3|Denmark||Region of Enrollment||participants|Number|39|39.0||||||
4402552|NCT00261495|4229534|B2|Denmark||Region of Enrollment||participants|Number|20|20.0||||||
4402553|NCT00261495|4229535|B1|Denmark||Region of Enrollment||participants|Number|19|19.0||||||
4402554|NCT00261495|4229533|B3|Czech Republic||Region of Enrollment||participants|Number|52|52.0||||||
4402555|NCT00261495|4229534|B2|Czech Republic||Region of Enrollment||participants|Number|18|18.0||||||
4402556|NCT00261495|4229535|B1|Czech Republic||Region of Enrollment||participants|Number|34|34.0||||||
4402557|NCT00261495|4229533|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4402558|NCT00261495|4229534|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4402559|NCT00261495|4229535|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4402560|NCT00261495|4229533|B3||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4402561|NCT00261495|4229534|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4402562|NCT00261495|4229535|B1||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4402563|NCT00261495|4229533|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|12.93|12.93|||
4402564|NCT00261495|4229534|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|12.82|12.82|||
4402565|NCT00261495|4229535|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|13.06|13.06|||
4402566|NCT00261443|4229698|B3|||Young-Mania Rating Scale (Y-MRS) Total Score|The Y-MRS consists of 11 items: 1) Elevated Mood, 2) Increased Motor Activity -Energy, 3) Sexual Interest, 4) Sleep, 5) Irritability, 6) Speech (Rate and Amount), 7) Language -Thought Disorder, 8) Content, 9) Disruptive-Aggressive Behavior, 10) Appearance, 11) Insight. Seven items are rated on a 0 to 4 scale, while 4 items (items 5, 6, 8 and 9) are rated on a 0 to 8 scale (twice the weight of the other items.) For all items, 0 is the “best” rating and 4 or 8 is the “worst” rating. Total Score is the sum of the ratings for all 11 items. The possible Total Scores are from 0 to 60.|units on a scale|Mean|4.1|4.1|Standard Deviation|3.43|3.43|||
4402567|NCT00261443|4229699|B2|||Young-Mania Rating Scale (Y-MRS) Total Score|The Y-MRS consists of 11 items: 1) Elevated Mood, 2) Increased Motor Activity -Energy, 3) Sexual Interest, 4) Sleep, 5) Irritability, 6) Speech (Rate and Amount), 7) Language -Thought Disorder, 8) Content, 9) Disruptive-Aggressive Behavior, 10) Appearance, 11) Insight. Seven items are rated on a 0 to 4 scale, while 4 items (items 5, 6, 8 and 9) are rated on a 0 to 8 scale (twice the weight of the other items.) For all items, 0 is the “best” rating and 4 or 8 is the “worst” rating. Total Score is the sum of the ratings for all 11 items. The possible Total Scores are from 0 to 60.|units on a scale|Mean|4.1|4.1|Standard Deviation|3.56|3.56|||
4402568|NCT00261443|4229700|B1|||Young-Mania Rating Scale (Y-MRS) Total Score|The Y-MRS consists of 11 items: 1) Elevated Mood, 2) Increased Motor Activity -Energy, 3) Sexual Interest, 4) Sleep, 5) Irritability, 6) Speech (Rate and Amount), 7) Language -Thought Disorder, 8) Content, 9) Disruptive-Aggressive Behavior, 10) Appearance, 11) Insight. Seven items are rated on a 0 to 4 scale, while 4 items (items 5, 6, 8 and 9) are rated on a 0 to 8 scale (twice the weight of the other items.) For all items, 0 is the “best” rating and 4 or 8 is the “worst” rating. Total Score is the sum of the ratings for all 11 items. The possible Total Scores are from 0 to 60.|units on a scale|Mean|4.1|4.1|Standard Deviation|3.31|3.31|||
4402569|NCT00261443|4229698|B3|||Weight||kg|Mean|81.0|81.0|Standard Deviation|22.20|22.2|||
4402570|NCT00261443|4229699|B2|||Weight||kg|Mean|80.6|80.6|Standard Deviation|18.89|18.89|||
4402571|NCT00261443|4229700|B1|||Weight||kg|Mean|81.3|81.3|Standard Deviation|25.11|25.11|||
4402572|NCT00261443|4229698|B3|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|MADRS consists of 10-items, ordinal rating scale The possible total scores are from 0 to 60 (0=no symptoms; 60=most severe symptoms). Change from baseline=postbaseline score - baseline score. A negative change score indicates improvement.|units on a scale|Mean|3.9|3.9|Standard Deviation|3.64|3.64|||
4402573|NCT00261443|4229699|B2|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|MADRS consists of 10-items, ordinal rating scale The possible total scores are from 0 to 60 (0=no symptoms; 60=most severe symptoms). Change from baseline=postbaseline score - baseline score. A negative change score indicates improvement.|units on a scale|Mean|4.1|4.1|Standard Deviation|3.82|3.82|||
4402574|NCT00261443|4229700|B1|||Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|MADRS consists of 10-items, ordinal rating scale The possible total scores are from 0 to 60 (0=no symptoms; 60=most severe symptoms). Change from baseline=postbaseline score - baseline score. A negative change score indicates improvement.|units on a scale|Mean|3.7|3.7|Standard Deviation|3.45|3.45|||
4402575|NCT00261443|4229698|B3|||CGI-BP Severity of Illness Score (Overall)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Severity of Illness (mania, depression, and overall bipolar illness) items (a 7-point scale from 1 to 7, with 1 being normal, not ill and 7 being very severely ill).|units on a scale|Mean|1.6|1.6|Standard Deviation|0.79|0.79|||
4402576|NCT00261443|4229699|B2|||CGI-BP Severity of Illness Score (Overall)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Severity of Illness (mania, depression, and overall bipolar illness) items (a 7-point scale from 1 to 7, with 1 being normal, not ill and 7 being very severely ill).|units on a scale|Mean|1.7|1.7|Standard Deviation|0.83|0.83|||
4402577|NCT00261443|4229700|B1|||CGI-BP Severity of Illness Score (Overall)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Severity of Illness (mania, depression, and overall bipolar illness) items (a 7-point scale from 1 to 7, with 1 being normal, not ill and 7 being very severely ill).|units on a scale|Mean|1.6|1.6|Standard Deviation|0.76|0.76|||
4402578|NCT00261443|4229698|B3|||CGI-BP Severity of Illness Score (Mania)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Severity of Illness (mania, depression, and overall bipolar illness) items (a 7-point scale from 1 to 7, with 1 being normal, not ill and 7 being very severely ill).|units on a scale|Mean|1.5|1.5|Standard Deviation|0.72|0.72|||
4402579|NCT00261443|4229699|B2|||CGI-BP Severity of Illness Score (Mania)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Severity of Illness (mania, depression, and overall bipolar illness) items (a 7-point scale from 1 to 7, with 1 being normal, not ill and 7 being very severely ill).|units on a scale|Mean|1.5|1.5|Standard Deviation|0.72|0.72|||
4402580|NCT00261443|4229700|B1|||CGI-BP Severity of Illness Score (Mania)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Severity of Illness (mania, depression, and overall bipolar illness) items (a 7-point scale from 1 to 7, with 1 being normal, not ill and 7 being very severely ill).|units on a scale|Mean|1.5|1.5|Standard Deviation|0.72|0.72|||
4402581|NCT00261443|4229698|B3|||CGI-BP Severity of Illness Score (Depression)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Severity of Illness (mania, depression, and overall bipolar illness) items (a 7-point scale from 1 to 7, with 1 being normal, not ill and 7 being very severely ill).|units on a scale|Mean|1.4|1.4|Standard Deviation|0.64|0.64|||
4402582|NCT00261443|4229699|B2|||CGI-BP Severity of Illness Score (Depression)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Severity of Illness (mania, depression, and overall bipolar illness) items (a 7-point scale from 1 to 7, with 1 being normal, not ill and 7 being very severely ill).|units on a scale|Mean|1.4|1.4|Standard Deviation|0.70|0.7|||
4402583|NCT00261443|4229700|B1|||CGI-BP Severity of Illness Score (Depression)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Severity of Illness (mania, depression, and overall bipolar illness) items (a 7-point scale from 1 to 7, with 1 being normal, not ill and 7 being very severely ill).|units on a scale|Mean|1.3|1.3|Standard Deviation|0.57|0.57|||
4402584|NCT00261443|4229698|B3|||CGI-BP Change from Preceding Phase Score (Overall)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Change from Preceding Phase (mania, depression and overall bipolar illness) items (also a 7-point scale (1 to 7), with 1 being very much improved and 7 being very much worse).|units on a scale|Mean|1.6|1.6|Standard Deviation|0.77|0.77|||
4402585|NCT00261443|4229699|B2|||CGI-BP Change from Preceding Phase Score (Overall)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Change from Preceding Phase (mania, depression and overall bipolar illness) items (also a 7-point scale (1 to 7), with 1 being very much improved and 7 being very much worse).|units on a scale|Mean|1.5|1.5|Standard Deviation|0.69|0.69|||
4402586|NCT00261443|4229700|B1|||CGI-BP Change from Preceding Phase Score (Overall)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Change from Preceding Phase (mania, depression and overall bipolar illness) items (also a 7-point scale (1 to 7), with 1 being very much improved and 7 being very much worse).|units on a scale|Mean|1.6|1.6|Standard Deviation|0.85|0.85|||
4402587|NCT00261443|4229698|B3|||CGI-BP Change from Preceding Phase Score (Mania)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Change from Preceding Phase (mania, depression and overall bipolar illness) items (also a 7-point scale (1 to 7), with 1 being very much improved and 7 being very much worse).|units on a scale|Mean|1.5|1.5|Standard Deviation|0.72|0.72|||
4402588|NCT00261443|4229699|B2|||CGI-BP Change from Preceding Phase Score (Mania)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Change from Preceding Phase (mania, depression and overall bipolar illness) items (also a 7-point scale (1 to 7), with 1 being very much improved and 7 being very much worse).|units on a scale|Mean|1.4|1.4|Standard Deviation|0.63|0.63|||
4402589|NCT00261443|4229700|B1|||CGI-BP Change from Preceding Phase Score (Mania)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Change from Preceding Phase (mania, depression and overall bipolar illness) items (also a 7-point scale (1 to 7), with 1 being very much improved and 7 being very much worse).|units on a scale|Mean|1.6|1.6|Standard Deviation|0.81|0.81|||
4402590|NCT00261443|4229698|B3|||CGI-BP Change from Preceding Phase Score (Depression)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Change from Preceding Phase (mania, depression and overall bipolar illness) items (also a 7-point scale (1 to 7), with 1 being very much improved and 7 being very much worse).|units on a scale|Mean|3.0|3.0|Standard Deviation|1.32|1.32|||
4402591|NCT00261443|4229699|B2|||CGI-BP Change from Preceding Phase Score (Depression)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Change from Preceding Phase (mania, depression and overall bipolar illness) items (also a 7-point scale (1 to 7), with 1 being very much improved and 7 being very much worse).|units on a scale|Mean|3.0|3.0|Standard Deviation|1.31|1.31|||
4402592|NCT00261443|4229700|B1|||CGI-BP Change from Preceding Phase Score (Depression)|Clinical Global Impression-Bipolar (CGI-BP) assesses global illness severity and change in patients with bipolar disorder. Patients are rated on Change from Preceding Phase (mania, depression and overall bipolar illness) items (also a 7-point scale (1 to 7), with 1 being very much improved and 7 being very much worse).|units on a scale|Mean|3.0|3.0|Standard Deviation|1.34|1.34|||
4402593|NCT00261443|4229698|B3|||Body Mass Index (BMI)|BMI is defined as weight in kilograms divided by the square of height in meters.|kg/m^2|Mean|28.6|28.6|Standard Deviation|6.90|6.9|||
4402594|NCT00261443|4229699|B2|||Body Mass Index (BMI)|BMI is defined as weight in kilograms divided by the square of height in meters.|kg/m^2|Mean|28.5|28.5|Standard Deviation|6.00|6.0|||
4402595|NCT00261443|4229700|B1|||Body Mass Index (BMI)|BMI is defined as weight in kilograms divided by the square of height in meters.|kg/m^2|Mean|28.7|28.7|Standard Deviation|7.72|7.72|||
4402596|NCT00261443|4229698|B3|>= 30 kg/m^2||Body Mass Index (BMI) Category|BMI is defined as weight in kilograms divided by the square of height in meters.|Participants|Number|112|112.0||||||
4402597|NCT00261443|4229699|B2|>= 30 kg/m^2||Body Mass Index (BMI) Category|BMI is defined as weight in kilograms divided by the square of height in meters.|Participants|Number|56|56.0||||||
4402598|NCT00261443|4229700|B1|>= 30 kg/m^2||Body Mass Index (BMI) Category|BMI is defined as weight in kilograms divided by the square of height in meters.|Participants|Number|56|56.0||||||
4402599|NCT00261443|4229698|B3|25 kg/m^2 to <30 kg/m^2||Body Mass Index (BMI) Category|BMI is defined as weight in kilograms divided by the square of height in meters.|Participants|Number|113|113.0||||||
4402600|NCT00261443|4229699|B2|25 kg/m^2 to <30 kg/m^2||Body Mass Index (BMI) Category|BMI is defined as weight in kilograms divided by the square of height in meters.|Participants|Number|63|63.0||||||
4402601|NCT00261443|4229700|B1|25 kg/m^2 to <30 kg/m^2||Body Mass Index (BMI) Category|BMI is defined as weight in kilograms divided by the square of height in meters.|Participants|Number|50|50.0||||||
4402602|NCT00261443|4229698|B3|18.5 kg/m^2 to <25 kg/m^2||Body Mass Index (BMI) Category|BMI is defined as weight in kilograms divided by the square of height in meters.|Participants|Number|107|107.0||||||
4402603|NCT00261443|4229699|B2|18.5 kg/m^2 to <25 kg/m^2||Body Mass Index (BMI) Category|BMI is defined as weight in kilograms divided by the square of height in meters.|Participants|Number|49|49.0||||||
4402663|NCT00260962|4229958|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4402604|NCT00261443|4229700|B1|18.5 kg/m^2 to <25 kg/m^2||Body Mass Index (BMI) Category|BMI is defined as weight in kilograms divided by the square of height in meters.|Participants|Number|58|58.0||||||
4402605|NCT00261443|4229698|B3|<18.5 kg/m^2||Body Mass Index (BMI) Category|BMI is defined as weight in kilograms divided by the square of height in meters.|Participants|Number|5|5.0||||||
4402606|NCT00261443|4229699|B2|<18.5 kg/m^2||Body Mass Index (BMI) Category|BMI is defined as weight in kilograms divided by the square of height in meters.|Participants|Number|0|0.0||||||
4402607|NCT00261443|4229700|B1|<18.5 kg/m^2||Body Mass Index (BMI) Category|BMI is defined as weight in kilograms divided by the square of height in meters.|Participants|Number|5|5.0||||||
4402608|NCT00261443|4229698|B3|India||Region of Enrollment||participants|Number|67|67.0||||||
4402609|NCT00261443|4229699|B2|India||Region of Enrollment||participants|Number|34|34.0||||||
4402610|NCT00261443|4229700|B1|India||Region of Enrollment||participants|Number|33|33.0||||||
4402611|NCT00261443|4229698|B3|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4402612|NCT00261443|4229699|B2|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4402613|NCT00261443|4229700|B1|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4402614|NCT00261443|4229698|B3|Russian Federation||Region of Enrollment||participants|Number|32|32.0||||||
4402615|NCT00261443|4229699|B2|Russian Federation||Region of Enrollment||participants|Number|15|15.0||||||
4402616|NCT00261443|4229700|B1|Russian Federation||Region of Enrollment||participants|Number|17|17.0||||||
4402617|NCT00261443|4229698|B3|Croatia||Region of Enrollment||participants|Number|7|7.0||||||
4402618|NCT00261443|4229699|B2|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
4402619|NCT00261443|4229700|B1|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
4402620|NCT00261443|4229698|B3|Brazil||Region of Enrollment||participants|Number|55|55.0||||||
4402621|NCT00261443|4229699|B2|Brazil||Region of Enrollment||participants|Number|27|27.0||||||
4402622|NCT00261443|4229700|B1|Brazil||Region of Enrollment||participants|Number|28|28.0||||||
4402623|NCT00261443|4229698|B3|Czech Republic||Region of Enrollment||participants|Number|32|32.0||||||
4402624|NCT00261443|4229699|B2|Czech Republic||Region of Enrollment||participants|Number|14|14.0||||||
4402625|NCT00261443|4229700|B1|Czech Republic||Region of Enrollment||participants|Number|18|18.0||||||
4402626|NCT00261443|4229698|B3|United States||Region of Enrollment||participants|Number|119|119.0||||||
4402627|NCT00261443|4229699|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4402628|NCT00261443|4229700|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4402629|NCT00261443|4229698|B3|France||Region of Enrollment||participants|Number|17|17.0||||||
4402630|NCT00261443|4229699|B2|France||Region of Enrollment||participants|Number|9|9.0||||||
4402631|NCT00261443|4229700|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
4402632|NCT00261443|4229698|B3|Non-US||Race/Ethnicity, Customized||Participants|Number|218|218.0||||||
4402633|NCT00261443|4229699|B2|Non-US||Race/Ethnicity, Customized||Participants|Number|107|107.0||||||
4402634|NCT00261443|4229700|B1|Non-US||Race/Ethnicity, Customized||Participants|Number|111|111.0||||||
4402635|NCT00261443|4229698|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|111|111.0||||||
4402636|NCT00261443|4229699|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4402637|NCT00261443|4229700|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4402638|NCT00261443|4229698|B3|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4402639|NCT00261443|4229699|B2|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4402640|NCT00261443|4229700|B1|Hispanic/Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4402641|NCT00261443|4229698|B3|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4402642|NCT00261443|4229699|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4402643|NCT00261443|4229700|B1|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4402644|NCT00261443|4229698|B3|Asian||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4402645|NCT00261443|4229699|B2|Asian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4402646|NCT00261443|4229700|B1|Asian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4402647|NCT00261443|4229698|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4402648|NCT00261443|4229699|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4402649|NCT00261443|4229700|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4402650|NCT00261443|4229698|B3|White||Race/Ethnicity, Customized||participants|Number|230|230.0||||||
4402651|NCT00261443|4229699|B2|White||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
4402652|NCT00261443|4229700|B1|White||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
4402653|NCT00261443|4229698|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4402654|NCT00261443|4229699|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4402655|NCT00261443|4229700|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4402656|NCT00261443|4229698|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4402657|NCT00261443|4229699|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4402658|NCT00261443|4229700|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4402659|NCT00261443|4229698|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|12.34|12.34|||
4402660|NCT00261443|4229699|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|12.43|12.43|||
4402661|NCT00261443|4229700|B1|||Age||years|Mean|38.8|38.8|Standard Deviation|12.29|12.29|||
4402662|NCT00260962|4229957|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4402664|NCT00260962|4229959|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4402665|NCT00260962|4229957|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4402666|NCT00260962|4229958|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4402667|NCT00260962|4229959|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4402668|NCT00260962|4229957|B3|||Age||years|Mean|27.03|27.03|Standard Deviation|9.90|9.9|||
4402669|NCT00260962|4229958|B2|||Age||years|Mean|23.61|23.61|Standard Deviation|6.5|6.5|||
4402670|NCT00260962|4229959|B1|||Age||years|Mean|29.67|29.67|Standard Deviation|11.59|11.59|||
4402671|NCT00260832|4229968|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402672|NCT00260832|4229969|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402673|NCT00260832|4229970|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402674|NCT00260832|4229968|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402675|NCT00260832|4229969|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402676|NCT00260832|4229970|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402677|NCT00260832|4229968|B3||White|Race (NIH/OMB)||Participants|Count of Participants|422|422.0||||||
4402678|NCT00260832|4229969|B2||White|Race (NIH/OMB)||Participants|Count of Participants|209|209.0||||||
4402679|NCT00260832|4229970|B1||White|Race (NIH/OMB)||Participants|Count of Participants|213|213.0||||||
4402680|NCT00260832|4229968|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4402681|NCT00260832|4229969|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402682|NCT00260832|4229970|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4402683|NCT00260832|4229968|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402684|NCT00260832|4229969|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402685|NCT00260832|4229970|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402686|NCT00260832|4229968|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4402687|NCT00260832|4229969|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4402688|NCT00260832|4229970|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4402689|NCT00260832|4229968|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402690|NCT00260832|4229969|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402691|NCT00260832|4229970|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402692|NCT00260832|4229968|B3||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4402693|NCT00260832|4229969|B2||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4402694|NCT00260832|4229970|B1||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4402695|NCT00260832|4229968|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4402696|NCT00260832|4229969|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4402697|NCT00260832|4229970|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4402698|NCT00260832|4229968|B3|||Age||years|Mean|73.34|73.34|Standard Deviation|5.46|5.46|||
4402699|NCT00260832|4229969|B2|||Age||years|Mean|73.14|73.14|Standard Deviation|5.24|5.24|||
4402700|NCT00260832|4229970|B1|||Age||years|Mean|73.53|73.53|Standard Deviation|5.67|5.67|||
4402701|NCT00260689|4229977|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4402702|NCT00260689|4229978|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4402703|NCT00260689|4229979|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4402704|NCT00260689|4229980|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4402705|NCT00260689|4229977|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4402706|NCT00260689|4229978|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402707|NCT00260689|4229979|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402708|NCT00260689|4229980|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4402709|NCT00260689|4229977|B4||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4402710|NCT00260689|4229978|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4402711|NCT00260689|4229979|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4402712|NCT00260689|4229980|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4402713|NCT00260689|4229977|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4402714|NCT00260689|4229978|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4402715|NCT00260689|4229979|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4402716|NCT00260689|4229980|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4402717|NCT00260689|4229977|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402718|NCT00260689|4229978|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402719|NCT00260689|4229979|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402720|NCT00260689|4229980|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402721|NCT00260689|4229977|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4402722|NCT00260689|4229978|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4402723|NCT00260689|4229979|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4402724|NCT00260689|4229980|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4402725|NCT00260689|4229977|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402726|NCT00260689|4229978|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402727|NCT00260689|4229979|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402728|NCT00260689|4229980|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402729|NCT00260689|4229977|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4402730|NCT00260689|4229978|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402731|NCT00260689|4229979|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4402732|NCT00260689|4229980|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4402733|NCT00260689|4229977|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4402734|NCT00260689|4229978|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4402735|NCT00260689|4229979|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4402736|NCT00260689|4229980|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4402737|NCT00260689|4229977|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4402738|NCT00260689|4229978|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4402739|NCT00260689|4229979|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4402740|NCT00260689|4229980|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4402741|NCT00260689|4229977|B4||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4402742|NCT00260689|4229978|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4402743|NCT00260689|4229979|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4402744|NCT00260689|4229980|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4402745|NCT00260689|4229977|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4402746|NCT00260689|4229978|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4402747|NCT00260689|4229979|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4402748|NCT00260689|4229980|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4402749|NCT00260689|4229977|B4||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4402750|NCT00260689|4229978|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4402751|NCT00260689|4229979|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4402752|NCT00260689|4229980|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4402753|NCT00260689|4229977|B4||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4402754|NCT00260689|4229978|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4402755|NCT00260689|4229979|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4402756|NCT00260689|4229980|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4402757|NCT00260689|4229977|B4||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4402758|NCT00260689|4229978|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4402759|NCT00260689|4229979|B2||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4402760|NCT00260689|4229980|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4402761|NCT00260533|4229996|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4402762|NCT00260533|4229997|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4402763|NCT00260533|4229998|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4402764|NCT00260533|4229996|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4402765|NCT00260533|4229997|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4402766|NCT00260533|4229998|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4402767|NCT00260533|4229996|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402768|NCT00260533|4229997|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402769|NCT00260533|4229998|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402770|NCT00260533|4229996|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4402771|NCT00260533|4229997|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4402772|NCT00260533|4229998|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4402773|NCT00260533|4229996|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402774|NCT00260533|4229997|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402775|NCT00260533|4229998|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402776|NCT00260429|4230005|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4402777|NCT00260429|4230006|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4402778|NCT00260429|4230007|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4402779|NCT00260429|4230005|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4402780|NCT00260429|4230006|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4402781|NCT00260429|4230007|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4402782|NCT00260429|4230005|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4402783|NCT00260429|4230006|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4402784|NCT00260429|4230007|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4402785|NCT00260429|4230005|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|8.5|8.5|||
4402786|NCT00260429|4230006|B2|||Age||years|Mean|63.8|63.8|Standard Deviation|10.0|10.0|||
4402787|NCT00260429|4230007|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|7.6|7.6|||
4402788|NCT00260429|4230005|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4402789|NCT00260429|4230006|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4402790|NCT00260429|4230007|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4402791|NCT00260429|4230005|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4402792|NCT00260429|4230006|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4402793|NCT00260429|4230007|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4402794|NCT00260429|4230005|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402795|NCT00260429|4230006|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402796|NCT00260429|4230007|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402797|NCT00260208|4230014|B3||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4402798|NCT00260208|4230015|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4402799|NCT00260208|4230016|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4402800|NCT00260208|4230014|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4402801|NCT00260208|4230015|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4402802|NCT00260208|4230016|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4402803|NCT00260208|4230014|B3|≥ 65 years||Age, Customized||Participants|Number|34|34.0||||||
4402804|NCT00260208|4230015|B2|≥ 65 years||Age, Customized||Participants|Number|15|15.0||||||
4402805|NCT00260208|4230016|B1|≥ 65 years||Age, Customized||Participants|Number|19|19.0||||||
4402806|NCT00260208|4230014|B3|< 65 years||Age, Customized||Participants|Number|317|317.0||||||
4402807|NCT00260208|4230015|B2|< 65 years||Age, Customized||Participants|Number|154|154.0||||||
4402808|NCT00260208|4230016|B1|< 65 years||Age, Customized||Participants|Number|163|163.0||||||
4402809|NCT00260208|4230014|B3|||Age|Baseline measurements were based on intent-to-treat population which included all patients as randomized that were transplanted, received at least one dose of study drug and had at least one post-baseline efficacy assessment.|years|Mean|54.4|54.4|Standard Deviation|7.0|7.0|||
4402810|NCT00260208|4230015|B2|||Age|Baseline measurements were based on intent-to-treat population which included all patients as randomized that were transplanted, received at least one dose of study drug and had at least one post-baseline efficacy assessment.|years|Mean|54.4|54.4|Standard Deviation|7.1|7.1|||
4402811|NCT00260208|4230016|B1|||Age|Baseline measurements were based on intent-to-treat population which included all patients as randomized that were transplanted, received at least one dose of study drug and had at least one post-baseline efficacy assessment.|years|Mean|54.4|54.4|Standard Deviation|6.9|6.9|||
4402812|NCT00260195|4230045|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
4402813|NCT00260195|4230046|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4402814|NCT00260195|4230047|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4402815|NCT00260195|4230045|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4402816|NCT00260195|4230046|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4402817|NCT00260195|4230047|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4402818|NCT00260195|4230045|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4402819|NCT00260195|4230046|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4402820|NCT00260195|4230047|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4402821|NCT00260195|4230045|B3|||Age||years|Mean|11.5|11.5|Standard Deviation|0.7|0.7|||
4402822|NCT00260195|4230046|B2|||Age||years|Mean|11.5|11.5|Standard Deviation|0.7|0.7|||
4402823|NCT00260195|4230047|B1|||Age||years|Mean|11.4|11.4|Standard Deviation|0.6|0.6|||
4402824|NCT00260195|4230045|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402825|NCT00260195|4230046|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402826|NCT00260195|4230047|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402827|NCT00260195|4230045|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4402828|NCT00260195|4230046|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4402829|NCT00260195|4230047|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4402830|NCT00260195|4230045|B3||<=18 years|Age||Participants|Count of Participants|76|76.0||||||
4402831|NCT00260195|4230046|B2||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4402832|NCT00260195|4230047|B1||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4402833|NCT00260065|4230060|B1|United States||Region of Enrollment||participants|Number|99|99.0||||||
4402834|NCT00260065|4230060|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4402835|NCT00260065|4230060|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402836|NCT00260065|4230060|B1||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4402837|NCT00260065|4230060|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4402838|NCT00260065|4230060|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402839|NCT00260065|4230060|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4402840|NCT00260065|4230060|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4402841|NCT00260065|4230060|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4402842|NCT00260065|4230060|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4402843|NCT00260065|4230060|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|8.78|8.78|||
4402844|NCT00260065|4230060|B1||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
4402845|NCT00260065|4230060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4402846|NCT00260065|4230060|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402847|NCT00259857|4230065|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4402848|NCT00259857|4230066|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4402849|NCT00259857|4230067|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4402850|NCT00259857|4230065|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4402851|NCT00259857|4230066|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4402852|NCT00259857|4230067|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4402853|NCT00259857|4230065|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4402854|NCT00259857|4230066|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4402855|NCT00259857|4230067|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4402856|NCT00259857|4230065|B3|||Age||years|Mean|9.32|9.32|Standard Deviation|0.2|0.2|||
4402857|NCT00259857|4230066|B2|||Age||years|Mean|9.47|9.47|Standard Deviation|2.3|2.3|||
4402858|NCT00259857|4230067|B1|||Age||years|Mean|9.17|9.17|Standard Deviation|2.8|2.8|||
4402859|NCT00259857|4230065|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402860|NCT00259857|4230066|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402861|NCT00259857|4230067|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402862|NCT00259857|4230065|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4402863|NCT00259857|4230066|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4402864|NCT00259857|4230067|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4402865|NCT00259857|4230065|B3||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4402866|NCT00259857|4230066|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4402867|NCT00259857|4230067|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4402868|NCT00259740|4230084|B3|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4402869|NCT00259740|4230085|B2|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4402870|NCT00259740|4230086|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4402871|NCT00259740|4230084|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4402872|NCT00259740|4230085|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4402873|NCT00259740|4230086|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4402874|NCT00259740|4230084|B3|African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4402875|NCT00259740|4230085|B2|African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4402876|NCT00259740|4230086|B1|African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4402877|NCT00259740|4230084|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|74|74.0||||||
4402878|NCT00259740|4230085|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4402879|NCT00259740|4230086|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4402880|NCT00259740|4230084|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4402881|NCT00259740|4230085|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4402882|NCT00259740|4230086|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4402883|NCT00259740|4230084|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4402884|NCT00259740|4230085|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4402885|NCT00259740|4230086|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4402886|NCT00259740|4230084|B3|||Age||Years|Mean|62.1|62.1|Standard Deviation|10.2|10.2|||
4402887|NCT00259740|4230085|B2|||Age||Years|Mean|62.9|62.9|Standard Deviation|9.2|9.2|||
4402888|NCT00259740|4230086|B1|||Age||Years|Mean|61.1|61.1|Standard Deviation|11.4|11.4|||
4402889|NCT00259649|4230097|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4402890|NCT00259649|4230097|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4402891|NCT00259649|4230097|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4402892|NCT00259649|4230097|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402893|NCT00259649|4230097|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4402894|NCT00259649|4230097|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402895|NCT00259610|4230101|B5|United States||Region of Enrollment||participants|Number|755|755.0||||||
4402896|NCT00259610|4230102|B4|United States||Region of Enrollment||participants|Number|124|124.0||||||
4402897|NCT00259610|4230103|B3|United States||Region of Enrollment||participants|Number|255|255.0||||||
4402898|NCT00259610|4230104|B2|United States||Region of Enrollment||participants|Number|132|132.0||||||
4402899|NCT00259610|4230105|B1|United States||Region of Enrollment||participants|Number|244|244.0||||||
4402900|NCT00259610|4230101|B5||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4402901|NCT00259610|4230102|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4402902|NCT00259610|4230103|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4402903|NCT00259610|4230104|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4402904|NCT00259610|4230105|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4402905|NCT00259610|4230101|B5||Female|Sex: Female, Male||Participants|Count of Participants|545|545.0||||||
4402906|NCT00259610|4230102|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4402907|NCT00259610|4230103|B3||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4402908|NCT00259610|4230104|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4402909|NCT00259610|4230105|B1||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4402910|NCT00259610|4230101|B5|||Age||years|Mean|49.4|49.4|Standard Deviation|12.8|12.8|||
4402911|NCT00259610|4230102|B4|||Age||years|Mean|49.3|49.3|Standard Deviation|12.0|12.0|||
4402912|NCT00259610|4230103|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|13.0|13.0|||
4402913|NCT00259610|4230104|B2|||Age||years|Mean|48.8|48.8|Standard Deviation|12.7|12.7|||
4402914|NCT00259610|4230105|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|13.4|13.4|||
4402915|NCT00259610|4230101|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402916|NCT00259610|4230102|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402917|NCT00259610|4230103|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402918|NCT00259610|4230104|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402919|NCT00259610|4230105|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4402920|NCT00259610|4230101|B5||Between 18 and 65 years|Age||Participants|Count of Participants|755|755.0||||||
4402921|NCT00259610|4230102|B4||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4402922|NCT00259610|4230103|B3||Between 18 and 65 years|Age||Participants|Count of Participants|255|255.0||||||
4402923|NCT00259610|4230104|B2||Between 18 and 65 years|Age||Participants|Count of Participants|132|132.0||||||
4402924|NCT00259610|4230105|B1||Between 18 and 65 years|Age||Participants|Count of Participants|244|244.0||||||
4402925|NCT00259610|4230101|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402926|NCT00259610|4230102|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402927|NCT00259610|4230103|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402928|NCT00259610|4230104|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402929|NCT00259610|4230105|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4402930|NCT00259298|4230122|B1|||Years post menopause||years|Mean|21.84|21.84|Standard Deviation|7.65|7.65|||
4402931|NCT00259298|4230122|B1|||Weight||kilogram|Mean|63.80|63.8|Standard Deviation|13.56|13.56|||
4402932|NCT00259298|4230122|B1|lower extremities||Skeletal uptake of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Skeletal uptake describes the percent uptake of radionuclide tracer by the skeleton. Skeletal uptake is defined as percentage of uptake of 99mTc-MDP 4 hours after injection. This value differs from skeletal plasma clearance measurements because it only quantifies the amount of 99mTc-MDP taken up by bone without consideration of concentration of tracer in the plasma.|percentage of uptake|Median|7.09|7.09|Inter-Quartile Range|||6.27|8.46|
4402933|NCT00259298|4230122|B1|upper extremities||Skeletal uptake of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Skeletal uptake describes the percent uptake of radionuclide tracer by the skeleton. Skeletal uptake is defined as percentage of uptake of 99mTc-MDP 4 hours after injection. This value differs from skeletal plasma clearance measurements because it only quantifies the amount of 99mTc-MDP taken up by bone without consideration of concentration of tracer in the plasma.|percentage of uptake|Median|2.98|2.98|Inter-Quartile Range|||2.29|3.81|
4402934|NCT00259298|4230122|B1|pelvis||Skeletal uptake of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Skeletal uptake describes the percent uptake of radionuclide tracer by the skeleton. Skeletal uptake is defined as percentage of uptake of 99mTc-MDP 4 hours after injection. This value differs from skeletal plasma clearance measurements because it only quantifies the amount of 99mTc-MDP taken up by bone without consideration of concentration of tracer in the plasma.|percentage of uptake|Median|4.57|4.57|Inter-Quartile Range|||4.06|5.28|
4402935|NCT00259298|4230122|B1|spine||Skeletal uptake of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Skeletal uptake describes the percent uptake of radionuclide tracer by the skeleton. Skeletal uptake is defined as percentage of uptake of 99mTc-MDP 4 hours after injection. This value differs from skeletal plasma clearance measurements because it only quantifies the amount of 99mTc-MDP taken up by bone without consideration of concentration of tracer in the plasma.|percentage of uptake|Median|4.85|4.85|Inter-Quartile Range|||3.87|5.68|
4402936|NCT00259298|4230122|B1|mandible||Skeletal uptake of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Skeletal uptake describes the percent uptake of radionuclide tracer by the skeleton. Skeletal uptake is defined as percentage of uptake of 99mTc-MDP 4 hours after injection. This value differs from skeletal plasma clearance measurements because it only quantifies the amount of 99mTc-MDP taken up by bone without consideration of concentration of tracer in the plasma.|percentage of uptake|Median|0.14|0.14|Inter-Quartile Range|||0.12|0.19|
4402937|NCT00259298|4230122|B1|skull||Skeletal uptake of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Skeletal uptake describes the percent uptake of radionuclide tracer by the skeleton. Skeletal uptake is defined as percentage of uptake of 99mTc-MDP 4 hours after injection. This value differs from skeletal plasma clearance measurements because it only quantifies the amount of 99mTc-MDP taken up by bone without consideration of concentration of tracer in the plasma.|percentage of uptake|Median|2.59|2.59|Inter-Quartile Range|||1.96|2.95|
4402998|NCT00259272|4230137|B4|Thymic Hypo-Reactivity||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|26|26.0||||||
4402938|NCT00259298|4230122|B1|whole skeleton||Skeletal uptake of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Skeletal uptake describes the percent uptake of radionuclide tracer by the skeleton. Skeletal uptake is defined as percentage of uptake of 99mTc-MDP 4 hours after injection. This value differs from skeletal plasma clearance measurements because it only quantifies the amount of 99mTc-MDP taken up by bone without consideration of concentration of tracer in the plasma.|percentage of uptake|Median|29.4|29.4|Inter-Quartile Range|||27.4|31.7|
4402939|NCT00259298|4230122|B1|lower extremities||Skeletal plasma clearance of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Skeletal plasma clearance is defined as the volume of plasma cleared of tracer (99m Tc-MDP) by the skeleton per unit time (milliliter/minute). Kbone is the rate constant representing plasma clearance of tracer to bone. The Patlak plot method was used to evaluate whole skeleton 99mTc-MDP skeletal plasma clearance (Kbone) and to derive regional values for the skull, mandible, spine, pelvis, and upper and lower extremities.|milliliter/minute|Median|9.12|9.12|Inter-Quartile Range|||7.82|9.86|
4402940|NCT00259298|4230122|B1|upper extremities||Skeletal plasma clearance of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Skeletal plasma clearance is defined as the volume of plasma cleared of tracer (99m Tc-MDP) by the skeleton per unit time (milliliter/minute). Kbone is the rate constant representing plasma clearance of tracer to bone. The Patlak plot method was used to evaluate whole skeleton 99mTc-MDP skeletal plasma clearance (Kbone) and to derive regional values for the skull, mandible, spine, pelvis, and upper and lower extremities.|milliliter/minute|Median|3.70|3.7|Inter-Quartile Range|||3.41|5.15|
4402941|NCT00259298|4230122|B1|pelvis||Skeletal plasma clearance of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Skeletal plasma clearance is defined as the volume of plasma cleared of tracer (99m Tc-MDP) by the skeleton per unit time (milliliter/minute). Kbone is the rate constant representing plasma clearance of tracer to bone. The Patlak plot method was used to evaluate whole skeleton 99mTc-MDP skeletal plasma clearance (Kbone) and to derive regional values for the skull, mandible, spine, pelvis, and upper and lower extremities.|milliliter/minute|Median|5.92|5.92|Inter-Quartile Range|||5.78|6.77|
4402942|NCT00259298|4230122|B1|spine||Skeletal plasma clearance of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Skeletal plasma clearance is defined as the volume of plasma cleared of tracer (99m Tc-MDP) by the skeleton per unit time (milliliter/minute). Kbone is the rate constant representing plasma clearance of tracer to bone. The Patlak plot method was used to evaluate whole skeleton 99mTc-MDP skeletal plasma clearance (Kbone) and to derive regional values for the skull, mandible, spine, pelvis, and upper and lower extremities.|milliliter/minute|Median|6.32|6.32|Inter-Quartile Range|||4.88|7.0|
4402943|NCT00259298|4230122|B1|mandible||Skeletal plasma clearance of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Skeletal plasma clearance is defined as the volume of plasma cleared of tracer (99m Tc-MDP) by the skeleton per unit time (milliliter/minute). Kbone is the rate constant representing plasma clearance of tracer to bone. The Patlak plot method was used to evaluate whole skeleton 99mTc-MDP skeletal plasma clearance (Kbone) and to derive regional values for the skull, mandible, spine, pelvis, and upper and lower extremities.|milliliter/minute|Median|0.17|0.17|Inter-Quartile Range|||0.13|0.24|
4402944|NCT00259298|4230122|B1|skull||Skeletal plasma clearance of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Skeletal plasma clearance is defined as the volume of plasma cleared of tracer (99m Tc-MDP) by the skeleton per unit time (milliliter/minute). Kbone is the rate constant representing plasma clearance of tracer to bone. The Patlak plot method was used to evaluate whole skeleton 99mTc-MDP skeletal plasma clearance (Kbone) and to derive regional values for the skull, mandible, spine, pelvis, and upper and lower extremities.|milliliter/minute|Median|3.07|3.07|Inter-Quartile Range|||2.43|3.74|
4402945|NCT00259298|4230122|B1|whole skeleton||Skeletal plasma clearance of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Skeletal plasma clearance is defined as the volume of plasma cleared of tracer (99m Tc-MDP) by the skeleton per unit time (milliliter/minute). Kbone is the rate constant representing plasma clearance of tracer to bone. The Patlak plot method was used to evaluate whole skeleton 99mTc-MDP skeletal plasma clearance (Kbone) and to derive regional values for the skull, mandible, spine, pelvis, and upper and lower extremities.|milliliter/minute|Median|38.30|38.3|Inter-Quartile Range|||33.0|40.9|
4402946|NCT00259298|4230122|B1|||Qualitative Visual Score of Focal uptake of 99m Technetium methylene diphosphonate (99m Tc-MDP)|Changes in focal uptake (localized, defined areas of uptake) in the whole skeleton were visually scored. Changes were rated on a scale from 0-4: 0=no clinically significant focal areas of skeletal uptake; 1=focal areas affecting <1% of skeleton; 2=focal areas affecting >=5% of skeleton; 3=focal areas affecting >=20% of skeleton; 4=focal areas affecting >=50% of skeleton.|units on scale|Mean|0.7|0.7|Standard Deviation|0.48|0.48|||
4402947|NCT00259298|4230122|B1|||Height||centimeter|Mean|161.25|161.25|Standard Deviation|6.88|6.88|||
4402948|NCT00259298|4230122|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kg/m2|Mean|24.56|24.56|Standard Deviation|5.16|5.16|||
4402949|NCT00259298|4230122|B1|not assessed||Qualitative Visual Assessment of Diffuse Uptake of 99m Technetium methylene diphosphonate|Presented are data only for participants who received a bone scan at baseline. Initial bone scans for each participant were evaluated by a radiologist for an increase in diffuse uptake in the whole skeleton compared to expected values in a healthy population. Subjective visual assessment categorized results into no increase, possible increase, and definite increase.|participants|Number|2|2.0||||||
4402950|NCT00259298|4230122|B1|definite increase||Qualitative Visual Assessment of Diffuse Uptake of 99m Technetium methylene diphosphonate|Presented are data only for participants who received a bone scan at baseline. Initial bone scans for each participant were evaluated by a radiologist for an increase in diffuse uptake in the whole skeleton compared to expected values in a healthy population. Subjective visual assessment categorized results into no increase, possible increase, and definite increase.|participants|Number|0|0.0||||||
4402951|NCT00259298|4230122|B1|possible increase||Qualitative Visual Assessment of Diffuse Uptake of 99m Technetium methylene diphosphonate|Presented are data only for participants who received a bone scan at baseline. Initial bone scans for each participant were evaluated by a radiologist for an increase in diffuse uptake in the whole skeleton compared to expected values in a healthy population. Subjective visual assessment categorized results into no increase, possible increase, and definite increase.|participants|Number|0|0.0||||||
4403154|NCT00259272|4230138|B3|Missing Data||Number of Lifetime Suicide Attempts||participants|Number|1|1.0||||||
4403155|NCT00259272|4230139|B2|Missing Data||Number of Lifetime Suicide Attempts||participants|Number|3|3.0||||||
4402952|NCT00259298|4230122|B1|no increase||Qualitative Visual Assessment of Diffuse Uptake of 99m Technetium methylene diphosphonate|Presented are data only for participants who received a bone scan at baseline. Initial bone scans for each participant were evaluated by a radiologist for an increase in diffuse uptake in the whole skeleton compared to expected values in a healthy population. Subjective visual assessment categorized results into no increase, possible increase, and definite increase.|participants|Number|10|10.0||||||
4402953|NCT00259298|4230122|B1|United Kingdom||Region of Enrollment||participants|Number|12|12.0||||||
4402954|NCT00259298|4230122|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4402955|NCT00259298|4230122|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4402956|NCT00259298|4230122|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4402957|NCT00259298|4230122|B1|||Age||years|Mean|67.17|67.17|Standard Deviation|7.64|7.64|||
4402958|NCT00259285|4230130|B1|||Weight||kilograms|Mean|72.8|72.8|Standard Deviation|12.2|12.2|||
4402959|NCT00259285|4230130|B1|||Height||meters|Mean|1.6|1.6|Standard Deviation|0.1|0.1|||
4402960|NCT00259285|4230130|B1|||Corporal Surface (Body Surface Area)|The total surface area of the body (BSA). BSA was calculated by taking the square root of product of the weight in kilograms times the height in centimeters divided by 3600.|square meters|Mean|1.8|1.8|Standard Deviation|0.2|0.2|||
4402961|NCT00259285|4230130|B1|||Body Mass Index|weight divided by square height|kilograms per square meters|Mean|27.1|27.1|Standard Deviation|4.3|4.3|||
4402962|NCT00259285|4230130|B1|Caucasian||Race/Ethnicity||participants|Number|10|10.0||||||
4402963|NCT00259285|4230130|B1|4 - Completely Disabled||Eastern Cooperative Oncology Group Functional Status||participants|Number|0|0.0||||||
4402964|NCT00259285|4230130|B1|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group Functional Status||participants|Number|0|0.0||||||
4402965|NCT00259285|4230130|B1|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group Functional Status||participants|Number|0|0.0||||||
4402966|NCT00259285|4230130|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Functional Status||participants|Number|2|2.0||||||
4402967|NCT00259285|4230130|B1|0 - Fully Active||Eastern Cooperative Oncology Group Functional Status||participants|Number|8|8.0||||||
4402968|NCT00259285|4230130|B1|Spain||Region of Enrollment||participants|Number|10|10.0||||||
4402969|NCT00259285|4230130|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4402970|NCT00259285|4230130|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4402971|NCT00259285|4230130|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|8.2|8.2|||
4402972|NCT00259272|4230136|B5|||Weight||kilograms|Mean|70.78|70.78|Standard Deviation|15.15|15.15|||
4402973|NCT00259272|4230137|B4|||Weight||kilograms|Mean|70.85|70.85|Standard Deviation|14.41|14.41|||
4402974|NCT00259272|4230138|B3|||Weight||kilograms|Mean|74.42|74.42|Standard Deviation|20.00|20.0|||
4402975|NCT00259272|4230139|B2|||Weight||kilograms|Mean|69.89|69.89|Standard Deviation|14.71|14.71|||
4402976|NCT00259272|4230140|B1|||Weight||kilograms|Mean|68.83|68.83|Standard Deviation|12.34|12.34|||
4402977|NCT00259272|4230136|B5|||Duration of Illness||years|Mean|15.91|15.91|Standard Deviation|12.46|12.46|||
4402978|NCT00259272|4230137|B4|||Duration of Illness||years|Mean|15.70|15.7|Standard Deviation|11.59|11.59|||
4402979|NCT00259272|4230138|B3|||Duration of Illness||years|Mean|19.28|19.28|Standard Deviation|14.54|14.54|||
4402980|NCT00259272|4230139|B2|||Duration of Illness||years|Mean|12.45|12.45|Standard Deviation|9.52|9.52|||
4402981|NCT00259272|4230140|B1|||Duration of Illness||years|Mean|16.86|16.86|Standard Deviation|13.93|13.93|||
4402982|NCT00259272|4230136|B5|||Duration of Current Episode||months|Mean|1.53|1.53|Standard Deviation|2.03|2.03|||
4402983|NCT00259272|4230137|B4|||Duration of Current Episode||months|Mean|1.51|1.51|Standard Deviation|1.49|1.49|||
4402984|NCT00259272|4230138|B3|||Duration of Current Episode||months|Mean|1.71|1.71|Standard Deviation|1.56|1.56|||
4402985|NCT00259272|4230139|B2|||Duration of Current Episode||months|Mean|1.95|1.95|Standard Deviation|3.22|3.22|||
4402986|NCT00259272|4230140|B1|||Duration of Current Episode||months|Mean|0.99|0.99|Standard Deviation|1.51|1.51|||
4402987|NCT00259272|4230136|B5|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilogram per meter squared|Mean|25.09|25.09|Standard Deviation|5.18|5.18|||
4402988|NCT00259272|4230137|B4|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilogram per meter squared|Mean|24.54|24.54|Standard Deviation|3.70|3.7|||
4402989|NCT00259272|4230138|B3|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilogram per meter squared|Mean|26.86|26.86|Standard Deviation|7.75|7.75|||
4402990|NCT00259272|4230139|B2|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilogram per meter squared|Mean|24.73|24.73|Standard Deviation|4.98|4.98|||
4402991|NCT00259272|4230140|B1|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilogram per meter squared|Mean|24.80|24.8|Standard Deviation|4.53|4.53|||
4402992|NCT00259272|4230136|B5|||Age at Time of Onset of First Episode||years|Mean|30.29|30.29|Standard Deviation|12.31|12.31|||
4402993|NCT00259272|4230137|B4|||Age at Time of Onset of First Episode||years|Mean|29.19|29.19|Standard Deviation|10.41|10.41|||
4402994|NCT00259272|4230138|B3|||Age at Time of Onset of First Episode||years|Mean|27.36|27.36|Standard Deviation|10.78|10.78|||
4402995|NCT00259272|4230139|B2|||Age at Time of Onset of First Episode||years|Mean|34.00|34.0|Standard Deviation|13.75|13.75|||
4402996|NCT00259272|4230140|B1|||Age at Time of Onset of First Episode||years|Mean|30.57|30.57|Standard Deviation|13.94|13.94|||
4402997|NCT00259272|4230136|B5|Thymic Hypo-Reactivity||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|30|30.0||||||
4402999|NCT00259272|4230138|B3|Thymic Hypo-Reactivity||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|2|2.0||||||
4403000|NCT00259272|4230139|B2|Thymic Hypo-Reactivity||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|1|1.0||||||
4403001|NCT00259272|4230140|B1|Thymic Hypo-Reactivity||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|1|1.0||||||
4403002|NCT00259272|4230136|B5|Thymic Hyper-Reactivity||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|101|101.0||||||
4403003|NCT00259272|4230137|B4|Thymic Hyper-Reactivity||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|19|19.0||||||
4403004|NCT00259272|4230138|B3|Thymic Hyper-Reactivity||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|20|20.0||||||
4403005|NCT00259272|4230139|B2|Thymic Hyper-Reactivity||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|28|28.0||||||
4403006|NCT00259272|4230140|B1|Thymic Hyper-Reactivity||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|34|34.0||||||
4403007|NCT00259272|4230136|B5|Neither||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|10|10.0||||||
4403008|NCT00259272|4230137|B4|Neither||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|3|3.0||||||
4403009|NCT00259272|4230138|B3|Neither||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|4|4.0||||||
4403010|NCT00259272|4230139|B2|Neither||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|2|2.0||||||
4403011|NCT00259272|4230140|B1|Neither||Thymic Reactivity - Investigator-Based Assessment|Investigators were asked - according to your clinical experience, is the patient with: neither; thymic hyper-reactivity; or thymic hypo-reactivity.|participants|Number|1|1.0||||||
4403012|NCT00259272|4230136|B5|4: Attempts Suicide||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|0|0.0||||||
4403013|NCT00259272|4230137|B4|4: Attempts Suicide||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|0|0.0||||||
4403014|NCT00259272|4230138|B3|4: Attempts Suicide||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|0|0.0||||||
4403015|NCT00259272|4230139|B2|4: Attempts Suicide||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|0|0.0||||||
4403016|NCT00259272|4230140|B1|4: Attempts Suicide||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|0|0.0||||||
4403017|NCT00259272|4230136|B5|3: Suicide Ideas or Gestures||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|0|0.0||||||
4403018|NCT00259272|4230137|B4|3: Suicide Ideas or Gestures||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|0|0.0||||||
4403019|NCT00259272|4230138|B3|3: Suicide Ideas or Gestures||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|0|0.0||||||
4403020|NCT00259272|4230139|B2|3: Suicide Ideas or Gestures||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|0|0.0||||||
4403021|NCT00259272|4230140|B1|3: Suicide Ideas or Gestures||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|0|0.0||||||
4403022|NCT00259272|4230136|B5|2:Wishes He Were Dead or Thoughts of Death to Self||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|14|14.0||||||
4403023|NCT00259272|4230137|B4|2:Wishes He Were Dead or Thoughts of Death to Self||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|10|10.0||||||
4403024|NCT00259272|4230138|B3|2:Wishes He Were Dead or Thoughts of Death to Self||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|3|3.0||||||
4403025|NCT00259272|4230139|B2|2:Wishes He Were Dead or Thoughts of Death to Self||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|0|0.0||||||
4403156|NCT00259272|4230140|B1|Missing Data||Number of Lifetime Suicide Attempts||participants|Number|2|2.0||||||
4403026|NCT00259272|4230140|B1|2:Wishes He Were Dead or Thoughts of Death to Self||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|1|1.0||||||
4403027|NCT00259272|4230136|B5|1: Feels Life Not Worth Living||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|22|22.0||||||
4403028|NCT00259272|4230137|B4|1: Feels Life Not Worth Living||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|12|12.0||||||
4403029|NCT00259272|4230138|B3|1: Feels Life Not Worth Living||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|8|8.0||||||
4403030|NCT00259272|4230139|B2|1: Feels Life Not Worth Living||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|2|2.0||||||
4403031|NCT00259272|4230140|B1|1: Feels Life Not Worth Living||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|0|0.0||||||
4403032|NCT00259272|4230136|B5|0: Absent||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|105|105.0||||||
4403033|NCT00259272|4230137|B4|0: Absent||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|26|26.0||||||
4403034|NCT00259272|4230138|B3|0: Absent||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|15|15.0||||||
4403035|NCT00259272|4230139|B2|0: Absent||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|29|29.0||||||
4403036|NCT00259272|4230140|B1|0: Absent||Suicide Ideation|Assessed via the 17-item Hamilton Depression Rating Scale (HAMD-17) item 3. Item 3 assesses presence and level of suicidal ideations.|participants|Number|35|35.0||||||
4403037|NCT00259272|4230136|B5|No||Previous Central Nervous System Treatment||participants|Number|5|5.0||||||
4403038|NCT00259272|4230137|B4|No||Previous Central Nervous System Treatment||participants|Number|2|2.0||||||
4403039|NCT00259272|4230138|B3|No||Previous Central Nervous System Treatment||participants|Number|0|0.0||||||
4403040|NCT00259272|4230139|B2|No||Previous Central Nervous System Treatment||participants|Number|1|1.0||||||
4403041|NCT00259272|4230140|B1|No||Previous Central Nervous System Treatment||participants|Number|2|2.0||||||
4403042|NCT00259272|4230136|B5|Yes||Previous Central Nervous System Treatment||participants|Number|136|136.0||||||
4403043|NCT00259272|4230137|B4|Yes||Previous Central Nervous System Treatment||participants|Number|46|46.0||||||
4403044|NCT00259272|4230138|B3|Yes||Previous Central Nervous System Treatment||participants|Number|26|26.0||||||
4403045|NCT00259272|4230139|B2|Yes||Previous Central Nervous System Treatment||participants|Number|30|30.0||||||
4403046|NCT00259272|4230140|B1|Yes||Previous Central Nervous System Treatment||participants|Number|34|34.0||||||
4403047|NCT00259272|4230136|B5|Outpatient||Patient Status||participants|Number|69|69.0||||||
4403048|NCT00259272|4230137|B4|Outpatient||Patient Status||participants|Number|24|24.0||||||
4403049|NCT00259272|4230138|B3|Outpatient||Patient Status||participants|Number|16|16.0||||||
4403050|NCT00259272|4230139|B2|Outpatient||Patient Status||participants|Number|19|19.0||||||
4403051|NCT00259272|4230140|B1|Outpatient||Patient Status||participants|Number|10|10.0||||||
4403052|NCT00259272|4230136|B5|Inpatient||Patient Status||participants|Number|72|72.0||||||
4403053|NCT00259272|4230137|B4|Inpatient||Patient Status||participants|Number|24|24.0||||||
4403054|NCT00259272|4230138|B3|Inpatient||Patient Status||participants|Number|10|10.0||||||
4403055|NCT00259272|4230139|B2|Inpatient||Patient Status||participants|Number|12|12.0||||||
4403056|NCT00259272|4230140|B1|Inpatient||Patient Status||participants|Number|26|26.0||||||
4403057|NCT00259272|4230136|B5|Yes||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|47|47.0||||||
4403058|NCT00259272|4230137|B4|Yes||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|14|14.0||||||
4403059|NCT00259272|4230138|B3|Yes||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|22|22.0||||||
4403060|NCT00259272|4230139|B2|Yes||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|3|3.0||||||
4403061|NCT00259272|4230140|B1|Yes||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|8|8.0||||||
4403062|NCT00259272|4230136|B5|No||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|87|87.0||||||
4403063|NCT00259272|4230137|B4|No||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|32|32.0||||||
4403064|NCT00259272|4230138|B3|No||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|3|3.0||||||
4403065|NCT00259272|4230139|B2|No||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|25|25.0||||||
4403066|NCT00259272|4230140|B1|No||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|27|27.0||||||
4403067|NCT00259272|4230136|B5|Missing Data||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|7|7.0||||||
4403068|NCT00259272|4230137|B4|Missing Data||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|2|2.0||||||
4403069|NCT00259272|4230138|B3|Missing Data||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|1|1.0||||||
4403070|NCT00259272|4230139|B2|Missing Data||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|3|3.0||||||
4403071|NCT00259272|4230140|B1|Missing Data||Participants with at Least One Episode of Mixed Episode|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|1|1.0||||||
4403072|NCT00259272|4230136|B5|Yes||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|89|89.0||||||
4403073|NCT00259272|4230137|B4|Yes||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|25|25.0||||||
4403074|NCT00259272|4230138|B3|Yes||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|14|14.0||||||
4403075|NCT00259272|4230139|B2|Yes||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|14|14.0||||||
4403076|NCT00259272|4230140|B1|Yes||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|36|36.0||||||
4403077|NCT00259272|4230136|B5|No||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|48|48.0||||||
4403078|NCT00259272|4230137|B4|No||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|23|23.0||||||
4403079|NCT00259272|4230138|B3|No||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|11|11.0||||||
4403080|NCT00259272|4230139|B2|No||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|14|14.0||||||
4403081|NCT00259272|4230140|B1|No||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|0|0.0||||||
4403082|NCT00259272|4230136|B5|Missing Data||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|4|4.0||||||
4403083|NCT00259272|4230137|B4|Missing Data||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|0|0.0||||||
4403084|NCT00259272|4230138|B3|Missing Data||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|1|1.0||||||
4403085|NCT00259272|4230139|B2|Missing Data||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|3|3.0||||||
4403157|NCT00259272|4230136|B5|Bipolar Disorder II - Depressed||Diagnostic Summary||participants|Number|18|18.0||||||
4403086|NCT00259272|4230140|B1|Missing Data||Participants with at Least One Episode of Mania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|0|0.0||||||
4403087|NCT00259272|4230136|B5|Yes||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|65|65.0||||||
4403088|NCT00259272|4230137|B4|Yes||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|22|22.0||||||
4403089|NCT00259272|4230138|B3|Yes||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|9|9.0||||||
4403090|NCT00259272|4230139|B2|Yes||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|30|30.0||||||
4403091|NCT00259272|4230140|B1|Yes||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|4|4.0||||||
4403092|NCT00259272|4230136|B5|No||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|70|70.0||||||
4403093|NCT00259272|4230137|B4|No||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|25|25.0||||||
4403094|NCT00259272|4230138|B3|No||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|14|14.0||||||
4403095|NCT00259272|4230139|B2|No||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|1|1.0||||||
4403096|NCT00259272|4230140|B1|No||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|30|30.0||||||
4403097|NCT00259272|4230136|B5|Missing Data||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|6|6.0||||||
4403098|NCT00259272|4230137|B4|Missing Data||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|1|1.0||||||
4403099|NCT00259272|4230138|B3|Missing Data||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|3|3.0||||||
4403100|NCT00259272|4230139|B2|Missing Data||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|0|0.0||||||
4403101|NCT00259272|4230140|B1|Missing Data||Participants with at Least One Episode of Hypomania|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|2|2.0||||||
4403102|NCT00259272|4230136|B5|Yes||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|128|128.0||||||
4403103|NCT00259272|4230137|B4|Yes||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|48|48.0||||||
4403104|NCT00259272|4230138|B3|Yes||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|21|21.0||||||
4403105|NCT00259272|4230139|B2|Yes||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|29|29.0||||||
4403106|NCT00259272|4230140|B1|Yes||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|30|30.0||||||
4403107|NCT00259272|4230136|B5|No||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|12|12.0||||||
4403158|NCT00259272|4230137|B4|Bipolar Disorder II - Depressed||Diagnostic Summary||participants|Number|17|17.0||||||
4403108|NCT00259272|4230137|B4|No||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|0|0.0||||||
4403109|NCT00259272|4230138|B3|No||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|4|4.0||||||
4403110|NCT00259272|4230139|B2|No||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|2|2.0||||||
4403111|NCT00259272|4230140|B1|No||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|6|6.0||||||
4403112|NCT00259272|4230136|B5|Missing Data||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|1|1.0||||||
4403113|NCT00259272|4230137|B4|Missing Data||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|0|0.0||||||
4403114|NCT00259272|4230138|B3|Missing Data||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|1|1.0||||||
4403115|NCT00259272|4230139|B2|Missing Data||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|0|0.0||||||
4403116|NCT00259272|4230140|B1|Missing Data||Participants with at Least One Episode of Depression|Presence of at least one previous episode was defined as: number of episodes in the past 12 months reported and/or number of episodes lifetime reported and/or year of onset of the first symptoms reported.|participants|Number|0|0.0||||||
4403117|NCT00259272|4230136|B5|10||Number of Lifetime Suicide Attempts||participants|Number|2|2.0||||||
4403118|NCT00259272|4230137|B4|10||Number of Lifetime Suicide Attempts||participants|Number|1|1.0||||||
4403119|NCT00259272|4230138|B3|10||Number of Lifetime Suicide Attempts||participants|Number|1|1.0||||||
4403120|NCT00259272|4230139|B2|10||Number of Lifetime Suicide Attempts||participants|Number|0|0.0||||||
4403121|NCT00259272|4230140|B1|10||Number of Lifetime Suicide Attempts||participants|Number|0|0.0||||||
4403122|NCT00259272|4230136|B5|6||Number of Lifetime Suicide Attempts||participants|Number|1|1.0||||||
4403123|NCT00259272|4230137|B4|6||Number of Lifetime Suicide Attempts||participants|Number|0|0.0||||||
4403124|NCT00259272|4230138|B3|6||Number of Lifetime Suicide Attempts||participants|Number|0|0.0||||||
4403125|NCT00259272|4230139|B2|6||Number of Lifetime Suicide Attempts||participants|Number|1|1.0||||||
4403126|NCT00259272|4230140|B1|6||Number of Lifetime Suicide Attempts||participants|Number|0|0.0||||||
4403127|NCT00259272|4230136|B5|5||Number of Lifetime Suicide Attempts||participants|Number|2|2.0||||||
4403128|NCT00259272|4230137|B4|5||Number of Lifetime Suicide Attempts||participants|Number|2|2.0||||||
4403129|NCT00259272|4230138|B3|5||Number of Lifetime Suicide Attempts||participants|Number|0|0.0||||||
4403130|NCT00259272|4230139|B2|5||Number of Lifetime Suicide Attempts||participants|Number|0|0.0||||||
4403131|NCT00259272|4230140|B1|5||Number of Lifetime Suicide Attempts||participants|Number|0|0.0||||||
4403132|NCT00259272|4230136|B5|4||Number of Lifetime Suicide Attempts||participants|Number|3|3.0||||||
4403133|NCT00259272|4230137|B4|4||Number of Lifetime Suicide Attempts||participants|Number|2|2.0||||||
4403134|NCT00259272|4230138|B3|4||Number of Lifetime Suicide Attempts||participants|Number|0|0.0||||||
4403135|NCT00259272|4230139|B2|4||Number of Lifetime Suicide Attempts||participants|Number|1|1.0||||||
4403136|NCT00259272|4230140|B1|4||Number of Lifetime Suicide Attempts||participants|Number|0|0.0||||||
4403137|NCT00259272|4230136|B5|2||Number of Lifetime Suicide Attempts||participants|Number|13|13.0||||||
4403138|NCT00259272|4230137|B4|2||Number of Lifetime Suicide Attempts||participants|Number|8|8.0||||||
4403139|NCT00259272|4230138|B3|2||Number of Lifetime Suicide Attempts||participants|Number|3|3.0||||||
4403140|NCT00259272|4230139|B2|2||Number of Lifetime Suicide Attempts||participants|Number|0|0.0||||||
4403141|NCT00259272|4230140|B1|2||Number of Lifetime Suicide Attempts||participants|Number|2|2.0||||||
4403142|NCT00259272|4230136|B5|1||Number of Lifetime Suicide Attempts||participants|Number|22|22.0||||||
4403143|NCT00259272|4230137|B4|1||Number of Lifetime Suicide Attempts||participants|Number|5|5.0||||||
4403144|NCT00259272|4230138|B3|1||Number of Lifetime Suicide Attempts||participants|Number|6|6.0||||||
4403145|NCT00259272|4230139|B2|1||Number of Lifetime Suicide Attempts||participants|Number|3|3.0||||||
4403146|NCT00259272|4230140|B1|1||Number of Lifetime Suicide Attempts||participants|Number|8|8.0||||||
4403147|NCT00259272|4230136|B5|0||Number of Lifetime Suicide Attempts||participants|Number|90|90.0||||||
4403148|NCT00259272|4230137|B4|0||Number of Lifetime Suicide Attempts||participants|Number|28|28.0||||||
4403149|NCT00259272|4230138|B3|0||Number of Lifetime Suicide Attempts||participants|Number|15|15.0||||||
4403150|NCT00259272|4230139|B2|0||Number of Lifetime Suicide Attempts||participants|Number|23|23.0||||||
4403151|NCT00259272|4230140|B1|0||Number of Lifetime Suicide Attempts||participants|Number|24|24.0||||||
4403152|NCT00259272|4230136|B5|Missing Data||Number of Lifetime Suicide Attempts||participants|Number|8|8.0||||||
4403153|NCT00259272|4230137|B4|Missing Data||Number of Lifetime Suicide Attempts||participants|Number|2|2.0||||||
4403159|NCT00259272|4230138|B3|Bipolar Disorder II - Depressed||Diagnostic Summary||participants|Number|1|1.0||||||
4403160|NCT00259272|4230139|B2|Bipolar Disorder II - Depressed||Diagnostic Summary||participants|Number|0|0.0||||||
4403161|NCT00259272|4230140|B1|Bipolar Disorder II - Depressed||Diagnostic Summary||participants|Number|0|0.0||||||
4403162|NCT00259272|4230136|B5|Bipolar Disorder II - Hypomanic||Diagnostic Summary||participants|Number|18|18.0||||||
4403163|NCT00259272|4230137|B4|Bipolar Disorder II - Hypomanic||Diagnostic Summary||participants|Number|0|0.0||||||
4403164|NCT00259272|4230138|B3|Bipolar Disorder II - Hypomanic||Diagnostic Summary||participants|Number|1|1.0||||||
4403165|NCT00259272|4230139|B2|Bipolar Disorder II - Hypomanic||Diagnostic Summary||participants|Number|17|17.0||||||
4403166|NCT00259272|4230140|B1|Bipolar Disorder II - Hypomanic||Diagnostic Summary||participants|Number|0|0.0||||||
4403167|NCT00259272|4230136|B5|Bipolar Disorder I||Diagnostic Summary||participants|Number|107|107.0||||||
4403168|NCT00259272|4230137|B4|Bipolar Disorder I||Diagnostic Summary||participants|Number|31|31.0||||||
4403169|NCT00259272|4230138|B3|Bipolar Disorder I||Diagnostic Summary||participants|Number|26|26.0||||||
4403170|NCT00259272|4230139|B2|Bipolar Disorder I||Diagnostic Summary||participants|Number|14|14.0||||||
4403171|NCT00259272|4230140|B1|Bipolar Disorder I||Diagnostic Summary||participants|Number|36|36.0||||||
4403172|NCT00259272|4230136|B5|France||Region of Enrollment||participants|Number|141|141.0||||||
4403173|NCT00259272|4230137|B4|France||Region of Enrollment||participants|Number|48|48.0||||||
4403174|NCT00259272|4230138|B3|France||Region of Enrollment||participants|Number|26|26.0||||||
4403175|NCT00259272|4230139|B2|France||Region of Enrollment||participants|Number|31|31.0||||||
4403176|NCT00259272|4230140|B1|France||Region of Enrollment||participants|Number|36|36.0||||||
4403177|NCT00259272|4230136|B5||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4403178|NCT00259272|4230137|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4403179|NCT00259272|4230138|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4403180|NCT00259272|4230139|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4403181|NCT00259272|4230140|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4403182|NCT00259272|4230136|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4403183|NCT00259272|4230137|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4403184|NCT00259272|4230138|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4403185|NCT00259272|4230139|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4403186|NCT00259272|4230140|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4403187|NCT00259272|4230136|B5|||Age||years|Mean|45.61|45.61|Standard Deviation|12.91|12.91|||
4403188|NCT00259272|4230137|B4|||Age||years|Mean|44.35|44.35|Standard Deviation|11.98|11.98|||
4403189|NCT00259272|4230138|B3|||Age||years|Mean|46.62|46.62|Standard Deviation|12.87|12.87|||
4403190|NCT00259272|4230139|B2|||Age||years|Mean|45.81|45.81|Standard Deviation|11.68|11.68|||
4403191|NCT00259272|4230140|B1|||Age||years|Mean|46.39|46.39|Standard Deviation|15.32|15.32|||
4403192|NCT00259090|4230218|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4403193|NCT00259090|4230219|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4403194|NCT00259090|4230220|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4403195|NCT00259090|4230221|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4403196|NCT00259090|4230218|B4||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4403197|NCT00259090|4230219|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4403198|NCT00259090|4230220|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4403199|NCT00259090|4230221|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4403200|NCT00259090|4230218|B4|Not available||Age, Customized||Participants|Number|4|4.0||||||
4403201|NCT00259090|4230219|B3|Not available||Age, Customized||Participants|Number|2|2.0||||||
4403202|NCT00259090|4230220|B2|Not available||Age, Customized||Participants|Number|2|2.0||||||
4403203|NCT00259090|4230221|B1|Not available||Age, Customized||Participants|Number|0|0.0||||||
4403204|NCT00259090|4230218|B4|80 - 89 years||Age, Customized||Participants|Number|7|7.0||||||
4403205|NCT00259090|4230219|B3|80 - 89 years||Age, Customized||Participants|Number|2|2.0||||||
4403206|NCT00259090|4230220|B2|80 - 89 years||Age, Customized||Participants|Number|3|3.0||||||
4403207|NCT00259090|4230221|B1|80 - 89 years||Age, Customized||Participants|Number|2|2.0||||||
4403208|NCT00259090|4230218|B4|70 - 79 years||Age, Customized||Participants|Number|28|28.0||||||
4403209|NCT00259090|4230219|B3|70 - 79 years||Age, Customized||Participants|Number|9|9.0||||||
4403210|NCT00259090|4230220|B2|70 - 79 years||Age, Customized||Participants|Number|6|6.0||||||
4403211|NCT00259090|4230221|B1|70 - 79 years||Age, Customized||Participants|Number|13|13.0||||||
4403212|NCT00259090|4230218|B4|60 - 69 years||Age, Customized||Participants|Number|34|34.0||||||
4403213|NCT00259090|4230219|B3|60 - 69 years||Age, Customized||Participants|Number|14|14.0||||||
4403214|NCT00259090|4230220|B2|60 - 69 years||Age, Customized||Participants|Number|7|7.0||||||
4403215|NCT00259090|4230221|B1|60 - 69 years||Age, Customized||Participants|Number|13|13.0||||||
4403216|NCT00259090|4230218|B4|50 - 59 years||Age, Customized||Participants|Number|30|30.0||9.0|9.0|||
4403217|NCT00259090|4230219|B3|50 - 59 years||Age, Customized||Participants|Number|10|10.0||8.7|8.7|||
4403218|NCT00259090|4230220|B2|50 - 59 years||Age, Customized||Participants|Number|13|13.0||10.5|10.5|||
4403219|NCT00259090|4230221|B1|50 - 59 years||Age, Customized||Participants|Number|7|7.0||8.5|8.5|||
4403220|NCT00259012|4230237|B3||Male|Sex: Female, Male||Participants|Count of Participants|39.0|39.0||||||
4403221|NCT00259012|4230238|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4403222|NCT00259012|4230239|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4403223|NCT00259012|4230237|B3||Female|Sex: Female, Male||Participants|Count of Participants|28.0|28.0||||||
4403224|NCT00259012|4230238|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4403225|NCT00259012|4230239|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4403226|NCT00259012|4230237|B3|||Age||months|Mean|5.94|5.94|Standard Deviation|3.19|3.19|||
4403227|NCT00259012|4230238|B2|||Age||months|Mean|5.91|5.91|Standard Deviation|3.42|3.42|||
4403228|NCT00259012|4230239|B1|||Age||months|Mean|5.98|5.98|Standard Deviation|2.98|2.98|||
4403229|NCT00258908|4230272|B1|Taiwan||Region of Enrollment||participants|Number|112|112.0||||||
4403230|NCT00258908|4230272|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4403231|NCT00258908|4230272|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4403232|NCT00258908|4230272|B1|||Age||years|Mean|6.8|6.8|Standard Deviation|0.30|0.3|||
4403233|NCT00258908|4230272|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403234|NCT00258908|4230272|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403235|NCT00258908|4230272|B1||<=18 years|Age||Participants|Count of Participants|112|112.0||||||
4403236|NCT00258895|4230278|B3|United States||Region of Enrollment||participants|Number|649|649.0||||||
4403237|NCT00258895|4230279|B2|United States||Region of Enrollment||participants|Number|162|162.0||||||
4403238|NCT00258895|4230280|B1|United States||Region of Enrollment||participants|Number|487|487.0||||||
4403239|NCT00258895|4230278|B3||Male|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4403240|NCT00258895|4230279|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4403241|NCT00258895|4230280|B1||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4403242|NCT00258895|4230278|B3||Female|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4403243|NCT00258895|4230279|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4403244|NCT00258895|4230280|B1||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4403245|NCT00258895|4230278|B3|||Age||Years|Mean|4.1|4.1|Standard Deviation|0.14|0.14|||
4403246|NCT00258895|4230279|B2|||Age||Years|Mean|4.1|4.1|Standard Deviation|0.16|0.16|||
4403247|NCT00258895|4230280|B1|||Age||Years|Mean|4.1|4.1|Standard Deviation|0.14|0.14|||
4403248|NCT00258895|4230278|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403249|NCT00258895|4230279|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403250|NCT00258895|4230280|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403251|NCT00258895|4230278|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403252|NCT00258895|4230279|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403253|NCT00258895|4230280|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403254|NCT00258895|4230278|B3||<=18 years|Age||Participants|Count of Participants|649|649.0||||||
4403255|NCT00258895|4230279|B2||<=18 years|Age||Participants|Count of Participants|162|162.0||||||
4403256|NCT00258895|4230280|B1||<=18 years|Age||Participants|Count of Participants|487|487.0||||||
4403257|NCT00258882|4230295|B3|September to November||Seasonality (Time of vaccination)||Participants|Number|65834|65834.0||||||
4403258|NCT00258882|4230296|B2|September to November||Seasonality (Time of vaccination)||Participants|Number|46812|46812.0||||||
4403259|NCT00258882|4230297|B1|September to November||Seasonality (Time of vaccination)||Participants|Number|19022|19022.0||||||
4403260|NCT00258882|4230295|B3|June to August||Seasonality (Time of vaccination)||Participants|Number|112079|112079.0||||||
4403261|NCT00258882|4230296|B2|June to August||Seasonality (Time of vaccination)||Participants|Number|62906|62906.0||||||
4403262|NCT00258882|4230297|B1|June to August||Seasonality (Time of vaccination)||Participants|Number|49173|49173.0||||||
4403263|NCT00258882|4230295|B3|March to May||Seasonality (Time of vaccination)||Participants|Number|86690|86690.0||||||
4403264|NCT00258882|4230296|B2|March to May||Seasonality (Time of vaccination)||Participants|Number|51039|51039.0||||||
4403265|NCT00258882|4230297|B1|March to May||Seasonality (Time of vaccination)||Participants|Number|35651|35651.0||||||
4403266|NCT00258882|4230295|B3|December to February||Seasonality (Time of vaccination)||Participants|Number|62690|62690.0||||||
4403267|NCT00258882|4230296|B2|December to February||Seasonality (Time of vaccination)||Participants|Number|42397|42397.0||||||
4403268|NCT00258882|4230297|B1|December to February||Seasonality (Time of vaccination)||Participants|Number|20293|20293.0||||||
4403269|NCT00258882|4230295|B3|United States||Region of Enrollment||participants|Number|327293|327293.0||||||
4403270|NCT00258882|4230296|B2|United States||Region of Enrollment||participants|Number|203154|203154.0||||||
4403271|NCT00258882|4230297|B1|United States||Region of Enrollment||participants|Number|124139|124139.0||||||
4403272|NCT00258882|4230295|B3||Male|Sex: Female, Male||Participants|Count of Participants|155328|155328.0||||||
4403273|NCT00258882|4230296|B2||Male|Sex: Female, Male||Participants|Count of Participants|98256|98256.0||||||
4403274|NCT00258882|4230297|B1||Male|Sex: Female, Male||Participants|Count of Participants|57072|57072.0||||||
4403275|NCT00258882|4230295|B3||Female|Sex: Female, Male||Participants|Count of Participants|171965|171965.0||||||
4403276|NCT00258882|4230296|B2||Female|Sex: Female, Male||Participants|Count of Participants|104898|104898.0||||||
4403277|NCT00258882|4230297|B1||Female|Sex: Female, Male||Participants|Count of Participants|67067|67067.0||||||
4403278|NCT00258882|4230295|B3|||Age||Years|Mean|36.4|36.4|Standard Deviation|20.9|20.9|||
4403279|NCT00258882|4230296|B2|||Age||Years|Mean|39.0|39.0|Standard Deviation|21.6|21.6|||
4403280|NCT00258882|4230297|B1|||Age||Years|Mean|32.1|32.1|Standard Deviation|19.0|19.0|||
4403281|NCT00258882|4230295|B3||>=65 years|Age||Participants|Count of Participants|28005|28005.0||||||
4403282|NCT00258882|4230296|B2||>=65 years|Age||Participants|Count of Participants|24941|24941.0||||||
4403283|NCT00258882|4230297|B1||>=65 years|Age||Participants|Count of Participants|3064|3064.0||||||
4403284|NCT00258882|4230295|B3||Between 18 and 65 years|Age||Participants|Count of Participants|190251|190251.0||||||
4403285|NCT00258882|4230296|B2||Between 18 and 65 years|Age||Participants|Count of Participants|119390|119390.0||||||
4403286|NCT00258882|4230297|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70861|70861.0||||||
4403287|NCT00258882|4230295|B3||<=18 years|Age||Participants|Count of Participants|109037|109037.0||||||
4403288|NCT00258882|4230296|B2||<=18 years|Age||Participants|Count of Participants|58823|58823.0||||||
4403289|NCT00258882|4230297|B1||<=18 years|Age||Participants|Count of Participants|50214|50214.0||||||
4403290|NCT00258856|4230313|B5|United States||Region of Enrollment||participants|Number|234|234.0||||||
4403291|NCT00258856|4230314|B4|United States||Region of Enrollment||participants|Number|59|59.0||||||
4403292|NCT00258856|4230315|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4403293|NCT00258856|4230316|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4403294|NCT00258856|4230317|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4403295|NCT00258856|4230313|B5||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4403296|NCT00258856|4230314|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4403297|NCT00258856|4230315|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4403298|NCT00258856|4230316|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4403299|NCT00258856|4230317|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4403300|NCT00258856|4230313|B5||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4403301|NCT00258856|4230314|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4403302|NCT00258856|4230315|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4403303|NCT00258856|4230316|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4403304|NCT00258856|4230317|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4403305|NCT00258856|4230313|B5|||Age||years|Mean|11.0|11.0|Standard Deviation|2.51|2.51|||
4403306|NCT00258856|4230314|B4|||Age||years|Mean|11.9|11.9|Standard Deviation|2.06|2.06|||
4403307|NCT00258856|4230315|B3|||Age||years|Mean|11.7|11.7|Standard Deviation|2.27|2.27|||
4403308|NCT00258856|4230316|B2|||Age||years|Mean|10.6|10.6|Standard Deviation|2.60|2.6|||
4403309|NCT00258856|4230317|B1|||Age||years|Mean|9.9|9.9|Standard Deviation|2.56|2.56|||
4403310|NCT00258856|4230313|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403311|NCT00258856|4230314|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403312|NCT00258856|4230315|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403313|NCT00258856|4230316|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403314|NCT00258856|4230317|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403315|NCT00258856|4230313|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403316|NCT00258856|4230314|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403317|NCT00258856|4230315|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403318|NCT00258856|4230316|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403319|NCT00258856|4230317|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403320|NCT00258856|4230313|B5||<=18 years|Age||Participants|Count of Participants|234|234.0||||||
4403321|NCT00258856|4230314|B4||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
4403322|NCT00258856|4230315|B3||<=18 years|Age||Participants|Count of Participants|58|58.0||||||
4403323|NCT00258856|4230316|B2||<=18 years|Age||Participants|Count of Participants|58|58.0||||||
4403324|NCT00258856|4230317|B1||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
4403325|NCT00258830|4230330|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4403326|NCT00258830|4230331|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4403327|NCT00258830|4230332|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4403328|NCT00258830|4230330|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4403329|NCT00258830|4230331|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4403330|NCT00258830|4230332|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4403331|NCT00258830|4230330|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4403332|NCT00258830|4230331|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4403333|NCT00258830|4230332|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4403334|NCT00258830|4230330|B3|||Age||Years|Mean|59.3|59.3|Standard Deviation|18.85|18.85|||
4403335|NCT00258830|4230331|B2|||Age||Years|Mean|75.7|75.7|Standard Deviation|6.24|6.24|||
4403336|NCT00258830|4230332|B1|||Age||Years|Mean|42.8|42.8|Standard Deviation|11.25|11.25|||
4403337|NCT00258830|4230330|B3||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4403338|NCT00258830|4230331|B2||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4403339|NCT00258830|4230332|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403340|NCT00258830|4230330|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4403341|NCT00258830|4230331|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4403342|NCT00258830|4230332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4403343|NCT00258830|4230330|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4403344|NCT00258830|4230331|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403345|NCT00258830|4230332|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4403346|NCT00258817|4230345|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4403347|NCT00258817|4230346|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4403348|NCT00258817|4230347|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4403349|NCT00258817|4230345|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4403350|NCT00258817|4230346|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4403351|NCT00258817|4230347|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4403352|NCT00258817|4230345|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4403353|NCT00258817|4230346|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4403354|NCT00258817|4230347|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4403355|NCT00258817|4230345|B3|||Age||Months|Mean|19.18|19.18|Standard Deviation|10.24|10.24|||
4403356|NCT00258817|4230346|B2|||Age||Months|Mean|26.43|26.43|Standard Deviation|8.00|8.0|||
4403357|NCT00258817|4230347|B1|||Age||Months|Mean|11.92|11.92|Standard Deviation|6.36|6.36|||
4403358|NCT00258817|4230345|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403359|NCT00258817|4230346|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403360|NCT00258817|4230347|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403361|NCT00258817|4230345|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403362|NCT00258817|4230346|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403363|NCT00258817|4230347|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403364|NCT00258817|4230345|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4403365|NCT00258817|4230346|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4403366|NCT00258817|4230347|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4403367|NCT00258674|4230358|B4|||Number of patients with a semi-annual HbA1c assessment (as determined form Medicare claims data)|As not all patients had claims histories for 2 HbA1c tests in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|1368|1368.0||||||
4403368|NCT00258674|4230359|B3|||Number of patients with a semi-annual HbA1c assessment (as determined form Medicare claims data)|As not all patients had claims histories for 2 HbA1c tests in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|434|434.0||||||
4403369|NCT00258674|4230360|B2|||Number of patients with a semi-annual HbA1c assessment (as determined form Medicare claims data)|As not all patients had claims histories for 2 HbA1c tests in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|540|540.0||||||
4403370|NCT00258674|4230361|B1|||Number of patients with a semi-annual HbA1c assessment (as determined form Medicare claims data)|As not all patients had claims histories for 2 HbA1c tests in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|394|394.0||||||
4403371|NCT00258674|4230358|B4|||Number of patients with an annual lipid assessment (as determined from Medicare claims data)|As not all patients had a claim history for a lipid assessment in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|1428|1428.0||||||
4403372|NCT00258674|4230359|B3|||Number of patients with an annual lipid assessment (as determined from Medicare claims data)|As not all patients had a claim history for a lipid assessment in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|448|448.0||||||
4403373|NCT00258674|4230360|B2|||Number of patients with an annual lipid assessment (as determined from Medicare claims data)|As not all patients had a claim history for a lipid assessment in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|582|582.0||||||
4403374|NCT00258674|4230361|B1|||Number of patients with an annual lipid assessment (as determined from Medicare claims data)|As not all patients had a claim history for a lipid assessment in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|398|398.0||||||
4403375|NCT00258674|4230358|B4|||Number of patients with an annual eye exam (as determined from Medicare claims data)|As not all patients had a claim history for an eye exam in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|1200|1200.0||||||
4403376|NCT00258674|4230359|B3|||Number of patients with an annual eye exam (as determined from Medicare claims data)|As not all patients had a claim history for an eye exam in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|353|353.0||||||
4403377|NCT00258674|4230360|B2|||Number of patients with an annual eye exam (as determined from Medicare claims data)|As not all patients had a claim history for an eye exam in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|497|497.0||||||
4403378|NCT00258674|4230361|B1|||Number of patients with an annual eye exam (as determined from Medicare claims data)|As not all patients had a claim history for an eye exam in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|350|350.0||||||
4403379|NCT00258674|4230358|B4|||Number of patients with annual HbA1c assessment (as determined from Medicare claims data)|As not all patients had a claim history for an HbA1c test in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|1725|1725.0||||||
4403380|NCT00258674|4230359|B3|||Number of patients with annual HbA1c assessment (as determined from Medicare claims data)|As not all patients had a claim history for an HbA1c test in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|533|533.0||||||
4403381|NCT00258674|4230360|B2|||Number of patients with annual HbA1c assessment (as determined from Medicare claims data)|As not all patients had a claim history for an HbA1c test in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|680|680.0||||||
4403382|NCT00258674|4230361|B1|||Number of patients with annual HbA1c assessment (as determined from Medicare claims data)|As not all patients had a claim history for an HbA1c test in the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|512|512.0||||||
4403383|NCT00258674|4230358|B4|||Number of patients with annual renal function test (as determined from medical record review)|As not all patients had a renal function test documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|706|706.0||||||
4403384|NCT00258674|4230359|B3|||Number of patients with annual renal function test (as determined from medical record review)|As not all patients had a renal function test documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|234|234.0||||||
4403385|NCT00258674|4230360|B2|||Number of patients with annual renal function test (as determined from medical record review)|As not all patients had a renal function test documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|304|304.0||||||
4403386|NCT00258674|4230361|B1|||Number of patients with annual renal function test (as determined from medical record review)|As not all patients had a renal function test documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|168|168.0||||||
4403387|NCT00258674|4230358|B4|||Number of patients with an annual foot exam (as determined from medical record review)|As not all patients had an eye exam documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|1001|1001.0||||||
4403388|NCT00258674|4230359|B3|||Number of patients with an annual foot exam (as determined from medical record review)|As not all patients had an eye exam documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|363|363.0||||||
4403389|NCT00258674|4230360|B2|||Number of patients with an annual foot exam (as determined from medical record review)|As not all patients had an eye exam documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|409|409.0||||||
4403390|NCT00258674|4230361|B1|||Number of patients with an annual foot exam (as determined from medical record review)|As not all patients had an eye exam documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|229|229.0||||||
4403391|NCT00258674|4230358|B4|||Number of patients with an annual eye exam (as determined from medical record review)|As not all patients had an eye assessment documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|307|307.0||||||
4403392|NCT00258674|4230359|B3|||Number of patients with an annual eye exam (as determined from medical record review)|As not all patients had an eye assessment documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|119|119.0||||||
4403393|NCT00258674|4230360|B2|||Number of patients with an annual eye exam (as determined from medical record review)|As not all patients had an eye assessment documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|127|127.0||||||
4403394|NCT00258674|4230361|B1|||Number of patients with an annual eye exam (as determined from medical record review)|As not all patients had an eye assessment documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|61|61.0||||||
4403395|NCT00258674|4230358|B4|||Number of patients with annual blood pressure assessment (as determined from medical record review)|As not all patients had a blood pressure assessment documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|1874|1874.0||||||
4403396|NCT00258674|4230359|B3|||Number of patients with annual blood pressure assessment (as determined from medical record review)|As not all patients had a blood pressure assessment documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|561|561.0||||||
4403457|NCT00258674|4230360|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403458|NCT00258674|4230361|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403397|NCT00258674|4230360|B2|||Number of patients with annual blood pressure assessment (as determined from medical record review)|As not all patients had a blood pressure assessment documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|751|751.0||||||
4403398|NCT00258674|4230361|B1|||Number of patients with annual blood pressure assessment (as determined from medical record review)|As not all patients had a blood pressure assessment documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|562|562.0||||||
4403399|NCT00258674|4230358|B4|||Number of patients with an annual lipid assessment (as determined from medical record review)|As not all patients had a lipid assessment documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|1388|1388.0||||||
4403400|NCT00258674|4230359|B3|||Number of patients with an annual lipid assessment (as determined from medical record review)|As not all patients had a lipid assessment documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|441|441.0||||||
4403401|NCT00258674|4230360|B2|||Number of patients with an annual lipid assessment (as determined from medical record review)|As not all patients had a lipid assessment documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|567|567.0||||||
4403402|NCT00258674|4230361|B1|||Number of patients with an annual lipid assessment (as determined from medical record review)|As not all patients had a lipid assessment documented in the medical record for the previous 12 months, the number of patients reported in each study arm for this measure is lower than the total number of baseline participants in that study arm.|participants|Number|380|380.0||||||
4403403|NCT00258674|4230358|B4|||number of patients with annual HbA1c assessment (as determined from medical record review)|Not all patients had an HbA1c test documented in the medical record within the past 12 months. As such, the number of participants in each study arm that have an annual HbA1c assessment is lower than the total number of baseline participants in that study arm.|participants|Number|1763|1763.0||||||
4403404|NCT00258674|4230359|B3|||number of patients with annual HbA1c assessment (as determined from medical record review)|Not all patients had an HbA1c test documented in the medical record within the past 12 months. As such, the number of participants in each study arm that have an annual HbA1c assessment is lower than the total number of baseline participants in that study arm.|participants|Number|562|562.0||||||
4403405|NCT00258674|4230360|B2|||number of patients with annual HbA1c assessment (as determined from medical record review)|Not all patients had an HbA1c test documented in the medical record within the past 12 months. As such, the number of participants in each study arm that have an annual HbA1c assessment is lower than the total number of baseline participants in that study arm.|participants|Number|693|693.0||||||
4403406|NCT00258674|4230361|B1|||number of patients with annual HbA1c assessment (as determined from medical record review)|Not all patients had an HbA1c test documented in the medical record within the past 12 months. As such, the number of participants in each study arm that have an annual HbA1c assessment is lower than the total number of baseline participants in that study arm.|participants|Number|508|508.0||||||
4403407|NCT00258674|4230358|B4|||mean systolic blood pressure||mmHg|Mean|139.6|139.6|Standard Deviation|0.4|0.4|||
4403408|NCT00258674|4230359|B3|||mean systolic blood pressure||mmHg|Mean|140.2|140.2|Standard Deviation|18.0|18.0|||
4403409|NCT00258674|4230360|B2|||mean systolic blood pressure||mmHg|Mean|139.7|139.7|Standard Deviation|18.6|18.6|||
4403410|NCT00258674|4230361|B1|||mean systolic blood pressure||mmHg|Mean|139.5|139.5|Standard Deviation|18.5|18.5|||
4403411|NCT00258674|4230358|B4|||mean diastolic blood pressure||mmHg|Mean|76.8|76.8|Standard Deviation|0.2|0.2|||
4403412|NCT00258674|4230359|B3|||mean diastolic blood pressure||mmHg|Mean|77.1|77.1|Standard Deviation|9.8|9.8|||
4403413|NCT00258674|4230360|B2|||mean diastolic blood pressure||mmHg|Mean|77.7|77.7|Standard Deviation|9.5|9.5|||
4403414|NCT00258674|4230361|B1|||mean diastolic blood pressure||mmHg|Mean|76.0|76.0|Standard Deviation|9.9|9.9|||
4403415|NCT00258674|4230358|B4|||mean LDL level||mg/dL|Mean|104.9|104.9|Standard Deviation|0.9|0.9|||
4403416|NCT00258674|4230359|B3|||mean LDL level||mg/dL|Mean|104.3|104.3|Standard Deviation|33.9|33.9|||
4403417|NCT00258674|4230360|B2|||mean LDL level||mg/dL|Mean|104.6|104.6|Standard Deviation|32.6|32.6|||
4403418|NCT00258674|4230361|B1|||mean LDL level||mg/dL|Mean|106.9|106.9|Standard Deviation|32.9|32.9|||
4403419|NCT00258674|4230358|B4|||Mean HbA1c level||percent|Mean|7.2|7.2|Standard Deviation|0.03|0.03|||
4403420|NCT00258674|4230359|B3|||Mean HbA1c level||percent|Mean|7.1|7.1|Standard Deviation|1.4|1.4|||
4403421|NCT00258674|4230360|B2|||Mean HbA1c level||percent|Mean|7.2|7.2|Standard Deviation|1.4|1.4|||
4403422|NCT00258674|4230361|B1|||Mean HbA1c level||percent|Mean|7.2|7.2|Standard Deviation|1.5|1.5|||
4403423|NCT00258674|4230358|B4|||Number of patients with blood pressure <130/80 mmHg|This measure reports the number of patients in each study arm who had achieved the recommended level of blood pressure control, as demonstrated by a value <130/80 mmHg. As not all patients achieved this level of control, the numbers differ from the Overall Number of Baseline Participants.|participants|Number|345|345.0||||||
4403424|NCT00258674|4230359|B3|||Number of patients with blood pressure <130/80 mmHg|This measure reports the number of patients in each study arm who had achieved the recommended level of blood pressure control, as demonstrated by a value <130/80 mmHg. As not all patients achieved this level of control, the numbers differ from the Overall Number of Baseline Participants.|participants|Number|99|99.0||||||
4403425|NCT00258674|4230360|B2|||Number of patients with blood pressure <130/80 mmHg|This measure reports the number of patients in each study arm who had achieved the recommended level of blood pressure control, as demonstrated by a value <130/80 mmHg. As not all patients achieved this level of control, the numbers differ from the Overall Number of Baseline Participants.|participants|Number|136|136.0||||||
4403426|NCT00258674|4230361|B1|||Number of patients with blood pressure <130/80 mmHg|This measure reports the number of patients in each study arm who had achieved the recommended level of blood pressure control, as demonstrated by a value <130/80 mmHg. As not all patients achieved this level of control, the numbers differ from the Overall Number of Baseline Participants.|participants|Number|110|110.0||||||
4403427|NCT00258674|4230358|B4|||Number of patients with LDL cholesterol <100mg/dL|This measure reports the number of patients in each study arm who had achieved the recommended level of LDL cholesterol control, as demonstrated by value <100 mg/dL. As not all patients achieved this level of control, the numbers differ from the Overall Number of Baseline Participants.|participants|Number|600|600.0||||||
4403428|NCT00258674|4230359|B3|||Number of patients with LDL cholesterol <100mg/dL|This measure reports the number of patients in each study arm who had achieved the recommended level of LDL cholesterol control, as demonstrated by value <100 mg/dL. As not all patients achieved this level of control, the numbers differ from the Overall Number of Baseline Participants.|participants|Number|198|198.0||||||
4403429|NCT00258674|4230360|B2|||Number of patients with LDL cholesterol <100mg/dL|This measure reports the number of patients in each study arm who had achieved the recommended level of LDL cholesterol control, as demonstrated by value <100 mg/dL. As not all patients achieved this level of control, the numbers differ from the Overall Number of Baseline Participants.|participants|Number|244|244.0||||||
4403430|NCT00258674|4230361|B1|||Number of patients with LDL cholesterol <100mg/dL|This measure reports the number of patients in each study arm who had achieved the recommended level of LDL cholesterol control, as demonstrated by value <100 mg/dL. As not all patients achieved this level of control, the numbers differ from the Overall Number of Baseline Participants.|participants|Number|158|158.0||||||
4403431|NCT00258674|4230358|B4|||number of patients with HbA1c <9 percent|This measure reports the number of patients in each study arm who had achieved the recommended level of glycemic control, as demonstrated by an HbA1c value of <9%. As not all patients achieved this level of control, the numbers differ from the Overall Number of Baseline Participants.|participants|Number|1572|1572.0||||||
4403432|NCT00258674|4230359|B3|||number of patients with HbA1c <9 percent|This measure reports the number of patients in each study arm who had achieved the recommended level of glycemic control, as demonstrated by an HbA1c value of <9%. As not all patients achieved this level of control, the numbers differ from the Overall Number of Baseline Participants.|participants|Number|481|481.0||||||
4403433|NCT00258674|4230360|B2|||number of patients with HbA1c <9 percent|This measure reports the number of patients in each study arm who had achieved the recommended level of glycemic control, as demonstrated by an HbA1c value of <9%. As not all patients achieved this level of control, the numbers differ from the Overall Number of Baseline Participants.|participants|Number|630|630.0||||||
4403434|NCT00258674|4230361|B1|||number of patients with HbA1c <9 percent|This measure reports the number of patients in each study arm who had achieved the recommended level of glycemic control, as demonstrated by an HbA1c value of <9%. As not all patients achieved this level of control, the numbers differ from the Overall Number of Baseline Participants.|participants|Number|461|461.0||||||
4403435|NCT00258674|4230358|B4||Male|Sex: Female, Male|Patient characteristics were only calculated by study arm for the 1891 patients who survived to final follow-up.|Participants|Count of Participants|942|942.0||||||
4403436|NCT00258674|4230359|B3||Male|Sex: Female, Male|Patient characteristics were only calculated by study arm for the 1891 patients who survived to final follow-up.|Participants|Count of Participants|289|289.0||||||
4403437|NCT00258674|4230360|B2||Male|Sex: Female, Male|Patient characteristics were only calculated by study arm for the 1891 patients who survived to final follow-up.|Participants|Count of Participants|378|378.0||||||
4403438|NCT00258674|4230361|B1||Male|Sex: Female, Male|Patient characteristics were only calculated by study arm for the 1891 patients who survived to final follow-up.|Participants|Count of Participants|275|275.0||||||
4403439|NCT00258674|4230358|B4||Female|Sex: Female, Male|Patient characteristics were only calculated by study arm for the 1891 patients who survived to final follow-up.|Participants|Count of Participants|949|949.0||||||
4403440|NCT00258674|4230359|B3||Female|Sex: Female, Male|Patient characteristics were only calculated by study arm for the 1891 patients who survived to final follow-up.|Participants|Count of Participants|279|279.0||||||
4403441|NCT00258674|4230360|B2||Female|Sex: Female, Male|Patient characteristics were only calculated by study arm for the 1891 patients who survived to final follow-up.|Participants|Count of Participants|380|380.0||||||
4403442|NCT00258674|4230361|B1||Female|Sex: Female, Male|Patient characteristics were only calculated by study arm for the 1891 patients who survived to final follow-up.|Participants|Count of Participants|290|290.0||||||
4403443|NCT00258674|4230358|B4|||Age|Patient characteristics were only described by study arm for the 1891 patients who survived to final follow-up.|years|Mean|72.9|72.9|Standard Deviation|0.1|0.1|||
4403444|NCT00258674|4230359|B3|||Age|Patient characteristics were only described by study arm for the 1891 patients who survived to final follow-up.|years|Mean|73.2|73.2|Standard Deviation|0.1|0.1|||
4403445|NCT00258674|4230360|B2|||Age|Patient characteristics were only described by study arm for the 1891 patients who survived to final follow-up.|years|Mean|72.6|72.6|Standard Deviation|0.1|0.1|||
4403446|NCT00258674|4230361|B1|||Age|Patient characteristics were only described by study arm for the 1891 patients who survived to final follow-up.|years|Mean|73.1|73.1|Standard Deviation|0.1|0.1|||
4403447|NCT00258674|4230358|B4||>=65 years|Age||Participants|Count of Participants|1891|1891.0||||||
4403448|NCT00258674|4230359|B3||>=65 years|Age||Participants|Count of Participants|568|568.0||||||
4403449|NCT00258674|4230360|B2||>=65 years|Age||Participants|Count of Participants|758|758.0||||||
4403450|NCT00258674|4230361|B1||>=65 years|Age||Participants|Count of Participants|565|565.0||||||
4403451|NCT00258674|4230358|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403452|NCT00258674|4230359|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403453|NCT00258674|4230360|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403454|NCT00258674|4230361|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403455|NCT00258674|4230358|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403456|NCT00258674|4230359|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403459|NCT00258440|4230419|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4403460|NCT00258440|4230420|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4403461|NCT00258440|4230422|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4403462|NCT00258440|4230419|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4403463|NCT00258440|4230420|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4403464|NCT00258440|4230422|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4403465|NCT00258440|4230419|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4403466|NCT00258440|4230420|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4403467|NCT00258440|4230422|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4403468|NCT00258440|4230419|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403469|NCT00258440|4230420|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403470|NCT00258440|4230422|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403471|NCT00258440|4230419|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4403472|NCT00258440|4230420|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4403473|NCT00258440|4230422|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4403474|NCT00258440|4230419|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403475|NCT00258440|4230420|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403476|NCT00258440|4230422|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403477|NCT00258362|4230435|B1|Endometroid + Serous||Histology|Type or classification of cancer|Participants|Number|1|1.0||||||
4403478|NCT00258362|4230435|B1|Adenosquamous||Histology|Type or classification of cancer|Participants|Number|3|3.0||||||
4403479|NCT00258362|4230435|B1|Mucinous||Histology|Type or classification of cancer|Participants|Number|1|1.0||||||
4403480|NCT00258362|4230435|B1|Serous||Histology|Type or classification of cancer|Participants|Number|4|4.0||||||
4403481|NCT00258362|4230435|B1|Endometroid||Histology|Type or classification of cancer|Participants|Number|32|32.0||||||
4403482|NCT00258362|4230435|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4403483|NCT00258362|4230435|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4403484|NCT00258362|4230435|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4403485|NCT00258362|4230435|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4403486|NCT00258362|4230435|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4403487|NCT00258362|4230435|B1|White||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4403488|NCT00258362|4230435|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4403489|NCT00258362|4230435|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4403490|NCT00258362|4230435|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|11.5|11.5|||
4403491|NCT00258362|4230435|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4403492|NCT00258362|4230435|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4403493|NCT00258362|4230435|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403494|NCT00258349|4230440|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4403495|NCT00258349|4230440|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4403496|NCT00258349|4230440|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4403497|NCT00258349|4230440|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|10.3|10.3|||
4403498|NCT00258310|4230447|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4403499|NCT00258310|4230447|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4403500|NCT00258310|4230447|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4403501|NCT00258310|4230447|B1|||Age||years|Median|58|58.0|Full Range|||43.0|74.0|
4403502|NCT00258206|4230451|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4403503|NCT00258206|4230451|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403504|NCT00258206|4230451|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403505|NCT00258206|4230451|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4403506|NCT00258206|4230451|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4403507|NCT00258206|4230451|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403508|NCT00258206|4230451|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403509|NCT00258206|4230451|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403510|NCT00258206|4230451|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4403511|NCT00258206|4230451|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4403512|NCT00258206|4230451|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4403513|NCT00258206|4230451|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4403514|NCT00258206|4230451|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403515|NCT00258154|4230455|B3|White||Race/Ethnicity, Customized||Participants|Number|373|373.0||||||
4403516|NCT00258154|4230456|B2|White||Race/Ethnicity, Customized||Participants|Number|187|187.0||||||
4403517|NCT00258154|4230457|B1|White||Race/Ethnicity, Customized||Participants|Number|186|186.0||||||
4403518|NCT00258154|4230455|B3|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4403519|NCT00258154|4230456|B2|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4403520|NCT00258154|4230457|B1|Multi-Racial||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4403521|NCT00258154|4230455|B3|Black||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4403522|NCT00258154|4230456|B2|Black||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4403523|NCT00258154|4230457|B1|Black||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4403524|NCT00258154|4230455|B3|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4403525|NCT00258154|4230456|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4403526|NCT00258154|4230457|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4403527|NCT00258154|4230455|B3||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4403528|NCT00258154|4230456|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4403529|NCT00258154|4230457|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4403530|NCT00258154|4230455|B3||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4403531|NCT00258154|4230456|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4403532|NCT00258154|4230457|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4403533|NCT00258154|4230455|B3|Over 12 Weeks of Age||Age, Customized||participants|Number|1|1.0||||||
4403534|NCT00258154|4230456|B2|Over 12 Weeks of Age||Age, Customized||participants|Number|0|0.0||||||
4403535|NCT00258154|4230457|B1|Over 12 Weeks of Age||Age, Customized||participants|Number|1|1.0||||||
4403536|NCT00258154|4230455|B3|6-12 Weeks of Age||Age, Customized||participants|Number|401|401.0||||||
4403537|NCT00258154|4230456|B2|6-12 Weeks of Age||Age, Customized||participants|Number|202|202.0||||||
4403538|NCT00258154|4230457|B1|6-12 Weeks of Age||Age, Customized||participants|Number|199|199.0||||||
4403539|NCT00258154|4230455|B3|5 Weeks of Age and Under||Age, Customized||participants|Number|1|1.0||||||
4403540|NCT00258154|4230456|B2|5 Weeks of Age and Under||Age, Customized||participants|Number|0|0.0||||||
4403541|NCT00258154|4230457|B1|5 Weeks of Age and Under||Age, Customized||participants|Number|1|1.0||||||
4403542|NCT00258011|4230526|B1|Asian (Japanese)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4403543|NCT00258011|4230526|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4403544|NCT00258011|4230526|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4403545|NCT00258011|4230526|B1|||Age||years|Mean|12.2|12.2|Standard Deviation|12.57|12.57|||
4403546|NCT00257933|4230531|B3|United States||Region of Enrollment||participants|Number|152|152.0||||||
4403547|NCT00257933|4230532|B2|United States||Region of Enrollment||participants|Number|78|78.0||||||
4403548|NCT00257933|4230533|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
4403549|NCT00257933|4230531|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4403550|NCT00257933|4230532|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4403551|NCT00257933|4230533|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4403552|NCT00257933|4230531|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4403553|NCT00257933|4230532|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4403554|NCT00257933|4230533|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4403555|NCT00257933|4230531|B3|||Age||years|Mean|7.4|7.4|Standard Deviation|4.2|4.2|||
4403556|NCT00257933|4230532|B2|||Age||years|Mean|7.0|7.0|Standard Deviation|3.8|3.8|||
4403557|NCT00257933|4230533|B1|||Age||years|Mean|7.9|7.9|Standard Deviation|4.4|4.4|||
4403558|NCT00257933|4230531|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403559|NCT00257933|4230532|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403560|NCT00257933|4230533|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403561|NCT00257933|4230531|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403562|NCT00257933|4230532|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403563|NCT00257933|4230533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403564|NCT00257933|4230531|B3||<=18 years|Age||Participants|Count of Participants|152|152.0||||||
4403565|NCT00257933|4230532|B2||<=18 years|Age||Participants|Count of Participants|78|78.0||||||
4403566|NCT00257933|4230533|B1||<=18 years|Age||Participants|Count of Participants|74|74.0||||||
4403567|NCT00257920|4230540|B3|||Calcium Absorption Fraction|Calcium Absorption Fraction= 5-hr calcium specific activity (fraction of oral dose per gram calcium) adjusted for body size differences|Fractions|Mean|0.107|0.107|Standard Deviation|0.0085|0.0085|||
4403568|NCT00257920|4230541|B2|||Calcium Absorption Fraction|Calcium Absorption Fraction= 5-hr calcium specific activity (fraction of oral dose per gram calcium) adjusted for body size differences|Fractions|Mean|0.130|0.13|Standard Deviation|0.0132|0.0132|||
4403569|NCT00257920|4230542|B1|||Calcium Absorption Fraction|Calcium Absorption Fraction= 5-hr calcium specific activity (fraction of oral dose per gram calcium) adjusted for body size differences|Fractions|Mean|0.085|0.085|Standard Deviation|0.0086|0.0086|||
4403570|NCT00257920|4230540|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4403571|NCT00257920|4230541|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4403572|NCT00257920|4230542|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4403573|NCT00257920|4230540|B3|No ethnicity||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4403574|NCT00257920|4230541|B2|No ethnicity||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4403575|NCT00257920|4230542|B1|No ethnicity||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4403576|NCT00257920|4230540|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4403577|NCT00257920|4230541|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4403578|NCT00257920|4230542|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4403579|NCT00257920|4230540|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403580|NCT00257920|4230541|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403581|NCT00257920|4230542|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403582|NCT00257920|4230540|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403583|NCT00257920|4230541|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403584|NCT00257920|4230542|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403585|NCT00257920|4230540|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4403586|NCT00257920|4230541|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4403587|NCT00257920|4230542|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4403588|NCT00257920|4230540|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4403589|NCT00257920|4230541|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4403590|NCT00257920|4230542|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4403591|NCT00257920|4230540|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403592|NCT00257920|4230541|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403593|NCT00257920|4230542|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403594|NCT00257920|4230540|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403595|NCT00257920|4230541|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403596|NCT00257920|4230542|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403597|NCT00257920|4230540|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4403598|NCT00257920|4230541|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4403599|NCT00257920|4230542|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4403600|NCT00257920|4230540|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4403601|NCT00257920|4230541|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4403602|NCT00257920|4230542|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4403603|NCT00257920|4230540|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4403604|NCT00257920|4230541|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4403605|NCT00257920|4230542|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4403606|NCT00257920|4230540|B3|>=60 years||Age, Customized||participants|Number|13|13.0||||||
4403607|NCT00257920|4230541|B2|>=60 years||Age, Customized||participants|Number|7|7.0||||||
4403608|NCT00257920|4230542|B1|>=60 years||Age, Customized||participants|Number|6|6.0||||||
4403609|NCT00257920|4230540|B3|40 - <60 years||Age, Customized||participants|Number|25|25.0||||||
4403610|NCT00257920|4230541|B2|40 - <60 years||Age, Customized||participants|Number|12|12.0||||||
4403611|NCT00257920|4230542|B1|40 - <60 years||Age, Customized||participants|Number|13|13.0||||||
4403612|NCT00257920|4230540|B3|<40 years||Age, Customized||participants|Number|3|3.0||||||
4403613|NCT00257920|4230541|B2|<40 years||Age, Customized||participants|Number|1|1.0||||||
4403614|NCT00257920|4230542|B1|<40 years||Age, Customized||participants|Number|2|2.0||||||
4403615|NCT00257920|4230540|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|10.34|10.34|||
4403616|NCT00257920|4230541|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|9.81|9.81|||
4403617|NCT00257920|4230542|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|11.03|11.03|||
4403618|NCT00257894|4230551|B3|||Number of years smoked daily||years|Mean|26.9|26.9|Standard Deviation|11.7|11.7|||
4403619|NCT00257894|4230552|B2|||Number of years smoked daily||years|Mean|24.9|24.9|Standard Deviation|11.7|11.7|||
4403620|NCT00257894|4230553|B1|||Number of years smoked daily||years|Mean|28.5|28.5|Standard Deviation|11.9|11.9|||
4403621|NCT00257894|4230551|B3|||Number of cigarettes smoked per day||cigarettes|Mean|19.7|19.7|Standard Deviation|7.8|7.8|||
4403622|NCT00257894|4230552|B2|||Number of cigarettes smoked per day||cigarettes|Mean|19.0|19.0|Standard Deviation|8.1|8.1|||
4403623|NCT00257894|4230553|B1|||Number of cigarettes smoked per day||cigarettes|Mean|20.4|20.4|Standard Deviation|7.6|7.6|||
4403624|NCT00257894|4230551|B3|||Fagerstrom Test for Nicotine Dependence|The total score of a measure of behaviors indicating tobacco dependence, with a range from 0 (least dependent) to 10 (most dependent).|units on a scale|Mean|6.06|6.06|Standard Deviation|2.18|2.18|||
4403625|NCT00257894|4230552|B2|||Fagerstrom Test for Nicotine Dependence|The total score of a measure of behaviors indicating tobacco dependence, with a range from 0 (least dependent) to 10 (most dependent).|units on a scale|Mean|5.93|5.93|Standard Deviation|2.76|2.76|||
4403626|NCT00257894|4230553|B1|||Fagerstrom Test for Nicotine Dependence|The total score of a measure of behaviors indicating tobacco dependence, with a range from 0 (least dependent) to 10 (most dependent).|units on a scale|Mean|6.18|6.18|Standard Deviation|1.59|1.59|||
4403627|NCT00257894|4230551|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4403628|NCT00257894|4230552|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4403629|NCT00257894|4230553|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4403630|NCT00257894|4230551|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4403631|NCT00257894|4230552|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4403632|NCT00257894|4230553|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4403633|NCT00257894|4230551|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4403634|NCT00257894|4230552|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4403635|NCT00257894|4230553|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4403636|NCT00257894|4230551|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|10.3|10.3|||
4403637|NCT00257894|4230552|B2|||Age||years|Mean|43.5|43.5|Standard Deviation|9.8|9.8|||
4403638|NCT00257894|4230553|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|10.7|10.7|||
4403639|NCT00257686|4230566|B7||Male|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
4403640|NCT00257686|4230567|B6||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4403641|NCT00257686|4230568|B5||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4403642|NCT00257686|4230569|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4403643|NCT00257686|4230570|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4403644|NCT00257686|4230571|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4403645|NCT00257686|4230572|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4403646|NCT00257686|4230566|B7||Female|Sex: Female, Male||Participants|Count of Participants|507|507.0||||||
4403647|NCT00257686|4230567|B6||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4403648|NCT00257686|4230568|B5||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4403649|NCT00257686|4230569|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4403650|NCT00257686|4230570|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4403651|NCT00257686|4230571|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4403652|NCT00257686|4230572|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4403653|NCT00257686|4230566|B7|||Age||years|Mean|70.2|70.2|Standard Deviation|4.49|4.49|||
4403654|NCT00257686|4230567|B6|||Age||years|Mean|70.2|70.2|Standard Deviation|4.94|4.94|||
4403655|NCT00257686|4230568|B5|||Age||years|Mean|70.2|70.2|Standard Deviation|4.10|4.1|||
4403656|NCT00257686|4230569|B4|||Age||years|Mean|69.9|69.9|Standard Deviation|4.51|4.51|||
4403657|NCT00257686|4230570|B3|||Age||years|Mean|70.5|70.5|Standard Deviation|4.49|4.49|||
4403658|NCT00257686|4230571|B2|||Age||years|Mean|70.5|70.5|Standard Deviation|4.61|4.61|||
4403659|NCT00257686|4230572|B1|||Age||years|Mean|70.0|70.0|Standard Deviation|4.60|4.6|||
4403660|NCT00257686|4230566|B7||>=65 years|Age||Participants|Count of Participants|942|942.0||||||
4403661|NCT00257686|4230567|B6||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
4403662|NCT00257686|4230568|B5||>=65 years|Age||Participants|Count of Participants|210|210.0||||||
4403663|NCT00257686|4230569|B4||>=65 years|Age||Participants|Count of Participants|96|96.0||||||
4403664|NCT00257686|4230570|B3||>=65 years|Age||Participants|Count of Participants|224|224.0||||||
4403665|NCT00257686|4230571|B2||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
4403666|NCT00257686|4230572|B1||>=65 years|Age||Participants|Count of Participants|207|207.0||||||
4403667|NCT00257686|4230566|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403668|NCT00257686|4230567|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403669|NCT00257686|4230568|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403670|NCT00257686|4230569|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403671|NCT00257686|4230570|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403672|NCT00257686|4230571|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403673|NCT00257686|4230572|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403674|NCT00257686|4230566|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403675|NCT00257686|4230567|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403676|NCT00257686|4230568|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403677|NCT00257686|4230569|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403678|NCT00257686|4230570|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403679|NCT00257686|4230571|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403680|NCT00257686|4230572|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403681|NCT00257660|4230597|B3|Russian Federation||Region of Enrollment||participants|Number|28|28.0||||||
4403682|NCT00257660|4230598|B2|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4403683|NCT00257660|4230599|B1|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4403684|NCT00257660|4230597|B3|United States||Region of Enrollment||participants|Number|88|88.0||||||
4403685|NCT00257660|4230598|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4403686|NCT00257660|4230599|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4403687|NCT00257660|4230597|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4403688|NCT00257660|4230598|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4403689|NCT00257660|4230599|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4403690|NCT00257660|4230597|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4403691|NCT00257660|4230598|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4403692|NCT00257660|4230599|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4403693|NCT00257660|4230597|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|12.9|12.9|||
4403694|NCT00257660|4230598|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|12.5|12.5|||
4403695|NCT00257660|4230599|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|13.4|13.4|||
4403696|NCT00257660|4230597|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4403697|NCT00257660|4230598|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4403698|NCT00257660|4230599|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4403699|NCT00257660|4230597|B3||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4403700|NCT00257660|4230598|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4403701|NCT00257660|4230599|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4403702|NCT00257660|4230597|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403703|NCT00257660|4230598|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403704|NCT00257660|4230599|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403705|NCT00257608|4230628|B3||Male|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
4403706|NCT00257608|4230629|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4403707|NCT00257608|4230630|B1||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4403708|NCT00257608|4230628|B3||Female|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4403709|NCT00257608|4230629|B2||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4403710|NCT00257608|4230630|B1||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4403711|NCT00257608|4230628|B3|||Age||Years|Mean|62.9|62.9|Standard Deviation|10.6|10.6|||
4403712|NCT00257608|4230629|B2|||Age||Years|Mean|62.9|62.9|Standard Deviation|10.3|10.3|||
4403713|NCT00257608|4230630|B1|||Age||Years|Mean|62.8|62.8|Standard Deviation|10.8|10.8|||
4403714|NCT00257556|4230656|B3|||Systolic Blood Pressure||mm Hg|Mean|115.7|115.7|Standard Deviation|13.51|13.51|||
4403715|NCT00257556|4230657|B2|||Systolic Blood Pressure||mm Hg|Mean|116.1|116.1|Standard Deviation|14.55|14.55|||
4403716|NCT00257556|4230658|B1|||Systolic Blood Pressure||mm Hg|Mean|115.3|115.3|Standard Deviation|12.50|12.5|||
4403717|NCT00257556|4230656|B3|||Pulse||beats per minute|Mean|75.1|75.1|Standard Deviation|9.35|9.35|||
4403718|NCT00257556|4230657|B2|||Pulse||beats per minute|Mean|74.5|74.5|Standard Deviation|9.16|9.16|||
4403719|NCT00257556|4230658|B1|||Pulse||beats per minute|Mean|75.7|75.7|Standard Deviation|9.63|9.63|||
4403720|NCT00257556|4230656|B3|||Diastolic Blood Pressure||mm Hg|Mean|74.0|74.0|Standard Deviation|9.37|9.37|||
4403721|NCT00257556|4230657|B2|||Diastolic Blood Pressure||mm Hg|Mean|73.8|73.8|Standard Deviation|9.96|9.96|||
4403722|NCT00257556|4230658|B1|||Diastolic Blood Pressure||mm Hg|Mean|74.1|74.1|Standard Deviation|8.83|8.83|||
4403723|NCT00257556|4230656|B3|||Body Mass Index|Body mass index (BMI) is measure of body fat based on height and weight that applies to both adult men and women|Kilograms/Meters squared|Mean|23.91|23.91|Standard Deviation|3.687|3.687|||
4403724|NCT00257556|4230657|B2|||Body Mass Index|Body mass index (BMI) is measure of body fat based on height and weight that applies to both adult men and women|Kilograms/Meters squared|Mean|23.81|23.81|Standard Deviation|3.731|3.731|||
4403725|NCT00257556|4230658|B1|||Body Mass Index|Body mass index (BMI) is measure of body fat based on height and weight that applies to both adult men and women|Kilograms/Meters squared|Mean|24.02|24.02|Standard Deviation|3.689|3.689|||
4403726|NCT00257556|4230656|B3|Never Smoked||Tobacco Use||participants|Number|51|51.0||||||
4403727|NCT00257556|4230657|B2|Never Smoked||Tobacco Use||participants|Number|26|26.0||||||
4403728|NCT00257556|4230658|B1|Never Smoked||Tobacco Use||participants|Number|25|25.0||||||
4403729|NCT00257556|4230656|B3|Ex-smoker||Tobacco Use||participants|Number|13|13.0||||||
4403730|NCT00257556|4230657|B2|Ex-smoker||Tobacco Use||participants|Number|5|5.0||||||
4403731|NCT00257556|4230658|B1|Ex-smoker||Tobacco Use||participants|Number|8|8.0||||||
4403732|NCT00257556|4230656|B3|Smoker||Tobacco Use||participants|Number|12|12.0||||||
4403733|NCT00257556|4230657|B2|Smoker||Tobacco Use||participants|Number|8|8.0||||||
4403734|NCT00257556|4230658|B1|Smoker||Tobacco Use||participants|Number|4|4.0||||||
4403735|NCT00257556|4230656|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4403736|NCT00257556|4230657|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4403737|NCT00257556|4230658|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4403738|NCT00257556|4230656|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4403739|NCT00257556|4230657|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4403740|NCT00257556|4230658|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4403741|NCT00257556|4230656|B3|||Age||years|Mean|30.8|30.8|Standard Deviation|3.06|3.06|||
4403742|NCT00257556|4230657|B2|||Age||years|Mean|30.9|30.9|Standard Deviation|2.67|2.67|||
4403743|NCT00257556|4230658|B1|||Age||years|Mean|30.7|30.7|Standard Deviation|3.45|3.45|||
4403744|NCT00257556|4230656|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403745|NCT00257556|4230657|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403746|NCT00257556|4230658|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4403747|NCT00257556|4230656|B3||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4403748|NCT00257556|4230657|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4403749|NCT00257556|4230658|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4403750|NCT00257556|4230656|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403751|NCT00257556|4230657|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403752|NCT00257556|4230658|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403753|NCT00257322|4230685|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4403754|NCT00257322|4230685|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4403755|NCT00257322|4230685|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4403756|NCT00257322|4230685|B1|||Age||years|Mean|62.65|62.65|Standard Deviation|13.52|13.52|||
4403757|NCT00257322|4230685|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4403758|NCT00257322|4230685|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4403759|NCT00257322|4230685|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403760|NCT00257309|4230690|B3|Spain||Region of Enrollment||participants|Number|266|266.0||||||
4403761|NCT00257309|4230691|B2|Spain||Region of Enrollment||participants|Number|132|132.0||||||
4403762|NCT00257309|4230692|B1|Spain||Region of Enrollment||participants|Number|134|134.0||||||
4403763|NCT00257309|4230690|B3||Male|Gender||Participants|Count of Participants|116|116.0||||||
4403764|NCT00257309|4230691|B2||Male|Gender||Participants|Count of Participants|58|58.0||||||
4403765|NCT00257309|4230692|B1||Male|Gender||Participants|Count of Participants|58|58.0||||||
4403766|NCT00257309|4230690|B3||Female|Gender||Participants|Count of Participants|150|150.0||||||
4403767|NCT00257309|4230691|B2||Female|Gender||Participants|Count of Participants|74|74.0||||||
4403768|NCT00257309|4230692|B1||Female|Gender||Participants|Count of Participants|76|76.0||||||
4403769|NCT00257309|4230690|B3|||Age|years of age at randomization|years|Mean|81.1|81.1|Standard Deviation|4.5|4.5|||
4403770|NCT00257309|4230691|B2|||Age|years of age at randomization|years|Mean|81.2|81.2|Standard Deviation|4.6|4.6|||
4403771|NCT00257309|4230692|B1|||Age|years of age at randomization|years|Mean|81.0|81.0|Standard Deviation|4.3|4.3|||
4403772|NCT00257309|4230690|B3||>=65 years|Age||Participants|Count of Participants|266|266.0||||||
4403773|NCT00257309|4230691|B2||>=65 years|Age||Participants|Count of Participants|132|132.0||||||
4403774|NCT00257309|4230692|B1||>=65 years|Age||Participants|Count of Participants|134|134.0||||||
4403775|NCT00257309|4230690|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403776|NCT00257309|4230691|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403777|NCT00257309|4230692|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4403778|NCT00257309|4230690|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403779|NCT00257309|4230691|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403780|NCT00257309|4230692|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4403781|NCT00257192|4230701|B3|||Weight||kilograms (kg)|Mean|62.2|62.2|Standard Deviation|15.6|15.6|||
4403782|NCT00257192|4230702|B2|||Weight||kilograms (kg)|Mean|64.3|64.3|Standard Deviation|15.7|15.7|||
4403783|NCT00257192|4230703|B1|||Weight||kilograms (kg)|Mean|61.2|61.2|Standard Deviation|15.5|15.5|||
4403784|NCT00257192|4230701|B3|||Height||centimeters (cm)|Mean|165.8|165.8|Standard Deviation|10.1|10.1|||
4403785|NCT00257192|4230702|B2|||Height||centimeters (cm)|Mean|167.8|167.8|Standard Deviation|10.0|10.0|||
4403786|NCT00257192|4230703|B1|||Height||centimeters (cm)|Mean|164.9|164.9|Standard Deviation|10.1|10.1|||
4403787|NCT00257192|4230701|B3|Missing (not answered)||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|2|2.0||||||
4403788|NCT00257192|4230702|B2|Missing (not answered)||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|0|0.0||||||
4403789|NCT00257192|4230703|B1|Missing (not answered)||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|2|2.0||||||
4403790|NCT00257192|4230701|B3|Stage 5||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|76|76.0||||||
4403791|NCT00257192|4230702|B2|Stage 5||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|24|24.0||||||
4403792|NCT00257192|4230703|B1|Stage 5||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|52|52.0||||||
4403942|NCT00256867|4230811|B5|White -White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4403793|NCT00257192|4230701|B3|Stage 4||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|133|133.0||||||
4403794|NCT00257192|4230702|B2|Stage 4||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|43|43.0||||||
4403795|NCT00257192|4230703|B1|Stage 4||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|90|90.0||||||
4403796|NCT00257192|4230701|B3|Stage 3||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|49|49.0||||||
4403797|NCT00257192|4230702|B2|Stage 3||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|13|13.0||||||
4403798|NCT00257192|4230703|B1|Stage 3||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|36|36.0||||||
4403799|NCT00257192|4230701|B3|Stage 2||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|20|20.0||||||
4403800|NCT00257192|4230702|B2|Stage 2||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|7|7.0||||||
4403801|NCT00257192|4230703|B1|Stage 2||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|13|13.0||||||
4403802|NCT00257192|4230701|B3|Stage 1||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|3|3.0||||||
4403803|NCT00257192|4230702|B2|Stage 1||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|3|3.0||||||
4403804|NCT00257192|4230703|B1|Stage 1||Tanner adolescent pubertal self-assessment: Pubic hair (females and males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|0|0.0||||||
4403805|NCT00257192|4230701|B3|Missing (not answered)||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|2|2.0||||||
4403806|NCT00257192|4230702|B2|Missing (not answered)||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|0|0.0||||||
4403807|NCT00257192|4230703|B1|Missing (not answered)||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|2|2.0||||||
4403808|NCT00257192|4230701|B3|Not applicable||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|110|110.0||||||
4403809|NCT00257192|4230702|B2|Not applicable||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|28|28.0||||||
4403810|NCT00257192|4230703|B1|Not applicable||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|82|82.0||||||
4403811|NCT00257192|4230701|B3|Stage 5||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|34|34.0||||||
4403812|NCT00257192|4230702|B2|Stage 5||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|16|16.0||||||
4403813|NCT00257192|4230703|B1|Stage 5||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|18|18.0||||||
4403814|NCT00257192|4230701|B3|Stage 4||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|83|83.0||||||
4403815|NCT00257192|4230702|B2|Stage 4||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|26|26.0||||||
4403816|NCT00257192|4230703|B1|Stage 4||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|57|57.0||||||
4403817|NCT00257192|4230701|B3|Stage 3||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|41|41.0||||||
4403818|NCT00257192|4230702|B2|Stage 3||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|16|16.0||||||
4404049|NCT00256750|4230906|B4|0||Previous Number of Transplant||participants|Number|636|636.0||||||
4403819|NCT00257192|4230703|B1|Stage 3||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|25|25.0||||||
4403820|NCT00257192|4230701|B3|Stage 2||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|12|12.0||||||
4403821|NCT00257192|4230702|B2|Stage 2||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|3|3.0||||||
4403822|NCT00257192|4230703|B1|Stage 2||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|9|9.0||||||
4403823|NCT00257192|4230701|B3|Stage 1||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|1|1.0||||||
4403824|NCT00257192|4230702|B2|Stage 1||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|1|1.0||||||
4403825|NCT00257192|4230703|B1|Stage 1||Tanner adolescent pubertal self-assessment: Genitalia (males)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|participants|Number|0|0.0||||||
4403826|NCT00257192|4230701|B3|Missing (not answered)||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|2|2.0||||||
4403827|NCT00257192|4230702|B2|Missing (not answered)||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|0|0.0||||||
4403828|NCT00257192|4230703|B1|Missing (not answered)||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|2|2.0||||||
4403829|NCT00257192|4230701|B3|Not applicable||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|171|171.0||||||
4403830|NCT00257192|4230702|B2|Not applicable||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|62|62.0||||||
4403831|NCT00257192|4230703|B1|Not applicable||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|109|109.0||||||
4404050|NCT00256750|4230907|B3|0||Previous Number of Transplant||participants|Number|210|210.0||||||
4403832|NCT00257192|4230701|B3|Stage 5||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|34|34.0||||||
4403833|NCT00257192|4230702|B2|Stage 5||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|9|9.0||||||
4403834|NCT00257192|4230703|B1|Stage 5||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|25|25.0||||||
4403835|NCT00257192|4230701|B3|Stage 4||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|46|46.0||||||
4403836|NCT00257192|4230702|B2|Stage 4||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|11|11.0||||||
4403837|NCT00257192|4230703|B1|Stage 4||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|35|35.0||||||
4403838|NCT00257192|4230701|B3|Stage 3||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|20|20.0||||||
4403839|NCT00257192|4230702|B2|Stage 3||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|4|4.0||||||
4403840|NCT00257192|4230703|B1|Stage 3||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|16|16.0||||||
4403841|NCT00257192|4230701|B3|Stage 2||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|9|9.0||||||
4403842|NCT00257192|4230702|B2|Stage 2||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|3|3.0||||||
4403843|NCT00257192|4230703|B1|Stage 2||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|6|6.0||||||
4403844|NCT00257192|4230701|B3|Stage 1||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|1|1.0||||||
4403943|NCT00256867|4230812|B4|White -White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4403845|NCT00257192|4230702|B2|Stage 1||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|1|1.0||||||
4403846|NCT00257192|4230703|B1|Stage 1||Tanner adolescent pubertal self-assessment: Breast (females)|At baseline, subjects self-administer a gender appropriate Tanner Adolescent Pubertal Staging Questionnaire to document the stage of development of secondary sexual characteristics. Female pubertal development staged by pubic hair development and breast size; males pubertal development staged by size of the genitalia and development of pubic hair. Rated in 5 stages: stage 1 (no development) to 5 (adult-like development in quantity and size).|particpants|Number|0|0.0||||||
4403847|NCT00257192|4230701|B3|Other||Race||particpants|Number|21|21.0||||||
4403848|NCT00257192|4230702|B2|Other||Race||particpants|Number|8|8.0||||||
4403849|NCT00257192|4230703|B1|Other||Race||particpants|Number|13|13.0||||||
4403850|NCT00257192|4230701|B3|Hispanic||Race||particpants|Number|12|12.0||||||
4403851|NCT00257192|4230702|B2|Hispanic||Race||particpants|Number|3|3.0||||||
4403852|NCT00257192|4230703|B1|Hispanic||Race||particpants|Number|9|9.0||||||
4403853|NCT00257192|4230701|B3|Asian||Race||particpants|Number|55|55.0||||||
4403854|NCT00257192|4230702|B2|Asian||Race||particpants|Number|17|17.0||||||
4403855|NCT00257192|4230703|B1|Asian||Race||particpants|Number|38|38.0||||||
4403856|NCT00257192|4230701|B3|Black||Race||particpants|Number|19|19.0||||||
4403857|NCT00257192|4230702|B2|Black||Race||particpants|Number|2|2.0||||||
4403858|NCT00257192|4230703|B1|Black||Race||particpants|Number|17|17.0||||||
4403859|NCT00257192|4230701|B3|White||Race||particpants|Number|176|176.0||||||
4403860|NCT00257192|4230702|B2|White||Race||particpants|Number|60|60.0||||||
4403861|NCT00257192|4230703|B1|White||Race||particpants|Number|116|116.0||||||
4403862|NCT00257192|4230701|B3|Not Hispanic / Latino||Ethnicity||participants|Number|253|253.0||||||
4403863|NCT00257192|4230702|B2|Not Hispanic / Latino||Ethnicity||participants|Number|81|81.0||||||
4403864|NCT00257192|4230703|B1|Not Hispanic / Latino||Ethnicity||participants|Number|172|172.0||||||
4403865|NCT00257192|4230701|B3|Hispanic / Latino||Ethnicity||participants|Number|30|30.0||||||
4403866|NCT00257192|4230702|B2|Hispanic / Latino||Ethnicity||participants|Number|9|9.0||||||
4403867|NCT00257192|4230703|B1|Hispanic / Latino||Ethnicity||participants|Number|21|21.0||||||
4403868|NCT00257192|4230701|B3||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4403869|NCT00257192|4230702|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4403870|NCT00257192|4230703|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4403871|NCT00257192|4230701|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4403872|NCT00257192|4230702|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4403873|NCT00257192|4230703|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4403874|NCT00257192|4230701|B3|||Age||years|Mean|15.3|15.3|Standard Deviation|1.4|1.4|||
4403875|NCT00257192|4230702|B2|||Age||years|Mean|15.4|15.4|Standard Deviation|1.4|1.4|||
4403876|NCT00257192|4230703|B1|||Age||years|Mean|15.3|15.3|Standard Deviation|1.4|1.4|||
4403877|NCT00257192|4230701|B3|Between 13 and 17 years||Age, Customized||participants|Number|279|279.0||||||
4403878|NCT00257192|4230702|B2|Between 13 and 17 years||Age, Customized||participants|Number|90|90.0||||||
4403879|NCT00257192|4230703|B1|Between 13 and 17 years||Age, Customized||participants|Number|189|189.0||||||
4403880|NCT00257192|4230701|B3|>12 years and <13 years at start of treatment||Age, Customized||participants|Number|4|4.0||||||
4403881|NCT00257192|4230702|B2|>12 years and <13 years at start of treatment||Age, Customized||participants|Number|0|0.0||||||
4403882|NCT00257192|4230703|B1|>12 years and <13 years at start of treatment||Age, Customized||participants|Number|4|4.0||||||
4403883|NCT00257166|4230746|B3||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4403884|NCT00257166|4230747|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4403885|NCT00257166|4230748|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4403886|NCT00257166|4230746|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4403887|NCT00257166|4230747|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4403888|NCT00257166|4230748|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4403889|NCT00257166|4230746|B3|>=18 years||Age, Customized||participants|Number|1|1.0||||||
4403890|NCT00257166|4230747|B2|>=18 years||Age, Customized||participants|Number|0|0.0||||||
4403891|NCT00257166|4230748|B1|>=18 years||Age, Customized||participants|Number|1|1.0||||||
4403892|NCT00257166|4230746|B3|14 to 17 years||Age, Customized||participants|Number|127|127.0||||||
4403893|NCT00257166|4230747|B2|14 to 17 years||Age, Customized||participants|Number|53|53.0||||||
4403894|NCT00257166|4230748|B1|14 to 17 years||Age, Customized||participants|Number|74|74.0||||||
4403895|NCT00257166|4230746|B3|10 to 13 years||Age, Customized||participants|Number|109|109.0||||||
4403896|NCT00257166|4230747|B2|10 to 13 years||Age, Customized||participants|Number|35|35.0||||||
4403897|NCT00257166|4230748|B1|10 to 13 years||Age, Customized||participants|Number|74|74.0||||||
4403898|NCT00257010|4230761|B1||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4403899|NCT00257010|4230761|B1||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4403900|NCT00257010|4230761|B1|||Age||years|Mean|14.4|14.4|Standard Deviation|1.63|1.63|||
4403944|NCT00256867|4230813|B3|White -White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4403901|NCT00256997|4230770|B3||Male|Sex: Female, Male|Out of a total of 167 participants, Baseline characteristic (Gender) was available for only 165 participants who were included in intent to treat (ITT) population.|Participants|Count of Participants|119|119.0||||||
4403902|NCT00256997|4230771|B2||Male|Sex: Female, Male|Out of a total of 167 participants, Baseline characteristic (Gender) was available for only 165 participants who were included in intent to treat (ITT) population.|Participants|Count of Participants|63|63.0||||||
4403903|NCT00256997|4230772|B1||Male|Sex: Female, Male|Out of a total of 167 participants, Baseline characteristic (Gender) was available for only 165 participants who were included in intent to treat (ITT) population.|Participants|Count of Participants|56|56.0||||||
4403904|NCT00256997|4230770|B3||Female|Sex: Female, Male|Out of a total of 167 participants, Baseline characteristic (Gender) was available for only 165 participants who were included in intent to treat (ITT) population.|Participants|Count of Participants|46|46.0||||||
4403905|NCT00256997|4230771|B2||Female|Sex: Female, Male|Out of a total of 167 participants, Baseline characteristic (Gender) was available for only 165 participants who were included in intent to treat (ITT) population.|Participants|Count of Participants|23|23.0||||||
4403906|NCT00256997|4230772|B1||Female|Sex: Female, Male|Out of a total of 167 participants, Baseline characteristic (Gender) was available for only 165 participants who were included in intent to treat (ITT) population.|Participants|Count of Participants|23|23.0||||||
4403907|NCT00256997|4230770|B3|||Age|Out of a total of 167 participants, Baseline characteristic (Age) was available for only 165 participants who were included in intent to treat (ITT) population.|Years|Mean|38.2|38.2|Standard Deviation|11.67|11.67|||
4403908|NCT00256997|4230771|B2|||Age|Out of a total of 167 participants, Baseline characteristic (Age) was available for only 165 participants who were included in intent to treat (ITT) population.|Years|Mean|38.9|38.9|Standard Deviation|10.9|10.9|||
4403909|NCT00256997|4230772|B1|||Age|Out of a total of 167 participants, Baseline characteristic (Age) was available for only 165 participants who were included in intent to treat (ITT) population.|Years|Mean|37.4|37.4|Standard Deviation|12.46|12.46|||
4403910|NCT00256984|4230797|B1|>=70 years||number of subjects in each age range having STARR procedure||participants|Number|7|7.0||||||
4403911|NCT00256984|4230797|B1|Between 60 and 69 years||number of subjects in each age range having STARR procedure||participants|Number|11|11.0||||||
4403912|NCT00256984|4230797|B1|Between 50 and 59 years||number of subjects in each age range having STARR procedure||participants|Number|18|18.0||||||
4403913|NCT00256984|4230797|B1|Between 40 and 49 years||number of subjects in each age range having STARR procedure||participants|Number|26|26.0||||||
4403914|NCT00256984|4230797|B1|Between 30 and 39 years||number of subjects in each age range having STARR procedure||participants|Number|9|9.0||||||
4403915|NCT00256984|4230797|B1|<=29 years||number of subjects in each age range having STARR procedure||participants|Number|4|4.0||||||
4403916|NCT00256984|4230797|B1|||ODS composite score|"Based upon Obstructed Defecation Syndrome (ODS) questionnaire. This questionnaire has eight questions, each dealing with frequency of a particular attribute associated with ODS (mechanical, difficulties to evacuate, digitation to evacuate, return to toilet to evacuate, feeling of incomplete evacuation, straining to evacuate, time needed to evacuate, and lifestyle alterations). Each is scored 0-3 (low to high on scale, no units. 0 is the lowest frequency of occurrence, 3 is the highest frequency of occurrence; the total of all attributes (0-24) is the final score."|units on a scale|Mean|6.19|6.19|Standard Deviation|3.13|3.13|||
4403917|NCT00256984|4230797|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4403918|NCT00256984|4230797|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4403919|NCT00256984|4230797|B1|||Age|Median age at consent|years|Median|48|48.0|Full Range|||23.0|80.0|
4403920|NCT00256867|4230807|B9|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4403921|NCT00256867|4230808|B8|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403922|NCT00256867|4230809|B7|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4403923|NCT00256867|4230810|B6|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403924|NCT00256867|4230811|B5|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403925|NCT00256867|4230812|B4|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403926|NCT00256867|4230813|B3|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403927|NCT00256867|4230814|B2|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403928|NCT00256867|4230815|B1|Missing||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403929|NCT00256867|4230807|B9|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|31|31.0||||||
4403930|NCT00256867|4230808|B8|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4403931|NCT00256867|4230809|B7|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4403932|NCT00256867|4230810|B6|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4403933|NCT00256867|4230811|B5|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4403934|NCT00256867|4230812|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4403935|NCT00256867|4230813|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4403936|NCT00256867|4230814|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4403937|NCT00256867|4230815|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4403938|NCT00256867|4230807|B9|White -White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|203|203.0||||||
4403939|NCT00256867|4230808|B8|White -White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4403940|NCT00256867|4230809|B7|White -White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4403941|NCT00256867|4230810|B6|White -White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4403945|NCT00256867|4230814|B2|White -White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4403946|NCT00256867|4230815|B1|White -White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4403947|NCT00256867|4230807|B9|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4403948|NCT00256867|4230808|B8|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4403949|NCT00256867|4230809|B7|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403950|NCT00256867|4230810|B6|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4403951|NCT00256867|4230811|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403952|NCT00256867|4230812|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4403953|NCT00256867|4230813|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4403954|NCT00256867|4230814|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403955|NCT00256867|4230815|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403956|NCT00256867|4230807|B9|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4403957|NCT00256867|4230808|B8|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403958|NCT00256867|4230809|B7|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403959|NCT00256867|4230810|B6|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403960|NCT00256867|4230811|B5|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403961|NCT00256867|4230812|B4|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403962|NCT00256867|4230813|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403963|NCT00256867|4230814|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4403964|NCT00256867|4230815|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4403965|NCT00256867|4230807|B9|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
4403966|NCT00256867|4230808|B8|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4403967|NCT00256867|4230809|B7|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4403968|NCT00256867|4230810|B6|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4403969|NCT00256867|4230811|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4403970|NCT00256867|4230812|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4403971|NCT00256867|4230813|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4403972|NCT00256867|4230814|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4403973|NCT00256867|4230815|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4403974|NCT00256867|4230807|B9|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4403975|NCT00256867|4230808|B8|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4403976|NCT00256867|4230809|B7|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403977|NCT00256867|4230810|B6|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403978|NCT00256867|4230811|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4403979|NCT00256867|4230812|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403980|NCT00256867|4230813|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403981|NCT00256867|4230814|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4403982|NCT00256867|4230815|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403983|NCT00256867|4230807|B9|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4403984|NCT00256867|4230808|B8|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4403985|NCT00256867|4230809|B7|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4403986|NCT00256867|4230810|B6|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4403987|NCT00256867|4230811|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4403988|NCT00256867|4230812|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4403989|NCT00256867|4230813|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4403990|NCT00256867|4230814|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4403991|NCT00256867|4230815|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4403992|NCT00256867|4230807|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4403993|NCT00256867|4230808|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403994|NCT00256867|4230809|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403995|NCT00256867|4230810|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403996|NCT00256867|4230811|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403997|NCT00256867|4230812|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403998|NCT00256867|4230813|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4403999|NCT00256867|4230814|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4404000|NCT00256867|4230815|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4404001|NCT00256867|4230807|B9|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4404002|NCT00256867|4230808|B8|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4404003|NCT00256867|4230809|B7|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4404004|NCT00256867|4230810|B6|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4404005|NCT00256867|4230811|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4404006|NCT00256867|4230812|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4404007|NCT00256867|4230813|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4404008|NCT00256867|4230814|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4404009|NCT00256867|4230815|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4404010|NCT00256867|4230807|B9||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4404011|NCT00256867|4230808|B8||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4404012|NCT00256867|4230809|B7||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4404013|NCT00256867|4230810|B6||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4404014|NCT00256867|4230811|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4404015|NCT00256867|4230812|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4404016|NCT00256867|4230813|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4404017|NCT00256867|4230814|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4404018|NCT00256867|4230815|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4404019|NCT00256867|4230807|B9||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4404020|NCT00256867|4230808|B8||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4404021|NCT00256867|4230809|B7||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4404022|NCT00256867|4230810|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4404023|NCT00256867|4230811|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4404024|NCT00256867|4230812|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4404025|NCT00256867|4230813|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4404026|NCT00256867|4230814|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4404027|NCT00256867|4230815|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4404028|NCT00256867|4230807|B9|||Age||Years|Mean|54.6|54.6|Standard Deviation|9.76|9.76|||
4404029|NCT00256867|4230808|B8|||Age||Years|Mean|53.5|53.5|Standard Deviation|10.49|10.49|||
4404030|NCT00256867|4230809|B7|||Age||Years|Mean|53.4|53.4|Standard Deviation|9.03|9.03|||
4404031|NCT00256867|4230810|B6|||Age||Years|Mean|54.6|54.6|Standard Deviation|9.93|9.93|||
4404032|NCT00256867|4230811|B5|||Age||Years|Mean|53.8|53.8|Standard Deviation|11.37|11.37|||
4404033|NCT00256867|4230812|B4|||Age||Years|Mean|55|55.0|Standard Deviation|8.65|8.65|||
4404034|NCT00256867|4230813|B3|||Age||Years|Mean|56.9|56.9|Standard Deviation|9.07|9.07|||
4404035|NCT00256867|4230814|B2|||Age||Years|Mean|55.1|55.1|Standard Deviation|10.31|10.31|||
4404036|NCT00256867|4230815|B1|||Age||Years|Mean|55|55.0|Standard Deviation|9.13|9.13|||
4404037|NCT00256750|4230906|B4|Missing||Previous Number of Transplant||participants|Number|10|10.0||||||
4404038|NCT00256750|4230907|B3|Missing||Previous Number of Transplant||participants|Number|3|3.0||||||
4404039|NCT00256750|4230908|B2|Missing||Previous Number of Transplant||participants|Number|3|3.0||||||
4404040|NCT00256750|4230909|B1|Missing||Previous Number of Transplant||participants|Number|4|4.0||||||
4404041|NCT00256750|4230906|B4|2||Previous Number of Transplant||participants|Number|1|1.0||||||
4404042|NCT00256750|4230907|B3|2||Previous Number of Transplant||participants|Number|1|1.0||||||
4404043|NCT00256750|4230908|B2|2||Previous Number of Transplant||participants|Number|0|0.0||||||
4404044|NCT00256750|4230909|B1|2||Previous Number of Transplant||participants|Number|0|0.0||||||
4404045|NCT00256750|4230906|B4|1||Previous Number of Transplant||participants|Number|19|19.0||||||
4404046|NCT00256750|4230907|B3|1||Previous Number of Transplant||participants|Number|5|5.0||||||
4404047|NCT00256750|4230908|B2|1||Previous Number of Transplant||participants|Number|5|5.0||||||
4404048|NCT00256750|4230909|B1|1||Previous Number of Transplant||participants|Number|9|9.0||||||
4404051|NCT00256750|4230908|B2|0||Previous Number of Transplant||participants|Number|218|218.0||||||
4404052|NCT00256750|4230909|B1|0||Previous Number of Transplant||participants|Number|208|208.0||||||
4404053|NCT00256750|4230906|B4||Male|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
4404054|NCT00256750|4230907|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4404055|NCT00256750|4230908|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4404056|NCT00256750|4230909|B1||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4404057|NCT00256750|4230906|B4||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4404058|NCT00256750|4230907|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4404059|NCT00256750|4230908|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4404060|NCT00256750|4230909|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4404061|NCT00256750|4230906|B4|> 65 years:||Age, Customized||participants|Number|34|34.0||||||
4404062|NCT00256750|4230907|B3|> 65 years:||Age, Customized||participants|Number|15|15.0||||||
4404063|NCT00256750|4230908|B2|> 65 years:||Age, Customized||participants|Number|9|9.0||||||
4404064|NCT00256750|4230909|B1|> 65 years:||Age, Customized||participants|Number|10|10.0||||||
4404065|NCT00256750|4230906|B4|Between 46 and 65 years:||Age, Customized||participants|Number|287|287.0||||||
4404066|NCT00256750|4230907|B3|Between 46 and 65 years:||Age, Customized||participants|Number|93|93.0||||||
4404067|NCT00256750|4230908|B2|Between 46 and 65 years:||Age, Customized||participants|Number|93|93.0||||||
4404068|NCT00256750|4230909|B1|Between 46 and 65 years:||Age, Customized||participants|Number|101|101.0||||||
4404069|NCT00256750|4230906|B4|Between 18 and 45 years:||Age, Customized||participants|Number|345|345.0||||||
4404070|NCT00256750|4230907|B3|Between 18 and 45 years:||Age, Customized||participants|Number|111|111.0||||||
4404071|NCT00256750|4230908|B2|Between 18 and 45 years:||Age, Customized||participants|Number|124|124.0||||||
4404072|NCT00256750|4230909|B1|Between 18 and 45 years:||Age, Customized||participants|Number|110|110.0||||||
4404073|NCT00256750|4230906|B4|||Age||years|Mean|43.2|43.2|Standard Deviation|14.1|14.1|||
4404074|NCT00256750|4230907|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|14.6|14.6|||
4404075|NCT00256750|4230908|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|13.4|13.4|||
4404076|NCT00256750|4230909|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|14.3|14.3|||
4404077|NCT00256724|4231045|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4404078|NCT00256724|4231046|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4404079|NCT00256724|4231047|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4404080|NCT00256724|4231045|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4404081|NCT00256724|4231046|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4404082|NCT00256724|4231047|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4404083|NCT00256724|4231045|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4404084|NCT00256724|4231046|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4404085|NCT00256724|4231047|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4404086|NCT00256724|4231045|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|15.0|15.0|||
4404087|NCT00256724|4231046|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|17.3|17.3|||
4404088|NCT00256724|4231047|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|11.8|11.8|||
4404089|NCT00256724|4231045|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4404090|NCT00256724|4231046|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4404091|NCT00256724|4231047|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4404092|NCT00256724|4231045|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4404093|NCT00256724|4231046|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4404094|NCT00256724|4231047|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4404095|NCT00256724|4231045|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4404096|NCT00256724|4231046|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4404097|NCT00256724|4231047|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404098|NCT00256698|4231056|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4404099|NCT00256698|4231057|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4404100|NCT00256698|4231058|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4404101|NCT00256698|4231056|B3||Female|Sex: Female, Male||Participants|Count of Participants|514|514.0||||||
4404102|NCT00256698|4231057|B2||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4404103|NCT00256698|4231058|B1||Female|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4404104|NCT00256698|4231056|B3|||Age||Years|Mean|64.3|64.3|Standard Deviation|10.0|10.0|||
4404105|NCT00256698|4231057|B2|||Age||Years|Mean|63.4|63.4|Standard Deviation|10.3|10.3|||
4404106|NCT00256698|4231058|B1|||Age||Years|Mean|65.2|65.2|Standard Deviation|9.6|9.6|||
4404107|NCT00256308|4231077|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4404108|NCT00256308|4231077|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4404109|NCT00256308|4231077|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4404110|NCT00256308|4231077|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4404111|NCT00256308|4231077|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4404112|NCT00256308|4231077|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4404113|NCT00256308|4231077|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4404114|NCT00256308|4231077|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4404115|NCT00256308|4231077|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4404116|NCT00256308|4231077|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4404117|NCT00256308|4231077|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4404118|NCT00256308|4231077|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4404119|NCT00256308|4231077|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4404120|NCT00256308|4231077|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4404121|NCT00256308|4231077|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4404122|NCT00256308|4231077|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404123|NCT00256295|4231085|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4404124|NCT00256295|4231085|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404125|NCT00256295|4231085|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404126|NCT00256295|4231085|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4404127|NCT00256295|4231085|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404128|NCT00256295|4231085|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404129|NCT00256295|4231085|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404130|NCT00256295|4231085|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4404131|NCT00256295|4231085|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404132|NCT00256295|4231085|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4404133|NCT00256295|4231085|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404134|NCT00256295|4231085|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4404135|NCT00256295|4231085|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4404136|NCT00256295|4231085|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4404137|NCT00256295|4231085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4404138|NCT00256295|4231085|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404139|NCT00256282|4231091|B1|United States||Region of Enrollment||Participants|Count of Participants|52|52.0||||||
4404140|NCT00256282|4231091|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4404141|NCT00256282|4231091|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4404142|NCT00256282|4231091|B1|||Age||years|Median|62.0|62.0|Full Range|||24.0|82.0|
4404143|NCT00256282|4231091|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4404144|NCT00256282|4231091|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4404145|NCT00256282|4231091|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404146|NCT00256243|4231096|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4404147|NCT00256243|4231096|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4404148|NCT00256243|4231096|B1|||Age||years|Mean|50.29|50.29|Standard Deviation|11.08|11.08|||
4404149|NCT00256243|4231096|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4404150|NCT00256243|4231096|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4404151|NCT00256243|4231096|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404152|NCT00256204|4231101|B5|Netherlands||Region of Enrollment||participants|Number|36|36.0||||||
4404153|NCT00256204|4231102|B4|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4404154|NCT00256204|4231103|B3|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4404155|NCT00256204|4231104|B2|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4404156|NCT00256204|4231105|B1|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4404157|NCT00256204|4231101|B5|Germany||Region of Enrollment||participants|Number|109|109.0||||||
4404158|NCT00256204|4231102|B4|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4404159|NCT00256204|4231103|B3|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4404160|NCT00256204|4231104|B2|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4404161|NCT00256204|4231105|B1|Germany||Region of Enrollment||participants|Number|27|27.0||||||
4404162|NCT00256204|4231101|B5|Romania||Region of Enrollment||participants|Number|98|98.0||||||
4404163|NCT00256204|4231102|B4|Romania||Region of Enrollment||participants|Number|24|24.0||||||
4404164|NCT00256204|4231103|B3|Romania||Region of Enrollment||participants|Number|25|25.0||||||
4404165|NCT00256204|4231104|B2|Romania||Region of Enrollment||participants|Number|24|24.0||||||
4404166|NCT00256204|4231105|B1|Romania||Region of Enrollment||participants|Number|25|25.0||||||
4404167|NCT00256204|4231101|B5|Argentina||Region of Enrollment||participants|Number|68|68.0||||||
4404168|NCT00256204|4231102|B4|Argentina||Region of Enrollment||participants|Number|18|18.0||||||
4404169|NCT00256204|4231103|B3|Argentina||Region of Enrollment||participants|Number|16|16.0||||||
4404170|NCT00256204|4231104|B2|Argentina||Region of Enrollment||participants|Number|17|17.0||||||
4404171|NCT00256204|4231105|B1|Argentina||Region of Enrollment||participants|Number|17|17.0||||||
4404172|NCT00256204|4231101|B5|Canada||Region of Enrollment||participants|Number|109|109.0||||||
4404173|NCT00256204|4231102|B4|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4404174|NCT00256204|4231103|B3|Canada||Region of Enrollment||participants|Number|29|29.0||||||
4404175|NCT00256204|4231104|B2|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4404176|NCT00256204|4231105|B1|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4404177|NCT00256204|4231101|B5|Hungary||Region of Enrollment||participants|Number|29|29.0||||||
4404178|NCT00256204|4231102|B4|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
4404179|NCT00256204|4231103|B3|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4404180|NCT00256204|4231104|B2|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4404181|NCT00256204|4231105|B1|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4404182|NCT00256204|4231101|B5|France||Region of Enrollment||participants|Number|48|48.0||||||
4404183|NCT00256204|4231102|B4|France||Region of Enrollment||participants|Number|14|14.0||||||
4404184|NCT00256204|4231103|B3|France||Region of Enrollment||participants|Number|12|12.0||||||
4404185|NCT00256204|4231104|B2|France||Region of Enrollment||participants|Number|11|11.0||||||
4404186|NCT00256204|4231105|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
4404187|NCT00256204|4231101|B5|Italy||Region of Enrollment||participants|Number|102|102.0||||||
4404188|NCT00256204|4231102|B4|Italy||Region of Enrollment||participants|Number|25|25.0||||||
4404189|NCT00256204|4231103|B3|Italy||Region of Enrollment||participants|Number|28|28.0||||||
4404190|NCT00256204|4231104|B2|Italy||Region of Enrollment||participants|Number|25|25.0||||||
4404191|NCT00256204|4231105|B1|Italy||Region of Enrollment||participants|Number|24|24.0||||||
4404192|NCT00256204|4231101|B5|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
4404193|NCT00256204|4231102|B4|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4404194|NCT00256204|4231103|B3|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4404195|NCT00256204|4231104|B2|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4404196|NCT00256204|4231105|B1|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4404197|NCT00256204|4231101|B5|Israel||Region of Enrollment||participants|Number|87|87.0||||||
4404198|NCT00256204|4231102|B4|Israel||Region of Enrollment||participants|Number|21|21.0||||||
4404199|NCT00256204|4231103|B3|Israel||Region of Enrollment||participants|Number|21|21.0||||||
4404200|NCT00256204|4231104|B2|Israel||Region of Enrollment||participants|Number|23|23.0||||||
4404201|NCT00256204|4231105|B1|Israel||Region of Enrollment||participants|Number|22|22.0||||||
4404202|NCT00256204|4231101|B5|Austria||Region of Enrollment||participants|Number|8|8.0||||||
4404203|NCT00256204|4231102|B4|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4404204|NCT00256204|4231103|B3|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4404205|NCT00256204|4231104|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4404206|NCT00256204|4231105|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4404207|NCT00256204|4231101|B5|Spain||Region of Enrollment||participants|Number|48|48.0||||||
4404208|NCT00256204|4231102|B4|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4404209|NCT00256204|4231103|B3|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4404210|NCT00256204|4231104|B2|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4404211|NCT00256204|4231105|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4404212|NCT00256204|4231101|B5|Portugal||Region of Enrollment||participants|Number|16|16.0||||||
4404213|NCT00256204|4231102|B4|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4404214|NCT00256204|4231103|B3|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4404215|NCT00256204|4231104|B2|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4404216|NCT00256204|4231105|B1|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4404217|NCT00256204|4231101|B5|United States||Region of Enrollment||participants|Number|385|385.0||||||
4404218|NCT00256204|4231102|B4|United States||Region of Enrollment||participants|Number|98|98.0||||||
4404219|NCT00256204|4231103|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4404220|NCT00256204|4231104|B2|United States||Region of Enrollment||participants|Number|91|91.0||||||
4404221|NCT00256204|4231105|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4404222|NCT00256204|4231101|B5||Male|Sex: Female, Male||Participants|Count of Participants|717|717.0||||||
4404223|NCT00256204|4231102|B4||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4404224|NCT00256204|4231103|B3||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4404225|NCT00256204|4231104|B2||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4404226|NCT00256204|4231105|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4404227|NCT00256204|4231101|B5||Female|Sex: Female, Male||Participants|Count of Participants|457|457.0||||||
4404228|NCT00256204|4231102|B4||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4404229|NCT00256204|4231103|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4404230|NCT00256204|4231104|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4404231|NCT00256204|4231105|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4404232|NCT00256204|4231101|B5|||Age||years|Mean|62.2|62.2|Standard Deviation|9.6|9.6|||
4404233|NCT00256204|4231102|B4|||Age||years|Mean|62.4|62.4|Standard Deviation|9.7|9.7|||
4404234|NCT00256204|4231103|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|9.6|9.6|||
4404235|NCT00256204|4231104|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|9.7|9.7|||
4404236|NCT00256204|4231105|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|9.6|9.6|||
4404237|NCT00256204|4231101|B5||>=65 years|Age||Participants|Count of Participants|494|494.0||||||
4404238|NCT00256204|4231102|B4||>=65 years|Age||Participants|Count of Participants|122|122.0||||||
4404239|NCT00256204|4231103|B3||>=65 years|Age||Participants|Count of Participants|124|124.0||||||
4404240|NCT00256204|4231104|B2||>=65 years|Age||Participants|Count of Participants|125|125.0||||||
4404241|NCT00256204|4231105|B1||>=65 years|Age||Participants|Count of Participants|123|123.0||||||
4404242|NCT00256204|4231101|B5||Between 18 and 65 years|Age||Participants|Count of Participants|680|680.0||||||
4404243|NCT00256204|4231102|B4||Between 18 and 65 years|Age||Participants|Count of Participants|173|173.0||||||
4404244|NCT00256204|4231103|B3||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
4404245|NCT00256204|4231104|B2||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
4404246|NCT00256204|4231105|B1||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4404247|NCT00256204|4231101|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404248|NCT00256204|4231102|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404249|NCT00256204|4231103|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404250|NCT00256204|4231104|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404251|NCT00256204|4231105|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404252|NCT00256126|4231121|B3||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4404253|NCT00256126|4231122|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4404254|NCT00256126|4231123|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4404255|NCT00256126|4231121|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4404256|NCT00256126|4231122|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4404257|NCT00256126|4231123|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4404258|NCT00256126|4231121|B3|||Age||years|Mean|9.11|9.11|Standard Deviation|3.62|3.62|||
4404259|NCT00256126|4231122|B2|||Age||years|Mean|8.94|8.94|Standard Deviation|3.17|3.17|||
4404260|NCT00256126|4231123|B1|||Age||years|Mean|9.3|9.3|Standard Deviation|4.08|4.08|||
4404261|NCT00255970|4231140|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4404262|NCT00255970|4231141|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4404263|NCT00255970|4231142|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4404264|NCT00255970|4231140|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4404265|NCT00255970|4231141|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4404266|NCT00255970|4231142|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4404267|NCT00255970|4231140|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4404268|NCT00255970|4231141|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4404269|NCT00255970|4231142|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4404270|NCT00255970|4231140|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|12.3|12.3|||
4404271|NCT00255970|4231141|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|14|14.0|||
4404272|NCT00255970|4231142|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|10.7|10.7|||
4404273|NCT00255970|4231140|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4404274|NCT00255970|4231141|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4404275|NCT00255970|4231142|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4404276|NCT00255970|4231140|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4404277|NCT00255970|4231141|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4404278|NCT00255970|4231142|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4404279|NCT00255970|4231140|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404280|NCT00255970|4231141|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404281|NCT00255970|4231142|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404282|NCT00255840|4231161|B3|South Africa||Region of Enrollment||participants|Number|812|812.0||||||
4404283|NCT00255840|4231162|B2|South Africa||Region of Enrollment||participants|Number|404|404.0||||||
4404284|NCT00255840|4231163|B1|South Africa||Region of Enrollment||participants|Number|408|408.0||||||
4404285|NCT00255840|4231161|B3||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4404286|NCT00255840|4231162|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4404287|NCT00255840|4231163|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4404288|NCT00255840|4231161|B3||Female|Sex: Female, Male||Participants|Count of Participants|573|573.0||||||
4404289|NCT00255840|4231162|B2||Female|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4404290|NCT00255840|4231163|B1||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4404291|NCT00255840|4231161|B3|||Age||years|Mean|33.12|33.12|Standard Deviation|7.29|7.29|||
4404292|NCT00255840|4231162|B2|||Age||years|Mean|32.9739630|32.973963|Standard Deviation|7.3921786|7.3921786|||
4404293|NCT00255840|4231163|B1|||Age||years|Mean|33.2612388|33.2612388|Standard Deviation|7.1934154|7.1934154|||
4404294|NCT00255840|4231161|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4404295|NCT00255840|4231162|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4404296|NCT00255840|4231163|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4404297|NCT00255840|4231161|B3||Between 18 and 65 years|Age||Participants|Count of Participants|812|812.0||||||
4404298|NCT00255840|4231162|B2||Between 18 and 65 years|Age||Participants|Count of Participants|404|404.0||||||
4404299|NCT00255840|4231163|B1||Between 18 and 65 years|Age||Participants|Count of Participants|408|408.0||||||
4404300|NCT00255840|4231161|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404301|NCT00255840|4231162|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404302|NCT00255840|4231163|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404303|NCT00255801|4231170|B1|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4404304|NCT00255801|4231170|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4404305|NCT00255801|4231170|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404306|NCT00255801|4231170|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4404307|NCT00255801|4231170|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4404308|NCT00255801|4231170|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404309|NCT00255801|4231170|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4404310|NCT00255801|4231170|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404311|NCT00255801|4231170|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404312|NCT00255801|4231170|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4404313|NCT00255801|4231170|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4404314|NCT00255801|4231170|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4404315|NCT00255801|4231170|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4404316|NCT00255801|4231170|B1|||Age||years|Median|56|56.0|Full Range|||27.0|81.0|
4404317|NCT00255723|4231175|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4404318|NCT00255723|4231176|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4404319|NCT00255723|4231177|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4404320|NCT00255723|4231175|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4404321|NCT00255723|4231176|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4404322|NCT00255723|4231177|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4404323|NCT00255723|4231175|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4404324|NCT00255723|4231176|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4404325|NCT00255723|4231177|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4404326|NCT00255723|4231175|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4404327|NCT00255723|4231176|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4404328|NCT00255723|4231177|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4404329|NCT00255723|4231175|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4404330|NCT00255723|4231176|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404331|NCT00255723|4231177|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4404332|NCT00255684|4231184|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4404333|NCT00255684|4231184|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4404334|NCT00255684|4231184|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4404335|NCT00255684|4231184|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4404336|NCT00255684|4231184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4404337|NCT00255684|4231184|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4404338|NCT00255190|4231189|B3|United States||Region of Enrollment||subjects|Number|591|591.0||||||
4404339|NCT00255190|4231190|B2|United States||Region of Enrollment||subjects|Number|438|438.0||||||
4404340|NCT00255190|4231191|B1|United States||Region of Enrollment||subjects|Number|153|153.0||||||
4404341|NCT00255190|4231189|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404342|NCT00255190|4231190|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404343|NCT00255190|4231191|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404344|NCT00255190|4231189|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|503|503.0||||||
4404345|NCT00255190|4231190|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|374|374.0||||||
4404346|NCT00255190|4231191|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4404347|NCT00255190|4231189|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4404348|NCT00255190|4231190|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4404349|NCT00255190|4231191|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4404350|NCT00255190|4231189|B3|Multiracial||Race/Ethnicity, Customized||subjects|Number|6|6.0||||||
4404351|NCT00255190|4231190|B2|Multiracial||Race/Ethnicity, Customized||subjects|Number|6|6.0||||||
4404352|NCT00255190|4231191|B1|Multiracial||Race/Ethnicity, Customized||subjects|Number|0|0.0||||||
4404353|NCT00255190|4231189|B3|White||Race/Ethnicity, Customized||subjects|Number|492|492.0||||||
4404354|NCT00255190|4231190|B2|White||Race/Ethnicity, Customized||subjects|Number|366|366.0||||||
4404355|NCT00255190|4231191|B1|White||Race/Ethnicity, Customized||subjects|Number|126|126.0||||||
4404356|NCT00255190|4231189|B3|Black of African Heritage||Race/Ethnicity, Customized||subjects|Number|62|62.0||||||
4404357|NCT00255190|4231190|B2|Black of African Heritage||Race/Ethnicity, Customized||subjects|Number|44|44.0||||||
4404358|NCT00255190|4231191|B1|Black of African Heritage||Race/Ethnicity, Customized||subjects|Number|18|18.0||||||
4404359|NCT00255190|4231189|B3|Asian||Race/Ethnicity, Customized||subjects|Number|20|20.0||||||
4404360|NCT00255190|4231190|B2|Asian||Race/Ethnicity, Customized||subjects|Number|14|14.0||||||
4404361|NCT00255190|4231191|B1|Asian||Race/Ethnicity, Customized||subjects|Number|6|6.0||||||
4404362|NCT00255190|4231189|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||subjects|Number|11|11.0||||||
4404363|NCT00255190|4231190|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||subjects|Number|8|8.0||||||
4404364|NCT00255190|4231191|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||subjects|Number|3|3.0||||||
4404365|NCT00255190|4231189|B3||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4404366|NCT00255190|4231190|B2||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4404367|NCT00255190|4231191|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4404368|NCT00255190|4231189|B3||Female|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
4404369|NCT00255190|4231190|B2||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4404370|NCT00255190|4231191|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4404371|NCT00255190|4231189|B3|≥65 years||Age, Customized||subjects|Number|60|60.0||||||
4404372|NCT00255190|4231190|B2|≥65 years||Age, Customized||subjects|Number|43|43.0||||||
4404373|NCT00255190|4231191|B1|≥65 years||Age, Customized||subjects|Number|17|17.0||||||
4404374|NCT00255190|4231189|B3|45 to <65 years||Age, Customized||subjects|Number|308|308.0||||||
4404375|NCT00255190|4231190|B2|45 to <65 years||Age, Customized||subjects|Number|237|237.0||||||
4404376|NCT00255190|4231191|B1|45 to <65 years||Age, Customized||subjects|Number|71|71.0||||||
4404377|NCT00255190|4231189|B3|<45 years||Age, Customized||subjects|Number|223|223.0||||||
4404378|NCT00255190|4231190|B2|<45 years||Age, Customized||subjects|Number|158|158.0||||||
4404379|NCT00255190|4231191|B1|<45 years||Age, Customized||subjects|Number|65|65.0||||||
4404380|NCT00255190|4231189|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|13.57|13.57|||
4404381|NCT00255190|4231190|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|13.50|13.5|||
4404382|NCT00255190|4231191|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|13.78|13.78|||
4404383|NCT00255177|4231256|B5|United States||Region of Enrollment||participants|Number|44|44.0||||||
4404384|NCT00255177|4231257|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4404385|NCT00255177|4231258|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4404386|NCT00255177|4231259|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4404387|NCT00255177|4231260|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4404388|NCT00255177|4231256|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4404389|NCT00255177|4231257|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4404390|NCT00255177|4231258|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4404391|NCT00255177|4231259|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4404392|NCT00255177|4231260|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4404393|NCT00255177|4231256|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4404394|NCT00255177|4231257|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4404395|NCT00255177|4231258|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4404396|NCT00255177|4231259|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4404397|NCT00255177|4231260|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4404398|NCT00255177|4231256|B5|||Age||years|Mean|47.5|47.5|Standard Deviation|6.7|6.7|||
4404399|NCT00255177|4231257|B4|||Age||years|Mean|52.0|52.0|Standard Deviation|3.7|3.7|||
4404400|NCT00255177|4231258|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|9.2|9.2|||
4404401|NCT00255177|4231259|B2|||Age||years|Mean|45.4|45.4|Standard Deviation|6.9|6.9|||
4404402|NCT00255177|4231260|B1|||Age||years|Mean|48.0|48.0|Standard Deviation|6.9|6.9|||
4404403|NCT00255164|4231273|B4|D: ≥1 mucosal break ≥75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|19|19.0||||||
4404404|NCT00255164|4231274|B3|D: ≥1 mucosal break ≥75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|8|8.0||||||
4404405|NCT00255164|4231275|B2|D: ≥1 mucosal break ≥75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|5|5.0||||||
4404406|NCT00255164|4231276|B1|D: ≥1 mucosal break ≥75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|6|6.0||||||
4404407|NCT00255164|4231273|B4|C: ≥1 mucosal break <75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|93|93.0||||||
4404408|NCT00255164|4231274|B3|C: ≥1 mucosal break <75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|32|32.0||||||
4404409|NCT00255164|4231275|B2|C: ≥1 mucosal break <75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|33|33.0||||||
4404453|NCT00255164|4231275|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4404454|NCT00255164|4231276|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4404410|NCT00255164|4231276|B1|C: ≥1 mucosal break <75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|28|28.0||||||
4404411|NCT00255164|4231273|B4|B: ≥1 mucosal break ≥5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|167|167.0||||||
4404412|NCT00255164|4231274|B3|B: ≥1 mucosal break ≥5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|58|58.0||||||
4404413|NCT00255164|4231275|B2|B: ≥1 mucosal break ≥5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|61|61.0||||||
4404414|NCT00255164|4231276|B1|B: ≥1 mucosal break ≥5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|48|48.0||||||
4404415|NCT00255164|4231273|B4|A: ≥1 mucosal break <5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|172|172.0||||||
4404416|NCT00255164|4231274|B3|A: ≥1 mucosal break <5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|54|54.0||||||
4404417|NCT00255164|4231275|B2|A: ≥1 mucosal break <5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|60|60.0||||||
4404418|NCT00255164|4231276|B1|A: ≥1 mucosal break <5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|58|58.0||||||
4404419|NCT00255164|4231273|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404420|NCT00255164|4231274|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404421|NCT00255164|4231275|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404422|NCT00255164|4231276|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404423|NCT00255164|4231273|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|403|403.0||||||
4404424|NCT00255164|4231274|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4404425|NCT00255164|4231275|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4404426|NCT00255164|4231276|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4404427|NCT00255164|4231273|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4404428|NCT00255164|4231274|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4404429|NCT00255164|4231275|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4404430|NCT00255164|4231276|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4404431|NCT00255164|4231273|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404432|NCT00255164|4231274|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404433|NCT00255164|4231275|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404434|NCT00255164|4231276|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404435|NCT00255164|4231273|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4404436|NCT00255164|4231274|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4404437|NCT00255164|4231275|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4404438|NCT00255164|4231276|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4404439|NCT00255164|4231273|B4||White|Race (NIH/OMB)||Participants|Count of Participants|395|395.0||||||
4404440|NCT00255164|4231274|B3||White|Race (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
4404441|NCT00255164|4231275|B2||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
4404442|NCT00255164|4231276|B1||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4404443|NCT00255164|4231273|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4404444|NCT00255164|4231274|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4404445|NCT00255164|4231275|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4404446|NCT00255164|4231276|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4404447|NCT00255164|4231273|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404448|NCT00255164|4231274|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404449|NCT00255164|4231275|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404450|NCT00255164|4231276|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404451|NCT00255164|4231273|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4404452|NCT00255164|4231274|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404455|NCT00255164|4231273|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4404456|NCT00255164|4231274|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4404457|NCT00255164|4231275|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4404458|NCT00255164|4231276|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4404459|NCT00255164|4231273|B4||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4404460|NCT00255164|4231274|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4404461|NCT00255164|4231275|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4404462|NCT00255164|4231276|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4404463|NCT00255164|4231273|B4||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4404464|NCT00255164|4231274|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4404465|NCT00255164|4231275|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4404466|NCT00255164|4231276|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4404467|NCT00255164|4231273|B4|≥65 years||Age, Customized||participants|Number|44|44.0||||||
4404468|NCT00255164|4231274|B3|≥65 years||Age, Customized||participants|Number|15|15.0||||||
4404469|NCT00255164|4231275|B2|≥65 years||Age, Customized||participants|Number|18|18.0||||||
4404470|NCT00255164|4231276|B1|≥65 years||Age, Customized||participants|Number|11|11.0||||||
4404471|NCT00255164|4231273|B4|45 to <65 years||Age, Customized||participants|Number|248|248.0||||||
4404472|NCT00255164|4231274|B3|45 to <65 years||Age, Customized||participants|Number|81|81.0||||||
4404473|NCT00255164|4231275|B2|45 to <65 years||Age, Customized||participants|Number|86|86.0||||||
4404474|NCT00255164|4231276|B1|45 to <65 years||Age, Customized||participants|Number|81|81.0||||||
4404475|NCT00255164|4231273|B4|<45 years||Age, Customized||participants|Number|159|159.0||||||
4404476|NCT00255164|4231274|B3|<45 years||Age, Customized||participants|Number|56|56.0||||||
4404477|NCT00255164|4231275|B2|<45 years||Age, Customized||participants|Number|55|55.0||||||
4404478|NCT00255164|4231276|B1|<45 years||Age, Customized||participants|Number|48|48.0||||||
4404479|NCT00255164|4231273|B4|||Age||years|Mean|48.9|48.9|Standard Deviation|13.09|13.09|||
4404480|NCT00255164|4231274|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|13.76|13.76|||
4404481|NCT00255164|4231275|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|12.66|12.66|||
4404482|NCT00255164|4231276|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|12.88|12.88|||
4404483|NCT00255151|4231301|B4|D: ≥1 mucosal break ≥75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|19|19.0||||||
4404484|NCT00255151|4231302|B3|D: ≥1 mucosal break ≥75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|8|8.0||||||
4404485|NCT00255151|4231303|B2|D: ≥1 mucosal break ≥75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|5|5.0||||||
4404486|NCT00255151|4231304|B1|D: ≥1 mucosal break ≥75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|6|6.0||||||
4404487|NCT00255151|4231301|B4|C: ≥1 mucosal break <75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|93|93.0||||||
4404488|NCT00255151|4231302|B3|C: ≥1 mucosal break <75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|32|32.0||||||
4404489|NCT00255151|4231303|B2|C: ≥1 mucosal break <75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|33|33.0||||||
4404490|NCT00255151|4231304|B1|C: ≥1 mucosal break <75% of circumference||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|28|28.0||||||
4404491|NCT00255151|4231301|B4|B: ≥1 mucosal break ≥5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|167|167.0||||||
4404492|NCT00255151|4231302|B3|B: ≥1 mucosal break ≥5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|58|58.0||||||
4404493|NCT00255151|4231303|B2|B: ≥1 mucosal break ≥5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|61|61.0||||||
4404494|NCT00255151|4231304|B1|B: ≥1 mucosal break ≥5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|48|48.0||||||
4404546|NCT00255151|4231304|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4404547|NCT00255151|4231301|B4|≥65 years||Age, Customized||participants|Number|44|44.0||||||
4404495|NCT00255151|4231301|B4|A: ≥1 mucosal break <5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|172|172.0||||||
4404496|NCT00255151|4231302|B3|A: ≥1 mucosal break <5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|54|54.0||||||
4404497|NCT00255151|4231303|B2|A: ≥1 mucosal break <5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|60|60.0||||||
4404498|NCT00255151|4231304|B1|A: ≥1 mucosal break <5 mm||Baseline Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|Baseline values from Studies T-EE04-084 (NCT00251693)and T-EE04-085 (NCT00251719), with severity of EE increasing from Grade A to Grade D.|participants|Number|58|58.0||||||
4404499|NCT00255151|4231301|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404500|NCT00255151|4231302|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404501|NCT00255151|4231303|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404502|NCT00255151|4231304|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404503|NCT00255151|4231301|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|403|403.0||||||
4404504|NCT00255151|4231302|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4404505|NCT00255151|4231303|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4404506|NCT00255151|4231304|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|125|125.0||||||
4404507|NCT00255151|4231301|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4404508|NCT00255151|4231302|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4404509|NCT00255151|4231303|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4404510|NCT00255151|4231304|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4404511|NCT00255151|4231301|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404512|NCT00255151|4231302|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404513|NCT00255151|4231303|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404514|NCT00255151|4231304|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404515|NCT00255151|4231301|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4404516|NCT00255151|4231302|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4404517|NCT00255151|4231303|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4404518|NCT00255151|4231304|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4404519|NCT00255151|4231301|B4||White|Race (NIH/OMB)||Participants|Count of Participants|395|395.0||||||
4404520|NCT00255151|4231302|B3||White|Race (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
4404521|NCT00255151|4231303|B2||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
4404522|NCT00255151|4231304|B1||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4404523|NCT00255151|4231301|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4404524|NCT00255151|4231302|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4404525|NCT00255151|4231303|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4404526|NCT00255151|4231304|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4404527|NCT00255151|4231301|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404528|NCT00255151|4231302|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404529|NCT00255151|4231303|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404530|NCT00255151|4231304|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404531|NCT00255151|4231301|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4404532|NCT00255151|4231302|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404533|NCT00255151|4231303|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4404534|NCT00255151|4231304|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4404535|NCT00255151|4231301|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4404536|NCT00255151|4231302|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4404537|NCT00255151|4231303|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4404538|NCT00255151|4231304|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4404539|NCT00255151|4231301|B4||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4404540|NCT00255151|4231302|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4404541|NCT00255151|4231303|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4404542|NCT00255151|4231304|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4404543|NCT00255151|4231301|B4||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4404544|NCT00255151|4231302|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4404545|NCT00255151|4231303|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4404548|NCT00255151|4231302|B3|≥65 years||Age, Customized||participants|Number|15|15.0||||||
4404549|NCT00255151|4231303|B2|≥65 years||Age, Customized||participants|Number|18|18.0||||||
4404550|NCT00255151|4231304|B1|≥65 years||Age, Customized||participants|Number|11|11.0||||||
4404551|NCT00255151|4231301|B4|45 to <65 years||Age, Customized||participants|Number|248|248.0||||||
4404552|NCT00255151|4231302|B3|45 to <65 years||Age, Customized||participants|Number|81|81.0||||||
4404553|NCT00255151|4231303|B2|45 to <65 years||Age, Customized||participants|Number|86|86.0||||||
4404554|NCT00255151|4231304|B1|45 to <65 years||Age, Customized||participants|Number|81|81.0||||||
4404555|NCT00255151|4231301|B4|<45 years||Age, Customized||participants|Number|159|159.0||||||
4404556|NCT00255151|4231302|B3|<45 years||Age, Customized||participants|Number|56|56.0||||||
4404557|NCT00255151|4231303|B2|<45 years||Age, Customized||participants|Number|55|55.0||||||
4404558|NCT00255151|4231304|B1|<45 years||Age, Customized||participants|Number|48|48.0||||||
4404559|NCT00255151|4231301|B4|||Age||years|Mean|48.9|48.9|Standard Deviation|13.09|13.09|||
4404560|NCT00255151|4231302|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|13.76|13.76|||
4404561|NCT00255151|4231303|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|12.66|12.66|||
4404562|NCT00255151|4231304|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|12.88|12.88|||
4404563|NCT00255125|4231329|B3|United States||Region of Enrollment||participants|Number|86|86.0||||||
4404564|NCT00255125|4231330|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4404565|NCT00255125|4231331|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4404566|NCT00255125|4231329|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404567|NCT00255125|4231330|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404568|NCT00255125|4231331|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404569|NCT00255125|4231329|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404570|NCT00255125|4231330|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404571|NCT00255125|4231331|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404572|NCT00255125|4231329|B3||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4404573|NCT00255125|4231330|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4404574|NCT00255125|4231331|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4404575|NCT00255125|4231329|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4404576|NCT00255125|4231330|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4404577|NCT00255125|4231331|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4404578|NCT00255125|4231329|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404579|NCT00255125|4231330|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404580|NCT00255125|4231331|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404581|NCT00255125|4231329|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404582|NCT00255125|4231330|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404583|NCT00255125|4231331|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404584|NCT00255125|4231329|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4404585|NCT00255125|4231330|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4404586|NCT00255125|4231331|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4404587|NCT00255125|4231329|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404588|NCT00255125|4231330|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404589|NCT00255125|4231331|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404590|NCT00255125|4231329|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4404591|NCT00255125|4231330|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4404592|NCT00255125|4231331|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4404593|NCT00255125|4231329|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4404594|NCT00255125|4231330|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4404595|NCT00255125|4231331|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4404596|NCT00255125|4231329|B3|Male||Sex/Gender, Customized||participants|Number|86|86.0||||||
4404597|NCT00255125|4231330|B2|Male||Sex/Gender, Customized||participants|Number|42|42.0||||||
4404598|NCT00255125|4231331|B1|Male||Sex/Gender, Customized||participants|Number|44|44.0||||||
4404599|NCT00255125|4231329|B3|||Age||Years|Mean|62|62.0|Standard Deviation|12|12.0|||
4404600|NCT00255125|4231330|B2|||Age||Years|Mean|62|62.0|Standard Deviation|7|7.0|||
4404601|NCT00255125|4231331|B1|||Age||Years|Mean|62|62.0|Standard Deviation|12|12.0|||
4404602|NCT00255086|4231338|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4404603|NCT00255086|4231339|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4404604|NCT00255086|4231340|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4404605|NCT00255086|4231338|B3|Male||Sex/Gender, Customized||participants|Number|8|8.0||||||
4404606|NCT00255086|4231339|B2|Male||Sex/Gender, Customized||participants|Number|2|2.0||||||
4404607|NCT00255086|4231340|B1|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
4404608|NCT00255086|4231338|B3|Female||Sex/Gender, Customized||participants|Number|5|5.0||||||
4404609|NCT00255086|4231339|B2|Female||Sex/Gender, Customized||participants|Number|4|4.0||||||
4404610|NCT00255086|4231340|B1|Female||Sex/Gender, Customized||participants|Number|1|1.0||||||
4404611|NCT00255086|4231338|B3|||Age||years|Mean|75.9|75.9|Full Range|||50.0|90.0|
4404612|NCT00255086|4231339|B2|||Age||years|Mean|75.4|75.4|Full Range|||50.0|90.0|
4404613|NCT00255086|4231340|B1|||Age||years|Mean|76.5|76.5|Full Range|||50.0|90.0|
4404614|NCT00255047|4231349|B5|United States||Region of Enrollment||participants|Number|2167|2167.0||||||
4404615|NCT00255047|4231350|B4|United States||Region of Enrollment||participants|Number|548|548.0||||||
4404616|NCT00255047|4231351|B3|United States||Region of Enrollment||participants|Number|546|546.0||||||
4404617|NCT00255047|4231352|B2|United States||Region of Enrollment||participants|Number|535|535.0||||||
4404618|NCT00255047|4231353|B1|United States||Region of Enrollment||participants|Number|538|538.0||||||
4404619|NCT00255047|4231349|B5||Male|Sex: Female, Male||Participants|Count of Participants|1151|1151.0||||||
4404620|NCT00255047|4231350|B4||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4404621|NCT00255047|4231351|B3||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4404622|NCT00255047|4231352|B2||Male|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
4404623|NCT00255047|4231353|B1||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4404624|NCT00255047|4231349|B5||Female|Sex: Female, Male||Participants|Count of Participants|1016|1016.0||||||
4404625|NCT00255047|4231350|B4||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4404626|NCT00255047|4231351|B3||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4404627|NCT00255047|4231352|B2||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4404628|NCT00255047|4231353|B1||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4404629|NCT00255047|4231349|B5|||Age||Months|Mean|2.1|2.1|Standard Deviation|0.27|0.27|||
4404630|NCT00255047|4231350|B4|||Age||Months|Mean|2.1|2.1|Standard Deviation|0.28|0.28|||
4404631|NCT00255047|4231351|B3|||Age||Months|Mean|2.2|2.2|Standard Deviation|0.27|0.27|||
4404632|NCT00255047|4231352|B2|||Age||Months|Mean|2.1|2.1|Standard Deviation|0.27|0.27|||
4404633|NCT00255047|4231353|B1|||Age||Months|Mean|2.2|2.2|Standard Deviation|0.27|0.27|||
4404634|NCT00255047|4231349|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4404635|NCT00255047|4231350|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4404636|NCT00255047|4231351|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4404637|NCT00255047|4231352|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4404638|NCT00255047|4231353|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4404639|NCT00255047|4231349|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4404640|NCT00255047|4231350|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4404641|NCT00255047|4231351|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4404642|NCT00255047|4231352|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4404643|NCT00255047|4231353|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4404644|NCT00255047|4231349|B5||<=18 years|Age||Participants|Count of Participants|2167|2167.0||||||
4404645|NCT00255047|4231350|B4||<=18 years|Age||Participants|Count of Participants|548|548.0||||||
4404646|NCT00255047|4231351|B3||<=18 years|Age||Participants|Count of Participants|546|546.0||||||
4404647|NCT00255047|4231352|B2||<=18 years|Age||Participants|Count of Participants|535|535.0||||||
4404648|NCT00255047|4231353|B1||<=18 years|Age||Participants|Count of Participants|538|538.0||||||
4404649|NCT00255034|4231378|B3|Transgender||Sex/Gender, Customized||participants|Number|1|1.0||||||
4404650|NCT00255034|4231379|B2|Transgender||Sex/Gender, Customized||participants|Number|1|1.0||||||
4404651|NCT00255034|4231380|B1|Transgender||Sex/Gender, Customized||participants|Number|0|0.0||||||
4404652|NCT00255034|4231378|B3|Male||Sex/Gender, Customized||participants|Number|103|103.0||||||
4404653|NCT00255034|4231379|B2|Male||Sex/Gender, Customized||participants|Number|51|51.0||||||
4404654|NCT00255034|4231380|B1|Male||Sex/Gender, Customized||participants|Number|52|52.0||||||
4404655|NCT00255034|4231378|B3|Female||Sex/Gender, Customized||participants|Number|39|39.0||||||
4404656|NCT00255034|4231379|B2|Female||Sex/Gender, Customized||participants|Number|12|12.0||||||
4404657|NCT00255034|4231380|B1|Female||Sex/Gender, Customized||participants|Number|27|27.0||||||
4404658|NCT00255034|4231378|B3|||Age||years|Mean|40.7|40.7|Standard Deviation|9.44|9.44|||
4404659|NCT00255034|4231379|B2|||Age||years|Mean|40.5|40.5|Standard Deviation|9.80|9.8|||
4404660|NCT00255034|4231380|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|9.20|9.2|||
4404661|NCT00255008|4231387|B5||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4404662|NCT00255008|4231388|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4404663|NCT00255008|4231389|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4404664|NCT00255008|4231390|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4404665|NCT00255008|4231391|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4404666|NCT00255008|4231387|B5||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4404667|NCT00255008|4231388|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4404668|NCT00255008|4231389|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4404669|NCT00255008|4231390|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4404670|NCT00255008|4231391|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4404671|NCT00255008|4231387|B5|||Age||years|Mean|45.2|45.2|Standard Deviation|10.89|10.89|||
4404672|NCT00255008|4231388|B4|||Age||years|Mean|46.3|46.3|Standard Deviation|10.71|10.71|||
4404673|NCT00255008|4231389|B3|||Age||years|Mean|46.8|46.8|Standard Deviation|10.56|10.56|||
4404674|NCT00255008|4231390|B2|||Age||years|Mean|43.6|43.6|Standard Deviation|12.30|12.3|||
4404675|NCT00255008|4231391|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|11.06|11.06|||
4404676|NCT00254995|4231404|B3|September - November||Seasonality|Data represents participants receiving vaccine each season or time period shown. Some participants (49) had received more than one dose of Menactra vaccine are counted for each dose in the seasonality section.|Participants|Number|11451|11451.0||||||
4404677|NCT00254995|4231405|B2|September - November||Seasonality|Data represents participants receiving vaccine each season or time period shown. Some participants (49) had received more than one dose of Menactra vaccine are counted for each dose in the seasonality section.|Participants|Number|5712|5712.0||||||
4404678|NCT00254995|4231406|B1|September - November||Seasonality|Data represents participants receiving vaccine each season or time period shown. Some participants (49) had received more than one dose of Menactra vaccine are counted for each dose in the seasonality section.|Participants|Number|5739|5739.0||||||
4404679|NCT00254995|4231404|B3|June - August||Seasonality|Data represents participants receiving vaccine each season or time period shown. Some participants (49) had received more than one dose of Menactra vaccine are counted for each dose in the seasonality section.|Participants|Number|34657|34657.0||||||
4404680|NCT00254995|4231405|B2|June - August||Seasonality|Data represents participants receiving vaccine each season or time period shown. Some participants (49) had received more than one dose of Menactra vaccine are counted for each dose in the seasonality section.|Participants|Number|17080|17080.0||||||
4404681|NCT00254995|4231406|B1|June - August||Seasonality|Data represents participants receiving vaccine each season or time period shown. Some participants (49) had received more than one dose of Menactra vaccine are counted for each dose in the seasonality section.|Participants|Number|17577|17577.0||||||
4404682|NCT00254995|4231404|B3|March - May||Seasonality|Data represents participants receiving vaccine each season or time period shown. Some participants (49) had received more than one dose of Menactra vaccine are counted for each dose in the seasonality section.|Participants|Number|7207|7207.0||||||
4404683|NCT00254995|4231405|B2|March - May||Seasonality|Data represents participants receiving vaccine each season or time period shown. Some participants (49) had received more than one dose of Menactra vaccine are counted for each dose in the seasonality section.|Participants|Number|3602|3602.0||||||
4404684|NCT00254995|4231406|B1|March - May||Seasonality|Data represents participants receiving vaccine each season or time period shown. Some participants (49) had received more than one dose of Menactra vaccine are counted for each dose in the seasonality section.|Participants|Number|3605|3605.0||||||
4404685|NCT00254995|4231404|B3|December - February||Seasonality|Data represents participants receiving vaccine each season or time period shown. Some participants (49) had received more than one dose of Menactra vaccine are counted for each dose in the seasonality section.|Participants|Number|9360|9360.0||||||
4404686|NCT00254995|4231405|B2|December - February||Seasonality|Data represents participants receiving vaccine each season or time period shown. Some participants (49) had received more than one dose of Menactra vaccine are counted for each dose in the seasonality section.|Participants|Number|4671|4671.0||||||
4404687|NCT00254995|4231406|B1|December - February||Seasonality|Data represents participants receiving vaccine each season or time period shown. Some participants (49) had received more than one dose of Menactra vaccine are counted for each dose in the seasonality section.|Participants|Number|4689|4689.0||||||
4404688|NCT00254995|4231404|B3|United States||Region of Enrollment||participants|Number|62626|62626.0||||||
4404689|NCT00254995|4231405|B2|United States||Region of Enrollment||participants|Number|31065|31065.0||||||
4404690|NCT00254995|4231406|B1|United States||Region of Enrollment||participants|Number|31561|31561.0||||||
4404691|NCT00254995|4231404|B3|Male||Gender|Gender information for 3 participants was not available in the database.|Participants|Number|31532|31532.0||||||
4404692|NCT00254995|4231405|B2|Male||Gender|Gender information for 3 participants was not available in the database.|Participants|Number|15696|15696.0||||||
4404693|NCT00254995|4231406|B1|Male||Gender|Gender information for 3 participants was not available in the database.|Participants|Number|15836|15836.0||||||
4404694|NCT00254995|4231404|B3|Female||Gender|Gender information for 3 participants was not available in the database.|Participants|Number|31091|31091.0||||||
4404695|NCT00254995|4231405|B2|Female||Gender|Gender information for 3 participants was not available in the database.|Participants|Number|15369|15369.0||||||
4404696|NCT00254995|4231406|B1|Female||Gender|Gender information for 3 participants was not available in the database.|Participants|Number|15722|15722.0||||||
4404697|NCT00254995|4231404|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4404698|NCT00254995|4231405|B2||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4404699|NCT00254995|4231406|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4404700|NCT00254995|4231404|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9390|9390.0||||||
4404701|NCT00254995|4231405|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4658|4658.0||||||
4404702|NCT00254995|4231406|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4732|4732.0||||||
4404703|NCT00254995|4231404|B3||<=18 years|Age||Participants|Count of Participants|53188|53188.0||||||
4404704|NCT00254995|4231405|B2||<=18 years|Age||Participants|Count of Participants|26383|26383.0||||||
4404705|NCT00254995|4231406|B1||<=18 years|Age||Participants|Count of Participants|26805|26805.0||||||
4404706|NCT00254995|4231404|B3|||Age||Years|Mean|15.6|15.6|Standard Deviation|5.56|5.56|||
4404707|NCT00254995|4231405|B2|||Age||Years|Mean|15.65|15.65|Standard Deviation|5.56|5.56|||
4404708|NCT00254995|4231406|B1|||Age||Years|Mean|15.6|15.6|Standard Deviation|5.56|5.56|||
4404709|NCT00254982|4231428|B3||Male|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
4404710|NCT00254982|4231429|B2||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4404711|NCT00254982|4231430|B1||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4404712|NCT00254982|4231428|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4404713|NCT00254982|4231429|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4404714|NCT00254982|4231430|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4404715|NCT00254982|4231428|B3|>83 years||Age, Customized||Participants|Number|0|0.0||||||
4404716|NCT00254982|4231429|B2|>83 years||Age, Customized||Participants|Number|0|0.0||||||
4404717|NCT00254982|4231430|B1|>83 years||Age, Customized||Participants|Number|0|0.0||||||
4404718|NCT00254982|4231428|B3|Between 18 and 83 years||Age, Customized||Participants|Number|593|593.0||||||
4404719|NCT00254982|4231429|B2|Between 18 and 83 years||Age, Customized||Participants|Number|296|296.0||||||
4404720|NCT00254982|4231430|B1|Between 18 and 83 years||Age, Customized||Participants|Number|297|297.0||||||
4404721|NCT00254982|4231428|B3|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4404722|NCT00254982|4231429|B2|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4404723|NCT00254982|4231430|B1|<18 years||Age, Customized||Participants|Number|0|0.0||||||
4404724|NCT00254592|4231437|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4404725|NCT00254592|4231437|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4404726|NCT00254592|4231437|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4404727|NCT00254592|4231437|B1|||Age||years|Mean|52|52.0|Standard Deviation|12.8|12.8|||
4404728|NCT00254592|4231437|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4404729|NCT00254592|4231437|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4404730|NCT00254592|4231437|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404731|NCT00254566|4231441|B3||Male|Sex: Female, Male||Participants|Count of Participants|357.0|357.0||||||
4404732|NCT00254566|4231442|B2||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4404733|NCT00254566|4231443|B1||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4404734|NCT00254566|4231441|B3||Female|Sex: Female, Male||Participants|Count of Participants|39.0|39.0||||||
4404735|NCT00254566|4231442|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4404736|NCT00254566|4231443|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4404737|NCT00254566|4231441|B3|||Age||years|Mean|67.1|67.1|Standard Deviation|8.6|8.6|||
4404738|NCT00254566|4231442|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|8.5|8.5|||
4404739|NCT00254566|4231443|B1|||Age||years|Mean|66.7|66.7|Standard Deviation|8.7|8.7|||
4404740|NCT00254540|4231466|B3|Score 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Score 0: Fully active, able to carry on all pre-disease performance without restriction.~Score 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|9|9.0||||||
4404741|NCT00254540|4231467|B2|Score 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Score 0: Fully active, able to carry on all pre-disease performance without restriction.~Score 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|4|4.0||||||
4404742|NCT00254540|4231468|B1|Score 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Score 0: Fully active, able to carry on all pre-disease performance without restriction.~Score 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|5|5.0||||||
4404743|NCT00254540|4231466|B3|Score 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Score 0: Fully active, able to carry on all pre-disease performance without restriction.~Score 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|42|42.0||||||
4404744|NCT00254540|4231467|B2|Score 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Score 0: Fully active, able to carry on all pre-disease performance without restriction.~Score 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|22|22.0||||||
4404745|NCT00254540|4231468|B1|Score 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"Score 0: Fully active, able to carry on all pre-disease performance without restriction.~Score 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|participants|Number|20|20.0||||||
4404746|NCT00254540|4231466|B3|Japan||Region of Enrollment||participants|Number|51|51.0||||||
4404747|NCT00254540|4231467|B2|Japan||Region of Enrollment||participants|Number|26|26.0||||||
4404748|NCT00254540|4231468|B1|Japan||Region of Enrollment||participants|Number|25|25.0||||||
4404749|NCT00254540|4231466|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4404750|NCT00254540|4231467|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4404751|NCT00254540|4231468|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4404752|NCT00254540|4231466|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4404753|NCT00254540|4231467|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4404754|NCT00254540|4231468|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4404755|NCT00254540|4231466|B3|>=65 years||Age, Customized||participants|Number|18|18.0||||||
4404756|NCT00254540|4231467|B2|>=65 years||Age, Customized||participants|Number|11|11.0||||||
4404757|NCT00254540|4231468|B1|>=65 years||Age, Customized||participants|Number|7|7.0||||||
4404758|NCT00254540|4231466|B3|45-64 years||Age, Customized||participants|Number|28|28.0||||||
4404759|NCT00254540|4231467|B2|45-64 years||Age, Customized||participants|Number|14|14.0||||||
4404760|NCT00254540|4231468|B1|45-64 years||Age, Customized||participants|Number|14|14.0||||||
4404761|NCT00254540|4231466|B3|20-44 years||Age, Customized||participants|Number|5|5.0||||||
4404762|NCT00254540|4231467|B2|20-44 years||Age, Customized||participants|Number|1|1.0||||||
4404763|NCT00254540|4231468|B1|20-44 years||Age, Customized||participants|Number|4|4.0||||||
4404764|NCT00254501|4231496|B3|||Years since diabetes diagnosis||years|Mean|9.0|9.0|Standard Deviation|9.1|9.1|||
4404765|NCT00254501|4231497|B2|||Years since diabetes diagnosis||years|Mean|9.9|9.9|Standard Deviation|10.3|10.3|||
4404766|NCT00254501|4231498|B1|||Years since diabetes diagnosis||years|Mean|8.0|8.0|Standard Deviation|7.4|7.4|||
4404767|NCT00254501|4231496|B3|No||Used diabetic supplies||participants|Number|39|39.0||||||
4404768|NCT00254501|4231497|B2|No||Used diabetic supplies||participants|Number|26|26.0||||||
4404769|NCT00254501|4231498|B1|No||Used diabetic supplies||participants|Number|13|13.0||||||
4404770|NCT00254501|4231496|B3|Yes||Used diabetic supplies||participants|Number|28|28.0||||||
4404771|NCT00254501|4231497|B2|Yes||Used diabetic supplies||participants|Number|10|10.0||||||
4404772|NCT00254501|4231498|B1|Yes||Used diabetic supplies||participants|Number|18|18.0||||||
4404773|NCT00254501|4231496|B3|No||On other diabetes medications||participants|Number|62|62.0||||||
4404774|NCT00254501|4231497|B2|No||On other diabetes medications||participants|Number|33|33.0||||||
4404775|NCT00254501|4231498|B1|No||On other diabetes medications||participants|Number|29|29.0||||||
4404776|NCT00254501|4231496|B3|Yes||On other diabetes medications||participants|Number|5|5.0||||||
4404777|NCT00254501|4231497|B2|Yes||On other diabetes medications||participants|Number|3|3.0||||||
4404778|NCT00254501|4231498|B1|Yes||On other diabetes medications||participants|Number|2|2.0||||||
4404779|NCT00254501|4231496|B3|No||On insulin||participants|Number|52|52.0||||||
4404780|NCT00254501|4231497|B2|No||On insulin||participants|Number|31|31.0||||||
4404781|NCT00254501|4231498|B1|No||On insulin||participants|Number|21|21.0||||||
4404782|NCT00254501|4231496|B3|Yes||On insulin||participants|Number|15|15.0||||||
4404783|NCT00254501|4231497|B2|Yes||On insulin||participants|Number|5|5.0||||||
4404784|NCT00254501|4231498|B1|Yes||On insulin||participants|Number|10|10.0||||||
4404785|NCT00254501|4231496|B3|No||On oral agents||participants|Number|23|23.0||||||
4404786|NCT00254501|4231497|B2|No||On oral agents||participants|Number|12|12.0||||||
4404787|NCT00254501|4231498|B1|No||On oral agents||participants|Number|11|11.0||||||
4404788|NCT00254501|4231496|B3|Yes||On oral agents||participants|Number|44|44.0||||||
4404789|NCT00254501|4231497|B2|Yes||On oral agents||participants|Number|24|24.0||||||
4404790|NCT00254501|4231498|B1|Yes||On oral agents||participants|Number|20|20.0||||||
4404791|NCT00254501|4231496|B3|No||On glucose-lowering therapy||participants|Number|15|15.0||||||
4404792|NCT00254501|4231497|B2|No||On glucose-lowering therapy||participants|Number|8|8.0||||||
4404793|NCT00254501|4231498|B1|No||On glucose-lowering therapy||participants|Number|7|7.0||||||
4404794|NCT00254501|4231496|B3|Yes||On glucose-lowering therapy||participants|Number|52|52.0||||||
4404795|NCT00254501|4231497|B2|Yes||On glucose-lowering therapy||participants|Number|28|28.0||||||
4404796|NCT00254501|4231498|B1|Yes||On glucose-lowering therapy||participants|Number|24|24.0||||||
4404797|NCT00254501|4231496|B3|No||Depression||participants|Number|51|51.0||||||
4404798|NCT00254501|4231497|B2|No||Depression||participants|Number|30|30.0||||||
4404799|NCT00254501|4231498|B1|No||Depression||participants|Number|21|21.0||||||
4404800|NCT00254501|4231496|B3|Yes||Depression||participants|Number|16|16.0||||||
4404801|NCT00254501|4231497|B2|Yes||Depression||participants|Number|6|6.0||||||
4404802|NCT00254501|4231498|B1|Yes||Depression||participants|Number|10|10.0||||||
4404803|NCT00254501|4231496|B3|No||Dyslipidemia||participants|Number|26|26.0||||||
4404804|NCT00254501|4231497|B2|No||Dyslipidemia||participants|Number|11|11.0||||||
4404805|NCT00254501|4231498|B1|No||Dyslipidemia||participants|Number|15|15.0||||||
4404806|NCT00254501|4231496|B3|Yes||Dyslipidemia||participants|Number|41|41.0||||||
4404807|NCT00254501|4231497|B2|Yes||Dyslipidemia||participants|Number|25|25.0||||||
4404808|NCT00254501|4231498|B1|Yes||Dyslipidemia||participants|Number|16|16.0||||||
4404809|NCT00254501|4231496|B3|No||Hypertension||participants|Number|25|25.0||||||
4404810|NCT00254501|4231497|B2|No||Hypertension||participants|Number|10|10.0||||||
4404811|NCT00254501|4231498|B1|No||Hypertension||participants|Number|15|15.0||||||
4404812|NCT00254501|4231496|B3|Yes||Hypertension||participants|Number|42|42.0||||||
4404813|NCT00254501|4231497|B2|Yes||Hypertension||participants|Number|26|26.0||||||
4404814|NCT00254501|4231498|B1|Yes||Hypertension||participants|Number|16|16.0||||||
4404815|NCT00254501|4231496|B3|Unspecified||Income categories||participants|Number|5|5.0||||||
4404816|NCT00254501|4231497|B2|Unspecified||Income categories||participants|Number|1|1.0||||||
4404817|NCT00254501|4231498|B1|Unspecified||Income categories||participants|Number|4|4.0||||||
4404818|NCT00254501|4231496|B3|$100 000 or more||Income categories||participants|Number|12|12.0||||||
4404819|NCT00254501|4231497|B2|$100 000 or more||Income categories||participants|Number|10|10.0||||||
4404820|NCT00254501|4231498|B1|$100 000 or more||Income categories||participants|Number|2|2.0||||||
4404821|NCT00254501|4231496|B3|$50 000 to <$100 000||Income categories||participants|Number|21|21.0||||||
4404822|NCT00254501|4231497|B2|$50 000 to <$100 000||Income categories||participants|Number|10|10.0||||||
4404823|NCT00254501|4231498|B1|$50 000 to <$100 000||Income categories||participants|Number|11|11.0||||||
4404824|NCT00254501|4231496|B3|$30 000 to <$50 000||Income categories||participants|Number|23|23.0||||||
4404825|NCT00254501|4231497|B2|$30 000 to <$50 000||Income categories||participants|Number|12|12.0||||||
4404826|NCT00254501|4231498|B1|$30 000 to <$50 000||Income categories||participants|Number|11|11.0||||||
4404827|NCT00254501|4231496|B3|$15 000 to <$30 000||Income categories||participants|Number|6|6.0||||||
4404828|NCT00254501|4231497|B2|$15 000 to <$30 000||Income categories||participants|Number|3|3.0||||||
4404829|NCT00254501|4231498|B1|$15 000 to <$30 000||Income categories||participants|Number|3|3.0||||||
4404830|NCT00254501|4231496|B3|Unspecified||Education categories||participants|Number|4|4.0||||||
4404831|NCT00254501|4231497|B2|Unspecified||Education categories||participants|Number|3|3.0||||||
4404832|NCT00254501|4231498|B1|Unspecified||Education categories||participants|Number|1|1.0||||||
4404833|NCT00254501|4231496|B3|At least a masters degree||Education categories||participants|Number|3|3.0||||||
4404834|NCT00254501|4231497|B2|At least a masters degree||Education categories||participants|Number|3|3.0||||||
4404835|NCT00254501|4231498|B1|At least a masters degree||Education categories||participants|Number|0|0.0||||||
4404836|NCT00254501|4231496|B3|College graduate||Education categories||participants|Number|19|19.0||||||
4404837|NCT00254501|4231497|B2|College graduate||Education categories||participants|Number|11|11.0||||||
4404838|NCT00254501|4231498|B1|College graduate||Education categories||participants|Number|8|8.0||||||
4404839|NCT00254501|4231496|B3|Some college||Education categories||participants|Number|32|32.0||||||
4404840|NCT00254501|4231497|B2|Some college||Education categories||participants|Number|15|15.0||||||
4404841|NCT00254501|4231498|B1|Some college||Education categories||participants|Number|17|17.0||||||
4404842|NCT00254501|4231496|B3|High school graduate||Education categories||participants|Number|9|9.0||||||
4404843|NCT00254501|4231497|B2|High school graduate||Education categories||participants|Number|4|4.0||||||
4404844|NCT00254501|4231498|B1|High school graduate||Education categories||participants|Number|5|5.0||||||
4404845|NCT00254501|4231496|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4404846|NCT00254501|4231497|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4404847|NCT00254501|4231498|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4404848|NCT00254501|4231496|B3|More than one race||Race (NIH/OMB)||participants|Number|2|2.0||||||
4404849|NCT00254501|4231497|B2|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4404850|NCT00254501|4231498|B1|More than one race||Race (NIH/OMB)||participants|Number|2|2.0||||||
4404851|NCT00254501|4231496|B3|White||Race (NIH/OMB)||participants|Number|62|62.0||||||
4404852|NCT00254501|4231497|B2|White||Race (NIH/OMB)||participants|Number|32|32.0||||||
4404853|NCT00254501|4231498|B1|White||Race (NIH/OMB)||participants|Number|30|30.0||||||
4404854|NCT00254501|4231496|B3|Black or African American||Race (NIH/OMB)||participants|Number|1|1.0||||||
4404855|NCT00254501|4231497|B2|Black or African American||Race (NIH/OMB)||participants|Number|1|1.0||||||
4404856|NCT00254501|4231498|B1|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4404857|NCT00254501|4231496|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|1|1.0||||||
4404858|NCT00254501|4231497|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|1|1.0||||||
4404859|NCT00254501|4231498|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4404860|NCT00254501|4231496|B3|Asian||Race (NIH/OMB)||participants|Number|2|2.0||||||
4404861|NCT00254501|4231497|B2|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4404862|NCT00254501|4231498|B1|Asian||Race (NIH/OMB)||participants|Number|2|2.0||||||
4404863|NCT00254501|4231496|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|2|2.0||||||
4404864|NCT00254501|4231497|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|1|1.0||||||
4404865|NCT00254501|4231498|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|1|1.0||||||
4404866|NCT00254501|4231496|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404867|NCT00254501|4231497|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404868|NCT00254501|4231498|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404869|NCT00254501|4231496|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4404870|NCT00254501|4231497|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4404871|NCT00254501|4231498|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4404872|NCT00254501|4231496|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4404873|NCT00254501|4231497|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4404874|NCT00254501|4231498|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404875|NCT00254501|4231496|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4404876|NCT00254501|4231497|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4404877|NCT00254501|4231498|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4404878|NCT00254501|4231496|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4404879|NCT00254501|4231497|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4404880|NCT00254501|4231498|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4404881|NCT00254501|4231496|B3|||Age||years|Mean|54.2|54.2|Standard Deviation|8.1|8.1|||
4404882|NCT00254501|4231497|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|6.8|6.8|||
4404883|NCT00254501|4231498|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|9.2|9.2|||
4404884|NCT00254488|4231511|B3|||Sedation score|The Sedation Item score of the UKU (Norwegian for Committee of Clinical Investigations) Side Effect Rating Scale. A higher value indicates greater severity. Range is 0-3 (not present, mild, moderate, or severe).|units on a scale|Mean|.5|0.5|Standard Deviation|.65|0.65|||
4404885|NCT00254488|4231512|B2|||Sedation score|The Sedation Item score of the UKU (Norwegian for Committee of Clinical Investigations) Side Effect Rating Scale. A higher value indicates greater severity. Range is 0-3 (not present, mild, moderate, or severe).|units on a scale|Mean|.5|0.5|Standard Deviation|.6|0.6|||
4404940|NCT00254293|4231546|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4404886|NCT00254488|4231513|B1|||Sedation score|The Sedation Item score of the UKU (Norwegian for Committee of Clinical Investigations) Side Effect Rating Scale. A higher value indicates greater severity. Range is 0-3 (not present, mild, moderate, or severe).|units on a scale|Mean|.5|0.5|Standard Deviation|.7|0.7|||
4404887|NCT00254488|4231511|B3|||Young Mania Rating Scale|The Young Mania Rating Scale (YMRS) is an eleven item interviewer-rated instrument. Four items are scored 0-8, the others 0-4. The total score therefore ranges from 0-60, with higher values reflecting greater severity.|units on a scale|Mean|26.3|26.3|Standard Deviation|6.8|6.8|||
4404888|NCT00254488|4231512|B2|||Young Mania Rating Scale|The Young Mania Rating Scale (YMRS) is an eleven item interviewer-rated instrument. Four items are scored 0-8, the others 0-4. The total score therefore ranges from 0-60, with higher values reflecting greater severity.|units on a scale|Mean|25.5|25.5|Standard Deviation|6.1|6.1|||
4404889|NCT00254488|4231513|B1|||Young Mania Rating Scale|The Young Mania Rating Scale (YMRS) is an eleven item interviewer-rated instrument. Four items are scored 0-8, the others 0-4. The total score therefore ranges from 0-60, with higher values reflecting greater severity.|units on a scale|Mean|27.1|27.1|Standard Deviation|7.4|7.4|||
4404890|NCT00254488|4231511|B3||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4404891|NCT00254488|4231512|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4404892|NCT00254488|4231513|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4404893|NCT00254488|4231511|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4404894|NCT00254488|4231512|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4404895|NCT00254488|4231513|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4404896|NCT00254488|4231511|B3|||Age||years|Mean|68.0|68.0|Standard Deviation|6.4|6.4|||
4404897|NCT00254488|4231512|B2|||Age||years|Mean|68.3|68.3|Standard Deviation|6.1|6.1|||
4404898|NCT00254488|4231513|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|6.8|6.8|||
4404899|NCT00254462|4231522|B3|United States||Region of Enrollment||participants|Number|93|93.0||||||
4404900|NCT00254462|4231523|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4404901|NCT00254462|4231524|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4404902|NCT00254462|4231522|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4404903|NCT00254462|4231523|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4404904|NCT00254462|4231524|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4404905|NCT00254462|4231522|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4404906|NCT00254462|4231523|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4404907|NCT00254462|4231524|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4404908|NCT00254462|4231522|B3|||Age||years|Mean|6.1|6.1|Standard Deviation|0.5|0.5|||
4404909|NCT00254462|4231523|B2|||Age||years|Mean|6.1|6.1|Standard Deviation|0.5|0.5|||
4404910|NCT00254462|4231524|B1|||Age||years|Mean|6.1|6.1|Standard Deviation|0.6|0.6|||
4404911|NCT00254462|4231522|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4404912|NCT00254462|4231523|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4404913|NCT00254462|4231524|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4404914|NCT00254462|4231522|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4404915|NCT00254462|4231523|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4404916|NCT00254462|4231524|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4404917|NCT00254462|4231522|B3||<=18 years|Age||Participants|Count of Participants|93|93.0||||||
4404918|NCT00254462|4231523|B2||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
4404919|NCT00254462|4231524|B1||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
4404920|NCT00254410|4231533|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4404921|NCT00254410|4231533|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404922|NCT00254410|4231533|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404923|NCT00254410|4231533|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4404924|NCT00254410|4231533|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4404925|NCT00254410|4231533|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404926|NCT00254410|4231533|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404927|NCT00254410|4231533|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4404928|NCT00254410|4231533|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4404929|NCT00254410|4231533|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4404930|NCT00254410|4231533|B1|||Age||years|Median|57|57.0|Full Range|||38.0|69.0|
4404931|NCT00254410|4231533|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4404932|NCT00254410|4231533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4404933|NCT00254410|4231533|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4404934|NCT00254293|4231540|B7|United States||Region of Enrollment||participants|Number|68|68.0||||||
4404935|NCT00254293|4231541|B6|United States||Region of Enrollment||participants|Number|17|17.0||||||
4404936|NCT00254293|4231542|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
4404937|NCT00254293|4231543|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4404938|NCT00254293|4231544|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4404939|NCT00254293|4231545|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4404941|NCT00254293|4231540|B7||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4404942|NCT00254293|4231541|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4404943|NCT00254293|4231542|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4404944|NCT00254293|4231543|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4404945|NCT00254293|4231544|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4404946|NCT00254293|4231545|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4404947|NCT00254293|4231546|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4404948|NCT00254293|4231540|B7||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4404949|NCT00254293|4231541|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4404950|NCT00254293|4231542|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4404951|NCT00254293|4231543|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4404952|NCT00254293|4231544|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4404953|NCT00254293|4231545|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4404954|NCT00254293|4231546|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4404955|NCT00254293|4231540|B7|||Age||years|Mean|60|60.0|Standard Deviation|11|11.0|||
4404956|NCT00254293|4231541|B6|||Age||years|Mean|59|59.0|Standard Deviation|11|11.0|||
4404957|NCT00254293|4231542|B5|||Age||years|Mean|55|55.0|Standard Deviation|9|9.0|||
4404958|NCT00254293|4231543|B4|||Age||years|Mean|51|51.0|Standard Deviation|9|9.0|||
4404959|NCT00254293|4231544|B3|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4404960|NCT00254293|4231545|B2|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4404961|NCT00254293|4231546|B1|||Age||years|Mean|72|72.0|Standard Deviation|5|5.0|||
4404962|NCT00254163|4231633|B3|United States||Region of Enrollment||participants|Number|184|184.0||||||
4404963|NCT00254163|4231634|B2|United States||Region of Enrollment||participants|Number|92|92.0||||||
4404964|NCT00254163|4231635|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4404965|NCT00254163|4231633|B3|Mixed: Black/Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4404966|NCT00254163|4231634|B2|Mixed: Black/Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4404967|NCT00254163|4231635|B1|Mixed: Black/Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4404968|NCT00254163|4231633|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4404969|NCT00254163|4231634|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4404970|NCT00254163|4231635|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4404971|NCT00254163|4231633|B3|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4404972|NCT00254163|4231634|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4404973|NCT00254163|4231635|B1|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4404974|NCT00254163|4231633|B3|Caucasion||Race/Ethnicity, Customized||participants|Number|165|165.0||||||
4404975|NCT00254163|4231634|B2|Caucasion||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4404976|NCT00254163|4231635|B1|Caucasion||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4404977|NCT00254163|4231633|B3||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4404978|NCT00254163|4231634|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4404979|NCT00254163|4231635|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4404980|NCT00254163|4231633|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4404981|NCT00254163|4231634|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4404982|NCT00254163|4231635|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4404983|NCT00254163|4231633|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|10.0|10.0|||
4404984|NCT00254163|4231634|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|9.9|9.9|||
4404985|NCT00254163|4231635|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|10.2|10.2|||
4404986|NCT00254072|4231658|B3|United States||Region of Enrollment||participants|Number|355|355.0||||||
4404987|NCT00254072|4231659|B2|United States||Region of Enrollment||participants|Number|175|175.0||||||
4404988|NCT00254072|4231660|B1|United States||Region of Enrollment||participants|Number|180|180.0||||||
4404989|NCT00254072|4231658|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4404990|NCT00254072|4231659|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4404991|NCT00254072|4231660|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4404992|NCT00254072|4231658|B3||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4404993|NCT00254072|4231659|B2||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4404994|NCT00254072|4231660|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4404995|NCT00254072|4231658|B3|||Age||years|Mean|43.1|43.1|Standard Deviation|10.5|10.5|||
4404996|NCT00254072|4231659|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|10.1|10.1|||
4404997|NCT00254072|4231660|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|10.8|10.8|||
4404998|NCT00254072|4231658|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4404999|NCT00254072|4231659|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405000|NCT00254072|4231660|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405001|NCT00254072|4231658|B3||Between 18 and 65 years|Age||Participants|Count of Participants|355|355.0||||||
4405002|NCT00254072|4231659|B2||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4405003|NCT00254072|4231660|B1||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
4405004|NCT00254072|4231658|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405005|NCT00254072|4231659|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405006|NCT00254072|4231660|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405007|NCT00253981|4231667|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4405008|NCT00253981|4231668|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4405009|NCT00253981|4231669|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4405010|NCT00253981|4231667|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4405011|NCT00253981|4231668|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4405012|NCT00253981|4231669|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4405013|NCT00253981|4231667|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4405014|NCT00253981|4231668|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405015|NCT00253981|4231669|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4405016|NCT00253981|4231667|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405017|NCT00253981|4231668|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405018|NCT00253981|4231669|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405019|NCT00253981|4231667|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4405020|NCT00253981|4231668|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4405021|NCT00253981|4231669|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4405022|NCT00253981|4231667|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405023|NCT00253981|4231668|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405024|NCT00253981|4231669|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405025|NCT00253890|4231676|B3|United States||Region of Enrollment||participants|Number|137|137.0||||||
4405026|NCT00253890|4231677|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
4405027|NCT00253890|4231678|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4405028|NCT00253890|4231676|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4405029|NCT00253890|4231677|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4405030|NCT00253890|4231678|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4405031|NCT00253890|4231676|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4405032|NCT00253890|4231677|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4405033|NCT00253890|4231678|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4405034|NCT00253890|4231676|B3|||Age||years|Mean|38.2|38.2|Standard Deviation|8.6|8.6|||
4405035|NCT00253890|4231677|B2|||Age||years|Mean|38.5|38.5|Standard Deviation|8.7|8.7|||
4405036|NCT00253890|4231678|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|8.8|8.8|||
4405037|NCT00253890|4231676|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405038|NCT00253890|4231677|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405039|NCT00253890|4231678|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405040|NCT00253890|4231676|B3||Between 18 and 65 years|Age||Participants|Count of Participants|137|137.0||||||
4405041|NCT00253890|4231677|B2||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4405042|NCT00253890|4231678|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4405043|NCT00253890|4231676|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405044|NCT00253890|4231677|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405045|NCT00253890|4231678|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405046|NCT00253747|4231685|B3|United States||Region of Enrollment||participants|Number|255|255.0||||||
4405047|NCT00253747|4231686|B2|United States||Region of Enrollment||participants|Number|128|128.0||||||
4405048|NCT00253747|4231687|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
4405049|NCT00253747|4231685|B3||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4405050|NCT00253747|4231686|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4405051|NCT00253747|4231687|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4405052|NCT00253747|4231685|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4405053|NCT00253747|4231686|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4405054|NCT00253747|4231687|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4405055|NCT00253747|4231685|B3|||Age||years|Mean|37.8|37.8|Standard Deviation|10.0|10.0|||
4405056|NCT00253747|4231686|B2|||Age||years|Mean|37.5|37.5|Standard Deviation|9.6|9.6|||
4405057|NCT00253747|4231687|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|10.4|10.4|||
4405058|NCT00253747|4231685|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405059|NCT00253747|4231686|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405060|NCT00253747|4231687|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405061|NCT00253747|4231685|B3||Between 18 and 65 years|Age||Participants|Count of Participants|255|255.0||||||
4405062|NCT00253747|4231686|B2||Between 18 and 65 years|Age||Participants|Count of Participants|128|128.0||||||
4405063|NCT00253747|4231687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4405064|NCT00253747|4231685|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405065|NCT00253747|4231686|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405066|NCT00253747|4231687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405067|NCT00253708|4231706|B4||>$50,000|Household income: Not available/refused/don't know, <$50,000, >$50,000||Participants|Count of Participants|25|25.0||||||
4405068|NCT00253708|4231707|B3||>$50,000|Household income: Not available/refused/don't know, <$50,000, >$50,000||Participants|Count of Participants|7|7.0||||||
4405069|NCT00253708|4231708|B2||>$50,000|Household income: Not available/refused/don't know, <$50,000, >$50,000||Participants|Count of Participants|5|5.0||||||
4405070|NCT00253708|4231709|B1||>$50,000|Household income: Not available/refused/don't know, <$50,000, >$50,000||Participants|Count of Participants|13|13.0||||||
4405071|NCT00253708|4231706|B4||<$50,000|Household income: Not available/refused/don't know, <$50,000, >$50,000||Participants|Count of Participants|7|7.0||||||
4405072|NCT00253708|4231707|B3||<$50,000|Household income: Not available/refused/don't know, <$50,000, >$50,000||Participants|Count of Participants|1|1.0||||||
4405073|NCT00253708|4231708|B2||<$50,000|Household income: Not available/refused/don't know, <$50,000, >$50,000||Participants|Count of Participants|2|2.0||||||
4405074|NCT00253708|4231709|B1||<$50,000|Household income: Not available/refused/don't know, <$50,000, >$50,000||Participants|Count of Participants|4|4.0||||||
4405075|NCT00253708|4231706|B4||Not available/refused/Don't know|Household income: Not available/refused/don't know, <$50,000, >$50,000||Participants|Count of Participants|7|7.0||||||
4405076|NCT00253708|4231707|B3||Not available/refused/Don't know|Household income: Not available/refused/don't know, <$50,000, >$50,000||Participants|Count of Participants|1|1.0||||||
4405077|NCT00253708|4231708|B2||Not available/refused/Don't know|Household income: Not available/refused/don't know, <$50,000, >$50,000||Participants|Count of Participants|3|3.0||||||
4405078|NCT00253708|4231709|B1||Not available/refused/Don't know|Household income: Not available/refused/don't know, <$50,000, >$50,000||Participants|Count of Participants|3|3.0||||||
4405079|NCT00253708|4231706|B4|||Employment: full-time or part-time||Participants|Count of Participants|14|14.0||||||
4405080|NCT00253708|4231707|B3|||Employment: full-time or part-time||Participants|Count of Participants|4|4.0||||||
4405081|NCT00253708|4231708|B2|||Employment: full-time or part-time||Participants|Count of Participants|5|5.0||||||
4405082|NCT00253708|4231709|B1|||Employment: full-time or part-time||Participants|Count of Participants|5|5.0||||||
4405083|NCT00253708|4231706|B4|||Education: College grad or more||Participants|Count of Participants|21|21.0||||||
4405084|NCT00253708|4231707|B3|||Education: College grad or more||Participants|Count of Participants|5|5.0||||||
4405085|NCT00253708|4231708|B2|||Education: College grad or more||Participants|Count of Participants|6|6.0||||||
4405086|NCT00253708|4231709|B1|||Education: College grad or more||Participants|Count of Participants|10|10.0||||||
4405087|NCT00253708|4231706|B4|||Not admitted to hospital in the last 12 months||Participants|Count of Participants|18|18.0||||||
4405088|NCT00253708|4231707|B3|||Not admitted to hospital in the last 12 months||Participants|Count of Participants|4|4.0||||||
4405089|NCT00253708|4231708|B2|||Not admitted to hospital in the last 12 months||Participants|Count of Participants|6|6.0||||||
4405090|NCT00253708|4231709|B1|||Not admitted to hospital in the last 12 months||Participants|Count of Participants|8|8.0||||||
4405091|NCT00253708|4231706|B4|||Living alone||Participants|Count of Participants|5|5.0||||||
4405092|NCT00253708|4231707|B3|||Living alone||Participants|Count of Participants|0|0.0||||||
4405093|NCT00253708|4231708|B2|||Living alone||Participants|Count of Participants|2|2.0||||||
4405094|NCT00253708|4231709|B1|||Living alone||Participants|Count of Participants|3|3.0||||||
4405095|NCT00253708|4231706|B4||Other|Marital status: Married, Other||Participants|Count of Participants|12|12.0||||||
4405096|NCT00253708|4231707|B3||Other|Marital status: Married, Other||Participants|Count of Participants|1|1.0||||||
4405097|NCT00253708|4231708|B2||Other|Marital status: Married, Other||Participants|Count of Participants|4|4.0||||||
4405098|NCT00253708|4231709|B1||Other|Marital status: Married, Other||Participants|Count of Participants|7|7.0||||||
4405099|NCT00253708|4231706|B4||Married|Marital status: Married, Other||Participants|Count of Participants|27|27.0||||||
4405100|NCT00253708|4231707|B3||Married|Marital status: Married, Other||Participants|Count of Participants|8|8.0||||||
4405101|NCT00253708|4231708|B2||Married|Marital status: Married, Other||Participants|Count of Participants|6|6.0||||||
4405102|NCT00253708|4231709|B1||Married|Marital status: Married, Other||Participants|Count of Participants|13|13.0||||||
4405103|NCT00253708|4231706|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|36|36.0||||||
4405104|NCT00253708|4231707|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4405105|NCT00253708|4231708|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4405106|NCT00253708|4231709|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4405107|NCT00253708|4231706|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4405108|NCT00253708|4231707|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4405109|NCT00253708|4231708|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4405110|NCT00253708|4231709|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4405111|NCT00253708|4231706|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4405112|NCT00253708|4231707|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4405113|NCT00253708|4231708|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4405114|NCT00253708|4231709|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4405115|NCT00253708|4231706|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4405116|NCT00253708|4231707|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4405117|NCT00253708|4231708|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4405118|NCT00253708|4231709|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4405119|NCT00253708|4231706|B4|||Age||years|Mean|55.1|55.1|Standard Deviation|11|11.0|||
4405120|NCT00253708|4231707|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|9|9.0|||
4405121|NCT00253708|4231708|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|10|10.0|||
4405122|NCT00253708|4231709|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|12|12.0|||
4405123|NCT00253643|4231737|B5|Prostatic Intraepithelial Neoplasia (PIN)||Diagnosis||participants|Number|13|13.0||||||
4405124|NCT00253643|4231738|B4|Prostatic Intraepithelial Neoplasia (PIN)||Diagnosis||participants|Number|1|1.0||||||
4405125|NCT00253643|4231739|B3|Prostatic Intraepithelial Neoplasia (PIN)||Diagnosis||participants|Number|6|6.0||||||
4405126|NCT00253643|4231740|B2|Prostatic Intraepithelial Neoplasia (PIN)||Diagnosis||participants|Number|3|3.0||||||
4405127|NCT00253643|4231741|B1|Prostatic Intraepithelial Neoplasia (PIN)||Diagnosis||participants|Number|3|3.0||||||
4405128|NCT00253643|4231737|B5|Prostate Cancer||Diagnosis||participants|Number|15|15.0||||||
4405129|NCT00253643|4231738|B4|Prostate Cancer||Diagnosis||participants|Number|6|6.0||||||
4405130|NCT00253643|4231739|B3|Prostate Cancer||Diagnosis||participants|Number|6|6.0||||||
4405131|NCT00253643|4231740|B2|Prostate Cancer||Diagnosis||participants|Number|1|1.0||||||
4405132|NCT00253643|4231741|B1|Prostate Cancer||Diagnosis||participants|Number|2|2.0||||||
4405133|NCT00253643|4231737|B5|Benign||Diagnosis||participants|Number|57|57.0||||||
4405134|NCT00253643|4231738|B4|Benign||Diagnosis||participants|Number|21|21.0||||||
4405135|NCT00253643|4231739|B3|Benign||Diagnosis||participants|Number|16|16.0||||||
4405136|NCT00253643|4231740|B2|Benign||Diagnosis||participants|Number|11|11.0||||||
4405137|NCT00253643|4231741|B1|Benign||Diagnosis||participants|Number|9|9.0||||||
4405138|NCT00253643|4231737|B5|United States||Region of Enrollment||participants|Number|85|85.0||||||
4405139|NCT00253643|4231738|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
4405140|NCT00253643|4231739|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4405141|NCT00253643|4231740|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4405142|NCT00253643|4231741|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4405143|NCT00253643|4231737|B5||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4405144|NCT00253643|4231738|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4405145|NCT00253643|4231739|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4405146|NCT00253643|4231740|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4405147|NCT00253643|4231741|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4405148|NCT00253643|4231737|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405149|NCT00253643|4231738|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405150|NCT00253643|4231739|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405151|NCT00253643|4231740|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405152|NCT00253643|4231741|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405153|NCT00253643|4231737|B5||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4405154|NCT00253643|4231738|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4405155|NCT00253643|4231739|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4405156|NCT00253643|4231740|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4405157|NCT00253643|4231741|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4405158|NCT00253643|4231737|B5||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4405159|NCT00253643|4231738|B4||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4405160|NCT00253643|4231739|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4405161|NCT00253643|4231740|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4405162|NCT00253643|4231741|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4405163|NCT00253643|4231737|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405164|NCT00253643|4231738|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405165|NCT00253643|4231739|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405166|NCT00253643|4231740|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405167|NCT00253643|4231741|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405168|NCT00253630|4231758|B1|United States||Region of Enrollment||Participants|Count of Participants|35|35.0||||||
4405169|NCT00253630|4231758|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4405170|NCT00253630|4231758|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4405171|NCT00253630|4231758|B1|||Age||years|Median|64.5|64.5|Full Range|||32.0|79.0|
4405172|NCT00253513|4231767|B1|Filgrastim-mobilized PBPC||Stem cell source||participants|Number|53|53.0||||||
4405173|NCT00253513|4231767|B1|Bone marrow||Stem cell source||participants|Number|7|7.0||||||
4405174|NCT00253513|4231767|B1|HLA-matched unrelated donor||Donor type||participants|Number|30|30.0||||||
4405175|NCT00253513|4231767|B1|HLA (human leukocyte antigen) -identical sibling||Donor type||participants|Number|30|30.0||||||
4405176|NCT00253513|4231767|B1|>=3||Hematopoietic Cell Transplantation Comorbidity Index (HCT CI)|Risk of mortality after allograft (0 is lower risk, >=3 is higher risk)|Participants|Number|28|28.0||||||
4405177|NCT00253513|4231767|B1|1-2||Hematopoietic Cell Transplantation Comorbidity Index (HCT CI)|Risk of mortality after allograft (0 is lower risk, >=3 is higher risk)|Participants|Number|19|19.0||||||
4405178|NCT00253513|4231767|B1|0||Hematopoietic Cell Transplantation Comorbidity Index (HCT CI)|Risk of mortality after allograft (0 is lower risk, >=3 is higher risk)|Participants|Number|13|13.0||||||
4405179|NCT00253513|4231767|B1|Poor||Cytogenetic risk group|Good risk cytogenetics: t(8;21), t(15;17), or inversion 16 for AML, hyperdiploidy for ALL, -Y, del(5q), del(20q), or normal for MDS; poor risk: 11q23 abnormalities, monosomy 7, monosomy 5, deletion 5q, or abnormalities of 3q for AML, t(9;22) or extreme hypodiploidy for ALL, chromosome 7 abnormalities in MDS,$3 chromosome abnormalities for any disease type; Intermediate risk: all others|Participants|Number|36|36.0||||||
4405180|NCT00253513|4231767|B1|Intermediate||Cytogenetic risk group|Good risk cytogenetics: t(8;21), t(15;17), or inversion 16 for AML, hyperdiploidy for ALL, -Y, del(5q), del(20q), or normal for MDS; poor risk: 11q23 abnormalities, monosomy 7, monosomy 5, deletion 5q, or abnormalities of 3q for AML, t(9;22) or extreme hypodiploidy for ALL, chromosome 7 abnormalities in MDS,$3 chromosome abnormalities for any disease type; Intermediate risk: all others|Participants|Number|8|8.0||||||
4405181|NCT00253513|4231767|B1|Good||Cytogenetic risk group|Good risk cytogenetics: t(8;21), t(15;17), or inversion 16 for AML, hyperdiploidy for ALL, -Y, del(5q), del(20q), or normal for MDS; poor risk: 11q23 abnormalities, monosomy 7, monosomy 5, deletion 5q, or abnormalities of 3q for AML, t(9;22) or extreme hypodiploidy for ALL, chromosome 7 abnormalities in MDS,$3 chromosome abnormalities for any disease type; Intermediate risk: all others|Participants|Number|16|16.0||||||
4405182|NCT00253513|4231767|B1|High -relapsed/refract. ALL/AML/MDS w/ IPSS>=2.5||Disease risk group|Low-risk disease: AML or ALL in first remission, MDS with IPSS (International Prognosis Scoring System)=0; standard risk: ALL or AML in second or greater remission, MDS with IPSS 0.5-2; high risk: relapsed/refractory ALL or AML, MDS with IPSS>=2.5.|Participants|Number|12|12.0||||||
4405183|NCT00253513|4231767|B1|Standard (ALL or AML in 2nd or greater rem.)||Disease risk group|Low-risk disease: AML or ALL in first remission, MDS with IPSS (International Prognosis Scoring System)=0; standard risk: ALL or AML in second or greater remission, MDS with IPSS 0.5-2; high risk: relapsed/refractory ALL or AML, MDS with IPSS>=2.5.|Participants|Number|22|22.0||||||
4405184|NCT00253513|4231767|B1|Low - AML/ALL in 1st rem., MDS with IPSS=0||Disease risk group|Low-risk disease: AML or ALL in first remission, MDS with IPSS (International Prognosis Scoring System)=0; standard risk: ALL or AML in second or greater remission, MDS with IPSS 0.5-2; high risk: relapsed/refractory ALL or AML, MDS with IPSS>=2.5.|Participants|Number|26|26.0||||||
4405185|NCT00253513|4231767|B1|MDS: RA with excess blasts in transformation||Disease status at transplantation||Participants|Number|7|7.0||||||
4405186|NCT00253513|4231767|B1|Myelodysplastic Syndrome(MDS): Refract. Anemia(RA)||Disease status at transplantation||Participants|Number|6|6.0||||||
4405187|NCT00253513|4231767|B1|AML, relapsed or primary refractory||Disease status at transplantation||Participants|Number|8|8.0||||||
4405188|NCT00253513|4231767|B1|AML, 2nd or greater remission.||Disease status at transplantation||Participants|Number|10|10.0||||||
4405189|NCT00253513|4231767|B1|Acute Myelogenous Leukemia(AML)1st remission||Disease status at transplantation||Participants|Number|26|26.0||||||
4405190|NCT00253513|4231767|B1|Acute Lymphoblastic Leukemia(ALL)2nd/3rd remission||Disease status at transplantation||Participants|Number|3|3.0||||||
4405191|NCT00253513|4231767|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4405192|NCT00253513|4231767|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4405193|NCT00253513|4231767|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4405194|NCT00253513|4231767|B1|Between 50 - 60 years||Age, Customized||Participants|Number|19|19.0||||||
4405195|NCT00253513|4231767|B1|Between 21 - 50 years||Age, Customized||Participants|Number|31|31.0||||||
4405196|NCT00253513|4231767|B1|< 21 years||Age, Customized||Participants|Number|10|10.0||||||
4405197|NCT00253448|4231774|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4405198|NCT00253448|4231774|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4405199|NCT00253448|4231774|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4405200|NCT00253448|4231774|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|12.5|12.5|||
4405201|NCT00253448|4231774|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4405202|NCT00253448|4231774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4405203|NCT00253448|4231774|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405204|NCT00253435|4231778|B3|Low GFR||GFR Status|"Pre-therapy glomerular filtration rate:~Normal GFR: >= 100 ml/min/1.73 m2 & Low GFR: 60-99 ml/min/1.73 m2"|participants|Number|13|13.0||||||
4405205|NCT00253435|4231779|B2|Low GFR||GFR Status|"Pre-therapy glomerular filtration rate:~Normal GFR: >= 100 ml/min/1.73 m2 & Low GFR: 60-99 ml/min/1.73 m2"|participants|Number|1|1.0||||||
4405206|NCT00253435|4231780|B1|Low GFR||GFR Status|"Pre-therapy glomerular filtration rate:~Normal GFR: >= 100 ml/min/1.73 m2 & Low GFR: 60-99 ml/min/1.73 m2"|participants|Number|12|12.0||||||
4405207|NCT00253435|4231778|B3|Normal GFR||GFR Status|"Pre-therapy glomerular filtration rate:~Normal GFR: >= 100 ml/min/1.73 m2 & Low GFR: 60-99 ml/min/1.73 m2"|participants|Number|37|37.0||||||
4405208|NCT00253435|4231779|B2|Normal GFR||GFR Status|"Pre-therapy glomerular filtration rate:~Normal GFR: >= 100 ml/min/1.73 m2 & Low GFR: 60-99 ml/min/1.73 m2"|participants|Number|7|7.0||||||
4405209|NCT00253435|4231780|B1|Normal GFR||GFR Status|"Pre-therapy glomerular filtration rate:~Normal GFR: >= 100 ml/min/1.73 m2 & Low GFR: 60-99 ml/min/1.73 m2"|participants|Number|30|30.0||||||
4405210|NCT00253435|4231778|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4405211|NCT00253435|4231779|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405212|NCT00253435|4231780|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4405213|NCT00253435|4231778|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405214|NCT00253435|4231779|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405215|NCT00253435|4231780|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405216|NCT00253435|4231778|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4405217|NCT00253435|4231779|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4405218|NCT00253435|4231780|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4405219|NCT00253435|4231778|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4405220|NCT00253435|4231779|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405221|NCT00253435|4231780|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4405222|NCT00253435|4231778|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405223|NCT00253435|4231779|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405224|NCT00253435|4231780|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405225|NCT00253435|4231778|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405226|NCT00253435|4231779|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405227|NCT00253435|4231780|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405228|NCT00253435|4231778|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405229|NCT00253435|4231779|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405230|NCT00253435|4231780|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405231|NCT00253435|4231778|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405232|NCT00253435|4231779|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405233|NCT00253435|4231780|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405234|NCT00253435|4231778|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4405235|NCT00253435|4231779|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4405236|NCT00253435|4231780|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4405237|NCT00253435|4231778|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4405238|NCT00253435|4231779|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405239|NCT00253435|4231780|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4405240|NCT00253435|4231778|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4405241|NCT00253435|4231779|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4405242|NCT00253435|4231780|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4405243|NCT00253435|4231778|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4405244|NCT00253435|4231779|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4405245|NCT00253435|4231780|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4405246|NCT00253435|4231778|B3|||Age|Age (in years) at time of treatment start.|years|Median|6.0|6.0|Full Range|||1.1|22.8|
4405247|NCT00253435|4231779|B2|||Age|Age (in years) at time of treatment start.|years|Median|7.7|7.7|Full Range|||4.3|16.4|
4405248|NCT00253435|4231780|B1|||Age|Age (in years) at time of treatment start.|years|Median|6.0|6.0|Full Range|||1.1|22.8|
4405249|NCT00253370|4231793|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4405250|NCT00253370|4231793|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4405251|NCT00253370|4231793|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4405252|NCT00253370|4231793|B1|||Age||years|Median|58.4|58.4|Full Range|||28.4|85.6|
4405253|NCT00253019|4231799|B4|>=65 years||The measure is of what contraceptive method the participants chose to use||participants|Number|0|0.0||||||
4405254|NCT00253019|4231800|B3|>=65 years||The measure is of what contraceptive method the participants chose to use||participants|Number|0|0.0||||||
4405255|NCT00253019|4231801|B2|>=65 years||The measure is of what contraceptive method the participants chose to use||participants|Number|0|0.0||||||
4405256|NCT00253019|4231802|B1|>=65 years||The measure is of what contraceptive method the participants chose to use||participants|Number|0|0.0||||||
4405257|NCT00253019|4231799|B4|Between 18 and 65 years||The measure is of what contraceptive method the participants chose to use||participants|Number|321|321.0||||||
4405258|NCT00253019|4231800|B3|Between 18 and 65 years||The measure is of what contraceptive method the participants chose to use||participants|Number|101|101.0||||||
4405259|NCT00253019|4231801|B2|Between 18 and 65 years||The measure is of what contraceptive method the participants chose to use||participants|Number|109|109.0||||||
4405260|NCT00253019|4231802|B1|Between 18 and 65 years||The measure is of what contraceptive method the participants chose to use||participants|Number|111|111.0||||||
4405261|NCT00253019|4231799|B4|<=18 years||The measure is of what contraceptive method the participants chose to use||participants|Number|0|0.0||||||
4405262|NCT00253019|4231800|B3|<=18 years||The measure is of what contraceptive method the participants chose to use||participants|Number|0|0.0||||||
4405263|NCT00253019|4231801|B2|<=18 years||The measure is of what contraceptive method the participants chose to use||participants|Number|0|0.0||||||
4405264|NCT00253019|4231802|B1|<=18 years||The measure is of what contraceptive method the participants chose to use||participants|Number|0|0.0||||||
4405265|NCT00253019|4231799|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405266|NCT00253019|4231800|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405267|NCT00253019|4231801|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405268|NCT00253019|4231802|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405269|NCT00253019|4231799|B4||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4405270|NCT00253019|4231800|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4405271|NCT00253019|4231801|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4405272|NCT00253019|4231802|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4405273|NCT00253019|4231799|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405274|NCT00253019|4231800|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405275|NCT00253019|4231801|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405276|NCT00253019|4231802|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405277|NCT00253019|4231799|B4||Between 18 and 65 years|Age||Participants|Count of Participants|321|321.0||||||
4405278|NCT00253019|4231800|B3||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4405279|NCT00253019|4231801|B2||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4405280|NCT00253019|4231802|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4405281|NCT00253019|4231799|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405282|NCT00253019|4231800|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405283|NCT00253019|4231801|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405284|NCT00253019|4231802|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405285|NCT00252967|4231812|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4405286|NCT00252967|4231813|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4405287|NCT00252967|4231814|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4405288|NCT00252967|4231812|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4405289|NCT00252967|4231813|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4405290|NCT00252967|4231814|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4405291|NCT00252967|4231812|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|12.8|12.8|||
4405292|NCT00252967|4231813|B2|||Age||years|Mean|58.2|58.2|Standard Deviation|11.6|11.6|||
4405293|NCT00252967|4231814|B1|||Age||years|Mean|58.9|58.9|Standard Deviation|13.9|13.9|||
4405294|NCT00252733|4231837|B3||Male|Sex: Female, Male||Participants|Count of Participants|805|805.0||||||
4405295|NCT00252733|4231838|B2||Male|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
4405296|NCT00252733|4231839|B1||Male|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
4405297|NCT00252733|4231837|B3||Female|Sex: Female, Male||Participants|Count of Participants|616|616.0||||||
4405298|NCT00252733|4231838|B2||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4405299|NCT00252733|4231839|B1||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4405300|NCT00252733|4231837|B3|||Age||years|Mean|29.75|29.75|Standard Deviation|8.05|8.05|||
4405301|NCT00252733|4231838|B2|||Age||years|Mean|29.90|29.9|Standard Deviation|8.1|8.1|||
4405302|NCT00252733|4231839|B1|||Age||years|Mean|29.60|29.6|Standard Deviation|8.0|8.0|||
4405303|NCT00252720|4231848|B3|South Africa||Region of Enrollment||participants|Number|203|203.0||||||
4405304|NCT00252720|4231849|B2|South Africa||Region of Enrollment||participants|Number|102|102.0||||||
4405305|NCT00252720|4231850|B1|South Africa||Region of Enrollment||participants|Number|101|101.0||||||
4405306|NCT00252720|4231848|B3|Canada||Region of Enrollment||participants|Number|140|140.0||||||
4405307|NCT00252720|4231849|B2|Canada||Region of Enrollment||participants|Number|71|71.0||||||
4405308|NCT00252720|4231850|B1|Canada||Region of Enrollment||participants|Number|69|69.0||||||
4405309|NCT00252720|4231848|B3|Europe||Region of Enrollment||participants|Number|1214|1214.0||||||
4405310|NCT00252720|4231849|B2|Europe||Region of Enrollment||participants|Number|619|619.0||||||
4405311|NCT00252720|4231850|B1|Europe||Region of Enrollment||participants|Number|595|595.0||||||
4405312|NCT00252720|4231848|B3|Russian Federation||Region of Enrollment||participants|Number|348|348.0||||||
4405313|NCT00252720|4231849|B2|Russian Federation||Region of Enrollment||participants|Number|162|162.0||||||
4405314|NCT00252720|4231850|B1|Russian Federation||Region of Enrollment||participants|Number|186|186.0||||||
4405315|NCT00252720|4231848|B3||Male|Sex: Female, Male||Participants|Count of Participants|1091|1091.0||||||
4405316|NCT00252720|4231849|B2||Male|Sex: Female, Male||Participants|Count of Participants|553|553.0||||||
4405317|NCT00252720|4231850|B1||Male|Sex: Female, Male||Participants|Count of Participants|538|538.0||||||
4405318|NCT00252720|4231848|B3||Female|Sex: Female, Male||Participants|Count of Participants|814|814.0||||||
4405319|NCT00252720|4231849|B2||Female|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
4405320|NCT00252720|4231850|B1||Female|Sex: Female, Male||Participants|Count of Participants|413|413.0||||||
4405321|NCT00252720|4231848|B3|||Age||years|Mean|31.7|31.7|Standard Deviation|8.5|8.5|||
4405322|NCT00252720|4231849|B2|||Age||years|Mean|31.9|31.9|Standard Deviation|8.5|8.5|||
4405323|NCT00252720|4231850|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|8.5|8.5|||
4405324|NCT00252720|4231848|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405325|NCT00252720|4231849|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405326|NCT00252720|4231850|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405327|NCT00252720|4231848|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1905|1905.0||||||
4405328|NCT00252720|4231849|B2||Between 18 and 65 years|Age||Participants|Count of Participants|954|954.0||||||
4405329|NCT00252720|4231850|B1||Between 18 and 65 years|Age||Participants|Count of Participants|951|951.0||||||
4405330|NCT00252720|4231848|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405331|NCT00252720|4231849|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405332|NCT00252720|4231850|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405333|NCT00252694|4231863|B3|South Africa||Region of Enrollment||participants|Number|360|360.0||||||
4405334|NCT00252694|4231864|B2|South Africa||Region of Enrollment||participants|Number|178|178.0||||||
4405335|NCT00252694|4231865|B1|South Africa||Region of Enrollment||participants|Number|182|182.0||||||
4405336|NCT00252694|4231863|B3|Israel||Region of Enrollment||participants|Number|361|361.0||||||
4405337|NCT00252694|4231864|B2|Israel||Region of Enrollment||participants|Number|173|173.0||||||
4405338|NCT00252694|4231865|B1|Israel||Region of Enrollment||participants|Number|188|188.0||||||
4405339|NCT00252694|4231863|B3|Europe||Region of Enrollment||participants|Number|857|857.0||||||
4405340|NCT00252694|4231864|B2|Europe||Region of Enrollment||participants|Number|438|438.0||||||
4405341|NCT00252694|4231865|B1|Europe||Region of Enrollment||participants|Number|419|419.0||||||
4405342|NCT00252694|4231863|B3|Russian Federation||Region of Enrollment||participants|Number|327|327.0||||||
4405343|NCT00252694|4231864|B2|Russian Federation||Region of Enrollment||participants|Number|165|165.0||||||
4405344|NCT00252694|4231865|B1|Russian Federation||Region of Enrollment||participants|Number|162|162.0||||||
4405345|NCT00252694|4231863|B3||Male|Sex: Female, Male||Participants|Count of Participants|948|948.0||||||
4405346|NCT00252694|4231864|B2||Male|Sex: Female, Male||Participants|Count of Participants|482|482.0||||||
4405347|NCT00252694|4231865|B1||Male|Sex: Female, Male||Participants|Count of Participants|466|466.0||||||
4405348|NCT00252694|4231863|B3||Female|Sex: Female, Male||Participants|Count of Participants|957|957.0||||||
4405349|NCT00252694|4231864|B2||Female|Sex: Female, Male||Participants|Count of Participants|472|472.0||||||
4405350|NCT00252694|4231865|B1||Female|Sex: Female, Male||Participants|Count of Participants|485|485.0||||||
4405351|NCT00252694|4231863|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|7.8|7.8|||
4405352|NCT00252694|4231864|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|7.9|7.9|||
4405353|NCT00252694|4231865|B1|||Age||years|Mean|56.9|56.9|Standard Deviation|7.6|7.6|||
4405354|NCT00252694|4231863|B3||>=65 years|Age||Participants|Count of Participants|288|288.0||||||
4405355|NCT00252694|4231864|B2||>=65 years|Age||Participants|Count of Participants|146|146.0||||||
4405356|NCT00252694|4231865|B1||>=65 years|Age||Participants|Count of Participants|142|142.0||||||
4405357|NCT00252694|4231863|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1617|1617.0||||||
4405358|NCT00252694|4231864|B2||Between 18 and 65 years|Age||Participants|Count of Participants|808|808.0||||||
4405359|NCT00252694|4231865|B1||Between 18 and 65 years|Age||Participants|Count of Participants|809|809.0||||||
4405360|NCT00252694|4231863|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405361|NCT00252694|4231864|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405362|NCT00252694|4231865|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405363|NCT00252629|4231878|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4405364|NCT00252629|4231879|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4405365|NCT00252629|4231880|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4405366|NCT00252629|4231881|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4405367|NCT00252629|4231878|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405368|NCT00252629|4231879|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405369|NCT00252629|4231880|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405370|NCT00252629|4231881|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405371|NCT00252629|4231878|B4|||Age||years|Mean|42.2|42.2|Standard Deviation|0.7|0.7|||
4405372|NCT00252629|4231879|B3|||Age||years|Mean|41|41.0|Standard Deviation|6.6|6.6|||
4405373|NCT00252629|4231880|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|3.1|3.1|||
4405374|NCT00252629|4231881|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|4.1|4.1|||
4405375|NCT00252590|4231896|B4|||Percentage Days Abstinent alcohol||percentage|Mean|52.1|52.1|Standard Deviation|30.7|30.7|||
4405376|NCT00252590|4231897|B3|||Percentage Days Abstinent alcohol||percentage|Mean|48.2|48.2|Standard Deviation|28.8|28.8|||
4405377|NCT00252590|4231898|B2|||Percentage Days Abstinent alcohol||percentage|Mean|60.1|60.1|Standard Deviation|31.9|31.9|||
4405378|NCT00252590|4231899|B1|||Percentage Days Abstinent alcohol||percentage|Mean|49.1|49.1|Standard Deviation|31.0|31.0|||
4405379|NCT00252590|4231896|B4|||Percentage Days Abstinent all substances||percentage|Mean|51.5|51.5|Standard Deviation|31.0|31.0|||
4405380|NCT00252590|4231897|B3|||Percentage Days Abstinent all substances||percentage|Mean|47.4|47.4|Standard Deviation|29.2|29.2|||
4405381|NCT00252590|4231898|B2|||Percentage Days Abstinent all substances||percentage|Mean|59.6|59.6|Standard Deviation|32.0|32.0|||
4405382|NCT00252590|4231899|B1|||Percentage Days Abstinent all substances||percentage|Mean|48.6|48.6|Standard Deviation|31.5|31.5|||
4405383|NCT00252590|4231896|B4|United States||Region of Enrollment||participants|Number|99|99.0||||||
4405384|NCT00252590|4231897|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4405385|NCT00252590|4231898|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4405386|NCT00252590|4231899|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4405387|NCT00252590|4231896|B4||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4405388|NCT00252590|4231897|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4405389|NCT00252590|4231898|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4405390|NCT00252590|4231899|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4405391|NCT00252590|4231896|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4405392|NCT00252590|4231897|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4405393|NCT00252590|4231898|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4405394|NCT00252590|4231899|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4405395|NCT00252590|4231896|B4|||Age||years|Mean|48.8|48.8|Standard Deviation|10.4|10.4|||
4405396|NCT00252590|4231897|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|11.7|11.7|||
4405397|NCT00252590|4231898|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|8.2|8.2|||
4405398|NCT00252590|4231899|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|11.0|11.0|||
4405399|NCT00252564|4231912|B3|United States||Region of Enrollment||participants|Number|247|247.0||||||
4405400|NCT00252564|4231913|B2|United States||Region of Enrollment||participants|Number|123|123.0||||||
4405401|NCT00252564|4231914|B1|United States||Region of Enrollment||participants|Number|124|124.0||||||
4405402|NCT00252564|4231912|B3|Other||Race (NIH/OMB)||participants|Number|10|10.0||||||
4405403|NCT00252564|4231913|B2|Other||Race (NIH/OMB)||participants|Number|6|6.0||||||
4405404|NCT00252564|4231914|B1|Other||Race (NIH/OMB)||participants|Number|4|4.0||||||
4405405|NCT00252564|4231912|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4405406|NCT00252564|4231913|B2|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4405407|NCT00252564|4231914|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4405408|NCT00252564|4231912|B3|White||Race (NIH/OMB)||participants|Number|199|199.0||||||
4405409|NCT00252564|4231913|B2|White||Race (NIH/OMB)||participants|Number|99|99.0||||||
4405410|NCT00252564|4231914|B1|White||Race (NIH/OMB)||participants|Number|100|100.0||||||
4405411|NCT00252564|4231912|B3|Black or African American||Race (NIH/OMB)||participants|Number|30|30.0||||||
4405412|NCT00252564|4231913|B2|Black or African American||Race (NIH/OMB)||participants|Number|15|15.0||||||
4405413|NCT00252564|4231914|B1|Black or African American||Race (NIH/OMB)||participants|Number|15|15.0||||||
4405414|NCT00252564|4231912|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4405415|NCT00252564|4231913|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4405416|NCT00252564|4231914|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4405417|NCT00252564|4231912|B3|Asian||Race (NIH/OMB)||participants|Number|6|6.0||||||
4405418|NCT00252564|4231913|B2|Asian||Race (NIH/OMB)||participants|Number|3|3.0||||||
4405419|NCT00252564|4231914|B1|Asian||Race (NIH/OMB)||participants|Number|3|3.0||||||
4405420|NCT00252564|4231912|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|2|2.0||||||
4405421|NCT00252564|4231913|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4405422|NCT00252564|4231914|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|2|2.0||||||
4405423|NCT00252564|4231912|B3||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4405424|NCT00252564|4231913|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4405425|NCT00252564|4231914|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4405426|NCT00252564|4231912|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4405427|NCT00252564|4231913|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4405428|NCT00252564|4231914|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4405429|NCT00252564|4231912|B3|||Age||years|Mean|62|62.0|Standard Deviation|12|12.0|||
4405430|NCT00252564|4231913|B2|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
4405431|NCT00252564|4231914|B1|||Age||years|Mean|61|61.0|Standard Deviation|12|12.0|||
4405432|NCT00252564|4231912|B3||>=65 years|Age||Participants|Count of Participants|107|107.0||||||
4405433|NCT00252564|4231913|B2||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4405434|NCT00252564|4231914|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4405435|NCT00252564|4231912|B3||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
4405436|NCT00252564|4231913|B2||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4405437|NCT00252564|4231914|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4405438|NCT00252564|4231912|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405439|NCT00252564|4231913|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405440|NCT00252564|4231914|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405441|NCT00252538|4231927|B1|United States||Region of Enrollment||participants|Number|133|133.0||||||
4405442|NCT00252538|4231927|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4405443|NCT00252538|4231927|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4405444|NCT00252538|4231927|B1|||Age||Years|Mean|49.1|49.1|Standard Deviation|10.5|10.5|||
4405445|NCT00252512|4231933|B3|United States||Region of Enrollment||Participants|Count of Participants|330|330.0||||||
4405446|NCT00252512|4231934|B2|United States||Region of Enrollment||Participants|Count of Participants|165|165.0||||||
4405447|NCT00252512|4231935|B1|United States||Region of Enrollment||Participants|Count of Participants|165|165.0||||||
4405448|NCT00252512|4231933|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4405449|NCT00252512|4231934|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4405450|NCT00252512|4231935|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4405451|NCT00252512|4231933|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405452|NCT00252512|4231934|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405453|NCT00252512|4231935|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405454|NCT00252512|4231933|B3||White|Race (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
4405455|NCT00252512|4231934|B2||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4405456|NCT00252512|4231935|B1||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4405457|NCT00252512|4231933|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4405458|NCT00252512|4231934|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4405459|NCT00252512|4231935|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4405460|NCT00252512|4231933|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405461|NCT00252512|4231934|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405462|NCT00252512|4231935|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405463|NCT00252512|4231933|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405464|NCT00252512|4231934|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405465|NCT00252512|4231935|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405466|NCT00252512|4231933|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405467|NCT00252512|4231934|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405468|NCT00252512|4231935|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405469|NCT00252512|4231933|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405470|NCT00252512|4231934|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405471|NCT00252512|4231935|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405472|NCT00252512|4231933|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|320|320.0||||||
4405473|NCT00252512|4231934|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4405474|NCT00252512|4231935|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
4405475|NCT00252512|4231933|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4405476|NCT00252512|4231934|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4405477|NCT00252512|4231935|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405478|NCT00252512|4231933|B3||Male|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
4405479|NCT00252512|4231934|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4405480|NCT00252512|4231935|B1||Male|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4405481|NCT00252512|4231933|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4405482|NCT00252512|4231934|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4405483|NCT00252512|4231935|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4405484|NCT00252512|4231933|B3|||Age||years|Mean|49.3|49.3|Standard Deviation|8.9|8.9|||
4405485|NCT00252512|4231934|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|8.1|8.1|||
4405486|NCT00252512|4231935|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|9.7|9.7|||
4405487|NCT00252499|4231952|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
4405488|NCT00252499|4231953|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4405489|NCT00252499|4231954|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4405490|NCT00252499|4231955|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4405491|NCT00252499|4231952|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4405492|NCT00252499|4231953|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4405493|NCT00252499|4231954|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4405494|NCT00252499|4231955|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4405495|NCT00252499|4231952|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4405496|NCT00252499|4231953|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4405497|NCT00252499|4231954|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4405498|NCT00252499|4231955|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4405499|NCT00252499|4231952|B4|||Age||years|Mean|52.6|52.6|Standard Deviation|6.27|6.27|||
4405500|NCT00252499|4231953|B3|||Age||years|Mean|54.17|54.17|Standard Deviation|5.08|5.08|||
4405501|NCT00252499|4231954|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|4.95|4.95|||
4405502|NCT00252499|4231955|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|7.3|7.3|||
4405503|NCT00252499|4231952|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405504|NCT00252499|4231953|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405505|NCT00252499|4231954|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405506|NCT00252499|4231955|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4405507|NCT00252499|4231952|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4405508|NCT00252499|4231953|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4405509|NCT00252499|4231954|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4405510|NCT00252499|4231955|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4405511|NCT00252499|4231952|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405512|NCT00252499|4231953|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405513|NCT00252499|4231954|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405514|NCT00252499|4231955|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405515|NCT00252382|4231980|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405516|NCT00252382|4231980|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405517|NCT00252382|4231980|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4405518|NCT00252382|4231980|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405519|NCT00252382|4231980|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405520|NCT00252382|4231980|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405521|NCT00252382|4231980|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405522|NCT00252382|4231980|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4405523|NCT00252382|4231980|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4405524|NCT00252382|4231980|B1|||Age|Age of participant at entry.|years|Mean|60.4|60.4|Standard Deviation|9.74|9.74|||
4405525|NCT00252239|4231985|B5|United States||Region of Enrollment||participants|Number|112|112.0||||||
4405526|NCT00252239|4231986|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
4405527|NCT00252239|4231987|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4405528|NCT00252239|4231988|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4405529|NCT00252239|4231989|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4405530|NCT00252239|4231985|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4405531|NCT00252239|4231986|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405532|NCT00252239|4231987|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405533|NCT00252239|4231988|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405534|NCT00252239|4231989|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4405535|NCT00252239|4231985|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405536|NCT00252239|4231986|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405537|NCT00252239|4231987|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405538|NCT00252239|4231988|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405539|NCT00252239|4231989|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405540|NCT00252239|4231985|B5||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4405541|NCT00252239|4231986|B4||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4405542|NCT00252239|4231987|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4405543|NCT00252239|4231988|B2||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4405544|NCT00252239|4231989|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4405545|NCT00252239|4231985|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4405546|NCT00252239|4231986|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4405547|NCT00252239|4231987|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4405548|NCT00252239|4231988|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4405549|NCT00252239|4231989|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4405550|NCT00252239|4231985|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405551|NCT00252239|4231986|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405552|NCT00252239|4231987|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405553|NCT00252239|4231988|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405554|NCT00252239|4231989|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405555|NCT00252239|4231985|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405556|NCT00252239|4231986|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405557|NCT00252239|4231987|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4405558|NCT00252239|4231988|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405559|NCT00252239|4231989|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405560|NCT00252239|4231985|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405561|NCT00252239|4231986|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405562|NCT00252239|4231987|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405563|NCT00252239|4231988|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405564|NCT00252239|4231989|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405565|NCT00252239|4231985|B5||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4405566|NCT00252239|4231986|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4405567|NCT00252239|4231987|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4405568|NCT00252239|4231988|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4405569|NCT00252239|4231989|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4405570|NCT00252239|4231985|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4405571|NCT00252239|4231986|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4405572|NCT00252239|4231987|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4405573|NCT00252239|4231988|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4405574|NCT00252239|4231989|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4405575|NCT00252239|4231985|B5|||Age||years|Mean|69|69.0|Standard Deviation|17|17.0|||
4405576|NCT00252239|4231986|B4|||Age||years|Mean|72|72.0|Standard Deviation|16|16.0|||
4405577|NCT00252239|4231987|B3|||Age||years|Mean|68|68.0|Standard Deviation|16|16.0|||
4405578|NCT00252239|4231988|B2|||Age||years|Mean|69|69.0|Standard Deviation|15|15.0|||
4405579|NCT00252239|4231989|B1|||Age||years|Mean|67|67.0|Standard Deviation|19|19.0|||
4405580|NCT00252187|4232002|B3|Diuretic (Thiazide)||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|7|7.0||||||
4405581|NCT00252187|4232003|B2|Diuretic (Thiazide)||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|3|3.0||||||
4405582|NCT00252187|4232004|B1|Diuretic (Thiazide)||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|4|4.0||||||
4405583|NCT00252187|4232002|B3|Diuretic (potassium sparing)||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|9|9.0||||||
4405584|NCT00252187|4232003|B2|Diuretic (potassium sparing)||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|4|4.0||||||
4405585|NCT00252187|4232004|B1|Diuretic (potassium sparing)||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|5|5.0||||||
4405586|NCT00252187|4232002|B3|Diuretic (thiazide)||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|7|7.0||||||
4405587|NCT00252187|4232003|B2|Diuretic (thiazide)||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|3|3.0||||||
4405588|NCT00252187|4232004|B1|Diuretic (thiazide)||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|4|4.0||||||
4405589|NCT00252187|4232002|B3|Diuretic (loop)||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|33|33.0||||||
4405590|NCT00252187|4232003|B2|Diuretic (loop)||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|15|15.0||||||
4405591|NCT00252187|4232004|B1|Diuretic (loop)||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|18|18.0||||||
4405592|NCT00252187|4232002|B3|Antiarrhythmics||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|5|5.0||||||
4405593|NCT00252187|4232003|B2|Antiarrhythmics||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|0|0.0||||||
4405594|NCT00252187|4232004|B1|Antiarrhythmics||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|5|5.0||||||
4405595|NCT00252187|4232002|B3|Coumadin||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|4|4.0||||||
4405596|NCT00252187|4232003|B2|Coumadin||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|1|1.0||||||
4405597|NCT00252187|4232004|B1|Coumadin||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|3|3.0||||||
4405598|NCT00252187|4232002|B3|Beta blocker||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|43|43.0||||||
4405599|NCT00252187|4232003|B2|Beta blocker||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|20|20.0||||||
4405600|NCT00252187|4232004|B1|Beta blocker||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|23|23.0||||||
4405601|NCT00252187|4232002|B3|Digoxin||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|17|17.0||||||
4405667|NCT00252187|4232002|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4405602|NCT00252187|4232003|B2|Digoxin||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|9|9.0||||||
4405603|NCT00252187|4232004|B1|Digoxin||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|8|8.0||||||
4405604|NCT00252187|4232002|B3|ACE I inhib, Angio II receptor blocker or nitrates||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|43|43.0||||||
4405605|NCT00252187|4232003|B2|ACE I inhib, Angio II receptor blocker or nitrates||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|20|20.0||||||
4405606|NCT00252187|4232004|B1|ACE I inhib, Angio II receptor blocker or nitrates||Concomitant Medication(s)|The sum of subjects taking a given class of medication will not equal the overall number of participants per arm, because all subjects would possibly not be taking all medication classes.|participants|Number|23|23.0||||||
4405607|NCT00252187|4232002|B3|History of high cholesterol||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|32|32.0||||||
4405608|NCT00252187|4232003|B2|History of high cholesterol||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|17|17.0||||||
4405609|NCT00252187|4232004|B1|History of high cholesterol||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|15|15.0||||||
4405610|NCT00252187|4232002|B3|History of diabetes||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|18|18.0||||||
4405611|NCT00252187|4232003|B2|History of diabetes||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|7|7.0||||||
4405612|NCT00252187|4232004|B1|History of diabetes||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|11|11.0||||||
4405613|NCT00252187|4232002|B3|History of smoking||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|18|18.0||||||
4405614|NCT00252187|4232003|B2|History of smoking||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|8|8.0||||||
4405615|NCT00252187|4232004|B1|History of smoking||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|10|10.0||||||
4405616|NCT00252187|4232002|B3|History of arrythmia||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|9|9.0||||||
4405617|NCT00252187|4232003|B2|History of arrythmia||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|4|4.0||||||
4405618|NCT00252187|4232004|B1|History of arrythmia||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|5|5.0||||||
4405619|NCT00252187|4232002|B3|History of hypertension||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|27|27.0||||||
4405620|NCT00252187|4232003|B2|History of hypertension||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|17|17.0||||||
4405621|NCT00252187|4232004|B1|History of hypertension||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|10|10.0||||||
4405622|NCT00252187|4232002|B3|History of Coronary Artery Disease||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|22|22.0||||||
4405668|NCT00252187|4232003|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4405623|NCT00252187|4232003|B2|History of Coronary Artery Disease||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|11|11.0||||||
4405624|NCT00252187|4232004|B1|History of Coronary Artery Disease||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|11|11.0||||||
4405625|NCT00252187|4232002|B3|History of chronic obstructive pulmonary disease||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|4|4.0||||||
4405626|NCT00252187|4232003|B2|History of chronic obstructive pulmonary disease||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|1|1.0||||||
4405627|NCT00252187|4232004|B1|History of chronic obstructive pulmonary disease||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|3|3.0||||||
4405628|NCT00252187|4232002|B3|History of peripheral vascular diseases||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|3|3.0||||||
4405629|NCT00252187|4232003|B2|History of peripheral vascular diseases||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|1|1.0||||||
4405630|NCT00252187|4232004|B1|History of peripheral vascular diseases||History or concomitant medical conditions|Because participants may have none, one, or more than one medical history or concomitant medical condition, the sum of the history categories will not be the same as the overall number of participants in a given arm of the study.|participants|Number|2|2.0||||||
4405631|NCT00252187|4232002|B3|||Glomerular Filtration Rate|Glomerular Filtration Rate (GFR) is a measure of the flow rate or speed the kidney filters fluid, measured in milliliters per minute per 1.73 m^2 of body-surface area. A lower GFR means the kidney is not filtering normally. An estimated GFR of less than 60 ml/min/1.73 m^2 of body-surface area is considered to be impaired kidney function.|ml/min/1.73 m^2|Mean|75|75.0|Standard Deviation|22|22.0|||
4405632|NCT00252187|4232003|B2|||Glomerular Filtration Rate|Glomerular Filtration Rate (GFR) is a measure of the flow rate or speed the kidney filters fluid, measured in milliliters per minute per 1.73 m^2 of body-surface area. A lower GFR means the kidney is not filtering normally. An estimated GFR of less than 60 ml/min/1.73 m^2 of body-surface area is considered to be impaired kidney function.|ml/min/1.73 m^2|Mean|77|77.0|Standard Deviation|21|21.0|||
4405633|NCT00252187|4232004|B1|||Glomerular Filtration Rate|Glomerular Filtration Rate (GFR) is a measure of the flow rate or speed the kidney filters fluid, measured in milliliters per minute per 1.73 m^2 of body-surface area. A lower GFR means the kidney is not filtering normally. An estimated GFR of less than 60 ml/min/1.73 m^2 of body-surface area is considered to be impaired kidney function.|ml/min/1.73 m^2|Mean|73|73.0|Standard Deviation|22|22.0|||
4405634|NCT00252187|4232002|B3|||Plasma BNP|B-type natriuretic peptide (BNP) is a cardiac hormone that affects cardiovascular function.|picograms/milliliter|Median|53|53.0|Inter-Quartile Range|||12.0|153.0|
4405635|NCT00252187|4232003|B2|||Plasma BNP|B-type natriuretic peptide (BNP) is a cardiac hormone that affects cardiovascular function.|picograms/milliliter|Median|63|63.0|Inter-Quartile Range|||10.0|318.0|
4405636|NCT00252187|4232004|B1|||Plasma BNP|B-type natriuretic peptide (BNP) is a cardiac hormone that affects cardiovascular function.|picograms/milliliter|Median|51|51.0|Inter-Quartile Range|||18.0|102.0|
4405637|NCT00252187|4232002|B3|||Heart Rate|Heart rate (HR) is a measure of how many times the heart beats per minute.|beats per minute|Mean|67|67.0|Standard Deviation|13|13.0|||
4405638|NCT00252187|4232003|B2|||Heart Rate|Heart rate (HR) is a measure of how many times the heart beats per minute.|beats per minute|Mean|68|68.0|Standard Deviation|12|12.0|||
4405639|NCT00252187|4232004|B1|||Heart Rate|Heart rate (HR) is a measure of how many times the heart beats per minute.|beats per minute|Mean|65|65.0|Standard Deviation|13|13.0|||
4405640|NCT00252187|4232002|B3|||Left Ventricle Ejection Fraction (Echo)|Left Ventricle Ejection Fraction (LVEF)is a clinical parameter used by cardiologists to describe how well the heart is pumping. LVEF is a measure of the amount of blood pumped out of the lower chamber (ventricle) of the heart during a heartbeat, measured by echocardiography. A normal LVEF ranges from 55-70%. A LVEF of 65, for example, means that 65% of the total amount of blood in the left ventricle is pumped out with each heartbeat.|Percentage|Mean|31|31.0|Standard Deviation|8|8.0|||
4405641|NCT00252187|4232003|B2|||Left Ventricle Ejection Fraction (Echo)|Left Ventricle Ejection Fraction (LVEF)is a clinical parameter used by cardiologists to describe how well the heart is pumping. LVEF is a measure of the amount of blood pumped out of the lower chamber (ventricle) of the heart during a heartbeat, measured by echocardiography. A normal LVEF ranges from 55-70%. A LVEF of 65, for example, means that 65% of the total amount of blood in the left ventricle is pumped out with each heartbeat.|Percentage|Mean|31|31.0|Standard Deviation|7|7.0|||
4405642|NCT00252187|4232004|B1|||Left Ventricle Ejection Fraction (Echo)|Left Ventricle Ejection Fraction (LVEF)is a clinical parameter used by cardiologists to describe how well the heart is pumping. LVEF is a measure of the amount of blood pumped out of the lower chamber (ventricle) of the heart during a heartbeat, measured by echocardiography. A normal LVEF ranges from 55-70%. A LVEF of 65, for example, means that 65% of the total amount of blood in the left ventricle is pumped out with each heartbeat.|Percentage|Mean|32|32.0|Standard Deviation|9|9.0|||
4405669|NCT00252187|4232004|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4405730|NCT00252057|4232070|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405643|NCT00252187|4232002|B3|NYHA CHF Class III||New York Heart Association (NYHA) CHF Classification|NYHA classifications of various stages of Congestive Heart Failure (CHF) help determine the severity. Class I-No symptoms at any level of exertion & no limitation in ordinary physical activity. Class II-Mild symptoms and slight limitation during regular activity. Comfortable at rest. Class III-Noticeable limitation due to symptoms, even during minimal activity; Comfortable only at rest. Class IV-Severe limitations. Symptoms even while at rest. Note: The sum of categorized subjects will not equal the total number of participants enrolled in each arm, because only Class II & III were reported.|participants|Number|3|3.0||||||
4405644|NCT00252187|4232003|B2|NYHA CHF Class III||New York Heart Association (NYHA) CHF Classification|NYHA classifications of various stages of Congestive Heart Failure (CHF) help determine the severity. Class I-No symptoms at any level of exertion & no limitation in ordinary physical activity. Class II-Mild symptoms and slight limitation during regular activity. Comfortable at rest. Class III-Noticeable limitation due to symptoms, even during minimal activity; Comfortable only at rest. Class IV-Severe limitations. Symptoms even while at rest. Note: The sum of categorized subjects will not equal the total number of participants enrolled in each arm, because only Class II & III were reported.|participants|Number|1|1.0||||||
4405645|NCT00252187|4232004|B1|NYHA CHF Class III||New York Heart Association (NYHA) CHF Classification|NYHA classifications of various stages of Congestive Heart Failure (CHF) help determine the severity. Class I-No symptoms at any level of exertion & no limitation in ordinary physical activity. Class II-Mild symptoms and slight limitation during regular activity. Comfortable at rest. Class III-Noticeable limitation due to symptoms, even during minimal activity; Comfortable only at rest. Class IV-Severe limitations. Symptoms even while at rest. Note: The sum of categorized subjects will not equal the total number of participants enrolled in each arm, because only Class II & III were reported.|participants|Number|2|2.0||||||
4405646|NCT00252187|4232002|B3|NYHA CHF Class II||New York Heart Association (NYHA) CHF Classification|NYHA classifications of various stages of Congestive Heart Failure (CHF) help determine the severity. Class I-No symptoms at any level of exertion & no limitation in ordinary physical activity. Class II-Mild symptoms and slight limitation during regular activity. Comfortable at rest. Class III-Noticeable limitation due to symptoms, even during minimal activity; Comfortable only at rest. Class IV-Severe limitations. Symptoms even while at rest. Note: The sum of categorized subjects will not equal the total number of participants enrolled in each arm, because only Class II & III were reported.|participants|Number|23|23.0||||||
4405647|NCT00252187|4232003|B2|NYHA CHF Class II||New York Heart Association (NYHA) CHF Classification|NYHA classifications of various stages of Congestive Heart Failure (CHF) help determine the severity. Class I-No symptoms at any level of exertion & no limitation in ordinary physical activity. Class II-Mild symptoms and slight limitation during regular activity. Comfortable at rest. Class III-Noticeable limitation due to symptoms, even during minimal activity; Comfortable only at rest. Class IV-Severe limitations. Symptoms even while at rest. Note: The sum of categorized subjects will not equal the total number of participants enrolled in each arm, because only Class II & III were reported.|participants|Number|10|10.0||||||
4405648|NCT00252187|4232004|B1|NYHA CHF Class II||New York Heart Association (NYHA) CHF Classification|NYHA classifications of various stages of Congestive Heart Failure (CHF) help determine the severity. Class I-No symptoms at any level of exertion & no limitation in ordinary physical activity. Class II-Mild symptoms and slight limitation during regular activity. Comfortable at rest. Class III-Noticeable limitation due to symptoms, even during minimal activity; Comfortable only at rest. Class IV-Severe limitations. Symptoms even while at rest. Note: The sum of categorized subjects will not equal the total number of participants enrolled in each arm, because only Class II & III were reported.|participants|Number|13|13.0||||||
4405649|NCT00252187|4232002|B3|Diastolic blood pressure||Blood pressure|Systolic blood pressure (SBP) the top number and diastolic blood pressure (DBP)the bottom number in a blood pressure reading, are measured in millimeters of mercury (mmHg) on a scale.|mmHg|Mean|72|72.0|Standard Deviation|12|12.0|||
4405650|NCT00252187|4232003|B2|Diastolic blood pressure||Blood pressure|Systolic blood pressure (SBP) the top number and diastolic blood pressure (DBP)the bottom number in a blood pressure reading, are measured in millimeters of mercury (mmHg) on a scale.|mmHg|Mean|72|72.0|Standard Deviation|14|14.0|||
4405651|NCT00252187|4232004|B1|Diastolic blood pressure||Blood pressure|Systolic blood pressure (SBP) the top number and diastolic blood pressure (DBP)the bottom number in a blood pressure reading, are measured in millimeters of mercury (mmHg) on a scale.|mmHg|Mean|72|72.0|Standard Deviation|11|11.0|||
4405652|NCT00252187|4232002|B3|Systolic blood pressure||Blood pressure|Systolic blood pressure (SBP) the top number and diastolic blood pressure (DBP)the bottom number in a blood pressure reading, are measured in millimeters of mercury (mmHg) on a scale.|mmHg|Mean|129|129.0|Standard Deviation|17|17.0|||
4405653|NCT00252187|4232003|B2|Systolic blood pressure||Blood pressure|Systolic blood pressure (SBP) the top number and diastolic blood pressure (DBP)the bottom number in a blood pressure reading, are measured in millimeters of mercury (mmHg) on a scale.|mmHg|Mean|127|127.0|Standard Deviation|17|17.0|||
4405654|NCT00252187|4232004|B1|Systolic blood pressure||Blood pressure|Systolic blood pressure (SBP) the top number and diastolic blood pressure (DBP)the bottom number in a blood pressure reading, are measured in millimeters of mercury (mmHg) on a scale.|mmHg|Mean|131|131.0|Standard Deviation|18|18.0|||
4405655|NCT00252187|4232002|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4405656|NCT00252187|4232003|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4405657|NCT00252187|4232004|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4405658|NCT00252187|4232002|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4405659|NCT00252187|4232003|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4405660|NCT00252187|4232004|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4405661|NCT00252187|4232002|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4405662|NCT00252187|4232003|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4405663|NCT00252187|4232004|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4405664|NCT00252187|4232002|B3|||Age||years|Mean|66|66.0|Standard Deviation|11|11.0|||
4405665|NCT00252187|4232003|B2|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
4405666|NCT00252187|4232004|B1|||Age||years|Mean|66|66.0|Standard Deviation|10|10.0|||
4405670|NCT00252187|4232002|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4405671|NCT00252187|4232003|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4405672|NCT00252187|4232004|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4405673|NCT00252187|4232002|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405674|NCT00252187|4232003|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405675|NCT00252187|4232004|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405676|NCT00252174|4232025|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4405677|NCT00252174|4232027|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4405678|NCT00252174|4232025|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405679|NCT00252174|4232027|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405680|NCT00252174|4232025|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405681|NCT00252174|4232027|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405682|NCT00252174|4232025|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4405683|NCT00252174|4232027|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4405684|NCT00252174|4232025|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405685|NCT00252174|4232027|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405686|NCT00252174|4232025|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405687|NCT00252174|4232027|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405688|NCT00252174|4232025|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405689|NCT00252174|4232027|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405690|NCT00252174|4232025|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405691|NCT00252174|4232027|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405692|NCT00252174|4232025|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405693|NCT00252174|4232027|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405694|NCT00252174|4232025|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4405695|NCT00252174|4232027|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4405696|NCT00252174|4232025|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405697|NCT00252174|4232027|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405698|NCT00252174|4232025|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4405699|NCT00252174|4232027|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4405700|NCT00252174|4232025|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405701|NCT00252174|4232027|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4405702|NCT00252174|4232025|B4|||Age||years|Mean|66|66.0|Full Range|||65.0|67.0|
4405703|NCT00252174|4232027|B2|||Age||years|Mean|66|66.0|Full Range|||65.0|67.0|
4405704|NCT00252174|4232025|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4405705|NCT00252174|4232027|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4405706|NCT00252174|4232025|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4405707|NCT00252174|4232027|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4405708|NCT00252174|4232025|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405709|NCT00252174|4232027|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405710|NCT00252057|4232068|B3|United States||Region of Enrollment||participants|Number|749|749.0||||||
4405711|NCT00252057|4232069|B2|United States||Region of Enrollment||participants|Number|376|376.0||||||
4405712|NCT00252057|4232070|B1|United States||Region of Enrollment||participants|Number|373|373.0||||||
4405713|NCT00252057|4232068|B3||Male|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
4405714|NCT00252057|4232069|B2||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4405715|NCT00252057|4232070|B1||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4405716|NCT00252057|4232068|B3||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4405717|NCT00252057|4232069|B2||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4405718|NCT00252057|4232070|B1||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4405719|NCT00252057|4232068|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|15.2|15.2|||
4405720|NCT00252057|4232069|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|15.3|15.3|||
4405721|NCT00252057|4232070|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|15.1|15.1|||
4405722|NCT00252057|4232068|B3||>=65 years|Age||Participants|Count of Participants|123|123.0||||||
4405723|NCT00252057|4232069|B2||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4405724|NCT00252057|4232070|B1||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4405725|NCT00252057|4232068|B3||Between 18 and 65 years|Age||Participants|Count of Participants|626|626.0||||||
4405726|NCT00252057|4232069|B2||Between 18 and 65 years|Age||Participants|Count of Participants|314|314.0||||||
4405727|NCT00252057|4232070|B1||Between 18 and 65 years|Age||Participants|Count of Participants|312|312.0||||||
4405728|NCT00252057|4232068|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405729|NCT00252057|4232069|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405731|NCT00251979|4232077|B3||Male|Sex: Female, Male||Participants|Count of Participants|522|522.0||||||
4405732|NCT00251979|4232078|B2||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4405733|NCT00251979|4232079|B1||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4405734|NCT00251979|4232077|B3||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4405735|NCT00251979|4232078|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4405736|NCT00251979|4232079|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4405737|NCT00251979|4232077|B3||>=65 years|Age||Participants|Count of Participants|372|372.0||||||
4405738|NCT00251979|4232078|B2||>=65 years|Age||Participants|Count of Participants|179|179.0||||||
4405739|NCT00251979|4232079|B1||>=65 years|Age||Participants|Count of Participants|193|193.0||||||
4405740|NCT00251979|4232077|B3||Between 18 and 65 years|Age||Participants|Count of Participants|392|392.0||||||
4405741|NCT00251979|4232078|B2||Between 18 and 65 years|Age||Participants|Count of Participants|210|210.0||||||
4405742|NCT00251979|4232079|B1||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
4405743|NCT00251979|4232077|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405744|NCT00251979|4232078|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405745|NCT00251979|4232079|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405746|NCT00251927|4232110|B3||Male|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4405747|NCT00251927|4232111|B2||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4405748|NCT00251927|4232112|B1||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4405749|NCT00251927|4232110|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4405750|NCT00251927|4232111|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4405751|NCT00251927|4232112|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4405752|NCT00251927|4232110|B3|||Age||Years|Mean|45.05|45.05|Standard Deviation|11.2|11.2|||
4405753|NCT00251927|4232111|B2|||Age||Years|Mean|45.3|45.3|Standard Deviation|11.5|11.5|||
4405754|NCT00251927|4232112|B1|||Age||Years|Mean|44.8|44.8|Standard Deviation|10.9|10.9|||
4405755|NCT00251862|4232140|B4|United States||Region of Enrollment||participants|Number|825|825.0||||||
4405756|NCT00251862|4232141|B3|United States||Region of Enrollment||participants|Number|276|276.0||||||
4405757|NCT00251862|4232142|B2|United States||Region of Enrollment||participants|Number|269|269.0||||||
4405758|NCT00251862|4232143|B1|United States||Region of Enrollment||participants|Number|280|280.0||||||
4405759|NCT00251862|4232140|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4405760|NCT00251862|4232141|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4405761|NCT00251862|4232142|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4405762|NCT00251862|4232143|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4405763|NCT00251862|4232140|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405764|NCT00251862|4232141|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405765|NCT00251862|4232142|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405766|NCT00251862|4232143|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405767|NCT00251862|4232140|B4||White|Race (NIH/OMB)||Participants|Count of Participants|283|283.0||||||
4405768|NCT00251862|4232141|B3||White|Race (NIH/OMB)||Participants|Count of Participants|88|88.0||||||
4405769|NCT00251862|4232142|B2||White|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4405770|NCT00251862|4232143|B1||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4405771|NCT00251862|4232140|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|512|512.0||||||
4405772|NCT00251862|4232141|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4405773|NCT00251862|4232142|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
4405774|NCT00251862|4232143|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
4405775|NCT00251862|4232140|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405776|NCT00251862|4232141|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405777|NCT00251862|4232142|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405778|NCT00251862|4232143|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405779|NCT00251862|4232140|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4405780|NCT00251862|4232141|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4405781|NCT00251862|4232142|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4405782|NCT00251862|4232143|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405783|NCT00251862|4232140|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405784|NCT00251862|4232141|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405785|NCT00251862|4232142|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405786|NCT00251862|4232143|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405787|NCT00251862|4232140|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405788|NCT00251862|4232141|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405904|NCT00251745|4232185|B3||White|Race (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
4405789|NCT00251862|4232142|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405790|NCT00251862|4232143|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405791|NCT00251862|4232140|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|782|782.0||||||
4405792|NCT00251862|4232141|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|261|261.0||||||
4405793|NCT00251862|4232142|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
4405794|NCT00251862|4232143|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|262|262.0||||||
4405795|NCT00251862|4232140|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4405796|NCT00251862|4232141|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4405797|NCT00251862|4232142|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4405798|NCT00251862|4232143|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4405799|NCT00251862|4232140|B4||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4405800|NCT00251862|4232141|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4405801|NCT00251862|4232142|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4405802|NCT00251862|4232143|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4405803|NCT00251862|4232140|B4||Female|Sex: Female, Male||Participants|Count of Participants|486|486.0||||||
4405804|NCT00251862|4232141|B3||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4405805|NCT00251862|4232142|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4405806|NCT00251862|4232143|B1||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4405807|NCT00251862|4232140|B4||>=65 years|Age||Participants|Count of Participants|129|129.0||||||
4405808|NCT00251862|4232141|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4405809|NCT00251862|4232142|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4405810|NCT00251862|4232143|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4405811|NCT00251862|4232140|B4||Between 18 and 65 years|Age||Participants|Count of Participants|696|696.0||||||
4405812|NCT00251862|4232141|B3||Between 18 and 65 years|Age||Participants|Count of Participants|230|230.0||||||
4405813|NCT00251862|4232142|B2||Between 18 and 65 years|Age||Participants|Count of Participants|234|234.0||||||
4405814|NCT00251862|4232143|B1||Between 18 and 65 years|Age||Participants|Count of Participants|232|232.0||||||
4405815|NCT00251862|4232140|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405816|NCT00251862|4232141|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405817|NCT00251862|4232142|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405818|NCT00251862|4232143|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4405819|NCT00251758|4232162|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405820|NCT00251758|4232163|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405821|NCT00251758|4232164|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405822|NCT00251758|4232165|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405823|NCT00251758|4232162|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|729|729.0||||||
4405824|NCT00251758|4232163|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
4405825|NCT00251758|4232164|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
4405826|NCT00251758|4232165|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
4405827|NCT00251758|4232162|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
4405828|NCT00251758|4232163|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4405829|NCT00251758|4232164|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4405830|NCT00251758|4232165|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4405831|NCT00251758|4232162|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405832|NCT00251758|4232163|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405833|NCT00251758|4232164|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405834|NCT00251758|4232165|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405835|NCT00251758|4232162|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4405836|NCT00251758|4232163|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405837|NCT00251758|4232164|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405838|NCT00251758|4232165|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4405839|NCT00251758|4232162|B4||White|Race (NIH/OMB)||Participants|Count of Participants|731|731.0||||||
4405840|NCT00251758|4232163|B3||White|Race (NIH/OMB)||Participants|Count of Participants|245|245.0||||||
4405841|NCT00251758|4232164|B2||White|Race (NIH/OMB)||Participants|Count of Participants|246|246.0||||||
4405842|NCT00251758|4232165|B1||White|Race (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
4405843|NCT00251758|4232162|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4405844|NCT00251758|4232163|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4405845|NCT00251758|4232164|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4405846|NCT00251758|4232165|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4405847|NCT00251758|4232162|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4405848|NCT00251758|4232163|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405849|NCT00251758|4232164|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405850|NCT00251758|4232165|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405851|NCT00251758|4232162|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4405852|NCT00251758|4232163|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4405853|NCT00251758|4232164|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4405854|NCT00251758|4232165|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4405855|NCT00251758|4232162|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4405856|NCT00251758|4232163|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4405857|NCT00251758|4232164|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405858|NCT00251758|4232165|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405859|NCT00251758|4232162|B4||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4405860|NCT00251758|4232163|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4405861|NCT00251758|4232164|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4405862|NCT00251758|4232165|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4405863|NCT00251758|4232162|B4||Female|Sex: Female, Male||Participants|Count of Participants|643|643.0||||||
4405864|NCT00251758|4232163|B3||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4405865|NCT00251758|4232164|B2||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4405866|NCT00251758|4232165|B1||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4405867|NCT00251758|4232162|B4|≥65 years||Age, Customized||participants|Number|101|101.0||||||
4405868|NCT00251758|4232163|B3|≥65 years||Age, Customized||participants|Number|30|30.0||||||
4405869|NCT00251758|4232164|B2|≥65 years||Age, Customized||participants|Number|32|32.0||||||
4405870|NCT00251758|4232165|B1|≥65 years||Age, Customized||participants|Number|39|39.0||||||
4405871|NCT00251758|4232162|B4|45 - <65 years||Age, Customized||participants|Number|440|440.0||||||
4405872|NCT00251758|4232163|B3|45 - <65 years||Age, Customized||participants|Number|139|139.0||||||
4405873|NCT00251758|4232164|B2|45 - <65 years||Age, Customized||participants|Number|155|155.0||||||
4405874|NCT00251758|4232165|B1|45 - <65 years||Age, Customized||participants|Number|146|146.0||||||
4405875|NCT00251758|4232162|B4|<45 years||Age, Customized||participants|Number|367|367.0||||||
4405876|NCT00251758|4232163|B3|<45 years||Age, Customized||participants|Number|135|135.0||||||
4405877|NCT00251758|4232164|B2|<45 years||Age, Customized||participants|Number|125|125.0||||||
4405878|NCT00251758|4232165|B1|<45 years||Age, Customized||participants|Number|107|107.0||||||
4405879|NCT00251758|4232162|B4|||Age||years|Mean|47.9|47.9|Standard Deviation|13.61|13.61|||
4405880|NCT00251758|4232163|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|13.64|13.64|||
4405881|NCT00251758|4232164|B2|||Age||years|Mean|48.0|48.0|Standard Deviation|13.55|13.55|||
4405882|NCT00251758|4232165|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|13.60|13.6|||
4405883|NCT00251745|4232184|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405884|NCT00251745|4232185|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405885|NCT00251745|4232186|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405886|NCT00251745|4232187|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405887|NCT00251745|4232184|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|729|729.0||||||
4405888|NCT00251745|4232185|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|243|243.0||||||
4405889|NCT00251745|4232186|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|254|254.0||||||
4405890|NCT00251745|4232187|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
4405891|NCT00251745|4232184|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
4405892|NCT00251745|4232185|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4405893|NCT00251745|4232186|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4405894|NCT00251745|4232187|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4405895|NCT00251745|4232184|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405896|NCT00251745|4232185|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405897|NCT00251745|4232186|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405898|NCT00251745|4232187|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405899|NCT00251745|4232184|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4405900|NCT00251745|4232185|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405901|NCT00251745|4232186|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405902|NCT00251745|4232187|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4405903|NCT00251745|4232184|B4||White|Race (NIH/OMB)||Participants|Count of Participants|731|731.0||||||
4405905|NCT00251745|4232186|B2||White|Race (NIH/OMB)||Participants|Count of Participants|246|246.0||||||
4405906|NCT00251745|4232187|B1||White|Race (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
4405907|NCT00251745|4232184|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4405908|NCT00251745|4232185|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4405909|NCT00251745|4232186|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4405910|NCT00251745|4232187|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4405911|NCT00251745|4232184|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4405912|NCT00251745|4232185|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405913|NCT00251745|4232186|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405914|NCT00251745|4232187|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405915|NCT00251745|4232184|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4405916|NCT00251745|4232185|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4405917|NCT00251745|4232186|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4405918|NCT00251745|4232187|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4405919|NCT00251745|4232184|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4405920|NCT00251745|4232185|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4405921|NCT00251745|4232186|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405922|NCT00251745|4232187|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405923|NCT00251745|4232184|B4||Male|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4405924|NCT00251745|4232185|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4405925|NCT00251745|4232186|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4405926|NCT00251745|4232187|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4405927|NCT00251745|4232184|B4||Female|Sex: Female, Male||Participants|Count of Participants|643|643.0||||||
4405928|NCT00251745|4232185|B3||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4405929|NCT00251745|4232186|B2||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4405930|NCT00251745|4232187|B1||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4405931|NCT00251745|4232184|B4|≥65 years||Age, Customized||participants|Number|101|101.0||||||
4405932|NCT00251745|4232185|B3|≥65 years||Age, Customized||participants|Number|30|30.0||||||
4405933|NCT00251745|4232186|B2|≥65 years||Age, Customized||participants|Number|32|32.0||||||
4405934|NCT00251745|4232187|B1|≥65 years||Age, Customized||participants|Number|39|39.0||||||
4405935|NCT00251745|4232184|B4|45 - <65 years||Age, Customized||participants|Number|440|440.0||||||
4405936|NCT00251745|4232185|B3|45 - <65 years||Age, Customized||participants|Number|139|139.0||||||
4405937|NCT00251745|4232186|B2|45 - <65 years||Age, Customized||participants|Number|155|155.0||||||
4405938|NCT00251745|4232187|B1|45 - <65 years||Age, Customized||participants|Number|146|146.0||||||
4405939|NCT00251745|4232184|B4|<45 years||Age, Customized||participants|Number|367|367.0||||||
4405940|NCT00251745|4232185|B3|<45 years||Age, Customized||participants|Number|135|135.0||||||
4405941|NCT00251745|4232186|B2|<45 years||Age, Customized||participants|Number|125|125.0||||||
4405942|NCT00251745|4232187|B1|<45 years||Age, Customized||participants|Number|107|107.0||||||
4405943|NCT00251745|4232184|B4|||Age||years|Mean|47.9|47.9|Standard Deviation|13.61|13.61|||
4405944|NCT00251745|4232185|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|13.64|13.64|||
4405945|NCT00251745|4232186|B2|||Age||years|Mean|48.0|48.0|Standard Deviation|13.55|13.55|||
4405946|NCT00251745|4232187|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|13.60|13.6|||
4405947|NCT00251719|4232206|B4|NA||LA Classification Grade||participant|Number|2|2.0||||||
4405948|NCT00251719|4232207|B3|NA||LA Classification Grade||participant|Number|0|0.0||||||
4405949|NCT00251719|4232208|B2|NA||LA Classification Grade||participant|Number|1|1.0||||||
4405950|NCT00251719|4232209|B1|NA||LA Classification Grade||participant|Number|1|1.0||||||
4405951|NCT00251719|4232206|B4|D: ≥1 mucosal break and ≥75% of the circumference||LA Classification Grade||participant|Number|132|132.0||||||
4405952|NCT00251719|4232207|B3|D: ≥1 mucosal break and ≥75% of the circumference||LA Classification Grade||participant|Number|44|44.0||||||
4405953|NCT00251719|4232208|B2|D: ≥1 mucosal break and ≥75% of the circumference||LA Classification Grade||participant|Number|42|42.0||||||
4405954|NCT00251719|4232209|B1|D: ≥1 mucosal break and ≥75% of the circumference||LA Classification Grade||participant|Number|46|46.0||||||
4405955|NCT00251719|4232206|B4|C: ≥1 mucosal break and <75% of the circumference||LA Classification Grade||participant|Number|458|458.0||||||
4405956|NCT00251719|4232207|B3|C: ≥1 mucosal break and <75% of the circumference||LA Classification Grade||participant|Number|150|150.0||||||
4405957|NCT00251719|4232208|B2|C: ≥1 mucosal break and <75% of the circumference||LA Classification Grade||participant|Number|152|152.0||||||
4405958|NCT00251719|4232209|B1|C: ≥1 mucosal break and <75% of the circumference||LA Classification Grade||participant|Number|156|156.0||||||
4405959|NCT00251719|4232206|B4|B: ≥1 mucosal break ≥5 mm||LA Classification Grade||participant|Number|735|735.0||||||
4405960|NCT00251719|4232207|B3|B: ≥1 mucosal break ≥5 mm||LA Classification Grade||participant|Number|257|257.0||||||
4405961|NCT00251719|4232208|B2|B: ≥1 mucosal break ≥5 mm||LA Classification Grade||participant|Number|221|221.0||||||
4405962|NCT00251719|4232209|B1|B: ≥1 mucosal break ≥5 mm||LA Classification Grade||participant|Number|257|257.0||||||
4405963|NCT00251719|4232206|B4|A: ≥1 mucosal break <5 mm||LA Classification Grade||participant|Number|727|727.0||||||
4405964|NCT00251719|4232207|B3|A: ≥1 mucosal break <5 mm||LA Classification Grade||participant|Number|222|222.0||||||
4405965|NCT00251719|4232208|B2|A: ≥1 mucosal break <5 mm||LA Classification Grade||participant|Number|271|271.0||||||
4405966|NCT00251719|4232209|B1|A: ≥1 mucosal break <5 mm||LA Classification Grade||participant|Number|234|234.0||||||
4405967|NCT00251719|4232206|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4405968|NCT00251719|4232207|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405969|NCT00251719|4232208|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405970|NCT00251719|4232209|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405971|NCT00251719|4232206|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4405972|NCT00251719|4232207|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4405973|NCT00251719|4232208|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4405974|NCT00251719|4232209|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4405975|NCT00251719|4232206|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1770|1770.0||||||
4405976|NCT00251719|4232207|B3||White|Race (NIH/OMB)||Participants|Count of Participants|584|584.0||||||
4405977|NCT00251719|4232208|B2||White|Race (NIH/OMB)||Participants|Count of Participants|588|588.0||||||
4405978|NCT00251719|4232209|B1||White|Race (NIH/OMB)||Participants|Count of Participants|598|598.0||||||
4405979|NCT00251719|4232206|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4405980|NCT00251719|4232207|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4405981|NCT00251719|4232208|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4405982|NCT00251719|4232209|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4405983|NCT00251719|4232206|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4405984|NCT00251719|4232207|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405985|NCT00251719|4232208|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405986|NCT00251719|4232209|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4405987|NCT00251719|4232206|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4405988|NCT00251719|4232207|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4405989|NCT00251719|4232208|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4405990|NCT00251719|4232209|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4405991|NCT00251719|4232206|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4405992|NCT00251719|4232207|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4405993|NCT00251719|4232208|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4405994|NCT00251719|4232209|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4405995|NCT00251719|4232206|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405996|NCT00251719|4232207|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405997|NCT00251719|4232208|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405998|NCT00251719|4232209|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4405999|NCT00251719|4232206|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1862|1862.0||||||
4406000|NCT00251719|4232207|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|615|615.0||||||
4406001|NCT00251719|4232208|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|620|620.0||||||
4406002|NCT00251719|4232209|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|627|627.0||||||
4406003|NCT00251719|4232206|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4406004|NCT00251719|4232207|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4406005|NCT00251719|4232208|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4406006|NCT00251719|4232209|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4406007|NCT00251719|4232206|B4||Male|Sex: Female, Male||Participants|Count of Participants|1091|1091.0||||||
4406008|NCT00251719|4232207|B3||Male|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4406009|NCT00251719|4232208|B2||Male|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4406010|NCT00251719|4232209|B1||Male|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4406011|NCT00251719|4232206|B4||Female|Sex: Female, Male||Participants|Count of Participants|963|963.0||||||
4406012|NCT00251719|4232207|B3||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4406013|NCT00251719|4232208|B2||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4406014|NCT00251719|4232209|B1||Female|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
4406015|NCT00251719|4232206|B4|||Age||years|Mean|47.9|47.9|Standard Deviation|13.66|13.66|||
4406016|NCT00251719|4232207|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|13.65|13.65|||
4406017|NCT00251719|4232208|B2|||Age||years|Mean|47.7|47.7|Standard Deviation|13.80|13.8|||
4406018|NCT00251719|4232209|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|13.53|13.53|||
4406019|NCT00251719|4232206|B4|>= 65 Years||Age, Customized||participants|Number|240|240.0||||||
4406020|NCT00251719|4232207|B3|>= 65 Years||Age, Customized||participants|Number|65|65.0||||||
4406021|NCT00251719|4232208|B2|>= 65 Years||Age, Customized||participants|Number|84|84.0||||||
4406022|NCT00251719|4232209|B1|>= 65 Years||Age, Customized||participants|Number|91|91.0||||||
4406023|NCT00251719|4232206|B4|45 Years to < 65 Years||Age, Customized||participants|Number|972|972.0||||||
4406024|NCT00251719|4232207|B3|45 Years to < 65 Years||Age, Customized||participants|Number|314|314.0||||||
4406025|NCT00251719|4232208|B2|45 Years to < 65 Years||Age, Customized||participants|Number|310|310.0||||||
4406026|NCT00251719|4232209|B1|45 Years to < 65 Years||Age, Customized||participants|Number|348|348.0||||||
4406027|NCT00251719|4232206|B4|< 45 Years||Age, Customized||participants|Number|842|842.0||||||
4406028|NCT00251719|4232207|B3|< 45 Years||Age, Customized||participants|Number|294|294.0||||||
4406029|NCT00251719|4232208|B2|< 45 Years||Age, Customized||participants|Number|293|293.0||||||
4406030|NCT00251719|4232209|B1|< 45 Years||Age, Customized||participants|Number|255|255.0||||||
4406031|NCT00251693|4232234|B4|Not Applicable||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|2|2.0||||||
4406032|NCT00251693|4232235|B3|Not Applicable||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|1|1.0||||||
4406033|NCT00251693|4232236|B2|Not Applicable||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|0|0.0||||||
4406034|NCT00251693|4232237|B1|Not Applicable||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|1|1.0||||||
4406035|NCT00251693|4232234|B4|D: ≥1 mucosal break and ≥75% of the circumference||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|118|118.0||||||
4406036|NCT00251693|4232235|B3|D: ≥1 mucosal break and ≥75% of the circumference||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|40|40.0||||||
4406037|NCT00251693|4232236|B2|D: ≥1 mucosal break and ≥75% of the circumference||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|45|45.0||||||
4406038|NCT00251693|4232237|B1|D: ≥1 mucosal break and ≥75% of the circumference||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|33|33.0||||||
4406039|NCT00251693|4232234|B4|C: ≥1 mucosal break and <75% of the circumference||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|481|481.0||||||
4406040|NCT00251693|4232235|B3|C: ≥1 mucosal break and <75% of the circumference||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|170|170.0||||||
4406041|NCT00251693|4232236|B2|C: ≥1 mucosal break and <75% of the circumference||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|148|148.0||||||
4406042|NCT00251693|4232237|B1|C: ≥1 mucosal break and <75% of the circumference||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|163|163.0||||||
4406043|NCT00251693|4232234|B4|B: ≥1 mucosal break ≥5mm||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|728|728.0||||||
4406044|NCT00251693|4232235|B3|B: ≥1 mucosal break ≥5mm||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|248|248.0||||||
4406045|NCT00251693|4232236|B2|B: ≥1 mucosal break ≥5mm||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|233|233.0||||||
4406046|NCT00251693|4232237|B1|B: ≥1 mucosal break ≥5mm||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|247|247.0||||||
4406047|NCT00251693|4232234|B4|A: ≥1 mucosal break <5mm||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|709|709.0||||||
4406048|NCT00251693|4232235|B3|A: ≥1 mucosal break <5mm||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|231|231.0||||||
4406049|NCT00251693|4232236|B2|A: ≥1 mucosal break <5mm||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|242|242.0||||||
4406050|NCT00251693|4232237|B1|A: ≥1 mucosal break <5mm||Los Angeles (LA) Classification Grade for Erosive Esophagitis (EE)|LA Classification for Esophagitis Grading System (grades A, B, C, D) with increasing severity from grade A to grade D.|Paricipants|Number|236|236.0||||||
4406051|NCT00251693|4232234|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4406052|NCT00251693|4232235|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4406053|NCT00251693|4232236|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4406054|NCT00251693|4232237|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4406055|NCT00251693|4232234|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4406056|NCT00251693|4232235|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4406057|NCT00251693|4232236|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4406058|NCT00251693|4232237|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4406059|NCT00251693|4232234|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1783|1783.0||||||
4406060|NCT00251693|4232235|B3||White|Race (NIH/OMB)||Participants|Count of Participants|601|601.0||||||
4406061|NCT00251693|4232236|B2||White|Race (NIH/OMB)||Participants|Count of Participants|580|580.0||||||
4406062|NCT00251693|4232237|B1||White|Race (NIH/OMB)||Participants|Count of Participants|602|602.0||||||
4406063|NCT00251693|4232234|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4406064|NCT00251693|4232235|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4406065|NCT00251693|4232236|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4406066|NCT00251693|4232237|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4406067|NCT00251693|4232234|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4406068|NCT00251693|4232235|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4406069|NCT00251693|4232236|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406070|NCT00251693|4232237|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4406071|NCT00251693|4232234|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4406072|NCT00251693|4232235|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4406073|NCT00251693|4232236|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4406074|NCT00251693|4232237|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4406075|NCT00251693|4232234|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4406076|NCT00251693|4232235|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4406077|NCT00251693|4232236|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4406078|NCT00251693|4232237|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4406079|NCT00251693|4232234|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406080|NCT00251693|4232235|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406081|NCT00251693|4232236|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406082|NCT00251693|4232237|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406083|NCT00251693|4232234|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1872|1872.0||||||
4406084|NCT00251693|4232235|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|636|636.0||||||
4406085|NCT00251693|4232236|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|616|616.0||||||
4406086|NCT00251693|4232237|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|620|620.0||||||
4406087|NCT00251693|4232234|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|166|166.0||||||
4406088|NCT00251693|4232235|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4406089|NCT00251693|4232236|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4406090|NCT00251693|4232237|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4406091|NCT00251693|4232234|B4||Male|Sex: Female, Male||Participants|Count of Participants|1111|1111.0||||||
4406092|NCT00251693|4232235|B3||Male|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4406093|NCT00251693|4232236|B2||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4406094|NCT00251693|4232237|B1||Male|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
4406095|NCT00251693|4232234|B4||Female|Sex: Female, Male||Participants|Count of Participants|927|927.0||||||
4406096|NCT00251693|4232235|B3||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4406097|NCT00251693|4232236|B2||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4406098|NCT00251693|4232237|B1||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4406099|NCT00251693|4232234|B4|||Age||years|Mean|47.5|47.5|Standard Deviation|13.79|13.79|||
4406100|NCT00251693|4232235|B3|||Age||years|Mean|47.3|47.3|Standard Deviation|13.74|13.74|||
4406101|NCT00251693|4232236|B2|||Age||years|Mean|47.3|47.3|Standard Deviation|13.93|13.93|||
4406102|NCT00251693|4232237|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|13.71|13.71|||
4406103|NCT00251693|4232234|B4|>=65 Years||Age, Customized||participants|Number|196|196.0||||||
4406104|NCT00251693|4232235|B3|>=65 Years||Age, Customized||participants|Number|70|70.0||||||
4406105|NCT00251693|4232236|B2|>=65 Years||Age, Customized||participants|Number|64|64.0||||||
4406106|NCT00251693|4232237|B1|>=65 Years||Age, Customized||participants|Number|62|62.0||||||
4406107|NCT00251693|4232234|B4|45 Years to <65 Years||Age, Customized||participants|Number|1009|1009.0||||||
4406108|NCT00251693|4232235|B3|45 Years to <65 Years||Age, Customized||participants|Number|332|332.0||||||
4406109|NCT00251693|4232236|B2|45 Years to <65 Years||Age, Customized||participants|Number|328|328.0||||||
4406110|NCT00251693|4232237|B1|45 Years to <65 Years||Age, Customized||participants|Number|349|349.0||||||
4406111|NCT00251693|4232234|B4|<45 Years||Age, Customized||participants|Number|833|833.0||||||
4406112|NCT00251693|4232235|B3|<45 Years||Age, Customized||participants|Number|288|288.0||||||
4406113|NCT00251693|4232236|B2|<45 Years||Age, Customized||participants|Number|276|276.0||||||
4406114|NCT00251693|4232237|B1|<45 Years||Age, Customized||participants|Number|269|269.0||||||
4406115|NCT00251641|4232262|B3||Male|Sex: Female, Male||Participants|Count of Participants|586|586.0||||||
4406116|NCT00251641|4232263|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4406117|NCT00251641|4232264|B1||Male|Sex: Female, Male||Participants|Count of Participants|438|438.0||||||
4406118|NCT00251641|4232262|B3||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4406119|NCT00251641|4232263|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4406120|NCT00251641|4232264|B1||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4406121|NCT00251641|4232262|B3|||Age||years|Mean|43.6|43.6|Full Range|||18.0|78.0|
4406122|NCT00251641|4232263|B2|||Age||years|Mean|41.9|41.9|Full Range|||18.0|69.0|
4406123|NCT00251641|4232264|B1|||Age||years|Mean|44.1|44.1|Full Range|||18.0|78.0|
4406124|NCT00251589|4232279|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4406125|NCT00251589|4232280|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4406126|NCT00251589|4232281|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4406127|NCT00251589|4232282|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4406128|NCT00251589|4232283|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4406129|NCT00251589|4232279|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4406130|NCT00251589|4232280|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4406131|NCT00251589|4232281|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4406132|NCT00251589|4232282|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4406133|NCT00251589|4232283|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4406134|NCT00251589|4232279|B5|> 65 years||Age, Customized||Participants|Number|6|6.0||||||
4406135|NCT00251589|4232280|B4|> 65 years||Age, Customized||Participants|Number|0|0.0||||||
4406136|NCT00251589|4232281|B3|> 65 years||Age, Customized||Participants|Number|1|1.0||||||
4406137|NCT00251589|4232282|B2|> 65 years||Age, Customized||Participants|Number|0|0.0||||||
4406138|NCT00251589|4232283|B1|> 65 years||Age, Customized||Participants|Number|5|5.0||||||
4406139|NCT00251589|4232279|B5|≤ 65 years||Age, Customized||Participants|Number|17|17.0||||||
4406140|NCT00251589|4232280|B4|≤ 65 years||Age, Customized||Participants|Number|2|2.0||||||
4406141|NCT00251589|4232281|B3|≤ 65 years||Age, Customized||Participants|Number|1|1.0||||||
4406142|NCT00251589|4232282|B2|≤ 65 years||Age, Customized||Participants|Number|3|3.0||||||
4406143|NCT00251589|4232283|B1|≤ 65 years||Age, Customized||Participants|Number|11|11.0||||||
4406144|NCT00251589|4232279|B5|||Age||Years|Mean|60.7|60.7|Standard Deviation|11.41|11.41|||
4406145|NCT00251589|4232280|B4|||Age||Years|Mean|59.1|59.1|Standard Deviation|11.59|11.59|||
4406146|NCT00251589|4232281|B3|||Age||Years|Mean|48.5|48.5|Standard Deviation|20.51|20.51|||
4406147|NCT00251589|4232282|B2|||Age||Years|Mean|66.0|66.0|Standard Deviation|8.49|8.49|||
4406148|NCT00251589|4232283|B1|||Age||Years|Mean|53.0|53.0|Standard Deviation|4.36|4.36|||
4406149|NCT00251316|4232321|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4406150|NCT00251316|4232322|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4406151|NCT00251316|4232323|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4406152|NCT00251316|4232321|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4406153|NCT00251316|4232322|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4406154|NCT00251316|4232323|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4406155|NCT00251316|4232321|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4406156|NCT00251316|4232322|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4406157|NCT00251316|4232323|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4406158|NCT00251316|4232321|B3|African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4406159|NCT00251316|4232322|B2|African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4406160|NCT00251316|4232323|B1|African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4406161|NCT00251316|4232321|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4406162|NCT00251316|4232322|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4406163|NCT00251316|4232323|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4406164|NCT00251316|4232321|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4406165|NCT00251316|4232322|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4406166|NCT00251316|4232323|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4406167|NCT00251316|4232321|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|10.9|10.9|||
4406168|NCT00251316|4232322|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|10.2|10.2|||
4406169|NCT00251316|4232323|B1|||Age||years|Mean|39.8|39.8|Standard Deviation|11.8|11.8|||
4406170|NCT00251303|4232330|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4406171|NCT00251303|4232331|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4406172|NCT00251303|4232332|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4406173|NCT00251303|4232330|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4406174|NCT00251303|4232331|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4406175|NCT00251303|4232332|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4406176|NCT00251303|4232330|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4406177|NCT00251303|4232331|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4406178|NCT00251303|4232332|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4406179|NCT00251303|4232330|B3|||Age||years|Mean|14.47|14.47|Standard Deviation|2.35|2.35|||
4406180|NCT00251303|4232331|B2|||Age||years|Mean|14.17|14.17|Standard Deviation|2.58|2.58|||
4406181|NCT00251303|4232332|B1|||Age||years|Mean|14.78|14.78|Standard Deviation|2.10|2.1|||
4406182|NCT00251303|4232330|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406183|NCT00251303|4232331|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406184|NCT00251303|4232332|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406185|NCT00251303|4232330|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4406186|NCT00251303|4232331|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4406187|NCT00251303|4232332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4406188|NCT00251303|4232330|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4406189|NCT00251303|4232331|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4406190|NCT00251303|4232332|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4406191|NCT00251238|4232341|B3|Netherlands||Region of Enrollment||participants|Number|41|41.0||||||
4406192|NCT00251238|4232342|B2|Netherlands||Region of Enrollment||participants|Number|20|20.0||||||
4406193|NCT00251238|4232343|B1|Netherlands||Region of Enrollment||participants|Number|21|21.0||||||
4406194|NCT00251238|4232341|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4406195|NCT00251238|4232342|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4406196|NCT00251238|4232343|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4406197|NCT00251238|4232341|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4406198|NCT00251238|4232342|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4406199|NCT00251238|4232343|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4406200|NCT00251238|4232341|B3|||Age||years|Mean|48|48.0|Standard Deviation|13|13.0|||
4406201|NCT00251238|4232342|B2|||Age||years|Mean|49|49.0|Standard Deviation|13|13.0|||
4406202|NCT00251238|4232343|B1|||Age||years|Mean|47|47.0|Standard Deviation|13|13.0|||
4406203|NCT00251238|4232341|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4406204|NCT00251238|4232342|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4406205|NCT00251238|4232343|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4406206|NCT00251238|4232341|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4406207|NCT00251238|4232342|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4406208|NCT00251238|4232343|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4406209|NCT00251238|4232341|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406210|NCT00251238|4232342|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406211|NCT00251238|4232343|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406212|NCT00251225|4232354|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4406213|NCT00251225|4232354|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406214|NCT00251225|4232354|B1|||Age||years|Median|69|69.0|Full Range|||54.0|86.0|
4406215|NCT00251004|4232360|B4||Male|Sex: Female, Male||Participants|Count of Participants|557|557.0||||||
4406216|NCT00251004|4232361|B3||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4406217|NCT00251004|4232362|B2||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4406218|NCT00251004|4232363|B1||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4406219|NCT00251004|4232360|B4||Female|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4406220|NCT00251004|4232361|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4406221|NCT00251004|4232362|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4406222|NCT00251004|4232363|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4406223|NCT00251004|4232360|B4|||Age||Years|Mean|46.1|46.1|Standard Deviation|12.95|12.95|||
4406224|NCT00251004|4232361|B3|||Age||Years|Mean|47.2|47.2|Standard Deviation|12.74|12.74|||
4406225|NCT00251004|4232362|B2|||Age||Years|Mean|45.3|45.3|Standard Deviation|13.36|13.36|||
4406226|NCT00251004|4232363|B1|||Age||Years|Mean|45.7|45.7|Standard Deviation|12.72|12.72|||
4406227|NCT00250926|4232382|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4406228|NCT00250926|4232382|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4406229|NCT00250926|4232382|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4406230|NCT00250926|4232382|B1|||Age||years|Mean|67|67.0|Standard Deviation|10|10.0|||
4406231|NCT00250926|4232382|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4406232|NCT00250926|4232382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4406233|NCT00250926|4232382|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406234|NCT00250835|4232389|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4406235|NCT00250835|4232389|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4406236|NCT00250835|4232389|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4406237|NCT00250835|4232389|B1|||Age||years|Mean|52|52.0|Full Range|||20.0|69.0|
4406238|NCT00250718|4232398|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4406239|NCT00250718|4232398|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4406240|NCT00250718|4232398|B1|||Age||years|Median|56|56.0|Full Range|||23.0|71.0|
4406241|NCT00250705|4232403|B1|Use of Weapons||Children's Aggression Scale-Parent Version|"CAS-P is a 33 item scale representing 5 domains of aggression: Items in a domain were computed based on two reference points. The first was based on a 5 point frequency range with 0 being best (never) and 4 (> 10 times being) worst. These same items were then adjusted such that more severe acts would be weighted more heavily compared to less severe aggressive behaviors. Within a domain, 0 was the best score. Worst score for the various aggression domains were: Verbal 26.16, Against Objects and Animals 11.8, Provoked 15.84, Initiated 17.84, and Use of Weapons 13.16"|units on a scale|Mean|0.4|0.4|Standard Deviation|1.0|1.0|||
4406242|NCT00250705|4232403|B1|Initiated Aggression||Children's Aggression Scale-Parent Version|"CAS-P is a 33 item scale representing 5 domains of aggression: Items in a domain were computed based on two reference points. The first was based on a 5 point frequency range with 0 being best (never) and 4 (> 10 times being) worst. These same items were then adjusted such that more severe acts would be weighted more heavily compared to less severe aggressive behaviors. Within a domain, 0 was the best score. Worst score for the various aggression domains were: Verbal 26.16, Against Objects and Animals 11.8, Provoked 15.84, Initiated 17.84, and Use of Weapons 13.16"|units on a scale|Mean|1.6|1.6|Standard Deviation|2.0|2.0|||
4406243|NCT00250705|4232403|B1|Provoked Aggression||Children's Aggression Scale-Parent Version|"CAS-P is a 33 item scale representing 5 domains of aggression: Items in a domain were computed based on two reference points. The first was based on a 5 point frequency range with 0 being best (never) and 4 (> 10 times being) worst. These same items were then adjusted such that more severe acts would be weighted more heavily compared to less severe aggressive behaviors. Within a domain, 0 was the best score. Worst score for the various aggression domains were: Verbal 26.16, Against Objects and Animals 11.8, Provoked 15.84, Initiated 17.84, and Use of Weapons 13.16"|units on a scale|Mean|2.1|2.1|Standard Deviation|2.2|2.2|||
4406244|NCT00250705|4232403|B1|Agression Against Objects and Animals||Children's Aggression Scale-Parent Version|"CAS-P is a 33 item scale representing 5 domains of aggression: Items in a domain were computed based on two reference points. The first was based on a 5 point frequency range with 0 being best (never) and 4 (> 10 times being) worst. These same items were then adjusted such that more severe acts would be weighted more heavily compared to less severe aggressive behaviors. Within a domain, 0 was the best score. Worst score for the various aggression domains were: Verbal 26.16, Against Objects and Animals 11.8, Provoked 15.84, Initiated 17.84, and Use of Weapons 13.16"|units on a scale|Mean|3.8|3.8|Standard Deviation|2.2|2.2|||
4406245|NCT00250705|4232403|B1|Verbal Aggression||Children's Aggression Scale-Parent Version|"CAS-P is a 33 item scale representing 5 domains of aggression: Items in a domain were computed based on two reference points. The first was based on a 5 point frequency range with 0 being best (never) and 4 (> 10 times being) worst. These same items were then adjusted such that more severe acts would be weighted more heavily compared to less severe aggressive behaviors. Within a domain, 0 was the best score. Worst score for the various aggression domains were: Verbal 26.16, Against Objects and Animals 11.8, Provoked 15.84, Initiated 17.84, and Use of Weapons 13.16"|units on a scale|Mean|12.9|12.9|Standard Deviation|4.3|4.3|||
4406246|NCT00250705|4232403|B1|OAS-M, physical aggression||Overt Aggression Scale-Modified (OAS-M) (Kay et al 1988)|"OAS-M divides aggressions into 4 subtypes: 1) verbal, 2) property, 3) self (autoaggression), and 4) physical. Each subtype has an initial score ranging from 0 (least aggressive) to 4 (most aggressive). The score for each subscale is further weighed (multiplied) by a constant: verbal scale's constant is 1 (max adjusted score of 4); property scale's constant is 2 (max adjusted score 8); self scale's constant is 3 (max adjusted score 12); and physical scale's constant is 4 (max adjusted score of 16). Within a given scale, 0 is the best score and maximum adjusted scale score is worst."|weighted scores on a scale|Mean|4.5|4.5|Standard Deviation|3.9|3.9|||
4406247|NCT00250705|4232403|B1|OAS-M, autoaggression||Overt Aggression Scale-Modified (OAS-M) (Kay et al 1988)|"OAS-M divides aggressions into 4 subtypes: 1) verbal, 2) property, 3) self (autoaggression), and 4) physical. Each subtype has an initial score ranging from 0 (least aggressive) to 4 (most aggressive). The score for each subscale is further weighed (multiplied) by a constant: verbal scale's constant is 1 (max adjusted score of 4); property scale's constant is 2 (max adjusted score 8); self scale's constant is 3 (max adjusted score 12); and physical scale's constant is 4 (max adjusted score of 16). Within a given scale, 0 is the best score and maximum adjusted scale score is worst."|weighted scores on a scale|Mean|0.6|0.6|Standard Deviation|1.9|1.9|||
4406248|NCT00250705|4232403|B1|OAS-M, aggression against property||Overt Aggression Scale-Modified (OAS-M) (Kay et al 1988)|"OAS-M divides aggressions into 4 subtypes: 1) verbal, 2) property, 3) self (autoaggression), and 4) physical. Each subtype has an initial score ranging from 0 (least aggressive) to 4 (most aggressive). The score for each subscale is further weighed (multiplied) by a constant: verbal scale's constant is 1 (max adjusted score of 4); property scale's constant is 2 (max adjusted score 8); self scale's constant is 3 (max adjusted score 12); and physical scale's constant is 4 (max adjusted score of 16). Within a given scale, 0 is the best score and maximum adjusted scale score is worst."|weighted scores on a scale|Mean|4.2|4.2|Standard Deviation|3.0|3.0|||
4406249|NCT00250705|4232403|B1|OAS-M, verbal aggression||Overt Aggression Scale-Modified (OAS-M) (Kay et al 1988)|"OAS-M divides aggressions into 4 subtypes: 1) verbal, 2) property, 3) self (autoaggression), and 4) physical. Each subtype has an initial score ranging from 0 (least aggressive) to 4 (most aggressive). The score for each subscale is further weighed (multiplied) by a constant: verbal scale's constant is 1 (max adjusted score of 4); property scale's constant is 2 (max adjusted score 8); self scale's constant is 3 (max adjusted score 12); and physical scale's constant is 4 (max adjusted score of 16). Within a given scale, 0 is the best score and maximum adjusted scale score is worst."|weighted scores on a scale|Mean|2.2|2.2|Standard Deviation|1.2|1.2|||
4406285|NCT00250679|4232411|B4|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4406286|NCT00250679|4232412|B3|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4406287|NCT00250679|4232413|B2|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4406288|NCT00250679|4232414|B1|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4406377|NCT00250588|4232514|B4|United States||Region of Enrollment||participants|Number|252|252.0||||||
4406250|NCT00250705|4232403|B1|||Rating of Aggression Against People and/or Property Scale|Rating of Aggression Against People and/or Property Scale (RAAPP) (Kemph et al 1993) is a global rating scale of aggression completed by clinicians. Score given based on following severity scale with subject assigned 1 number: Intolerable behavior-frequently physically attacks others and destroys property (5); Severe-occasionally physically attacks people and destroys property (4); Moderately 21); and No aggressiveness reported (1). A minimum score of 1 is best and a maximum score of 5 is worst. There are no subscale scores.|scores on a scale|Mean|3.0|3.0|Standard Deviation|0.9|0.9|||
4406251|NCT00250705|4232403|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4406252|NCT00250705|4232403|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406253|NCT00250705|4232403|B1|||Age||years|Mean|14.6|14.6|Standard Deviation|1.1|1.1|||
4406254|NCT00250705|4232403|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406255|NCT00250705|4232403|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4406256|NCT00250705|4232403|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4406257|NCT00250679|4232411|B4|||Percent Predicted Forced Expiratory Volume (FEV1)|FEV1 stands for 'forced expiratory volume 1 second'. It is the amount of air that you can forcibly blow out in one second, measured in liters. FEV1 can be predicted using patients' height and age. This value is the percent of the predicted FEV1.|percent predicted FEV1|Mean|40.76|40.76|Standard Deviation|12.46|12.46|||
4406258|NCT00250679|4232412|B3|||Percent Predicted Forced Expiratory Volume (FEV1)|FEV1 stands for 'forced expiratory volume 1 second'. It is the amount of air that you can forcibly blow out in one second, measured in liters. FEV1 can be predicted using patients' height and age. This value is the percent of the predicted FEV1.|percent predicted FEV1|Mean|40.22|40.22|Standard Deviation|12.22|12.22|||
4406259|NCT00250679|4232413|B2|||Percent Predicted Forced Expiratory Volume (FEV1)|FEV1 stands for 'forced expiratory volume 1 second'. It is the amount of air that you can forcibly blow out in one second, measured in liters. FEV1 can be predicted using patients' height and age. This value is the percent of the predicted FEV1.|percent predicted FEV1|Mean|40.87|40.87|Standard Deviation|13.59|13.59|||
4406260|NCT00250679|4232414|B1|||Percent Predicted Forced Expiratory Volume (FEV1)|FEV1 stands for 'forced expiratory volume 1 second'. It is the amount of air that you can forcibly blow out in one second, measured in liters. FEV1 can be predicted using patients' height and age. This value is the percent of the predicted FEV1.|percent predicted FEV1|Mean|41.19|41.19|Standard Deviation|11.52|11.52|||
4406261|NCT00250679|4232411|B4|||Forced Expiratory Volume (FEV1)|FEV1 stands for 'forced expiratory volume 1 second'. It is the amount of air that you can forcibly blow out in one second, measured in liters|Liter|Mean|1.212|1.212|Standard Deviation|0.435|0.435|||
4406262|NCT00250679|4232412|B3|||Forced Expiratory Volume (FEV1)|FEV1 stands for 'forced expiratory volume 1 second'. It is the amount of air that you can forcibly blow out in one second, measured in liters|Liter|Mean|1.204|1.204|Standard Deviation|0.422|0.422|||
4406263|NCT00250679|4232413|B2|||Forced Expiratory Volume (FEV1)|FEV1 stands for 'forced expiratory volume 1 second'. It is the amount of air that you can forcibly blow out in one second, measured in liters|Liter|Mean|1.222|1.222|Standard Deviation|0.465|0.465|||
4406264|NCT00250679|4232414|B1|||Forced Expiratory Volume (FEV1)|FEV1 stands for 'forced expiratory volume 1 second'. It is the amount of air that you can forcibly blow out in one second, measured in liters|Liter|Mean|1.210|1.21|Standard Deviation|0.420|0.42|||
4406265|NCT00250679|4232411|B4|||Baseline Dyspnea Index|Baseline Dyspnea Index (range 0-12) is defined to be the sum of the Functional Impairment, Magnitude of Task, and Magnitude of Effort scores (each on a 0-4 scale) obtained at visit 2 (baseline). On each scale, a high measurement represents the most impairment to health.|units on a scale|Mean|5.26|5.26|Standard Deviation|2.09|2.09|||
4406266|NCT00250679|4232412|B3|||Baseline Dyspnea Index|Baseline Dyspnea Index (range 0-12) is defined to be the sum of the Functional Impairment, Magnitude of Task, and Magnitude of Effort scores (each on a 0-4 scale) obtained at visit 2 (baseline). On each scale, a high measurement represents the most impairment to health.|units on a scale|Mean|5.10|5.1|Standard Deviation|2.38|2.38|||
4406267|NCT00250679|4232413|B2|||Baseline Dyspnea Index|Baseline Dyspnea Index (range 0-12) is defined to be the sum of the Functional Impairment, Magnitude of Task, and Magnitude of Effort scores (each on a 0-4 scale) obtained at visit 2 (baseline). On each scale, a high measurement represents the most impairment to health.|units on a scale|Mean|5.34|5.34|Standard Deviation|2.18|2.18|||
4406268|NCT00250679|4232414|B1|||Baseline Dyspnea Index|Baseline Dyspnea Index (range 0-12) is defined to be the sum of the Functional Impairment, Magnitude of Task, and Magnitude of Effort scores (each on a 0-4 scale) obtained at visit 2 (baseline). On each scale, a high measurement represents the most impairment to health.|units on a scale|Mean|5.34|5.34|Standard Deviation|1.72|1.72|||
4406269|NCT00250679|4232411|B4|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4406270|NCT00250679|4232412|B3|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4406271|NCT00250679|4232413|B2|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4406272|NCT00250679|4232414|B1|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4406273|NCT00250679|4232411|B4|Hispanic||Race/Ethnicity||participants|Number|4|4.0||||||
4406274|NCT00250679|4232412|B3|Hispanic||Race/Ethnicity||participants|Number|2|2.0||||||
4406275|NCT00250679|4232413|B2|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4406276|NCT00250679|4232414|B1|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4406277|NCT00250679|4232411|B4|Caucasian||Race/Ethnicity||participants|Number|375|375.0||||||
4406278|NCT00250679|4232412|B3|Caucasian||Race/Ethnicity||participants|Number|122|122.0||||||
4406279|NCT00250679|4232413|B2|Caucasian||Race/Ethnicity||participants|Number|126|126.0||||||
4406280|NCT00250679|4232414|B1|Caucasian||Race/Ethnicity||participants|Number|127|127.0||||||
4406281|NCT00250679|4232411|B4|Black or African American||Race/Ethnicity||participants|Number|63|63.0||||||
4406282|NCT00250679|4232412|B3|Black or African American||Race/Ethnicity||participants|Number|23|23.0||||||
4406283|NCT00250679|4232413|B2|Black or African American||Race/Ethnicity||participants|Number|21|21.0||||||
4406284|NCT00250679|4232414|B1|Black or African American||Race/Ethnicity||participants|Number|19|19.0||||||
4406289|NCT00250679|4232411|B4|No||Oral or Inhaled Steroid Use|Number of participants taking oral or inhaled corticosteriod at baseline. These were allowed at study entry and for the duration of the study as long as the regimen was stable for at least 14 days prior to entry and throughout the study.|participants|Number|273|273.0||||||
4406290|NCT00250679|4232412|B3|No||Oral or Inhaled Steroid Use|Number of participants taking oral or inhaled corticosteriod at baseline. These were allowed at study entry and for the duration of the study as long as the regimen was stable for at least 14 days prior to entry and throughout the study.|participants|Number|88|88.0||||||
4406291|NCT00250679|4232413|B2|No||Oral or Inhaled Steroid Use|Number of participants taking oral or inhaled corticosteriod at baseline. These were allowed at study entry and for the duration of the study as long as the regimen was stable for at least 14 days prior to entry and throughout the study.|participants|Number|90|90.0||||||
4406292|NCT00250679|4232414|B1|No||Oral or Inhaled Steroid Use|Number of participants taking oral or inhaled corticosteriod at baseline. These were allowed at study entry and for the duration of the study as long as the regimen was stable for at least 14 days prior to entry and throughout the study.|participants|Number|95|95.0||||||
4406293|NCT00250679|4232411|B4|Yes||Oral or Inhaled Steroid Use|Number of participants taking oral or inhaled corticosteriod at baseline. These were allowed at study entry and for the duration of the study as long as the regimen was stable for at least 14 days prior to entry and throughout the study.|participants|Number|170|170.0||||||
4406294|NCT00250679|4232412|B3|Yes||Oral or Inhaled Steroid Use|Number of participants taking oral or inhaled corticosteriod at baseline. These were allowed at study entry and for the duration of the study as long as the regimen was stable for at least 14 days prior to entry and throughout the study.|participants|Number|59|59.0||||||
4406295|NCT00250679|4232413|B2|Yes||Oral or Inhaled Steroid Use|Number of participants taking oral or inhaled corticosteriod at baseline. These were allowed at study entry and for the duration of the study as long as the regimen was stable for at least 14 days prior to entry and throughout the study.|participants|Number|59|59.0||||||
4406296|NCT00250679|4232414|B1|Yes||Oral or Inhaled Steroid Use|Number of participants taking oral or inhaled corticosteriod at baseline. These were allowed at study entry and for the duration of the study as long as the regimen was stable for at least 14 days prior to entry and throughout the study.|participants|Number|52|52.0||||||
4406297|NCT00250679|4232411|B4|>= 30 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|378|378.0||||||
4406298|NCT00250679|4232412|B3|>= 30 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|123|123.0||||||
4406299|NCT00250679|4232413|B2|>= 30 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|126|126.0||||||
4406300|NCT00250679|4232414|B1|>= 30 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|129|129.0||||||
4406301|NCT00250679|4232411|B4|>= 25 - < 30 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|31|31.0||||||
4406302|NCT00250679|4232412|B3|>= 25 - < 30 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|11|11.0||||||
4406303|NCT00250679|4232413|B2|>= 25 - < 30 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|10|10.0||||||
4406304|NCT00250679|4232414|B1|>= 25 - < 30 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|10|10.0||||||
4406305|NCT00250679|4232411|B4|>= 15 - < 25 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|34|34.0||||||
4406306|NCT00250679|4232412|B3|>= 15 - < 25 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|13|13.0||||||
4406307|NCT00250679|4232413|B2|>= 15 - < 25 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|13|13.0||||||
4406308|NCT00250679|4232414|B1|>= 15 - < 25 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|8|8.0||||||
4406309|NCT00250679|4232411|B4|< 15 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|0|0.0||||||
4406310|NCT00250679|4232412|B3|< 15 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|0|0.0||||||
4406311|NCT00250679|4232413|B2|< 15 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|0|0.0||||||
4406312|NCT00250679|4232414|B1|< 15 pack years smoked||Number of Pack-Years Smoked|Number of participants with a specified number range of pack years smoked. Number of pack years smoked is defined as the number of cigarette packs smoked per day times the number of years smoked.|participants|Number|0|0.0||||||
4406313|NCT00250679|4232411|B4|>4 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|0|0.0||||||
4406314|NCT00250679|4232412|B3|>4 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|0|0.0||||||
4406315|NCT00250679|4232413|B2|>4 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|0|0.0||||||
4406316|NCT00250679|4232414|B1|>4 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|0|0.0||||||
4406317|NCT00250679|4232411|B4|>2 - <=4 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|7|7.0||||||
4406318|NCT00250679|4232412|B3|>2 - <=4 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|4|4.0||||||
4406319|NCT00250679|4232413|B2|>2 - <=4 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|1|1.0||||||
4406320|NCT00250679|4232414|B1|>2 - <=4 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|2|2.0||||||
4406321|NCT00250679|4232411|B4|>1 - <=2 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|52|52.0||||||
4406322|NCT00250679|4232412|B3|>1 - <=2 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|17|17.0||||||
4406323|NCT00250679|4232413|B2|>1 - <=2 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|21|21.0||||||
4406324|NCT00250679|4232414|B1|>1 - <=2 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|14|14.0||||||
4406325|NCT00250679|4232411|B4|>0 - <=1 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|141|141.0||||||
4406326|NCT00250679|4232412|B3|>0 - <=1 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|44|44.0||||||
4406327|NCT00250679|4232413|B2|>0 - <=1 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|38|38.0||||||
4406328|NCT00250679|4232414|B1|>0 - <=1 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|59|59.0||||||
4406329|NCT00250679|4232411|B4|0 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|243|243.0||||||
4406330|NCT00250679|4232412|B3|0 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|82|82.0||||||
4406331|NCT00250679|4232413|B2|0 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|89|89.0||||||
4406332|NCT00250679|4232414|B1|0 packs per day||# Packs Currently Smoked Per Day|Number of participants with a specified range of packs of cigarettes smoked per day.|participants|Number|72|72.0||||||
4406333|NCT00250679|4232411|B4|>2 exacerbations||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|1|1.0||||||
4406334|NCT00250679|4232412|B3|>2 exacerbations||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|1|1.0||||||
4406335|NCT00250679|4232413|B2|>2 exacerbations||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|0|0.0||||||
4406336|NCT00250679|4232414|B1|>2 exacerbations||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|0|0.0||||||
4406337|NCT00250679|4232411|B4|2 exacerbations||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|0|0.0||||||
4406338|NCT00250679|4232412|B3|2 exacerbations||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|0|0.0||||||
4406375|NCT00250679|4232413|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406376|NCT00250679|4232414|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406339|NCT00250679|4232413|B2|2 exacerbations||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|0|0.0||||||
4406340|NCT00250679|4232414|B1|2 exacerbations||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|0|0.0||||||
4406341|NCT00250679|4232411|B4|1 exacerbation||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|4|4.0||||||
4406342|NCT00250679|4232412|B3|1 exacerbation||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|1|1.0||||||
4406343|NCT00250679|4232413|B2|1 exacerbation||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|2|2.0||||||
4406344|NCT00250679|4232414|B1|1 exacerbation||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|1|1.0||||||
4406345|NCT00250679|4232411|B4|0 exacerbations||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|438|438.0||||||
4406346|NCT00250679|4232412|B3|0 exacerbations||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|145|145.0||||||
4406347|NCT00250679|4232413|B2|0 exacerbations||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|147|147.0||||||
4406348|NCT00250679|4232414|B1|0 exacerbations||# Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in 30 days prior to screening|Number of patients with a specified number of COPD exacerbations in the 30 days prior to screening. COPD stands for 'chronic obstructive pulmonary disease' and is a progressive disease that makes it hard to breath. Exacerbations refers to a worsening of the condition.|participants|Number|146|146.0||||||
4406349|NCT00250679|4232411|B4|United States||Region of Enrollment||participants|Number|443|443.0||||||
4406350|NCT00250679|4232412|B3|United States||Region of Enrollment||participants|Number|147|147.0||||||
4406351|NCT00250679|4232413|B2|United States||Region of Enrollment||participants|Number|149|149.0||||||
4406352|NCT00250679|4232414|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
4406353|NCT00250679|4232411|B4||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4406354|NCT00250679|4232412|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4406355|NCT00250679|4232413|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4406356|NCT00250679|4232414|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4406357|NCT00250679|4232411|B4||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4406358|NCT00250679|4232412|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4406359|NCT00250679|4232413|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4406360|NCT00250679|4232414|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4406361|NCT00250679|4232411|B4|||Age||years|Mean|64.4|64.4|Standard Deviation|8.5|8.5|||
4406362|NCT00250679|4232412|B3|||Age||years|Mean|63.8|63.8|Standard Deviation|8.6|8.6|||
4406363|NCT00250679|4232413|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|9.0|9.0|||
4406364|NCT00250679|4232414|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|7.8|7.8|||
4406365|NCT00250679|4232411|B4||>=65 years|Age||Participants|Count of Participants|218|218.0||||||
4406366|NCT00250679|4232412|B3||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
4406367|NCT00250679|4232413|B2||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
4406368|NCT00250679|4232414|B1||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
4406369|NCT00250679|4232411|B4||Between 18 and 65 years|Age||Participants|Count of Participants|225|225.0||||||
4406370|NCT00250679|4232412|B3||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4406371|NCT00250679|4232413|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4406372|NCT00250679|4232414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4406373|NCT00250679|4232411|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406374|NCT00250679|4232412|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406378|NCT00250588|4232515|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4406379|NCT00250588|4232516|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
4406380|NCT00250588|4232517|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4406381|NCT00250588|4232514|B4||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4406382|NCT00250588|4232515|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4406383|NCT00250588|4232516|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4406384|NCT00250588|4232517|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4406385|NCT00250588|4232514|B4||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4406386|NCT00250588|4232515|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4406387|NCT00250588|4232516|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4406388|NCT00250588|4232517|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4406389|NCT00250588|4232514|B4|||Age||years|Mean|7.37|7.37|Standard Deviation|3.07|3.07|||
4406390|NCT00250588|4232515|B3|||Age||years|Mean|7.26|7.26|Standard Deviation|3.02|3.02|||
4406391|NCT00250588|4232516|B2|||Age||years|Mean|7.37|7.37|Standard Deviation|3.1|3.1|||
4406392|NCT00250588|4232517|B1|||Age||years|Mean|7.47|7.47|Standard Deviation|3.13|3.13|||
4406393|NCT00250588|4232514|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406394|NCT00250588|4232515|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406395|NCT00250588|4232516|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406396|NCT00250588|4232517|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406397|NCT00250588|4232514|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4406398|NCT00250588|4232515|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4406399|NCT00250588|4232516|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4406400|NCT00250588|4232517|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4406401|NCT00250588|4232514|B4||<=18 years|Age||Participants|Count of Participants|252|252.0||||||
4406402|NCT00250588|4232515|B3||<=18 years|Age||Participants|Count of Participants|87|87.0||||||
4406403|NCT00250588|4232516|B2||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
4406404|NCT00250588|4232517|B1||<=18 years|Age||Participants|Count of Participants|81|81.0||||||
4406405|NCT00250497|4232533|B3|United States||Region of Enrollment||participants|Number|356|356.0||||||
4406406|NCT00250497|4232534|B2|United States||Region of Enrollment||participants|Number|174|174.0||||||
4406407|NCT00250497|4232535|B1|United States||Region of Enrollment||participants|Number|182|182.0||||||
4406408|NCT00250497|4232533|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406409|NCT00250497|4232534|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406410|NCT00250497|4232535|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406411|NCT00250497|4232533|B3||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4406412|NCT00250497|4232534|B2||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4406413|NCT00250497|4232535|B1||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4406414|NCT00250497|4232533|B3|||Age||years|Mean|15.8|15.8|Standard Deviation|1.17|1.17|||
4406415|NCT00250497|4232534|B2|||Age||years|Mean|15.8|15.8|Standard Deviation|1.22|1.22|||
4406416|NCT00250497|4232535|B1|||Age||years|Mean|15.7|15.7|Standard Deviation|1.13|1.13|||
4406417|NCT00250497|4232533|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406418|NCT00250497|4232534|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406419|NCT00250497|4232535|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406420|NCT00250497|4232533|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4406421|NCT00250497|4232534|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4406422|NCT00250497|4232535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4406423|NCT00250497|4232533|B3||<=18 years|Age||Participants|Count of Participants|339|339.0||||||
4406424|NCT00250497|4232534|B2||<=18 years|Age||Participants|Count of Participants|165|165.0||||||
4406425|NCT00250497|4232535|B1||<=18 years|Age||Participants|Count of Participants|174|174.0||||||
4406426|NCT00250484|4232552|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4406427|NCT00250484|4232553|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4406428|NCT00250484|4232554|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4406429|NCT00250484|4232552|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4406430|NCT00250484|4232553|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4406431|NCT00250484|4232554|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4406432|NCT00250484|4232552|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4406433|NCT00250484|4232553|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4406434|NCT00250484|4232554|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4406435|NCT00250484|4232552|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|11.9|11.9|||
4406436|NCT00250484|4232553|B2|||Age||years|Mean|46.71|46.71|Standard Deviation|13.03|13.03|||
4406437|NCT00250484|4232554|B1|||Age||years|Mean|41.11|41.11|Standard Deviation|11.27|11.27|||
4406438|NCT00250484|4232552|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406439|NCT00250484|4232553|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406440|NCT00250484|4232554|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406441|NCT00250484|4232552|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4406442|NCT00250484|4232553|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4406443|NCT00250484|4232554|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4406444|NCT00250484|4232552|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406445|NCT00250484|4232553|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406446|NCT00250484|4232554|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406447|NCT00250458|4232565|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4406448|NCT00250458|4232566|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4406449|NCT00250458|4232567|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4406450|NCT00250458|4232565|B3||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4406451|NCT00250458|4232566|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4406452|NCT00250458|4232567|B1||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4406453|NCT00250458|4232565|B3|||Age||Years|Mean|40|40.0|Full Range|||18.0|65.0|
4406454|NCT00250458|4232566|B2|||Age||Years|Mean|41|41.0|Full Range|||18.0|60.0|
4406455|NCT00250458|4232567|B1|||Age||Years|Mean|40|40.0|Full Range|||18.0|65.0|
4406456|NCT00250432|4232576|B3|||APACHE II Score (at Study Entry)|APACHE (Acute Physiology and Chronic Health Evaluation) is a system of classifying severity of illnesses in intensive care patients. The possible range of values is 0 (minimum severity) to 71 (maximum severity).|Units on a Scale|Mean|16.8|16.8|Full Range|||2.0|39.0|
4406457|NCT00250432|4232577|B2|||APACHE II Score (at Study Entry)|APACHE (Acute Physiology and Chronic Health Evaluation) is a system of classifying severity of illnesses in intensive care patients. The possible range of values is 0 (minimum severity) to 71 (maximum severity).|Units on a Scale|Mean|17.0|17.0|Full Range|||2.0|39.0|
4406458|NCT00250432|4232578|B1|||APACHE II Score (at Study Entry)|APACHE (Acute Physiology and Chronic Health Evaluation) is a system of classifying severity of illnesses in intensive care patients. The possible range of values is 0 (minimum severity) to 71 (maximum severity).|Units on a Scale|Mean|16.5|16.5|Full Range|||3.0|38.0|
4406459|NCT00250432|4232576|B3|Pleural fluid (Empyema)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|1|1.0||||||
4406460|NCT00250432|4232577|B2|Pleural fluid (Empyema)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|0|0.0||||||
4406461|NCT00250432|4232578|B1|Pleural fluid (Empyema)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|1|1.0||||||
4406462|NCT00250432|4232576|B3|Peritoneal fluid (Peritonitis)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|9|9.0||||||
4406463|NCT00250432|4232577|B2|Peritoneal fluid (Peritonitis)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|5|5.0||||||
4406464|NCT00250432|4232578|B1|Peritoneal fluid (Peritonitis)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|4|4.0||||||
4406465|NCT00250432|4232576|B3|Lung (Pneumonia)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|2|2.0||||||
4406466|NCT00250432|4232577|B2|Lung (Pneumonia)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|1|1.0||||||
4406467|NCT00250432|4232578|B1|Lung (Pneumonia)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|1|1.0||||||
4406468|NCT00250432|4232576|B3|Kidney (Pyelonephritis)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|1|1.0||||||
4406469|NCT00250432|4232577|B2|Kidney (Pyelonephritis)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|1|1.0||||||
4406470|NCT00250432|4232578|B1|Kidney (Pyelonephritis)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|0|0.0||||||
4406471|NCT00250432|4232576|B3|Fungemia (non Candida)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|2|2.0||||||
4406472|NCT00250432|4232577|B2|Fungemia (non Candida)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|2|2.0||||||
4406473|NCT00250432|4232578|B1|Fungemia (non Candida)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|0|0.0||||||
4406474|NCT00250432|4232576|B3|Chronic disseminated candidiasis (hepatosplenic)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|1|1.0||||||
4406475|NCT00250432|4232577|B2|Chronic disseminated candidiasis (hepatosplenic)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|0|0.0||||||
4406476|NCT00250432|4232578|B1|Chronic disseminated candidiasis (hepatosplenic)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|1|1.0||||||
4406477|NCT00250432|4232576|B3|Blood (candidemia)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|172|172.0||||||
4406478|NCT00250432|4232577|B2|Blood (candidemia)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|81|81.0||||||
4406479|NCT00250432|4232578|B1|Blood (candidemia)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|91|91.0||||||
4406480|NCT00250432|4232576|B3|Acute disseminated candidiasis or multiple sites||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|13|13.0||||||
4406481|NCT00250432|4232577|B2|Acute disseminated candidiasis or multiple sites||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|7|7.0||||||
4406482|NCT00250432|4232578|B1|Acute disseminated candidiasis or multiple sites||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|6|6.0||||||
4406483|NCT00250432|4232576|B3|Abscess (involving a non-abdominal site)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|1|1.0||||||
4406484|NCT00250432|4232577|B2|Abscess (involving a non-abdominal site)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|1|1.0||||||
4406485|NCT00250432|4232578|B1|Abscess (involving a non-abdominal site)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|0|0.0||||||
4406486|NCT00250432|4232576|B3|Abscess(involving an intra-abdominal site)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|2|2.0||||||
4406487|NCT00250432|4232577|B2|Abscess(involving an intra-abdominal site)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|2|2.0||||||
4406488|NCT00250432|4232578|B1|Abscess(involving an intra-abdominal site)||Site Of Invasive Candida Infection|"This table lists the site of invasive candidiasis. Patients are included in only 1 category. Patients with more than 1 site of infection are counted under Acute disseminated candidiasis or multiple sites."|Participants|Number|0|0.0||||||
4406489|NCT00250432|4232576|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4406490|NCT00250432|4232577|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4406491|NCT00250432|4232578|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4406492|NCT00250432|4232576|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4406493|NCT00250432|4232577|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4406494|NCT00250432|4232578|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4406495|NCT00250432|4232576|B3|Asian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4406496|NCT00250432|4232577|B2|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4406497|NCT00250432|4232578|B1|Asian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4406498|NCT00250432|4232576|B3|Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4406499|NCT00250432|4232577|B2|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4406500|NCT00250432|4232578|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4406501|NCT00250432|4232576|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|135|135.0||||||
4406502|NCT00250432|4232577|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4406503|NCT00250432|4232578|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4406504|NCT00250432|4232576|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4406505|NCT00250432|4232577|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4406506|NCT00250432|4232578|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4406507|NCT00250432|4232576|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4406508|NCT00250432|4232577|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4406509|NCT00250432|4232578|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4406510|NCT00250432|4232576|B3|||Age||years|Mean|56.9|56.9|Full Range|||16.0|90.0|
4406511|NCT00250432|4232577|B2|||Age||years|Mean|57.8|57.8|Full Range|||20.0|87.0|
4406512|NCT00250432|4232578|B1|||Age||years|Mean|56.0|56.0|Full Range|||16.0|90.0|
4406513|NCT00250276|4232587|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406514|NCT00250276|4232588|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406515|NCT00250276|4232589|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406516|NCT00250276|4232590|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406517|NCT00250276|4232591|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406518|NCT00250276|4232587|B5||Female|Sex: Female, Male||Participants|Count of Participants|798|798.0||||||
4406519|NCT00250276|4232588|B4||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4406520|NCT00250276|4232589|B3||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4406521|NCT00250276|4232590|B2||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4406522|NCT00250276|4232591|B1||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4406523|NCT00250276|4232587|B5|||Age||Years|Mean|21.88|21.88|Standard Deviation|2.03|2.03|||
4406524|NCT00250276|4232588|B4|||Age||Years|Mean|22.0|22.0|Standard Deviation|1.96|1.96|||
4406525|NCT00250276|4232589|B3|||Age||Years|Mean|21.9|21.9|Standard Deviation|2.00|2.0|||
4406526|NCT00250276|4232590|B2|||Age||Years|Mean|21.8|21.8|Standard Deviation|2.08|2.08|||
4406527|NCT00250276|4232591|B1|||Age||Years|Mean|21.8|21.8|Standard Deviation|2.08|2.08|||
4406528|NCT00249873|4232672|B3|||Body Mass Index (BMI)||kg/m²|Mean|28.415|28.415|Standard Deviation|5.803|5.803|||
4406529|NCT00249873|4232673|B2|||Body Mass Index (BMI)||kg/m²|Mean|28.459|28.459|Standard Deviation|6.022|6.022|||
4406530|NCT00249873|4232674|B1|||Body Mass Index (BMI)||kg/m²|Mean|28.370|28.37|Standard Deviation|5.575|5.575|||
4406531|NCT00249873|4232672|B3|Missing||Sitting Systolic Blood Pressure||participants|Number|6|6.0||||||
4406532|NCT00249873|4232673|B2|Missing||Sitting Systolic Blood Pressure||participants|Number|3|3.0||||||
4406533|NCT00249873|4232674|B1|Missing||Sitting Systolic Blood Pressure||participants|Number|3|3.0||||||
4406534|NCT00249873|4232672|B3|>=120 mmHg||Sitting Systolic Blood Pressure||participants|Number|6325|6325.0||||||
4406535|NCT00249873|4232673|B2|>=120 mmHg||Sitting Systolic Blood Pressure||participants|Number|3159|3159.0||||||
4406536|NCT00249873|4232674|B1|>=120 mmHg||Sitting Systolic Blood Pressure||participants|Number|3166|3166.0||||||
4406537|NCT00249873|4232672|B3|<120 mmHg||Sitting Systolic Blood Pressure||participants|Number|1223|1223.0||||||
4406538|NCT00249873|4232673|B2|<120 mmHg||Sitting Systolic Blood Pressure||participants|Number|620|620.0||||||
4406539|NCT00249873|4232674|B1|<120 mmHg||Sitting Systolic Blood Pressure||participants|Number|603|603.0||||||
4406540|NCT00249873|4232672|B3|Missing||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|4|4.0||||||
4406541|NCT00249873|4232673|B2|Missing||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|0|0.0||||||
4406542|NCT00249873|4232674|B1|Missing||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|4|4.0||||||
4406543|NCT00249873|4232672|B3|>2||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|2068|2068.0||||||
4406544|NCT00249873|4232673|B2|>2||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|1028|1028.0||||||
4406545|NCT00249873|4232674|B1|>2||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|1040|1040.0||||||
4406582|NCT00249834|4232687|B9||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4406583|NCT00249834|4232688|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4406584|NCT00249834|4232689|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4406546|NCT00249873|4232672|B3|2||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|2578|2578.0||||||
4406547|NCT00249873|4232673|B2|2||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|1315|1315.0||||||
4406548|NCT00249873|4232674|B1|2||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|1263|1263.0||||||
4406549|NCT00249873|4232672|B3|1||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|2698|2698.0||||||
4406550|NCT00249873|4232673|B2|1||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|1338|1338.0||||||
4406551|NCT00249873|4232674|B1|1||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|1360|1360.0||||||
4406552|NCT00249873|4232672|B3|0||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|206|206.0||||||
4406553|NCT00249873|4232673|B2|0||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|101|101.0||||||
4406554|NCT00249873|4232674|B1|0||CHADS2 Score|CHADS2 score is the Congestive heart failure, High blood pressure, Age, Diabetes, Stroke 2 score. It is a validated clinical prediction rule for determining the risk of stroke. It assigns points (0-6) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke. A high score means higher risk of stroke.|participants|Number|105|105.0||||||
4406555|NCT00249873|4232672|B3||Male|Sex: Female, Male||Participants|Count of Participants|4397|4397.0||||||
4406556|NCT00249873|4232673|B2||Male|Sex: Female, Male||Participants|Count of Participants|2185|2185.0||||||
4406557|NCT00249873|4232674|B1||Male|Sex: Female, Male||Participants|Count of Participants|2212|2212.0||||||
4406558|NCT00249873|4232672|B3||Female|Sex: Female, Male||Participants|Count of Participants|3157|3157.0||||||
4406559|NCT00249873|4232673|B2||Female|Sex: Female, Male||Participants|Count of Participants|1597|1597.0||||||
4406560|NCT00249873|4232674|B1||Female|Sex: Female, Male||Participants|Count of Participants|1560|1560.0||||||
4406561|NCT00249873|4232672|B3|||Age||years|Mean|71.0|71.0|Standard Deviation|10.2|10.2|||
4406562|NCT00249873|4232673|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|10.2|10.2|||
4406563|NCT00249873|4232674|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|10.2|10.2|||
4406564|NCT00249873|4232672|B3|>= 75 years||Age, Customized||participants|Number|3139|3139.0||||||
4406565|NCT00249873|4232673|B2|>= 75 years||Age, Customized||participants|Number|1589|1589.0||||||
4406566|NCT00249873|4232674|B1|>= 75 years||Age, Customized||participants|Number|1550|1550.0||||||
4406567|NCT00249873|4232672|B3|65 to <75 years||Age, Customized||participants|Number|2549|2549.0||||||
4406568|NCT00249873|4232673|B2|65 to <75 years||Age, Customized||participants|Number|1258|1258.0||||||
4406569|NCT00249873|4232674|B1|65 to <75 years||Age, Customized||participants|Number|1291|1291.0||||||
4406570|NCT00249873|4232672|B3|18 to <65 years||Age, Customized||participants|Number|1866|1866.0||||||
4406571|NCT00249873|4232673|B2|18 to <65 years||Age, Customized||participants|Number|935|935.0||||||
4406572|NCT00249873|4232674|B1|18 to <65 years||Age, Customized||participants|Number|931|931.0||||||
4406573|NCT00249834|4232687|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406574|NCT00249834|4232688|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406575|NCT00249834|4232689|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406576|NCT00249834|4232690|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406577|NCT00249834|4232691|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406578|NCT00249834|4232692|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406579|NCT00249834|4232693|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406580|NCT00249834|4232694|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406581|NCT00249834|4232695|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406585|NCT00249834|4232690|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4406586|NCT00249834|4232691|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4406587|NCT00249834|4232692|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4406588|NCT00249834|4232693|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4406589|NCT00249834|4232694|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4406590|NCT00249834|4232695|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4406591|NCT00249834|4232687|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406592|NCT00249834|4232688|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406593|NCT00249834|4232689|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406594|NCT00249834|4232690|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406595|NCT00249834|4232691|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406596|NCT00249834|4232692|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406597|NCT00249834|4232693|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406598|NCT00249834|4232694|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406599|NCT00249834|4232695|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406600|NCT00249834|4232687|B9||Between 18 and 65 years|Age||Participants|Count of Participants|166|166.0||||||
4406601|NCT00249834|4232688|B8||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4406602|NCT00249834|4232689|B7||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4406603|NCT00249834|4232690|B6||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4406604|NCT00249834|4232691|B5||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4406605|NCT00249834|4232692|B4||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4406606|NCT00249834|4232693|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4406607|NCT00249834|4232694|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4406608|NCT00249834|4232695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4406609|NCT00249834|4232687|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406610|NCT00249834|4232688|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406611|NCT00249834|4232689|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406612|NCT00249834|4232690|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406613|NCT00249834|4232691|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406614|NCT00249834|4232692|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406615|NCT00249834|4232693|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406616|NCT00249834|4232694|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406617|NCT00249834|4232695|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406618|NCT00249821|4232749|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4406619|NCT00249821|4232750|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4406620|NCT00249821|4232751|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4406621|NCT00249821|4232749|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4406622|NCT00249821|4232750|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4406623|NCT00249821|4232751|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4406624|NCT00249821|4232749|B3|||Age||years|Mean|8.00|8.0|Standard Deviation|1.17|1.17|||
4406625|NCT00249821|4232750|B2|||Age||years|Mean|7.90|7.9|Standard Deviation|0.90|0.9|||
4406626|NCT00249821|4232751|B1|||Age||years|Mean|8.00|8.0|Standard Deviation|1.49|1.49|||
4406627|NCT00249808|4232772|B1||Male|Sex: Female, Male||Participants|Count of Participants|860|860.0||||||
4406628|NCT00249808|4232772|B1||Female|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4406629|NCT00249808|4232772|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|12.9|12.9|||
4406630|NCT00249795|4232778|B3|ACTIVE W: OAC||ACTIVE A / ACTIVE W|Distribution of the patients according to their initial randomization in the ACTIVE program|participants|Number|2048|2048.0||||||
4406631|NCT00249795|4232779|B2|ACTIVE W: OAC||ACTIVE A / ACTIVE W|Distribution of the patients according to their initial randomization in the ACTIVE program|participants|Number|1049|1049.0||||||
4406632|NCT00249795|4232780|B1|ACTIVE W: OAC||ACTIVE A / ACTIVE W|Distribution of the patients according to their initial randomization in the ACTIVE program|participants|Number|999|999.0||||||
4406633|NCT00249795|4232778|B3|ACTIVE W: clopidogrel + ASA||ACTIVE A / ACTIVE W|Distribution of the patients according to their initial randomization in the ACTIVE program|participants|Number|1970|1970.0||||||
4406634|NCT00249795|4232779|B2|ACTIVE W: clopidogrel + ASA||ACTIVE A / ACTIVE W|Distribution of the patients according to their initial randomization in the ACTIVE program|participants|Number|959|959.0||||||
4406635|NCT00249795|4232780|B1|ACTIVE W: clopidogrel + ASA||ACTIVE A / ACTIVE W|Distribution of the patients according to their initial randomization in the ACTIVE program|participants|Number|1011|1011.0||||||
4406636|NCT00249795|4232778|B3|ACTIVE A: ASA||ACTIVE A / ACTIVE W|Distribution of the patients according to their initial randomization in the ACTIVE program|participants|Number|2504|2504.0||||||
4406637|NCT00249795|4232779|B2|ACTIVE A: ASA||ACTIVE A / ACTIVE W|Distribution of the patients according to their initial randomization in the ACTIVE program|participants|Number|1259|1259.0||||||
4406638|NCT00249795|4232780|B1|ACTIVE A: ASA||ACTIVE A / ACTIVE W|Distribution of the patients according to their initial randomization in the ACTIVE program|participants|Number|1245|1245.0||||||
4406639|NCT00249795|4232778|B3|ACTIVE A: clopidogrel + ASA||ACTIVE A / ACTIVE W|Distribution of the patients according to their initial randomization in the ACTIVE program|participants|Number|2494|2494.0||||||
4406640|NCT00249795|4232779|B2|ACTIVE A: clopidogrel + ASA||ACTIVE A / ACTIVE W|Distribution of the patients according to their initial randomization in the ACTIVE program|participants|Number|1231|1231.0||||||
4406641|NCT00249795|4232780|B1|ACTIVE A: clopidogrel + ASA||ACTIVE A / ACTIVE W|Distribution of the patients according to their initial randomization in the ACTIVE program|participants|Number|1263|1263.0||||||
4406642|NCT00249795|4232778|B3|||Body Mass Index (BMI)||kg/m²|Mean|28.998|28.998|Standard Deviation|5.519|5.519|||
4406643|NCT00249795|4232779|B2|||Body Mass Index (BMI)||kg/m²|Mean|28.867|28.867|Standard Deviation|5.420|5.42|||
4406644|NCT00249795|4232780|B1|||Body Mass Index (BMI)||kg/m²|Mean|29.129|29.129|Standard Deviation|5.614|5.614|||
4406645|NCT00249795|4232778|B3|Missing||Sitting Systolic Blood Pressure||participants|Number|5|5.0||||||
4406646|NCT00249795|4232779|B2|Missing||Sitting Systolic Blood Pressure||participants|Number|2|2.0||||||
4406647|NCT00249795|4232780|B1|Missing||Sitting Systolic Blood Pressure||participants|Number|3|3.0||||||
4406648|NCT00249795|4232778|B3|>=120 mmHg||Sitting Systolic Blood Pressure||participants|Number|8002|8002.0||||||
4406649|NCT00249795|4232779|B2|>=120 mmHg||Sitting Systolic Blood Pressure||participants|Number|3996|3996.0||||||
4406650|NCT00249795|4232780|B1|>=120 mmHg||Sitting Systolic Blood Pressure||participants|Number|4006|4006.0||||||
4406651|NCT00249795|4232778|B3|<120 mmHg||Sitting Systolic Blood Pressure||participants|Number|1009|1009.0||||||
4406652|NCT00249795|4232779|B2|<120 mmHg||Sitting Systolic Blood Pressure||participants|Number|500|500.0||||||
4406653|NCT00249795|4232780|B1|<120 mmHg||Sitting Systolic Blood Pressure||participants|Number|509|509.0||||||
4406654|NCT00249795|4232778|B3|Missing||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|3|3.0||||||
4406655|NCT00249795|4232779|B2|Missing||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|1|1.0||||||
4406656|NCT00249795|4232780|B1|Missing||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|2|2.0||||||
4406657|NCT00249795|4232778|B3|> 2||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|2373|2373.0||||||
4406658|NCT00249795|4232779|B2|> 2||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|1163|1163.0||||||
4406659|NCT00249795|4232780|B1|> 2||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|1210|1210.0||||||
4406660|NCT00249795|4232778|B3|2||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|3076|3076.0||||||
4406661|NCT00249795|4232779|B2|2||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|1560|1560.0||||||
4406662|NCT00249795|4232780|B1|2||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|1516|1516.0||||||
4406663|NCT00249795|4232778|B3|1||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|3365|3365.0||||||
4406664|NCT00249795|4232779|B2|1||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|1678|1678.0||||||
4406665|NCT00249795|4232780|B1|1||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|1687|1687.0||||||
4406666|NCT00249795|4232778|B3|0||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|199|199.0||||||
4406724|NCT00249470|4232829|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4406667|NCT00249795|4232779|B2|0||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|96|96.0||||||
4406668|NCT00249795|4232780|B1|0||Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score|7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.|participants|Number|103|103.0||||||
4406669|NCT00249795|4232778|B3||Male|Sex: Female, Male||Participants|Count of Participants|5475|5475.0||||||
4406670|NCT00249795|4232779|B2||Male|Sex: Female, Male||Participants|Count of Participants|2730|2730.0||||||
4406671|NCT00249795|4232780|B1||Male|Sex: Female, Male||Participants|Count of Participants|2745|2745.0||||||
4406672|NCT00249795|4232778|B3||Female|Sex: Female, Male||Participants|Count of Participants|3541|3541.0||||||
4406673|NCT00249795|4232779|B2||Female|Sex: Female, Male||Participants|Count of Participants|1768|1768.0||||||
4406674|NCT00249795|4232780|B1||Female|Sex: Female, Male||Participants|Count of Participants|1773|1773.0||||||
4406675|NCT00249795|4232778|B3|>=75 years||Age, Customized||participants|Number|3117|3117.0||||||
4406676|NCT00249795|4232779|B2|>=75 years||Age, Customized||participants|Number|1570|1570.0||||||
4406677|NCT00249795|4232780|B1|>=75 years||Age, Customized||participants|Number|1547|1547.0||||||
4406678|NCT00249795|4232778|B3|65 to <75 years||Age, Customized||participants|Number|3357|3357.0||||||
4406679|NCT00249795|4232779|B2|65 to <75 years||Age, Customized||participants|Number|1673|1673.0||||||
4406680|NCT00249795|4232780|B1|65 to <75 years||Age, Customized||participants|Number|1684|1684.0||||||
4406681|NCT00249795|4232778|B3|18 to <65 years||Age, Customized||participants|Number|2542|2542.0||||||
4406682|NCT00249795|4232779|B2|18 to <65 years||Age, Customized||participants|Number|1255|1255.0||||||
4406683|NCT00249795|4232780|B1|18 to <65 years||Age, Customized||participants|Number|1287|1287.0||||||
4406684|NCT00249795|4232778|B3|||Age||years|Mean|69.6|69.6|Standard Deviation|9.7|9.7|||
4406685|NCT00249795|4232779|B2|||Age||years|Mean|69.6|69.6|Standard Deviation|9.7|9.7|||
4406686|NCT00249795|4232780|B1|||Age||years|Mean|69.5|69.5|Standard Deviation|9.7|9.7|||
4406687|NCT00249613|4232799|B3|United States||Region of Enrollment||participants|Number|291|291.0||||||
4406688|NCT00249613|4232800|B2|United States||Region of Enrollment||participants|Number|139|139.0||||||
4406689|NCT00249613|4232801|B1|United States||Region of Enrollment||participants|Number|152|152.0||||||
4406690|NCT00249613|4232799|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406691|NCT00249613|4232800|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406692|NCT00249613|4232801|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4406693|NCT00249613|4232799|B3||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4406694|NCT00249613|4232800|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4406695|NCT00249613|4232801|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4406696|NCT00249613|4232799|B3|||Age||years|Mean|35.7|35.7|Standard Deviation|10.2|10.2|||
4406697|NCT00249613|4232800|B2|||Age||years|Mean|36.5|36.5|Standard Deviation|10.2|10.2|||
4406698|NCT00249613|4232801|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|10.1|10.1|||
4406699|NCT00249496|4232811|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4406700|NCT00249496|4232812|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4406701|NCT00249496|4232813|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4406702|NCT00249496|4232811|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4406703|NCT00249496|4232812|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4406704|NCT00249496|4232813|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4406705|NCT00249496|4232811|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4406706|NCT00249496|4232812|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4406707|NCT00249496|4232813|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4406708|NCT00249496|4232811|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|7.4|7.4|||
4406709|NCT00249496|4232812|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|7.2|7.2|||
4406710|NCT00249496|4232813|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|7.7|7.7|||
4406711|NCT00249496|4232811|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406712|NCT00249496|4232812|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406713|NCT00249496|4232813|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406714|NCT00249496|4232811|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4406715|NCT00249496|4232812|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4406716|NCT00249496|4232813|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4406717|NCT00249496|4232811|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406718|NCT00249496|4232812|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406719|NCT00249496|4232813|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406720|NCT00249470|4232828|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4406721|NCT00249470|4232829|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4406722|NCT00249470|4232830|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4406723|NCT00249470|4232828|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4406725|NCT00249470|4232830|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4406726|NCT00249470|4232828|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4406727|NCT00249470|4232829|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4406728|NCT00249470|4232830|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4406729|NCT00249470|4232828|B3|||Age||years|Mean|45.7|45.7|Standard Deviation|6.36|6.36|||
4406730|NCT00249470|4232829|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|5.8|5.8|||
4406731|NCT00249470|4232830|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|6.5|6.5|||
4406732|NCT00249444|4232841|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4406733|NCT00249444|4232842|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4406734|NCT00249444|4232843|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406735|NCT00249444|4232841|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4406736|NCT00249444|4232842|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4406737|NCT00249444|4232843|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4406738|NCT00249444|4232841|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4406739|NCT00249444|4232842|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4406740|NCT00249444|4232843|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4406741|NCT00249444|4232841|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4406742|NCT00249444|4232842|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4406743|NCT00249444|4232843|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4406744|NCT00249444|4232841|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406745|NCT00249444|4232842|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406746|NCT00249444|4232843|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406747|NCT00249444|4232841|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406748|NCT00249444|4232842|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406749|NCT00249444|4232843|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406750|NCT00249444|4232841|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4406751|NCT00249444|4232842|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4406752|NCT00249444|4232843|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4406753|NCT00249444|4232841|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4406754|NCT00249444|4232842|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4406755|NCT00249444|4232843|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4406756|NCT00249444|4232841|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4406757|NCT00249444|4232842|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4406758|NCT00249444|4232843|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4406759|NCT00249444|4232841|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|7.9|7.9|||
4406760|NCT00249444|4232842|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|8.4|8.4|||
4406761|NCT00249444|4232843|B1|||Age||years|Mean|42.7|42.7|Standard Deviation|7.6|7.6|||
4406762|NCT00249379|4232852|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4406763|NCT00249379|4232853|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4406764|NCT00249379|4232854|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4406765|NCT00249379|4232852|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4406766|NCT00249379|4232853|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4406767|NCT00249379|4232854|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4406768|NCT00249379|4232852|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4406769|NCT00249379|4232853|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4406770|NCT00249379|4232854|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4406771|NCT00249379|4232852|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|3|3.0|||
4406772|NCT00249379|4232853|B2|||Age||years|Mean|37.9|37.9|Standard Deviation|3|3.0|||
4406773|NCT00249379|4232854|B1|||Age||years|Mean|37.9|37.9|Standard Deviation|3|3.0|||
4406774|NCT00249379|4232852|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406775|NCT00249379|4232853|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406776|NCT00249379|4232854|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406777|NCT00249379|4232852|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4406778|NCT00249379|4232853|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4406779|NCT00249379|4232854|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4406780|NCT00249379|4232852|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406781|NCT00249379|4232853|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406782|NCT00249379|4232854|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406783|NCT00249288|4232867|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4406784|NCT00249288|4232868|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4406785|NCT00249288|4232869|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4406786|NCT00249288|4232867|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4406787|NCT00249288|4232868|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4406788|NCT00249288|4232869|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4406789|NCT00249288|4232867|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4406790|NCT00249288|4232868|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4406791|NCT00249288|4232869|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4406792|NCT00249288|4232867|B3|||Age||years|Mean|46|46.0|Standard Deviation|10.3|10.3|||
4406793|NCT00249288|4232868|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|9.6|9.6|||
4406794|NCT00249288|4232869|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|11.3|11.3|||
4406795|NCT00249288|4232867|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406796|NCT00249288|4232868|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406797|NCT00249288|4232869|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406798|NCT00249288|4232867|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4406799|NCT00249288|4232868|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4406800|NCT00249288|4232869|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4406801|NCT00249288|4232867|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406802|NCT00249288|4232868|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406803|NCT00249288|4232869|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406804|NCT00249249|4232901|B5||Male|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
4406805|NCT00249249|4232902|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4406806|NCT00249249|4232903|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4406807|NCT00249249|4232904|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4406808|NCT00249249|4232905|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4406809|NCT00249249|4232901|B5||Female|Sex: Female, Male||Participants|Count of Participants|443|443.0||||||
4406810|NCT00249249|4232902|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4406811|NCT00249249|4232903|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4406812|NCT00249249|4232904|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4406813|NCT00249249|4232905|B1||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4406814|NCT00249249|4232901|B5|||Age||years|Mean|58.3|58.3|Standard Deviation|9.58|9.58|||
4406815|NCT00249249|4232902|B4|||Age||years|Mean|58.0|58.0|Standard Deviation|9.14|9.14|||
4406816|NCT00249249|4232903|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|10.1|10.1|||
4406817|NCT00249249|4232904|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|8.63|8.63|||
4406818|NCT00249249|4232905|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|9.51|9.51|||
4406819|NCT00249249|4232901|B5||>=65 years|Age||Participants|Count of Participants|247|247.0||||||
4406820|NCT00249249|4232902|B4||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4406821|NCT00249249|4232903|B3||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
4406822|NCT00249249|4232904|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4406823|NCT00249249|4232905|B1||>=65 years|Age||Participants|Count of Participants|97|97.0||||||
4406824|NCT00249249|4232901|B5||Between 18 and 65 years|Age||Participants|Count of Participants|574|574.0||||||
4406825|NCT00249249|4232902|B4||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4406826|NCT00249249|4232903|B3||Between 18 and 65 years|Age||Participants|Count of Participants|207|207.0||||||
4406827|NCT00249249|4232904|B2||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4406828|NCT00249249|4232905|B1||Between 18 and 65 years|Age||Participants|Count of Participants|219|219.0||||||
4406829|NCT00249249|4232901|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406830|NCT00249249|4232902|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406831|NCT00249249|4232903|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406832|NCT00249249|4232904|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406833|NCT00249249|4232905|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406834|NCT00249002|4232962|B1|||Weight||kg|Mean|71.78|71.78|Standard Deviation|13.271|13.271|||
4406835|NCT00249002|4232962|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4406836|NCT00249002|4232962|B1|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4406837|NCT00249002|4232962|B1|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4406838|NCT00249002|4232962|B1|Black of African heritage||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4406839|NCT00249002|4232962|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4406840|NCT00249002|4232962|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4406841|NCT00249002|4232962|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4406842|NCT00249002|4232962|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4406843|NCT00249002|4232962|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4406844|NCT00249002|4232962|B1|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4406845|NCT00249002|4232962|B1|<65 years||Age, Customized||participants|Number|4|4.0||||||
4406846|NCT00249002|4232962|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|8.16|8.16|||
4406847|NCT00248833|4232978|B4|United States||Region of Enrollment||participants|Number|34|34.0||||||
4406848|NCT00248833|4232979|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4406849|NCT00248833|4232980|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4406850|NCT00248833|4232981|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4406851|NCT00248833|4232978|B4|Asian||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|1|1.0||||||
4406852|NCT00248833|4232979|B3|Asian||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|0|0.0||||||
4406853|NCT00248833|4232980|B2|Asian||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|0|0.0||||||
4406854|NCT00248833|4232981|B1|Asian||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|1|1.0||||||
4406855|NCT00248833|4232978|B4|Hispanic or Latino||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|3|3.0||||||
4406856|NCT00248833|4232979|B3|Hispanic or Latino||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|1|1.0||||||
4406857|NCT00248833|4232980|B2|Hispanic or Latino||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|1|1.0||||||
4406858|NCT00248833|4232981|B1|Hispanic or Latino||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|1|1.0||||||
4406859|NCT00248833|4232978|B4|Black or African American||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|19|19.0||||||
4406860|NCT00248833|4232979|B3|Black or African American||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|7|7.0||||||
4406861|NCT00248833|4232980|B2|Black or African American||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|7|7.0||||||
4406862|NCT00248833|4232981|B1|Black or African American||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|5|5.0||||||
4406863|NCT00248833|4232978|B4|White||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|16|16.0||||||
4406864|NCT00248833|4232979|B3|White||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|4|4.0||||||
4406921|NCT00248781|4233043|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4406865|NCT00248833|4232980|B2|White||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|5|5.0||||||
4406866|NCT00248833|4232981|B1|White||Race/Ethnicity, Customized|There is discrepancy in the demographic data within the Final Clinical Study Report (FCSR). Number of subject for 1) 25ug states total number of 12 subjects analyzed, but the race data indicates 13 subjects. Number of subjects for 2) 25ug states total number of 11 subjects analyzed, but the race data indicates 12 subjects analyzed. Data must me entered as indicated in the FCSR.|Participants|Count of Participants|7|7.0||||||
4406867|NCT00248833|4232978|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4406868|NCT00248833|4232979|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4406869|NCT00248833|4232980|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4406870|NCT00248833|4232981|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4406871|NCT00248833|4232978|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4406872|NCT00248833|4232979|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4406873|NCT00248833|4232980|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4406874|NCT00248833|4232981|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4406875|NCT00248833|4232978|B4|||Age||Years|Mean|31.6|31.6|Standard Deviation|8.4|8.4|||
4406876|NCT00248833|4232979|B3|||Age||Years|Mean|29.9|29.9|Standard Deviation|8.4|8.4|||
4406877|NCT00248833|4232980|B2|||Age||Years|Mean|33.4|33.4|Standard Deviation|7.6|7.6|||
4406878|NCT00248833|4232981|B1|||Age||Years|Mean|31.6|31.6|Standard Deviation|9.3|9.3|||
4406879|NCT00248807|4232999|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4406880|NCT00248807|4233000|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4406881|NCT00248807|4233001|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4406882|NCT00248807|4232999|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4406883|NCT00248807|4233000|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4406884|NCT00248807|4233001|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4406885|NCT00248807|4232999|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4406886|NCT00248807|4233000|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4406887|NCT00248807|4233001|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4406888|NCT00248807|4232999|B3|||Age||years|Mean|39|39.0|Standard Deviation|12|12.0|||
4406889|NCT00248807|4233000|B2|||Age||years|Mean|35|35.0|Standard Deviation|12|12.0|||
4406890|NCT00248807|4233001|B1|||Age||years|Mean|41|41.0|Standard Deviation|11|11.0|||
4406891|NCT00248807|4232999|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406892|NCT00248807|4233000|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406893|NCT00248807|4233001|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4406894|NCT00248807|4232999|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4406895|NCT00248807|4233000|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4406896|NCT00248807|4233001|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4406897|NCT00248807|4232999|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406898|NCT00248807|4233000|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406899|NCT00248807|4233001|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406900|NCT00248794|4233016|B4|United States||Region of Enrollment||participants|Number|59|59.0||||||
4406901|NCT00248794|4233017|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4406902|NCT00248794|4233018|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4406903|NCT00248794|4233019|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4406904|NCT00248794|4233016|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4406905|NCT00248794|4233017|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4406906|NCT00248794|4233018|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4406907|NCT00248794|4233019|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4406908|NCT00248794|4233016|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4406909|NCT00248794|4233017|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4406910|NCT00248794|4233018|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4406911|NCT00248794|4233019|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4406912|NCT00248794|4233016|B4|||Age||years|Mean|47.8|47.8|Standard Deviation|7.2|7.2|||
4406913|NCT00248794|4233017|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|6.9|6.9|||
4406914|NCT00248794|4233018|B2|||Age||years|Mean|47.6|47.6|Standard Deviation|8.1|8.1|||
4406915|NCT00248794|4233019|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|6.7|6.7|||
4406916|NCT00248781|4233041|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
4406917|NCT00248781|4233042|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4406918|NCT00248781|4233043|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4406919|NCT00248781|4233041|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4406920|NCT00248781|4233042|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4406922|NCT00248781|4233041|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4406923|NCT00248781|4233042|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4406924|NCT00248781|4233043|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4406925|NCT00248781|4233041|B3|||Age||years|Mean|71|71.0|Standard Deviation|7.4|7.4|||
4406926|NCT00248781|4233042|B2|||Age||years|Mean|71.7|71.7|Standard Deviation|7.2|7.2|||
4406927|NCT00248781|4233043|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|7.5|7.5|||
4406928|NCT00248651|4233068|B4|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4406929|NCT00248651|4233069|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4406930|NCT00248651|4233070|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4406931|NCT00248651|4233071|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4406932|NCT00248651|4233068|B4|United States||Region of Enrollment||participants|Number|284|284.0||||||
4406933|NCT00248651|4233069|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
4406934|NCT00248651|4233070|B2|United States||Region of Enrollment||participants|Number|94|94.0||||||
4406935|NCT00248651|4233071|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
4406936|NCT00248651|4233068|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4406937|NCT00248651|4233069|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4406938|NCT00248651|4233070|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4406939|NCT00248651|4233071|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4406940|NCT00248651|4233068|B4||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4406941|NCT00248651|4233069|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4406942|NCT00248651|4233070|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4406943|NCT00248651|4233071|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4406944|NCT00248651|4233068|B4|||Age||years|Mean|44|44.0|Standard Deviation|15|15.0|||
4406945|NCT00248651|4233069|B3|||Age||years|Mean|45|45.0|Standard Deviation|16|16.0|||
4406946|NCT00248651|4233070|B2|||Age||years|Mean|45|45.0|Standard Deviation|15|15.0|||
4406947|NCT00248651|4233071|B1|||Age||years|Mean|43|43.0|Standard Deviation|15|15.0|||
4406948|NCT00248638|4233090|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4406949|NCT00248638|4233091|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4406950|NCT00248638|4233092|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4406951|NCT00248638|4233090|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4406952|NCT00248638|4233091|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4406953|NCT00248638|4233092|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4406954|NCT00248638|4233090|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4406955|NCT00248638|4233091|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4406956|NCT00248638|4233092|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4406957|NCT00248638|4233090|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|13.2|13.2|||
4406958|NCT00248638|4233091|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|13.0|13.0|||
4406959|NCT00248638|4233092|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|13.6|13.6|||
4406960|NCT00248638|4233090|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4406961|NCT00248638|4233091|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4406962|NCT00248638|4233092|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4406963|NCT00248638|4233090|B3||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4406964|NCT00248638|4233091|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4406965|NCT00248638|4233092|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4406966|NCT00248638|4233090|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406967|NCT00248638|4233091|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406968|NCT00248638|4233092|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4406969|NCT00248625|4233107|B3|2-4||Coma Grade of Hepatic Encephalopathy|West Haven Criteria for hepatic encephalopathy (Grade 0 - IV ) is used for participants > 3 year of age. Coma grade IV indicates a participant who is comatose , with no reflexes, is decerebrate and has abnormal EEG changes with very slow delta activity. For participants less than 3 years the Whittington Scale was used. The Whittington scale does not use EEG changes and has only 3 levels, early (grades I and II), Mid (III) with somnolence, stupor, combativeness and Late (IV) for participants who are comatose with absent reflexes and decerebrate or decorticate posturing.|participants|Number|51|51.0||||||
4406970|NCT00248625|4233108|B2|2-4||Coma Grade of Hepatic Encephalopathy|West Haven Criteria for hepatic encephalopathy (Grade 0 - IV ) is used for participants > 3 year of age. Coma grade IV indicates a participant who is comatose , with no reflexes, is decerebrate and has abnormal EEG changes with very slow delta activity. For participants less than 3 years the Whittington Scale was used. The Whittington scale does not use EEG changes and has only 3 levels, early (grades I and II), Mid (III) with somnolence, stupor, combativeness and Late (IV) for participants who are comatose with absent reflexes and decerebrate or decorticate posturing.|participants|Number|24|24.0||||||
4407013|NCT00248625|4233109|B1|||Age||years|Median|3.7|3.7|Inter-Quartile Range|||0.8|10.5|
4407014|NCT00248625|4233107|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407015|NCT00248625|4233108|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407016|NCT00248625|4233109|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407017|NCT00248625|4233107|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4406971|NCT00248625|4233109|B1|2-4||Coma Grade of Hepatic Encephalopathy|West Haven Criteria for hepatic encephalopathy (Grade 0 - IV ) is used for participants > 3 year of age. Coma grade IV indicates a participant who is comatose , with no reflexes, is decerebrate and has abnormal EEG changes with very slow delta activity. For participants less than 3 years the Whittington Scale was used. The Whittington scale does not use EEG changes and has only 3 levels, early (grades I and II), Mid (III) with somnolence, stupor, combativeness and Late (IV) for participants who are comatose with absent reflexes and decerebrate or decorticate posturing.|participants|Number|27|27.0||||||
4406972|NCT00248625|4233107|B3|0-1||Coma Grade of Hepatic Encephalopathy|West Haven Criteria for hepatic encephalopathy (Grade 0 - IV ) is used for participants > 3 year of age. Coma grade IV indicates a participant who is comatose , with no reflexes, is decerebrate and has abnormal EEG changes with very slow delta activity. For participants less than 3 years the Whittington Scale was used. The Whittington scale does not use EEG changes and has only 3 levels, early (grades I and II), Mid (III) with somnolence, stupor, combativeness and Late (IV) for participants who are comatose with absent reflexes and decerebrate or decorticate posturing.|participants|Number|133|133.0||||||
4406973|NCT00248625|4233108|B2|0-1||Coma Grade of Hepatic Encephalopathy|West Haven Criteria for hepatic encephalopathy (Grade 0 - IV ) is used for participants > 3 year of age. Coma grade IV indicates a participant who is comatose , with no reflexes, is decerebrate and has abnormal EEG changes with very slow delta activity. For participants less than 3 years the Whittington Scale was used. The Whittington scale does not use EEG changes and has only 3 levels, early (grades I and II), Mid (III) with somnolence, stupor, combativeness and Late (IV) for participants who are comatose with absent reflexes and decerebrate or decorticate posturing.|participants|Number|68|68.0||||||
4406974|NCT00248625|4233109|B1|0-1||Coma Grade of Hepatic Encephalopathy|West Haven Criteria for hepatic encephalopathy (Grade 0 - IV ) is used for participants > 3 year of age. Coma grade IV indicates a participant who is comatose , with no reflexes, is decerebrate and has abnormal EEG changes with very slow delta activity. For participants less than 3 years the Whittington Scale was used. The Whittington scale does not use EEG changes and has only 3 levels, early (grades I and II), Mid (III) with somnolence, stupor, combativeness and Late (IV) for participants who are comatose with absent reflexes and decerebrate or decorticate posturing.|participants|Number|65|65.0||||||
4406975|NCT00248625|4233107|B3|United Kingdom||Region of Enrollment||participants|Number|50|50.0||||||
4406976|NCT00248625|4233108|B2|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4406977|NCT00248625|4233109|B1|United Kingdom||Region of Enrollment||participants|Number|29|29.0||||||
4406978|NCT00248625|4233107|B3|United States||Region of Enrollment||participants|Number|129|129.0||||||
4406979|NCT00248625|4233108|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
4406980|NCT00248625|4233109|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4406981|NCT00248625|4233107|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4406982|NCT00248625|4233108|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4406983|NCT00248625|4233109|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4406984|NCT00248625|4233107|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4406985|NCT00248625|4233108|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4406986|NCT00248625|4233109|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4406987|NCT00248625|4233107|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4406988|NCT00248625|4233108|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4406989|NCT00248625|4233109|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4406990|NCT00248625|4233107|B3||White|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
4406991|NCT00248625|4233108|B2||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4406992|NCT00248625|4233109|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4406993|NCT00248625|4233107|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4406994|NCT00248625|4233108|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4406995|NCT00248625|4233109|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4406996|NCT00248625|4233107|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406997|NCT00248625|4233108|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406998|NCT00248625|4233109|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4406999|NCT00248625|4233107|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4407000|NCT00248625|4233108|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4407001|NCT00248625|4233109|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4407002|NCT00248625|4233107|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4407003|NCT00248625|4233108|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4407004|NCT00248625|4233109|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4407005|NCT00248625|4233107|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4407006|NCT00248625|4233108|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4407007|NCT00248625|4233109|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4407008|NCT00248625|4233107|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4407009|NCT00248625|4233108|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4407010|NCT00248625|4233109|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4407011|NCT00248625|4233107|B3|||Age||years|Median|4.1|4.1|Inter-Quartile Range|||0.9|10.0|
4407012|NCT00248625|4233108|B2|||Age||years|Median|4.5|4.5|Inter-Quartile Range|||1.0|9.5|
4407018|NCT00248625|4233108|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4407019|NCT00248625|4233109|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4407020|NCT00248625|4233107|B3||<=18 years|Age||Participants|Count of Participants|184|184.0||||||
4407021|NCT00248625|4233108|B2||<=18 years|Age||Participants|Count of Participants|92|92.0||||||
4407022|NCT00248625|4233109|B1||<=18 years|Age||Participants|Count of Participants|92|92.0||||||
4407023|NCT00248612|4233130|B5|||Drinks per day|The average number of drinks per day was obtained by taking the mean of the number of drinks each day for the 90 day long pre-screening period.|number of drinks|Mean|8.6|8.6|Standard Deviation|6.1|6.1|||
4407024|NCT00248612|4233131|B4|||Drinks per day|The average number of drinks per day was obtained by taking the mean of the number of drinks each day for the 90 day long pre-screening period.|number of drinks|Mean|9.7|9.7|Standard Deviation|7.5|7.5|||
4407025|NCT00248612|4233132|B3|||Drinks per day|The average number of drinks per day was obtained by taking the mean of the number of drinks each day for the 90 day long pre-screening period.|number of drinks|Mean|9.6|9.6|Standard Deviation|4.3|4.3|||
4407026|NCT00248612|4233133|B2|||Drinks per day|The average number of drinks per day was obtained by taking the mean of the number of drinks each day for the 90 day long pre-screening period.|number of drinks|Mean|7.0|7.0|Standard Deviation|4.6|4.6|||
4407027|NCT00248612|4233134|B1|||Drinks per day|The average number of drinks per day was obtained by taking the mean of the number of drinks each day for the 90 day long pre-screening period.|number of drinks|Mean|8.4|8.4|Standard Deviation|6.5|6.5|||
4407028|NCT00248612|4233130|B5|||ADS Scores|The ADS provides a quantitative measure of the severity of alcohol dependence consistent with the concept of the alcohol dependence syndrome. The 25 items cover alcohol withdrawal symptoms, impaired control over drinking, awareness of a compulsion to drink, increased tolerance to alcohol, and salience of drink-seeking behavior. Scores range from 0-47.0= no alcohol dependence, 1-13=low, 14-21 =intermediate, 22-30= substantial and 31-47= severe level of alcohol dependence.|units on a scale|Mean|15.8|15.8|Standard Deviation|7.6|7.6|||
4407029|NCT00248612|4233131|B4|||ADS Scores|The ADS provides a quantitative measure of the severity of alcohol dependence consistent with the concept of the alcohol dependence syndrome. The 25 items cover alcohol withdrawal symptoms, impaired control over drinking, awareness of a compulsion to drink, increased tolerance to alcohol, and salience of drink-seeking behavior. Scores range from 0-47.0= no alcohol dependence, 1-13=low, 14-21 =intermediate, 22-30= substantial and 31-47= severe level of alcohol dependence.|units on a scale|Mean|16.1|16.1|Standard Deviation|5.9|5.9|||
4407030|NCT00248612|4233132|B3|||ADS Scores|The ADS provides a quantitative measure of the severity of alcohol dependence consistent with the concept of the alcohol dependence syndrome. The 25 items cover alcohol withdrawal symptoms, impaired control over drinking, awareness of a compulsion to drink, increased tolerance to alcohol, and salience of drink-seeking behavior. Scores range from 0-47.0= no alcohol dependence, 1-13=low, 14-21 =intermediate, 22-30= substantial and 31-47= severe level of alcohol dependence.|units on a scale|Mean|16.6|16.6|Standard Deviation|6.6|6.6|||
4407031|NCT00248612|4233133|B2|||ADS Scores|The ADS provides a quantitative measure of the severity of alcohol dependence consistent with the concept of the alcohol dependence syndrome. The 25 items cover alcohol withdrawal symptoms, impaired control over drinking, awareness of a compulsion to drink, increased tolerance to alcohol, and salience of drink-seeking behavior. Scores range from 0-47.0= no alcohol dependence, 1-13=low, 14-21 =intermediate, 22-30= substantial and 31-47= severe level of alcohol dependence.|units on a scale|Mean|15.8|15.8|Standard Deviation|7.7|7.7|||
4407032|NCT00248612|4233134|B1|||ADS Scores|The ADS provides a quantitative measure of the severity of alcohol dependence consistent with the concept of the alcohol dependence syndrome. The 25 items cover alcohol withdrawal symptoms, impaired control over drinking, awareness of a compulsion to drink, increased tolerance to alcohol, and salience of drink-seeking behavior. Scores range from 0-47.0= no alcohol dependence, 1-13=low, 14-21 =intermediate, 22-30= substantial and 31-47= severe level of alcohol dependence.|units on a scale|Mean|15.0|15.0|Standard Deviation|7.6|7.6|||
4407033|NCT00248612|4233130|B5|percent days heavy drinking||Drinking status|Drinking status was measured for the 90 day long pre-screening period by calculating the mean percent and standard deviation of the days drinking and of the days heavy drinking|percent of days|Mean|65.6|65.6|Standard Deviation|28.2|28.2|||
4407034|NCT00248612|4233131|B4|percent days heavy drinking||Drinking status|Drinking status was measured for the 90 day long pre-screening period by calculating the mean percent and standard deviation of the days drinking and of the days heavy drinking|percent of days|Mean|67.2|67.2|Standard Deviation|28.6|28.6|||
4407035|NCT00248612|4233132|B3|percent days heavy drinking||Drinking status|Drinking status was measured for the 90 day long pre-screening period by calculating the mean percent and standard deviation of the days drinking and of the days heavy drinking|percent of days|Mean|76.9|76.9|Standard Deviation|19.1|19.1|||
4407036|NCT00248612|4233133|B2|percent days heavy drinking||Drinking status|Drinking status was measured for the 90 day long pre-screening period by calculating the mean percent and standard deviation of the days drinking and of the days heavy drinking|percent of days|Mean|59.1|59.1|Standard Deviation|33.7|33.7|||
4407037|NCT00248612|4233134|B1|percent days heavy drinking||Drinking status|Drinking status was measured for the 90 day long pre-screening period by calculating the mean percent and standard deviation of the days drinking and of the days heavy drinking|percent of days|Mean|63.1|63.1|Standard Deviation|28.0|28.0|||
4407038|NCT00248612|4233130|B5|percent days drinking||Drinking status|Drinking status was measured for the 90 day long pre-screening period by calculating the mean percent and standard deviation of the days drinking and of the days heavy drinking|percent of days|Mean|77|77.0|Standard Deviation|23.8|23.8|||
4407039|NCT00248612|4233131|B4|percent days drinking||Drinking status|Drinking status was measured for the 90 day long pre-screening period by calculating the mean percent and standard deviation of the days drinking and of the days heavy drinking|percent of days|Mean|76.5|76.5|Standard Deviation|25.8|25.8|||
4407040|NCT00248612|4233132|B3|percent days drinking||Drinking status|Drinking status was measured for the 90 day long pre-screening period by calculating the mean percent and standard deviation of the days drinking and of the days heavy drinking|percent of days|Mean|88.0|88.0|Standard Deviation|12.7|12.7|||
4407097|NCT00248547|4233185|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4407041|NCT00248612|4233133|B2|percent days drinking||Drinking status|Drinking status was measured for the 90 day long pre-screening period by calculating the mean percent and standard deviation of the days drinking and of the days heavy drinking|percent of days|Mean|76.0|76.0|Standard Deviation|25.6|25.6|||
4407042|NCT00248612|4233134|B1|percent days drinking||Drinking status|Drinking status was measured for the 90 day long pre-screening period by calculating the mean percent and standard deviation of the days drinking and of the days heavy drinking|percent of days|Mean|72.0|72.0|Standard Deviation|24.5|24.5|||
4407043|NCT00248612|4233130|B5|United States||Region of Enrollment||Participants|Count of Participants|81|81.0||||||
4407044|NCT00248612|4233131|B4|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4407045|NCT00248612|4233132|B3|United States||Region of Enrollment||Participants|Count of Participants|14|14.0||||||
4407046|NCT00248612|4233133|B2|United States||Region of Enrollment||Participants|Count of Participants|21|21.0||||||
4407047|NCT00248612|4233134|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4407048|NCT00248612|4233130|B5||Other|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4407049|NCT00248612|4233131|B4||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4407050|NCT00248612|4233132|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4407051|NCT00248612|4233133|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4407052|NCT00248612|4233134|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4407053|NCT00248612|4233130|B5||African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4407054|NCT00248612|4233131|B4||African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4407055|NCT00248612|4233132|B3||African American|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4407056|NCT00248612|4233133|B2||African American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4407057|NCT00248612|4233134|B1||African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4407058|NCT00248612|4233130|B5||White|Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
4407059|NCT00248612|4233131|B4||White|Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4407060|NCT00248612|4233132|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4407061|NCT00248612|4233133|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4407062|NCT00248612|4233134|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4407063|NCT00248612|4233130|B5||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4407064|NCT00248612|4233131|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4407065|NCT00248612|4233132|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4407066|NCT00248612|4233133|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4407067|NCT00248612|4233134|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4407068|NCT00248612|4233130|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4407069|NCT00248612|4233131|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4407070|NCT00248612|4233132|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4407071|NCT00248612|4233133|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4407072|NCT00248612|4233134|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4407073|NCT00248612|4233130|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407074|NCT00248612|4233131|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407075|NCT00248612|4233132|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407076|NCT00248612|4233133|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407077|NCT00248612|4233134|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407078|NCT00248612|4233130|B5||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4407079|NCT00248612|4233131|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4407080|NCT00248612|4233132|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4407081|NCT00248612|4233133|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4407082|NCT00248612|4233134|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4407083|NCT00248612|4233130|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407084|NCT00248612|4233131|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407085|NCT00248612|4233132|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407086|NCT00248612|4233133|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407087|NCT00248612|4233134|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407088|NCT00248560|4233179|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4407089|NCT00248560|4233179|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4407090|NCT00248560|4233179|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4407091|NCT00248560|4233179|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|8.9|8.9|||
4407092|NCT00248547|4233183|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4407093|NCT00248547|4233184|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4407094|NCT00248547|4233185|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4407095|NCT00248547|4233183|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4407096|NCT00248547|4233184|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4407098|NCT00248547|4233183|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4407099|NCT00248547|4233184|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4407100|NCT00248547|4233185|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4407101|NCT00248547|4233183|B3|||Age||years|Mean|46|46.0|Standard Deviation|13|13.0|||
4407102|NCT00248547|4233184|B2|||Age||years|Mean|46|46.0|Standard Deviation|13|13.0|||
4407103|NCT00248547|4233185|B1|||Age||years|Mean|46|46.0|Standard Deviation|12.9|12.9|||
4407104|NCT00248547|4233183|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407105|NCT00248547|4233184|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407106|NCT00248547|4233185|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407107|NCT00248547|4233183|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4407108|NCT00248547|4233184|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4407109|NCT00248547|4233185|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4407110|NCT00248547|4233183|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407111|NCT00248547|4233184|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407112|NCT00248547|4233185|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407113|NCT00248534|4233192|B1|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4407114|NCT00248534|4233192|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4407115|NCT00248534|4233192|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4407116|NCT00248534|4233192|B1|||Age, Customized||years|Median|63|63.0|Full Range|||42.0|79.0|
4407117|NCT00248495|4233199|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4407118|NCT00248495|4233199|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4407119|NCT00248495|4233199|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|9.4|9.4|||
4407120|NCT00248287|4233208|B3|United States||Region of Enrollment||participants|Number|154|154.0||||||
4407121|NCT00248287|4233209|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
4407122|NCT00248287|4233210|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4407123|NCT00248287|4233208|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4407124|NCT00248287|4233209|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4407125|NCT00248287|4233210|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4407126|NCT00248287|4233208|B3|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4407127|NCT00248287|4233209|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4407128|NCT00248287|4233210|B1|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4407129|NCT00248287|4233208|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4407130|NCT00248287|4233209|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4407131|NCT00248287|4233210|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4407132|NCT00248287|4233208|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407133|NCT00248287|4233209|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407134|NCT00248287|4233210|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407135|NCT00248287|4233208|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4407136|NCT00248287|4233209|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4407137|NCT00248287|4233210|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4407138|NCT00248287|4233208|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|11.0|11.0|||
4407139|NCT00248287|4233209|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|10.7|10.7|||
4407140|NCT00248287|4233210|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|11.4|11.4|||
4407141|NCT00248170|4233223|B3|Female||Sex/Gender, Customized||Participants|Number|4136|4136.0||||||
4407142|NCT00248170|4233224|B2|Female||Sex/Gender, Customized||Participants|Number|2075|2075.0||||||
4407143|NCT00248170|4233225|B1|Female||Sex/Gender, Customized||Participants|Number|2061|2061.0||||||
4407144|NCT00248170|4233223|B3|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.46|8.46|||
4407145|NCT00248170|4233224|B2|||Age||Years|Mean|63.1|63.1|Standard Deviation|8.45|8.45|||
4407146|NCT00248170|4233225|B1|||Age||Years|Mean|63.2|63.2|Standard Deviation|8.48|8.48|||
4407147|NCT00247962|4233246|B3|Portugal||Region of Enrollment||participants|Number|6|6.0||||||
4407148|NCT00247962|4233247|B2|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4407149|NCT00247962|4233248|B1|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4407150|NCT00247962|4233246|B3|Colombia||Region of Enrollment||participants|Number|12|12.0||||||
4407151|NCT00247962|4233247|B2|Colombia||Region of Enrollment||participants|Number|4|4.0||||||
4407152|NCT00247962|4233248|B1|Colombia||Region of Enrollment||participants|Number|8|8.0||||||
4407153|NCT00247962|4233246|B3|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4407154|NCT00247962|4233247|B2|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4407155|NCT00247962|4233248|B1|Mexico||Region of Enrollment||participants|Number|11|11.0||||||
4407156|NCT00247962|4233246|B3|Serbia||Region of Enrollment||participants|Number|81|81.0||||||
4407157|NCT00247962|4233247|B2|Serbia||Region of Enrollment||participants|Number|27|27.0||||||
4407158|NCT00247962|4233248|B1|Serbia||Region of Enrollment||participants|Number|54|54.0||||||
4407159|NCT00247962|4233246|B3|Greece||Region of Enrollment||participants|Number|7|7.0||||||
4407160|NCT00247962|4233247|B2|Greece||Region of Enrollment||participants|Number|3|3.0||||||
4407161|NCT00247962|4233248|B1|Greece||Region of Enrollment||participants|Number|4|4.0||||||
4407162|NCT00247962|4233246|B3|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4407163|NCT00247962|4233247|B2|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4407164|NCT00247962|4233248|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4407165|NCT00247962|4233246|B3|China||Region of Enrollment||participants|Number|26|26.0||||||
4407166|NCT00247962|4233247|B2|China||Region of Enrollment||participants|Number|9|9.0||||||
4407167|NCT00247962|4233248|B1|China||Region of Enrollment||participants|Number|17|17.0||||||
4407168|NCT00247962|4233246|B3|Germany||Region of Enrollment||participants|Number|93|93.0||||||
4407169|NCT00247962|4233247|B2|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4407170|NCT00247962|4233248|B1|Germany||Region of Enrollment||participants|Number|62|62.0||||||
4407171|NCT00247962|4233246|B3|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4407172|NCT00247962|4233247|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4407173|NCT00247962|4233248|B1|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4407174|NCT00247962|4233246|B3|Denmark||Region of Enrollment||participants|Number|19|19.0||||||
4407175|NCT00247962|4233247|B2|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
4407176|NCT00247962|4233248|B1|Denmark||Region of Enrollment||participants|Number|13|13.0||||||
4407177|NCT00247962|4233246|B3|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4407178|NCT00247962|4233247|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4407179|NCT00247962|4233248|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4407180|NCT00247962|4233246|B3|Poland||Region of Enrollment||participants|Number|45|45.0||||||
4407181|NCT00247962|4233247|B2|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4407182|NCT00247962|4233248|B1|Poland||Region of Enrollment||participants|Number|30|30.0||||||
4407183|NCT00247962|4233246|B3|Hungary||Region of Enrollment||participants|Number|42|42.0||||||
4407184|NCT00247962|4233247|B2|Hungary||Region of Enrollment||participants|Number|15|15.0||||||
4407185|NCT00247962|4233248|B1|Hungary||Region of Enrollment||participants|Number|27|27.0||||||
4407186|NCT00247962|4233246|B3|Czech Republic||Region of Enrollment||participants|Number|54|54.0||||||
4407187|NCT00247962|4233247|B2|Czech Republic||Region of Enrollment||participants|Number|18|18.0||||||
4407188|NCT00247962|4233248|B1|Czech Republic||Region of Enrollment||participants|Number|36|36.0||||||
4407189|NCT00247962|4233246|B3|France||Region of Enrollment||participants|Number|5|5.0||||||
4407190|NCT00247962|4233247|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4407191|NCT00247962|4233248|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
4407192|NCT00247962|4233246|B3|United Kingdom||Region of Enrollment||participants|Number|57|57.0||||||
4407193|NCT00247962|4233247|B2|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4407194|NCT00247962|4233248|B1|United Kingdom||Region of Enrollment||participants|Number|38|38.0||||||
4407195|NCT00247962|4233246|B3|Italy||Region of Enrollment||participants|Number|27|27.0||||||
4407196|NCT00247962|4233247|B2|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4407197|NCT00247962|4233248|B1|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4407198|NCT00247962|4233246|B3|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4407199|NCT00247962|4233247|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4407200|NCT00247962|4233248|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4407201|NCT00247962|4233246|B3|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4407202|NCT00247962|4233247|B2|Ireland||Region of Enrollment||participants|Number|0|0.0||||||
4407203|NCT00247962|4233248|B1|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4407204|NCT00247962|4233246|B3|Spain||Region of Enrollment||participants|Number|19|19.0||||||
4407205|NCT00247962|4233247|B2|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4407206|NCT00247962|4233248|B1|Spain||Region of Enrollment||participants|Number|12|12.0||||||
4407207|NCT00247962|4233246|B3|Finland||Region of Enrollment||participants|Number|14|14.0||||||
4407208|NCT00247962|4233247|B2|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4407209|NCT00247962|4233248|B1|Finland||Region of Enrollment||participants|Number|11|11.0||||||
4407210|NCT00247962|4233246|B3|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4407211|NCT00247962|4233247|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4407212|NCT00247962|4233248|B1|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4407213|NCT00247962|4233246|B3|Qatar||Region of Enrollment||participants|Number|10|10.0||||||
4407214|NCT00247962|4233247|B2|Qatar||Region of Enrollment||participants|Number|3|3.0||||||
4407215|NCT00247962|4233248|B1|Qatar||Region of Enrollment||participants|Number|7|7.0||||||
4407216|NCT00247962|4233246|B3||Male|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
4407217|NCT00247962|4233247|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4407218|NCT00247962|4233248|B1||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4407219|NCT00247962|4233246|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4407220|NCT00247962|4233247|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4407221|NCT00247962|4233248|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4407222|NCT00247962|4233246|B3|||Age||years|Mean|40.76|40.76|Standard Deviation|11.86|11.86|||
4407223|NCT00247962|4233247|B2|||Age||years|Mean|40.90|40.9|Standard Deviation|12.23|12.23|||
4407224|NCT00247962|4233248|B1|||Age||years|Mean|40.69|40.69|Standard Deviation|11.69|11.69|||
4407225|NCT00247676|4233257|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4407226|NCT00247676|4233257|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4407227|NCT00247676|4233257|B1|||Age||years|Mean|59.0|59.0|Standard Deviation|12.4|12.4|||
4407228|NCT00247624|4233285|B3|||BASIS 32 DLRF|"The BASIS 32 psychometric includes several subscales, including daily living and role functioning (DLRF). This subscale is rated from 0-4, with higher scores indicating a greater deal of difficulty in this dimension"|units|Mean|2.0|2.0|Standard Deviation|0.7|0.7|||
4407229|NCT00247624|4233286|B2|||BASIS 32 DLRF|"The BASIS 32 psychometric includes several subscales, including daily living and role functioning (DLRF). This subscale is rated from 0-4, with higher scores indicating a greater deal of difficulty in this dimension"|units|Mean|2.0|2.0|Standard Deviation|0.7|0.7|||
4407230|NCT00247624|4233287|B1|||BASIS 32 DLRF|"The BASIS 32 psychometric includes several subscales, including daily living and role functioning (DLRF). This subscale is rated from 0-4, with higher scores indicating a greater deal of difficulty in this dimension"|units|Mean|1.9|1.9|Standard Deviation|0.7|0.7|||
4407231|NCT00247624|4233285|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4407232|NCT00247624|4233286|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4407233|NCT00247624|4233287|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4407234|NCT00247624|4233285|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4407235|NCT00247624|4233286|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4407236|NCT00247624|4233287|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4407237|NCT00247624|4233285|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|12.5|12.5|||
4407238|NCT00247624|4233286|B2|||Age||years|Mean|38.0|38.0|Standard Deviation|12.5|12.5|||
4407239|NCT00247624|4233287|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|11.7|11.7|||
4407240|NCT00247624|4233285|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407241|NCT00247624|4233286|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407242|NCT00247624|4233287|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407243|NCT00247624|4233285|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4407244|NCT00247624|4233286|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4407245|NCT00247624|4233287|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4407246|NCT00247624|4233285|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407247|NCT00247624|4233286|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407248|NCT00247624|4233287|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407249|NCT00247611|4233300|B3|United States||Region of Enrollment|Intent to Treat (ITT) Sample|participants|Number|594|594.0||||||
4407250|NCT00247611|4233301|B2|United States||Region of Enrollment|Intent to Treat (ITT) Sample|participants|Number|290|290.0||||||
4407251|NCT00247611|4233302|B1|United States||Region of Enrollment|Intent to Treat (ITT) Sample|participants|Number|304|304.0||||||
4407252|NCT00247611|4233300|B3|Male||Gender|On Protocol (OP)|participants|Number|190|190.0||||||
4407253|NCT00247611|4233301|B2|Male||Gender|On Protocol (OP)|participants|Number|86|86.0||||||
4407254|NCT00247611|4233302|B1|Male||Gender|On Protocol (OP)|participants|Number|104|104.0||||||
4407255|NCT00247611|4233300|B3|Female||Gender|On Protocol (OP)|participants|Number|138|138.0||||||
4407256|NCT00247611|4233301|B2|Female||Gender|On Protocol (OP)|participants|Number|66|66.0||||||
4407257|NCT00247611|4233302|B1|Female||Gender|On Protocol (OP)|participants|Number|72|72.0||||||
4407258|NCT00247611|4233300|B3||Male|Sex: Female, Male|Intent to Treat (ITT) Sample|Participants|Count of Participants|365|365.0||||||
4407259|NCT00247611|4233301|B2||Male|Sex: Female, Male|Intent to Treat (ITT) Sample|Participants|Count of Participants|180|180.0||||||
4407260|NCT00247611|4233302|B1||Male|Sex: Female, Male|Intent to Treat (ITT) Sample|Participants|Count of Participants|185|185.0||||||
4407261|NCT00247611|4233300|B3||Female|Sex: Female, Male|Intent to Treat (ITT) Sample|Participants|Count of Participants|229|229.0||||||
4407262|NCT00247611|4233301|B2||Female|Sex: Female, Male|Intent to Treat (ITT) Sample|Participants|Count of Participants|110|110.0||||||
4407263|NCT00247611|4233302|B1||Female|Sex: Female, Male|Intent to Treat (ITT) Sample|Participants|Count of Participants|119|119.0||||||
4407264|NCT00247611|4233300|B3|||Age|Intent to Treat (ITT) Sample|years|Mean|47|47.0|Standard Deviation|8|8.0|||
4407265|NCT00247611|4233301|B2|||Age|Intent to Treat (ITT) Sample|years|Mean|46.76|46.76|Standard Deviation|8.00|8.0|||
4407266|NCT00247611|4233302|B1|||Age|Intent to Treat (ITT) Sample|years|Mean|47.28|47.28|Standard Deviation|8.01|8.01|||
4407267|NCT00247611|4233300|B3|>=65 years||Age|On Protocol (OP) The On-Protocol sample was derived from the ITT sample who also had completed >=6 assessments and had no ART receipt interruptions.|participants|Number|5|5.0||||||
4407268|NCT00247611|4233301|B2|>=65 years||Age|On Protocol (OP) The On-Protocol sample was derived from the ITT sample who also had completed >=6 assessments and had no ART receipt interruptions.|participants|Number|3|3.0||||||
4407269|NCT00247611|4233302|B1|>=65 years||Age|On Protocol (OP) The On-Protocol sample was derived from the ITT sample who also had completed >=6 assessments and had no ART receipt interruptions.|participants|Number|2|2.0||||||
4407270|NCT00247611|4233300|B3|Between 18 and 65 years||Age|On Protocol (OP) The On-Protocol sample was derived from the ITT sample who also had completed >=6 assessments and had no ART receipt interruptions.|participants|Number|323|323.0||||||
4407271|NCT00247611|4233301|B2|Between 18 and 65 years||Age|On Protocol (OP) The On-Protocol sample was derived from the ITT sample who also had completed >=6 assessments and had no ART receipt interruptions.|participants|Number|149|149.0||||||
4407272|NCT00247611|4233302|B1|Between 18 and 65 years||Age|On Protocol (OP) The On-Protocol sample was derived from the ITT sample who also had completed >=6 assessments and had no ART receipt interruptions.|participants|Number|174|174.0||||||
4407273|NCT00247611|4233300|B3|<=18 years||Age|On Protocol (OP) The On-Protocol sample was derived from the ITT sample who also had completed >=6 assessments and had no ART receipt interruptions.|participants|Number|0|0.0||||||
4407274|NCT00247611|4233301|B2|<=18 years||Age|On Protocol (OP) The On-Protocol sample was derived from the ITT sample who also had completed >=6 assessments and had no ART receipt interruptions.|participants|Number|0|0.0||||||
4407275|NCT00247611|4233302|B1|<=18 years||Age|On Protocol (OP) The On-Protocol sample was derived from the ITT sample who also had completed >=6 assessments and had no ART receipt interruptions.|participants|Number|0|0.0||||||
4407276|NCT00247611|4233300|B3||>=65 years|Age|Intent to Treat (ITT) Sample|Participants|Count of Participants|9|9.0||||||
4407277|NCT00247611|4233301|B2||>=65 years|Age|Intent to Treat (ITT) Sample|Participants|Count of Participants|6|6.0||||||
4407278|NCT00247611|4233302|B1||>=65 years|Age|Intent to Treat (ITT) Sample|Participants|Count of Participants|3|3.0||||||
4407279|NCT00247611|4233300|B3||Between 18 and 65 years|Age|Intent to Treat (ITT) Sample|Participants|Count of Participants|585|585.0||||||
4407280|NCT00247611|4233301|B2||Between 18 and 65 years|Age|Intent to Treat (ITT) Sample|Participants|Count of Participants|284|284.0||||||
4407281|NCT00247611|4233302|B1||Between 18 and 65 years|Age|Intent to Treat (ITT) Sample|Participants|Count of Participants|301|301.0||||||
4407282|NCT00247611|4233300|B3||<=18 years|Age|Intent to Treat (ITT) Sample|Participants|Count of Participants|0|0.0||||||
4407283|NCT00247611|4233301|B2||<=18 years|Age|Intent to Treat (ITT) Sample|Participants|Count of Participants|0|0.0||||||
4407284|NCT00247611|4233302|B1||<=18 years|Age|Intent to Treat (ITT) Sample|Participants|Count of Participants|0|0.0||||||
4407285|NCT00247416|4233319|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4407286|NCT00247416|4233320|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4407287|NCT00247416|4233321|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4407288|NCT00247416|4233319|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4407289|NCT00247416|4233320|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4407290|NCT00247416|4233321|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4407291|NCT00247416|4233319|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4407292|NCT00247416|4233320|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4407293|NCT00247416|4233321|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4407294|NCT00247416|4233319|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4407295|NCT00247416|4233320|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4407296|NCT00247416|4233321|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4407297|NCT00247416|4233319|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4407298|NCT00247416|4233320|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4407299|NCT00247416|4233321|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4407300|NCT00247416|4233319|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407301|NCT00247416|4233320|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407302|NCT00247416|4233321|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407303|NCT00247377|4233334|B3|United States||Region of Enrollment||participants|Number|197|197.0||||||
4407304|NCT00247377|4233335|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
4407305|NCT00247377|4233336|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
4407306|NCT00247377|4233334|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4407307|NCT00247377|4233335|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4407308|NCT00247377|4233336|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4407309|NCT00247377|4233334|B3||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4407310|NCT00247377|4233335|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4407311|NCT00247377|4233336|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4407312|NCT00247377|4233334|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|10.4|10.4|||
4407313|NCT00247377|4233335|B2|||Age||years|Mean|45.8|45.8|Standard Deviation|9.8|9.8|||
4407314|NCT00247377|4233336|B1|||Age||years|Mean|41.4|41.4|Standard Deviation|11.0|11.0|||
4407315|NCT00247377|4233334|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407316|NCT00247377|4233335|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407317|NCT00247377|4233336|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407318|NCT00247377|4233334|B3||Between 18 and 65 years|Age||Participants|Count of Participants|197|197.0||||||
4407319|NCT00247377|4233335|B2||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4407320|NCT00247377|4233336|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4407321|NCT00247377|4233334|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407322|NCT00247377|4233335|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407323|NCT00247377|4233336|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407324|NCT00247273|4233361|B3|United States||Region of Enrollment|ITT Population|participants|Number|47|47.0||||||
4407325|NCT00247273|4233362|B2|United States||Region of Enrollment|ITT Population|participants|Number|23|23.0||||||
4407326|NCT00247273|4233363|B1|United States||Region of Enrollment|ITT Population|participants|Number|24|24.0||||||
4407327|NCT00247273|4233361|B3|Poland||Region of Enrollment|ITT Population|participants|Number|207|207.0||||||
4407328|NCT00247273|4233362|B2|Poland||Region of Enrollment|ITT Population|participants|Number|104|104.0||||||
4407329|NCT00247273|4233363|B1|Poland||Region of Enrollment|ITT Population|participants|Number|103|103.0||||||
4407330|NCT00247273|4233361|B3|Norway||Region of Enrollment|ITT Population|participants|Number|49|49.0||||||
4407331|NCT00247273|4233362|B2|Norway||Region of Enrollment|ITT Population|participants|Number|25|25.0||||||
4407332|NCT00247273|4233363|B1|Norway||Region of Enrollment|ITT Population|participants|Number|24|24.0||||||
4407333|NCT00247273|4233361|B3|Lebanon||Region of Enrollment|ITT Population|participants|Number|12|12.0||||||
4407334|NCT00247273|4233362|B2|Lebanon||Region of Enrollment|ITT Population|participants|Number|6|6.0||||||
4407335|NCT00247273|4233363|B1|Lebanon||Region of Enrollment|ITT Population|participants|Number|6|6.0||||||
4407336|NCT00247273|4233361|B3|Hungary||Region of Enrollment|ITT Population|participants|Number|44|44.0||||||
4407337|NCT00247273|4233362|B2|Hungary||Region of Enrollment|ITT Population|participants|Number|22|22.0||||||
4407338|NCT00247273|4233363|B1|Hungary||Region of Enrollment|ITT Population|participants|Number|22|22.0||||||
4407339|NCT00247273|4233361|B3|France||Region of Enrollment|ITT Population|participants|Number|99|99.0||||||
4407340|NCT00247273|4233362|B2|France||Region of Enrollment|ITT Population|participants|Number|49|49.0||||||
4407341|NCT00247273|4233363|B1|France||Region of Enrollment|ITT Population|participants|Number|50|50.0||||||
4407342|NCT00247273|4233361|B3|Finland||Region of Enrollment|ITT Population|participants|Number|35|35.0||||||
4407343|NCT00247273|4233362|B2|Finland||Region of Enrollment|ITT Population|participants|Number|18|18.0||||||
4407344|NCT00247273|4233363|B1|Finland||Region of Enrollment|ITT Population|participants|Number|17|17.0||||||
4407345|NCT00247273|4233361|B3|Estonia||Region of Enrollment|ITT Population|participants|Number|98|98.0||||||
4407346|NCT00247273|4233362|B2|Estonia||Region of Enrollment|ITT Population|participants|Number|50|50.0||||||
4407347|NCT00247273|4233363|B1|Estonia||Region of Enrollment|ITT Population|participants|Number|48|48.0||||||
4407348|NCT00247273|4233361|B3|Spain||Region of Enrollment|ITT Population|participants|Number|16|16.0||||||
4407349|NCT00247273|4233362|B2|Spain||Region of Enrollment|ITT Population|participants|Number|9|9.0||||||
4407350|NCT00247273|4233363|B1|Spain||Region of Enrollment|ITT Population|participants|Number|7|7.0||||||
4407351|NCT00247273|4233361|B3|Canada||Region of Enrollment|ITT Population|participants|Number|38|38.0||||||
4407352|NCT00247273|4233362|B2|Canada||Region of Enrollment|ITT Population|participants|Number|19|19.0||||||
4407353|NCT00247273|4233363|B1|Canada||Region of Enrollment|ITT Population|participants|Number|19|19.0||||||
4407354|NCT00247273|4233361|B3|Belgium||Region of Enrollment|ITT Population|participants|Number|27|27.0||||||
4407355|NCT00247273|4233362|B2|Belgium||Region of Enrollment|ITT Population|participants|Number|14|14.0||||||
4407356|NCT00247273|4233363|B1|Belgium||Region of Enrollment|ITT Population|participants|Number|13|13.0||||||
4407357|NCT00247273|4233361|B3|Australia||Region of Enrollment|ITT Population|participants|Number|14|14.0||||||
4407358|NCT00247273|4233362|B2|Australia||Region of Enrollment|ITT Population|participants|Number|7|7.0||||||
4407359|NCT00247273|4233363|B1|Australia||Region of Enrollment|ITT Population|participants|Number|7|7.0||||||
4407360|NCT00247273|4233361|B3|Argentina||Region of Enrollment|ITT Population|participants|Number|606|606.0||||||
4407361|NCT00247273|4233362|B2|Argentina||Region of Enrollment|ITT Population|participants|Number|304|304.0||||||
4407362|NCT00247273|4233363|B1|Argentina||Region of Enrollment|ITT Population|participants|Number|302|302.0||||||
4407363|NCT00247273|4233361|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407364|NCT00247273|4233362|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407365|NCT00247273|4233363|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407366|NCT00247273|4233361|B3||Female|Sex: Female, Male||Participants|Count of Participants|1294|1294.0||||||
4407367|NCT00247273|4233362|B2||Female|Sex: Female, Male||Participants|Count of Participants|650|650.0||||||
4407368|NCT00247273|4233363|B1||Female|Sex: Female, Male||Participants|Count of Participants|644|644.0||||||
4407369|NCT00247273|4233361|B3|> = 75 years||Age, Customized|ITT Population|Partcipants|Number|153|153.0||||||
4407370|NCT00247273|4233362|B2|> = 75 years||Age, Customized|ITT Population|Partcipants|Number|78|78.0||||||
4407371|NCT00247273|4233363|B1|> = 75 years||Age, Customized|ITT Population|Partcipants|Number|75|75.0||||||
4407372|NCT00247273|4233361|B3|65 - <75 years||Age, Customized|ITT Population|Partcipants|Number|500|500.0||||||
4407373|NCT00247273|4233362|B2|65 - <75 years||Age, Customized|ITT Population|Partcipants|Number|268|268.0||||||
4407374|NCT00247273|4233363|B1|65 - <75 years||Age, Customized|ITT Population|Partcipants|Number|232|232.0||||||
4407375|NCT00247273|4233361|B3|< 65 years||Age, Customized|ITT Population|Partcipants|Number|639|639.0||||||
4407376|NCT00247273|4233362|B2|< 65 years||Age, Customized|ITT Population|Partcipants|Number|304|304.0||||||
4407377|NCT00247273|4233363|B1|< 65 years||Age, Customized|ITT Population|Partcipants|Number|335|335.0||||||
4407378|NCT00247273|4233361|B3|||Age|ITT (intent to treat) Population|years|Mean|64.9|64.9|Standard Deviation|7.5|7.5|||
4407379|NCT00247273|4233362|B2|||Age|ITT (intent to treat) Population|years|Mean|65.5|65.5|Standard Deviation|7.2|7.2|||
4407380|NCT00247273|4233363|B1|||Age|ITT (intent to treat) Population|years|Mean|64.4|64.4|Standard Deviation|7.7|7.7|||
4407381|NCT00246805|4233408|B3|Italy||Region of Enrollment||participants|Number|67|67.0||||||
4407382|NCT00246805|4233409|B2|Italy||Region of Enrollment||participants|Number|33|33.0||||||
4407383|NCT00246805|4233410|B1|Italy||Region of Enrollment||participants|Number|34|34.0||||||
4407384|NCT00246805|4233408|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4407385|NCT00246805|4233409|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4407386|NCT00246805|4233410|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4407387|NCT00246805|4233408|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4407388|NCT00246805|4233409|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4407389|NCT00246805|4233410|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4407390|NCT00246805|4233408|B3|||Age||years|Mean|80|80.0|Standard Deviation|6|6.0|||
4407391|NCT00246805|4233409|B2|||Age||years|Mean|80|80.0|Standard Deviation|6|6.0|||
4407392|NCT00246805|4233410|B1|||Age||years|Mean|80|80.0|Standard Deviation|6|6.0|||
4407393|NCT00246805|4233408|B3||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4407394|NCT00246805|4233409|B2||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4407395|NCT00246805|4233410|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4407396|NCT00246805|4233408|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4407397|NCT00246805|4233409|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4407398|NCT00246805|4233410|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4407399|NCT00246805|4233408|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407400|NCT00246805|4233409|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407401|NCT00246805|4233410|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407402|NCT00246753|4233417|B1||No metastasis|Disease Status|Metastasis is the development of secondary malignant growths at a distance from a primary site of cancer. Measurable disease is the presence of at least one measurable lesion. This is based on RECIST criteria. Response Evaluation Criteria In Solid Tumors (RECIST) is a set of published rules that defines the status of cancer in a patient. Looking at when tumors improve, stay the same, or worsen.|Participants|Count of Participants|7|7.0||||||
4407403|NCT00246753|4233417|B1||Both bone and measureable disease|Disease Status|Metastasis is the development of secondary malignant growths at a distance from a primary site of cancer. Measurable disease is the presence of at least one measurable lesion. This is based on RECIST criteria. Response Evaluation Criteria In Solid Tumors (RECIST) is a set of published rules that defines the status of cancer in a patient. Looking at when tumors improve, stay the same, or worsen.|Participants|Count of Participants|7|7.0||||||
4407404|NCT00246753|4233417|B1||Measurable disease only|Disease Status|Metastasis is the development of secondary malignant growths at a distance from a primary site of cancer. Measurable disease is the presence of at least one measurable lesion. This is based on RECIST criteria. Response Evaluation Criteria In Solid Tumors (RECIST) is a set of published rules that defines the status of cancer in a patient. Looking at when tumors improve, stay the same, or worsen.|Participants|Count of Participants|7|7.0||||||
4407405|NCT00246753|4233417|B1||Bone metastases only|Disease Status|Metastasis is the development of secondary malignant growths at a distance from a primary site of cancer. Measurable disease is the presence of at least one measurable lesion. This is based on RECIST criteria. Response Evaluation Criteria In Solid Tumors (RECIST) is a set of published rules that defines the status of cancer in a patient. Looking at when tumors improve, stay the same, or worsen.|Participants|Count of Participants|8|8.0||||||
4407406|NCT00246753|4233417|B1|||Hemoglobin|Hemoglobin is a component of red blood cells. The normal level is around 15 grams per deciliter (g/dl) and lower levels in men with prostate cancer indicate a worse prognosis.|grams per deciliter|Median|13|13.0|Full Range|||11.0|14.7|
4407407|NCT00246753|4233417|B1|||Alkaline phosphatase|Alkaline phosphatase (ALP) is an enzyme found in your bloodstream. ALP helps break down proteins in the body and exists in different forms, depending on where it originates. Normal range is 44 to 147 U/L ( units per liter)|U/L|Median|85|85.0|Full Range|||55.0|110.0|
4407408|NCT00246753|4233417|B1|||PSA|Prostate-specific antigen, or PSA, is a protein produced by cells of the prostate gland. The PSA test measures the level of PSA in an individual's blood.The results are usually reported as nanograms of PSA per (ng/mL) of blood. In this study PSA response is defined as >50% decrease in PSA from baseline for 2 successive measurements at lease 4 weeks apart.|ng/mL|Median|21.6|21.6|Full Range|||4.5|196.5|
4407409|NCT00246753|4233417|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4407410|NCT00246753|4233417|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4407411|NCT00246753|4233417|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4407412|NCT00246753|4233417|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4407413|NCT00246753|4233417|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4407414|NCT00246753|4233417|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4407415|NCT00246753|4233417|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4407416|NCT00246753|4233417|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4407417|NCT00246753|4233417|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4407418|NCT00246753|4233417|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407419|NCT00246753|4233417|B1|||Age||years|Median|72.5|72.5|Full Range|||58.0|90.0|
4407420|NCT00246740|4233423|B3|Canada||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4407421|NCT00246740|4233424|B2|Canada||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4407422|NCT00246740|4233425|B1|Canada||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4407423|NCT00246740|4233423|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4407424|NCT00246740|4233424|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4407425|NCT00246740|4233425|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4407426|NCT00246740|4233423|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4407427|NCT00246740|4233424|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4407428|NCT00246740|4233425|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4407429|NCT00246740|4233423|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|1.2|1.2|||
4407430|NCT00246740|4233424|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|2|2.0|||
4407431|NCT00246740|4233425|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|1.5|1.5|||
4407432|NCT00246571|4233448|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407433|NCT00246571|4233449|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407434|NCT00246571|4233450|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407435|NCT00246571|4233448|B3||Female|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4407436|NCT00246571|4233449|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4407437|NCT00246571|4233450|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4407438|NCT00246571|4233448|B3|Greater than or equal to 65 years||Age, Customized||Participants|Number|24|24.0||||||
4407439|NCT00246571|4233449|B2|Greater than or equal to 65 years||Age, Customized||Participants|Number|14|14.0||||||
4407440|NCT00246571|4233450|B1|Greater than or equal to 65 years||Age, Customized||Participants|Number|10|10.0||||||
4407441|NCT00246571|4233448|B3|Less than 65 years||Age, Customized||Participants|Number|193|193.0||||||
4407442|NCT00246571|4233449|B2|Less than 65 years||Age, Customized||Participants|Number|90|90.0||||||
4407443|NCT00246571|4233450|B1|Less than 65 years||Age, Customized||Participants|Number|103|103.0||||||
4407444|NCT00246519|4233489|B3|United States||Region of Enrollment||participants|Number|888|888.0||||||
4407445|NCT00246519|4233490|B2|United States||Region of Enrollment||participants|Number|446|446.0||||||
4407446|NCT00246519|4233491|B1|United States||Region of Enrollment||participants|Number|442|442.0||||||
4407447|NCT00246519|4233489|B3||Male|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
4407448|NCT00246519|4233490|B2||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4407449|NCT00246519|4233491|B1||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4407450|NCT00246519|4233489|B3||Female|Sex: Female, Male||Participants|Count of Participants|474|474.0||||||
4407451|NCT00246519|4233490|B2||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4407452|NCT00246519|4233491|B1||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4407453|NCT00246519|4233489|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|9.3|9.3|||
4407454|NCT00246519|4233490|B2|||Age||years|Mean|48.8|48.8|Standard Deviation|9.2|9.2|||
4407455|NCT00246519|4233491|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|9.3|9.3|||
4407456|NCT00246519|4233489|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4407457|NCT00246519|4233490|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4407458|NCT00246519|4233491|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4407459|NCT00246519|4233489|B3||Between 18 and 65 years|Age||Participants|Count of Participants|877|877.0||||||
4407460|NCT00246519|4233490|B2||Between 18 and 65 years|Age||Participants|Count of Participants|440|440.0||||||
4407461|NCT00246519|4233491|B1||Between 18 and 65 years|Age||Participants|Count of Participants|437|437.0||||||
4407462|NCT00246519|4233489|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4407463|NCT00246519|4233490|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407464|NCT00246519|4233491|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4407465|NCT00246441|4233498|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4407466|NCT00246441|4233499|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4407467|NCT00246441|4233500|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4407468|NCT00246441|4233498|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4407469|NCT00246441|4233499|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4407470|NCT00246441|4233500|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4407471|NCT00246441|4233498|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4407472|NCT00246441|4233499|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4407473|NCT00246441|4233500|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4407474|NCT00246441|4233498|B3|||Age||years|Mean|29|29.0|Standard Deviation|7.4|7.4|||
4407475|NCT00246441|4233499|B2|||Age||years|Mean|30|30.0|Standard Deviation|8.3|8.3|||
4407476|NCT00246441|4233500|B1|||Age||years|Mean|28|28.0|Standard Deviation|6.5|6.5|||
4407477|NCT00246441|4233498|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407478|NCT00246441|4233499|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407479|NCT00246441|4233500|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407480|NCT00246441|4233498|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4407481|NCT00246441|4233499|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4407482|NCT00246441|4233500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4407483|NCT00246441|4233498|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407484|NCT00246441|4233499|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407485|NCT00246441|4233500|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407486|NCT00246376|4233511|B6|United States||Region of Enrollment||participants|Number|221|221.0||||||
4407487|NCT00246376|4233512|B5|United States||Region of Enrollment||participants|Number|45|45.0||||||
4407488|NCT00246376|4233513|B4|United States||Region of Enrollment||participants|Number|47|47.0||||||
4407489|NCT00246376|4233514|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4407490|NCT00246376|4233515|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4407491|NCT00246376|4233516|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4407492|NCT00246376|4233511|B6||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4407493|NCT00246376|4233512|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4407494|NCT00246376|4233513|B4||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4407495|NCT00246376|4233514|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4407496|NCT00246376|4233515|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4407497|NCT00246376|4233516|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4407498|NCT00246376|4233511|B6||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4407499|NCT00246376|4233512|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4407500|NCT00246376|4233513|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4407501|NCT00246376|4233514|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4407502|NCT00246376|4233515|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4407503|NCT00246376|4233516|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4407504|NCT00246376|4233511|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4407505|NCT00246376|4233512|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407506|NCT00246376|4233513|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407507|NCT00246376|4233514|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407508|NCT00246376|4233515|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407509|NCT00246376|4233516|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4407510|NCT00246376|4233511|B6||Between 18 and 65 years|Age||Participants|Count of Participants|220|220.0||||||
4407511|NCT00246376|4233512|B5||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4407512|NCT00246376|4233513|B4||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4407513|NCT00246376|4233514|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4407514|NCT00246376|4233515|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4407515|NCT00246376|4233516|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4407516|NCT00246376|4233511|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407517|NCT00246376|4233512|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407518|NCT00246376|4233513|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407519|NCT00246376|4233514|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407520|NCT00246376|4233515|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407521|NCT00246376|4233516|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407522|NCT00246337|4233562|B10|Baseline Severity data missing||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|1|1.0||||||
4407523|NCT00246337|4233563|B9|Baseline Severity data missing||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|0|0.0||||||
4407524|NCT00246337|4233564|B8|Baseline Severity data missing||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|0|0.0||||||
4407525|NCT00246337|4233565|B7|Baseline Severity data missing||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|0|0.0||||||
4407526|NCT00246337|4233566|B6|Baseline Severity data missing||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|1|1.0||||||
4407527|NCT00246337|4233567|B5|Baseline Severity data missing||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|0|0.0||||||
4407528|NCT00246337|4233568|B4|Baseline Severity data missing||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|0|0.0||||||
4407529|NCT00246337|4233569|B3|Baseline Severity data missing||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|0|0.0||||||
4407530|NCT00246337|4233570|B2|Baseline Severity data missing||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|0|0.0||||||
4407531|NCT00246337|4233571|B1|Baseline Severity data missing||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|0|0.0||||||
4407532|NCT00246337|4233562|B10|Severe||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|90|90.0||||||
4407533|NCT00246337|4233563|B9|Severe||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|7|7.0||||||
4407570|NCT00246337|4233570|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407534|NCT00246337|4233564|B8|Severe||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|10|10.0||||||
4407535|NCT00246337|4233565|B7|Severe||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|11|11.0||||||
4407536|NCT00246337|4233566|B6|Severe||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|12|12.0||||||
4407537|NCT00246337|4233567|B5|Severe||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|6|6.0||||||
4407538|NCT00246337|4233568|B4|Severe||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|1|1.0||||||
4407539|NCT00246337|4233569|B3|Severe||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|6|6.0||||||
4407540|NCT00246337|4233570|B2|Severe||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|3|3.0||||||
4407541|NCT00246337|4233571|B1|Severe||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|34|34.0||||||
4407542|NCT00246337|4233562|B10|Moderate||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|239|239.0||||||
4407543|NCT00246337|4233563|B9|Moderate||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|27|27.0||||||
4407544|NCT00246337|4233564|B8|Moderate||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|30|30.0||||||
4407545|NCT00246337|4233565|B7|Moderate||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|34|34.0||||||
4407546|NCT00246337|4233566|B6|Moderate||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|26|26.0||||||
4407547|NCT00246337|4233567|B5|Moderate||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|6|6.0||||||
4407548|NCT00246337|4233568|B4|Moderate||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|15|15.0||||||
4407549|NCT00246337|4233569|B3|Moderate||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|9|9.0||||||
4407550|NCT00246337|4233570|B2|Moderate||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|11|11.0||||||
4407551|NCT00246337|4233571|B1|Moderate||Baseline Severity|Baseline severity was self-reported by the participant and recorded in the take-home diary. Migraine pain was rated on a 4-point scale (No Pain=0, Mild Pain=1, Moderate Pain=2, Severe Pain=3).|Participants|Number|81|81.0||||||
4407552|NCT00246337|4233562|B10|Multi-Racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407553|NCT00246337|4233563|B9|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407554|NCT00246337|4233564|B8|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407555|NCT00246337|4233565|B7|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407556|NCT00246337|4233566|B6|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407557|NCT00246337|4233567|B5|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407558|NCT00246337|4233568|B4|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407559|NCT00246337|4233569|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407560|NCT00246337|4233570|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407561|NCT00246337|4233571|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407562|NCT00246337|4233562|B10|Hispanic American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4407563|NCT00246337|4233563|B9|Hispanic American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407564|NCT00246337|4233564|B8|Hispanic American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407565|NCT00246337|4233565|B7|Hispanic American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407566|NCT00246337|4233566|B6|Hispanic American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4407567|NCT00246337|4233567|B5|Hispanic American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407568|NCT00246337|4233568|B4|Hispanic American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407569|NCT00246337|4233569|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407571|NCT00246337|4233571|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4407572|NCT00246337|4233562|B10|European||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407573|NCT00246337|4233563|B9|European||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407574|NCT00246337|4233564|B8|European||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407575|NCT00246337|4233565|B7|European||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407576|NCT00246337|4233566|B6|European||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407577|NCT00246337|4233567|B5|European||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407578|NCT00246337|4233568|B4|European||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407579|NCT00246337|4233569|B3|European||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407580|NCT00246337|4233570|B2|European||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407581|NCT00246337|4233571|B1|European||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407582|NCT00246337|4233562|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407583|NCT00246337|4233563|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407584|NCT00246337|4233564|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407585|NCT00246337|4233565|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407586|NCT00246337|4233566|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407587|NCT00246337|4233567|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407588|NCT00246337|4233568|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407589|NCT00246337|4233569|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407590|NCT00246337|4233570|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407591|NCT00246337|4233571|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407592|NCT00246337|4233562|B10|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4407593|NCT00246337|4233563|B9|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407594|NCT00246337|4233564|B8|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407595|NCT00246337|4233565|B7|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407596|NCT00246337|4233566|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407597|NCT00246337|4233567|B5|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407598|NCT00246337|4233568|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407599|NCT00246337|4233569|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407600|NCT00246337|4233570|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407601|NCT00246337|4233571|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407602|NCT00246337|4233562|B10|Black||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4407603|NCT00246337|4233563|B9|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4407604|NCT00246337|4233564|B8|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4407605|NCT00246337|4233565|B7|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4407606|NCT00246337|4233566|B6|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4407607|NCT00246337|4233567|B5|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4407608|NCT00246337|4233568|B4|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4407609|NCT00246337|4233569|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4407610|NCT00246337|4233570|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4407611|NCT00246337|4233571|B1|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4407612|NCT00246337|4233562|B10|White||Race/Ethnicity, Customized||participants|Number|259|259.0||||||
4407613|NCT00246337|4233563|B9|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4407614|NCT00246337|4233564|B8|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4407615|NCT00246337|4233565|B7|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4407616|NCT00246337|4233566|B6|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4407617|NCT00246337|4233567|B5|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4407618|NCT00246337|4233568|B4|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4407619|NCT00246337|4233569|B3|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4407620|NCT00246337|4233570|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4407621|NCT00246337|4233571|B1|White||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4407622|NCT00246337|4233562|B10||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4407623|NCT00246337|4233563|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4407624|NCT00246337|4233564|B8||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4407625|NCT00246337|4233565|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4407626|NCT00246337|4233566|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4407627|NCT00246337|4233567|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4407628|NCT00246337|4233568|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4407629|NCT00246337|4233569|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4407630|NCT00246337|4233570|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4407631|NCT00246337|4233571|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4407632|NCT00246337|4233562|B10||Female|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4407633|NCT00246337|4233563|B9||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4407634|NCT00246337|4233564|B8||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4407635|NCT00246337|4233565|B7||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4407636|NCT00246337|4233566|B6||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4407637|NCT00246337|4233567|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4407638|NCT00246337|4233568|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4407639|NCT00246337|4233569|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4407640|NCT00246337|4233570|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4407641|NCT00246337|4233571|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4407642|NCT00246337|4233562|B10|||Age||years|Mean|41.5|41.5|Standard Deviation|10.9|10.9|||
4407643|NCT00246337|4233563|B9|||Age||years|Mean|40.2|40.2|Standard Deviation|10.8|10.8|||
4407644|NCT00246337|4233564|B8|||Age||years|Mean|44.5|44.5|Standard Deviation|12.0|12.0|||
4407645|NCT00246337|4233565|B7|||Age||years|Mean|40.1|40.1|Standard Deviation|11.9|11.9|||
4407646|NCT00246337|4233566|B6|||Age||years|Mean|40.5|40.5|Standard Deviation|10.4|10.4|||
4407647|NCT00246337|4233567|B5|||Age||years|Mean|34.3|34.3|Standard Deviation|11.7|11.7|||
4407648|NCT00246337|4233568|B4|||Age||years|Mean|40.9|40.9|Standard Deviation|7.5|7.5|||
4407649|NCT00246337|4233569|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|10.9|10.9|||
4407650|NCT00246337|4233570|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|10.1|10.1|||
4407651|NCT00246337|4233571|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|10.6|10.6|||
4407652|NCT00246324|4233626|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4407653|NCT00246324|4233626|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4407654|NCT00246324|4233626|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4407655|NCT00246324|4233626|B1|||Age||years|Mean|44.5|44.5|Standard Deviation|10.6|10.6|||
4407656|NCT00246324|4233626|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407657|NCT00246324|4233626|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4407658|NCT00246324|4233626|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407659|NCT00246259|4233631|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4407660|NCT00246259|4233632|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4407661|NCT00246259|4233633|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4407662|NCT00246259|4233631|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4407663|NCT00246259|4233632|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4407664|NCT00246259|4233633|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4407665|NCT00246259|4233631|B3|||Age||Years|Mean|22.7|22.7|Standard Deviation|3.03|3.03|||
4407666|NCT00246259|4233632|B2|||Age||Years|Mean|23.0|23.0|Standard Deviation|2.93|2.93|||
4407667|NCT00246259|4233633|B1|||Age||Years|Mean|22.5|22.5|Standard Deviation|3.12|3.12|||
4407668|NCT00246090|4233668|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4407669|NCT00246090|4233668|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4407670|NCT00246090|4233668|B1|White||Race/Ethnicity, Customized||participants|Number|199|199.0||||||
4407671|NCT00246090|4233668|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4407672|NCT00246090|4233668|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4407673|NCT00246090|4233668|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407674|NCT00246090|4233668|B1||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4407675|NCT00246090|4233668|B1|||Age|Safety Population|years|Mean|55.4|55.4|Standard Deviation|10.8|10.8|||
4407676|NCT00246025|4233673|B5||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4407677|NCT00246025|4233674|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4407678|NCT00246025|4233675|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4407679|NCT00246025|4233676|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4407680|NCT00246025|4233677|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4407681|NCT00246025|4233673|B5||Female|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4407682|NCT00246025|4233674|B4||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4407683|NCT00246025|4233675|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4407684|NCT00246025|4233676|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4407685|NCT00246025|4233677|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4407686|NCT00246025|4233673|B5|||Age||years|Mean|71.6|71.6|Standard Deviation|7.8|7.8|||
4407687|NCT00246025|4233674|B4|||Age||years|Mean|72.7|72.7|Standard Deviation|6.8|6.8|||
4407688|NCT00246025|4233675|B3|||Age||years|Mean|70.9|70.9|Standard Deviation|7.7|7.7|||
4407689|NCT00246025|4233676|B2|||Age||years|Mean|71.3|71.3|Standard Deviation|7.9|7.9|||
4407690|NCT00246025|4233677|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|8.5|8.5|||
4407691|NCT00246012|4233730|B10|United States||Region of Enrollment||Participants|Number|74|74.0||||||
4407692|NCT00246012|4233731|B9|United States||Region of Enrollment||Participants|Number|14|14.0||||||
4407693|NCT00246012|4233732|B8|United States||Region of Enrollment||Participants|Number|19|19.0||||||
4407694|NCT00246012|4233733|B7|United States||Region of Enrollment||Participants|Number|10|10.0||||||
4407695|NCT00246012|4233734|B6|United States||Region of Enrollment||Participants|Number|16|16.0||||||
4407696|NCT00246012|4233735|B5|United States||Region of Enrollment||Participants|Number|3|3.0||||||
4407697|NCT00246012|4233736|B4|United States||Region of Enrollment||Participants|Number|3|3.0||||||
4407698|NCT00246012|4233737|B3|United States||Region of Enrollment||Participants|Number|3|3.0||||||
4407699|NCT00246012|4233738|B2|United States||Region of Enrollment||Participants|Number|3|3.0||||||
4407700|NCT00246012|4233739|B1|United States||Region of Enrollment||Participants|Number|3|3.0||||||
4407701|NCT00246012|4233730|B10|United Kingdom||Region of Enrollment||Participants|Number|24|24.0||||||
4407702|NCT00246012|4233731|B9|United Kingdom||Region of Enrollment||Participants|Number|5|5.0||||||
4407703|NCT00246012|4233732|B8|United Kingdom||Region of Enrollment||Participants|Number|4|4.0||||||
4407704|NCT00246012|4233733|B7|United Kingdom||Region of Enrollment||Participants|Number|9|9.0||||||
4407705|NCT00246012|4233734|B6|United Kingdom||Region of Enrollment||Participants|Number|6|6.0||||||
4407706|NCT00246012|4233735|B5|United Kingdom||Region of Enrollment||Participants|Number|0|0.0||||||
4407707|NCT00246012|4233736|B4|United Kingdom||Region of Enrollment||Participants|Number|0|0.0||||||
4407708|NCT00246012|4233737|B3|United Kingdom||Region of Enrollment||Participants|Number|0|0.0||||||
4407709|NCT00246012|4233738|B2|United Kingdom||Region of Enrollment||Participants|Number|0|0.0||||||
4407710|NCT00246012|4233739|B1|United Kingdom||Region of Enrollment||Participants|Number|0|0.0||||||
4407711|NCT00246012|4233730|B10|Germany||Region of Enrollment||Participants|Number|44|44.0||||||
4407712|NCT00246012|4233731|B9|Germany||Region of Enrollment||Participants|Number|13|13.0||||||
4407713|NCT00246012|4233732|B8|Germany||Region of Enrollment||Participants|Number|10|10.0||||||
4407714|NCT00246012|4233733|B7|Germany||Region of Enrollment||Participants|Number|12|12.0||||||
4407715|NCT00246012|4233734|B6|Germany||Region of Enrollment||Participants|Number|9|9.0||||||
4407716|NCT00246012|4233735|B5|Germany||Region of Enrollment||Participants|Number|0|0.0||||||
4407717|NCT00246012|4233736|B4|Germany||Region of Enrollment||Participants|Number|0|0.0||||||
4407718|NCT00246012|4233737|B3|Germany||Region of Enrollment||Participants|Number|0|0.0||||||
4407719|NCT00246012|4233738|B2|Germany||Region of Enrollment||Participants|Number|0|0.0||||||
4407720|NCT00246012|4233739|B1|Germany||Region of Enrollment||Participants|Number|0|0.0||||||
4407721|NCT00246012|4233730|B10||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4407722|NCT00246012|4233731|B9||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4407723|NCT00246012|4233732|B8||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4407724|NCT00246012|4233733|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4407725|NCT00246012|4233734|B6||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4407726|NCT00246012|4233735|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4407727|NCT00246012|4233736|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4407728|NCT00246012|4233737|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4407729|NCT00246012|4233738|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4407730|NCT00246012|4233739|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4407731|NCT00246012|4233730|B10||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4407732|NCT00246012|4233731|B9||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4407733|NCT00246012|4233732|B8||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4407734|NCT00246012|4233733|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4407735|NCT00246012|4233734|B6||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4407736|NCT00246012|4233735|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4407737|NCT00246012|4233736|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4407738|NCT00246012|4233737|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4407739|NCT00246012|4233738|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4407740|NCT00246012|4233739|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4407741|NCT00246012|4233730|B10|||Age||Years|Mean|61.8|61.8|Standard Deviation|12.87|12.87|||
4407742|NCT00246012|4233731|B9|||Age||Years|Mean|57.2|57.2|Standard Deviation|11.45|11.45|||
4407743|NCT00246012|4233732|B8|||Age||Years|Mean|61.5|61.5|Standard Deviation|12.39|12.39|||
4407744|NCT00246012|4233733|B7|||Age||Years|Mean|67.3|67.3|Standard Deviation|11.44|11.44|||
4407745|NCT00246012|4233734|B6|||Age||Years|Mean|63.5|63.5|Standard Deviation|14.17|14.17|||
4407746|NCT00246012|4233735|B5|||Age||Years|Mean|66.0|66.0|Standard Deviation|18.73|18.73|||
4407747|NCT00246012|4233736|B4|||Age||Years|Mean|52.7|52.7|Standard Deviation|15.01|15.01|||
4407748|NCT00246012|4233737|B3|||Age||Years|Mean|61.7|61.7|Standard Deviation|11.59|11.59|||
4407749|NCT00246012|4233738|B2|||Age||Years|Mean|46.7|46.7|Standard Deviation|6.66|6.66|||
4407750|NCT00246012|4233739|B1|||Age||Years|Mean|62.0|62.0|Standard Deviation|10.82|10.82|||
4407751|NCT00245960|4233840|B3||Male|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
4407752|NCT00245960|4233841|B2||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4407753|NCT00245960|4233842|B1||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4407754|NCT00245960|4233840|B3||Female|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4407755|NCT00245960|4233841|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4407756|NCT00245960|4233842|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4407757|NCT00245960|4233840|B3|||Age||years|Mean|46.52|46.52|Standard Deviation|11.40|11.4|||
4407758|NCT00245960|4233841|B2|||Age||years|Mean|46.93|46.93|Standard Deviation|11.41|11.41|||
4407759|NCT00245960|4233842|B1|||Age||years|Mean|46.11|46.11|Standard Deviation|11.39|11.39|||
4407760|NCT00245856|4233851|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4407761|NCT00245856|4233851|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4407762|NCT00245856|4233851|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4407763|NCT00245856|4233851|B1|||Age||years|Mean|52|52.0|Standard Deviation|30|30.0|||
4407764|NCT00245856|4233851|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4407765|NCT00245856|4233851|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4407766|NCT00245856|4233851|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407767|NCT00245635|4233859|B3|||BDD-Y-BOCS|Total scores at Baseline on the Body Dysmorphic Disorder-Yale-Brown Obsessive Compulsive Scale (BDD-Y-BOCS)|units on a scale|Mean|32.65|32.65|Standard Deviation|5.02|5.02|||
4407768|NCT00245635|4233860|B2|||BDD-Y-BOCS|Total scores at Baseline on the Body Dysmorphic Disorder-Yale-Brown Obsessive Compulsive Scale (BDD-Y-BOCS)|units on a scale|Mean|35.16|35.16|Standard Deviation|5.10|5.1|||
4407769|NCT00245635|4233861|B1|||BDD-Y-BOCS|Total scores at Baseline on the Body Dysmorphic Disorder-Yale-Brown Obsessive Compulsive Scale (BDD-Y-BOCS)|units on a scale|Mean|30.84|30.84|Standard Deviation|4.2|4.2|||
4407770|NCT00245635|4233859|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4407771|NCT00245635|4233860|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4407772|NCT00245635|4233861|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4407773|NCT00245635|4233859|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4407774|NCT00245635|4233860|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4407775|NCT00245635|4233861|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4407776|NCT00245635|4233859|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4407777|NCT00245635|4233860|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4407778|NCT00245635|4233861|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4407779|NCT00245635|4233859|B3|||Age||years|Mean|14.96|14.96|Full Range|||9.0|18.0|
4407780|NCT00245635|4233860|B2|||Age||years|Mean|14.88|14.88|Full Range|||10.0|18.0|
4407781|NCT00245635|4233861|B1|||Age||years|Mean|15.04|15.04|Full Range|||9.0|18.0|
4407782|NCT00245570|4233868|B1|||Time to recovery from maximal percent fall|The duration between the time at which the maximum percent fall in FEV1 occurs and the time when FEV1 returns to within 5% of the preexercise baseline for the first time.|Minutes|Mean|55.03|55.03|Standard Deviation|32.62|32.62|||
4407783|NCT00245570|4233868|B1|||Maximum percent fall in forced expiratory volume in 1 second (FEV1) post-exercise challenge||Percent Change from Baseline|Mean|27.75|27.75|Standard Deviation|6.26|6.26|||
4407784|NCT00245570|4233868|B1|||Area under the FEV1 percent change from baseline time curve for 0-60 mins after exercise challenge||% * minutes|Mean|957.46|957.46|Standard Deviation|518.69|518.69|||
4407785|NCT00245570|4233868|B1|Yes||Need for β-agonist rescue medication following exercise challenge||participants|Number|16|16.0||||||
4407786|NCT00245570|4233868|B1|No||Need for β-agonist rescue medication following exercise challenge||participants|Number|31|31.0||||||
4407787|NCT00245570|4233868|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4407788|NCT00245570|4233868|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4407789|NCT00245570|4233868|B1|||Age||years|Mean|26.0|26.0|Standard Deviation|7.92|7.92|||
4407790|NCT00245557|4233917|B3|United States||Region of Enrollment||participants|Number|43.0|43.0||||||
4407791|NCT00245557|4233918|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4407792|NCT00245557|4233919|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4407793|NCT00245557|4233917|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4407794|NCT00245557|4233918|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4407795|NCT00245557|4233919|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4407796|NCT00245557|4233917|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4407797|NCT00245557|4233918|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4407798|NCT00245557|4233919|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4407799|NCT00245557|4233917|B3|||Age||years|Mean|70.6|70.6|Standard Deviation|8.9|8.9|||
4407800|NCT00245557|4233918|B2|||Age||years|Mean|69.3|69.3|Standard Deviation|10.7|10.7|||
4407801|NCT00245557|4233919|B1|||Age||years|Mean|72.6|72.6|Standard Deviation|4.8|4.8|||
4407802|NCT00245557|4233917|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4407803|NCT00245557|4233918|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4407804|NCT00245557|4233919|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4407805|NCT00245557|4233917|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4407806|NCT00245557|4233918|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4407807|NCT00245557|4233919|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4407808|NCT00245557|4233917|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407809|NCT00245557|4233918|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407810|NCT00245557|4233919|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407811|NCT00245518|4233931|B3|United States||Region of Enrollment||Participants|Count of Participants|33|33.0||||||
4407812|NCT00245518|4233932|B2|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4407813|NCT00245518|4233933|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4407814|NCT00245518|4233931|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4407815|NCT00245518|4233932|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4407816|NCT00245518|4233933|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4407817|NCT00245518|4233931|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407818|NCT00245518|4233932|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407819|NCT00245518|4233933|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407820|NCT00245518|4233931|B3|>= 21 years||Age, Customized||Participants|Count of Participants|33|33.0||||||
4407821|NCT00245518|4233932|B2|>= 21 years||Age, Customized||Participants|Count of Participants|16|16.0||||||
4407822|NCT00245518|4233933|B1|>= 21 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
4407823|NCT00245466|4234004|B4|||Weight||kilogram|Mean|77.5|77.5|Standard Deviation|12.0|12.0|||
4407824|NCT00245466|4234005|B3|||Weight||kilogram|Mean|76.3|76.3|Standard Deviation|9.78|9.78|||
4407825|NCT00245466|4234006|B2|||Weight||kilogram|Mean|78.5|78.5|Standard Deviation|14.2|14.2|||
4407826|NCT00245466|4234007|B1|||Weight||kilogram|Mean|77.6|77.6|Standard Deviation|11.4|11.4|||
4407827|NCT00245466|4234004|B4|||Serum testosterone levels||nanogram per milliliter|Median|3.98|3.98|Inter-Quartile Range|||3.21|5.53|
4407828|NCT00245466|4234005|B3|||Serum testosterone levels||nanogram per milliliter|Median|4.70|4.7|Inter-Quartile Range|||3.54|5.77|
4407829|NCT00245466|4234006|B2|||Serum testosterone levels||nanogram per milliliter|Median|4.11|4.11|Inter-Quartile Range|||3.32|5.73|
4407830|NCT00245466|4234007|B1|||Serum testosterone levels||nanogram per milliliter|Median|3.74|3.74|Inter-Quartile Range|||3.08|4.94|
4407831|NCT00245466|4234004|B4|||Body mass index|Body mass index is a measure of body fat based on height and weight.|kilogram per square meter|Mean|26.4|26.4|Standard Deviation|3.93|3.93|||
4407832|NCT00245466|4234005|B3|||Body mass index|Body mass index is a measure of body fat based on height and weight.|kilogram per square meter|Mean|25.9|25.9|Standard Deviation|3.93|3.93|||
4407833|NCT00245466|4234006|B2|||Body mass index|Body mass index is a measure of body fat based on height and weight.|kilogram per square meter|Mean|26.6|26.6|Standard Deviation|4.06|4.06|||
4407834|NCT00245466|4234007|B1|||Body mass index|Body mass index is a measure of body fat based on height and weight.|kilogram per square meter|Mean|26.6|26.6|Standard Deviation|4.15|4.15|||
4407835|NCT00245466|4234004|B4|Not classifiable||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4407836|NCT00245466|4234005|B3|Not classifiable||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|0|0.0||||||
4407837|NCT00245466|4234006|B2|Not classifiable||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4407838|NCT00245466|4234007|B1|Not classifiable||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4407839|NCT00245466|4234004|B4|Metastatic||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|42|42.0||||||
4407840|NCT00245466|4234005|B3|Metastatic||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|17|17.0||||||
4407841|NCT00245466|4234006|B2|Metastatic||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|14|14.0||||||
4407842|NCT00245466|4234007|B1|Metastatic||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|11|11.0||||||
4407843|NCT00245466|4234004|B4|Locally advanced||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|60|60.0||||||
4407867|NCT00245466|4234004|B4|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|9|9.0||||||
4407844|NCT00245466|4234005|B3|Locally advanced||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|18|18.0||||||
4407845|NCT00245466|4234006|B2|Locally advanced||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|21|21.0||||||
4407846|NCT00245466|4234007|B1|Locally advanced||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|21|21.0||||||
4407847|NCT00245466|4234004|B4|Localized||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|22|22.0||||||
4407848|NCT00245466|4234005|B3|Localized||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4407849|NCT00245466|4234006|B2|Localized||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|9|9.0||||||
4407850|NCT00245466|4234007|B1|Localized||Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|8|8.0||||||
4407851|NCT00245466|4234004|B4|No||Number of Participants With Curative Intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|126|126.0||||||
4407852|NCT00245466|4234005|B3|No||Number of Participants With Curative Intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|39|39.0||||||
4407853|NCT00245466|4234006|B2|No||Number of Participants With Curative Intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|44|44.0||||||
4407854|NCT00245466|4234007|B1|No||Number of Participants With Curative Intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|43|43.0||||||
4407855|NCT00245466|4234004|B4|Yes||Number of Participants With Curative Intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|3|3.0||||||
4407856|NCT00245466|4234005|B3|Yes||Number of Participants With Curative Intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|1|1.0||||||
4407857|NCT00245466|4234006|B2|Yes||Number of Participants With Curative Intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|2|2.0||||||
4407858|NCT00245466|4234007|B1|Yes||Number of Participants With Curative Intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|0|0.0||||||
4407859|NCT00245466|4234004|B4|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|88|88.0||||||
4407860|NCT00245466|4234005|B3|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|26|26.0||||||
4407861|NCT00245466|4234006|B2|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|34|34.0||||||
4407862|NCT00245466|4234007|B1|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|28|28.0||||||
4407863|NCT00245466|4234004|B4|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|29|29.0||||||
4407864|NCT00245466|4234005|B3|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|11|11.0||||||
4407865|NCT00245466|4234006|B2|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|7|7.0||||||
4407866|NCT00245466|4234007|B1|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|11|11.0||||||
4407868|NCT00245466|4234005|B3|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|2|2.0||||||
4407869|NCT00245466|4234006|B2|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|4|4.0||||||
4407870|NCT00245466|4234007|B1|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|3|3.0||||||
4407871|NCT00245466|4234004|B4|Unknown||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|3|3.0||||||
4407872|NCT00245466|4234005|B3|Unknown||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4407873|NCT00245466|4234006|B2|Unknown||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4407874|NCT00245466|4234007|B1|Unknown||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4407875|NCT00245466|4234004|B4|Afro-Carribean||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407876|NCT00245466|4234005|B3|Afro-Carribean||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407877|NCT00245466|4234006|B2|Afro-Carribean||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407878|NCT00245466|4234007|B1|Afro-Carribean||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407879|NCT00245466|4234004|B4|Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407880|NCT00245466|4234005|B3|Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407881|NCT00245466|4234006|B2|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407882|NCT00245466|4234007|B1|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407883|NCT00245466|4234004|B4|White||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
4407884|NCT00245466|4234005|B3|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4407885|NCT00245466|4234006|B2|White||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4407886|NCT00245466|4234007|B1|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4407887|NCT00245466|4234004|B4|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4407888|NCT00245466|4234005|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407889|NCT00245466|4234006|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4407890|NCT00245466|4234007|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407891|NCT00245466|4234004|B4||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4407892|NCT00245466|4234005|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4407893|NCT00245466|4234006|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4407894|NCT00245466|4234007|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4407895|NCT00245466|4234004|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407896|NCT00245466|4234005|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407897|NCT00245466|4234006|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407898|NCT00245466|4234007|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407899|NCT00245466|4234004|B4|||Age||years|Mean|72.7|72.7|Standard Deviation|6.97|6.97|||
4407900|NCT00245466|4234005|B3|||Age||years|Mean|71.8|71.8|Standard Deviation|7.08|7.08|||
4407901|NCT00245466|4234006|B2|||Age||years|Mean|73.7|73.7|Standard Deviation|7.22|7.22|||
4407902|NCT00245466|4234007|B1|||Age||years|Mean|72.4|72.4|Standard Deviation|6.60|6.6|||
4407903|NCT00245466|4234004|B4||>=65 years|Age||Participants|Count of Participants|111|111.0||||||
4407904|NCT00245466|4234005|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4407905|NCT00245466|4234006|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4407906|NCT00245466|4234007|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4407907|NCT00245466|4234004|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4407908|NCT00245466|4234005|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4407909|NCT00245466|4234006|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4407910|NCT00245466|4234007|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4407911|NCT00245466|4234004|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407912|NCT00245466|4234005|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407913|NCT00245466|4234006|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407914|NCT00245466|4234007|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407915|NCT00245219|4234023|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4407916|NCT00245219|4234024|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4407917|NCT00245219|4234025|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4407918|NCT00245219|4234026|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4407919|NCT00245219|4234023|B4|Black, African-American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4407920|NCT00245219|4234024|B3|Black, African-American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4407921|NCT00245219|4234025|B2|Black, African-American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4407922|NCT00245219|4234026|B1|Black, African-American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4407923|NCT00245219|4234023|B4|White, Caucasian||Race/Ethnicity, Customized||participants|Number|220|220.0||||||
4407924|NCT00245219|4234024|B3|White, Caucasian||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4407925|NCT00245219|4234025|B2|White, Caucasian||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4407926|NCT00245219|4234026|B1|White, Caucasian||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4407927|NCT00245219|4234023|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407928|NCT00245219|4234024|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407929|NCT00245219|4234025|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407930|NCT00245219|4234026|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4407931|NCT00245219|4234023|B4||Female|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4407932|NCT00245219|4234024|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4407933|NCT00245219|4234025|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4407934|NCT00245219|4234026|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4407935|NCT00245219|4234023|B4|||Age||years|Mean|50.96|50.96|Standard Deviation|9.61|9.61|||
4407936|NCT00245219|4234024|B3|||Age||years|Mean|49.68|49.68|Standard Deviation|8.64|8.64|||
4407937|NCT00245219|4234025|B2|||Age||years|Mean|51.40|51.4|Standard Deviation|10.19|10.19|||
4407938|NCT00245219|4234026|B1|||Age||years|Mean|51.26|51.26|Standard Deviation|9.56|9.56|||
4407939|NCT00245128|4234042|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4407940|NCT00245128|4234042|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4407941|NCT00245128|4234042|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4407942|NCT00245128|4234042|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|11.00303|11.00303|||
4407943|NCT00245128|4234042|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4407944|NCT00245128|4234042|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4407945|NCT00245128|4234042|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407946|NCT00245102|4234046|B7|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4407947|NCT00245102|4234047|B6|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4407948|NCT00245102|4234048|B5|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4407949|NCT00245102|4234049|B4|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4407950|NCT00245102|4234050|B3|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4407951|NCT00245102|4234051|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4407952|NCT00245102|4234052|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4407953|NCT00245102|4234046|B7|United States||Region of Enrollment||participants|Number|146|146.0||||||
4407954|NCT00245102|4234047|B6|United States||Region of Enrollment||participants|Number|23|23.0||||||
4407955|NCT00245102|4234048|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
4407956|NCT00245102|4234049|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
4407957|NCT00245102|4234050|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4407958|NCT00245102|4234051|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4407959|NCT00245102|4234052|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4407960|NCT00245102|4234046|B7||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4407961|NCT00245102|4234047|B6||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4407962|NCT00245102|4234048|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4407963|NCT00245102|4234049|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4407964|NCT00245102|4234050|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4407965|NCT00245102|4234051|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4407966|NCT00245102|4234052|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4407967|NCT00245102|4234046|B7||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4407968|NCT00245102|4234047|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4407969|NCT00245102|4234048|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4407970|NCT00245102|4234049|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4407971|NCT00245102|4234050|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4407972|NCT00245102|4234051|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4407973|NCT00245102|4234052|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4407974|NCT00245102|4234046|B7|||Age||years|Mean|54|54.0|Standard Deviation|50.91168825|50.91168825|||
4407975|NCT00245102|4234047|B6|||Age||years|Mean|44|44.0|Standard Deviation|31.11269837|31.11269837|||
4407976|NCT00245102|4234048|B5|||Age||years|Mean|43.5|43.5|Standard Deviation|10.60660172|10.60660172|||
4407977|NCT00245102|4234049|B4|||Age||years|Mean|62.5|62.5|Standard Deviation|31.81980515|31.81980515|||
4407978|NCT00245102|4234050|B3|||Age||years|Mean|56|56.0|Standard Deviation|33.9411255|33.9411255|||
4407979|NCT00245102|4234051|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|34.64823228|34.64823228|||
4407980|NCT00245102|4234052|B1|||Age||years|Mean|54|54.0|Standard Deviation|50.91168825|50.91168825|||
4407981|NCT00245102|4234046|B7||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4407982|NCT00245102|4234047|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4407983|NCT00245102|4234048|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4407984|NCT00245102|4234049|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4407985|NCT00245102|4234050|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4407986|NCT00245102|4234051|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4407987|NCT00245102|4234052|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4407988|NCT00245102|4234046|B7||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4407989|NCT00245102|4234047|B6||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4407990|NCT00245102|4234048|B5||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4407991|NCT00245102|4234049|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4407992|NCT00245102|4234050|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4407993|NCT00245102|4234051|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4407994|NCT00245102|4234052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4407995|NCT00245102|4234046|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407996|NCT00245102|4234047|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407997|NCT00245102|4234048|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407998|NCT00245102|4234049|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4407999|NCT00245102|4234050|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408000|NCT00245102|4234051|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408001|NCT00245102|4234052|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408002|NCT00245063|4234071|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4408003|NCT00245063|4234072|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4408004|NCT00245063|4234073|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4408005|NCT00245063|4234071|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4408006|NCT00245063|4234072|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4408007|NCT00245063|4234073|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4408008|NCT00245063|4234071|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4408009|NCT00245063|4234072|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4408010|NCT00245063|4234073|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4408011|NCT00245063|4234071|B3|||Age||years|Median|61|61.0|Full Range|||37.0|86.0|
4408012|NCT00245063|4234072|B2|||Age||years|Median|60|60.0|Full Range|||37.0|78.0|
4408013|NCT00245063|4234073|B1|||Age||years|Median|63|63.0|Full Range|||51.0|86.0|
4408014|NCT00245050|4234080|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4408015|NCT00245050|4234081|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4408016|NCT00245050|4234082|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4408017|NCT00245050|4234080|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408018|NCT00245050|4234081|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408019|NCT00245050|4234082|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408020|NCT00245050|4234080|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4408021|NCT00245050|4234081|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4408022|NCT00245050|4234082|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4408023|NCT00245050|4234080|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|10.2|10.2|||
4408024|NCT00245050|4234081|B2|||Age||years|Mean|65.9|65.9|Standard Deviation|11.0|11.0|||
4408025|NCT00245050|4234082|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|9.4|9.4|||
4408026|NCT00245050|4234080|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4408027|NCT00245050|4234081|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4408028|NCT00245050|4234082|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4408029|NCT00245050|4234080|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4408030|NCT00245050|4234081|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4408031|NCT00245050|4234082|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4408032|NCT00245050|4234080|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408033|NCT00245050|4234081|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408034|NCT00245050|4234082|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408035|NCT00245037|4234091|B1||F/M|Donor/Recipient Gender||Participants|Count of Participants|30|30.0||||||
4408036|NCT00245037|4234091|B1||F/F, M/M, M/F|Donor/Recipient Gender||Participants|Count of Participants|117|117.0||||||
4408037|NCT00245037|4234091|B1||All other combinations|Cytomegalovirus (CMV) Status||Participants|Count of Participants|118|118.0||||||
4408038|NCT00245037|4234091|B1||-/- recipient/donor|Cytomegalovirus (CMV) Status||Participants|Count of Participants|22|22.0||||||
4408039|NCT00245037|4234091|B1||Unrelated Donor|Donor Relation||Participants|Count of Participants|108|108.0||||||
4408040|NCT00245037|4234091|B1||Related Sibling Donor|Donor Relation||Participants|Count of Participants|39|39.0||||||
4408041|NCT00245037|4234091|B1||7/8|HLA Match|"HLA Criteria:~Related to the patient and genotypically or phenotypically HLA-identical (8/8). Single antigen mismatch (7/8) can be accepted if no other donor is available.~OR~Unrelated to the patient and HLA matched by molecular typing, allowing a single allele or antigen mismatch (7/8)."|Participants|Count of Participants|12|12.0||||||
4408042|NCT00245037|4234091|B1||8/8|HLA Match|"HLA Criteria:~Related to the patient and genotypically or phenotypically HLA-identical (8/8). Single antigen mismatch (7/8) can be accepted if no other donor is available.~OR~Unrelated to the patient and HLA matched by molecular typing, allowing a single allele or antigen mismatch (7/8)."|Participants|Count of Participants|135|135.0||||||
4408043|NCT00245037|4234091|B1||High or Very High|Disease Risk Index (DRI)||Participants|Count of Participants|51|51.0||||||
4408044|NCT00245037|4234091|B1||Low or intermediate|Disease Risk Index (DRI)||Participants|Count of Participants|93|93.0||||||
4408045|NCT00245037|4234091|B1||Not in Complete Remission|Pre-Transplant Disease Status||Participants|Count of Participants|62|62.0||||||
4408046|NCT00245037|4234091|B1||In Complete Remission|Pre-Transplant Disease Status||Participants|Count of Participants|85|85.0||||||
4408047|NCT00245037|4234091|B1||KPS < 90|Karnofsky Performance Score (KPS)|"KPS Scale:~100 = Normal, no complaints, no evidence of disease. 90 = Able to carry on normal activity; minor signs or symptoms of disease. 80 = Normal activity with effort; some signs or symptoms of disease. 70 = Cares for self, unable to carry on normal activity or to do active work. 60 = Requires occasional assistance, but is able to care for most of his/her needs.~50 = Requires considerable assistance and frequent medical care. 40-0 = Not eligible"|Participants|Count of Participants|48|48.0||||||
4408048|NCT00245037|4234091|B1||KPS ≥ 90|Karnofsky Performance Score (KPS)|"KPS Scale:~100 = Normal, no complaints, no evidence of disease. 90 = Able to carry on normal activity; minor signs or symptoms of disease. 80 = Normal activity with effort; some signs or symptoms of disease. 70 = Cares for self, unable to carry on normal activity or to do active work. 60 = Requires occasional assistance, but is able to care for most of his/her needs.~50 = Requires considerable assistance and frequent medical care. 40-0 = Not eligible"|Participants|Count of Participants|91|91.0||||||
4408049|NCT00245037|4234091|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4408050|NCT00245037|4234091|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4408051|NCT00245037|4234091|B1||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4408052|NCT00245037|4234091|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4408053|NCT00245037|4234091|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408054|NCT00245011|4234101|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4408055|NCT00245011|4234101|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4408056|NCT00245011|4234101|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4408057|NCT00245011|4234101|B1|||Age||years|Median|18|18.0|Full Range|||14.0|30.0|
4408058|NCT00245011|4234101|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408059|NCT00245011|4234101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4408060|NCT00245011|4234101|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4408061|NCT00244985|4234105|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408062|NCT00244985|4234105|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408063|NCT00244985|4234105|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4408064|NCT00244985|4234105|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4408065|NCT00244985|4234105|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408066|NCT00244985|4234105|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408067|NCT00244985|4234105|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408068|NCT00244985|4234105|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4408069|NCT00244985|4234105|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4408070|NCT00244985|4234105|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|11.2|11.2|||
4408071|NCT00244985|4234105|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4408072|NCT00244985|4234105|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4408073|NCT00244985|4234105|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408074|NCT00244933|4234113|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4408075|NCT00244933|4234113|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408076|NCT00244933|4234113|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408077|NCT00244933|4234113|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4408078|NCT00244933|4234113|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4408079|NCT00244933|4234113|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408080|NCT00244933|4234113|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408081|NCT00244933|4234113|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408082|NCT00244933|4234113|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408083|NCT00244933|4234113|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4408084|NCT00244933|4234113|B1|||Age||years|Median|53|53.0|Inter-Quartile Range|||31.0|57.0|
4408085|NCT00244881|4234117|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4408086|NCT00244881|4234117|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408087|NCT00244881|4234117|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4408088|NCT00244881|4234117|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|11|11.0|||
4408089|NCT00244881|4234117|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4408090|NCT00244881|4234117|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4408091|NCT00244881|4234117|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408092|NCT00244855|4234123|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4408093|NCT00244855|4234124|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4408094|NCT00244855|4234125|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4408095|NCT00244855|4234123|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408096|NCT00244855|4234124|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408097|NCT00244855|4234125|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408098|NCT00244855|4234123|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408099|NCT00244855|4234124|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408100|NCT00244855|4234125|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408101|NCT00244855|4234123|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4408102|NCT00244855|4234124|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4408103|NCT00244855|4234125|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4408104|NCT00244855|4234123|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408105|NCT00244855|4234124|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408106|NCT00244855|4234125|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408107|NCT00244855|4234123|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408108|NCT00244855|4234124|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408109|NCT00244855|4234125|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408110|NCT00244855|4234123|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408111|NCT00244855|4234124|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408112|NCT00244855|4234125|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408113|NCT00244855|4234123|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408114|NCT00244855|4234124|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408115|NCT00244855|4234125|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408116|NCT00244855|4234123|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4408117|NCT00244855|4234124|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4408118|NCT00244855|4234125|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4408119|NCT00244855|4234123|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4408120|NCT00244855|4234124|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4408121|NCT00244855|4234125|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4408122|NCT00244855|4234123|B3|||Age||years|Median|64|64.0|Full Range|||38.0|85.0|
4408123|NCT00244855|4234124|B2|||Age||years|Median|64|64.0|Full Range|||38.0|85.0|
4408124|NCT00244855|4234125|B1|||Age||years|Median|67|67.0|Full Range|||42.0|79.0|
4408125|NCT00244855|4234123|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4408126|NCT00244855|4234124|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4408127|NCT00244855|4234125|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4408128|NCT00244855|4234123|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4408129|NCT00244855|4234124|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4408130|NCT00244855|4234125|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4408131|NCT00244855|4234123|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408132|NCT00244855|4234124|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408133|NCT00244855|4234125|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408134|NCT00244764|4234134|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4408135|NCT00244764|4234134|B1|Asian-Mixed Asian Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4408136|NCT00244764|4234134|B1|American Indian or Alaska Native and White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4408137|NCT00244764|4234134|B1|Asian-Central/South Asian Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4408138|NCT00244764|4234134|B1|African American/African Heritage (HER)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4408139|NCT00244764|4234134|B1|Asian-Japanese/East Asian/South East Asian HER||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4408140|NCT00244764|4234134|B1|White||Race/Ethnicity, Customized||participants|Number|178|178.0||||||
4408141|NCT00244764|4234134|B1||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4408142|NCT00244764|4234134|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4408143|NCT00244764|4234134|B1|||Age||years|Mean|59.8|59.8|Standard Deviation|10.33|10.33|||
4408144|NCT00244751|4234141|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408145|NCT00244751|4234142|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408146|NCT00244751|4234143|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408147|NCT00244751|4234144|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408148|NCT00244751|4234141|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408149|NCT00244751|4234142|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408150|NCT00244751|4234143|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408151|NCT00244751|4234144|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408152|NCT00244751|4234141|B4||White|Race (NIH/OMB)||Participants|Count of Participants|198|198.0||||||
4408153|NCT00244751|4234142|B3||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4408154|NCT00244751|4234143|B2||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4408155|NCT00244751|4234144|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4408156|NCT00244751|4234141|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4408157|NCT00244751|4234142|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4408158|NCT00244751|4234143|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4408159|NCT00244751|4234144|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4408160|NCT00244751|4234141|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408161|NCT00244751|4234142|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408162|NCT00244751|4234143|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408163|NCT00244751|4234144|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408164|NCT00244751|4234141|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4408165|NCT00244751|4234142|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4408166|NCT00244751|4234143|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4408167|NCT00244751|4234144|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4408168|NCT00244751|4234141|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4408169|NCT00244751|4234142|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4408170|NCT00244751|4234143|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4408171|NCT00244751|4234144|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4408172|NCT00244751|4234141|B4||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4408173|NCT00244751|4234142|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4408174|NCT00244751|4234143|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4408175|NCT00244751|4234144|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4408176|NCT00244751|4234141|B4||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4408177|NCT00244751|4234142|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4408178|NCT00244751|4234143|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4408179|NCT00244751|4234144|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4408180|NCT00244751|4234141|B4|||Age||Years|Mean|51.9|51.9|Standard Deviation|6.27|6.27|||
4408181|NCT00244751|4234142|B3|||Age||Years|Mean|51.4|51.4|Standard Deviation|5.81|5.81|||
4408182|NCT00244751|4234143|B2|||Age||Years|Mean|52.2|52.2|Standard Deviation|7.25|7.25|||
4408183|NCT00244751|4234144|B1|||Age||Years|Mean|52.1|52.1|Standard Deviation|5.64|5.64|||
4408184|NCT00244725|4234243|B5|Mixed Race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4408185|NCT00244725|4234244|B4|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4408186|NCT00244725|4234245|B3|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4408187|NCT00244725|4234246|B2|Mixed Race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4408188|NCT00244725|4234247|B1|Mixed Race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4408189|NCT00244725|4234243|B5|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|866|866.0||||||
4408190|NCT00244725|4234244|B4|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|220|220.0||||||
4408191|NCT00244725|4234245|B3|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|210|210.0||||||
4408192|NCT00244725|4234246|B2|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|224|224.0||||||
4408193|NCT00244725|4234247|B1|White - White/Caucasian/European Heritage||Race/Ethnicity, Customized||Participants|Number|212|212.0||||||
4408194|NCT00244725|4234243|B5|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4408195|NCT00244725|4234244|B4|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4408196|NCT00244725|4234245|B3|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4408197|NCT00244725|4234246|B2|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4408198|NCT00244725|4234247|B1|White - Arabic/North African Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4408199|NCT00244725|4234243|B5|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4408200|NCT00244725|4234244|B4|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4408201|NCT00244725|4234245|B3|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4408202|NCT00244725|4234246|B2|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4408203|NCT00244725|4234247|B1|Asian - South East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4408204|NCT00244725|4234243|B5|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4408205|NCT00244725|4234244|B4|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4408206|NCT00244725|4234245|B3|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4408207|NCT00244725|4234246|B2|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4408208|NCT00244725|4234247|B1|Asian - East Asian Heritage||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4408209|NCT00244725|4234243|B5|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4408210|NCT00244725|4234244|B4|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4408211|NCT00244725|4234245|B3|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4408212|NCT00244725|4234246|B2|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4408213|NCT00244725|4234247|B1|Asian - Central/South Asian Heritage||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4408214|NCT00244725|4234243|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4408215|NCT00244725|4234244|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4408216|NCT00244725|4234245|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4408217|NCT00244725|4234246|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4408218|NCT00244725|4234247|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4408219|NCT00244725|4234243|B5|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|67|67.0||||||
4408220|NCT00244725|4234244|B4|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4408221|NCT00244725|4234245|B3|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4408222|NCT00244725|4234246|B2|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4408223|NCT00244725|4234247|B1|African American/African Heritage||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4408224|NCT00244725|4234243|B5||Male|Sex: Female, Male||Participants|Count of Participants|343|343.0||||||
4408225|NCT00244725|4234244|B4||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4408226|NCT00244725|4234245|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4408227|NCT00244725|4234246|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4408228|NCT00244725|4234247|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4408229|NCT00244725|4234243|B5||Female|Sex: Female, Male||Participants|Count of Participants|611|611.0||||||
4408230|NCT00244725|4234244|B4||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4408231|NCT00244725|4234245|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4408232|NCT00244725|4234246|B2||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4408233|NCT00244725|4234247|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4408234|NCT00244725|4234243|B5|||Age||Years|Mean|65.5|65.5|Standard Deviation|9.12|9.12|||
4408235|NCT00244725|4234244|B4|||Age||Years|Mean|66.1|66.1|Standard Deviation|9.30|9.3|||
4408236|NCT00244725|4234245|B3|||Age||Years|Mean|64.5|64.5|Standard Deviation|8.68|8.68|||
4408237|NCT00244725|4234246|B2|||Age||Years|Mean|65.3|65.3|Standard Deviation|8.93|8.93|||
4408238|NCT00244725|4234247|B1|||Age||Years|Mean|66.1|66.1|Standard Deviation|9.53|9.53|||
4408239|NCT00244712|4234304|B3|||Baseline HIV-1 RNA|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid|log10 copies/mL|Median|4.876|4.876|Full Range|||1.69|6.994|
4408240|NCT00244712|4234305|B2|||Baseline HIV-1 RNA|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid|log10 copies/mL|Median|4.844|4.844|Full Range|||1.69|6.565|
4408241|NCT00244712|4234306|B1|||Baseline HIV-1 RNA|HIV-1 RNA, Human Immunodeficiency Virus type 1 Ribonucleic acid|log10 copies/mL|Median|4.903|4.903|Full Range|||2.658|6.994|
4408242|NCT00244712|4234304|B3|||Baseline CD4+ Cell Count||cells per cmm|Median|202|202.0|Full Range|||19.0|962.0|
4408243|NCT00244712|4234305|B2|||Baseline CD4+ Cell Count||cells per cmm|Median|193|193.0|Full Range|||19.0|953.0|
4408244|NCT00244712|4234306|B1|||Baseline CD4+ Cell Count||cells per cmm|Median|214|214.0|Full Range|||19.0|962.0|
4408245|NCT00244712|4234304|B3|Missing||Hepatitis C Infection||participants|Number|2|2.0||||||
4408246|NCT00244712|4234305|B2|Missing||Hepatitis C Infection||participants|Number|2|2.0||||||
4408247|NCT00244712|4234306|B1|Missing||Hepatitis C Infection||participants|Number|0|0.0||||||
4408248|NCT00244712|4234304|B3|Non-Reactive||Hepatitis C Infection||participants|Number|635|635.0||||||
4408249|NCT00244712|4234305|B2|Non-Reactive||Hepatitis C Infection||participants|Number|319|319.0||||||
4408250|NCT00244712|4234306|B1|Non-Reactive||Hepatitis C Infection||participants|Number|316|316.0||||||
4408251|NCT00244712|4234304|B3|Reactive||Hepatitis C Infection||participants|Number|51|51.0||||||
4408252|NCT00244712|4234305|B2|Reactive||Hepatitis C Infection||participants|Number|24|24.0||||||
4408253|NCT00244712|4234306|B1|Reactive||Hepatitis C Infection||participants|Number|27|27.0||||||
4408254|NCT00244712|4234304|B3|Missing||Hepatitis B Infection||participants|Number|2|2.0||||||
4408255|NCT00244712|4234305|B2|Missing||Hepatitis B Infection||participants|Number|2|2.0||||||
4408256|NCT00244712|4234306|B1|Missing||Hepatitis B Infection||participants|Number|0|0.0||||||
4408257|NCT00244712|4234304|B3|Non-Reactive||Hepatitis B Infection||participants|Number|658|658.0||||||
4408258|NCT00244712|4234305|B2|Non-Reactive||Hepatitis B Infection||participants|Number|334|334.0||||||
4408259|NCT00244712|4234306|B1|Non-Reactive||Hepatitis B Infection||participants|Number|324|324.0||||||
4408260|NCT00244712|4234304|B3|Reactive||Hepatitis B Infection||participants|Number|28|28.0||||||
4408261|NCT00244712|4234305|B2|Reactive||Hepatitis B Infection||participants|Number|9|9.0||||||
4408262|NCT00244712|4234306|B1|Reactive||Hepatitis B Infection||participants|Number|19|19.0||||||
4408373|NCT00244101|4234398|B2|United States||Region of Enrollment||participants|Number|223|223.0||||||
4408263|NCT00244712|4234304|B3|C: AIDS||Centers for Disease Control (CDC) Classification|HIV, Human Immunodeficiency Virus; AIDS, Acquired Immunodeficiency Syndrome|participants|Number|112|112.0||||||
4408264|NCT00244712|4234305|B2|C: AIDS||Centers for Disease Control (CDC) Classification|HIV, Human Immunodeficiency Virus; AIDS, Acquired Immunodeficiency Syndrome|participants|Number|57|57.0||||||
4408265|NCT00244712|4234306|B1|C: AIDS||Centers for Disease Control (CDC) Classification|HIV, Human Immunodeficiency Virus; AIDS, Acquired Immunodeficiency Syndrome|participants|Number|55|55.0||||||
4408266|NCT00244712|4234304|B3|B: Symptomatic HIV infection||Centers for Disease Control (CDC) Classification|HIV, Human Immunodeficiency Virus; AIDS, Acquired Immunodeficiency Syndrome|participants|Number|107|107.0||||||
4408267|NCT00244712|4234305|B2|B: Symptomatic HIV infection||Centers for Disease Control (CDC) Classification|HIV, Human Immunodeficiency Virus; AIDS, Acquired Immunodeficiency Syndrome|participants|Number|48|48.0||||||
4408268|NCT00244712|4234306|B1|B: Symptomatic HIV infection||Centers for Disease Control (CDC) Classification|HIV, Human Immunodeficiency Virus; AIDS, Acquired Immunodeficiency Syndrome|participants|Number|59|59.0||||||
4408269|NCT00244712|4234304|B3|A: Asymptomatic HIV infection||Centers for Disease Control (CDC) Classification|HIV, Human Immunodeficiency Virus; AIDS, Acquired Immunodeficiency Syndrome|participants|Number|469|469.0||||||
4408270|NCT00244712|4234305|B2|A: Asymptomatic HIV infection||Centers for Disease Control (CDC) Classification|HIV, Human Immunodeficiency Virus; AIDS, Acquired Immunodeficiency Syndrome|participants|Number|240|240.0||||||
4408271|NCT00244712|4234306|B1|A: Asymptomatic HIV infection||Centers for Disease Control (CDC) Classification|HIV, Human Immunodeficiency Virus; AIDS, Acquired Immunodeficiency Syndrome|participants|Number|229|229.0||||||
4408272|NCT00244712|4234304|B3|>=500,000 copies/mL||Baseline HIV-1 RNA Level||participants|Number|82|82.0||||||
4408273|NCT00244712|4234305|B2|>=500,000 copies/mL||Baseline HIV-1 RNA Level||participants|Number|32|32.0||||||
4408274|NCT00244712|4234306|B1|>=500,000 copies/mL||Baseline HIV-1 RNA Level||participants|Number|50|50.0||||||
4408275|NCT00244712|4234304|B3|250,000 - <500,000 copies/mL||Baseline HIV-1 RNA Level||participants|Number|70|70.0||||||
4408276|NCT00244712|4234305|B2|250,000 - <500,000 copies/mL||Baseline HIV-1 RNA Level||participants|Number|33|33.0||||||
4408277|NCT00244712|4234306|B1|250,000 - <500,000 copies/mL||Baseline HIV-1 RNA Level||participants|Number|37|37.0||||||
4408278|NCT00244712|4234304|B3|100,000 - <250,000 copies/mL||Baseline HIV-1 RNA Level||participants|Number|143|143.0||||||
4408279|NCT00244712|4234305|B2|100,000 - <250,000 copies/mL||Baseline HIV-1 RNA Level||participants|Number|75|75.0||||||
4408280|NCT00244712|4234306|B1|100,000 - <250,000 copies/mL||Baseline HIV-1 RNA Level||participants|Number|68|68.0||||||
4408281|NCT00244712|4234304|B3|<100,000 copies/mL||Baseline HIV-1 RNA Level||participants|Number|393|393.0||||||
4408282|NCT00244712|4234305|B2|<100,000 copies/mL||Baseline HIV-1 RNA Level||participants|Number|205|205.0||||||
4408283|NCT00244712|4234306|B1|<100,000 copies/mL||Baseline HIV-1 RNA Level||participants|Number|188|188.0||||||
4408284|NCT00244712|4234304|B3|>= 200 cells per cmm||Baseline CD4+ Cell Count Level||participants|Number|348|348.0||||||
4408285|NCT00244712|4234305|B2|>= 200 cells per cmm||Baseline CD4+ Cell Count Level||participants|Number|165|165.0||||||
4408286|NCT00244712|4234306|B1|>= 200 cells per cmm||Baseline CD4+ Cell Count Level||participants|Number|183|183.0||||||
4408287|NCT00244712|4234304|B3|50 - <200 cells per cmm||Baseline CD4+ Cell Count Level||participants|Number|209|209.0||||||
4408288|NCT00244712|4234305|B2|50 - <200 cells per cmm||Baseline CD4+ Cell Count Level||participants|Number|110|110.0||||||
4408289|NCT00244712|4234306|B1|50 - <200 cells per cmm||Baseline CD4+ Cell Count Level||participants|Number|99|99.0||||||
4408290|NCT00244712|4234304|B3|<50 cells per cmm||Baseline CD4+ Cell Count Level||participants|Number|131|131.0||||||
4408291|NCT00244712|4234305|B2|<50 cells per cmm||Baseline CD4+ Cell Count Level||participants|Number|70|70.0||||||
4408292|NCT00244712|4234306|B1|<50 cells per cmm||Baseline CD4+ Cell Count Level||participants|Number|61|61.0||||||
4408293|NCT00244712|4234304|B3|Missing Information||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4408294|NCT00244712|4234305|B2|Missing Information||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4408295|NCT00244712|4234306|B1|Missing Information||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4408296|NCT00244712|4234304|B3|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|552|552.0||||||
4408297|NCT00244712|4234305|B2|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|282|282.0||||||
4408298|NCT00244712|4234306|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|270|270.0||||||
4408299|NCT00244712|4234304|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|135|135.0||||||
4408300|NCT00244712|4234305|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4408301|NCT00244712|4234306|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4408302|NCT00244712|4234304|B3|Unspecified||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4408303|NCT00244712|4234305|B2|Unspecified||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4408304|NCT00244712|4234306|B1|Unspecified||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4408305|NCT00244712|4234304|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4408306|NCT00244712|4234305|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4408307|NCT00244712|4234306|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4408308|NCT00244712|4234304|B3|White||Race/Ethnicity, Customized||participants|Number|351|351.0||||||
4408309|NCT00244712|4234305|B2|White||Race/Ethnicity, Customized||participants|Number|174|174.0||||||
4408310|NCT00244712|4234306|B1|White||Race/Ethnicity, Customized||participants|Number|177|177.0||||||
4408311|NCT00244712|4234304|B3|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4408312|NCT00244712|4234305|B2|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4408313|NCT00244712|4234306|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4408314|NCT00244712|4234304|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4408315|NCT00244712|4234305|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4408316|NCT00244712|4234306|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4408317|NCT00244712|4234304|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|246|246.0||||||
4408318|NCT00244712|4234305|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
4408319|NCT00244712|4234306|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
4408320|NCT00244712|4234304|B3||Male|Sex: Female, Male||Participants|Count of Participants|563|563.0||||||
4408321|NCT00244712|4234305|B2||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4408322|NCT00244712|4234306|B1||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4408323|NCT00244712|4234304|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4408324|NCT00244712|4234305|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4408325|NCT00244712|4234306|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4408326|NCT00244712|4234304|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|9.68|9.68|||
4408327|NCT00244712|4234305|B2|||Age||years|Mean|38.7|38.7|Standard Deviation|9.55|9.55|||
4408328|NCT00244712|4234306|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|9.80|9.8|||
4408329|NCT00244621|4234339|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4408330|NCT00244621|4234340|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4408331|NCT00244621|4234341|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4408332|NCT00244621|4234342|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4408333|NCT00244621|4234339|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4408334|NCT00244621|4234340|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4408335|NCT00244621|4234341|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4408336|NCT00244621|4234342|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4408337|NCT00244621|4234339|B4|2 to <6 years||Age, Customized||Participants|Number|77|77.0||||||
4408338|NCT00244621|4234340|B3|2 to <6 years||Age, Customized||Participants|Number|27|27.0||||||
4408339|NCT00244621|4234341|B2|2 to <6 years||Age, Customized||Participants|Number|27|27.0||||||
4408340|NCT00244621|4234342|B1|2 to <6 years||Age, Customized||Participants|Number|23|23.0||||||
4408341|NCT00244621|4234339|B4|1 to <2 years||Age, Customized||Participants|Number|16|16.0||||||
4408342|NCT00244621|4234340|B3|1 to <2 years||Age, Customized||Participants|Number|5|5.0||||||
4408343|NCT00244621|4234341|B2|1 to <2 years||Age, Customized||Participants|Number|5|5.0||||||
4408344|NCT00244621|4234342|B1|1 to <2 years||Age, Customized||Participants|Number|6|6.0||||||
4408345|NCT00244374|4234361|B1|United States||Region of Enrollment||participants|Number|546|546.0||||||
4408346|NCT00244374|4234361|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4408347|NCT00244374|4234361|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4408348|NCT00244374|4234361|B1||White|Race (NIH/OMB)||Participants|Count of Participants|392|392.0||||||
4408349|NCT00244374|4234361|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4408350|NCT00244374|4234361|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4408351|NCT00244374|4234361|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4408352|NCT00244374|4234361|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4408353|NCT00244374|4234361|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4408354|NCT00244374|4234361|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|460|460.0||||||
4408355|NCT00244374|4234361|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4408356|NCT00244374|4234361|B1|Unknown/Other/Not Reported||Sex/Gender, Customized|Gender: Male, Female, Unknown or Not Reported|Participants|Number|2|2.0||||||
4408357|NCT00244374|4234361|B1|Male||Sex/Gender, Customized|Gender: Male, Female, Unknown or Not Reported|Participants|Number|395|395.0||||||
4408358|NCT00244374|4234361|B1|Female||Sex/Gender, Customized|Gender: Male, Female, Unknown or Not Reported|Participants|Number|149|149.0||||||
4408359|NCT00244374|4234361|B1|Age >= 30 years||Age, Customized||Participants|Number|0|0.0||||||
4408360|NCT00244374|4234361|B1|Age 15 - 29 years||Age, Customized||Participants|Number|546|546.0||||||
4408361|NCT00244374|4234361|B1|Age 0 - 14 years||Age, Customized||Participants|Number|0|0.0||||||
4408362|NCT00244140|4234381|B3||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4408363|NCT00244140|4234382|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4408364|NCT00244140|4234383|B1||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4408365|NCT00244140|4234381|B3||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4408366|NCT00244140|4234382|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4408367|NCT00244140|4234383|B1||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4408368|NCT00244140|4234381|B3|||Age||years|Mean|52.1|52.1|Standard Deviation|15.13|15.13|||
4408369|NCT00244140|4234382|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|14.54|14.54|||
4408370|NCT00244140|4234383|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|15.15|15.15|||
4408371|NCT00244101|4234396|B4|United States||Region of Enrollment||participants|Number|648|648.0||||||
4408372|NCT00244101|4234397|B3|United States||Region of Enrollment||participants|Number|216|216.0||||||
4408374|NCT00244101|4234399|B1|United States||Region of Enrollment||participants|Number|209|209.0||||||
4408375|NCT00244101|4234396|B4||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4408376|NCT00244101|4234397|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4408377|NCT00244101|4234398|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4408378|NCT00244101|4234399|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4408379|NCT00244101|4234396|B4||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4408380|NCT00244101|4234397|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4408381|NCT00244101|4234398|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4408382|NCT00244101|4234399|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4408383|NCT00244101|4234396|B4|||Age||years|Mean|28.0|28.0|Standard Deviation|1.1|1.1|||
4408384|NCT00244101|4234397|B3|||Age||years|Mean|28.1|28.1|Standard Deviation|1.1|1.1|||
4408385|NCT00244101|4234398|B2|||Age||years|Mean|28.1|28.1|Standard Deviation|1.3|1.3|||
4408386|NCT00244101|4234399|B1|||Age||years|Mean|28.0|28.0|Standard Deviation|1.1|1.1|||
4408387|NCT00244101|4234396|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408388|NCT00244101|4234397|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408389|NCT00244101|4234398|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408390|NCT00244101|4234399|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408391|NCT00244101|4234396|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4408392|NCT00244101|4234397|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4408393|NCT00244101|4234398|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4408394|NCT00244101|4234399|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4408395|NCT00244101|4234396|B4||<=18 years|Age||Participants|Count of Participants|648|648.0||||||
4408396|NCT00244101|4234397|B3||<=18 years|Age||Participants|Count of Participants|216|216.0||||||
4408397|NCT00244101|4234398|B2||<=18 years|Age||Participants|Count of Participants|223|223.0||||||
4408398|NCT00244101|4234399|B1||<=18 years|Age||Participants|Count of Participants|209|209.0||||||
4408399|NCT00244010|4234409|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4408400|NCT00244010|4234410|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4408401|NCT00244010|4234411|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408402|NCT00244010|4234409|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4408403|NCT00244010|4234410|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4408404|NCT00244010|4234411|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4408405|NCT00244010|4234409|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408406|NCT00244010|4234410|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408407|NCT00244010|4234411|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408408|NCT00244010|4234409|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4408409|NCT00244010|4234410|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4408410|NCT00244010|4234411|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4408411|NCT00244010|4234409|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4408412|NCT00244010|4234410|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408413|NCT00244010|4234411|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4408414|NCT00243932|4234418|B4|United States||Region of Enrollment||participants|Number|185|185.0||||||
4408415|NCT00243932|4234419|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4408416|NCT00243932|4234420|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4408417|NCT00243932|4234421|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4408418|NCT00243932|4234418|B4||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4408419|NCT00243932|4234419|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4408420|NCT00243932|4234420|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4408421|NCT00243932|4234421|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4408422|NCT00243932|4234418|B4||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4408423|NCT00243932|4234419|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4408424|NCT00243932|4234420|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4408425|NCT00243932|4234421|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4408426|NCT00243932|4234418|B4|||Age||years|Mean|56.9|56.9|Standard Deviation|11.2|11.2|||
4408427|NCT00243932|4234419|B3|||Age||years|Mean|58.9|58.9|Standard Deviation|12.5|12.5|||
4408428|NCT00243932|4234420|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|11|11.0|||
4408429|NCT00243932|4234421|B1|||Age||years|Mean|56|56.0|Standard Deviation|10.8|10.8|||
4408430|NCT00243932|4234418|B4||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4408431|NCT00243932|4234419|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4408432|NCT00243932|4234420|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4408433|NCT00243932|4234421|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4408434|NCT00243932|4234418|B4||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4408435|NCT00243932|4234419|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4408436|NCT00243932|4234420|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4408437|NCT00243932|4234421|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4408438|NCT00243932|4234418|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408439|NCT00243932|4234419|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408440|NCT00243932|4234420|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408441|NCT00243932|4234421|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408442|NCT00243919|4234431|B4|||Comfortable walking speed (m/sec)|Assessed with 10 meter walk test.|m/sec|Mean|0.38|0.38|Standard Deviation|0.22|0.22|||
4408443|NCT00243919|4234432|B3|||Comfortable walking speed (m/sec)|Assessed with 10 meter walk test.|m/sec|Mean|0.39|0.39|Standard Deviation|0.22|0.22|||
4408444|NCT00243919|4234433|B2|||Comfortable walking speed (m/sec)|Assessed with 10 meter walk test.|m/sec|Mean|0.38|0.38|Standard Deviation|0.23|0.23|||
4408445|NCT00243919|4234434|B1|||Comfortable walking speed (m/sec)|Assessed with 10 meter walk test.|m/sec|Mean|0.36|0.36|Standard Deviation|0.22|0.22|||
4408446|NCT00243919|4234431|B4|Moderate Disability (0.4 - 0.8 m/sec)||Walking Speed (m/sec)|Comfortable walking speed assessed by 10 meter walk.|participants|Number|190|190.0||||||
4408447|NCT00243919|4234432|B3|Moderate Disability (0.4 - 0.8 m/sec)||Walking Speed (m/sec)|Comfortable walking speed assessed by 10 meter walk.|participants|Number|60|60.0||||||
4408448|NCT00243919|4234433|B2|Moderate Disability (0.4 - 0.8 m/sec)||Walking Speed (m/sec)|Comfortable walking speed assessed by 10 meter walk.|participants|Number|66|66.0||||||
4408449|NCT00243919|4234434|B1|Moderate Disability (0.4 - 0.8 m/sec)||Walking Speed (m/sec)|Comfortable walking speed assessed by 10 meter walk.|participants|Number|64|64.0||||||
4408450|NCT00243919|4234431|B4|Severe Disability (<0.4 m/sec)||Walking Speed (m/sec)|Comfortable walking speed assessed by 10 meter walk.|participants|Number|218|218.0||||||
4408451|NCT00243919|4234432|B3|Severe Disability (<0.4 m/sec)||Walking Speed (m/sec)|Comfortable walking speed assessed by 10 meter walk.|participants|Number|66|66.0||||||
4408452|NCT00243919|4234433|B2|Severe Disability (<0.4 m/sec)||Walking Speed (m/sec)|Comfortable walking speed assessed by 10 meter walk.|participants|Number|77|77.0||||||
4408453|NCT00243919|4234434|B1|Severe Disability (<0.4 m/sec)||Walking Speed (m/sec)|Comfortable walking speed assessed by 10 meter walk.|participants|Number|75|75.0||||||
4408454|NCT00243919|4234431|B4|||Mini Mental Status Exam|Higher Score is Better;Range = 0-30|scores on a scale|Mean|26.1|26.1|Standard Deviation|3.5|3.5|||
4408455|NCT00243919|4234432|B3|||Mini Mental Status Exam|Higher Score is Better;Range = 0-30|scores on a scale|Mean|26.0|26.0|Standard Deviation|3.6|3.6|||
4408456|NCT00243919|4234433|B2|||Mini Mental Status Exam|Higher Score is Better;Range = 0-30|scores on a scale|Mean|26.2|26.2|Standard Deviation|3.7|3.7|||
4408457|NCT00243919|4234434|B1|||Mini Mental Status Exam|Higher Score is Better;Range = 0-30|scores on a scale|Mean|26.0|26.0|Standard Deviation|3.2|3.2|||
4408458|NCT00243919|4234431|B4|Depression (Personal Health Questionnaire-9 >= 10)||Comorbidities||participants|Number|67|67.0||||||
4408459|NCT00243919|4234432|B3|Depression (Personal Health Questionnaire-9 >= 10)||Comorbidities||participants|Number|19|19.0||||||
4408460|NCT00243919|4234433|B2|Depression (Personal Health Questionnaire-9 >= 10)||Comorbidities||participants|Number|28|28.0||||||
4408461|NCT00243919|4234434|B1|Depression (Personal Health Questionnaire-9 >= 10)||Comorbidities||participants|Number|20|20.0||||||
4408462|NCT00243919|4234431|B4|Diabetes||Comorbidities||participants|Number|141|141.0||||||
4408463|NCT00243919|4234432|B3|Diabetes||Comorbidities||participants|Number|43|43.0||||||
4408464|NCT00243919|4234433|B2|Diabetes||Comorbidities||participants|Number|51|51.0||||||
4408465|NCT00243919|4234434|B1|Diabetes||Comorbidities||participants|Number|47|47.0||||||
4408466|NCT00243919|4234431|B4|Arthritis/other musculoskeletal||Comorbidities||participants|Number|146|146.0||||||
4408467|NCT00243919|4234432|B3|Arthritis/other musculoskeletal||Comorbidities||participants|Number|47|47.0||||||
4408468|NCT00243919|4234433|B2|Arthritis/other musculoskeletal||Comorbidities||participants|Number|52|52.0||||||
4408469|NCT00243919|4234434|B1|Arthritis/other musculoskeletal||Comorbidities||participants|Number|47|47.0||||||
4408470|NCT00243919|4234431|B4|Chronic Obstructive Pulmonary Disease (COPD)||Comorbidities||participants|Number|26|26.0||||||
4408471|NCT00243919|4234432|B3|Chronic Obstructive Pulmonary Disease (COPD)||Comorbidities||participants|Number|7|7.0||||||
4408472|NCT00243919|4234433|B2|Chronic Obstructive Pulmonary Disease (COPD)||Comorbidities||participants|Number|14|14.0||||||
4408473|NCT00243919|4234434|B1|Chronic Obstructive Pulmonary Disease (COPD)||Comorbidities||participants|Number|5|5.0||||||
4408474|NCT00243919|4234431|B4|Peripheral vascular disease||Comorbidities||participants|Number|37|37.0||||||
4408475|NCT00243919|4234432|B3|Peripheral vascular disease||Comorbidities||participants|Number|13|13.0||||||
4408476|NCT00243919|4234433|B2|Peripheral vascular disease||Comorbidities||participants|Number|12|12.0||||||
4408477|NCT00243919|4234434|B1|Peripheral vascular disease||Comorbidities||participants|Number|12|12.0||||||
4408478|NCT00243919|4234431|B4|Hypertension||Comorbidities||participants|Number|331|331.0||||||
4408479|NCT00243919|4234432|B3|Hypertension||Comorbidities||participants|Number|104|104.0||||||
4408480|NCT00243919|4234433|B2|Hypertension||Comorbidities||participants|Number|111|111.0||||||
4408481|NCT00243919|4234434|B1|Hypertension||Comorbidities||participants|Number|116|116.0||||||
4408482|NCT00243919|4234431|B4|Cardiovascular||Comorbidities||participants|Number|109|109.0||||||
4408483|NCT00243919|4234432|B3|Cardiovascular||Comorbidities||participants|Number|37|37.0||||||
4408484|NCT00243919|4234433|B2|Cardiovascular||Comorbidities||participants|Number|36|36.0||||||
4408485|NCT00243919|4234434|B1|Cardiovascular||Comorbidities||participants|Number|36|36.0||||||
4408486|NCT00243919|4234431|B4|Rankin 4 (moderately severe disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|180|180.0||||||
4408487|NCT00243919|4234432|B3|Rankin 4 (moderately severe disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|56|56.0||||||
4408488|NCT00243919|4234433|B2|Rankin 4 (moderately severe disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|63|63.0||||||
4408489|NCT00243919|4234434|B1|Rankin 4 (moderately severe disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|61|61.0||||||
4408490|NCT00243919|4234431|B4|Rankin 3 (moderate disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|172|172.0||||||
4408491|NCT00243919|4234432|B3|Rankin 3 (moderate disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|49|49.0||||||
4408492|NCT00243919|4234433|B2|Rankin 3 (moderate disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|57|57.0||||||
4408493|NCT00243919|4234434|B1|Rankin 3 (moderate disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|66|66.0||||||
4408494|NCT00243919|4234431|B4|Rankin 2 (slight disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|54|54.0||||||
4408495|NCT00243919|4234432|B3|Rankin 2 (slight disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|21|21.0||||||
4408496|NCT00243919|4234433|B2|Rankin 2 (slight disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|21|21.0||||||
4408497|NCT00243919|4234434|B1|Rankin 2 (slight disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|12|12.0||||||
4408498|NCT00243919|4234431|B4|Rankin 0 - 1 (no significant disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|2|2.0||||||
4408499|NCT00243919|4234432|B3|Rankin 0 - 1 (no significant disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|0|0.0||||||
4408500|NCT00243919|4234433|B2|Rankin 0 - 1 (no significant disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|2|2.0||||||
4408501|NCT00243919|4234434|B1|Rankin 0 - 1 (no significant disability)||Modified Rankin Scale|Global measure of stroke disability|participants|Number|0|0.0||||||
4408502|NCT00243919|4234431|B4|Undefined||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|48|48.0||||||
4408503|NCT00243919|4234432|B3|Undefined||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|15|15.0||||||
4408504|NCT00243919|4234433|B2|Undefined||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|16|16.0||||||
4408505|NCT00243919|4234434|B1|Undefined||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|17|17.0||||||
4408506|NCT00243919|4234431|B4|Hemorrhage||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|70|70.0||||||
4408507|NCT00243919|4234432|B3|Hemorrhage||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|21|21.0||||||
4408508|NCT00243919|4234433|B2|Hemorrhage||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|22|22.0||||||
4408509|NCT00243919|4234434|B1|Hemorrhage||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|27|27.0||||||
4408510|NCT00243919|4234431|B4|Lacune||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|128|128.0||||||
4408511|NCT00243919|4234432|B3|Lacune||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|43|43.0||||||
4408512|NCT00243919|4234433|B2|Lacune||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|45|45.0||||||
4408513|NCT00243919|4234434|B1|Lacune||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|40|40.0||||||
4408514|NCT00243919|4234431|B4|Large Vessel||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|162|162.0||||||
4408515|NCT00243919|4234432|B3|Large Vessel||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|47|47.0||||||
4408516|NCT00243919|4234433|B2|Large Vessel||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|60|60.0||||||
4408517|NCT00243919|4234434|B1|Large Vessel||Stroke Type|Based on CT/MRI overread by study neurologists.|participants|Number|55|55.0||||||
4408518|NCT00243919|4234431|B4|Right Hemiparesis||Side of involvement||participants|Number|226|226.0||||||
4408519|NCT00243919|4234432|B3|Right Hemiparesis||Side of involvement||participants|Number|65|65.0||||||
4408520|NCT00243919|4234433|B2|Right Hemiparesis||Side of involvement||participants|Number|85|85.0||||||
4408521|NCT00243919|4234434|B1|Right Hemiparesis||Side of involvement||participants|Number|76|76.0||||||
4408522|NCT00243919|4234431|B4|Left Hemiparesis||Side of involvement||participants|Number|182|182.0||||||
4408523|NCT00243919|4234432|B3|Left Hemiparesis||Side of involvement||participants|Number|61|61.0||||||
4408524|NCT00243919|4234433|B2|Left Hemiparesis||Side of involvement||participants|Number|58|58.0||||||
4408525|NCT00243919|4234434|B1|Left Hemiparesis||Side of involvement||participants|Number|63|63.0||||||
4408526|NCT00243919|4234431|B4|||Time since stroke to randomization - days||days|Mean|63.8|63.8|Standard Deviation|8.5|8.5|||
4408527|NCT00243919|4234432|B3|||Time since stroke to randomization - days||days|Mean|62.9|62.9|Standard Deviation|8.0|8.0|||
4408528|NCT00243919|4234433|B2|||Time since stroke to randomization - days||days|Mean|64.18|64.18|Standard Deviation|9.0|9.0|||
4408529|NCT00243919|4234434|B1|||Time since stroke to randomization - days||days|Mean|64.1|64.1|Standard Deviation|8.3|8.3|||
4408530|NCT00243919|4234431|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408531|NCT00243919|4234432|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408532|NCT00243919|4234433|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408533|NCT00243919|4234434|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408534|NCT00243919|4234431|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4408535|NCT00243919|4234432|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4408536|NCT00243919|4234433|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408537|NCT00243919|4234434|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408538|NCT00243919|4234431|B4||White|Race (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
4408539|NCT00243919|4234432|B3||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4408540|NCT00243919|4234433|B2||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4408541|NCT00243919|4234434|B1||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4408542|NCT00243919|4234431|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4408543|NCT00243919|4234432|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4408544|NCT00243919|4234433|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4408545|NCT00243919|4234434|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4408546|NCT00243919|4234431|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4408547|NCT00243919|4234432|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4408548|NCT00243919|4234433|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4408549|NCT00243919|4234434|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4408550|NCT00243919|4234431|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4408551|NCT00243919|4234432|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4408552|NCT00243919|4234433|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4408553|NCT00243919|4234434|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4408554|NCT00243919|4234431|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4408555|NCT00243919|4234432|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408556|NCT00243919|4234433|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4408557|NCT00243919|4234434|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4408558|NCT00243919|4234431|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408559|NCT00243919|4234432|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408560|NCT00243919|4234433|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408561|NCT00243919|4234434|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408562|NCT00243919|4234431|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|345|345.0||||||
4408563|NCT00243919|4234432|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4408564|NCT00243919|4234433|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4408565|NCT00243919|4234434|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4408566|NCT00243919|4234431|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4408567|NCT00243919|4234432|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4408568|NCT00243919|4234433|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4408569|NCT00243919|4234434|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4408570|NCT00243919|4234431|B4||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4408571|NCT00243919|4234432|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4408572|NCT00243919|4234433|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4408573|NCT00243919|4234434|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4408574|NCT00243919|4234431|B4||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4408575|NCT00243919|4234432|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4408576|NCT00243919|4234433|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4408577|NCT00243919|4234434|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4408578|NCT00243919|4234431|B4|||Age||years|Mean|62.0|62.0|Standard Deviation|12.7|12.7|||
4408579|NCT00243919|4234432|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|13.3|13.3|||
4408580|NCT00243919|4234433|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|12.5|12.5|||
4408581|NCT00243919|4234434|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|12.3|12.3|||
4408582|NCT00243841|4234477|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408583|NCT00243841|4234478|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408584|NCT00243841|4234479|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408585|NCT00243841|4234480|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408586|NCT00243841|4234477|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408587|NCT00243841|4234478|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408588|NCT00243841|4234479|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408589|NCT00243841|4234480|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408590|NCT00243841|4234477|B4||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4408591|NCT00243841|4234478|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4408592|NCT00243841|4234479|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4408593|NCT00243841|4234480|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4408594|NCT00243841|4234477|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4408595|NCT00243841|4234478|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4408596|NCT00243841|4234479|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4408597|NCT00243841|4234480|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4408598|NCT00243841|4234477|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408599|NCT00243841|4234478|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408600|NCT00243841|4234479|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408601|NCT00243841|4234480|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408602|NCT00243841|4234477|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4408603|NCT00243841|4234478|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408604|NCT00243841|4234479|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4408605|NCT00243841|4234480|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408606|NCT00243841|4234477|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408607|NCT00243841|4234478|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408608|NCT00243841|4234479|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408609|NCT00243841|4234480|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408610|NCT00243841|4234477|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4408611|NCT00243841|4234478|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408612|NCT00243841|4234479|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408613|NCT00243841|4234480|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408614|NCT00243841|4234477|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4408615|NCT00243841|4234478|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4408616|NCT00243841|4234479|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4408617|NCT00243841|4234480|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4408618|NCT00243841|4234477|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408619|NCT00243841|4234478|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408620|NCT00243841|4234479|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408621|NCT00243841|4234480|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408622|NCT00243841|4234477|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4408623|NCT00243841|4234478|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4408624|NCT00243841|4234479|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4408625|NCT00243841|4234480|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4408626|NCT00243841|4234477|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4408627|NCT00243841|4234478|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4408628|NCT00243841|4234479|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4408629|NCT00243841|4234480|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4408630|NCT00243841|4234477|B4|||Age||years|Mean|60.2|60.2|Standard Deviation|9.6|9.6|||
4408631|NCT00243841|4234478|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|7.55|7.55|||
4408632|NCT00243841|4234479|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|10.62|10.62|||
4408633|NCT00243841|4234480|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|9.76|9.76|||
4408634|NCT00243841|4234477|B4||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4408635|NCT00243841|4234478|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4408636|NCT00243841|4234479|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4408637|NCT00243841|4234480|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4408638|NCT00243841|4234477|B4||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4408639|NCT00243841|4234478|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4408640|NCT00243841|4234479|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4408641|NCT00243841|4234480|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4408642|NCT00243841|4234477|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408643|NCT00243841|4234478|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408644|NCT00243841|4234479|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408645|NCT00243841|4234480|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408646|NCT00243659|4234505|B3||Male|Sex: Female, Male||Participants|Count of Participants|30.0|30.0||||||
4408647|NCT00243659|4234506|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4408648|NCT00243659|4234507|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4408649|NCT00243659|4234505|B3||Female|Sex: Female, Male||Participants|Count of Participants|0.0|0.0||||||
4408650|NCT00243659|4234506|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408651|NCT00243659|4234507|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408652|NCT00243659|4234505|B3|||Age||years|Mean|35.87|35.87|Standard Deviation|9.22|9.22|||
4408653|NCT00243659|4234506|B2|||Age||years|Mean|38.13|38.13|Standard Deviation|8.54|8.54|||
4408654|NCT00243659|4234507|B1|||Age||years|Mean|35.05|35.05|Standard Deviation|9.51|9.51|||
4408655|NCT00243503|4234516|B1|Others :Future health perspective (n=48)||EORTC QLQ Breast Cancer Module (BR23)|"EORTC QLQ (BR23): consist of 23 questions. Response range: not at all to very much. Scale score range: 0 to 100. Higher symptom score = greater degree of symptoms.~The 'n' is signifying those participants who received study drug and were evaluated for this measure at the timepoint for each group respectively."|scores on a scale|Mean|39.6|39.6|Standard Deviation|32.0|32.0|||
4408656|NCT00243503|4234516|B1|Others :Upset of hair loss (n=6)||EORTC QLQ Breast Cancer Module (BR23)|"EORTC QLQ (BR23): consist of 23 questions. Response range: not at all to very much. Scale score range: 0 to 100. Higher symptom score = greater degree of symptoms.~The 'n' is signifying those participants who received study drug and were evaluated for this measure at the timepoint for each group respectively."|scores on a scale|Mean|50.0|50.0|Standard Deviation|27.9|27.9|||
4408657|NCT00243503|4234516|B1|Symptom Score: systemic therapy side effects(n=48)||EORTC QLQ Breast Cancer Module (BR23)|"EORTC QLQ (BR23): consist of 23 questions. Response range: not at all to very much. Scale score range: 0 to 100. Higher symptom score = greater degree of symptoms.~The 'n' is signifying those participants who received study drug and were evaluated for this measure at the timepoint for each group respectively."|scores on a scale|Mean|17.2|17.2|Standard Deviation|17.4|17.4|||
4408658|NCT00243503|4234516|B1|Symptom Score: Breast (n=47)||EORTC QLQ Breast Cancer Module (BR23)|"EORTC QLQ (BR23): consist of 23 questions. Response range: not at all to very much. Scale score range: 0 to 100. Higher symptom score = greater degree of symptoms.~The 'n' is signifying those participants who received study drug and were evaluated for this measure at the timepoint for each group respectively."|scores on a scale|Mean|25.9|25.9|Standard Deviation|27.5|27.5|||
4408659|NCT00243503|4234516|B1|Symptom Score: Arm (n=48)||EORTC QLQ Breast Cancer Module (BR23)|"EORTC QLQ (BR23): consist of 23 questions. Response range: not at all to very much. Scale score range: 0 to 100. Higher symptom score = greater degree of symptoms.~The 'n' is signifying those participants who received study drug and were evaluated for this measure at the timepoint for each group respectively."|scores on a scale|Mean|23.8|23.8|Standard Deviation|25.3|25.3|||
4408660|NCT00243503|4234516|B1|Function Score: Sexual enjoyment (n=15)||EORTC QLQ Breast Cancer Module (BR23)|"EORTC QLQ (BR23): consist of 23 questions. Response range: not at all to very much. Scale score range: 0 to 100. Higher symptom score = greater degree of symptoms.~The 'n' is signifying those participants who received study drug and were evaluated for this measure at the timepoint for each group respectively."|scores on a scale|Mean|53.3|53.3|Standard Deviation|21.1|21.1|||
4408661|NCT00243503|4234516|B1|Function Score: Sexual function (n=44)||EORTC QLQ Breast Cancer Module (BR23)|"EORTC QLQ (BR23): consist of 23 questions. Response range: not at all to very much. Scale score range: 0 to 100. Higher symptom score = greater degree of symptoms.~The 'n' is signifying those participants who received study drug and were evaluated for this measure at the timepoint for each group respectively."|scores on a scale|Mean|21.6|21.6|Standard Deviation|24.5|24.5|||
4408662|NCT00243503|4234516|B1|Function Score : Body image (n=46)||EORTC QLQ Breast Cancer Module (BR23)|"EORTC QLQ (BR23): consist of 23 questions. Response range: not at all to very much. Scale score range: 0 to 100. Higher symptom score = greater degree of symptoms.~The 'n' is signifying those participants who received study drug and were evaluated for this measure at the timepoint for each group respectively."|scores on a scale|Mean|77.2|77.2|Standard Deviation|25.4|25.4|||
4408663|NCT00243503|4234516|B1|Symptom Score: Financial difficulty (n=48)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|15.3|15.3|Standard Deviation|28.3|28.3|||
4408664|NCT00243503|4234516|B1|Symptom Score: Diarrhea (n=49)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|6.8|6.8|Standard Deviation|15.2|15.2|||
4408665|NCT00243503|4234516|B1|Symptom Score: Constipation (n=48)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|18.1|18.1|Standard Deviation|32.9|32.9|||
4408666|NCT00243503|4234516|B1|Symptom Score: Insomnia (n=49)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|35.4|35.4|Standard Deviation|31.5|31.5|||
4408667|NCT00243503|4234516|B1|Symptom Score: Loss of appetite (n=49)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|14.3|14.3|Standard Deviation|28.1|28.1|||
4408668|NCT00243503|4234516|B1|Symptom Score: Dyspnea (n=48)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|22.9|22.9|Standard Deviation|28.5|28.5|||
4408669|NCT00243503|4234516|B1|Symptom Score: Nausea/vomiting (n=49)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|7.1|7.1|Standard Deviation|18.0|18.0|||
4408707|NCT00243269|4234634|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4408670|NCT00243503|4234516|B1|Symptom Score: Pain (n=49)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|38.8|38.8|Standard Deviation|33.7|33.7|||
4408671|NCT00243503|4234516|B1|Symptom Score: Fatigue (n=49)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|35.6|35.6|Standard Deviation|27.6|27.6|||
4408672|NCT00243503|4234516|B1|Function Score: Social function (n=49)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|75.5|75.5|Standard Deviation|29.9|29.9|||
4408673|NCT00243503|4234516|B1|Function Score: Emotional function (n=49)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|62.8|62.8|Standard Deviation|26.4|26.4|||
4408674|NCT00243503|4234516|B1|Function Score: Cognitive function (n=49)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|82.0|82.0|Standard Deviation|25.6|25.6|||
4408675|NCT00243503|4234516|B1|Function Score: Role function (n=49)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|76.2|76.2|Standard Deviation|30.0|30.0|||
4408676|NCT00243503|4234516|B1|Function Score: Physical function (n=49)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|79.5|79.5|Standard Deviation|21.3|21.3|||
4408677|NCT00243503|4234516|B1|Function Score: Global health (n=48)||EORTC QLQ-C30|European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30).Response range:not at all-very much,global/QOL range:very poor-excellent.Scale/single-item-score 0-100.Higher functional/global=better functioning and symptom=greater degree of symptoms.'n' = participants evaluated at timepoint for each group.|scores on a scale|Mean|66.8|66.8|Standard Deviation|26.8|26.8|||
4408678|NCT00243503|4234516|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408679|NCT00243503|4234516|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4408680|NCT00243503|4234516|B1|||Age||Years|Mean|55.1|55.1|Standard Deviation|12.8|12.8|||
4408681|NCT00243412|4234531|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4408682|NCT00243412|4234532|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4408683|NCT00243412|4234533|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4408684|NCT00243412|4234531|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4408685|NCT00243412|4234532|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4408686|NCT00243412|4234533|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4408687|NCT00243412|4234531|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|10.3|10.3|||
4408688|NCT00243412|4234532|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|11.1|11.1|||
4408689|NCT00243412|4234533|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|9.6|9.6|||
4408690|NCT00243412|4234531|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4408691|NCT00243412|4234532|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4408692|NCT00243412|4234533|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408693|NCT00243412|4234531|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4408694|NCT00243412|4234532|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4408695|NCT00243412|4234533|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4408696|NCT00243412|4234531|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408697|NCT00243412|4234532|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408698|NCT00243412|4234533|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408699|NCT00243386|4234560|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4408700|NCT00243386|4234560|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408701|NCT00243386|4234560|B1|||Age||years|Median|26|26.0|Full Range|||7.0|59.0|
4408702|NCT00243347|4234627|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4408703|NCT00243347|4234627|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4408704|NCT00243347|4234627|B1|||Age||Years|Mean|58.1|58.1|Standard Deviation|12.32|12.32|||
4408705|NCT00243269|4234632|B5|United States||Region of Enrollment||participants|Number|83|83.0||||||
4408706|NCT00243269|4234633|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
4408708|NCT00243269|4234635|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4408709|NCT00243269|4234636|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4408710|NCT00243269|4234632|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408711|NCT00243269|4234633|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408712|NCT00243269|4234634|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408713|NCT00243269|4234635|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408714|NCT00243269|4234636|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408715|NCT00243269|4234632|B5||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4408716|NCT00243269|4234633|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4408717|NCT00243269|4234634|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4408718|NCT00243269|4234635|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4408719|NCT00243269|4234636|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4408720|NCT00243269|4234632|B5|||Age||years|Mean|51.6|51.6|Standard Deviation|10.6|10.6|||
4408721|NCT00243269|4234633|B4|||Age||years|Mean|55.4|55.4|Standard Deviation|9.9|9.9|||
4408722|NCT00243269|4234634|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|11.1|11.1|||
4408723|NCT00243269|4234635|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|9.4|9.4|||
4408724|NCT00243269|4234636|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|10.5|10.5|||
4408725|NCT00243269|4234632|B5||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4408726|NCT00243269|4234633|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4408727|NCT00243269|4234634|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4408728|NCT00243269|4234635|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4408729|NCT00243269|4234636|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4408730|NCT00243269|4234632|B5||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4408731|NCT00243269|4234633|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4408732|NCT00243269|4234634|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4408733|NCT00243269|4234635|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4408734|NCT00243269|4234636|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4408735|NCT00243269|4234632|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408736|NCT00243269|4234633|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408737|NCT00243269|4234634|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408738|NCT00243269|4234635|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408739|NCT00243269|4234636|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408740|NCT00243243|4234653|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4408741|NCT00243243|4234654|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4408742|NCT00243243|4234655|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4408743|NCT00243243|4234653|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4408744|NCT00243243|4234654|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4408745|NCT00243243|4234655|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4408746|NCT00243243|4234653|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4408747|NCT00243243|4234654|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408748|NCT00243243|4234655|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4408749|NCT00243243|4234653|B3|||Age||years|Mean|29.1|29.1|Standard Deviation|9.32|9.32|||
4408750|NCT00243243|4234654|B2|||Age||years|Mean|28.8|28.8|Standard Deviation|10.24|10.24|||
4408751|NCT00243243|4234655|B1|||Age||years|Mean|29.6|29.6|Standard Deviation|8.33|8.33|||
4408752|NCT00243243|4234653|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408753|NCT00243243|4234654|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408754|NCT00243243|4234655|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408755|NCT00243243|4234653|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4408756|NCT00243243|4234654|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4408757|NCT00243243|4234655|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4408758|NCT00243243|4234653|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408759|NCT00243243|4234654|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408760|NCT00243243|4234655|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408761|NCT00243191|4234662|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4408762|NCT00243191|4234662|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4408763|NCT00243191|4234662|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4408764|NCT00243191|4234662|B1|||Age||years|Mean|49|49.0|Standard Deviation|14|14.0|||
4408765|NCT00243191|4234662|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4408766|NCT00243191|4234662|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4408767|NCT00243191|4234662|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408768|NCT00243152|4234666|B1|||Non-smokers||participants|Number|6|6.0||||||
4408769|NCT00243152|4234666|B1|||Right-handed||participants|Number|6|6.0||||||
4408825|NCT00243022|4234700|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408770|NCT00243152|4234666|B1|||Allodynia brush greater than 5 of 10|Pain Scale Description: 0-10 rating scale where 0 indicates no pain and 10 indicates the highest pain|participants|Number|6|6.0||||||
4408771|NCT00243152|4234666|B1|||Spontaneous pain greater than 3 of 10|Pain Scale Description: 0-10 rating scale where 0 indicates no pain and 10 indicates the highest pain|participants|Number|6|6.0||||||
4408772|NCT00243152|4234666|B1|||Continuous pain for more than 3 months||participants|Number|6|6.0||||||
4408773|NCT00243152|4234666|B1|||Diagnosed with facial pain||participants|Number|6|6.0||||||
4408774|NCT00243152|4234666|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4408775|NCT00243152|4234666|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4408776|NCT00243152|4234666|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4408777|NCT00243152|4234666|B1|Ages 18 to 60 Years||Age, Customized||participants|Number|6|6.0||||||
4408778|NCT00243074|4234674|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4408779|NCT00243074|4234674|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408780|NCT00243074|4234674|B1||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4408781|NCT00243074|4234674|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408782|NCT00243074|4234674|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408783|NCT00243074|4234674|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408784|NCT00243074|4234674|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408785|NCT00243074|4234674|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4408786|NCT00243074|4234674|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4408787|NCT00243074|4234674|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4408788|NCT00243074|4234674|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4408789|NCT00243074|4234674|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4408790|NCT00243074|4234674|B1|||Age||years|Median|66|66.0|Full Range|||43.0|84.0|
4408791|NCT00243061|4234684|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4408792|NCT00243061|4234684|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4408793|NCT00243061|4234684|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4408794|NCT00243061|4234684|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4408795|NCT00243061|4234684|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4408796|NCT00243061|4234684|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4408797|NCT00243061|4234684|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408798|NCT00243061|4234684|B1|||Age||years|Median|67|67.0|Full Range|||28.0|82.0|
4408799|NCT00243022|4234698|B3|||Baseline edema measure|Baseline measure was acquired for 11 patients. Six on Arm I and five on Arm II.|cm^3|Mean|11.1|11.1|Standard Deviation|9.4|9.4|||
4408800|NCT00243022|4234699|B2|||Baseline edema measure|Baseline measure was acquired for 11 patients. Six on Arm I and five on Arm II.|cm^3|Mean|11.3|11.3|Standard Deviation|8.1|8.1|||
4408801|NCT00243022|4234700|B1|||Baseline edema measure|Baseline measure was acquired for 11 patients. Six on Arm I and five on Arm II.|cm^3|Mean|10.8|10.8|Standard Deviation|11.1|11.1|||
4408802|NCT00243022|4234698|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4408803|NCT00243022|4234699|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4408804|NCT00243022|4234700|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4408805|NCT00243022|4234698|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408806|NCT00243022|4234699|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408807|NCT00243022|4234700|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408808|NCT00243022|4234698|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408809|NCT00243022|4234699|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408810|NCT00243022|4234700|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408811|NCT00243022|4234698|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4408812|NCT00243022|4234699|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4408813|NCT00243022|4234700|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4408814|NCT00243022|4234698|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408815|NCT00243022|4234699|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408816|NCT00243022|4234700|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408817|NCT00243022|4234698|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408818|NCT00243022|4234699|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408819|NCT00243022|4234700|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408820|NCT00243022|4234698|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408821|NCT00243022|4234699|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4408822|NCT00243022|4234700|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408823|NCT00243022|4234698|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408824|NCT00243022|4234699|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408826|NCT00243022|4234698|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408827|NCT00243022|4234699|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408828|NCT00243022|4234700|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408829|NCT00243022|4234698|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4408830|NCT00243022|4234699|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4408831|NCT00243022|4234700|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4408832|NCT00243022|4234698|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408833|NCT00243022|4234699|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408834|NCT00243022|4234700|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408835|NCT00243022|4234698|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4408836|NCT00243022|4234699|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4408837|NCT00243022|4234700|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4408838|NCT00243022|4234698|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4408839|NCT00243022|4234699|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4408840|NCT00243022|4234700|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4408841|NCT00243022|4234698|B3|70-79 years||Age, Customized||participants|Number|1|1.0||||||
4408842|NCT00243022|4234699|B2|70-79 years||Age, Customized||participants|Number|0|0.0||||||
4408843|NCT00243022|4234700|B1|70-79 years||Age, Customized||participants|Number|1|1.0||||||
4408844|NCT00243022|4234698|B3|60-69 years||Age, Customized||participants|Number|1|1.0||||||
4408845|NCT00243022|4234699|B2|60-69 years||Age, Customized||participants|Number|0|0.0||||||
4408846|NCT00243022|4234700|B1|60-69 years||Age, Customized||participants|Number|1|1.0||||||
4408847|NCT00243022|4234698|B3|50-59 years||Age, Customized||participants|Number|3|3.0||||||
4408848|NCT00243022|4234699|B2|50-59 years||Age, Customized||participants|Number|2|2.0||||||
4408849|NCT00243022|4234700|B1|50-59 years||Age, Customized||participants|Number|1|1.0||||||
4408850|NCT00243022|4234698|B3|40-49 years||Age, Customized||participants|Number|6|6.0||||||
4408851|NCT00243022|4234699|B2|40-49 years||Age, Customized||participants|Number|3|3.0||||||
4408852|NCT00243022|4234700|B1|40-49 years||Age, Customized||participants|Number|3|3.0||||||
4408853|NCT00243022|4234698|B3|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4408854|NCT00243022|4234699|B2|30-39 years||Age, Customized||participants|Number|0|0.0||||||
4408855|NCT00243022|4234700|B1|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4408856|NCT00242710|4234719|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408857|NCT00242710|4234720|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408858|NCT00242710|4234721|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408859|NCT00242710|4234722|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408860|NCT00242710|4234723|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408861|NCT00242710|4234719|B5||Female|Sex: Female, Male||Participants|Count of Participants|1061|1061.0||||||
4408862|NCT00242710|4234720|B4||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4408863|NCT00242710|4234721|B3||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4408864|NCT00242710|4234722|B2||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4408865|NCT00242710|4234723|B1||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
4408866|NCT00242710|4234719|B5|||Age||years|Mean|54.44|54.44|Standard Deviation|4.65|4.65|||
4408867|NCT00242710|4234720|B4|||Age||years|Mean|54.19|54.19|Standard Deviation|4.62|4.62|||
4408868|NCT00242710|4234721|B3|||Age||years|Mean|54.30|54.3|Standard Deviation|4.56|4.56|||
4408869|NCT00242710|4234722|B2|||Age||years|Mean|54.44|54.44|Standard Deviation|4.62|4.62|||
4408870|NCT00242710|4234723|B1|||Age||years|Mean|54.62|54.62|Standard Deviation|4.74|4.74|||
4408871|NCT00242684|4234776|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408872|NCT00242684|4234776|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408873|NCT00242684|4234776|B1||White|Race (NIH/OMB)||Participants|Count of Participants|392|392.0||||||
4408874|NCT00242684|4234776|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4408875|NCT00242684|4234776|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408876|NCT00242684|4234776|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408877|NCT00242684|4234776|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408878|NCT00242684|4234776|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|446|446.0||||||
4408879|NCT00242684|4234776|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408880|NCT00242684|4234776|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4408881|NCT00242684|4234776|B1||Male|Sex: Female, Male||Participants|Count of Participants|437|437.0||||||
4408882|NCT00242684|4234776|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4408883|NCT00242684|4234776|B1|||Age||Years|Mean|78.6|78.6|Standard Deviation|7.5|7.5|||
4408884|NCT00242658|4234781|B3|United States||Region of Enrollment||participants|Number|394|394.0||||||
4408885|NCT00242658|4234782|B2|United States||Region of Enrollment||participants|Number|207|207.0||||||
4408886|NCT00242658|4234783|B1|United States||Region of Enrollment||participants|Number|187|187.0||||||
4408887|NCT00242658|4234781|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4408888|NCT00242658|4234782|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4408889|NCT00242658|4234783|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4408890|NCT00242658|4234781|B3||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4408891|NCT00242658|4234782|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4408892|NCT00242658|4234783|B1||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4408893|NCT00242658|4234781|B3|||Age||years|Mean|46.4|46.4|Standard Deviation|11.4|11.4|||
4408894|NCT00242658|4234782|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|11.1|11.1|||
4408895|NCT00242658|4234783|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|11.2|11.2|||
4408896|NCT00242658|4234781|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408897|NCT00242658|4234782|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408898|NCT00242658|4234783|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408899|NCT00242658|4234781|B3||Between 18 and 65 years|Age||Participants|Count of Participants|394|394.0||||||
4408900|NCT00242658|4234782|B2||Between 18 and 65 years|Age||Participants|Count of Participants|207|207.0||||||
4408901|NCT00242658|4234783|B1||Between 18 and 65 years|Age||Participants|Count of Participants|187|187.0||||||
4408902|NCT00242658|4234781|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408903|NCT00242658|4234782|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408904|NCT00242658|4234783|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408905|NCT00242632|4234792|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4408906|NCT00242632|4234793|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4408907|NCT00242632|4234794|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4408908|NCT00242632|4234792|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408909|NCT00242632|4234793|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408910|NCT00242632|4234794|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408911|NCT00242632|4234792|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4408912|NCT00242632|4234793|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4408913|NCT00242632|4234794|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4408914|NCT00242632|4234792|B3|||Age||years|Mean|58.41|58.41|Standard Deviation|0|0.0|||
4408915|NCT00242632|4234793|B2|||Age||years|Mean|59.09|59.09|Standard Deviation|0|0.0|||
4408916|NCT00242632|4234794|B1|||Age||years|Mean|57.73|57.73|Standard Deviation|0|0.0|||
4408917|NCT00242632|4234792|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408918|NCT00242632|4234793|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408919|NCT00242632|4234794|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408920|NCT00242632|4234792|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4408921|NCT00242632|4234793|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4408922|NCT00242632|4234794|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4408923|NCT00242632|4234792|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408924|NCT00242632|4234793|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408925|NCT00242632|4234794|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408926|NCT00242619|4234801|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4408927|NCT00242619|4234802|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4408928|NCT00242619|4234803|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4408929|NCT00242619|4234801|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
4408930|NCT00242619|4234802|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4408931|NCT00242619|4234803|B1||Male|Gender||Participants|Count of Participants|1|1.0||||||
4408932|NCT00242619|4234801|B3||Female|Gender||Participants|Count of Participants|11|11.0||||||
4408933|NCT00242619|4234802|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
4408934|NCT00242619|4234803|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
4408935|NCT00242619|4234801|B3|||Age||years|Mean|51.95|51.95|Standard Deviation|6.05|6.05|||
4408936|NCT00242619|4234802|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|6.5|6.5|||
4408937|NCT00242619|4234803|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|5.6|5.6|||
4408938|NCT00242619|4234801|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408939|NCT00242619|4234802|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408940|NCT00242619|4234803|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4408941|NCT00242619|4234801|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4408942|NCT00242619|4234802|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4408943|NCT00242619|4234803|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4408944|NCT00242619|4234801|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408945|NCT00242619|4234802|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408946|NCT00242619|4234803|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4408947|NCT00242580|4234812|B4|United States||Region of Enrollment||participants|Number|111|111.0||||||
4408948|NCT00242580|4234813|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4408949|NCT00242580|4234814|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4408950|NCT00242580|4234815|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4408951|NCT00242580|4234812|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4408952|NCT00242580|4234813|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4408953|NCT00242580|4234814|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4408954|NCT00242580|4234815|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4408955|NCT00242580|4234812|B4||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4408956|NCT00242580|4234813|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4408957|NCT00242580|4234814|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4408958|NCT00242580|4234815|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4408959|NCT00242580|4234812|B4|||Age||years|Mean|78|78.0|Standard Deviation|8|8.0|||
4408960|NCT00242580|4234813|B3|||Age||years|Mean|81|81.0|Standard Deviation|6|6.0|||
4408961|NCT00242580|4234814|B2|||Age||years|Mean|78|78.0|Standard Deviation|8|8.0|||
4408962|NCT00242580|4234815|B1|||Age||years|Mean|76|76.0|Standard Deviation|9|9.0|||
4408963|NCT00242567|4234840|B3||Male|Sex: Female, Male||Participants|Count of Participants|522|522.0||||||
4408964|NCT00242567|4234841|B2||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4408965|NCT00242567|4234842|B1||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4408966|NCT00242567|4234840|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408967|NCT00242567|4234841|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408968|NCT00242567|4234842|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4408969|NCT00242567|4234840|B3|||Age||years|Mean|69.8|69.8|Standard Deviation|8.37|8.37|||
4408970|NCT00242567|4234841|B2|||Age||years|Mean|70.2|70.2|Standard Deviation|8.26|8.26|||
4408971|NCT00242567|4234842|B1|||Age||years|Mean|69.4|69.4|Standard Deviation|8.46|8.46|||
4408972|NCT00242502|4234859|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4408973|NCT00242502|4234859|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4408974|NCT00242502|4234859|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4408975|NCT00242502|4234859|B1|||Age||years|Median|63|63.0|Full Range|||29.0|82.0|
4408976|NCT00242385|4234863|B1|New Zealand||Region of Enrollment||participants|Number|11|11.0||||||
4408977|NCT00242385|4234863|B1|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4408978|NCT00242385|4234863|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4408979|NCT00242385|4234863|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4408980|NCT00242385|4234863|B1|||Age||years|Median|59|59.0|Full Range|||20.0|75.0|
4408981|NCT00242216|4234888|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
4408982|NCT00242216|4234889|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4408983|NCT00242216|4234890|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4408984|NCT00242216|4234888|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4408985|NCT00242216|4234889|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4408986|NCT00242216|4234890|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4408987|NCT00242216|4234888|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4408988|NCT00242216|4234889|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4408989|NCT00242216|4234890|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4408990|NCT00242216|4234888|B3|||Age||years|Mean|48|48.0|Standard Deviation|10|10.0|||
4408991|NCT00242216|4234889|B2|||Age||years|Mean|48|48.0|Standard Deviation|10|10.0|||
4408992|NCT00242216|4234890|B1|||Age||years|Mean|48|48.0|Standard Deviation|9.7|9.7|||
4408993|NCT00242216|4234888|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4408994|NCT00242216|4234889|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4408995|NCT00242216|4234890|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4408996|NCT00242216|4234888|B3||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4408997|NCT00242216|4234889|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4408998|NCT00242216|4234890|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4408999|NCT00242216|4234888|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409000|NCT00242216|4234889|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409001|NCT00242216|4234890|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409002|NCT00241969|4234899|B3|||Weight for Age Z score|Weight for age Z score was calculated using the mean measurement and the Centers for Disease Control and Prevention Anthropometric Software Program. The z score is a measure of the number of standard deviations that an observation is above or below the mean. A positive z score indicates that the observation is above the mean, a negative z score that the observation is below the mean.|z-score|Mean|-0.44|-0.44|Standard Deviation|0.81|0.81|||
4409003|NCT00241969|4234900|B2|||Weight for Age Z score|Weight for age Z score was calculated using the mean measurement and the Centers for Disease Control and Prevention Anthropometric Software Program. The z score is a measure of the number of standard deviations that an observation is above or below the mean. A positive z score indicates that the observation is above the mean, a negative z score that the observation is below the mean.|z-score|Mean|-0.51|-0.51|Standard Deviation|.85|0.85|||
4409062|NCT00241644|4234945|B2||Male|Gender||Participants|Count of Participants|812|812.0||||||
4409063|NCT00241644|4234946|B1||Male|Gender||Participants|Count of Participants|836|836.0||||||
4409064|NCT00241644|4234942|B5||Female|Gender||Participants|Count of Participants|4100|4100.0||||||
4409004|NCT00241969|4234901|B1|||Weight for Age Z score|Weight for age Z score was calculated using the mean measurement and the Centers for Disease Control and Prevention Anthropometric Software Program. The z score is a measure of the number of standard deviations that an observation is above or below the mean. A positive z score indicates that the observation is above the mean, a negative z score that the observation is below the mean.|z-score|Mean|-0.36|-0.36|Standard Deviation|0.75|0.75|||
4409005|NCT00241969|4234899|B3|||Energy Intake (kcal/day)||calories/day (kcal/day)|Mean|1462|1462.0|Standard Deviation|329|329.0|||
4409006|NCT00241969|4234900|B2|||Energy Intake (kcal/day)||calories/day (kcal/day)|Mean|1461|1461.0|Standard Deviation|332|332.0|||
4409007|NCT00241969|4234901|B1|||Energy Intake (kcal/day)||calories/day (kcal/day)|Mean|1462|1462.0|Standard Deviation|330|330.0|||
4409008|NCT00241969|4234899|B3|Race-White||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
4409009|NCT00241969|4234900|B2|Race-White||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4409010|NCT00241969|4234901|B1|Race-White||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4409011|NCT00241969|4234899|B3|Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|75|75.0||||||
4409012|NCT00241969|4234900|B2|Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4409013|NCT00241969|4234901|B1|Non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|35|35.0||||||
4409014|NCT00241969|4234899|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4409015|NCT00241969|4234900|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4409016|NCT00241969|4234901|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4409017|NCT00241969|4234899|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4409018|NCT00241969|4234900|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4409019|NCT00241969|4234901|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4409020|NCT00241969|4234899|B3|||Age||years|Mean|3.8|3.8|Standard Deviation|1.3|1.3|||
4409021|NCT00241969|4234900|B2|||Age||years|Mean|3.7|3.7|Standard Deviation|1.3|1.3|||
4409022|NCT00241969|4234901|B1|||Age||years|Mean|3.8|3.8|Standard Deviation|1.2|1.2|||
4409023|NCT00241904|4234912|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|108|108.0||||||
4409024|NCT00241904|4234913|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
4409025|NCT00241904|4234914|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
4409026|NCT00241904|4234912|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|417|417.0||||||
4409027|NCT00241904|4234913|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|210|210.0||||||
4409028|NCT00241904|4234914|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|207|207.0||||||
4409029|NCT00241904|4234912|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4409030|NCT00241904|4234913|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4409031|NCT00241904|4234914|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4409032|NCT00241904|4234912|B3||Female|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
4409033|NCT00241904|4234913|B2||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4409034|NCT00241904|4234914|B1||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4409035|NCT00241904|4234912|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|11.7|11.7|||
4409036|NCT00241904|4234913|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|11.5|11.5|||
4409037|NCT00241904|4234914|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|12|12.0|||
4409038|NCT00241839|4234927|B3|United States||Region of Enrollment||participants|Number|142|142.0||||||
4409039|NCT00241839|4234928|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4409040|NCT00241839|4234929|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4409041|NCT00241839|4234927|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4409042|NCT00241839|4234928|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4409043|NCT00241839|4234929|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4409044|NCT00241839|4234927|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4409045|NCT00241839|4234928|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4409046|NCT00241839|4234929|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4409047|NCT00241839|4234927|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|8.8|8.8|||
4409048|NCT00241839|4234928|B2|||Age||years|Mean|48.0|48.0|Standard Deviation|7.7|7.7|||
4409049|NCT00241839|4234929|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|10.1|10.1|||
4409050|NCT00241839|4234927|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4409051|NCT00241839|4234928|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409052|NCT00241839|4234929|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4409053|NCT00241839|4234927|B3||Between 18 and 65 years|Age||Participants|Count of Participants|141|141.0||||||
4409054|NCT00241839|4234928|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4409055|NCT00241839|4234929|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4409056|NCT00241839|4234927|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409057|NCT00241839|4234928|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409058|NCT00241839|4234929|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409059|NCT00241644|4234942|B5||Male|Gender||Participants|Count of Participants|4137|4137.0||||||
4409060|NCT00241644|4234943|B4||Male|Gender||Participants|Count of Participants|1648|1648.0||||||
4409061|NCT00241644|4234944|B3||Male|Gender||Participants|Count of Participants|841|841.0||||||
4409065|NCT00241644|4234943|B4||Female|Gender||Participants|Count of Participants|1650|1650.0||||||
4409066|NCT00241644|4234944|B3||Female|Gender||Participants|Count of Participants|800|800.0||||||
4409067|NCT00241644|4234945|B2||Female|Gender||Participants|Count of Participants|839|839.0||||||
4409068|NCT00241644|4234946|B1||Female|Gender||Participants|Count of Participants|811|811.0||||||
4409069|NCT00241644|4234942|B5|||Age||weeks|Mean|6.4|6.4|Standard Deviation|0.95|0.95|||
4409070|NCT00241644|4234943|B4|||Age||weeks|Mean|6.4|6.4|Standard Deviation|0.95|0.95|||
4409071|NCT00241644|4234944|B3|||Age||weeks|Mean|6.4|6.4|Standard Deviation|0.97|0.97|||
4409072|NCT00241644|4234945|B2|||Age||weeks|Mean|6.4|6.4|Standard Deviation|0.98|0.98|||
4409073|NCT00241644|4234946|B1|||Age||weeks|Mean|6.3|6.3|Standard Deviation|0.92|0.92|||
4409074|NCT00241358|4235031|B4|United States||Region of Enrollment||participants|Number|92|92.0||||||
4409075|NCT00241358|4235032|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4409076|NCT00241358|4235033|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4409077|NCT00241358|4235034|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4409078|NCT00241358|4235031|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4409079|NCT00241358|4235032|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4409080|NCT00241358|4235033|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4409081|NCT00241358|4235034|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4409082|NCT00241358|4235031|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4409083|NCT00241358|4235032|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4409084|NCT00241358|4235033|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4409085|NCT00241358|4235034|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4409086|NCT00241358|4235031|B4|||Age||years|Median|52|52.0|Full Range|||21.0|67.0|
4409087|NCT00241358|4235032|B3|||Age||years|Median|51|51.0|Full Range|||21.0|67.0|
4409088|NCT00241358|4235033|B2|||Age||years|Median|53|53.0|Full Range|||23.0|66.0|
4409089|NCT00241358|4235034|B1|||Age||years|Median|54|54.0|Full Range|||24.0|66.0|
4409090|NCT00241280|4235067|B3|United States||Region of Enrollment||participants|Number|501|501.0||||||
4409091|NCT00241280|4235068|B2|United States||Region of Enrollment||participants|Number|254|254.0||||||
4409092|NCT00241280|4235069|B1|United States||Region of Enrollment||participants|Number|247|247.0||||||
4409093|NCT00241280|4235067|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4409094|NCT00241280|4235068|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4409095|NCT00241280|4235069|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4409096|NCT00241280|4235067|B3|Asian-Indian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4409097|NCT00241280|4235068|B2|Asian-Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4409098|NCT00241280|4235069|B1|Asian-Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4409099|NCT00241280|4235067|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4409100|NCT00241280|4235068|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4409101|NCT00241280|4235069|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4409102|NCT00241280|4235067|B3|African-American||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4409103|NCT00241280|4235068|B2|African-American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4409104|NCT00241280|4235069|B1|African-American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4409105|NCT00241280|4235067|B3|White||Race/Ethnicity, Customized||participants|Number|420|420.0||||||
4409106|NCT00241280|4235068|B2|White||Race/Ethnicity, Customized||participants|Number|217|217.0||||||
4409107|NCT00241280|4235069|B1|White||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
4409108|NCT00241280|4235067|B3|Asian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4409109|NCT00241280|4235068|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4409110|NCT00241280|4235069|B1|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4409111|NCT00241280|4235067|B3||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4409112|NCT00241280|4235068|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4409113|NCT00241280|4235069|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4409114|NCT00241280|4235067|B3||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4409115|NCT00241280|4235068|B2||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4409116|NCT00241280|4235069|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4409117|NCT00241280|4235067|B3|||Age||years|Mean|32.2|32.2|Full Range|||18.0|60.0|
4409118|NCT00241280|4235068|B2|||Age||years|Mean|32.8|32.8|Full Range|||18.0|60.0|
4409119|NCT00241280|4235069|B1|||Age||years|Mean|31.7|31.7|Full Range|||18.0|51.0|
4409120|NCT00241176|4235078|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4409121|NCT00241176|4235078|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
4409122|NCT00241176|4235078|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4409123|NCT00241176|4235078|B1|||Age||years|Mean|13.36|13.36|Standard Deviation|3.33|3.33|||
4409124|NCT00241176|4235078|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409125|NCT00241176|4235078|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4409126|NCT00241176|4235078|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4409127|NCT00240994|4235085|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4409128|NCT00240994|4235085|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
4409129|NCT00240994|4235085|B1||Female|Gender||Participants|Count of Participants|20|20.0||||||
4409130|NCT00240994|4235085|B1|All Participants (N=35)||Age||years|Mean|12.6|12.6|Standard Deviation|5.5|5.5|||
4409131|NCT00240994|4235085|B1|Final status: Discontinued Study (N=3)||Age||years|Mean|17.7|17.7|Standard Deviation|2.4|2.4|||
4409132|NCT00240994|4235085|B1|Final status: Discontinued Therapy (N=10)||Age||years|Mean|9.8|9.8|Standard Deviation|6.2|6.2|||
4409133|NCT00240994|4235085|B1|Final status: Completed (N=22)||Age||years|Mean|13.1|13.1|Standard Deviation|5.0|5.0|||
4409134|NCT00240981|4235089|B3|United States||Region of Enrollment||participants|Number|209|209.0||||||
4409135|NCT00240981|4235090|B2|United States||Region of Enrollment||participants|Number|103|103.0||||||
4409136|NCT00240981|4235091|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
4409137|NCT00240981|4235089|B3||Male|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4409138|NCT00240981|4235090|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4409139|NCT00240981|4235091|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4409140|NCT00240981|4235089|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409141|NCT00240981|4235090|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409142|NCT00240981|4235091|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409143|NCT00240981|4235089|B3|||Age||Years|Mean|74|74.0|Standard Deviation|5.4|5.4|||
4409144|NCT00240981|4235090|B2|||Age||Years|Mean|74|74.0|Standard Deviation|5|5.0|||
4409145|NCT00240981|4235091|B1|||Age||Years|Mean|74|74.0|Standard Deviation|6|6.0|||
4409146|NCT00240981|4235089|B3||>=65 years|Age||Participants|Count of Participants|209|209.0||||||
4409147|NCT00240981|4235090|B2||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
4409148|NCT00240981|4235091|B1||>=65 years|Age||Participants|Count of Participants|106|106.0||||||
4409149|NCT00240981|4235089|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4409150|NCT00240981|4235090|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4409151|NCT00240981|4235091|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4409152|NCT00240981|4235089|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409153|NCT00240981|4235090|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409154|NCT00240981|4235091|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409155|NCT00240539|4235116|B5||Male|Gender||Participants|Count of Participants|13|13.0||||||
4409156|NCT00240539|4235117|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
4409157|NCT00240539|4235118|B3||Male|Gender||Participants|Count of Participants|13|13.0||||||
4409158|NCT00240539|4235119|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4409159|NCT00240539|4235120|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4409160|NCT00240539|4235116|B5||Female|Gender||Participants|Count of Participants|23|23.0||||||
4409161|NCT00240539|4235117|B4||Female|Gender||Participants|Count of Participants|1|1.0||||||
4409162|NCT00240539|4235118|B3||Female|Gender||Participants|Count of Participants|18|18.0||||||
4409163|NCT00240539|4235119|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
4409164|NCT00240539|4235120|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4409165|NCT00240539|4235116|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409166|NCT00240539|4235117|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409167|NCT00240539|4235118|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409168|NCT00240539|4235119|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409169|NCT00240539|4235120|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409170|NCT00240539|4235116|B5||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4409171|NCT00240539|4235117|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4409172|NCT00240539|4235118|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4409173|NCT00240539|4235119|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4409174|NCT00240539|4235120|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4409175|NCT00240539|4235116|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409176|NCT00240539|4235117|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409177|NCT00240539|4235118|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409178|NCT00240539|4235119|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409179|NCT00240539|4235120|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409180|NCT00240526|4235141|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4409181|NCT00240526|4235142|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4409182|NCT00240526|4235143|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4409183|NCT00240526|4235144|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4409184|NCT00240526|4235145|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4409185|NCT00240526|4235141|B5||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4409186|NCT00240526|4235142|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4409187|NCT00240526|4235143|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4409188|NCT00240526|4235144|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4409189|NCT00240526|4235145|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4409252|NCT00240227|4235239|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409190|NCT00240526|4235141|B5|||Age|Data are given for the Year 15 time point.|years|Mean|14.6|14.6|Standard Deviation|0.49|0.49|||
4409191|NCT00240526|4235142|B4|||Age|Data are given for the Year 15 time point.|years|Mean|14.5|14.5|Standard Deviation|0.51|0.51|||
4409192|NCT00240526|4235143|B3|||Age|Data are given for the Year 15 time point.|years|Mean|14.6|14.6|Standard Deviation|0.50|0.5|||
4409193|NCT00240526|4235144|B2|||Age|Data are given for the Year 15 time point.|years|Mean|14.7|14.7|Standard Deviation|0.45|0.45|||
4409194|NCT00240526|4235145|B1|||Age|Data are given for the Year 15 time point.|years|Mean|14.5|14.5|Standard Deviation|0.51|0.51|||
4409195|NCT00240500|4235178|B7||Male|Gender||Participants|Count of Participants|56|56.0||||||
4409196|NCT00240500|4235179|B6||Male|Gender||Participants|Count of Participants|2|2.0||||||
4409197|NCT00240500|4235180|B5||Male|Gender||Participants|Count of Participants|11|11.0||||||
4409198|NCT00240500|4235181|B4||Male|Gender||Participants|Count of Participants|16|16.0||||||
4409199|NCT00240500|4235182|B3||Male|Gender||Participants|Count of Participants|6|6.0||||||
4409200|NCT00240500|4235183|B2||Male|Gender||Participants|Count of Participants|11|11.0||||||
4409201|NCT00240500|4235184|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
4409202|NCT00240500|4235178|B7||Female|Gender||Participants|Count of Participants|53|53.0||||||
4409203|NCT00240500|4235179|B6||Female|Gender||Participants|Count of Participants|1|1.0||||||
4409204|NCT00240500|4235180|B5||Female|Gender||Participants|Count of Participants|18|18.0||||||
4409205|NCT00240500|4235181|B4||Female|Gender||Participants|Count of Participants|7|7.0||||||
4409206|NCT00240500|4235182|B3||Female|Gender||Participants|Count of Participants|11|11.0||||||
4409207|NCT00240500|4235183|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
4409208|NCT00240500|4235184|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
4409209|NCT00240500|4235178|B7|||Age||years|Mean|16.6|16.6|Standard Deviation|0.50|0.5|||
4409210|NCT00240500|4235179|B6|||Age||years|Mean|16.7|16.7|Standard Deviation|0.58|0.58|||
4409211|NCT00240500|4235180|B5|||Age||years|Mean|16.8|16.8|Standard Deviation|0.44|0.44|||
4409212|NCT00240500|4235181|B4|||Age||years|Mean|16.4|16.4|Standard Deviation|0.51|0.51|||
4409213|NCT00240500|4235182|B3|||Age||years|Mean|16.5|16.5|Standard Deviation|0.51|0.51|||
4409214|NCT00240500|4235183|B2|||Age||years|Mean|16.6|16.6|Standard Deviation|0.5|0.5|||
4409215|NCT00240500|4235184|B1|||Age||years|Mean|16.5|16.5|Standard Deviation|0.51|0.51|||
4409216|NCT00240487|4235209|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4409217|NCT00240487|4235210|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4409218|NCT00240487|4235211|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4409219|NCT00240487|4235209|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4409220|NCT00240487|4235210|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4409221|NCT00240487|4235211|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4409222|NCT00240487|4235209|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4409223|NCT00240487|4235210|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4409224|NCT00240487|4235211|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4409225|NCT00240487|4235209|B3|||Age||years|Mean|8.84|8.84|Standard Deviation|6.5|6.5|||
4409226|NCT00240487|4235210|B2|||Age||years|Mean|8.06|8.06|Standard Deviation|6.28|6.28|||
4409227|NCT00240487|4235211|B1|||Age||years|Mean|9.93|9.93|Standard Deviation|6.79|6.79|||
4409228|NCT00240487|4235209|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409229|NCT00240487|4235210|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409230|NCT00240487|4235211|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409231|NCT00240487|4235209|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4409232|NCT00240487|4235210|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4409233|NCT00240487|4235211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4409234|NCT00240487|4235209|B3||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
4409235|NCT00240487|4235210|B2||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4409236|NCT00240487|4235211|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4409237|NCT00240331|4235218|B3||Male|Sex: Female, Male||Participants|Count of Participants|1723|1723.0||||||
4409238|NCT00240331|4235219|B2||Male|Sex: Female, Male||Participants|Count of Participants|872|872.0||||||
4409239|NCT00240331|4235220|B1||Male|Sex: Female, Male||Participants|Count of Participants|851|851.0||||||
4409240|NCT00240331|4235218|B3||Female|Sex: Female, Male||Participants|Count of Participants|1050|1050.0||||||
4409241|NCT00240331|4235219|B2||Female|Sex: Female, Male||Participants|Count of Participants|512|512.0||||||
4409242|NCT00240331|4235220|B1||Female|Sex: Female, Male||Participants|Count of Participants|538|538.0||||||
4409243|NCT00240331|4235218|B3|||Age||Years|Mean|64.2|64.2|Standard Deviation|8.6|8.6|||
4409244|NCT00240331|4235219|B2|||Age||Years|Mean|64.3|64.3|Standard Deviation|8.7|8.7|||
4409245|NCT00240331|4235220|B1|||Age||Years|Mean|64.1|64.1|Standard Deviation|8.6|8.6|||
4409246|NCT00240227|4235239|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4409247|NCT00240227|4235239|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4409248|NCT00240227|4235239|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409249|NCT00240227|4235239|B1|||Age||years|Mean|42|42.0|Standard Deviation|8|8.0|||
4409250|NCT00240227|4235239|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409251|NCT00240227|4235239|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4409253|NCT00240162|4235255|B1|No available cytogenetics||Conventional cytogenetics||participants|Number|1|1.0||||||
4409254|NCT00240162|4235255|B1|Others||Conventional cytogenetics||participants|Number|8|8.0||||||
4409255|NCT00240162|4235255|B1|Monosomy 13 and t(4:14)||Conventional cytogenetics||participants|Number|2|2.0||||||
4409256|NCT00240162|4235255|B1|Hypodiploid karyotype with t(11;14)||Conventional cytogenetics||participants|Number|1|1.0||||||
4409257|NCT00240162|4235255|B1|Monosomy 13||Conventional cytogenetics||participants|Number|1|1.0||||||
4409258|NCT00240162|4235255|B1|Normal karyotype||Conventional cytogenetics||participants|Number|8|8.0||||||
4409259|NCT00240162|4235255|B1|||Bone marrow aspirate plasma||percentage of cells at study entry|Median|5|5.0|Full Range|||0.0|15.0|
4409260|NCT00240162|4235255|B1|||Serum M-spike at study entry||g/dL|Median|0.5|0.5|Full Range|||0.0|2.4|
4409261|NCT00240162|4235255|B1|IgA||Paraprotein at study entry||participants|Number|3|3.0||||||
4409262|NCT00240162|4235255|B1|IgG||Paraprotein at study entry||participants|Number|18|18.0||||||
4409263|NCT00240162|4235255|B1|||Beta-2 Microglobulin at study entry||mg/L|Median|2.3|2.3|Full Range|||1.2|5.65|
4409264|NCT00240162|4235255|B1|Stage III||International Staging System (ISS) at study entry|"Stage I:Beta 2-microglobulin level <3.5 mg/L & Albumin level ≥3.5 g/dL~Stage II Beta 2-microglobulin level <3.5 g/L & Albumin level <3.5 g/dL OR Beta 2-microglobulin level is 3.5 to 5.5 mg/L~Stage III Beta 2-microglobulin level is ≥5.5 mg/L"|participants|Number|1|1.0||||||
4409265|NCT00240162|4235255|B1|Stage II||International Staging System (ISS) at study entry|"Stage I:Beta 2-microglobulin level <3.5 mg/L & Albumin level ≥3.5 g/dL~Stage II Beta 2-microglobulin level <3.5 g/L & Albumin level <3.5 g/dL OR Beta 2-microglobulin level is 3.5 to 5.5 mg/L~Stage III Beta 2-microglobulin level is ≥5.5 mg/L"|participants|Number|3|3.0||||||
4409266|NCT00240162|4235255|B1|Stage I||International Staging System (ISS) at study entry|"Stage I:Beta 2-microglobulin level <3.5 mg/L & Albumin level ≥3.5 g/dL~Stage II Beta 2-microglobulin level <3.5 g/L & Albumin level <3.5 g/dL OR Beta 2-microglobulin level is 3.5 to 5.5 mg/L~Stage III Beta 2-microglobulin level is ≥5.5 mg/L"|participants|Number|17|17.0||||||
4409267|NCT00240162|4235255|B1|Stage IIIA||Durie-Salmon stage at study entry|"Stage I:Hemoglobin (hgb) level >10.5 g/dL & calcium level is normal or ≤12 mg/dL & Low M-protein levels (IgG level is <5 g/dL; IgA level <3 g/dL) & Urine light chains <4 g per 24 hours, & Bone X-ray normal bone structure or a solitary bone plasmacytoma~Stage IIA:Levels of hgb, calcium, M-protein and Bence Jones protein fall somewhere between stages I and III & No kidney failure (creatinine ≤2 mg/dL)~Stage III: High M protein (IgG is>7 g/dL; IgA is >5g/dL) & Urine light chains >12 g per 24 hours & hgb <8.5 g/dL & calcium >2 m/dL) & X-ray studies of bone >3 lytic bone lesions"|participants|Number|7|7.0||||||
4409268|NCT00240162|4235255|B1|Stage IIA||Durie-Salmon stage at study entry|"Stage I:Hemoglobin (hgb) level >10.5 g/dL & calcium level is normal or ≤12 mg/dL & Low M-protein levels (IgG level is <5 g/dL; IgA level <3 g/dL) & Urine light chains <4 g per 24 hours, & Bone X-ray normal bone structure or a solitary bone plasmacytoma~Stage IIA:Levels of hgb, calcium, M-protein and Bence Jones protein fall somewhere between stages I and III & No kidney failure (creatinine ≤2 mg/dL)~Stage III: High M protein (IgG is>7 g/dL; IgA is >5g/dL) & Urine light chains >12 g per 24 hours & hgb <8.5 g/dL & calcium >2 m/dL) & X-ray studies of bone >3 lytic bone lesions"|participants|Number|7|7.0||||||
4409269|NCT00240162|4235255|B1|Stage IA||Durie-Salmon stage at study entry|"Stage I:Hemoglobin (hgb) level >10.5 g/dL & calcium level is normal or ≤12 mg/dL & Low M-protein levels (IgG level is <5 g/dL; IgA level <3 g/dL) & Urine light chains <4 g per 24 hours, & Bone X-ray normal bone structure or a solitary bone plasmacytoma~Stage IIA:Levels of hgb, calcium, M-protein and Bence Jones protein fall somewhere between stages I and III & No kidney failure (creatinine ≤2 mg/dL)~Stage III: High M protein (IgG is>7 g/dL; IgA is >5g/dL) & Urine light chains >12 g per 24 hours & hgb <8.5 g/dL & calcium >2 m/dL) & X-ray studies of bone >3 lytic bone lesions"|participants|Number|7|7.0||||||
4409270|NCT00240162|4235255|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4409271|NCT00240162|4235255|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4409272|NCT00240162|4235255|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4409273|NCT00240162|4235255|B1|||Age||years|Median|57|57.0|Full Range|||38.0|76.0|
4409274|NCT00240110|4235262|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409275|NCT00240110|4235263|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409276|NCT00240110|4235264|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409277|NCT00240110|4235262|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409278|NCT00240110|4235263|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409279|NCT00240110|4235264|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409280|NCT00240110|4235262|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4409281|NCT00240110|4235263|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4409282|NCT00240110|4235264|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4409283|NCT00240110|4235262|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4409284|NCT00240110|4235263|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4409285|NCT00240110|4235264|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4409286|NCT00240110|4235262|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409287|NCT00240110|4235263|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409288|NCT00240110|4235264|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409289|NCT00240110|4235262|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409290|NCT00240110|4235263|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409291|NCT00240110|4235264|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409292|NCT00240110|4235262|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409293|NCT00240110|4235263|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409294|NCT00240110|4235264|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409295|NCT00240110|4235262|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409296|NCT00240110|4235263|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409297|NCT00240110|4235264|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409298|NCT00240110|4235262|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4409299|NCT00240110|4235263|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4409300|NCT00240110|4235264|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4409301|NCT00240110|4235262|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4409302|NCT00240110|4235263|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4409303|NCT00240110|4235264|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4409304|NCT00240110|4235262|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4409305|NCT00240110|4235263|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4409306|NCT00240110|4235264|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4409307|NCT00240110|4235262|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4409308|NCT00240110|4235263|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4409309|NCT00240110|4235264|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4409310|NCT00240110|4235262|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|7.6|7.6|||
4409311|NCT00240110|4235263|B2|||Age||years|Mean|44|44.0|Standard Deviation|7.7|7.7|||
4409312|NCT00240110|4235264|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|7.4|7.4|||
4409313|NCT00240110|4235262|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409314|NCT00240110|4235263|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409315|NCT00240110|4235264|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409316|NCT00240110|4235262|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4409317|NCT00240110|4235263|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4409318|NCT00240110|4235264|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4409319|NCT00240110|4235262|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409320|NCT00240110|4235263|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409321|NCT00240110|4235264|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409322|NCT00240097|4235273|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4409323|NCT00240097|4235273|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4409324|NCT00240097|4235273|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4409325|NCT00240097|4235273|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4409326|NCT00240097|4235273|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4409327|NCT00240097|4235273|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409328|NCT00240071|4235283|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4409329|NCT00240071|4235283|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409330|NCT00240071|4235283|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4409331|NCT00240071|4235283|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|16|16.0|||
4409332|NCT00240071|4235283|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4409333|NCT00240071|4235283|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4409334|NCT00240071|4235283|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409335|NCT00239928|4235288|B1|Japan||Region of Enrollment||participants|Number|61|61.0||||||
4409336|NCT00239928|4235288|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4409337|NCT00239928|4235288|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4409338|NCT00239928|4235288|B1|||Age||years|Mean|73.3|73.3|Standard Deviation|8.1|8.1|||
4409339|NCT00239928|4235288|B1|>=65 years||Age, Customized||participants|Number|54|54.0||||||
4409340|NCT00239928|4235288|B1|18-64 years||Age, Customized||participants|Number|7|7.0||||||
4409341|NCT00239928|4235288|B1|< 18 years||Age, Customized||participants|Number|0|0.0||||||
4409342|NCT00239837|4235298|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4409343|NCT00239837|4235299|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4409344|NCT00239837|4235300|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4409345|NCT00239837|4235298|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409346|NCT00239837|4235299|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409347|NCT00239837|4235300|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409348|NCT00239837|4235298|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4409349|NCT00239837|4235299|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4409350|NCT00239837|4235300|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4409351|NCT00239837|4235298|B3|||Age||years|Mean|11.54|11.54|Standard Deviation|.48|0.48|||
4409352|NCT00239837|4235299|B2|||Age||years|Mean|11.59|11.59|Standard Deviation|.45|0.45|||
4409353|NCT00239837|4235300|B1|||Age||years|Mean|11.48|11.48|Standard Deviation|.51|0.51|||
4409354|NCT00239837|4235298|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409355|NCT00239837|4235299|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409356|NCT00239837|4235300|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409357|NCT00239837|4235298|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4409358|NCT00239837|4235299|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4409359|NCT00239837|4235300|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4409360|NCT00239837|4235298|B3||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4409361|NCT00239837|4235299|B2||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
4409362|NCT00239837|4235300|B1||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4409363|NCT00239733|4235321|B1|Decompensated Cirrhosis||Other baseline characteristics||Participants|Count of Participants|3|3.0||||||
4409364|NCT00239733|4235321|B1|Cirrhosis||Other baseline characteristics||Participants|Count of Participants|5|5.0||||||
4409365|NCT00239733|4235321|B1|HIV coinfected||Other baseline characteristics||Participants|Count of Participants|1|1.0||||||
4409366|NCT00239733|4235321|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4409367|NCT00239733|4235321|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4409368|NCT00239733|4235321|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4409369|NCT00239733|4235321|B1|||Age||years|Median|51|51.0|Full Range|||32.0|66.0|
4409370|NCT00239720|4235326|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4409371|NCT00239720|4235327|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4409372|NCT00239720|4235328|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4409373|NCT00239720|4235326|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4409374|NCT00239720|4235327|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4409375|NCT00239720|4235328|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4409376|NCT00239720|4235326|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4409377|NCT00239720|4235327|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409378|NCT00239720|4235328|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4409379|NCT00239720|4235326|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|9.4|9.4|||
4409380|NCT00239720|4235327|B2|||Age||years|Mean|54|54.0|Standard Deviation|0|0.0|||
4409381|NCT00239720|4235328|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|9.6|9.6|||
4409382|NCT00239720|4235326|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409383|NCT00239720|4235327|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409384|NCT00239720|4235328|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409385|NCT00239720|4235326|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4409386|NCT00239720|4235327|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4409387|NCT00239720|4235328|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4409388|NCT00239720|4235326|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409389|NCT00239720|4235327|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409390|NCT00239720|4235328|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409391|NCT00239681|4235335|B3||Male|Sex: Female, Male||Participants|Count of Participants|11001|11001.0||||||
4409392|NCT00239681|4235336|B2||Male|Sex: Female, Male||Participants|Count of Participants|5526|5526.0||||||
4409393|NCT00239681|4235337|B1||Male|Sex: Female, Male||Participants|Count of Participants|5475|5475.0||||||
4409394|NCT00239681|4235335|B3||Female|Sex: Female, Male||Participants|Count of Participants|6801|6801.0||||||
4409395|NCT00239681|4235336|B2||Female|Sex: Female, Male||Participants|Count of Participants|3375|3375.0||||||
4409396|NCT00239681|4235337|B1||Female|Sex: Female, Male||Participants|Count of Participants|3426|3426.0||||||
4409397|NCT00239681|4235335|B3|||Age||years|Mean|66.1|66.1|Standard Deviation|7.72|7.72|||
4409398|NCT00239681|4235336|B2|||Age||years|Mean|66.1|66.1|Standard Deviation|7.8|7.8|||
4409399|NCT00239681|4235337|B1|||Age||years|Mean|66.1|66.1|Standard Deviation|7.64|7.64|||
4409400|NCT00239642|4235354|B4|Russian Federation||Region of Enrollment||participants|Number|63|63.0||||||
4409401|NCT00239642|4235355|B3|Russian Federation||Region of Enrollment||participants|Number|24|24.0||||||
4409402|NCT00239642|4235356|B2|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
4409403|NCT00239642|4235357|B1|Russian Federation||Region of Enrollment||participants|Number|23|23.0||||||
4409404|NCT00239642|4235354|B4|United States||Region of Enrollment||participants|Number|82|82.0||||||
4409405|NCT00239642|4235355|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4409406|NCT00239642|4235356|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4409407|NCT00239642|4235357|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4409408|NCT00239642|4235354|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4409409|NCT00239642|4235355|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4409410|NCT00239642|4235356|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4409411|NCT00239642|4235357|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4409412|NCT00239642|4235354|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4409413|NCT00239642|4235355|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4409414|NCT00239642|4235356|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4409415|NCT00239642|4235357|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4409416|NCT00239642|4235354|B4|||Age||years|Mean|13.3|13.3|Standard Deviation|4.64|4.64|||
4409417|NCT00239642|4235355|B3|||Age||years|Mean|13.1|13.1|Standard Deviation|4.87|4.87|||
4409418|NCT00239642|4235356|B2|||Age||years|Mean|13.1|13.1|Standard Deviation|4.62|4.62|||
4409419|NCT00239642|4235357|B1|||Age||years|Mean|13.8|13.8|Standard Deviation|4.40|4.4|||
4409420|NCT00239642|4235354|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409421|NCT00239642|4235355|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409422|NCT00239642|4235356|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409423|NCT00239642|4235357|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409424|NCT00239642|4235354|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4409425|NCT00239642|4235355|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4409426|NCT00239642|4235356|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4409427|NCT00239642|4235357|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4409428|NCT00239642|4235354|B4||<=18 years|Age||Participants|Count of Participants|130|130.0||||||
4409429|NCT00239642|4235355|B3||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
4409430|NCT00239642|4235356|B2||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4409431|NCT00239642|4235357|B1||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
4409432|NCT00239356|4235391|B3|||Clinical Global Impression (CGI) Severity|Clinical Global Impression (CGI) Severity Scores are measured on a scale of 1 to 7, with 1 being least severe and 7 being the most severe.|Units on a scale|Mean|2.3|2.3|Standard Deviation|1.06|1.06|||
4409433|NCT00239356|4235392|B2|||Clinical Global Impression (CGI) Severity|Clinical Global Impression (CGI) Severity Scores are measured on a scale of 1 to 7, with 1 being least severe and 7 being the most severe.|Units on a scale|Mean|1.0|1.0|Standard Deviation|0.00|0.0|||
4409434|NCT00239356|4235393|B1|||Clinical Global Impression (CGI) Severity|Clinical Global Impression (CGI) Severity Scores are measured on a scale of 1 to 7, with 1 being least severe and 7 being the most severe.|Units on a scale|Mean|2.6|2.6|Standard Deviation|0.97|0.97|||
4409435|NCT00239356|4235391|B3|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4409436|NCT00239356|4235392|B2|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4409437|NCT00239356|4235393|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4409438|NCT00239356|4235391|B3|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4409439|NCT00239356|4235392|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4409440|NCT00239356|4235393|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4409441|NCT00239356|4235391|B3|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4409442|NCT00239356|4235392|B2|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4409443|NCT00239356|4235393|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4409444|NCT00239356|4235391|B3|India||Region of Enrollment||participants|Number|20|20.0||||||
4409445|NCT00239356|4235392|B2|India||Region of Enrollment||participants|Number|20|20.0||||||
4409446|NCT00239356|4235393|B1|India||Region of Enrollment||participants|Number|0|0.0||||||
4409447|NCT00239356|4235391|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4409448|NCT00239356|4235392|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4409449|NCT00239356|4235393|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4409450|NCT00239356|4235391|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4409451|NCT00239356|4235392|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4409452|NCT00239356|4235393|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4409453|NCT00239356|4235391|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4409454|NCT00239356|4235392|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4409455|NCT00239356|4235393|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4409456|NCT00239356|4235391|B3|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4409457|NCT00239356|4235392|B2|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4409458|NCT00239356|4235393|B1|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4409459|NCT00239356|4235391|B3|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4409460|NCT00239356|4235392|B2|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4409461|NCT00239356|4235393|B1|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4409462|NCT00239356|4235391|B3|Croatia||Region of Enrollment||participants|Number|11|11.0||||||
4409463|NCT00239356|4235392|B2|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4409464|NCT00239356|4235393|B1|Croatia||Region of Enrollment||participants|Number|11|11.0||||||
4409465|NCT00239356|4235391|B3|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4409466|NCT00239356|4235392|B2|Romania||Region of Enrollment||participants|Number|0|0.0||||||
4409467|NCT00239356|4235393|B1|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4409468|NCT00239356|4235391|B3|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4409469|NCT00239356|4235392|B2|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4409470|NCT00239356|4235393|B1|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4409471|NCT00239356|4235391|B3|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4409472|NCT00239356|4235392|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4409473|NCT00239356|4235393|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4409474|NCT00239356|4235391|B3|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4409475|NCT00239356|4235392|B2|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4409476|NCT00239356|4235393|B1|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4409477|NCT00239356|4235391|B3|Hungary||Region of Enrollment||participants|Number|10|10.0||||||
4409478|NCT00239356|4235392|B2|Hungary||Region of Enrollment||participants|Number|0|0.0||||||
4409479|NCT00239356|4235393|B1|Hungary||Region of Enrollment||participants|Number|10|10.0||||||
4409480|NCT00239356|4235391|B3|France||Region of Enrollment||participants|Number|24|24.0||||||
4409481|NCT00239356|4235392|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4409482|NCT00239356|4235393|B1|France||Region of Enrollment||participants|Number|24|24.0||||||
4409483|NCT00239356|4235391|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4409484|NCT00239356|4235392|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4409485|NCT00239356|4235393|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4409486|NCT00239356|4235391|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4409487|NCT00239356|4235392|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4409488|NCT00239356|4235393|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4409489|NCT00239356|4235391|B3|||Age||years|Mean|39.5|39.5|Standard Deviation|11.63|11.63|||
4409490|NCT00239356|4235392|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|11.78|11.78|||
4409491|NCT00239356|4235393|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|11.66|11.66|||
4409492|NCT00239226|4235412|B5|Italy||Region of Enrollment||participants|Number|102|102.0||||||
4409493|NCT00239226|4235413|B4|Italy||Region of Enrollment||participants|Number|17|17.0||||||
4409494|NCT00239226|4235414|B3|Italy||Region of Enrollment||participants|Number|37|37.0||||||
4409495|NCT00239226|4235415|B2|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4409496|NCT00239226|4235416|B1|Italy||Region of Enrollment||participants|Number|30|30.0||||||
4409497|NCT00239226|4235412|B5||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4409498|NCT00239226|4235413|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4409499|NCT00239226|4235414|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4409500|NCT00239226|4235415|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4409501|NCT00239226|4235416|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4409502|NCT00239226|4235412|B5||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4409503|NCT00239226|4235413|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4409504|NCT00239226|4235414|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4409505|NCT00239226|4235415|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4409506|NCT00239226|4235416|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4409507|NCT00239226|4235412|B5|||Age||years|Mean|77|77.0|Standard Deviation|7|7.0|||
4409508|NCT00239226|4235413|B4|||Age||years|Mean|81|81.0|Standard Deviation|5|5.0|||
4409509|NCT00239226|4235414|B3|||Age||years|Mean|75|75.0|Standard Deviation|7|7.0|||
4409510|NCT00239226|4235415|B2|||Age||years|Mean|79|79.0|Standard Deviation|6|6.0|||
4409511|NCT00239226|4235416|B1|||Age||years|Mean|75|75.0|Standard Deviation|7|7.0|||
4409512|NCT00239226|4235412|B5||>=65 years|Age||Participants|Count of Participants|92|92.0||||||
4409513|NCT00239226|4235413|B4||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4409514|NCT00239226|4235414|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4409515|NCT00239226|4235415|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4409516|NCT00239226|4235416|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4409517|NCT00239226|4235412|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4409518|NCT00239226|4235413|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4409519|NCT00239226|4235414|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4409520|NCT00239226|4235415|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4409521|NCT00239226|4235416|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4409522|NCT00239226|4235412|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409523|NCT00239226|4235413|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409524|NCT00239226|4235414|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409525|NCT00239226|4235415|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409526|NCT00239226|4235416|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409527|NCT00239005|4235429|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4409528|NCT00239005|4235430|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4409529|NCT00239005|4235431|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4409530|NCT00239005|4235429|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4409531|NCT00239005|4235430|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4409532|NCT00239005|4235431|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4409533|NCT00239005|4235429|B3|>=65 years||Age, Customized|Baseline Measures are based on Intention to treat (ITT) population.|participants|Number|13|13.0||||||
4409534|NCT00239005|4235430|B2|>=65 years||Age, Customized|Baseline Measures are based on Intention to treat (ITT) population.|participants|Number|10|10.0||||||
4409535|NCT00239005|4235431|B1|>=65 years||Age, Customized|Baseline Measures are based on Intention to treat (ITT) population.|participants|Number|3|3.0||||||
4409536|NCT00239005|4235429|B3|<65 years||Age, Customized|Baseline Measures are based on Intention to treat (ITT) population.|participants|Number|116|116.0||||||
4409597|NCT00238264|4235492|B1||Male|Gender||Participants|Count of Participants|43|43.0||||||
4409537|NCT00239005|4235430|B2|<65 years||Age, Customized|Baseline Measures are based on Intention to treat (ITT) population.|participants|Number|51|51.0||||||
4409538|NCT00239005|4235431|B1|<65 years||Age, Customized|Baseline Measures are based on Intention to treat (ITT) population.|participants|Number|65|65.0||||||
4409539|NCT00238615|4235442|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4409540|NCT00238615|4235442|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4409541|NCT00238615|4235442|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4409542|NCT00238615|4235442|B1|||Age||years|Mean|63|63.0|Standard Deviation|24|24.0|||
4409543|NCT00238615|4235442|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4409544|NCT00238615|4235442|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4409545|NCT00238615|4235442|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409546|NCT00238433|4235448|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4409547|NCT00238433|4235448|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409548|NCT00238433|4235448|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4409549|NCT00238433|4235448|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4409550|NCT00238433|4235448|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4409551|NCT00238433|4235448|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4409552|NCT00238433|4235448|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409553|NCT00238433|4235448|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4409554|NCT00238433|4235448|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4409555|NCT00238420|4235453|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4409556|NCT00238420|4235454|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4409557|NCT00238420|4235455|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4409558|NCT00238420|4235453|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4409559|NCT00238420|4235454|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4409560|NCT00238420|4235455|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4409561|NCT00238420|4235453|B3|||Age||years|Median|75|75.0|Full Range|||51.0|90.0|
4409562|NCT00238420|4235454|B2|||Age||years|Median|73|73.0|Full Range|||53.0|90.0|
4409563|NCT00238420|4235455|B1|||Age||years|Median|80|80.0|Full Range|||51.0|86.0|
4409564|NCT00238355|4235466|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4409565|NCT00238355|4235466|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4409566|NCT00238355|4235466|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4409567|NCT00238355|4235466|B1|||Age||years|Mean|45.916|45.916|Standard Deviation|15.370|15.37|||
4409568|NCT00238355|4235466|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4409569|NCT00238355|4235466|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4409570|NCT00238355|4235466|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409571|NCT00238303|4235470|B4|United States||Region of Enrollment||participants|Number|103|103.0||||||
4409572|NCT00238303|4235471|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4409573|NCT00238303|4235472|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4409574|NCT00238303|4235473|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4409575|NCT00238303|4235470|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4409576|NCT00238303|4235471|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4409577|NCT00238303|4235472|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4409578|NCT00238303|4235473|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4409579|NCT00238303|4235470|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4409580|NCT00238303|4235471|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4409581|NCT00238303|4235472|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4409582|NCT00238303|4235473|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4409583|NCT00238303|4235470|B4|||Age||years|Median|56|56.0|Full Range|||23.0|78.0|
4409584|NCT00238303|4235471|B3|||Age||years|Median|55.5|55.5|Full Range|||25.0|78.0|
4409585|NCT00238303|4235472|B2|||Age||years|Median|49|49.0|Full Range|||23.0|61.0|
4409586|NCT00238303|4235473|B1|||Age||years|Median|58|58.0|Full Range|||26.0|78.0|
4409587|NCT00238264|4235492|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4409588|NCT00238264|4235492|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409589|NCT00238264|4235492|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4409590|NCT00238264|4235492|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4409591|NCT00238264|4235492|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409592|NCT00238264|4235492|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4409593|NCT00238264|4235492|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409594|NCT00238264|4235492|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4409595|NCT00238264|4235492|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4409596|NCT00238264|4235492|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4409598|NCT00238264|4235492|B1||Female|Gender||Participants|Count of Participants|49|49.0||||||
4409599|NCT00238264|4235492|B1|||Age||Years|Median|13.6|13.6|Full Range|||4.4|20.4|
4409600|NCT00238264|4235492|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409601|NCT00238264|4235492|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4409602|NCT00238264|4235492|B1||<=18 years|Age||Participants|Count of Participants|86|86.0||||||
4409603|NCT00238238|4235502|B4|United States||Region of Enrollment||participants|Number|91|91.0||||||
4409604|NCT00238238|4235503|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4409605|NCT00238238|4235504|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4409606|NCT00238238|4235502|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4409607|NCT00238238|4235503|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409608|NCT00238238|4235504|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4409609|NCT00238238|4235502|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409610|NCT00238238|4235503|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409611|NCT00238238|4235504|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409612|NCT00238238|4235502|B4||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4409613|NCT00238238|4235503|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4409614|NCT00238238|4235504|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4409615|NCT00238238|4235502|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4409616|NCT00238238|4235503|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4409617|NCT00238238|4235504|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4409618|NCT00238238|4235502|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4409619|NCT00238238|4235503|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409620|NCT00238238|4235504|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4409621|NCT00238238|4235502|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4409622|NCT00238238|4235503|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4409623|NCT00238238|4235504|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409624|NCT00238238|4235502|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409625|NCT00238238|4235503|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409626|NCT00238238|4235504|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409627|NCT00238238|4235502|B4||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4409628|NCT00238238|4235503|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4409629|NCT00238238|4235504|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4409630|NCT00238238|4235502|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4409631|NCT00238238|4235503|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4409632|NCT00238238|4235504|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4409633|NCT00238238|4235502|B4|||Age||years|Median|63|63.0|Full Range|||34.0|89.0|
4409634|NCT00238238|4235503|B3|||Age||years|Median|64|64.0|Full Range|||36.0|89.0|
4409635|NCT00238238|4235504|B2|||Age||years|Median|63|63.0|Full Range|||34.0|85.0|
4409636|NCT00238121|4235518|B3|Carcinosarcoma||Histology||participants|Number|16|16.0||||||
4409637|NCT00238121|4235519|B2|Carcinosarcoma||Histology||participants|Number|16|16.0||||||
4409638|NCT00238121|4235520|B1|Carcinosarcoma||Histology||participants|Number|0|0.0||||||
4409639|NCT00238121|4235518|B3|Endometrioid||Histology||participants|Number|24|24.0||||||
4409640|NCT00238121|4235519|B2|Endometrioid||Histology||participants|Number|0|0.0||||||
4409641|NCT00238121|4235520|B1|Endometrioid||Histology||participants|Number|24|24.0||||||
4409642|NCT00238121|4235518|B3|Clear cell||Histology||participants|Number|1|1.0||||||
4409643|NCT00238121|4235519|B2|Clear cell||Histology||participants|Number|0|0.0||||||
4409644|NCT00238121|4235520|B1|Clear cell||Histology||participants|Number|1|1.0||||||
4409645|NCT00238121|4235518|B3|Serous||Histology||participants|Number|3|3.0||||||
4409646|NCT00238121|4235519|B2|Serous||Histology||participants|Number|0|0.0||||||
4409647|NCT00238121|4235520|B1|Serous||Histology||participants|Number|3|3.0||||||
4409648|NCT00238121|4235518|B3|Adenocarcinoma (unspecified)||Histology||participants|Number|12|12.0||||||
4409649|NCT00238121|4235519|B2|Adenocarcinoma (unspecified)||Histology||participants|Number|0|0.0||||||
4409650|NCT00238121|4235520|B1|Adenocarcinoma (unspecified)||Histology||participants|Number|12|12.0||||||
4409651|NCT00238121|4235518|B3|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4409652|NCT00238121|4235519|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4409653|NCT00238121|4235520|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4409654|NCT00238121|4235518|B3|African-American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4409655|NCT00238121|4235519|B2|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4409656|NCT00238121|4235520|B1|African-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4409657|NCT00238121|4235518|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4409658|NCT00238121|4235519|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4409659|NCT00238121|4235520|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4409660|NCT00238121|4235518|B3|Non-Hispanic white||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4409661|NCT00238121|4235519|B2|Non-Hispanic white||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4409662|NCT00238121|4235520|B1|Non-Hispanic white||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4409663|NCT00238121|4235518|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409664|NCT00238121|4235519|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409665|NCT00238121|4235520|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409666|NCT00238121|4235518|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4409667|NCT00238121|4235519|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4409668|NCT00238121|4235520|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4409669|NCT00238121|4235518|B3|||Age, Customized||years|Median|64|64.0|Full Range|||40.0|87.0|
4409670|NCT00238121|4235519|B2|||Age, Customized||years|Median|64|64.0|Full Range|||40.0|87.0|
4409671|NCT00238121|4235520|B1|||Age, Customized||years|Median|64|64.0|Full Range|||44.0|83.0|
4409672|NCT00238108|4235532|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4409673|NCT00238108|4235533|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4409674|NCT00238108|4235534|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4409675|NCT00238108|4235532|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4409676|NCT00238108|4235533|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4409677|NCT00238108|4235534|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4409678|NCT00238108|4235532|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4409679|NCT00238108|4235533|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4409680|NCT00238108|4235534|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4409681|NCT00238108|4235532|B3|||Age||years|Mean|56|56.0|Standard Deviation|6.1|6.1|||
4409682|NCT00238108|4235533|B2|||Age||years|Mean|56|56.0|Standard Deviation|5.7|5.7|||
4409683|NCT00238108|4235534|B1|||Age||years|Mean|56|56.0|Standard Deviation|6.9|6.9|||
4409684|NCT00238108|4235532|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409685|NCT00238108|4235533|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409686|NCT00238108|4235534|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409687|NCT00238108|4235532|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4409688|NCT00238108|4235533|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4409689|NCT00238108|4235534|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4409690|NCT00238108|4235532|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409691|NCT00238108|4235533|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409692|NCT00238108|4235534|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409693|NCT00237809|4235543|B5||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4409694|NCT00237809|4235544|B4||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4409695|NCT00237809|4235545|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4409696|NCT00237809|4235546|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4409697|NCT00237809|4235547|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4409698|NCT00237809|4235543|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4409699|NCT00237809|4235544|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4409700|NCT00237809|4235545|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4409701|NCT00237809|4235546|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4409702|NCT00237809|4235547|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4409703|NCT00237809|4235543|B5|||Age||years|Mean|35.21|35.21|Standard Deviation|8.72|8.72|||
4409704|NCT00237809|4235544|B4|||Age||years|Mean|34.4545|34.4545|Standard Deviation|9.36420|9.3642|||
4409705|NCT00237809|4235545|B3|||Age||years|Mean|36.3158|36.3158|Standard Deviation|9.16547|9.16547|||
4409706|NCT00237809|4235546|B2|||Age||years|Mean|34.4762|34.4762|Standard Deviation|8.76139|8.76139|||
4409707|NCT00237809|4235547|B1|||Age||years|Mean|35.7500|35.75|Standard Deviation|8.01889|8.01889|||
4409708|NCT00237796|4235584|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4409709|NCT00237796|4235585|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4409710|NCT00237796|4235586|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4409711|NCT00237796|4235584|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4409712|NCT00237796|4235585|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4409713|NCT00237796|4235586|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4409714|NCT00237796|4235584|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4409715|NCT00237796|4235585|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4409716|NCT00237796|4235586|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4409717|NCT00237796|4235584|B3|Between ages 45 to 78||Age, Customized||participants|Number|64|64.0||||||
4409718|NCT00237796|4235585|B2|Between ages 45 to 78||Age, Customized||participants|Number|33|33.0||||||
4409719|NCT00237796|4235586|B1|Between ages 45 to 78||Age, Customized||participants|Number|31|31.0||||||
4409720|NCT00237770|4235605|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4409721|NCT00237770|4235606|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4409722|NCT00237770|4235607|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4409723|NCT00237770|4235605|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4409724|NCT00237770|4235606|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4409725|NCT00237770|4235607|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4409726|NCT00237770|4235605|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4409727|NCT00237770|4235606|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4409728|NCT00237770|4235607|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4409729|NCT00237770|4235605|B3|||Age||years|Mean|38|38.0|Standard Deviation|12|12.0|||
4409730|NCT00237770|4235606|B2|||Age||years|Mean|33|33.0|Standard Deviation|9|9.0|||
4409731|NCT00237770|4235607|B1|||Age||years|Mean|40|40.0|Standard Deviation|10|10.0|||
4409732|NCT00237770|4235605|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409733|NCT00237770|4235606|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409734|NCT00237770|4235607|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409735|NCT00237770|4235605|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4409736|NCT00237770|4235606|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4409737|NCT00237770|4235607|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4409738|NCT00237770|4235605|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409739|NCT00237770|4235606|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409740|NCT00237770|4235607|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409741|NCT00237744|4235618|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
4409742|NCT00237744|4235619|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4409743|NCT00237744|4235620|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4409744|NCT00237744|4235621|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4409745|NCT00237744|4235618|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4409746|NCT00237744|4235619|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4409747|NCT00237744|4235620|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4409748|NCT00237744|4235621|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4409749|NCT00237744|4235618|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4409750|NCT00237744|4235619|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4409751|NCT00237744|4235620|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4409752|NCT00237744|4235621|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4409753|NCT00237744|4235618|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4409754|NCT00237744|4235619|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4409755|NCT00237744|4235620|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4409756|NCT00237744|4235621|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4409757|NCT00237744|4235618|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4409758|NCT00237744|4235619|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4409759|NCT00237744|4235620|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4409760|NCT00237744|4235621|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4409761|NCT00237744|4235618|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409762|NCT00237744|4235619|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409763|NCT00237744|4235620|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409764|NCT00237744|4235621|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409765|NCT00237718|4235634|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4409766|NCT00237718|4235635|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4409767|NCT00237718|4235636|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4409768|NCT00237718|4235634|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409769|NCT00237718|4235635|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409770|NCT00237718|4235636|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409771|NCT00237718|4235634|B3||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4409772|NCT00237718|4235635|B2||White|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4409773|NCT00237718|4235636|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4409774|NCT00237718|4235634|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|188|188.0||||||
4409775|NCT00237718|4235635|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4409776|NCT00237718|4235636|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4409777|NCT00237718|4235634|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409778|NCT00237718|4235635|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409779|NCT00237718|4235636|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409780|NCT00237718|4235634|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4409781|NCT00237718|4235635|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409782|NCT00237718|4235636|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4409783|NCT00237718|4235634|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409784|NCT00237718|4235635|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409785|NCT00237718|4235636|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4409786|NCT00237718|4235634|B3||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4409787|NCT00237718|4235635|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4409788|NCT00237718|4235636|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4409789|NCT00237718|4235634|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4409790|NCT00237718|4235635|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4409791|NCT00237718|4235636|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4409792|NCT00237718|4235634|B3|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
4409793|NCT00237718|4235635|B2|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
4409794|NCT00237718|4235636|B1|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
4409795|NCT00237692|4235645|B5|United States||Region of Enrollment||participants|Number|591|591.0||||||
4409796|NCT00237692|4235646|B4|United States||Region of Enrollment||participants|Number|147|147.0||||||
4409797|NCT00237692|4235647|B3|United States||Region of Enrollment||participants|Number|149|149.0||||||
4409798|NCT00237692|4235648|B2|United States||Region of Enrollment||participants|Number|148|148.0||||||
4409799|NCT00237692|4235649|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
4409800|NCT00237692|4235645|B5|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4409801|NCT00237692|4235646|B4|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4409802|NCT00237692|4235647|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4409803|NCT00237692|4235648|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4409804|NCT00237692|4235649|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4409805|NCT00237692|4235645|B5|African American||Race/Ethnicity, Customized||participants|Number|285|285.0||||||
4409806|NCT00237692|4235646|B4|African American||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4409807|NCT00237692|4235647|B3|African American||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4409808|NCT00237692|4235648|B2|African American||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4409809|NCT00237692|4235649|B1|African American||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4409810|NCT00237692|4235645|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|289|289.0||||||
4409811|NCT00237692|4235646|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4409812|NCT00237692|4235647|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4409813|NCT00237692|4235648|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4409814|NCT00237692|4235649|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|74|74.0||||||
4409815|NCT00237692|4235645|B5||Male|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
4409816|NCT00237692|4235646|B4||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4409817|NCT00237692|4235647|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4409818|NCT00237692|4235648|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4409819|NCT00237692|4235649|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4409820|NCT00237692|4235645|B5||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4409821|NCT00237692|4235646|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4409822|NCT00237692|4235647|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4409823|NCT00237692|4235648|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4409824|NCT00237692|4235649|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4409825|NCT00237692|4235645|B5|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4409826|NCT00237692|4235646|B4|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
4409827|NCT00237692|4235647|B3|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4409828|NCT00237692|4235648|B2|||Age||years|Mean|63|63.0|Standard Deviation|11|11.0|||
4409829|NCT00237692|4235649|B1|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4409830|NCT00237666|4235682|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4409831|NCT00237666|4235682|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4409832|NCT00237666|4235682|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4409833|NCT00237666|4235682|B1|||Age||years|Mean|38.61|38.61|Standard Deviation|13.34|13.34|||
4409834|NCT00237666|4235682|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409835|NCT00237666|4235682|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4409836|NCT00237666|4235682|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409837|NCT00237458|4235692|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4409838|NCT00237458|4235692|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4409839|NCT00237458|4235692|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4409840|NCT00237458|4235692|B1|||Age||years|Mean|47.4|47.4|Standard Deviation|10.18|10.18|||
4409841|NCT00237458|4235692|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409842|NCT00237458|4235692|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4409843|NCT00237458|4235692|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409844|NCT00237185|4235708|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4409845|NCT00237185|4235709|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4409846|NCT00237185|4235710|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4409847|NCT00237185|4235708|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4409848|NCT00237185|4235709|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4409849|NCT00237185|4235710|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4409850|NCT00237185|4235708|B3|||Age||Years|Mean|54.4|54.4|Standard Deviation|12.2|12.2|||
4409851|NCT00237185|4235709|B2|||Age||Years|Mean|52.2|52.2|Standard Deviation|11.12|11.12|||
4409852|NCT00237185|4235710|B1|||Age||Years|Mean|56.6|56.6|Standard Deviation|12.9|12.9|||
4409853|NCT00237042|4235739|B4|United States||Region of Enrollment||participants|Number|147|147.0||||||
4409854|NCT00237042|4235740|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4409855|NCT00237042|4235741|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4409856|NCT00237042|4235742|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4409857|NCT00237042|4235739|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409858|NCT00237042|4235740|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409859|NCT00237042|4235741|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409860|NCT00237042|4235742|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4409861|NCT00237042|4235739|B4||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4409862|NCT00237042|4235740|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4409863|NCT00237042|4235741|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4409864|NCT00237042|4235742|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4409865|NCT00237042|4235739|B4|||Age||years|Mean|27.8|27.8|Standard Deviation|6.9|6.9|||
4409866|NCT00237042|4235740|B3|||Age||years|Mean|28.6|28.6|Standard Deviation|6.9|6.9|||
4409867|NCT00237042|4235741|B2|||Age||years|Mean|25.4|25.4|Standard Deviation|5.7|5.7|||
4409868|NCT00237042|4235742|B1|||Age||years|Mean|29.1|29.1|Standard Deviation|7.4|7.4|||
4409869|NCT00237042|4235739|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409870|NCT00237042|4235740|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409871|NCT00237042|4235741|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409872|NCT00237042|4235742|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4409873|NCT00237042|4235739|B4||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4409874|NCT00237042|4235740|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4409875|NCT00237042|4235741|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4409876|NCT00237042|4235742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4409877|NCT00237042|4235739|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409878|NCT00237042|4235740|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409879|NCT00237042|4235741|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409880|NCT00237042|4235742|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409881|NCT00236977|4235761|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4409882|NCT00236977|4235762|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4409883|NCT00236977|4235763|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4409884|NCT00236977|4235761|B3||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4409885|NCT00236977|4235762|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4409886|NCT00236977|4235763|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4409887|NCT00236977|4235761|B3||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
4409888|NCT00236977|4235762|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4409889|NCT00236977|4235763|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4409890|NCT00236977|4235761|B3||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4409891|NCT00236977|4235762|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4409892|NCT00236977|4235763|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4409893|NCT00236977|4235761|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409894|NCT00236977|4235762|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409895|NCT00236977|4235763|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409896|NCT00236951|4235782|B5||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4409897|NCT00236951|4235783|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4409898|NCT00236951|4235784|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4409899|NCT00236951|4235785|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4409900|NCT00236951|4235786|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4409901|NCT00236951|4235782|B5||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4409902|NCT00236951|4235783|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4409903|NCT00236951|4235784|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4409904|NCT00236951|4235785|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4409905|NCT00236951|4235786|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4409906|NCT00236951|4235782|B5||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
4409907|NCT00236951|4235783|B4||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4409908|NCT00236951|4235784|B3||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4409909|NCT00236951|4235785|B2||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4409910|NCT00236951|4235786|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4409911|NCT00236951|4235782|B5||Between 18 and 65 years|Age||Participants|Count of Participants|124|124.0||||||
4409912|NCT00236951|4235783|B4||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4409913|NCT00236951|4235784|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4409914|NCT00236951|4235785|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4409915|NCT00236951|4235786|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4409916|NCT00236951|4235782|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409917|NCT00236951|4235783|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409918|NCT00236951|4235784|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409919|NCT00236951|4235785|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409920|NCT00236951|4235786|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409921|NCT00236938|4235799|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4409922|NCT00236938|4235800|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4409923|NCT00236938|4235801|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4409924|NCT00236938|4235799|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4409925|NCT00236938|4235800|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4409926|NCT00236938|4235801|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4409927|NCT00236938|4235799|B3||>=65 years|Age||Participants|Count of Participants|97|97.0||||||
4409928|NCT00236938|4235800|B2||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4409929|NCT00236938|4235801|B1||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4409930|NCT00236938|4235799|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4409931|NCT00236938|4235800|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4409932|NCT00236938|4235801|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4409933|NCT00236938|4235799|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409934|NCT00236938|4235800|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409935|NCT00236938|4235801|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4409936|NCT00236899|4235814|B5|No Response||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|77|77.0||||||
4409937|NCT00236899|4235815|B4|No Response||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|16|16.0||||||
4409938|NCT00236899|4235816|B3|No Response||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|22|22.0||||||
4409939|NCT00236899|4235817|B2|No Response||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|24|24.0||||||
4409940|NCT00236899|4235818|B1|No Response||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|15|15.0||||||
4409941|NCT00236899|4235814|B5|Extremely Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|4|4.0||||||
4409942|NCT00236899|4235815|B4|Extremely Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|0|0.0||||||
4409943|NCT00236899|4235816|B3|Extremely Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|1|1.0||||||
4409944|NCT00236899|4235817|B2|Extremely Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|1|1.0||||||
4410065|NCT00236197|4235851|B3||White|Race (NIH/OMB)||Participants|Count of Participants|384|384.0||||||
4409945|NCT00236899|4235818|B1|Extremely Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|2|2.0||||||
4409946|NCT00236899|4235814|B5|Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|11|11.0||||||
4409947|NCT00236899|4235815|B4|Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|3|3.0||||||
4409948|NCT00236899|4235816|B3|Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|5|5.0||||||
4409949|NCT00236899|4235817|B2|Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|2|2.0||||||
4409950|NCT00236899|4235818|B1|Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|1|1.0||||||
4409951|NCT00236899|4235814|B5|Rather Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|19|19.0||||||
4409952|NCT00236899|4235815|B4|Rather Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|8|8.0||||||
4409953|NCT00236899|4235816|B3|Rather Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|1|1.0||||||
4409954|NCT00236899|4235817|B2|Rather Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|4|4.0||||||
4409955|NCT00236899|4235818|B1|Rather Poor||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|6|6.0||||||
4409956|NCT00236899|4235814|B5|Neither Good Nor Bad||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|28|28.0||||||
4409957|NCT00236899|4235815|B4|Neither Good Nor Bad||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|8|8.0||||||
4409958|NCT00236899|4235816|B3|Neither Good Nor Bad||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|6|6.0||||||
4409959|NCT00236899|4235817|B2|Neither Good Nor Bad||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|6|6.0||||||
4409960|NCT00236899|4235818|B1|Neither Good Nor Bad||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|8|8.0||||||
4409961|NCT00236899|4235814|B5|Moderately Good||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|33|33.0||||||
4409962|NCT00236899|4235815|B4|Moderately Good||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|10|10.0||||||
4409963|NCT00236899|4235816|B3|Moderately Good||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|7|7.0||||||
4409964|NCT00236899|4235817|B2|Moderately Good||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|10|10.0||||||
4409965|NCT00236899|4235818|B1|Moderately Good||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|6|6.0||||||
4409966|NCT00236899|4235814|B5|Good||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|59|59.0||||||
4409967|NCT00236899|4235815|B4|Good||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|13|13.0||||||
4409968|NCT00236899|4235816|B3|Good||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|14|14.0||||||
4409969|NCT00236899|4235817|B2|Good||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|15|15.0||||||
4409970|NCT00236899|4235818|B1|Good||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|17|17.0||||||
4409971|NCT00236899|4235814|B5|Excellent||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|10|10.0||||||
4409972|NCT00236899|4235815|B4|Excellent||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|1|1.0||||||
4409973|NCT00236899|4235816|B3|Excellent||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|2|2.0||||||
4409974|NCT00236899|4235817|B2|Excellent||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|2|2.0||||||
4409975|NCT00236899|4235818|B1|Excellent||Quality of Life (QOL) using the Rotterdam Symptom Scale Checklist (RSSC)|The RSSC is a valid and reliable instrument use to measure psychological and physical distress of cancer patients. The overall QOL of patients are assessed and categorized as: Excellent, Good, Moderately Good, Neither Good nor Bad, Rather Poor, Poor, and Extremely Poor.|participants|Number|5|5.0||||||
4409976|NCT00236899|4235814|B5|Unknown||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|1|1.0||||||
4409977|NCT00236899|4235815|B4|Unknown||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|0|0.0||||||
4409978|NCT00236899|4235816|B3|Unknown||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|1|1.0||||||
4409979|NCT00236899|4235817|B2|Unknown||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|0|0.0||||||
4409980|NCT00236899|4235818|B1|Unknown||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|0|0.0||||||
4409981|NCT00236899|4235814|B5|No||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|164|164.0||||||
4409982|NCT00236899|4235815|B4|No||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|40|40.0||||||
4410066|NCT00236197|4235852|B2||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4409983|NCT00236899|4235816|B3|No||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|45|45.0||||||
4409984|NCT00236899|4235817|B2|No||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|40|40.0||||||
4409985|NCT00236899|4235818|B1|No||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|39|39.0||||||
4409986|NCT00236899|4235814|B5|Yes||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|76|76.0||||||
4409987|NCT00236899|4235815|B4|Yes||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|19|19.0||||||
4409988|NCT00236899|4235816|B3|Yes||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|12|12.0||||||
4409989|NCT00236899|4235817|B2|Yes||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|24|24.0||||||
4409990|NCT00236899|4235818|B1|Yes||Number of Participants with Previous Adjuvant/Neoadjuvant Taxane Therapy|This baseline measure presents the number of participants who had previously received adjuvant/neoadjuvant taxane therapy.|participants|Number|21|21.0||||||
4409991|NCT00236899|4235814|B5|Presence||Presence or Absence of Visceral Metastases|Visceral metastases are defined as any metastases to the major organs excluding bone, skin, soft tissue, and lymph nodes.|participants|Number|164|164.0||||||
4409992|NCT00236899|4235815|B4|Presence||Presence or Absence of Visceral Metastases|Visceral metastases are defined as any metastases to the major organs excluding bone, skin, soft tissue, and lymph nodes.|participants|Number|36|36.0||||||
4409993|NCT00236899|4235816|B3|Presence||Presence or Absence of Visceral Metastases|Visceral metastases are defined as any metastases to the major organs excluding bone, skin, soft tissue, and lymph nodes.|participants|Number|42|42.0||||||
4409994|NCT00236899|4235817|B2|Presence||Presence or Absence of Visceral Metastases|Visceral metastases are defined as any metastases to the major organs excluding bone, skin, soft tissue, and lymph nodes.|participants|Number|45|45.0||||||
4409995|NCT00236899|4235818|B1|Presence||Presence or Absence of Visceral Metastases|Visceral metastases are defined as any metastases to the major organs excluding bone, skin, soft tissue, and lymph nodes.|participants|Number|41|41.0||||||
4409996|NCT00236899|4235814|B5|Absence||Presence or Absence of Visceral Metastases|Visceral metastases are defined as any metastases to the major organs excluding bone, skin, soft tissue, and lymph nodes.|participants|Number|77|77.0||||||
4409997|NCT00236899|4235815|B4|Absence||Presence or Absence of Visceral Metastases|Visceral metastases are defined as any metastases to the major organs excluding bone, skin, soft tissue, and lymph nodes.|participants|Number|23|23.0||||||
4409998|NCT00236899|4235816|B3|Absence||Presence or Absence of Visceral Metastases|Visceral metastases are defined as any metastases to the major organs excluding bone, skin, soft tissue, and lymph nodes.|participants|Number|16|16.0||||||
4409999|NCT00236899|4235817|B2|Absence||Presence or Absence of Visceral Metastases|Visceral metastases are defined as any metastases to the major organs excluding bone, skin, soft tissue, and lymph nodes.|participants|Number|19|19.0||||||
4410000|NCT00236899|4235818|B1|Absence||Presence or Absence of Visceral Metastases|Visceral metastases are defined as any metastases to the major organs excluding bone, skin, soft tissue, and lymph nodes.|participants|Number|19|19.0||||||
4410001|NCT00236899|4235814|B5|Unknown||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|1|1.0||||||
4410002|NCT00236899|4235815|B4|Unknown||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|0|0.0||||||
4410003|NCT00236899|4235816|B3|Unknown||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|1|1.0||||||
4410004|NCT00236899|4235817|B2|Unknown||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|0|0.0||||||
4410005|NCT00236899|4235818|B1|Unknown||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|0|0.0||||||
4410006|NCT00236899|4235814|B5|No||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|62|62.0||||||
4410007|NCT00236899|4235815|B4|No||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|13|13.0||||||
4410008|NCT00236899|4235816|B3|No||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|17|17.0||||||
4410009|NCT00236899|4235817|B2|No||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|16|16.0||||||
4410010|NCT00236899|4235818|B1|No||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|16|16.0||||||
4410011|NCT00236899|4235814|B5|Yes||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|178|178.0||||||
4410012|NCT00236899|4235815|B4|Yes||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|46|46.0||||||
4410067|NCT00236197|4235853|B1||White|Race (NIH/OMB)||Participants|Count of Participants|192|192.0||||||
4410013|NCT00236899|4235816|B3|Yes||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|40|40.0||||||
4410014|NCT00236899|4235817|B2|Yes||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|48|48.0||||||
4410015|NCT00236899|4235818|B1|Yes||Previous Hormonal Therapy|Previous hormonal therapy status is defined as the number of participants who had previously received hormonal therapy.|participants|Number|44|44.0||||||
4410016|NCT00236899|4235814|B5|Postmenopausal||Menopausal Status|Menopausal status is defined as the number of participants with premenopausal or postmenopausal status.|participants|Number|168|168.0||||||
4410017|NCT00236899|4235815|B4|Postmenopausal||Menopausal Status|Menopausal status is defined as the number of participants with premenopausal or postmenopausal status.|participants|Number|38|38.0||||||
4410018|NCT00236899|4235816|B3|Postmenopausal||Menopausal Status|Menopausal status is defined as the number of participants with premenopausal or postmenopausal status.|participants|Number|42|42.0||||||
4410019|NCT00236899|4235817|B2|Postmenopausal||Menopausal Status|Menopausal status is defined as the number of participants with premenopausal or postmenopausal status.|participants|Number|47|47.0||||||
4410020|NCT00236899|4235818|B1|Postmenopausal||Menopausal Status|Menopausal status is defined as the number of participants with premenopausal or postmenopausal status.|participants|Number|41|41.0||||||
4410021|NCT00236899|4235814|B5|Premenopausal||Menopausal Status|Menopausal status is defined as the number of participants with premenopausal or postmenopausal status.|participants|Number|73|73.0||||||
4410022|NCT00236899|4235815|B4|Premenopausal||Menopausal Status|Menopausal status is defined as the number of participants with premenopausal or postmenopausal status.|participants|Number|21|21.0||||||
4410023|NCT00236899|4235816|B3|Premenopausal||Menopausal Status|Menopausal status is defined as the number of participants with premenopausal or postmenopausal status.|participants|Number|16|16.0||||||
4410024|NCT00236899|4235817|B2|Premenopausal||Menopausal Status|Menopausal status is defined as the number of participants with premenopausal or postmenopausal status.|participants|Number|17|17.0||||||
4410025|NCT00236899|4235818|B1|Premenopausal||Menopausal Status|Menopausal status is defined as the number of participants with premenopausal or postmenopausal status.|participants|Number|19|19.0||||||
4410026|NCT00236899|4235814|B5|Italy||Region of Enrollment||participants|Number|241|241.0||||||
4410027|NCT00236899|4235815|B4|Italy||Region of Enrollment||participants|Number|59|59.0||||||
4410028|NCT00236899|4235816|B3|Italy||Region of Enrollment||participants|Number|58|58.0||||||
4410029|NCT00236899|4235817|B2|Italy||Region of Enrollment||participants|Number|64|64.0||||||
4410030|NCT00236899|4235818|B1|Italy||Region of Enrollment||participants|Number|60|60.0||||||
4410031|NCT00236899|4235814|B5|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4410032|NCT00236899|4235815|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4410033|NCT00236899|4235816|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4410034|NCT00236899|4235817|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4410035|NCT00236899|4235818|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4410036|NCT00236899|4235814|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|238|238.0||||||
4410037|NCT00236899|4235815|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4410038|NCT00236899|4235816|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4410039|NCT00236899|4235817|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4410040|NCT00236899|4235818|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4410041|NCT00236899|4235814|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4410042|NCT00236899|4235815|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4410043|NCT00236899|4235816|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4410044|NCT00236899|4235817|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4410045|NCT00236899|4235818|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4410046|NCT00236899|4235814|B5||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4410047|NCT00236899|4235815|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4410048|NCT00236899|4235816|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4410049|NCT00236899|4235817|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4410050|NCT00236899|4235818|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4410051|NCT00236899|4235814|B5|||Age||years|Mean|55.85|55.85|Standard Deviation|9.76|9.76|||
4410052|NCT00236899|4235815|B4|||Age||years|Mean|54.66|54.66|Standard Deviation|10.04|10.04|||
4410053|NCT00236899|4235816|B3|||Age||years|Mean|55.78|55.78|Standard Deviation|8.99|8.99|||
4410054|NCT00236899|4235817|B2|||Age||years|Mean|56.31|56.31|Standard Deviation|9.84|9.84|||
4410055|NCT00236899|4235818|B1|||Age||years|Mean|56.58|56.58|Standard Deviation|10.21|10.21|||
4410056|NCT00236197|4235851|B3|United States||Region of Enrollment||participants|Number|619|619.0||||||
4410057|NCT00236197|4235852|B2|United States||Region of Enrollment||participants|Number|307|307.0||||||
4410058|NCT00236197|4235853|B1|United States||Region of Enrollment||participants|Number|312|312.0||||||
4410059|NCT00236197|4235851|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
4410060|NCT00236197|4235852|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4410061|NCT00236197|4235853|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4410062|NCT00236197|4235851|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410063|NCT00236197|4235852|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410064|NCT00236197|4235853|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410068|NCT00236197|4235851|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4410069|NCT00236197|4235852|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4410070|NCT00236197|4235853|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4410071|NCT00236197|4235851|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410072|NCT00236197|4235852|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410073|NCT00236197|4235853|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410074|NCT00236197|4235851|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4410075|NCT00236197|4235852|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4410076|NCT00236197|4235853|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4410077|NCT00236197|4235851|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410078|NCT00236197|4235852|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410079|NCT00236197|4235853|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410080|NCT00236197|4235851|B3||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4410081|NCT00236197|4235852|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4410082|NCT00236197|4235853|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4410083|NCT00236197|4235851|B3||Female|Sex: Female, Male||Participants|Count of Participants|411|411.0||||||
4410084|NCT00236197|4235852|B2||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4410085|NCT00236197|4235853|B1||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4410086|NCT00236197|4235851|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|14.4|14.4|||
4410087|NCT00236197|4235852|B2|||Age||years|Mean|48.8|48.8|Standard Deviation|14.0|14.0|||
4410088|NCT00236197|4235853|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|14.7|14.7|||
4410089|NCT00236184|4235860|B3|United States||Region of Enrollment||participants|Number|629|629.0||||||
4410090|NCT00236184|4235861|B2|United States||Region of Enrollment||participants|Number|319|319.0||||||
4410091|NCT00236184|4235862|B1|United States||Region of Enrollment||participants|Number|310|310.0||||||
4410092|NCT00236184|4235860|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4410093|NCT00236184|4235861|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4410094|NCT00236184|4235862|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4410095|NCT00236184|4235860|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410096|NCT00236184|4235861|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410097|NCT00236184|4235862|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410098|NCT00236184|4235860|B3||White|Race (NIH/OMB)||Participants|Count of Participants|484|484.0||||||
4410099|NCT00236184|4235861|B2||White|Race (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
4410100|NCT00236184|4235862|B1||White|Race (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
4410101|NCT00236184|4235860|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4410102|NCT00236184|4235861|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4410103|NCT00236184|4235862|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4410104|NCT00236184|4235860|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410105|NCT00236184|4235861|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410106|NCT00236184|4235862|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410107|NCT00236184|4235860|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4410108|NCT00236184|4235861|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4410109|NCT00236184|4235862|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4410110|NCT00236184|4235860|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4410111|NCT00236184|4235861|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4410112|NCT00236184|4235862|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4410113|NCT00236184|4235860|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4410114|NCT00236184|4235861|B2||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4410115|NCT00236184|4235862|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4410116|NCT00236184|4235860|B3||Female|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
4410117|NCT00236184|4235861|B2||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4410118|NCT00236184|4235862|B1||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4410119|NCT00236184|4235860|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|13.8|13.8|||
4410120|NCT00236184|4235861|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|14.4|14.4|||
4410121|NCT00236184|4235862|B1|||Age||years|Mean|45.4|45.4|Standard Deviation|13.3|13.3|||
4410122|NCT00236184|4235860|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4410123|NCT00236184|4235861|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4410124|NCT00236184|4235862|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4410125|NCT00236184|4235860|B3||Between 18 and 65 years|Age||Participants|Count of Participants|583|583.0||||||
4410126|NCT00236184|4235861|B2||Between 18 and 65 years|Age||Participants|Count of Participants|298|298.0||||||
4410127|NCT00236184|4235862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|285|285.0||||||
4410128|NCT00236184|4235860|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410129|NCT00236184|4235861|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410130|NCT00236184|4235862|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410131|NCT00236080|4235869|B6|United States||Region of Enrollment|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|134|134.0||||||
4410132|NCT00236080|4235870|B5|United States||Region of Enrollment|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|26|26.0||||||
4410133|NCT00236080|4235871|B4|United States||Region of Enrollment|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|25|25.0||||||
4410134|NCT00236080|4235872|B3|United States||Region of Enrollment|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|26|26.0||||||
4410135|NCT00236080|4235873|B2|United States||Region of Enrollment|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|28|28.0||||||
4410136|NCT00236080|4235874|B1|United States||Region of Enrollment|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|29|29.0||||||
4410137|NCT00236080|4235869|B6|Male||Gender|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|77|77.0||||||
4410138|NCT00236080|4235870|B5|Male||Gender|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|20|20.0||||||
4410139|NCT00236080|4235871|B4|Male||Gender|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|17|17.0||||||
4410140|NCT00236080|4235872|B3|Male||Gender|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|13|13.0||||||
4410141|NCT00236080|4235873|B2|Male||Gender|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|16|16.0||||||
4410142|NCT00236080|4235874|B1|Male||Gender|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|11|11.0||||||
4410143|NCT00236080|4235869|B6|Female||Gender|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|57|57.0||||||
4410144|NCT00236080|4235870|B5|Female||Gender|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|6|6.0||||||
4410145|NCT00236080|4235871|B4|Female||Gender|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|8|8.0||||||
4410146|NCT00236080|4235872|B3|Female||Gender|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|13|13.0||||||
4410147|NCT00236080|4235873|B2|Female||Gender|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|12|12.0||||||
4410148|NCT00236080|4235874|B1|Female||Gender|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|18|18.0||||||
4410149|NCT00236080|4235869|B6|||Age||years|Mean|36.3|36.3|Standard Deviation|9.90|9.9|||
4410150|NCT00236080|4235870|B5|||Age||years|Mean|38.0|38.0|Standard Deviation|9.83|9.83|||
4410151|NCT00236080|4235871|B4|||Age||years|Mean|38.3|38.3|Standard Deviation|12.83|12.83|||
4410152|NCT00236080|4235872|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|7.60|7.6|||
4410153|NCT00236080|4235873|B2|||Age||years|Mean|34.3|34.3|Standard Deviation|9.87|9.87|||
4410154|NCT00236080|4235874|B1|||Age||years|Mean|36.8|36.8|Standard Deviation|8.92|8.92|||
4410155|NCT00236080|4235869|B6|>=65 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|0|0.0||||||
4410156|NCT00236080|4235870|B5|>=65 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|0|0.0||||||
4410157|NCT00236080|4235871|B4|>=65 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|0|0.0||||||
4410158|NCT00236080|4235872|B3|>=65 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|0|0.0||||||
4410159|NCT00236080|4235873|B2|>=65 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|0|0.0||||||
4410160|NCT00236080|4235874|B1|>=65 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|0|0.0||||||
4410161|NCT00236080|4235869|B6|Between 18 and 65 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|134|134.0||||||
4410162|NCT00236080|4235870|B5|Between 18 and 65 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|26|26.0||||||
4410163|NCT00236080|4235871|B4|Between 18 and 65 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|25|25.0||||||
4410164|NCT00236080|4235872|B3|Between 18 and 65 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|26|26.0||||||
4410165|NCT00236080|4235873|B2|Between 18 and 65 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|28|28.0||||||
4410166|NCT00236080|4235874|B1|Between 18 and 65 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|29|29.0||||||
4410167|NCT00236080|4235869|B6|<=18 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|0|0.0||||||
4410168|NCT00236080|4235870|B5|<=18 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|0|0.0||||||
4410169|NCT00236080|4235871|B4|<=18 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|0|0.0||||||
4410170|NCT00236080|4235872|B3|<=18 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|0|0.0||||||
4410171|NCT00236080|4235873|B2|<=18 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|0|0.0||||||
4410172|NCT00236080|4235874|B1|<=18 years||Age|2 male participants withdrew after randomization but prior to receiving study drug (1 for noncompliance and 1 at the request of the sponsor)|participants|Number|0|0.0||||||
4410173|NCT00235989|4235895|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4410174|NCT00235989|4235896|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4410175|NCT00235989|4235897|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4410176|NCT00235989|4235898|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4410177|NCT00235989|4235899|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4410178|NCT00235989|4235895|B5||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4410179|NCT00235989|4235896|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4410180|NCT00235989|4235897|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4410181|NCT00235989|4235898|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4410182|NCT00235989|4235899|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4410183|NCT00235989|4235895|B5|>50 years||Age, Customized||participants|Number|5|5.0||||||
4410184|NCT00235989|4235896|B4|>50 years||Age, Customized||participants|Number|1|1.0||||||
4410185|NCT00235989|4235897|B3|>50 years||Age, Customized||participants|Number|2|2.0||||||
4410186|NCT00235989|4235898|B2|>50 years||Age, Customized||participants|Number|0|0.0||||||
4410187|NCT00235989|4235899|B1|>50 years||Age, Customized||participants|Number|2|2.0||||||
4410188|NCT00235989|4235895|B5|>40-50 years||Age, Customized||participants|Number|21|21.0||||||
4410189|NCT00235989|4235896|B4|>40-50 years||Age, Customized||participants|Number|8|8.0||||||
4410190|NCT00235989|4235897|B3|>40-50 years||Age, Customized||participants|Number|8|8.0||||||
4410191|NCT00235989|4235898|B2|>40-50 years||Age, Customized||participants|Number|1|1.0||||||
4410192|NCT00235989|4235899|B1|>40-50 years||Age, Customized||participants|Number|4|4.0||||||
4410193|NCT00235989|4235895|B5|>30-40 years||Age, Customized||participants|Number|26|26.0||||||
4410194|NCT00235989|4235896|B4|>30-40 years||Age, Customized||participants|Number|10|10.0||||||
4410195|NCT00235989|4235897|B3|>30-40 years||Age, Customized||participants|Number|6|6.0||||||
4410196|NCT00235989|4235898|B2|>30-40 years||Age, Customized||participants|Number|3|3.0||||||
4410197|NCT00235989|4235899|B1|>30-40 years||Age, Customized||participants|Number|7|7.0||||||
4410198|NCT00235989|4235895|B5|>20-30 years||Age, Customized||participants|Number|9|9.0||||||
4410199|NCT00235989|4235896|B4|>20-30 years||Age, Customized||participants|Number|1|1.0||||||
4410200|NCT00235989|4235897|B3|>20-30 years||Age, Customized||participants|Number|3|3.0||||||
4410201|NCT00235989|4235898|B2|>20-30 years||Age, Customized||participants|Number|2|2.0||||||
4410202|NCT00235989|4235899|B1|>20-30 years||Age, Customized||participants|Number|3|3.0||||||
4410203|NCT00235989|4235895|B5|||Age||years|Mean|38.1|38.1|Standard Deviation|7.98|7.98|||
4410204|NCT00235989|4235896|B4|||Age||years|Mean|39.3|39.3|Standard Deviation|7.17|7.17|||
4410205|NCT00235989|4235897|B3|||Age||years|Mean|38.8|38.8|Standard Deviation|7.57|7.57|||
4410206|NCT00235989|4235898|B2|||Age||years|Mean|32.2|32.2|Standard Deviation|6.79|6.79|||
4410207|NCT00235989|4235899|B1|||Age||years|Mean|37.8|37.8|Standard Deviation|9.22|9.22|||
4410208|NCT00235872|4235918|B1|Japan||Region of Enrollment||participants|Number|309|309.0||||||
4410209|NCT00235872|4235918|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4410210|NCT00235872|4235918|B1||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4410211|NCT00235872|4235918|B1|>/= 60 years||Age, Customized||participants|Number|106|106.0||||||
4410212|NCT00235872|4235918|B1|Between 50 and 59 years||Age, Customized||participants|Number|111|111.0||||||
4410213|NCT00235872|4235918|B1|Between 40 and 49 years||Age, Customized||participants|Number|57|57.0||||||
4410214|NCT00235872|4235918|B1|< 40 years||Age, Customized||participants|Number|35|35.0||||||
4410215|NCT00235833|4235933|B1|Japan||Region of Enrollment||participants|Number|25|25.0||||||
4410216|NCT00235833|4235933|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4410217|NCT00235833|4235933|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4410218|NCT00235833|4235933|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|11.1|11.1|||
4410219|NCT00235755|4235946|B4|Mixed Race||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4410220|NCT00235755|4235947|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4410221|NCT00235755|4235948|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4410222|NCT00235755|4235949|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4410223|NCT00235755|4235946|B4|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4410224|NCT00235755|4235947|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4410225|NCT00235755|4235948|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4410226|NCT00235755|4235949|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4410227|NCT00235755|4235946|B4|African-American (black)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4410228|NCT00235755|4235947|B3|African-American (black)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4410229|NCT00235755|4235948|B2|African-American (black)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4410230|NCT00235755|4235949|B1|African-American (black)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4410231|NCT00235755|4235946|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|512|512.0||||||
4410232|NCT00235755|4235947|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|170|170.0||||||
4410233|NCT00235755|4235948|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|173|173.0||||||
4410234|NCT00235755|4235949|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|169|169.0||||||
4410235|NCT00235755|4235946|B4||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4410236|NCT00235755|4235947|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4410237|NCT00235755|4235948|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4410238|NCT00235755|4235949|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4410239|NCT00235755|4235946|B4||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4410240|NCT00235755|4235947|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4410241|NCT00235755|4235948|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4410242|NCT00235755|4235949|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4410243|NCT00235755|4235946|B4|||Age|Baseline characteristics are summarized for the Safety Population, comprised of all participants who were randomized and received at least one dose of study medication.|Years|Mean|37.6|37.6|Standard Deviation|12.16|12.16|||
4410244|NCT00235755|4235947|B3|||Age|Baseline characteristics are summarized for the Safety Population, comprised of all participants who were randomized and received at least one dose of study medication.|Years|Mean|37.7|37.7|Standard Deviation|12.77|12.77|||
4410245|NCT00235755|4235948|B2|||Age|Baseline characteristics are summarized for the Safety Population, comprised of all participants who were randomized and received at least one dose of study medication.|Years|Mean|37.5|37.5|Standard Deviation|12.02|12.02|||
4410246|NCT00235755|4235949|B1|||Age|Baseline characteristics are summarized for the Safety Population, comprised of all participants who were randomized and received at least one dose of study medication.|Years|Mean|37.7|37.7|Standard Deviation|11.75|11.75|||
4410247|NCT00235716|4236025|B5|Level 5||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|66|66.0||||||
4410248|NCT00235716|4236026|B4|Level 5||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|20|20.0||||||
4410249|NCT00235716|4236027|B3|Level 5||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|17|17.0||||||
4410250|NCT00235716|4236028|B2|Level 5||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|10|10.0||||||
4410251|NCT00235716|4236029|B1|Level 5||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|19|19.0||||||
4410252|NCT00235716|4236025|B5|Level 4||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|29|29.0||||||
4410253|NCT00235716|4236026|B4|Level 4||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|8|8.0||||||
4410254|NCT00235716|4236027|B3|Level 4||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|10|10.0||||||
4410255|NCT00235716|4236028|B2|Level 4||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|7|7.0||||||
4410256|NCT00235716|4236029|B1|Level 4||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|4|4.0||||||
4410257|NCT00235716|4236025|B5|Level 3||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|134|134.0||||||
4410258|NCT00235716|4236026|B4|Level 3||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|37|37.0||||||
4410259|NCT00235716|4236027|B3|Level 3||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|31|31.0||||||
4410260|NCT00235716|4236028|B2|Level 3||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|35|35.0||||||
4410261|NCT00235716|4236029|B1|Level 3||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|31|31.0||||||
4410262|NCT00235716|4236025|B5|Level 2||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|335|335.0||||||
4410263|NCT00235716|4236026|B4|Level 2||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|79|79.0||||||
4410264|NCT00235716|4236027|B3|Level 2||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|80|80.0||||||
4410265|NCT00235716|4236028|B2|Level 2||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|91|91.0||||||
4410266|NCT00235716|4236029|B1|Level 2||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|85|85.0||||||
4410267|NCT00235716|4236025|B5|Level 1||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|27|27.0||||||
4410268|NCT00235716|4236026|B4|Level 1||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|5|5.0||||||
4410269|NCT00235716|4236027|B3|Level 1||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|8|8.0||||||
4410270|NCT00235716|4236028|B2|Level 1||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|6|6.0||||||
4410271|NCT00235716|4236029|B1|Level 1||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|8|8.0||||||
4410272|NCT00235716|4236025|B5|Level 0||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|22|22.0||||||
4410273|NCT00235716|4236026|B4|Level 0||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|3|3.0||||||
4410274|NCT00235716|4236027|B3|Level 0||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|8|8.0||||||
4410275|NCT00235716|4236028|B2|Level 0||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|6|6.0||||||
4410276|NCT00235716|4236029|B1|Level 0||Dependence Scale|Higher the level the more dependence / less independence.|participants|Number|5|5.0||||||
4410277|NCT00235716|4236025|B5|||Caregiver Activity Survey||hours per day|Mean|6.8|6.8|Standard Deviation|10.9|10.9|||
4410278|NCT00235716|4236026|B4|||Caregiver Activity Survey||hours per day|Mean|6.5|6.5|Standard Deviation|9.2|9.2|||
4410279|NCT00235716|4236027|B3|||Caregiver Activity Survey||hours per day|Mean|6.6|6.6|Standard Deviation|10.5|10.5|||
4410280|NCT00235716|4236028|B2|||Caregiver Activity Survey||hours per day|Mean|6.7|6.7|Standard Deviation|9.0|9.0|||
4410281|NCT00235716|4236029|B1|||Caregiver Activity Survey||hours per day|Mean|7.3|7.3|Standard Deviation|14.3|14.3|||
4410282|NCT00235716|4236025|B5|||Neuropsychiatric Inventory||units on a scale|Mean|12.5|12.5|Standard Deviation|13.4|13.4|||
4410283|NCT00235716|4236026|B4|||Neuropsychiatric Inventory||units on a scale|Mean|13.5|13.5|Standard Deviation|14.2|14.2|||
4410284|NCT00235716|4236027|B3|||Neuropsychiatric Inventory||units on a scale|Mean|12.3|12.3|Standard Deviation|13.3|13.3|||
4410285|NCT00235716|4236028|B2|||Neuropsychiatric Inventory||units on a scale|Mean|12.1|12.1|Standard Deviation|13.1|13.1|||
4410286|NCT00235716|4236029|B1|||Neuropsychiatric Inventory||units on a scale|Mean|12.2|12.2|Standard Deviation|13.3|13.3|||
4410287|NCT00235716|4236025|B5|||Alzheimer's Disease Assessment Scale - Cognitive portion||units on a scale|Mean|18.8|18.8|Standard Deviation|8.4|8.4|||
4410288|NCT00235716|4236026|B4|||Alzheimer's Disease Assessment Scale - Cognitive portion||units on a scale|Mean|19.1|19.1|Standard Deviation|8.4|8.4|||
4410289|NCT00235716|4236027|B3|||Alzheimer's Disease Assessment Scale - Cognitive portion||units on a scale|Mean|18.0|18.0|Standard Deviation|8.4|8.4|||
4410290|NCT00235716|4236028|B2|||Alzheimer's Disease Assessment Scale - Cognitive portion||units on a scale|Mean|19.5|19.5|Standard Deviation|7.9|7.9|||
4410291|NCT00235716|4236029|B1|||Alzheimer's Disease Assessment Scale - Cognitive portion||units on a scale|Mean|18.5|18.5|Standard Deviation|8.8|8.8|||
4410292|NCT00235716|4236025|B5|||Mini-Mental State Examination||units on a scale|Mean|21.0|21.0|Standard Deviation|3.6|3.6|||
4410293|NCT00235716|4236026|B4|||Mini-Mental State Examination||units on a scale|Mean|20.8|20.8|Standard Deviation|3.8|3.8|||
4410294|NCT00235716|4236027|B3|||Mini-Mental State Examination||units on a scale|Mean|21.3|21.3|Standard Deviation|3.4|3.4|||
4410295|NCT00235716|4236028|B2|||Mini-Mental State Examination||units on a scale|Mean|20.8|20.8|Standard Deviation|3.8|3.8|||
4410296|NCT00235716|4236029|B1|||Mini-Mental State Examination||units on a scale|Mean|21.3|21.3|Standard Deviation|3.3|3.3|||
4410297|NCT00235716|4236025|B5|||Alzheimer's Disease Cooperative Study/Activities of Daily Living Inventory||units on a scale|Mean|56.8|56.8|Standard Deviation|14.2|14.2|||
4410298|NCT00235716|4236026|B4|||Alzheimer's Disease Cooperative Study/Activities of Daily Living Inventory||units on a scale|Mean|56.8|56.8|Standard Deviation|13.7|13.7|||
4410299|NCT00235716|4236027|B3|||Alzheimer's Disease Cooperative Study/Activities of Daily Living Inventory||units on a scale|Mean|56.4|56.4|Standard Deviation|14.0|14.0|||
4410300|NCT00235716|4236028|B2|||Alzheimer's Disease Cooperative Study/Activities of Daily Living Inventory||units on a scale|Mean|57.3|57.3|Standard Deviation|14.2|14.2|||
4410301|NCT00235716|4236029|B1|||Alzheimer's Disease Cooperative Study/Activities of Daily Living Inventory||units on a scale|Mean|56.6|56.6|Standard Deviation|14.9|14.9|||
4410302|NCT00235716|4236025|B5|Missing||Weeks from AChEI Initiation to Randomization||participants|Number|2|2.0||||||
4410303|NCT00235716|4236026|B4|Missing||Weeks from AChEI Initiation to Randomization||participants|Number|0|0.0||||||
4410304|NCT00235716|4236027|B3|Missing||Weeks from AChEI Initiation to Randomization||participants|Number|1|1.0||||||
4410305|NCT00235716|4236028|B2|Missing||Weeks from AChEI Initiation to Randomization||participants|Number|0|0.0||||||
4410306|NCT00235716|4236029|B1|Missing||Weeks from AChEI Initiation to Randomization||participants|Number|1|1.0||||||
4410307|NCT00235716|4236025|B5|> 12 weeks||Weeks from AChEI Initiation to Randomization||participants|Number|443|443.0||||||
4410308|NCT00235716|4236026|B4|> 12 weeks||Weeks from AChEI Initiation to Randomization||participants|Number|115|115.0||||||
4410309|NCT00235716|4236027|B3|> 12 weeks||Weeks from AChEI Initiation to Randomization||participants|Number|104|104.0||||||
4410310|NCT00235716|4236028|B2|> 12 weeks||Weeks from AChEI Initiation to Randomization||participants|Number|119|119.0||||||
4410311|NCT00235716|4236029|B1|> 12 weeks||Weeks from AChEI Initiation to Randomization||participants|Number|105|105.0||||||
4410312|NCT00235716|4236025|B5|≤ 12 weeks||Weeks from AChEI Initiation to Randomization||participants|Number|168|168.0||||||
4410313|NCT00235716|4236026|B4|≤ 12 weeks||Weeks from AChEI Initiation to Randomization||participants|Number|37|37.0||||||
4410476|NCT00235443|4236089|B7||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4410314|NCT00235716|4236027|B3|≤ 12 weeks||Weeks from AChEI Initiation to Randomization||participants|Number|49|49.0||||||
4410315|NCT00235716|4236028|B2|≤ 12 weeks||Weeks from AChEI Initiation to Randomization||participants|Number|36|36.0||||||
4410316|NCT00235716|4236029|B1|≤ 12 weeks||Weeks from AChEI Initiation to Randomization||participants|Number|46|46.0||||||
4410317|NCT00235716|4236025|B5|None||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|1|1.0||||||
4410318|NCT00235716|4236026|B4|None||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|0|0.0||||||
4410319|NCT00235716|4236027|B3|None||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|1|1.0||||||
4410320|NCT00235716|4236028|B2|None||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|0|0.0||||||
4410321|NCT00235716|4236029|B1|None||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|0|0.0||||||
4410322|NCT00235716|4236025|B5|Rivastigmine||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|18|18.0||||||
4410323|NCT00235716|4236026|B4|Rivastigmine||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|1|1.0||||||
4410324|NCT00235716|4236027|B3|Rivastigmine||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|4|4.0||||||
4410325|NCT00235716|4236028|B2|Rivastigmine||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|8|8.0||||||
4410326|NCT00235716|4236029|B1|Rivastigmine||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|5|5.0||||||
4410327|NCT00235716|4236025|B5|Galantamine||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|194|194.0||||||
4410328|NCT00235716|4236026|B4|Galantamine||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|55|55.0||||||
4410329|NCT00235716|4236027|B3|Galantamine||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|49|49.0||||||
4410330|NCT00235716|4236028|B2|Galantamine||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|47|47.0||||||
4410331|NCT00235716|4236029|B1|Galantamine||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|43|43.0||||||
4410332|NCT00235716|4236025|B5|Donepezil||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|400|400.0||||||
4410333|NCT00235716|4236026|B4|Donepezil||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|96|96.0||||||
4410334|NCT00235716|4236027|B3|Donepezil||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|100|100.0||||||
4410335|NCT00235716|4236028|B2|Donepezil||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|100|100.0||||||
4410336|NCT00235716|4236029|B1|Donepezil||Concomitant Medications Acetylcholinesterase Inhibitors (AChEI)||participants|Number|104|104.0||||||
4410337|NCT00235716|4236025|B5|Not Tested||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|198|198.0||||||
4410338|NCT00235716|4236026|B4|Not Tested||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|49|49.0||||||
4410339|NCT00235716|4236027|B3|Not Tested||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|43|43.0||||||
4410340|NCT00235716|4236028|B2|Not Tested||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|50|50.0||||||
4410341|NCT00235716|4236029|B1|Not Tested||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|56|56.0||||||
4410342|NCT00235716|4236025|B5|Two ε4 alleles||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|41|41.0||||||
4410343|NCT00235716|4236026|B4|Two ε4 alleles||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|10|10.0||||||
4410344|NCT00235716|4236027|B3|Two ε4 alleles||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|8|8.0||||||
4410345|NCT00235716|4236028|B2|Two ε4 alleles||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|13|13.0||||||
4410346|NCT00235716|4236029|B1|Two ε4 alleles||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|10|10.0||||||
4410347|NCT00235716|4236025|B5|One ε4 allele||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|165|165.0||||||
4410348|NCT00235716|4236026|B4|One ε4 allele||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|38|38.0||||||
4410349|NCT00235716|4236027|B3|One ε4 allele||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|44|44.0||||||
4410350|NCT00235716|4236028|B2|One ε4 allele||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|44|44.0||||||
4410351|NCT00235716|4236029|B1|One ε4 allele||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|39|39.0||||||
4410352|NCT00235716|4236025|B5|Non-carriers||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|209|209.0||||||
4410353|NCT00235716|4236026|B4|Non-carriers||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|55|55.0||||||
4410354|NCT00235716|4236027|B3|Non-carriers||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|59|59.0||||||
4410355|NCT00235716|4236028|B2|Non-carriers||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|48|48.0||||||
4410356|NCT00235716|4236029|B1|Non-carriers||Apolipoprotein E ε4 status|Data collected through genetic sub-study with separate informed consent.|participants|Number|47|47.0||||||
4410477|NCT00235443|4236090|B6||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4410357|NCT00235716|4236025|B5|College Graduation or Advanced Degree||Education||participants|Number|134|134.0||||||
4410358|NCT00235716|4236026|B4|College Graduation or Advanced Degree||Education||participants|Number|34|34.0||||||
4410359|NCT00235716|4236027|B3|College Graduation or Advanced Degree||Education||participants|Number|34|34.0||||||
4410360|NCT00235716|4236028|B2|College Graduation or Advanced Degree||Education||participants|Number|28|28.0||||||
4410361|NCT00235716|4236029|B1|College Graduation or Advanced Degree||Education||participants|Number|38|38.0||||||
4410362|NCT00235716|4236025|B5|Some College||Education||participants|Number|135|135.0||||||
4410363|NCT00235716|4236026|B4|Some College||Education||participants|Number|33|33.0||||||
4410364|NCT00235716|4236027|B3|Some College||Education||participants|Number|37|37.0||||||
4410365|NCT00235716|4236028|B2|Some College||Education||participants|Number|38|38.0||||||
4410366|NCT00235716|4236029|B1|Some College||Education||participants|Number|27|27.0||||||
4410367|NCT00235716|4236025|B5|High School Graduation||Education||participants|Number|207|207.0||||||
4410368|NCT00235716|4236026|B4|High School Graduation||Education||participants|Number|56|56.0||||||
4410369|NCT00235716|4236027|B3|High School Graduation||Education||participants|Number|57|57.0||||||
4410370|NCT00235716|4236028|B2|High School Graduation||Education||participants|Number|48|48.0||||||
4410371|NCT00235716|4236029|B1|High School Graduation||Education||participants|Number|46|46.0||||||
4410372|NCT00235716|4236025|B5|<High School Graduation||Education||participants|Number|137|137.0||||||
4410373|NCT00235716|4236026|B4|<High School Graduation||Education||participants|Number|29|29.0||||||
4410374|NCT00235716|4236027|B3|<High School Graduation||Education||participants|Number|26|26.0||||||
4410375|NCT00235716|4236028|B2|<High School Graduation||Education||participants|Number|41|41.0||||||
4410376|NCT00235716|4236029|B1|<High School Graduation||Education||participants|Number|41|41.0||||||
4410377|NCT00235716|4236025|B5|United States||Region of Enrollment||participants|Number|613|613.0||||||
4410378|NCT00235716|4236026|B4|United States||Region of Enrollment||participants|Number|152|152.0||||||
4410379|NCT00235716|4236027|B3|United States||Region of Enrollment||participants|Number|154|154.0||||||
4410380|NCT00235716|4236028|B2|United States||Region of Enrollment||participants|Number|155|155.0||||||
4410381|NCT00235716|4236029|B1|United States||Region of Enrollment||participants|Number|152|152.0||||||
4410382|NCT00235716|4236025|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410383|NCT00235716|4236026|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410384|NCT00235716|4236027|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410385|NCT00235716|4236028|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410386|NCT00235716|4236029|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410387|NCT00235716|4236025|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4410388|NCT00235716|4236026|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410389|NCT00235716|4236027|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410390|NCT00235716|4236028|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410391|NCT00235716|4236029|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4410392|NCT00235716|4236025|B5||White|Race (NIH/OMB)||Participants|Count of Participants|529|529.0||||||
4410393|NCT00235716|4236026|B4||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4410394|NCT00235716|4236027|B3||White|Race (NIH/OMB)||Participants|Count of Participants|136|136.0||||||
4410395|NCT00235716|4236028|B2||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4410396|NCT00235716|4236029|B1||White|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4410397|NCT00235716|4236025|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4410398|NCT00235716|4236026|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4410399|NCT00235716|4236027|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4410400|NCT00235716|4236028|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4410401|NCT00235716|4236029|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4410402|NCT00235716|4236025|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4410403|NCT00235716|4236026|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410404|NCT00235716|4236027|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410405|NCT00235716|4236028|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4410406|NCT00235716|4236029|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410407|NCT00235716|4236025|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4410408|NCT00235716|4236026|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410409|NCT00235716|4236027|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410410|NCT00235716|4236028|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4410411|NCT00235716|4236029|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410412|NCT00235716|4236025|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4410413|NCT00235716|4236026|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4410414|NCT00235716|4236027|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410415|NCT00235716|4236028|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410416|NCT00235716|4236029|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410417|NCT00235716|4236025|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410418|NCT00235716|4236026|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410419|NCT00235716|4236027|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410420|NCT00235716|4236028|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410421|NCT00235716|4236029|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410422|NCT00235716|4236025|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|547|547.0||||||
4410423|NCT00235716|4236026|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
4410424|NCT00235716|4236027|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
4410425|NCT00235716|4236028|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4410426|NCT00235716|4236029|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
4410427|NCT00235716|4236025|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4410428|NCT00235716|4236026|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4410429|NCT00235716|4236027|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4410430|NCT00235716|4236028|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4410431|NCT00235716|4236029|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4410432|NCT00235716|4236025|B5||Male|Sex: Female, Male||Participants|Count of Participants|594|594.0||||||
4410433|NCT00235716|4236026|B4||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4410434|NCT00235716|4236027|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4410435|NCT00235716|4236028|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4410436|NCT00235716|4236029|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4410437|NCT00235716|4236025|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4410438|NCT00235716|4236026|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4410439|NCT00235716|4236027|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4410440|NCT00235716|4236028|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4410441|NCT00235716|4236029|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4410442|NCT00235716|4236025|B5|||Age||years|Mean|78.8|78.8|Standard Deviation|7.1|7.1|||
4410443|NCT00235716|4236026|B4|||Age||years|Mean|79.4|79.4|Standard Deviation|7.0|7.0|||
4410444|NCT00235716|4236027|B3|||Age||years|Mean|78.3|78.3|Standard Deviation|7.0|7.0|||
4410445|NCT00235716|4236028|B2|||Age||years|Mean|78.8|78.8|Standard Deviation|7.2|7.2|||
4410446|NCT00235716|4236029|B1|||Age||years|Mean|78.6|78.6|Standard Deviation|7.2|7.2|||
4410447|NCT00235573|4236066|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4410448|NCT00235573|4236066|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4410449|NCT00235573|4236066|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4410450|NCT00235573|4236066|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4410451|NCT00235573|4236066|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4410452|NCT00235573|4236066|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410453|NCT00235456|4236070|B3||Male|Gender||Participants|Count of Participants|162|162.0||||||
4410454|NCT00235456|4236071|B2||Male|Gender||Participants|Count of Participants|91|91.0||||||
4410455|NCT00235456|4236072|B1||Male|Gender||Participants|Count of Participants|71|71.0||||||
4410456|NCT00235456|4236070|B3||Female|Gender||Participants|Count of Participants|129|129.0||||||
4410457|NCT00235456|4236071|B2||Female|Gender||Participants|Count of Participants|52|52.0||||||
4410458|NCT00235456|4236072|B1||Female|Gender||Participants|Count of Participants|77|77.0||||||
4410459|NCT00235456|4236070|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|12.2|12.2|||
4410460|NCT00235456|4236071|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|12.5|12.5|||
4410461|NCT00235456|4236072|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|11.8|11.8|||
4410462|NCT00235443|4236089|B7|United States||Region of Enrollment||participants|Number|451|451.0||||||
4410463|NCT00235443|4236090|B6|United States||Region of Enrollment||participants|Number|54|54.0||||||
4410464|NCT00235443|4236091|B5|United States||Region of Enrollment||participants|Number|39|39.0||||||
4410465|NCT00235443|4236092|B4|United States||Region of Enrollment||participants|Number|205|205.0||||||
4410466|NCT00235443|4236093|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
4410467|NCT00235443|4236094|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4410468|NCT00235443|4236095|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4410469|NCT00235443|4236089|B7||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4410470|NCT00235443|4236090|B6||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4410471|NCT00235443|4236091|B5||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4410472|NCT00235443|4236092|B4||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4410473|NCT00235443|4236093|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4410474|NCT00235443|4236094|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4410475|NCT00235443|4236095|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4410478|NCT00235443|4236091|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4410479|NCT00235443|4236092|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4410480|NCT00235443|4236093|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4410481|NCT00235443|4236094|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4410482|NCT00235443|4236095|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4410483|NCT00235443|4236089|B7|||Age||years|Mean|58.1|58.1|Standard Deviation|9.60|9.6|||
4410484|NCT00235443|4236090|B6|||Age||years|Mean|55.5|55.5|Standard Deviation|10.10|10.1|||
4410485|NCT00235443|4236091|B5|||Age||years|Mean|56.9|56.9|Standard Deviation|9.52|9.52|||
4410486|NCT00235443|4236092|B4|||Age||years|Mean|57.3|57.3|Standard Deviation|9.43|9.43|||
4410487|NCT00235443|4236093|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|8.55|8.55|||
4410488|NCT00235443|4236094|B2|||Age||years|Mean|59.3|59.3|Standard Deviation|10.53|10.53|||
4410489|NCT00235443|4236095|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|8.16|8.16|||
4410490|NCT00235443|4236089|B7||>=65 years|Age||Participants|Count of Participants|112|112.0||||||
4410491|NCT00235443|4236090|B6||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4410492|NCT00235443|4236091|B5||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4410493|NCT00235443|4236092|B4||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4410494|NCT00235443|4236093|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4410495|NCT00235443|4236094|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4410496|NCT00235443|4236095|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4410497|NCT00235443|4236089|B7||Between 18 and 65 years|Age||Participants|Count of Participants|339|339.0||||||
4410498|NCT00235443|4236090|B6||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4410499|NCT00235443|4236091|B5||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4410500|NCT00235443|4236092|B4||Between 18 and 65 years|Age||Participants|Count of Participants|160|160.0||||||
4410501|NCT00235443|4236093|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4410502|NCT00235443|4236094|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4410503|NCT00235443|4236095|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4410504|NCT00235443|4236089|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410505|NCT00235443|4236090|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410506|NCT00235443|4236091|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410507|NCT00235443|4236092|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410508|NCT00235443|4236093|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410509|NCT00235443|4236094|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410510|NCT00235443|4236095|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410511|NCT00235391|4236235|B7|Reason for inadequate therapy information missing||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|10|10.0||||||
4410512|NCT00235391|4236236|B6|Reason for inadequate therapy information missing||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|1|1.0||||||
4410513|NCT00235391|4236237|B5|Reason for inadequate therapy information missing||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|0|0.0||||||
4410514|NCT00235391|4236238|B4|Reason for inadequate therapy information missing||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|0|0.0||||||
4410515|NCT00235391|4236239|B3|Reason for inadequate therapy information missing||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|0|0.0||||||
4410516|NCT00235391|4236240|B2|Reason for inadequate therapy information missing||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|3|3.0||||||
4410517|NCT00235391|4236241|B1|Reason for inadequate therapy information missing||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|6|6.0||||||
4410518|NCT00235391|4236235|B7|Therapy unacceptable discomfort||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|87|87.0||||||
4410519|NCT00235391|4236236|B6|Therapy unacceptable discomfort||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|2|2.0||||||
4410520|NCT00235391|4236237|B5|Therapy unacceptable discomfort||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|3|3.0||||||
4410521|NCT00235391|4236238|B4|Therapy unacceptable discomfort||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|78|78.0||||||
4410522|NCT00235391|4236239|B3|Therapy unacceptable discomfort||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|0|0.0||||||
4410523|NCT00235391|4236240|B2|Therapy unacceptable discomfort||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|2|2.0||||||
4410524|NCT00235391|4236241|B1|Therapy unacceptable discomfort||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|2|2.0||||||
4410644|NCT00235326|4236261|B3|Canada||Region of Enrollment||participants|Number|4561.0|4561.0||||||
4410525|NCT00235391|4236235|B7|Therapy poor response||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|367|367.0||||||
4410526|NCT00235391|4236236|B6|Therapy poor response||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|0|0.0||||||
4410527|NCT00235391|4236237|B5|Therapy poor response||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|8|8.0||||||
4410528|NCT00235391|4236238|B4|Therapy poor response||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|267|267.0||||||
4410529|NCT00235391|4236239|B3|Therapy poor response||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|38|38.0||||||
4410530|NCT00235391|4236240|B2|Therapy poor response||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|34|34.0||||||
4410531|NCT00235391|4236241|B1|Therapy poor response||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|20|20.0||||||
4410532|NCT00235391|4236235|B7|Therapy unacceptable toxicity||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|200|200.0||||||
4410533|NCT00235391|4236236|B6|Therapy unacceptable toxicity||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|1|1.0||||||
4410534|NCT00235391|4236237|B5|Therapy unacceptable toxicity||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|6|6.0||||||
4410535|NCT00235391|4236238|B4|Therapy unacceptable toxicity||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|131|131.0||||||
4410536|NCT00235391|4236239|B3|Therapy unacceptable toxicity||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|22|22.0||||||
4410537|NCT00235391|4236240|B2|Therapy unacceptable toxicity||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|29|29.0||||||
4410538|NCT00235391|4236241|B1|Therapy unacceptable toxicity||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|11|11.0||||||
4410539|NCT00235391|4236235|B7|Therapy contraindication||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|45|45.0||||||
4410540|NCT00235391|4236236|B6|Therapy contraindication||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|1|1.0||||||
4410541|NCT00235391|4236237|B5|Therapy contraindication||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|1|1.0||||||
4410542|NCT00235391|4236238|B4|Therapy contraindication||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|29|29.0||||||
4410543|NCT00235391|4236239|B3|Therapy contraindication||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|6|6.0||||||
4410544|NCT00235391|4236240|B2|Therapy contraindication||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|7|7.0||||||
4410545|NCT00235391|4236241|B1|Therapy contraindication||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|1|1.0||||||
4410546|NCT00235391|4236235|B7|Therapy non-compliance||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|974|974.0||||||
4410547|NCT00235391|4236236|B6|Therapy non-compliance||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|2|2.0||||||
4410548|NCT00235391|4236237|B5|Therapy non-compliance||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|25|25.0||||||
4410549|NCT00235391|4236238|B4|Therapy non-compliance||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|659|659.0||||||
4410550|NCT00235391|4236239|B3|Therapy non-compliance||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|106|106.0||||||
4410551|NCT00235391|4236240|B2|Therapy non-compliance||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|125|125.0||||||
4410552|NCT00235391|4236241|B1|Therapy non-compliance||Reason for inadequate prior chelation therapy|The number of participants for each reason for inadequate prior chelation therapy category.|participants|Number|57|57.0||||||
4410553|NCT00235391|4236235|B7|Prior Chelatation Drug Information Missing||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|12|12.0||||||
4410554|NCT00235391|4236236|B6|Prior Chelatation Drug Information Missing||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|1|1.0||||||
4410555|NCT00235391|4236237|B5|Prior Chelatation Drug Information Missing||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|0|0.0||||||
4410556|NCT00235391|4236238|B4|Prior Chelatation Drug Information Missing||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|0|0.0||||||
4410645|NCT00235326|4236262|B2|Canada||Region of Enrollment||participants|Number|2986|2986.0||||||
4410557|NCT00235391|4236239|B3|Prior Chelatation Drug Information Missing||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|0|0.0||||||
4410558|NCT00235391|4236240|B2|Prior Chelatation Drug Information Missing||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|3|3.0||||||
4410559|NCT00235391|4236241|B1|Prior Chelatation Drug Information Missing||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|8|8.0||||||
4410560|NCT00235391|4236235|B7|Other Chelation Drug||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|19|19.0||||||
4410561|NCT00235391|4236236|B6|Other Chelation Drug||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|0|0.0||||||
4410562|NCT00235391|4236237|B5|Other Chelation Drug||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|0|0.0||||||
4410563|NCT00235391|4236238|B4|Other Chelation Drug||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|4|4.0||||||
4410564|NCT00235391|4236239|B3|Other Chelation Drug||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|3|3.0||||||
4410565|NCT00235391|4236240|B2|Other Chelation Drug||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|6|6.0||||||
4410566|NCT00235391|4236241|B1|Other Chelation Drug||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|6|6.0||||||
4410567|NCT00235391|4236235|B7|Deferoxamine and Deferiprone||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|314|314.0||||||
4410568|NCT00235391|4236236|B6|Deferoxamine and Deferiprone||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|0|0.0||||||
4410569|NCT00235391|4236237|B5|Deferoxamine and Deferiprone||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|6|6.0||||||
4410570|NCT00235391|4236238|B4|Deferoxamine and Deferiprone||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|269|269.0||||||
4410571|NCT00235391|4236239|B3|Deferoxamine and Deferiprone||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|21|21.0||||||
4410572|NCT00235391|4236240|B2|Deferoxamine and Deferiprone||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|16|16.0||||||
4410573|NCT00235391|4236241|B1|Deferoxamine and Deferiprone||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|2|2.0||||||
4410574|NCT00235391|4236235|B7|Deferiprone||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|173|173.0||||||
4410575|NCT00235391|4236236|B6|Deferiprone||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|1|1.0||||||
4410576|NCT00235391|4236237|B5|Deferiprone||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|6|6.0||||||
4410577|NCT00235391|4236238|B4|Deferiprone||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|146|146.0||||||
4410578|NCT00235391|4236239|B3|Deferiprone||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|11|11.0||||||
4410579|NCT00235391|4236240|B2|Deferiprone||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|8|8.0||||||
4410580|NCT00235391|4236241|B1|Deferiprone||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|1|1.0||||||
4410581|NCT00235391|4236235|B7|Deferoxamine||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|1165|1165.0||||||
4410582|NCT00235391|4236236|B6|Deferoxamine||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|5|5.0||||||
4410583|NCT00235391|4236237|B5|Deferoxamine||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|31|31.0||||||
4410584|NCT00235391|4236238|B4|Deferoxamine||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|745|745.0||||||
4410585|NCT00235391|4236239|B3|Deferoxamine||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|137|137.0||||||
4410586|NCT00235391|4236240|B2|Deferoxamine||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|167|167.0||||||
4410587|NCT00235391|4236241|B1|Deferoxamine||Prior Chelation Drug Therapy|The number of participants for each chelation drug category.|participants|Number|80|80.0||||||
4410588|NCT00235391|4236235|B7|Other Diseases||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|87|87.0||||||
4410589|NCT00235391|4236236|B6|Other Diseases||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|3|3.0||||||
4410590|NCT00235391|4236237|B5|Other Diseases||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|11|11.0||||||
4410591|NCT00235391|4236238|B4|Other Diseases||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|48|48.0||||||
4410592|NCT00235391|4236239|B3|Other Diseases||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|3|3.0||||||
4410593|NCT00235391|4236240|B2|Other Diseases||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|12|12.0||||||
4410594|NCT00235391|4236241|B1|Other Diseases||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|10|10.0||||||
4410595|NCT00235391|4236235|B7|Diamond-Blackfan Anemia||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|43|43.0||||||
4410596|NCT00235391|4236236|B6|Diamond-Blackfan Anemia||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|0|0.0||||||
4410597|NCT00235391|4236237|B5|Diamond-Blackfan Anemia||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|0|0.0||||||
4410598|NCT00235391|4236238|B4|Diamond-Blackfan Anemia||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|24|24.0||||||
4410599|NCT00235391|4236239|B3|Diamond-Blackfan Anemia||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|8|8.0||||||
4410600|NCT00235391|4236240|B2|Diamond-Blackfan Anemia||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|7|7.0||||||
4410601|NCT00235391|4236241|B1|Diamond-Blackfan Anemia||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|4|4.0||||||
4410602|NCT00235391|4236235|B7|Sickle Cell Disease||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|176|176.0||||||
4410603|NCT00235391|4236236|B6|Sickle Cell Disease||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|1|1.0||||||
4410604|NCT00235391|4236237|B5|Sickle Cell Disease||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|2|2.0||||||
4410605|NCT00235391|4236238|B4|Sickle Cell Disease||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|93|93.0||||||
4410606|NCT00235391|4236239|B3|Sickle Cell Disease||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|31|31.0||||||
4410607|NCT00235391|4236240|B2|Sickle Cell Disease||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|41|41.0||||||
4410608|NCT00235391|4236241|B1|Sickle Cell Disease||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|8|8.0||||||
4410609|NCT00235391|4236235|B7|Beta-Thalassemia Intermedia||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|156|156.0||||||
4410610|NCT00235391|4236236|B6|Beta-Thalassemia Intermedia||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|3|3.0||||||
4410611|NCT00235391|4236237|B5|Beta-Thalassemia Intermedia||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|20|20.0||||||
4410612|NCT00235391|4236238|B4|Beta-Thalassemia Intermedia||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|94|94.0||||||
4410613|NCT00235391|4236239|B3|Beta-Thalassemia Intermedia||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|16|16.0||||||
4410614|NCT00235391|4236240|B2|Beta-Thalassemia Intermedia||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|22|22.0||||||
4410615|NCT00235391|4236241|B1|Beta-Thalassemia Intermedia||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|1|1.0||||||
4410616|NCT00235391|4236235|B7|Beta-Thalassemia Major||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|1221|1221.0||||||
4410617|NCT00235391|4236236|B6|Beta-Thalassemia Major||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|0|0.0||||||
4410618|NCT00235391|4236237|B5|Beta-Thalassemia Major||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|10|10.0||||||
4410619|NCT00235391|4236238|B4|Beta-Thalassemia Major||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|905|905.0||||||
4410620|NCT00235391|4236239|B3|Beta-Thalassemia Major||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|114|114.0||||||
4410621|NCT00235391|4236240|B2|Beta-Thalassemia Major||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|118|118.0||||||
4410622|NCT00235391|4236241|B1|Beta-Thalassemia Major||Baseline Disease Characteristics|The number of participants with each disease category.|participants|Number|74|74.0||||||
4410623|NCT00235391|4236235|B7||Male|Sex: Female, Male||Participants|Count of Participants|787|787.0||||||
4410624|NCT00235391|4236236|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4410625|NCT00235391|4236237|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4410626|NCT00235391|4236238|B4||Male|Sex: Female, Male||Participants|Count of Participants|531|531.0||||||
4410627|NCT00235391|4236239|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4410628|NCT00235391|4236240|B2||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4410629|NCT00235391|4236241|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4410630|NCT00235391|4236235|B7||Female|Sex: Female, Male||Participants|Count of Participants|896|896.0||||||
4410631|NCT00235391|4236236|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4410632|NCT00235391|4236237|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4410633|NCT00235391|4236238|B4||Female|Sex: Female, Male||Participants|Count of Participants|633|633.0||||||
4410634|NCT00235391|4236239|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4410635|NCT00235391|4236240|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4410636|NCT00235391|4236241|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4410637|NCT00235391|4236235|B7|||Age||years|Mean|24.27|24.27|Standard Deviation|12.63|12.63|||
4410638|NCT00235391|4236236|B6|||Age||years|Mean|70.14|70.14|Standard Deviation|3.98|3.98|||
4410639|NCT00235391|4236237|B5|||Age||years|Mean|54.58|54.58|Standard Deviation|3.92|3.92|||
4410640|NCT00235391|4236238|B4|||Age||years|Mean|28.91|28.91|Standard Deviation|8.06|8.06|||
4410641|NCT00235391|4236239|B3|||Age||years|Mean|13.48|13.48|Standard Deviation|1.20|1.2|||
4410642|NCT00235391|4236240|B2|||Age||years|Mean|8.52|8.52|Standard Deviation|1.64|1.64|||
4410643|NCT00235391|4236241|B1|||Age||years|Mean|3.48|3.48|Standard Deviation|1.13|1.13|||
4410646|NCT00235326|4236263|B1|Canada||Region of Enrollment||participants|Number|1575|1575.0||||||
4410647|NCT00235326|4236261|B3||Male|Sex: Female, Male||Participants|Count of Participants|2004.0|2004.0||||||
4410648|NCT00235326|4236262|B2||Male|Sex: Female, Male||Participants|Count of Participants|1321|1321.0||||||
4410649|NCT00235326|4236263|B1||Male|Sex: Female, Male||Participants|Count of Participants|683|683.0||||||
4410650|NCT00235326|4236261|B3||Female|Sex: Female, Male||Participants|Count of Participants|2557.0|2557.0||||||
4410651|NCT00235326|4236262|B2||Female|Sex: Female, Male||Participants|Count of Participants|1665|1665.0||||||
4410652|NCT00235326|4236263|B1||Female|Sex: Female, Male||Participants|Count of Participants|892|892.0||||||
4410653|NCT00235326|4236261|B3|||Age||years|Mean|35.66|35.66|Standard Deviation|22.03|22.03|||
4410654|NCT00235326|4236262|B2|||Age||years|Mean|34.97|34.97|Standard Deviation|21.61|21.61|||
4410655|NCT00235326|4236263|B1|||Age||years|Mean|36.96|36.96|Standard Deviation|22.76|22.76|||
4410656|NCT00235326|4236261|B3||>=65 years|Age||Participants|Count of Participants|468.0|468.0||||||
4410657|NCT00235326|4236262|B2||>=65 years|Age||Participants|Count of Participants|269|269.0||||||
4410658|NCT00235326|4236263|B1||>=65 years|Age||Participants|Count of Participants|199|199.0||||||
4410659|NCT00235326|4236261|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2715.0|2715.0||||||
4410660|NCT00235326|4236262|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1810|1810.0||||||
4410661|NCT00235326|4236263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|905|905.0||||||
4410662|NCT00235326|4236261|B3||<=18 years|Age||Participants|Count of Participants|1378.0|1378.0||||||
4410663|NCT00235326|4236262|B2||<=18 years|Age||Participants|Count of Participants|907|907.0||||||
4410664|NCT00235326|4236263|B1||<=18 years|Age||Participants|Count of Participants|471|471.0||||||
4410665|NCT00234884|4236268|B1|Italy||Region of Enrollment||participants|Number|672|672.0||||||
4410666|NCT00234884|4236268|B1|United Kingdom||Region of Enrollment||participants|Number|69|69.0||||||
4410667|NCT00234884|4236268|B1|Germany||Region of Enrollment||participants|Number|561|561.0||||||
4410668|NCT00234884|4236268|B1|Netherlands||Region of Enrollment||participants|Number|248|248.0||||||
4410669|NCT00234884|4236268|B1|Austria||Region of Enrollment||participants|Number|95|95.0||||||
4410670|NCT00234884|4236268|B1|Australia||Region of Enrollment||participants|Number|20|20.0||||||
4410671|NCT00234884|4236268|B1|Belgium||Region of Enrollment||participants|Number|318|318.0||||||
4410672|NCT00234884|4236268|B1|Spain||Region of Enrollment||participants|Number|476|476.0||||||
4410673|NCT00234884|4236268|B1|Greece||Region of Enrollment||participants|Number|232|232.0||||||
4410674|NCT00234884|4236268|B1|France||Region of Enrollment||participants|Number|689|689.0||||||
4410675|NCT00234884|4236268|B1|Portugal||Region of Enrollment||participants|Number|55|55.0||||||
4410676|NCT00234884|4236268|B1||Male|Sex: Female, Male||Participants|Count of Participants|711|711.0||||||
4410677|NCT00234884|4236268|B1||Female|Sex: Female, Male||Participants|Count of Participants|2724|2724.0||||||
4410678|NCT00234884|4236268|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|12.5|12.5|||
4410679|NCT00234832|4236276|B3|Unknown CV risk group status||Cardiovascular (CV) risk group status|Subjects were categorized at study entry into 1 of 3 prespecified CV risk groups: 1) diabetes mellitus (DM) only = history of type 2 DM with at least one other risk factor but no history of CV disease, 2) CV only = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, but no history of type 2 DM with at least one other risk factor, and 3) CV + DM = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, and a history of type 2 DM with at least one other risk factor.|Participants|Number|60|60.0||||||
4410680|NCT00234832|4236277|B2|Unknown CV risk group status||Cardiovascular (CV) risk group status|Subjects were categorized at study entry into 1 of 3 prespecified CV risk groups: 1) diabetes mellitus (DM) only = history of type 2 DM with at least one other risk factor but no history of CV disease, 2) CV only = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, but no history of type 2 DM with at least one other risk factor, and 3) CV + DM = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, and a history of type 2 DM with at least one other risk factor.|Participants|Number|26|26.0||||||
4410681|NCT00234832|4236278|B1|Unknown CV risk group status||Cardiovascular (CV) risk group status|Subjects were categorized at study entry into 1 of 3 prespecified CV risk groups: 1) diabetes mellitus (DM) only = history of type 2 DM with at least one other risk factor but no history of CV disease, 2) CV only = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, but no history of type 2 DM with at least one other risk factor, and 3) CV + DM = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, and a history of type 2 DM with at least one other risk factor.|Participants|Number|34|34.0||||||
4410682|NCT00234832|4236276|B3|CV + DM||Cardiovascular (CV) risk group status|Subjects were categorized at study entry into 1 of 3 prespecified CV risk groups: 1) diabetes mellitus (DM) only = history of type 2 DM with at least one other risk factor but no history of CV disease, 2) CV only = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, but no history of type 2 DM with at least one other risk factor, and 3) CV + DM = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, and a history of type 2 DM with at least one other risk factor.|Participants|Number|5807|5807.0||||||
4410683|NCT00234832|4236277|B2|CV + DM||Cardiovascular (CV) risk group status|Subjects were categorized at study entry into 1 of 3 prespecified CV risk groups: 1) diabetes mellitus (DM) only = history of type 2 DM with at least one other risk factor but no history of CV disease, 2) CV only = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, but no history of type 2 DM with at least one other risk factor, and 3) CV + DM = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, and a history of type 2 DM with at least one other risk factor.|Participants|Number|2901|2901.0||||||
4410715|NCT00234832|4236276|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6037|6037.0||||||
4410716|NCT00234832|4236277|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2997|2997.0||||||
4410684|NCT00234832|4236278|B1|CV + DM||Cardiovascular (CV) risk group status|Subjects were categorized at study entry into 1 of 3 prespecified CV risk groups: 1) diabetes mellitus (DM) only = history of type 2 DM with at least one other risk factor but no history of CV disease, 2) CV only = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, but no history of type 2 DM with at least one other risk factor, and 3) CV + DM = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, and a history of type 2 DM with at least one other risk factor.|Participants|Number|2906|2906.0||||||
4410685|NCT00234832|4236276|B3|CV only||Cardiovascular (CV) risk group status|Subjects were categorized at study entry into 1 of 3 prespecified CV risk groups: 1) diabetes mellitus (DM) only = history of type 2 DM with at least one other risk factor but no history of CV disease, 2) CV only = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, but no history of type 2 DM with at least one other risk factor, and 3) CV + DM = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, and a history of type 2 DM with at least one other risk factor.|Participants|Number|1552|1552.0||||||
4410686|NCT00234832|4236277|B2|CV only||Cardiovascular (CV) risk group status|Subjects were categorized at study entry into 1 of 3 prespecified CV risk groups: 1) diabetes mellitus (DM) only = history of type 2 DM with at least one other risk factor but no history of CV disease, 2) CV only = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, but no history of type 2 DM with at least one other risk factor, and 3) CV + DM = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, and a history of type 2 DM with at least one other risk factor.|Participants|Number|793|793.0||||||
4410687|NCT00234832|4236278|B1|CV only||Cardiovascular (CV) risk group status|Subjects were categorized at study entry into 1 of 3 prespecified CV risk groups: 1) diabetes mellitus (DM) only = history of type 2 DM with at least one other risk factor but no history of CV disease, 2) CV only = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, but no history of type 2 DM with at least one other risk factor, and 3) CV + DM = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, and a history of type 2 DM with at least one other risk factor.|Participants|Number|759|759.0||||||
4410688|NCT00234832|4236276|B3|DM only||Cardiovascular (CV) risk group status|Subjects were categorized at study entry into 1 of 3 prespecified CV risk groups: 1) diabetes mellitus (DM) only = history of type 2 DM with at least one other risk factor but no history of CV disease, 2) CV only = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, but no history of type 2 DM with at least one other risk factor, and 3) CV + DM = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, and a history of type 2 DM with at least one other risk factor.|Participants|Number|2385|2385.0||||||
4410689|NCT00234832|4236277|B2|DM only||Cardiovascular (CV) risk group status|Subjects were categorized at study entry into 1 of 3 prespecified CV risk groups: 1) diabetes mellitus (DM) only = history of type 2 DM with at least one other risk factor but no history of CV disease, 2) CV only = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, but no history of type 2 DM with at least one other risk factor, and 3) CV + DM = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, and a history of type 2 DM with at least one other risk factor.|Participants|Number|1178|1178.0||||||
4410690|NCT00234832|4236278|B1|DM only||Cardiovascular (CV) risk group status|Subjects were categorized at study entry into 1 of 3 prespecified CV risk groups: 1) diabetes mellitus (DM) only = history of type 2 DM with at least one other risk factor but no history of CV disease, 2) CV only = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, but no history of type 2 DM with at least one other risk factor, and 3) CV + DM = history of coronary artery disease, cerebrovascular disease, or peripheral arterial occlusive disease, and a history of type 2 DM with at least one other risk factor.|Participants|Number|1207|1207.0||||||
4410691|NCT00234832|4236276|B3|Mexico||Region of Enrollment||participants|Number|258|258.0||||||
4410692|NCT00234832|4236277|B2|Mexico||Region of Enrollment||participants|Number|129|129.0||||||
4410693|NCT00234832|4236278|B1|Mexico||Region of Enrollment||participants|Number|129|129.0||||||
4410694|NCT00234832|4236276|B3|Brazil||Region of Enrollment||participants|Number|467|467.0||||||
4410695|NCT00234832|4236277|B2|Brazil||Region of Enrollment||participants|Number|234|234.0||||||
4410696|NCT00234832|4236278|B1|Brazil||Region of Enrollment||participants|Number|233|233.0||||||
4410697|NCT00234832|4236276|B3|Australia||Region of Enrollment||participants|Number|769|769.0||||||
4410698|NCT00234832|4236277|B2|Australia||Region of Enrollment||participants|Number|385|385.0||||||
4410699|NCT00234832|4236278|B1|Australia||Region of Enrollment||participants|Number|384|384.0||||||
4410700|NCT00234832|4236276|B3|Europe||Region of Enrollment||participants|Number|8310|8310.0||||||
4410701|NCT00234832|4236277|B2|Europe||Region of Enrollment||participants|Number|4150|4150.0||||||
4410702|NCT00234832|4236278|B1|Europe||Region of Enrollment||participants|Number|4160|4160.0||||||
4410703|NCT00234832|4236276|B3||Male|Sex: Female, Male||Participants|Count of Participants|5650|5650.0||||||
4410704|NCT00234832|4236277|B2||Male|Sex: Female, Male||Participants|Count of Participants|2843|2843.0||||||
4410705|NCT00234832|4236278|B1||Male|Sex: Female, Male||Participants|Count of Participants|2807|2807.0||||||
4410706|NCT00234832|4236276|B3||Female|Sex: Female, Male||Participants|Count of Participants|4154|4154.0||||||
4410707|NCT00234832|4236277|B2||Female|Sex: Female, Male||Participants|Count of Participants|2055|2055.0||||||
4410708|NCT00234832|4236278|B1||Female|Sex: Female, Male||Participants|Count of Participants|2099|2099.0||||||
4410709|NCT00234832|4236276|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|6.12|6.12|||
4410710|NCT00234832|4236277|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|6.15|6.15|||
4410711|NCT00234832|4236278|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|6.09|6.09|||
4410712|NCT00234832|4236276|B3||>=65 years|Age||Participants|Count of Participants|3767|3767.0||||||
4410713|NCT00234832|4236277|B2||>=65 years|Age||Participants|Count of Participants|1901|1901.0||||||
4410714|NCT00234832|4236278|B1||>=65 years|Age||Participants|Count of Participants|1866|1866.0||||||
4410717|NCT00234832|4236278|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3040|3040.0||||||
4410718|NCT00234832|4236276|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410719|NCT00234832|4236277|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410720|NCT00234832|4236278|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410721|NCT00234533|4236304|B1|||Auxological Parameter - Calculated annualised GV SDS||SD|Mean|-0.56|-0.56|Standard Deviation|2.67|2.67|||
4410722|NCT00234533|4236304|B1|||Auxological Parameter - Annualised Growth Velocity (GV)||cm/year|Mean|4.94|4.94|Standard Deviation|2.56|2.56|||
4410723|NCT00234533|4236304|B1|||Auxological Parameter - Calculated weight SDS||SD|Mean|-1.85|-1.85|Standard Deviation|1.88|1.88|||
4410724|NCT00234533|4236304|B1|||Auxological Parameter - Weight||kg|Mean|27.97|27.97|Standard Deviation|11.91|11.91|||
4410725|NCT00234533|4236304|B1|||Auxological Parameter - Calculated height SDS||SD|Mean|-2.68|-2.68|Standard Deviation|1.33|1.33|||
4410726|NCT00234533|4236304|B1|||Auxological Parameter - Height||cm|Mean|122.95|122.95|Standard Deviation|20.24|20.24|||
4410727|NCT00234533|4236304|B1|||Duration of previous Growth Hormone (GH) treatment||years|Mean|1.68|1.68|Standard Deviation|1.56|1.56|||
4410728|NCT00234533|4236304|B1|||Calculated genetic target height Standard Deviation Score (SDS)|"The genetic potential height, or target height was estimated as follows:~Boys Target Height = [(mother height cm + father height cm)/2] + 6.5 cm.~Girls Target Height = [(mother height cm + father height cm)/2] - 6.5 cm. The French growth charts were used for the calculation of standard deviation score (SDS) parameters: the charts provide for each age range and sex a mean parameter and standard deviation (SD) value, from which the SDS parameter can be derived assuming a normal distribution. For example: Height SDS = (height – reference mean height (age, sex)) / reference SD (age, sex)."|Standard Deviations (SD)|Mean|-0.33|-0.33|Standard Deviation|0.95|0.95|||
4410729|NCT00234533|4236304|B1|||Genetic target height|The genetic potential height, or target height was estimated using the adult height of each parent (i.e. genetic mother and father).|cm|Mean|166.26|166.26|Standard Deviation|8.16|8.16|||
4410730|NCT00234533|4236304|B1|||Duration of gestation||weeks of amenorrhea|Mean|38.7|38.7|Standard Deviation|2.6|2.6|||
4410731|NCT00234533|4236304|B1|||Birth weight||kg|Mean|2.94|2.94|Standard Deviation|0.60|0.6|||
4410732|NCT00234533|4236304|B1|||Birth height||centimeters (cm)|Mean|48.49|48.49|Standard Deviation|3.36|3.36|||
4410733|NCT00234533|4236304|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4410734|NCT00234533|4236304|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4410735|NCT00234533|4236304|B1|||Age||years|Mean|9.9|9.9|Standard Deviation|3.9|3.9|||
4410736|NCT00234494|4236323|B1|Poor risk||Modified Bajorin risk group|"Modified Bajorin risk groups were defined as follows:PS0 and no visceral metastases(lowrisk); PS1 and no visceral metastases or PS 0 and visceral metastases (intermediate risk); and PS~1 and visceral metastases (high risk)"|participants|Number|12|12.0||||||
4410737|NCT00234494|4236323|B1|Intermediate risk||Modified Bajorin risk group|"Modified Bajorin risk groups were defined as follows:PS0 and no visceral metastases(lowrisk); PS1 and no visceral metastases or PS 0 and visceral metastases (intermediate risk); and PS~1 and visceral metastases (high risk)"|participants|Number|23|23.0||||||
4410738|NCT00234494|4236323|B1|Good risk||Modified Bajorin risk group|"Modified Bajorin risk groups were defined as follows:PS0 and no visceral metastases(lowrisk); PS1 and no visceral metastases or PS 0 and visceral metastases (intermediate risk); and PS~1 and visceral metastases (high risk)"|participants|Number|8|8.0||||||
4410739|NCT00234494|4236323|B1|Bone||Metastatic Site Locations||number of metastatic sites per location|Number|11|11.0||||||
4410740|NCT00234494|4236323|B1|Lung||Metastatic Site Locations||number of metastatic sites per location|Number|18|18.0||||||
4410741|NCT00234494|4236323|B1|Any visceral metastases||Metastatic Site Locations||number of metastatic sites per location|Number|30|30.0||||||
4410742|NCT00234494|4236323|B1|Pelvic/abdominal lymph node||Metastatic Site Locations||number of metastatic sites per location|Number|27|27.0||||||
4410743|NCT00234494|4236323|B1|Any lymph node||Metastatic Site Locations||number of metastatic sites per location|Number|39|39.0||||||
4410744|NCT00234494|4236323|B1|ECOG 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|17|17.0||||||
4410745|NCT00234494|4236323|B1|ECOG 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|26|26.0||||||
4410746|NCT00234494|4236323|B1|No||Prior cystectomy||participants|Number|26|26.0||||||
4410747|NCT00234494|4236323|B1|Yes||Prior cystectomy||participants|Number|17|17.0||||||
4410748|NCT00234494|4236323|B1|||Number of metastatic sites||number of metastatic sites|Median|2|2.0|Full Range|||0.0|6.0|
4410749|NCT00234494|4236323|B1|||Platelet count||platelets per ul|Median|291000|291000.0|Full Range|||139000.0|770000.0|
4410750|NCT00234494|4236323|B1|||Hemoglobin||g/dL|Median|13.0|13.0|Full Range|||9.1|15.6|
4410751|NCT00234494|4236323|B1|||WBC Count||K/ul|Median|7600|7600.0|Full Range|||4100.0|22000.0|
4410752|NCT00234494|4236323|B1|||Creatinine, mg/dL||mg/dL|Median|1.1|1.1|Full Range|||0.6|1.4|
4410753|NCT00234494|4236323|B1|||Body Mass Index, kg/m2||kg/m2|Median|27.7|27.7|Full Range|||19.1|44.0|
4410754|NCT00234494|4236323|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4410755|NCT00234494|4236323|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4410756|NCT00234494|4236323|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4410757|NCT00234494|4236323|B1|Age||Age, Customized||years|Median|66|66.0|Full Range|||41.0|78.0|
4410798|NCT00234104|4236365|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410799|NCT00234104|4236366|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410800|NCT00234104|4236367|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410758|NCT00234286|4236330|B1|Native Hawaiian/Pacific Islander||Race/Ethnicity, Customized|The total numbers of participants with race/ethnicity reported is 5423 which differs from the 6066 participant total previously reported. All outcomes and demogaphics for participants were collected by examination of VA electronic records. Race/ethnicity could not be identified from electronic records for 643 participants.|participants|Number|4|4.0||||||
4410759|NCT00234286|4236330|B1|Asian||Race/Ethnicity, Customized|The total numbers of participants with race/ethnicity reported is 5423 which differs from the 6066 participant total previously reported. All outcomes and demogaphics for participants were collected by examination of VA electronic records. Race/ethnicity could not be identified from electronic records for 643 participants.|participants|Number|1|1.0||||||
4410760|NCT00234286|4236330|B1|Native American||Race/Ethnicity, Customized|The total numbers of participants with race/ethnicity reported is 5423 which differs from the 6066 participant total previously reported. All outcomes and demogaphics for participants were collected by examination of VA electronic records. Race/ethnicity could not be identified from electronic records for 643 participants.|participants|Number|4|4.0||||||
4410761|NCT00234286|4236330|B1|Hispanic black||Race/Ethnicity, Customized|The total numbers of participants with race/ethnicity reported is 5423 which differs from the 6066 participant total previously reported. All outcomes and demogaphics for participants were collected by examination of VA electronic records. Race/ethnicity could not be identified from electronic records for 643 participants.|participants|Number|2|2.0||||||
4410762|NCT00234286|4236330|B1|Hispanic white||Race/Ethnicity, Customized|The total numbers of participants with race/ethnicity reported is 5423 which differs from the 6066 participant total previously reported. All outcomes and demogaphics for participants were collected by examination of VA electronic records. Race/ethnicity could not be identified from electronic records for 643 participants.|participants|Number|8|8.0||||||
4410763|NCT00234286|4236330|B1|Black||Race/Ethnicity, Customized|The total numbers of participants with race/ethnicity reported is 5423 which differs from the 6066 participant total previously reported. All outcomes and demogaphics for participants were collected by examination of VA electronic records. Race/ethnicity could not be identified from electronic records for 643 participants.|participants|Number|1876|1876.0||||||
4410764|NCT00234286|4236330|B1|White||Race/Ethnicity, Customized|The total numbers of participants with race/ethnicity reported is 5423 which differs from the 6066 participant total previously reported. All outcomes and demogaphics for participants were collected by examination of VA electronic records. Race/ethnicity could not be identified from electronic records for 643 participants.|participants|Number|3528|3528.0||||||
4410765|NCT00234286|4236330|B1|Male||Gender|The total numbers of participants with gender reported is 5921 which differs from the 6066 participant total previously reported. All outcomes and demogaphics for participants were collected by examination of VA electronic records. Gender could not not identified for 145 participants.|participants|Number|5812|5812.0||||||
4410766|NCT00234286|4236330|B1|Female||Gender|The total numbers of participants with gender reported is 5921 which differs from the 6066 participant total previously reported. All outcomes and demogaphics for participants were collected by examination of VA electronic records. Gender could not not identified for 145 participants.|participants|Number|109|109.0||||||
4410767|NCT00234286|4236330|B1|||Age||years|Mean|71.2|71.2|Standard Deviation|12.0|12.0|||
4410768|NCT00234104|4236365|B5|Japan||Region of Enrollment||participants|Number|118|118.0||||||
4410769|NCT00234104|4236366|B4|Japan||Region of Enrollment||participants|Number|28|28.0||||||
4410770|NCT00234104|4236367|B3|Japan||Region of Enrollment||participants|Number|33|33.0||||||
4410771|NCT00234104|4236368|B2|Japan||Region of Enrollment||participants|Number|28|28.0||||||
4410772|NCT00234104|4236369|B1|Japan||Region of Enrollment||participants|Number|29|29.0||||||
4410773|NCT00234104|4236365|B5||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4410774|NCT00234104|4236366|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4410775|NCT00234104|4236367|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4410776|NCT00234104|4236368|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4410777|NCT00234104|4236369|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4410778|NCT00234104|4236365|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4410779|NCT00234104|4236366|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4410780|NCT00234104|4236367|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4410781|NCT00234104|4236368|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4410782|NCT00234104|4236369|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4410783|NCT00234104|4236365|B5|||Age||years|Mean|66.0|66.0|Standard Deviation|11.2|11.2|||
4410784|NCT00234104|4236366|B4|||Age||years|Mean|62.6|62.6|Standard Deviation|12.5|12.5|||
4410785|NCT00234104|4236367|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|12.5|12.5|||
4410786|NCT00234104|4236368|B2|||Age||years|Mean|66.9|66.9|Standard Deviation|9.6|9.6|||
4410787|NCT00234104|4236369|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|9.4|9.4|||
4410788|NCT00234104|4236365|B5||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
4410789|NCT00234104|4236366|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4410790|NCT00234104|4236367|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4410791|NCT00234104|4236368|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4410792|NCT00234104|4236369|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4410793|NCT00234104|4236365|B5||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4410794|NCT00234104|4236366|B4||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4410795|NCT00234104|4236367|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4410796|NCT00234104|4236368|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4410797|NCT00234104|4236369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4410801|NCT00234104|4236368|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410802|NCT00234104|4236369|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410803|NCT00234078|4236382|B5|Japan||Region of Enrollment||participants|Number|290|290.0||||||
4410804|NCT00234078|4236383|B4|Japan||Region of Enrollment||participants|Number|72|72.0||||||
4410805|NCT00234078|4236384|B3|Japan||Region of Enrollment||participants|Number|74|74.0||||||
4410806|NCT00234078|4236385|B2|Japan||Region of Enrollment||participants|Number|72|72.0||||||
4410807|NCT00234078|4236386|B1|Japan||Region of Enrollment||participants|Number|72|72.0||||||
4410808|NCT00234078|4236382|B5||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4410809|NCT00234078|4236383|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4410810|NCT00234078|4236384|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4410811|NCT00234078|4236385|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4410812|NCT00234078|4236386|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4410813|NCT00234078|4236382|B5||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4410814|NCT00234078|4236383|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4410815|NCT00234078|4236384|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4410816|NCT00234078|4236385|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4410817|NCT00234078|4236386|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4410818|NCT00234078|4236382|B5||>=65 years|Age||Participants|Count of Participants|121|121.0||||||
4410819|NCT00234078|4236383|B4||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4410820|NCT00234078|4236384|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4410821|NCT00234078|4236385|B2||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4410822|NCT00234078|4236386|B1||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4410823|NCT00234078|4236382|B5||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
4410824|NCT00234078|4236383|B4||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4410825|NCT00234078|4236384|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4410826|NCT00234078|4236385|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4410827|NCT00234078|4236386|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4410828|NCT00234078|4236382|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410829|NCT00234078|4236383|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410830|NCT00234078|4236384|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410831|NCT00234078|4236385|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410832|NCT00234078|4236386|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410833|NCT00234078|4236382|B5|||Age||years|Mean|59.8|59.8|Standard Deviation|13.9|13.9|||
4410834|NCT00234078|4236383|B4|||Age||years|Mean|56.0|56.0|Standard Deviation|16.2|16.2|||
4410835|NCT00234078|4236384|B3|||Age||years|Mean|60.3|60.3|Standard Deviation|11.5|11.5|||
4410836|NCT00234078|4236385|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|13.5|13.5|||
4410837|NCT00234078|4236386|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|13.6|13.6|||
4410838|NCT00234065|4236411|B3|Japan||Region of Enrollment||participants|Number|2672|2672.0||||||
4410839|NCT00234065|4236412|B2|Japan||Region of Enrollment||participants|Number|1335|1335.0||||||
4410840|NCT00234065|4236413|B1|Japan||Region of Enrollment||participants|Number|1337|1337.0||||||
4410841|NCT00234065|4236411|B3||Male|Sex: Female, Male||Participants|Count of Participants|1916|1916.0||||||
4410842|NCT00234065|4236412|B2||Male|Sex: Female, Male||Participants|Count of Participants|957|957.0||||||
4410843|NCT00234065|4236413|B1||Male|Sex: Female, Male||Participants|Count of Participants|959|959.0||||||
4410844|NCT00234065|4236411|B3||Female|Sex: Female, Male||Participants|Count of Participants|756|756.0||||||
4410845|NCT00234065|4236412|B2||Female|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
4410846|NCT00234065|4236413|B1||Female|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
4410847|NCT00234065|4236411|B3|||Age||years|Mean|63.4|63.4|Standard Deviation|9.1|9.1|||
4410848|NCT00234065|4236412|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|9.0|9.0|||
4410849|NCT00234065|4236413|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|9.2|9.2|||
4410850|NCT00234065|4236411|B3||>=65 years|Age||Participants|Count of Participants|1306|1306.0||||||
4410851|NCT00234065|4236412|B2||>=65 years|Age||Participants|Count of Participants|650|650.0||||||
4410852|NCT00234065|4236413|B1||>=65 years|Age||Participants|Count of Participants|656|656.0||||||
4410853|NCT00234065|4236411|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1366|1366.0||||||
4410854|NCT00234065|4236412|B2||Between 18 and 65 years|Age||Participants|Count of Participants|685|685.0||||||
4410855|NCT00234065|4236413|B1||Between 18 and 65 years|Age||Participants|Count of Participants|681|681.0||||||
4410856|NCT00234065|4236411|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410857|NCT00234065|4236412|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410858|NCT00234065|4236413|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410859|NCT00234039|4236430|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410860|NCT00234039|4236430|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4410861|NCT00234039|4236430|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4410862|NCT00234039|4236430|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410978|NCT00233103|4236518|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4410863|NCT00234039|4236430|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410864|NCT00234039|4236430|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4410865|NCT00234039|4236430|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410866|NCT00234039|4236430|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4410867|NCT00234039|4236430|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4410868|NCT00234039|4236430|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410869|NCT00234039|4236430|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4410870|NCT00234039|4236430|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4410871|NCT00234039|4236430|B1|||Age||years|Median|70|70.0|Full Range|||50.0|88.0|
4410872|NCT00233987|4236437|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4410873|NCT00233987|4236437|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410874|NCT00233987|4236437|B1||White|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4410875|NCT00233987|4236437|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4410876|NCT00233987|4236437|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410877|NCT00233987|4236437|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4410878|NCT00233987|4236437|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410879|NCT00233987|4236437|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4410880|NCT00233987|4236437|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4410881|NCT00233987|4236437|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4410882|NCT00233987|4236437|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4410883|NCT00233987|4236437|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4410884|NCT00233987|4236437|B1|||Age||years|Median|34.1|34.1|Full Range|||18.2|60.3|
4410885|NCT00233948|4236444|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4410886|NCT00233948|4236445|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4410887|NCT00233948|4236446|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4410888|NCT00233948|4236444|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4410889|NCT00233948|4236445|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4410890|NCT00233948|4236446|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4410891|NCT00233948|4236444|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4410892|NCT00233948|4236445|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4410893|NCT00233948|4236446|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4410894|NCT00233948|4236444|B3|||Age||years|Median|64|64.0|Full Range|||37.0|84.0|
4410895|NCT00233948|4236445|B2|||Age||years|Median|63|63.0|Full Range|||46.0|84.0|
4410896|NCT00233948|4236446|B1|||Age||years|Median|64|64.0|Full Range|||37.0|81.0|
4410897|NCT00233519|4236466|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4410898|NCT00233519|4236467|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4410899|NCT00233519|4236468|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4410900|NCT00233519|4236466|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4410901|NCT00233519|4236467|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4410902|NCT00233519|4236468|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4410903|NCT00233519|4236466|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4410904|NCT00233519|4236467|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4410905|NCT00233519|4236468|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4410906|NCT00233519|4236466|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4410907|NCT00233519|4236467|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4410908|NCT00233519|4236468|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4410909|NCT00233519|4236466|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4410910|NCT00233519|4236467|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4410911|NCT00233519|4236468|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4410912|NCT00233519|4236466|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410913|NCT00233519|4236467|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410914|NCT00233519|4236468|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410915|NCT00233454|4236475|B1||Mast cell leukemia (MCL)|Disease Sub-type|Systemic mastocytosis (SM) is comprised of 3 primary sub-types, aggressive SM (ASM); SM with an associated hematologic neoplasm (SM-AHN); and mast cell leukemia (MCL).|Participants|Count of Participants|6|6.0||||||
4410916|NCT00233454|4236475|B1||SM with associated hematologic neoplasm (SM-AHN)|Disease Sub-type|Systemic mastocytosis (SM) is comprised of 3 primary sub-types, aggressive SM (ASM); SM with an associated hematologic neoplasm (SM-AHN); and mast cell leukemia (MCL).|Participants|Count of Participants|17|17.0||||||
4410917|NCT00233454|4236475|B1||Aggressive systemic mastocytosis (ASM)|Disease Sub-type|Systemic mastocytosis (SM) is comprised of 3 primary sub-types, aggressive SM (ASM); SM with an associated hematologic neoplasm (SM-AHN); and mast cell leukemia (MCL).|Participants|Count of Participants|3|3.0||||||
4410918|NCT00233454|4236475|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4410919|NCT00233454|4236475|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410920|NCT00233454|4236475|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4410921|NCT00233454|4236475|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4410922|NCT00233454|4236475|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410923|NCT00233454|4236475|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410924|NCT00233454|4236475|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410925|NCT00233454|4236475|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410926|NCT00233454|4236475|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4410927|NCT00233454|4236475|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4410928|NCT00233454|4236475|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4410929|NCT00233454|4236475|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4410930|NCT00233454|4236475|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4410931|NCT00233454|4236475|B1|||Age||years|Median|65|65.0|Full Range|||24.8|79.6|
4410932|NCT00233454|4236475|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4410933|NCT00233454|4236475|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4410934|NCT00233454|4236475|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410935|NCT00233402|4236481|B3||Male|Sex: Female, Male||Participants|Count of Participants|562|562.0||||||
4410936|NCT00233402|4236482|B2||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4410937|NCT00233402|4236483|B1||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4410938|NCT00233402|4236481|B3||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4410939|NCT00233402|4236482|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4410940|NCT00233402|4236483|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4410941|NCT00233402|4236481|B3|||Age||years|Mean|69|69.0|Standard Deviation|10.7|10.7|||
4410942|NCT00233402|4236482|B2|||Age||years|Mean|68.5|68.5|Standard Deviation|10.68|10.68|||
4410943|NCT00233402|4236483|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|10.63|10.63|||
4410944|NCT00233402|4236481|B3||>=65 years|Age||Participants|Count of Participants|490|490.0||||||
4410945|NCT00233402|4236482|B2||>=65 years|Age||Participants|Count of Participants|243|243.0||||||
4410946|NCT00233402|4236483|B1||>=65 years|Age||Participants|Count of Participants|247|247.0||||||
4410947|NCT00233402|4236481|B3||Between 18 and 65 years|Age||Participants|Count of Participants|236|236.0||||||
4410948|NCT00233402|4236482|B2||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4410949|NCT00233402|4236483|B1||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4410950|NCT00233402|4236481|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410951|NCT00233402|4236482|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410952|NCT00233402|4236483|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4410953|NCT00233324|4236495|B5|United States||Region of Enrollment||participants|Number|1316|1316.0||||||
4410954|NCT00233324|4236496|B4|United States||Region of Enrollment||participants|Number|335|335.0||||||
4410955|NCT00233324|4236497|B3|United States||Region of Enrollment||participants|Number|318|318.0||||||
4410956|NCT00233324|4236498|B2|United States||Region of Enrollment||participants|Number|327|327.0||||||
4410957|NCT00233324|4236499|B1|United States||Region of Enrollment||participants|Number|336|336.0||||||
4410958|NCT00233324|4236495|B5||Male|Sex: Female, Male||Participants|Count of Participants|712|712.0||||||
4410959|NCT00233324|4236496|B4||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4410960|NCT00233324|4236497|B3||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4410961|NCT00233324|4236498|B2||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4410962|NCT00233324|4236499|B1||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4410963|NCT00233324|4236495|B5||Female|Sex: Female, Male||Participants|Count of Participants|604|604.0||||||
4410964|NCT00233324|4236496|B4||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4410965|NCT00233324|4236497|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4410966|NCT00233324|4236498|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4410967|NCT00233324|4236499|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4410968|NCT00233324|4236495|B5|>23 weeks and <28 weeks gestational age||Age, Customized||participants|Number|1316|1316.0||||||
4410969|NCT00233324|4236496|B4|>23 weeks and <28 weeks gestational age||Age, Customized||participants|Number|335|335.0||||||
4410970|NCT00233324|4236497|B3|>23 weeks and <28 weeks gestational age||Age, Customized||participants|Number|318|318.0||||||
4410971|NCT00233324|4236498|B2|>23 weeks and <28 weeks gestational age||Age, Customized||participants|Number|327|327.0||||||
4410972|NCT00233324|4236499|B1|>23 weeks and <28 weeks gestational age||Age, Customized||participants|Number|336|336.0||||||
4410973|NCT00233103|4236516|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4410974|NCT00233103|4236517|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4410975|NCT00233103|4236518|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4410976|NCT00233103|4236516|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4410977|NCT00233103|4236517|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4410979|NCT00233103|4236516|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|10.9|10.9|||
4410980|NCT00233103|4236517|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|8.2|8.2|||
4410981|NCT00233103|4236518|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|12.8|12.8|||
4410982|NCT00233090|4236531|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4410983|NCT00233090|4236532|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4410984|NCT00233090|4236533|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4410985|NCT00233090|4236531|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4410986|NCT00233090|4236532|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4410987|NCT00233090|4236533|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4410988|NCT00233090|4236531|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4410989|NCT00233090|4236532|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4410990|NCT00233090|4236533|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4410991|NCT00233090|4236531|B3|||Age||years|Mean|53|53.0|Standard Deviation|12|12.0|||
4410992|NCT00233090|4236532|B2|||Age||years|Mean|54|54.0|Standard Deviation|13|13.0|||
4410993|NCT00233090|4236533|B1|||Age||years|Mean|52|52.0|Standard Deviation|12|12.0|||
4410994|NCT00233064|4236554|B3|||Weight at Day 0||Kilogram|Mean|5.205|5.205|Standard Deviation|2.270|2.27|||
4410995|NCT00233064|4236555|B2|||Weight at Day 0||Kilogram|Mean|5.079|5.079|Standard Deviation|2.264|2.264|||
4410996|NCT00233064|4236556|B1|||Weight at Day 0||Kilogram|Mean|5.326|5.326|Standard Deviation|2.274|2.274|||
4410997|NCT00233064|4236554|B3|||Gestational Age at Birth||Weeks|Mean|32.5|32.5|Standard Deviation|2.6|2.6|||
4410998|NCT00233064|4236555|B2|||Gestational Age at Birth||Weeks|Mean|32.7|32.7|Standard Deviation|2.5|2.5|||
4410999|NCT00233064|4236556|B1|||Gestational Age at Birth||Weeks|Mean|32.4|32.4|Standard Deviation|2.7|2.7|||
4411000|NCT00233064|4236554|B3|Other||Race/Ethnicity||Participants|Number|24|24.0||||||
4411001|NCT00233064|4236555|B2|Other||Race/Ethnicity||Participants|Number|12|12.0||||||
4411002|NCT00233064|4236556|B1|Other||Race/Ethnicity||Participants|Number|12|12.0||||||
4411003|NCT00233064|4236554|B3|Hispanic||Race/Ethnicity||Participants|Number|36|36.0||||||
4411004|NCT00233064|4236555|B2|Hispanic||Race/Ethnicity||Participants|Number|14|14.0||||||
4411005|NCT00233064|4236556|B1|Hispanic||Race/Ethnicity||Participants|Number|22|22.0||||||
4411006|NCT00233064|4236554|B3|Unknown or Not Reported||Race/Ethnicity||Participants|Number|0|0.0||||||
4411007|NCT00233064|4236555|B2|Unknown or Not Reported||Race/Ethnicity||Participants|Number|0|0.0||||||
4411008|NCT00233064|4236556|B1|Unknown or Not Reported||Race/Ethnicity||Participants|Number|0|0.0||||||
4411009|NCT00233064|4236554|B3|More than one race||Race/Ethnicity||Participants|Number|0|0.0||||||
4411010|NCT00233064|4236555|B2|More than one race||Race/Ethnicity||Participants|Number|0|0.0||||||
4411011|NCT00233064|4236556|B1|More than one race||Race/Ethnicity||Participants|Number|0|0.0||||||
4411012|NCT00233064|4236554|B3|White||Race/Ethnicity||Participants|Number|300|300.0||||||
4411013|NCT00233064|4236555|B2|White||Race/Ethnicity||Participants|Number|149|149.0||||||
4411014|NCT00233064|4236556|B1|White||Race/Ethnicity||Participants|Number|151|151.0||||||
4411015|NCT00233064|4236554|B3|Black or African American||Race/Ethnicity||Participants|Number|49|49.0||||||
4411016|NCT00233064|4236555|B2|Black or African American||Race/Ethnicity||Participants|Number|24|24.0||||||
4411017|NCT00233064|4236556|B1|Black or African American||Race/Ethnicity||Participants|Number|25|25.0||||||
4411018|NCT00233064|4236554|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity||Participants|Number|0|0.0||||||
4411019|NCT00233064|4236555|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity||Participants|Number|0|0.0||||||
4411020|NCT00233064|4236556|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity||Participants|Number|0|0.0||||||
4411021|NCT00233064|4236554|B3|Asian||Race/Ethnicity||Participants|Number|4|4.0||||||
4411022|NCT00233064|4236555|B2|Asian||Race/Ethnicity||Participants|Number|3|3.0||||||
4411023|NCT00233064|4236556|B1|Asian||Race/Ethnicity||Participants|Number|1|1.0||||||
4411024|NCT00233064|4236554|B3|American Indian or Alaska Native||Race/Ethnicity||Participants|Number|0|0.0||||||
4411025|NCT00233064|4236555|B2|American Indian or Alaska Native||Race/Ethnicity||Participants|Number|0|0.0||||||
4411026|NCT00233064|4236556|B1|American Indian or Alaska Native||Race/Ethnicity||Participants|Number|0|0.0||||||
4411027|NCT00233064|4236554|B3|No||Chronic Lung Disease at Prematurity||Participants|Number|352|352.0||||||
4411028|NCT00233064|4236555|B2|No||Chronic Lung Disease at Prematurity||Participants|Number|176|176.0||||||
4411029|NCT00233064|4236556|B1|No||Chronic Lung Disease at Prematurity||Participants|Number|176|176.0||||||
4411030|NCT00233064|4236554|B3|Yes||Chronic Lung Disease at Prematurity||Participants|Number|61|61.0||||||
4411031|NCT00233064|4236555|B2|Yes||Chronic Lung Disease at Prematurity||Participants|Number|26|26.0||||||
4411032|NCT00233064|4236556|B1|Yes||Chronic Lung Disease at Prematurity||Participants|Number|35|35.0||||||
4411033|NCT00233064|4236554|B3|United States||Region of Enrollment||participants|Number|413|413.0||||||
4411034|NCT00233064|4236555|B2|United States||Region of Enrollment||participants|Number|202|202.0||||||
4411035|NCT00233064|4236556|B1|United States||Region of Enrollment||participants|Number|211|211.0||||||
4411036|NCT00233064|4236554|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4411037|NCT00233064|4236555|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4411038|NCT00233064|4236556|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4411039|NCT00233064|4236554|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4411040|NCT00233064|4236555|B2||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4411041|NCT00233064|4236556|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4411042|NCT00233064|4236554|B3|||Age||months|Mean|4.29|4.29|Standard Deviation|4.34|4.34|||
4411043|NCT00233064|4236555|B2|||Age||months|Mean|4.00|4.0|Standard Deviation|4.16|4.16|||
4411044|NCT00233064|4236556|B1|||Age||months|Mean|4.56|4.56|Standard Deviation|4.50|4.5|||
4411045|NCT00232739|4236564|B1|N/A||History of Myocardial Infarction (MI)||participants|Number|6|6.0||||||
4411046|NCT00232739|4236564|B1|Without History of MI||History of Myocardial Infarction (MI)||participants|Number|61|61.0||||||
4411047|NCT00232739|4236564|B1|History of MI||History of Myocardial Infarction (MI)||participants|Number|33|33.0||||25.5|45.6|
4411048|NCT00232739|4236564|B1|Without Diabetes Mellitus||Diabetes Mellitus||participants|Number|60|60.0||||30.3|50.3|
4411049|NCT00232739|4236564|B1|Diabetes Mellitus||Diabetes Mellitus||participants|Number|40|40.0||||||
4411050|NCT00232739|4236564|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4411051|NCT00232739|4236564|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4411052|NCT00232739|4236564|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4411053|NCT00232739|4236564|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|9.90|9.9|||
4411054|NCT00232739|4236564|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4411055|NCT00232739|4236564|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4411056|NCT00232739|4236564|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411057|NCT00232596|4236581|B3|Mixed Race||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|16|16.0||||||
4411058|NCT00232596|4236582|B2|Mixed Race||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|8|8.0||||||
4411059|NCT00232596|4236583|B1|Mixed Race||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|8|8.0||||||
4411060|NCT00232596|4236581|B3|Mestizo||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|1|1.0||||||
4411061|NCT00232596|4236582|B2|Mestizo||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|0|0.0||||||
4411062|NCT00232596|4236583|B1|Mestizo||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|1|1.0||||||
4411063|NCT00232596|4236581|B3|American Indian||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|1|1.0||||||
4411064|NCT00232596|4236582|B2|American Indian||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|0|0.0||||||
4411065|NCT00232596|4236583|B1|American Indian||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|1|1.0||||||
4411066|NCT00232596|4236581|B3|Asian||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|2|2.0||||||
4411067|NCT00232596|4236582|B2|Asian||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|1|1.0||||||
4411068|NCT00232596|4236583|B1|Asian||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|1|1.0||||||
4411069|NCT00232596|4236581|B3|Hispanic||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|87|87.0||||||
4411070|NCT00232596|4236582|B2|Hispanic||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|39|39.0||||||
4411071|NCT00232596|4236583|B1|Hispanic||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|48|48.0||||||
4411072|NCT00232596|4236581|B3|African - American (Black)||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|30|30.0||||||
4411073|NCT00232596|4236582|B2|African - American (Black)||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|15|15.0||||||
4411074|NCT00232596|4236583|B1|African - American (Black)||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|15|15.0||||||
4411075|NCT00232596|4236581|B3|Caucasian||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|168|168.0||||||
4411076|NCT00232596|4236582|B2|Caucasian||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|90|90.0||||||
4411077|NCT00232596|4236583|B1|Caucasian||Race/Ethnicity, Customized|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|participants|Number|78|78.0||||||
4411078|NCT00232596|4236581|B3||Male|Gender|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|Participants|Count of Participants|140|140.0||||||
4411079|NCT00232596|4236582|B2||Male|Gender|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|Participants|Count of Participants|68|68.0||||||
4411080|NCT00232596|4236583|B1||Male|Gender|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|Participants|Count of Participants|72|72.0||||||
4411081|NCT00232596|4236581|B3||Female|Gender|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|Participants|Count of Participants|165|165.0||||||
4411082|NCT00232596|4236582|B2||Female|Gender|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|Participants|Count of Participants|85|85.0||||||
4411083|NCT00232596|4236583|B1||Female|Gender|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|Participants|Count of Participants|80|80.0||||||
4411084|NCT00232596|4236581|B3|||Age|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|Years|Mean|37.2|37.2|Standard Deviation|12.09|12.09|||
4411085|NCT00232596|4236582|B2|||Age|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|Years|Mean|37.7|37.7|Standard Deviation|12.55|12.55|||
4411086|NCT00232596|4236583|B1|||Age|Baseline characteristics were collected in the Safety Population, comprised of all participants who received at least one dose of study medication. One participant randomized to the Retigabine group did not receive study medication in the 6-week Titration Phase.|Years|Mean|36.7|36.7|Standard Deviation|11.63|11.63|||
4411087|NCT00232583|4236634|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4411088|NCT00232583|4236635|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4411089|NCT00232583|4236636|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4411090|NCT00232583|4236634|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4411091|NCT00232583|4236635|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4411092|NCT00232583|4236636|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4411093|NCT00232583|4236634|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4411094|NCT00232583|4236635|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4411095|NCT00232583|4236636|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4411096|NCT00232583|4236634|B3|||Age||years|Mean|44.9|44.9|Standard Deviation|10.1|10.1|||
4411097|NCT00232583|4236635|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|10.7|10.7|||
4411098|NCT00232583|4236636|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|9.7|9.7|||
4411099|NCT00232583|4236634|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411100|NCT00232583|4236635|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411101|NCT00232583|4236636|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411102|NCT00232583|4236634|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4411103|NCT00232583|4236635|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4411104|NCT00232583|4236636|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4411105|NCT00232583|4236634|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411106|NCT00232583|4236635|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411107|NCT00232583|4236636|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411108|NCT00232557|4236673|B3||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4411109|NCT00232557|4236674|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4411110|NCT00232557|4236675|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4411111|NCT00232557|4236673|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4411112|NCT00232557|4236674|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4411113|NCT00232557|4236675|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4411114|NCT00232557|4236673|B3|||Age||years|Mean|61.9|61.9|Standard Deviation|14.3|14.3|||
4411115|NCT00232557|4236674|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|14.3|14.3|||
4411116|NCT00232557|4236675|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|13.9|13.9|||
4411117|NCT00232544|4236684|B3|United States||Region of Enrollment||participants|Number|250|250.0||||||
4411118|NCT00232544|4236685|B2|United States||Region of Enrollment||participants|Number|126|126.0||||||
4411119|NCT00232544|4236686|B1|United States||Region of Enrollment||participants|Number|124|124.0||||||
4411120|NCT00232544|4236684|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4411121|NCT00232544|4236685|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4411122|NCT00232544|4236686|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4411123|NCT00232544|4236684|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4411124|NCT00232544|4236685|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4411125|NCT00232544|4236686|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4411126|NCT00232544|4236684|B3|||Age||years|Median|55|55.0|Inter-Quartile Range|||46.0|63.0|
4411127|NCT00232544|4236685|B2|||Age||years|Median|54|54.0|Inter-Quartile Range|||45.0|62.0|
4411128|NCT00232544|4236686|B1|||Age||years|Median|56|56.0|Inter-Quartile Range|||48.0|63.0|
4411129|NCT00232505|4236695|B3|Metastatic||Treatment||participants|Number|55|55.0||||||
4411130|NCT00232505|4236696|B2|Metastatic||Treatment||participants|Number|34|34.0||||||
4411131|NCT00232505|4236697|B1|Metastatic||Treatment||participants|Number|21|21.0||||||
4411132|NCT00232505|4236695|B3|Adjuvant/neoadjuvant||Treatment||participants|Number|86|86.0||||||
4411133|NCT00232505|4236696|B2|Adjuvant/neoadjuvant||Treatment||participants|Number|60|60.0||||||
4411134|NCT00232505|4236697|B1|Adjuvant/neoadjuvant||Treatment||participants|Number|26|26.0||||||
4411135|NCT00232505|4236695|B3|Prior chemotherapy||Treatment||participants|Number|97|97.0||||||
4411136|NCT00232505|4236696|B2|Prior chemotherapy||Treatment||participants|Number|67|67.0||||||
4411137|NCT00232505|4236697|B1|Prior chemotherapy||Treatment||participants|Number|30|30.0||||||
4411138|NCT00232505|4236695|B3||Other|Dominant metastatic site||Participants|Count of Participants|2|2.0||||||
4411139|NCT00232505|4236696|B2||Other|Dominant metastatic site||Participants|Count of Participants|1|1.0||||||
4411140|NCT00232505|4236697|B1||Other|Dominant metastatic site||Participants|Count of Participants|1|1.0||||||
4411141|NCT00232505|4236695|B3||Skin/soft tissue|Dominant metastatic site||Participants|Count of Participants|8|8.0||||||
4411142|NCT00232505|4236696|B2||Skin/soft tissue|Dominant metastatic site||Participants|Count of Participants|5|5.0||||||
4411143|NCT00232505|4236697|B1||Skin/soft tissue|Dominant metastatic site||Participants|Count of Participants|3|3.0||||||
4411144|NCT00232505|4236695|B3||Bone|Dominant metastatic site||Participants|Count of Participants|5|5.0||||||
4411145|NCT00232505|4236696|B2||Bone|Dominant metastatic site||Participants|Count of Participants|4|4.0||||||
4411146|NCT00232505|4236697|B1||Bone|Dominant metastatic site||Participants|Count of Participants|1|1.0||||||
4411147|NCT00232505|4236695|B3||Locoregional|Dominant metastatic site||Participants|Count of Participants|15|15.0||||||
4411148|NCT00232505|4236696|B2||Locoregional|Dominant metastatic site||Participants|Count of Participants|10|10.0||||||
4411149|NCT00232505|4236697|B1||Locoregional|Dominant metastatic site||Participants|Count of Participants|5|5.0||||||
4411150|NCT00232505|4236695|B3||Lymph nodes|Dominant metastatic site||Participants|Count of Participants|18|18.0||||||
4411151|NCT00232505|4236696|B2||Lymph nodes|Dominant metastatic site||Participants|Count of Participants|14|14.0||||||
4411152|NCT00232505|4236697|B1||Lymph nodes|Dominant metastatic site||Participants|Count of Participants|4|4.0||||||
4411153|NCT00232505|4236695|B3||Liver|Dominant metastatic site||Participants|Count of Participants|25|25.0||||||
4411154|NCT00232505|4236696|B2||Liver|Dominant metastatic site||Participants|Count of Participants|17|17.0||||||
4411155|NCT00232505|4236697|B1||Liver|Dominant metastatic site||Participants|Count of Participants|8|8.0||||||
4411156|NCT00232505|4236695|B3||Lung|Dominant metastatic site||Participants|Count of Participants|29|29.0||||||
4411157|NCT00232505|4236696|B2||Lung|Dominant metastatic site||Participants|Count of Participants|20|20.0||||||
4411158|NCT00232505|4236697|B1||Lung|Dominant metastatic site||Participants|Count of Participants|9|9.0||||||
4411159|NCT00232505|4236695|B3||Pre- or perimenopausal|Menopausal Status||Participants|Count of Participants|25|25.0||||||
4411160|NCT00232505|4236696|B2||Pre- or perimenopausal|Menopausal Status||Participants|Count of Participants|15|15.0||||||
4411161|NCT00232505|4236697|B1||Pre- or perimenopausal|Menopausal Status||Participants|Count of Participants|10|10.0||||||
4411162|NCT00232505|4236695|B3||Postmenopausal|Menopausal Status||Participants|Count of Participants|77|77.0||||||
4411163|NCT00232505|4236696|B2||Postmenopausal|Menopausal Status||Participants|Count of Participants|56|56.0||||||
4411164|NCT00232505|4236697|B1||Postmenopausal|Menopausal Status||Participants|Count of Participants|21|21.0||||||
4411165|NCT00232505|4236695|B3||missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|2|2.0||||||
4411166|NCT00232505|4236696|B2||missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|2|2.0||||||
4411167|NCT00232505|4236697|B1||missing|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|0|0.0||||||
4411168|NCT00232505|4236695|B3||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|4|4.0||||||
4411169|NCT00232505|4236696|B2||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|4|4.0||||||
4411170|NCT00232505|4236697|B1||2|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|0|0.0||||||
4411171|NCT00232505|4236695|B3||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|42|42.0||||||
4411172|NCT00232505|4236696|B2||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|28|28.0||||||
4411173|NCT00232505|4236697|B1||1|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|14|14.0||||||
4411174|NCT00232505|4236695|B3||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|54|54.0||||||
4411175|NCT00232505|4236696|B2||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|37|37.0||||||
4411176|NCT00232505|4236697|B1||0|Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale from 0-5 to describe a patient's level of functioning in terms of selfcare ability and activity level.~0, Fully active~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours"|Participants|Count of Participants|17|17.0||||||
4411177|NCT00232505|4236695|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4411178|NCT00232505|4236696|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4411179|NCT00232505|4236697|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4411180|NCT00232505|4236695|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411181|NCT00232505|4236696|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411182|NCT00232505|4236697|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411183|NCT00232505|4236695|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411184|NCT00232505|4236696|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411185|NCT00232505|4236697|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411186|NCT00232505|4236695|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4411187|NCT00232505|4236696|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4411188|NCT00232505|4236697|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4411189|NCT00232505|4236695|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4411190|NCT00232505|4236696|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4411191|NCT00232505|4236697|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4411192|NCT00232505|4236695|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411193|NCT00232505|4236696|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411194|NCT00232505|4236697|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411195|NCT00232505|4236695|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4411196|NCT00232505|4236696|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4411197|NCT00232505|4236697|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411198|NCT00232505|4236695|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4411199|NCT00232505|4236696|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4411200|NCT00232505|4236697|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4411201|NCT00232505|4236695|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411202|NCT00232505|4236696|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411203|NCT00232505|4236697|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411204|NCT00232505|4236695|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4411205|NCT00232505|4236696|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4411206|NCT00232505|4236697|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4411207|NCT00232505|4236695|B3|||Age||years|Median|50.5|50.5|Full Range|||28.0|83.0|
4411208|NCT00232505|4236696|B2|||Age||years|Median|52|52.0|Full Range|||28.0|83.0|
4411209|NCT00232505|4236697|B1|||Age||years|Median|49|49.0|Full Range|||33.0|71.0|
4411210|NCT00232479|4236711|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4411211|NCT00232479|4236711|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411212|NCT00232479|4236711|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4411213|NCT00232479|4236711|B1|||Age||years|Mean|51|51.0|Standard Deviation|5|5.0|||
4411214|NCT00232479|4236711|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4411215|NCT00232479|4236711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4411216|NCT00232479|4236711|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411217|NCT00232180|4236716|B3||Male|Sex: Female, Male||Participants|Count of Participants|2132|2132.0||||||
4411218|NCT00232180|4236717|B2||Male|Sex: Female, Male||Participants|Count of Participants|1074|1074.0||||||
4411219|NCT00232180|4236718|B1||Male|Sex: Female, Male||Participants|Count of Participants|1058|1058.0||||||
4411220|NCT00232180|4236716|B3||Female|Sex: Female, Male||Participants|Count of Participants|611|611.0||||||
4411221|NCT00232180|4236717|B2||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4411222|NCT00232180|4236718|B1||Female|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4411223|NCT00232180|4236716|B3|Greater than or equal to (>=) 85 years||Age, Customized||participants|Number|57|57.0||||||
4411224|NCT00232180|4236717|B2|Greater than or equal to (>=) 85 years||Age, Customized||participants|Number|29|29.0||||||
4411225|NCT00232180|4236718|B1|Greater than or equal to (>=) 85 years||Age, Customized||participants|Number|28|28.0||||||
4411226|NCT00232180|4236716|B3|75 to 84 years||Age, Customized||participants|Number|601|601.0||||||
4411227|NCT00232180|4236717|B2|75 to 84 years||Age, Customized||participants|Number|299|299.0||||||
4411228|NCT00232180|4236718|B1|75 to 84 years||Age, Customized||participants|Number|302|302.0||||||
4411229|NCT00232180|4236716|B3|65 to 74 years||Age, Customized||participants|Number|1201|1201.0||||||
4411230|NCT00232180|4236717|B2|65 to 74 years||Age, Customized||participants|Number|607|607.0||||||
4411231|NCT00232180|4236718|B1|65 to 74 years||Age, Customized||participants|Number|594|594.0||||||
4411232|NCT00232180|4236716|B3|Less than (<) 65 years||Age, Customized||participants|Number|884|884.0||||||
4411233|NCT00232180|4236717|B2|Less than (<) 65 years||Age, Customized||participants|Number|441|441.0||||||
4411234|NCT00232180|4236718|B1|Less than (<) 65 years||Age, Customized||participants|Number|443|443.0||||||
4411235|NCT00232141|4236763|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4411236|NCT00232141|4236764|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4411237|NCT00232141|4236765|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4411238|NCT00232141|4236763|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4411239|NCT00232141|4236764|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4411240|NCT00232141|4236765|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4411241|NCT00232141|4236763|B3|||Age||years|Mean|47.5|47.5|Standard Deviation|7.8|7.8|||
4411242|NCT00232141|4236764|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|7.5|7.5|||
4411243|NCT00232141|4236765|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|8.1|8.1|||
4411244|NCT00231894|4236834|B3|China||Region of Enrollment||participants|Number|10|10.0||||||
4411245|NCT00231894|4236835|B2|China||Region of Enrollment||participants|Number|5|5.0||||||
4411246|NCT00231894|4236836|B1|China||Region of Enrollment||participants|Number|5|5.0||||||
4411247|NCT00231894|4236834|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4411248|NCT00231894|4236835|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4411249|NCT00231894|4236836|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4411250|NCT00231894|4236834|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4411251|NCT00231894|4236835|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4411252|NCT00231894|4236836|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4411253|NCT00231894|4236834|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4411254|NCT00231894|4236835|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4411255|NCT00231894|4236836|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4411256|NCT00231894|4236834|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|9.8|9.8|||
4411257|NCT00231894|4236835|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|10.17|10.17|||
4411258|NCT00231894|4236836|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|9.06|9.06|||
4411259|NCT00231816|4236859|B3|White||Race/Ethnicity, Customized||participants|Number|519|519.0||||||
4411260|NCT00231816|4236860|B2|White||Race/Ethnicity, Customized||participants|Number|261|261.0||||||
4411261|NCT00231816|4236861|B1|White||Race/Ethnicity, Customized||participants|Number|258|258.0||||||
4411262|NCT00231816|4236859|B3|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4411263|NCT00231816|4236860|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4411264|NCT00231816|4236861|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4411265|NCT00231816|4236859|B3|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4411266|NCT00231816|4236860|B2|Multiracial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4411267|NCT00231816|4236861|B1|Multiracial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4411268|NCT00231816|4236859|B3|Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4411269|NCT00231816|4236860|B2|Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4411270|NCT00231816|4236861|B1|Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4411271|NCT00231816|4236859|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4411272|NCT00231816|4236860|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4411273|NCT00231816|4236861|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4411274|NCT00231816|4236859|B3|Black||Race/Ethnicity, Customized||participants|Number|206|206.0||||||
4411275|NCT00231816|4236860|B2|Black||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4411276|NCT00231816|4236861|B1|Black||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4411277|NCT00231816|4236859|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4411278|NCT00231816|4236860|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4411279|NCT00231816|4236861|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4411280|NCT00231816|4236859|B3|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4411281|NCT00231816|4236860|B2|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4411282|NCT00231816|4236861|B1|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4411283|NCT00231816|4236859|B3||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4411284|NCT00231816|4236860|B2||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4411285|NCT00231816|4236861|B1||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4411286|NCT00231816|4236859|B3||Female|Sex: Female, Male||Participants|Count of Participants|427|427.0||||||
4411287|NCT00231816|4236860|B2||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4411288|NCT00231816|4236861|B1||Female|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4411289|NCT00231816|4236859|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|8.11|8.11|||
4411290|NCT00231816|4236860|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|8.24|8.24|||
4411291|NCT00231816|4236861|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|7.99|7.99|||
4411292|NCT00231777|4236875|B3|White||Race/Ethnicity, Customized||participants|Number|155|155.0||||||
4411293|NCT00231777|4236876|B2|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4411294|NCT00231777|4236877|B1|White||Race/Ethnicity, Customized||participants|Number|124|124.0||||||
4411295|NCT00231777|4236875|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4411296|NCT00231777|4236876|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4411297|NCT00231777|4236877|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4411298|NCT00231777|4236875|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4411299|NCT00231777|4236876|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4411300|NCT00231777|4236877|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4411301|NCT00231777|4236875|B3|Black||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4411302|NCT00231777|4236876|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4411303|NCT00231777|4236877|B1|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4411304|NCT00231777|4236875|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4411305|NCT00231777|4236876|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4411306|NCT00231777|4236877|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4411307|NCT00231777|4236875|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4411308|NCT00231777|4236876|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4411309|NCT00231777|4236877|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4411310|NCT00231777|4236875|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4411311|NCT00231777|4236876|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4411312|NCT00231777|4236877|B1||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4411313|NCT00231777|4236875|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|10.59|10.59|||
4411314|NCT00231777|4236876|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|8.51|8.51|||
4411315|NCT00231777|4236877|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|11.01|11.01|||
4411316|NCT00231478|4236890|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4411317|NCT00231478|4236891|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4411318|NCT00231478|4236892|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4411319|NCT00231478|4236890|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4411320|NCT00231478|4236891|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4411321|NCT00231478|4236892|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4411322|NCT00231478|4236890|B3|||Age|The safety population was all evaluable population. The evaluable population consisted of 143 pediatric subjects from 2 to 16 years.|years|Mean|6.1|6.1|Standard Deviation|3.24|3.24|||
4411323|NCT00231478|4236891|B2|||Age|The safety population was all evaluable population. The evaluable population consisted of 143 pediatric subjects from 2 to 16 years.|years|Mean|6.2|6.2|Standard Deviation|3.12|3.12|||
4411324|NCT00231478|4236892|B1|||Age|The safety population was all evaluable population. The evaluable population consisted of 143 pediatric subjects from 2 to 16 years.|years|Mean|6.0|6.0|Standard Deviation|3.37|3.37|||
4411325|NCT00231465|4236905|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4411326|NCT00231465|4236905|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4411327|NCT00231465|4236905|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4411328|NCT00231465|4236905|B1|||Age, Customized||years|Median|75|75.0|Full Range|||70.0|84.0|
4411329|NCT00231309|4236911|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4411330|NCT00231309|4236911|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4411331|NCT00231309|4236911|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411332|NCT00231309|4236911|B1|||Age||years|Mean|11.47|11.47|Standard Deviation|4.78|4.78|||
4411333|NCT00231309|4236911|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411334|NCT00231309|4236911|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4411335|NCT00231309|4236911|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4411336|NCT00231283|4236916|B1|Without Diabetes Mellitus||Patients with Diabetes Mellitus||participants|Number|75|75.0||||||
4411337|NCT00231283|4236916|B1|With Diabetes Mellitus||Patients with Diabetes Mellitus||participants|Number|25|25.0||||||
4411338|NCT00231283|4236916|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4411339|NCT00231283|4236916|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4411340|NCT00231283|4236916|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4411341|NCT00231283|4236916|B1|||Age||years|Mean|64.39|64.39|Standard Deviation|10.80|10.8|||
4411342|NCT00231283|4236916|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4411343|NCT00231283|4236916|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4411344|NCT00231283|4236916|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411345|NCT00231179|4236923|B3|United States||Region of Enrollment||participants|Number|302|302.0||||||
4411346|NCT00231179|4236924|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
4411347|NCT00231179|4236925|B1|United States||Region of Enrollment||participants|Number|152|152.0||||||
4411348|NCT00231179|4236923|B3||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4411349|NCT00231179|4236924|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4411350|NCT00231179|4236925|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4411351|NCT00231179|4236923|B3||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4411352|NCT00231179|4236924|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4411353|NCT00231179|4236925|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4411354|NCT00231179|4236923|B3|4-5 years||Age, Customized||participants|Number|302|302.0||||||
4411355|NCT00231179|4236924|B2|4-5 years||Age, Customized||participants|Number|150|150.0||||||
4411356|NCT00231179|4236925|B1|4-5 years||Age, Customized||participants|Number|152|152.0||||||
4411357|NCT00231153|4236940|B3|Europe||Region of Enrollment||participants|Number|1085|1085.0||||||
4411358|NCT00231153|4236941|B2|Europe||Region of Enrollment||participants|Number|542|542.0||||||
4411359|NCT00231153|4236942|B1|Europe||Region of Enrollment||participants|Number|543|543.0||||||
4411360|NCT00231153|4236940|B3|United States||Region of Enrollment||participants|Number|730|730.0||||||
4411361|NCT00231153|4236941|B2|United States||Region of Enrollment||participants|Number|366|366.0||||||
4411362|NCT00231153|4236942|B1|United States||Region of Enrollment||participants|Number|364|364.0||||||
4411363|NCT00231153|4236940|B3||Male|Sex: Female, Male||Participants|Count of Participants|1103|1103.0||||||
4411364|NCT00231153|4236941|B2||Male|Sex: Female, Male||Participants|Count of Participants|546|546.0||||||
4411365|NCT00231153|4236942|B1||Male|Sex: Female, Male||Participants|Count of Participants|557|557.0||||||
4411366|NCT00231153|4236940|B3||Female|Sex: Female, Male||Participants|Count of Participants|712|712.0||||||
4411367|NCT00231153|4236941|B2||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4411368|NCT00231153|4236942|B1||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4411369|NCT00231153|4236940|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|17.00|17.0|||
4411370|NCT00231153|4236941|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|17.17|17.17|||
4411371|NCT00231153|4236942|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|16.82|16.82|||
4411372|NCT00231153|4236940|B3||>=65 years|Age||Participants|Count of Participants|820|820.0||||||
4411373|NCT00231153|4236941|B2||>=65 years|Age||Participants|Count of Participants|402|402.0||||||
4411374|NCT00231153|4236942|B1||>=65 years|Age||Participants|Count of Participants|418|418.0||||||
4411375|NCT00231153|4236940|B3||Between 18 and 65 years|Age||Participants|Count of Participants|987|987.0||||||
4411376|NCT00231153|4236941|B2||Between 18 and 65 years|Age||Participants|Count of Participants|499|499.0||||||
4411377|NCT00231153|4236942|B1||Between 18 and 65 years|Age||Participants|Count of Participants|488|488.0||||||
4411378|NCT00231153|4236940|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4411379|NCT00231153|4236941|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4411380|NCT00231153|4236942|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4411381|NCT00231114|4236951|B3|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4411382|NCT00231114|4236952|B2|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4411383|NCT00231114|4236953|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4411384|NCT00231114|4236951|B3|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4411385|NCT00231114|4236952|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4411386|NCT00231114|4236953|B1|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4411387|NCT00231114|4236951|B3|United Kingdom||Region of Enrollment||participants|Number|43|43.0||||||
4411388|NCT00231114|4236952|B2|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4411389|NCT00231114|4236953|B1|United Kingdom||Region of Enrollment||participants|Number|28|28.0||||||
4411390|NCT00231114|4236951|B3|Brazil||Region of Enrollment||participants|Number|84|84.0||||||
4411391|NCT00231114|4236952|B2|Brazil||Region of Enrollment||participants|Number|29|29.0||||||
4411392|NCT00231114|4236953|B1|Brazil||Region of Enrollment||participants|Number|55|55.0||||||
4411393|NCT00231114|4236951|B3|Canada||Region of Enrollment||participants|Number|53|53.0||||||
4411394|NCT00231114|4236952|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4411395|NCT00231114|4236953|B1|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4411396|NCT00231114|4236951|B3|United States||Region of Enrollment||participants|Number|88|88.0||||||
4411397|NCT00231114|4236952|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4411398|NCT00231114|4236953|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4411399|NCT00231114|4236951|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4411400|NCT00231114|4236952|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4411401|NCT00231114|4236953|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4411402|NCT00231114|4236951|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4411403|NCT00231114|4236952|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4411404|NCT00231114|4236953|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4411405|NCT00231114|4236951|B3|||Age||years|Mean|40.65|40.65|Standard Deviation|11.86|11.86|||
4411406|NCT00231114|4236952|B2|||Age||years|Mean|40.6|40.6|Standard Deviation|11.85|11.85|||
4411407|NCT00231114|4236953|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|11.89|11.89|||
4411408|NCT00231062|4236990|B1|United States||Region of Enrollment||participants|Number|115|115.0||||||
4411409|NCT00231062|4236990|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4411410|NCT00231062|4236990|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4411411|NCT00231062|4236990|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|12.59|12.59|||
4411412|NCT00231062|4236990|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4411413|NCT00231062|4236990|B1||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4411414|NCT00231062|4236990|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411415|NCT00230971|4236996|B3||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4411416|NCT00230971|4236997|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4411417|NCT00230971|4236998|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4411418|NCT00230971|4236996|B3||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4411419|NCT00230971|4236997|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4411420|NCT00230971|4236998|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4411421|NCT00230971|4236996|B3|||Age||years|Mean|47.67|47.67|Standard Deviation|18.37|18.37|||
4411422|NCT00230971|4236997|B2|||Age||years|Mean|46.81|46.81|Standard Deviation|18.38|18.38|||
4411423|NCT00230971|4236998|B1|||Age||years|Mean|48.55|48.55|Standard Deviation|18.37|18.37|||
4411424|NCT00230802|4237011|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4411425|NCT00230802|4237012|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4411426|NCT00230802|4237013|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4411427|NCT00230802|4237011|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4411428|NCT00230802|4237012|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4411429|NCT00230802|4237013|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4411430|NCT00230802|4237011|B3||Female|Gender||Participants|Count of Participants|48|48.0||||||
4411431|NCT00230802|4237012|B2||Female|Gender||Participants|Count of Participants|23|23.0||||||
4411432|NCT00230802|4237013|B1||Female|Gender||Participants|Count of Participants|25|25.0||||||
4411433|NCT00230802|4237011|B3|||Age||years|Mean|29|29.0|Standard Deviation|5|5.0|||
4411434|NCT00230802|4237012|B2|||Age||years|Mean|28|28.0|Standard Deviation|5|5.0|||
4411435|NCT00230802|4237013|B1|||Age||years|Mean|29|29.0|Standard Deviation|3|3.0|||
4411436|NCT00230802|4237011|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411437|NCT00230802|4237012|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411438|NCT00230802|4237013|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411439|NCT00230802|4237011|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4411440|NCT00230802|4237012|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4411441|NCT00230802|4237013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4411442|NCT00230802|4237011|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411443|NCT00230802|4237012|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411444|NCT00230802|4237013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411445|NCT00230737|4237024|B4|United States||Region of Enrollment||participants|Number|27|27.0||||||
4411446|NCT00230737|4237025|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4411447|NCT00230737|4237026|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4411448|NCT00230737|4237027|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4411449|NCT00230737|4237024|B4||Male|Gender||Participants|Count of Participants|7|7.0||||||
4411450|NCT00230737|4237025|B3||Male|Gender||Participants|Count of Participants|1|1.0||||||
4411451|NCT00230737|4237026|B2||Male|Gender||Participants|Count of Participants|3|3.0||||||
4411452|NCT00230737|4237027|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
4411453|NCT00230737|4237024|B4||Female|Gender||Participants|Count of Participants|20|20.0||||||
4411454|NCT00230737|4237025|B3||Female|Gender||Participants|Count of Participants|7|7.0||||||
4411455|NCT00230737|4237026|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
4411456|NCT00230737|4237027|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4411457|NCT00230737|4237024|B4|||Age||years|Mean|74.6|74.6|Standard Deviation|5.6|5.6|||
4411458|NCT00230737|4237025|B3|||Age||years|Mean|75.1|75.1|Standard Deviation|6.2|6.2|||
4411459|NCT00230737|4237026|B2|||Age||years|Mean|75.7|75.7|Standard Deviation|4.7|4.7|||
4411460|NCT00230737|4237027|B1|||Age||years|Mean|73|73.0|Standard Deviation|5.9|5.9|||
4411461|NCT00230282|4237037|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4411462|NCT00230282|4237037|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4411463|NCT00230282|4237037|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4411464|NCT00230282|4237037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4411465|NCT00230282|4237037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411466|NCT00230178|4237042|B4||Male|Sex: Female, Male||Participants|Count of Participants|174.0|174.0||||||
4411467|NCT00230178|4237043|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4411468|NCT00230178|4237044|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4411469|NCT00230178|4237045|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4411470|NCT00230178|4237042|B4||Female|Sex: Female, Male||Participants|Count of Participants|106.0|106.0||||||
4411471|NCT00230178|4237043|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4411472|NCT00230178|4237044|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4411473|NCT00230178|4237045|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4411474|NCT00230178|4237042|B4|>=65 years||Age, Customized||participants|Number|83.0|83.0||||||
4411475|NCT00230178|4237043|B3|>=65 years||Age, Customized||participants|Number|24|24.0||||||
4411476|NCT00230178|4237044|B2|>=65 years||Age, Customized||participants|Number|28|28.0||||||
4411477|NCT00230178|4237045|B1|>=65 years||Age, Customized||participants|Number|31|31.0||||||
4411478|NCT00230178|4237042|B4|<65 years||Age, Customized||participants|Number|197.0|197.0||||||
4411479|NCT00230178|4237043|B3|<65 years||Age, Customized||participants|Number|69|69.0||||||
4411480|NCT00230178|4237044|B2|<65 years||Age, Customized||participants|Number|65|65.0||||||
4411481|NCT00230178|4237045|B1|<65 years||Age, Customized||participants|Number|63|63.0||||||
4411482|NCT00230126|4237061|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4411483|NCT00230126|4237062|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4411484|NCT00230126|4237063|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4411485|NCT00230126|4237061|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4411486|NCT00230126|4237062|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4411487|NCT00230126|4237063|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4411488|NCT00230126|4237061|B3|||Age||years|Median|62|62.0|Full Range|||29.0|96.0|
4411489|NCT00230126|4237062|B2|||Age||years|Median|59|59.0|Full Range|||37.0|96.0|
4411490|NCT00230126|4237063|B1|||Age||years|Median|63|63.0|Full Range|||29.0|83.0|
4411491|NCT00230100|4237074|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4411492|NCT00230100|4237075|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4411493|NCT00230100|4237076|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4411494|NCT00230100|4237074|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411495|NCT00230100|4237075|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411496|NCT00230100|4237076|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411497|NCT00230100|4237074|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411498|NCT00230100|4237075|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411499|NCT00230100|4237076|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411500|NCT00230100|4237074|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4411501|NCT00230100|4237075|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4411502|NCT00230100|4237076|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4411503|NCT00230100|4237074|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411504|NCT00230100|4237075|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411505|NCT00230100|4237076|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411506|NCT00230100|4237074|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411507|NCT00230100|4237075|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411508|NCT00230100|4237076|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411509|NCT00230100|4237074|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411510|NCT00230100|4237075|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411511|NCT00230100|4237076|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411512|NCT00230100|4237074|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4411513|NCT00230100|4237075|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4411514|NCT00230100|4237076|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4411515|NCT00230100|4237074|B3||Male|Gender||Participants|Count of Participants|10|10.0||||||
4411516|NCT00230100|4237075|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
4411517|NCT00230100|4237076|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4411518|NCT00230100|4237074|B3||Female|Gender||Participants|Count of Participants|36|36.0||||||
4411519|NCT00230100|4237075|B2||Female|Gender||Participants|Count of Participants|7|7.0||||||
4411520|NCT00230100|4237076|B1||Female|Gender||Participants|Count of Participants|29|29.0||||||
4411521|NCT00230100|4237074|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|11.5|11.5|||
4411522|NCT00230100|4237075|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|12.5|12.5|||
4411523|NCT00230100|4237076|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|10.73|10.73|||
4411524|NCT00230048|4237097|B3|United States||Region of Enrollment||participants|Number|107|107.0||||||
4411525|NCT00230048|4237098|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4411526|NCT00230048|4237099|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4411527|NCT00230048|4237097|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411528|NCT00230048|4237098|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411529|NCT00230048|4237099|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411530|NCT00230048|4237097|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4411531|NCT00230048|4237098|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4411532|NCT00230048|4237099|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4411533|NCT00230048|4237097|B3|||Age||years|Mean|25.1|25.1|Standard Deviation|5.6|5.6|||
4411534|NCT00230048|4237098|B2|||Age||years|Mean|25.9|25.9|Standard Deviation|5.7|5.7|||
4411535|NCT00230048|4237099|B1|||Age||years|Mean|24.2|24.2|Standard Deviation|5.4|5.4|||
4411536|NCT00230048|4237097|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411537|NCT00230048|4237098|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411538|NCT00230048|4237099|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411539|NCT00230048|4237097|B3||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4411540|NCT00230048|4237098|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4411541|NCT00230048|4237099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4411542|NCT00230048|4237097|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411543|NCT00230048|4237098|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411544|NCT00230048|4237099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411545|NCT00230022|4237108|B3|||Baseline motivation|Visual analog scale questions were used to assess baseline motivation, self-efficacy, problem recognition, and change likelihood. The average of the items were calculated for baseline measurement resulting in a score ranging from 1 to 100. Higher scores represent increase motivation for change, self-efficacy, problem recognition and increased likelihood of making a change.|units on a scale|Mean|81.0|81.0|Standard Deviation|20.3|20.3|||
4411546|NCT00230022|4237109|B2|||Baseline motivation|Visual analog scale questions were used to assess baseline motivation, self-efficacy, problem recognition, and change likelihood. The average of the items were calculated for baseline measurement resulting in a score ranging from 1 to 100. Higher scores represent increase motivation for change, self-efficacy, problem recognition and increased likelihood of making a change.|units on a scale|Mean|79.5|79.5|Standard Deviation|21.2|21.2|||
4411547|NCT00230022|4237110|B1|||Baseline motivation|Visual analog scale questions were used to assess baseline motivation, self-efficacy, problem recognition, and change likelihood. The average of the items were calculated for baseline measurement resulting in a score ranging from 1 to 100. Higher scores represent increase motivation for change, self-efficacy, problem recognition and increased likelihood of making a change.|units on a scale|Mean|82.5|82.5|Standard Deviation|18.9|18.9|||
4411548|NCT00230022|4237108|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4411549|NCT00230022|4237109|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4411550|NCT00230022|4237110|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4411551|NCT00230022|4237108|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411552|NCT00230022|4237109|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411553|NCT00230022|4237110|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411554|NCT00230022|4237108|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4411555|NCT00230022|4237109|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4411556|NCT00230022|4237110|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4411557|NCT00230022|4237108|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411558|NCT00230022|4237109|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411559|NCT00230022|4237110|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411560|NCT00230022|4237108|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4411561|NCT00230022|4237109|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4411562|NCT00230022|4237110|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4411563|NCT00230022|4237108|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411564|NCT00230022|4237109|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411565|NCT00230022|4237110|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411566|NCT00230009|4237117|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4411567|NCT00230009|4237118|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4411568|NCT00230009|4237119|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4411569|NCT00230009|4237117|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411570|NCT00230009|4237118|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411571|NCT00230009|4237119|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411572|NCT00230009|4237117|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4411573|NCT00230009|4237118|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4411574|NCT00230009|4237119|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4411575|NCT00230009|4237117|B3|||Age||years|Mean|23.1|23.1|Standard Deviation|4.4|4.4|||
4411576|NCT00230009|4237118|B2|||Age||years|Mean|23.6|23.6|Standard Deviation|4.5|4.5|||
4411577|NCT00230009|4237119|B1|||Age||years|Mean|22.6|22.6|Standard Deviation|4.4|4.4|||
4411578|NCT00230009|4237117|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411579|NCT00230009|4237118|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411580|NCT00230009|4237119|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411581|NCT00230009|4237117|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4411582|NCT00230009|4237118|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4411583|NCT00230009|4237119|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4411584|NCT00230009|4237117|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411585|NCT00230009|4237118|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411586|NCT00230009|4237119|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411587|NCT00229970|4237134|B4|||Duration of Asthma||Years|Mean|17.3|17.3|Standard Deviation|11.6|11.6|||
4411588|NCT00229970|4237135|B3|||Duration of Asthma||Years|Mean|17.7|17.7|Standard Deviation|11.7|11.7|||
4411589|NCT00229970|4237136|B2|||Duration of Asthma||Years|Mean|15.46|15.46|Standard Deviation|11.6|11.6|||
4411590|NCT00229970|4237137|B1|||Duration of Asthma||Years|Mean|18.7|18.7|Standard Deviation|11.5|11.5|||
4411591|NCT00229970|4237134|B4|||Baseline Forced Expiratory Volume in One Second (FEV1)||Liter|Mean|1.68|1.68|Standard Deviation|0.58|0.58|||
4411592|NCT00229970|4237135|B3|||Baseline Forced Expiratory Volume in One Second (FEV1)||Liter|Mean|1.76|1.76|Standard Deviation|0.61|0.61|||
4411593|NCT00229970|4237136|B2|||Baseline Forced Expiratory Volume in One Second (FEV1)||Liter|Mean|1.62|1.62|Standard Deviation|0.59|0.59|||
4411594|NCT00229970|4237137|B1|||Baseline Forced Expiratory Volume in One Second (FEV1)||Liter|Mean|1.67|1.67|Standard Deviation|0.55|0.55|||
4411595|NCT00229970|4237134|B4|Serious||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|0|0.0||||||
4411596|NCT00229970|4237135|B3|Serious||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|0|0.0||||||
4411597|NCT00229970|4237136|B2|Serious||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|0|0.0||||||
4411598|NCT00229970|4237137|B1|Serious||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|0|0.0||||||
4411599|NCT00229970|4237134|B4|Severe||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|1|1.0||||||
4411600|NCT00229970|4237135|B3|Severe||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|0|0.0||||||
4411601|NCT00229970|4237136|B2|Severe||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|0|0.0||||||
4411602|NCT00229970|4237137|B1|Severe||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|1|1.0||||||
4411603|NCT00229970|4237134|B4|Moderate||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|70|70.0||||||
4411604|NCT00229970|4237135|B3|Moderate||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|19|19.0||||||
4411605|NCT00229970|4237136|B2|Moderate||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|28|28.0||||||
4411606|NCT00229970|4237137|B1|Moderate||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|23|23.0||||||
4411607|NCT00229970|4237134|B4|Mild||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|154|154.0||||||
4411608|NCT00229970|4237135|B3|Mild||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|56|56.0||||||
4411609|NCT00229970|4237136|B2|Mild||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|44|44.0||||||
4411610|NCT00229970|4237137|B1|Mild||Asthma Attack Severity based on Asthma Prevention and Management Guideline 2003, Japan|Mild (Peak Expiratory Flow: 70%-80%), Moderate (Peak Expiratory Flow: 50%-70%), Severe (Peak Expiratory Flow: <=50%) or Serious (Peak Expiratory Flow: incapable measurement, cyanosis, head trip, disturbed consciousness, incontinence or asphyxia)|participants|Number|54|54.0||||||
4411611|NCT00229970|4237134|B4||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4411612|NCT00229970|4237135|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4411613|NCT00229970|4237136|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4411614|NCT00229970|4237137|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4411615|NCT00229970|4237134|B4||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4411616|NCT00229970|4237135|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4411617|NCT00229970|4237136|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4411618|NCT00229970|4237137|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4411619|NCT00229970|4237134|B4|||Age||years|Mean|41.4|41.4|Standard Deviation|12.7|12.7|||
4411620|NCT00229970|4237135|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|12.5|12.5|||
4411621|NCT00229970|4237136|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|13.1|13.1|||
4411622|NCT00229970|4237137|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|12.5|12.5|||
4411623|NCT00229957|4237147|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4411624|NCT00229957|4237148|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4411625|NCT00229957|4237149|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4411626|NCT00229957|4237147|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4411627|NCT00229957|4237148|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4411628|NCT00229957|4237149|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4411629|NCT00229957|4237147|B3||>=65 years|Age||Participants|Count of Participants|131|131.0||||||
4411630|NCT00229957|4237148|B2||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
4411631|NCT00229957|4237149|B1||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4411632|NCT00229957|4237147|B3||Between 18 and 65 years|Age||Participants|Count of Participants|172|172.0||||||
4411633|NCT00229957|4237148|B2||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4411634|NCT00229957|4237149|B1||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4411635|NCT00229957|4237147|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411636|NCT00229957|4237148|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411637|NCT00229957|4237149|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411638|NCT00229931|4237156|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4411639|NCT00229931|4237157|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4411640|NCT00229931|4237158|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4411641|NCT00229931|4237156|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4411642|NCT00229931|4237157|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4411643|NCT00229931|4237158|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411644|NCT00229931|4237156|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4411645|NCT00229931|4237157|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4411646|NCT00229931|4237158|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4411647|NCT00229931|4237156|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4411648|NCT00229931|4237157|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4411649|NCT00229931|4237158|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4411650|NCT00229931|4237156|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4411651|NCT00229931|4237157|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4411652|NCT00229931|4237158|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4411653|NCT00229931|4237156|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411654|NCT00229931|4237157|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411655|NCT00229931|4237158|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411656|NCT00229723|4237167|B8|Not recorded||WHO Performance Status||Participants|Number|18|18.0||||||
4411657|NCT00229723|4237168|B7|Not recorded||WHO Performance Status||Participants|Number|1|1.0||||||
4411658|NCT00229723|4237169|B6|Not recorded||WHO Performance Status||Participants|Number|4|4.0||||||
4411659|NCT00229723|4237170|B5|Not recorded||WHO Performance Status||Participants|Number|1|1.0||||||
4411660|NCT00229723|4237171|B4|Not recorded||WHO Performance Status||Participants|Number|3|3.0||||||
4411661|NCT00229723|4237172|B3|Not recorded||WHO Performance Status||Participants|Number|1|1.0||||||
4411662|NCT00229723|4237173|B2|Not recorded||WHO Performance Status||Participants|Number|2|2.0||||||
4411663|NCT00229723|4237174|B1|Not recorded||WHO Performance Status||Participants|Number|6|6.0||||||
4411664|NCT00229723|4237167|B8|4 (100% Bed ridden)||WHO Performance Status||Participants|Number|0|0.0||||||
4411665|NCT00229723|4237168|B7|4 (100% Bed ridden)||WHO Performance Status||Participants|Number|0|0.0||||||
4411666|NCT00229723|4237169|B6|4 (100% Bed ridden)||WHO Performance Status||Participants|Number|0|0.0||||||
4411667|NCT00229723|4237170|B5|4 (100% Bed ridden)||WHO Performance Status||Participants|Number|0|0.0||||||
4411668|NCT00229723|4237171|B4|4 (100% Bed ridden)||WHO Performance Status||Participants|Number|0|0.0||||||
4411669|NCT00229723|4237172|B3|4 (100% Bed ridden)||WHO Performance Status||Participants|Number|0|0.0||||||
4411670|NCT00229723|4237173|B2|4 (100% Bed ridden)||WHO Performance Status||Participants|Number|0|0.0||||||
4411671|NCT00229723|4237174|B1|4 (100% Bed ridden)||WHO Performance Status||Participants|Number|0|0.0||||||
4411672|NCT00229723|4237167|B8|3 (in bed > 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411673|NCT00229723|4237168|B7|3 (in bed > 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411674|NCT00229723|4237169|B6|3 (in bed > 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411675|NCT00229723|4237170|B5|3 (in bed > 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411676|NCT00229723|4237171|B4|3 (in bed > 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411677|NCT00229723|4237172|B3|3 (in bed > 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411678|NCT00229723|4237173|B2|3 (in bed > 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411679|NCT00229723|4237174|B1|3 (in bed > 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411680|NCT00229723|4237167|B8|2 (in bed ≤ 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411681|NCT00229723|4237168|B7|2 (in bed ≤ 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411682|NCT00229723|4237169|B6|2 (in bed ≤ 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411683|NCT00229723|4237170|B5|2 (in bed ≤ 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411684|NCT00229723|4237171|B4|2 (in bed ≤ 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411685|NCT00229723|4237172|B3|2 (in bed ≤ 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411686|NCT00229723|4237173|B2|2 (in bed ≤ 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411687|NCT00229723|4237174|B1|2 (in bed ≤ 50% of the time)||WHO Performance Status||Participants|Number|0|0.0||||||
4411688|NCT00229723|4237167|B8|1 (Restricted activity)||WHO Performance Status||Participants|Number|48|48.0||||||
4411689|NCT00229723|4237168|B7|1 (Restricted activity)||WHO Performance Status||Participants|Number|5|5.0||||||
4411690|NCT00229723|4237169|B6|1 (Restricted activity)||WHO Performance Status||Participants|Number|6|6.0||||||
4411691|NCT00229723|4237170|B5|1 (Restricted activity)||WHO Performance Status||Participants|Number|6|6.0||||||
4411692|NCT00229723|4237171|B4|1 (Restricted activity)||WHO Performance Status||Participants|Number|4|4.0||||||
4411693|NCT00229723|4237172|B3|1 (Restricted activity)||WHO Performance Status||Participants|Number|6|6.0||||||
4411694|NCT00229723|4237173|B2|1 (Restricted activity)||WHO Performance Status||Participants|Number|8|8.0||||||
4411695|NCT00229723|4237174|B1|1 (Restricted activity)||WHO Performance Status||Participants|Number|13|13.0||||||
4411696|NCT00229723|4237167|B8|0 (Normal activity)||WHO Performance Status||Participants|Number|160|160.0||||||
4411697|NCT00229723|4237168|B7|0 (Normal activity)||WHO Performance Status||Participants|Number|16|16.0||||||
4411698|NCT00229723|4237169|B6|0 (Normal activity)||WHO Performance Status||Participants|Number|24|24.0||||||
4411699|NCT00229723|4237170|B5|0 (Normal activity)||WHO Performance Status||Participants|Number|17|17.0||||||
4411700|NCT00229723|4237171|B4|0 (Normal activity)||WHO Performance Status||Participants|Number|24|24.0||||||
4411701|NCT00229723|4237172|B3|0 (Normal activity)||WHO Performance Status||Participants|Number|24|24.0||||||
4411702|NCT00229723|4237173|B2|0 (Normal activity)||WHO Performance Status||Participants|Number|14|14.0||||||
4411703|NCT00229723|4237174|B1|0 (Normal activity)||WHO Performance Status||Participants|Number|41|41.0||||||
4411704|NCT00229723|4237167|B8|Stage IV (All these patients had Stage IVa cancer)||Stage of disease at entry to study||Participants|Number|177|177.0||||||
4411705|NCT00229723|4237168|B7|Stage IV (All these patients had Stage IVa cancer)||Stage of disease at entry to study||Participants|Number|14|14.0||||||
4411706|NCT00229723|4237169|B6|Stage IV (All these patients had Stage IVa cancer)||Stage of disease at entry to study||Participants|Number|28|28.0||||||
4411707|NCT00229723|4237170|B5|Stage IV (All these patients had Stage IVa cancer)||Stage of disease at entry to study||Participants|Number|20|20.0||||||
4411708|NCT00229723|4237171|B4|Stage IV (All these patients had Stage IVa cancer)||Stage of disease at entry to study||Participants|Number|24|24.0||||||
4411709|NCT00229723|4237172|B3|Stage IV (All these patients had Stage IVa cancer)||Stage of disease at entry to study||Participants|Number|24|24.0||||||
4411710|NCT00229723|4237173|B2|Stage IV (All these patients had Stage IVa cancer)||Stage of disease at entry to study||Participants|Number|17|17.0||||||
4411711|NCT00229723|4237174|B1|Stage IV (All these patients had Stage IVa cancer)||Stage of disease at entry to study||Participants|Number|50|50.0||||||
4411712|NCT00229723|4237167|B8|Stage III||Stage of disease at entry to study||Participants|Number|49|49.0||||||
4411713|NCT00229723|4237168|B7|Stage III||Stage of disease at entry to study||Participants|Number|8|8.0||||||
4411714|NCT00229723|4237169|B6|Stage III||Stage of disease at entry to study||Participants|Number|6|6.0||||||
4411715|NCT00229723|4237170|B5|Stage III||Stage of disease at entry to study||Participants|Number|4|4.0||||||
4411716|NCT00229723|4237171|B4|Stage III||Stage of disease at entry to study||Participants|Number|7|7.0||||||
4411717|NCT00229723|4237172|B3|Stage III||Stage of disease at entry to study||Participants|Number|7|7.0||||||
4411718|NCT00229723|4237173|B2|Stage III||Stage of disease at entry to study||Participants|Number|7|7.0||||||
4411719|NCT00229723|4237174|B1|Stage III||Stage of disease at entry to study||Participants|Number|10|10.0||||||
4411720|NCT00229723|4237167|B8|Other||Original site of primary cancer||Participants|Number|7|7.0||||||
4411721|NCT00229723|4237168|B7|Other||Original site of primary cancer||Participants|Number|2|2.0||||||
4411722|NCT00229723|4237169|B6|Other||Original site of primary cancer||Participants|Number|1|1.0||||||
4411723|NCT00229723|4237170|B5|Other||Original site of primary cancer||Participants|Number|1|1.0||||||
4411724|NCT00229723|4237171|B4|Other||Original site of primary cancer||Participants|Number|0|0.0||||||
4411725|NCT00229723|4237172|B3|Other||Original site of primary cancer||Participants|Number|1|1.0||||||
4411726|NCT00229723|4237173|B2|Other||Original site of primary cancer||Participants|Number|1|1.0||||||
4411727|NCT00229723|4237174|B1|Other||Original site of primary cancer||Participants|Number|1|1.0||||||
4411728|NCT00229723|4237167|B8|Oropharynx / Hypopharynx||Original site of primary cancer||Participants|Number|1|1.0||||||
4411729|NCT00229723|4237168|B7|Oropharynx / Hypopharynx||Original site of primary cancer||Participants|Number|0|0.0||||||
4411730|NCT00229723|4237169|B6|Oropharynx / Hypopharynx||Original site of primary cancer||Participants|Number|0|0.0||||||
4411731|NCT00229723|4237170|B5|Oropharynx / Hypopharynx||Original site of primary cancer||Participants|Number|0|0.0||||||
4411732|NCT00229723|4237171|B4|Oropharynx / Hypopharynx||Original site of primary cancer||Participants|Number|1|1.0||||||
4411733|NCT00229723|4237172|B3|Oropharynx / Hypopharynx||Original site of primary cancer||Participants|Number|0|0.0||||||
4411734|NCT00229723|4237173|B2|Oropharynx / Hypopharynx||Original site of primary cancer||Participants|Number|0|0.0||||||
4411735|NCT00229723|4237174|B1|Oropharynx / Hypopharynx||Original site of primary cancer||Participants|Number|0|0.0||||||
4411736|NCT00229723|4237167|B8|Larynx||Original site of primary cancer||Participants|Number|27|27.0||||||
4411737|NCT00229723|4237168|B7|Larynx||Original site of primary cancer||Participants|Number|3|3.0||||||
4411738|NCT00229723|4237169|B6|Larynx||Original site of primary cancer||Participants|Number|4|4.0||||||
4411739|NCT00229723|4237170|B5|Larynx||Original site of primary cancer||Participants|Number|3|3.0||||||
4411740|NCT00229723|4237171|B4|Larynx||Original site of primary cancer||Participants|Number|1|1.0||||||
4411741|NCT00229723|4237172|B3|Larynx||Original site of primary cancer||Participants|Number|4|4.0||||||
4411742|NCT00229723|4237173|B2|Larynx||Original site of primary cancer||Participants|Number|2|2.0||||||
4411743|NCT00229723|4237174|B1|Larynx||Original site of primary cancer||Participants|Number|10|10.0||||||
4411744|NCT00229723|4237167|B8|Hypopharynx||Original site of primary cancer||Participants|Number|67|67.0||||||
4411745|NCT00229723|4237168|B7|Hypopharynx||Original site of primary cancer||Participants|Number|4|4.0||||||
4411746|NCT00229723|4237169|B6|Hypopharynx||Original site of primary cancer||Participants|Number|12|12.0||||||
4411747|NCT00229723|4237170|B5|Hypopharynx||Original site of primary cancer||Participants|Number|4|4.0||||||
4411748|NCT00229723|4237171|B4|Hypopharynx||Original site of primary cancer||Participants|Number|10|10.0||||||
4411749|NCT00229723|4237172|B3|Hypopharynx||Original site of primary cancer||Participants|Number|9|9.0||||||
4411750|NCT00229723|4237173|B2|Hypopharynx||Original site of primary cancer||Participants|Number|9|9.0||||||
4411751|NCT00229723|4237174|B1|Hypopharynx||Original site of primary cancer||Participants|Number|19|19.0||||||
4411752|NCT00229723|4237167|B8|Oropharynx||Original site of primary cancer||Participants|Number|109|109.0||||||
4411753|NCT00229723|4237168|B7|Oropharynx||Original site of primary cancer||Participants|Number|10|10.0||||||
4411754|NCT00229723|4237169|B6|Oropharynx||Original site of primary cancer||Participants|Number|15|15.0||||||
4411755|NCT00229723|4237170|B5|Oropharynx||Original site of primary cancer||Participants|Number|13|13.0||||||
4411756|NCT00229723|4237171|B4|Oropharynx||Original site of primary cancer||Participants|Number|18|18.0||||||
4411757|NCT00229723|4237172|B3|Oropharynx||Original site of primary cancer||Participants|Number|15|15.0||||||
4411758|NCT00229723|4237173|B2|Oropharynx||Original site of primary cancer||Participants|Number|12|12.0||||||
4411759|NCT00229723|4237174|B1|Oropharynx||Original site of primary cancer||Participants|Number|26|26.0||||||
4411760|NCT00229723|4237167|B8|Oral cavity||Original site of primary cancer||Participants|Number|15|15.0||||||
4411761|NCT00229723|4237168|B7|Oral cavity||Original site of primary cancer||Participants|Number|3|3.0||||||
4411762|NCT00229723|4237169|B6|Oral cavity||Original site of primary cancer||Participants|Number|2|2.0||||||
4411763|NCT00229723|4237170|B5|Oral cavity||Original site of primary cancer||Participants|Number|3|3.0||||||
4411764|NCT00229723|4237171|B4|Oral cavity||Original site of primary cancer||Participants|Number|1|1.0||||||
4411765|NCT00229723|4237172|B3|Oral cavity||Original site of primary cancer||Participants|Number|2|2.0||||||
4411766|NCT00229723|4237173|B2|Oral cavity||Original site of primary cancer||Participants|Number|0|0.0||||||
4411767|NCT00229723|4237174|B1|Oral cavity||Original site of primary cancer||Participants|Number|4|4.0||||||
4411768|NCT00229723|4237167|B8|Oriental||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4411769|NCT00229723|4237168|B7|Oriental||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4411770|NCT00229723|4237169|B6|Oriental||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4411771|NCT00229723|4237170|B5|Oriental||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4411772|NCT00229723|4237171|B4|Oriental||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4411773|NCT00229723|4237172|B3|Oriental||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4411774|NCT00229723|4237173|B2|Oriental||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4411775|NCT00229723|4237174|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4411776|NCT00229723|4237167|B8|Caucasian (includes Indian)||Race/Ethnicity, Customized||Participants|Number|210|210.0||||||
4411777|NCT00229723|4237168|B7|Caucasian (includes Indian)||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4411778|NCT00229723|4237169|B6|Caucasian (includes Indian)||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4411779|NCT00229723|4237170|B5|Caucasian (includes Indian)||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4411780|NCT00229723|4237171|B4|Caucasian (includes Indian)||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4411781|NCT00229723|4237172|B3|Caucasian (includes Indian)||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4411782|NCT00229723|4237173|B2|Caucasian (includes Indian)||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4411783|NCT00229723|4237174|B1|Caucasian (includes Indian)||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4411784|NCT00229723|4237167|B8||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4411785|NCT00229723|4237168|B7||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4411786|NCT00229723|4237169|B6||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4411787|NCT00229723|4237170|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4411788|NCT00229723|4237171|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4411789|NCT00229723|4237172|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4411790|NCT00229723|4237173|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4411791|NCT00229723|4237174|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4411792|NCT00229723|4237167|B8||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4411793|NCT00229723|4237168|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4411794|NCT00229723|4237169|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4411795|NCT00229723|4237170|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4411796|NCT00229723|4237171|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4411797|NCT00229723|4237172|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4411798|NCT00229723|4237173|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4411799|NCT00229723|4237174|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4411800|NCT00229723|4237167|B8|||Age||Years|Mean|53.2|53.2|Full Range|||21.0|74.0|
4411801|NCT00229723|4237168|B7|||Age||Years|Mean|54.9|54.9|Full Range|||31.0|73.0|
4411802|NCT00229723|4237169|B6|||Age||Years|Mean|53.4|53.4|Full Range|||45.0|70.0|
4411803|NCT00229723|4237170|B5|||Age||Years|Mean|50.8|50.8|Full Range|||33.0|72.0|
4411804|NCT00229723|4237171|B4|||Age||Years|Mean|54.3|54.3|Full Range|||33.0|69.0|
4411805|NCT00229723|4237172|B3|||Age||Years|Mean|53.4|53.4|Full Range|||30.0|74.0|
4411806|NCT00229723|4237173|B2|||Age||Years|Mean|52.5|52.5|Full Range|||21.0|73.0|
4411807|NCT00229723|4237174|B1|||Age||Years|Mean|53.1|53.1|Full Range|||29.0|67.0|
4411808|NCT00229658|4237231|B3|||HbA1c||%|Mean|8.01|8.01|Standard Deviation|1.301|1.301|||
4411809|NCT00229658|4237232|B2|||HbA1c||%|Mean|8.23|8.23|Standard Deviation|1.538|1.538|||
4411810|NCT00229658|4237233|B1|||HbA1c||%|Mean|7.86|7.86|Standard Deviation|1.082|1.082|||
4411811|NCT00229658|4237231|B3|||Duration of Diabetes||years|Mean|18.24|18.24|Standard Deviation|10.857|10.857|||
4411812|NCT00229658|4237232|B2|||Duration of Diabetes||years|Mean|14.76|14.76|Standard Deviation|8.355|8.355|||
4411813|NCT00229658|4237233|B1|||Duration of Diabetes||years|Mean|20.66|20.66|Standard Deviation|11.709|11.709|||
4411814|NCT00229658|4237231|B3|||Body Weight||kg|Mean|97.57|97.57|Standard Deviation|25.273|25.273|||
4411815|NCT00229658|4237232|B2|||Body Weight||kg|Mean|112.53|112.53|Standard Deviation|24.790|24.79|||
4411816|NCT00229658|4237233|B1|||Body Weight||kg|Mean|87.21|87.21|Standard Deviation|19.843|19.843|||
4411817|NCT00229658|4237231|B3|United States||Region of Enrollment||participants|Number|1297|1297.0||||||
4411818|NCT00229658|4237232|B2|United States||Region of Enrollment||participants|Number|531|531.0||||||
4411819|NCT00229658|4237233|B1|United States||Region of Enrollment||participants|Number|766|766.0||||||
4411820|NCT00229658|4237231|B3||Male|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
4411821|NCT00229658|4237232|B2||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4411822|NCT00229658|4237233|B1||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4411823|NCT00229658|4237231|B3||Female|Sex: Female, Male||Participants|Count of Participants|796|796.0||||||
4411824|NCT00229658|4237232|B2||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4411825|NCT00229658|4237233|B1||Female|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4411826|NCT00229658|4237231|B3|||Age||years|Mean|48.8|48.8|Standard Deviation|14.10|14.1|||
4411827|NCT00229658|4237232|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|11.10|11.1|||
4411828|NCT00229658|4237233|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|13.22|13.22|||
4411829|NCT00229658|4237231|B3||>=65 years|Age||Participants|Count of Participants|162|162.0||||||
4411830|NCT00229658|4237232|B2||>=65 years|Age||Participants|Count of Participants|125|125.0||||||
4411831|NCT00229658|4237233|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4411832|NCT00229658|4237231|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1127|1127.0||||||
4411833|NCT00229658|4237232|B2||Between 18 and 65 years|Age||Participants|Count of Participants|406|406.0||||||
4411834|NCT00229658|4237233|B1||Between 18 and 65 years|Age||Participants|Count of Participants|721|721.0||||||
4411835|NCT00229658|4237231|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4411836|NCT00229658|4237232|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411837|NCT00229658|4237233|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4411838|NCT00229619|4237262|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4411839|NCT00229619|4237262|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4411840|NCT00229619|4237262|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411841|NCT00229619|4237262|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4411842|NCT00229619|4237262|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411843|NCT00229203|4237268|B3|2 Units of Scale||ECOG PS|ECOG PS: Eastern Cooperative Oncology Group Performance Status This scale is used by doctors to assess how a patient's disease is progressing, how the disease affects the daily living abilities of patients, and determine appropriate treatment and prognosis. Scale points: 0, 1, 2, 3, 4 & 5; 0: Fully active, able to carry on all pre-disease performance without restriction, and 5: Death|patients|Number|12|12.0||||||
4411844|NCT00229203|4237269|B2|2 Units of Scale||ECOG PS|ECOG PS: Eastern Cooperative Oncology Group Performance Status This scale is used by doctors to assess how a patient's disease is progressing, how the disease affects the daily living abilities of patients, and determine appropriate treatment and prognosis. Scale points: 0, 1, 2, 3, 4 & 5; 0: Fully active, able to carry on all pre-disease performance without restriction, and 5: Death|patients|Number|4|4.0||||||
4411845|NCT00229203|4237270|B1|2 Units of Scale||ECOG PS|ECOG PS: Eastern Cooperative Oncology Group Performance Status This scale is used by doctors to assess how a patient's disease is progressing, how the disease affects the daily living abilities of patients, and determine appropriate treatment and prognosis. Scale points: 0, 1, 2, 3, 4 & 5; 0: Fully active, able to carry on all pre-disease performance without restriction, and 5: Death|patients|Number|8|8.0||||||
4411846|NCT00229203|4237268|B3|1 Units of Scale||ECOG PS|ECOG PS: Eastern Cooperative Oncology Group Performance Status This scale is used by doctors to assess how a patient's disease is progressing, how the disease affects the daily living abilities of patients, and determine appropriate treatment and prognosis. Scale points: 0, 1, 2, 3, 4 & 5; 0: Fully active, able to carry on all pre-disease performance without restriction, and 5: Death|patients|Number|27|27.0||||||
4411847|NCT00229203|4237269|B2|1 Units of Scale||ECOG PS|ECOG PS: Eastern Cooperative Oncology Group Performance Status This scale is used by doctors to assess how a patient's disease is progressing, how the disease affects the daily living abilities of patients, and determine appropriate treatment and prognosis. Scale points: 0, 1, 2, 3, 4 & 5; 0: Fully active, able to carry on all pre-disease performance without restriction, and 5: Death|patients|Number|9|9.0||||||
4411848|NCT00229203|4237270|B1|1 Units of Scale||ECOG PS|ECOG PS: Eastern Cooperative Oncology Group Performance Status This scale is used by doctors to assess how a patient's disease is progressing, how the disease affects the daily living abilities of patients, and determine appropriate treatment and prognosis. Scale points: 0, 1, 2, 3, 4 & 5; 0: Fully active, able to carry on all pre-disease performance without restriction, and 5: Death|patients|Number|18|18.0||||||
4411849|NCT00229203|4237268|B3|0 Units of Scale||ECOG PS|ECOG PS: Eastern Cooperative Oncology Group Performance Status This scale is used by doctors to assess how a patient's disease is progressing, how the disease affects the daily living abilities of patients, and determine appropriate treatment and prognosis. Scale points: 0, 1, 2, 3, 4 & 5; 0: Fully active, able to carry on all pre-disease performance without restriction, and 5: Death|patients|Number|12|12.0||||||
4412208|NCT00227591|4237500|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4411850|NCT00229203|4237269|B2|0 Units of Scale||ECOG PS|ECOG PS: Eastern Cooperative Oncology Group Performance Status This scale is used by doctors to assess how a patient's disease is progressing, how the disease affects the daily living abilities of patients, and determine appropriate treatment and prognosis. Scale points: 0, 1, 2, 3, 4 & 5; 0: Fully active, able to carry on all pre-disease performance without restriction, and 5: Death|patients|Number|6|6.0||||||
4411851|NCT00229203|4237270|B1|0 Units of Scale||ECOG PS|ECOG PS: Eastern Cooperative Oncology Group Performance Status This scale is used by doctors to assess how a patient's disease is progressing, how the disease affects the daily living abilities of patients, and determine appropriate treatment and prognosis. Scale points: 0, 1, 2, 3, 4 & 5; 0: Fully active, able to carry on all pre-disease performance without restriction, and 5: Death|patients|Number|6|6.0||||||
4411852|NCT00229203|4237268|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4411853|NCT00229203|4237269|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4411854|NCT00229203|4237270|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4411855|NCT00229203|4237268|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4411856|NCT00229203|4237269|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4411857|NCT00229203|4237270|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4411858|NCT00229203|4237268|B3|||Age||years|Median|64.0|64.0|Full Range|||47.0|86.0|
4411859|NCT00229203|4237269|B2|||Age||years|Median|63|63.0|Full Range|||47.0|86.0|
4411860|NCT00229203|4237270|B1|||Age||years|Median|66|66.0|Full Range|||47.0|82.0|
4411861|NCT00228943|4237283|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4411862|NCT00228943|4237283|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4411863|NCT00228943|4237283|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4411864|NCT00228943|4237283|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|9.6|9.6|||
4411865|NCT00228943|4237283|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4411866|NCT00228943|4237283|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4411867|NCT00228943|4237283|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411868|NCT00228917|4237291|B5||Male|Sex: Female, Male||Participants|Count of Participants|644|644.0||||||
4411869|NCT00228917|4237292|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4411870|NCT00228917|4237293|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4411871|NCT00228917|4237294|B2||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4411872|NCT00228917|4237295|B1||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4411873|NCT00228917|4237291|B5||Female|Sex: Female, Male||Participants|Count of Participants|646|646.0||||||
4411874|NCT00228917|4237292|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4411875|NCT00228917|4237293|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4411876|NCT00228917|4237294|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4411877|NCT00228917|4237295|B1||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4411878|NCT00228917|4237291|B5|||Age||Months|Mean|17.59|17.59|Standard Deviation|0.76|0.76|||
4411879|NCT00228917|4237292|B4|||Age||Months|Mean|17.5|17.5|Standard Deviation|0.77|0.77|||
4411880|NCT00228917|4237293|B3|||Age||Months|Mean|17.6|17.6|Standard Deviation|0.8|0.8|||
4411881|NCT00228917|4237294|B2|||Age||Months|Mean|17.6|17.6|Standard Deviation|0.76|0.76|||
4411882|NCT00228917|4237295|B1|||Age||Months|Mean|17.6|17.6|Standard Deviation|0.74|0.74|||
4411883|NCT00228813|4237324|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4411884|NCT00228813|4237324|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4411885|NCT00228813|4237324|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4411886|NCT00228813|4237324|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4411887|NCT00228813|4237324|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4411888|NCT00228566|4237330|B1|United States||Region of Enrollment||participants|Number|247|247.0||||||
4411889|NCT00228566|4237330|B1|Male||Gender|1 female participant withdrew for noncompliance after randomization but prior to receiving study drug|participants|Number|109|109.0||||||
4411890|NCT00228566|4237330|B1|Female||Gender|1 female participant withdrew for noncompliance after randomization but prior to receiving study drug|participants|Number|137|137.0||||||
4411891|NCT00228566|4237330|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|12.53|12.53|||
4411892|NCT00228566|4237330|B1|>=65 years||Age|1 female participant withdrew for noncompliance after randomization but prior to receiving study drug|participants|Number|3|3.0||||||
4411893|NCT00228566|4237330|B1|Between 18 and 65 years||Age|1 female participant withdrew for noncompliance after randomization but prior to receiving study drug|participants|Number|243|243.0||||||
4411894|NCT00228566|4237330|B1|<=18 years||Age|1 female participant withdrew for noncompliance after randomization but prior to receiving study drug|participants|Number|0|0.0||||||
4411895|NCT00228553|4237334|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4411896|NCT00228553|4237334|B1|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
4411897|NCT00228553|4237334|B1|Australia||Region of Enrollment||participants|Number|25|25.0||||||
4411898|NCT00228553|4237334|B1|Canada||Region of Enrollment||participants|Number|70|70.0||||||
4411899|NCT00228553|4237334|B1|United States||Region of Enrollment||participants|Number|611|611.0||||||
4411900|NCT00228553|4237334|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
4411901|NCT00228553|4237334|B1||Male|Sex: Female, Male|12 participants (3 female ; 9 male) withdrew after randomization but prior to receiving study drug|Participants|Count of Participants|474|474.0||||||
4411989|NCT00227903|4237391|B2|Participants without such a diagnosis||MINI drug or alcohol abuse or dependence||participants|Number|63|63.0||||||
4411902|NCT00228553|4237334|B1||Female|Sex: Female, Male|12 participants (3 female ; 9 male) withdrew after randomization but prior to receiving study drug|Participants|Count of Participants|257|257.0||||||
4411903|NCT00228553|4237334|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|10.97|10.97|||
4411904|NCT00228553|4237334|B1||>=65 years|Age|12 participants (3 female ; 9 male) withdrew after randomization but prior to receiving study drug|Participants|Count of Participants|5|5.0||||||
4411905|NCT00228553|4237334|B1||Between 18 and 65 years|Age|12 participants (3 female ; 9 male) withdrew after randomization but prior to receiving study drug|Participants|Count of Participants|726|726.0||||||
4411906|NCT00228553|4237334|B1||<=18 years|Age|12 participants (3 female ; 9 male) withdrew after randomization but prior to receiving study drug|Participants|Count of Participants|0|0.0||||||
4411907|NCT00228384|4237338|B3|United States||Region of Enrollment||participants|Number|148|148.0||||||
4411908|NCT00228384|4237339|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4411909|NCT00228384|4237340|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4411910|NCT00228384|4237338|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4411911|NCT00228384|4237339|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4411912|NCT00228384|4237340|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4411913|NCT00228384|4237338|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4411914|NCT00228384|4237339|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4411915|NCT00228384|4237340|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4411916|NCT00228384|4237338|B3|||Age||years|Median|67|67.0|Full Range|||43.0|90.0|
4411917|NCT00228384|4237339|B2|||Age||years|Median|63|63.0|Full Range|||43.0|89.0|
4411918|NCT00228384|4237340|B1|||Age||years|Median|69|69.0|Full Range|||45.0|90.0|
4411919|NCT00227994|4237379|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4411920|NCT00227994|4237380|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4411921|NCT00227994|4237381|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4411922|NCT00227994|4237379|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4411923|NCT00227994|4237380|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4411924|NCT00227994|4237381|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4411925|NCT00227994|4237379|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4411926|NCT00227994|4237380|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4411927|NCT00227994|4237381|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4411928|NCT00227994|4237379|B3|||Age||years|Mean|69.5|69.5|Standard Deviation|7.0|7.0|||
4411929|NCT00227994|4237380|B2|||Age||years|Mean|69.1|69.1|Standard Deviation|6.4|6.4|||
4411930|NCT00227994|4237381|B1|||Age||years|Mean|69.9|69.9|Standard Deviation|7.5|7.5|||
4411931|NCT00227994|4237379|B3||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4411932|NCT00227994|4237380|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4411933|NCT00227994|4237381|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4411934|NCT00227994|4237379|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4411935|NCT00227994|4237380|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4411936|NCT00227994|4237381|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4411937|NCT00227994|4237379|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411938|NCT00227994|4237380|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411939|NCT00227994|4237381|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4411940|NCT00227903|4237390|B3|Other||Primary Drug|"Primary drug was determined by combining a) self-reported recent use of substances and b) preferred substance according to the subject. If the participant used only one substance in the past 28 days, it was designated as primary. If the woman used more than one or did not endorse use of a substance in the prior 28 days, we used patient-identified primary drug. Subjects who reported more than one drug as primary were classified as other regardless of substances endorsed."|participants|Number|11|11.0||||||
4411941|NCT00227903|4237391|B2|Other||Primary Drug|"Primary drug was determined by combining a) self-reported recent use of substances and b) preferred substance according to the subject. If the participant used only one substance in the past 28 days, it was designated as primary. If the woman used more than one or did not endorse use of a substance in the prior 28 days, we used patient-identified primary drug. Subjects who reported more than one drug as primary were classified as other regardless of substances endorsed."|participants|Number|5|5.0||||||
4411942|NCT00227903|4237392|B1|Other||Primary Drug|"Primary drug was determined by combining a) self-reported recent use of substances and b) preferred substance according to the subject. If the participant used only one substance in the past 28 days, it was designated as primary. If the woman used more than one or did not endorse use of a substance in the prior 28 days, we used patient-identified primary drug. Subjects who reported more than one drug as primary were classified as other regardless of substances endorsed."|participants|Number|6|6.0||||||
4411943|NCT00227903|4237390|B3|Marijuana||Primary Drug|"Primary drug was determined by combining a) self-reported recent use of substances and b) preferred substance according to the subject. If the participant used only one substance in the past 28 days, it was designated as primary. If the woman used more than one or did not endorse use of a substance in the prior 28 days, we used patient-identified primary drug. Subjects who reported more than one drug as primary were classified as other regardless of substances endorsed."|participants|Number|77|77.0||||||
4411962|NCT00227903|4237391|B2|Amphetamines||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|0|0.0||||||
4411990|NCT00227903|4237392|B1|Participants without such a diagnosis||MINI drug or alcohol abuse or dependence||participants|Number|58|58.0||||||
4411944|NCT00227903|4237391|B2|Marijuana||Primary Drug|"Primary drug was determined by combining a) self-reported recent use of substances and b) preferred substance according to the subject. If the participant used only one substance in the past 28 days, it was designated as primary. If the woman used more than one or did not endorse use of a substance in the prior 28 days, we used patient-identified primary drug. Subjects who reported more than one drug as primary were classified as other regardless of substances endorsed."|participants|Number|37|37.0||||||
4411945|NCT00227903|4237392|B1|Marijuana||Primary Drug|"Primary drug was determined by combining a) self-reported recent use of substances and b) preferred substance according to the subject. If the participant used only one substance in the past 28 days, it was designated as primary. If the woman used more than one or did not endorse use of a substance in the prior 28 days, we used patient-identified primary drug. Subjects who reported more than one drug as primary were classified as other regardless of substances endorsed."|participants|Number|40|40.0||||||
4411946|NCT00227903|4237390|B3|Cocaine||Primary Drug|"Primary drug was determined by combining a) self-reported recent use of substances and b) preferred substance according to the subject. If the participant used only one substance in the past 28 days, it was designated as primary. If the woman used more than one or did not endorse use of a substance in the prior 28 days, we used patient-identified primary drug. Subjects who reported more than one drug as primary were classified as other regardless of substances endorsed."|participants|Number|29|29.0||||||
4411947|NCT00227903|4237391|B2|Cocaine||Primary Drug|"Primary drug was determined by combining a) self-reported recent use of substances and b) preferred substance according to the subject. If the participant used only one substance in the past 28 days, it was designated as primary. If the woman used more than one or did not endorse use of a substance in the prior 28 days, we used patient-identified primary drug. Subjects who reported more than one drug as primary were classified as other regardless of substances endorsed."|participants|Number|14|14.0||||||
4411948|NCT00227903|4237392|B1|Cocaine||Primary Drug|"Primary drug was determined by combining a) self-reported recent use of substances and b) preferred substance according to the subject. If the participant used only one substance in the past 28 days, it was designated as primary. If the woman used more than one or did not endorse use of a substance in the prior 28 days, we used patient-identified primary drug. Subjects who reported more than one drug as primary were classified as other regardless of substances endorsed."|participants|Number|15|15.0||||||
4411949|NCT00227903|4237390|B3|Alcohol||Primary Drug|"Primary drug was determined by combining a) self-reported recent use of substances and b) preferred substance according to the subject. If the participant used only one substance in the past 28 days, it was designated as primary. If the woman used more than one or did not endorse use of a substance in the prior 28 days, we used patient-identified primary drug. Subjects who reported more than one drug as primary were classified as other regardless of substances endorsed."|participants|Number|51|51.0||||||
4411950|NCT00227903|4237391|B2|Alcohol||Primary Drug|"Primary drug was determined by combining a) self-reported recent use of substances and b) preferred substance according to the subject. If the participant used only one substance in the past 28 days, it was designated as primary. If the woman used more than one or did not endorse use of a substance in the prior 28 days, we used patient-identified primary drug. Subjects who reported more than one drug as primary were classified as other regardless of substances endorsed."|participants|Number|26|26.0||||||
4411951|NCT00227903|4237392|B1|Alcohol||Primary Drug|"Primary drug was determined by combining a) self-reported recent use of substances and b) preferred substance according to the subject. If the participant used only one substance in the past 28 days, it was designated as primary. If the woman used more than one or did not endorse use of a substance in the prior 28 days, we used patient-identified primary drug. Subjects who reported more than one drug as primary were classified as other regardless of substances endorsed."|participants|Number|25|25.0||||||
4411952|NCT00227903|4237390|B3|Inhalants||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|0|0.0||||||
4411953|NCT00227903|4237391|B2|Inhalants||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|0|0.0||||||
4411954|NCT00227903|4237392|B1|Inhalants||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|0|0.0||||||
4411955|NCT00227903|4237390|B3|Hallucinogens||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|3|3.0||||||
4411956|NCT00227903|4237391|B2|Hallucinogens||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|1|1.0||||||
4411957|NCT00227903|4237392|B1|Hallucinogens||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|2|2.0||||||
4411958|NCT00227903|4237390|B3|Marijuana||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|74|74.0||||||
4411959|NCT00227903|4237391|B2|Marijuana||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|34|34.0||||||
4411960|NCT00227903|4237392|B1|Marijuana||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|40|40.0||||||
4411961|NCT00227903|4237390|B3|Amphetamines||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|1|1.0||||||
4411988|NCT00227903|4237390|B3|Participants without such a diagnosis||MINI drug or alcohol abuse or dependence||participants|Number|121|121.0||||||
4411963|NCT00227903|4237392|B1|Amphetamines||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|1|1.0||||||
4411964|NCT00227903|4237390|B3|Cocaine||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|18|18.0||||||
4411965|NCT00227903|4237391|B2|Cocaine||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|7|7.0||||||
4411966|NCT00227903|4237392|B1|Cocaine||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|11|11.0||||||
4411967|NCT00227903|4237390|B3|Sedatives||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|6|6.0||||||
4411968|NCT00227903|4237391|B2|Sedatives||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|1|1.0||||||
4411969|NCT00227903|4237392|B1|Sedatives||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|5|5.0||||||
4411970|NCT00227903|4237390|B3|Barbiturates||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|0|0.0||||||
4411971|NCT00227903|4237391|B2|Barbiturates||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|0|0.0||||||
4411972|NCT00227903|4237392|B1|Barbiturates||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|0|0.0||||||
4411973|NCT00227903|4237390|B3|Opiates (excluding methadone)||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|10|10.0||||||
4411974|NCT00227903|4237391|B2|Opiates (excluding methadone)||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|4|4.0||||||
4411975|NCT00227903|4237392|B1|Opiates (excluding methadone)||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|6|6.0||||||
4411976|NCT00227903|4237390|B3|Methadone||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|13|13.0||||||
4411977|NCT00227903|4237391|B2|Methadone||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|8|8.0||||||
4411978|NCT00227903|4237392|B1|Methadone||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|5|5.0||||||
4411979|NCT00227903|4237390|B3|Heroin||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|4|4.0||||||
4411980|NCT00227903|4237391|B2|Heroin||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|3|3.0||||||
4411981|NCT00227903|4237392|B1|Heroin||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|1|1.0||||||
4411982|NCT00227903|4237390|B3|Alcohol (intoxication)||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|16|16.0||||||
4411983|NCT00227903|4237391|B2|Alcohol (intoxication)||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|9|9.0||||||
4411984|NCT00227903|4237392|B1|Alcohol (intoxication)||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|7|7.0||||||
4411985|NCT00227903|4237390|B3|Alcohol (any)||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|52|52.0||||||
4411986|NCT00227903|4237391|B2|Alcohol (any)||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|19|19.0||||||
4411987|NCT00227903|4237392|B1|Alcohol (any)||Past-month use|Participants could indicate use of more than one substance in the past month. All results were counted and categorized, leading to a total count greater than the number of baseline participants.|participants|Number|33|33.0||||||
4411991|NCT00227903|4237390|B3|Participants diagnosed with abuse or dependence||MINI drug or alcohol abuse or dependence||participants|Number|47|47.0||||||
4411992|NCT00227903|4237391|B2|Participants diagnosed with abuse or dependence||MINI drug or alcohol abuse or dependence||participants|Number|19|19.0||||||
4411993|NCT00227903|4237392|B1|Participants diagnosed with abuse or dependence||MINI drug or alcohol abuse or dependence||participants|Number|28|28.0||||||
4411994|NCT00227903|4237390|B3|Yale New Haven Hospital||Site||participants|Number|121|121.0||||||
4411995|NCT00227903|4237391|B2|Yale New Haven Hospital||Site||participants|Number|57|57.0||||||
4411996|NCT00227903|4237392|B1|Yale New Haven Hospital||Site||participants|Number|64|64.0||||||
4411997|NCT00227903|4237390|B3|Bridgeport Hospital||Site||participants|Number|47|47.0||||||
4411998|NCT00227903|4237391|B2|Bridgeport Hospital||Site||participants|Number|25|25.0||||||
4411999|NCT00227903|4237392|B1|Bridgeport Hospital||Site||participants|Number|22|22.0||||||
4412000|NCT00227903|4237390|B3|Unknown||Prenatal care initiation||participants|Number|5|5.0||||||
4412001|NCT00227903|4237391|B2|Unknown||Prenatal care initiation||participants|Number|4|4.0||||||
4412002|NCT00227903|4237392|B1|Unknown||Prenatal care initiation||participants|Number|1|1.0||||||
4412003|NCT00227903|4237390|B3|Week 25 or later||Prenatal care initiation||participants|Number|9|9.0||||||
4412004|NCT00227903|4237391|B2|Week 25 or later||Prenatal care initiation||participants|Number|5|5.0||||||
4412005|NCT00227903|4237392|B1|Week 25 or later||Prenatal care initiation||participants|Number|4|4.0||||||
4412006|NCT00227903|4237390|B3|Weeks 17-24||Prenatal care initiation||participants|Number|23|23.0||||||
4412007|NCT00227903|4237391|B2|Weeks 17-24||Prenatal care initiation||participants|Number|10|10.0||||||
4412008|NCT00227903|4237392|B1|Weeks 17-24||Prenatal care initiation||participants|Number|13|13.0||||||
4412009|NCT00227903|4237390|B3|Weeks 9-16||Prenatal care initiation||participants|Number|87|87.0||||||
4412010|NCT00227903|4237391|B2|Weeks 9-16||Prenatal care initiation||participants|Number|40|40.0||||||
4412011|NCT00227903|4237392|B1|Weeks 9-16||Prenatal care initiation||participants|Number|47|47.0||||||
4412012|NCT00227903|4237390|B3|Weeks 1-8||Prenatal care initiation||participants|Number|44|44.0||||||
4412013|NCT00227903|4237391|B2|Weeks 1-8||Prenatal care initiation||participants|Number|23|23.0||||||
4412014|NCT00227903|4237392|B1|Weeks 1-8||Prenatal care initiation||participants|Number|21|21.0||||||
4412015|NCT00227903|4237390|B3|Weeks 25 or later||Gestational age at intake||participants|Number|49|49.0||||||
4412016|NCT00227903|4237391|B2|Weeks 25 or later||Gestational age at intake||participants|Number|24|24.0||||||
4412017|NCT00227903|4237392|B1|Weeks 25 or later||Gestational age at intake||participants|Number|25|25.0||||||
4412018|NCT00227903|4237390|B3|Weeks 17-24||Gestational age at intake||participants|Number|58|58.0||||||
4412019|NCT00227903|4237391|B2|Weeks 17-24||Gestational age at intake||participants|Number|27|27.0||||||
4412020|NCT00227903|4237392|B1|Weeks 17-24||Gestational age at intake||participants|Number|31|31.0||||||
4412021|NCT00227903|4237390|B3|Weeks 9-16||Gestational age at intake||participants|Number|53|53.0||||||
4412022|NCT00227903|4237391|B2|Weeks 9-16||Gestational age at intake||participants|Number|28|28.0||||||
4412023|NCT00227903|4237392|B1|Weeks 9-16||Gestational age at intake||participants|Number|25|25.0||||||
4412024|NCT00227903|4237390|B3|Weeks 1-8||Gestational age at intake||participants|Number|8|8.0||||||
4412025|NCT00227903|4237391|B2|Weeks 1-8||Gestational age at intake||participants|Number|3|3.0||||||
4412026|NCT00227903|4237392|B1|Weeks 1-8||Gestational age at intake||participants|Number|5|5.0||||||
4412027|NCT00227903|4237390|B3|2+||Parity|Parity defined as number of previous births|Participants|Count of Participants|50|50.0||||||
4412028|NCT00227903|4237391|B2|2+||Parity|Parity defined as number of previous births|Participants|Count of Participants|26|26.0||||||
4412029|NCT00227903|4237392|B1|2+||Parity|Parity defined as number of previous births|Participants|Count of Participants|24|24.0||||||
4412030|NCT00227903|4237390|B3|1||Parity|Parity defined as number of previous births|Participants|Count of Participants|52|52.0||||||
4412031|NCT00227903|4237391|B2|1||Parity|Parity defined as number of previous births|Participants|Count of Participants|25|25.0||||||
4412032|NCT00227903|4237392|B1|1||Parity|Parity defined as number of previous births|Participants|Count of Participants|27|27.0||||||
4412033|NCT00227903|4237390|B3|0||Parity|Parity defined as number of previous births|Participants|Count of Participants|66|66.0||||||
4412034|NCT00227903|4237391|B2|0||Parity|Parity defined as number of previous births|Participants|Count of Participants|31|31.0||||||
4412035|NCT00227903|4237392|B1|0||Parity|Parity defined as number of previous births|Participants|Count of Participants|35|35.0||||||
4412036|NCT00227903|4237390|B3|16+||Education (years)||participants|Number|7|7.0||||||
4412037|NCT00227903|4237391|B2|16+||Education (years)||participants|Number|1|1.0||||||
4412038|NCT00227903|4237392|B1|16+||Education (years)||participants|Number|6|6.0||||||
4412039|NCT00227903|4237390|B3|13-15||Education (years)||participants|Number|37|37.0||||||
4412040|NCT00227903|4237391|B2|13-15||Education (years)||participants|Number|14|14.0||||||
4412041|NCT00227903|4237392|B1|13-15||Education (years)||participants|Number|23|23.0||||||
4412042|NCT00227903|4237390|B3|12||Education (years)||participants|Number|66|66.0||||||
4412043|NCT00227903|4237391|B2|12||Education (years)||participants|Number|35|35.0||||||
4412044|NCT00227903|4237392|B1|12||Education (years)||participants|Number|31|31.0||||||
4412045|NCT00227903|4237390|B3|<12||Education (years)||participants|Number|58|58.0||||||
4412046|NCT00227903|4237391|B2|<12||Education (years)||participants|Number|32|32.0||||||
4412047|NCT00227903|4237392|B1|<12||Education (years)||participants|Number|26|26.0||||||
4412048|NCT00227903|4237390|B3|United States||Region of Enrollment||participants|Number|168|168.0||||||
4412049|NCT00227903|4237391|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
4412050|NCT00227903|4237392|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
4412051|NCT00227903|4237390|B3|Other||Race/Ethnicity, Customized|Participants could indicate more than one race/ethnicity category. All results were counted and categorized, leading to a total count greater than the number baseline participants.|participants|Number|3|3.0||||||
4412052|NCT00227903|4237391|B2|Other||Race/Ethnicity, Customized|Participants could indicate more than one race/ethnicity category. All results were counted and categorized, leading to a total count greater than the number baseline participants.|participants|Number|2|2.0||||||
4412053|NCT00227903|4237392|B1|Other||Race/Ethnicity, Customized|Participants could indicate more than one race/ethnicity category. All results were counted and categorized, leading to a total count greater than the number baseline participants.|participants|Number|1|1.0||||||
4412054|NCT00227903|4237390|B3|Hispanic||Race/Ethnicity, Customized|Participants could indicate more than one race/ethnicity category. All results were counted and categorized, leading to a total count greater than the number baseline participants.|participants|Number|43|43.0||||||
4412055|NCT00227903|4237391|B2|Hispanic||Race/Ethnicity, Customized|Participants could indicate more than one race/ethnicity category. All results were counted and categorized, leading to a total count greater than the number baseline participants.|participants|Number|19|19.0||||||
4412056|NCT00227903|4237392|B1|Hispanic||Race/Ethnicity, Customized|Participants could indicate more than one race/ethnicity category. All results were counted and categorized, leading to a total count greater than the number baseline participants.|participants|Number|24|24.0||||||
4412057|NCT00227903|4237390|B3|Black||Race/Ethnicity, Customized|Participants could indicate more than one race/ethnicity category. All results were counted and categorized, leading to a total count greater than the number baseline participants.|participants|Number|89|89.0||||||
4412058|NCT00227903|4237391|B2|Black||Race/Ethnicity, Customized|Participants could indicate more than one race/ethnicity category. All results were counted and categorized, leading to a total count greater than the number baseline participants.|participants|Number|42|42.0||||||
4412059|NCT00227903|4237392|B1|Black||Race/Ethnicity, Customized|Participants could indicate more than one race/ethnicity category. All results were counted and categorized, leading to a total count greater than the number baseline participants.|participants|Number|47|47.0||||||
4412060|NCT00227903|4237390|B3|White||Race/Ethnicity, Customized|Participants could indicate more than one race/ethnicity category. All results were counted and categorized, leading to a total count greater than the number baseline participants.|participants|Number|36|36.0||||||
4412061|NCT00227903|4237391|B2|White||Race/Ethnicity, Customized|Participants could indicate more than one race/ethnicity category. All results were counted and categorized, leading to a total count greater than the number baseline participants.|participants|Number|19|19.0||||||
4412062|NCT00227903|4237392|B1|White||Race/Ethnicity, Customized|Participants could indicate more than one race/ethnicity category. All results were counted and categorized, leading to a total count greater than the number baseline participants.|participants|Number|17|17.0||||||
4412063|NCT00227903|4237390|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4412064|NCT00227903|4237391|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4412065|NCT00227903|4237392|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4412066|NCT00227903|4237390|B3||Female|Gender||Participants|Count of Participants|168|168.0||||||
4412067|NCT00227903|4237391|B2||Female|Gender||Participants|Count of Participants|82|82.0||||||
4412068|NCT00227903|4237392|B1||Female|Gender||Participants|Count of Participants|86|86.0||||||
4412069|NCT00227903|4237390|B3|>35 years||Age, Customized||participants|Number|13|13.0||||||
4412070|NCT00227903|4237391|B2|>35 years||Age, Customized||participants|Number|5|5.0||||||
4412071|NCT00227903|4237392|B1|>35 years||Age, Customized||participants|Number|8|8.0||||||
4412072|NCT00227903|4237390|B3|20-34 years||Age, Customized||participants|Number|126|126.0||||||
4412073|NCT00227903|4237391|B2|20-34 years||Age, Customized||participants|Number|61|61.0||||||
4412074|NCT00227903|4237392|B1|20-34 years||Age, Customized||participants|Number|65|65.0||||||
4412075|NCT00227903|4237390|B3|<20 years||Age, Customized||participants|Number|29|29.0||||||
4412076|NCT00227903|4237391|B2|<20 years||Age, Customized||participants|Number|16|16.0||||||
4412077|NCT00227903|4237392|B1|<20 years||Age, Customized||participants|Number|13|13.0||||||
4412078|NCT00227877|4237453|B5|||Peer substance abuse||Participants|Count of Participants|1661|1661.0||||||
4412079|NCT00227877|4237454|B4|||Peer substance abuse||Participants|Count of Participants|192|192.0||||||
4412080|NCT00227877|4237455|B3|||Peer substance abuse||Participants|Count of Participants|204|204.0||||||
4412081|NCT00227877|4237456|B2|||Peer substance abuse||Participants|Count of Participants|607|607.0||||||
4412082|NCT00227877|4237457|B1|||Peer substance abuse||Participants|Count of Participants|658|658.0||||||
4412083|NCT00227877|4237453|B5|||Sibling Substance Abuse||Participants|Count of Participants|469|469.0||||||
4412084|NCT00227877|4237454|B4|||Sibling Substance Abuse||Participants|Count of Participants|36|36.0||||||
4412085|NCT00227877|4237455|B3|||Sibling Substance Abuse||Participants|Count of Participants|41|41.0||||||
4412086|NCT00227877|4237456|B2|||Sibling Substance Abuse||Participants|Count of Participants|187|187.0||||||
4412087|NCT00227877|4237457|B1|||Sibling Substance Abuse||Participants|Count of Participants|205|205.0||||||
4412088|NCT00227877|4237453|B5|||Parent Substance Use||Participants|Count of Participants|386|386.0||||||
4412089|NCT00227877|4237454|B4|||Parent Substance Use||Participants|Count of Participants|32|32.0||||||
4412090|NCT00227877|4237455|B3|||Parent Substance Use||Participants|Count of Participants|32|32.0||||||
4412091|NCT00227877|4237456|B2|||Parent Substance Use||Participants|Count of Participants|152|152.0||||||
4412092|NCT00227877|4237457|B1|||Parent Substance Use||Participants|Count of Participants|170|170.0||||||
4412093|NCT00227877|4237453|B5|Female provider|No|Visit type||Participants|Count of Participants|792|792.0||||||
4412094|NCT00227877|4237454|B4|Female provider|No|Visit type||Participants|Count of Participants|33|33.0||||||
4412095|NCT00227877|4237455|B3|Female provider|No|Visit type||Participants|Count of Participants|33|33.0||||||
4412096|NCT00227877|4237456|B2|Female provider|No|Visit type||Participants|Count of Participants|335|335.0||||||
4412097|NCT00227877|4237457|B1|Female provider|No|Visit type||Participants|Count of Participants|391|391.0||||||
4412098|NCT00227877|4237453|B5|Female provider|Yes|Visit type||Participants|Count of Participants|1869|1869.0||||||
4412099|NCT00227877|4237454|B4|Female provider|Yes|Visit type||Participants|Count of Participants|259|259.0||||||
4412100|NCT00227877|4237455|B3|Female provider|Yes|Visit type||Participants|Count of Participants|263|263.0||||||
4412101|NCT00227877|4237456|B2|Female provider|Yes|Visit type||Participants|Count of Participants|684|684.0||||||
4412102|NCT00227877|4237457|B1|Female provider|Yes|Visit type||Participants|Count of Participants|663|663.0||||||
4412103|NCT00227877|4237453|B5|First visit|No|Visit type||Participants|Count of Participants|1844|1844.0||||||
4412104|NCT00227877|4237454|B4|First visit|No|Visit type||Participants|Count of Participants|0|0.0||||||
4412105|NCT00227877|4237455|B3|First visit|No|Visit type||Participants|Count of Participants|0|0.0||||||
4412106|NCT00227877|4237456|B2|First visit|No|Visit type||Participants|Count of Participants|914|914.0||||||
4412107|NCT00227877|4237457|B1|First visit|No|Visit type||Participants|Count of Participants|930|930.0||||||
4412108|NCT00227877|4237453|B5|First visit|Yes|Visit type||Participants|Count of Participants|220|220.0||||||
4412109|NCT00227877|4237454|B4|First visit|Yes|Visit type||Participants|Count of Participants|0|0.0||||||
4412110|NCT00227877|4237455|B3|First visit|Yes|Visit type||Participants|Count of Participants|0|0.0||||||
4412111|NCT00227877|4237456|B2|First visit|Yes|Visit type||Participants|Count of Participants|105|105.0||||||
4412112|NCT00227877|4237457|B1|First visit|Yes|Visit type||Participants|Count of Participants|115|115.0||||||
4412113|NCT00227877|4237453|B5|Well visit|No|Visit type||Participants|Count of Participants|250|250.0||||||
4412114|NCT00227877|4237454|B4|Well visit|No|Visit type||Participants|Count of Participants|0|0.0||||||
4412115|NCT00227877|4237455|B3|Well visit|No|Visit type||Participants|Count of Participants|0|0.0||||||
4412116|NCT00227877|4237456|B2|Well visit|No|Visit type||Participants|Count of Participants|51|51.0||||||
4412117|NCT00227877|4237457|B1|Well visit|No|Visit type||Participants|Count of Participants|199|199.0||||||
4412118|NCT00227877|4237453|B5|Well visit|Yes|Visit type||Participants|Count of Participants|2408|2408.0||||||
4412119|NCT00227877|4237454|B4|Well visit|Yes|Visit type||Participants|Count of Participants|292|292.0||||||
4412120|NCT00227877|4237455|B3|Well visit|Yes|Visit type||Participants|Count of Participants|297|297.0||||||
4412121|NCT00227877|4237456|B2|Well visit|Yes|Visit type||Participants|Count of Participants|968|968.0||||||
4412122|NCT00227877|4237457|B1|Well visit|Yes|Visit type||Participants|Count of Participants|851|851.0||||||
4412123|NCT00227877|4237453|B5||Don't know|Parents Highest Education Level||Participants|Count of Participants|222|222.0||||||
4412124|NCT00227877|4237454|B4||Don't know|Parents Highest Education Level||Participants|Count of Participants|38|38.0||||||
4412125|NCT00227877|4237455|B3||Don't know|Parents Highest Education Level||Participants|Count of Participants|43|43.0||||||
4412126|NCT00227877|4237456|B2||Don't know|Parents Highest Education Level||Participants|Count of Participants|42|42.0||||||
4412127|NCT00227877|4237457|B1||Don't know|Parents Highest Education Level||Participants|Count of Participants|99|99.0||||||
4412128|NCT00227877|4237453|B5||Did not complete high school/secondary school|Parents Highest Education Level||Participants|Count of Participants|169|169.0||||||
4412129|NCT00227877|4237454|B4||Did not complete high school/secondary school|Parents Highest Education Level||Participants|Count of Participants|46|46.0||||||
4412130|NCT00227877|4237455|B3||Did not complete high school/secondary school|Parents Highest Education Level||Participants|Count of Participants|44|44.0||||||
4412131|NCT00227877|4237456|B2||Did not complete high school/secondary school|Parents Highest Education Level||Participants|Count of Participants|33|33.0||||||
4412132|NCT00227877|4237457|B1||Did not complete high school/secondary school|Parents Highest Education Level||Participants|Count of Participants|46|46.0||||||
4412133|NCT00227877|4237453|B5||High school/Secondary school graduate|Parents Highest Education Level||Participants|Count of Participants|1049|1049.0||||||
4412134|NCT00227877|4237454|B4||High school/Secondary school graduate|Parents Highest Education Level||Participants|Count of Participants|106|106.0||||||
4412135|NCT00227877|4237455|B3||High school/Secondary school graduate|Parents Highest Education Level||Participants|Count of Participants|111|111.0||||||
4412136|NCT00227877|4237456|B2||High school/Secondary school graduate|Parents Highest Education Level||Participants|Count of Participants|405|405.0||||||
4412137|NCT00227877|4237457|B1||High school/Secondary school graduate|Parents Highest Education Level||Participants|Count of Participants|427|427.0||||||
4412138|NCT00227877|4237453|B5||College/university degree or higher|Parents Highest Education Level||Participants|Count of Participants|1165|1165.0||||||
4412139|NCT00227877|4237454|B4||College/university degree or higher|Parents Highest Education Level||Participants|Count of Participants|100|100.0||||||
4412140|NCT00227877|4237455|B3||College/university degree or higher|Parents Highest Education Level||Participants|Count of Participants|92|92.0||||||
4412141|NCT00227877|4237456|B2||College/university degree or higher|Parents Highest Education Level||Participants|Count of Participants|522|522.0||||||
4412142|NCT00227877|4237457|B1||College/university degree or higher|Parents Highest Education Level||Participants|Count of Participants|451|451.0||||||
4412143|NCT00227877|4237453|B5||One parent or Other|Parents at Home||Participants|Count of Participants|839|839.0||||||
4412144|NCT00227877|4237454|B4||One parent or Other|Parents at Home||Participants|Count of Participants|97|97.0||||||
4412145|NCT00227877|4237455|B3||One parent or Other|Parents at Home||Participants|Count of Participants|107|107.0||||||
4412146|NCT00227877|4237456|B2||One parent or Other|Parents at Home||Participants|Count of Participants|294|294.0||||||
4412147|NCT00227877|4237457|B1||One parent or Other|Parents at Home||Participants|Count of Participants|341|341.0||||||
4412148|NCT00227877|4237453|B5||Two parents|Parents at Home||Participants|Count of Participants|1803|1803.0||||||
4412149|NCT00227877|4237454|B4||Two parents|Parents at Home||Participants|Count of Participants|195|195.0||||||
4412150|NCT00227877|4237455|B3||Two parents|Parents at Home||Participants|Count of Participants|184|184.0||||||
4412151|NCT00227877|4237456|B2||Two parents|Parents at Home||Participants|Count of Participants|721|721.0||||||
4412152|NCT00227877|4237457|B1||Two parents|Parents at Home||Participants|Count of Participants|703|703.0||||||
4412153|NCT00227877|4237453|B5|Other non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|145|145.0||||||
4412154|NCT00227877|4237454|B4|Other non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4412155|NCT00227877|4237455|B3|Other non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4412156|NCT00227877|4237456|B2|Other non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4412157|NCT00227877|4237457|B1|Other non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|96|96.0||||||
4412158|NCT00227877|4237453|B5|Black non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|217|217.0||||||
4412159|NCT00227877|4237454|B4|Black non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4412160|NCT00227877|4237455|B3|Black non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4412161|NCT00227877|4237456|B2|Black non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|117|117.0||||||
4412162|NCT00227877|4237457|B1|Black non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|100|100.0||||||
4412163|NCT00227877|4237453|B5|Asian non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|151|151.0||||||
4412164|NCT00227877|4237454|B4|Asian non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4412165|NCT00227877|4237455|B3|Asian non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4412166|NCT00227877|4237456|B2|Asian non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|74|74.0||||||
4412167|NCT00227877|4237457|B1|Asian non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|77|77.0||||||
4412168|NCT00227877|4237453|B5|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|230|230.0||||||
4412169|NCT00227877|4237454|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4412170|NCT00227877|4237455|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4412171|NCT00227877|4237456|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|124|124.0||||||
4412172|NCT00227877|4237457|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|106|106.0||||||
4412173|NCT00227877|4237453|B5|White non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1942|1942.0||||||
4412174|NCT00227877|4237454|B4|White non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|292|292.0||||||
4412175|NCT00227877|4237455|B3|White non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|297|297.0||||||
4412176|NCT00227877|4237456|B2|White non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|664|664.0||||||
4412177|NCT00227877|4237457|B1|White non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|689|689.0||||||
4412178|NCT00227877|4237453|B5||Male|Sex: Female, Male||Participants|Count of Participants|1187|1187.0||||||
4412179|NCT00227877|4237454|B4||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4412180|NCT00227877|4237455|B3||Male|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4412181|NCT00227877|4237456|B2||Male|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
4412182|NCT00227877|4237457|B1||Male|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
4412183|NCT00227877|4237453|B5||Female|Sex: Female, Male||Participants|Count of Participants|1498|1498.0||||||
4412184|NCT00227877|4237454|B4||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4412185|NCT00227877|4237455|B3||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4412186|NCT00227877|4237456|B2||Female|Sex: Female, Male||Participants|Count of Participants|561|561.0||||||
4412187|NCT00227877|4237457|B1||Female|Sex: Female, Male||Participants|Count of Participants|659|659.0||||||
4412188|NCT00227877|4237453|B5|Age||Age||years|Mean|15.8|15.8|Standard Deviation|2.0|2.0|||
4412189|NCT00227877|4237454|B4|Age||Age||years|Mean|15.0|15.0|Standard Deviation|1.6|1.6|||
4412190|NCT00227877|4237455|B3|Age||Age||years|Mean|15.0|15.0|Standard Deviation|1.6|1.6|||
4412191|NCT00227877|4237456|B2|Age||Age||years|Mean|15.6|15.6|Standard Deviation|2.0|2.0|||
4412192|NCT00227877|4237457|B1|Age||Age||years|Mean|15.9|15.9|Standard Deviation|2.0|2.0|||
4412193|NCT00227760|4237490|B1|Canada||Region of Enrollment||participants|Number|44|44.0||||||
4412194|NCT00227760|4237490|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4412195|NCT00227760|4237490|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4412196|NCT00227760|4237490|B1|||Age||years|Median|62|62.0|Full Range|||44.0|83.0|
4412197|NCT00227760|4237490|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4412198|NCT00227760|4237490|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4412199|NCT00227760|4237490|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412200|NCT00227721|4237496|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4412201|NCT00227721|4237496|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412202|NCT00227721|4237496|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4412203|NCT00227721|4237496|B1|||Age||years|Median|57.5|57.5|Full Range|||41.0|80.0|
4412204|NCT00227591|4237500|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4412205|NCT00227591|4237500|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4412206|NCT00227591|4237500|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4412207|NCT00227591|4237500|B1|||Age||years|Mean|63|63.0|Standard Deviation|11.2|11.2|||
4412209|NCT00227591|4237500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4412210|NCT00227591|4237500|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412211|NCT00227539|4237504|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4412212|NCT00227539|4237504|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4412213|NCT00227539|4237504|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4412214|NCT00227539|4237504|B1|||Age||years|Median|62|62.0|Full Range|||47.0|74.0|
4412215|NCT00227539|4237504|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4412216|NCT00227539|4237504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4412217|NCT00227539|4237504|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412218|NCT00227370|4237510|B3|No supplemental oxygen use||Daily Supplemental Oxygen Use|the number of subjects requiring supplemental daily oxygen through nasal canula or face mask.|subjects|Number|32|32.0||||||
4412219|NCT00227370|4237511|B2|No supplemental oxygen use||Daily Supplemental Oxygen Use|the number of subjects requiring supplemental daily oxygen through nasal canula or face mask.|subjects|Number|19|19.0||||||
4412220|NCT00227370|4237512|B1|No supplemental oxygen use||Daily Supplemental Oxygen Use|the number of subjects requiring supplemental daily oxygen through nasal canula or face mask.|subjects|Number|13|13.0||||||
4412221|NCT00227370|4237510|B3|Supplemental Oxygen use||Daily Supplemental Oxygen Use|the number of subjects requiring supplemental daily oxygen through nasal canula or face mask.|subjects|Number|104|104.0||||||
4412222|NCT00227370|4237511|B2|Supplemental Oxygen use||Daily Supplemental Oxygen Use|the number of subjects requiring supplemental daily oxygen through nasal canula or face mask.|subjects|Number|51|51.0||||||
4412223|NCT00227370|4237512|B1|Supplemental Oxygen use||Daily Supplemental Oxygen Use|the number of subjects requiring supplemental daily oxygen through nasal canula or face mask.|subjects|Number|53|53.0||||||
4412224|NCT00227370|4237510|B3|Current Smoking||Smoking History|Placebo Treatment Past:44/66 49/70 Current: 0 0 No hx:22/66 21/70|subjects|Number|0|0.0||||||
4412225|NCT00227370|4237511|B2|Current Smoking||Smoking History|Placebo Treatment Past:44/66 49/70 Current: 0 0 No hx:22/66 21/70|subjects|Number|0|0.0||||||
4412226|NCT00227370|4237512|B1|Current Smoking||Smoking History|Placebo Treatment Past:44/66 49/70 Current: 0 0 No hx:22/66 21/70|subjects|Number|0|0.0||||||
4412227|NCT00227370|4237510|B3|Past Smoking History: former smokers who quit||Smoking History|Placebo Treatment Past:44/66 49/70 Current: 0 0 No hx:22/66 21/70|subjects|Number|93|93.0||||||
4412228|NCT00227370|4237511|B2|Past Smoking History: former smokers who quit||Smoking History|Placebo Treatment Past:44/66 49/70 Current: 0 0 No hx:22/66 21/70|subjects|Number|49|49.0||||||
4412229|NCT00227370|4237512|B1|Past Smoking History: former smokers who quit||Smoking History|Placebo Treatment Past:44/66 49/70 Current: 0 0 No hx:22/66 21/70|subjects|Number|44|44.0||||||
4412230|NCT00227370|4237510|B3|No Smoking History/Never Smoked (past or present)||Smoking History|Placebo Treatment Past:44/66 49/70 Current: 0 0 No hx:22/66 21/70|subjects|Number|43|43.0||||||
4412231|NCT00227370|4237511|B2|No Smoking History/Never Smoked (past or present)||Smoking History|Placebo Treatment Past:44/66 49/70 Current: 0 0 No hx:22/66 21/70|subjects|Number|21|21.0||||||
4412232|NCT00227370|4237512|B1|No Smoking History/Never Smoked (past or present)||Smoking History|Placebo Treatment Past:44/66 49/70 Current: 0 0 No hx:22/66 21/70|subjects|Number|22|22.0||||||
4412233|NCT00227370|4237510|B3|||6MWD, feet|the distance in feet a subject walks in 6 minutes|feet|Median|1155|1155.0|Inter-Quartile Range|||945.0|1380.0|
4412234|NCT00227370|4237511|B2|||6MWD, feet|the distance in feet a subject walks in 6 minutes|feet|Median|1120|1120.0|Inter-Quartile Range|||945.0|1380.0|
4412235|NCT00227370|4237512|B1|||6MWD, feet|the distance in feet a subject walks in 6 minutes|feet|Median|1168|1168.0|Inter-Quartile Range|||946.0|1350.0|
4412236|NCT00227370|4237510|B3|||FVC, liters|forced vital capacity|liters|Median|1.95|1.95|Inter-Quartile Range|||1.51|2.48|
4412237|NCT00227370|4237511|B2|||FVC, liters|forced vital capacity|liters|Median|1.89|1.89|Inter-Quartile Range|||1.49|2.32|
4412238|NCT00227370|4237512|B1|||FVC, liters|forced vital capacity|liters|Median|2.02|2.02|Inter-Quartile Range|||1.52|2.62|
4412239|NCT00227370|4237510|B3|Other||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|8|8.0||||||
4412240|NCT00227370|4237511|B2|Other||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|6|6.0||||||
4412241|NCT00227370|4237512|B1|Other||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|2|2.0||||||
4412242|NCT00227370|4237510|B3|Sarcoid||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|5|5.0||||||
4412243|NCT00227370|4237511|B2|Sarcoid||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|3|3.0||||||
4412244|NCT00227370|4237512|B1|Sarcoid||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|2|2.0||||||
4412245|NCT00227370|4237510|B3|Cystic Fibrosis||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|23|23.0||||||
4412246|NCT00227370|4237511|B2|Cystic Fibrosis||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|12|12.0||||||
4412247|NCT00227370|4237512|B1|Cystic Fibrosis||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|11|11.0||||||
4412248|NCT00227370|4237510|B3|Idiopathic Pulmonary Fibrosis||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|32|32.0||||||
4412249|NCT00227370|4237511|B2|Idiopathic Pulmonary Fibrosis||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|16|16.0||||||
4412250|NCT00227370|4237512|B1|Idiopathic Pulmonary Fibrosis||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|16|16.0||||||
4412251|NCT00227370|4237510|B3|COPD||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|68|68.0||||||
4412252|NCT00227370|4237511|B2|COPD||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|33|33.0||||||
4412253|NCT00227370|4237512|B1|COPD||Indication for Lung Transplant|"Placebo Group: Treatment Group:~COPD: 35 33 Cystic Fibrosis: 11 12 IPF: 16 16 Sarcoid: 2 3 Other: 2 6"|subjects|Number|35|35.0||||||
4412254|NCT00227370|4237510|B3|||FEV1, liters|Forced Expiratory Volume in 1 second, liters|liters|Median|0.79|0.79|Inter-Quartile Range|||0.57|1.24|
4412255|NCT00227370|4237511|B2|||FEV1, liters|Forced Expiratory Volume in 1 second, liters|liters|Median|0.80|0.8|Inter-Quartile Range|||0.64|1.23|
4412256|NCT00227370|4237512|B1|||FEV1, liters|Forced Expiratory Volume in 1 second, liters|liters|Median|0.75|0.75|Inter-Quartile Range|||0.53|1.32|
4412257|NCT00227370|4237510|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412258|NCT00227370|4237511|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412259|NCT00227370|4237512|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412260|NCT00227370|4237510|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412261|NCT00227370|4237511|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412262|NCT00227370|4237512|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412263|NCT00227370|4237510|B3||White|Race (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4412264|NCT00227370|4237511|B2||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4412265|NCT00227370|4237512|B1||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4412266|NCT00227370|4237510|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4412267|NCT00227370|4237511|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4412268|NCT00227370|4237512|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4412269|NCT00227370|4237510|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412270|NCT00227370|4237511|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412271|NCT00227370|4237512|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412272|NCT00227370|4237510|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412273|NCT00227370|4237511|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412274|NCT00227370|4237512|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412275|NCT00227370|4237510|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412276|NCT00227370|4237511|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412277|NCT00227370|4237512|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412278|NCT00227370|4237510|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4412279|NCT00227370|4237511|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4412280|NCT00227370|4237512|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4412281|NCT00227370|4237510|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4412282|NCT00227370|4237511|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4412283|NCT00227370|4237512|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4412284|NCT00227370|4237510|B3|Age||Age||years|Mean|51.3|51.3|Standard Deviation|13.0|13.0|||
4412285|NCT00227370|4237511|B2|Age||Age||years|Mean|51.9|51.9|Standard Deviation|12.2|12.2|||
4412286|NCT00227370|4237512|B1|Age||Age||years|Mean|50.6|50.6|Standard Deviation|13.8|13.8|||
4412287|NCT00227344|4237531|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4412288|NCT00227344|4237532|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4412289|NCT00227344|4237533|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4412290|NCT00227344|4237531|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4412291|NCT00227344|4237532|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4412292|NCT00227344|4237533|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4412293|NCT00227344|4237531|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|8.5|8.5|||
4412294|NCT00227344|4237532|B2|||Age||years|Mean|64.3|64.3|Standard Deviation|4.7|4.7|||
4412295|NCT00227344|4237533|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|8.9|8.9|||
4412296|NCT00227305|4237554|B1|Schizophrenia||Diagnosis||participant from feeder studies|Number|175|175.0||||||
4412297|NCT00227305|4237554|B1|Bipolar||Diagnosis||participant from feeder studies|Number|205|205.0||||||
4412298|NCT00227305|4237554|B1||Male|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4412299|NCT00227305|4237554|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4412300|NCT00227305|4237554|B1|13 - 18 years||Age, Customized||Participants|Number|293|293.0||||||
4412301|NCT00227305|4237554|B1|10 - 12 years||Age, Customized||Participants|Number|87|87.0||||||
4412302|NCT00227266|4237568|B4|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4412303|NCT00227266|4237569|B3|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4412304|NCT00227266|4237570|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4412305|NCT00227266|4237571|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4412306|NCT00227266|4237568|B4|United States||Region of Enrollment||participants|Number|80|80.0||||||
4412307|NCT00227266|4237569|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4412308|NCT00227266|4237570|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4412309|NCT00227266|4237571|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4412310|NCT00227266|4237568|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4412311|NCT00227266|4237569|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4412312|NCT00227266|4237570|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4412313|NCT00227266|4237571|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4412314|NCT00227266|4237568|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412315|NCT00227266|4237569|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412316|NCT00227266|4237570|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412317|NCT00227266|4237571|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412318|NCT00227266|4237568|B4||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4412319|NCT00227266|4237569|B3||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4412320|NCT00227266|4237570|B2||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4412321|NCT00227266|4237571|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4412322|NCT00227266|4237568|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4412323|NCT00227266|4237569|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412324|NCT00227266|4237570|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412325|NCT00227266|4237571|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4412326|NCT00227266|4237568|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412327|NCT00227266|4237569|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412328|NCT00227266|4237570|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412329|NCT00227266|4237571|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412330|NCT00227266|4237568|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4412331|NCT00227266|4237569|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4412332|NCT00227266|4237570|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4412333|NCT00227266|4237571|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4412334|NCT00227266|4237568|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412335|NCT00227266|4237569|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412336|NCT00227266|4237570|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412337|NCT00227266|4237571|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412338|NCT00227266|4237568|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4412339|NCT00227266|4237569|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4412340|NCT00227266|4237570|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4412341|NCT00227266|4237571|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412342|NCT00227266|4237568|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4412343|NCT00227266|4237569|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4412344|NCT00227266|4237570|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4412345|NCT00227266|4237571|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4412346|NCT00227266|4237568|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4412347|NCT00227266|4237569|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412348|NCT00227266|4237570|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4412349|NCT00227266|4237571|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4412350|NCT00227266|4237568|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4412351|NCT00227266|4237569|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4412352|NCT00227266|4237570|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4412353|NCT00227266|4237571|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4412354|NCT00227266|4237568|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4412355|NCT00227266|4237569|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4412356|NCT00227266|4237570|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4412357|NCT00227266|4237571|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4412358|NCT00227266|4237568|B4|||Age||years|Mean|5.4|5.4|Standard Deviation|3.0|3.0|||
4412359|NCT00227266|4237569|B3|||Age||years|Mean|7.3|7.3|Standard Deviation|3.7|3.7|||
4412360|NCT00227266|4237570|B2|||Age||years|Mean|4.3|4.3|Standard Deviation|2.1|2.1|||
4412361|NCT00227266|4237571|B1|||Age||years|Mean|4.4|4.4|Standard Deviation|1.9|1.9|||
4412362|NCT00227266|4237568|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4412363|NCT00227266|4237569|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4412364|NCT00227266|4237570|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4412365|NCT00227266|4237571|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4412366|NCT00227266|4237568|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4412367|NCT00227266|4237569|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4412368|NCT00227266|4237570|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4412369|NCT00227266|4237571|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4412370|NCT00227266|4237568|B4||<=18 years|Age||Participants|Count of Participants|94|94.0||||||
4412371|NCT00227266|4237569|B3||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4412372|NCT00227266|4237570|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4412373|NCT00227266|4237571|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4412374|NCT00227019|4237593|B1|Not otherwise specified (NOS)||Histology|Histology refers to the type of non-small cell lung cancer (NSCLC)|participants|Number|4|4.0||||||
4412375|NCT00227019|4237593|B1|Large cell carinoma||Histology|Histology refers to the type of non-small cell lung cancer (NSCLC)|participants|Number|0|0.0||||||
4412376|NCT00227019|4237593|B1|Adeno-carcinoma||Histology|Histology refers to the type of non-small cell lung cancer (NSCLC)|participants|Number|12|12.0||||||
4412377|NCT00227019|4237593|B1|2||Eastern Cooperative Oncology Group (ECOG) performance status|"ECOG performance status~0 = Fully active, able to carry on all pre-disease performance without restriction~1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work~2 = Unable to work, must sit or lie > 50% waking hours~3 = Capable of limited selfcare; confined to bed or chair > 50% waking hours~4 = Completely disabled; cannot carry on any selfcare; totally confined to bed/chair~5 = Deceased"|participants|Number|1|1.0||||||
4412378|NCT00227019|4237593|B1|0-1||Eastern Cooperative Oncology Group (ECOG) performance status|"ECOG performance status~0 = Fully active, able to carry on all pre-disease performance without restriction~1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work~2 = Unable to work, must sit or lie > 50% waking hours~3 = Capable of limited selfcare; confined to bed or chair > 50% waking hours~4 = Completely disabled; cannot carry on any selfcare; totally confined to bed/chair~5 = Deceased"|participants|Number|15|15.0||||||
4412379|NCT00227019|4237593|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412380|NCT00227019|4237593|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412381|NCT00227019|4237593|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4412382|NCT00227019|4237593|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412383|NCT00227019|4237593|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412384|NCT00227019|4237593|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4412385|NCT00227019|4237593|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412386|NCT00227019|4237593|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
4412387|NCT00227019|4237593|B1||Female|Gender||Participants|Count of Participants|9|9.0||||||
4412388|NCT00227019|4237593|B1|||Age||years|Median|60|60.0|Full Range|||33.0|78.0|
4412389|NCT00226941|4237599|B5||Adenosarcoma|Histology||Participants|Count of Participants|1|1.0||||||
4412390|NCT00226941|4237600|B4||Adenosarcoma|Histology||Participants|Count of Participants|0|0.0||||||
4412391|NCT00226941|4237601|B3||Adenosarcoma|Histology||Participants|Count of Participants|1|1.0||||||
4412392|NCT00226941|4237602|B2||Adenosarcoma|Histology||Participants|Count of Participants|0|0.0||||||
4412393|NCT00226941|4237603|B1||Adenosarcoma|Histology||Participants|Count of Participants|0|0.0||||||
4412394|NCT00226941|4237599|B5||Adenocarcinoma, Nos|Histology||Participants|Count of Participants|17|17.0||||||
4412395|NCT00226941|4237600|B4||Adenocarcinoma, Nos|Histology||Participants|Count of Participants|3|3.0||||||
4412396|NCT00226941|4237601|B3||Adenocarcinoma, Nos|Histology||Participants|Count of Participants|2|2.0||||||
4412397|NCT00226941|4237602|B2||Adenocarcinoma, Nos|Histology||Participants|Count of Participants|6|6.0||||||
4412398|NCT00226941|4237603|B1||Adenocarcinoma, Nos|Histology||Participants|Count of Participants|6|6.0||||||
4412399|NCT00226941|4237599|B5||Adenocarcinoid Tumor|Histology||Participants|Count of Participants|5|5.0||||||
4412400|NCT00226941|4237600|B4||Adenocarcinoid Tumor|Histology||Participants|Count of Participants|4|4.0||||||
4412401|NCT00226941|4237601|B3||Adenocarcinoid Tumor|Histology||Participants|Count of Participants|1|1.0||||||
4412402|NCT00226941|4237602|B2||Adenocarcinoid Tumor|Histology||Participants|Count of Participants|0|0.0||||||
4412403|NCT00226941|4237603|B1||Adenocarcinoid Tumor|Histology||Participants|Count of Participants|0|0.0||||||
4412404|NCT00226941|4237599|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4412405|NCT00226941|4237600|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4412406|NCT00226941|4237601|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412407|NCT00226941|4237602|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412408|NCT00226941|4237603|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4412409|NCT00226941|4237599|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412410|NCT00226941|4237600|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412411|NCT00226941|4237601|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412412|NCT00226941|4237602|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412413|NCT00226941|4237603|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412414|NCT00226941|4237599|B5||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4412415|NCT00226941|4237600|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4412416|NCT00226941|4237601|B3||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4412417|NCT00226941|4237602|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4412418|NCT00226941|4237603|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4412419|NCT00226941|4237599|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412420|NCT00226941|4237600|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412421|NCT00226941|4237601|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412422|NCT00226941|4237602|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412423|NCT00226941|4237603|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412424|NCT00226941|4237599|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412425|NCT00226941|4237600|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412426|NCT00226941|4237601|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412427|NCT00226941|4237602|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412428|NCT00226941|4237603|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412429|NCT00226941|4237599|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4412430|NCT00226941|4237600|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4412431|NCT00226941|4237601|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412432|NCT00226941|4237602|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412433|NCT00226941|4237603|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4412434|NCT00226941|4237599|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412435|NCT00226941|4237600|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412436|NCT00226941|4237601|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412437|NCT00226941|4237602|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412438|NCT00226941|4237603|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412439|NCT00226941|4237599|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412440|NCT00226941|4237600|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412441|NCT00226941|4237601|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412442|NCT00226941|4237602|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412443|NCT00226941|4237603|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412444|NCT00226941|4237599|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4412445|NCT00226941|4237600|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4412446|NCT00226941|4237601|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4412447|NCT00226941|4237602|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4412448|NCT00226941|4237603|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4412449|NCT00226941|4237599|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4412450|NCT00226941|4237600|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4412451|NCT00226941|4237601|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412452|NCT00226941|4237602|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412453|NCT00226941|4237603|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412454|NCT00226941|4237599|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4412455|NCT00226941|4237600|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4412456|NCT00226941|4237601|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4412457|NCT00226941|4237602|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4412458|NCT00226941|4237603|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4412459|NCT00226941|4237599|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4412460|NCT00226941|4237600|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4412461|NCT00226941|4237601|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412462|NCT00226941|4237602|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4412463|NCT00226941|4237603|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4412464|NCT00226941|4237599|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4412465|NCT00226941|4237600|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4412466|NCT00226941|4237601|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4412467|NCT00226941|4237602|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4412468|NCT00226941|4237603|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4412469|NCT00226941|4237599|B5||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4412470|NCT00226941|4237600|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4412471|NCT00226941|4237601|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4412472|NCT00226941|4237602|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4412473|NCT00226941|4237603|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4412474|NCT00226941|4237599|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412475|NCT00226941|4237600|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412476|NCT00226941|4237601|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412477|NCT00226941|4237602|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412478|NCT00226941|4237603|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412479|NCT00226811|4237640|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4412480|NCT00226811|4237640|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4412481|NCT00226811|4237640|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|12.4|12.4|||
4412482|NCT00226655|4237650|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4412483|NCT00226655|4237650|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4412484|NCT00226655|4237650|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4412485|NCT00226655|4237650|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
4412486|NCT00226655|4237650|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4412487|NCT00226655|4237650|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4412488|NCT00226655|4237650|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|11.0|11.0|||
4412489|NCT00226655|4237650|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4412490|NCT00226655|4237650|B1||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4412491|NCT00226655|4237650|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412492|NCT00226590|4237654|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4412493|NCT00226590|4237654|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4412494|NCT00226590|4237654|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4412495|NCT00226590|4237654|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4412496|NCT00226590|4237654|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4412497|NCT00226590|4237654|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412498|NCT00226577|4237661|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4412499|NCT00226577|4237661|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4412500|NCT00226577|4237661|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4412501|NCT00226577|4237661|B1|||Age||years|Median|67|67.0|Full Range|||41.0|83.0|
4412502|NCT00226577|4237661|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4412503|NCT00226577|4237661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4412504|NCT00226577|4237661|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412505|NCT00226239|4237669|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4412506|NCT00226239|4237669|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4412507|NCT00226239|4237669|B1|||Age||years|Median|55|55.0|Full Range|||21.0|74.0|
4412508|NCT00225784|4237678|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4412509|NCT00225784|4237678|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4412510|NCT00225784|4237678|B1|>=65 years||Age||years|Mean|73.1|73.1|Inter-Quartile Range|||67.0|82.0|
4412511|NCT00225784|4237678|B1|Between 18 and 65 years||Age||years|Mean|54.7|54.7|Inter-Quartile Range|||39.0|65.0|
4412512|NCT00225758|4237689|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4412513|NCT00225758|4237689|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412514|NCT00225758|4237689|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412515|NCT00225758|4237689|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4412516|NCT00225758|4237689|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412517|NCT00225758|4237689|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412518|NCT00225758|4237689|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412519|NCT00225758|4237689|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412520|NCT00225758|4237689|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412521|NCT00225758|4237689|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4412522|NCT00225758|4237689|B1|||Age||years|Median|62|62.0|Inter-Quartile Range|||52.0|70.0|
4412523|NCT00225732|4237697|B3|Greater than 75 kilograms||Weight||Kilograms|Number|201|201.0||||||
4412524|NCT00225732|4237698|B2|Greater than 75 kilograms||Weight||Kilograms|Number|105|105.0||||||
4412525|NCT00225732|4237699|B1|Greater than 75 kilograms||Weight||Kilograms|Number|96|96.0||||||
4412526|NCT00225732|4237697|B3|Less than or equal to 75 kilograms||Weight||Kilograms|Number|118|118.0||||||
4412527|NCT00225732|4237698|B2|Less than or equal to 75 kilograms||Weight||Kilograms|Number|61|61.0||||||
4412528|NCT00225732|4237699|B1|Less than or equal to 75 kilograms||Weight||Kilograms|Number|57|57.0||||||
4412529|NCT00225732|4237697|B3|United States||Region of Enrollment||participants|Number|319|319.0||||||
4412530|NCT00225732|4237698|B2|United States||Region of Enrollment||participants|Number|166|166.0||||||
4412531|NCT00225732|4237699|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
4412532|NCT00225732|4237697|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4412533|NCT00225732|4237698|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4412534|NCT00225732|4237699|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4412535|NCT00225732|4237697|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4412536|NCT00225732|4237698|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4412537|NCT00225732|4237699|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4412538|NCT00225732|4237697|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4412539|NCT00225732|4237698|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4412540|NCT00225732|4237699|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4412541|NCT00225732|4237697|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|175|175.0||||||
4412542|NCT00225732|4237698|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|84|84.0||||||
4412543|NCT00225732|4237699|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
4412544|NCT00225732|4237697|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|123|123.0||||||
4412545|NCT00225732|4237698|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
4412546|NCT00225732|4237699|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|52|52.0||||||
4412547|NCT00225732|4237697|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412548|NCT00225732|4237698|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412549|NCT00225732|4237699|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412550|NCT00225732|4237697|B3||Female|Sex: Female, Male||Participants|Count of Participants|319|319.0||||||
4412551|NCT00225732|4237698|B2||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4412552|NCT00225732|4237699|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4412553|NCT00225732|4237697|B3|45 to 70 years of age||Age, Customized||participants|Number|105|105.0||||||
4412554|NCT00225732|4237698|B2|45 to 70 years of age||Age, Customized||participants|Number|56|56.0||||||
4412555|NCT00225732|4237699|B1|45 to 70 years of age||Age, Customized||participants|Number|49|49.0||||||
4412556|NCT00225732|4237697|B3|Less than or equal to 45 years||Age, Customized||participants|Number|214|214.0||||||
4412557|NCT00225732|4237698|B2|Less than or equal to 45 years||Age, Customized||participants|Number|110|110.0||||||
4412558|NCT00225732|4237699|B1|Less than or equal to 45 years||Age, Customized||participants|Number|104|104.0||||||
4412559|NCT00225498|4237706|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4412560|NCT00225498|4237706|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4412561|NCT00225498|4237706|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4412562|NCT00225498|4237706|B1|||Age||years|Mean|34.2834|34.2834|Standard Deviation|8.83101|8.83101|||
4412563|NCT00225498|4237706|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4412564|NCT00225498|4237706|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4412565|NCT00225498|4237706|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412566|NCT00225420|4237710|B1||>100 ng/mL|PSA level, ng/mL|Prostate-specific antigen (PSA) is a protein produced by cells of the prostate gland. The PSA test measures the level of PSA in the blood. PSA levels are often elevated in men with prostate cancer.|Participants|Count of Participants|3|3.0||||||
4412567|NCT00225420|4237710|B1||20-100 ng/mL|PSA level, ng/mL|Prostate-specific antigen (PSA) is a protein produced by cells of the prostate gland. The PSA test measures the level of PSA in the blood. PSA levels are often elevated in men with prostate cancer.|Participants|Count of Participants|5|5.0||||||
4412568|NCT00225420|4237710|B1||10-19 ng/mL|PSA level, ng/mL|Prostate-specific antigen (PSA) is a protein produced by cells of the prostate gland. The PSA test measures the level of PSA in the blood. PSA levels are often elevated in men with prostate cancer.|Participants|Count of Participants|4|4.0||||||
4412569|NCT00225420|4237710|B1||<10 ng/mL|PSA level, ng/mL|Prostate-specific antigen (PSA) is a protein produced by cells of the prostate gland. The PSA test measures the level of PSA in the blood. PSA levels are often elevated in men with prostate cancer.|Participants|Count of Participants|6|6.0||||||
4412570|NCT00225420|4237710|B1|Grade 8-10||Gleason Score|A Gleason score is given based on how the prostate cancer tissue looks under the microscope. Gleason scores range from 2 to 10 and indicates how likely the tumor will spread. The higher the Gleason score the more likely the cancer tissue will spread.|Participants|Count of Participants|15|15.0||||||
4412571|NCT00225420|4237710|B1|Grade 7||Gleason Score|A Gleason score is given based on how the prostate cancer tissue looks under the microscope. Gleason scores range from 2 to 10 and indicates how likely the tumor will spread. The higher the Gleason score the more likely the cancer tissue will spread.|Participants|Count of Participants|3|3.0||||||
4412572|NCT00225420|4237710|B1||T3|Clinical Stage|The Classification of Malignant Tumours (TNM) system is a widely used cancer staging system. The T refers to the size and extent of the main tumor. The main tumor is usually called the primary tumor. T0 means the main tumor cannot be found. The higher the number following T, the larger the tumor or the more it has grown.|Participants|Count of Participants|4|4.0||||||
4412573|NCT00225420|4237710|B1||T2b-T2c|Clinical Stage|The Classification of Malignant Tumours (TNM) system is a widely used cancer staging system. The T refers to the size and extent of the main tumor. The main tumor is usually called the primary tumor. T0 means the main tumor cannot be found. The higher the number following T, the larger the tumor or the more it has grown.|Participants|Count of Participants|5|5.0||||||
4412574|NCT00225420|4237710|B1||T1c-T2a|Clinical Stage|The Classification of Malignant Tumours (TNM) system is a widely used cancer staging system. The T refers to the size and extent of the main tumor. The main tumor is usually called the primary tumor. T0 means the main tumor cannot be found. The higher the number following T, the larger the tumor or the more it has grown.|Participants|Count of Participants|9|9.0||||||
4412575|NCT00225420|4237710|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4412576|NCT00225420|4237710|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412577|NCT00225420|4237710|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412578|NCT00225420|4237710|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4412579|NCT00225420|4237710|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4412580|NCT00225420|4237710|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412581|NCT00225420|4237710|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412582|NCT00225420|4237710|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412583|NCT00225420|4237710|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4412584|NCT00225420|4237710|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412585|NCT00225420|4237710|B1|||Age||years|Mean|62|62.0|Full Range|||45.0|77.0|
4412586|NCT00225277|4237719|B3|||Duration of Diabetes Mellitus|The mean for total was calculated as the weighted average of the means of the two treatment arms.|Months|Mean|97.1|97.1|Full Range|0|0.0|0.0|624.0|
4412587|NCT00225277|4237720|B2|||Duration of Diabetes Mellitus|The mean for total was calculated as the weighted average of the means of the two treatment arms.|Months|Mean|96.3|96.3|Full Range|89.51|89.51|0.0|556.0|
4412588|NCT00225277|4237721|B1|||Duration of Diabetes Mellitus|The mean for total was calculated as the weighted average of the means of the two treatment arms.|Months|Mean|98.0|98.0|Full Range|100.25|100.25|0.0|624.0|
4412589|NCT00225277|4237719|B3|||Duration of Coronary Artery Disease|The mean for total was calculated as the weighted average of the means of the two treatment arms.|Months|Mean|40.4|40.4|Full Range|0|0.0|0.0|468.0|
4412590|NCT00225277|4237720|B2|||Duration of Coronary Artery Disease|The mean for total was calculated as the weighted average of the means of the two treatment arms.|Months|Mean|40.5|40.5|Full Range|67.20|67.2|0.0|468.0|
4412591|NCT00225277|4237721|B1|||Duration of Coronary Artery Disease|The mean for total was calculated as the weighted average of the means of the two treatment arms.|Months|Mean|40.4|40.4|Full Range|65.10|65.1|0.0|378.0|
4412592|NCT00225277|4237719|B3|||Body Mass Index|The mean for total was calculated as the weighted average of the means of the two treatment arms.|Kg/m squared|Mean|32.05|32.05|Full Range|0|0.0|19.7|49.3|
4412593|NCT00225277|4237720|B2|||Body Mass Index|The mean for total was calculated as the weighted average of the means of the two treatment arms.|Kg/m squared|Mean|32.03|32.03|Full Range|5.233|5.233|19.7|47.9|
4412594|NCT00225277|4237721|B1|||Body Mass Index|The mean for total was calculated as the weighted average of the means of the two treatment arms.|Kg/m squared|Mean|32.08|32.08|Full Range|5.264|5.264|21.1|49.3|
4412595|NCT00225277|4237719|B3|No Family History||Family History of Coronary Artery Disease|Was first degree male or female relative diagnosed with Coronary Artery Disease at age < 55 years or < 65 years, respectively?|Participants|Number|256|256.0||||||
4412596|NCT00225277|4237720|B2|No Family History||Family History of Coronary Artery Disease|Was first degree male or female relative diagnosed with Coronary Artery Disease at age < 55 years or < 65 years, respectively?|Participants|Number|137|137.0||||||
4412597|NCT00225277|4237721|B1|No Family History||Family History of Coronary Artery Disease|Was first degree male or female relative diagnosed with Coronary Artery Disease at age < 55 years or < 65 years, respectively?|Participants|Number|119|119.0||||||
4412598|NCT00225277|4237719|B3|Female Relative History||Family History of Coronary Artery Disease|Was first degree male or female relative diagnosed with Coronary Artery Disease at age < 55 years or < 65 years, respectively?|Participants|Number|119|119.0||||||
4412599|NCT00225277|4237720|B2|Female Relative History||Family History of Coronary Artery Disease|Was first degree male or female relative diagnosed with Coronary Artery Disease at age < 55 years or < 65 years, respectively?|Participants|Number|59|59.0||||||
4412600|NCT00225277|4237721|B1|Female Relative History||Family History of Coronary Artery Disease|Was first degree male or female relative diagnosed with Coronary Artery Disease at age < 55 years or < 65 years, respectively?|Participants|Number|60|60.0||||||
4412601|NCT00225277|4237719|B3|Male Relative History||Family History of Coronary Artery Disease|Was first degree male or female relative diagnosed with Coronary Artery Disease at age < 55 years or < 65 years, respectively?|Participants|Number|168|168.0||||||
4412602|NCT00225277|4237720|B2|Male Relative History||Family History of Coronary Artery Disease|Was first degree male or female relative diagnosed with Coronary Artery Disease at age < 55 years or < 65 years, respectively?|Participants|Number|77|77.0||||||
4412603|NCT00225277|4237721|B1|Male Relative History||Family History of Coronary Artery Disease|Was first degree male or female relative diagnosed with Coronary Artery Disease at age < 55 years or < 65 years, respectively?|Participants|Number|91|91.0||||||
4412604|NCT00225277|4237719|B3|White||Race/Ethnicity, Customized||participants|Number|445|445.0||||||
4412605|NCT00225277|4237720|B2|White||Race/Ethnicity, Customized||participants|Number|220|220.0||||||
4412606|NCT00225277|4237721|B1|White||Race/Ethnicity, Customized||participants|Number|225|225.0||||||
4412607|NCT00225277|4237719|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4412608|NCT00225277|4237720|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4412609|NCT00225277|4237721|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4412610|NCT00225277|4237719|B3|Asian||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4412611|NCT00225277|4237720|B2|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4412612|NCT00225277|4237721|B1|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4412613|NCT00225277|4237719|B3|Native American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4412614|NCT00225277|4237720|B2|Native American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4412615|NCT00225277|4237721|B1|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4412616|NCT00225277|4237719|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412617|NCT00225277|4237720|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412618|NCT00225277|4237721|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412619|NCT00225277|4237719|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|409|409.0||||||
4412620|NCT00225277|4237720|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|202|202.0||||||
4412621|NCT00225277|4237721|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
4412622|NCT00225277|4237719|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4412623|NCT00225277|4237720|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4412624|NCT00225277|4237721|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4412625|NCT00225277|4237719|B3||Male|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4412626|NCT00225277|4237720|B2||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4412627|NCT00225277|4237721|B1||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4412628|NCT00225277|4237719|B3||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4412629|NCT00225277|4237720|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4412630|NCT00225277|4237721|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4412631|NCT00225277|4237719|B3||>=65 years|Age||Participants|Count of Participants|161|161.0||||||
4412632|NCT00225277|4237720|B2||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
4412633|NCT00225277|4237721|B1||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4412634|NCT00225277|4237719|B3||Between 18 and 65 years|Age||Participants|Count of Participants|382|382.0||||||
4412635|NCT00225277|4237720|B2||Between 18 and 65 years|Age||Participants|Count of Participants|193|193.0||||||
4412636|NCT00225277|4237721|B1||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4412637|NCT00225277|4237719|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412638|NCT00225277|4237720|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412639|NCT00225277|4237721|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412640|NCT00225251|4237738|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4412641|NCT00225251|4237739|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4412642|NCT00225251|4237740|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4412643|NCT00225251|4237738|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412644|NCT00225251|4237739|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412645|NCT00225251|4237740|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412646|NCT00225251|4237738|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412647|NCT00225251|4237739|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412648|NCT00225251|4237740|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412649|NCT00225251|4237738|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4412650|NCT00225251|4237739|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4412651|NCT00225251|4237740|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4412652|NCT00225251|4237738|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4412653|NCT00225251|4237739|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4412654|NCT00225251|4237740|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4412655|NCT00225251|4237738|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412656|NCT00225251|4237739|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412657|NCT00225251|4237740|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412658|NCT00225251|4237738|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412659|NCT00225251|4237739|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412660|NCT00225251|4237740|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412661|NCT00225251|4237738|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412662|NCT00225251|4237739|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412663|NCT00225251|4237740|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412664|NCT00225251|4237738|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4412665|NCT00225251|4237739|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4412666|NCT00225251|4237740|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4412667|NCT00225251|4237738|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4412668|NCT00225251|4237739|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4412669|NCT00225251|4237740|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4412670|NCT00225251|4237738|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|11.3|11.3|||
4412671|NCT00225251|4237739|B2|||Age||years|Mean|40.0|40.0|Standard Deviation|10.9|10.9|||
4412672|NCT00225251|4237740|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|11.5|11.5|||
4412673|NCT00225212|4237755|B1|Other B-cell lymphoma||Lymphoma sub-types||participants|Number|4|4.0||||||
4412674|NCT00225212|4237755|B1|Transformed lymphoma||Lymphoma sub-types||participants|Number|3|3.0||||||
4412675|NCT00225212|4237755|B1|Mantle cell lymphoma (MCL)||Lymphoma sub-types||participants|Number|3|3.0||||||
4412676|NCT00225212|4237755|B1|Diffuse large B-cell lymphoma (DLCL)||Lymphoma sub-types||participants|Number|25|25.0||||||
4412677|NCT00225212|4237755|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4412678|NCT00225212|4237755|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4412679|NCT00225212|4237755|B1|aged 16 and older||Age, Customized|B-cell lymphoma patients aged 16 and older|years|Median|51|51.0|Full Range|||28.0|70.0|
4412680|NCT00225147|4237760|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4412681|NCT00225147|4237761|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4412682|NCT00225147|4237762|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4412683|NCT00225147|4237763|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4412684|NCT00225147|4237764|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4412685|NCT00225147|4237760|B5||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4412686|NCT00225147|4237761|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4412687|NCT00225147|4237762|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4412688|NCT00225147|4237763|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4412689|NCT00225147|4237764|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4412690|NCT00225147|4237760|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4412691|NCT00225147|4237761|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4412692|NCT00225147|4237762|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4412693|NCT00225147|4237763|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4412694|NCT00225147|4237764|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4412695|NCT00225147|4237760|B5||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4412696|NCT00225147|4237761|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4412697|NCT00225147|4237762|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4412698|NCT00225147|4237763|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4412699|NCT00225147|4237764|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4412700|NCT00225147|4237760|B5||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4412701|NCT00225147|4237761|B4||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4412702|NCT00225147|4237762|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4412703|NCT00225147|4237763|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412704|NCT00225147|4237764|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4412705|NCT00225017|4237781|B3|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4412706|NCT00225017|4237782|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4412707|NCT00225017|4237783|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4412708|NCT00225017|4237781|B3|Argentina||Region of Enrollment||participants|Number|15|15.0||||||
4412709|NCT00225017|4237782|B2|Argentina||Region of Enrollment||participants|Number|7|7.0||||||
4412710|NCT00225017|4237783|B1|Argentina||Region of Enrollment||participants|Number|8|8.0||||||
4412711|NCT00225017|4237781|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4412712|NCT00225017|4237782|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4412713|NCT00225017|4237783|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4412714|NCT00225017|4237781|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4412715|NCT00225017|4237782|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4412716|NCT00225017|4237783|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4412717|NCT00225017|4237781|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4412718|NCT00225017|4237782|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4412719|NCT00225017|4237783|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4412720|NCT00225017|4237781|B3|||Age||years|Mean|43|43.0|Full Range|||25.0|68.0|
4412721|NCT00225017|4237782|B2|||Age||years|Mean|43|43.0|Full Range|||33.0|58.0|
4412722|NCT00225017|4237783|B1|||Age||years|Mean|43|43.0|Full Range|||25.0|68.0|
4412723|NCT00225017|4237781|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4412724|NCT00225017|4237782|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4412725|NCT00225017|4237783|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4412726|NCT00225017|4237781|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4412727|NCT00225017|4237782|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4412728|NCT00225017|4237783|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4412729|NCT00225017|4237781|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412730|NCT00225017|4237782|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412731|NCT00225017|4237783|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412732|NCT00224952|4237794|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4412733|NCT00224952|4237795|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4412734|NCT00224952|4237796|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412735|NCT00224952|4237797|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412736|NCT00224952|4237794|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4412737|NCT00224952|4237795|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4412738|NCT00224952|4237796|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4412739|NCT00224952|4237797|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4412740|NCT00224952|4237794|B4||White|Race (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
4412741|NCT00224952|4237795|B3||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4412742|NCT00224952|4237796|B2||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4412743|NCT00224952|4237797|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4412744|NCT00224952|4237794|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4412745|NCT00224952|4237795|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4412746|NCT00224952|4237796|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412747|NCT00224952|4237797|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4412748|NCT00224952|4237794|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412749|NCT00224952|4237795|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412750|NCT00224952|4237796|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412751|NCT00224952|4237797|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412752|NCT00224952|4237794|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4412753|NCT00224952|4237795|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4412754|NCT00224952|4237796|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4412755|NCT00224952|4237797|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412756|NCT00224952|4237794|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412757|NCT00224952|4237795|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412758|NCT00224952|4237796|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412759|NCT00224952|4237797|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412760|NCT00224952|4237794|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412761|NCT00224952|4237795|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412762|NCT00224952|4237796|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412763|NCT00224952|4237797|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4412764|NCT00224952|4237794|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|260|260.0||||||
4412765|NCT00224952|4237795|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4412766|NCT00224952|4237796|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4412767|NCT00224952|4237797|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4412768|NCT00224952|4237794|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4412769|NCT00224952|4237795|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4412770|NCT00224952|4237796|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4412771|NCT00224952|4237797|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4412772|NCT00224952|4237794|B4||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4412773|NCT00224952|4237795|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4412774|NCT00224952|4237796|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4412775|NCT00224952|4237797|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4412776|NCT00224952|4237794|B4||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4412777|NCT00224952|4237795|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4412778|NCT00224952|4237796|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4412779|NCT00224952|4237797|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4412780|NCT00224952|4237794|B4|||Age||Years|Mean|10.38|10.38|Standard Deviation|4.16|4.16|||
4412781|NCT00224952|4237795|B3|||Age||Years|Mean|10.2|10.2|Standard Deviation|4.1|4.1|||
4412782|NCT00224952|4237796|B2|||Age||Years|Mean|11.0|11.0|Standard Deviation|4.0|4.0|||
4412783|NCT00224952|4237797|B1|||Age||Years|Mean|9.8|9.8|Standard Deviation|4.6|4.6|||
4412784|NCT00224874|4237810|B5|Liver||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|25|25.0||||||
4412785|NCT00224874|4237811|B4|Liver||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|5|5.0||||||
4412786|NCT00224874|4237812|B3|Liver||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|7|7.0||||||
4412787|NCT00224874|4237813|B2|Liver||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|7|7.0||||||
4412788|NCT00224874|4237814|B1|Liver||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|6|6.0||||||
4412789|NCT00224874|4237810|B5|GI tract, upper||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|49|49.0||||||
4412790|NCT00224874|4237811|B4|GI tract, upper||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|13|13.0||||||
4412791|NCT00224874|4237812|B3|GI tract, upper||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|14|14.0||||||
4412792|NCT00224874|4237813|B2|GI tract, upper||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|12|12.0||||||
4412793|NCT00224874|4237814|B1|GI tract, upper||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|10|10.0||||||
4412794|NCT00224874|4237810|B5|GI tract, lower||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|61|61.0||||||
4412795|NCT00224874|4237811|B4|GI tract, lower||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|17|17.0||||||
4412796|NCT00224874|4237812|B3|GI tract, lower||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|14|14.0||||||
4412797|NCT00224874|4237813|B2|GI tract, lower||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|18|18.0||||||
4412798|NCT00224874|4237814|B1|GI tract, lower||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|12|12.0||||||
4412799|NCT00224874|4237810|B5|Skin||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|140|140.0||||||
4412800|NCT00224874|4237811|B4|Skin||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|34|34.0||||||
4412801|NCT00224874|4237812|B3|Skin||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|35|35.0||||||
4412802|NCT00224874|4237813|B2|Skin||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|35|35.0||||||
4412803|NCT00224874|4237814|B1|Skin||Organ Involvement at Randomization|Some participants had multiple organ involvement at time of randomization and are be considered in more then one category.|participants|Number|36|36.0||||||
4412804|NCT00224874|4237810|B5|Grade IV||Enrollment Acute GVHD||participants|Number|3|3.0||||||
4412805|NCT00224874|4237811|B4|Grade IV||Enrollment Acute GVHD||participants|Number|1|1.0||||||
4412806|NCT00224874|4237812|B3|Grade IV||Enrollment Acute GVHD||participants|Number|1|1.0||||||
4412807|NCT00224874|4237813|B2|Grade IV||Enrollment Acute GVHD||participants|Number|1|1.0||||||
4412808|NCT00224874|4237814|B1|Grade IV||Enrollment Acute GVHD||participants|Number|0|0.0||||||
4412809|NCT00224874|4237810|B5|Grade III||Enrollment Acute GVHD||participants|Number|54|54.0||||||
4412810|NCT00224874|4237811|B4|Grade III||Enrollment Acute GVHD||participants|Number|11|11.0||||||
4412811|NCT00224874|4237812|B3|Grade III||Enrollment Acute GVHD||participants|Number|15|15.0||||||
4412812|NCT00224874|4237813|B2|Grade III||Enrollment Acute GVHD||participants|Number|16|16.0||||||
4412813|NCT00224874|4237814|B1|Grade III||Enrollment Acute GVHD||participants|Number|12|12.0||||||
4412814|NCT00224874|4237810|B5|Grade II||Enrollment Acute GVHD||participants|Number|99|99.0||||||
4412815|NCT00224874|4237811|B4|Grade II||Enrollment Acute GVHD||participants|Number|26|26.0||||||
4412816|NCT00224874|4237812|B3|Grade II||Enrollment Acute GVHD||participants|Number|23|23.0||||||
4412817|NCT00224874|4237813|B2|Grade II||Enrollment Acute GVHD||participants|Number|25|25.0||||||
4412818|NCT00224874|4237814|B1|Grade II||Enrollment Acute GVHD||participants|Number|25|25.0||||||
4412819|NCT00224874|4237810|B5|Grade I||Enrollment Acute GVHD||participants|Number|23|23.0||||||
4412820|NCT00224874|4237811|B4|Grade I||Enrollment Acute GVHD||participants|Number|4|4.0||||||
4412821|NCT00224874|4237812|B3|Grade I||Enrollment Acute GVHD||participants|Number|8|8.0||||||
4412822|NCT00224874|4237813|B2|Grade I||Enrollment Acute GVHD||participants|Number|3|3.0||||||
4412823|NCT00224874|4237814|B1|Grade I||Enrollment Acute GVHD||participants|Number|8|8.0||||||
4412824|NCT00224874|4237810|B5|Grade 0||Enrollment Acute GVHD||participants|Number|1|1.0||||||
4412825|NCT00224874|4237811|B4|Grade 0||Enrollment Acute GVHD||participants|Number|0|0.0||||||
4412826|NCT00224874|4237812|B3|Grade 0||Enrollment Acute GVHD||participants|Number|0|0.0||||||
4412827|NCT00224874|4237813|B2|Grade 0||Enrollment Acute GVHD||participants|Number|0|0.0||||||
4412828|NCT00224874|4237814|B1|Grade 0||Enrollment Acute GVHD||participants|Number|1|1.0||||||
4412829|NCT00224874|4237810|B5|No||MMF Prophylaxis||participants|Number|136|136.0||||||
4412830|NCT00224874|4237811|B4|No||MMF Prophylaxis||participants|Number|28|28.0||||||
4412831|NCT00224874|4237812|B3|No||MMF Prophylaxis||participants|Number|31|31.0||||||
4412832|NCT00224874|4237813|B2|No||MMF Prophylaxis||participants|Number|45|45.0||||||
4412833|NCT00224874|4237814|B1|No||MMF Prophylaxis||participants|Number|32|32.0||||||
4412834|NCT00224874|4237810|B5|Yes||MMF Prophylaxis||participants|Number|44|44.0||||||
4412835|NCT00224874|4237811|B4|Yes||MMF Prophylaxis||participants|Number|14|14.0||||||
4412836|NCT00224874|4237812|B3|Yes||MMF Prophylaxis||participants|Number|16|16.0||||||
4412837|NCT00224874|4237813|B2|Yes||MMF Prophylaxis||participants|Number|0|0.0||||||
4412838|NCT00224874|4237814|B1|Yes||MMF Prophylaxis||participants|Number|14|14.0||||||
4412839|NCT00224874|4237810|B5|Unknown||Stem Cell Type||participants|Number|2|2.0||||||
4412840|NCT00224874|4237811|B4|Unknown||Stem Cell Type||participants|Number|1|1.0||||||
4412841|NCT00224874|4237812|B3|Unknown||Stem Cell Type||participants|Number|1|1.0||||||
4412842|NCT00224874|4237813|B2|Unknown||Stem Cell Type||participants|Number|0|0.0||||||
4412843|NCT00224874|4237814|B1|Unknown||Stem Cell Type||participants|Number|0|0.0||||||
4412844|NCT00224874|4237810|B5|Umbilical Cord Blood||Stem Cell Type||participants|Number|25|25.0||||||
4412845|NCT00224874|4237811|B4|Umbilical Cord Blood||Stem Cell Type||participants|Number|5|5.0||||||
4412846|NCT00224874|4237812|B3|Umbilical Cord Blood||Stem Cell Type||participants|Number|12|12.0||||||
4412847|NCT00224874|4237813|B2|Umbilical Cord Blood||Stem Cell Type||participants|Number|3|3.0||||||
4412848|NCT00224874|4237814|B1|Umbilical Cord Blood||Stem Cell Type||participants|Number|5|5.0||||||
4412849|NCT00224874|4237810|B5|Peripheral Blood||Stem Cell Type||participants|Number|111|111.0||||||
4412850|NCT00224874|4237811|B4|Peripheral Blood||Stem Cell Type||participants|Number|27|27.0||||||
4412851|NCT00224874|4237812|B3|Peripheral Blood||Stem Cell Type||participants|Number|19|19.0||||||
4412852|NCT00224874|4237813|B2|Peripheral Blood||Stem Cell Type||participants|Number|29|29.0||||||
4412853|NCT00224874|4237814|B1|Peripheral Blood||Stem Cell Type||participants|Number|36|36.0||||||
4412854|NCT00224874|4237810|B5|Bone Marrow||Stem Cell Type||participants|Number|42|42.0||||||
4412855|NCT00224874|4237811|B4|Bone Marrow||Stem Cell Type||participants|Number|9|9.0||||||
4412856|NCT00224874|4237812|B3|Bone Marrow||Stem Cell Type||participants|Number|15|15.0||||||
4412857|NCT00224874|4237813|B2|Bone Marrow||Stem Cell Type||participants|Number|13|13.0||||||
4412858|NCT00224874|4237814|B1|Bone Marrow||Stem Cell Type||participants|Number|5|5.0||||||
4412859|NCT00224874|4237810|B5|Unknown||Donor Status||participants|Number|3|3.0||||||
4412860|NCT00224874|4237811|B4|Unknown||Donor Status||participants|Number|1|1.0||||||
4412861|NCT00224874|4237812|B3|Unknown||Donor Status||participants|Number|1|1.0||||||
4412862|NCT00224874|4237813|B2|Unknown||Donor Status||participants|Number|0|0.0||||||
4412863|NCT00224874|4237814|B1|Unknown||Donor Status||participants|Number|1|1.0||||||
4412864|NCT00224874|4237810|B5|Unrelated||Donor Status||participants|Number|94|94.0||||||
4412865|NCT00224874|4237811|B4|Unrelated||Donor Status||participants|Number|24|24.0||||||
4412866|NCT00224874|4237812|B3|Unrelated||Donor Status||participants|Number|25|25.0||||||
4412867|NCT00224874|4237813|B2|Unrelated||Donor Status||participants|Number|21|21.0||||||
4412868|NCT00224874|4237814|B1|Unrelated||Donor Status||participants|Number|24|24.0||||||
4412869|NCT00224874|4237810|B5|Related||Donor Status||participants|Number|83|83.0||||||
4412870|NCT00224874|4237811|B4|Related||Donor Status||participants|Number|17|17.0||||||
4412871|NCT00224874|4237812|B3|Related||Donor Status||participants|Number|21|21.0||||||
4412872|NCT00224874|4237813|B2|Related||Donor Status||participants|Number|24|24.0||||||
4412873|NCT00224874|4237814|B1|Related||Donor Status||participants|Number|21|21.0||||||
4412874|NCT00224874|4237810|B5|Unknown||Conditioning Regimen||participants|Number|2|2.0||||||
4412875|NCT00224874|4237811|B4|Unknown||Conditioning Regimen||participants|Number|1|1.0||||||
4412876|NCT00224874|4237812|B3|Unknown||Conditioning Regimen||participants|Number|1|1.0||||||
4412877|NCT00224874|4237813|B2|Unknown||Conditioning Regimen||participants|Number|0|0.0||||||
4412878|NCT00224874|4237814|B1|Unknown||Conditioning Regimen||participants|Number|0|0.0||||||
4412879|NCT00224874|4237810|B5|Non-myeloablative||Conditioning Regimen||participants|Number|61|61.0||||||
4412880|NCT00224874|4237811|B4|Non-myeloablative||Conditioning Regimen||participants|Number|15|15.0||||||
4412881|NCT00224874|4237812|B3|Non-myeloablative||Conditioning Regimen||participants|Number|21|21.0||||||
4412882|NCT00224874|4237813|B2|Non-myeloablative||Conditioning Regimen||participants|Number|8|8.0||||||
4412883|NCT00224874|4237814|B1|Non-myeloablative||Conditioning Regimen||participants|Number|17|17.0||||||
4412884|NCT00224874|4237810|B5|Myeloablative||Conditioning Regimen||participants|Number|117|117.0||||||
4412885|NCT00224874|4237811|B4|Myeloablative||Conditioning Regimen||participants|Number|26|26.0||||||
4412886|NCT00224874|4237812|B3|Myeloablative||Conditioning Regimen||participants|Number|25|25.0||||||
4412887|NCT00224874|4237813|B2|Myeloablative||Conditioning Regimen||participants|Number|37|37.0||||||
4412888|NCT00224874|4237814|B1|Myeloablative||Conditioning Regimen||participants|Number|29|29.0||||||
4412889|NCT00224874|4237810|B5|Other||Primary Disease||participants|Number|35|35.0||||||
4412890|NCT00224874|4237811|B4|Other||Primary Disease||participants|Number|9|9.0||||||
4412891|NCT00224874|4237812|B3|Other||Primary Disease||participants|Number|10|10.0||||||
4412892|NCT00224874|4237813|B2|Other||Primary Disease||participants|Number|7|7.0||||||
4412893|NCT00224874|4237814|B1|Other||Primary Disease||participants|Number|9|9.0||||||
4412894|NCT00224874|4237810|B5|Lymphoma||Primary Disease||participants|Number|25|25.0||||||
4412895|NCT00224874|4237811|B4|Lymphoma||Primary Disease||participants|Number|6|6.0||||||
4412896|NCT00224874|4237812|B3|Lymphoma||Primary Disease||participants|Number|8|8.0||||||
4412897|NCT00224874|4237813|B2|Lymphoma||Primary Disease||participants|Number|6|6.0||||||
4412898|NCT00224874|4237814|B1|Lymphoma||Primary Disease||participants|Number|5|5.0||||||
4412899|NCT00224874|4237810|B5|Chronic Myeloid Leukemia (CML)||Primary Disease||participants|Number|5|5.0||||||
4412900|NCT00224874|4237811|B4|Chronic Myeloid Leukemia (CML)||Primary Disease||participants|Number|0|0.0||||||
4412901|NCT00224874|4237812|B3|Chronic Myeloid Leukemia (CML)||Primary Disease||participants|Number|1|1.0||||||
4412902|NCT00224874|4237813|B2|Chronic Myeloid Leukemia (CML)||Primary Disease||participants|Number|2|2.0||||||
4412903|NCT00224874|4237814|B1|Chronic Myeloid Leukemia (CML)||Primary Disease||participants|Number|2|2.0||||||
4412904|NCT00224874|4237810|B5|Acute Lymphoblastic Leukemia (ALL)||Primary Disease||participants|Number|26|26.0||||||
4412905|NCT00224874|4237811|B4|Acute Lymphoblastic Leukemia (ALL)||Primary Disease||participants|Number|7|7.0||||||
4412906|NCT00224874|4237812|B3|Acute Lymphoblastic Leukemia (ALL)||Primary Disease||participants|Number|4|4.0||||||
4412907|NCT00224874|4237813|B2|Acute Lymphoblastic Leukemia (ALL)||Primary Disease||participants|Number|9|9.0||||||
4412908|NCT00224874|4237814|B1|Acute Lymphoblastic Leukemia (ALL)||Primary Disease||participants|Number|6|6.0||||||
4412909|NCT00224874|4237810|B5|Acute Myeloid Leukemia (AML) / MDS||Primary Disease||participants|Number|89|89.0||||||
4412910|NCT00224874|4237811|B4|Acute Myeloid Leukemia (AML) / MDS||Primary Disease||participants|Number|20|20.0||||||
4412911|NCT00224874|4237812|B3|Acute Myeloid Leukemia (AML) / MDS||Primary Disease||participants|Number|24|24.0||||||
4412912|NCT00224874|4237813|B2|Acute Myeloid Leukemia (AML) / MDS||Primary Disease||participants|Number|21|21.0||||||
4412913|NCT00224874|4237814|B1|Acute Myeloid Leukemia (AML) / MDS||Primary Disease||participants|Number|24|24.0||||||
4412914|NCT00224874|4237810|B5||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4412915|NCT00224874|4237811|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4412916|NCT00224874|4237812|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4412917|NCT00224874|4237813|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4412918|NCT00224874|4237814|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4412919|NCT00224874|4237810|B5||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4412920|NCT00224874|4237811|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4412921|NCT00224874|4237812|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4412922|NCT00224874|4237813|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4412923|NCT00224874|4237814|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4412924|NCT00224874|4237810|B5|||Age||years|Median|50|50.0|Full Range|||8.0|70.0|
4412925|NCT00224874|4237811|B4|||Age||years|Median|53|53.0|Full Range|||24.0|68.0|
4412926|NCT00224874|4237812|B3|||Age||years|Median|51|51.0|Full Range|||11.0|67.0|
4412927|NCT00224874|4237813|B2|||Age||years|Median|42|42.0|Full Range|||13.0|63.0|
4412928|NCT00224874|4237814|B1|||Age||years|Median|50|50.0|Full Range|||8.0|70.0|
4412929|NCT00224770|4237859|B4|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4412930|NCT00224770|4237860|B3|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4412931|NCT00224770|4237861|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4412932|NCT00224770|4237862|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4412933|NCT00224770|4237859|B4|United States||Region of Enrollment||participants|Number|108|108.0||||||
4412934|NCT00224770|4237860|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4412935|NCT00224770|4237861|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
4412936|NCT00224770|4237862|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4412937|NCT00224770|4237859|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4412938|NCT00224770|4237860|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4412939|NCT00224770|4237861|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4412940|NCT00224770|4237862|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4412941|NCT00224770|4237859|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4412942|NCT00224770|4237860|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4412943|NCT00224770|4237861|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4412944|NCT00224770|4237862|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4412945|NCT00224770|4237859|B4|||Age||years|Median|61|61.0|Inter-Quartile Range|||53.3|70.0|
4412946|NCT00224770|4237860|B3|||Age||years|Median|59|59.0|Inter-Quartile Range|||53.2|68.2|
4412947|NCT00224770|4237861|B2|||Age||years|Median|60|60.0|Inter-Quartile Range|||54.0|69.0|
4412948|NCT00224770|4237862|B1|||Age||years|Median|62|62.0|Inter-Quartile Range|||49.5|73.0|
4412949|NCT00224770|4237859|B4||>=65 years|Age||Participants|Count of Participants|58|58.0||||||
4412950|NCT00224770|4237860|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4412951|NCT00224770|4237861|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4412952|NCT00224770|4237862|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4412953|NCT00224770|4237859|B4||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4412954|NCT00224770|4237860|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4412955|NCT00224770|4237861|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4412956|NCT00224770|4237862|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4412957|NCT00224770|4237859|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412958|NCT00224770|4237860|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412959|NCT00224770|4237861|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412960|NCT00224770|4237862|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412961|NCT00224484|4237896|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412962|NCT00224484|4237897|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412963|NCT00224484|4237898|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412964|NCT00224484|4237899|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412965|NCT00224484|4237896|B4||Female|Sex: Female, Male||Participants|Count of Participants|5955|5955.0||||||
4412966|NCT00224484|4237897|B3||Female|Sex: Female, Male||Participants|Count of Participants|1487|1487.0||||||
4412967|NCT00224484|4237898|B2||Female|Sex: Female, Male||Participants|Count of Participants|1491|1491.0||||||
4412968|NCT00224484|4237899|B1||Female|Sex: Female, Male||Participants|Count of Participants|2977|2977.0||||||
4412969|NCT00224484|4237896|B4|||Age||Years|Mean|13.81|13.81|Standard Deviation|2.21|2.21|||
4412970|NCT00224484|4237897|B3|||Age||Years|Mean|13.83|13.83|Standard Deviation|2.21|2.21|||
4412971|NCT00224484|4237898|B2|||Age||Years|Mean|13.81|13.81|Standard Deviation|2.21|2.21|||
4412972|NCT00224484|4237899|B1|||Age||Years|Mean|13.81|13.81|Standard Deviation|2.21|2.21|||
4412973|NCT00224289|4237960|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4412974|NCT00224289|4237960|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4412975|NCT00224289|4237960|B1|||Age||years|Mean|61.6|61.6|Standard Deviation|12.2|12.2|||
4412976|NCT00224133|4237965|B1|United States||Region of Enrollment||participants|Number|661|661.0||||||
4412977|NCT00224133|4237965|B1||Male|Sex: Female, Male||Participants|Count of Participants|661|661.0||||||
4412978|NCT00224133|4237965|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412979|NCT00224133|4237965|B1|||Age||years|Mean|65.0|65.0|Standard Deviation|7.79|7.79|||
4412980|NCT00224133|4237965|B1||>=65 years|Age||Participants|Count of Participants|305|305.0||||||
4412981|NCT00224133|4237965|B1||Between 18 and 65 years|Age||Participants|Count of Participants|356|356.0||||||
4412982|NCT00224133|4237965|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4412983|NCT00224120|4237969|B3|United States||Region of Enrollment||participants|Number|462|462.0||||||
4412984|NCT00224120|4237970|B2|United States||Region of Enrollment||participants|Number|229|229.0||||||
4412985|NCT00224120|4237971|B1|United States||Region of Enrollment||participants|Number|233|233.0||||||
4412986|NCT00224120|4237969|B3||Male|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
4412987|NCT00224120|4237970|B2||Male|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4412988|NCT00224120|4237971|B1||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4412989|NCT00224120|4237969|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412990|NCT00224120|4237970|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412991|NCT00224120|4237971|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4412992|NCT00224120|4237969|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|8.21|8.21|||
4412993|NCT00224120|4237970|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|8.23|8.23|||
4412994|NCT00224120|4237971|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|8.21|8.21|||
4412995|NCT00224120|4237969|B3||>=65 years|Age||Participants|Count of Participants|220|220.0||||||
4412996|NCT00224120|4237970|B2||>=65 years|Age||Participants|Count of Participants|110|110.0||||||
4412997|NCT00224120|4237971|B1||>=65 years|Age||Participants|Count of Participants|110|110.0||||||
4412998|NCT00224120|4237969|B3||Between 18 and 65 years|Age||Participants|Count of Participants|242|242.0||||||
4412999|NCT00224120|4237970|B2||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4413000|NCT00224120|4237971|B1||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4413001|NCT00224120|4237969|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413002|NCT00224120|4237970|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413003|NCT00224120|4237971|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413004|NCT00224107|4237980|B3|United States||Region of Enrollment||participants|Number|461|461.0||||||
4413005|NCT00224107|4237981|B2|United States||Region of Enrollment||participants|Number|228|228.0||||||
4413006|NCT00224107|4237982|B1|United States||Region of Enrollment||participants|Number|233|233.0||||||
4413007|NCT00224107|4237980|B3||Male|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
4413008|NCT00224107|4237981|B2||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4413009|NCT00224107|4237982|B1||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4413010|NCT00224107|4237980|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413011|NCT00224107|4237981|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413012|NCT00224107|4237982|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413013|NCT00224107|4237980|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|7.88|7.88|||
4413014|NCT00224107|4237981|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|7.84|7.84|||
4413015|NCT00224107|4237982|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|7.94|7.94|||
4413016|NCT00224107|4237980|B3||>=65 years|Age||Participants|Count of Participants|195|195.0||||||
4413017|NCT00224107|4237981|B2||>=65 years|Age||Participants|Count of Participants|98|98.0||||||
4413018|NCT00224107|4237982|B1||>=65 years|Age||Participants|Count of Participants|97|97.0||||||
4413019|NCT00224107|4237980|B3||Between 18 and 65 years|Age||Participants|Count of Participants|266|266.0||||||
4413020|NCT00224107|4237981|B2||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4413021|NCT00224107|4237982|B1||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4413022|NCT00224107|4237980|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413023|NCT00224107|4237981|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413024|NCT00224107|4237982|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413025|NCT00224055|4237991|B3|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4413026|NCT00224055|4237992|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4413027|NCT00224055|4237993|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4413028|NCT00224055|4237991|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4413029|NCT00224055|4237992|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4413030|NCT00224055|4237993|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4413031|NCT00224055|4237991|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4413032|NCT00224055|4237992|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4413033|NCT00224055|4237993|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4413034|NCT00224055|4237991|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4413035|NCT00224055|4237992|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4413036|NCT00224055|4237993|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4413037|NCT00224055|4237991|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|13.70|13.7|||
4413038|NCT00224055|4237992|B2|||Age||years|Mean|62.6|62.6|Standard Deviation|14.86|14.86|||
4413039|NCT00224055|4237993|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|12.27|12.27|||
4413040|NCT00224055|4237991|B3||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4413041|NCT00224055|4237992|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4413042|NCT00224055|4237993|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4413043|NCT00224055|4237991|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4413044|NCT00224055|4237992|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4413045|NCT00224055|4237993|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4413046|NCT00224055|4237991|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413047|NCT00224055|4237992|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413048|NCT00224055|4237993|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413049|NCT00224042|4238002|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4413050|NCT00224042|4238003|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4413051|NCT00224042|4238004|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4413052|NCT00224042|4238002|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4413053|NCT00224042|4238003|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4413054|NCT00224042|4238004|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4413055|NCT00224042|4238002|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4413056|NCT00224042|4238003|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4413057|NCT00224042|4238004|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4413058|NCT00224042|4238002|B3|||Age||years|Mean|66.8|66.8|Standard Deviation|16.13|16.13|||
4413059|NCT00224042|4238003|B2|||Age||years|Mean|66.1|66.1|Standard Deviation|14.65|14.65|||
4413060|NCT00224042|4238004|B1|||Age||years|Mean|67.4|67.4|Standard Deviation|17.75|17.75|||
4413061|NCT00224042|4238002|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4413062|NCT00224042|4238003|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4413063|NCT00224042|4238004|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4413064|NCT00224042|4238002|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4413065|NCT00224042|4238003|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4413066|NCT00224042|4238004|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4413067|NCT00224042|4238002|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413068|NCT00224042|4238003|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413069|NCT00224042|4238004|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413070|NCT00224029|4238017|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4413071|NCT00224029|4238017|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4413072|NCT00224029|4238017|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4413073|NCT00224029|4238017|B1|||Age||years|Mean|41.9|41.9|Standard Deviation|10.35|10.35|||
4413074|NCT00224029|4238017|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413075|NCT00224029|4238017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4413076|NCT00224029|4238017|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413077|NCT00224016|4238021|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4413078|NCT00224016|4238022|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4413079|NCT00224016|4238023|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4413080|NCT00224016|4238021|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4413081|NCT00224016|4238022|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4413082|NCT00224016|4238023|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4413083|NCT00224016|4238021|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4413084|NCT00224016|4238022|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4413085|NCT00224016|4238023|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4413086|NCT00224016|4238021|B3|||Age||years|Mean|10.6|10.6|Standard Deviation|2.76|2.76|||
4413087|NCT00224016|4238022|B2|||Age||years|Mean|11.8|11.8|Standard Deviation|2.82|2.82|||
4413088|NCT00224016|4238023|B1|||Age||years|Mean|10.2|10.2|Standard Deviation|2.64|2.64|||
4413089|NCT00224016|4238021|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413090|NCT00224016|4238022|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413091|NCT00224016|4238023|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413092|NCT00224016|4238021|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4413093|NCT00224016|4238022|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4413094|NCT00224016|4238023|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4413095|NCT00224016|4238021|B3||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4413096|NCT00224016|4238022|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4413097|NCT00224016|4238023|B1||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4413098|NCT00224003|4238032|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4413099|NCT00224003|4238032|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4413100|NCT00224003|4238032|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4413101|NCT00224003|4238032|B1|||Age||years|Mean|13.2|13.2|Standard Deviation|2.39|2.39|||
4413102|NCT00224003|4238032|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413103|NCT00224003|4238032|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4413104|NCT00224003|4238032|B1||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4413105|NCT00223977|4238036|B4|India||Region of Enrollment||participants|Number|16|16.0||||||
4413106|NCT00223977|4238037|B3|India||Region of Enrollment||participants|Number|4|4.0||||||
4413107|NCT00223977|4238038|B2|India||Region of Enrollment||participants|Number|7|7.0||||||
4413108|NCT00223977|4238039|B1|India||Region of Enrollment||participants|Number|5|5.0||||||
4413109|NCT00223977|4238036|B4|Russian Federation||Region of Enrollment||participants|Number|52|52.0||||||
4413110|NCT00223977|4238037|B3|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4413111|NCT00223977|4238038|B2|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
4413112|NCT00223977|4238039|B1|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
4413113|NCT00223977|4238036|B4|Bulgaria||Region of Enrollment||participants|Number|5|5.0||||||
4413114|NCT00223977|4238037|B3|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
4413115|NCT00223977|4238038|B2|Bulgaria||Region of Enrollment||participants|Number|3|3.0||||||
4413116|NCT00223977|4238039|B1|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
4413117|NCT00223977|4238036|B4|Croatia||Region of Enrollment||participants|Number|16|16.0||||||
4413118|NCT00223977|4238037|B3|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
4413119|NCT00223977|4238038|B2|Croatia||Region of Enrollment||participants|Number|8|8.0||||||
4413120|NCT00223977|4238039|B1|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
4413121|NCT00223977|4238036|B4|Poland||Region of Enrollment||participants|Number|24|24.0||||||
4413122|NCT00223977|4238037|B3|Poland||Region of Enrollment||participants|Number|7|7.0||||||
4413123|NCT00223977|4238038|B2|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4413124|NCT00223977|4238039|B1|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4413125|NCT00223977|4238036|B4|Mexico||Region of Enrollment||participants|Number|23|23.0||||||
4413126|NCT00223977|4238037|B3|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4413127|NCT00223977|4238038|B2|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4413128|NCT00223977|4238039|B1|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4413129|NCT00223977|4238036|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4413130|NCT00223977|4238037|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4413131|NCT00223977|4238038|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4413132|NCT00223977|4238039|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4413133|NCT00223977|4238036|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4413134|NCT00223977|4238037|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4413135|NCT00223977|4238038|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4413136|NCT00223977|4238039|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4413137|NCT00223977|4238036|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4413138|NCT00223977|4238037|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4413139|NCT00223977|4238038|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4413140|NCT00223977|4238039|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4413141|NCT00223977|4238036|B4|||Age||years|Mean|50.5|50.5|Standard Deviation|13.18|13.18|||
4413142|NCT00223977|4238037|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|12.88|12.88|||
4413143|NCT00223977|4238038|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|12.49|12.49|||
4413144|NCT00223977|4238039|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|14.11|14.11|||
4413145|NCT00223977|4238036|B4||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4413146|NCT00223977|4238037|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4413147|NCT00223977|4238038|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4413148|NCT00223977|4238039|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4413149|NCT00223977|4238036|B4||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4413150|NCT00223977|4238037|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4413151|NCT00223977|4238038|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4413152|NCT00223977|4238039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4413153|NCT00223977|4238036|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413154|NCT00223977|4238037|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413155|NCT00223977|4238038|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413156|NCT00223977|4238039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413157|NCT00223821|4238061|B3|Severe (> 10 episodes/wk)||Incontinence severity||participant|Number|39|39.0||||||
4413158|NCT00223821|4238062|B2|Severe (> 10 episodes/wk)||Incontinence severity||participant|Number|18|18.0||||||
4413159|NCT00223821|4238063|B1|Severe (> 10 episodes/wk)||Incontinence severity||participant|Number|21|21.0||||||
4413160|NCT00223821|4238061|B3|Moderate (5-10 episodes/wk)||Incontinence severity||participant|Number|17|17.0||||||
4413161|NCT00223821|4238062|B2|Moderate (5-10 episodes/wk)||Incontinence severity||participant|Number|10|10.0||||||
4413162|NCT00223821|4238063|B1|Moderate (5-10 episodes/wk)||Incontinence severity||participant|Number|7|7.0||||||
4413163|NCT00223821|4238061|B3|Mild (less than 5 episodes/wk)||Incontinence severity||participant|Number|8|8.0||||||
4413164|NCT00223821|4238062|B2|Mild (less than 5 episodes/wk)||Incontinence severity||participant|Number|4|4.0||||||
4413165|NCT00223821|4238063|B1|Mild (less than 5 episodes/wk)||Incontinence severity||participant|Number|4|4.0||||||
4413166|NCT00223821|4238061|B3|missing||Incontinence type||participants|Number|1|1.0||||||
4413167|NCT00223821|4238062|B2|missing||Incontinence type||participants|Number|1|1.0||||||
4413168|NCT00223821|4238063|B1|missing||Incontinence type||participants|Number|0|0.0||||||
4413169|NCT00223821|4238061|B3|Mixed urge + stress||Incontinence type||participants|Number|12|12.0||||||
4413170|NCT00223821|4238062|B2|Mixed urge + stress||Incontinence type||participants|Number|5|5.0||||||
4413171|NCT00223821|4238063|B1|Mixed urge + stress||Incontinence type||participants|Number|7|7.0||||||
4413172|NCT00223821|4238061|B3|Urge only||Incontinence type||participants|Number|51|51.0||||||
4413173|NCT00223821|4238062|B2|Urge only||Incontinence type||participants|Number|26|26.0||||||
4413174|NCT00223821|4238063|B1|Urge only||Incontinence type||participants|Number|25|25.0||||||
4413175|NCT00223821|4238061|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4413176|NCT00223821|4238062|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4413177|NCT00223821|4238063|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4413178|NCT00223821|4238061|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413179|NCT00223821|4238062|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413180|NCT00223821|4238063|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413181|NCT00223821|4238061|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413182|NCT00223821|4238062|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413183|NCT00223821|4238063|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413184|NCT00223821|4238061|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4413185|NCT00223821|4238062|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4413186|NCT00223821|4238063|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4413187|NCT00223821|4238061|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4413188|NCT00223821|4238062|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4413189|NCT00223821|4238063|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4413190|NCT00223821|4238061|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413191|NCT00223821|4238062|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413192|NCT00223821|4238063|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413193|NCT00223821|4238061|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413194|NCT00223821|4238062|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413195|NCT00223821|4238063|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413196|NCT00223821|4238061|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413197|NCT00223821|4238062|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413198|NCT00223821|4238063|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413199|NCT00223821|4238061|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413200|NCT00223821|4238062|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413201|NCT00223821|4238063|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413202|NCT00223821|4238061|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4413203|NCT00223821|4238062|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4413204|NCT00223821|4238063|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4413205|NCT00223821|4238061|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413206|NCT00223821|4238062|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413207|NCT00223821|4238063|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413208|NCT00223821|4238061|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413209|NCT00223821|4238062|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413210|NCT00223821|4238063|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413211|NCT00223821|4238061|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4413212|NCT00223821|4238062|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4413213|NCT00223821|4238063|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4413214|NCT00223821|4238061|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|11.9|11.9|||
4413215|NCT00223821|4238062|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|12.6|12.6|||
4413216|NCT00223821|4238063|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|11.2|11.2|||
4413217|NCT00223808|4238072|B4|United States||Region of Enrollment||participants|Number|67|67.0||||||
4413218|NCT00223808|4238073|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4413219|NCT00223808|4238074|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4413220|NCT00223808|4238075|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4413221|NCT00223808|4238072|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4413222|NCT00223808|4238073|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4413223|NCT00223808|4238074|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4413224|NCT00223808|4238075|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4413225|NCT00223808|4238072|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4413226|NCT00223808|4238073|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413227|NCT00223808|4238074|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4413228|NCT00223808|4238075|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413229|NCT00223808|4238072|B4|||Age||years|Mean|63.36|63.36|Standard Deviation|10.75|10.75|||
4413230|NCT00223808|4238073|B3|||Age||years|Mean|67.87|67.87|Standard Deviation|12.56|12.56|||
4413231|NCT00223808|4238074|B2|||Age||years|Mean|59.04|59.04|Standard Deviation|9.30|9.3|||
4413232|NCT00223808|4238075|B1|||Age||years|Mean|62.95|62.95|Standard Deviation|8.34|8.34|||
4413233|NCT00223808|4238072|B4||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4413234|NCT00223808|4238073|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4413235|NCT00223808|4238074|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4413236|NCT00223808|4238075|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4413237|NCT00223808|4238072|B4||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4413238|NCT00223808|4238073|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4413239|NCT00223808|4238074|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4413240|NCT00223808|4238075|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4413241|NCT00223808|4238072|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413242|NCT00223808|4238073|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413243|NCT00223808|4238074|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413244|NCT00223808|4238075|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413245|NCT00223795|4238094|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4413246|NCT00223795|4238094|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4413247|NCT00223795|4238094|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4413248|NCT00223795|4238094|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|7.6|7.6|||
4413249|NCT00223795|4238094|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4413250|NCT00223795|4238094|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4413251|NCT00223795|4238094|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413252|NCT00223704|4238102|B4|United States||Region of Enrollment||participants|Number|115|115.0||||||
4413253|NCT00223704|4238103|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4413254|NCT00223704|4238104|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4413255|NCT00223704|4238105|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4413256|NCT00223704|4238102|B4||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4413257|NCT00223704|4238103|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4413258|NCT00223704|4238104|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4413259|NCT00223704|4238105|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4413260|NCT00223704|4238102|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4413261|NCT00223704|4238103|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4413262|NCT00223704|4238104|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4413263|NCT00223704|4238105|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4413264|NCT00223704|4238102|B4|||Age||years|Mean|59.9|59.9|Standard Deviation|11.8|11.8|||
4413265|NCT00223704|4238103|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|12.8|12.8|||
4413266|NCT00223704|4238104|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|12.0|12.0|||
4413267|NCT00223704|4238105|B1|||Age||years|Mean|60.1|60.1|Standard Deviation|10.8|10.8|||
4413268|NCT00223704|4238102|B4||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4413269|NCT00223704|4238103|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4413270|NCT00223704|4238104|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4413271|NCT00223704|4238105|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4413272|NCT00223704|4238102|B4||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4413273|NCT00223704|4238103|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4413274|NCT00223704|4238104|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4413275|NCT00223704|4238105|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4413276|NCT00223704|4238102|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413277|NCT00223704|4238103|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413278|NCT00223704|4238104|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413279|NCT00223704|4238105|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413280|NCT00223678|4238127|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4413281|NCT00223678|4238128|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4413282|NCT00223678|4238129|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4413283|NCT00223678|4238127|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4413284|NCT00223678|4238128|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4413285|NCT00223678|4238129|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4413286|NCT00223678|4238127|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4413287|NCT00223678|4238128|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4413288|NCT00223678|4238129|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4413289|NCT00223678|4238127|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413290|NCT00223678|4238128|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413291|NCT00223678|4238129|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413292|NCT00223678|4238127|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4413293|NCT00223678|4238128|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4413294|NCT00223678|4238129|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4413295|NCT00223678|4238127|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413296|NCT00223678|4238128|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413297|NCT00223678|4238129|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413298|NCT00223665|4238136|B1|United States||Region of Enrollment||Participants|Count of Participants|102|102.0||||||
4413299|NCT00223665|4238136|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413300|NCT00223665|4238136|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413301|NCT00223665|4238136|B1||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4413302|NCT00223665|4238136|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4413303|NCT00223665|4238136|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413304|NCT00223665|4238136|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4413305|NCT00223665|4238136|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413306|NCT00223665|4238136|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4413307|NCT00223665|4238136|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413308|NCT00223665|4238136|B1|||Age||years|Median|66|66.0|Full Range|||60.0|81.0|
4413309|NCT00223652|4238154|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
4413310|NCT00223652|4238155|B2|United States||Region of Enrollment||participants|Number|44|44.0||||||
4413311|NCT00223652|4238156|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4413312|NCT00223652|4238154|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4413313|NCT00223652|4238155|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4413314|NCT00223652|4238156|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4413315|NCT00223652|4238154|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413316|NCT00223652|4238155|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413317|NCT00223652|4238156|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413318|NCT00223652|4238154|B3||White|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4413319|NCT00223652|4238155|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4413320|NCT00223652|4238156|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4413321|NCT00223652|4238154|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413322|NCT00223652|4238155|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413323|NCT00223652|4238156|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413324|NCT00223652|4238154|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413325|NCT00223652|4238155|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413326|NCT00223652|4238156|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413327|NCT00223652|4238154|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413328|NCT00223652|4238155|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413329|NCT00223652|4238156|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413330|NCT00223652|4238154|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413331|NCT00223652|4238155|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413332|NCT00223652|4238156|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413333|NCT00223652|4238154|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4413334|NCT00223652|4238155|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4413335|NCT00223652|4238156|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4413336|NCT00223652|4238154|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4413337|NCT00223652|4238155|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4413338|NCT00223652|4238156|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4413339|NCT00223652|4238154|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|10.59|10.59|||
4413340|NCT00223652|4238155|B2|||Age||years|Mean|54.98|54.98|Standard Deviation|10.42|10.42|||
4413341|NCT00223652|4238156|B1|||Age||years|Mean|56.83|56.83|Standard Deviation|10.81|10.81|||
4413342|NCT00223496|4238173|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4413343|NCT00223496|4238173|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4413344|NCT00223496|4238173|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4413345|NCT00223496|4238173|B1|||Age||years|Mean|41|41.0|Standard Deviation|10.0|10.0|||
4413346|NCT00223496|4238173|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413347|NCT00223496|4238173|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4413348|NCT00223496|4238173|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413349|NCT00223236|4238177|B3|Unknown||cocaine used|Urine drug screen is conducted and if no cocaine is detected in urine, then no cocaine was used. if a positive amount of cocaine is detected in urine, then cocaine was used.|participants|Number|1|1.0||||||
4413350|NCT00223236|4238178|B2|Unknown||cocaine used|Urine drug screen is conducted and if no cocaine is detected in urine, then no cocaine was used. if a positive amount of cocaine is detected in urine, then cocaine was used.|participants|Number|1|1.0||||||
4413351|NCT00223236|4238179|B1|Unknown||cocaine used|Urine drug screen is conducted and if no cocaine is detected in urine, then no cocaine was used. if a positive amount of cocaine is detected in urine, then cocaine was used.|participants|Number|0|0.0||||||
4413352|NCT00223236|4238177|B3|Cocaine used||cocaine used|Urine drug screen is conducted and if no cocaine is detected in urine, then no cocaine was used. if a positive amount of cocaine is detected in urine, then cocaine was used.|participants|Number|5|5.0||||||
4413353|NCT00223236|4238178|B2|Cocaine used||cocaine used|Urine drug screen is conducted and if no cocaine is detected in urine, then no cocaine was used. if a positive amount of cocaine is detected in urine, then cocaine was used.|participants|Number|1|1.0||||||
4413354|NCT00223236|4238179|B1|Cocaine used||cocaine used|Urine drug screen is conducted and if no cocaine is detected in urine, then no cocaine was used. if a positive amount of cocaine is detected in urine, then cocaine was used.|participants|Number|4|4.0||||||
4413355|NCT00223236|4238177|B3|No cocaine used||cocaine used|Urine drug screen is conducted and if no cocaine is detected in urine, then no cocaine was used. if a positive amount of cocaine is detected in urine, then cocaine was used.|participants|Number|38|38.0||||||
4413356|NCT00223236|4238178|B2|No cocaine used||cocaine used|Urine drug screen is conducted and if no cocaine is detected in urine, then no cocaine was used. if a positive amount of cocaine is detected in urine, then cocaine was used.|participants|Number|19|19.0||||||
4413357|NCT00223236|4238179|B1|No cocaine used||cocaine used|Urine drug screen is conducted and if no cocaine is detected in urine, then no cocaine was used. if a positive amount of cocaine is detected in urine, then cocaine was used.|participants|Number|19|19.0||||||
4413358|NCT00223236|4238177|B3|||Rey Auditory Verbal Learning Scale|The RAVLT consists of 15 nouns read aloud for five consecutive trials with each trial followed by a free-recall trial. The total score is the total number of words recalled through the five trials. Normative RAVLT T-scores was used. the higher T score, the better memory.|T scores|Mean|36.33|36.33|Standard Deviation|9.47|9.47|||
4413359|NCT00223236|4238178|B2|||Rey Auditory Verbal Learning Scale|The RAVLT consists of 15 nouns read aloud for five consecutive trials with each trial followed by a free-recall trial. The total score is the total number of words recalled through the five trials. Normative RAVLT T-scores was used. the higher T score, the better memory.|T scores|Mean|36.0|36.0|Standard Deviation|9.0|9.0|||
4413360|NCT00223236|4238179|B1|||Rey Auditory Verbal Learning Scale|The RAVLT consists of 15 nouns read aloud for five consecutive trials with each trial followed by a free-recall trial. The total score is the total number of words recalled through the five trials. Normative RAVLT T-scores was used. the higher T score, the better memory.|T scores|Mean|36.6|36.6|Standard Deviation|10.0|10.0|||
4413361|NCT00223236|4238177|B3|||Young Mania Rating Scale|The YMRS questionnaire has 11 items with scale range 0 to 4 for 7 items and 0 to 8 for 4 items. 0=normal and and 4 or 8 =most abnormal. The total possible score is 0 to 60, 0 being no symptom and 60 the worst symptom. The higher the score, the worse the mania symptoms are.|Units on a scale|Mean|11.34|11.34|Standard Deviation|5.89|5.89|||
4413362|NCT00223236|4238178|B2|||Young Mania Rating Scale|The YMRS questionnaire has 11 items with scale range 0 to 4 for 7 items and 0 to 8 for 4 items. 0=normal and and 4 or 8 =most abnormal. The total possible score is 0 to 60, 0 being no symptom and 60 the worst symptom. The higher the score, the worse the mania symptoms are.|Units on a scale|Mean|11.5|11.5|Standard Deviation|7.0|7.0|||
4413363|NCT00223236|4238179|B1|||Young Mania Rating Scale|The YMRS questionnaire has 11 items with scale range 0 to 4 for 7 items and 0 to 8 for 4 items. 0=normal and and 4 or 8 =most abnormal. The total possible score is 0 to 60, 0 being no symptom and 60 the worst symptom. The higher the score, the worse the mania symptoms are.|Units on a scale|Mean|11.2|11.2|Standard Deviation|4.9|4.9|||
4413364|NCT00223236|4238177|B3|||Inventory of Depressive Symptomatology|The IDS-SR is a 30 item self report used to assess the severity of depressive symptoms. The each item has a 4-likert scale, 0 to 3, with 3 representing the worst symptom. The total score of IDS-SR is calculated as a sum of each item score. The range of possible score is between 0 and 90, 0 as no symptom and 90 the worst symptom. The higher the score, the more severe the depression.|Units on a scale|Mean|41.26|41.26|Standard Deviation|11.9|11.9|||
4413365|NCT00223236|4238178|B2|||Inventory of Depressive Symptomatology|The IDS-SR is a 30 item self report used to assess the severity of depressive symptoms. The each item has a 4-likert scale, 0 to 3, with 3 representing the worst symptom. The total score of IDS-SR is calculated as a sum of each item score. The range of possible score is between 0 and 90, 0 as no symptom and 90 the worst symptom. The higher the score, the more severe the depression.|Units on a scale|Mean|38.7|38.7|Standard Deviation|13|13.0|||
4413428|NCT00223080|4238193|B2|Rayong||Province||participants|Number|4091|4091.0||||||
4413429|NCT00223080|4238194|B1|Rayong||Province||participants|Number|4090|4090.0||||||
4413430|NCT00223080|4238192|B3|Chon Buri||Province||participants|Number|8214|8214.0||||||
4413366|NCT00223236|4238179|B1|||Inventory of Depressive Symptomatology|The IDS-SR is a 30 item self report used to assess the severity of depressive symptoms. The each item has a 4-likert scale, 0 to 3, with 3 representing the worst symptom. The total score of IDS-SR is calculated as a sum of each item score. The range of possible score is between 0 and 90, 0 as no symptom and 90 the worst symptom. The higher the score, the more severe the depression.|Units on a scale|Mean|43.6|43.6|Standard Deviation|10.6|10.6|||
4413367|NCT00223236|4238177|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4413368|NCT00223236|4238178|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4413369|NCT00223236|4238179|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4413370|NCT00223236|4238177|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4413371|NCT00223236|4238178|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4413372|NCT00223236|4238179|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4413373|NCT00223236|4238177|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4413374|NCT00223236|4238178|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4413375|NCT00223236|4238179|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4413376|NCT00223236|4238177|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|7.1|7.1|||
4413377|NCT00223236|4238178|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|8.0|8.0|||
4413378|NCT00223236|4238179|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|6.6|6.6|||
4413379|NCT00223236|4238177|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413380|NCT00223236|4238178|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413381|NCT00223236|4238179|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413382|NCT00223236|4238177|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4413383|NCT00223236|4238178|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4413384|NCT00223236|4238179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4413385|NCT00223236|4238177|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413386|NCT00223236|4238178|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413387|NCT00223236|4238179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413388|NCT00223080|4238192|B3|High||Risk group||participants|Number|3945|3945.0||||||
4413389|NCT00223080|4238193|B2|High||Risk group||participants|Number|1982|1982.0||||||
4413390|NCT00223080|4238194|B1|High||Risk group||participants|Number|1963|1963.0||||||
4413391|NCT00223080|4238192|B3|Medium||Risk group||participants|Number|4661|4661.0||||||
4413392|NCT00223080|4238193|B2|Medium||Risk group||participants|Number|2292|2292.0||||||
4413393|NCT00223080|4238194|B1|Medium||Risk group||participants|Number|2369|2369.0||||||
4413394|NCT00223080|4238192|B3|Low||Risk group||participants|Number|7789|7789.0||||||
4413395|NCT00223080|4238193|B2|Low||Risk group||participants|Number|3924|3924.0||||||
4413396|NCT00223080|4238194|B1|Low||Risk group||participants|Number|3865|3865.0||||||
4413397|NCT00223080|4238192|B3|Missing data||Number of sex partners||participants|Number|15|15.0||||||
4413398|NCT00223080|4238193|B2|Missing data||Number of sex partners||participants|Number|9|9.0||||||
4413399|NCT00223080|4238194|B1|Missing data||Number of sex partners||participants|Number|6|6.0||||||
4413400|NCT00223080|4238192|B3|Did not answer||Number of sex partners||participants|Number|553|553.0||||||
4413401|NCT00223080|4238193|B2|Did not answer||Number of sex partners||participants|Number|273|273.0||||||
4413402|NCT00223080|4238194|B1|Did not answer||Number of sex partners||participants|Number|280|280.0||||||
4413403|NCT00223080|4238192|B3|> 1||Number of sex partners||participants|Number|1239|1239.0||||||
4413404|NCT00223080|4238193|B2|> 1||Number of sex partners||participants|Number|620|620.0||||||
4413405|NCT00223080|4238194|B1|> 1||Number of sex partners||participants|Number|619|619.0||||||
4413406|NCT00223080|4238192|B3|1||Number of sex partners||participants|Number|10923|10923.0||||||
4413407|NCT00223080|4238193|B2|1||Number of sex partners||participants|Number|5495|5495.0||||||
4413408|NCT00223080|4238194|B1|1||Number of sex partners||participants|Number|5428|5428.0||||||
4413409|NCT00223080|4238192|B3|0||Number of sex partners||participants|Number|3665|3665.0||||||
4413410|NCT00223080|4238193|B2|0||Number of sex partners||participants|Number|1801|1801.0||||||
4413411|NCT00223080|4238194|B1|0||Number of sex partners||participants|Number|1864|1864.0||||||
4413412|NCT00223080|4238192|B3|Separated||Marital status||participants|Number|168|168.0||||||
4413413|NCT00223080|4238193|B2|Separated||Marital status||participants|Number|86|86.0||||||
4413414|NCT00223080|4238194|B1|Separated||Marital status||participants|Number|82|82.0||||||
4413415|NCT00223080|4238192|B3|Widowed||Marital status||participants|Number|114|114.0||||||
4413416|NCT00223080|4238193|B2|Widowed||Marital status||participants|Number|64|64.0||||||
4413417|NCT00223080|4238194|B1|Widowed||Marital status||participants|Number|50|50.0||||||
4413418|NCT00223080|4238192|B3|Divorced||Marital status||participants|Number|1143|1143.0||||||
4413419|NCT00223080|4238193|B2|Divorced||Marital status||participants|Number|541|541.0||||||
4413420|NCT00223080|4238194|B1|Divorced||Marital status||participants|Number|602|602.0||||||
4413421|NCT00223080|4238192|B3|Married||Marital status||participants|Number|8279|8279.0||||||
4413422|NCT00223080|4238193|B2|Married||Marital status||participants|Number|4169|4169.0||||||
4413423|NCT00223080|4238194|B1|Married||Marital status||participants|Number|4110|4110.0||||||
4413424|NCT00223080|4238192|B3|Single||Marital status||participants|Number|6691|6691.0||||||
4413425|NCT00223080|4238193|B2|Single||Marital status||participants|Number|3338|3338.0||||||
4413426|NCT00223080|4238194|B1|Single||Marital status||participants|Number|3353|3353.0||||||
4413427|NCT00223080|4238192|B3|Rayong||Province||participants|Number|8181|8181.0||||||
4413431|NCT00223080|4238193|B2|Chon Buri||Province||participants|Number|4107|4107.0||||||
4413432|NCT00223080|4238194|B1|Chon Buri||Province||participants|Number|4107|4107.0||||||
4413433|NCT00223080|4238192|B3||Male|Sex: Female, Male||Participants|Count of Participants|10064|10064.0||||||
4413434|NCT00223080|4238193|B2||Male|Sex: Female, Male||Participants|Count of Participants|5031|5031.0||||||
4413435|NCT00223080|4238194|B1||Male|Sex: Female, Male||Participants|Count of Participants|5033|5033.0||||||
4413436|NCT00223080|4238192|B3||Female|Sex: Female, Male||Participants|Count of Participants|6331|6331.0||||||
4413437|NCT00223080|4238193|B2||Female|Sex: Female, Male||Participants|Count of Participants|3167|3167.0||||||
4413438|NCT00223080|4238194|B1||Female|Sex: Female, Male||Participants|Count of Participants|3164|3164.0||||||
4413439|NCT00223080|4238192|B3|26 - 30||Age, Customized||Participants|Count of Participants|4511|4511.0||||||
4413440|NCT00223080|4238193|B2|26 - 30||Age, Customized||Participants|Count of Participants|2244|2244.0||||||
4413441|NCT00223080|4238194|B1|26 - 30||Age, Customized||Participants|Count of Participants|2267|2267.0||||||
4413442|NCT00223080|4238192|B3|21 - 25||Age, Customized||Participants|Count of Participants|7341|7341.0||||||
4413443|NCT00223080|4238193|B2|21 - 25||Age, Customized||Participants|Count of Participants|3708|3708.0||||||
4413444|NCT00223080|4238194|B1|21 - 25||Age, Customized||Participants|Count of Participants|3633|3633.0||||||
4413445|NCT00223080|4238192|B3|18 - 20||Age, Customized||Participants|Count of Participants|4543|4543.0||||||
4413446|NCT00223080|4238193|B2|18 - 20||Age, Customized||Participants|Count of Participants|2246|2246.0||||||
4413447|NCT00223080|4238194|B1|18 - 20||Age, Customized||Participants|Count of Participants|2297|2297.0||||||
4413448|NCT00222729|4238213|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4413449|NCT00222729|4238213|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4413450|NCT00222729|4238213|B1|||Age||years|Median|59|59.0|Full Range|||36.0|85.0|
4413451|NCT00222105|4238220|B1|United States||Region of Enrollment||Participants|Count of Participants|25|25.0||||||
4413452|NCT00222105|4238220|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4413453|NCT00222105|4238220|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4413454|NCT00222105|4238220|B1|||Age||years|Median|61|61.0|Full Range|||49.0|79.0|
4413455|NCT00221299|4238225|B4|United States||Region of Enrollment||participants|Number|49|49.0||||||
4413456|NCT00221299|4238226|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4413457|NCT00221299|4238227|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4413458|NCT00221299|4238228|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4413459|NCT00221299|4238225|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413460|NCT00221299|4238226|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413461|NCT00221299|4238227|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413462|NCT00221299|4238228|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413463|NCT00221299|4238225|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4413464|NCT00221299|4238226|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4413465|NCT00221299|4238227|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4413466|NCT00221299|4238228|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4413467|NCT00221299|4238225|B4|||Age||years|Mean|50.6|50.6|Standard Deviation|15.9|15.9|||
4413468|NCT00221299|4238226|B3|||Age||years|Mean|53|53.0|Standard Deviation|18.8|18.8|||
4413469|NCT00221299|4238227|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|14.9|14.9|||
4413470|NCT00221299|4238228|B1|||Age||years|Mean|50.4|50.4|Standard Deviation|14|14.0|||
4413471|NCT00221195|4238239|B3|Europe||Region of Enrollment||participants|Number|28|28.0||||||
4413472|NCT00221195|4238240|B2|Europe||Region of Enrollment||participants|Number|14|14.0||||||
4413473|NCT00221195|4238241|B1|Europe||Region of Enrollment||participants|Number|14|14.0||||||
4413474|NCT00221195|4238239|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4413475|NCT00221195|4238240|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4413476|NCT00221195|4238241|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4413477|NCT00221195|4238239|B3||Male|Gender||Participants|Count of Participants|34|34.0||||||
4413478|NCT00221195|4238240|B2||Male|Gender||Participants|Count of Participants|17|17.0||||||
4413479|NCT00221195|4238241|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
4413480|NCT00221195|4238239|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4413481|NCT00221195|4238240|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4413482|NCT00221195|4238241|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4413483|NCT00221195|4238239|B3|||Age||years|Mean|27.1|27.1|Standard Deviation|17.3|17.3|||
4413484|NCT00221195|4238240|B2|||Age||years|Mean|24.9|24.9|Standard Deviation|20.6|20.6|||
4413485|NCT00221195|4238241|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|13.4|13.4|||
4413486|NCT00221195|4238239|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4413487|NCT00221195|4238240|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4413488|NCT00221195|4238241|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413489|NCT00221195|4238239|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4413490|NCT00221195|4238240|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4413491|NCT00221195|4238241|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4413492|NCT00221195|4238239|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4413493|NCT00221195|4238240|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4413494|NCT00221195|4238241|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4413495|NCT00221117|4238249|B3|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4413496|NCT00221117|4238250|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4413497|NCT00221117|4238251|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4413498|NCT00221117|4238249|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4413499|NCT00221117|4238250|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4413500|NCT00221117|4238251|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4413501|NCT00221117|4238249|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4413502|NCT00221117|4238250|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4413503|NCT00221117|4238251|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4413504|NCT00221117|4238249|B3|||Age||years|Mean|43.975|43.975|Standard Deviation|5.085|5.085|||
4413505|NCT00221117|4238250|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|5.45|5.45|||
4413506|NCT00221117|4238251|B1|||Age||years|Mean|44.75|44.75|Standard Deviation|4.72|4.72|||
4413507|NCT00221117|4238249|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4413508|NCT00221117|4238250|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4413509|NCT00221117|4238251|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4413510|NCT00221117|4238249|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4413511|NCT00221117|4238250|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4413512|NCT00221117|4238251|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4413513|NCT00221117|4238249|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4413514|NCT00221117|4238250|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4413515|NCT00221117|4238251|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413516|NCT00221104|4238262|B3|No||Diabetes mellitus||participants|Number|1209|1209.0||||||
4413517|NCT00221104|4238263|B2|No||Diabetes mellitus||participants|Number|601|601.0||||||
4413518|NCT00221104|4238264|B1|No||Diabetes mellitus||participants|Number|608|608.0||||||
4413519|NCT00221104|4238262|B3|Yes||Diabetes mellitus||participants|Number|369|369.0||||||
4413520|NCT00221104|4238263|B2|Yes||Diabetes mellitus||participants|Number|184|184.0||||||
4413521|NCT00221104|4238264|B1|Yes||Diabetes mellitus||participants|Number|185|185.0||||||
4413522|NCT00221104|4238262|B3|No||High blood pressure|The high blood pressure was defined ≥150/90 mmHg at baseline.|participants|Number|961|961.0||||||
4413523|NCT00221104|4238263|B2|No||High blood pressure|The high blood pressure was defined ≥150/90 mmHg at baseline.|participants|Number|476|476.0||||||
4413524|NCT00221104|4238264|B1|No||High blood pressure|The high blood pressure was defined ≥150/90 mmHg at baseline.|participants|Number|485|485.0||||||
4413525|NCT00221104|4238262|B3|Yes||High blood pressure|The high blood pressure was defined ≥150/90 mmHg at baseline.|participants|Number|617|617.0||||||
4413526|NCT00221104|4238263|B2|Yes||High blood pressure|The high blood pressure was defined ≥150/90 mmHg at baseline.|participants|Number|309|309.0||||||
4413527|NCT00221104|4238264|B1|Yes||High blood pressure|The high blood pressure was defined ≥150/90 mmHg at baseline.|participants|Number|308|308.0||||||
4413528|NCT00221104|4238262|B3|Infarction of undetermined etiology||Ischemic stroke subtype||participants|Number|171|171.0||||||
4413529|NCT00221104|4238263|B2|Infarction of undetermined etiology||Ischemic stroke subtype||participants|Number|75|75.0||||||
4413530|NCT00221104|4238264|B1|Infarction of undetermined etiology||Ischemic stroke subtype||participants|Number|96|96.0||||||
4413531|NCT00221104|4238262|B3|Lacunar infarction||Ischemic stroke subtype||participants|Number|1006|1006.0||||||
4413532|NCT00221104|4238263|B2|Lacunar infarction||Ischemic stroke subtype||participants|Number|504|504.0||||||
4413533|NCT00221104|4238264|B1|Lacunar infarction||Ischemic stroke subtype||participants|Number|502|502.0||||||
4413534|NCT00221104|4238262|B3|Atherothrombotic infarction||Ischemic stroke subtype||participants|Number|401|401.0||||||
4413535|NCT00221104|4238263|B2|Atherothrombotic infarction||Ischemic stroke subtype||participants|Number|206|206.0||||||
4413536|NCT00221104|4238264|B1|Atherothrombotic infarction||Ischemic stroke subtype||participants|Number|195|195.0||||||
4413537|NCT00221104|4238262|B3|Japan||Region of Enrollment||participants|Number|1578|1578.0||||||
4413538|NCT00221104|4238263|B2|Japan||Region of Enrollment||participants|Number|785|785.0||||||
4413539|NCT00221104|4238264|B1|Japan||Region of Enrollment||participants|Number|793|793.0||||||
4413540|NCT00221104|4238262|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413541|NCT00221104|4238263|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413542|NCT00221104|4238264|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413543|NCT00221104|4238262|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413544|NCT00221104|4238263|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413545|NCT00221104|4238264|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413546|NCT00221104|4238262|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413547|NCT00221104|4238263|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413548|NCT00221104|4238264|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413549|NCT00221104|4238262|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413550|NCT00221104|4238263|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413551|NCT00221104|4238264|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413552|NCT00221104|4238262|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413553|NCT00221104|4238263|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413554|NCT00221104|4238264|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413555|NCT00221104|4238262|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1578|1578.0||||||
4413556|NCT00221104|4238263|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|785|785.0||||||
4413557|NCT00221104|4238264|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|793|793.0||||||
4413558|NCT00221104|4238262|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413559|NCT00221104|4238263|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413560|NCT00221104|4238264|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4413561|NCT00221104|4238262|B3||Male|Sex: Female, Male||Participants|Count of Participants|1087|1087.0||||||
4413562|NCT00221104|4238263|B2||Male|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
4413563|NCT00221104|4238264|B1||Male|Sex: Female, Male||Participants|Count of Participants|545|545.0||||||
4413564|NCT00221104|4238262|B3||Female|Sex: Female, Male||Participants|Count of Participants|491|491.0||||||
4413565|NCT00221104|4238263|B2||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4413566|NCT00221104|4238264|B1||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4413567|NCT00221104|4238262|B3||>=65 years|Age||Participants|Count of Participants|914|914.0||||||
4413568|NCT00221104|4238263|B2||>=65 years|Age||Participants|Count of Participants|456|456.0||||||
4413569|NCT00221104|4238264|B1||>=65 years|Age||Participants|Count of Participants|458|458.0||||||
4413570|NCT00221104|4238262|B3||Between 18 and 65 years|Age||Participants|Count of Participants|664|664.0||||||
4413571|NCT00221104|4238263|B2||Between 18 and 65 years|Age||Participants|Count of Participants|329|329.0||||||
4413572|NCT00221104|4238264|B1||Between 18 and 65 years|Age||Participants|Count of Participants|335|335.0||||||
4413573|NCT00221104|4238262|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413574|NCT00221104|4238263|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413575|NCT00221104|4238264|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413576|NCT00220961|4238279|B3|United States||Region of Enrollment||participants|Number|602|602.0||||||
4413577|NCT00220961|4238280|B2|United States||Region of Enrollment||participants|Number|303|303.0||||||
4413578|NCT00220961|4238281|B1|United States||Region of Enrollment||participants|Number|299|299.0||||||
4413579|NCT00220961|4238279|B3||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4413580|NCT00220961|4238280|B2||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4413581|NCT00220961|4238281|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4413582|NCT00220961|4238279|B3||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4413583|NCT00220961|4238280|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4413584|NCT00220961|4238281|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4413585|NCT00220961|4238279|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|0.5|0.5|||
4413586|NCT00220961|4238280|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|0.5|0.5|||
4413587|NCT00220961|4238281|B1|||Age||years|Mean|52.3|52.3|Standard Deviation|0.5|0.5|||
4413588|NCT00220961|4238279|B3||>=65 years|Age||Participants|Count of Participants|62|62.0||||||
4413589|NCT00220961|4238280|B2||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4413590|NCT00220961|4238281|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4413591|NCT00220961|4238279|B3||Between 18 and 65 years|Age||Participants|Count of Participants|540|540.0||||||
4413592|NCT00220961|4238280|B2||Between 18 and 65 years|Age||Participants|Count of Participants|271|271.0||||||
4413593|NCT00220961|4238281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|269|269.0||||||
4413594|NCT00220961|4238279|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413595|NCT00220961|4238280|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413596|NCT00220961|4238281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413597|NCT00220805|4238296|B3|||Logarithm of the Minimum Angle of Resolution (LogMAR) of the Study Eyes||LogMAR|Mean|0.559|0.559|Standard Deviation|0.186|0.186|||
4413598|NCT00220805|4238297|B2|||Logarithm of the Minimum Angle of Resolution (LogMAR) of the Study Eyes||LogMAR|Mean|0.533|0.533|Standard Deviation|0.153|0.153|||
4413599|NCT00220805|4238298|B1|||Logarithm of the Minimum Angle of Resolution (LogMAR) of the Study Eyes||LogMAR|Mean|0.581|0.581|Standard Deviation|0.209|0.209|||
4413600|NCT00220805|4238296|B3|||Visual Acuity Score (VAS) of the Study Eyes||units on a scale|Mean|57.0|57.0|Standard Deviation|9.3|9.3|||
4413601|NCT00220805|4238297|B2|||Visual Acuity Score (VAS) of the Study Eyes||units on a scale|Mean|58.4|58.4|Standard Deviation|7.7|7.7|||
4413602|NCT00220805|4238298|B1|||Visual Acuity Score (VAS) of the Study Eyes||units on a scale|Mean|55.9|55.9|Standard Deviation|10.4|10.4|||
4413603|NCT00220805|4238296|B3|Germany||Region of Enrollment||participants|Number|53|53.0||||||
4413604|NCT00220805|4238297|B2|Germany||Region of Enrollment||participants|Number|24|24.0||||||
4413605|NCT00220805|4238298|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4413606|NCT00220805|4238296|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4413607|NCT00220805|4238297|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4413608|NCT00220805|4238298|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4413609|NCT00220805|4238296|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4413610|NCT00220805|4238297|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4413611|NCT00220805|4238298|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4413612|NCT00220805|4238296|B3|||Age||years|Mean|74.415|74.415|Standard Deviation|9.189|9.189|||
4413613|NCT00220805|4238297|B2|||Age||years|Mean|74.042|74.042|Standard Deviation|10.217|10.217|||
4413614|NCT00220805|4238298|B1|||Age||years|Mean|74.724|74.724|Standard Deviation|8.417|8.417|||
4413615|NCT00220805|4238296|B3||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4413616|NCT00220805|4238297|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4413617|NCT00220805|4238298|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4413618|NCT00220805|4238296|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4413619|NCT00220805|4238297|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4413620|NCT00220805|4238298|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4413621|NCT00220805|4238296|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413622|NCT00220805|4238297|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413623|NCT00220805|4238298|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413624|NCT00220779|4238317|B4|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4413625|NCT00220779|4238318|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4413626|NCT00220779|4238319|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4413627|NCT00220779|4238320|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4413628|NCT00220779|4238317|B4|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4413629|NCT00220779|4238318|B3|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4413630|NCT00220779|4238319|B2|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4413631|NCT00220779|4238320|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4413632|NCT00220779|4238317|B4|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4413633|NCT00220779|4238318|B3|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4413634|NCT00220779|4238319|B2|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4413635|NCT00220779|4238320|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4413636|NCT00220779|4238317|B4|Austria||Region of Enrollment||participants|Number|6|6.0||||||
4413637|NCT00220779|4238318|B3|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4413638|NCT00220779|4238319|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4413639|NCT00220779|4238320|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4413640|NCT00220779|4238317|B4|Poland||Region of Enrollment||participants|Number|24|24.0||||||
4413641|NCT00220779|4238318|B3|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4413642|NCT00220779|4238319|B2|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4413643|NCT00220779|4238320|B1|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4413644|NCT00220779|4238317|B4|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4413645|NCT00220779|4238318|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4413646|NCT00220779|4238319|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4413647|NCT00220779|4238320|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4413648|NCT00220779|4238317|B4|Greece||Region of Enrollment||participants|Number|3|3.0||||||
4413649|NCT00220779|4238318|B3|Greece||Region of Enrollment||participants|Number|0|0.0||||||
4413650|NCT00220779|4238319|B2|Greece||Region of Enrollment||participants|Number|2|2.0||||||
4413651|NCT00220779|4238320|B1|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4413652|NCT00220779|4238317|B4|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4413653|NCT00220779|4238318|B3|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4413654|NCT00220779|4238319|B2|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4413655|NCT00220779|4238320|B1|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
4413656|NCT00220779|4238317|B4|Czech Republic||Region of Enrollment||participants|Number|22|22.0||||||
4413657|NCT00220779|4238318|B3|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4413658|NCT00220779|4238319|B2|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
4413659|NCT00220779|4238320|B1|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4413660|NCT00220779|4238317|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4413661|NCT00220779|4238318|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4413662|NCT00220779|4238319|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4413663|NCT00220779|4238320|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4413664|NCT00220779|4238317|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4413665|NCT00220779|4238318|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4413666|NCT00220779|4238319|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4413667|NCT00220779|4238320|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4413668|NCT00220779|4238317|B4||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4413669|NCT00220779|4238318|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4413670|NCT00220779|4238319|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4413671|NCT00220779|4238320|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4413672|NCT00220779|4238317|B4|||Age||years|Mean|33.1|33.1|Standard Deviation|8.0|8.0|||
4413673|NCT00220779|4238318|B3|||Age||years|Mean|33.0|33.0|Standard Deviation|8.7|8.7|||
4413674|NCT00220779|4238319|B2|||Age||years|Mean|34.4|34.4|Standard Deviation|7.9|7.9|||
4413675|NCT00220779|4238320|B1|||Age||years|Mean|31.9|31.9|Standard Deviation|7.5|7.5|||
4413676|NCT00220779|4238317|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413677|NCT00220779|4238318|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413678|NCT00220779|4238319|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413679|NCT00220779|4238320|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413680|NCT00220779|4238317|B4||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4413681|NCT00220779|4238318|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4413682|NCT00220779|4238319|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4413683|NCT00220779|4238320|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4413684|NCT00220779|4238317|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4413685|NCT00220779|4238318|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413686|NCT00220779|4238319|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4413687|NCT00220779|4238320|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413688|NCT00220740|4238330|B3|Lower Extremity Disability Score||Baseline INCAT Score|"Baseline INCAT score for all subjects and subgroups for Efficacy Period, Rescue treatment, and Randomized Withdrawal Period (ITT population) Measurements are reported in Inflammatory Neuropathy Case And Treatment (INCAT) scale of 0-5 in both lower and upper extremities, for a total score of 0 to 10.~INCAT scores for arm disability: 0 = no upper limb problems; 5 = inability to use either arm for any purposeful movement.~INCAT scores for leg disability: 0= walking not affected; 5 = restricted to wheelchair, unable to stand and walk a few steps with help"|units on a scale|Mean|1.9|1.9|Standard Deviation|0.9|0.9|||
4413689|NCT00220740|4238331|B2|Lower Extremity Disability Score||Baseline INCAT Score|"Baseline INCAT score for all subjects and subgroups for Efficacy Period, Rescue treatment, and Randomized Withdrawal Period (ITT population) Measurements are reported in Inflammatory Neuropathy Case And Treatment (INCAT) scale of 0-5 in both lower and upper extremities, for a total score of 0 to 10.~INCAT scores for arm disability: 0 = no upper limb problems; 5 = inability to use either arm for any purposeful movement.~INCAT scores for leg disability: 0= walking not affected; 5 = restricted to wheelchair, unable to stand and walk a few steps with help"|units on a scale|Mean|1.9|1.9|Standard Deviation|1.1|1.1|||
4413690|NCT00220740|4238332|B1|Lower Extremity Disability Score||Baseline INCAT Score|"Baseline INCAT score for all subjects and subgroups for Efficacy Period, Rescue treatment, and Randomized Withdrawal Period (ITT population) Measurements are reported in Inflammatory Neuropathy Case And Treatment (INCAT) scale of 0-5 in both lower and upper extremities, for a total score of 0 to 10.~INCAT scores for arm disability: 0 = no upper limb problems; 5 = inability to use either arm for any purposeful movement.~INCAT scores for leg disability: 0= walking not affected; 5 = restricted to wheelchair, unable to stand and walk a few steps with help"|units on a scale|Mean|1.9|1.9|Standard Deviation|0.8|0.8|||
4413691|NCT00220740|4238330|B3|Upper Extremity Disability Score||Baseline INCAT Score|"Baseline INCAT score for all subjects and subgroups for Efficacy Period, Rescue treatment, and Randomized Withdrawal Period (ITT population) Measurements are reported in Inflammatory Neuropathy Case And Treatment (INCAT) scale of 0-5 in both lower and upper extremities, for a total score of 0 to 10.~INCAT scores for arm disability: 0 = no upper limb problems; 5 = inability to use either arm for any purposeful movement.~INCAT scores for leg disability: 0= walking not affected; 5 = restricted to wheelchair, unable to stand and walk a few steps with help"|units on a scale|Mean|2.2|2.2|Standard Deviation|1.0|1.0|||
4413692|NCT00220740|4238331|B2|Upper Extremity Disability Score||Baseline INCAT Score|"Baseline INCAT score for all subjects and subgroups for Efficacy Period, Rescue treatment, and Randomized Withdrawal Period (ITT population) Measurements are reported in Inflammatory Neuropathy Case And Treatment (INCAT) scale of 0-5 in both lower and upper extremities, for a total score of 0 to 10.~INCAT scores for arm disability: 0 = no upper limb problems; 5 = inability to use either arm for any purposeful movement.~INCAT scores for leg disability: 0= walking not affected; 5 = restricted to wheelchair, unable to stand and walk a few steps with help"|units on a scale|Mean|2.1|2.1|Standard Deviation|1.0|1.0|||
4413693|NCT00220740|4238332|B1|Upper Extremity Disability Score||Baseline INCAT Score|"Baseline INCAT score for all subjects and subgroups for Efficacy Period, Rescue treatment, and Randomized Withdrawal Period (ITT population) Measurements are reported in Inflammatory Neuropathy Case And Treatment (INCAT) scale of 0-5 in both lower and upper extremities, for a total score of 0 to 10.~INCAT scores for arm disability: 0 = no upper limb problems; 5 = inability to use either arm for any purposeful movement.~INCAT scores for leg disability: 0= walking not affected; 5 = restricted to wheelchair, unable to stand and walk a few steps with help"|units on a scale|Mean|2.3|2.3|Standard Deviation|1.0|1.0|||
4413694|NCT00220740|4238330|B3|Total Overall Disability Score||Baseline INCAT Score|"Baseline INCAT score for all subjects and subgroups for Efficacy Period, Rescue treatment, and Randomized Withdrawal Period (ITT population) Measurements are reported in Inflammatory Neuropathy Case And Treatment (INCAT) scale of 0-5 in both lower and upper extremities, for a total score of 0 to 10.~INCAT scores for arm disability: 0 = no upper limb problems; 5 = inability to use either arm for any purposeful movement.~INCAT scores for leg disability: 0= walking not affected; 5 = restricted to wheelchair, unable to stand and walk a few steps with help"|units on a scale|Mean|4.2|4.2|Standard Deviation|1.4|1.4|||
4413695|NCT00220740|4238331|B2|Total Overall Disability Score||Baseline INCAT Score|"Baseline INCAT score for all subjects and subgroups for Efficacy Period, Rescue treatment, and Randomized Withdrawal Period (ITT population) Measurements are reported in Inflammatory Neuropathy Case And Treatment (INCAT) scale of 0-5 in both lower and upper extremities, for a total score of 0 to 10.~INCAT scores for arm disability: 0 = no upper limb problems; 5 = inability to use either arm for any purposeful movement.~INCAT scores for leg disability: 0= walking not affected; 5 = restricted to wheelchair, unable to stand and walk a few steps with help"|units on a scale|Mean|4.1|4.1|Standard Deviation|1.5|1.5|||
4413754|NCT00220727|4238345|B3|||Age||years|Mean|47.63|47.63|Standard Deviation|14.20|14.2|||
4413755|NCT00220727|4238346|B2|||Age||years|Mean|47.50|47.5|Standard Deviation|14.89|14.89|||
4413756|NCT00220727|4238347|B1|||Age||years|Mean|47.75|47.75|Standard Deviation|15.78|15.78|||
4413757|NCT00220727|4238345|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4413758|NCT00220727|4238346|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413696|NCT00220740|4238332|B1|Total Overall Disability Score||Baseline INCAT Score|"Baseline INCAT score for all subjects and subgroups for Efficacy Period, Rescue treatment, and Randomized Withdrawal Period (ITT population) Measurements are reported in Inflammatory Neuropathy Case And Treatment (INCAT) scale of 0-5 in both lower and upper extremities, for a total score of 0 to 10.~INCAT scores for arm disability: 0 = no upper limb problems; 5 = inability to use either arm for any purposeful movement.~INCAT scores for leg disability: 0= walking not affected; 5 = restricted to wheelchair, unable to stand and walk a few steps with help"|units on a scale|Mean|4.2|4.2|Standard Deviation|1.4|1.4|||
4413697|NCT00220740|4238330|B3|Macedonia, The Former Yugoslav Republic of||Region of Enrollment||participants|Number|11|11.0||||||
4413698|NCT00220740|4238331|B2|Macedonia, The Former Yugoslav Republic of||Region of Enrollment||participants|Number|6|6.0||||||
4413699|NCT00220740|4238332|B1|Macedonia, The Former Yugoslav Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4413700|NCT00220740|4238330|B3|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4413701|NCT00220740|4238331|B2|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4413702|NCT00220740|4238332|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4413703|NCT00220740|4238330|B3|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4413704|NCT00220740|4238331|B2|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4413705|NCT00220740|4238332|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4413706|NCT00220740|4238330|B3|Israel||Region of Enrollment||participants|Number|15|15.0||||||
4413707|NCT00220740|4238331|B2|Israel||Region of Enrollment||participants|Number|7|7.0||||||
4413708|NCT00220740|4238332|B1|Israel||Region of Enrollment||participants|Number|8|8.0||||||
4413709|NCT00220740|4238330|B3|Poland||Region of Enrollment||participants|Number|30|30.0||||||
4413710|NCT00220740|4238331|B2|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4413711|NCT00220740|4238332|B1|Poland||Region of Enrollment||participants|Number|15|15.0||||||
4413712|NCT00220740|4238330|B3|Argentina||Region of Enrollment||participants|Number|15|15.0||||||
4413713|NCT00220740|4238331|B2|Argentina||Region of Enrollment||participants|Number|7|7.0||||||
4413714|NCT00220740|4238332|B1|Argentina||Region of Enrollment||participants|Number|8|8.0||||||
4413715|NCT00220740|4238330|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4413716|NCT00220740|4238331|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4413717|NCT00220740|4238332|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4413718|NCT00220740|4238330|B3|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4413719|NCT00220740|4238331|B2|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4413720|NCT00220740|4238332|B1|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4413721|NCT00220740|4238330|B3|Czech Republic||Region of Enrollment||participants|Number|13|13.0||||||
4413722|NCT00220740|4238331|B2|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4413723|NCT00220740|4238332|B1|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4413724|NCT00220740|4238330|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4413725|NCT00220740|4238331|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4413726|NCT00220740|4238332|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4413727|NCT00220740|4238330|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4413728|NCT00220740|4238331|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4413729|NCT00220740|4238332|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4413730|NCT00220740|4238330|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4413731|NCT00220740|4238331|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4413732|NCT00220740|4238332|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4413733|NCT00220740|4238330|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|16.51|16.51|||
4413734|NCT00220740|4238331|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|15.63|15.63|||
4413735|NCT00220740|4238332|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|17.31|17.31|||
4413736|NCT00220740|4238330|B3||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4413737|NCT00220740|4238331|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4413738|NCT00220740|4238332|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4413739|NCT00220740|4238330|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4413740|NCT00220740|4238331|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4413741|NCT00220740|4238332|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4413742|NCT00220740|4238330|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4413743|NCT00220740|4238331|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4413744|NCT00220740|4238332|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413745|NCT00220727|4238345|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4413746|NCT00220727|4238346|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4413747|NCT00220727|4238347|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4413748|NCT00220727|4238345|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4413749|NCT00220727|4238346|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413750|NCT00220727|4238347|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4413751|NCT00220727|4238345|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4413752|NCT00220727|4238346|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4413753|NCT00220727|4238347|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4413759|NCT00220727|4238347|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4413760|NCT00220727|4238345|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4413761|NCT00220727|4238346|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4413762|NCT00220727|4238347|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4413763|NCT00220727|4238345|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413764|NCT00220727|4238346|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413765|NCT00220727|4238347|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413766|NCT00220701|4238362|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4413767|NCT00220701|4238363|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4413768|NCT00220701|4238364|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4413769|NCT00220701|4238362|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4413770|NCT00220701|4238363|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4413771|NCT00220701|4238364|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4413772|NCT00220701|4238362|B3|||Age||years|Mean|43.74|43.74|Standard Deviation|10.49|10.49|||
4413773|NCT00220701|4238363|B2|||Age||years|Mean|43.59|43.59|Standard Deviation|11.33|11.33|||
4413774|NCT00220701|4238364|B1|||Age||years|Mean|43.88|43.88|Standard Deviation|9.92|9.92|||
4413775|NCT00220636|4238381|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4413776|NCT00220636|4238381|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4413777|NCT00220636|4238381|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4413778|NCT00220636|4238381|B1|||Age||years|Mean|46|46.0|Standard Deviation|13|13.0|||
4413779|NCT00220636|4238381|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4413780|NCT00220636|4238381|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4413781|NCT00220636|4238381|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413782|NCT00219557|4238388|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4413783|NCT00219557|4238389|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4413784|NCT00219557|4238390|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4413785|NCT00219557|4238391|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4413786|NCT00219557|4238388|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4413787|NCT00219557|4238389|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4413788|NCT00219557|4238390|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4413789|NCT00219557|4238391|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4413790|NCT00219557|4238388|B4|Greater than or equal to 65 years||Age, Customized||Participants|Number|49|49.0||||||
4413791|NCT00219557|4238389|B3|Greater than or equal to 65 years||Age, Customized||Participants|Number|10|10.0||||||
4413792|NCT00219557|4238390|B2|Greater than or equal to 65 years||Age, Customized||Participants|Number|36|36.0||||||
4413793|NCT00219557|4238391|B1|Greater than or equal to 65 years||Age, Customized||Participants|Number|3|3.0||||||
4413794|NCT00219557|4238388|B4|45 years to 64 years||Age, Customized||Participants|Number|56|56.0||||||
4413795|NCT00219557|4238389|B3|45 years to 64 years||Age, Customized||Participants|Number|20|20.0||||||
4413796|NCT00219557|4238390|B2|45 years to 64 years||Age, Customized||Participants|Number|31|31.0||||||
4413797|NCT00219557|4238391|B1|45 years to 64 years||Age, Customized||Participants|Number|5|5.0||||||
4413798|NCT00219557|4238388|B4|18 years to 44 years||Age, Customized||Participants|Number|6|6.0||||||
4413799|NCT00219557|4238389|B3|18 years to 44 years||Age, Customized||Participants|Number|4|4.0||||||
4413800|NCT00219557|4238390|B2|18 years to 44 years||Age, Customized||Participants|Number|2|2.0||||||
4413801|NCT00219557|4238391|B1|18 years to 44 years||Age, Customized||Participants|Number|0|0.0||||||
4413802|NCT00219544|4238421|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4413803|NCT00219544|4238421|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4413804|NCT00219544|4238421|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|10.4|10.4|||
4413805|NCT00219349|4238460|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4413806|NCT00219349|4238460|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4413807|NCT00219349|4238460|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4413808|NCT00219349|4238460|B1|||Age||years|Mean|41|41.0|Standard Deviation|11.8|11.8|||
4413809|NCT00219349|4238460|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413810|NCT00219349|4238460|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4413811|NCT00219349|4238460|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413812|NCT00219284|4238471|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4413813|NCT00219284|4238472|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4413814|NCT00219284|4238473|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4413815|NCT00219284|4238471|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4413816|NCT00219284|4238472|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4413817|NCT00219284|4238473|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4413818|NCT00219284|4238471|B3|||Age||years|Mean|68.5|68.5|Standard Deviation|9.78|9.78|||
4413819|NCT00219284|4238472|B2|||Age||years|Mean|68.3|68.3|Standard Deviation|10.38|10.38|||
4413820|NCT00219284|4238473|B1|||Age||years|Mean|68.7|68.7|Standard Deviation|9.18|9.18|||
4413821|NCT00219141|4238496|B4||Male|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
4413822|NCT00219141|4238497|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4413823|NCT00219141|4238498|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4413824|NCT00219141|4238499|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4413825|NCT00219141|4238496|B4||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4413826|NCT00219141|4238497|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4413827|NCT00219141|4238498|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4413828|NCT00219141|4238499|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4413829|NCT00219141|4238496|B4|||Age||years|Mean|58.8|58.8|Standard Deviation|10.41|10.41|||
4413830|NCT00219141|4238497|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|10.62|10.62|||
4413831|NCT00219141|4238498|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|11.00|11.0|||
4413832|NCT00219141|4238499|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|9.61|9.61|||
4413833|NCT00218634|4238545|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
4413834|NCT00218634|4238546|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4413835|NCT00218634|4238547|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4413836|NCT00218634|4238545|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4413837|NCT00218634|4238546|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4413838|NCT00218634|4238547|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4413839|NCT00218634|4238545|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4413840|NCT00218634|4238546|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4413841|NCT00218634|4238547|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4413842|NCT00218634|4238545|B3|||Age||years|Mean|46.85|46.85|Standard Deviation|7.15|7.15|||
4413843|NCT00218634|4238546|B2|||Age||years|Mean|46.67|46.67|Standard Deviation|7.05|7.05|||
4413844|NCT00218634|4238547|B1|||Age||years|Mean|47.05|47.05|Standard Deviation|7.34|7.34|||
4413845|NCT00218634|4238545|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413846|NCT00218634|4238546|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413847|NCT00218634|4238547|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413848|NCT00218634|4238545|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4413849|NCT00218634|4238546|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4413850|NCT00218634|4238547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4413851|NCT00218634|4238545|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413852|NCT00218634|4238546|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413853|NCT00218634|4238547|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413854|NCT00218543|4238568|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4413855|NCT00218543|4238568|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4413856|NCT00218543|4238568|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4413857|NCT00218543|4238568|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|6.6|6.6|||
4413858|NCT00218543|4238568|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413859|NCT00218543|4238568|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4413860|NCT00218543|4238568|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413861|NCT00218465|4238573|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
4413862|NCT00218465|4238574|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4413863|NCT00218465|4238575|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4413864|NCT00218465|4238573|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413865|NCT00218465|4238574|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413866|NCT00218465|4238575|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413867|NCT00218465|4238573|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4413868|NCT00218465|4238574|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4413869|NCT00218465|4238575|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4413870|NCT00218465|4238573|B3|||Age||years|Mean|47.9|47.9|Standard Deviation|10.5|10.5|||
4413871|NCT00218465|4238574|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|10.4|10.4|||
4413872|NCT00218465|4238575|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|10.5|10.5|||
4413873|NCT00218465|4238573|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413874|NCT00218465|4238574|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413875|NCT00218465|4238575|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413876|NCT00218465|4238573|B3||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4413877|NCT00218465|4238574|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4413878|NCT00218465|4238575|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4413879|NCT00218465|4238573|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413880|NCT00218465|4238574|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413881|NCT00218465|4238575|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413882|NCT00218439|4238586|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4413883|NCT00218439|4238587|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4413884|NCT00218439|4238588|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4413885|NCT00218439|4238586|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4413886|NCT00218439|4238587|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4413887|NCT00218439|4238588|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4413888|NCT00218439|4238586|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4413889|NCT00218439|4238587|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4413890|NCT00218439|4238588|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4413891|NCT00218439|4238586|B3|||Age||years|Mean|40.2|40.2|Standard Deviation|12.7|12.7|||
4413892|NCT00218439|4238587|B2|||Age||years|Mean|40.0|40.0|Standard Deviation|11.0|11.0|||
4413893|NCT00218439|4238588|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|14.1|14.1|||
4413894|NCT00218439|4238586|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413895|NCT00218439|4238587|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413896|NCT00218439|4238588|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413897|NCT00218439|4238586|B3||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4413898|NCT00218439|4238587|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4413899|NCT00218439|4238588|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4413900|NCT00218439|4238586|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413901|NCT00218439|4238587|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413902|NCT00218439|4238588|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413903|NCT00218335|4238603|B5|United States||Region of Enrollment||participants|Number|1024|1024.0||||||
4413904|NCT00218335|4238604|B4|United States||Region of Enrollment||participants|Number|424|424.0||||||
4413905|NCT00218335|4238605|B3|United States||Region of Enrollment||participants|Number|373|373.0||||||
4413906|NCT00218335|4238606|B2|United States||Region of Enrollment||participants|Number|113|113.0||||||
4413907|NCT00218335|4238607|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4413908|NCT00218335|4238603|B5||Male|Sex: Female, Male||Participants|Count of Participants|621|621.0||||||
4413909|NCT00218335|4238604|B4||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4413910|NCT00218335|4238605|B3||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4413911|NCT00218335|4238606|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4413912|NCT00218335|4238607|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4413913|NCT00218335|4238603|B5||Female|Sex: Female, Male||Participants|Count of Participants|403|403.0||||||
4413914|NCT00218335|4238604|B4||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4413915|NCT00218335|4238605|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4413916|NCT00218335|4238606|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4413917|NCT00218335|4238607|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4413918|NCT00218335|4238603|B5|||Age||years|Mean|43.2|43.2|Standard Deviation|8|8.0|||
4413919|NCT00218335|4238604|B4|||Age||years|Mean|43.7|43.7|Standard Deviation|8|8.0|||
4413920|NCT00218335|4238605|B3|||Age||years|Mean|42.4|42.4|Standard Deviation|9|9.0|||
4413921|NCT00218335|4238606|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|7|7.0|||
4413922|NCT00218335|4238607|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|8|8.0|||
4413923|NCT00218335|4238603|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4413924|NCT00218335|4238604|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4413925|NCT00218335|4238605|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413926|NCT00218335|4238606|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413927|NCT00218335|4238607|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413928|NCT00218335|4238603|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1021|1021.0||||||
4413929|NCT00218335|4238604|B4||Between 18 and 65 years|Age||Participants|Count of Participants|422|422.0||||||
4413930|NCT00218335|4238605|B3||Between 18 and 65 years|Age||Participants|Count of Participants|372|372.0||||||
4413931|NCT00218335|4238606|B2||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4413932|NCT00218335|4238607|B1||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4413933|NCT00218335|4238603|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4413934|NCT00218335|4238604|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413935|NCT00218335|4238605|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4413936|NCT00218335|4238606|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413937|NCT00218335|4238607|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413938|NCT00218296|4238672|B3|United States||Region of Enrollment||participants|Number|199|199.0||||||
4413939|NCT00218296|4238673|B2|United States||Region of Enrollment||participants|Number|102|102.0||||||
4413940|NCT00218296|4238674|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
4413941|NCT00218296|4238672|B3||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4413942|NCT00218296|4238673|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4413943|NCT00218296|4238674|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4413944|NCT00218296|4238672|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413945|NCT00218296|4238673|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413946|NCT00218296|4238674|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4413947|NCT00218296|4238672|B3|||Age||years|Mean|34.8|34.8|Standard Deviation|8.5|8.5|||
4413948|NCT00218296|4238673|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|8.6|8.6|||
4413949|NCT00218296|4238674|B1|||Age||years|Mean|34.4|34.4|Standard Deviation|8.4|8.4|||
4413950|NCT00218296|4238672|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413951|NCT00218296|4238673|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413952|NCT00218296|4238674|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4413953|NCT00218296|4238672|B3||Between 18 and 65 years|Age||Participants|Count of Participants|199|199.0||||||
4413954|NCT00218296|4238673|B2||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4413955|NCT00218296|4238674|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4413956|NCT00218296|4238672|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413957|NCT00218296|4238673|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413958|NCT00218296|4238674|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4413959|NCT00218062|4238691|B5|United States||Region of Enrollment||participants|Number|73|73.0||||||
4413960|NCT00218062|4238692|B4|United States||Region of Enrollment||participants|Number|16|16.0||||||
4413961|NCT00218062|4238693|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4413962|NCT00218062|4238694|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4413963|NCT00218062|4238695|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4413964|NCT00218062|4238691|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4413965|NCT00218062|4238692|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4413966|NCT00218062|4238693|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4413967|NCT00218062|4238694|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4413968|NCT00218062|4238695|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4413969|NCT00218062|4238691|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4413970|NCT00218062|4238692|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4413971|NCT00218062|4238693|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4413972|NCT00218062|4238694|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4413973|NCT00218062|4238695|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4413974|NCT00218062|4238691|B5|||Age||years|Mean|42|42.0|Standard Deviation|8.1|8.1|||
4413975|NCT00218062|4238692|B4|||Age||years|Mean|41.9|41.9|Standard Deviation|9|9.0|||
4413976|NCT00218062|4238693|B3|||Age||years|Mean|41.2|41.2|Standard Deviation|8.5|8.5|||
4413977|NCT00218062|4238694|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|8.3|8.3|||
4413978|NCT00218062|4238695|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|6.5|6.5|||
4413979|NCT00218036|4238724|B6|United States||Region of Enrollment||Participants|Count of Participants|51|51.0||||||
4413980|NCT00218036|4238725|B5|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4413981|NCT00218036|4238726|B4|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4413982|NCT00218036|4238727|B3|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4413983|NCT00218036|4238728|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4413984|NCT00218036|4238729|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4413985|NCT00218036|4238724|B6||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4413986|NCT00218036|4238725|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4413987|NCT00218036|4238726|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4413988|NCT00218036|4238727|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4413989|NCT00218036|4238728|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4413990|NCT00218036|4238729|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4413991|NCT00218036|4238724|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4413992|NCT00218036|4238725|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4413993|NCT00218036|4238726|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4413994|NCT00218036|4238727|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4413995|NCT00218036|4238728|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4413996|NCT00218036|4238729|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4413997|NCT00218036|4238724|B6|||Age||years|Mean|37.510|37.51|Standard Deviation|8.941|8.941|||
4413998|NCT00218036|4238725|B5|||Age||years|Mean|36.556|36.556|Standard Deviation|7.618|7.618|||
4413999|NCT00218036|4238726|B4|||Age||years|Mean|36.500|36.5|Standard Deviation|9.050|9.05|||
4414000|NCT00218036|4238727|B3|||Age||years|Mean|38.769|38.769|Standard Deviation|7.350|7.35|||
4414001|NCT00218036|4238728|B2|||Age||years|Mean|40.333|40.333|Standard Deviation|8.335|8.335|||
4414002|NCT00218036|4238729|B1|||Age||years|Mean|36.364|36.364|Standard Deviation|11.474|11.474|||
4414003|NCT00218023|4238755|B5|United States||Region of Enrollment||participants|Number|81|81.0||||||
4414004|NCT00218023|4238756|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4414005|NCT00218023|4238757|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4414006|NCT00218023|4238758|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4414007|NCT00218023|4238759|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4414008|NCT00218023|4238755|B5||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4414009|NCT00218023|4238756|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4414010|NCT00218023|4238757|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4414011|NCT00218023|4238758|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4414012|NCT00218023|4238759|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4414013|NCT00218023|4238755|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4414014|NCT00218023|4238756|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4414015|NCT00218023|4238757|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4414016|NCT00218023|4238758|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4414017|NCT00218023|4238759|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4414018|NCT00218023|4238755|B5|||Age||years|Mean|42.16|42.16|Standard Deviation|8.67|8.67|||
4414019|NCT00218023|4238756|B4|||Age||years|Mean|42.29|42.29|Standard Deviation|10.5|10.5|||
4414020|NCT00218023|4238757|B3|||Age||years|Mean|42.08|42.08|Standard Deviation|9.89|9.89|||
4414021|NCT00218023|4238758|B2|||Age||years|Mean|40.66|40.66|Standard Deviation|8.6|8.6|||
4414022|NCT00218023|4238759|B1|||Age||years|Mean|43.64|43.64|Standard Deviation|5.71|5.71|||
4414023|NCT00217971|4238776|B3|United States||Region of Enrollment||participants|Number|156|156.0||||||
4414024|NCT00217971|4238777|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4414025|NCT00217971|4238778|B1|United States||Region of Enrollment||participants|Number|79|79.0||||||
4414026|NCT00217971|4238776|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4414027|NCT00217971|4238777|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4414028|NCT00217971|4238778|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4414029|NCT00217971|4238776|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4414030|NCT00217971|4238777|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4414031|NCT00217971|4238778|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4414032|NCT00217971|4238776|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|10.1|10.1|||
4414033|NCT00217971|4238777|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|9.2|9.2|||
4414034|NCT00217971|4238778|B1|||Age||years|Mean|36.9|36.9|Standard Deviation|10.8|10.8|||
4414035|NCT00217724|4238785|B1|Uterine sarcoma||Cancer Diagnosis|Type of cancer diagnosis enrolled subject was receiving treatment for|Participants|Number|1|1.0||||||
4414036|NCT00217724|4238785|B1|Esophageal||Cancer Diagnosis|Type of cancer diagnosis enrolled subject was receiving treatment for|Participants|Number|1|1.0||||||
4414037|NCT00217724|4238785|B1|Ovarian||Cancer Diagnosis|Type of cancer diagnosis enrolled subject was receiving treatment for|Participants|Number|5|5.0||||||
4414038|NCT00217724|4238785|B1|Breast||Cancer Diagnosis|Type of cancer diagnosis enrolled subject was receiving treatment for|Participants|Number|11|11.0||||||
4414039|NCT00217724|4238785|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4414040|NCT00217724|4238785|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414041|NCT00217724|4238785|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414042|NCT00217724|4238785|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4414043|NCT00217724|4238785|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4414044|NCT00217724|4238785|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414045|NCT00217724|4238785|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414046|NCT00217724|4238785|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414047|NCT00217724|4238785|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4414048|NCT00217724|4238785|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4414049|NCT00217724|4238785|B1|||Age||years|Mean|54|54.0|Standard Deviation|1|1.0|||
4414050|NCT00217724|4238785|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4414051|NCT00217724|4238785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4414052|NCT00217724|4238785|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414053|NCT00217672|4238794|B1|more than 3||Number of metastatic sites||participants|Number|30|30.0||||||
4414054|NCT00217672|4238794|B1|less than 3||Number of metastatic sites||participants|Number|37|37.0||||||
4414055|NCT00217672|4238794|B1|ER-PR-||Hormone receptor status||participants|Number|22|22.0||||||
4414056|NCT00217672|4238794|B1|ER-PR+||Hormone receptor status||participants|Number|3|3.0||||||
4414057|NCT00217672|4238794|B1|ER+PR-||Hormone receptor status||participants|Number|13|13.0||||||
4414058|NCT00217672|4238794|B1|Estrogen Receptor(ER)+ Progesterone Receptor(PR)+||Hormone receptor status||participants|Number|29|29.0||||||
4414059|NCT00217672|4238794|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4414060|NCT00217672|4238794|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414061|NCT00217672|4238794|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4414062|NCT00217672|4238794|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4414063|NCT00217672|4238794|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414064|NCT00217672|4238794|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4414065|NCT00217672|4238794|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414066|NCT00217672|4238794|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414067|NCT00217672|4238794|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4414068|NCT00217672|4238794|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4414069|NCT00217672|4238794|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414070|NCT00217672|4238794|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4414071|NCT00217672|4238794|B1|||Age||years|Median|57|57.0|Full Range|||32.0|83.0|
4414072|NCT00217620|4238801|B1|1||Performance Status|Performance status is graded according to the Zubrod Performance Status Scale. Patients with a performance status of 0 are fully active, able to carry on all pre-disease performance without restriction. Patients with a performance status of 1 are restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.|participants|Number|22|22.0||||||
4414073|NCT00217620|4238801|B1|0||Performance Status|Performance status is graded according to the Zubrod Performance Status Scale. Patients with a performance status of 0 are fully active, able to carry on all pre-disease performance without restriction. Patients with a performance status of 1 are restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.|participants|Number|15|15.0||||||
4414074|NCT00217620|4238801|B1|Soft Tissue Sarcoma of Vascular Derivation||Histology||participants|Number|8|8.0||||||
4414075|NCT00217620|4238801|B1|Liposarcoma||Histology||participants|Number|10|10.0||||||
4414076|NCT00217620|4238801|B1|Leiomyosarcoma||Histology||participants|Number|19|19.0||||||
4414077|NCT00217620|4238801|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4414078|NCT00217620|4238801|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4414079|NCT00217620|4238801|B1|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4414080|NCT00217620|4238801|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4414081|NCT00217620|4238801|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4414082|NCT00217620|4238801|B1|||Age||years|Median|62.7|62.7|Full Range|||24.0|88.5|
4414083|NCT00217594|4238812|B1|Race/Ethnicity|Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4414084|NCT00217594|4238812|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4414085|NCT00217594|4238812|B1|Race/Ethnicity|African American|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4414086|NCT00217594|4238812|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4414087|NCT00217594|4238812|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4414088|NCT00217594|4238812|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4414089|NCT00217594|4238812|B1|||Age||years|Median|57|57.0|Full Range|||23.0|72.0|
4414090|NCT00217581|4238816|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4414091|NCT00217581|4238816|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4414092|NCT00217581|4238816|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4414093|NCT00217581|4238816|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4414094|NCT00217581|4238816|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4414095|NCT00217581|4238816|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414096|NCT00217490|4238824|B5|United States||Region of Enrollment||participants|Number|615|615.0||||||
4414097|NCT00217490|4238825|B4|United States||Region of Enrollment||participants|Number|153|153.0||||||
4414098|NCT00217490|4238826|B3|United States||Region of Enrollment||participants|Number|155|155.0||||||
4414099|NCT00217490|4238827|B2|United States||Region of Enrollment||participants|Number|153|153.0||||||
4414100|NCT00217490|4238828|B1|United States||Region of Enrollment||participants|Number|154|154.0||||||
4414101|NCT00217490|4238824|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4414102|NCT00217490|4238825|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4414103|NCT00217490|4238826|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4414104|NCT00217490|4238827|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4414105|NCT00217490|4238828|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4414106|NCT00217490|4238824|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414107|NCT00217490|4238825|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414108|NCT00217490|4238826|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414109|NCT00217490|4238827|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414110|NCT00217490|4238828|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414111|NCT00217490|4238824|B5||White|Race (NIH/OMB)||Participants|Count of Participants|527|527.0||||||
4414112|NCT00217490|4238825|B4||White|Race (NIH/OMB)||Participants|Count of Participants|129|129.0||||||
4414113|NCT00217490|4238826|B3||White|Race (NIH/OMB)||Participants|Count of Participants|135|135.0||||||
4414114|NCT00217490|4238827|B2||White|Race (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4414115|NCT00217490|4238828|B1||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4414116|NCT00217490|4238824|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4414117|NCT00217490|4238825|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4414118|NCT00217490|4238826|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4414119|NCT00217490|4238827|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4414120|NCT00217490|4238828|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4414121|NCT00217490|4238824|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4414122|NCT00217490|4238825|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414123|NCT00217490|4238826|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4414124|NCT00217490|4238827|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4414125|NCT00217490|4238828|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414126|NCT00217490|4238824|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4414127|NCT00217490|4238825|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4414128|NCT00217490|4238826|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4414129|NCT00217490|4238827|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4414130|NCT00217490|4238828|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4414131|NCT00217490|4238824|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4414132|NCT00217490|4238825|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4414133|NCT00217490|4238826|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4414134|NCT00217490|4238827|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4414135|NCT00217490|4238828|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4414136|NCT00217490|4238824|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4414137|NCT00217490|4238825|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4414138|NCT00217490|4238826|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4414139|NCT00217490|4238827|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4414140|NCT00217490|4238828|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4414141|NCT00217490|4238824|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|586|586.0||||||
4414142|NCT00217490|4238825|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
4414143|NCT00217490|4238826|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
4414144|NCT00217490|4238827|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|148|148.0||||||
4414145|NCT00217490|4238828|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|145|145.0||||||
4414146|NCT00217490|4238824|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4414147|NCT00217490|4238825|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4414148|NCT00217490|4238826|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4414149|NCT00217490|4238827|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4414150|NCT00217490|4238828|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4414151|NCT00217490|4238824|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414152|NCT00217490|4238825|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414153|NCT00217490|4238826|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414154|NCT00217490|4238827|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414155|NCT00217490|4238828|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414156|NCT00217490|4238824|B5||Female|Sex: Female, Male||Participants|Count of Participants|615|615.0||||||
4414157|NCT00217490|4238825|B4||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4414158|NCT00217490|4238826|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4414159|NCT00217490|4238827|B2||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4414160|NCT00217490|4238828|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4414161|NCT00217490|4238824|B5||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4414162|NCT00217490|4238825|B4||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4414163|NCT00217490|4238826|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4414164|NCT00217490|4238827|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4414165|NCT00217490|4238828|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4414166|NCT00217490|4238824|B5||Between 18 and 65 years|Age||Participants|Count of Participants|574|574.0||||||
4414167|NCT00217490|4238825|B4||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4414168|NCT00217490|4238826|B3||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
4414169|NCT00217490|4238827|B2||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
4414170|NCT00217490|4238828|B1||Between 18 and 65 years|Age||Participants|Count of Participants|144|144.0||||||
4414171|NCT00217490|4238824|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414172|NCT00217490|4238825|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414173|NCT00217490|4238826|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414174|NCT00217490|4238827|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414175|NCT00217490|4238828|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414176|NCT00217464|4238845|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4414177|NCT00217464|4238845|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414178|NCT00217464|4238845|B1|||Age||years|Mean|63.01|63.01|Standard Deviation|8.98|8.98|||
4414179|NCT00217438|4238850|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4414180|NCT00217438|4238851|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4414181|NCT00217438|4238852|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4414182|NCT00217438|4238850|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4414183|NCT00217438|4238851|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4414184|NCT00217438|4238852|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4414185|NCT00217438|4238850|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4414186|NCT00217438|4238851|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4414187|NCT00217438|4238852|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4414188|NCT00217438|4238850|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4414189|NCT00217438|4238851|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4414190|NCT00217438|4238852|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4414191|NCT00217438|4238850|B3||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4414192|NCT00217438|4238851|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4414193|NCT00217438|4238852|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4414194|NCT00217438|4238850|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414195|NCT00217438|4238851|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414196|NCT00217438|4238852|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414197|NCT00217425|4238861|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4414198|NCT00217425|4238861|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4414199|NCT00217425|4238861|B1|||Age||years|Median|60|60.0|Full Range|||21.0|81.0|
4414200|NCT00217399|4238867|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4414201|NCT00217399|4238867|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414202|NCT00217399|4238867|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4414203|NCT00217399|4238867|B1|||Age||years|Mean|55|55.0|Standard Deviation|30|30.0|||
4414204|NCT00217399|4238867|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4414205|NCT00217399|4238867|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4414206|NCT00217399|4238867|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414207|NCT00217087|4238873|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4414208|NCT00217087|4238874|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4414209|NCT00217087|4238875|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4414210|NCT00217087|4238873|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4414211|NCT00217087|4238874|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4414212|NCT00217087|4238875|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4414213|NCT00217087|4238873|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4414214|NCT00217087|4238874|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4414215|NCT00217087|4238875|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4414216|NCT00217087|4238873|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4414217|NCT00217087|4238874|B2||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4414218|NCT00217087|4238875|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4414219|NCT00217087|4238873|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4414220|NCT00217087|4238874|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4414221|NCT00217087|4238875|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4414222|NCT00217087|4238873|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414223|NCT00217087|4238874|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414224|NCT00217087|4238875|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414225|NCT00217022|4238888|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4414226|NCT00217022|4238889|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4414227|NCT00217022|4238890|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4414228|NCT00217022|4238888|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4414229|NCT00217022|4238889|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4414230|NCT00217022|4238890|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4414231|NCT00217022|4238888|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4414232|NCT00217022|4238889|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4414233|NCT00217022|4238890|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4414234|NCT00217022|4238888|B3|||Age||years|Mean|58|58.0|Standard Deviation|13|13.0|||
4414235|NCT00217022|4238889|B2|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4414236|NCT00217022|4238890|B1|||Age||years|Mean|56|56.0|Standard Deviation|19|19.0|||
4414237|NCT00217022|4238888|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414238|NCT00217022|4238889|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414239|NCT00217022|4238890|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414240|NCT00217022|4238888|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4414241|NCT00217022|4238889|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4414242|NCT00217022|4238890|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4414243|NCT00217022|4238888|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414244|NCT00217022|4238889|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414245|NCT00217022|4238890|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414246|NCT00216736|4238899|B3|Australia||Region of Enrollment||participants|Number|63|63.0||||||
4414247|NCT00216736|4238900|B2|Australia||Region of Enrollment||participants|Number|31|31.0||||||
4414248|NCT00216736|4238901|B1|Australia||Region of Enrollment||participants|Number|32|32.0||||||
4414249|NCT00216736|4238899|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4414250|NCT00216736|4238900|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4414251|NCT00216736|4238901|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4414252|NCT00216736|4238899|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4414253|NCT00216736|4238900|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4414254|NCT00216736|4238901|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4414255|NCT00216736|4238899|B3|||Age||years|Mean|39|39.0|Standard Deviation|12|12.0|||
4414256|NCT00216736|4238900|B2|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
4414257|NCT00216736|4238901|B1|||Age||years|Mean|39|39.0|Standard Deviation|13|13.0|||
4414258|NCT00216736|4238899|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414259|NCT00216736|4238900|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414260|NCT00216736|4238901|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414261|NCT00216736|4238899|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4414262|NCT00216736|4238900|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4414263|NCT00216736|4238901|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4414264|NCT00216736|4238899|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414265|NCT00216736|4238900|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414266|NCT00216736|4238901|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414267|NCT00216671|4238914|B3||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4414268|NCT00216671|4238915|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4414269|NCT00216671|4238916|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4414270|NCT00216671|4238914|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4414271|NCT00216671|4238915|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4414272|NCT00216671|4238916|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4414273|NCT00216671|4238914|B3|||Age|Two enrolled patients from each group were excluded from the baseline analysis as these patients dropped out early and no safety or efficacy data were present.|years|Mean|38|38.0|Standard Deviation|11|11.0|||
4414274|NCT00216671|4238915|B2|||Age|Two enrolled patients from each group were excluded from the baseline analysis as these patients dropped out early and no safety or efficacy data were present.|years|Mean|38|38.0|Standard Deviation|11|11.0|||
4414275|NCT00216671|4238916|B1|||Age|Two enrolled patients from each group were excluded from the baseline analysis as these patients dropped out early and no safety or efficacy data were present.|years|Mean|38|38.0|Standard Deviation|11|11.0|||
4414276|NCT00216476|4238933|B3|||Weight|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|kg|Mean|79.7|79.7|Standard Deviation|17.35|17.35|||
4414277|NCT00216476|4238934|B2|||Weight|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|kg|Mean|79.0|79.0|Standard Deviation|17.75|17.75|||
4414278|NCT00216476|4238935|B1|||Weight|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|kg|Mean|80.4|80.4|Standard Deviation|16.93|16.93|||
4414279|NCT00216476|4238933|B3|||Body Mass Index (BMI)|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|kg/m2|Mean|27.3|27.3|Standard Deviation|5.28|5.28|||
4414280|NCT00216476|4238934|B2|||Body Mass Index (BMI)|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|kg/m2|Mean|27.0|27.0|Standard Deviation|5.32|5.32|||
4414281|NCT00216476|4238935|B1|||Body Mass Index (BMI)|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|kg/m2|Mean|27.6|27.6|Standard Deviation|5.23|5.23|||
4414282|NCT00216476|4238933|B3|Pakistani||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|1|1.0||||||
4414283|NCT00216476|4238934|B2|Pakistani||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|1|1.0||||||
4414284|NCT00216476|4238935|B1|Pakistani||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|0|0.0||||||
4414285|NCT00216476|4238933|B3|Arab||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|9|9.0||||||
4414286|NCT00216476|4238934|B2|Arab||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|4|4.0||||||
4414287|NCT00216476|4238935|B1|Arab||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|5|5.0||||||
4414288|NCT00216476|4238933|B3|Black||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|1|1.0||||||
4414289|NCT00216476|4238934|B2|Black||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|0|0.0||||||
4414290|NCT00216476|4238935|B1|Black||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|1|1.0||||||
4414291|NCT00216476|4238933|B3|Hispanic||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|2|2.0||||||
4414292|NCT00216476|4238934|B2|Hispanic||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|0|0.0||||||
4414293|NCT00216476|4238935|B1|Hispanic||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|2|2.0||||||
4414294|NCT00216476|4238933|B3|Oriental||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|3|3.0||||||
4414295|NCT00216476|4238934|B2|Oriental||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|2|2.0||||||
4414296|NCT00216476|4238935|B1|Oriental||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|1|1.0||||||
4414297|NCT00216476|4238933|B3|Caucasian||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|650|650.0||||||
4414298|NCT00216476|4238934|B2|Caucasian||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|330|330.0||||||
4414299|NCT00216476|4238935|B1|Caucasian||Race/Ethnicity, Customized|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|participants|Number|320|320.0||||||
4414300|NCT00216476|4238933|B3||Male|Sex: Female, Male|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|Participants|Count of Participants|386|386.0||||||
4414301|NCT00216476|4238934|B2||Male|Sex: Female, Male|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|Participants|Count of Participants|191|191.0||||||
4414302|NCT00216476|4238935|B1||Male|Sex: Female, Male|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|Participants|Count of Participants|195|195.0||||||
4414303|NCT00216476|4238933|B3||Female|Sex: Female, Male|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|Participants|Count of Participants|280|280.0||||||
4414304|NCT00216476|4238934|B2||Female|Sex: Female, Male|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|Participants|Count of Participants|146|146.0||||||
4414305|NCT00216476|4238935|B1||Female|Sex: Female, Male|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|Participants|Count of Participants|134|134.0||||||
4414306|NCT00216476|4238933|B3|||Age|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|years|Mean|41.6|41.6|Standard Deviation|12.85|12.85|||
4414307|NCT00216476|4238934|B2|||Age|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|years|Mean|42.6|42.6|Standard Deviation|13.14|13.14|||
4414308|NCT00216476|4238935|B1|||Age|As aripiprazole was not part of the primary analysis but was only added for exploratory purposes, data on this arm are not presented here.|years|Mean|40.6|40.6|Standard Deviation|12.48|12.48|||
4414309|NCT00216320|4238954|B4|||Chronicity|Chronicity refers to the number of years since onset of stroke|years|Mean|6.4|6.4|Standard Deviation|3.6|3.6|||
4414310|NCT00216320|4238955|B3|||Chronicity|Chronicity refers to the number of years since onset of stroke|years|Mean|5.8|5.8|Standard Deviation|3.7|3.7|||
4414311|NCT00216320|4238956|B2|||Chronicity|Chronicity refers to the number of years since onset of stroke|years|Mean|6.9|6.9|Standard Deviation|3.2|3.2|||
4414312|NCT00216320|4238957|B1|||Chronicity|Chronicity refers to the number of years since onset of stroke|years|Mean|6.4|6.4|Standard Deviation|3.8|3.8|||
4414313|NCT00216320|4238954|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4414314|NCT00216320|4238955|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4414315|NCT00216320|4238956|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4414316|NCT00216320|4238957|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4414317|NCT00216320|4238954|B4||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4414318|NCT00216320|4238955|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4414319|NCT00216320|4238956|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4414320|NCT00216320|4238957|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4414321|NCT00216320|4238954|B4|||Age||years|Mean|57.0|57.0|Standard Deviation|11.8|11.8|||
4414322|NCT00216320|4238955|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|9.8|9.8|||
4414323|NCT00216320|4238956|B2|||Age||years|Mean|55.6|55.6|Standard Deviation|11.9|11.9|||
4414324|NCT00216320|4238957|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|12.9|12.9|||
4414325|NCT00216203|4238974|B1|Previous radiotherapy||Previous Treatment||participants|Number|14|14.0||||||
4414326|NCT00216203|4238974|B1|Previous Targeted Therapy||Previous Treatment||participants|Number|6|6.0||||||
4414327|NCT00216203|4238974|B1|>2 Chemotherapy||Previous Treatment||participants|Number|2|2.0||||||
4414328|NCT00216203|4238974|B1|2 Chemotherapy||Previous Treatment||participants|Number|5|5.0||||||
4414329|NCT00216203|4238974|B1|1 Chemotherapy||Previous Treatment||participants|Number|26|26.0||||||
4414330|NCT00216203|4238974|B1|Never a Smoker||Smoking History||participants|Number|3|3.0||||||
4414331|NCT00216203|4238974|B1|Former Smoker||Smoking History||participants|Number|24|24.0||||||
4414332|NCT00216203|4238974|B1|Current Smoker||Smoking History||participants|Number|6|6.0||||||
4414333|NCT00216203|4238974|B1|Non-small cell carcinoma (NOS)||Tumor Histology||participants|Number|5|5.0||||||
4414334|NCT00216203|4238974|B1|Large cell carcinoma||Tumor Histology||participants|Number|2|2.0||||||
4414335|NCT00216203|4238974|B1|Squamous cell carcinoma||Tumor Histology||participants|Number|8|8.0||||||
4414336|NCT00216203|4238974|B1|Adenocarcinoma||Tumor Histology||participants|Number|18|18.0||||||
4414337|NCT00216203|4238974|B1|Disease Stage IV||Disease Stage|"Stage III: Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.~Stage IV: The cancer has spread to distant parts of the body."|participants|Number|31|31.0||||||
4414338|NCT00216203|4238974|B1|Disease Stage III||Disease Stage|"Stage III: Cancer is present. The higher the number, the larger the cancer tumor and the more it has spread into nearby tissues.~Stage IV: The cancer has spread to distant parts of the body."|participants|Number|2|2.0||||||
4414339|NCT00216203|4238974|B1|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|14|14.0||||||
4414340|NCT00216203|4238974|B1|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|19|19.0||||||
4414341|NCT00216203|4238974|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4414342|NCT00216203|4238974|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4414343|NCT00216203|4238974|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4414344|NCT00216203|4238974|B1|||Age||years|Median|64|64.0|Full Range|||37.0|80.0|
4414345|NCT00216125|4238982|B1|||Percentage of participants with Stage IIIa vs IIIb disease at baseline||percentage|Number|41.15|41.15||||||
4414346|NCT00216125|4238982|B1|United States||Region of Enrollment||participants|Number|243|243.0||||||
4414347|NCT00216125|4238982|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4414348|NCT00216125|4238982|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4414349|NCT00216125|4238982|B1|||Age||years|Median|63.0|63.0|Standard Deviation|9.50|9.5|||
4414350|NCT00216099|4238993|B1|unknown||Days Since Last Docetaxel||participants|Number|1|1.0||||||
4414351|NCT00216099|4238993|B1|>180||Days Since Last Docetaxel||participants|Number|6|6.0||||||
4414352|NCT00216099|4238993|B1|91-180||Days Since Last Docetaxel||participants|Number|5|5.0||||||
4414353|NCT00216099|4238993|B1|29-90||Days Since Last Docetaxel||participants|Number|7|7.0||||||
4414354|NCT00216099|4238993|B1|0-28||Days Since Last Docetaxel||participants|Number|30|30.0||||||
4414355|NCT00216099|4238993|B1|Visceral||Metastatic Sites|Number of patients who had metastatic disease present at the specified site at trial entry|participants|Number|7|7.0||||||
4414356|NCT00216099|4238993|B1|Lymph Node||Metastatic Sites|Number of patients who had metastatic disease present at the specified site at trial entry|participants|Number|16|16.0||||||
4414357|NCT00216099|4238993|B1|Bone||Metastatic Sites|Number of patients who had metastatic disease present at the specified site at trial entry|participants|Number|31|31.0||||||
4414358|NCT00216099|4238993|B1|||Baseline Opiate Use||Intramuscular morphine equivalents|Mean|9.6|9.6|Full Range|||0.0|80.0|
4414359|NCT00216099|4238993|B1|||Baseline Pain Score|Patients self-scored their pain on a scale of 0-10 where 0=no pain and 10=extreme pain|units on a scale|Median|2|2.0|Full Range|||0.0|10.0|
4414360|NCT00216099|4238993|B1|||Baseline Karnofsky Performance Status (KPS)|Karnofsky Performance Status (KPS) is a general indicator of a subject's well being and ability to carry on daily activities. The KPS scale ranges from 0-100 in 10 unit increments where 100=Normal; no complaints; no evidence of disease and 0=Dead|units on a scale|Median|90|90.0|Full Range|||70.0|100.0|
4414361|NCT00216099|4238993|B1|||Baseline Prostate-Specific Antigen (PSA)|Prostate-Specific Antigen (PSA) is a protein produced by the prostate in men. Elevated PSA levels (>4ng/mL) can be an indicator of infection or cancer of the prostate.|ng/mL|Median|72.2|72.2|Full Range|||0.8|1015.0|
4414362|NCT00216099|4238993|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4414363|NCT00216099|4238993|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4414364|NCT00216099|4238993|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414365|NCT00216099|4238993|B1|||Age||years|Median|68|68.0|Full Range|||58.0|83.0|
4414366|NCT00216086|4239004|B1|T4||Tumor Node Metastatis (TNM) Stage|Tumor Node Metastasis (TNM) Staging. This system classifies tumors by size and extent of the primary tumor (T), involvement of regional lymph nodes (N), and the presence or absence of distant metastases (M) T0=No evidence of primary tumor, Tis=Carcinoma in situ, and T1, T2, T3, T4=Increasing size and/or local extension of the primary tumor, TX=Not assessed N0=No Regional lymph node metastases, N1, N2, N3=Increasing number or extent of regional lymph node involvement, NX=not assessed M0=No distant metastases, M1=Distant metastases present|participants|Number|2|2.0||||||
4414414|NCT00216060|4239013|B1|Yes||Previous Adjuvant Hormone Therapy||participants|Number|2|2.0||||||
4414415|NCT00216060|4239011|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4414367|NCT00216086|4239004|B1|T3||Tumor Node Metastatis (TNM) Stage|Tumor Node Metastasis (TNM) Staging. This system classifies tumors by size and extent of the primary tumor (T), involvement of regional lymph nodes (N), and the presence or absence of distant metastases (M) T0=No evidence of primary tumor, Tis=Carcinoma in situ, and T1, T2, T3, T4=Increasing size and/or local extension of the primary tumor, TX=Not assessed N0=No Regional lymph node metastases, N1, N2, N3=Increasing number or extent of regional lymph node involvement, NX=not assessed M0=No distant metastases, M1=Distant metastases present|participants|Number|19|19.0||||||
4414368|NCT00216086|4239004|B1|T2||Tumor Node Metastatis (TNM) Stage|Tumor Node Metastasis (TNM) Staging. This system classifies tumors by size and extent of the primary tumor (T), involvement of regional lymph nodes (N), and the presence or absence of distant metastases (M) T0=No evidence of primary tumor, Tis=Carcinoma in situ, and T1, T2, T3, T4=Increasing size and/or local extension of the primary tumor, TX=Not assessed N0=No Regional lymph node metastases, N1, N2, N3=Increasing number or extent of regional lymph node involvement, NX=not assessed M0=No distant metastases, M1=Distant metastases present|participants|Number|1|1.0||||||
4414369|NCT00216086|4239004|B1|1||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|15|15.0||||||
4414370|NCT00216086|4239004|B1|0||Eastern Cooperative Oncology Group (ECOG) performance status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|7|7.0||||||
4414371|NCT00216086|4239004|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4414372|NCT00216086|4239004|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414373|NCT00216086|4239004|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414374|NCT00216086|4239004|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4414375|NCT00216086|4239004|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4414376|NCT00216086|4239004|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414377|NCT00216086|4239004|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414378|NCT00216086|4239004|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4414379|NCT00216086|4239004|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4414380|NCT00216086|4239004|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4414381|NCT00216086|4239004|B1|||Age||years|Median|54|54.0|Full Range|||36.0|67.0|
4414382|NCT00216060|4239011|B3|Severe||Comorbidity Score|"Comorbidity Scores were determined using the Adult Comorbidity Evaluation-27 Index (ACE-27). The ACE-27 grades 27 cogent comorbid ailments on a scale from 0-3 where 0=None, 1=Mild, 2=Moderate, 3=Severe.~The highest ranked comorbid ailment determines the overall comorbidity score.~The data reported in this table represents the data that was collected before the termination of the study."|participants|Number|8|8.0||||||
4414383|NCT00216060|4239012|B2|Severe||Comorbidity Score|"Comorbidity Scores were determined using the Adult Comorbidity Evaluation-27 Index (ACE-27). The ACE-27 grades 27 cogent comorbid ailments on a scale from 0-3 where 0=None, 1=Mild, 2=Moderate, 3=Severe.~The highest ranked comorbid ailment determines the overall comorbidity score.~The data reported in this table represents the data that was collected before the termination of the study."|participants|Number|5|5.0||||||
4414384|NCT00216060|4239013|B1|Severe||Comorbidity Score|"Comorbidity Scores were determined using the Adult Comorbidity Evaluation-27 Index (ACE-27). The ACE-27 grades 27 cogent comorbid ailments on a scale from 0-3 where 0=None, 1=Mild, 2=Moderate, 3=Severe.~The highest ranked comorbid ailment determines the overall comorbidity score.~The data reported in this table represents the data that was collected before the termination of the study."|participants|Number|3|3.0||||||
4414385|NCT00216060|4239011|B3|Moderate||Comorbidity Score|"Comorbidity Scores were determined using the Adult Comorbidity Evaluation-27 Index (ACE-27). The ACE-27 grades 27 cogent comorbid ailments on a scale from 0-3 where 0=None, 1=Mild, 2=Moderate, 3=Severe.~The highest ranked comorbid ailment determines the overall comorbidity score.~The data reported in this table represents the data that was collected before the termination of the study."|participants|Number|23|23.0||||||
4414386|NCT00216060|4239012|B2|Moderate||Comorbidity Score|"Comorbidity Scores were determined using the Adult Comorbidity Evaluation-27 Index (ACE-27). The ACE-27 grades 27 cogent comorbid ailments on a scale from 0-3 where 0=None, 1=Mild, 2=Moderate, 3=Severe.~The highest ranked comorbid ailment determines the overall comorbidity score.~The data reported in this table represents the data that was collected before the termination of the study."|participants|Number|11|11.0||||||
4414387|NCT00216060|4239013|B1|Moderate||Comorbidity Score|"Comorbidity Scores were determined using the Adult Comorbidity Evaluation-27 Index (ACE-27). The ACE-27 grades 27 cogent comorbid ailments on a scale from 0-3 where 0=None, 1=Mild, 2=Moderate, 3=Severe.~The highest ranked comorbid ailment determines the overall comorbidity score.~The data reported in this table represents the data that was collected before the termination of the study."|participants|Number|12|12.0||||||
4414388|NCT00216060|4239011|B3|Mild||Comorbidity Score|"Comorbidity Scores were determined using the Adult Comorbidity Evaluation-27 Index (ACE-27). The ACE-27 grades 27 cogent comorbid ailments on a scale from 0-3 where 0=None, 1=Mild, 2=Moderate, 3=Severe.~The highest ranked comorbid ailment determines the overall comorbidity score.~The data reported in this table represents the data that was collected before the termination of the study."|participants|Number|18|18.0||||||
4414389|NCT00216060|4239012|B2|Mild||Comorbidity Score|"Comorbidity Scores were determined using the Adult Comorbidity Evaluation-27 Index (ACE-27). The ACE-27 grades 27 cogent comorbid ailments on a scale from 0-3 where 0=None, 1=Mild, 2=Moderate, 3=Severe.~The highest ranked comorbid ailment determines the overall comorbidity score.~The data reported in this table represents the data that was collected before the termination of the study."|participants|Number|11|11.0||||||
4414416|NCT00216060|4239012|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4414417|NCT00216060|4239013|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4414418|NCT00216060|4239011|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414390|NCT00216060|4239013|B1|Mild||Comorbidity Score|"Comorbidity Scores were determined using the Adult Comorbidity Evaluation-27 Index (ACE-27). The ACE-27 grades 27 cogent comorbid ailments on a scale from 0-3 where 0=None, 1=Mild, 2=Moderate, 3=Severe.~The highest ranked comorbid ailment determines the overall comorbidity score.~The data reported in this table represents the data that was collected before the termination of the study."|participants|Number|7|7.0||||||
4414391|NCT00216060|4239011|B3|None||Comorbidity Score|"Comorbidity Scores were determined using the Adult Comorbidity Evaluation-27 Index (ACE-27). The ACE-27 grades 27 cogent comorbid ailments on a scale from 0-3 where 0=None, 1=Mild, 2=Moderate, 3=Severe.~The highest ranked comorbid ailment determines the overall comorbidity score.~The data reported in this table represents the data that was collected before the termination of the study."|participants|Number|9|9.0||||||
4414392|NCT00216060|4239012|B2|None||Comorbidity Score|"Comorbidity Scores were determined using the Adult Comorbidity Evaluation-27 Index (ACE-27). The ACE-27 grades 27 cogent comorbid ailments on a scale from 0-3 where 0=None, 1=Mild, 2=Moderate, 3=Severe.~The highest ranked comorbid ailment determines the overall comorbidity score.~The data reported in this table represents the data that was collected before the termination of the study."|participants|Number|3|3.0||||||
4414393|NCT00216060|4239013|B1|None||Comorbidity Score|"Comorbidity Scores were determined using the Adult Comorbidity Evaluation-27 Index (ACE-27). The ACE-27 grades 27 cogent comorbid ailments on a scale from 0-3 where 0=None, 1=Mild, 2=Moderate, 3=Severe.~The highest ranked comorbid ailment determines the overall comorbidity score.~The data reported in this table represents the data that was collected before the termination of the study."|participants|Number|6|6.0||||||
4414394|NCT00216060|4239011|B3|Extensive Disease||Disease Extent|"Minimal disease was defined as metastases limited to the pelvic and axial skeleton.~Extensive disease was defined as metastases involving the appendicular skeleton or visceral metastases"|participants|Number|41|41.0||||||
4414395|NCT00216060|4239012|B2|Extensive Disease||Disease Extent|"Minimal disease was defined as metastases limited to the pelvic and axial skeleton.~Extensive disease was defined as metastases involving the appendicular skeleton or visceral metastases"|participants|Number|20|20.0||||||
4414396|NCT00216060|4239013|B1|Extensive Disease||Disease Extent|"Minimal disease was defined as metastases limited to the pelvic and axial skeleton.~Extensive disease was defined as metastases involving the appendicular skeleton or visceral metastases"|participants|Number|21|21.0||||||
4414397|NCT00216060|4239011|B3|Minimal Disease||Disease Extent|"Minimal disease was defined as metastases limited to the pelvic and axial skeleton.~Extensive disease was defined as metastases involving the appendicular skeleton or visceral metastases"|participants|Number|22|22.0||||||
4414398|NCT00216060|4239012|B2|Minimal Disease||Disease Extent|"Minimal disease was defined as metastases limited to the pelvic and axial skeleton.~Extensive disease was defined as metastases involving the appendicular skeleton or visceral metastases"|participants|Number|11|11.0||||||
4414399|NCT00216060|4239013|B1|Minimal Disease||Disease Extent|"Minimal disease was defined as metastases limited to the pelvic and axial skeleton.~Extensive disease was defined as metastases involving the appendicular skeleton or visceral metastases"|participants|Number|11|11.0||||||
4414400|NCT00216060|4239011|B3|ECOG 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|4|4.0||||||
4414401|NCT00216060|4239012|B2|ECOG 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|2|2.0||||||
4414402|NCT00216060|4239013|B1|ECOG 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|2|2.0||||||
4414403|NCT00216060|4239011|B3|ECOG 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|14|14.0||||||
4414404|NCT00216060|4239012|B2|ECOG 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|10|10.0||||||
4414405|NCT00216060|4239013|B1|ECOG 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|4|4.0||||||
4414406|NCT00216060|4239011|B3|ECOG 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|45|45.0||||||
4414407|NCT00216060|4239012|B2|ECOG 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|19|19.0||||||
4414408|NCT00216060|4239013|B1|ECOG 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) from 0-5 that describes a patient's level of functioning where 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Dead:|participants|Number|26|26.0||||||
4414409|NCT00216060|4239011|B3|No||Previous Adjuvant Hormone Therapy||participants|Number|56|56.0||||||
4414410|NCT00216060|4239012|B2|No||Previous Adjuvant Hormone Therapy||participants|Number|26|26.0||||||
4414411|NCT00216060|4239013|B1|No||Previous Adjuvant Hormone Therapy||participants|Number|30|30.0||||||
4414412|NCT00216060|4239011|B3|Yes||Previous Adjuvant Hormone Therapy||participants|Number|7|7.0||||||
4414413|NCT00216060|4239012|B2|Yes||Previous Adjuvant Hormone Therapy||participants|Number|5|5.0||||||
4414419|NCT00216060|4239012|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414420|NCT00216060|4239013|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414421|NCT00216060|4239011|B3|||Age||years|Mean|70.2|70.2|Standard Deviation|8.95|8.95|||
4414422|NCT00216060|4239012|B2|||Age||years|Mean|70.2|70.2|Standard Deviation|8.4|8.4|||
4414423|NCT00216060|4239013|B1|||Age||years|Mean|70.2|70.2|Standard Deviation|9.5|9.5|||
4414424|NCT00216060|4239011|B3||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4414425|NCT00216060|4239012|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4414426|NCT00216060|4239013|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4414427|NCT00216060|4239011|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4414428|NCT00216060|4239012|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4414429|NCT00216060|4239013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4414430|NCT00216060|4239011|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414431|NCT00216060|4239012|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414432|NCT00216060|4239013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414433|NCT00215943|4239034|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4414434|NCT00215943|4239035|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4414435|NCT00215943|4239036|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4414436|NCT00215943|4239034|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4414437|NCT00215943|4239035|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4414438|NCT00215943|4239036|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4414439|NCT00215943|4239034|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4414440|NCT00215943|4239035|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4414441|NCT00215943|4239036|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4414442|NCT00215943|4239034|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4414443|NCT00215943|4239035|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4414444|NCT00215943|4239036|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4414445|NCT00215943|4239034|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4414446|NCT00215943|4239035|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4414447|NCT00215943|4239036|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4414448|NCT00215943|4239034|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414449|NCT00215943|4239035|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414450|NCT00215943|4239036|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414451|NCT00215930|4239049|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4414452|NCT00215930|4239049|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4414453|NCT00215930|4239049|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4414454|NCT00215930|4239049|B1|||Age, Customized||years|Median|63|63.0|Full Range|||38.0|78.0|
4414455|NCT00215930|4239049|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4414456|NCT00215930|4239049|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4414457|NCT00215930|4239049|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414458|NCT00215787|4239055|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4414459|NCT00215787|4239055|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4414460|NCT00215787|4239055|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4414461|NCT00215787|4239055|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414462|NCT00215787|4239055|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4414463|NCT00215787|4239055|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414464|NCT00215683|4239059|B4|||Time since Prostate Cancer Diagnosis|Safety analysis set.|days|Mean|343|343.0|Standard Deviation|798|798.0|||
4414465|NCT00215683|4239060|B3|||Time since Prostate Cancer Diagnosis|Safety analysis set.|days|Mean|457|457.0|Standard Deviation|1086|1086.0|||
4414466|NCT00215683|4239061|B2|||Time since Prostate Cancer Diagnosis|Safety analysis set.|days|Mean|227|227.0|Standard Deviation|590|590.0|||
4414467|NCT00215683|4239062|B1|||Time since Prostate Cancer Diagnosis|Safety analysis set.|days|Mean|355|355.0|Standard Deviation|645|645.0|||
4414468|NCT00215683|4239059|B4|Not classifiable||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|38|38.0||||||
4414469|NCT00215683|4239060|B3|Not classifiable||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|12|12.0||||||
4414470|NCT00215683|4239061|B2|Not classifiable||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|12|12.0||||||
4414521|NCT00215683|4239060|B3||White|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|44|44.0||||||
4414471|NCT00215683|4239062|B1|Not classifiable||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|14|14.0||||||
4414472|NCT00215683|4239059|B4|Metastatic||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|18|18.0||||||
4414473|NCT00215683|4239060|B3|Metastatic||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|6|6.0||||||
4414474|NCT00215683|4239061|B2|Metastatic||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|7|7.0||||||
4414475|NCT00215683|4239062|B1|Metastatic||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4414476|NCT00215683|4239059|B4|Locally advanced||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|49|49.0||||||
4414477|NCT00215683|4239060|B3|Locally advanced||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|18|18.0||||||
4414478|NCT00215683|4239061|B2|Locally advanced||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|15|15.0||||||
4414479|NCT00215683|4239062|B1|Locally advanced||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|16|16.0||||||
4414480|NCT00215683|4239059|B4|Localized||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|32|32.0||||||
4414481|NCT00215683|4239060|B3|Localized||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|8|8.0||||||
4414482|NCT00215683|4239061|B2|Localized||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|14|14.0||||||
4414483|NCT00215683|4239062|B1|Localized||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|10|10.0||||||
4414484|NCT00215683|4239059|B4|7-10||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason score for one patient in 160 mg group was missing.|participants|Number|54|54.0||||||
4414485|NCT00215683|4239060|B3|7-10||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason score for one patient in 160 mg group was missing.|participants|Number|22|22.0||||||
4414486|NCT00215683|4239061|B2|7-10||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason score for one patient in 160 mg group was missing.|participants|Number|15|15.0||||||
4414487|NCT00215683|4239062|B1|7-10||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason score for one patient in 160 mg group was missing.|participants|Number|17|17.0||||||
4414522|NCT00215683|4239061|B2||White|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|44|44.0||||||
4414488|NCT00215683|4239059|B4|5-6||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason score for one patient in 160 mg group was missing.|participants|Number|56|56.0||||||
4414489|NCT00215683|4239060|B3|5-6||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason score for one patient in 160 mg group was missing.|participants|Number|16|16.0||||||
4414490|NCT00215683|4239061|B2|5-6||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason score for one patient in 160 mg group was missing.|participants|Number|22|22.0||||||
4414491|NCT00215683|4239062|B1|5-6||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason score for one patient in 160 mg group was missing.|participants|Number|18|18.0||||||
4414492|NCT00215683|4239059|B4|2-4||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason score for one patient in 160 mg group was missing.|participants|Number|26|26.0||||||
4414493|NCT00215683|4239060|B3|2-4||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason score for one patient in 160 mg group was missing.|participants|Number|5|5.0||||||
4414494|NCT00215683|4239061|B2|2-4||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason score for one patient in 160 mg group was missing.|participants|Number|11|11.0||||||
4414495|NCT00215683|4239062|B1|2-4||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason score for one patient in 160 mg group was missing.|participants|Number|10|10.0||||||
4414496|NCT00215683|4239059|B4|No||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|128|128.0||||||
4414497|NCT00215683|4239060|B3|No||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|41|41.0||||||
4414498|NCT00215683|4239061|B2|No||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|45|45.0||||||
4414499|NCT00215683|4239062|B1|No||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|42|42.0||||||
4414500|NCT00215683|4239059|B4|Yes||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|9|9.0||||||
4414501|NCT00215683|4239060|B3|Yes||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|3|3.0||||||
4414502|NCT00215683|4239061|B2|Yes||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|3|3.0||||||
4414503|NCT00215683|4239062|B1|Yes||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|3|3.0||||||
4414504|NCT00215683|4239059|B4|||Body Mass Index|Safety analysis set|kilogram per square meter|Mean|26.2|26.2|Standard Deviation|3.8|3.8|||
4414505|NCT00215683|4239060|B3|||Body Mass Index|Safety analysis set|kilogram per square meter|Mean|25.7|25.7|Standard Deviation|3.4|3.4|||
4414506|NCT00215683|4239061|B2|||Body Mass Index|Safety analysis set|kilogram per square meter|Mean|26.4|26.4|Standard Deviation|3.4|3.4|||
4414507|NCT00215683|4239062|B1|||Body Mass Index|Safety analysis set|kilogram per square meter|Mean|26.4|26.4|Standard Deviation|4.5|4.5|||
4414508|NCT00215683|4239059|B4|||Body Weight|Safety analysis set|kilogram|Mean|78.4|78.4|Standard Deviation|13.9|13.9|||
4414509|NCT00215683|4239060|B3|||Body Weight|Safety analysis set|kilogram|Mean|76.8|76.8|Standard Deviation|12.4|12.4|||
4414510|NCT00215683|4239061|B2|||Body Weight|Safety analysis set|kilogram|Mean|79.1|79.1|Standard Deviation|13.2|13.2|||
4414511|NCT00215683|4239062|B1|||Body Weight|Safety analysis set|kilogram|Mean|79.4|79.4|Standard Deviation|15.9|15.9|||
4414512|NCT00215683|4239059|B4||Unknown or Not Reported|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414513|NCT00215683|4239060|B3||Unknown or Not Reported|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414514|NCT00215683|4239061|B2||Unknown or Not Reported|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414515|NCT00215683|4239062|B1||Unknown or Not Reported|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414516|NCT00215683|4239059|B4||More than one race|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414517|NCT00215683|4239060|B3||More than one race|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414518|NCT00215683|4239061|B2||More than one race|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414519|NCT00215683|4239062|B1||More than one race|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414520|NCT00215683|4239059|B4||White|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|133|133.0||||||
4414523|NCT00215683|4239062|B1||White|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|45|45.0||||||
4414524|NCT00215683|4239059|B4||Black or African American|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|3|3.0||||||
4414525|NCT00215683|4239060|B3||Black or African American|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414526|NCT00215683|4239061|B2||Black or African American|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|3|3.0||||||
4414527|NCT00215683|4239062|B1||Black or African American|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414528|NCT00215683|4239059|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414529|NCT00215683|4239060|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414530|NCT00215683|4239061|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414531|NCT00215683|4239062|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414532|NCT00215683|4239059|B4||Asian|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|1|1.0||||||
4414533|NCT00215683|4239060|B3||Asian|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414534|NCT00215683|4239061|B2||Asian|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|1|1.0||||||
4414535|NCT00215683|4239062|B1||Asian|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414536|NCT00215683|4239059|B4||American Indian or Alaska Native|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414537|NCT00215683|4239060|B3||American Indian or Alaska Native|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414538|NCT00215683|4239061|B2||American Indian or Alaska Native|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414539|NCT00215683|4239062|B1||American Indian or Alaska Native|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4414540|NCT00215683|4239059|B4||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4414541|NCT00215683|4239060|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4414542|NCT00215683|4239061|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4414543|NCT00215683|4239062|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4414544|NCT00215683|4239059|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414545|NCT00215683|4239060|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414546|NCT00215683|4239061|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414547|NCT00215683|4239062|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414548|NCT00215683|4239059|B4|||Age||years|Mean|71.4|71.4|Standard Deviation|7.3|7.3|||
4414549|NCT00215683|4239060|B3|||Age||years|Mean|72.4|72.4|Standard Deviation|7.7|7.7|||
4414550|NCT00215683|4239061|B2|||Age||years|Mean|70.8|70.8|Standard Deviation|6.3|6.3|||
4414551|NCT00215683|4239062|B1|||Age||years|Mean|71.0|71.0|Standard Deviation|7.9|7.9|||
4414552|NCT00215657|4239075|B9|||Weight|ITT population.|kilogram|Mean|78.4|78.4|Standard Deviation|11.6|11.6|||
4414553|NCT00215657|4239076|B8|||Weight|ITT population.|kilogram|Mean|81.7|81.7|Standard Deviation|11.1|11.1|||
4414554|NCT00215657|4239077|B7|||Weight|ITT population.|kilogram|Mean|73.5|73.5|Standard Deviation|9.55|9.55|||
4414555|NCT00215657|4239078|B6|||Weight|ITT population.|kilogram|Mean|81.5|81.5|Standard Deviation|10.7|10.7|||
4414556|NCT00215657|4239079|B5|||Weight|ITT population.|kilogram|Mean|74.2|74.2|Standard Deviation|9.88|9.88|||
4414557|NCT00215657|4239080|B4|||Weight|ITT population.|kilogram|Mean|78.2|78.2|Standard Deviation|13.7|13.7|||
4414558|NCT00215657|4239081|B3|||Weight|ITT population.|kilogram|Mean|80.7|80.7|Standard Deviation|11.8|11.8|||
4414559|NCT00215657|4239082|B2|||Weight|ITT population.|kilogram|Mean|82.2|82.2|Standard Deviation|12.1|12.1|||
4414560|NCT00215657|4239083|B1|||Weight|ITT population.|kilogram|Mean|77.8|77.8|Standard Deviation|12.4|12.4|||
4414561|NCT00215657|4239075|B9|||Time since prostate cancer diagnosis|ITT population.|days|Mean|156|156.0|Standard Deviation|439|439.0|||
4414562|NCT00215657|4239076|B8|||Time since prostate cancer diagnosis|ITT population.|days|Mean|47|47.0|Standard Deviation|54|54.0|||
4414563|NCT00215657|4239077|B7|||Time since prostate cancer diagnosis|ITT population.|days|Mean|121|121.0|Standard Deviation|425|425.0|||
4414564|NCT00215657|4239078|B6|||Time since prostate cancer diagnosis|ITT population.|days|Mean|303|303.0|Standard Deviation|837|837.0|||
4414565|NCT00215657|4239079|B5|||Time since prostate cancer diagnosis|ITT population.|days|Mean|252|252.0|Standard Deviation|560|560.0|||
4414566|NCT00215657|4239080|B4|||Time since prostate cancer diagnosis|ITT population.|days|Mean|146|146.0|Standard Deviation|298|298.0|||
4414567|NCT00215657|4239081|B3|||Time since prostate cancer diagnosis|ITT population.|days|Mean|222|222.0|Standard Deviation|328|328.0|||
4414568|NCT00215657|4239082|B2|||Time since prostate cancer diagnosis|ITT population.|days|Mean|66|66.0|Standard Deviation|53|53.0|||
4414569|NCT00215657|4239083|B1|||Time since prostate cancer diagnosis|ITT population.|days|Mean|83|83.0|Standard Deviation|157|157.0|||
4414570|NCT00215657|4239075|B9|||Body mass index|ITT population.|kilogram per square meter|Mean|26.0|26.0|Standard Deviation|3.32|3.32|||
4414571|NCT00215657|4239076|B8|||Body mass index|ITT population.|kilogram per square meter|Mean|27.1|27.1|Standard Deviation|3.63|3.63|||
4414572|NCT00215657|4239077|B7|||Body mass index|ITT population.|kilogram per square meter|Mean|24.8|24.8|Standard Deviation|2.72|2.72|||
4414573|NCT00215657|4239078|B6|||Body mass index|ITT population.|kilogram per square meter|Mean|26.9|26.9|Standard Deviation|3.18|3.18|||
4414574|NCT00215657|4239079|B5|||Body mass index|ITT population.|kilogram per square meter|Mean|24.5|24.5|Standard Deviation|2.92|2.92|||
4414575|NCT00215657|4239080|B4|||Body mass index|ITT population.|kilogram per square meter|Mean|25.9|25.9|Standard Deviation|2.99|2.99|||
4414576|NCT00215657|4239081|B3|||Body mass index|ITT population.|kilogram per square meter|Mean|26.3|26.3|Standard Deviation|3.74|3.74|||
4414577|NCT00215657|4239082|B2|||Body mass index|ITT population.|kilogram per square meter|Mean|26.6|26.6|Standard Deviation|4.58|4.58|||
4414578|NCT00215657|4239083|B1|||Body mass index|ITT population.|kilogram per square meter|Mean|26.2|26.2|Standard Deviation|2.97|2.97|||
4414579|NCT00215657|4239075|B9|Not classifiable||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|11|11.0||||||
4414580|NCT00215657|4239076|B8|Not classifiable||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4414581|NCT00215657|4239077|B7|Not classifiable||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|1|1.0||||||
4414582|NCT00215657|4239078|B6|Not classifiable||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4414583|NCT00215657|4239079|B5|Not classifiable||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4414584|NCT00215657|4239080|B4|Not classifiable||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|1|1.0||||||
4414585|NCT00215657|4239081|B3|Not classifiable||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|0|0.0||||||
4414586|NCT00215657|4239082|B2|Not classifiable||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4414587|NCT00215657|4239083|B1|Not classifiable||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|0|0.0||||||
4414588|NCT00215657|4239075|B9|Metastatic||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|52|52.0||||||
4414589|NCT00215657|4239076|B8|Metastatic||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4414590|NCT00215657|4239077|B7|Metastatic||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|10|10.0||||||
4414591|NCT00215657|4239078|B6|Metastatic||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|6|6.0||||||
4414592|NCT00215657|4239079|B5|Metastatic||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|12|12.0||||||
4414593|NCT00215657|4239080|B4|Metastatic||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|6|6.0||||||
4414632|NCT00215657|4239083|B1|5-6||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|4|4.0||||||
4414594|NCT00215657|4239081|B3|Metastatic||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|4|4.0||||||
4414595|NCT00215657|4239082|B2|Metastatic||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4414596|NCT00215657|4239083|B1|Metastatic||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|9|9.0||||||
4414597|NCT00215657|4239075|B9|Locally advanced||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|63|63.0||||||
4414598|NCT00215657|4239076|B8|Locally advanced||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|9|9.0||||||
4414599|NCT00215657|4239077|B7|Locally advanced||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4414600|NCT00215657|4239078|B6|Locally advanced||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|10|10.0||||||
4414601|NCT00215657|4239079|B5|Locally advanced||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|8|8.0||||||
4414602|NCT00215657|4239080|B4|Locally advanced||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|14|14.0||||||
4414603|NCT00215657|4239081|B3|Locally advanced||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4414604|NCT00215657|4239082|B2|Locally advanced||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|6|6.0||||||
4414605|NCT00215657|4239083|B1|Locally advanced||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|6|6.0||||||
4414606|NCT00215657|4239075|B9|Localized||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|46|46.0||||||
4414607|NCT00215657|4239076|B8|Localized||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|14|14.0||||||
4414608|NCT00215657|4239077|B7|Localized||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|8|8.0||||||
4414609|NCT00215657|4239078|B6|Localized||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|6|6.0||||||
4414610|NCT00215657|4239079|B5|Localized||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|1|1.0||||||
4414779|NCT00215553|4239146|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|24.0|24.0|||
4414611|NCT00215657|4239080|B4|Localized||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4414612|NCT00215657|4239081|B3|Localized||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4414613|NCT00215657|4239082|B2|Localized||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|1|1.0||||||
4414614|NCT00215657|4239083|B1|Localized||Stage of prostate cancer|ITT population. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|10|10.0||||||
4414615|NCT00215657|4239075|B9|7-10||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|98|98.0||||||
4414616|NCT00215657|4239076|B8|7-10||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|9|9.0||||||
4414617|NCT00215657|4239077|B7|7-10||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|13|13.0||||||
4414618|NCT00215657|4239078|B6|7-10||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|16|16.0||||||
4414619|NCT00215657|4239079|B5|7-10||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|16|16.0||||||
4414620|NCT00215657|4239080|B4|7-10||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|17|17.0||||||
4414621|NCT00215657|4239081|B3|7-10||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|5|5.0||||||
4414622|NCT00215657|4239082|B2|7-10||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|5|5.0||||||
4414623|NCT00215657|4239083|B1|7-10||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|17|17.0||||||
4414624|NCT00215657|4239075|B9|5-6||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|43|43.0||||||
4414625|NCT00215657|4239076|B8|5-6||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|6|6.0||||||
4414626|NCT00215657|4239077|B7|5-6||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|6|6.0||||||
4414627|NCT00215657|4239078|B6|5-6||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|6|6.0||||||
4414628|NCT00215657|4239079|B5|5-6||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|3|3.0||||||
4414629|NCT00215657|4239080|B4|5-6||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|6|6.0||||||
4414630|NCT00215657|4239081|B3|5-6||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|5|5.0||||||
4414631|NCT00215657|4239082|B2|5-6||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|7|7.0||||||
4414663|NCT00215657|4239078|B6|Caucasian||Race/Ethnicity, Customized|ITT population.|participants|Number|24|24.0||||||
4414633|NCT00215657|4239075|B9|2-4||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|31|31.0||||||
4414634|NCT00215657|4239076|B8|2-4||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|12|12.0||||||
4414635|NCT00215657|4239077|B7|2-4||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|5|5.0||||||
4414636|NCT00215657|4239078|B6|2-4||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|2|2.0||||||
4414637|NCT00215657|4239079|B5|2-4||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|5|5.0||||||
4414638|NCT00215657|4239080|B4|2-4||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4414639|NCT00215657|4239081|B3|2-4||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|2|2.0||||||
4414640|NCT00215657|4239082|B2|2-4||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4414641|NCT00215657|4239083|B1|2-4||Gleason score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|4|4.0||||||
4414642|NCT00215657|4239075|B9|No||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|165|165.0||||||
4414643|NCT00215657|4239076|B8|No||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|26|26.0||||||
4414644|NCT00215657|4239077|B7|No||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|24|24.0||||||
4414645|NCT00215657|4239078|B6|No||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|24|24.0||||||
4414646|NCT00215657|4239079|B5|No||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|23|23.0||||||
4414647|NCT00215657|4239080|B4|No||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|21|21.0||||||
4414648|NCT00215657|4239081|B3|No||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|10|10.0||||||
4414649|NCT00215657|4239082|B2|No||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|12|12.0||||||
4414650|NCT00215657|4239083|B1|No||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|25|25.0||||||
4414651|NCT00215657|4239075|B9|Yes||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|7|7.0||||||
4414652|NCT00215657|4239076|B8|Yes||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|1|1.0||||||
4414653|NCT00215657|4239077|B7|Yes||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|0|0.0||||||
4414654|NCT00215657|4239078|B6|Yes||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|0|0.0||||||
4414655|NCT00215657|4239079|B5|Yes||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|1|1.0||||||
4414656|NCT00215657|4239080|B4|Yes||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|3|3.0||||||
4414657|NCT00215657|4239081|B3|Yes||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|2|2.0||||||
4414658|NCT00215657|4239082|B2|Yes||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|0|0.0||||||
4414659|NCT00215657|4239083|B1|Yes||Curative intent|ITT population. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|0|0.0||||||
4414660|NCT00215657|4239075|B9|Caucasian||Race/Ethnicity, Customized|ITT population.|participants|Number|172|172.0||||||
4414661|NCT00215657|4239076|B8|Caucasian||Race/Ethnicity, Customized|ITT population.|participants|Number|27|27.0||||||
4414662|NCT00215657|4239077|B7|Caucasian||Race/Ethnicity, Customized|ITT population.|participants|Number|24|24.0||||||
4414664|NCT00215657|4239079|B5|Caucasian||Race/Ethnicity, Customized|ITT population.|participants|Number|24|24.0||||||
4414665|NCT00215657|4239080|B4|Caucasian||Race/Ethnicity, Customized|ITT population.|participants|Number|24|24.0||||||
4414666|NCT00215657|4239081|B3|Caucasian||Race/Ethnicity, Customized|ITT population.|participants|Number|12|12.0||||||
4414667|NCT00215657|4239082|B2|Caucasian||Race/Ethnicity, Customized|ITT population.|participants|Number|12|12.0||||||
4414668|NCT00215657|4239083|B1|Caucasian||Race/Ethnicity, Customized|ITT population.|participants|Number|25|25.0||||||
4414669|NCT00215657|4239075|B9||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|172|172.0||||||
4414670|NCT00215657|4239076|B8||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|27|27.0||||||
4414671|NCT00215657|4239077|B7||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|24|24.0||||||
4414672|NCT00215657|4239078|B6||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|24|24.0||||||
4414673|NCT00215657|4239079|B5||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|24|24.0||||||
4414674|NCT00215657|4239080|B4||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|24|24.0||||||
4414675|NCT00215657|4239081|B3||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|12|12.0||||||
4414676|NCT00215657|4239082|B2||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|12|12.0||||||
4414677|NCT00215657|4239083|B1||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|25|25.0||||||
4414678|NCT00215657|4239075|B9||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4414679|NCT00215657|4239076|B8||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4414680|NCT00215657|4239077|B7||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4414681|NCT00215657|4239078|B6||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4414682|NCT00215657|4239079|B5||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4414683|NCT00215657|4239080|B4||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4414684|NCT00215657|4239081|B3||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4414685|NCT00215657|4239082|B2||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4414686|NCT00215657|4239083|B1||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4414687|NCT00215657|4239075|B9|||Age|ITT population.|years|Mean|71.9|71.9|Standard Deviation|7.83|7.83|||
4414688|NCT00215657|4239076|B8|||Age|ITT population.|years|Mean|71.1|71.1|Standard Deviation|6.87|6.87|||
4414689|NCT00215657|4239077|B7|||Age|ITT population.|years|Mean|71.7|71.7|Standard Deviation|9.54|9.54|||
4414690|NCT00215657|4239078|B6|||Age|ITT population.|years|Mean|73.1|73.1|Standard Deviation|5.96|5.96|||
4414691|NCT00215657|4239079|B5|||Age|ITT population.|years|Mean|71.5|71.5|Standard Deviation|8.27|8.27|||
4414692|NCT00215657|4239080|B4|||Age|ITT population.|years|Mean|74.3|74.3|Standard Deviation|6.48|6.48|||
4414693|NCT00215657|4239081|B3|||Age|ITT population.|years|Mean|70.1|70.1|Standard Deviation|8.08|8.08|||
4414694|NCT00215657|4239082|B2|||Age|ITT population.|years|Mean|73.8|73.8|Standard Deviation|3.97|3.97|||
4414695|NCT00215657|4239083|B1|||Age|ITT population.|years|Mean|70.0|70.0|Standard Deviation|10.3|10.3|||
4414696|NCT00215657|4239075|B9||>=65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|143|143.0||||||
4414697|NCT00215657|4239076|B8||>=65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|21|21.0||||||
4414698|NCT00215657|4239077|B7||>=65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|18|18.0||||||
4414699|NCT00215657|4239078|B6||>=65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|22|22.0||||||
4414700|NCT00215657|4239079|B5||>=65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|20|20.0||||||
4414701|NCT00215657|4239080|B4||>=65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|22|22.0||||||
4414702|NCT00215657|4239081|B3||>=65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|10|10.0||||||
4414703|NCT00215657|4239082|B2||>=65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|12|12.0||||||
4414704|NCT00215657|4239083|B1||>=65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|18|18.0||||||
4414705|NCT00215657|4239075|B9||Between 18 and 65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|29|29.0||||||
4414706|NCT00215657|4239076|B8||Between 18 and 65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|6|6.0||||||
4414707|NCT00215657|4239077|B7||Between 18 and 65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|6|6.0||||||
4414708|NCT00215657|4239078|B6||Between 18 and 65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|2|2.0||||||
4414709|NCT00215657|4239079|B5||Between 18 and 65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|4|4.0||||||
4414710|NCT00215657|4239080|B4||Between 18 and 65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|2|2.0||||||
4414711|NCT00215657|4239081|B3||Between 18 and 65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|2|2.0||||||
4414712|NCT00215657|4239082|B2||Between 18 and 65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|0|0.0||||||
4414713|NCT00215657|4239083|B1||Between 18 and 65 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|7|7.0||||||
4414714|NCT00215657|4239075|B9||<=18 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|0|0.0||||||
4414715|NCT00215657|4239076|B8||<=18 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|0|0.0||||||
4414716|NCT00215657|4239077|B7||<=18 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|0|0.0||||||
4414717|NCT00215657|4239078|B6||<=18 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|0|0.0||||||
4414718|NCT00215657|4239079|B5||<=18 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|0|0.0||||||
4414719|NCT00215657|4239080|B4||<=18 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|0|0.0||||||
4414720|NCT00215657|4239081|B3||<=18 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|0|0.0||||||
4414721|NCT00215657|4239082|B2||<=18 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|0|0.0||||||
4414722|NCT00215657|4239083|B1||<=18 years|Age|Intention-to-treat (ITT) population.|Participants|Count of Participants|0|0.0||||||
4414723|NCT00215644|4239116|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4414724|NCT00215644|4239117|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4414725|NCT00215644|4239118|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4414726|NCT00215644|4239116|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4414727|NCT00215644|4239117|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4414728|NCT00215644|4239118|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4414729|NCT00215644|4239116|B3|||Age||years|Median|62|62.0|Full Range|||29.0|79.0|
4414730|NCT00215644|4239117|B2|||Age||years|Median|64|64.0|Full Range|||36.0|76.0|
4414731|NCT00215644|4239118|B1|||Age||years|Median|59|59.0|Full Range|||29.0|79.0|
4414732|NCT00215553|4239139|B8|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
4414733|NCT00215553|4239140|B7|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
4414734|NCT00215553|4239141|B6|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4414735|NCT00215553|4239142|B5|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4414736|NCT00215553|4239143|B4|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4414737|NCT00215553|4239144|B3|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4414738|NCT00215553|4239145|B2|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4414739|NCT00215553|4239146|B1|Russian Federation||Region of Enrollment||participants|Number|0|0.0||||||
4414740|NCT00215553|4239139|B8|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4414741|NCT00215553|4239140|B7|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4414742|NCT00215553|4239141|B6|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4414743|NCT00215553|4239142|B5|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4414744|NCT00215553|4239143|B4|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4414745|NCT00215553|4239144|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4414746|NCT00215553|4239145|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4414747|NCT00215553|4239146|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4414748|NCT00215553|4239139|B8|United States||Region of Enrollment||participants|Number|102|102.0||||||
4414749|NCT00215553|4239140|B7|United States||Region of Enrollment||participants|Number|23|23.0||||||
4414750|NCT00215553|4239141|B6|United States||Region of Enrollment||participants|Number|32|32.0||||||
4414751|NCT00215553|4239142|B5|United States||Region of Enrollment||participants|Number|25|25.0||||||
4414752|NCT00215553|4239143|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
4414753|NCT00215553|4239144|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4414754|NCT00215553|4239145|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4414755|NCT00215553|4239146|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4414756|NCT00215553|4239139|B8||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4414757|NCT00215553|4239140|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4414758|NCT00215553|4239141|B6||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4414759|NCT00215553|4239142|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4414760|NCT00215553|4239143|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4414761|NCT00215553|4239144|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4414762|NCT00215553|4239145|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4414763|NCT00215553|4239146|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4414764|NCT00215553|4239139|B8||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4414765|NCT00215553|4239140|B7||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4414766|NCT00215553|4239141|B6||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4414767|NCT00215553|4239142|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4414768|NCT00215553|4239143|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4414769|NCT00215553|4239144|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4414770|NCT00215553|4239145|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4414771|NCT00215553|4239146|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4414772|NCT00215553|4239139|B8|||Age||years|Mean|48.5|48.5|Standard Deviation|13.1|13.1|||
4414773|NCT00215553|4239140|B7|||Age||years|Mean|47.3|47.3|Standard Deviation|12.6|12.6|||
4414774|NCT00215553|4239141|B6|||Age||years|Mean|51.8|51.8|Standard Deviation|13.0|13.0|||
4414775|NCT00215553|4239142|B5|||Age||years|Mean|46.3|46.3|Standard Deviation|12.5|12.5|||
4414776|NCT00215553|4239143|B4|||Age||years|Mean|41.6|41.6|Standard Deviation|6.2|6.2|||
4414777|NCT00215553|4239144|B3|||Age||years|Mean|45.6|45.6|Standard Deviation|16.0|16.0|||
4414778|NCT00215553|4239145|B2|||Age||years|Mean|50.5|50.5|Standard Deviation|17.1|17.1|||
4414780|NCT00215553|4239139|B8||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4414781|NCT00215553|4239140|B7||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4414782|NCT00215553|4239141|B6||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4414783|NCT00215553|4239142|B5||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4414784|NCT00215553|4239143|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414785|NCT00215553|4239144|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4414786|NCT00215553|4239145|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4414787|NCT00215553|4239146|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4414788|NCT00215553|4239139|B8||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4414789|NCT00215553|4239140|B7||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4414790|NCT00215553|4239141|B6||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4414791|NCT00215553|4239142|B5||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4414792|NCT00215553|4239143|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4414793|NCT00215553|4239144|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4414794|NCT00215553|4239145|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4414795|NCT00215553|4239146|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4414796|NCT00215553|4239139|B8||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4414797|NCT00215553|4239140|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414798|NCT00215553|4239141|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414799|NCT00215553|4239142|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414800|NCT00215553|4239143|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414801|NCT00215553|4239144|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414802|NCT00215553|4239145|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414803|NCT00215553|4239146|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4414804|NCT00215540|4239182|B4|||Gestational Age||weeks|Mean|25.8|25.8|Standard Deviation|1.49|1.49|||
4414805|NCT00215540|4239183|B3|||Gestational Age||weeks|Mean|25.7|25.7|Standard Deviation|1.36|1.36|||
4414806|NCT00215540|4239184|B2|||Gestational Age||weeks|Mean|25.5|25.5|Standard Deviation|1.43|1.43|||
4414807|NCT00215540|4239185|B1|||Gestational Age||weeks|Mean|26.1|26.1|Standard Deviation|1.68|1.68|||
4414808|NCT00215540|4239182|B4|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4414809|NCT00215540|4239183|B3|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4414810|NCT00215540|4239184|B2|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4414811|NCT00215540|4239185|B1|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4414812|NCT00215540|4239182|B4|Poland||Region of Enrollment||participants|Number|47|47.0||||||
4414813|NCT00215540|4239183|B3|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4414814|NCT00215540|4239184|B2|Poland||Region of Enrollment||participants|Number|14|14.0||||||
4414815|NCT00215540|4239185|B1|Poland||Region of Enrollment||participants|Number|17|17.0||||||
4414816|NCT00215540|4239182|B4|Chile||Region of Enrollment||participants|Number|25|25.0||||||
4414817|NCT00215540|4239183|B3|Chile||Region of Enrollment||participants|Number|7|7.0||||||
4414818|NCT00215540|4239184|B2|Chile||Region of Enrollment||participants|Number|10|10.0||||||
4414819|NCT00215540|4239185|B1|Chile||Region of Enrollment||participants|Number|8|8.0||||||
4414820|NCT00215540|4239182|B4|United States||Region of Enrollment||participants|Number|56|56.0||||||
4414821|NCT00215540|4239183|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4414822|NCT00215540|4239184|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4414823|NCT00215540|4239185|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4414824|NCT00215540|4239182|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4414825|NCT00215540|4239183|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4414826|NCT00215540|4239184|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4414827|NCT00215540|4239185|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4414828|NCT00215540|4239182|B4||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4414829|NCT00215540|4239183|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4414830|NCT00215540|4239184|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4414831|NCT00215540|4239185|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4414832|NCT00215540|4239182|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414833|NCT00215540|4239183|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414834|NCT00215540|4239184|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414835|NCT00215540|4239185|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414836|NCT00215540|4239182|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414837|NCT00215540|4239183|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414838|NCT00215540|4239184|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414839|NCT00215540|4239185|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414840|NCT00215540|4239182|B4||<=18 years|Age||Participants|Count of Participants|136|136.0||||||
4414841|NCT00215540|4239183|B3||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
4414842|NCT00215540|4239184|B2||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
4414843|NCT00215540|4239185|B1||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
4414844|NCT00215150|4239222|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4414845|NCT00215150|4239222|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4414846|NCT00215150|4239222|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4414847|NCT00215150|4239222|B1|||Age||years|Mean|33.5|33.5|Standard Deviation|10.3|10.3|||
4414848|NCT00215150|4239222|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414849|NCT00215150|4239222|B1||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4414850|NCT00215150|4239222|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414851|NCT00215137|4239230|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4414852|NCT00215137|4239230|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4414853|NCT00215137|4239230|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4414854|NCT00215137|4239230|B1|||Age||years|Mean|39.14|39.14|Standard Deviation|13.27|13.27|||
4414855|NCT00215137|4239230|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414856|NCT00215137|4239230|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4414857|NCT00215137|4239230|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414858|NCT00214903|4239240|B5|Europe||Region of Enrollment|This study was conducted in seven European countries: Austria, Belgium, Germany, Italy, the Netherlands, Spain, and Turkey. 23,025 participants were eligibly enrolled in Central Europe, and 7,572 participants in Southern Europe.|participants|Number|30597|30597.0||||||
4414859|NCT00214903|4239241|B4|Europe||Region of Enrollment|This study was conducted in seven European countries: Austria, Belgium, Germany, Italy, the Netherlands, Spain, and Turkey. 23,025 participants were eligibly enrolled in Central Europe, and 7,572 participants in Southern Europe.|participants|Number|3057|3057.0||||||
4414860|NCT00214903|4239242|B3|Europe||Region of Enrollment|This study was conducted in seven European countries: Austria, Belgium, Germany, Italy, the Netherlands, Spain, and Turkey. 23,025 participants were eligibly enrolled in Central Europe, and 7,572 participants in Southern Europe.|participants|Number|4113|4113.0||||||
4414861|NCT00214903|4239243|B2|Europe||Region of Enrollment|This study was conducted in seven European countries: Austria, Belgium, Germany, Italy, the Netherlands, Spain, and Turkey. 23,025 participants were eligibly enrolled in Central Europe, and 7,572 participants in Southern Europe.|participants|Number|13384|13384.0||||||
4414862|NCT00214903|4239244|B1|Europe||Region of Enrollment|This study was conducted in seven European countries: Austria, Belgium, Germany, Italy, the Netherlands, Spain, and Turkey. 23,025 participants were eligibly enrolled in Central Europe, and 7,572 participants in Southern Europe.|participants|Number|10043|10043.0||||||
4414863|NCT00214903|4239240|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414864|NCT00214903|4239241|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414865|NCT00214903|4239242|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414866|NCT00214903|4239243|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414867|NCT00214903|4239244|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414868|NCT00214903|4239240|B5||Female|Sex: Female, Male||Participants|Count of Participants|30597|30597.0||||||
4414869|NCT00214903|4239241|B4||Female|Sex: Female, Male||Participants|Count of Participants|3057|3057.0||||||
4414870|NCT00214903|4239242|B3||Female|Sex: Female, Male||Participants|Count of Participants|4113|4113.0||||||
4414871|NCT00214903|4239243|B2||Female|Sex: Female, Male||Participants|Count of Participants|13384|13384.0||||||
4414872|NCT00214903|4239244|B1||Female|Sex: Female, Male||Participants|Count of Participants|10043|10043.0||||||
4414873|NCT00214903|4239240|B5|||Age||years|Mean|54.0|54.0|Standard Deviation|7.3|7.3|||
4414874|NCT00214903|4239241|B4|||Age||years|Mean|56.2|56.2|Standard Deviation|7.7|7.7|||
4414875|NCT00214903|4239242|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|8.3|8.3|||
4414876|NCT00214903|4239243|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|6.9|6.9|||
4414877|NCT00214903|4239244|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|6.4|6.4|||
4414878|NCT00214786|4239261|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4414879|NCT00214786|4239261|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4414880|NCT00214786|4239261|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4414881|NCT00214786|4239261|B1|||Age||years|Mean|35.5|35.5|Standard Deviation|11.56143|11.56143|||
4414882|NCT00214786|4239261|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414883|NCT00214786|4239261|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4414884|NCT00214786|4239261|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414885|NCT00214539|4239274|B3|Brazil||Region of Enrollment||participants|Number|3|3.0||||||
4414886|NCT00214539|4239275|B2|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4414887|NCT00214539|4239276|B1|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
4414888|NCT00214539|4239274|B3|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4414889|NCT00214539|4239275|B2|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4414890|NCT00214539|4239276|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4414891|NCT00214539|4239274|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4414892|NCT00214539|4239275|B2|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4414893|NCT00214539|4239276|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4414894|NCT00214539|4239274|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4414895|NCT00214539|4239275|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4414896|NCT00214539|4239276|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4414897|NCT00214539|4239274|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4414898|NCT00214539|4239275|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4414899|NCT00214539|4239276|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4414900|NCT00214539|4239274|B3|||Age||years|Mean|40.69|40.69|Standard Deviation|12.64|12.64|||
4414901|NCT00214539|4239275|B2|||Age||years|Mean|42.06|42.06|Standard Deviation|12.57|12.57|||
4414902|NCT00214539|4239276|B1|||Age||years|Mean|39.13|39.13|Standard Deviation|12.97|12.97|||
4414903|NCT00214526|4239301|B3|Brazil||Region of Enrollment||participants|Number|24|24.0||||||
4414904|NCT00214526|4239302|B2|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4414905|NCT00214526|4239303|B1|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4414906|NCT00214526|4239301|B3|Denmark||Region of Enrollment||participants|Number|7|7.0||||||
4414907|NCT00214526|4239302|B2|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4414908|NCT00214526|4239303|B1|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4414909|NCT00214526|4239301|B3|United Kingdom||Region of Enrollment||participants|Number|36|36.0||||||
4414910|NCT00214526|4239302|B2|United Kingdom||Region of Enrollment||participants|Number|17|17.0||||||
4414911|NCT00214526|4239303|B1|United Kingdom||Region of Enrollment||participants|Number|19|19.0||||||
4414912|NCT00214526|4239301|B3|Canada||Region of Enrollment||participants|Number|42|42.0||||||
4414913|NCT00214526|4239302|B2|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4414914|NCT00214526|4239303|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4414915|NCT00214526|4239301|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4414916|NCT00214526|4239302|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4414917|NCT00214526|4239303|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4414918|NCT00214526|4239301|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4414919|NCT00214526|4239302|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4414920|NCT00214526|4239303|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4414921|NCT00214526|4239301|B3|||Age||years|Mean|40.50|40.5|Standard Deviation|11.27|11.27|||
4414922|NCT00214526|4239302|B2|||Age||years|Mean|41.65|41.65|Standard Deviation|11.35|11.35|||
4414923|NCT00214526|4239303|B1|||Age||years|Mean|39.36|39.36|Standard Deviation|11.18|11.18|||
4414924|NCT00214500|4239330|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4414925|NCT00214500|4239330|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4414926|NCT00214500|4239330|B1|58 years||Age, Customized|2 participants (aged 17 and 58) did not meet the age inclusion criterion but were granted approval by the Sponsor for enrollment before migalastat was administered.|Participants|Count of Participants|1|1.0||||||
4414927|NCT00214500|4239330|B1|18 to 55 years||Age, Customized|2 participants (aged 17 and 58) did not meet the age inclusion criterion but were granted approval by the Sponsor for enrollment before migalastat was administered.|Participants|Count of Participants|7|7.0||||||
4414928|NCT00214500|4239330|B1|17 years||Age, Customized|2 participants (aged 17 and 58) did not meet the age inclusion criterion but were granted approval by the Sponsor for enrollment before migalastat was administered.|Participants|Count of Participants|1|1.0||||||
4414929|NCT00214500|4239330|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|13.0|13.0|||
4414930|NCT00214487|4239338|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4414931|NCT00214487|4239339|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4414932|NCT00214487|4239340|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4414933|NCT00214487|4239338|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4414934|NCT00214487|4239339|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4414935|NCT00214487|4239340|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4414936|NCT00214487|4239338|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414937|NCT00214487|4239339|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414938|NCT00214487|4239340|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414939|NCT00214487|4239338|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414940|NCT00214487|4239339|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414941|NCT00214487|4239340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414942|NCT00214487|4239338|B3||<=18 years|Age||Participants|Count of Participants|78|78.0||||||
4414943|NCT00214487|4239339|B2||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4414944|NCT00214487|4239340|B1||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4414945|NCT00214461|4239347|B5|United States||Region of Enrollment||participants|Number|48|48.0||||||
4414946|NCT00214461|4239348|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4414947|NCT00214461|4239349|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4414948|NCT00214461|4239350|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4414949|NCT00214461|4239351|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4414950|NCT00214461|4239347|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4414951|NCT00214461|4239348|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4414952|NCT00214461|4239349|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4414953|NCT00214461|4239350|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4414954|NCT00214461|4239351|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4414955|NCT00214461|4239347|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4414956|NCT00214461|4239348|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4414957|NCT00214461|4239349|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4414958|NCT00214461|4239350|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4414959|NCT00214461|4239351|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4414960|NCT00214461|4239347|B5|||Age||Years|Mean|71.4|71.4|Standard Deviation|5.60|5.6|||
4414961|NCT00214461|4239348|B4|||Age||Years|Mean|68.9|68.9|Standard Deviation|4.32|4.32|||
4414962|NCT00214461|4239349|B3|||Age||Years|Mean|75.5|75.5|Standard Deviation|6.47|6.47|||
4414963|NCT00214461|4239350|B2|||Age||Years|Mean|72.2|72.2|Standard Deviation|5.32|5.32|||
4414964|NCT00214461|4239351|B1|||Age||Years|Mean|69.0|69.0|Standard Deviation|3.59|3.59|||
4414965|NCT00214461|4239347|B5||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4414966|NCT00214461|4239348|B4||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4414967|NCT00214461|4239349|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4414968|NCT00214461|4239350|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4414969|NCT00214461|4239351|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4414970|NCT00214461|4239347|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414971|NCT00214461|4239348|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414972|NCT00214461|4239349|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414973|NCT00214461|4239350|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414974|NCT00214461|4239351|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414975|NCT00214461|4239347|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414976|NCT00214461|4239348|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414977|NCT00214461|4239349|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414978|NCT00214461|4239350|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414979|NCT00214461|4239351|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4414980|NCT00214383|4239368|B3|United States||Region of Enrollment||participants|Number|301|301.0||||||
4414981|NCT00214383|4239369|B2|United States||Region of Enrollment||participants|Number|153|153.0||||||
4414982|NCT00214383|4239370|B1|United States||Region of Enrollment||participants|Number|148|148.0||||||
4414983|NCT00214383|4239368|B3||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4414984|NCT00214383|4239369|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4414985|NCT00214383|4239370|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4414986|NCT00214383|4239368|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4414987|NCT00214383|4239369|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4414988|NCT00214383|4239370|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4414989|NCT00214383|4239368|B3|||Age||years|Mean|7.92|7.92|Standard Deviation|2.54|2.54|||
4414990|NCT00214383|4239369|B2|||Age||years|Mean|8.18|8.18|Standard Deviation|2.45|2.45|||
4414991|NCT00214383|4239370|B1|||Age||years|Mean|7.65|7.65|Standard Deviation|2.61|2.61|||
4414992|NCT00214383|4239368|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414993|NCT00214383|4239369|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414994|NCT00214383|4239370|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4414995|NCT00214383|4239368|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414996|NCT00214383|4239369|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414997|NCT00214383|4239370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4414998|NCT00214383|4239368|B3||<=18 years|Age||Participants|Count of Participants|301|301.0||||||
4414999|NCT00214383|4239369|B2||<=18 years|Age||Participants|Count of Participants|153|153.0||||||
4415000|NCT00214383|4239370|B1||<=18 years|Age||Participants|Count of Participants|148|148.0||||||
4415001|NCT00214201|4239381|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4415002|NCT00214201|4239382|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4415003|NCT00214201|4239383|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4415004|NCT00214201|4239381|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4415005|NCT00214201|4239382|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4415006|NCT00214201|4239383|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4415007|NCT00214201|4239381|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|9.2|9.2|||
4415008|NCT00214201|4239382|B2|||Age||years|Mean|55.3|55.3|Standard Deviation|9.4|9.4|||
4415009|NCT00214201|4239383|B1|||Age||years|Mean|54.1|54.1|Standard Deviation|9.2|9.2|||
4415010|NCT00214201|4239381|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4415011|NCT00214201|4239382|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4415012|NCT00214201|4239383|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4415013|NCT00214201|4239381|B3||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4415014|NCT00214201|4239382|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4415015|NCT00214201|4239383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4415016|NCT00214201|4239381|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415017|NCT00214201|4239382|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415018|NCT00214201|4239383|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415019|NCT00214149|4239394|B1|United States||Region of Enrollment||participants|Number|127|127.0||||||
4415020|NCT00214149|4239394|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4415021|NCT00214149|4239394|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415022|NCT00214149|4239394|B1||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4415023|NCT00214149|4239394|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415024|NCT00214149|4239394|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415025|NCT00214149|4239394|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4415026|NCT00214149|4239394|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415027|NCT00214149|4239394|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4415028|NCT00214149|4239394|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4415029|NCT00214149|4239394|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4415030|NCT00214149|4239394|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415031|NCT00214149|4239394|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4415032|NCT00214149|4239394|B1|Age 80-89||Age, Customized||years|Number|2|2.0||||||
4415033|NCT00214149|4239394|B1|Age 70-79||Age, Customized||years|Number|14|14.0||||||
4415034|NCT00214149|4239394|B1|Age 60-69||Age, Customized||years|Number|45|45.0||||||
4415035|NCT00214149|4239394|B1|Age 50-59||Age, Customized||years|Number|35|35.0||||||
4415036|NCT00214149|4239394|B1|Age 40-49||Age, Customized||years|Number|29|29.0||||||
4415037|NCT00214149|4239394|B1|Age 30-39||Age, Customized||years|Number|2|2.0||||||
4415038|NCT00214136|4239399|B1||Not reported|T stage|"Participants with stage T1-T4 disease, as defined by 1997 AJCC classification, were enrolled. The T Stage information of the last 5 participants enrolled is not included. The T stages reported in this table are refer to the following stages:~T1c: Tumor identified by needle biopsy (eg, because of elevated PSA) T2a: Tumor involves one lobe T2b,c: Tumor involves both lobes T3a,b: Tumor extends through the prostate capsule, extracapsular extension (unilateral or bilateral), and tumor invades seminal vesicle(s) T4: Tumor is fixed or invades adjacent structures other than seminal vesicles"|Participants|Count of Participants|5|5.0||||||
4415039|NCT00214136|4239399|B1||T4|T stage|"Participants with stage T1-T4 disease, as defined by 1997 AJCC classification, were enrolled. The T Stage information of the last 5 participants enrolled is not included. The T stages reported in this table are refer to the following stages:~T1c: Tumor identified by needle biopsy (eg, because of elevated PSA) T2a: Tumor involves one lobe T2b,c: Tumor involves both lobes T3a,b: Tumor extends through the prostate capsule, extracapsular extension (unilateral or bilateral), and tumor invades seminal vesicle(s) T4: Tumor is fixed or invades adjacent structures other than seminal vesicles"|Participants|Count of Participants|1|1.0||||||
4415040|NCT00214136|4239399|B1||T3a,b|T stage|"Participants with stage T1-T4 disease, as defined by 1997 AJCC classification, were enrolled. The T Stage information of the last 5 participants enrolled is not included. The T stages reported in this table are refer to the following stages:~T1c: Tumor identified by needle biopsy (eg, because of elevated PSA) T2a: Tumor involves one lobe T2b,c: Tumor involves both lobes T3a,b: Tumor extends through the prostate capsule, extracapsular extension (unilateral or bilateral), and tumor invades seminal vesicle(s) T4: Tumor is fixed or invades adjacent structures other than seminal vesicles"|Participants|Count of Participants|5|5.0||||||
4415041|NCT00214136|4239399|B1||T2b,c|T stage|"Participants with stage T1-T4 disease, as defined by 1997 AJCC classification, were enrolled. The T Stage information of the last 5 participants enrolled is not included. The T stages reported in this table are refer to the following stages:~T1c: Tumor identified by needle biopsy (eg, because of elevated PSA) T2a: Tumor involves one lobe T2b,c: Tumor involves both lobes T3a,b: Tumor extends through the prostate capsule, extracapsular extension (unilateral or bilateral), and tumor invades seminal vesicle(s) T4: Tumor is fixed or invades adjacent structures other than seminal vesicles"|Participants|Count of Participants|7|7.0||||||
4415042|NCT00214136|4239399|B1||T2a|T stage|"Participants with stage T1-T4 disease, as defined by 1997 AJCC classification, were enrolled. The T Stage information of the last 5 participants enrolled is not included. The T stages reported in this table are refer to the following stages:~T1c: Tumor identified by needle biopsy (eg, because of elevated PSA) T2a: Tumor involves one lobe T2b,c: Tumor involves both lobes T3a,b: Tumor extends through the prostate capsule, extracapsular extension (unilateral or bilateral), and tumor invades seminal vesicle(s) T4: Tumor is fixed or invades adjacent structures other than seminal vesicles"|Participants|Count of Participants|3|3.0||||||
4415043|NCT00214136|4239399|B1||T1c|T stage|"Participants with stage T1-T4 disease, as defined by 1997 AJCC classification, were enrolled. The T Stage information of the last 5 participants enrolled is not included. The T stages reported in this table are refer to the following stages:~T1c: Tumor identified by needle biopsy (eg, because of elevated PSA) T2a: Tumor involves one lobe T2b,c: Tumor involves both lobes T3a,b: Tumor extends through the prostate capsule, extracapsular extension (unilateral or bilateral), and tumor invades seminal vesicle(s) T4: Tumor is fixed or invades adjacent structures other than seminal vesicles"|Participants|Count of Participants|9|9.0||||||
4415044|NCT00214136|4239399|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4415045|NCT00214136|4239399|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415046|NCT00214136|4239399|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415047|NCT00214136|4239399|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4415048|NCT00214136|4239399|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415049|NCT00214136|4239399|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415050|NCT00214136|4239399|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415051|NCT00214136|4239399|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415052|NCT00214136|4239399|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415053|NCT00214136|4239399|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415054|NCT00214136|4239399|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4415055|NCT00214136|4239399|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4415056|NCT00214136|4239399|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415057|NCT00214136|4239399|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4415058|NCT00214136|4239399|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4415059|NCT00214136|4239399|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415060|NCT00214019|4239404|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4415061|NCT00214019|4239404|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4415062|NCT00214019|4239404|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4415063|NCT00214019|4239404|B1|||Age||years|Mean|25.5|25.5|Standard Deviation|6.2|6.2|||
4415064|NCT00214019|4239404|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415065|NCT00214019|4239404|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4415066|NCT00214019|4239404|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415067|NCT00213980|4239411|B3||Unknown|Performance Status|"Participants were required to have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. ECOG performance is used to assess how a participant's disease is progressing, assess how the disease affects daily living abilities, and determine appropriate treatment and prognosis. A score of 0 is fully active, able to carry on all pre-disease performance without restriction, and 2 is ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|2|2.0||||||
4415068|NCT00213980|4239412|B2||Unknown|Performance Status|"Participants were required to have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. ECOG performance is used to assess how a participant's disease is progressing, assess how the disease affects daily living abilities, and determine appropriate treatment and prognosis. A score of 0 is fully active, able to carry on all pre-disease performance without restriction, and 2 is ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|1|1.0||||||
4415069|NCT00213980|4239413|B1||Unknown|Performance Status|"Participants were required to have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. ECOG performance is used to assess how a participant's disease is progressing, assess how the disease affects daily living abilities, and determine appropriate treatment and prognosis. A score of 0 is fully active, able to carry on all pre-disease performance without restriction, and 2 is ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|1|1.0||||||
4415070|NCT00213980|4239411|B3||1|Performance Status|"Participants were required to have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. ECOG performance is used to assess how a participant's disease is progressing, assess how the disease affects daily living abilities, and determine appropriate treatment and prognosis. A score of 0 is fully active, able to carry on all pre-disease performance without restriction, and 2 is ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|7|7.0||||||
4415071|NCT00213980|4239412|B2||1|Performance Status|"Participants were required to have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. ECOG performance is used to assess how a participant's disease is progressing, assess how the disease affects daily living abilities, and determine appropriate treatment and prognosis. A score of 0 is fully active, able to carry on all pre-disease performance without restriction, and 2 is ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|4|4.0||||||
4415072|NCT00213980|4239413|B1||1|Performance Status|"Participants were required to have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. ECOG performance is used to assess how a participant's disease is progressing, assess how the disease affects daily living abilities, and determine appropriate treatment and prognosis. A score of 0 is fully active, able to carry on all pre-disease performance without restriction, and 2 is ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|3|3.0||||||
4415073|NCT00213980|4239411|B3||0|Performance Status|"Participants were required to have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. ECOG performance is used to assess how a participant's disease is progressing, assess how the disease affects daily living abilities, and determine appropriate treatment and prognosis. A score of 0 is fully active, able to carry on all pre-disease performance without restriction, and 2 is ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|59|59.0||||||
4415074|NCT00213980|4239412|B2||0|Performance Status|"Participants were required to have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. ECOG performance is used to assess how a participant's disease is progressing, assess how the disease affects daily living abilities, and determine appropriate treatment and prognosis. A score of 0 is fully active, able to carry on all pre-disease performance without restriction, and 2 is ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|31|31.0||||||
4415075|NCT00213980|4239413|B1||0|Performance Status|"Participants were required to have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. ECOG performance is used to assess how a participant's disease is progressing, assess how the disease affects daily living abilities, and determine appropriate treatment and prognosis. A score of 0 is fully active, able to carry on all pre-disease performance without restriction, and 2 is ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|Participants|Count of Participants|28|28.0||||||
4415076|NCT00213980|4239411|B3||No data available|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|7|7.0||||||
4415133|NCT00213239|4239426|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4415077|NCT00213980|4239412|B2||No data available|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|3|3.0||||||
4415078|NCT00213980|4239413|B1||No data available|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|4|4.0||||||
4415079|NCT00213980|4239411|B3||Tamoxifen switched to AI during study year|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|3|3.0||||||
4415080|NCT00213980|4239412|B2||Tamoxifen switched to AI during study year|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|1|1.0||||||
4415081|NCT00213980|4239413|B1||Tamoxifen switched to AI during study year|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|2|2.0||||||
4415082|NCT00213980|4239411|B3||Aromatase Inhibitor (AI)|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|9|9.0||||||
4415083|NCT00213980|4239412|B2||Aromatase Inhibitor (AI)|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|4|4.0||||||
4415084|NCT00213980|4239413|B1||Aromatase Inhibitor (AI)|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|5|5.0||||||
4415085|NCT00213980|4239411|B3||Tamoxifen or other SERM|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|41|41.0||||||
4415086|NCT00213980|4239412|B2||Tamoxifen or other SERM|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|23|23.0||||||
4415087|NCT00213980|4239413|B1||Tamoxifen or other SERM|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|18|18.0||||||
4415088|NCT00213980|4239411|B3||None|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|8|8.0||||||
4415089|NCT00213980|4239412|B2||None|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|5|5.0||||||
4415090|NCT00213980|4239413|B1||None|Endocrine Therapy During Year 1 on Study||Participants|Count of Participants|3|3.0||||||
4415091|NCT00213980|4239411|B3|Node positive||Lymph Node Status||Participants|Count of Participants|66|66.0||||||
4415092|NCT00213980|4239412|B2|Node positive||Lymph Node Status||Participants|Count of Participants|35|35.0||||||
4415093|NCT00213980|4239413|B1|Node positive||Lymph Node Status||Participants|Count of Participants|31|31.0||||||
4415094|NCT00213980|4239411|B3|Node negative||Lymph Node Status||Participants|Count of Participants|2|2.0||||||
4415095|NCT00213980|4239412|B2|Node negative||Lymph Node Status||Participants|Count of Participants|1|1.0||||||
4415096|NCT00213980|4239413|B1|Node negative||Lymph Node Status||Participants|Count of Participants|1|1.0||||||
4415097|NCT00213980|4239411|B3||Unknown|Tumor Size||Participants|Count of Participants|1|1.0||||||
4415098|NCT00213980|4239412|B2||Unknown|Tumor Size||Participants|Count of Participants|1|1.0||||||
4415099|NCT00213980|4239413|B1||Unknown|Tumor Size||Participants|Count of Participants|0|0.0||||||
4415100|NCT00213980|4239411|B3||Inflammatory|Tumor Size||Participants|Count of Participants|4|4.0||||||
4415101|NCT00213980|4239412|B2||Inflammatory|Tumor Size||Participants|Count of Participants|1|1.0||||||
4415102|NCT00213980|4239413|B1||Inflammatory|Tumor Size||Participants|Count of Participants|3|3.0||||||
4415103|NCT00213980|4239411|B3||> 5cm|Tumor Size||Participants|Count of Participants|18|18.0||||||
4415104|NCT00213980|4239412|B2||> 5cm|Tumor Size||Participants|Count of Participants|9|9.0||||||
4415105|NCT00213980|4239413|B1||> 5cm|Tumor Size||Participants|Count of Participants|9|9.0||||||
4415106|NCT00213980|4239411|B3||2.1cm - 5cm|Tumor Size||Participants|Count of Participants|29|29.0||||||
4415107|NCT00213980|4239412|B2||2.1cm - 5cm|Tumor Size||Participants|Count of Participants|11|11.0||||||
4415108|NCT00213980|4239413|B1||2.1cm - 5cm|Tumor Size||Participants|Count of Participants|18|18.0||||||
4415109|NCT00213980|4239411|B3||=< 2cm|Tumor Size||Participants|Count of Participants|16|16.0||||||
4415110|NCT00213980|4239412|B2||=< 2cm|Tumor Size||Participants|Count of Participants|14|14.0||||||
4415111|NCT00213980|4239413|B1||=< 2cm|Tumor Size||Participants|Count of Participants|2|2.0||||||
4415112|NCT00213980|4239411|B3|United States||Region of Enrollment||Participants|Count of Participants|68|68.0||||||
4415113|NCT00213980|4239412|B2|United States||Region of Enrollment||Participants|Count of Participants|36|36.0||||||
4415114|NCT00213980|4239413|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4415115|NCT00213980|4239411|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415116|NCT00213980|4239412|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415117|NCT00213980|4239413|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415118|NCT00213980|4239411|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4415119|NCT00213980|4239412|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4415120|NCT00213980|4239413|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4415121|NCT00213980|4239411|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4415122|NCT00213980|4239412|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4415123|NCT00213980|4239413|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415124|NCT00213980|4239411|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415125|NCT00213980|4239412|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415126|NCT00213980|4239413|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415127|NCT00213980|4239411|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4415128|NCT00213980|4239412|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4415129|NCT00213980|4239413|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4415130|NCT00213980|4239411|B3|||Age||years|Median|52.5|52.5|Full Range|||37.0|83.0|
4415131|NCT00213980|4239412|B2|||Age||years|Median|54.5|54.5|Full Range|||41.0|83.0|
4415132|NCT00213980|4239413|B1|||Age||years|Median|50.5|50.5|Full Range|||37.0|65.0|
4415134|NCT00213239|4239427|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4415135|NCT00213239|4239428|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4415136|NCT00213239|4239426|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4415137|NCT00213239|4239427|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4415138|NCT00213239|4239428|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4415139|NCT00213239|4239426|B3|||Age||years|Mean|5.3|5.3|Standard Deviation|2.4|2.4|||
4415140|NCT00213239|4239427|B2|||Age||years|Mean|5.2|5.2|Standard Deviation|2.1|2.1|||
4415141|NCT00213239|4239428|B1|||Age||years|Mean|5.6|5.6|Standard Deviation|2.6|2.6|||
4415142|NCT00213148|4239437|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415143|NCT00213148|4239438|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415144|NCT00213148|4239439|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415145|NCT00213148|4239440|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415146|NCT00213148|4239441|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415147|NCT00213148|4239437|B5||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4415148|NCT00213148|4239438|B4||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4415149|NCT00213148|4239439|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4415150|NCT00213148|4239440|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4415151|NCT00213148|4239441|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4415152|NCT00213148|4239437|B5|||Age||years|Mean|29.2|29.2|Standard Deviation|3.8|3.8|||
4415153|NCT00213148|4239438|B4|||Age||years|Mean|29.3|29.3|Standard Deviation|3.4|3.4|||
4415154|NCT00213148|4239439|B3|||Age||years|Mean|29.6|29.6|Standard Deviation|3.9|3.9|||
4415155|NCT00213148|4239440|B2|||Age||years|Mean|28.8|28.8|Standard Deviation|3.9|3.9|||
4415156|NCT00213148|4239441|B1|||Age||years|Mean|29.0|29.0|Standard Deviation|3.9|3.9|||
4415157|NCT00213135|4239469|B4||Male|Sex: Female, Male||Participants|Count of Participants|428|428.0||||||
4415158|NCT00213135|4239470|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4415159|NCT00213135|4239471|B2||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4415160|NCT00213135|4239472|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4415161|NCT00213135|4239469|B4||Female|Sex: Female, Male||Participants|Count of Participants|898|898.0||||||
4415162|NCT00213135|4239470|B3||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4415163|NCT00213135|4239471|B2||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4415164|NCT00213135|4239472|B1||Female|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4415165|NCT00213135|4239469|B4|||Age||years|Mean|38.6|38.6|Standard Deviation|10.0|10.0|||
4415166|NCT00213135|4239470|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|9.9|9.9|||
4415167|NCT00213135|4239471|B2|||Age||years|Mean|37.9|37.9|Standard Deviation|10.3|10.3|||
4415168|NCT00213135|4239472|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|9.9|9.9|||
4415169|NCT00212758|4239491|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4415170|NCT00212758|4239491|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4415171|NCT00212758|4239491|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4415172|NCT00212758|4239491|B1|||Age||years|Mean|7.6|7.6|Standard Deviation|4|4.0|||
4415173|NCT00212758|4239491|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415174|NCT00212758|4239491|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4415175|NCT00212758|4239491|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4415176|NCT00212446|4239498|B1|||pre-EI effacement||percent of effacement|Mean|80.00|80.0|Standard Deviation|17.73|17.73|||
4415177|NCT00212446|4239498|B1|||pre-EI cervical dilatation||cm|Mean|3.0|3.0|Standard Deviation|2.33|2.33|||
4415178|NCT00212446|4239498|B1|||Gestational Age||weeks|Mean|31.11|31.11|Standard Deviation|2.19|2.19|||
4415179|NCT00212446|4239498|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415180|NCT00212446|4239498|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4415181|NCT00212446|4239498|B1|||Age|Maternal age|years|Mean|31.65|31.65|Standard Deviation|8.00|8.0|||
4415182|NCT00212355|4239508|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4415183|NCT00212355|4239508|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4415184|NCT00212355|4239508|B1|≥1~＜6||Age, Customized||participants|Number|2|2.0||||||
4415185|NCT00212355|4239508|B1|≥6~＜16||Age, Customized||participants|Number|15|15.0||||||
4415186|NCT00212355|4239508|B1|≥16||Age, Customized||participants|Number|20|20.0||||||
4415187|NCT00212264|4239512|B4|||Incontinence Episodes per Week||Incontinence Episodes per Week|Mean|26.2|26.2|Standard Deviation|22.6|22.6|||
4415188|NCT00212264|4239513|B3|||Incontinence Episodes per Week||Incontinence Episodes per Week|Mean|24.8|24.8|Standard Deviation|19.9|19.9|||
4415189|NCT00212264|4239514|B2|||Incontinence Episodes per Week||Incontinence Episodes per Week|Mean|25.6|25.6|Standard Deviation|26.0|26.0|||
4415190|NCT00212264|4239515|B1|||Incontinence Episodes per Week||Incontinence Episodes per Week|Mean|28.1|28.1|Standard Deviation|22.0|22.0|||
4415191|NCT00212264|4239512|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415192|NCT00212264|4239513|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415193|NCT00212264|4239514|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415194|NCT00212264|4239515|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415195|NCT00212264|4239512|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415196|NCT00212264|4239513|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415197|NCT00212264|4239514|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415198|NCT00212264|4239515|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415199|NCT00212264|4239512|B4||White|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4415200|NCT00212264|4239513|B3||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4415201|NCT00212264|4239514|B2||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4415202|NCT00212264|4239515|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4415203|NCT00212264|4239512|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4415204|NCT00212264|4239513|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4415205|NCT00212264|4239514|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4415206|NCT00212264|4239515|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4415207|NCT00212264|4239512|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415208|NCT00212264|4239513|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415209|NCT00212264|4239514|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415210|NCT00212264|4239515|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415211|NCT00212264|4239512|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4415212|NCT00212264|4239513|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4415213|NCT00212264|4239514|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4415214|NCT00212264|4239515|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415215|NCT00212264|4239512|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4415216|NCT00212264|4239513|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4415217|NCT00212264|4239514|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415218|NCT00212264|4239515|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415219|NCT00212264|4239512|B4||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4415220|NCT00212264|4239513|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4415221|NCT00212264|4239514|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4415222|NCT00212264|4239515|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4415223|NCT00212264|4239512|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415224|NCT00212264|4239513|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415225|NCT00212264|4239514|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415226|NCT00212264|4239515|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415227|NCT00212264|4239512|B4|||Age||years|Mean|66.7|66.7|Standard Deviation|7.4|7.4|||
4415228|NCT00212264|4239513|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|7.7|7.7|||
4415229|NCT00212264|4239514|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|7.0|7.0|||
4415230|NCT00212264|4239515|B1|||Age||years|Mean|66.3|66.3|Standard Deviation|7.5|7.5|||
4415231|NCT00212134|4239527|B3|||Refractive Error - Fellow Eye|Spherical equivalent of the refraction measured under cycloplegia|diopters|Mean|2.3|2.3|Standard Deviation|2.0|2.0|||
4415232|NCT00212134|4239528|B2|||Refractive Error - Fellow Eye|Spherical equivalent of the refraction measured under cycloplegia|diopters|Mean|2.3|2.3|Standard Deviation|2.2|2.2|||
4415233|NCT00212134|4239529|B1|||Refractive Error - Fellow Eye|Spherical equivalent of the refraction measured under cycloplegia|diopters|Mean|2.4|2.4|Standard Deviation|1.8|1.8|||
4415234|NCT00212134|4239527|B3|||Axial Length - Fellow Eye||mm|Mean|18.6|18.6|Standard Deviation|0.9|0.9|||
4415235|NCT00212134|4239528|B2|||Axial Length - Fellow Eye||mm|Mean|18.7|18.7|Standard Deviation|0.9|0.9|||
4415236|NCT00212134|4239529|B1|||Axial Length - Fellow Eye||mm|Mean|18.4|18.4|Standard Deviation|0.9|0.9|||
4415237|NCT00212134|4239527|B3|||Axial Length - Cataractous Eye||mm|Mean|18.0|18.0|Standard Deviation|1.3|1.3|||
4415238|NCT00212134|4239528|B2|||Axial Length - Cataractous Eye||mm|Mean|18.1|18.1|Standard Deviation|1.3|1.3|||
4415239|NCT00212134|4239529|B1|||Axial Length - Cataractous Eye||mm|Mean|18.0|18.0|Standard Deviation|1.3|1.3|||
4415240|NCT00212134|4239527|B3|||Keratometric Power - Fellow Eye||diopters|Mean|45.5|45.5|Standard Deviation|1.8|1.8|||
4415241|NCT00212134|4239528|B2|||Keratometric Power - Fellow Eye||diopters|Mean|45.4|45.4|Standard Deviation|1.9|1.9|||
4415242|NCT00212134|4239529|B1|||Keratometric Power - Fellow Eye||diopters|Mean|45.5|45.5|Standard Deviation|1.8|1.8|||
4415243|NCT00212134|4239527|B3|||Keratometric Power - Cataractous Eye||diopters|Mean|46.4|46.4|Standard Deviation|2.7|2.7|||
4415244|NCT00212134|4239528|B2|||Keratometric Power - Cataractous Eye||diopters|Mean|46.4|46.4|Standard Deviation|2.7|2.7|||
4415245|NCT00212134|4239529|B1|||Keratometric Power - Cataractous Eye||diopters|Mean|46.4|46.4|Standard Deviation|2.7|2.7|||
4415246|NCT00212134|4239527|B3|||Intraocular Pressure - Fellow Eye||mmHg|Mean|12.9|12.9|Standard Deviation|4.7|4.7|||
4415247|NCT00212134|4239528|B2|||Intraocular Pressure - Fellow Eye||mmHg|Mean|12.9|12.9|Standard Deviation|4.3|4.3|||
4415248|NCT00212134|4239529|B1|||Intraocular Pressure - Fellow Eye||mmHg|Mean|12.8|12.8|Standard Deviation|5.1|5.1|||
4415249|NCT00212134|4239527|B3|||Intraocular Pressure - Cataractous Eye||mmHg|Mean|12.2|12.2|Standard Deviation|4.9|4.9|||
4415250|NCT00212134|4239528|B2|||Intraocular Pressure - Cataractous Eye||mmHg|Mean|11.8|11.8|Standard Deviation|4.9|4.9|||
4415251|NCT00212134|4239529|B1|||Intraocular Pressure - Cataractous Eye||mmHg|Mean|12.7|12.7|Standard Deviation|4.9|4.9|||
4415252|NCT00212134|4239527|B3|||Corneal Diameter - Fellow Eye||mm|Mean|10.8|10.8|Standard Deviation|0.6|0.6|||
4415253|NCT00212134|4239528|B2|||Corneal Diameter - Fellow Eye||mm|Mean|10.8|10.8|Standard Deviation|0.7|0.7|||
4415254|NCT00212134|4239529|B1|||Corneal Diameter - Fellow Eye||mm|Mean|10.8|10.8|Standard Deviation|0.6|0.6|||
4415255|NCT00212134|4239527|B3|||Corneal Diameter - Cataractous Eye||mm|Mean|10.5|10.5|Standard Deviation|0.7|0.7|||
4415256|NCT00212134|4239528|B2|||Corneal Diameter - Cataractous Eye||mm|Mean|10.5|10.5|Standard Deviation|0.8|0.8|||
4415257|NCT00212134|4239529|B1|||Corneal Diameter - Cataractous Eye||mm|Mean|10.5|10.5|Standard Deviation|0.7|0.7|||
4415258|NCT00212134|4239527|B3|||Pupil Diameter - Fellow Eye||mm|Mean|3.4|3.4|Standard Deviation|0.9|0.9|||
4415259|NCT00212134|4239528|B2|||Pupil Diameter - Fellow Eye||mm|Mean|3.4|3.4|Standard Deviation|0.9|0.9|||
4415260|NCT00212134|4239529|B1|||Pupil Diameter - Fellow Eye||mm|Mean|3.5|3.5|Standard Deviation|0.9|0.9|||
4415261|NCT00212134|4239527|B3|||Pupil Diameter - Cataractous Eye||mm|Mean|3.3|3.3|Standard Deviation|1.0|1.0|||
4415262|NCT00212134|4239528|B2|||Pupil Diameter - Cataractous Eye||mm|Mean|3.2|3.2|Standard Deviation|1.0|1.0|||
4415263|NCT00212134|4239529|B1|||Pupil Diameter - Cataractous Eye||mm|Mean|3.3|3.3|Standard Deviation|1.0|1.0|||
4415264|NCT00212134|4239527|B3|Yes||Qualified for Medicaid||participants|Number|39|39.0||||||
4415265|NCT00212134|4239528|B2|Yes||Qualified for Medicaid||participants|Number|22|22.0||||||
4415266|NCT00212134|4239529|B1|Yes||Qualified for Medicaid||participants|Number|17|17.0||||||
4415267|NCT00212134|4239527|B3|No||Qualified for Medicaid||participants|Number|75|75.0||||||
4415268|NCT00212134|4239528|B2|No||Qualified for Medicaid||participants|Number|35|35.0||||||
4415269|NCT00212134|4239529|B1|No||Qualified for Medicaid||participants|Number|40|40.0||||||
4415270|NCT00212134|4239527|B3|Yes||Private Insurance||participants|Number|70|70.0||||||
4415271|NCT00212134|4239528|B2|Yes||Private Insurance||participants|Number|33|33.0||||||
4415272|NCT00212134|4239529|B1|Yes||Private Insurance||participants|Number|37|37.0||||||
4415273|NCT00212134|4239527|B3|No||Private Insurance||participants|Number|44|44.0||||||
4415274|NCT00212134|4239528|B2|No||Private Insurance||participants|Number|24|24.0||||||
4415275|NCT00212134|4239529|B1|No||Private Insurance||participants|Number|20|20.0||||||
4415276|NCT00212134|4239527|B3|United States||Region of Enrollment||participants|Number|114|114.0||||||
4415277|NCT00212134|4239528|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4415278|NCT00212134|4239529|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4415279|NCT00212134|4239527|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4415280|NCT00212134|4239528|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415281|NCT00212134|4239529|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4415282|NCT00212134|4239527|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4415283|NCT00212134|4239528|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4415284|NCT00212134|4239529|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415285|NCT00212134|4239527|B3||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4415286|NCT00212134|4239528|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4415287|NCT00212134|4239529|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4415288|NCT00212134|4239527|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4415289|NCT00212134|4239528|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4415290|NCT00212134|4239529|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4415291|NCT00212134|4239527|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415292|NCT00212134|4239528|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415293|NCT00212134|4239529|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415294|NCT00212134|4239527|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4415295|NCT00212134|4239528|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4415296|NCT00212134|4239529|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4415297|NCT00212134|4239527|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4415298|NCT00212134|4239528|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415299|NCT00212134|4239529|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4415300|NCT00212134|4239527|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415301|NCT00212134|4239528|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415302|NCT00212134|4239529|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415303|NCT00212134|4239527|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|95|95.0||||||
4415304|NCT00212134|4239528|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4415305|NCT00212134|4239529|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4415306|NCT00212134|4239527|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4415307|NCT00212134|4239528|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4415308|NCT00212134|4239529|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4415309|NCT00212134|4239527|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4415310|NCT00212134|4239528|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4415311|NCT00212134|4239529|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4415312|NCT00212134|4239527|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4415313|NCT00212134|4239528|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4415314|NCT00212134|4239529|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4415315|NCT00212134|4239527|B3|5.1 - 6.8 months||Age, Customized||participants|Number|13|13.0||||||
4415316|NCT00212134|4239528|B2|5.1 - 6.8 months||Age, Customized||participants|Number|7|7.0||||||
4415317|NCT00212134|4239529|B1|5.1 - 6.8 months||Age, Customized||participants|Number|6|6.0||||||
4415318|NCT00212134|4239527|B3|3.1 - 5.0 months||Age, Customized||participants|Number|19|19.0||||||
4415319|NCT00212134|4239528|B2|3.1 - 5.0 months||Age, Customized||participants|Number|10|10.0||||||
4415320|NCT00212134|4239529|B1|3.1 - 5.0 months||Age, Customized||participants|Number|9|9.0||||||
4415321|NCT00212134|4239527|B3|49 days - 3.0 months||Age, Customized||participants|Number|32|32.0||||||
4415322|NCT00212134|4239528|B2|49 days - 3.0 months||Age, Customized||participants|Number|15|15.0||||||
4415323|NCT00212134|4239529|B1|49 days - 3.0 months||Age, Customized||participants|Number|17|17.0||||||
4415324|NCT00212134|4239527|B3|28 - 48 days||Age, Customized||participants|Number|50|50.0||||||
4415325|NCT00212134|4239528|B2|28 - 48 days||Age, Customized||participants|Number|25|25.0||||||
4415326|NCT00212134|4239529|B1|28 - 48 days||Age, Customized||participants|Number|25|25.0||||||
4415327|NCT00212134|4239527|B3|mean/sd||Age||months|Mean|2.5|2.5|Standard Deviation|1.6|1.6|||
4415328|NCT00212134|4239528|B2|mean/sd||Age||months|Mean|2.5|2.5|Standard Deviation|1.6|1.6|||
4415329|NCT00212134|4239529|B1|mean/sd||Age||months|Mean|2.4|2.4|Standard Deviation|1.6|1.6|||
4415330|NCT00211887|4239548|B4||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4415331|NCT00211887|4239549|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4415332|NCT00211887|4239550|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4415333|NCT00211887|4239551|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4415334|NCT00211887|4239548|B4||Female|Sex: Female, Male||Participants|Count of Participants|730|730.0||||||
4415335|NCT00211887|4239549|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4415336|NCT00211887|4239550|B2||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4415337|NCT00211887|4239551|B1||Female|Sex: Female, Male||Participants|Count of Participants|372|372.0||||||
4415338|NCT00211887|4239548|B4|||Age||years|Mean|37.7|37.7|Standard Deviation|9.7|9.7|||
4415339|NCT00211887|4239549|B3|||Age||years|Mean|39.0|39.0|Standard Deviation|9.5|9.5|||
4415340|NCT00211887|4239550|B2|||Age||years|Mean|37.6|37.6|Standard Deviation|10.2|10.2|||
4415341|NCT00211887|4239551|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|9.4|9.4|||
4415342|NCT00211809|4239570|B1||prior failed SSRI trials|SSRI history||Participants|Count of Participants|10|10.0||||||
4415343|NCT00211809|4239570|B1||SSRI naive|SSRI history||Participants|Count of Participants|7|7.0||||||
4415344|NCT00211809|4239570|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4415345|NCT00211809|4239570|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4415346|NCT00211809|4239570|B1|||Age||years|Mean|29.7|29.7|Standard Deviation|8.4|8.4|||
4415347|NCT00211757|4239584|B3||Asperger's Syndrome|Diagnosis|Subjects were either diagnosed with Autistic Disorder or Asperger's syndrome|Participants|Count of Participants|4|4.0||||||
4415348|NCT00211757|4239585|B2||Asperger's Syndrome|Diagnosis|Subjects were either diagnosed with Autistic Disorder or Asperger's syndrome|Participants|Count of Participants|2|2.0||||||
4415349|NCT00211757|4239586|B1||Asperger's Syndrome|Diagnosis|Subjects were either diagnosed with Autistic Disorder or Asperger's syndrome|Participants|Count of Participants|2|2.0||||||
4415350|NCT00211757|4239584|B3||Autistic Disorder|Diagnosis|Subjects were either diagnosed with Autistic Disorder or Asperger's syndrome|Participants|Count of Participants|23|23.0||||||
4415351|NCT00211757|4239585|B2||Autistic Disorder|Diagnosis|Subjects were either diagnosed with Autistic Disorder or Asperger's syndrome|Participants|Count of Participants|14|14.0||||||
4415352|NCT00211757|4239586|B1||Autistic Disorder|Diagnosis|Subjects were either diagnosed with Autistic Disorder or Asperger's syndrome|Participants|Count of Participants|9|9.0||||||
4415353|NCT00211757|4239584|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4415354|NCT00211757|4239585|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4415355|NCT00211757|4239586|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4415356|NCT00211757|4239584|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4415357|NCT00211757|4239585|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4415358|NCT00211757|4239586|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4415359|NCT00211757|4239584|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415360|NCT00211757|4239585|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415361|NCT00211757|4239586|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415362|NCT00211757|4239584|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4415363|NCT00211757|4239585|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4415364|NCT00211757|4239586|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4415365|NCT00211757|4239584|B3||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4415366|NCT00211757|4239585|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4415367|NCT00211757|4239586|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4415368|NCT00211692|4239595|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4415369|NCT00211692|4239596|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4415370|NCT00211692|4239597|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415371|NCT00211692|4239595|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415372|NCT00211692|4239596|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415373|NCT00211692|4239597|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415374|NCT00211692|4239595|B3||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4415375|NCT00211692|4239596|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4415376|NCT00211692|4239597|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4415377|NCT00211692|4239595|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4415378|NCT00211692|4239596|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4415379|NCT00211692|4239597|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4415380|NCT00211692|4239595|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415381|NCT00211692|4239596|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415382|NCT00211692|4239597|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415383|NCT00211692|4239595|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415384|NCT00211692|4239596|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415385|NCT00211692|4239597|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415386|NCT00211692|4239595|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415387|NCT00211692|4239596|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415388|NCT00211692|4239597|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415389|NCT00211692|4239595|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4415390|NCT00211692|4239596|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4415391|NCT00211692|4239597|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4415392|NCT00211692|4239595|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4415393|NCT00211692|4239596|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4415394|NCT00211692|4239597|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4415395|NCT00211692|4239595|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|8.4|8.4|||
4415396|NCT00211692|4239596|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|8.8|8.8|||
4415397|NCT00211692|4239597|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|8.0|8.0|||
4415398|NCT00211692|4239595|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415399|NCT00211692|4239596|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415400|NCT00211692|4239597|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415401|NCT00211692|4239595|B3||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4415402|NCT00211692|4239596|B2||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4415403|NCT00211692|4239597|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4415404|NCT00211692|4239595|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415405|NCT00211692|4239596|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415406|NCT00211692|4239597|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415407|NCT00211536|4239606|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4415408|NCT00211536|4239607|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4415409|NCT00211536|4239608|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4415410|NCT00211536|4239606|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4415411|NCT00211536|4239607|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4415412|NCT00211536|4239608|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4415413|NCT00211536|4239606|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4415414|NCT00211536|4239607|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4415415|NCT00211536|4239608|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4415416|NCT00211536|4239606|B3|||Age|Results reported on the As-Treated Data Analysis set (n=100). This is the primary efficacy analysis set and will include all subjects randomized and followed, at least, to Visit 5. Missing data are treated as missing. There is no extrapolation or interpolation of missing values.|years|Mean|42|42.0|Standard Deviation|11.4|11.4|||
4415417|NCT00211536|4239607|B2|||Age|Results reported on the As-Treated Data Analysis set (n=100). This is the primary efficacy analysis set and will include all subjects randomized and followed, at least, to Visit 5. Missing data are treated as missing. There is no extrapolation or interpolation of missing values.|years|Mean|40.7|40.7|Standard Deviation|11.9|11.9|||
4415418|NCT00211536|4239608|B1|||Age|Results reported on the As-Treated Data Analysis set (n=100). This is the primary efficacy analysis set and will include all subjects randomized and followed, at least, to Visit 5. Missing data are treated as missing. There is no extrapolation or interpolation of missing values.|years|Mean|43.3|43.3|Standard Deviation|10.8|10.8|||
4415419|NCT00211536|4239606|B3||>=65 years|Age|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|Participants|Count of Participants|0|0.0||||||
4415420|NCT00211536|4239607|B2||>=65 years|Age|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|Participants|Count of Participants|0|0.0||||||
4415421|NCT00211536|4239608|B1||>=65 years|Age|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|Participants|Count of Participants|0|0.0||||||
4415422|NCT00211536|4239606|B3||Between 18 and 65 years|Age|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|Participants|Count of Participants|100|100.0||||||
4415423|NCT00211536|4239607|B2||Between 18 and 65 years|Age|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|Participants|Count of Participants|48|48.0||||||
4415424|NCT00211536|4239608|B1||Between 18 and 65 years|Age|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|Participants|Count of Participants|52|52.0||||||
4415425|NCT00211536|4239606|B3||<=18 years|Age|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|Participants|Count of Participants|0|0.0||||||
4415426|NCT00211536|4239607|B2||<=18 years|Age|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|Participants|Count of Participants|0|0.0||||||
4415427|NCT00211536|4239608|B1||<=18 years|Age|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|Participants|Count of Participants|0|0.0||||||
4415428|NCT00211510|4239623|B3|United States||Region of Enrollment||participants|Number|146|146.0||||||
4415429|NCT00211510|4239624|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4415430|NCT00211510|4239625|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4415431|NCT00211510|4239623|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4415432|NCT00211510|4239624|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4415433|NCT00211510|4239625|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4415434|NCT00211510|4239623|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4415435|NCT00211510|4239624|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4415436|NCT00211510|4239625|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4415437|NCT00211510|4239623|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|15.4|15.4|||
4415438|NCT00211510|4239624|B2|||Age||years|Mean|32.9|32.9|Standard Deviation|16.3|16.3|||
4415439|NCT00211510|4239625|B1|||Age||years|Mean|32|32.0|Standard Deviation|14.6|14.6|||
4415440|NCT00211510|4239623|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415441|NCT00211510|4239624|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415442|NCT00211510|4239625|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415443|NCT00211510|4239623|B3||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4415444|NCT00211510|4239624|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4415445|NCT00211510|4239625|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4415446|NCT00211510|4239623|B3||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
4415447|NCT00211510|4239624|B2||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4415448|NCT00211510|4239625|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4415449|NCT00211237|4239642|B3|Missing||Sex/Gender, Customized||participants|Number|5|5.0||||||
4415450|NCT00211237|4239643|B2|Missing||Sex/Gender, Customized||participants|Number|3|3.0||||||
4415451|NCT00211237|4239644|B1|Missing||Sex/Gender, Customized||participants|Number|2|2.0||||||
4415452|NCT00211237|4239642|B3|Female||Sex/Gender, Customized||participants|Number|75|75.0||||||
4415453|NCT00211237|4239643|B2|Female||Sex/Gender, Customized||participants|Number|35|35.0||||||
4415454|NCT00211237|4239644|B1|Female||Sex/Gender, Customized||participants|Number|40|40.0||||||
4415455|NCT00211237|4239642|B3|Male||Sex/Gender, Customized||participants|Number|54|54.0||||||
4415456|NCT00211237|4239643|B2|Male||Sex/Gender, Customized||participants|Number|26|26.0||||||
4415457|NCT00211237|4239644|B1|Male||Sex/Gender, Customized||participants|Number|28|28.0||||||
4415458|NCT00211237|4239642|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|11.0|11.0|||
4415459|NCT00211237|4239643|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|11.4|11.4|||
4415460|NCT00211237|4239644|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|10.8|10.8|||
4415461|NCT00211172|4239736|B3|United States||Region of Enrollment||participants|Number|907|907.0||||||
4415462|NCT00211172|4239737|B2|United States||Region of Enrollment||participants|Number|458|458.0||||||
4415463|NCT00211172|4239738|B1|United States||Region of Enrollment||participants|Number|449|449.0||||||
4415464|NCT00211172|4239736|B3||Male|Sex: Female, Male||Participants|Count of Participants|611|611.0||||||
4415465|NCT00211172|4239737|B2||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4415466|NCT00211172|4239738|B1||Male|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4415467|NCT00211172|4239736|B3||Female|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4415468|NCT00211172|4239737|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4415469|NCT00211172|4239738|B1||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4415470|NCT00211172|4239736|B3|||Age||years|Mean|64.95|64.95|Standard Deviation|27.68|27.68|||
4415471|NCT00211172|4239737|B2|||Age||years|Mean|64.78|64.78|Standard Deviation|14.22|14.22|||
4415472|NCT00211172|4239738|B1|||Age||years|Mean|65.13|65.13|Standard Deviation|13.46|13.46|||
4415473|NCT00211172|4239736|B3|>=65 years||Age||years|Mean|77.11|77.11|Standard Deviation|14.62|14.62|||
4415474|NCT00211172|4239737|B2|>=65 years||Age||years|Mean|77.64|77.64|Standard Deviation|7.41|7.41|||
4415475|NCT00211172|4239738|B1|>=65 years||Age||years|Mean|76.58|76.58|Standard Deviation|7.21|7.21|||
4415476|NCT00211172|4239736|B3|Between 18 and 65 years||Age||years|Mean|53.61|53.61|Standard Deviation|14.66|14.66|||
4415477|NCT00211172|4239737|B2|Between 18 and 65 years||Age||years|Mean|53.50|53.5|Standard Deviation|7.68|7.68|||
4415478|NCT00211172|4239738|B1|Between 18 and 65 years||Age||years|Mean|53.72|53.72|Standard Deviation|6.98|6.98|||
4415479|NCT00211081|4239745|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4415480|NCT00211081|4239745|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4415481|NCT00211081|4239745|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4415482|NCT00211081|4239745|B1|||Age||years|Median|28|28.0|Full Range|||15.0|42.0|
4415483|NCT00211081|4239745|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415484|NCT00211081|4239745|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4415485|NCT00211081|4239745|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4415486|NCT00210639|4239755|B3|12-<17 YEARS||AgeCategorical||participants|Number|6|6.0||||||
4415487|NCT00210639|4239756|B2|12-<17 YEARS||AgeCategorical||participants|Number|2|2.0||||||
4415488|NCT00210639|4239757|B1|12-<17 YEARS||AgeCategorical||participants|Number|4|4.0||||||
4415489|NCT00210639|4239755|B3|6-<12 YEARS||AgeCategorical||participants|Number|14|14.0||||||
4415490|NCT00210639|4239756|B2|6-<12 YEARS||AgeCategorical||participants|Number|5|5.0||||||
4415491|NCT00210639|4239757|B1|6-<12 YEARS||AgeCategorical||participants|Number|9|9.0||||||
4415492|NCT00210639|4239755|B3|2-<6 YEARS||AgeCategorical||participants|Number|157|157.0||||||
4415493|NCT00210639|4239756|B2|2-<6 YEARS||AgeCategorical||participants|Number|62|62.0||||||
4415494|NCT00210639|4239757|B1|2-<6 YEARS||AgeCategorical||participants|Number|95|95.0||||||
4415495|NCT00210639|4239755|B3|<2 YEARS||AgeCategorical||participants|Number|30|30.0||||||
4415496|NCT00210639|4239756|B2|<2 YEARS||AgeCategorical||participants|Number|14|14.0||||||
4415497|NCT00210639|4239757|B1|<2 YEARS||AgeCategorical||participants|Number|16|16.0||||||
4415498|NCT00210639|4239755|B3|UNITED STATES||Region of Enrollment||participants|Number|100|100.0||||||
4415499|NCT00210639|4239756|B2|UNITED STATES||Region of Enrollment||participants|Number|39|39.0||||||
4415500|NCT00210639|4239757|B1|UNITED STATES||Region of Enrollment||participants|Number|61|61.0||||||
4415501|NCT00210639|4239755|B3|PANAMA||Region of Enrollment||participants|Number|1|1.0||||||
4415502|NCT00210639|4239756|B2|PANAMA||Region of Enrollment||participants|Number|1|1.0||||||
4415503|NCT00210639|4239757|B1|PANAMA||Region of Enrollment||participants|Number|0|0.0||||||
4415504|NCT00210639|4239755|B3|MEXICO||Region of Enrollment||participants|Number|1|1.0||||||
4415505|NCT00210639|4239756|B2|MEXICO||Region of Enrollment||participants|Number|1|1.0||||||
4415506|NCT00210639|4239757|B1|MEXICO||Region of Enrollment||participants|Number|0|0.0||||||
4415507|NCT00210639|4239755|B3|ISRAEL||Region of Enrollment||participants|Number|2|2.0||||||
4415508|NCT00210639|4239756|B2|ISRAEL||Region of Enrollment||participants|Number|0|0.0||||||
4415509|NCT00210639|4239757|B1|ISRAEL||Region of Enrollment||participants|Number|2|2.0||||||
4415510|NCT00210639|4239755|B3|COSTA RICA||Region of Enrollment||participants|Number|42|42.0||||||
4415511|NCT00210639|4239756|B2|COSTA RICA||Region of Enrollment||participants|Number|15|15.0||||||
4415512|NCT00210639|4239757|B1|COSTA RICA||Region of Enrollment||participants|Number|27|27.0||||||
4415513|NCT00210639|4239755|B3|CHILE||Region of Enrollment||participants|Number|22|22.0||||||
4415514|NCT00210639|4239756|B2|CHILE||Region of Enrollment||participants|Number|12|12.0||||||
4415515|NCT00210639|4239757|B1|CHILE||Region of Enrollment||participants|Number|10|10.0||||||
4415516|NCT00210639|4239755|B3|BRAZIL||Region of Enrollment||participants|Number|12|12.0||||||
4415517|NCT00210639|4239756|B2|BRAZIL||Region of Enrollment||participants|Number|4|4.0||||||
4415518|NCT00210639|4239757|B1|BRAZIL||Region of Enrollment||participants|Number|8|8.0||||||
4415519|NCT00210639|4239755|B3|ARGENTINA||Region of Enrollment||participants|Number|27|27.0||||||
4415520|NCT00210639|4239756|B2|ARGENTINA||Region of Enrollment||participants|Number|11|11.0||||||
4415521|NCT00210639|4239757|B1|ARGENTINA||Region of Enrollment||participants|Number|16|16.0||||||
4415522|NCT00210639|4239755|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4415523|NCT00210639|4239756|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4415524|NCT00210639|4239757|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4415525|NCT00210639|4239755|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4415526|NCT00210639|4239756|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4415527|NCT00210639|4239757|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4415528|NCT00210639|4239755|B3|||Age||years|Mean|3.7|3.7|Standard Deviation|2.50|2.5|||
4415529|NCT00210639|4239756|B2|||Age||years|Mean|3.5|3.5|Standard Deviation|2.46|2.46|||
4415530|NCT00210639|4239757|B1|||Age||years|Mean|3.9|3.9|Standard Deviation|2.52|2.52|||
4415531|NCT00210626|4239764|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4415532|NCT00210626|4239765|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4415533|NCT00210626|4239766|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4415534|NCT00210626|4239764|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4415535|NCT00210626|4239765|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4415536|NCT00210626|4239766|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4415537|NCT00210626|4239764|B3|||Age||years|Mean|32.8|32.8|Standard Deviation|10.99|10.99|||
4415538|NCT00210626|4239765|B2|||Age||years|Mean|33.5|33.5|Standard Deviation|11.06|11.06|||
4415539|NCT00210626|4239766|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|10.94|10.94|||
4415540|NCT00210626|4239764|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415541|NCT00210626|4239765|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415542|NCT00210626|4239766|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415543|NCT00210626|4239764|B3||Between 18 and 65 years|Age||Participants|Count of Participants|178|178.0||||||
4415544|NCT00210626|4239765|B2||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4415545|NCT00210626|4239766|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4415546|NCT00210626|4239764|B3||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4415547|NCT00210626|4239765|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4415548|NCT00210626|4239766|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4415549|NCT00210470|4239775|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4415550|NCT00210470|4239775|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4415551|NCT00210470|4239775|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4415552|NCT00210470|4239775|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4415553|NCT00210470|4239775|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|9.4|9.4|||
4415554|NCT00210470|4239775|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4415555|NCT00210470|4239775|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4415556|NCT00210470|4239775|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415557|NCT00209560|4239779|B3|No history of sedation||History of Adverse Reactions following a Previous Sedation||participants|Number|10|10.0||||||
4415558|NCT00209560|4239780|B2|No history of sedation||History of Adverse Reactions following a Previous Sedation||participants|Number|3|3.0||||||
4415559|NCT00209560|4239781|B1|No history of sedation||History of Adverse Reactions following a Previous Sedation||participants|Number|7|7.0||||||
4415560|NCT00209560|4239779|B3|No||History of Adverse Reactions following a Previous Sedation||participants|Number|148|148.0||||||
4415561|NCT00209560|4239780|B2|No||History of Adverse Reactions following a Previous Sedation||participants|Number|37|37.0||||||
4415562|NCT00209560|4239781|B1|No||History of Adverse Reactions following a Previous Sedation||participants|Number|111|111.0||||||
4415563|NCT00209560|4239779|B3|Yes||History of Adverse Reactions following a Previous Sedation||participants|Number|5|5.0||||||
4415564|NCT00209560|4239780|B2|Yes||History of Adverse Reactions following a Previous Sedation||participants|Number|2|2.0||||||
4415565|NCT00209560|4239781|B1|Yes||History of Adverse Reactions following a Previous Sedation||participants|Number|3|3.0||||||
4415566|NCT00209560|4239779|B3|III (A patient with severe systemic disease)||American Society of Anesthesiologists Status (ASA)||particpants|Number|4|4.0||||||
4415567|NCT00209560|4239780|B2|III (A patient with severe systemic disease)||American Society of Anesthesiologists Status (ASA)||particpants|Number|2|2.0||||||
4415568|NCT00209560|4239781|B1|III (A patient with severe systemic disease)||American Society of Anesthesiologists Status (ASA)||particpants|Number|2|2.0||||||
4415569|NCT00209560|4239779|B3|II (A patient with mild systemic disease)||American Society of Anesthesiologists Status (ASA)||particpants|Number|92|92.0||||||
4415570|NCT00209560|4239780|B2|II (A patient with mild systemic disease)||American Society of Anesthesiologists Status (ASA)||particpants|Number|21|21.0||||||
4415571|NCT00209560|4239781|B1|II (A patient with mild systemic disease)||American Society of Anesthesiologists Status (ASA)||particpants|Number|71|71.0||||||
4415572|NCT00209560|4239779|B3|I (A normal healthy patient)||American Society of Anesthesiologists Status (ASA)||particpants|Number|67|67.0||||||
4415573|NCT00209560|4239780|B2|I (A normal healthy patient)||American Society of Anesthesiologists Status (ASA)||particpants|Number|19|19.0||||||
4415574|NCT00209560|4239781|B1|I (A normal healthy patient)||American Society of Anesthesiologists Status (ASA)||particpants|Number|48|48.0||||||
4415575|NCT00209560|4239779|B3|>80||Weight (kg)||particpants|Number|101|101.0||||||
4415576|NCT00209560|4239780|B2|>80||Weight (kg)||particpants|Number|28|28.0||||||
4415577|NCT00209560|4239781|B1|>80||Weight (kg)||particpants|Number|73|73.0||||||
4415578|NCT00209560|4239779|B3|55 to > 80||Weight (kg)||particpants|Number|55|55.0||||||
4415579|NCT00209560|4239780|B2|55 to > 80||Weight (kg)||particpants|Number|14|14.0||||||
4415580|NCT00209560|4239781|B1|55 to > 80||Weight (kg)||particpants|Number|41|41.0||||||
4415581|NCT00209560|4239779|B3|<55||Weight (kg)||particpants|Number|7|7.0||||||
4415582|NCT00209560|4239780|B2|<55||Weight (kg)||particpants|Number|0|0.0||||||
4415583|NCT00209560|4239781|B1|<55||Weight (kg)||particpants|Number|7|7.0||||||
4415584|NCT00209560|4239779|B3|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4415585|NCT00209560|4239780|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4415586|NCT00209560|4239781|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4415587|NCT00209560|4239779|B3|White||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4415588|NCT00209560|4239780|B2|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4415589|NCT00209560|4239781|B1|White||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4415590|NCT00209560|4239779|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4415591|NCT00209560|4239780|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4415592|NCT00209560|4239781|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4415593|NCT00209560|4239779|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4415594|NCT00209560|4239780|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4415595|NCT00209560|4239781|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4415596|NCT00209560|4239779|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4415597|NCT00209560|4239780|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4415598|NCT00209560|4239781|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4415599|NCT00209560|4239779|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4415600|NCT00209560|4239780|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4415601|NCT00209560|4239781|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4415602|NCT00209560|4239779|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4415603|NCT00209560|4239780|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4415604|NCT00209560|4239781|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4415605|NCT00209560|4239779|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4415606|NCT00209560|4239780|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4415607|NCT00209560|4239781|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4415608|NCT00209560|4239779|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4415609|NCT00209560|4239780|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4415610|NCT00209560|4239781|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4415611|NCT00209560|4239779|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4415612|NCT00209560|4239780|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4415613|NCT00209560|4239781|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4415614|NCT00209560|4239779|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4415615|NCT00209560|4239780|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4415616|NCT00209560|4239781|B1||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4415617|NCT00209560|4239779|B3|||Age||years|Mean|45.3|45.3|Standard Deviation|11.1|11.1|||
4415618|NCT00209560|4239780|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|11.5|11.5|||
4415619|NCT00209560|4239781|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|11.0|11.0|||
4415620|NCT00209417|4239790|B3|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4415621|NCT00209417|4239791|B2|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4415622|NCT00209417|4239792|B1|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4415623|NCT00209417|4239790|B3|Sweden||Region of Enrollment||participants|Number|14|14.0||||||
4415624|NCT00209417|4239791|B2|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
4415625|NCT00209417|4239792|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4415626|NCT00209417|4239790|B3|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4415627|NCT00209417|4239791|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4415628|NCT00209417|4239792|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4415629|NCT00209417|4239790|B3|Russian Federation||Region of Enrollment||participants|Number|113|113.0||||||
4415630|NCT00209417|4239791|B2|Russian Federation||Region of Enrollment||participants|Number|56|56.0||||||
4415631|NCT00209417|4239792|B1|Russian Federation||Region of Enrollment||participants|Number|57|57.0||||||
4415632|NCT00209417|4239790|B3|Poland||Region of Enrollment||participants|Number|115|115.0||||||
4415633|NCT00209417|4239791|B2|Poland||Region of Enrollment||participants|Number|55|55.0||||||
4415634|NCT00209417|4239792|B1|Poland||Region of Enrollment||participants|Number|60|60.0||||||
4415635|NCT00209417|4239790|B3|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4415636|NCT00209417|4239791|B2|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4415637|NCT00209417|4239792|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4415638|NCT00209417|4239790|B3|Hungary||Region of Enrollment||participants|Number|14|14.0||||||
4415639|NCT00209417|4239791|B2|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4415640|NCT00209417|4239792|B1|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4415641|NCT00209417|4239790|B3|Germany||Region of Enrollment||participants|Number|72|72.0||||||
4415642|NCT00209417|4239791|B2|Germany||Region of Enrollment||participants|Number|38|38.0||||||
4415643|NCT00209417|4239792|B1|Germany||Region of Enrollment||participants|Number|34|34.0||||||
4415644|NCT00209417|4239790|B3|France||Region of Enrollment||participants|Number|17|17.0||||||
4415645|NCT00209417|4239791|B2|France||Region of Enrollment||participants|Number|9|9.0||||||
4415646|NCT00209417|4239792|B1|France||Region of Enrollment||participants|Number|8|8.0||||||
4415647|NCT00209417|4239790|B3|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4415648|NCT00209417|4239791|B2|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4415649|NCT00209417|4239792|B1|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4415650|NCT00209417|4239790|B3|China||Region of Enrollment||participants|Number|93|93.0||||||
4415651|NCT00209417|4239791|B2|China||Region of Enrollment||participants|Number|48|48.0||||||
4415652|NCT00209417|4239792|B1|China||Region of Enrollment||participants|Number|45|45.0||||||
4415653|NCT00209417|4239790|B3|Austria||Region of Enrollment||participants|Number|23|23.0||||||
4415654|NCT00209417|4239791|B2|Austria||Region of Enrollment||participants|Number|12|12.0||||||
4415655|NCT00209417|4239792|B1|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4415656|NCT00209417|4239790|B3|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
4415657|NCT00209417|4239791|B2|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4415658|NCT00209417|4239792|B1|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4415659|NCT00209417|4239790|B3|United States||Region of Enrollment||participants|Number|141|141.0||||||
4415660|NCT00209417|4239791|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4415661|NCT00209417|4239792|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4415662|NCT00209417|4239790|B3||Male|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
4415663|NCT00209417|4239791|B2||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4415664|NCT00209417|4239792|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4415665|NCT00209417|4239790|B3||Female|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
4415666|NCT00209417|4239791|B2||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4415667|NCT00209417|4239792|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4415668|NCT00209417|4239790|B3||>=65 years|Age||Participants|Count of Participants|379|379.0||||||
4415669|NCT00209417|4239791|B2||>=65 years|Age||Participants|Count of Participants|191|191.0||||||
4415670|NCT00209417|4239792|B1||>=65 years|Age||Participants|Count of Participants|188|188.0||||||
4415671|NCT00209417|4239790|B3||Between 18 and 65 years|Age||Participants|Count of Participants|269|269.0||||||
4415672|NCT00209417|4239791|B2||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4415673|NCT00209417|4239792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
4415674|NCT00209417|4239790|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415675|NCT00209417|4239791|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415676|NCT00209417|4239792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415677|NCT00209417|4239790|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|12.01|12.01|||
4415678|NCT00209417|4239791|B2|||Age||years|Mean|66.5|66.5|Standard Deviation|12.01|12.01|||
4415679|NCT00209417|4239792|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|12.02|12.02|||
4415680|NCT00209339|4239801|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4415681|NCT00209339|4239801|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415682|NCT00209339|4239801|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4415683|NCT00209339|4239801|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4415684|NCT00209339|4239801|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4415685|NCT00209339|4239801|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415686|NCT00209339|4239801|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415687|NCT00209339|4239801|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415688|NCT00209339|4239801|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4415689|NCT00209339|4239801|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4415690|NCT00209339|4239801|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4415691|NCT00209339|4239801|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4415692|NCT00209339|4239801|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4415693|NCT00209339|4239801|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|13.8|13.8|||
4415694|NCT00209274|4239883|B3|Mental Component Score||36-Item Short Form Health Survey (SF-36) Quality of Life (QOL)|The SF-36 is a multidimensional, patient-reported survey containing 36 questions on a 0-100 scale measuring physical (Physical Component Score PCS) & mental health status (Mental Component Score MCS) in relation to 8 health concepts: physical functioning, role limitations due to physical or emotional health, bodily pain, general health perceptions, vitality, social functioning, & general mental health. Higher scores represent better self-perceived health. The PCS & MCS norms for 65-75 year olds are 44 and 52, while the norms for CHF population are 31 and 46, respectively.|scores on a scale|Mean|46.9|46.9|Standard Deviation|12.0|12.0|||
4415695|NCT00209274|4239884|B2|Mental Component Score||36-Item Short Form Health Survey (SF-36) Quality of Life (QOL)|The SF-36 is a multidimensional, patient-reported survey containing 36 questions on a 0-100 scale measuring physical (Physical Component Score PCS) & mental health status (Mental Component Score MCS) in relation to 8 health concepts: physical functioning, role limitations due to physical or emotional health, bodily pain, general health perceptions, vitality, social functioning, & general mental health. Higher scores represent better self-perceived health. The PCS & MCS norms for 65-75 year olds are 44 and 52, while the norms for CHF population are 31 and 46, respectively.|scores on a scale|Mean|46.6|46.6|Standard Deviation|12.5|12.5|||
4415696|NCT00209274|4239885|B1|Mental Component Score||36-Item Short Form Health Survey (SF-36) Quality of Life (QOL)|The SF-36 is a multidimensional, patient-reported survey containing 36 questions on a 0-100 scale measuring physical (Physical Component Score PCS) & mental health status (Mental Component Score MCS) in relation to 8 health concepts: physical functioning, role limitations due to physical or emotional health, bodily pain, general health perceptions, vitality, social functioning, & general mental health. Higher scores represent better self-perceived health. The PCS & MCS norms for 65-75 year olds are 44 and 52, while the norms for CHF population are 31 and 46, respectively.|scores on a scale|Mean|47.1|47.1|Standard Deviation|11.9|11.9|||
4415697|NCT00209274|4239883|B3|Physical Component Score||36-Item Short Form Health Survey (SF-36) Quality of Life (QOL)|The SF-36 is a multidimensional, patient-reported survey containing 36 questions on a 0-100 scale measuring physical (Physical Component Score PCS) & mental health status (Mental Component Score MCS) in relation to 8 health concepts: physical functioning, role limitations due to physical or emotional health, bodily pain, general health perceptions, vitality, social functioning, & general mental health. Higher scores represent better self-perceived health. The PCS & MCS norms for 65-75 year olds are 44 and 52, while the norms for CHF population are 31 and 46, respectively.|scores on a scale|Mean|41.4|41.4|Standard Deviation|10.3|10.3|||
4415743|NCT00209274|4239884|B2|United States||Region of Enrollment||Participants|Count of Participants|93|93.0||||||
4415744|NCT00209274|4239885|B1|United States||Region of Enrollment||Participants|Count of Participants|177|177.0||||||
4415745|NCT00209274|4239883|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4415698|NCT00209274|4239884|B2|Physical Component Score||36-Item Short Form Health Survey (SF-36) Quality of Life (QOL)|The SF-36 is a multidimensional, patient-reported survey containing 36 questions on a 0-100 scale measuring physical (Physical Component Score PCS) & mental health status (Mental Component Score MCS) in relation to 8 health concepts: physical functioning, role limitations due to physical or emotional health, bodily pain, general health perceptions, vitality, social functioning, & general mental health. Higher scores represent better self-perceived health. The PCS & MCS norms for 65-75 year olds are 44 and 52, while the norms for CHF population are 31 and 46, respectively.|scores on a scale|Mean|41.9|41.9|Standard Deviation|11.1|11.1|||
4415699|NCT00209274|4239885|B1|Physical Component Score||36-Item Short Form Health Survey (SF-36) Quality of Life (QOL)|The SF-36 is a multidimensional, patient-reported survey containing 36 questions on a 0-100 scale measuring physical (Physical Component Score PCS) & mental health status (Mental Component Score MCS) in relation to 8 health concepts: physical functioning, role limitations due to physical or emotional health, bodily pain, general health perceptions, vitality, social functioning, & general mental health. Higher scores represent better self-perceived health. The PCS & MCS norms for 65-75 year olds are 44 and 52, while the norms for CHF population are 31 and 46, respectively.|scores on a scale|Mean|41.1|41.1|Standard Deviation|10.0|10.0|||
4415700|NCT00209274|4239883|B3|LV internal dimension systole (LVIDs)||Left Ventricular (LV) Measurement||cm|Mean|3.6|3.6|Standard Deviation|0.85|0.85|||
4415701|NCT00209274|4239884|B2|LV internal dimension systole (LVIDs)||Left Ventricular (LV) Measurement||cm|Mean|3.5|3.5|Standard Deviation|0.8|0.8|||
4415702|NCT00209274|4239885|B1|LV internal dimension systole (LVIDs)||Left Ventricular (LV) Measurement||cm|Mean|3.7|3.7|Standard Deviation|0.9|0.9|||
4415703|NCT00209274|4239883|B3|LV internal dimension diastole (LVIDd)||Left Ventricular (LV) Measurement||cm|Mean|5.5|5.5|Standard Deviation|0.7|0.7|||
4415704|NCT00209274|4239884|B2|LV internal dimension diastole (LVIDd)||Left Ventricular (LV) Measurement||cm|Mean|5.5|5.5|Standard Deviation|0.7|0.7|||
4415705|NCT00209274|4239885|B1|LV internal dimension diastole (LVIDd)||Left Ventricular (LV) Measurement||cm|Mean|5.5|5.5|Standard Deviation|0.7|0.7|||
4415706|NCT00209274|4239883|B3|LV End Systolic Volume (LVESV)||Left Ventricular (LV) Measurement||mL|Mean|63.65|63.65|Standard Deviation|27.20|27.2|||
4415707|NCT00209274|4239884|B2|LV End Systolic Volume (LVESV)||Left Ventricular (LV) Measurement||mL|Mean|63.8|63.8|Standard Deviation|28.9|28.9|||
4415708|NCT00209274|4239885|B1|LV End Systolic Volume (LVESV)||Left Ventricular (LV) Measurement||mL|Mean|63.5|63.5|Standard Deviation|25.5|25.5|||
4415709|NCT00209274|4239883|B3|LV End Diastolic Volume (LVEDV)||Left Ventricular (LV) Measurement||mL|Mean|158.05|158.05|Standard Deviation|42.65|42.65|||
4415710|NCT00209274|4239884|B2|LV End Diastolic Volume (LVEDV)||Left Ventricular (LV) Measurement||mL|Mean|159.6|159.6|Standard Deviation|46.3|46.3|||
4415711|NCT00209274|4239885|B1|LV End Diastolic Volume (LVEDV)||Left Ventricular (LV) Measurement||mL|Mean|156.5|156.5|Standard Deviation|39.0|39.0|||
4415712|NCT00209274|4239883|B3|4+: Severe||Mitral regurgitation (MR)||Participants|Count of Participants|67|67.0||||||
4415713|NCT00209274|4239884|B2|4+: Severe||Mitral regurgitation (MR)||Participants|Count of Participants|21|21.0||||||
4415714|NCT00209274|4239885|B1|4+: Severe||Mitral regurgitation (MR)||Participants|Count of Participants|46|46.0||||||
4415715|NCT00209274|4239883|B3|3+: Moderate-to-Severe||Mitral regurgitation (MR)||Participants|Count of Participants|197|197.0||||||
4415716|NCT00209274|4239884|B2|3+: Moderate-to-Severe||Mitral regurgitation (MR)||Participants|Count of Participants|67|67.0||||||
4415717|NCT00209274|4239885|B1|3+: Moderate-to-Severe||Mitral regurgitation (MR)||Participants|Count of Participants|130|130.0||||||
4415718|NCT00209274|4239883|B3|2+: Moderate||Mitral regurgitation (MR)||Participants|Count of Participants|15|15.0||||||
4415719|NCT00209274|4239884|B2|2+: Moderate||Mitral regurgitation (MR)||Participants|Count of Participants|7|7.0||||||
4415720|NCT00209274|4239885|B1|2+: Moderate||Mitral regurgitation (MR)||Participants|Count of Participants|8|8.0||||||
4415721|NCT00209274|4239883|B3|1+: Mild||Mitral regurgitation (MR)||Participants|Count of Participants|0|0.0||||||
4415722|NCT00209274|4239884|B2|1+: Mild||Mitral regurgitation (MR)||Participants|Count of Participants|0|0.0||||||
4415723|NCT00209274|4239885|B1|1+: Mild||Mitral regurgitation (MR)||Participants|Count of Participants|0|0.0||||||
4415724|NCT00209274|4239883|B3|0: None||Mitral regurgitation (MR)||Participants|Count of Participants|0|0.0||||||
4415725|NCT00209274|4239884|B2|0: None||Mitral regurgitation (MR)||Participants|Count of Participants|0|0.0||||||
4415726|NCT00209274|4239885|B1|0: None||Mitral regurgitation (MR)||Participants|Count of Participants|0|0.0||||||
4415727|NCT00209274|4239883|B3|NYHA Functional Class IV||NYHA Functional Class|Class I: Patients with cardiac disease but without resulting limitations of physical activity. Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest. Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity.|Participants|Count of Participants|16|16.0||||||
4415728|NCT00209274|4239884|B2|NYHA Functional Class IV||NYHA Functional Class|Class I: Patients with cardiac disease but without resulting limitations of physical activity. Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest. Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity.|Participants|Count of Participants|4|4.0||||||
4415746|NCT00209274|4239884|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4415747|NCT00209274|4239885|B1||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4415748|NCT00209274|4239883|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4415749|NCT00209274|4239884|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4415729|NCT00209274|4239885|B1|NYHA Functional Class IV||NYHA Functional Class|Class I: Patients with cardiac disease but without resulting limitations of physical activity. Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest. Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity.|Participants|Count of Participants|12|12.0||||||
4415730|NCT00209274|4239883|B3|NYHA Functional Class III||NYHA Functional Class|Class I: Patients with cardiac disease but without resulting limitations of physical activity. Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest. Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity.|Participants|Count of Participants|123|123.0||||||
4415731|NCT00209274|4239884|B2|NYHA Functional Class III||NYHA Functional Class|Class I: Patients with cardiac disease but without resulting limitations of physical activity. Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest. Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity.|Participants|Count of Participants|41|41.0||||||
4415732|NCT00209274|4239885|B1|NYHA Functional Class III||NYHA Functional Class|Class I: Patients with cardiac disease but without resulting limitations of physical activity. Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest. Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity.|Participants|Count of Participants|82|82.0||||||
4415733|NCT00209274|4239883|B3|NYHA Functional Class II||NYHA Functional Class|Class I: Patients with cardiac disease but without resulting limitations of physical activity. Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest. Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity.|Participants|Count of Participants|104|104.0||||||
4415734|NCT00209274|4239884|B2|NYHA Functional Class II||NYHA Functional Class|Class I: Patients with cardiac disease but without resulting limitations of physical activity. Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest. Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity.|Participants|Count of Participants|31|31.0||||||
4415735|NCT00209274|4239885|B1|NYHA Functional Class II||NYHA Functional Class|Class I: Patients with cardiac disease but without resulting limitations of physical activity. Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest. Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity.|Participants|Count of Participants|73|73.0||||||
4415736|NCT00209274|4239883|B3|NYHA Functional Class I||NYHA Functional Class|Class I: Patients with cardiac disease but without resulting limitations of physical activity. Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest. Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity.|Participants|Count of Participants|36|36.0||||||
4415737|NCT00209274|4239884|B2|NYHA Functional Class I||NYHA Functional Class|Class I: Patients with cardiac disease but without resulting limitations of physical activity. Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest. Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity.|Participants|Count of Participants|19|19.0||||||
4415738|NCT00209274|4239885|B1|NYHA Functional Class I||NYHA Functional Class|Class I: Patients with cardiac disease but without resulting limitations of physical activity. Class II: Patients with cardiac disease resulting in slight limitation of physical activity. Patients are comfortable at rest. Class III: Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Class IV: Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency or anginal syndrome may be present even at rest & discomfort is increased with physical activity.|Participants|Count of Participants|17|17.0||||||
4415739|NCT00209274|4239883|B3|Canada||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4415740|NCT00209274|4239884|B2|Canada||Region of Enrollment||Participants|Count of Participants|2|2.0||||||
4415741|NCT00209274|4239885|B1|Canada||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4415742|NCT00209274|4239883|B3|United States||Region of Enrollment||Participants|Count of Participants|270|270.0||||||
4415750|NCT00209274|4239885|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4415751|NCT00209274|4239883|B3|>75 years||Age, Customized||Participants|Count of Participants|81|81.0||||||
4415752|NCT00209274|4239884|B2|>75 years||Age, Customized||Participants|Count of Participants|26|26.0||||||
4415753|NCT00209274|4239885|B1|>75 years||Age, Customized||Participants|Count of Participants|55|55.0||||||
4415754|NCT00209274|4239883|B3|18-75 years||Age, Customized||Participants|Count of Participants|198|198.0||||||
4415755|NCT00209274|4239884|B2|18-75 years||Age, Customized||Participants|Count of Participants|69|69.0||||||
4415756|NCT00209274|4239885|B1|18-75 years||Age, Customized||Participants|Count of Participants|129|129.0||||||
4415757|NCT00209274|4239883|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|12.8|12.8|||
4415758|NCT00209274|4239884|B2|||Age||years|Mean|65.7|65.7|Standard Deviation|12.9|12.9|||
4415759|NCT00209274|4239885|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|12.8|12.8|||
4415760|NCT00209170|4240204|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4415761|NCT00209170|4240205|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4415762|NCT00209170|4240206|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415763|NCT00209170|4240204|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4415764|NCT00209170|4240205|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4415765|NCT00209170|4240206|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4415766|NCT00209170|4240204|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415767|NCT00209170|4240205|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415768|NCT00209170|4240206|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415769|NCT00209170|4240204|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4415770|NCT00209170|4240205|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4415771|NCT00209170|4240206|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4415772|NCT00209170|4240204|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415773|NCT00209170|4240205|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415774|NCT00209170|4240206|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415775|NCT00209131|4240213|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4415776|NCT00209131|4240214|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4415777|NCT00209131|4240215|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4415778|NCT00209131|4240213|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4415779|NCT00209131|4240214|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4415780|NCT00209131|4240215|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4415781|NCT00209131|4240213|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4415782|NCT00209131|4240214|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4415783|NCT00209131|4240215|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4415784|NCT00209131|4240213|B3|||Age||years|Mean|54|54.0|Standard Deviation|5|5.0|||
4415785|NCT00209131|4240214|B2|||Age||years|Mean|53|53.0|Standard Deviation|5|5.0|||
4415786|NCT00209131|4240215|B1|||Age||years|Mean|55|55.0|Standard Deviation|5|5.0|||
4415787|NCT00209131|4240213|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415788|NCT00209131|4240214|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415789|NCT00209131|4240215|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415790|NCT00209131|4240213|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4415791|NCT00209131|4240214|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4415792|NCT00209131|4240215|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4415793|NCT00209131|4240213|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415794|NCT00209131|4240214|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415795|NCT00209131|4240215|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415796|NCT00209092|4240224|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4415797|NCT00209092|4240225|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4415798|NCT00209092|4240226|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4415799|NCT00209092|4240224|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415800|NCT00209092|4240225|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415801|NCT00209092|4240226|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415802|NCT00209092|4240224|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4415803|NCT00209092|4240225|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4415804|NCT00209092|4240226|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4415805|NCT00209092|4240224|B3|||Age, Customized||participants|Median|50.3|50.3|Full Range|||29.0|66.0|
4415806|NCT00209092|4240225|B2|||Age, Customized||participants|Median|49.8|49.8|Full Range|||29.0|66.0|
4415807|NCT00209092|4240226|B1|||Age, Customized||participants|Median|50.8|50.8|Full Range|||38.0|63.0|
4415808|NCT00209092|4240224|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4415809|NCT00209092|4240225|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4415810|NCT00209092|4240226|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415811|NCT00209092|4240224|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4415812|NCT00209092|4240225|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4415813|NCT00209092|4240226|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4415814|NCT00209092|4240224|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415815|NCT00209092|4240225|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415816|NCT00209092|4240226|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415817|NCT00209027|4240235|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4415818|NCT00209027|4240236|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4415819|NCT00209027|4240237|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4415820|NCT00209027|4240235|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4415821|NCT00209027|4240236|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4415822|NCT00209027|4240237|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4415823|NCT00209027|4240235|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415824|NCT00209027|4240236|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415825|NCT00209027|4240237|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415826|NCT00209027|4240235|B3|||Age||years|Mean|40.6|40.6|Standard Deviation|9.0|9.0|||
4415827|NCT00209027|4240236|B2|||Age||years|Mean|38.6|38.6|Standard Deviation|7.2|7.2|||
4415828|NCT00209027|4240237|B1|||Age||years|Mean|42.5|42.5|Standard Deviation|10.9|10.9|||
4415829|NCT00209027|4240235|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415830|NCT00209027|4240236|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415831|NCT00209027|4240237|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415832|NCT00209027|4240235|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4415833|NCT00209027|4240236|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4415834|NCT00209027|4240237|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4415835|NCT00209027|4240235|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415836|NCT00209027|4240236|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415837|NCT00209027|4240237|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415838|NCT00208975|4240244|B1|Chronic Lymphocytic Leukemia (CLL)||Diagnosis Type||Participants|Number|8|8.0||||||
4415839|NCT00208975|4240244|B1|Low Grade Non Hodgkin's Lymphoma(NHL)||Diagnosis Type||Participants|Number|7|7.0||||||
4415840|NCT00208975|4240244|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4415841|NCT00208975|4240244|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4415842|NCT00208975|4240244|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4415843|NCT00208975|4240244|B1|||Age||years|Median|62|62.0|Full Range|||45.0|81.0|
4415844|NCT00208975|4240244|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4415845|NCT00208975|4240244|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4415846|NCT00208975|4240244|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415847|NCT00208949|4240249|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4415848|NCT00208949|4240250|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4415849|NCT00208949|4240251|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4415850|NCT00208949|4240249|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4415851|NCT00208949|4240250|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4415852|NCT00208949|4240251|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4415853|NCT00208949|4240249|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4415854|NCT00208949|4240250|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4415855|NCT00208949|4240251|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4415856|NCT00208949|4240249|B3|||Age, Customized||years|Median|49|49.0|Full Range|||22.0|69.0|
4415857|NCT00208949|4240250|B2|||Age, Customized||years|Median|53|53.0|Full Range|||24.0|69.0|
4415858|NCT00208949|4240251|B1|||Age, Customized||years|Median|43|43.0|Full Range|||22.0|64.0|
4415859|NCT00208949|4240249|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4415860|NCT00208949|4240250|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4415861|NCT00208949|4240251|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4415862|NCT00208949|4240249|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4415863|NCT00208949|4240250|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4415864|NCT00208949|4240251|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4415865|NCT00208949|4240249|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415866|NCT00208949|4240250|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415867|NCT00208949|4240251|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415868|NCT00208767|4240260|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4415869|NCT00208767|4240261|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4415870|NCT00208767|4240262|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4415871|NCT00208767|4240260|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4415872|NCT00208767|4240261|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4415873|NCT00208767|4240262|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4415874|NCT00208767|4240260|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4415875|NCT00208767|4240261|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4415876|NCT00208767|4240262|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4415877|NCT00208767|4240260|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415878|NCT00208767|4240261|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415879|NCT00208767|4240262|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415880|NCT00208767|4240260|B3||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4415881|NCT00208767|4240261|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4415882|NCT00208767|4240262|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4415883|NCT00208767|4240260|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415884|NCT00208767|4240261|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415885|NCT00208767|4240262|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415886|NCT00208767|4240260|B3|||Age||years|Mean|60|60.0|Standard Deviation|9|9.0|||
4415887|NCT00208767|4240261|B2|||Age||years|Mean|62|62.0|Standard Deviation|9|9.0|||
4415888|NCT00208767|4240262|B1|||Age||years|Mean|59|59.0|Standard Deviation|9|9.0|||
4415889|NCT00208507|4240269|B3|United States||Region of Enrollment||participants|Number|264|264.0||||||
4415890|NCT00208507|4240270|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
4415891|NCT00208507|4240271|B1|United States||Region of Enrollment||participants|Number|177|177.0||||||
4415892|NCT00208507|4240269|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4415893|NCT00208507|4240270|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4415894|NCT00208507|4240271|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4415895|NCT00208507|4240269|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4415896|NCT00208507|4240270|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4415897|NCT00208507|4240271|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4415898|NCT00208507|4240269|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|10.5|10.5|||
4415899|NCT00208507|4240270|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|10.3|10.3|||
4415900|NCT00208507|4240271|B1|||Age||years|Mean|56.4|56.4|Standard Deviation|10.6|10.6|||
4415901|NCT00208494|4240278|B3|United States||Region of Enrollment||participants|Number|390|390.0||||||
4415902|NCT00208494|4240279|B2|United States||Region of Enrollment||participants|Number|196|196.0||||||
4415903|NCT00208494|4240280|B1|United States||Region of Enrollment||participants|Number|194|194.0||||||
4415904|NCT00208494|4240278|B3||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4415905|NCT00208494|4240279|B2||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4415906|NCT00208494|4240280|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4415907|NCT00208494|4240278|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4415908|NCT00208494|4240279|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4415909|NCT00208494|4240280|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4415910|NCT00208494|4240278|B3|Age||Age||Years|Mean|59|59.0|Standard Deviation|9.78|9.78|||
4415911|NCT00208494|4240279|B2|Age||Age||Years|Mean|59.1|59.1|Standard Deviation|9.5|9.5|||
4415912|NCT00208494|4240280|B1|Age||Age||Years|Mean|58.9|58.9|Standard Deviation|10.1|10.1|||
4415913|NCT00208325|4240287|B5|United Kingdom||Region of Enrollment||participants|Number|683|683.0||||||
4415914|NCT00208325|4240288|B4|United Kingdom||Region of Enrollment||participants|Number|161|161.0||||||
4415915|NCT00208325|4240289|B3|United Kingdom||Region of Enrollment||participants|Number|170|170.0||||||
4415916|NCT00208325|4240290|B2|United Kingdom||Region of Enrollment||participants|Number|176|176.0||||||
4415917|NCT00208325|4240291|B1|United Kingdom||Region of Enrollment||participants|Number|176|176.0||||||
4415918|NCT00208325|4240287|B5||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4415919|NCT00208325|4240288|B4||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4415920|NCT00208325|4240289|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4415921|NCT00208325|4240290|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4415922|NCT00208325|4240291|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4415923|NCT00208325|4240287|B5||Female|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4415924|NCT00208325|4240288|B4||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4415925|NCT00208325|4240289|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4415926|NCT00208325|4240290|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4415927|NCT00208325|4240291|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4415928|NCT00208325|4240287|B5|||Age||years|Mean|69.8|69.8|Standard Deviation|8.06|8.06|||
4415929|NCT00208325|4240288|B4|||Age||years|Mean|69.2|69.2|Standard Deviation|8.59|8.59|||
4415930|NCT00208325|4240289|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|7.88|7.88|||
4415931|NCT00208325|4240290|B2|||Age||years|Mean|70.2|70.2|Standard Deviation|7.60|7.6|||
4415932|NCT00208325|4240291|B1|||Age||years|Mean|69.8|69.8|Standard Deviation|8.16|8.16|||
4415933|NCT00208091|4240402|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4415934|NCT00208091|4240402|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4415935|NCT00208091|4240402|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4415936|NCT00208091|4240402|B1|||Age||years|Mean|49.375|49.375|Standard Deviation|13.93|13.93|||
4415937|NCT00208091|4240402|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4415938|NCT00208091|4240402|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4415939|NCT00208091|4240402|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4415940|NCT00208026|4240410|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4415941|NCT00208026|4240410|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4415942|NCT00208026|4240410|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4415943|NCT00208026|4240410|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415944|NCT00208026|4240410|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4415945|NCT00208026|4240410|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4415946|NCT00207883|4240414|B3|Patients for whom gender was recorded||Sex/Gender, Customized|Number of patients for whom gender was recorded.|Participants|Count of Participants|0|0.0||||||
4415947|NCT00207883|4240415|B2|Patients for whom gender was recorded||Sex/Gender, Customized|Number of patients for whom gender was recorded.|Participants|Count of Participants|0|0.0||||||
4415948|NCT00207883|4240416|B1|Patients for whom gender was recorded||Sex/Gender, Customized|Number of patients for whom gender was recorded.|Participants|Count of Participants|0|0.0||||||
4415949|NCT00207883|4240414|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415950|NCT00207883|4240415|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415951|NCT00207883|4240416|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4415952|NCT00207883|4240414|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4415953|NCT00207883|4240415|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4415954|NCT00207883|4240416|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4415955|NCT00207883|4240414|B3||<=18 years|Age||Participants|Count of Participants|212|212.0||||||
4415956|NCT00207883|4240415|B2||<=18 years|Age||Participants|Count of Participants|119|119.0||||||
4415957|NCT00207883|4240416|B1||<=18 years|Age||Participants|Count of Participants|93|93.0||||||
4415958|NCT00207740|4240425|B5||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4415959|NCT00207740|4240426|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4415960|NCT00207740|4240427|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4415961|NCT00207740|4240428|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4415962|NCT00207740|4240429|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4415963|NCT00207740|4240425|B5||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4415964|NCT00207740|4240426|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4415965|NCT00207740|4240427|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4415966|NCT00207740|4240428|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4415967|NCT00207740|4240429|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4415968|NCT00207740|4240425|B5|||Age||years|Mean|50.1|50.1|Standard Deviation|12.14|12.14|||
4415969|NCT00207740|4240426|B4|||Age||years|Mean|52.7|52.7|Standard Deviation|12.26|12.26|||
4415970|NCT00207740|4240427|B3|||Age||years|Mean|49.1|49.1|Standard Deviation|12.85|12.85|||
4415971|NCT00207740|4240428|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|11.26|11.26|||
4415972|NCT00207740|4240429|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|12.03|12.03|||
4415973|NCT00207727|4240473|B6||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4415974|NCT00207727|4240474|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4415975|NCT00207727|4240475|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4415976|NCT00207727|4240476|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4415977|NCT00207727|4240477|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4415978|NCT00207727|4240478|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4415979|NCT00207727|4240473|B6||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4415980|NCT00207727|4240474|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4415981|NCT00207727|4240475|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4415982|NCT00207727|4240476|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4415983|NCT00207727|4240477|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4415984|NCT00207727|4240478|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4415985|NCT00207727|4240473|B6|||Age||Years|Mean|39.0|39.0|Standard Deviation|10.46|10.46|||
4415986|NCT00207727|4240474|B5|||Age||Years|Mean|41.1|41.1|Standard Deviation|8.34|8.34|||
4415987|NCT00207727|4240475|B4|||Age||Years|Mean|39.8|39.8|Standard Deviation|11.01|11.01|||
4415988|NCT00207727|4240476|B3|||Age||Years|Mean|38.6|38.6|Standard Deviation|11.53|11.53|||
4415989|NCT00207727|4240477|B2|||Age||Years|Mean|39.0|39.0|Standard Deviation|10.34|10.34|||
4415990|NCT00207727|4240478|B1|||Age||Years|Mean|36.3|36.3|Standard Deviation|10.65|10.65|||
4415991|NCT00207714|4240504|B6||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4415992|NCT00207714|4240505|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4415993|NCT00207714|4240506|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4415994|NCT00207714|4240507|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4415995|NCT00207714|4240508|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4415996|NCT00207714|4240509|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4415997|NCT00207714|4240504|B6||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4415998|NCT00207714|4240505|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4415999|NCT00207714|4240506|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4416000|NCT00207714|4240507|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4416001|NCT00207714|4240508|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4416002|NCT00207714|4240509|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4416003|NCT00207714|4240504|B6|||Age||Years|Mean|54.2|54.2|Standard Deviation|12.6|12.6|||
4416004|NCT00207714|4240505|B5|||Age||Years|Mean|54.1|54.1|Standard Deviation|14.1|14.1|||
4416005|NCT00207714|4240506|B4|||Age||Years|Mean|56.3|56.3|Standard Deviation|12.1|12.1|||
4416006|NCT00207714|4240507|B3|||Age||Years|Mean|50.4|50.4|Standard Deviation|13.1|13.1|||
4416007|NCT00207714|4240508|B2|||Age||Years|Mean|56.1|56.1|Standard Deviation|10.5|10.5|||
4416008|NCT00207714|4240509|B1|||Age||Years|Mean|53.8|53.8|Standard Deviation|12.9|12.9|||
4416009|NCT00207142|4240532|B4|||Baseline HIV-1 RNA||log10c/mL|Median|4.95|4.95|Full Range|||3.51|5.88|
4416010|NCT00207142|4240533|B3|||Baseline HIV-1 RNA||log10c/mL|Median|5.46|5.46|Full Range|||3.74|5.88|
4416011|NCT00207142|4240534|B2|||Baseline HIV-1 RNA||log10c/mL|Median|4.86|4.86|Full Range|||3.58|5.88|
4416012|NCT00207142|4240535|B1|||Baseline HIV-1 RNA||log10c/mL|Median|4.85|4.85|Full Range|||3.51|5.88|
4416013|NCT00207142|4240532|B4|||Baseline CD4||cells/mm3|Median|245|245.0|Full Range|||2.0|876.0|
4416014|NCT00207142|4240533|B3|||Baseline CD4||cells/mm3|Median|227|227.0|Full Range|||2.0|876.0|
4416015|NCT00207142|4240534|B2|||Baseline CD4||cells/mm3|Median|265|265.0|Full Range|||64.0|490.0|
4416016|NCT00207142|4240535|B1|||Baseline CD4||cells/mm3|Median|255|255.0|Full Range|||50.0|660.0|
4416017|NCT00207142|4240532|B4|Hepatitis B/C negative||Hepatitis B or C||Participants|Number|193|193.0||||||
4416018|NCT00207142|4240533|B3|Hepatitis B/C negative||Hepatitis B or C||Participants|Number|57|57.0||||||
4416019|NCT00207142|4240534|B2|Hepatitis B/C negative||Hepatitis B or C||Participants|Number|65|65.0||||||
4416020|NCT00207142|4240535|B1|Hepatitis B/C negative||Hepatitis B or C||Participants|Number|71|71.0||||||
4416021|NCT00207142|4240532|B4|Hepatitis B/C positive||Hepatitis B or C||Participants|Number|59|59.0||||||
4416022|NCT00207142|4240533|B3|Hepatitis B/C positive||Hepatitis B or C||Participants|Number|23|23.0||||||
4416023|NCT00207142|4240534|B2|Hepatitis B/C positive||Hepatitis B or C||Participants|Number|20|20.0||||||
4416024|NCT00207142|4240535|B1|Hepatitis B/C positive||Hepatitis B or C||Participants|Number|16|16.0||||||
4416025|NCT00207142|4240532|B4|Russian Federation||Region of Enrollment||participants|Number|56|56.0||||||
4416026|NCT00207142|4240533|B3|Russian Federation||Region of Enrollment||participants|Number|20|20.0||||||
4416027|NCT00207142|4240534|B2|Russian Federation||Region of Enrollment||participants|Number|17|17.0||||||
4416028|NCT00207142|4240535|B1|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
4416029|NCT00207142|4240532|B4|Europe||Region of Enrollment||participants|Number|196|196.0||||||
4416030|NCT00207142|4240533|B3|Europe||Region of Enrollment||participants|Number|60|60.0||||||
4416031|NCT00207142|4240534|B2|Europe||Region of Enrollment||participants|Number|68|68.0||||||
4416032|NCT00207142|4240535|B1|Europe||Region of Enrollment||participants|Number|68|68.0||||||
4416033|NCT00207142|4240532|B4|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4416034|NCT00207142|4240533|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4416035|NCT00207142|4240534|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4416036|NCT00207142|4240535|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4416037|NCT00207142|4240532|B4|Black||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4416038|NCT00207142|4240533|B3|Black||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4416039|NCT00207142|4240534|B2|Black||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4416040|NCT00207142|4240535|B1|Black||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4416041|NCT00207142|4240532|B4|White||Race/Ethnicity, Customized||Participants|Number|209|209.0||||||
4416042|NCT00207142|4240533|B3|White||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
4416043|NCT00207142|4240534|B2|White||Race/Ethnicity, Customized||Participants|Number|70|70.0||||||
4416044|NCT00207142|4240535|B1|White||Race/Ethnicity, Customized||Participants|Number|73|73.0||||||
4416045|NCT00207142|4240532|B4||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4416046|NCT00207142|4240533|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4416047|NCT00207142|4240534|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4416048|NCT00207142|4240535|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4416049|NCT00207142|4240532|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4416050|NCT00207142|4240533|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4416051|NCT00207142|4240534|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4416052|NCT00207142|4240535|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4416053|NCT00207142|4240532|B4|||Age, Customized||years|Median|36|36.0|Full Range|||19.0|71.0|
4416054|NCT00207142|4240533|B3|||Age, Customized||years|Median|36|36.0|Full Range|||20.0|71.0|
4416055|NCT00207142|4240534|B2|||Age, Customized||years|Median|35|35.0|Full Range|||19.0|70.0|
4416056|NCT00207142|4240535|B1|||Age, Customized||years|Median|35|35.0|Full Range|||21.0|66.0|
4416057|NCT00207090|4240575|B1|||Weight continuous||kilogram|Mean|80.3|80.3|Standard Deviation|18.5|18.5|||
4416058|NCT00207090|4240575|B1|||Height continuous||centimeter|Mean|173.5|173.5|Standard Deviation|9.0|9.0|||
4416059|NCT00207090|4240575|B1|||Body surface area (BSA) continuous|BSA is the measured or calculated surface of a human body.|square meter|Mean|1.9|1.9|Standard Deviation|0.3|0.3|||
4416060|NCT00207090|4240575|B1|Not Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4416061|NCT00207090|4240575|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4416062|NCT00207090|4240575|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4416063|NCT00207090|4240575|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4416064|NCT00207090|4240575|B1|>=65 years||Age, Customized||participants|Number|8|8.0||||||
4416065|NCT00207090|4240575|B1|< 65 years||Age, Customized||participants|Number|7|7.0||||||
4416066|NCT00207090|4240575|B1|||Age||years|Mean|62|62.0|Standard Deviation|14|14.0|||
4416067|NCT00206726|4240604|B1|Missing||Rai Stage|Staging system for chronic lymphocytic leukemia (CLL) based on lymphocyte count and percent lymphocytes in bone marrow plus enlarged lymph nodes, or enlarged spleen or liver, or anemia, or thrombocytopenia|participants|Number|0|0.0||||||
4416068|NCT00206726|4240604|B1|3 to 4||Rai Stage|Staging system for chronic lymphocytic leukemia (CLL) based on lymphocyte count and percent lymphocytes in bone marrow plus enlarged lymph nodes, or enlarged spleen or liver, or anemia, or thrombocytopenia|participants|Number|33|33.0||||||
4416069|NCT00206726|4240604|B1|1 to 2||Rai Stage|Staging system for chronic lymphocytic leukemia (CLL) based on lymphocyte count and percent lymphocytes in bone marrow plus enlarged lymph nodes, or enlarged spleen or liver, or anemia, or thrombocytopenia|participants|Number|22|22.0||||||
4416070|NCT00206726|4240604|B1|0||Rai Stage|Staging system for chronic lymphocytic leukemia (CLL) based on lymphocyte count and percent lymphocytes in bone marrow plus enlarged lymph nodes, or enlarged spleen or liver, or anemia, or thrombocytopenia|participants|Number|5|5.0||||||
4416071|NCT00206726|4240604|B1|>10||Number of prior cancer therapies||Participants|Number|2|2.0||||||
4416072|NCT00206726|4240604|B1|5-10||Number of prior cancer therapies||Participants|Number|16|16.0||||||
4416073|NCT00206726|4240604|B1|4||Number of prior cancer therapies||Participants|Number|5|5.0||||||
4416074|NCT00206726|4240604|B1|3||Number of prior cancer therapies||Participants|Number|13|13.0||||||
4416075|NCT00206726|4240604|B1|2||Number of prior cancer therapies||Participants|Number|14|14.0||||||
4416076|NCT00206726|4240604|B1|1||Number of prior cancer therapies||Participants|Number|10|10.0||||||
4416077|NCT00206726|4240604|B1|missing||Lymph node size|Bidimensional measurement by palpation|participants|Number|5|5.0||||||
4416078|NCT00206726|4240604|B1|>= 5 cm||Lymph node size|Bidimensional measurement by palpation|participants|Number|12|12.0||||||
4416079|NCT00206726|4240604|B1|< 5 centimeters (cm)||Lymph node size|Bidimensional measurement by palpation|participants|Number|43|43.0||||||
4416080|NCT00206726|4240604|B1|>= 2mg/L||Beta 2-micro-globulin|Blood serum levels|Participants|Number|48|48.0||||||
4416081|NCT00206726|4240604|B1|< 2 milligrams per liter (mg/L) or missing||Beta 2-micro-globulin|Blood serum levels|Participants|Number|12|12.0||||||
4416082|NCT00206726|4240604|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4416083|NCT00206726|4240604|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4416084|NCT00206726|4240604|B1|||Age||years|Median|62|62.0|Full Range|||37.0|86.0|
4416085|NCT00206518|4240613|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4416086|NCT00206518|4240614|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4416087|NCT00206518|4240615|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4416088|NCT00206518|4240613|B3|Black||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4416089|NCT00206518|4240614|B2|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4416090|NCT00206518|4240615|B1|Black||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4416091|NCT00206518|4240613|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4416092|NCT00206518|4240614|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4416093|NCT00206518|4240615|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4416094|NCT00206518|4240613|B3|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4416095|NCT00206518|4240614|B2|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4416096|NCT00206518|4240615|B1|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4416097|NCT00206518|4240613|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416098|NCT00206518|4240614|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416099|NCT00206518|4240615|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416100|NCT00206518|4240613|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4416101|NCT00206518|4240614|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4416102|NCT00206518|4240615|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4416103|NCT00206518|4240613|B3|>50 years||Age, Customized||participants|Number|62|62.0||||||
4416104|NCT00206518|4240614|B2|>50 years||Age, Customized||participants|Number|35|35.0||||||
4416105|NCT00206518|4240615|B1|>50 years||Age, Customized||participants|Number|27|27.0||||||
4416106|NCT00206518|4240613|B3|<=50 years||Age, Customized||participants|Number|105|105.0||||||
4416107|NCT00206518|4240614|B2|<=50 years||Age, Customized||participants|Number|49|49.0||||||
4416108|NCT00206518|4240615|B1|<=50 years||Age, Customized||participants|Number|56|56.0||||||
4416109|NCT00206440|4240626|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416110|NCT00206440|4240627|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416111|NCT00206440|4240628|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416112|NCT00206440|4240626|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4416113|NCT00206440|4240627|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4416114|NCT00206440|4240628|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4416115|NCT00206440|4240626|B3|>=70 years||Age, Customized||participants|Number|2|2.0||||||
4416116|NCT00206440|4240627|B2|>=70 years||Age, Customized||participants|Number|2|2.0||||||
4416117|NCT00206440|4240628|B1|>=70 years||Age, Customized||participants|Number|0|0.0||||||
4416118|NCT00206440|4240626|B3|Between 60 and 69 years||Age, Customized||participants|Number|7|7.0||||||
4416119|NCT00206440|4240627|B2|Between 60 and 69 years||Age, Customized||participants|Number|3|3.0||||||
4416120|NCT00206440|4240628|B1|Between 60 and 69 years||Age, Customized||participants|Number|4|4.0||||||
4416121|NCT00206440|4240626|B3|Between 50 and 59 years||Age, Customized||participants|Number|19|19.0||||||
4416122|NCT00206440|4240627|B2|Between 50 and 59 years||Age, Customized||participants|Number|8|8.0||||||
4416123|NCT00206440|4240628|B1|Between 50 and 59 years||Age, Customized||participants|Number|11|11.0||||||
4416124|NCT00206440|4240626|B3|Between 40 and 49 years||Age, Customized||participants|Number|10|10.0||||||
4416125|NCT00206440|4240627|B2|Between 40 and 49 years||Age, Customized||participants|Number|6|6.0||||||
4416126|NCT00206440|4240628|B1|Between 40 and 49 years||Age, Customized||participants|Number|4|4.0||||||
4416127|NCT00206440|4240626|B3|<40 years||Age, Customized||participants|Number|5|5.0||||||
4416128|NCT00206440|4240627|B2|<40 years||Age, Customized||participants|Number|3|3.0||||||
4416129|NCT00206440|4240628|B1|<40 years||Age, Customized||participants|Number|2|2.0||||||
4416130|NCT00206427|4240635|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416131|NCT00206427|4240635|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4416132|NCT00206427|4240635|B1|||Age||years|Median|53|53.0|Full Range|||27.0|83.0|
4416133|NCT00206336|4240639|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4416134|NCT00206336|4240639|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4416135|NCT00206336|4240639|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4416136|NCT00206336|4240639|B1|||Age||years|Mean|16.5|16.5|Standard Deviation|9.89|9.89|||
4416137|NCT00206336|4240639|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416138|NCT00206336|4240639|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4416139|NCT00206336|4240639|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4416140|NCT00206323|4240643|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4416141|NCT00206323|4240644|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4416142|NCT00206323|4240645|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4416143|NCT00206323|4240643|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4416144|NCT00206323|4240644|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4416145|NCT00206323|4240645|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4416146|NCT00206323|4240643|B3|||Age|Age 7-65 with DSM-IV criteria for Tourette Syndrome to be enrolled in study.|years|Mean|16.5|16.5|Standard Deviation|9.89|9.89|||
4416147|NCT00206323|4240644|B2|||Age|Age 7-65 with DSM-IV criteria for Tourette Syndrome to be enrolled in study.|years|Mean|18.8|18.8|Standard Deviation|10.93|10.93|||
4416148|NCT00206323|4240645|B1|||Age|Age 7-65 with DSM-IV criteria for Tourette Syndrome to be enrolled in study.|years|Mean|14.1|14.1|Standard Deviation|8.35|8.35|||
4416149|NCT00206323|4240643|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416150|NCT00206323|4240644|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416151|NCT00206323|4240645|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416152|NCT00206323|4240643|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4416153|NCT00206323|4240644|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4416154|NCT00206323|4240645|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4416155|NCT00206323|4240643|B3||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
4416156|NCT00206323|4240644|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4416157|NCT00206323|4240645|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4416158|NCT00206102|4240652|B3||Male|Sex: Female, Male|Participants in the United States (USA) randomized by the study's Interactive Voice Response System (IVRS).|Participants|Count of Participants|646|646.0||||||
4416159|NCT00206102|4240653|B2||Male|Sex: Female, Male|Participants in the United States (USA) randomized by the study's Interactive Voice Response System (IVRS).|Participants|Count of Participants|303|303.0||||||
4416160|NCT00206102|4240654|B1||Male|Sex: Female, Male|Participants in the United States (USA) randomized by the study's Interactive Voice Response System (IVRS).|Participants|Count of Participants|343|343.0||||||
4416161|NCT00206102|4240652|B3||Female|Sex: Female, Male|Participants in the United States (USA) randomized by the study's Interactive Voice Response System (IVRS).|Participants|Count of Participants|452|452.0||||||
4416162|NCT00206102|4240653|B2||Female|Sex: Female, Male|Participants in the United States (USA) randomized by the study's Interactive Voice Response System (IVRS).|Participants|Count of Participants|199|199.0||||||
4416163|NCT00206102|4240654|B1||Female|Sex: Female, Male|Participants in the United States (USA) randomized by the study's Interactive Voice Response System (IVRS).|Participants|Count of Participants|253|253.0||||||
4416164|NCT00206102|4240652|B3|40 to 65 years||Age, Customized||Participants|Number|610|610.0||||||
4416165|NCT00206102|4240653|B2|40 to 65 years||Age, Customized||Participants|Number|279|279.0||||||
4416166|NCT00206102|4240654|B1|40 to 65 years||Age, Customized||Participants|Number|331|331.0||||||
4416167|NCT00206102|4240652|B3|< 40 years||Age, Customized||Participants|Number|488|488.0||||||
4416168|NCT00206102|4240653|B2|< 40 years||Age, Customized||Participants|Number|223|223.0||||||
4416169|NCT00206102|4240654|B1|< 40 years||Age, Customized||Participants|Number|265|265.0||||||
4416170|NCT00206076|4240689|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4416171|NCT00206076|4240690|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4416172|NCT00206076|4240691|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4416173|NCT00206076|4240689|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4416174|NCT00206076|4240690|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4416175|NCT00206076|4240691|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4416176|NCT00206076|4240689|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4416177|NCT00206076|4240690|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4416178|NCT00206076|4240691|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4416179|NCT00206076|4240689|B3|||Age||years|Mean|55.32|55.32|Standard Deviation|7.67|7.67|||
4416180|NCT00206076|4240690|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|7.26|7.26|||
4416181|NCT00206076|4240691|B1|||Age||years|Mean|56.11|56.11|Standard Deviation|8.46|8.46|||
4416182|NCT00206076|4240689|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4416183|NCT00206076|4240690|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416184|NCT00206076|4240691|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4416185|NCT00206076|4240689|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4416186|NCT00206076|4240690|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4416187|NCT00206076|4240691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4416188|NCT00206076|4240689|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416189|NCT00206076|4240690|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416190|NCT00206076|4240691|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416191|NCT00205881|4240702|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4416192|NCT00205881|4240702|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4416193|NCT00205881|4240702|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4416194|NCT00205881|4240702|B1|||Age||years|Mean|52.6|52.6|Standard Deviation|12.56|12.56|||
4416195|NCT00205881|4240702|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4416196|NCT00205881|4240702|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4416197|NCT00205881|4240702|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416198|NCT00205855|4240707|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4416199|NCT00205855|4240707|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4416200|NCT00205855|4240707|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4416201|NCT00205855|4240707|B1|||Age||years|Mean|52|52.0|Standard Deviation|14|14.0|||
4416202|NCT00205855|4240707|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4416203|NCT00205855|4240707|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4416204|NCT00205855|4240707|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416205|NCT00205803|4240711|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4416206|NCT00205803|4240712|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4416207|NCT00205803|4240713|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4416208|NCT00205803|4240711|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4416209|NCT00205803|4240712|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4416210|NCT00205803|4240713|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4416211|NCT00205803|4240711|B3|||Age||weeks|Mean|9.2|9.2|Standard Deviation|1.3|1.3|||
4416212|NCT00205803|4240712|B2|||Age||weeks|Mean|9.1|9.1|Standard Deviation|1.2|1.2|||
4416213|NCT00205803|4240713|B1|||Age||weeks|Mean|9.2|9.2|Standard Deviation|1.4|1.4|||
4416214|NCT00205777|4240766|B5|||Height|Height (cm) was measured 3 times using standardized Harpenden stadiometer (height based on the middle stadiometer reading was recorded). Number of participants analyzed (N) = 1883, 1869, 1848, 1883 for each arm group.|centimeter (cm)|Mean|156.40|156.4|Standard Deviation|7.18|7.18|||
4416215|NCT00205777|4240767|B4|||Height|Height (cm) was measured 3 times using standardized Harpenden stadiometer (height based on the middle stadiometer reading was recorded). Number of participants analyzed (N) = 1883, 1869, 1848, 1883 for each arm group.|centimeter (cm)|Mean|156.35|156.35|Standard Deviation|6.90|6.9|||
4416216|NCT00205777|4240768|B3|||Height|Height (cm) was measured 3 times using standardized Harpenden stadiometer (height based on the middle stadiometer reading was recorded). Number of participants analyzed (N) = 1883, 1869, 1848, 1883 for each arm group.|centimeter (cm)|Mean|156.37|156.37|Standard Deviation|7.23|7.23|||
4416217|NCT00205777|4240769|B2|||Height|Height (cm) was measured 3 times using standardized Harpenden stadiometer (height based on the middle stadiometer reading was recorded). Number of participants analyzed (N) = 1883, 1869, 1848, 1883 for each arm group.|centimeter (cm)|Mean|156.28|156.28|Standard Deviation|7.38|7.38|||
4416218|NCT00205777|4240770|B1|||Height|Height (cm) was measured 3 times using standardized Harpenden stadiometer (height based on the middle stadiometer reading was recorded). Number of participants analyzed (N) = 1883, 1869, 1848, 1883 for each arm group.|centimeter (cm)|Mean|156.60|156.6|Standard Deviation|7.21|7.21|||
4416219|NCT00205777|4240766|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416220|NCT00205777|4240767|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416221|NCT00205777|4240768|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416222|NCT00205777|4240769|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416223|NCT00205777|4240770|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416224|NCT00205777|4240766|B5||Female|Sex: Female, Male||Participants|Count of Participants|7492|7492.0||||||
4416225|NCT00205777|4240767|B4||Female|Sex: Female, Male||Participants|Count of Participants|1885|1885.0||||||
4416226|NCT00205777|4240768|B3||Female|Sex: Female, Male||Participants|Count of Participants|1849|1849.0||||||
4416227|NCT00205777|4240769|B2||Female|Sex: Female, Male||Participants|Count of Participants|1872|1872.0||||||
4416228|NCT00205777|4240770|B1||Female|Sex: Female, Male||Participants|Count of Participants|1886|1886.0||||||
4416229|NCT00205777|4240766|B5|||Age||years|Mean|66.38|66.38|Standard Deviation|6.71|6.71|||
4416230|NCT00205777|4240767|B4|||Age||years|Mean|66.47|66.47|Standard Deviation|6.76|6.76|||
4416231|NCT00205777|4240768|B3|||Age||years|Mean|66.36|66.36|Standard Deviation|6.74|6.74|||
4416232|NCT00205777|4240769|B2|||Age||years|Mean|66.22|66.22|Standard Deviation|6.80|6.8|||
4416233|NCT00205777|4240770|B1|||Age||years|Mean|66.48|66.48|Standard Deviation|6.53|6.53|||
4416234|NCT00205712|4240982|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4416235|NCT00205712|4240983|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4416236|NCT00205712|4240984|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4416237|NCT00205712|4240982|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4416238|NCT00205712|4240983|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4416239|NCT00205712|4240984|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4416240|NCT00205712|4240982|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4416241|NCT00205712|4240983|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4416242|NCT00205712|4240984|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4416243|NCT00205712|4240982|B3|||Age||years|Mean|11|11.0|Standard Deviation|2.3|2.3|||
4416244|NCT00205712|4240983|B2|||Age||years|Mean|10.9|10.9|Standard Deviation|2.4|2.4|||
4416245|NCT00205712|4240984|B1|||Age||years|Mean|11.2|11.2|Standard Deviation|2.2|2.2|||
4416246|NCT00205712|4240982|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416247|NCT00205712|4240983|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416248|NCT00205712|4240984|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416249|NCT00205712|4240982|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4416250|NCT00205712|4240983|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4416251|NCT00205712|4240984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4416252|NCT00205712|4240982|B3||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4416253|NCT00205712|4240983|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4416254|NCT00205712|4240984|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4416255|NCT00205699|4240995|B4|||Hemoglobin A1c||%|Mean|5.52|5.52|Standard Deviation|0.29|0.29|||
4416256|NCT00205699|4240996|B3|||Hemoglobin A1c||%|Mean|5.54|5.54|Standard Deviation|0.28|0.28|||
4416257|NCT00205699|4240997|B2|||Hemoglobin A1c||%|Mean|5.54|5.54|Standard Deviation|0.34|0.34|||
4416258|NCT00205699|4240998|B1|||Hemoglobin A1c||%|Mean|5.46|5.46|Standard Deviation|0.26|0.26|||
4416259|NCT00205699|4240995|B4|||Fasting Insulin||uU/mL|Mean|7.65|7.65|Standard Deviation|6.50|6.5|||
4416260|NCT00205699|4240996|B3|||Fasting Insulin||uU/mL|Mean|9.00|9.0|Standard Deviation|8.68|8.68|||
4416261|NCT00205699|4240997|B2|||Fasting Insulin||uU/mL|Mean|6.24|6.24|Standard Deviation|3.74|3.74|||
4416262|NCT00205699|4240998|B1|||Fasting Insulin||uU/mL|Mean|7.64|7.64|Standard Deviation|5.85|5.85|||
4416263|NCT00205699|4240995|B4|||High Sensitivity c-Reactive Protein (HS-CRP)||mg/L|Mean|1.37|1.37|Standard Deviation|2.62|2.62|||
4416264|NCT00205699|4240996|B3|||High Sensitivity c-Reactive Protein (HS-CRP)||mg/L|Mean|1.12|1.12|Standard Deviation|1.53|1.53|||
4416265|NCT00205699|4240997|B2|||High Sensitivity c-Reactive Protein (HS-CRP)||mg/L|Mean|1.37|1.37|Standard Deviation|3.04|3.04|||
4416266|NCT00205699|4240998|B1|||High Sensitivity c-Reactive Protein (HS-CRP)||mg/L|Mean|1.61|1.61|Standard Deviation|3.04|3.04|||
4416267|NCT00205699|4240995|B4|Total Protein||Baseline fasting laboratory values (g/dL)||g/dL|Mean|6.94|6.94|Standard Deviation|0.40|0.4|||
4416268|NCT00205699|4240996|B3|Total Protein||Baseline fasting laboratory values (g/dL)||g/dL|Mean|6.95|6.95|Standard Deviation|0.34|0.34|||
4416269|NCT00205699|4240997|B2|Total Protein||Baseline fasting laboratory values (g/dL)||g/dL|Mean|6.90|6.9|Standard Deviation|0.39|0.39|||
4416270|NCT00205699|4240998|B1|Total Protein||Baseline fasting laboratory values (g/dL)||g/dL|Mean|6.95|6.95|Standard Deviation|0.46|0.46|||
4416271|NCT00205699|4240995|B4|Albumin||Baseline fasting laboratory values (g/dL)||g/dL|Mean|4.05|4.05|Standard Deviation|0.25|0.25|||
4416272|NCT00205699|4240996|B3|Albumin||Baseline fasting laboratory values (g/dL)||g/dL|Mean|4.05|4.05|Standard Deviation|0.25|0.25|||
4416273|NCT00205699|4240997|B2|Albumin||Baseline fasting laboratory values (g/dL)||g/dL|Mean|4.06|4.06|Standard Deviation|0.27|0.27|||
4416274|NCT00205699|4240998|B1|Albumin||Baseline fasting laboratory values (g/dL)||g/dL|Mean|4.02|4.02|Standard Deviation|0.25|0.25|||
4416275|NCT00205699|4240995|B4|Alkaline Phosphatase||Baseline Fasting Laboratory Values (IU/L)||IU/L|Mean|212.56|212.56|Standard Deviation|83.19|83.19|||
4416276|NCT00205699|4240996|B3|Alkaline Phosphatase||Baseline Fasting Laboratory Values (IU/L)||IU/L|Mean|206.41|206.41|Standard Deviation|85.35|85.35|||
4416277|NCT00205699|4240997|B2|Alkaline Phosphatase||Baseline Fasting Laboratory Values (IU/L)||IU/L|Mean|222.54|222.54|Standard Deviation|75.69|75.69|||
4416278|NCT00205699|4240998|B1|Alkaline Phosphatase||Baseline Fasting Laboratory Values (IU/L)||IU/L|Mean|209.33|209.33|Standard Deviation|88.42|88.42|||
4416279|NCT00205699|4240995|B4|Aspartate aminostransferase (AST)||Baseline Fasting Laboratory Values (IU/L)||IU/L|Mean|24.31|24.31|Standard Deviation|6.72|6.72|||
4416280|NCT00205699|4240996|B3|Aspartate aminostransferase (AST)||Baseline Fasting Laboratory Values (IU/L)||IU/L|Mean|23.94|23.94|Standard Deviation|6.78|6.78|||
4416281|NCT00205699|4240997|B2|Aspartate aminostransferase (AST)||Baseline Fasting Laboratory Values (IU/L)||IU/L|Mean|23.26|23.26|Standard Deviation|6.12|6.12|||
4416282|NCT00205699|4240998|B1|Aspartate aminostransferase (AST)||Baseline Fasting Laboratory Values (IU/L)||IU/L|Mean|25.65|25.65|Standard Deviation|7.10|7.1|||
4416283|NCT00205699|4240995|B4|Alanine aminotransferase (ALT)||Baseline Fasting Laboratory Values (IU/L)||IU/L|Mean|15.86|15.86|Standard Deviation|5.96|5.96|||
4416284|NCT00205699|4240996|B3|Alanine aminotransferase (ALT)||Baseline Fasting Laboratory Values (IU/L)||IU/L|Mean|15.53|15.53|Standard Deviation|4.49|4.49|||
4416285|NCT00205699|4240997|B2|Alanine aminotransferase (ALT)||Baseline Fasting Laboratory Values (IU/L)||IU/L|Mean|13.83|13.83|Standard Deviation|4.20|4.2|||
4416286|NCT00205699|4240998|B1|Alanine aminotransferase (ALT)||Baseline Fasting Laboratory Values (IU/L)||IU/L|Mean|18.10|18.1|Standard Deviation|7.74|7.74|||
4416287|NCT00205699|4240995|B4|Total Bilirubin||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|0.37|0.37|Standard Deviation|0.21|0.21|||
4416288|NCT00205699|4240996|B3|Total Bilirubin||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|0.33|0.33|Standard Deviation|0.18|0.18|||
4416289|NCT00205699|4240997|B2|Total Bilirubin||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|0.40|0.4|Standard Deviation|0.18|0.18|||
4416290|NCT00205699|4240998|B1|Total Bilirubin||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|0.37|0.37|Standard Deviation|0.25|0.25|||
4416291|NCT00205699|4240995|B4|LDL Cholesterol||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|74.84|74.84|Standard Deviation|25.40|25.4|||
4416292|NCT00205699|4240996|B3|LDL Cholesterol||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|72.82|72.82|Standard Deviation|26.00|26.0|||
4416293|NCT00205699|4240997|B2|LDL Cholesterol||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|72.00|72.0|Standard Deviation|24.56|24.56|||
4416294|NCT00205699|4240998|B1|LDL Cholesterol||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|79.53|79.53|Standard Deviation|25.41|25.41|||
4416295|NCT00205699|4240995|B4|Triglycerides||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|57.78|57.78|Standard Deviation|29.69|29.69|||
4416296|NCT00205699|4240996|B3|Triglycerides||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|52.16|52.16|Standard Deviation|23.13|23.13|||
4416297|NCT00205699|4240997|B2|Triglycerides||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|60.98|60.98|Standard Deviation|31.89|31.89|||
4416298|NCT00205699|4240998|B1|Triglycerides||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|60.40|60.4|Standard Deviation|33.00|33.0|||
4416299|NCT00205699|4240995|B4|Total Cholesterol||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|139.14|139.14|Standard Deviation|27.71|27.71|||
4416300|NCT00205699|4240996|B3|Total Cholesterol||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|135.45|135.45|Standard Deviation|28.34|28.34|||
4416301|NCT00205699|4240997|B2|Total Cholesterol||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|137.09|137.09|Standard Deviation|25.31|25.31|||
4416302|NCT00205699|4240998|B1|Total Cholesterol||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|144.74|144.74|Standard Deviation|28.88|28.88|||
4416303|NCT00205699|4240995|B4|Fasting Glucose||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|88.56|88.56|Standard Deviation|7.27|7.27|||
4416304|NCT00205699|4240996|B3|Fasting Glucose||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|88.98|88.98|Standard Deviation|6.16|6.16|||
4416305|NCT00205699|4240997|B2|Fasting Glucose||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|87.48|87.48|Standard Deviation|6.55|6.55|||
4416306|NCT00205699|4240998|B1|Fasting Glucose||Baseline fasting laboratory values (mg/dL)||mg/dL|Mean|89.14|89.14|Standard Deviation|8.81|8.81|||
4416307|NCT00205699|4240995|B4|||Body Mass index z-score||z-score|Mean|0.45|0.45|Standard Deviation|1.12|1.12|||
4416308|NCT00205699|4240996|B3|||Body Mass index z-score||z-score|Mean|0.55|0.55|Standard Deviation|1.13|1.13|||
4416309|NCT00205699|4240997|B2|||Body Mass index z-score||z-score|Mean|0.30|0.3|Standard Deviation|1.11|1.11|||
4416310|NCT00205699|4240998|B1|||Body Mass index z-score||z-score|Mean|0.49|0.49|Standard Deviation|1.12|1.12|||
4416311|NCT00205699|4240995|B4|||Body Mass Index Percentile||percentile|Mean|61.25|61.25|Standard Deviation|30.22|30.22|||
4416312|NCT00205699|4240996|B3|||Body Mass Index Percentile||percentile|Mean|63.05|63.05|Standard Deviation|30.12|30.12|||
4416313|NCT00205699|4240997|B2|||Body Mass Index Percentile||percentile|Mean|58.38|58.38|Standard Deviation|31.33|31.33|||
4416314|NCT00205699|4240998|B1|||Body Mass Index Percentile||percentile|Mean|62.13|62.13|Standard Deviation|29.70|29.7|||
4416315|NCT00205699|4240995|B4|||Waist Circumference||centimeters|Mean|68.09|68.09|Standard Deviation|13.50|13.5|||
4416316|NCT00205699|4240996|B3|||Waist Circumference||centimeters|Mean|69.54|69.54|Standard Deviation|15.50|15.5|||
4416317|NCT00205699|4240997|B2|||Waist Circumference||centimeters|Mean|65.87|65.87|Standard Deviation|11.03|11.03|||
4416318|NCT00205699|4240998|B1|||Waist Circumference||centimeters|Mean|68.72|68.72|Standard Deviation|13.47|13.47|||
4416319|NCT00205699|4240995|B4|||Body Weight||kilograms|Mean|45.28|45.28|Standard Deviation|19.34|19.34|||
4416320|NCT00205699|4240996|B3|||Body Weight||kilograms|Mean|47.94|47.94|Standard Deviation|23.57|23.57|||
4416321|NCT00205699|4240997|B2|||Body Weight||kilograms|Mean|42.23|42.23|Standard Deviation|13.81|13.81|||
4416322|NCT00205699|4240998|B1|||Body Weight||kilograms|Mean|45.49|45.49|Standard Deviation|19.08|19.08|||
4416323|NCT00205699|4240995|B4|MRI Total Fat||MRI-measured abdominal fat||cm squared|Mean|131.56|131.56|Standard Deviation|115.76|115.76|||
4416324|NCT00205699|4240996|B3|MRI Total Fat||MRI-measured abdominal fat||cm squared|Mean|137.85|137.85|Standard Deviation|116.24|116.24|||
4416325|NCT00205699|4240997|B2|MRI Total Fat||MRI-measured abdominal fat||cm squared|Mean|106.09|106.09|Standard Deviation|82.28|82.28|||
4416326|NCT00205699|4240998|B1|MRI Total Fat||MRI-measured abdominal fat||cm squared|Mean|147.17|147.17|Standard Deviation|137.36|137.36|||
4416327|NCT00205699|4240995|B4|MRI Visceral Fat||MRI-measured abdominal fat||cm squared|Mean|24.11|24.11|Standard Deviation|20.96|20.96|||
4416328|NCT00205699|4240996|B3|MRI Visceral Fat||MRI-measured abdominal fat||cm squared|Mean|26.70|26.7|Standard Deviation|24.14|24.14|||
4416329|NCT00205699|4240997|B2|MRI Visceral Fat||MRI-measured abdominal fat||cm squared|Mean|19.37|19.37|Standard Deviation|19.74|19.74|||
4416330|NCT00205699|4240998|B1|MRI Visceral Fat||MRI-measured abdominal fat||cm squared|Mean|25.79|25.79|Standard Deviation|18.45|18.45|||
4416331|NCT00205699|4240995|B4|MRI Subcutaneous Fat||MRI-measured abdominal fat||cm squared|Mean|107.23|107.23|Standard Deviation|98.53|98.53|||
4416332|NCT00205699|4240996|B3|MRI Subcutaneous Fat||MRI-measured abdominal fat||cm squared|Mean|111.16|111.16|Standard Deviation|94.16|94.16|||
4416333|NCT00205699|4240997|B2|MRI Subcutaneous Fat||MRI-measured abdominal fat||cm squared|Mean|86.17|86.17|Standard Deviation|65.10|65.1|||
4416334|NCT00205699|4240998|B1|MRI Subcutaneous Fat||MRI-measured abdominal fat||cm squared|Mean|121.38|121.38|Standard Deviation|123.05|123.05|||
4416335|NCT00205699|4240995|B4|Whole Body Sensitivity||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|12.80|12.8|Standard Deviation|5.44|5.44|||
4416336|NCT00205699|4240996|B3|Whole Body Sensitivity||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|12.87|12.87|Standard Deviation|6.36|6.36|||
4416337|NCT00205699|4240997|B2|Whole Body Sensitivity||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|12.53|12.53|Standard Deviation|4.47|4.47|||
4416338|NCT00205699|4240998|B1|Whole Body Sensitivity||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|12.96|12.96|Standard Deviation|5.33|5.33|||
4416339|NCT00205699|4240995|B4|% Change in Glycerol Rate of Appearance||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|53.89|53.89|Standard Deviation|14.59|14.59|||
4416340|NCT00205699|4240996|B3|% Change in Glycerol Rate of Appearance||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|50.46|50.46|Standard Deviation|15.04|15.04|||
4416341|NCT00205699|4240997|B2|% Change in Glycerol Rate of Appearance||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|55.94|55.94|Standard Deviation|15.08|15.08|||
4416342|NCT00205699|4240998|B1|% Change in Glycerol Rate of Appearance||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|55.59|55.59|Standard Deviation|13.42|13.42|||
4416343|NCT00205699|4240995|B4|% Change in Glucose Rate of Appearance||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|82.83|82.83|Standard Deviation|11.01|11.01|||
4416344|NCT00205699|4240996|B3|% Change in Glucose Rate of Appearance||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|82.70|82.7|Standard Deviation|12.15|12.15|||
4416345|NCT00205699|4240997|B2|% Change in Glucose Rate of Appearance||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|82.53|82.53|Standard Deviation|9.90|9.9|||
4416346|NCT00205699|4240998|B1|% Change in Glucose Rate of Appearance||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|83.19|83.19|Standard Deviation|10.94|10.94|||
4416347|NCT00205699|4240995|B4|% Change in Glucose Rate of Disappearance||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|163.56|163.56|Standard Deviation|80.06|80.06|||
4416348|NCT00205699|4240996|B3|% Change in Glucose Rate of Disappearance||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|156.49|156.49|Standard Deviation|81.14|81.14|||
4416349|NCT00205699|4240997|B2|% Change in Glucose Rate of Disappearance||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|168.75|168.75|Standard Deviation|82.09|82.09|||
4416350|NCT00205699|4240998|B1|% Change in Glucose Rate of Disappearance||Baseline Insulin Stimulated % Change in Isotopomer Measurement during Week 0 Clamp||% change during baseline clamp|Mean|166.26|166.26|Standard Deviation|78.79|78.79|||
4416351|NCT00205699|4240995|B4|DEXA Total Lean kg||DEXA-measured body composition (kg)||kilograms|Mean|30.58|30.58|Standard Deviation|12.04|12.04|||
4416352|NCT00205699|4240996|B3|DEXA Total Lean kg||DEXA-measured body composition (kg)||kilograms|Mean|31.98|31.98|Standard Deviation|14.69|14.69|||
4416353|NCT00205699|4240997|B2|DEXA Total Lean kg||DEXA-measured body composition (kg)||kilograms|Mean|29.30|29.3|Standard Deviation|9.83|9.83|||
4416354|NCT00205699|4240998|B1|DEXA Total Lean kg||DEXA-measured body composition (kg)||kilograms|Mean|30.38|30.38|Standard Deviation|11.01|11.01|||
4416355|NCT00205699|4240995|B4|DEXA Total Fat kg||DEXA-measured body composition (kg)||kilograms|Mean|12.10|12.1|Standard Deviation|9.07|9.07|||
4416356|NCT00205699|4240996|B3|DEXA Total Fat kg||DEXA-measured body composition (kg)||kilograms|Mean|13.24|13.24|Standard Deviation|10.40|10.4|||
4416357|NCT00205699|4240997|B2|DEXA Total Fat kg||DEXA-measured body composition (kg)||kilograms|Mean|10.46|10.46|Standard Deviation|6.68|6.68|||
4416358|NCT00205699|4240998|B1|DEXA Total Fat kg||DEXA-measured body composition (kg)||kilograms|Mean|12.50|12.5|Standard Deviation|9.53|9.53|||
4416359|NCT00205699|4240995|B4|DEXA Total % Lean||DEXA-measured body composition (%)||percentage of body composition|Mean|70.84|70.84|Standard Deviation|10.25|10.25|||
4416360|NCT00205699|4240996|B3|DEXA Total % Lean||DEXA-measured body composition (%)||percentage of body composition|Mean|70.32|70.32|Standard Deviation|10.53|10.53|||
4416361|NCT00205699|4240997|B2|DEXA Total % Lean||DEXA-measured body composition (%)||percentage of body composition|Mean|71.96|71.96|Standard Deviation|9.96|9.96|||
4416362|NCT00205699|4240998|B1|DEXA Total % Lean||DEXA-measured body composition (%)||percentage of body composition|Mean|70.30|70.3|Standard Deviation|10.35|10.35|||
4416363|NCT00205699|4240995|B4|DEXA Total % Fat||DEXA-measured body composition (%)||percentage of body composition|Mean|25.68|25.68|Standard Deviation|10.52|10.52|||
4416364|NCT00205699|4240996|B3|DEXA Total % Fat||DEXA-measured body composition (%)||percentage of body composition|Mean|26.23|26.23|Standard Deviation|10.83|10.83|||
4416365|NCT00205699|4240997|B2|DEXA Total % Fat||DEXA-measured body composition (%)||percentage of body composition|Mean|24.48|24.48|Standard Deviation|10.19|10.19|||
4416366|NCT00205699|4240998|B1|DEXA Total % Fat||DEXA-measured body composition (%)||percentage of body composition|Mean|26.25|26.25|Standard Deviation|10.64|10.64|||
4416367|NCT00205699|4240995|B4|No||On Selective Serotonin Reuptake Inhibitors (SSRI)||participants|Number|127|127.0||||||
4416368|NCT00205699|4240996|B3|No||On Selective Serotonin Reuptake Inhibitors (SSRI)||participants|Number|45|45.0||||||
4416369|NCT00205699|4240997|B2|No||On Selective Serotonin Reuptake Inhibitors (SSRI)||participants|Number|41|41.0||||||
4416370|NCT00205699|4240998|B1|No||On Selective Serotonin Reuptake Inhibitors (SSRI)||participants|Number|41|41.0||||||
4416371|NCT00205699|4240995|B4|Yes||On Selective Serotonin Reuptake Inhibitors (SSRI)||participants|Number|17|17.0||||||
4416372|NCT00205699|4240996|B3|Yes||On Selective Serotonin Reuptake Inhibitors (SSRI)||participants|Number|4|4.0||||||
4416373|NCT00205699|4240997|B2|Yes||On Selective Serotonin Reuptake Inhibitors (SSRI)||participants|Number|5|5.0||||||
4416374|NCT00205699|4240998|B1|Yes||On Selective Serotonin Reuptake Inhibitors (SSRI)||participants|Number|8|8.0||||||
4416375|NCT00205699|4240995|B4|No||On stimulant||participants|Number|72|72.0||||||
4416376|NCT00205699|4240996|B3|No||On stimulant||participants|Number|27|27.0||||||
4416377|NCT00205699|4240997|B2|No||On stimulant||participants|Number|25|25.0||||||
4416378|NCT00205699|4240998|B1|No||On stimulant||participants|Number|20|20.0||||||
4416379|NCT00205699|4240995|B4|Yes||On stimulant||participants|Number|72|72.0||||||
4416380|NCT00205699|4240996|B3|Yes||On stimulant||participants|Number|22|22.0||||||
4416381|NCT00205699|4240997|B2|Yes||On stimulant||participants|Number|21|21.0||||||
4416382|NCT00205699|4240998|B1|Yes||On stimulant||participants|Number|29|29.0||||||
4416383|NCT00205699|4240995|B4|||Number of Suspensions||number of discrete school suspensions|Mean|2.72|2.72|Standard Deviation|4.07|4.07|||
4416384|NCT00205699|4240996|B3|||Number of Suspensions||number of discrete school suspensions|Mean|2.85|2.85|Standard Deviation|4.18|4.18|||
4416385|NCT00205699|4240997|B2|||Number of Suspensions||number of discrete school suspensions|Mean|2.71|2.71|Standard Deviation|3.98|3.98|||
4416386|NCT00205699|4240998|B1|||Number of Suspensions||number of discrete school suspensions|Mean|2.60|2.6|Standard Deviation|4.11|4.11|||
4416387|NCT00205699|4240995|B4|||Clinical Global Assessment of Functioning|This instrument is a global measure of severity based on psychiatric symptomatology and impairment of adaptation in family, social, school, and work areas. On this scale 0 is worst, 100 is best, and ≤ 60 is definite clinical impairment.|units on a scale|Mean|51.10|51.1|Standard Deviation|5.31|5.31|||
4416388|NCT00205699|4240996|B3|||Clinical Global Assessment of Functioning|This instrument is a global measure of severity based on psychiatric symptomatology and impairment of adaptation in family, social, school, and work areas. On this scale 0 is worst, 100 is best, and ≤ 60 is definite clinical impairment.|units on a scale|Mean|50.88|50.88|Standard Deviation|6.00|6.0|||
4416389|NCT00205699|4240997|B2|||Clinical Global Assessment of Functioning|This instrument is a global measure of severity based on psychiatric symptomatology and impairment of adaptation in family, social, school, and work areas. On this scale 0 is worst, 100 is best, and ≤ 60 is definite clinical impairment.|units on a scale|Mean|50.67|50.67|Standard Deviation|5.44|5.44|||
4416390|NCT00205699|4240998|B1|||Clinical Global Assessment of Functioning|This instrument is a global measure of severity based on psychiatric symptomatology and impairment of adaptation in family, social, school, and work areas. On this scale 0 is worst, 100 is best, and ≤ 60 is definite clinical impairment.|units on a scale|Mean|51.71|51.71|Standard Deviation|4.44|4.44|||
4416391|NCT00205699|4240995|B4|Inappropriate Speech||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|4.03|4.03|Standard Deviation|2.85|2.85|||
4416392|NCT00205699|4240996|B3|Inappropriate Speech||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|3.69|3.69|Standard Deviation|2.76|2.76|||
4416393|NCT00205699|4240997|B2|Inappropriate Speech||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|3.78|3.78|Standard Deviation|2.71|2.71|||
4416394|NCT00205699|4240998|B1|Inappropriate Speech||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|4.60|4.6|Standard Deviation|3.02|3.02|||
4416417|NCT00205699|4240997|B2|Severely ill||Clinical Global Improvement (CGI)-Severity of Illness||participants|Number|1|1.0||||||
4416418|NCT00205699|4240998|B1|Severely ill||Clinical Global Improvement (CGI)-Severity of Illness||participants|Number|0|0.0||||||
4416419|NCT00205699|4240995|B4|Markedly ill||Clinical Global Improvement (CGI)-Severity of Illness||participants|Number|80|80.0||||||
4416395|NCT00205699|4240995|B4|Hyperactivity||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|32.59|32.59|Standard Deviation|10.28|10.28|||
4416396|NCT00205699|4240996|B3|Hyperactivity||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|32.80|32.8|Standard Deviation|10.88|10.88|||
4416397|NCT00205699|4240997|B2|Hyperactivity||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|32.11|32.11|Standard Deviation|10.45|10.45|||
4416398|NCT00205699|4240998|B1|Hyperactivity||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|32.83|32.83|Standard Deviation|9.68|9.68|||
4416399|NCT00205699|4240995|B4|Stereotypy||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|4.99|4.99|Standard Deviation|4.67|4.67|||
4416400|NCT00205699|4240996|B3|Stereotypy||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|4.29|4.29|Standard Deviation|4.61|4.61|||
4416401|NCT00205699|4240997|B2|Stereotypy||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|5.15|5.15|Standard Deviation|4.42|4.42|||
4416402|NCT00205699|4240998|B1|Stereotypy||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|5.54|5.54|Standard Deviation|4.95|4.95|||
4416403|NCT00205699|4240995|B4|Lethargy||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|14.66|14.66|Standard Deviation|9.12|9.12|||
4416404|NCT00205699|4240996|B3|Lethargy||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|14.61|14.61|Standard Deviation|8.83|8.83|||
4416420|NCT00205699|4240996|B3|Markedly ill||Clinical Global Improvement (CGI)-Severity of Illness||participants|Number|23|23.0||||||
4416421|NCT00205699|4240997|B2|Markedly ill||Clinical Global Improvement (CGI)-Severity of Illness||participants|Number|26|26.0||||||
4416405|NCT00205699|4240997|B2|Lethargy||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|12.67|12.67|Standard Deviation|8.15|8.15|||
4416406|NCT00205699|4240998|B1|Lethargy||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|16.57|16.57|Standard Deviation|10.01|10.01|||
4416407|NCT00205699|4240995|B4|Irritability/Aggression||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|28.27|28.27|Standard Deviation|5.81|5.81|||
4416408|NCT00205699|4240996|B3|Irritability/Aggression||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|28.14|28.14|Standard Deviation|6.27|6.27|||
4416409|NCT00205699|4240997|B2|Irritability/Aggression||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|28.17|28.17|Standard Deviation|5.73|5.73|||
4416410|NCT00205699|4240998|B1|Irritability/Aggression||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|28.49|28.49|Standard Deviation|5.53|5.53|||
4416411|NCT00205699|4240995|B4|Total||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|84.54|84.54|Standard Deviation|23.82|23.82|||
4416412|NCT00205699|4240996|B3|Total||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|83.53|83.53|Standard Deviation|25.70|25.7|||
4416413|NCT00205699|4240997|B2|Total||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|81.89|81.89|Standard Deviation|21.55|21.55|||
4416414|NCT00205699|4240998|B1|Total||Aberrant Behavioral Checklist Subscales|This instrument is a five-factor scale comprising 58 items in 5 sub scales. Items are scored on a scale of 0 (not a problem) to 3 (severe problem). Each sub scale score is the sum of items in the scale. The overall score is the sum of all items. Sub scales are Irritability (15 items, 0-45, clinical significance >18); Lethargy (16 items, min 0, max 48, clinical significance >9); Stereotypic Behavior; (7 items, 0 - 21, clinical significance >3) Hyperactivity, Noncompliance (16 items, 0-48, clinical significance >24); and Inappropriate Speech (4 items, 0-12, clinical significance >3).|units on a scale|Mean|88.03|88.03|Standard Deviation|23.96|23.96|||
4416415|NCT00205699|4240995|B4|Severely ill||Clinical Global Improvement (CGI)-Severity of Illness||participants|Number|4|4.0||||||
4416416|NCT00205699|4240996|B3|Severely ill||Clinical Global Improvement (CGI)-Severity of Illness||participants|Number|3|3.0||||||
4416422|NCT00205699|4240998|B1|Markedly ill||Clinical Global Improvement (CGI)-Severity of Illness||participants|Number|31|31.0||||||
4416423|NCT00205699|4240995|B4|Moderately ill||Clinical Global Improvement (CGI)-Severity of Illness||participants|Number|60|60.0||||||
4416424|NCT00205699|4240996|B3|Moderately ill||Clinical Global Improvement (CGI)-Severity of Illness||participants|Number|23|23.0||||||
4416425|NCT00205699|4240997|B2|Moderately ill||Clinical Global Improvement (CGI)-Severity of Illness||participants|Number|19|19.0||||||
4416426|NCT00205699|4240998|B1|Moderately ill||Clinical Global Improvement (CGI)-Severity of Illness||participants|Number|18|18.0||||||
4416427|NCT00205699|4240995|B4|Tourette Disorder||Primary Diagnosis||participants|Number|1|1.0||||||
4416428|NCT00205699|4240996|B3|Tourette Disorder||Primary Diagnosis||participants|Number|0|0.0||||||
4416429|NCT00205699|4240997|B2|Tourette Disorder||Primary Diagnosis||participants|Number|0|0.0||||||
4416430|NCT00205699|4240998|B1|Tourette Disorder||Primary Diagnosis||participants|Number|1|1.0||||||
4416431|NCT00205699|4240995|B4|Obsessive Compulsive Disorder||Primary Diagnosis||participants|Number|1|1.0||||||
4416432|NCT00205699|4240996|B3|Obsessive Compulsive Disorder||Primary Diagnosis||participants|Number|0|0.0||||||
4416433|NCT00205699|4240997|B2|Obsessive Compulsive Disorder||Primary Diagnosis||participants|Number|1|1.0||||||
4416434|NCT00205699|4240998|B1|Obsessive Compulsive Disorder||Primary Diagnosis||participants|Number|0|0.0||||||
4416435|NCT00205699|4240995|B4|Psychosis||Primary Diagnosis||participants|Number|4|4.0||||||
4416436|NCT00205699|4240996|B3|Psychosis||Primary Diagnosis||participants|Number|0|0.0||||||
4416437|NCT00205699|4240997|B2|Psychosis||Primary Diagnosis||participants|Number|2|2.0||||||
4416438|NCT00205699|4240998|B1|Psychosis||Primary Diagnosis||participants|Number|2|2.0||||||
4416439|NCT00205699|4240995|B4|Autism Spectrum Disorder||Primary Diagnosis||participants|Number|10|10.0||||||
4416440|NCT00205699|4240996|B3|Autism Spectrum Disorder||Primary Diagnosis||participants|Number|3|3.0||||||
4416441|NCT00205699|4240997|B2|Autism Spectrum Disorder||Primary Diagnosis||participants|Number|4|4.0||||||
4416442|NCT00205699|4240998|B1|Autism Spectrum Disorder||Primary Diagnosis||participants|Number|3|3.0||||||
4416443|NCT00205699|4240995|B4|Mood Disorder||Primary Diagnosis||participants|Number|16|16.0||||||
4416444|NCT00205699|4240996|B3|Mood Disorder||Primary Diagnosis||participants|Number|4|4.0||||||
4416445|NCT00205699|4240997|B2|Mood Disorder||Primary Diagnosis||participants|Number|5|5.0||||||
4416446|NCT00205699|4240998|B1|Mood Disorder||Primary Diagnosis||participants|Number|7|7.0||||||
4416447|NCT00205699|4240995|B4|Disruptive Behavior Disorder||Primary Diagnosis||participants|Number|32|32.0||||||
4416448|NCT00205699|4240996|B3|Disruptive Behavior Disorder||Primary Diagnosis||participants|Number|13|13.0||||||
4416449|NCT00205699|4240997|B2|Disruptive Behavior Disorder||Primary Diagnosis||participants|Number|11|11.0||||||
4416450|NCT00205699|4240998|B1|Disruptive Behavior Disorder||Primary Diagnosis||participants|Number|8|8.0||||||
4416451|NCT00205699|4240995|B4|Attention Deficit Hyperactivity Disorder||Primary Diagnosis||participants|Number|80|80.0||||||
4416452|NCT00205699|4240996|B3|Attention Deficit Hyperactivity Disorder||Primary Diagnosis||participants|Number|29|29.0||||||
4416453|NCT00205699|4240997|B2|Attention Deficit Hyperactivity Disorder||Primary Diagnosis||participants|Number|23|23.0||||||
4416454|NCT00205699|4240998|B1|Attention Deficit Hyperactivity Disorder||Primary Diagnosis||participants|Number|28|28.0||||||
4416455|NCT00205699|4240995|B4|Non-White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4416456|NCT00205699|4240996|B3|Non-White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4416457|NCT00205699|4240997|B2|Non-White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4416458|NCT00205699|4240998|B1|Non-White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4416459|NCT00205699|4240995|B4|White||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4416460|NCT00205699|4240996|B3|White||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4416461|NCT00205699|4240997|B2|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4416462|NCT00205699|4240998|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4416463|NCT00205699|4240995|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416464|NCT00205699|4240996|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416465|NCT00205699|4240997|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416466|NCT00205699|4240998|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416467|NCT00205699|4240995|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4416468|NCT00205699|4240996|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4416469|NCT00205699|4240997|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4416470|NCT00205699|4240998|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4416471|NCT00205699|4240995|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4416472|NCT00205699|4240996|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4416473|NCT00205699|4240997|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4416474|NCT00205699|4240998|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4416475|NCT00205699|4240995|B4||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4416476|NCT00205699|4240996|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4416477|NCT00205699|4240997|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4416478|NCT00205699|4240998|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4416479|NCT00205699|4240995|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4416480|NCT00205699|4240996|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4416481|NCT00205699|4240997|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4416482|NCT00205699|4240998|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4416483|NCT00205699|4240995|B4|||Age||years|Mean|11.35|11.35|Standard Deviation|2.79|2.79|||
4416484|NCT00205699|4240996|B3|||Age||years|Mean|11.60|11.6|Standard Deviation|2.92|2.92|||
4416485|NCT00205699|4240997|B2|||Age||years|Mean|11.10|11.1|Standard Deviation|2.52|2.52|||
4416486|NCT00205699|4240998|B1|||Age||years|Mean|11.32|11.32|Standard Deviation|2.95|2.95|||
4416487|NCT00205504|4241023|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4416488|NCT00205504|4241024|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4416489|NCT00205504|4241025|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4416490|NCT00205504|4241023|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416491|NCT00205504|4241024|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416492|NCT00205504|4241025|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416493|NCT00205504|4241023|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4416494|NCT00205504|4241024|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4416495|NCT00205504|4241025|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4416496|NCT00205504|4241023|B3|||Age||years|Mean|23.4|23.4|Standard Deviation|5.8|5.8|||
4416497|NCT00205504|4241024|B2|||Age||years|Mean|21.4|21.4|Standard Deviation|2.3|2.3|||
4416498|NCT00205504|4241025|B1|||Age||years|Mean|25.3|25.3|Standard Deviation|6.9|6.9|||
4416499|NCT00205504|4241023|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416500|NCT00205504|4241024|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416501|NCT00205504|4241025|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416502|NCT00205504|4241023|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4416503|NCT00205504|4241024|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4416504|NCT00205504|4241025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4416505|NCT00205504|4241023|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416506|NCT00205504|4241024|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416507|NCT00205504|4241025|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416508|NCT00205374|4241050|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4416509|NCT00205374|4241051|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4416510|NCT00205374|4241052|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4416511|NCT00205374|4241050|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4416512|NCT00205374|4241051|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4416513|NCT00205374|4241052|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4416514|NCT00205374|4241050|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4416515|NCT00205374|4241051|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4416516|NCT00205374|4241052|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4416517|NCT00205374|4241050|B3|||Age||years|Mean|31|31.0|Standard Deviation|15|15.0|||
4416518|NCT00205374|4241051|B2|||Age||years|Mean|29|29.0|Standard Deviation|12|12.0|||
4416519|NCT00205374|4241052|B1|||Age||years|Mean|33|33.0|Standard Deviation|18|18.0|||
4416520|NCT00205374|4241050|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416521|NCT00205374|4241051|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416522|NCT00205374|4241052|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416523|NCT00205374|4241050|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4416524|NCT00205374|4241051|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4416525|NCT00205374|4241052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4416526|NCT00205374|4241050|B3||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4416527|NCT00205374|4241051|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4416528|NCT00205374|4241052|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4416529|NCT00205348|4241061|B1|United States||Region of Enrollment||participants|Number|116|116.0||||||
4416530|NCT00205348|4241061|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4416531|NCT00205348|4241061|B1||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4416532|NCT00205348|4241061|B1|||Age||years|Mean|49|49.0|Standard Deviation|13|13.0|||
4416533|NCT00205348|4241061|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416534|NCT00205348|4241061|B1||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4416535|NCT00205348|4241061|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416536|NCT00204932|4241074|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4416537|NCT00204932|4241075|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4416538|NCT00204932|4241076|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4416539|NCT00204932|4241074|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4416540|NCT00204932|4241075|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4416541|NCT00204932|4241076|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4416542|NCT00204932|4241074|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4416543|NCT00204932|4241075|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4416544|NCT00204932|4241076|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4416545|NCT00204932|4241074|B3|||Age||years|Mean|33|33.0|Standard Deviation|9|9.0|||
4416546|NCT00204932|4241075|B2|||Age||years|Mean|32|32.0|Standard Deviation|7|7.0|||
4416547|NCT00204932|4241076|B1|||Age||years|Mean|34|34.0|Standard Deviation|8|8.0|||
4416548|NCT00204932|4241074|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416549|NCT00204932|4241075|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416550|NCT00204932|4241076|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416551|NCT00204932|4241074|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4416552|NCT00204932|4241075|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4416553|NCT00204932|4241076|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4416554|NCT00204932|4241074|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416555|NCT00204932|4241075|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416556|NCT00204932|4241076|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416557|NCT00204373|4241083|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4416558|NCT00204373|4241083|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4416559|NCT00204373|4241083|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4416560|NCT00204373|4241083|B1|||Age||years|Mean|54|54.0|Standard Deviation|11.6|11.6|||
4416561|NCT00204373|4241083|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4416562|NCT00204373|4241083|B1||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4416563|NCT00204373|4241083|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416564|NCT00203996|4241088|B7|Male||Gender||participants|Number|9|9.0||||||
4416565|NCT00203996|4241089|B6|Male||Gender||participants|Number|9|9.0||||||
4416566|NCT00203996|4241090|B5|Male||Gender||participants|Number|0|0.0||||||
4416567|NCT00203996|4241091|B4|Male||Gender||participants|Number|0|0.0||||||
4416568|NCT00203996|4241088|B7|Female||Gender||participants|Number|28|28.0||||||
4416569|NCT00203996|4241089|B6|Female||Gender||participants|Number|5|5.0||||||
4416570|NCT00203996|4241090|B5|Female||Gender||participants|Number|4|4.0||||||
4416571|NCT00203996|4241091|B4|Female||Gender||participants|Number|19|19.0||||||
4416572|NCT00203996|4241088|B7|||Age||years|Mean|28.8|28.8|Standard Deviation|4.4|4.4|||
4416573|NCT00203996|4241089|B6|||Age||years|Mean|24.6|24.6|Standard Deviation|2.7|2.7|||
4416574|NCT00203996|4241090|B5|||Age||years|Mean|32.2|32.2|Standard Deviation|5.8|5.8|||
4416575|NCT00203996|4241091|B4|||Age||years|Mean|31.2|31.2|Standard Deviation|5.3|5.3|||
4416576|NCT00203931|4241150|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4416577|NCT00203931|4241151|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4416578|NCT00203931|4241152|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4416579|NCT00203931|4241150|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4416580|NCT00203931|4241151|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4416581|NCT00203931|4241152|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4416582|NCT00203931|4241150|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4416583|NCT00203931|4241151|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4416584|NCT00203931|4241152|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4416585|NCT00203931|4241150|B3|||Age||years|Median|58|58.0|Full Range|||36.0|76.0|
4416586|NCT00203931|4241151|B2|||Age||years|Median|55|55.0|Full Range|||45.0|75.0|
4416587|NCT00203931|4241152|B1|||Age||years|Median|62|62.0|Full Range|||36.0|76.0|
4416588|NCT00203892|4241167|B4|1||Performance Status|ECOG performance status scores on a scale from 0-5, with 0 denoting Asymptomatic (Fully active, able to carry on all predisease activities without restriction) and 5 death|participants|Number|9|9.0||||||
4416589|NCT00203892|4241168|B3|1||Performance Status|ECOG performance status scores on a scale from 0-5, with 0 denoting Asymptomatic (Fully active, able to carry on all predisease activities without restriction) and 5 death|participants|Number|2|2.0||||||
4416590|NCT00203892|4241169|B2|1||Performance Status|ECOG performance status scores on a scale from 0-5, with 0 denoting Asymptomatic (Fully active, able to carry on all predisease activities without restriction) and 5 death|participants|Number|4|4.0||||||
4416591|NCT00203892|4241170|B1|1||Performance Status|ECOG performance status scores on a scale from 0-5, with 0 denoting Asymptomatic (Fully active, able to carry on all predisease activities without restriction) and 5 death|participants|Number|3|3.0||||||
4416592|NCT00203892|4241167|B4|0||Performance Status|ECOG performance status scores on a scale from 0-5, with 0 denoting Asymptomatic (Fully active, able to carry on all predisease activities without restriction) and 5 death|participants|Number|10|10.0||||||
4416593|NCT00203892|4241168|B3|0||Performance Status|ECOG performance status scores on a scale from 0-5, with 0 denoting Asymptomatic (Fully active, able to carry on all predisease activities without restriction) and 5 death|participants|Number|4|4.0||||||
4416594|NCT00203892|4241169|B2|0||Performance Status|ECOG performance status scores on a scale from 0-5, with 0 denoting Asymptomatic (Fully active, able to carry on all predisease activities without restriction) and 5 death|participants|Number|4|4.0||||||
4416595|NCT00203892|4241170|B1|0||Performance Status|ECOG performance status scores on a scale from 0-5, with 0 denoting Asymptomatic (Fully active, able to carry on all predisease activities without restriction) and 5 death|participants|Number|2|2.0||||||
4416596|NCT00203892|4241167|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
4416597|NCT00203892|4241168|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4416598|NCT00203892|4241169|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4416599|NCT00203892|4241170|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4416600|NCT00203892|4241167|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4416601|NCT00203892|4241168|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4416602|NCT00203892|4241169|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4416603|NCT00203892|4241170|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4416604|NCT00203892|4241167|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4416605|NCT00203892|4241168|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4416606|NCT00203892|4241169|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4416607|NCT00203892|4241170|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4416608|NCT00203892|4241167|B4|||Age||years|Median|60|60.0|Full Range|||27.0|86.0|
4416609|NCT00203892|4241168|B3|||Age||years|Median|61.5|61.5|Full Range|||47.0|77.0|
4416610|NCT00203892|4241169|B2|||Age||years|Median|57.5|57.5|Full Range|||50.0|86.0|
4416611|NCT00203892|4241170|B1|||Age||years|Median|51|51.0|Full Range|||27.0|71.0|
4416612|NCT00203502|4241183|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4416613|NCT00203502|4241183|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416614|NCT00203502|4241183|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4416615|NCT00203502|4241183|B1|||Age||years|Median|45|45.0|Full Range|||26.0|72.0|
4416616|NCT00203502|4241183|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4416617|NCT00203502|4241183|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4416618|NCT00203502|4241183|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416619|NCT00203476|4241191|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4416620|NCT00203476|4241192|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4416621|NCT00203476|4241193|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4416622|NCT00203476|4241194|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4416623|NCT00203476|4241191|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4416624|NCT00203476|4241192|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4416625|NCT00203476|4241193|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4416626|NCT00203476|4241194|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4416627|NCT00203476|4241191|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416628|NCT00203476|4241192|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416629|NCT00203476|4241193|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416630|NCT00203476|4241194|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416631|NCT00203476|4241191|B4|Age =>50||Age, Customized||participants|Number|30|30.0||||||
4416632|NCT00203476|4241192|B3|Age =>50||Age, Customized||participants|Number|10|10.0||||||
4416633|NCT00203476|4241193|B2|Age =>50||Age, Customized||participants|Number|10|10.0||||||
4416634|NCT00203476|4241194|B1|Age =>50||Age, Customized||participants|Number|10|10.0||||||
4416635|NCT00203424|4241213|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416636|NCT00203424|4241213|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416637|NCT00203424|4241213|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4416638|NCT00203424|4241213|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416639|NCT00203424|4241213|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416640|NCT00203424|4241213|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4416641|NCT00203424|4241213|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416642|NCT00203424|4241213|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4416643|NCT00203424|4241213|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416644|NCT00203424|4241213|B1|||Age||years|Median|67|67.0|Full Range|||51.0|76.0|
4416645|NCT00203411|4241220|B1|Score of 2||Eastern Cooperative Oncology Group (ECOG)|"ECOG Grade Evaluated by Physical Exam 0 Fully active, able to carry on all predisease activities with restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self-care but unable to carry out any work activities. Out of bed > 50%~Capable of only limited self-care, confined to bed or chair > 50% waking hours~Completely disabled, cannot carry on any self-care, totally confined to bed or chair"|subjects|Number|28|28.0||||||
4416646|NCT00203411|4241220|B1|Score of 1||Eastern Cooperative Oncology Group (ECOG)|"ECOG Grade Evaluated by Physical Exam 0 Fully active, able to carry on all predisease activities with restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all self-care but unable to carry out any work activities. Out of bed > 50%~Capable of only limited self-care, confined to bed or chair > 50% waking hours~Completely disabled, cannot carry on any self-care, totally confined to bed or chair"|subjects|Number|17|17.0||||||
4416647|NCT00203411|4241220|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4416648|NCT00203411|4241220|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4416649|NCT00203411|4241220|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416650|NCT00203411|4241220|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4416651|NCT00203411|4241220|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4416652|NCT00203411|4241220|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416653|NCT00203411|4241220|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4416654|NCT00203411|4241220|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416655|NCT00203411|4241220|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4416656|NCT00203411|4241220|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4416657|NCT00203411|4241220|B1|||Age||years|Median|79|79.0|Full Range|||54.0|93.0|
4416658|NCT00203307|4241227|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4416659|NCT00203307|4241229|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4416660|NCT00203307|4241227|B3|Male||Gender||participants|Number|1|1.0||||||
4416661|NCT00203307|4241229|B1|Male||Gender||participants|Number|1|1.0||||||
4416662|NCT00203307|4241227|B3|Female||Gender||participants|Number|2|2.0||||||
4416663|NCT00203307|4241229|B1|Female||Gender||participants|Number|2|2.0||||||
4416664|NCT00203307|4241227|B3|||Age||years|Mean|50|50.0|Standard Deviation|3|3.0|||
4416665|NCT00203307|4241229|B1|||Age||years|Mean|50|50.0|Standard Deviation|3|3.0|||
4416666|NCT00203307|4241227|B3|>=65 years||Age||participants|Number|0|0.0||||||
4416667|NCT00203307|4241229|B1|>=65 years||Age||participants|Number|0|0.0||||||
4416668|NCT00203307|4241227|B3|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4416669|NCT00203307|4241229|B1|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4416670|NCT00203307|4241227|B3|<=18 years||Age||participants|Number|0|0.0||||||
4416671|NCT00203307|4241229|B1|<=18 years||Age||participants|Number|0|0.0||||||
4416672|NCT00203294|4241236|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4416673|NCT00203294|4241237|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4416674|NCT00203294|4241238|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4416675|NCT00203294|4241236|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4416676|NCT00203294|4241237|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4416677|NCT00203294|4241238|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4416678|NCT00203294|4241236|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4416679|NCT00203294|4241237|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4416680|NCT00203294|4241238|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4416681|NCT00203294|4241236|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416682|NCT00203294|4241237|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416683|NCT00203294|4241238|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416684|NCT00203294|4241236|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4416685|NCT00203294|4241237|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4416686|NCT00203294|4241238|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4416687|NCT00203294|4241236|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416688|NCT00203294|4241237|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416689|NCT00203294|4241238|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416690|NCT00203268|4241245|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4416691|NCT00203268|4241245|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416692|NCT00203268|4241245|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4416693|NCT00203268|4241245|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416694|NCT00203268|4241245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4416695|NCT00203268|4241245|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416696|NCT00203242|4241251|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4416697|NCT00203242|4241251|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4416698|NCT00203242|4241251|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4416699|NCT00203242|4241251|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|10.8|10.8|||
4416700|NCT00203242|4241251|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416701|NCT00203242|4241251|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4416702|NCT00203242|4241251|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416703|NCT00203229|4241255|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4416704|NCT00203229|4241256|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4416705|NCT00203229|4241257|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4416706|NCT00203229|4241255|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4416707|NCT00203229|4241256|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4416708|NCT00203229|4241257|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4416709|NCT00203229|4241255|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4416710|NCT00203229|4241256|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4416711|NCT00203229|4241257|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4416712|NCT00203229|4241255|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416713|NCT00203229|4241256|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416714|NCT00203229|4241257|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416715|NCT00203229|4241255|B3||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4416716|NCT00203229|4241256|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4416717|NCT00203229|4241257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4416718|NCT00203229|4241255|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416719|NCT00203229|4241256|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416720|NCT00203229|4241257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416721|NCT00203216|4241264|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4416722|NCT00203216|4241264|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4416723|NCT00203216|4241264|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4416724|NCT00203216|4241264|B1|||Age||years|Mean|39|39.0|Standard Deviation|12.47|12.47|||
4416725|NCT00203216|4241264|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416726|NCT00203216|4241264|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4416727|NCT00203216|4241264|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416728|NCT00203203|4241268|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4416729|NCT00203203|4241269|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4416730|NCT00203203|4241270|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4416731|NCT00203203|4241268|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4416732|NCT00203203|4241269|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4416733|NCT00203203|4241270|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4416734|NCT00203203|4241268|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4416735|NCT00203203|4241269|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4416736|NCT00203203|4241270|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4416737|NCT00203203|4241268|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|8.1|8.1|||
4416738|NCT00203203|4241269|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|6.4|6.4|||
4416739|NCT00203203|4241270|B1|||Age||years|Mean|56.3|56.3|Standard Deviation|8.6|8.6|||
4416740|NCT00203203|4241268|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4416741|NCT00203203|4241269|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4416742|NCT00203203|4241270|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416743|NCT00203203|4241268|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4416744|NCT00203203|4241269|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4416745|NCT00203203|4241270|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4416746|NCT00203203|4241268|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416747|NCT00203203|4241269|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416748|NCT00203203|4241270|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416749|NCT00203047|4241301|B3|||T2 Lesions Volume at Baseline|"T2 lesions are hyperintense lesions meaning that they appear as bright spots on the MRI image. These tend to show the total number of lesions and disease burden.~171 GA + Placebo and 155 GA + Prednisone participants had baseline MRI data in the database as of January 29, 2009."|cm^3|Mean|5.44|5.44|Standard Deviation|7.55|7.55|||
4416750|NCT00203047|4241302|B2|||T2 Lesions Volume at Baseline|"T2 lesions are hyperintense lesions meaning that they appear as bright spots on the MRI image. These tend to show the total number of lesions and disease burden.~171 GA + Placebo and 155 GA + Prednisone participants had baseline MRI data in the database as of January 29, 2009."|cm^3|Mean|5.35|5.35|Standard Deviation|7.97|7.97|||
4416751|NCT00203047|4241303|B1|||T2 Lesions Volume at Baseline|"T2 lesions are hyperintense lesions meaning that they appear as bright spots on the MRI image. These tend to show the total number of lesions and disease burden.~171 GA + Placebo and 155 GA + Prednisone participants had baseline MRI data in the database as of January 29, 2009."|cm^3|Mean|5.51|5.51|Standard Deviation|7.17|7.17|||
4416752|NCT00203047|4241301|B3|||T1 Hypointense Lesions Volume at Baseline|"Hypointense lesions display as dark areas on the MRI image, and represent areas of permanent axonal damage.~171 GA + Placebo and 155 GA + Prednisone participants had baseline MRI data in the database as of January 29, 2009."|cm^3|Mean|0.89|0.89|Standard Deviation|1.64|1.64|||
4416753|NCT00203047|4241302|B2|||T1 Hypointense Lesions Volume at Baseline|"Hypointense lesions display as dark areas on the MRI image, and represent areas of permanent axonal damage.~171 GA + Placebo and 155 GA + Prednisone participants had baseline MRI data in the database as of January 29, 2009."|cm^3|Mean|0.84|0.84|Standard Deviation|1.50|1.5|||
4416754|NCT00203047|4241303|B1|||T1 Hypointense Lesions Volume at Baseline|"Hypointense lesions display as dark areas on the MRI image, and represent areas of permanent axonal damage.~171 GA + Placebo and 155 GA + Prednisone participants had baseline MRI data in the database as of January 29, 2009."|cm^3|Mean|0.94|0.94|Standard Deviation|1.77|1.77|||
4416755|NCT00203047|4241301|B3|||T1 Enhancing Lesions at Baseline|"Enhancing lesions represent new lesions due to recent disease activity and may indicate a relapse.~171 GA + Placebo and 155 GA + Prednisone participants had baseline MRI data in the database as of January 29, 2009."|lesions|Mean|1.43|1.43|Standard Deviation|7.12|7.12|||
4416756|NCT00203047|4241302|B2|||T1 Enhancing Lesions at Baseline|"Enhancing lesions represent new lesions due to recent disease activity and may indicate a relapse.~171 GA + Placebo and 155 GA + Prednisone participants had baseline MRI data in the database as of January 29, 2009."|lesions|Mean|1.86|1.86|Standard Deviation|9.91|9.91|||
4416757|NCT00203047|4241303|B1|||T1 Enhancing Lesions at Baseline|"Enhancing lesions represent new lesions due to recent disease activity and may indicate a relapse.~171 GA + Placebo and 155 GA + Prednisone participants had baseline MRI data in the database as of January 29, 2009."|lesions|Mean|1.05|1.05|Standard Deviation|2.77|2.77|||
4416758|NCT00203047|4241301|B3|||Time from MS Diagnosis||months|Mean|41.3|41.3|Standard Deviation|67.1|67.1|||
4416759|NCT00203047|4241302|B2|||Time from MS Diagnosis||months|Mean|42.1|42.1|Standard Deviation|62.9|62.9|||
4416760|NCT00203047|4241303|B1|||Time from MS Diagnosis||months|Mean|40.5|40.5|Standard Deviation|71.4|71.4|||
4416761|NCT00203047|4241301|B3|||Time from First Multiple Sclerosis (MS) Symptom||months|Mean|83.1|83.1|Standard Deviation|91.0|91.0|||
4416762|NCT00203047|4241302|B2|||Time from First Multiple Sclerosis (MS) Symptom||months|Mean|76.7|76.7|Standard Deviation|75.5|75.5|||
4416763|NCT00203047|4241303|B1|||Time from First Multiple Sclerosis (MS) Symptom||months|Mean|89.8|89.8|Standard Deviation|104.5|104.5|||
4416764|NCT00203047|4241301|B3|United States||Region of Enrollment||participants|Number|367|367.0||||||
4416765|NCT00203047|4241302|B2|United States||Region of Enrollment||participants|Number|188|188.0||||||
4416766|NCT00203047|4241303|B1|United States||Region of Enrollment||participants|Number|179|179.0||||||
4416767|NCT00203047|4241301|B3|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4416768|NCT00203047|4241302|B2|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4416769|NCT00203047|4241303|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4416770|NCT00203047|4241301|B3|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4416771|NCT00203047|4241302|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4416772|NCT00203047|4241303|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4416773|NCT00203047|4241301|B3|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4416774|NCT00203047|4241302|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4416775|NCT00203047|4241303|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4416776|NCT00203047|4241301|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|350|350.0||||||
4416777|NCT00203047|4241302|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|179|179.0||||||
4416778|NCT00203047|4241303|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|171|171.0||||||
4416779|NCT00203047|4241301|B3|Black of African Heritage||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4416780|NCT00203047|4241302|B2|Black of African Heritage||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4416781|NCT00203047|4241303|B1|Black of African Heritage||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4416782|NCT00203047|4241301|B3|Asian / Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4416783|NCT00203047|4241302|B2|Asian / Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4416784|NCT00203047|4241303|B1|Asian / Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4416785|NCT00203047|4241301|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4416786|NCT00203047|4241302|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4416787|NCT00203047|4241303|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4416788|NCT00203047|4241301|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4416789|NCT00203047|4241302|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4416790|NCT00203047|4241303|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4416791|NCT00203047|4241301|B3||Female|Sex: Female, Male||Participants|Count of Participants|308|308.0||||||
4416792|NCT00203047|4241302|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4416793|NCT00203047|4241303|B1||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4416794|NCT00203047|4241301|B3|>= 55 years||Age, Customized||participants|Number|3|3.0||||||
4416795|NCT00203047|4241302|B2|>= 55 years||Age, Customized||participants|Number|2|2.0||||||
4416796|NCT00203047|4241303|B1|>= 55 years||Age, Customized||participants|Number|1|1.0||||||
4416797|NCT00203047|4241301|B3|=50 and < 55 years||Age, Customized||participants|Number|64|64.0||||||
4416798|NCT00203047|4241302|B2|=50 and < 55 years||Age, Customized||participants|Number|29|29.0||||||
4416799|NCT00203047|4241303|B1|=50 and < 55 years||Age, Customized||participants|Number|35|35.0||||||
4416800|NCT00203047|4241301|B3|=40 and < 50 years||Age, Customized||participants|Number|140|140.0||||||
4416801|NCT00203047|4241302|B2|=40 and < 50 years||Age, Customized||participants|Number|70|70.0||||||
4416802|NCT00203047|4241303|B1|=40 and < 50 years||Age, Customized||participants|Number|70|70.0||||||
4416803|NCT00203047|4241301|B3|=30 and < 40 years||Age, Customized||participants|Number|129|129.0||||||
4416804|NCT00203047|4241302|B2|=30 and < 40 years||Age, Customized||participants|Number|68|68.0||||||
4416805|NCT00203047|4241303|B1|=30 and < 40 years||Age, Customized||participants|Number|61|61.0||||||
4416806|NCT00203047|4241301|B3|<=29 years||Age, Customized||participants|Number|72|72.0||||||
4416807|NCT00203047|4241302|B2|<=29 years||Age, Customized||participants|Number|40|40.0||||||
4416808|NCT00203047|4241303|B1|<=29 years||Age, Customized||participants|Number|32|32.0||||||
4416809|NCT00202878|4241316|B3||Male|Sex: Female, Male||Participants|Count of Participants|13728|13728.0||||||
4416810|NCT00202878|4241317|B2||Male|Sex: Female, Male||Participants|Count of Participants|6886|6886.0||||||
4416811|NCT00202878|4241318|B1||Male|Sex: Female, Male||Participants|Count of Participants|6842|6842.0||||||
4416812|NCT00202878|4241316|B3||Female|Sex: Female, Male||Participants|Count of Participants|4416|4416.0||||||
4416813|NCT00202878|4241317|B2||Female|Sex: Female, Male||Participants|Count of Participants|2191|2191.0||||||
4416814|NCT00202878|4241318|B1||Female|Sex: Female, Male||Participants|Count of Participants|2225|2225.0||||||
4416815|NCT00202878|4241316|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|9.8|9.8|||
4416816|NCT00202878|4241317|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|9.8|9.8|||
4416817|NCT00202878|4241318|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|9.7|9.7|||
4416818|NCT00202839|4241331|B3|Taiwan, Province Of China||Region of Enrollment||participants|Number|160|160.0||||||
4416819|NCT00202839|4241332|B2|Taiwan, Province Of China||Region of Enrollment||participants|Number|82|82.0||||||
4416820|NCT00202839|4241333|B1|Taiwan, Province Of China||Region of Enrollment||participants|Number|78|78.0||||||
4416821|NCT00202839|4241331|B3||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4416822|NCT00202839|4241332|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4416823|NCT00202839|4241333|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4416824|NCT00202839|4241331|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4416825|NCT00202839|4241332|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4416826|NCT00202839|4241333|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4416827|NCT00202839|4241331|B3|||Age||years|Mean|50.55|50.55|Standard Deviation|10.74|10.74|||
4416828|NCT00202839|4241332|B2|||Age||years|Mean|50.46|50.46|Standard Deviation|10.93|10.93|||
4416829|NCT00202839|4241333|B1|||Age||years|Mean|50.63|50.63|Standard Deviation|10.6|10.6|||
4416830|NCT00202722|4241342|B1|Norway||Region of Enrollment||participants|Number|41|41.0||||||
4416831|NCT00202722|4241342|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416832|NCT00202722|4241342|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4416833|NCT00202722|4241342|B1|||Age||years|Mean|27|27.0|Full Range|||20.0|33.0|
4416834|NCT00202644|4241347|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4416835|NCT00202644|4241348|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4416836|NCT00202644|4241349|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4416837|NCT00202644|4241347|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4416838|NCT00202644|4241348|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4416839|NCT00202644|4241349|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4416840|NCT00202644|4241347|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|15.91|15.91|||
4416841|NCT00202644|4241348|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|15.80|15.8|||
4416842|NCT00202644|4241349|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|16.10|16.1|||
4416843|NCT00202449|4241374|B4|United States||Region of Enrollment||participants|Number|59|59.0||||||
4416844|NCT00202449|4241375|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4416845|NCT00202449|4241376|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4416846|NCT00202449|4241377|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4416847|NCT00202449|4241374|B4||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4416848|NCT00202449|4241375|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4416849|NCT00202449|4241376|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4416850|NCT00202449|4241377|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4416851|NCT00202449|4241374|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4416852|NCT00202449|4241375|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4416853|NCT00202449|4241376|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4416854|NCT00202449|4241377|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4416855|NCT00202449|4241374|B4|||Age||years|Mean|30|30.0|Standard Deviation|7|7.0|||
4416856|NCT00202449|4241375|B3|||Age||years|Mean|32|32.0|Standard Deviation|9|9.0|||
4416857|NCT00202449|4241376|B2|||Age||years|Mean|28|28.0|Standard Deviation|5|5.0|||
4416858|NCT00202449|4241377|B1|||Age||years|Mean|29|29.0|Standard Deviation|7|7.0|||
4416859|NCT00202449|4241374|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416860|NCT00202449|4241375|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416861|NCT00202449|4241376|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416862|NCT00202449|4241377|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4416863|NCT00202449|4241374|B4||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4416864|NCT00202449|4241375|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4416865|NCT00202449|4241376|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4416866|NCT00202449|4241377|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4416867|NCT00202449|4241374|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416868|NCT00202449|4241375|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416869|NCT00202449|4241376|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416870|NCT00202449|4241377|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416871|NCT00201877|4241393|B1|Follicular lymphoma||Disease Type||participants|Number|11|11.0||||||
4416872|NCT00201877|4241393|B1|Mantle cell lymphoma||Disease Type||participants|Number|14|14.0||||||
4416873|NCT00201877|4241393|B1|No||B-symptoms||participants|Number|19|19.0||||||
4416874|NCT00201877|4241393|B1|Yes||B-symptoms||participants|Number|6|6.0||||||
4416875|NCT00201877|4241393|B1|IV(outside lymph system into organ)||Lymphoma Disease Stages|Ann Arbor staging system|participants|Number|13|13.0||||||
4416876|NCT00201877|4241393|B1|Stage III(lymph node areas on both sides)||Lymphoma Disease Stages|Ann Arbor staging system|participants|Number|9|9.0||||||
4416877|NCT00201877|4241393|B1|II(2 or more groups of lymph nodes)||Lymphoma Disease Stages|Ann Arbor staging system|participants|Number|1|1.0||||||
4416878|NCT00201877|4241393|B1|I(lymph node area or 1 organ outside lymph system||Lymphoma Disease Stages|Ann Arbor staging system|participants|Number|2|2.0||||||
4416879|NCT00201877|4241393|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4416880|NCT00201877|4241393|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4416881|NCT00201877|4241393|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4416882|NCT00201877|4241393|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4416883|NCT00201877|4241393|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4416884|NCT00201877|4241393|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416885|NCT00201864|4241400|B1|Never on adjuvant hormonal therapy||Relapse and/or Progression||participants|Number|9|9.0||||||
4416886|NCT00201864|4241400|B1|Presenting with de novo metastatic disease||Relapse and/or Progression||participants|Number|8|8.0||||||
4416887|NCT00201864|4241400|B1|>12 mo after completion adjuvant therapy||Relapse and/or Progression||participants|Number|9|9.0||||||
4416888|NCT00201864|4241400|B1|During adjuvant endocrine therapy||Relapse and/or Progression||participants|Number|14|14.0||||||
4416889|NCT00201864|4241400|B1|||Time From Primary Diagnosis to Metastatic Disease||years|Median|5|5.0|Full Range|||0.0|21.0|
4416890|NCT00201864|4241400|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4416891|NCT00201864|4241400|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416892|NCT00201864|4241400|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416893|NCT00201864|4241400|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4416894|NCT00201864|4241400|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4416895|NCT00201864|4241400|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416896|NCT00201864|4241400|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416897|NCT00201864|4241400|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416898|NCT00201864|4241400|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416899|NCT00201864|4241400|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4416900|NCT00201864|4241400|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4416901|NCT00201864|4241400|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416902|NCT00201864|4241400|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4416903|NCT00201864|4241400|B1|||Age||years|Median|58|58.0|Full Range|||43.0|84.0|
4416904|NCT00201864|4241400|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4416905|NCT00201864|4241400|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4416906|NCT00201864|4241400|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4416907|NCT00201851|4241408|B4|5+||Progesterone level on day of surgery (ng/ml)||participants|Number|292|292.0||||||
4416908|NCT00201851|4241409|B3|5+||Progesterone level on day of surgery (ng/ml)||participants|Number|117|117.0||||||
4416909|NCT00201851|4241410|B2|5+||Progesterone level on day of surgery (ng/ml)||participants|Number|57|57.0||||||
4416910|NCT00201851|4241411|B1|5+||Progesterone level on day of surgery (ng/ml)||participants|Number|118|118.0||||||
4416911|NCT00201851|4241408|B4|2-4.99||Progesterone level on day of surgery (ng/ml)||participants|Number|73|73.0||||||
4416912|NCT00201851|4241409|B3|2-4.99||Progesterone level on day of surgery (ng/ml)||participants|Number|24|24.0||||||
4416913|NCT00201851|4241410|B2|2-4.99||Progesterone level on day of surgery (ng/ml)||participants|Number|22|22.0||||||
4416914|NCT00201851|4241411|B1|2-4.99||Progesterone level on day of surgery (ng/ml)||participants|Number|27|27.0||||||
4416915|NCT00201851|4241408|B4|<2||Progesterone level on day of surgery (ng/ml)||participants|Number|307|307.0||||||
4416916|NCT00201851|4241409|B3|<2||Progesterone level on day of surgery (ng/ml)||participants|Number|74|74.0||||||
4416917|NCT00201851|4241410|B2|<2||Progesterone level on day of surgery (ng/ml)||participants|Number|158|158.0||||||
4416918|NCT00201851|4241411|B1|<2||Progesterone level on day of surgery (ng/ml)||participants|Number|75|75.0||||||
4416919|NCT00201851|4241408|B4|||Pathologic tumor size||cm|Mean|4.5|4.5|Standard Deviation|2.8|2.8|||
4416920|NCT00201851|4241409|B3|||Pathologic tumor size||cm|Mean|4.1|4.1|Standard Deviation|2.3|2.3|||
4416921|NCT00201851|4241410|B2|||Pathologic tumor size||cm|Mean|4.7|4.7|Standard Deviation|3.2|3.2|||
4416922|NCT00201851|4241411|B1|||Pathologic tumor size||cm|Mean|4.5|4.5|Standard Deviation|2.8|2.8|||
4416923|NCT00201851|4241408|B4|4+||Number of positive axillary nodes||participants|Number|219|219.0||||||
4416924|NCT00201851|4241409|B3|4+||Number of positive axillary nodes||participants|Number|68|68.0||||||
4416925|NCT00201851|4241410|B2|4+||Number of positive axillary nodes||participants|Number|70|70.0||||||
4416926|NCT00201851|4241411|B1|4+||Number of positive axillary nodes||participants|Number|81|81.0||||||
4416927|NCT00201851|4241408|B4|1-3||Number of positive axillary nodes||participants|Number|189|189.0||||||
4416928|NCT00201851|4241409|B3|1-3||Number of positive axillary nodes||participants|Number|56|56.0||||||
4416929|NCT00201851|4241410|B2|1-3||Number of positive axillary nodes||participants|Number|73|73.0||||||
4416930|NCT00201851|4241411|B1|1-3||Number of positive axillary nodes||participants|Number|60|60.0||||||
4416931|NCT00201851|4241408|B4|None||Number of positive axillary nodes||participants|Number|310|310.0||||||
4416932|NCT00201851|4241409|B3|None||Number of positive axillary nodes||participants|Number|103|103.0||||||
4416933|NCT00201851|4241410|B2|None||Number of positive axillary nodes||participants|Number|111|111.0||||||
4416934|NCT00201851|4241411|B1|None||Number of positive axillary nodes||participants|Number|96|96.0||||||
4416935|NCT00201851|4241408|B4|Negative||HER2/Neu status||participants|Number|459|459.0||||||
4416936|NCT00201851|4241409|B3|Negative||HER2/Neu status||participants|Number|153|153.0||||||
4416937|NCT00201851|4241410|B2|Negative||HER2/Neu status||participants|Number|160|160.0||||||
4416938|NCT00201851|4241411|B1|Negative||HER2/Neu status||participants|Number|146|146.0||||||
4416939|NCT00201851|4241408|B4|Positive||HER2/Neu status||participants|Number|118|118.0||||||
4416940|NCT00201851|4241409|B3|Positive||HER2/Neu status||participants|Number|32|32.0||||||
4416941|NCT00201851|4241410|B2|Positive||HER2/Neu status||participants|Number|45|45.0||||||
4416942|NCT00201851|4241411|B1|Positive||HER2/Neu status||participants|Number|41|41.0||||||
4416943|NCT00201851|4241408|B4|Negative||Progesterone receptor status||participants|Number|56|56.0||||||
4416944|NCT00201851|4241409|B3|Negative||Progesterone receptor status||participants|Number|11|11.0||||||
4416945|NCT00201851|4241410|B2|Negative||Progesterone receptor status||participants|Number|20|20.0||||||
4416946|NCT00201851|4241411|B1|Negative||Progesterone receptor status||participants|Number|25|25.0||||||
4416947|NCT00201851|4241408|B4|Positive||Progesterone receptor status||participants|Number|671|671.0||||||
4416948|NCT00201851|4241409|B3|Positive||Progesterone receptor status||participants|Number|219|219.0||||||
4416949|NCT00201851|4241410|B2|Positive||Progesterone receptor status||participants|Number|234|234.0||||||
4416950|NCT00201851|4241411|B1|Positive||Progesterone receptor status||participants|Number|218|218.0||||||
4416951|NCT00201851|4241408|B4|Negative||Estrogen receptor status||participants|Number|48|48.0||||||
4416952|NCT00201851|4241409|B3|Negative||Estrogen receptor status||participants|Number|13|13.0||||||
4416953|NCT00201851|4241410|B2|Negative||Estrogen receptor status||participants|Number|19|19.0||||||
4416954|NCT00201851|4241411|B1|Negative||Estrogen receptor status||participants|Number|16|16.0||||||
4416955|NCT00201851|4241408|B4|Positive||Estrogen receptor status||participants|Number|678|678.0||||||
4416956|NCT00201851|4241409|B3|Positive||Estrogen receptor status||participants|Number|217|217.0||||||
4416957|NCT00201851|4241410|B2|Positive||Estrogen receptor status||participants|Number|235|235.0||||||
4416958|NCT00201851|4241411|B1|Positive||Estrogen receptor status||participants|Number|226|226.0||||||
4416959|NCT00201851|4241408|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416960|NCT00201851|4241409|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416961|NCT00201851|4241410|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416962|NCT00201851|4241411|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4416963|NCT00201851|4241408|B4||Female|Sex: Female, Male||Participants|Count of Participants|729|729.0||||||
4416964|NCT00201851|4241409|B3||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4416965|NCT00201851|4241410|B2||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4416966|NCT00201851|4241411|B1||Female|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4416967|NCT00201851|4241408|B4|||Age||years|Mean|42.2|42.2|Standard Deviation|4.5|4.5|||
4416968|NCT00201851|4241409|B3|||Age||years|Mean|42.1|42.1|Standard Deviation|4.4|4.4|||
4416969|NCT00201851|4241410|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|4.7|4.7|||
4416970|NCT00201851|4241411|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|4.5|4.5|||
4416971|NCT00201838|4241421|B3|PS 2 (Ambulatory and capable of selfcare)||ECOG Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG)|patients|Number|2|2.0||||||
4416972|NCT00201838|4241422|B2|PS 2 (Ambulatory and capable of selfcare)||ECOG Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG)|patients|Number|0|0.0||||||
4416973|NCT00201838|4241423|B1|PS 2 (Ambulatory and capable of selfcare)||ECOG Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG)|patients|Number|2|2.0||||||
4416974|NCT00201838|4241421|B3|PS 1 (Restricted in physical activity)||ECOG Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG)|patients|Number|26|26.0||||||
4416975|NCT00201838|4241422|B2|PS 1 (Restricted in physical activity)||ECOG Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG)|patients|Number|5|5.0||||||
4416976|NCT00201838|4241423|B1|PS 1 (Restricted in physical activity)||ECOG Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG)|patients|Number|21|21.0||||||
4416977|NCT00201838|4241421|B3|PS 0 (Fully active)||ECOG Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG)|patients|Number|10|10.0||||||
4416978|NCT00201838|4241422|B2|PS 0 (Fully active)||ECOG Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG)|patients|Number|3|3.0||||||
4416979|NCT00201838|4241423|B1|PS 0 (Fully active)||ECOG Performance Status (PS)|Eastern Cooperative Oncology Group (ECOG)|patients|Number|7|7.0||||||
4416980|NCT00201838|4241421|B3|other site||Metastatic Site||patients|Number|6|6.0||||||
4416981|NCT00201838|4241422|B2|other site||Metastatic Site||patients|Number|2|2.0||||||
4416982|NCT00201838|4241423|B1|other site||Metastatic Site||patients|Number|4|4.0||||||
4416983|NCT00201838|4241421|B3|Liver + other||Metastatic Site||patients|Number|16|16.0||||||
4416984|NCT00201838|4241422|B2|Liver + other||Metastatic Site||patients|Number|6|6.0||||||
4416985|NCT00201838|4241423|B1|Liver + other||Metastatic Site||patients|Number|10|10.0||||||
4416986|NCT00201838|4241421|B3|Liver only||Metastatic Site||patients|Number|16|16.0||||||
4416987|NCT00201838|4241422|B2|Liver only||Metastatic Site||patients|Number|0|0.0||||||
4416988|NCT00201838|4241423|B1|Liver only||Metastatic Site||patients|Number|16|16.0||||||
4416989|NCT00201838|4241421|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4416990|NCT00201838|4241422|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4416991|NCT00201838|4241423|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4416992|NCT00201838|4241421|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4416993|NCT00201838|4241422|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4416994|NCT00201838|4241423|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4416995|NCT00201838|4241421|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4416996|NCT00201838|4241422|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4416997|NCT00201838|4241423|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4416998|NCT00201838|4241421|B3|||Age||years|Median|59|59.0|Full Range|||46.0|81.0|
4416999|NCT00201838|4241422|B2|||Age||years|Median|59|59.0|Full Range|||46.0|75.0|
4417000|NCT00201838|4241423|B1|||Age||years|Median|59|59.0|Full Range|||46.0|81.0|
4417001|NCT00201825|4241438|B1|Performance status 1 (Restricted activity)||ECOG (Eastern Cooperative Oncology Group)||patients|Number|21|21.0||||||
4417002|NCT00201825|4241438|B1|Performance status 0 (Fully active)||ECOG (Eastern Cooperative Oncology Group)||patients|Number|8|8.0||||||
4417003|NCT00201825|4241438|B1|NSCLC not specified||Histology||patients|Number|8|8.0||||||
4417004|NCT00201825|4241438|B1|Large cell Carcinoma||Histology||patients|Number|2|2.0||||||
4417005|NCT00201825|4241438|B1|Squamous cell carcinoma||Histology||patients|Number|6|6.0||||||
4417006|NCT00201825|4241438|B1|Adenocarcinoma||Histology||patients|Number|13|13.0||||||
4417007|NCT00201825|4241438|B1|United States||Region of Enrollment||patients|Number|29|29.0||||||
4417008|NCT00201825|4241438|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417009|NCT00201825|4241438|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417010|NCT00201825|4241438|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4417011|NCT00201825|4241438|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4417012|NCT00201825|4241438|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417013|NCT00201825|4241438|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417014|NCT00201825|4241438|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417015|NCT00201825|4241438|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4417016|NCT00201825|4241438|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4417017|NCT00201825|4241438|B1|||Age||years|Median|61|61.0|Full Range|||39.0|76.0|
4417018|NCT00201773|4241445|B1|Occult primary (axillary metastases)||Clinical Stage||patients|Number|1|1.0||||||
4417019|NCT00201773|4241445|B1|IIIA (cancer considered advanced)||Clinical Stage||patients|Number|3|3.0||||||
4417020|NCT00201773|4241445|B1|IIB (tumor between 2-5 cm or larger)||Clinical Stage||patients|Number|3|3.0||||||
4417021|NCT00201773|4241445|B1|IIA (evidence cancer has begun to grow/spread)||Clinical Stage||patients|Number|14|14.0||||||
4417022|NCT00201773|4241445|B1|I (cancer cells confined to limited area)||Clinical Stage||patients|Number|1|1.0||||||
4417023|NCT00201773|4241445|B1|Sentinel||Axillary Nodal Evaluation||patients|Number|1|1.0||||||
4417024|NCT00201773|4241445|B1|Fine needle aspiration||Axillary Nodal Evaluation||patients|Number|2|2.0||||||
4417025|NCT00201773|4241445|B1|Negative||Clinical Axillary Status||patients|Number|15|15.0||||||
4417026|NCT00201773|4241445|B1|Positive||Clinical Axillary Status||patients|Number|7|7.0||||||
4417027|NCT00201773|4241445|B1|Mixed invasive and lobular||Histology||patients|Number|2|2.0||||||
4417028|NCT00201773|4241445|B1|Lobular||Histology||patients|Number|5|5.0||||||
4417029|NCT00201773|4241445|B1|Invasive||Histology||patients|Number|15|15.0||||||
4417030|NCT00201773|4241445|B1|Not available||Her-2 FISH|Fluorescence in situ hybridization|patients|Number|10|10.0||||||
4417031|NCT00201773|4241445|B1|Negative||Her-2 FISH|Fluorescence in situ hybridization|patients|Number|8|8.0||||||
4417032|NCT00201773|4241445|B1|Positive||Her-2 FISH|Fluorescence in situ hybridization|patients|Number|4|4.0||||||
4417033|NCT00201773|4241445|B1|Negative||Progesterone Receptor status||patients|Number|6|6.0||||||
4417034|NCT00201773|4241445|B1|Positive||Progesterone Receptor status||patients|Number|16|16.0||||||
4417035|NCT00201773|4241445|B1|||Menopause Status of Postmenopausal||patients|Number|22|22.0||||||
4417036|NCT00201773|4241445|B1|||ECOG (Eastern Cooperative Oncology Group) Performance Status 0-1|"ECOG Performance Status 0 is defined as fully active, able to carry on all pre-disease performance without restriction.~ECOG Performance Status1 is defined as restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work."|patients|Number|22|22.0||||||
4417037|NCT00201773|4241445|B1|United States||Region of Enrollment||patients|Number|22|22.0||||||
4417038|NCT00201773|4241445|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417039|NCT00201773|4241445|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4417040|NCT00201773|4241445|B1|||Age||years|Median|63|63.0|Full Range|||49.0|87.0|
4417041|NCT00201760|4241452|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4417042|NCT00201760|4241453|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4417043|NCT00201760|4241454|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4417044|NCT00201760|4241452|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417045|NCT00201760|4241453|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417046|NCT00201760|4241454|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417047|NCT00201760|4241452|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4417048|NCT00201760|4241453|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4417049|NCT00201760|4241454|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4417050|NCT00201760|4241452|B3|||Age||years|Median|47.5|47.5|Full Range|||33.0|62.0|
4417051|NCT00201760|4241453|B2|||Age||years|Median|42|42.0|Full Range|||36.0|57.0|
4417052|NCT00201760|4241454|B1|||Age||years|Median|51|51.0|Full Range|||33.0|62.0|
4417053|NCT00201734|4241465|B3|United States||Region of Enrollment||patients|Number|57|57.0||||||
4417054|NCT00201734|4241466|B2|United States||Region of Enrollment||patients|Number|25|25.0||||||
4417055|NCT00201734|4241467|B1|United States||Region of Enrollment||patients|Number|32|32.0||||||
4417056|NCT00201734|4241465|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417057|NCT00201734|4241466|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417058|NCT00201734|4241467|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417059|NCT00201734|4241465|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417060|NCT00201734|4241466|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417061|NCT00201734|4241467|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417062|NCT00201734|4241465|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4417063|NCT00201734|4241466|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4417064|NCT00201734|4241467|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4417065|NCT00201734|4241465|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4417066|NCT00201734|4241466|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417067|NCT00201734|4241467|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4417068|NCT00201734|4241465|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417069|NCT00201734|4241466|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417070|NCT00201734|4241467|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417071|NCT00201734|4241465|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417072|NCT00201734|4241466|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417073|NCT00201734|4241467|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417074|NCT00201734|4241465|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417075|NCT00201734|4241466|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417076|NCT00201734|4241467|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417077|NCT00201734|4241465|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4417078|NCT00201734|4241466|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4417079|NCT00201734|4241467|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4417080|NCT00201734|4241465|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4417081|NCT00201734|4241466|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4417082|NCT00201734|4241467|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4417083|NCT00201734|4241465|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4417084|NCT00201734|4241466|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4417085|NCT00201734|4241467|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4417086|NCT00201734|4241465|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4417087|NCT00201734|4241466|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4417088|NCT00201734|4241467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4417089|NCT00201734|4241465|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417090|NCT00201734|4241466|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417091|NCT00201734|4241467|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417092|NCT00201643|4241483|B3|United States||Region of Enrollment||participants|Number|437|437.0||||||
4417093|NCT00201643|4241484|B2|United States||Region of Enrollment||participants|Number|214|214.0||||||
4417094|NCT00201643|4241485|B1|United States||Region of Enrollment||participants|Number|223|223.0||||||
4417095|NCT00201643|4241483|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417096|NCT00201643|4241484|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417097|NCT00201643|4241485|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417098|NCT00201643|4241483|B3||Female|Sex: Female, Male||Participants|Count of Participants|437|437.0||||||
4417099|NCT00201643|4241484|B2||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4417100|NCT00201643|4241485|B1||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4417101|NCT00201643|4241483|B3|||Age||years|Mean|29|29.0|Standard Deviation|6|6.0|||
4417102|NCT00201643|4241484|B2|||Age||years|Mean|29|29.0|Standard Deviation|6|6.0|||
4417103|NCT00201643|4241485|B1|||Age||years|Mean|29|29.0|Standard Deviation|6|6.0|||
4417104|NCT00201643|4241483|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417105|NCT00201643|4241484|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417106|NCT00201643|4241485|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417107|NCT00201643|4241483|B3||Between 18 and 65 years|Age||Participants|Count of Participants|437|437.0||||||
4417108|NCT00201643|4241484|B2||Between 18 and 65 years|Age||Participants|Count of Participants|214|214.0||||||
4417109|NCT00201643|4241485|B1||Between 18 and 65 years|Age||Participants|Count of Participants|223|223.0||||||
4417110|NCT00201643|4241483|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417111|NCT00201643|4241484|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417112|NCT00201643|4241485|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417113|NCT00201448|4241508|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
4417114|NCT00201448|4241509|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4417115|NCT00201448|4241510|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4417116|NCT00201448|4241508|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417117|NCT00201448|4241509|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417118|NCT00201448|4241510|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417119|NCT00201448|4241508|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4417120|NCT00201448|4241509|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4417121|NCT00201448|4241510|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4417122|NCT00201448|4241508|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417123|NCT00201448|4241509|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417124|NCT00201448|4241510|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417125|NCT00201448|4241508|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4417126|NCT00201448|4241509|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4417127|NCT00201448|4241510|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4417128|NCT00201448|4241508|B3|||Age||years|Mean|33.5|33.5|Standard Deviation|5|5.0|||
4417129|NCT00201448|4241509|B2|||Age||years|Mean|34|34.0|Standard Deviation|5.6|5.6|||
4417130|NCT00201448|4241510|B1|||Age||years|Mean|33|33.0|Standard Deviation|4.5|4.5|||
4417131|NCT00201448|4241508|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417132|NCT00201448|4241509|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417133|NCT00201448|4241510|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417134|NCT00201448|4241508|B3||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4417135|NCT00201448|4241509|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4417136|NCT00201448|4241510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4417137|NCT00201448|4241508|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417138|NCT00201448|4241509|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417139|NCT00201448|4241510|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417140|NCT00201409|4241519|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4417141|NCT00201409|4241520|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4417142|NCT00201409|4241521|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4417143|NCT00201409|4241519|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4417144|NCT00201409|4241520|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4417145|NCT00201409|4241521|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4417146|NCT00201409|4241519|B3|||Age||years|Mean|48.4|48.4|Standard Deviation|14.6|14.6|||
4417147|NCT00201409|4241520|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|13.8|13.8|||
4417148|NCT00201409|4241521|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|15.6|15.6|||
4417149|NCT00201240|4241532|B1|Negative||Recipient CMV Status|Cytomegalovirus (CMV)|participants|Number|27|27.0||||||
4417150|NCT00201240|4241532|B1|Positive||Recipient CMV Status|Cytomegalovirus (CMV)|participants|Number|17|17.0||||||
4417151|NCT00201240|4241532|B1|Unknown||Cytogenetic risk||participants|Number|1|1.0||||||
4417152|NCT00201240|4241532|B1|Unfavorable||Cytogenetic risk||participants|Number|14|14.0||||||
4417153|NCT00201240|4241532|B1|Intermediate||Cytogenetic risk||participants|Number|28|28.0||||||
4417154|NCT00201240|4241532|B1|Favorable||Cytogenetic risk||participants|Number|1|1.0||||||
4417155|NCT00201240|4241532|B1|CR2||Leukemia stage|First complete remission (CR1) is achieved after an initial treatment. Second complete remission (CR2) is achieved after a second treatment when a relapse has occured. Complete remission (CR) is defined according to the revised recommendations of the international working group: Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, Estey EH, et al. Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 21(24): 4642-9, 2003.|participants|Number|7|7.0||||||
4417156|NCT00201240|4241532|B1|CR1||Leukemia stage|First complete remission (CR1) is achieved after an initial treatment. Second complete remission (CR2) is achieved after a second treatment when a relapse has occured. Complete remission (CR) is defined according to the revised recommendations of the international working group: Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, Estey EH, et al. Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 21(24): 4642-9, 2003.|participants|Number|37|37.0||||||
4417157|NCT00201240|4241532|B1|70%||Karnofsky Performance Status|Karnofsky performance status of participants at baseline. The range is 0 to 100 with 100 being the best.|participants|Number|2|2.0||||||
4417158|NCT00201240|4241532|B1|80%||Karnofsky Performance Status|Karnofsky performance status of participants at baseline. The range is 0 to 100 with 100 being the best.|participants|Number|8|8.0||||||
4417159|NCT00201240|4241532|B1|90%||Karnofsky Performance Status|Karnofsky performance status of participants at baseline. The range is 0 to 100 with 100 being the best.|participants|Number|17|17.0||||||
4417160|NCT00201240|4241532|B1|100%||Karnofsky Performance Status|Karnofsky performance status of participants at baseline. The range is 0 to 100 with 100 being the best.|participants|Number|17|17.0||||||
4417161|NCT00201240|4241532|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4417162|NCT00201240|4241532|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4417163|NCT00201240|4241532|B1|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4417164|NCT00201240|4241532|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4417165|NCT00201240|4241532|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4417166|NCT00201240|4241532|B1|50-59||Age, Customized|Age of the participant in years|participants|Number|19|19.0||||||
4417167|NCT00201240|4241532|B1|40-49||Age, Customized|Age of the participant in years|participants|Number|14|14.0||||||
4417168|NCT00201240|4241532|B1|30-39||Age, Customized|Age of the participant in years|participants|Number|4|4.0||||||
4417169|NCT00201240|4241532|B1|20-29||Age, Customized|Age of the participant in years|participants|Number|7|7.0||||||
4417170|NCT00201240|4241532|B1|<20||Age, Customized|Age of the participant in years|participants|Number|0|0.0||||||
4417171|NCT00201201|4241548|B3|United States||Region of Enrollment||participants|Number|160|160.0||||||
4417172|NCT00201201|4241549|B2|United States||Region of Enrollment||participants|Number|73|73.0||||||
4417173|NCT00201201|4241550|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4417174|NCT00201201|4241548|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4417175|NCT00201201|4241549|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4417176|NCT00201201|4241550|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4417177|NCT00201201|4241548|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4417178|NCT00201201|4241549|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4417179|NCT00201201|4241550|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4417180|NCT00201201|4241548|B3|||Age||years|Mean|68.6|68.6|Standard Deviation|8.7|8.7|||
4417181|NCT00201201|4241549|B2|||Age||years|Mean|69.6|69.6|Standard Deviation|7.7|7.7|||
4417182|NCT00201201|4241550|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|9.5|9.5|||
4417183|NCT00201201|4241548|B3||>=65 years|Age||Participants|Count of Participants|113|113.0||||||
4417184|NCT00201201|4241549|B2||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4417185|NCT00201201|4241550|B1||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4417186|NCT00201201|4241548|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4417187|NCT00201201|4241549|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4417188|NCT00201201|4241550|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4417189|NCT00201201|4241548|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417190|NCT00201201|4241549|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417191|NCT00201201|4241550|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417192|NCT00201123|4241567|B4|South Africa||Region of Enrollment||participants|Number|89|89.0||||||
4417193|NCT00201123|4241568|B3|South Africa||Region of Enrollment||participants|Number|27|27.0||||||
4417194|NCT00201123|4241569|B2|South Africa||Region of Enrollment||participants|Number|32|32.0||||||
4417195|NCT00201123|4241570|B1|South Africa||Region of Enrollment||participants|Number|30|30.0||||||
4417196|NCT00201123|4241567|B4||Male|Gender||Participants|Count of Participants|62|62.0||||||
4417197|NCT00201123|4241568|B3||Male|Gender||Participants|Count of Participants|18|18.0||||||
4417198|NCT00201123|4241569|B2||Male|Gender||Participants|Count of Participants|24|24.0||||||
4417199|NCT00201123|4241570|B1||Male|Gender||Participants|Count of Participants|20|20.0||||||
4417200|NCT00201123|4241567|B4||Female|Gender||Participants|Count of Participants|27|27.0||||||
4417201|NCT00201123|4241568|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
4417202|NCT00201123|4241569|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
4417203|NCT00201123|4241570|B1||Female|Gender||Participants|Count of Participants|10|10.0||||||
4417204|NCT00201123|4241567|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417205|NCT00201123|4241568|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417206|NCT00201123|4241569|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417207|NCT00201123|4241570|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417208|NCT00201123|4241567|B4||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4417209|NCT00201123|4241568|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4417210|NCT00201123|4241569|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4417211|NCT00201123|4241570|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4417212|NCT00201123|4241567|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417213|NCT00201123|4241568|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417214|NCT00201123|4241569|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417215|NCT00201123|4241570|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417216|NCT00201123|4241567|B4|||Age||years|Mean|34|34.0|Standard Deviation|10|10.0|||
4417217|NCT00201123|4241568|B3|||Age||years|Mean|35|35.0|Standard Deviation|13|13.0|||
4417218|NCT00201123|4241569|B2|||Age||years|Mean|34|34.0|Standard Deviation|10|10.0|||
4417219|NCT00201123|4241570|B1|||Age||years|Mean|32|32.0|Standard Deviation|11|11.0|||
4417220|NCT00201006|4241586|B4|||Body weight||kg|Mean|96.4|96.4|Standard Deviation|15.6|15.6|||
4417221|NCT00201006|4241587|B3|||Body weight||kg|Mean|95.0|95.0|Standard Deviation|13.4|13.4|||
4417222|NCT00201006|4241588|B2|||Body weight||kg|Mean|96.4|96.4|Standard Deviation|16.8|16.8|||
4417223|NCT00201006|4241589|B1|||Body weight||kg|Mean|97.8|97.8|Standard Deviation|14.3|14.3|||
4417224|NCT00201006|4241586|B4|United States||Region of Enrollment||participants|Number|234|234.0||||||
4417225|NCT00201006|4241587|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
4417226|NCT00201006|4241588|B2|United States||Region of Enrollment||participants|Number|72|72.0||||||
4417227|NCT00201006|4241589|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
4417228|NCT00201006|4241586|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417229|NCT00201006|4241587|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417230|NCT00201006|4241588|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417231|NCT00201006|4241589|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417232|NCT00201006|4241586|B4||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4417233|NCT00201006|4241587|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4417234|NCT00201006|4241588|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4417235|NCT00201006|4241589|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4417236|NCT00201006|4241586|B4|||Age||years|Mean|59.4|59.4|Standard Deviation|6.1|6.1|||
4417237|NCT00201006|4241587|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|6.0|6.0|||
4417238|NCT00201006|4241588|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|6.2|6.2|||
4417239|NCT00201006|4241589|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|6.2|6.2|||
4417240|NCT00200967|4241599|B3|United States||Region of Enrollment||participants|Number|87.0|87.0||||||
4417241|NCT00200967|4241600|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4417242|NCT00200967|4241601|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4417243|NCT00200967|4241599|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4417244|NCT00200967|4241600|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4417245|NCT00200967|4241601|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4417246|NCT00200967|4241599|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4417247|NCT00200967|4241600|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4417248|NCT00200967|4241601|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4417249|NCT00200967|4241599|B3|||Age||years|Mean|41|41.0|Standard Deviation|12|12.0|||
4417250|NCT00200967|4241600|B2|||Age||years|Mean|42|42.0|Standard Deviation|12|12.0|||
4417251|NCT00200967|4241601|B1|||Age||years|Mean|39|39.0|Standard Deviation|11|11.0|||
4417252|NCT00200967|4241599|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417253|NCT00200967|4241600|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417254|NCT00200967|4241601|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417255|NCT00200967|4241599|B3||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4417256|NCT00200967|4241600|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4417257|NCT00200967|4241601|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4417258|NCT00200967|4241599|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417259|NCT00200967|4241600|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417260|NCT00200967|4241601|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417261|NCT00200785|4241630|B3|||percent platelet aggregation at 0 weeks|collagen-induced aggregation in platelet-rich plasma (PRP)|percent platelet aggregation|Mean|73.9|73.9|Standard Deviation|3.7|3.7|||
4417262|NCT00200785|4241631|B2|||percent platelet aggregation at 0 weeks|collagen-induced aggregation in platelet-rich plasma (PRP)|percent platelet aggregation|Mean|71.8|71.8|Standard Deviation|5.7|5.7|||
4417263|NCT00200785|4241632|B1|||percent platelet aggregation at 0 weeks|collagen-induced aggregation in platelet-rich plasma (PRP)|percent platelet aggregation|Mean|76.0|76.0|Standard Deviation|1.6|1.6|||
4417264|NCT00200785|4241630|B3|||electrical impedance (ohms) at 0 weeks|collagen-induced platelet aggregation in whole blood (WB)|ohms|Mean|13.9|13.9|Standard Deviation|1.4|1.4|||
4417265|NCT00200785|4241631|B2|||electrical impedance (ohms) at 0 weeks|collagen-induced platelet aggregation in whole blood (WB)|ohms|Mean|15.0|15.0|Standard Deviation|1.6|1.6|||
4417266|NCT00200785|4241632|B1|||electrical impedance (ohms) at 0 weeks|collagen-induced platelet aggregation in whole blood (WB)|ohms|Mean|12.7|12.7|Standard Deviation|1.2|1.2|||
4417267|NCT00200785|4241630|B3|United States||Region of Enrollment||participants|Number|15.0|15.0||||||
4417268|NCT00200785|4241631|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4417269|NCT00200785|4241632|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4417270|NCT00200785|4241630|B3||Male|Sex: Female, Male||Participants|Count of Participants|8.0|8.0||||||
4417271|NCT00200785|4241631|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4417272|NCT00200785|4241632|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4417273|NCT00200785|4241630|B3||Female|Sex: Female, Male||Participants|Count of Participants|7.0|7.0||||||
4417274|NCT00200785|4241631|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4417275|NCT00200785|4241632|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4417276|NCT00200785|4241630|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|13.7|13.7|||
4417277|NCT00200785|4241631|B2|||Age||years|Mean|36.5|36.5|Standard Deviation|15.1|15.1|||
4417278|NCT00200785|4241632|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|13.7|13.7|||
4417279|NCT00200785|4241630|B3||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4417280|NCT00200785|4241631|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417281|NCT00200785|4241632|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4417282|NCT00200785|4241630|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15.0|15.0||||||
4417283|NCT00200785|4241631|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4417284|NCT00200785|4241632|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4417285|NCT00200785|4241630|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4417286|NCT00200785|4241631|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417287|NCT00200785|4241632|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417288|NCT00200356|4241641|B3||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4417289|NCT00200356|4241642|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4417290|NCT00200356|4241643|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4417291|NCT00200356|4241641|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4417292|NCT00200356|4241642|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4417293|NCT00200356|4241643|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4417294|NCT00200356|4241641|B3|65- years||Age, Customized||years|Number|264|264.0||||||
4417295|NCT00200356|4241642|B2|65- years||Age, Customized||years|Number|137|137.0||||||
4417296|NCT00200356|4241643|B1|65- years||Age, Customized||years|Number|127|127.0||||||
4417297|NCT00200356|4241641|B3|20-64 years||Age, Customized||years|Number|122|122.0||||||
4417298|NCT00200356|4241642|B2|20-64 years||Age, Customized||years|Number|58|58.0||||||
4417299|NCT00200356|4241643|B1|20-64 years||Age, Customized||years|Number|64|64.0||||||
4417300|NCT00200356|4241641|B3|birth-19 years||Age, Customized||years|Number|0|0.0||||||
4417301|NCT00200356|4241642|B2|birth-19 years||Age, Customized||years|Number|0|0.0||||||
4417302|NCT00200356|4241643|B1|birth-19 years||Age, Customized||years|Number|0|0.0||||||
4417303|NCT00200343|4241668|B4||Male|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
4417304|NCT00200343|4241669|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4417305|NCT00200343|4241670|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4417306|NCT00200343|4241671|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4417307|NCT00200343|4241668|B4||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4417308|NCT00200343|4241669|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4417309|NCT00200343|4241670|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4417310|NCT00200343|4241671|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4417311|NCT00200343|4241668|B4|||Age|10 patients were excluded from analysis population due to luck of sufficient data.|years|Mean|58.4|58.4|Standard Deviation|11.5|11.5|||
4417312|NCT00200343|4241669|B3|||Age|10 patients were excluded from analysis population due to luck of sufficient data.|years|Mean|59.8|59.8|Standard Deviation|10.1|10.1|||
4417313|NCT00200343|4241670|B2|||Age|10 patients were excluded from analysis population due to luck of sufficient data.|years|Mean|57.7|57.7|Standard Deviation|12.0|12.0|||
4417314|NCT00200343|4241671|B1|||Age|10 patients were excluded from analysis population due to luck of sufficient data.|years|Mean|58.0|58.0|Standard Deviation|12.2|12.2|||
4417315|NCT00200161|4241696|B3|United States||Region of Enrollment||Participants|Count of Participants|85|85.0||||||
4417316|NCT00200161|4241697|B2|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4417317|NCT00200161|4241698|B1|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4417318|NCT00200161|4241696|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4417319|NCT00200161|4241697|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4417320|NCT00200161|4241698|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417321|NCT00200161|4241696|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417322|NCT00200161|4241697|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417323|NCT00200161|4241698|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417324|NCT00200161|4241696|B3||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4417325|NCT00200161|4241697|B2||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4417326|NCT00200161|4241698|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4417327|NCT00200161|4241696|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4417328|NCT00200161|4241697|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417329|NCT00200161|4241698|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4417330|NCT00200161|4241696|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417331|NCT00200161|4241697|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417332|NCT00200161|4241698|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417333|NCT00200161|4241696|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4417334|NCT00200161|4241697|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417335|NCT00200161|4241698|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4417336|NCT00200161|4241696|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417337|NCT00200161|4241697|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417338|NCT00200161|4241698|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417339|NCT00200161|4241696|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4417340|NCT00200161|4241697|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4417341|NCT00200161|4241698|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417342|NCT00200161|4241696|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4417343|NCT00200161|4241697|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4417344|NCT00200161|4241698|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4417345|NCT00200161|4241696|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417433|NCT00199875|4241730|B6||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4417346|NCT00200161|4241697|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417347|NCT00200161|4241698|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417348|NCT00200161|4241696|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4417349|NCT00200161|4241697|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4417350|NCT00200161|4241698|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4417351|NCT00200161|4241696|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4417352|NCT00200161|4241697|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4417353|NCT00200161|4241698|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4417354|NCT00200161|4241696|B3|||Age||years|Median|56.3|56.3|Full Range|||21.0|71.0|
4417355|NCT00200161|4241697|B2|||Age||years|Median|59.1|59.1|Full Range|||30.0|70.0|
4417356|NCT00200161|4241698|B1|||Age||years|Median|54.1|54.1|Full Range|||21.0|71.0|
4417357|NCT00200057|4241711|B1|||FIQOL Scale 4 - Embarrassment|Baseline measure from all subjects who were successfully implanted and completed the FIQOL at baseline, n=119. Scales range from 1 to 5, with a 1 indicating a lower functional status of quality of life.|units on a scale|Mean|1.60|1.6|Standard Deviation|0.63|0.63|||
4417358|NCT00200057|4241711|B1|||FIQOL Scale 3 - Depression/Self-Perception|Baseline measure from all subjects who were successfully implanted and completed the FIQOL at baseline, n=119. Scales range from 1 to 5, with a 1 indicating a lower functional status of quality of life.|units on a scale|Mean|2.53|2.53|Standard Deviation|0.81|0.81|||
4417359|NCT00200057|4241711|B1|||FIQOL Scale 2 - Coping/Behavior|Baseline measure from all subjects who were successfully implanted and completed the FIQOL at baseline, n=119. Scales range from 1 to 5, with a 1 indicating a lower functional status of quality of life.|units on a scale|Mean|1.49|1.49|Standard Deviation|0.53|0.53|||
4417360|NCT00200057|4241711|B1|||Fecal Incontinence Quality of Life (FIQOL) Scale 1 - Lifestyle|Baseline measure from all subjects who were successfully implanted and completed the Fecal Incontinence Quality of Life (FIQOL) at baseline, n=119. Scales range from 1 to 5, with a 1 indicating a lower functional status of quality of life.|units on a scale|Mean|2.31|2.31|Standard Deviation|0.85|0.85|||
4417361|NCT00200057|4241711|B1|||Weekly Urgent Fecal Incontinent Episodes|A bowel diary was used by subjects to record information about their bowel elimination frequency. Over the 14-day diary period, subjects recorded the date and time of each bowel episode and responded to questions related to each episode, including amount of incontinence (none, staining, minor soiling, major soiling) and urgency (no, yes). A bowel movement was considered incontinent if the amount of incontinence was minor or major soiling. A bowel movement was considered urgent if the answer to the urgency question was yes and it was associated with incontinence.|urgent incontinent episodes per week|Mean|4.95|4.95|Standard Deviation|4.88|4.88|||
4417362|NCT00200057|4241711|B1|||Weekly Fecal Incontinent Days|A bowel diary was used by subjects to record information about their bowel elimination frequency. Over the 14-day diary period, subjects recorded the date and time of each bowel episode and responded to questions related to each bowel episode, including amount of incontinence (none, staining, minor soiling, major soiling) and urgency (no, yes). A bowel movement was considered incontinent if the amount of incontinence was minor or major soiling. A day in a diary period was considered as an incontinent day if there was at least one incontinent episode during that day.|incontinent days per week|Mean|4.51|4.51|Standard Deviation|1.61|1.61|||
4417363|NCT00200057|4241711|B1|||Weekly Fecal Incontinent Episodes|A bowel diary was used by subjects to record information about their bowel elimination frequency. Over the 14-day diary period, subjects recorded the date and time of each bowel episode and responded to questions related to each bowel episode, including amount of incontinence (none, staining, minor soiling, major soiling) and urgency (no, yes). A bowel movement was considered incontinent if the amount of incontinence was minor or major soiling.|incontinent episodes per week|Mean|9.39|9.39|Standard Deviation|7.27|7.27|||
4417364|NCT00200057|4241711|B1|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4417365|NCT00200057|4241711|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4417366|NCT00200057|4241711|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4417367|NCT00200057|4241711|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4417368|NCT00200057|4241711|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4417369|NCT00200057|4241711|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|12.5|12.5|||
4417370|NCT00200057|4241711|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4417371|NCT00200057|4241711|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4417372|NCT00200057|4241711|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417373|NCT00199914|4241721|B3|Thailand||Region of Enrollment||participants|Number|113|113.0||||||
4417374|NCT00199914|4241722|B2|Thailand||Region of Enrollment||participants|Number|60|60.0||||||
4417375|NCT00199914|4241723|B1|Thailand||Region of Enrollment||participants|Number|53|53.0||||||
4417376|NCT00199914|4241721|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417377|NCT00199914|4241722|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417378|NCT00199914|4241723|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417379|NCT00199914|4241721|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4417380|NCT00199914|4241722|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4417381|NCT00199914|4241723|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4417382|NCT00199914|4241721|B3|||Age||years|Mean|62.88|62.88|Standard Deviation|8.05|8.05|||
4417383|NCT00199914|4241722|B2|||Age||years|Mean|62.48|62.48|Standard Deviation|8.47|8.47|||
4417384|NCT00199914|4241723|B1|||Age||years|Mean|63.32|63.32|Standard Deviation|7.61|7.61|||
4417431|NCT00199875|4241734|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417432|NCT00199875|4241735|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417385|NCT00199875|4241730|B6|Missing||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|1|1.0||||||
4417386|NCT00199875|4241731|B5|Missing||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|0|0.0||||||
4417387|NCT00199875|4241732|B4|Missing||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|0|0.0||||||
4417388|NCT00199875|4241733|B3|Missing||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|0|0.0||||||
4417389|NCT00199875|4241734|B2|Missing||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|1|1.0||||||
4417390|NCT00199875|4241735|B1|Missing||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|0|0.0||||||
4417391|NCT00199875|4241730|B6|100||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|2|2.0||||||
4417392|NCT00199875|4241731|B5|100||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|0|0.0||||||
4417393|NCT00199875|4241732|B4|100||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|1|1.0||||||
4417394|NCT00199875|4241733|B3|100||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|1|1.0||||||
4417395|NCT00199875|4241734|B2|100||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|0|0.0||||||
4417396|NCT00199875|4241735|B1|100||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|0|0.0||||||
4417397|NCT00199875|4241730|B6|90||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|9|9.0||||||
4417398|NCT00199875|4241731|B5|90||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|0|0.0||||||
4417399|NCT00199875|4241732|B4|90||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|2|2.0||||||
4417400|NCT00199875|4241733|B3|90||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|3|3.0||||||
4417401|NCT00199875|4241734|B2|90||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|2|2.0||||||
4417402|NCT00199875|4241735|B1|90||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|2|2.0||||||
4417403|NCT00199875|4241730|B6|80||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|5|5.0||||||
4417404|NCT00199875|4241731|B5|80||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|3|3.0||||||
4417405|NCT00199875|4241732|B4|80||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|0|0.0||||||
4417406|NCT00199875|4241733|B3|80||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|1|1.0||||||
4417407|NCT00199875|4241734|B2|80||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|0|0.0||||||
4417408|NCT00199875|4241735|B1|80||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|1|1.0||||||
4417409|NCT00199875|4241730|B6|70||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|1|1.0||||||
4417410|NCT00199875|4241731|B5|70||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|0|0.0||||||
4417411|NCT00199875|4241732|B4|70||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|0|0.0||||||
4417412|NCT00199875|4241733|B3|70||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|1|1.0||||||
4417413|NCT00199875|4241734|B2|70||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|0|0.0||||||
4417414|NCT00199875|4241735|B1|70||Karnofsky Performance Status|"Higher performance status indicates higher functional abilities, as follows:~100=Normal, no complaints/evidence of disease. 90=Able to carry on normal activity; minor signs/symptoms of disease. 80=Normal activity with effort; some signs/symptoms of disease. 70=Cares for self; unable to carry on normal activity or do active work. 60=Requires occasional assistance but is able to care for most personal needs. 50=Requires considerable assistance & frequent medical care. 0-40=Unable to care for self; requires equivalent of institutional or hospital care; disease may be progressing rapidly."|Participants|Count of Participants|0|0.0||||||
4417415|NCT00199875|4241730|B6|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4417416|NCT00199875|4241731|B5|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4417417|NCT00199875|4241732|B4|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4417418|NCT00199875|4241733|B3|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4417419|NCT00199875|4241734|B2|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4417420|NCT00199875|4241735|B1|United States||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4417421|NCT00199875|4241730|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417422|NCT00199875|4241731|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417423|NCT00199875|4241732|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417424|NCT00199875|4241733|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417425|NCT00199875|4241734|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417426|NCT00199875|4241735|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417427|NCT00199875|4241730|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417428|NCT00199875|4241731|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417429|NCT00199875|4241732|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417430|NCT00199875|4241733|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417434|NCT00199875|4241731|B5||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4417435|NCT00199875|4241732|B4||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4417436|NCT00199875|4241733|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4417437|NCT00199875|4241734|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4417438|NCT00199875|4241735|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4417439|NCT00199875|4241730|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417440|NCT00199875|4241731|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417441|NCT00199875|4241732|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417442|NCT00199875|4241733|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417443|NCT00199875|4241734|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417444|NCT00199875|4241735|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417445|NCT00199875|4241730|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417446|NCT00199875|4241731|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417447|NCT00199875|4241732|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417448|NCT00199875|4241733|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417449|NCT00199875|4241734|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417450|NCT00199875|4241735|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417451|NCT00199875|4241730|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417452|NCT00199875|4241731|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417453|NCT00199875|4241732|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417454|NCT00199875|4241733|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417455|NCT00199875|4241734|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417456|NCT00199875|4241735|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417457|NCT00199875|4241730|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417458|NCT00199875|4241731|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417459|NCT00199875|4241732|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417460|NCT00199875|4241733|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417461|NCT00199875|4241734|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417462|NCT00199875|4241735|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417463|NCT00199875|4241730|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417464|NCT00199875|4241731|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417465|NCT00199875|4241732|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417466|NCT00199875|4241733|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417467|NCT00199875|4241734|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417468|NCT00199875|4241735|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417469|NCT00199875|4241730|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4417470|NCT00199875|4241731|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4417471|NCT00199875|4241732|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4417472|NCT00199875|4241733|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4417473|NCT00199875|4241734|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4417474|NCT00199875|4241735|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4417475|NCT00199875|4241730|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417476|NCT00199875|4241731|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417477|NCT00199875|4241732|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417478|NCT00199875|4241733|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417479|NCT00199875|4241734|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417480|NCT00199875|4241735|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417481|NCT00199875|4241730|B6||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4417482|NCT00199875|4241731|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4417483|NCT00199875|4241732|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4417484|NCT00199875|4241733|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4417485|NCT00199875|4241734|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4417486|NCT00199875|4241735|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4417487|NCT00199875|4241730|B6||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4417488|NCT00199875|4241731|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4417489|NCT00199875|4241732|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417490|NCT00199875|4241733|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4417491|NCT00199875|4241734|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4417492|NCT00199875|4241735|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4417493|NCT00199875|4241730|B6|||Age||years|Mean|63.7|63.7|Standard Deviation|7.3|7.3|||
4417494|NCT00199875|4241731|B5|||Age||years|Mean|63.0|63.0|Standard Deviation|5.9|5.9|||
4417495|NCT00199875|4241732|B4|||Age||years|Mean|63.7|63.7|Standard Deviation|6.8|6.8|||
4417496|NCT00199875|4241733|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|7.9|7.9|||
4417497|NCT00199875|4241734|B2|||Age||years|Mean|64.7|64.7|Standard Deviation|4.9|4.9|||
4417498|NCT00199875|4241735|B1|||Age||years|Mean|65.7|65.7|Standard Deviation|9.2|9.2|||
4417499|NCT00199381|4241761|B1|Canada||Region of Enrollment|61 centers in the US and 12 centers in Canada recruited at least 1 subject|participants|Number|102|102.0||||||
4417500|NCT00199381|4241761|B1|United States||Region of Enrollment|61 centers in the US and 12 centers in Canada recruited at least 1 subject|participants|Number|401|401.0||||||
4417501|NCT00199381|4241761|B1||Male|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
4417502|NCT00199381|4241761|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4417503|NCT00199381|4241761|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|8.98|8.98|||
4417504|NCT00199381|4241761|B1||>=65 years|Age||Participants|Count of Participants|259|259.0||||||
4417505|NCT00199381|4241761|B1||Between 18 and 65 years|Age||Participants|Count of Participants|244|244.0||||||
4417506|NCT00199381|4241761|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417507|NCT00198822|4241765|B4|Bangladesh||Region of Enrollment||participants|Number|59666|59666.0||||||
4417508|NCT00198822|4241766|B3|Bangladesh||Region of Enrollment||participants|Number|19998|19998.0||||||
4417509|NCT00198822|4241767|B2|Bangladesh||Region of Enrollment||participants|Number|19806|19806.0||||||
4417510|NCT00198822|4241768|B1|Bangladesh||Region of Enrollment||participants|Number|19862|19862.0||||||
4417511|NCT00198822|4241765|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417512|NCT00198822|4241766|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417513|NCT00198822|4241767|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417514|NCT00198822|4241768|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4417515|NCT00198822|4241765|B4||Female|Sex: Female, Male||Participants|Count of Participants|59666|59666.0||||||
4417516|NCT00198822|4241766|B3||Female|Sex: Female, Male||Participants|Count of Participants|19998|19998.0||||||
4417517|NCT00198822|4241767|B2||Female|Sex: Female, Male||Participants|Count of Participants|19806|19806.0||||||
4417518|NCT00198822|4241768|B1||Female|Sex: Female, Male||Participants|Count of Participants|19862|19862.0||||||
4417519|NCT00198822|4241765|B4|||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|years|Mean|23.09|23.09|Standard Deviation|6.55|6.55|||
4417520|NCT00198822|4241766|B3|||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|years|Mean|23.06|23.06|Standard Deviation|6.56|6.56|||
4417521|NCT00198822|4241767|B2|||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|years|Mean|23.17|23.17|Standard Deviation|6.56|6.56|||
4417522|NCT00198822|4241768|B1|||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|years|Mean|23.03|23.03|Standard Deviation|6.53|6.53|||
4417523|NCT00198822|4241765|B4|>=65 years||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|participants|Number|0|0.0||||||
4417524|NCT00198822|4241766|B3|>=65 years||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|participants|Number|0|0.0||||||
4417525|NCT00198822|4241767|B2|>=65 years||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|participants|Number|0|0.0||||||
4417526|NCT00198822|4241768|B1|>=65 years||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|participants|Number|0|0.0||||||
4417527|NCT00198822|4241765|B4|Between 18 and 65 years||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|participants|Number|42046|42046.0||||||
4417528|NCT00198822|4241766|B3|Between 18 and 65 years||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|participants|Number|14056|14056.0||||||
4417575|NCT00198081|4241802|B1|Unknown||IPMN type||participants|Number|1|1.0||||||
4417529|NCT00198822|4241767|B2|Between 18 and 65 years||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|participants|Number|14017|14017.0||||||
4417530|NCT00198822|4241768|B1|Between 18 and 65 years||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|participants|Number|13973|13973.0||||||
4417531|NCT00198822|4241765|B4|<=18 years||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|participants|Number|17585|17585.0||||||
4417532|NCT00198822|4241766|B3|<=18 years||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|participants|Number|5936|5936.0||||||
4417533|NCT00198822|4241767|B2|<=18 years||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|participants|Number|5774|5774.0||||||
4417534|NCT00198822|4241768|B1|<=18 years||Age|A very small number of women in the study were unable to recollect or even work out their age. In rural South Asia, this is not uncommon and of the 35 women for whom we do not have an age, 14 are in the placebo group, 15 in the Vitamin A group and 6 in the beta-carotene group.|participants|Number|5875|5875.0||||||
4417535|NCT00198133|4241787|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417536|NCT00198133|4241788|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417537|NCT00198133|4241789|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417538|NCT00198133|4241787|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417539|NCT00198133|4241788|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417540|NCT00198133|4241789|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417541|NCT00198133|4241787|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4417542|NCT00198133|4241788|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4417543|NCT00198133|4241789|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4417544|NCT00198133|4241787|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4417545|NCT00198133|4241788|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417546|NCT00198133|4241789|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4417547|NCT00198133|4241787|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417548|NCT00198133|4241788|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417549|NCT00198133|4241789|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417550|NCT00198133|4241787|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4417551|NCT00198133|4241788|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417552|NCT00198133|4241789|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4417553|NCT00198133|4241787|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417554|NCT00198133|4241788|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417555|NCT00198133|4241789|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417556|NCT00198133|4241787|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417557|NCT00198133|4241788|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417558|NCT00198133|4241789|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417559|NCT00198133|4241787|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4417560|NCT00198133|4241788|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4417561|NCT00198133|4241789|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4417562|NCT00198133|4241787|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417563|NCT00198133|4241788|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417564|NCT00198133|4241789|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417565|NCT00198133|4241787|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4417566|NCT00198133|4241788|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4417567|NCT00198133|4241789|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4417568|NCT00198133|4241787|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4417569|NCT00198133|4241788|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4417570|NCT00198133|4241789|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4417571|NCT00198133|4241787|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|14.0|14.0|||
4417572|NCT00198133|4241788|B2|||Age||years|Mean|53.3|53.3|Standard Deviation|14.4|14.4|||
4417573|NCT00198133|4241789|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|14.2|14.2|||
4417574|NCT00198081|4241800|B3|Unknown||IPMN type||participants|Number|1|1.0||||||
4417576|NCT00198081|4241800|B3|Not Otherwise Specified||IPMN type||participants|Number|1|1.0||||||
4417577|NCT00198081|4241802|B1|Not Otherwise Specified||IPMN type||participants|Number|1|1.0||||||
4417578|NCT00198081|4241800|B3|Invasive||IPMN type||participants|Number|1|1.0||||||
4417579|NCT00198081|4241802|B1|Invasive||IPMN type||participants|Number|1|1.0||||||
4417580|NCT00198081|4241800|B3|Low grade||IPMN type||participants|Number|1|1.0||||||
4417581|NCT00198081|4241802|B1|Low grade||IPMN type||participants|Number|1|1.0||||||
4417582|NCT00198081|4241800|B3|Adenoma||IPMN type||participants|Number|1|1.0||||||
4417583|NCT00198081|4241802|B1|Adenoma||IPMN type||participants|Number|1|1.0||||||
4417584|NCT00198081|4241800|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4417585|NCT00198081|4241802|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4417586|NCT00198081|4241800|B3|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4417587|NCT00198081|4241802|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|0|0.0||||||
4417588|NCT00198081|4241800|B3|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4417589|NCT00198081|4241802|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4417590|NCT00198081|4241800|B3|White||Race (NIH/OMB)||participants|Number|4|4.0||||||
4417591|NCT00198081|4241802|B1|White||Race (NIH/OMB)||participants|Number|4|4.0||||||
4417592|NCT00198081|4241800|B3|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4417593|NCT00198081|4241802|B1|Black or African American||Race (NIH/OMB)||participants|Number|0|0.0||||||
4417594|NCT00198081|4241800|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|1|1.0||||||
4417595|NCT00198081|4241802|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|1|1.0||||||
4417596|NCT00198081|4241800|B3|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4417597|NCT00198081|4241802|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4417598|NCT00198081|4241800|B3|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4417599|NCT00198081|4241802|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4417600|NCT00198081|4241800|B3|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4417601|NCT00198081|4241802|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4417602|NCT00198081|4241800|B3|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|5|5.0||||||
4417603|NCT00198081|4241802|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|5|5.0||||||
4417604|NCT00198081|4241800|B3|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4417605|NCT00198081|4241802|B1|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4417606|NCT00198081|4241800|B3|Male||Gender||participants|Number|5|5.0||||||
4417607|NCT00198081|4241802|B1|Male||Gender||participants|Number|5|5.0||||||
4417608|NCT00198081|4241800|B3|Female||Gender||participants|Number|0|0.0||||||
4417609|NCT00198081|4241802|B1|Female||Gender||participants|Number|0|0.0||||||
4417610|NCT00198081|4241800|B3|>=65 years||Age||participants|Number|3|3.0||||||
4417611|NCT00198081|4241802|B1|>=65 years||Age||participants|Number|3|3.0||||||
4417612|NCT00198081|4241800|B3|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4417613|NCT00198081|4241802|B1|Between 18 and 65 years||Age||participants|Number|2|2.0||||||
4417614|NCT00198081|4241800|B3|<=18 years||Age||participants|Number|0|0.0||||||
4417615|NCT00198081|4241802|B1|<=18 years||Age||participants|Number|0|0.0||||||
4417616|NCT00198042|4241829|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4417617|NCT00198042|4241829|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417618|NCT00198042|4241829|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417619|NCT00198042|4241829|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4417620|NCT00198042|4241829|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4417621|NCT00198042|4241829|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417622|NCT00198042|4241829|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4417623|NCT00198042|4241829|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417624|NCT00198042|4241829|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4417625|NCT00198042|4241829|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4417626|NCT00198042|4241829|B1|||Age|age in years|age, years|Mean|35|35.0|Full Range|||26.0|44.0|
4417627|NCT00198042|4241829|B1||>=65 years|Age|Age, categorical|Participants|Count of Participants|0|0.0||||||
4417628|NCT00198042|4241829|B1||Between 18 and 65 years|Age|Age, categorical|Participants|Count of Participants|18|18.0||||||
4417629|NCT00198042|4241829|B1||<=18 years|Age|Age, categorical|Participants|Count of Participants|0|0.0||||||
4417630|NCT00198029|4241833|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4417631|NCT00198029|4241833|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4417632|NCT00198029|4241833|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4417633|NCT00198029|4241833|B1|||Age||years|Mean|64|64.0|Standard Deviation|8|8.0|||
4417634|NCT00198029|4241833|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4417635|NCT00198029|4241833|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4417636|NCT00198029|4241833|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417637|NCT00197496|4241838|B3|||Falls Self-efficacy Scale|0-40, higher means greater efficacy|units on a scale|Mean|22.2|22.2|Standard Deviation|8.7|8.7|||
4417698|NCT00197392|4241855|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|14.7|14.7|||
4417638|NCT00197496|4241839|B2|||Falls Self-efficacy Scale|0-40, higher means greater efficacy|units on a scale|Mean|22.0|22.0|Standard Deviation|8.2|8.2|||
4417639|NCT00197496|4241840|B1|||Falls Self-efficacy Scale|0-40, higher means greater efficacy|units on a scale|Mean|22.4|22.4|Standard Deviation|9.2|9.2|||
4417640|NCT00197496|4241838|B3|||Lower Extremity Functional Score|range 0-80 higher mean better functioning|units on a scale|Mean|19.7|19.7|Standard Deviation|11.9|11.9|||
4417641|NCT00197496|4241839|B2|||Lower Extremity Functional Score|range 0-80 higher mean better functioning|units on a scale|Mean|25.7|25.7|Standard Deviation|16.5|16.5|||
4417642|NCT00197496|4241840|B1|||Lower Extremity Functional Score|range 0-80 higher mean better functioning|units on a scale|Mean|16.6|16.6|Standard Deviation|8|8.0|||
4417643|NCT00197496|4241838|B3|||2 Minute Walk Test time||metres|Mean|20.6|20.6|Standard Deviation|17.3|17.3|||
4417644|NCT00197496|4241839|B2|||2 Minute Walk Test time||metres|Mean|23.6|23.6|Standard Deviation|15.3|15.3|||
4417645|NCT00197496|4241840|B1|||2 Minute Walk Test time||metres|Mean|18.7|18.7|Standard Deviation|18.9|18.9|||
4417646|NCT00197496|4241838|B3|||Timed up and go time||seconds|Mean|64.8|64.8|Standard Deviation|27.8|27.8|||
4417647|NCT00197496|4241839|B2|||Timed up and go time||seconds|Mean|45.6|45.6|Standard Deviation|10.3|10.3|||
4417648|NCT00197496|4241840|B1|||Timed up and go time||seconds|Mean|73.9|73.9|Standard Deviation|29.1|29.1|||
4417649|NCT00197496|4241838|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4417650|NCT00197496|4241839|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4417651|NCT00197496|4241840|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4417652|NCT00197496|4241838|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4417653|NCT00197496|4241839|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4417654|NCT00197496|4241840|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4417655|NCT00197496|4241838|B3|||Age||years|Mean|81.2|81.2|Standard Deviation|7|7.0|||
4417656|NCT00197496|4241839|B2|||Age||years|Mean|83.7|83.7|Standard Deviation|8.6|8.6|||
4417657|NCT00197496|4241840|B1|||Age||years|Mean|79.9|79.9|Standard Deviation|7.0|7.0|||
4417658|NCT00197496|4241838|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4417659|NCT00197496|4241839|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4417660|NCT00197496|4241840|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4417661|NCT00197496|4241838|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4417662|NCT00197496|4241839|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4417663|NCT00197496|4241840|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4417664|NCT00197496|4241838|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417665|NCT00197496|4241839|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417666|NCT00197496|4241840|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4417667|NCT00197392|4241854|B3|United Kingdom||Region of Enrollment||participants|Number|83|83.0||||||
4417668|NCT00197392|4241855|B2|United Kingdom||Region of Enrollment||participants|Number|45|45.0||||||
4417669|NCT00197392|4241856|B1|United Kingdom||Region of Enrollment||participants|Number|38|38.0||||||
4417670|NCT00197392|4241854|B3|China||Region of Enrollment||participants|Number|35|35.0||||||
4417671|NCT00197392|4241855|B2|China||Region of Enrollment||participants|Number|17|17.0||||||
4417672|NCT00197392|4241856|B1|China||Region of Enrollment||participants|Number|18|18.0||||||
4417673|NCT00197392|4241854|B3|Norway||Region of Enrollment||participants|Number|56|56.0||||||
4417674|NCT00197392|4241855|B2|Norway||Region of Enrollment||participants|Number|26|26.0||||||
4417675|NCT00197392|4241856|B1|Norway||Region of Enrollment||participants|Number|30|30.0||||||
4417676|NCT00197392|4241854|B3|Singapore||Region of Enrollment||participants|Number|25|25.0||||||
4417677|NCT00197392|4241855|B2|Singapore||Region of Enrollment||participants|Number|11|11.0||||||
4417678|NCT00197392|4241856|B1|Singapore||Region of Enrollment||participants|Number|14|14.0||||||
4417679|NCT00197392|4241854|B3|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4417680|NCT00197392|4241855|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4417681|NCT00197392|4241856|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4417682|NCT00197392|4241854|B3|Hong Kong||Region of Enrollment||participants|Number|60|60.0||||||
4417683|NCT00197392|4241855|B2|Hong Kong||Region of Enrollment||participants|Number|33|33.0||||||
4417684|NCT00197392|4241856|B1|Hong Kong||Region of Enrollment||participants|Number|27|27.0||||||
4417685|NCT00197392|4241854|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
4417686|NCT00197392|4241855|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4417687|NCT00197392|4241856|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4417688|NCT00197392|4241854|B3|France||Region of Enrollment||participants|Number|59|59.0||||||
4417689|NCT00197392|4241855|B2|France||Region of Enrollment||participants|Number|29|29.0||||||
4417690|NCT00197392|4241856|B1|France||Region of Enrollment||participants|Number|30|30.0||||||
4417691|NCT00197392|4241854|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4417692|NCT00197392|4241855|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4417693|NCT00197392|4241856|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4417694|NCT00197392|4241854|B3||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4417695|NCT00197392|4241855|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4417696|NCT00197392|4241856|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4417697|NCT00197392|4241854|B3|||Age||years|Mean|53.05|53.05|Standard Deviation|15.45|15.45|||
4417699|NCT00197392|4241856|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|16.2|16.2|||
4417700|NCT00197236|4241886|B4||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4417701|NCT00197236|4241887|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4417702|NCT00197236|4241888|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4417703|NCT00197236|4241889|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4417704|NCT00197236|4241886|B4||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4417705|NCT00197236|4241887|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4417706|NCT00197236|4241888|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4417707|NCT00197236|4241889|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4417708|NCT00197236|4241886|B4|||Age||months|Mean|15.1|15.1|Standard Deviation|0.30|0.3|||
4417709|NCT00197236|4241887|B3|||Age||months|Mean|15.0|15.0|Standard Deviation|0.21|0.21|||
4417710|NCT00197236|4241888|B2|||Age||months|Mean|15.1|15.1|Standard Deviation|0.3|0.3|||
4417711|NCT00197236|4241889|B1|||Age||months|Mean|15.1|15.1|Standard Deviation|0.36|0.36|||
4417712|NCT00197184|4241938|B3||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4417713|NCT00197184|4241939|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4417714|NCT00197184|4241940|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4417715|NCT00197184|4241938|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4417716|NCT00197184|4241939|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4417717|NCT00197184|4241940|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4417718|NCT00197184|4241938|B3|||Age||years|Mean|11.4|11.4|Standard Deviation|3.04|3.04|||
4417719|NCT00197184|4241939|B2|||Age||years|Mean|11.2|11.2|Standard Deviation|3.11|3.11|||
4417720|NCT00197184|4241940|B1|||Age||years|Mean|11.6|11.6|Standard Deviation|2.97|2.97|||
4417721|NCT00197145|4241963|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417722|NCT00197145|4241964|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417723|NCT00197145|4241965|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417724|NCT00197145|4241963|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417725|NCT00197145|4241964|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417726|NCT00197145|4241965|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417727|NCT00197145|4241963|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4417728|NCT00197145|4241964|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4417729|NCT00197145|4241965|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4417730|NCT00197145|4241963|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4417731|NCT00197145|4241964|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4417732|NCT00197145|4241965|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4417733|NCT00197145|4241963|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417734|NCT00197145|4241964|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417735|NCT00197145|4241965|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417736|NCT00197145|4241963|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417737|NCT00197145|4241964|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417738|NCT00197145|4241965|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417739|NCT00197145|4241963|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417740|NCT00197145|4241964|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417741|NCT00197145|4241965|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4417742|NCT00197145|4241963|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4417743|NCT00197145|4241964|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4417744|NCT00197145|4241965|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4417745|NCT00197145|4241963|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4417746|NCT00197145|4241964|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4417747|NCT00197145|4241965|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4417748|NCT00197145|4241963|B3|||Age||Years|Mean|45.8|45.8|Standard Deviation|6.42|6.42|||
4417749|NCT00197145|4241964|B2|||Age||Years|Mean|44.5|44.5|Standard Deviation|5.68|5.68|||
4417750|NCT00197145|4241965|B1|||Age||Years|Mean|46.8|46.8|Standard Deviation|7.03|7.03|||
4417751|NCT00197119|4242022|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4417752|NCT00197119|4242023|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4417753|NCT00197119|4242024|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4417754|NCT00197119|4242022|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4417755|NCT00197119|4242023|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4417756|NCT00197119|4242024|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4417757|NCT00197119|4242022|B3|||Age|Subjects' mean age at Year 6, the time of first enrollment into the long-term follow-up phase of the study.|years|Mean|19.4|19.4|Standard Deviation|1.08|1.08|||
4417758|NCT00197119|4242023|B2|||Age|Subjects' mean age at Year 6, the time of first enrollment into the long-term follow-up phase of the study.|years|Mean|19.4|19.4|Standard Deviation|1.12|1.12|||
4417759|NCT00197119|4242024|B1|||Age|Subjects' mean age at Year 6, the time of first enrollment into the long-term follow-up phase of the study.|years|Mean|19.4|19.4|Standard Deviation|1.04|1.04|||
4417760|NCT00197106|4242035|B3|||Asthma duration|Mean asthma duration before enrollment in study|years|Mean|5.6|5.6|Standard Deviation|3.0|3.0|||
4417761|NCT00197106|4242036|B2|||Asthma duration|Mean asthma duration before enrollment in study|years|Mean|5.5|5.5|Standard Deviation|3.0|3.0|||
4417762|NCT00197106|4242037|B1|||Asthma duration|Mean asthma duration before enrollment in study|years|Mean|5.7|5.7|Standard Deviation|3.1|3.1|||
4417763|NCT00197106|4242035|B3|African||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4417764|NCT00197106|4242036|B2|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4417765|NCT00197106|4242037|B1|African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4417766|NCT00197106|4242035|B3|African-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4417767|NCT00197106|4242036|B2|African-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4417768|NCT00197106|4242037|B1|African-American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4417769|NCT00197106|4242035|B3|Mixed||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4417770|NCT00197106|4242036|B2|Mixed||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4417771|NCT00197106|4242037|B1|Mixed||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4417772|NCT00197106|4242035|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|148|148.0||||||
4417773|NCT00197106|4242036|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4417774|NCT00197106|4242037|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|73|73.0||||||
4417775|NCT00197106|4242035|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4417776|NCT00197106|4242036|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4417777|NCT00197106|4242037|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4417778|NCT00197106|4242035|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4417779|NCT00197106|4242036|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4417780|NCT00197106|4242037|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4417781|NCT00197106|4242035|B3|||Age||years|Mean|9.3|9.3|Standard Deviation|1.8|1.8|||
4417782|NCT00197106|4242036|B2|||Age||years|Mean|9.3|9.3|Standard Deviation|1.9|1.9|||
4417783|NCT00197106|4242037|B1|||Age||years|Mean|9.4|9.4|Standard Deviation|1.8|1.8|||
4417784|NCT00197028|4242073|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4417785|NCT00197028|4242074|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4417786|NCT00197028|4242075|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4417787|NCT00197028|4242073|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4417788|NCT00197028|4242074|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4417789|NCT00197028|4242075|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4417790|NCT00197028|4242073|B3|||Age||Weeks|Mean|8.3|8.3|Standard Deviation|1.25|1.25|||
4417791|NCT00197028|4242074|B2|||Age||Weeks|Mean|8.3|8.3|Standard Deviation|1.08|1.08|||
4417792|NCT00197028|4242075|B1|||Age||Weeks|Mean|8.3|8.3|Standard Deviation|1.42|1.42|||
4417793|NCT00197015|4242116|B4||Male|Sex: Female, Male||Participants|Count of Participants|647|647.0||||||
4417794|NCT00197015|4242117|B3||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4417795|NCT00197015|4242118|B2||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4417796|NCT00197015|4242119|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4417797|NCT00197015|4242116|B4||Female|Sex: Female, Male||Participants|Count of Participants|594|594.0||||||
4417798|NCT00197015|4242117|B3||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4417799|NCT00197015|4242118|B2||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4417800|NCT00197015|4242119|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4417801|NCT00197015|4242116|B4|||Age||months|Mean|15.0|15.0|Standard Deviation|0.25|0.25|||
4417802|NCT00197015|4242117|B3|||Age||months|Mean|15.0|15.0|Standard Deviation|0.25|0.25|||
4417803|NCT00197015|4242118|B2|||Age||months|Mean|15.0|15.0|Standard Deviation|0.22|0.22|||
4417804|NCT00197015|4242119|B1|||Age||months|Mean|15.0|15.0|Standard Deviation|0.27|0.27|||
4417805|NCT00197002|4242177|B4||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4417806|NCT00197002|4242178|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4417807|NCT00197002|4242179|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4417808|NCT00197002|4242180|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4417809|NCT00197002|4242177|B4||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4417810|NCT00197002|4242178|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4417811|NCT00197002|4242179|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4417812|NCT00197002|4242180|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4417813|NCT00197002|4242177|B4|||Age||Months|Mean|15.0|15.0|Standard Deviation|0.18|0.18|||
4417814|NCT00197002|4242178|B3|||Age||Months|Mean|15.0|15.0|Standard Deviation|0.24|0.24|||
4417815|NCT00197002|4242179|B2|||Age||Months|Mean|15.0|15.0|Standard Deviation|0.09|0.09|||
4417816|NCT00197002|4242180|B1|||Age||Months|Mean|15.0|15.0|Standard Deviation|0.16|0.16|||
4417858|NCT00196976|4242230|B4|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|1|1.0||||||
4417817|NCT00196976|4242219|B15|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4417818|NCT00196976|4242220|B14|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|0|0.0||||||
4417819|NCT00196976|4242221|B13|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|1|1.0||||||
4417820|NCT00196976|4242222|B12|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|1|1.0||||||
4417821|NCT00196976|4242223|B11|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|1|1.0||||||
4417822|NCT00196976|4242224|B10|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417823|NCT00196976|4242225|B9|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417824|NCT00196976|4242226|B8|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417825|NCT00196976|4242227|B7|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417826|NCT00196976|4242228|B6|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417827|NCT00196976|4242229|B5|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417828|NCT00196976|4242230|B4|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417829|NCT00196976|4242231|B3|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417830|NCT00196976|4242232|B2|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417831|NCT00196976|4242233|B1|Arabic/north African||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417832|NCT00196976|4242219|B15|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4417833|NCT00196976|4242220|B14|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|43|43.0||||||
4417834|NCT00196976|4242221|B13|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|44|44.0||||||
4417835|NCT00196976|4242222|B12|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|31|31.0||||||
4417836|NCT00196976|4242223|B11|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|32|32.0||||||
4417837|NCT00196976|4242224|B10|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417838|NCT00196976|4242225|B9|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417839|NCT00196976|4242226|B8|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417840|NCT00196976|4242227|B7|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417841|NCT00196976|4242228|B6|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417842|NCT00196976|4242229|B5|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417843|NCT00196976|4242230|B4|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417844|NCT00196976|4242231|B3|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417845|NCT00196976|4242232|B2|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417846|NCT00196976|4242233|B1|White/Caucasian||Race/Ethnicity, Customized|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417847|NCT00196976|4242219|B15|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4417848|NCT00196976|4242220|B14|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417849|NCT00196976|4242221|B13|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417850|NCT00196976|4242222|B12|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417851|NCT00196976|4242223|B11|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417852|NCT00196976|4242224|B10|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|1|1.0||||||
4417853|NCT00196976|4242225|B9|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|1|1.0||||||
4417854|NCT00196976|4242226|B8|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417855|NCT00196976|4242227|B7|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417856|NCT00196976|4242228|B6|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417857|NCT00196976|4242229|B5|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417859|NCT00196976|4242231|B3|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417860|NCT00196976|4242232|B2|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417861|NCT00196976|4242233|B1|Black||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417862|NCT00196976|4242219|B15|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4417863|NCT00196976|4242220|B14|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417864|NCT00196976|4242221|B13|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417865|NCT00196976|4242222|B12|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417866|NCT00196976|4242223|B11|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417867|NCT00196976|4242224|B10|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417868|NCT00196976|4242225|B9|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417869|NCT00196976|4242226|B8|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417870|NCT00196976|4242227|B7|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417871|NCT00196976|4242228|B6|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417872|NCT00196976|4242229|B5|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417873|NCT00196976|4242230|B4|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|1|1.0||||||
4417874|NCT00196976|4242231|B3|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417875|NCT00196976|4242232|B2|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|1|1.0||||||
4417876|NCT00196976|4242233|B1|East/ south east asian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417877|NCT00196976|4242219|B15|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4417878|NCT00196976|4242220|B14|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417879|NCT00196976|4242221|B13|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417880|NCT00196976|4242222|B12|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417881|NCT00196976|4242223|B11|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417882|NCT00196976|4242224|B10|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417883|NCT00196976|4242225|B9|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|1|1.0||||||
4417884|NCT00196976|4242226|B8|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|2|2.0||||||
4417885|NCT00196976|4242227|B7|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417886|NCT00196976|4242228|B6|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|1|1.0||||||
4417887|NCT00196976|4242229|B5|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|1|1.0||||||
4417888|NCT00196976|4242230|B4|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417889|NCT00196976|4242231|B3|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|1|1.0||||||
4417890|NCT00196976|4242232|B2|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|0|0.0||||||
4417891|NCT00196976|4242233|B1|Arabic/ north african||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|1|1.0||||||
4417892|NCT00196976|4242219|B15|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4417893|NCT00196976|4242220|B14|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417894|NCT00196976|4242221|B13|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417895|NCT00196976|4242222|B12|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417896|NCT00196976|4242223|B11|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417897|NCT00196976|4242224|B10|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|51|51.0||||||
4417898|NCT00196976|4242225|B9|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|50|50.0||||||
4417899|NCT00196976|4242226|B8|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|50|50.0||||||
4417900|NCT00196976|4242227|B7|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|50|50.0||||||
4417901|NCT00196976|4242228|B6|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|53|53.0||||||
4417902|NCT00196976|4242229|B5|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|39|39.0||||||
4417903|NCT00196976|4242230|B4|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|38|38.0||||||
4417904|NCT00196976|4242231|B3|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|40|40.0||||||
4417905|NCT00196976|4242232|B2|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|40|40.0||||||
4417906|NCT00196976|4242233|B1|White/ Caucasian||Race/Ethnicity, Customized|Primary study|Participants|Count of Participants|38|38.0||||||
4417907|NCT00196976|4242219|B15||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4417908|NCT00196976|4242220|B14||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|20|20.0||||||
4417909|NCT00196976|4242221|B13||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|29|29.0||||||
4417910|NCT00196976|4242222|B12||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|17|17.0||||||
4417911|NCT00196976|4242223|B11||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|22|22.0||||||
4417912|NCT00196976|4242224|B10||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417913|NCT00196976|4242225|B9||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417914|NCT00196976|4242226|B8||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417915|NCT00196976|4242227|B7||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417916|NCT00196976|4242228|B6||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417917|NCT00196976|4242229|B5||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417918|NCT00196976|4242230|B4||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417919|NCT00196976|4242231|B3||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417920|NCT00196976|4242232|B2||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417921|NCT00196976|4242233|B1||Male|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417922|NCT00196976|4242219|B15||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4417923|NCT00196976|4242220|B14||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|23|23.0||||||
4417924|NCT00196976|4242221|B13||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|16|16.0||||||
4417925|NCT00196976|4242222|B12||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|15|15.0||||||
4417926|NCT00196976|4242223|B11||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|11|11.0||||||
4417927|NCT00196976|4242224|B10||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417928|NCT00196976|4242225|B9||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417929|NCT00196976|4242226|B8||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417930|NCT00196976|4242227|B7||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417931|NCT00196976|4242228|B6||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417932|NCT00196976|4242229|B5||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417933|NCT00196976|4242230|B4||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417934|NCT00196976|4242231|B3||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417935|NCT00196976|4242232|B2||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417936|NCT00196976|4242233|B1||Female|Sex: Female, Male|Booster study|Participants|Count of Participants|NA|||||||This group was only included in the Primary study.
4417937|NCT00196976|4242219|B15||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4417938|NCT00196976|4242220|B14||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417939|NCT00196976|4242221|B13||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417940|NCT00196976|4242222|B12||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417941|NCT00196976|4242223|B11||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417942|NCT00196976|4242224|B10||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|25|25.0||||||
4417943|NCT00196976|4242225|B9||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|25|25.0||||||
4417944|NCT00196976|4242226|B8||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|29|29.0||||||
4417945|NCT00196976|4242227|B7||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|34|34.0||||||
4417946|NCT00196976|4242228|B6||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|33|33.0||||||
4417947|NCT00196976|4242229|B5||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|21|21.0||||||
4417948|NCT00196976|4242230|B4||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|16|16.0||||||
4417949|NCT00196976|4242231|B3||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|24|24.0||||||
4417950|NCT00196976|4242232|B2||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|26|26.0||||||
4417951|NCT00196976|4242233|B1||Male|Sex: Female, Male|Primary study|Participants|Count of Participants|24|24.0||||||
4417952|NCT00196976|4242219|B15||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4417953|NCT00196976|4242220|B14||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417954|NCT00196976|4242221|B13||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417955|NCT00196976|4242222|B12||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417956|NCT00196976|4242223|B11||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|NA|||||||This group was only included in the Booster study.
4417957|NCT00196976|4242224|B10||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|27|27.0||||||
4417958|NCT00196976|4242225|B9||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|27|27.0||||||
4417959|NCT00196976|4242226|B8||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|23|23.0||||||
4417960|NCT00196976|4242227|B7||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|16|16.0||||||
4417961|NCT00196976|4242228|B6||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|21|21.0||||||
4417962|NCT00196976|4242229|B5||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|19|19.0||||||
4417963|NCT00196976|4242230|B4||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|24|24.0||||||
4417964|NCT00196976|4242231|B3||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|17|17.0||||||
4417965|NCT00196976|4242232|B2||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|15|15.0||||||
4417966|NCT00196976|4242233|B1||Female|Sex: Female, Male|Primary study|Participants|Count of Participants|15|15.0||||||
4417967|NCT00196976|4242219|B15|||Age|Booster study|Months|Mean|45.32|45.32|Standard Deviation|18.47|18.47|||
4417968|NCT00196976|4242220|B14|||Age|Booster study|Months|Mean|60.0|60.0|Standard Deviation|7.36|7.36|||
4417969|NCT00196976|4242221|B13|||Age|Booster study|Months|Mean|60.8|60.8|Standard Deviation|7.23|7.23|||
4417970|NCT00196976|4242222|B12|||Age|Booster study|Months|Mean|24.9|24.9|Standard Deviation|1.27|1.27|||
4417971|NCT00196976|4242223|B11|||Age|Booster study|Months|Mean|24.9|24.9|Standard Deviation|1.24|1.24|||
4417972|NCT00196976|4242224|B10|||Age|Booster study|Months|Mean|NA||Standard Deviation|NA||||This group was only included in the Primary study.
4417973|NCT00196976|4242225|B9|||Age|Booster study|Months|Mean|NA||Standard Deviation|NA||||This group was only included in the Primary study.
4417974|NCT00196976|4242226|B8|||Age|Booster study|Months|Mean|NA||Standard Deviation|NA||||This group was only included in the Primary study.
4417975|NCT00196976|4242227|B7|||Age|Booster study|Months|Mean|NA||Standard Deviation|NA||||This group was only included in the Primary study.
4417976|NCT00196976|4242228|B6|||Age|Booster study|Months|Mean|NA||Standard Deviation|NA||||This group was only included in the Primary study.
4417977|NCT00196976|4242229|B5|||Age|Booster study|Months|Mean|NA||Standard Deviation|NA||||This group was only included in the Primary study.
4417978|NCT00196976|4242230|B4|||Age|Booster study|Months|Mean|NA||Standard Deviation|NA||||This group was only included in the Primary study.
4417979|NCT00196976|4242231|B3|||Age|Booster study|Months|Mean|NA||Standard Deviation|NA||||This group was only included in the Primary study.
4417980|NCT00196976|4242232|B2|||Age|Booster study|Months|Mean|NA||Standard Deviation|NA||||This group was only included in the Primary study.
4417981|NCT00196976|4242233|B1|||Age|Booster study|Months|Mean|NA||Standard Deviation|NA||||This group was only included in the Primary study.
4417982|NCT00196976|4242219|B15|||Age|Primary study|Months|Mean|32.59|32.59|Standard Deviation|4.45|4.45|||
4417983|NCT00196976|4242220|B14|||Age|Primary study|Months|Mean|NA||Standard Deviation|NA||||This group was only included in the Booster study.
4417984|NCT00196976|4242221|B13|||Age|Primary study|Months|Mean|NA||Standard Deviation|NA||||This group was only included in the Booster study.
4417985|NCT00196976|4242222|B12|||Age|Primary study|Months|Mean|NA||Standard Deviation|NA||||This group was only included in the Booster study.
4417986|NCT00196976|4242223|B11|||Age|Primary study|Months|Mean|NA||Standard Deviation|NA||||This group was only included in the Booster study.
4417987|NCT00196976|4242224|B10|||Age|Primary study|Months|Mean|47.7|47.7|Standard Deviation|7.15|7.15|||
4417988|NCT00196976|4242225|B9|||Age|Primary study|Months|Mean|48|48.0|Standard Deviation|7.78|7.78|||
4417989|NCT00196976|4242226|B8|||Age|Primary study|Months|Mean|47.8|47.8|Standard Deviation|7.01|7.01|||
4417990|NCT00196976|4242227|B7|||Age|Primary study|Months|Mean|48|48.0|Standard Deviation|7.22|7.22|||
4417991|NCT00196976|4242228|B6|||Age|Primary study|Months|Mean|48.1|48.1|Standard Deviation|7.12|7.12|||
4417992|NCT00196976|4242229|B5|||Age|Primary study|Months|Mean|12.8|12.8|Standard Deviation|0.79|0.79|||
4417993|NCT00196976|4242230|B4|||Age|Primary study|Months|Mean|12.9|12.9|Standard Deviation|0.83|0.83|||
4417994|NCT00196976|4242231|B3|||Age|Primary study|Months|Mean|12.8|12.8|Standard Deviation|0.86|0.86|||
4417995|NCT00196976|4242232|B2|||Age|Primary study|Months|Mean|12.8|12.8|Standard Deviation|0.86|0.86|||
4417996|NCT00196976|4242233|B1|||Age|Primary study|Months|Mean|12.5|12.5|Standard Deviation|0.82|0.82|||
4417997|NCT00196937|4242439|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
4417998|NCT00196937|4242440|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4417999|NCT00196937|4242441|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4418000|NCT00196937|4242442|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4418001|NCT00196937|4242439|B4||Female|Gender||Participants|Count of Participants|666|666.0||||||
4418002|NCT00196937|4242440|B3||Female|Gender||Participants|Count of Participants|211|211.0||||||
4418003|NCT00196937|4242441|B2||Female|Gender||Participants|Count of Participants|226|226.0||||||
4418004|NCT00196937|4242442|B1||Female|Gender||Participants|Count of Participants|229|229.0||||||
4418005|NCT00196937|4242439|B4|||Age||years|Mean|34.9|34.9|Standard Deviation|12.38|12.38|||
4418006|NCT00196937|4242440|B3|||Age||years|Mean|49.6|49.6|Standard Deviation|2.80|2.8|||
4418007|NCT00196937|4242441|B2|||Age||years|Mean|35.5|35.5|Standard Deviation|6.02|6.02|||
4418008|NCT00196937|4242442|B1|||Age||years|Mean|20.9|20.9|Standard Deviation|2.67|2.67|||
4418009|NCT00196716|4242482|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4418010|NCT00196716|4242482|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4418011|NCT00196716|4242482|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418012|NCT00196716|4242482|B1|||Age||years|Mean|34.0|34.0|Standard Deviation|10.0|10.0|||
4418013|NCT00196326|4242492|B1|||Body Mass Index|n=2183|kg/m^2|Mean|26.7|26.7|Standard Deviation|6.65|6.65|||
4418014|NCT00196326|4242492|B1|||Weight||pounds|Mean|158.7|158.7|Standard Deviation|41.26|41.26|||
4418015|NCT00196326|4242492|B1|United States||Region of Enrollment||participants|Number|2185|2185.0||||||
4418016|NCT00196326|4242492|B1|Other||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4418017|NCT00196326|4242492|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|218|218.0||||||
4418018|NCT00196326|4242492|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|1627|1627.0||||||
4418019|NCT00196326|4242492|B1|Asian||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4418020|NCT00196326|4242492|B1|African-American||Race/Ethnicity, Customized||participants|Number|256|256.0||||||
4418021|NCT00196326|4242492|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418022|NCT00196326|4242492|B1||Female|Sex: Female, Male||Participants|Count of Participants|2185|2185.0||||||
4418023|NCT00196326|4242492|B1|||Age||years|Mean|27.7|27.7|Standard Deviation|5.80|5.8|||
4418024|NCT00196313|4242498|B3|||Body Mass Index||kg/m^2|Mean|25.6|25.6|Standard Deviation|7.04|7.04|||
4418025|NCT00196313|4242499|B2|||Body Mass Index||kg/m^2|Mean|26.4|26.4|Standard Deviation|7.16|7.16|||
4418026|NCT00196313|4242500|B1|||Body Mass Index||kg/m^2|Mean|24.8|24.8|Standard Deviation|6.88|6.88|||
4418027|NCT00196313|4242498|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4418028|NCT00196313|4242499|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4418029|NCT00196313|4242500|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4418030|NCT00196313|4242498|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4418031|NCT00196313|4242499|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4418032|NCT00196313|4242500|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4418033|NCT00196313|4242498|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4418034|NCT00196313|4242499|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4418035|NCT00196313|4242500|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4418036|NCT00196313|4242498|B3|African-American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4418037|NCT00196313|4242499|B2|African-American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4418038|NCT00196313|4242500|B1|African-American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4418039|NCT00196313|4242498|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418040|NCT00196313|4242499|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418041|NCT00196313|4242500|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418042|NCT00196313|4242498|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4418043|NCT00196313|4242499|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4418044|NCT00196313|4242500|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4418045|NCT00196313|4242498|B3|||Age||Years|Mean|15.5|15.5|Standard Deviation|1.29|1.29|||
4418046|NCT00196313|4242499|B2|||Age||Years|Mean|15.4|15.4|Standard Deviation|1.36|1.36|||
4418047|NCT00196313|4242500|B1|||Age||Years|Mean|15.5|15.5|Standard Deviation|1.23|1.23|||
4418048|NCT00196196|4242515|B1|United States||Region of Enrollment||participants|Number|267|267.0||||||
4418049|NCT00196196|4242515|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4418050|NCT00196196|4242515|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4418051|NCT00196196|4242515|B1|||Age||years|Mean|57|57.0|Standard Deviation|26.1|26.1|||
4418052|NCT00196196|4242515|B1||>=65 years|Age||Participants|Count of Participants|142|142.0||||||
4418053|NCT00196196|4242515|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4418054|NCT00196196|4242515|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4418055|NCT00196105|4242520|B4|||Karnofsky Index|"The Karnofsky index runs from 100 to 0, where 100 is perfect health and 0 is death."|Units on a Scale|Mean|80.8|80.8|Standard Deviation|9.5|9.5|||
4418056|NCT00196105|4242521|B3|||Karnofsky Index|"The Karnofsky index runs from 100 to 0, where 100 is perfect health and 0 is death."|Units on a Scale|Mean|81.2|81.2|Standard Deviation|9.2|9.2|||
4418057|NCT00196105|4242522|B2|||Karnofsky Index|"The Karnofsky index runs from 100 to 0, where 100 is perfect health and 0 is death."|Units on a Scale|Mean|80.6|80.6|Standard Deviation|9.9|9.9|||
4418058|NCT00196105|4242523|B1|||Karnofsky Index|"The Karnofsky index runs from 100 to 0, where 100 is perfect health and 0 is death."|Units on a Scale|Mean|80.5|80.5|Standard Deviation|9.5|9.5|||
4418059|NCT00196105|4242520|B4|||Bilirubin||mg/dL|Mean|8.8|8.8|Standard Deviation|8.2|8.2|||
4418060|NCT00196105|4242521|B3|||Bilirubin||mg/dL|Mean|8.3|8.3|Standard Deviation|8.7|8.7|||
4418061|NCT00196105|4242522|B2|||Bilirubin||mg/dL|Mean|8.7|8.7|Standard Deviation|7.3|7.3|||
4418062|NCT00196105|4242523|B1|||Bilirubin||mg/dL|Mean|9.6|9.6|Standard Deviation|8.7|8.7|||
4418063|NCT00196105|4242520|B4|Patients without Tumor||Tumor Diagnosis||Participants|Number|3|3.0||||||
4418064|NCT00196105|4242521|B3|Patients without Tumor||Tumor Diagnosis||Participants|Number|1|1.0||||||
4418065|NCT00196105|4242522|B2|Patients without Tumor||Tumor Diagnosis||Participants|Number|1|1.0||||||
4418066|NCT00196105|4242523|B1|Patients without Tumor||Tumor Diagnosis||Participants|Number|1|1.0||||||
4418067|NCT00196105|4242520|B4|Patients with Other Cancer||Tumor Diagnosis||Participants|Number|13|13.0||||||
4418068|NCT00196105|4242521|B3|Patients with Other Cancer||Tumor Diagnosis||Participants|Number|3|3.0||||||
4418069|NCT00196105|4242522|B2|Patients with Other Cancer||Tumor Diagnosis||Participants|Number|7|7.0||||||
4418070|NCT00196105|4242523|B1|Patients with Other Cancer||Tumor Diagnosis||Participants|Number|3|3.0||||||
4418071|NCT00196105|4242520|B4|Patients with Gallbladder Cancer||Tumor Diagnosis||Participants|Number|3|3.0||||||
4418072|NCT00196105|4242521|B3|Patients with Gallbladder Cancer||Tumor Diagnosis||Participants|Number|2|2.0||||||
4418073|NCT00196105|4242522|B2|Patients with Gallbladder Cancer||Tumor Diagnosis||Participants|Number|0|0.0||||||
4418074|NCT00196105|4242523|B1|Patients with Gallbladder Cancer||Tumor Diagnosis||Participants|Number|1|1.0||||||
4418075|NCT00196105|4242520|B4|Patients with Cholangiocarcinoma||Tumor Diagnosis||Participants|Number|17|17.0||||||
4418076|NCT00196105|4242521|B3|Patients with Cholangiocarcinoma||Tumor Diagnosis||Participants|Number|5|5.0||||||
4418077|NCT00196105|4242522|B2|Patients with Cholangiocarcinoma||Tumor Diagnosis||Participants|Number|5|5.0||||||
4418078|NCT00196105|4242523|B1|Patients with Cholangiocarcinoma||Tumor Diagnosis||Participants|Number|7|7.0||||||
4418079|NCT00196105|4242520|B4|Patients with Metastatic Cancer||Tumor Diagnosis||Participants|Number|24|24.0||||||
4418080|NCT00196105|4242521|B3|Patients with Metastatic Cancer||Tumor Diagnosis||Participants|Number|8|8.0||||||
4418081|NCT00196105|4242522|B2|Patients with Metastatic Cancer||Tumor Diagnosis||Participants|Number|12|12.0||||||
4418082|NCT00196105|4242523|B1|Patients with Metastatic Cancer||Tumor Diagnosis||Participants|Number|4|4.0||||||
4418083|NCT00196105|4242520|B4|Patients with Pancreatic Cancer||Tumor Diagnosis||Participants|Number|181|181.0||||||
4418084|NCT00196105|4242521|B3|Patients with Pancreatic Cancer||Tumor Diagnosis||Participants|Number|70|70.0||||||
4418085|NCT00196105|4242522|B2|Patients with Pancreatic Cancer||Tumor Diagnosis||Participants|Number|63|63.0||||||
4418086|NCT00196105|4242523|B1|Patients with Pancreatic Cancer||Tumor Diagnosis||Participants|Number|48|48.0||||||
4418087|NCT00196105|4242520|B4|Patients without Previous Plastic Stent||Previous Plastic Stent||Participants|Number|127|127.0||||||
4418088|NCT00196105|4242521|B3|Patients without Previous Plastic Stent||Previous Plastic Stent||Participants|Number|42|42.0||||||
4418089|NCT00196105|4242522|B2|Patients without Previous Plastic Stent||Previous Plastic Stent||Participants|Number|53|53.0||||||
4418090|NCT00196105|4242523|B1|Patients without Previous Plastic Stent||Previous Plastic Stent||Participants|Number|32|32.0||||||
4418091|NCT00196105|4242520|B4|Patients with Previous Plastic Stent||Previous Plastic Stent||Participants|Number|114|114.0||||||
4418092|NCT00196105|4242521|B3|Patients with Previous Plastic Stent||Previous Plastic Stent||Participants|Number|47|47.0||||||
4418093|NCT00196105|4242522|B2|Patients with Previous Plastic Stent||Previous Plastic Stent||Participants|Number|35|35.0||||||
4418094|NCT00196105|4242523|B1|Patients with Previous Plastic Stent||Previous Plastic Stent||Participants|Number|32|32.0||||||
4418095|NCT00196105|4242520|B4|Patients without Biliary Sphincterotomy||Biliary Sphincterotomy||Participants|Number|103|103.0||||||
4418096|NCT00196105|4242521|B3|Patients without Biliary Sphincterotomy||Biliary Sphincterotomy||Participants|Number|40|40.0||||||
4418097|NCT00196105|4242522|B2|Patients without Biliary Sphincterotomy||Biliary Sphincterotomy||Participants|Number|38|38.0||||||
4418098|NCT00196105|4242523|B1|Patients without Biliary Sphincterotomy||Biliary Sphincterotomy||Participants|Number|25|25.0||||||
4418099|NCT00196105|4242520|B4|Patients with Biliary Sphincterotomy||Biliary Sphincterotomy||Participants|Number|138|138.0||||||
4418100|NCT00196105|4242521|B3|Patients with Biliary Sphincterotomy||Biliary Sphincterotomy||Participants|Number|49|49.0||||||
4418101|NCT00196105|4242522|B2|Patients with Biliary Sphincterotomy||Biliary Sphincterotomy||Participants|Number|50|50.0||||||
4418102|NCT00196105|4242523|B1|Patients with Biliary Sphincterotomy||Biliary Sphincterotomy||Participants|Number|39|39.0||||||
4418103|NCT00196105|4242520|B4||Male|Sex: Female, Male||Participants|Count of Participants|126.0|126.0||||||
4418104|NCT00196105|4242521|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4418105|NCT00196105|4242522|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4418106|NCT00196105|4242523|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4418107|NCT00196105|4242520|B4||Female|Sex: Female, Male||Participants|Count of Participants|115.0|115.0||||||
4418108|NCT00196105|4242521|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4418109|NCT00196105|4242522|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4418110|NCT00196105|4242523|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4418111|NCT00196105|4242520|B4|||Age||Years|Mean|71.9|71.9|Full Range|||41.0|96.0|
4418112|NCT00196105|4242521|B3|||Age||Years|Mean|71.5|71.5|Full Range|||49.0|96.0|
4418113|NCT00196105|4242522|B2|||Age||Years|Mean|72.8|72.8|Full Range|||48.0|94.0|
4418114|NCT00196105|4242523|B1|||Age||Years|Mean|71.3|71.3|Full Range|||41.0|90.0|
4418115|NCT00195819|4242545|B1|Canada||Region of Enrollment||participants|Number|82|82.0||||||
4418116|NCT00195819|4242545|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4418117|NCT00195819|4242545|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4418118|NCT00195819|4242545|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|10.97|10.97|||
4418119|NCT00195819|4242545|B1|>=65 years||Age||participants|Number|2|2.0||||||
4418120|NCT00195819|4242545|B1|Between 40 and 65 years||Age||participants|Number|45|45.0||||||
4418121|NCT00195819|4242545|B1|<=40 years||Age||participants|Number|35|35.0||||||
4418122|NCT00195715|4242596|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4418123|NCT00195715|4242596|B1|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4418124|NCT00195715|4242596|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4418125|NCT00195715|4242596|B1|South Africa||Region of Enrollment||participants|Number|20|20.0||||||
4418126|NCT00195715|4242596|B1|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4418127|NCT00195715|4242596|B1|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4418128|NCT00195715|4242596|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4418129|NCT00195715|4242596|B1|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4418130|NCT00195715|4242596|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4418131|NCT00195715|4242596|B1|France||Region of Enrollment||participants|Number|24|24.0||||||
4418132|NCT00195715|4242596|B1|Denmark||Region of Enrollment||participants|Number|18|18.0||||||
4418133|NCT00195715|4242596|B1|Canada||Region of Enrollment||participants|Number|197|197.0||||||
4418134|NCT00195715|4242596|B1|Belgium||Region of Enrollment||participants|Number|66|66.0||||||
4418135|NCT00195715|4242596|B1|Australia||Region of Enrollment||participants|Number|40|40.0||||||
4418136|NCT00195715|4242596|B1|United States||Region of Enrollment||participants|Number|349|349.0||||||
4418137|NCT00195715|4242596|B1||Male|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4418138|NCT00195715|4242596|B1||Female|Sex: Female, Male||Participants|Count of Participants|485|485.0||||||
4418139|NCT00195715|4242596|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|11.75|11.75|||
4418140|NCT00195702|4242624|B4||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4418141|NCT00195702|4242625|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4418142|NCT00195702|4242626|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4418143|NCT00195702|4242627|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4418144|NCT00195702|4242624|B4||Female|Sex: Female, Male||Participants|Count of Participants|464|464.0||||||
4418145|NCT00195702|4242625|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4418146|NCT00195702|4242626|B2||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4418147|NCT00195702|4242627|B1||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4418148|NCT00195702|4242624|B4|>= 75 years||Age, Customized||participants|Number|32|32.0||||||
4418149|NCT00195702|4242625|B3|>= 75 years||Age, Customized||participants|Number|10|10.0||||||
4418150|NCT00195702|4242626|B2|>= 75 years||Age, Customized||participants|Number|11|11.0||||||
4418151|NCT00195702|4242627|B1|>= 75 years||Age, Customized||participants|Number|11|11.0||||||
4418152|NCT00195702|4242624|B4|Between 65 and 74 years||Age, Customized||participants|Number|130|130.0||||||
4418153|NCT00195702|4242625|B3|Between 65 and 74 years||Age, Customized||participants|Number|35|35.0||||||
4418154|NCT00195702|4242626|B2|Between 65 and 74 years||Age, Customized||participants|Number|54|54.0||||||
4418155|NCT00195702|4242627|B1|Between 65 and 74 years||Age, Customized||participants|Number|41|41.0||||||
4418156|NCT00195702|4242624|B4|Between 40 and 64 years||Age, Customized||participants|Number|402|402.0||||||
4418157|NCT00195702|4242625|B3|Between 40 and 64 years||Age, Customized||participants|Number|137|137.0||||||
4418158|NCT00195702|4242626|B2|Between 40 and 64 years||Age, Customized||participants|Number|115|115.0||||||
4418159|NCT00195702|4242627|B1|Between 40 and 64 years||Age, Customized||participants|Number|150|150.0||||||
4418160|NCT00195702|4242624|B4|< 40 years||Age, Customized||participants|Number|55|55.0||||||
4418161|NCT00195702|4242625|B3|< 40 years||Age, Customized||participants|Number|18|18.0||||||
4418162|NCT00195702|4242626|B2|< 40 years||Age, Customized||participants|Number|27|27.0||||||
4418163|NCT00195702|4242627|B1|< 40 years||Age, Customized||participants|Number|10|10.0||||||
4418164|NCT00195676|4242696|B1|Germany||Region of Enrollment||participants|Number|36|36.0||||||
4418165|NCT00195676|4242696|B1|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4418166|NCT00195676|4242696|B1|Spain||Region of Enrollment||participants|Number|20|20.0||||||
4418167|NCT00195676|4242696|B1|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4418168|NCT00195676|4242696|B1|France||Region of Enrollment||participants|Number|45|45.0||||||
4418169|NCT00195676|4242696|B1|Belgium||Region of Enrollment||participants|Number|15|15.0||||||
4418170|NCT00195676|4242696|B1|Austria||Region of Enrollment||participants|Number|34|34.0||||||
4418171|NCT00195676|4242696|B1|Canada||Region of Enrollment||participants|Number|501|501.0||||||
4418172|NCT00195676|4242696|B1|United States||Region of Enrollment||participants|Number|802|802.0||||||
4418173|NCT00195676|4242696|B1||Male|Sex: Female, Male||Participants|Count of Participants|998|998.0||||||
4418174|NCT00195676|4242696|B1||Female|Sex: Female, Male||Participants|Count of Participants|470|470.0||||||
4418175|NCT00195676|4242696|B1|||Age||years|Mean|44.1|44.1|Standard Deviation|12.75|12.75|||
4418176|NCT00195663|4242707|B4||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4418177|NCT00195663|4242708|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4418178|NCT00195663|4242709|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4418179|NCT00195663|4242710|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4418180|NCT00195663|4242707|B4||Female|Sex: Female, Male||Participants|Count of Participants|595|595.0||||||
4418181|NCT00195663|4242708|B3||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4418182|NCT00195663|4242709|B2||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4418183|NCT00195663|4242710|B1||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4418184|NCT00195663|4242707|B4|||Age||years|Mean|52.0|52.0|Standard Deviation|13.5|13.5|||
4418185|NCT00195663|4242708|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|14.0|14.0|||
4418186|NCT00195663|4242709|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|13.5|13.5|||
4418187|NCT00195663|4242710|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|13.1|13.1|||
4418188|NCT00195650|4242806|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4418189|NCT00195650|4242806|B1||Female|Sex: Female, Male||Participants|Count of Participants|661|661.0||||||
4418190|NCT00195650|4242806|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|12.19|12.19|||
4418191|NCT00195507|4242820|B3|Sweden||Region of Enrollment||participants|Number|33|33.0||||||
4418192|NCT00195507|4242821|B2|Sweden||Region of Enrollment||participants|Number|17|17.0||||||
4418193|NCT00195507|4242822|B1|Sweden||Region of Enrollment||participants|Number|16|16.0||||||
4418194|NCT00195507|4242820|B3|Norway||Region of Enrollment||participants|Number|15|15.0||||||
4418195|NCT00195507|4242821|B2|Norway||Region of Enrollment||participants|Number|8|8.0||||||
4418196|NCT00195507|4242822|B1|Norway||Region of Enrollment||participants|Number|7|7.0||||||
4418197|NCT00195507|4242820|B3|Germany||Region of Enrollment||participants|Number|115|115.0||||||
4418198|NCT00195507|4242821|B2|Germany||Region of Enrollment||participants|Number|58|58.0||||||
4418199|NCT00195507|4242822|B1|Germany||Region of Enrollment||participants|Number|57|57.0||||||
4418200|NCT00195507|4242820|B3|Netherlands||Region of Enrollment||participants|Number|48|48.0||||||
4418201|NCT00195507|4242821|B2|Netherlands||Region of Enrollment||participants|Number|25|25.0||||||
4418202|NCT00195507|4242822|B1|Netherlands||Region of Enrollment||participants|Number|23|23.0||||||
4418203|NCT00195507|4242820|B3|Denmark||Region of Enrollment||participants|Number|19|19.0||||||
4418204|NCT00195507|4242821|B2|Denmark||Region of Enrollment||participants|Number|9|9.0||||||
4418205|NCT00195507|4242822|B1|Denmark||Region of Enrollment||participants|Number|10|10.0||||||
4418206|NCT00195507|4242820|B3|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4418207|NCT00195507|4242821|B2|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4418208|NCT00195507|4242822|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4418209|NCT00195507|4242820|B3|Belgium||Region of Enrollment||participants|Number|43|43.0||||||
4418210|NCT00195507|4242821|B2|Belgium||Region of Enrollment||participants|Number|21|21.0||||||
4418211|NCT00195507|4242822|B1|Belgium||Region of Enrollment||participants|Number|22|22.0||||||
4418212|NCT00195507|4242820|B3|Hungary||Region of Enrollment||participants|Number|5|5.0||||||
4418213|NCT00195507|4242821|B2|Hungary||Region of Enrollment||participants|Number|3|3.0||||||
4418214|NCT00195507|4242822|B1|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4418215|NCT00195507|4242820|B3|Czech Republic||Region of Enrollment||participants|Number|6|6.0||||||
4418216|NCT00195507|4242821|B2|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4418217|NCT00195507|4242822|B1|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4418218|NCT00195507|4242820|B3|France||Region of Enrollment||participants|Number|102|102.0||||||
4418219|NCT00195507|4242821|B2|France||Region of Enrollment||participants|Number|52|52.0||||||
4418220|NCT00195507|4242822|B1|France||Region of Enrollment||participants|Number|50|50.0||||||
4418221|NCT00195507|4242820|B3|Italy||Region of Enrollment||participants|Number|79|79.0||||||
4418222|NCT00195507|4242821|B2|Italy||Region of Enrollment||participants|Number|39|39.0||||||
4418223|NCT00195507|4242822|B1|Italy||Region of Enrollment||participants|Number|40|40.0||||||
4418224|NCT00195507|4242820|B3|Switzerland||Region of Enrollment||participants|Number|7|7.0||||||
4418225|NCT00195507|4242821|B2|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4418226|NCT00195507|4242822|B1|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4418227|NCT00195507|4242820|B3|United Kingdom||Region of Enrollment||participants|Number|119|119.0||||||
4418228|NCT00195507|4242821|B2|United Kingdom||Region of Enrollment||participants|Number|60|60.0||||||
4418229|NCT00195507|4242822|B1|United Kingdom||Region of Enrollment||participants|Number|59|59.0||||||
4418230|NCT00195507|4242820|B3|Austria||Region of Enrollment||participants|Number|24|24.0||||||
4418231|NCT00195507|4242821|B2|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4418232|NCT00195507|4242822|B1|Austria||Region of Enrollment||participants|Number|13|13.0||||||
4418233|NCT00195507|4242820|B3|Turkey||Region of Enrollment||participants|Number|18|18.0||||||
4418234|NCT00195507|4242821|B2|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
4418235|NCT00195507|4242822|B1|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
4418236|NCT00195507|4242820|B3|Spain||Region of Enrollment||participants|Number|38|38.0||||||
4418237|NCT00195507|4242821|B2|Spain||Region of Enrollment||participants|Number|19|19.0||||||
4418238|NCT00195507|4242822|B1|Spain||Region of Enrollment||participants|Number|19|19.0||||||
4418239|NCT00195507|4242820|B3|Finland||Region of Enrollment||participants|Number|10|10.0||||||
4418240|NCT00195507|4242821|B2|Finland||Region of Enrollment||participants|Number|5|5.0||||||
4418241|NCT00195507|4242822|B1|Finland||Region of Enrollment||participants|Number|5|5.0||||||
4418242|NCT00195507|4242820|B3|Greece||Region of Enrollment||participants|Number|17|17.0||||||
4418243|NCT00195507|4242821|B2|Greece||Region of Enrollment||participants|Number|8|8.0||||||
4418244|NCT00195507|4242822|B1|Greece||Region of Enrollment||participants|Number|9|9.0||||||
4418245|NCT00195507|4242820|B3|Portugal||Region of Enrollment||participants|Number|12|12.0||||||
4418246|NCT00195507|4242821|B2|Portugal||Region of Enrollment||participants|Number|6|6.0||||||
4418247|NCT00195507|4242822|B1|Portugal||Region of Enrollment||participants|Number|6|6.0||||||
4418248|NCT00195507|4242820|B3||Male|Sex: Female, Male||Participants|Count of Participants|517|517.0||||||
4418249|NCT00195507|4242821|B2||Male|Sex: Female, Male||Participants|Count of Participants|261|261.0||||||
4418250|NCT00195507|4242822|B1||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4418251|NCT00195507|4242820|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4418252|NCT00195507|4242821|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4418253|NCT00195507|4242822|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4418254|NCT00195507|4242820|B3|||Age||years|Mean|45.03|45.03|Standard Deviation|11.85|11.85|||
4418255|NCT00195507|4242821|B2|||Age||years|Mean|45.20|45.2|Standard Deviation|11.88|11.88|||
4418256|NCT00195507|4242822|B1|||Age||years|Mean|44.87|44.87|Standard Deviation|11.83|11.83|||
4418257|NCT00195494|4242835|B3||Male|Sex: Female, Male|Year 1 participants collected from Arms M and E+M equal the stated overall participant population of 542. 411 of those participants were then entered into Year 2 Arms E+M/E+M, M/M+E, E+M/E, M/M. This measure provides the gender population for Year 1 only in order to accurately reflect the overall baseline population of 542.|Participants|Count of Participants|144|144.0||||||
4418258|NCT00195494|4242836|B2||Male|Sex: Female, Male|Year 1 participants collected from Arms M and E+M equal the stated overall participant population of 542. 411 of those participants were then entered into Year 2 Arms E+M/E+M, M/M+E, E+M/E, M/M. This measure provides the gender population for Year 1 only in order to accurately reflect the overall baseline population of 542.|Participants|Count of Participants|70|70.0||||||
4418259|NCT00195494|4242837|B1||Male|Sex: Female, Male|Year 1 participants collected from Arms M and E+M equal the stated overall participant population of 542. 411 of those participants were then entered into Year 2 Arms E+M/E+M, M/M+E, E+M/E, M/M. This measure provides the gender population for Year 1 only in order to accurately reflect the overall baseline population of 542.|Participants|Count of Participants|74|74.0||||||
4418260|NCT00195494|4242835|B3||Female|Sex: Female, Male|Year 1 participants collected from Arms M and E+M equal the stated overall participant population of 542. 411 of those participants were then entered into Year 2 Arms E+M/E+M, M/M+E, E+M/E, M/M. This measure provides the gender population for Year 1 only in order to accurately reflect the overall baseline population of 542.|Participants|Count of Participants|398|398.0||||||
4418261|NCT00195494|4242836|B2||Female|Sex: Female, Male|Year 1 participants collected from Arms M and E+M equal the stated overall participant population of 542. 411 of those participants were then entered into Year 2 Arms E+M/E+M, M/M+E, E+M/E, M/M. This measure provides the gender population for Year 1 only in order to accurately reflect the overall baseline population of 542.|Participants|Count of Participants|204|204.0||||||
4418262|NCT00195494|4242837|B1||Female|Sex: Female, Male|Year 1 participants collected from Arms M and E+M equal the stated overall participant population of 542. 411 of those participants were then entered into Year 2 Arms E+M/E+M, M/M+E, E+M/E, M/M. This measure provides the gender population for Year 1 only in order to accurately reflect the overall baseline population of 542.|Participants|Count of Participants|194|194.0||||||
4418263|NCT00195494|4242835|B3|||Age|Year 1 Overall Number of Baseline Participants is 542|years|Median|52.00|52.0|Full Range|||18.0|84.0|
4418264|NCT00195494|4242836|B2|||Age|Year 1 Overall Number of Baseline Participants is 542|years|Median|52.50|52.5|Full Range|||18.0|82.0|
4418265|NCT00195494|4242837|B1|||Age|Year 1 Overall Number of Baseline Participants is 542|years|Median|51.50|51.5|Full Range|||20.0|84.0|
4418266|NCT00195442|4242860|B1||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4418267|NCT00195442|4242860|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418268|NCT00195442|4242860|B1|Adults ≥ 18 years of age||Age, Customized||participants|Number|182|182.0||||||
4418269|NCT00195442|4242860|B1|Children < 18 years of age||Age, Customized||participants|Number|106|106.0||||||
4418270|NCT00195429|4242877|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4418271|NCT00195429|4242878|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4418272|NCT00195429|4242879|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4418273|NCT00195429|4242877|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4418274|NCT00195429|4242878|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4418275|NCT00195429|4242879|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4418276|NCT00195429|4242877|B3|||Age||years|Mean|35.0|35.0|Standard Deviation|11.6|11.6|||
4418277|NCT00195429|4242878|B2|||Age||years|Mean|34.7|34.7|Standard Deviation|12.2|12.2|||
4418278|NCT00195429|4242879|B1|||Age||years|Mean|35.3|35.3|Standard Deviation|11.3|11.3|||
4418279|NCT00195403|4242888|B1|Psoriatic Arthritis||Primary diagnosis||participants|Number|3|3.0||||||
4418280|NCT00195403|4242888|B1|Rheumatoid Arthritis||Primary diagnosis||participants|Number|475|475.0||||||
4418281|NCT00195403|4242888|B1|Ankylosing Spondylitis||Primary diagnosis||participants|Number|520|520.0||||||
4418282|NCT00195403|4242888|B1||Male|Sex: Female, Male||Participants|Count of Participants|533|533.0||||||
4418283|NCT00195403|4242888|B1||Female|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
4418284|NCT00195403|4242888|B1|||Age||years|Mean|40.21|40.21|Standard Deviation|15.13|15.13|||
4418285|NCT00195351|4242894|B3|Chile||Region of Enrollment||participants|Number|18|18.0||||||
4418286|NCT00195351|4242895|B2|Chile||Region of Enrollment||participants|Number|12|12.0||||||
4418287|NCT00195351|4242896|B1|Chile||Region of Enrollment||participants|Number|6|6.0||||||
4418288|NCT00195351|4242894|B3|Brazil||Region of Enrollment||participants|Number|46|46.0||||||
4418289|NCT00195351|4242895|B2|Brazil||Region of Enrollment||participants|Number|23|23.0||||||
4418290|NCT00195351|4242896|B1|Brazil||Region of Enrollment||participants|Number|23|23.0||||||
4418291|NCT00195351|4242894|B3|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
4418292|NCT00195351|4242895|B2|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4418293|NCT00195351|4242896|B1|Argentina||Region of Enrollment||participants|Number|4|4.0||||||
4418294|NCT00195351|4242894|B3|Canada||Region of Enrollment||participants|Number|64|64.0||||||
4418295|NCT00195351|4242895|B2|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4418296|NCT00195351|4242896|B1|Canada||Region of Enrollment||participants|Number|39|39.0||||||
4418297|NCT00195351|4242894|B3|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4418298|NCT00195351|4242895|B2|Mexico||Region of Enrollment||participants|Number|0|0.0||||||
4418299|NCT00195351|4242896|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4418300|NCT00195351|4242894|B3|United States||Region of Enrollment||participants|Number|332|332.0||||||
4418301|NCT00195351|4242895|B2|United States||Region of Enrollment||participants|Number|169|169.0||||||
4418302|NCT00195351|4242896|B1|United States||Region of Enrollment||participants|Number|163|163.0||||||
4418303|NCT00195351|4242894|B3||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4418304|NCT00195351|4242895|B2||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4418305|NCT00195351|4242896|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4418306|NCT00195351|4242894|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4418307|NCT00195351|4242895|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4418308|NCT00195351|4242896|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4418309|NCT00195351|4242894|B3|||Age||years|Mean|48.48|48.48|Standard Deviation|17.74|17.74|||
4418310|NCT00195351|4242895|B2|||Age||years|Mean|48.79|48.79|Standard Deviation|17.46|17.46|||
4418311|NCT00195351|4242896|B1|||Age||years|Mean|48.17|48.17|Standard Deviation|18.05|18.05|||
4418312|NCT00195338|4242907|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4418313|NCT00195338|4242907|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4418314|NCT00195338|4242907|B1|||Age||years|Mean|50.20|50.2|Standard Deviation|13.93|13.93|||
4418315|NCT00195273|4242915|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4418316|NCT00195273|4242916|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4418317|NCT00195273|4242917|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4418318|NCT00195273|4242915|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4418319|NCT00195273|4242916|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4418320|NCT00195273|4242917|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4418321|NCT00195273|4242915|B3|||Age||years|Mean|60.31|60.31|Standard Deviation|10.04|10.04|||
4418322|NCT00195273|4242916|B2|||Age||years|Mean|59.60|59.6|Standard Deviation|10.10|10.1|||
4418323|NCT00195273|4242917|B1|||Age||years|Mean|61.00|61.0|Standard Deviation|10.00|10.0|||
4418324|NCT00195260|4242930|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4418325|NCT00195260|4242931|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4418326|NCT00195260|4242932|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4418327|NCT00195260|4242930|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4418328|NCT00195260|4242931|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4418329|NCT00195260|4242932|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||participants|0.0|||
4418330|NCT00195260|4242930|B3|||Age||years|Mean|59.10|59.1|Standard Deviation|11.95|11.95|||
4418331|NCT00195260|4242931|B2|||Age||years|Mean|60.30|60.3|Standard Deviation|11.48|11.48|||
4418332|NCT00195260|4242932|B1|||Age||years|Mean|57.00|57.0|Standard Deviation|12.67|12.67|||
4418333|NCT00195039|4243088|B1|Other||Prior radiation||Participants|Count of Participants|1|1.0||||||
4418334|NCT00195039|4243088|B1|Palliative to bone metastasis||Prior radiation||Participants|Count of Participants|3|3.0||||||
4418335|NCT00195039|4243088|B1|Prostate/prostate bed||Prior radiation||Participants|Count of Participants|21|21.0||||||
4418336|NCT00195039|4243088|B1|>/= 2||No. of previous chemotherapy regimens||Participants|Count of Participants|7|7.0||||||
4418337|NCT00195039|4243088|B1|1||No. of previous chemotherapy regimens||Participants|Count of Participants|19|19.0||||||
4418338|NCT00195039|4243088|B1|0||No. of previous chemotherapy regimens||Participants|Count of Participants|21|21.0||||||
4418339|NCT00195039|4243088|B1|4||No. of previous hormonal therapies||Participants|Count of Participants|6|6.0||||||
4418340|NCT00195039|4243088|B1|3||No. of previous hormonal therapies||Participants|Count of Participants|14|14.0||||||
4418341|NCT00195039|4243088|B1|2||No. of previous hormonal therapies||Participants|Count of Participants|21|21.0||||||
4418342|NCT00195039|4243088|B1|1||No. of previous hormonal therapies||Participants|Count of Participants|6|6.0||||||
4418343|NCT00195039|4243088|B1|||Cancer And Leukemia Group B (CALGB) prognostic score|Score based on participant's Opioid analgesic use (No-Yes), LDH (</= 1xULN - >1xULN), disease site (lymph node only, bone+lymph node, any visceral), ECOG (0-2), Albumin (1-6), Hemoglobin (7-17), Alkaline Phosphatase (33-4915), PSA (0-8103.1) Once all prognostic points for predictors have been determined, the prognostic points are added for each prognostic variable. The total scale range values are 0-280. Higher values for each variable indicate earlier predicted death.|points|Median|149|149.0|Full Range|||88.0|184.0|
4418344|NCT00195039|4243088|B1|||Alkaline phosphatase||IU/L|Median|99|99.0|Full Range|||23.0|1170.0|
4418345|NCT00195039|4243088|B1|||Hemoglobin||g/dL|Median|11.9|11.9|Full Range|||9.8|14.1|
4418346|NCT00195039|4243088|B1|||LDH||IU/L|Median|217.5|217.5|Full Range|||134.0|647.0|
4418379|NCT00195013|4243099|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4418380|NCT00195013|4243100|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4418347|NCT00195039|4243088|B1|2||ECOG performance scale|"0. Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|0|0.0||||||
4418348|NCT00195039|4243088|B1|1||ECOG performance scale|"0. Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|34|34.0||||||
4418349|NCT00195039|4243088|B1|0||ECOG performance scale|"0. Fully active, able to carry on all pre-disease performance without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work~Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours~Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours~Completely disabled; cannot carry on any selfcare; totally confined to bed or chair~Dead"|Participants|Count of Participants|13|13.0||||||
4418350|NCT00195039|4243088|B1|Other||Sites of metastases||Participants|Count of Participants|3|3.0||||||
4418351|NCT00195039|4243088|B1|Liver||Sites of metastases||Participants|Count of Participants|4|4.0||||||
4418352|NCT00195039|4243088|B1|Lung||Sites of metastases||Participants|Count of Participants|11|11.0||||||
4418353|NCT00195039|4243088|B1|Lymph Node||Sites of metastases||Participants|Count of Participants|28|28.0||||||
4418354|NCT00195039|4243088|B1|Bone||Sites of metastases||Participants|Count of Participants|46|46.0||||||
4418355|NCT00195039|4243088|B1|||PSA (ng/mL)||ng/mL|Median|74.4|74.4|Full Range|||3.31|2184.6|
4418356|NCT00195039|4243088|B1|unknown||Gleason sum|Gleason score is the sum of 2 numbers. Primary grade is where the cancer is most prominent (or common). It is then determined where the cancer is next most prominent and assigns that region the secondary grade. A score from 1-5 is assigned for each area based on how aggressive the tumor appears. A tumor with cells that appear close to normal is assigned a low Gleason score (6 or below); low-grade tumors are less likely to spread. A tumor with cells that appear clearly different from those of a normal prostate is assigned a high Gleason score (7 or above) and is more likely to spread.|participants|Number|2|2.0||||||
4418357|NCT00195039|4243088|B1|8-10||Gleason sum|Gleason score is the sum of 2 numbers. Primary grade is where the cancer is most prominent (or common). It is then determined where the cancer is next most prominent and assigns that region the secondary grade. A score from 1-5 is assigned for each area based on how aggressive the tumor appears. A tumor with cells that appear close to normal is assigned a low Gleason score (6 or below); low-grade tumors are less likely to spread. A tumor with cells that appear clearly different from those of a normal prostate is assigned a high Gleason score (7 or above) and is more likely to spread.|participants|Number|29|29.0||||||
4418358|NCT00195039|4243088|B1|7||Gleason sum|Gleason score is the sum of 2 numbers. Primary grade is where the cancer is most prominent (or common). It is then determined where the cancer is next most prominent and assigns that region the secondary grade. A score from 1-5 is assigned for each area based on how aggressive the tumor appears. A tumor with cells that appear close to normal is assigned a low Gleason score (6 or below); low-grade tumors are less likely to spread. A tumor with cells that appear clearly different from those of a normal prostate is assigned a high Gleason score (7 or above) and is more likely to spread.|participants|Number|10|10.0||||||
4418359|NCT00195039|4243088|B1|6||Gleason sum|Gleason score is the sum of 2 numbers. Primary grade is where the cancer is most prominent (or common). It is then determined where the cancer is next most prominent and assigns that region the secondary grade. A score from 1-5 is assigned for each area based on how aggressive the tumor appears. A tumor with cells that appear close to normal is assigned a low Gleason score (6 or below); low-grade tumors are less likely to spread. A tumor with cells that appear clearly different from those of a normal prostate is assigned a high Gleason score (7 or above) and is more likely to spread.|participants|Number|6|6.0||||||
4418360|NCT00195039|4243088|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4418361|NCT00195039|4243088|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418362|NCT00195039|4243088|B1|||Age||years|Median|73.9|73.9|Full Range|||49.7|90.4|
4418363|NCT00195013|4243099|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4418364|NCT00195013|4243100|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4418365|NCT00195013|4243101|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4418366|NCT00195013|4243099|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4418367|NCT00195013|4243099|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418368|NCT00195013|4243100|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418369|NCT00195013|4243101|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418370|NCT00195013|4243099|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4418371|NCT00195013|4243100|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4418372|NCT00195013|4243101|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4418373|NCT00195013|4243099|B3|||Age||years|Median|58|58.0|Full Range|||37.0|74.0|
4418374|NCT00195013|4243100|B2|||Age||years|Median|55|55.0|Full Range|||37.0|74.0|
4418375|NCT00195013|4243101|B1|||Age||years|Median|58|58.0|Full Range|||39.0|69.0|
4418376|NCT00195013|4243099|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4418377|NCT00195013|4243100|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4418378|NCT00195013|4243101|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4418381|NCT00195013|4243101|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4418382|NCT00195013|4243099|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418383|NCT00195013|4243100|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418384|NCT00195013|4243101|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418385|NCT00194987|4243108|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4418386|NCT00194987|4243109|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4418387|NCT00194987|4243110|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4418388|NCT00194987|4243108|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4418389|NCT00194987|4243109|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4418390|NCT00194987|4243110|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4418391|NCT00194987|4243108|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418392|NCT00194987|4243109|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418393|NCT00194987|4243110|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418394|NCT00194987|4243108|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4418395|NCT00194987|4243109|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4418396|NCT00194987|4243110|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4418397|NCT00194987|4243108|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4418398|NCT00194987|4243109|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4418399|NCT00194987|4243110|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4418400|NCT00194987|4243108|B3||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4418401|NCT00194987|4243109|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4418402|NCT00194987|4243110|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4418403|NCT00194987|4243108|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418404|NCT00194987|4243109|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418405|NCT00194987|4243110|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418406|NCT00194896|4243123|B5|United States||Region of Enrollment||participants|Number|64|64.0||||||
4418407|NCT00194896|4243124|B4|United States||Region of Enrollment||participants|Number|21|21.0||||||
4418408|NCT00194896|4243125|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4418409|NCT00194896|4243126|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4418410|NCT00194896|4243127|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4418411|NCT00194896|4243123|B5||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4418412|NCT00194896|4243124|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4418413|NCT00194896|4243125|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4418414|NCT00194896|4243126|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4418415|NCT00194896|4243127|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4418416|NCT00194896|4243123|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4418417|NCT00194896|4243124|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4418418|NCT00194896|4243125|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4418419|NCT00194896|4243126|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4418420|NCT00194896|4243127|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4418421|NCT00194896|4243123|B5|||Age||years|Mean|55.8|55.8|Standard Deviation|1.6|1.6|||
4418422|NCT00194896|4243124|B4|||Age||years|Mean|57.5|57.5|Standard Deviation|6.9|6.9|||
4418423|NCT00194896|4243125|B3|||Age||years|Mean|53.7|53.7|Standard Deviation|9|9.0|||
4418424|NCT00194896|4243126|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|8.7|8.7|||
4418425|NCT00194896|4243127|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|8.8|8.8|||
4418426|NCT00194896|4243123|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4418427|NCT00194896|4243124|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4418428|NCT00194896|4243125|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4418429|NCT00194896|4243126|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4418430|NCT00194896|4243127|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4418431|NCT00194896|4243123|B5||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4418432|NCT00194896|4243124|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4418433|NCT00194896|4243125|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4418434|NCT00194896|4243126|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4418435|NCT00194896|4243127|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4418436|NCT00194896|4243123|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418437|NCT00194896|4243124|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418438|NCT00194896|4243125|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418439|NCT00194896|4243126|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418440|NCT00194896|4243127|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418441|NCT00194792|4243144|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4418442|NCT00194792|4243144|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4418443|NCT00194792|4243144|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4418444|NCT00194792|4243144|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4418445|NCT00194792|4243144|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4418446|NCT00194792|4243144|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4418447|NCT00194792|4243144|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4418448|NCT00194792|4243144|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4418449|NCT00194792|4243144|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4418450|NCT00194792|4243144|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4418451|NCT00194792|4243144|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418452|NCT00194792|4243144|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4418453|NCT00194792|4243144|B1|||Age||years|Median|55|55.0|Full Range|||35.0|76.0|
4418454|NCT00194779|4243154|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4418455|NCT00194779|4243154|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4418456|NCT00194779|4243154|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4418457|NCT00194779|4243154|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4418458|NCT00194779|4243154|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4418459|NCT00194779|4243154|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4418460|NCT00194779|4243154|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4418461|NCT00194779|4243154|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4418462|NCT00194779|4243154|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4418463|NCT00194779|4243154|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4418464|NCT00194779|4243154|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418465|NCT00194779|4243154|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4418466|NCT00194779|4243154|B1|||Age||years|Median|47|47.0|Full Range|||27.0|66.0|
4418467|NCT00194675|4243166|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4418468|NCT00194675|4243167|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4418469|NCT00194675|4243168|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4418470|NCT00194675|4243166|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4418471|NCT00194675|4243167|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4418472|NCT00194675|4243168|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4418473|NCT00194675|4243166|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418474|NCT00194675|4243167|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418475|NCT00194675|4243168|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418476|NCT00194675|4243166|B3|Between 50 and 82 years||Age, Customized||participants|Median|63.55|63.55|Standard Deviation|6.8|6.8|||
4418477|NCT00194675|4243167|B2|Between 50 and 82 years||Age, Customized||participants|Median|63.6|63.6|Standard Deviation|5.5|5.5|||
4418478|NCT00194675|4243168|B1|Between 50 and 82 years||Age, Customized||participants|Median|63.5|63.5|Standard Deviation|8.0|8.0|||
4418479|NCT00194610|4243185|B3|Males||Sex/Gender, Customized||participants|Number|0|0.0||||||
4418480|NCT00194610|4243186|B2|Males||Sex/Gender, Customized||participants|Number|0|0.0||||||
4418481|NCT00194610|4243187|B1|Males||Sex/Gender, Customized||participants|Number|0|0.0||||||
4418482|NCT00194610|4243185|B3|Females||Sex/Gender, Customized||participants|Number|20|20.0||||||
4418483|NCT00194610|4243186|B2|Females||Sex/Gender, Customized||participants|Number|9|9.0||||||
4418484|NCT00194610|4243187|B1|Females||Sex/Gender, Customized||participants|Number|11|11.0||||||
4418485|NCT00194610|4243185|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4418486|NCT00194610|4243186|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4418487|NCT00194610|4243187|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4418488|NCT00194610|4243185|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4418489|NCT00194610|4243186|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4418490|NCT00194610|4243187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4418491|NCT00194610|4243185|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418492|NCT00194610|4243186|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418493|NCT00194610|4243187|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418494|NCT00194532|4243194|B3|United States||Region of Enrollment||participants|Number|300|300.0||||||
4418495|NCT00194532|4243195|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
4418496|NCT00194532|4243196|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
4418497|NCT00194532|4243194|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418498|NCT00194532|4243195|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418499|NCT00194532|4243196|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418500|NCT00194532|4243194|B3||Female|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4418501|NCT00194532|4243195|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4418502|NCT00194532|4243196|B1||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4418503|NCT00194532|4243194|B3|||Age||years|Mean|24|24.0|Full Range|||17.0|55.0|
4418504|NCT00194532|4243195|B2|||Age||years|Mean|23|23.0|Full Range|||17.0|44.0|
4418505|NCT00194532|4243196|B1|||Age||years|Mean|24|24.0|Full Range|||18.0|55.0|
4418506|NCT00194129|4243205|B3|Bipolar II disorder||Illness Type|Bipolar I disorder involves periods of severe mood episodes from mania to depression. Bipolar II disorder is a milder form of mood elevation, involving milder episodes of hypomania that alternate with periods of severe depression.|participants|Number|5|5.0||||||
4418507|NCT00194129|4243206|B2|Bipolar II disorder||Illness Type|Bipolar I disorder involves periods of severe mood episodes from mania to depression. Bipolar II disorder is a milder form of mood elevation, involving milder episodes of hypomania that alternate with periods of severe depression.|participants|Number|3|3.0||||||
4418508|NCT00194129|4243207|B1|Bipolar II disorder||Illness Type|Bipolar I disorder involves periods of severe mood episodes from mania to depression. Bipolar II disorder is a milder form of mood elevation, involving milder episodes of hypomania that alternate with periods of severe depression.|participants|Number|2|2.0||||||
4418509|NCT00194129|4243205|B3|Bipolar I disorder||Illness Type|Bipolar I disorder involves periods of severe mood episodes from mania to depression. Bipolar II disorder is a milder form of mood elevation, involving milder episodes of hypomania that alternate with periods of severe depression.|participants|Number|26|26.0||||||
4418510|NCT00194129|4243206|B2|Bipolar I disorder||Illness Type|Bipolar I disorder involves periods of severe mood episodes from mania to depression. Bipolar II disorder is a milder form of mood elevation, involving milder episodes of hypomania that alternate with periods of severe depression.|participants|Number|13|13.0||||||
4418511|NCT00194129|4243207|B1|Bipolar I disorder||Illness Type|Bipolar I disorder involves periods of severe mood episodes from mania to depression. Bipolar II disorder is a milder form of mood elevation, involving milder episodes of hypomania that alternate with periods of severe depression.|participants|Number|13|13.0||||||
4418512|NCT00194129|4243205|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4418513|NCT00194129|4243206|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4418514|NCT00194129|4243207|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4418515|NCT00194129|4243205|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4418516|NCT00194129|4243206|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4418517|NCT00194129|4243207|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4418518|NCT00194129|4243205|B3|||Age||years|Mean|38.4|38.4|Standard Deviation|10.7|10.7|||
4418519|NCT00194129|4243206|B2|||Age||years|Mean|40|40.0|Standard Deviation|10.6|10.6|||
4418520|NCT00194129|4243207|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|10.9|10.9|||
4418521|NCT00194077|4243221|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4418522|NCT00194077|4243222|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4418523|NCT00194077|4243223|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4418524|NCT00194077|4243221|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4418525|NCT00194077|4243222|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4418526|NCT00194077|4243223|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4418527|NCT00194077|4243221|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4418528|NCT00194077|4243222|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4418529|NCT00194077|4243223|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4418530|NCT00194077|4243221|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4418531|NCT00194077|4243222|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4418532|NCT00194077|4243223|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4418533|NCT00194077|4243221|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4418534|NCT00194077|4243222|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4418535|NCT00194077|4243223|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4418536|NCT00194077|4243221|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4418537|NCT00194077|4243222|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4418538|NCT00194077|4243223|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4418539|NCT00194025|4243230|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4418540|NCT00194025|4243230|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4418541|NCT00194025|4243230|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4418542|NCT00194025|4243230|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|9.6|9.6|||
4418543|NCT00194025|4243230|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4418544|NCT00194025|4243230|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4418545|NCT00194025|4243230|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418546|NCT00194012|4243243|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4418547|NCT00194012|4243244|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4418548|NCT00194012|4243245|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4418549|NCT00194012|4243243|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4418550|NCT00194012|4243244|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4418551|NCT00194012|4243245|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4418552|NCT00194012|4243243|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4418553|NCT00194012|4243244|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4418554|NCT00194012|4243245|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4418555|NCT00194012|4243243|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4418556|NCT00194012|4243244|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4418557|NCT00194012|4243245|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4418558|NCT00194012|4243243|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4418559|NCT00194012|4243244|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4418560|NCT00194012|4243245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4418561|NCT00194012|4243243|B3||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
4418562|NCT00194012|4243244|B2||<=18 years|Age||Participants|Count of Participants|29|29.0||||||
4418563|NCT00194012|4243245|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4418564|NCT00193609|4243282|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4418565|NCT00193609|4243282|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4418566|NCT00193609|4243282|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4418567|NCT00193609|4243282|B1|||Age||years|Median|59|59.0|Full Range|||25.0|80.0|
4418568|NCT00193596|4243287|B3|United States||Region of Enrollment||participants|Number|198|198.0||||||
4418569|NCT00193596|4243288|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
4418570|NCT00193596|4243289|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
4418571|NCT00193596|4243287|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4418572|NCT00193596|4243288|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4418573|NCT00193596|4243289|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4418574|NCT00193596|4243287|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4418575|NCT00193596|4243288|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4418576|NCT00193596|4243289|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4418577|NCT00193596|4243287|B3|||Age||years|Median|60|60.0|Full Range|||33.0|83.0|
4418578|NCT00193596|4243288|B2|||Age||years|Median|59|59.0|Full Range|||33.0|83.0|
4418579|NCT00193596|4243289|B1|||Age||years|Median|61|61.0|Full Range|||39.0|82.0|
4418580|NCT00193492|4243298|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4418581|NCT00193492|4243299|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4418582|NCT00193492|4243300|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4418583|NCT00193492|4243298|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4418584|NCT00193492|4243299|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4418585|NCT00193492|4243300|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4418586|NCT00193492|4243298|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4418587|NCT00193492|4243299|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4418588|NCT00193492|4243300|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4418589|NCT00193492|4243298|B3|||Age||years|Median|67|67.0|Full Range|||45.0|91.0|
4418590|NCT00193492|4243299|B2|||Age||years|Median|68|68.0|Full Range|||45.0|91.0|
4418591|NCT00193492|4243300|B1|||Age||years|Median|65|65.0|Full Range|||47.0|80.0|
4418592|NCT00193479|4243309|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4418593|NCT00193479|4243309|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4418594|NCT00193479|4243309|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4418595|NCT00193479|4243309|B1|||Age||years|Median|78|78.0|Full Range|||61.0|90.0|
4418596|NCT00193453|4243313|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4418597|NCT00193453|4243313|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4418598|NCT00193453|4243313|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4418599|NCT00193453|4243313|B1|||Age||years|Mean|68|68.0|Standard Deviation|8.7|8.7|||
4418600|NCT00193453|4243313|B1||>=65 years|Age||Participants|Count of Participants|51|51.0||||||
4418601|NCT00193453|4243313|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4418602|NCT00193453|4243313|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418603|NCT00193427|4243319|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4418604|NCT00193427|4243319|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4418605|NCT00193427|4243319|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4418606|NCT00193427|4243319|B1|||Age||years|Median|62|62.0|Full Range|||42.0|82.0|
4418607|NCT00193414|4243326|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4418608|NCT00193414|4243326|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4418609|NCT00193414|4243326|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4418610|NCT00193414|4243326|B1|||Age||years|Mean|66|66.0|Standard Deviation|8.7|8.7|||
4418611|NCT00193414|4243326|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4418612|NCT00193414|4243326|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4418613|NCT00193414|4243326|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4418614|NCT00193375|4243332|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4418615|NCT00193375|4243332|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4418616|NCT00193375|4243332|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4418617|NCT00193375|4243332|B1|||Age||years|Median|65|65.0|Full Range|||42.0|80.0|
4418618|NCT00193258|4243338|B1|United States||Region of Enrollment||participants|Number|94|94.0||||||
4418619|NCT00193258|4243338|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4418620|NCT00193258|4243338|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4418621|NCT00193258|4243338|B1|||Age||years|Median|60|60.0|Full Range|||39.0|88.0|
4418622|NCT00193219|4243344|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4418623|NCT00193219|4243344|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4418624|NCT00193219|4243344|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4418625|NCT00193219|4243344|B1|||Age||years|Median|55|55.0|Full Range|||29.0|78.0|
4418626|NCT00193206|4243350|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
4418627|NCT00193206|4243350|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418628|NCT00193206|4243350|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4418629|NCT00193206|4243350|B1|||Age||years|Median|51|51.0|Full Range|||29.0|82.0|
4418630|NCT00193180|4243354|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4418631|NCT00193180|4243354|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418632|NCT00193180|4243354|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4418633|NCT00193180|4243354|B1|||Age||years|Median|59|59.0|Full Range|||32.0|74.0|
4418634|NCT00193128|4243360|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4418635|NCT00193128|4243361|B2|United States||Region of Enrollment||participants|Number|49|49.0||||||
4418636|NCT00193128|4243362|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4418637|NCT00193128|4243360|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4418638|NCT00193128|4243361|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4418639|NCT00193128|4243362|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4418640|NCT00193128|4243360|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4418641|NCT00193128|4243361|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4418642|NCT00193128|4243362|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4418643|NCT00193128|4243360|B3|||Age||years|Median|61|61.0|Full Range|||42.0|81.0|
4418644|NCT00193128|4243361|B2|||Age||years|Median|63|63.0|Full Range|||42.0|81.0|
4418645|NCT00193128|4243362|B1|||Age||years|Median|60|60.0|Full Range|||44.0|77.0|
4418646|NCT00193063|4243369|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4418647|NCT00193063|4243369|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418648|NCT00193063|4243369|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4418649|NCT00193063|4243369|B1|||Age||years|Median|57|57.0|Full Range|||27.0|79.0|
4418650|NCT00193050|4243375|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
4418651|NCT00193050|4243375|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418652|NCT00193050|4243375|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4418653|NCT00193050|4243375|B1|||Age||years|Median|51|51.0|Full Range|||27.0|75.0|
4418654|NCT00193037|4243379|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4418655|NCT00193037|4243380|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4418656|NCT00193037|4243381|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4418657|NCT00193037|4243379|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418658|NCT00193037|4243380|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418659|NCT00193037|4243381|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418660|NCT00193037|4243379|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4418661|NCT00193037|4243380|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4418662|NCT00193037|4243381|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4418663|NCT00193037|4243379|B3|||Age||years|Median|62|62.0|Full Range|||31.0|87.0|
4418664|NCT00193037|4243380|B2|||Age||years|Median|62|62.0|Full Range|||31.0|87.0|
4418665|NCT00193037|4243381|B1|||Age||years|Median|62|62.0|Full Range|||31.0|87.0|
4418666|NCT00192647|4243390|B3||Male|Sex: Female, Male||Participants|Count of Participants|583|583.0||||||
4418667|NCT00192647|4243391|B2||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4418668|NCT00192647|4243392|B1||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4418669|NCT00192647|4243390|B3||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4418670|NCT00192647|4243391|B2||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4418671|NCT00192647|4243392|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4418672|NCT00192647|4243390|B3|||Age||years|Mean|43.4|43.4|Standard Deviation|9.37|9.37|||
4418673|NCT00192647|4243391|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|9.19|9.19|||
4418674|NCT00192647|4243392|B1|||Age||years|Mean|43.6|43.6|Standard Deviation|9.55|9.55|||
4418675|NCT00192296|4243409|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4418676|NCT00192296|4243410|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4418677|NCT00192296|4243411|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4418678|NCT00192296|4243412|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4418679|NCT00192296|4243413|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4418680|NCT00192296|4243409|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4418681|NCT00192296|4243410|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4418682|NCT00192296|4243411|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4418683|NCT00192296|4243412|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4418684|NCT00192296|4243413|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4418685|NCT00192296|4243409|B5|||Age||Years|Mean|27.9|27.9|Standard Deviation|8.9|8.9|||
4418686|NCT00192296|4243410|B4|||Age||Years|Mean|30.5|30.5|Standard Deviation|8.2|8.2|||
4418687|NCT00192296|4243411|B3|||Age||Years|Mean|25.5|25.5|Standard Deviation|8.8|8.8|||
4418688|NCT00192296|4243412|B2|||Age||Years|Mean|29.8|29.8|Standard Deviation|8.4|8.4|||
4418689|NCT00192296|4243413|B1|||Age||Years|Mean|25.8|25.8|Standard Deviation|11.1|11.1|||
4418690|NCT00192075|4243470|B3|Distant metastasis||Tumor Stage|Patients could experience multiple tumors.|participants|Number|45|45.0||||||
4418691|NCT00192075|4243471|B2|Distant metastasis||Tumor Stage|Patients could experience multiple tumors.|participants|Number|20|20.0||||||
4418692|NCT00192075|4243472|B1|Distant metastasis||Tumor Stage|Patients could experience multiple tumors.|participants|Number|25|25.0||||||
4418693|NCT00192075|4243470|B3|Regional lymph nodes||Tumor Stage|Patients could experience multiple tumors.|participants|Number|53|53.0||||||
4418694|NCT00192075|4243471|B2|Regional lymph nodes||Tumor Stage|Patients could experience multiple tumors.|participants|Number|29|29.0||||||
4418695|NCT00192075|4243472|B1|Regional lymph nodes||Tumor Stage|Patients could experience multiple tumors.|participants|Number|24|24.0||||||
4418696|NCT00192075|4243470|B3|Primary tumor||Tumor Stage|Patients could experience multiple tumors.|participants|Number|78|78.0||||||
4418697|NCT00192075|4243471|B2|Primary tumor||Tumor Stage|Patients could experience multiple tumors.|participants|Number|41|41.0||||||
4418698|NCT00192075|4243472|B1|Primary tumor||Tumor Stage|Patients could experience multiple tumors.|participants|Number|37|37.0||||||
4418699|NCT00192075|4243470|B3|Other||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|11|11.0||||||
4418700|NCT00192075|4243471|B2|Other||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|3|3.0||||||
4418701|NCT00192075|4243472|B1|Other||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|8|8.0||||||
4418702|NCT00192075|4243470|B3|Genitourinary||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|1|1.0||||||
4418703|NCT00192075|4243471|B2|Genitourinary||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|0|0.0||||||
4418704|NCT00192075|4243472|B1|Genitourinary||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|1|1.0||||||
4418705|NCT00192075|4243470|B3|Distant lymph nodes||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|7|7.0||||||
4418706|NCT00192075|4243471|B2|Distant lymph nodes||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|3|3.0||||||
4418707|NCT00192075|4243472|B1|Distant lymph nodes||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|4|4.0||||||
4418708|NCT00192075|4243470|B3|Regional lymph nodes||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|28|28.0||||||
4418709|NCT00192075|4243471|B2|Regional lymph nodes||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|14|14.0||||||
4418710|NCT00192075|4243472|B1|Regional lymph nodes||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|14|14.0||||||
4418711|NCT00192075|4243470|B3|Abdominal||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|6|6.0||||||
4418712|NCT00192075|4243471|B2|Abdominal||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|3|3.0||||||
4418713|NCT00192075|4243472|B1|Abdominal||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|3|3.0||||||
4418714|NCT00192075|4243470|B3|Lung||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|24|24.0||||||
4418715|NCT00192075|4243471|B2|Lung||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|11|11.0||||||
4418716|NCT00192075|4243472|B1|Lung||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|13|13.0||||||
4418717|NCT00192075|4243470|B3|Liver||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|57|57.0||||||
4418718|NCT00192075|4243471|B2|Liver||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|29|29.0||||||
4418719|NCT00192075|4243472|B1|Liver||Site of Metastasis|Metastasis could occur in multiple sites.|participants|Number|28|28.0||||||
4418720|NCT00192075|4243470|B3|Hispanic||Race/Ethnicity||participants|Number|5|5.0||||||
4418721|NCT00192075|4243471|B2|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4418722|NCT00192075|4243472|B1|Hispanic||Race/Ethnicity||participants|Number|4|4.0||||||
4418723|NCT00192075|4243470|B3|Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4418724|NCT00192075|4243471|B2|Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4418725|NCT00192075|4243472|B1|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4418726|NCT00192075|4243470|B3|African descent||Race/Ethnicity||participants|Number|11|11.0||||||
4418727|NCT00192075|4243471|B2|African descent||Race/Ethnicity||participants|Number|6|6.0||||||
4418728|NCT00192075|4243472|B1|African descent||Race/Ethnicity||participants|Number|5|5.0||||||
4418729|NCT00192075|4243470|B3|Caucasian||Race/Ethnicity||participants|Number|67|67.0||||||
4418730|NCT00192075|4243471|B2|Caucasian||Race/Ethnicity||participants|Number|34|34.0||||||
4418731|NCT00192075|4243472|B1|Caucasian||Race/Ethnicity||participants|Number|33|33.0||||||
4418732|NCT00192075|4243470|B3|No||Prior Adjuvant Therapy||participants|Number|58|58.0||||||
4418733|NCT00192075|4243471|B2|No||Prior Adjuvant Therapy||participants|Number|28|28.0||||||
4418734|NCT00192075|4243472|B1|No||Prior Adjuvant Therapy||participants|Number|30|30.0||||||
4418735|NCT00192075|4243470|B3|Yes||Prior Adjuvant Therapy||participants|Number|26|26.0||||||
4418736|NCT00192075|4243471|B2|Yes||Prior Adjuvant Therapy||participants|Number|14|14.0||||||
4418737|NCT00192075|4243472|B1|Yes||Prior Adjuvant Therapy||participants|Number|12|12.0||||||
4418738|NCT00192075|4243470|B3|Other||Primary Tumor Site||participants|Number|10|10.0||||||
4418739|NCT00192075|4243471|B2|Other||Primary Tumor Site||participants|Number|3|3.0||||||
4418740|NCT00192075|4243472|B1|Other||Primary Tumor Site||participants|Number|7|7.0||||||
4418741|NCT00192075|4243470|B3|Rectum||Primary Tumor Site||participants|Number|14|14.0||||||
4418742|NCT00192075|4243471|B2|Rectum||Primary Tumor Site||participants|Number|4|4.0||||||
4418743|NCT00192075|4243472|B1|Rectum||Primary Tumor Site||participants|Number|10|10.0||||||
4418744|NCT00192075|4243470|B3|Colon||Primary Tumor Site||participants|Number|60|60.0||||||
4418745|NCT00192075|4243471|B2|Colon||Primary Tumor Site||participants|Number|35|35.0||||||
4418746|NCT00192075|4243472|B1|Colon||Primary Tumor Site||participants|Number|25|25.0||||||
4418747|NCT00192075|4243470|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|41|41.0||||||
4418748|NCT00192075|4243471|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|22|22.0||||||
4418749|NCT00192075|4243472|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|19|19.0||||||
4418750|NCT00192075|4243470|B3|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|43|43.0||||||
4418751|NCT00192075|4243471|B2|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|20|20.0||||||
4418752|NCT00192075|4243472|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|23|23.0||||||
4418753|NCT00192075|4243470|B3|>=6 months||Diagnosis to Enrollment||participants|Number|26|26.0||||||
4418754|NCT00192075|4243471|B2|>=6 months||Diagnosis to Enrollment||participants|Number|13|13.0||||||
4418755|NCT00192075|4243472|B1|>=6 months||Diagnosis to Enrollment||participants|Number|13|13.0||||||
4418756|NCT00192075|4243470|B3|<6 months||Diagnosis to Enrollment||participants|Number|58|58.0||||||
4418757|NCT00192075|4243471|B2|<6 months||Diagnosis to Enrollment||participants|Number|29|29.0||||||
4418758|NCT00192075|4243472|B1|<6 months||Diagnosis to Enrollment||participants|Number|29|29.0||||||
4418759|NCT00192075|4243470|B3|United States||Region of Enrollment||participants|Number|84|84.0||||||
4418760|NCT00192075|4243471|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4418761|NCT00192075|4243472|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4418762|NCT00192075|4243470|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4418763|NCT00192075|4243471|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4418764|NCT00192075|4243472|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4418765|NCT00192075|4243470|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4418766|NCT00192075|4243471|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4418767|NCT00192075|4243472|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4418768|NCT00192075|4243470|B3|||Age||years|Median|63|63.0|Full Range|||28.0|81.0|
4418769|NCT00192075|4243471|B2|||Age||years|Median|64|64.0|Full Range|||32.0|81.0|
4418770|NCT00192075|4243472|B1|||Age||years|Median|62|62.0|Full Range|||28.0|79.0|
4418771|NCT00192036|4243498|B1|||Time Since Diagnosis||months|Mean|0.5|0.5|Standard Deviation|0.25|0.25|||
4418772|NCT00192036|4243498|B1|Squamous Cell||Pathological Diagnosis||participants|Number|22|22.0||||||
4418773|NCT00192036|4243498|B1|Other Pathological Diagnosis||Pathological Diagnosis||participants|Number|2|2.0||||||
4418774|NCT00192036|4243498|B1|Large Cell||Pathological Diagnosis||participants|Number|7|7.0||||||
4418775|NCT00192036|4243498|B1|Adenocarcinoma of Lung||Pathological Diagnosis||participants|Number|18|18.0||||||
4418776|NCT00192036|4243498|B1|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|16|16.0||||||
4418777|NCT00192036|4243498|B1|90 - Normal activity; minor signs of disease||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|24|24.0||||||
4418778|NCT00192036|4243498|B1|80 - Activity with effort; some signs of disease||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|9|9.0||||||
4418779|NCT00192036|4243498|B1|Stage IIIB||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to near by lymph nodes. Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung.|participants|Number|35|35.0||||||
4418780|NCT00192036|4243498|B1|Stage IIIA||Disease Stage|Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body). Stage IIIA - the cancer has spread to nearby tissue or spread to near by lymph nodes. Stage IIIB - cancer spread to opposite side of chest, more than one tumor within same lobe of lung.|participants|Number|14|14.0||||||
4418781|NCT00192036|4243498|B1|Cytological||Basis for Pathological Diagnosis||participants|Number|10|10.0||||||
4418782|NCT00192036|4243498|B1|Histopathological||Basis for Pathological Diagnosis||participants|Number|39|39.0||||||
4418783|NCT00192036|4243498|B1|Belgium||Region of Enrollment||participants|Number|49|49.0||||||
4418784|NCT00192036|4243498|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4418785|NCT00192036|4243498|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4418786|NCT00192036|4243498|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|8.41|8.41|||
4418787|NCT00192023|4243506|B3|||Weight||kilograms|Mean|39.8|39.8|Standard Deviation|15.4|15.4|||
4418788|NCT00192023|4243507|B2|||Weight||kilograms|Mean|41.4|41.4|Standard Deviation|14.1|14.1|||
4418789|NCT00192023|4243508|B1|||Weight||kilograms|Mean|39.3|39.3|Standard Deviation|15.8|15.8|||
4418790|NCT00192023|4243506|B3|||Height||centimeters|Mean|140.4|140.4|Standard Deviation|15.1|15.1|||
4418791|NCT00192023|4243507|B2|||Height||centimeters|Mean|141.6|141.6|Standard Deviation|15.3|15.3|||
4418792|NCT00192023|4243508|B1|||Height||centimeters|Mean|140.1|140.1|Standard Deviation|15.2|15.2|||
4418793|NCT00192023|4243506|B3|Hispanic||Race/Ethnicity||participants|Number|4|4.0||||||
4418794|NCT00192023|4243507|B2|Hispanic||Race/Ethnicity||participants|Number|3|3.0||||||
4418795|NCT00192023|4243508|B1|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4418796|NCT00192023|4243506|B3|Caucasian||Race/Ethnicity||participants|Number|133|133.0||||||
4418797|NCT00192023|4243507|B2|Caucasian||Race/Ethnicity||participants|Number|29|29.0||||||
4418798|NCT00192023|4243508|B1|Caucasian||Race/Ethnicity||participants|Number|104|104.0||||||
4418799|NCT00192023|4243506|B3|Italy||Region of Enrollment||participants|Number|137|137.0||||||
4418800|NCT00192023|4243507|B2|Italy||Region of Enrollment||participants|Number|32|32.0||||||
4418801|NCT00192023|4243508|B1|Italy||Region of Enrollment||participants|Number|105|105.0||||||
4418802|NCT00192023|4243506|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4418803|NCT00192023|4243507|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4418804|NCT00192023|4243508|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4418805|NCT00192023|4243506|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4418806|NCT00192023|4243507|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4418807|NCT00192023|4243508|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4418808|NCT00192023|4243506|B3|||Age||years|Mean|9.8|9.8|Standard Deviation|2.3|2.3|||
4418809|NCT00192023|4243507|B2|||Age||years|Mean|10.0|10.0|Standard Deviation|2.4|2.4|||
4418810|NCT00192023|4243508|B1|||Age||years|Mean|9.7|9.7|Standard Deviation|2.2|2.2|||
4418811|NCT00191984|4243531|B1|||Weight||kilograms|Mean|69.3|69.3|Standard Deviation|11.7|11.7|||
4418812|NCT00191984|4243531|B1|||Height||centimeters|Mean|169.3|169.3|Standard Deviation|8.5|8.5|||
4418813|NCT00191984|4243531|B1|Colorectal Cancer||Pathological Diagnosis||participants|Number|2|2.0||||||
4418814|NCT00191984|4243531|B1|Adenocarcinoma of Rectum||Pathological Diagnosis||participants|Number|20|20.0||||||
4418815|NCT00191984|4243531|B1|Adenocarcinoma of Colon||Pathological Diagnosis||participants|Number|22|22.0||||||
4418816|NCT00191984|4243531|B1|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|units on a scale|Number|5|5.0||||||
4418817|NCT00191984|4243531|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|units on a scale|Number|15|15.0||||||
4418818|NCT00191984|4243531|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|units on a scale|Number|24|24.0||||||
4418819|NCT00191984|4243531|B1|France||Region of Enrollment||participants|Number|44|44.0||||||
4418820|NCT00191984|4243531|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4418821|NCT00191984|4243531|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4418822|NCT00191984|4243531|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|11.5|11.5|||
4418823|NCT00191945|4243539|B3|||Body Weight||kilograms|Mean|37.7|37.7|Standard Deviation|11.93|11.93|||
4418824|NCT00191945|4243540|B2|||Body Weight||kilograms|Mean|37.4|37.4|Standard Deviation|12.18|12.18|||
4418825|NCT00191945|4243541|B1|||Body Weight||kilograms|Mean|37.9|37.9|Standard Deviation|11.86|11.86|||
4418826|NCT00191945|4243539|B3|Diastolic Blood Pressure||Blood Pressure||mmHg|Mean|57.9|57.9|Standard Deviation|7.31|7.31|||
4418827|NCT00191945|4243540|B2|Diastolic Blood Pressure||Blood Pressure||mmHg|Mean|58.0|58.0|Standard Deviation|7.68|7.68|||
4418828|NCT00191945|4243541|B1|Diastolic Blood Pressure||Blood Pressure||mmHg|Mean|57.9|57.9|Standard Deviation|7.15|7.15|||
4418829|NCT00191945|4243539|B3|Systolic Blood Pressure||Blood Pressure||mmHg|Mean|101.0|101.0|Standard Deviation|9.98|9.98|||
4418830|NCT00191945|4243540|B2|Systolic Blood Pressure||Blood Pressure||mmHg|Mean|100.5|100.5|Standard Deviation|10.01|10.01|||
4418831|NCT00191945|4243541|B1|Systolic Blood Pressure||Blood Pressure||mmHg|Mean|101.2|101.2|Standard Deviation|10.01|10.01|||
4418832|NCT00191945|4243539|B3|||Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered|Measures the 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision (DSM-IV-TR) diagnosis of Attention-Deficit/Hyperactivity Disorder. Individual item scores range from 0 (none/never or rarely) to 3 (severe/very often). Total scores range from 0 to 54.|units on a scale|Mean|39.2|39.2|Standard Deviation|9.0|9.0|||
4418886|NCT00191906|4243577|B2|ADHD-Combined Type||Study Arm - Diagnosis||participants|Number|15|15.0||||||
4418887|NCT00191906|4243578|B1|ADHD-Combined Type||Study Arm - Diagnosis||participants|Number|13|13.0||||||
4418888|NCT00191906|4243574|B5|Netherlands||Region of Enrollment||participants|Number|72|72.0||||||
4418833|NCT00191945|4243540|B2|||Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered|Measures the 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision (DSM-IV-TR) diagnosis of Attention-Deficit/Hyperactivity Disorder. Individual item scores range from 0 (none/never or rarely) to 3 (severe/very often). Total scores range from 0 to 54.|units on a scale|Mean|39.5|39.5|Standard Deviation|9.0|9.0|||
4418834|NCT00191945|4243541|B1|||Attention-Deficit/Hyperactivity Disorder Rating Scale-IV-Parent Version:Investigator-Administered|Measures the 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision (DSM-IV-TR) diagnosis of Attention-Deficit/Hyperactivity Disorder. Individual item scores range from 0 (none/never or rarely) to 3 (severe/very often). Total scores range from 0 to 54.|units on a scale|Mean|39.1|39.1|Standard Deviation|9.0|9.0|||
4418835|NCT00191945|4243539|B3|Hispanic||Race/Ethnicity||participants|Number|5|5.0||||||
4418836|NCT00191945|4243540|B2|Hispanic||Race/Ethnicity||participants|Number|3|3.0||||||
4418837|NCT00191945|4243541|B1|Hispanic||Race/Ethnicity||participants|Number|2|2.0||||||
4418838|NCT00191945|4243539|B3|African||Race/Ethnicity||participants|Number|1|1.0||||||
4418839|NCT00191945|4243540|B2|African||Race/Ethnicity||participants|Number|1|1.0||||||
4418840|NCT00191945|4243541|B1|African||Race/Ethnicity||participants|Number|0|0.0||||||
4418841|NCT00191945|4243539|B3|Caucasian||Race/Ethnicity||participants|Number|145|145.0||||||
4418842|NCT00191945|4243540|B2|Caucasian||Race/Ethnicity||participants|Number|47|47.0||||||
4418843|NCT00191945|4243541|B1|Caucasian||Race/Ethnicity||participants|Number|98|98.0||||||
4418844|NCT00191945|4243539|B3|Not Assessed||Attention-Deficit/Hyperactivity Disorder Subtype||participants|Number|2.0|2.0||||||
4418845|NCT00191945|4243540|B2|Not Assessed||Attention-Deficit/Hyperactivity Disorder Subtype||participants|Number|1|1.0||||||
4418846|NCT00191945|4243541|B1|Not Assessed||Attention-Deficit/Hyperactivity Disorder Subtype||participants|Number|1|1.0||||||
4418847|NCT00191945|4243539|B3|Combined (Hyperactive-Inattentive)||Attention-Deficit/Hyperactivity Disorder Subtype||participants|Number|94.0|94.0||||||
4418848|NCT00191945|4243540|B2|Combined (Hyperactive-Inattentive)||Attention-Deficit/Hyperactivity Disorder Subtype||participants|Number|30|30.0||||||
4418849|NCT00191945|4243541|B1|Combined (Hyperactive-Inattentive)||Attention-Deficit/Hyperactivity Disorder Subtype||participants|Number|64|64.0||||||
4418850|NCT00191945|4243539|B3|Hyperactive||Attention-Deficit/Hyperactivity Disorder Subtype||participants|Number|6.0|6.0||||||
4418851|NCT00191945|4243540|B2|Hyperactive||Attention-Deficit/Hyperactivity Disorder Subtype||participants|Number|1|1.0||||||
4418852|NCT00191945|4243541|B1|Hyperactive||Attention-Deficit/Hyperactivity Disorder Subtype||participants|Number|5|5.0||||||
4418853|NCT00191945|4243539|B3|Inattentive||Attention-Deficit/Hyperactivity Disorder Subtype||participants|Number|49.0|49.0||||||
4418854|NCT00191945|4243540|B2|Inattentive||Attention-Deficit/Hyperactivity Disorder Subtype||participants|Number|19|19.0||||||
4418855|NCT00191945|4243541|B1|Inattentive||Attention-Deficit/Hyperactivity Disorder Subtype||participants|Number|30|30.0||||||
4418856|NCT00191945|4243539|B3|Spain||Region of Enrollment||participants|Number|151|151.0||||||
4418857|NCT00191945|4243540|B2|Spain||Region of Enrollment||participants|Number|51|51.0||||||
4418858|NCT00191945|4243541|B1|Spain||Region of Enrollment||participants|Number|100|100.0||||||
4418859|NCT00191945|4243539|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4418860|NCT00191945|4243540|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4418861|NCT00191945|4243541|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4418862|NCT00191945|4243539|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4418863|NCT00191945|4243540|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4418864|NCT00191945|4243541|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4418865|NCT00191945|4243539|B3|||Age||years|Mean|10.3|10.3|Standard Deviation|2.46|2.46|||
4418866|NCT00191945|4243540|B2|||Age||years|Mean|10.3|10.3|Standard Deviation|2.43|2.43|||
4418867|NCT00191945|4243541|B1|||Age||years|Mean|10.3|10.3|Standard Deviation|2.48|2.48|||
4418868|NCT00191906|4243574|B5|No Disorder||Study Arm - Diagnosis||participants|Number|27|27.0||||||
4418869|NCT00191906|4243575|B4|No Disorder||Study Arm - Diagnosis||participants|Number|0|0.0||||||
4418870|NCT00191906|4243576|B3|No Disorder||Study Arm - Diagnosis||participants|Number|27|27.0||||||
4418871|NCT00191906|4243577|B2|No Disorder||Study Arm - Diagnosis||participants|Number|0|0.0||||||
4418872|NCT00191906|4243578|B1|No Disorder||Study Arm - Diagnosis||participants|Number|0|0.0||||||
4418873|NCT00191906|4243574|B5|ADHD-Combined Type + Reading Disorder||Study Arm - Diagnosis||participants|Number|25|25.0||||||
4418874|NCT00191906|4243575|B4|ADHD-Combined Type + Reading Disorder||Study Arm - Diagnosis||participants|Number|0|0.0||||||
4418875|NCT00191906|4243576|B3|ADHD-Combined Type + Reading Disorder||Study Arm - Diagnosis||participants|Number|0|0.0||||||
4418876|NCT00191906|4243577|B2|ADHD-Combined Type + Reading Disorder||Study Arm - Diagnosis||participants|Number|10|10.0||||||
4418877|NCT00191906|4243578|B1|ADHD-Combined Type + Reading Disorder||Study Arm - Diagnosis||participants|Number|15|15.0||||||
4418878|NCT00191906|4243574|B5|Reading Disorder||Study Arm - Diagnosis||participants|Number|41|41.0||||||
4418879|NCT00191906|4243575|B4|Reading Disorder||Study Arm - Diagnosis||participants|Number|18|18.0||||||
4418880|NCT00191906|4243576|B3|Reading Disorder||Study Arm - Diagnosis||participants|Number|0|0.0||||||
4418881|NCT00191906|4243577|B2|Reading Disorder||Study Arm - Diagnosis||participants|Number|12|12.0||||||
4418882|NCT00191906|4243578|B1|Reading Disorder||Study Arm - Diagnosis||participants|Number|11|11.0||||||
4418883|NCT00191906|4243574|B5|ADHD-Combined Type||Study Arm - Diagnosis||participants|Number|28|28.0||||||
4418884|NCT00191906|4243575|B4|ADHD-Combined Type||Study Arm - Diagnosis||participants|Number|0|0.0||||||
4418885|NCT00191906|4243576|B3|ADHD-Combined Type||Study Arm - Diagnosis||participants|Number|0|0.0||||||
4418889|NCT00191906|4243575|B4|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4418890|NCT00191906|4243576|B3|Netherlands||Region of Enrollment||participants|Number|27|27.0||||||
4418891|NCT00191906|4243577|B2|Netherlands||Region of Enrollment||participants|Number|22|22.0||||||
4418892|NCT00191906|4243578|B1|Netherlands||Region of Enrollment||participants|Number|21|21.0||||||
4418893|NCT00191906|4243574|B5|Belgium||Region of Enrollment||participants|Number|49|49.0||||||
4418894|NCT00191906|4243575|B4|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4418895|NCT00191906|4243576|B3|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4418896|NCT00191906|4243577|B2|Belgium||Region of Enrollment||participants|Number|15|15.0||||||
4418897|NCT00191906|4243578|B1|Belgium||Region of Enrollment||participants|Number|18|18.0||||||
4418898|NCT00191906|4243574|B5||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4418899|NCT00191906|4243575|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4418900|NCT00191906|4243576|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4418901|NCT00191906|4243577|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4418902|NCT00191906|4243578|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4418903|NCT00191906|4243574|B5||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4418904|NCT00191906|4243575|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4418905|NCT00191906|4243576|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4418906|NCT00191906|4243577|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4418907|NCT00191906|4243578|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4418908|NCT00191906|4243574|B5|||Age||years|Mean|10.0|10.0|Standard Deviation|1.2|1.2|||
4418909|NCT00191906|4243575|B4|||Age||years|Mean|10.6|10.6|Standard Deviation|0.99|0.99|||
4418910|NCT00191906|4243576|B3|||Age||years|Mean|9.9|9.9|Standard Deviation|1.01|1.01|||
4418911|NCT00191906|4243577|B2|||Age||years|Mean|9.9|9.9|Standard Deviation|1.25|1.25|||
4418912|NCT00191906|4243578|B1|||Age||years|Mean|10.0|10.0|Standard Deviation|1.34|1.34|||
4418913|NCT00191854|4243621|B4|West Asian (West Indian)||Race/Ethnicity||participants|Number|24|24.0||||||
4418914|NCT00191854|4243622|B3|West Asian (West Indian)||Race/Ethnicity||participants|Number|8|8.0||||||
4418915|NCT00191854|4243623|B2|West Asian (West Indian)||Race/Ethnicity||participants|Number|8|8.0||||||
4418916|NCT00191854|4243624|B1|West Asian (West Indian)||Race/Ethnicity||participants|Number|8|8.0||||||
4418917|NCT00191854|4243621|B4|Hispanic||Race/Ethnicity||participants|Number|8|8.0||||||
4418918|NCT00191854|4243622|B3|Hispanic||Race/Ethnicity||participants|Number|3|3.0||||||
4418919|NCT00191854|4243623|B2|Hispanic||Race/Ethnicity||participants|Number|3|3.0||||||
4418920|NCT00191854|4243624|B1|Hispanic||Race/Ethnicity||participants|Number|2|2.0||||||
4418921|NCT00191854|4243621|B4|East Asian||Race/Ethnicity||participants|Number|92|92.0||||||
4418922|NCT00191854|4243622|B3|East Asian||Race/Ethnicity||participants|Number|32|32.0||||||
4418923|NCT00191854|4243623|B2|East Asian||Race/Ethnicity||participants|Number|30|30.0||||||
4418924|NCT00191854|4243624|B1|East Asian||Race/Ethnicity||participants|Number|30|30.0||||||
4418925|NCT00191854|4243621|B4|Caucasian||Race/Ethnicity||participants|Number|21|21.0||||||
4418926|NCT00191854|4243622|B3|Caucasian||Race/Ethnicity||participants|Number|7|7.0||||||
4418927|NCT00191854|4243623|B2|Caucasian||Race/Ethnicity||participants|Number|6|6.0||||||
4418928|NCT00191854|4243624|B1|Caucasian||Race/Ethnicity||participants|Number|8|8.0||||||
4418929|NCT00191854|4243621|B4|African||Race/Ethnicity||participants|Number|2|2.0||||||
4418930|NCT00191854|4243622|B3|African||Race/Ethnicity||participants|Number|1|1.0||||||
4418931|NCT00191854|4243623|B2|African||Race/Ethnicity||participants|Number|0|0.0||||||
4418932|NCT00191854|4243624|B1|African||Race/Ethnicity||participants|Number|1|1.0||||||
4418933|NCT00191854|4243621|B4|Missing Data||Pathological Diagnosis||participants|Number|1|1.0||||||
4418934|NCT00191854|4243622|B3|Missing Data||Pathological Diagnosis||participants|Number|1|1.0||||||
4418935|NCT00191854|4243623|B2|Missing Data||Pathological Diagnosis||participants|Number|0|0.0||||||
4418936|NCT00191854|4243624|B1|Missing Data||Pathological Diagnosis||participants|Number|0|0.0||||||
4418937|NCT00191854|4243621|B4|Comedocarcinoma||Pathological Diagnosis||participants|Number|1|1.0||||||
4418938|NCT00191854|4243622|B3|Comedocarcinoma||Pathological Diagnosis||participants|Number|1|1.0||||||
4418939|NCT00191854|4243623|B2|Comedocarcinoma||Pathological Diagnosis||participants|Number|0|0.0||||||
4418940|NCT00191854|4243624|B1|Comedocarcinoma||Pathological Diagnosis||participants|Number|0|0.0||||||
4418941|NCT00191854|4243621|B4|Carcinoma, Undifferentiated||Pathological Diagnosis||participants|Number|1|1.0||||||
4418942|NCT00191854|4243622|B3|Carcinoma, Undifferentiated||Pathological Diagnosis||participants|Number|0|0.0||||||
4418943|NCT00191854|4243623|B2|Carcinoma, Undifferentiated||Pathological Diagnosis||participants|Number|1|1.0||||||
4418944|NCT00191854|4243624|B1|Carcinoma, Undifferentiated||Pathological Diagnosis||participants|Number|0|0.0||||||
4418945|NCT00191854|4243621|B4|Carcinoma, Infiltrating Lobular||Pathological Diagnosis||participants|Number|12|12.0||||||
4418946|NCT00191854|4243622|B3|Carcinoma, Infiltrating Lobular||Pathological Diagnosis||participants|Number|2|2.0||||||
4418947|NCT00191854|4243623|B2|Carcinoma, Infiltrating Lobular||Pathological Diagnosis||participants|Number|4|4.0||||||
4418948|NCT00191854|4243624|B1|Carcinoma, Infiltrating Lobular||Pathological Diagnosis||participants|Number|6|6.0||||||
4418949|NCT00191854|4243621|B4|Carcinoma, Infiltrating Ductal||Pathological Diagnosis||participants|Number|127|127.0||||||
4418950|NCT00191854|4243622|B3|Carcinoma, Infiltrating Ductal||Pathological Diagnosis||participants|Number|45|45.0||||||
4418951|NCT00191854|4243623|B2|Carcinoma, Infiltrating Ductal||Pathological Diagnosis||participants|Number|40|40.0||||||
4418952|NCT00191854|4243624|B1|Carcinoma, Infiltrating Ductal||Pathological Diagnosis||participants|Number|42|42.0||||||
4418953|NCT00191854|4243621|B4|Adenocarcinoma||Pathological Diagnosis||participants|Number|5|5.0||||||
4418954|NCT00191854|4243622|B3|Adenocarcinoma||Pathological Diagnosis||participants|Number|2|2.0||||||
4418955|NCT00191854|4243623|B2|Adenocarcinoma||Pathological Diagnosis||participants|Number|2|2.0||||||
4418956|NCT00191854|4243624|B1|Adenocarcinoma||Pathological Diagnosis||participants|Number|1|1.0||||||
4418957|NCT00191854|4243621|B4|Missing Data||Menopausal Status||participants|Number|2|2.0||||||
4418958|NCT00191854|4243622|B3|Missing Data||Menopausal Status||participants|Number|1|1.0||||||
4418959|NCT00191854|4243623|B2|Missing Data||Menopausal Status||participants|Number|1|1.0||||||
4418960|NCT00191854|4243624|B1|Missing Data||Menopausal Status||participants|Number|0|0.0||||||
4418961|NCT00191854|4243621|B4|Post Menopausal||Menopausal Status||participants|Number|93|93.0||||||
4418962|NCT00191854|4243622|B3|Post Menopausal||Menopausal Status||participants|Number|33|33.0||||||
4418963|NCT00191854|4243623|B2|Post Menopausal||Menopausal Status||participants|Number|26|26.0||||||
4418964|NCT00191854|4243624|B1|Post Menopausal||Menopausal Status||participants|Number|34|34.0||||||
4418965|NCT00191854|4243621|B4|Peri Menopausal||Menopausal Status||participants|Number|12|12.0||||||
4418966|NCT00191854|4243622|B3|Peri Menopausal||Menopausal Status||participants|Number|4|4.0||||||
4418967|NCT00191854|4243623|B2|Peri Menopausal||Menopausal Status||participants|Number|4|4.0||||||
4418968|NCT00191854|4243624|B1|Peri Menopausal||Menopausal Status||participants|Number|4|4.0||||||
4418969|NCT00191854|4243621|B4|Pre-Menopausal||Menopausal Status||participants|Number|40|40.0||||||
4418970|NCT00191854|4243622|B3|Pre-Menopausal||Menopausal Status||participants|Number|13|13.0||||||
4418971|NCT00191854|4243623|B2|Pre-Menopausal||Menopausal Status||participants|Number|16|16.0||||||
4418972|NCT00191854|4243624|B1|Pre-Menopausal||Menopausal Status||participants|Number|11|11.0||||||
4418973|NCT00191854|4243621|B4|Missing Data||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|1|1.0||||||
4418974|NCT00191854|4243622|B3|Missing Data||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|1|1.0||||||
4418975|NCT00191854|4243623|B2|Missing Data||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|0|0.0||||||
4418976|NCT00191854|4243624|B1|Missing Data||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|0|0.0||||||
4418977|NCT00191854|4243621|B4|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|69|69.0||||||
4418978|NCT00191854|4243622|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|24|24.0||||||
4418979|NCT00191854|4243623|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|18|18.0||||||
4418980|NCT00191854|4243624|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|27|27.0||||||
4418981|NCT00191854|4243621|B4|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|77|77.0||||||
4418982|NCT00191854|4243622|B3|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|26|26.0||||||
4418983|NCT00191854|4243623|B2|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|29|29.0||||||
4418984|NCT00191854|4243624|B1|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|22|22.0||||||
4418985|NCT00191854|4243621|B4|India||Region of Enrollment||participants|Number|24|24.0||||||
4418986|NCT00191854|4243622|B3|India||Region of Enrollment||participants|Number|8|8.0||||||
4418987|NCT00191854|4243623|B2|India||Region of Enrollment||participants|Number|8|8.0||||||
4418988|NCT00191854|4243624|B1|India||Region of Enrollment||participants|Number|8|8.0||||||
4418989|NCT00191854|4243621|B4|Korea, Republic of||Region of Enrollment||participants|Number|16|16.0||||||
4418990|NCT00191854|4243622|B3|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
4418991|NCT00191854|4243623|B2|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4418992|NCT00191854|4243624|B1|Korea, Republic of||Region of Enrollment||participants|Number|5|5.0||||||
4418993|NCT00191854|4243621|B4|China||Region of Enrollment||participants|Number|76|76.0||||||
4418994|NCT00191854|4243622|B3|China||Region of Enrollment||participants|Number|26|26.0||||||
4418995|NCT00191854|4243623|B2|China||Region of Enrollment||participants|Number|25|25.0||||||
4418996|NCT00191854|4243624|B1|China||Region of Enrollment||participants|Number|25|25.0||||||
4418997|NCT00191854|4243621|B4|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
4418998|NCT00191854|4243622|B3|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
4418999|NCT00191854|4243623|B2|Turkey||Region of Enrollment||participants|Number|2|2.0||||||
4419000|NCT00191854|4243624|B1|Turkey||Region of Enrollment||participants|Number|5|5.0||||||
4419001|NCT00191854|4243621|B4|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
4419002|NCT00191854|4243622|B3|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4419003|NCT00191854|4243623|B2|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4419004|NCT00191854|4243624|B1|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4419005|NCT00191854|4243621|B4|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4419006|NCT00191854|4243622|B3|Mexico||Region of Enrollment||participants|Number|3|3.0||||||
4419007|NCT00191854|4243623|B2|Mexico||Region of Enrollment||participants|Number|2|2.0||||||
4419008|NCT00191854|4243624|B1|Mexico||Region of Enrollment||participants|Number|1|1.0||||||
4419009|NCT00191854|4243621|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419010|NCT00191854|4243622|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419011|NCT00191854|4243623|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419012|NCT00191854|4243624|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419013|NCT00191854|4243621|B4||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4419014|NCT00191854|4243622|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4419015|NCT00191854|4243623|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4419016|NCT00191854|4243624|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4419017|NCT00191854|4243621|B4|||Age||years|Mean|48.4|48.4|Standard Deviation|8.9|8.9|||
4419018|NCT00191854|4243622|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|10.3|10.3|||
4419019|NCT00191854|4243623|B2|||Age||years|Mean|46.0|46.0|Standard Deviation|6.9|6.9|||
4419020|NCT00191854|4243624|B1|||Age||years|Mean|49.8|49.8|Standard Deviation|8.8|8.8|||
4419021|NCT00191815|4243646|B1|||Time from Initial Diagnosis to Study Entry||month|Mean|37.6|37.6|Standard Deviation|39.7|39.7|||
4419022|NCT00191815|4243646|B1|Stage IV||Stage of Disease at Time of Diagnosis|Stage of disease was determined using American Joint Committee on Cancer Staging Criteria for Breast Cancer. The higher the stage, the more severe the disease.|participants|Number|5|5.0||||||
4419023|NCT00191815|4243646|B1|Stage IIIb||Stage of Disease at Time of Diagnosis|Stage of disease was determined using American Joint Committee on Cancer Staging Criteria for Breast Cancer. The higher the stage, the more severe the disease.|participants|Number|15|15.0||||||
4419024|NCT00191815|4243646|B1|Stage IIIa||Stage of Disease at Time of Diagnosis|Stage of disease was determined using American Joint Committee on Cancer Staging Criteria for Breast Cancer. The higher the stage, the more severe the disease.|participants|Number|12|12.0||||||
4419025|NCT00191815|4243646|B1|Stage IIb||Stage of Disease at Time of Diagnosis|Stage of disease was determined using American Joint Committee on Cancer Staging Criteria for Breast Cancer. The higher the stage, the more severe the disease.|participants|Number|22|22.0||||||
4419026|NCT00191815|4243646|B1|Stage IIa||Stage of Disease at Time of Diagnosis|Stage of disease was determined using American Joint Committee on Cancer Staging Criteria for Breast Cancer. The higher the stage, the more severe the disease.|participants|Number|13|13.0||||||
4419027|NCT00191815|4243646|B1|Stage I||Stage of Disease at Time of Diagnosis|Stage of disease was determined using American Joint Committee on Cancer Staging Criteria for Breast Cancer. The higher the stage, the more severe the disease.|participants|Number|3|3.0||||||
4419028|NCT00191815|4243646|B1|Stage IV||Stage of Disease at Entry to the Study|Stage of disease was determined using American Joint Committee on Cancer Staging Criteria for Breast Cancer. The higher the stage, the more severe the disease.|participants|Number|69|69.0||||||
4419029|NCT00191815|4243646|B1|Stage IIIb||Stage of Disease at Entry to the Study|Stage of disease was determined using American Joint Committee on Cancer Staging Criteria for Breast Cancer. The higher the stage, the more severe the disease.|participants|Number|1|1.0||||||
4419030|NCT00191815|4243646|B1|Unknown||Pathological Diagnosis||participants|Number|7|7.0||||||
4419031|NCT00191815|4243646|B1|Papillary carcinoma||Pathological Diagnosis||participants|Number|1|1.0||||||
4419032|NCT00191815|4243646|B1|Adenocystic breast carcinoma||Pathological Diagnosis||participants|Number|10|10.0||||||
4419033|NCT00191815|4243646|B1|Mucinous breast carcinoma||Pathological Diagnosis||participants|Number|1|1.0||||||
4419034|NCT00191815|4243646|B1|Lobular breast carcinoma||Pathological Diagnosis||participants|Number|5|5.0||||||
4419035|NCT00191815|4243646|B1|Ductal and lobular breast carcinoma||Pathological Diagnosis||participants|Number|2|2.0||||||
4419036|NCT00191815|4243646|B1|Ductal breast carcinoma||Pathological Diagnosis||participants|Number|44|44.0||||||
4419037|NCT00191815|4243646|B1|Post-menopausal||Menopausal Status||participants|Number|54|54.0||||||
4419038|NCT00191815|4243646|B1|Pre-menopausal||Menopausal Status||participants|Number|16|16.0||||||
4419039|NCT00191815|4243646|B1|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4419040|NCT00191815|4243646|B1|Russian Federation||Region of Enrollment||participants|Number|63|63.0||||||
4419041|NCT00191815|4243646|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419042|NCT00191815|4243646|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4419043|NCT00191815|4243646|B1|||Age||years|Mean|50.5|50.5|Standard Deviation|9.7|9.7|||
4419044|NCT00191789|4243658|B1|||Weight||kilograms (kg)|Median|57|57.0|Full Range|||34.0|87.0|
4419045|NCT00191789|4243658|B1|||Largest Lesion Size||millimeters (mm)|Median|30|30.0|Full Range|||7.8|85.8|
4419046|NCT00191789|4243658|B1|||Height||centimeters (cm)|Median|153|153.0|Full Range|||141.0|170.0|
4419047|NCT00191789|4243658|B1|||Body Surface Area|The calculation is from the formula of DuBois and DuBois: BSA = (Weight^0.425 x Height^0.725) x 0.007184, where weight is in kilograms and height is in centimeters.|meters squared (m^2)|Median|1.44|1.44|Full Range|||1.19|1.77|
4419048|NCT00191789|4243658|B1|Postmenopausal||Menopausal Status||participants|Number|36|36.0||||||
4419049|NCT00191789|4243658|B1|Premenopausal||Menopausal Status||participants|Number|29|29.0||||||
4419074|NCT00191724|4243670|B6|||Body Weight||kilograms|Mean|86.0|86.0|Standard Deviation|16.0|16.0|||
4419050|NCT00191789|4243658|B1|90 - Normal activity; minor signs of disease||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100 (in increments of 10), the lower the score, the worse the survival for most serious illnesses.|participants|Number|56|56.0||||||
4419051|NCT00191789|4243658|B1|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100 (in increments of 10), the lower the score, the worse the survival for most serious illnesses.|participants|Number|9|9.0||||||
4419052|NCT00191789|4243658|B1|Insufficient Sample||Human Epidermal Growth Factor Receptor 2 (HER-2) Status|Status determines if there is too much HER-2 receptor protein on the surface of the breast cancer cell. Results range from 0 (negative), 1+ (negative), 2+ (borderline) to 3+ (positive).|participants|Number|2|2.0||||||
4419053|NCT00191789|4243658|B1|Not Detected||Human Epidermal Growth Factor Receptor 2 (HER-2) Status|Status determines if there is too much HER-2 receptor protein on the surface of the breast cancer cell. Results range from 0 (negative), 1+ (negative), 2+ (borderline) to 3+ (positive).|participants|Number|7|7.0||||||
4419054|NCT00191789|4243658|B1|3+||Human Epidermal Growth Factor Receptor 2 (HER-2) Status|Status determines if there is too much HER-2 receptor protein on the surface of the breast cancer cell. Results range from 0 (negative), 1+ (negative), 2+ (borderline) to 3+ (positive).|participants|Number|19|19.0||||||
4419055|NCT00191789|4243658|B1|2+||Human Epidermal Growth Factor Receptor 2 (HER-2) Status|Status determines if there is too much HER-2 receptor protein on the surface of the breast cancer cell. Results range from 0 (negative), 1+ (negative), 2+ (borderline) to 3+ (positive).|participants|Number|2|2.0||||||
4419056|NCT00191789|4243658|B1|1+||Human Epidermal Growth Factor Receptor 2 (HER-2) Status|Status determines if there is too much HER-2 receptor protein on the surface of the breast cancer cell. Results range from 0 (negative), 1+ (negative), 2+ (borderline) to 3+ (positive).|participants|Number|8|8.0||||||
4419057|NCT00191789|4243658|B1|0||Human Epidermal Growth Factor Receptor 2 (HER-2) Status|Status determines if there is too much HER-2 receptor protein on the surface of the breast cancer cell. Results range from 0 (negative), 1+ (negative), 2+ (borderline) to 3+ (positive).|participants|Number|27|27.0||||||
4419058|NCT00191789|4243658|B1|No Assessment||Hormone Receptor Status|Status of the estrogen receptors (ER) and progesterone receptors (PR). A score of Estrogen Receptor positive (ER+) means that estrogen is causing the tumor to grow and Progesterone Receptor positive (PR+) means that progesterone is causing the tumor to grow.|participants|Number|2|2.0||||||
4419059|NCT00191789|4243658|B1|ER- / PR-||Hormone Receptor Status|Status of the estrogen receptors (ER) and progesterone receptors (PR). A score of Estrogen Receptor positive (ER+) means that estrogen is causing the tumor to grow and Progesterone Receptor positive (PR+) means that progesterone is causing the tumor to grow.|participants|Number|25|25.0||||||
4419060|NCT00191789|4243658|B1|ER- / PR+||Hormone Receptor Status|Status of the estrogen receptors (ER) and progesterone receptors (PR). A score of Estrogen Receptor positive (ER+) means that estrogen is causing the tumor to grow and Progesterone Receptor positive (PR+) means that progesterone is causing the tumor to grow.|participants|Number|3|3.0||||||
4419061|NCT00191789|4243658|B1|ER+ / PR-||Hormone Receptor Status|Status of the estrogen receptors (ER) and progesterone receptors (PR). A score of Estrogen Receptor positive (ER+) means that estrogen is causing the tumor to grow and Progesterone Receptor positive (PR+) means that progesterone is causing the tumor to grow.|participants|Number|8|8.0||||||
4419062|NCT00191789|4243658|B1|ER+ / PR+||Hormone Receptor Status|Status of the estrogen receptors (ER) and progesterone receptors (PR). A score of Estrogen Receptor positive (ER+) means that estrogen is causing the tumor to grow and Progesterone Receptor positive (PR+) means that progesterone is causing the tumor to grow.|participants|Number|27|27.0||||||
4419063|NCT00191789|4243658|B1|Stage IIIB||Disease Stage|"Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage IIA-cancer cells found in lymph nodes, or tumor is larger than 2 cm, but less than 5 cm and not in lymph nodes; Stage IIB - tumor larger than 2 cm, but less than 5 cm and in lymph nodes, or tumor larger than 5 cm but not in lymph nodes; Stage IIIA - cancer has spread to nearby tissues; Stage IIIB - cancer has spread to chestwall and/or skin, and lymph nodes near breastbone."|participants|Number|14|14.0||||||
4419064|NCT00191789|4243658|B1|Stage IIIA||Disease Stage|"Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage IIA-cancer cells found in lymph nodes, or tumor is larger than 2 cm, but less than 5 cm and not in lymph nodes; Stage IIB - tumor larger than 2 cm, but less than 5 cm and in lymph nodes, or tumor larger than 5 cm but not in lymph nodes; Stage IIIA - cancer has spread to nearby tissues; Stage IIIB - cancer has spread to chestwall and/or skin, and lymph nodes near breastbone."|participants|Number|18|18.0||||||
4419065|NCT00191789|4243658|B1|Stage IIB||Disease Stage|"Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage IIA-cancer cells found in lymph nodes, or tumor is larger than 2 cm, but less than 5 cm and not in lymph nodes; Stage IIB - tumor larger than 2 cm, but less than 5 cm and in lymph nodes, or tumor larger than 5 cm but not in lymph nodes; Stage IIIA - cancer has spread to nearby tissues; Stage IIIB - cancer has spread to chestwall and/or skin, and lymph nodes near breastbone."|participants|Number|30|30.0||||||
4419066|NCT00191789|4243658|B1|Stage IIA||Disease Stage|"Stage means how big the tumor is and how far it has spread. Stages range from 0 (not spread) to IV (spread throughout the body).~Stage IIA-cancer cells found in lymph nodes, or tumor is larger than 2 cm, but less than 5 cm and not in lymph nodes; Stage IIB - tumor larger than 2 cm, but less than 5 cm and in lymph nodes, or tumor larger than 5 cm but not in lymph nodes; Stage IIIA - cancer has spread to nearby tissues; Stage IIIB - cancer has spread to chestwall and/or skin, and lymph nodes near breastbone."|participants|Number|3|3.0||||||
4419067|NCT00191789|4243658|B1|Cytological||Diagnosis||participants|Number|53|53.0||||||
4419068|NCT00191789|4243658|B1|Histopathological||Diagnosis||participants|Number|12|12.0||||||
4419069|NCT00191789|4243658|B1|India||Region of Enrollment||participants|Number|65|65.0||||||
4419070|NCT00191789|4243658|B1|Indian||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4419071|NCT00191789|4243658|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419072|NCT00191789|4243658|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4419073|NCT00191789|4243658|B1|||Age||years|Median|46|46.0|Full Range|||31.0|70.0|
4419075|NCT00191724|4243671|B5|||Body Weight||kilograms|Mean|85.7|85.7|Standard Deviation|18.6|18.6|||
4419076|NCT00191724|4243672|B4|||Body Weight||kilograms|Mean|86.4|86.4|Standard Deviation|13.8|13.8|||
4419077|NCT00191724|4243673|B3|||Body Weight||kilograms|Mean|85.2|85.2|Standard Deviation|17.6|17.6|||
4419078|NCT00191724|4243674|B2|||Body Weight||kilograms|Mean|93.9|93.9|Standard Deviation|13.3|13.3|||
4419079|NCT00191724|4243675|B1|||Body Weight||kilograms|Mean|76.0|76.0|Standard Deviation|9.7|9.7|||
4419080|NCT00191724|4243670|B6|Unknown||Race/Ethnicity||participants|Number|1|1.0||||||
4419081|NCT00191724|4243671|B5|Unknown||Race/Ethnicity||participants|Number|0|0.0||||||
4419082|NCT00191724|4243672|B4|Unknown||Race/Ethnicity||participants|Number|0|0.0||||||
4419083|NCT00191724|4243673|B3|Unknown||Race/Ethnicity||participants|Number|1|1.0||||||
4419084|NCT00191724|4243674|B2|Unknown||Race/Ethnicity||participants|Number|0|0.0||||||
4419085|NCT00191724|4243675|B1|Unknown||Race/Ethnicity||participants|Number|0|0.0||||||
4419086|NCT00191724|4243670|B6|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4419087|NCT00191724|4243671|B5|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4419088|NCT00191724|4243672|B4|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4419089|NCT00191724|4243673|B3|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4419090|NCT00191724|4243674|B2|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4419091|NCT00191724|4243675|B1|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4419092|NCT00191724|4243670|B6|Caucasian||Race/Ethnicity||participants|Number|45|45.0||||||
4419093|NCT00191724|4243671|B5|Caucasian||Race/Ethnicity||participants|Number|15|15.0||||||
4419094|NCT00191724|4243672|B4|Caucasian||Race/Ethnicity||participants|Number|7|7.0||||||
4419095|NCT00191724|4243673|B3|Caucasian||Race/Ethnicity||participants|Number|8|8.0||||||
4419096|NCT00191724|4243674|B2|Caucasian||Race/Ethnicity||participants|Number|9|9.0||||||
4419097|NCT00191724|4243675|B1|Caucasian||Race/Ethnicity||participants|Number|6|6.0||||||
4419098|NCT00191724|4243670|B6|Venous Thromboembolism - Unknown||Medical History - Venous Thromboembolism||participants|Number|6|6.0||||||
4419099|NCT00191724|4243671|B5|Venous Thromboembolism - Unknown||Medical History - Venous Thromboembolism||participants|Number|2|2.0||||||
4419100|NCT00191724|4243672|B4|Venous Thromboembolism - Unknown||Medical History - Venous Thromboembolism||participants|Number|1|1.0||||||
4419101|NCT00191724|4243673|B3|Venous Thromboembolism - Unknown||Medical History - Venous Thromboembolism||participants|Number|0|0.0||||||
4419102|NCT00191724|4243674|B2|Venous Thromboembolism - Unknown||Medical History - Venous Thromboembolism||participants|Number|0|0.0||||||
4419103|NCT00191724|4243675|B1|Venous Thromboembolism - Unknown||Medical History - Venous Thromboembolism||participants|Number|3|3.0||||||
4419104|NCT00191724|4243670|B6|Venous Thromboembolism - No||Medical History - Venous Thromboembolism||participants|Number|37|37.0||||||
4419105|NCT00191724|4243671|B5|Venous Thromboembolism - No||Medical History - Venous Thromboembolism||participants|Number|12|12.0||||||
4419106|NCT00191724|4243672|B4|Venous Thromboembolism - No||Medical History - Venous Thromboembolism||participants|Number|7|7.0||||||
4419107|NCT00191724|4243673|B3|Venous Thromboembolism - No||Medical History - Venous Thromboembolism||participants|Number|8|8.0||||||
4419108|NCT00191724|4243674|B2|Venous Thromboembolism - No||Medical History - Venous Thromboembolism||participants|Number|7|7.0||||||
4419109|NCT00191724|4243675|B1|Venous Thromboembolism - No||Medical History - Venous Thromboembolism||participants|Number|3|3.0||||||
4419110|NCT00191724|4243670|B6|Venous Thromboembolism - Yes||Medical History - Venous Thromboembolism||participants|Number|4|4.0||||||
4419111|NCT00191724|4243671|B5|Venous Thromboembolism - Yes||Medical History - Venous Thromboembolism||participants|Number|1|1.0||||||
4419112|NCT00191724|4243672|B4|Venous Thromboembolism - Yes||Medical History - Venous Thromboembolism||participants|Number|0|0.0||||||
4419113|NCT00191724|4243673|B3|Venous Thromboembolism - Yes||Medical History - Venous Thromboembolism||participants|Number|1|1.0||||||
4419114|NCT00191724|4243674|B2|Venous Thromboembolism - Yes||Medical History - Venous Thromboembolism||participants|Number|2|2.0||||||
4419115|NCT00191724|4243675|B1|Venous Thromboembolism - Yes||Medical History - Venous Thromboembolism||participants|Number|0|0.0||||||
4419116|NCT00191724|4243670|B6|Pulmonary Embolism - Unknown||Medical History - Pulmonary Embolism||participants|Number|2|2.0||||||
4419117|NCT00191724|4243671|B5|Pulmonary Embolism - Unknown||Medical History - Pulmonary Embolism||participants|Number|0|0.0||||||
4419118|NCT00191724|4243672|B4|Pulmonary Embolism - Unknown||Medical History - Pulmonary Embolism||participants|Number|0|0.0||||||
4419119|NCT00191724|4243673|B3|Pulmonary Embolism - Unknown||Medical History - Pulmonary Embolism||participants|Number|0|0.0||||||
4419120|NCT00191724|4243674|B2|Pulmonary Embolism - Unknown||Medical History - Pulmonary Embolism||participants|Number|0|0.0||||||
4419121|NCT00191724|4243675|B1|Pulmonary Embolism - Unknown||Medical History - Pulmonary Embolism||participants|Number|2|2.0||||||
4419122|NCT00191724|4243670|B6|Pulmonary Embolism - No||Medical History - Pulmonary Embolism||participants|Number|41|41.0||||||
4419123|NCT00191724|4243671|B5|Pulmonary Embolism - No||Medical History - Pulmonary Embolism||participants|Number|15|15.0||||||
4419124|NCT00191724|4243672|B4|Pulmonary Embolism - No||Medical History - Pulmonary Embolism||participants|Number|7|7.0||||||
4419125|NCT00191724|4243673|B3|Pulmonary Embolism - No||Medical History - Pulmonary Embolism||participants|Number|9|9.0||||||
4419126|NCT00191724|4243674|B2|Pulmonary Embolism - No||Medical History - Pulmonary Embolism||participants|Number|7|7.0||||||
4419127|NCT00191724|4243675|B1|Pulmonary Embolism - No||Medical History - Pulmonary Embolism||participants|Number|3|3.0||||||
4419128|NCT00191724|4243670|B6|Pulmonary Embolism - Yes||Medical History - Pulmonary Embolism||participants|Number|4|4.0||||||
4419129|NCT00191724|4243671|B5|Pulmonary Embolism - Yes||Medical History - Pulmonary Embolism||participants|Number|0|0.0||||||
4419130|NCT00191724|4243672|B4|Pulmonary Embolism - Yes||Medical History - Pulmonary Embolism||participants|Number|1|1.0||||||
4419131|NCT00191724|4243673|B3|Pulmonary Embolism - Yes||Medical History - Pulmonary Embolism||participants|Number|0|0.0||||||
4419132|NCT00191724|4243674|B2|Pulmonary Embolism - Yes||Medical History - Pulmonary Embolism||participants|Number|2|2.0||||||
4419133|NCT00191724|4243675|B1|Pulmonary Embolism - Yes||Medical History - Pulmonary Embolism||participants|Number|1|1.0||||||
4419134|NCT00191724|4243670|B6|Ischemic Stroke - Unknown||Medical History - Ischemic Stroke||participants|Number|1|1.0||||||
4419135|NCT00191724|4243671|B5|Ischemic Stroke - Unknown||Medical History - Ischemic Stroke||participants|Number|0|0.0||||||
4419136|NCT00191724|4243672|B4|Ischemic Stroke - Unknown||Medical History - Ischemic Stroke||participants|Number|0|0.0||||||
4419137|NCT00191724|4243673|B3|Ischemic Stroke - Unknown||Medical History - Ischemic Stroke||participants|Number|0|0.0||||||
4419138|NCT00191724|4243674|B2|Ischemic Stroke - Unknown||Medical History - Ischemic Stroke||participants|Number|0|0.0||||||
4419139|NCT00191724|4243675|B1|Ischemic Stroke - Unknown||Medical History - Ischemic Stroke||participants|Number|1|1.0||||||
4419140|NCT00191724|4243670|B6|Ischemic Stroke - No||Medical History - Ischemic Stroke||participants|Number|41|41.0||||||
4419141|NCT00191724|4243671|B5|Ischemic Stroke - No||Medical History - Ischemic Stroke||participants|Number|12|12.0||||||
4419142|NCT00191724|4243672|B4|Ischemic Stroke - No||Medical History - Ischemic Stroke||participants|Number|8|8.0||||||
4419143|NCT00191724|4243673|B3|Ischemic Stroke - No||Medical History - Ischemic Stroke||participants|Number|9|9.0||||||
4419144|NCT00191724|4243674|B2|Ischemic Stroke - No||Medical History - Ischemic Stroke||participants|Number|8|8.0||||||
4419145|NCT00191724|4243675|B1|Ischemic Stroke - No||Medical History - Ischemic Stroke||participants|Number|4|4.0||||||
4419146|NCT00191724|4243670|B6|Ischemic Stroke - Yes||Medical History - Ischemic Stroke||participants|Number|5|5.0||||||
4419147|NCT00191724|4243671|B5|Ischemic Stroke - Yes||Medical History - Ischemic Stroke||participants|Number|3|3.0||||||
4419148|NCT00191724|4243672|B4|Ischemic Stroke - Yes||Medical History - Ischemic Stroke||participants|Number|0|0.0||||||
4419149|NCT00191724|4243673|B3|Ischemic Stroke - Yes||Medical History - Ischemic Stroke||participants|Number|0|0.0||||||
4419150|NCT00191724|4243674|B2|Ischemic Stroke - Yes||Medical History - Ischemic Stroke||participants|Number|1|1.0||||||
4419151|NCT00191724|4243675|B1|Ischemic Stroke - Yes||Medical History - Ischemic Stroke||participants|Number|1|1.0||||||
4419152|NCT00191724|4243670|B6|Deep Vein Thrombosis - Unknown||Medical History - Deep Vein Thrombosis||participants|Number|3|3.0||||||
4419153|NCT00191724|4243671|B5|Deep Vein Thrombosis - Unknown||Medical History - Deep Vein Thrombosis||participants|Number|0|0.0||||||
4419154|NCT00191724|4243672|B4|Deep Vein Thrombosis - Unknown||Medical History - Deep Vein Thrombosis||participants|Number|0|0.0||||||
4419155|NCT00191724|4243673|B3|Deep Vein Thrombosis - Unknown||Medical History - Deep Vein Thrombosis||participants|Number|0|0.0||||||
4419156|NCT00191724|4243674|B2|Deep Vein Thrombosis - Unknown||Medical History - Deep Vein Thrombosis||participants|Number|0|0.0||||||
4419157|NCT00191724|4243675|B1|Deep Vein Thrombosis - Unknown||Medical History - Deep Vein Thrombosis||participants|Number|3|3.0||||||
4419158|NCT00191724|4243670|B6|Deep Vein Thrombosis - No||Medical History - Deep Vein Thrombosis||participants|Number|36|36.0||||||
4419159|NCT00191724|4243671|B5|Deep Vein Thrombosis - No||Medical History - Deep Vein Thrombosis||participants|Number|13|13.0||||||
4419160|NCT00191724|4243672|B4|Deep Vein Thrombosis - No||Medical History - Deep Vein Thrombosis||participants|Number|6|6.0||||||
4419161|NCT00191724|4243673|B3|Deep Vein Thrombosis - No||Medical History - Deep Vein Thrombosis||participants|Number|8|8.0||||||
4419162|NCT00191724|4243674|B2|Deep Vein Thrombosis - No||Medical History - Deep Vein Thrombosis||participants|Number|7|7.0||||||
4419163|NCT00191724|4243675|B1|Deep Vein Thrombosis - No||Medical History - Deep Vein Thrombosis||participants|Number|2|2.0||||||
4419164|NCT00191724|4243670|B6|Deep Vein Thrombosis - Yes||Medical History - Deep Vein Thrombosis||participants|Number|8|8.0||||||
4419165|NCT00191724|4243671|B5|Deep Vein Thrombosis - Yes||Medical History - Deep Vein Thrombosis||participants|Number|2|2.0||||||
4419166|NCT00191724|4243672|B4|Deep Vein Thrombosis - Yes||Medical History - Deep Vein Thrombosis||participants|Number|2|2.0||||||
4419167|NCT00191724|4243673|B3|Deep Vein Thrombosis - Yes||Medical History - Deep Vein Thrombosis||participants|Number|1|1.0||||||
4419168|NCT00191724|4243674|B2|Deep Vein Thrombosis - Yes||Medical History - Deep Vein Thrombosis||participants|Number|2|2.0||||||
4419169|NCT00191724|4243675|B1|Deep Vein Thrombosis - Yes||Medical History - Deep Vein Thrombosis||participants|Number|1|1.0||||||
4419170|NCT00191724|4243670|B6|Chronic Obstructive Pulmonary Disease - Unknown||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|3|3.0||||||
4419171|NCT00191724|4243671|B5|Chronic Obstructive Pulmonary Disease - Unknown||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|2|2.0||||||
4419172|NCT00191724|4243672|B4|Chronic Obstructive Pulmonary Disease - Unknown||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|0|0.0||||||
4419173|NCT00191724|4243673|B3|Chronic Obstructive Pulmonary Disease - Unknown||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|0|0.0||||||
4419174|NCT00191724|4243674|B2|Chronic Obstructive Pulmonary Disease - Unknown||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|0|0.0||||||
4419175|NCT00191724|4243675|B1|Chronic Obstructive Pulmonary Disease - Unknown||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|1|1.0||||||
4419176|NCT00191724|4243670|B6|Chronic Obstructive Pulmonary Disease - No||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|42|42.0||||||
4419177|NCT00191724|4243671|B5|Chronic Obstructive Pulmonary Disease - No||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|13|13.0||||||
4419178|NCT00191724|4243672|B4|Chronic Obstructive Pulmonary Disease - No||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|8|8.0||||||
4419179|NCT00191724|4243673|B3|Chronic Obstructive Pulmonary Disease - No||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|9|9.0||||||
4419180|NCT00191724|4243674|B2|Chronic Obstructive Pulmonary Disease - No||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|7|7.0||||||
4419181|NCT00191724|4243675|B1|Chronic Obstructive Pulmonary Disease - No||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|5|5.0||||||
4419182|NCT00191724|4243670|B6|Chronic Obstructive Pulmonary Disease - Yes||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|2|2.0||||||
4419183|NCT00191724|4243671|B5|Chronic Obstructive Pulmonary Disease - Yes||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|0|0.0||||||
4419184|NCT00191724|4243672|B4|Chronic Obstructive Pulmonary Disease - Yes||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|0|0.0||||||
4419185|NCT00191724|4243673|B3|Chronic Obstructive Pulmonary Disease - Yes||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|0|0.0||||||
4419186|NCT00191724|4243674|B2|Chronic Obstructive Pulmonary Disease - Yes||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|2|2.0||||||
4419187|NCT00191724|4243675|B1|Chronic Obstructive Pulmonary Disease - Yes||Medical History - Chronic Obstructive Pulmonary Disease||participants|Number|0|0.0||||||
4419188|NCT00191724|4243670|B6|Acute Coronary Syndrome/MI - Unknown||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|2|2.0||||||
4419189|NCT00191724|4243671|B5|Acute Coronary Syndrome/MI - Unknown||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|2|2.0||||||
4419190|NCT00191724|4243672|B4|Acute Coronary Syndrome/MI - Unknown||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|0|0.0||||||
4419191|NCT00191724|4243673|B3|Acute Coronary Syndrome/MI - Unknown||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|0|0.0||||||
4419192|NCT00191724|4243674|B2|Acute Coronary Syndrome/MI - Unknown||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|0|0.0||||||
4419193|NCT00191724|4243675|B1|Acute Coronary Syndrome/MI - Unknown||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|0|0.0||||||
4419194|NCT00191724|4243670|B6|Acute Coronary Syndrome/MI - No||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|44|44.0||||||
4419195|NCT00191724|4243671|B5|Acute Coronary Syndrome/MI - No||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|13|13.0||||||
4419196|NCT00191724|4243672|B4|Acute Coronary Syndrome/MI - No||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|8|8.0||||||
4419197|NCT00191724|4243673|B3|Acute Coronary Syndrome/MI - No||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|9|9.0||||||
4419198|NCT00191724|4243674|B2|Acute Coronary Syndrome/MI - No||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|8|8.0||||||
4419199|NCT00191724|4243675|B1|Acute Coronary Syndrome/MI - No||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|6|6.0||||||
4419200|NCT00191724|4243670|B6|Acute Coronary Syndrome/MI - Yes||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|1|1.0||||||
4419201|NCT00191724|4243671|B5|Acute Coronary Syndrome/MI - Yes||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|0|0.0||||||
4419202|NCT00191724|4243672|B4|Acute Coronary Syndrome/MI - Yes||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|0|0.0||||||
4419203|NCT00191724|4243673|B3|Acute Coronary Syndrome/MI - Yes||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|0|0.0||||||
4419204|NCT00191724|4243674|B2|Acute Coronary Syndrome/MI - Yes||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|1|1.0||||||
4419205|NCT00191724|4243675|B1|Acute Coronary Syndrome/MI - Yes||Medical History - Acute Coronary Syndrome/Myocardial Infarction||participants|Number|0|0.0||||||
4419206|NCT00191724|4243670|B6|Germany||Region of Enrollment||participants|Number|47|47.0||||||
4419207|NCT00191724|4243671|B5|Germany||Region of Enrollment||participants|Number|15|15.0||||||
4419208|NCT00191724|4243672|B4|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4419209|NCT00191724|4243673|B3|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4419210|NCT00191724|4243674|B2|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4419211|NCT00191724|4243675|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4419212|NCT00191724|4243670|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4419213|NCT00191724|4243671|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4419214|NCT00191724|4243672|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4419215|NCT00191724|4243673|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4419216|NCT00191724|4243674|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4419217|NCT00191724|4243675|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4419218|NCT00191724|4243670|B6||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4419219|NCT00191724|4243671|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4419220|NCT00191724|4243672|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4419221|NCT00191724|4243673|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4419222|NCT00191724|4243674|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4419223|NCT00191724|4243675|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4419224|NCT00191724|4243670|B6|||Age||years|Mean|58.7|58.7|Standard Deviation|18.9|18.9|||
4419225|NCT00191724|4243671|B5|||Age||years|Mean|60.7|60.7|Standard Deviation|21.9|21.9|||
4419226|NCT00191724|4243672|B4|||Age||years|Mean|45.6|45.6|Standard Deviation|22.6|22.6|||
4419227|NCT00191724|4243673|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|16.5|16.5|||
4419228|NCT00191724|4243674|B2|||Age||years|Mean|65.7|65.7|Standard Deviation|8.9|8.9|||
4419229|NCT00191724|4243675|B1|||Age||years|Mean|70.8|70.8|Standard Deviation|4.4|4.4|||
4419230|NCT00191646|4243706|B3|||CA-125 Units per milliliter at Baseline for All Patients|Cancer Antigen 125, units per milliliter|units per milliliter|Mean|486.329|486.329|Standard Deviation|1127.213|1127.213|||
4419231|NCT00191646|4243707|B2|||CA-125 Units per milliliter at Baseline for All Patients|Cancer Antigen 125, units per milliliter|units per milliliter|Mean|479.854|479.854|Standard Deviation|1117.040|1117.04|||
4419232|NCT00191646|4243708|B1|||CA-125 Units per milliliter at Baseline for All Patients|Cancer Antigen 125, units per milliliter|units per milliliter|Mean|492.772|492.772|Standard Deviation|1138.556|1138.556|||
4419233|NCT00191646|4243706|B3|Missing Data||Volume of Residual Tumor Following Debulking Surgery||participants|Number|10|10.0||||||
4419234|NCT00191646|4243707|B2|Missing Data||Volume of Residual Tumor Following Debulking Surgery||participants|Number|4|4.0||||||
4419235|NCT00191646|4243708|B1|Missing Data||Volume of Residual Tumor Following Debulking Surgery||participants|Number|6|6.0||||||
4419236|NCT00191646|4243706|B3|>= 2 centimeters||Volume of Residual Tumor Following Debulking Surgery||participants|Number|198|198.0||||||
4419237|NCT00191646|4243707|B2|>= 2 centimeters||Volume of Residual Tumor Following Debulking Surgery||participants|Number|96|96.0||||||
4419238|NCT00191646|4243708|B1|>= 2 centimeters||Volume of Residual Tumor Following Debulking Surgery||participants|Number|102|102.0||||||
4419239|NCT00191646|4243706|B3|< 2 centimeters||Volume of Residual Tumor Following Debulking Surgery||participants|Number|623|623.0||||||
4419240|NCT00191646|4243707|B2|< 2 centimeters||Volume of Residual Tumor Following Debulking Surgery||participants|Number|314|314.0||||||
4419241|NCT00191646|4243708|B1|< 2 centimeters||Volume of Residual Tumor Following Debulking Surgery||participants|Number|309|309.0||||||
4419242|NCT00191646|4243706|B3|Missing Data||Histology||participants|Number|1|1.0||||||
4419243|NCT00191646|4243707|B2|Missing Data||Histology||participants|Number|0|0.0||||||
4419244|NCT00191646|4243708|B1|Missing Data||Histology||participants|Number|1|1.0||||||
4419245|NCT00191646|4243706|B3|Other||Histology||participants|Number|38|38.0||||||
4419246|NCT00191646|4243707|B2|Other||Histology||participants|Number|21|21.0||||||
4419247|NCT00191646|4243708|B1|Other||Histology||participants|Number|17|17.0||||||
4419248|NCT00191646|4243706|B3|Adenocarcinoma Not Otherwise Specified (NOS)||Histology||participants|Number|45|45.0||||||
4419249|NCT00191646|4243707|B2|Adenocarcinoma Not Otherwise Specified (NOS)||Histology||participants|Number|23|23.0||||||
4419250|NCT00191646|4243708|B1|Adenocarcinoma Not Otherwise Specified (NOS)||Histology||participants|Number|22|22.0||||||
4419251|NCT00191646|4243706|B3|Malignant Brenner's Tumor||Histology||participants|Number|0|0.0||||||
4419252|NCT00191646|4243707|B2|Malignant Brenner's Tumor||Histology||participants|Number|0|0.0||||||
4419253|NCT00191646|4243708|B1|Malignant Brenner's Tumor||Histology||participants|Number|0|0.0||||||
4419254|NCT00191646|4243706|B3|Transitional Cell||Histology||participants|Number|4|4.0||||||
4419255|NCT00191646|4243707|B2|Transitional Cell||Histology||participants|Number|1|1.0||||||
4419256|NCT00191646|4243708|B1|Transitional Cell||Histology||participants|Number|3|3.0||||||
4419257|NCT00191646|4243706|B3|Mixed Epithelial||Histology||participants|Number|22|22.0||||||
4419258|NCT00191646|4243707|B2|Mixed Epithelial||Histology||participants|Number|13|13.0||||||
4419259|NCT00191646|4243708|B1|Mixed Epithelial||Histology||participants|Number|9|9.0||||||
4419260|NCT00191646|4243706|B3|Clear Cell||Histology||participants|Number|44|44.0||||||
4419261|NCT00191646|4243707|B2|Clear Cell||Histology||participants|Number|23|23.0||||||
4419262|NCT00191646|4243708|B1|Clear Cell||Histology||participants|Number|21|21.0||||||
4419263|NCT00191646|4243706|B3|Undifferentiated||Histology||participants|Number|14|14.0||||||
4419264|NCT00191646|4243707|B2|Undifferentiated||Histology||participants|Number|7|7.0||||||
4419265|NCT00191646|4243708|B1|Undifferentiated||Histology||participants|Number|7|7.0||||||
4419266|NCT00191646|4243706|B3|Endometroid||Histology||participants|Number|84|84.0||||||
4419267|NCT00191646|4243707|B2|Endometroid||Histology||participants|Number|40|40.0||||||
4419268|NCT00191646|4243708|B1|Endometroid||Histology||participants|Number|44|44.0||||||
4419269|NCT00191646|4243706|B3|Serous||Histology||participants|Number|559|559.0||||||
4419270|NCT00191646|4243707|B2|Serous||Histology||participants|Number|276|276.0||||||
4419271|NCT00191646|4243708|B1|Serous||Histology||participants|Number|283|283.0||||||
4419272|NCT00191646|4243706|B3|Mucinous||Histology||participants|Number|20|20.0||||||
4419273|NCT00191646|4243707|B2|Mucinous||Histology||participants|Number|10|10.0||||||
4419274|NCT00191646|4243708|B1|Mucinous||Histology||participants|Number|10|10.0||||||
4419275|NCT00191646|4243706|B3|Missing Data||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|1|1.0||||||
4419276|NCT00191646|4243707|B2|Missing Data||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|1|1.0||||||
4419277|NCT00191646|4243708|B1|Missing Data||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|0|0.0||||||
4419292|NCT00191646|4243708|B1|Missing Data||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|12|12.0||||||
4419278|NCT00191646|4243706|B3|Stage IV||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|131|131.0||||||
4419279|NCT00191646|4243707|B2|Stage IV||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|63|63.0||||||
4419280|NCT00191646|4243708|B1|Stage IV||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|68|68.0||||||
4419281|NCT00191646|4243706|B3|Stage III||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|573|573.0||||||
4419282|NCT00191646|4243707|B2|Stage III||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|289|289.0||||||
4419283|NCT00191646|4243708|B1|Stage III||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|284|284.0||||||
4419284|NCT00191646|4243706|B3|Stage II||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|83|83.0||||||
4419285|NCT00191646|4243707|B2|Stage II||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|39|39.0||||||
4419286|NCT00191646|4243708|B1|Stage II||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|44|44.0||||||
4419287|NCT00191646|4243706|B3|Stage Ic||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|43|43.0||||||
4419288|NCT00191646|4243707|B2|Stage Ic||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|22|22.0||||||
4419289|NCT00191646|4243708|B1|Stage Ic||International Federation of Gynecology and Obstetrics (FIGO) Stage at Initial Surgery|"Ic: Tumor is either Stage IA or IB level but the capsule is ruptured or there is tumor on the ovarian surface or malignant cells are present in ascites or washings.~II: Tumor involves one or both ovaries with pelvic extension~III: Tumor involving one or both ovaries, with microscopically confirmed peritoneal metastases outside the pelvis and/or regional lymph node metastases~IV: Distant metastases (Excludes peritoneal metastases)"|participants|Number|21|21.0||||||
4419290|NCT00191646|4243706|B3|Missing Data||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|21|21.0||||||
4419291|NCT00191646|4243707|B2|Missing Data||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|9|9.0||||||
4419293|NCT00191646|4243706|B3|>= 3||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|0|0.0||||||
4419294|NCT00191646|4243707|B2|>= 3||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|0|0.0||||||
4419295|NCT00191646|4243708|B1|>= 3||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|0|0.0||||||
4419296|NCT00191646|4243706|B3|2||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|43|43.0||||||
4419297|NCT00191646|4243707|B2|2||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|16|16.0||||||
4419298|NCT00191646|4243708|B1|2||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|27|27.0||||||
4419299|NCT00191646|4243706|B3|1||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|296|296.0||||||
4419300|NCT00191646|4243707|B2|1||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|157|157.0||||||
4419301|NCT00191646|4243708|B1|1||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|139|139.0||||||
4419302|NCT00191646|4243706|B3|0||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|471|471.0||||||
4419303|NCT00191646|4243707|B2|0||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|232|232.0||||||
4419304|NCT00191646|4243708|B1|0||Zubrod Performance Status|"0 Asymptomatic~Symptomatic, fully ambulatory~Symptomatic, in bed < 50% of the day~Symptomatic, in bed > 50% of the day but not bedridden~Bedridden~Dead"|participants|Number|239|239.0||||||
4419305|NCT00191646|4243706|B3|Missing Data||Extent of Residual Disease|Patients either had no clinical evidence of residual disease (non-measurable), either by physical or radiologic exam, that was measurable as defined below or they had residual disease that was measured by either of the following techniques. Measurable lesions were those which could be measured accurately and followed in at least one dimension (the longest dimension being the one recorded). Each lesion must be >= 20 millimeters (mm) when measured by conventional techniques [palpation, plain X-ray, Computed tomography (CT), and Magnetic resonance imaging (MRI)], or >= 10 mm by spiral CT.|participants|Number|2|2.0||||||
4419306|NCT00191646|4243707|B2|Missing Data||Extent of Residual Disease|Patients either had no clinical evidence of residual disease (non-measurable), either by physical or radiologic exam, that was measurable as defined below or they had residual disease that was measured by either of the following techniques. Measurable lesions were those which could be measured accurately and followed in at least one dimension (the longest dimension being the one recorded). Each lesion must be >= 20 millimeters (mm) when measured by conventional techniques [palpation, plain X-ray, Computed tomography (CT), and Magnetic resonance imaging (MRI)], or >= 10 mm by spiral CT.|participants|Number|0|0.0||||||
4419307|NCT00191646|4243708|B1|Missing Data||Extent of Residual Disease|Patients either had no clinical evidence of residual disease (non-measurable), either by physical or radiologic exam, that was measurable as defined below or they had residual disease that was measured by either of the following techniques. Measurable lesions were those which could be measured accurately and followed in at least one dimension (the longest dimension being the one recorded). Each lesion must be >= 20 millimeters (mm) when measured by conventional techniques [palpation, plain X-ray, Computed tomography (CT), and Magnetic resonance imaging (MRI)], or >= 10 mm by spiral CT.|participants|Number|2|2.0||||||
4419308|NCT00191646|4243706|B3|Non-measurable||Extent of Residual Disease|Patients either had no clinical evidence of residual disease (non-measurable), either by physical or radiologic exam, that was measurable as defined below or they had residual disease that was measured by either of the following techniques. Measurable lesions were those which could be measured accurately and followed in at least one dimension (the longest dimension being the one recorded). Each lesion must be >= 20 millimeters (mm) when measured by conventional techniques [palpation, plain X-ray, Computed tomography (CT), and Magnetic resonance imaging (MRI)], or >= 10 mm by spiral CT.|participants|Number|576|576.0||||||
4419309|NCT00191646|4243707|B2|Non-measurable||Extent of Residual Disease|Patients either had no clinical evidence of residual disease (non-measurable), either by physical or radiologic exam, that was measurable as defined below or they had residual disease that was measured by either of the following techniques. Measurable lesions were those which could be measured accurately and followed in at least one dimension (the longest dimension being the one recorded). Each lesion must be >= 20 millimeters (mm) when measured by conventional techniques [palpation, plain X-ray, Computed tomography (CT), and Magnetic resonance imaging (MRI)], or >= 10 mm by spiral CT.|participants|Number|300|300.0||||||
4419310|NCT00191646|4243708|B1|Non-measurable||Extent of Residual Disease|Patients either had no clinical evidence of residual disease (non-measurable), either by physical or radiologic exam, that was measurable as defined below or they had residual disease that was measured by either of the following techniques. Measurable lesions were those which could be measured accurately and followed in at least one dimension (the longest dimension being the one recorded). Each lesion must be >= 20 millimeters (mm) when measured by conventional techniques [palpation, plain X-ray, Computed tomography (CT), and Magnetic resonance imaging (MRI)], or >= 10 mm by spiral CT.|participants|Number|276|276.0||||||
4419351|NCT00191477|4243728|B2|GX - Unknown||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|1|1.0||||||
4419483|NCT00191451|4243747|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4419311|NCT00191646|4243706|B3|Measurable||Extent of Residual Disease|Patients either had no clinical evidence of residual disease (non-measurable), either by physical or radiologic exam, that was measurable as defined below or they had residual disease that was measured by either of the following techniques. Measurable lesions were those which could be measured accurately and followed in at least one dimension (the longest dimension being the one recorded). Each lesion must be >= 20 millimeters (mm) when measured by conventional techniques [palpation, plain X-ray, Computed tomography (CT), and Magnetic resonance imaging (MRI)], or >= 10 mm by spiral CT.|participants|Number|253|253.0||||||
4419312|NCT00191646|4243707|B2|Measurable||Extent of Residual Disease|Patients either had no clinical evidence of residual disease (non-measurable), either by physical or radiologic exam, that was measurable as defined below or they had residual disease that was measured by either of the following techniques. Measurable lesions were those which could be measured accurately and followed in at least one dimension (the longest dimension being the one recorded). Each lesion must be >= 20 millimeters (mm) when measured by conventional techniques [palpation, plain X-ray, Computed tomography (CT), and Magnetic resonance imaging (MRI)], or >= 10 mm by spiral CT.|participants|Number|114|114.0||||||
4419313|NCT00191646|4243708|B1|Measurable||Extent of Residual Disease|Patients either had no clinical evidence of residual disease (non-measurable), either by physical or radiologic exam, that was measurable as defined below or they had residual disease that was measured by either of the following techniques. Measurable lesions were those which could be measured accurately and followed in at least one dimension (the longest dimension being the one recorded). Each lesion must be >= 20 millimeters (mm) when measured by conventional techniques [palpation, plain X-ray, Computed tomography (CT), and Magnetic resonance imaging (MRI)], or >= 10 mm by spiral CT.|participants|Number|139|139.0||||||
4419314|NCT00191646|4243706|B3|Missing Data||Organ of Origin|Organ from which disease originated|participants|Number|8|8.0||||||
4419315|NCT00191646|4243707|B2|Missing Data||Organ of Origin|Organ from which disease originated|participants|Number|2|2.0||||||
4419316|NCT00191646|4243708|B1|Missing Data||Organ of Origin|Organ from which disease originated|participants|Number|6|6.0||||||
4419317|NCT00191646|4243706|B3|Peritoneum||Organ of Origin|Organ from which disease originated|participants|Number|106|106.0||||||
4419318|NCT00191646|4243707|B2|Peritoneum||Organ of Origin|Organ from which disease originated|participants|Number|50|50.0||||||
4419319|NCT00191646|4243708|B1|Peritoneum||Organ of Origin|Organ from which disease originated|participants|Number|56|56.0||||||
4419320|NCT00191646|4243706|B3|Ovary||Organ of Origin|Organ from which disease originated|participants|Number|717|717.0||||||
4419321|NCT00191646|4243707|B2|Ovary||Organ of Origin|Organ from which disease originated|participants|Number|362|362.0||||||
4419322|NCT00191646|4243708|B1|Ovary||Organ of Origin|Organ from which disease originated|participants|Number|355|355.0||||||
4419323|NCT00191646|4243706|B3|Other||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4419324|NCT00191646|4243707|B2|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4419325|NCT00191646|4243708|B1|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4419326|NCT00191646|4243706|B3|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4419327|NCT00191646|4243707|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4419328|NCT00191646|4243708|B1|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4419329|NCT00191646|4243706|B3|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4419330|NCT00191646|4243707|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4419331|NCT00191646|4243708|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4419332|NCT00191646|4243706|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4419333|NCT00191646|4243707|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4419334|NCT00191646|4243708|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4419335|NCT00191646|4243706|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|758|758.0||||||
4419336|NCT00191646|4243707|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|379|379.0||||||
4419337|NCT00191646|4243708|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|379|379.0||||||
4419338|NCT00191646|4243706|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419339|NCT00191646|4243707|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419340|NCT00191646|4243708|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419341|NCT00191646|4243706|B3||Female|Sex: Female, Male||Participants|Count of Participants|831|831.0||||||
4419342|NCT00191646|4243707|B2||Female|Sex: Female, Male||Participants|Count of Participants|414|414.0||||||
4419343|NCT00191646|4243708|B1||Female|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
4419344|NCT00191646|4243706|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|11.1|11.1|||
4419345|NCT00191646|4243707|B2|||Age||years|Mean|60.3|60.3|Standard Deviation|10.8|10.8|||
4419346|NCT00191646|4243708|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|11.4|11.4|||
4419347|NCT00191477|4243727|B3|Unspecified||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|43.0|43.0||||||
4419348|NCT00191477|4243728|B2|Unspecified||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|22|22.0||||||
4419349|NCT00191477|4243729|B1|Unspecified||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|21|21.0||||||
4419350|NCT00191477|4243727|B3|GX - Unknown||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|9.0|9.0||||||
4419477|NCT00191451|4243749|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4419478|NCT00191451|4243746|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419352|NCT00191477|4243729|B1|GX - Unknown||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|8|8.0||||||
4419353|NCT00191477|4243727|B3|G4 - Undifferentiated||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|4.0|4.0||||||
4419354|NCT00191477|4243728|B2|G4 - Undifferentiated||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|1|1.0||||||
4419355|NCT00191477|4243729|B1|G4 - Undifferentiated||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|3|3.0||||||
4419356|NCT00191477|4243727|B3|G3 - Poorly Differentiated||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|49.0|49.0||||||
4419357|NCT00191477|4243728|B2|G3 - Poorly Differentiated||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|24|24.0||||||
4419358|NCT00191477|4243729|B1|G3 - Poorly Differentiated||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|25|25.0||||||
4419359|NCT00191477|4243727|B3|G2 - Moderately Differentiated||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|98.0|98.0||||||
4419360|NCT00191477|4243728|B2|G2 - Moderately Differentiated||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|48|48.0||||||
4419361|NCT00191477|4243729|B1|G2 - Moderately Differentiated||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|50|50.0||||||
4419362|NCT00191477|4243727|B3|G1 - Well Differentiated||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|125.0|125.0||||||
4419363|NCT00191477|4243728|B2|G1 - Well Differentiated||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|66|66.0||||||
4419364|NCT00191477|4243729|B1|G1 - Well Differentiated||Results of Transurethral Resection on a Bladder Tumor (TUR-BT): Final Disease Grade|Worst grading of the initial and optional second transurethral resection of bladder tumor.|participants|Number|59|59.0||||||
4419365|NCT00191477|4243727|B3|Unspecified||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|1.0|1.0||||||
4419366|NCT00191477|4243728|B2|Unspecified||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|0|0.0||||||
4419367|NCT00191477|4243729|B1|Unspecified||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|1|1.0||||||
4419368|NCT00191477|4243727|B3|No Malignancy||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|43.0|43.0||||||
4419369|NCT00191477|4243728|B2|No Malignancy||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|22|22.0||||||
4419370|NCT00191477|4243729|B1|No Malignancy||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|21|21.0||||||
4419371|NCT00191477|4243727|B3|"Cis: Carcinoma in situ (Flat Tumor)"||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|11.0|11.0||||||
4419372|NCT00191477|4243728|B2|"Cis: Carcinoma in situ (Flat Tumor)"||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|6|6.0||||||
4419373|NCT00191477|4243729|B1|"Cis: Carcinoma in situ (Flat Tumor)"||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|5|5.0||||||
4419374|NCT00191477|4243727|B3|>=pT2: Tumor Invades Wider Area||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|22.0|22.0||||||
4419375|NCT00191477|4243728|B2|>=pT2: Tumor Invades Wider Area||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|10|10.0||||||
4419376|NCT00191477|4243729|B1|>=pT2: Tumor Invades Wider Area||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|12|12.0||||||
4419377|NCT00191477|4243727|B3|pT1: Tumor Invades Subepithelial Connective Tissue||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|67.0|67.0||||||
4419378|NCT00191477|4243728|B2|pT1: Tumor Invades Subepithelial Connective Tissue||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|36|36.0||||||
4419379|NCT00191477|4243729|B1|pT1: Tumor Invades Subepithelial Connective Tissue||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|31|31.0||||||
4419380|NCT00191477|4243727|B3|pTa: Noninvasive Papillary Carcinoma||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|181.0|181.0||||||
4419381|NCT00191477|4243728|B2|pTa: Noninvasive Papillary Carcinoma||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|88|88.0||||||
4419382|NCT00191477|4243729|B1|pTa: Noninvasive Papillary Carcinoma||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|93|93.0||||||
4419383|NCT00191477|4243727|B3|pT0: No Evidence of Primary Tumor||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|0.0|0.0||||||
4419384|NCT00191477|4243728|B2|pT0: No Evidence of Primary Tumor||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|0|0.0||||||
4419385|NCT00191477|4243729|B1|pT0: No Evidence of Primary Tumor||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|0|0.0||||||
4419386|NCT00191477|4243727|B3|pTx: Primary Tumor Cannot be Assessed||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|3.0|3.0||||||
4419387|NCT00191477|4243728|B2|pTx: Primary Tumor Cannot be Assessed||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|0|0.0||||||
4419388|NCT00191477|4243729|B1|pTx: Primary Tumor Cannot be Assessed||Results of Transurethral Resection of Bladder Tumor (TUR-BT): Final Pathological Disease Stage|Worst staging of the initial and optional second transurethral resection of bladder tumor.|participants|Number|3|3.0||||||
4419389|NCT00191477|4243727|B3|>=5 Lesions||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|18.0|18.0||||||
4419390|NCT00191477|4243728|B2|>=5 Lesions||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|10|10.0||||||
4419391|NCT00191477|4243729|B1|>=5 Lesions||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|8|8.0||||||
4419392|NCT00191477|4243727|B3|4 Lesions||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|17.0|17.0||||||
4419393|NCT00191477|4243728|B2|4 Lesions||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|10|10.0||||||
4419394|NCT00191477|4243729|B1|4 Lesions||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|7|7.0||||||
4419395|NCT00191477|4243727|B3|3 Lesions||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|32.0|32.0||||||
4419396|NCT00191477|4243728|B2|3 Lesions||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|14|14.0||||||
4419397|NCT00191477|4243729|B1|3 Lesions||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|18|18.0||||||
4419398|NCT00191477|4243727|B3|2 Lesions||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|69.0|69.0||||||
4419399|NCT00191477|4243728|B2|2 Lesions||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|27|27.0||||||
4419400|NCT00191477|4243729|B1|2 Lesions||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|42|42.0||||||
4419401|NCT00191477|4243727|B3|1 Lesion||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|183.0|183.0||||||
4419402|NCT00191477|4243728|B2|1 Lesion||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|96|96.0||||||
4419403|NCT00191477|4243729|B1|1 Lesion||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|87|87.0||||||
4419479|NCT00191451|4243747|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419480|NCT00191451|4243748|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419404|NCT00191477|4243727|B3|No Lesions (No Specific Sites Documented)||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|9.0|9.0||||||
4419405|NCT00191477|4243728|B2|No Lesions (No Specific Sites Documented)||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|5|5.0||||||
4419406|NCT00191477|4243729|B1|No Lesions (No Specific Sites Documented)||Results of Initial Transurethral Resection of a Bladder Tumor (TUR-BT): Number of Visible Lesions|The initial TUR-BT was the first and mandatory TUR-BT during the study. An optional second TUR-BT was allowed.|participants|Number|4|4.0||||||
4419407|NCT00191477|4243727|B3|White||Race/Ethnicity||participants|Number|328|328.0||||||
4419408|NCT00191477|4243728|B2|White||Race/Ethnicity||participants|Number|162|162.0||||||
4419409|NCT00191477|4243729|B1|White||Race/Ethnicity||participants|Number|166|166.0||||||
4419410|NCT00191477|4243727|B3|Newly Diagnosed||Newly Diagnosed versus Recurrent Disease||participants|Number|245.0|245.0||||||
4419411|NCT00191477|4243728|B2|Newly Diagnosed||Newly Diagnosed versus Recurrent Disease||participants|Number|122|122.0||||||
4419412|NCT00191477|4243729|B1|Newly Diagnosed||Newly Diagnosed versus Recurrent Disease||participants|Number|123|123.0||||||
4419413|NCT00191477|4243727|B3|Recurrent Disease||Newly Diagnosed versus Recurrent Disease||participants|Number|83.0|83.0||||||
4419414|NCT00191477|4243728|B2|Recurrent Disease||Newly Diagnosed versus Recurrent Disease||participants|Number|40|40.0||||||
4419415|NCT00191477|4243729|B1|Recurrent Disease||Newly Diagnosed versus Recurrent Disease||participants|Number|43|43.0||||||
4419416|NCT00191477|4243727|B3|Unspecified||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|2.0|2.0||||||
4419417|NCT00191477|4243728|B2|Unspecified||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|1|1.0||||||
4419418|NCT00191477|4243729|B1|Unspecified||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|1|1.0||||||
4419419|NCT00191477|4243727|B3|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|222.0|222.0||||||
4419420|NCT00191477|4243728|B2|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|104|104.0||||||
4419421|NCT00191477|4243729|B1|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|118|118.0||||||
4419422|NCT00191477|4243727|B3|90 - Normal activity; minor signs of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|82.0|82.0||||||
4419423|NCT00191477|4243728|B2|90 - Normal activity; minor signs of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|49|49.0||||||
4419424|NCT00191477|4243729|B1|90 - Normal activity; minor signs of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|33|33.0||||||
4419425|NCT00191477|4243727|B3|80 - Activity with effort; some signs of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|20.0|20.0||||||
4419426|NCT00191477|4243728|B2|80 - Activity with effort; some signs of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|7|7.0||||||
4419427|NCT00191477|4243729|B1|80 - Activity with effort; some signs of disease||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|13|13.0||||||
4419428|NCT00191477|4243727|B3|70 - Unable to carry on normal activity||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|2.0|2.0||||||
4419429|NCT00191477|4243728|B2|70 - Unable to carry on normal activity||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|1|1.0||||||
4419481|NCT00191451|4243749|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419482|NCT00191451|4243746|B4||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4419430|NCT00191477|4243729|B1|70 - Unable to carry on normal activity||Karnofsky Performance Status|Classifies patients according to their functional impairment. Rating occurs in steps of 10 score points (0=death, 10, 20,....up to 100=Normal no complaints, no evidence of disease). Lower scores indicate poorer patient condition.|participants|Number|1|1.0||||||
4419431|NCT00191477|4243727|B3|Turkey||Region of Enrollment||participants|Number|71.0|71.0||||||
4419432|NCT00191477|4243728|B2|Turkey||Region of Enrollment||participants|Number|36|36.0||||||
4419433|NCT00191477|4243729|B1|Turkey||Region of Enrollment||participants|Number|35|35.0||||||
4419434|NCT00191477|4243727|B3|Germany||Region of Enrollment||participants|Number|257.0|257.0||||||
4419435|NCT00191477|4243728|B2|Germany||Region of Enrollment||participants|Number|126|126.0||||||
4419436|NCT00191477|4243729|B1|Germany||Region of Enrollment||participants|Number|131|131.0||||||
4419437|NCT00191477|4243727|B3||Male|Sex: Female, Male||Participants|Count of Participants|263.0|263.0||||||
4419438|NCT00191477|4243728|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4419439|NCT00191477|4243729|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4419440|NCT00191477|4243727|B3||Female|Sex: Female, Male||Participants|Count of Participants|65.0|65.0||||||
4419441|NCT00191477|4243728|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4419442|NCT00191477|4243729|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4419443|NCT00191477|4243727|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|11.5|11.5|||
4419444|NCT00191477|4243728|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|11.0|11.0|||
4419445|NCT00191477|4243729|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|11.9|11.9|||
4419446|NCT00191451|4243746|B4|Other||Race/Ethnicity||participants|Number|5|5.0||||||
4419447|NCT00191451|4243747|B3|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4419448|NCT00191451|4243748|B2|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4419449|NCT00191451|4243749|B1|Other||Race/Ethnicity||participants|Number|4|4.0||||||
4419450|NCT00191451|4243746|B4|Hispanic||Race/Ethnicity||participants|Number|12|12.0||||||
4419451|NCT00191451|4243747|B3|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4419452|NCT00191451|4243748|B2|Hispanic||Race/Ethnicity||participants|Number|4|4.0||||||
4419453|NCT00191451|4243749|B1|Hispanic||Race/Ethnicity||participants|Number|7|7.0||||||
4419454|NCT00191451|4243746|B4|Black||Race/Ethnicity||participants|Number|24|24.0||||||
4419455|NCT00191451|4243747|B3|Black||Race/Ethnicity||participants|Number|11|11.0||||||
4419456|NCT00191451|4243748|B2|Black||Race/Ethnicity||participants|Number|5|5.0||||||
4419457|NCT00191451|4243749|B1|Black||Race/Ethnicity||participants|Number|8|8.0||||||
4419458|NCT00191451|4243746|B4|Caucasian||Race/Ethnicity||participants|Number|109|109.0||||||
4419459|NCT00191451|4243747|B3|Caucasian||Race/Ethnicity||participants|Number|36|36.0||||||
4419460|NCT00191451|4243748|B2|Caucasian||Race/Ethnicity||participants|Number|42|42.0||||||
4419461|NCT00191451|4243749|B1|Caucasian||Race/Ethnicity||participants|Number|31|31.0||||||
4419462|NCT00191451|4243746|B4|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|2|2.0||||||
4419463|NCT00191451|4243747|B3|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|0|0.0||||||
4419464|NCT00191451|4243748|B2|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|1|1.0||||||
4419465|NCT00191451|4243749|B1|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|1|1.0||||||
4419466|NCT00191451|4243746|B4|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|39|39.0||||||
4419467|NCT00191451|4243747|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|17|17.0||||||
4419468|NCT00191451|4243748|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|14|14.0||||||
4419469|NCT00191451|4243749|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|8|8.0||||||
4419470|NCT00191451|4243746|B4|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|109|109.0||||||
4419471|NCT00191451|4243747|B3|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|32|32.0||||||
4419472|NCT00191451|4243748|B2|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|36|36.0||||||
4419473|NCT00191451|4243749|B1|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|41|41.0||||||
4419474|NCT00191451|4243746|B4|United States||Region of Enrollment||participants|Number|150|150.0||||||
4419475|NCT00191451|4243747|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4419476|NCT00191451|4243748|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4419484|NCT00191451|4243748|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4419485|NCT00191451|4243749|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4419486|NCT00191451|4243746|B4|||Age||years|Mean|55.55|55.55|Standard Deviation|10.16|10.16|||
4419487|NCT00191451|4243747|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|9.92|9.92|||
4419488|NCT00191451|4243748|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|11.17|11.17|||
4419489|NCT00191451|4243749|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|9.45|9.45|||
4419490|NCT00191386|4243771|B1|Obsessive Compulsive Disorder||Kiddie Schedule for Affective Disorders and Schizophrenia for School Aged Children-PL|The Kiddie Schedule for Affective Disorders and Schizophrenia for School Aged Children-Present and Lifetime Version (K-SADS-PL) is a semi-structured interview schedule for assessing psychiatric disorders in children and adolescents. It is used to assess the status of 32 DSM-IV child and adolescent psychiatric diagnosis.|Participants with Disorder Presently|Number|1|1.0||||||
4419491|NCT00191386|4243771|B1|Generalized Anxiety Disorder||Kiddie Schedule for Affective Disorders and Schizophrenia for School Aged Children-PL|The Kiddie Schedule for Affective Disorders and Schizophrenia for School Aged Children-Present and Lifetime Version (K-SADS-PL) is a semi-structured interview schedule for assessing psychiatric disorders in children and adolescents. It is used to assess the status of 32 DSM-IV child and adolescent psychiatric diagnosis.|Participants with Disorder Presently|Number|1|1.0||||||
4419492|NCT00191386|4243771|B1|Specific Phobia||Kiddie Schedule for Affective Disorders and Schizophrenia for School Aged Children-PL|The Kiddie Schedule for Affective Disorders and Schizophrenia for School Aged Children-Present and Lifetime Version (K-SADS-PL) is a semi-structured interview schedule for assessing psychiatric disorders in children and adolescents. It is used to assess the status of 32 DSM-IV child and adolescent psychiatric diagnosis.|Participants with Disorder Presently|Number|3|3.0||||||
4419493|NCT00191386|4243771|B1|Conduct Disorder||Kiddie Schedule for Affective Disorders and Schizophrenia for School Aged Children-PL|The Kiddie Schedule for Affective Disorders and Schizophrenia for School Aged Children-Present and Lifetime Version (K-SADS-PL) is a semi-structured interview schedule for assessing psychiatric disorders in children and adolescents. It is used to assess the status of 32 DSM-IV child and adolescent psychiatric diagnosis.|Participants with Disorder Presently|Number|2|2.0||||||
4419494|NCT00191386|4243771|B1|Oppositional Defiant Disorder||Kiddie Schedule for Affective Disorders and Schizophrenia for School Aged Children-PL|The Kiddie Schedule for Affective Disorders and Schizophrenia for School Aged Children-Present and Lifetime Version (K-SADS-PL) is a semi-structured interview schedule for assessing psychiatric disorders in children and adolescents. It is used to assess the status of 32 DSM-IV child and adolescent psychiatric diagnosis.|Participants with Disorder Presently|Number|32|32.0||||||
4419495|NCT00191386|4243771|B1|14 Years||Duration of ADHD||Participants|Number|3|3.0||||||
4419496|NCT00191386|4243771|B1|13 Years||Duration of ADHD||Participants|Number|3|3.0||||||
4419497|NCT00191386|4243771|B1|12 Years||Duration of ADHD||Participants|Number|7|7.0||||||
4419498|NCT00191386|4243771|B1|11 Years||Duration of ADHD||Participants|Number|4|4.0||||||
4419499|NCT00191386|4243771|B1|10 Years||Duration of ADHD||Participants|Number|11|11.0||||||
4419500|NCT00191386|4243771|B1|9 Years||Duration of ADHD||Participants|Number|22|22.0||||||
4419501|NCT00191386|4243771|B1|8 Years||Duration of ADHD||Participants|Number|21|21.0||||||
4419502|NCT00191386|4243771|B1|7 Years||Duration of ADHD||Participants|Number|31|31.0||||||
4419503|NCT00191386|4243771|B1|6 Years||Duration of ADHD||Participants|Number|26|26.0||||||
4419504|NCT00191386|4243771|B1|5 Years||Duration of ADHD||Participants|Number|32|32.0||||||
4419505|NCT00191386|4243771|B1|4 Years||Duration of ADHD||Participants|Number|24|24.0||||||
4419506|NCT00191386|4243771|B1|3 Years||Duration of ADHD||Participants|Number|30|30.0||||||
4419507|NCT00191386|4243771|B1|2 Years||Duration of ADHD||Participants|Number|8|8.0||||||
4419508|NCT00191386|4243771|B1|1 Years||Duration of ADHD||Participants|Number|6|6.0||||||
4419509|NCT00191386|4243771|B1|||Duration of ADHD||Years|Mean|6.25|6.25|Standard Deviation|2.85|2.85|||
4419510|NCT00191386|4243771|B1|7 Years||Age at Onset of ADHD||Participants|Number|4|4.0||||||
4419511|NCT00191386|4243771|B1|6 Years||Age at Onset of ADHD||Participants|Number|40|40.0||||||
4419512|NCT00191386|4243771|B1|5 Years||Age at Onset of ADHD||Participants|Number|47|47.0||||||
4419513|NCT00191386|4243771|B1|4 Years||Age at Onset of ADHD||Participants|Number|45|45.0||||||
4419514|NCT00191386|4243771|B1|3 Years||Age at Onset of ADHD||Participants|Number|49|49.0||||||
4419515|NCT00191386|4243771|B1|2 Years||Age at Onset of ADHD||Participants|Number|25|25.0||||||
4419516|NCT00191386|4243771|B1|1 Years||Age at Onset of ADHD||Participants|Number|17|17.0||||||
4419517|NCT00191386|4243771|B1|0 Years||Age at Onset of ADHD||Participants|Number|1|1.0||||||
4419518|NCT00191386|4243771|B1|||Mean Age at Onset of Attention Deficit Hyperactivity Disorder (ADHD)||Years|Mean|3.93|3.93|Standard Deviation|1.57|1.57|||
4419519|NCT00191386|4243771|B1|||Clinical Global Impressions-Attention Deficit Hyperactivity Disorder-Severity (CGI-ADHD-S)|Measures total improvement (or worsening) of a participant's ADHD symptoms from the beginning of treatment. (1=very much improved, 7=very much worsened).|Units on a scale|Mean|4.00|4.0|Standard Deviation|1.04|1.04|||
4419520|NCT00191386|4243771|B1|||ADHD Rating Scale-IV-Translated in Japanese Parent Version: Investigator Administered/Scored|Measures the 18 symptoms contained in the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision (DSM-IV-TR) diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD). Individual item scores range from 0 (none/never or rarely) to 3 (severe/very often). Total scores range from 0 to 54.|Units on a scale|Mean|22.23|22.23|Standard Deviation|10.42|10.42|||
4419521|NCT00191386|4243771|B1|Japan||Region of Enrollment||participants|Number|228|228.0||||||
4419522|NCT00191386|4243771|B1|East Asian||Race/Ethnicity, Customized||Participants|Number|228|228.0||||||
4419523|NCT00191386|4243771|B1||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4419524|NCT00191386|4243771|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4419525|NCT00191386|4243771|B1|||Age||years|Mean|10.69|10.69|Standard Deviation|2.48|2.48|||
4419526|NCT00191334|4243778|B1|||Time from Initial Diagnosis to Study Entry||days|Mean|14.0|14.0|Standard Deviation|10.3|10.3|||
4419527|NCT00191334|4243778|B1|Post-Menopause||State of Patient Relative to Menopause||participants|Number|46|46.0||||||
4419528|NCT00191334|4243778|B1|Fertile Period||State of Patient Relative to Menopause||participants|Number|4|4.0||||||
4419529|NCT00191334|4243778|B1|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4419530|NCT00191334|4243778|B1|Caucasian||Race/Ethnicity||participants|Number|49|49.0||||||
4419531|NCT00191334|4243778|B1|Other||Postoperational Pathomorphological Diagnosis||participants|Number|6|6.0||||||
4419532|NCT00191334|4243778|B1|Endometrioid Carcinoma||Postoperational Pathomorphological Diagnosis||participants|Number|4|4.0||||||
4419533|NCT00191334|4243778|B1|Mucinosa Cystadenocarcinoma||Postoperational Pathomorphological Diagnosis||participants|Number|3|3.0||||||
4419534|NCT00191334|4243778|B1|Serous Cystadenocarcinoma||Postoperational Pathomorphological Diagnosis||participants|Number|37|37.0||||||
4419535|NCT00191334|4243778|B1|4 - Completely Disabled||Eastern Cooperative Oncology Group Performance Status Score||participants|Number|0|0.0||||||
4419536|NCT00191334|4243778|B1|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group Performance Status Score||participants|Number|0|0.0||||||
4419537|NCT00191334|4243778|B1|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group Performance Status Score||participants|Number|2|2.0||||||
4419538|NCT00191334|4243778|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Performance Status Score||participants|Number|20|20.0||||||
4419539|NCT00191334|4243778|B1|0 - Fully Active||Eastern Cooperative Oncology Group Performance Status Score||participants|Number|28|28.0||||||
4419540|NCT00191334|4243778|B1|Stage IV - Distant Metastases||Disease Stage||participants|Number|25|25.0||||||
4419541|NCT00191334|4243778|B1|Stage IIIc - Peritoneal Metastasis More Than 2 cm||Disease Stage||participants|Number|21|21.0||||||
4419542|NCT00191334|4243778|B1|Stage IIIb - Macroscopic Peritoneal Metastasis||Disease Stage||participants|Number|3|3.0||||||
4419543|NCT00191334|4243778|B1|Stage IIIa - Microscopic Peritoneal Metastasis||Disease Stage||participants|Number|1|1.0||||||
4419544|NCT00191334|4243778|B1|Stage II - Pelvic Extension and/or Implants||Disease Stage||participants|Number|0|0.0||||||
4419545|NCT00191334|4243778|B1|Stage I - Tumor Limited to Ovaries||Disease Stage||participants|Number|0|0.0||||||
4419546|NCT00191334|4243778|B1|Russian Federation||Region of Enrollment||participants|Number|50|50.0||||||
4419547|NCT00191334|4243778|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419548|NCT00191334|4243778|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4419549|NCT00191334|4243778|B1|||Age||years|Mean|54.9|54.9|Standard Deviation|10.7|10.7|||
4419550|NCT00191308|4243786|B1|Stage IIB||Stage of Disease at Study Entry|Tumor stages ranged from 0 (not spread) to IV (spread throughout the body). Stage IB=tumor was larger or grew deeper than IA, but was not in the lymph nodes; Stage IIA=cancer spread to some lymph nodes near the original tumor; Stage IIB=cancer was not in the lymph nodes but in the chest wall region, or was a larger tumor in the lymph nodes.|participants|Number|10|10.0||||||
4419551|NCT00191308|4243786|B1|Stage IIA||Stage of Disease at Study Entry|Tumor stages ranged from 0 (not spread) to IV (spread throughout the body). Stage IB=tumor was larger or grew deeper than IA, but was not in the lymph nodes; Stage IIA=cancer spread to some lymph nodes near the original tumor; Stage IIB=cancer was not in the lymph nodes but in the chest wall region, or was a larger tumor in the lymph nodes.|participants|Number|2|2.0||||||
4419552|NCT00191308|4243786|B1|Stage IB||Stage of Disease at Study Entry|Tumor stages ranged from 0 (not spread) to IV (spread throughout the body). Stage IB=tumor was larger or grew deeper than IA, but was not in the lymph nodes; Stage IIA=cancer spread to some lymph nodes near the original tumor; Stage IIB=cancer was not in the lymph nodes but in the chest wall region, or was a larger tumor in the lymph nodes.|participants|Number|18|18.0||||||
4419553|NCT00191308|4243786|B1|Other||Initial Pathological Diagnosis|Pemetrexed was approved in April 2008 for first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC), other than predominantly squamous. Of the 30 participants enrolled at that time, 20 had squamous cell histology. The protocol was not amended since enrollment stopped early (October 2008) due to lack of eligible participants.|participants|Number|8|8.0||||||
4419554|NCT00191308|4243786|B1|Bronchoalveolar Carcinoma||Initial Pathological Diagnosis|Pemetrexed was approved in April 2008 for first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC), other than predominantly squamous. Of the 30 participants enrolled at that time, 20 had squamous cell histology. The protocol was not amended since enrollment stopped early (October 2008) due to lack of eligible participants.|participants|Number|0|0.0||||||
4419555|NCT00191308|4243786|B1|Large Cell Carcinoma of Lung||Initial Pathological Diagnosis|Pemetrexed was approved in April 2008 for first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC), other than predominantly squamous. Of the 30 participants enrolled at that time, 20 had squamous cell histology. The protocol was not amended since enrollment stopped early (October 2008) due to lack of eligible participants.|participants|Number|0|0.0||||||
4419556|NCT00191308|4243786|B1|Squamous Cell Carcinoma of Lung||Initial Pathological Diagnosis|Pemetrexed was approved in April 2008 for first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC), other than predominantly squamous. Of the 30 participants enrolled at that time, 20 had squamous cell histology. The protocol was not amended since enrollment stopped early (October 2008) due to lack of eligible participants.|participants|Number|20|20.0||||||
4419557|NCT00191308|4243786|B1|Mixed Cell Carcinoma of Lung||Initial Pathological Diagnosis|Pemetrexed was approved in April 2008 for first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC), other than predominantly squamous. Of the 30 participants enrolled at that time, 20 had squamous cell histology. The protocol was not amended since enrollment stopped early (October 2008) due to lack of eligible participants.|participants|Number|0|0.0||||||
4419619|NCT00191282|4243796|B1|Lebanon||Region of Enrollment||participants|Number|18|18.0||||||
4419620|NCT00191282|4243794|B3|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4419621|NCT00191282|4243795|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4419558|NCT00191308|4243786|B1|Adenocarcinoma of Lung||Initial Pathological Diagnosis|Pemetrexed was approved in April 2008 for first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC), other than predominantly squamous. Of the 30 participants enrolled at that time, 20 had squamous cell histology. The protocol was not amended since enrollment stopped early (October 2008) due to lack of eligible participants.|participants|Number|2|2.0||||||
4419559|NCT00191308|4243786|B1|Cytological||Basis for Diagnosis||participants|Number|0|0.0||||||
4419560|NCT00191308|4243786|B1|Histopathological||Basis for Diagnosis||participants|Number|30|30.0||||||
4419561|NCT00191308|4243786|B1|Poland||Region of Enrollment||participants|Number|30|30.0||||||
4419562|NCT00191308|4243786|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4419563|NCT00191308|4243786|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4419564|NCT00191308|4243786|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4419565|NCT00191308|4243786|B1|||Age||years|Mean|55.94|55.94|Standard Deviation|8.214|8.214|||
4419566|NCT00191282|4243794|B3|Other||Race/Ethnicity||participants|Number|22|22.0||||||
4419567|NCT00191282|4243795|B2|Other||Race/Ethnicity||participants|Number|11|11.0||||||
4419568|NCT00191282|4243796|B1|Other||Race/Ethnicity||participants|Number|11|11.0||||||
4419569|NCT00191282|4243794|B3|African Descent||Race/Ethnicity||participants|Number|7|7.0||||||
4419570|NCT00191282|4243795|B2|African Descent||Race/Ethnicity||participants|Number|6|6.0||||||
4419571|NCT00191282|4243796|B1|African Descent||Race/Ethnicity||participants|Number|1|1.0||||||
4419572|NCT00191282|4243794|B3|Western Asian||Race/Ethnicity||participants|Number|119|119.0||||||
4419573|NCT00191282|4243795|B2|Western Asian||Race/Ethnicity||participants|Number|58|58.0||||||
4419574|NCT00191282|4243796|B1|Western Asian||Race/Ethnicity||participants|Number|61|61.0||||||
4419575|NCT00191282|4243794|B3|Caucasian||Race/Ethnicity||participants|Number|967|967.0||||||
4419576|NCT00191282|4243795|B2|Caucasian||Race/Ethnicity||participants|Number|483|483.0||||||
4419577|NCT00191282|4243796|B1|Caucasian||Race/Ethnicity||participants|Number|484|484.0||||||
4419578|NCT00191282|4243794|B3|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4419579|NCT00191282|4243795|B2|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4419580|NCT00191282|4243796|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4419581|NCT00191282|4243794|B3|South Africa||Region of Enrollment||participants|Number|89|89.0||||||
4419582|NCT00191282|4243795|B2|South Africa||Region of Enrollment||participants|Number|45|45.0||||||
4419583|NCT00191282|4243796|B1|South Africa||Region of Enrollment||participants|Number|44|44.0||||||
4419584|NCT00191282|4243794|B3|Romania||Region of Enrollment||participants|Number|64|64.0||||||
4419585|NCT00191282|4243795|B2|Romania||Region of Enrollment||participants|Number|31|31.0||||||
4419586|NCT00191282|4243796|B1|Romania||Region of Enrollment||participants|Number|33|33.0||||||
4419587|NCT00191282|4243794|B3|Croatia||Region of Enrollment||participants|Number|143|143.0||||||
4419588|NCT00191282|4243795|B2|Croatia||Region of Enrollment||participants|Number|71|71.0||||||
4419589|NCT00191282|4243796|B1|Croatia||Region of Enrollment||participants|Number|72|72.0||||||
4419590|NCT00191282|4243794|B3|Poland||Region of Enrollment||participants|Number|205|205.0||||||
4419591|NCT00191282|4243795|B2|Poland||Region of Enrollment||participants|Number|103|103.0||||||
4419592|NCT00191282|4243796|B1|Poland||Region of Enrollment||participants|Number|102|102.0||||||
4419593|NCT00191282|4243794|B3|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4419594|NCT00191282|4243795|B2|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4419595|NCT00191282|4243796|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4419596|NCT00191282|4243794|B3|Hungary||Region of Enrollment||participants|Number|82|82.0||||||
4419597|NCT00191282|4243795|B2|Hungary||Region of Enrollment||participants|Number|41|41.0||||||
4419598|NCT00191282|4243796|B1|Hungary||Region of Enrollment||participants|Number|41|41.0||||||
4419599|NCT00191282|4243794|B3|Czech Republic||Region of Enrollment||participants|Number|50|50.0||||||
4419600|NCT00191282|4243795|B2|Czech Republic||Region of Enrollment||participants|Number|24|24.0||||||
4419601|NCT00191282|4243796|B1|Czech Republic||Region of Enrollment||participants|Number|26|26.0||||||
4419602|NCT00191282|4243794|B3|India||Region of Enrollment||participants|Number|70|70.0||||||
4419603|NCT00191282|4243795|B2|India||Region of Enrollment||participants|Number|34|34.0||||||
4419604|NCT00191282|4243796|B1|India||Region of Enrollment||participants|Number|36|36.0||||||
4419605|NCT00191282|4243794|B3|United Kingdom||Region of Enrollment||participants|Number|33|33.0||||||
4419606|NCT00191282|4243795|B2|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4419607|NCT00191282|4243796|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4419608|NCT00191282|4243794|B3|Russian Federation||Region of Enrollment||participants|Number|128|128.0||||||
4419609|NCT00191282|4243795|B2|Russian Federation||Region of Enrollment||participants|Number|65|65.0||||||
4419610|NCT00191282|4243796|B1|Russian Federation||Region of Enrollment||participants|Number|63|63.0||||||
4419611|NCT00191282|4243794|B3|Israel||Region of Enrollment||participants|Number|76|76.0||||||
4419612|NCT00191282|4243795|B2|Israel||Region of Enrollment||participants|Number|38|38.0||||||
4419613|NCT00191282|4243796|B1|Israel||Region of Enrollment||participants|Number|38|38.0||||||
4419614|NCT00191282|4243794|B3|Turkey||Region of Enrollment||participants|Number|36|36.0||||||
4419615|NCT00191282|4243795|B2|Turkey||Region of Enrollment||participants|Number|17|17.0||||||
4419616|NCT00191282|4243796|B1|Turkey||Region of Enrollment||participants|Number|19|19.0||||||
4419617|NCT00191282|4243794|B3|Lebanon||Region of Enrollment||participants|Number|37|37.0||||||
4419618|NCT00191282|4243795|B2|Lebanon||Region of Enrollment||participants|Number|19|19.0||||||
4419622|NCT00191282|4243796|B1|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4419623|NCT00191282|4243794|B3|Slovenia||Region of Enrollment||participants|Number|32|32.0||||||
4419624|NCT00191282|4243795|B2|Slovenia||Region of Enrollment||participants|Number|16|16.0||||||
4419625|NCT00191282|4243796|B1|Slovenia||Region of Enrollment||participants|Number|16|16.0||||||
4419626|NCT00191282|4243794|B3|Slovakia (Slovak Republic)||Region of Enrollment||participants|Number|19|19.0||||||
4419627|NCT00191282|4243795|B2|Slovakia (Slovak Republic)||Region of Enrollment||participants|Number|11|11.0||||||
4419628|NCT00191282|4243796|B1|Slovakia (Slovak Republic)||Region of Enrollment||participants|Number|8|8.0||||||
4419629|NCT00191282|4243794|B3||Male|Sex: Female, Male||Participants|Count of Participants|706|706.0||||||
4419630|NCT00191282|4243795|B2||Male|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4419631|NCT00191282|4243796|B1||Male|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4419632|NCT00191282|4243794|B3||Female|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
4419633|NCT00191282|4243795|B2||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4419634|NCT00191282|4243796|B1||Female|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4419635|NCT00191282|4243794|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|9.8|9.8|||
4419636|NCT00191282|4243795|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|9.8|9.8|||
4419637|NCT00191282|4243796|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|9.7|9.7|||
4419638|NCT00191269|4243855|B3|||Weight||kilograms|Mean|56.20|56.2|Standard Deviation|9.13|9.13|||
4419639|NCT00191269|4243856|B2|||Weight||kilograms|Mean|57.02|57.02|Standard Deviation|9.15|9.15|||
4419640|NCT00191269|4243857|B1|||Weight||kilograms|Mean|47.73|47.73|Standard Deviation|1.46|1.46|||
4419641|NCT00191269|4243855|B3|||Height||centimeters|Mean|156.08|156.08|Standard Deviation|5.98|5.98|||
4419642|NCT00191269|4243856|B2|||Height||centimeters|Mean|156.43|156.43|Standard Deviation|6.04|6.04|||
4419643|NCT00191269|4243857|B1|||Height||centimeters|Mean|152.45|152.45|Standard Deviation|4.05|4.05|||
4419644|NCT00191269|4243855|B3|No Recurrence||Time to Recurrence||participants|Number|11.0|11.0||||||
4419645|NCT00191269|4243856|B2|No Recurrence||Time to Recurrence||participants|Number|10|10.0||||||
4419646|NCT00191269|4243857|B1|No Recurrence||Time to Recurrence||participants|Number|1|1.0||||||
4419647|NCT00191269|4243855|B3|≥5 to <10 years||Time to Recurrence||participants|Number|5.0|5.0||||||
4419648|NCT00191269|4243856|B2|≥5 to <10 years||Time to Recurrence||participants|Number|4|4.0||||||
4419649|NCT00191269|4243857|B1|≥5 to <10 years||Time to Recurrence||participants|Number|1|1.0||||||
4419650|NCT00191269|4243855|B3|≥4 years and < 5 years||Time to Recurrence||participants|Number|2.0|2.0||||||
4419651|NCT00191269|4243856|B2|≥4 years and < 5 years||Time to Recurrence||participants|Number|2|2.0||||||
4419652|NCT00191269|4243857|B1|≥4 years and < 5 years||Time to Recurrence||participants|Number|0|0.0||||||
4419653|NCT00191269|4243855|B3|≥3 years and <4 years||Time to Recurrence||participants|Number|2.0|2.0||||||
4419654|NCT00191269|4243856|B2|≥3 years and <4 years||Time to Recurrence||participants|Number|2|2.0||||||
4419655|NCT00191269|4243857|B1|≥3 years and <4 years||Time to Recurrence||participants|Number|0|0.0||||||
4419656|NCT00191269|4243855|B3|≥2 years and <3 years||Time to Recurrence||participants|Number|4.0|4.0||||||
4419657|NCT00191269|4243856|B2|≥2 years and <3 years||Time to Recurrence||participants|Number|4|4.0||||||
4419658|NCT00191269|4243857|B1|≥2 years and <3 years||Time to Recurrence||participants|Number|0|0.0||||||
4419659|NCT00191269|4243855|B3|≥1 year and <2 years||Time to Recurrence||participants|Number|18.0|18.0||||||
4419660|NCT00191269|4243856|B2|≥1 year and <2 years||Time to Recurrence||participants|Number|18|18.0||||||
4419661|NCT00191269|4243857|B1|≥1 year and <2 years||Time to Recurrence||participants|Number|0|0.0||||||
4419662|NCT00191269|4243855|B3|<1 year||Time to Recurrence||participants|Number|26.0|26.0||||||
4419663|NCT00191269|4243856|B2|<1 year||Time to Recurrence||participants|Number|22|22.0||||||
4419664|NCT00191269|4243857|B1|<1 year||Time to Recurrence||participants|Number|4|4.0||||||
4419665|NCT00191269|4243855|B3|≥3 years before||Time of Latest Chemotherapy Completion||participants|Number|2.0|2.0||||||
4419666|NCT00191269|4243856|B2|≥3 years before||Time of Latest Chemotherapy Completion||participants|Number|2|2.0||||||
4419667|NCT00191269|4243857|B1|≥3 years before||Time of Latest Chemotherapy Completion||participants|Number|0|0.0||||||
4419668|NCT00191269|4243855|B3|≥2 years and <3 years||Time of Latest Chemotherapy Completion||participants|Number|2.0|2.0||||||
4419669|NCT00191269|4243856|B2|≥2 years and <3 years||Time of Latest Chemotherapy Completion||participants|Number|2|2.0||||||
4419670|NCT00191269|4243857|B1|≥2 years and <3 years||Time of Latest Chemotherapy Completion||participants|Number|0|0.0||||||
4419671|NCT00191269|4243855|B3|≥1 year and <2 years||Time of Latest Chemotherapy Completion||participants|Number|3.0|3.0||||||
4419672|NCT00191269|4243856|B2|≥1 year and <2 years||Time of Latest Chemotherapy Completion||participants|Number|3|3.0||||||
4419673|NCT00191269|4243857|B1|≥1 year and <2 years||Time of Latest Chemotherapy Completion||participants|Number|0|0.0||||||
4419674|NCT00191269|4243855|B3|≥6 months and <1 year||Time of Latest Chemotherapy Completion||participants|Number|12.0|12.0||||||
4419675|NCT00191269|4243856|B2|≥6 months and <1 year||Time of Latest Chemotherapy Completion||participants|Number|9|9.0||||||
4419676|NCT00191269|4243857|B1|≥6 months and <1 year||Time of Latest Chemotherapy Completion||participants|Number|3|3.0||||||
4419677|NCT00191269|4243855|B3|≥3 months and <6 months||Time of Latest Chemotherapy Completion||participants|Number|7.0|7.0||||||
4419678|NCT00191269|4243856|B2|≥3 months and <6 months||Time of Latest Chemotherapy Completion||participants|Number|6|6.0||||||
4419679|NCT00191269|4243857|B1|≥3 months and <6 months||Time of Latest Chemotherapy Completion||participants|Number|1|1.0||||||
4419680|NCT00191269|4243855|B3|<3 months||Time of Latest Chemotherapy Completion||participants|Number|42.0|42.0||||||
4419681|NCT00191269|4243856|B2|<3 months||Time of Latest Chemotherapy Completion||participants|Number|40|40.0||||||
4419682|NCT00191269|4243857|B1|<3 months||Time of Latest Chemotherapy Completion||participants|Number|2|2.0||||||
4419683|NCT00191269|4243855|B3|Unknown||Presence of Progesterone Hormone Receptor||participant|Number|1.0|1.0||||||
4419684|NCT00191269|4243856|B2|Unknown||Presence of Progesterone Hormone Receptor||participant|Number|0|0.0||||||
4419685|NCT00191269|4243857|B1|Unknown||Presence of Progesterone Hormone Receptor||participant|Number|1|1.0||||||
4419686|NCT00191269|4243855|B3|Present||Presence of Progesterone Hormone Receptor||participant|Number|25.0|25.0||||||
4419687|NCT00191269|4243856|B2|Present||Presence of Progesterone Hormone Receptor||participant|Number|23|23.0||||||
4419688|NCT00191269|4243857|B1|Present||Presence of Progesterone Hormone Receptor||participant|Number|2|2.0||||||
4419689|NCT00191269|4243855|B3|None||Presence of Progesterone Hormone Receptor||participant|Number|42.0|42.0||||||
4419690|NCT00191269|4243856|B2|None||Presence of Progesterone Hormone Receptor||participant|Number|39|39.0||||||
4419691|NCT00191269|4243857|B1|None||Presence of Progesterone Hormone Receptor||participant|Number|3|3.0||||||
4419692|NCT00191269|4243855|B3|Other Sites||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|13.0|13.0||||||
4419693|NCT00191269|4243856|B2|Other Sites||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|13|13.0||||||
4419694|NCT00191269|4243857|B1|Other Sites||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|0|0.0||||||
4419695|NCT00191269|4243855|B3|Skin||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|7.0|7.0||||||
4419696|NCT00191269|4243856|B2|Skin||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|6|6.0||||||
4419697|NCT00191269|4243857|B1|Skin||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|1|1.0||||||
4419698|NCT00191269|4243855|B3|Lymph Node||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|25.0|25.0||||||
4419699|NCT00191269|4243856|B2|Lymph Node||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|23|23.0||||||
4419700|NCT00191269|4243857|B1|Lymph Node||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|2|2.0||||||
4419701|NCT00191269|4243855|B3|Brain||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|0.0|0.0||||||
4419702|NCT00191269|4243856|B2|Brain||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|0|0.0||||||
4419703|NCT00191269|4243857|B1|Brain||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|0|0.0||||||
4419704|NCT00191269|4243855|B3|Liver||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|27.0|27.0||||||
4419705|NCT00191269|4243856|B2|Liver||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|25|25.0||||||
4419706|NCT00191269|4243857|B1|Liver||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|2|2.0||||||
4419707|NCT00191269|4243855|B3|Bone||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|25.0|25.0||||||
4419708|NCT00191269|4243856|B2|Bone||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|24|24.0||||||
4419709|NCT00191269|4243857|B1|Bone||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|1|1.0||||||
4419710|NCT00191269|4243855|B3|Lung||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|27.0|27.0||||||
4419711|NCT00191269|4243856|B2|Lung||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|27|27.0||||||
4419712|NCT00191269|4243857|B1|Lung||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|0|0.0||||||
4419713|NCT00191269|4243855|B3|None||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|5.0|5.0||||||
4419835|NCT00191165|4243891|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4419714|NCT00191269|4243856|B2|None||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|5|5.0||||||
4419715|NCT00191269|4243857|B1|None||Presence of Metastasis|Metastasis could occur in more than one site, resulting in a higher sum for all categories in the arm/group than the overall number of participants in the arm/group.|participants|Number|0|0.0||||||
4419716|NCT00191269|4243855|B3|Unknown||Presence of Estrogen Hormone Receptor||participants|Number|0.0|0.0||||||
4419717|NCT00191269|4243856|B2|Unknown||Presence of Estrogen Hormone Receptor||participants|Number|0|0.0||||||
4419718|NCT00191269|4243857|B1|Unknown||Presence of Estrogen Hormone Receptor||participants|Number|0|0.0||||||
4419719|NCT00191269|4243855|B3|Present||Presence of Estrogen Hormone Receptor||participants|Number|39.0|39.0||||||
4419720|NCT00191269|4243856|B2|Present||Presence of Estrogen Hormone Receptor||participants|Number|37|37.0||||||
4419721|NCT00191269|4243857|B1|Present||Presence of Estrogen Hormone Receptor||participants|Number|2|2.0||||||
4419722|NCT00191269|4243855|B3|None||Presence of Estrogen Hormone Receptor||participants|Number|29.0|29.0||||||
4419723|NCT00191269|4243856|B2|None||Presence of Estrogen Hormone Receptor||participants|Number|25|25.0||||||
4419724|NCT00191269|4243857|B1|None||Presence of Estrogen Hormone Receptor||participants|Number|4|4.0||||||
4419725|NCT00191269|4243855|B3|Unknown||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|2.0|2.0||||||
4419726|NCT00191269|4243856|B2|Unknown||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|2|2.0||||||
4419727|NCT00191269|4243857|B1|Unknown||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|0|0.0||||||
4419728|NCT00191269|4243855|B3|3+||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|10.0|10.0||||||
4419729|NCT00191269|4243856|B2|3+||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|9|9.0||||||
4419730|NCT00191269|4243857|B1|3+||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|1|1.0||||||
4419731|NCT00191269|4243855|B3|2+||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|6.0|6.0||||||
4419732|NCT00191269|4243856|B2|2+||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|4|4.0||||||
4419733|NCT00191269|4243857|B1|2+||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|2|2.0||||||
4419734|NCT00191269|4243855|B3|1+||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|21.0|21.0||||||
4419735|NCT00191269|4243856|B2|1+||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|20|20.0||||||
4419736|NCT00191269|4243857|B1|1+||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|1|1.0||||||
4419737|NCT00191269|4243855|B3|0||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|29.0|29.0||||||
4419738|NCT00191269|4243856|B2|0||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|27|27.0||||||
4419739|NCT00191269|4243857|B1|0||Human Epidermal Growth Factor Receptor 2 Expression Status||participants|Number|2|2.0||||||
4419740|NCT00191269|4243855|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|19.0|19.0||||||
4419741|NCT00191269|4243856|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|17|17.0||||||
4419742|NCT00191269|4243857|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|2|2.0||||||
4419743|NCT00191269|4243855|B3|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|49.0|49.0||||||
4419744|NCT00191269|4243856|B2|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|45|45.0||||||
4419745|NCT00191269|4243857|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|4|4.0||||||
4419746|NCT00191269|4243855|B3|Japan||Region of Enrollment||participants|Number|68.0|68.0||||||
4419747|NCT00191269|4243856|B2|Japan||Region of Enrollment||participants|Number|62|62.0||||||
4419748|NCT00191269|4243857|B1|Japan||Region of Enrollment||participants|Number|6|6.0||||||
4419749|NCT00191269|4243855|B3||Male|Sex: Female, Male||Participants|Count of Participants|0.0|0.0||||||
4419750|NCT00191269|4243856|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419751|NCT00191269|4243857|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4419752|NCT00191269|4243855|B3||Female|Sex: Female, Male||Participants|Count of Participants|68.0|68.0||||||
4419753|NCT00191269|4243856|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4419754|NCT00191269|4243857|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4419755|NCT00191269|4243855|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|10.93|10.93|||
4419756|NCT00191269|4243856|B2|||Age||years|Mean|52.4|52.4|Standard Deviation|11.25|11.25|||
4419757|NCT00191269|4243857|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|7.45|7.45|||
4419758|NCT00191191|4243872|B3|||Weight||kilograms|Mean|59.5|59.5|Standard Deviation|10.9|10.9|||
4419759|NCT00191191|4243873|B2|||Weight||kilograms|Mean|59.1|59.1|Standard Deviation|11.9|11.9|||
4419760|NCT00191191|4243874|B1|||Weight||kilograms|Mean|59.8|59.8|Standard Deviation|9.9|9.9|||
4419761|NCT00191191|4243872|B3|||Height||centimeters (cm)|Mean|161.0|161.0|Standard Deviation|8.3|8.3|||
4419762|NCT00191191|4243873|B2|||Height||centimeters (cm)|Mean|161.1|161.1|Standard Deviation|8.7|8.7|||
4419763|NCT00191191|4243874|B1|||Height||centimeters (cm)|Mean|161.0|161.0|Standard Deviation|7.9|7.9|||
4419764|NCT00191191|4243872|B3|Other||Histological Types||participants|Number|4|4.0||||||
4419765|NCT00191191|4243873|B2|Other||Histological Types||participants|Number|2|2.0||||||
4419766|NCT00191191|4243874|B1|Other||Histological Types||participants|Number|2|2.0||||||
4419767|NCT00191191|4243872|B3|Adenosquamous Carcinoma||Histological Types||participants|Number|1|1.0||||||
4419768|NCT00191191|4243873|B2|Adenosquamous Carcinoma||Histological Types||participants|Number|0|0.0||||||
4419769|NCT00191191|4243874|B1|Adenosquamous Carcinoma||Histological Types||participants|Number|1|1.0||||||
4419770|NCT00191191|4243872|B3|Large Cell Carcinoma||Histological Types||participants|Number|6|6.0||||||
4419771|NCT00191191|4243873|B2|Large Cell Carcinoma||Histological Types||participants|Number|1|1.0||||||
4419772|NCT00191191|4243874|B1|Large Cell Carcinoma||Histological Types||participants|Number|5|5.0||||||
4419773|NCT00191191|4243872|B3|Squamous Cell Carcinoma||Histological Types||participants|Number|48|48.0||||||
4419774|NCT00191191|4243873|B2|Squamous Cell Carcinoma||Histological Types||participants|Number|25|25.0||||||
4419775|NCT00191191|4243874|B1|Squamous Cell Carcinoma||Histological Types||participants|Number|23|23.0||||||
4419776|NCT00191191|4243872|B3|Adenocarcinoma||Histological Types||participants|Number|157|157.0||||||
4419777|NCT00191191|4243873|B2|Adenocarcinoma||Histological Types||participants|Number|80|80.0||||||
4419778|NCT00191191|4243874|B1|Adenocarcinoma||Histological Types||participants|Number|77|77.0||||||
4419779|NCT00191191|4243872|B3|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|12|12.0||||||
4419780|NCT00191191|4243873|B2|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|6|6.0||||||
4419781|NCT00191191|4243874|B1|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|6|6.0||||||
4419782|NCT00191191|4243872|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|125|125.0||||||
4419783|NCT00191191|4243873|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|66|66.0||||||
4419784|NCT00191191|4243874|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|59|59.0||||||
4419785|NCT00191191|4243872|B3|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|79|79.0||||||
4419786|NCT00191191|4243873|B2|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|36|36.0||||||
4419787|NCT00191191|4243874|B1|0 - Fully Active||Eastern Cooperative Oncology Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|43|43.0||||||
4419788|NCT00191191|4243872|B3|Japan||Region of Enrollment||participants|Number|216|216.0||||||
4419789|NCT00191191|4243873|B2|Japan||Region of Enrollment||participants|Number|108|108.0||||||
4419790|NCT00191191|4243874|B1|Japan||Region of Enrollment||participants|Number|108|108.0||||||
4419791|NCT00191191|4243872|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4419792|NCT00191191|4243873|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4419793|NCT00191191|4243874|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4419794|NCT00191191|4243872|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4419795|NCT00191191|4243873|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4419796|NCT00191191|4243874|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4419797|NCT00191191|4243872|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|8.7|8.7|||
4419798|NCT00191191|4243873|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|8.8|8.8|||
4419799|NCT00191191|4243874|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|8.7|8.7|||
4419800|NCT00191165|4243889|B3|||Target Height Standard Deviation Score (SDS)|Target height expressed as height SDS value (see height SDS description for how height SDS value was derived) based on patient’s gender, compared to British reference population at age 18 years for males and 16 years for females.|standard deviation score|Mean|-0.8|-0.8|Standard Deviation|0.6|0.6|||
4419801|NCT00191165|4243890|B2|||Target Height Standard Deviation Score (SDS)|Target height expressed as height SDS value (see height SDS description for how height SDS value was derived) based on patient’s gender, compared to British reference population at age 18 years for males and 16 years for females.|standard deviation score|Mean|-0.6|-0.6|Standard Deviation|0.5|0.5|||
4419802|NCT00191165|4243891|B1|||Target Height Standard Deviation Score (SDS)|Target height expressed as height SDS value (see height SDS description for how height SDS value was derived) based on patient’s gender, compared to British reference population at age 18 years for males and 16 years for females.|standard deviation score|Mean|-0.9|-0.9|Standard Deviation|0.7|0.7|||
4419803|NCT00191165|4243889|B3|||Target Height|Target Height represents the approximate adult height that the patient could be expected to attain, based on the heights of her/his parents. This is a gender-adjusted, average height of the patient’s parents’ heights calculated in centimeters, modified from the method of Tanner et al.|centimeters|Mean|168|168.0|Standard Deviation|6.2|6.2|||
4419804|NCT00191165|4243890|B2|||Target Height|Target Height represents the approximate adult height that the patient could be expected to attain, based on the heights of her/his parents. This is a gender-adjusted, average height of the patient’s parents’ heights calculated in centimeters, modified from the method of Tanner et al.|centimeters|Mean|168|168.0|Standard Deviation|7.5|7.5|||
4419805|NCT00191165|4243891|B1|||Target Height|Target Height represents the approximate adult height that the patient could be expected to attain, based on the heights of her/his parents. This is a gender-adjusted, average height of the patient’s parents’ heights calculated in centimeters, modified from the method of Tanner et al.|centimeters|Mean|168|168.0|Standard Deviation|5.0|5.0|||
4419806|NCT00191165|4243889|B3|||Height Standard Deviation Score (SDS)|Height SDS was derived by subtracting the age-and-gender-matched population 50th percentile height from the patient’s height and then dividing this value by the age-and-gender-matched population height standard deviation (SD).|standard deviation score|Mean|-1.4|-1.4|Standard Deviation|1.0|1.0|||
4419807|NCT00191165|4243890|B2|||Height Standard Deviation Score (SDS)|Height SDS was derived by subtracting the age-and-gender-matched population 50th percentile height from the patient’s height and then dividing this value by the age-and-gender-matched population height standard deviation (SD).|standard deviation score|Mean|-1.1|-1.1|Standard Deviation|1.0|1.0|||
4419808|NCT00191165|4243891|B1|||Height Standard Deviation Score (SDS)|Height SDS was derived by subtracting the age-and-gender-matched population 50th percentile height from the patient’s height and then dividing this value by the age-and-gender-matched population height standard deviation (SD).|standard deviation score|Mean|-1.7|-1.7|Standard Deviation|1.0|1.0|||
4419809|NCT00191165|4243889|B3|||Height|Standing measurements were to be made using a standard wall-mounted stadiometer.|centimeters|Mean|145|145.0|Standard Deviation|6.5|6.5|||
4419810|NCT00191165|4243890|B2|||Height|Standing measurements were to be made using a standard wall-mounted stadiometer.|centimeters|Mean|146|146.0|Standard Deviation|7.8|7.8|||
4419811|NCT00191165|4243891|B1|||Height|Standing measurements were to be made using a standard wall-mounted stadiometer.|centimeters|Mean|145|145.0|Standard Deviation|5.1|5.1|||
4419812|NCT00191165|4243889|B3|||Bone Age|Bone age was determined by the Greulich-Pyle method.|years|Mean|12.2|12.2|Standard Deviation|0.8|0.8|||
4419813|NCT00191165|4243890|B2|||Bone Age|Bone age was determined by the Greulich-Pyle method.|years|Mean|12.1|12.1|Standard Deviation|1.0|1.0|||
4419814|NCT00191165|4243891|B1|||Bone Age|Bone age was determined by the Greulich-Pyle method.|years|Mean|12.4|12.4|Standard Deviation|0.7|0.7|||
4419815|NCT00191165|4243889|B3|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m2)|Mean|19.2|19.2|Standard Deviation|3.4|3.4|||
4419816|NCT00191165|4243890|B2|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m2)|Mean|19.4|19.4|Standard Deviation|3.7|3.7|||
4419817|NCT00191165|4243891|B1|||Body Mass Index|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms per square meter (kg/m2)|Mean|18.9|18.9|Standard Deviation|3.2|3.2|||
4419818|NCT00191165|4243889|B3|||Baseline Predicted Height Standard Deviation Score (SDS)|BLPH expressed as a height SDS value (height SDS was derived by subtracting the age-and-gender-matched population 50th percentile height from the patient’s height and then dividing this value by the age-and-gender-matched population height standard deviation) using the British standards at age 18 for boys and 16 for girls.|standard deviation score|Mean|-0.7|-0.7|Standard Deviation|0.9|0.9|||
4419819|NCT00191165|4243890|B2|||Baseline Predicted Height Standard Deviation Score (SDS)|BLPH expressed as a height SDS value (height SDS was derived by subtracting the age-and-gender-matched population 50th percentile height from the patient’s height and then dividing this value by the age-and-gender-matched population height standard deviation) using the British standards at age 18 for boys and 16 for girls.|standard deviation score|Mean|-0.5|-0.5|Standard Deviation|1.0|1.0|||
4419820|NCT00191165|4243891|B1|||Baseline Predicted Height Standard Deviation Score (SDS)|BLPH expressed as a height SDS value (height SDS was derived by subtracting the age-and-gender-matched population 50th percentile height from the patient’s height and then dividing this value by the age-and-gender-matched population height standard deviation) using the British standards at age 18 for boys and 16 for girls.|standard deviation score|Mean|-0.9|-0.9|Standard Deviation|0.8|0.8|||
4419821|NCT00191165|4243889|B3|||Baseline Predicted Height|"Bone age, chronological age, gender, and height at Visit 0 were used to calculate the Baseline Predicted Height (BLPH) using the method of Bayley and Pinneau.~Bone age for the BLPH was based on the Greulich-Pyle bone age assessment of the Visit 0 bone age x-ray."|centimeters|Mean|168|168.0|Standard Deviation|8.7|8.7|||
4419822|NCT00191165|4243890|B2|||Baseline Predicted Height|"Bone age, chronological age, gender, and height at Visit 0 were used to calculate the Baseline Predicted Height (BLPH) using the method of Bayley and Pinneau.~Bone age for the BLPH was based on the Greulich-Pyle bone age assessment of the Visit 0 bone age x-ray."|centimeters|Mean|169|169.0|Standard Deviation|10.7|10.7|||
4419823|NCT00191165|4243891|B1|||Baseline Predicted Height|"Bone age, chronological age, gender, and height at Visit 0 were used to calculate the Baseline Predicted Height (BLPH) using the method of Bayley and Pinneau.~Bone age for the BLPH was based on the Greulich-Pyle bone age assessment of the Visit 0 bone age x-ray."|centimeters|Mean|168|168.0|Standard Deviation|6.8|6.8|||
4419824|NCT00191165|4243889|B3|Other||Race/Ethnicity||participants|Number|1.0|1.0||||||
4419825|NCT00191165|4243890|B2|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4419826|NCT00191165|4243891|B1|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4419827|NCT00191165|4243889|B3|Caucasian||Race/Ethnicity||participants|Number|26.0|26.0||||||
4419828|NCT00191165|4243890|B2|Caucasian||Race/Ethnicity||participants|Number|12|12.0||||||
4419829|NCT00191165|4243891|B1|Caucasian||Race/Ethnicity||participants|Number|14|14.0||||||
4419830|NCT00191165|4243889|B3|Italy||Region of Enrollment||participants|Number|27.0|27.0||||||
4419831|NCT00191165|4243890|B2|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4419832|NCT00191165|4243891|B1|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4419833|NCT00191165|4243889|B3||Male|Sex: Female, Male||Participants|Count of Participants|23.0|23.0||||||
4419834|NCT00191165|4243890|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4419836|NCT00191165|4243889|B3||Female|Sex: Female, Male||Participants|Count of Participants|4.0|4.0||||||
4419837|NCT00191165|4243890|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4419838|NCT00191165|4243891|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4419839|NCT00191165|4243889|B3|||Age||years|Mean|13.3|13.3|Standard Deviation|1.3|1.3|||
4419840|NCT00191165|4243890|B2|||Age||years|Mean|13.0|13.0|Standard Deviation|1.5|1.5|||
4419841|NCT00191165|4243891|B1|||Age||years|Mean|13.5|13.5|Standard Deviation|1.2|1.2|||
4419842|NCT00191152|4243902|B3|Other||Race/Ethnicity||participants|Number|2|2.0||||||
4419843|NCT00191152|4243903|B2|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4419844|NCT00191152|4243904|B1|Other||Race/Ethnicity||participants|Number|2|2.0||||||
4419845|NCT00191152|4243902|B3|Hispanic||Race/Ethnicity||participants|Number|62|62.0||||||
4419846|NCT00191152|4243903|B2|Hispanic||Race/Ethnicity||participants|Number|36|36.0||||||
4419847|NCT00191152|4243904|B1|Hispanic||Race/Ethnicity||participants|Number|26|26.0||||||
4419848|NCT00191152|4243902|B3|Oriental||Race/Ethnicity||participants|Number|58|58.0||||||
4419849|NCT00191152|4243903|B2|Oriental||Race/Ethnicity||participants|Number|30|30.0||||||
4419850|NCT00191152|4243904|B1|Oriental||Race/Ethnicity||participants|Number|28|28.0||||||
4419851|NCT00191152|4243902|B3|African Descent||Race/Ethnicity||participants|Number|35|35.0||||||
4419852|NCT00191152|4243903|B2|African Descent||Race/Ethnicity||participants|Number|12|12.0||||||
4419853|NCT00191152|4243904|B1|African Descent||Race/Ethnicity||participants|Number|23|23.0||||||
4419854|NCT00191152|4243902|B3|Caucasian||Race/Ethnicity||participants|Number|318|318.0||||||
4419855|NCT00191152|4243903|B2|Caucasian||Race/Ethnicity||participants|Number|158|158.0||||||
4419856|NCT00191152|4243904|B1|Caucasian||Race/Ethnicity||participants|Number|160|160.0||||||
4419857|NCT00191152|4243902|B3|Missing||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|9|9.0||||||
4419858|NCT00191152|4243903|B2|Missing||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|5|5.0||||||
4419859|NCT00191152|4243904|B1|Missing||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|4|4.0||||||
4419860|NCT00191152|4243902|B3|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|149|149.0||||||
4419861|NCT00191152|4243903|B2|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|75|75.0||||||
4419862|NCT00191152|4243904|B1|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|74|74.0||||||
4419863|NCT00191152|4243902|B3|90 - Normal activity; minor signs of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|202|202.0||||||
4419864|NCT00191152|4243903|B2|90 - Normal activity; minor signs of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|101|101.0||||||
4419865|NCT00191152|4243904|B1|90 - Normal activity; minor signs of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|101|101.0||||||
4419866|NCT00191152|4243902|B3|80 - Activity with effort; some signs of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|84|84.0||||||
4419867|NCT00191152|4243903|B2|80 - Activity with effort; some signs of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|40|40.0||||||
4419868|NCT00191152|4243904|B1|80 - Activity with effort; some signs of disease||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|44|44.0||||||
4419869|NCT00191152|4243902|B3|70 - Unable to carry on normal activity||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|31|31.0||||||
4419870|NCT00191152|4243903|B2|70 - Unable to carry on normal activity||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|15|15.0||||||
4419871|NCT00191152|4243904|B1|70 - Unable to carry on normal activity||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|16|16.0||||||
4419872|NCT00191152|4243902|B3|<=60 Needs increasing assistance up to Death (0)||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|0|0.0||||||
4419921|NCT00191139|4243936|B2|China||Region of Enrollment||participants|Number|7|7.0||||||
4419873|NCT00191152|4243903|B2|<=60 Needs increasing assistance up to Death (0)||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|0|0.0||||||
4419874|NCT00191152|4243904|B1|<=60 Needs increasing assistance up to Death (0)||Karnofsky Performance Status-Baseline|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|units on a scale|Number|0|0.0||||||
4419875|NCT00191152|4243902|B3|Korea, Republic of||Region of Enrollment||participants|Number|20|20.0||||||
4419876|NCT00191152|4243903|B2|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
4419877|NCT00191152|4243904|B1|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
4419878|NCT00191152|4243902|B3|Australia||Region of Enrollment||participants|Number|23|23.0||||||
4419879|NCT00191152|4243903|B2|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4419880|NCT00191152|4243904|B1|Australia||Region of Enrollment||participants|Number|11|11.0||||||
4419881|NCT00191152|4243902|B3|Brazil||Region of Enrollment||participants|Number|2|2.0||||||
4419882|NCT00191152|4243903|B2|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
4419883|NCT00191152|4243904|B1|Brazil||Region of Enrollment||participants|Number|1|1.0||||||
4419884|NCT00191152|4243902|B3|Argentina||Region of Enrollment||participants|Number|24|24.0||||||
4419885|NCT00191152|4243903|B2|Argentina||Region of Enrollment||participants|Number|13|13.0||||||
4419886|NCT00191152|4243904|B1|Argentina||Region of Enrollment||participants|Number|11|11.0||||||
4419887|NCT00191152|4243902|B3|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4419888|NCT00191152|4243903|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4419889|NCT00191152|4243904|B1|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4419890|NCT00191152|4243902|B3|Mexico||Region of Enrollment||participants|Number|29|29.0||||||
4419891|NCT00191152|4243903|B2|Mexico||Region of Enrollment||participants|Number|15|15.0||||||
4419892|NCT00191152|4243904|B1|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
4419893|NCT00191152|4243902|B3|Taiwan||Region of Enrollment||participants|Number|33|33.0||||||
4419894|NCT00191152|4243903|B2|Taiwan||Region of Enrollment||participants|Number|18|18.0||||||
4419895|NCT00191152|4243904|B1|Taiwan||Region of Enrollment||participants|Number|15|15.0||||||
4419896|NCT00191152|4243902|B3|United States||Region of Enrollment||participants|Number|339|339.0||||||
4419897|NCT00191152|4243903|B2|United States||Region of Enrollment||participants|Number|166|166.0||||||
4419898|NCT00191152|4243904|B1|United States||Region of Enrollment||participants|Number|173|173.0||||||
4419899|NCT00191152|4243902|B3||Male|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4419900|NCT00191152|4243903|B2||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4419901|NCT00191152|4243904|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4419902|NCT00191152|4243902|B3||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4419903|NCT00191152|4243903|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4419904|NCT00191152|4243904|B1||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4419905|NCT00191152|4243902|B3|||Age||years|Mean|55.2|55.2|Standard Deviation|11.69|11.69|||
4419906|NCT00191152|4243903|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|11.60|11.6|||
4419907|NCT00191152|4243904|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|11.77|11.77|||
4419908|NCT00191139|4243935|B3|2 - Ambulatory, No Work Activities||Eastern Oncology Cooperative Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|units on a scale|Number|1|1.0||||||
4419909|NCT00191139|4243936|B2|2 - Ambulatory, No Work Activities||Eastern Oncology Cooperative Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|units on a scale|Number|0|0.0||||||
4419910|NCT00191139|4243937|B1|2 - Ambulatory, No Work Activities||Eastern Oncology Cooperative Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|units on a scale|Number|1|1.0||||||
4419911|NCT00191139|4243935|B3|1 - Ambulatory, Restricted Strenuous Activity||Eastern Oncology Cooperative Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|units on a scale|Number|37|37.0||||||
4419912|NCT00191139|4243936|B2|1 - Ambulatory, Restricted Strenuous Activity||Eastern Oncology Cooperative Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|units on a scale|Number|18|18.0||||||
4419913|NCT00191139|4243937|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Oncology Cooperative Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|units on a scale|Number|19|19.0||||||
4419914|NCT00191139|4243935|B3|0 - Fully Active||Eastern Oncology Cooperative Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|units on a scale|Number|26|26.0||||||
4419915|NCT00191139|4243936|B2|0 - Fully Active||Eastern Oncology Cooperative Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|units on a scale|Number|14|14.0||||||
4419916|NCT00191139|4243937|B1|0 - Fully Active||Eastern Oncology Cooperative Group (ECOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|units on a scale|Number|12|12.0||||||
4419917|NCT00191139|4243935|B3|Korea, Republic of||Region of Enrollment||participants|Number|6|6.0||||||
4419918|NCT00191139|4243936|B2|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4419919|NCT00191139|4243937|B1|Korea, Republic of||Region of Enrollment||participants|Number|3|3.0||||||
4419920|NCT00191139|4243935|B3|China||Region of Enrollment||participants|Number|17|17.0||||||
4419922|NCT00191139|4243937|B1|China||Region of Enrollment||participants|Number|10|10.0||||||
4419923|NCT00191139|4243935|B3|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4419924|NCT00191139|4243936|B2|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4419925|NCT00191139|4243937|B1|Argentina||Region of Enrollment||participants|Number|1|1.0||||||
4419926|NCT00191139|4243935|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4419927|NCT00191139|4243936|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4419928|NCT00191139|4243937|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4419929|NCT00191139|4243935|B3|Hispanic||Race/Ethnicity, Customized|breakdown of participants by ethnic origin|participants|Number|1|1.0||||||
4419930|NCT00191139|4243936|B2|Hispanic||Race/Ethnicity, Customized|breakdown of participants by ethnic origin|participants|Number|1|1.0||||||
4419931|NCT00191139|4243937|B1|Hispanic||Race/Ethnicity, Customized|breakdown of participants by ethnic origin|participants|Number|0|0.0||||||
4419932|NCT00191139|4243935|B3|Asian||Race/Ethnicity, Customized|breakdown of participants by ethnic origin|participants|Number|23|23.0||||||
4419933|NCT00191139|4243936|B2|Asian||Race/Ethnicity, Customized|breakdown of participants by ethnic origin|participants|Number|10|10.0||||||
4419934|NCT00191139|4243937|B1|Asian||Race/Ethnicity, Customized|breakdown of participants by ethnic origin|participants|Number|13|13.0||||||
4419935|NCT00191139|4243935|B3|Black||Race/Ethnicity, Customized|breakdown of participants by ethnic origin|participants|Number|3|3.0||||||
4419936|NCT00191139|4243936|B2|Black||Race/Ethnicity, Customized|breakdown of participants by ethnic origin|participants|Number|2|2.0||||||
4419937|NCT00191139|4243937|B1|Black||Race/Ethnicity, Customized|breakdown of participants by ethnic origin|participants|Number|1|1.0||||||
4419938|NCT00191139|4243935|B3|Caucasian||Race/Ethnicity, Customized|breakdown of participants by ethnic origin|participants|Number|37|37.0||||||
4419939|NCT00191139|4243936|B2|Caucasian||Race/Ethnicity, Customized|breakdown of participants by ethnic origin|participants|Number|19|19.0||||||
4419940|NCT00191139|4243937|B1|Caucasian||Race/Ethnicity, Customized|breakdown of participants by ethnic origin|participants|Number|18|18.0||||||
4419941|NCT00191139|4243935|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4419942|NCT00191139|4243936|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4419943|NCT00191139|4243937|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4419944|NCT00191139|4243935|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4419945|NCT00191139|4243936|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4419946|NCT00191139|4243937|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4419947|NCT00191139|4243935|B3|||Age||years|Median|59.5|59.5|Standard Deviation|8.48|8.48|||
4419948|NCT00191139|4243936|B2|||Age||years|Median|59.5|59.5|Standard Deviation|9.61|9.61|||
4419949|NCT00191139|4243937|B1|||Age||years|Median|59.5|59.5|Standard Deviation|7.31|7.31|||
4419950|NCT00191113|4243952|B3|||Height Standard Deviation Score (SDS) [National Center for Health Statistics (NCHS)]|SDS report the number of standard deviations from the mean for age and sex for an individual measurement (normal range: -2 to +2 SDS). Height SDS [NCHS] uses the NCHS US general female population reference height values for age (Kuczmarski RJ et al. 2000) as the population mean and standard deviation. Calculation of Height SDS is provided in Height SDS [Lyon] description (baseline). Since data reported by Kuczmarski RJ et al provides US general female population standards, values of Height SDS [NCHS] for untreated patients with Turner syndrome tend to be below zero e.g, -2.0 to -4.0 SDS.|Standard Deviation Score (SDS)|Mean|-3.23|-3.23|Standard Deviation|0.82|0.82|||
4419951|NCT00191113|4243953|B2|||Height Standard Deviation Score (SDS) [National Center for Health Statistics (NCHS)]|SDS report the number of standard deviations from the mean for age and sex for an individual measurement (normal range: -2 to +2 SDS). Height SDS [NCHS] uses the NCHS US general female population reference height values for age (Kuczmarski RJ et al. 2000) as the population mean and standard deviation. Calculation of Height SDS is provided in Height SDS [Lyon] description (baseline). Since data reported by Kuczmarski RJ et al provides US general female population standards, values of Height SDS [NCHS] for untreated patients with Turner syndrome tend to be below zero e.g, -2.0 to -4.0 SDS.|Standard Deviation Score (SDS)|Mean|-3.21|-3.21|Standard Deviation|0.82|0.82|||
4419952|NCT00191113|4243954|B1|||Height Standard Deviation Score (SDS) [National Center for Health Statistics (NCHS)]|SDS report the number of standard deviations from the mean for age and sex for an individual measurement (normal range: -2 to +2 SDS). Height SDS [NCHS] uses the NCHS US general female population reference height values for age (Kuczmarski RJ et al. 2000) as the population mean and standard deviation. Calculation of Height SDS is provided in Height SDS [Lyon] description (baseline). Since data reported by Kuczmarski RJ et al provides US general female population standards, values of Height SDS [NCHS] for untreated patients with Turner syndrome tend to be below zero e.g, -2.0 to -4.0 SDS.|Standard Deviation Score (SDS)|Mean|-3.25|-3.25|Standard Deviation|0.82|0.82|||
4419953|NCT00191113|4243952|B3|||Height Standard Deviation Score (SDS) [Lyon]|SDS report the number of standard deviations from the mean for age and sex for an individual measurement (normal range: -2 to +2 SDS). Height SDS [Lyon] uses the Turner syndrome reference height values for age (Lyon AJ et al. 1985) as the population mean and standard deviation. Height SDS is derived by subtracting the population mean from individual’s height value and then dividing that difference by the population standard deviation. Since the data reported by Lyon AJ et al represent a Turner syndrome reference standard, values for patients with Turner syndrome are centered around zero.|Standard Deviation Score (SDS)|Mean|-0.11|-0.11|Standard Deviation|0.87|0.87|||
4420009|NCT00191113|4243954|B1|45,X/46,XX||Karyotype||participants|Number|3|3.0||||||
4420010|NCT00191113|4243952|B3|45,X/46,XXr||Karyotype||participants|Number|3|3.0||||||
4420011|NCT00191113|4243953|B2|45,X/46,XXr||Karyotype||participants|Number|2|2.0||||||
4420012|NCT00191113|4243954|B1|45,X/46,XXr||Karyotype||participants|Number|1|1.0||||||
4420013|NCT00191113|4243952|B3|45,X/46,XXqi||Karyotype||participants|Number|8|8.0||||||
4420014|NCT00191113|4243953|B2|45,X/46,XXqi||Karyotype||participants|Number|2|2.0||||||
4419954|NCT00191113|4243953|B2|||Height Standard Deviation Score (SDS) [Lyon]|SDS report the number of standard deviations from the mean for age and sex for an individual measurement (normal range: -2 to +2 SDS). Height SDS [Lyon] uses the Turner syndrome reference height values for age (Lyon AJ et al. 1985) as the population mean and standard deviation. Height SDS is derived by subtracting the population mean from individual’s height value and then dividing that difference by the population standard deviation. Since the data reported by Lyon AJ et al represent a Turner syndrome reference standard, values for patients with Turner syndrome are centered around zero.|Standard Deviation Score (SDS)|Mean|-0.10|-0.1|Standard Deviation|0.88|0.88|||
4419955|NCT00191113|4243954|B1|||Height Standard Deviation Score (SDS) [Lyon]|SDS report the number of standard deviations from the mean for age and sex for an individual measurement (normal range: -2 to +2 SDS). Height SDS [Lyon] uses the Turner syndrome reference height values for age (Lyon AJ et al. 1985) as the population mean and standard deviation. Height SDS is derived by subtracting the population mean from individual’s height value and then dividing that difference by the population standard deviation. Since the data reported by Lyon AJ et al represent a Turner syndrome reference standard, values for patients with Turner syndrome are centered around zero.|Standard Deviation Score (SDS)|Mean|-0.13|-0.13|Standard Deviation|0.86|0.86|||
4419956|NCT00191113|4243952|B3|||Height||centimeters|Mean|119.96|119.96|Standard Deviation|8.33|8.33|||
4419957|NCT00191113|4243953|B2|||Height||centimeters|Mean|119.84|119.84|Standard Deviation|8.45|8.45|||
4419958|NCT00191113|4243954|B1|||Height||centimeters|Mean|120.06|120.06|Standard Deviation|8.26|8.26|||
4419959|NCT00191113|4243952|B3|||Bone Age|Bone age was determined by the Greulich-Pyle method.|years|Mean|8.69|8.69|Standard Deviation|1.46|1.46|||
4419960|NCT00191113|4243953|B2|||Bone Age|Bone age was determined by the Greulich-Pyle method.|years|Mean|8.79|8.79|Standard Deviation|1.42|1.42|||
4419961|NCT00191113|4243954|B1|||Bone Age|Bone age was determined by the Greulich-Pyle method.|years|Mean|8.57|8.57|Standard Deviation|1.51|1.51|||
4419962|NCT00191113|4243952|B3|Unknown||Race/Ethnicity||participants|Number|12|12.0||||||
4419963|NCT00191113|4243953|B2|Unknown||Race/Ethnicity||participants|Number|1|1.0||||||
4419964|NCT00191113|4243954|B1|Unknown||Race/Ethnicity||participants|Number|11|11.0||||||
4419965|NCT00191113|4243952|B3|Other||Race/Ethnicity||participants|Number|4|4.0||||||
4419966|NCT00191113|4243953|B2|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4419967|NCT00191113|4243954|B1|Other||Race/Ethnicity||participants|Number|4|4.0||||||
4419968|NCT00191113|4243952|B3|Hispanic||Race/Ethnicity||participants|Number|2|2.0||||||
4419969|NCT00191113|4243953|B2|Hispanic||Race/Ethnicity||participants|Number|2|2.0||||||
4419970|NCT00191113|4243954|B1|Hispanic||Race/Ethnicity||participants|Number|0|0.0||||||
4419971|NCT00191113|4243952|B3|White||Race/Ethnicity||participants|Number|120|120.0||||||
4419972|NCT00191113|4243953|B2|White||Race/Ethnicity||participants|Number|66|66.0||||||
4419973|NCT00191113|4243954|B1|White||Race/Ethnicity||participants|Number|54|54.0||||||
4419974|NCT00191113|4243952|B3|Black or African American||Race/Ethnicity||participants|Number|1|1.0||||||
4419975|NCT00191113|4243953|B2|Black or African American||Race/Ethnicity||participants|Number|0|0.0||||||
4419976|NCT00191113|4243954|B1|Black or African American||Race/Ethnicity||participants|Number|1|1.0||||||
4419977|NCT00191113|4243952|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity||participants|Number|0|0.0||||||
4419978|NCT00191113|4243953|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity||participants|Number|0|0.0||||||
4419979|NCT00191113|4243954|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity||participants|Number|0|0.0||||||
4419980|NCT00191113|4243952|B3|Asian||Race/Ethnicity||participants|Number|13|13.0||||||
4419981|NCT00191113|4243953|B2|Asian||Race/Ethnicity||participants|Number|6|6.0||||||
4419982|NCT00191113|4243954|B1|Asian||Race/Ethnicity||participants|Number|7|7.0||||||
4419983|NCT00191113|4243952|B3|American Indian or Alaska Native||Race/Ethnicity||participants|Number|2|2.0||||||
4419984|NCT00191113|4243953|B2|American Indian or Alaska Native||Race/Ethnicity||participants|Number|1|1.0||||||
4419985|NCT00191113|4243954|B1|American Indian or Alaska Native||Race/Ethnicity||participants|Number|1|1.0||||||
4419986|NCT00191113|4243952|B3|Other||Karyotype||participants|Number|30|30.0||||||
4419987|NCT00191113|4243953|B2|Other||Karyotype||participants|Number|15|15.0||||||
4419988|NCT00191113|4243954|B1|Other||Karyotype||participants|Number|15|15.0||||||
4419989|NCT00191113|4243952|B3|46,XXr||Karyotype||participants|Number|0|0.0||||||
4419990|NCT00191113|4243953|B2|46,XXr||Karyotype||participants|Number|0|0.0||||||
4419991|NCT00191113|4243954|B1|46,XXr||Karyotype||participants|Number|0|0.0||||||
4419992|NCT00191113|4243952|B3|45,X/46,XX/47,XXX||Karyotype||participants|Number|0|0.0||||||
4419993|NCT00191113|4243953|B2|45,X/46,XX/47,XXX||Karyotype||participants|Number|0|0.0||||||
4419994|NCT00191113|4243954|B1|45,X/46,XX/47,XXX||Karyotype||participants|Number|0|0.0||||||
4419995|NCT00191113|4243952|B3|45,X/46,XXp||Karyotype||participants|Number|2|2.0||||||
4419996|NCT00191113|4243953|B2|45,X/46,XXp||Karyotype||participants|Number|1|1.0||||||
4419997|NCT00191113|4243954|B1|45,X/46,XXp||Karyotype||participants|Number|1|1.0||||||
4419998|NCT00191113|4243952|B3|46,XXp||Karyotype||participants|Number|1|1.0||||||
4419999|NCT00191113|4243953|B2|46,XXp||Karyotype||participants|Number|0|0.0||||||
4420000|NCT00191113|4243954|B1|46,XXp||Karyotype||participants|Number|1|1.0||||||
4420001|NCT00191113|4243952|B3|45,X/47,XXX||Karyotype||participants|Number|3|3.0||||||
4420002|NCT00191113|4243953|B2|45,X/47,XXX||Karyotype||participants|Number|2|2.0||||||
4420003|NCT00191113|4243954|B1|45,X/47,XXX||Karyotype||participants|Number|1|1.0||||||
4420004|NCT00191113|4243952|B3|46,XXqi||Karyotype||participants|Number|8|8.0||||||
4420005|NCT00191113|4243953|B2|46,XXqi||Karyotype||participants|Number|6|6.0||||||
4420006|NCT00191113|4243954|B1|46,XXqi||Karyotype||participants|Number|2|2.0||||||
4420007|NCT00191113|4243952|B3|45,X/46,XX||Karyotype||participants|Number|6|6.0||||||
4420008|NCT00191113|4243953|B2|45,X/46,XX||Karyotype||participants|Number|3|3.0||||||
4420015|NCT00191113|4243954|B1|45,X/46,XXqi||Karyotype||participants|Number|6|6.0||||||
4420016|NCT00191113|4243952|B3|45,X||Karyotype||participants|Number|93|93.0||||||
4420017|NCT00191113|4243953|B2|45,X||Karyotype||participants|Number|45|45.0||||||
4420018|NCT00191113|4243954|B1|45,X||Karyotype||participants|Number|48|48.0||||||
4420019|NCT00191113|4243952|B3|Canada||Region of Enrollment||participants|Number|154|154.0||||||
4420020|NCT00191113|4243953|B2|Canada||Region of Enrollment||participants|Number|76|76.0||||||
4420021|NCT00191113|4243954|B1|Canada||Region of Enrollment||participants|Number|78|78.0||||||
4420022|NCT00191113|4243952|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4420023|NCT00191113|4243953|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4420024|NCT00191113|4243954|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4420025|NCT00191113|4243952|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4420026|NCT00191113|4243953|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4420027|NCT00191113|4243954|B1||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4420028|NCT00191113|4243952|B3|||Age||years|Mean|10.41|10.41|Standard Deviation|1.78|1.78|||
4420029|NCT00191113|4243953|B2|||Age||years|Mean|10.36|10.36|Standard Deviation|1.80|1.8|||
4420030|NCT00191113|4243954|B1|||Age||years|Mean|10.46|10.46|Standard Deviation|1.77|1.77|||
4420031|NCT00191100|4243995|B3|||Weight||kilograms|Mean|61.8|61.8|Standard Deviation|12.2|12.2|||
4420032|NCT00191100|4243996|B2|||Weight||kilograms|Mean|62.4|62.4|Standard Deviation|13.0|13.0|||
4420033|NCT00191100|4243997|B1|||Weight||kilograms|Mean|61.2|61.2|Standard Deviation|11.3|11.3|||
4420034|NCT00191100|4243995|B3|||Height||centimeters|Mean|154.9|154.9|Standard Deviation|6.6|6.6|||
4420035|NCT00191100|4243996|B2|||Height||centimeters|Mean|154.6|154.6|Standard Deviation|6.7|6.7|||
4420036|NCT00191100|4243997|B1|||Height||centimeters|Mean|155.2|155.2|Standard Deviation|6.6|6.6|||
4420037|NCT00191100|4243995|B3|Stage IVA||Stage of Disease||participants|Number|9.0|9.0||||||
4420038|NCT00191100|4243996|B2|Stage IVA||Stage of Disease||participants|Number|5|5.0||||||
4420039|NCT00191100|4243997|B1|Stage IVA||Stage of Disease||participants|Number|4|4.0||||||
4420040|NCT00191100|4243995|B3|Stage IIB||Stage of Disease||participants|Number|316.0|316.0||||||
4420041|NCT00191100|4243996|B2|Stage IIB||Stage of Disease||participants|Number|156|156.0||||||
4420042|NCT00191100|4243997|B1|Stage IIB||Stage of Disease||participants|Number|160|160.0||||||
4420043|NCT00191100|4243995|B3|Stage IIIB||Stage of Disease||participants|Number|188.0|188.0||||||
4420044|NCT00191100|4243996|B2|Stage IIIB||Stage of Disease||participants|Number|94|94.0||||||
4420045|NCT00191100|4243997|B1|Stage IIIB||Stage of Disease||participants|Number|94|94.0||||||
4420046|NCT00191100|4243995|B3|Stage IIIA||Stage of Disease||participants|Number|2.0|2.0||||||
4420047|NCT00191100|4243996|B2|Stage IIIA||Stage of Disease||participants|Number|1|1.0||||||
4420048|NCT00191100|4243997|B1|Stage IIIA||Stage of Disease||participants|Number|1|1.0||||||
4420049|NCT00191100|4243995|B3|Hispanic||Race/Ethnicity||participants|Number|214.0|214.0||||||
4420050|NCT00191100|4243996|B2|Hispanic||Race/Ethnicity||participants|Number|109|109.0||||||
4420051|NCT00191100|4243997|B1|Hispanic||Race/Ethnicity||participants|Number|105|105.0||||||
4420052|NCT00191100|4243995|B3|East/Southeast Asian||Race/Ethnicity||participants|Number|67.0|67.0||||||
4420053|NCT00191100|4243996|B2|East/Southeast Asian||Race/Ethnicity||participants|Number|33|33.0||||||
4420054|NCT00191100|4243997|B1|East/Southeast Asian||Race/Ethnicity||participants|Number|34|34.0||||||
4420055|NCT00191100|4243995|B3|Caucasian||Race/Ethnicity||participants|Number|62.0|62.0||||||
4420056|NCT00191100|4243996|B2|Caucasian||Race/Ethnicity||participants|Number|29|29.0||||||
4420057|NCT00191100|4243997|B1|Caucasian||Race/Ethnicity||participants|Number|33|33.0||||||
4420058|NCT00191100|4243995|B3|Western Asian||Race/Ethnicity||participants|Number|172.0|172.0||||||
4420059|NCT00191100|4243996|B2|Western Asian||Race/Ethnicity||participants|Number|85|85.0||||||
4420060|NCT00191100|4243997|B1|Western Asian||Race/Ethnicity||participants|Number|87|87.0||||||
4420061|NCT00191100|4243995|B3|Other - Squamous||Pathological Diagnosis||participants|Number|85.0|85.0||||||
4420062|NCT00191100|4243996|B2|Other - Squamous||Pathological Diagnosis||participants|Number|42|42.0||||||
4420063|NCT00191100|4243997|B1|Other - Squamous||Pathological Diagnosis||participants|Number|43|43.0||||||
4420064|NCT00191100|4243995|B3|Other - Poorly Differentiated Carcinoma||Pathological Diagnosis||participants|Number|1.0|1.0||||||
4420065|NCT00191100|4243996|B2|Other - Poorly Differentiated Carcinoma||Pathological Diagnosis||participants|Number|0|0.0||||||
4420066|NCT00191100|4243997|B1|Other - Poorly Differentiated Carcinoma||Pathological Diagnosis||participants|Number|1|1.0||||||
4420067|NCT00191100|4243995|B3|Adeno/Squamous Cell Carcinoma||Pathological Diagnosis||participants|Number|397.0|397.0||||||
4420068|NCT00191100|4243996|B2|Adeno/Squamous Cell Carcinoma||Pathological Diagnosis||participants|Number|199|199.0||||||
4420069|NCT00191100|4243997|B1|Adeno/Squamous Cell Carcinoma||Pathological Diagnosis||participants|Number|198|198.0||||||
4420070|NCT00191100|4243995|B3|Adenocarcinoma of Cervix||Pathological Diagnosis||participants|Number|32.0|32.0||||||
4420071|NCT00191100|4243996|B2|Adenocarcinoma of Cervix||Pathological Diagnosis||participants|Number|15|15.0||||||
4420072|NCT00191100|4243997|B1|Adenocarcinoma of Cervix||Pathological Diagnosis||participants|Number|17|17.0||||||
4420073|NCT00191100|4243995|B3|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|204.0|204.0||||||
4420113|NCT00191100|4243996|B2|Peru||Region of Enrollment||participants|Number|31|31.0||||||
4420114|NCT00191100|4243997|B1|Peru||Region of Enrollment||participants|Number|29|29.0||||||
4420074|NCT00191100|4243996|B2|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|101|101.0||||||
4420075|NCT00191100|4243997|B1|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|103|103.0||||||
4420076|NCT00191100|4243995|B3|90 - Normal activity; minor signs of disease||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|292.0|292.0||||||
4420077|NCT00191100|4243996|B2|90 - Normal activity; minor signs of disease||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|145|145.0||||||
4420078|NCT00191100|4243997|B1|90 - Normal activity; minor signs of disease||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|147|147.0||||||
4420079|NCT00191100|4243995|B3|80 - Activity with effort; some signs of disease||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|17.0|17.0||||||
4420080|NCT00191100|4243996|B2|80 - Activity with effort; some signs of disease||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|9|9.0||||||
4420081|NCT00191100|4243997|B1|80 - Activity with effort; some signs of disease||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|8|8.0||||||
4420082|NCT00191100|4243995|B3|70 - Unable to carry on normal activity||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|1.0|1.0||||||
4420083|NCT00191100|4243996|B2|70 - Unable to carry on normal activity||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|1|1.0||||||
4420084|NCT00191100|4243997|B1|70 - Unable to carry on normal activity||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|0|0.0||||||
4420085|NCT00191100|4243995|B3|Unknown (Missing)||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|1.0|1.0||||||
4420086|NCT00191100|4243996|B2|Unknown (Missing)||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|0|0.0||||||
4420087|NCT00191100|4243997|B1|Unknown (Missing)||Karnofsky Performance Status Scale|Classifies patients according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses.|participants|Number|1|1.0||||||
4420088|NCT00191100|4243995|B3|Well Differentiated||Grade of Histological Diagnosis||participants|Number|50.0|50.0||||||
4420089|NCT00191100|4243996|B2|Well Differentiated||Grade of Histological Diagnosis||participants|Number|24|24.0||||||
4420090|NCT00191100|4243997|B1|Well Differentiated||Grade of Histological Diagnosis||participants|Number|26|26.0||||||
4420091|NCT00191100|4243995|B3|Undifferentiated||Grade of Histological Diagnosis||participants|Number|2.0|2.0||||||
4420092|NCT00191100|4243996|B2|Undifferentiated||Grade of Histological Diagnosis||participants|Number|0|0.0||||||
4420093|NCT00191100|4243997|B1|Undifferentiated||Grade of Histological Diagnosis||participants|Number|2|2.0||||||
4420094|NCT00191100|4243995|B3|Unknown||Grade of Histological Diagnosis||participants|Number|138.0|138.0||||||
4420095|NCT00191100|4243996|B2|Unknown||Grade of Histological Diagnosis||participants|Number|69|69.0||||||
4420096|NCT00191100|4243997|B1|Unknown||Grade of Histological Diagnosis||participants|Number|69|69.0||||||
4420097|NCT00191100|4243995|B3|Poorly Differentiated||Grade of Histological Diagnosis||participants|Number|92.0|92.0||||||
4420098|NCT00191100|4243996|B2|Poorly Differentiated||Grade of Histological Diagnosis||participants|Number|44|44.0||||||
4420099|NCT00191100|4243997|B1|Poorly Differentiated||Grade of Histological Diagnosis||participants|Number|48|48.0||||||
4420100|NCT00191100|4243995|B3|Moderately Differentiated||Grade of Histological Diagnosis||participants|Number|233.0|233.0||||||
4420101|NCT00191100|4243996|B2|Moderately Differentiated||Grade of Histological Diagnosis||participants|Number|119|119.0||||||
4420102|NCT00191100|4243997|B1|Moderately Differentiated||Grade of Histological Diagnosis||participants|Number|114|114.0||||||
4420103|NCT00191100|4243995|B3|Panama||Region of Enrollment||participants|Number|61.0|61.0||||||
4420104|NCT00191100|4243996|B2|Panama||Region of Enrollment||participants|Number|30|30.0||||||
4420105|NCT00191100|4243997|B1|Panama||Region of Enrollment||participants|Number|31|31.0||||||
4420106|NCT00191100|4243995|B3|Bosnia and Herzegovina||Region of Enrollment||participants|Number|61.0|61.0||||||
4420107|NCT00191100|4243996|B2|Bosnia and Herzegovina||Region of Enrollment||participants|Number|28|28.0||||||
4420108|NCT00191100|4243997|B1|Bosnia and Herzegovina||Region of Enrollment||participants|Number|33|33.0||||||
4420109|NCT00191100|4243995|B3|India||Region of Enrollment||participants|Number|116.0|116.0||||||
4420110|NCT00191100|4243996|B2|India||Region of Enrollment||participants|Number|56|56.0||||||
4420111|NCT00191100|4243997|B1|India||Region of Enrollment||participants|Number|60|60.0||||||
4420112|NCT00191100|4243995|B3|Peru||Region of Enrollment||participants|Number|60.0|60.0||||||
4420115|NCT00191100|4243995|B3|Thailand||Region of Enrollment||participants|Number|67.0|67.0||||||
4420116|NCT00191100|4243996|B2|Thailand||Region of Enrollment||participants|Number|33|33.0||||||
4420117|NCT00191100|4243997|B1|Thailand||Region of Enrollment||participants|Number|34|34.0||||||
4420118|NCT00191100|4243995|B3|Argentina||Region of Enrollment||participants|Number|35.0|35.0||||||
4420119|NCT00191100|4243996|B2|Argentina||Region of Enrollment||participants|Number|18|18.0||||||
4420120|NCT00191100|4243997|B1|Argentina||Region of Enrollment||participants|Number|17|17.0||||||
4420121|NCT00191100|4243995|B3|Mexico||Region of Enrollment||participants|Number|59.0|59.0||||||
4420122|NCT00191100|4243996|B2|Mexico||Region of Enrollment||participants|Number|31|31.0||||||
4420123|NCT00191100|4243997|B1|Mexico||Region of Enrollment||participants|Number|28|28.0||||||
4420124|NCT00191100|4243995|B3|Pakistan||Region of Enrollment||participants|Number|56.0|56.0||||||
4420125|NCT00191100|4243996|B2|Pakistan||Region of Enrollment||participants|Number|29|29.0||||||
4420126|NCT00191100|4243997|B1|Pakistan||Region of Enrollment||participants|Number|27|27.0||||||
4420127|NCT00191100|4243995|B3||Male|Sex: Female, Male||Participants|Count of Participants|0.0|0.0||||||
4420128|NCT00191100|4243996|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4420129|NCT00191100|4243997|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4420130|NCT00191100|4243995|B3||Female|Sex: Female, Male||Participants|Count of Participants|515.0|515.0||||||
4420131|NCT00191100|4243996|B2||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4420132|NCT00191100|4243997|B1||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4420133|NCT00191100|4243995|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|9.5|9.5|||
4420134|NCT00191100|4243996|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|9.2|9.2|||
4420135|NCT00191100|4243997|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|9.8|9.8|||
4420136|NCT00190983|4244014|B1|Unspecified||Tumor Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|2|2.0||||||
4420137|NCT00190983|4244014|B1|G3 - Poorly Differentiated||Tumor Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|5|5.0||||||
4420138|NCT00190983|4244014|B1|G2 - Moderately Differentiated||Tumor Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|15|15.0||||||
4420139|NCT00190983|4244014|B1|G1 - Well-Differentiated||Tumor Grade|Assesses the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. Grades range from 1 (least aggressive and best prognosis) to 4 (most aggressive and worst prognosis).|participants|Number|5|5.0||||||
4420140|NCT00190983|4244014|B1|No Prior Radiotherapy||Prior Therapy||participants|Number|4|4.0||||||
4420141|NCT00190983|4244014|B1|Prior Radiotherapy||Prior Therapy||participants|Number|23|23.0||||||
4420142|NCT00190983|4244014|B1|No Prior Chemotherapy||Prior Therapy||participants|Number|0|0.0||||||
4420143|NCT00190983|4244014|B1|Prior Chemotherapy||Prior Therapy||participants|Number|27|27.0||||||
4420144|NCT00190983|4244014|B1|2 - Ambulatory, No Work Activities||Gynecologic Oncology Group (GOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|2|2.0||||||
4420145|NCT00190983|4244014|B1|1 - Ambulatory, Restricted Strenuous Activity||Gynecologic Oncology Group (GOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|9|9.0||||||
4420146|NCT00190983|4244014|B1|0 - Fully active||Gynecologic Oncology Group (GOG) Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (Fully Active) to 5 (Death).|participants|Number|16|16.0||||||
4420147|NCT00190983|4244014|B1|Adenosquamous||Cell Type||participants|Number|1|1.0||||||
4420148|NCT00190983|4244014|B1|Clear cell||Cell Type||participants|Number|1|1.0||||||
4420149|NCT00190983|4244014|B1|Adenocarcinoma||Cell Type||participants|Number|6|6.0||||||
4420150|NCT00190983|4244014|B1|Squamous||Cell Type||participants|Number|19|19.0||||||
4420151|NCT00190983|4244014|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4420152|NCT00190983|4244014|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4420153|NCT00190983|4244014|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4420154|NCT00190983|4244014|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4420155|NCT00190983|4244014|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4420156|NCT00190983|4244014|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4420157|NCT00190983|4244014|B1|>69 years||Age, Customized||participants|Number|1|1.0||||||
4420158|NCT00190983|4244014|B1|60-69 years||Age, Customized||participants|Number|4|4.0||||||
4420159|NCT00190983|4244014|B1|50-59 years||Age, Customized||participants|Number|7|7.0||||||
4420160|NCT00190983|4244014|B1|40-49 years||Age, Customized||participants|Number|9|9.0||||||
4420161|NCT00190983|4244014|B1|<40 years||Age, Customized||participants|Number|6|6.0||||||
4420162|NCT00190775|4244021|B3|||Weight||Kilograms|Mean|86.65|86.65|Standard Deviation|20.14|20.14|||
4420163|NCT00190775|4244022|B2|||Weight||Kilograms|Mean|84.84|84.84|Standard Deviation|19.72|19.72|||
4420164|NCT00190775|4244023|B1|||Weight||Kilograms|Mean|88.22|88.22|Standard Deviation|20.40|20.4|||
4420421|NCT00190775|4244022|B2|Western Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4420422|NCT00190775|4244023|B1|Western Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4420423|NCT00190775|4244021|B3|East/Southeast Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4420165|NCT00190775|4244021|B3|Trait Anxiety Score||State-Trait Anxiety Inventories (STAI)|Self-report scale completed by the participant. Separate scales measure state (20 items) and trait (20 items) anxiety. The participant reports how they feel “right now at this moment” for state anxiety and how they “generally” feel for trait anxiety. The “state” items are scored as: 1 (not at all), 2 (somewhat true), 3 (moderately true), 4 (very true). The “trait” items are scored as: 1 (almost never), 2 (sometimes), 3 (often), 4 (almost always). Scores range from 4-80 for each scale. Higher scores indicate more impaired participants.|Units on a scale|Mean|46.79|46.79|Standard Deviation|10.94|10.94|||
4420166|NCT00190775|4244022|B2|Trait Anxiety Score||State-Trait Anxiety Inventories (STAI)|Self-report scale completed by the participant. Separate scales measure state (20 items) and trait (20 items) anxiety. The participant reports how they feel “right now at this moment” for state anxiety and how they “generally” feel for trait anxiety. The “state” items are scored as: 1 (not at all), 2 (somewhat true), 3 (moderately true), 4 (very true). The “trait” items are scored as: 1 (almost never), 2 (sometimes), 3 (often), 4 (almost always). Scores range from 4-80 for each scale. Higher scores indicate more impaired participants.|Units on a scale|Mean|46.05|46.05|Standard Deviation|11.22|11.22|||
4420167|NCT00190775|4244023|B1|Trait Anxiety Score||State-Trait Anxiety Inventories (STAI)|Self-report scale completed by the participant. Separate scales measure state (20 items) and trait (20 items) anxiety. The participant reports how they feel “right now at this moment” for state anxiety and how they “generally” feel for trait anxiety. The “state” items are scored as: 1 (not at all), 2 (somewhat true), 3 (moderately true), 4 (very true). The “trait” items are scored as: 1 (almost never), 2 (sometimes), 3 (often), 4 (almost always). Scores range from 4-80 for each scale. Higher scores indicate more impaired participants.|Units on a scale|Mean|47.44|47.44|Standard Deviation|10.68|10.68|||
4420168|NCT00190775|4244021|B3|State Anxiety Score||State-Trait Anxiety Inventories (STAI)|Self-report scale completed by the participant. Separate scales measure state (20 items) and trait (20 items) anxiety. The participant reports how they feel “right now at this moment” for state anxiety and how they “generally” feel for trait anxiety. The “state” items are scored as: 1 (not at all), 2 (somewhat true), 3 (moderately true), 4 (very true). The “trait” items are scored as: 1 (almost never), 2 (sometimes), 3 (often), 4 (almost always). Scores range from 4-80 for each scale. Higher scores indicate more impaired participants.|Units on a scale|Mean|40.61|40.61|Standard Deviation|11.38|11.38|||
4420169|NCT00190775|4244022|B2|State Anxiety Score||State-Trait Anxiety Inventories (STAI)|Self-report scale completed by the participant. Separate scales measure state (20 items) and trait (20 items) anxiety. The participant reports how they feel “right now at this moment” for state anxiety and how they “generally” feel for trait anxiety. The “state” items are scored as: 1 (not at all), 2 (somewhat true), 3 (moderately true), 4 (very true). The “trait” items are scored as: 1 (almost never), 2 (sometimes), 3 (often), 4 (almost always). Scores range from 4-80 for each scale. Higher scores indicate more impaired participants.|Units on a scale|Mean|41.16|41.16|Standard Deviation|11.18|11.18|||
4420170|NCT00190775|4244023|B1|State Anxiety Score||State-Trait Anxiety Inventories (STAI)|Self-report scale completed by the participant. Separate scales measure state (20 items) and trait (20 items) anxiety. The participant reports how they feel “right now at this moment” for state anxiety and how they “generally” feel for trait anxiety. The “state” items are scored as: 1 (not at all), 2 (somewhat true), 3 (moderately true), 4 (very true). The “trait” items are scored as: 1 (almost never), 2 (sometimes), 3 (often), 4 (almost always). Scores range from 4-80 for each scale. Higher scores indicate more impaired participants.|Units on a scale|Mean|40.13|40.13|Standard Deviation|11.55|11.55|||
4420171|NCT00190775|4244021|B3|Efficacy Scale||Parenting Sense of Competence (PSOC) Scale|16-item scale to assess parenting self-esteem: the Satisfaction Subscale has 9 questions (2,3,4,5,8,9,12,14,16)=54; the Efficacy Subscale has 7 questions (1,6,7,10,11,13,15)=43. Each response on the satisfaction subscale is answered on a 6-point scale (strongly agree/strongly disagree). Higher scores indicate greater satisfaction and greater self-efficacy. Lower scores mean more impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|25.50|25.5|Standard Deviation|4.54|4.54|||
4420172|NCT00190775|4244022|B2|Efficacy Scale||Parenting Sense of Competence (PSOC) Scale|16-item scale to assess parenting self-esteem: the Satisfaction Subscale has 9 questions (2,3,4,5,8,9,12,14,16)=54; the Efficacy Subscale has 7 questions (1,6,7,10,11,13,15)=43. Each response on the satisfaction subscale is answered on a 6-point scale (strongly agree/strongly disagree). Higher scores indicate greater satisfaction and greater self-efficacy. Lower scores mean more impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|25.86|25.86|Standard Deviation|4.31|4.31|||
4420173|NCT00190775|4244023|B1|Efficacy Scale||Parenting Sense of Competence (PSOC) Scale|16-item scale to assess parenting self-esteem: the Satisfaction Subscale has 9 questions (2,3,4,5,8,9,12,14,16)=54; the Efficacy Subscale has 7 questions (1,6,7,10,11,13,15)=43. Each response on the satisfaction subscale is answered on a 6-point scale (strongly agree/strongly disagree). Higher scores indicate greater satisfaction and greater self-efficacy. Lower scores mean more impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|25.18|25.18|Standard Deviation|4.72|4.72|||
4420174|NCT00190775|4244021|B3|Satisfaction Scale||Parenting Sense of Competence (PSOC) Scale|16-item scale to assess parenting self-esteem: the Satisfaction Subscale has 9 questions (2,3,4,5,8,9,12,14,16)=54; the Efficacy Subscale has 7 questions (1,6,7,10,11,13,15)=43. Each response on the satisfaction subscale is answered on a 6-point scale (strongly agree/strongly disagree). Higher scores indicate greater satisfaction and greater self-efficacy. Lower scores mean more impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|34.15|34.15|Standard Deviation|6.52|6.52|||
4420175|NCT00190775|4244022|B2|Satisfaction Scale||Parenting Sense of Competence (PSOC) Scale|16-item scale to assess parenting self-esteem: the Satisfaction Subscale has 9 questions (2,3,4,5,8,9,12,14,16)=54; the Efficacy Subscale has 7 questions (1,6,7,10,11,13,15)=43. Each response on the satisfaction subscale is answered on a 6-point scale (strongly agree/strongly disagree). Higher scores indicate greater satisfaction and greater self-efficacy. Lower scores mean more impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|34.94|34.94|Standard Deviation|6.38|6.38|||
4420424|NCT00190775|4244022|B2|East/Southeast Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4420425|NCT00190775|4244023|B1|East/Southeast Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4420176|NCT00190775|4244023|B1|Satisfaction Scale||Parenting Sense of Competence (PSOC) Scale|16-item scale to assess parenting self-esteem: the Satisfaction Subscale has 9 questions (2,3,4,5,8,9,12,14,16)=54; the Efficacy Subscale has 7 questions (1,6,7,10,11,13,15)=43. Each response on the satisfaction subscale is answered on a 6-point scale (strongly agree/strongly disagree). Higher scores indicate greater satisfaction and greater self-efficacy. Lower scores mean more impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|33.46|33.46|Standard Deviation|6.58|6.58|||
4420177|NCT00190775|4244021|B3|Total||Parenting Sense of Competence (PSOC) Scale|16-item scale to assess parenting self-esteem: the Satisfaction Subscale has 9 questions (2,3,4,5,8,9,12,14,16)=54; the Efficacy Subscale has 7 questions (1,6,7,10,11,13,15)=43. Each response on the satisfaction subscale is answered on a 6-point scale (strongly agree/strongly disagree). Higher scores indicate greater satisfaction and greater self-efficacy. Lower scores mean more impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|59.65|59.65|Standard Deviation|9.58|9.58|||
4420178|NCT00190775|4244022|B2|Total||Parenting Sense of Competence (PSOC) Scale|16-item scale to assess parenting self-esteem: the Satisfaction Subscale has 9 questions (2,3,4,5,8,9,12,14,16)=54; the Efficacy Subscale has 7 questions (1,6,7,10,11,13,15)=43. Each response on the satisfaction subscale is answered on a 6-point scale (strongly agree/strongly disagree). Higher scores indicate greater satisfaction and greater self-efficacy. Lower scores mean more impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|60.80|60.8|Standard Deviation|9.18|9.18|||
4420179|NCT00190775|4244023|B1|Total||Parenting Sense of Competence (PSOC) Scale|16-item scale to assess parenting self-esteem: the Satisfaction Subscale has 9 questions (2,3,4,5,8,9,12,14,16)=54; the Efficacy Subscale has 7 questions (1,6,7,10,11,13,15)=43. Each response on the satisfaction subscale is answered on a 6-point scale (strongly agree/strongly disagree). Higher scores indicate greater satisfaction and greater self-efficacy. Lower scores mean more impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|58.64|58.64|Standard Deviation|9.83|9.83|||
4420180|NCT00190775|4244021|B3|Child Domain Acceptability||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|15.59|15.59|Standard Deviation|4.72|4.72|||
4420181|NCT00190775|4244022|B2|Child Domain Acceptability||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|15.18|15.18|Standard Deviation|4.67|4.67|||
4420182|NCT00190775|4244023|B1|Child Domain Acceptability||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|15.94|15.94|Standard Deviation|4.75|4.75|||
4420183|NCT00190775|4244021|B3|Child Domain Mood||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|12.25|12.25|Standard Deviation|3.96|3.96|||
4420184|NCT00190775|4244022|B2|Child Domain Mood||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|12.06|12.06|Standard Deviation|4.03|4.03|||
4420185|NCT00190775|4244023|B1|Child Domain Mood||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|12.42|12.42|Standard Deviation|3.89|3.89|||
4420186|NCT00190775|4244021|B3|Child Domain Demandingness||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|20.85|20.85|Standard Deviation|6.27|6.27|||
4420187|NCT00190775|4244022|B2|Child Domain Demandingness||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|20.71|20.71|Standard Deviation|6.48|6.48|||
4420188|NCT00190775|4244023|B1|Child Domain Demandingness||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|20.99|20.99|Standard Deviation|6.09|6.09|||
4420189|NCT00190775|4244021|B3|Child Domain Reinforces Parent||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|24.34|24.34|Standard Deviation|7.12|7.12|||
4420190|NCT00190775|4244022|B2|Child Domain Reinforces Parent||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|23.75|23.75|Standard Deviation|7.07|7.07|||
4420191|NCT00190775|4244023|B1|Child Domain Reinforces Parent||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|24.87|24.87|Standard Deviation|7.13|7.13|||
4420192|NCT00190775|4244021|B3|Child Domain Adaptability||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|47.96|47.96|Standard Deviation|11.89|11.89|||
4420193|NCT00190775|4244022|B2|Child Domain Adaptability||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|47.59|47.59|Standard Deviation|12.28|12.28|||
4420194|NCT00190775|4244023|B1|Child Domain Adaptability||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|48.29|48.29|Standard Deviation|11.56|11.56|||
4420195|NCT00190775|4244021|B3|Child Domain Distractibility/Hyperactivity||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|27.54|27.54|Standard Deviation|6.47|6.47|||
4420196|NCT00190775|4244022|B2|Child Domain Distractibility/Hyperactivity||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|27.59|27.59|Standard Deviation|6.48|6.48|||
4420426|NCT00190775|4244021|B3|African Descent||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4420427|NCT00190775|4244022|B2|African Descent||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4420197|NCT00190775|4244023|B1|Child Domain Distractibility/Hyperactivity||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|27.49|27.49|Standard Deviation|6.46|6.46|||
4420198|NCT00190775|4244021|B3|Child Domain Total||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|148.54|148.54|Standard Deviation|34.45|34.45|||
4420199|NCT00190775|4244022|B2|Child Domain Total||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|146.88|146.88|Standard Deviation|34.44|34.44|||
4420200|NCT00190775|4244023|B1|Child Domain Total||Parent Stress Index (PSI) Child Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Child Domain characteristics’ subscales and score ranges include: Distractibility/Hyperactivity (9-45), Adaptability (11-55), Reinforces Parent (6-30), Demandingness (9-45), Mood (5-25), Acceptability (7-35). Total Score measures relative magnitude of stress in parent-child system. A Child Domain score >=116 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|150.00|150.0|Standard Deviation|34.46|34.46|||
4420201|NCT00190775|4244021|B3|Parent Domain Health||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|13.63|13.63|Standard Deviation|2.67|2.67|||
4420202|NCT00190775|4244022|B2|Parent Domain Health||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|13.52|13.52|Standard Deviation|2.62|2.62|||
4420203|NCT00190775|4244023|B1|Parent Domain Health||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|13.72|13.72|Standard Deviation|2.71|2.71|||
4420204|NCT00190775|4244021|B3|Parent Domain Attachment||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|13.37|13.37|Standard Deviation|3.96|3.96|||
4420205|NCT00190775|4244022|B2|Parent Domain Attachment||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|12.95|12.95|Standard Deviation|3.61|3.61|||
4420206|NCT00190775|4244023|B1|Parent Domain Attachment||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|13.74|13.74|Standard Deviation|4.21|4.21|||
4420428|NCT00190775|4244023|B1|African Descent||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4420429|NCT00190775|4244021|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|426|426.0||||||
4420430|NCT00190775|4244022|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|199|199.0||||||
4420207|NCT00190775|4244021|B3|Parent Domain Isolation||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|15.06|15.06|Standard Deviation|4.68|4.68|||
4420208|NCT00190775|4244022|B2|Parent Domain Isolation||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|14.56|14.56|Standard Deviation|4.61|4.61|||
4420209|NCT00190775|4244023|B1|Parent Domain Isolation||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|15.49|15.49|Standard Deviation|4.71|4.71|||
4420210|NCT00190775|4244021|B3|Parent Domain Competence||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|32.23|32.23|Standard Deviation|6.89|6.89|||
4420211|NCT00190775|4244022|B2|Parent Domain Competence||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|31.78|31.78|Standard Deviation|7.10|7.1|||
4420212|NCT00190775|4244023|B1|Parent Domain Competence||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|32.63|32.63|Standard Deviation|6.69|6.69|||
4420213|NCT00190775|4244021|B3|Parent Domain Spouse||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|18.17|18.17|Standard Deviation|5.03|5.03|||
4420214|NCT00190775|4244022|B2|Parent Domain Spouse||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|18.14|18.14|Standard Deviation|5.04|5.04|||
4420215|NCT00190775|4244023|B1|Parent Domain Spouse||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|18.19|18.19|Standard Deviation|5.03|5.03|||
4420216|NCT00190775|4244021|B3|Parent Domain Depression||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|21.96|21.96|Standard Deviation|5.97|5.97|||
4420431|NCT00190775|4244023|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|227|227.0||||||
4420432|NCT00190775|4244021|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4420433|NCT00190775|4244022|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4420434|NCT00190775|4244023|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4420217|NCT00190775|4244022|B2|Parent Domain Depression||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|21.01|21.01|Standard Deviation|5.68|5.68|||
4420218|NCT00190775|4244023|B1|Parent Domain Depression||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|22.79|22.79|Standard Deviation|6.10|6.1|||
4420219|NCT00190775|4244021|B3|Parent Domain Role Restriction||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|18.62|18.62|Standard Deviation|5.18|5.18|||
4420220|NCT00190775|4244022|B2|Parent Domain Role Restriction||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|18.26|18.26|Standard Deviation|4.99|4.99|||
4420221|NCT00190775|4244023|B1|Parent Domain Role Restriction||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|18.93|18.93|Standard Deviation|5.33|5.33|||
4420222|NCT00190775|4244021|B3|Parent Domain Total||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|132.98|132.98|Standard Deviation|25.05|25.05|||
4420223|NCT00190775|4244022|B2|Parent Domain Total||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|130.22|130.22|Standard Deviation|24.62|24.62|||
4420224|NCT00190775|4244023|B1|Parent Domain Total||Parent Stress Index (PSI) Parent Domains|120-item scale includes 101 items rated on 5-point Likert scale (strongly agree/strongly disagree) or 4-5 point multiple choices. Adult Domain characteristics’ subscales and score ranges include: Competence (13-65), Isolation (6-30), Attachment (7-35), Health (5-25), Role Restriction (7-35), Depression (9-45), Spouse (7-35). Total Score measures relative magnitude of stress in parent-child system. Parent Domain score >=148 (>=85th percentile) is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|135.40|135.4|Standard Deviation|25.22|25.22|||
4420225|NCT00190775|4244021|B3|Life Stress||Parent Stress Index (PSI) Total Stress and Life Stress|The PSI 19-item Stress Life Events scale has yes/no responses and measures situational circumstances beyond control (death of family member, divorce, etc.) in the past 12 months. Maximum score (all answers=yes) is 79; a Life Stress raw score >=17 indicates high stress. Each question is weighted based upon the event. Total Score measures relative magnitude of stress in parent-child system. High scores (>=85th percentile) indicate higher stress. Total Stress >=258 is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|1.66|1.66|Standard Deviation|3.62|3.62|||
4420226|NCT00190775|4244022|B2|Life Stress||Parent Stress Index (PSI) Total Stress and Life Stress|The PSI 19-item Stress Life Events scale has yes/no responses and measures situational circumstances beyond control (death of family member, divorce, etc.) in the past 12 months. Maximum score (all answers=yes) is 79; a Life Stress raw score >=17 indicates high stress. Each question is weighted based upon the event. Total Score measures relative magnitude of stress in parent-child system. High scores (>=85th percentile) indicate higher stress. Total Stress >=258 is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|1.76|1.76|Standard Deviation|3.68|3.68|||
4420435|NCT00190775|4244021|B3||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4420436|NCT00190775|4244022|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4420437|NCT00190775|4244023|B1||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4420227|NCT00190775|4244023|B1|Life Stress||Parent Stress Index (PSI) Total Stress and Life Stress|The PSI 19-item Stress Life Events scale has yes/no responses and measures situational circumstances beyond control (death of family member, divorce, etc.) in the past 12 months. Maximum score (all answers=yes) is 79; a Life Stress raw score >=17 indicates high stress. Each question is weighted based upon the event. Total Score measures relative magnitude of stress in parent-child system. High scores (>=85th percentile) indicate higher stress. Total Stress >=258 is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|1.57|1.57|Standard Deviation|3.56|3.56|||
4420228|NCT00190775|4244021|B3|Total Stress||Parent Stress Index (PSI) Total Stress and Life Stress|The PSI 19-item Stress Life Events scale has yes/no responses and measures situational circumstances beyond control (death of family member, divorce, etc.) in the past 12 months. Maximum score (all answers=yes) is 79; a Life Stress raw score >=17 indicates high stress. Each question is weighted based upon the event. Total Score measures relative magnitude of stress in parent-child system. High scores (>=85th percentile) indicate higher stress. Total Stress >=258 is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|281.53|281.53|Standard Deviation|53.18|53.18|||
4420229|NCT00190775|4244022|B2|Total Stress||Parent Stress Index (PSI) Total Stress and Life Stress|The PSI 19-item Stress Life Events scale has yes/no responses and measures situational circumstances beyond control (death of family member, divorce, etc.) in the past 12 months. Maximum score (all answers=yes) is 79; a Life Stress raw score >=17 indicates high stress. Each question is weighted based upon the event. Total Score measures relative magnitude of stress in parent-child system. High scores (>=85th percentile) indicate higher stress. Total Stress >=258 is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|277.11|277.11|Standard Deviation|52.65|52.65|||
4420230|NCT00190775|4244023|B1|Total Stress||Parent Stress Index (PSI) Total Stress and Life Stress|The PSI 19-item Stress Life Events scale has yes/no responses and measures situational circumstances beyond control (death of family member, divorce, etc.) in the past 12 months. Maximum score (all answers=yes) is 79; a Life Stress raw score >=17 indicates high stress. Each question is weighted based upon the event. Total Score measures relative magnitude of stress in parent-child system. High scores (>=85th percentile) indicate higher stress. Total Stress >=258 is indicative of impairment. Participants with a child aged 6-12 or 13-17 years living at home completed the scale.|Units on a scale|Mean|285.40|285.4|Standard Deviation|53.45|53.45|||
4420231|NCT00190775|4244021|B3|||Montgomery-Asberg Depression Rating Scale Total Score (MADRS)|The MADRS is an investigator administered rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|Units on a scale|Mean|8.13|8.13|Standard Deviation|4.89|4.89|||
4420232|NCT00190775|4244022|B2|||Montgomery-Asberg Depression Rating Scale Total Score (MADRS)|The MADRS is an investigator administered rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|Units on a scale|Mean|8.12|8.12|Standard Deviation|5.01|5.01|||
4420233|NCT00190775|4244023|B1|||Montgomery-Asberg Depression Rating Scale Total Score (MADRS)|The MADRS is an investigator administered rating scale for severity of depressive mood symptoms. The MADRS has a 10-item checklist. Items are rated on a scale of 0-6, for a total score range of 0 (low severity of depressive symptoms) to 60 (high severity of depressive symptoms).|Units on a scale|Mean|8.13|8.13|Standard Deviation|4.80|4.8|||
4420234|NCT00190775|4244021|B3|||Height||Centimeters|Mean|170.66|170.66|Standard Deviation|10.09|10.09|||
4420235|NCT00190775|4244022|B2|||Height||Centimeters|Mean|170.01|170.01|Standard Deviation|9.74|9.74|||
4420236|NCT00190775|4244023|B1|||Height||Centimeters|Mean|171.23|171.23|Standard Deviation|10.37|10.37|||
4420237|NCT00190775|4244021|B3|Values and Norms||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|65.41|65.41|Standard Deviation|7.13|7.13|||
4420238|NCT00190775|4244022|B2|Values and Norms||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|65.52|65.52|Standard Deviation|7.17|7.17|||
4420239|NCT00190775|4244023|B1|Values and Norms||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|65.32|65.32|Standard Deviation|7.11|7.11|||
4420240|NCT00190775|4244021|B3|Control||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|61.68|61.68|Standard Deviation|6.40|6.4|||
4420241|NCT00190775|4244022|B2|Control||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|61.34|61.34|Standard Deviation|6.25|6.25|||
4420242|NCT00190775|4244023|B1|Control||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|61.98|61.98|Standard Deviation|6.52|6.52|||
4420243|NCT00190775|4244021|B3|Involvement||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|64.76|64.76|Standard Deviation|8.86|8.86|||
4420244|NCT00190775|4244022|B2|Involvement||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|64.52|64.52|Standard Deviation|8.77|8.77|||
4420245|NCT00190775|4244023|B1|Involvement||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|64.96|64.96|Standard Deviation|8.95|8.95|||
4420246|NCT00190775|4244021|B3|Affective Expression||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|61.84|61.84|Standard Deviation|9.39|9.39|||
4420247|NCT00190775|4244022|B2|Affective Expression||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|61.68|61.68|Standard Deviation|9.07|9.07|||
4420248|NCT00190775|4244023|B1|Affective Expression||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|61.97|61.97|Standard Deviation|9.67|9.67|||
4420249|NCT00190775|4244021|B3|Communication||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|63.78|63.78|Standard Deviation|6.68|6.68|||
4420250|NCT00190775|4244022|B2|Communication||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|63.47|63.47|Standard Deviation|7.02|7.02|||
4420438|NCT00190775|4244021|B3||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4420251|NCT00190775|4244023|B1|Communication||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|64.05|64.05|Standard Deviation|6.37|6.37|||
4420252|NCT00190775|4244021|B3|Role Performance||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|60.96|60.96|Standard Deviation|5.83|5.83|||
4420253|NCT00190775|4244022|B2|Role Performance||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|60.59|60.59|Standard Deviation|6.00|6.0|||
4420254|NCT00190775|4244023|B1|Role Performance||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|61.28|61.28|Standard Deviation|5.67|5.67|||
4420255|NCT00190775|4244021|B3|Task Accomplishment||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|61.23|61.23|Standard Deviation|5.91|5.91|||
4420256|NCT00190775|4244022|B2|Task Accomplishment||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|60.90|60.9|Standard Deviation|5.83|5.83|||
4420257|NCT00190775|4244023|B1|Task Accomplishment||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Spouse/Significant Other|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. The spouse/significant other completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation (SD)=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|61.52|61.52|Standard Deviation|5.97|5.97|||
4420258|NCT00190775|4244021|B3|Values and Norms||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|65.30|65.3|Standard Deviation|7.06|7.06|||
4420259|NCT00190775|4244022|B2|Values and Norms||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|64.90|64.9|Standard Deviation|7.44|7.44|||
4420260|NCT00190775|4244023|B1|Values and Norms||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|65.66|65.66|Standard Deviation|6.70|6.7|||
4420439|NCT00190775|4244022|B2||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4420261|NCT00190775|4244021|B3|Control||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|62.43|62.43|Standard Deviation|6.01|6.01|||
4420262|NCT00190775|4244022|B2|Control||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|62.13|62.13|Standard Deviation|6.07|6.07|||
4420263|NCT00190775|4244023|B1|Control||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|62.70|62.7|Standard Deviation|5.95|5.95|||
4420264|NCT00190775|4244021|B3|Involvement||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|64.31|64.31|Standard Deviation|7.66|7.66|||
4420265|NCT00190775|4244022|B2|Involvement||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|64.59|64.59|Standard Deviation|7.35|7.35|||
4420266|NCT00190775|4244023|B1|Involvement||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|64.07|64.07|Standard Deviation|7.92|7.92|||
4420267|NCT00190775|4244021|B3|Affective Expression||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|61.59|61.59|Standard Deviation|9.02|9.02|||
4420268|NCT00190775|4244022|B2|Affective Expression||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|61.71|61.71|Standard Deviation|9.47|9.47|||
4420269|NCT00190775|4244023|B1|Affective Expression||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|61.48|61.48|Standard Deviation|8.63|8.63|||
4420270|NCT00190775|4244021|B3|Communication||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|64.63|64.63|Standard Deviation|6.43|6.43|||
4420440|NCT00190775|4244023|B1||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4420441|NCT00190775|4244021|B3|||Age||Years|Mean|41.30|41.3|Standard Deviation|7.17|7.17|||
4420442|NCT00190775|4244022|B2|||Age||Years|Mean|41.39|41.39|Standard Deviation|7.49|7.49|||
4420271|NCT00190775|4244022|B2|Communication||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|64.24|64.24|Standard Deviation|6.35|6.35|||
4420272|NCT00190775|4244023|B1|Communication||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|64.97|64.97|Standard Deviation|6.49|6.49|||
4420273|NCT00190775|4244021|B3|Role Performance||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|60.96|60.96|Standard Deviation|5.37|5.37|||
4420274|NCT00190775|4244022|B2|Role Performance||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|61.13|61.13|Standard Deviation|5.75|5.75|||
4420275|NCT00190775|4244023|B1|Role Performance||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|60.81|60.81|Standard Deviation|5.03|5.03|||
4420276|NCT00190775|4244021|B3|Task Accomplishment||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|62.59|62.59|Standard Deviation|5.50|5.5|||
4420277|NCT00190775|4244022|B2|Task Accomplishment||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|62.38|62.38|Standard Deviation|5.43|5.43|||
4420278|NCT00190775|4244023|B1|Task Accomplishment||Family Assessment Measure III (FAM) Dyadic Relationship Scale (DRS) - Participant (Self)|FAM consists of 3 components: General Scale; Dyadic Relationships Scale (DRS), and Self-Rating Scale. Participants completed the DRS scale, a 42-item self-report scale providing quantitative indices of family strengths/weaknesses. Items are rated 0-3 (strongly agree, agree, disagree, strongly disagree). Raw scores=0-18 (each subscale) and are converted to a t-score (mean=50, standard deviation=10; scores range from 0-100). T-scores should be between 40-60. T-scores >=60 indicate disturbance in family functioning.|T-scores of units on a scale|Mean|62.78|62.78|Standard Deviation|5.56|5.56|||
4420279|NCT00190775|4244021|B3|Dyadic Satisfaction||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|42.06|42.06|Standard Deviation|10.64|10.64|||
4420280|NCT00190775|4244022|B2|Dyadic Satisfaction||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|41.84|41.84|Standard Deviation|10.53|10.53|||
4420443|NCT00190775|4244023|B1|||Age||Years|Mean|41.21|41.21|Standard Deviation|6.89|6.89|||
4420561|NCT00190671|4244181|B1|Unknown||Progesterone-Receptor Status||participants|Number|7|7.0||||||
4420281|NCT00190775|4244023|B1|Dyadic Satisfaction||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|42.25|42.25|Standard Deviation|10.75|10.75|||
4420282|NCT00190775|4244021|B3|Dyadic Consensus||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|40.64|40.64|Standard Deviation|10.10|10.1|||
4420283|NCT00190775|4244022|B2|Dyadic Consensus||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|40.44|40.44|Standard Deviation|10.02|10.02|||
4420284|NCT00190775|4244023|B1|Dyadic Consensus||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|40.82|40.82|Standard Deviation|10.18|10.18|||
4420285|NCT00190775|4244021|B3|Dyadic Cohesion||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|51.51|51.51|Standard Deviation|10.72|10.72|||
4420286|NCT00190775|4244022|B2|Dyadic Cohesion||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|51.70|51.7|Standard Deviation|10.30|10.3|||
4420287|NCT00190775|4244023|B1|Dyadic Cohesion||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|51.35|51.35|Standard Deviation|11.09|11.09|||
4420288|NCT00190775|4244021|B3|Affectational Expression||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|43.41|43.41|Standard Deviation|12.10|12.1|||
4420289|NCT00190775|4244022|B2|Affectational Expression||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|43.66|43.66|Standard Deviation|12.28|12.28|||
4420332|NCT00190775|4244023|B1|Total Score||Child Disruptive Behavior Rating Scale (CDBRS) Parent Form|Child Disruptive Behavior Rating Scale (CDBRS) contains the symptoms of ADHD (9 items for Inattention/9 items for Hyperactive-Impulsive). Total maximum severity score is 54 (0-27 for each subscore). Higher scores indicate greater impairment. Participants with a child aged 6-12 or 13-17 years old living in the home completed the scale.|Units on a scale|Mean|24.56|24.56|Standard Deviation|13.30|13.3|||
4420556|NCT00190671|4244179|B3|Missing||Progesterone-Receptor Status||participants|Number|12.0|12.0||||||
4420290|NCT00190775|4244023|B1|Affectational Expression||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|43.18|43.18|Standard Deviation|11.97|11.97|||
4420291|NCT00190775|4244021|B3|Total Dyadic Adjustment||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|41.85|41.85|Standard Deviation|11.36|11.36|||
4420292|NCT00190775|4244022|B2|Total Dyadic Adjustment||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|41.75|41.75|Standard Deviation|11.29|11.29|||
4420293|NCT00190775|4244023|B1|Total Dyadic Adjustment||Dyadic Adjustment Scale (DAS) - Spouse/Significant Other|32-item self-report scale to assess quality of the relationship perceived by the spouse/significant other. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), and affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, SD=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|41.93|41.93|Standard Deviation|11.44|11.44|||
4420294|NCT00190775|4244021|B3|Dyadic Satisfaction||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|42.75|42.75|Standard Deviation|10.55|10.55|||
4420295|NCT00190775|4244022|B2|Dyadic Satisfaction||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|42.49|42.49|Standard Deviation|10.24|10.24|||
4420296|NCT00190775|4244023|B1|Dyadic Satisfaction||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|42.98|42.98|Standard Deviation|10.82|10.82|||
4420297|NCT00190775|4244021|B3|Dyadic Consensus||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|44.65|44.65|Standard Deviation|8.98|8.98|||
4420298|NCT00190775|4244022|B2|Dyadic Consensus||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|44.26|44.26|Standard Deviation|8.69|8.69|||
4420333|NCT00190775|4244021|B3|||Body Mass Index (BMI)|Body mass index (BMI) is an estimate of body fat based on body weight divided by height squared.|Kilograms/square meters|Mean|29.76|29.76|Standard Deviation|6.56|6.56|||
4420334|NCT00190775|4244022|B2|||Body Mass Index (BMI)|Body mass index (BMI) is an estimate of body fat based on body weight divided by height squared.|Kilograms/square meters|Mean|29.31|29.31|Standard Deviation|6.51|6.51|||
4420557|NCT00190671|4244180|B2|Missing||Progesterone-Receptor Status||participants|Number|9|9.0||||||
4420299|NCT00190775|4244023|B1|Dyadic Consensus||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|44.99|44.99|Standard Deviation|9.22|9.22|||
4420300|NCT00190775|4244021|B3|Dyadic Cohesion||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|52.08|52.08|Standard Deviation|10.35|10.35|||
4420301|NCT00190775|4244022|B2|Dyadic Cohesion||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|51.58|51.58|Standard Deviation|10.02|10.02|||
4420302|NCT00190775|4244023|B1|Dyadic Cohesion||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|52.51|52.51|Standard Deviation|10.63|10.63|||
4420303|NCT00190775|4244021|B3|Affectional Expression||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|44.24|44.24|Standard Deviation|12.14|12.14|||
4420304|NCT00190775|4244022|B2|Affectional Expression||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|44.85|44.85|Standard Deviation|11.68|11.68|||
4420305|NCT00190775|4244023|B1|Affectional Expression||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|43.70|43.7|Standard Deviation|12.52|12.52|||
4420306|NCT00190775|4244021|B3|Total Dyadic Adjustment||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|42.74|42.74|Standard Deviation|11.53|11.53|||
4420307|NCT00190775|4244022|B2|Total Dyadic Adjustment||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|42.37|42.37|Standard Deviation|11.11|11.11|||
4420308|NCT00190775|4244023|B1|Total Dyadic Adjustment||Dyadic Adjustment Scale (DAS) - Participant (Self)|32-item self-report scale to assess quality of the relationship perceived by participants. Response anchors vary and include a 5-, 6- or 7-point Likert scale (always agree/disagree; all the time/never); and 2 yes/no items. Assesses 4 relationship aspects (# items): dyadic satisfaction (10), cohesion (5), and consensus (13), affectional expression (4). Raw score total=0-151 and is converted to a t-score (0-100; mean=50, standard deviation (SD)=10). T-scores of 45-55 indicate a typical score (no concern). Scores <30 indicate significant impairment. Lower scores indicate poorer dyadic adjustment.|T-scores of units on a scale|Mean|43.06|43.06|Standard Deviation|11.90|11.9|||
4420309|NCT00190775|4244021|B3|Index Subscale||Conners' Adult ADHD Rating Scale Screening Version (CAARS-Inv:SV)|30-item scale containing 3 subscales: inattention (9 items), hyperactivity/ impulsivity (9 items), and ADHD Index (12 items). Each item is scored 0-3 (0=not at all/never; 1=just a little/once in a while; 2=pretty much/often; 3=very much/very frequently). Total ADHD symptoms score=sum of the inattention and hyperactivity/impulsivity subscales. Total Scores range from 0-54 (range of 0-27 for the inattention and hyperactivity subscales; 0-36 for the ADHD Index) with higher scores indicating more impaired participants. The scale was administered by a physician/PhD at the investigative site.|Units on a scale|Mean|21.55|21.55|Standard Deviation|5.54|5.54|||
4420310|NCT00190775|4244022|B2|Index Subscale||Conners' Adult ADHD Rating Scale Screening Version (CAARS-Inv:SV)|30-item scale containing 3 subscales: inattention (9 items), hyperactivity/ impulsivity (9 items), and ADHD Index (12 items). Each item is scored 0-3 (0=not at all/never; 1=just a little/once in a while; 2=pretty much/often; 3=very much/very frequently). Total ADHD symptoms score=sum of the inattention and hyperactivity/impulsivity subscales. Total Scores range from 0-54 (range of 0-27 for the inattention and hyperactivity subscales; 0-36 for the ADHD Index) with higher scores indicating more impaired participants. The scale was administered by a physician/PhD at the investigative site.|Units on a scale|Mean|21.49|21.49|Standard Deviation|5.74|5.74|||
4420311|NCT00190775|4244023|B1|Index Subscale||Conners' Adult ADHD Rating Scale Screening Version (CAARS-Inv:SV)|30-item scale containing 3 subscales: inattention (9 items), hyperactivity/ impulsivity (9 items), and ADHD Index (12 items). Each item is scored 0-3 (0=not at all/never; 1=just a little/once in a while; 2=pretty much/often; 3=very much/very frequently). Total ADHD symptoms score=sum of the inattention and hyperactivity/impulsivity subscales. Total Scores range from 0-54 (range of 0-27 for the inattention and hyperactivity subscales; 0-36 for the ADHD Index) with higher scores indicating more impaired participants. The scale was administered by a physician/PhD at the investigative site.|Units on a scale|Mean|21.60|21.6|Standard Deviation|5.37|5.37|||
4420312|NCT00190775|4244021|B3|Hyper/Impulsive Subscale||Conners' Adult ADHD Rating Scale Screening Version (CAARS-Inv:SV)|30-item scale containing 3 subscales: inattention (9 items), hyperactivity/ impulsivity (9 items), and ADHD Index (12 items). Each item is scored 0-3 (0=not at all/never; 1=just a little/once in a while; 2=pretty much/often; 3=very much/very frequently). Total ADHD symptoms score=sum of the inattention and hyperactivity/impulsivity subscales. Total Scores range from 0-54 (range of 0-27 for the inattention and hyperactivity subscales; 0-36 for the ADHD Index) with higher scores indicating more impaired participants. The scale was administered by a physician/PhD at the investigative site.|Units on a scale|Mean|15.11|15.11|Standard Deviation|5.86|5.86|||
4420313|NCT00190775|4244022|B2|Hyper/Impulsive Subscale||Conners' Adult ADHD Rating Scale Screening Version (CAARS-Inv:SV)|30-item scale containing 3 subscales: inattention (9 items), hyperactivity/ impulsivity (9 items), and ADHD Index (12 items). Each item is scored 0-3 (0=not at all/never; 1=just a little/once in a while; 2=pretty much/often; 3=very much/very frequently). Total ADHD symptoms score=sum of the inattention and hyperactivity/impulsivity subscales. Total Scores range from 0-54 (range of 0-27 for the inattention and hyperactivity subscales; 0-36 for the ADHD Index) with higher scores indicating more impaired participants. The scale was administered by a physician/PhD at the investigative site.|Units on a scale|Mean|15.60|15.6|Standard Deviation|5.80|5.8|||
4420314|NCT00190775|4244023|B1|Hyper/Impulsive Subscale||Conners' Adult ADHD Rating Scale Screening Version (CAARS-Inv:SV)|30-item scale containing 3 subscales: inattention (9 items), hyperactivity/ impulsivity (9 items), and ADHD Index (12 items). Each item is scored 0-3 (0=not at all/never; 1=just a little/once in a while; 2=pretty much/often; 3=very much/very frequently). Total ADHD symptoms score=sum of the inattention and hyperactivity/impulsivity subscales. Total Scores range from 0-54 (range of 0-27 for the inattention and hyperactivity subscales; 0-36 for the ADHD Index) with higher scores indicating more impaired participants. The scale was administered by a physician/PhD at the investigative site.|Units on a scale|Mean|14.67|14.67|Standard Deviation|5.89|5.89|||
4420315|NCT00190775|4244021|B3|Inattention Subscale||Conners' Adult ADHD Rating Scale Screening Version (CAARS-Inv:SV)|30-item scale containing 3 subscales: inattention (9 items), hyperactivity/ impulsivity (9 items), and ADHD Index (12 items). Each item is scored 0-3 (0=not at all/never; 1=just a little/once in a while; 2=pretty much/often; 3=very much/very frequently). Total ADHD symptoms score=sum of the inattention and hyperactivity/impulsivity subscales. Total Scores range from 0-54 (range of 0-27 for the inattention and hyperactivity subscales; 0-36 for the ADHD Index) with higher scores indicating more impaired participants. The scale was administered by a physician/PhD at the investigative site.|Units on a scale|Mean|19.94|19.94|Standard Deviation|4.39|4.39|||
4420316|NCT00190775|4244022|B2|Inattention Subscale||Conners' Adult ADHD Rating Scale Screening Version (CAARS-Inv:SV)|30-item scale containing 3 subscales: inattention (9 items), hyperactivity/ impulsivity (9 items), and ADHD Index (12 items). Each item is scored 0-3 (0=not at all/never; 1=just a little/once in a while; 2=pretty much/often; 3=very much/very frequently). Total ADHD symptoms score=sum of the inattention and hyperactivity/impulsivity subscales. Total Scores range from 0-54 (range of 0-27 for the inattention and hyperactivity subscales; 0-36 for the ADHD Index) with higher scores indicating more impaired participants. The scale was administered by a physician/PhD at the investigative site.|Units on a scale|Mean|19.90|19.9|Standard Deviation|4.33|4.33|||
4420317|NCT00190775|4244023|B1|Inattention Subscale||Conners' Adult ADHD Rating Scale Screening Version (CAARS-Inv:SV)|30-item scale containing 3 subscales: inattention (9 items), hyperactivity/ impulsivity (9 items), and ADHD Index (12 items). Each item is scored 0-3 (0=not at all/never; 1=just a little/once in a while; 2=pretty much/often; 3=very much/very frequently). Total ADHD symptoms score=sum of the inattention and hyperactivity/impulsivity subscales. Total Scores range from 0-54 (range of 0-27 for the inattention and hyperactivity subscales; 0-36 for the ADHD Index) with higher scores indicating more impaired participants. The scale was administered by a physician/PhD at the investigative site.|Units on a scale|Mean|19.97|19.97|Standard Deviation|4.45|4.45|||
4420318|NCT00190775|4244021|B3|Total ADHD Symptoms Score||Conners' Adult ADHD Rating Scale Screening Version (CAARS-Inv:SV)|30-item scale containing 3 subscales: inattention (9 items), hyperactivity/ impulsivity (9 items), and ADHD Index (12 items). Each item is scored 0-3 (0=not at all/never; 1=just a little/once in a while; 2=pretty much/often; 3=very much/very frequently). Total ADHD symptoms score=sum of the inattention and hyperactivity/impulsivity subscales. Total Scores range from 0-54 (range of 0-27 for the inattention and hyperactivity subscales; 0-36 for the ADHD Index) with higher scores indicating more impaired participants. The scale was administered by a physician/PhD at the investigative site.|Units on a scale|Mean|35.04|35.04|Standard Deviation|8.46|8.46|||
4420319|NCT00190775|4244022|B2|Total ADHD Symptoms Score||Conners' Adult ADHD Rating Scale Screening Version (CAARS-Inv:SV)|30-item scale containing 3 subscales: inattention (9 items), hyperactivity/ impulsivity (9 items), and ADHD Index (12 items). Each item is scored 0-3 (0=not at all/never; 1=just a little/once in a while; 2=pretty much/often; 3=very much/very frequently). Total ADHD symptoms score=sum of the inattention and hyperactivity/impulsivity subscales. Total Scores range from 0-54 (range of 0-27 for the inattention and hyperactivity subscales; 0-36 for the ADHD Index) with higher scores indicating more impaired participants. The scale was administered by a physician/PhD at the investigative site.|Units on a scale|Mean|35.50|35.5|Standard Deviation|8.53|8.53|||
4420320|NCT00190775|4244023|B1|Total ADHD Symptoms Score||Conners' Adult ADHD Rating Scale Screening Version (CAARS-Inv:SV)|30-item scale containing 3 subscales: inattention (9 items), hyperactivity/ impulsivity (9 items), and ADHD Index (12 items). Each item is scored 0-3 (0=not at all/never; 1=just a little/once in a while; 2=pretty much/often; 3=very much/very frequently). Total ADHD symptoms score=sum of the inattention and hyperactivity/impulsivity subscales. Total Scores range from 0-54 (range of 0-27 for the inattention and hyperactivity subscales; 0-36 for the ADHD Index) with higher scores indicating more impaired participants. The scale was administered by a physician/PhD at the investigative site.|Units on a scale|Mean|34.64|34.64|Standard Deviation|8.39|8.39|||
4420321|NCT00190775|4244021|B3|||Clinical Global Improvement Attention Deficit Hyperactivity Disorder Severity (CGI-ADHD-S)|The CGI-ADHD-S is a single-item rating of the clinician’s assessment of the severity of ADHD symptoms in relation to the clinician’s total experience with ADHD subjects. Severity is rated on a 7-point scale (1=normal, not at all ill; 7=among the most extremely ill subjects). The scale was administered by a physician or PhD at the investigative site.|Units on a scale|Mean|4.57|4.57|Standard Deviation|0.61|0.61|||
4420322|NCT00190775|4244022|B2|||Clinical Global Improvement Attention Deficit Hyperactivity Disorder Severity (CGI-ADHD-S)|The CGI-ADHD-S is a single-item rating of the clinician’s assessment of the severity of ADHD symptoms in relation to the clinician’s total experience with ADHD subjects. Severity is rated on a 7-point scale (1=normal, not at all ill; 7=among the most extremely ill subjects). The scale was administered by a physician or PhD at the investigative site.|Units on a scale|Mean|4.58|4.58|Standard Deviation|0.60|0.6|||
4420323|NCT00190775|4244023|B1|||Clinical Global Improvement Attention Deficit Hyperactivity Disorder Severity (CGI-ADHD-S)|The CGI-ADHD-S is a single-item rating of the clinician’s assessment of the severity of ADHD symptoms in relation to the clinician’s total experience with ADHD subjects. Severity is rated on a 7-point scale (1=normal, not at all ill; 7=among the most extremely ill subjects). The scale was administered by a physician or PhD at the investigative site.|Units on a scale|Mean|4.56|4.56|Standard Deviation|0.62|0.62|||
4420324|NCT00190775|4244021|B3|Hyperactive-Impulsive Symptom ADHD Score||Child Disruptive Behavior Rating Scale (CDBRS) Parent Form|Child Disruptive Behavior Rating Scale (CDBRS) contains the symptoms of ADHD (9 items for Inattention/9 items for Hyperactive-Impulsive). Total maximum severity score is 54 (0-27 for each subscore). Higher scores indicate greater impairment. Participants with a child aged 6-12 or 13-17 years old living in the home completed the scale.|Units on a scale|Mean|11.09|11.09|Standard Deviation|6.96|6.96|||
4420325|NCT00190775|4244022|B2|Hyperactive-Impulsive Symptom ADHD Score||Child Disruptive Behavior Rating Scale (CDBRS) Parent Form|Child Disruptive Behavior Rating Scale (CDBRS) contains the symptoms of ADHD (9 items for Inattention/9 items for Hyperactive-Impulsive). Total maximum severity score is 54 (0-27 for each subscore). Higher scores indicate greater impairment. Participants with a child aged 6-12 or 13-17 years old living in the home completed the scale.|Units on a scale|Mean|11.00|11.0|Standard Deviation|6.95|6.95|||
4420326|NCT00190775|4244023|B1|Hyperactive-Impulsive Symptom ADHD Score||Child Disruptive Behavior Rating Scale (CDBRS) Parent Form|Child Disruptive Behavior Rating Scale (CDBRS) contains the symptoms of ADHD (9 items for Inattention/9 items for Hyperactive-Impulsive). Total maximum severity score is 54 (0-27 for each subscore). Higher scores indicate greater impairment. Participants with a child aged 6-12 or 13-17 years old living in the home completed the scale.|Units on a scale|Mean|11.17|11.17|Standard Deviation|6.98|6.98|||
4420327|NCT00190775|4244021|B3|Inattention Symptom ADHD Score||Child Disruptive Behavior Rating Scale (CDBRS) Parent Form|Child Disruptive Behavior Rating Scale (CDBRS) contains the symptoms of ADHD (9 items for Inattention/9 items for Hyperactive-Impulsive). Total maximum severity score is 54 (0-27 for each subscore). Higher scores indicate greater impairment. Participants with a child aged 6-12 or 13-17 years old living in the home completed the scale.|Units on a scale|Mean|13.37|13.37|Standard Deviation|7.09|7.09|||
4420328|NCT00190775|4244022|B2|Inattention Symptom ADHD Score||Child Disruptive Behavior Rating Scale (CDBRS) Parent Form|Child Disruptive Behavior Rating Scale (CDBRS) contains the symptoms of ADHD (9 items for Inattention/9 items for Hyperactive-Impulsive). Total maximum severity score is 54 (0-27 for each subscore). Higher scores indicate greater impairment. Participants with a child aged 6-12 or 13-17 years old living in the home completed the scale.|Units on a scale|Mean|13.35|13.35|Standard Deviation|6.86|6.86|||
4420329|NCT00190775|4244023|B1|Inattention Symptom ADHD Score||Child Disruptive Behavior Rating Scale (CDBRS) Parent Form|Child Disruptive Behavior Rating Scale (CDBRS) contains the symptoms of ADHD (9 items for Inattention/9 items for Hyperactive-Impulsive). Total maximum severity score is 54 (0-27 for each subscore). Higher scores indicate greater impairment. Participants with a child aged 6-12 or 13-17 years old living in the home completed the scale.|Units on a scale|Mean|13.39|13.39|Standard Deviation|7.30|7.3|||
4420330|NCT00190775|4244021|B3|Total Score||Child Disruptive Behavior Rating Scale (CDBRS) Parent Form|Child Disruptive Behavior Rating Scale (CDBRS) contains the symptoms of ADHD (9 items for Inattention/9 items for Hyperactive-Impulsive). Total maximum severity score is 54 (0-27 for each subscore). Higher scores indicate greater impairment. Participants with a child aged 6-12 or 13-17 years old living in the home completed the scale.|Units on a scale|Mean|24.46|24.46|Standard Deviation|13.16|13.16|||
4420331|NCT00190775|4244022|B2|Total Score||Child Disruptive Behavior Rating Scale (CDBRS) Parent Form|Child Disruptive Behavior Rating Scale (CDBRS) contains the symptoms of ADHD (9 items for Inattention/9 items for Hyperactive-Impulsive). Total maximum severity score is 54 (0-27 for each subscore). Higher scores indicate greater impairment. Participants with a child aged 6-12 or 13-17 years old living in the home completed the scale.|Units on a scale|Mean|24.35|24.35|Standard Deviation|13.01|13.01|||
4420335|NCT00190775|4244023|B1|||Body Mass Index (BMI)|Body mass index (BMI) is an estimate of body fat based on body weight divided by height squared.|Kilograms/square meters|Mean|30.15|30.15|Standard Deviation|6.58|6.58|||
4420336|NCT00190775|4244021|B3|Parent Positive Parenting||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|-0.04|-0.04|Standard Deviation|1.00|1.0|||
4420337|NCT00190775|4244022|B2|Parent Positive Parenting||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|-0.07|-0.07|Standard Deviation|1.05|1.05|||
4420338|NCT00190775|4244023|B1|Parent Positive Parenting||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|-0.00|0.0|Standard Deviation|0.95|0.95|||
4420339|NCT00190775|4244021|B3|Parent Negative Parenting||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|0.21|0.21|Standard Deviation|1.02|1.02|||
4420340|NCT00190775|4244022|B2|Parent Negative Parenting||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|0.21|0.21|Standard Deviation|0.99|0.99|||
4420341|NCT00190775|4244023|B1|Parent Negative Parenting||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|0.21|0.21|Standard Deviation|1.05|1.05|||
4420342|NCT00190775|4244021|B3|Parent Dysfunctional Parenting Composite||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|0.14|0.14|Standard Deviation|0.99|0.99|||
4420343|NCT00190775|4244022|B2|Parent Dysfunctional Parenting Composite||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|0.17|0.17|Standard Deviation|1.01|1.01|||
4420344|NCT00190775|4244023|B1|Parent Dysfunctional Parenting Composite||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|0.12|0.12|Standard Deviation|0.98|0.98|||
4420345|NCT00190775|4244021|B3|Parent Other Discipline Practice||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|19.58|19.58|Standard Deviation|3.02|3.02|||
4420415|NCT00190775|4244022|B2|United States||Region of Enrollment||Participants|Number|224|224.0||||||
4420346|NCT00190775|4244022|B2|Parent Other Discipline Practice||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|19.64|19.64|Standard Deviation|2.96|2.96|||
4420347|NCT00190775|4244023|B1|Parent Other Discipline Practice||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|19.53|19.53|Standard Deviation|3.08|3.08|||
4420348|NCT00190775|4244021|B3|Parent Corporal Punishment||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|4.74|4.74|Standard Deviation|1.67|1.67|||
4420349|NCT00190775|4244022|B2|Parent Corporal Punishment||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|4.75|4.75|Standard Deviation|1.76|1.76|||
4420350|NCT00190775|4244023|B1|Parent Corporal Punishment||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|4.73|4.73|Standard Deviation|1.60|1.6|||
4420351|NCT00190775|4244021|B3|Parent Inconsistent Discipline||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|15.42|15.42|Standard Deviation|3.42|3.42|||
4420352|NCT00190775|4244022|B2|Parent Inconsistent Discipline||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|15.48|15.48|Standard Deviation|3.42|3.42|||
4420353|NCT00190775|4244023|B1|Parent Inconsistent Discipline||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|15.37|15.37|Standard Deviation|3.44|3.44|||
4420354|NCT00190775|4244021|B3|Parent Poor Monitoring Supervision||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|16.58|16.58|Standard Deviation|4.85|4.85|||
4420355|NCT00190775|4244022|B2|Parent Poor Monitoring Supervision||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|16.50|16.5|Standard Deviation|4.78|4.78|||
4420416|NCT00190775|4244023|B1|United States||Region of Enrollment||Participants|Number|255|255.0||||||
4420356|NCT00190775|4244023|B1|Parent Poor Monitoring Supervision||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|16.64|16.64|Standard Deviation|4.91|4.91|||
4420357|NCT00190775|4244021|B3|Parent Positive Parenting||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|24.31|24.31|Standard Deviation|3.42|3.42|||
4420358|NCT00190775|4244022|B2|Parent Positive Parenting||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|24.06|24.06|Standard Deviation|3.58|3.58|||
4420359|NCT00190775|4244023|B1|Parent Positive Parenting||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|24.53|24.53|Standard Deviation|3.26|3.26|||
4420360|NCT00190775|4244021|B3|Parent Involvement||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|37.67|37.67|Standard Deviation|5.34|5.34|||
4420361|NCT00190775|4244022|B2|Parent Involvement||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|37.61|37.61|Standard Deviation|5.62|5.62|||
4420362|NCT00190775|4244023|B1|Parent Involvement||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|37.71|37.71|Standard Deviation|5.11|5.11|||
4420363|NCT00190775|4244021|B3|Child Other Discipline Practice||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|17.88|17.88|Standard Deviation|3.70|3.7|||
4420364|NCT00190775|4244022|B2|Child Other Discipline Practice||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|18.18|18.18|Standard Deviation|3.88|3.88|||
4420365|NCT00190775|4244023|B1|Child Other Discipline Practice||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|17.62|17.62|Standard Deviation|3.52|3.52|||
4420417|NCT00190775|4244021|B3|Other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4420366|NCT00190775|4244021|B3|Child Corporal Punishment||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|4.92|4.92|Standard Deviation|2.22|2.22|||
4420367|NCT00190775|4244022|B2|Child Corporal Punishment||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|4.99|4.99|Standard Deviation|2.37|2.37|||
4420368|NCT00190775|4244023|B1|Child Corporal Punishment||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|4.86|4.86|Standard Deviation|2.08|2.08|||
4420369|NCT00190775|4244021|B3|Child Inconsistent Discipline||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|12.83|12.83|Standard Deviation|3.50|3.5|||
4420370|NCT00190775|4244022|B2|Child Inconsistent Discipline||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|13.01|13.01|Standard Deviation|3.57|3.57|||
4420371|NCT00190775|4244023|B1|Child Inconsistent Discipline||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|12.66|12.66|Standard Deviation|3.44|3.44|||
4420372|NCT00190775|4244021|B3|Child Poor Monitoring/Supervision||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|17.09|17.09|Standard Deviation|5.12|5.12|||
4420373|NCT00190775|4244022|B2|Child Poor Monitoring/Supervision||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|17.27|17.27|Standard Deviation|5.34|5.34|||
4420374|NCT00190775|4244023|B1|Child Poor Monitoring/Supervision||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|16.93|16.93|Standard Deviation|4.92|4.92|||
4420375|NCT00190775|4244021|B3|Child Positive Parenting||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|23.64|23.64|Standard Deviation|4.03|4.03|||
4420418|NCT00190775|4244022|B2|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4420376|NCT00190775|4244022|B2|Child Positive Parenting||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|23.40|23.4|Standard Deviation|4.02|4.02|||
4420377|NCT00190775|4244023|B1|Child Positive Parenting||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|23.85|23.85|Standard Deviation|4.04|4.04|||
4420378|NCT00190775|4244021|B3|Child Involvement Father||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|31.90|31.9|Standard Deviation|6.86|6.86|||
4420379|NCT00190775|4244022|B2|Child Involvement Father||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|32.35|32.35|Standard Deviation|6.86|6.86|||
4420380|NCT00190775|4244023|B1|Child Involvement Father||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|31.50|31.5|Standard Deviation|6.85|6.85|||
4420381|NCT00190775|4244021|B3|Child Involvement Mother||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|35.67|35.67|Standard Deviation|5.97|5.97|||
4420382|NCT00190775|4244022|B2|Child Involvement Mother||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|36.09|36.09|Standard Deviation|5.90|5.9|||
4420383|NCT00190775|4244023|B1|Child Involvement Mother||Alabama Parenting Questionnaire (APQ)|42-item scale, 3 subscales (z-scores [-2 to 2]): Dysfunctional/Negative/Positive Parenting. Each construct rated 1=never/5=always (# items): involvement (10), supervision (10), positive parenting (6), inconsistent discipline (6), other discipline (7), harsh discipline (3). Higher scores indicate impairment: dysfunctional/negative parenting composite; supervision, inconsistent discipline, harsh punishment, other discipline. Lower scores indicate impairment: positive parenting composite; positive parenting, involvement. Completed by participants with a child 6-12 or 13-17 years living at home.|Units on a scale|Mean|35.30|35.3|Standard Deviation|6.02|6.02|||
4420384|NCT00190775|4244021|B3|AISRS Hyperactivity Score||Adult Attention Deficit Hyperactivity Disorder (ADHD) Investigator Symptom Rating Scale (AISRS)|18-item scale that captures the 18-item Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) symptoms of ADHD. 9 inattentive items alternate with 9 hyperactive/impulsive items. Each item is scored 0 (none), 1 (mild), 2 (moderate), or 3 (severe). The total score range is 0-54 (0-27 for each subscale). Higher scores indicate more impaired participants. The scale was administered by a physician or PhD at the investigative site.|Units on a scale|Mean|15.54|15.54|Standard Deviation|5.85|5.85|||
4420385|NCT00190775|4244022|B2|AISRS Hyperactivity Score||Adult Attention Deficit Hyperactivity Disorder (ADHD) Investigator Symptom Rating Scale (AISRS)|18-item scale that captures the 18-item Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) symptoms of ADHD. 9 inattentive items alternate with 9 hyperactive/impulsive items. Each item is scored 0 (none), 1 (mild), 2 (moderate), or 3 (severe). The total score range is 0-54 (0-27 for each subscale). Higher scores indicate more impaired participants. The scale was administered by a physician or PhD at the investigative site.|Units on a scale|Mean|15.97|15.97|Standard Deviation|5.94|5.94|||
4420419|NCT00190775|4244023|B1|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4420420|NCT00190775|4244021|B3|Western Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4420386|NCT00190775|4244023|B1|AISRS Hyperactivity Score||Adult Attention Deficit Hyperactivity Disorder (ADHD) Investigator Symptom Rating Scale (AISRS)|18-item scale that captures the 18-item Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) symptoms of ADHD. 9 inattentive items alternate with 9 hyperactive/impulsive items. Each item is scored 0 (none), 1 (mild), 2 (moderate), or 3 (severe). The total score range is 0-54 (0-27 for each subscale). Higher scores indicate more impaired participants. The scale was administered by a physician or PhD at the investigative site.|Units on a scale|Mean|15.16|15.16|Standard Deviation|5.75|5.75|||
4420387|NCT00190775|4244021|B3|AISRS Inattention Score||Adult Attention Deficit Hyperactivity Disorder (ADHD) Investigator Symptom Rating Scale (AISRS)|18-item scale that captures the 18-item Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) symptoms of ADHD. 9 inattentive items alternate with 9 hyperactive/impulsive items. Each item is scored 0 (none), 1 (mild), 2 (moderate), or 3 (severe). The total score range is 0-54 (0-27 for each subscale). Higher scores indicate more impaired participants. The scale was administered by a physician or PhD at the investigative site.|Units on a scale|Mean|20.77|20.77|Standard Deviation|3.92|3.92|||
4420388|NCT00190775|4244022|B2|AISRS Inattention Score||Adult Attention Deficit Hyperactivity Disorder (ADHD) Investigator Symptom Rating Scale (AISRS)|18-item scale that captures the 18-item Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) symptoms of ADHD. 9 inattentive items alternate with 9 hyperactive/impulsive items. Each item is scored 0 (none), 1 (mild), 2 (moderate), or 3 (severe). The total score range is 0-54 (0-27 for each subscale). Higher scores indicate more impaired participants. The scale was administered by a physician or PhD at the investigative site.|Units on a scale|Mean|20.62|20.62|Standard Deviation|4.02|4.02|||
4420389|NCT00190775|4244023|B1|AISRS Inattention Score||Adult Attention Deficit Hyperactivity Disorder (ADHD) Investigator Symptom Rating Scale (AISRS)|18-item scale that captures the 18-item Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) symptoms of ADHD. 9 inattentive items alternate with 9 hyperactive/impulsive items. Each item is scored 0 (none), 1 (mild), 2 (moderate), or 3 (severe). The total score range is 0-54 (0-27 for each subscale). Higher scores indicate more impaired participants. The scale was administered by a physician or PhD at the investigative site.|Units on a scale|Mean|20.91|20.91|Standard Deviation|3.83|3.83|||
4420390|NCT00190775|4244021|B3|AISRS Total Score||Adult Attention Deficit Hyperactivity Disorder (ADHD) Investigator Symptom Rating Scale (AISRS)|18-item scale that captures the 18-item Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) symptoms of ADHD. 9 inattentive items alternate with 9 hyperactive/impulsive items. Each item is scored 0 (none), 1 (mild), 2 (moderate), or 3 (severe). The total score range is 0-54 (0-27 for each subscale). Higher scores indicate more impaired participants. The scale was administered by a physician or PhD at the investigative site.|Units on a scale|Mean|36.31|36.31|Standard Deviation|7.97|7.97|||
4420391|NCT00190775|4244022|B2|AISRS Total Score||Adult Attention Deficit Hyperactivity Disorder (ADHD) Investigator Symptom Rating Scale (AISRS)|18-item scale that captures the 18-item Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) symptoms of ADHD. 9 inattentive items alternate with 9 hyperactive/impulsive items. Each item is scored 0 (none), 1 (mild), 2 (moderate), or 3 (severe). The total score range is 0-54 (0-27 for each subscale). Higher scores indicate more impaired participants. The scale was administered by a physician or PhD at the investigative site.|Units on a scale|Mean|36.59|36.59|Standard Deviation|8.34|8.34|||
4420392|NCT00190775|4244023|B1|AISRS Total Score||Adult Attention Deficit Hyperactivity Disorder (ADHD) Investigator Symptom Rating Scale (AISRS)|18-item scale that captures the 18-item Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) symptoms of ADHD. 9 inattentive items alternate with 9 hyperactive/impulsive items. Each item is scored 0 (none), 1 (mild), 2 (moderate), or 3 (severe). The total score range is 0-54 (0-27 for each subscale). Higher scores indicate more impaired participants. The scale was administered by a physician or PhD at the investigative site.|Units on a scale|Mean|36.07|36.07|Standard Deviation|7.64|7.64|||
4420393|NCT00190775|4244021|B3|Unknown or Not Reported||Previous Stimulant Exposure||Participants|Number|2|2.0||||||
4420394|NCT00190775|4244022|B2|Unknown or Not Reported||Previous Stimulant Exposure||Participants|Number|1|1.0||||||
4420395|NCT00190775|4244023|B1|Unknown or Not Reported||Previous Stimulant Exposure||Participants|Number|1|1.0||||||
4420396|NCT00190775|4244021|B3|No||Previous Stimulant Exposure||Participants|Number|418|418.0||||||
4420397|NCT00190775|4244022|B2|No||Previous Stimulant Exposure||Participants|Number|198|198.0||||||
4420398|NCT00190775|4244023|B1|No||Previous Stimulant Exposure||Participants|Number|220|220.0||||||
4420399|NCT00190775|4244021|B3|Yes||Previous Stimulant Exposure||Participants|Number|82|82.0||||||
4420400|NCT00190775|4244022|B2|Yes||Previous Stimulant Exposure||Participants|Number|35|35.0||||||
4420401|NCT00190775|4244023|B1|Yes||Previous Stimulant Exposure||Participants|Number|47|47.0||||||
4420402|NCT00190775|4244021|B3|Hyperactive/Impulsive||Attention Deficit Hyperactivity Disorder (ADHD) Subtype||Participants|Number|1|1.0||||||
4420403|NCT00190775|4244022|B2|Hyperactive/Impulsive||Attention Deficit Hyperactivity Disorder (ADHD) Subtype||Participants|Number|1|1.0||||||
4420404|NCT00190775|4244023|B1|Hyperactive/Impulsive||Attention Deficit Hyperactivity Disorder (ADHD) Subtype||Participants|Number|0|0.0||||||
4420405|NCT00190775|4244021|B3|Inattentive||Attention Deficit Hyperactivity Disorder (ADHD) Subtype||Participants|Number|156|156.0||||||
4420406|NCT00190775|4244022|B2|Inattentive||Attention Deficit Hyperactivity Disorder (ADHD) Subtype||Participants|Number|67|67.0||||||
4420407|NCT00190775|4244023|B1|Inattentive||Attention Deficit Hyperactivity Disorder (ADHD) Subtype||Participants|Number|89|89.0||||||
4420408|NCT00190775|4244021|B3|Combined||Attention Deficit Hyperactivity Disorder (ADHD) Subtype||Participants|Number|345|345.0||||||
4420409|NCT00190775|4244022|B2|Combined||Attention Deficit Hyperactivity Disorder (ADHD) Subtype||Participants|Number|166|166.0||||||
4420410|NCT00190775|4244023|B1|Combined||Attention Deficit Hyperactivity Disorder (ADHD) Subtype||Participants|Number|179|179.0||||||
4420411|NCT00190775|4244021|B3|Puerto Rico||Region of Enrollment||Participants|Number|23|23.0||||||
4420412|NCT00190775|4244022|B2|Puerto Rico||Region of Enrollment||Participants|Number|10|10.0||||||
4420413|NCT00190775|4244023|B1|Puerto Rico||Region of Enrollment||Participants|Number|13|13.0||||||
4420414|NCT00190775|4244021|B3|United States||Region of Enrollment||Participants|Number|479|479.0||||||
4420444|NCT00190749|4244093|B3|||Extrapyramidal Scores/Simpson-Angus-Baseline|Measures neuroleptic-induced parkinsonism. Total score of Simpson Angus Scale consists of the sum of 10 itemsrated on a 5-point severity scale where 0=normal and 4=extreme. The total score ranges from 0 to 40.|units on a scale|Mean|0.94|0.94|Standard Deviation|1.83|1.83|||
4420445|NCT00190749|4244094|B2|||Extrapyramidal Scores/Simpson-Angus-Baseline|Measures neuroleptic-induced parkinsonism. Total score of Simpson Angus Scale consists of the sum of 10 itemsrated on a 5-point severity scale where 0=normal and 4=extreme. The total score ranges from 0 to 40.|units on a scale|Mean|0.90|0.9|Standard Deviation|1.80|1.8|||
4420446|NCT00190749|4244095|B1|||Extrapyramidal Scores/Simpson-Angus-Baseline|Measures neuroleptic-induced parkinsonism. Total score of Simpson Angus Scale consists of the sum of 10 itemsrated on a 5-point severity scale where 0=normal and 4=extreme. The total score ranges from 0 to 40.|units on a scale|Mean|0.97|0.97|Standard Deviation|1.87|1.87|||
4420447|NCT00190749|4244093|B3|||Extrapyramidal Scores/Barnes Akathisia Rating Scale (BARS) Global Clinical Assessment-Baseline|The BARS is a 4-item instrument that evaluates akathisia associated with use of antipsychotic medications. Item 4 is the Global clinical assessment and is rated 0 to 5 (0 = absent, 5 = severe).|units on a scale|Mean|0.29|0.29|Standard Deviation|0.67|0.67|||
4420448|NCT00190749|4244094|B2|||Extrapyramidal Scores/Barnes Akathisia Rating Scale (BARS) Global Clinical Assessment-Baseline|The BARS is a 4-item instrument that evaluates akathisia associated with use of antipsychotic medications. Item 4 is the Global clinical assessment and is rated 0 to 5 (0 = absent, 5 = severe).|units on a scale|Mean|0.32|0.32|Standard Deviation|0.67|0.67|||
4420449|NCT00190749|4244095|B1|||Extrapyramidal Scores/Barnes Akathisia Rating Scale (BARS) Global Clinical Assessment-Baseline|The BARS is a 4-item instrument that evaluates akathisia associated with use of antipsychotic medications. Item 4 is the Global clinical assessment and is rated 0 to 5 (0 = absent, 5 = severe).|units on a scale|Mean|0.27|0.27|Standard Deviation|0.66|0.66|||
4420450|NCT00190749|4244093|B3|||Extrapyramidal Scores/Abnormal Involuntary Movement-Baseline|A 12-item instrument assesses observed abnormal movements in different parts of body. Seven items are scored in a 5-point scale (0 = none/normal, 4 = severe) which evaluates abnormal movements in 3 main anatomic areas (orofacial area, extremities, and trunk). Total scores range from 0 to 28. Five collected elements are not used in this total.|units on a scale|Mean|0.44|0.44|Standard Deviation|1.13|1.13|||
4420451|NCT00190749|4244094|B2|||Extrapyramidal Scores/Abnormal Involuntary Movement-Baseline|A 12-item instrument assesses observed abnormal movements in different parts of body. Seven items are scored in a 5-point scale (0 = none/normal, 4 = severe) which evaluates abnormal movements in 3 main anatomic areas (orofacial area, extremities, and trunk). Total scores range from 0 to 28. Five collected elements are not used in this total.|units on a scale|Mean|0.47|0.47|Standard Deviation|1.13|1.13|||
4420452|NCT00190749|4244095|B1|||Extrapyramidal Scores/Abnormal Involuntary Movement-Baseline|A 12-item instrument assesses observed abnormal movements in different parts of body. Seven items are scored in a 5-point scale (0 = none/normal, 4 = severe) which evaluates abnormal movements in 3 main anatomic areas (orofacial area, extremities, and trunk). Total scores range from 0 to 28. Five collected elements are not used in this total.|units on a scale|Mean|0.42|0.42|Standard Deviation|1.14|1.14|||
4420453|NCT00190749|4244093|B3|||Clinical Global Impression Severity Score- Baseline|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|3.66|3.66|Standard Deviation|0.54|0.54|||
4420454|NCT00190749|4244094|B2|||Clinical Global Impression Severity Score- Baseline|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|3.65|3.65|Standard Deviation|0.52|0.52|||
4420455|NCT00190749|4244095|B1|||Clinical Global Impression Severity Score- Baseline|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|3.68|3.68|Standard Deviation|0.56|0.56|||
4420456|NCT00190749|4244093|B3|||Brief Psychiatric Rating Scale Total Score-Baseline|Brief Psychiatric Rating Scale (BPRS) Total Score is an 18-item clinician-administered scale used to assess the degree of severity of a subject's general psychopathological symptoms. Item scores range from 0 (not present) to 6 (extremely severe). Total Scores range from 0 to 108.|units on a scale|Mean|14.99|14.99|Standard Deviation|6.04|6.04|||
4420457|NCT00190749|4244094|B2|||Brief Psychiatric Rating Scale Total Score-Baseline|Brief Psychiatric Rating Scale (BPRS) Total Score is an 18-item clinician-administered scale used to assess the degree of severity of a subject's general psychopathological symptoms. Item scores range from 0 (not present) to 6 (extremely severe). Total Scores range from 0 to 108.|units on a scale|Mean|14.29|14.29|Standard Deviation|6.00|6.0|||
4420458|NCT00190749|4244095|B1|||Brief Psychiatric Rating Scale Total Score-Baseline|Brief Psychiatric Rating Scale (BPRS) Total Score is an 18-item clinician-administered scale used to assess the degree of severity of a subject's general psychopathological symptoms. Item scores range from 0 (not present) to 6 (extremely severe). Total Scores range from 0 to 108.|units on a scale|Mean|15.63|15.63|Standard Deviation|6.06|6.06|||
4420459|NCT00190749|4244093|B3|||Brief Psychiatric Rating Scale Positive Symptom Score-Baseline|Brief Psychiatric Rating Scale (BPRS) Positive Score assesses the degree of severity of a subject's positive symptoms. BPRS Positive Score is the sum of Item Scores 4, 11, 12, and 15. Item scores range from 0 (not present) to 6 (extremely severe). Total Scores for Positive Score range from 0 to 24.|units on a scale|Mean|5.43|5.43|Standard Deviation|2.60|2.6|||
4420460|NCT00190749|4244094|B2|||Brief Psychiatric Rating Scale Positive Symptom Score-Baseline|Brief Psychiatric Rating Scale (BPRS) Positive Score assesses the degree of severity of a subject's positive symptoms. BPRS Positive Score is the sum of Item Scores 4, 11, 12, and 15. Item scores range from 0 (not present) to 6 (extremely severe). Total Scores for Positive Score range from 0 to 24.|units on a scale|Mean|5.47|5.47|Standard Deviation|2.52|2.52|||
4420461|NCT00190749|4244095|B1|||Brief Psychiatric Rating Scale Positive Symptom Score-Baseline|Brief Psychiatric Rating Scale (BPRS) Positive Score assesses the degree of severity of a subject's positive symptoms. BPRS Positive Score is the sum of Item Scores 4, 11, 12, and 15. Item scores range from 0 (not present) to 6 (extremely severe). Total Scores for Positive Score range from 0 to 24.|units on a scale|Mean|5.40|5.4|Standard Deviation|2.69|2.69|||
4420558|NCT00190671|4244181|B1|Missing||Progesterone-Receptor Status||participants|Number|3|3.0||||||
4420462|NCT00190749|4244093|B3|||Brief Psychiatric Rating Scale Negative Symptom Score-Baseline|Brief Psychiatric Rating Scale (BPRS) Negative Score assesses the degree of severity of a subject's negative symptoms. BPRS Negative Score is the sum of Item Scores 3, 13, and 16. Item scores range from 0 (not present) to 6 (extremely severe). Total Scores for Negative Score range from 0 to 18.|units on a scale|Mean|2.09|2.09|Standard Deviation|1.89|1.89|||
4420463|NCT00190749|4244094|B2|||Brief Psychiatric Rating Scale Negative Symptom Score-Baseline|Brief Psychiatric Rating Scale (BPRS) Negative Score assesses the degree of severity of a subject's negative symptoms. BPRS Negative Score is the sum of Item Scores 3, 13, and 16. Item scores range from 0 (not present) to 6 (extremely severe). Total Scores for Negative Score range from 0 to 18.|units on a scale|Mean|1.89|1.89|Standard Deviation|1.79|1.79|||
4420464|NCT00190749|4244095|B1|||Brief Psychiatric Rating Scale Negative Symptom Score-Baseline|Brief Psychiatric Rating Scale (BPRS) Negative Score assesses the degree of severity of a subject's negative symptoms. BPRS Negative Score is the sum of Item Scores 3, 13, and 16. Item scores range from 0 (not present) to 6 (extremely severe). Total Scores for Negative Score range from 0 to 18.|units on a scale|Mean|2.28|2.28|Standard Deviation|1.98|1.98|||
4420465|NCT00190749|4244093|B3|||Brief Psychiatric Rating Scale Anxiety Depression Score-Baseline|Brief Psychiatric Rating Scale (BPRS) Anxiety-Depression Score assesses the degree of severity of a subject's anxiety-depression symptoms. BPRS Anxiety-Depression Score is the sum of Item Scores 1, 2, 5 and 9. Item scores range from 0 (not present) to 6 (extremely severe). Total Scores for Anxiety-Depression range from 0 to 24.|units on a scale|Mean|4.12|4.12|Standard Deviation|2.33|2.33|||
4420466|NCT00190749|4244094|B2|||Brief Psychiatric Rating Scale Anxiety Depression Score-Baseline|Brief Psychiatric Rating Scale (BPRS) Anxiety-Depression Score assesses the degree of severity of a subject's anxiety-depression symptoms. BPRS Anxiety-Depression Score is the sum of Item Scores 1, 2, 5 and 9. Item scores range from 0 (not present) to 6 (extremely severe). Total Scores for Anxiety-Depression range from 0 to 24.|units on a scale|Mean|3.74|3.74|Standard Deviation|2.13|2.13|||
4420467|NCT00190749|4244095|B1|||Brief Psychiatric Rating Scale Anxiety Depression Score-Baseline|Brief Psychiatric Rating Scale (BPRS) Anxiety-Depression Score assesses the degree of severity of a subject's anxiety-depression symptoms. BPRS Anxiety-Depression Score is the sum of Item Scores 1, 2, 5 and 9. Item scores range from 0 (not present) to 6 (extremely severe). Total Scores for Anxiety-Depression range from 0 to 24.|units on a scale|Mean|4.46|4.46|Standard Deviation|2.46|2.46|||
4420468|NCT00190749|4244093|B3|Other||Race/Ethnicity||participants|Number|3|3.0||||||
4420469|NCT00190749|4244094|B2|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4420470|NCT00190749|4244095|B1|Other||Race/Ethnicity||participants|Number|2|2.0||||||
4420471|NCT00190749|4244093|B3|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4420472|NCT00190749|4244094|B2|East Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4420473|NCT00190749|4244095|B1|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4420474|NCT00190749|4244093|B3|Hispanic||Race/Ethnicity||participants|Number|9|9.0||||||
4420475|NCT00190749|4244094|B2|Hispanic||Race/Ethnicity||participants|Number|5|5.0||||||
4420476|NCT00190749|4244095|B1|Hispanic||Race/Ethnicity||participants|Number|4|4.0||||||
4420477|NCT00190749|4244093|B3|African descent||Race/Ethnicity||participants|Number|60|60.0||||||
4420478|NCT00190749|4244094|B2|African descent||Race/Ethnicity||participants|Number|26|26.0||||||
4420479|NCT00190749|4244095|B1|African descent||Race/Ethnicity||participants|Number|34|34.0||||||
4420480|NCT00190749|4244093|B3|Caucasian||Race/Ethnicity||participants|Number|57|57.0||||||
4420481|NCT00190749|4244094|B2|Caucasian||Race/Ethnicity||participants|Number|30|30.0||||||
4420482|NCT00190749|4244095|B1|Caucasian||Race/Ethnicity||participants|Number|27|27.0||||||
4420483|NCT00190749|4244093|B3|Schizophrenia, undifferentiated||Diagnosis||participants|Number|2|2.0||||||
4420484|NCT00190749|4244094|B2|Schizophrenia, undifferentiated||Diagnosis||participants|Number|1|1.0||||||
4420485|NCT00190749|4244095|B1|Schizophrenia, undifferentiated||Diagnosis||participants|Number|1|1.0||||||
4420486|NCT00190749|4244093|B3|Schizoaffective disorder||Diagnosis||participants|Number|43|43.0||||||
4420487|NCT00190749|4244094|B2|Schizoaffective disorder||Diagnosis||participants|Number|16|16.0||||||
4420488|NCT00190749|4244095|B1|Schizoaffective disorder||Diagnosis||participants|Number|27|27.0||||||
4420489|NCT00190749|4244093|B3|Schizophrenia,paranoid||Diagnosis||participants|Number|85|85.0||||||
4420490|NCT00190749|4244094|B2|Schizophrenia,paranoid||Diagnosis||participants|Number|45|45.0||||||
4420491|NCT00190749|4244095|B1|Schizophrenia,paranoid||Diagnosis||participants|Number|40|40.0||||||
4420492|NCT00190749|4244093|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4420493|NCT00190749|4244094|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
4420494|NCT00190749|4244095|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4420495|NCT00190749|4244093|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4420496|NCT00190749|4244094|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4420497|NCT00190749|4244095|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4420498|NCT00190749|4244093|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4420499|NCT00190749|4244094|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4420500|NCT00190749|4244095|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4420501|NCT00190749|4244093|B3|||Age||years|Mean|43.06|43.06|Standard Deviation|9.20|9.2|||
4420502|NCT00190749|4244094|B2|||Age||years|Mean|42.58|42.58|Standard Deviation|8.98|8.98|||
4420503|NCT00190749|4244095|B1|||Age||years|Mean|43.49|43.49|Standard Deviation|9.45|9.45|||
4420504|NCT00190684|4244160|B1|Unknown||Attention Deficit Hyperactive Disorder (ADHD) Subtype|Summary of baseline characteristics is based on 1553 participants, but only 1547 participants have non-missing baseline measurement of ADHD subtype diagnosis.|participants|Number|6|6.0||||||
4420559|NCT00190671|4244179|B3|Unknown||Progesterone-Receptor Status||participants|Number|11.0|11.0||||||
4420560|NCT00190671|4244180|B2|Unknown||Progesterone-Receptor Status||participants|Number|4|4.0||||||
4420505|NCT00190684|4244160|B1|Not Applicable||Attention Deficit Hyperactive Disorder (ADHD) Subtype|Summary of baseline characteristics is based on 1553 participants, but only 1547 participants have non-missing baseline measurement of ADHD subtype diagnosis.|participants|Number|72|72.0||||||
4420506|NCT00190684|4244160|B1|Combined||Attention Deficit Hyperactive Disorder (ADHD) Subtype|Summary of baseline characteristics is based on 1553 participants, but only 1547 participants have non-missing baseline measurement of ADHD subtype diagnosis.|participants|Number|1016|1016.0||||||
4420507|NCT00190684|4244160|B1|Hyperactive/Impulsive||Attention Deficit Hyperactive Disorder (ADHD) Subtype|Summary of baseline characteristics is based on 1553 participants, but only 1547 participants have non-missing baseline measurement of ADHD subtype diagnosis.|participants|Number|46|46.0||||||
4420508|NCT00190684|4244160|B1|Inattentive||Attention Deficit Hyperactive Disorder (ADHD) Subtype|Summary of baseline characteristics is based on 1553 participants, but only 1547 participants have non-missing baseline measurement of ADHD subtype diagnosis.|participants|Number|413|413.0||||||
4420509|NCT00190684|4244160|B1|||Weight|Summary of baseline characteristics is based on 1553 participants, but only 1548 participants have non-missing baseline measurement of weight.|kilograms (kg)|Mean|43.73|43.73|Standard Deviation|16.03|16.03|||
4420510|NCT00190684|4244160|B1|||Height|Summary of baseline characteristics is based on 1553 participants, but only 1527 participants have non-missing baseline measurement of height.|centimeters (cm)|Mean|147.89|147.89|Standard Deviation|15.72|15.72|||
4420511|NCT00190684|4244160|B1|Spain||Region of Enrollment||participants|Number|23|23.0||||||
4420512|NCT00190684|4244160|B1|Sweden||Region of Enrollment||participants|Number|27|27.0||||||
4420513|NCT00190684|4244160|B1|Norway||Region of Enrollment||participants|Number|13|13.0||||||
4420514|NCT00190684|4244160|B1|Netherlands||Region of Enrollment||participants|Number|15|15.0||||||
4420515|NCT00190684|4244160|B1|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4420516|NCT00190684|4244160|B1|South Africa||Region of Enrollment||participants|Number|19|19.0||||||
4420517|NCT00190684|4244160|B1|Australia||Region of Enrollment||participants|Number|22|22.0||||||
4420518|NCT00190684|4244160|B1|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
4420519|NCT00190684|4244160|B1|Puerto Rico||Region of Enrollment||participants|Number|19|19.0||||||
4420520|NCT00190684|4244160|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4420521|NCT00190684|4244160|B1|France||Region of Enrollment||participants|Number|21|21.0||||||
4420522|NCT00190684|4244160|B1|Italy||Region of Enrollment||participants|Number|11|11.0||||||
4420523|NCT00190684|4244160|B1|United Kingdom||Region of Enrollment||participants|Number|24|24.0||||||
4420524|NCT00190684|4244160|B1|Israel||Region of Enrollment||participants|Number|16|16.0||||||
4420525|NCT00190684|4244160|B1|United States||Region of Enrollment||participants|Number|1288|1288.0||||||
4420526|NCT00190684|4244160|B1|Other||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4420527|NCT00190684|4244160|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4420528|NCT00190684|4244160|B1|Western Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4420529|NCT00190684|4244160|B1|East/ Southeast Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4420530|NCT00190684|4244160|B1|African Descent||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4420531|NCT00190684|4244160|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|1317|1317.0||||||
4420532|NCT00190684|4244160|B1||Male|Sex: Female, Male||Participants|Count of Participants|1215|1215.0||||||
4420533|NCT00190684|4244160|B1||Female|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4420534|NCT00190684|4244160|B1|||Age||years|Mean|11.62|11.62|Standard Deviation|2.6|2.6|||
4420535|NCT00190671|4244179|B3|||Weight||kilograms|Median|70.0|70.0|Full Range|||45.0|120.0|
4420536|NCT00190671|4244180|B2|||Weight||kilograms|Median|70.0|70.0|Full Range|||45.0|120.0|
4420537|NCT00190671|4244181|B1|||Weight||kilograms|Median|71.5|71.5|Full Range|||50.0|104.0|
4420538|NCT00190671|4244179|B3|||Height||centimeters|Median|160.0|160.0|Full Range|||143.0|180.0|
4420539|NCT00190671|4244180|B2|||Height||centimeters|Median|160.0|160.0|Full Range|||143.0|180.0|
4420540|NCT00190671|4244181|B1|||Height||centimeters|Median|160.0|160.0|Full Range|||148.0|176.0|
4420541|NCT00190671|4244179|B3|||Body Surface Area||square meters|Median|1.7|1.7|Full Range|||1.4|2.4|
4420542|NCT00190671|4244180|B2|||Body Surface Area||square meters|Median|1.7|1.7|Full Range|||1.4|2.4|
4420543|NCT00190671|4244181|B1|||Body Surface Area||square meters|Median|1.8|1.8|Full Range|||1.4|2.1|
4420544|NCT00190671|4244179|B3|2 - Symptomatic, ambulatory, no work activities||World Health Organization Performance Status||participants|Number|5.0|5.0||||||
4420545|NCT00190671|4244180|B2|2 - Symptomatic, ambulatory, no work activities||World Health Organization Performance Status||participants|Number|3|3.0||||||
4420546|NCT00190671|4244181|B1|2 - Symptomatic, ambulatory, no work activities||World Health Organization Performance Status||participants|Number|2|2.0||||||
4420547|NCT00190671|4244179|B3|1 - Symptomatic, fully ambulatory, light activity||World Health Organization Performance Status||participants|Number|40.0|40.0||||||
4420548|NCT00190671|4244180|B2|1 - Symptomatic, fully ambulatory, light activity||World Health Organization Performance Status||participants|Number|18|18.0||||||
4420549|NCT00190671|4244181|B1|1 - Symptomatic, fully ambulatory, light activity||World Health Organization Performance Status||participants|Number|22|22.0||||||
4420550|NCT00190671|4244179|B3|0 - Asymptomatic, fully active||World Health Organization Performance Status||participants|Number|58.0|58.0||||||
4420551|NCT00190671|4244180|B2|0 - Asymptomatic, fully active||World Health Organization Performance Status||participants|Number|40|40.0||||||
4420552|NCT00190671|4244181|B1|0 - Asymptomatic, fully active||World Health Organization Performance Status||participants|Number|18|18.0||||||
4420553|NCT00190671|4244179|B3|Caucasian||Race/Ethnicity||participants|Number|103.0|103.0||||||
4420554|NCT00190671|4244180|B2|Caucasian||Race/Ethnicity||participants|Number|61|61.0||||||
4420555|NCT00190671|4244181|B1|Caucasian||Race/Ethnicity||participants|Number|42|42.0||||||
4420562|NCT00190671|4244179|B3|Negative||Progesterone-Receptor Status||participants|Number|36.0|36.0||||||
4420563|NCT00190671|4244180|B2|Negative||Progesterone-Receptor Status||participants|Number|23|23.0||||||
4420564|NCT00190671|4244181|B1|Negative||Progesterone-Receptor Status||participants|Number|13|13.0||||||
4420565|NCT00190671|4244179|B3|Positive||Progesterone-Receptor Status||participants|Number|44.0|44.0||||||
4420566|NCT00190671|4244180|B2|Positive||Progesterone-Receptor Status||participants|Number|25|25.0||||||
4420567|NCT00190671|4244181|B1|Positive||Progesterone-Receptor Status||participants|Number|19|19.0||||||
4420568|NCT00190671|4244179|B3|Other||Pathological Diagnosis||participant|Number|42.0|42.0||||||
4420569|NCT00190671|4244180|B2|Other||Pathological Diagnosis||participant|Number|24|24.0||||||
4420570|NCT00190671|4244181|B1|Other||Pathological Diagnosis||participant|Number|18|18.0||||||
4420571|NCT00190671|4244179|B3|Adenocarcinoma of the Breast||Pathological Diagnosis||participant|Number|44.0|44.0||||||
4420572|NCT00190671|4244180|B2|Adenocarcinoma of the Breast||Pathological Diagnosis||participant|Number|27|27.0||||||
4420573|NCT00190671|4244181|B1|Adenocarcinoma of the Breast||Pathological Diagnosis||participant|Number|17|17.0||||||
4420574|NCT00190671|4244179|B3|Inflammatory Breast Carcinoma||Pathological Diagnosis||participant|Number|17.0|17.0||||||
4420575|NCT00190671|4244180|B2|Inflammatory Breast Carcinoma||Pathological Diagnosis||participant|Number|10|10.0||||||
4420576|NCT00190671|4244181|B1|Inflammatory Breast Carcinoma||Pathological Diagnosis||participant|Number|7|7.0||||||
4420577|NCT00190671|4244179|B3|Not Done||Human Epidermal Growth Factor Receptor 2 (HER-2/NEU) Status||participants|Number|41.0|41.0||||||
4420578|NCT00190671|4244180|B2|Not Done||Human Epidermal Growth Factor Receptor 2 (HER-2/NEU) Status||participants|Number|23|23.0||||||
4420579|NCT00190671|4244181|B1|Not Done||Human Epidermal Growth Factor Receptor 2 (HER-2/NEU) Status||participants|Number|18|18.0||||||
4420580|NCT00190671|4244179|B3|Unknown||Human Epidermal Growth Factor Receptor 2 (HER-2/NEU) Status||participants|Number|17.0|17.0||||||
4420581|NCT00190671|4244180|B2|Unknown||Human Epidermal Growth Factor Receptor 2 (HER-2/NEU) Status||participants|Number|8|8.0||||||
4420582|NCT00190671|4244181|B1|Unknown||Human Epidermal Growth Factor Receptor 2 (HER-2/NEU) Status||participants|Number|9|9.0||||||
4420583|NCT00190671|4244179|B3|Negative||Human Epidermal Growth Factor Receptor 2 (HER-2/NEU) Status||participants|Number|38.0|38.0||||||
4420584|NCT00190671|4244180|B2|Negative||Human Epidermal Growth Factor Receptor 2 (HER-2/NEU) Status||participants|Number|27|27.0||||||
4420585|NCT00190671|4244181|B1|Negative||Human Epidermal Growth Factor Receptor 2 (HER-2/NEU) Status||participants|Number|11|11.0||||||
4420586|NCT00190671|4244179|B3|Positive||Human Epidermal Growth Factor Receptor 2 (HER-2/NEU) Status||participants|Number|7.0|7.0||||||
4420587|NCT00190671|4244180|B2|Positive||Human Epidermal Growth Factor Receptor 2 (HER-2/NEU) Status||participants|Number|3|3.0||||||
4420588|NCT00190671|4244181|B1|Positive||Human Epidermal Growth Factor Receptor 2 (HER-2/NEU) Status||participants|Number|4|4.0||||||
4420589|NCT00190671|4244179|B3|Missing||Estrogen-Receptor Status||participants|Number|12.0|12.0||||||
4420590|NCT00190671|4244180|B2|Missing||Estrogen-Receptor Status||participants|Number|9|9.0||||||
4420591|NCT00190671|4244181|B1|Missing||Estrogen-Receptor Status||participants|Number|3|3.0||||||
4420592|NCT00190671|4244179|B3|Unknown||Estrogen-Receptor Status||participants|Number|11.0|11.0||||||
4420593|NCT00190671|4244180|B2|Unknown||Estrogen-Receptor Status||participants|Number|4|4.0||||||
4420594|NCT00190671|4244181|B1|Unknown||Estrogen-Receptor Status||participants|Number|7|7.0||||||
4420595|NCT00190671|4244179|B3|Negative||Estrogen-Receptor Status||participants|Number|31.0|31.0||||||
4420596|NCT00190671|4244180|B2|Negative||Estrogen-Receptor Status||participants|Number|21|21.0||||||
4420597|NCT00190671|4244181|B1|Negative||Estrogen-Receptor Status||participants|Number|10|10.0||||||
4420598|NCT00190671|4244179|B3|Positive||Estrogen-Receptor Status||participants|Number|49.0|49.0||||||
4420599|NCT00190671|4244180|B2|Positive||Estrogen-Receptor Status||participants|Number|27|27.0||||||
4420600|NCT00190671|4244181|B1|Positive||Estrogen-Receptor Status||participants|Number|22|22.0||||||
4420601|NCT00190671|4244179|B3|Russian Federation||Region of Enrollment||participants|Number|25.0|25.0||||||
4420602|NCT00190671|4244180|B2|Russian Federation||Region of Enrollment||participants|Number|17|17.0||||||
4420603|NCT00190671|4244181|B1|Russian Federation||Region of Enrollment||participants|Number|8|8.0||||||
4420604|NCT00190671|4244179|B3|Austria||Region of Enrollment||participants|Number|14.0|14.0||||||
4420605|NCT00190671|4244180|B2|Austria||Region of Enrollment||participants|Number|11|11.0||||||
4420606|NCT00190671|4244181|B1|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4420607|NCT00190671|4244179|B3|Romania||Region of Enrollment||participants|Number|18.0|18.0||||||
4420608|NCT00190671|4244180|B2|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4420609|NCT00190671|4244181|B1|Romania||Region of Enrollment||participants|Number|9|9.0||||||
4420610|NCT00190671|4244179|B3|Poland||Region of Enrollment||participants|Number|20.0|20.0||||||
4420611|NCT00190671|4244180|B2|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4420612|NCT00190671|4244181|B1|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4420613|NCT00190671|4244179|B3|Czech Republic||Region of Enrollment||participants|Number|4.0|4.0||||||
4420614|NCT00190671|4244180|B2|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4420615|NCT00190671|4244181|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4420616|NCT00190671|4244179|B3|Hungary||Region of Enrollment||participants|Number|22.0|22.0||||||
4420617|NCT00190671|4244180|B2|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4420618|NCT00190671|4244181|B1|Hungary||Region of Enrollment||participants|Number|11|11.0||||||
4420619|NCT00190671|4244179|B3||Male|Sex: Female, Male||Participants|Count of Participants|0.0|0.0||||||
4420620|NCT00190671|4244180|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4420621|NCT00190671|4244181|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4420622|NCT00190671|4244179|B3||Female|Sex: Female, Male||Participants|Count of Participants|103.0|103.0||||||
4420623|NCT00190671|4244180|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4420624|NCT00190671|4244181|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4420625|NCT00190671|4244179|B3|||Age||years|Median|58.0|58.0|Full Range|||32.0|81.0|
4420626|NCT00190671|4244180|B2|||Age||years|Median|56.0|56.0|Full Range|||32.0|81.0|
4420627|NCT00190671|4244181|B1|||Age||years|Median|59.0|59.0|Full Range|||35.0|80.0|
4420628|NCT00189540|4244200|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4420629|NCT00189540|4244201|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4420630|NCT00189540|4244202|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4420631|NCT00189540|4244200|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4420632|NCT00189540|4244201|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4420633|NCT00189540|4244202|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4420634|NCT00189540|4244200|B3|||Age||years|Mean|76.2|76.2|Standard Deviation|1.97|1.97|||
4420635|NCT00189540|4244201|B2|||Age||years|Mean|78.0|78.0|Standard Deviation|1.86|1.86|||
4420636|NCT00189540|4244202|B1|||Age||years|Mean|75.7|75.7|Standard Deviation|2.49|2.49|||
4420637|NCT00189488|4244219|B3|No||Prior radiotherapy||participants|Number|148|148.0||||||
4420638|NCT00189488|4244220|B2|No||Prior radiotherapy||participants|Number|73|73.0||||||
4420639|NCT00189488|4244221|B1|No||Prior radiotherapy||participants|Number|75|75.0||||||
4420640|NCT00189488|4244219|B3|Yes||Prior radiotherapy||participants|Number|7|7.0||||||
4420641|NCT00189488|4244220|B2|Yes||Prior radiotherapy||participants|Number|4|4.0||||||
4420642|NCT00189488|4244221|B1|Yes||Prior radiotherapy||participants|Number|3|3.0||||||
4420643|NCT00189488|4244219|B3|Peripheral blood progenitor cell(s)||Donor source||participants|Number|120|120.0||||||
4420644|NCT00189488|4244220|B2|Peripheral blood progenitor cell(s)||Donor source||participants|Number|59|59.0||||||
4420645|NCT00189488|4244221|B1|Peripheral blood progenitor cell(s)||Donor source||participants|Number|61|61.0||||||
4420646|NCT00189488|4244219|B3|Marrow||Donor source||participants|Number|35|35.0||||||
4420647|NCT00189488|4244220|B2|Marrow||Donor source||participants|Number|18|18.0||||||
4420648|NCT00189488|4244221|B1|Marrow||Donor source||participants|Number|17|17.0||||||
4420649|NCT00189488|4244219|B3|Unrelated||Donor type||participants|Number|64|64.0||||||
4420650|NCT00189488|4244220|B2|Unrelated||Donor type||participants|Number|32|32.0||||||
4420651|NCT00189488|4244221|B1|Unrelated||Donor type||participants|Number|32|32.0||||||
4420652|NCT00189488|4244219|B3|Related Family Member||Donor type||participants|Number|91|91.0||||||
4420653|NCT00189488|4244220|B2|Related Family Member||Donor type||participants|Number|45|45.0||||||
4420654|NCT00189488|4244221|B1|Related Family Member||Donor type||participants|Number|46|46.0||||||
4420655|NCT00189488|4244219|B3|Myelodysplastic Syndrome||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|21|21.0||||||
4420656|NCT00189488|4244220|B2|Myelodysplastic Syndrome||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|12|12.0||||||
4420657|NCT00189488|4244221|B1|Myelodysplastic Syndrome||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|9|9.0||||||
4420658|NCT00189488|4244219|B3|Multiple Myeloma||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|1|1.0||||||
4420659|NCT00189488|4244220|B2|Multiple Myeloma||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|0|0.0||||||
4420660|NCT00189488|4244221|B1|Multiple Myeloma||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|1|1.0||||||
4420661|NCT00189488|4244219|B3|Non-Hodgkin's lymphoma||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|15|15.0||||||
4420662|NCT00189488|4244220|B2|Non-Hodgkin's lymphoma||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|9|9.0||||||
4420663|NCT00189488|4244221|B1|Non-Hodgkin's lymphoma||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|6|6.0||||||
4420664|NCT00189488|4244219|B3|Hodgkin's disease||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|1|1.0||||||
4420665|NCT00189488|4244220|B2|Hodgkin's disease||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|1|1.0||||||
4420666|NCT00189488|4244221|B1|Hodgkin's disease||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|0|0.0||||||
4420667|NCT00189488|4244219|B3|Chronic myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|12|12.0||||||
4420710|NCT00189475|4244243|B2|United States||Region of Enrollment|All subjects were enrolled through the Asthma and Allergy Dept at West Penn Allegheny Health System.|participants|Number|42|42.0||||||
4420668|NCT00189488|4244220|B2|Chronic myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|6|6.0||||||
4420669|NCT00189488|4244221|B1|Chronic myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|6|6.0||||||
4420670|NCT00189488|4244219|B3|Chronic lymphocytic leukemia||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|10|10.0||||||
4420671|NCT00189488|4244220|B2|Chronic lymphocytic leukemia||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|3|3.0||||||
4420672|NCT00189488|4244221|B1|Chronic lymphocytic leukemia||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|7|7.0||||||
4420673|NCT00189488|4244219|B3|Acute myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|63|63.0||||||
4420674|NCT00189488|4244220|B2|Acute myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|29|29.0||||||
4420675|NCT00189488|4244221|B1|Acute myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|34|34.0||||||
4420676|NCT00189488|4244219|B3|Acute lymphoblastic leukemia||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|32|32.0||||||
4420677|NCT00189488|4244220|B2|Acute lymphoblastic leukemia||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|17|17.0||||||
4420678|NCT00189488|4244221|B1|Acute lymphoblastic leukemia||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|15|15.0||||||
4420679|NCT00189488|4244219|B3|Leukemia - all types||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|117|117.0||||||
4420680|NCT00189488|4244220|B2|Leukemia - all types||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|55|55.0||||||
4420681|NCT00189488|4244221|B1|Leukemia - all types||Type of diagnosis|Acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia are subsets of leukemia.|participants|Number|62|62.0||||||
4420682|NCT00189488|4244219|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4420683|NCT00189488|4244220|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4420684|NCT00189488|4244221|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4420685|NCT00189488|4244219|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4420686|NCT00189488|4244220|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4420687|NCT00189488|4244221|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4420688|NCT00189488|4244219|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4420689|NCT00189488|4244220|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4420690|NCT00189488|4244221|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4420691|NCT00189488|4244219|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4420692|NCT00189488|4244220|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4420693|NCT00189488|4244221|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4420694|NCT00189488|4244219|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4420695|NCT00189488|4244220|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4420696|NCT00189488|4244221|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4420697|NCT00189488|4244219|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4420698|NCT00189488|4244220|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4420699|NCT00189488|4244221|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4420700|NCT00189488|4244219|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4420701|NCT00189488|4244220|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4420702|NCT00189488|4244221|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4420703|NCT00189488|4244219|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4420704|NCT00189488|4244220|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4420705|NCT00189488|4244221|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4420706|NCT00189488|4244219|B3|||Age||Years|Mean|41.3|41.3|Standard Deviation|11.3|11.3|||
4420707|NCT00189488|4244220|B2|||Age||Years|Mean|40.4|40.4|Standard Deviation|12.1|12.1|||
4420708|NCT00189488|4244221|B1|||Age||Years|Mean|42.2|42.2|Standard Deviation|10.5|10.5|||
4420709|NCT00189475|4244242|B3|United States||Region of Enrollment|All subjects were enrolled through the Asthma and Allergy Dept at West Penn Allegheny Health System.|participants|Number|84|84.0||||||
4420772|NCT00189423|4244269|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4420711|NCT00189475|4244244|B1|United States||Region of Enrollment|All subjects were enrolled through the Asthma and Allergy Dept at West Penn Allegheny Health System.|participants|Number|42|42.0||||||
4420712|NCT00189475|4244242|B3|Female||Sex/Gender, Customized||participants|Number|58|58.0||||||
4420713|NCT00189475|4244243|B2|Female||Sex/Gender, Customized||participants|Number|29|29.0||||||
4420714|NCT00189475|4244244|B1|Female||Sex/Gender, Customized||participants|Number|29|29.0||||||
4420715|NCT00189475|4244242|B3|Male||Sex/Gender, Customized||participants|Number|26|26.0||||||
4420716|NCT00189475|4244243|B2|Male||Sex/Gender, Customized||participants|Number|13|13.0||||||
4420717|NCT00189475|4244244|B1|Male||Sex/Gender, Customized||participants|Number|13|13.0||||||
4420718|NCT00189475|4244242|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420719|NCT00189475|4244243|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420720|NCT00189475|4244244|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420721|NCT00189475|4244242|B3||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4420722|NCT00189475|4244243|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4420723|NCT00189475|4244244|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4420724|NCT00189475|4244242|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420725|NCT00189475|4244243|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420726|NCT00189475|4244244|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420727|NCT00189462|4244251|B3|United States||Region of Enrollment|All subjects were enrolled in the Pittsburgh area|participants|Number|99|99.0||||||
4420728|NCT00189462|4244252|B2|United States||Region of Enrollment|All subjects were enrolled in the Pittsburgh area|participants|Number|49|49.0||||||
4420729|NCT00189462|4244253|B1|United States||Region of Enrollment|All subjects were enrolled in the Pittsburgh area|participants|Number|50|50.0||||||
4420730|NCT00189462|4244251|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4420731|NCT00189462|4244252|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4420732|NCT00189462|4244253|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4420733|NCT00189462|4244251|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4420734|NCT00189462|4244252|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4420735|NCT00189462|4244253|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4420736|NCT00189462|4244251|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420737|NCT00189462|4244252|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420738|NCT00189462|4244253|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420739|NCT00189462|4244251|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4420740|NCT00189462|4244252|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4420741|NCT00189462|4244253|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4420742|NCT00189462|4244251|B3||<=18 years|Age||Participants|Count of Participants|99|99.0||||||
4420743|NCT00189462|4244252|B2||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
4420744|NCT00189462|4244253|B1||<=18 years|Age||Participants|Count of Participants|50|50.0||||||
4420745|NCT00189436|4244260|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4420746|NCT00189436|4244261|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4420747|NCT00189436|4244262|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4420748|NCT00189436|4244260|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4420749|NCT00189436|4244261|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4420750|NCT00189436|4244262|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4420751|NCT00189436|4244260|B3|||Age||years|Mean|5.1|5.1|Standard Deviation|0.084|0.084|||
4420752|NCT00189436|4244261|B2|||Age||years|Mean|5.4|5.4|Standard Deviation|1.6|1.6|||
4420753|NCT00189436|4244262|B1|||Age||years|Mean|4.8|4.8|Standard Deviation|2.0|2.0|||
4420754|NCT00189423|4244269|B3|United States||Region of Enrollment||participants|Number|1653|1653.0||||||
4420755|NCT00189423|4244270|B2|United States||Region of Enrollment||participants|Number|840|840.0||||||
4420756|NCT00189423|4244271|B1|United States||Region of Enrollment||participants|Number|813|813.0||||||
4420757|NCT00189423|4244269|B3||Male|Sex: Female, Male||Participants|Count of Participants|1097|1097.0||||||
4420758|NCT00189423|4244270|B2||Male|Sex: Female, Male||Participants|Count of Participants|558|558.0||||||
4420759|NCT00189423|4244271|B1||Male|Sex: Female, Male||Participants|Count of Participants|539|539.0||||||
4420760|NCT00189423|4244269|B3||Female|Sex: Female, Male||Participants|Count of Participants|556|556.0||||||
4420761|NCT00189423|4244270|B2||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4420762|NCT00189423|4244271|B1||Female|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4420763|NCT00189423|4244269|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|14.9|14.9|||
4420764|NCT00189423|4244270|B2|||Age||years|Mean|67.0|67.0|Standard Deviation|15.2|15.2|||
4420765|NCT00189423|4244271|B1|||Age||years|Mean|66.8|66.8|Standard Deviation|14.5|14.5|||
4420766|NCT00189423|4244269|B3||>=65 years|Age||Participants|Count of Participants|906|906.0||||||
4420767|NCT00189423|4244270|B2||>=65 years|Age||Participants|Count of Participants|470|470.0||||||
4420768|NCT00189423|4244271|B1||>=65 years|Age||Participants|Count of Participants|436|436.0||||||
4420769|NCT00189423|4244269|B3||Between 18 and 65 years|Age||Participants|Count of Participants|746|746.0||||||
4420770|NCT00189423|4244270|B2||Between 18 and 65 years|Age||Participants|Count of Participants|369|369.0||||||
4420771|NCT00189423|4244271|B1||Between 18 and 65 years|Age||Participants|Count of Participants|377|377.0||||||
4420773|NCT00189423|4244270|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4420774|NCT00189423|4244271|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420775|NCT00189306|4244294|B1|New Zealand||Region of Enrollment||participants|Number|46|46.0||||||
4420776|NCT00189306|4244294|B1|Australia||Region of Enrollment||participants|Number|123|123.0||||||
4420777|NCT00189306|4244294|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4420778|NCT00189306|4244294|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4420779|NCT00189306|4244294|B1|||Age||years|Mean|57|57.0|Standard Deviation|13|13.0|||
4420780|NCT00189306|4244294|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4420781|NCT00189306|4244294|B1||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4420782|NCT00189306|4244294|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420783|NCT00189202|4244299|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4420784|NCT00189202|4244299|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4420785|NCT00189202|4244299|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4420786|NCT00189202|4244299|B1|||Age||years|Mean|46|46.0|Standard Deviation|13.1|13.1|||
4420787|NCT00189137|4244308|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4420788|NCT00189137|4244309|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4420789|NCT00189137|4244310|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4420790|NCT00189137|4244308|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4420791|NCT00189137|4244309|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4420792|NCT00189137|4244310|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4420793|NCT00189137|4244308|B3|||Age||years|Median|56|56.0|Full Range|||19.0|76.0|
4420794|NCT00189137|4244309|B2|||Age||years|Median|57|57.0|Full Range|||19.0|74.0|
4420795|NCT00189137|4244310|B1|||Age||years|Median|55|55.0|Full Range|||19.0|76.0|
4420796|NCT00189098|4244319|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4420797|NCT00189098|4244320|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4420798|NCT00189098|4244321|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4420799|NCT00189098|4244319|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4420800|NCT00189098|4244320|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4420801|NCT00189098|4244321|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4420802|NCT00189098|4244319|B3|||Age||months|Median|50|50.0|Full Range|||12.0|144.0|
4420803|NCT00189098|4244320|B2|||Age||months|Median|48|48.0|Full Range|||12.0|144.0|
4420804|NCT00189098|4244321|B1|||Age||months|Median|51|51.0|Full Range|||15.0|143.0|
4420805|NCT00187889|4244338|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4420806|NCT00187889|4244339|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4420807|NCT00187889|4244340|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4420808|NCT00187889|4244338|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4420809|NCT00187889|4244339|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4420810|NCT00187889|4244340|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4420811|NCT00187889|4244338|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4420812|NCT00187889|4244339|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4420813|NCT00187889|4244340|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4420814|NCT00187889|4244338|B3|||Age||years|Mean|53|53.0|Standard Deviation|10|10.0|||
4420815|NCT00187889|4244339|B2|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4420816|NCT00187889|4244340|B1|||Age||years|Mean|53|53.0|Standard Deviation|9|9.0|||
4420817|NCT00187889|4244338|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4420818|NCT00187889|4244339|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4420819|NCT00187889|4244340|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4420820|NCT00187889|4244338|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4420821|NCT00187889|4244339|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4420822|NCT00187889|4244340|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4420823|NCT00187889|4244338|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420824|NCT00187889|4244339|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420825|NCT00187889|4244340|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420826|NCT00187876|4244349|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4420827|NCT00187876|4244350|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4420828|NCT00187876|4244351|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4420829|NCT00187876|4244349|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4420830|NCT00187876|4244350|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4420831|NCT00187876|4244351|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4420832|NCT00187876|4244349|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4420833|NCT00187876|4244350|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4420834|NCT00187876|4244351|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4420835|NCT00187876|4244349|B3|||Age||years|Mean|33.5|33.5|Standard Deviation|9.05|9.05|||
4420836|NCT00187876|4244350|B2|||Age||years|Mean|35.6|35.6|Standard Deviation|8.9|8.9|||
4420837|NCT00187876|4244351|B1|||Age||years|Mean|31.3|31.3|Standard Deviation|9.2|9.2|||
4420838|NCT00187720|4244358|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4420839|NCT00187720|4244359|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4420840|NCT00187720|4244360|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4420841|NCT00187720|4244358|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4420842|NCT00187720|4244359|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4420843|NCT00187720|4244360|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4420844|NCT00187720|4244358|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4420845|NCT00187720|4244359|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4420846|NCT00187720|4244360|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4420847|NCT00187720|4244358|B3|||Age||years|Mean|28.8|28.8|Standard Deviation|6.2|6.2|||
4420848|NCT00187720|4244359|B2|||Age||years|Mean|31.2|31.2|Standard Deviation|5.5|5.5|||
4420849|NCT00187720|4244360|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|6.6|6.6|||
4420850|NCT00187720|4244358|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420851|NCT00187720|4244359|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420852|NCT00187720|4244360|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420853|NCT00187720|4244358|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4420854|NCT00187720|4244359|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4420855|NCT00187720|4244360|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4420856|NCT00187720|4244358|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420857|NCT00187720|4244359|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420858|NCT00187720|4244360|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420859|NCT00187681|4244367|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4420860|NCT00187681|4244368|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4420861|NCT00187681|4244369|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4420862|NCT00187681|4244367|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4420863|NCT00187681|4244368|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4420864|NCT00187681|4244369|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4420865|NCT00187681|4244367|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4420866|NCT00187681|4244368|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4420867|NCT00187681|4244369|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4420868|NCT00187681|4244367|B3|||Age||years|Mean|30.5|30.5|Standard Deviation|5.6|5.6|||
4420869|NCT00187681|4244368|B2|||Age||years|Mean|31.3|31.3|Standard Deviation|5.4|5.4|||
4420870|NCT00187681|4244369|B1|||Age||years|Mean|30.0|30.0|Standard Deviation|5.9|5.9|||
4420871|NCT00187681|4244367|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420872|NCT00187681|4244368|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420873|NCT00187681|4244369|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420874|NCT00187681|4244367|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4420875|NCT00187681|4244368|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4420876|NCT00187681|4244369|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4420877|NCT00187681|4244367|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420878|NCT00187681|4244368|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420879|NCT00187681|4244369|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420880|NCT00187655|4244378|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4420881|NCT00187655|4244378|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4420882|NCT00187655|4244378|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4420883|NCT00187655|4244378|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|2|2.0|||
4420884|NCT00187655|4244378|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420885|NCT00187655|4244378|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4420886|NCT00187655|4244378|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420887|NCT00187486|4244383|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4420888|NCT00187486|4244383|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4420889|NCT00187486|4244383|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4420890|NCT00187486|4244383|B1|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4420891|NCT00187486|4244383|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4420892|NCT00187486|4244383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4420893|NCT00187486|4244383|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420894|NCT00187226|4244388|B7||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4420895|NCT00187226|4244389|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4420896|NCT00187226|4244390|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4420897|NCT00187226|4244391|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4420898|NCT00187226|4244392|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4420899|NCT00187226|4244393|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4420900|NCT00187226|4244394|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4420901|NCT00187226|4244388|B7||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4420902|NCT00187226|4244389|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4420903|NCT00187226|4244390|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4420904|NCT00187226|4244391|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4420905|NCT00187226|4244392|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4420906|NCT00187226|4244393|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4420907|NCT00187226|4244394|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4420908|NCT00187226|4244388|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420909|NCT00187226|4244389|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420910|NCT00187226|4244390|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420911|NCT00187226|4244391|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420912|NCT00187226|4244392|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420913|NCT00187226|4244393|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420914|NCT00187226|4244394|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4420915|NCT00187226|4244388|B7||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4420916|NCT00187226|4244389|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4420917|NCT00187226|4244390|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4420918|NCT00187226|4244391|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4420919|NCT00187226|4244392|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4420920|NCT00187226|4244393|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4420921|NCT00187226|4244394|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4420922|NCT00187226|4244388|B7||<=18 years|Age||Participants|Count of Participants|191|191.0||||||
4420923|NCT00187226|4244389|B6||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4420924|NCT00187226|4244390|B5||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4420925|NCT00187226|4244391|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4420926|NCT00187226|4244392|B3||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4420927|NCT00187226|4244393|B2||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4420928|NCT00187226|4244394|B1||<=18 years|Age||Participants|Count of Participants|86|86.0||||||
4420929|NCT00187200|4244413|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4420930|NCT00187200|4244414|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4420931|NCT00187200|4244415|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4420932|NCT00187200|4244413|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4420933|NCT00187200|4244414|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4420934|NCT00187200|4244415|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4420935|NCT00187200|4244413|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4420936|NCT00187200|4244414|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4420937|NCT00187200|4244415|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4420938|NCT00187200|4244413|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|10.7|10.7|||
4420939|NCT00187200|4244414|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|11.2|11.2|||
4420940|NCT00187200|4244415|B1|||Age||years|Mean|68.2|68.2|Standard Deviation|8.0|8.0|||
4420941|NCT00187200|4244413|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4420942|NCT00187200|4244414|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4420943|NCT00187200|4244415|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4420944|NCT00187200|4244413|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4420945|NCT00187200|4244414|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4420946|NCT00187200|4244415|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4420947|NCT00187200|4244413|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420948|NCT00187200|4244414|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420949|NCT00187200|4244415|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4420950|NCT00187135|4244428|B7||Male|Sex: Female, Male|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|Participants|Count of Participants|92|92.0||||||
4420951|NCT00187135|4244429|B6||Male|Sex: Female, Male|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|Participants|Count of Participants|15|15.0||||||
4420952|NCT00187135|4244430|B5||Male|Sex: Female, Male|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|Participants|Count of Participants|16|16.0||||||
4420953|NCT00187135|4244431|B4||Male|Sex: Female, Male|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|Participants|Count of Participants|16|16.0||||||
4420954|NCT00187135|4244432|B3||Male|Sex: Female, Male|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|Participants|Count of Participants|13|13.0||||||
4420955|NCT00187135|4244433|B2||Male|Sex: Female, Male|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|Participants|Count of Participants|17|17.0||||||
4420956|NCT00187135|4244434|B1||Male|Sex: Female, Male|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|Participants|Count of Participants|15|15.0||||||
4420957|NCT00187135|4244428|B7||Female|Sex: Female, Male|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|Participants|Count of Participants|70|70.0||||||
4420958|NCT00187135|4244429|B6||Female|Sex: Female, Male|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|Participants|Count of Participants|13|13.0||||||
4420959|NCT00187135|4244430|B5||Female|Sex: Female, Male|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|Participants|Count of Participants|9|9.0||||||
4420960|NCT00187135|4244431|B4||Female|Sex: Female, Male|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|Participants|Count of Participants|10|10.0||||||
4420961|NCT00187135|4244432|B3||Female|Sex: Female, Male|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|Participants|Count of Participants|12|12.0||||||
4420962|NCT00187135|4244433|B2||Female|Sex: Female, Male|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|Participants|Count of Participants|11|11.0||||||
4420963|NCT00187135|4244434|B1||Female|Sex: Female, Male|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|Participants|Count of Participants|15|15.0||||||
4420964|NCT00187135|4244428|B7|||Age|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|years|Mean|7.1|7.1|Standard Deviation|4.4|4.4|||
4420965|NCT00187135|4244429|B6|||Age|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|years|Mean|7.1|7.1|Standard Deviation|4.4|4.4|||
4420966|NCT00187135|4244430|B5|||Age|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|years|Mean|7.3|7.3|Standard Deviation|4.7|4.7|||
4420967|NCT00187135|4244431|B4|||Age|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|years|Mean|7.1|7.1|Standard Deviation|4.1|4.1|||
4420968|NCT00187135|4244432|B3|||Age|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|years|Mean|7.6|7.6|Standard Deviation|4.8|4.8|||
4420969|NCT00187135|4244433|B2|||Age|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|years|Mean|7.2|7.2|Standard Deviation|4.5|4.5|||
4420970|NCT00187135|4244434|B1|||Age|All 162 participants who enrolled and were randomized on the study are included in the baseline summary statistics.|years|Mean|6.4|6.4|Standard Deviation|4.3|4.3|||
4420971|NCT00187096|4244459|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4420972|NCT00187096|4244460|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4420973|NCT00187096|4244461|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4420974|NCT00187096|4244462|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4420975|NCT00187096|4244459|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4420976|NCT00187096|4244460|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4420977|NCT00187096|4244461|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4420978|NCT00187096|4244462|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4420979|NCT00187096|4244459|B4|||Age||years|Mean|8.48|8.48|Standard Deviation|6.40|6.4|||
4420980|NCT00187096|4244460|B3|||Age||years|Mean|10.11|10.11|Standard Deviation|5.9|5.9|||
4420981|NCT00187096|4244461|B2|||Age||years|Mean|6.05|6.05|Standard Deviation|6.46|6.46|||
4420982|NCT00187096|4244462|B1|||Age||years|Mean|7.26|7.26|Standard Deviation|7.74|7.74|||
4420983|NCT00186901|4244499|B4||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4420984|NCT00186901|4244500|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4420985|NCT00186901|4244501|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4420986|NCT00186901|4244502|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4420987|NCT00186901|4244499|B4||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4420988|NCT00186901|4244500|B3||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4420989|NCT00186901|4244501|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4420990|NCT00186901|4244502|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4420991|NCT00186901|4244499|B4|||Age||years|Mean|17.8|17.8|Standard Deviation|5.9|5.9|||
4420992|NCT00186901|4244500|B3|||Age||years|Mean|19.2|19.2|Standard Deviation|6.6|6.6|||
4420993|NCT00186901|4244501|B2|||Age||years|Mean|17.6|17.6|Standard Deviation|6.3|6.3|||
4420994|NCT00186901|4244502|B1|||Age||years|Mean|17.9|17.9|Standard Deviation|5.6|5.6|||
4420995|NCT00186888|4244541|B4||Unilateral Tumor|Tumor Laterality||Participants|Count of Participants|50|50.0||||||
4420996|NCT00186888|4244542|B3||Unilateral Tumor|Tumor Laterality||Participants|Count of Participants|41|41.0||||||
4420997|NCT00186888|4244543|B2||Unilateral Tumor|Tumor Laterality||Participants|Count of Participants|0|0.0||||||
4420998|NCT00186888|4244544|B1||Unilateral Tumor|Tumor Laterality||Participants|Count of Participants|9|9.0||||||
4420999|NCT00186888|4244541|B4||Bilateral Tumor|Tumor Laterality||Participants|Count of Participants|27|27.0||||||
4421000|NCT00186888|4244542|B3||Bilateral Tumor|Tumor Laterality||Participants|Count of Participants|0|0.0||||||
4421001|NCT00186888|4244543|B2||Bilateral Tumor|Tumor Laterality||Participants|Count of Participants|24|24.0||||||
4421002|NCT00186888|4244544|B1||Bilateral Tumor|Tumor Laterality||Participants|Count of Participants|3|3.0||||||
4421003|NCT00186888|4244541|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4421004|NCT00186888|4244542|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4421005|NCT00186888|4244543|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4421006|NCT00186888|4244544|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4421007|NCT00186888|4244541|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4421008|NCT00186888|4244542|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4421009|NCT00186888|4244543|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4421010|NCT00186888|4244544|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4421011|NCT00186888|4244541|B4|||Age||months|Mean|18.9|18.9|Standard Deviation|19.7|19.7|||
4421012|NCT00186888|4244542|B3|||Age||months|Mean|29.6|29.6|Standard Deviation|22.1|22.1|||
4421013|NCT00186888|4244543|B2|||Age||months|Mean|8.5|8.5|Standard Deviation|4.6|4.6|||
4421014|NCT00186888|4244544|B1|||Age||months|Mean|5.7|5.7|Standard Deviation|3.6|3.6|||
4421015|NCT00186875|4244621|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4421016|NCT00186875|4244622|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4421017|NCT00186875|4244623|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4421018|NCT00186875|4244621|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4421019|NCT00186875|4244622|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4421020|NCT00186875|4244623|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4421021|NCT00186875|4244621|B3|||Age||Years|Median|10|10.0|Full Range|||2.6|22.2|
4421022|NCT00186875|4244622|B2|||Age||Years|Median|12|12.0|Full Range|||2.6|21.8|
4421023|NCT00186875|4244623|B1|||Age||Years|Median|9.7|9.7|Full Range|||3.3|22.2|
4421024|NCT00186875|4244621|B3|||Age||years|Mean|11.2|11.2|Standard Deviation|5.5|5.5|||
4421025|NCT00186875|4244622|B2|||Age||years|Mean|11.3|11.3|Standard Deviation|6.6|6.6|||
4421026|NCT00186875|4244623|B1|||Age||years|Mean|11.1|11.1|Standard Deviation|5.0|5.0|||
4421027|NCT00186628|4244638|B1|unknown or Not Reported||Patient Disease characteristics||participants|Number|1|1.0||||||
4421028|NCT00186628|4244638|B1|MCL- Mantle Cell lymphoma||Patient Disease characteristics||participants|Number|13|13.0||||||
4421029|NCT00186628|4244638|B1|CLL- Chronic Lymphocytic Leukemia||Patient Disease characteristics||participants|Number|22|22.0||||||
4421030|NCT00186628|4244638|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4421031|NCT00186628|4244638|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421032|NCT00186628|4244638|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4421033|NCT00186628|4244638|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421034|NCT00186628|4244638|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421035|NCT00186628|4244638|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421036|NCT00186628|4244638|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421037|NCT00186628|4244638|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421038|NCT00186628|4244638|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4421039|NCT00186628|4244638|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4421040|NCT00186628|4244638|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4421041|NCT00186628|4244638|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4421042|NCT00186628|4244638|B1|||Age||years|Mean|57|57.0|Full Range|||31.0|66.0|
4421043|NCT00186537|4244646|B4||Male|Gender||Participants|Count of Participants|23|23.0||||||
4421044|NCT00186537|4244647|B3||Male|Gender||Participants|Count of Participants|7|7.0||||||
4421045|NCT00186537|4244648|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
4421046|NCT00186537|4244649|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4421047|NCT00186537|4244646|B4||Female|Gender||Participants|Count of Participants|14|14.0||||||
4421048|NCT00186537|4244647|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
4421049|NCT00186537|4244648|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
4421050|NCT00186537|4244649|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4421051|NCT00186537|4244646|B4|||Age||years|Mean|53|53.0|Standard Deviation|7|7.0|||
4421052|NCT00186537|4244647|B3|||Age||years|Mean|53|53.0|Standard Deviation|7|7.0|||
4421053|NCT00186537|4244648|B2|||Age||years|Mean|52|52.0|Standard Deviation|6|6.0|||
4421054|NCT00186537|4244649|B1|||Age||years|Mean|55|55.0|Standard Deviation|7|7.0|||
4421055|NCT00186485|4244665|B1|||Prior Failed Medication Trials||Number of medications|Mean|14.6|14.6|Standard Deviation|3.2|3.2|||
4421056|NCT00186485|4244665|B1|||Concurrent Medications|Medications currently taken by the patient was provided by the patient.|number of medications|Number|4|4.0||||||
4421057|NCT00186485|4244665|B1|Bipolar NOS||Number of Subjects with Bipolar Subtype Diagnosis at Baseline|The number of patients with a diagnosis of Bipolar Type I, Type II. and Not Otherwise Specified|Participants|Count of Participants|1|1.0||||||
4421058|NCT00186485|4244665|B1|Bipolar Type II||Number of Subjects with Bipolar Subtype Diagnosis at Baseline|The number of patients with a diagnosis of Bipolar Type I, Type II. and Not Otherwise Specified|Participants|Count of Participants|11|11.0||||||
4421059|NCT00186485|4244665|B1|Bipolar Type I||Number of Subjects with Bipolar Subtype Diagnosis at Baseline|The number of patients with a diagnosis of Bipolar Type I, Type II. and Not Otherwise Specified|Participants|Count of Participants|16|16.0||||||
4421060|NCT00186485|4244665|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4421061|NCT00186485|4244665|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4421062|NCT00186485|4244665|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4421063|NCT00186485|4244665|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|9.8|9.8|||
4421064|NCT00186485|4244665|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421065|NCT00186485|4244665|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4421066|NCT00186485|4244665|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421067|NCT00186446|4244671|B1|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4421068|NCT00186446|4244671|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421069|NCT00186446|4244671|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421070|NCT00186446|4244671|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4421071|NCT00186446|4244671|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421072|NCT00186446|4244671|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421073|NCT00186446|4244671|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4421074|NCT00186446|4244671|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421075|NCT00186446|4244671|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4421076|NCT00186446|4244671|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4421077|NCT00186446|4244671|B1|||Age||years|Mean|44.35|44.35|Standard Deviation|10.0|10.0|||
4421078|NCT00186186|4244677|B1|||Montgomery Asberg Depression Rating Scale (MADRS) Total Score|"The Montgomery–Åsberg Depression Rating Scale (MADRS) is a ten-item diagnostic questionnaire which psychiatrists use to measure the severity of depressive episodes in patients with mood disorders.~Higher MADRS score indicates more severe depression the overall score ranges from 0 to 60.~Usual cutoff points are:~0 to 6 – normal/symptom absent 7 to 19 – mild depression 20 to 34 – moderate depression >34 – severe depression."|units on a scale|Mean|30.1|30.1|Standard Deviation|4.5|4.5|||
4421079|NCT00186186|4244677|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4421080|NCT00186186|4244677|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4421081|NCT00186186|4244677|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4421082|NCT00186186|4244677|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|9.1|9.1|||
4421083|NCT00186121|4244682|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421084|NCT00186121|4244682|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421085|NCT00186121|4244682|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4421086|NCT00186121|4244682|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4421087|NCT00186121|4244682|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421088|NCT00186121|4244682|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4421089|NCT00186121|4244682|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421090|NCT00186121|4244682|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421091|NCT00186121|4244682|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4421092|NCT00186121|4244682|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421093|NCT00186121|4244682|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421094|NCT00186121|4244682|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4421095|NCT00186121|4244682|B1|||Age||years|Mean|43|43.0|Full Range|||28.0|51.0|
4421096|NCT00186069|4244692|B3|Heavy||Vaginal bleeding before study drug administered||participants|Number|0|0.0||||||
4421097|NCT00186069|4244693|B2|Heavy||Vaginal bleeding before study drug administered||participants|Number|0|0.0||||||
4421098|NCT00186069|4244694|B1|Heavy||Vaginal bleeding before study drug administered||participants|Number|0|0.0||||||
4421099|NCT00186069|4244692|B3|Moderate||Vaginal bleeding before study drug administered||participants|Number|8|8.0||||||
4421100|NCT00186069|4244693|B2|Moderate||Vaginal bleeding before study drug administered||participants|Number|4|4.0||||||
4421101|NCT00186069|4244694|B1|Moderate||Vaginal bleeding before study drug administered||participants|Number|4|4.0||||||
4421102|NCT00186069|4244692|B3|Mild||Vaginal bleeding before study drug administered||participants|Number|22|22.0||||||
4421103|NCT00186069|4244693|B2|Mild||Vaginal bleeding before study drug administered||participants|Number|11|11.0||||||
4421104|NCT00186069|4244694|B1|Mild||Vaginal bleeding before study drug administered||participants|Number|11|11.0||||||
4421105|NCT00186069|4244692|B3|Lateral||Placental location||participants|Number|1|1.0||||||
4421106|NCT00186069|4244693|B2|Lateral||Placental location||participants|Number|0|0.0||||||
4421107|NCT00186069|4244694|B1|Lateral||Placental location||participants|Number|1|1.0||||||
4421108|NCT00186069|4244692|B3|Fundal||Placental location||participants|Number|3|3.0||||||
4421109|NCT00186069|4244693|B2|Fundal||Placental location||participants|Number|2|2.0||||||
4421110|NCT00186069|4244694|B1|Fundal||Placental location||participants|Number|1|1.0||||||
4421111|NCT00186069|4244692|B3|Posterior||Placental location||participants|Number|15|15.0||||||
4421112|NCT00186069|4244693|B2|Posterior||Placental location||participants|Number|6|6.0||||||
4421113|NCT00186069|4244694|B1|Posterior||Placental location||participants|Number|9|9.0||||||
4421114|NCT00186069|4244692|B3|Anterior||Placental location||participants|Number|11|11.0||||||
4421115|NCT00186069|4244693|B2|Anterior||Placental location||participants|Number|7|7.0||||||
4421116|NCT00186069|4244694|B1|Anterior||Placental location||participants|Number|4|4.0||||||
4421117|NCT00186069|4244692|B3|||Gestational age at randomization (weeks)||weeks of gestation|Median|30|30.0|Full Range|||25.0|32.0|
4421195|NCT00186043|4244714|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|11.2|11.2|||
4421118|NCT00186069|4244693|B2|||Gestational age at randomization (weeks)||weeks of gestation|Median|30|30.0|Full Range|||25.0|31.0|
4421119|NCT00186069|4244694|B1|||Gestational age at randomization (weeks)||weeks of gestation|Median|30|30.0|Full Range|||28.0|32.0|
4421120|NCT00186069|4244692|B3|Multiparous||Parity|Number of women who were nulliparous at enrollment|participants|Number|23|23.0||||||
4421121|NCT00186069|4244693|B2|Multiparous||Parity|Number of women who were nulliparous at enrollment|participants|Number|10|10.0||||||
4421122|NCT00186069|4244694|B1|Multiparous||Parity|Number of women who were nulliparous at enrollment|participants|Number|13|13.0||||||
4421123|NCT00186069|4244692|B3|Nulliparous||Parity|Number of women who were nulliparous at enrollment|participants|Number|7|7.0||||||
4421124|NCT00186069|4244693|B2|Nulliparous||Parity|Number of women who were nulliparous at enrollment|participants|Number|5|5.0||||||
4421125|NCT00186069|4244694|B1|Nulliparous||Parity|Number of women who were nulliparous at enrollment|participants|Number|2|2.0||||||
4421126|NCT00186069|4244692|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421127|NCT00186069|4244693|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421128|NCT00186069|4244694|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421129|NCT00186069|4244692|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4421130|NCT00186069|4244693|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4421131|NCT00186069|4244694|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4421132|NCT00186069|4244692|B3|||Age||years|Mean|27.8|27.8|Standard Deviation|6.8|6.8|||
4421133|NCT00186069|4244693|B2|||Age||years|Mean|26.4|26.4|Standard Deviation|6.3|6.3|||
4421134|NCT00186069|4244694|B1|||Age||years|Mean|29.2|29.2|Standard Deviation|7.2|7.2|||
4421135|NCT00186056|4244705|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4421136|NCT00186056|4244706|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4421137|NCT00186056|4244707|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4421138|NCT00186056|4244705|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4421139|NCT00186056|4244706|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4421140|NCT00186056|4244707|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4421141|NCT00186056|4244705|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421142|NCT00186056|4244706|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421143|NCT00186056|4244707|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421144|NCT00186056|4244705|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4421145|NCT00186056|4244706|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4421146|NCT00186056|4244707|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4421147|NCT00186056|4244705|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421148|NCT00186056|4244706|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421149|NCT00186056|4244707|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421150|NCT00186056|4244705|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421151|NCT00186056|4244706|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421152|NCT00186056|4244707|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421153|NCT00186056|4244705|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421154|NCT00186056|4244706|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421155|NCT00186056|4244707|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421156|NCT00186056|4244705|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421157|NCT00186056|4244706|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421158|NCT00186056|4244707|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421159|NCT00186056|4244705|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4421160|NCT00186056|4244706|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4421161|NCT00186056|4244707|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4421162|NCT00186056|4244705|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4421163|NCT00186056|4244706|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4421164|NCT00186056|4244707|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4421165|NCT00186056|4244705|B3|||Age||years|Mean|51.43|51.43|Standard Deviation|9.3|9.3|||
4421166|NCT00186056|4244706|B2|||Age||years|Mean|51.82|51.82|Standard Deviation|9.6|9.6|||
4421167|NCT00186056|4244707|B1|||Age||years|Mean|50.92|50.92|Standard Deviation|9.4|9.4|||
4421168|NCT00186043|4244714|B3|||GAF|The Global Assessment of Functioning (GAF) is a numeric scale used by mental health clinicians and physicians to rate subjectively the social, occupational, and psychological functioning of an individual, e.g., how well one is meeting various problems-in-living. Scores range from 100 (extremely high functioning) to 1 (severely impaired).|units on a scale|Mean|56.0|56.0|Standard Deviation|4.6|4.6|||
4421169|NCT00186043|4244715|B2|||GAF|The Global Assessment of Functioning (GAF) is a numeric scale used by mental health clinicians and physicians to rate subjectively the social, occupational, and psychological functioning of an individual, e.g., how well one is meeting various problems-in-living. Scores range from 100 (extremely high functioning) to 1 (severely impaired).|units on a scale|Mean|56.8|56.8|Standard Deviation|4.7|4.7|||
4421170|NCT00186043|4244716|B1|||GAF|The Global Assessment of Functioning (GAF) is a numeric scale used by mental health clinicians and physicians to rate subjectively the social, occupational, and psychological functioning of an individual, e.g., how well one is meeting various problems-in-living. Scores range from 100 (extremely high functioning) to 1 (severely impaired).|units on a scale|Mean|55.3|55.3|Standard Deviation|4.5|4.5|||
4421171|NCT00186043|4244714|B3|||YMRS|YMRS: an 11-item clinician-administered instrument to assess the severity of mania. Ratings are based on self-report of clinical condition during past 48 hours and clinician's observations. Four items (irritability, speech, thought content, and disruptive/aggressive behavior) are graded on a 5-pt scale of no symptoms (0) to most severe symptoms (8), while the remaining 7 items items are graded on a 5-pt scale of 0 to 4. The 11 items are them summed for a total score ranging from 0 to 60 with higher scores indicating more severe mania and worse outcomes.|units on a scale|Mean|20.9|20.9|Standard Deviation|4.7|4.7|||
4421172|NCT00186043|4244715|B2|||YMRS|YMRS: an 11-item clinician-administered instrument to assess the severity of mania. Ratings are based on self-report of clinical condition during past 48 hours and clinician's observations. Four items (irritability, speech, thought content, and disruptive/aggressive behavior) are graded on a 5-pt scale of no symptoms (0) to most severe symptoms (8), while the remaining 7 items items are graded on a 5-pt scale of 0 to 4. The 11 items are them summed for a total score ranging from 0 to 60 with higher scores indicating more severe mania and worse outcomes.|units on a scale|Mean|20.0|20.0|Standard Deviation|3.9|3.9|||
4421173|NCT00186043|4244716|B1|||YMRS|YMRS: an 11-item clinician-administered instrument to assess the severity of mania. Ratings are based on self-report of clinical condition during past 48 hours and clinician's observations. Four items (irritability, speech, thought content, and disruptive/aggressive behavior) are graded on a 5-pt scale of no symptoms (0) to most severe symptoms (8), while the remaining 7 items items are graded on a 5-pt scale of 0 to 4. The 11 items are them summed for a total score ranging from 0 to 60 with higher scores indicating more severe mania and worse outcomes.|units on a scale|Mean|21.6|21.6|Standard Deviation|5.2|5.2|||
4421174|NCT00186043|4244714|B3|||MADRS|Higher score indicates more severe depression; each item yields a score of 0 to 6. Overall score ranges: 0 to 60. Questions following symptoms 1. Apparent sadness 2. Reported sadness 3. Inner tension 4. Reduced sleep 5. Reduced appetite 6. Concentration difficulties 7. Lassitude 8. Inability to feel 9. Pessimistic thoughts 10. Suicidal thoughts. Cutoff points:0 to 6- normal/symptom absent; 7 to 19- mild depression; 20 to 34- moderate depression; >34- severe depression.|units on a scale|Mean|28.1|28.1|Standard Deviation|7.6|7.6|||
4421175|NCT00186043|4244715|B2|||MADRS|Higher score indicates more severe depression; each item yields a score of 0 to 6. Overall score ranges: 0 to 60. Questions following symptoms 1. Apparent sadness 2. Reported sadness 3. Inner tension 4. Reduced sleep 5. Reduced appetite 6. Concentration difficulties 7. Lassitude 8. Inability to feel 9. Pessimistic thoughts 10. Suicidal thoughts. Cutoff points:0 to 6- normal/symptom absent; 7 to 19- mild depression; 20 to 34- moderate depression; >34- severe depression.|units on a scale|Mean|29.1|29.1|Standard Deviation|7.5|7.5|||
4421176|NCT00186043|4244716|B1|||MADRS|Higher score indicates more severe depression; each item yields a score of 0 to 6. Overall score ranges: 0 to 60. Questions following symptoms 1. Apparent sadness 2. Reported sadness 3. Inner tension 4. Reduced sleep 5. Reduced appetite 6. Concentration difficulties 7. Lassitude 8. Inability to feel 9. Pessimistic thoughts 10. Suicidal thoughts. Cutoff points:0 to 6- normal/symptom absent; 7 to 19- mild depression; 20 to 34- moderate depression; >34- severe depression.|units on a scale|Mean|27.3|27.3|Standard Deviation|7.7|7.7|||
4421177|NCT00186043|4244714|B3|||Clinical Global Impression for Bipolar Disorders Overall Severity|0-7 scale: rated on the following seven-point scale:) 0=not assessed, 1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; 7=among the most extremely ill patients. This rating is based upon observed and reported symptoms, behavior, and function in the past seven days.|units on a scale|Mean|4.3|4.3|Standard Deviation|0.6|0.6|||
4421178|NCT00186043|4244715|B2|||Clinical Global Impression for Bipolar Disorders Overall Severity|0-7 scale: rated on the following seven-point scale:) 0=not assessed, 1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; 7=among the most extremely ill patients. This rating is based upon observed and reported symptoms, behavior, and function in the past seven days.|units on a scale|Mean|4.4|4.4|Standard Deviation|0.7|0.7|||
4421179|NCT00186043|4244716|B1|||Clinical Global Impression for Bipolar Disorders Overall Severity|0-7 scale: rated on the following seven-point scale:) 0=not assessed, 1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; 7=among the most extremely ill patients. This rating is based upon observed and reported symptoms, behavior, and function in the past seven days.|units on a scale|Mean|4.3|4.3|Standard Deviation|0.6|0.6|||
4421180|NCT00186043|4244714|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4421181|NCT00186043|4244715|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4421182|NCT00186043|4244716|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4421183|NCT00186043|4244714|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4421184|NCT00186043|4244715|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4421185|NCT00186043|4244716|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4421186|NCT00186043|4244714|B3|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|47|47.0||||||
4421187|NCT00186043|4244715|B2|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4421188|NCT00186043|4244716|B1|Race/Ethnicity|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4421189|NCT00186043|4244714|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4421190|NCT00186043|4244715|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4421191|NCT00186043|4244716|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4421192|NCT00186043|4244714|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4421193|NCT00186043|4244715|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4421194|NCT00186043|4244716|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4421196|NCT00186043|4244715|B2|||Age||years|Mean|38.1|38.1|Standard Deviation|11.1|11.1|||
4421197|NCT00186043|4244716|B1|||Age||years|Mean|38.5|38.5|Standard Deviation|11.4|11.4|||
4421198|NCT00186017|4244727|B3|||CGI-BP_OS|"Clinical Global Impressions-Bipolar Version-Overall Severity of Illness (CGI-BP-OS) Scale is 0-7 0=not Assessed~1=Normal 7=Worst"|units on a scale|Mean|4.8|4.8|Standard Deviation|.8|0.8|||
4421199|NCT00186017|4244728|B2|||CGI-BP_OS|"Clinical Global Impressions-Bipolar Version-Overall Severity of Illness (CGI-BP-OS) Scale is 0-7 0=not Assessed~1=Normal 7=Worst"|units on a scale|Mean|4.7|4.7|Standard Deviation|.8|0.8|||
4421200|NCT00186017|4244729|B1|||CGI-BP_OS|"Clinical Global Impressions-Bipolar Version-Overall Severity of Illness (CGI-BP-OS) Scale is 0-7 0=not Assessed~1=Normal 7=Worst"|units on a scale|Mean|4.8|4.8|Standard Deviation|.8|0.8|||
4421201|NCT00186017|4244727|B3|Bipolar NOS||Bipolar Subtype||participants|Number|4|4.0||||||
4421202|NCT00186017|4244728|B2|Bipolar NOS||Bipolar Subtype||participants|Number|4|4.0||||||
4421203|NCT00186017|4244729|B1|Bipolar NOS||Bipolar Subtype||participants|Number|0|0.0||||||
4421204|NCT00186017|4244727|B3|Bipolar 2||Bipolar Subtype||participants|Number|18|18.0||||||
4421205|NCT00186017|4244728|B2|Bipolar 2||Bipolar Subtype||participants|Number|7|7.0||||||
4421206|NCT00186017|4244729|B1|Bipolar 2||Bipolar Subtype||participants|Number|11|11.0||||||
4421207|NCT00186017|4244727|B3|Bipolar 1||Bipolar Subtype||participants|Number|23|23.0||||||
4421208|NCT00186017|4244728|B2|Bipolar 1||Bipolar Subtype||participants|Number|11|11.0||||||
4421209|NCT00186017|4244729|B1|Bipolar 1||Bipolar Subtype||participants|Number|12|12.0||||||
4421210|NCT00186017|4244727|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4421211|NCT00186017|4244728|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4421212|NCT00186017|4244729|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4421213|NCT00186017|4244727|B3|Race/Ethnicity|Non-White|Race/Ethnicity, Customized||Participants|Count of Participants|15|15.0||||||
4421214|NCT00186017|4244728|B2|Race/Ethnicity|Non-White|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4421215|NCT00186017|4244729|B1|Race/Ethnicity|Non-White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4421216|NCT00186017|4244727|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4421217|NCT00186017|4244728|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4421218|NCT00186017|4244729|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4421219|NCT00186017|4244727|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4421220|NCT00186017|4244728|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4421221|NCT00186017|4244729|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4421222|NCT00186017|4244727|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4421223|NCT00186017|4244728|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4421224|NCT00186017|4244729|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4421225|NCT00186017|4244727|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|11.5|11.5|||
4421226|NCT00186017|4244728|B2|||Age||years|Mean|42.9|42.9|Standard Deviation|9.9|9.9|||
4421227|NCT00186017|4244729|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|12|12.0|||
4421228|NCT00185965|4244742|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4421229|NCT00185965|4244743|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4421230|NCT00185965|4244744|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4421231|NCT00185965|4244742|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4421232|NCT00185965|4244743|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4421233|NCT00185965|4244744|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4421234|NCT00185965|4244742|B3|||Age||years|Median|60|60.0|Full Range|||18.0|71.0|
4421235|NCT00185965|4244743|B2|||Age||years|Median|57|57.0|Full Range|||18.0|71.0|
4421236|NCT00185965|4244744|B1|||Age||years|Median|62|62.0|Full Range|||38.0|65.0|
4421237|NCT00185900|4244751|B3|United States||Region of Enrollment||participants|Number|192|192.0||||||
4421238|NCT00185900|4244752|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
4421239|NCT00185900|4244753|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4421240|NCT00185900|4244751|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421241|NCT00185900|4244752|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421242|NCT00185900|4244753|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421243|NCT00185900|4244751|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4421244|NCT00185900|4244752|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4421245|NCT00185900|4244753|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4421246|NCT00185900|4244751|B3|||Age||years|Mean|26.5|26.5|Standard Deviation|6.6|6.6|||
4421247|NCT00185900|4244752|B2|||Age||years|Mean|26.3|26.3|Standard Deviation|6.3|6.3|||
4421248|NCT00185900|4244753|B1|||Age||years|Mean|26.6|26.6|Standard Deviation|6.8|6.8|||
4421249|NCT00185731|4244770|B1|Splenic Marginal Zone B-Cell Lymphoma||Histology||Participants|Count of Participants|1|1.0||||||
4421250|NCT00185731|4244770|B1|Marginal Zone B-Cell Lymphoma||Histology||Participants|Count of Participants|2|2.0||||||
4421251|NCT00185731|4244770|B1|Follicular Lymphoma||Histology||Participants|Count of Participants|6|6.0||||||
4421252|NCT00185731|4244770|B1|Small Lymphocytic Lymphoma||Histology||Participants|Count of Participants|16|16.0||||||
4421253|NCT00185731|4244770|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4421254|NCT00185731|4244770|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421255|NCT00185731|4244770|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4421256|NCT00185731|4244770|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421257|NCT00185731|4244770|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421258|NCT00185731|4244770|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421259|NCT00185731|4244770|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421260|NCT00185731|4244770|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421261|NCT00185731|4244770|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4421262|NCT00185731|4244770|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4421263|NCT00185731|4244770|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4421264|NCT00185731|4244770|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4421265|NCT00185731|4244770|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4421266|NCT00185731|4244770|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4421267|NCT00185731|4244770|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421268|NCT00185692|4244776|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421269|NCT00185692|4244776|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421270|NCT00185692|4244776|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4421271|NCT00185692|4244776|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421272|NCT00185692|4244776|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421273|NCT00185692|4244776|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421274|NCT00185692|4244776|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421275|NCT00185692|4244776|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421276|NCT00185692|4244776|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4421277|NCT00185692|4244776|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4421278|NCT00185692|4244776|B1||Male|Gender||Participants|Count of Participants|10|10.0||||||
4421279|NCT00185692|4244776|B1||Female|Gender||Participants|Count of Participants|6|6.0||||||
4421280|NCT00185692|4244776|B1|||Age||years|Median|52|52.0|Full Range|||14.0|61.0|
4421281|NCT00185679|4244781|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4421282|NCT00185679|4244781|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4421283|NCT00185679|4244781|B1|||Age||years|Median|27|27.0|Full Range|||21.0|51.0|
4421284|NCT00185640|4244787|B1|Unknown||Histology||participants|Number|1|1.0||||||
4421285|NCT00185640|4244787|B1|Subcutaneous Panniculitis-Like T-Cell Lymphoma||Histology||participants|Number|1|1.0||||||
4421286|NCT00185640|4244787|B1|Prolymphocytic Leukemia, T-Cell Type||Histology||participants|Number|1|1.0||||||
4421287|NCT00185640|4244787|B1|Prolymphocytic Leukemia, Nos||Histology||participants|Number|1|1.0||||||
4421288|NCT00185640|4244787|B1|Precursor Cell Lymphoblastic Leukemia, Nos||Histology||participants|Number|15|15.0||||||
4421289|NCT00185640|4244787|B1|Myelodysplastic Syndrome, Nos||Histology||participants|Number|3|3.0||||||
4421290|NCT00185640|4244787|B1|Ml, Small B Lymphocytic, Nos||Histology||participants|Number|1|1.0||||||
4421291|NCT00185640|4244787|B1|Ml, Large B-Cell, Diffuse||Histology||participants|Number|2|2.0||||||
4421292|NCT00185640|4244787|B1|Mature T-Cell Lymphoma, Nos||Histology||participants|Number|1|1.0||||||
4421293|NCT00185640|4244787|B1|Marginal Zone B-Cell Lymphoma, Nos||Histology||participants|Number|2|2.0||||||
4421294|NCT00185640|4244787|B1|Mantle Cell Lymphoma||Histology||participants|Number|10|10.0||||||
4421295|NCT00185640|4244787|B1|Malignant Lymphoma, Non-Hodgkin||Histology||participants|Number|86|86.0||||||
4421296|NCT00185640|4244787|B1|Hodgkin Lymphoma, Nos||Histology||participants|Number|20|20.0||||||
4421297|NCT00185640|4244787|B1|Hodgkin Lymphoma, Nodular Sclerosis, Nos||Histology||participants|Number|4|4.0||||||
4421298|NCT00185640|4244787|B1|Follicular Lymphoma, Grade 1-3||Histology||participants|Number|4|4.0||||||
4421299|NCT00185640|4244787|B1|Cutaneous T-Cell Lymphoma, Nos||Histology||participants|Number|1|1.0||||||
4421300|NCT00185640|4244787|B1|Chronic Myeloproliferative Disease, Nos||Histology||participants|Number|2|2.0||||||
4421301|NCT00185640|4244787|B1|Chronic Myeloid Leukemia, Nos||Histology||participants|Number|8|8.0||||||
4421302|NCT00185640|4244787|B1|Chronic Myelogenous Leukemia, Bcr/Abl Positive||Histology||participants|Number|1|1.0||||||
4421303|NCT00185640|4244787|B1|B-Cell Chr. Lymph. Leuk./Small Lymph. Lymphoma||Histology||participants|Number|45|45.0||||||
4421304|NCT00185640|4244787|B1|B lymphoblastic leukemia/lymphoma, NOS||Histology||participants|Number|1|1.0||||||
4421305|NCT00185640|4244787|B1|Angioimmunoblastic T-Cell Lymphoma||Histology||participants|Number|1|1.0||||||
4421306|NCT00185640|4244787|B1|Acute Promyelocytic Leukemia||Histology||participants|Number|4|4.0||||||
4421307|NCT00185640|4244787|B1|Acute Myeloid Leukemia||Histology||participants|Number|84|84.0||||||
4421308|NCT00185640|4244787|B1|Acute Monocytic Leukemia||Histology||participants|Number|2|2.0||||||
4421309|NCT00185640|4244787|B1|Acute Leukemia, Nos||Histology||participants|Number|1|1.0||||||
4421310|NCT00185640|4244787|B1|Acute Biphenotypic Leukemia||Histology||participants|Number|1|1.0||||||
4421311|NCT00185640|4244787|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4421312|NCT00185640|4244787|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421313|NCT00185640|4244787|B1||White|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
4421314|NCT00185640|4244787|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4421315|NCT00185640|4244787|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4421316|NCT00185640|4244787|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4421317|NCT00185640|4244787|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421318|NCT00185640|4244787|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4421319|NCT00185640|4244787|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|276|276.0||||||
4421320|NCT00185640|4244787|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4421321|NCT00185640|4244787|B1||Male|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4421322|NCT00185640|4244787|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4421323|NCT00185640|4244787|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4421324|NCT00185640|4244787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|260|260.0||||||
4421325|NCT00185640|4244787|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421326|NCT00185614|4244796|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4421327|NCT00185614|4244796|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421328|NCT00185614|4244796|B1||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4421329|NCT00185614|4244796|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4421330|NCT00185614|4244796|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4421331|NCT00185614|4244796|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4421332|NCT00185614|4244796|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421333|NCT00185614|4244796|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4421334|NCT00185614|4244796|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4421335|NCT00185614|4244796|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4421336|NCT00185614|4244796|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4421337|NCT00185614|4244796|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4421338|NCT00185614|4244796|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4421339|NCT00185614|4244796|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4421340|NCT00185614|4244796|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421341|NCT00185588|4244804|B5|United States||Region of Enrollment||participants|Number|33|33.0||||||
4421342|NCT00185588|4244805|B4|United States||Region of Enrollment||participants|Number|17|17.0||||||
4421343|NCT00185588|4244806|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4421344|NCT00185588|4244807|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4421345|NCT00185588|4244808|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4421346|NCT00185588|4244804|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4421347|NCT00185588|4244805|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4421348|NCT00185588|4244806|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4421349|NCT00185588|4244807|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4421350|NCT00185588|4244808|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4421351|NCT00185588|4244804|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4421352|NCT00185588|4244805|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4421353|NCT00185588|4244806|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4421354|NCT00185588|4244807|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4421355|NCT00185588|4244808|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4421356|NCT00185588|4244804|B5||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4421357|NCT00185588|4244805|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4421358|NCT00185588|4244806|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4421359|NCT00185588|4244807|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4421360|NCT00185588|4244808|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4421361|NCT00185588|4244804|B5||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4421362|NCT00185588|4244805|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4421363|NCT00185588|4244806|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4421364|NCT00185588|4244807|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4421365|NCT00185588|4244808|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4421366|NCT00185588|4244804|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421367|NCT00185588|4244805|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421368|NCT00185588|4244806|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421369|NCT00185588|4244807|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421370|NCT00185588|4244808|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421371|NCT00185588|4244804|B5|||Age||years|Median|58|58.0|Full Range|||40.0|82.0|
4421372|NCT00185588|4244805|B4|||Age||years|Median|55|55.0|Full Range|||40.0|79.0|
4421373|NCT00185588|4244806|B3|||Age||years|Median|70|70.0|Full Range|||53.0|75.0|
4421374|NCT00185588|4244807|B2|||Age||years|Median|69|69.0|Full Range|||53.0|82.0|
4421375|NCT00185588|4244808|B1|||Age||years|Median|55|55.0|Full Range|||40.0|76.0|
4421376|NCT00185458|4244825|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421377|NCT00185458|4244825|B1||Female|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
4421378|NCT00185458|4244825|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|1.42|1.42|||
4421379|NCT00185380|4244885|B4||Male|Sex: Female, Male|Whilst 742 subjects were randomized, only 738 were treated.|Participants|Count of Participants|0|0.0||||||
4421380|NCT00185380|4244886|B3||Male|Sex: Female, Male|Whilst 742 subjects were randomized, only 738 were treated.|Participants|Count of Participants|0|0.0||||||
4421381|NCT00185380|4244887|B2||Male|Sex: Female, Male|Whilst 742 subjects were randomized, only 738 were treated.|Participants|Count of Participants|0|0.0||||||
4421382|NCT00185380|4244888|B1||Male|Sex: Female, Male|Whilst 742 subjects were randomized, only 738 were treated.|Participants|Count of Participants|0|0.0||||||
4421383|NCT00185380|4244885|B4||Female|Sex: Female, Male|Whilst 742 subjects were randomized, only 738 were treated.|Participants|Count of Participants|738|738.0||||||
4421384|NCT00185380|4244886|B3||Female|Sex: Female, Male|Whilst 742 subjects were randomized, only 738 were treated.|Participants|Count of Participants|254|254.0||||||
4421385|NCT00185380|4244887|B2||Female|Sex: Female, Male|Whilst 742 subjects were randomized, only 738 were treated.|Participants|Count of Participants|245|245.0||||||
4421386|NCT00185380|4244888|B1||Female|Sex: Female, Male|Whilst 742 subjects were randomized, only 738 were treated.|Participants|Count of Participants|239|239.0||||||
4421387|NCT00185380|4244885|B4|||Age||years|Mean|32.1|32.1|Standard Deviation|5.31|5.31|||
4421388|NCT00185380|4244886|B3|||Age||years|Mean|32.0|32.0|Standard Deviation|5.21|5.21|||
4421389|NCT00185380|4244887|B2|||Age||years|Mean|32.1|32.1|Standard Deviation|5.31|5.31|||
4421390|NCT00185380|4244888|B1|||Age||years|Mean|32.2|32.2|Standard Deviation|5.44|5.44|||
4421391|NCT00185211|4244916|B3|multifocal disease||Type of onset of disease (classification of first demyelinating event)|On the basis of the central classification of the patient’s symptoms and signs, the first event was classified as either monofocal (a single central nervous system (CNS) lesion suffices to explain the patient’s symptoms and signs) or multifocal (the patient’s symptoms and signs can only be explained by multiple (i.e. more than one) CNS lesions.|participants|Number|222|222.0||||||
4421392|NCT00185211|4244917|B2|multifocal disease||Type of onset of disease (classification of first demyelinating event)|On the basis of the central classification of the patient’s symptoms and signs, the first event was classified as either monofocal (a single central nervous system (CNS) lesion suffices to explain the patient’s symptoms and signs) or multifocal (the patient’s symptoms and signs can only be explained by multiple (i.e. more than one) CNS lesions.|participants|Number|83|83.0||||||
4421393|NCT00185211|4244918|B1|multifocal disease||Type of onset of disease (classification of first demyelinating event)|On the basis of the central classification of the patient’s symptoms and signs, the first event was classified as either monofocal (a single central nervous system (CNS) lesion suffices to explain the patient’s symptoms and signs) or multifocal (the patient’s symptoms and signs can only be explained by multiple (i.e. more than one) CNS lesions.|participants|Number|139|139.0||||||
4421394|NCT00185211|4244916|B3|monofocal disease||Type of onset of disease (classification of first demyelinating event)|On the basis of the central classification of the patient’s symptoms and signs, the first event was classified as either monofocal (a single central nervous system (CNS) lesion suffices to explain the patient’s symptoms and signs) or multifocal (the patient’s symptoms and signs can only be explained by multiple (i.e. more than one) CNS lesions.|participants|Number|246|246.0||||||
4421395|NCT00185211|4244917|B2|monofocal disease||Type of onset of disease (classification of first demyelinating event)|On the basis of the central classification of the patient’s symptoms and signs, the first event was classified as either monofocal (a single central nervous system (CNS) lesion suffices to explain the patient’s symptoms and signs) or multifocal (the patient’s symptoms and signs can only be explained by multiple (i.e. more than one) CNS lesions.|participants|Number|93|93.0||||||
4421396|NCT00185211|4244918|B1|monofocal disease||Type of onset of disease (classification of first demyelinating event)|On the basis of the central classification of the patient’s symptoms and signs, the first event was classified as either monofocal (a single central nervous system (CNS) lesion suffices to explain the patient’s symptoms and signs) or multifocal (the patient’s symptoms and signs can only be explained by multiple (i.e. more than one) CNS lesions.|participants|Number|153|153.0||||||
4421397|NCT00185211|4244916|B3|No Steroid Use||Number of participants with steroid use during the first clinical demyelinating event|The allocation of participants to the treatment arms was according to a minimization procedure with an element of randomization to minimize imbalances of treatment groups with respect to e.g. steroid use during first clinical demyelinating event. Steroid treatment was at the discretion of the investigator.|participants|Number|136|136.0||||||
4421398|NCT00185211|4244917|B2|No Steroid Use||Number of participants with steroid use during the first clinical demyelinating event|The allocation of participants to the treatment arms was according to a minimization procedure with an element of randomization to minimize imbalances of treatment groups with respect to e.g. steroid use during first clinical demyelinating event. Steroid treatment was at the discretion of the investigator.|participants|Number|53|53.0||||||
4421399|NCT00185211|4244918|B1|No Steroid Use||Number of participants with steroid use during the first clinical demyelinating event|The allocation of participants to the treatment arms was according to a minimization procedure with an element of randomization to minimize imbalances of treatment groups with respect to e.g. steroid use during first clinical demyelinating event. Steroid treatment was at the discretion of the investigator.|participants|Number|83|83.0||||||
4421400|NCT00185211|4244916|B3|Steroid Use||Number of participants with steroid use during the first clinical demyelinating event|The allocation of participants to the treatment arms was according to a minimization procedure with an element of randomization to minimize imbalances of treatment groups with respect to e.g. steroid use during first clinical demyelinating event. Steroid treatment was at the discretion of the investigator.|participants|Number|332|332.0||||||
4421401|NCT00185211|4244917|B2|Steroid Use||Number of participants with steroid use during the first clinical demyelinating event|The allocation of participants to the treatment arms was according to a minimization procedure with an element of randomization to minimize imbalances of treatment groups with respect to e.g. steroid use during first clinical demyelinating event. Steroid treatment was at the discretion of the investigator.|participants|Number|123|123.0||||||
4421402|NCT00185211|4244918|B1|Steroid Use||Number of participants with steroid use during the first clinical demyelinating event|The allocation of participants to the treatment arms was according to a minimization procedure with an element of randomization to minimize imbalances of treatment groups with respect to e.g. steroid use during first clinical demyelinating event. Steroid treatment was at the discretion of the investigator.|participants|Number|209|209.0||||||
4421403|NCT00185211|4244916|B3|at least 9 T2 lesions||Number of T2 lesions detected in screening MRI (Magnet-Resonance Imaging)|Only patients with at least two clinically silent lesions on the T2-weighted brain MRI scan with a size of at least 3 mm, at least one of which is ovoid or periventricular or infratentorial, were included. Number of T2 lesions with the three categories was used in the minimization procedure.|participants|Number|330|330.0||||||
4421404|NCT00185211|4244917|B2|at least 9 T2 lesions||Number of T2 lesions detected in screening MRI (Magnet-Resonance Imaging)|Only patients with at least two clinically silent lesions on the T2-weighted brain MRI scan with a size of at least 3 mm, at least one of which is ovoid or periventricular or infratentorial, were included. Number of T2 lesions with the three categories was used in the minimization procedure.|participants|Number|123|123.0||||||
4421405|NCT00185211|4244918|B1|at least 9 T2 lesions||Number of T2 lesions detected in screening MRI (Magnet-Resonance Imaging)|Only patients with at least two clinically silent lesions on the T2-weighted brain MRI scan with a size of at least 3 mm, at least one of which is ovoid or periventricular or infratentorial, were included. Number of T2 lesions with the three categories was used in the minimization procedure.|participants|Number|207|207.0||||||
4421406|NCT00185211|4244916|B3|5 to 8 T2 lesions||Number of T2 lesions detected in screening MRI (Magnet-Resonance Imaging)|Only patients with at least two clinically silent lesions on the T2-weighted brain MRI scan with a size of at least 3 mm, at least one of which is ovoid or periventricular or infratentorial, were included. Number of T2 lesions with the three categories was used in the minimization procedure.|participants|Number|71|71.0||||||
4421407|NCT00185211|4244917|B2|5 to 8 T2 lesions||Number of T2 lesions detected in screening MRI (Magnet-Resonance Imaging)|Only patients with at least two clinically silent lesions on the T2-weighted brain MRI scan with a size of at least 3 mm, at least one of which is ovoid or periventricular or infratentorial, were included. Number of T2 lesions with the three categories was used in the minimization procedure.|participants|Number|28|28.0||||||
4421408|NCT00185211|4244918|B1|5 to 8 T2 lesions||Number of T2 lesions detected in screening MRI (Magnet-Resonance Imaging)|Only patients with at least two clinically silent lesions on the T2-weighted brain MRI scan with a size of at least 3 mm, at least one of which is ovoid or periventricular or infratentorial, were included. Number of T2 lesions with the three categories was used in the minimization procedure.|participants|Number|43|43.0||||||
4421409|NCT00185211|4244916|B3|2 to 4 T2 lesions||Number of T2 lesions detected in screening MRI (Magnet-Resonance Imaging)|Only patients with at least two clinically silent lesions on the T2-weighted brain MRI scan with a size of at least 3 mm, at least one of which is ovoid or periventricular or infratentorial, were included. Number of T2 lesions with the three categories was used in the minimization procedure.|participants|Number|67|67.0||||||
4421410|NCT00185211|4244917|B2|2 to 4 T2 lesions||Number of T2 lesions detected in screening MRI (Magnet-Resonance Imaging)|Only patients with at least two clinically silent lesions on the T2-weighted brain MRI scan with a size of at least 3 mm, at least one of which is ovoid or periventricular or infratentorial, were included. Number of T2 lesions with the three categories was used in the minimization procedure.|participants|Number|25|25.0||||||
4421411|NCT00185211|4244918|B1|2 to 4 T2 lesions||Number of T2 lesions detected in screening MRI (Magnet-Resonance Imaging)|Only patients with at least two clinically silent lesions on the T2-weighted brain MRI scan with a size of at least 3 mm, at least one of which is ovoid or periventricular or infratentorial, were included. Number of T2 lesions with the three categories was used in the minimization procedure.|participants|Number|42|42.0||||||
4421412|NCT00185211|4244916|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4421413|NCT00185211|4244917|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4421414|NCT00185211|4244918|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4421415|NCT00185211|4244916|B3||Female|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
4421416|NCT00185211|4244917|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4421417|NCT00185211|4244918|B1||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4421418|NCT00185211|4244916|B3|||Age||years|Mean|30.7|30.7|Standard Deviation|7.4|7.4|||
4421419|NCT00185211|4244917|B2|||Age||years|Mean|30.7|30.7|Standard Deviation|7.1|7.1|||
4421420|NCT00185211|4244918|B1|||Age||years|Mean|30.8|30.8|Standard Deviation|7.6|7.6|||
4421421|NCT00184717|4244944|B4|||Body weight||kg|Mean|12.88|12.88|Standard Deviation|2.36|2.36|||
4421422|NCT00184717|4244945|B3|||Body weight||kg|Mean|12.47|12.47|Standard Deviation|2.93|2.93|||
4421423|NCT00184717|4244946|B2|||Body weight||kg|Mean|12.62|12.62|Standard Deviation|1.81|1.81|||
4421424|NCT00184717|4244947|B1|||Body weight||kg|Mean|13.31|13.31|Standard Deviation|2.55|2.55|||
4421425|NCT00184717|4244944|B4|||Height||cm|Mean|95.22|95.22|Standard Deviation|7.96|7.96|||
4421426|NCT00184717|4244945|B3|||Height||cm|Mean|94.42|94.42|Standard Deviation|8.48|8.48|||
4421427|NCT00184717|4244946|B2|||Height||cm|Mean|94.57|94.57|Standard Deviation|7.28|7.28|||
4421428|NCT00184717|4244947|B1|||Height||cm|Mean|96.19|96.19|Standard Deviation|8.48|8.48|||
4421429|NCT00184717|4244944|B4|Japan||Region of Enrollment||participants|Number|84|84.0||||||
4421430|NCT00184717|4244945|B3|Japan||Region of Enrollment||participants|Number|15|15.0||||||
4421431|NCT00184717|4244946|B2|Japan||Region of Enrollment||participants|Number|34|34.0||||||
4421432|NCT00184717|4244947|B1|Japan||Region of Enrollment||participants|Number|35|35.0||||||
4421433|NCT00184717|4244944|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421434|NCT00184717|4244945|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421435|NCT00184717|4244946|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421436|NCT00184717|4244947|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421437|NCT00184717|4244944|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421438|NCT00184717|4244945|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421439|NCT00184717|4244946|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421440|NCT00184717|4244947|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421441|NCT00184717|4244944|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421442|NCT00184717|4244945|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421443|NCT00184717|4244946|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421444|NCT00184717|4244947|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421445|NCT00184717|4244944|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421446|NCT00184717|4244945|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421447|NCT00184717|4244946|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421448|NCT00184717|4244947|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421449|NCT00184717|4244944|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421450|NCT00184717|4244945|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421451|NCT00184717|4244946|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421452|NCT00184717|4244947|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421453|NCT00184717|4244944|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4421454|NCT00184717|4244945|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4421455|NCT00184717|4244946|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4421456|NCT00184717|4244947|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4421457|NCT00184717|4244944|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421458|NCT00184717|4244945|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421459|NCT00184717|4244946|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421460|NCT00184717|4244947|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421461|NCT00184717|4244944|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421462|NCT00184717|4244945|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421463|NCT00184717|4244946|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421464|NCT00184717|4244947|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421465|NCT00184717|4244944|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4421466|NCT00184717|4244945|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4421467|NCT00184717|4244946|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4421468|NCT00184717|4244947|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4421469|NCT00184717|4244944|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421470|NCT00184717|4244945|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421471|NCT00184717|4244946|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421472|NCT00184717|4244947|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421473|NCT00184717|4244944|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4421474|NCT00184717|4244945|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4421475|NCT00184717|4244946|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4421476|NCT00184717|4244947|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4421477|NCT00184717|4244944|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4421478|NCT00184717|4244945|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4421479|NCT00184717|4244946|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4421480|NCT00184717|4244947|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4421481|NCT00184717|4244944|B4|||Age||years|Mean|5.27|5.27|Standard Deviation|1.3|1.3|||
4421482|NCT00184717|4244945|B3|||Age||years|Mean|5.09|5.09|Standard Deviation|1.37|1.37|||
4421483|NCT00184717|4244946|B2|||Age||years|Mean|5.15|5.15|Standard Deviation|1.2|1.2|||
4421484|NCT00184717|4244947|B1|||Age||years|Mean|5.46|5.46|Standard Deviation|1.37|1.37|||
4421485|NCT00184600|4244989|B4|At 3 am||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|166|166.0|Standard Deviation|58|58.0|||
4421486|NCT00184600|4244990|B3|At 3 am||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|171|171.0|Standard Deviation|58|58.0|||
4421487|NCT00184600|4244991|B2|At 3 am||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|164|164.0|Standard Deviation|59|59.0|||
4421488|NCT00184600|4244992|B1|At 3 am||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|164|164.0|Standard Deviation|56|56.0|||
4421489|NCT00184600|4244989|B4|Postprandial||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|227|227.0|Standard Deviation|54|54.0|||
4421490|NCT00184600|4244990|B3|Postprandial||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|229|229.0|Standard Deviation|54|54.0|||
4421491|NCT00184600|4244991|B2|Postprandial||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|227|227.0|Standard Deviation|56|56.0|||
4421492|NCT00184600|4244992|B1|Postprandial||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|223|223.0|Standard Deviation|50|50.0|||
4421493|NCT00184600|4244989|B4|Fasting plasma||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|173|173.0|Standard Deviation|49|49.0|||
4421494|NCT00184600|4244990|B3|Fasting plasma||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|175|175.0|Standard Deviation|50|50.0|||
4421495|NCT00184600|4244991|B2|Fasting plasma||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|173|173.0|Standard Deviation|49|49.0|||
4421496|NCT00184600|4244992|B1|Fasting plasma||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|171|171.0|Standard Deviation|47|47.0|||
4421497|NCT00184600|4244989|B4|All time pointsexcluding 3 am||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|200|200.0|Standard Deviation|47|47.0|||
4421498|NCT00184600|4244990|B3|All time pointsexcluding 3 am||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|202|202.0|Standard Deviation|47|47.0|||
4421499|NCT00184600|4244991|B2|All time pointsexcluding 3 am||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|200|200.0|Standard Deviation|49|49.0|||
4421500|NCT00184600|4244992|B1|All time pointsexcluding 3 am||Eight-point Capillary Plasma Glucose Profiles||mg/dL|Mean|196|196.0|Standard Deviation|43|43.0|||
4421501|NCT00184600|4244989|B4|Women||Waist|Waist circumference of participants|cm|Mean|98|98.0|Standard Deviation|12|12.0|||
4421502|NCT00184600|4244990|B3|Women||Waist|Waist circumference of participants|cm|Mean|98|98.0|Standard Deviation|13|13.0|||
4421503|NCT00184600|4244991|B2|Women||Waist|Waist circumference of participants|cm|Mean|100|100.0|Standard Deviation|11|11.0|||
4421504|NCT00184600|4244992|B1|Women||Waist|Waist circumference of participants|cm|Mean|97|97.0|Standard Deviation|12|12.0|||
4421505|NCT00184600|4244989|B4|Men||Waist|Waist circumference of participants|cm|Mean|103|103.0|Standard Deviation|12|12.0|||
4421506|NCT00184600|4244990|B3|Men||Waist|Waist circumference of participants|cm|Mean|104|104.0|Standard Deviation|12|12.0|||
4421507|NCT00184600|4244991|B2|Men||Waist|Waist circumference of participants|cm|Mean|102|102.0|Standard Deviation|11|11.0|||
4421508|NCT00184600|4244992|B1|Men||Waist|Waist circumference of participants|cm|Mean|104|104.0|Standard Deviation|12|12.0|||
4421509|NCT00184600|4244989|B4|||Body Mass Index (BMI)|BMI of participants|kg/m^2|Mean|29.8|29.8|Standard Deviation|4.6|4.6|||
4421510|NCT00184600|4244990|B3|||Body Mass Index (BMI)|BMI of participants|kg/m^2|Mean|30.34|30.34|Standard Deviation|4.73|4.73|||
4421511|NCT00184600|4244991|B2|||Body Mass Index (BMI)|BMI of participants|kg/m^2|Mean|29.74|29.74|Standard Deviation|4.51|4.51|||
4421512|NCT00184600|4244992|B1|||Body Mass Index (BMI)|BMI of participants|kg/m^2|Mean|29.82|29.82|Standard Deviation|4.59|4.59|||
4421513|NCT00184600|4244989|B4|||Weight|Weight of participants|kg|Mean|85.8|85.8|Standard Deviation|15.9|15.9|||
4421514|NCT00184600|4244990|B3|||Weight|Weight of participants|kg|Mean|86.91|86.91|Standard Deviation|16.82|16.82|||
4421515|NCT00184600|4244991|B2|||Weight|Weight of participants|kg|Mean|84.92|84.92|Standard Deviation|14.43|14.43|||
4421516|NCT00184600|4244992|B1|||Weight|Weight of participants|kg|Mean|85.52|85.52|Standard Deviation|16.25|16.25|||
4421517|NCT00184600|4244989|B4|||Alcohol|Number of units consumed weekly. One unit of alcohol = 10ml pure alcohol by volume or 8g by weight.|units|Median|5|5.0|Inter-Quartile Range|||2.0|12.0|
4421518|NCT00184600|4244990|B3|||Alcohol|Number of units consumed weekly. One unit of alcohol = 10ml pure alcohol by volume or 8g by weight.|units|Median|6|6.0|Inter-Quartile Range|9.61|9.61|2.0|12.0|
4421519|NCT00184600|4244991|B2|||Alcohol|Number of units consumed weekly. One unit of alcohol = 10ml pure alcohol by volume or 8g by weight.|units|Median|5|5.0|Inter-Quartile Range|7.88|7.88|2.0|12.0|
4421520|NCT00184600|4244992|B1|||Alcohol|Number of units consumed weekly. One unit of alcohol = 10ml pure alcohol by volume or 8g by weight.|units|Median|4|4.0|Inter-Quartile Range|9.16|9.16|2.0|12.0|
4421521|NCT00184600|4244989|B4|||Duration of diabetes|Number of years since diagnosis|years|Median|9|9.0|Inter-Quartile Range|||6.0|13.0|
4421522|NCT00184600|4244990|B3|||Duration of diabetes|Number of years since diagnosis|years|Median|9|9.0|Inter-Quartile Range|5.23|5.23|6.0|12.0|
4421523|NCT00184600|4244991|B2|||Duration of diabetes|Number of years since diagnosis|years|Median|9|9.0|Inter-Quartile Range|5.54|5.54|6.0|14.0|
4421524|NCT00184600|4244992|B1|||Duration of diabetes|Number of years since diagnosis|years|Median|9|9.0|Inter-Quartile Range|5.13|5.13|6.0|12.0|
4421525|NCT00184600|4244989|B4|No||Diabetic complication, Macroaniopathy|Diabetic complication at baseline|participants|Number|570|570.0||||||
4421526|NCT00184600|4244990|B3|No||Diabetic complication, Macroaniopathy|Diabetic complication at baseline|participants|Number|183|183.0||||||
4421527|NCT00184600|4244991|B2|No||Diabetic complication, Macroaniopathy|Diabetic complication at baseline|participants|Number|197|197.0||||||
4421528|NCT00184600|4244992|B1|No||Diabetic complication, Macroaniopathy|Diabetic complication at baseline|participants|Number|190|190.0||||||
4421529|NCT00184600|4244989|B4|Yes||Diabetic complication, Macroaniopathy|Diabetic complication at baseline|participants|Number|138|138.0||||||
4421530|NCT00184600|4244990|B3|Yes||Diabetic complication, Macroaniopathy|Diabetic complication at baseline|participants|Number|52|52.0||||||
4421531|NCT00184600|4244991|B2|Yes||Diabetic complication, Macroaniopathy|Diabetic complication at baseline|participants|Number|42|42.0||||||
4421532|NCT00184600|4244992|B1|Yes||Diabetic complication, Macroaniopathy|Diabetic complication at baseline|participants|Number|44|44.0||||||
4421533|NCT00184600|4244989|B4|No||Diabetic complication, Nephropathy|Diabetic complication at baseline|participants|Number|640|640.0||||||
4421534|NCT00184600|4244990|B3|No||Diabetic complication, Nephropathy|Diabetic complication at baseline|participants|Number|214|214.0||||||
4421535|NCT00184600|4244991|B2|No||Diabetic complication, Nephropathy|Diabetic complication at baseline|participants|Number|215|215.0||||||
4421536|NCT00184600|4244992|B1|No||Diabetic complication, Nephropathy|Diabetic complication at baseline|participants|Number|211|211.0||||||
4421537|NCT00184600|4244989|B4|Yes||Diabetic complication, Nephropathy|Diabetic complication at baseline|participants|Number|68|68.0||||||
4421538|NCT00184600|4244990|B3|Yes||Diabetic complication, Nephropathy|Diabetic complication at baseline|participants|Number|21|21.0||||||
4421539|NCT00184600|4244991|B2|Yes||Diabetic complication, Nephropathy|Diabetic complication at baseline|participants|Number|24|24.0||||||
4421540|NCT00184600|4244992|B1|Yes||Diabetic complication, Nephropathy|Diabetic complication at baseline|participants|Number|23|23.0||||||
4421541|NCT00184600|4244989|B4|No||Diabetic complication, Neuropathy|Diabetic complication at baseline|participants|Number|573|573.0||||||
4421542|NCT00184600|4244990|B3|No||Diabetic complication, Neuropathy|Diabetic complication at baseline|participants|Number|194|194.0||||||
4421543|NCT00184600|4244991|B2|No||Diabetic complication, Neuropathy|Diabetic complication at baseline|participants|Number|184|184.0||||||
4421544|NCT00184600|4244992|B1|No||Diabetic complication, Neuropathy|Diabetic complication at baseline|participants|Number|195|195.0||||||
4421545|NCT00184600|4244989|B4|Yes||Diabetic complication, Neuropathy|Diabetic complication at baseline|participants|Number|135|135.0||||||
4421546|NCT00184600|4244990|B3|Yes||Diabetic complication, Neuropathy|Diabetic complication at baseline|participants|Number|41|41.0||||||
4421547|NCT00184600|4244991|B2|Yes||Diabetic complication, Neuropathy|Diabetic complication at baseline|participants|Number|55|55.0||||||
4421548|NCT00184600|4244992|B1|Yes||Diabetic complication, Neuropathy|Diabetic complication at baseline|participants|Number|39|39.0||||||
4421549|NCT00184600|4244989|B4|No||Diabetic complication, Retinopathy|Diabetic complication at baseline|participants|Number|586|586.0||||||
4421550|NCT00184600|4244990|B3|No||Diabetic complication, Retinopathy|Diabetic complication at baseline|participants|Number|201|201.0||||||
4421551|NCT00184600|4244991|B2|No||Diabetic complication, Retinopathy|Diabetic complication at baseline|participants|Number|194|194.0||||||
4421552|NCT00184600|4244992|B1|No||Diabetic complication, Retinopathy|Diabetic complication at baseline|participants|Number|191|191.0||||||
4421553|NCT00184600|4244989|B4|Yes||Diabetic complication, Retinopathy|Diabetic complication at baseline|participants|Number|122|122.0||||||
4421554|NCT00184600|4244990|B3|Yes||Diabetic complication, Retinopathy|Diabetic complication at baseline|participants|Number|34|34.0||||||
4421555|NCT00184600|4244991|B2|Yes||Diabetic complication, Retinopathy|Diabetic complication at baseline|participants|Number|45|45.0||||||
4421556|NCT00184600|4244992|B1|Yes||Diabetic complication, Retinopathy|Diabetic complication at baseline|participants|Number|43|43.0||||||
4421557|NCT00184600|4244989|B4|Metformin + Sulphonylurea||Oral Anti-Diabetic Drugs (OADs)|Identifying which OAD (oral anti-diabetic drug) treatment the participant is on|participants|Number|672|672.0||||||
4421558|NCT00184600|4244990|B3|Metformin + Sulphonylurea||Oral Anti-Diabetic Drugs (OADs)|Identifying which OAD (oral anti-diabetic drug) treatment the participant is on|participants|Number|221|221.0||||||
4421559|NCT00184600|4244991|B2|Metformin + Sulphonylurea||Oral Anti-Diabetic Drugs (OADs)|Identifying which OAD (oral anti-diabetic drug) treatment the participant is on|participants|Number|227|227.0||||||
4421560|NCT00184600|4244992|B1|Metformin + Sulphonylurea||Oral Anti-Diabetic Drugs (OADs)|Identifying which OAD (oral anti-diabetic drug) treatment the participant is on|participants|Number|224|224.0||||||
4421561|NCT00184600|4244989|B4|Sulphonylurea||Oral Anti-Diabetic Drugs (OADs)|Identifying which OAD (oral anti-diabetic drug) treatment the participant is on|participants|Number|30|30.0||||||
4421562|NCT00184600|4244990|B3|Sulphonylurea||Oral Anti-Diabetic Drugs (OADs)|Identifying which OAD (oral anti-diabetic drug) treatment the participant is on|participants|Number|10|10.0||||||
4421563|NCT00184600|4244991|B2|Sulphonylurea||Oral Anti-Diabetic Drugs (OADs)|Identifying which OAD (oral anti-diabetic drug) treatment the participant is on|participants|Number|12|12.0||||||
4421564|NCT00184600|4244992|B1|Sulphonylurea||Oral Anti-Diabetic Drugs (OADs)|Identifying which OAD (oral anti-diabetic drug) treatment the participant is on|participants|Number|8|8.0||||||
4421565|NCT00184600|4244989|B4|Metformin||Oral Anti-Diabetic Drugs (OADs)|Identifying which OAD (oral anti-diabetic drug) treatment the participant is on|participants|Number|6|6.0||||||
4421566|NCT00184600|4244990|B3|Metformin||Oral Anti-Diabetic Drugs (OADs)|Identifying which OAD (oral anti-diabetic drug) treatment the participant is on|participants|Number|4|4.0||||||
4421567|NCT00184600|4244991|B2|Metformin||Oral Anti-Diabetic Drugs (OADs)|Identifying which OAD (oral anti-diabetic drug) treatment the participant is on|participants|Number|0|0.0||||||
4421568|NCT00184600|4244992|B1|Metformin||Oral Anti-Diabetic Drugs (OADs)|Identifying which OAD (oral anti-diabetic drug) treatment the participant is on|participants|Number|2|2.0||||||
4421569|NCT00184600|4244989|B4|Current Smoker||Smoking|Identifying participants as smokers/non-smokers|participants|Number|109|109.0||||||
4421570|NCT00184600|4244990|B3|Current Smoker||Smoking|Identifying participants as smokers/non-smokers|participants|Number|33|33.0||||||
4421571|NCT00184600|4244991|B2|Current Smoker||Smoking|Identifying participants as smokers/non-smokers|participants|Number|43|43.0||||||
4421572|NCT00184600|4244992|B1|Current Smoker||Smoking|Identifying participants as smokers/non-smokers|participants|Number|33|33.0||||||
4421573|NCT00184600|4244989|B4|Ex Smoker||Smoking|Identifying participants as smokers/non-smokers|participants|Number|323|323.0||||||
4421574|NCT00184600|4244990|B3|Ex Smoker||Smoking|Identifying participants as smokers/non-smokers|participants|Number|120|120.0||||||
4421575|NCT00184600|4244991|B2|Ex Smoker||Smoking|Identifying participants as smokers/non-smokers|participants|Number|108|108.0||||||
4421576|NCT00184600|4244992|B1|Ex Smoker||Smoking|Identifying participants as smokers/non-smokers|participants|Number|95|95.0||||||
4421577|NCT00184600|4244989|B4|Non Smoker, Never Smoked||Smoking|Identifying participants as smokers/non-smokers|participants|Number|276|276.0||||||
4421578|NCT00184600|4244990|B3|Non Smoker, Never Smoked||Smoking|Identifying participants as smokers/non-smokers|participants|Number|82|82.0||||||
4421579|NCT00184600|4244991|B2|Non Smoker, Never Smoked||Smoking|Identifying participants as smokers/non-smokers|participants|Number|88|88.0||||||
4421580|NCT00184600|4244992|B1|Non Smoker, Never Smoked||Smoking|Identifying participants as smokers/non-smokers|participants|Number|106|106.0||||||
4421581|NCT00184600|4244989|B4|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4421582|NCT00184600|4244990|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4421583|NCT00184600|4244991|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4421584|NCT00184600|4244992|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4421585|NCT00184600|4244989|B4|Black / Black British||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4421586|NCT00184600|4244990|B3|Black / Black British||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4421587|NCT00184600|4244991|B2|Black / Black British||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4421588|NCT00184600|4244992|B1|Black / Black British||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4421589|NCT00184600|4244989|B4|Asian / Asian British||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4421590|NCT00184600|4244990|B3|Asian / Asian British||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4421591|NCT00184600|4244991|B2|Asian / Asian British||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4421592|NCT00184600|4244992|B1|Asian / Asian British||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4421593|NCT00184600|4244989|B4|Mixed||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4421594|NCT00184600|4244990|B3|Mixed||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4421595|NCT00184600|4244991|B2|Mixed||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4421596|NCT00184600|4244992|B1|Mixed||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4421597|NCT00184600|4244989|B4|White||Race/Ethnicity, Customized||participants|Number|653|653.0||||||
4421598|NCT00184600|4244990|B3|White||Race/Ethnicity, Customized||participants|Number|221|221.0||||||
4421599|NCT00184600|4244991|B2|White||Race/Ethnicity, Customized||participants|Number|214|214.0||||||
4421600|NCT00184600|4244992|B1|White||Race/Ethnicity, Customized||participants|Number|218|218.0||||||
4421601|NCT00184600|4244989|B4||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
4421602|NCT00184600|4244990|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4421603|NCT00184600|4244991|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4421604|NCT00184600|4244992|B1||Male|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4421605|NCT00184600|4244989|B4||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4421606|NCT00184600|4244990|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4421607|NCT00184600|4244991|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4421608|NCT00184600|4244992|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4421609|NCT00184600|4244989|B4|||Age||years|Mean|61.7|61.7|Standard Deviation|9.8|9.8|||
4421610|NCT00184600|4244990|B3|||Age||years|Mean|61.67|61.67|Standard Deviation|8.93|8.93|||
4421611|NCT00184600|4244991|B2|||Age||years|Mean|61.60|61.6|Standard Deviation|10.54|10.54|||
4421612|NCT00184600|4244992|B1|||Age||years|Mean|61.87|61.87|Standard Deviation|9.97|9.97|||
4421613|NCT00184548|4245044|B5||Male|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
4421614|NCT00184548|4245045|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4421615|NCT00184548|4245046|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4421616|NCT00184548|4245047|B2||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4421617|NCT00184548|4245048|B1||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4421618|NCT00184548|4245044|B5||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4421619|NCT00184548|4245045|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4421620|NCT00184548|4245046|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4421621|NCT00184548|4245047|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4421622|NCT00184548|4245048|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4421623|NCT00184548|4245044|B5|||Age||years|Mean|38.4|38.4|Standard Deviation|14.1|14.1|||
4421624|NCT00184548|4245045|B4|||Age||years|Mean|29.4|29.4|Standard Deviation|10.3|10.3|||
4421625|NCT00184548|4245046|B3|||Age||years|Mean|33.8|33.8|Standard Deviation|11.9|11.9|||
4421626|NCT00184548|4245047|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|14.2|14.2|||
4421627|NCT00184548|4245048|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|14.4|14.4|||
4421628|NCT00184093|4245085|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4421629|NCT00184093|4245085|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4421630|NCT00184093|4245085|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421631|NCT00184093|4245085|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421632|NCT00184093|4245085|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421633|NCT00184093|4245085|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421634|NCT00184093|4245085|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4421635|NCT00184093|4245085|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421636|NCT00184093|4245085|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421637|NCT00184093|4245085|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4421638|NCT00184093|4245085|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4421639|NCT00184093|4245085|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421640|NCT00184093|4245085|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4421641|NCT00184093|4245085|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421642|NCT00184093|4245085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4421643|NCT00184093|4245085|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421644|NCT00184054|4245090|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4421645|NCT00184054|4245090|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4421646|NCT00184054|4245090|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4421647|NCT00184054|4245090|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4421648|NCT00184054|4245090|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4421649|NCT00184054|4245090|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421650|NCT00184028|4245095|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4421651|NCT00184028|4245095|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4421652|NCT00184028|4245095|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421653|NCT00184028|4245095|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4421654|NCT00184028|4245095|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4421655|NCT00184028|4245095|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421656|NCT00184028|4245095|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4421657|NCT00184028|4245095|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421658|NCT00184028|4245095|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421659|NCT00184028|4245095|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4421660|NCT00184028|4245095|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4421661|NCT00184028|4245095|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4421662|NCT00184028|4245095|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4421663|NCT00184028|4245095|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4421664|NCT00184028|4245095|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4421665|NCT00184028|4245095|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421666|NCT00184002|4245100|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4421667|NCT00184002|4245100|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4421668|NCT00184002|4245100|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421669|NCT00184002|4245100|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4421670|NCT00184002|4245100|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421671|NCT00184002|4245100|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421672|NCT00184002|4245100|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4421673|NCT00184002|4245100|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421674|NCT00184002|4245100|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421675|NCT00184002|4245100|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4421676|NCT00184002|4245100|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4421677|NCT00184002|4245100|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4421678|NCT00184002|4245100|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4421679|NCT00184002|4245100|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4421680|NCT00184002|4245100|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4421681|NCT00184002|4245100|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421682|NCT00183963|4245105|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
4421683|NCT00183963|4245106|B4|United States||Region of Enrollment||participants|Number|1|1.0||||||
4421684|NCT00183963|4245107|B3|United States||Region of Enrollment||participants|Number|1|1.0||||||
4421685|NCT00183963|4245108|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4421686|NCT00183963|4245109|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4421687|NCT00183963|4245105|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4421688|NCT00183963|4245106|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421689|NCT00183963|4245107|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421690|NCT00183963|4245108|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421691|NCT00183963|4245109|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421692|NCT00183963|4245105|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421693|NCT00183963|4245106|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421694|NCT00183963|4245107|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421695|NCT00183963|4245108|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421696|NCT00183963|4245109|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421697|NCT00183963|4245105|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421698|NCT00183963|4245106|B4||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421699|NCT00183963|4245107|B3||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421700|NCT00183963|4245108|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421701|NCT00183963|4245109|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421702|NCT00183963|4245105|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421703|NCT00183963|4245106|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421704|NCT00183963|4245107|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421705|NCT00183963|4245108|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421706|NCT00183963|4245109|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421707|NCT00183963|4245105|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421708|NCT00183963|4245106|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421709|NCT00183963|4245107|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421710|NCT00183963|4245108|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421711|NCT00183963|4245109|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421712|NCT00183963|4245105|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421713|NCT00183963|4245106|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421714|NCT00183963|4245107|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421715|NCT00183963|4245108|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421716|NCT00183963|4245109|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421717|NCT00183963|4245105|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421718|NCT00183963|4245106|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421719|NCT00183963|4245107|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421720|NCT00183963|4245108|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421721|NCT00183963|4245109|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421722|NCT00183963|4245105|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421723|NCT00183963|4245106|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421724|NCT00183963|4245107|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421725|NCT00183963|4245108|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421726|NCT00183963|4245109|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421727|NCT00183963|4245105|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421728|NCT00183963|4245106|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421729|NCT00183963|4245107|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421730|NCT00183963|4245108|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421731|NCT00183963|4245109|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421732|NCT00183963|4245105|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4421733|NCT00183963|4245106|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421734|NCT00183963|4245107|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421735|NCT00183963|4245108|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421736|NCT00183963|4245109|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421737|NCT00183963|4245105|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421738|NCT00183963|4245106|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421739|NCT00183963|4245107|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421740|NCT00183963|4245108|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421741|NCT00183963|4245109|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421742|NCT00183963|4245105|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4421743|NCT00183963|4245106|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4421744|NCT00183963|4245107|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4421745|NCT00183963|4245108|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4421746|NCT00183963|4245109|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4421747|NCT00183963|4245105|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421748|NCT00183963|4245106|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421749|NCT00183963|4245107|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421750|NCT00183963|4245108|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421751|NCT00183963|4245109|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421752|NCT00183963|4245105|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4421753|NCT00183963|4245106|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4421754|NCT00183963|4245107|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4421755|NCT00183963|4245108|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4421756|NCT00183963|4245109|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4421757|NCT00183963|4245105|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421758|NCT00183963|4245106|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421759|NCT00183963|4245107|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421760|NCT00183963|4245108|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421761|NCT00183963|4245109|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421762|NCT00183872|4245126|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4421763|NCT00183872|4245126|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4421764|NCT00183872|4245126|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421765|NCT00183872|4245126|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4421766|NCT00183872|4245126|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421767|NCT00183872|4245126|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421768|NCT00183872|4245126|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4421769|NCT00183872|4245126|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421770|NCT00183872|4245126|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421771|NCT00183872|4245126|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4421772|NCT00183872|4245126|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4421773|NCT00183872|4245126|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4421774|NCT00183872|4245126|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4421775|NCT00183872|4245126|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4421776|NCT00183872|4245126|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4421777|NCT00183872|4245126|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421778|NCT00183794|4245131|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4421779|NCT00183794|4245131|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4421780|NCT00183794|4245131|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421781|NCT00183794|4245131|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4421782|NCT00183794|4245131|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421783|NCT00183794|4245131|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421784|NCT00183794|4245131|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4421785|NCT00183794|4245131|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421786|NCT00183794|4245131|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421787|NCT00183794|4245131|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4421788|NCT00183794|4245131|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4421789|NCT00183794|4245131|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421790|NCT00183794|4245131|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4421791|NCT00183794|4245131|B1|Between 43 and 75 years||Age||years|Median|59|59.0|Full Range|||43.0|75.0|
4421792|NCT00183729|4245136|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4421793|NCT00183729|4245137|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4421794|NCT00183729|4245138|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4421795|NCT00183729|4245136|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4421796|NCT00183729|4245137|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4421797|NCT00183729|4245138|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4421798|NCT00183729|4245136|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4421799|NCT00183729|4245137|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4421800|NCT00183729|4245138|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4421801|NCT00183729|4245136|B3|||Age||years|Mean|79.1|79.1|Standard Deviation|9.5|9.5|||
4421802|NCT00183729|4245137|B2|||Age||years|Mean|78|78.0|Standard Deviation|9.2|9.2|||
4421803|NCT00183729|4245138|B1|||Age||years|Mean|80.1|80.1|Standard Deviation|9.7|9.7|||
4421804|NCT00183729|4245136|B3||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4421805|NCT00183729|4245137|B2||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4421806|NCT00183729|4245138|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4421807|NCT00183729|4245136|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4421808|NCT00183729|4245137|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4421809|NCT00183729|4245138|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4421810|NCT00183729|4245136|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421811|NCT00183729|4245137|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421812|NCT00183729|4245138|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421813|NCT00183677|4245149|B1|United States||Region of Enrollment||participants|Number|97|97.0||||||
4421814|NCT00183677|4245149|B1||Male|Gender||Participants|Count of Participants|55|55.0||||||
4421815|NCT00183677|4245149|B1||Female|Gender||Participants|Count of Participants|42|42.0||||||
4421816|NCT00183677|4245149|B1|||Age||years|Mean|41.54|41.54|Standard Deviation|13.42|13.42|||
4421817|NCT00183677|4245149|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421818|NCT00183677|4245149|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4421819|NCT00183677|4245149|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421820|NCT00183625|4245153|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4421821|NCT00183625|4245154|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4421822|NCT00183625|4245155|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4421823|NCT00183625|4245153|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4421824|NCT00183625|4245154|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4421825|NCT00183625|4245155|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4421826|NCT00183625|4245153|B3|||Age||years|Mean|42.0|42.0|Standard Deviation|9.9|9.9|||
4421827|NCT00183625|4245154|B2|||Age||years|Mean|42.2|42.2|Standard Deviation|9.4|9.4|||
4421828|NCT00183625|4245155|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|10.4|10.4|||
4421829|NCT00183469|4245166|B3|United States||Region of Enrollment||participants|Number|86|86.0||||||
4421830|NCT00183469|4245167|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4421831|NCT00183469|4245168|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4421832|NCT00183469|4245166|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4421833|NCT00183469|4245167|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4421834|NCT00183469|4245168|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4421835|NCT00183469|4245166|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4421836|NCT00183469|4245167|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4421837|NCT00183469|4245168|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4421838|NCT00183469|4245166|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|11.9|11.9|||
4421839|NCT00183469|4245167|B2|||Age||years|Mean|42.1|42.1|Standard Deviation|12.7|12.7|||
4421840|NCT00183469|4245168|B1|||Age||years|Mean|37.6|37.6|Standard Deviation|11.0|11.0|||
4421841|NCT00183469|4245166|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421842|NCT00183469|4245167|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421843|NCT00183469|4245168|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421844|NCT00183469|4245166|B3||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4421845|NCT00183469|4245167|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4421846|NCT00183469|4245168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4421847|NCT00183469|4245166|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421848|NCT00183469|4245167|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421849|NCT00183469|4245168|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421850|NCT00183456|4245175|B5|United States||Region of Enrollment||participants|Number|746|746.0||||||
4421851|NCT00183456|4245176|B4|United States||Region of Enrollment||participants|Number|248|248.0||||||
4421852|NCT00183456|4245177|B3|United States||Region of Enrollment||participants|Number|329|329.0||||||
4421853|NCT00183456|4245178|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
4421854|NCT00183456|4245179|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
4421855|NCT00183456|4245175|B5||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4421856|NCT00183456|4245176|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421857|NCT00183456|4245177|B3||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4421858|NCT00183456|4245178|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421859|NCT00183456|4245179|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421860|NCT00183456|4245175|B5||Female|Sex: Female, Male||Participants|Count of Participants|567|567.0||||||
4421861|NCT00183456|4245176|B4||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4421862|NCT00183456|4245177|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4421863|NCT00183456|4245178|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4421864|NCT00183456|4245179|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4421865|NCT00183456|4245175|B5|||Age||years|Mean|42|42.0|Standard Deviation|9|9.0|||
4421866|NCT00183456|4245176|B4|||Age||years|Mean|40.6|40.6|Standard Deviation|8|8.0|||
4421867|NCT00183456|4245177|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|10|10.0|||
4421868|NCT00183456|4245178|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|7|7.0|||
4421869|NCT00183456|4245179|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|7|7.0|||
4421870|NCT00183456|4245175|B5||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4421871|NCT00183456|4245176|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421872|NCT00183456|4245177|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4421873|NCT00183456|4245178|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421874|NCT00183456|4245179|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421875|NCT00183456|4245175|B5||Between 18 and 65 years|Age||Participants|Count of Participants|739|739.0||||||
4421876|NCT00183456|4245176|B4||Between 18 and 65 years|Age||Participants|Count of Participants|247|247.0||||||
4421877|NCT00183456|4245177|B3||Between 18 and 65 years|Age||Participants|Count of Participants|323|323.0||||||
4421878|NCT00183456|4245178|B2||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4421879|NCT00183456|4245179|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4421880|NCT00183456|4245175|B5||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4421881|NCT00183456|4245176|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4421882|NCT00183456|4245177|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4421883|NCT00183456|4245178|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421884|NCT00183456|4245179|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421885|NCT00183443|4245228|B4|||Mean Number of Lifetime Episodes of Depression||episodes of depression|Mean|3.5|3.5|Standard Deviation|1.1|1.1|||
4421886|NCT00183443|4245229|B3|||Mean Number of Lifetime Episodes of Depression||episodes of depression|Mean|3.7|3.7|Standard Deviation|0.9|0.9|||
4421887|NCT00183443|4245230|B2|||Mean Number of Lifetime Episodes of Depression||episodes of depression|Mean|3.5|3.5|Standard Deviation|1.3|1.3|||
4421888|NCT00183443|4245231|B1|||Mean Number of Lifetime Episodes of Depression||episodes of depression|Mean|3.4|3.4|Standard Deviation|1.0|1.0|||
4421889|NCT00183443|4245228|B4|United States||Region of Enrollment||participants|Number|75|75.0||||||
4421890|NCT00183443|4245229|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4421891|NCT00183443|4245230|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4421892|NCT00183443|4245231|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4421893|NCT00183443|4245228|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421894|NCT00183443|4245229|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421895|NCT00183443|4245230|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421896|NCT00183443|4245231|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421897|NCT00183443|4245228|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4421898|NCT00183443|4245229|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4421899|NCT00183443|4245230|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4421900|NCT00183443|4245231|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4421901|NCT00183443|4245228|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4421902|NCT00183443|4245229|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4421903|NCT00183443|4245230|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421904|NCT00183443|4245231|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4421905|NCT00183443|4245228|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4421906|NCT00183443|4245229|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4421907|NCT00183443|4245230|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4421908|NCT00183443|4245231|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4421909|NCT00183443|4245228|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4421910|NCT00183443|4245229|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4421911|NCT00183443|4245230|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4421912|NCT00183443|4245231|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4421913|NCT00183443|4245228|B4|||Age||years|Mean|35.6|35.6|Standard Deviation|10.3|10.3|||
4421914|NCT00183443|4245229|B3|||Age||years|Mean|34.9|34.9|Standard Deviation|9.0|9.0|||
4421915|NCT00183443|4245230|B2|||Age||years|Mean|33.1|33.1|Standard Deviation|9.8|9.8|||
4421916|NCT00183443|4245231|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|11.6|11.6|||
4421917|NCT00183443|4245228|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421918|NCT00183443|4245229|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421919|NCT00183443|4245230|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421920|NCT00183443|4245231|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421921|NCT00183443|4245228|B4||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4421922|NCT00183443|4245229|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4421923|NCT00183443|4245230|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4421924|NCT00183443|4245231|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4421925|NCT00183443|4245228|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421926|NCT00183443|4245229|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421927|NCT00183443|4245230|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421928|NCT00183443|4245231|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421929|NCT00183430|4245253|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4421930|NCT00183430|4245254|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4421931|NCT00183430|4245255|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4421932|NCT00183430|4245253|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4421933|NCT00183430|4245254|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4421934|NCT00183430|4245255|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4421935|NCT00183430|4245253|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4421936|NCT00183430|4245254|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4421937|NCT00183430|4245255|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4421938|NCT00183430|4245253|B3|||Age||years|Mean|44|44.0|Standard Deviation|10.4|10.4|||
4421939|NCT00183430|4245254|B2|||Age||years|Mean|46|46.0|Standard Deviation|9.4|9.4|||
4421940|NCT00183430|4245255|B1|||Age||years|Mean|42|42.0|Standard Deviation|11.6|11.6|||
4421941|NCT00183430|4245253|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421942|NCT00183430|4245254|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421943|NCT00183430|4245255|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421944|NCT00183430|4245253|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4421945|NCT00183430|4245254|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4421946|NCT00183430|4245255|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4421947|NCT00183430|4245253|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421948|NCT00183430|4245254|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421949|NCT00183430|4245255|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4421950|NCT00183391|4245266|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4421951|NCT00183391|4245267|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4421952|NCT00183391|4245268|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4421953|NCT00183391|4245266|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4421954|NCT00183391|4245267|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4421955|NCT00183391|4245268|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4421956|NCT00183391|4245266|B3|||Age||years|Mean|10.41|10.41|Standard Deviation|2.72|2.72|||
4421957|NCT00183391|4245267|B2|||Age||years|Mean|10.56|10.56|Standard Deviation|2.83|2.83|||
4421958|NCT00183391|4245268|B1|||Age||years|Mean|10.34|10.34|Standard Deviation|2.61|2.61|||
4421959|NCT00183339|4245327|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4421960|NCT00183339|4245328|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4421961|NCT00183339|4245329|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4421962|NCT00183339|4245327|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421963|NCT00183339|4245328|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421964|NCT00183339|4245329|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421965|NCT00183339|4245327|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421966|NCT00183339|4245328|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421967|NCT00183339|4245329|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421968|NCT00183339|4245327|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4421969|NCT00183339|4245328|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4421970|NCT00183339|4245329|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4421971|NCT00183339|4245327|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4421972|NCT00183339|4245328|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4421973|NCT00183339|4245329|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421974|NCT00183339|4245327|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421975|NCT00183339|4245328|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421976|NCT00183339|4245329|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421977|NCT00183339|4245327|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4421978|NCT00183339|4245328|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421979|NCT00183339|4245329|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4421980|NCT00183339|4245327|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421981|NCT00183339|4245328|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421982|NCT00183339|4245329|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4421983|NCT00183339|4245327|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4421984|NCT00183339|4245328|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4421985|NCT00183339|4245329|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4421986|NCT00183339|4245327|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421987|NCT00183339|4245328|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421988|NCT00183339|4245329|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4421989|NCT00183339|4245327|B3|||Age||months|Mean|43.4|43.4|Standard Deviation|7.4|7.4|||
4421990|NCT00183339|4245328|B2|||Age||months|Mean|42.6|42.6|Standard Deviation|8.1|8.1|||
4421991|NCT00183339|4245329|B1|||Age||months|Mean|44.0|44.0|Standard Deviation|6.6|6.6|||
4421992|NCT00183339|4245327|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421993|NCT00183339|4245328|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421994|NCT00183339|4245329|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4421995|NCT00183339|4245327|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4421996|NCT00183339|4245328|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4421997|NCT00183339|4245329|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4421998|NCT00183339|4245327|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4421999|NCT00183339|4245328|B2||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4422000|NCT00183339|4245329|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4422001|NCT00183274|4245342|B1|United States||Region of Enrollment||participants|Number|334|334.0||||||
4422002|NCT00183274|4245342|B1||Male|Gender||Participants|Count of Participants|124|124.0||||||
4422003|NCT00183274|4245342|B1||Female|Gender||Participants|Count of Participants|210|210.0||||||
4422004|NCT00183274|4245342|B1|||Age||years|Mean|46.11|46.11|Standard Deviation|16.14|16.14|||
4422005|NCT00183274|4245342|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4422006|NCT00183274|4245342|B1||Between 18 and 65 years|Age||Participants|Count of Participants|280|280.0||||||
4422007|NCT00183274|4245342|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4422008|NCT00183248|4245362|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4422009|NCT00183248|4245363|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4422010|NCT00183248|4245364|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4422011|NCT00183248|4245362|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4422012|NCT00183248|4245363|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4422013|NCT00183248|4245364|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4422014|NCT00183248|4245362|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4422015|NCT00183248|4245363|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422016|NCT00183248|4245364|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4422017|NCT00183248|4245362|B3|||Age||years|Mean|41.4|41.4|Standard Deviation|9.7|9.7|||
4422018|NCT00183248|4245363|B2|||Age||years|Mean|41.8|41.8|Standard Deviation|7.9|7.9|||
4422019|NCT00183248|4245364|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|12.0|12.0|||
4422020|NCT00183248|4245362|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422021|NCT00183248|4245363|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422022|NCT00183248|4245364|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422023|NCT00183248|4245362|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4422024|NCT00183248|4245363|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4422025|NCT00183248|4245364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4422026|NCT00183248|4245362|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422027|NCT00183248|4245363|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422028|NCT00183248|4245364|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422029|NCT00183196|4245383|B4|United States||Region of Enrollment||participants|Number|150|150.0||||||
4422030|NCT00183196|4245384|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4422031|NCT00183196|4245385|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4422032|NCT00183196|4245386|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4422033|NCT00183196|4245383|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4422034|NCT00183196|4245384|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4422035|NCT00183196|4245385|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4422036|NCT00183196|4245386|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4422037|NCT00183196|4245383|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4422038|NCT00183196|4245384|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4422039|NCT00183196|4245385|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4422040|NCT00183196|4245386|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4422041|NCT00183196|4245383|B4|||Age||years|Mean|44.6|44.6|Standard Deviation|9.7|9.7|||
4422042|NCT00183196|4245384|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|9.0|9.0|||
4422043|NCT00183196|4245385|B2|||Age||years|Mean|44.4|44.4|Standard Deviation|10.1|10.1|||
4422044|NCT00183196|4245386|B1|||Age||years|Mean|43|43.0|Standard Deviation|9.8|9.8|||
4422045|NCT00183196|4245383|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4422046|NCT00183196|4245384|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4422047|NCT00183196|4245385|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4422048|NCT00183196|4245386|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422049|NCT00183196|4245383|B4||Between 18 and 65 years|Age||Participants|Count of Participants|148|148.0||||||
4422050|NCT00183196|4245384|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4422051|NCT00183196|4245385|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4422052|NCT00183196|4245386|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4422053|NCT00183196|4245383|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422054|NCT00183196|4245384|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422055|NCT00183196|4245385|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422056|NCT00183196|4245386|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422057|NCT00183092|4245396|B3|United States||Region of Enrollment||participants|Number|51|51.0||||||
4422058|NCT00183092|4245397|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4422059|NCT00183092|4245398|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4422060|NCT00183092|4245396|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4422061|NCT00183092|4245397|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4422062|NCT00183092|4245398|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4422063|NCT00183092|4245396|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4422064|NCT00183092|4245397|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4422065|NCT00183092|4245398|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4422066|NCT00183092|4245396|B3|||Age||years|Mean|62.5|62.5|Full Range|||38.0|82.0|
4422067|NCT00183092|4245397|B2|||Age||years|Mean|60.5|60.5|Full Range|8.0|8.0|40.0|75.0|
4422068|NCT00183092|4245398|B1|||Age||years|Mean|64.4|64.4|Full Range|10.9|10.9|38.0|82.0|
4422069|NCT00182793|4245422|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4422070|NCT00182793|4245422|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422071|NCT00182793|4245422|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4422072|NCT00182793|4245422|B1|||Age||years|Median|47|47.0|Full Range|||32.0|66.0|
4422073|NCT00182767|4245427|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422074|NCT00182767|4245427|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4422075|NCT00182767|4245427|B1|||Age||years|Median|59|59.0|Full Range|||34.0|82.0|
4422076|NCT00182754|4245446|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422077|NCT00182754|4245447|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422078|NCT00182754|4245448|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422079|NCT00182754|4245446|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4422080|NCT00182754|4245447|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4422081|NCT00182754|4245448|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4422082|NCT00182754|4245446|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422083|NCT00182754|4245447|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422084|NCT00182754|4245448|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422085|NCT00182754|4245446|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4422086|NCT00182754|4245447|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4422087|NCT00182754|4245448|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4422088|NCT00182754|4245446|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4422089|NCT00182754|4245447|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4422090|NCT00182754|4245448|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4422091|NCT00182754|4245446|B3|||Age||years|Median|63|63.0|Full Range|||40.0|90.0|
4422092|NCT00182754|4245447|B2|||Age||years|Median|69|69.0|Full Range|||40.0|88.0|
4422093|NCT00182754|4245448|B1|||Age||years|Median|62|62.0|Full Range|||45.0|90.0|
4422094|NCT00182728|4245459|B1|"triple negative"||Markers|Tumor markers are substances that are produced by cancer or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. The following markers are proteins.|Participants|Count of Participants|12|12.0||||||
4422095|NCT00182728|4245459|B1|ER+, PR+, HER2-||Markers|Tumor markers are substances that are produced by cancer or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. The following markers are proteins.|Participants|Count of Participants|46|46.0||||||
4422096|NCT00182728|4245459|B1|Human Epidermal Growth Factor receptor (HER) 2 pos||Markers|Tumor markers are substances that are produced by cancer or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. The following markers are proteins.|Participants|Count of Participants|8|8.0||||||
4422097|NCT00182728|4245459|B1|Progesterone Receptor (PR) positive||Markers|Tumor markers are substances that are produced by cancer or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. The following markers are proteins.|Participants|Count of Participants|50|50.0||||||
4422098|NCT00182728|4245459|B1|Estrogen Receptor (ER) positive||Markers|Tumor markers are substances that are produced by cancer or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. The following markers are proteins.|Participants|Count of Participants|54|54.0||||||
4422099|NCT00182728|4245459|B1|III||Grade|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I – cancer cells that resemble normal cells and aren't growing rapidly. grade II – cancer cells that don't look like normal cells and are growing faster than normal cells. grade III – cancer cells that look abnormal and may grow or spread more aggressively|Participants|Count of Participants|22|22.0||||||
4422100|NCT00182728|4245459|B1|II||Grade|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I – cancer cells that resemble normal cells and aren't growing rapidly. grade II – cancer cells that don't look like normal cells and are growing faster than normal cells. grade III – cancer cells that look abnormal and may grow or spread more aggressively|Participants|Count of Participants|24|24.0||||||
4422101|NCT00182728|4245459|B1|I||Grade|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I – cancer cells that resemble normal cells and aren't growing rapidly. grade II – cancer cells that don't look like normal cells and are growing faster than normal cells. grade III – cancer cells that look abnormal and may grow or spread more aggressively|Participants|Count of Participants|25|25.0||||||
4422165|NCT00182689|4245469|B3||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4422166|NCT00182689|4245470|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4422102|NCT00182728|4245459|B1|cN0||Clinical Staging|"The TNM Classification of Malignant Tumours (TNM) is a cancer staging notation system that describes the stage of a cancer which originates from a solid tumor with alphanumeric codes. Higher numbers mean the cancer is more advanced.~T describes the size of the original (primary) tumor and whether it has invaded nearby tissue, N describes nearby (regional) lymph nodes that are involved, M describes distant metastasis (spread of cancer from one part of the body to another)."|Participants|Count of Participants|71|71.0||||||
4422103|NCT00182728|4245459|B1|cT2 (<3 cm)||Clinical Staging|"The TNM Classification of Malignant Tumours (TNM) is a cancer staging notation system that describes the stage of a cancer which originates from a solid tumor with alphanumeric codes. Higher numbers mean the cancer is more advanced.~T describes the size of the original (primary) tumor and whether it has invaded nearby tissue, N describes nearby (regional) lymph nodes that are involved, M describes distant metastasis (spread of cancer from one part of the body to another)."|Participants|Count of Participants|16|16.0||||||
4422104|NCT00182728|4245459|B1|cT1c||Clinical Staging|"The TNM Classification of Malignant Tumours (TNM) is a cancer staging notation system that describes the stage of a cancer which originates from a solid tumor with alphanumeric codes. Higher numbers mean the cancer is more advanced.~T describes the size of the original (primary) tumor and whether it has invaded nearby tissue, N describes nearby (regional) lymph nodes that are involved, M describes distant metastasis (spread of cancer from one part of the body to another)."|Participants|Count of Participants|35|35.0||||||
4422105|NCT00182728|4245459|B1|cT1b||Clinical Staging|"The TNM Classification of Malignant Tumours (TNM) is a cancer staging notation system that describes the stage of a cancer which originates from a solid tumor with alphanumeric codes. Higher numbers mean the cancer is more advanced.~T describes the size of the original (primary) tumor and whether it has invaded nearby tissue, N describes nearby (regional) lymph nodes that are involved, M describes distant metastasis (spread of cancer from one part of the body to another)."|Participants|Count of Participants|18|18.0||||||
4422106|NCT00182728|4245459|B1|cT1a||Clinical Staging|"The TNM Classification of Malignant Tumours (TNM) is a cancer staging notation system that describes the stage of a cancer which originates from a solid tumor with alphanumeric codes. Higher numbers mean the cancer is more advanced.~T describes the size of the original (primary) tumor and whether it has invaded nearby tissue, N describes nearby (regional) lymph nodes that are involved, M describes distant metastasis (spread of cancer from one part of the body to another)."|Participants|Count of Participants|2|2.0||||||
4422107|NCT00182728|4245459|B1|United States||Region of Enrollment||Participants|Count of Participants|71|71.0||||||
4422108|NCT00182728|4245459|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422109|NCT00182728|4245459|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4422110|NCT00182728|4245459|B1|||Age||years|Mean|64.8|64.8|Full Range|||48.0|92.0|
4422111|NCT00182689|4245469|B3|Not reported||Weight Loss Prior 6 Months||participants|Number|7|7.0||||||
4422112|NCT00182689|4245470|B2|Not reported||Weight Loss Prior 6 Months||participants|Number|2|2.0||||||
4422113|NCT00182689|4245471|B1|Not reported||Weight Loss Prior 6 Months||participants|Number|5|5.0||||||
4422114|NCT00182689|4245469|B3|> or = 20%||Weight Loss Prior 6 Months||participants|Number|2|2.0||||||
4422115|NCT00182689|4245470|B2|> or = 20%||Weight Loss Prior 6 Months||participants|Number|1|1.0||||||
4422116|NCT00182689|4245471|B1|> or = 20%||Weight Loss Prior 6 Months||participants|Number|1|1.0||||||
4422117|NCT00182689|4245469|B3|10% to < 20%||Weight Loss Prior 6 Months||participants|Number|6|6.0||||||
4422118|NCT00182689|4245470|B2|10% to < 20%||Weight Loss Prior 6 Months||participants|Number|5|5.0||||||
4422119|NCT00182689|4245471|B1|10% to < 20%||Weight Loss Prior 6 Months||participants|Number|1|1.0||||||
4422120|NCT00182689|4245469|B3|5% to < 10%||Weight Loss Prior 6 Months||participants|Number|11|11.0||||||
4422121|NCT00182689|4245470|B2|5% to < 10%||Weight Loss Prior 6 Months||participants|Number|6|6.0||||||
4422122|NCT00182689|4245471|B1|5% to < 10%||Weight Loss Prior 6 Months||participants|Number|5|5.0||||||
4422123|NCT00182689|4245469|B3|< 5%||Weight Loss Prior 6 Months||participants|Number|57|57.0||||||
4422124|NCT00182689|4245470|B2|< 5%||Weight Loss Prior 6 Months||participants|Number|31|31.0||||||
4422125|NCT00182689|4245471|B1|< 5%||Weight Loss Prior 6 Months||participants|Number|26|26.0||||||
4422126|NCT00182689|4245469|B3|Not reported||Smoking History||participants|Number|1|1.0||||||
4422127|NCT00182689|4245470|B2|Not reported||Smoking History||participants|Number|1|1.0||||||
4422128|NCT00182689|4245471|B1|Not reported||Smoking History||participants|Number|0|0.0||||||
4422129|NCT00182689|4245469|B3|Never||Smoking History||participants|Number|0|0.0||||||
4422130|NCT00182689|4245470|B2|Never||Smoking History||participants|Number|0|0.0||||||
4422131|NCT00182689|4245471|B1|Never||Smoking History||participants|Number|0|0.0||||||
4422132|NCT00182689|4245469|B3|Former||Smoking History||participants|Number|40|40.0||||||
4422133|NCT00182689|4245470|B2|Former||Smoking History||participants|Number|19|19.0||||||
4422134|NCT00182689|4245471|B1|Former||Smoking History||participants|Number|21|21.0||||||
4422135|NCT00182689|4245469|B3|Current||Smoking History||participants|Number|42|42.0||||||
4422136|NCT00182689|4245470|B2|Current||Smoking History||participants|Number|25|25.0||||||
4422137|NCT00182689|4245471|B1|Current||Smoking History||participants|Number|17|17.0||||||
4422138|NCT00182689|4245469|B3|Not reported||Performance Status|Performance status is graded according to the Zubrod Scale (0-4). 0: Fully active, able to carry on all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed/chair.|participants|Number|2|2.0||||||
4422167|NCT00182689|4245471|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4422168|NCT00182689|4245469|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4422169|NCT00182689|4245470|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422139|NCT00182689|4245470|B2|Not reported||Performance Status|Performance status is graded according to the Zubrod Scale (0-4). 0: Fully active, able to carry on all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed/chair.|participants|Number|1|1.0||||||
4422140|NCT00182689|4245471|B1|Not reported||Performance Status|Performance status is graded according to the Zubrod Scale (0-4). 0: Fully active, able to carry on all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed/chair.|participants|Number|1|1.0||||||
4422141|NCT00182689|4245469|B3|1||Performance Status|Performance status is graded according to the Zubrod Scale (0-4). 0: Fully active, able to carry on all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed/chair.|participants|Number|51|51.0||||||
4422142|NCT00182689|4245470|B2|1||Performance Status|Performance status is graded according to the Zubrod Scale (0-4). 0: Fully active, able to carry on all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed/chair.|participants|Number|29|29.0||||||
4422143|NCT00182689|4245471|B1|1||Performance Status|Performance status is graded according to the Zubrod Scale (0-4). 0: Fully active, able to carry on all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed/chair.|participants|Number|22|22.0||||||
4422144|NCT00182689|4245469|B3|0||Performance Status|Performance status is graded according to the Zubrod Scale (0-4). 0: Fully active, able to carry on all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed/chair.|participants|Number|30|30.0||||||
4422145|NCT00182689|4245470|B2|0||Performance Status|Performance status is graded according to the Zubrod Scale (0-4). 0: Fully active, able to carry on all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed/chair.|participants|Number|15|15.0||||||
4422146|NCT00182689|4245471|B1|0||Performance Status|Performance status is graded according to the Zubrod Scale (0-4). 0: Fully active, able to carry on all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed/chair > 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed/chair.|participants|Number|15|15.0||||||
4422147|NCT00182689|4245469|B3|Not reported||Sites of Metastases||participants|Number|2|2.0||||||
4422148|NCT00182689|4245470|B2|Not reported||Sites of Metastases||participants|Number|1|1.0||||||
4422149|NCT00182689|4245471|B1|Not reported||Sites of Metastases||participants|Number|1|1.0||||||
4422150|NCT00182689|4245469|B3|None||Sites of Metastases||participants|Number|4|4.0||||||
4422151|NCT00182689|4245470|B2|None||Sites of Metastases||participants|Number|3|3.0||||||
4422152|NCT00182689|4245471|B1|None||Sites of Metastases||participants|Number|1|1.0||||||
4422153|NCT00182689|4245469|B3|Multiple organs||Sites of Metastases||participants|Number|66|66.0||||||
4422154|NCT00182689|4245470|B2|Multiple organs||Sites of Metastases||participants|Number|34|34.0||||||
4422155|NCT00182689|4245471|B1|Multiple organs||Sites of Metastases||participants|Number|32|32.0||||||
4422156|NCT00182689|4245469|B3|Single organ||Sites of Metastases||participants|Number|11|11.0||||||
4422157|NCT00182689|4245470|B2|Single organ||Sites of Metastases||participants|Number|7|7.0||||||
4422158|NCT00182689|4245471|B1|Single organ||Sites of Metastases||participants|Number|4|4.0||||||
4422159|NCT00182689|4245469|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422160|NCT00182689|4245470|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422161|NCT00182689|4245471|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422162|NCT00182689|4245469|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422163|NCT00182689|4245470|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422164|NCT00182689|4245471|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422170|NCT00182689|4245471|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422171|NCT00182689|4245469|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422172|NCT00182689|4245470|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422173|NCT00182689|4245471|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422174|NCT00182689|4245469|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422175|NCT00182689|4245470|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422176|NCT00182689|4245471|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422177|NCT00182689|4245469|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4422178|NCT00182689|4245470|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4422179|NCT00182689|4245471|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422180|NCT00182689|4245469|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4422181|NCT00182689|4245470|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4422182|NCT00182689|4245471|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4422183|NCT00182689|4245469|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4422184|NCT00182689|4245470|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4422185|NCT00182689|4245471|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4422186|NCT00182689|4245469|B3|||Age||years|Median|62|62.0|Full Range|||44.0|85.0|
4422187|NCT00182689|4245470|B2|||Age||years|Median|60|60.0|Full Range|||44.0|80.0|
4422188|NCT00182689|4245471|B1|||Age||years|Median|65|65.0|Full Range|||48.0|85.0|
4422189|NCT00182637|4245482|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4422190|NCT00182637|4245482|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422191|NCT00182637|4245482|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422192|NCT00182637|4245482|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4422193|NCT00182637|4245482|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422194|NCT00182637|4245482|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422195|NCT00182637|4245482|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422196|NCT00182637|4245482|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422197|NCT00182637|4245482|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4422198|NCT00182637|4245482|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4422199|NCT00182637|4245482|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4422200|NCT00182637|4245482|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4422201|NCT00182637|4245482|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422202|NCT00182091|4245488|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4422203|NCT00182091|4245489|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4422204|NCT00182091|4245490|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4422205|NCT00182091|4245491|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4422206|NCT00182091|4245492|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4422207|NCT00182091|4245488|B5||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4422208|NCT00182091|4245489|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4422209|NCT00182091|4245490|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4422210|NCT00182091|4245491|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4422211|NCT00182091|4245492|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4422212|NCT00182091|4245488|B5|||Age||years|Mean|46|46.0|Standard Deviation|12|12.0|||
4422213|NCT00182091|4245489|B4|||Age||years|Mean|46|46.0|Standard Deviation|14|14.0|||
4422214|NCT00182091|4245490|B3|||Age||years|Mean|47|47.0|Standard Deviation|12|12.0|||
4422215|NCT00182091|4245491|B2|||Age||years|Mean|47|47.0|Standard Deviation|11|11.0|||
4422216|NCT00182091|4245492|B1|||Age||years|Mean|47|47.0|Standard Deviation|12|12.0|||
4422217|NCT00182078|4245509|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4422218|NCT00182078|4245510|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4422219|NCT00182078|4245511|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4422220|NCT00182078|4245509|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4422221|NCT00182078|4245510|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4422222|NCT00182078|4245511|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4422223|NCT00182078|4245509|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4422224|NCT00182078|4245510|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4422225|NCT00182078|4245511|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4422226|NCT00182078|4245509|B3|||Age||years|Mean|12.35|12.35|Standard Deviation|3.71|3.71|||
4422227|NCT00182078|4245510|B2|||Age||years|Mean|12.3|12.3|Standard Deviation|3.9|3.9|||
4422228|NCT00182078|4245511|B1|||Age||years|Mean|12.4|12.4|Standard Deviation|3.5|3.5|||
4422229|NCT00182078|4245509|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422230|NCT00182078|4245510|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422231|NCT00182078|4245511|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422232|NCT00182078|4245509|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4422233|NCT00182078|4245510|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4422234|NCT00182078|4245511|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4422235|NCT00182078|4245509|B3||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4422236|NCT00182078|4245510|B2||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4422237|NCT00182078|4245511|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4422238|NCT00182000|4245522|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4422239|NCT00182000|4245523|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4422240|NCT00182000|4245524|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4422241|NCT00182000|4245522|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4422242|NCT00182000|4245523|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4422243|NCT00182000|4245524|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4422244|NCT00182000|4245522|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4422245|NCT00182000|4245523|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4422246|NCT00182000|4245524|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4422247|NCT00182000|4245522|B3|||Age||years|Mean|38.18|38.18|Standard Deviation|12.4|12.4|||
4422248|NCT00182000|4245523|B2|||Age||years|Mean|38.07|38.07|Standard Deviation|12.28|12.28|||
4422249|NCT00182000|4245524|B1|||Age||years|Mean|38.29|38.29|Standard Deviation|13.01|13.01|||
4422250|NCT00182000|4245522|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422251|NCT00182000|4245523|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422252|NCT00182000|4245524|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422253|NCT00182000|4245522|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4422254|NCT00182000|4245523|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4422255|NCT00182000|4245524|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4422256|NCT00182000|4245522|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422257|NCT00182000|4245523|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422258|NCT00182000|4245524|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422259|NCT00181883|4245531|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4422260|NCT00181883|4245531|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4422261|NCT00181883|4245531|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4422262|NCT00181883|4245531|B1|||Age||years|Mean|5.2|5.2|Standard Deviation|0.7|0.7|||
4422263|NCT00181883|4245531|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422264|NCT00181883|4245531|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4422265|NCT00181883|4245531|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4422266|NCT00181844|4245535|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4422267|NCT00181844|4245535|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4422268|NCT00181844|4245535|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4422269|NCT00181844|4245535|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|2.9|2.9|||
4422270|NCT00181844|4245535|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422271|NCT00181844|4245535|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4422272|NCT00181844|4245535|B1||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4422273|NCT00181766|4245539|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4422274|NCT00181766|4245539|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4422275|NCT00181766|4245539|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4422276|NCT00181766|4245539|B1|||Age||years|Mean|39.5|39.5|Standard Deviation|9.6|9.6|||
4422277|NCT00181766|4245539|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422278|NCT00181766|4245539|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4422279|NCT00181766|4245539|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422280|NCT00181714|4245544|B1|United States||Region of Enrollment||participants|Number|154|154.0||||||
4422281|NCT00181714|4245544|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4422282|NCT00181714|4245544|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4422283|NCT00181714|4245544|B1|||Age||years|Mean|15.3|15.3|Standard Deviation|1.8|1.8|||
4422284|NCT00181714|4245544|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422285|NCT00181714|4245544|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4422286|NCT00181714|4245544|B1||<=18 years|Age||Participants|Count of Participants|154|154.0||||||
4422287|NCT00181623|4245548|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4422288|NCT00181623|4245548|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422289|NCT00181623|4245548|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4422290|NCT00181623|4245548|B1|||Age||years|Mean|30|30.0|Standard Deviation|5|5.0|||
4422291|NCT00181623|4245548|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422292|NCT00181623|4245548|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4422293|NCT00181623|4245548|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422294|NCT00181610|4245553|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4422295|NCT00181610|4245554|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4422296|NCT00181610|4245555|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4422297|NCT00181610|4245556|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4422298|NCT00181610|4245553|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422299|NCT00181610|4245554|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422300|NCT00181610|4245555|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422301|NCT00181610|4245556|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422302|NCT00181610|4245553|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4422303|NCT00181610|4245554|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4422304|NCT00181610|4245555|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4422305|NCT00181610|4245556|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4422306|NCT00181610|4245553|B4|||Age||years|Mean|32|32.0|Standard Deviation|5|5.0|||
4422307|NCT00181610|4245554|B3|||Age||years|Mean|32|32.0|Standard Deviation|6|6.0|||
4422308|NCT00181610|4245555|B2|||Age||years|Mean|30|30.0|Standard Deviation|5|5.0|||
4422309|NCT00181610|4245556|B1|||Age||years|Mean|30|30.0|Standard Deviation|5|5.0|||
4422310|NCT00181610|4245553|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422311|NCT00181610|4245554|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422312|NCT00181610|4245555|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422313|NCT00181610|4245556|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422314|NCT00181610|4245553|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4422315|NCT00181610|4245554|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4422316|NCT00181610|4245555|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4422317|NCT00181610|4245556|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4422318|NCT00181610|4245553|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422319|NCT00181610|4245554|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422320|NCT00181610|4245555|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422321|NCT00181610|4245556|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422322|NCT00181285|4245569|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4422323|NCT00181285|4245569|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422324|NCT00181285|4245569|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422325|NCT00181285|4245569|B3|||Age||years|Median|48.5|48.5|Inter-Quartile Range|||41.1|55.3|
4422326|NCT00181285|4245570|B2|||Age||years|Median|46.5|46.5|Inter-Quartile Range|||38.6|52.8|
4422327|NCT00181285|4245571|B1|||Age||years|Median|50.4|50.4|Inter-Quartile Range|||43.9|60.7|
4422328|NCT00181207|4245580|B3|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4422329|NCT00181207|4245581|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4422330|NCT00181207|4245582|B1|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4422331|NCT00181207|4245580|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422332|NCT00181207|4245581|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422333|NCT00181207|4245582|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422334|NCT00181207|4245580|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422335|NCT00181207|4245581|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422336|NCT00181207|4245582|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422337|NCT00181207|4245580|B3||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4422338|NCT00181207|4245581|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4422339|NCT00181207|4245582|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4422340|NCT00181207|4245580|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4422341|NCT00181207|4245581|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4422342|NCT00181207|4245582|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4422343|NCT00181207|4245580|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422344|NCT00181207|4245581|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422345|NCT00181207|4245582|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422346|NCT00181207|4245580|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422347|NCT00181207|4245581|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422348|NCT00181207|4245582|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422349|NCT00181207|4245580|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422350|NCT00181207|4245581|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422351|NCT00181207|4245582|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422352|NCT00181207|4245580|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4422353|NCT00181207|4245581|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4422354|NCT00181207|4245582|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4422355|NCT00181207|4245580|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4422356|NCT00181207|4245581|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4422357|NCT00181207|4245582|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4422358|NCT00181207|4245580|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|8.1|8.1|||
4422359|NCT00181207|4245581|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|7.4|7.4|||
4422360|NCT00181207|4245582|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|9.0|9.0|||
4422361|NCT00181168|4245591|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4422362|NCT00181168|4245592|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4422363|NCT00181168|4245593|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4422364|NCT00181168|4245591|B3|France||Region of Enrollment||participants|Number|27|27.0||||||
4422365|NCT00181168|4245592|B2|France||Region of Enrollment||participants|Number|14|14.0||||||
4422366|NCT00181168|4245593|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4422367|NCT00181168|4245591|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4422368|NCT00181168|4245592|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4422369|NCT00181168|4245593|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4422370|NCT00181168|4245591|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4422371|NCT00181168|4245592|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4422372|NCT00181168|4245593|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4422373|NCT00181168|4245591|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422374|NCT00181168|4245592|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422375|NCT00181168|4245593|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422376|NCT00181168|4245591|B3||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4422377|NCT00181168|4245592|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4422378|NCT00181168|4245593|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4422379|NCT00181168|4245591|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422380|NCT00181168|4245592|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422381|NCT00181168|4245593|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422382|NCT00181155|4245600|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4422383|NCT00181155|4245600|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4422384|NCT00181155|4245600|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4422385|NCT00181155|4245600|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|12.9|12.9|||
4422386|NCT00181155|4245600|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422387|NCT00181155|4245600|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4422388|NCT00181155|4245600|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422389|NCT00180687|4245609|B5|United Kingdom||Region of Enrollment||participants|Number|80|80.0||||||
4422390|NCT00180687|4245610|B4|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4422391|NCT00180687|4245611|B3|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4422392|NCT00180687|4245612|B2|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4422393|NCT00180687|4245613|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4422394|NCT00180687|4245609|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4422395|NCT00180687|4245610|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4422396|NCT00180687|4245611|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4422397|NCT00180687|4245612|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4422398|NCT00180687|4245613|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4422399|NCT00180687|4245609|B5||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4422400|NCT00180687|4245610|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4422401|NCT00180687|4245611|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4422402|NCT00180687|4245612|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4422403|NCT00180687|4245613|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4422404|NCT00180687|4245609|B5|||Age||Years|Mean|49|49.0|Full Range|||25.0|83.0|
4422405|NCT00180687|4245610|B4|||Age||Years|Mean|48.70|48.7|Full Range|||34.0|79.0|
4422406|NCT00180687|4245611|B3|||Age||Years|Mean|51.60|51.6|Full Range|||25.0|83.0|
4422407|NCT00180687|4245612|B2|||Age||Years|Mean|47.65|47.65|Full Range|||26.0|74.0|
4422408|NCT00180687|4245613|B1|||Age||Years|Mean|47.65|47.65|Full Range|||25.0|75.0|
4422409|NCT00180479|4245638|B3|United States||Region of Enrollment|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|1002|1002.0||||||
4422410|NCT00180479|4245639|B2|United States||Region of Enrollment|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|333|333.0||||||
4422411|NCT00180479|4245640|B1|United States||Region of Enrollment|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|669|669.0||||||
4422412|NCT00180479|4245638|B3|Male||Gender|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|687|687.0||||||
4422466|NCT00180271|4245742|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4422413|NCT00180479|4245639|B2|Male||Gender|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|218|218.0||||||
4422414|NCT00180479|4245640|B1|Male||Gender|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|469|469.0||||||
4422415|NCT00180479|4245638|B3|Female||Gender|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|314|314.0||||||
4422416|NCT00180479|4245639|B2|Female||Gender|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|114|114.0||||||
4422417|NCT00180479|4245640|B1|Female||Gender|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|200|200.0||||||
4422418|NCT00180479|4245638|B3|||Age|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|years|Mean|63.08|63.08|Standard Deviation|10.43|10.43|||
4422419|NCT00180479|4245639|B2|||Age|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|years|Mean|62.80|62.8|Standard Deviation|10.24|10.24|||
4422420|NCT00180479|4245640|B1|||Age|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|years|Mean|63.23|63.23|Standard Deviation|10.53|10.53|||
4422421|NCT00180479|4245638|B3|>=65 years||Age|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|434|434.0||||||
4422422|NCT00180479|4245639|B2|>=65 years||Age|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|141|141.0||||||
4422423|NCT00180479|4245640|B1|>=65 years||Age|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|293|293.0||||||
4422424|NCT00180479|4245638|B3|Between 18 and 65 years||Age|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|567|567.0||||||
4422425|NCT00180479|4245639|B2|Between 18 and 65 years||Age|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|191|191.0||||||
4422426|NCT00180479|4245640|B1|Between 18 and 65 years||Age|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|376|376.0||||||
4422427|NCT00180479|4245638|B3|<=18 years||Age|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|0|0.0||||||
4422428|NCT00180479|4245639|B2|<=18 years||Age|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|0|0.0||||||
4422429|NCT00180479|4245640|B1|<=18 years||Age|1 patient randomized never signed consent, therefore no data collected. Taxus analysis group = 332.|participants|Number|0|0.0||||||
4422430|NCT00180323|4245733|B1|Denmark||Region of Enrollment||participants|Number|43|43.0||||||
4422431|NCT00180323|4245733|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4422432|NCT00180323|4245733|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4422433|NCT00180323|4245733|B1|||Age||years|Mean|61|61.0|Standard Deviation|11|11.0|||
4422434|NCT00180323|4245733|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4422435|NCT00180323|4245733|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4422436|NCT00180323|4245733|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422437|NCT00180271|4245740|B3|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4422438|NCT00180271|4245741|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4422439|NCT00180271|4245742|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4422440|NCT00180271|4245740|B3|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
4422441|NCT00180271|4245741|B2|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4422442|NCT00180271|4245742|B1|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4422443|NCT00180271|4245740|B3|Spain||Region of Enrollment||participants|Number|60|60.0||||||
4422444|NCT00180271|4245741|B2|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4422445|NCT00180271|4245742|B1|Spain||Region of Enrollment||participants|Number|36|36.0||||||
4422446|NCT00180271|4245740|B3|Poland||Region of Enrollment||participants|Number|24|24.0||||||
4422447|NCT00180271|4245741|B2|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4422448|NCT00180271|4245742|B1|Poland||Region of Enrollment||participants|Number|14|14.0||||||
4422449|NCT00180271|4245740|B3|Netherlands||Region of Enrollment||participants|Number|58|58.0||||||
4422450|NCT00180271|4245741|B2|Netherlands||Region of Enrollment||participants|Number|24|24.0||||||
4422451|NCT00180271|4245742|B1|Netherlands||Region of Enrollment||participants|Number|34|34.0||||||
4422452|NCT00180271|4245740|B3|Italy||Region of Enrollment||participants|Number|27|27.0||||||
4422453|NCT00180271|4245741|B2|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4422454|NCT00180271|4245742|B1|Italy||Region of Enrollment||participants|Number|15|15.0||||||
4422455|NCT00180271|4245740|B3|Israel||Region of Enrollment||participants|Number|75|75.0||||||
4422456|NCT00180271|4245741|B2|Israel||Region of Enrollment||participants|Number|30|30.0||||||
4422457|NCT00180271|4245742|B1|Israel||Region of Enrollment||participants|Number|45|45.0||||||
4422458|NCT00180271|4245740|B3|Hungary||Region of Enrollment||participants|Number|26|26.0||||||
4422459|NCT00180271|4245741|B2|Hungary||Region of Enrollment||participants|Number|10|10.0||||||
4422460|NCT00180271|4245742|B1|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
4422461|NCT00180271|4245740|B3|Germany||Region of Enrollment||participants|Number|159|159.0||||||
4422462|NCT00180271|4245741|B2|Germany||Region of Enrollment||participants|Number|61|61.0||||||
4422463|NCT00180271|4245742|B1|Germany||Region of Enrollment||participants|Number|98|98.0||||||
4422464|NCT00180271|4245740|B3|France||Region of Enrollment||participants|Number|22|22.0||||||
4422465|NCT00180271|4245741|B2|France||Region of Enrollment||participants|Number|9|9.0||||||
4422467|NCT00180271|4245740|B3|Denmark||Region of Enrollment||participants|Number|35|35.0||||||
4422468|NCT00180271|4245741|B2|Denmark||Region of Enrollment||participants|Number|13|13.0||||||
4422469|NCT00180271|4245742|B1|Denmark||Region of Enrollment||participants|Number|22|22.0||||||
4422470|NCT00180271|4245740|B3|Czech Republic||Region of Enrollment||participants|Number|28|28.0||||||
4422471|NCT00180271|4245741|B2|Czech Republic||Region of Enrollment||participants|Number|11|11.0||||||
4422472|NCT00180271|4245742|B1|Czech Republic||Region of Enrollment||participants|Number|17|17.0||||||
4422473|NCT00180271|4245740|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4422474|NCT00180271|4245741|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4422475|NCT00180271|4245742|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4422476|NCT00180271|4245740|B3|United States||Region of Enrollment||participants|Number|1271|1271.0||||||
4422477|NCT00180271|4245741|B2|United States||Region of Enrollment||participants|Number|514|514.0||||||
4422478|NCT00180271|4245742|B1|United States||Region of Enrollment||participants|Number|757|757.0||||||
4422479|NCT00180271|4245740|B3||Male|Sex: Female, Male||Participants|Count of Participants|1367|1367.0||||||
4422480|NCT00180271|4245741|B2||Male|Sex: Female, Male||Participants|Count of Participants|553|553.0||||||
4422481|NCT00180271|4245742|B1||Male|Sex: Female, Male||Participants|Count of Participants|814|814.0||||||
4422482|NCT00180271|4245740|B3||Female|Sex: Female, Male||Participants|Count of Participants|453|453.0||||||
4422483|NCT00180271|4245741|B2||Female|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4422484|NCT00180271|4245742|B1||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4422485|NCT00180271|4245740|B3|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
4422486|NCT00180271|4245741|B2|||Age||years|Mean|64|64.0|Standard Deviation|11|11.0|||
4422487|NCT00180271|4245742|B1|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
4422488|NCT00180271|4245740|B3||>=65 years|Age||Participants|Count of Participants|897|897.0||||||
4422489|NCT00180271|4245741|B2||>=65 years|Age||Participants|Count of Participants|351|351.0||||||
4422490|NCT00180271|4245742|B1||>=65 years|Age||Participants|Count of Participants|546|546.0||||||
4422491|NCT00180271|4245740|B3||Between 18 and 65 years|Age||Participants|Count of Participants|923|923.0||||||
4422492|NCT00180271|4245741|B2||Between 18 and 65 years|Age||Participants|Count of Participants|380|380.0||||||
4422493|NCT00180271|4245742|B1||Between 18 and 65 years|Age||Participants|Count of Participants|543|543.0||||||
4422494|NCT00180271|4245740|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422495|NCT00180271|4245741|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422496|NCT00180271|4245742|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422497|NCT00179959|4245751|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4422498|NCT00179959|4245752|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4422499|NCT00179959|4245753|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4422500|NCT00179959|4245751|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4422501|NCT00179959|4245752|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4422502|NCT00179959|4245753|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4422503|NCT00179959|4245751|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4422504|NCT00179959|4245752|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4422505|NCT00179959|4245753|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4422506|NCT00179959|4245751|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422507|NCT00179959|4245752|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422508|NCT00179959|4245753|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422509|NCT00179959|4245751|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4422510|NCT00179959|4245752|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4422511|NCT00179959|4245753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4422512|NCT00179959|4245751|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4422513|NCT00179959|4245752|B2||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4422514|NCT00179959|4245753|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4422515|NCT00179673|4245760|B1|2 = ambulatory and capable of self care but unable||Eastern Cooperative Oncology Group (ECOG) performance status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determines appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|4|4.0||||||
4422516|NCT00179673|4245760|B1|1 = restricted but ambulatory and capable of light||Eastern Cooperative Oncology Group (ECOG) performance status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determines appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|12|12.0||||||
4422582|NCT00179621|4245783|B2|Specimen not adequate from diagnosis||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|11|11.0||||||
4422517|NCT00179673|4245760|B1|0 = fully active, no restrictions;||Eastern Cooperative Oncology Group (ECOG) performance status|"ECOG-Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determines appropriate treatment and prognosis.~0 = Fully Active (Most Favorable Activity); 1 = Restricted activity but ambulatory; 2 = Ambulatory but unable to carry out work activities; 3 = Limited Self-Care; 4 = Completely Disabled, No self-care (Least Favorable Activity)"|participants|Number|27|27.0||||||
4422518|NCT00179673|4245760|B1|High (4 to 5)||International Prognostic Index (IPI)]|"A clinical tool to aid in predicting the prognosis of patients with NHL. One point is assigned for each of the following risk factors:~Age greater than 60 years~Stage III or IV disease~Elevated serum lactate dehydrogenase~ECOG performance status of 2, 3, or 4~1 extranodal site~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points): 5-year survival of 73%; Low-intermediate risk (2 points): 5-year survival of 51%; High-intermediate risk (3 points): 5-year survival of 43%; High risk (4-5 points): 5-year survival of 26%."|participants|Number|8|8.0||||||
4422519|NCT00179673|4245760|B1|High/Intermediate (3)||International Prognostic Index (IPI)]|"A clinical tool to aid in predicting the prognosis of patients with NHL. One point is assigned for each of the following risk factors:~Age greater than 60 years~Stage III or IV disease~Elevated serum lactate dehydrogenase~ECOG performance status of 2, 3, or 4~1 extranodal site~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points): 5-year survival of 73%; Low-intermediate risk (2 points): 5-year survival of 51%; High-intermediate risk (3 points): 5-year survival of 43%; High risk (4-5 points): 5-year survival of 26%."|participants|Number|6|6.0||||||
4422520|NCT00179673|4245760|B1|Low/Intermediate (2)||International Prognostic Index (IPI)]|"A clinical tool to aid in predicting the prognosis of patients with NHL. One point is assigned for each of the following risk factors:~Age greater than 60 years~Stage III or IV disease~Elevated serum lactate dehydrogenase~ECOG performance status of 2, 3, or 4~1 extranodal site~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points): 5-year survival of 73%; Low-intermediate risk (2 points): 5-year survival of 51%; High-intermediate risk (3 points): 5-year survival of 43%; High risk (4-5 points): 5-year survival of 26%."|participants|Number|15|15.0||||||
4422521|NCT00179673|4245760|B1|Low (0 to 1)||International Prognostic Index (IPI)]|"A clinical tool to aid in predicting the prognosis of patients with NHL. One point is assigned for each of the following risk factors:~Age greater than 60 years~Stage III or IV disease~Elevated serum lactate dehydrogenase~ECOG performance status of 2, 3, or 4~1 extranodal site~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points): 5-year survival of 73%; Low-intermediate risk (2 points): 5-year survival of 51%; High-intermediate risk (3 points): 5-year survival of 43%; High risk (4-5 points): 5-year survival of 26%."|participants|Number|14|14.0||||||
4422522|NCT00179673|4245760|B1|Stage IV||Non-Hodgkin's Lymphoma (NHL)-Stage|"I: The lymphoma is in only 1 lymph node area or 1 area of a single organ outside the lymph system.~II: The lymphoma is in 2 or more groups of lymph nodes on the same side of the diaphragm, or extends from a single group of node(s) into a nearby organ.~III: The lymphoma is found in lymph node areas on both sides of the diaphragm, or may also have spread into an area or organ next to the lymph nodes, the spleen, or both.~IV: The lymphoma has spread outside the lymph system into an organ that is not next to an involved node or has spread to bone marrow, liver, brain, spinal cord or the pleura."|participants|Number|25|25.0||||||
4422523|NCT00179673|4245760|B1|Stage III||Non-Hodgkin's Lymphoma (NHL)-Stage|"I: The lymphoma is in only 1 lymph node area or 1 area of a single organ outside the lymph system.~II: The lymphoma is in 2 or more groups of lymph nodes on the same side of the diaphragm, or extends from a single group of node(s) into a nearby organ.~III: The lymphoma is found in lymph node areas on both sides of the diaphragm, or may also have spread into an area or organ next to the lymph nodes, the spleen, or both.~IV: The lymphoma has spread outside the lymph system into an organ that is not next to an involved node or has spread to bone marrow, liver, brain, spinal cord or the pleura."|participants|Number|6|6.0||||||
4422524|NCT00179673|4245760|B1|Stage II||Non-Hodgkin's Lymphoma (NHL)-Stage|"I: The lymphoma is in only 1 lymph node area or 1 area of a single organ outside the lymph system.~II: The lymphoma is in 2 or more groups of lymph nodes on the same side of the diaphragm, or extends from a single group of node(s) into a nearby organ.~III: The lymphoma is found in lymph node areas on both sides of the diaphragm, or may also have spread into an area or organ next to the lymph nodes, the spleen, or both.~IV: The lymphoma has spread outside the lymph system into an organ that is not next to an involved node or has spread to bone marrow, liver, brain, spinal cord or the pleura."|participants|Number|11|11.0||||||
4422525|NCT00179673|4245760|B1|Stage I||Non-Hodgkin's Lymphoma (NHL)-Stage|"I: The lymphoma is in only 1 lymph node area or 1 area of a single organ outside the lymph system.~II: The lymphoma is in 2 or more groups of lymph nodes on the same side of the diaphragm, or extends from a single group of node(s) into a nearby organ.~III: The lymphoma is found in lymph node areas on both sides of the diaphragm, or may also have spread into an area or organ next to the lymph nodes, the spleen, or both.~IV: The lymphoma has spread outside the lymph system into an organ that is not next to an involved node or has spread to bone marrow, liver, brain, spinal cord or the pleura."|participants|Number|1|1.0||||||
4422526|NCT00179673|4245760|B1|Extranodal marginal-zone B-cell type (MALT)||Non-Hodgkin's Lymphoma (NHL) Histology|"I: The lymphoma is in only 1 lymph node area or 1 area of a single organ outside the lymph system.~II: The lymphoma is in 2 or more groups of lymph nodes on the same side of the diaphragm, or extends from a single group of node(s) into a nearby organ.~III: The lymphoma is found in lymph node areas on both sides of the diaphragm, or may also have spread into an area or organ next to the lymph nodes, the spleen, or both.~IV: The lymphoma has spread outside the lymph system into an organ that is not next to an involved node or has spread to bone marrow, liver, brain, spinal cord or the pleura."|participants|Number|1|1.0||||||
4422527|NCT00179673|4245760|B1|Nodal marginal-zone B-cell lymphoma||Non-Hodgkin's Lymphoma (NHL) Histology|"I: The lymphoma is in only 1 lymph node area or 1 area of a single organ outside the lymph system.~II: The lymphoma is in 2 or more groups of lymph nodes on the same side of the diaphragm, or extends from a single group of node(s) into a nearby organ.~III: The lymphoma is found in lymph node areas on both sides of the diaphragm, or may also have spread into an area or organ next to the lymph nodes, the spleen, or both.~IV: The lymphoma has spread outside the lymph system into an organ that is not next to an involved node or has spread to bone marrow, liver, brain, spinal cord or the pleura."|participants|Number|2|2.0||||||
4422528|NCT00179673|4245760|B1|Small Lymphocytic lymphoma||Non-Hodgkin's Lymphoma (NHL) Histology|"I: The lymphoma is in only 1 lymph node area or 1 area of a single organ outside the lymph system.~II: The lymphoma is in 2 or more groups of lymph nodes on the same side of the diaphragm, or extends from a single group of node(s) into a nearby organ.~III: The lymphoma is found in lymph node areas on both sides of the diaphragm, or may also have spread into an area or organ next to the lymph nodes, the spleen, or both.~IV: The lymphoma has spread outside the lymph system into an organ that is not next to an involved node or has spread to bone marrow, liver, brain, spinal cord or the pleura."|participants|Number|18|18.0||||||
4422529|NCT00179673|4245760|B1|Follicular lymphoma grade 1 or 2||Non-Hodgkin's Lymphoma (NHL) Histology|"I: The lymphoma is in only 1 lymph node area or 1 area of a single organ outside the lymph system.~II: The lymphoma is in 2 or more groups of lymph nodes on the same side of the diaphragm, or extends from a single group of node(s) into a nearby organ.~III: The lymphoma is found in lymph node areas on both sides of the diaphragm, or may also have spread into an area or organ next to the lymph nodes, the spleen, or both.~IV: The lymphoma has spread outside the lymph system into an organ that is not next to an involved node or has spread to bone marrow, liver, brain, spinal cord or the pleura."|participants|Number|22|22.0||||||
4422530|NCT00179673|4245760|B1|||NHL Duration||years|Mean|5.6|5.6|Standard Deviation|4.38|4.38|||
4422531|NCT00179673|4245760|B1|Other = Unspecified||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4422532|NCT00179673|4245760|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4422533|NCT00179673|4245760|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4422534|NCT00179673|4245760|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4422535|NCT00179673|4245760|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4422536|NCT00179673|4245760|B1|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4422537|NCT00179673|4245760|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4422538|NCT00179673|4245760|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4422539|NCT00179673|4245760|B1|>75 years||Age, Customized||participants|Number|9|9.0||||||
4422540|NCT00179673|4245760|B1|65 - 75||Age, Customized||participants|Number|10|10.0||||||
4422541|NCT00179673|4245760|B1|<65 years||Age, Customized||participants|Number|24|24.0||||||
4422542|NCT00179673|4245760|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|10.95|10.95|||
4422543|NCT00179660|4245768|B1|High (4 to 5)||International Prognostic Index (IPI)|"A clinical tool to aid in predicting the prognosis of patients with aggressive NHL. One point is assigned for each of the following risk factors:~Age greater than 60 years~Stage III or IV disease~Elevated serum lactate dehydrogenase~ECOG performance status of 2, 3, or 4 -> 1 extranodal site~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points): 5-year survival of 73% Low-intermediate risk (2 points): 5-year survival of 51% High-intermediate risk (3 points): 5-year survival of 43% High risk (4-5 points): 5-year survival of 26%"|participants|Number|6|6.0||||||
4422544|NCT00179660|4245768|B1|High/Intermediate (3)||International Prognostic Index (IPI)|"A clinical tool to aid in predicting the prognosis of patients with aggressive NHL. One point is assigned for each of the following risk factors:~Age greater than 60 years~Stage III or IV disease~Elevated serum lactate dehydrogenase~ECOG performance status of 2, 3, or 4 -> 1 extranodal site~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points): 5-year survival of 73% Low-intermediate risk (2 points): 5-year survival of 51% High-intermediate risk (3 points): 5-year survival of 43% High risk (4-5 points): 5-year survival of 26%"|participants|Number|13|13.0||||||
4422545|NCT00179660|4245768|B1|Low/Intermediate (2)||International Prognostic Index (IPI)|"A clinical tool to aid in predicting the prognosis of patients with aggressive NHL. One point is assigned for each of the following risk factors:~Age greater than 60 years~Stage III or IV disease~Elevated serum lactate dehydrogenase~ECOG performance status of 2, 3, or 4 -> 1 extranodal site~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points): 5-year survival of 73% Low-intermediate risk (2 points): 5-year survival of 51% High-intermediate risk (3 points): 5-year survival of 43% High risk (4-5 points): 5-year survival of 26%"|participants|Number|22|22.0||||||
4422546|NCT00179660|4245768|B1|Low (0 to 1)||International Prognostic Index (IPI)|"A clinical tool to aid in predicting the prognosis of patients with aggressive NHL. One point is assigned for each of the following risk factors:~Age greater than 60 years~Stage III or IV disease~Elevated serum lactate dehydrogenase~ECOG performance status of 2, 3, or 4 -> 1 extranodal site~The sum of the points allotted correlates with the following risk groups:~Low risk (0-1 points): 5-year survival of 73% Low-intermediate risk (2 points): 5-year survival of 51% High-intermediate risk (3 points): 5-year survival of 43% High risk (4-5 points): 5-year survival of 26%"|participants|Number|8|8.0||||||
4422547|NCT00179660|4245768|B1|||NHL Duration||years|Mean|4.0|4.0|Standard Deviation|4.91|4.91|||
4422548|NCT00179660|4245768|B1|Transformed||NHL histology||participants|Number|3|3.0||||||
4422549|NCT00179660|4245768|B1|Mantle cell lymphoma||NHL histology||participants|Number|15|15.0||||||
4422550|NCT00179660|4245768|B1|Diffuse large B-cell lymphoma||NHL histology||participants|Number|26|26.0||||||
4422551|NCT00179660|4245768|B1|Follicular lymphoma grade 3||NHL histology||participants|Number|5|5.0||||||
4422552|NCT00179660|4245768|B1|Stage IV||Non-Hodgkin's Lymphoma (NHL) Stage|"I: The lymphoma is in only 1 lymph node area or 1 area of a single organ outside the lymph system.~II: The lymphoma is in 2 or more groups of lymph nodes on the same side of the diaphragm, or extends from a single group of node(s) into a nearby organ.~III: The lymphoma is found in lymph node areas on both sides of the diaphragm, or may also have spread into an area or organ next to the lymph nodes, the spleen, or both.~IV: The lymphoma has spread outside the lymph system into an organ that is not next to an involved node or has spread to bone marrow, liver, brain, spinal cord or the pleura."|participants|Number|32|32.0||||||
4422583|NCT00179621|4245784|B1|Specimen not adequate from diagnosis||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|12|12.0||||||
4422745|NCT00179413|4245877|B3||Male|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
4422553|NCT00179660|4245768|B1|Stage III||Non-Hodgkin's Lymphoma (NHL) Stage|"I: The lymphoma is in only 1 lymph node area or 1 area of a single organ outside the lymph system.~II: The lymphoma is in 2 or more groups of lymph nodes on the same side of the diaphragm, or extends from a single group of node(s) into a nearby organ.~III: The lymphoma is found in lymph node areas on both sides of the diaphragm, or may also have spread into an area or organ next to the lymph nodes, the spleen, or both.~IV: The lymphoma has spread outside the lymph system into an organ that is not next to an involved node or has spread to bone marrow, liver, brain, spinal cord or the pleura."|participants|Number|9|9.0||||||
4422554|NCT00179660|4245768|B1|Stage II||Non-Hodgkin's Lymphoma (NHL) Stage|"I: The lymphoma is in only 1 lymph node area or 1 area of a single organ outside the lymph system.~II: The lymphoma is in 2 or more groups of lymph nodes on the same side of the diaphragm, or extends from a single group of node(s) into a nearby organ.~III: The lymphoma is found in lymph node areas on both sides of the diaphragm, or may also have spread into an area or organ next to the lymph nodes, the spleen, or both.~IV: The lymphoma has spread outside the lymph system into an organ that is not next to an involved node or has spread to bone marrow, liver, brain, spinal cord or the pleura."|participants|Number|7|7.0||||||
4422555|NCT00179660|4245768|B1|Stage I||Non-Hodgkin's Lymphoma (NHL) Stage|"I: The lymphoma is in only 1 lymph node area or 1 area of a single organ outside the lymph system.~II: The lymphoma is in 2 or more groups of lymph nodes on the same side of the diaphragm, or extends from a single group of node(s) into a nearby organ.~III: The lymphoma is found in lymph node areas on both sides of the diaphragm, or may also have spread into an area or organ next to the lymph nodes, the spleen, or both.~IV: The lymphoma has spread outside the lymph system into an organ that is not next to an involved node or has spread to bone marrow, liver, brain, spinal cord or the pleura."|participants|Number|1|1.0||||||
4422556|NCT00179660|4245768|B1|Missing||Eastern Cooperative Oncology Group (ECOG) performance status|0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self care but unable to work.|participants|Number|1|1.0||||||
4422557|NCT00179660|4245768|B1|2||Eastern Cooperative Oncology Group (ECOG) performance status|0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self care but unable to work.|participants|Number|5|5.0||||||
4422558|NCT00179660|4245768|B1|1||Eastern Cooperative Oncology Group (ECOG) performance status|0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self care but unable to work.|participants|Number|23|23.0||||||
4422559|NCT00179660|4245768|B1|0||Eastern Cooperative Oncology Group (ECOG) performance status|0 = fully active, no restrictions; 1 = restricted but ambulatory and capable of light work; 2 = ambulatory and capable of self care but unable to work.|participants|Number|20|20.0||||||
4422560|NCT00179660|4245768|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4422561|NCT00179660|4245768|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4422562|NCT00179660|4245768|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4422563|NCT00179660|4245768|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4422564|NCT00179660|4245768|B1|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4422565|NCT00179660|4245768|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4422566|NCT00179660|4245768|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4422567|NCT00179660|4245768|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|11.53|11.53|||
4422568|NCT00179647|4245777|B1|Canada||Region of Enrollment||participants|Number|730|730.0||||||
4422569|NCT00179647|4245777|B1|United States||Region of Enrollment||participants|Number|1183|1183.0||||||
4422570|NCT00179647|4245777|B1||Male|Sex: Female, Male||Participants|Count of Participants|1151|1151.0||||||
4422571|NCT00179647|4245777|B1||Female|Sex: Female, Male||Participants|Count of Participants|762|762.0||||||
4422572|NCT00179647|4245777|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|10.31|10.31|||
4422573|NCT00179647|4245777|B1||>=65 years|Age||Participants|Count of Participants|823|823.0||||||
4422574|NCT00179647|4245777|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1090|1090.0||||||
4422575|NCT00179647|4245777|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422576|NCT00179621|4245781|B4|Other or missing||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|7|7.0||||||
4422577|NCT00179621|4245782|B3|Other or missing||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|1|1.0||||||
4422578|NCT00179621|4245783|B2|Other or missing||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|2|2.0||||||
4422579|NCT00179621|4245784|B1|Other or missing||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|4|4.0||||||
4422580|NCT00179621|4245781|B4|Specimen not adequate from diagnosis||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|40|40.0||||||
4422581|NCT00179621|4245782|B3|Specimen not adequate from diagnosis||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|17|17.0||||||
4422746|NCT00179413|4245878|B2||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4422584|NCT00179621|4245781|B4|Chronic myelogenous leukemia (CML)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|1|1.0||||||
4422585|NCT00179621|4245782|B3|Chronic myelogenous leukemia (CML)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|1|1.0||||||
4422586|NCT00179621|4245783|B2|Chronic myelogenous leukemia (CML)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|0|0.0||||||
4422587|NCT00179621|4245784|B1|Chronic myelogenous leukemia (CML)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|0|0.0||||||
4422588|NCT00179621|4245781|B4|RAEB in transformation||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|1|1.0||||||
4422589|NCT00179621|4245782|B3|RAEB in transformation||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|0|0.0||||||
4422590|NCT00179621|4245783|B2|RAEB in transformation||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|0|0.0||||||
4422591|NCT00179621|4245784|B1|RAEB in transformation||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|1|1.0||||||
4422592|NCT00179621|4245781|B4|Chronic myelomonocytic leukemia (CMML)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|3|3.0||||||
4422593|NCT00179621|4245782|B3|Chronic myelomonocytic leukemia (CMML)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|0|0.0||||||
4422594|NCT00179621|4245783|B2|Chronic myelomonocytic leukemia (CMML)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|2|2.0||||||
4422595|NCT00179621|4245784|B1|Chronic myelomonocytic leukemia (CMML)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|1|1.0||||||
4422596|NCT00179621|4245781|B4|Refractory anemia with excess blasts (RAEB)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|22|22.0||||||
4422597|NCT00179621|4245782|B3|Refractory anemia with excess blasts (RAEB)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|9|9.0||||||
4422598|NCT00179621|4245783|B2|Refractory anemia with excess blasts (RAEB)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|9|9.0||||||
4422599|NCT00179621|4245784|B1|Refractory anemia with excess blasts (RAEB)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|4|4.0||||||
4422600|NCT00179621|4245781|B4|Refractory anemia with ringed sideroblasts (RARS)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|24|24.0||||||
4422601|NCT00179621|4245782|B3|Refractory anemia with ringed sideroblasts (RARS)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|9|9.0||||||
4422602|NCT00179621|4245783|B2|Refractory anemia with ringed sideroblasts (RARS)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|7|7.0||||||
4422603|NCT00179621|4245784|B1|Refractory anemia with ringed sideroblasts (RARS)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|8|8.0||||||
4422604|NCT00179621|4245781|B4|Refractory anemia (RA)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|107|107.0||||||
4422605|NCT00179621|4245782|B3|Refractory anemia (RA)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|32|32.0||||||
4422606|NCT00179621|4245783|B2|Refractory anemia (RA)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|38|38.0||||||
4422607|NCT00179621|4245784|B1|Refractory anemia (RA)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|37|37.0||||||
4422608|NCT00179621|4245781|B4|Missing data||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|50|50.0||||||
4422609|NCT00179621|4245782|B3|Missing data||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|22|22.0||||||
4422610|NCT00179621|4245783|B2|Missing data||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|15|15.0||||||
4422611|NCT00179621|4245784|B1|Missing data||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|13|13.0||||||
4422612|NCT00179621|4245781|B4|High Risk (≥ 2.5)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|1|1.0||||||
4422613|NCT00179621|4245782|B3|High Risk (≥ 2.5)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|1|1.0||||||
4422614|NCT00179621|4245783|B2|High Risk (≥ 2.5)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|0|0.0||||||
4422615|NCT00179621|4245784|B1|High Risk (≥ 2.5)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|0|0.0||||||
4422684|NCT00179478|4245865|B1|||Median T2 lesion # at onset||lesion counts|Median|13|13.0|Inter-Quartile Range|||8.0|22.0|
4422685|NCT00179478|4245863|B3|||EDSS > 2.5 at onset||Participants|Count of Participants|14|14.0||||||
4422686|NCT00179478|4245864|B2|||EDSS > 2.5 at onset||Participants|Count of Participants|4|4.0||||||
4422687|NCT00179478|4245865|B1|||EDSS > 2.5 at onset||Participants|Count of Participants|10|10.0||||||
4422616|NCT00179621|4245781|B4|Intermediate-2 (1.5 - 2.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|10|10.0||||||
4422617|NCT00179621|4245782|B3|Intermediate-2 (1.5 - 2.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|3|3.0||||||
4422618|NCT00179621|4245783|B2|Intermediate-2 (1.5 - 2.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|5|5.0||||||
4422619|NCT00179621|4245784|B1|Intermediate-2 (1.5 - 2.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|2|2.0||||||
4422620|NCT00179621|4245781|B4|Intermediate-1 (0.5 - 1.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|74|74.0||||||
4422621|NCT00179621|4245782|B3|Intermediate-1 (0.5 - 1.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|23|23.0||||||
4422622|NCT00179621|4245783|B2|Intermediate-1 (0.5 - 1.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|29|29.0||||||
4422623|NCT00179621|4245784|B1|Intermediate-1 (0.5 - 1.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|22|22.0||||||
4422624|NCT00179621|4245781|B4|Low risk (0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|70|70.0||||||
4422625|NCT00179621|4245782|B3|Low risk (0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|20|20.0||||||
4422626|NCT00179621|4245783|B2|Low risk (0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|20|20.0||||||
4422688|NCT00179478|4245863|B3|||EDSS 2.0-2.5 at onset||Participants|Count of Participants|39|39.0||||||
4422689|NCT00179478|4245864|B2|||EDSS 2.0-2.5 at onset||Participants|Count of Participants|15|15.0||||||
4422690|NCT00179478|4245865|B1|||EDSS 2.0-2.5 at onset||Participants|Count of Participants|24|24.0||||||
4422627|NCT00179621|4245784|B1|Low risk (0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|30|30.0||||||
4422628|NCT00179621|4245781|B4|Missing||5q- (31-33) Chromosomal Abnormality||Participants|Number|10|10.0||||||
4422629|NCT00179621|4245782|B3|Missing||5q- (31-33) Chromosomal Abnormality||Participants|Number|4|4.0||||||
4422630|NCT00179621|4245783|B2|Missing||5q- (31-33) Chromosomal Abnormality||Participants|Number|3|3.0||||||
4422631|NCT00179621|4245784|B1|Missing||5q- (31-33) Chromosomal Abnormality||Participants|Number|3|3.0||||||
4422632|NCT00179621|4245781|B4|No||5q- (31-33) Chromosomal Abnormality||Participants|Number|4|4.0||||||
4422633|NCT00179621|4245782|B3|No||5q- (31-33) Chromosomal Abnormality||Participants|Number|1|1.0||||||
4422634|NCT00179621|4245783|B2|No||5q- (31-33) Chromosomal Abnormality||Participants|Number|2|2.0||||||
4422635|NCT00179621|4245784|B1|No||5q- (31-33) Chromosomal Abnormality||Participants|Number|1|1.0||||||
4422636|NCT00179621|4245781|B4|Yes||5q- (31-33) Chromosomal Abnormality||Participants|Number|191|191.0||||||
4422637|NCT00179621|4245782|B3|Yes||5q- (31-33) Chromosomal Abnormality||Participants|Number|64|64.0||||||
4422638|NCT00179621|4245783|B2|Yes||5q- (31-33) Chromosomal Abnormality||Participants|Number|64|64.0||||||
4422639|NCT00179621|4245784|B1|Yes||5q- (31-33) Chromosomal Abnormality||Participants|Number|63|63.0||||||
4422640|NCT00179621|4245781|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4422641|NCT00179621|4245782|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4422642|NCT00179621|4245783|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4422643|NCT00179621|4245784|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4422644|NCT00179621|4245781|B4|White||Race/Ethnicity, Customized||participants|Number|202|202.0||||||
4422645|NCT00179621|4245782|B3|White||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4422646|NCT00179621|4245783|B2|White||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4422647|NCT00179621|4245784|B1|White||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4422648|NCT00179621|4245781|B4||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4422649|NCT00179621|4245782|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4422650|NCT00179621|4245783|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4422651|NCT00179621|4245784|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4422652|NCT00179621|4245781|B4||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4422653|NCT00179621|4245782|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4422654|NCT00179621|4245783|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4422655|NCT00179621|4245784|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4422656|NCT00179621|4245781|B4|||Age||years|Median|68.0|68.0|Full Range|||36.0|86.0|
4422657|NCT00179621|4245782|B3|||Age||years|Median|68.0|68.0|Full Range|||36.0|84.0|
4422658|NCT00179621|4245783|B2|||Age||years|Median|66.0|66.0|Full Range|||40.0|86.0|
4422659|NCT00179621|4245784|B1|||Age||years|Median|69.9|69.9|Full Range|||39.0|85.0|
4422660|NCT00179517|4245838|B3|||Participants with Epilepsy||Participants|Count of Participants|37|37.0||||||
4422661|NCT00179517|4245839|B2|||Participants with Epilepsy||Participants|Count of Participants|19|19.0||||||
4422662|NCT00179517|4245840|B1|||Participants with Epilepsy||Participants|Count of Participants|18|18.0||||||
4422663|NCT00179517|4245838|B3|United States||Region of Enrollment||Participants|Count of Participants|37|37.0||||||
4422664|NCT00179517|4245839|B2|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4422665|NCT00179517|4245840|B1|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4422666|NCT00179517|4245838|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4422667|NCT00179517|4245838|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4422668|NCT00179517|4245839|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4422669|NCT00179517|4245840|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4422670|NCT00179517|4245838|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422671|NCT00179517|4245839|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422672|NCT00179517|4245840|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422673|NCT00179517|4245838|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|7.3|7.3|||
4422674|NCT00179517|4245839|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|7.2|7.2|||
4422675|NCT00179517|4245840|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|7.5|7.5|||
4422676|NCT00179478|4245863|B3|||Gad enhancing lesions at onset||Participants|Count of Participants|43|43.0||||||
4422677|NCT00179478|4245864|B2|||Gad enhancing lesions at onset||Participants|Count of Participants|17|17.0||||||
4422678|NCT00179478|4245865|B1|||Gad enhancing lesions at onset||Participants|Count of Participants|26|26.0||||||
4422679|NCT00179478|4245863|B3|||Median T2 lesion vol at onset||mm^3|Median|1930|1930.0|Inter-Quartile Range|||918.0|4945.0|
4422680|NCT00179478|4245864|B2|||Median T2 lesion vol at onset||mm^3|Median|1774|1774.0|Inter-Quartile Range|||786.0|4883.0|
4422681|NCT00179478|4245865|B1|||Median T2 lesion vol at onset||mm^3|Median|2063|2063.0|Inter-Quartile Range|||1003.0|4945.0|
4422682|NCT00179478|4245863|B3|||Median T2 lesion # at onset||lesion counts|Median|13|13.0|Inter-Quartile Range|||8.0|21.0|
4422683|NCT00179478|4245864|B2|||Median T2 lesion # at onset||lesion counts|Median|13|13.0|Inter-Quartile Range|||9.0|20.0|
4422691|NCT00179478|4245863|B3|||EDSS < 2.0 at onset|Expanded Disability Status Scale (EDSS) is an ordinal measure of Neurological disability in Multiple Sclerosis ranging from 0-10 (0.5 increments) where 0 is normal and 10 is death from MS|Participants|Count of Participants|102|102.0||||||
4422692|NCT00179478|4245864|B2|||EDSS < 2.0 at onset|Expanded Disability Status Scale (EDSS) is an ordinal measure of Neurological disability in Multiple Sclerosis ranging from 0-10 (0.5 increments) where 0 is normal and 10 is death from MS|Participants|Count of Participants|55|55.0||||||
4422693|NCT00179478|4245865|B1|||EDSS < 2.0 at onset|Expanded Disability Status Scale (EDSS) is an ordinal measure of Neurological disability in Multiple Sclerosis ranging from 0-10 (0.5 increments) where 0 is normal and 10 is death from MS|Participants|Count of Participants|47|47.0||||||
4422694|NCT00179478|4245863|B3|||Spinal cord syndrome at onset||Participants|Count of Participants|37|37.0||||||
4422695|NCT00179478|4245864|B2|||Spinal cord syndrome at onset||Participants|Count of Participants|17|17.0||||||
4422696|NCT00179478|4245865|B1|||Spinal cord syndrome at onset||Participants|Count of Participants|20|20.0||||||
4422697|NCT00179478|4245863|B3|||Optic neuritis at onset||Participants|Count of Participants|78|78.0||||||
4422698|NCT00179478|4245864|B2|||Optic neuritis at onset||Participants|Count of Participants|38|38.0||||||
4422699|NCT00179478|4245865|B1|||Optic neuritis at onset||Participants|Count of Participants|40|40.0||||||
4422700|NCT00179478|4245863|B3|||Brainstem/Cerebellar at onset||Participants|Count of Participants|40|40.0||||||
4422701|NCT00179478|4245864|B2|||Brainstem/Cerebellar at onset||Participants|Count of Participants|19|19.0||||||
4422702|NCT00179478|4245865|B1|||Brainstem/Cerebellar at onset||Participants|Count of Participants|21|21.0||||||
4422703|NCT00179478|4245863|B3|||Family History of MS||Participants|Count of Participants|19|19.0||||||
4422704|NCT00179478|4245864|B2|||Family History of MS||Participants|Count of Participants|7|7.0||||||
4422705|NCT00179478|4245865|B1|||Family History of MS||Participants|Count of Participants|12|12.0||||||
4422706|NCT00179478|4245863|B3|Race/Ethnicity|Non White|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4422707|NCT00179478|4245864|B2|Race/Ethnicity|Non White|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4422708|NCT00179478|4245865|B1|Race/Ethnicity|Non White|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4422709|NCT00179478|4245863|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|141|141.0||||||
4422710|NCT00179478|4245864|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|69|69.0||||||
4422711|NCT00179478|4245865|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|72|72.0||||||
4422712|NCT00179478|4245863|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4422713|NCT00179478|4245864|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4422714|NCT00179478|4245865|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4422715|NCT00179478|4245863|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4422716|NCT00179478|4245864|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4422717|NCT00179478|4245865|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4422718|NCT00179478|4245863|B3|||Age||years|Mean|34|34.0|Standard Deviation|7|7.0|||
4422719|NCT00179478|4245864|B2|||Age||years|Mean|34|34.0|Standard Deviation|7|7.0|||
4422720|NCT00179478|4245865|B1|||Age||years|Mean|35|35.0|Standard Deviation|7|7.0|||
4422721|NCT00179413|4245877|B3|United States||Region of Enrollment||participants|Number|549|549.0||||||
4422722|NCT00179413|4245878|B2|United States||Region of Enrollment||participants|Number|267|267.0||||||
4422723|NCT00179413|4245879|B1|United States||Region of Enrollment||participants|Number|282|282.0||||||
4422724|NCT00179413|4245877|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422725|NCT00179413|4245878|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422726|NCT00179413|4245879|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422727|NCT00179413|4245877|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422728|NCT00179413|4245878|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422729|NCT00179413|4245879|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422730|NCT00179413|4245877|B3||White|Race (NIH/OMB)||Participants|Count of Participants|467|467.0||||||
4422731|NCT00179413|4245878|B2||White|Race (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
4422732|NCT00179413|4245879|B1||White|Race (NIH/OMB)||Participants|Count of Participants|240|240.0||||||
4422733|NCT00179413|4245877|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4422734|NCT00179413|4245878|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4422735|NCT00179413|4245879|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4422736|NCT00179413|4245877|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422737|NCT00179413|4245878|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422738|NCT00179413|4245879|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422739|NCT00179413|4245877|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4422740|NCT00179413|4245878|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4422741|NCT00179413|4245879|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4422742|NCT00179413|4245877|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422743|NCT00179413|4245878|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422744|NCT00179413|4245879|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422747|NCT00179413|4245879|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4422748|NCT00179413|4245877|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4422749|NCT00179413|4245878|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4422750|NCT00179413|4245879|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4422751|NCT00179413|4245877|B3|||Age||years|Mean|50.2|50.2|Standard Deviation|7.7|7.7|||
4422752|NCT00179413|4245878|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|7.1|7.1|||
4422753|NCT00179413|4245879|B1|||Age||years|Mean|50|50.0|Standard Deviation|8.4|8.4|||
4422754|NCT00179309|4245890|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4422755|NCT00179309|4245891|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4422756|NCT00179309|4245892|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4422757|NCT00179309|4245890|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422758|NCT00179309|4245891|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422759|NCT00179309|4245892|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422760|NCT00179309|4245890|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422761|NCT00179309|4245891|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422762|NCT00179309|4245892|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422763|NCT00179309|4245890|B3||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4422764|NCT00179309|4245891|B2||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4422765|NCT00179309|4245892|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4422766|NCT00179309|4245890|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4422767|NCT00179309|4245891|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4422768|NCT00179309|4245892|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4422769|NCT00179309|4245890|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422770|NCT00179309|4245891|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422771|NCT00179309|4245892|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422772|NCT00179309|4245890|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4422773|NCT00179309|4245891|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4422774|NCT00179309|4245892|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422775|NCT00179309|4245890|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422776|NCT00179309|4245891|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422777|NCT00179309|4245892|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422778|NCT00179309|4245890|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422779|NCT00179309|4245891|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422780|NCT00179309|4245892|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422781|NCT00179309|4245890|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4422782|NCT00179309|4245891|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4422783|NCT00179309|4245892|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4422784|NCT00179309|4245890|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4422785|NCT00179309|4245891|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4422786|NCT00179309|4245892|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422787|NCT00179309|4245890|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4422788|NCT00179309|4245891|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4422789|NCT00179309|4245892|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422790|NCT00179309|4245890|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4422791|NCT00179309|4245891|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4422792|NCT00179309|4245892|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4422793|NCT00179309|4245890|B3|||Age||years|Mean|54.31|54.31|Standard Deviation|11.21|11.21|||
4422794|NCT00179309|4245891|B2|||Age||years|Mean|53.01|53.01|Standard Deviation|12.22|12.22|||
4422795|NCT00179309|4245892|B1|||Age||years|Mean|55.52|55.52|Standard Deviation|10.52|10.52|||
4422796|NCT00179309|4245890|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4422797|NCT00179309|4245891|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4422798|NCT00179309|4245892|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4422799|NCT00179309|4245890|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4422800|NCT00179309|4245891|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4422801|NCT00179309|4245892|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4422802|NCT00179309|4245890|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422803|NCT00179309|4245891|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422804|NCT00179309|4245892|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422805|NCT00178919|4245914|B3|United States||Region of Enrollment||participants|Number|112|112.0||||||
4422806|NCT00178919|4245915|B2|United States||Region of Enrollment||participants|Number|93|93.0||||||
4422807|NCT00178919|4245916|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4422808|NCT00178919|4245914|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4422809|NCT00178919|4245915|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4422810|NCT00178919|4245916|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4422811|NCT00178919|4245914|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4422812|NCT00178919|4245915|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4422813|NCT00178919|4245916|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4422814|NCT00178919|4245914|B3|||Age||years|Mean|41|41.0|Standard Deviation|14.8|14.8|||
4422815|NCT00178919|4245915|B2|||Age||years|Mean|37|37.0|Standard Deviation|11.8|11.8|||
4422816|NCT00178919|4245916|B1|||Age||years|Mean|62|62.0|Standard Deviation|10.4|10.4|||
4422817|NCT00178919|4245914|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4422818|NCT00178919|4245915|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422819|NCT00178919|4245916|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4422820|NCT00178919|4245914|B3||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4422821|NCT00178919|4245915|B2||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4422822|NCT00178919|4245916|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4422823|NCT00178919|4245914|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422824|NCT00178919|4245915|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422825|NCT00178919|4245916|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422826|NCT00178841|4245925|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4422827|NCT00178841|4245925|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4422828|NCT00178841|4245925|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4422829|NCT00178841|4245925|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4422830|NCT00178841|4245925|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4422831|NCT00178841|4245925|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422832|NCT00178841|4245925|B1|||Age||years|Median|53|53.0|Full Range|||50.0|66.0|
4422833|NCT00178711|4245931|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4422834|NCT00178711|4245932|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4422835|NCT00178711|4245933|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4422836|NCT00178711|4245931|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4422837|NCT00178711|4245932|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4422838|NCT00178711|4245933|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4422839|NCT00178711|4245931|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4422840|NCT00178711|4245932|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4422841|NCT00178711|4245933|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422842|NCT00178711|4245931|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4422843|NCT00178711|4245932|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4422844|NCT00178711|4245933|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4422845|NCT00178711|4245931|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4422846|NCT00178711|4245932|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4422847|NCT00178711|4245933|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4422848|NCT00178711|4245931|B3|||Age||years|Mean|28|28.0|Standard Deviation|10|10.0|||
4422849|NCT00178711|4245932|B2|||Age||years|Mean|31|31.0|Standard Deviation|11|11.0|||
4422850|NCT00178711|4245933|B1|||Age||years|Mean|26|26.0|Standard Deviation|9|9.0|||
4422851|NCT00178685|4245942|B4||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4422852|NCT00178685|4245943|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4422853|NCT00178685|4245944|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4422854|NCT00178685|4245945|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4422855|NCT00178685|4245942|B4||Female|Sex: Female, Male||Participants|Count of Participants|488|488.0||||||
4422856|NCT00178685|4245943|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4422857|NCT00178685|4245944|B2||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4422858|NCT00178685|4245945|B1||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4422859|NCT00178685|4245942|B4|||Age||years|Mean|47.39|47.39|Standard Deviation|11.69|11.69|||
4422860|NCT00178685|4245943|B3|||Age||years|Mean|48.32|48.32|Standard Deviation|11.69470|11.6947|||
4422861|NCT00178685|4245944|B2|||Age||years|Mean|46.27|46.27|Standard Deviation|12.14891|12.14891|||
4422862|NCT00178685|4245945|B1|||Age||years|Mean|47.74|47.74|Standard Deviation|11.49614|11.49614|||
4422863|NCT00178685|4245942|B4||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4422864|NCT00178685|4245943|B3||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4422865|NCT00178685|4245944|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4422866|NCT00178685|4245945|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4422867|NCT00178685|4245942|B4||Between 18 and 65 years|Age||Participants|Count of Participants|775|775.0||||||
4422868|NCT00178685|4245943|B3||Between 18 and 65 years|Age||Participants|Count of Participants|303|303.0||||||
4422869|NCT00178685|4245944|B2||Between 18 and 65 years|Age||Participants|Count of Participants|309|309.0||||||
4422870|NCT00178685|4245945|B1||Between 18 and 65 years|Age||Participants|Count of Participants|163|163.0||||||
4422871|NCT00178685|4245942|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422872|NCT00178685|4245943|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422873|NCT00178685|4245944|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422874|NCT00178685|4245945|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422875|NCT00178633|4245958|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4422876|NCT00178633|4245958|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4422877|NCT00178633|4245958|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4422878|NCT00178633|4245958|B1|||Age||years|Mean|45|45.0|Standard Deviation|1.6|1.6|||
4422879|NCT00178503|4245966|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4422880|NCT00178503|4245966|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4422881|NCT00178503|4245966|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4422882|NCT00178503|4245966|B1|||Age||years|Mean|8.8|8.8|Standard Deviation|1.7|1.7|||
4422883|NCT00178503|4245966|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422884|NCT00178503|4245966|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4422885|NCT00178503|4245966|B1||<=18 years|Age||Participants|Count of Participants|24|24.0||||||
4422886|NCT00178477|4245984|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4422887|NCT00178477|4245984|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4422888|NCT00178477|4245984|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4422889|NCT00178477|4245984|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422890|NCT00178477|4245984|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4422891|NCT00178477|4245984|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422892|NCT00178464|4245988|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4422893|NCT00178464|4245988|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4422894|NCT00178464|4245988|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4422895|NCT00178464|4245988|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4422896|NCT00178464|4245988|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4422897|NCT00178464|4245988|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4422898|NCT00178399|4245993|B1|United States||Region of Enrollment||Participants|Count of Participants|128|128.0||||||
4422899|NCT00178399|4245993|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4422900|NCT00178399|4245993|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4422901|NCT00178399|4245993|B1|||Age||years|Median|60|60.0|Full Range|||40.0|88.0|
4422902|NCT00178256|4246000|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4422903|NCT00178256|4246000|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4422904|NCT00178256|4246000|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4422905|NCT00178256|4246000|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|11.3|11.3|||
4422906|NCT00178256|4246000|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4422907|NCT00178256|4246000|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4422908|NCT00178256|4246000|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422909|NCT00178191|4246010|B4|United States||Region of Enrollment||participants|Number|28.0|28.0||||||
4422910|NCT00178191|4246011|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4422911|NCT00178191|4246012|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4422912|NCT00178191|4246013|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4422913|NCT00178191|4246010|B4||Male|Sex: Female, Male||Participants|Count of Participants|0.0|0.0||||||
4422914|NCT00178191|4246011|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422915|NCT00178191|4246012|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422916|NCT00178191|4246013|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4422917|NCT00178191|4246010|B4||Female|Sex: Female, Male||Participants|Count of Participants|28.0|28.0||||||
4422918|NCT00178191|4246011|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4422919|NCT00178191|4246012|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4422920|NCT00178191|4246013|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4422921|NCT00178191|4246010|B4|||Age||years|Mean|70|70.0|Standard Deviation|13.19|13.19|||
4422922|NCT00178191|4246011|B3|||Age||years|Mean|74.14|74.14|Standard Deviation|11.01|11.01|||
4422923|NCT00178191|4246012|B2|||Age||years|Mean|61.72|61.72|Standard Deviation|13|13.0|||
4422924|NCT00178191|4246013|B1|||Age||years|Mean|76.20|76.2|Standard Deviation|10.65|10.65|||
4422925|NCT00178191|4246010|B4||>=65 years|Age||Participants|Count of Participants|16.0|16.0||||||
4422926|NCT00178191|4246011|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4422927|NCT00178191|4246012|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4422928|NCT00178191|4246013|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4422929|NCT00178191|4246010|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12.0|12.0||||||
4422930|NCT00178191|4246011|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4422931|NCT00178191|4246012|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4422932|NCT00178191|4246013|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4422933|NCT00178191|4246010|B4||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4422934|NCT00178191|4246011|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422935|NCT00178191|4246012|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422936|NCT00178191|4246013|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4422937|NCT00178178|4246023|B5|United States||Region of Enrollment||participants|Number|96|96.0||||||
4422938|NCT00178178|4246024|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4422939|NCT00178178|4246025|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4422940|NCT00178178|4246026|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4422941|NCT00178178|4246027|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4422942|NCT00178178|4246023|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422943|NCT00178178|4246024|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422944|NCT00178178|4246025|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422945|NCT00178178|4246026|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422946|NCT00178178|4246027|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422947|NCT00178178|4246023|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422948|NCT00178178|4246024|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422949|NCT00178178|4246025|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422950|NCT00178178|4246026|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422951|NCT00178178|4246027|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422952|NCT00178178|4246023|B5||White|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4422953|NCT00178178|4246024|B4||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4422954|NCT00178178|4246025|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4422955|NCT00178178|4246026|B2||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4422956|NCT00178178|4246027|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4422957|NCT00178178|4246023|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4422958|NCT00178178|4246024|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4422959|NCT00178178|4246025|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422960|NCT00178178|4246026|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422961|NCT00178178|4246027|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422962|NCT00178178|4246023|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422963|NCT00178178|4246024|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422964|NCT00178178|4246025|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422965|NCT00178178|4246026|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422966|NCT00178178|4246027|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422967|NCT00178178|4246023|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4422968|NCT00178178|4246024|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422969|NCT00178178|4246025|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4422970|NCT00178178|4246026|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422971|NCT00178178|4246027|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422972|NCT00178178|4246023|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422973|NCT00178178|4246024|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422974|NCT00178178|4246025|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422975|NCT00178178|4246026|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422976|NCT00178178|4246027|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422977|NCT00178178|4246023|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4422978|NCT00178178|4246024|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4422979|NCT00178178|4246025|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4422980|NCT00178178|4246026|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4422981|NCT00178178|4246027|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4422982|NCT00178178|4246023|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422983|NCT00178178|4246024|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422984|NCT00178178|4246025|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422985|NCT00178178|4246026|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422986|NCT00178178|4246027|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422987|NCT00178178|4246023|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422988|NCT00178178|4246024|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422989|NCT00178178|4246025|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422990|NCT00178178|4246026|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422991|NCT00178178|4246027|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4422992|NCT00178178|4246023|B5||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4422993|NCT00178178|4246024|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4422994|NCT00178178|4246025|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4422995|NCT00178178|4246026|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4422996|NCT00178178|4246027|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4422997|NCT00178178|4246023|B5||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4422998|NCT00178178|4246024|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4422999|NCT00178178|4246025|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4423000|NCT00178178|4246026|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4423001|NCT00178178|4246027|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4423002|NCT00178178|4246023|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423003|NCT00178178|4246024|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423004|NCT00178178|4246025|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423005|NCT00178178|4246026|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423006|NCT00178178|4246027|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423007|NCT00178178|4246023|B5||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4423008|NCT00178178|4246024|B4||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4423009|NCT00178178|4246025|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4423010|NCT00178178|4246026|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4423011|NCT00178178|4246027|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4423012|NCT00178178|4246023|B5||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4423013|NCT00178178|4246024|B4||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4423014|NCT00178178|4246025|B3||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4423015|NCT00178178|4246026|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4423016|NCT00178178|4246027|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4423017|NCT00178126|4246040|B3|||Incontinence||participants|Number|194|194.0||||||
4423018|NCT00178126|4246041|B2|||Incontinence||participants|Number|97|97.0||||||
4423019|NCT00178126|4246042|B1|||Incontinence||participants|Number|97|97.0||||||
4423020|NCT00178126|4246040|B3|||Body Mass Index||kg/m^2|Mean|24.8|24.8|Standard Deviation|4.8|4.8|||
4423021|NCT00178126|4246041|B2|||Body Mass Index||kg/m^2|Mean|24.6|24.6|Standard Deviation|4.4|4.4|||
4423022|NCT00178126|4246042|B1|||Body Mass Index||kg/m^2|Mean|25.0|25.0|Standard Deviation|5.2|5.2|||
4423023|NCT00178126|4246040|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4423024|NCT00178126|4246041|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4423025|NCT00178126|4246042|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4423026|NCT00178126|4246040|B3||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4423027|NCT00178126|4246041|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4423028|NCT00178126|4246042|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4423029|NCT00178126|4246040|B3|||Age||years|Mean|86.6|86.6|Standard Deviation|7.6|7.6|||
4423030|NCT00178126|4246041|B2|||Age||years|Mean|86.7|86.7|Standard Deviation|7.4|7.4|||
4423031|NCT00178126|4246042|B1|||Age||years|Mean|86.5|86.5|Standard Deviation|7.7|7.7|||
4423032|NCT00178126|4246040|B3||>=65 years|Age||Participants|Count of Participants|232|232.0||||||
4423033|NCT00178126|4246041|B2||>=65 years|Age||Participants|Count of Participants|113|113.0||||||
4423034|NCT00178126|4246042|B1||>=65 years|Age||Participants|Count of Participants|119|119.0||||||
4423035|NCT00178126|4246040|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423036|NCT00178126|4246041|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423037|NCT00178126|4246042|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423038|NCT00178126|4246040|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423039|NCT00178126|4246041|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423040|NCT00178126|4246042|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423041|NCT00177671|4246083|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4423042|NCT00177671|4246084|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4423043|NCT00177671|4246085|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4423044|NCT00177671|4246083|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4423045|NCT00177671|4246084|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4423046|NCT00177671|4246085|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4423047|NCT00177671|4246083|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4423048|NCT00177671|4246084|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4423049|NCT00177671|4246085|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4423050|NCT00177671|4246083|B3|||Age||years|Mean|73.5|73.5|Standard Deviation|6.2|6.2|||
4423051|NCT00177671|4246084|B2|||Age||years|Mean|73.9|73.9|Standard Deviation|5.8|5.8|||
4423052|NCT00177671|4246085|B1|||Age||years|Mean|73.1|73.1|Standard Deviation|6.5|6.5|||
4423053|NCT00177671|4246083|B3||>=65 years|Age||Participants|Count of Participants|130|130.0||||||
4423054|NCT00177671|4246084|B2||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4423055|NCT00177671|4246085|B1||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4423056|NCT00177671|4246083|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423057|NCT00177671|4246084|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423058|NCT00177671|4246085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423059|NCT00177671|4246083|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423060|NCT00177671|4246084|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423061|NCT00177671|4246085|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423062|NCT00177307|4246098|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4423063|NCT00177307|4246098|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4423064|NCT00177307|4246098|B1|||Age||years|Median|62|62.0|Full Range|||38.0|80.0|
4423065|NCT00177294|4246105|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
4423066|NCT00177294|4246106|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4423067|NCT00177294|4246107|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4423068|NCT00177294|4246105|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4423069|NCT00177294|4246106|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4423070|NCT00177294|4246107|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4423071|NCT00177294|4246105|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4423072|NCT00177294|4246106|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4423073|NCT00177294|4246107|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4423074|NCT00177294|4246105|B3|||Age||years|Mean|72.27|72.27|Standard Deviation|7.51|7.51|||
4423075|NCT00177294|4246106|B2|||Age||years|Mean|73.4|73.4|Standard Deviation|7.7|7.7|||
4423076|NCT00177294|4246107|B1|||Age||years|Mean|71.1|71.1|Standard Deviation|7.1|7.1|||
4423077|NCT00177294|4246105|B3||>=65 years|Age||Participants|Count of Participants|104|104.0||||||
4423078|NCT00177294|4246106|B2||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4423079|NCT00177294|4246107|B1||>=65 years|Age||Participants|Count of Participants|49|49.0||||||
4423080|NCT00177294|4246105|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4423081|NCT00177294|4246106|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4423082|NCT00177294|4246107|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4423083|NCT00177294|4246105|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423084|NCT00177294|4246106|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423085|NCT00177294|4246107|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423086|NCT00177255|4246114|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4423087|NCT00177255|4246114|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4423088|NCT00177255|4246114|B1|||Age||years|Median|61|61.0|Full Range|||21.0|84.0|
4423089|NCT00177216|4246119|B4|United States||Region of Enrollment||participants|Number|69|69.0||||||
4423090|NCT00177216|4246120|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4423091|NCT00177216|4246121|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4423092|NCT00177216|4246122|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4423093|NCT00177216|4246119|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4423094|NCT00177216|4246120|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4423095|NCT00177216|4246121|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4423096|NCT00177216|4246122|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4423097|NCT00177216|4246119|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4423098|NCT00177216|4246120|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4423099|NCT00177216|4246121|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4423100|NCT00177216|4246122|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4423101|NCT00177216|4246119|B4|||Age||years|Mean|36.67|36.67|Standard Deviation|9.05|9.05|||
4423102|NCT00177216|4246120|B3|||Age||years|Mean|37.46|37.46|Standard Deviation|8.63|8.63|||
4423103|NCT00177216|4246121|B2|||Age||years|Mean|34.49|34.49|Standard Deviation|9.34|9.34|||
4423104|NCT00177216|4246122|B1|||Age||years|Mean|38.07|38.07|Standard Deviation|9.07|9.07|||
4423105|NCT00177216|4246119|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423106|NCT00177216|4246120|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423107|NCT00177216|4246121|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423108|NCT00177216|4246122|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423109|NCT00177216|4246119|B4||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4423110|NCT00177216|4246120|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4423111|NCT00177216|4246121|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4423112|NCT00177216|4246122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4423113|NCT00177216|4246119|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423114|NCT00177216|4246120|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423115|NCT00177216|4246121|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423116|NCT00177216|4246122|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423117|NCT00177164|4246138|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4423118|NCT00177164|4246139|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4423119|NCT00177164|4246140|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4423120|NCT00177164|4246138|B3||Unknown or Not Reported|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|1|1.0||||||
4423121|NCT00177164|4246139|B2||Unknown or Not Reported|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|0|0.0||||||
4423122|NCT00177164|4246140|B1||Unknown or Not Reported|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|1|1.0||||||
4423123|NCT00177164|4246138|B3||More than one race|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|0|0.0||||||
4423124|NCT00177164|4246139|B2||More than one race|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|0|0.0||||||
4423125|NCT00177164|4246140|B1||More than one race|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|0|0.0||||||
4423126|NCT00177164|4246138|B3||White|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|38|38.0||||||
4423127|NCT00177164|4246139|B2||White|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|22|22.0||||||
4423128|NCT00177164|4246140|B1||White|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|16|16.0||||||
4423129|NCT00177164|4246138|B3||Black or African American|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|9|9.0||||||
4423130|NCT00177164|4246139|B2||Black or African American|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|3|3.0||||||
4423131|NCT00177164|4246140|B1||Black or African American|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|6|6.0||||||
4423132|NCT00177164|4246138|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|0|0.0||||||
4423133|NCT00177164|4246139|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|0|0.0||||||
4423134|NCT00177164|4246140|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|0|0.0||||||
4423135|NCT00177164|4246138|B3||Asian|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|0|0.0||||||
4423136|NCT00177164|4246139|B2||Asian|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|0|0.0||||||
4423179|NCT00176865|4246179|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4423137|NCT00177164|4246140|B1||Asian|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|0|0.0||||||
4423138|NCT00177164|4246138|B3||American Indian or Alaska Native|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|0|0.0||||||
4423139|NCT00177164|4246139|B2||American Indian or Alaska Native|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|0|0.0||||||
4423140|NCT00177164|4246140|B1||American Indian or Alaska Native|Race (NIH/OMB)|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|0|0.0||||||
4423141|NCT00177164|4246138|B3||Male|Sex: Female, Male|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|14|14.0||||||
4423142|NCT00177164|4246139|B2||Male|Sex: Female, Male|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|7|7.0||||||
4423143|NCT00177164|4246140|B1||Male|Sex: Female, Male|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|7|7.0||||||
4423144|NCT00177164|4246138|B3||Female|Sex: Female, Male|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|34|34.0||||||
4423145|NCT00177164|4246139|B2||Female|Sex: Female, Male|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|18|18.0||||||
4423146|NCT00177164|4246140|B1||Female|Sex: Female, Male|2 patients in the risperidone LAI group were not included in the ITT (intention to treat) analyses as they did not receive assessment after the baseline assessment. Therefore, outcomes were assessed for only 23 of 25 patients in the risperidone LAI group.|Participants|Count of Participants|16|16.0||||||
4423147|NCT00177164|4246138|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423148|NCT00177164|4246139|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423149|NCT00177164|4246140|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423150|NCT00177164|4246138|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4423151|NCT00177164|4246139|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4423152|NCT00177164|4246140|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4423153|NCT00177164|4246138|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423154|NCT00177164|4246139|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423155|NCT00177164|4246140|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423156|NCT00176917|4246153|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4423157|NCT00176917|4246153|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4423158|NCT00176917|4246153|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4423159|NCT00176917|4246153|B1|||Age||years|Mean|1.8|1.8|Standard Deviation|1.4|1.4|||
4423160|NCT00176917|4246153|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423161|NCT00176917|4246153|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423162|NCT00176917|4246153|B1||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
4423163|NCT00176904|4246160|B1|United States||Region of Enrollment||participants|Number|135|135.0||||||
4423164|NCT00176904|4246160|B1||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4423165|NCT00176904|4246160|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4423166|NCT00176904|4246160|B1|||Age||years|Mean|8.7|8.7|Standard Deviation|8.9|8.9|||
4423167|NCT00176904|4246160|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423168|NCT00176904|4246160|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4423169|NCT00176904|4246160|B1||<=18 years|Age||Participants|Count of Participants|117|117.0||||||
4423170|NCT00176878|4246168|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4423171|NCT00176878|4246168|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4423172|NCT00176878|4246168|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4423173|NCT00176878|4246168|B1|||Age||years|Mean|4.8|4.8|Standard Deviation|7.6|7.6|||
4423174|NCT00176878|4246168|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423175|NCT00176878|4246168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423176|NCT00176878|4246168|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4423177|NCT00176865|4246177|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
4423178|NCT00176865|4246178|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4423180|NCT00176865|4246180|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4423181|NCT00176865|4246177|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4423182|NCT00176865|4246178|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4423183|NCT00176865|4246179|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4423184|NCT00176865|4246180|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4423185|NCT00176865|4246177|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4423186|NCT00176865|4246178|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4423187|NCT00176865|4246179|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4423188|NCT00176865|4246180|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4423189|NCT00176865|4246177|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423190|NCT00176865|4246178|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423191|NCT00176865|4246179|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423192|NCT00176865|4246180|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423193|NCT00176865|4246177|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423194|NCT00176865|4246178|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423195|NCT00176865|4246179|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423196|NCT00176865|4246180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423197|NCT00176865|4246177|B4||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4423198|NCT00176865|4246178|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4423199|NCT00176865|4246179|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4423200|NCT00176865|4246180|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4423201|NCT00176852|4246217|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4423202|NCT00176852|4246218|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4423203|NCT00176852|4246219|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4423204|NCT00176852|4246220|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4423205|NCT00176852|4246217|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4423206|NCT00176852|4246218|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4423207|NCT00176852|4246219|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4423208|NCT00176852|4246220|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4423209|NCT00176852|4246217|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423210|NCT00176852|4246218|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423211|NCT00176852|4246219|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423212|NCT00176852|4246220|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423213|NCT00176852|4246217|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4423214|NCT00176852|4246218|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4423215|NCT00176852|4246219|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423216|NCT00176852|4246220|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423217|NCT00176852|4246217|B4||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4423218|NCT00176852|4246218|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4423219|NCT00176852|4246219|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4423220|NCT00176852|4246220|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4423221|NCT00176839|4246281|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4423222|NCT00176839|4246281|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4423223|NCT00176839|4246281|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423224|NCT00176839|4246281|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4423225|NCT00176839|4246281|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4423226|NCT00176839|4246281|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423227|NCT00176839|4246281|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423228|NCT00176839|4246281|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423229|NCT00176839|4246281|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4423230|NCT00176839|4246281|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4423231|NCT00176839|4246281|B1|||Age||years|Mean|10.3|10.3|Standard Deviation|8.4|8.4|||
4423232|NCT00176839|4246281|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423233|NCT00176839|4246281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4423234|NCT00176839|4246281|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4423235|NCT00176826|4246290|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4423236|NCT00176826|4246290|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4423237|NCT00176826|4246290|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4423238|NCT00176826|4246290|B1|||Age||years|Mean|1.7|1.7|Standard Deviation|0.9|0.9|||
4423239|NCT00176826|4246290|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423240|NCT00176826|4246290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423241|NCT00176826|4246290|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4423242|NCT00176800|4246300|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4423243|NCT00176800|4246300|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4423244|NCT00176800|4246300|B1|||Age||years|Median|60|60.0|Full Range|||42.0|74.0|
4423245|NCT00176644|4246306|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4423246|NCT00176644|4246306|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4423247|NCT00176644|4246306|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4423248|NCT00176644|4246306|B1|||Age||years|Mean|72.4|72.4|Standard Deviation|8.2|8.2|||
4423249|NCT00176644|4246306|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4423250|NCT00176644|4246306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4423251|NCT00176644|4246306|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423252|NCT00176631|4246314|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4423253|NCT00176631|4246314|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4423254|NCT00176631|4246314|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4423255|NCT00176631|4246314|B1|||Age||years|Mean|70|70.0|Standard Deviation|10.3|10.3|||
4423256|NCT00176631|4246314|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4423257|NCT00176631|4246314|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4423258|NCT00176631|4246314|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423259|NCT00176605|4246319|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4423260|NCT00176605|4246319|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4423261|NCT00176605|4246319|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4423262|NCT00176605|4246319|B1|||Age||years|Mean|62.1|62.1|Standard Deviation|8.0|8.0|||
4423263|NCT00176605|4246319|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4423264|NCT00176605|4246319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4423265|NCT00176605|4246319|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423266|NCT00176501|4246324|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4423267|NCT00176501|4246324|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4423268|NCT00176501|4246324|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4423269|NCT00176501|4246324|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|7.1|7.1|||
4423270|NCT00176501|4246324|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423271|NCT00176501|4246324|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4423272|NCT00176501|4246324|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423273|NCT00176488|4246330|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4423274|NCT00176488|4246330|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4423275|NCT00176488|4246330|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4423276|NCT00176488|4246330|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|10.6|10.6|||
4423277|NCT00176488|4246330|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4423278|NCT00176488|4246330|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4423279|NCT00176488|4246330|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423280|NCT00176462|4246336|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4423281|NCT00176462|4246337|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4423282|NCT00176462|4246338|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4423283|NCT00176462|4246336|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4423284|NCT00176462|4246337|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4423285|NCT00176462|4246338|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4423286|NCT00176462|4246336|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4423287|NCT00176462|4246337|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4423288|NCT00176462|4246338|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4423289|NCT00176462|4246336|B3|||Age||years|Mean|11.7|11.7|Standard Deviation|9.89|9.89|||
4423290|NCT00176462|4246337|B2|||Age||years|Mean|16|16.0|Standard Deviation|9.8|9.8|||
4423291|NCT00176462|4246338|B1|||Age||years|Mean|3.71|3.71|Standard Deviation|1.77|1.77|||
4423292|NCT00176462|4246336|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423293|NCT00176462|4246337|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423294|NCT00176462|4246338|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423295|NCT00176462|4246336|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4423296|NCT00176462|4246337|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4423297|NCT00176462|4246338|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423298|NCT00176462|4246336|B3||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4423299|NCT00176462|4246337|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4423300|NCT00176462|4246338|B1||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4423301|NCT00176436|4246346|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4423302|NCT00176436|4246347|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4423303|NCT00176436|4246348|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4423304|NCT00176436|4246346|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4423305|NCT00176436|4246347|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4423306|NCT00176436|4246348|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4423307|NCT00176436|4246346|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4423308|NCT00176436|4246347|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4423309|NCT00176436|4246348|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4423310|NCT00176436|4246346|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|8.8|8.8|||
4423311|NCT00176436|4246347|B2|||Age||years|Mean|46.1|46.1|Standard Deviation|9.4|9.4|||
4423312|NCT00176436|4246348|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|8.4|8.4|||
4423313|NCT00176436|4246346|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423314|NCT00176436|4246347|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423315|NCT00176436|4246348|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423316|NCT00176436|4246346|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4423317|NCT00176436|4246347|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4423318|NCT00176436|4246348|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4423319|NCT00176436|4246346|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423320|NCT00176436|4246347|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423321|NCT00176436|4246348|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423322|NCT00176306|4246355|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4423323|NCT00176306|4246355|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4423324|NCT00176306|4246355|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4423325|NCT00176306|4246355|B1|||Age||years|Mean|38.4|38.4|Standard Deviation|12.8|12.8|||
4423326|NCT00176306|4246355|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423327|NCT00176306|4246355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4423328|NCT00176306|4246355|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423329|NCT00176254|4246359|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4423330|NCT00176254|4246359|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4423331|NCT00176254|4246359|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4423332|NCT00176254|4246359|B1|||Age||Years|Median|54|54.0|Full Range|||36.0|81.0|
4423333|NCT00176228|4246367|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4423334|NCT00176228|4246367|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4423335|NCT00176228|4246367|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4423336|NCT00176228|4246367|B1|||Age||years|Mean|13.3|13.3|Standard Deviation|2.85|2.85|||
4423337|NCT00176228|4246367|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423338|NCT00176228|4246367|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4423339|NCT00176228|4246367|B1||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4423340|NCT00176202|4246372|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4423341|NCT00176202|4246373|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4423342|NCT00176202|4246374|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4423343|NCT00176202|4246372|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4423344|NCT00176202|4246373|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4423345|NCT00176202|4246374|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4423346|NCT00176202|4246372|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4423347|NCT00176202|4246373|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4423348|NCT00176202|4246374|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4423349|NCT00176202|4246372|B3|||Age||years|Mean|10.85|10.85|Standard Deviation|3.34|3.34|||
4423350|NCT00176202|4246373|B2|||Age||years|Mean|11.23|11.23|Standard Deviation|3.50|3.5|||
4423351|NCT00176202|4246374|B1|||Age||years|Mean|10.47|10.47|Standard Deviation|3.18|3.18|||
4423352|NCT00175877|4246387|B1|||Height||centimeter (cm)|Mean|164.30|164.3|Standard Deviation|8.88|8.88|||
4423353|NCT00175877|4246387|B1|||Weight||kilogram (kg)|Mean|73.69|73.69|Standard Deviation|16.17|16.17|||
4423354|NCT00175877|4246387|B1|New Zealand||Region of Enrollment||participants|Number|18|18.0||||||
4423355|NCT00175877|4246387|B1|Latvia||Region of Enrollment||participants|Number|26|26.0||||||
4423356|NCT00175877|4246387|B1|Bulgaria||Region of Enrollment||participants|Number|28|28.0||||||
4423357|NCT00175877|4246387|B1|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4423358|NCT00175877|4246387|B1|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
4423359|NCT00175877|4246387|B1|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4423360|NCT00175877|4246387|B1|Argentina||Region of Enrollment||participants|Number|122|122.0||||||
4423361|NCT00175877|4246387|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4423362|NCT00175877|4246387|B1|Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4423363|NCT00175877|4246387|B1|Hungary||Region of Enrollment||participants|Number|57|57.0||||||
4423364|NCT00175877|4246387|B1|Czech Republic||Region of Enrollment||participants|Number|122|122.0||||||
4423365|NCT00175877|4246387|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4423366|NCT00175877|4246387|B1|Chile||Region of Enrollment||participants|Number|11|11.0||||||
4423367|NCT00175877|4246387|B1|Israel||Region of Enrollment||participants|Number|24|24.0||||||
4423368|NCT00175877|4246387|B1|Russian Federation||Region of Enrollment||participants|Number|102|102.0||||||
4423369|NCT00175877|4246387|B1|Lithuania||Region of Enrollment||participants|Number|42|42.0||||||
4423370|NCT00175877|4246387|B1|Ukraine||Region of Enrollment||participants|Number|81|81.0||||||
4423371|NCT00175877|4246387|B1|Finland||Region of Enrollment||participants|Number|5|5.0||||||
4423372|NCT00175877|4246387|B1|Slovakia||Region of Enrollment||participants|Number|45|45.0||||||
4423373|NCT00175877|4246387|B1|Estonia||Region of Enrollment||participants|Number|16|16.0||||||
4423374|NCT00175877|4246387|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4423375|NCT00175877|4246387|B1|Serbia||Region of Enrollment||participants|Number|45|45.0||||||
4423376|NCT00175877|4246387|B1||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4423377|NCT00175877|4246387|B1||Female|Sex: Female, Male||Participants|Count of Participants|701|701.0||||||
4423378|NCT00175877|4246387|B1|||Age||years|Mean|51.5|51.5|Full Range|11.4|11.4|18.0|81.0|
4423379|NCT00175877|4246387|B1||>=65 years|Age||Participants|Count of Participants|109|109.0||||||
4423380|NCT00175877|4246387|B1||Between 18 and 65 years|Age||Participants|Count of Participants|736|736.0||||||
4423381|NCT00175877|4246387|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4423382|NCT00175825|4246418|B5||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4423383|NCT00175825|4246419|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4423384|NCT00175825|4246420|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4423385|NCT00175825|4246421|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4423386|NCT00175825|4246422|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4423387|NCT00175825|4246418|B5||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4423388|NCT00175825|4246419|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4423389|NCT00175825|4246420|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4423390|NCT00175825|4246421|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4423391|NCT00175825|4246422|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4423392|NCT00175825|4246418|B5|||Age||years|Mean|33.15|33.15|Standard Deviation|12.20|12.2|||
4423393|NCT00175825|4246419|B4|||Age||years|Mean|30.92|30.92|Standard Deviation|11.57|11.57|||
4423394|NCT00175825|4246420|B3|||Age||years|Mean|35.31|35.31|Standard Deviation|13.66|13.66|||
4423395|NCT00175825|4246421|B2|||Age||years|Mean|32.72|32.72|Standard Deviation|12.16|12.16|||
4423396|NCT00175825|4246422|B1|||Age||years|Mean|33.59|33.59|Standard Deviation|11.26|11.26|||
4423397|NCT00175825|4246418|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4423398|NCT00175825|4246419|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423399|NCT00175825|4246420|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4423400|NCT00175825|4246421|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423401|NCT00175825|4246422|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4423402|NCT00175825|4246418|B5||Between 18 and 65 years|Age||Participants|Count of Participants|194|194.0||||||
4423403|NCT00175825|4246419|B4||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4423404|NCT00175825|4246420|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4423405|NCT00175825|4246421|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4423406|NCT00175825|4246422|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4423407|NCT00175825|4246418|B5||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4423408|NCT00175825|4246419|B4||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4423409|NCT00175825|4246420|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4423410|NCT00175825|4246421|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4423411|NCT00175825|4246422|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4423412|NCT00175019|4246475|B4|||Serum Urate|Based on Final Stable Treatment in study C02-021|mg/dL|Mean|9.81|9.81|Standard Deviation|1.25|1.25|||
4423413|NCT00175019|4246476|B3|||Serum Urate|Based on Final Stable Treatment in study C02-021|mg/dL|Mean|9.83|9.83|Standard Deviation|1.27|1.27|||
4423414|NCT00175019|4246477|B2|||Serum Urate|Based on Final Stable Treatment in study C02-021|mg/dL|Mean|10.05|10.05|Standard Deviation|1.29|1.29|||
4423415|NCT00175019|4246478|B1|||Serum Urate|Based on Final Stable Treatment in study C02-021|mg/dL|Mean|9.65|9.65|Standard Deviation|1.20|1.2|||
4423416|NCT00175019|4246475|B4|||Body Mass Index (BMI)|Based on Final Stable Treatment in study C02-021|kg/m²|Mean|31.9|31.9|Standard Deviation|5.49|5.49|||
4423417|NCT00175019|4246476|B3|||Body Mass Index (BMI)|Based on Final Stable Treatment in study C02-021|kg/m²|Mean|32.4|32.4|Standard Deviation|5.58|5.58|||
4423418|NCT00175019|4246477|B2|||Body Mass Index (BMI)|Based on Final Stable Treatment in study C02-021|kg/m²|Mean|34.1|34.1|Standard Deviation|6.71|6.71|||
4423419|NCT00175019|4246478|B1|||Body Mass Index (BMI)|Based on Final Stable Treatment in study C02-021|kg/m²|Mean|31.9|31.9|Standard Deviation|5.49|5.49|||
4423420|NCT00175019|4246475|B4|Impaired||Renal Function|Based on Final Stable Treatment in study C02-021. Impaired defined as serum creatinine <1.5 mg/dL.|participants|Number|20|20.0||||||
4423421|NCT00175019|4246476|B3|Impaired||Renal Function|Based on Final Stable Treatment in study C02-021. Impaired defined as serum creatinine <1.5 mg/dL.|participants|Number|0|0.0||||||
4423422|NCT00175019|4246477|B2|Impaired||Renal Function|Based on Final Stable Treatment in study C02-021. Impaired defined as serum creatinine <1.5 mg/dL.|participants|Number|7|7.0||||||
4423423|NCT00175019|4246478|B1|Impaired||Renal Function|Based on Final Stable Treatment in study C02-021. Impaired defined as serum creatinine <1.5 mg/dL.|participants|Number|13|13.0||||||
4423471|NCT00175006|4246524|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4423424|NCT00175019|4246475|B4|Normal||Renal Function|Based on Final Stable Treatment in study C02-021. Impaired defined as serum creatinine <1.5 mg/dL.|participants|Number|1066|1066.0||||||
4423425|NCT00175019|4246476|B3|Normal||Renal Function|Based on Final Stable Treatment in study C02-021. Impaired defined as serum creatinine <1.5 mg/dL.|participants|Number|92|92.0||||||
4423426|NCT00175019|4246477|B2|Normal||Renal Function|Based on Final Stable Treatment in study C02-021. Impaired defined as serum creatinine <1.5 mg/dL.|participants|Number|381|381.0||||||
4423427|NCT00175019|4246478|B1|Normal||Renal Function|Based on Final Stable Treatment in study C02-021. Impaired defined as serum creatinine <1.5 mg/dL.|participants|Number|593|593.0||||||
4423428|NCT00175019|4246475|B4|Other||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|34|34.0||||||
4423429|NCT00175019|4246476|B3|Other||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|1|1.0||||||
4423430|NCT00175019|4246477|B2|Other||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|18|18.0||||||
4423431|NCT00175019|4246478|B1|Other||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|15|15.0||||||
4423432|NCT00175019|4246475|B4|Hispanic||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|66|66.0||||||
4423433|NCT00175019|4246476|B3|Hispanic||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|7|7.0||||||
4423434|NCT00175019|4246477|B2|Hispanic||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|29|29.0||||||
4423435|NCT00175019|4246478|B1|Hispanic||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|30|30.0||||||
4423436|NCT00175019|4246475|B4|White||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|862|862.0||||||
4423437|NCT00175019|4246476|B3|White||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|64|64.0||||||
4423438|NCT00175019|4246477|B2|White||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|299|299.0||||||
4423439|NCT00175019|4246478|B1|White||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|499|499.0||||||
4423440|NCT00175019|4246475|B4|Black or African American||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|96|96.0||||||
4423441|NCT00175019|4246476|B3|Black or African American||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|16|16.0||||||
4423442|NCT00175019|4246477|B2|Black or African American||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|33|33.0||||||
4423443|NCT00175019|4246478|B1|Black or African American||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|47|47.0||||||
4423444|NCT00175019|4246475|B4|Asian||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|28|28.0||||||
4423445|NCT00175019|4246476|B3|Asian||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|4|4.0||||||
4423446|NCT00175019|4246477|B2|Asian||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|9|9.0||||||
4423447|NCT00175019|4246478|B1|Asian||Race/Ethnicity|Based on Final Stable Treatment in study C02-021|participants|Number|15|15.0||||||
4423448|NCT00175019|4246475|B4|Absent||Presence of Tophus|Based on Final Stable Treatment in study C02-021|participants|Number|872|872.0||||||
4423449|NCT00175019|4246476|B3|Absent||Presence of Tophus|Based on Final Stable Treatment in study C02-021|participants|Number|77|77.0||||||
4423450|NCT00175019|4246477|B2|Absent||Presence of Tophus|Based on Final Stable Treatment in study C02-021|participants|Number|305|305.0||||||
4423451|NCT00175019|4246478|B1|Absent||Presence of Tophus|Based on Final Stable Treatment in study C02-021|participants|Number|490|490.0||||||
4423452|NCT00175019|4246475|B4|Present||Presence of Tophus|Based on Final Stable Treatment in study C02-021|participants|Number|214|214.0||||||
4423453|NCT00175019|4246476|B3|Present||Presence of Tophus|Based on Final Stable Treatment in study C02-021|participants|Number|15|15.0||||||
4423454|NCT00175019|4246477|B2|Present||Presence of Tophus|Based on Final Stable Treatment in study C02-021|participants|Number|83|83.0||||||
4423455|NCT00175019|4246478|B1|Present||Presence of Tophus|Based on Final Stable Treatment in study C02-021|participants|Number|116|116.0||||||
4423456|NCT00175019|4246475|B4||Male|Sex: Female, Male|Based on Final Stable Treatment in study C02-021|Participants|Count of Participants|1042|1042.0||||||
4423457|NCT00175019|4246476|B3||Male|Sex: Female, Male|Based on Final Stable Treatment in study C02-021|Participants|Count of Participants|90|90.0||||||
4423458|NCT00175019|4246477|B2||Male|Sex: Female, Male|Based on Final Stable Treatment in study C02-021|Participants|Count of Participants|371|371.0||||||
4423459|NCT00175019|4246478|B1||Male|Sex: Female, Male|Based on Final Stable Treatment in study C02-021|Participants|Count of Participants|581|581.0||||||
4423460|NCT00175019|4246475|B4||Female|Sex: Female, Male|Based on Final Stable Treatment in study C02-021|Participants|Count of Participants|44|44.0||||||
4423461|NCT00175019|4246476|B3||Female|Sex: Female, Male|Based on Final Stable Treatment in study C02-021|Participants|Count of Participants|2|2.0||||||
4423462|NCT00175019|4246477|B2||Female|Sex: Female, Male|Based on Final Stable Treatment in study C02-021|Participants|Count of Participants|17|17.0||||||
4423463|NCT00175019|4246478|B1||Female|Sex: Female, Male|Based on Final Stable Treatment in study C02-021|Participants|Count of Participants|25|25.0||||||
4423464|NCT00175019|4246475|B4|||Age|Based on Final Stable Treatment in study C02-021|years|Mean|51.2|51.2|Standard Deviation|11.76|11.76|||
4423465|NCT00175019|4246476|B3|||Age|Based on Final Stable Treatment in study C02-021|years|Mean|51.3|51.3|Standard Deviation|12.72|12.72|||
4423466|NCT00175019|4246477|B2|||Age|Based on Final Stable Treatment in study C02-021|years|Mean|48.4|48.4|Standard Deviation|11.02|11.02|||
4423467|NCT00175019|4246478|B1|||Age|Based on Final Stable Treatment in study C02-021|years|Mean|53.0|53.0|Standard Deviation|11.74|11.74|||
4423468|NCT00175006|4246524|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4423469|NCT00175006|4246524|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4423470|NCT00175006|4246524|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4423472|NCT00175006|4246524|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4423473|NCT00175006|4246524|B1|66 years to 85 years||Age, Customized||participants|Number|5|5.0||||||
4423474|NCT00175006|4246524|B1|51 years to 65 years||Age, Customized||participants|Number|6|6.0||||||
4423475|NCT00175006|4246524|B1|36 years to 50 years||Age, Customized||participants|Number|2|2.0||||||
4423476|NCT00175006|4246524|B1|18 years to 35 years||Age, Customized||participants|Number|0|0.0||||||
4423477|NCT00175006|4246524|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|14.1|14.1|||
4423478|NCT00174967|4246529|B5|missing||Body Mass Index||participants|Number|1|1.0||||||
4423479|NCT00174967|4246530|B4|missing||Body Mass Index||participants|Number|0|0.0||||||
4423480|NCT00174967|4246531|B3|missing||Body Mass Index||participants|Number|1|1.0||||||
4423481|NCT00174967|4246532|B2|missing||Body Mass Index||participants|Number|0|0.0||||||
4423482|NCT00174967|4246533|B1|missing||Body Mass Index||participants|Number|0|0.0||||||
4423483|NCT00174967|4246529|B5|>40 kg/m²||Body Mass Index||participants|Number|15|15.0||||||
4423484|NCT00174967|4246530|B4|>40 kg/m²||Body Mass Index||participants|Number|3|3.0||||||
4423485|NCT00174967|4246531|B3|>40 kg/m²||Body Mass Index||participants|Number|3|3.0||||||
4423486|NCT00174967|4246532|B2|>40 kg/m²||Body Mass Index||participants|Number|6|6.0||||||
4423487|NCT00174967|4246533|B1|>40 kg/m²||Body Mass Index||participants|Number|3|3.0||||||
4423488|NCT00174967|4246529|B5|>35 kg/m² to 40 kg/m²||Body Mass Index||participants|Number|22|22.0||||||
4423489|NCT00174967|4246530|B4|>35 kg/m² to 40 kg/m²||Body Mass Index||participants|Number|6|6.0||||||
4423490|NCT00174967|4246531|B3|>35 kg/m² to 40 kg/m²||Body Mass Index||participants|Number|5|5.0||||||
4423491|NCT00174967|4246532|B2|>35 kg/m² to 40 kg/m²||Body Mass Index||participants|Number|7|7.0||||||
4423492|NCT00174967|4246533|B1|>35 kg/m² to 40 kg/m²||Body Mass Index||participants|Number|4|4.0||||||
4423493|NCT00174967|4246529|B5|>30 kg/m² to 35 kg/m²||Body Mass Index||participants|Number|56|56.0||||||
4423494|NCT00174967|4246530|B4|>30 kg/m² to 35 kg/m²||Body Mass Index||participants|Number|16|16.0||||||
4423495|NCT00174967|4246531|B3|>30 kg/m² to 35 kg/m²||Body Mass Index||participants|Number|12|12.0||||||
4423496|NCT00174967|4246532|B2|>30 kg/m² to 35 kg/m²||Body Mass Index||participants|Number|12|12.0||||||
4423497|NCT00174967|4246533|B1|>30 kg/m² to 35 kg/m²||Body Mass Index||participants|Number|16|16.0||||||
4423498|NCT00174967|4246529|B5|>25 kg/m² to 30 kg/m²||Body Mass Index||participants|Number|51|51.0||||||
4423499|NCT00174967|4246530|B4|>25 kg/m² to 30 kg/m²||Body Mass Index||participants|Number|13|13.0||||||
4423500|NCT00174967|4246531|B3|>25 kg/m² to 30 kg/m²||Body Mass Index||participants|Number|14|14.0||||||
4423501|NCT00174967|4246532|B2|>25 kg/m² to 30 kg/m²||Body Mass Index||participants|Number|12|12.0||||||
4423502|NCT00174967|4246533|B1|>25 kg/m² to 30 kg/m²||Body Mass Index||participants|Number|12|12.0||||||
4423503|NCT00174967|4246529|B5|≤25 kilogram per meter² (kg/m²)||Body Mass Index||participants|Number|8|8.0||||||
4423504|NCT00174967|4246530|B4|≤25 kilogram per meter² (kg/m²)||Body Mass Index||participants|Number|0|0.0||||||
4423505|NCT00174967|4246531|B3|≤25 kilogram per meter² (kg/m²)||Body Mass Index||participants|Number|3|3.0||||||
4423506|NCT00174967|4246532|B2|≤25 kilogram per meter² (kg/m²)||Body Mass Index||participants|Number|3|3.0||||||
4423507|NCT00174967|4246533|B1|≤25 kilogram per meter² (kg/m²)||Body Mass Index||participants|Number|2|2.0||||||
4423508|NCT00174967|4246529|B5|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4423509|NCT00174967|4246530|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4423510|NCT00174967|4246531|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4423511|NCT00174967|4246532|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4423512|NCT00174967|4246533|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4423513|NCT00174967|4246529|B5|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4423514|NCT00174967|4246530|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4423515|NCT00174967|4246531|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4423516|NCT00174967|4246532|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4423517|NCT00174967|4246533|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4423518|NCT00174967|4246529|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4423519|NCT00174967|4246530|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4423520|NCT00174967|4246531|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4423521|NCT00174967|4246532|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4423522|NCT00174967|4246533|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4423523|NCT00174967|4246529|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4423524|NCT00174967|4246530|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4423525|NCT00174967|4246531|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4423526|NCT00174967|4246532|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4423527|NCT00174967|4246533|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4423528|NCT00174967|4246529|B5|White||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
4423529|NCT00174967|4246530|B4|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4423530|NCT00174967|4246531|B3|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4423531|NCT00174967|4246532|B2|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4423532|NCT00174967|4246533|B1|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4423533|NCT00174967|4246529|B5||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4423534|NCT00174967|4246530|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4423535|NCT00174967|4246531|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4423536|NCT00174967|4246532|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4423537|NCT00174967|4246533|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4423538|NCT00174967|4246529|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4423539|NCT00174967|4246530|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4423540|NCT00174967|4246531|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4423541|NCT00174967|4246532|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4423542|NCT00174967|4246533|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4423543|NCT00174967|4246529|B5|≥65 years||Age, Customized||participants|Number|36|36.0||||||
4423544|NCT00174967|4246530|B4|≥65 years||Age, Customized||participants|Number|9|9.0||||||
4423545|NCT00174967|4246531|B3|≥65 years||Age, Customized||participants|Number|8|8.0||||||
4423546|NCT00174967|4246532|B2|≥65 years||Age, Customized||participants|Number|11|11.0||||||
4423547|NCT00174967|4246533|B1|≥65 years||Age, Customized||participants|Number|8|8.0||||||
4423548|NCT00174967|4246529|B5|45 years to <65 years||Age, Customized||participants|Number|80|80.0||||||
4423549|NCT00174967|4246530|B4|45 years to <65 years||Age, Customized||participants|Number|17|17.0||||||
4423550|NCT00174967|4246531|B3|45 years to <65 years||Age, Customized||participants|Number|23|23.0||||||
4423551|NCT00174967|4246532|B2|45 years to <65 years||Age, Customized||participants|Number|19|19.0||||||
4423552|NCT00174967|4246533|B1|45 years to <65 years||Age, Customized||participants|Number|21|21.0||||||
4423553|NCT00174967|4246529|B5|<45 years||Age, Customized||participants|Number|37|37.0||||||
4423554|NCT00174967|4246530|B4|<45 years||Age, Customized||participants|Number|12|12.0||||||
4423555|NCT00174967|4246531|B3|<45 years||Age, Customized||participants|Number|7|7.0||||||
4423556|NCT00174967|4246532|B2|<45 years||Age, Customized||participants|Number|10|10.0||||||
4423557|NCT00174967|4246533|B1|<45 years||Age, Customized||participants|Number|8|8.0||||||
4423558|NCT00174967|4246529|B5|||Age||years|Mean|54.0|54.0|Standard Deviation|12.69|12.69|||
4423559|NCT00174967|4246530|B4|||Age||years|Mean|52.4|52.4|Standard Deviation|12.63|12.63|||
4423560|NCT00174967|4246531|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|10.83|10.83|||
4423561|NCT00174967|4246532|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|13.09|13.09|||
4423562|NCT00174967|4246533|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|14.04|14.04|||
4423563|NCT00174954|4246582|B1|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4423564|NCT00174954|4246582|B1|Black or African American||Race/Ethnicity||participants|Number|9|9.0||||||
4423565|NCT00174954|4246582|B1|White||Race/Ethnicity||participants|Number|22|22.0||||||
4423566|NCT00174954|4246582|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4423567|NCT00174954|4246582|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4423568|NCT00174954|4246582|B1|>85 years||Age, Customized||participants|Number|2|2.0||||||
4423569|NCT00174954|4246582|B1|66 years to 85 years||Age, Customized||participants|Number|13|13.0||||||
4423570|NCT00174954|4246582|B1|51 years to 65 years||Age, Customized||participants|Number|7|7.0||||||
4423571|NCT00174954|4246582|B1|36 years to 50 years||Age, Customized||participants|Number|9|9.0||||||
4423572|NCT00174954|4246582|B1|18 years to 35 years||Age, Customized||participants|Number|1|1.0||||||
4423573|NCT00174954|4246582|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|15.5|15.5|||
4423574|NCT00174941|4246587|B4|||Serum Urate||mg/dL|Mean|9.7|9.7|Standard Deviation|1.30|1.3|||
4423575|NCT00174941|4246588|B3|||Serum Urate||mg/dL|Mean|10.23|10.23|Standard Deviation|1.74|1.74|||
4423576|NCT00174941|4246589|B2|||Serum Urate||mg/dL|Mean|9.48|9.48|Standard Deviation|1.04|1.04|||
4423577|NCT00174941|4246590|B1|||Serum Urate||mg/dL|Mean|9.58|9.58|Standard Deviation|1.18|1.18|||
4423578|NCT00174941|4246587|B4|||Body Mass Index||kiligram per meter² (kg/m²)|Mean|32.9|32.9|Standard Deviation|5.69|5.69|||
4423579|NCT00174941|4246588|B3|||Body Mass Index||kiligram per meter² (kg/m²)|Mean|33.9|33.9|Standard Deviation|6.82|6.82|||
4423580|NCT00174941|4246589|B2|||Body Mass Index||kiligram per meter² (kg/m²)|Mean|32.9|32.9|Standard Deviation|5.28|5.28|||
4423581|NCT00174941|4246590|B1|||Body Mass Index||kiligram per meter² (kg/m²)|Mean|28.4|28.4|Standard Deviation|2.78|2.78|||
4423582|NCT00174941|4246587|B4|Missing||Urine Uric Acid||Subjects|Number|2|2.0||||||
4423583|NCT00174941|4246588|B3|Missing||Urine Uric Acid||Subjects|Number|1|1.0||||||
4423584|NCT00174941|4246589|B2|Missing||Urine Uric Acid||Subjects|Number|1|1.0||||||
4423585|NCT00174941|4246590|B1|Missing||Urine Uric Acid||Subjects|Number|0|0.0||||||
4423586|NCT00174941|4246587|B4|Overproducer||Urine Uric Acid||Subjects|Number|26|26.0||||||
4423587|NCT00174941|4246588|B3|Overproducer||Urine Uric Acid||Subjects|Number|7|7.0||||||
4423588|NCT00174941|4246589|B2|Overproducer||Urine Uric Acid||Subjects|Number|16|16.0||||||
4423589|NCT00174941|4246590|B1|Overproducer||Urine Uric Acid||Subjects|Number|3|3.0||||||
4423590|NCT00174941|4246587|B4|Underexcretor||Urine Uric Acid||Subjects|Number|88|88.0||||||
4423591|NCT00174941|4246588|B3|Underexcretor||Urine Uric Acid||Subjects|Number|21|21.0||||||
4423592|NCT00174941|4246589|B2|Underexcretor||Urine Uric Acid||Subjects|Number|62|62.0||||||
4423593|NCT00174941|4246590|B1|Underexcretor||Urine Uric Acid||Subjects|Number|5|5.0||||||
4423594|NCT00174941|4246587|B4|Impaired||Renal Function|Impaired renal function was defined as serum creatinine >1.5 milligrams per deciliter (mg/dL) or a creatinine clearance of ≤80 milliliters per minute (mL/min)|Subjects|Number|68|68.0||||||
4423654|NCT00174941|4246587|B4|45 to <65 years||Age, Customized||Subjects|Number|59|59.0||||||
4423595|NCT00174941|4246588|B3|Impaired||Renal Function|Impaired renal function was defined as serum creatinine >1.5 milligrams per deciliter (mg/dL) or a creatinine clearance of ≤80 milliliters per minute (mL/min)|Subjects|Number|17|17.0||||||
4423596|NCT00174941|4246589|B2|Impaired||Renal Function|Impaired renal function was defined as serum creatinine >1.5 milligrams per deciliter (mg/dL) or a creatinine clearance of ≤80 milliliters per minute (mL/min)|Subjects|Number|46|46.0||||||
4423597|NCT00174941|4246590|B1|Impaired||Renal Function|Impaired renal function was defined as serum creatinine >1.5 milligrams per deciliter (mg/dL) or a creatinine clearance of ≤80 milliliters per minute (mL/min)|Subjects|Number|5|5.0||||||
4423598|NCT00174941|4246587|B4|Normal||Renal Function|Impaired renal function was defined as serum creatinine >1.5 milligrams per deciliter (mg/dL) or a creatinine clearance of ≤80 milliliters per minute (mL/min)|Subjects|Number|48|48.0||||||
4423599|NCT00174941|4246588|B3|Normal||Renal Function|Impaired renal function was defined as serum creatinine >1.5 milligrams per deciliter (mg/dL) or a creatinine clearance of ≤80 milliliters per minute (mL/min)|Subjects|Number|12|12.0||||||
4423600|NCT00174941|4246589|B2|Normal||Renal Function|Impaired renal function was defined as serum creatinine >1.5 milligrams per deciliter (mg/dL) or a creatinine clearance of ≤80 milliliters per minute (mL/min)|Subjects|Number|33|33.0||||||
4423601|NCT00174941|4246590|B1|Normal||Renal Function|Impaired renal function was defined as serum creatinine >1.5 milligrams per deciliter (mg/dL) or a creatinine clearance of ≤80 milliliters per minute (mL/min)|Subjects|Number|3|3.0||||||
4423602|NCT00174941|4246587|B4|Other||Race/Ethnicity||Subjects|Number|3|3.0||||||
4423603|NCT00174941|4246588|B3|Other||Race/Ethnicity||Subjects|Number|2|2.0||||||
4423604|NCT00174941|4246589|B2|Other||Race/Ethnicity||Subjects|Number|1|1.0||||||
4423605|NCT00174941|4246590|B1|Other||Race/Ethnicity||Subjects|Number|0|0.0||||||
4423606|NCT00174941|4246587|B4|Hispanic||Race/Ethnicity||Subjects|Number|3|3.0||||||
4423607|NCT00174941|4246588|B3|Hispanic||Race/Ethnicity||Subjects|Number|1|1.0||||||
4423608|NCT00174941|4246589|B2|Hispanic||Race/Ethnicity||Subjects|Number|2|2.0||||||
4423609|NCT00174941|4246590|B1|Hispanic||Race/Ethnicity||Subjects|Number|0|0.0||||||
4423610|NCT00174941|4246587|B4|White||Race/Ethnicity||Subjects|Number|99|99.0||||||
4423611|NCT00174941|4246588|B3|White||Race/Ethnicity||Subjects|Number|21|21.0||||||
4423612|NCT00174941|4246589|B2|White||Race/Ethnicity||Subjects|Number|71|71.0||||||
4423613|NCT00174941|4246590|B1|White||Race/Ethnicity||Subjects|Number|7|7.0||||||
4423614|NCT00174941|4246587|B4|Black or African American||Race/Ethnicity||Subjects|Number|9|9.0||||||
4423615|NCT00174941|4246588|B3|Black or African American||Race/Ethnicity||Subjects|Number|3|3.0||||||
4423616|NCT00174941|4246589|B2|Black or African American||Race/Ethnicity||Subjects|Number|5|5.0||||||
4423617|NCT00174941|4246590|B1|Black or African American||Race/Ethnicity||Subjects|Number|1|1.0||||||
4423618|NCT00174941|4246587|B4|Asian||Race/Ethnicity||Subjects|Number|2|2.0||||||
4423619|NCT00174941|4246588|B3|Asian||Race/Ethnicity||Subjects|Number|2|2.0||||||
4423620|NCT00174941|4246589|B2|Asian||Race/Ethnicity||Subjects|Number|0|0.0||||||
4423621|NCT00174941|4246590|B1|Asian||Race/Ethnicity||Subjects|Number|0|0.0||||||
4423622|NCT00174941|4246587|B4|No||Presence of Tophus||Subjects|Number|90|90.0||||||
4423623|NCT00174941|4246588|B3|No||Presence of Tophus||Subjects|Number|17|17.0||||||
4423624|NCT00174941|4246589|B2|No||Presence of Tophus||Subjects|Number|66|66.0||||||
4423625|NCT00174941|4246590|B1|No||Presence of Tophus||Subjects|Number|7|7.0||||||
4423626|NCT00174941|4246587|B4|Yes||Presence of Tophus||Subjects|Number|26|26.0||||||
4423627|NCT00174941|4246588|B3|Yes||Presence of Tophus||Subjects|Number|12|12.0||||||
4423628|NCT00174941|4246589|B2|Yes||Presence of Tophus||Subjects|Number|13|13.0||||||
4423629|NCT00174941|4246590|B1|Yes||Presence of Tophus||Subjects|Number|1|1.0||||||
4423630|NCT00174941|4246587|B4|No||History of Kidney Stone||Subjects|Number|102|102.0||||||
4423631|NCT00174941|4246588|B3|No||History of Kidney Stone||Subjects|Number|26|26.0||||||
4423632|NCT00174941|4246589|B2|No||History of Kidney Stone||Subjects|Number|68|68.0||||||
4423633|NCT00174941|4246590|B1|No||History of Kidney Stone||Subjects|Number|8|8.0||||||
4423634|NCT00174941|4246587|B4|Yes||History of Kidney Stone||Subjects|Number|14|14.0||||||
4423635|NCT00174941|4246588|B3|Yes||History of Kidney Stone||Subjects|Number|3|3.0||||||
4423636|NCT00174941|4246589|B2|Yes||History of Kidney Stone||Subjects|Number|11|11.0||||||
4423637|NCT00174941|4246590|B1|Yes||History of Kidney Stone||Subjects|Number|0|0.0||||||
4423638|NCT00174941|4246587|B4||Male|Sex: Female, Male||Participants|Count of Participants|105.0|105.0||||||
4423639|NCT00174941|4246588|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4423640|NCT00174941|4246589|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4423641|NCT00174941|4246590|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4423642|NCT00174941|4246587|B4||Female|Sex: Female, Male||Participants|Count of Participants|11.0|11.0||||||
4423643|NCT00174941|4246588|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4423644|NCT00174941|4246589|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4423645|NCT00174941|4246590|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4423646|NCT00174941|4246587|B4|||Age||years|Mean|53.3|53.3|Standard Deviation|12.74|12.74|||
4423647|NCT00174941|4246588|B3|||Age||years|Mean|51.3|51.3|Standard Deviation|13.01|13.01|||
4423648|NCT00174941|4246589|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|12.85|12.85|||
4423649|NCT00174941|4246590|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|11.44|11.44|||
4423650|NCT00174941|4246587|B4|≥65 years||Age, Customized||Subjects|Number|26|26.0||||||
4423651|NCT00174941|4246588|B3|≥65 years||Age, Customized||Subjects|Number|5|5.0||||||
4423652|NCT00174941|4246589|B2|≥65 years||Age, Customized||Subjects|Number|19|19.0||||||
4423653|NCT00174941|4246590|B1|≥65 years||Age, Customized||Subjects|Number|2|2.0||||||
4423655|NCT00174941|4246588|B3|45 to <65 years||Age, Customized||Subjects|Number|15|15.0||||||
4423656|NCT00174941|4246589|B2|45 to <65 years||Age, Customized||Subjects|Number|40|40.0||||||
4423657|NCT00174941|4246590|B1|45 to <65 years||Age, Customized||Subjects|Number|4|4.0||||||
4423658|NCT00174941|4246587|B4|<45 years||Age, Customized||Subjects|Number|31|31.0||||||
4423659|NCT00174941|4246588|B3|<45 years||Age, Customized||Subjects|Number|9|9.0||||||
4423660|NCT00174941|4246589|B2|<45 years||Age, Customized||Subjects|Number|20|20.0||||||
4423661|NCT00174941|4246590|B1|<45 years||Age, Customized||Subjects|Number|2|2.0||||||
4423662|NCT00174915|4246663|B6|>1.5 mg/dL||Serum Creatinine||subjects|Number|40|40.0||||||
4423663|NCT00174915|4246664|B5|>1.5 mg/dL||Serum Creatinine||subjects|Number|5|5.0||||||
4423664|NCT00174915|4246665|B4|>1.5 mg/dL||Serum Creatinine||subjects|Number|10|10.0||||||
4423665|NCT00174915|4246666|B3|>1.5 mg/dL||Serum Creatinine||subjects|Number|5|5.0||||||
4423666|NCT00174915|4246667|B2|>1.5 mg/dL||Serum Creatinine||subjects|Number|11|11.0||||||
4423667|NCT00174915|4246668|B1|>1.5 mg/dL||Serum Creatinine||subjects|Number|9|9.0||||||
4423668|NCT00174915|4246663|B6|≤1.5 milligram per deciliter (mg/dL)||Serum Creatinine||subjects|Number|1032|1032.0||||||
4423669|NCT00174915|4246664|B5|≤1.5 milligram per deciliter (mg/dL)||Serum Creatinine||subjects|Number|129|129.0||||||
4423670|NCT00174915|4246665|B4|≤1.5 milligram per deciliter (mg/dL)||Serum Creatinine||subjects|Number|258|258.0||||||
4423671|NCT00174915|4246666|B3|≤1.5 milligram per deciliter (mg/dL)||Serum Creatinine||subjects|Number|129|129.0||||||
4423672|NCT00174915|4246667|B2|≤1.5 milligram per deciliter (mg/dL)||Serum Creatinine||subjects|Number|258|258.0||||||
4423673|NCT00174915|4246668|B1|≤1.5 milligram per deciliter (mg/dL)||Serum Creatinine||subjects|Number|258|258.0||||||
4423674|NCT00174915|4246663|B6|No, and no other tophi present||Presence of a Primary PalpableTophus||subjects|Number|847|847.0||||||
4423675|NCT00174915|4246664|B5|No, and no other tophi present||Presence of a Primary PalpableTophus||subjects|Number|104|104.0||||||
4423676|NCT00174915|4246665|B4|No, and no other tophi present||Presence of a Primary PalpableTophus||subjects|Number|203|203.0||||||
4423677|NCT00174915|4246666|B3|No, and no other tophi present||Presence of a Primary PalpableTophus||subjects|Number|108|108.0||||||
4423678|NCT00174915|4246667|B2|No, and no other tophi present||Presence of a Primary PalpableTophus||subjects|Number|213|213.0||||||
4423679|NCT00174915|4246668|B1|No, and no other tophi present||Presence of a Primary PalpableTophus||subjects|Number|219|219.0||||||
4423680|NCT00174915|4246663|B6|No, but other tophi present||Presence of a Primary PalpableTophus||subjects|Number|6|6.0||||||
4423681|NCT00174915|4246664|B5|No, but other tophi present||Presence of a Primary PalpableTophus||subjects|Number|1|1.0||||||
4423682|NCT00174915|4246665|B4|No, but other tophi present||Presence of a Primary PalpableTophus||subjects|Number|1|1.0||||||
4423683|NCT00174915|4246666|B3|No, but other tophi present||Presence of a Primary PalpableTophus||subjects|Number|1|1.0||||||
4423684|NCT00174915|4246667|B2|No, but other tophi present||Presence of a Primary PalpableTophus||subjects|Number|3|3.0||||||
4423685|NCT00174915|4246668|B1|No, but other tophi present||Presence of a Primary PalpableTophus||subjects|Number|0|0.0||||||
4423686|NCT00174915|4246663|B6|Yes||Presence of a Primary PalpableTophus||subjects|Number|219|219.0||||||
4423687|NCT00174915|4246664|B5|Yes||Presence of a Primary PalpableTophus||subjects|Number|29|29.0||||||
4423688|NCT00174915|4246665|B4|Yes||Presence of a Primary PalpableTophus||subjects|Number|64|64.0||||||
4423689|NCT00174915|4246666|B3|Yes||Presence of a Primary PalpableTophus||subjects|Number|25|25.0||||||
4423690|NCT00174915|4246667|B2|Yes||Presence of a Primary PalpableTophus||subjects|Number|53|53.0||||||
4423691|NCT00174915|4246668|B1|Yes||Presence of a Primary PalpableTophus||subjects|Number|48|48.0||||||
4423692|NCT00174915|4246663|B6|missing||Body Mass Index||subjects|Number|2|2.0||||||
4423693|NCT00174915|4246664|B5|missing||Body Mass Index||subjects|Number|0|0.0||||||
4423694|NCT00174915|4246665|B4|missing||Body Mass Index||subjects|Number|1|1.0||||||
4423695|NCT00174915|4246666|B3|missing||Body Mass Index||subjects|Number|0|0.0||||||
4423696|NCT00174915|4246667|B2|missing||Body Mass Index||subjects|Number|1|1.0||||||
4423697|NCT00174915|4246668|B1|missing||Body Mass Index||subjects|Number|0|0.0||||||
4423698|NCT00174915|4246663|B6|≥30 kg/m²||Body Mass Index||subjects|Number|662|662.0||||||
4423699|NCT00174915|4246664|B5|≥30 kg/m²||Body Mass Index||subjects|Number|70|70.0||||||
4423700|NCT00174915|4246665|B4|≥30 kg/m²||Body Mass Index||subjects|Number|161|161.0||||||
4423701|NCT00174915|4246666|B3|≥30 kg/m²||Body Mass Index||subjects|Number|83|83.0||||||
4423702|NCT00174915|4246667|B2|≥30 kg/m²||Body Mass Index||subjects|Number|176|176.0||||||
4423703|NCT00174915|4246668|B1|≥30 kg/m²||Body Mass Index||subjects|Number|172|172.0||||||
4423704|NCT00174915|4246663|B6|25 kg/m² to <30 kg/m²||Body Mass Index||subjects|Number|347|347.0||||||
4423705|NCT00174915|4246664|B5|25 kg/m² to <30 kg/m²||Body Mass Index||subjects|Number|48|48.0||||||
4423706|NCT00174915|4246665|B4|25 kg/m² to <30 kg/m²||Body Mass Index||subjects|Number|91|91.0||||||
4423707|NCT00174915|4246666|B3|25 kg/m² to <30 kg/m²||Body Mass Index||subjects|Number|42|42.0||||||
4423708|NCT00174915|4246667|B2|25 kg/m² to <30 kg/m²||Body Mass Index||subjects|Number|81|81.0||||||
4423709|NCT00174915|4246668|B1|25 kg/m² to <30 kg/m²||Body Mass Index||subjects|Number|85|85.0||||||
4423710|NCT00174915|4246663|B6|18.5 kg/m² to <25 kg/m²||Body Mass Index||subjects|Number|61|61.0||||||
4423711|NCT00174915|4246664|B5|18.5 kg/m² to <25 kg/m²||Body Mass Index||subjects|Number|16|16.0||||||
4423712|NCT00174915|4246665|B4|18.5 kg/m² to <25 kg/m²||Body Mass Index||subjects|Number|15|15.0||||||
4423713|NCT00174915|4246666|B3|18.5 kg/m² to <25 kg/m²||Body Mass Index||subjects|Number|9|9.0||||||
4423714|NCT00174915|4246667|B2|18.5 kg/m² to <25 kg/m²||Body Mass Index||subjects|Number|11|11.0||||||
4423715|NCT00174915|4246668|B1|18.5 kg/m² to <25 kg/m²||Body Mass Index||subjects|Number|10|10.0||||||
4423716|NCT00174915|4246663|B6|<18.5 kilogram per meter² (kg/m²)||Body Mass Index||subjects|Number|0|0.0||||||
4423717|NCT00174915|4246664|B5|<18.5 kilogram per meter² (kg/m²)||Body Mass Index||subjects|Number|0|0.0||||||
4423718|NCT00174915|4246665|B4|<18.5 kilogram per meter² (kg/m²)||Body Mass Index||subjects|Number|0|0.0||||||
4423719|NCT00174915|4246666|B3|<18.5 kilogram per meter² (kg/m²)||Body Mass Index||subjects|Number|0|0.0||||||
4423720|NCT00174915|4246667|B2|<18.5 kilogram per meter² (kg/m²)||Body Mass Index||subjects|Number|0|0.0||||||
4423721|NCT00174915|4246668|B1|<18.5 kilogram per meter² (kg/m²)||Body Mass Index||subjects|Number|0|0.0||||||
4423722|NCT00174915|4246663|B6|Other||Race/Ethnicity, Customized||subjects|Number|27|27.0||||||
4423723|NCT00174915|4246664|B5|Other||Race/Ethnicity, Customized||subjects|Number|4|4.0||||||
4423724|NCT00174915|4246665|B4|Other||Race/Ethnicity, Customized||subjects|Number|6|6.0||||||
4423725|NCT00174915|4246666|B3|Other||Race/Ethnicity, Customized||subjects|Number|5|5.0||||||
4423726|NCT00174915|4246667|B2|Other||Race/Ethnicity, Customized||subjects|Number|4|4.0||||||
4423727|NCT00174915|4246668|B1|Other||Race/Ethnicity, Customized||subjects|Number|8|8.0||||||
4423728|NCT00174915|4246663|B6|Asian||Race/Ethnicity, Customized||subjects|Number|26|26.0||||||
4423729|NCT00174915|4246664|B5|Asian||Race/Ethnicity, Customized||subjects|Number|3|3.0||||||
4423730|NCT00174915|4246665|B4|Asian||Race/Ethnicity, Customized||subjects|Number|6|6.0||||||
4423731|NCT00174915|4246666|B3|Asian||Race/Ethnicity, Customized||subjects|Number|1|1.0||||||
4423732|NCT00174915|4246667|B2|Asian||Race/Ethnicity, Customized||subjects|Number|8|8.0||||||
4423733|NCT00174915|4246668|B1|Asian||Race/Ethnicity, Customized||subjects|Number|8|8.0||||||
4423734|NCT00174915|4246663|B6|Hispanic||Race/Ethnicity, Customized||subjects|Number|64|64.0||||||
4423735|NCT00174915|4246664|B5|Hispanic||Race/Ethnicity, Customized||subjects|Number|10|10.0||||||
4423736|NCT00174915|4246665|B4|Hispanic||Race/Ethnicity, Customized||subjects|Number|17|17.0||||||
4423737|NCT00174915|4246666|B3|Hispanic||Race/Ethnicity, Customized||subjects|Number|8|8.0||||||
4423738|NCT00174915|4246667|B2|Hispanic||Race/Ethnicity, Customized||subjects|Number|16|16.0||||||
4423739|NCT00174915|4246668|B1|Hispanic||Race/Ethnicity, Customized||subjects|Number|13|13.0||||||
4423740|NCT00174915|4246663|B6|Black or African American||Race/Ethnicity, Customized||subjects|Number|120|120.0||||||
4423741|NCT00174915|4246664|B5|Black or African American||Race/Ethnicity, Customized||subjects|Number|9|9.0||||||
4423742|NCT00174915|4246665|B4|Black or African American||Race/Ethnicity, Customized||subjects|Number|33|33.0||||||
4423743|NCT00174915|4246666|B3|Black or African American||Race/Ethnicity, Customized||subjects|Number|13|13.0||||||
4423744|NCT00174915|4246667|B2|Black or African American||Race/Ethnicity, Customized||subjects|Number|27|27.0||||||
4423745|NCT00174915|4246668|B1|Black or African American||Race/Ethnicity, Customized||subjects|Number|38|38.0||||||
4423746|NCT00174915|4246663|B6|White||Race/Ethnicity, Customized||subjects|Number|835|835.0||||||
4423747|NCT00174915|4246664|B5|White||Race/Ethnicity, Customized||subjects|Number|108|108.0||||||
4423748|NCT00174915|4246665|B4|White||Race/Ethnicity, Customized||subjects|Number|206|206.0||||||
4423749|NCT00174915|4246666|B3|White||Race/Ethnicity, Customized||subjects|Number|107|107.0||||||
4423750|NCT00174915|4246667|B2|White||Race/Ethnicity, Customized||subjects|Number|214|214.0||||||
4423751|NCT00174915|4246668|B1|White||Race/Ethnicity, Customized||subjects|Number|200|200.0||||||
4423752|NCT00174915|4246663|B6||Male|Sex: Female, Male||Participants|Count of Participants|1005|1005.0||||||
4423753|NCT00174915|4246664|B5||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4423754|NCT00174915|4246665|B4||Male|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4423755|NCT00174915|4246666|B3||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4423756|NCT00174915|4246667|B2||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4423757|NCT00174915|4246668|B1||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4423758|NCT00174915|4246663|B6||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4423759|NCT00174915|4246664|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4423760|NCT00174915|4246665|B4||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4423761|NCT00174915|4246666|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4423762|NCT00174915|4246667|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4423763|NCT00174915|4246668|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4423764|NCT00174915|4246663|B6|||Age||years|Mean|51.6|51.6|Standard Deviation|12.17|12.17|||
4423765|NCT00174915|4246664|B5|||Age||years|Mean|51.5|51.5|Standard Deviation|12.18|12.18|||
4423766|NCT00174915|4246665|B4|||Age||years|Mean|51.8|51.8|Standard Deviation|12.25|12.25|||
4423767|NCT00174915|4246666|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|12.83|12.83|||
4423768|NCT00174915|4246667|B2|||Age||years|Mean|51.2|51.2|Standard Deviation|11.57|11.57|||
4423769|NCT00174915|4246668|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|12.24|12.24|||
4423770|NCT00174915|4246663|B6|≥65 years||Age, Customized||subjects|Number|163|163.0||||||
4423771|NCT00174915|4246664|B5|≥65 years||Age, Customized||subjects|Number|19|19.0||||||
4423772|NCT00174915|4246665|B4|≥65 years||Age, Customized||subjects|Number|39|39.0||||||
4423773|NCT00174915|4246666|B3|≥65 years||Age, Customized||subjects|Number|30|30.0||||||
4423774|NCT00174915|4246667|B2|≥65 years||Age, Customized||subjects|Number|36|36.0||||||
4423775|NCT00174915|4246668|B1|≥65 years||Age, Customized||subjects|Number|39|39.0||||||
4423776|NCT00174915|4246663|B6|45 years to <65 years||Age, Customized||subjects|Number|597|597.0||||||
4423777|NCT00174915|4246664|B5|45 years to <65 years||Age, Customized||subjects|Number|79|79.0||||||
4423778|NCT00174915|4246665|B4|45 years to <65 years||Age, Customized||subjects|Number|147|147.0||||||
4423779|NCT00174915|4246666|B3|45 years to <65 years||Age, Customized||subjects|Number|71|71.0||||||
4423780|NCT00174915|4246667|B2|45 years to <65 years||Age, Customized||subjects|Number|154|154.0||||||
4423781|NCT00174915|4246668|B1|45 years to <65 years||Age, Customized||subjects|Number|146|146.0||||||
4423782|NCT00174915|4246663|B6|<45 years||Age, Customized||subjects|Number|312|312.0||||||
4423783|NCT00174915|4246664|B5|<45 years||Age, Customized||subjects|Number|36|36.0||||||
4423784|NCT00174915|4246665|B4|<45 years||Age, Customized||subjects|Number|82|82.0||||||
4423785|NCT00174915|4246666|B3|<45 years||Age, Customized||subjects|Number|33|33.0||||||
4423786|NCT00174915|4246667|B2|<45 years||Age, Customized||subjects|Number|79|79.0||||||
4423787|NCT00174915|4246668|B1|<45 years||Age, Customized||subjects|Number|82|82.0||||||
4423788|NCT00174785|4246729|B3||Male|Sex: Female, Male||Participants|Count of Participants|2459|2459.0||||||
4423789|NCT00174785|4246730|B2||Male|Sex: Female, Male||Participants|Count of Participants|1289|1289.0||||||
4423790|NCT00174785|4246731|B1||Male|Sex: Female, Male||Participants|Count of Participants|1170|1170.0||||||
4423791|NCT00174785|4246729|B3||Female|Sex: Female, Male||Participants|Count of Participants|2169|2169.0||||||
4423792|NCT00174785|4246730|B2||Female|Sex: Female, Male||Participants|Count of Participants|1038|1038.0||||||
4423793|NCT00174785|4246731|B1||Female|Sex: Female, Male||Participants|Count of Participants|1131|1131.0||||||
4423794|NCT00174785|4246729|B3|||Age||years|Mean|71.6|71.6|Standard Deviation|9.0|9.0|||
4423795|NCT00174785|4246730|B2|||Age||years|Mean|71.7|71.7|Standard Deviation|9.0|9.0|||
4423796|NCT00174785|4246731|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|8.9|8.9|||
4423797|NCT00174785|4246729|B3|>= 75 years||Age, Customized||participants|Number|1925|1925.0||||||
4423798|NCT00174785|4246730|B2|>= 75 years||Age, Customized||participants|Number|978|978.0||||||
4423799|NCT00174785|4246731|B1|>= 75 years||Age, Customized||participants|Number|947|947.0||||||
4423800|NCT00174785|4246729|B3|65 to < 75 years||Age, Customized||participants|Number|1830|1830.0||||||
4423801|NCT00174785|4246730|B2|65 to < 75 years||Age, Customized||participants|Number|907|907.0||||||
4423802|NCT00174785|4246731|B1|65 to < 75 years||Age, Customized||participants|Number|923|923.0||||||
4423803|NCT00174785|4246729|B3|18 to < 65 years||Age, Customized||participants|Number|873|873.0||||||
4423804|NCT00174785|4246730|B2|18 to < 65 years||Age, Customized||participants|Number|442|442.0||||||
4423805|NCT00174785|4246731|B1|18 to < 65 years||Age, Customized||participants|Number|431|431.0||||||
4423806|NCT00174460|4246746|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4423807|NCT00174460|4246747|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4423808|NCT00174460|4246748|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4423809|NCT00174460|4246746|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4423810|NCT00174460|4246747|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4423811|NCT00174460|4246748|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4423812|NCT00174460|4246746|B3|≥8 years and <12 years||Age, Customized|1 subject in each treatment group was below the age of 4 at screening. However, both of them were 4 years old when treatment began; they did not violate the corresponding inclusion criterion.|Participants|Number|6|6.0||||||
4423813|NCT00174460|4246747|B2|≥8 years and <12 years||Age, Customized|1 subject in each treatment group was below the age of 4 at screening. However, both of them were 4 years old when treatment began; they did not violate the corresponding inclusion criterion.|Participants|Number|3|3.0||||||
4423814|NCT00174460|4246748|B1|≥8 years and <12 years||Age, Customized|1 subject in each treatment group was below the age of 4 at screening. However, both of them were 4 years old when treatment began; they did not violate the corresponding inclusion criterion.|Participants|Number|3|3.0||||||
4423815|NCT00174460|4246746|B3|≥4 years and <8 years||Age, Customized|1 subject in each treatment group was below the age of 4 at screening. However, both of them were 4 years old when treatment began; they did not violate the corresponding inclusion criterion.|Participants|Number|25|25.0||||||
4423816|NCT00174460|4246747|B2|≥4 years and <8 years||Age, Customized|1 subject in each treatment group was below the age of 4 at screening. However, both of them were 4 years old when treatment began; they did not violate the corresponding inclusion criterion.|Participants|Number|11|11.0||||||
4423817|NCT00174460|4246748|B1|≥4 years and <8 years||Age, Customized|1 subject in each treatment group was below the age of 4 at screening. However, both of them were 4 years old when treatment began; they did not violate the corresponding inclusion criterion.|Participants|Number|14|14.0||||||
4423818|NCT00174460|4246746|B3|<4 years||Age, Customized|1 subject in each treatment group was below the age of 4 at screening. However, both of them were 4 years old when treatment began; they did not violate the corresponding inclusion criterion.|Participants|Number|2|2.0||1.7|1.7|||
4423819|NCT00174460|4246747|B2|<4 years||Age, Customized|1 subject in each treatment group was below the age of 4 at screening. However, both of them were 4 years old when treatment began; they did not violate the corresponding inclusion criterion.|Participants|Number|1|1.0||1.9|1.9|||
4423820|NCT00174460|4246748|B1|<4 years||Age, Customized|1 subject in each treatment group was below the age of 4 at screening. However, both of them were 4 years old when treatment began; they did not violate the corresponding inclusion criterion.|Participants|Number|1|1.0||1.5|1.5|||
4423821|NCT00174460|4246746|B3|||Age||years|Mean|5.5|5.5|Standard Deviation|1.7|1.7|||
4423822|NCT00174460|4246747|B2|||Age||years|Mean|5.7|5.7|Standard Deviation|1.9|1.9|||
4423823|NCT00174460|4246748|B1|||Age||years|Mean|5.4|5.4|Standard Deviation|1.6|1.6|||
4423824|NCT00174447|4246795|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4423825|NCT00174447|4246795|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4423826|NCT00174447|4246795|B1|||Age||years|Mean|41.1|41.1|Standard Deviation|13.3|13.3|||
4423827|NCT00174382|4246804|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4423828|NCT00174382|4246804|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4423829|NCT00174382|4246804|B1|>= 65||Age, Customized||Participants|Number|129|129.0||||||
4423830|NCT00174382|4246804|B1|45-64||Age, Customized||Participants|Number|20|20.0||||||
4423831|NCT00174382|4246804|B1|< 45||Age, Customized||Participants|Number|0|0.0||||||
4423832|NCT00174291|4246821|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4423833|NCT00174291|4246822|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4423834|NCT00174291|4246823|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4423835|NCT00174291|4246821|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4423836|NCT00174291|4246822|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4423837|NCT00174291|4246823|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4423838|NCT00174291|4246821|B3|||Age||years|Mean|8.4|8.4|Standard Deviation|2.9|2.9|||
4423839|NCT00174291|4246822|B2|||Age||years|Mean|8.5|8.5|Standard Deviation|3.3|3.3|||
4423840|NCT00174291|4246823|B1|||Age||years|Mean|8.3|8.3|Standard Deviation|2.6|2.6|||
4423841|NCT00174265|4246852|B3||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4423842|NCT00174265|4246853|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4423843|NCT00174265|4246854|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4423844|NCT00174265|4246852|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4423845|NCT00174265|4246853|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4423846|NCT00174265|4246854|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4423847|NCT00174265|4246852|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4423848|NCT00174265|4246853|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4423849|NCT00174265|4246854|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4423850|NCT00174265|4246852|B3||Between 18 and 65 years|Age||Participants|Count of Participants|192|192.0||||||
4423851|NCT00174265|4246853|B2||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4423852|NCT00174265|4246854|B1||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4423853|NCT00174265|4246852|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423854|NCT00174265|4246853|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423855|NCT00174265|4246854|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4423856|NCT00174252|4246863|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4423857|NCT00174252|4246863|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4423858|NCT00174252|4246863|B1|>=12 years||Age, Customized||participants|Number|0|0.0||||||
4423859|NCT00174252|4246863|B1|Between 8 and 12 years||Age, Customized||participants|Number|7|7.0||||||
4423860|NCT00174252|4246863|B1|Between 4 and 8 years||Age, Customized||participants|Number|49|49.0||||||
4423861|NCT00174252|4246863|B1|<4 years||Age, Customized||participants|Number|1|1.0||||||
4423862|NCT00174187|4246896|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4423863|NCT00174187|4246897|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4423864|NCT00174187|4246898|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4423865|NCT00174187|4246896|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4423866|NCT00174187|4246897|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4423867|NCT00174187|4246898|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4423868|NCT00174187|4246896|B3|||Age||years|Mean|11.55|11.55|Standard Deviation|3.53|3.53|||
4423869|NCT00174187|4246897|B2|||Age||years|Mean|11.96|11.96|Standard Deviation|3.80|3.8|||
4423870|NCT00174187|4246898|B1|||Age||years|Mean|11.14|11.14|Standard Deviation|3.32|3.32|||
4423871|NCT00172185|4246961|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423872|NCT00172185|4246962|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423873|NCT00172185|4246963|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423874|NCT00172185|4246964|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423875|NCT00172185|4246965|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423876|NCT00172185|4246961|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423877|NCT00172185|4246962|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423878|NCT00172185|4246963|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423879|NCT00172185|4246964|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423880|NCT00172185|4246965|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423881|NCT00172185|4246961|B5||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4423882|NCT00172185|4246962|B4||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4423883|NCT00172185|4246963|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4423884|NCT00172185|4246964|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4423885|NCT00172185|4246965|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4423886|NCT00172185|4246961|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4423887|NCT00172185|4246962|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4423888|NCT00172185|4246963|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4423889|NCT00172185|4246964|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423890|NCT00172185|4246965|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4423891|NCT00172185|4246961|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423892|NCT00172185|4246962|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423893|NCT00172185|4246963|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423894|NCT00172185|4246964|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423895|NCT00172185|4246965|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423896|NCT00172185|4246961|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423897|NCT00172185|4246962|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423898|NCT00172185|4246963|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423899|NCT00172185|4246964|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423900|NCT00172185|4246965|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423901|NCT00172185|4246961|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423902|NCT00172185|4246962|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423903|NCT00172185|4246963|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423904|NCT00172185|4246964|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423905|NCT00172185|4246965|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4423906|NCT00172185|4246961|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4423907|NCT00172185|4246962|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4423908|NCT00172185|4246963|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4423909|NCT00172185|4246964|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4423910|NCT00172185|4246965|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4423911|NCT00172185|4246961|B5||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4423912|NCT00172185|4246962|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4423913|NCT00172185|4246963|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4423914|NCT00172185|4246964|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4423915|NCT00172185|4246965|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4423916|NCT00172185|4246961|B5|||Age||years|Mean|48.5|48.5|Standard Deviation|13.61|13.61|||
4423917|NCT00172185|4246962|B4|||Age||years|Mean|49.4|49.4|Standard Deviation|14.04|14.04|||
4423918|NCT00172185|4246963|B3|||Age||years|Mean|46.7|46.7|Standard Deviation|13.48|13.48|||
4423919|NCT00172185|4246964|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|9.74|9.74|||
4423920|NCT00172185|4246965|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|14.06|14.06|||
4423921|NCT00172042|4246982|B3||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4423922|NCT00172042|4246983|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4423923|NCT00172042|4246984|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4423924|NCT00172042|4246982|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4423925|NCT00172042|4246983|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4423926|NCT00172042|4246984|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4423927|NCT00172042|4246982|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|9.23|9.23|||
4423928|NCT00172042|4246983|B2|||Age||years|Mean|60.0|60.0|Standard Deviation|9.27|9.27|||
4423929|NCT00172042|4246984|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|9.19|9.19|||
4423930|NCT00171925|4247005|B3|Germany||Region of Enrollment||participants|Number|143|143.0||||||
4423931|NCT00171925|4247006|B2|Germany||Region of Enrollment||participants|Number|71|71.0||||||
4423932|NCT00171925|4247007|B1|Germany||Region of Enrollment||participants|Number|72|72.0||||||
4423933|NCT00171925|4247005|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4423934|NCT00171925|4247006|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4423935|NCT00171925|4247007|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4423936|NCT00171925|4247005|B3|Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4423937|NCT00171925|4247006|B2|Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4423938|NCT00171925|4247007|B1|Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4423939|NCT00171925|4247005|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
4423940|NCT00171925|4247006|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4423941|NCT00171925|4247007|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4423942|NCT00171925|4247005|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4423943|NCT00171925|4247006|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4423944|NCT00171925|4247007|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4423945|NCT00171925|4247005|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4423946|NCT00171925|4247006|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4423947|NCT00171925|4247007|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4423948|NCT00171925|4247005|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|11.5|11.5|||
4423949|NCT00171925|4247006|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|10.79|10.79|||
4423950|NCT00171925|4247007|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|12.02|12.02|||
4423951|NCT00171873|4247018|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4423952|NCT00171873|4247019|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4423953|NCT00171873|4247020|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4423954|NCT00171873|4247018|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4423955|NCT00171873|4247019|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4423956|NCT00171873|4247020|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4423957|NCT00171873|4247018|B3|||Age||years|Median|62|62.0|Full Range|||38.0|82.0|
4423958|NCT00171873|4247019|B2|||Age||years|Median|61|61.0|Full Range|||39.0|82.0|
4423959|NCT00171873|4247020|B1|||Age||years|Median|63.5|63.5|Full Range|||38.0|79.0|
4423960|NCT00171834|4247027|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4423961|NCT00171834|4247028|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4423962|NCT00171834|4247029|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4423963|NCT00171834|4247030|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4423964|NCT00171834|4247031|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4423965|NCT00171834|4247032|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4423966|NCT00171834|4247033|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4423967|NCT00171834|4247034|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4423968|NCT00171834|4247027|B8|Caucasian||Race/Ethnicity, Customized||participants|Number|88|88.0||||||
4423969|NCT00171834|4247028|B7|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4423970|NCT00171834|4247029|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4423971|NCT00171834|4247030|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4423972|NCT00171834|4247031|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4423973|NCT00171834|4247032|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4423974|NCT00171834|4247033|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4423975|NCT00171834|4247034|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4423976|NCT00171834|4247027|B8||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4423977|NCT00171834|4247028|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4423978|NCT00171834|4247029|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4423979|NCT00171834|4247030|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4423980|NCT00171834|4247031|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4423981|NCT00171834|4247032|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4423982|NCT00171834|4247033|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4423983|NCT00171834|4247034|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4423984|NCT00171834|4247027|B8||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4423985|NCT00171834|4247028|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4423986|NCT00171834|4247029|B6||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4423987|NCT00171834|4247030|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4423988|NCT00171834|4247031|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4423989|NCT00171834|4247032|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4423990|NCT00171834|4247033|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4423991|NCT00171834|4247034|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4423992|NCT00171834|4247027|B8|||Age||years|Mean|57.9|57.9|Standard Deviation|9.85|9.85|||
4423993|NCT00171834|4247028|B7|||Age||years|Mean|60.5|60.5|Standard Deviation|9.71|9.71|||
4423994|NCT00171834|4247029|B6|||Age||years|Mean|63.3|63.3|Standard Deviation|8.04|8.04|||
4423995|NCT00171834|4247030|B5|||Age||years|Mean|56.3|56.3|Standard Deviation|13.31|13.31|||
4423996|NCT00171834|4247031|B4|||Age||years|Mean|57.6|57.6|Standard Deviation|9.07|9.07|||
4423997|NCT00171834|4247032|B3|||Age||years|Mean|57.8|57.8|Standard Deviation|9.31|9.31|||
4423998|NCT00171834|4247033|B2|||Age||years|Mean|59.4|59.4|Standard Deviation|8.98|8.98|||
4423999|NCT00171834|4247034|B1|||Age||years|Mean|58.3|58.3|Standard Deviation|12.01|12.01|||
4424000|NCT00171704|4247078|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424001|NCT00171704|4247079|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424002|NCT00171704|4247080|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424003|NCT00171704|4247078|B3||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4424004|NCT00171704|4247079|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4424005|NCT00171704|4247080|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4424006|NCT00171704|4247078|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|6.2|6.2|||
4424007|NCT00171704|4247079|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|6.2|6.2|||
4424008|NCT00171704|4247080|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|6.1|6.1|||
4424009|NCT00171340|4247101|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424010|NCT00171340|4247102|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424011|NCT00171340|4247103|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424012|NCT00171340|4247101|B3||Female|Sex: Female, Male||Participants|Count of Participants|1065|1065.0||||||
4424013|NCT00171340|4247102|B2||Female|Sex: Female, Male||Participants|Count of Participants|533|533.0||||||
4424014|NCT00171340|4247103|B1||Female|Sex: Female, Male||Participants|Count of Participants|532|532.0||||||
4424015|NCT00171340|4247101|B3|||Age||Years|Median|57|57.0|Full Range|||36.0|87.0|
4424016|NCT00171340|4247102|B2|||Age||Years|Median|58|58.0|Full Range|(37-81)|0.0|37.0|81.0|
4424017|NCT00171340|4247103|B1|||Age||Years|Median|57|57.0|Full Range|(36-87)|0.0|36.0|87.0|
4424018|NCT00171314|4247118|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424019|NCT00171314|4247119|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424020|NCT00171314|4247120|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424021|NCT00171314|4247118|B3||Female|Sex: Female, Male||Participants|Count of Participants|527|527.0||||||
4424022|NCT00171314|4247119|B2||Female|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4424023|NCT00171314|4247120|B1||Female|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4424024|NCT00171314|4247118|B3|||Age||years|Mean|58.29|58.29|Standard Deviation|7.96|7.96|||
4424025|NCT00171314|4247119|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|7.73|7.73|||
4424026|NCT00171314|4247120|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|8.19|8.19|||
4424027|NCT00171301|4247135|B3|Male||Sex/Gender, Customized|Safety Population consisting of all participants who received study drug in the Extension study n=231.|participants|Number|118|118.0||||||
4424028|NCT00171301|4247136|B2|Male||Sex/Gender, Customized|Safety Population consisting of all participants who received study drug in the Extension study n=231.|participants|Number|36|36.0||||||
4424029|NCT00171301|4247137|B1|Male||Sex/Gender, Customized|Safety Population consisting of all participants who received study drug in the Extension study n=231.|participants|Number|82|82.0||||||
4424030|NCT00171301|4247135|B3|Female||Sex/Gender, Customized|Safety Population consisting of all participants who received study drug in the Extension study n=231.|participants|Number|115|115.0||||||
4424031|NCT00171301|4247136|B2|Female||Sex/Gender, Customized|Safety Population consisting of all participants who received study drug in the Extension study n=231.|participants|Number|35|35.0||||||
4424032|NCT00171301|4247137|B1|Female||Sex/Gender, Customized|Safety Population consisting of all participants who received study drug in the Extension study n=231.|participants|Number|80|80.0||||||
4424033|NCT00171301|4247135|B3|||Age|Safety Population consisting of all participants who received study drug in the Extension study n= 231.|years|Mean|13.0|13.0|Standard Deviation|6.93|6.93|||
4424034|NCT00171301|4247136|B2|||Age|Safety Population consisting of all participants who received study drug in the Extension study n= 231.|years|Mean|21.2|21.2|Standard Deviation|5.82|5.82|||
4424035|NCT00171301|4247137|B1|||Age|Safety Population consisting of all participants who received study drug in the Extension study n= 231.|years|Mean|9.5|9.5|Standard Deviation|3.59|3.59|||
4424036|NCT00171210|4247149|B3|Other||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4424037|NCT00171210|4247150|B2|Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4424038|NCT00171210|4247151|B1|Other||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4424039|NCT00171210|4247149|B3|Oriental||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4424040|NCT00171210|4247150|B2|Oriental||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4424041|NCT00171210|4247151|B1|Oriental||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4424042|NCT00171210|4247149|B3|White||Race/Ethnicity, Customized||participants|Number|488|488.0||||||
4424043|NCT00171210|4247150|B2|White||Race/Ethnicity, Customized||participants|Number|263|263.0||||||
4424044|NCT00171210|4247151|B1|White||Race/Ethnicity, Customized||participants|Number|225|225.0||||||
4424045|NCT00171210|4247149|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4424046|NCT00171210|4247150|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4424047|NCT00171210|4247151|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4424048|NCT00171210|4247149|B3||Male|Sex: Female, Male||Participants|Count of Participants|274|274.0||||||
4424049|NCT00171210|4247150|B2||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4424050|NCT00171210|4247151|B1||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4424051|NCT00171210|4247149|B3||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4424052|NCT00171210|4247150|B2||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4424053|NCT00171210|4247151|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4424054|NCT00171210|4247149|B3|||Age||years|Mean|17.7|17.7|Standard Deviation|9.64|9.64|||
4424055|NCT00171210|4247150|B2|||Age||years|Mean|17.1|17.1|Standard Deviation|9.46|9.46|||
4424056|NCT00171210|4247151|B1|||Age||years|Mean|18.3|18.3|Standard Deviation|9.82|9.82|||
4424057|NCT00171054|4247180|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424058|NCT00171054|4247181|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424059|NCT00171054|4247182|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424060|NCT00171054|4247180|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4424061|NCT00171054|4247181|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4424062|NCT00171054|4247182|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4424063|NCT00171054|4247180|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|5.50|5.5|||
4424064|NCT00171054|4247181|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|5.08|5.08|||
4424065|NCT00171054|4247182|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|5.76|5.76|||
4424120|NCT00169442|4247260|B4||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4424066|NCT00170950|4247213|B3||Male|Sex: Female, Male|Demographic data for 1 patient in the benazepril/hydrochlorothiazide was not available.|Participants|Count of Participants|6963|6963.0||||||
4424067|NCT00170950|4247214|B2||Male|Sex: Female, Male|Demographic data for 1 patient in the benazepril/hydrochlorothiazide was not available.|Participants|Count of Participants|3515|3515.0||||||
4424068|NCT00170950|4247215|B1||Male|Sex: Female, Male|Demographic data for 1 patient in the benazepril/hydrochlorothiazide was not available.|Participants|Count of Participants|3448|3448.0||||||
4424069|NCT00170950|4247213|B3||Female|Sex: Female, Male|Demographic data for 1 patient in the benazepril/hydrochlorothiazide was not available.|Participants|Count of Participants|4542|4542.0||||||
4424070|NCT00170950|4247214|B2||Female|Sex: Female, Male|Demographic data for 1 patient in the benazepril/hydrochlorothiazide was not available.|Participants|Count of Participants|2246|2246.0||||||
4424071|NCT00170950|4247215|B1||Female|Sex: Female, Male|Demographic data for 1 patient in the benazepril/hydrochlorothiazide was not available.|Participants|Count of Participants|2296|2296.0||||||
4424072|NCT00170950|4247213|B3|||Age|Demographic data for 1 patient in the benazepril/hydrochlorothiazide was not available.|Years|Mean|68.4|68.4|Standard Deviation|6.86|6.86|||
4424073|NCT00170950|4247214|B2|||Age|Demographic data for 1 patient in the benazepril/hydrochlorothiazide was not available.|Years|Mean|68.3|68.3|Standard Deviation|6.86|6.86|||
4424074|NCT00170950|4247215|B1|||Age|Demographic data for 1 patient in the benazepril/hydrochlorothiazide was not available.|Years|Mean|68.4|68.4|Standard Deviation|6.86|6.86|||
4424075|NCT00170846|4247226|B4|||Time since transplantation||years|Mean|5.6|5.6|Standard Deviation|4.13|4.13|||
4424076|NCT00170846|4247227|B3|||Time since transplantation||years|Mean|5.4|5.4|Standard Deviation|3.99|3.99|||
4424077|NCT00170846|4247228|B2|||Time since transplantation||years|Mean|5.4|5.4|Standard Deviation|4.28|4.28|||
4424078|NCT00170846|4247229|B1|||Time since transplantation||years|Mean|5.8|5.8|Standard Deviation|4.14|4.14|||
4424079|NCT00170846|4247226|B4||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4424080|NCT00170846|4247227|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4424081|NCT00170846|4247228|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4424082|NCT00170846|4247229|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4424083|NCT00170846|4247226|B4||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4424084|NCT00170846|4247227|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4424085|NCT00170846|4247228|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4424086|NCT00170846|4247229|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4424087|NCT00170846|4247226|B4|||Age||years|Mean|49.1|49.1|Standard Deviation|12.34|12.34|||
4424088|NCT00170846|4247227|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|12.95|12.95|||
4424089|NCT00170846|4247228|B2|||Age||years|Mean|49.4|49.4|Standard Deviation|11.81|11.81|||
4424090|NCT00170846|4247229|B1|||Age||years|Mean|48.2|48.2|Standard Deviation|12.18|12.18|||
4424091|NCT00170625|4247245|B1|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4424092|NCT00170625|4247245|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4424093|NCT00170625|4247245|B1||Female|Gender||Participants|Count of Participants|26|26.0||||||
4424094|NCT00170625|4247245|B1|||Age||years|Median|61.5|61.5|Full Range|||28.0|75.0|
4424095|NCT00170157|4247250|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
4424096|NCT00170157|4247250|B1||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4424097|NCT00170157|4247250|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424098|NCT00170157|4247250|B1|>= 70||Age, Customized||participants|Number|30|30.0||||||
4424099|NCT00170157|4247250|B1|60-69||Age, Customized||participants|Number|48|48.0||||||
4424100|NCT00170157|4247250|B1|50-59||Age, Customized||participants|Number|29|29.0||||||
4424101|NCT00170157|4247250|B1|40-49||Age, Customized||participants|Number|5|5.0||||||
4424102|NCT00170157|4247250|B1|<= 39||Age, Customized||participants|Number|0|0.0||||||
4424103|NCT00169442|4247257|B7|East/South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|745|745.0||||||
4424104|NCT00169442|4247258|B6|East/South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|43|43.0||||||
4424105|NCT00169442|4247259|B5|East/South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|42|42.0||||||
4424106|NCT00169442|4247260|B4|East/South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|250|250.0||||||
4424107|NCT00169442|4247261|B3|East/South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|167|167.0||||||
4424108|NCT00169442|4247262|B2|East/South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|124|124.0||||||
4424109|NCT00169442|4247263|B1|East/South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|119|119.0||||||
4424110|NCT00169442|4247257|B7||Male|Sex: Female, Male||Participants|Count of Participants|386|386.0||||||
4424111|NCT00169442|4247258|B6||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4424112|NCT00169442|4247259|B5||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4424113|NCT00169442|4247260|B4||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4424114|NCT00169442|4247261|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4424115|NCT00169442|4247262|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4424116|NCT00169442|4247263|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4424117|NCT00169442|4247257|B7||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4424118|NCT00169442|4247258|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4424119|NCT00169442|4247259|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4424121|NCT00169442|4247261|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4424122|NCT00169442|4247262|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4424123|NCT00169442|4247263|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4424124|NCT00169442|4247257|B7|||Age||Months|Mean|14.23|14.23|Standard Deviation|1.75|1.75|||
4424125|NCT00169442|4247258|B6|||Age||Months|Mean|9.8|9.8|Standard Deviation|0.61|0.61|||
4424126|NCT00169442|4247259|B5|||Age||Months|Mean|9.9|9.9|Standard Deviation|0.68|0.68|||
4424127|NCT00169442|4247260|B4|||Age||Months|Mean|15.0|15.0|Standard Deviation|2.04|2.04|||
4424128|NCT00169442|4247261|B3|||Age||Months|Mean|14.7|14.7|Standard Deviation|1.89|1.89|||
4424129|NCT00169442|4247262|B2|||Age||Months|Mean|14.8|14.8|Standard Deviation|2.07|2.07|||
4424130|NCT00169442|4247263|B1|||Age||Months|Mean|14.5|14.5|Standard Deviation|1.44|1.44|||
4424131|NCT00169104|4247375|B3|United States||Region of Enrollment||Participants|Count of Participants|19|19.0||||||
4424132|NCT00169104|4247376|B2|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4424133|NCT00169104|4247377|B1|United States||Region of Enrollment||Participants|Count of Participants|11|11.0||||||
4424134|NCT00169104|4247375|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424135|NCT00169104|4247376|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424136|NCT00169104|4247377|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424137|NCT00169104|4247375|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4424138|NCT00169104|4247376|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4424139|NCT00169104|4247377|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4424140|NCT00169104|4247375|B3|||Age||years|Mean|52.2|52.2|Standard Deviation|11.3|11.3|||
4424141|NCT00169104|4247376|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|12.6|12.6|||
4424142|NCT00169104|4247377|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|10.0|10.0|||
4424143|NCT00169104|4247375|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4424144|NCT00169104|4247376|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4424145|NCT00169104|4247377|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4424146|NCT00169104|4247375|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4424147|NCT00169104|4247376|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4424148|NCT00169104|4247377|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4424149|NCT00169104|4247375|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424150|NCT00169104|4247376|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424151|NCT00169104|4247377|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424152|NCT00168844|4247389|B4||Male|Sex: Female, Male||Participants|Count of Participants|747|747.0||||||
4424153|NCT00168844|4247390|B3||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4424154|NCT00168844|4247391|B2||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4424155|NCT00168844|4247392|B1||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4424156|NCT00168844|4247389|B4||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4424157|NCT00168844|4247390|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4424158|NCT00168844|4247391|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4424159|NCT00168844|4247392|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4424160|NCT00168844|4247389|B4|||Age||years|Mean|64.8|64.8|Standard Deviation|8.5|8.5|||
4424161|NCT00168844|4247390|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|8.9|8.9|||
4424162|NCT00168844|4247391|B2|||Age||years|Mean|64.6|64.6|Standard Deviation|8.4|8.4|||
4424163|NCT00168844|4247392|B1|||Age||years|Mean|65|65.0|Standard Deviation|8.2|8.2|||
4424164|NCT00168831|4247573|B4||Male|Sex: Female, Male||Participants|Count of Participants|729|729.0||||||
4424165|NCT00168831|4247574|B3||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4424166|NCT00168831|4247575|B2||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4424167|NCT00168831|4247576|B1||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4424168|NCT00168831|4247573|B4||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4424169|NCT00168831|4247574|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4424170|NCT00168831|4247575|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4424171|NCT00168831|4247576|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4424172|NCT00168831|4247573|B4|||Age||years|Mean|65.2|65.2|Standard Deviation|8.7|8.7|||
4424173|NCT00168831|4247574|B3|||Age||years|Mean|65.7|65.7|Standard Deviation|8.4|8.4|||
4424174|NCT00168831|4247575|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|8.6|8.6|||
4424175|NCT00168831|4247576|B1|||Age||years|Mean|64.4|64.4|Standard Deviation|8.9|8.9|||
4424176|NCT00168818|4247757|B4|||Body Mass Index N=(1146;1163;1151;3460)||kg/m^2|Mean|27.7|27.7|Standard Deviation|4.5|4.5|||
4424177|NCT00168818|4247758|B3|||Body Mass Index N=(1146;1163;1151;3460)||kg/m^2|Mean|27.5|27.5|Standard Deviation|4.3|4.3|||
4424178|NCT00168818|4247759|B2|||Body Mass Index N=(1146;1163;1151;3460)||kg/m^2|Mean|27.8|27.8|Standard Deviation|4.6|4.6|||
4424179|NCT00168818|4247760|B1|||Body Mass Index N=(1146;1163;1151;3460)||kg/m^2|Mean|27.7|27.7|Standard Deviation|4.6|4.6|||
4424180|NCT00168818|4247757|B4||Male|Sex: Female, Male||Participants|Count of Participants|1509|1509.0||||||
4424181|NCT00168818|4247758|B3||Male|Sex: Female, Male||Participants|Count of Participants|503|503.0||||||
4424182|NCT00168818|4247759|B2||Male|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
4424183|NCT00168818|4247760|B1||Male|Sex: Female, Male||Participants|Count of Participants|510|510.0||||||
4424184|NCT00168818|4247757|B4||Female|Sex: Female, Male||Participants|Count of Participants|1954|1954.0||||||
4424185|NCT00168818|4247758|B3||Female|Sex: Female, Male||Participants|Count of Participants|651|651.0||||||
4424186|NCT00168818|4247759|B2||Female|Sex: Female, Male||Participants|Count of Participants|667|667.0||||||
4424187|NCT00168818|4247760|B1||Female|Sex: Female, Male||Participants|Count of Participants|636|636.0||||||
4424188|NCT00168818|4247757|B4|||Age||Years|Mean|63.9|63.9|Standard Deviation|10.8|10.8|||
4424189|NCT00168818|4247758|B3|||Age||Years|Mean|63.8|63.8|Standard Deviation|10.8|10.8|||
4424190|NCT00168818|4247759|B2|||Age||Years|Mean|63.4|63.4|Standard Deviation|11.1|11.1|||
4424191|NCT00168818|4247760|B1|||Age||Years|Mean|64.6|64.6|Standard Deviation|10.4|10.4|||
4424192|NCT00168805|4247803|B4|||Body Mass Index N=(677;702;692;2071)||kg/m^2|Mean|29.9|29.9|Standard Deviation|4.9|4.9|||
4424193|NCT00168805|4247804|B3|||Body Mass Index N=(677;702;692;2071)||kg/m^2|Mean|29.8|29.8|Standard Deviation|4.9|4.9|||
4424194|NCT00168805|4247805|B2|||Body Mass Index N=(677;702;692;2071)||kg/m^2|Mean|30.1|30.1|Standard Deviation|5.0|5.0|||
4424195|NCT00168805|4247806|B1|||Body Mass Index N=(677;702;692;2071)||kg/m^2|Mean|29.9|29.9|Standard Deviation|4.9|4.9|||
4424196|NCT00168805|4247803|B4||Male|Sex: Female, Male||Participants|Count of Participants|706|706.0||||||
4424197|NCT00168805|4247804|B3||Male|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4424198|NCT00168805|4247805|B2||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4424199|NCT00168805|4247806|B1||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4424200|NCT00168805|4247803|B4||Female|Sex: Female, Male||Participants|Count of Participants|1370|1370.0||||||
4424201|NCT00168805|4247804|B3||Female|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
4424202|NCT00168805|4247805|B2||Female|Sex: Female, Male||Participants|Count of Participants|451|451.0||||||
4424203|NCT00168805|4247806|B1||Female|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
4424204|NCT00168805|4247803|B4|||Age||Years|Mean|67.7|67.7|Standard Deviation|8.9|8.9|||
4424205|NCT00168805|4247804|B3|||Age||Years|Mean|68.3|68.3|Standard Deviation|8.8|8.8|||
4424206|NCT00168805|4247805|B2|||Age||Years|Mean|67.5|67.5|Standard Deviation|8.8|8.8|||
4424207|NCT00168805|4247806|B1|||Age||Years|Mean|67.3|67.3|Standard Deviation|9.0|9.0|||
4424208|NCT00168454|4247849|B7||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4424209|NCT00168454|4247850|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4424210|NCT00168454|4247851|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4424211|NCT00168454|4247852|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4424212|NCT00168454|4247853|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4424213|NCT00168454|4247854|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4424214|NCT00168454|4247855|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4424215|NCT00168454|4247849|B7||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4424216|NCT00168454|4247850|B6||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4424217|NCT00168454|4247851|B5||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4424218|NCT00168454|4247852|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4424219|NCT00168454|4247853|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4424220|NCT00168454|4247854|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4424221|NCT00168454|4247855|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4424222|NCT00168454|4247849|B7|>=75 years||Age, Customized||participants|Number|36|36.0||||||
4424223|NCT00168454|4247850|B6|>=75 years||Age, Customized||participants|Number|6|6.0||||||
4424224|NCT00168454|4247851|B5|>=75 years||Age, Customized||participants|Number|6|6.0||||||
4424225|NCT00168454|4247852|B4|>=75 years||Age, Customized||participants|Number|2|2.0||||||
4424226|NCT00168454|4247853|B3|>=75 years||Age, Customized||participants|Number|7|7.0||||||
4424227|NCT00168454|4247854|B2|>=75 years||Age, Customized||participants|Number|8|8.0||||||
4424228|NCT00168454|4247855|B1|>=75 years||Age, Customized||participants|Number|7|7.0||||||
4424229|NCT00168454|4247849|B7|65-74 years||Age, Customized||participants|Number|82|82.0||||||
4424230|NCT00168454|4247850|B6|65-74 years||Age, Customized||participants|Number|15|15.0||||||
4424231|NCT00168454|4247851|B5|65-74 years||Age, Customized||participants|Number|20|20.0||||||
4424232|NCT00168454|4247852|B4|65-74 years||Age, Customized||participants|Number|12|12.0||||||
4424233|NCT00168454|4247853|B3|65-74 years||Age, Customized||participants|Number|16|16.0||||||
4424234|NCT00168454|4247854|B2|65-74 years||Age, Customized||participants|Number|13|13.0||||||
4424235|NCT00168454|4247855|B1|65-74 years||Age, Customized||participants|Number|6|6.0||||||
4424236|NCT00168454|4247849|B7|45-64 years||Age, Customized||participants|Number|153|153.0||||||
4424237|NCT00168454|4247850|B6|45-64 years||Age, Customized||participants|Number|29|29.0||||||
4424238|NCT00168454|4247851|B5|45-64 years||Age, Customized||participants|Number|21|21.0||||||
4424239|NCT00168454|4247852|B4|45-64 years||Age, Customized||participants|Number|27|27.0||||||
4424240|NCT00168454|4247853|B3|45-64 years||Age, Customized||participants|Number|25|25.0||||||
4424241|NCT00168454|4247854|B2|45-64 years||Age, Customized||participants|Number|27|27.0||||||
4424242|NCT00168454|4247855|B1|45-64 years||Age, Customized||participants|Number|24|24.0||||||
4424243|NCT00168454|4247849|B7|<45 years||Age, Customized||participants|Number|42|42.0||||||
4424244|NCT00168454|4247850|B6|<45 years||Age, Customized||participants|Number|6|6.0||||||
4424245|NCT00168454|4247851|B5|<45 years||Age, Customized||participants|Number|6|6.0||||||
4424246|NCT00168454|4247852|B4|<45 years||Age, Customized||participants|Number|8|8.0||||||
4424247|NCT00168454|4247853|B3|<45 years||Age, Customized||participants|Number|6|6.0||||||
4424248|NCT00168454|4247854|B2|<45 years||Age, Customized||participants|Number|9|9.0||||||
4424249|NCT00168454|4247855|B1|<45 years||Age, Customized||participants|Number|7|7.0||||||
4424250|NCT00168428|4247904|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4424251|NCT00168428|4247905|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4424252|NCT00168428|4247906|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4424253|NCT00168428|4247904|B3||Female|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
4424254|NCT00168428|4247905|B2||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4424255|NCT00168428|4247906|B1||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4424256|NCT00168428|4247904|B3|>= 40 years||Age, Customized||participants|Number|396|396.0||||||
4424257|NCT00168428|4247905|B2|>= 40 years||Age, Customized||participants|Number|198|198.0||||||
4424258|NCT00168428|4247906|B1|>= 40 years||Age, Customized||participants|Number|198|198.0||||||
4424259|NCT00168428|4247904|B3|< 40 years||Age, Customized||participants|Number|309|309.0||||||
4424260|NCT00168428|4247905|B2|< 40 years||Age, Customized||participants|Number|160|160.0||||||
4424261|NCT00168428|4247906|B1|< 40 years||Age, Customized||participants|Number|149|149.0||||||
4424262|NCT00168389|4247923|B4||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4424263|NCT00168389|4247924|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4424264|NCT00168389|4247925|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4424265|NCT00168389|4247926|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4424266|NCT00168389|4247923|B4||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4424267|NCT00168389|4247924|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4424268|NCT00168389|4247925|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4424269|NCT00168389|4247926|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4424270|NCT00168389|4247923|B4|>65 years||Age, Customized||Participants|Number|197|197.0||||||
4424271|NCT00168389|4247924|B3|>65 years||Age, Customized||Participants|Number|63|63.0||||||
4424272|NCT00168389|4247925|B2|>65 years||Age, Customized||Participants|Number|64|64.0||||||
4424273|NCT00168389|4247926|B1|>65 years||Age, Customized||Participants|Number|70|70.0||||||
4424274|NCT00168389|4247923|B4|45 to 65 years||Age, Customized||Participants|Number|281|281.0||||||
4424275|NCT00168389|4247924|B3|45 to 65 years||Age, Customized||Participants|Number|95|95.0||||||
4424276|NCT00168389|4247925|B2|45 to 65 years||Age, Customized||Participants|Number|97|97.0||||||
4424277|NCT00168389|4247926|B1|45 to 65 years||Age, Customized||Participants|Number|89|89.0||||||
4424278|NCT00168389|4247923|B4|<45 years||Age, Customized||Participants|Number|16|16.0||||||
4424279|NCT00168389|4247924|B3|<45 years||Age, Customized||Participants|Number|7|7.0||||||
4424280|NCT00168389|4247925|B2|<45 years||Age, Customized||Participants|Number|5|5.0||||||
4424281|NCT00168389|4247926|B1|<45 years||Age, Customized||Participants|Number|4|4.0||||||
4424282|NCT00168337|4247954|B4||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4424283|NCT00168337|4247955|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4424284|NCT00168337|4247956|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4424285|NCT00168337|4247957|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4424286|NCT00168337|4247954|B4||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4424287|NCT00168337|4247955|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4424288|NCT00168337|4247956|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4424289|NCT00168337|4247957|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4424290|NCT00168337|4247954|B4|>65 years||Age, Customized||Participants|Number|205|205.0||||||
4424291|NCT00168337|4247955|B3|>65 years||Age, Customized||Participants|Number|71|71.0||||||
4424292|NCT00168337|4247956|B2|>65 years||Age, Customized||Participants|Number|64|64.0||||||
4424293|NCT00168337|4247957|B1|>65 years||Age, Customized||Participants|Number|70|70.0||||||
4424294|NCT00168337|4247954|B4|45 to 65 years||Age, Customized||Participants|Number|333|333.0||||||
4424295|NCT00168337|4247955|B3|45 to 65 years||Age, Customized||Participants|Number|108|108.0||||||
4424296|NCT00168337|4247956|B2|45 to 65 years||Age, Customized||Participants|Number|109|109.0||||||
4424297|NCT00168337|4247957|B1|45 to 65 years||Age, Customized||Participants|Number|116|116.0||||||
4424298|NCT00168337|4247954|B4|<45 years||Age, Customized||Participants|Number|16|16.0||||||
4424299|NCT00168337|4247955|B3|<45 years||Age, Customized||Participants|Number|6|6.0||||||
4424300|NCT00168337|4247956|B2|<45 years||Age, Customized||Participants|Number|8|8.0||||||
4424301|NCT00168337|4247957|B1|<45 years||Age, Customized||Participants|Number|2|2.0||||||
4424302|NCT00168324|4247985|B4||Male|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4424303|NCT00168324|4247986|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4424304|NCT00168324|4247987|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4424305|NCT00168324|4247988|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4424306|NCT00168324|4247985|B4||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4424307|NCT00168324|4247986|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4424308|NCT00168324|4247987|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4424309|NCT00168324|4247988|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4424310|NCT00168324|4247985|B4|>65 years||Age, Customized||participants|Number|317|317.0||||||
4424311|NCT00168324|4247986|B3|>65 years||Age, Customized||participants|Number|103|103.0||||||
4424312|NCT00168324|4247987|B2|>65 years||Age, Customized||participants|Number|105|105.0||||||
4424313|NCT00168324|4247988|B1|>65 years||Age, Customized||participants|Number|109|109.0||||||
4424314|NCT00168324|4247985|B4|45-65 years||Age, Customized||participants|Number|257|257.0||||||
4424315|NCT00168324|4247986|B3|45-65 years||Age, Customized||participants|Number|90|90.0||||||
4424316|NCT00168324|4247987|B2|45-65 years||Age, Customized||participants|Number|84|84.0||||||
4424317|NCT00168324|4247988|B1|45-65 years||Age, Customized||participants|Number|83|83.0||||||
4424318|NCT00168324|4247985|B4|<45 years||Age, Customized||participants|Number|25|25.0||||||
4424319|NCT00168324|4247986|B3|<45 years||Age, Customized||participants|Number|9|9.0||||||
4424320|NCT00168324|4247987|B2|<45 years||Age, Customized||participants|Number|7|7.0||||||
4424321|NCT00168324|4247988|B1|<45 years||Age, Customized||participants|Number|9|9.0||||||
4424322|NCT00168311|4248010|B3|Australia||Region of Enrollment||participants|Number|22|22.0||||||
4424323|NCT00168311|4248011|B2|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4424324|NCT00168311|4248012|B1|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4424325|NCT00168311|4248010|B3||Male|Sex: Female, Male|16 men and 4 women|Participants|Count of Participants|18|18.0||||||
4424326|NCT00168311|4248011|B2||Male|Sex: Female, Male|16 men and 4 women|Participants|Count of Participants|8|8.0||||||
4424327|NCT00168311|4248012|B1||Male|Sex: Female, Male|16 men and 4 women|Participants|Count of Participants|10|10.0||||||
4424328|NCT00168311|4248010|B3||Female|Sex: Female, Male|16 men and 4 women|Participants|Count of Participants|4|4.0||||||
4424329|NCT00168311|4248011|B2||Female|Sex: Female, Male|16 men and 4 women|Participants|Count of Participants|2|2.0||||||
4424330|NCT00168311|4248012|B1||Female|Sex: Female, Male|16 men and 4 women|Participants|Count of Participants|2|2.0||||||
4424331|NCT00168311|4248010|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424332|NCT00168311|4248011|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424333|NCT00168311|4248012|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424334|NCT00168311|4248010|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4424335|NCT00168311|4248011|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4424336|NCT00168311|4248012|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4424337|NCT00168311|4248010|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424338|NCT00168311|4248011|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424339|NCT00168311|4248012|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424340|NCT00168298|4248019|B4||Male|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4424341|NCT00168298|4248020|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4424342|NCT00168298|4248021|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4424343|NCT00168298|4248022|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4424344|NCT00168298|4248019|B4||Female|Sex: Female, Male||Participants|Count of Participants|318|318.0||||||
4424345|NCT00168298|4248020|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4424346|NCT00168298|4248021|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4424347|NCT00168298|4248022|B1||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4424348|NCT00168298|4248019|B4|>65 years||Age, Customized||participants|Number|298|298.0||||||
4424349|NCT00168298|4248020|B3|>65 years||Age, Customized||participants|Number|100|100.0||||||
4424350|NCT00168298|4248021|B2|>65 years||Age, Customized||participants|Number|95|95.0||||||
4424351|NCT00168298|4248022|B1|>65 years||Age, Customized||participants|Number|103|103.0||||||
4424352|NCT00168298|4248019|B4|45-65 years||Age, Customized||participants|Number|328|328.0||||||
4424353|NCT00168298|4248020|B3|45-65 years||Age, Customized||participants|Number|111|111.0||||||
4424354|NCT00168298|4248021|B2|45-65 years||Age, Customized||participants|Number|108|108.0||||||
4424355|NCT00168298|4248022|B1|45-65 years||Age, Customized||participants|Number|109|109.0||||||
4424356|NCT00168298|4248019|B4|<45 years||Age, Customized||participants|Number|42|42.0||||||
4424357|NCT00168298|4248020|B3|<45 years||Age, Customized||participants|Number|13|13.0||||||
4424358|NCT00168298|4248021|B2|<45 years||Age, Customized||participants|Number|15|15.0||||||
4424359|NCT00168298|4248022|B1|<45 years||Age, Customized||participants|Number|14|14.0||||||
4424360|NCT00168103|4248041|B4|Missing||Primary Disease Characteristic|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-INH molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|Participants|Number|1|1.0||||||
4424361|NCT00168103|4248042|B3|Missing||Primary Disease Characteristic|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-INH molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|Participants|Number|0|0.0||||||
4424389|NCT00168103|4248042|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4424390|NCT00168103|4248043|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4424362|NCT00168103|4248043|B2|Missing||Primary Disease Characteristic|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-INH molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|Participants|Number|0|0.0||||||
4424363|NCT00168103|4248044|B1|Missing||Primary Disease Characteristic|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-INH molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|Participants|Number|1|1.0||||||
4424364|NCT00168103|4248041|B4|Type II HAE||Primary Disease Characteristic|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-INH molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|Participants|Number|15|15.0||||||
4424365|NCT00168103|4248042|B3|Type II HAE||Primary Disease Characteristic|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-INH molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|Participants|Number|4|4.0||||||
4424366|NCT00168103|4248043|B2|Type II HAE||Primary Disease Characteristic|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-INH molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|Participants|Number|8|8.0||||||
4424367|NCT00168103|4248044|B1|Type II HAE||Primary Disease Characteristic|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-INH molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|Participants|Number|3|3.0||||||
4424368|NCT00168103|4248041|B4|Type I HAE||Primary Disease Characteristic|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-INH molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|Participants|Number|108|108.0||||||
4424369|NCT00168103|4248042|B3|Type I HAE||Primary Disease Characteristic|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-INH molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|Participants|Number|38|38.0||||||
4424370|NCT00168103|4248043|B2|Type I HAE||Primary Disease Characteristic|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-INH molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|Participants|Number|35|35.0||||||
4424371|NCT00168103|4248044|B1|Type I HAE||Primary Disease Characteristic|"Type I HAE (common form genotype): An impaired synthesis and an elevated turnover of a normal and functionally active C1-INH molecule occurs, causing a reduction in the availability of functionally active C1-INH to levels of 5% to 30% of normal.~Type II HAE (variant form genotype): Normal levels of a functionally impaired C1-INH molecule are synthesized while the normal form of C1-INH is considerably reduced in the circulation."|Participants|Number|35|35.0||||||
4424372|NCT00168103|4248041|B4|Severe||Intensity of Baseline HAE Attack||Participants|Number|39|39.0||||||
4424373|NCT00168103|4248042|B3|Severe||Intensity of Baseline HAE Attack||Participants|Number|16|16.0||||||
4424374|NCT00168103|4248043|B2|Severe||Intensity of Baseline HAE Attack||Participants|Number|16|16.0||||||
4424375|NCT00168103|4248044|B1|Severe||Intensity of Baseline HAE Attack||Participants|Number|7|7.0||||||
4424376|NCT00168103|4248041|B4|Moderate||Intensity of Baseline HAE Attack||Participants|Number|85|85.0||||||
4424377|NCT00168103|4248042|B3|Moderate||Intensity of Baseline HAE Attack||Participants|Number|26|26.0||||||
4424378|NCT00168103|4248043|B2|Moderate||Intensity of Baseline HAE Attack||Participants|Number|27|27.0||||||
4424379|NCT00168103|4248044|B1|Moderate||Intensity of Baseline HAE Attack||Participants|Number|32|32.0||||||
4424380|NCT00168103|4248041|B4|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4424381|NCT00168103|4248042|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4424382|NCT00168103|4248043|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4424383|NCT00168103|4248044|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4424384|NCT00168103|4248041|B4|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4424385|NCT00168103|4248042|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4424386|NCT00168103|4248043|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4424387|NCT00168103|4248044|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4424388|NCT00168103|4248041|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4424391|NCT00168103|4248044|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4424392|NCT00168103|4248041|B4|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4424393|NCT00168103|4248042|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4424394|NCT00168103|4248043|B2|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4424395|NCT00168103|4248044|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4424396|NCT00168103|4248041|B4|White||Race/Ethnicity, Customized||Participants|Number|111|111.0||||||
4424397|NCT00168103|4248042|B3|White||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4424398|NCT00168103|4248043|B2|White||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4424399|NCT00168103|4248044|B1|White||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4424400|NCT00168103|4248041|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4424401|NCT00168103|4248042|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4424402|NCT00168103|4248043|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4424403|NCT00168103|4248044|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4424404|NCT00168103|4248041|B4||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4424405|NCT00168103|4248042|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4424406|NCT00168103|4248043|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4424407|NCT00168103|4248044|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4424408|NCT00168103|4248041|B4|||Age||years|Mean|33.1|33.1|Standard Deviation|13.76|13.76|||
4424409|NCT00168103|4248042|B3|||Age||years|Mean|31.5|31.5|Standard Deviation|13.57|13.57|||
4424410|NCT00168103|4248043|B2|||Age||years|Mean|34.6|34.6|Standard Deviation|14.91|14.91|||
4424411|NCT00168103|4248044|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|12.77|12.77|||
4424412|NCT00168103|4248041|B4|>= 65 years||Age, Customized||participants|Number|4|4.0||||||
4424413|NCT00168103|4248042|B3|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4424414|NCT00168103|4248043|B2|>= 65 years||Age, Customized||participants|Number|3|3.0||||||
4424415|NCT00168103|4248044|B1|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
4424416|NCT00168103|4248041|B4|17 to < 65 years||Age, Customized||participants|Number|107|107.0||||||
4424417|NCT00168103|4248042|B3|17 to < 65 years||Age, Customized||participants|Number|37|37.0||||||
4424418|NCT00168103|4248043|B2|17 to < 65 years||Age, Customized||participants|Number|35|35.0||||||
4424419|NCT00168103|4248044|B1|17 to < 65 years||Age, Customized||participants|Number|35|35.0||||||
4424420|NCT00168103|4248041|B4|12 to < 17 years||Age, Customized||participants|Number|10|10.0||||||
4424421|NCT00168103|4248042|B3|12 to < 17 years||Age, Customized||participants|Number|3|3.0||||||
4424422|NCT00168103|4248043|B2|12 to < 17 years||Age, Customized||participants|Number|4|4.0||||||
4424423|NCT00168103|4248044|B1|12 to < 17 years||Age, Customized||participants|Number|3|3.0||||||
4424424|NCT00168103|4248041|B4|3 to < 12 years||Age, Customized||participants|Number|3|3.0||||||
4424425|NCT00168103|4248042|B3|3 to < 12 years||Age, Customized||participants|Number|2|2.0||||||
4424426|NCT00168103|4248043|B2|3 to < 12 years||Age, Customized||participants|Number|1|1.0||||||
4424427|NCT00168103|4248044|B1|3 to < 12 years||Age, Customized||participants|Number|0|0.0||||||
4424428|NCT00168064|4248067|B3|United States||Region of Enrollment||participants|Number|260|260.0||||||
4424429|NCT00168064|4248068|B2|United States||Region of Enrollment||participants|Number|130|130.0||||||
4424430|NCT00168064|4248069|B1|United States||Region of Enrollment||participants|Number|130|130.0||||||
4424431|NCT00168064|4248067|B3||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4424432|NCT00168064|4248068|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4424433|NCT00168064|4248069|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4424434|NCT00168064|4248067|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4424435|NCT00168064|4248068|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4424436|NCT00168064|4248069|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4424437|NCT00168064|4248067|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|14.28|14.28|||
4424438|NCT00168064|4248068|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|14.34|14.34|||
4424439|NCT00168064|4248069|B1|||Age||years|Mean|54.7|54.7|Standard Deviation|14.20|14.2|||
4424440|NCT00168064|4248067|B3||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
4424441|NCT00168064|4248068|B2||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4424442|NCT00168064|4248069|B1||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4424443|NCT00168064|4248067|B3||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
4424444|NCT00168064|4248068|B2||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4424445|NCT00168064|4248069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4424446|NCT00168064|4248067|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4424447|NCT00168064|4248068|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4424448|NCT00168064|4248069|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424449|NCT00168038|4248078|B1|||Body Mass Index||kg/m^2|Mean|25.69|25.69|Standard Deviation|4.56|4.56|||
4424450|NCT00168038|4248078|B1|||Weight||kg|Mean|74.0|74.0|Standard Deviation|15.5|15.5|||
4424451|NCT00168038|4248078|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4424452|NCT00168038|4248078|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4424453|NCT00168038|4248078|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4424454|NCT00168038|4248078|B1|||Age||years|Mean|38|38.0|Standard Deviation|15|15.0|||
4424455|NCT00167778|4248090|B1|||Height||m|Mean|1.79|1.79|Standard Deviation|.08|0.08|||
4424456|NCT00167778|4248090|B1|||Weight||kg|Mean|88|88.0|Standard Deviation|11|11.0|||
4424457|NCT00167778|4248090|B1|||Torsion adapter stiffness|Settings on the torsion adapter ranged from -5 to 5 in integer increments, where 5 was the stiffest possible setting.|units on a scale|Mean|4|4.0|Standard Deviation|2|2.0|||
4424458|NCT00167778|4248090|B1|Tumor||Amputation Etiology||participants|Number|1|1.0||||||
4424459|NCT00167778|4248090|B1|Diabetic/Dysvascular||Amputation Etiology||participants|Number|4|4.0||||||
4424460|NCT00167778|4248090|B1|Trauma||Amputation Etiology||participants|Number|5|5.0||||||
4424461|NCT00167778|4248090|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4424462|NCT00167778|4248090|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4424463|NCT00167778|4248090|B1|||Age||years|Mean|56|56.0|Standard Deviation|12|12.0|||
4424464|NCT00167778|4248090|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4424465|NCT00167778|4248090|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4424466|NCT00167778|4248090|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424467|NCT00167544|4248139|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4424468|NCT00167544|4248140|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4424469|NCT00167544|4248141|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4424470|NCT00167544|4248139|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4424471|NCT00167544|4248140|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4424472|NCT00167544|4248141|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4424473|NCT00167544|4248139|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4424474|NCT00167544|4248140|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4424475|NCT00167544|4248141|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4424476|NCT00167544|4248139|B3|||Age|Gestational age|weeks|Median|25|25.0|Inter-Quartile Range|3|3.0|24.0|27.0|
4424477|NCT00167544|4248140|B2|||Age|Gestational age|weeks|Median|25|25.0|Inter-Quartile Range|3|3.0|24.0|27.0|
4424478|NCT00167544|4248141|B1|||Age|Gestational age|weeks|Median|25|25.0|Inter-Quartile Range|3|3.0|24.0|26.0|
4424479|NCT00167544|4248139|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424480|NCT00167544|4248140|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424481|NCT00167544|4248141|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424482|NCT00167544|4248139|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4424483|NCT00167544|4248140|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4424484|NCT00167544|4248141|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4424485|NCT00167544|4248139|B3||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
4424486|NCT00167544|4248140|B2||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4424487|NCT00167544|4248141|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4424488|NCT00167414|4248156|B1|United States||Region of Enrollment||Participants|Count of Participants|39|39.0||||||
4424489|NCT00167414|4248156|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424490|NCT00167414|4248156|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4424491|NCT00167414|4248156|B1|||Age||years|Mean|53|53.0|Standard Deviation|14|14.0|||
4424492|NCT00167388|4248164|B5|||Weight at time of study||grams|Mean|1127|1127.0|Full Range|||696.0|2393.0|
4424493|NCT00167388|4248165|B4|||Weight at time of study||grams|Mean|1856|1856.0|Full Range|||1409.0|2393.0|
4424494|NCT00167388|4248166|B3|||Weight at time of study||grams|Mean|1752|1752.0|Full Range|||1595.0|1945.0|
4424495|NCT00167388|4248167|B2|||Weight at time of study||grams|Mean|736|736.0|Full Range|||696.0|1105.0|
4424496|NCT00167388|4248168|B1|||Weight at time of study||grams|Mean|886|886.0|Full Range|||839.0|1248.0|
4424497|NCT00167388|4248164|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4424498|NCT00167388|4248165|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4424499|NCT00167388|4248166|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4424500|NCT00167388|4248167|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4424501|NCT00167388|4248168|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4424502|NCT00167388|4248164|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4424503|NCT00167388|4248165|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4424504|NCT00167388|4248166|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4424505|NCT00167388|4248167|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4424506|NCT00167388|4248168|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4424507|NCT00167388|4248164|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424508|NCT00167388|4248165|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424509|NCT00167388|4248166|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424510|NCT00167388|4248167|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424511|NCT00167388|4248168|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424512|NCT00167388|4248164|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4424513|NCT00167388|4248165|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4424514|NCT00167388|4248166|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4424515|NCT00167388|4248167|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4424516|NCT00167388|4248168|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4424517|NCT00167388|4248164|B5||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4424518|NCT00167388|4248165|B4||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4424519|NCT00167388|4248166|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4424520|NCT00167388|4248167|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4424521|NCT00167388|4248168|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4424522|NCT00167310|4248179|B3|||Body Mass Index||kg/m^2|Mean|31|31.0|Standard Deviation|6|6.0|||
4424523|NCT00167310|4248180|B2|||Body Mass Index||kg/m^2|Mean|31|31.0|Standard Deviation|6|6.0|||
4424524|NCT00167310|4248181|B1|||Body Mass Index||kg/m^2|Mean|31|31.0|Standard Deviation|7|7.0|||
4424525|NCT00167310|4248179|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4424526|NCT00167310|4248180|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4424527|NCT00167310|4248181|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4424528|NCT00167310|4248179|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4424529|NCT00167310|4248180|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4424530|NCT00167310|4248181|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4424531|NCT00167310|4248179|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4424532|NCT00167310|4248180|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424533|NCT00167310|4248181|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4424534|NCT00167310|4248179|B3|||Age||years|Mean|55|55.0|Standard Deviation|8|8.0|||
4424535|NCT00167310|4248180|B2|||Age||years|Mean|54|54.0|Standard Deviation|8|8.0|||
4424536|NCT00167310|4248181|B1|||Age||years|Mean|56|56.0|Standard Deviation|8|8.0|||
4424537|NCT00167245|4248190|B3|United States||Region of Enrollment||participants|Number|170|170.0||||||
4424538|NCT00167245|4248191|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
4424539|NCT00167245|4248192|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
4424540|NCT00167245|4248190|B3||Male|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4424541|NCT00167245|4248191|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4424542|NCT00167245|4248192|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4424543|NCT00167245|4248190|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4424544|NCT00167245|4248191|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4424545|NCT00167245|4248192|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4424546|NCT00167245|4248190|B3|||Age||years|Mean|44|44.0|Standard Deviation|7.0|7.0|||
4424547|NCT00167245|4248191|B2|||Age||years|Mean|43|43.0|Standard Deviation|8.0|8.0|||
4424548|NCT00167245|4248192|B1|||Age||years|Mean|45|45.0|Standard Deviation|7.0|7.0|||
4424549|NCT00167245|4248190|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424550|NCT00167245|4248191|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424551|NCT00167245|4248192|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424552|NCT00167245|4248190|B3||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
4424553|NCT00167245|4248191|B2||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4424554|NCT00167245|4248192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4424555|NCT00167245|4248190|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424556|NCT00167245|4248191|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424557|NCT00167245|4248192|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424558|NCT00167206|4248201|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4424559|NCT00167206|4248201|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4424560|NCT00167206|4248201|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4424561|NCT00167206|4248201|B1|||Age||years|Mean|9.8|9.8|Standard Deviation|4.5|4.5|||
4424562|NCT00167206|4248201|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424563|NCT00167206|4248201|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4424564|NCT00167206|4248201|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4424565|NCT00167180|4248213|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4424566|NCT00167180|4248214|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4424567|NCT00167180|4248215|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4424568|NCT00167180|4248213|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4424569|NCT00167180|4248214|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4424570|NCT00167180|4248215|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4424571|NCT00167180|4248213|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4424572|NCT00167180|4248214|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4424573|NCT00167180|4248215|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424574|NCT00167180|4248213|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4424575|NCT00167180|4248214|B2||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4424576|NCT00167180|4248215|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4424577|NCT00167180|4248213|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4424578|NCT00167180|4248214|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4424579|NCT00167180|4248215|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4424580|NCT00167102|4248230|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4424581|NCT00167102|4248231|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4424582|NCT00167102|4248232|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4424583|NCT00167102|4248230|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4424584|NCT00167102|4248231|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4424585|NCT00167102|4248232|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4424586|NCT00167102|4248230|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4424587|NCT00167102|4248231|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4424588|NCT00167102|4248232|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4424589|NCT00167102|4248230|B3|||Age||years|Mean|36.3|36.3|Standard Deviation|11.1|11.1|||
4424590|NCT00167102|4248231|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|11.8|11.8|||
4424591|NCT00167102|4248232|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|10.3|10.3|||
4424592|NCT00167102|4248230|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424593|NCT00167102|4248231|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424594|NCT00167102|4248232|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424595|NCT00167102|4248230|B3||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4424596|NCT00167102|4248231|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4424597|NCT00167102|4248232|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4424598|NCT00167102|4248230|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424599|NCT00167102|4248231|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424600|NCT00167102|4248232|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424601|NCT00166712|4248241|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4424602|NCT00166712|4248242|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4424603|NCT00166712|4248243|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4424604|NCT00166712|4248241|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4424605|NCT00166712|4248242|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4424606|NCT00166712|4248243|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4424607|NCT00166712|4248241|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4424608|NCT00166712|4248242|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4424609|NCT00166712|4248243|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4424610|NCT00166712|4248241|B3|||Age||years|Mean|47.125|47.125|Standard Deviation|11.24366|11.24366|||
4424611|NCT00166712|4248242|B2|||Age||years|Mean|48.125|48.125|Standard Deviation|11.51738|11.51738|||
4424612|NCT00166712|4248243|B1|||Age||years|Mean|46.45833|46.45833|Standard Deviation|11.25584|11.25584|||
4424613|NCT00166712|4248241|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424614|NCT00166712|4248242|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424615|NCT00166712|4248243|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424616|NCT00166712|4248241|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4424617|NCT00166712|4248242|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4424618|NCT00166712|4248243|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4424619|NCT00166712|4248241|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424620|NCT00166712|4248242|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424621|NCT00166712|4248243|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424622|NCT00166517|4248259|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4424623|NCT00166517|4248260|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4424624|NCT00166517|4248261|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4424625|NCT00166517|4248259|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4424626|NCT00166517|4248260|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4424627|NCT00166517|4248261|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4424628|NCT00166517|4248259|B3|Over 12 Weeks of Age||Age, Customized||participants|Number|1|1.0||||||
4424629|NCT00166517|4248260|B2|Over 12 Weeks of Age||Age, Customized||participants|Number|0|0.0||||||
4424630|NCT00166517|4248261|B1|Over 12 Weeks of Age||Age, Customized||participants|Number|1|1.0||||||
4424631|NCT00166517|4248259|B3|6-12 Weeks of Age||Age, Customized||participants|Number|177|177.0||||||
4424632|NCT00166517|4248260|B2|6-12 Weeks of Age||Age, Customized||participants|Number|63|63.0||||||
4424633|NCT00166517|4248261|B1|6-12 Weeks of Age||Age, Customized||participants|Number|114|114.0||||||
4424634|NCT00166504|4248270|B3|||Body Mass Index||kg/m2|Mean|25.2|25.2|Standard Deviation|2.8|2.8|||
4424635|NCT00166504|4248271|B2|||Body Mass Index||kg/m2|Mean|25|25.0|Standard Deviation|2.8|2.8|||
4424636|NCT00166504|4248272|B1|||Body Mass Index||kg/m2|Mean|25.3|25.3|Standard Deviation|2.9|2.9|||
4424637|NCT00166504|4248270|B3|>=190 mg/dl||Baseline Low Density Lipoprotein Cholesterol (LDL-C) Strata||Participants|Number|37|37.0||||||
4424638|NCT00166504|4248271|B2|>=190 mg/dl||Baseline Low Density Lipoprotein Cholesterol (LDL-C) Strata||Participants|Number|17|17.0||||||
4424639|NCT00166504|4248272|B1|>=190 mg/dl||Baseline Low Density Lipoprotein Cholesterol (LDL-C) Strata||Participants|Number|20|20.0||||||
4424640|NCT00166504|4248270|B3|>=160 to <190 mg/dl||Baseline Low Density Lipoprotein Cholesterol (LDL-C) Strata||Participants|Number|84|84.0||||||
4424641|NCT00166504|4248271|B2|>=160 to <190 mg/dl||Baseline Low Density Lipoprotein Cholesterol (LDL-C) Strata||Participants|Number|43|43.0||||||
4424642|NCT00166504|4248272|B1|>=160 to <190 mg/dl||Baseline Low Density Lipoprotein Cholesterol (LDL-C) Strata||Participants|Number|41|41.0||||||
4424643|NCT00166504|4248270|B3|>=130 to <160 mg/dl||Baseline Low Density Lipoprotein Cholesterol (LDL-C) Strata||Participants|Number|77|77.0||||||
4424644|NCT00166504|4248271|B2|>=130 to <160 mg/dl||Baseline Low Density Lipoprotein Cholesterol (LDL-C) Strata||Participants|Number|32|32.0||||||
4424645|NCT00166504|4248272|B1|>=130 to <160 mg/dl||Baseline Low Density Lipoprotein Cholesterol (LDL-C) Strata||Participants|Number|45|45.0||||||
4424646|NCT00166504|4248270|B3|<130 mg/dl||Baseline Low Density Lipoprotein Cholesterol (LDL-C) Strata||Participants|Number|5|5.0||||||
4424647|NCT00166504|4248271|B2|<130 mg/dl||Baseline Low Density Lipoprotein Cholesterol (LDL-C) Strata||Participants|Number|3|3.0||||||
4424648|NCT00166504|4248272|B1|<130 mg/dl||Baseline Low Density Lipoprotein Cholesterol (LDL-C) Strata||Participants|Number|2|2.0||||||
4424649|NCT00166504|4248270|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4424650|NCT00166504|4248271|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4424651|NCT00166504|4248272|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4424652|NCT00166504|4248270|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4424653|NCT00166504|4248271|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4424654|NCT00166504|4248272|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4424655|NCT00166504|4248270|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|9.8|9.8|||
4424656|NCT00166504|4248271|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|8.7|8.7|||
4424657|NCT00166504|4248272|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|10.7|10.7|||
4424658|NCT00166361|4248279|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4424659|NCT00166361|4248280|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4424660|NCT00166361|4248281|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4424661|NCT00166361|4248279|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4424662|NCT00166361|4248280|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4424663|NCT00166361|4248281|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4424664|NCT00166361|4248279|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4424665|NCT00166361|4248280|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4424666|NCT00166361|4248281|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4424667|NCT00166361|4248279|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4424668|NCT00166361|4248280|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4424669|NCT00166361|4248281|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4424670|NCT00166361|4248279|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4424671|NCT00166361|4248280|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4424672|NCT00166361|4248281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4424673|NCT00166361|4248279|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424674|NCT00166361|4248280|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424675|NCT00166361|4248281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424676|NCT00166296|4248288|B3|Spain||Region of Enrollment||participants|Number|133|133.0||||||
4424677|NCT00166296|4248289|B2|Spain||Region of Enrollment||participants|Number|66|66.0||||||
4424678|NCT00166296|4248290|B1|Spain||Region of Enrollment||participants|Number|67|67.0||||||
4424679|NCT00166296|4248288|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4424680|NCT00166296|4248289|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4424681|NCT00166296|4248290|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4424682|NCT00166296|4248288|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4424683|NCT00166296|4248289|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4424684|NCT00166296|4248290|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4424685|NCT00166296|4248288|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|10.7|10.7|||
4424686|NCT00166296|4248289|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|10.8|10.8|||
4424687|NCT00166296|4248290|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|10.6|10.6|||
4424688|NCT00166296|4248288|B3||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
4424689|NCT00166296|4248289|B2||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4424690|NCT00166296|4248290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4424691|NCT00166205|4248303|B1|||Mean Excess Body Weight|Excess weight is computed as baseline weight minus Ideal weight. Ideal weight as provided in the 1983 Metropolitan Life Height and Weight Table using the upper limit of the midpoint range.|Pounds|Mean|130.0|130.0|Standard Deviation|33.1|33.1|||
4424692|NCT00166205|4248303|B1|United States||Region of Enrollment||participants|Number|276|276.0||||||
4424693|NCT00166205|4248303|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4424694|NCT00166205|4248303|B1||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4424695|NCT00166205|4248303|B1|||Age||years|Mean|38.6|38.6|Standard Deviation|9.4|9.4|||
4424696|NCT00166205|4248303|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424697|NCT00166205|4248303|B1||Between 18 and 65 years|Age||Participants|Count of Participants|276|276.0||||||
4424698|NCT00166205|4248303|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424699|NCT00166166|4248317|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4424700|NCT00166166|4248318|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4424701|NCT00166166|4248319|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4424702|NCT00166166|4248317|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4424703|NCT00166166|4248318|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4424704|NCT00166166|4248319|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4424705|NCT00166166|4248317|B3|||Age||years|Mean|40|40.0|Standard Deviation|12|12.0|||
4424706|NCT00166166|4248318|B2|||Age||years|Mean|46|46.0|Standard Deviation|12|12.0|||
4424707|NCT00166166|4248319|B1|||Age||years|Mean|34|34.0|Standard Deviation|11|11.0|||
4424708|NCT00166114|4248341|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4424709|NCT00166114|4248342|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4424710|NCT00166114|4248343|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4424711|NCT00166114|4248341|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4424712|NCT00166114|4248342|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4424713|NCT00166114|4248343|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4424714|NCT00166114|4248341|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4424715|NCT00166114|4248342|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4424716|NCT00166114|4248343|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4424717|NCT00166114|4248341|B3||>=65 years|Age|Age, Categorical|Participants|Count of Participants|0|0.0||||||
4424718|NCT00166114|4248342|B2||>=65 years|Age|Age, Categorical|Participants|Count of Participants|0|0.0||||||
4424719|NCT00166114|4248343|B1||>=65 years|Age|Age, Categorical|Participants|Count of Participants|0|0.0||||||
4424720|NCT00166114|4248341|B3||Between 18 and 65 years|Age|Age, Categorical|Participants|Count of Participants|40|40.0||||||
4424721|NCT00166114|4248342|B2||Between 18 and 65 years|Age|Age, Categorical|Participants|Count of Participants|19|19.0||||||
4424722|NCT00166114|4248343|B1||Between 18 and 65 years|Age|Age, Categorical|Participants|Count of Participants|21|21.0||||||
4424723|NCT00166114|4248341|B3||<=18 years|Age|Age, Categorical|Participants|Count of Participants|0|0.0||||||
4424724|NCT00166114|4248342|B2||<=18 years|Age|Age, Categorical|Participants|Count of Participants|0|0.0||||||
4424725|NCT00166114|4248343|B1||<=18 years|Age|Age, Categorical|Participants|Count of Participants|0|0.0||||||
4424726|NCT00166036|4248350|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4424727|NCT00166036|4248351|B2||Male|Sex: Female, Male||Participants|Count of Participants|05|5.0||||||
4424728|NCT00166036|4248352|B1||Male|Sex: Female, Male||Participants|Count of Participants|08|8.0||||||
4424729|NCT00166036|4248350|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4424730|NCT00166036|4248351|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4424731|NCT00166036|4248352|B1||Female|Sex: Female, Male||Participants|Count of Participants|09|9.0||||||
4424732|NCT00166036|4248350|B3|||Age||years|Mean|52.9|52.9|Standard Deviation|9.1|9.1|||
4424733|NCT00166036|4248351|B2|||Age||years|Mean|51.7|51.7|Standard Deviation|10.8|10.8|||
4424734|NCT00166036|4248352|B1|||Age||years|Mean|54.2|54.2|Standard Deviation|6.6|6.6|||
4424735|NCT00166036|4248350|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4424736|NCT00166036|4248351|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4424737|NCT00166036|4248352|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4424738|NCT00166036|4248350|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4424739|NCT00166036|4248351|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4424740|NCT00166036|4248352|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4424741|NCT00166036|4248350|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424742|NCT00166036|4248351|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424743|NCT00166036|4248352|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424744|NCT00165984|4248361|B1|United States||Region of Enrollment||participants|Number|165|165.0||||||
4424745|NCT00165984|4248361|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4424746|NCT00165984|4248361|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4424747|NCT00165984|4248361|B1|||Age||years|Mean|7|7.0|Standard Deviation|3|3.0|||
4424748|NCT00165984|4248361|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424749|NCT00165984|4248361|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4424750|NCT00165984|4248361|B1||<=18 years|Age||Participants|Count of Participants|165|165.0||||||
4424751|NCT00165958|4248368|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4424752|NCT00165958|4248369|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4424753|NCT00165958|4248370|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4424754|NCT00165958|4248368|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4424755|NCT00165958|4248369|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4424756|NCT00165958|4248370|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4424757|NCT00165958|4248368|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4424758|NCT00165958|4248369|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4424759|NCT00165958|4248370|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4424760|NCT00165958|4248368|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|10.7|10.7|||
4424761|NCT00165958|4248369|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|9.9|9.9|||
4424762|NCT00165958|4248370|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|11.8|11.8|||
4424763|NCT00165958|4248368|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4424764|NCT00165958|4248369|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4424765|NCT00165958|4248370|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4424766|NCT00165958|4248368|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4424767|NCT00165958|4248369|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4424768|NCT00165958|4248370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4424769|NCT00165958|4248368|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424770|NCT00165958|4248369|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424771|NCT00165958|4248370|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424772|NCT00165841|4248377|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4424773|NCT00165841|4248378|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4424774|NCT00165841|4248379|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4424775|NCT00165841|4248377|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4424776|NCT00165841|4248378|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4424777|NCT00165841|4248379|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4424778|NCT00165841|4248377|B3||White|Race (NIH/OMB)||Participants|Count of Participants|138|138.0||||||
4424779|NCT00165841|4248378|B2||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4424780|NCT00165841|4248379|B1||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4424781|NCT00165841|4248377|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4424782|NCT00165841|4248378|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4424783|NCT00165841|4248379|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4424784|NCT00165841|4248377|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4424785|NCT00165841|4248378|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4424786|NCT00165841|4248379|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4424787|NCT00165841|4248377|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4424788|NCT00165841|4248378|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4424789|NCT00165841|4248379|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4424790|NCT00165841|4248377|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4424791|NCT00165841|4248378|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4424792|NCT00165841|4248379|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4424793|NCT00165841|4248377|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4424794|NCT00165841|4248378|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4424795|NCT00165841|4248379|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4424796|NCT00165841|4248377|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4424797|NCT00165841|4248378|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4424798|NCT00165841|4248379|B1||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4424799|NCT00165841|4248377|B3|||Age||years|Mean|46.3|46.3|Standard Deviation|11.66|11.66|||
4424800|NCT00165841|4248378|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|11.69|11.69|||
4424801|NCT00165841|4248379|B1|||Age||years|Mean|46.0|46.0|Standard Deviation|11.67|11.67|||
4424802|NCT00165789|4248386|B5||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4424803|NCT00165789|4248387|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4424804|NCT00165789|4248388|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4424805|NCT00165789|4248389|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4424806|NCT00165789|4248390|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4424807|NCT00165789|4248386|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4424808|NCT00165789|4248387|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4424809|NCT00165789|4248388|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4424810|NCT00165789|4248389|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4424811|NCT00165789|4248390|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4424812|NCT00165789|4248386|B5|||Age||Years|Mean|68.025|68.025|Standard Deviation|10.35|10.35|||
4424813|NCT00165789|4248387|B4|||Age||Years|Mean|67.5|67.5|Standard Deviation|10.48|10.48|||
4424814|NCT00165789|4248388|B3|||Age||Years|Mean|68.5|68.5|Standard Deviation|12.71|12.71|||
4424815|NCT00165789|4248389|B2|||Age||Years|Mean|68.5|68.5|Standard Deviation|7.78|7.78|||
4424816|NCT00165789|4248390|B1|||Age||Years|Mean|67.6|67.6|Standard Deviation|10.43|10.43|||
4424817|NCT00165776|4248443|B5|Japanese||Race/Ethnicity, Customized||Participants|Number|130|130.0||||||
4424818|NCT00165776|4248444|B4|Japanese||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4424819|NCT00165776|4248445|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4424820|NCT00165776|4248446|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4424821|NCT00165776|4248447|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4424822|NCT00165776|4248443|B5||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4424823|NCT00165776|4248444|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4424824|NCT00165776|4248445|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4424825|NCT00165776|4248446|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4424826|NCT00165776|4248447|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4424827|NCT00165776|4248443|B5||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4424828|NCT00165776|4248444|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4424829|NCT00165776|4248445|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4424830|NCT00165776|4248446|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4424831|NCT00165776|4248447|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4424832|NCT00165776|4248443|B5|Greater than or equal to 60 years||Age, Customized||Participants|Number|40|40.0||||||
4424833|NCT00165776|4248444|B4|Greater than or equal to 60 years||Age, Customized||Participants|Number|10|10.0||||||
4424834|NCT00165776|4248445|B3|Greater than or equal to 60 years||Age, Customized||Participants|Number|4|4.0||||||
4424835|NCT00165776|4248446|B2|Greater than or equal to 60 years||Age, Customized||Participants|Number|15|15.0||||||
4424836|NCT00165776|4248447|B1|Greater than or equal to 60 years||Age, Customized||Participants|Number|11|11.0||||||
4424837|NCT00165776|4248443|B5|40 to less than 60 years||Age, Customized||Participants|Number|51|51.0||||||
4424838|NCT00165776|4248444|B4|40 to less than 60 years||Age, Customized||Participants|Number|13|13.0||||||
4424839|NCT00165776|4248445|B3|40 to less than 60 years||Age, Customized||Participants|Number|18|18.0||||||
4424840|NCT00165776|4248446|B2|40 to less than 60 years||Age, Customized||Participants|Number|8|8.0||||||
4424841|NCT00165776|4248447|B1|40 to less than 60 years||Age, Customized||Participants|Number|12|12.0||||||
4424842|NCT00165776|4248443|B5|Less than 40 years||Age, Customized||Participants|Number|39|39.0||||||
4424843|NCT00165776|4248444|B4|Less than 40 years||Age, Customized||Participants|Number|8|8.0||||||
4424844|NCT00165776|4248445|B3|Less than 40 years||Age, Customized||Participants|Number|10|10.0||||||
4424845|NCT00165776|4248446|B2|Less than 40 years||Age, Customized||Participants|Number|11|11.0||||||
4424846|NCT00165776|4248447|B1|Less than 40 years||Age, Customized||Participants|Number|10|10.0||||||
4424847|NCT00165698|4248484|B3|China||Region of Enrollment||participants|Number|220|220.0||||||
4424848|NCT00165698|4248485|B2|China||Region of Enrollment||participants|Number|108|108.0||||||
4424849|NCT00165698|4248486|B1|China||Region of Enrollment||participants|Number|112|112.0||||||
4424850|NCT00165698|4248484|B3|Asian||Race/Ethnicity, Customized|Race|participants|Number|220|220.0||||||
4424851|NCT00165698|4248485|B2|Asian||Race/Ethnicity, Customized|Race|participants|Number|108|108.0||||||
4424852|NCT00165698|4248486|B1|Asian||Race/Ethnicity, Customized|Race|participants|Number|112|112.0||||||
4424853|NCT00165698|4248484|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424854|NCT00165698|4248485|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424855|NCT00165698|4248486|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424856|NCT00165698|4248484|B3||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4424857|NCT00165698|4248485|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4424858|NCT00165698|4248486|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4424859|NCT00165698|4248484|B3|||Age|Baseline Participants are Full Anaylsis Set (FAS) Population|years|Mean|64.4|64.4|Standard Deviation|6.2|6.2|||
4424860|NCT00165698|4248485|B2|||Age|Baseline Participants are Full Anaylsis Set (FAS) Population|years|Mean|64.2|64.2|Standard Deviation|6.3|6.3|||
4424861|NCT00165698|4248486|B1|||Age|Baseline Participants are Full Anaylsis Set (FAS) Population|years|Mean|64.6|64.6|Standard Deviation|6.1|6.1|||
4424862|NCT00165672|4248511|B3|Japan||Region of Enrollment||participants|Number|18|18.0||||||
4424863|NCT00165672|4248512|B2|Japan||Region of Enrollment||participants|Number|9|9.0||||||
4424864|NCT00165672|4248513|B1|Japan||Region of Enrollment||participants|Number|9|9.0||||||
4424865|NCT00165672|4248511|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4424866|NCT00165672|4248512|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4424867|NCT00165672|4248513|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4424868|NCT00165672|4248511|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4424869|NCT00165672|4248512|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4424870|NCT00165672|4248513|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4424871|NCT00165672|4248511|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4424872|NCT00165672|4248512|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4424873|NCT00165672|4248513|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4424874|NCT00165672|4248511|B3|||Age|This number is the population for data analysis of clinical pharmacology.|years|Mean|41.6|41.6|Standard Deviation|17.5|17.5|||
4424875|NCT00165672|4248512|B2|||Age|This number is the population for data analysis of clinical pharmacology.|years|Mean|42.7|42.7|Standard Deviation|15.8|15.8|||
4424876|NCT00165672|4248513|B1|||Age|This number is the population for data analysis of clinical pharmacology.|years|Mean|40.6|40.6|Standard Deviation|20.0|20.0|||
4424877|NCT00165646|4248520|B4|Japan||Region of Enrollment||participants|Number|285|285.0||||||
4424878|NCT00165646|4248521|B3|Japan||Region of Enrollment||participants|Number|101|101.0||||||
4424879|NCT00165646|4248522|B2|Japan||Region of Enrollment||participants|Number|93|93.0||||||
4424880|NCT00165646|4248523|B1|Japan||Region of Enrollment||participants|Number|91|91.0||||||
4424881|NCT00165646|4248520|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|285|285.0||||||
4424882|NCT00165646|4248521|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4424883|NCT00165646|4248522|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4424884|NCT00165646|4248523|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4424885|NCT00165646|4248520|B4||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4424886|NCT00165646|4248521|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4424887|NCT00165646|4248522|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4424888|NCT00165646|4248523|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4424889|NCT00165646|4248520|B4||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4424890|NCT00165646|4248521|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4424891|NCT00165646|4248522|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4424892|NCT00165646|4248523|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4424893|NCT00165646|4248520|B4|||Age|Full Analysis Set Population|years|Mean|47.6|47.6|Standard Deviation|16.0|16.0|||
4424894|NCT00165646|4248521|B3|||Age|Full Analysis Set Population|years|Mean|46.8|46.8|Standard Deviation|15.7|15.7|||
4424895|NCT00165646|4248522|B2|||Age|Full Analysis Set Population|years|Mean|46.3|46.3|Standard Deviation|15.3|15.3|||
4424896|NCT00165646|4248523|B1|||Age|Full Analysis Set Population|years|Mean|49.7|49.7|Standard Deviation|17.0|17.0|||
4424897|NCT00165503|4248533|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4424898|NCT00165503|4248533|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4424899|NCT00165503|4248533|B1|Non-Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4424900|NCT00165503|4248533|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4424901|NCT00165503|4248533|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4424902|NCT00165503|4248533|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4424903|NCT00165503|4248533|B1|||Age||years|Mean|71.5|71.5|Full Range|||45.0|84.0|
4424904|NCT00163657|4248537|B4|||Reduce HCV recurrent post liver transplant|Patients receiving a liver transplant for chronic HCV|participants|Number|312|312.0||||||
4424905|NCT00163657|4248538|B3|||Reduce HCV recurrent post liver transplant|Patients receiving a liver transplant for chronic HCV|participants|Number|153|153.0||||||
4424906|NCT00163657|4248539|B2|||Reduce HCV recurrent post liver transplant|Patients receiving a liver transplant for chronic HCV|participants|Number|79|79.0||||||
4424907|NCT00163657|4248540|B1|||Reduce HCV recurrent post liver transplant|Patients receiving a liver transplant for chronic HCV|participants|Number|80|80.0||||||
4424908|NCT00163657|4248537|B4|United States||Region of Enrollment||Participants|Count of Participants|312|312.0||||||
4424909|NCT00163657|4248538|B3|United States||Region of Enrollment||Participants|Count of Participants|153|153.0||||||
4424910|NCT00163657|4248539|B2|United States||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
4424911|NCT00163657|4248540|B1|United States||Region of Enrollment||Participants|Count of Participants|80|80.0||||||
4424912|NCT00163657|4248537|B4||Male|Gender||Participants|Count of Participants|225|225.0||||||
4424913|NCT00163657|4248538|B3||Male|Gender||Participants|Count of Participants|109|109.0||||||
4424914|NCT00163657|4248539|B2||Male|Gender||Participants|Count of Participants|60|60.0||||||
4424915|NCT00163657|4248540|B1||Male|Gender||Participants|Count of Participants|56|56.0||||||
4424916|NCT00163657|4248537|B4||Female|Gender||Participants|Count of Participants|87|87.0||||||
4424917|NCT00163657|4248538|B3||Female|Gender||Participants|Count of Participants|44|44.0||||||
4424918|NCT00163657|4248539|B2||Female|Gender||Participants|Count of Participants|19|19.0||||||
4424919|NCT00163657|4248540|B1||Female|Gender||Participants|Count of Participants|24|24.0||||||
4424920|NCT00163657|4248537|B4|Years||Age, Customized||years|Mean|51.6|51.6|Standard Deviation|7.4|7.4|||
4424921|NCT00163657|4248538|B3|Years||Age, Customized||years|Mean|51.5|51.5|Standard Deviation|7.4|7.4|||
4424922|NCT00163657|4248539|B2|Years||Age, Customized||years|Mean|51.4|51.4|Standard Deviation|7.8|7.8|||
4424923|NCT00163657|4248540|B1|Years||Age, Customized||years|Mean|51.7|51.7|Standard Deviation|7.2|7.2|||
4424924|NCT00163293|4248553|B4|||Smoking Classification (Non-smoker)||participants|Number|239|239.0||||||
4424925|NCT00163293|4248554|B3|||Smoking Classification (Non-smoker)||participants|Number|84|84.0||||||
4424926|NCT00163293|4248555|B2|||Smoking Classification (Non-smoker)||participants|Number|76|76.0||||||
4424927|NCT00163293|4248556|B1|||Smoking Classification (Non-smoker)||participants|Number|79|79.0||||||
4424928|NCT00163293|4248553|B4|||Body Mass Index (BMI)|BMI data was only available for n=77, 76, 84 participants, respectively.|kg/m^2|Mean|17.91|17.91|Standard Deviation|3.478|3.478|||
4424929|NCT00163293|4248554|B3|||Body Mass Index (BMI)|BMI data was only available for n=77, 76, 84 participants, respectively.|kg/m^2|Mean|18.68|18.68|Standard Deviation|4.069|4.069|||
4424930|NCT00163293|4248555|B2|||Body Mass Index (BMI)|BMI data was only available for n=77, 76, 84 participants, respectively.|kg/m^2|Mean|17.69|17.69|Standard Deviation|2.977|2.977|||
4424931|NCT00163293|4248556|B1|||Body Mass Index (BMI)|BMI data was only available for n=77, 76, 84 participants, respectively.|kg/m^2|Mean|17.30|17.3|Standard Deviation|3.107|3.107|||
4424932|NCT00163293|4248553|B4|||Weight|Weight data was only available for n=77, 76, 84 participants, respectively.|kg|Mean|31.08|31.08|Standard Deviation|10.365|10.365|||
4424933|NCT00163293|4248554|B3|||Weight|Weight data was only available for n=77, 76, 84 participants, respectively.|kg|Mean|33.13|33.13|Standard Deviation|11.640|11.64|||
4424934|NCT00163293|4248555|B2|||Weight|Weight data was only available for n=77, 76, 84 participants, respectively.|kg|Mean|30.01|30.01|Standard Deviation|9.247|9.247|||
4424935|NCT00163293|4248556|B1|||Weight|Weight data was only available for n=77, 76, 84 participants, respectively.|kg|Mean|29.90|29.9|Standard Deviation|9.701|9.701|||
4424936|NCT00163293|4248553|B4|Other||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4424937|NCT00163293|4248554|B3|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4424938|NCT00163293|4248555|B2|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4424939|NCT00163293|4248556|B1|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4424940|NCT00163293|4248553|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
4424941|NCT00163293|4248554|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4424942|NCT00163293|4248555|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4424943|NCT00163293|4248556|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4424944|NCT00163293|4248553|B4|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4424945|NCT00163293|4248554|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4424946|NCT00163293|4248555|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4424947|NCT00163293|4248556|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4424948|NCT00163293|4248553|B4|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4424949|NCT00163293|4248554|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4424950|NCT00163293|4248555|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4424951|NCT00163293|4248556|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4424952|NCT00163293|4248553|B4||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4424953|NCT00163293|4248554|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4424954|NCT00163293|4248555|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4424955|NCT00163293|4248556|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4424956|NCT00163293|4248553|B4||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4424957|NCT00163293|4248554|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4424958|NCT00163293|4248555|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4424959|NCT00163293|4248556|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4424960|NCT00163293|4248553|B4|||Age||years|Mean|7.9|7.9|Standard Deviation|2.04|2.04|||
4424961|NCT00163293|4248554|B3|||Age||years|Mean|8.1|8.1|Standard Deviation|2.19|2.19|||
4424962|NCT00163293|4248555|B2|||Age||years|Mean|7.7|7.7|Standard Deviation|1.84|1.84|||
4424963|NCT00163293|4248556|B1|||Age||years|Mean|7.9|7.9|Standard Deviation|2.06|2.06|||
4424964|NCT00163215|4248632|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4424965|NCT00163215|4248632|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4424966|NCT00163215|4248632|B1|||Age||years|Mean|10.3|10.3|Standard Deviation|3.6|3.6|||
4424967|NCT00163189|4248652|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4424968|NCT00163189|4248652|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4424969|NCT00163189|4248652|B1|||Age||years|Mean|11.8|11.8|Standard Deviation|3.2|3.2|||
4424970|NCT00163020|4248674|B3|United States||Region of Enrollment||participants|Number|321|321.0||||||
4424971|NCT00163020|4248675|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
4424972|NCT00163020|4248676|B1|United States||Region of Enrollment||participants|Number|216|216.0||||||
4424973|NCT00163020|4248674|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424974|NCT00163020|4248675|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424975|NCT00163020|4248676|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4424976|NCT00163020|4248674|B3||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4424977|NCT00163020|4248675|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4424978|NCT00163020|4248676|B1||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4424979|NCT00163020|4248674|B3|triplets||Age||years|Mean|33.5|33.5|Standard Deviation|5.2|5.2|||
4424980|NCT00163020|4248675|B2|triplets||Age||years|Mean|33.6|33.6|Standard Deviation|5.4|5.4|||
4424981|NCT00163020|4248676|B1|triplets||Age||years|Mean|33.4|33.4|Standard Deviation|5.0|5.0|||
4424982|NCT00163020|4248674|B3|twins||Age||years|Mean|34.3|34.3|Standard Deviation|6.2|6.2|||
4424983|NCT00163020|4248675|B2|twins||Age||years|Mean|34.5|34.5|Standard Deviation|6.6|6.6|||
4424984|NCT00163020|4248676|B1|twins||Age||years|Mean|34.0|34.0|Standard Deviation|5.8|5.8|||
4424985|NCT00163020|4248674|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424986|NCT00163020|4248675|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424987|NCT00163020|4248676|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4424988|NCT00163020|4248674|B3||Between 18 and 65 years|Age||Participants|Count of Participants|321|321.0||||||
4424989|NCT00163020|4248675|B2||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4424990|NCT00163020|4248676|B1||Between 18 and 65 years|Age||Participants|Count of Participants|216|216.0||||||
4424991|NCT00163020|4248674|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424992|NCT00163020|4248675|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424993|NCT00163020|4248676|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4424994|NCT00162981|4248715|B3||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4424995|NCT00162981|4248716|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4424996|NCT00162981|4248717|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4424997|NCT00162981|4248715|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4424998|NCT00162981|4248716|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4424999|NCT00162981|4248717|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4425000|NCT00162981|4248715|B3|||Age||years|Mean|8.82|8.82|Standard Deviation|5.22|5.22|||
4425001|NCT00162981|4248716|B2|||Age||years|Mean|8.51|8.51|Standard Deviation|5.14|5.14|||
4425002|NCT00162981|4248717|B1|||Age||years|Mean|9.18|9.18|Standard Deviation|5.37|5.37|||
4425003|NCT00162981|4248715|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425004|NCT00162981|4248716|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425005|NCT00162981|4248717|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425006|NCT00162981|4248715|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4425007|NCT00162981|4248716|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4425008|NCT00162981|4248717|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4425009|NCT00162981|4248715|B3||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
4425010|NCT00162981|4248716|B2||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4425011|NCT00162981|4248717|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4425012|NCT00162942|4248732|B3|||Weight||kilogram|Mean|74.03|74.03|Standard Deviation|17.28|17.28|||
4425013|NCT00162942|4248733|B2|||Weight||kilogram|Mean|72.29|72.29|Standard Deviation|19.23|19.23|||
4425014|NCT00162942|4248734|B1|||Weight||kilogram|Mean|74.89|74.89|Standard Deviation|16.22|16.22|||
4425015|NCT00162942|4248732|B3|||Inflammatory Bowel Disease Flares in the Past 12 Months||flares|Mean|2.3|2.3|Standard Deviation|2.4|2.4|||
4425016|NCT00162942|4248733|B2|||Inflammatory Bowel Disease Flares in the Past 12 Months||flares|Mean|2.5|2.5|Standard Deviation|2.8|2.8|||
4425017|NCT00162942|4248734|B1|||Inflammatory Bowel Disease Flares in the Past 12 Months||flares|Mean|2.2|2.2|Standard Deviation|2.2|2.2|||
4425018|NCT00162942|4248732|B3|||Height||centimeter|Mean|170.2|170.2|Standard Deviation|9.9|9.9|||
4425019|NCT00162942|4248733|B2|||Height||centimeter|Mean|169.9|169.9|Standard Deviation|10.3|10.3|||
4425020|NCT00162942|4248734|B1|||Height||centimeter|Mean|170.3|170.3|Standard Deviation|9.7|9.7|||
4425021|NCT00162942|4248732|B3|||Crohn's Disease History|Time, since diagnosis of Crohn's Disease, was collected at baseline.|months|Mean|136.3|136.3|Standard Deviation|124.3|124.3|||
4425022|NCT00162942|4248733|B2|||Crohn's Disease History|Time, since diagnosis of Crohn's Disease, was collected at baseline.|months|Mean|129.9|129.9|Standard Deviation|123.1|123.1|||
4425023|NCT00162942|4248734|B1|||Crohn's Disease History|Time, since diagnosis of Crohn's Disease, was collected at baseline.|months|Mean|139.5|139.5|Standard Deviation|125.1|125.1|||
4425024|NCT00162942|4248732|B3|||Baseline Crohn's Disease Activity Index Score|601-point, ordinal scale which quantifies the symptoms of patients with Crohn's Disease from 0 (complete remission) to 600 (most severe active disease)|units on a scale|Mean|311.3|311.3|Standard Deviation|54.9|54.9|||
4425025|NCT00162942|4248733|B2|||Baseline Crohn's Disease Activity Index Score|601-point, ordinal scale which quantifies the symptoms of patients with Crohn's Disease from 0 (complete remission) to 600 (most severe active disease)|units on a scale|Mean|314.7|314.7|Standard Deviation|53.5|53.5|||
4425026|NCT00162942|4248734|B1|||Baseline Crohn's Disease Activity Index Score|601-point, ordinal scale which quantifies the symptoms of patients with Crohn's Disease from 0 (complete remission) to 600 (most severe active disease)|units on a scale|Mean|309.6|309.6|Standard Deviation|55.7|55.7|||
4425027|NCT00162942|4248732|B3|Non-Smoker||Smoking Status||participants|Number|101|101.0||||||
4425028|NCT00162942|4248733|B2|Non-Smoker||Smoking Status||participants|Number|29|29.0||||||
4425029|NCT00162942|4248734|B1|Non-Smoker||Smoking Status||participants|Number|72|72.0||||||
4425030|NCT00162942|4248732|B3|Ex-Smoker||Smoking Status||participants|Number|62|62.0||||||
4425031|NCT00162942|4248733|B2|Ex-Smoker||Smoking Status||participants|Number|23|23.0||||||
4425032|NCT00162942|4248734|B1|Ex-Smoker||Smoking Status||participants|Number|39|39.0||||||
4425033|NCT00162942|4248732|B3|Current Smoker||Smoking Status||participants|Number|72|72.0||||||
4425034|NCT00162942|4248733|B2|Current Smoker||Smoking Status||participants|Number|26|26.0||||||
4425035|NCT00162942|4248734|B1|Current Smoker||Smoking Status||participants|Number|46|46.0||||||
4425036|NCT00162942|4248732|B3|Never Drank||Alcohol Use||participants|Number|51|51.0||||||
4425037|NCT00162942|4248733|B2|Never Drank||Alcohol Use||participants|Number|12|12.0||||||
4425038|NCT00162942|4248734|B1|Never Drank||Alcohol Use||participants|Number|39|39.0||||||
4425039|NCT00162942|4248732|B3|Previously Drank||Alcohol Use||participants|Number|45|45.0||||||
4425040|NCT00162942|4248733|B2|Previously Drank||Alcohol Use||participants|Number|12|12.0||||||
4425041|NCT00162942|4248734|B1|Previously Drank||Alcohol Use||participants|Number|33|33.0||||||
4425042|NCT00162942|4248732|B3|Consumes Alcohol||Alcohol Use||participants|Number|139|139.0||||||
4425043|NCT00162942|4248733|B2|Consumes Alcohol||Alcohol Use||participants|Number|54|54.0||||||
4425044|NCT00162942|4248734|B1|Consumes Alcohol||Alcohol Use||participants|Number|85|85.0||||||
4425045|NCT00162942|4248732|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4425046|NCT00162942|4248733|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425047|NCT00162942|4248734|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4425048|NCT00162942|4248732|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425049|NCT00162942|4248733|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425050|NCT00162942|4248734|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425051|NCT00162942|4248732|B3|African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4425052|NCT00162942|4248733|B2|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4425053|NCT00162942|4248734|B1|African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4425054|NCT00162942|4248732|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4425055|NCT00162942|4248733|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425056|NCT00162942|4248734|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4425057|NCT00162942|4248732|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|217|217.0||||||
4425058|NCT00162942|4248733|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4425059|NCT00162942|4248734|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
4425060|NCT00162942|4248732|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4425061|NCT00162942|4248733|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4425062|NCT00162942|4248734|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4425063|NCT00162942|4248732|B3||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4425064|NCT00162942|4248733|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4425065|NCT00162942|4248734|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4425066|NCT00162942|4248732|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|12.8|12.8|||
4425067|NCT00162942|4248733|B2|||Age||years|Mean|41.4|41.4|Standard Deviation|13.6|13.6|||
4425068|NCT00162942|4248734|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|12.5|12.5|||
4425069|NCT00162773|4248783|B1|United States||Region of Enrollment||Participants|Count of Participants|29|29.0||||||
4425070|NCT00162773|4248783|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4425071|NCT00162773|4248783|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4425072|NCT00162773|4248783|B1|>=18 and <=80||Age, Customized||Participants|Count of Participants|29|29.0||||||
4425073|NCT00162370|4248787|B1|United States||Region of Enrollment||participants|Number|400|400.0||||||
4425074|NCT00162370|4248787|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425075|NCT00162370|4248787|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4425076|NCT00162370|4248787|B1||White|Race (NIH/OMB)||Participants|Count of Participants|386|386.0||||||
4425077|NCT00162370|4248787|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4425078|NCT00162370|4248787|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425079|NCT00162370|4248787|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4425080|NCT00162370|4248787|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4425081|NCT00162370|4248787|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4425082|NCT00162370|4248787|B1||Female|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4425083|NCT00162370|4248787|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4425084|NCT00162370|4248787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|394|394.0||||||
4425085|NCT00162370|4248787|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425086|NCT00162370|4248787|B1|||Age||Years|Mean|54.4|54.4|Full Range|||40.0|65.0|
4425087|NCT00162266|4248792|B4|||Duration of Participant Rheumatoid Arthritis (RA)||Years|Mean|9.4|9.4|Standard Deviation|8.8|8.8|||
4425088|NCT00162266|4248793|B3|||Duration of Participant Rheumatoid Arthritis (RA)||Years|Mean|8.9|8.9|Standard Deviation|8.3|8.3|||
4425089|NCT00162266|4248794|B2|||Duration of Participant Rheumatoid Arthritis (RA)||Years|Mean|9.7|9.7|Standard Deviation|8.1|8.1|||
4425090|NCT00162266|4248795|B1|||Duration of Participant Rheumatoid Arthritis (RA)||Years|Mean|9.7|9.7|Standard Deviation|9.8|9.8|||
4425091|NCT00162266|4248792|B4|||C-Reactive Protein (CRP) Serum Level||mg/dL|Mean|3.1|3.1|Standard Deviation|2.9|2.9|||
4425092|NCT00162266|4248793|B3|||C-Reactive Protein (CRP) Serum Level||mg/dL|Mean|3.2|3.2|Standard Deviation|3.2|3.2|||
4425093|NCT00162266|4248794|B2|||C-Reactive Protein (CRP) Serum Level||mg/dL|Mean|3.2|3.2|Standard Deviation|2.5|2.5|||
4425094|NCT00162266|4248795|B1|||C-Reactive Protein (CRP) Serum Level||mg/dL|Mean|2.9|2.9|Standard Deviation|2.8|2.8|||
4425095|NCT00162266|4248792|B4|||Number of Swollen Joints||Joints|Mean|21.1|21.1|Standard Deviation|8.7|8.7|||
4425096|NCT00162266|4248793|B3|||Number of Swollen Joints||Joints|Mean|21.8|21.8|Standard Deviation|8.8|8.8|||
4425097|NCT00162266|4248794|B2|||Number of Swollen Joints||Joints|Mean|20.2|20.2|Standard Deviation|8.9|8.9|||
4425098|NCT00162266|4248795|B1|||Number of Swollen Joints||Joints|Mean|21.3|21.3|Standard Deviation|8.4|8.4|||
4425099|NCT00162266|4248792|B4|||Number of Tender Joints||Joints|Mean|29.4|29.4|Standard Deviation|12.4|12.4|||
4425100|NCT00162266|4248793|B3|||Number of Tender Joints||Joints|Mean|29.2|29.2|Standard Deviation|13.0|13.0|||
4425101|NCT00162266|4248794|B2|||Number of Tender Joints||Joints|Mean|28.2|28.2|Standard Deviation|12.0|12.0|||
4425102|NCT00162266|4248795|B1|||Number of Tender Joints||Joints|Mean|30.8|30.8|Standard Deviation|12.2|12.2|||
4425103|NCT00162266|4248792|B4|Positive||Rheumatoid Factor Status|Status was not recorded for 4 participants.|Participants|Number|279|279.0||||||
4425104|NCT00162266|4248793|B3|Positive||Rheumatoid Factor Status|Status was not recorded for 4 participants.|Participants|Number|90|90.0||||||
4425105|NCT00162266|4248794|B2|Positive||Rheumatoid Factor Status|Status was not recorded for 4 participants.|Participants|Number|90|90.0||||||
4425106|NCT00162266|4248795|B1|Positive||Rheumatoid Factor Status|Status was not recorded for 4 participants.|Participants|Number|99|99.0||||||
4425107|NCT00162266|4248792|B4|Negative||Rheumatoid Factor Status|Status was not recorded for 4 participants.|Participants|Number|56|56.0||||||
4425108|NCT00162266|4248793|B3|Negative||Rheumatoid Factor Status|Status was not recorded for 4 participants.|Participants|Number|27|27.0||||||
4425109|NCT00162266|4248794|B2|Negative||Rheumatoid Factor Status|Status was not recorded for 4 participants.|Participants|Number|15|15.0||||||
4425110|NCT00162266|4248795|B1|Negative||Rheumatoid Factor Status|Status was not recorded for 4 participants.|Participants|Number|14|14.0||||||
4425111|NCT00162266|4248792|B4|||Weight||Kg|Mean|78.8|78.8|Standard Deviation|19.2|19.2|||
4425112|NCT00162266|4248793|B3|||Weight||Kg|Mean|79.9|79.9|Standard Deviation|17.6|17.6|||
4425113|NCT00162266|4248794|B2|||Weight||Kg|Mean|78.7|78.7|Standard Deviation|21.4|21.4|||
4425114|NCT00162266|4248795|B1|||Weight||Kg|Mean|77.8|77.8|Standard Deviation|18.6|18.6|||
4425115|NCT00162266|4248792|B4|Other||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4425116|NCT00162266|4248793|B3|Other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4425117|NCT00162266|4248794|B2|Other||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4425118|NCT00162266|4248795|B1|Other||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4425119|NCT00162266|4248792|B4|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4425120|NCT00162266|4248793|B3|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4425121|NCT00162266|4248794|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425122|NCT00162266|4248795|B1|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4425123|NCT00162266|4248792|B4|White||Race/Ethnicity, Customized||Participants|Number|295|295.0||||||
4425124|NCT00162266|4248793|B3|White||Race/Ethnicity, Customized||Participants|Number|104|104.0||||||
4425125|NCT00162266|4248794|B2|White||Race/Ethnicity, Customized||Participants|Number|91|91.0||||||
4425126|NCT00162266|4248795|B1|White||Race/Ethnicity, Customized||Participants|Number|100|100.0||||||
4425127|NCT00162266|4248792|B4||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4425128|NCT00162266|4248793|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4425129|NCT00162266|4248794|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4425130|NCT00162266|4248795|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4425131|NCT00162266|4248792|B4||Female|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4425132|NCT00162266|4248793|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4425133|NCT00162266|4248794|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4425134|NCT00162266|4248795|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4425135|NCT00162266|4248792|B4|||Age||years|Mean|55.0|55.0|Standard Deviation|11.9|11.9|||
4425136|NCT00162266|4248793|B3|||Age||years|Mean|54.7|54.7|Standard Deviation|12.0|12.0|||
4425137|NCT00162266|4248794|B2|||Age||years|Mean|54.4|54.4|Standard Deviation|11.3|11.3|||
4425138|NCT00162266|4248795|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|12.5|12.5|||
4425139|NCT00162136|4248993|B7|0 to 60||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|0|0.0||||||
4425140|NCT00162136|4248994|B6|0 to 60||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|0|0.0||||||
4425141|NCT00162136|4248995|B5|0 to 60||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|0|0.0||||||
4425142|NCT00162136|4248996|B4|0 to 60||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|0|0.0||||||
4425143|NCT00162136|4248997|B3|0 to 60||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|0|0.0||||||
4425144|NCT00162136|4248998|B2|0 to 60||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|0|0.0||||||
4425145|NCT00162136|4248999|B1|0 to 60||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|0|0.0||||||
4425146|NCT00162136|4248993|B7|70 to 80||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|13|13.0||||||
4425147|NCT00162136|4248994|B6|70 to 80||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|2|2.0||||||
4425148|NCT00162136|4248995|B5|70 to 80||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|4|4.0||||||
4425190|NCT00162136|4248995|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4425191|NCT00162136|4248996|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4425149|NCT00162136|4248996|B4|70 to 80||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|2|2.0||||||
4425150|NCT00162136|4248997|B3|70 to 80||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|2|2.0||||||
4425151|NCT00162136|4248998|B2|70 to 80||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|1|1.0||||||
4425152|NCT00162136|4248999|B1|70 to 80||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|2|2.0||||||
4425153|NCT00162136|4248993|B7|90 to 100||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|22|22.0||||||
4425154|NCT00162136|4248994|B6|90 to 100||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|3|3.0||||||
4425155|NCT00162136|4248995|B5|90 to 100||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|7|7.0||||||
4425156|NCT00162136|4248996|B4|90 to 100||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|2|2.0||||||
4425157|NCT00162136|4248997|B3|90 to 100||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|6|6.0||||||
4425158|NCT00162136|4248998|B2|90 to 100||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|2|2.0||||||
4425159|NCT00162136|4248999|B1|90 to 100||Karnofsky Performance Status|The Karnofsky Performance Status (KPS) measures the ability of cancer patients to perform ordinary tasks. Scores are reported in multiples of 10 and range from 0 to 100; a higher score means the patient is better able to carry out daily activities.|participants|Number|2|2.0||||||
4425160|NCT00162136|4248993|B7|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4425161|NCT00162136|4248994|B6|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425162|NCT00162136|4248995|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425163|NCT00162136|4248996|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425164|NCT00162136|4248997|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425165|NCT00162136|4248998|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425166|NCT00162136|4248999|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425167|NCT00162136|4248993|B7|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4425168|NCT00162136|4248994|B6|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4425169|NCT00162136|4248995|B5|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425170|NCT00162136|4248996|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425171|NCT00162136|4248997|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425172|NCT00162136|4248998|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425173|NCT00162136|4248999|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425174|NCT00162136|4248993|B7|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4425175|NCT00162136|4248994|B6|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4425176|NCT00162136|4248995|B5|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4425177|NCT00162136|4248996|B4|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4425178|NCT00162136|4248997|B3|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4425179|NCT00162136|4248998|B2|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4425180|NCT00162136|4248999|B1|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4425181|NCT00162136|4248993|B7||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4425182|NCT00162136|4248994|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4425183|NCT00162136|4248995|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4425184|NCT00162136|4248996|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4425185|NCT00162136|4248997|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4425186|NCT00162136|4248998|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4425187|NCT00162136|4248999|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4425188|NCT00162136|4248993|B7||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4425189|NCT00162136|4248994|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4425192|NCT00162136|4248997|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4425193|NCT00162136|4248998|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4425194|NCT00162136|4248999|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4425195|NCT00162136|4248993|B7|||Age||years|Mean|59.0|59.0|Full Range|||39.0|79.0|
4425196|NCT00162136|4248994|B6|||Age||years|Mean|52.0|52.0|Full Range|||40.0|60.0|
4425197|NCT00162136|4248995|B5|||Age||years|Mean|58.0|58.0|Full Range|||53.0|79.0|
4425198|NCT00162136|4248996|B4|||Age||years|Mean|59.5|59.5|Full Range|||53.0|62.0|
4425199|NCT00162136|4248997|B3|||Age||years|Mean|61.5|61.5|Full Range|||39.0|70.0|
4425200|NCT00162136|4248998|B2|||Age||years|Mean|59.0|59.0|Full Range|||58.0|64.0|
4425201|NCT00162136|4248999|B1|||Age||years|Mean|63.5|63.5|Full Range|||54.0|74.0|
4425202|NCT00162123|4249023|B9|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|17|17.0||||||
4425203|NCT00162123|4249024|B8|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|17|17.0||||||
4425204|NCT00162123|4249025|B7|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425205|NCT00162123|4249026|B6|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425206|NCT00162123|4249027|B5|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425207|NCT00162123|4249028|B4|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425208|NCT00162123|4249029|B3|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425209|NCT00162123|4249030|B2|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425267|NCT00162123|4249025|B7|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425268|NCT00162123|4249026|B6|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425269|NCT00162123|4249027|B5|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425270|NCT00162123|4249028|B4|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425271|NCT00162123|4249029|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425210|NCT00162123|4249031|B1|Not reported||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425211|NCT00162123|4249023|B9|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|1|1.0||||||
4425212|NCT00162123|4249024|B8|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|1|1.0||||||
4425213|NCT00162123|4249025|B7|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425214|NCT00162123|4249026|B6|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425215|NCT00162123|4249027|B5|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425216|NCT00162123|4249028|B4|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425217|NCT00162123|4249029|B3|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425218|NCT00162123|4249030|B2|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425219|NCT00162123|4249031|B1|3||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425272|NCT00162123|4249030|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425273|NCT00162123|4249031|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4425274|NCT00162123|4249023|B9|White||Race/Ethnicity, Customized||Participants|Number|236|236.0||||||
4425220|NCT00162123|4249023|B9|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|3|3.0||||||
4425221|NCT00162123|4249024|B8|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|1|1.0||||||
4425222|NCT00162123|4249025|B7|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425223|NCT00162123|4249026|B6|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425224|NCT00162123|4249027|B5|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425225|NCT00162123|4249028|B4|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425226|NCT00162123|4249029|B3|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|1|1.0||||||
4425227|NCT00162123|4249030|B2|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|1|1.0||||||
4425228|NCT00162123|4249031|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|0|0.0||||||
4425229|NCT00162123|4249023|B9|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|59|59.0||||||
4425275|NCT00162123|4249024|B8|White||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4425276|NCT00162123|4249025|B7|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4425277|NCT00162123|4249026|B6|White||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4425278|NCT00162123|4249027|B5|White||Race/Ethnicity, Customized||Participants|Number|45|45.0||||||
4425230|NCT00162123|4249024|B8|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|10|10.0||||||
4425231|NCT00162123|4249025|B7|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|1|1.0||||||
4425232|NCT00162123|4249026|B6|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|1|1.0||||||
4425233|NCT00162123|4249027|B5|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|5|5.0||||||
4425234|NCT00162123|4249028|B4|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|2|2.0||||||
4425235|NCT00162123|4249029|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|13|13.0||||||
4425236|NCT00162123|4249030|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|11|11.0||||||
4425237|NCT00162123|4249031|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|16|16.0||||||
4425238|NCT00162123|4249023|B9|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|162|162.0||||||
4425239|NCT00162123|4249024|B8|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|29|29.0||||||
4425279|NCT00162123|4249028|B4|White||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4425280|NCT00162123|4249029|B3|White||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4425281|NCT00162123|4249030|B2|White||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4425282|NCT00162123|4249031|B1|White||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4425240|NCT00162123|4249025|B7|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|3|3.0||||||
4425241|NCT00162123|4249026|B6|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|12|12.0||||||
4425242|NCT00162123|4249027|B5|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|40|40.0||||||
4425243|NCT00162123|4249028|B4|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|9|9.0||||||
4425244|NCT00162123|4249029|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|10|10.0||||||
4425245|NCT00162123|4249030|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|22|22.0||||||
4425246|NCT00162123|4249031|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|ECOG performance status assesses a patient's physical ability against a 6-point scale: 0=fully active, able to carry on all predisease activities without restriction; 1=restricted in physically strenuous activity, ambulatory and able to carry out light or sedentary work; 2=ambulatory (>50% of waking hours), capable of all self care, unable to carry out any work activities; 3=capable of only limited self care, confined to bed/chair >50% of waking hours; 4=completely disabled, cannot carry on any self care, totally confined to bed/chair; 5=dead. Score ranges from 0=best status to 5=worst status.|Units on a scale|Number|37|37.0||||||
4425247|NCT00162123|4249023|B9|Other: Brazilian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4425248|NCT00162123|4249024|B8|Other: Brazilian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4425249|NCT00162123|4249025|B7|Other: Brazilian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425250|NCT00162123|4249026|B6|Other: Brazilian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425251|NCT00162123|4249027|B5|Other: Brazilian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425252|NCT00162123|4249028|B4|Other: Brazilian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425253|NCT00162123|4249029|B3|Other: Brazilian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425254|NCT00162123|4249030|B2|Other: Brazilian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425255|NCT00162123|4249031|B1|Other: Brazilian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425256|NCT00162123|4249023|B9|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4425257|NCT00162123|4249024|B8|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4425258|NCT00162123|4249025|B7|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425259|NCT00162123|4249026|B6|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425260|NCT00162123|4249027|B5|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425261|NCT00162123|4249028|B4|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425262|NCT00162123|4249029|B3|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425263|NCT00162123|4249030|B2|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425264|NCT00162123|4249031|B1|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425265|NCT00162123|4249023|B9|More than one race||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4425266|NCT00162123|4249024|B8|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425283|NCT00162123|4249023|B9|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4425284|NCT00162123|4249024|B8|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425285|NCT00162123|4249025|B7|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425286|NCT00162123|4249026|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425287|NCT00162123|4249027|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425288|NCT00162123|4249028|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425289|NCT00162123|4249029|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425290|NCT00162123|4249030|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425291|NCT00162123|4249031|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4425292|NCT00162123|4249023|B9|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4425293|NCT00162123|4249024|B8|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4425294|NCT00162123|4249025|B7|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425295|NCT00162123|4249026|B6|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425296|NCT00162123|4249027|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425297|NCT00162123|4249028|B4|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4425298|NCT00162123|4249029|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425299|NCT00162123|4249030|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425300|NCT00162123|4249031|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4425301|NCT00162123|4249023|B9||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4425302|NCT00162123|4249024|B8||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4425303|NCT00162123|4249025|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4425304|NCT00162123|4249026|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4425305|NCT00162123|4249027|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4425306|NCT00162123|4249028|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4425307|NCT00162123|4249029|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4425308|NCT00162123|4249030|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4425309|NCT00162123|4249031|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4425310|NCT00162123|4249023|B9||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4425311|NCT00162123|4249024|B8||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4425312|NCT00162123|4249025|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4425313|NCT00162123|4249026|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4425314|NCT00162123|4249027|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4425315|NCT00162123|4249028|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4425316|NCT00162123|4249029|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4425317|NCT00162123|4249030|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4425318|NCT00162123|4249031|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4425319|NCT00162123|4249023|B9|||Age||Years|Mean|57.7|57.7|Standard Deviation|12.55|12.55|||
4425320|NCT00162123|4249024|B8|||Age||Years|Mean|56.3|56.3|Standard Deviation|12.96|12.96|||
4425321|NCT00162123|4249025|B7|||Age||Years|Mean|65.5|65.5|Standard Deviation|4.80|4.8|||
4425322|NCT00162123|4249026|B6|||Age||Years|Mean|59.0|59.0|Standard Deviation|16.65|16.65|||
4425323|NCT00162123|4249027|B5|||Age||Years|Mean|60.5|60.5|Standard Deviation|12.42|12.42|||
4425324|NCT00162123|4249028|B4|||Age||Years|Mean|57.8|57.8|Standard Deviation|13.7|13.7|||
4425325|NCT00162123|4249029|B3|||Age||Years|Mean|56.0|56.0|Standard Deviation|15.3|15.3|||
4425326|NCT00162123|4249030|B2|||Age||Years|Mean|58.8|58.8|Standard Deviation|9.9|9.9|||
4425327|NCT00162123|4249031|B1|||Age||Years|Mean|55.4|55.4|Standard Deviation|11.7|11.7|||
4425328|NCT00162097|4249067|B5|||Weight, Continuous||kilogram|Mean|70.7|70.7|Standard Deviation|7.9|7.9|||
4425329|NCT00162097|4249068|B4|||Weight, Continuous||kilogram|Mean|70.4|70.4|Standard Deviation|9.6|9.6|||
4425330|NCT00162097|4249069|B3|||Weight, Continuous||kilogram|Mean|61.5|61.5|Standard Deviation|||||
4425331|NCT00162097|4249070|B2|||Weight, Continuous||kilogram|Mean|73.9|73.9|Standard Deviation|2.9|2.9|||
4425332|NCT00162097|4249071|B1|||Weight, Continuous||kilogram|Mean|71.5|71.5|Standard Deviation|7.2|7.2|||
4425333|NCT00162097|4249067|B5|||Height Continuous||cm|Mean|170.6|170.6|Standard Deviation|10.0|10.0|||
4425334|NCT00162097|4249068|B4|||Height Continuous||cm|Mean|175.6|175.6|Standard Deviation|7.2|7.2|||
4425335|NCT00162097|4249069|B3|||Height Continuous||cm|Mean|160.0|160.0|Standard Deviation|||||
4425336|NCT00162097|4249070|B2|||Height Continuous||cm|Mean|173.4|173.4|Standard Deviation|3.7|3.7|||
4425337|NCT00162097|4249071|B1|||Height Continuous||cm|Mean|165.5|165.5|Standard Deviation|11.9|11.9|||
4425338|NCT00162097|4249067|B5|||Body mass index (BMI) Continuous|BMI is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|24.4|24.4|Standard Deviation|3.0|3.0|||
4425339|NCT00162097|4249068|B4|||Body mass index (BMI) Continuous|BMI is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|22.8|22.8|Standard Deviation|2.2|2.2|||
4425340|NCT00162097|4249069|B3|||Body mass index (BMI) Continuous|BMI is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|24.0|24.0|Standard Deviation|||||
4425400|NCT00162097|4249069|B3|||Age||years|Mean|47|47.0|Standard Deviation|||||
4425341|NCT00162097|4249070|B2|||Body mass index (BMI) Continuous|BMI is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|24.6|24.6|Standard Deviation|0.1|0.1|||
4425342|NCT00162097|4249071|B1|||Body mass index (BMI) Continuous|BMI is defined as the individual's body weight divided by the square of his or her height.|kg/m^2|Mean|26.3|26.3|Standard Deviation|3.7|3.7|||
4425343|NCT00162097|4249067|B5|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425344|NCT00162097|4249068|B4|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425345|NCT00162097|4249069|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425346|NCT00162097|4249070|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425347|NCT00162097|4249071|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425348|NCT00162097|4249067|B5|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4425349|NCT00162097|4249068|B4|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4425350|NCT00162097|4249069|B3|White||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425351|NCT00162097|4249070|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425352|NCT00162097|4249071|B1|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4425353|NCT00162097|4249067|B5|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4425354|NCT00162097|4249068|B4|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4425355|NCT00162097|4249069|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425356|NCT00162097|4249070|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425357|NCT00162097|4249071|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4425358|NCT00162097|4249067|B5|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425359|NCT00162097|4249068|B4|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425360|NCT00162097|4249069|B3|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425361|NCT00162097|4249070|B2|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425362|NCT00162097|4249071|B1|American Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425363|NCT00162097|4249067|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4425364|NCT00162097|4249068|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4425365|NCT00162097|4249069|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425366|NCT00162097|4249070|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425367|NCT00162097|4249071|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425368|NCT00162097|4249067|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4425369|NCT00162097|4249068|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4425370|NCT00162097|4249069|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425371|NCT00162097|4249070|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4425372|NCT00162097|4249071|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4425373|NCT00162097|4249067|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4425374|NCT00162097|4249068|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425375|NCT00162097|4249069|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4425376|NCT00162097|4249070|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425377|NCT00162097|4249071|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4425378|NCT00162097|4249067|B5||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4425379|NCT00162097|4249068|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4425380|NCT00162097|4249069|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4425381|NCT00162097|4249070|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4425382|NCT00162097|4249071|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4425383|NCT00162097|4249067|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4425384|NCT00162097|4249068|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4425385|NCT00162097|4249069|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4425386|NCT00162097|4249070|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4425387|NCT00162097|4249071|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4425388|NCT00162097|4249067|B5|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
4425389|NCT00162097|4249068|B4|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4425390|NCT00162097|4249069|B3|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4425391|NCT00162097|4249070|B2|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4425392|NCT00162097|4249071|B1|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
4425393|NCT00162097|4249067|B5|< 65 years||Age, Customized||participants|Number|15|15.0||||||
4425394|NCT00162097|4249068|B4|< 65 years||Age, Customized||participants|Number|7|7.0||||||
4425395|NCT00162097|4249069|B3|< 65 years||Age, Customized||participants|Number|1|1.0||||||
4425396|NCT00162097|4249070|B2|< 65 years||Age, Customized||participants|Number|2|2.0||||||
4425397|NCT00162097|4249071|B1|< 65 years||Age, Customized||participants|Number|5|5.0||||||
4425398|NCT00162097|4249067|B5|||Age||years|Mean|49|49.0|Standard Deviation|7|7.0|||
4425399|NCT00162097|4249068|B4|||Age||years|Mean|49|49.0|Standard Deviation|4|4.0|||
4425401|NCT00162097|4249070|B2|||Age||years|Mean|51|51.0|Standard Deviation|1|1.0|||
4425402|NCT00162097|4249071|B1|||Age||years|Mean|50|50.0|Standard Deviation|11|11.0|||
4425403|NCT00162032|4249134|B3|Singapore||Region of Enrollment||participants|Number|10|10.0||||||
4425404|NCT00162032|4249135|B2|Singapore||Region of Enrollment||participants|Number|4|4.0||||||
4425405|NCT00162032|4249136|B1|Singapore||Region of Enrollment||participants|Number|6|6.0||||||
4425406|NCT00162032|4249134|B3|Korea, Republic of||Region of Enrollment||participants|Number|53|53.0||||||
4425407|NCT00162032|4249135|B2|Korea, Republic of||Region of Enrollment||participants|Number|10|10.0||||||
4425408|NCT00162032|4249136|B1|Korea, Republic of||Region of Enrollment||participants|Number|43|43.0||||||
4425409|NCT00162032|4249134|B3|Thailand||Region of Enrollment||participants|Number|52|52.0||||||
4425410|NCT00162032|4249135|B2|Thailand||Region of Enrollment||participants|Number|6|6.0||||||
4425411|NCT00162032|4249136|B1|Thailand||Region of Enrollment||participants|Number|46|46.0||||||
4425412|NCT00162032|4249134|B3|Brazil||Region of Enrollment||participants|Number|39|39.0||||||
4425413|NCT00162032|4249135|B2|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4425414|NCT00162032|4249136|B1|Brazil||Region of Enrollment||participants|Number|34|34.0||||||
4425415|NCT00162032|4249134|B3|Canada||Region of Enrollment||participants|Number|35|35.0||||||
4425416|NCT00162032|4249135|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4425417|NCT00162032|4249136|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4425418|NCT00162032|4249134|B3|Taiwan||Region of Enrollment||participants|Number|112|112.0||||||
4425419|NCT00162032|4249135|B2|Taiwan||Region of Enrollment||participants|Number|27|27.0||||||
4425420|NCT00162032|4249136|B1|Taiwan||Region of Enrollment||participants|Number|85|85.0||||||
4425421|NCT00162032|4249134|B3|Philippines||Region of Enrollment||participants|Number|41|41.0||||||
4425422|NCT00162032|4249135|B2|Philippines||Region of Enrollment||participants|Number|8|8.0||||||
4425423|NCT00162032|4249136|B1|Philippines||Region of Enrollment||participants|Number|33|33.0||||||
4425424|NCT00162032|4249134|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
4425425|NCT00162032|4249135|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4425426|NCT00162032|4249136|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4425427|NCT00162032|4249134|B3||Male|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4425428|NCT00162032|4249135|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4425429|NCT00162032|4249136|B1||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4425430|NCT00162032|4249134|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4425431|NCT00162032|4249135|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4425432|NCT00162032|4249136|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4425433|NCT00162032|4249134|B3|||Age||years|Mean|9.0|9.0|Standard Deviation|3.27|3.27|||
4425434|NCT00162032|4249135|B2|||Age||years|Mean|13.6|13.6|Standard Deviation|1.31|1.31|||
4425435|NCT00162032|4249136|B1|||Age||years|Mean|7.7|7.7|Standard Deviation|2.16|2.16|||
4425436|NCT00162032|4249134|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425437|NCT00162032|4249135|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425438|NCT00162032|4249136|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425439|NCT00162032|4249134|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4425440|NCT00162032|4249135|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4425441|NCT00162032|4249136|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4425442|NCT00162032|4249134|B3||<=18 years|Age||Participants|Count of Participants|445|445.0||||||
4425443|NCT00162032|4249135|B2||<=18 years|Age||Participants|Count of Participants|116|116.0||||||
4425444|NCT00162032|4249136|B1||<=18 years|Age||Participants|Count of Participants|329|329.0||||||
4425445|NCT00161616|4249145|B3||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4425446|NCT00161616|4249146|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4425447|NCT00161616|4249147|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4425448|NCT00161616|4249145|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4425449|NCT00161616|4249146|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4425450|NCT00161616|4249147|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4425451|NCT00161616|4249145|B3|||Age||years|Mean|38.52|38.52|Standard Deviation|15.14|15.14|||
4425452|NCT00161616|4249146|B2|||Age||years|Mean|37.54|37.54|Standard Deviation|14.87|14.87|||
4425453|NCT00161616|4249147|B1|||Age||years|Mean|39.48|39.48|Standard Deviation|15.40|15.4|||
4425454|NCT00161473|4249156|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4425455|NCT00161473|4249157|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4425456|NCT00161473|4249158|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4425457|NCT00161473|4249156|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4425458|NCT00161473|4249157|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4425459|NCT00161473|4249158|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4425460|NCT00161473|4249156|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4425461|NCT00161473|4249157|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4425462|NCT00161473|4249158|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4425463|NCT00161473|4249156|B3|||Age||years|Mean|80.6|80.6|Standard Deviation|11.2|11.2|||
4425464|NCT00161473|4249157|B2|||Age||years|Mean|78.1|78.1|Standard Deviation|10.8|10.8|||
4425465|NCT00161473|4249158|B1|||Age||years|Mean|83.2|83.2|Standard Deviation|11.5|11.5|||
4425466|NCT00161473|4249156|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4425467|NCT00161473|4249157|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4425468|NCT00161473|4249158|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4425469|NCT00161473|4249156|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4425470|NCT00161473|4249157|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4425471|NCT00161473|4249158|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4425472|NCT00161473|4249156|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425473|NCT00161473|4249157|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425474|NCT00161473|4249158|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425475|NCT00161382|4249171|B3||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4425476|NCT00161382|4249172|B2||Male|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4425477|NCT00161382|4249173|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4425478|NCT00161382|4249171|B3||Female|Sex: Female, Male||Participants|Count of Participants|536|536.0||||||
4425479|NCT00161382|4249172|B2||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4425480|NCT00161382|4249173|B1||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4425481|NCT00161382|4249171|B3|||Age||years|Mean|13.0|13.0|Standard Deviation|.54|0.54|||
4425482|NCT00161382|4249172|B2|||Age||years|Mean|13.0|13.0|Standard Deviation|.51|0.51|||
4425483|NCT00161382|4249173|B1|||Age||years|Mean|13.1|13.1|Standard Deviation|.57|0.57|||
4425484|NCT00161213|4249180|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4425485|NCT00161213|4249180|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4425486|NCT00161213|4249180|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4425487|NCT00161213|4249180|B1|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
4425488|NCT00161213|4249180|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4425489|NCT00161213|4249180|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4425490|NCT00161213|4249180|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425491|NCT00160706|4249187|B1|New Zealand||Region of Enrollment||participants|Number|10|10.0||||||
4425492|NCT00160706|4249187|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4425493|NCT00160706|4249187|B1|Norway||Region of Enrollment||participants|Number|7|7.0||||||
4425494|NCT00160706|4249187|B1|Bulgaria||Region of Enrollment||participants|Number|1|1.0||||||
4425495|NCT00160706|4249187|B1|South Africa||Region of Enrollment||participants|Number|31|31.0||||||
4425496|NCT00160706|4249187|B1|Denmark||Region of Enrollment||participants|Number|11|11.0||||||
4425497|NCT00160706|4249187|B1|Australia||Region of Enrollment||participants|Number|43|43.0||||||
4425498|NCT00160706|4249187|B1|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4425499|NCT00160706|4249187|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4425500|NCT00160706|4249187|B1|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4425501|NCT00160706|4249187|B1|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4425502|NCT00160706|4249187|B1|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
4425503|NCT00160706|4249187|B1|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
4425504|NCT00160706|4249187|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4425505|NCT00160706|4249187|B1|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4425506|NCT00160706|4249187|B1|Russian Federation||Region of Enrollment||participants|Number|17|17.0||||||
4425507|NCT00160706|4249187|B1|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4425508|NCT00160706|4249187|B1|Ukraine||Region of Enrollment||participants|Number|3|3.0||||||
4425509|NCT00160706|4249187|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4425510|NCT00160706|4249187|B1|Slovenia||Region of Enrollment||participants|Number|3|3.0||||||
4425511|NCT00160706|4249187|B1|Estonia||Region of Enrollment||participants|Number|5|5.0||||||
4425512|NCT00160706|4249187|B1|Belarus||Region of Enrollment||participants|Number|2|2.0||||||
4425513|NCT00160706|4249187|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
4425514|NCT00160706|4249187|B1|Serbia||Region of Enrollment||participants|Number|4|4.0||||||
4425515|NCT00160706|4249187|B1||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4425516|NCT00160706|4249187|B1||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4425517|NCT00160706|4249187|B1|||Age||years|Mean|36.5|36.5|Standard Deviation|11.67|11.67|||
4425518|NCT00160706|4249187|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4425519|NCT00160706|4249187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|299|299.0||||||
4425520|NCT00160706|4249187|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4425521|NCT00160693|4249199|B1|||Disease Duration||years|Mean|9.46|9.46|Standard Deviation|8.13|8.13|||
4425522|NCT00160693|4249199|B1|||Body Mass Index (BMI)|The BMI was calculated as: Weight (kg)/(Height(cm)/100)^2|kilogram/ meter^2 (kg / m^2)|Mean|28.20|28.2|Standard Deviation|6.34|6.34|||
4425523|NCT00160693|4249199|B1|||Height||centimeter (cm)|Mean|166.4|166.4|Standard Deviation|8.6|8.6|||
4425524|NCT00160693|4249199|B1|||Weight||kilogram (kg)|Mean|78.00|78.0|Standard Deviation|17.88|17.88|||
4425525|NCT00160693|4249199|B1|United Kingdom||Region of Enrollment||participants|Number|36|36.0||||||
4425526|NCT00160693|4249199|B1|Germany||Region of Enrollment||participants|Number|87|87.0||||||
4425527|NCT00160693|4249199|B1|Austria||Region of Enrollment||participants|Number|19|19.0||||||
4425528|NCT00160693|4249199|B1|Ireland||Region of Enrollment||participants|Number|8|8.0||||||
4425529|NCT00160693|4249199|B1|Belgium||Region of Enrollment||participants|Number|11|11.0||||||
4425530|NCT00160693|4249199|B1|Czech Republic||Region of Enrollment||participants|Number|81|81.0||||||
4425531|NCT00160693|4249199|B1|United States||Region of Enrollment||participants|Number|160|160.0||||||
4425532|NCT00160693|4249199|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4425533|NCT00160693|4249199|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425534|NCT00160693|4249199|B1||White|Race (NIH/OMB)||Participants|Count of Participants|363|363.0||||||
4425535|NCT00160693|4249199|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4425536|NCT00160693|4249199|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425537|NCT00160693|4249199|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4425538|NCT00160693|4249199|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425539|NCT00160693|4249199|B1||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4425540|NCT00160693|4249199|B1||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4425541|NCT00160693|4249199|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|12.1|12.1|||
4425542|NCT00160693|4249199|B1||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4425543|NCT00160693|4249199|B1||Between 18 and 65 years|Age||Participants|Count of Participants|327|327.0||||||
4425544|NCT00160693|4249199|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425545|NCT00160641|4249216|B1|||Height||centimeter (cm)|Mean|165.23|165.23|Standard Deviation|8.16|8.16|||
4425546|NCT00160641|4249216|B1|||Weight||kilogram (kg)|Mean|72.37|72.37|Standard Deviation|14.86|14.86|||
4425547|NCT00160641|4249216|B1|Latvia||Region of Enrollment||participants|Number|12|12.0||||||
4425548|NCT00160641|4249216|B1|Bulgaria||Region of Enrollment||participants|Number|14|14.0||||||
4425549|NCT00160641|4249216|B1|Croatia||Region of Enrollment||participants|Number|10|10.0||||||
4425550|NCT00160641|4249216|B1|Poland||Region of Enrollment||participants|Number|86|86.0||||||
4425551|NCT00160641|4249216|B1|Czech Republic||Region of Enrollment||participants|Number|93|93.0||||||
4425552|NCT00160641|4249216|B1|Russian Federation||Region of Enrollment||participants|Number|105|105.0||||||
4425553|NCT00160641|4249216|B1|Israel||Region of Enrollment||participants|Number|17|17.0||||||
4425554|NCT00160641|4249216|B1|Lithuania||Region of Enrollment||participants|Number|43|43.0||||||
4425555|NCT00160641|4249216|B1|Ukraine||Region of Enrollment||participants|Number|70|70.0||||||
4425556|NCT00160641|4249216|B1|Slovakia||Region of Enrollment||participants|Number|30|30.0||||||
4425557|NCT00160641|4249216|B1|Estonia||Region of Enrollment||participants|Number|6|6.0||||||
4425558|NCT00160641|4249216|B1|Serbia||Region of Enrollment||participants|Number|46|46.0||||||
4425559|NCT00160641|4249216|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4425560|NCT00160641|4249216|B1||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4425561|NCT00160641|4249216|B1||Female|Sex: Female, Male||Participants|Count of Participants|463|463.0||||||
4425562|NCT00160641|4249216|B1|||Age||years|Mean|51.6|51.6|Standard Deviation|11.6|11.6|||
4425563|NCT00160641|4249216|B1||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4425564|NCT00160641|4249216|B1||Between 18 and 65 years|Age||Participants|Count of Participants|486|486.0||||||
4425565|NCT00160641|4249216|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425566|NCT00160563|4249247|B4|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4425567|NCT00160563|4249248|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4425568|NCT00160563|4249249|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4425569|NCT00160563|4249250|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4425570|NCT00160563|4249247|B4|Italy||Region of Enrollment||participants|Number|26|26.0||||||
4425571|NCT00160563|4249248|B3|Italy||Region of Enrollment||participants|Number|13|13.0||||||
4425572|NCT00160563|4249249|B2|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4425573|NCT00160563|4249250|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4425574|NCT00160563|4249247|B4|Germany||Region of Enrollment||participants|Number|26|26.0||||||
4425575|NCT00160563|4249248|B3|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4425576|NCT00160563|4249249|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4425577|NCT00160563|4249250|B1|Germany||Region of Enrollment||participants|Number|9|9.0||||||
4425578|NCT00160563|4249247|B4|South Africa||Region of Enrollment||participants|Number|47|47.0||||||
4425579|NCT00160563|4249248|B3|South Africa||Region of Enrollment||participants|Number|22|22.0||||||
4425580|NCT00160563|4249249|B2|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4425581|NCT00160563|4249250|B1|South Africa||Region of Enrollment||participants|Number|15|15.0||||||
4425582|NCT00160563|4249247|B4|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4425583|NCT00160563|4249248|B3|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4425584|NCT00160563|4249249|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4425585|NCT00160563|4249250|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4425586|NCT00160563|4249247|B4|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4425587|NCT00160563|4249248|B3|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4425588|NCT00160563|4249249|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4425589|NCT00160563|4249250|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4425590|NCT00160563|4249247|B4|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4425591|NCT00160563|4249248|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4425592|NCT00160563|4249249|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4425593|NCT00160563|4249250|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4425594|NCT00160563|4249247|B4|Poland||Region of Enrollment||participants|Number|38|38.0||||||
4425595|NCT00160563|4249248|B3|Poland||Region of Enrollment||participants|Number|18|18.0||||||
4425596|NCT00160563|4249249|B2|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4425597|NCT00160563|4249250|B1|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4425598|NCT00160563|4249247|B4|Czech Republic||Region of Enrollment||participants|Number|34|34.0||||||
4425599|NCT00160563|4249248|B3|Czech Republic||Region of Enrollment||participants|Number|17|17.0||||||
4425600|NCT00160563|4249249|B2|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
4425601|NCT00160563|4249250|B1|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
4425602|NCT00160563|4249247|B4|France||Region of Enrollment||participants|Number|14|14.0||||||
4425603|NCT00160563|4249248|B3|France||Region of Enrollment||participants|Number|9|9.0||||||
4425604|NCT00160563|4249249|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4425605|NCT00160563|4249250|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4425606|NCT00160563|4249247|B4||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4425607|NCT00160563|4249248|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4425608|NCT00160563|4249249|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4425609|NCT00160563|4249250|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4425610|NCT00160563|4249247|B4||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4425611|NCT00160563|4249248|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4425612|NCT00160563|4249249|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4425613|NCT00160563|4249250|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4425614|NCT00160563|4249247|B4|||Age||months|Mean|19.2|19.2|Standard Deviation|3.94|3.94|||
4425615|NCT00160563|4249248|B3|||Age||months|Mean|19.2|19.2|Standard Deviation|4.10|4.1|||
4425616|NCT00160563|4249249|B2|||Age||months|Mean|18.9|18.9|Standard Deviation|4.08|4.08|||
4425617|NCT00160563|4249250|B1|||Age||months|Mean|19.6|19.6|Standard Deviation|3.58|3.58|||
4425618|NCT00160524|4249264|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4425619|NCT00160524|4249264|B1|New Zealand||Region of Enrollment||participants|Number|10|10.0||||||
4425620|NCT00160524|4249264|B1|Norway||Region of Enrollment||participants|Number|7|7.0||||||
4425621|NCT00160524|4249264|B1|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4425622|NCT00160524|4249264|B1|Bulgaria||Region of Enrollment||participants|Number|20|20.0||||||
4425623|NCT00160524|4249264|B1|Georgia||Region of Enrollment||participants|Number|1|1.0||||||
4425624|NCT00160524|4249264|B1|Singapore||Region of Enrollment||participants|Number|2|2.0||||||
4425625|NCT00160524|4249264|B1|Poland||Region of Enrollment||participants|Number|72|72.0||||||
4425626|NCT00160524|4249264|B1|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4425627|NCT00160524|4249264|B1|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4425628|NCT00160524|4249264|B1|Hungary||Region of Enrollment||participants|Number|48|48.0||||||
4425629|NCT00160524|4249264|B1|Czech Republic||Region of Enrollment||participants|Number|54|54.0||||||
4425630|NCT00160524|4249264|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4425631|NCT00160524|4249264|B1|Lithuania||Region of Enrollment||participants|Number|1|1.0||||||
4425632|NCT00160524|4249264|B1|Slovenia||Region of Enrollment||participants|Number|15|15.0||||||
4425633|NCT00160524|4249264|B1|Latvia||Region of Enrollment||participants|Number|4|4.0||||||
4425634|NCT00160524|4249264|B1|South Africa||Region of Enrollment||participants|Number|45|45.0||||||
4425635|NCT00160524|4249264|B1|Australia||Region of Enrollment||participants|Number|30|30.0||||||
4425636|NCT00160524|4249264|B1|Denmark||Region of Enrollment||participants|Number|21|21.0||||||
4425637|NCT00160524|4249264|B1|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4425638|NCT00160524|4249264|B1|Russian Federation||Region of Enrollment||participants|Number|22|22.0||||||
4425639|NCT00160524|4249264|B1|Israel||Region of Enrollment||participants|Number|13|13.0||||||
4425640|NCT00160524|4249264|B1|Ukraine||Region of Enrollment||participants|Number|18|18.0||||||
4425641|NCT00160524|4249264|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4425642|NCT00160524|4249264|B1|Hong Kong||Region of Enrollment||participants|Number|2|2.0||||||
4425643|NCT00160524|4249264|B1|Estonia||Region of Enrollment||participants|Number|4|4.0||||||
4425644|NCT00160524|4249264|B1|Serbia||Region of Enrollment||participants|Number|29|29.0||||||
4425645|NCT00160524|4249264|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
4425646|NCT00160524|4249264|B1|Belarus||Region of Enrollment||participants|Number|12|12.0||||||
4425647|NCT00160524|4249264|B1||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4425648|NCT00160524|4249264|B1||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4425649|NCT00160524|4249264|B1|||Age||years|Mean|38.1|38.1|Standard Deviation|11.87|11.87|||
4425650|NCT00160524|4249264|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4425651|NCT00160524|4249264|B1||Between 18 and 65 years|Age||Participants|Count of Participants|574|574.0||||||
4425652|NCT00160524|4249264|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4425653|NCT00160251|4249275|B7||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4425654|NCT00160251|4249276|B6||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4425655|NCT00160251|4249277|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4425656|NCT00160251|4249278|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4425657|NCT00160251|4249279|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4425658|NCT00160251|4249280|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4425659|NCT00160251|4249281|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4425660|NCT00160251|4249275|B7||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4425661|NCT00160251|4249276|B6||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4425662|NCT00160251|4249277|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4425663|NCT00160251|4249278|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4425664|NCT00160251|4249279|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4425665|NCT00160251|4249280|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4425666|NCT00160251|4249281|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4425667|NCT00160251|4249275|B7|||Age||years|Mean|49.5|49.5|Standard Deviation|8.6|8.6|||
4425668|NCT00160251|4249276|B6|||Age||years|Mean|50.4|50.4|Standard Deviation|7.3|7.3|||
4425669|NCT00160251|4249277|B5|||Age||years|Mean|49.2|49.2|Standard Deviation|8.7|8.7|||
4425670|NCT00160251|4249278|B4|||Age||years|Mean|48.2|48.2|Standard Deviation|8.9|8.9|||
4425671|NCT00160251|4249279|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|9.4|9.4|||
4425672|NCT00160251|4249280|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|7.0|7.0|||
4425673|NCT00160251|4249281|B1|||Age||years|Mean|48.9|48.9|Standard Deviation|9.7|9.7|||
4425674|NCT00160199|4249362|B3|United States||Region of Enrollment|The participant flow chart was done on all Randomized subjects set (i.e. subjects who received at least one dose of open-label study medication) . The baseline results are presented on the Full Analysis set (i.e. subjects randomized with at least one post-baseline evaluable efficacy assessment).|participants|Number|206|206.0||||||
4425675|NCT00160199|4249363|B2|United States||Region of Enrollment|The participant flow chart was done on all Randomized subjects set (i.e. subjects who received at least one dose of open-label study medication) . The baseline results are presented on the Full Analysis set (i.e. subjects randomized with at least one post-baseline evaluable efficacy assessment).|participants|Number|99|99.0||||||
4425676|NCT00160199|4249364|B1|United States||Region of Enrollment|The participant flow chart was done on all Randomized subjects set (i.e. subjects who received at least one dose of open-label study medication) . The baseline results are presented on the Full Analysis set (i.e. subjects randomized with at least one post-baseline evaluable efficacy assessment).|participants|Number|107|107.0||||||
4425677|NCT00160199|4249362|B3||Male|Sex: Female, Male|The participant flow chart was done on all Randomized subjects set (i.e. subjects who received at least one dose of open-label study medication) . The baseline results are presented on the Full Analysis set (i.e. subjects randomized with at least one post-baseline evaluable efficacy assessment).|Participants|Count of Participants|0|0.0||||||
4425678|NCT00160199|4249363|B2||Male|Sex: Female, Male|The participant flow chart was done on all Randomized subjects set (i.e. subjects who received at least one dose of open-label study medication) . The baseline results are presented on the Full Analysis set (i.e. subjects randomized with at least one post-baseline evaluable efficacy assessment).|Participants|Count of Participants|0|0.0||||||
4425679|NCT00160199|4249364|B1||Male|Sex: Female, Male|The participant flow chart was done on all Randomized subjects set (i.e. subjects who received at least one dose of open-label study medication) . The baseline results are presented on the Full Analysis set (i.e. subjects randomized with at least one post-baseline evaluable efficacy assessment).|Participants|Count of Participants|0|0.0||||||
4425680|NCT00160199|4249362|B3||Female|Sex: Female, Male|The participant flow chart was done on all Randomized subjects set (i.e. subjects who received at least one dose of open-label study medication) . The baseline results are presented on the Full Analysis set (i.e. subjects randomized with at least one post-baseline evaluable efficacy assessment).|Participants|Count of Participants|206|206.0||||||
4425681|NCT00160199|4249363|B2||Female|Sex: Female, Male|The participant flow chart was done on all Randomized subjects set (i.e. subjects who received at least one dose of open-label study medication) . The baseline results are presented on the Full Analysis set (i.e. subjects randomized with at least one post-baseline evaluable efficacy assessment).|Participants|Count of Participants|99|99.0||||||
4425682|NCT00160199|4249364|B1||Female|Sex: Female, Male|The participant flow chart was done on all Randomized subjects set (i.e. subjects who received at least one dose of open-label study medication) . The baseline results are presented on the Full Analysis set (i.e. subjects randomized with at least one post-baseline evaluable efficacy assessment).|Participants|Count of Participants|107|107.0||||||
4425683|NCT00160199|4249362|B3|||Age|The participant flow chart was done on all Randomized subjects set (i.e. subjects who received at least one dose of open-label study medication) . The baseline results are presented on the Full Analysis set (i.e. subjects randomized with at least one post-baseline evaluable efficacy assessment).|years|Mean|29.0|29.0|Standard Deviation|6.49|6.49|||
4425684|NCT00160199|4249363|B2|||Age|The participant flow chart was done on all Randomized subjects set (i.e. subjects who received at least one dose of open-label study medication) . The baseline results are presented on the Full Analysis set (i.e. subjects randomized with at least one post-baseline evaluable efficacy assessment).|years|Mean|28.7|28.7|Standard Deviation|6.35|6.35|||
4425685|NCT00160199|4249364|B1|||Age|The participant flow chart was done on all Randomized subjects set (i.e. subjects who received at least one dose of open-label study medication) . The baseline results are presented on the Full Analysis set (i.e. subjects randomized with at least one post-baseline evaluable efficacy assessment).|years|Mean|29.2|29.2|Standard Deviation|6.63|6.63|||
4425686|NCT00159965|4249383|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4425687|NCT00159965|4249384|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4425688|NCT00159965|4249385|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4425689|NCT00159965|4249383|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4425690|NCT00159965|4249384|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4425691|NCT00159965|4249385|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4425692|NCT00159965|4249383|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4425693|NCT00159965|4249384|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4425694|NCT00159965|4249385|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4425695|NCT00159965|4249383|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|13.2|13.2|||
4425696|NCT00159965|4249384|B2|||Age||years|Mean|34.4|34.4|Standard Deviation|12.6|12.6|||
4425697|NCT00159965|4249385|B1|||Age||years|Mean|38|38.0|Standard Deviation|13.9|13.9|||
4425698|NCT00159965|4249383|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425699|NCT00159965|4249384|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425700|NCT00159965|4249385|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425701|NCT00159965|4249383|B3||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4425702|NCT00159965|4249384|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4425703|NCT00159965|4249385|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4425704|NCT00159965|4249383|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425705|NCT00159965|4249384|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425706|NCT00159965|4249385|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425707|NCT00159913|4249418|B5||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4425708|NCT00159913|4249419|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4425709|NCT00159913|4249420|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4425710|NCT00159913|4249421|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4425711|NCT00159913|4249422|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4425712|NCT00159913|4249418|B5||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4425713|NCT00159913|4249419|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4425714|NCT00159913|4249420|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4425715|NCT00159913|4249421|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4425716|NCT00159913|4249422|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4425717|NCT00159913|4249418|B5|>= 18 Years||Age, Customized||participants|Number|0|0.0||||||
4425718|NCT00159913|4249419|B4|>= 18 Years||Age, Customized||participants|Number|0|0.0||||||
4425719|NCT00159913|4249420|B3|>= 18 Years||Age, Customized||participants|Number|0|0.0||||||
4425720|NCT00159913|4249421|B2|>= 18 Years||Age, Customized||participants|Number|0|0.0||||||
4425721|NCT00159913|4249422|B1|>= 18 Years||Age, Customized||participants|Number|0|0.0||||||
4425722|NCT00159913|4249418|B5|13-17 Years||Age, Customized||participants|Number|73|73.0||||||
4425723|NCT00159913|4249419|B4|13-17 Years||Age, Customized||participants|Number|16|16.0||||||
4425724|NCT00159913|4249420|B3|13-17 Years||Age, Customized||participants|Number|22|22.0||||||
4425725|NCT00159913|4249421|B2|13-17 Years||Age, Customized||participants|Number|18|18.0||||||
4425726|NCT00159913|4249422|B1|13-17 Years||Age, Customized||participants|Number|17|17.0||||||
4425727|NCT00159913|4249418|B5|5-12 Years||Age, Customized||participants|Number|126|126.0||||||
4425728|NCT00159913|4249419|B4|5-12 Years||Age, Customized||participants|Number|37|37.0||||||
4425729|NCT00159913|4249420|B3|5-12 Years||Age, Customized||participants|Number|36|36.0||||||
4425730|NCT00159913|4249421|B2|5-12 Years||Age, Customized||participants|Number|28|28.0||||||
4425731|NCT00159913|4249422|B1|5-12 Years||Age, Customized||participants|Number|25|25.0||||||
4425732|NCT00159913|4249418|B5|1-4 Years||Age, Customized||participants|Number|35|35.0||||||
4425733|NCT00159913|4249419|B4|1-4 Years||Age, Customized||participants|Number|7|7.0||||||
4425734|NCT00159913|4249420|B3|1-4 Years||Age, Customized||participants|Number|19|19.0||||||
4425735|NCT00159913|4249421|B2|1-4 Years||Age, Customized||participants|Number|9|9.0||||||
4425736|NCT00159913|4249422|B1|1-4 Years||Age, Customized||participants|Number|0|0.0||||||
4425737|NCT00159874|4249492|B8||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4425738|NCT00159874|4249493|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4425739|NCT00159874|4249494|B6||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4425740|NCT00159874|4249495|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4425741|NCT00159874|4249496|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4425742|NCT00159874|4249497|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4425743|NCT00159874|4249498|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4425744|NCT00159874|4249499|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4425745|NCT00159874|4249492|B8||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4425746|NCT00159874|4249493|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4425747|NCT00159874|4249494|B6||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4425748|NCT00159874|4249495|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4425749|NCT00159874|4249496|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4425750|NCT00159874|4249497|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4425751|NCT00159874|4249498|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4425752|NCT00159874|4249499|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4425753|NCT00159874|4249492|B8|>=18||Age, Customized||Participants|Number|0|0.0||||||
4425754|NCT00159874|4249493|B7|>=18||Age, Customized||Participants|Number|0|0.0||||||
4425755|NCT00159874|4249494|B6|>=18||Age, Customized||Participants|Number|0|0.0||||||
4425756|NCT00159874|4249495|B5|>=18||Age, Customized||Participants|Number|0|0.0||||||
4425757|NCT00159874|4249496|B4|>=18||Age, Customized||Participants|Number|0|0.0||||||
4425758|NCT00159874|4249497|B3|>=18||Age, Customized||Participants|Number|0|0.0||||||
4425759|NCT00159874|4249498|B2|>=18||Age, Customized||Participants|Number|0|0.0||||||
4425760|NCT00159874|4249499|B1|>=18||Age, Customized||Participants|Number|0|0.0||||||
4425761|NCT00159874|4249492|B8|13-17||Age, Customized||Participants|Number|73|73.0||||||
4425762|NCT00159874|4249493|B7|13-17||Age, Customized||Participants|Number|2|2.0||||||
4425763|NCT00159874|4249494|B6|13-17||Age, Customized||Participants|Number|7|7.0||||||
4425764|NCT00159874|4249495|B5|13-17||Age, Customized||Participants|Number|6|6.0||||||
4425765|NCT00159874|4249496|B4|13-17||Age, Customized||Participants|Number|1|1.0||||||
4425766|NCT00159874|4249497|B3|13-17||Age, Customized||Participants|Number|22|22.0||||||
4425767|NCT00159874|4249498|B2|13-17||Age, Customized||Participants|Number|18|18.0||||||
4425768|NCT00159874|4249499|B1|13-17||Age, Customized||Participants|Number|17|17.0||||||
4425769|NCT00159874|4249492|B8|5-12||Age, Customized||Participants|Number|126|126.0||||||
4425770|NCT00159874|4249493|B7|5-12||Age, Customized||Participants|Number|2|2.0||||||
4425771|NCT00159874|4249494|B6|5-12||Age, Customized||Participants|Number|14|14.0||||||
4425772|NCT00159874|4249495|B5|5-12||Age, Customized||Participants|Number|10|10.0||||||
4425773|NCT00159874|4249496|B4|5-12||Age, Customized||Participants|Number|11|11.0||||||
4425774|NCT00159874|4249497|B3|5-12||Age, Customized||Participants|Number|36|36.0||||||
4425775|NCT00159874|4249498|B2|5-12||Age, Customized||Participants|Number|28|28.0||||||
4425776|NCT00159874|4249499|B1|5-12||Age, Customized||Participants|Number|25|25.0||||||
4425777|NCT00159874|4249492|B8|1-4||Age, Customized||Participants|Number|35|35.0||||||
4425778|NCT00159874|4249493|B7|1-4||Age, Customized||Participants|Number|1|1.0||||||
4425779|NCT00159874|4249494|B6|1-4||Age, Customized||Participants|Number|2|2.0||||||
4425780|NCT00159874|4249495|B5|1-4||Age, Customized||Participants|Number|3|3.0||||||
4425781|NCT00159874|4249496|B4|1-4||Age, Customized||Participants|Number|1|1.0||||||
4425782|NCT00159874|4249497|B3|1-4||Age, Customized||Participants|Number|19|19.0||||||
4425783|NCT00159874|4249498|B2|1-4||Age, Customized||Participants|Number|9|9.0||||||
4425784|NCT00159874|4249499|B1|1-4||Age, Customized||Participants|Number|0|0.0||||||
4425785|NCT00159861|4249673|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4425786|NCT00159861|4249674|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4425787|NCT00159861|4249675|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4425788|NCT00159861|4249673|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4425789|NCT00159861|4249674|B2||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4425790|NCT00159861|4249675|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4425791|NCT00159861|4249673|B3|>= 65 years||Age, Customized||participants|Number|27|27.0||||||
4425792|NCT00159861|4249674|B2|>= 65 years||Age, Customized||participants|Number|16|16.0||||||
4425793|NCT00159861|4249675|B1|>= 65 years||Age, Customized||participants|Number|11|11.0||||||
4425794|NCT00159861|4249673|B3|45 to 64 years||Age, Customized||participants|Number|137|137.0||||||
4425795|NCT00159861|4249674|B2|45 to 64 years||Age, Customized||participants|Number|64|64.0||||||
4425796|NCT00159861|4249675|B1|45 to 64 years||Age, Customized||participants|Number|73|73.0||||||
4425797|NCT00159861|4249673|B3|18 to 44 years||Age, Customized||participants|Number|101|101.0||||||
4425798|NCT00159861|4249674|B2|18 to 44 years||Age, Customized||participants|Number|54|54.0||||||
4425799|NCT00159861|4249675|B1|18 to 44 years||Age, Customized||participants|Number|47|47.0||||||
4425800|NCT00159822|4249697|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4425801|NCT00159822|4249697|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4425802|NCT00159822|4249697|B1|||Age||years|Mean|57.27|57.27|Standard Deviation|13.85|13.85|||
4425803|NCT00159783|4249712|B4||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4425804|NCT00159783|4249713|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4425805|NCT00159783|4249714|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4425806|NCT00159783|4249715|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4425807|NCT00159783|4249712|B4||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4425808|NCT00159783|4249713|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4425809|NCT00159783|4249714|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4425810|NCT00159783|4249715|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4425811|NCT00159783|4249712|B4||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4425812|NCT00159783|4249713|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4425813|NCT00159783|4249714|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4425814|NCT00159783|4249715|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4425815|NCT00159783|4249712|B4||Between 18 and 65 years|Age||Participants|Count of Participants|214|214.0||||||
4425816|NCT00159783|4249713|B3||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4425817|NCT00159783|4249714|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4425818|NCT00159783|4249715|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4425819|NCT00159783|4249712|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425820|NCT00159783|4249713|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425821|NCT00159783|4249714|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425822|NCT00159783|4249715|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425823|NCT00159432|4249747|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4425824|NCT00159432|4249747|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4425825|NCT00159432|4249747|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425826|NCT00159432|4249747|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4425827|NCT00159432|4249747|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4425828|NCT00159432|4249747|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425829|NCT00159432|4249747|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4425830|NCT00159432|4249747|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425831|NCT00159432|4249747|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425832|NCT00159432|4249747|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4425833|NCT00159432|4249747|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4425834|NCT00159432|4249747|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4425835|NCT00159432|4249747|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4425836|NCT00159432|4249747|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4425837|NCT00159432|4249747|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4425838|NCT00159432|4249747|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425839|NCT00159419|4249752|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4425840|NCT00159419|4249753|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4425841|NCT00159419|4249754|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4425842|NCT00159419|4249752|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4425843|NCT00159419|4249753|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4425844|NCT00159419|4249754|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4425845|NCT00159419|4249752|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4425846|NCT00159419|4249753|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4425847|NCT00159419|4249754|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4425848|NCT00159419|4249752|B3|||Age||years|Mean|8.7|8.7|Full Range|||3.0|13.7|
4425849|NCT00159419|4249753|B2|||Age||years|Mean|9.0|9.0|Full Range|||3.8|12.7|
4425850|NCT00159419|4249754|B1|||Age||years|Mean|8.4|8.4|Full Range|||3.0|13.7|
4425851|NCT00159419|4249752|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425852|NCT00159419|4249753|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425853|NCT00159419|4249754|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425854|NCT00159419|4249752|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4425855|NCT00159419|4249753|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4425856|NCT00159419|4249754|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4425857|NCT00159419|4249752|B3||<=18 years|Age||Participants|Count of Participants|18|18.0||||||
4425858|NCT00159419|4249753|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4425859|NCT00159419|4249754|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4425860|NCT00158925|4249761|B1|Sweden||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4425861|NCT00158925|4249761|B1|Canada||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4425862|NCT00158925|4249761|B1|United States||Region of Enrollment||Participants|Count of Participants|88|88.0||||||
4425863|NCT00158925|4249761|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4425864|NCT00158925|4249761|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4425865|NCT00158925|4249761|B1|||Age||years|Mean|68.1|68.1|Standard Deviation|12.6|12.6|||
4425866|NCT00158756|4249769|B6||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4425867|NCT00158756|4249770|B5||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4425868|NCT00158756|4249771|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4425869|NCT00158756|4249772|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4425870|NCT00158756|4249773|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4425871|NCT00158756|4249774|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4425872|NCT00158756|4249769|B6||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4425873|NCT00158756|4249770|B5||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4425874|NCT00158756|4249771|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4425875|NCT00158756|4249772|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4425876|NCT00158756|4249773|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4425877|NCT00158756|4249774|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4425878|NCT00158756|4249769|B6|||Age||Weeks|Mean|12.93|12.93|Standard Deviation|1.51|1.51|||
4425879|NCT00158756|4249770|B5|||Age||Weeks|Mean|12.9|12.9|Standard Deviation|1.33|1.33|||
4425880|NCT00158756|4249771|B4|||Age||Weeks|Mean|12.8|12.8|Standard Deviation|1.56|1.56|||
4425881|NCT00158756|4249772|B3|||Age||Weeks|Mean|12.8|12.8|Standard Deviation|1.39|1.39|||
4425882|NCT00158756|4249773|B2|||Age||Weeks|Mean|13.4|13.4|Standard Deviation|1.87|1.87|||
4425883|NCT00158756|4249774|B1|||Age||Weeks|Mean|13.0|13.0|Standard Deviation|1.70|1.7|||
4425884|NCT00158743|4249873|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425885|NCT00158743|4249874|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425886|NCT00158743|4249875|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425887|NCT00158743|4249873|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4425888|NCT00158743|4249874|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4425889|NCT00158743|4249875|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4425890|NCT00158743|4249873|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4425891|NCT00158743|4249874|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4425892|NCT00158743|4249875|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4425893|NCT00158743|4249873|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4425894|NCT00158743|4249874|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4425895|NCT00158743|4249875|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4425896|NCT00158743|4249873|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425897|NCT00158743|4249874|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425898|NCT00158743|4249875|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425899|NCT00158743|4249873|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425900|NCT00158743|4249874|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425901|NCT00158743|4249875|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425902|NCT00158743|4249873|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425903|NCT00158743|4249874|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425904|NCT00158743|4249875|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425905|NCT00158743|4249873|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4425906|NCT00158743|4249874|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4425907|NCT00158743|4249875|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4425908|NCT00158743|4249873|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4425909|NCT00158743|4249874|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4425910|NCT00158743|4249875|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4425911|NCT00158743|4249873|B3|||Age||years|Mean|26|26.0|Standard Deviation|6.6|6.6|||
4425912|NCT00158743|4249874|B2|||Age||years|Mean|26|26.0|Standard Deviation|6.2|6.2|||
4425913|NCT00158743|4249875|B1|||Age||years|Mean|26|26.0|Standard Deviation|7.1|7.1|||
4425914|NCT00158600|4249882|B3|Unknown or not reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4425915|NCT00158600|4249883|B2|Unknown or not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425916|NCT00158600|4249884|B1|Unknown or not reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425917|NCT00158600|4249882|B3|White||Race/Ethnicity, Customized||participants|Number|84|84.0||||||
4425918|NCT00158600|4249883|B2|White||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4425919|NCT00158600|4249884|B1|White||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4425920|NCT00158600|4249882|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425921|NCT00158600|4249883|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425922|NCT00158600|4249884|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4425923|NCT00158600|4249882|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4425924|NCT00158600|4249883|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425925|NCT00158600|4249884|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425926|NCT00158600|4249882|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4425927|NCT00158600|4249883|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425928|NCT00158600|4249884|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4425929|NCT00158600|4249882|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4425930|NCT00158600|4249883|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4425931|NCT00158600|4249884|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4425932|NCT00158600|4249882|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4425933|NCT00158600|4249883|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4425934|NCT00158600|4249884|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4425935|NCT00158600|4249882|B3|||Age|Age at First Infusion|years|Mean|44.4|44.4|Standard Deviation|12.14|12.14|||
4425936|NCT00158600|4249883|B2|||Age|Age at First Infusion|years|Mean|42.6|42.6|Standard Deviation|11.63|11.63|||
4425937|NCT00158600|4249884|B1|||Age|Age at First Infusion|years|Mean|45.3|45.3|Standard Deviation|12.37|12.37|||
4425938|NCT00158379|4249903|B1|Germany||Region of Enrollment||participants|Number|105|105.0||||||
4425939|NCT00158379|4249903|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4425940|NCT00158379|4249903|B1||Female|Gender||Participants|Count of Participants|105|105.0||||||
4425941|NCT00158379|4249903|B1|||Age||years|Median|60.4|60.4|Full Range|||23.4|80.3|
4425942|NCT00158262|4249908|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4425943|NCT00158262|4249909|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4425944|NCT00158262|4249910|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4425945|NCT00158262|4249908|B3|Male||Sex/Gender, Customized||participants|Number|24|24.0||||||
4425946|NCT00158262|4249909|B2|Male||Sex/Gender, Customized||participants|Number|11|11.0||||||
4425947|NCT00158262|4249910|B1|Male||Sex/Gender, Customized||participants|Number|13|13.0||||||
4425948|NCT00158262|4249908|B3|Female||Sex/Gender, Customized||participants|Number|17|17.0||||||
4425949|NCT00158262|4249909|B2|Female||Sex/Gender, Customized||participants|Number|10|10.0||||||
4425950|NCT00158262|4249910|B1|Female||Sex/Gender, Customized||participants|Number|7|7.0||||||
4425951|NCT00158262|4249908|B3|||Age||years|Mean|33.6|33.6|Standard Deviation|10.2|10.2|||
4425952|NCT00158262|4249909|B2|||Age||years|Mean|33.3|33.3|Standard Deviation|11.0|11.0|||
4425953|NCT00158262|4249910|B1|||Age||years|Mean|33.8|33.8|Standard Deviation|9.4|9.4|||
4425954|NCT00158262|4249908|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425955|NCT00158262|4249909|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425956|NCT00158262|4249910|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4425957|NCT00158262|4249908|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4425958|NCT00158262|4249909|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4425959|NCT00158262|4249910|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4425960|NCT00158262|4249908|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425961|NCT00158262|4249909|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425962|NCT00158262|4249910|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4425963|NCT00158249|4249921|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4425964|NCT00158249|4249922|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4425965|NCT00158249|4249923|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4425966|NCT00158249|4249921|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425967|NCT00158249|4249922|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425968|NCT00158249|4249923|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425969|NCT00158249|4249921|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4425970|NCT00158249|4249922|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4425971|NCT00158249|4249923|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4425972|NCT00158249|4249921|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4425973|NCT00158249|4249922|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4425974|NCT00158249|4249923|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4425975|NCT00158249|4249921|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425976|NCT00158249|4249922|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425977|NCT00158249|4249923|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425978|NCT00158249|4249921|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4425979|NCT00158249|4249922|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4425980|NCT00158249|4249923|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4425981|NCT00158249|4249921|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4425982|NCT00158249|4249922|B2||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4425983|NCT00158249|4249923|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4425984|NCT00158249|4249921|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4425985|NCT00158249|4249922|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4425986|NCT00158249|4249923|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4425987|NCT00158249|4249921|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425988|NCT00158249|4249922|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425989|NCT00158249|4249923|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425990|NCT00158249|4249921|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425991|NCT00158249|4249922|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425992|NCT00158249|4249923|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425993|NCT00158249|4249921|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425994|NCT00158249|4249922|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425995|NCT00158249|4249923|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4425996|NCT00158249|4249921|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4425997|NCT00158249|4249922|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4425998|NCT00158249|4249923|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4425999|NCT00158249|4249921|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4426000|NCT00158249|4249922|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426001|NCT00158249|4249923|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4426002|NCT00158249|4249921|B3|||Age||years|Mean|29.0|29.0|Standard Deviation|7.0|7.0|||
4426003|NCT00158249|4249922|B2|||Age||years|Mean|27.7|27.7|Standard Deviation|6.9|6.9|||
4426004|NCT00158249|4249923|B1|||Age||years|Mean|30.4|30.4|Standard Deviation|7.2|7.2|||
4426005|NCT00158223|4249932|B3|Outpatient||Treatment Setting||participants|Number|19|19.0||||||
4426006|NCT00158223|4249933|B2|Outpatient||Treatment Setting||participants|Number|10|10.0||||||
4426007|NCT00158223|4249934|B1|Outpatient||Treatment Setting||participants|Number|9|9.0||||||
4426008|NCT00158223|4249932|B3|Inpatient||Treatment Setting||participants|Number|34|34.0||||||
4426009|NCT00158223|4249933|B2|Inpatient||Treatment Setting||participants|Number|15|15.0||||||
4426010|NCT00158223|4249934|B1|Inpatient||Treatment Setting||participants|Number|19|19.0||||||
4426011|NCT00158223|4249932|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4426012|NCT00158223|4249933|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4426013|NCT00158223|4249934|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4426014|NCT00158223|4249932|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4426015|NCT00158223|4249933|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4426016|NCT00158223|4249934|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4426017|NCT00158223|4249932|B3|||Age||years|Mean|44.9|44.9|Standard Deviation|9.5|9.5|||
4426018|NCT00158223|4249933|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|10.2|10.2|||
4426019|NCT00158223|4249934|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|8.7|8.7|||
4426020|NCT00158197|4249945|B5|United States||Region of Enrollment||participants|Number|119|119.0||||||
4426021|NCT00158197|4249946|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
4426022|NCT00158197|4249947|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4426023|NCT00158197|4249948|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4426024|NCT00158197|4249949|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4426025|NCT00158197|4249945|B5||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4426026|NCT00158197|4249946|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4426027|NCT00158197|4249947|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4426028|NCT00158197|4249948|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4426029|NCT00158197|4249949|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4426030|NCT00158197|4249945|B5||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4426031|NCT00158197|4249946|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4426032|NCT00158197|4249947|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4426033|NCT00158197|4249948|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4426034|NCT00158197|4249949|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4426035|NCT00158197|4249945|B5|||Age||years|Mean|32|32.0|Standard Deviation|10|10.0|||
4426036|NCT00158197|4249946|B4|||Age||years|Mean|24.8|24.8|Standard Deviation|10.1|10.1|||
4426037|NCT00158197|4249947|B3|||Age||years|Mean|30.3|30.3|Standard Deviation|10.9|10.9|||
4426038|NCT00158197|4249948|B2|||Age||years|Mean|32.5|32.5|Standard Deviation|10|10.0|||
4426039|NCT00158197|4249949|B1|||Age||years|Mean|33.1|33.1|Standard Deviation|8.2|8.2|||
4426040|NCT00158197|4249945|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426041|NCT00158197|4249946|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426042|NCT00158197|4249947|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426043|NCT00158197|4249948|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426044|NCT00158197|4249949|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426045|NCT00158197|4249945|B5||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4426046|NCT00158197|4249946|B4||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4426047|NCT00158197|4249947|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4426048|NCT00158197|4249948|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4426049|NCT00158197|4249949|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4426050|NCT00158197|4249945|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426051|NCT00158197|4249946|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426052|NCT00158197|4249947|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426053|NCT00158197|4249948|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426054|NCT00158197|4249949|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426055|NCT00158184|4249970|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4426056|NCT00158184|4249971|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4426057|NCT00158184|4249972|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4426058|NCT00158184|4249970|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4426059|NCT00158184|4249971|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4426060|NCT00158184|4249972|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4426061|NCT00158184|4249970|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4426062|NCT00158184|4249971|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4426063|NCT00158184|4249972|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4426064|NCT00158184|4249970|B3|||Age||years|Mean|30|30.0|Standard Deviation|7|7.0|||
4426065|NCT00158184|4249971|B2|||Age||years|Mean|28|28.0|Standard Deviation|6|6.0|||
4426066|NCT00158184|4249972|B1|||Age||years|Mean|32|32.0|Standard Deviation|8|8.0|||
4426067|NCT00158054|4249981|B3|||GRACE ACS Risk and Mortality Score|"The GRACE Risk and Mortality score is one tool used to help clinicians assess the future risk of death or myocardial infarction (MI), as a guide to treatment options, in a patient with an acute coronary syndrome (ACS).~Range of values: 2 to 372. Patients are categorized as low risk (score <= 108), medium risk (score between 109 - 140), and high risk (>140 score)."|units on a scale|Mean|93|93.0|Standard Deviation|23|23.0|||
4426068|NCT00158054|4249982|B2|||GRACE ACS Risk and Mortality Score|"The GRACE Risk and Mortality score is one tool used to help clinicians assess the future risk of death or myocardial infarction (MI), as a guide to treatment options, in a patient with an acute coronary syndrome (ACS).~Range of values: 2 to 372. Patients are categorized as low risk (score <= 108), medium risk (score between 109 - 140), and high risk (>140 score)."|units on a scale|Mean|94|94.0|Standard Deviation|23|23.0|||
4426069|NCT00158054|4249983|B1|||GRACE ACS Risk and Mortality Score|"The GRACE Risk and Mortality score is one tool used to help clinicians assess the future risk of death or myocardial infarction (MI), as a guide to treatment options, in a patient with an acute coronary syndrome (ACS).~Range of values: 2 to 372. Patients are categorized as low risk (score <= 108), medium risk (score between 109 - 140), and high risk (>140 score)."|units on a scale|Mean|91|91.0|Standard Deviation|24|24.0|||
4426070|NCT00158054|4249981|B3|No||Diagnosis of major depressive episode||participants|Number|113|113.0||||||
4426071|NCT00158054|4249982|B2|No||Diagnosis of major depressive episode||participants|Number|56|56.0||||||
4426072|NCT00158054|4249983|B1|No||Diagnosis of major depressive episode||participants|Number|57|57.0||||||
4426073|NCT00158054|4249981|B3|Yes||Diagnosis of major depressive episode||participants|Number|44|44.0||||||
4426074|NCT00158054|4249982|B2|Yes||Diagnosis of major depressive episode||participants|Number|21|21.0||||||
4426075|NCT00158054|4249983|B1|Yes||Diagnosis of major depressive episode||participants|Number|23|23.0||||||
4426076|NCT00158054|4249981|B3|BDI score < 16||Beck Depression Inventory Score, categorical|The Beck Depression Inventory (BDI) is a 21-item multiple choice, self-report instrument that is used to assess the severity of symptoms of depression. The score ranges from 0 (no symptoms) to 63 (worst symptoms).|participants|Number|53|53.0||||||
4426077|NCT00158054|4249982|B2|BDI score < 16||Beck Depression Inventory Score, categorical|The Beck Depression Inventory (BDI) is a 21-item multiple choice, self-report instrument that is used to assess the severity of symptoms of depression. The score ranges from 0 (no symptoms) to 63 (worst symptoms).|participants|Number|25|25.0||||||
4426078|NCT00158054|4249983|B1|BDI score < 16||Beck Depression Inventory Score, categorical|The Beck Depression Inventory (BDI) is a 21-item multiple choice, self-report instrument that is used to assess the severity of symptoms of depression. The score ranges from 0 (no symptoms) to 63 (worst symptoms).|participants|Number|28|28.0||||||
4426079|NCT00158054|4249981|B3|BDI score >=16||Beck Depression Inventory Score, categorical|The Beck Depression Inventory (BDI) is a 21-item multiple choice, self-report instrument that is used to assess the severity of symptoms of depression. The score ranges from 0 (no symptoms) to 63 (worst symptoms).|participants|Number|104|104.0||||||
4426080|NCT00158054|4249982|B2|BDI score >=16||Beck Depression Inventory Score, categorical|The Beck Depression Inventory (BDI) is a 21-item multiple choice, self-report instrument that is used to assess the severity of symptoms of depression. The score ranges from 0 (no symptoms) to 63 (worst symptoms).|participants|Number|52|52.0||||||
4426081|NCT00158054|4249983|B1|BDI score >=16||Beck Depression Inventory Score, categorical|The Beck Depression Inventory (BDI) is a 21-item multiple choice, self-report instrument that is used to assess the severity of symptoms of depression. The score ranges from 0 (no symptoms) to 63 (worst symptoms).|participants|Number|52|52.0||||||
4426082|NCT00158054|4249981|B3|Other||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|1|1.0||||||
4426083|NCT00158054|4249982|B2|Other||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|0|0.0||||||
4426084|NCT00158054|4249983|B1|Other||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|1|1.0||||||
4426085|NCT00158054|4249981|B3|ST-segment elevation MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|16|16.0||||||
4426086|NCT00158054|4249982|B2|ST-segment elevation MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|8|8.0||||||
4426087|NCT00158054|4249983|B1|ST-segment elevation MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|8|8.0||||||
4426088|NCT00158054|4249981|B3|Non–ST-segment elevation MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|22|22.0||||||
4426089|NCT00158054|4249982|B2|Non–ST-segment elevation MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|9|9.0||||||
4426090|NCT00158054|4249983|B1|Non–ST-segment elevation MI||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|13|13.0||||||
4426091|NCT00158054|4249981|B3|Unstable angina||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|118|118.0||||||
4426092|NCT00158054|4249982|B2|Unstable angina||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|60|60.0||||||
4426093|NCT00158054|4249983|B1|Unstable angina||Type of presenting acute coronary syndrome|MI = Myocardial Infarction|participants|Number|58|58.0||||||
4426094|NCT00158054|4249981|B3|Unknown/Decline to state||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4426095|NCT00158054|4249982|B2|Unknown/Decline to state||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4426096|NCT00158054|4249983|B1|Unknown/Decline to state||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4426097|NCT00158054|4249981|B3|Other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4426098|NCT00158054|4249982|B2|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4426099|NCT00158054|4249983|B1|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4426100|NCT00158054|4249981|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4426101|NCT00158054|4249982|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4426102|NCT00158054|4249983|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4426103|NCT00158054|4249981|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4426104|NCT00158054|4249982|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4426105|NCT00158054|4249983|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4426106|NCT00158054|4249981|B3|Asian/Indian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4426107|NCT00158054|4249982|B2|Asian/Indian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4426108|NCT00158054|4249983|B1|Asian/Indian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4426109|NCT00158054|4249981|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4426110|NCT00158054|4249982|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4426111|NCT00158054|4249983|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4426112|NCT00158054|4249981|B3|White||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4426113|NCT00158054|4249982|B2|White||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4426114|NCT00158054|4249983|B1|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4426115|NCT00158054|4249981|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4426116|NCT00158054|4249982|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4426117|NCT00158054|4249983|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4426118|NCT00158054|4249981|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4426119|NCT00158054|4249982|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4426120|NCT00158054|4249983|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4426121|NCT00158054|4249981|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4426122|NCT00158054|4249982|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4426123|NCT00158054|4249983|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4426124|NCT00158054|4249981|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4426125|NCT00158054|4249982|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4426126|NCT00158054|4249983|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4426127|NCT00158054|4249981|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4426128|NCT00158054|4249982|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4426129|NCT00158054|4249983|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4426130|NCT00158054|4249981|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|10.6|10.6|||
4426131|NCT00158054|4249982|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|10.6|10.6|||
4426132|NCT00158054|4249983|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|10.6|10.6|||
4426133|NCT00157950|4249996|B3|||Race/Ethnicity, Customized||participants|Number|176|176.0||||||
4426134|NCT00157950|4249997|B2|||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4426135|NCT00157950|4249998|B1|||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4426136|NCT00157950|4249996|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426137|NCT00157950|4249997|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426138|NCT00157950|4249998|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426139|NCT00157950|4249996|B3||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4426140|NCT00157950|4249997|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4426141|NCT00157950|4249998|B1||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4426142|NCT00157950|4249996|B3|||Age||years|Mean|16.6|16.6|Standard Deviation|5.0|5.0|||
4426143|NCT00157950|4249997|B2|||Age||years|Mean|16.5|16.5|Standard Deviation|5.2|5.2|||
4426144|NCT00157950|4249998|B1|||Age||years|Mean|16.7|16.7|Standard Deviation|4.9|4.9|||
4426145|NCT00157820|4250013|B4|||LVEF|Left Ventricle Ejection Fraction (percentage)|percentage|Mean|36|36.0|Standard Deviation|13|13.0|||
4426146|NCT00157820|4250014|B3|||LVEF|Left Ventricle Ejection Fraction (percentage)|percentage|Mean|34|34.0|Standard Deviation|12|12.0|||
4426147|NCT00157820|4250015|B2|||LVEF|Left Ventricle Ejection Fraction (percentage)|percentage|Mean|39|39.0|Standard Deviation|14|14.0|||
4426148|NCT00157820|4250016|B1|||LVEF|Left Ventricle Ejection Fraction (percentage)|percentage|Mean|35|35.0|Standard Deviation|13|13.0|||
4426149|NCT00157820|4250013|B4|Portugal||Region of Enrollment||participants|Number|9|9.0||||||
4426150|NCT00157820|4250014|B3|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4426151|NCT00157820|4250015|B2|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4426152|NCT00157820|4250016|B1|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4426153|NCT00157820|4250013|B4|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4426154|NCT00157820|4250014|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4426155|NCT00157820|4250015|B2|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4426156|NCT00157820|4250016|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4426157|NCT00157820|4250013|B4|Israel||Region of Enrollment||participants|Number|26|26.0||||||
4426158|NCT00157820|4250014|B3|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4426159|NCT00157820|4250015|B2|Israel||Region of Enrollment||participants|Number|8|8.0||||||
4426160|NCT00157820|4250016|B1|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4426161|NCT00157820|4250013|B4|Italy||Region of Enrollment||participants|Number|61|61.0||||||
4426162|NCT00157820|4250014|B3|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4426163|NCT00157820|4250015|B2|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4426164|NCT00157820|4250016|B1|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4426165|NCT00157820|4250013|B4|Germany||Region of Enrollment||participants|Number|89|89.0||||||
4426166|NCT00157820|4250014|B3|Germany||Region of Enrollment||participants|Number|31|31.0||||||
4426167|NCT00157820|4250015|B2|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4426168|NCT00157820|4250016|B1|Germany||Region of Enrollment||participants|Number|29|29.0||||||
4426169|NCT00157820|4250013|B4|Spain||Region of Enrollment||participants|Number|131|131.0||||||
4426170|NCT00157820|4250014|B3|Spain||Region of Enrollment||participants|Number|44|44.0||||||
4426171|NCT00157820|4250015|B2|Spain||Region of Enrollment||participants|Number|44|44.0||||||
4426172|NCT00157820|4250016|B1|Spain||Region of Enrollment||participants|Number|43|43.0||||||
4426173|NCT00157820|4250013|B4||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4426174|NCT00157820|4250014|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4426175|NCT00157820|4250015|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4426176|NCT00157820|4250016|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4426177|NCT00157820|4250013|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4426178|NCT00157820|4250014|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4426179|NCT00157820|4250015|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4426180|NCT00157820|4250016|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4426181|NCT00157820|4250013|B4|||Age||years|Mean|64|64.0|Standard Deviation|10|10.0|||
4426182|NCT00157820|4250014|B3|||Age||years|Mean|66|66.0|Standard Deviation|9|9.0|||
4426183|NCT00157820|4250015|B2|||Age||years|Mean|62|62.0|Standard Deviation|11|11.0|||
4426184|NCT00157820|4250016|B1|||Age||years|Mean|63|63.0|Standard Deviation|10|10.0|||
4426185|NCT00157820|4250013|B4||>=65 years|Age||Participants|Count of Participants|157|157.0||||||
4426186|NCT00157820|4250014|B3||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4426187|NCT00157820|4250015|B2||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4426188|NCT00157820|4250016|B1||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4426189|NCT00157820|4250013|B4||Between 18 and 65 years|Age||Participants|Count of Participants|177|177.0||||||
4426190|NCT00157820|4250014|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4426191|NCT00157820|4250015|B2||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4426192|NCT00157820|4250016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4426193|NCT00157820|4250013|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426194|NCT00157820|4250014|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426195|NCT00157820|4250015|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426196|NCT00157820|4250016|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426197|NCT00157755|4250029|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4426198|NCT00157755|4250030|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4426199|NCT00157755|4250031|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4426200|NCT00157755|4250029|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4426201|NCT00157755|4250030|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4426202|NCT00157755|4250031|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4426203|NCT00157755|4250029|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4426204|NCT00157755|4250030|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4426205|NCT00157755|4250031|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4426206|NCT00157755|4250029|B3|||Age||years|Mean|38.7|38.7|Standard Deviation|10.0|10.0|||
4426207|NCT00157755|4250030|B2|||Age||years|Mean|39.4|39.4|Standard Deviation|10.4|10.4|||
4426208|NCT00157755|4250031|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|9.8|9.8|||
4426209|NCT00157755|4250029|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426210|NCT00157755|4250030|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426211|NCT00157755|4250031|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426212|NCT00157755|4250029|B3||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4426213|NCT00157755|4250030|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4426214|NCT00157755|4250031|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4426215|NCT00157755|4250029|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426216|NCT00157755|4250030|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426217|NCT00157755|4250031|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426218|NCT00157573|4250058|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4426219|NCT00157573|4250058|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426220|NCT00157573|4250058|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4426221|NCT00157573|4250058|B1|||Age||years|Mean|60|60.0|Standard Deviation|9.15|9.15|||
4426222|NCT00157573|4250058|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4426223|NCT00157573|4250058|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4426224|NCT00157573|4250058|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426225|NCT00157248|4250068|B5|Paroxysmal||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|82|82.0||||||
4426226|NCT00157248|4250069|B4|Paroxysmal||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|31|31.0||||||
4426227|NCT00157248|4250070|B3|Paroxysmal||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|10|10.0||||||
4426228|NCT00157248|4250071|B2|Paroxysmal||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|23|23.0||||||
4426229|NCT00157248|4250072|B1|Paroxysmal||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|18|18.0||||||
4426230|NCT00157248|4250068|B5|Permanent||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|140|140.0||||||
4426231|NCT00157248|4250069|B4|Permanent||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|47|47.0||||||
4426232|NCT00157248|4250070|B3|Permanent||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|25|25.0||||||
4426233|NCT00157248|4250071|B2|Permanent||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|28|28.0||||||
4426234|NCT00157248|4250072|B1|Permanent||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|40|40.0||||||
4426235|NCT00157248|4250068|B5|Persistent||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|139|139.0||||||
4426236|NCT00157248|4250069|B4|Persistent||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|46|46.0||15|15.0|||
4426237|NCT00157248|4250070|B3|Persistent||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|15|15.0||38|38.0|||
4426238|NCT00157248|4250071|B2|Persistent||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|38|38.0||40|40.0|||
4426239|NCT00157248|4250072|B1|Persistent||Atrial fibrillation|Atrial fibrillation measured at baseline|Participants|Number|40|40.0||139|139.0|||
4426240|NCT00157248|4250068|B5||Male|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4426241|NCT00157248|4250069|B4||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4426242|NCT00157248|4250070|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4426243|NCT00157248|4250071|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4426244|NCT00157248|4250072|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4426245|NCT00157248|4250068|B5||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4426246|NCT00157248|4250069|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4426247|NCT00157248|4250070|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4426248|NCT00157248|4250071|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4426249|NCT00157248|4250072|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4426250|NCT00157248|4250068|B5|||Age||Years|Mean|69.7|69.7|Standard Deviation|8.2|8.2|||
4426251|NCT00157248|4250069|B4|||Age||Years|Mean|68.8|68.8|Standard Deviation|8.5|8.5|||
4426252|NCT00157248|4250070|B3|||Age||Years|Mean|71.0|71.0|Standard Deviation|6.8|6.8|||
4426253|NCT00157248|4250071|B2|||Age||Years|Mean|69.3|69.3|Standard Deviation|8.2|8.2|||
4426254|NCT00157248|4250072|B1|||Age||Years|Mean|70.4|70.4|Standard Deviation|8.6|8.6|||
4426255|NCT00157209|4250179|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4426256|NCT00157209|4250180|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4426257|NCT00157209|4250181|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4426258|NCT00157209|4250179|B3||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4426259|NCT00157209|4250180|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4426260|NCT00157209|4250181|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4426261|NCT00157209|4250179|B3|||Age||years|Mean|59.6|59.6|Standard Deviation|10.7|10.7|||
4426262|NCT00157209|4250180|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|11.3|11.3|||
4426263|NCT00157209|4250181|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|10.0|10.0|||
4426264|NCT00157196|4250196|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4426265|NCT00157196|4250196|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4426266|NCT00157196|4250196|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|9.66|9.66|||
4426267|NCT00157157|4250202|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4426268|NCT00157157|4250202|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426269|NCT00157157|4250202|B1|≥13 months||Age, Customized||participants|Number|8|8.0||||||
4426270|NCT00157157|4250202|B1|6-12 months||Age, Customized||participants|Number|26|26.0||||||
4426271|NCT00157157|4250202|B1|<6 months||Age, Customized||participants|Number|21|21.0||||||
4426272|NCT00157014|4250225|B5|Aboriginal||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4426273|NCT00157014|4250226|B4|Aboriginal||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4426274|NCT00157014|4250227|B3|Aboriginal||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4426275|NCT00157014|4250228|B2|Aboriginal||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4426276|NCT00157014|4250229|B1|Aboriginal||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4426277|NCT00157014|4250225|B5|Latin American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4426278|NCT00157014|4250226|B4|Latin American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4426279|NCT00157014|4250227|B3|Latin American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4426280|NCT00157014|4250228|B2|Latin American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4426281|NCT00157014|4250229|B1|Latin American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4426282|NCT00157014|4250225|B5|East Indian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4426283|NCT00157014|4250226|B4|East Indian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4426284|NCT00157014|4250227|B3|East Indian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4426285|NCT00157014|4250228|B2|East Indian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4426286|NCT00157014|4250229|B1|East Indian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4426287|NCT00157014|4250225|B5|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4426288|NCT00157014|4250226|B4|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4426289|NCT00157014|4250227|B3|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4426290|NCT00157014|4250228|B2|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4426291|NCT00157014|4250229|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4426292|NCT00157014|4250225|B5|European descent/ White||Race/Ethnicity, Customized||Participants|Number|97|97.0||||||
4426293|NCT00157014|4250226|B4|European descent/ White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4426294|NCT00157014|4250227|B3|European descent/ White||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4426295|NCT00157014|4250228|B2|European descent/ White||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4426296|NCT00157014|4250229|B1|European descent/ White||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
4426297|NCT00157014|4250225|B5|Female||Sex/Gender, Customized||Participants|Number|27|27.0||||||
4426298|NCT00157014|4250226|B4|Female||Sex/Gender, Customized||Participants|Number|4|4.0||||||
4426299|NCT00157014|4250227|B3|Female||Sex/Gender, Customized||Participants|Number|5|5.0||||||
4426300|NCT00157014|4250228|B2|Female||Sex/Gender, Customized||Participants|Number|9|9.0||||||
4426301|NCT00157014|4250229|B1|Female||Sex/Gender, Customized||Participants|Number|9|9.0||||||
4426302|NCT00157014|4250225|B5|Male||Sex/Gender, Customized||Participants|Number|82|82.0||||||
4426303|NCT00157014|4250226|B4|Male||Sex/Gender, Customized||Participants|Number|2|2.0||||||
4426304|NCT00157014|4250227|B3|Male||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4426305|NCT00157014|4250228|B2|Male||Sex/Gender, Customized||Participants|Number|37|37.0||||||
4426306|NCT00157014|4250229|B1|Male||Sex/Gender, Customized||Participants|Number|43|43.0||||||
4426307|NCT00157014|4250225|B5|70 Years and Older||Age, Customized||Participants|Number|3|3.0||||||
4426308|NCT00157014|4250226|B4|70 Years and Older||Age, Customized||Participants|Number|0|0.0||||||
4426309|NCT00157014|4250227|B3|70 Years and Older||Age, Customized||Participants|Number|0|0.0||||||
4426310|NCT00157014|4250228|B2|70 Years and Older||Age, Customized||Participants|Number|1|1.0||||||
4426311|NCT00157014|4250229|B1|70 Years and Older||Age, Customized||Participants|Number|2|2.0||||||
4426312|NCT00157014|4250225|B5|60 - 69 Years||Age, Customized||Participants|Number|30|30.0||||||
4426313|NCT00157014|4250226|B4|60 - 69 Years||Age, Customized||Participants|Number|0|0.0||||||
4426314|NCT00157014|4250227|B3|60 - 69 Years||Age, Customized||Participants|Number|0|0.0||||||
4426315|NCT00157014|4250228|B2|60 - 69 Years||Age, Customized||Participants|Number|12|12.0||||||
4426316|NCT00157014|4250229|B1|60 - 69 Years||Age, Customized||Participants|Number|18|18.0||||||
4426317|NCT00157014|4250225|B5|50 - 59 Years||Age, Customized||Participants|Number|33|33.0||||||
4426318|NCT00157014|4250226|B4|50 - 59 Years||Age, Customized||Participants|Number|0|0.0||||||
4426319|NCT00157014|4250227|B3|50 - 59 Years||Age, Customized||Participants|Number|0|0.0||||||
4426320|NCT00157014|4250228|B2|50 - 59 Years||Age, Customized||Participants|Number|15|15.0||||||
4426321|NCT00157014|4250229|B1|50 - 59 Years||Age, Customized||Participants|Number|18|18.0||||||
4426322|NCT00157014|4250225|B5|18 - 49 Years||Age, Customized||Participants|Number|32|32.0||||||
4426323|NCT00157014|4250226|B4|18 - 49 Years||Age, Customized||Participants|Number|0|0.0||||||
4426324|NCT00157014|4250227|B3|18 - 49 Years||Age, Customized||Participants|Number|0|0.0||||||
4426325|NCT00157014|4250228|B2|18 - 49 Years||Age, Customized||Participants|Number|18|18.0||||||
4426326|NCT00157014|4250229|B1|18 - 49 Years||Age, Customized||Participants|Number|14|14.0||||||
4426327|NCT00157014|4250225|B5|10 - ˂ 18 Years||Age, Customized||Participants|Number|6|6.0||||||
4426328|NCT00157014|4250226|B4|10 - ˂ 18 Years||Age, Customized||Participants|Number|3|3.0||||||
4426329|NCT00157014|4250227|B3|10 - ˂ 18 Years||Age, Customized||Participants|Number|3|3.0||||||
4426330|NCT00157014|4250228|B2|10 - ˂ 18 Years||Age, Customized||Participants|Number|0|0.0||||||
4426331|NCT00157014|4250229|B1|10 - ˂ 18 Years||Age, Customized||Participants|Number|0|0.0||||||
4426332|NCT00157014|4250225|B5|2 - 10 Years||Age, Customized||Participants|Number|3|3.0||||||
4426333|NCT00157014|4250226|B4|2 - 10 Years||Age, Customized||Participants|Number|2|2.0||||||
4426334|NCT00157014|4250227|B3|2 - 10 Years||Age, Customized||Participants|Number|1|1.0||||||
4426335|NCT00157014|4250228|B2|2 - 10 Years||Age, Customized||Participants|Number|0|0.0||||||
4426336|NCT00157014|4250229|B1|2 - 10 Years||Age, Customized||Participants|Number|0|0.0||||||
4426337|NCT00157014|4250225|B5|0 - ˂ 2 Years||Age, Customized||Participants|Number|2|2.0||||||
4426338|NCT00157014|4250226|B4|0 - ˂ 2 Years||Age, Customized||Participants|Number|1|1.0||||||
4426339|NCT00157014|4250227|B3|0 - ˂ 2 Years||Age, Customized||Participants|Number|1|1.0||||||
4426340|NCT00157014|4250228|B2|0 - ˂ 2 Years||Age, Customized||Participants|Number|0|0.0||||||
4426341|NCT00157014|4250229|B1|0 - ˂ 2 Years||Age, Customized||Participants|Number|0|0.0||||||
4426342|NCT00156936|4250310|B3|United States||Region of Enrollment||participants|Number|108|108.0||||||
4426343|NCT00156936|4250311|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4426344|NCT00156936|4250312|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4426345|NCT00156936|4250310|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4426346|NCT00156936|4250311|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4426347|NCT00156936|4250312|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4426348|NCT00156936|4250310|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4426349|NCT00156936|4250311|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4426350|NCT00156936|4250312|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4426351|NCT00156936|4250310|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|10.3|10.3|||
4426352|NCT00156936|4250311|B2|||Age||years|Mean|45.3|45.3|Standard Deviation|11.5|11.5|||
4426353|NCT00156936|4250312|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|10.0|10.0|||
4426354|NCT00156936|4250310|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426355|NCT00156936|4250311|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426356|NCT00156936|4250312|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426357|NCT00156936|4250310|B3||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4426358|NCT00156936|4250311|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4426359|NCT00156936|4250312|B1||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4426360|NCT00156936|4250310|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426361|NCT00156936|4250311|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426362|NCT00156936|4250312|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426363|NCT00156923|4250319|B3|United States||Region of Enrollment||participants|Number|108|108.0||||||
4426364|NCT00156923|4250320|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4426365|NCT00156923|4250321|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4426366|NCT00156923|4250319|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4426367|NCT00156923|4250320|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4426368|NCT00156923|4250321|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4426369|NCT00156923|4250319|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4426370|NCT00156923|4250320|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4426371|NCT00156923|4250321|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4426372|NCT00156923|4250319|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|9.5|9.5|||
4426373|NCT00156923|4250320|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|10.0|10.0|||
4426374|NCT00156923|4250321|B1|||Age||years|Mean|45.9|45.9|Standard Deviation|9.0|9.0|||
4426375|NCT00156923|4250319|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4426376|NCT00156923|4250320|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4426377|NCT00156923|4250321|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4426378|NCT00156923|4250319|B3||Between 18 and 65 years|Age||Participants|Count of Participants|100|100.0||||||
4426379|NCT00156923|4250320|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4426380|NCT00156923|4250321|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4426381|NCT00156923|4250319|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426382|NCT00156923|4250320|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426383|NCT00156923|4250321|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426384|NCT00156910|4250328|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4426385|NCT00156910|4250329|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4426386|NCT00156910|4250330|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4426387|NCT00156910|4250328|B3||Female|Sex: Female, Male||Participants|Count of Participants|594|594.0||||||
4426388|NCT00156910|4250329|B2||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4426389|NCT00156910|4250330|B1||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4426390|NCT00156910|4250328|B3|>= 40 years||Age, Customized||participants|Number|407|407.0||||||
4426391|NCT00156910|4250329|B2|>= 40 years||Age, Customized||participants|Number|210|210.0||||||
4426392|NCT00156910|4250330|B1|>= 40 years||Age, Customized||participants|Number|197|197.0||||||
4426393|NCT00156910|4250328|B3|< 40years||Age, Customized||participants|Number|272|272.0||||||
4426394|NCT00156910|4250329|B2|< 40years||Age, Customized||participants|Number|128|128.0||||||
4426395|NCT00156910|4250330|B1|< 40years||Age, Customized||participants|Number|144|144.0||||||
4426396|NCT00156819|4250345|B4||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4426397|NCT00156819|4250346|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4426398|NCT00156819|4250347|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4426399|NCT00156819|4250348|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4426400|NCT00156819|4250345|B4||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4426401|NCT00156819|4250346|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4426402|NCT00156819|4250347|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4426403|NCT00156819|4250348|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4426404|NCT00156819|4250345|B4|||Age||years|Mean|30.8|30.8|Standard Deviation|15.0|15.0|||
4426405|NCT00156819|4250346|B3|||Age||years|Mean|30.8|30.8|Standard Deviation|14.9|14.9|||
4426406|NCT00156819|4250347|B2|||Age||years|Mean|32.4|32.4|Standard Deviation|15.4|15.4|||
4426407|NCT00156819|4250348|B1|||Age||years|Mean|29.3|29.3|Standard Deviation|14.6|14.6|||
4426408|NCT00156715|4250358|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4426409|NCT00156715|4250358|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4426410|NCT00156715|4250358|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4426411|NCT00156715|4250358|B1|||Age||years|Mean|35.8|35.8|Standard Deviation|9.9|9.9|||
4426412|NCT00156715|4250358|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426413|NCT00156715|4250358|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4426414|NCT00156715|4250358|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426415|NCT00156533|4250363|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4426416|NCT00156533|4250364|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4426417|NCT00156533|4250365|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4426418|NCT00156533|4250366|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4426419|NCT00156533|4250367|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4426420|NCT00156533|4250363|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4426421|NCT00156533|4250364|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4426422|NCT00156533|4250365|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4426423|NCT00156533|4250366|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4426424|NCT00156533|4250367|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4426425|NCT00156533|4250363|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426426|NCT00156533|4250364|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426427|NCT00156533|4250365|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426428|NCT00156533|4250366|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426429|NCT00156533|4250367|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426430|NCT00156533|4250363|B5||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4426431|NCT00156533|4250364|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4426432|NCT00156533|4250365|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4426433|NCT00156533|4250366|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4426434|NCT00156533|4250367|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4426435|NCT00156533|4250363|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426436|NCT00156533|4250364|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426437|NCT00156533|4250365|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426438|NCT00156533|4250366|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426439|NCT00156533|4250367|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426440|NCT00156390|4250384|B3|United States||Region of Enrollment||participants|Number|187|187.0||||||
4426441|NCT00156390|4250385|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4426442|NCT00156390|4250386|B1|United States||Region of Enrollment||participants|Number|110|110.0||||||
4426443|NCT00156390|4250384|B3||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4426444|NCT00156390|4250385|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4426445|NCT00156390|4250386|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4426446|NCT00156390|4250384|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4426447|NCT00156390|4250385|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4426448|NCT00156390|4250386|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4426449|NCT00156390|4250384|B3|||Age||years|Mean|66.5|66.5|Full Range|||54.0|80.0|
4426450|NCT00156390|4250385|B2|||Age||years|Mean|67|67.0|Full Range|||54.0|80.0|
4426451|NCT00156390|4250386|B1|||Age||years|Mean|66|66.0|Full Range|||55.0|77.0|
4426452|NCT00156247|4250395|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4426453|NCT00156247|4250395|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4426454|NCT00156247|4250395|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4426455|NCT00156247|4250395|B1|||Age||years|Mean|45|45.0|Standard Deviation|14.7|14.7|||
4426456|NCT00156247|4250395|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4426457|NCT00156247|4250395|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4426458|NCT00156247|4250395|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426459|NCT00156065|4250401|B4||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4426460|NCT00156065|4250402|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4426461|NCT00156065|4250403|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4426462|NCT00156065|4250404|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4426463|NCT00156065|4250401|B4||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4426464|NCT00156065|4250402|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4426465|NCT00156065|4250403|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4426466|NCT00156065|4250404|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4426467|NCT00156065|4250401|B4|||Age||years|Mean|38.0|38.0|Standard Deviation|11.6|11.6|||
4426468|NCT00156065|4250402|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|11.6|11.6|||
4426469|NCT00156065|4250403|B2|||Age||years|Mean|35.3|35.3|Standard Deviation|10.4|10.4|||
4426470|NCT00156065|4250404|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|12.6|12.6|||
4426471|NCT00156013|4250417|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4426472|NCT00156013|4250417|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4426473|NCT00156013|4250417|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4426474|NCT00156013|4250417|B1|||Age||years|Mean|69|69.0|Full Range|||27.0|85.0|
4426475|NCT00156013|4250417|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4426476|NCT00156013|4250417|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4426477|NCT00156013|4250417|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426478|NCT00154466|4250423|B4|Taiwan||Region of Enrollment||participants|Number|58|58.0||||||
4426479|NCT00154466|4250424|B3|Taiwan||Region of Enrollment||participants|Number|19|19.0||||||
4426480|NCT00154466|4250425|B2|Taiwan||Region of Enrollment||participants|Number|19|19.0||||||
4426481|NCT00154466|4250426|B1|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
4426482|NCT00154466|4250423|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4426483|NCT00154466|4250424|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4426484|NCT00154466|4250425|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4426485|NCT00154466|4250426|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4426486|NCT00154466|4250423|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426487|NCT00154466|4250424|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426488|NCT00154466|4250425|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426489|NCT00154466|4250426|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426490|NCT00154466|4250423|B4|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
4426491|NCT00154466|4250424|B3|||Age||years|Mean|50|50.0|Standard Deviation|9|9.0|||
4426492|NCT00154466|4250425|B2|||Age||years|Mean|52|52.0|Standard Deviation|9|9.0|||
4426493|NCT00154466|4250426|B1|||Age||years|Mean|52|52.0|Standard Deviation|8|8.0|||
4426494|NCT00154466|4250423|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426495|NCT00154466|4250424|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426496|NCT00154466|4250425|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426497|NCT00154466|4250426|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426498|NCT00154466|4250423|B4||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4426499|NCT00154466|4250424|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4426500|NCT00154466|4250425|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4426501|NCT00154466|4250426|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4426502|NCT00154466|4250423|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426503|NCT00154466|4250424|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426504|NCT00154466|4250425|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426505|NCT00154466|4250426|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426506|NCT00154375|4250438|B3||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4426507|NCT00154375|4250439|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4426508|NCT00154375|4250440|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4426509|NCT00154375|4250438|B3||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4426510|NCT00154375|4250439|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4426511|NCT00154375|4250440|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4426512|NCT00154375|4250438|B3|||Age||years|Mean|51.2|51.2|Standard Deviation|11.4|11.4|||
4426513|NCT00154375|4250439|B2|||Age||years|Mean|50.2|50.2|Standard Deviation|11.4|11.4|||
4426514|NCT00154375|4250440|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|11.3|11.3|||
4426515|NCT00154310|4250450|B3||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4426516|NCT00154310|4250451|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4426517|NCT00154310|4250452|B1||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4426518|NCT00154310|4250450|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4426519|NCT00154310|4250451|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4426520|NCT00154310|4250452|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4426521|NCT00154310|4250450|B3|||Age||Years|Mean|46.8|46.8|Standard Deviation|11.73|11.73|||
4426522|NCT00154310|4250451|B2|||Age||Years|Mean|46.7|46.7|Standard Deviation|11.85|11.85|||
4426523|NCT00154310|4250452|B1|||Age||Years|Mean|46.9|46.9|Standard Deviation|11.67|11.67|||
4426524|NCT00154297|4250467|B3||Male|Sex: Female, Male|Baseline measure based on randomized population.|Participants|Count of Participants|100|100.0||||||
4426525|NCT00154297|4250468|B2||Male|Sex: Female, Male|Baseline measure based on randomized population.|Participants|Count of Participants|54|54.0||||||
4426526|NCT00154297|4250469|B1||Male|Sex: Female, Male|Baseline measure based on randomized population.|Participants|Count of Participants|46|46.0||||||
4426527|NCT00154297|4250467|B3||Female|Sex: Female, Male|Baseline measure based on randomized population.|Participants|Count of Participants|39|39.0||||||
4426528|NCT00154297|4250468|B2||Female|Sex: Female, Male|Baseline measure based on randomized population.|Participants|Count of Participants|20|20.0||||||
4426529|NCT00154297|4250469|B1||Female|Sex: Female, Male|Baseline measure based on randomized population.|Participants|Count of Participants|19|19.0||||||
4426530|NCT00154297|4250467|B3|||Age|baseline measure based on randomized population.|years|Mean|57.9|57.9|Standard Deviation|10.13|10.13|||
4426531|NCT00154297|4250468|B2|||Age|baseline measure based on randomized population.|years|Mean|58.4|58.4|Standard Deviation|9.86|9.86|||
4426532|NCT00154297|4250469|B1|||Age|baseline measure based on randomized population.|years|Mean|57.3|57.3|Standard Deviation|10.46|10.46|||
4426533|NCT00154284|4250486|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4426534|NCT00154284|4250487|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4426535|NCT00154284|4250488|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4426536|NCT00154284|4250486|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4426537|NCT00154284|4250487|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4426538|NCT00154284|4250488|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4426539|NCT00154284|4250486|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|12.07|12.07|||
4426540|NCT00154284|4250487|B2|||Age||years|Mean|41.5|41.5|Standard Deviation|12.27|12.27|||
4426541|NCT00154284|4250488|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|11.62|11.62|||
4426542|NCT00154102|4250501|B3|Rest of the World||Region of Enrollment||participants|Number|265|265.0||||||
4426543|NCT00154102|4250502|B2|Rest of the World||Region of Enrollment||participants|Number|131|131.0||||||
4426544|NCT00154102|4250503|B1|Rest of the World||Region of Enrollment||participants|Number|134|134.0||||||
4426545|NCT00154102|4250501|B3|Eastern Europe||Region of Enrollment||participants|Number|404|404.0||||||
4426546|NCT00154102|4250502|B2|Eastern Europe||Region of Enrollment||participants|Number|201|201.0||||||
4426547|NCT00154102|4250503|B1|Eastern Europe||Region of Enrollment||participants|Number|203|203.0||||||
4426548|NCT00154102|4250501|B3|Western Europe||Region of Enrollment||participants|Number|529|529.0||||||
4426549|NCT00154102|4250502|B2|Western Europe||Region of Enrollment||participants|Number|267|267.0||||||
4426550|NCT00154102|4250503|B1|Western Europe||Region of Enrollment||participants|Number|262|262.0||||||
4426551|NCT00154102|4250501|B3||Male|Gender||Participants|Count of Participants|725|725.0||||||
4426552|NCT00154102|4250502|B2||Male|Gender||Participants|Count of Participants|356|356.0||||||
4426553|NCT00154102|4250503|B1||Male|Gender||Participants|Count of Participants|369|369.0||||||
4426554|NCT00154102|4250501|B3||Female|Gender||Participants|Count of Participants|473|473.0||||||
4426555|NCT00154102|4250502|B2||Female|Gender||Participants|Count of Participants|243|243.0||||||
4426556|NCT00154102|4250503|B1||Female|Gender||Participants|Count of Participants|230|230.0||||||
4426557|NCT00154102|4250501|B3|>=65 years||Age, Customized|Age missing for 1 subject|participants|Number|446|446.0||||||
4426558|NCT00154102|4250502|B2|>=65 years||Age, Customized|Age missing for 1 subject|participants|Number|222|222.0||||||
4426559|NCT00154102|4250503|B1|>=65 years||Age, Customized|Age missing for 1 subject|participants|Number|224|224.0||||||
4426560|NCT00154102|4250501|B3|Between 18 and 65 years||Age, Customized|Age missing for 1 subject|participants|Number|751|751.0||||||
4426561|NCT00154102|4250502|B2|Between 18 and 65 years||Age, Customized|Age missing for 1 subject|participants|Number|377|377.0||||||
4426562|NCT00154102|4250503|B1|Between 18 and 65 years||Age, Customized|Age missing for 1 subject|participants|Number|374|374.0||||||
4426563|NCT00154102|4250501|B3|Missing||Age, Customized|Age missing for 1 subject|participants|Number|1|1.0||||||
4426564|NCT00154102|4250502|B2|Missing||Age, Customized|Age missing for 1 subject|participants|Number|0|0.0||||||
4426565|NCT00154102|4250503|B1|Missing||Age, Customized|Age missing for 1 subject|participants|Number|1|1.0||||||
4426566|NCT00154102|4250501|B3|||Age|Age missing for 1 subject|years|Mean|59.9|59.9|Standard Deviation|10.79|10.79|||
4426567|NCT00154102|4250502|B2|||Age|Age missing for 1 subject|years|Mean|59.8|59.8|Standard Deviation|11.06|11.06|||
4426568|NCT00154102|4250503|B1|||Age|Age missing for 1 subject|years|Mean|60.0|60.0|Standard Deviation|10.52|10.52|||
4426569|NCT00154063|4250538|B3||Male|Sex: Female, Male|Male and female (either of non-childbearing potential, childbearing potential and practicing a medically acceptable method of contraception, surgically sterile, or postmenopausal for greater or equal to 1 year) subjects with a history of migraine experiencing 4 to 12 migraine attacks per month during both the 3 months prior to Screening and the Baseline Phase.|Participants|Count of Participants|27|27.0||||||
4426570|NCT00154063|4250539|B2||Male|Sex: Female, Male|Male and female (either of non-childbearing potential, childbearing potential and practicing a medically acceptable method of contraception, surgically sterile, or postmenopausal for greater or equal to 1 year) subjects with a history of migraine experiencing 4 to 12 migraine attacks per month during both the 3 months prior to Screening and the Baseline Phase.|Participants|Count of Participants|13|13.0||||||
4426571|NCT00154063|4250540|B1||Male|Sex: Female, Male|Male and female (either of non-childbearing potential, childbearing potential and practicing a medically acceptable method of contraception, surgically sterile, or postmenopausal for greater or equal to 1 year) subjects with a history of migraine experiencing 4 to 12 migraine attacks per month during both the 3 months prior to Screening and the Baseline Phase.|Participants|Count of Participants|14|14.0||||||
4426572|NCT00154063|4250538|B3||Female|Sex: Female, Male|Male and female (either of non-childbearing potential, childbearing potential and practicing a medically acceptable method of contraception, surgically sterile, or postmenopausal for greater or equal to 1 year) subjects with a history of migraine experiencing 4 to 12 migraine attacks per month during both the 3 months prior to Screening and the Baseline Phase.|Participants|Count of Participants|179|179.0||||||
4426573|NCT00154063|4250539|B2||Female|Sex: Female, Male|Male and female (either of non-childbearing potential, childbearing potential and practicing a medically acceptable method of contraception, surgically sterile, or postmenopausal for greater or equal to 1 year) subjects with a history of migraine experiencing 4 to 12 migraine attacks per month during both the 3 months prior to Screening and the Baseline Phase.|Participants|Count of Participants|89|89.0||||||
4426627|NCT00153816|4250616|B3||White|Race (NIH/OMB)||Participants|Count of Participants|364|364.0||||||
4426628|NCT00153816|4250617|B2||White|Race (NIH/OMB)||Participants|Count of Participants|354|354.0||||||
4426629|NCT00153816|4250618|B1||White|Race (NIH/OMB)||Participants|Count of Participants|357|357.0||||||
4426574|NCT00154063|4250540|B1||Female|Sex: Female, Male|Male and female (either of non-childbearing potential, childbearing potential and practicing a medically acceptable method of contraception, surgically sterile, or postmenopausal for greater or equal to 1 year) subjects with a history of migraine experiencing 4 to 12 migraine attacks per month during both the 3 months prior to Screening and the Baseline Phase.|Participants|Count of Participants|90|90.0||||||
4426575|NCT00154063|4250538|B3|||Age||Years|Mean|41.4|41.4|Standard Deviation|12|12.0|||
4426576|NCT00154063|4250539|B2|||Age||Years|Mean|41.3|41.3|Standard Deviation|12.5|12.5|||
4426577|NCT00154063|4250540|B1|||Age||Years|Mean|41.5|41.5|Standard Deviation|11.5|11.5|||
4426578|NCT00153985|4250597|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4426579|NCT00153985|4250597|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426580|NCT00153985|4250597|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4426581|NCT00153985|4250597|B1|||Age||years|Mean|25|25.0|Standard Deviation|2|2.0|||
4426582|NCT00153985|4250597|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426583|NCT00153985|4250597|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4426584|NCT00153985|4250597|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426585|NCT00153920|4250603|B1|Unknown||ISS Stage|International Staging System (ISS) Stage I: serum ß2-M < 3.5 mg/L and serum albumin >/= 3.5 g/dL Stage II: Neither stage I nor stage III Stage III: serum ß2-M >/= 5.5 mg/L|participants|Number|2|2.0||||||
4426586|NCT00153920|4250603|B1|ISS Stage III||ISS Stage|International Staging System (ISS) Stage I: serum ß2-M < 3.5 mg/L and serum albumin >/= 3.5 g/dL Stage II: Neither stage I nor stage III Stage III: serum ß2-M >/= 5.5 mg/L|participants|Number|4|4.0||||||
4426587|NCT00153920|4250603|B1|ISS Stage II||ISS Stage|International Staging System (ISS) Stage I: serum ß2-M < 3.5 mg/L and serum albumin >/= 3.5 g/dL Stage II: Neither stage I nor stage III Stage III: serum ß2-M >/= 5.5 mg/L|participants|Number|26|26.0||||||
4426588|NCT00153920|4250603|B1|ISS Stage I||ISS Stage|International Staging System (ISS) Stage I: serum ß2-M < 3.5 mg/L and serum albumin >/= 3.5 g/dL Stage II: Neither stage I nor stage III Stage III: serum ß2-M >/= 5.5 mg/L|participants|Number|32|32.0||||||
4426589|NCT00153920|4250603|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4426590|NCT00153920|4250603|B1|Non-White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4426591|NCT00153920|4250603|B1|White||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4426592|NCT00153920|4250603|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4426593|NCT00153920|4250603|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4426594|NCT00153920|4250603|B1|||Age||years|Median|60|60.0|Full Range|||33.0|76.0|
4426595|NCT00153816|4250612|B7|United States||Region of Enrollment||participants|Number|2222|2222.0||||||
4426596|NCT00153816|4250613|B6|United States||Region of Enrollment||participants|Number|285|285.0||||||
4426597|NCT00153816|4250614|B5|United States||Region of Enrollment||participants|Number|290|290.0||||||
4426598|NCT00153816|4250615|B4|United States||Region of Enrollment||participants|Number|414|414.0||||||
4426599|NCT00153816|4250616|B3|United States||Region of Enrollment||participants|Number|413|413.0||||||
4426600|NCT00153816|4250617|B2|United States||Region of Enrollment||participants|Number|412|412.0||||||
4426601|NCT00153816|4250618|B1|United States||Region of Enrollment||participants|Number|408|408.0||||||
4426602|NCT00153816|4250612|B7|Puerto Rico||Region of Enrollment||participants|Number|37|37.0||||||
4426603|NCT00153816|4250613|B6|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4426604|NCT00153816|4250614|B5|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4426605|NCT00153816|4250615|B4|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4426606|NCT00153816|4250616|B3|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4426607|NCT00153816|4250617|B2|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4426608|NCT00153816|4250618|B1|Puerto Rico||Region of Enrollment||participants|Number|7|7.0||||||
4426609|NCT00153816|4250612|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4426610|NCT00153816|4250613|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4426611|NCT00153816|4250614|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4426612|NCT00153816|4250615|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4426613|NCT00153816|4250616|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4426614|NCT00153816|4250617|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4426615|NCT00153816|4250618|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4426616|NCT00153816|4250612|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4426617|NCT00153816|4250613|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4426618|NCT00153816|4250614|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4426619|NCT00153816|4250615|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4426620|NCT00153816|4250616|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4426621|NCT00153816|4250617|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4426622|NCT00153816|4250618|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4426623|NCT00153816|4250612|B7||White|Race (NIH/OMB)||Participants|Count of Participants|1900|1900.0||||||
4426624|NCT00153816|4250613|B6||White|Race (NIH/OMB)||Participants|Count of Participants|237|237.0||||||
4426625|NCT00153816|4250614|B5||White|Race (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
4426626|NCT00153816|4250615|B4||White|Race (NIH/OMB)||Participants|Count of Participants|350|350.0||||||
4426630|NCT00153816|4250612|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
4426631|NCT00153816|4250613|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4426632|NCT00153816|4250614|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4426633|NCT00153816|4250615|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4426634|NCT00153816|4250616|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4426635|NCT00153816|4250617|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4426636|NCT00153816|4250618|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4426637|NCT00153816|4250612|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4426638|NCT00153816|4250613|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4426639|NCT00153816|4250614|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4426640|NCT00153816|4250615|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4426641|NCT00153816|4250616|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4426642|NCT00153816|4250617|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4426643|NCT00153816|4250618|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4426644|NCT00153816|4250612|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4426645|NCT00153816|4250613|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4426646|NCT00153816|4250614|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4426647|NCT00153816|4250615|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4426648|NCT00153816|4250616|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4426649|NCT00153816|4250617|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4426650|NCT00153816|4250618|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4426651|NCT00153816|4250612|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4426652|NCT00153816|4250613|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4426653|NCT00153816|4250614|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4426654|NCT00153816|4250615|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4426655|NCT00153816|4250616|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4426656|NCT00153816|4250617|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4426657|NCT00153816|4250618|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4426658|NCT00153816|4250612|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4426659|NCT00153816|4250613|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4426660|NCT00153816|4250614|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4426661|NCT00153816|4250615|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4426662|NCT00153816|4250616|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4426663|NCT00153816|4250617|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4426664|NCT00153816|4250618|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4426665|NCT00153816|4250612|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2110|2110.0||||||
4426666|NCT00153816|4250613|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|263|263.0||||||
4426667|NCT00153816|4250614|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|267|267.0||||||
4426668|NCT00153816|4250615|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|394|394.0||||||
4426669|NCT00153816|4250616|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|396|396.0||||||
4426670|NCT00153816|4250617|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|395|395.0||||||
4426671|NCT00153816|4250618|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|395|395.0||||||
4426672|NCT00153816|4250612|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
4426673|NCT00153816|4250613|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4426674|NCT00153816|4250614|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4426675|NCT00153816|4250615|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4426676|NCT00153816|4250616|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4426677|NCT00153816|4250617|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4426678|NCT00153816|4250618|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4426679|NCT00153816|4250612|B7||Male|Sex: Female, Male||Participants|Count of Participants|1423|1423.0||||||
4426680|NCT00153816|4250613|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426681|NCT00153816|4250614|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426682|NCT00153816|4250615|B4||Male|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4426683|NCT00153816|4250616|B3||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4426684|NCT00153816|4250617|B2||Male|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4426685|NCT00153816|4250618|B1||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4426686|NCT00153816|4250612|B7||Female|Sex: Female, Male||Participants|Count of Participants|836|836.0||||||
4426687|NCT00153816|4250613|B6||Female|Sex: Female, Male||Participants|Count of Participants|289|289.0||||||
4426688|NCT00153816|4250614|B5||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4426689|NCT00153816|4250615|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4426690|NCT00153816|4250616|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4426691|NCT00153816|4250617|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4426692|NCT00153816|4250618|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4426693|NCT00153816|4250612|B7|||Age||years|Mean|58.1|58.1|Standard Deviation|6.8|6.8|||
4426694|NCT00153816|4250613|B6|||Age||years|Mean|57.0|57.0|Standard Deviation|6.6|6.6|||
4426695|NCT00153816|4250614|B5|||Age||years|Mean|56.7|56.7|Standard Deviation|6.0|6.0|||
4426696|NCT00153816|4250615|B4|||Age||years|Mean|58.7|58.7|Standard Deviation|6.9|6.9|||
4426697|NCT00153816|4250616|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|7.0|7.0|||
4426698|NCT00153816|4250617|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|7.0|7.0|||
4426699|NCT00153816|4250618|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|7.0|7.0|||
4426700|NCT00153179|4250643|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4426701|NCT00153179|4250644|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4426702|NCT00153179|4250645|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4426703|NCT00153179|4250643|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4426704|NCT00153179|4250644|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4426705|NCT00153179|4250645|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4426706|NCT00153179|4250643|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4426707|NCT00153179|4250644|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4426708|NCT00153179|4250645|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4426709|NCT00153179|4250643|B3|||Age||years|Mean|55.6|55.6|Standard Deviation|8.05|8.05|||
4426710|NCT00153179|4250644|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|8.1|8.1|||
4426711|NCT00153179|4250645|B1|||Age||years|Mean|52.1|52.1|Standard Deviation|5.6|5.6|||
4426712|NCT00153179|4250643|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426713|NCT00153179|4250644|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426714|NCT00153179|4250645|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426715|NCT00153179|4250643|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4426716|NCT00153179|4250644|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4426717|NCT00153179|4250645|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4426718|NCT00153179|4250643|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426719|NCT00153179|4250644|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426720|NCT00153179|4250645|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426721|NCT00153166|4250658|B4|United States||Region of Enrollment||participants|Number|76|76.0||||||
4426722|NCT00153166|4250659|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4426723|NCT00153166|4250660|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4426724|NCT00153166|4250661|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4426725|NCT00153166|4250658|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4426726|NCT00153166|4250659|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4426727|NCT00153166|4250660|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4426728|NCT00153166|4250661|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4426729|NCT00153166|4250658|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4426730|NCT00153166|4250659|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4426731|NCT00153166|4250660|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4426732|NCT00153166|4250661|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4426733|NCT00153166|4250658|B4|||Age||years|Mean|64.2|64.2|Standard Deviation|9.5|9.5|||
4426734|NCT00153166|4250659|B3|||Age||years|Mean|64.6|64.6|Standard Deviation|8.8|8.8|||
4426735|NCT00153166|4250660|B2|||Age||years|Mean|66|66.0|Standard Deviation|8.7|8.7|||
4426736|NCT00153166|4250661|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|6|6.0|||
4426737|NCT00153166|4250658|B4||>=65 years|Age||Participants|Count of Participants|61|61.0||||||
4426738|NCT00153166|4250659|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4426739|NCT00153166|4250660|B2||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4426740|NCT00153166|4250661|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4426741|NCT00153166|4250658|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4426742|NCT00153166|4250659|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4426743|NCT00153166|4250660|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4426744|NCT00153166|4250661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4426745|NCT00153166|4250658|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426746|NCT00153166|4250659|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426747|NCT00153166|4250660|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426748|NCT00153166|4250661|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4426749|NCT00153101|4250675|B6||Male|Sex: Female, Male||Participants|Count of Participants|22168|22168.0||||||
4426750|NCT00153101|4250676|B5||Male|Sex: Female, Male||Participants|Count of Participants|1705|1705.0||||||
4426751|NCT00153101|4250677|B4||Male|Sex: Female, Male||Participants|Count of Participants|1674|1674.0||||||
4426752|NCT00153101|4250678|B3||Male|Sex: Female, Male||Participants|Count of Participants|6245|6245.0||||||
4426753|NCT00153101|4250679|B2||Male|Sex: Female, Male||Participants|Count of Participants|6292|6292.0||||||
4426754|NCT00153101|4250680|B1||Male|Sex: Female, Male||Participants|Count of Participants|6252|6252.0||||||
4426755|NCT00153101|4250675|B6||Female|Sex: Female, Male||Participants|Count of Participants|9378|9378.0||||||
4426756|NCT00153101|4250676|B5||Female|Sex: Female, Male||Participants|Count of Participants|1267|1267.0||||||
4426757|NCT00153101|4250677|B4||Female|Sex: Female, Male||Participants|Count of Participants|1280|1280.0||||||
4426758|NCT00153101|4250678|B3||Female|Sex: Female, Male||Participants|Count of Participants|2331|2331.0||||||
4426759|NCT00153101|4250679|B2||Female|Sex: Female, Male||Participants|Count of Participants|2250|2250.0||||||
4426760|NCT00153101|4250680|B1||Female|Sex: Female, Male||Participants|Count of Participants|2250|2250.0||||||
4426761|NCT00153101|4250675|B6|||Age||years|Mean|66.5|66.5|Standard Deviation|7.2|7.2|||
4426762|NCT00153101|4250676|B5|||Age||years|Mean|66.9|66.9|Standard Deviation|7.4|7.4|||
4426763|NCT00153101|4250677|B4|||Age||years|Mean|66.9|66.9|Standard Deviation|7.3|7.3|||
4426764|NCT00153101|4250678|B3|||Age||years|Mean|66.4|66.4|Standard Deviation|7.2|7.2|||
4426765|NCT00153101|4250679|B2|||Age||years|Mean|66.4|66.4|Standard Deviation|7.1|7.1|||
4426766|NCT00153101|4250680|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|7.3|7.3|||
4426767|NCT00153062|4250788|B5||Male|Sex: Female, Male||Participants|Count of Participants|13022.0|13022.0||||||
4426768|NCT00153062|4250789|B4||Male|Sex: Female, Male||Participants|Count of Participants|3251|3251.0||||||
4426769|NCT00153062|4250790|B3||Male|Sex: Female, Male||Participants|Count of Participants|3243|3243.0||||||
4426770|NCT00153062|4250791|B2||Male|Sex: Female, Male||Participants|Count of Participants|3244|3244.0||||||
4426771|NCT00153062|4250792|B1||Male|Sex: Female, Male||Participants|Count of Participants|3284|3284.0||||||
4426772|NCT00153062|4250788|B5||Female|Sex: Female, Male||Participants|Count of Participants|7310.0|7310.0||||||
4426773|NCT00153062|4250789|B4||Female|Sex: Female, Male||Participants|Count of Participants|1840|1840.0||||||
4426774|NCT00153062|4250790|B3||Female|Sex: Female, Male||Participants|Count of Participants|1817|1817.0||||||
4426775|NCT00153062|4250791|B2||Female|Sex: Female, Male||Participants|Count of Participants|1851|1851.0||||||
4426776|NCT00153062|4250792|B1||Female|Sex: Female, Male||Participants|Count of Participants|1802|1802.0||||||
4426777|NCT00153062|4250788|B5|||Age||years|Mean|66.1|66.1|Standard Deviation|8.6|8.6|||
4426778|NCT00153062|4250789|B4|||Age||years|Mean|66.2|66.2|Standard Deviation|8.5|8.5|||
4426779|NCT00153062|4250790|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|8.6|8.6|||
4426780|NCT00153062|4250791|B2|||Age||years|Mean|66.2|66.2|Standard Deviation|8.6|8.6|||
4426781|NCT00153062|4250792|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|8.5|8.5|||
4426782|NCT00152971|4250811|B4|||Body Mass Index||kg/m^2|Mean|31.5|31.5|Standard Deviation|6.1|6.1|||
4426783|NCT00152971|4250812|B3|||Body Mass Index||kg/m^2|Mean|31.4|31.4|Standard Deviation|6.0|6.0|||
4426784|NCT00152971|4250813|B2|||Body Mass Index||kg/m^2|Mean|31.4|31.4|Standard Deviation|6.1|6.1|||
4426785|NCT00152971|4250814|B1|||Body Mass Index||kg/m^2|Mean|31.6|31.6|Standard Deviation|6.0|6.0|||
4426786|NCT00152971|4250811|B4||Male|Sex: Female, Male||Participants|Count of Participants|1099|1099.0||||||
4426787|NCT00152971|4250812|B3||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4426788|NCT00152971|4250813|B2||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4426789|NCT00152971|4250814|B1||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4426790|NCT00152971|4250811|B4||Female|Sex: Female, Male||Participants|Count of Participants|1497|1497.0||||||
4426791|NCT00152971|4250812|B3||Female|Sex: Female, Male||Participants|Count of Participants|504|504.0||||||
4426792|NCT00152971|4250813|B2||Female|Sex: Female, Male||Participants|Count of Participants|507|507.0||||||
4426793|NCT00152971|4250814|B1||Female|Sex: Female, Male||Participants|Count of Participants|486|486.0||||||
4426794|NCT00152971|4250811|B4|||Age||Years|Mean|66.1|66.1|Standard Deviation|9.5|9.5|||
4426795|NCT00152971|4250812|B3|||Age||Years|Mean|66.3|66.3|Standard Deviation|9.6|9.6|||
4426796|NCT00152971|4250813|B2|||Age||Years|Mean|65.9|65.9|Standard Deviation|9.5|9.5|||
4426797|NCT00152971|4250814|B1|||Age||Years|Mean|66.2|66.2|Standard Deviation|9.5|9.5|||
4426798|NCT00152763|4250848|B5||Male|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4426799|NCT00152763|4250849|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4426800|NCT00152763|4250850|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426801|NCT00152763|4250851|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426802|NCT00152763|4250852|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4426803|NCT00152763|4250848|B5||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4426804|NCT00152763|4250849|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426805|NCT00152763|4250850|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4426806|NCT00152763|4250851|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4426807|NCT00152763|4250852|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4426808|NCT00152763|4250848|B5|||Age||years|Mean|61.68|61.68|Standard Deviation|14.18|14.18|||
4426809|NCT00152763|4250849|B4|||Age||years|Mean|64.2|64.2|Standard Deviation|13.35|13.35|||
4426810|NCT00152763|4250850|B3|||Age||years|Mean|55.35|55.35|Standard Deviation|18.30|18.3|||
4426811|NCT00152763|4250851|B2|||Age||years|Mean|54.58|54.58|Standard Deviation|15.75|15.75|||
4426812|NCT00152763|4250852|B1|||Age||years|Mean|61.29|61.29|Standard Deviation|13.17|13.17|||
4426813|NCT00152516|4250971|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4426814|NCT00152516|4250971|B1|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
4426815|NCT00152516|4250971|B1|Romania||Region of Enrollment||participants|Number|7|7.0||||||
4426816|NCT00152516|4250971|B1|Belgium||Region of Enrollment||participants|Number|4|4.0||||||
4426817|NCT00152516|4250971|B1|Brazil||Region of Enrollment||participants|Number|29|29.0||||||
4426818|NCT00152516|4250971|B1|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4426819|NCT00152516|4250971|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4426820|NCT00152516|4250971|B1|Mexico||Region of Enrollment||participants|Number|6|6.0||||||
4426821|NCT00152516|4250971|B1|Hungary||Region of Enrollment||participants|Number|4|4.0||||||
4426822|NCT00152516|4250971|B1|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
4426823|NCT00152516|4250971|B1|France||Region of Enrollment||participants|Number|7|7.0||||||
4426824|NCT00152516|4250971|B1|India||Region of Enrollment||participants|Number|20|20.0||||||
4426825|NCT00152516|4250971|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4426826|NCT00152516|4250971|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4426827|NCT00152516|4250971|B1|Russian Federation||Region of Enrollment||participants|Number|7|7.0||||||
4426828|NCT00152516|4250971|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
4426829|NCT00152516|4250971|B1||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4426830|NCT00152516|4250971|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4426831|NCT00152516|4250971|B1|||Age||years|Mean|5.28|5.28|Standard Deviation|4.69|4.69|||
4426832|NCT00152516|4250971|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426833|NCT00152516|4250971|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4426834|NCT00152516|4250971|B1||<=18 years|Age||Participants|Count of Participants|255|255.0||||||
4426835|NCT00152009|4250995|B5|United States||Region of Enrollment||participants|Number|345|345.0||||||
4426836|NCT00152009|4250996|B4|United States||Region of Enrollment||participants|Number|86|86.0||||||
4426837|NCT00152009|4250997|B3|United States||Region of Enrollment||participants|Number|86|86.0||||||
4426838|NCT00152009|4250998|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
4426839|NCT00152009|4250999|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4426840|NCT00152009|4250995|B5||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4426841|NCT00152009|4250996|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4426842|NCT00152009|4250997|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4426843|NCT00152009|4250998|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4426844|NCT00152009|4250999|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4426845|NCT00152009|4250995|B5||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4426846|NCT00152009|4250996|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4426847|NCT00152009|4250997|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4426848|NCT00152009|4250998|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4426849|NCT00152009|4250999|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4426850|NCT00152009|4250995|B5|||Age||years|Mean|10.5|10.5|Standard Deviation|2.68|2.68|||
4426851|NCT00152009|4250996|B4|||Age||years|Mean|10.6|10.6|Standard Deviation|2.70|2.7|||
4426852|NCT00152009|4250997|B3|||Age||years|Mean|10.1|10.1|Standard Deviation|2.86|2.86|||
4426853|NCT00152009|4250998|B2|||Age||years|Mean|10.8|10.8|Standard Deviation|2.76|2.76|||
4426854|NCT00152009|4250999|B1|||Age||years|Mean|10.6|10.6|Standard Deviation|2.35|2.35|||
4426855|NCT00152009|4250995|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426856|NCT00152009|4250996|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426857|NCT00152009|4250997|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426858|NCT00152009|4250998|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426859|NCT00152009|4250999|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426860|NCT00152009|4250995|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4426861|NCT00152009|4250996|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4426862|NCT00152009|4250997|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4426863|NCT00152009|4250998|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4426864|NCT00152009|4250999|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4426865|NCT00152009|4250995|B5||<=18 years|Age||Participants|Count of Participants|345|345.0||||||
4426866|NCT00152009|4250996|B4||<=18 years|Age||Participants|Count of Participants|86|86.0||||||
4426867|NCT00152009|4250997|B3||<=18 years|Age||Participants|Count of Participants|86|86.0||||||
4426868|NCT00152009|4250998|B2||<=18 years|Age||Participants|Count of Participants|86|86.0||||||
4426869|NCT00152009|4250999|B1||<=18 years|Age||Participants|Count of Participants|87|87.0||||||
4426870|NCT00151996|4251032|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4426871|NCT00151996|4251033|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4426872|NCT00151996|4251034|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4426873|NCT00151996|4251032|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4426874|NCT00151996|4251033|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4426875|NCT00151996|4251034|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4426876|NCT00151996|4251032|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4426877|NCT00151996|4251033|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4426878|NCT00151996|4251034|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4426879|NCT00151996|4251032|B3|||Age||years|Mean|11.4|11.4|Standard Deviation|2.19|2.19|||
4426880|NCT00151996|4251033|B2|||Age||years|Mean|11.6|11.6|Standard Deviation|2.62|2.62|||
4426881|NCT00151996|4251034|B1|||Age||years|Mean|11.1|11.1|Standard Deviation|1.79|1.79|||
4426882|NCT00151996|4251032|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426883|NCT00151996|4251033|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426884|NCT00151996|4251034|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4426885|NCT00151996|4251032|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4426886|NCT00151996|4251033|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4426887|NCT00151996|4251034|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4426888|NCT00151996|4251032|B3||<=18 years|Age||Participants|Count of Participants|75|75.0||||||
4426889|NCT00151996|4251033|B2||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4426890|NCT00151996|4251034|B1||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4426891|NCT00151892|4251049|B3|Sweden||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|4|4.0||||||
4426892|NCT00151892|4251050|B2|Sweden||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|1|1.0||||||
4426893|NCT00151892|4251051|B1|Sweden||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|3|3.0||||||
4426894|NCT00151892|4251049|B3|New Zealand||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|6|6.0||||||
4426895|NCT00151892|4251050|B2|New Zealand||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|2|2.0||||||
4426896|NCT00151892|4251051|B1|New Zealand||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|4|4.0||||||
4426897|NCT00151892|4251049|B3|Germany||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|3|3.0||||||
4426898|NCT00151892|4251050|B2|Germany||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|1|1.0||||||
4426899|NCT00151892|4251051|B1|Germany||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|2|2.0||||||
4426900|NCT00151892|4251049|B3|Romania||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|21|21.0||||||
4426901|NCT00151892|4251050|B2|Romania||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|10|10.0||||||
4426902|NCT00151892|4251051|B1|Romania||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|11|11.0||||||
4426903|NCT00151892|4251049|B3|Singapore||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|7|7.0||||||
4426904|NCT00151892|4251050|B2|Singapore||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|4|4.0||||||
4426905|NCT00151892|4251051|B1|Singapore||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|3|3.0||||||
4426906|NCT00151892|4251049|B3|Poland||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|60|60.0||||||
4426907|NCT00151892|4251050|B2|Poland||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|31|31.0||||||
4426908|NCT00151892|4251051|B1|Poland||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|29|29.0||||||
4426909|NCT00151892|4251049|B3|Belgium||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|22|22.0||||||
4426910|NCT00151892|4251050|B2|Belgium||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|11|11.0||||||
4426911|NCT00151892|4251051|B1|Belgium||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|11|11.0||||||
4426912|NCT00151892|4251049|B3|Brazil||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|53|53.0||||||
4426913|NCT00151892|4251050|B2|Brazil||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|28|28.0||||||
4426914|NCT00151892|4251051|B1|Brazil||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|25|25.0||||||
4426915|NCT00151892|4251049|B3|Argentina||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|6|6.0||||||
4426916|NCT00151892|4251050|B2|Argentina||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|2|2.0||||||
4426917|NCT00151892|4251051|B1|Argentina||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|4|4.0||||||
4426918|NCT00151892|4251049|B3|Canada||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|29|29.0||||||
4426919|NCT00151892|4251050|B2|Canada||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|14|14.0||||||
4426920|NCT00151892|4251051|B1|Canada||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|15|15.0||||||
4426921|NCT00151892|4251049|B3|Mexico||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|17|17.0||||||
4426922|NCT00151892|4251050|B2|Mexico||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|10|10.0||||||
4426923|NCT00151892|4251051|B1|Mexico||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|7|7.0||||||
4426924|NCT00151892|4251049|B3|Czech Republic||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|104|104.0||||||
4426925|NCT00151892|4251050|B2|Czech Republic||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|54|54.0||||||
4426926|NCT00151892|4251051|B1|Czech Republic||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|50|50.0||||||
4426927|NCT00151892|4251049|B3|Hungary||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|50|50.0||||||
4426928|NCT00151892|4251050|B2|Hungary||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|25|25.0||||||
4426929|NCT00151892|4251051|B1|Hungary||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|25|25.0||||||
4426930|NCT00151892|4251049|B3|United Kingdom||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|14|14.0||||||
4426931|NCT00151892|4251050|B2|United Kingdom||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|7|7.0||||||
4426932|NCT00151892|4251051|B1|United Kingdom||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|7|7.0||||||
4426933|NCT00151892|4251049|B3|Korea, Republic of||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|31|31.0||||||
4426934|NCT00151892|4251050|B2|Korea, Republic of||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|14|14.0||||||
4426935|NCT00151892|4251051|B1|Korea, Republic of||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|17|17.0||||||
4426936|NCT00151892|4251049|B3|Netherlands||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|1|1.0||||||
4426937|NCT00151892|4251050|B2|Netherlands||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|0|0.0||||||
4426938|NCT00151892|4251051|B1|Netherlands||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|1|1.0||||||
4426939|NCT00151892|4251049|B3|South Africa||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|35|35.0||||||
4426940|NCT00151892|4251050|B2|South Africa||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|17|17.0||||||
4426941|NCT00151892|4251051|B1|South Africa||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|18|18.0||||||
4426942|NCT00151892|4251049|B3|Peru||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|14|14.0||||||
4426943|NCT00151892|4251050|B2|Peru||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|7|7.0||||||
4426944|NCT00151892|4251051|B1|Peru||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|7|7.0||||||
4426945|NCT00151892|4251049|B3|Australia||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|7|7.0||||||
4426946|NCT00151892|4251050|B2|Australia||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|3|3.0||||||
4426947|NCT00151892|4251051|B1|Australia||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|4|4.0||||||
4426948|NCT00151892|4251049|B3|Denmark||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|11|11.0||||||
4426949|NCT00151892|4251050|B2|Denmark||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|5|5.0||||||
4426950|NCT00151892|4251051|B1|Denmark||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|6|6.0||||||
4426951|NCT00151892|4251049|B3|France||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|5|5.0||||||
4426952|NCT00151892|4251050|B2|France||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|3|3.0||||||
4426953|NCT00151892|4251051|B1|France||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|2|2.0||||||
4426954|NCT00151892|4251049|B3|India||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|164|164.0||||||
4426955|NCT00151892|4251050|B2|India||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|83|83.0||||||
4426956|NCT00151892|4251051|B1|India||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|81|81.0||||||
4426957|NCT00151892|4251049|B3|Russian Federation||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|100|100.0||||||
4426958|NCT00151892|4251050|B2|Russian Federation||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|49|49.0||||||
4426959|NCT00151892|4251051|B1|Russian Federation||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|51|51.0||||||
4426960|NCT00151892|4251049|B3|Chile||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|8|8.0||||||
4426961|NCT00151892|4251050|B2|Chile||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|4|4.0||||||
4426962|NCT00151892|4251051|B1|Chile||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|4|4.0||||||
4426963|NCT00151892|4251049|B3|Spain||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|7|7.0||||||
4426993|NCT00151814|4251069|B1|||Weight||kg|Mean|32.0|32.0|Standard Deviation|16.31|16.31|||
4426964|NCT00151892|4251050|B2|Spain||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|4|4.0||||||
4426965|NCT00151892|4251051|B1|Spain||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|3|3.0||||||
4426966|NCT00151892|4251049|B3|Taiwan||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|1|1.0||||||
4426967|NCT00151892|4251050|B2|Taiwan||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|0|0.0||||||
4426968|NCT00151892|4251051|B1|Taiwan||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|1|1.0||||||
4426969|NCT00151892|4251049|B3|United States||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|46|46.0||||||
4426970|NCT00151892|4251050|B2|United States||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|22|22.0||||||
4426971|NCT00151892|4251051|B1|United States||Region of Enrollment|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|24|24.0||||||
4426972|NCT00151892|4251049|B3||Male|Sex: Female, Male|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|Participants|Count of Participants|426|426.0||||||
4426973|NCT00151892|4251050|B2||Male|Sex: Female, Male|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|Participants|Count of Participants|214|214.0||||||
4426974|NCT00151892|4251051|B1||Male|Sex: Female, Male|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|Participants|Count of Participants|212|212.0||||||
4426975|NCT00151892|4251049|B3||Female|Sex: Female, Male|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|Participants|Count of Participants|400|400.0||||||
4426976|NCT00151892|4251050|B2||Female|Sex: Female, Male|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|Participants|Count of Participants|197|197.0||||||
4426977|NCT00151892|4251051|B1||Female|Sex: Female, Male|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|Participants|Count of Participants|203|203.0||||||
4426978|NCT00151892|4251049|B3|||Age|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|years|Mean|45.1|45.1|Standard Deviation|13.74|13.74|||
4426979|NCT00151892|4251050|B2|||Age|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|years|Mean|45.2|45.2|Standard Deviation|13.44|13.44|||
4426980|NCT00151892|4251051|B1|||Age|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|years|Mean|45.0|45.0|Standard Deviation|14.05|14.05|||
4426981|NCT00151892|4251049|B3|>=65 years||Age, Customized|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|69|69.0||||||
4426982|NCT00151892|4251050|B2|>=65 years||Age, Customized|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|34|34.0||||||
4426983|NCT00151892|4251051|B1|>=65 years||Age, Customized|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|35|35.0||||||
4426984|NCT00151892|4251049|B3|18 to 64 years||Age, Customized|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|757|757.0||||||
4426985|NCT00151892|4251050|B2|18 to 64 years||Age, Customized|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|377|377.0||||||
4426986|NCT00151892|4251051|B1|18 to 64 years||Age, Customized|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|380|380.0||||||
4426987|NCT00151892|4251049|B3|<18 years||Age, Customized|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|0|0.0||||||
4426988|NCT00151892|4251050|B2|<18 years||Age, Customized|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|0|0.0||||||
4426989|NCT00151892|4251051|B1|<18 years||Age, Customized|Baseline characteristics were calculated from the Safety Population (n = 826) defined as all randomized subjects who received at least 1 dose of investigational product.|participants|Number|0|0.0||||||
4426990|NCT00151814|4251066|B4|||Weight||kg|Mean|70.6|70.6|Standard Deviation|30.09|30.09|||
4426991|NCT00151814|4251067|B3|||Weight||kg|Mean|86.3|86.3|Standard Deviation|29.50|29.5|||
4426992|NCT00151814|4251068|B2|||Weight||kg|Mean|70.3|70.3|Standard Deviation|20.53|20.53|||
4426994|NCT00151814|4251066|B4|||Height||cm|Mean|151.6|151.6|Standard Deviation|19.44|19.44|||
4426995|NCT00151814|4251067|B3|||Height||cm|Mean|165.5|165.5|Standard Deviation|9.74|9.74|||
4426996|NCT00151814|4251068|B2|||Height||cm|Mean|151.8|151.8|Standard Deviation|9.44|9.44|||
4426997|NCT00151814|4251069|B1|||Height||cm|Mean|116.7|116.7|Standard Deviation|9.01|9.01|||
4426998|NCT00151814|4251066|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4426999|NCT00151814|4251067|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4427000|NCT00151814|4251068|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4427001|NCT00151814|4251069|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4427002|NCT00151814|4251066|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4427003|NCT00151814|4251067|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4427004|NCT00151814|4251068|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4427005|NCT00151814|4251069|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4427006|NCT00151814|4251066|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4427007|NCT00151814|4251067|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4427008|NCT00151814|4251068|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4427009|NCT00151814|4251069|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4427010|NCT00151814|4251066|B4|||Age||years|Mean|11.2|11.2|Standard Deviation|3.76|3.76|||
4427011|NCT00151814|4251067|B3|||Age||years|Mean|14.8|14.8|Standard Deviation|1.03|1.03|||
4427012|NCT00151814|4251068|B2|||Age||years|Mean|10.2|10.2|Standard Deviation|1.03|1.03|||
4427013|NCT00151814|4251069|B1|||Age||years|Mean|4.8|4.8|Standard Deviation|0.50|0.5|||
4427014|NCT00151775|4251092|B6|||Weight|The data provided for the total study population is only for Cohort A+B|kg|Mean|71.1|71.1|Standard Deviation|36.72|36.72|||
4427015|NCT00151775|4251093|B5|||Weight|The data provided for the total study population is only for Cohort A+B|kg|Mean|16.9|16.9|Standard Deviation|6.61|6.61|||
4427016|NCT00151775|4251094|B4|||Weight|The data provided for the total study population is only for Cohort A+B|kg|Mean|68.1|68.1|Standard Deviation|34.36|34.36|||
4427017|NCT00151775|4251095|B3|||Weight|The data provided for the total study population is only for Cohort A+B|kg|Mean|66.2|66.2|Standard Deviation|32.39|32.39|||
4427018|NCT00151775|4251096|B2|||Weight|The data provided for the total study population is only for Cohort A+B|kg|Mean|78.9|78.9|Standard Deviation|41.85|41.85|||
4427019|NCT00151775|4251097|B1|||Weight|The data provided for the total study population is only for Cohort A+B|kg|Mean|68.0|68.0|Standard Deviation|34.22|34.22|||
4427020|NCT00151775|4251092|B6|||Seated diastolic blood pressure|The data provided for the total study population consists only of Cohort A+B|mm Hg|Mean|78.0|78.0|Standard Deviation|8.18|8.18|||
4427021|NCT00151775|4251093|B5|||Seated diastolic blood pressure|The data provided for the total study population consists only of Cohort A+B|mm Hg|Mean|72.7|72.7|Standard Deviation|8.74|8.74|||
4427022|NCT00151775|4251094|B4|||Seated diastolic blood pressure|The data provided for the total study population consists only of Cohort A+B|mm Hg|Mean|79.4|79.4|Standard Deviation|9.05|9.05|||
4427023|NCT00151775|4251095|B3|||Seated diastolic blood pressure|The data provided for the total study population consists only of Cohort A+B|mm Hg|Mean|79.2|79.2|Standard Deviation|7.08|7.08|||
4427024|NCT00151775|4251096|B2|||Seated diastolic blood pressure|The data provided for the total study population consists only of Cohort A+B|mm Hg|Mean|78.1|78.1|Standard Deviation|8.17|8.17|||
4427025|NCT00151775|4251097|B1|||Seated diastolic blood pressure|The data provided for the total study population consists only of Cohort A+B|mm Hg|Mean|76.3|76.3|Standard Deviation|8.09|8.09|||
4427026|NCT00151775|4251092|B6|||Seated Systolic blood pressure|The data provided for the total study population is only for Cohort A+B|mm Hg|Mean|130.0|130.0|Standard Deviation|9.00|9.0|||
4427027|NCT00151775|4251093|B5|||Seated Systolic blood pressure|The data provided for the total study population is only for Cohort A+B|mm Hg|Mean|115.2|115.2|Standard Deviation|8.74|8.74|||
4427028|NCT00151775|4251094|B4|||Seated Systolic blood pressure|The data provided for the total study population is only for Cohort A+B|mm Hg|Mean|131.7|131.7|Standard Deviation|9.12|9.12|||
4427029|NCT00151775|4251095|B3|||Seated Systolic blood pressure|The data provided for the total study population is only for Cohort A+B|mm Hg|Mean|130.8|130.8|Standard Deviation|9.73|9.73|||
4427030|NCT00151775|4251096|B2|||Seated Systolic blood pressure|The data provided for the total study population is only for Cohort A+B|mm Hg|Mean|129.5|129.5|Standard Deviation|9.10|9.1|||
4427031|NCT00151775|4251097|B1|||Seated Systolic blood pressure|The data provided for the total study population is only for Cohort A+B|mm Hg|Mean|129.1|129.1|Standard Deviation|8.32|8.32|||
4427032|NCT00151775|4251092|B6|||Height|The data provided for the total study population is only for Cohorts A+B|cm|Mean|154.6|154.6|Standard Deviation|17.79|17.79|||
4427033|NCT00151775|4251093|B5|||Height|The data provided for the total study population is only for Cohorts A+B|cm|Mean|98.3|98.3|Standard Deviation|12.92|12.92|||
4427034|NCT00151775|4251094|B4|||Height|The data provided for the total study population is only for Cohorts A+B|cm|Mean|156.1|156.1|Standard Deviation|14.21|14.21|||
4427035|NCT00151775|4251095|B3|||Height|The data provided for the total study population is only for Cohorts A+B|cm|Mean|154.2|154.2|Standard Deviation|17.83|17.83|||
4427036|NCT00151775|4251096|B2|||Height|The data provided for the total study population is only for Cohorts A+B|cm|Mean|155.1|155.1|Standard Deviation|19.12|19.12|||
4427037|NCT00151775|4251097|B1|||Height|The data provided for the total study population is only for Cohorts A+B|cm|Mean|153.3|153.3|Standard Deviation|18.46|18.46|||
4427038|NCT00151775|4251092|B6|non-Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|245|245.0||||||
4427039|NCT00151775|4251093|B5|non-Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4427040|NCT00151775|4251094|B4|non-Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4427161|NCT00150813|4251281|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4427041|NCT00151775|4251095|B3|non-Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4427042|NCT00151775|4251096|B2|non-Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
4427043|NCT00151775|4251097|B1|non-Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|53|53.0||||||
4427044|NCT00151775|4251092|B6|Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|117|117.0||||||
4427045|NCT00151775|4251093|B5|Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4427046|NCT00151775|4251094|B4|Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4427047|NCT00151775|4251095|B3|Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4427048|NCT00151775|4251096|B2|Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4427049|NCT00151775|4251097|B1|Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4427050|NCT00151775|4251092|B6||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4427051|NCT00151775|4251093|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4427052|NCT00151775|4251094|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4427053|NCT00151775|4251095|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4427054|NCT00151775|4251096|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4427055|NCT00151775|4251097|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4427056|NCT00151775|4251092|B6||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4427057|NCT00151775|4251093|B5||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4427058|NCT00151775|4251094|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4427059|NCT00151775|4251095|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4427060|NCT00151775|4251096|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4427061|NCT00151775|4251097|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4427062|NCT00151775|4251092|B6|||Age|The data provided for the total study population includes only Cohorts A+B.|years|Mean|12.3|12.3|Standard Deviation|2.85|2.85|||
4427063|NCT00151775|4251093|B5|||Age|The data provided for the total study population includes only Cohorts A+B.|years|Mean|3.4|3.4|Standard Deviation|1.45|1.45|||
4427064|NCT00151775|4251094|B4|||Age|The data provided for the total study population includes only Cohorts A+B.|years|Mean|12.8|12.8|Standard Deviation|2.42|2.42|||
4427065|NCT00151775|4251095|B3|||Age|The data provided for the total study population includes only Cohorts A+B.|years|Mean|12.2|12.2|Standard Deviation|2.83|2.83|||
4427066|NCT00151775|4251096|B2|||Age|The data provided for the total study population includes only Cohorts A+B.|years|Mean|12.3|12.3|Standard Deviation|2.98|2.98|||
4427067|NCT00151775|4251097|B1|||Age|The data provided for the total study population includes only Cohorts A+B.|years|Mean|12.1|12.1|Standard Deviation|2.97|2.97|||
4427068|NCT00151476|4251149|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4427069|NCT00151476|4251150|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4427070|NCT00151476|4251151|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4427071|NCT00151476|4251152|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4427072|NCT00151476|4251149|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4427073|NCT00151476|4251150|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4427074|NCT00151476|4251151|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4427075|NCT00151476|4251152|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4427076|NCT00151476|4251149|B4|Age not available (no surgery)||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|7|7.0||||||
4427077|NCT00151476|4251150|B3|Age not available (no surgery)||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|6|6.0||||||
4427078|NCT00151476|4251151|B2|Age not available (no surgery)||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|1|1.0||||||
4427079|NCT00151476|4251152|B1|Age not available (no surgery)||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|0|0.0||||||
4427080|NCT00151476|4251149|B4|>64 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|0|0.0||||||
4427081|NCT00151476|4251150|B3|>64 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|0|0.0||||||
4427082|NCT00151476|4251151|B2|>64 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|0|0.0||||||
4427162|NCT00150813|4251281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4427163|NCT00150813|4251281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427083|NCT00151476|4251152|B1|>64 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|0|0.0||||||
4427084|NCT00151476|4251149|B4|55 to 64 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|1|1.0||||||
4427085|NCT00151476|4251150|B3|55 to 64 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|1|1.0||||||
4427086|NCT00151476|4251151|B2|55 to 64 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|0|0.0||||||
4427087|NCT00151476|4251152|B1|55 to 64 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|0|0.0||||||
4427088|NCT00151476|4251149|B4|45 to 54 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|5|5.0||||||
4427089|NCT00151476|4251150|B3|45 to 54 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|3|3.0||||||
4427090|NCT00151476|4251151|B2|45 to 54 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|1|1.0||9.00|9.0|||
4427091|NCT00151476|4251152|B1|45 to 54 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|1|1.0||11.24|11.24|||
4427092|NCT00151476|4251149|B4|35 to 44 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|13|13.0||||||
4427093|NCT00151476|4251150|B3|35 to 44 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|8|8.0||||||
4427094|NCT00151476|4251151|B2|35 to 44 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|2|2.0||||||
4427095|NCT00151476|4251152|B1|35 to 44 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|3|3.0||||||
4427096|NCT00151476|4251149|B4|25 to 34 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|14|14.0||||||
4427097|NCT00151476|4251150|B3|25 to 34 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|5|5.0||||||
4427098|NCT00151476|4251151|B2|25 to 34 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|4|4.0||||||
4427099|NCT00151476|4251152|B1|25 to 34 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|5|5.0||||||
4427100|NCT00151476|4251149|B4|<25 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|27|27.0||||||
4427101|NCT00151476|4251150|B3|<25 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|18|18.0||||||
4427102|NCT00151476|4251151|B2|<25 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|5|5.0||||||
4427164|NCT00150800|4251285|B1||Other/Mixed|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
4427227|NCT00150592|4251335|B3|||Age||years|Mean|12.6|12.6|Standard Deviation|2.81|2.81|||
4427103|NCT00151476|4251152|B1|<25 years||Age, Customized|Age range groups at most recent FAP-related surgery (years). Prior to start of study follow-up = prior to baseline. Start of study follow-up: start of on-study celecoxib treatment period for celecoxib-treated subjects and index date for control subjects = baseline.|participants|Number|4|4.0||||||
4427104|NCT00151411|4251208|B3|United States||Region of Enrollment||participants|Number|114|114.0||||||
4427105|NCT00151411|4251209|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4427106|NCT00151411|4251210|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4427107|NCT00151411|4251208|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4427108|NCT00151411|4251209|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4427109|NCT00151411|4251210|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4427110|NCT00151411|4251208|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4427111|NCT00151411|4251209|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4427112|NCT00151411|4251210|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4427113|NCT00151411|4251208|B3|||Age||years|Mean|28.9|28.9|Standard Deviation|4.6|4.6|||
4427114|NCT00151411|4251209|B2|||Age||years|Mean|28.8|28.8|Standard Deviation|4.6|4.6|||
4427115|NCT00151411|4251210|B1|||Age||years|Mean|29|29.0|Standard Deviation|4.5|4.5|||
4427116|NCT00151411|4251208|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427117|NCT00151411|4251209|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427118|NCT00151411|4251210|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427119|NCT00151411|4251208|B3||Between 18 and 65 years|Age||Participants|Count of Participants|114|114.0||||||
4427120|NCT00151411|4251209|B2||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4427121|NCT00151411|4251210|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4427122|NCT00151411|4251208|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427123|NCT00151411|4251209|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427124|NCT00151411|4251210|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427125|NCT00151372|4251221|B3|United States||Region of Enrollment||participants|Number|141|141.0||||||
4427126|NCT00151372|4251222|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4427127|NCT00151372|4251223|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4427128|NCT00151372|4251221|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4427129|NCT00151372|4251222|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4427130|NCT00151372|4251223|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4427131|NCT00151372|4251221|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4427132|NCT00151372|4251222|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4427133|NCT00151372|4251223|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4427134|NCT00151372|4251221|B3|||Age||years|Mean|71.4|71.4|Standard Deviation|8.4|8.4|||
4427135|NCT00151372|4251222|B2|||Age||years|Mean|71.5|71.5|Standard Deviation|8.0|8.0|||
4427136|NCT00151372|4251223|B1|||Age||years|Mean|71.24|71.24|Standard Deviation|8.54|8.54|||
4427137|NCT00151320|4251232|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4427138|NCT00151320|4251233|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4427139|NCT00151320|4251234|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4427140|NCT00151320|4251232|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4427141|NCT00151320|4251233|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4427142|NCT00151320|4251234|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4427143|NCT00151320|4251232|B3|||Age||years|Median|63|63.0|Full Range|||20.0|87.0|
4427144|NCT00151320|4251233|B2|||Age||years|Median|66|66.0|Full Range|||45.0|80.0|
4427145|NCT00151320|4251234|B1|||Age||years|Median|56|56.0|Full Range|||20.0|87.0|
4427146|NCT00151281|4251239|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4427147|NCT00151281|4251239|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4427148|NCT00151281|4251239|B1|||Age||years|Median|68|68.0|Full Range|||52.0|81.0|
4427149|NCT00150969|4251246|B3||Male|Sex: Female, Male|All Participants were community dwelling post-menopausal women|Participants|Count of Participants|0|0.0||||||
4427150|NCT00150969|4251247|B2||Male|Sex: Female, Male|All Participants were community dwelling post-menopausal women|Participants|Count of Participants|0|0.0||||||
4427151|NCT00150969|4251248|B1||Male|Sex: Female, Male|All Participants were community dwelling post-menopausal women|Participants|Count of Participants|0|0.0||||||
4427152|NCT00150969|4251246|B3||Female|Sex: Female, Male|All Participants were community dwelling post-menopausal women|Participants|Count of Participants|440|440.0||||||
4427153|NCT00150969|4251247|B2||Female|Sex: Female, Male|All Participants were community dwelling post-menopausal women|Participants|Count of Participants|223|223.0||||||
4427154|NCT00150969|4251248|B1||Female|Sex: Female, Male|All Participants were community dwelling post-menopausal women|Participants|Count of Participants|217|217.0||||||
4427155|NCT00150969|4251246|B3|||Age||years|Mean|59.0|59.0|Full Range|||40.1|82.3|
4427156|NCT00150969|4251247|B2|||Age||years|Mean|59.2|59.2|Full Range|||46.1|82.3|
4427157|NCT00150969|4251248|B1|||Age||years|Mean|58.9|58.9|Full Range|||40.1|80.5|
4427158|NCT00150813|4251281|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4427159|NCT00150813|4251281|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4427160|NCT00150813|4251281|B1|||Age||years|Mean|41.39|41.39|Standard Deviation|18.27|18.27|||
4427165|NCT00150800|4251285|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|361|361.0||||||
4427166|NCT00150800|4251285|B1||Native Hawaiian Or Other Pacific Islander|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4427167|NCT00150800|4251285|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4427168|NCT00150800|4251285|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|206|206.0||||||
4427169|NCT00150800|4251285|B1||American Indian/Alaskan Native|Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4427170|NCT00150800|4251285|B1||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4427171|NCT00150800|4251285|B1||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4427172|NCT00150800|4251285|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|12.2|12.2|||
4427173|NCT00150800|4251285|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4427174|NCT00150800|4251285|B1||Between 18 and 65 years|Age||Participants|Count of Participants|632|632.0||||||
4427175|NCT00150800|4251285|B1||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4427176|NCT00150618|4251294|B6|United States||Region of Enrollment||participants|Number|322|322.0||||||
4427177|NCT00150618|4251295|B5|United States||Region of Enrollment||participants|Number|66|66.0||||||
4427178|NCT00150618|4251296|B4|United States||Region of Enrollment||participants|Number|65|65.0||||||
4427179|NCT00150618|4251297|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4427180|NCT00150618|4251298|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4427181|NCT00150618|4251299|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4427182|NCT00150618|4251294|B6||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4427183|NCT00150618|4251295|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4427184|NCT00150618|4251296|B4||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4427185|NCT00150618|4251297|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4427186|NCT00150618|4251298|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4427187|NCT00150618|4251299|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4427188|NCT00150618|4251294|B6||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4427189|NCT00150618|4251295|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4427190|NCT00150618|4251296|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4427191|NCT00150618|4251297|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4427192|NCT00150618|4251298|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4427193|NCT00150618|4251299|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4427194|NCT00150618|4251294|B6|||Age||years|Mean|10.5|10.5|Standard Deviation|2.74|2.74|||
4427195|NCT00150618|4251295|B5|||Age||years|Mean|10.8|10.8|Standard Deviation|2.89|2.89|||
4427196|NCT00150618|4251296|B4|||Age||years|Mean|10.5|10.5|Standard Deviation|2.53|2.53|||
4427197|NCT00150618|4251297|B3|||Age||years|Mean|11.1|11.1|Standard Deviation|2.96|2.96|||
4427198|NCT00150618|4251298|B2|||Age||years|Mean|10.6|10.6|Standard Deviation|2.81|2.81|||
4427199|NCT00150618|4251299|B1|||Age||years|Mean|9.3|9.3|Standard Deviation|2.14|2.14|||
4427200|NCT00150618|4251294|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427201|NCT00150618|4251295|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427202|NCT00150618|4251296|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427203|NCT00150618|4251297|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427204|NCT00150618|4251298|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427205|NCT00150618|4251299|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427206|NCT00150618|4251294|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4427207|NCT00150618|4251295|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4427208|NCT00150618|4251296|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4427209|NCT00150618|4251297|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4427210|NCT00150618|4251298|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4427211|NCT00150618|4251299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4427212|NCT00150618|4251294|B6||<=18 years|Age||Participants|Count of Participants|322|322.0||||||
4427213|NCT00150618|4251295|B5||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
4427214|NCT00150618|4251296|B4||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
4427215|NCT00150618|4251297|B3||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
4427216|NCT00150618|4251298|B2||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
4427217|NCT00150618|4251299|B1||<=18 years|Age||Participants|Count of Participants|61|61.0||||||
4427218|NCT00150592|4251335|B3|United States||Region of Enrollment||participants|Number|178|178.0||||||
4427219|NCT00150592|4251336|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4427220|NCT00150592|4251337|B1|United States||Region of Enrollment||participants|Number|121|121.0||||||
4427221|NCT00150592|4251335|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4427222|NCT00150592|4251336|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4427223|NCT00150592|4251337|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4427224|NCT00150592|4251335|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4427225|NCT00150592|4251336|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4427226|NCT00150592|4251337|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4427228|NCT00150592|4251336|B2|||Age||years|Mean|12.8|12.8|Standard Deviation|2.77|2.77|||
4427229|NCT00150592|4251337|B1|||Age||years|Mean|12.6|12.6|Standard Deviation|2.83|2.83|||
4427230|NCT00150592|4251335|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427231|NCT00150592|4251336|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427232|NCT00150592|4251337|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427233|NCT00150592|4251335|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4427234|NCT00150592|4251336|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4427235|NCT00150592|4251337|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4427236|NCT00150592|4251335|B3||<=18 years|Age||Participants|Count of Participants|178|178.0||||||
4427237|NCT00150592|4251336|B2||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4427238|NCT00150592|4251337|B1||<=18 years|Age||Participants|Count of Participants|121|121.0||||||
4427239|NCT00150462|4251358|B12|Hodgkin's Disease||Disease Diagnosis||participants|Number|1|1.0||||||
4427240|NCT00150462|4251359|B11|Hodgkin's Disease||Disease Diagnosis||participants|Number|0|0.0||||||
4427241|NCT00150462|4251360|B10|Hodgkin's Disease||Disease Diagnosis||participants|Number|0|0.0||||||
4427242|NCT00150462|4251361|B9|Hodgkin's Disease||Disease Diagnosis||participants|Number|0|0.0||||||
4427243|NCT00150462|4251362|B8|Hodgkin's Disease||Disease Diagnosis||participants|Number|0|0.0||||||
4427244|NCT00150462|4251363|B7|Hodgkin's Disease||Disease Diagnosis||participants|Number|0|0.0||||||
4427245|NCT00150462|4251364|B6|Hodgkin's Disease||Disease Diagnosis||participants|Number|0|0.0||||||
4427246|NCT00150462|4251365|B5|Hodgkin's Disease||Disease Diagnosis||participants|Number|0|0.0||||||
4427247|NCT00150462|4251366|B4|Hodgkin's Disease||Disease Diagnosis||participants|Number|0|0.0||||||
4427248|NCT00150462|4251367|B3|Hodgkin's Disease||Disease Diagnosis||participants|Number|1|1.0||||||
4427249|NCT00150462|4251368|B2|Hodgkin's Disease||Disease Diagnosis||participants|Number|0|0.0||||||
4427250|NCT00150462|4251369|B1|Hodgkin's Disease||Disease Diagnosis||participants|Number|0|0.0||||||
4427251|NCT00150462|4251358|B12|Waldenstrom's Macroglobulinemia||Disease Diagnosis||participants|Number|2|2.0||||||
4427252|NCT00150462|4251359|B11|Waldenstrom's Macroglobulinemia||Disease Diagnosis||participants|Number|0|0.0||||||
4427253|NCT00150462|4251360|B10|Waldenstrom's Macroglobulinemia||Disease Diagnosis||participants|Number|2|2.0||||||
4427254|NCT00150462|4251361|B9|Waldenstrom's Macroglobulinemia||Disease Diagnosis||participants|Number|0|0.0||||||
4427255|NCT00150462|4251362|B8|Waldenstrom's Macroglobulinemia||Disease Diagnosis||participants|Number|0|0.0||||||
4427256|NCT00150462|4251363|B7|Waldenstrom's Macroglobulinemia||Disease Diagnosis||participants|Number|0|0.0||||||
4427257|NCT00150462|4251364|B6|Waldenstrom's Macroglobulinemia||Disease Diagnosis||participants|Number|0|0.0||||||
4427258|NCT00150462|4251365|B5|Waldenstrom's Macroglobulinemia||Disease Diagnosis||participants|Number|0|0.0||||||
4427259|NCT00150462|4251366|B4|Waldenstrom's Macroglobulinemia||Disease Diagnosis||participants|Number|0|0.0||||||
4427260|NCT00150462|4251367|B3|Waldenstrom's Macroglobulinemia||Disease Diagnosis||participants|Number|0|0.0||||||
4427261|NCT00150462|4251368|B2|Waldenstrom's Macroglobulinemia||Disease Diagnosis||participants|Number|0|0.0||||||
4427262|NCT00150462|4251369|B1|Waldenstrom's Macroglobulinemia||Disease Diagnosis||participants|Number|0|0.0||||||
4427263|NCT00150462|4251358|B12|Non-Hodgkin's Lymphoma||Disease Diagnosis||participants|Number|17|17.0||||||
4427264|NCT00150462|4251359|B11|Non-Hodgkin's Lymphoma||Disease Diagnosis||participants|Number|0|0.0||||||
4427265|NCT00150462|4251360|B10|Non-Hodgkin's Lymphoma||Disease Diagnosis||participants|Number|2|2.0||||||
4427266|NCT00150462|4251361|B9|Non-Hodgkin's Lymphoma||Disease Diagnosis||participants|Number|1|1.0||||||
4427267|NCT00150462|4251362|B8|Non-Hodgkin's Lymphoma||Disease Diagnosis||participants|Number|2|2.0||||||
4427268|NCT00150462|4251363|B7|Non-Hodgkin's Lymphoma||Disease Diagnosis||participants|Number|1|1.0||||||
4427269|NCT00150462|4251364|B6|Non-Hodgkin's Lymphoma||Disease Diagnosis||participants|Number|2|2.0||||||
4427270|NCT00150462|4251365|B5|Non-Hodgkin's Lymphoma||Disease Diagnosis||participants|Number|2|2.0||||||
4427271|NCT00150462|4251366|B4|Non-Hodgkin's Lymphoma||Disease Diagnosis||participants|Number|1|1.0||||||
4427272|NCT00150462|4251367|B3|Non-Hodgkin's Lymphoma||Disease Diagnosis||participants|Number|3|3.0||||||
4427273|NCT00150462|4251368|B2|Non-Hodgkin's Lymphoma||Disease Diagnosis||participants|Number|0|0.0||||||
4427274|NCT00150462|4251369|B1|Non-Hodgkin's Lymphoma||Disease Diagnosis||participants|Number|3|3.0||||||
4427275|NCT00150462|4251358|B12|Multiple Myeloma||Disease Diagnosis||participants|Number|28|28.0||||||
4427276|NCT00150462|4251359|B11|Multiple Myeloma||Disease Diagnosis||participants|Number|4|4.0||||||
4427277|NCT00150462|4251360|B10|Multiple Myeloma||Disease Diagnosis||participants|Number|3|3.0||||||
4427278|NCT00150462|4251361|B9|Multiple Myeloma||Disease Diagnosis||participants|Number|5|5.0||||||
4427279|NCT00150462|4251362|B8|Multiple Myeloma||Disease Diagnosis||participants|Number|6|6.0||||||
4427280|NCT00150462|4251363|B7|Multiple Myeloma||Disease Diagnosis||participants|Number|2|2.0||||||
4427281|NCT00150462|4251364|B6|Multiple Myeloma||Disease Diagnosis||participants|Number|2|2.0||||||
4427282|NCT00150462|4251365|B5|Multiple Myeloma||Disease Diagnosis||participants|Number|1|1.0||||||
4427283|NCT00150462|4251366|B4|Multiple Myeloma||Disease Diagnosis||participants|Number|2|2.0||||||
4427284|NCT00150462|4251367|B3|Multiple Myeloma||Disease Diagnosis||participants|Number|0|0.0||||||
4427285|NCT00150462|4251368|B2|Multiple Myeloma||Disease Diagnosis||participants|Number|3|3.0||||||
4427286|NCT00150462|4251369|B1|Multiple Myeloma||Disease Diagnosis||participants|Number|0|0.0||||||
4427287|NCT00150462|4251358|B12|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4427288|NCT00150462|4251359|B11|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427289|NCT00150462|4251360|B10|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427290|NCT00150462|4251361|B9|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427291|NCT00150462|4251362|B8|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4427292|NCT00150462|4251363|B7|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427293|NCT00150462|4251364|B6|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427294|NCT00150462|4251365|B5|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427295|NCT00150462|4251366|B4|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427296|NCT00150462|4251367|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4427297|NCT00150462|4251368|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427298|NCT00150462|4251369|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427299|NCT00150462|4251358|B12|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4427300|NCT00150462|4251359|B11|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427301|NCT00150462|4251360|B10|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427302|NCT00150462|4251361|B9|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427303|NCT00150462|4251362|B8|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427304|NCT00150462|4251363|B7|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427305|NCT00150462|4251364|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427306|NCT00150462|4251365|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427307|NCT00150462|4251366|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427308|NCT00150462|4251367|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427309|NCT00150462|4251368|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4427310|NCT00150462|4251369|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427311|NCT00150462|4251358|B12|Caucasian||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4427312|NCT00150462|4251359|B11|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4427313|NCT00150462|4251360|B10|Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4427314|NCT00150462|4251361|B9|Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4427315|NCT00150462|4251362|B8|Caucasian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4427316|NCT00150462|4251363|B7|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4427317|NCT00150462|4251364|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4427318|NCT00150462|4251365|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4427319|NCT00150462|4251366|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4427320|NCT00150462|4251367|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4427321|NCT00150462|4251368|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4427322|NCT00150462|4251369|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4427323|NCT00150462|4251358|B12|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4427324|NCT00150462|4251359|B11|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4427325|NCT00150462|4251360|B10|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4427326|NCT00150462|4251361|B9|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427327|NCT00150462|4251362|B8|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427328|NCT00150462|4251363|B7|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427329|NCT00150462|4251364|B6|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427330|NCT00150462|4251365|B5|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4427331|NCT00150462|4251366|B4|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427332|NCT00150462|4251367|B3|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427333|NCT00150462|4251368|B2|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427334|NCT00150462|4251369|B1|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427335|NCT00150462|4251358|B12||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4427336|NCT00150462|4251359|B11||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4427337|NCT00150462|4251360|B10||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4427338|NCT00150462|4251361|B9||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4427339|NCT00150462|4251362|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4427340|NCT00150462|4251363|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4427341|NCT00150462|4251364|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4427342|NCT00150462|4251365|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4427343|NCT00150462|4251366|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4427344|NCT00150462|4251367|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4427345|NCT00150462|4251368|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4427346|NCT00150462|4251369|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4427347|NCT00150462|4251358|B12||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4427348|NCT00150462|4251359|B11||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4427349|NCT00150462|4251360|B10||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4427350|NCT00150462|4251361|B9||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4427351|NCT00150462|4251362|B8||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4427352|NCT00150462|4251363|B7||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4427353|NCT00150462|4251364|B6||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4427354|NCT00150462|4251365|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4427355|NCT00150462|4251366|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4427356|NCT00150462|4251367|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4427357|NCT00150462|4251368|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4427358|NCT00150462|4251369|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4427359|NCT00150462|4251358|B12|Dose Expansion (Part 2)||Age||years|Mean|61.9|61.9|Standard Deviation|11.96|11.96|||
4427360|NCT00150462|4251359|B11|Dose Expansion (Part 2)||Age||years|Mean|54.3|54.3|Standard Deviation|13.57|13.57|||
4427361|NCT00150462|4251360|B10|Dose Expansion (Part 2)||Age||years|Mean|66.3|66.3|Standard Deviation|9.21|9.21|||
4427362|NCT00150462|4251361|B9|Dose Expansion (Part 2)||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for Part 1 groups
4427363|NCT00150462|4251362|B8|Dose Expansion (Part 2)||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for Part 1 groups
4427364|NCT00150462|4251363|B7|Dose Expansion (Part 2)||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for Part 1 groups
4427365|NCT00150462|4251364|B6|Dose Expansion (Part 2)||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for Part 1 groups
4427366|NCT00150462|4251365|B5|Dose Expansion (Part 2)||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for Part 1 groups
4427367|NCT00150462|4251366|B4|Dose Expansion (Part 2)||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for Part 1 groups
4427368|NCT00150462|4251367|B3|Dose Expansion (Part 2)||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for Part 1 groups
4427369|NCT00150462|4251368|B2|Dose Expansion (Part 2)||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for Part 1 groups
4427370|NCT00150462|4251369|B1|Dose Expansion (Part 2)||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for Part 1 groups
4427371|NCT00150462|4251358|B12|Dose Escalation (Part 1)||Age||years|Mean|60.6|60.6|Standard Deviation|12.25|12.25|||
4427372|NCT00150462|4251359|B11|Dose Escalation (Part 1)||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for Part 2 groups
4427373|NCT00150462|4251360|B10|Dose Escalation (Part 1)||Age||years|Mean|NA||Standard Deviation|NA||||Not applicable for Part 2 groups
4427374|NCT00150462|4251361|B9|Dose Escalation (Part 1)||Age||years|Mean|67.6|67.6|Standard Deviation|9.82|9.82|||
4427375|NCT00150462|4251362|B8|Dose Escalation (Part 1)||Age||years|Mean|60.6|60.6|Standard Deviation|11.99|11.99|||
4427376|NCT00150462|4251363|B7|Dose Escalation (Part 1)||Age||years|Mean|50.3|50.3|Standard Deviation|12.99|12.99|||
4427377|NCT00150462|4251364|B6|Dose Escalation (Part 1)||Age||years|Mean|61.3|61.3|Standard Deviation|3.76|3.76|||
4427378|NCT00150462|4251365|B5|Dose Escalation (Part 1)||Age||years|Mean|61.6|61.6|Standard Deviation|9.15|9.15|||
4427379|NCT00150462|4251366|B4|Dose Escalation (Part 1)||Age||years|Mean|51.7|51.7|Standard Deviation|6.20|6.2|||
4427380|NCT00150462|4251367|B3|Dose Escalation (Part 1)||Age||years|Mean|55.3|55.3|Standard Deviation|21.71|21.71|||
4427381|NCT00150462|4251368|B2|Dose Escalation (Part 1)||Age||years|Mean|69.6|69.6|Standard Deviation|4.80|4.8|||
4427382|NCT00150462|4251369|B1|Dose Escalation (Part 1)||Age||years|Mean|62.5|62.5|Standard Deviation|17.47|17.47|||
4427383|NCT00150345|4251487|B3|||Height||centimeters (cm)|Mean|172.0|172.0|Full Range|||150.0|198.0|
4427384|NCT00150345|4251488|B2|||Height||centimeters (cm)|Mean|171.9|171.9|Full Range|||153.0|198.0|
4427385|NCT00150345|4251489|B1|||Height||centimeters (cm)|Mean|172.1|172.1|Full Range|||150.0|196.0|
4427386|NCT00150345|4251487|B3|||Weight||kilograms (kg)|Mean|78.1|78.1|Full Range|||42.0|152.0|
4427387|NCT00150345|4251488|B2|||Weight||kilograms (kg)|Mean|79.2|79.2|Full Range|||45.3|152.0|
4427388|NCT00150345|4251489|B1|||Weight||kilograms (kg)|Mean|77.1|77.1|Full Range|||42.0|112.5|
4427389|NCT00150345|4251487|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4427390|NCT00150345|4251488|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4427391|NCT00150345|4251489|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4427392|NCT00150345|4251487|B3|White||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
4427393|NCT00150345|4251488|B2|White||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4427394|NCT00150345|4251489|B1|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4427395|NCT00150345|4251487|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4427396|NCT00150345|4251488|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4427397|NCT00150345|4251489|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4427398|NCT00150345|4251487|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4427399|NCT00150345|4251488|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4427400|NCT00150345|4251489|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4427401|NCT00150345|4251487|B3|>=65 years||Age, Customized||participants|Number|35|35.0||||||
4427402|NCT00150345|4251488|B2|>=65 years||Age, Customized||participants|Number|14|14.0||||||
4427403|NCT00150345|4251489|B1|>=65 years||Age, Customized||participants|Number|21|21.0||||||
4427404|NCT00150345|4251487|B3|Between 45 and 64 years||Age, Customized||participants|Number|66|66.0||||||
4427405|NCT00150345|4251488|B2|Between 45 and 64 years||Age, Customized||participants|Number|35|35.0||||||
4427406|NCT00150345|4251489|B1|Between 45 and 64 years||Age, Customized||participants|Number|31|31.0||||||
4427407|NCT00150345|4251487|B3|Between 18 and 44 years||Age, Customized||participants|Number|46|46.0||||||
4427408|NCT00150345|4251488|B2|Between 18 and 44 years||Age, Customized||participants|Number|17|17.0||||||
4427409|NCT00150345|4251489|B1|Between 18 and 44 years||Age, Customized||participants|Number|29|29.0||||||
4427410|NCT00150176|4251552|B3||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4427411|NCT00150176|4251553|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4427412|NCT00150176|4251554|B1||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4427413|NCT00150176|4251552|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4427414|NCT00150176|4251553|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4427415|NCT00150176|4251554|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4427416|NCT00150176|4251552|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|12.08|12.08|||
4427417|NCT00150176|4251553|B2|||Age||years|Mean|38.7|38.7|Standard Deviation|11.64|11.64|||
4427418|NCT00150176|4251554|B1|||Age||years|Mean|39.2|39.2|Standard Deviation|12.53|12.53|||
4427419|NCT00149994|4251564|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4427420|NCT00149994|4251565|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4427421|NCT00149994|4251566|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4427422|NCT00149994|4251564|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4427423|NCT00149994|4251565|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4427424|NCT00149994|4251566|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4427425|NCT00149994|4251564|B3|||Age|Baseline measures are based on intention to treat (ITT) population.|Years|Mean|48.98|48.98|Standard Deviation|11.029|11.029|||
4427426|NCT00149994|4251565|B2|||Age|Baseline measures are based on intention to treat (ITT) population.|Years|Mean|49.9|49.9|Standard Deviation|9.886|9.886|||
4427427|NCT00149994|4251566|B1|||Age|Baseline measures are based on intention to treat (ITT) population.|Years|Mean|48.1|48.1|Standard Deviation|12.069|12.069|||
4427428|NCT00149890|4251573|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4427429|NCT00149890|4251574|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4427430|NCT00149890|4251575|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4427431|NCT00149890|4251573|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4427432|NCT00149890|4251574|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4427433|NCT00149890|4251575|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4427434|NCT00149890|4251573|B3|from 2 to 16 years||Age, Customized||participants|Number|32|32.0||||||
4427435|NCT00149890|4251574|B2|from 2 to 16 years||Age, Customized||participants|Number|14|14.0||||||
4427436|NCT00149890|4251575|B1|from 2 to 16 years||Age, Customized||participants|Number|18|18.0||||||
4427437|NCT00149890|4251573|B3|<2 years||Age, Customized||participants|Number|45|45.0||||||
4427438|NCT00149890|4251574|B2|<2 years||Age, Customized||participants|Number|24|24.0||||||
4427439|NCT00149890|4251575|B1|<2 years||Age, Customized||participants|Number|21|21.0||||||
4427440|NCT00149890|4251573|B3|||Age||years|Mean|3.39|3.39|Standard Deviation|4.74|4.74|||
4427441|NCT00149890|4251574|B2|||Age||years|Mean|3.71|3.71|Standard Deviation|5.36|5.36|||
4427442|NCT00149890|4251575|B1|||Age||years|Mean|3.08|3.08|Standard Deviation|4.09|4.09|||
4427443|NCT00149838|4251594|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4427444|NCT00149838|4251595|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4427445|NCT00149838|4251596|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4427446|NCT00149838|4251594|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4427447|NCT00149838|4251595|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4427448|NCT00149838|4251596|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4427449|NCT00149838|4251594|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|11.5|11.5|||
4427450|NCT00149838|4251595|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|12.3|12.3|||
4427451|NCT00149838|4251596|B1|||Age||years|Mean|47.7|47.7|Standard Deviation|10.6|10.6|||
4427452|NCT00149825|4251609|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4427453|NCT00149825|4251610|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4427454|NCT00149825|4251611|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4427455|NCT00149825|4251609|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4427456|NCT00149825|4251610|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4427457|NCT00149825|4251611|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4427458|NCT00149825|4251609|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4427459|NCT00149825|4251610|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4427460|NCT00149825|4251611|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4427461|NCT00149825|4251609|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|13.3|13.3|||
4427462|NCT00149825|4251610|B2|||Age||years|Mean|47.8|47.8|Standard Deviation|13.4|13.4|||
4427463|NCT00149825|4251611|B1|||Age||years|Mean|49.5|49.5|Standard Deviation|13.6|13.6|||
4427464|NCT00149825|4251609|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4427465|NCT00149825|4251610|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4427466|NCT00149825|4251611|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4427467|NCT00149825|4251609|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4427468|NCT00149825|4251610|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4427469|NCT00149825|4251611|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4427470|NCT00149825|4251609|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427471|NCT00149825|4251610|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427472|NCT00149825|4251611|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427473|NCT00149799|4251620|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4427474|NCT00149799|4251621|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4427475|NCT00149799|4251622|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4427476|NCT00149799|4251620|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4427477|NCT00149799|4251621|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4427478|NCT00149799|4251622|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427479|NCT00149799|4251620|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4427480|NCT00149799|4251621|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4427481|NCT00149799|4251622|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4427482|NCT00149799|4251620|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4427483|NCT00149799|4251621|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4427484|NCT00149799|4251622|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4427485|NCT00149799|4251620|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427486|NCT00149799|4251621|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427487|NCT00149799|4251622|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427488|NCT00149799|4251620|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4427489|NCT00149799|4251621|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4427490|NCT00149799|4251622|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4427491|NCT00149799|4251620|B3||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4427492|NCT00149799|4251621|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4427493|NCT00149799|4251622|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4427494|NCT00149799|4251620|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4427495|NCT00149799|4251621|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4427496|NCT00149799|4251622|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4427497|NCT00149799|4251620|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427498|NCT00149799|4251621|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427499|NCT00149799|4251622|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427500|NCT00149799|4251620|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4427501|NCT00149799|4251621|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427502|NCT00149799|4251622|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4427503|NCT00149799|4251620|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4427504|NCT00149799|4251621|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4427505|NCT00149799|4251622|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427506|NCT00149799|4251620|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4427507|NCT00149799|4251621|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4427508|NCT00149799|4251622|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4427509|NCT00149799|4251620|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4427510|NCT00149799|4251621|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4427511|NCT00149799|4251622|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4427512|NCT00149799|4251620|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4427513|NCT00149799|4251621|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4427514|NCT00149799|4251622|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4427515|NCT00149799|4251620|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4427516|NCT00149799|4251621|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4427517|NCT00149799|4251622|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4427518|NCT00149799|4251620|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4427519|NCT00149799|4251621|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4427520|NCT00149799|4251622|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427521|NCT00149799|4251620|B3|||Age||years|Mean|33.5|33.5|Standard Deviation|12.4|12.4|||
4427522|NCT00149799|4251621|B2|||Age||years|Mean|31.8|31.8|Standard Deviation|13.5|13.5|||
4427523|NCT00149799|4251622|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|12.4|12.4|||
4427524|NCT00149747|4251638|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4427525|NCT00149747|4251639|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4427526|NCT00149747|4251640|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4427527|NCT00149747|4251638|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4427528|NCT00149747|4251639|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4427529|NCT00149747|4251640|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4427530|NCT00149747|4251638|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427531|NCT00149747|4251639|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427532|NCT00149747|4251640|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427533|NCT00149747|4251638|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4427534|NCT00149747|4251639|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4427535|NCT00149747|4251640|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4427536|NCT00149747|4251638|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427537|NCT00149747|4251639|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427538|NCT00149747|4251640|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427539|NCT00149669|4251651|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4427540|NCT00149669|4251652|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4427541|NCT00149669|4251653|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4427542|NCT00149669|4251651|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4427543|NCT00149669|4251652|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4427544|NCT00149669|4251653|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4427545|NCT00149669|4251651|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4427546|NCT00149669|4251652|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4427547|NCT00149669|4251653|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4427548|NCT00149669|4251651|B3|||Age||years|Mean|45|45.0|Standard Deviation|8|8.0|||
4427549|NCT00149669|4251652|B2|||Age||years|Mean|43|43.0|Standard Deviation|9|9.0|||
4427550|NCT00149669|4251653|B1|||Age||years|Mean|47|47.0|Standard Deviation|7|7.0|||
4427551|NCT00149669|4251651|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427552|NCT00149669|4251652|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427553|NCT00149669|4251653|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427554|NCT00149669|4251651|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4427555|NCT00149669|4251652|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4427556|NCT00149669|4251653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4427557|NCT00149669|4251651|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427558|NCT00149669|4251652|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427559|NCT00149669|4251653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427560|NCT00149643|4251672|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4427561|NCT00149643|4251673|B2|United States||Region of Enrollment||participants|Number|36|36.0||||||
4427562|NCT00149643|4251674|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4427563|NCT00149643|4251672|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4427564|NCT00149643|4251673|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4427565|NCT00149643|4251674|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4427566|NCT00149643|4251672|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4427567|NCT00149643|4251673|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4427568|NCT00149643|4251674|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4427569|NCT00149643|4251672|B3|||Age||years|Mean|21.1|21.1|Standard Deviation|2.4|2.4|||
4427570|NCT00149643|4251673|B2|||Age||years|Mean|21.1|21.1|Standard Deviation|2.4|2.4|||
4427571|NCT00149643|4251674|B1|||Age||years|Mean|21.1|21.1|Standard Deviation|2.4|2.4|||
4427572|NCT00149643|4251672|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427573|NCT00149643|4251673|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427574|NCT00149643|4251674|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427575|NCT00149643|4251672|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4427576|NCT00149643|4251673|B2||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4427577|NCT00149643|4251674|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4427578|NCT00149643|4251672|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4427579|NCT00149643|4251673|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4427580|NCT00149643|4251674|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4427581|NCT00149630|4251685|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4427582|NCT00149630|4251686|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4427583|NCT00149630|4251687|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4427584|NCT00149630|4251685|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4427585|NCT00149630|4251686|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4427586|NCT00149630|4251687|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4427587|NCT00149630|4251685|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4427588|NCT00149630|4251686|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4427589|NCT00149630|4251687|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4427590|NCT00149630|4251685|B3|||Age||years|Mean|38.75|38.75|Standard Deviation|10|10.0|||
4427591|NCT00149630|4251686|B2|||Age||years|Mean|40|40.0|Standard Deviation|10|10.0|||
4427592|NCT00149630|4251687|B1|||Age||years|Mean|37.5|37.5|Standard Deviation|10.5|10.5|||
4427593|NCT00149630|4251685|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427594|NCT00149630|4251686|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427595|NCT00149630|4251687|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427596|NCT00149630|4251685|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4427597|NCT00149630|4251686|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4427598|NCT00149630|4251687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4427599|NCT00149630|4251685|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427600|NCT00149630|4251686|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427601|NCT00149630|4251687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427602|NCT00149396|4251698|B1|KPS 80||Karnofsky Performance Status (KPS)|"The KPS was rated as follows:~100 - Normal, no complaints, no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease; 80 - Normal activity with effort; some signs or symptoms of disease"|participants|Number|1|1.0||||||
4427603|NCT00149396|4251698|B1|KPS 90||Karnofsky Performance Status (KPS)|"The KPS was rated as follows:~100 - Normal, no complaints, no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease; 80 - Normal activity with effort; some signs or symptoms of disease"|participants|Number|17|17.0||||||
4427604|NCT00149396|4251698|B1|KPS 100||Karnofsky Performance Status (KPS)|"The KPS was rated as follows:~100 - Normal, no complaints, no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease; 80 - Normal activity with effort; some signs or symptoms of disease"|participants|Number|14|14.0||||||
4427605|NCT00149396|4251698|B1|||Prior Chemotherapy||participants|Number|32|32.0||||||
4427606|NCT00149396|4251698|B1|||Carcinoembryonic Antigen (CEA) Level at Screening||ng/mL|Mean|175.5|175.5|Standard Deviation|517.4|517.4|||
4427607|NCT00149396|4251698|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4427608|NCT00149396|4251698|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4427609|NCT00149396|4251698|B1|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4427610|NCT00149396|4251698|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4427611|NCT00149396|4251698|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4427612|NCT00149396|4251698|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4427613|NCT00149396|4251698|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|11.9|11.9|||
4427614|NCT00149227|4251739|B3|Japan||Region of Enrollment||participants|Number|3031|3031.0||||||
4427615|NCT00149227|4251740|B2|Japan||Region of Enrollment||participants|Number|1514|1514.0||||||
4427616|NCT00149227|4251741|B1|Japan||Region of Enrollment||participants|Number|1517|1517.0||||||
4427617|NCT00149227|4251739|B3||Male|Sex: Female, Male||Participants|Count of Participants|1728|1728.0||||||
4427618|NCT00149227|4251740|B2||Male|Sex: Female, Male||Participants|Count of Participants|867|867.0||||||
4427619|NCT00149227|4251741|B1||Male|Sex: Female, Male||Participants|Count of Participants|861|861.0||||||
4427620|NCT00149227|4251739|B3||Female|Sex: Female, Male||Participants|Count of Participants|1303|1303.0||||||
4427621|NCT00149227|4251740|B2||Female|Sex: Female, Male||Participants|Count of Participants|647|647.0||||||
4427622|NCT00149227|4251741|B1||Female|Sex: Female, Male||Participants|Count of Participants|656|656.0||||||
4427623|NCT00149227|4251739|B3|||Age||years|Mean|65.9|65.9|Standard Deviation|11.1|11.1|||
4427624|NCT00149227|4251740|B2|||Age||years|Mean|66.1|66.1|Standard Deviation|10.9|10.9|||
4427625|NCT00149227|4251741|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|11.2|11.2|||
4427626|NCT00149214|4251766|B3|Hispanic||Race/Ethnicity||participants|Number|3|3.0||||||
4427627|NCT00149214|4251767|B2|Hispanic||Race/Ethnicity||participants|Number|3|3.0||||||
4427628|NCT00149214|4251768|B1|Hispanic||Race/Ethnicity||participants|Number|0|0.0||||||
4427629|NCT00149214|4251766|B3|Caucasian||Race/Ethnicity||participants|Number|254|254.0||||||
4427630|NCT00149214|4251767|B2|Caucasian||Race/Ethnicity||participants|Number|119|119.0||||||
4427631|NCT00149214|4251768|B1|Caucasian||Race/Ethnicity||participants|Number|135|135.0||||||
4427632|NCT00149214|4251766|B3|Post-Menopausal||Menopausal Status||participants|Number|108|108.0||||||
4427633|NCT00149214|4251767|B2|Post-Menopausal||Menopausal Status||participants|Number|48|48.0||||||
4427634|NCT00149214|4251768|B1|Post-Menopausal||Menopausal Status||participants|Number|60|60.0||||||
4427635|NCT00149214|4251766|B3|Peri-Menopausal||Menopausal Status||participants|Number|13|13.0||||||
4427636|NCT00149214|4251767|B2|Peri-Menopausal||Menopausal Status||participants|Number|7|7.0||||||
4427637|NCT00149214|4251768|B1|Peri-Menopausal||Menopausal Status||participants|Number|6|6.0||||||
4427638|NCT00149214|4251766|B3|Pre-Menopausal||Menopausal Status||participants|Number|135|135.0||||||
4427639|NCT00149214|4251767|B2|Pre-Menopausal||Menopausal Status||participants|Number|66|66.0||||||
4427640|NCT00149214|4251768|B1|Pre-Menopausal||Menopausal Status||participants|Number|69|69.0||||||
4427641|NCT00149214|4251766|B3|Unknown||Menopausal Status||participants|Number|1|1.0||||||
4427642|NCT00149214|4251767|B2|Unknown||Menopausal Status||participants|Number|1|1.0||||||
4427643|NCT00149214|4251768|B1|Unknown||Menopausal Status||participants|Number|0|0.0||||||
4427644|NCT00149214|4251766|B3|Both negative||Estrogen and Progesterone Receptor Status||participants|Number|89|89.0||||||
4427645|NCT00149214|4251767|B2|Both negative||Estrogen and Progesterone Receptor Status||participants|Number|44|44.0||||||
4427646|NCT00149214|4251768|B1|Both negative||Estrogen and Progesterone Receptor Status||participants|Number|45|45.0||||||
4427647|NCT00149214|4251766|B3|At least one positive||Estrogen and Progesterone Receptor Status||participants|Number|168|168.0||||||
4427648|NCT00149214|4251767|B2|At least one positive||Estrogen and Progesterone Receptor Status||participants|Number|78|78.0||||||
4427649|NCT00149214|4251768|B1|At least one positive||Estrogen and Progesterone Receptor Status||participants|Number|90|90.0||||||
4427650|NCT00149214|4251766|B3|Status Unknown||Eastern Cooperative Oncology Group Performance Status||participants|Number|8|8.0||||||
4427651|NCT00149214|4251767|B2|Status Unknown||Eastern Cooperative Oncology Group Performance Status||participants|Number|5|5.0||||||
4427652|NCT00149214|4251768|B1|Status Unknown||Eastern Cooperative Oncology Group Performance Status||participants|Number|3|3.0||||||
4427653|NCT00149214|4251766|B3|Grade 1- Ambulatory; strenuous activity restricted||Eastern Cooperative Oncology Group Performance Status||participants|Number|5|5.0||||||
4427654|NCT00149214|4251767|B2|Grade 1- Ambulatory; strenuous activity restricted||Eastern Cooperative Oncology Group Performance Status||participants|Number|4|4.0||||||
4427655|NCT00149214|4251768|B1|Grade 1- Ambulatory; strenuous activity restricted||Eastern Cooperative Oncology Group Performance Status||participants|Number|1|1.0||||||
4427656|NCT00149214|4251766|B3|Grade 0 - Fully active||Eastern Cooperative Oncology Group Performance Status||participants|Number|244|244.0||||||
4427657|NCT00149214|4251767|B2|Grade 0 - Fully active||Eastern Cooperative Oncology Group Performance Status||participants|Number|113|113.0||||||
4427658|NCT00149214|4251768|B1|Grade 0 - Fully active||Eastern Cooperative Oncology Group Performance Status||participants|Number|131|131.0||||||
4427659|NCT00149214|4251766|B3|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4427660|NCT00149214|4251767|B2|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4427661|NCT00149214|4251768|B1|Italy||Region of Enrollment||participants|Number|11|11.0||||||
4427662|NCT00149214|4251766|B3|Germany||Region of Enrollment||participants|Number|145|145.0||||||
4427663|NCT00149214|4251767|B2|Germany||Region of Enrollment||participants|Number|71|71.0||||||
4427664|NCT00149214|4251768|B1|Germany||Region of Enrollment||participants|Number|74|74.0||||||
4427665|NCT00149214|4251766|B3|Russian Federation||Region of Enrollment||participants|Number|28|28.0||||||
4427666|NCT00149214|4251767|B2|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4427667|NCT00149214|4251768|B1|Russian Federation||Region of Enrollment||participants|Number|14|14.0||||||
4427668|NCT00149214|4251766|B3|Spain||Region of Enrollment||participants|Number|65|65.0||||||
4427669|NCT00149214|4251767|B2|Spain||Region of Enrollment||participants|Number|29|29.0||||||
4427670|NCT00149214|4251768|B1|Spain||Region of Enrollment||participants|Number|36|36.0||||||
4427671|NCT00149214|4251766|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4427672|NCT00149214|4251767|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4427673|NCT00149214|4251768|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4427674|NCT00149214|4251766|B3||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4427675|NCT00149214|4251767|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4427676|NCT00149214|4251768|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4427677|NCT00149214|4251766|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|10.0|10.0|||
4427678|NCT00149214|4251767|B2|||Age||years|Mean|49.5|49.5|Standard Deviation|9.7|9.7|||
4427679|NCT00149214|4251768|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|10.2|10.2|||
4427680|NCT00148954|4251783|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4427681|NCT00148954|4251784|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4427682|NCT00148954|4251785|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4427683|NCT00148954|4251783|B3|Europe||Region of Enrollment||participants|Number|128|128.0||||||
4427684|NCT00148954|4251784|B2|Europe||Region of Enrollment||participants|Number|63|63.0||||||
4427685|NCT00148954|4251785|B1|Europe||Region of Enrollment||participants|Number|65|65.0||||||
4427686|NCT00148954|4251783|B3|United States||Region of Enrollment||participants|Number|1824|1824.0||||||
4427687|NCT00148954|4251784|B2|United States||Region of Enrollment||participants|Number|909|909.0||||||
4427688|NCT00148954|4251785|B1|United States||Region of Enrollment||participants|Number|915|915.0||||||
4427689|NCT00148954|4251783|B3||Male|Sex: Female, Male||Participants|Count of Participants|1542|1542.0||||||
4427690|NCT00148954|4251784|B2||Male|Sex: Female, Male||Participants|Count of Participants|780|780.0||||||
4427691|NCT00148954|4251785|B1||Male|Sex: Female, Male||Participants|Count of Participants|762|762.0||||||
4427692|NCT00148954|4251783|B3||Female|Sex: Female, Male||Participants|Count of Participants|420|420.0||||||
4427693|NCT00148954|4251784|B2||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4427694|NCT00148954|4251785|B1||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4427695|NCT00148954|4251783|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|12.2|12.2|||
4427696|NCT00148954|4251784|B2|||Age||years|Mean|64.4|64.4|Standard Deviation|12.0|12.0|||
4427697|NCT00148954|4251785|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|12.4|12.4|||
4427698|NCT00148954|4251783|B3||>=65 years|Age||Participants|Count of Participants|991|991.0||||||
4427699|NCT00148954|4251784|B2||>=65 years|Age||Participants|Count of Participants|495|495.0||||||
4427700|NCT00148954|4251785|B1||>=65 years|Age||Participants|Count of Participants|496|496.0||||||
4427701|NCT00148954|4251783|B3||Between 18 and 65 years|Age||Participants|Count of Participants|971|971.0||||||
4427702|NCT00148954|4251784|B2||Between 18 and 65 years|Age||Participants|Count of Participants|482|482.0||||||
4427703|NCT00148954|4251785|B1||Between 18 and 65 years|Age||Participants|Count of Participants|489|489.0||||||
4427704|NCT00148954|4251783|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427705|NCT00148954|4251784|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427706|NCT00148954|4251785|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427707|NCT00148798|4251792|B3|Brazil||Region of Enrollment||participants|Number|99|99.0||||||
4427708|NCT00148798|4251793|B2|Brazil||Region of Enrollment||participants|Number|51|51.0||||||
4427709|NCT00148798|4251794|B1|Brazil||Region of Enrollment||participants|Number|48|48.0||||||
4427710|NCT00148798|4251792|B3|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4427711|NCT00148798|4251793|B2|Mexico||Region of Enrollment||participants|Number|8|8.0||||||
4427712|NCT00148798|4251794|B1|Mexico||Region of Enrollment||participants|Number|9|9.0||||||
4427713|NCT00148798|4251792|B3|Argentina||Region of Enrollment||participants|Number|7|7.0||||||
4427714|NCT00148798|4251793|B2|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4427715|NCT00148798|4251794|B1|Argentina||Region of Enrollment||participants|Number|5|5.0||||||
4427716|NCT00148798|4251792|B3|Italy||Region of Enrollment||participants|Number|41|41.0||||||
4427717|NCT00148798|4251793|B2|Italy||Region of Enrollment||participants|Number|23|23.0||||||
4427718|NCT00148798|4251794|B1|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4427719|NCT00148798|4251792|B3|Chile||Region of Enrollment||participants|Number|26|26.0||||||
4427720|NCT00148798|4251793|B2|Chile||Region of Enrollment||participants|Number|16|16.0||||||
4427721|NCT00148798|4251794|B1|Chile||Region of Enrollment||participants|Number|10|10.0||||||
4427722|NCT00148798|4251792|B3|Ukraine||Region of Enrollment||participants|Number|127|127.0||||||
4427723|NCT00148798|4251793|B2|Ukraine||Region of Enrollment||participants|Number|71|71.0||||||
4427724|NCT00148798|4251794|B1|Ukraine||Region of Enrollment||participants|Number|56|56.0||||||
4427725|NCT00148798|4251792|B3|United Kingdom||Region of Enrollment||participants|Number|44|44.0||||||
4427726|NCT00148798|4251793|B2|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4427727|NCT00148798|4251794|B1|United Kingdom||Region of Enrollment||participants|Number|23|23.0||||||
4427728|NCT00148798|4251792|B3|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
4427729|NCT00148798|4251793|B2|Turkey||Region of Enrollment||participants|Number|2|2.0||||||
4427730|NCT00148798|4251794|B1|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4427731|NCT00148798|4251792|B3|Switzerland||Region of Enrollment||participants|Number|16|16.0||||||
4427732|NCT00148798|4251793|B2|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
4427733|NCT00148798|4251794|B1|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
4427734|NCT00148798|4251792|B3|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
4427735|NCT00148798|4251793|B2|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4427736|NCT00148798|4251794|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4427737|NCT00148798|4251792|B3|Spain||Region of Enrollment||participants|Number|29|29.0||||||
4427738|NCT00148798|4251793|B2|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4427739|NCT00148798|4251794|B1|Spain||Region of Enrollment||participants|Number|16|16.0||||||
4427740|NCT00148798|4251792|B3|Slovakia||Region of Enrollment||participants|Number|20|20.0||||||
4427741|NCT00148798|4251793|B2|Slovakia||Region of Enrollment||participants|Number|12|12.0||||||
4427742|NCT00148798|4251794|B1|Slovakia||Region of Enrollment||participants|Number|8|8.0||||||
4427743|NCT00148798|4251792|B3|Russian Federation||Region of Enrollment||participants|Number|39|39.0||||||
4427744|NCT00148798|4251793|B2|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
4427745|NCT00148798|4251794|B1|Russian Federation||Region of Enrollment||participants|Number|23|23.0||||||
4427746|NCT00148798|4251792|B3|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4427747|NCT00148798|4251793|B2|Portugal||Region of Enrollment||participants|Number|0|0.0||||||
4427748|NCT00148798|4251794|B1|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4427749|NCT00148798|4251792|B3|Poland||Region of Enrollment||participants|Number|109|109.0||||||
4427750|NCT00148798|4251793|B2|Poland||Region of Enrollment||participants|Number|50|50.0||||||
4427751|NCT00148798|4251794|B1|Poland||Region of Enrollment||participants|Number|59|59.0||||||
4427752|NCT00148798|4251792|B3|Netherlands||Region of Enrollment||participants|Number|20|20.0||||||
4427753|NCT00148798|4251793|B2|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4427754|NCT00148798|4251794|B1|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4427755|NCT00148798|4251792|B3|Ireland||Region of Enrollment||participants|Number|7|7.0||||||
4427756|NCT00148798|4251793|B2|Ireland||Region of Enrollment||participants|Number|4|4.0||||||
4427757|NCT00148798|4251794|B1|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
4427758|NCT00148798|4251792|B3|Hungary||Region of Enrollment||participants|Number|44|44.0||||||
4427759|NCT00148798|4251793|B2|Hungary||Region of Enrollment||participants|Number|23|23.0||||||
4427760|NCT00148798|4251794|B1|Hungary||Region of Enrollment||participants|Number|21|21.0||||||
4427761|NCT00148798|4251792|B3|Germany||Region of Enrollment||participants|Number|179|179.0||||||
4427762|NCT00148798|4251793|B2|Germany||Region of Enrollment||participants|Number|88|88.0||||||
4427763|NCT00148798|4251794|B1|Germany||Region of Enrollment||participants|Number|91|91.0||||||
4427764|NCT00148798|4251792|B3|France||Region of Enrollment||participants|Number|50|50.0||||||
4427765|NCT00148798|4251793|B2|France||Region of Enrollment||participants|Number|25|25.0||||||
4427766|NCT00148798|4251794|B1|France||Region of Enrollment||participants|Number|25|25.0||||||
4427767|NCT00148798|4251792|B3|Czech Republic||Region of Enrollment||participants|Number|29|29.0||||||
4427768|NCT00148798|4251793|B2|Czech Republic||Region of Enrollment||participants|Number|17|17.0||||||
4427769|NCT00148798|4251794|B1|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4427770|NCT00148798|4251792|B3|Bulgaria||Region of Enrollment||participants|Number|24|24.0||||||
4427771|NCT00148798|4251793|B2|Bulgaria||Region of Enrollment||participants|Number|12|12.0||||||
4427772|NCT00148798|4251794|B1|Bulgaria||Region of Enrollment||participants|Number|12|12.0||||||
4427773|NCT00148798|4251792|B3|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
4427774|NCT00148798|4251793|B2|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
4427775|NCT00148798|4251794|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4427776|NCT00148798|4251792|B3|Austria||Region of Enrollment||participants|Number|16|16.0||||||
4427777|NCT00148798|4251793|B2|Austria||Region of Enrollment||participants|Number|7|7.0||||||
4427778|NCT00148798|4251794|B1|Austria||Region of Enrollment||participants|Number|9|9.0||||||
4427779|NCT00148798|4251792|B3|Taiwan||Region of Enrollment||participants|Number|43|43.0||||||
4427780|NCT00148798|4251793|B2|Taiwan||Region of Enrollment||participants|Number|22|22.0||||||
4427781|NCT00148798|4251794|B1|Taiwan||Region of Enrollment||participants|Number|21|21.0||||||
4427782|NCT00148798|4251792|B3|Korea, Republic of||Region of Enrollment||participants|Number|54|54.0||||||
4427783|NCT00148798|4251793|B2|Korea, Republic of||Region of Enrollment||participants|Number|26|26.0||||||
4427784|NCT00148798|4251794|B1|Korea, Republic of||Region of Enrollment||participants|Number|28|28.0||||||
4427785|NCT00148798|4251792|B3|Singapore||Region of Enrollment||participants|Number|10|10.0||||||
4427786|NCT00148798|4251793|B2|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
4427787|NCT00148798|4251794|B1|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
4427788|NCT00148798|4251792|B3|Hong Kong||Region of Enrollment||participants|Number|4|4.0||||||
4427789|NCT00148798|4251793|B2|Hong Kong||Region of Enrollment||participants|Number|2|2.0||||||
4427790|NCT00148798|4251794|B1|Hong Kong||Region of Enrollment||participants|Number|2|2.0||||||
4427791|NCT00148798|4251792|B3|Australia||Region of Enrollment||participants|Number|43|43.0||||||
4427792|NCT00148798|4251793|B2|Australia||Region of Enrollment||participants|Number|23|23.0||||||
4427793|NCT00148798|4251794|B1|Australia||Region of Enrollment||participants|Number|20|20.0||||||
4427794|NCT00148798|4251792|B3||Male|Sex: Female, Male||Participants|Count of Participants|790|790.0||||||
4427795|NCT00148798|4251793|B2||Male|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
4427796|NCT00148798|4251794|B1||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
4427797|NCT00148798|4251792|B3||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4427798|NCT00148798|4251793|B2||Female|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4427799|NCT00148798|4251794|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4427800|NCT00148798|4251792|B3|>=65 years||Age, Customized||participants|Number|351|351.0||||||
4427801|NCT00148798|4251793|B2|>=65 years||Age, Customized||participants|Number|179|179.0||||||
4427802|NCT00148798|4251794|B1|>=65 years||Age, Customized||participants|Number|172|172.0||||||
4427803|NCT00148798|4251792|B3|Between 18 and 65 years||Age, Customized||participants|Number|774|774.0||||||
4427804|NCT00148798|4251793|B2|Between 18 and 65 years||Age, Customized||participants|Number|389|389.0||||||
4427805|NCT00148798|4251794|B1|Between 18 and 65 years||Age, Customized||participants|Number|385|385.0||||||
4427806|NCT00148798|4251792|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4427807|NCT00148798|4251793|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4427808|NCT00148798|4251794|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4427809|NCT00148798|4251792|B3|||Age||years|Median|59|59.0|Full Range|||18.0|83.0|
4427810|NCT00148798|4251793|B2|||Age||years|Median|60|60.0|Full Range|||20.0|83.0|
4427811|NCT00148798|4251794|B1|||Age||years|Median|59|59.0|Full Range|||18.0|78.0|
4427812|NCT00148759|4251815|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4427813|NCT00148759|4251816|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4427814|NCT00148759|4251817|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4427815|NCT00148759|4251815|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4427816|NCT00148759|4251816|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4427817|NCT00148759|4251817|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4427818|NCT00148759|4251815|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4427819|NCT00148759|4251816|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4427820|NCT00148759|4251817|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4427821|NCT00148759|4251815|B3|||Age||years|Mean|38|38.0|Standard Deviation|16|16.0|||
4427822|NCT00148759|4251816|B2|||Age||years|Mean|39|39.0|Standard Deviation|18|18.0|||
4427823|NCT00148759|4251817|B1|||Age||years|Mean|37|37.0|Standard Deviation|16|16.0|||
4427824|NCT00148759|4251815|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427825|NCT00148759|4251816|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427826|NCT00148759|4251817|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427827|NCT00148759|4251815|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4427828|NCT00148759|4251816|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4427829|NCT00148759|4251817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4427830|NCT00148759|4251815|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427831|NCT00148759|4251816|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427832|NCT00148759|4251817|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427833|NCT00148733|4251826|B3||Male|Sex: Female, Male||Participants|Count of Participants|1477|1477.0||||||
4427834|NCT00148733|4251827|B2||Male|Sex: Female, Male||Participants|Count of Participants|738|738.0||||||
4427835|NCT00148733|4251828|B1||Male|Sex: Female, Male||Participants|Count of Participants|739|739.0||||||
4427836|NCT00148733|4251826|B3||Female|Sex: Female, Male||Participants|Count of Participants|1151|1151.0||||||
4427837|NCT00148733|4251827|B2||Female|Sex: Female, Male||Participants|Count of Participants|576|576.0||||||
4427838|NCT00148733|4251828|B1||Female|Sex: Female, Male||Participants|Count of Participants|575|575.0||||||
4427839|NCT00148733|4251826|B3|||Age||months|Mean|7.2|7.2|Standard Deviation|7.3|7.3|||
4427840|NCT00148733|4251827|B2|||Age||months|Mean|7.2|7.2|Standard Deviation|7.2|7.2|||
4427841|NCT00148733|4251828|B1|||Age||months|Mean|7.3|7.3|Standard Deviation|7.4|7.4|||
4427842|NCT00148668|4251835|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4427843|NCT00148668|4251836|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4427844|NCT00148668|4251837|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4427845|NCT00148668|4251835|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4427846|NCT00148668|4251836|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4427847|NCT00148668|4251837|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4427848|NCT00148668|4251835|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4427849|NCT00148668|4251836|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4427850|NCT00148668|4251837|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4427851|NCT00148668|4251835|B3|||Age||years|Mean|48|48.0|Standard Deviation|10.7|10.7|||
4427852|NCT00148668|4251836|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|8.5|8.5|||
4427853|NCT00148668|4251837|B1|||Age||years|Mean|47.8|47.8|Standard Deviation|12.6|12.6|||
4427854|NCT00148343|4251844|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
4427855|NCT00148343|4251845|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4427856|NCT00148343|4251846|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4427857|NCT00148343|4251844|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4427858|NCT00148343|4251845|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4427859|NCT00148343|4251846|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4427860|NCT00148343|4251844|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4427861|NCT00148343|4251845|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4427862|NCT00148343|4251846|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4427863|NCT00148343|4251844|B3|||Age||years|Mean|53.0|53.0|Standard Deviation|11.1|11.1|||
4427864|NCT00148343|4251845|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|10.1|10.1|||
4427865|NCT00148343|4251846|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|12.2|12.2|||
4427866|NCT00148343|4251844|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4427867|NCT00148343|4251845|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4427868|NCT00148343|4251846|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4427869|NCT00148343|4251844|B3||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4427870|NCT00148343|4251845|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4427871|NCT00148343|4251846|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4427872|NCT00148343|4251844|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427873|NCT00148343|4251845|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427874|NCT00148343|4251846|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427875|NCT00148317|4251861|B1|Stable Disease||Best response prior to induction therapy|Best response was noted using the International Myeloma Working Group Guidelines: http://imwg.myeloma.org/international-myeloma-working-group-imwg-uniform-response-criteria-for-multiple-myeloma/|participants|Number|10|10.0||||||
4427876|NCT00148317|4251861|B1|partial Response||Best response prior to induction therapy|Best response was noted using the International Myeloma Working Group Guidelines: http://imwg.myeloma.org/international-myeloma-working-group-imwg-uniform-response-criteria-for-multiple-myeloma/|participants|Number|27|27.0||||||
4427877|NCT00148317|4251861|B1|Complete Response||Best response prior to induction therapy|Best response was noted using the International Myeloma Working Group Guidelines: http://imwg.myeloma.org/international-myeloma-working-group-imwg-uniform-response-criteria-for-multiple-myeloma/|participants|Number|1|1.0||||||
4427878|NCT00148317|4251861|B1|dexamethasone, then single-agent lenalidomide||Prior induction therapy||participants|Number|1|1.0||||||
4427879|NCT00148317|4251861|B1|melphalan + cyclophosphamide||Prior induction therapy||participants|Number|1|1.0||||||
4427880|NCT00148317|4251861|B1|pulsed dexamethasone only||Prior induction therapy||participants|Number|2|2.0||||||
4427881|NCT00148317|4251861|B1|thalidomide only||Prior induction therapy||participants|Number|2|2.0||||||
4427882|NCT00148317|4251861|B1|Thalidomide + dexamethasone||Prior induction therapy||participants|Number|3|3.0||||||
4427883|NCT00148317|4251861|B1|Thalidomide + lenalidomide + dexamethasone± BIAXIN||Prior induction therapy||participants|Number|8|8.0||||||
4427884|NCT00148317|4251861|B1|lenalidomide + dexamethasone ± BIAXIN||Prior induction therapy||participants|Number|21|21.0||||||
4427885|NCT00148317|4251861|B1|none||Abnormalities by FISH|Cytogenetic abnormalities were assessed in patients using fluorescence in situ hybridization (FISH), which detects chromosomal abnormalities. Del (17p), t(4;14), and t (14;16) were considered High Risk cytogenetic abnormalities. All other abnormalities were considered standard risk cytogenetics.|participants|Number|16|16.0||||||
4427886|NCT00148317|4251861|B1|t (14;16)||Abnormalities by FISH|Cytogenetic abnormalities were assessed in patients using fluorescence in situ hybridization (FISH), which detects chromosomal abnormalities. Del (17p), t(4;14), and t (14;16) were considered High Risk cytogenetic abnormalities. All other abnormalities were considered standard risk cytogenetics.|participants|Number|2|2.0||||||
4427887|NCT00148317|4251861|B1|t (11;14)||Abnormalities by FISH|Cytogenetic abnormalities were assessed in patients using fluorescence in situ hybridization (FISH), which detects chromosomal abnormalities. Del (17p), t(4;14), and t (14;16) were considered High Risk cytogenetic abnormalities. All other abnormalities were considered standard risk cytogenetics.|participants|Number|5|5.0||||||
4427888|NCT00148317|4251861|B1|del (17p)||Abnormalities by FISH|Cytogenetic abnormalities were assessed in patients using fluorescence in situ hybridization (FISH), which detects chromosomal abnormalities. Del (17p), t(4;14), and t (14;16) were considered High Risk cytogenetic abnormalities. All other abnormalities were considered standard risk cytogenetics.|participants|Number|1|1.0||||||
4427889|NCT00148317|4251861|B1|p53||Abnormalities by FISH|Cytogenetic abnormalities were assessed in patients using fluorescence in situ hybridization (FISH), which detects chromosomal abnormalities. Del (17p), t(4;14), and t (14;16) were considered High Risk cytogenetic abnormalities. All other abnormalities were considered standard risk cytogenetics.|participants|Number|4|4.0||||||
4427890|NCT00148317|4251861|B1|t (4;14)||Abnormalities by FISH|Cytogenetic abnormalities were assessed in patients using fluorescence in situ hybridization (FISH), which detects chromosomal abnormalities. Del (17p), t(4;14), and t (14;16) were considered High Risk cytogenetic abnormalities. All other abnormalities were considered standard risk cytogenetics.|participants|Number|4|4.0||||||
4427891|NCT00148317|4251861|B1|hyperdiploidy||Abnormalities by FISH|Cytogenetic abnormalities were assessed in patients using fluorescence in situ hybridization (FISH), which detects chromosomal abnormalities. Del (17p), t(4;14), and t (14;16) were considered High Risk cytogenetic abnormalities. All other abnormalities were considered standard risk cytogenetics.|participants|Number|7|7.0||||||
4427892|NCT00148317|4251861|B1|trisomy 11||Abnormalities by FISH|Cytogenetic abnormalities were assessed in patients using fluorescence in situ hybridization (FISH), which detects chromosomal abnormalities. Del (17p), t(4;14), and t (14;16) were considered High Risk cytogenetic abnormalities. All other abnormalities were considered standard risk cytogenetics.|participants|Number|10|10.0||||||
4427893|NCT00148317|4251861|B1|III||International Staging System|Measure Description: Stage I ß2-M < 3.5 mg/dL and albumin =3.5 g/dL Stage II Neither stage I nor stage III Stage III ß2-M ≥ 5.5 mg/L|participants|Number|3|3.0||||||
4427894|NCT00148317|4251861|B1|II||International Staging System|Measure Description: Stage I ß2-M < 3.5 mg/dL and albumin =3.5 g/dL Stage II Neither stage I nor stage III Stage III ß2-M ≥ 5.5 mg/L|participants|Number|17|17.0||||||
4427895|NCT00148317|4251861|B1|I||International Staging System|Measure Description: Stage I ß2-M < 3.5 mg/dL and albumin =3.5 g/dL Stage II Neither stage I nor stage III Stage III ß2-M ≥ 5.5 mg/L|participants|Number|18|18.0||||||
4427896|NCT00148317|4251861|B1|3b||Durie Salmon Staging System|The Durie Salmon Staging System was used to assess patients status. Stage 1A is associated with a better outcome & a low tumor burden, stage 2A with a intermediate outcome and tumor burden, and stage 3A with a worse outcome & higher tumor burden. Criteria for staging is based on multiple factors including hematology values, disease burden, and renal function. The staging system can be found here: https://www.themmrf.org/multiple-myeloma/prognosis/myeloma-stages/durie-salmon-staging-system/ As assessed by the treating physician, the 1a subject:had active myeloma based on the IMWG criteria.|participants|Number|1|1.0||||||
4427897|NCT00148317|4251861|B1|3a||Durie Salmon Staging System|The Durie Salmon Staging System was used to assess patients status. Stage 1A is associated with a better outcome & a low tumor burden, stage 2A with a intermediate outcome and tumor burden, and stage 3A with a worse outcome & higher tumor burden. Criteria for staging is based on multiple factors including hematology values, disease burden, and renal function. The staging system can be found here: https://www.themmrf.org/multiple-myeloma/prognosis/myeloma-stages/durie-salmon-staging-system/ As assessed by the treating physician, the 1a subject:had active myeloma based on the IMWG criteria.|participants|Number|17|17.0||||||
4427898|NCT00148317|4251861|B1|2a||Durie Salmon Staging System|The Durie Salmon Staging System was used to assess patients status. Stage 1A is associated with a better outcome & a low tumor burden, stage 2A with a intermediate outcome and tumor burden, and stage 3A with a worse outcome & higher tumor burden. Criteria for staging is based on multiple factors including hematology values, disease burden, and renal function. The staging system can be found here: https://www.themmrf.org/multiple-myeloma/prognosis/myeloma-stages/durie-salmon-staging-system/ As assessed by the treating physician, the 1a subject:had active myeloma based on the IMWG criteria.|participants|Number|19|19.0||||||
4427899|NCT00148317|4251861|B1|1a||Durie Salmon Staging System|The Durie Salmon Staging System was used to assess patients status. Stage 1A is associated with a better outcome & a low tumor burden, stage 2A with a intermediate outcome and tumor burden, and stage 3A with a worse outcome & higher tumor burden. Criteria for staging is based on multiple factors including hematology values, disease burden, and renal function. The staging system can be found here: https://www.themmrf.org/multiple-myeloma/prognosis/myeloma-stages/durie-salmon-staging-system/ As assessed by the treating physician, the 1a subject:had active myeloma based on the IMWG criteria.|participants|Number|1|1.0||||||
4427900|NCT00148317|4251861|B1|||Serum Albumin||g/dL|Median|3.5|3.5|Full Range|||2.0|4.3|
4427901|NCT00148317|4251861|B1|||Beta-2 Microglubilin||mg/L|Median|2.05|2.05|Full Range|||1.0|10.2|
4427902|NCT00148317|4251861|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4427903|NCT00148317|4251861|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427904|NCT00148317|4251861|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4427905|NCT00148317|4251861|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4427906|NCT00148317|4251861|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427907|NCT00148317|4251861|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4427908|NCT00148317|4251861|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427909|NCT00148317|4251861|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427910|NCT00148317|4251861|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4427911|NCT00148317|4251861|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4427912|NCT00148317|4251861|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4427913|NCT00148317|4251861|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4427914|NCT00148317|4251861|B1|Age > or = 70||Age, Customized||Participants|Count of Participants|4|4.0||||||
4427915|NCT00148317|4251861|B1|Age <70 years||Age, Customized||Participants|Count of Participants|34|34.0||||||
4427916|NCT00148317|4251861|B1|||Age||years|Median|61|61.0|Full Range|||27.0|76.0|
4427917|NCT00148122|4251868|B1|Missing||Disease Extent||participants|Number|1|1.0||||||
4427918|NCT00148122|4251868|B1|Local Regional Distant||Disease Extent||participants|Number|7|7.0||||||
4427919|NCT00148122|4251868|B1|Distant||Disease Extent||participants|Number|17|17.0||||||
4427920|NCT00148122|4251868|B1|Local Regional||Disease Extent||participants|Number|13|13.0||||||
4427921|NCT00148122|4251868|B1|Others||Histology||participants|Number|1|1.0||||||
4427922|NCT00148122|4251868|B1|Adenocarcinoma||Histology||participants|Number|1|1.0||||||
4427923|NCT00148122|4251868|B1|Squamous Cell Cancer||Histology||participants|Number|36|36.0||||||
4427924|NCT00148122|4251868|B1|2 (Symtomatic; <50% in Bed During the Day)||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status score is an attempt to quantify a cancer patients' general well-being and activities of daily life. It runs from 0 to 5, with 0 denoting perfect health and 5 death|participants|Number|2|2.0||||||
4427925|NCT00148122|4251868|B1|1 (Symptomatic but Completely Ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status score is an attempt to quantify a cancer patients' general well-being and activities of daily life. It runs from 0 to 5, with 0 denoting perfect health and 5 death|participants|Number|9|9.0||||||
4427926|NCT00148122|4251868|B1|0 (Asymptomatic)||Eastern Cooperative Oncology Group (ECOG) Performance Status|The Eastern Cooperative Oncology Group (ECOG) Performance Status score is an attempt to quantify a cancer patients' general well-being and activities of daily life. It runs from 0 to 5, with 0 denoting perfect health and 5 death|participants|Number|27|27.0||||||
4427927|NCT00148122|4251868|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4427928|NCT00148122|4251868|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4427929|NCT00148122|4251868|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427930|NCT00148122|4251868|B1||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4427931|NCT00148122|4251868|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427932|NCT00148122|4251868|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427933|NCT00148122|4251868|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427934|NCT00148122|4251868|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4427935|NCT00148122|4251868|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4427936|NCT00148122|4251868|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4427937|NCT00148122|4251868|B1|||Age||years|Median|59.46|59.46|Full Range|||39.86|75.08|
4427938|NCT00148109|4251874|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4427939|NCT00148109|4251875|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4427940|NCT00148109|4251876|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4427941|NCT00148109|4251874|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4427942|NCT00148109|4251875|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4427943|NCT00148109|4251876|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4427944|NCT00148109|4251874|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4427945|NCT00148109|4251875|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4427946|NCT00148109|4251876|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4427947|NCT00148109|4251874|B3|||Age||years|Median|54|54.0|Full Range|2|2.0|23.0|78.0|
4427948|NCT00148109|4251875|B2|||Age||years|Median|54|54.0|Full Range|2|2.0|29.0|78.0|
4427949|NCT00148109|4251876|B1|||Age||years|Median|49|49.0|Full Range|2|2.0|23.0|77.0|
4427950|NCT00148109|4251874|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4427951|NCT00148109|4251875|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4427952|NCT00148109|4251876|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4427953|NCT00148109|4251874|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4427954|NCT00148109|4251875|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4427955|NCT00148109|4251876|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4427956|NCT00148109|4251874|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427957|NCT00148109|4251875|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427958|NCT00148109|4251876|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427959|NCT00147966|4251887|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4427960|NCT00147966|4251887|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4427961|NCT00147966|4251887|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4427962|NCT00147966|4251887|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4427963|NCT00147966|4251887|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4427964|NCT00147966|4251887|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4427965|NCT00147823|4251891|B3|United States||Region of Enrollment||participants|Number|63|63.0||||||
4427966|NCT00147823|4251892|B2|United States||Region of Enrollment||participants|Number|32|32.0||||||
4427967|NCT00147823|4251893|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4427968|NCT00147823|4251891|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4427969|NCT00147823|4251892|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4427970|NCT00147823|4251893|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4427971|NCT00147823|4251891|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4427972|NCT00147823|4251892|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4427973|NCT00147823|4251893|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4427974|NCT00147823|4251891|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4427975|NCT00147823|4251892|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4427976|NCT00147823|4251893|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4427977|NCT00147823|4251891|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4427978|NCT00147823|4251892|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4427979|NCT00147823|4251893|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4427980|NCT00147823|4251891|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4427981|NCT00147823|4251892|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4427982|NCT00147823|4251893|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4427983|NCT00147745|4251922|B4|||Weight||kg|Mean|98.3|98.3|Full Range|||72.8|144.8|
4427984|NCT00147745|4251923|B3|||Weight||kg|Mean|103.4|103.4|Full Range|||75.8|144.8|
4427985|NCT00147745|4251924|B2|||Weight||kg|Mean|95.8|95.8|Full Range|||72.8|130.5|
4427986|NCT00147745|4251925|B1|||Weight||kg|Mean|98.6|98.6|Full Range|||73.2|128.5|
4427987|NCT00147745|4251922|B4|||Height||cm|Mean|170.4|170.4|Full Range|||157.0|190.0|
4427988|NCT00147745|4251923|B3|||Height||cm|Mean|170.8|170.8|Full Range|||157.0|179.0|
4427989|NCT00147745|4251924|B2|||Height||cm|Mean|168.6|168.6|Full Range|||162.0|187.0|
4427990|NCT00147745|4251925|B1|||Height||cm|Mean|171.7|171.7|Full Range|||159.0|190.0|
4427991|NCT00147745|4251922|B4|||HbA1c||percent|Mean|8.5|8.5|Full Range|||7.1|10.9|
4427992|NCT00147745|4251923|B3|||HbA1c||percent|Mean|9.3|9.3|Full Range|||8.2|10.9|
4427993|NCT00147745|4251924|B2|||HbA1c||percent|Mean|8.5|8.5|Full Range|||7.3|10.0|
4427994|NCT00147745|4251925|B1|||HbA1c||percent|Mean|8.2|8.2|Full Range|||7.1|9.8|
4427995|NCT00147745|4251922|B4|||Fasting Plasma Glucose||mg/dL|Mean|186.3|186.3|Full Range|||81.0|418.0|
4427996|NCT00147745|4251923|B3|||Fasting Plasma Glucose||mg/dL|Mean|199.0|199.0|Full Range|||129.0|314.0|
4427997|NCT00147745|4251924|B2|||Fasting Plasma Glucose||mg/dL|Mean|207.9|207.9|Full Range|||135.0|418.0|
4427998|NCT00147745|4251925|B1|||Fasting Plasma Glucose||mg/dL|Mean|162.6|162.6|Full Range|||81.0|208.0|
4427999|NCT00147745|4251922|B4|||Body Mass||kg/m2|Mean|34.0|34.0|Full Range|||24.6|46.7|
4428000|NCT00147745|4251923|B3|||Body Mass||kg/m2|Mean|35.2|35.2|Full Range|||29.9|46.7|
4428001|NCT00147745|4251924|B2|||Body Mass||kg/m2|Mean|33.7|33.7|Full Range|||27.7|44.8|
4428002|NCT00147745|4251925|B1|||Body Mass||kg/m2|Mean|33.7|33.7|Full Range|||24.6|46.1|
4428003|NCT00147745|4251922|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
4428004|NCT00147745|4251923|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4428005|NCT00147745|4251924|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4428006|NCT00147745|4251925|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4428007|NCT00147745|4251922|B4|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4428008|NCT00147745|4251923|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4428009|NCT00147745|4251924|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4428010|NCT00147745|4251925|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4428011|NCT00147745|4251922|B4|White||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4428012|NCT00147745|4251923|B3|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4428013|NCT00147745|4251924|B2|White||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4428014|NCT00147745|4251925|B1|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4428015|NCT00147745|4251922|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4428016|NCT00147745|4251923|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4428017|NCT00147745|4251924|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4428018|NCT00147745|4251925|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4428019|NCT00147745|4251922|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4428020|NCT00147745|4251923|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4428021|NCT00147745|4251924|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4428022|NCT00147745|4251925|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4428023|NCT00147745|4251922|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4428024|NCT00147745|4251923|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4428025|NCT00147745|4251924|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4428026|NCT00147745|4251925|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4428027|NCT00147745|4251922|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4428028|NCT00147745|4251923|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4428029|NCT00147745|4251924|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4428030|NCT00147745|4251925|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4428031|NCT00147745|4251922|B4|||Age||years|Mean|54.6|54.6|Full Range|||30.0|71.0|
4428032|NCT00147745|4251923|B3|||Age||years|Mean|52.8|52.8|Full Range|||34.0|71.0|
4428033|NCT00147745|4251924|B2|||Age||years|Mean|54.0|54.0|Full Range|||38.0|66.0|
4428034|NCT00147745|4251925|B1|||Age||years|Mean|55.7|55.7|Full Range|||30.0|71.0|
4428035|NCT00147537|4251945|B5|Unspecified||Sex/Gender, Customized||participants|Number|1|1.0||||||
4428036|NCT00147537|4251946|B4|Unspecified||Sex/Gender, Customized||participants|Number|0|0.0||||||
4428037|NCT00147537|4251947|B3|Unspecified||Sex/Gender, Customized||participants|Number|0|0.0||||||
4428038|NCT00147537|4251948|B2|Unspecified||Sex/Gender, Customized||participants|Number|1|1.0||||||
4428039|NCT00147537|4251949|B1|Unspecified||Sex/Gender, Customized||participants|Number|0|0.0||||||
4428040|NCT00147537|4251945|B5|Male||Sex/Gender, Customized||participants|Number|185|185.0||||||
4428041|NCT00147537|4251946|B4|Male||Sex/Gender, Customized||participants|Number|34|34.0||||||
4428042|NCT00147537|4251947|B3|Male||Sex/Gender, Customized||participants|Number|117|117.0||||||
4428043|NCT00147537|4251948|B2|Male||Sex/Gender, Customized||participants|Number|9|9.0||||||
4428044|NCT00147537|4251949|B1|Male||Sex/Gender, Customized||participants|Number|25|25.0||||||
4428045|NCT00147537|4251945|B5|Female||Sex/Gender, Customized||participants|Number|96|96.0||||||
4428046|NCT00147537|4251946|B4|Female||Sex/Gender, Customized||participants|Number|21|21.0||||||
4428047|NCT00147537|4251947|B3|Female||Sex/Gender, Customized||participants|Number|49|49.0||||||
4428048|NCT00147537|4251948|B2|Female||Sex/Gender, Customized||participants|Number|8|8.0||||||
4428049|NCT00147537|4251949|B1|Female||Sex/Gender, Customized||participants|Number|18|18.0||||||
4428050|NCT00147537|4251945|B5|Unspecified||Age, Customized||participants|Number|1|1.0||||||
4428051|NCT00147537|4251946|B4|Unspecified||Age, Customized||participants|Number|0|0.0||||||
4428052|NCT00147537|4251947|B3|Unspecified||Age, Customized||participants|Number|0|0.0||||||
4428053|NCT00147537|4251948|B2|Unspecified||Age, Customized||participants|Number|1|1.0||||||
4428054|NCT00147537|4251949|B1|Unspecified||Age, Customized||participants|Number|0|0.0||||||
4428055|NCT00147537|4251945|B5|70 years old and more than 70 years old (>=70)||Age, Customized||participants|Number|65|65.0||||||
4428056|NCT00147537|4251946|B4|70 years old and more than 70 years old (>=70)||Age, Customized||participants|Number|11|11.0||||||
4428057|NCT00147537|4251947|B3|70 years old and more than 70 years old (>=70)||Age, Customized||participants|Number|42|42.0||||||
4428058|NCT00147537|4251948|B2|70 years old and more than 70 years old (>=70)||Age, Customized||participants|Number|2|2.0||||||
4428059|NCT00147537|4251949|B1|70 years old and more than 70 years old (>=70)||Age, Customized||participants|Number|10|10.0||||||
4428060|NCT00147537|4251945|B5|65 to 69 years old (65 - 69)||Age, Customized||participants|Number|61|61.0||||||
4428061|NCT00147537|4251946|B4|65 to 69 years old (65 - 69)||Age, Customized||participants|Number|11|11.0||||||
4428062|NCT00147537|4251947|B3|65 to 69 years old (65 - 69)||Age, Customized||participants|Number|42|42.0||||||
4428063|NCT00147537|4251948|B2|65 to 69 years old (65 - 69)||Age, Customized||participants|Number|2|2.0||||||
4428064|NCT00147537|4251949|B1|65 to 69 years old (65 - 69)||Age, Customized||participants|Number|6|6.0||||||
4428065|NCT00147537|4251945|B5|Less than 65 years old (<65)||Age, Customized||participants|Number|155|155.0||||||
4428066|NCT00147537|4251946|B4|Less than 65 years old (<65)||Age, Customized||participants|Number|33|33.0||||||
4428067|NCT00147537|4251947|B3|Less than 65 years old (<65)||Age, Customized||participants|Number|82|82.0||||||
4428068|NCT00147537|4251948|B2|Less than 65 years old (<65)||Age, Customized||participants|Number|13|13.0||||||
4428069|NCT00147537|4251949|B1|Less than 65 years old (<65)||Age, Customized||participants|Number|27|27.0||||||
4428070|NCT00147498|4252138|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4428071|NCT00147498|4252139|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4428072|NCT00147498|4252140|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4428073|NCT00147498|4252141|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4428074|NCT00147498|4252142|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4428075|NCT00147498|4252138|B5||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4428076|NCT00147498|4252139|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4428077|NCT00147498|4252140|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4428078|NCT00147498|4252141|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4428079|NCT00147498|4252142|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4428080|NCT00147498|4252138|B5|||Age||years|Mean|50.6|50.6|Standard Deviation|11.7|11.7|||
4428081|NCT00147498|4252139|B4|||Age||years|Mean|51.3|51.3|Standard Deviation|12.1|12.1|||
4428082|NCT00147498|4252140|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|10.6|10.6|||
4428083|NCT00147498|4252141|B2|||Age||years|Mean|51.8|51.8|Standard Deviation|13.0|13.0|||
4428084|NCT00147498|4252142|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|10.8|10.8|||
4428085|NCT00147446|4252239|B3|United States||Region of Enrollment||participants|Number|121|121.0||||||
4428086|NCT00147446|4252240|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4428087|NCT00147446|4252241|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4428088|NCT00147446|4252239|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4428089|NCT00147446|4252240|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4428090|NCT00147446|4252241|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4428091|NCT00147446|4252239|B3||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4428092|NCT00147446|4252240|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4428093|NCT00147446|4252241|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4428094|NCT00147446|4252239|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|9.79|9.79|||
4428095|NCT00147446|4252240|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|9.08|9.08|||
4428096|NCT00147446|4252241|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|9.03|9.03|||
4428097|NCT00147446|4252239|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4428098|NCT00147446|4252240|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4428099|NCT00147446|4252241|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428100|NCT00147446|4252239|B3||Between 18 and 65 years|Age||Participants|Count of Participants|118|118.0||||||
4428101|NCT00147446|4252240|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4428102|NCT00147446|4252241|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4428103|NCT00147446|4252239|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428104|NCT00147446|4252240|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428105|NCT00147446|4252241|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428106|NCT00147316|4252250|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4428107|NCT00147316|4252250|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4428108|NCT00147316|4252250|B1|||Age||years|Mean|70.9|70.9|Standard Deviation|9.8|9.8|||
4428109|NCT00147290|4252255|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4428110|NCT00147290|4252256|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4428111|NCT00147290|4252257|B1|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4428112|NCT00147290|4252255|B3|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4428113|NCT00147290|4252256|B2|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4428114|NCT00147290|4252257|B1|Portugal||Region of Enrollment||participants|Number|1|1.0||||||
4428115|NCT00147290|4252255|B3|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4428116|NCT00147290|4252256|B2|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4428117|NCT00147290|4252257|B1|Israel||Region of Enrollment||participants|Number|5|5.0||||||
4428118|NCT00147290|4252255|B3|Spain||Region of Enrollment||participants|Number|42|42.0||||||
4428119|NCT00147290|4252256|B2|Spain||Region of Enrollment||participants|Number|20|20.0||||||
4428120|NCT00147290|4252257|B1|Spain||Region of Enrollment||participants|Number|22|22.0||||||
4428121|NCT00147290|4252255|B3|Germany||Region of Enrollment||participants|Number|94|94.0||||||
4428122|NCT00147290|4252256|B2|Germany||Region of Enrollment||participants|Number|46|46.0||||||
4428123|NCT00147290|4252257|B1|Germany||Region of Enrollment||participants|Number|48|48.0||||||
4428124|NCT00147290|4252255|B3|France||Region of Enrollment||participants|Number|128|128.0||||||
4428125|NCT00147290|4252256|B2|France||Region of Enrollment||participants|Number|61|61.0||||||
4428126|NCT00147290|4252257|B1|France||Region of Enrollment||participants|Number|67|67.0||||||
4428127|NCT00147290|4252255|B3|Italy||Region of Enrollment||participants|Number|249|249.0||||||
4428128|NCT00147290|4252256|B2|Italy||Region of Enrollment||participants|Number|127|127.0||||||
4428129|NCT00147290|4252257|B1|Italy||Region of Enrollment||participants|Number|122|122.0||||||
4428130|NCT00147290|4252255|B3||Male|Sex: Female, Male||Participants|Count of Participants|449|449.0||||||
4428131|NCT00147290|4252256|B2||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4428132|NCT00147290|4252257|B1||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4428133|NCT00147290|4252255|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4428134|NCT00147290|4252256|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4428135|NCT00147290|4252257|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4428136|NCT00147290|4252255|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|9.8|9.8|||
4428137|NCT00147290|4252256|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|9.5|9.5|||
4428138|NCT00147290|4252257|B1|||Age||years|Mean|66.6|66.6|Standard Deviation|10.2|10.2|||
4428139|NCT00147290|4252255|B3||>=65 years|Age||Participants|Count of Participants|337|337.0||||||
4428140|NCT00147290|4252256|B2||>=65 years|Age||Participants|Count of Participants|165|165.0||||||
4428141|NCT00147290|4252257|B1||>=65 years|Age||Participants|Count of Participants|172|172.0||||||
4428142|NCT00147290|4252255|B3||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4428143|NCT00147290|4252256|B2||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4428144|NCT00147290|4252257|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4428145|NCT00147290|4252255|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428146|NCT00147290|4252256|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428147|NCT00147290|4252257|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428148|NCT00147277|4252262|B3|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4428149|NCT00147277|4252263|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4428150|NCT00147277|4252264|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4428151|NCT00147277|4252262|B3|Israel||Region of Enrollment||participants|Number|15|15.0||||||
4428152|NCT00147277|4252263|B2|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4428153|NCT00147277|4252264|B1|Israel||Region of Enrollment||participants|Number|9|9.0||||||
4428154|NCT00147277|4252262|B3|Belgium||Region of Enrollment||participants|Number|15|15.0||||||
4428155|NCT00147277|4252263|B2|Belgium||Region of Enrollment||participants|Number|7|7.0||||||
4428156|NCT00147277|4252264|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4428157|NCT00147277|4252262|B3|Portugal||Region of Enrollment||participants|Number|15|15.0||||||
4428158|NCT00147277|4252263|B2|Portugal||Region of Enrollment||participants|Number|8|8.0||||||
4428159|NCT00147277|4252264|B1|Portugal||Region of Enrollment||participants|Number|7|7.0||||||
4428160|NCT00147277|4252262|B3|Spain||Region of Enrollment||participants|Number|151|151.0||||||
4428161|NCT00147277|4252263|B2|Spain||Region of Enrollment||participants|Number|75|75.0||||||
4428162|NCT00147277|4252264|B1|Spain||Region of Enrollment||participants|Number|76|76.0||||||
4428163|NCT00147277|4252262|B3|France||Region of Enrollment||participants|Number|161|161.0||||||
4428164|NCT00147277|4252263|B2|France||Region of Enrollment||participants|Number|77|77.0||||||
4428165|NCT00147277|4252264|B1|France||Region of Enrollment||participants|Number|84|84.0||||||
4428166|NCT00147277|4252262|B3|Germany||Region of Enrollment||participants|Number|215|215.0||||||
4428167|NCT00147277|4252263|B2|Germany||Region of Enrollment||participants|Number|106|106.0||||||
4428168|NCT00147277|4252264|B1|Germany||Region of Enrollment||participants|Number|109|109.0||||||
4428169|NCT00147277|4252262|B3|Italy||Region of Enrollment||participants|Number|349|349.0||||||
4428170|NCT00147277|4252263|B2|Italy||Region of Enrollment||participants|Number|169|169.0||||||
4428171|NCT00147277|4252264|B1|Italy||Region of Enrollment||participants|Number|180|180.0||||||
4428172|NCT00147277|4252262|B3||Male|Sex: Female, Male||Participants|Count of Participants|811|811.0||||||
4428173|NCT00147277|4252263|B2||Male|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
4428174|NCT00147277|4252264|B1||Male|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
4428175|NCT00147277|4252262|B3||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4428176|NCT00147277|4252263|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4428177|NCT00147277|4252264|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4428178|NCT00147277|4252262|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|11.6|11.6|||
4428179|NCT00147277|4252263|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|12.2|12.2|||
4428180|NCT00147277|4252264|B1|||Age||years|Mean|64|64.0|Standard Deviation|10.9|10.9|||
4428181|NCT00147277|4252262|B3||>=65 years|Age||Participants|Count of Participants|508|508.0||||||
4428182|NCT00147277|4252263|B2||>=65 years|Age||Participants|Count of Participants|247|247.0||||||
4428183|NCT00147277|4252264|B1||>=65 years|Age||Participants|Count of Participants|261|261.0||||||
4428184|NCT00147277|4252262|B3||Between 18 and 65 years|Age||Participants|Count of Participants|417|417.0||||||
4428185|NCT00147277|4252263|B2||Between 18 and 65 years|Age||Participants|Count of Participants|203|203.0||||||
4428186|NCT00147277|4252264|B1||Between 18 and 65 years|Age||Participants|Count of Participants|214|214.0||||||
4428187|NCT00147277|4252262|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428188|NCT00147277|4252263|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428189|NCT00147277|4252264|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428190|NCT00147238|4252269|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4428191|NCT00147238|4252269|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4428192|NCT00147238|4252269|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4428193|NCT00147238|4252269|B1|||Age||years|Mean|64|64.0|Full Range|||55.0|73.0|
4428194|NCT00147225|4252273|B7|United States||Region of Enrollment||participants|Number|51|51.0||||||
4428195|NCT00147225|4252274|B6|United States||Region of Enrollment||participants|Number|12|12.0||||||
4428196|NCT00147225|4252275|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
4428197|NCT00147225|4252276|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4428198|NCT00147225|4252277|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4428199|NCT00147225|4252278|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4428200|NCT00147225|4252279|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4428201|NCT00147225|4252273|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4428202|NCT00147225|4252274|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4428203|NCT00147225|4252275|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4428204|NCT00147225|4252276|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4428205|NCT00147225|4252277|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4428206|NCT00147225|4252278|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4428207|NCT00147225|4252279|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4428208|NCT00147225|4252273|B7||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4428209|NCT00147225|4252274|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4428210|NCT00147225|4252275|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4428211|NCT00147225|4252276|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4428212|NCT00147225|4252277|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4428213|NCT00147225|4252278|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4428214|NCT00147225|4252279|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4428215|NCT00147225|4252273|B7|||Age||years|Median|43|43.0|Full Range|||19.0|67.0|
4428216|NCT00147225|4252274|B6|||Age||years|Median|49|49.0|Full Range|||20.0|62.0|
4428217|NCT00147225|4252275|B5|||Age||years|Median|46|46.0|Full Range|||33.0|61.0|
4428218|NCT00147225|4252276|B4|||Age||years|Median|37|37.0|Full Range|||19.0|59.0|
4428219|NCT00147225|4252277|B3|||Age||years|Median|31|31.0|Full Range|||24.0|63.0|
4428220|NCT00147225|4252278|B2|||Age||years|Median|50|50.0|Full Range|||23.0|67.0|
4428221|NCT00147225|4252279|B1|||Age||years|Median|46|46.0|Full Range|||27.0|60.0|
4428222|NCT00147212|4252304|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4428223|NCT00147212|4252304|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4428224|NCT00147212|4252304|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4428225|NCT00147212|4252304|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4428226|NCT00147212|4252304|B1|||Age||years|Mean|65|65.0|Standard Deviation|5|5.0|||
4428227|NCT00147212|4252304|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4428228|NCT00147212|4252304|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4428229|NCT00147212|4252304|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428230|NCT00147199|4252308|B3|||Baseline Six-Minute Walk Distance (6MWD)||meters|Mean|348|348.0|Standard Deviation|66|66.0|||
4428231|NCT00147199|4252309|B2|||Baseline Six-Minute Walk Distance (6MWD)||meters|Mean|351|351.0|Standard Deviation|69|69.0|||
4428232|NCT00147199|4252310|B1|||Baseline Six-Minute Walk Distance (6MWD)||meters|Mean|346|346.0|Standard Deviation|63|63.0|||
4428233|NCT00147199|4252308|B3|Class IV||Baseline NYHA Class||participants|Number|5|5.0||||||
4428234|NCT00147199|4252309|B2|Class IV||Baseline NYHA Class||participants|Number|2|2.0||||||
4428235|NCT00147199|4252310|B1|Class IV||Baseline NYHA Class||participants|Number|3|3.0||||||
4428236|NCT00147199|4252308|B3|Class III||Baseline NYHA Class||participants|Number|230|230.0||||||
4428237|NCT00147199|4252309|B2|Class III||Baseline NYHA Class||participants|Number|118|118.0||||||
4428238|NCT00147199|4252310|B1|Class III||Baseline NYHA Class||participants|Number|112|112.0||||||
4428239|NCT00147199|4252308|B3|Sildenafil||Time on Background Therapy||weeks|Mean|70|70.0|Standard Deviation|64|64.0|||
4428240|NCT00147199|4252309|B2|Sildenafil||Time on Background Therapy||weeks|Mean|77|77.0|Standard Deviation|69|69.0|||
4428241|NCT00147199|4252310|B1|Sildenafil||Time on Background Therapy||weeks|Mean|65|65.0|Standard Deviation|60|60.0|||
4428242|NCT00147199|4252308|B3|Bosentan||Time on Background Therapy||weeks|Mean|94|94.0|Standard Deviation|77|77.0|||
4428243|NCT00147199|4252309|B2|Bosentan||Time on Background Therapy||weeks|Mean|90|90.0|Standard Deviation|75|75.0|||
4428244|NCT00147199|4252310|B1|Bosentan||Time on Background Therapy||weeks|Mean|98|98.0|Standard Deviation|79|79.0|||
4428245|NCT00147199|4252308|B3|Sildenafil||Background PAH Therapy||participants|Number|70|70.0||||||
4428246|NCT00147199|4252309|B2|Sildenafil||Background PAH Therapy||participants|Number|32|32.0||||||
4428247|NCT00147199|4252310|B1|Sildenafil||Background PAH Therapy||participants|Number|38|38.0||||||
4428248|NCT00147199|4252308|B3|Bosentan||Background PAH Therapy||participants|Number|165|165.0||||||
4428249|NCT00147199|4252309|B2|Bosentan||Background PAH Therapy||participants|Number|88|88.0||||||
4428250|NCT00147199|4252310|B1|Bosentan||Background PAH Therapy||participants|Number|77|77.0||||||
4428251|NCT00147199|4252308|B3|Other||PAH Etiology||participants|Number|27|27.0||||||
4428252|NCT00147199|4252309|B2|Other||PAH Etiology||participants|Number|16|16.0||||||
4428253|NCT00147199|4252310|B1|Other||PAH Etiology||participants|Number|11|11.0||||||
4428254|NCT00147199|4252308|B3|Connective Tissue Disease (CTD)||PAH Etiology||participants|Number|77|77.0||||||
4428255|NCT00147199|4252309|B2|Connective Tissue Disease (CTD)||PAH Etiology||participants|Number|37|37.0||||||
4428256|NCT00147199|4252310|B1|Connective Tissue Disease (CTD)||PAH Etiology||participants|Number|40|40.0||||||
4428257|NCT00147199|4252308|B3|Idiopathic PAH (IPAH)||PAH Etiology||participants|Number|131|131.0||||||
4428258|NCT00147199|4252309|B2|Idiopathic PAH (IPAH)||PAH Etiology||participants|Number|67|67.0||||||
4428259|NCT00147199|4252310|B1|Idiopathic PAH (IPAH)||PAH Etiology||participants|Number|64|64.0||||||
4428260|NCT00147199|4252308|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4428261|NCT00147199|4252309|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4428262|NCT00147199|4252310|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4428263|NCT00147199|4252308|B3||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4428264|NCT00147199|4252309|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4428265|NCT00147199|4252310|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4428266|NCT00147199|4252308|B3|||Age||years|Mean|54|54.0|Full Range|||18.0|75.0|
4428267|NCT00147199|4252309|B2|||Age||years|Mean|52|52.0|Full Range|||18.0|75.0|
4428268|NCT00147199|4252310|B1|||Age||years|Mean|55|55.0|Full Range|13.1|13.1|20.0|75.0|
4428269|NCT00147030|4252333|B3||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4428270|NCT00147030|4252334|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4428271|NCT00147030|4252335|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4428272|NCT00147030|4252333|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4428273|NCT00147030|4252334|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4428274|NCT00147030|4252335|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4428275|NCT00147030|4252333|B3|Age 4-6 hours||Age, Customized|All participants were < 6 hours of age at randomization.|participants|Number|220|220.0||||||
4428276|NCT00147030|4252334|B2|Age 4-6 hours||Age, Customized|All participants were < 6 hours of age at randomization.|participants|Number|105|105.0||||||
4428277|NCT00147030|4252335|B1|Age 4-6 hours||Age, Customized|All participants were < 6 hours of age at randomization.|participants|Number|115|115.0||||||
4428278|NCT00147030|4252333|B3|Age 0-4 hours||Age, Customized|All participants were < 6 hours of age at randomization.|participants|Number|105|105.0||||||
4428279|NCT00147030|4252334|B2|Age 0-4 hours||Age, Customized|All participants were < 6 hours of age at randomization.|participants|Number|57|57.0||||||
4428280|NCT00147030|4252335|B1|Age 0-4 hours||Age, Customized|All participants were < 6 hours of age at randomization.|participants|Number|48|48.0||||||
4428281|NCT00146848|4252384|B4||Male|Sex: Female, Male||Participants|Count of Participants|947|947.0||||||
4428282|NCT00146848|4252385|B3||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4428283|NCT00146848|4252386|B2||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4428284|NCT00146848|4252387|B1||Male|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4428285|NCT00146848|4252384|B4||Female|Sex: Female, Male||Participants|Count of Participants|486|486.0||||||
4428286|NCT00146848|4252385|B3||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4428287|NCT00146848|4252386|B2||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4428288|NCT00146848|4252387|B1||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4428289|NCT00146848|4252384|B4|||Age||years|Mean|67.2|67.2|Standard Deviation|11.1|11.1|||
4428290|NCT00146848|4252385|B3|||Age||years|Mean|66.7|66.7|Standard Deviation|11.6|11.6|||
4428291|NCT00146848|4252386|B2|||Age||years|Mean|67.5|67.5|Standard Deviation|10.4|10.4|||
4428292|NCT00146848|4252387|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|11.4|11.4|||
4428293|NCT00146770|4252403|B3|Other||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|2|2.0||||||
4428294|NCT00146770|4252404|B2|Other||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|1|1.0||||||
4428295|NCT00146770|4252405|B1|Other||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|1|1.0||||||
4428296|NCT00146770|4252403|B3|Asian||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|2|2.0||||||
4428297|NCT00146770|4252404|B2|Asian||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|1|1.0||||||
4428298|NCT00146770|4252405|B1|Asian||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|1|1.0||||||
4428299|NCT00146770|4252403|B3|Hispanic||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|4|4.0||||||
4428300|NCT00146770|4252404|B2|Hispanic||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|4|4.0||||||
4428301|NCT00146770|4252405|B1|Hispanic||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|0|0.0||||||
4428302|NCT00146770|4252403|B3|Black||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|0|0.0||||||
4428303|NCT00146770|4252404|B2|Black||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|0|0.0||||||
4428304|NCT00146770|4252405|B1|Black||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|0|0.0||||||
4428305|NCT00146770|4252403|B3|Caucasian||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|37|37.0||||||
4428306|NCT00146770|4252404|B2|Caucasian||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|16|16.0||||||
4428307|NCT00146770|4252405|B1|Caucasian||Race/Ethnicity|Race characteristics presented were recorded at Baseline in the Double-Blind Study.|participants|Number|21|21.0||||||
4428308|NCT00146770|4252403|B3||Male|Sex: Female, Male|Gender characteristics presented were recorded at Baseline in the Double-Blind Study.|Participants|Count of Participants|22|22.0||||||
4428309|NCT00146770|4252404|B2||Male|Sex: Female, Male|Gender characteristics presented were recorded at Baseline in the Double-Blind Study.|Participants|Count of Participants|11|11.0||||||
4428310|NCT00146770|4252405|B1||Male|Sex: Female, Male|Gender characteristics presented were recorded at Baseline in the Double-Blind Study.|Participants|Count of Participants|11|11.0||||||
4428311|NCT00146770|4252403|B3||Female|Sex: Female, Male|Gender characteristics presented were recorded at Baseline in the Double-Blind Study.|Participants|Count of Participants|23|23.0||||||
4428312|NCT00146770|4252404|B2||Female|Sex: Female, Male|Gender characteristics presented were recorded at Baseline in the Double-Blind Study.|Participants|Count of Participants|11|11.0||||||
4428313|NCT00146770|4252405|B1||Female|Sex: Female, Male|Gender characteristics presented were recorded at Baseline in the Double-Blind Study.|Participants|Count of Participants|12|12.0||||||
4428314|NCT00146770|4252403|B3|||Age|Age characteristics presented were recorded at Baseline in the Double-Blind Study.|years|Mean|15.5|15.5|Standard Deviation|8.04|8.04|||
4428315|NCT00146770|4252404|B2|||Age|Age characteristics presented were recorded at Baseline in the Double-Blind Study.|years|Mean|15.6|15.6|Standard Deviation|8.63|8.63|||
4428316|NCT00146770|4252405|B1|||Age|Age characteristics presented were recorded at Baseline in the Double-Blind Study.|years|Mean|15.4|15.4|Standard Deviation|7.63|7.63|||
4428317|NCT00146770|4252403|B3|19 to <= 65 years||Age, Customized||participants|Number|12|12.0||||||
4428318|NCT00146770|4252404|B2|19 to <= 65 years||Age, Customized||participants|Number|7|7.0||||||
4428319|NCT00146770|4252405|B1|19 to <= 65 years||Age, Customized||participants|Number|5|5.0||||||
4428320|NCT00146770|4252403|B3|13 to <= 18 years||Age, Customized||participants|Number|11|11.0||||||
4428321|NCT00146770|4252404|B2|13 to <= 18 years||Age, Customized||participants|Number|3|3.0||||||
4428322|NCT00146770|4252405|B1|13 to <= 18 years||Age, Customized||participants|Number|8|8.0||||||
4428323|NCT00146770|4252403|B3|<=12 years||Age, Customized||participants|Number|22|22.0||||||
4428324|NCT00146770|4252404|B2|<=12 years||Age, Customized||participants|Number|12|12.0||||||
4428325|NCT00146770|4252405|B1|<=12 years||Age, Customized||participants|Number|10|10.0||||||
4428326|NCT00146757|4252424|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4428327|NCT00146757|4252424|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4428328|NCT00146757|4252424|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4428329|NCT00146757|4252424|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4428330|NCT00146757|4252424|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4428331|NCT00146757|4252424|B1|||Age||years|Mean|2.9|2.9|Standard Deviation|1.48|1.48|||
4428332|NCT00146640|4252442|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4428333|NCT00146640|4252443|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4428334|NCT00146640|4252444|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4428335|NCT00146640|4252442|B3||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4428336|NCT00146640|4252443|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4428337|NCT00146640|4252444|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4428338|NCT00146640|4252442|B3|||Age||years|Mean|55.0|55.0|Standard Deviation|11.3|11.3|||
4428339|NCT00146640|4252443|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|11.4|11.4|||
4428340|NCT00146640|4252444|B1|||Age||years|Mean|54.6|54.6|Standard Deviation|11.2|11.2|||
4428341|NCT00146328|4252465|B4||Male|Sex: Female, Male||Participants|Count of Participants|896|896.0||||||
4428342|NCT00146328|4252466|B3||Male|Sex: Female, Male||Participants|Count of Participants|405|405.0||||||
4428343|NCT00146328|4252467|B2||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4428344|NCT00146328|4252468|B1||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4428345|NCT00146328|4252465|B4||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4428346|NCT00146328|4252466|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4428347|NCT00146328|4252467|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4428348|NCT00146328|4252468|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4428349|NCT00146328|4252465|B4|||Age||years|Mean|44.1|44.1|Standard Deviation|8|8.0|||
4428350|NCT00146328|4252466|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|7.7|7.7|||
4428351|NCT00146328|4252467|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|8.2|8.2|||
4428352|NCT00146328|4252468|B1|||Age||years|Mean|43.7|43.7|Standard Deviation|8|8.0|||
4428353|NCT00146172|4252553|B9||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4428354|NCT00146172|4252554|B8||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4428355|NCT00146172|4252555|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4428356|NCT00146172|4252556|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4428357|NCT00146172|4252557|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4428358|NCT00146172|4252558|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4428359|NCT00146172|4252559|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4428360|NCT00146172|4252560|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4428361|NCT00146172|4252561|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4428362|NCT00146172|4252553|B9||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4428363|NCT00146172|4252554|B8||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4428364|NCT00146172|4252555|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4428365|NCT00146172|4252556|B6||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4428366|NCT00146172|4252557|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4428367|NCT00146172|4252558|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4428368|NCT00146172|4252559|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4428369|NCT00146172|4252560|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4428370|NCT00146172|4252561|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4428371|NCT00146172|4252553|B9|||Age||years|Mean|57.68|57.68|Standard Deviation|12.06|12.06|||
4428372|NCT00146172|4252554|B8|||Age||years|Mean|58.18|58.18|Standard Deviation|11.05|11.05|||
4428373|NCT00146172|4252555|B7|||Age||years|Mean|51.33|51.33|Standard Deviation|8.91|8.91|||
4428374|NCT00146172|4252556|B6|||Age||years|Mean|63.71|63.71|Standard Deviation|15.70|15.7|||
4428375|NCT00146172|4252557|B5|||Age||years|Mean|57.00|57.0|Standard Deviation|8.89|8.89|||
4428376|NCT00146172|4252558|B4|||Age||years|Mean|60.67|60.67|Standard Deviation|15.31|15.31|||
4428377|NCT00146172|4252559|B3|||Age||years|Mean|56.25|56.25|Standard Deviation|20.43|20.43|||
4428378|NCT00146172|4252560|B2|||Age||years|Mean|54.00|54.0|Standard Deviation|7.66|7.66|||
4428379|NCT00146172|4252561|B1|||Age||years|Mean|51.33|51.33|Standard Deviation|12.50|12.5|||
4428380|NCT00146172|4252553|B9||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4428381|NCT00146172|4252554|B8||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4428382|NCT00146172|4252555|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428383|NCT00146172|4252556|B6||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4428384|NCT00146172|4252557|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428385|NCT00146172|4252558|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4428386|NCT00146172|4252559|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4428387|NCT00146172|4252560|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428388|NCT00146172|4252561|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428389|NCT00146172|4252553|B9||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4428390|NCT00146172|4252554|B8||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4428391|NCT00146172|4252555|B7||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4428392|NCT00146172|4252556|B6||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4428393|NCT00146172|4252557|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4428394|NCT00146172|4252558|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4428395|NCT00146172|4252559|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4428396|NCT00146172|4252560|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4428397|NCT00146172|4252561|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4428398|NCT00146172|4252553|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428399|NCT00146172|4252554|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428400|NCT00146172|4252555|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428401|NCT00146172|4252556|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428402|NCT00146172|4252557|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428403|NCT00146172|4252558|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428404|NCT00146172|4252559|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428405|NCT00146172|4252560|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428406|NCT00146172|4252561|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428407|NCT00145977|4252601|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4428408|NCT00145977|4252602|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4428409|NCT00145977|4252603|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4428410|NCT00145977|4252601|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4428411|NCT00145977|4252602|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4428412|NCT00145977|4252603|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4428413|NCT00145977|4252601|B3|||Age||years|Mean|64.4|64.4|Standard Deviation|9.4|9.4|||
4428414|NCT00145977|4252602|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|7.7|7.7|||
4428415|NCT00145977|4252603|B1|||Age||years|Mean|67.4|67.4|Standard Deviation|10.1|10.1|||
4428416|NCT00145795|4252628|B3|Three NRTIs||HAART regimen at enrollment|NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor; Boosted PI: Combine low-dose ritonavir with a second PI and two or more NRTIs|participants|Number|3|3.0||||||
4428417|NCT00145795|4252629|B2|Three NRTIs||HAART regimen at enrollment|NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor; Boosted PI: Combine low-dose ritonavir with a second PI and two or more NRTIs|participants|Number|2|2.0||||||
4428418|NCT00145795|4252630|B1|Three NRTIs||HAART regimen at enrollment|NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor; Boosted PI: Combine low-dose ritonavir with a second PI and two or more NRTIs|participants|Number|1|1.0||||||
4428419|NCT00145795|4252628|B3|Two NRTIs + boosted PI||HAART regimen at enrollment|NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor; Boosted PI: Combine low-dose ritonavir with a second PI and two or more NRTIs|participants|Number|1|1.0||||||
4428420|NCT00145795|4252629|B2|Two NRTIs + boosted PI||HAART regimen at enrollment|NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor; Boosted PI: Combine low-dose ritonavir with a second PI and two or more NRTIs|participants|Number|1|1.0||||||
4428421|NCT00145795|4252630|B1|Two NRTIs + boosted PI||HAART regimen at enrollment|NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor; Boosted PI: Combine low-dose ritonavir with a second PI and two or more NRTIs|participants|Number|0|0.0||||||
4428422|NCT00145795|4252628|B3|Two NRTIs + PI||HAART regimen at enrollment|NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor; Boosted PI: Combine low-dose ritonavir with a second PI and two or more NRTIs|participants|Number|3|3.0||||||
4428423|NCT00145795|4252629|B2|Two NRTIs + PI||HAART regimen at enrollment|NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor; Boosted PI: Combine low-dose ritonavir with a second PI and two or more NRTIs|participants|Number|1|1.0||||||
4428424|NCT00145795|4252630|B1|Two NRTIs + PI||HAART regimen at enrollment|NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor; Boosted PI: Combine low-dose ritonavir with a second PI and two or more NRTIs|participants|Number|2|2.0||||||
4428425|NCT00145795|4252628|B3|Two NRTIs + NNRTI||HAART regimen at enrollment|NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor; Boosted PI: Combine low-dose ritonavir with a second PI and two or more NRTIs|participants|Number|13|13.0||||||
4428426|NCT00145795|4252629|B2|Two NRTIs + NNRTI||HAART regimen at enrollment|NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor; Boosted PI: Combine low-dose ritonavir with a second PI and two or more NRTIs|participants|Number|6|6.0||||||
4428427|NCT00145795|4252630|B1|Two NRTIs + NNRTI||HAART regimen at enrollment|NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: protease inhibitor; Boosted PI: Combine low-dose ritonavir with a second PI and two or more NRTIs|participants|Number|7|7.0||||||
4428428|NCT00145795|4252628|B3|||Duration of HAART prior to study entry||months|Mean|33.6|33.6|Standard Deviation|25.5|25.5|||
4428429|NCT00145795|4252629|B2|||Duration of HAART prior to study entry||months|Mean|38.3|38.3|Standard Deviation|28.8|28.8|||
4428430|NCT00145795|4252630|B1|||Duration of HAART prior to study entry||months|Mean|28.8|28.8|Standard Deviation|23.4|23.4|||
4428431|NCT00145795|4252628|B3|Complete responder||Immune response at enrollment|"We grouped patients according to their baseline absolute CD4+ lymphocyte counts before the initiation of HAART as follows: group 1, CD4+ <100/mm3; group 2, 100–199/mm3; group 3, 200–399/mm3, group 4, 400–699/mm3; and group 5, >= 700/mm3.~Then, we categorized patients as complete or partial immune responders as follows. Complete immune responders have CD4+ counts increase to >700/mm3 after initiation of HAART. Partial immune responders have an increase in CD4+ count of >50% and improvement by at least one immunological grouping. All other patients are considered nonresponders."|participants|Number|0|0.0||||||
4428457|NCT00145704|4252657|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4428432|NCT00145795|4252629|B2|Complete responder||Immune response at enrollment|"We grouped patients according to their baseline absolute CD4+ lymphocyte counts before the initiation of HAART as follows: group 1, CD4+ <100/mm3; group 2, 100–199/mm3; group 3, 200–399/mm3, group 4, 400–699/mm3; and group 5, >= 700/mm3.~Then, we categorized patients as complete or partial immune responders as follows. Complete immune responders have CD4+ counts increase to >700/mm3 after initiation of HAART. Partial immune responders have an increase in CD4+ count of >50% and improvement by at least one immunological grouping. All other patients are considered nonresponders."|participants|Number|0|0.0||||||
4428433|NCT00145795|4252630|B1|Complete responder||Immune response at enrollment|"We grouped patients according to their baseline absolute CD4+ lymphocyte counts before the initiation of HAART as follows: group 1, CD4+ <100/mm3; group 2, 100–199/mm3; group 3, 200–399/mm3, group 4, 400–699/mm3; and group 5, >= 700/mm3.~Then, we categorized patients as complete or partial immune responders as follows. Complete immune responders have CD4+ counts increase to >700/mm3 after initiation of HAART. Partial immune responders have an increase in CD4+ count of >50% and improvement by at least one immunological grouping. All other patients are considered nonresponders."|participants|Number|0|0.0||||||
4428434|NCT00145795|4252628|B3|Partial responder||Immune response at enrollment|"We grouped patients according to their baseline absolute CD4+ lymphocyte counts before the initiation of HAART as follows: group 1, CD4+ <100/mm3; group 2, 100–199/mm3; group 3, 200–399/mm3, group 4, 400–699/mm3; and group 5, >= 700/mm3.~Then, we categorized patients as complete or partial immune responders as follows. Complete immune responders have CD4+ counts increase to >700/mm3 after initiation of HAART. Partial immune responders have an increase in CD4+ count of >50% and improvement by at least one immunological grouping. All other patients are considered nonresponders."|participants|Number|10|10.0||||||
4428435|NCT00145795|4252629|B2|Partial responder||Immune response at enrollment|"We grouped patients according to their baseline absolute CD4+ lymphocyte counts before the initiation of HAART as follows: group 1, CD4+ <100/mm3; group 2, 100–199/mm3; group 3, 200–399/mm3, group 4, 400–699/mm3; and group 5, >= 700/mm3.~Then, we categorized patients as complete or partial immune responders as follows. Complete immune responders have CD4+ counts increase to >700/mm3 after initiation of HAART. Partial immune responders have an increase in CD4+ count of >50% and improvement by at least one immunological grouping. All other patients are considered nonresponders."|participants|Number|5|5.0||||||
4428436|NCT00145795|4252630|B1|Partial responder||Immune response at enrollment|"We grouped patients according to their baseline absolute CD4+ lymphocyte counts before the initiation of HAART as follows: group 1, CD4+ <100/mm3; group 2, 100–199/mm3; group 3, 200–399/mm3, group 4, 400–699/mm3; and group 5, >= 700/mm3.~Then, we categorized patients as complete or partial immune responders as follows. Complete immune responders have CD4+ counts increase to >700/mm3 after initiation of HAART. Partial immune responders have an increase in CD4+ count of >50% and improvement by at least one immunological grouping. All other patients are considered nonresponders."|participants|Number|5|5.0||||||
4428437|NCT00145795|4252628|B3|Nonresponder||Immune response at enrollment|"We grouped patients according to their baseline absolute CD4+ lymphocyte counts before the initiation of HAART as follows: group 1, CD4+ <100/mm3; group 2, 100–199/mm3; group 3, 200–399/mm3, group 4, 400–699/mm3; and group 5, >= 700/mm3.~Then, we categorized patients as complete or partial immune responders as follows. Complete immune responders have CD4+ counts increase to >700/mm3 after initiation of HAART. Partial immune responders have an increase in CD4+ count of >50% and improvement by at least one immunological grouping. All other patients are considered nonresponders."|participants|Number|10|10.0||||||
4428438|NCT00145795|4252629|B2|Nonresponder||Immune response at enrollment|"We grouped patients according to their baseline absolute CD4+ lymphocyte counts before the initiation of HAART as follows: group 1, CD4+ <100/mm3; group 2, 100–199/mm3; group 3, 200–399/mm3, group 4, 400–699/mm3; and group 5, >= 700/mm3.~Then, we categorized patients as complete or partial immune responders as follows. Complete immune responders have CD4+ counts increase to >700/mm3 after initiation of HAART. Partial immune responders have an increase in CD4+ count of >50% and improvement by at least one immunological grouping. All other patients are considered nonresponders."|participants|Number|5|5.0||||||
4428439|NCT00145795|4252630|B1|Nonresponder||Immune response at enrollment|"We grouped patients according to their baseline absolute CD4+ lymphocyte counts before the initiation of HAART as follows: group 1, CD4+ <100/mm3; group 2, 100–199/mm3; group 3, 200–399/mm3, group 4, 400–699/mm3; and group 5, >= 700/mm3.~Then, we categorized patients as complete or partial immune responders as follows. Complete immune responders have CD4+ counts increase to >700/mm3 after initiation of HAART. Partial immune responders have an increase in CD4+ count of >50% and improvement by at least one immunological grouping. All other patients are considered nonresponders."|participants|Number|5|5.0||||||
4428440|NCT00145795|4252628|B3|||CD4 T cell count/mm^3||number of cells per cubic mm|Mean|218|218.0|Standard Deviation|95.3|95.3|||
4428441|NCT00145795|4252629|B2|||CD4 T cell count/mm^3||number of cells per cubic mm|Mean|264|264.0|Standard Deviation|106|106.0|||
4428442|NCT00145795|4252630|B1|||CD4 T cell count/mm^3||number of cells per cubic mm|Mean|172|172.0|Standard Deviation|89|89.0|||
4428443|NCT00145795|4252628|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4428444|NCT00145795|4252629|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4428445|NCT00145795|4252630|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4428446|NCT00145795|4252628|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4428447|NCT00145795|4252629|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4428448|NCT00145795|4252630|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4428449|NCT00145795|4252628|B3|||Age||years|Mean|43|43.0|Standard Deviation|11.9|11.9|||
4428450|NCT00145795|4252629|B2|||Age||years|Mean|40.5|40.5|Standard Deviation|9.6|9.6|||
4428451|NCT00145795|4252630|B1|||Age||years|Mean|45.5|45.5|Standard Deviation|14.4|14.4|||
4428452|NCT00145704|4252655|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4428453|NCT00145704|4252656|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4428454|NCT00145704|4252657|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4428455|NCT00145704|4252655|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4428456|NCT00145704|4252656|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4428458|NCT00145704|4252655|B3|||Age||years|Median|25|25.0|Full Range|||18.0|40.0|
4428459|NCT00145704|4252656|B2|||Age||years|Median|25|25.0|Full Range|||18.0|40.0|
4428460|NCT00145704|4252657|B1|||Age||years|Median|25|25.0|Full Range|||18.0|40.0|
4428461|NCT00145626|4252664|B3|White||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4428462|NCT00145626|4252665|B2|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4428463|NCT00145626|4252666|B1|White||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4428464|NCT00145626|4252664|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4428465|NCT00145626|4252665|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4428466|NCT00145626|4252666|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4428467|NCT00145626|4252664|B3|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4428468|NCT00145626|4252665|B2|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4428469|NCT00145626|4252666|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4428470|NCT00145626|4252664|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4428471|NCT00145626|4252665|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4428472|NCT00145626|4252666|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4428473|NCT00145626|4252664|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4428474|NCT00145626|4252665|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4428475|NCT00145626|4252666|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4428476|NCT00145626|4252664|B3|||Age||years|Median|0.9|0.9|Full Range|||0.5|1.8|
4428477|NCT00145626|4252665|B2|||Age||years|Median|0.8|0.8|Full Range|||0.5|1.8|
4428478|NCT00145626|4252666|B1|||Age||years|Median|1.0|1.0|Full Range|||0.6|1.5|
4428479|NCT00145626|4252664|B3|||Age||years|Mean|1.0|1.0|Standard Deviation|0.42|0.42|||
4428480|NCT00145626|4252665|B2|||Age||years|Mean|1.0|1.0|Standard Deviation|0.52|0.52|||
4428481|NCT00145626|4252666|B1|||Age||years|Mean|1.0|1.0|Standard Deviation|0.34|0.34|||
4428482|NCT00145600|4252708|B5||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4428483|NCT00145600|4252709|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4428484|NCT00145600|4252710|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4428485|NCT00145600|4252711|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4428486|NCT00145600|4252712|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4428487|NCT00145600|4252708|B5||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4428488|NCT00145600|4252709|B4||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4428489|NCT00145600|4252710|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4428490|NCT00145600|4252711|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4428491|NCT00145600|4252712|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4428492|NCT00145600|4252708|B5|||Age||years|Mean|14.48|14.48|Standard Deviation|3.63|3.63|||
4428493|NCT00145600|4252709|B4|||Age||years|Mean|15.06|15.06|Standard Deviation|3.37|3.37|||
4428494|NCT00145600|4252710|B3|||Age||years|Mean|14.85|14.85|Standard Deviation|3.21|3.21|||
4428495|NCT00145600|4252711|B2|||Age||years|Mean|15.35|15.35|Standard Deviation|3.28|3.28|||
4428496|NCT00145600|4252712|B1|||Age||years|Mean|13.08|13.08|Standard Deviation|3.91|3.91|||
4428497|NCT00145600|4252708|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428498|NCT00145600|4252709|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428499|NCT00145600|4252710|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428500|NCT00145600|4252711|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428501|NCT00145600|4252712|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428502|NCT00145600|4252708|B5||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4428503|NCT00145600|4252709|B4||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4428504|NCT00145600|4252710|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4428505|NCT00145600|4252711|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4428506|NCT00145600|4252712|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4428507|NCT00145600|4252708|B5||<=18 years|Age||Participants|Count of Participants|253|253.0||||||
4428508|NCT00145600|4252709|B4||<=18 years|Age||Participants|Count of Participants|122|122.0||||||
4428509|NCT00145600|4252710|B3||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4428510|NCT00145600|4252711|B2||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4428511|NCT00145600|4252712|B1||<=18 years|Age||Participants|Count of Participants|84|84.0||||||
4428512|NCT00145587|4252827|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4428513|NCT00145587|4252828|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4428514|NCT00145587|4252829|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4428515|NCT00145587|4252827|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4428516|NCT00145587|4252828|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4428517|NCT00145587|4252829|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4428518|NCT00145587|4252827|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428519|NCT00145587|4252828|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428520|NCT00145587|4252829|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428521|NCT00145587|4252827|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4428522|NCT00145587|4252828|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4428523|NCT00145587|4252829|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4428524|NCT00145587|4252827|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4428525|NCT00145587|4252828|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4428526|NCT00145587|4252829|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4428527|NCT00145574|4252836|B4|||weight|mean weight in kilograms (kg) and standard deviation (SD)|kg|Mean|60.3|60.3|Standard Deviation|17.72|17.72|||
4428528|NCT00145574|4252837|B3|||weight|mean weight in kilograms (kg) and standard deviation (SD)|kg|Mean|59.0|59.0|Standard Deviation|16.81|16.81|||
4428529|NCT00145574|4252838|B2|||weight|mean weight in kilograms (kg) and standard deviation (SD)|kg|Mean|61.5|61.5|Standard Deviation|20.77|20.77|||
4428530|NCT00145574|4252839|B1|||weight|mean weight in kilograms (kg) and standard deviation (SD)|kg|Mean|60.3|60.3|Standard Deviation|15.32|15.32|||
4428531|NCT00145574|4252836|B4|||height|height in centimeters (cm)|cm|Mean|162.5|162.5|Standard Deviation|11.16|11.16|||
4428532|NCT00145574|4252837|B3|||height|height in centimeters (cm)|cm|Mean|162.1|162.1|Standard Deviation|11.94|11.94|||
4428533|NCT00145574|4252838|B2|||height|height in centimeters (cm)|cm|Mean|160.7|160.7|Standard Deviation|10.90|10.9|||
4428534|NCT00145574|4252839|B1|||height|height in centimeters (cm)|cm|Mean|164.8|164.8|Standard Deviation|10.35|10.35|||
4428535|NCT00145574|4252836|B4|||Body Mass Index|Body Mass Index (BMI) kg/m2|kg/m2|Mean|22.5|22.5|Standard Deviation|5.14|5.14|||
4428536|NCT00145574|4252837|B3|||Body Mass Index|Body Mass Index (BMI) kg/m2|kg/m2|Mean|22.2|22.2|Standard Deviation|4.75|4.75|||
4428537|NCT00145574|4252838|B2|||Body Mass Index|Body Mass Index (BMI) kg/m2|kg/m2|Mean|23.4|23.4|Standard Deviation|6.14|6.14|||
4428538|NCT00145574|4252839|B1|||Body Mass Index|Body Mass Index (BMI) kg/m2|kg/m2|Mean|21.9|21.9|Standard Deviation|4.30|4.3|||
4428539|NCT00145574|4252836|B4|V||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|41|41.0||||||
4428540|NCT00145574|4252837|B3|V||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|13|13.0||||||
4428541|NCT00145574|4252838|B2|V||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|15|15.0||||||
4428542|NCT00145574|4252839|B1|V||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|13|13.0||||||
4428543|NCT00145574|4252836|B4|IV||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|62|62.0||||||
4428544|NCT00145574|4252837|B3|IV||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|20|20.0||||||
4428545|NCT00145574|4252838|B2|IV||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|19|19.0||||||
4428546|NCT00145574|4252839|B1|IV||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|23|23.0||||||
4428547|NCT00145574|4252836|B4|III||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|52|52.0||||||
4428548|NCT00145574|4252837|B3|III||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|16|16.0||||||
4428572|NCT00145574|4252837|B3|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4428549|NCT00145574|4252838|B2|III||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|16|16.0||||||
4428550|NCT00145574|4252839|B1|III||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|20|20.0||||||
4428551|NCT00145574|4252836|B4|II||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|39|39.0||||||
4428552|NCT00145574|4252837|B3|II||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|15|15.0||||||
4428553|NCT00145574|4252838|B2|II||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|15|15.0||||||
4428554|NCT00145574|4252839|B1|II||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|9|9.0||||||
4428555|NCT00145574|4252836|B4|I||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|0|0.0||||||
4428556|NCT00145574|4252837|B3|I||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|0|0.0||||||
4428557|NCT00145574|4252838|B2|I||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|0|0.0||||||
4428558|NCT00145574|4252839|B1|I||Tanner Stage|Tanner Stage represents a scale measuring physical development in children based on primary and secondary sexual characteristics. The scale has five stages, with Stage I representing prepuberty and Stage 5 representing adult physical development. Please refer to Tanner, JM; Growth at Adolescence, @nd ed. Oxford, England, Blackwell Scientific Publications, 1962 for complete definitions of each Tanner Stage of development.|participants|Number|0|0.0||||||
4428559|NCT00145574|4252836|B4|naive||Statin Status|Non-naive refers to the number of participants who are taking statins. Naive refers to the number of participants who are not taking statins.|participants|Number|47|47.0||||||
4428560|NCT00145574|4252837|B3|naive||Statin Status|Non-naive refers to the number of participants who are taking statins. Naive refers to the number of participants who are not taking statins.|participants|Number|15|15.0||||||
4428561|NCT00145574|4252838|B2|naive||Statin Status|Non-naive refers to the number of participants who are taking statins. Naive refers to the number of participants who are not taking statins.|participants|Number|15|15.0||||||
4428562|NCT00145574|4252839|B1|naive||Statin Status|Non-naive refers to the number of participants who are taking statins. Naive refers to the number of participants who are not taking statins.|participants|Number|17|17.0||||||
4428563|NCT00145574|4252836|B4|non-naive||Statin Status|Non-naive refers to the number of participants who are taking statins. Naive refers to the number of participants who are not taking statins.|participants|Number|147|147.0||||||
4428564|NCT00145574|4252837|B3|non-naive||Statin Status|Non-naive refers to the number of participants who are taking statins. Naive refers to the number of participants who are not taking statins.|participants|Number|49|49.0||||||
4428565|NCT00145574|4252838|B2|non-naive||Statin Status|Non-naive refers to the number of participants who are taking statins. Naive refers to the number of participants who are not taking statins.|participants|Number|50|50.0||||||
4428566|NCT00145574|4252839|B1|non-naive||Statin Status|Non-naive refers to the number of participants who are taking statins. Naive refers to the number of participants who are not taking statins.|participants|Number|48|48.0||||||
4428567|NCT00145574|4252836|B4|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
4428568|NCT00145574|4252837|B3|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4428569|NCT00145574|4252838|B2|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4428570|NCT00145574|4252839|B1|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4428571|NCT00145574|4252836|B4|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
4428573|NCT00145574|4252838|B2|Slovakia||Region of Enrollment||participants|Number|0|0.0||||||
4428574|NCT00145574|4252839|B1|Slovakia||Region of Enrollment||participants|Number|2|2.0||||||
4428575|NCT00145574|4252836|B4|New Zealand||Region of Enrollment||participants|Number|5|5.0||||||
4428576|NCT00145574|4252837|B3|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4428577|NCT00145574|4252838|B2|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4428578|NCT00145574|4252839|B1|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4428579|NCT00145574|4252836|B4|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
4428580|NCT00145574|4252837|B3|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4428581|NCT00145574|4252838|B2|Hungary||Region of Enrollment||participants|Number|7|7.0||||||
4428582|NCT00145574|4252839|B1|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4428583|NCT00145574|4252836|B4|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4428584|NCT00145574|4252837|B3|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4428585|NCT00145574|4252838|B2|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4428586|NCT00145574|4252839|B1|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4428587|NCT00145574|4252836|B4|Norway||Region of Enrollment||participants|Number|10|10.0||||||
4428588|NCT00145574|4252837|B3|Norway||Region of Enrollment||participants|Number|4|4.0||||||
4428589|NCT00145574|4252838|B2|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4428590|NCT00145574|4252839|B1|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4428591|NCT00145574|4252836|B4|Israel||Region of Enrollment||participants|Number|16|16.0||||||
4428592|NCT00145574|4252837|B3|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4428593|NCT00145574|4252838|B2|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4428594|NCT00145574|4252839|B1|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4428595|NCT00145574|4252836|B4|South Africa||Region of Enrollment||participants|Number|51|51.0||||||
4428596|NCT00145574|4252837|B3|South Africa||Region of Enrollment||participants|Number|17|17.0||||||
4428597|NCT00145574|4252838|B2|South Africa||Region of Enrollment||participants|Number|16|16.0||||||
4428598|NCT00145574|4252839|B1|South Africa||Region of Enrollment||participants|Number|18|18.0||||||
4428599|NCT00145574|4252836|B4|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4428600|NCT00145574|4252837|B3|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4428601|NCT00145574|4252838|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4428602|NCT00145574|4252839|B1|Austria||Region of Enrollment||participants|Number|0|0.0||||||
4428603|NCT00145574|4252836|B4|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4428604|NCT00145574|4252837|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4428605|NCT00145574|4252838|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4428606|NCT00145574|4252839|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4428607|NCT00145574|4252836|B4|United States||Region of Enrollment||participants|Number|45|45.0||||||
4428608|NCT00145574|4252837|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4428609|NCT00145574|4252838|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4428610|NCT00145574|4252839|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4428611|NCT00145574|4252836|B4||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4428612|NCT00145574|4252837|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4428613|NCT00145574|4252838|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4428614|NCT00145574|4252839|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4428615|NCT00145574|4252836|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4428616|NCT00145574|4252837|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4428617|NCT00145574|4252838|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4428618|NCT00145574|4252839|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4428619|NCT00145574|4252836|B4|||Age||years|Mean|14.1|14.1|Standard Deviation|1.98|1.98|||
4428620|NCT00145574|4252837|B3|||Age||years|Mean|13.9|13.9|Standard Deviation|2.0|2.0|||
4428621|NCT00145574|4252838|B2|||Age||years|Mean|14.1|14.1|Standard Deviation|2.19|2.19|||
4428622|NCT00145574|4252839|B1|||Age||years|Mean|14.3|14.3|Standard Deviation|1.74|1.74|||
4428623|NCT00145574|4252836|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428624|NCT00145574|4252837|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428625|NCT00145574|4252838|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428626|NCT00145574|4252839|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428627|NCT00145574|4252836|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4428628|NCT00145574|4252837|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4428629|NCT00145574|4252838|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4428630|NCT00145574|4252839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4428631|NCT00145574|4252836|B4||<=18 years|Age||Participants|Count of Participants|194|194.0||||||
4428632|NCT00145574|4252837|B3||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
4428633|NCT00145574|4252838|B2||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
4428634|NCT00145574|4252839|B1||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
4428635|NCT00145509|4252896|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4428636|NCT00145509|4252897|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4428637|NCT00145509|4252898|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4428638|NCT00145509|4252896|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4428639|NCT00145509|4252897|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4428640|NCT00145509|4252898|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4428641|NCT00145509|4252896|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|12.49|12.49|||
4428642|NCT00145509|4252897|B2|||Age||years|Mean|38.7|38.7|Standard Deviation|13.42|13.42|||
4428643|NCT00145509|4252898|B1|||Age||years|Mean|39.0|39.0|Standard Deviation|11.79|11.79|||
4428644|NCT00145496|4252911|B3|||Body Weight||kg|Mean|84.8|84.8|Standard Deviation|18.86|18.86|||
4428645|NCT00145496|4252912|B2|||Body Weight||kg|Mean|85.7|85.7|Standard Deviation|18.71|18.71|||
4428646|NCT00145496|4252913|B1|||Body Weight||kg|Mean|84.0|84.0|Standard Deviation|19.01|19.01|||
4428647|NCT00145496|4252911|B3||Male|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4428648|NCT00145496|4252912|B2||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4428649|NCT00145496|4252913|B1||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4428650|NCT00145496|4252911|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4428651|NCT00145496|4252912|B2||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4428652|NCT00145496|4252913|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4428653|NCT00145496|4252911|B3|>=65 years||Age, Customized||participants|Number|12|12.0||||||
4428654|NCT00145496|4252912|B2|>=65 years||Age, Customized||participants|Number|7|7.0||||||
4428655|NCT00145496|4252913|B1|>=65 years||Age, Customized||participants|Number|5|5.0||||||
4428656|NCT00145496|4252911|B3|18 to 64 years||Age, Customized||participants|Number|456|456.0||||||
4428657|NCT00145496|4252912|B2|18 to 64 years||Age, Customized||participants|Number|217|217.0||||||
4428658|NCT00145496|4252913|B1|18 to 64 years||Age, Customized||participants|Number|239|239.0||||||
4428659|NCT00145496|4252911|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4428660|NCT00145496|4252912|B2|<18 years||Age, Customized||participants|Number|0|0.0||||||
4428661|NCT00145496|4252913|B1|<18 years||Age, Customized||participants|Number|0|0.0||||||
4428662|NCT00145496|4252911|B3|||Age||years|Mean|42.9|42.9|Standard Deviation|11.34|11.34|||
4428663|NCT00145496|4252912|B2|||Age||years|Mean|42.8|42.8|Standard Deviation|11.27|11.27|||
4428664|NCT00145496|4252913|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|11.43|11.43|||
4428665|NCT00145418|4252924|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4428666|NCT00145418|4252924|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4428667|NCT00145418|4252924|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4428668|NCT00145418|4252924|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4428669|NCT00145418|4252924|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4428670|NCT00145418|4252924|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428671|NCT00145327|4252931|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4428672|NCT00145327|4252932|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4428673|NCT00145327|4252933|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4428674|NCT00145327|4252934|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4428675|NCT00145327|4252931|B4||Female|Sex: Female, Male||Participants|Count of Participants|2456|2456.0||||||
4428676|NCT00145327|4252932|B3||Female|Sex: Female, Male||Participants|Count of Participants|1223|1223.0||||||
4428677|NCT00145327|4252933|B2||Female|Sex: Female, Male||Participants|Count of Participants|617|617.0||||||
4428678|NCT00145327|4252934|B1||Female|Sex: Female, Male||Participants|Count of Participants|616|616.0||||||
4428679|NCT00145327|4252931|B4|||Age||Years|Mean|75.5|75.5|Standard Deviation|4.92|4.92|||
4428680|NCT00145327|4252932|B3|||Age||Years|Mean|75.6|75.6|Standard Deviation|4.95|4.95|||
4428681|NCT00145327|4252933|B2|||Age||Years|Mean|75.5|75.5|Standard Deviation|4.89|4.89|||
4428682|NCT00145327|4252934|B1|||Age||Years|Mean|75.5|75.5|Standard Deviation|4.88|4.88|||
4428683|NCT00145249|4252989|B4|Thailand||Region of Enrollment||participants|Number|99|99.0||||||
4428684|NCT00145249|4252990|B3|Thailand||Region of Enrollment||participants|Number|35|35.0||||||
4428685|NCT00145249|4252991|B2|Thailand||Region of Enrollment||participants|Number|33|33.0||||||
4428686|NCT00145249|4252992|B1|Thailand||Region of Enrollment||participants|Number|31|31.0||||||
4428687|NCT00145249|4252989|B4|United States||Region of Enrollment||participants|Number|42|42.0||||||
4428688|NCT00145249|4252990|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4428689|NCT00145249|4252991|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4428690|NCT00145249|4252992|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4428691|NCT00145249|4252989|B4||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4428692|NCT00145249|4252990|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4428693|NCT00145249|4252991|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4428694|NCT00145249|4252992|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4428695|NCT00145249|4252989|B4||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4428696|NCT00145249|4252990|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4428697|NCT00145249|4252991|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4428698|NCT00145249|4252992|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4428699|NCT00145249|4252989|B4|||Age||years|Mean|36.5|36.5|Standard Deviation|8.69|8.69|||
4428700|NCT00145249|4252990|B3|||Age||years|Mean|35.9|35.9|Standard Deviation|9.44|9.44|||
4428701|NCT00145249|4252991|B2|||Age||years|Mean|36.5|36.5|Standard Deviation|8.21|8.21|||
4428702|NCT00145249|4252992|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|8.47|8.47|||
4428703|NCT00145249|4252989|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4428704|NCT00145249|4252990|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4428705|NCT00145249|4252991|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428706|NCT00145249|4252992|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4428707|NCT00145249|4252989|B4||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
4428708|NCT00145249|4252990|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4428709|NCT00145249|4252991|B2||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4428710|NCT00145249|4252992|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4428711|NCT00145249|4252989|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4428712|NCT00145249|4252990|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4428713|NCT00145249|4252991|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428714|NCT00145249|4252992|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428715|NCT00145119|4253035|B1|||Pior MI||participants|Number|116|116.0||||||
4428716|NCT00145119|4253035|B1|||Ejection fraction index < 7 days after index MI||percent|Mean|31|31.0|Standard Deviation|6|6.0|||
4428717|NCT00145119|4253035|B1|||Diabetes||participants|Number|62|62.0||||||
4428718|NCT00145119|4253035|B1||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4428719|NCT00145119|4253035|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4428720|NCT00145119|4253035|B1|||Age||years|Mean|65|65.0|Standard Deviation|11|11.0|||
4428721|NCT00145041|4253039|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4428722|NCT00145041|4253039|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4428723|NCT00145041|4253039|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4428724|NCT00145041|4253039|B1|||Age||years|Mean|60.7|60.7|Standard Deviation|8.10|8.1|||
4428725|NCT00145041|4253039|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4428726|NCT00145041|4253039|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4428727|NCT00145041|4253039|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428728|NCT00144963|4253045|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4428729|NCT00144963|4253045|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4428730|NCT00144963|4253045|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4428731|NCT00144963|4253045|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|13.83|13.83|||
4428732|NCT00144963|4253045|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4428733|NCT00144963|4253045|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4428734|NCT00144963|4253045|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428735|NCT00144781|4253049|B5|Other||Study Specific Race/Ethnicity||participants|Number|9|9.0||||||
4428736|NCT00144781|4253050|B4|Other||Study Specific Race/Ethnicity||participants|Number|2|2.0||||||
4428737|NCT00144781|4253051|B3|Other||Study Specific Race/Ethnicity||participants|Number|2|2.0||||||
4428738|NCT00144781|4253052|B2|Other||Study Specific Race/Ethnicity||participants|Number|3|3.0||||||
4428739|NCT00144781|4253053|B1|Other||Study Specific Race/Ethnicity||participants|Number|2|2.0||||||
4428740|NCT00144781|4253049|B5|Asian||Study Specific Race/Ethnicity||participants|Number|0|0.0||||||
4428741|NCT00144781|4253050|B4|Asian||Study Specific Race/Ethnicity||participants|Number|0|0.0||||||
4428742|NCT00144781|4253051|B3|Asian||Study Specific Race/Ethnicity||participants|Number|0|0.0||||||
4428743|NCT00144781|4253052|B2|Asian||Study Specific Race/Ethnicity||participants|Number|0|0.0||||||
4428744|NCT00144781|4253053|B1|Asian||Study Specific Race/Ethnicity||participants|Number|0|0.0||||||
4428745|NCT00144781|4253049|B5|Hispanic||Study Specific Race/Ethnicity||participants|Number|3|3.0||||||
4428746|NCT00144781|4253050|B4|Hispanic||Study Specific Race/Ethnicity||participants|Number|1|1.0||||||
4428747|NCT00144781|4253051|B3|Hispanic||Study Specific Race/Ethnicity||participants|Number|1|1.0||||||
4428748|NCT00144781|4253052|B2|Hispanic||Study Specific Race/Ethnicity||participants|Number|0|0.0||||||
4428749|NCT00144781|4253053|B1|Hispanic||Study Specific Race/Ethnicity||participants|Number|1|1.0||||||
4428750|NCT00144781|4253049|B5|Black||Study Specific Race/Ethnicity||participants|Number|1|1.0||||||
4428751|NCT00144781|4253050|B4|Black||Study Specific Race/Ethnicity||participants|Number|0|0.0||||||
4428752|NCT00144781|4253051|B3|Black||Study Specific Race/Ethnicity||participants|Number|0|0.0||||||
4428753|NCT00144781|4253052|B2|Black||Study Specific Race/Ethnicity||participants|Number|0|0.0||||||
4428754|NCT00144781|4253053|B1|Black||Study Specific Race/Ethnicity||participants|Number|1|1.0||||||
4428755|NCT00144781|4253049|B5|Caucasian||Study Specific Race/Ethnicity||participants|Number|21|21.0||||||
4428756|NCT00144781|4253050|B4|Caucasian||Study Specific Race/Ethnicity||participants|Number|6|6.0||||||
4428757|NCT00144781|4253051|B3|Caucasian||Study Specific Race/Ethnicity||participants|Number|5|5.0||||||
4428758|NCT00144781|4253052|B2|Caucasian||Study Specific Race/Ethnicity||participants|Number|6|6.0||||||
4428759|NCT00144781|4253053|B1|Caucasian||Study Specific Race/Ethnicity||participants|Number|4|4.0||||||
4428760|NCT00144781|4253049|B5||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4428761|NCT00144781|4253050|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4428762|NCT00144781|4253051|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4428763|NCT00144781|4253052|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4428764|NCT00144781|4253053|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4428765|NCT00144781|4253049|B5||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4428766|NCT00144781|4253050|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4428767|NCT00144781|4253051|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4428768|NCT00144781|4253052|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4428769|NCT00144781|4253053|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4428770|NCT00144781|4253049|B5|||Age||years|Mean|8.7|8.7|Standard Deviation|5.34|5.34|||
4428771|NCT00144781|4253050|B4|||Age||years|Mean|9.3|9.3|Standard Deviation|5.48|5.48|||
4428772|NCT00144781|4253051|B3|||Age||years|Mean|9.1|9.1|Standard Deviation|4.97|4.97|||
4428773|NCT00144781|4253052|B2|||Age||years|Mean|8.0|8.0|Standard Deviation|6.64|6.64|||
4428774|NCT00144781|4253053|B1|||Age||years|Mean|8.5|8.5|Standard Deviation|4.86|4.86|||
4428775|NCT00144391|4253074|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4428776|NCT00144391|4253075|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428777|NCT00144391|4253076|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4428778|NCT00144391|4253074|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4428779|NCT00144391|4253075|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4428780|NCT00144391|4253076|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4428781|NCT00144391|4253074|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4428782|NCT00144391|4253075|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4428783|NCT00144391|4253076|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4428784|NCT00144391|4253074|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4428785|NCT00144391|4253075|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4428786|NCT00144391|4253076|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4428787|NCT00144391|4253074|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4428788|NCT00144391|4253075|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4428789|NCT00144391|4253076|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4428790|NCT00144391|4253074|B3|||Age||years|Mean|43|43.0|Standard Deviation|11|11.0|||
4428791|NCT00144391|4253075|B2|||Age||years|Mean|42|42.0|Standard Deviation|14|14.0|||
4428792|NCT00144391|4253076|B1|||Age||years|Mean|43|43.0|Standard Deviation|9|9.0|||
4428793|NCT00144339|4253083|B3||Male|Sex: Female, Male||Participants|Count of Participants|4473.0|4473.0||||||
4428794|NCT00144339|4253084|B2||Male|Sex: Female, Male||Participants|Count of Participants|2251|2251.0||||||
4428795|NCT00144339|4253085|B1||Male|Sex: Female, Male||Participants|Count of Participants|2222|2222.0||||||
4428796|NCT00144339|4253083|B3||Female|Sex: Female, Male||Participants|Count of Participants|1519.0|1519.0||||||
4428797|NCT00144339|4253084|B2||Female|Sex: Female, Male||Participants|Count of Participants|735|735.0||||||
4428798|NCT00144339|4253085|B1||Female|Sex: Female, Male||Participants|Count of Participants|784|784.0||||||
4428799|NCT00144339|4253083|B3|||Age||years|Mean|64.51|64.51|Standard Deviation|8.45|8.45|||
4428800|NCT00144339|4253084|B2|||Age||years|Mean|64.50|64.5|Standard Deviation|8.41|8.41|||
4428801|NCT00144339|4253085|B1|||Age||years|Mean|64.52|64.52|Standard Deviation|8.48|8.48|||
4428802|NCT00144300|4253292|B3|Fulfills criteria for Abuse/Dependence||Alcohol history||Participants|Number|0|0.0||||||
4428803|NCT00144300|4253293|B2|Fulfills criteria for Abuse/Dependence||Alcohol history||Participants|Number|0|0.0||||||
4428804|NCT00144300|4253294|B1|Fulfills criteria for Abuse/Dependence||Alcohol history||Participants|Number|0|0.0||||||
4428805|NCT00144300|4253292|B3|Has an average consumption||Alcohol history||Participants|Number|151|151.0||||||
4428806|NCT00144300|4253293|B2|Has an average consumption||Alcohol history||Participants|Number|76|76.0||||||
4428807|NCT00144300|4253294|B1|Has an average consumption||Alcohol history||Participants|Number|75|75.0||||||
4428808|NCT00144300|4253292|B3|Does not drink||Alcohol history||Participants|Number|95|95.0||||||
4428809|NCT00144300|4253293|B2|Does not drink||Alcohol history||Participants|Number|49|49.0||||||
4428810|NCT00144300|4253294|B1|Does not drink||Alcohol history||Participants|Number|46|46.0||||||
4428811|NCT00144300|4253292|B3|Stage 5||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|0|0.0||||||
4428812|NCT00144300|4253293|B2|Stage 5||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|0|0.0||||||
4428813|NCT00144300|4253294|B1|Stage 5||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|0|0.0||||||
4428814|NCT00144300|4253292|B3|Stage 4||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|0|0.0||||||
4428815|NCT00144300|4253293|B2|Stage 4||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|0|0.0||||||
4428849|NCT00144300|4253294|B1|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4428850|NCT00144300|4253292|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4428816|NCT00144300|4253294|B1|Stage 4||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|0|0.0||||||
4428817|NCT00144300|4253292|B3|Stage 3||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|10|10.0||||||
4428818|NCT00144300|4253293|B2|Stage 3||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|7|7.0||||||
4428819|NCT00144300|4253294|B1|Stage 3||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|3|3.0||||||
4428820|NCT00144300|4253292|B3|Stage 2.5||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|13|13.0||||||
4428821|NCT00144300|4253293|B2|Stage 2.5||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|5|5.0||||||
4428822|NCT00144300|4253294|B1|Stage 2.5||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|8|8.0||||||
4428823|NCT00144300|4253292|B3|Stage 2||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|142|142.0||||||
4428824|NCT00144300|4253293|B2|Stage 2||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|71|71.0||||||
4428825|NCT00144300|4253294|B1|Stage 2||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|71|71.0||||||
4428826|NCT00144300|4253292|B3|Stage 1.5||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|30|30.0||||||
4428827|NCT00144300|4253293|B2|Stage 1.5||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|19|19.0||||||
4428828|NCT00144300|4253294|B1|Stage 1.5||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|11|11.0||||||
4428829|NCT00144300|4253292|B3|Stage 1||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|51|51.0||||||
4428830|NCT00144300|4253293|B2|Stage 1||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|23|23.0||||||
4428831|NCT00144300|4253294|B1|Stage 1||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|28|28.0||||||
4428832|NCT00144300|4253292|B3|Stage 0||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|0|0.0||||||
4428833|NCT00144300|4253293|B2|Stage 0||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|0|0.0||||||
4428834|NCT00144300|4253294|B1|Stage 0||Hoehn and Yahr stage|This scale is an investigator-completed assessment of the degree of complications arising from Parkinson's disease. The scale ranges from 0 (No signs) to 5 (Bedridden)|Participants|Number|0|0.0||||||
4428835|NCT00144300|4253292|B3|||Duration of Parkinson's disease diagnosis||years|Mean|1.13|1.13|Standard Deviation|1.46|1.46|||
4428836|NCT00144300|4253293|B2|||Duration of Parkinson's disease diagnosis||years|Mean|1.29|1.29|Standard Deviation|1.70|1.7|||
4428837|NCT00144300|4253294|B1|||Duration of Parkinson's disease diagnosis||years|Mean|0.97|0.97|Standard Deviation|1.15|1.15|||
4428838|NCT00144300|4253292|B3|||Weight|Measurements collected for 119, 122 participants in Pramipexole, Ropinirole respectively|kilograms|Mean|82.07|82.07|Standard Deviation|18.00|18.0|||
4428839|NCT00144300|4253293|B2|||Weight|Measurements collected for 119, 122 participants in Pramipexole, Ropinirole respectively|kilograms|Mean|82.80|82.8|Standard Deviation|18.39|18.39|||
4428840|NCT00144300|4253294|B1|||Weight|Measurements collected for 119, 122 participants in Pramipexole, Ropinirole respectively|kilograms|Mean|81.32|81.32|Standard Deviation|17.64|17.64|||
4428841|NCT00144300|4253292|B3|||Height|Measurements collected for 120, 125 participants in Pramipexole, Ropinirole respectively|centimeters|Mean|171.5|171.5|Standard Deviation|10.9|10.9|||
4428842|NCT00144300|4253293|B2|||Height|Measurements collected for 120, 125 participants in Pramipexole, Ropinirole respectively|centimeters|Mean|171.6|171.6|Standard Deviation|12.4|12.4|||
4428843|NCT00144300|4253294|B1|||Height|Measurements collected for 120, 125 participants in Pramipexole, Ropinirole respectively|centimeters|Mean|171.3|171.3|Standard Deviation|9.2|9.2|||
4428844|NCT00144300|4253292|B3|White||Race/Ethnicity, Customized||Participants|Number|234|234.0||||||
4428845|NCT00144300|4253293|B2|White||Race/Ethnicity, Customized||Participants|Number|121|121.0||||||
4428846|NCT00144300|4253294|B1|White||Race/Ethnicity, Customized||Participants|Number|113|113.0||||||
4428847|NCT00144300|4253292|B3|Black||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4428848|NCT00144300|4253293|B2|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4428851|NCT00144300|4253293|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4428852|NCT00144300|4253294|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4428853|NCT00144300|4253292|B3||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4428854|NCT00144300|4253293|B2||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4428855|NCT00144300|4253294|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4428856|NCT00144300|4253292|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4428857|NCT00144300|4253293|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4428858|NCT00144300|4253294|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4428859|NCT00144300|4253292|B3|>= 75 years||Age, Customized||Participants|Number|10|10.0||||||
4428860|NCT00144300|4253293|B2|>= 75 years||Age, Customized||Participants|Number|4|4.0||||||
4428861|NCT00144300|4253294|B1|>= 75 years||Age, Customized||Participants|Number|6|6.0||||||
4428862|NCT00144300|4253292|B3|65 to < 75 years||Age, Customized||Participants|Number|51|51.0||||||
4428863|NCT00144300|4253293|B2|65 to < 75 years||Age, Customized||Participants|Number|30|30.0||||||
4428864|NCT00144300|4253294|B1|65 to < 75 years||Age, Customized||Participants|Number|21|21.0||||||
4428865|NCT00144300|4253292|B3|50 to < 65 years||Age, Customized||Participants|Number|145|145.0||||||
4428866|NCT00144300|4253293|B2|50 to < 65 years||Age, Customized||Participants|Number|74|74.0||||||
4428867|NCT00144300|4253294|B1|50 to < 65 years||Age, Customized||Participants|Number|71|71.0||||||
4428868|NCT00144300|4253292|B3|< 50 years||Age, Customized||Participants|Number|40|40.0||||||
4428869|NCT00144300|4253293|B2|< 50 years||Age, Customized||Participants|Number|17|17.0||||||
4428870|NCT00144300|4253294|B1|< 50 years||Age, Customized||Participants|Number|23|23.0||||||
4428871|NCT00144300|4253292|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|9.0|9.0|||
4428872|NCT00144300|4253293|B2|||Age||years|Mean|59.1|59.1|Standard Deviation|8.7|8.7|||
4428873|NCT00144300|4253294|B1|||Age||years|Mean|57.5|57.5|Standard Deviation|9.3|9.3|||
4428874|NCT00144170|4253341|B3||Male|Sex: Female, Male|3 patients were not randomized but treated with TPV/r. They are included in the participant flow and adverse events but not in the efficacy analysis.|Participants|Count of Participants|715|715.0||||||
4428875|NCT00144170|4253342|B2||Male|Sex: Female, Male|3 patients were not randomized but treated with TPV/r. They are included in the participant flow and adverse events but not in the efficacy analysis.|Participants|Count of Participants|364|364.0||||||
4428876|NCT00144170|4253343|B1||Male|Sex: Female, Male|3 patients were not randomized but treated with TPV/r. They are included in the participant flow and adverse events but not in the efficacy analysis.|Participants|Count of Participants|351|351.0||||||
4428877|NCT00144170|4253341|B3||Female|Sex: Female, Male|3 patients were not randomized but treated with TPV/r. They are included in the participant flow and adverse events but not in the efficacy analysis.|Participants|Count of Participants|148|148.0||||||
4428878|NCT00144170|4253342|B2||Female|Sex: Female, Male|3 patients were not randomized but treated with TPV/r. They are included in the participant flow and adverse events but not in the efficacy analysis.|Participants|Count of Participants|64|64.0||||||
4428879|NCT00144170|4253343|B1||Female|Sex: Female, Male|3 patients were not randomized but treated with TPV/r. They are included in the participant flow and adverse events but not in the efficacy analysis.|Participants|Count of Participants|84|84.0||||||
4428880|NCT00144170|4253341|B3|||Age|3 patients were not randomized but treated with TPV/r. They are included in the participant flow and adverse events but not in the efficacy analysis.|years|Mean|42.7|42.7|Standard Deviation|8.2|8.2|||
4428881|NCT00144170|4253342|B2|||Age|3 patients were not randomized but treated with TPV/r. They are included in the participant flow and adverse events but not in the efficacy analysis.|years|Mean|42.9|42.9|Standard Deviation|8|8.0|||
4428882|NCT00144170|4253343|B1|||Age|3 patients were not randomized but treated with TPV/r. They are included in the participant flow and adverse events but not in the efficacy analysis.|years|Mean|42.5|42.5|Standard Deviation|8.4|8.4|||
4428883|NCT00144027|4253532|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428884|NCT00144027|4253533|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428885|NCT00144027|4253534|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428886|NCT00144027|4253532|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428887|NCT00144027|4253533|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428888|NCT00144027|4253534|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428889|NCT00144027|4253532|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4428890|NCT00144027|4253533|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4428891|NCT00144027|4253534|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4428892|NCT00144027|4253532|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4428893|NCT00144027|4253533|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4428894|NCT00144027|4253534|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4428895|NCT00144027|4253532|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428896|NCT00144027|4253533|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428897|NCT00144027|4253534|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428898|NCT00144027|4253532|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428899|NCT00144027|4253533|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428900|NCT00144027|4253534|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429095|NCT00143312|4253680|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4428901|NCT00144027|4253532|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428902|NCT00144027|4253533|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428903|NCT00144027|4253534|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4428904|NCT00144027|4253532|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4428905|NCT00144027|4253533|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4428906|NCT00144027|4253534|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4428907|NCT00144027|4253532|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4428908|NCT00144027|4253533|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4428909|NCT00144027|4253534|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4428910|NCT00144027|4253532|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|7.3|7.3|||
4428911|NCT00144027|4253533|B2|||Age||years|Mean|52.9|52.9|Standard Deviation|5.6|5.6|||
4428912|NCT00144027|4253534|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|8.3|8.3|||
4428913|NCT00143845|4253541|B1||Male|Gender||Participants|Count of Participants|23|23.0||||||
4428914|NCT00143845|4253541|B1||Female|Gender||Participants|Count of Participants|22|22.0||||||
4428915|NCT00143845|4253541|B1|||Age||years|Median|56|56.0|Full Range|||2.0|67.0|
4428916|NCT00143819|4253547|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4428917|NCT00143819|4253548|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4428918|NCT00143819|4253549|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4428919|NCT00143819|4253547|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4428920|NCT00143819|4253548|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4428921|NCT00143819|4253549|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4428922|NCT00143819|4253547|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4428923|NCT00143819|4253548|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4428924|NCT00143819|4253549|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4428925|NCT00143819|4253547|B3|||Age||years|Mean|63|63.0|Full Range|||42.0|85.0|
4428926|NCT00143819|4253548|B2|||Age||years|Mean|61|61.0|Full Range|||42.0|85.0|
4428927|NCT00143819|4253549|B1|||Age||years|Mean|66|66.0|Full Range|||49.0|79.0|
4428928|NCT00143819|4253547|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4428929|NCT00143819|4253548|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4428930|NCT00143819|4253549|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4428931|NCT00143819|4253547|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4428932|NCT00143819|4253548|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4428933|NCT00143819|4253549|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4428934|NCT00143819|4253547|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428935|NCT00143819|4253548|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428936|NCT00143819|4253549|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4428937|NCT00143598|4253563|B3|Duration of Oral Anti-Coagulation (OAC)||Duration of DVT Treatment||days|Median|185|185.0|Inter-Quartile Range|||109.5|231.0|
4428938|NCT00143598|4253564|B2|Duration of Oral Anti-Coagulation (OAC)||Duration of DVT Treatment||days|Median|182|182.0|Inter-Quartile Range|||104.0|220.0|
4428939|NCT00143598|4253565|B1|Duration of Oral Anti-Coagulation (OAC)||Duration of DVT Treatment||days|Median|186|186.0|Inter-Quartile Range|||113.0|253.0|
4428940|NCT00143598|4253563|B3|Duration of heparin||Duration of DVT Treatment||days|Median|8|8.0|Inter-Quartile Range|||6.0|11.0|
4428941|NCT00143598|4253564|B2|Duration of heparin||Duration of DVT Treatment||days|Median|8|8.0|Inter-Quartile Range|||6.0|10.0|
4428942|NCT00143598|4253565|B1|Duration of heparin||Duration of DVT Treatment||days|Median|8|8.0|Inter-Quartile Range|||6.0|11.0|
4428943|NCT00143598|4253563|B3|Investigational anitcoagulant||Type of DVT Treatment||participants|Number|26|26.0||||||
4428944|NCT00143598|4253564|B2|Investigational anitcoagulant||Type of DVT Treatment||participants|Number|11|11.0||||||
4428945|NCT00143598|4253565|B1|Investigational anitcoagulant||Type of DVT Treatment||participants|Number|15|15.0||||||
4428946|NCT00143598|4253563|B3|Warfarin||Type of DVT Treatment||participants|Number|647|647.0||||||
4428947|NCT00143598|4253564|B2|Warfarin||Type of DVT Treatment||participants|Number|317|317.0||||||
4428948|NCT00143598|4253565|B1|Warfarin||Type of DVT Treatment||participants|Number|330|330.0||||||
4428949|NCT00143598|4253563|B3|Unfractionated heparin||Type of DVT Treatment||participants|Number|52|52.0||||||
4428950|NCT00143598|4253564|B2|Unfractionated heparin||Type of DVT Treatment||participants|Number|21|21.0||||||
4428951|NCT00143598|4253565|B1|Unfractionated heparin||Type of DVT Treatment||participants|Number|31|31.0||||||
4428952|NCT00143598|4253563|B3|Low molecular weight heparin||Type of DVT Treatment||participants|Number|772|772.0||||||
4428953|NCT00143598|4253564|B2|Low molecular weight heparin||Type of DVT Treatment||participants|Number|384|384.0||||||
4428954|NCT00143598|4253565|B1|Low molecular weight heparin||Type of DVT Treatment||participants|Number|388|388.0||||||
4428955|NCT00143598|4253563|B3|Family history of venous thromboembolism||Venous thrombosis risk factors||participants|Number|167|167.0||||||
4428956|NCT00143598|4253564|B2|Family history of venous thromboembolism||Venous thrombosis risk factors||participants|Number|82|82.0||||||
4428957|NCT00143598|4253565|B1|Family history of venous thromboembolism||Venous thrombosis risk factors||participants|Number|85|85.0||||||
4428958|NCT00143598|4253563|B3|Pregnant, post partum, OCT, or HRT||Venous thrombosis risk factors||participants|Number|92|92.0||||||
4428959|NCT00143598|4253564|B2|Pregnant, post partum, OCT, or HRT||Venous thrombosis risk factors||participants|Number|55|55.0||||||
4428960|NCT00143598|4253565|B1|Pregnant, post partum, OCT, or HRT||Venous thrombosis risk factors||participants|Number|37|37.0||||||
4428961|NCT00143598|4253563|B3|Active cancer||Venous thrombosis risk factors||participants|Number|98|98.0||||||
4428962|NCT00143598|4253564|B2|Active cancer||Venous thrombosis risk factors||participants|Number|46|46.0||||||
4428963|NCT00143598|4253565|B1|Active cancer||Venous thrombosis risk factors||participants|Number|52|52.0||||||
4428964|NCT00143598|4253563|B3|Immobilised in past month||Venous thrombosis risk factors||participants|Number|128|128.0||||||
4428965|NCT00143598|4253564|B2|Immobilised in past month||Venous thrombosis risk factors||participants|Number|61|61.0||||||
4428966|NCT00143598|4253565|B1|Immobilised in past month||Venous thrombosis risk factors||participants|Number|67|67.0||||||
4428967|NCT00143598|4253563|B3|Trauma, past 3 months||Venous thrombosis risk factors||participants|Number|93|93.0||||||
4428968|NCT00143598|4253564|B2|Trauma, past 3 months||Venous thrombosis risk factors||participants|Number|51|51.0||||||
4428969|NCT00143598|4253565|B1|Trauma, past 3 months||Venous thrombosis risk factors||participants|Number|42|42.0||||||
4428970|NCT00143598|4253563|B3|Surgery, past 3 months||Venous thrombosis risk factors||participants|Number|141|141.0||||||
4428971|NCT00143598|4253564|B2|Surgery, past 3 months||Venous thrombosis risk factors||participants|Number|64|64.0||||||
4428972|NCT00143598|4253565|B1|Surgery, past 3 months||Venous thrombosis risk factors||participants|Number|77|77.0||||||
4428973|NCT00143598|4253563|B3|||Concurrent pulmonary embolism||participants|Number|114|114.0||||||
4428974|NCT00143598|4253564|B2|||Concurrent pulmonary embolism||participants|Number|57|57.0||||||
4428975|NCT00143598|4253565|B1|||Concurrent pulmonary embolism||participants|Number|57|57.0||||||
4428976|NCT00143598|4253563|B3|||Villalta score at baseline|"The Villalta Scale for assessment of the post-thrombotic syndrome~The Villalta scale has a range of 0-33. A Villalta scale score >4 indicates post-thrombotic syndrome (severity of post-thrombotic syndrome is categorized as 5-9 points, mild; 10-14 points, moderate; >14 points or presence of an ulcer, severe).~Higher values signify worse outcome.~Points on each item in the scale are simply summed to a total score."|Score on a scale|Mean|8.4|8.4|Standard Deviation|4.6|4.6|||
4428977|NCT00143598|4253564|B2|||Villalta score at baseline|"The Villalta Scale for assessment of the post-thrombotic syndrome~The Villalta scale has a range of 0-33. A Villalta scale score >4 indicates post-thrombotic syndrome (severity of post-thrombotic syndrome is categorized as 5-9 points, mild; 10-14 points, moderate; >14 points or presence of an ulcer, severe).~Higher values signify worse outcome.~Points on each item in the scale are simply summed to a total score."|Score on a scale|Mean|8.7|8.7|Standard Deviation|4.8|4.8|||
4428978|NCT00143598|4253565|B1|||Villalta score at baseline|"The Villalta Scale for assessment of the post-thrombotic syndrome~The Villalta scale has a range of 0-33. A Villalta scale score >4 indicates post-thrombotic syndrome (severity of post-thrombotic syndrome is categorized as 5-9 points, mild; 10-14 points, moderate; >14 points or presence of an ulcer, severe).~Higher values signify worse outcome.~Points on each item in the scale are simply summed to a total score."|Score on a scale|Mean|8.2|8.2|Standard Deviation|4.4|4.4|||
4428979|NCT00143598|4253563|B3|Popliteal vein||Most proximal extent of DVT||participants|Number|243|243.0||||||
4428980|NCT00143598|4253564|B2|Popliteal vein||Most proximal extent of DVT||participants|Number|115|115.0||||||
4428981|NCT00143598|4253565|B1|Popliteal vein||Most proximal extent of DVT||participants|Number|128|128.0||||||
4428982|NCT00143598|4253563|B3|Femoral Vein||Most proximal extent of DVT||participants|Number|251|251.0||||||
4428983|NCT00143598|4253564|B2|Femoral Vein||Most proximal extent of DVT||participants|Number|123|123.0||||||
4428984|NCT00143598|4253565|B1|Femoral Vein||Most proximal extent of DVT||participants|Number|128|128.0||||||
4428985|NCT00143598|4253563|B3|Common femoral vein||Most proximal extent of DVT||participants|Number|216|216.0||||||
4428986|NCT00143598|4253564|B2|Common femoral vein||Most proximal extent of DVT||participants|Number|107|107.0||||||
4428987|NCT00143598|4253565|B1|Common femoral vein||Most proximal extent of DVT||participants|Number|109|109.0||||||
4428988|NCT00143598|4253563|B3|Iliac vein||Most proximal extent of DVT||participants|Number|93|93.0||||||
4428989|NCT00143598|4253564|B2|Iliac vein||Most proximal extent of DVT||participants|Number|49|49.0||||||
4428990|NCT00143598|4253565|B1|Iliac vein||Most proximal extent of DVT||participants|Number|44|44.0||||||
4428991|NCT00143598|4253563|B3|Bilateral||Side of DVT||participants|Number|12|12.0||||||
4428992|NCT00143598|4253564|B2|Bilateral||Side of DVT||participants|Number|5|5.0||||||
4428993|NCT00143598|4253565|B1|Bilateral||Side of DVT||participants|Number|7|7.0||||||
4428994|NCT00143598|4253563|B3|Right||Side of DVT||participants|Number|438|438.0||||||
4428995|NCT00143598|4253564|B2|Right||Side of DVT||participants|Number|216|216.0||||||
4428996|NCT00143598|4253565|B1|Right||Side of DVT||participants|Number|222|222.0||||||
4428997|NCT00143598|4253563|B3|Left||Side of DVT||participants|Number|353|353.0||||||
4428998|NCT00143598|4253564|B2|Left||Side of DVT||participants|Number|173|173.0||||||
4428999|NCT00143598|4253565|B1|Left||Side of DVT||participants|Number|180|180.0||||||
4429000|NCT00143598|4253563|B3|||Time from DVT diagnosis to randomization||days|Mean|4.7|4.7|Standard Deviation|3.9|3.9|||
4429001|NCT00143598|4253564|B2|||Time from DVT diagnosis to randomization||days|Mean|4.6|4.6|Standard Deviation|3.8|3.8|||
4429002|NCT00143598|4253565|B1|||Time from DVT diagnosis to randomization||days|Mean|4.8|4.8|Standard Deviation|4.1|4.1|||
4429003|NCT00143598|4253563|B3|||Body-mass index, kg/m2||kg/m^2|Mean|28.95|28.95|Standard Deviation|6.1|6.1|||
4429004|NCT00143598|4253564|B2|||Body-mass index, kg/m2||kg/m^2|Mean|28.9|28.9|Standard Deviation|6.1|6.1|||
4429005|NCT00143598|4253565|B1|||Body-mass index, kg/m2||kg/m^2|Mean|29.0|29.0|Standard Deviation|6.1|6.1|||
4429006|NCT00143598|4253563|B3|||Outpatients||participants|Number|699|699.0||||||
4429007|NCT00143598|4253564|B2|||Outpatients||participants|Number|344|344.0||||||
4429008|NCT00143598|4253565|B1|||Outpatients||participants|Number|355|355.0||||||
4429009|NCT00143598|4253563|B3|White ethnic origin||Race/Ethnicity, Customized||participants|Number|725|725.0||||||
4429010|NCT00143598|4253564|B2|White ethnic origin||Race/Ethnicity, Customized||participants|Number|354|354.0||||||
4429011|NCT00143598|4253565|B1|White ethnic origin||Race/Ethnicity, Customized||participants|Number|371|371.0||||||
4429012|NCT00143598|4253563|B3||Male|Sex: Female, Male||Participants|Count of Participants|483|483.0||||||
4429013|NCT00143598|4253564|B2||Male|Sex: Female, Male||Participants|Count of Participants|228|228.0||||||
4429014|NCT00143598|4253565|B1||Male|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4429015|NCT00143598|4253563|B3||Female|Sex: Female, Male||Participants|Count of Participants|320|320.0||||||
4429016|NCT00143598|4253564|B2||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4429017|NCT00143598|4253565|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4429018|NCT00143598|4253563|B3|>65 years||Age, Customized||participants|Number|230|230.0||||||
4429019|NCT00143598|4253564|B2|>65 years||Age, Customized||participants|Number|110|110.0||||||
4429020|NCT00143598|4253565|B1|>65 years||Age, Customized||participants|Number|120|120.0||||||
4429021|NCT00143598|4253563|B3|40-65 years||Age, Customized||participants|Number|439|439.0||||||
4429022|NCT00143598|4253564|B2|40-65 years||Age, Customized||participants|Number|217|217.0||||||
4429023|NCT00143598|4253565|B1|40-65 years||Age, Customized||participants|Number|222|222.0||||||
4429024|NCT00143598|4253563|B3|<40 years||Age, Customized||participants|Number|134|134.0||||||
4429025|NCT00143598|4253564|B2|<40 years||Age, Customized||participants|Number|67|67.0||||||
4429026|NCT00143598|4253565|B1|<40 years||Age, Customized||participants|Number|67|67.0||||||
4429027|NCT00143598|4253563|B3|||Age||years|Mean|55.1|55.1|Standard Deviation|15.5|15.5|||
4429028|NCT00143598|4253564|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|15.8|15.8|||
4429029|NCT00143598|4253565|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|15.3|15.3|||
4429030|NCT00143507|4253578|B3|No||Beta-blocker intake||participants|Number|1430|1430.0||||||
4429031|NCT00143507|4253579|B2|No||Beta-blocker intake||participants|Number|700|700.0||||||
4429032|NCT00143507|4253580|B1|No||Beta-blocker intake||participants|Number|730|730.0||||||
4429033|NCT00143507|4253578|B3|Yes||Beta-blocker intake||participants|Number|9487|9487.0||||||
4429034|NCT00143507|4253579|B2|Yes||Beta-blocker intake||participants|Number|4738|4738.0||||||
4429035|NCT00143507|4253580|B1|Yes||Beta-blocker intake||participants|Number|4749|4749.0||||||
4429036|NCT00143507|4253578|B3||Male|Sex: Female, Male||Participants|Count of Participants|9047|9047.0||||||
4429037|NCT00143507|4253579|B2||Male|Sex: Female, Male||Participants|Count of Participants|4507|4507.0||||||
4429038|NCT00143507|4253580|B1||Male|Sex: Female, Male||Participants|Count of Participants|4540|4540.0||||||
4429039|NCT00143507|4253578|B3||Female|Sex: Female, Male||Participants|Count of Participants|1870|1870.0||||||
4429040|NCT00143507|4253579|B2||Female|Sex: Female, Male||Participants|Count of Participants|931|931.0||||||
4429041|NCT00143507|4253580|B1||Female|Sex: Female, Male||Participants|Count of Participants|939|939.0||||||
4429042|NCT00143507|4253578|B3|||Age||years|Mean|65.2|65.2|Standard Deviation|8.5|8.5|||
4429043|NCT00143507|4253579|B2|||Age||years|Mean|65|65.0|Standard Deviation|8.4|8.4|||
4429044|NCT00143507|4253580|B1|||Age||years|Mean|65.3|65.3|Standard Deviation|8.5|8.5|||
4429045|NCT00143455|4253611|B5||Male|Sex: Female, Male|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|Participants|Count of Participants|372|372.0||||||
4429046|NCT00143455|4253612|B4||Male|Sex: Female, Male|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|Participants|Count of Participants|155|155.0||||||
4429047|NCT00143455|4253613|B3||Male|Sex: Female, Male|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|Participants|Count of Participants|154|154.0||||||
4429048|NCT00143455|4253614|B2||Male|Sex: Female, Male|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|Participants|Count of Participants|31|31.0||||||
4429049|NCT00143455|4253615|B1||Male|Sex: Female, Male|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|Participants|Count of Participants|32|32.0||||||
4429050|NCT00143455|4253611|B5||Female|Sex: Female, Male|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|Participants|Count of Participants|110|110.0||||||
4429051|NCT00143455|4253612|B4||Female|Sex: Female, Male|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|Participants|Count of Participants|48|48.0||||||
4429052|NCT00143455|4253613|B3||Female|Sex: Female, Male|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|Participants|Count of Participants|48|48.0||||||
4429053|NCT00143455|4253614|B2||Female|Sex: Female, Male|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|Participants|Count of Participants|7|7.0||||||
4429054|NCT00143455|4253615|B1||Female|Sex: Female, Male|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|Participants|Count of Participants|7|7.0||||||
4429096|NCT00143312|4253680|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|14.1|14.1|||
4429055|NCT00143455|4253611|B5|> = 65 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|147|147.0||||||
4429056|NCT00143455|4253612|B4|> = 65 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|67|67.0||||||
4429057|NCT00143455|4253613|B3|> = 65 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|57|57.0||||||
4429058|NCT00143455|4253614|B2|> = 65 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|13|13.0||||||
4429059|NCT00143455|4253615|B1|> = 65 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|10|10.0||||||
4429060|NCT00143455|4253611|B5|45 to 64 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|315|315.0||||||
4429061|NCT00143455|4253612|B4|45 to 64 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|130|130.0||||||
4429062|NCT00143455|4253613|B3|45 to 64 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|134|134.0||||||
4429063|NCT00143455|4253614|B2|45 to 64 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|24|24.0||||||
4429064|NCT00143455|4253615|B1|45 to 64 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|27|27.0||||||
4429065|NCT00143455|4253611|B5|18 to 44 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|20|20.0||||||
4429066|NCT00143455|4253612|B4|18 to 44 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|6|6.0||||||
4429067|NCT00143455|4253613|B3|18 to 44 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|11|11.0||||||
4429068|NCT00143455|4253614|B2|18 to 44 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|1|1.0||||||
4429069|NCT00143455|4253615|B1|18 to 44 years||Age, Customized|Protocol amendment (29 September 2003) reduced Irinotecan dose from 80 to 65mg/m2. Subjects recruited prior to amendment were referred to as Cohort 1; those afterwards were referred to as Cohort 2.|participants|Number|2|2.0||||||
4429070|NCT00143403|4253650|B3||Male|Sex: Female, Male||Participants|Count of Participants|190.0|190.0||||||
4429071|NCT00143403|4253651|B2||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4429072|NCT00143403|4253652|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4429073|NCT00143403|4253650|B3||Female|Sex: Female, Male||Participants|Count of Participants|116.0|116.0||||||
4429074|NCT00143403|4253651|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4429075|NCT00143403|4253652|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4429076|NCT00143403|4253650|B3|||Age||years|Median|62|62.0|Full Range|||27.0|76.0|
4429077|NCT00143403|4253651|B2|||Age||years|Median|63|63.0|Full Range|||27.0|75.0|
4429078|NCT00143403|4253652|B1|||Age||years|Median|61|61.0|Full Range|||34.0|76.0|
4429079|NCT00143390|4253661|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429080|NCT00143390|4253662|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429081|NCT00143390|4253663|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429082|NCT00143390|4253661|B3||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4429083|NCT00143390|4253662|B2||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4429084|NCT00143390|4253663|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4429085|NCT00143390|4253661|B3|>=65 years old||Age, Customized||participants|Number|122|122.0||||||
4429086|NCT00143390|4253662|B2|>=65 years old||Age, Customized||participants|Number|61|61.0||||||
4429087|NCT00143390|4253663|B1|>=65 years old||Age, Customized||participants|Number|61|61.0||||||
4429088|NCT00143390|4253661|B3|45-64 years old||Age, Customized||participants|Number|174|174.0||||||
4429089|NCT00143390|4253662|B2|45-64 years old||Age, Customized||participants|Number|88|88.0||||||
4429090|NCT00143390|4253663|B1|45-64 years old||Age, Customized||participants|Number|86|86.0||||||
4429091|NCT00143390|4253661|B3|18-44 years old||Age, Customized||participants|Number|2|2.0||||||
4429092|NCT00143390|4253662|B2|18-44 years old||Age, Customized||participants|Number|0|0.0||||||
4429093|NCT00143390|4253663|B1|18-44 years old||Age, Customized||participants|Number|2|2.0||||||
4429094|NCT00143312|4253680|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4429097|NCT00143247|4253690|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4429098|NCT00143247|4253690|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4429099|NCT00143247|4253690|B1|||Age||years|Mean|46.6|46.6|Standard Deviation|10.7|10.7|||
4429100|NCT00142935|4253704|B4|United States||Region of Enrollment||participants|Number|87|87.0||||||
4429101|NCT00142935|4253705|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4429102|NCT00142935|4253706|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4429103|NCT00142935|4253707|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4429104|NCT00142935|4253704|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4429105|NCT00142935|4253705|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4429106|NCT00142935|4253706|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4429107|NCT00142935|4253707|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4429108|NCT00142935|4253704|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4429109|NCT00142935|4253705|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4429110|NCT00142935|4253706|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4429111|NCT00142935|4253707|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4429112|NCT00142935|4253704|B4|||Age||years|Mean|37.6|37.6|Standard Deviation|8.27|8.27|||
4429113|NCT00142935|4253705|B3|||Age||years|Mean|38.4|38.4|Standard Deviation|9.25|9.25|||
4429114|NCT00142935|4253706|B2|||Age||years|Mean|37|37.0|Standard Deviation|6.69|6.69|||
4429115|NCT00142935|4253707|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|8.79|8.79|||
4429116|NCT00142935|4253704|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429117|NCT00142935|4253705|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429118|NCT00142935|4253706|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429119|NCT00142935|4253707|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429120|NCT00142935|4253704|B4||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4429121|NCT00142935|4253705|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4429122|NCT00142935|4253706|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4429123|NCT00142935|4253707|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4429124|NCT00142935|4253704|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429125|NCT00142935|4253705|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429126|NCT00142935|4253706|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429127|NCT00142935|4253707|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429128|NCT00142909|4253732|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4429129|NCT00142909|4253733|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4429130|NCT00142909|4253734|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4429131|NCT00142909|4253732|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4429132|NCT00142909|4253733|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4429133|NCT00142909|4253734|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4429134|NCT00142909|4253732|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4429135|NCT00142909|4253733|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4429136|NCT00142909|4253734|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4429137|NCT00142909|4253732|B3|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4429138|NCT00142909|4253733|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4429139|NCT00142909|4253734|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4429140|NCT00142909|4253732|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4429141|NCT00142909|4253733|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4429142|NCT00142909|4253734|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4429143|NCT00142909|4253732|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4429144|NCT00142909|4253733|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4429145|NCT00142909|4253734|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4429146|NCT00142909|4253732|B3|||Age||years|Mean|26.24|26.24|Standard Deviation|7.96|7.96|||
4429147|NCT00142909|4253733|B2|||Age||years|Mean|25.56|25.56|Standard Deviation|7.66|7.66|||
4429148|NCT00142909|4253734|B1|||Age||years|Mean|28.63|28.63|Standard Deviation|9.99|9.99|||
4429149|NCT00142818|4253751|B5|United States||Region of Enrollment||participants|Number|164|164.0||||||
4429150|NCT00142818|4253752|B4|United States||Region of Enrollment||participants|Number|42|42.0||||||
4429151|NCT00142818|4253753|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4429152|NCT00142818|4253754|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4429153|NCT00142818|4253755|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4429154|NCT00142818|4253751|B5||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4429155|NCT00142818|4253752|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4429156|NCT00142818|4253753|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4429157|NCT00142818|4253754|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4429158|NCT00142818|4253755|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4429159|NCT00142818|4253751|B5||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4429160|NCT00142818|4253752|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4429161|NCT00142818|4253753|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4429162|NCT00142818|4253754|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4429163|NCT00142818|4253755|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4429164|NCT00142818|4253751|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429165|NCT00142818|4253752|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429166|NCT00142818|4253753|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429167|NCT00142818|4253754|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429168|NCT00142818|4253755|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429169|NCT00142818|4253751|B5||Between 18 and 65 years|Age||Participants|Count of Participants|164|164.0||||||
4429170|NCT00142818|4253752|B4||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4429171|NCT00142818|4253753|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4429172|NCT00142818|4253754|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4429173|NCT00142818|4253755|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4429174|NCT00142818|4253751|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429175|NCT00142818|4253752|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429176|NCT00142818|4253753|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429177|NCT00142818|4253754|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429178|NCT00142818|4253755|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429179|NCT00142792|4253768|B4|||Months from Stroke||months|Median|2.8|2.8|Inter-Quartile Range|||1.5|4.5|
4429180|NCT00142792|4253769|B3|||Months from Stroke||months|Median|3.2|3.2|Inter-Quartile Range|||1.7|5.0|
4429181|NCT00142792|4253770|B2|||Months from Stroke||months|Median|2.9|2.9|Inter-Quartile Range|||1.5|4.7|
4429182|NCT00142792|4253771|B1|||Months from Stroke||months|Median|2.0|2.0|Inter-Quartile Range|||1.3|4.2|
4429183|NCT00142792|4253768|B4|United States||Region of Enrollment||participants|Number|122|122.0||||||
4429184|NCT00142792|4253769|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4429185|NCT00142792|4253770|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4429186|NCT00142792|4253771|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4429187|NCT00142792|4253768|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4429188|NCT00142792|4253769|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4429189|NCT00142792|4253770|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429190|NCT00142792|4253771|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429191|NCT00142792|4253768|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429192|NCT00142792|4253769|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429193|NCT00142792|4253770|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429194|NCT00142792|4253771|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429195|NCT00142792|4253768|B4||White|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4429196|NCT00142792|4253769|B3||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4429197|NCT00142792|4253770|B2||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4429198|NCT00142792|4253771|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4429199|NCT00142792|4253768|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4429200|NCT00142792|4253769|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4429201|NCT00142792|4253770|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4429202|NCT00142792|4253771|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4429203|NCT00142792|4253768|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429204|NCT00142792|4253769|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429205|NCT00142792|4253770|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429206|NCT00142792|4253771|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429207|NCT00142792|4253768|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4429208|NCT00142792|4253769|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4429209|NCT00142792|4253770|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429210|NCT00142792|4253771|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429211|NCT00142792|4253768|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429212|NCT00142792|4253769|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429213|NCT00142792|4253770|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429214|NCT00142792|4253771|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429215|NCT00142792|4253768|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4429216|NCT00142792|4253769|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4429217|NCT00142792|4253770|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429218|NCT00142792|4253771|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429219|NCT00142792|4253768|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4429220|NCT00142792|4253769|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4429221|NCT00142792|4253770|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4429222|NCT00142792|4253771|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4429223|NCT00142792|4253768|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4429224|NCT00142792|4253769|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429225|NCT00142792|4253770|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4429226|NCT00142792|4253771|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4429227|NCT00142792|4253768|B4||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4429228|NCT00142792|4253769|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4429229|NCT00142792|4253770|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4429230|NCT00142792|4253771|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4429231|NCT00142792|4253768|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4429232|NCT00142792|4253769|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4429233|NCT00142792|4253770|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4429234|NCT00142792|4253771|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4429235|NCT00142792|4253768|B4|||Age||years|Median|55.1|55.1|Inter-Quartile Range|||47.6|67.1|
4429236|NCT00142792|4253769|B3|||Age||years|Median|55.8|55.8|Inter-Quartile Range|||47.6|66.7|
4429237|NCT00142792|4253770|B2|||Age||years|Median|58.6|58.6|Inter-Quartile Range|||48.9|67.5|
4429238|NCT00142792|4253771|B1|||Age||years|Median|55.0|55.0|Inter-Quartile Range|||47.4|65.9|
4429239|NCT00142597|4253784|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4429240|NCT00142597|4253785|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4429241|NCT00142597|4253786|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4429242|NCT00142597|4253784|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429243|NCT00142597|4253785|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429244|NCT00142597|4253786|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429245|NCT00142597|4253784|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4429246|NCT00142597|4253785|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4429247|NCT00142597|4253786|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4429248|NCT00142597|4253784|B3|||Age||years|Mean|46.70|46.7|Standard Deviation|13.95|13.95|||
4429249|NCT00142597|4253785|B2|||Age||years|Mean|44.87|44.87|Standard Deviation|15.03|15.03|||
4429250|NCT00142597|4253786|B1|||Age||years|Mean|48.52|48.52|Standard Deviation|12.85|12.85|||
4429251|NCT00142506|4253793|B3|United States||Region of Enrollment||participants|Number|290|290.0||||||
4429252|NCT00142506|4253794|B2|United States||Region of Enrollment||participants|Number|106|106.0||||||
4429253|NCT00142506|4253795|B1|United States||Region of Enrollment||participants|Number|184|184.0||||||
4429254|NCT00142506|4253793|B3||Male|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4429255|NCT00142506|4253794|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4429256|NCT00142506|4253795|B1||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4429257|NCT00142506|4253793|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429258|NCT00142506|4253794|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429259|NCT00142506|4253795|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429260|NCT00142506|4253793|B3||>=65 years|Age||Participants|Count of Participants|118|118.0||||||
4429261|NCT00142506|4253794|B2||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4429262|NCT00142506|4253795|B1||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
4429263|NCT00142506|4253793|B3||Between 18 and 65 years|Age||Participants|Count of Participants|172|172.0||||||
4429264|NCT00142506|4253794|B2||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4429265|NCT00142506|4253795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4429266|NCT00142506|4253793|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429267|NCT00142506|4253794|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429268|NCT00142506|4253795|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429269|NCT00142415|4253802|B7|||Body Mass Index||kg/m^2|Mean|27.3|27.3|Standard Deviation|3.95|3.95|||
4429270|NCT00142415|4253803|B6|||Body Mass Index||kg/m^2|Mean|26.7|26.7|Standard Deviation|1.78|1.78|||
4429271|NCT00142415|4253804|B5|||Body Mass Index||kg/m^2|Mean|31.2|31.2|Standard Deviation|5.35|5.35|||
4429272|NCT00142415|4253805|B4|||Body Mass Index||kg/m^2|Mean|28.5|28.5|Standard Deviation|5.84|5.84|||
4429273|NCT00142415|4253806|B3|||Body Mass Index||kg/m^2|Mean|27.2|27.2|Standard Deviation|4.52|4.52|||
4429274|NCT00142415|4253807|B2|||Body Mass Index||kg/m^2|Mean|28.6|28.6|Standard Deviation|3.38|3.38|||
4429275|NCT00142415|4253808|B1|||Body Mass Index||kg/m^2|Mean|23.0|23.0|Standard Deviation|1.29|1.29|||
4429276|NCT00142415|4253802|B7|Netherlands||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4429277|NCT00142415|4253803|B6|Netherlands||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4429278|NCT00142415|4253804|B5|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4429279|NCT00142415|4253805|B4|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4429280|NCT00142415|4253806|B3|Netherlands||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4429281|NCT00142415|4253807|B2|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4429282|NCT00142415|4253808|B1|Netherlands||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4429283|NCT00142415|4253802|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429284|NCT00142415|4253803|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429285|NCT00142415|4253804|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429286|NCT00142415|4253805|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429287|NCT00142415|4253806|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429288|NCT00142415|4253807|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429289|NCT00142415|4253808|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429290|NCT00142415|4253802|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429291|NCT00142415|4253803|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429292|NCT00142415|4253804|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429293|NCT00142415|4253805|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429294|NCT00142415|4253806|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429295|NCT00142415|4253807|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429296|NCT00142415|4253808|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429297|NCT00142415|4253802|B7||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4429298|NCT00142415|4253803|B6||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4429299|NCT00142415|4253804|B5||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4429300|NCT00142415|4253805|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4429301|NCT00142415|4253806|B3||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4429302|NCT00142415|4253807|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4429303|NCT00142415|4253808|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4429304|NCT00142415|4253802|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429305|NCT00142415|4253803|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429306|NCT00142415|4253804|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429307|NCT00142415|4253805|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429308|NCT00142415|4253806|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429309|NCT00142415|4253807|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429310|NCT00142415|4253808|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429311|NCT00142415|4253802|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429312|NCT00142415|4253803|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429313|NCT00142415|4253804|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429314|NCT00142415|4253805|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429315|NCT00142415|4253806|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429316|NCT00142415|4253807|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429317|NCT00142415|4253808|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429318|NCT00142415|4253802|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429319|NCT00142415|4253803|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429320|NCT00142415|4253804|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429321|NCT00142415|4253805|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429322|NCT00142415|4253806|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429323|NCT00142415|4253807|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429324|NCT00142415|4253808|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429325|NCT00142415|4253802|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429326|NCT00142415|4253803|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429327|NCT00142415|4253804|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429328|NCT00142415|4253805|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429329|NCT00142415|4253806|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429330|NCT00142415|4253807|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429331|NCT00142415|4253808|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429332|NCT00142415|4253802|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4429333|NCT00142415|4253803|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4429334|NCT00142415|4253804|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429335|NCT00142415|4253805|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429336|NCT00142415|4253806|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429337|NCT00142415|4253807|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429338|NCT00142415|4253808|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4429339|NCT00142415|4253802|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4429340|NCT00142415|4253803|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4429341|NCT00142415|4253804|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4429342|NCT00142415|4253805|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4429343|NCT00142415|4253806|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4429344|NCT00142415|4253807|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4429345|NCT00142415|4253808|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429346|NCT00142415|4253802|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429347|NCT00142415|4253803|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429348|NCT00142415|4253804|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429349|NCT00142415|4253805|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429350|NCT00142415|4253806|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429351|NCT00142415|4253807|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429352|NCT00142415|4253808|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4429353|NCT00142415|4253802|B7||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4429354|NCT00142415|4253803|B6||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4429355|NCT00142415|4253804|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4429356|NCT00142415|4253805|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4429357|NCT00142415|4253806|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4429358|NCT00142415|4253807|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4429359|NCT00142415|4253808|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4429360|NCT00142415|4253802|B7||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4429361|NCT00142415|4253803|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4429362|NCT00142415|4253804|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4429363|NCT00142415|4253805|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429364|NCT00142415|4253806|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4429365|NCT00142415|4253807|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429366|NCT00142415|4253808|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4429367|NCT00142415|4253802|B7|||Age||years|Mean|57.8|57.8|Standard Deviation|10.53|10.53|||
4429368|NCT00142415|4253803|B6|||Age||years|Mean|58.3|58.3|Standard Deviation|8.94|8.94|||
4429369|NCT00142415|4253804|B5|||Age||years|Mean|44.7|44.7|Standard Deviation|13.80|13.8|||
4429370|NCT00142415|4253805|B4|||Age||years|Mean|51.3|51.3|Standard Deviation|6.11|6.11|||
4429371|NCT00142415|4253806|B3|||Age||years|Mean|64.7|64.7|Standard Deviation|7.87|7.87|||
4429372|NCT00142415|4253807|B2|||Age||years|Mean|60.7|60.7|Standard Deviation|12.86|12.86|||
4429373|NCT00142415|4253808|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|8.74|8.74|||
4429374|NCT00142298|4253841|B11||Male|Sex: Female, Male||Participants|Count of Participants|1436|1436.0||||||
4429375|NCT00142298|4253842|B10||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4429376|NCT00142298|4253843|B9||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4429377|NCT00142298|4253844|B8||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4429378|NCT00142298|4253845|B7||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4429379|NCT00142298|4253846|B6||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4429380|NCT00142298|4253847|B5||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4429381|NCT00142298|4253848|B4||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4429382|NCT00142298|4253849|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4429383|NCT00142298|4253850|B2||Male|Sex: Female, Male||Participants|Count of Participants|490|490.0||||||
4429384|NCT00142298|4253851|B1||Male|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4429385|NCT00142298|4253841|B11||Female|Sex: Female, Male||Participants|Count of Participants|433|433.0||||||
4429386|NCT00142298|4253842|B10||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4429387|NCT00142298|4253843|B9||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4429388|NCT00142298|4253844|B8||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4429389|NCT00142298|4253845|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4429390|NCT00142298|4253846|B6||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4429391|NCT00142298|4253847|B5||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4429392|NCT00142298|4253848|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4429393|NCT00142298|4253849|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4429394|NCT00142298|4253850|B2||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4429395|NCT00142298|4253851|B1||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4429396|NCT00142298|4253841|B11|> 50 years||Age, Customized||Participants|Number|258|258.0||||||
4429397|NCT00142298|4253842|B10|> 50 years||Age, Customized||Participants|Number|0|0.0||||||
4429398|NCT00142298|4253843|B9|> 50 years||Age, Customized||Participants|Number|6|6.0||||||
4429399|NCT00142298|4253844|B8|> 50 years||Age, Customized||Participants|Number|5|5.0||||||
4429400|NCT00142298|4253845|B7|> 50 years||Age, Customized||Participants|Number|18|18.0||||||
4429401|NCT00142298|4253846|B6|> 50 years||Age, Customized||Participants|Number|15|15.0||||||
4429402|NCT00142298|4253847|B5|> 50 years||Age, Customized||Participants|Number|7|7.0||||||
4429403|NCT00142298|4253848|B4|> 50 years||Age, Customized||Participants|Number|30|30.0||||||
4429404|NCT00142298|4253849|B3|> 50 years||Age, Customized||Participants|Number|6|6.0||||||
4429405|NCT00142298|4253850|B2|> 50 years||Age, Customized||Participants|Number|100|100.0||||||
4429406|NCT00142298|4253851|B1|> 50 years||Age, Customized||Participants|Number|71|71.0||||||
4429407|NCT00142298|4253841|B11|30-50 years||Age, Customized||Participants|Number|948|948.0||||||
4429408|NCT00142298|4253842|B10|30-50 years||Age, Customized||Participants|Number|5|5.0||||||
4429409|NCT00142298|4253843|B9|30-50 years||Age, Customized||Participants|Number|24|24.0||||||
4429410|NCT00142298|4253844|B8|30-50 years||Age, Customized||Participants|Number|31|31.0||||||
4429411|NCT00142298|4253845|B7|30-50 years||Age, Customized||Participants|Number|5|5.0||||||
4429412|NCT00142298|4253846|B6|30-50 years||Age, Customized||Participants|Number|10|10.0||||||
4429413|NCT00142298|4253847|B5|30-50 years||Age, Customized||Participants|Number|40|40.0||||||
4429414|NCT00142298|4253848|B4|30-50 years||Age, Customized||Participants|Number|122|122.0||||||
4429415|NCT00142298|4253849|B3|30-50 years||Age, Customized||Participants|Number|66|66.0||||||
4429416|NCT00142298|4253850|B2|30-50 years||Age, Customized||Participants|Number|325|325.0||||||
4429417|NCT00142298|4253851|B1|30-50 years||Age, Customized||Participants|Number|320|320.0||||||
4429418|NCT00142298|4253841|B11|< 30 years||Age, Customized||Participants|Number|663|663.0||||||
4429419|NCT00142298|4253842|B10|< 30 years||Age, Customized||Participants|Number|8|8.0||||||
4429420|NCT00142298|4253843|B9|< 30 years||Age, Customized||Participants|Number|27|27.0||||||
4429421|NCT00142298|4253844|B8|< 30 years||Age, Customized||Participants|Number|30|30.0||||||
4429422|NCT00142298|4253845|B7|< 30 years||Age, Customized||Participants|Number|0|0.0||||||
4429423|NCT00142298|4253846|B6|< 30 years||Age, Customized||Participants|Number|1|1.0||||||
4429424|NCT00142298|4253847|B5|< 30 years||Age, Customized||Participants|Number|9|9.0||||||
4429425|NCT00142298|4253848|B4|< 30 years||Age, Customized||Participants|Number|54|54.0||||||
4429426|NCT00142298|4253849|B3|< 30 years||Age, Customized||Participants|Number|51|51.0||||||
4429427|NCT00142298|4253850|B2|< 30 years||Age, Customized||Participants|Number|207|207.0||||||
4429428|NCT00142298|4253851|B1|< 30 years||Age, Customized||Participants|Number|276|276.0||||||
4429429|NCT00142168|4253882|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4429430|NCT00142168|4253882|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4429431|NCT00142168|4253882|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4429432|NCT00142168|4253882|B1|||Age||years|Mean|59|59.0|Standard Deviation|9|9.0|||
4429433|NCT00142168|4253882|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4429434|NCT00142168|4253882|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4429435|NCT00142168|4253882|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429436|NCT00142116|4253889|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4429437|NCT00142116|4253889|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4429438|NCT00142116|4253889|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4429439|NCT00142116|4253889|B1|||Age||years|Mean|63|63.0|Standard Deviation|11.2|11.2|||
4429440|NCT00142116|4253889|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4429441|NCT00142116|4253889|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4429442|NCT00142116|4253889|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429443|NCT00141921|4253894|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4429444|NCT00141921|4253894|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4429445|NCT00141921|4253894|B1|Asian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4429446|NCT00141921|4253894|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4429447|NCT00141921|4253894|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4429448|NCT00141921|4253894|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
4429449|NCT00141921|4253894|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4429450|NCT00141921|4253894|B1||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4429451|NCT00141921|4253894|B1|||Age||years|Mean|12.8|12.8|Standard Deviation|3.5|3.5|||
4429452|NCT00141817|4253916|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4429453|NCT00141817|4253917|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4429454|NCT00141817|4253918|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4429455|NCT00141817|4253919|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4429456|NCT00141817|4253920|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4429457|NCT00141817|4253916|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4429458|NCT00141817|4253917|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4429459|NCT00141817|4253918|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4429460|NCT00141817|4253919|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4429461|NCT00141817|4253920|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4429462|NCT00141817|4253916|B5|||Age||years|Mean|6.41|6.41|Standard Deviation|3.11|3.11|||
4429463|NCT00141817|4253917|B4|||Age||years|Mean|8.77|8.77|Standard Deviation|1.09|1.09|||
4429464|NCT00141817|4253918|B3|||Age||years|Mean|8.55|8.55|Standard Deviation|1.97|1.97|||
4429465|NCT00141817|4253919|B2|||Age||years|Mean|2.80|2.8|Standard Deviation|1.55|1.55|||
4429466|NCT00141817|4253920|B1|||Age||years|Mean|3.86|3.86|Standard Deviation|1.46|1.46|||
4429467|NCT00141778|4253961|B4|United States||Region of Enrollment||participants|Number|445|445.0||||||
4429468|NCT00141778|4253962|B3|United States||Region of Enrollment||participants|Number|147|147.0||||||
4429469|NCT00141778|4253963|B2|United States||Region of Enrollment||participants|Number|151|151.0||||||
4429470|NCT00141778|4253964|B1|United States||Region of Enrollment||participants|Number|147|147.0||||||
4429471|NCT00141778|4253961|B4||Male|Sex: Female, Male||Participants|Count of Participants|296|296.0||||||
4429472|NCT00141778|4253962|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4429473|NCT00141778|4253963|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4429474|NCT00141778|4253964|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4429475|NCT00141778|4253961|B4||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4429476|NCT00141778|4253962|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4429477|NCT00141778|4253963|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4429478|NCT00141778|4253964|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4429479|NCT00141778|4253961|B4|||Age||years|Mean|59.3|59.3|Standard Deviation|12.2|12.2|||
4429480|NCT00141778|4253962|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|12.3|12.3|||
4429481|NCT00141778|4253963|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|12.3|12.3|||
4429482|NCT00141778|4253964|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|12.0|12.0|||
4429483|NCT00141778|4253961|B4||>=65 years|Age||Participants|Count of Participants|151|151.0||||||
4429484|NCT00141778|4253962|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4429485|NCT00141778|4253963|B2||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4429486|NCT00141778|4253964|B1||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4429487|NCT00141778|4253961|B4||Between 18 and 65 years|Age||Participants|Count of Participants|294|294.0||||||
4429488|NCT00141778|4253962|B3||Between 18 and 65 years|Age||Participants|Count of Participants|99|99.0||||||
4429489|NCT00141778|4253963|B2||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4429490|NCT00141778|4253964|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4429491|NCT00141778|4253961|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429492|NCT00141778|4253962|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429493|NCT00141778|4253963|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429494|NCT00141778|4253964|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429495|NCT00141765|4254004|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4429496|NCT00141765|4254004|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4429497|NCT00141765|4254004|B1|||Age||years|Mean|6|6.0|Full Range|||1.0|21.0|
4429498|NCT00141739|4254008|B1|Total body radiation||Conditioning Regimen Parameter|Those subjects that did or did not receive Total body irradiation as part of their conditioning regimen.|participants|Number|29|29.0||||||
4429499|NCT00141739|4254008|B1|Non-Total body radiation||Conditioning Regimen Parameter|Those subjects that did or did not receive Total body irradiation as part of their conditioning regimen.|participants|Number|71|71.0||||||
4429500|NCT00141739|4254008|B1|7/8 mismatched related||Donor match||participants|Number|3|3.0||||||
4429501|NCT00141739|4254008|B1|7/8 mismatched unrelated||Donor match||participants|Number|26|26.0||||||
4429502|NCT00141739|4254008|B1|8/8 matched unrelated||Donor match||participants|Number|71|71.0||||||
4429503|NCT00141739|4254008|B1|High risk||Disease status at transplantation|Disease classifications correspond to the Center for International Blood and Marrow Transplant Research Request for Information Disease Classifications Form (www.cibmtr.org).|participants|Number|28|28.0||||||
4429504|NCT00141739|4254008|B1|Intermediate risk||Disease status at transplantation|Disease classifications correspond to the Center for International Blood and Marrow Transplant Research Request for Information Disease Classifications Form (www.cibmtr.org).|participants|Number|33|33.0||||||
4429505|NCT00141739|4254008|B1|Low risk||Disease status at transplantation|Disease classifications correspond to the Center for International Blood and Marrow Transplant Research Request for Information Disease Classifications Form (www.cibmtr.org).|participants|Number|39|39.0||||||
4429506|NCT00141739|4254008|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4429507|NCT00141739|4254008|B1||Male|Gender||Participants|Count of Participants|57|57.0||||||
4429508|NCT00141739|4254008|B1||Female|Gender||Participants|Count of Participants|43|43.0||||||
4429509|NCT00141739|4254008|B1|||Age||years|Median|47|47.0|Full Range|5|5.0|2.0|61.0|
4429510|NCT00141726|4254019|B1|Obstructive||Lung Injury Pattern||participants|Number|25|25.0||||||
4429511|NCT00141726|4254019|B1|Restrictive||Lung Injury Pattern||participants|Number|9|9.0||||||
4429512|NCT00141726|4254019|B1|No||Chronic Graft Versus Host Disease (GVHD) Present||participants|Number|0|0.0||||||
4429513|NCT00141726|4254019|B1|Yes||Chronic Graft Versus Host Disease (GVHD) Present||participants|Number|34|34.0||||||
4429514|NCT00141726|4254019|B1|Unrelated Donor (URD)||Donor Type||participants|Number|12|12.0||||||
4429515|NCT00141726|4254019|B1|Matched Related Donor (MRD)||Donor Type||participants|Number|22|22.0||||||
4429516|NCT00141726|4254019|B1|Marrow||Cell Source|Cell source for transplant.|participants|Number|9|9.0||||||
4429517|NCT00141726|4254019|B1|Pluripotent Stem Cell (PSC)||Cell Source|Cell source for transplant.|participants|Number|25|25.0||||||
4429518|NCT00141726|4254019|B1|Mismatch||Human Leukocyte Antigen (HLA) Match||participants|Number|3|3.0||||||
4429519|NCT00141726|4254019|B1|HLA Matched||Human Leukocyte Antigen (HLA) Match||participants|Number|31|31.0||||||
4429520|NCT00141726|4254019|B1|Nonmalignant||Diagnosis||participants|Number|2|2.0||||||
4429521|NCT00141726|4254019|B1|Myeloma||Diagnosis||participants|Number|2|2.0||||||
4429522|NCT00141726|4254019|B1|NHL/CLL||Diagnosis||participants|Number|6|6.0||||||
4429523|NCT00141726|4254019|B1|Chronic Mylogenous Leukemia (CML)||Diagnosis||participants|Number|5|5.0||||||
4429524|NCT00141726|4254019|B1|Acute Lymphoblastic Leukemia (ALL)||Diagnosis||participants|Number|3|3.0||||||
4429525|NCT00141726|4254019|B1|AML/MDS/MF||Diagnosis||participants|Number|16|16.0||||||
4429526|NCT00141726|4254019|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4429527|NCT00141726|4254019|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4429528|NCT00141726|4254019|B1|||Age||years|Mean|39|39.0|Full Range|||8.0|65.0|
4429529|NCT00141518|4254024|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4429530|NCT00141518|4254025|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4429531|NCT00141518|4254026|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4429532|NCT00141518|4254027|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4429533|NCT00141518|4254024|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4429534|NCT00141518|4254025|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4429535|NCT00141518|4254026|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4429536|NCT00141518|4254027|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4429537|NCT00141518|4254024|B4|||Age||years|Mean|65.4|65.4|Standard Deviation|6.8|6.8|||
4429538|NCT00141518|4254025|B3|||Age||years|Mean|66.6|66.6|Standard Deviation|8.7|8.7|||
4429539|NCT00141518|4254026|B2|||Age||years|Mean|65.4|65.4|Standard Deviation|5.2|5.2|||
4429540|NCT00141518|4254027|B1|||Age||years|Mean|64.6|64.6|Standard Deviation|6.4|6.4|||
4429541|NCT00141453|4254216|B3|||Urinary protein: creatinine ratio||g/g|Median|2.12|2.12|Inter-Quartile Range|||1.03|3.82|
4429542|NCT00141453|4254217|B2|||Urinary protein: creatinine ratio||g/g|Median|2.05|2.05|Inter-Quartile Range|||1.1|3.8|
4429543|NCT00141453|4254218|B1|||Urinary protein: creatinine ratio||g/g|Median|2.19|2.19|Inter-Quartile Range|||0.99|3.87|
4429544|NCT00141453|4254216|B3|||Urinary albumin:creatinine ratio||g/g|Median|1.69|1.69|Inter-Quartile Range|||0.82|3.03|
4429545|NCT00141453|4254217|B2|||Urinary albumin:creatinine ratio||g/g|Median|1.69|1.69|Inter-Quartile Range|||0.87|3.12|
4429546|NCT00141453|4254218|B1|||Urinary albumin:creatinine ratio||g/g|Median|1.70|1.7|Inter-Quartile Range|||0.77|3.0|
4429547|NCT00141453|4254216|B3|||Systolic Blood Pressure||mmHg|Mean|141.3|141.3|Standard Deviation|17.5|17.5|||
4429548|NCT00141453|4254217|B2|||Systolic Blood Pressure||mmHg|Mean|140.8|140.8|Standard Deviation|18.0|18.0|||
4429549|NCT00141453|4254218|B1|||Systolic Blood Pressure||mmHg|Mean|141.7|141.7|Standard Deviation|17.0|17.0|||
4429550|NCT00141453|4254216|B3|||Serum creatinine||mg/dL|Mean|1.62|1.62|Standard Deviation|0.34|0.34|||
4429551|NCT00141453|4254217|B2|||Serum creatinine||mg/dL|Mean|1.62|1.62|Standard Deviation|0.35|0.35|||
4429552|NCT00141453|4254218|B1|||Serum creatinine||mg/dL|Mean|1.62|1.62|Standard Deviation|0.32|0.32|||
4429553|NCT00141453|4254216|B3|||HbA1c||Percentage of HbA1c|Mean|7.08|7.08|Standard Deviation|1.22|1.22|||
4429554|NCT00141453|4254217|B2|||HbA1c||Percentage of HbA1c|Mean|7.05|7.05|Standard Deviation|1.24|1.24|||
4429555|NCT00141453|4254218|B1|||HbA1c||Percentage of HbA1c|Mean|7.11|7.11|Standard Deviation|1.20|1.2|||
4429556|NCT00141453|4254216|B3|||Diastolic blood pressure||mmHg|Mean|77.5|77.5|Standard Deviation|10.5|10.5|||
4429557|NCT00141453|4254217|B2|||Diastolic blood pressure||mmHg|Mean|77.2|77.2|Standard Deviation|10.6|10.6|||
4429558|NCT00141453|4254218|B1|||Diastolic blood pressure||mmHg|Mean|77.8|77.8|Standard Deviation|10.4|10.4|||
4429559|NCT00141453|4254216|B3|Did not use ACE Inhibitors||Use of ACE inhibitors||participants|Number|152|152.0||||||
4429560|NCT00141453|4254217|B2|Did not use ACE Inhibitors||Use of ACE inhibitors||participants|Number|75|75.0||||||
4429561|NCT00141453|4254218|B1|Did not use ACE Inhibitors||Use of ACE inhibitors||participants|Number|77|77.0||||||
4429562|NCT00141453|4254216|B3|Used ACE Inhibitors||Use of ACE inhibitors||participants|Number|414|414.0||||||
4429563|NCT00141453|4254217|B2|Used ACE Inhibitors||Use of ACE inhibitors||participants|Number|209|209.0||||||
4429564|NCT00141453|4254218|B1|Used ACE Inhibitors||Use of ACE inhibitors||participants|Number|205|205.0||||||
4429565|NCT00141453|4254216|B3|East Asia||Region of Enrollment||participants|Number|566|566.0||||||
4429566|NCT00141453|4254217|B2|East Asia||Region of Enrollment||participants|Number|284|284.0||||||
4429567|NCT00141453|4254218|B1|East Asia||Region of Enrollment||participants|Number|282|282.0||||||
4429568|NCT00141453|4254216|B3||Male|Sex: Female, Male||Participants|Count of Participants|391|391.0||||||
4429569|NCT00141453|4254217|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4429570|NCT00141453|4254218|B1||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4429571|NCT00141453|4254216|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4429572|NCT00141453|4254217|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4429573|NCT00141453|4254218|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4429574|NCT00141453|4254216|B3|||Age||years|Mean|59.2|59.2|Standard Deviation|8.1|8.1|||
4429575|NCT00141453|4254217|B2|||Age||years|Mean|59.2|59.2|Standard Deviation|8.1|8.1|||
4429576|NCT00141453|4254218|B1|||Age||years|Mean|59.1|59.1|Standard Deviation|8.1|8.1|||
4429577|NCT00141297|4254231|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4429578|NCT00141297|4254232|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4429579|NCT00141297|4254233|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4429580|NCT00141297|4254231|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4429581|NCT00141297|4254232|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4429582|NCT00141297|4254233|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4429583|NCT00141297|4254231|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|12.7|12.7|||
4429584|NCT00141297|4254232|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|11.5|11.5|||
4429585|NCT00141297|4254233|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|13.1|13.1|||
4429586|NCT00141271|4254517|B4||Male|Sex: Female, Male||Participants|Count of Participants|220.0|220.0||||||
4429587|NCT00141271|4254518|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4429588|NCT00141271|4254519|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4429589|NCT00141271|4254520|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4429590|NCT00141271|4254517|B4||Female|Sex: Female, Male||Participants|Count of Participants|284.0|284.0||||||
4429591|NCT00141271|4254518|B3||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4429592|NCT00141271|4254519|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4429593|NCT00141271|4254520|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4429594|NCT00141271|4254517|B4|||Age||years|Mean|39.9|39.9|Standard Deviation|11.8|11.8|||
4429595|NCT00141271|4254518|B3|||Age||years|Mean|39.3|39.3|Standard Deviation|11.2|11.2|||
4429596|NCT00141271|4254519|B2|||Age||years|Mean|40.0|40.0|Standard Deviation|11.4|11.4|||
4429597|NCT00141271|4254520|B1|||Age||years|Mean|40.4|40.4|Standard Deviation|12.9|12.9|||
4429598|NCT00141219|4254641|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4429599|NCT00141219|4254642|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4429600|NCT00141219|4254643|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4429601|NCT00141219|4254641|B3||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4429602|NCT00141219|4254642|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4429603|NCT00141219|4254643|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4429604|NCT00141219|4254641|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|11.5|11.5|||
4429605|NCT00141219|4254642|B2|||Age||years|Mean|61.3|61.3|Standard Deviation|12.9|12.9|||
4429606|NCT00141219|4254643|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|10.8|10.8|||
4429607|NCT00141115|4254694|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4429608|NCT00141115|4254694|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4429609|NCT00141115|4254694|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429610|NCT00141115|4254694|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4429611|NCT00141115|4254694|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429612|NCT00141102|4254699|B3||Male|Sex: Female, Male||Participants|Count of Participants|814|814.0||||||
4429613|NCT00141102|4254700|B2||Male|Sex: Female, Male||Participants|Count of Participants|424|424.0||||||
4429614|NCT00141102|4254701|B1||Male|Sex: Female, Male||Participants|Count of Participants|390|390.0||||||
4429615|NCT00141102|4254699|B3||Female|Sex: Female, Male||Participants|Count of Participants|3670|3670.0||||||
4429616|NCT00141102|4254700|B2||Female|Sex: Female, Male||Participants|Count of Participants|1822|1822.0||||||
4429617|NCT00141102|4254701|B1||Female|Sex: Female, Male||Participants|Count of Participants|1848|1848.0||||||
4429618|NCT00141102|4254699|B3|> = 75 years||Age, Customized||participants|Number|454|454.0||||||
4429619|NCT00141102|4254700|B2|> = 75 years||Age, Customized||participants|Number|219|219.0||||||
4429620|NCT00141102|4254701|B1|> = 75 years||Age, Customized||participants|Number|235|235.0||||||
4429621|NCT00141102|4254699|B3|70 to 74 years||Age, Customized||participants|Number|751|751.0||||||
4429622|NCT00141102|4254700|B2|70 to 74 years||Age, Customized||participants|Number|390|390.0||||||
4429623|NCT00141102|4254701|B1|70 to 74 years||Age, Customized||participants|Number|361|361.0||||||
4429624|NCT00141102|4254699|B3|65 to 69 years||Age, Customized||participants|Number|1241|1241.0||||||
4429625|NCT00141102|4254700|B2|65 to 69 years||Age, Customized||participants|Number|618|618.0||||||
4429626|NCT00141102|4254701|B1|65 to 69 years||Age, Customized||participants|Number|623|623.0||||||
4429627|NCT00141102|4254699|B3|60 to 64 years||Age, Customized||participants|Number|1463|1463.0||||||
4429628|NCT00141102|4254700|B2|60 to 64 years||Age, Customized||participants|Number|742|742.0||||||
4429629|NCT00141102|4254701|B1|60 to 64 years||Age, Customized||participants|Number|721|721.0||||||
4429630|NCT00141102|4254699|B3|55 to 59 years||Age, Customized||participants|Number|235|235.0||||||
4429631|NCT00141102|4254700|B2|55 to 59 years||Age, Customized||participants|Number|113|113.0||||||
4429632|NCT00141102|4254701|B1|55 to 59 years||Age, Customized||participants|Number|122|122.0||||||
4429633|NCT00141102|4254699|B3|< 55 years||Age, Customized||participants|Number|340|340.0||||||
4429634|NCT00141102|4254700|B2|< 55 years||Age, Customized||participants|Number|164|164.0||||||
4429635|NCT00141102|4254701|B1|< 55 years||Age, Customized||participants|Number|176|176.0||||||
4429636|NCT00141037|4254740|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4429637|NCT00141037|4254741|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4429638|NCT00141037|4254742|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4429639|NCT00141037|4254740|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4429640|NCT00141037|4254741|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4429641|NCT00141037|4254742|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4429642|NCT00141037|4254740|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4429643|NCT00141037|4254741|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4429644|NCT00141037|4254742|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4429645|NCT00141037|4254740|B3|||Age||years|Mean|11.9|11.9|Standard Deviation|5.8|5.8|||
4429646|NCT00141037|4254741|B2|||Age||years|Mean|11.9|11.9|Standard Deviation|6.1|6.1|||
4429647|NCT00141037|4254742|B1|||Age||years|Mean|11.8|11.8|Standard Deviation|5.4|5.4|||
4429648|NCT00140842|4254751|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429649|NCT00140842|4254752|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429650|NCT00140842|4254753|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429651|NCT00140842|4254751|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4429652|NCT00140842|4254752|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4429653|NCT00140842|4254753|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4429654|NCT00140842|4254751|B3|||Age||years|Mean|14.9|14.9|Standard Deviation|3.3|3.3|||
4429655|NCT00140842|4254752|B2|||Age||years|Mean|14.0|14.0|Standard Deviation|1.9|1.9|||
4429656|NCT00140842|4254753|B1|||Age||years|Mean|15.9|15.9|Standard Deviation|1.7|1.7|||
4429657|NCT00140842|4254751|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429658|NCT00140842|4254752|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429659|NCT00140842|4254753|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429660|NCT00140842|4254751|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4429661|NCT00140842|4254752|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4429662|NCT00140842|4254753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4429663|NCT00140842|4254751|B3||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4429664|NCT00140842|4254752|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4429665|NCT00140842|4254753|B1||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4429666|NCT00140621|4254762|B1|Not Measured||Globotriaosylceramide (GL-3) Accumulation in the Myocardium||participants|Number|5|5.0||||||
4429667|NCT00140621|4254762|B1|Yes||Globotriaosylceramide (GL-3) Accumulation in the Myocardium||participants|Number|1|1.0||||||
4429668|NCT00140621|4254762|B1|No||Globotriaosylceramide (GL-3) Accumulation in the Myocardium||participants|Number|0|0.0||||||
4429669|NCT00140621|4254762|B1|Yes||Left Ventricular Hypertrophy||participants|Number|6|6.0||||||
4429670|NCT00140621|4254762|B1|No||Left Ventricular Hypertrophy||participants|Number|0|0.0||||||
4429671|NCT00140621|4254762|B1|||Height||centimeters (cm)|Mean|156.63|156.63|Standard Deviation|7.20|7.2|||
4429672|NCT00140621|4254762|B1|||Weight||kilograms (kg)|Mean|58.50|58.5|Standard Deviation|9.24|9.24|||
4429673|NCT00140621|4254762|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4429674|NCT00140621|4254762|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4429675|NCT00140621|4254762|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|5.7|5.7|||
4429676|NCT00140556|4254772|B1|No Feeding Tube at Baseline||Feeding Tube|Feeding tube present before start of treatment|Participants|Number|24|24.0||||||
4429677|NCT00140556|4254772|B1|Feeding Tube Present Baseline||Feeding Tube|Feeding tube present before start of treatment|Participants|Number|4|4.0||||||
4429678|NCT00140556|4254772|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4429679|NCT00140556|4254772|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4429680|NCT00140556|4254772|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4429681|NCT00140556|4254772|B1|||Age||years|Mean|57|57.0|Standard Deviation|9|9.0|||
4429682|NCT00140556|4254772|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429683|NCT00140556|4254772|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4429684|NCT00140556|4254772|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429685|NCT00140426|4254776|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4429686|NCT00140426|4254777|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4429687|NCT00140426|4254778|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4429688|NCT00140426|4254776|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429689|NCT00140426|4254777|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429690|NCT00140426|4254778|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429691|NCT00140426|4254776|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4429692|NCT00140426|4254777|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4429693|NCT00140426|4254778|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4429694|NCT00140426|4254776|B3|||Age||years|Mean|15.98|15.98|Standard Deviation|2.35|2.35|||
4429695|NCT00140426|4254777|B2|||Age||years|Mean|16.2|16.2|Standard Deviation|2.5|2.5|||
4429696|NCT00140426|4254778|B1|||Age||years|Mean|15.8|15.8|Standard Deviation|2.3|2.3|||
4429697|NCT00140426|4254776|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429698|NCT00140426|4254777|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429699|NCT00140426|4254778|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429700|NCT00140426|4254776|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4429701|NCT00140426|4254777|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4429702|NCT00140426|4254778|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4429703|NCT00140426|4254776|B3||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4429704|NCT00140426|4254777|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4429705|NCT00140426|4254778|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4429706|NCT00140413|4254809|B4|||Body Mass Index (BMI) z-score|"BMI adjusts weight for stature and is calculated as weight (kg)/height (m) squared. In children, BMI is age specific. BMI reference data from the CDC growth charts compares a child's BMI with the BMI distribution of children of the same age but not necessarily of the same stature.~Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA)."|Z-score|Median|1.14|1.14|Inter-Quartile Range|||0.05|2.06|
4429707|NCT00140413|4254810|B3|||Body Mass Index (BMI) z-score|"BMI adjusts weight for stature and is calculated as weight (kg)/height (m) squared. In children, BMI is age specific. BMI reference data from the CDC growth charts compares a child's BMI with the BMI distribution of children of the same age but not necessarily of the same stature.~Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA)."|Z-score|Median|1.35|1.35|Inter-Quartile Range|||0.38|1.7|
4429708|NCT00140413|4254811|B2|||Body Mass Index (BMI) z-score|"BMI adjusts weight for stature and is calculated as weight (kg)/height (m) squared. In children, BMI is age specific. BMI reference data from the CDC growth charts compares a child's BMI with the BMI distribution of children of the same age but not necessarily of the same stature.~Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA)."|Z-score|Median|2.06|2.06|Inter-Quartile Range|||1.14|2.62|
4429709|NCT00140413|4254812|B1|||Body Mass Index (BMI) z-score|"BMI adjusts weight for stature and is calculated as weight (kg)/height (m) squared. In children, BMI is age specific. BMI reference data from the CDC growth charts compares a child's BMI with the BMI distribution of children of the same age but not necessarily of the same stature.~Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA)."|Z-score|Median|-0.2|-0.2|Inter-Quartile Range|||-0.5|0.11|
4429710|NCT00140413|4254809|B4|||Weight-for-stature z-score|"Weight (wt.) for stature expresses wt. relative to stature (length or height); data are not age specific. The wt. for stature reference data from CDC growth charts compares a child's wt. with the wt. distribution of children of the same stature but not necessarily of the same age.~Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA)."|Z-score|Median|0.82|0.82|Inter-Quartile Range|||-0.38|1.91|
4429711|NCT00140413|4254810|B3|||Weight-for-stature z-score|"Weight (wt.) for stature expresses wt. relative to stature (length or height); data are not age specific. The wt. for stature reference data from CDC growth charts compares a child's wt. with the wt. distribution of children of the same stature but not necessarily of the same age.~Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA)."|Z-score|Median|1.34|1.34|Inter-Quartile Range|||0.22|1.73|
4429712|NCT00140413|4254811|B2|||Weight-for-stature z-score|"Weight (wt.) for stature expresses wt. relative to stature (length or height); data are not age specific. The wt. for stature reference data from CDC growth charts compares a child's wt. with the wt. distribution of children of the same stature but not necessarily of the same age.~Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA)."|Z-score|Median|1.94|1.94|Inter-Quartile Range|||0.88|2.49|
4429713|NCT00140413|4254812|B1|||Weight-for-stature z-score|"Weight (wt.) for stature expresses wt. relative to stature (length or height); data are not age specific. The wt. for stature reference data from CDC growth charts compares a child's wt. with the wt. distribution of children of the same stature but not necessarily of the same age.~Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA)."|Z-score|Median|-0.38|-0.38|Inter-Quartile Range|||-0.99|-0.23|
4429714|NCT00140413|4254809|B4|||Stature z-score|Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. A positive z-score indicates a datum above the mean, while a negative z-score indicates a datum below the mean. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA).|Z-score|Median|-1.73|-1.73|Inter-Quartile Range|||-2.16|-0.95|
4429754|NCT00140244|4254820|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4429755|NCT00140244|4254820|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4429756|NCT00140244|4254820|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429715|NCT00140413|4254810|B3|||Stature z-score|Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. A positive z-score indicates a datum above the mean, while a negative z-score indicates a datum below the mean. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA).|Z-score|Median|-1.3|-1.3|Inter-Quartile Range|||-1.79|-0.91|
4429716|NCT00140413|4254811|B2|||Stature z-score|Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. A positive z-score indicates a datum above the mean, while a negative z-score indicates a datum below the mean. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA).|Z-score|Median|-0.95|-0.95|Inter-Quartile Range|||-1.73|-0.22|
4429717|NCT00140413|4254812|B1|||Stature z-score|Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. A positive z-score indicates a datum above the mean, while a negative z-score indicates a datum below the mean. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA).|Z-score|Median|-2.16|-2.16|Inter-Quartile Range|||-2.35|-1.94|
4429718|NCT00140413|4254809|B4|||Weight z-score|Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. A positive z-score indicates a datum above the mean, while a negative z-score indicates a datum below the mean. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA).|Z-score|Median|-1.36|-1.36|Inter-Quartile Range|||-1.73|0.6|
4429719|NCT00140413|4254810|B3|||Weight z-score|Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. A positive z-score indicates a datum above the mean, while a negative z-score indicates a datum below the mean. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA).|Z-score|Median|-1.36|-1.36|Inter-Quartile Range|||-1.73|0.41|
4429720|NCT00140413|4254811|B2|||Weight z-score|Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. A positive z-score indicates a datum above the mean, while a negative z-score indicates a datum below the mean. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA).|Z-score|Median|0.6|0.6|Inter-Quartile Range|||-0.47|1.49|
4429721|NCT00140413|4254812|B1|||Weight z-score|Z-score indicates how many standard deviations an element is from the mean. It is calculated as z = (x – µ) σ, where µ is the mean of the population, and σ is the standard deviation of the population. A positive z-score indicates a datum above the mean, while a negative z-score indicates a datum below the mean. All z-scores were obtained using Epi Info ™ 3.5.4. (Centers for Disease Control, Atlanta, GA).|Z-score|Median|-1.76|-1.76|Inter-Quartile Range|||-2.48|-1.6|
4429722|NCT00140413|4254809|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4429723|NCT00140413|4254810|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4429724|NCT00140413|4254811|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4429725|NCT00140413|4254812|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4429726|NCT00140413|4254809|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4429727|NCT00140413|4254810|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4429728|NCT00140413|4254811|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4429729|NCT00140413|4254812|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4429730|NCT00140413|4254809|B4|||Age||Months|Median|30|30.0|Inter-Quartile Range|||24.0|50.0|
4429731|NCT00140413|4254810|B3|||Age||Months|Median|26|26.0|Inter-Quartile Range|||23.0|50.0|
4429732|NCT00140413|4254811|B2|||Age||Months|Median|41|41.0|Inter-Quartile Range|||33.0|61.0|
4429733|NCT00140413|4254812|B1|||Age||Months|Median|28|28.0|Inter-Quartile Range|||24.0|30.0|
4429734|NCT00140413|4254809|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429735|NCT00140413|4254810|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429736|NCT00140413|4254811|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429737|NCT00140413|4254812|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429738|NCT00140413|4254809|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4429739|NCT00140413|4254810|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4429740|NCT00140413|4254811|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4429741|NCT00140413|4254812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4429742|NCT00140413|4254809|B4||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4429743|NCT00140413|4254810|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4429744|NCT00140413|4254811|B2||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4429745|NCT00140413|4254812|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4429746|NCT00140244|4254820|B1|||HIV viral load||copies/ml|Mean|24524|24524.0|Standard Deviation|13693|13693.0|||
4429747|NCT00140244|4254820|B1|||CD4 count||cells/μl|Mean|454|454.0|Standard Deviation|94|94.0|||
4429748|NCT00140244|4254820|B1|||hemoglobin A1c||%|Mean|5.1|5.1|Standard Deviation|0.3|0.3|||
4429749|NCT00140244|4254820|B1|||glucose||mg/dl|Mean|81.1|81.1|Standard Deviation|6.7|6.7|||
4429750|NCT00140244|4254820|B1|||insulin||micro international units(μIU)/ml|Mean|11.5|11.5|Standard Deviation|2.7|2.7|||
4429751|NCT00140244|4254820|B1|||triglycerides||mg/dl|Mean|530|530.0|Standard Deviation|53.8|53.8|||
4429752|NCT00140244|4254820|B1|||Fasting leptin concentration||ng/ml|Mean|1.34|1.34|Standard Deviation|0.2|0.2|||
4429753|NCT00140244|4254820|B1|||Body mass index||kg/m^2|Mean|22.2|22.2|Standard Deviation|0.83|0.83|||
4429757|NCT00140244|4254820|B1|||Age||years|Mean|45.8|45.8|Standard Deviation|2|2.0|||
4429758|NCT00140244|4254820|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429759|NCT00140244|4254820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4429760|NCT00140244|4254820|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429761|NCT00140231|4254851|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4429762|NCT00140231|4254852|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4429763|NCT00140231|4254853|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4429764|NCT00140231|4254851|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429765|NCT00140231|4254852|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429766|NCT00140231|4254853|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429767|NCT00140231|4254851|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4429768|NCT00140231|4254852|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4429769|NCT00140231|4254853|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4429770|NCT00140231|4254851|B3|||Age||years|Mean|25.5|25.5|Standard Deviation|0.5|0.5|||
4429771|NCT00140231|4254852|B2|||Age||years|Mean|25|25.0|Standard Deviation|5|5.0|||
4429772|NCT00140231|4254853|B1|||Age||years|Mean|26|26.0|Standard Deviation|5|5.0|||
4429773|NCT00140231|4254851|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429774|NCT00140231|4254852|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429775|NCT00140231|4254853|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429776|NCT00140231|4254851|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4429777|NCT00140231|4254852|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4429778|NCT00140231|4254853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4429779|NCT00140231|4254851|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429780|NCT00140231|4254852|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429781|NCT00140231|4254853|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429782|NCT00140205|4254870|B4|BMI<25kg/m2||BMI||participants|Number|10|10.0||||||
4429783|NCT00140205|4254871|B3|BMI<25kg/m2||BMI||participants|Number|5|5.0||||||
4429784|NCT00140205|4254872|B2|BMI<25kg/m2||BMI||participants|Number|0|0.0||||||
4429785|NCT00140205|4254873|B1|BMI<25kg/m2||BMI||participants|Number|5|5.0||||||
4429786|NCT00140205|4254870|B4|BMI>30kg/m2||BMI||participants|Number|5|5.0||||||
4429787|NCT00140205|4254871|B3|BMI>30kg/m2||BMI||participants|Number|0|0.0||||||
4429788|NCT00140205|4254872|B2|BMI>30kg/m2||BMI||participants|Number|5|5.0||||||
4429789|NCT00140205|4254873|B1|BMI>30kg/m2||BMI||participants|Number|0|0.0||||||
4429790|NCT00140205|4254870|B4|United States||Region of Enrollment||Participants|Count of Participants|15|15.0||||||
4429791|NCT00140205|4254871|B3|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4429792|NCT00140205|4254872|B2|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4429793|NCT00140205|4254873|B1|United States||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4429794|NCT00140205|4254870|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4429795|NCT00140205|4254871|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429796|NCT00140205|4254872|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4429797|NCT00140205|4254873|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4429798|NCT00140205|4254870|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4429799|NCT00140205|4254871|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4429800|NCT00140205|4254872|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429801|NCT00140205|4254873|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429802|NCT00140205|4254870|B4|||Age||YEARS|Mean|23|23.0|Standard Deviation|.07|0.07|||
4429803|NCT00140205|4254871|B3|||Age||YEARS|Mean|22|22.0|Standard Deviation|.05|0.05|||
4429804|NCT00140205|4254872|B2|||Age||YEARS|Mean|23|23.0|Standard Deviation|.08|0.08|||
4429805|NCT00140205|4254873|B1|||Age||YEARS|Mean|22|22.0|Standard Deviation|.09|0.09|||
4429806|NCT00140205|4254870|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429807|NCT00140205|4254871|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429808|NCT00140205|4254872|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429809|NCT00140205|4254873|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429810|NCT00140205|4254870|B4||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4429811|NCT00140205|4254871|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4429812|NCT00140205|4254872|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4429813|NCT00140205|4254873|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4429814|NCT00140205|4254870|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429815|NCT00140205|4254871|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429816|NCT00140205|4254872|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429817|NCT00140205|4254873|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429818|NCT00140140|4254941|B4|Status 5 (Death)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4429819|NCT00140140|4254942|B3|Status 5 (Death)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4429820|NCT00140140|4254943|B2|Status 5 (Death)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4429821|NCT00140140|4254944|B1|Status 5 (Death)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4429822|NCT00140140|4254941|B4|Status 4 (Completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4429823|NCT00140140|4254942|B3|Status 4 (Completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4429824|NCT00140140|4254943|B2|Status 4 (Completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4429825|NCT00140140|4254944|B1|Status 4 (Completely disabled)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4429826|NCT00140140|4254941|B4|Status 3 (Limited self-care)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4429827|NCT00140140|4254942|B3|Status 3 (Limited self-care)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4429828|NCT00140140|4254943|B2|Status 3 (Limited self-care)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4429829|NCT00140140|4254944|B1|Status 3 (Limited self-care)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4429830|NCT00140140|4254941|B4|Status 2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|1|1.0||||||
4429831|NCT00140140|4254942|B3|Status 2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|1|1.0||||||
4429832|NCT00140140|4254943|B2|Status 2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4429833|NCT00140140|4254944|B1|Status 2 (Ambulatory but unable to work)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|0|0.0||||||
4429834|NCT00140140|4254941|B4|Status 1 (Symptomatic but completely ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|11|11.0||||||
4429835|NCT00140140|4254942|B3|Status 1 (Symptomatic but completely ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|4|4.0||||||
4429836|NCT00140140|4254943|B2|Status 1 (Symptomatic but completely ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|4|4.0||||||
4429837|NCT00140140|4254944|B1|Status 1 (Symptomatic but completely ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|3|3.0||||||
4429838|NCT00140140|4254941|B4|Status 0 (Asymptomatic)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|4|4.0||||||
4429839|NCT00140140|4254942|B3|Status 0 (Asymptomatic)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|1|1.0||||||
4429840|NCT00140140|4254943|B2|Status 0 (Asymptomatic)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|2|2.0||||||
4429841|NCT00140140|4254944|B1|Status 0 (Asymptomatic)||Eastern Cooperative Oncology Group (ECOG) Performance Status||participants|Number|1|1.0||||||
4429842|NCT00140140|4254941|B4|Previous Smoker, but have Stopped||Smoking Status||participants|Number|5|5.0||||||
4429843|NCT00140140|4254942|B3|Previous Smoker, but have Stopped||Smoking Status||participants|Number|3|3.0||||||
4429844|NCT00140140|4254943|B2|Previous Smoker, but have Stopped||Smoking Status||participants|Number|1|1.0||||||
4429845|NCT00140140|4254944|B1|Previous Smoker, but have Stopped||Smoking Status||participants|Number|1|1.0||||||
4429846|NCT00140140|4254941|B4|Current Smoker||Smoking Status||participants|Number|2|2.0||||||
4429847|NCT00140140|4254942|B3|Current Smoker||Smoking Status||participants|Number|0|0.0||||||
4429848|NCT00140140|4254943|B2|Current Smoker||Smoking Status||participants|Number|1|1.0||||||
4429849|NCT00140140|4254944|B1|Current Smoker||Smoking Status||participants|Number|1|1.0||||||
4429850|NCT00140140|4254941|B4|Never Smoked||Smoking Status||participants|Number|9|9.0||||||
4429851|NCT00140140|4254942|B3|Never Smoked||Smoking Status||participants|Number|3|3.0||||||
4429852|NCT00140140|4254943|B2|Never Smoked||Smoking Status||participants|Number|4|4.0||||||
4429853|NCT00140140|4254944|B1|Never Smoked||Smoking Status||participants|Number|2|2.0||||||
4429854|NCT00140140|4254941|B4|Post-menopausal||Menopausal Status||participants|Number|12|12.0||||||
4429855|NCT00140140|4254942|B3|Post-menopausal||Menopausal Status||participants|Number|5|5.0||||||
4429856|NCT00140140|4254943|B2|Post-menopausal||Menopausal Status||participants|Number|4|4.0||||||
4429857|NCT00140140|4254944|B1|Post-menopausal||Menopausal Status||participants|Number|3|3.0||||||
4429858|NCT00140140|4254941|B4|Pre-menopausal||Menopausal Status||participants|Number|4|4.0||||||
4429859|NCT00140140|4254942|B3|Pre-menopausal||Menopausal Status||participants|Number|1|1.0||||||
4429860|NCT00140140|4254943|B2|Pre-menopausal||Menopausal Status||participants|Number|2|2.0||||||
4429861|NCT00140140|4254944|B1|Pre-menopausal||Menopausal Status||participants|Number|1|1.0||||||
4429862|NCT00140140|4254941|B4|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4429863|NCT00140140|4254942|B3|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4429864|NCT00140140|4254943|B2|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4429865|NCT00140140|4254944|B1|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4429866|NCT00140140|4254941|B4|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4429867|NCT00140140|4254942|B3|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4429868|NCT00140140|4254943|B2|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4429869|NCT00140140|4254944|B1|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4429870|NCT00140140|4254941|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4429871|NCT00140140|4254942|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4429872|NCT00140140|4254943|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4429873|NCT00140140|4254944|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4429874|NCT00140140|4254941|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429875|NCT00140140|4254942|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429876|NCT00140140|4254943|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429877|NCT00140140|4254944|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4429878|NCT00140140|4254941|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4429879|NCT00140140|4254942|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4429880|NCT00140140|4254943|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4429881|NCT00140140|4254944|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4429882|NCT00140140|4254941|B4|>= 65 years||Age, Customized||participants|Number|2|2.0||||||
4429883|NCT00140140|4254942|B3|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
4429884|NCT00140140|4254943|B2|>= 65 years||Age, Customized||participants|Number|1|1.0||||||
4429885|NCT00140140|4254944|B1|>= 65 years||Age, Customized||participants|Number|0|0.0||||||
4429886|NCT00140140|4254941|B4|< 65 years||Age, Customized||participants|Number|14|14.0||||||
4429887|NCT00140140|4254942|B3|< 65 years||Age, Customized||participants|Number|5|5.0||12.23|12.23|||
4429888|NCT00140140|4254943|B2|< 65 years||Age, Customized||participants|Number|5|5.0||12.60|12.6|||
4429889|NCT00140140|4254944|B1|< 65 years||Age, Customized||participants|Number|4|4.0||5.74|5.74|||
4429890|NCT00139997|4254983|B3|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4429891|NCT00139997|4254984|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4429892|NCT00139997|4254985|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4429893|NCT00139997|4254983|B3|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4429894|NCT00139997|4254984|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4429895|NCT00139997|4254985|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4429896|NCT00139997|4254983|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4429897|NCT00139997|4254984|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4429898|NCT00139997|4254985|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4429899|NCT00139997|4254983|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4429900|NCT00139997|4254984|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4429901|NCT00139997|4254985|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4429902|NCT00139997|4254983|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4429903|NCT00139997|4254984|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4429904|NCT00139997|4254985|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4429905|NCT00139997|4254983|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|10.8|10.8|||
4429906|NCT00139997|4254984|B2|||Age||years|Mean|44.9|44.9|Standard Deviation|10.4|10.4|||
4429907|NCT00139997|4254985|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|11.4|11.4|||
4429908|NCT00139997|4254983|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429909|NCT00139997|4254984|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429910|NCT00139997|4254985|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429911|NCT00139997|4254983|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4429912|NCT00139997|4254984|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4429913|NCT00139997|4254985|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4429914|NCT00139997|4254983|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429915|NCT00139997|4254984|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429916|NCT00139997|4254985|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4429917|NCT00139776|4254994|B3||Male|Sex: Female, Male||Participants|Count of Participants|238.0|238.0||||||
4429918|NCT00139776|4254995|B2||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4429919|NCT00139776|4254996|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4429920|NCT00139776|4254994|B3||Female|Sex: Female, Male||Participants|Count of Participants|620.0|620.0||||||
4429921|NCT00139776|4254995|B2||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4429922|NCT00139776|4254996|B1||Female|Sex: Female, Male||Participants|Count of Participants|317|317.0||||||
4429923|NCT00139776|4254994|B3|||Age||years|Mean|58.6|58.6|Standard Deviation|9.8|9.8|||
4429924|NCT00139776|4254995|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|9.6|9.6|||
4429925|NCT00139776|4254996|B1|||Age||years|Mean|58.5|58.5|Standard Deviation|10.00|10.0|||
4429926|NCT00139737|4255034|B1||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4429927|NCT00139737|4255034|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4429928|NCT00139737|4255034|B1|45-64 years||Age, Customized||Participants|Number|93|93.0||||||
4429929|NCT00139737|4255034|B1|18-44 years||Age, Customized||Participants|Number|238|238.0||||||
4429930|NCT00139659|4255038|B3||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4429931|NCT00139659|4255039|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4429932|NCT00139659|4255040|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4429933|NCT00139659|4255038|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4429934|NCT00139659|4255039|B2||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4429935|NCT00139659|4255040|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4429936|NCT00139659|4255038|B3|66-75 years||Age, Customized||participants|Number|37|37.0||||||
4429937|NCT00139659|4255039|B2|66-75 years||Age, Customized||participants|Number|17|17.0||||||
4429938|NCT00139659|4255040|B1|66-75 years||Age, Customized||participants|Number|20|20.0||||||
4429939|NCT00139659|4255038|B3|56-65 years||Age, Customized||participants|Number|77|77.0||||||
4429940|NCT00139659|4255039|B2|56-65 years||Age, Customized||participants|Number|37|37.0||||||
4429941|NCT00139659|4255040|B1|56-65 years||Age, Customized||participants|Number|40|40.0||||||
4429942|NCT00139659|4255038|B3|46-55 years||Age, Customized||participants|Number|74|74.0||||||
4429943|NCT00139659|4255039|B2|46-55 years||Age, Customized||participants|Number|41|41.0||||||
4429944|NCT00139659|4255040|B1|46-55 years||Age, Customized||participants|Number|33|33.0||||||
4429945|NCT00139659|4255038|B3|36-45 years||Age, Customized||participants|Number|48|48.0||||||
4429946|NCT00139659|4255039|B2|36-45 years||Age, Customized||participants|Number|25|25.0||||||
4429947|NCT00139659|4255040|B1|36-45 years||Age, Customized||participants|Number|23|23.0||||||
4429948|NCT00139659|4255038|B3|26-35 years||Age, Customized||participants|Number|31|31.0||||||
4429949|NCT00139659|4255039|B2|26-35 years||Age, Customized||participants|Number|13|13.0||||||
4429950|NCT00139659|4255040|B1|26-35 years||Age, Customized||participants|Number|18|18.0||||||
4429951|NCT00139659|4255038|B3|18-25 years||Age, Customized||participants|Number|20|20.0||||||
4429952|NCT00139659|4255039|B2|18-25 years||Age, Customized||participants|Number|8|8.0||||||
4429953|NCT00139659|4255040|B1|18-25 years||Age, Customized||participants|Number|12|12.0||||||
4429954|NCT00139477|4255117|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4429955|NCT00139477|4255118|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4429956|NCT00139477|4255119|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4429957|NCT00139477|4255117|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4429958|NCT00139477|4255118|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4429959|NCT00139477|4255119|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4429960|NCT00139477|4255117|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4429961|NCT00139477|4255118|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4429962|NCT00139477|4255119|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4429963|NCT00139477|4255117|B3|||Age||years|Mean|12.2|12.2|Standard Deviation|2.7|2.7|||
4429964|NCT00139477|4255118|B2|||Age||years|Mean|12.3|12.3|Standard Deviation|0.5|0.5|||
4429965|NCT00139477|4255119|B1|||Age||years|Mean|12|12.0|Standard Deviation|0.4|0.4|||
4429966|NCT00139477|4255117|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429967|NCT00139477|4255118|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429968|NCT00139477|4255119|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4429969|NCT00139477|4255117|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4429970|NCT00139477|4255118|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4429971|NCT00139477|4255119|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4429972|NCT00139477|4255117|B3||<=18 years|Age||Participants|Count of Participants|66|66.0||||||
4429973|NCT00139477|4255118|B2||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4429974|NCT00139477|4255119|B1||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4429975|NCT00138671|4255140|B3|Type II||Primary Diagnosis (Diabetes Type I or II)|Type I or Type II diabetes mellitus was defined using the American Diabetes Association criteria (2002).|participants|Number|92|92.0||||||
4429976|NCT00138671|4255141|B2|Type II||Primary Diagnosis (Diabetes Type I or II)|Type I or Type II diabetes mellitus was defined using the American Diabetes Association criteria (2002).|participants|Number|40|40.0||||||
4429977|NCT00138671|4255142|B1|Type II||Primary Diagnosis (Diabetes Type I or II)|Type I or Type II diabetes mellitus was defined using the American Diabetes Association criteria (2002).|participants|Number|52|52.0||||||
4429978|NCT00138671|4255140|B3|Type I||Primary Diagnosis (Diabetes Type I or II)|Type I or Type II diabetes mellitus was defined using the American Diabetes Association criteria (2002).|participants|Number|13|13.0||||||
4429979|NCT00138671|4255141|B2|Type I||Primary Diagnosis (Diabetes Type I or II)|Type I or Type II diabetes mellitus was defined using the American Diabetes Association criteria (2002).|participants|Number|6|6.0||||||
4429980|NCT00138671|4255142|B1|Type I||Primary Diagnosis (Diabetes Type I or II)|Type I or Type II diabetes mellitus was defined using the American Diabetes Association criteria (2002).|participants|Number|7|7.0||||||
4429981|NCT00138671|4255140|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4429982|NCT00138671|4255141|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4429983|NCT00138671|4255142|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4429984|NCT00138671|4255140|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4429985|NCT00138671|4255141|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4429986|NCT00138671|4255142|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4429987|NCT00138671|4255140|B3|> 75 years||Age, Customized||participants|Number|2|2.0||||||
4429988|NCT00138671|4255141|B2|> 75 years||Age, Customized||participants|Number|1|1.0||||||
4429989|NCT00138671|4255142|B1|> 75 years||Age, Customized||participants|Number|1|1.0||||||
4429990|NCT00138671|4255140|B3|66 to 75 years||Age, Customized||participants|Number|42|42.0||||||
4429991|NCT00138671|4255141|B2|66 to 75 years||Age, Customized||participants|Number|15|15.0||||||
4429992|NCT00138671|4255142|B1|66 to 75 years||Age, Customized||participants|Number|27|27.0||||||
4429993|NCT00138671|4255140|B3|56 to 65 years||Age, Customized||participants|Number|43|43.0||||||
4429994|NCT00138671|4255141|B2|56 to 65 years||Age, Customized||participants|Number|23|23.0||||||
4429995|NCT00138671|4255142|B1|56 to 65 years||Age, Customized||participants|Number|20|20.0||||||
4429996|NCT00138671|4255140|B3|46 to 55 years||Age, Customized||participants|Number|14|14.0||||||
4429997|NCT00138671|4255141|B2|46 to 55 years||Age, Customized||participants|Number|4|4.0||||||
4429998|NCT00138671|4255142|B1|46 to 55 years||Age, Customized||participants|Number|10|10.0||||||
4429999|NCT00138671|4255140|B3|36 to 45 years||Age, Customized||participants|Number|4|4.0||||||
4430000|NCT00138671|4255141|B2|36 to 45 years||Age, Customized||participants|Number|3|3.0||||||
4430001|NCT00138671|4255142|B1|36 to 45 years||Age, Customized||participants|Number|1|1.0||||||
4430002|NCT00138658|4255193|B1|Stage IV||Cancer Stage|"Patients enrolled in this study were required to be either Stage IIIB or Stage IV.~Stage IIIB lung cancer is defined as a tumor of any size that has spread to distant lymph nodes, has invaded other structures in the chest (such as the heart or esophagus), or has a malignant pleural effusion (fluid build-up containing cancer cells between the layers lining the lungs).~Stage IV non-small cell lung cancer is defined as a tumor of any size that has spread (metastasized) to another region of the body or to another lobe of the lungs."|participants|Number|66|66.0||||||
4430003|NCT00138658|4255193|B1|Stage IIIB||Cancer Stage|"Patients enrolled in this study were required to be either Stage IIIB or Stage IV.~Stage IIIB lung cancer is defined as a tumor of any size that has spread to distant lymph nodes, has invaded other structures in the chest (such as the heart or esophagus), or has a malignant pleural effusion (fluid build-up containing cancer cells between the layers lining the lungs).~Stage IV non-small cell lung cancer is defined as a tumor of any size that has spread (metastasized) to another region of the body or to another lobe of the lungs."|participants|Number|15|15.0||||||
4430004|NCT00138658|4255193|B1|ECOG 2||Baseline ECOG|"The ECOG score is a performance status which attempts to quantify cancer patients' general well-being.~Grade 0=Fully active, able to carry on all pre-disease performance without restriction.~Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~Grade 2=Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|participants|Number|1|1.0||||||
4430005|NCT00138658|4255193|B1|ECOG 1||Baseline ECOG|"The ECOG score is a performance status which attempts to quantify cancer patients' general well-being.~Grade 0=Fully active, able to carry on all pre-disease performance without restriction.~Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~Grade 2=Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|participants|Number|54|54.0||||||
4430006|NCT00138658|4255193|B1|ECOG O||Baseline ECOG|"The ECOG score is a performance status which attempts to quantify cancer patients' general well-being.~Grade 0=Fully active, able to carry on all pre-disease performance without restriction.~Grade 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~Grade 2=Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|participants|Number|26|26.0||||||
4430007|NCT00138658|4255193|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4430008|NCT00138658|4255193|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430009|NCT00138658|4255193|B1||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4430010|NCT00138658|4255193|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4430011|NCT00138658|4255193|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430012|NCT00138658|4255193|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4430013|NCT00138658|4255193|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430014|NCT00138658|4255193|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4430015|NCT00138658|4255193|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4430016|NCT00138658|4255193|B1|||Age||years|Mean|60.4|60.4|Full Range|||43.0|79.0|
4430017|NCT00138658|4255193|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4430018|NCT00138658|4255193|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4430019|NCT00138658|4255193|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430020|NCT00138645|4255203|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4430021|NCT00138645|4255204|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4430022|NCT00138645|4255205|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4430023|NCT00138645|4255203|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4430024|NCT00138645|4255204|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4430025|NCT00138645|4255205|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4430026|NCT00138645|4255203|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4430027|NCT00138645|4255204|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4430028|NCT00138645|4255205|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4430029|NCT00138645|4255203|B3|||Age||years|Mean|42|42.0|Standard Deviation|11.4|11.4|||
4430030|NCT00138645|4255204|B2|||Age||years|Mean|43|43.0|Standard Deviation|11.4|11.4|||
4430031|NCT00138645|4255205|B1|||Age||years|Mean|40|40.0|Standard Deviation|11.4|11.4|||
4430032|NCT00138645|4255203|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430033|NCT00138645|4255204|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430034|NCT00138645|4255205|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430035|NCT00138645|4255203|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4430036|NCT00138645|4255204|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4430037|NCT00138645|4255205|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4430038|NCT00138645|4255203|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430039|NCT00138645|4255204|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430040|NCT00138645|4255205|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430041|NCT00138424|4255212|B5|United States||Region of Enrollment||participants|Number|22|22.0||||||
4430042|NCT00138424|4255213|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4430043|NCT00138424|4255214|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4430044|NCT00138424|4255215|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4430045|NCT00138424|4255216|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4430046|NCT00138424|4255212|B5||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4430047|NCT00138424|4255213|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4430048|NCT00138424|4255214|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4430049|NCT00138424|4255215|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4430050|NCT00138424|4255216|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4430051|NCT00138424|4255212|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4430052|NCT00138424|4255213|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4430053|NCT00138424|4255214|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4430054|NCT00138424|4255215|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4430055|NCT00138424|4255216|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4430056|NCT00138424|4255212|B5|>= 70 years old||Age, Customized||participants|Number|2|2.0||||||
4430057|NCT00138424|4255213|B4|>= 70 years old||Age, Customized||participants|Number|1|1.0||||||
4430058|NCT00138424|4255214|B3|>= 70 years old||Age, Customized||participants|Number|1|1.0||||||
4430059|NCT00138424|4255215|B2|>= 70 years old||Age, Customized||participants|Number|0|0.0||||||
4430060|NCT00138424|4255216|B1|>= 70 years old||Age, Customized||participants|Number|0|0.0||||||
4430061|NCT00138424|4255212|B5|60-69 years old||Age, Customized||participants|Number|7|7.0||||||
4430062|NCT00138424|4255213|B4|60-69 years old||Age, Customized||participants|Number|1|1.0||||||
4430063|NCT00138424|4255214|B3|60-69 years old||Age, Customized||participants|Number|2|2.0||||||
4430064|NCT00138424|4255215|B2|60-69 years old||Age, Customized||participants|Number|0|0.0||||||
4430065|NCT00138424|4255216|B1|60-69 years old||Age, Customized||participants|Number|4|4.0||||||
4430066|NCT00138424|4255212|B5|50-59 years old||Age, Customized||participants|Number|6|6.0||||||
4430067|NCT00138424|4255213|B4|50-59 years old||Age, Customized||participants|Number|0|0.0||||||
4430068|NCT00138424|4255214|B3|50-59 years old||Age, Customized||participants|Number|2|2.0||||||
4430069|NCT00138424|4255215|B2|50-59 years old||Age, Customized||participants|Number|1|1.0||||||
4430070|NCT00138424|4255216|B1|50-59 years old||Age, Customized||participants|Number|3|3.0||||||
4430071|NCT00138424|4255212|B5|40-49 years old||Age, Customized||participants|Number|4|4.0||||||
4430072|NCT00138424|4255213|B4|40-49 years old||Age, Customized||participants|Number|1|1.0||||||
4430073|NCT00138424|4255214|B3|40-49 years old||Age, Customized||participants|Number|0|0.0||||||
4430074|NCT00138424|4255215|B2|40-49 years old||Age, Customized||participants|Number|2|2.0||||||
4430075|NCT00138424|4255216|B1|40-49 years old||Age, Customized||participants|Number|1|1.0||||||
4430076|NCT00138424|4255212|B5|30-39 years old||Age, Customized||participants|Number|0|0.0||||||
4430077|NCT00138424|4255213|B4|30-39 years old||Age, Customized||participants|Number|0|0.0||||||
4430078|NCT00138424|4255214|B3|30-39 years old||Age, Customized||participants|Number|0|0.0||||||
4430079|NCT00138424|4255215|B2|30-39 years old||Age, Customized||participants|Number|0|0.0||||||
4430080|NCT00138424|4255216|B1|30-39 years old||Age, Customized||participants|Number|0|0.0||||||
4430081|NCT00138424|4255212|B5|< 30 years old||Age, Customized||participants|Number|3|3.0||||||
4430082|NCT00138424|4255213|B4|< 30 years old||Age, Customized||participants|Number|0|0.0||||||
4430083|NCT00138424|4255214|B3|< 30 years old||Age, Customized||participants|Number|0|0.0||||||
4430084|NCT00138424|4255215|B2|< 30 years old||Age, Customized||participants|Number|2|2.0||||||
4430085|NCT00138424|4255216|B1|< 30 years old||Age, Customized||participants|Number|1|1.0||||||
4430086|NCT00138294|4255285|B1|United States||Region of Enrollment||participants|Number|29255|29255.0||||||
4430087|NCT00138294|4255285|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430088|NCT00138294|4255285|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1499|1499.0||||||
4430089|NCT00138294|4255285|B1||White|Race (NIH/OMB)||Participants|Count of Participants|24699|24699.0||||||
4430090|NCT00138294|4255285|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2335|2335.0||||||
4430091|NCT00138294|4255285|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430092|NCT00138294|4255285|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|519|519.0||||||
4430093|NCT00138294|4255285|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|203|203.0||||||
4430094|NCT00138294|4255285|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430095|NCT00138294|4255285|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20092|20092.0||||||
4430096|NCT00138294|4255285|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9163|9163.0||||||
4430097|NCT00138294|4255285|B1||Male|Sex: Female, Male||Participants|Count of Participants|14149|14149.0||||||
4430098|NCT00138294|4255285|B1||Female|Sex: Female, Male||Participants|Count of Participants|15106|15106.0||||||
4430099|NCT00138294|4255285|B1|||Age||years|Mean|8|8.0|Full Range|||5.0|17.0|
4430100|NCT00138294|4255285|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430101|NCT00138294|4255285|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4430102|NCT00138294|4255285|B1||<=18 years|Age||Participants|Count of Participants|29255|29255.0||||||
4430103|NCT00138203|4255295|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4430104|NCT00138203|4255295|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4430105|NCT00138203|4255295|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4430106|NCT00138203|4255295|B1|||Age||years|Mean|59.5|59.5|Standard Deviation|16|16.0|||
4430107|NCT00138203|4255295|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4430108|NCT00138203|4255295|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4430109|NCT00138203|4255295|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430110|NCT00138151|4255302|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4430111|NCT00138151|4255302|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4430112|NCT00138151|4255302|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4430113|NCT00138151|4255302|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|12.7|12.7|||
4430114|NCT00138151|4255302|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4430115|NCT00138151|4255302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4430116|NCT00138151|4255302|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430117|NCT00138125|4255308|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430118|NCT00138125|4255308|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430119|NCT00138125|4255308|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4430120|NCT00138125|4255308|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4430121|NCT00138125|4255308|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4430122|NCT00138125|4255308|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430123|NCT00138125|4255308|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4430124|NCT00138125|4255308|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430125|NCT00138073|4255312|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4430126|NCT00138073|4255312|B1|any gender||Sex/Gender, Customized|Baseline measure of gender was not collected.|participants|Number|55|55.0||||||
4430127|NCT00138073|4255312|B1|any age||Age, Customized|Baseline measure of age was not collected.|participants|Number|55|55.0||||||
4430128|NCT00138034|4255317|B3|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4430129|NCT00138034|4255318|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4430130|NCT00138034|4255319|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4430131|NCT00138034|4255317|B3|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4430132|NCT00138034|4255318|B2|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4430133|NCT00138034|4255319|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4430134|NCT00138034|4255317|B3|Netherlands||Region of Enrollment||participants|Number|40|40.0||||||
4430135|NCT00138034|4255318|B2|Netherlands||Region of Enrollment||participants|Number|20|20.0||||||
4430136|NCT00138034|4255319|B1|Netherlands||Region of Enrollment||participants|Number|20|20.0||||||
4430137|NCT00138034|4255317|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4430138|NCT00138034|4255318|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4430139|NCT00138034|4255319|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4430140|NCT00138034|4255317|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4430141|NCT00138034|4255318|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4430142|NCT00138034|4255319|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4430143|NCT00138034|4255317|B3|||Age||years|Mean|59|59.0|Standard Deviation|12|12.0|||
4430144|NCT00138034|4255318|B2|||Age||years|Mean|59|59.0|Standard Deviation|13|13.0|||
4430145|NCT00138034|4255319|B1|||Age||years|Mean|60|60.0|Standard Deviation|12|12.0|||
4430146|NCT00138034|4255317|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4430147|NCT00138034|4255318|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4430148|NCT00138034|4255319|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4430149|NCT00138034|4255317|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4430150|NCT00138034|4255318|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4430151|NCT00138034|4255319|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4430152|NCT00138034|4255317|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430153|NCT00138034|4255318|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430154|NCT00138034|4255319|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430155|NCT00137969|4255328|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4430156|NCT00137969|4255329|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4430157|NCT00137969|4255330|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4430158|NCT00137969|4255328|B3||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4430159|NCT00137969|4255329|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4430160|NCT00137969|4255330|B1||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4430161|NCT00137969|4255328|B3|> 64 years||Age, Customized||participants|Number|4|4.0||||||
4430162|NCT00137969|4255329|B2|> 64 years||Age, Customized||participants|Number|3|3.0||||||
4430163|NCT00137969|4255330|B1|> 64 years||Age, Customized||participants|Number|1|1.0||||||
4430164|NCT00137969|4255328|B3|20 to 64 years||Age, Customized||participants|Number|249|249.0||||||
4430165|NCT00137969|4255329|B2|20 to 64 years||Age, Customized||participants|Number|83|83.0||||||
4430166|NCT00137969|4255330|B1|20 to 64 years||Age, Customized||participants|Number|166|166.0||||||
4430167|NCT00137969|4255328|B3|< 20 years||Age, Customized||participants|Number|4|4.0||||||
4430168|NCT00137969|4255329|B2|< 20 years||Age, Customized||participants|Number|2|2.0||||||
4430169|NCT00137969|4255330|B1|< 20 years||Age, Customized||participants|Number|2|2.0||||||
4430170|NCT00137969|4255328|B3|||Age||years|Mean|40.3|40.3|Standard Deviation|11.9|11.9|||
4430171|NCT00137969|4255329|B2|||Age||years|Mean|40.5|40.5|Standard Deviation|12.8|12.8|||
4430172|NCT00137969|4255330|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|11.4|11.4|||
4430173|NCT00137631|4255351|B3|United States||Region of Enrollment||participants|Number|338.0|338.0||||||
4430174|NCT00137631|4255352|B2|United States||Region of Enrollment||participants|Number|174|174.0||||||
4430175|NCT00137631|4255353|B1|United States||Region of Enrollment||participants|Number|164|164.0||||||
4430176|NCT00137631|4255351|B3||Male|Sex: Female, Male||Participants|Count of Participants|338.0|338.0||||||
4430177|NCT00137631|4255352|B2||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4430178|NCT00137631|4255353|B1||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4430179|NCT00137631|4255351|B3||Female|Sex: Female, Male||Participants|Count of Participants|0.0|0.0||||||
4430180|NCT00137631|4255352|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4430181|NCT00137631|4255353|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4430182|NCT00137631|4255351|B3|||Age||years|Mean|29.6|29.6|Standard Deviation|9.3|9.3|||
4430183|NCT00137631|4255352|B2|||Age||years|Mean|29.7|29.7|Standard Deviation|9.5|9.5|||
4430184|NCT00137631|4255353|B1|||Age||years|Mean|29.5|29.5|Standard Deviation|9.1|9.1|||
4430185|NCT00137449|4255368|B3||Male|Sex: Female, Male||Participants|Count of Participants|28.0|28.0||||||
4430186|NCT00137449|4255369|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4430187|NCT00137449|4255370|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4430188|NCT00137449|4255368|B3||Female|Sex: Female, Male||Participants|Count of Participants|32.0|32.0||||||
4430189|NCT00137449|4255369|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4430190|NCT00137449|4255370|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4430191|NCT00137449|4255368|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|14.6|14.6|||
4430192|NCT00137449|4255369|B2|||Age||years|Mean|57.0|57.0|Standard Deviation|14.8|14.8|||
4430193|NCT00137449|4255370|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|14.5|14.5|||
4430194|NCT00137449|4255368|B3||>=65 years|Age||Participants|Count of Participants|25.0|25.0||||||
4430195|NCT00137449|4255369|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4430196|NCT00137449|4255370|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4430197|NCT00137449|4255368|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35.0|35.0||||||
4430198|NCT00137449|4255369|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4430199|NCT00137449|4255370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4430200|NCT00137449|4255368|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4430201|NCT00137449|4255369|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430202|NCT00137449|4255370|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430203|NCT00137436|4255408|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4430204|NCT00137436|4255408|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4430205|NCT00137436|4255408|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|9.1|9.1|||
4430206|NCT00137436|4255408|B1||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4430207|NCT00137436|4255408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4430208|NCT00137436|4255408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430209|NCT00137423|4255425|B3||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4430210|NCT00137423|4255426|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4430211|NCT00137423|4255427|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4430212|NCT00137423|4255425|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4430213|NCT00137423|4255426|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4430214|NCT00137423|4255427|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4430215|NCT00137423|4255425|B3|||Age||years|Mean|58.2|58.2|Standard Deviation|10.43|10.43|||
4430216|NCT00137423|4255426|B2|||Age||years|Mean|57.2|57.2|Standard Deviation|11.48|11.48|||
4430217|NCT00137423|4255427|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|9.27|9.27|||
4430218|NCT00137280|4255448|B3|Symptomatic Functioning||Functioning, Global Assessment of Functioning Scale|The Global Assessment of Functioning Scale consists of three scales: occupational functioning, social functioning, and symptomatic functioning. Each scale ranges from 1 (worst possible functioning) to 100 (superior functioning).|units on a scale|Mean|51.7|51.7|Standard Deviation|14.5|14.5|||
4430291|NCT00137280|4255449|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4430292|NCT00137280|4255450|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4430219|NCT00137280|4255449|B2|Symptomatic Functioning||Functioning, Global Assessment of Functioning Scale|The Global Assessment of Functioning Scale consists of three scales: occupational functioning, social functioning, and symptomatic functioning. Each scale ranges from 1 (worst possible functioning) to 100 (superior functioning).|units on a scale|Mean|50.2|50.2|Standard Deviation|13.8|13.8|||
4430220|NCT00137280|4255450|B1|Symptomatic Functioning||Functioning, Global Assessment of Functioning Scale|The Global Assessment of Functioning Scale consists of three scales: occupational functioning, social functioning, and symptomatic functioning. Each scale ranges from 1 (worst possible functioning) to 100 (superior functioning).|units on a scale|Mean|53.4|53.4|Standard Deviation|15.1|15.1|||
4430221|NCT00137280|4255448|B3|Social Functioning||Functioning, Global Assessment of Functioning Scale|The Global Assessment of Functioning Scale consists of three scales: occupational functioning, social functioning, and symptomatic functioning. Each scale ranges from 1 (worst possible functioning) to 100 (superior functioning).|units on a scale|Mean|53.9|53.9|Standard Deviation|13.5|13.5|||
4430222|NCT00137280|4255449|B2|Social Functioning||Functioning, Global Assessment of Functioning Scale|The Global Assessment of Functioning Scale consists of three scales: occupational functioning, social functioning, and symptomatic functioning. Each scale ranges from 1 (worst possible functioning) to 100 (superior functioning).|units on a scale|Mean|54.4|54.4|Standard Deviation|12.9|12.9|||
4430223|NCT00137280|4255450|B1|Social Functioning||Functioning, Global Assessment of Functioning Scale|The Global Assessment of Functioning Scale consists of three scales: occupational functioning, social functioning, and symptomatic functioning. Each scale ranges from 1 (worst possible functioning) to 100 (superior functioning).|units on a scale|Mean|53.4|53.4|Standard Deviation|14.1|14.1|||
4430224|NCT00137280|4255448|B3|Occupational Functioning||Functioning, Global Assessment of Functioning Scale|The Global Assessment of Functioning Scale consists of three scales: occupational functioning, social functioning, and symptomatic functioning. Each scale ranges from 1 (worst possible functioning) to 100 (superior functioning).|units on a scale|Mean|38.8|38.8|Standard Deviation|18.8|18.8|||
4430225|NCT00137280|4255449|B2|Occupational Functioning||Functioning, Global Assessment of Functioning Scale|The Global Assessment of Functioning Scale consists of three scales: occupational functioning, social functioning, and symptomatic functioning. Each scale ranges from 1 (worst possible functioning) to 100 (superior functioning).|units on a scale|Mean|38.2|38.2|Standard Deviation|16.8|16.8|||
4430226|NCT00137280|4255450|B1|Occupational Functioning||Functioning, Global Assessment of Functioning Scale|The Global Assessment of Functioning Scale consists of three scales: occupational functioning, social functioning, and symptomatic functioning. Each scale ranges from 1 (worst possible functioning) to 100 (superior functioning).|units on a scale|Mean|39.5|39.5|Standard Deviation|20.6|20.6|||
4430227|NCT00137280|4255448|B3|||Negative Symptoms, Brief Psychiatric Rating Scale|The Brief Psychiatric Rating Scale includes a number of scales that measure domains of psychopathology. Item scores and scale scores range from 1 (none) to 7 (extremely severe). The negative symptoms scale measures severity of negative symptoms.|units on a scale|Mean|1.8|1.8|Standard Deviation|0.8|0.8|||
4430228|NCT00137280|4255449|B2|||Negative Symptoms, Brief Psychiatric Rating Scale|The Brief Psychiatric Rating Scale includes a number of scales that measure domains of psychopathology. Item scores and scale scores range from 1 (none) to 7 (extremely severe). The negative symptoms scale measures severity of negative symptoms.|units on a scale|Mean|2.0|2.0|Standard Deviation|1.3|1.3|||
4430229|NCT00137280|4255450|B1|||Negative Symptoms, Brief Psychiatric Rating Scale|The Brief Psychiatric Rating Scale includes a number of scales that measure domains of psychopathology. Item scores and scale scores range from 1 (none) to 7 (extremely severe). The negative symptoms scale measures severity of negative symptoms.|units on a scale|Mean|1.5|1.5|Standard Deviation|0.8|0.8|||
4430230|NCT00137280|4255448|B3|||Psychotic Symptoms, Brief Psychiatric Rating Scale|The Brief Psychiatric Rating Scale includes a number of scales that measure domains of psychopathology. Item scores and scale scores range from 1 (none) to 7 (extremely severe). The psychotic symptoms scale measures severity of psychosis.|units on a scale|Mean|2.4|2.4|Standard Deviation|1.3|1.3|||
4430231|NCT00137280|4255449|B2|||Psychotic Symptoms, Brief Psychiatric Rating Scale|The Brief Psychiatric Rating Scale includes a number of scales that measure domains of psychopathology. Item scores and scale scores range from 1 (none) to 7 (extremely severe). The psychotic symptoms scale measures severity of psychosis.|units on a scale|Mean|2.5|2.5|Standard Deviation|1.3|1.3|||
4430232|NCT00137280|4255450|B1|||Psychotic Symptoms, Brief Psychiatric Rating Scale|The Brief Psychiatric Rating Scale includes a number of scales that measure domains of psychopathology. Item scores and scale scores range from 1 (none) to 7 (extremely severe). The psychotic symptoms scale measures severity of psychosis.|units on a scale|Mean|2.3|2.3|Standard Deviation|1.3|1.3|||
4430233|NCT00137280|4255448|B3|||Waist Circumference, centimeters||centimeters|Mean|104.6|104.6|Standard Deviation|16.0|16.0|||
4430234|NCT00137280|4255449|B2|||Waist Circumference, centimeters||centimeters|Mean|104.3|104.3|Standard Deviation|15.7|15.7|||
4430235|NCT00137280|4255450|B1|||Waist Circumference, centimeters||centimeters|Mean|104.9|104.9|Standard Deviation|16.3|16.3|||
4430236|NCT00137280|4255448|B3|No||Diagnosis of Diabetes||participants|Number|563|563.0||||||
4430237|NCT00137280|4255449|B2|No||Diagnosis of Diabetes||participants|Number|294|294.0||||||
4430238|NCT00137280|4255450|B1|No||Diagnosis of Diabetes||participants|Number|269|269.0||||||
4430239|NCT00137280|4255448|B3|Yes||Diagnosis of Diabetes||participants|Number|238|238.0||||||
4430240|NCT00137280|4255449|B2|Yes||Diagnosis of Diabetes||participants|Number|118|118.0||||||
4430241|NCT00137280|4255450|B1|Yes||Diagnosis of Diabetes||participants|Number|120|120.0||||||
4430242|NCT00137280|4255448|B3|||Body Mass Index||kg/m^2|Mean|30.1|30.1|Standard Deviation|6.3|6.3|||
4430243|NCT00137280|4255449|B2|||Body Mass Index||kg/m^2|Mean|29.9|29.9|Standard Deviation|6.5|6.5|||
4430244|NCT00137280|4255450|B1|||Body Mass Index||kg/m^2|Mean|30.2|30.2|Standard Deviation|6.1|6.1|||
4430245|NCT00137280|4255448|B3|||Weight, kilograms||kilograms|Mean|93.8|93.8|Standard Deviation|20.2|20.2|||
4430246|NCT00137280|4255449|B2|||Weight, kilograms||kilograms|Mean|93.0|93.0|Standard Deviation|20.1|20.1|||
4430247|NCT00137280|4255450|B1|||Weight, kilograms||kilograms|Mean|94.6|94.6|Standard Deviation|20.4|20.4|||
4430248|NCT00137280|4255448|B3|Unknown/Not Reported||Psychotropic medications by weight gain potential|Participants are only counted in one category; Participants are counted in the highest weight gain potential category.|participants|Number|171|171.0||||||
4430249|NCT00137280|4255449|B2|Unknown/Not Reported||Psychotropic medications by weight gain potential|Participants are only counted in one category; Participants are counted in the highest weight gain potential category.|participants|Number|97|97.0||||||
4430250|NCT00137280|4255450|B1|Unknown/Not Reported||Psychotropic medications by weight gain potential|Participants are only counted in one category; Participants are counted in the highest weight gain potential category.|participants|Number|74|74.0||||||
4430251|NCT00137280|4255448|B3|Low Weight Gain Potential||Psychotropic medications by weight gain potential|Participants are only counted in one category; Participants are counted in the highest weight gain potential category.|participants|Number|188|188.0||||||
4430252|NCT00137280|4255449|B2|Low Weight Gain Potential||Psychotropic medications by weight gain potential|Participants are only counted in one category; Participants are counted in the highest weight gain potential category.|participants|Number|92|92.0||||||
4430253|NCT00137280|4255450|B1|Low Weight Gain Potential||Psychotropic medications by weight gain potential|Participants are only counted in one category; Participants are counted in the highest weight gain potential category.|participants|Number|96|96.0||||||
4430254|NCT00137280|4255448|B3|Moderate Weight Gain Potential||Psychotropic medications by weight gain potential|Participants are only counted in one category; Participants are counted in the highest weight gain potential category.|participants|Number|307|307.0||||||
4430255|NCT00137280|4255449|B2|Moderate Weight Gain Potential||Psychotropic medications by weight gain potential|Participants are only counted in one category; Participants are counted in the highest weight gain potential category.|participants|Number|158|158.0||||||
4430256|NCT00137280|4255450|B1|Moderate Weight Gain Potential||Psychotropic medications by weight gain potential|Participants are only counted in one category; Participants are counted in the highest weight gain potential category.|participants|Number|149|149.0||||||
4430257|NCT00137280|4255448|B3|High Weight Gain Potential||Psychotropic medications by weight gain potential|Participants are only counted in one category; Participants are counted in the highest weight gain potential category.|participants|Number|135|135.0||||||
4430258|NCT00137280|4255449|B2|High Weight Gain Potential||Psychotropic medications by weight gain potential|Participants are only counted in one category; Participants are counted in the highest weight gain potential category.|participants|Number|65|65.0||||||
4430259|NCT00137280|4255450|B1|High Weight Gain Potential||Psychotropic medications by weight gain potential|Participants are only counted in one category; Participants are counted in the highest weight gain potential category.|participants|Number|70|70.0||||||
4430260|NCT00137280|4255448|B3|||Duration with Schizophrenia, years||years|Mean|26.0|26.0|Standard Deviation|12.3|12.3|||
4430261|NCT00137280|4255449|B2|||Duration with Schizophrenia, years||years|Mean|25.8|25.8|Standard Deviation|12.7|12.7|||
4430262|NCT00137280|4255450|B1|||Duration with Schizophrenia, years||years|Mean|26.2|26.2|Standard Deviation|11.7|11.7|||
4430263|NCT00137280|4255448|B3|United States||Region of Enrollment||participants|Number|801|801.0||||||
4430264|NCT00137280|4255449|B2|United States||Region of Enrollment||participants|Number|412|412.0||||||
4430265|NCT00137280|4255450|B1|United States||Region of Enrollment||participants|Number|389|389.0||||||
4430266|NCT00137280|4255448|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4430267|NCT00137280|4255449|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4430268|NCT00137280|4255450|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4430269|NCT00137280|4255448|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|692|692.0||||||
4430270|NCT00137280|4255449|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|380|380.0||||||
4430271|NCT00137280|4255450|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|312|312.0||||||
4430272|NCT00137280|4255448|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4430273|NCT00137280|4255449|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4430274|NCT00137280|4255450|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4430275|NCT00137280|4255448|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4430276|NCT00137280|4255449|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4430277|NCT00137280|4255450|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4430278|NCT00137280|4255448|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4430279|NCT00137280|4255449|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4430280|NCT00137280|4255450|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4430281|NCT00137280|4255448|B3||White|Race (NIH/OMB)||Participants|Count of Participants|355|355.0||||||
4430282|NCT00137280|4255449|B2||White|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4430283|NCT00137280|4255450|B1||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
4430284|NCT00137280|4255448|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|355|355.0||||||
4430285|NCT00137280|4255449|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
4430286|NCT00137280|4255450|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|160|160.0||||||
4430287|NCT00137280|4255448|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4430288|NCT00137280|4255449|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4430289|NCT00137280|4255450|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4430290|NCT00137280|4255448|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4430293|NCT00137280|4255448|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4430294|NCT00137280|4255449|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4430295|NCT00137280|4255450|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4430296|NCT00137280|4255448|B3||Male|Sex: Female, Male||Participants|Count of Participants|732|732.0||||||
4430297|NCT00137280|4255449|B2||Male|Sex: Female, Male||Participants|Count of Participants|373|373.0||||||
4430298|NCT00137280|4255450|B1||Male|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4430299|NCT00137280|4255448|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4430300|NCT00137280|4255449|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4430301|NCT00137280|4255450|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4430302|NCT00137280|4255448|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|9.4|9.4|||
4430303|NCT00137280|4255449|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|9.5|9.5|||
4430304|NCT00137280|4255450|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|9.3|9.3|||
4430305|NCT00137267|4255463|B3|United States||Region of Enrollment||participants|Number|66|66.0||||||
4430306|NCT00137267|4255464|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4430307|NCT00137267|4255465|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4430308|NCT00137267|4255463|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4430309|NCT00137267|4255464|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4430310|NCT00137267|4255465|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4430311|NCT00137267|4255463|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4430312|NCT00137267|4255464|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4430313|NCT00137267|4255465|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4430314|NCT00137267|4255463|B3|50 and older||Age, Customized||participants|Number|33|33.0||||||
4430315|NCT00137267|4255464|B2|50 and older||Age, Customized||participants|Number|14|14.0||||||
4430316|NCT00137267|4255465|B1|50 and older||Age, Customized||participants|Number|19|19.0||||||
4430317|NCT00137267|4255463|B3|40 - 49 years||Age, Customized||participants|Number|25|25.0||||||
4430318|NCT00137267|4255464|B2|40 - 49 years||Age, Customized||participants|Number|8|8.0||||||
4430319|NCT00137267|4255465|B1|40 - 49 years||Age, Customized||participants|Number|17|17.0||||||
4430320|NCT00137267|4255463|B3|less than 40 years||Age, Customized||participants|Number|8|8.0||||||
4430321|NCT00137267|4255464|B2|less than 40 years||Age, Customized||participants|Number|4|4.0||||||
4430322|NCT00137267|4255465|B1|less than 40 years||Age, Customized||participants|Number|4|4.0||||||
4430323|NCT00137111|4255474|B5||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4430324|NCT00137111|4255478|B1||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4430325|NCT00137111|4255474|B5||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4430326|NCT00137111|4255478|B1||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4430327|NCT00137111|4255474|B5|>=10 years||Age, Customized|Prior experience indicate different responses for children under the age of ten and those who are 10 and older.|participants|Number|126|126.0||||||
4430328|NCT00137111|4255478|B1|>=10 years||Age, Customized|Prior experience indicate different responses for children under the age of ten and those who are 10 and older.|participants|Number|126|126.0||||||
4430329|NCT00137111|4255474|B5|1 to 9 years||Age, Customized|Prior experience indicate different responses for children under the age of ten and those who are 10 and older.|participants|Number|372|372.0||||||
4430330|NCT00137111|4255478|B1|1 to 9 years||Age, Customized|Prior experience indicate different responses for children under the age of ten and those who are 10 and older.|participants|Number|372|372.0||||||
4430331|NCT00137046|4255493|B3||Male|Sex: Female, Male||Participants|Count of Participants|330|330.0||||||
4430332|NCT00137046|4255494|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4430333|NCT00137046|4255495|B1||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4430334|NCT00137046|4255493|B3||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4430335|NCT00137046|4255494|B2||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4430336|NCT00137046|4255495|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4430337|NCT00137046|4255493|B3|56 to 65||Age, Customized||years|Number|37|37.0||||||
4430338|NCT00137046|4255494|B2|56 to 65||Age, Customized||years|Number|22|22.0||||||
4430339|NCT00137046|4255495|B1|56 to 65||Age, Customized||years|Number|15|15.0||||||
4430340|NCT00137046|4255493|B3|46 to 55||Age, Customized||years|Number|100|100.0||||||
4430341|NCT00137046|4255494|B2|46 to 55||Age, Customized||years|Number|48|48.0||||||
4430342|NCT00137046|4255495|B1|46 to 55||Age, Customized||years|Number|52|52.0||||||
4430343|NCT00137046|4255493|B3|36 to 45||Age, Customized||years|Number|165|165.0||||||
4430344|NCT00137046|4255494|B2|36 to 45||Age, Customized||years|Number|71|71.0||||||
4430345|NCT00137046|4255495|B1|36 to 45||Age, Customized||years|Number|94|94.0||||||
4430346|NCT00137046|4255493|B3|26 to 35||Age, Customized||years|Number|177|177.0||||||
4430347|NCT00137046|4255494|B2|26 to 35||Age, Customized||years|Number|96|96.0||||||
4430348|NCT00137046|4255495|B1|26 to 35||Age, Customized||years|Number|81|81.0||||||
4430349|NCT00137046|4255493|B3|18 to 25||Age, Customized||years|Number|101|101.0||||||
4430350|NCT00137046|4255494|B2|18 to 25||Age, Customized||years|Number|53|53.0||||||
4430351|NCT00137046|4255495|B1|18 to 25||Age, Customized||years|Number|48|48.0||||||
4430352|NCT00136955|4255544|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4430353|NCT00136955|4255544|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4430354|NCT00136955|4255544|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|9.6|9.6|||
4430355|NCT00136916|4255551|B3||Male|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4430356|NCT00136916|4255552|B2||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4430357|NCT00136916|4255553|B1||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4430358|NCT00136916|4255551|B3||Female|Sex: Female, Male||Participants|Count of Participants|229|229.0||||||
4430359|NCT00136916|4255552|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4430360|NCT00136916|4255553|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4430361|NCT00136916|4255551|B3|||Age||years|Mean|56.1|56.1|Standard Deviation|9.6|9.6|||
4430362|NCT00136916|4255552|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|9.9|9.9|||
4430363|NCT00136916|4255553|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|9.2|9.2|||
4430364|NCT00136916|4255551|B3|Between 66 and 75 years||Age, Customized||participants|Number|122|122.0||||||
4430365|NCT00136916|4255552|B2|Between 66 and 75 years||Age, Customized||participants|Number|61|61.0||||||
4430366|NCT00136916|4255553|B1|Between 66 and 75 years||Age, Customized||participants|Number|61|61.0||||||
4430367|NCT00136916|4255551|B3|Between 56 and 65 years||Age, Customized||participants|Number|218|218.0||||||
4430368|NCT00136916|4255552|B2|Between 56 and 65 years||Age, Customized||participants|Number|101|101.0||||||
4430369|NCT00136916|4255553|B1|Between 56 and 65 years||Age, Customized||participants|Number|117|117.0||||||
4430370|NCT00136916|4255551|B3|Between 46 and 55 years||Age, Customized||participants|Number|193|193.0||||||
4430371|NCT00136916|4255552|B2|Between 46 and 55 years||Age, Customized||participants|Number|93|93.0||||||
4430372|NCT00136916|4255553|B1|Between 46 and 55 years||Age, Customized||participants|Number|100|100.0||||||
4430373|NCT00136916|4255551|B3|Between 36 and 45 years||Age, Customized||participants|Number|85|85.0||||||
4430374|NCT00136916|4255552|B2|Between 36 and 45 years||Age, Customized||participants|Number|49|49.0||||||
4430375|NCT00136916|4255553|B1|Between 36 and 45 years||Age, Customized||participants|Number|36|36.0||||||
4430376|NCT00136916|4255551|B3|Between 26 and 35 years||Age, Customized||participants|Number|9|9.0||||||
4430377|NCT00136916|4255552|B2|Between 26 and 35 years||Age, Customized||participants|Number|7|7.0||||||
4430378|NCT00136916|4255553|B1|Between 26 and 35 years||Age, Customized||participants|Number|2|2.0||||||
4430379|NCT00136838|4255608|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430380|NCT00136838|4255608|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430381|NCT00136838|4255608|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4430382|NCT00136838|4255608|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4430383|NCT00136838|4255608|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430384|NCT00136838|4255608|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430385|NCT00136838|4255608|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430386|NCT00136838|4255608|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4430387|NCT00136838|4255608|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4430388|NCT00136838|4255608|B1|||Age||years|Mean|31|31.0|Standard Deviation|6.7|6.7|||
4430389|NCT00136812|4255617|B3|Other||Sex/Gender, Customized||participants|Number|6|6.0||||||
4430390|NCT00136812|4255618|B2|Other||Sex/Gender, Customized||participants|Number|2|2.0||||||
4430391|NCT00136812|4255619|B1|Other||Sex/Gender, Customized||participants|Number|4|4.0||||||
4430392|NCT00136812|4255617|B3|Male||Sex/Gender, Customized||participants|Number|84|84.0||||||
4430393|NCT00136812|4255618|B2|Male||Sex/Gender, Customized||participants|Number|48|48.0||||||
4430394|NCT00136812|4255619|B1|Male||Sex/Gender, Customized||participants|Number|36|36.0||||||
4430395|NCT00136812|4255617|B3|Female||Sex/Gender, Customized||participants|Number|134|134.0||||||
4430396|NCT00136812|4255618|B2|Female||Sex/Gender, Customized||participants|Number|63|63.0||||||
4430397|NCT00136812|4255619|B1|Female||Sex/Gender, Customized||participants|Number|71|71.0||||||
4430398|NCT00136812|4255617|B3|||Age||years|Mean|39.9|39.9|Standard Deviation|14|14.0|||
4430399|NCT00136812|4255618|B2|||Age||years|Mean|39.9|39.9|Standard Deviation|13.5|13.5|||
4430400|NCT00136812|4255619|B1|||Age||years|Mean|39.9|39.9|Standard Deviation|14.1|14.1|||
4430401|NCT00136760|4255626|B5|United States||Region of Enrollment||participants|Number|52|52.0||||||
4430402|NCT00136760|4255627|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
4430403|NCT00136760|4255628|B3|United States||Region of Enrollment||participants|Number|11|11.0||||||
4430404|NCT00136760|4255629|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4430405|NCT00136760|4255630|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4430406|NCT00136760|4255626|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4430407|NCT00136760|4255627|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4430408|NCT00136760|4255628|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4430409|NCT00136760|4255629|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4430410|NCT00136760|4255630|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4430411|NCT00136760|4255626|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4430412|NCT00136760|4255627|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4430413|NCT00136760|4255628|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4430414|NCT00136760|4255629|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4430415|NCT00136760|4255630|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4430416|NCT00136760|4255626|B5|||Age||years|Mean|45.1|45.1|Standard Deviation|8.2|8.2|||
4430417|NCT00136760|4255627|B4|||Age||years|Mean|46.9|46.9|Standard Deviation|6.8|6.8|||
4430418|NCT00136760|4255628|B3|||Age||years|Mean|43.7|43.7|Standard Deviation|7.3|7.3|||
4430419|NCT00136760|4255629|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|6.7|6.7|||
4430420|NCT00136760|4255630|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|11.9|11.9|||
4430421|NCT00136760|4255626|B5||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4430422|NCT00136760|4255627|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430423|NCT00136760|4255628|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4430424|NCT00136760|4255629|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4430425|NCT00136760|4255630|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430426|NCT00136760|4255626|B5||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4430427|NCT00136760|4255627|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4430428|NCT00136760|4255628|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4430429|NCT00136760|4255629|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4430430|NCT00136760|4255630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4430431|NCT00136760|4255626|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430432|NCT00136760|4255627|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430433|NCT00136760|4255628|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430434|NCT00136760|4255629|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430435|NCT00136760|4255630|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430436|NCT00136695|4255647|B3||Male|Gender||Participants|Count of Participants|69|69.0||||||
4430437|NCT00136695|4255648|B2||Male|Gender||Participants|Count of Participants|35|35.0||||||
4430438|NCT00136695|4255649|B1||Male|Gender||Participants|Count of Participants|34|34.0||||||
4430439|NCT00136695|4255647|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4430440|NCT00136695|4255648|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4430441|NCT00136695|4255649|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4430442|NCT00136695|4255647|B3|||Age||years|Mean|66|66.0|Standard Deviation|4|4.0|||
4430443|NCT00136695|4255648|B2|||Age||years|Mean|66|66.0|Standard Deviation|4|4.0|||
4430444|NCT00136695|4255649|B1|||Age||years|Mean|66|66.0|Standard Deviation|4|4.0|||
4430445|NCT00136604|4255656|B6|East - South East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|617|617.0||||||
4430446|NCT00136604|4255657|B5|East - South East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|125|125.0||||||
4430447|NCT00136604|4255658|B4|East - South East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|41|41.0||||||
4430448|NCT00136604|4255659|B3|East - South East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
4430449|NCT00136604|4255660|B2|East - South East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|123|123.0||||||
4430450|NCT00136604|4255661|B1|East - South East Asian||Race/Ethnicity, Customized||Participants|Count of Participants|249|249.0||||||
4430451|NCT00136604|4255656|B6||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4430452|NCT00136604|4255657|B5||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4430453|NCT00136604|4255658|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4430454|NCT00136604|4255659|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4430455|NCT00136604|4255660|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4430456|NCT00136604|4255661|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4430457|NCT00136604|4255656|B6||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4430458|NCT00136604|4255657|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4430459|NCT00136604|4255658|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4430460|NCT00136604|4255659|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4430461|NCT00136604|4255660|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4430462|NCT00136604|4255661|B1||Female|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4430463|NCT00136604|4255656|B6|||Age||Months|Mean|17.82|17.82|Standard Deviation|0.56|0.56|||
4430464|NCT00136604|4255657|B5|||Age||Months|Mean|17.8|17.8|Standard Deviation|0.55|0.55|||
4430465|NCT00136604|4255658|B4|||Age||Months|Mean|17.7|17.7|Standard Deviation|0.67|0.67|||
4430466|NCT00136604|4255659|B3|||Age||Months|Mean|17.7|17.7|Standard Deviation|0.59|0.59|||
4430467|NCT00136604|4255660|B2|||Age||Months|Mean|17.8|17.8|Standard Deviation|0.59|0.59|||
4430468|NCT00136604|4255661|B1|||Age||Months|Mean|17.90|17.9|Standard Deviation|0.52|0.52|||
4430469|NCT00136357|4255771|B3|Kosovo||Region of Enrollment||participants|Number|82|82.0||||||
4430470|NCT00136357|4255772|B2|Kosovo||Region of Enrollment||participants|Number|41|41.0||||||
4430471|NCT00136357|4255773|B1|Kosovo||Region of Enrollment||participants|Number|41|41.0||||||
4430472|NCT00136357|4255771|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4430473|NCT00136357|4255772|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4430474|NCT00136357|4255773|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4430475|NCT00136357|4255771|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4430476|NCT00136357|4255772|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4430477|NCT00136357|4255773|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4430478|NCT00136357|4255771|B3|||Age||years|Mean|16.3|16.3|Standard Deviation|1.1|1.1|||
4430479|NCT00136357|4255772|B2|||Age||years|Mean|16.3|16.3|Standard Deviation|1.2|1.2|||
4430480|NCT00136357|4255773|B1|||Age||years|Mean|16.3|16.3|Standard Deviation|1.1|1.1|||
4430481|NCT00136357|4255771|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430482|NCT00136357|4255772|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430483|NCT00136357|4255773|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430484|NCT00136357|4255771|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4430485|NCT00136357|4255772|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4430486|NCT00136357|4255773|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4430487|NCT00136357|4255771|B3||<=18 years|Age||Participants|Count of Participants|82|82.0||||||
4430488|NCT00136357|4255772|B2||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
4430489|NCT00136357|4255773|B1||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
4430490|NCT00136318|4255780|B3|Germany||Region of Enrollment||participants|Number|181|181.0||||||
4430491|NCT00136318|4255781|B2|Germany||Region of Enrollment||participants|Number|91|91.0||||||
4430492|NCT00136318|4255782|B1|Germany||Region of Enrollment||participants|Number|90|90.0||||||
4430493|NCT00136318|4255780|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4430494|NCT00136318|4255781|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4430495|NCT00136318|4255782|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4430496|NCT00136318|4255780|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4430497|NCT00136318|4255781|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4430498|NCT00136318|4255782|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4430499|NCT00136318|4255780|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|11|11.0|||
4430500|NCT00136318|4255781|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|11|11.0|||
4430501|NCT00136318|4255782|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|11|11.0|||
4430502|NCT00136318|4255780|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4430503|NCT00136318|4255781|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4430504|NCT00136318|4255782|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4430505|NCT00136318|4255780|B3||Between 18 and 65 years|Age||Participants|Count of Participants|168|168.0||||||
4430506|NCT00136318|4255781|B2||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4430507|NCT00136318|4255782|B1||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4430508|NCT00136318|4255780|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430509|NCT00136318|4255781|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430510|NCT00136318|4255782|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430511|NCT00136214|4255797|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4430512|NCT00136214|4255798|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4430513|NCT00136214|4255799|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4430514|NCT00136214|4255797|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430515|NCT00136214|4255798|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430516|NCT00136214|4255799|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430517|NCT00136214|4255797|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430518|NCT00136214|4255798|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430519|NCT00136214|4255799|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430520|NCT00136214|4255797|B3||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4430521|NCT00136214|4255798|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4430522|NCT00136214|4255799|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4430523|NCT00136214|4255797|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4430524|NCT00136214|4255798|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4430525|NCT00136214|4255799|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4430526|NCT00136214|4255797|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430527|NCT00136214|4255798|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430528|NCT00136214|4255799|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430529|NCT00136214|4255797|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430530|NCT00136214|4255798|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430531|NCT00136214|4255799|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430532|NCT00136214|4255797|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430533|NCT00136214|4255798|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430534|NCT00136214|4255799|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430535|NCT00136214|4255797|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4430536|NCT00136214|4255798|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4430537|NCT00136214|4255799|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4430538|NCT00136214|4255797|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4430539|NCT00136214|4255798|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4430540|NCT00136214|4255799|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4430541|NCT00136214|4255797|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430542|NCT00136214|4255798|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430543|NCT00136214|4255799|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430544|NCT00136214|4255797|B3||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4430545|NCT00136214|4255798|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4430546|NCT00136214|4255799|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4430547|NCT00136214|4255797|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430548|NCT00136214|4255798|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430549|NCT00136214|4255799|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430550|NCT00136084|4255808|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4430551|NCT00136084|4255809|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4430552|NCT00136084|4255810|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4430553|NCT00136084|4255808|B3||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4430554|NCT00136084|4255809|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4430555|NCT00136084|4255810|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4430556|NCT00136084|4255808|B3|||Age||years|Mean|8.49|8.49|Standard Deviation|6.19|6.19|||
4430557|NCT00136084|4255809|B2|||Age||years|Mean|8.48|8.48|Standard Deviation|6.32|6.32|||
4430558|NCT00136084|4255810|B1|||Age||years|Mean|8.57|8.57|Standard Deviation|6.08|6.08|||
4430559|NCT00135798|4255824|B4|United States||Region of Enrollment||participants|Number|79|79.0||||||
4430560|NCT00135798|4255825|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4430561|NCT00135798|4255826|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4430562|NCT00135798|4255827|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4430563|NCT00135798|4255824|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4430564|NCT00135798|4255825|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4430565|NCT00135798|4255826|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4430566|NCT00135798|4255827|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4430567|NCT00135798|4255824|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4430568|NCT00135798|4255825|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4430569|NCT00135798|4255826|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4430570|NCT00135798|4255827|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4430571|NCT00135798|4255824|B4|||Age||years|Mean|55.7|55.7|Standard Deviation|6.7|6.7|||
4430572|NCT00135798|4255825|B3|||Age||years|Mean|56.6|56.6|Standard Deviation|6.5|6.5|||
4430573|NCT00135798|4255826|B2|||Age||years|Mean|54.6|54.6|Standard Deviation|7.4|7.4|||
4430574|NCT00135798|4255827|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|5.4|5.4|||
4430575|NCT00135798|4255824|B4||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4430576|NCT00135798|4255825|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4430577|NCT00135798|4255826|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4430578|NCT00135798|4255827|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4430579|NCT00135798|4255824|B4||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4430580|NCT00135798|4255825|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4430581|NCT00135798|4255826|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4430582|NCT00135798|4255827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4430583|NCT00135798|4255824|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430584|NCT00135798|4255825|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430585|NCT00135798|4255826|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430586|NCT00135798|4255827|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430587|NCT00135707|4255845|B3|Diastolic||Blood pressure||mm Hg|Mean|65|65.0|Standard Deviation|6.6|6.6|||
4430588|NCT00135707|4255846|B2|Diastolic||Blood pressure||mm Hg|Mean|65|65.0|Standard Deviation|8|8.0|||
4430589|NCT00135707|4255847|B1|Diastolic||Blood pressure||mm Hg|Mean|66|66.0|Standard Deviation|8|8.0|||
4430590|NCT00135707|4255845|B3|Systolic||Blood pressure||mm Hg|Mean|109|109.0|Standard Deviation|9.1|9.1|||
4430591|NCT00135707|4255846|B2|Systolic||Blood pressure||mm Hg|Mean|109|109.0|Standard Deviation|10|10.0|||
4430592|NCT00135707|4255847|B1|Systolic||Blood pressure||mm Hg|Mean|109|109.0|Standard Deviation|10|10.0|||
4430593|NCT00135707|4255845|B3|||Family history of preeclampsia|Family history is based on self-reported preeclampsia in a first-degree relative (mother, sister, or grandmother).|Participants|Count of Participants|1324|1324.0||||||
4430594|NCT00135707|4255846|B2|||Family history of preeclampsia|Family history is based on self-reported preeclampsia in a first-degree relative (mother, sister, or grandmother).|Participants|Count of Participants|674|674.0||||||
4430595|NCT00135707|4255847|B1|||Family history of preeclampsia|Family history is based on self-reported preeclampsia in a first-degree relative (mother, sister, or grandmother).|Participants|Count of Participants|650|650.0||||||
4430596|NCT00135707|4255845|B3|||Previous pregnancy||Participants|Count of Participants|2331|2331.0||||||
4430597|NCT00135707|4255846|B2|||Previous pregnancy||Participants|Count of Participants|1170|1170.0||||||
4430598|NCT00135707|4255847|B1|||Previous pregnancy||Participants|Count of Participants|1161|1161.0||||||
4430599|NCT00135707|4255845|B3|||Daily dose of vitamin E||IU|Median|22|22.0|Inter-Quartile Range|||2.0|30.0|
4430600|NCT00135707|4255846|B2|||Daily dose of vitamin E||IU|Median|22|22.0|Inter-Quartile Range|||0.0|30.0|
4430601|NCT00135707|4255847|B1|||Daily dose of vitamin E||IU|Median|22|22.0|Inter-Quartile Range|||3.0|30.0|
4430602|NCT00135707|4255845|B3|||Daily dose of vitamin C||mg|Median|100|100.0|Inter-Quartile Range|||50.0|120.0|
4430603|NCT00135707|4255846|B2|||Daily dose of vitamin C||mg|Median|100|100.0|Inter-Quartile Range|||50.0|120.0|
4430604|NCT00135707|4255847|B1|||Daily dose of vitamin C||mg|Median|120|120.0|Inter-Quartile Range|||50.0|120.0|
4430605|NCT00135707|4255845|B3|||Use of prenatal vitamins or multivitamins||Participants|Count of Participants|7792|7792.0||||||
4430606|NCT00135707|4255846|B2|||Use of prenatal vitamins or multivitamins||Participants|Count of Participants|3889|3889.0||||||
4430607|NCT00135707|4255847|B1|||Use of prenatal vitamins or multivitamins||Participants|Count of Participants|3903|3903.0||||||
4430608|NCT00135707|4255845|B3|||Educational level||year|Mean|12.8|12.8|Standard Deviation|2.7|2.7|||
4430609|NCT00135707|4255846|B2|||Educational level||year|Mean|12.8|12.8|Standard Deviation|2.7|2.7|||
4430610|NCT00135707|4255847|B1|||Educational level||year|Mean|12.8|12.8|Standard Deviation|2.7|2.7|||
4430611|NCT00135707|4255845|B3|||Smoker||Participants|Count of Participants|1593|1593.0||||||
4430612|NCT00135707|4255846|B2|||Smoker||Participants|Count of Participants|781|781.0||||||
4430613|NCT00135707|4255847|B1|||Smoker||Participants|Count of Participants|812|812.0||||||
4430614|NCT00135707|4255845|B3|||Prepregnancy body-mass index|The body-mass index is the weight in kilograms divided by the square of the height in meters. Prepregnancy weight used to calculate body-mass index was self-reported. Values were unavailable for 99 women in the vitamin group and 111 in the placebo group.|kg/m2|Mean|25.4|25.4|Standard Deviation|6.0|6.0|||
4430615|NCT00135707|4255846|B2|||Prepregnancy body-mass index|The body-mass index is the weight in kilograms divided by the square of the height in meters. Prepregnancy weight used to calculate body-mass index was self-reported. Values were unavailable for 99 women in the vitamin group and 111 in the placebo group.|kg/m2|Mean|25.4|25.4|Standard Deviation|5.9|5.9|||
4430616|NCT00135707|4255847|B1|||Prepregnancy body-mass index|The body-mass index is the weight in kilograms divided by the square of the height in meters. Prepregnancy weight used to calculate body-mass index was self-reported. Values were unavailable for 99 women in the vitamin group and 111 in the placebo group.|kg/m2|Mean|25.4|25.4|Standard Deviation|6.0|6.0|||
4430617|NCT00135707|4255845|B3|||<13th week of pregnancy at randomization||Participants|Count of Participants|4430|4430.0||||||
4430618|NCT00135707|4255846|B2|||<13th week of pregnancy at randomization||Participants|Count of Participants|2203|2203.0||||||
4430619|NCT00135707|4255847|B1|||<13th week of pregnancy at randomization||Participants|Count of Participants|2227|2227.0||||||
4430620|NCT00135707|4255845|B3|||Week of pregnancy at randomization||weeks|Mean|13.4|13.4|Standard Deviation|2.1|2.1|||
4430621|NCT00135707|4255846|B2|||Week of pregnancy at randomization||weeks|Mean|13.4|13.4|Standard Deviation|2.1|2.1|||
4430622|NCT00135707|4255847|B1|||Week of pregnancy at randomization||weeks|Mean|13.4|13.4|Standard Deviation|2.1|2.1|||
4430623|NCT00135707|4255845|B3|Other||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|Participants|Count of Participants|4421|4421.0||||||
4430624|NCT00135707|4255846|B2|Other||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|Participants|Count of Participants|2204|2204.0||||||
4430625|NCT00135707|4255847|B1|Other||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|Participants|Count of Participants|2217|2217.0||||||
4430626|NCT00135707|4255845|B3|Hispanic||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|Participants|Count of Participants|3168|3168.0||||||
4430627|NCT00135707|4255846|B2|Hispanic||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|Participants|Count of Participants|1566|1566.0||||||
4430628|NCT00135707|4255847|B1|Hispanic||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|Participants|Count of Participants|1602|1602.0||||||
4430629|NCT00135707|4255845|B3|Black||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|Participants|Count of Participants|2563|2563.0||||||
4430630|NCT00135707|4255846|B2|Black||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|Participants|Count of Participants|1295|1295.0||||||
4430631|NCT00135707|4255847|B1|Black||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|Participants|Count of Participants|1268|1268.0||||||
4430632|NCT00135707|4255845|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4430633|NCT00135707|4255846|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4430634|NCT00135707|4255847|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4430635|NCT00135707|4255845|B3||Female|Sex: Female, Male||Participants|Count of Participants|10152|10152.0||||||
4430636|NCT00135707|4255846|B2||Female|Sex: Female, Male||Participants|Count of Participants|5065|5065.0||||||
4430637|NCT00135707|4255847|B1||Female|Sex: Female, Male||Participants|Count of Participants|5087|5087.0||||||
4430638|NCT00135707|4255845|B3|||Age||years|Mean|23.5|23.5|Standard Deviation|5.2|5.2|||
4430639|NCT00135707|4255846|B2|||Age||years|Mean|23.5|23.5|Standard Deviation|5.2|5.2|||
4430640|NCT00135707|4255847|B1|||Age||years|Mean|23.5|23.5|Standard Deviation|5.2|5.2|||
4430641|NCT00135694|4255928|B4|||Serum Creatinine|The latest creatinine value collected at the screening or baseline visit prior to transplant was used for this measure. The test measures kidney function. According to Harrison's Principles of Internal Medicine, normal results are 0.6 to 1.2 mg/dL for men and 0.5 to 0.9 mg/dL for women. Abnormal kidney function results in increased levels of serum creatinine.|mg/dL|Mean|1.4|1.4|Standard Deviation|1.04|1.04|||
4430690|NCT00135694|4255929|B3||Male|Gender||Participants|Count of Participants|13|13.0||||||
4430642|NCT00135694|4255929|B3|||Serum Creatinine|The latest creatinine value collected at the screening or baseline visit prior to transplant was used for this measure. The test measures kidney function. According to Harrison's Principles of Internal Medicine, normal results are 0.6 to 1.2 mg/dL for men and 0.5 to 0.9 mg/dL for women. Abnormal kidney function results in increased levels of serum creatinine.|mg/dL|Mean|1.1|1.1|Standard Deviation|0.68|0.68|||
4430643|NCT00135694|4255930|B2|||Serum Creatinine|The latest creatinine value collected at the screening or baseline visit prior to transplant was used for this measure. The test measures kidney function. According to Harrison's Principles of Internal Medicine, normal results are 0.6 to 1.2 mg/dL for men and 0.5 to 0.9 mg/dL for women. Abnormal kidney function results in increased levels of serum creatinine.|mg/dL|Mean|1.3|1.3|Standard Deviation|0.65|0.65|||
4430644|NCT00135694|4255931|B1|||Serum Creatinine|The latest creatinine value collected at the screening or baseline visit prior to transplant was used for this measure. The test measures kidney function. According to Harrison's Principles of Internal Medicine, normal results are 0.6 to 1.2 mg/dL for men and 0.5 to 0.9 mg/dL for women. Abnormal kidney function results in increased levels of serum creatinine.|mg/dL|Mean|1.5|1.5|Standard Deviation|1.18|1.18|||
4430645|NCT00135694|4255928|B4|United States||Region of Enrollment||participants|Number|275|275.0||||||
4430646|NCT00135694|4255929|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4430647|NCT00135694|4255930|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4430648|NCT00135694|4255931|B1|United States||Region of Enrollment||participants|Number|180|180.0||||||
4430649|NCT00135694|4255928|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4430650|NCT00135694|4255929|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430651|NCT00135694|4255930|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4430652|NCT00135694|4255931|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4430653|NCT00135694|4255928|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4430654|NCT00135694|4255929|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430655|NCT00135694|4255930|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4430656|NCT00135694|4255931|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430657|NCT00135694|4255928|B4||White|Race (NIH/OMB)||Participants|Count of Participants|236|236.0||||||
4430658|NCT00135694|4255929|B3||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4430659|NCT00135694|4255930|B2||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4430660|NCT00135694|4255931|B1||White|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4430661|NCT00135694|4255928|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4430662|NCT00135694|4255929|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430663|NCT00135694|4255930|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4430664|NCT00135694|4255931|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4430665|NCT00135694|4255928|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4430666|NCT00135694|4255929|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430667|NCT00135694|4255930|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4430668|NCT00135694|4255931|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430669|NCT00135694|4255928|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4430670|NCT00135694|4255929|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4430671|NCT00135694|4255930|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4430672|NCT00135694|4255931|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4430673|NCT00135694|4255928|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4430674|NCT00135694|4255929|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430675|NCT00135694|4255930|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430676|NCT00135694|4255931|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4430677|NCT00135694|4255928|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4430678|NCT00135694|4255929|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430679|NCT00135694|4255930|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4430680|NCT00135694|4255931|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4430681|NCT00135694|4255928|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
4430682|NCT00135694|4255929|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4430683|NCT00135694|4255930|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4430684|NCT00135694|4255931|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4430685|NCT00135694|4255928|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4430686|NCT00135694|4255929|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4430687|NCT00135694|4255930|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4430688|NCT00135694|4255931|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4430689|NCT00135694|4255928|B4||Male|Gender||Participants|Count of Participants|203|203.0||||||
4430691|NCT00135694|4255930|B2||Male|Gender||Participants|Count of Participants|63|63.0||||||
4430692|NCT00135694|4255931|B1||Male|Gender||Participants|Count of Participants|127|127.0||||||
4430693|NCT00135694|4255928|B4||Female|Gender||Participants|Count of Participants|72|72.0||||||
4430694|NCT00135694|4255929|B3||Female|Gender||Participants|Count of Participants|5|5.0||||||
4430695|NCT00135694|4255930|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
4430696|NCT00135694|4255931|B1||Female|Gender||Participants|Count of Participants|53|53.0||||||
4430697|NCT00135694|4255928|B4|||Age||years|Mean|55.3|55.3|Standard Deviation|8.47|8.47|||
4430698|NCT00135694|4255929|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|7.70|7.7|||
4430699|NCT00135694|4255930|B2|||Age||years|Mean|54.3|54.3|Standard Deviation|9.92|9.92|||
4430700|NCT00135694|4255931|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|7.83|7.83|||
4430701|NCT00135694|4255928|B4||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4430702|NCT00135694|4255929|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4430703|NCT00135694|4255930|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4430704|NCT00135694|4255931|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4430705|NCT00135694|4255928|B4||Between 18 and 65 years|Age||Participants|Count of Participants|242|242.0||||||
4430706|NCT00135694|4255929|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4430707|NCT00135694|4255930|B2||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4430708|NCT00135694|4255931|B1||Between 18 and 65 years|Age||Participants|Count of Participants|161|161.0||||||
4430709|NCT00135694|4255928|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430710|NCT00135694|4255929|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430711|NCT00135694|4255930|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430712|NCT00135694|4255931|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430713|NCT00135356|4255951|B3|||Waist-to-Hip Ratio|131 participants in ATV/RTV arm and 68 participants in PI/RTV arm had this baseline measurement.|ratio|Median|0.99|0.99|Inter-Quartile Range|||0.95|1.03|
4430714|NCT00135356|4255952|B2|||Waist-to-Hip Ratio|131 participants in ATV/RTV arm and 68 participants in PI/RTV arm had this baseline measurement.|ratio|Median|0.97|0.97|Inter-Quartile Range|||0.94|1.02|
4430715|NCT00135356|4255953|B1|||Waist-to-Hip Ratio|131 participants in ATV/RTV arm and 68 participants in PI/RTV arm had this baseline measurement.|ratio|Median|0.99|0.99|Inter-Quartile Range|||0.95|1.03|
4430716|NCT00135356|4255951|B3|||Waist Circumference||cm|Median|94|94.0|Inter-Quartile Range|||90.0|102.0|
4430717|NCT00135356|4255952|B2|||Waist Circumference||cm|Median|95|95.0|Inter-Quartile Range|||91.0|100.0|
4430718|NCT00135356|4255953|B1|||Waist Circumference||cm|Median|94|94.0|Inter-Quartile Range|||90.0|103.0|
4430719|NCT00135356|4255951|B3|||Trunk-to-Limb Fat Ratio|117 participants in ATV/RTV arm and 56 participants in PI/RTV arm had this measure at baseline.|ratio|Median|1.62|1.62|Inter-Quartile Range|||1.23|2.1|
4430720|NCT00135356|4255952|B2|||Trunk-to-Limb Fat Ratio|117 participants in ATV/RTV arm and 56 participants in PI/RTV arm had this measure at baseline.|ratio|Median|1.73|1.73|Inter-Quartile Range|||1.17|2.15|
4430721|NCT00135356|4255953|B1|||Trunk-to-Limb Fat Ratio|117 participants in ATV/RTV arm and 56 participants in PI/RTV arm had this measure at baseline.|ratio|Median|1.59|1.59|Inter-Quartile Range|||1.27|2.04|
4430722|NCT00135356|4255951|B3|Total Body Fat||Trunk Fat, Limb Fat, Total Body Fat|Values for all 3 baseline fat measurements were missing for 14 participants in the ATV/RTV arm (n=117). Values for baseline trunk fat measurements were missing for 10 participants in the PI/RTV arm (n=59); values for baseline limb fat and total body fat measurements were missing for 13 participants in the PI/RTV arm (n=56).|kg|Median|19.8|19.8|Inter-Quartile Range|||14.8|25.7|
4430723|NCT00135356|4255952|B2|Total Body Fat||Trunk Fat, Limb Fat, Total Body Fat|Values for all 3 baseline fat measurements were missing for 14 participants in the ATV/RTV arm (n=117). Values for baseline trunk fat measurements were missing for 10 participants in the PI/RTV arm (n=59); values for baseline limb fat and total body fat measurements were missing for 13 participants in the PI/RTV arm (n=56).|kg|Median|18.7|18.7|Inter-Quartile Range|||15.6|22.4|
4430724|NCT00135356|4255953|B1|Total Body Fat||Trunk Fat, Limb Fat, Total Body Fat|Values for all 3 baseline fat measurements were missing for 14 participants in the ATV/RTV arm (n=117). Values for baseline trunk fat measurements were missing for 10 participants in the PI/RTV arm (n=59); values for baseline limb fat and total body fat measurements were missing for 13 participants in the PI/RTV arm (n=56).|kg|Median|20.8|20.8|Inter-Quartile Range|||14.1|26.0|
4430725|NCT00135356|4255951|B3|Limb Fat||Trunk Fat, Limb Fat, Total Body Fat|Values for all 3 baseline fat measurements were missing for 14 participants in the ATV/RTV arm (n=117). Values for baseline trunk fat measurements were missing for 10 participants in the PI/RTV arm (n=59); values for baseline limb fat and total body fat measurements were missing for 13 participants in the PI/RTV arm (n=56).|kg|Median|7.0|7.0|Inter-Quartile Range|||4.6|10.0|
4430726|NCT00135356|4255952|B2|Limb Fat||Trunk Fat, Limb Fat, Total Body Fat|Values for all 3 baseline fat measurements were missing for 14 participants in the ATV/RTV arm (n=117). Values for baseline trunk fat measurements were missing for 10 participants in the PI/RTV arm (n=59); values for baseline limb fat and total body fat measurements were missing for 13 participants in the PI/RTV arm (n=56).|kg|Median|6.7|6.7|Inter-Quartile Range|||4.6|9.4|
4430727|NCT00135356|4255953|B1|Limb Fat||Trunk Fat, Limb Fat, Total Body Fat|Values for all 3 baseline fat measurements were missing for 14 participants in the ATV/RTV arm (n=117). Values for baseline trunk fat measurements were missing for 10 participants in the PI/RTV arm (n=59); values for baseline limb fat and total body fat measurements were missing for 13 participants in the PI/RTV arm (n=56).|kg|Median|7.1|7.1|Inter-Quartile Range|||4.6|10.4|
4430728|NCT00135356|4255951|B3|Trunk Fat||Trunk Fat, Limb Fat, Total Body Fat|Values for all 3 baseline fat measurements were missing for 14 participants in the ATV/RTV arm (n=117). Values for baseline trunk fat measurements were missing for 10 participants in the PI/RTV arm (n=59); values for baseline limb fat and total body fat measurements were missing for 13 participants in the PI/RTV arm (n=56).|kg|Median|11.4|11.4|Inter-Quartile Range|||8.7|14.6|
4430729|NCT00135356|4255952|B2|Trunk Fat||Trunk Fat, Limb Fat, Total Body Fat|Values for all 3 baseline fat measurements were missing for 14 participants in the ATV/RTV arm (n=117). Values for baseline trunk fat measurements were missing for 10 participants in the PI/RTV arm (n=59); values for baseline limb fat and total body fat measurements were missing for 13 participants in the PI/RTV arm (n=56).|kg|Median|10.9|10.9|Inter-Quartile Range|||8.8|13.8|
4430730|NCT00135356|4255953|B1|Trunk Fat||Trunk Fat, Limb Fat, Total Body Fat|Values for all 3 baseline fat measurements were missing for 14 participants in the ATV/RTV arm (n=117). Values for baseline trunk fat measurements were missing for 10 participants in the PI/RTV arm (n=59); values for baseline limb fat and total body fat measurements were missing for 13 participants in the PI/RTV arm (n=56).|kg|Median|11.8|11.8|Inter-Quartile Range|||8.6|15.3|
4430731|NCT00135356|4255951|B3|||CD4 Cell Count|CD4 cell=a type of white blood cell that bears the CD4 surface receptor and helps coordinate a range of immune system activities.|cells/mm3|Median|459|459.0|Full Range|||90.0|1919.0|
4430732|NCT00135356|4255952|B2|||CD4 Cell Count|CD4 cell=a type of white blood cell that bears the CD4 surface receptor and helps coordinate a range of immune system activities.|cells/mm3|Median|437|437.0|Full Range|||100.0|1078.0|
4430733|NCT00135356|4255953|B1|||CD4 Cell Count|CD4 cell=a type of white blood cell that bears the CD4 surface receptor and helps coordinate a range of immune system activities.|cells/mm3|Median|470|470.0|Full Range|||90.0|1919.0|
4430734|NCT00135356|4255951|B3|||Body Weight||kg|Median|76|76.0|Inter-Quartile Range|||69.0|84.0|
4430735|NCT00135356|4255952|B2|||Body Weight||kg|Median|77|77.0|Inter-Quartile Range|||69.0|87.0|
4430736|NCT00135356|4255953|B1|||Body Weight||kg|Median|75|75.0|Inter-Quartile Range|||69.0|83.0|
4430737|NCT00135356|4255951|B3|||Body Mass Index (BMI)|131 participants in ATV/RTV arm and 67 participants in PI/RTV arm had this baseline measurement.|kg/m2|Median|25.9|25.9|Inter-Quartile Range|||24.2|28.5|
4430738|NCT00135356|4255952|B2|||Body Mass Index (BMI)|131 participants in ATV/RTV arm and 67 participants in PI/RTV arm had this baseline measurement.|kg/m2|Median|25.7|25.7|Inter-Quartile Range|||24.2|28.8|
4430739|NCT00135356|4255953|B1|||Body Mass Index (BMI)|131 participants in ATV/RTV arm and 67 participants in PI/RTV arm had this baseline measurement.|kg/m2|Median|25.9|25.9|Inter-Quartile Range|||24.1|28.5|
4430740|NCT00135356|4255951|B3|TAT||Adipose Tissue at Baseline|Visceral, subcutaneous, and total adipose tissue (VAT, SAT, and TAT) as assessed by computed tomography (CT). Values for all 3 measurements were missing for 20 participants in the ATV/RTV arm (n=111). Values for all 3 measurements were missing for 10 participants in the PI/RTV arm (n=59).|cm2|Median|352.0|352.0|Inter-Quartile Range|||268.5|453.1|
4430741|NCT00135356|4255952|B2|TAT||Adipose Tissue at Baseline|Visceral, subcutaneous, and total adipose tissue (VAT, SAT, and TAT) as assessed by computed tomography (CT). Values for all 3 measurements were missing for 20 participants in the ATV/RTV arm (n=111). Values for all 3 measurements were missing for 10 participants in the PI/RTV arm (n=59).|cm2|Median|328.6|328.6|Inter-Quartile Range|||287.3|457.8|
4430742|NCT00135356|4255953|B1|TAT||Adipose Tissue at Baseline|Visceral, subcutaneous, and total adipose tissue (VAT, SAT, and TAT) as assessed by computed tomography (CT). Values for all 3 measurements were missing for 20 participants in the ATV/RTV arm (n=111). Values for all 3 measurements were missing for 10 participants in the PI/RTV arm (n=59).|cm2|Median|356.2|356.2|Inter-Quartile Range|||263.9|446.3|
4430743|NCT00135356|4255951|B3|SAT||Adipose Tissue at Baseline|Visceral, subcutaneous, and total adipose tissue (VAT, SAT, and TAT) as assessed by computed tomography (CT). Values for all 3 measurements were missing for 20 participants in the ATV/RTV arm (n=111). Values for all 3 measurements were missing for 10 participants in the PI/RTV arm (n=59).|cm2|Median|193.6|193.6|Inter-Quartile Range|||140.3|289.2|
4430744|NCT00135356|4255952|B2|SAT||Adipose Tissue at Baseline|Visceral, subcutaneous, and total adipose tissue (VAT, SAT, and TAT) as assessed by computed tomography (CT). Values for all 3 measurements were missing for 20 participants in the ATV/RTV arm (n=111). Values for all 3 measurements were missing for 10 participants in the PI/RTV arm (n=59).|cm2|Median|183.9|183.9|Inter-Quartile Range|||151.4|282.4|
4430745|NCT00135356|4255953|B1|SAT||Adipose Tissue at Baseline|Visceral, subcutaneous, and total adipose tissue (VAT, SAT, and TAT) as assessed by computed tomography (CT). Values for all 3 measurements were missing for 20 participants in the ATV/RTV arm (n=111). Values for all 3 measurements were missing for 10 participants in the PI/RTV arm (n=59).|cm2|Median|209.5|209.5|Inter-Quartile Range|||123.6|300.7|
4430746|NCT00135356|4255951|B3|VAT||Adipose Tissue at Baseline|Visceral, subcutaneous, and total adipose tissue (VAT, SAT, and TAT) as assessed by computed tomography (CT). Values for all 3 measurements were missing for 20 participants in the ATV/RTV arm (n=111). Values for all 3 measurements were missing for 10 participants in the PI/RTV arm (n=59).|cm2|Median|129.4|129.4|Inter-Quartile Range|||94.3|186.1|
4430747|NCT00135356|4255952|B2|VAT||Adipose Tissue at Baseline|Visceral, subcutaneous, and total adipose tissue (VAT, SAT, and TAT) as assessed by computed tomography (CT). Values for all 3 measurements were missing for 20 participants in the ATV/RTV arm (n=111). Values for all 3 measurements were missing for 10 participants in the PI/RTV arm (n=59).|cm2|Median|128.1|128.1|Inter-Quartile Range|||95.8|193.7|
4430748|NCT00135356|4255953|B1|VAT||Adipose Tissue at Baseline|Visceral, subcutaneous, and total adipose tissue (VAT, SAT, and TAT) as assessed by computed tomography (CT). Values for all 3 measurements were missing for 20 participants in the ATV/RTV arm (n=111). Values for all 3 measurements were missing for 10 participants in the PI/RTV arm (n=59).|cm2|Median|131.9|131.9|Inter-Quartile Range|||93.8|185.8|
4430749|NCT00135356|4255951|B3|≥1000 c/mL||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA) Distribution||Participants|Number|2|2.0||||||
4430750|NCT00135356|4255952|B2|≥1000 c/mL||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA) Distribution||Participants|Number|0|0.0||||||
4430751|NCT00135356|4255953|B1|≥1000 c/mL||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA) Distribution||Participants|Number|2|2.0||||||
4430752|NCT00135356|4255951|B3|400 to <1000 c/mL||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA) Distribution||Participants|Number|2|2.0||||||
4430753|NCT00135356|4255952|B2|400 to <1000 c/mL||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA) Distribution||Participants|Number|0|0.0||||||
4430754|NCT00135356|4255953|B1|400 to <1000 c/mL||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA) Distribution||Participants|Number|2|2.0||||||
4430878|NCT00135356|4255951|B3|||Age||Years|Median|43|43.0|Full Range|||23.0|79.0|
4430755|NCT00135356|4255951|B3|50 to <400 c/mL||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA) Distribution||Participants|Number|15|15.0||||||
4430756|NCT00135356|4255952|B2|50 to <400 c/mL||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA) Distribution||Participants|Number|5|5.0||||||
4430757|NCT00135356|4255953|B1|50 to <400 c/mL||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA) Distribution||Participants|Number|10|10.0||||||
4430758|NCT00135356|4255951|B3|<50 c/mL||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA) Distribution||Participants|Number|181|181.0||||||
4430759|NCT00135356|4255952|B2|<50 c/mL||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA) Distribution||Participants|Number|64|64.0||||||
4430760|NCT00135356|4255953|B1|<50 c/mL||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA) Distribution||Participants|Number|117|117.0||||||
4430761|NCT00135356|4255951|B3|HDL Cholesterol >=60 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|29|29.0||||||
4430762|NCT00135356|4255952|B2|HDL Cholesterol >=60 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|9|9.0||||||
4430763|NCT00135356|4255953|B1|HDL Cholesterol >=60 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|20|20.0||||||
4430764|NCT00135356|4255951|B3|HDL Cholesterol 40 mg/dL to <60 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|112|112.0||||||
4430765|NCT00135356|4255952|B2|HDL Cholesterol 40 mg/dL to <60 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|32|32.0||||||
4430766|NCT00135356|4255953|B1|HDL Cholesterol 40 mg/dL to <60 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|80|80.0||||||
4430767|NCT00135356|4255951|B3|HDL Cholesterol <40 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|44|44.0||||||
4430768|NCT00135356|4255952|B2|HDL Cholesterol <40 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|21|21.0||||||
4430769|NCT00135356|4255953|B1|HDL Cholesterol <40 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|23|23.0||||||
4430770|NCT00135356|4255951|B3|Total Cholesterol >=300 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|11|11.0||||||
4430771|NCT00135356|4255952|B2|Total Cholesterol >=300 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|4|4.0||||||
4430772|NCT00135356|4255953|B1|Total Cholesterol >=300 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|7|7.0||||||
4430879|NCT00135356|4255952|B2|||Age||Years|Median|42|42.0|Full Range|||26.0|65.0|
4430880|NCT00135356|4255953|B1|||Age||Years|Median|43|43.0|Full Range|||23.0|79.0|
4430773|NCT00135356|4255951|B3|Total Cholesterol 240 mg/dL to 300 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|40|40.0||||||
4430774|NCT00135356|4255952|B2|Total Cholesterol 240 mg/dL to 300 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|11|11.0||||||
4430775|NCT00135356|4255953|B1|Total Cholesterol 240 mg/dL to 300 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|29|29.0||||||
4430776|NCT00135356|4255951|B3|Total Cholesterol 200 mg/dL to 240 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|61|61.0||||||
4430777|NCT00135356|4255952|B2|Total Cholesterol 200 mg/dL to 240 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|19|19.0||||||
4430778|NCT00135356|4255953|B1|Total Cholesterol 200 mg/dL to 240 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|42|42.0||||||
4430779|NCT00135356|4255951|B3|Total Cholesterol <200 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|73|73.0||||||
4430780|NCT00135356|4255952|B2|Total Cholesterol <200 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|28|28.0||||||
4430781|NCT00135356|4255953|B1|Total Cholesterol <200 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|45|45.0||||||
4430782|NCT00135356|4255951|B3|LDL Cholesterol >=190 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|8|8.0||||||
4430783|NCT00135356|4255952|B2|LDL Cholesterol >=190 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|2|2.0||||||
4430784|NCT00135356|4255953|B1|LDL Cholesterol >=190 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|6|6.0||||||
4430785|NCT00135356|4255951|B3|LDL Cholesterol 160 mg/dL to <190 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|12|12.0||||||
4430786|NCT00135356|4255952|B2|LDL Cholesterol 160 mg/dL to <190 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|1|1.0||||||
4430881|NCT00135330|4255994|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4430787|NCT00135356|4255953|B1|LDL Cholesterol 160 mg/dL to <190 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|11|11.0||||||
4430788|NCT00135356|4255951|B3|LDL Cholesterol 130 mg/dL to <160 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|41|41.0||||||
4430789|NCT00135356|4255952|B2|LDL Cholesterol 130 mg/dL to <160 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|11|11.0||||||
4430790|NCT00135356|4255953|B1|LDL Cholesterol 130 mg/dL to <160 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|30|30.0||||||
4430791|NCT00135356|4255951|B3|LDL Cholesterol 100 mg/dL to <130 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|61|61.0||||||
4430792|NCT00135356|4255952|B2|LDL Cholesterol 100 mg/dL to <130 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|25|25.0||||||
4430793|NCT00135356|4255953|B1|LDL Cholesterol 100 mg/dL to <130 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|36|36.0||||||
4430794|NCT00135356|4255951|B3|LDL Cholesterol <100 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|62|62.0||||||
4430795|NCT00135356|4255952|B2|LDL Cholesterol <100 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|22|22.0||||||
4430796|NCT00135356|4255953|B1|LDL Cholesterol <100 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|40|40.0||||||
4430797|NCT00135356|4255951|B3|Non-HDL Cholesterol >=220 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|24|24.0||||||
4430798|NCT00135356|4255952|B2|Non-HDL Cholesterol >=220 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|8|8.0||||||
4430799|NCT00135356|4255953|B1|Non-HDL Cholesterol >=220 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|16|16.0||||||
4430800|NCT00135356|4255951|B3|Non-HDL Cholesterol 190 mg/dL to <220 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|31|31.0||||||
4430801|NCT00135356|4255952|B2|Non-HDL Cholesterol 190 mg/dL to <220 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|9|9.0||||||
4430802|NCT00135356|4255953|B1|Non-HDL Cholesterol 190 mg/dL to <220 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|22|22.0||||||
4430803|NCT00135356|4255951|B3|Non-HDL Cholesterol 160 mg/dL to <190 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|47|47.0||||||
4430804|NCT00135356|4255952|B2|Non-HDL Cholesterol 160 mg/dL to <190 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|15|15.0||||||
4430805|NCT00135356|4255953|B1|Non-HDL Cholesterol 160 mg/dL to <190 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|32|32.0||||||
4430806|NCT00135356|4255951|B3|Non-HDL Cholesterol 130 mg/dL to <160 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|45|45.0||||||
4430807|NCT00135356|4255952|B2|Non-HDL Cholesterol 130 mg/dL to <160 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|14|14.0||||||
4430808|NCT00135356|4255953|B1|Non-HDL Cholesterol 130 mg/dL to <160 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|31|31.0||||||
4430809|NCT00135356|4255951|B3|Non-HDL Cholesterol <130 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|38|38.0||||||
4430810|NCT00135356|4255952|B2|Non-HDL Cholesterol <130 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|16|16.0||||78.0|111.0|
4430811|NCT00135356|4255953|B1|Non-HDL Cholesterol <130 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|22|22.0||||80.0|111.0|
4430812|NCT00135356|4255951|B3|Triglycerides >=500 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|26|26.0||||||
4430813|NCT00135356|4255952|B2|Triglycerides >=500 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|12|12.0||||154.0|425.0|
4430814|NCT00135356|4255953|B1|Triglycerides >=500 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|14|14.0||||151.0|326.0|
4430815|NCT00135356|4255951|B3|Triglycerides 200 mg/dL to <500 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|79|79.0||||||
4430816|NCT00135356|4255952|B2|Triglycerides 200 mg/dL to <500 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|27|27.0||||84.0|125.0|
4430817|NCT00135356|4255953|B1|Triglycerides 200 mg/dL to <500 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|52|52.0||||90.0|143.0|
4430818|NCT00135356|4255951|B3|Triglycerides 150 mg/dL to <200 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|37|37.0||||||
4430819|NCT00135356|4255952|B2|Triglycerides 150 mg/dL to <200 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|9|9.0||||126.0|192.0|
4430820|NCT00135356|4255953|B1|Triglycerides 150 mg/dL to <200 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|28|28.0||||139.0|198.0|
4430821|NCT00135356|4255951|B3|Triglycerides <150 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|43|43.0||||||
4430822|NCT00135356|4255952|B2|Triglycerides <150 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|14|14.0||||35.0|53.0|
4430823|NCT00135356|4255953|B1|Triglycerides <150 mg/dL||Fasting Lipids|Triglycerides, non-high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, total cholesterol, and HDL cholesterol. Values for all baseline fasting lipid measurements were missing for 8 participants in the ATV/RTV arm. Values for baseline fasting LDL cholesterol were missing for 8 participants in the PI/RTV arm; values for all other baseline lipid measurements were missing for 7 participants.|participants|Number|29|29.0||||41.0|54.0|
4430824|NCT00135356|4255951|B3|>=126 mg/dL||Fasting Glucose|7 participants in ATV/RTV arm and 3 participants in PI/RTV arm were missing this baseline measurement.|participants|Number|9|9.0||||||
4430825|NCT00135356|4255952|B2|>=126 mg/dL||Fasting Glucose|7 participants in ATV/RTV arm and 3 participants in PI/RTV arm were missing this baseline measurement.|participants|Number|4|4.0||||||
4430826|NCT00135356|4255953|B1|>=126 mg/dL||Fasting Glucose|7 participants in ATV/RTV arm and 3 participants in PI/RTV arm were missing this baseline measurement.|participants|Number|5|5.0||||||
4430827|NCT00135356|4255951|B3|100 mg/dL to <126 mg/dL||Fasting Glucose|7 participants in ATV/RTV arm and 3 participants in PI/RTV arm were missing this baseline measurement.|participants|Number|36|36.0||||||
4430828|NCT00135356|4255952|B2|100 mg/dL to <126 mg/dL||Fasting Glucose|7 participants in ATV/RTV arm and 3 participants in PI/RTV arm were missing this baseline measurement.|participants|Number|13|13.0||||||
4430829|NCT00135356|4255953|B1|100 mg/dL to <126 mg/dL||Fasting Glucose|7 participants in ATV/RTV arm and 3 participants in PI/RTV arm were missing this baseline measurement.|participants|Number|23|23.0||||||
4430830|NCT00135356|4255951|B3|<100 mg/dL||Fasting Glucose|7 participants in ATV/RTV arm and 3 participants in PI/RTV arm were missing this baseline measurement.|participants|Number|145|145.0||||||
4430831|NCT00135356|4255952|B2|<100 mg/dL||Fasting Glucose|7 participants in ATV/RTV arm and 3 participants in PI/RTV arm were missing this baseline measurement.|participants|Number|49|49.0||||82.0|100.0|
4430832|NCT00135356|4255953|B1|<100 mg/dL||Fasting Glucose|7 participants in ATV/RTV arm and 3 participants in PI/RTV arm were missing this baseline measurement.|participants|Number|96|96.0||||83.0|99.0|
4430833|NCT00135356|4255951|B3|Missing||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|1|1.0||||||
4430834|NCT00135356|4255952|B2|Missing||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|1|1.0||||||
4430835|NCT00135356|4255953|B1|Missing||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|0|0.0||||||
4430836|NCT00135356|4255951|B3|≥500 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|87|87.0||||||
4430837|NCT00135356|4255952|B2|≥500 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|27|27.0||||||
4430838|NCT00135356|4255953|B1|≥500 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|60|60.0||||||
4430839|NCT00135356|4255951|B3|350 to <500 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|47|47.0||||||
4430840|NCT00135356|4255952|B2|350 to <500 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|16|16.0||||||
4430841|NCT00135356|4255953|B1|350 to <500 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|31|31.0||||||
4430842|NCT00135356|4255951|B3|200 to <350 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|46|46.0||||||
4430843|NCT00135356|4255952|B2|200 to <350 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|22|22.0||||||
4430844|NCT00135356|4255953|B1|200 to <350 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|24|24.0||||||
4430845|NCT00135356|4255951|B3|100 to <200 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|17|17.0||||||
4430846|NCT00135356|4255952|B2|100 to <200 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|3|3.0||||||
4430847|NCT00135356|4255953|B1|100 to <200 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|14|14.0||||||
4430848|NCT00135356|4255951|B3|50 to <100 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|2|2.0||||||
4430849|NCT00135356|4255952|B2|50 to <100 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|0|0.0||||||
4430850|NCT00135356|4255953|B1|50 to <100 cells/mm3||Cluster of Differentiation 4 (CD4) Distribution|CD4=a protein marker on the surface of certain types of T lymphocytes and other cells; HIV binds to CD4 receptors to enter host cells.|Participants|Number|2|2.0||||||
4430851|NCT00135356|4255951|B3|North America||Region of Enrollment||participants|Number|84|84.0||||||
4430852|NCT00135356|4255952|B2|North America||Region of Enrollment||participants|Number|30|30.0||||||
4430853|NCT00135356|4255953|B1|North America||Region of Enrollment||participants|Number|54|54.0||||||
4430854|NCT00135356|4255951|B3|Europe||Region of Enrollment||participants|Number|116|116.0||||||
4430855|NCT00135356|4255952|B2|Europe||Region of Enrollment||participants|Number|39|39.0||||||
4430856|NCT00135356|4255953|B1|Europe||Region of Enrollment||participants|Number|77|77.0||||||
4430857|NCT00135356|4255951|B3|Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4430858|NCT00135356|4255952|B2|Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4430859|NCT00135356|4255953|B1|Latino/Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4430860|NCT00135356|4255951|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4430861|NCT00135356|4255952|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4430862|NCT00135356|4255953|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4430863|NCT00135356|4255951|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4430864|NCT00135356|4255952|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4430865|NCT00135356|4255953|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4430866|NCT00135356|4255951|B3|Mestizo||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4430867|NCT00135356|4255952|B2|Mestizo||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4430868|NCT00135356|4255953|B1|Mestizo||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4430869|NCT00135356|4255951|B3|White||Race/Ethnicity, Customized||Participants|Number|126|126.0||||||
4430870|NCT00135356|4255952|B2|White||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4430871|NCT00135356|4255953|B1|White||Race/Ethnicity, Customized||Participants|Number|83|83.0||||||
4430872|NCT00135356|4255951|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4430873|NCT00135356|4255952|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4430874|NCT00135356|4255953|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4430875|NCT00135356|4255951|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4430876|NCT00135356|4255952|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4430877|NCT00135356|4255953|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4430882|NCT00135330|4255995|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4430883|NCT00135330|4255996|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4430884|NCT00135330|4255997|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4430885|NCT00135330|4255994|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4430886|NCT00135330|4255995|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4430887|NCT00135330|4255996|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4430888|NCT00135330|4255997|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4430889|NCT00135330|4255994|B4|||Age||years|Mean|55.70|55.7|Standard Deviation|10.09|10.09|||
4430890|NCT00135330|4255995|B3|||Age||years|Mean|55.54|55.54|Standard Deviation|10.71|10.71|||
4430891|NCT00135330|4255996|B2|||Age||years|Mean|54.63|54.63|Standard Deviation|9.91|9.91|||
4430892|NCT00135330|4255997|B1|||Age||years|Mean|56.99|56.99|Standard Deviation|9.71|9.71|||
4430893|NCT00135330|4255994|B4||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4430894|NCT00135330|4255995|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4430895|NCT00135330|4255996|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4430896|NCT00135330|4255997|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4430897|NCT00135330|4255994|B4||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4430898|NCT00135330|4255995|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4430899|NCT00135330|4255996|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4430900|NCT00135330|4255997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4430901|NCT00135330|4255994|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430902|NCT00135330|4255995|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430903|NCT00135330|4255996|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430904|NCT00135330|4255997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430905|NCT00135200|4256091|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4430906|NCT00135200|4256091|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4430907|NCT00135200|4256091|B1|||Age||years|Median|56|56.0|Full Range|||45.0|77.0|
4430908|NCT00134901|4256096|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4430909|NCT00134901|4256097|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4430910|NCT00134901|4256098|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4430911|NCT00134901|4256096|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4430912|NCT00134901|4256097|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4430913|NCT00134901|4256098|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4430914|NCT00134901|4256096|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4430915|NCT00134901|4256097|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4430916|NCT00134901|4256098|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4430917|NCT00134901|4256096|B3|||Age||years|Mean|40|40.0|Standard Deviation|8|8.0|||
4430918|NCT00134901|4256097|B2|||Age||years|Mean|40|40.0|Standard Deviation|9|9.0|||
4430919|NCT00134901|4256098|B1|||Age||years|Mean|40|40.0|Standard Deviation|7|7.0|||
4430920|NCT00134901|4256096|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430921|NCT00134901|4256097|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430922|NCT00134901|4256098|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4430923|NCT00134901|4256096|B3||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4430924|NCT00134901|4256097|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4430925|NCT00134901|4256098|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4430926|NCT00134901|4256096|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430927|NCT00134901|4256097|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430928|NCT00134901|4256098|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4430929|NCT00134784|4256107|B5|Male||Sex/Gender, Customized||participants|Number|101|101.0||||||
4430930|NCT00134784|4256108|B4|Male||Sex/Gender, Customized||participants|Number|27|27.0||||||
4430931|NCT00134784|4256109|B3|Male||Sex/Gender, Customized||participants|Number|29|29.0||||||
4430932|NCT00134784|4256110|B2|Male||Sex/Gender, Customized||participants|Number|23|23.0||||||
4430933|NCT00134784|4256111|B1|Male||Sex/Gender, Customized||participants|Number|22|22.0||||||
4430934|NCT00134784|4256107|B5|Female||Sex/Gender, Customized||participants|Number|41|41.0||||||
4430935|NCT00134784|4256108|B4|Female||Sex/Gender, Customized||participants|Number|11|11.0||||||
4430936|NCT00134784|4256109|B3|Female||Sex/Gender, Customized||participants|Number|8|8.0||||||
4430937|NCT00134784|4256110|B2|Female||Sex/Gender, Customized||participants|Number|15|15.0||||||
4430938|NCT00134784|4256111|B1|Female||Sex/Gender, Customized||participants|Number|7|7.0||||||
4430939|NCT00134784|4256107|B5|Age of Subject in Years||Age||years|Mean|63.4|63.4|Standard Deviation|10.6|10.6|||
4430940|NCT00134784|4256108|B4|Age of Subject in Years||Age||years|Mean|62.3|62.3|Standard Deviation|9.8|9.8|||
4430941|NCT00134784|4256109|B3|Age of Subject in Years||Age||years|Mean|63.1|63.1|Standard Deviation|10.2|10.2|||
4430942|NCT00134784|4256110|B2|Age of Subject in Years||Age||years|Mean|64.5|64.5|Standard Deviation|11.8|11.8|||
4430943|NCT00134784|4256111|B1|Age of Subject in Years||Age||years|Mean|63.9|63.9|Standard Deviation|10.5|10.5|||
4430944|NCT00134719|4256121|B4||Male|Sex: Female, Male||Participants|Count of Participants|554|554.0||||||
4430945|NCT00134719|4256122|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4430946|NCT00134719|4256123|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4430947|NCT00134719|4256124|B1||Male|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4430948|NCT00134719|4256121|B4||Female|Sex: Female, Male||Participants|Count of Participants|549|549.0||||||
4430949|NCT00134719|4256122|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4430950|NCT00134719|4256123|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4430951|NCT00134719|4256124|B1||Female|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
4430952|NCT00134719|4256121|B4|||Age||Days|Mean|61.2|61.2|Standard Deviation|7.46|7.46|||
4430953|NCT00134719|4256122|B3|||Age||Days|Mean|61.5|61.5|Standard Deviation|7.95|7.95|||
4430954|NCT00134719|4256123|B2|||Age||Days|Mean|61.5|61.5|Standard Deviation|7.22|7.22|||
4430955|NCT00134719|4256124|B1|||Age||Days|Mean|61.0|61.0|Standard Deviation|7.38|7.38|||
4430956|NCT00134563|4256254|B4|> 3.5||Baseline EDSS total score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|249|249.0||||||
4430957|NCT00134563|4256255|B3|> 3.5||Baseline EDSS total score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|82|82.0||||||
4430958|NCT00134563|4256256|B2|> 3.5||Baseline EDSS total score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|85|85.0||||||
4430959|NCT00134563|4256257|B1|> 3.5||Baseline EDSS total score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|82|82.0||||||
4430960|NCT00134563|4256254|B4|≤ 3.5||Baseline EDSS total score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|837|837.0||||||
4430961|NCT00134563|4256255|B3|≤ 3.5||Baseline EDSS total score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|276|276.0||||||
4430962|NCT00134563|4256256|B2|≤ 3.5||Baseline EDSS total score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|280|280.0||||||
4430963|NCT00134563|4256257|B1|≤ 3.5||Baseline EDSS total score|"EDSS is an ordinal scale in half-point increments that qualifies disability in patients with MS. It consists of 8 ordinal rating scales assessing seven functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation.~EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS)."|participants|Number|281|281.0||||||
4430964|NCT00134563|4256254|B4|No||MS medication in the past 2 years||participants|Number|792|792.0||||||
4430965|NCT00134563|4256255|B3|No||MS medication in the past 2 years||participants|Number|256|256.0||||||
4430966|NCT00134563|4256256|B2|No||MS medication in the past 2 years||participants|Number|263|263.0||||||
4430967|NCT00134563|4256257|B1|No||MS medication in the past 2 years||participants|Number|273|273.0||||||
4430968|NCT00134563|4256254|B4|Yes||MS medication in the past 2 years||participants|Number|294|294.0||||||
4430969|NCT00134563|4256255|B3|Yes||MS medication in the past 2 years||participants|Number|102|102.0||||||
4430970|NCT00134563|4256256|B2|Yes||MS medication in the past 2 years||participants|Number|102|102.0||||||
4430971|NCT00134563|4256257|B1|Yes||MS medication in the past 2 years||participants|Number|90|90.0||||||
4430972|NCT00134563|4256254|B4|Progressive Relapsing||MS subtype||participants|Number|42|42.0||||||
4430973|NCT00134563|4256255|B3|Progressive Relapsing||MS subtype||participants|Number|14|14.0||||||
4430974|NCT00134563|4256256|B2|Progressive Relapsing||MS subtype||participants|Number|16|16.0||||||
4430975|NCT00134563|4256257|B1|Progressive Relapsing||MS subtype||participants|Number|12|12.0||||||
4430976|NCT00134563|4256254|B4|Secondary Progressive||MS subtype||participants|Number|51|51.0||||||
4430977|NCT00134563|4256255|B3|Secondary Progressive||MS subtype||participants|Number|12|12.0||||||
4430978|NCT00134563|4256256|B2|Secondary Progressive||MS subtype||participants|Number|17|17.0||||||
4430979|NCT00134563|4256257|B1|Secondary Progressive||MS subtype||participants|Number|22|22.0||||||
4430980|NCT00134563|4256254|B4|Relapsing Remitting||MS subtype||participants|Number|993|993.0||||||
4430981|NCT00134563|4256255|B3|Relapsing Remitting||MS subtype||participants|Number|332|332.0||||||
4430982|NCT00134563|4256256|B2|Relapsing Remitting||MS subtype||participants|Number|332|332.0||||||
4430983|NCT00134563|4256257|B1|Relapsing Remitting||MS subtype||participants|Number|329|329.0||||||
4430984|NCT00134563|4256254|B4|||Time since most recent MS relapse onset||months|Mean|6.35|6.35|Standard Deviation|3.54|3.54|||
4430985|NCT00134563|4256255|B3|||Time since most recent MS relapse onset||months|Mean|6.50|6.5|Standard Deviation|3.71|3.71|||
4430986|NCT00134563|4256256|B2|||Time since most recent MS relapse onset||months|Mean|6.29|6.29|Standard Deviation|3.29|3.29|||
4430987|NCT00134563|4256257|B1|||Time since most recent MS relapse onset||months|Mean|6.28|6.28|Standard Deviation|3.62|3.62|||
4430988|NCT00134563|4256254|B4|Within the past 2 years||Number of MS relapses||MS relapses|Median|2|2.0|Full Range|||1.0|12.0|
4430989|NCT00134563|4256255|B3|Within the past 2 years||Number of MS relapses||MS relapses|Median|2|2.0|Full Range|||1.0|9.0|
4430990|NCT00134563|4256256|B2|Within the past 2 years||Number of MS relapses||MS relapses|Median|2|2.0|Full Range|||1.0|12.0|
4430991|NCT00134563|4256257|B1|Within the past 2 years||Number of MS relapses||MS relapses|Median|2|2.0|Full Range|||1.0|7.0|
4430992|NCT00134563|4256254|B4|Within the past year||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|6.0|
4430993|NCT00134563|4256255|B3|Within the past year||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|4.0|
4430994|NCT00134563|4256256|B2|Within the past year||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|6.0|
4430995|NCT00134563|4256257|B1|Within the past year||Number of MS relapses||MS relapses|Median|1|1.0|Full Range|||0.0|6.0|
4430996|NCT00134563|4256254|B4|||Time since first diagnosis of multiple sclerosis (MS)|The information was missing for one participant in the Teriflunomide 7 mg group.|Years|Mean|5.33|5.33|Standard Deviation|5.48|5.48|||
4430997|NCT00134563|4256255|B3|||Time since first diagnosis of multiple sclerosis (MS)|The information was missing for one participant in the Teriflunomide 7 mg group.|Years|Mean|5.59|5.59|Standard Deviation|5.44|5.44|||
4430998|NCT00134563|4256256|B2|||Time since first diagnosis of multiple sclerosis (MS)|The information was missing for one participant in the Teriflunomide 7 mg group.|Years|Mean|5.29|5.29|Standard Deviation|5.36|5.36|||
4430999|NCT00134563|4256257|B1|||Time since first diagnosis of multiple sclerosis (MS)|The information was missing for one participant in the Teriflunomide 7 mg group.|Years|Mean|5.13|5.13|Standard Deviation|5.59|5.59|||
4431000|NCT00134563|4256254|B4|Western Europe||Region of enrollment|"America: Canada, Chile, and United States;~Eastern Europe: Czech Republic, Estonia, Poland, Russia and Ukraine;~Western Europe: Austria, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Sweden, Switzerland, Turkey, and United Kingdom;"|participants|Number|503|503.0||||||
4431001|NCT00134563|4256255|B3|Western Europe||Region of enrollment|"America: Canada, Chile, and United States;~Eastern Europe: Czech Republic, Estonia, Poland, Russia and Ukraine;~Western Europe: Austria, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Sweden, Switzerland, Turkey, and United Kingdom;"|participants|Number|170|170.0||||||
4431002|NCT00134563|4256256|B2|Western Europe||Region of enrollment|"America: Canada, Chile, and United States;~Eastern Europe: Czech Republic, Estonia, Poland, Russia and Ukraine;~Western Europe: Austria, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Sweden, Switzerland, Turkey, and United Kingdom;"|participants|Number|166|166.0||||||
4431003|NCT00134563|4256257|B1|Western Europe||Region of enrollment|"America: Canada, Chile, and United States;~Eastern Europe: Czech Republic, Estonia, Poland, Russia and Ukraine;~Western Europe: Austria, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Sweden, Switzerland, Turkey, and United Kingdom;"|participants|Number|167|167.0||||||
4431004|NCT00134563|4256254|B4|Eastern Europe||Region of enrollment|"America: Canada, Chile, and United States;~Eastern Europe: Czech Republic, Estonia, Poland, Russia and Ukraine;~Western Europe: Austria, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Sweden, Switzerland, Turkey, and United Kingdom;"|participants|Number|338|338.0||||||
4431005|NCT00134563|4256255|B3|Eastern Europe||Region of enrollment|"America: Canada, Chile, and United States;~Eastern Europe: Czech Republic, Estonia, Poland, Russia and Ukraine;~Western Europe: Austria, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Sweden, Switzerland, Turkey, and United Kingdom;"|participants|Number|108|108.0||||||
4431006|NCT00134563|4256256|B2|Eastern Europe||Region of enrollment|"America: Canada, Chile, and United States;~Eastern Europe: Czech Republic, Estonia, Poland, Russia and Ukraine;~Western Europe: Austria, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Sweden, Switzerland, Turkey, and United Kingdom;"|participants|Number|116|116.0||||||
4431007|NCT00134563|4256257|B1|Eastern Europe||Region of enrollment|"America: Canada, Chile, and United States;~Eastern Europe: Czech Republic, Estonia, Poland, Russia and Ukraine;~Western Europe: Austria, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Sweden, Switzerland, Turkey, and United Kingdom;"|participants|Number|114|114.0||||||
4431008|NCT00134563|4256254|B4|America||Region of enrollment|"America: Canada, Chile, and United States;~Eastern Europe: Czech Republic, Estonia, Poland, Russia and Ukraine;~Western Europe: Austria, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Sweden, Switzerland, Turkey, and United Kingdom;"|participants|Number|245|245.0||||||
4431009|NCT00134563|4256255|B3|America||Region of enrollment|"America: Canada, Chile, and United States;~Eastern Europe: Czech Republic, Estonia, Poland, Russia and Ukraine;~Western Europe: Austria, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Sweden, Switzerland, Turkey, and United Kingdom;"|participants|Number|80|80.0||||||
4431010|NCT00134563|4256256|B2|America||Region of enrollment|"America: Canada, Chile, and United States;~Eastern Europe: Czech Republic, Estonia, Poland, Russia and Ukraine;~Western Europe: Austria, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Sweden, Switzerland, Turkey, and United Kingdom;"|participants|Number|83|83.0||||||
4431011|NCT00134563|4256257|B1|America||Region of enrollment|"America: Canada, Chile, and United States;~Eastern Europe: Czech Republic, Estonia, Poland, Russia and Ukraine;~Western Europe: Austria, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Sweden, Switzerland, Turkey, and United Kingdom;"|participants|Number|82|82.0||||||
4431012|NCT00134563|4256254|B4||Male|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4431013|NCT00134563|4256255|B3||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4431014|NCT00134563|4256256|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4431015|NCT00134563|4256257|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4431016|NCT00134563|4256254|B4||Female|Sex: Female, Male||Participants|Count of Participants|783|783.0||||||
4431017|NCT00134563|4256255|B3||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4431018|NCT00134563|4256256|B2||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4431019|NCT00134563|4256257|B1||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4431020|NCT00134563|4256254|B4|||Age|Baseline characteristics of the population included in analyses|years|Mean|37.9|37.9|Standard Deviation|8.8|8.8|||
4431021|NCT00134563|4256255|B3|||Age|Baseline characteristics of the population included in analyses|years|Mean|37.8|37.8|Standard Deviation|8.2|8.2|||
4431022|NCT00134563|4256256|B2|||Age|Baseline characteristics of the population included in analyses|years|Mean|37.5|37.5|Standard Deviation|9.0|9.0|||
4431023|NCT00134563|4256257|B1|||Age|Baseline characteristics of the population included in analyses|years|Mean|38.4|38.4|Standard Deviation|9.0|9.0|||
4431024|NCT00134381|4256282|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4431025|NCT00134381|4256282|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431026|NCT00134381|4256282|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431027|NCT00134381|4256282|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4431028|NCT00134381|4256282|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4431029|NCT00134381|4256282|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431030|NCT00134381|4256282|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4431031|NCT00134381|4256282|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431032|NCT00134381|4256282|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431033|NCT00134381|4256282|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4431034|NCT00134381|4256282|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4431035|NCT00134381|4256282|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4431036|NCT00134381|4256282|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4431037|NCT00134381|4256282|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431038|NCT00134381|4256282|B1||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4431039|NCT00134381|4256282|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431040|NCT00134056|4256320|B3||Missing|Gleason score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|68|68.0||||||
4431041|NCT00134056|4256321|B2||Missing|Gleason score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|30|30.0||||||
4431042|NCT00134056|4256322|B1||Missing|Gleason score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|38|38.0||||||
4431043|NCT00134056|4256320|B3||8-10|Gleason score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|547|547.0||||||
4431044|NCT00134056|4256321|B2||8-10|Gleason score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|275|275.0||||||
4431045|NCT00134056|4256322|B1||8-10|Gleason score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|272|272.0||||||
4431058|NCT00134056|4256320|B3|||Previous prostatectomy||Participants|Count of Participants|313|313.0||||||
4431059|NCT00134056|4256321|B2|||Previous prostatectomy||Participants|Count of Participants|168|168.0||||||
4431060|NCT00134056|4256322|B1|||Previous prostatectomy||Participants|Count of Participants|145|145.0||||||
4431046|NCT00134056|4256320|B3||7|Gleason score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|278|278.0||||||
4431047|NCT00134056|4256321|B2||7|Gleason score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|141|141.0||||||
4431048|NCT00134056|4256322|B1||7|Gleason score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|137|137.0||||||
4431049|NCT00134056|4256320|B3||5-6|Gleason score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|101|101.0||||||
4431050|NCT00134056|4256321|B2||5-6|Gleason score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|52|52.0||||||
4431051|NCT00134056|4256322|B1||5-6|Gleason score|"Pathologists grade prostate cancers using numbers from 1 to 5 based on how much the cells in the cancerous tissue look like normal tissue. This is called the Gleason system.~If the cancerous tissue looks like normal tissue, a grade of 1 is assigned. If the cancer cells look very abnormal, a grade of 5 is assigned. Grades 2-4 have features in between these extremes.~Since prostate cancers often have areas with different grades, a grade is assigned to the 2 areas that make up most of the cancer. These 2 grades are added to yield the Gleason score. The highest a Gleason score can be is 10."|Participants|Count of Participants|49|49.0||||||
4431052|NCT00134056|4256320|B3||0-1|Performance status|"SWOG Performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~= Capable of limited self-care, confined to bed or chair more than 50% of waking hours."|Participants|Count of Participants|919|919.0||||||
4431053|NCT00134056|4256321|B2||0-1|Performance status|"SWOG Performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~= Capable of limited self-care, confined to bed or chair more than 50% of waking hours."|Participants|Count of Participants|462|462.0||||||
4431054|NCT00134056|4256322|B1||0-1|Performance status|"SWOG Performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~= Capable of limited self-care, confined to bed or chair more than 50% of waking hours."|Participants|Count of Participants|457|457.0||||||
4431055|NCT00134056|4256320|B3||2-3|Performance status|"SWOG Performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~= Capable of limited self-care, confined to bed or chair more than 50% of waking hours."|Participants|Count of Participants|75|75.0||||||
4431056|NCT00134056|4256321|B2||2-3|Performance status|"SWOG Performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~= Capable of limited self-care, confined to bed or chair more than 50% of waking hours."|Participants|Count of Participants|36|36.0||||||
4431057|NCT00134056|4256322|B1||2-3|Performance status|"SWOG Performance status:~0 = Fully active, able to carry on all pre-disease performance without restriction.~= Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.~= Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.~= Capable of limited self-care, confined to bed or chair more than 50% of waking hours."|Participants|Count of Participants|39|39.0||||||
4431061|NCT00134056|4256320|B3||Extraskeletal|Metastases||Participants|Count of Participants|93|93.0||||||
4431062|NCT00134056|4256321|B2||Extraskeletal|Metastases||Participants|Count of Participants|45|45.0||||||
4431063|NCT00134056|4256322|B1||Extraskeletal|Metastases||Participants|Count of Participants|48|48.0||||||
4431064|NCT00134056|4256320|B3||Lung, liver or brain|Metastases||Participants|Count of Participants|195|195.0||||||
4431065|NCT00134056|4256321|B2||Lung, liver or brain|Metastases||Participants|Count of Participants|101|101.0||||||
4431066|NCT00134056|4256322|B1||Lung, liver or brain|Metastases||Participants|Count of Participants|94|94.0||||||
4431067|NCT00134056|4256320|B3||Lymph nodes|Metastases||Participants|Count of Participants|297|297.0||||||
4431068|NCT00134056|4256321|B2||Lymph nodes|Metastases||Participants|Count of Participants|149|149.0||||||
4431069|NCT00134056|4256322|B1||Lymph nodes|Metastases||Participants|Count of Participants|148|148.0||||||
4431070|NCT00134056|4256320|B3||Skeletal only|Metastases||Participants|Count of Participants|409|409.0||||||
4431071|NCT00134056|4256321|B2||Skeletal only|Metastases||Participants|Count of Participants|203|203.0||||||
4431072|NCT00134056|4256322|B1||Skeletal only|Metastases||Participants|Count of Participants|206|206.0||||||
4431073|NCT00134056|4256320|B3||<4|Brief Pain Inventory, worst pain|score >=4 vs <4 in the Brief Pain Inventory scale for worst pain|Participants|Count of Participants|571|571.0||||||
4431074|NCT00134056|4256321|B2||<4|Brief Pain Inventory, worst pain|score >=4 vs <4 in the Brief Pain Inventory scale for worst pain|Participants|Count of Participants|288|288.0||||||
4431075|NCT00134056|4256322|B1||<4|Brief Pain Inventory, worst pain|score >=4 vs <4 in the Brief Pain Inventory scale for worst pain|Participants|Count of Participants|283|283.0||||||
4431076|NCT00134056|4256320|B3||>= 4|Brief Pain Inventory, worst pain|score >=4 vs <4 in the Brief Pain Inventory scale for worst pain|Participants|Count of Participants|423|423.0||||||
4431077|NCT00134056|4256321|B2||>= 4|Brief Pain Inventory, worst pain|score >=4 vs <4 in the Brief Pain Inventory scale for worst pain|Participants|Count of Participants|210|210.0||||||
4431078|NCT00134056|4256322|B1||>= 4|Brief Pain Inventory, worst pain|score >=4 vs <4 in the Brief Pain Inventory scale for worst pain|Participants|Count of Participants|213|213.0||||||
4431079|NCT00134056|4256320|B3|||Bisphosphonate use at study entry||Participants|Count of Participants|609|609.0||||||
4431080|NCT00134056|4256321|B2|||Bisphosphonate use at study entry||Participants|Count of Participants|304|304.0||||||
4431081|NCT00134056|4256322|B1|||Bisphosphonate use at study entry||Participants|Count of Participants|305|305.0||||||
4431082|NCT00134056|4256320|B3||PSA increase only|Type of Progression at study entry||Participants|Count of Participants|193|193.0||||||
4431083|NCT00134056|4256321|B2||PSA increase only|Type of Progression at study entry||Participants|Count of Participants|91|91.0||||||
4431084|NCT00134056|4256322|B1||PSA increase only|Type of Progression at study entry||Participants|Count of Participants|102|102.0||||||
4431085|NCT00134056|4256320|B3||Measurable or evaluable|Type of Progression at study entry||Participants|Count of Participants|801|801.0||||||
4431086|NCT00134056|4256321|B2||Measurable or evaluable|Type of Progression at study entry||Participants|Count of Participants|407|407.0||||||
4431087|NCT00134056|4256322|B1||Measurable or evaluable|Type of Progression at study entry||Participants|Count of Participants|394|394.0||||||
4431088|NCT00134056|4256320|B3|||Serum PSA||ug/L|Median|72.7|72.7|Inter-Quartile Range|||24.4|213.8|
4431089|NCT00134056|4256321|B2|||Serum PSA||ug/L|Median|79.0|79.0|Inter-Quartile Range|||23.5|228.3|
4431090|NCT00134056|4256322|B1|||Serum PSA||ug/L|Median|67.7|67.7|Inter-Quartile Range|||24.6|202.4|
4431091|NCT00134056|4256320|B3|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|24|24.0||||||
4431092|NCT00134056|4256321|B2|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4431093|NCT00134056|4256322|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4431094|NCT00134056|4256320|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4431095|NCT00134056|4256321|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4431096|NCT00134056|4256322|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4431097|NCT00134056|4256320|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|137|137.0||||||
4431098|NCT00134056|4256321|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
4431099|NCT00134056|4256322|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|64|64.0||||||
4431100|NCT00134056|4256320|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|806|806.0||||||
4431101|NCT00134056|4256321|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|403|403.0||||||
4431102|NCT00134056|4256322|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|403|403.0||||||
4431103|NCT00134056|4256320|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431104|NCT00134056|4256321|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431105|NCT00134056|4256322|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431106|NCT00134056|4256320|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|953|953.0||||||
4431107|NCT00134056|4256321|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|477|477.0||||||
4431108|NCT00134056|4256322|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|476|476.0||||||
4431109|NCT00134056|4256320|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4431110|NCT00134056|4256321|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4431111|NCT00134056|4256322|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4431112|NCT00134056|4256320|B3||Male|Sex: Female, Male||Participants|Count of Participants|994|994.0||||||
4431113|NCT00134056|4256321|B2||Male|Sex: Female, Male||Participants|Count of Participants|498|498.0||||||
4431114|NCT00134056|4256322|B1||Male|Sex: Female, Male||Participants|Count of Participants|496|496.0||||||
4431115|NCT00134056|4256320|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431116|NCT00134056|4256321|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431117|NCT00134056|4256322|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431118|NCT00134056|4256320|B3|||Age||years|Median|69|69.0|Full Range|||40.0|92.0|
4431119|NCT00134056|4256321|B2|||Age||years|Median|69|69.0|Full Range|||40.0|92.0|
4431120|NCT00134056|4256322|B1|||Age||years|Median|69|69.0|Full Range|||43.0|89.0|
4431121|NCT00134043|4256343|B3|MTC||Pathology of thyroid carcinoma||participants|Number|3|3.0||||||
4431122|NCT00134043|4256344|B2|MTC||Pathology of thyroid carcinoma||participants|Number|3|3.0||||||
4431123|NCT00134043|4256345|B1|MTC||Pathology of thyroid carcinoma||participants|Number|0|0.0||||||
4431124|NCT00134043|4256343|B3|Hurthle cell||Pathology of thyroid carcinoma||participants|Number|1|1.0||||||
4431125|NCT00134043|4256344|B2|Hurthle cell||Pathology of thyroid carcinoma||participants|Number|0|0.0||||||
4431126|NCT00134043|4256345|B1|Hurthle cell||Pathology of thyroid carcinoma||participants|Number|1|1.0||||||
4431127|NCT00134043|4256343|B3|FTC||Pathology of thyroid carcinoma||participants|Number|1|1.0||||||
4431128|NCT00134043|4256344|B2|FTC||Pathology of thyroid carcinoma||participants|Number|0|0.0||||||
4431129|NCT00134043|4256345|B1|FTC||Pathology of thyroid carcinoma||participants|Number|1|1.0||||||
4431130|NCT00134043|4256343|B3|Follicular variant of PTC||Pathology of thyroid carcinoma||participants|Number|2|2.0||||||
4431131|NCT00134043|4256344|B2|Follicular variant of PTC||Pathology of thyroid carcinoma||participants|Number|0|0.0||||||
4431132|NCT00134043|4256345|B1|Follicular variant of PTC||Pathology of thyroid carcinoma||participants|Number|2|2.0||||||
4431133|NCT00134043|4256343|B3|Classic PTC||Pathology of thyroid carcinoma||participants|Number|12|12.0||||||
4431134|NCT00134043|4256344|B2|Classic PTC||Pathology of thyroid carcinoma||participants|Number|0|0.0||||||
4431135|NCT00134043|4256345|B1|Classic PTC||Pathology of thyroid carcinoma||participants|Number|12|12.0||||||
4431136|NCT00134043|4256343|B3|Cytotoxic chemotherapy||Previous therapies||number of|Number|8|8.0||||||
4431137|NCT00134043|4256344|B2|Cytotoxic chemotherapy||Previous therapies||number of|Number|2|2.0||||||
4431138|NCT00134043|4256345|B1|Cytotoxic chemotherapy||Previous therapies||number of|Number|6|6.0||||||
4431139|NCT00134043|4256343|B3|External beam radiation||Previous therapies||number of|Number|8|8.0||||||
4431140|NCT00134043|4256344|B2|External beam radiation||Previous therapies||number of|Number|2|2.0||||||
4431141|NCT00134043|4256345|B1|External beam radiation||Previous therapies||number of|Number|6|6.0||||||
4431142|NCT00134043|4256343|B3|Iodin-131||Previous therapies||number of|Number|16|16.0||||||
4431143|NCT00134043|4256344|B2|Iodin-131||Previous therapies||number of|Number|0|0.0||||||
4431144|NCT00134043|4256345|B1|Iodin-131||Previous therapies||number of|Number|16|16.0||||||
4431145|NCT00134043|4256343|B3|Surgery||Previous therapies||number of|Number|18|18.0||||||
4431146|NCT00134043|4256344|B2|Surgery||Previous therapies||number of|Number|3|3.0||||||
4431147|NCT00134043|4256345|B1|Surgery||Previous therapies||number of|Number|15|15.0||||||
4431148|NCT00134043|4256343|B3|More than 2 sites||Site of metastasis||participants|Number|5|5.0||||||
4431149|NCT00134043|4256344|B2|More than 2 sites||Site of metastasis||participants|Number|2|2.0||||||
4431150|NCT00134043|4256345|B1|More than 2 sites||Site of metastasis||participants|Number|3|3.0||||||
4431151|NCT00134043|4256343|B3|1-2 sites||Site of metastasis||participants|Number|14|14.0||||||
4431152|NCT00134043|4256344|B2|1-2 sites||Site of metastasis||participants|Number|1|1.0||||||
4431153|NCT00134043|4256345|B1|1-2 sites||Site of metastasis||participants|Number|13|13.0||||||
4431154|NCT00134043|4256343|B3|Brain||Site of metastasis||participants|Number|4|4.0||||||
4431155|NCT00134043|4256344|B2|Brain||Site of metastasis||participants|Number|0|0.0||||||
4431156|NCT00134043|4256345|B1|Brain||Site of metastasis||participants|Number|4|4.0||||||
4431157|NCT00134043|4256343|B3|Bones||Site of metastasis||participants|Number|6|6.0||||||
4431158|NCT00134043|4256344|B2|Bones||Site of metastasis||participants|Number|2|2.0||||||
4431159|NCT00134043|4256345|B1|Bones||Site of metastasis||participants|Number|4|4.0||||||
4431160|NCT00134043|4256343|B3|Lymph nodes||Site of metastasis||participants|Number|9|9.0||||||
4431161|NCT00134043|4256344|B2|Lymph nodes||Site of metastasis||participants|Number|1|1.0||||||
4431162|NCT00134043|4256345|B1|Lymph nodes||Site of metastasis||participants|Number|8|8.0||||||
4431163|NCT00134043|4256343|B3|Lungs||Site of metastasis||participants|Number|16|16.0||||||
4431164|NCT00134043|4256344|B2|Lungs||Site of metastasis||participants|Number|0|0.0||||||
4431165|NCT00134043|4256345|B1|Lungs||Site of metastasis||participants|Number|16|16.0||||||
4431166|NCT00134043|4256343|B3|1(restricted in physically strenuous activity)||ECOG (Eastern Cooperative Oncology Group) performance status||participants|Number|11|11.0||||||
4431167|NCT00134043|4256344|B2|1(restricted in physically strenuous activity)||ECOG (Eastern Cooperative Oncology Group) performance status||participants|Number|1|1.0||||||
4431168|NCT00134043|4256345|B1|1(restricted in physically strenuous activity)||ECOG (Eastern Cooperative Oncology Group) performance status||participants|Number|10|10.0||||||
4431169|NCT00134043|4256343|B3|0 (Fully active)||ECOG (Eastern Cooperative Oncology Group) performance status||participants|Number|8|8.0||||||
4431170|NCT00134043|4256344|B2|0 (Fully active)||ECOG (Eastern Cooperative Oncology Group) performance status||participants|Number|2|2.0||||||
4431171|NCT00134043|4256345|B1|0 (Fully active)||ECOG (Eastern Cooperative Oncology Group) performance status||participants|Number|6|6.0||||||
4431172|NCT00134043|4256343|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4431173|NCT00134043|4256344|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4431174|NCT00134043|4256345|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4431175|NCT00134043|4256343|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4431176|NCT00134043|4256344|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4431177|NCT00134043|4256345|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4431178|NCT00134043|4256343|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431179|NCT00134043|4256344|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431180|NCT00134043|4256345|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431181|NCT00134043|4256343|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431182|NCT00134043|4256344|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431183|NCT00134043|4256345|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431184|NCT00134043|4256343|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4431185|NCT00134043|4256344|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4431186|NCT00134043|4256345|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4431187|NCT00134043|4256343|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4431188|NCT00134043|4256344|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431189|NCT00134043|4256345|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4431190|NCT00134043|4256343|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431191|NCT00134043|4256344|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431192|NCT00134043|4256345|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431193|NCT00134043|4256343|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4431194|NCT00134043|4256344|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431195|NCT00134043|4256345|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4431196|NCT00134043|4256343|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431197|NCT00134043|4256344|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431198|NCT00134043|4256345|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431199|NCT00134043|4256343|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431200|NCT00134043|4256344|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431201|NCT00134043|4256345|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431202|NCT00134043|4256343|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4431203|NCT00134043|4256344|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4431204|NCT00134043|4256345|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4431205|NCT00134043|4256343|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431206|NCT00134043|4256344|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431207|NCT00134043|4256345|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431208|NCT00134043|4256343|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4431209|NCT00134043|4256344|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4431210|NCT00134043|4256345|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4431211|NCT00134043|4256343|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4431212|NCT00134043|4256344|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4431213|NCT00134043|4256345|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4431214|NCT00134043|4256343|B3|||Age||years|Median|64|64.0|Full Range|||40.0|77.0|
4431215|NCT00134043|4256344|B2|||Age||years|Median|65|65.0|Full Range|||54.0|67.0|
4431216|NCT00134043|4256345|B1|||Age||years|Median|62|62.0|Full Range|||40.0|77.0|
4431217|NCT00134017|4256351|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4431218|NCT00134017|4256351|B1||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4431219|NCT00134017|4256351|B1|||Age||years|Median|47|47.0|Full Range|||21.0|66.0|
4431220|NCT00134017|4256351|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4431221|NCT00134017|4256351|B1||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4431222|NCT00134017|4256351|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4431223|NCT00134004|4256359|B1|United States||Region of Enrollment||participants|Number|210|210.0||||||
4431224|NCT00134004|4256359|B1||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4431225|NCT00134004|4256359|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4431226|NCT00134004|4256359|B1|||Age||years|Mean|52|52.0|Full Range|||1.0|73.0|
4431227|NCT00133991|4256367|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4431228|NCT00133991|4256367|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4431229|NCT00133991|4256367|B1|||Age||years|Median|53|53.0|Full Range|||34.0|75.0|
4431230|NCT00133991|4256367|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4431231|NCT00133991|4256367|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4431232|NCT00133991|4256367|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431233|NCT00133978|4256375|B5|Switzerland||Region of Enrollment||participants|Number|12|12.0||||||
4431234|NCT00133978|4256376|B4|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4431235|NCT00133978|4256377|B3|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4431236|NCT00133978|4256378|B2|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4431237|NCT00133978|4256379|B1|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4431238|NCT00133978|4256375|B5|Belgium||Region of Enrollment||participants|Number|10|10.0||||||
4431239|NCT00133978|4256376|B4|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4431240|NCT00133978|4256377|B3|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4431241|NCT00133978|4256378|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4431242|NCT00133978|4256379|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4431243|NCT00133978|4256375|B5|Germany||Region of Enrollment||participants|Number|21|21.0||||||
4431244|NCT00133978|4256376|B4|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4431245|NCT00133978|4256377|B3|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4431246|NCT00133978|4256378|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4431247|NCT00133978|4256379|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4431248|NCT00133978|4256375|B5|United States||Region of Enrollment||participants|Number|131|131.0||||||
4431249|NCT00133978|4256376|B4|United States||Region of Enrollment||participants|Number|31|31.0||||||
4431250|NCT00133978|4256377|B3|United States||Region of Enrollment||participants|Number|34|34.0||||||
4431251|NCT00133978|4256378|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4431252|NCT00133978|4256379|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4431253|NCT00133978|4256375|B5|Canada||Region of Enrollment||participants|Number|1044|1044.0||||||
4431254|NCT00133978|4256376|B4|Canada||Region of Enrollment||participants|Number|260|260.0||||||
4431255|NCT00133978|4256377|B3|Canada||Region of Enrollment||participants|Number|263|263.0||||||
4431256|NCT00133978|4256378|B2|Canada||Region of Enrollment||participants|Number|262|262.0||||||
4431257|NCT00133978|4256379|B1|Canada||Region of Enrollment||participants|Number|259|259.0||||||
4431258|NCT00133978|4256375|B5||Male|Sex: Female, Male||Participants|Count of Participants|726|726.0||||||
4431259|NCT00133978|4256376|B4||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4431260|NCT00133978|4256377|B3||Male|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4431261|NCT00133978|4256378|B2||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4431262|NCT00133978|4256379|B1||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4431263|NCT00133978|4256375|B5||Female|Sex: Female, Male||Participants|Count of Participants|492|492.0||||||
4431264|NCT00133978|4256376|B4||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4431265|NCT00133978|4256377|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4431266|NCT00133978|4256378|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4431267|NCT00133978|4256379|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4431268|NCT00133978|4256375|B5|||Age||years|Mean|63.3|63.3|Standard Deviation|14.3|14.3|||
4431269|NCT00133978|4256376|B4|||Age||years|Mean|62.8|62.8|Standard Deviation|13.7|13.7|||
4431270|NCT00133978|4256377|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|14.0|14.0|||
4431271|NCT00133978|4256378|B2|||Age||years|Mean|63.6|63.6|Standard Deviation|14.3|14.3|||
4431272|NCT00133978|4256379|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|15.0|15.0|||
4431273|NCT00133978|4256375|B5||>=65 years|Age||Participants|Count of Participants|597|597.0||||||
4431274|NCT00133978|4256376|B4||>=65 years|Age||Participants|Count of Participants|141|141.0||||||
4431275|NCT00133978|4256377|B3||>=65 years|Age||Participants|Count of Participants|165|165.0||||||
4431276|NCT00133978|4256378|B2||>=65 years|Age||Participants|Count of Participants|151|151.0||||||
4431277|NCT00133978|4256379|B1||>=65 years|Age||Participants|Count of Participants|140|140.0||||||
4431278|NCT00133978|4256375|B5||Between 18 and 65 years|Age||Participants|Count of Participants|621|621.0||||||
4431279|NCT00133978|4256376|B4||Between 18 and 65 years|Age||Participants|Count of Participants|159|159.0||||||
4431280|NCT00133978|4256377|B3||Between 18 and 65 years|Age||Participants|Count of Participants|145|145.0||||||
4431281|NCT00133978|4256378|B2||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4431282|NCT00133978|4256379|B1||Between 18 and 65 years|Age||Participants|Count of Participants|161|161.0||||||
4431283|NCT00133978|4256375|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431284|NCT00133978|4256376|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431285|NCT00133978|4256377|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431286|NCT00133978|4256378|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431287|NCT00133978|4256379|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431288|NCT00133952|4256404|B3|France||Region of Enrollment||participants|Number|10|10.0||||||
4431289|NCT00133952|4256405|B2|France||Region of Enrollment||participants|Number|6|6.0||||||
4431290|NCT00133952|4256406|B1|France||Region of Enrollment||participants|Number|4|4.0||||||
4431291|NCT00133952|4256404|B3|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4431292|NCT00133952|4256405|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4431293|NCT00133952|4256406|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4431294|NCT00133952|4256404|B3|Germany||Region of Enrollment||participants|Number|23|23.0||||||
4431295|NCT00133952|4256405|B2|Germany||Region of Enrollment||participants|Number|10|10.0||||||
4431296|NCT00133952|4256406|B1|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4431297|NCT00133952|4256404|B3|Denmark||Region of Enrollment||participants|Number|52|52.0||||||
4431298|NCT00133952|4256405|B2|Denmark||Region of Enrollment||participants|Number|26|26.0||||||
4431299|NCT00133952|4256406|B1|Denmark||Region of Enrollment||participants|Number|26|26.0||||||
4431300|NCT00133952|4256404|B3|Romania||Region of Enrollment||participants|Number|25|25.0||||||
4431301|NCT00133952|4256405|B2|Romania||Region of Enrollment||participants|Number|12|12.0||||||
4431302|NCT00133952|4256406|B1|Romania||Region of Enrollment||participants|Number|13|13.0||||||
4431303|NCT00133952|4256404|B3|Lithuania||Region of Enrollment||participants|Number|1|1.0||||||
4431304|NCT00133952|4256405|B2|Lithuania||Region of Enrollment||participants|Number|0|0.0||||||
4431305|NCT00133952|4256406|B1|Lithuania||Region of Enrollment||participants|Number|1|1.0||||||
4431306|NCT00133952|4256404|B3|Spain||Region of Enrollment||participants|Number|18|18.0||||||
4431307|NCT00133952|4256405|B2|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4431308|NCT00133952|4256406|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4431309|NCT00133952|4256404|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4431310|NCT00133952|4256405|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4431311|NCT00133952|4256406|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4431312|NCT00133952|4256404|B3|Mexico||Region of Enrollment||participants|Number|17|17.0||||||
4431313|NCT00133952|4256405|B2|Mexico||Region of Enrollment||participants|Number|10|10.0||||||
4431314|NCT00133952|4256406|B1|Mexico||Region of Enrollment||participants|Number|7|7.0||||||
4431315|NCT00133952|4256404|B3|Portugal||Region of Enrollment||participants|Number|33|33.0||||||
4431316|NCT00133952|4256405|B2|Portugal||Region of Enrollment||participants|Number|17|17.0||||||
4431317|NCT00133952|4256406|B1|Portugal||Region of Enrollment||participants|Number|16|16.0||||||
4431318|NCT00133952|4256404|B3|United States||Region of Enrollment||participants|Number|98|98.0||||||
4431319|NCT00133952|4256405|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4431320|NCT00133952|4256406|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4431321|NCT00133952|4256404|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4431322|NCT00133952|4256405|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4431323|NCT00133952|4256406|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4431324|NCT00133952|4256404|B3|West Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4431325|NCT00133952|4256405|B2|West Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4431326|NCT00133952|4256406|B1|West Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4431327|NCT00133952|4256404|B3|East Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4431328|NCT00133952|4256405|B2|East Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4431329|NCT00133952|4256406|B1|East Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4431330|NCT00133952|4256404|B3|African Descent||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4431331|NCT00133952|4256405|B2|African Descent||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4431332|NCT00133952|4256406|B1|African Descent||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4431333|NCT00133952|4256404|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|228|228.0||||||
4431334|NCT00133952|4256405|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|111|111.0||||||
4431335|NCT00133952|4256406|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4431336|NCT00133952|4256404|B3||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4431337|NCT00133952|4256405|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4431338|NCT00133952|4256406|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4431339|NCT00133952|4256404|B3||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4431340|NCT00133952|4256405|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4431341|NCT00133952|4256406|B1||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4431342|NCT00133952|4256404|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|9.6|9.6|||
4431343|NCT00133952|4256405|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|9.9|9.9|||
4431344|NCT00133952|4256406|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|9.3|9.3|||
4431345|NCT00133809|4256429|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4431346|NCT00133809|4256429|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431347|NCT00133809|4256429|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431348|NCT00133809|4256429|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4431349|NCT00133809|4256429|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431350|NCT00133809|4256429|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431351|NCT00133809|4256429|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431352|NCT00133809|4256429|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431353|NCT00133809|4256429|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4431354|NCT00133809|4256429|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4431355|NCT00133809|4256429|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431356|NCT00133809|4256429|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4431357|NCT00133809|4256429|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431358|NCT00133705|4256436|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431359|NCT00133705|4256437|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431360|NCT00133705|4256438|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431361|NCT00133705|4256436|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4431362|NCT00133705|4256437|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4431363|NCT00133705|4256438|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4431364|NCT00133705|4256436|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|5.5|5.5|||
4431365|NCT00133705|4256437|B2|||Age||years|Mean|43.2|43.2|Standard Deviation|4.7|4.7|||
4431366|NCT00133705|4256438|B1|||Age||years|Mean|42.8|42.8|Standard Deviation|6.2|6.2|||
4431367|NCT00133705|4256436|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431368|NCT00133705|4256437|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431369|NCT00133705|4256438|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431370|NCT00133705|4256436|B3||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4431371|NCT00133705|4256437|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4431372|NCT00133705|4256438|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4431373|NCT00133705|4256436|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431374|NCT00133705|4256437|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431375|NCT00133705|4256438|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431376|NCT00133575|4256445|B8|United States||Region of Enrollment||participants|Number|72|72.0||||||
4431377|NCT00133575|4256446|B7|United States||Region of Enrollment||participants|Number|12|12.0||||||
4431378|NCT00133575|4256447|B6|United States||Region of Enrollment||participants|Number|10|10.0||||||
4431379|NCT00133575|4256448|B5|United States||Region of Enrollment||participants|Number|10|10.0||||||
4431380|NCT00133575|4256449|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4431381|NCT00133575|4256450|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4431382|NCT00133575|4256451|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4431383|NCT00133575|4256452|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4431384|NCT00133575|4256445|B8||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4431385|NCT00133575|4256446|B7||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4431386|NCT00133575|4256447|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4431387|NCT00133575|4256448|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4431388|NCT00133575|4256449|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4431389|NCT00133575|4256450|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4431390|NCT00133575|4256451|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4431391|NCT00133575|4256452|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4431392|NCT00133575|4256445|B8||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4431393|NCT00133575|4256446|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4431394|NCT00133575|4256447|B6||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4431395|NCT00133575|4256448|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4431396|NCT00133575|4256449|B4||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4431397|NCT00133575|4256450|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4431398|NCT00133575|4256451|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4431399|NCT00133575|4256452|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4431400|NCT00133575|4256445|B8|||Age||years|Mean|25.2|25.2|Standard Deviation|3.7|3.7|||
4431401|NCT00133575|4256446|B7|||Age||years|Mean|25.6|25.6|Standard Deviation|3.9|3.9|||
4431402|NCT00133575|4256447|B6|||Age||years|Mean|24.2|24.2|Standard Deviation|3.6|3.6|||
4431403|NCT00133575|4256448|B5|||Age||years|Mean|26.5|26.5|Standard Deviation|2.2|2.2|||
4431404|NCT00133575|4256449|B4|||Age||years|Mean|24.7|24.7|Standard Deviation|4.1|4.1|||
4431405|NCT00133575|4256450|B3|||Age||years|Mean|24|24.0|Standard Deviation|3.9|3.9|||
4431406|NCT00133575|4256451|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|4.7|4.7|||
4431407|NCT00133575|4256452|B1|||Age||years|Mean|24.3|24.3|Standard Deviation|3.1|3.1|||
4431408|NCT00133575|4256445|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431409|NCT00133575|4256446|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431410|NCT00133575|4256447|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431411|NCT00133575|4256448|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431412|NCT00133575|4256449|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431413|NCT00133575|4256450|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431414|NCT00133575|4256451|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431415|NCT00133575|4256452|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431416|NCT00133575|4256445|B8||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4431417|NCT00133575|4256446|B7||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4431418|NCT00133575|4256447|B6||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4431419|NCT00133575|4256448|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4431420|NCT00133575|4256449|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4431421|NCT00133575|4256450|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4431422|NCT00133575|4256451|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4431423|NCT00133575|4256452|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4431424|NCT00133575|4256445|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431425|NCT00133575|4256446|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431426|NCT00133575|4256447|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431427|NCT00133575|4256448|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431428|NCT00133575|4256449|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431429|NCT00133575|4256450|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431430|NCT00133575|4256451|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431431|NCT00133575|4256452|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431432|NCT00132873|4256565|B1|Canada||Region of Enrollment||participants|Number|59|59.0||||||
4431433|NCT00132873|4256565|B1|Male||Gender||participants|Number|17|17.0||||||
4431434|NCT00132873|4256565|B1|Female||Gender||participants|Number|41|41.0||||||
4431435|NCT00132873|4256565|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|15.37|15.37|||
4431436|NCT00132808|4256570|B4||Male|Sex: Female, Male|Data presented for Overall number of Participants and Gender include participants from both strata of the study.|Participants|Count of Participants|0|0.0||||||
4431437|NCT00132808|4256571|B3||Male|Sex: Female, Male|Data presented for Overall number of Participants and Gender include participants from both strata of the study.|Participants|Count of Participants|0|0.0||||||
4431438|NCT00132808|4256572|B2||Male|Sex: Female, Male|Data presented for Overall number of Participants and Gender include participants from both strata of the study.|Participants|Count of Participants|0|0.0||||||
4431439|NCT00132808|4256573|B1||Male|Sex: Female, Male|Data presented for Overall number of Participants and Gender include participants from both strata of the study.|Participants|Count of Participants|0|0.0||||||
4431440|NCT00132808|4256570|B4||Female|Sex: Female, Male|Data presented for Overall number of Participants and Gender include participants from both strata of the study.|Participants|Count of Participants|581|581.0||||||
4431441|NCT00132808|4256571|B3||Female|Sex: Female, Male|Data presented for Overall number of Participants and Gender include participants from both strata of the study.|Participants|Count of Participants|202|202.0||||||
4431442|NCT00132808|4256572|B2||Female|Sex: Female, Male|Data presented for Overall number of Participants and Gender include participants from both strata of the study.|Participants|Count of Participants|181|181.0||||||
4431443|NCT00132808|4256573|B1||Female|Sex: Female, Male|Data presented for Overall number of Participants and Gender include participants from both strata of the study.|Participants|Count of Participants|198|198.0||||||
4431444|NCT00132808|4256570|B4|Stratum II (Women >= 5 Years From Menopause)||Age||years|Mean|63.8|63.8|Standard Deviation|7.34|7.34|||
4431445|NCT00132808|4256571|B3|Stratum II (Women >= 5 Years From Menopause)||Age||years|Mean|64.2|64.2|Standard Deviation|7.65|7.65|||
4431446|NCT00132808|4256572|B2|Stratum II (Women >= 5 Years From Menopause)||Age||years|Mean|63.4|63.4|Standard Deviation|7.74|7.74|||
4431447|NCT00132808|4256573|B1|Stratum II (Women >= 5 Years From Menopause)||Age||years|Mean|63.9|63.9|Standard Deviation|6.62|6.62|||
4431448|NCT00132808|4256570|B4|Stratum I (Women < 5 Years From Menopause)||Age||years|Mean|53.9|53.9|Standard Deviation|3.68|3.68|||
4431449|NCT00132808|4256571|B3|Stratum I (Women < 5 Years From Menopause)||Age||years|Mean|54.4|54.4|Standard Deviation|3.83|3.83|||
4431450|NCT00132808|4256572|B2|Stratum I (Women < 5 Years From Menopause)||Age||years|Mean|53.7|53.7|Standard Deviation|3.59|3.59|||
4431451|NCT00132808|4256573|B1|Stratum I (Women < 5 Years From Menopause)||Age||years|Mean|53.6|53.6|Standard Deviation|3.62|3.62|||
4431452|NCT00132769|4256598|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4431453|NCT00132769|4256599|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4431454|NCT00132769|4256600|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4431455|NCT00132769|4256598|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4431456|NCT00132769|4256599|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4431457|NCT00132769|4256600|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4431458|NCT00132769|4256598|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|9.19|9.19|||
4431459|NCT00132769|4256599|B2|||Age||years|Mean|53.5|53.5|Standard Deviation|8.99|8.99|||
4431460|NCT00132769|4256600|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|9.30|9.3|||
4431461|NCT00132730|4256623|B5||Male|Sex: Female, Male||Participants|Count of Participants|437|437.0||||||
4431462|NCT00132730|4256624|B4||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4431463|NCT00132730|4256625|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4431464|NCT00132730|4256626|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4431465|NCT00132730|4256627|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4431466|NCT00132730|4256623|B5||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4431467|NCT00132730|4256624|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4431468|NCT00132730|4256625|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4431469|NCT00132730|4256626|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4431470|NCT00132730|4256627|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4431471|NCT00132730|4256623|B5|||Age, Customized|Number of Participants Between 42 and 77 Years of Age|participants|Number|604|604.0||||||
4431472|NCT00132730|4256624|B4|||Age, Customized|Number of Participants Between 42 and 77 Years of Age|participants|Number|153|153.0||||||
4431473|NCT00132730|4256625|B3|||Age, Customized|Number of Participants Between 42 and 77 Years of Age|participants|Number|153|153.0||||||
4431538|NCT00132678|4256717|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|11.81|11.81|||
4431474|NCT00132730|4256626|B2|||Age, Customized|Number of Participants Between 42 and 77 Years of Age|participants|Number|148|148.0||||||
4431475|NCT00132730|4256627|B1|||Age, Customized|Number of Participants Between 42 and 77 Years of Age|participants|Number|150|150.0||||||
4431476|NCT00132691|4256674|B3|||Visual acuity 20/200 or worse||eyes|Number|74|74.0||||||
4431477|NCT00132691|4256675|B2|||Visual acuity 20/200 or worse||eyes|Number|35|35.0||||||
4431478|NCT00132691|4256676|B1|||Visual acuity 20/200 or worse||eyes|Number|39|39.0||||||
4431479|NCT00132691|4256674|B3|||Active uveitis||eyes|Number|373|373.0||||||
4431480|NCT00132691|4256675|B2|||Active uveitis||eyes|Number|181|181.0||||||
4431481|NCT00132691|4256676|B1|||Active uveitis||eyes|Number|192|192.0||||||
4431482|NCT00132691|4256674|B3|||Visual acuity 20/40 or better||eyes|Number|238|238.0||||||
4431483|NCT00132691|4256675|B2|||Visual acuity 20/40 or better||eyes|Number|122|122.0||||||
4431484|NCT00132691|4256676|B1|||Visual acuity 20/40 or better||eyes|Number|116|116.0||||||
4431485|NCT00132691|4256674|B3|no||Associated systemic inflammatory disease||participants|Number|186|186.0||||||
4431486|NCT00132691|4256675|B2|no||Associated systemic inflammatory disease||participants|Number|93|93.0||||||
4431487|NCT00132691|4256676|B1|no||Associated systemic inflammatory disease||participants|Number|93|93.0||||||
4431488|NCT00132691|4256674|B3|Yes||Associated systemic inflammatory disease||participants|Number|69|69.0||||||
4431489|NCT00132691|4256675|B2|Yes||Associated systemic inflammatory disease||participants|Number|33|33.0||||||
4431490|NCT00132691|4256676|B1|Yes||Associated systemic inflammatory disease||participants|Number|36|36.0||||||
4431491|NCT00132691|4256674|B3|Posterior or Panuveitis||Site of uveitis||participants|Number|158|158.0||||||
4431492|NCT00132691|4256675|B2|Posterior or Panuveitis||Site of uveitis||participants|Number|79|79.0||||||
4431493|NCT00132691|4256676|B1|Posterior or Panuveitis||Site of uveitis||participants|Number|79|79.0||||||
4431494|NCT00132691|4256674|B3|Intermediate||Site of uveitis||participants|Number|97|97.0||||||
4431495|NCT00132691|4256675|B2|Intermediate||Site of uveitis||participants|Number|47|47.0||||||
4431496|NCT00132691|4256676|B1|Intermediate||Site of uveitis||participants|Number|50|50.0||||||
4431497|NCT00132691|4256674|B3|||Bilateral uveitis||participants|Number|224|224.0||||||
4431498|NCT00132691|4256675|B2|||Bilateral uveitis||participants|Number|108|108.0||||||
4431499|NCT00132691|4256676|B1|||Bilateral uveitis||participants|Number|116|116.0||||||
4431500|NCT00132691|4256674|B3|United Kingdom||Region of Enrollment||participants|Number|31|31.0||||||
4431501|NCT00132691|4256675|B2|United Kingdom||Region of Enrollment||participants|Number|16|16.0||||||
4431502|NCT00132691|4256676|B1|United Kingdom||Region of Enrollment||participants|Number|15|15.0||||||
4431503|NCT00132691|4256674|B3|Australia||Region of Enrollment||participants|Number|11|11.0||||||
4431504|NCT00132691|4256675|B2|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4431505|NCT00132691|4256676|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4431506|NCT00132691|4256674|B3|United States||Region of Enrollment||participants|Number|213|213.0||||||
4431507|NCT00132691|4256675|B2|United States||Region of Enrollment||participants|Number|104|104.0||||||
4431508|NCT00132691|4256676|B1|United States||Region of Enrollment||participants|Number|109|109.0||||||
4431509|NCT00132691|4256674|B3|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4431510|NCT00132691|4256675|B2|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4431511|NCT00132691|4256676|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4431512|NCT00132691|4256674|B3|Black||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4431513|NCT00132691|4256675|B2|Black||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4431514|NCT00132691|4256676|B1|Black||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4431515|NCT00132691|4256674|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4431516|NCT00132691|4256675|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4431517|NCT00132691|4256676|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4431518|NCT00132691|4256674|B3|White||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
4431519|NCT00132691|4256675|B2|White||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4431520|NCT00132691|4256676|B1|White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4431521|NCT00132691|4256674|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4431522|NCT00132691|4256675|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4431523|NCT00132691|4256676|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4431524|NCT00132691|4256674|B3||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4431525|NCT00132691|4256675|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4431526|NCT00132691|4256676|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4431527|NCT00132691|4256674|B3|||Age||years|Mean|46|46.0|Standard Deviation|15|15.0|||
4431528|NCT00132691|4256675|B2|||Age||years|Mean|47|47.0|Standard Deviation|15|15.0|||
4431529|NCT00132691|4256676|B1|||Age||years|Mean|46|46.0|Standard Deviation|15|15.0|||
4431530|NCT00132678|4256715|B3||Male|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4431531|NCT00132678|4256716|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4431532|NCT00132678|4256717|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4431533|NCT00132678|4256715|B3||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4431534|NCT00132678|4256716|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4431535|NCT00132678|4256717|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4431536|NCT00132678|4256715|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|12.08|12.08|||
4431537|NCT00132678|4256716|B2|||Age||years|Mean|39.2|39.2|Standard Deviation|12.40|12.4|||
4431539|NCT00132496|4256731|B3|United States||Region of Enrollment||participants|Number|111|111.0||||||
4431540|NCT00132496|4256732|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4431541|NCT00132496|4256733|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4431542|NCT00132496|4256731|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4431543|NCT00132496|4256732|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4431544|NCT00132496|4256733|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4431545|NCT00132496|4256731|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4431546|NCT00132496|4256732|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4431547|NCT00132496|4256733|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4431548|NCT00132496|4256731|B3|White||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4431549|NCT00132496|4256732|B2|White||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4431550|NCT00132496|4256733|B1|White||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4431551|NCT00132496|4256731|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4431552|NCT00132496|4256732|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4431553|NCT00132496|4256733|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4431554|NCT00132496|4256731|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4431555|NCT00132496|4256732|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4431556|NCT00132496|4256733|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4431557|NCT00132496|4256731|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4431558|NCT00132496|4256732|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4431559|NCT00132496|4256733|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4431560|NCT00132496|4256731|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4431561|NCT00132496|4256732|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4431562|NCT00132496|4256733|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4431563|NCT00132496|4256731|B3|||Age||years|Mean|14.2|14.2|Standard Deviation|1.4|1.4|||
4431564|NCT00132496|4256732|B2|||Age||years|Mean|14.1|14.1|Standard Deviation|1.5|1.5|||
4431565|NCT00132496|4256733|B1|||Age||years|Mean|14.2|14.2|Standard Deviation|1.3|1.3|||
4431566|NCT00132314|4256740|B3||Male|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
4431567|NCT00132314|4256741|B2||Male|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4431568|NCT00132314|4256742|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4431569|NCT00132314|4256740|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4431570|NCT00132314|4256741|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4431571|NCT00132314|4256742|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4431572|NCT00132314|4256740|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|9.3|9.3|||
4431573|NCT00132314|4256741|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|8.8|8.8|||
4431574|NCT00132314|4256742|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|9.7|9.7|||
4431575|NCT00132301|4256751|B3||> T3b|Pathology Stage|The T score describes how much the prostate cancer has spread within the prostate and its surrounding structures. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer. The higher the score, shows the greatest risk, which is >T3b in this analysis.|Participants|Count of Participants|103|103.0||||||
4431576|NCT00132301|4256752|B2||> T3b|Pathology Stage|The T score describes how much the prostate cancer has spread within the prostate and its surrounding structures. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer. The higher the score, shows the greatest risk, which is >T3b in this analysis.|Participants|Count of Participants|55|55.0||||||
4431577|NCT00132301|4256753|B1||> T3b|Pathology Stage|The T score describes how much the prostate cancer has spread within the prostate and its surrounding structures. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer. The higher the score, shows the greatest risk, which is >T3b in this analysis.|Participants|Count of Participants|48|48.0||||||
4431578|NCT00132301|4256751|B3||T3a|Pathology Stage|The T score describes how much the prostate cancer has spread within the prostate and its surrounding structures. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer. The higher the score, shows the greatest risk, which is >T3b in this analysis.|Participants|Count of Participants|168|168.0||||||
4431579|NCT00132301|4256752|B2||T3a|Pathology Stage|The T score describes how much the prostate cancer has spread within the prostate and its surrounding structures. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer. The higher the score, shows the greatest risk, which is >T3b in this analysis.|Participants|Count of Participants|87|87.0||||||
4431580|NCT00132301|4256753|B1||T3a|Pathology Stage|The T score describes how much the prostate cancer has spread within the prostate and its surrounding structures. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer. The higher the score, shows the greatest risk, which is >T3b in this analysis.|Participants|Count of Participants|81|81.0||||||
4431581|NCT00132301|4256751|B3||T2a, T2b, T2c|Pathology Stage|The T score describes how much the prostate cancer has spread within the prostate and its surrounding structures. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer. The higher the score, shows the greatest risk, which is >T3b in this analysis.|Participants|Count of Participants|26|26.0||||||
4431582|NCT00132301|4256752|B2||T2a, T2b, T2c|Pathology Stage|The T score describes how much the prostate cancer has spread within the prostate and its surrounding structures. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer. The higher the score, shows the greatest risk, which is >T3b in this analysis.|Participants|Count of Participants|15|15.0||||||
4431583|NCT00132301|4256753|B1||T2a, T2b, T2c|Pathology Stage|The T score describes how much the prostate cancer has spread within the prostate and its surrounding structures. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer. The higher the score, shows the greatest risk, which is >T3b in this analysis.|Participants|Count of Participants|11|11.0||||||
4431584|NCT00132301|4256751|B3||unknown or not reported|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|1|1.0||||||
4431585|NCT00132301|4256752|B2||unknown or not reported|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|1|1.0||||||
4431586|NCT00132301|4256753|B1||unknown or not reported|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|0|0.0||||||
4431587|NCT00132301|4256751|B3||cT2c|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|29|29.0||||||
4431588|NCT00132301|4256752|B2||cT2c|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|17|17.0||||||
4431589|NCT00132301|4256753|B1||cT2c|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|12|12.0||||||
4431590|NCT00132301|4256751|B3||cT2b|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|49|49.0||||||
4431591|NCT00132301|4256752|B2||cT2b|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|24|24.0||||||
4431592|NCT00132301|4256753|B1||cT2b|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|25|25.0||||||
4431593|NCT00132301|4256751|B3||cT2a|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|64|64.0||||||
4431594|NCT00132301|4256752|B2||cT2a|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|28|28.0||||||
4431595|NCT00132301|4256753|B1||cT2a|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|36|36.0||||||
4431596|NCT00132301|4256751|B3||cT1|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|154|154.0||||||
4431597|NCT00132301|4256752|B2||cT1|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|87|87.0||||||
4431598|NCT00132301|4256753|B1||cT1|Clinical Stage|cT stands for the clinical stage. The number is the stage of prostate cancer. The letter indicates further spreading of the cancer, such that 1<2a<2b<2c.|Participants|Count of Participants|67|67.0||||||
4431599|NCT00132301|4256751|B3||8-10|Prostatectomy Gleason Score|Gleason score is the grade of the tumor at prostatectomy. Scores range from 2 through 10, with higher number indicating greater risks and higher mortality. A Gleason Score of 7=3+4 means that most of the tumor is grade 3 and less is grade 4. A Gleason score of 7=4+3 means that the most of the tumor is grade 4 and less is grade 3. A Gleason score 4+3=7 tumor is more likely to grow and spread than a 3+4=7 tumor, yet not as likely as a Gleason score 8 tumor.|Participants|Count of Participants|103|103.0||||||
4431600|NCT00132301|4256752|B2||8-10|Prostatectomy Gleason Score|Gleason score is the grade of the tumor at prostatectomy. Scores range from 2 through 10, with higher number indicating greater risks and higher mortality. A Gleason Score of 7=3+4 means that most of the tumor is grade 3 and less is grade 4. A Gleason score of 7=4+3 means that the most of the tumor is grade 4 and less is grade 3. A Gleason score 4+3=7 tumor is more likely to grow and spread than a 3+4=7 tumor, yet not as likely as a Gleason score 8 tumor.|Participants|Count of Participants|57|57.0||||||
4431601|NCT00132301|4256753|B1||8-10|Prostatectomy Gleason Score|Gleason score is the grade of the tumor at prostatectomy. Scores range from 2 through 10, with higher number indicating greater risks and higher mortality. A Gleason Score of 7=3+4 means that most of the tumor is grade 3 and less is grade 4. A Gleason score of 7=4+3 means that the most of the tumor is grade 4 and less is grade 3. A Gleason score 4+3=7 tumor is more likely to grow and spread than a 3+4=7 tumor, yet not as likely as a Gleason score 8 tumor.|Participants|Count of Participants|46|46.0||||||
4431602|NCT00132301|4256751|B3||7: 4+3|Prostatectomy Gleason Score|Gleason score is the grade of the tumor at prostatectomy. Scores range from 2 through 10, with higher number indicating greater risks and higher mortality. A Gleason Score of 7=3+4 means that most of the tumor is grade 3 and less is grade 4. A Gleason score of 7=4+3 means that the most of the tumor is grade 4 and less is grade 3. A Gleason score 4+3=7 tumor is more likely to grow and spread than a 3+4=7 tumor, yet not as likely as a Gleason score 8 tumor.|Participants|Count of Participants|71|71.0||||||
4431603|NCT00132301|4256752|B2||7: 4+3|Prostatectomy Gleason Score|Gleason score is the grade of the tumor at prostatectomy. Scores range from 2 through 10, with higher number indicating greater risks and higher mortality. A Gleason Score of 7=3+4 means that most of the tumor is grade 3 and less is grade 4. A Gleason score of 7=4+3 means that the most of the tumor is grade 4 and less is grade 3. A Gleason score 4+3=7 tumor is more likely to grow and spread than a 3+4=7 tumor, yet not as likely as a Gleason score 8 tumor.|Participants|Count of Participants|36|36.0||||||
4431627|NCT00132301|4256752|B2||Unknown or not reported|Pre Biopsy PSA (ng/ml)||Participants|Count of Participants|1|1.0||||||
4431628|NCT00132301|4256753|B1||Unknown or not reported|Pre Biopsy PSA (ng/ml)||Participants|Count of Participants|1|1.0||||||
4431604|NCT00132301|4256753|B1||7: 4+3|Prostatectomy Gleason Score|Gleason score is the grade of the tumor at prostatectomy. Scores range from 2 through 10, with higher number indicating greater risks and higher mortality. A Gleason Score of 7=3+4 means that most of the tumor is grade 3 and less is grade 4. A Gleason score of 7=4+3 means that the most of the tumor is grade 4 and less is grade 3. A Gleason score 4+3=7 tumor is more likely to grow and spread than a 3+4=7 tumor, yet not as likely as a Gleason score 8 tumor.|Participants|Count of Participants|35|35.0||||||
4431605|NCT00132301|4256751|B3||7: 3+4|Prostatectomy Gleason Score|Gleason score is the grade of the tumor at prostatectomy. Scores range from 2 through 10, with higher number indicating greater risks and higher mortality. A Gleason Score of 7=3+4 means that most of the tumor is grade 3 and less is grade 4. A Gleason score of 7=4+3 means that the most of the tumor is grade 4 and less is grade 3. A Gleason score 4+3=7 tumor is more likely to grow and spread than a 3+4=7 tumor, yet not as likely as a Gleason score 8 tumor.|Participants|Count of Participants|112|112.0||||||
4431606|NCT00132301|4256752|B2||7: 3+4|Prostatectomy Gleason Score|Gleason score is the grade of the tumor at prostatectomy. Scores range from 2 through 10, with higher number indicating greater risks and higher mortality. A Gleason Score of 7=3+4 means that most of the tumor is grade 3 and less is grade 4. A Gleason score of 7=4+3 means that the most of the tumor is grade 4 and less is grade 3. A Gleason score 4+3=7 tumor is more likely to grow and spread than a 3+4=7 tumor, yet not as likely as a Gleason score 8 tumor.|Participants|Count of Participants|60|60.0||||||
4431607|NCT00132301|4256753|B1||7: 3+4|Prostatectomy Gleason Score|Gleason score is the grade of the tumor at prostatectomy. Scores range from 2 through 10, with higher number indicating greater risks and higher mortality. A Gleason Score of 7=3+4 means that most of the tumor is grade 3 and less is grade 4. A Gleason score of 7=4+3 means that the most of the tumor is grade 4 and less is grade 3. A Gleason score 4+3=7 tumor is more likely to grow and spread than a 3+4=7 tumor, yet not as likely as a Gleason score 8 tumor.|Participants|Count of Participants|52|52.0||||||
4431608|NCT00132301|4256751|B3||<= 7|Prostatectomy Gleason Score|Gleason score is the grade of the tumor at prostatectomy. Scores range from 2 through 10, with higher number indicating greater risks and higher mortality. A Gleason Score of 7=3+4 means that most of the tumor is grade 3 and less is grade 4. A Gleason score of 7=4+3 means that the most of the tumor is grade 4 and less is grade 3. A Gleason score 4+3=7 tumor is more likely to grow and spread than a 3+4=7 tumor, yet not as likely as a Gleason score 8 tumor.|Participants|Count of Participants|11|11.0||||||
4431609|NCT00132301|4256752|B2||<= 7|Prostatectomy Gleason Score|Gleason score is the grade of the tumor at prostatectomy. Scores range from 2 through 10, with higher number indicating greater risks and higher mortality. A Gleason Score of 7=3+4 means that most of the tumor is grade 3 and less is grade 4. A Gleason score of 7=4+3 means that the most of the tumor is grade 4 and less is grade 3. A Gleason score 4+3=7 tumor is more likely to grow and spread than a 3+4=7 tumor, yet not as likely as a Gleason score 8 tumor.|Participants|Count of Participants|4|4.0||||||
4431610|NCT00132301|4256753|B1||<= 7|Prostatectomy Gleason Score|Gleason score is the grade of the tumor at prostatectomy. Scores range from 2 through 10, with higher number indicating greater risks and higher mortality. A Gleason Score of 7=3+4 means that most of the tumor is grade 3 and less is grade 4. A Gleason score of 7=4+3 means that the most of the tumor is grade 4 and less is grade 3. A Gleason score 4+3=7 tumor is more likely to grow and spread than a 3+4=7 tumor, yet not as likely as a Gleason score 8 tumor.|Participants|Count of Participants|7|7.0||||||
4431611|NCT00132301|4256751|B3||8 to 10|Biopsy Gleason Score|The Gleason grading system is used to help evaluate the prognosis of men with prostate cancer using samples from a prostate biopsy. Pathological scores range from 2 through 10, with higher number indicating greater risks and higher mortality.|Participants|Count of Participants|96|96.0||||||
4431612|NCT00132301|4256752|B2||8 to 10|Biopsy Gleason Score|The Gleason grading system is used to help evaluate the prognosis of men with prostate cancer using samples from a prostate biopsy. Pathological scores range from 2 through 10, with higher number indicating greater risks and higher mortality.|Participants|Count of Participants|53|53.0||||||
4431613|NCT00132301|4256753|B1||8 to 10|Biopsy Gleason Score|The Gleason grading system is used to help evaluate the prognosis of men with prostate cancer using samples from a prostate biopsy. Pathological scores range from 2 through 10, with higher number indicating greater risks and higher mortality.|Participants|Count of Participants|43|43.0||||||
4431614|NCT00132301|4256751|B3||<= 7|Biopsy Gleason Score|The Gleason grading system is used to help evaluate the prognosis of men with prostate cancer using samples from a prostate biopsy. Pathological scores range from 2 through 10, with higher number indicating greater risks and higher mortality.|Participants|Count of Participants|201|201.0||||||
4431615|NCT00132301|4256752|B2||<= 7|Biopsy Gleason Score|The Gleason grading system is used to help evaluate the prognosis of men with prostate cancer using samples from a prostate biopsy. Pathological scores range from 2 through 10, with higher number indicating greater risks and higher mortality.|Participants|Count of Participants|104|104.0||||||
4431616|NCT00132301|4256753|B1||<= 7|Biopsy Gleason Score|The Gleason grading system is used to help evaluate the prognosis of men with prostate cancer using samples from a prostate biopsy. Pathological scores range from 2 through 10, with higher number indicating greater risks and higher mortality.|Participants|Count of Participants|97|97.0||||||
4431617|NCT00132301|4256751|B3||>=20|Pre Prostatectomy PSA (ng/ml)||Participants|Count of Participants|36|36.0||||||
4431618|NCT00132301|4256752|B2||>=20|Pre Prostatectomy PSA (ng/ml)||Participants|Count of Participants|19|19.0||||||
4431619|NCT00132301|4256753|B1||>=20|Pre Prostatectomy PSA (ng/ml)||Participants|Count of Participants|17|17.0||||||
4431620|NCT00132301|4256751|B3||10 to < 20|Pre Prostatectomy PSA (ng/ml)||Participants|Count of Participants|70|70.0||||||
4431621|NCT00132301|4256752|B2||10 to < 20|Pre Prostatectomy PSA (ng/ml)||Participants|Count of Participants|32|32.0||||||
4431622|NCT00132301|4256753|B1||10 to < 20|Pre Prostatectomy PSA (ng/ml)||Participants|Count of Participants|38|38.0||||||
4431623|NCT00132301|4256751|B3||< 10|Pre Prostatectomy PSA (ng/ml)||Participants|Count of Participants|191|191.0||||||
4431624|NCT00132301|4256752|B2||< 10|Pre Prostatectomy PSA (ng/ml)||Participants|Count of Participants|106|106.0||||||
4431625|NCT00132301|4256753|B1||< 10|Pre Prostatectomy PSA (ng/ml)||Participants|Count of Participants|85|85.0||||||
4431626|NCT00132301|4256751|B3||Unknown or not reported|Pre Biopsy PSA (ng/ml)||Participants|Count of Participants|2|2.0||||||
4431687|NCT00132301|4256752|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|5.3|5.3|||
4431629|NCT00132301|4256751|B3||>= 20|Pre Biopsy PSA (ng/ml)||Participants|Count of Participants|33|33.0||||||
4431630|NCT00132301|4256752|B2||>= 20|Pre Biopsy PSA (ng/ml)||Participants|Count of Participants|16|16.0||||||
4431631|NCT00132301|4256753|B1||>= 20|Pre Biopsy PSA (ng/ml)||Participants|Count of Participants|17|17.0||||||
4431632|NCT00132301|4256751|B3||10 to < 20|Pre Biopsy PSA (ng/ml)||Participants|Count of Participants|61|61.0||||||
4431633|NCT00132301|4256752|B2||10 to < 20|Pre Biopsy PSA (ng/ml)||Participants|Count of Participants|30|30.0||||||
4431634|NCT00132301|4256753|B1||10 to < 20|Pre Biopsy PSA (ng/ml)||Participants|Count of Participants|31|31.0||||||
4431635|NCT00132301|4256751|B3||< 10|Pre Biopsy PSA (ng/ml)||Participants|Count of Participants|201|201.0||||||
4431636|NCT00132301|4256752|B2||< 10|Pre Biopsy PSA (ng/ml)||Participants|Count of Participants|110|110.0||||||
4431637|NCT00132301|4256753|B1||< 10|Pre Biopsy PSA (ng/ml)||Participants|Count of Participants|91|91.0||||||
4431638|NCT00132301|4256751|B3||BMI >= 30|BMI||Participants|Count of Participants|109|109.0||||||
4431639|NCT00132301|4256752|B2||BMI >= 30|BMI||Participants|Count of Participants|58|58.0||||||
4431640|NCT00132301|4256753|B1||BMI >= 30|BMI||Participants|Count of Participants|51|51.0||||||
4431641|NCT00132301|4256751|B3||BMI 25 to < 30|BMI||Participants|Count of Participants|131|131.0||||||
4431642|NCT00132301|4256752|B2||BMI 25 to < 30|BMI||Participants|Count of Participants|71|71.0||||||
4431643|NCT00132301|4256753|B1||BMI 25 to < 30|BMI||Participants|Count of Participants|60|60.0||||||
4431644|NCT00132301|4256751|B3||BMI < 25|BMI||Participants|Count of Participants|57|57.0||||||
4431645|NCT00132301|4256752|B2||BMI < 25|BMI||Participants|Count of Participants|28|28.0||||||
4431646|NCT00132301|4256753|B1||BMI < 25|BMI||Participants|Count of Participants|29|29.0||||||
4431647|NCT00132301|4256751|B3|United States||Region of Enrollment||Participants|Count of Participants|297|297.0||||||
4431648|NCT00132301|4256752|B2|United States||Region of Enrollment||Participants|Count of Participants|157|157.0||||||
4431649|NCT00132301|4256753|B1|United States||Region of Enrollment||Participants|Count of Participants|140|140.0||||||
4431650|NCT00132301|4256751|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4431651|NCT00132301|4256752|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4431652|NCT00132301|4256753|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4431653|NCT00132301|4256751|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431654|NCT00132301|4256752|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431655|NCT00132301|4256753|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431656|NCT00132301|4256751|B3||White|Race (NIH/OMB)||Participants|Count of Participants|207|207.0||||||
4431657|NCT00132301|4256752|B2||White|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4431658|NCT00132301|4256753|B1||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4431659|NCT00132301|4256751|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4431660|NCT00132301|4256752|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4431661|NCT00132301|4256753|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4431662|NCT00132301|4256751|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431663|NCT00132301|4256752|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431664|NCT00132301|4256753|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431665|NCT00132301|4256751|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431666|NCT00132301|4256752|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431667|NCT00132301|4256753|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431668|NCT00132301|4256751|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431669|NCT00132301|4256752|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431670|NCT00132301|4256753|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431671|NCT00132301|4256751|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431672|NCT00132301|4256752|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431673|NCT00132301|4256753|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431674|NCT00132301|4256751|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|269|269.0||||||
4431675|NCT00132301|4256752|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|146|146.0||||||
4431676|NCT00132301|4256753|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|123|123.0||||||
4431677|NCT00132301|4256751|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4431678|NCT00132301|4256752|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4431679|NCT00132301|4256753|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4431680|NCT00132301|4256751|B3||Male|Sex: Female, Male||Participants|Count of Participants|297|297.0||||||
4431681|NCT00132301|4256752|B2||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4431682|NCT00132301|4256753|B1||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4431683|NCT00132301|4256751|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431684|NCT00132301|4256752|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431685|NCT00132301|4256753|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431686|NCT00132301|4256751|B3|||Age||years|Mean|62.27|62.27|Standard Deviation|5.6|5.6|||
4431688|NCT00132301|4256753|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|6.0|6.0|||
4431689|NCT00132301|4256751|B3||>=65 years|Age||Participants|Count of Participants|76|76.0||||||
4431690|NCT00132301|4256752|B2||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4431691|NCT00132301|4256753|B1||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4431692|NCT00132301|4256751|B3||Between 18 and 65 years|Age||Participants|Count of Participants|221|221.0||||||
4431693|NCT00132301|4256752|B2||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4431694|NCT00132301|4256753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4431695|NCT00132301|4256751|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431696|NCT00132301|4256752|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431697|NCT00132301|4256753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431698|NCT00132132|4256760|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4431699|NCT00132132|4256761|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4431700|NCT00132132|4256762|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4431701|NCT00132132|4256760|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4431702|NCT00132132|4256761|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4431703|NCT00132132|4256762|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4431704|NCT00132132|4256760|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4431705|NCT00132132|4256761|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4431706|NCT00132132|4256762|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4431707|NCT00132132|4256760|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431708|NCT00132132|4256761|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431709|NCT00132132|4256762|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431710|NCT00132132|4256760|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4431711|NCT00132132|4256761|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4431712|NCT00132132|4256762|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4431713|NCT00132132|4256760|B3||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4431714|NCT00132132|4256761|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4431715|NCT00132132|4256762|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4431716|NCT00132028|4256771|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4431717|NCT00132028|4256771|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431718|NCT00132028|4256771|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4431719|NCT00132028|4256771|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4431720|NCT00132028|4256771|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431721|NCT00132028|4256771|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4431722|NCT00132028|4256771|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4431723|NCT00132028|4256771|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4431724|NCT00132028|4256771|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4431725|NCT00132028|4256771|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4431726|NCT00132028|4256771|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4431727|NCT00132028|4256771|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4431728|NCT00132028|4256771|B1|||Age||years|Median|41.6|41.6|Full Range|||19.9|71.1|
4431729|NCT00132002|4256777|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4431730|NCT00132002|4256777|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431731|NCT00132002|4256777|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4431732|NCT00132002|4256777|B1|||Age||years|Median|60|60.0|Full Range|||37.0|89.0|
4431733|NCT00131937|4256783|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4431734|NCT00131937|4256783|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4431735|NCT00131937|4256783|B1|||Age||years|Median|69.5|69.5|Full Range|||38.0|88.0|
4431736|NCT00131911|4256789|B3|United States||Region of Enrollment||participants|Number|93|93.0||||||
4431737|NCT00131911|4256790|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4431738|NCT00131911|4256791|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4431739|NCT00131911|4256789|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4431740|NCT00131911|4256790|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4431741|NCT00131911|4256791|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4431742|NCT00131911|4256789|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4431743|NCT00131911|4256790|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4431744|NCT00131911|4256791|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4431745|NCT00131911|4256789|B3|||Age||years|Median|59|59.0|Full Range|||26.0|82.0|
4431746|NCT00131911|4256790|B2|||Age||years|Median|56.5|56.5|Full Range|||26.0|78.0|
4431747|NCT00131911|4256791|B1|||Age||years|Median|60|60.0|Full Range|||38.0|82.0|
4431748|NCT00131885|4256805|B5|United States||Region of Enrollment||participants|Number|36|36.0||||||
4431749|NCT00131885|4256806|B4|United States||Region of Enrollment||participants|Number|9|9.0||||||
4431750|NCT00131885|4256807|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4431751|NCT00131885|4256808|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4431752|NCT00131885|4256809|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4431753|NCT00131885|4256805|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431754|NCT00131885|4256806|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431755|NCT00131885|4256807|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431756|NCT00131885|4256808|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431757|NCT00131885|4256809|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431758|NCT00131885|4256805|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4431759|NCT00131885|4256806|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4431760|NCT00131885|4256807|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4431761|NCT00131885|4256808|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4431762|NCT00131885|4256809|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4431763|NCT00131885|4256805|B5|||Age||years|Mean|22.9|22.9|Standard Deviation|3.3|3.3|||
4431764|NCT00131885|4256806|B4|||Age||years|Mean|22.9|22.9|Standard Deviation|3.4|3.4|||
4431765|NCT00131885|4256807|B3|||Age||years|Mean|23|23.0|Standard Deviation|3.5|3.5|||
4431766|NCT00131885|4256808|B2|||Age||years|Mean|22.4|22.4|Standard Deviation|3.1|3.1|||
4431767|NCT00131885|4256809|B1|||Age||years|Mean|23.1|23.1|Standard Deviation|3.6|3.6|||
4431768|NCT00131885|4256805|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431769|NCT00131885|4256806|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431770|NCT00131885|4256807|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431771|NCT00131885|4256808|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431772|NCT00131885|4256809|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431773|NCT00131885|4256805|B5||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4431774|NCT00131885|4256806|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4431775|NCT00131885|4256807|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4431776|NCT00131885|4256808|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4431777|NCT00131885|4256809|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4431778|NCT00131885|4256805|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431779|NCT00131885|4256806|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431780|NCT00131885|4256807|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431781|NCT00131885|4256808|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431782|NCT00131885|4256809|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431783|NCT00131677|4256842|B3|United States||Region of Enrollment||participants|Number|400|400.0||||||
4431784|NCT00131677|4256843|B2|United States||Region of Enrollment||participants|Number|199|199.0||||||
4431785|NCT00131677|4256844|B1|United States||Region of Enrollment||participants|Number|201|201.0||||||
4431786|NCT00131677|4256842|B3||Male|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4431787|NCT00131677|4256843|B2||Male|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4431788|NCT00131677|4256844|B1||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4431789|NCT00131677|4256842|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431790|NCT00131677|4256843|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431791|NCT00131677|4256844|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431792|NCT00131677|4256842|B3|||Age||years|Mean|37.7|37.7|Standard Deviation|10.2|10.2|||
4431793|NCT00131677|4256843|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|11.0|11.0|||
4431794|NCT00131677|4256844|B1|||Age||years|Mean|38.7|38.7|Standard Deviation|9.3|9.3|||
4431795|NCT00131677|4256842|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431796|NCT00131677|4256843|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431797|NCT00131677|4256844|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431798|NCT00131677|4256842|B3||Between 18 and 65 years|Age||Participants|Count of Participants|400|400.0||||||
4431799|NCT00131677|4256843|B2||Between 18 and 65 years|Age||Participants|Count of Participants|199|199.0||||||
4431800|NCT00131677|4256844|B1||Between 18 and 65 years|Age||Participants|Count of Participants|201|201.0||||||
4431801|NCT00131677|4256842|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431802|NCT00131677|4256843|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431803|NCT00131677|4256844|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431804|NCT00131664|4256859|B4|Canada||Region of Enrollment||participants|Number|391|391.0||||||
4431805|NCT00131664|4256860|B3|Canada||Region of Enrollment||participants|Number|120|120.0||||||
4431806|NCT00131664|4256861|B2|Canada||Region of Enrollment||participants|Number|135|135.0||||||
4431807|NCT00131664|4256862|B1|Canada||Region of Enrollment||participants|Number|136|136.0||||||
4431808|NCT00131664|4256859|B4||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4431809|NCT00131664|4256860|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4431810|NCT00131664|4256861|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4431811|NCT00131664|4256862|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4431812|NCT00131664|4256859|B4||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4431813|NCT00131664|4256860|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4431814|NCT00131664|4256861|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4431815|NCT00131664|4256862|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4431816|NCT00131664|4256859|B4|||Age||years|Mean|54.6|54.6|Standard Deviation|10.7|10.7|||
4431817|NCT00131664|4256860|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|10.1|10.1|||
4431818|NCT00131664|4256861|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|11.6|11.6|||
4431819|NCT00131664|4256862|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|10.1|10.1|||
4431820|NCT00131573|4256926|B3|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4431821|NCT00131573|4256927|B2|Unknown||Sex/Gender, Customized||participants|Number|0|0.0||||||
4431822|NCT00131573|4256928|B1|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4431823|NCT00131573|4256926|B3|Male||Sex/Gender, Customized||participants|Number|12|12.0||||||
4431824|NCT00131573|4256927|B2|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
4431825|NCT00131573|4256928|B1|Male||Sex/Gender, Customized||participants|Number|6|6.0||||||
4431826|NCT00131573|4256926|B3|Female||Sex/Gender, Customized||participants|Number|72|72.0||||||
4431827|NCT00131573|4256927|B2|Female||Sex/Gender, Customized||participants|Number|33|33.0||||||
4431828|NCT00131573|4256928|B1|Female||Sex/Gender, Customized||participants|Number|39|39.0||||||
4431829|NCT00131573|4256926|B3|||Age, Customized||Years|Mean|47.35|47.35|Standard Deviation|13.53|13.53|||
4431830|NCT00131573|4256927|B2|||Age, Customized||Years|Mean|46.64|46.64|Standard Deviation|15.55|15.55|||
4431831|NCT00131573|4256928|B1|||Age, Customized||Years|Mean|47.96|47.96|Standard Deviation|11.66|11.66|||
4431832|NCT00131508|4256937|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4431833|NCT00131508|4256938|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4431834|NCT00131508|4256939|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4431835|NCT00131508|4256937|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4431836|NCT00131508|4256938|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4431837|NCT00131508|4256939|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4431838|NCT00131508|4256937|B3|||Age||years|Mean|9.1|9.1|Standard Deviation|3.2|3.2|||
4431839|NCT00131508|4256938|B2|||Age||years|Mean|9.1|9.1|Standard Deviation|3.6|3.6|||
4431840|NCT00131508|4256939|B1|||Age||years|Mean|9.1|9.1|Standard Deviation|2.9|2.9|||
4431841|NCT00131456|4256962|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
4431842|NCT00131456|4256963|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4431843|NCT00131456|4256964|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4431844|NCT00131456|4256962|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4431845|NCT00131456|4256963|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4431846|NCT00131456|4256964|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4431847|NCT00131456|4256962|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4431848|NCT00131456|4256963|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4431849|NCT00131456|4256964|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4431850|NCT00131456|4256962|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|10.1|10.1|||
4431851|NCT00131456|4256963|B2|||Age||years|Mean|34.2|34.2|Standard Deviation|10.8|10.8|||
4431852|NCT00131456|4256964|B1|||Age||years|Mean|35.9|35.9|Standard Deviation|9.3|9.3|||
4431853|NCT00131456|4256962|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431854|NCT00131456|4256963|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431855|NCT00131456|4256964|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431856|NCT00131456|4256962|B3||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4431857|NCT00131456|4256963|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4431858|NCT00131456|4256964|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4431859|NCT00131456|4256962|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431860|NCT00131456|4256963|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431861|NCT00131456|4256964|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431862|NCT00131378|4256971|B5|United States||Region of Enrollment||participants|Number|142|142.0||||||
4431863|NCT00131378|4256972|B4|United States||Region of Enrollment||participants|Number|30|30.0||||||
4431864|NCT00131378|4256973|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4431865|NCT00131378|4256974|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4431866|NCT00131378|4256975|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4431867|NCT00131378|4256971|B5||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4431868|NCT00131378|4256972|B4||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4431869|NCT00131378|4256973|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4431870|NCT00131378|4256974|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431871|NCT00131378|4256975|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431872|NCT00131378|4256971|B5||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4431873|NCT00131378|4256972|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431874|NCT00131378|4256973|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4431875|NCT00131378|4256974|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4431876|NCT00131378|4256975|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4431877|NCT00131378|4256971|B5|||Age||years|Mean|34.6|34.6|Standard Deviation|1.13|1.13|||
4431878|NCT00131378|4256972|B4|||Age||years|Mean|34.3|34.3|Standard Deviation|1.1|1.1|||
4431879|NCT00131378|4256973|B3|||Age||years|Mean|32.4|32.4|Standard Deviation|1.2|1.2|||
4431880|NCT00131378|4256974|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|1.1|1.1|||
4431881|NCT00131378|4256975|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|1.1|1.1|||
4431882|NCT00131378|4256971|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431883|NCT00131378|4256972|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431884|NCT00131378|4256973|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431885|NCT00131378|4256974|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431886|NCT00131378|4256975|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431887|NCT00131378|4256971|B5||Between 18 and 65 years|Age||Participants|Count of Participants|142|142.0||||||
4431888|NCT00131378|4256972|B4||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4431889|NCT00131378|4256973|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4431890|NCT00131378|4256974|B2||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4431891|NCT00131378|4256975|B1||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4431892|NCT00131378|4256971|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431893|NCT00131378|4256972|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431894|NCT00131378|4256973|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431895|NCT00131378|4256974|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431896|NCT00131378|4256975|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431897|NCT00131352|4257000|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4431898|NCT00131352|4257001|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4431899|NCT00131352|4257002|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4431900|NCT00131352|4257000|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4431901|NCT00131352|4257001|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4431902|NCT00131352|4257002|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4431903|NCT00131352|4257000|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4431904|NCT00131352|4257001|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4431905|NCT00131352|4257002|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4431906|NCT00131352|4257000|B3|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4431907|NCT00131352|4257001|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4431908|NCT00131352|4257002|B1|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4431909|NCT00131352|4257000|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|243|243.0||||||
4431910|NCT00131352|4257001|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4431911|NCT00131352|4257002|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|118|118.0||||||
4431912|NCT00131352|4257000|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4431913|NCT00131352|4257001|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4431914|NCT00131352|4257002|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4431915|NCT00131352|4257000|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4431916|NCT00131352|4257001|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4431917|NCT00131352|4257002|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4431918|NCT00131352|4257000|B3|||Age||years|Mean|63.0|63.0|Standard Deviation|9.40|9.4|||
4431919|NCT00131352|4257001|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|9.17|9.17|||
4431920|NCT00131352|4257002|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|9.64|9.64|||
4431921|NCT00131248|4257025|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4431922|NCT00131248|4257025|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4431923|NCT00131248|4257025|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4431924|NCT00131248|4257025|B1|||Age||years|Mean|0.1|0.1|Standard Deviation|0.06|0.06|||
4431925|NCT00131248|4257025|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431926|NCT00131248|4257025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4431927|NCT00131248|4257025|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4431928|NCT00130923|4257032|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
4431929|NCT00130923|4257033|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4431930|NCT00130923|4257034|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4431931|NCT00130923|4257032|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4431932|NCT00130923|4257033|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4431933|NCT00130923|4257034|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4431934|NCT00130923|4257032|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4431935|NCT00130923|4257033|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4431936|NCT00130923|4257034|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4431937|NCT00130923|4257032|B3|||Age||years|Mean|41.70|41.7|Standard Deviation|10.7|10.7|||
4431938|NCT00130923|4257033|B2|||Age||years|Mean|41.7|41.7|Standard Deviation|11.5|11.5|||
4431939|NCT00130923|4257034|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|10.1|10.1|||
4431940|NCT00130923|4257032|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431941|NCT00130923|4257033|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431942|NCT00130923|4257034|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4431943|NCT00130923|4257032|B3||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4431944|NCT00130923|4257033|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4431945|NCT00130923|4257034|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4431946|NCT00130923|4257032|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431947|NCT00130923|4257033|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431948|NCT00130923|4257034|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4431949|NCT00130832|4257041|B3|White||Race/Ethnicity, Customized||participants|Number|78|78.0||||||
4431950|NCT00130832|4257042|B2|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4431951|NCT00130832|4257043|B1|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4431952|NCT00130832|4257041|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4431953|NCT00130832|4257042|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4431954|NCT00130832|4257043|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4431955|NCT00130832|4257041|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|520|520.0||||||
4431956|NCT00130832|4257042|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|257|257.0||||||
4431957|NCT00130832|4257043|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|263|263.0||||||
4431958|NCT00130832|4257041|B3|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4431959|NCT00130832|4257042|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4431960|NCT00130832|4257043|B1|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4431961|NCT00130832|4257041|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4431962|NCT00130832|4257042|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4431963|NCT00130832|4257043|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4431964|NCT00130832|4257041|B3||Male|Sex: Female, Male||Participants|Count of Participants|352|352.0||||||
4431965|NCT00130832|4257042|B2||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4431966|NCT00130832|4257043|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4431967|NCT00130832|4257041|B3||Female|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4431968|NCT00130832|4257042|B2||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4431969|NCT00130832|4257043|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4431970|NCT00130832|4257041|B3|Over 12 Weeks of Age||Age, Customized||participants|Number|0|0.0||||||
4431971|NCT00130832|4257042|B2|Over 12 Weeks of Age||Age, Customized||participants|Number|0|0.0||||||
4431972|NCT00130832|4257043|B1|Over 12 Weeks of Age||Age, Customized||participants|Number|0|0.0||||||
4431973|NCT00130832|4257041|B3|6 to 12 Weeks of Age||Age, Customized||participants|Number|726|726.0||||||
4431974|NCT00130832|4257042|B2|6 to 12 Weeks of Age||Age, Customized||participants|Number|362|362.0||||||
4431975|NCT00130832|4257043|B1|6 to 12 Weeks of Age||Age, Customized||participants|Number|364|364.0||||||
4431976|NCT00130832|4257041|B3|5 Weeks of Age and Under||Age, Customized||participants|Number|9|9.0||||||
4431977|NCT00130832|4257042|B2|5 Weeks of Age and Under||Age, Customized||participants|Number|1|1.0||||||
4431978|NCT00130832|4257043|B1|5 Weeks of Age and Under||Age, Customized||participants|Number|8|8.0||||||
4431979|NCT00130793|4257054|B3|White||Race/Ethnicity||participants|Number|250|250.0||||||
4431980|NCT00130793|4257055|B2|White||Race/Ethnicity||participants|Number|126|126.0||||||
4431981|NCT00130793|4257056|B1|White||Race/Ethnicity||participants|Number|124|124.0||||||
4431982|NCT00130793|4257054|B3|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4431983|NCT00130793|4257055|B2|Native American||Race/Ethnicity||participants|Number|0|0.0||||||
4431984|NCT00130793|4257056|B1|Native American||Race/Ethnicity||participants|Number|1|1.0||||||
4431985|NCT00130793|4257054|B3|Indian||Race/Ethnicity||participants|Number|1|1.0||||||
4431986|NCT00130793|4257055|B2|Indian||Race/Ethnicity||participants|Number|0|0.0||||||
4431987|NCT00130793|4257056|B1|Indian||Race/Ethnicity||participants|Number|1|1.0||||||
4431988|NCT00130793|4257054|B3|Hispanic American||Race/Ethnicity||participants|Number|64|64.0||||||
4431989|NCT00130793|4257055|B2|Hispanic American||Race/Ethnicity||participants|Number|34|34.0||||||
4431990|NCT00130793|4257056|B1|Hispanic American||Race/Ethnicity||participants|Number|30|30.0||||||
4431991|NCT00130793|4257054|B3|Black||Race/Ethnicity||participants|Number|34|34.0||||||
4431992|NCT00130793|4257055|B2|Black||Race/Ethnicity||participants|Number|15|15.0||||||
4431993|NCT00130793|4257056|B1|Black||Race/Ethnicity||participants|Number|19|19.0||||||
4431994|NCT00130793|4257054|B3|Asiatic||Race/Ethnicity||participants|Number|5|5.0||||||
4431995|NCT00130793|4257055|B2|Asiatic||Race/Ethnicity||participants|Number|4|4.0||||||
4431996|NCT00130793|4257056|B1|Asiatic||Race/Ethnicity||participants|Number|1|1.0||||||
4431997|NCT00130793|4257054|B3|Asian||Race/Ethnicity||participants|Number|12|12.0||||||
4431998|NCT00130793|4257055|B2|Asian||Race/Ethnicity||participants|Number|6|6.0||||||
4431999|NCT00130793|4257056|B1|Asian||Race/Ethnicity||participants|Number|6|6.0||||||
4432000|NCT00130793|4257054|B3||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4432001|NCT00130793|4257055|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4432002|NCT00130793|4257056|B1||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4432003|NCT00130793|4257054|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4432004|NCT00130793|4257055|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4432005|NCT00130793|4257056|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4432006|NCT00130793|4257054|B3|||Age||years|Mean|63.35|63.35|Standard Deviation|8.83|8.83|||
4432007|NCT00130793|4257055|B2|||Age||years|Mean|63.2|63.2|Standard Deviation|8.44|8.44|||
4432008|NCT00130793|4257056|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|9.25|9.25|||
4432009|NCT00130780|4257067|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
4432010|NCT00130780|4257068|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4432011|NCT00130780|4257069|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4432012|NCT00130780|4257067|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4432013|NCT00130780|4257068|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4432014|NCT00130780|4257069|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4432015|NCT00130780|4257067|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4432016|NCT00130780|4257068|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4432017|NCT00130780|4257069|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4432018|NCT00130780|4257067|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4432019|NCT00130780|4257068|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4432020|NCT00130780|4257069|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4432021|NCT00130780|4257067|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4432022|NCT00130780|4257068|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4432023|NCT00130780|4257069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4432024|NCT00130780|4257067|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432025|NCT00130780|4257068|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432026|NCT00130780|4257069|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432027|NCT00130728|4257076|B3||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4432028|NCT00130728|4257077|B2||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4432029|NCT00130728|4257078|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4432030|NCT00130728|4257076|B3||Female|Sex: Female, Male||Participants|Count of Participants|295|295.0||||||
4432031|NCT00130728|4257077|B2||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4432032|NCT00130728|4257078|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4432033|NCT00130728|4257076|B3|>= 70 years||Age, Customized||participants|Number|215|215.0||||||
4432034|NCT00130728|4257077|B2|>= 70 years||Age, Customized||participants|Number|108|108.0||||||
4432035|NCT00130728|4257078|B1|>= 70 years||Age, Customized||participants|Number|107|107.0||||||
4432036|NCT00130728|4257076|B3|Between 65 and 69 years||Age, Customized||participants|Number|112|112.0||||||
4432037|NCT00130728|4257077|B2|Between 65 and 69 years||Age, Customized||participants|Number|53|53.0||||||
4432038|NCT00130728|4257078|B1|Between 65 and 69 years||Age, Customized||participants|Number|59|59.0||||||
4432039|NCT00130728|4257076|B3|Between 60 and 64 years||Age, Customized||participants|Number|128|128.0||||||
4432040|NCT00130728|4257077|B2|Between 60 and 64 years||Age, Customized||participants|Number|66|66.0||||||
4432041|NCT00130728|4257078|B1|Between 60 and 64 years||Age, Customized||participants|Number|62|62.0||||||
4432042|NCT00130728|4257076|B3|Between 18 and 59 years||Age, Customized||participants|Number|181|181.0||||||
4432043|NCT00130728|4257077|B2|Between 18 and 59 years||Age, Customized||participants|Number|90|90.0||||||
4432044|NCT00130728|4257078|B1|Between 18 and 59 years||Age, Customized||participants|Number|91|91.0||||||
4432045|NCT00130728|4257076|B3|||Age||years|Mean|64.9|64.9|Standard Deviation|10.4|10.4|||
4432046|NCT00130728|4257077|B2|||Age||years|Mean|65.0|65.0|Standard Deviation|10.3|10.3|||
4432047|NCT00130728|4257078|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|10.4|10.4|||
4432048|NCT00130689|4257091|B1|Gastric||Primary Tumor||participants|Number|15|15.0||||||
4432049|NCT00130689|4257091|B1|GE Junction||Primary Tumor||participants|Number|8|8.0||||||
4432050|NCT00130689|4257091|B1|Esophagael||Primary Tumor||participants|Number|12|12.0||||||
4432051|NCT00130689|4257091|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4432052|NCT00130689|4257091|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4432053|NCT00130689|4257091|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4432054|NCT00130689|4257091|B1|||Age, Customized||years|Median|61|61.0|Full Range|||42.0|81.0|
4432055|NCT00130637|4257095|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4432056|NCT00130637|4257095|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4432057|NCT00130637|4257095|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4432058|NCT00130637|4257095|B1|||Age||years|Mean|10.2|10.2|Standard Deviation|4.8|4.8|||
4432059|NCT00130637|4257095|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432060|NCT00130637|4257095|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4432061|NCT00130637|4257095|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4432062|NCT00130520|4257100|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4432063|NCT00130520|4257100|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432064|NCT00130520|4257100|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4432065|NCT00130520|4257100|B1|||Age||years|Mean|59.35|59.35|Standard Deviation|11.07|11.07|||
4432066|NCT00130520|4257100|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4432067|NCT00130520|4257100|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4432068|NCT00130520|4257100|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432069|NCT00130286|4257106|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432070|NCT00130286|4257107|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432071|NCT00130286|4257108|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432072|NCT00130286|4257109|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432073|NCT00130286|4257110|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432074|NCT00130286|4257106|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4432075|NCT00130286|4257107|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4432076|NCT00130286|4257108|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4432077|NCT00130286|4257109|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4432078|NCT00130286|4257110|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4432079|NCT00130286|4257106|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4432080|NCT00130286|4257107|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4432081|NCT00130286|4257108|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4432082|NCT00130286|4257109|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4432083|NCT00130286|4257110|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4432084|NCT00130286|4257106|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432085|NCT00130286|4257107|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432086|NCT00130286|4257108|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432087|NCT00130286|4257109|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432088|NCT00130286|4257110|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432089|NCT00130286|4257106|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4432090|NCT00130286|4257107|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4432091|NCT00130286|4257108|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432092|NCT00130286|4257109|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4432093|NCT00130286|4257110|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4432094|NCT00130286|4257106|B5||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4432095|NCT00130286|4257107|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4432096|NCT00130286|4257108|B3||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4432097|NCT00130286|4257109|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4432098|NCT00130286|4257110|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4432099|NCT00130286|4257106|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4432100|NCT00130286|4257107|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4432101|NCT00130286|4257108|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4432102|NCT00130286|4257109|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4432103|NCT00130286|4257110|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4432104|NCT00130286|4257106|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432105|NCT00130286|4257107|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432106|NCT00130286|4257108|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432107|NCT00130286|4257109|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432108|NCT00130286|4257110|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432109|NCT00130286|4257106|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432110|NCT00130286|4257107|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432111|NCT00130286|4257108|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432112|NCT00130286|4257109|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432113|NCT00130286|4257110|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432114|NCT00130286|4257106|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432115|NCT00130286|4257107|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432116|NCT00130286|4257108|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432117|NCT00130286|4257109|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432118|NCT00130286|4257110|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432119|NCT00130286|4257106|B5||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4432120|NCT00130286|4257107|B4||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4432121|NCT00130286|4257108|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4432122|NCT00130286|4257109|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4432123|NCT00130286|4257110|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4432124|NCT00130286|4257106|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4432125|NCT00130286|4257107|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4432126|NCT00130286|4257108|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4432127|NCT00130286|4257109|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4432128|NCT00130286|4257110|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4432129|NCT00130286|4257106|B5|||Age||years|Mean|47.9|47.9|Standard Deviation|7.1|7.1|||
4432130|NCT00130286|4257107|B4|||Age||years|Mean|46.6|46.6|Standard Deviation|6.7|6.7|||
4432131|NCT00130286|4257108|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|4.9|4.9|||
4432132|NCT00130286|4257109|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|6.1|6.1|||
4432133|NCT00130286|4257110|B1|||Age||years|Mean|46.8|46.8|Standard Deviation|9.4|9.4|||
4432134|NCT00130247|4257131|B3|Uganda||Region of Enrollment||participants|Number|137|137.0||||||
4432135|NCT00130247|4257132|B2|Uganda||Region of Enrollment||participants|Number|69|69.0||||||
4432136|NCT00130247|4257133|B1|Uganda||Region of Enrollment||participants|Number|68|68.0||||||
4432137|NCT00130247|4257131|B3|Brazil||Region of Enrollment||participants|Number|162|162.0||||||
4432138|NCT00130247|4257132|B2|Brazil||Region of Enrollment||participants|Number|81|81.0||||||
4432139|NCT00130247|4257133|B1|Brazil||Region of Enrollment||participants|Number|81|81.0||||||
4432140|NCT00130247|4257131|B3|Philippines||Region of Enrollment||participants|Number|95|95.0||||||
4432141|NCT00130247|4257132|B2|Philippines||Region of Enrollment||participants|Number|48|48.0||||||
4432142|NCT00130247|4257133|B1|Philippines||Region of Enrollment||participants|Number|47|47.0||||||
4432143|NCT00130247|4257131|B3||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4432144|NCT00130247|4257132|B2||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4432145|NCT00130247|4257133|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4432146|NCT00130247|4257131|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4432147|NCT00130247|4257132|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4432148|NCT00130247|4257133|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4432149|NCT00130247|4257131|B3|||Age||years|Mean|30.8|30.8|Standard Deviation|10|10.0|||
4432150|NCT00130247|4257132|B2|||Age||years|Mean|30.3|30.3|Standard Deviation|10|10.0|||
4432151|NCT00130247|4257133|B1|||Age||years|Mean|31.2|31.2|Standard Deviation|10|10.0|||
4432152|NCT00130247|4257131|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432153|NCT00130247|4257132|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432154|NCT00130247|4257133|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432155|NCT00130247|4257131|B3||Between 18 and 65 years|Age||Participants|Count of Participants|394|394.0||||||
4432156|NCT00130247|4257132|B2||Between 18 and 65 years|Age||Participants|Count of Participants|198|198.0||||||
4432157|NCT00130247|4257133|B1||Between 18 and 65 years|Age||Participants|Count of Participants|196|196.0||||||
4432158|NCT00130247|4257131|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432159|NCT00130247|4257132|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432160|NCT00130247|4257133|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432161|NCT00130208|4257150|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4432162|NCT00130208|4257151|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432163|NCT00130208|4257152|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4432164|NCT00130208|4257150|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4432165|NCT00130208|4257151|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4432166|NCT00130208|4257152|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4432167|NCT00130208|4257150|B3||White|Race (NIH/OMB)||Participants|Count of Participants|891|891.0||||||
4432168|NCT00130208|4257151|B2||White|Race (NIH/OMB)||Participants|Count of Participants|451|451.0||||||
4432169|NCT00130208|4257152|B1||White|Race (NIH/OMB)||Participants|Count of Participants|440|440.0||||||
4432170|NCT00130208|4257150|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4432171|NCT00130208|4257151|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4432172|NCT00130208|4257152|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4432173|NCT00130208|4257150|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4432174|NCT00130208|4257151|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4432175|NCT00130208|4257152|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4432176|NCT00130208|4257150|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4432177|NCT00130208|4257151|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4432178|NCT00130208|4257152|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4432179|NCT00130208|4257150|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4432180|NCT00130208|4257151|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4432242|NCT00130039|4257187|B3||>=65 years|Age||Participants|Count of Participants|252|252.0||||||
4432181|NCT00130208|4257152|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4432182|NCT00130208|4257150|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432183|NCT00130208|4257151|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432184|NCT00130208|4257152|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432185|NCT00130208|4257150|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|997|997.0||||||
4432186|NCT00130208|4257151|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|501|501.0||||||
4432187|NCT00130208|4257152|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|496|496.0||||||
4432188|NCT00130208|4257150|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4432189|NCT00130208|4257151|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4432190|NCT00130208|4257152|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4432191|NCT00130208|4257150|B3||Male|Sex: Female, Male||Participants|Count of Participants|802|802.0||||||
4432192|NCT00130208|4257151|B2||Male|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
4432193|NCT00130208|4257152|B1||Male|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
4432194|NCT00130208|4257150|B3||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4432195|NCT00130208|4257151|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4432196|NCT00130208|4257152|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4432197|NCT00130208|4257150|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|9.82|9.82|||
4432198|NCT00130208|4257151|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|9.90|9.9|||
4432199|NCT00130208|4257152|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|9.73|9.73|||
4432200|NCT00130117|4257163|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4432201|NCT00130117|4257164|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4432202|NCT00130117|4257165|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4432203|NCT00130117|4257163|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432204|NCT00130117|4257164|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432205|NCT00130117|4257165|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432206|NCT00130117|4257163|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4432207|NCT00130117|4257164|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4432208|NCT00130117|4257165|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4432209|NCT00130117|4257163|B3|||Age||years|Mean|26|26.0|Standard Deviation|1.3|1.3|||
4432210|NCT00130117|4257164|B2|||Age||years|Mean|25.4|25.4|Standard Deviation|1.2|1.2|||
4432211|NCT00130117|4257165|B1|||Age||years|Mean|26.6|26.6|Standard Deviation|1.4|1.4|||
4432212|NCT00130117|4257163|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432213|NCT00130117|4257164|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432214|NCT00130117|4257165|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432215|NCT00130117|4257163|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4432216|NCT00130117|4257164|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4432217|NCT00130117|4257165|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4432218|NCT00130117|4257163|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432219|NCT00130117|4257164|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432220|NCT00130117|4257165|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432221|NCT00130039|4257187|B3|Korea, Republic of||Region of Enrollment||participants|Number|413|413.0||||||
4432222|NCT00130039|4257188|B2|Korea, Republic of||Region of Enrollment||participants|Number|203|203.0||||||
4432223|NCT00130039|4257189|B1|Korea, Republic of||Region of Enrollment||participants|Number|210|210.0||||||
4432224|NCT00130039|4257187|B3|Thailand||Region of Enrollment||participants|Number|11|11.0||||||
4432225|NCT00130039|4257188|B2|Thailand||Region of Enrollment||participants|Number|5|5.0||||||
4432226|NCT00130039|4257189|B1|Thailand||Region of Enrollment||participants|Number|6|6.0||||||
4432227|NCT00130039|4257187|B3|Hong Kong||Region of Enrollment||participants|Number|23|23.0||||||
4432228|NCT00130039|4257188|B2|Hong Kong||Region of Enrollment||participants|Number|12|12.0||||||
4432229|NCT00130039|4257189|B1|Hong Kong||Region of Enrollment||participants|Number|11|11.0||||||
4432230|NCT00130039|4257187|B3|Philippines||Region of Enrollment||participants|Number|10|10.0||||||
4432231|NCT00130039|4257188|B2|Philippines||Region of Enrollment||participants|Number|5|5.0||||||
4432232|NCT00130039|4257189|B1|Philippines||Region of Enrollment||participants|Number|5|5.0||||||
4432233|NCT00130039|4257187|B3||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4432234|NCT00130039|4257188|B2||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4432235|NCT00130039|4257189|B1||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4432236|NCT00130039|4257187|B3||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4432237|NCT00130039|4257188|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4432238|NCT00130039|4257189|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4432239|NCT00130039|4257187|B3|||Age||years|Mean|65.52|65.52|Standard Deviation|11.24|11.24|||
4432240|NCT00130039|4257188|B2|||Age||years|Mean|64.58|64.58|Standard Deviation|11.11|11.11|||
4432241|NCT00130039|4257189|B1|||Age||years|Mean|66.42|66.42|Standard Deviation|11.33|11.33|||
4432243|NCT00130039|4257188|B2||>=65 years|Age||Participants|Count of Participants|113|113.0||||||
4432244|NCT00130039|4257189|B1||>=65 years|Age||Participants|Count of Participants|139|139.0||||||
4432245|NCT00130039|4257187|B3||Between 18 and 65 years|Age||Participants|Count of Participants|205|205.0||||||
4432246|NCT00130039|4257188|B2||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4432247|NCT00130039|4257189|B1||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4432248|NCT00130039|4257187|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432249|NCT00130039|4257188|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432250|NCT00130039|4257189|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432251|NCT00129974|4257206|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4432252|NCT00129974|4257206|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4432253|NCT00129974|4257206|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432254|NCT00129974|4257206|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432255|NCT00129974|4257206|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4432256|NCT00129974|4257206|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432257|NCT00129961|4257211|B3|||Time from Current Transplantation to Randomization||Months|Mean|112.02|112.02|Standard Deviation|55.98|55.98|||
4432258|NCT00129961|4257212|B2|||Time from Current Transplantation to Randomization||Months|Mean|109.57|109.57|Standard Deviation|55.08|55.08|||
4432259|NCT00129961|4257213|B1|||Time from Current Transplantation to Randomization||Months|Mean|114.98|114.98|Standard Deviation|57.63|57.63|||
4432260|NCT00129961|4257211|B3|6-20 Lesions in 12 months prior||Stratification Group||subjects|Number|14|14.0||||||
4432261|NCT00129961|4257212|B2|6-20 Lesions in 12 months prior||Stratification Group||subjects|Number|8|8.0||||||
4432262|NCT00129961|4257213|B1|6-20 Lesions in 12 months prior||Stratification Group||subjects|Number|6|6.0||||||
4432263|NCT00129961|4257211|B3|0-5 Lesions in 12 months prior||Stratification Group||subjects|Number|72|72.0||||||
4432264|NCT00129961|4257212|B2|0-5 Lesions in 12 months prior||Stratification Group||subjects|Number|39|39.0||||||
4432265|NCT00129961|4257213|B1|0-5 Lesions in 12 months prior||Stratification Group||subjects|Number|33|33.0||||||
4432266|NCT00129961|4257211|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4432267|NCT00129961|4257212|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4432268|NCT00129961|4257213|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4432269|NCT00129961|4257211|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4432270|NCT00129961|4257212|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4432271|NCT00129961|4257213|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4432272|NCT00129961|4257211|B3|||Age||years|Mean|59.02|59.02|Full Range|||36.0|78.0|
4432273|NCT00129961|4257212|B2|||Age||years|Mean|58.98|58.98|Full Range|||37.0|78.0|
4432274|NCT00129961|4257213|B1|||Age||years|Mean|59.08|59.08|Full Range|||36.0|76.0|
4432275|NCT00129766|4257248|B3|Sweden||Region of Enrollment||participants|Number|109|109.0||||||
4432276|NCT00129766|4257249|B2|Sweden||Region of Enrollment||participants|Number|55|55.0||||||
4432277|NCT00129766|4257250|B1|Sweden||Region of Enrollment||participants|Number|54|54.0||||||
4432278|NCT00129766|4257248|B3|New Zealand||Region of Enrollment||participants|Number|52|52.0||||||
4432279|NCT00129766|4257249|B2|New Zealand||Region of Enrollment||participants|Number|26|26.0||||||
4432280|NCT00129766|4257250|B1|New Zealand||Region of Enrollment||participants|Number|26|26.0||||||
4432281|NCT00129766|4257248|B3|Germany||Region of Enrollment||participants|Number|253|253.0||||||
4432282|NCT00129766|4257249|B2|Germany||Region of Enrollment||participants|Number|122|122.0||||||
4432283|NCT00129766|4257250|B1|Germany||Region of Enrollment||participants|Number|131|131.0||||||
4432284|NCT00129766|4257248|B3|Iceland||Region of Enrollment||participants|Number|39|39.0||||||
4432285|NCT00129766|4257249|B2|Iceland||Region of Enrollment||participants|Number|19|19.0||||||
4432286|NCT00129766|4257250|B1|Iceland||Region of Enrollment||participants|Number|20|20.0||||||
4432287|NCT00129766|4257248|B3|Bulgaria||Region of Enrollment||participants|Number|196|196.0||||||
4432288|NCT00129766|4257249|B2|Bulgaria||Region of Enrollment||participants|Number|101|101.0||||||
4432289|NCT00129766|4257250|B1|Bulgaria||Region of Enrollment||participants|Number|95|95.0||||||
4432290|NCT00129766|4257248|B3|Denmark||Region of Enrollment||participants|Number|57|57.0||||||
4432291|NCT00129766|4257249|B2|Denmark||Region of Enrollment||participants|Number|27|27.0||||||
4432292|NCT00129766|4257250|B1|Denmark||Region of Enrollment||participants|Number|30|30.0||||||
4432293|NCT00129766|4257248|B3|Australia||Region of Enrollment||participants|Number|166|166.0||||||
4432294|NCT00129766|4257249|B2|Australia||Region of Enrollment||participants|Number|81|81.0||||||
4432295|NCT00129766|4257250|B1|Australia||Region of Enrollment||participants|Number|85|85.0||||||
4432296|NCT00129766|4257248|B3|Brazil||Region of Enrollment||participants|Number|135|135.0||||||
4432297|NCT00129766|4257249|B2|Brazil||Region of Enrollment||participants|Number|66|66.0||||||
4432298|NCT00129766|4257250|B1|Brazil||Region of Enrollment||participants|Number|69|69.0||||||
4432299|NCT00129766|4257248|B3|Poland||Region of Enrollment||participants|Number|211|211.0||||||
4432300|NCT00129766|4257249|B2|Poland||Region of Enrollment||participants|Number|105|105.0||||||
4432301|NCT00129766|4257250|B1|Poland||Region of Enrollment||participants|Number|106|106.0||||||
4432302|NCT00129766|4257248|B3|Argentina||Region of Enrollment||participants|Number|72|72.0||||||
4432303|NCT00129766|4257249|B2|Argentina||Region of Enrollment||participants|Number|34|34.0||||||
4432304|NCT00129766|4257250|B1|Argentina||Region of Enrollment||participants|Number|38|38.0||||||
4432305|NCT00129766|4257248|B3|Canada||Region of Enrollment||participants|Number|266|266.0||||||
4432306|NCT00129766|4257249|B2|Canada||Region of Enrollment||participants|Number|132|132.0||||||
4432307|NCT00129766|4257250|B1|Canada||Region of Enrollment||participants|Number|134|134.0||||||
4432308|NCT00129766|4257248|B3|Czech Republic||Region of Enrollment||participants|Number|348|348.0||||||
4432309|NCT00129766|4257249|B2|Czech Republic||Region of Enrollment||participants|Number|177|177.0||||||
4432310|NCT00129766|4257250|B1|Czech Republic||Region of Enrollment||participants|Number|171|171.0||||||
4432311|NCT00129766|4257248|B3|Hungary||Region of Enrollment||participants|Number|390|390.0||||||
4432312|NCT00129766|4257249|B2|Hungary||Region of Enrollment||participants|Number|192|192.0||||||
4432313|NCT00129766|4257250|B1|Hungary||Region of Enrollment||participants|Number|198|198.0||||||
4432314|NCT00129766|4257248|B3|France||Region of Enrollment||participants|Number|218|218.0||||||
4432315|NCT00129766|4257249|B2|France||Region of Enrollment||participants|Number|111|111.0||||||
4432316|NCT00129766|4257250|B1|France||Region of Enrollment||participants|Number|107|107.0||||||
4432317|NCT00129766|4257248|B3|Italy||Region of Enrollment||participants|Number|189|189.0||||||
4432318|NCT00129766|4257249|B2|Italy||Region of Enrollment||participants|Number|96|96.0||||||
4432319|NCT00129766|4257250|B1|Italy||Region of Enrollment||participants|Number|93|93.0||||||
4432320|NCT00129766|4257248|B3|United Kingdom||Region of Enrollment||participants|Number|179|179.0||||||
4432321|NCT00129766|4257249|B2|United Kingdom||Region of Enrollment||participants|Number|90|90.0||||||
4432322|NCT00129766|4257250|B1|United Kingdom||Region of Enrollment||participants|Number|89|89.0||||||
4432323|NCT00129766|4257248|B3|Chile||Region of Enrollment||participants|Number|180|180.0||||||
4432324|NCT00129766|4257249|B2|Chile||Region of Enrollment||participants|Number|87|87.0||||||
4432325|NCT00129766|4257250|B1|Chile||Region of Enrollment||participants|Number|93|93.0||||||
4432326|NCT00129766|4257248|B3|Israel||Region of Enrollment||participants|Number|606|606.0||||||
4432327|NCT00129766|4257249|B2|Israel||Region of Enrollment||participants|Number|305|305.0||||||
4432328|NCT00129766|4257250|B1|Israel||Region of Enrollment||participants|Number|301|301.0||||||
4432329|NCT00129766|4257248|B3|Russian Federation||Region of Enrollment||participants|Number|87|87.0||||||
4432330|NCT00129766|4257249|B2|Russian Federation||Region of Enrollment||participants|Number|45|45.0||||||
4432331|NCT00129766|4257250|B1|Russian Federation||Region of Enrollment||participants|Number|42|42.0||||||
4432332|NCT00129766|4257248|B3|Austria||Region of Enrollment||participants|Number|69|69.0||||||
4432333|NCT00129766|4257249|B2|Austria||Region of Enrollment||participants|Number|34|34.0||||||
4432334|NCT00129766|4257250|B1|Austria||Region of Enrollment||participants|Number|35|35.0||||||
4432335|NCT00129766|4257248|B3|Turkey||Region of Enrollment||participants|Number|78|78.0||||||
4432336|NCT00129766|4257249|B2|Turkey||Region of Enrollment||participants|Number|42|42.0||||||
4432337|NCT00129766|4257250|B1|Turkey||Region of Enrollment||participants|Number|36|36.0||||||
4432338|NCT00129766|4257248|B3|Spain||Region of Enrollment||participants|Number|372|372.0||||||
4432339|NCT00129766|4257249|B2|Spain||Region of Enrollment||participants|Number|181|181.0||||||
4432340|NCT00129766|4257250|B1|Spain||Region of Enrollment||participants|Number|191|191.0||||||
4432341|NCT00129766|4257248|B3|Greece||Region of Enrollment||participants|Number|66|66.0||||||
4432342|NCT00129766|4257249|B2|Greece||Region of Enrollment||participants|Number|34|34.0||||||
4432343|NCT00129766|4257250|B1|Greece||Region of Enrollment||participants|Number|32|32.0||||||
4432344|NCT00129766|4257248|B3|United States||Region of Enrollment||participants|Number|2297|2297.0||||||
4432345|NCT00129766|4257249|B2|United States||Region of Enrollment||participants|Number|1167|1167.0||||||
4432346|NCT00129766|4257250|B1|United States||Region of Enrollment||participants|Number|1130|1130.0||||||
4432347|NCT00129766|4257248|B3||Male|Sex: Female, Male||Participants|Count of Participants|3627|3627.0||||||
4432348|NCT00129766|4257249|B2||Male|Sex: Female, Male||Participants|Count of Participants|1816|1816.0||||||
4432349|NCT00129766|4257250|B1||Male|Sex: Female, Male||Participants|Count of Participants|1811|1811.0||||||
4432350|NCT00129766|4257248|B3||Female|Sex: Female, Male||Participants|Count of Participants|3008|3008.0||||||
4432351|NCT00129766|4257249|B2||Female|Sex: Female, Male||Participants|Count of Participants|1513|1513.0||||||
4432352|NCT00129766|4257250|B1||Female|Sex: Female, Male||Participants|Count of Participants|1495|1495.0||||||
4432353|NCT00129766|4257248|B3|||Age||months|Mean|3.99|3.99|Standard Deviation|3.76|3.76|||
4432354|NCT00129766|4257249|B2|||Age||months|Mean|3.99|3.99|Standard Deviation|3.75|3.75|||
4432355|NCT00129766|4257250|B1|||Age||months|Mean|3.98|3.98|Standard Deviation|3.78|3.78|||
4432356|NCT00129727|4257289|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4432357|NCT00129727|4257289|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432358|NCT00129727|4257289|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4432359|NCT00129727|4257289|B1|||Age||years|Mean|57|57.0|Standard Deviation|12|12.0|||
4432360|NCT00129727|4257289|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4432361|NCT00129727|4257289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4432362|NCT00129727|4257289|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4432363|NCT00129623|4257295|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432364|NCT00129623|4257296|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432365|NCT00129623|4257297|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432366|NCT00129623|4257295|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4432367|NCT00129623|4257296|B2||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4432368|NCT00129623|4257297|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4432369|NCT00129623|4257295|B3|||Age||years|Mean|53.5|53.5|Standard Deviation|3.73|3.73|||
4432370|NCT00129623|4257296|B2|||Age||years|Mean|53.7|53.7|Standard Deviation|3.64|3.64|||
4432371|NCT00129623|4257297|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|3.83|3.83|||
4432372|NCT00129545|4257320|B4|Germany||Region of Enrollment||participants|Number|98|98.0||||||
4432373|NCT00129545|4257321|B3|Germany||Region of Enrollment||participants|Number|3|3.0||||||
4432374|NCT00129545|4257322|B2|Germany||Region of Enrollment||participants|Number|33|33.0||||||
4432375|NCT00129545|4257323|B1|Germany||Region of Enrollment||participants|Number|62|62.0||||||
4432376|NCT00129545|4257320|B4|Czech Republic||Region of Enrollment||participants|Number|32|32.0||||||
4432377|NCT00129545|4257321|B3|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4432378|NCT00129545|4257322|B2|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
4432379|NCT00129545|4257323|B1|Czech Republic||Region of Enrollment||participants|Number|19|19.0||||||
4432380|NCT00129545|4257320|B4|United States||Region of Enrollment||participants|Number|670|670.0||||||
4432381|NCT00129545|4257321|B3|United States||Region of Enrollment||participants|Number|87|87.0||||||
4432382|NCT00129545|4257322|B2|United States||Region of Enrollment||participants|Number|201|201.0||||||
4432383|NCT00129545|4257323|B1|United States||Region of Enrollment||participants|Number|382|382.0||||||
4432384|NCT00129545|4257320|B4|other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4432385|NCT00129545|4257321|B3|other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4432386|NCT00129545|4257322|B2|other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4432387|NCT00129545|4257323|B1|other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4432388|NCT00129545|4257320|B4|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4432389|NCT00129545|4257321|B3|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4432390|NCT00129545|4257322|B2|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4432391|NCT00129545|4257323|B1|Hawaiian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4432392|NCT00129545|4257320|B4|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4432393|NCT00129545|4257321|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4432394|NCT00129545|4257322|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4432395|NCT00129545|4257323|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4432396|NCT00129545|4257320|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|734|734.0||||||
4432397|NCT00129545|4257321|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4432398|NCT00129545|4257322|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|222|222.0||||||
4432399|NCT00129545|4257323|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|425|425.0||||||
4432400|NCT00129545|4257320|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4432401|NCT00129545|4257321|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4432402|NCT00129545|4257322|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4432403|NCT00129545|4257323|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4432404|NCT00129545|4257320|B4|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4432405|NCT00129545|4257321|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4432406|NCT00129545|4257322|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4432407|NCT00129545|4257323|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4432408|NCT00129545|4257320|B4||Male|Sex: Female, Male||Participants|Count of Participants|562|562.0||||||
4432409|NCT00129545|4257321|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4432410|NCT00129545|4257322|B2||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4432411|NCT00129545|4257323|B1||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4432412|NCT00129545|4257320|B4||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4432413|NCT00129545|4257321|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4432414|NCT00129545|4257322|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4432415|NCT00129545|4257323|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4432416|NCT00129545|4257320|B4|||Age||years|Mean|72.0|72.0|Standard Deviation|8.9|8.9|||
4432417|NCT00129545|4257321|B3|||Age||years|Mean|72.2|72.2|Standard Deviation|8.9|8.9|||
4432418|NCT00129545|4257322|B2|||Age||years|Mean|72.7|72.7|Standard Deviation|9.2|9.2|||
4432419|NCT00129545|4257323|B1|||Age||years|Mean|71.7|71.7|Standard Deviation|8.8|8.8|||
4432420|NCT00129480|4257335|B3|United States||Region of Enrollment||participants|Number|401|401.0||||||
4432421|NCT00129480|4257336|B2|United States||Region of Enrollment||participants|Number|214|214.0||||||
4432422|NCT00129480|4257337|B1|United States||Region of Enrollment||participants|Number|187|187.0||||||
4432423|NCT00129480|4257335|B3|Unknown||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4432424|NCT00129480|4257336|B2|Unknown||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4432425|NCT00129480|4257337|B1|Unknown||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4432426|NCT00129480|4257335|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4432427|NCT00129480|4257336|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4432428|NCT00129480|4257337|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4432429|NCT00129480|4257335|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4432430|NCT00129480|4257336|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4432431|NCT00129480|4257337|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4432432|NCT00129480|4257335|B3|White||Race/Ethnicity, Customized||participants|Number|357|357.0||||||
4432433|NCT00129480|4257336|B2|White||Race/Ethnicity, Customized||participants|Number|189|189.0||||||
4432434|NCT00129480|4257337|B1|White||Race/Ethnicity, Customized||participants|Number|168|168.0||||||
4432435|NCT00129480|4257335|B3||Male|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
4432436|NCT00129480|4257336|B2||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4432437|NCT00129480|4257337|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4432438|NCT00129480|4257335|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4432439|NCT00129480|4257336|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4432440|NCT00129480|4257337|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4432441|NCT00129480|4257335|B3|||Age||years|Mean|61.7|61.7|Standard Deviation|11.8|11.8|||
4432442|NCT00129480|4257336|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|11.2|11.2|||
4432443|NCT00129480|4257337|B1|||Age||years|Mean|61.3|61.3|Standard Deviation|12.3|12.3|||
4432444|NCT00129467|4257344|B3|Hematological||Type of Cancer||Participants|Number|0|0.0||||||
4432445|NCT00129467|4257345|B2|Hematological||Type of Cancer||Participants|Number|0|0.0||||||
4432446|NCT00129467|4257346|B1|Hematological||Type of Cancer||Participants|Number|0|0.0||||||
4432447|NCT00129467|4257344|B3|Head and Neck||Type of Cancer||Participants|Number|4|4.0||||||
4432448|NCT00129467|4257345|B2|Head and Neck||Type of Cancer||Participants|Number|1|1.0||||||
4432449|NCT00129467|4257346|B1|Head and Neck||Type of Cancer||Participants|Number|3|3.0||||||
4432450|NCT00129467|4257344|B3|Dermatological||Type of Cancer||Participants|Number|3|3.0||||||
4432451|NCT00129467|4257345|B2|Dermatological||Type of Cancer||Participants|Number|1|1.0||||||
4432452|NCT00129467|4257346|B1|Dermatological||Type of Cancer||Participants|Number|2|2.0||||||
4432453|NCT00129467|4257344|B3|Neurological||Type of Cancer||Participants|Number|0|0.0||||||
4432454|NCT00129467|4257345|B2|Neurological||Type of Cancer||Participants|Number|0|0.0||||||
4432455|NCT00129467|4257346|B1|Neurological||Type of Cancer||Participants|Number|0|0.0||||||
4432456|NCT00129467|4257344|B3|Prostate||Type of Cancer||Participants|Number|2|2.0||||||
4432457|NCT00129467|4257345|B2|Prostate||Type of Cancer||Participants|Number|1|1.0||||||
4432458|NCT00129467|4257346|B1|Prostate||Type of Cancer||Participants|Number|1|1.0||||||
4432459|NCT00129467|4257344|B3|Breast||Type of Cancer||Participants|Number|2|2.0||||||
4432460|NCT00129467|4257345|B2|Breast||Type of Cancer||Participants|Number|0|0.0||||||
4432461|NCT00129467|4257346|B1|Breast||Type of Cancer||Participants|Number|2|2.0||||||
4432462|NCT00129467|4257344|B3|Urogenital||Type of Cancer||Participants|Number|2|2.0||||||
4432463|NCT00129467|4257345|B2|Urogenital||Type of Cancer||Participants|Number|2|2.0||||||
4432464|NCT00129467|4257346|B1|Urogenital||Type of Cancer||Participants|Number|0|0.0||||||
4432465|NCT00129467|4257344|B3|Pulmonary||Type of Cancer||Participants|Number|7|7.0||||||
4432466|NCT00129467|4257345|B2|Pulmonary||Type of Cancer||Participants|Number|5|5.0||||||
4432467|NCT00129467|4257346|B1|Pulmonary||Type of Cancer||Participants|Number|2|2.0||||||
4432468|NCT00129467|4257344|B3|Gastrointestinal||Type of Cancer||Participants|Number|12|12.0||||||
4432469|NCT00129467|4257345|B2|Gastrointestinal||Type of Cancer||Participants|Number|7|7.0||||||
4432470|NCT00129467|4257346|B1|Gastrointestinal||Type of Cancer||Participants|Number|5|5.0||||||
4432471|NCT00129467|4257344|B3|||Education||Years|Mean|12.7|12.7|Standard Deviation|2.8|2.8|||
4432472|NCT00129467|4257345|B2|||Education||Years|Mean|11.9|11.9|Standard Deviation|3.3|3.3|||
4432473|NCT00129467|4257346|B1|||Education||Years|Mean|13.5|13.5|Standard Deviation|2|2.0|||
4432474|NCT00129467|4257344|B3|Partnership||Marital Status||Participants|Number|1|1.0||||||
4432475|NCT00129467|4257345|B2|Partnership||Marital Status||Participants|Number|1|1.0||||||
4432476|NCT00129467|4257346|B1|Partnership||Marital Status||Participants|Number|0|0.0||||||
4432477|NCT00129467|4257344|B3|Widowed||Marital Status||Participants|Number|5|5.0||||||
4432478|NCT00129467|4257345|B2|Widowed||Marital Status||Participants|Number|3|3.0||||||
4432479|NCT00129467|4257346|B1|Widowed||Marital Status||Participants|Number|2|2.0||||||
4432480|NCT00129467|4257344|B3|Divorced||Marital Status||Participants|Number|12|12.0||||||
4432481|NCT00129467|4257345|B2|Divorced||Marital Status||Participants|Number|5|5.0||||||
4432482|NCT00129467|4257346|B1|Divorced||Marital Status||Participants|Number|7|7.0||||||
4432483|NCT00129467|4257344|B3|Single||Marital Status||Participants|Number|3|3.0||||||
4432484|NCT00129467|4257345|B2|Single||Marital Status||Participants|Number|1|1.0||||||
4432485|NCT00129467|4257346|B1|Single||Marital Status||Participants|Number|2|2.0||||||
4432486|NCT00129467|4257344|B3|Married||Marital Status||Participants|Number|11|11.0||||||
4432487|NCT00129467|4257345|B2|Married||Marital Status||Participants|Number|7|7.0||||||
4432488|NCT00129467|4257346|B1|Married||Marital Status||Participants|Number|4|4.0||||||
4432489|NCT00129467|4257344|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4432490|NCT00129467|4257345|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4432491|NCT00129467|4257346|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4432492|NCT00129467|4257344|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432493|NCT00129467|4257345|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432494|NCT00129467|4257346|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432495|NCT00129467|4257344|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432496|NCT00129467|4257345|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432497|NCT00129467|4257346|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432498|NCT00129467|4257344|B3||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4432499|NCT00129467|4257345|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4432500|NCT00129467|4257346|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4432501|NCT00129467|4257344|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4432502|NCT00129467|4257345|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432503|NCT00129467|4257346|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4432504|NCT00129467|4257344|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432505|NCT00129467|4257345|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432506|NCT00129467|4257346|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432507|NCT00129467|4257344|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432508|NCT00129467|4257345|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432509|NCT00129467|4257346|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432510|NCT00129467|4257344|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432511|NCT00129467|4257345|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432512|NCT00129467|4257346|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432513|NCT00129467|4257344|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432514|NCT00129467|4257345|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432515|NCT00129467|4257346|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432516|NCT00129467|4257344|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4432517|NCT00129467|4257345|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4432518|NCT00129467|4257346|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4432519|NCT00129467|4257344|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432520|NCT00129467|4257345|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432521|NCT00129467|4257346|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432522|NCT00129467|4257344|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4432523|NCT00129467|4257345|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4432524|NCT00129467|4257346|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4432525|NCT00129467|4257344|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4432526|NCT00129467|4257345|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432527|NCT00129467|4257346|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4432528|NCT00129467|4257344|B3|||Age||years|Mean|64|64.0|Standard Deviation|14|14.0|||
4432529|NCT00129467|4257345|B2|||Age||years|Mean|66|66.0|Standard Deviation|13|13.0|||
4432530|NCT00129467|4257346|B1|||Age||years|Mean|62|62.0|Standard Deviation|15|15.0|||
4432531|NCT00129467|4257344|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4432532|NCT00129467|4257345|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4432533|NCT00129467|4257346|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4432534|NCT00129467|4257344|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4432535|NCT00129467|4257345|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4432536|NCT00129467|4257346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4432537|NCT00129467|4257344|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432538|NCT00129467|4257345|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432539|NCT00129467|4257346|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432540|NCT00129441|4257353|B3|||Repeatable Battery for the Assessment of Neuropsychological Status: RBANS Delayed Memory Subindex|"The Delayed Memory Index consists of verbal and nonverbal recall tasks (words, drawings) that the subject views early in the evaluation and without warning, is asked to recall ~1/2 hr later. Scores are expressed as standardized scores normalized to a population mean of 100, with a standard deviation of 15 (possible scores between 40-135). Higher scores reflect better performance. Subjects received the A form at baseline and wk-4 visit and the B form at the wk-2 visit (A/B forms are equivalent alternate forms, which allow for retesting patients without the confound of practice effects)."|Standard Score|Mean|70.4|70.4|Standard Deviation|17.2|17.2|||
4432541|NCT00129441|4257354|B2|||Repeatable Battery for the Assessment of Neuropsychological Status: RBANS Delayed Memory Subindex|"The Delayed Memory Index consists of verbal and nonverbal recall tasks (words, drawings) that the subject views early in the evaluation and without warning, is asked to recall ~1/2 hr later. Scores are expressed as standardized scores normalized to a population mean of 100, with a standard deviation of 15 (possible scores between 40-135). Higher scores reflect better performance. Subjects received the A form at baseline and wk-4 visit and the B form at the wk-2 visit (A/B forms are equivalent alternate forms, which allow for retesting patients without the confound of practice effects)."|Standard Score|Mean|60.8|60.8|Standard Deviation|16.1|16.1|||
4432577|NCT00129441|4257354|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432578|NCT00129441|4257355|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432579|NCT00129441|4257353|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4432542|NCT00129441|4257355|B1|||Repeatable Battery for the Assessment of Neuropsychological Status: RBANS Delayed Memory Subindex|"The Delayed Memory Index consists of verbal and nonverbal recall tasks (words, drawings) that the subject views early in the evaluation and without warning, is asked to recall ~1/2 hr later. Scores are expressed as standardized scores normalized to a population mean of 100, with a standard deviation of 15 (possible scores between 40-135). Higher scores reflect better performance. Subjects received the A form at baseline and wk-4 visit and the B form at the wk-2 visit (A/B forms are equivalent alternate forms, which allow for retesting patients without the confound of practice effects)."|Standard Score|Mean|76.8|76.8|Standard Deviation|15.5|15.5|||
4432543|NCT00129441|4257353|B3|||Repeatable Battery for the Assessment of Neuropsychological Status: RBANS Total Score|"Five index scores are computed from the RBANS (immediate memory, language, visuospatial, attention, delayed memory) that are combined to provide the Total Score. The Total Score is expressed as a standardized score normalized to a population mean of 100, with a standard deviation of 15 (possible scores 40-135). Higher scores reflect better performance. All subjects received the A form at baseline and the wk-4 visit and the B form at the wk-2 visit (the A/B forms are equivalent alternate forms, which allow for retesting patients without the confound of practice effects)."|Standard Score|Mean|68.5|68.5|Standard Deviation|10.0|10.0|||
4432544|NCT00129441|4257354|B2|||Repeatable Battery for the Assessment of Neuropsychological Status: RBANS Total Score|"Five index scores are computed from the RBANS (immediate memory, language, visuospatial, attention, delayed memory) that are combined to provide the Total Score. The Total Score is expressed as a standardized score normalized to a population mean of 100, with a standard deviation of 15 (possible scores 40-135). Higher scores reflect better performance. All subjects received the A form at baseline and the wk-4 visit and the B form at the wk-2 visit (the A/B forms are equivalent alternate forms, which allow for retesting patients without the confound of practice effects)."|Standard Score|Mean|63.5|63.5|Standard Deviation|7.1|7.1|||
4432545|NCT00129441|4257355|B1|||Repeatable Battery for the Assessment of Neuropsychological Status: RBANS Total Score|"Five index scores are computed from the RBANS (immediate memory, language, visuospatial, attention, delayed memory) that are combined to provide the Total Score. The Total Score is expressed as a standardized score normalized to a population mean of 100, with a standard deviation of 15 (possible scores 40-135). Higher scores reflect better performance. All subjects received the A form at baseline and the wk-4 visit and the B form at the wk-2 visit (the A/B forms are equivalent alternate forms, which allow for retesting patients without the confound of practice effects)."|Standard Score|Mean|71.8|71.8|Standard Deviation|10.6|10.6|||
4432546|NCT00129441|4257353|B3|||Brief Psychiatric Rating Scale (BPRS) Total Score|The Brief Psychiatric Rating Scale-anchored (BPRS; Overall and Gorham, 1962; Woerner, Mannuzza, Kane, 1988) is an 18-item scale that is among the most widely used measure of psychopathology. Scores range from 1-7, with higher scores reflecting greater pathology. A total score is derived from the sum of all 18 items (possible scores range from 18-126). It relies on clinical judgment in the assessment of key areas of psychopathology (depression, anxiety, psychosis).|Scores on a scale|Mean|28.3|28.3|Standard Deviation|6.9|6.9|||
4432547|NCT00129441|4257354|B2|||Brief Psychiatric Rating Scale (BPRS) Total Score|The Brief Psychiatric Rating Scale-anchored (BPRS; Overall and Gorham, 1962; Woerner, Mannuzza, Kane, 1988) is an 18-item scale that is among the most widely used measure of psychopathology. Scores range from 1-7, with higher scores reflecting greater pathology. A total score is derived from the sum of all 18 items (possible scores range from 18-126). It relies on clinical judgment in the assessment of key areas of psychopathology (depression, anxiety, psychosis).|Scores on a scale|Mean|34.2|34.2|Standard Deviation|7.1|7.1|||
4432548|NCT00129441|4257355|B1|||Brief Psychiatric Rating Scale (BPRS) Total Score|The Brief Psychiatric Rating Scale-anchored (BPRS; Overall and Gorham, 1962; Woerner, Mannuzza, Kane, 1988) is an 18-item scale that is among the most widely used measure of psychopathology. Scores range from 1-7, with higher scores reflecting greater pathology. A total score is derived from the sum of all 18 items (possible scores range from 18-126). It relies on clinical judgment in the assessment of key areas of psychopathology (depression, anxiety, psychosis).|Scores on a scale|Mean|24.3|24.3|Standard Deviation|2.6|2.6|||
4432549|NCT00129441|4257353|B3|||Preparing to Overcome Prepotency (POP) Task - Error Rate|The POP task is a cued stimulus-response reversal paradigm that, similar to the AX Continuous Performance Test, requires increases in cognitive control through the maintenance and use of context information to overcome prepotent response tendencies.|proportion of errors|Mean|0.046|0.046|Standard Deviation|0.058|0.058|||
4432550|NCT00129441|4257354|B2|||Preparing to Overcome Prepotency (POP) Task - Error Rate|The POP task is a cued stimulus-response reversal paradigm that, similar to the AX Continuous Performance Test, requires increases in cognitive control through the maintenance and use of context information to overcome prepotent response tendencies.|proportion of errors|Mean|0.064|0.064|Standard Deviation|0.068|0.068|||
4432551|NCT00129441|4257355|B1|||Preparing to Overcome Prepotency (POP) Task - Error Rate|The POP task is a cued stimulus-response reversal paradigm that, similar to the AX Continuous Performance Test, requires increases in cognitive control through the maintenance and use of context information to overcome prepotent response tendencies.|proportion of errors|Mean|0.034|0.034|Standard Deviation|0.050|0.05|||
4432552|NCT00129441|4257353|B3|||Preparing to Overcome Prepotency (POP) Task - Reaction Time|The POP task is a cued stimulus-response reversal paradigm that, similar to the AX Continuous Performance Test, requires increases in cognitive control through the maintenance and use of context information to overcome prepotent response tendencies.|msec|Mean|54|54.0|Standard Deviation|53|53.0|||
4432553|NCT00129441|4257354|B2|||Preparing to Overcome Prepotency (POP) Task - Reaction Time|The POP task is a cued stimulus-response reversal paradigm that, similar to the AX Continuous Performance Test, requires increases in cognitive control through the maintenance and use of context information to overcome prepotent response tendencies.|msec|Mean|36|36.0|Standard Deviation|61|61.0|||
4432554|NCT00129441|4257355|B1|||Preparing to Overcome Prepotency (POP) Task - Reaction Time|The POP task is a cued stimulus-response reversal paradigm that, similar to the AX Continuous Performance Test, requires increases in cognitive control through the maintenance and use of context information to overcome prepotent response tendencies.|msec|Mean|66|66.0|Standard Deviation|48|48.0|||
4432580|NCT00129441|4257354|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4432581|NCT00129441|4257355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4432555|NCT00129441|4257353|B3|||AX Continuous Performance Test Task d-prime|For the AX Continuous Performance Test (AXCPT), subjects are required to maintain an attentional set across a delay interval in order to overcome a prepotent response tendency (target responses are required when an X is presented but only in the context of a preceding A; non-target conditions are AY, BX and BY). The dependent measure was d-prime at the long delay (calculated as AX hits minus BX false alarms, which is particularly sensitive to context processing impairments in individuals with schizophrenia.|d-prime|Mean|0.8|0.8|Standard Deviation|0.7|0.7|||
4432556|NCT00129441|4257354|B2|||AX Continuous Performance Test Task d-prime|For the AX Continuous Performance Test (AXCPT), subjects are required to maintain an attentional set across a delay interval in order to overcome a prepotent response tendency (target responses are required when an X is presented but only in the context of a preceding A; non-target conditions are AY, BX and BY). The dependent measure was d-prime at the long delay (calculated as AX hits minus BX false alarms, which is particularly sensitive to context processing impairments in individuals with schizophrenia.|d-prime|Mean|0.7|0.7|Standard Deviation|0.9|0.9|||
4432557|NCT00129441|4257355|B1|||AX Continuous Performance Test Task d-prime|For the AX Continuous Performance Test (AXCPT), subjects are required to maintain an attentional set across a delay interval in order to overcome a prepotent response tendency (target responses are required when an X is presented but only in the context of a preceding A; non-target conditions are AY, BX and BY). The dependent measure was d-prime at the long delay (calculated as AX hits minus BX false alarms, which is particularly sensitive to context processing impairments in individuals with schizophrenia.|d-prime|Mean|0.9|0.9|Standard Deviation|0.7|0.7|||
4432558|NCT00129441|4257353|B3|||N-back Task Error Rate|The N-back task is a sequential-letter memory task for which working memory load is varied, as the respondent must indicate when the current stimulus matches the one from 'n' steps earlier in the sequence. Those with schizophrenia exhibit substantially impaired performance and decreased functional activation of the dorsolateral prefrontal cortex (DLPFC) relative to matched comparison subjects for the 2-back load condition. 2-back condition was used as the dependent measure, as it provides the best index of performance and DLPFC disturbances in subjects with schizophrenia.|proportion of errors|Mean|0.248|0.248|Standard Deviation|0.081|0.081|||
4432559|NCT00129441|4257354|B2|||N-back Task Error Rate|The N-back task is a sequential-letter memory task for which working memory load is varied, as the respondent must indicate when the current stimulus matches the one from 'n' steps earlier in the sequence. Those with schizophrenia exhibit substantially impaired performance and decreased functional activation of the dorsolateral prefrontal cortex (DLPFC) relative to matched comparison subjects for the 2-back load condition. 2-back condition was used as the dependent measure, as it provides the best index of performance and DLPFC disturbances in subjects with schizophrenia.|proportion of errors|Mean|0.250|0.25|Standard Deviation|0.028|0.028|||
4432560|NCT00129441|4257355|B1|||N-back Task Error Rate|The N-back task is a sequential-letter memory task for which working memory load is varied, as the respondent must indicate when the current stimulus matches the one from 'n' steps earlier in the sequence. Those with schizophrenia exhibit substantially impaired performance and decreased functional activation of the dorsolateral prefrontal cortex (DLPFC) relative to matched comparison subjects for the 2-back load condition. 2-back condition was used as the dependent measure, as it provides the best index of performance and DLPFC disturbances in subjects with schizophrenia.|proportion of errors|Mean|0.247|0.247|Standard Deviation|0.102|0.102|||
4432561|NCT00129441|4257353|B3|||N-back Task Reaction Time|The N-back task is a sequential-letter memory task for which working memory load is varied, as the respondent must indicate when the current stimulus matches the one from 'n' steps earlier in the sequence. Those with schizophrenia exhibit substantially impaired performance and decreased functional activation of the dorsolateral prefrontal cortex (DLPFC) relative to matched comparison subjects for the 2-back load condition. 2-back condition was used as the dependent measure, as it provides the best index of performance and DLPFC disturbances in subjects with schizophrenia.|msec|Mean|801|801.0|Standard Deviation|230|230.0|||
4432562|NCT00129441|4257354|B2|||N-back Task Reaction Time|The N-back task is a sequential-letter memory task for which working memory load is varied, as the respondent must indicate when the current stimulus matches the one from 'n' steps earlier in the sequence. Those with schizophrenia exhibit substantially impaired performance and decreased functional activation of the dorsolateral prefrontal cortex (DLPFC) relative to matched comparison subjects for the 2-back load condition. 2-back condition was used as the dependent measure, as it provides the best index of performance and DLPFC disturbances in subjects with schizophrenia.|msec|Mean|669|669.0|Standard Deviation|158|158.0|||
4432563|NCT00129441|4257355|B1|||N-back Task Reaction Time|The N-back task is a sequential-letter memory task for which working memory load is varied, as the respondent must indicate when the current stimulus matches the one from 'n' steps earlier in the sequence. Those with schizophrenia exhibit substantially impaired performance and decreased functional activation of the dorsolateral prefrontal cortex (DLPFC) relative to matched comparison subjects for the 2-back load condition. 2-back condition was used as the dependent measure, as it provides the best index of performance and DLPFC disturbances in subjects with schizophrenia.|msec|Mean|874|874.0|Standard Deviation|238|238.0|||
4432564|NCT00129441|4257353|B3|United States||Region of Enrollment||Participants|Number|15|15.0||||||
4432565|NCT00129441|4257354|B2|United States||Region of Enrollment||Participants|Number|6|6.0||||||
4432566|NCT00129441|4257355|B1|United States||Region of Enrollment||Participants|Number|9|9.0||||||
4432567|NCT00129441|4257353|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4432568|NCT00129441|4257354|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4432569|NCT00129441|4257355|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4432570|NCT00129441|4257353|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432571|NCT00129441|4257354|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432572|NCT00129441|4257355|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432573|NCT00129441|4257353|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|9.2|9.2|||
4432574|NCT00129441|4257354|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|6.8|6.8|||
4432575|NCT00129441|4257355|B1|||Age||years|Mean|39.3|39.3|Standard Deviation|10.6|10.6|||
4432576|NCT00129441|4257353|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432582|NCT00129441|4257353|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432583|NCT00129441|4257354|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432584|NCT00129441|4257355|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432585|NCT00129402|4257376|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4432586|NCT00129402|4257377|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4432587|NCT00129402|4257378|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4432588|NCT00129402|4257376|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4432589|NCT00129402|4257377|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4432590|NCT00129402|4257378|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4432591|NCT00129402|4257376|B3|||Age||years|Mean|14.2|14.2|Standard Deviation|1.9|1.9|||
4432592|NCT00129402|4257377|B2|||Age||years|Mean|14.3|14.3|Standard Deviation|1.8|1.8|||
4432593|NCT00129402|4257378|B1|||Age||years|Mean|14.0|14.0|Standard Deviation|1.9|1.9|||
4432594|NCT00129311|4257401|B3|||Duration of Smoking (years)||years|Mean|30.7|30.7|Standard Deviation|12.6|12.6|||
4432595|NCT00129311|4257402|B2|||Duration of Smoking (years)||years|Mean|29.8|29.8|Standard Deviation|13.6|13.6|||
4432596|NCT00129311|4257403|B1|||Duration of Smoking (years)||years|Mean|31.6|31.6|Standard Deviation|11.6|11.6|||
4432597|NCT00129311|4257401|B3|||Age of Smoking Onset||years|Mean|16.3|16.3|Standard Deviation|5.6|5.6|||
4432598|NCT00129311|4257402|B2|||Age of Smoking Onset||years|Mean|16.3|16.3|Standard Deviation|4.1|4.1|||
4432599|NCT00129311|4257403|B1|||Age of Smoking Onset||years|Mean|16.2|16.2|Standard Deviation|6.9|6.9|||
4432600|NCT00129311|4257401|B3|||Education||years|Mean|14.0|14.0|Standard Deviation|2.1|2.1|||
4432601|NCT00129311|4257402|B2|||Education||years|Mean|14.2|14.2|Standard Deviation|2.2|2.2|||
4432602|NCT00129311|4257403|B1|||Education||years|Mean|13.8|13.8|Standard Deviation|2.0|2.0|||
4432603|NCT00129311|4257401|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
4432604|NCT00129311|4257402|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4432605|NCT00129311|4257403|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4432606|NCT00129311|4257401|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4432607|NCT00129311|4257402|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4432608|NCT00129311|4257403|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4432609|NCT00129311|4257401|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4432610|NCT00129311|4257402|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4432611|NCT00129311|4257403|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4432612|NCT00129311|4257401|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|12|12.0|||
4432613|NCT00129311|4257402|B2|||Age||years|Mean|46.2|46.2|Standard Deviation|13.0|13.0|||
4432614|NCT00129311|4257403|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|11.0|11.0|||
4432615|NCT00129285|4257412|B4|United States||Region of Enrollment||participants|Number|210|210.0||||||
4432616|NCT00129285|4257413|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4432617|NCT00129285|4257414|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4432618|NCT00129285|4257415|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4432619|NCT00129285|4257412|B4||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4432620|NCT00129285|4257413|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4432621|NCT00129285|4257414|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4432622|NCT00129285|4257415|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4432623|NCT00129285|4257412|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4432624|NCT00129285|4257413|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4432625|NCT00129285|4257414|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4432626|NCT00129285|4257415|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4432627|NCT00129285|4257412|B4|||Age||years|Mean|42.64|42.64|Standard Deviation|8.7|8.7|||
4432628|NCT00129285|4257413|B3|||Age||years|Mean|42.46|42.46|Standard Deviation|7.5|7.5|||
4432629|NCT00129285|4257414|B2|||Age||years|Mean|43.64|43.64|Standard Deviation|7.7|7.7|||
4432630|NCT00129285|4257415|B1|||Age||years|Mean|41.72|41.72|Standard Deviation|6.9|6.9|||
4432631|NCT00129285|4257412|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432632|NCT00129285|4257413|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432633|NCT00129285|4257414|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432634|NCT00129285|4257415|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4432635|NCT00129285|4257412|B4||Between 18 and 65 years|Age||Participants|Count of Participants|210|210.0||||||
4432636|NCT00129285|4257413|B3||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4432637|NCT00129285|4257414|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4432638|NCT00129285|4257415|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4432639|NCT00129285|4257412|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432640|NCT00129285|4257413|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432641|NCT00129285|4257414|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432642|NCT00129285|4257415|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4432643|NCT00129272|4257431|B3|||Expired carbon monoxide||Parts per million; higher worse|Mean|13.9|13.9|Standard Deviation|6.9|6.9|||
4432644|NCT00129272|4257432|B2|||Expired carbon monoxide||Parts per million; higher worse|Mean|14.0|14.0|Standard Deviation|8.9|8.9|||
4432645|NCT00129272|4257433|B1|||Expired carbon monoxide||Parts per million; higher worse|Mean|13.9|13.9|Standard Deviation|5.3|5.3|||
4432646|NCT00129272|4257431|B3|||Nicotine dependence|Fagerstrom Tolerance Questionnaire|units on a scale;range 0-9;higher worse|Mean|5.5|5.5|Standard Deviation|1.5|1.5|||
4432647|NCT00129272|4257432|B2|||Nicotine dependence|Fagerstrom Tolerance Questionnaire|units on a scale;range 0-9;higher worse|Mean|5.4|5.4|Standard Deviation|1.3|1.3|||
4432648|NCT00129272|4257433|B1|||Nicotine dependence|Fagerstrom Tolerance Questionnaire|units on a scale;range 0-9;higher worse|Mean|5.6|5.6|Standard Deviation|1.6|1.6|||
4432649|NCT00129272|4257431|B3|||Withdrawal symptoms|Hughes-Hatsukami Withdrawal Scale|units on a scale;range 0-36;higher worse|Mean|4.2|4.2|Standard Deviation|3.5|3.5|||
4432650|NCT00129272|4257432|B2|||Withdrawal symptoms|Hughes-Hatsukami Withdrawal Scale|units on a scale;range 0-36;higher worse|Mean|4.1|4.1|Standard Deviation|3.5|3.5|||
4432651|NCT00129272|4257433|B1|||Withdrawal symptoms|Hughes-Hatsukami Withdrawal Scale|units on a scale;range 0-36;higher worse|Mean|4.3|4.3|Standard Deviation|3.3|3.3|||
4432652|NCT00129272|4257431|B3|||Daily smoking diary|Number of cigarettes smoked per day|cigarettes/day in previous week|Mean|16.9|16.9|Standard Deviation|7.2|7.2|||
4432653|NCT00129272|4257432|B2|||Daily smoking diary|Number of cigarettes smoked per day|cigarettes/day in previous week|Mean|16.4|16.4|Standard Deviation|6.8|6.8|||
4432654|NCT00129272|4257433|B1|||Daily smoking diary|Number of cigarettes smoked per day|cigarettes/day in previous week|Mean|17.5|17.5|Standard Deviation|7.6|7.6|||
4432655|NCT00129272|4257431|B3|United States||Region of Enrollment|The data were collected in Southwestern Region of the United States|participants|Number|144|144.0||||||
4432656|NCT00129272|4257432|B2|United States||Region of Enrollment|The data were collected in Southwestern Region of the United States|participants|Number|73|73.0||||||
4432657|NCT00129272|4257433|B1|United States||Region of Enrollment|The data were collected in Southwestern Region of the United States|participants|Number|71|71.0||||||
4432658|NCT00129272|4257431|B3|More than one race : Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4432659|NCT00129272|4257432|B2|More than one race : Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4432660|NCT00129272|4257433|B1|More than one race : Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4432661|NCT00129272|4257431|B3|More than one race : non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4432662|NCT00129272|4257432|B2|More than one race : non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4432663|NCT00129272|4257433|B1|More than one race : non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4432664|NCT00129272|4257431|B3|White : Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4432665|NCT00129272|4257432|B2|White : Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4432666|NCT00129272|4257433|B1|White : Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4432667|NCT00129272|4257431|B3|White : non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|103|103.0||||||
4432668|NCT00129272|4257432|B2|White : non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|51|51.0||||||
4432669|NCT00129272|4257433|B1|White : non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
4432670|NCT00129272|4257431|B3|Black : Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4432671|NCT00129272|4257432|B2|Black : Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4432672|NCT00129272|4257433|B1|Black : Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4432673|NCT00129272|4257431|B3|Black : non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4432674|NCT00129272|4257432|B2|Black : non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4432675|NCT00129272|4257433|B1|Black : non-Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4432676|NCT00129272|4257431|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4432677|NCT00129272|4257432|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4432678|NCT00129272|4257433|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4432679|NCT00129272|4257431|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4432680|NCT00129272|4257432|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4432681|NCT00129272|4257433|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4432682|NCT00129272|4257431|B3|||Age|Participants were between 12 and 25 years of age.|Years|Mean|19.0|19.0|Standard Deviation|3.6|3.6|||
4432683|NCT00129272|4257432|B2|||Age|Participants were between 12 and 25 years of age.|Years|Mean|18.3|18.3|Standard Deviation|3.9|3.9|||
4432684|NCT00129272|4257433|B1|||Age|Participants were between 12 and 25 years of age.|Years|Mean|19.6|19.6|Standard Deviation|3.2|3.2|||
4432685|NCT00129259|4257442|B3|||Average Total Daily Insulin Dose Per Body Weight at Baseline (Pre-treatment)|This measure is computed using the subject’s average amount of exogenous insulin taken per day for the 3 days prior to the visit. (Formula: Total daily insulin dose=total daily insulin requirement (in units of insulin) multiplied by total body weight in kilograms).|Units of Insulin/kilogram/day (U/kg/day)|Mean|0.39|0.39|Standard Deviation|0.23|0.23|||
4432686|NCT00129259|4257443|B2|||Average Total Daily Insulin Dose Per Body Weight at Baseline (Pre-treatment)|This measure is computed using the subject’s average amount of exogenous insulin taken per day for the 3 days prior to the visit. (Formula: Total daily insulin dose=total daily insulin requirement (in units of insulin) multiplied by total body weight in kilograms).|Units of Insulin/kilogram/day (U/kg/day)|Mean|0.39|0.39|Standard Deviation|0.17|0.17|||
4432827|NCT00129129|4257515|B1|||Age||Days|Mean|64.2|64.2|Standard Deviation|8.05|8.05|||
4432828|NCT00129116|4257721|B6||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4432687|NCT00129259|4257444|B1|||Average Total Daily Insulin Dose Per Body Weight at Baseline (Pre-treatment)|This measure is computed using the subject’s average amount of exogenous insulin taken per day for the 3 days prior to the visit. (Formula: Total daily insulin dose=total daily insulin requirement (in units of insulin) multiplied by total body weight in kilograms).|Units of Insulin/kilogram/day (U/kg/day)|Mean|0.39|0.39|Standard Deviation|0.26|0.26|||
4432688|NCT00129259|4257442|B3|||Hemoglobin A1c at Baseline (Pre-treatment)|Glycosylated hemoglobin (HbA1c) is a measure of the average plasma glucose concentration over prolonged periods of time. (Normal :< 5.7%; pre-diabetes: 5.7% -6.4%; diabetes: 6.5% or higher).|Percentage (%)|Mean|7.5|7.5|Standard Deviation|1.07|1.07|||
4432689|NCT00129259|4257443|B2|||Hemoglobin A1c at Baseline (Pre-treatment)|Glycosylated hemoglobin (HbA1c) is a measure of the average plasma glucose concentration over prolonged periods of time. (Normal :< 5.7%; pre-diabetes: 5.7% -6.4%; diabetes: 6.5% or higher).|Percentage (%)|Mean|7.7|7.7|Standard Deviation|1.23|1.23|||
4432690|NCT00129259|4257444|B1|||Hemoglobin A1c at Baseline (Pre-treatment)|Glycosylated hemoglobin (HbA1c) is a measure of the average plasma glucose concentration over prolonged periods of time. (Normal :< 5.7%; pre-diabetes: 5.7% -6.4%; diabetes: 6.5% or higher).|Percentage (%)|Mean|7.4|7.4|Standard Deviation|0.99|0.99|||
4432691|NCT00129259|4257442|B3|||C-peptide Area Under the Curve (AUC) Response to a Mixed Meal Tolerance Test (MMTT) at Baseline|C-peptide AUC is computed using the trapezoidal rule and dividing by the interval of time from the 4 hour Mixed Meal Tolerance Test (MMTT) where assessments are taken every 30 minutes after initial assessments 15 minutes apart. A higher C-peptide AUC is desirable as detectable C-peptide is a marker for the ability of the pancreas to produce insulin in response to a MMTT.|pmol/mL|Mean|0.70|0.7|Standard Deviation|0.29|0.29|||
4432692|NCT00129259|4257443|B2|||C-peptide Area Under the Curve (AUC) Response to a Mixed Meal Tolerance Test (MMTT) at Baseline|C-peptide AUC is computed using the trapezoidal rule and dividing by the interval of time from the 4 hour Mixed Meal Tolerance Test (MMTT) where assessments are taken every 30 minutes after initial assessments 15 minutes apart. A higher C-peptide AUC is desirable as detectable C-peptide is a marker for the ability of the pancreas to produce insulin in response to a MMTT.|pmol/mL|Mean|0.67|0.67|Standard Deviation|0.28|0.28|||
4432693|NCT00129259|4257444|B1|||C-peptide Area Under the Curve (AUC) Response to a Mixed Meal Tolerance Test (MMTT) at Baseline|C-peptide AUC is computed using the trapezoidal rule and dividing by the interval of time from the 4 hour Mixed Meal Tolerance Test (MMTT) where assessments are taken every 30 minutes after initial assessments 15 minutes apart. A higher C-peptide AUC is desirable as detectable C-peptide is a marker for the ability of the pancreas to produce insulin in response to a MMTT.|pmol/mL|Mean|0.72|0.72|Standard Deviation|0.29|0.29|||
4432694|NCT00129259|4257442|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4432695|NCT00129259|4257443|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4432696|NCT00129259|4257444|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4432697|NCT00129259|4257442|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4432698|NCT00129259|4257443|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4432699|NCT00129259|4257444|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4432700|NCT00129259|4257442|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4432701|NCT00129259|4257443|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4432702|NCT00129259|4257444|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4432703|NCT00129259|4257442|B3|18-30||Age, Customized||participants|Number|5|5.0||||||
4432704|NCT00129259|4257443|B2|18-30||Age, Customized||participants|Number|1|1.0||||||
4432705|NCT00129259|4257444|B1|18-30||Age, Customized||participants|Number|4|4.0||||||
4432706|NCT00129259|4257442|B3|13-17||Age, Customized||participants|Number|23|23.0||||||
4432707|NCT00129259|4257443|B2|13-17||Age, Customized||participants|Number|9|9.0||||||
4432708|NCT00129259|4257444|B1|13-17||Age, Customized||participants|Number|14|14.0||||||
4432709|NCT00129259|4257442|B3|8-12||Age, Customized||participants|Number|49|49.0||||||
4432710|NCT00129259|4257443|B2|8-12||Age, Customized||participants|Number|15|15.0||||||
4432711|NCT00129259|4257444|B1|8-12||Age, Customized||participants|Number|34|34.0||||||
4432712|NCT00129259|4257442|B3|||Age||years|Mean|12.5|12.5|Standard Deviation|4.6|4.6|||
4432713|NCT00129259|4257443|B2|||Age||years|Mean|12.3|12.3|Standard Deviation|4.1|4.1|||
4432714|NCT00129259|4257444|B1|||Age||years|Mean|12.7|12.7|Standard Deviation|4.9|4.9|||
4432715|NCT00129246|4257455|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4432716|NCT00129246|4257456|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4432717|NCT00129246|4257457|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4432718|NCT00129246|4257455|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4432719|NCT00129246|4257456|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4432720|NCT00129246|4257457|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4432721|NCT00129246|4257455|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|11.6|11.6|||
4432722|NCT00129246|4257456|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|11.2|11.2|||
4432723|NCT00129246|4257457|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|12.3|12.3|||
4432724|NCT00129220|4257470|B4|||Young Mania Rating Scale (YMRS) Total Score|The YMRS is an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60.|units on a scale|Mean|27.3|27.3|Standard Deviation|5.7|5.7|||
4432725|NCT00129220|4257471|B3|||Young Mania Rating Scale (YMRS) Total Score|The YMRS is an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60.|units on a scale|Mean|26.9|26.9|Standard Deviation|5.6|5.6|||
4432726|NCT00129220|4257472|B2|||Young Mania Rating Scale (YMRS) Total Score|The YMRS is an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60.|units on a scale|Mean|26.6|26.6|Standard Deviation|4.5|4.5|||
4432727|NCT00129220|4257473|B1|||Young Mania Rating Scale (YMRS) Total Score|The YMRS is an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60.|units on a scale|Mean|27.7|27.7|Standard Deviation|5.9|5.9|||
4432728|NCT00129220|4257470|B4|||Weight||kilograms (kg)|Mean|61.17|61.17|Standard Deviation|12.49|12.49|||
4432729|NCT00129220|4257471|B3|||Weight||kilograms (kg)|Mean|61.86|61.86|Standard Deviation|13.78|13.78|||
4432730|NCT00129220|4257472|B2|||Weight||kilograms (kg)|Mean|59.20|59.2|Standard Deviation|9.87|9.87|||
4432731|NCT00129220|4257473|B1|||Weight||kilograms (kg)|Mean|60.88|60.88|Standard Deviation|11.69|11.69|||
4432732|NCT00129220|4257470|B4|||Positive and Negative Syndrome Scale Positive Subscale Score|Assesses positive symptoms associated with schizophrenia. 7 items make up the Positive scale (ex. delusions, conceptual disorganization, and hallucinatory behavior). Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Total Positive Subscale scores range from 7 to 49. For this study, the score was converted to 0 to 6 for each item range; hence, the total positive subscale score ranges from 0 to 42.|units on a scale|Mean|11.1|11.1|Standard Deviation|4.7|4.7|||
4432733|NCT00129220|4257471|B3|||Positive and Negative Syndrome Scale Positive Subscale Score|Assesses positive symptoms associated with schizophrenia. 7 items make up the Positive scale (ex. delusions, conceptual disorganization, and hallucinatory behavior). Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Total Positive Subscale scores range from 7 to 49. For this study, the score was converted to 0 to 6 for each item range; hence, the total positive subscale score ranges from 0 to 42.|units on a scale|Mean|10.7|10.7|Standard Deviation|4.7|4.7|||
4432734|NCT00129220|4257472|B2|||Positive and Negative Syndrome Scale Positive Subscale Score|Assesses positive symptoms associated with schizophrenia. 7 items make up the Positive scale (ex. delusions, conceptual disorganization, and hallucinatory behavior). Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Total Positive Subscale scores range from 7 to 49. For this study, the score was converted to 0 to 6 for each item range; hence, the total positive subscale score ranges from 0 to 42.|units on a scale|Mean|11.3|11.3|Standard Deviation|4.5|4.5|||
4432735|NCT00129220|4257473|B1|||Positive and Negative Syndrome Scale Positive Subscale Score|Assesses positive symptoms associated with schizophrenia. 7 items make up the Positive scale (ex. delusions, conceptual disorganization, and hallucinatory behavior). Each item is rated on a scale from 1 (symptom not present) to 7 (symptoms extremely severe). Total Positive Subscale scores range from 7 to 49. For this study, the score was converted to 0 to 6 for each item range; hence, the total positive subscale score ranges from 0 to 42.|units on a scale|Mean|11.5|11.5|Standard Deviation|4.8|4.8|||
4432736|NCT00129220|4257470|B4|||Length of Current Illness Episode||days|Mean|34.1|34.1|Standard Deviation|23.9|23.9|||
4432737|NCT00129220|4257471|B3|||Length of Current Illness Episode||days|Mean|33.5|33.5|Standard Deviation|25.4|25.4|||
4432738|NCT00129220|4257472|B2|||Length of Current Illness Episode||days|Mean|34.2|34.2|Standard Deviation|22.0|22.0|||
4432739|NCT00129220|4257473|B1|||Length of Current Illness Episode||days|Mean|34.6|34.6|Standard Deviation|22.9|22.9|||
4432740|NCT00129220|4257470|B4|||Height||centimeters (cm)|Mean|162.84|162.84|Standard Deviation|8.76|8.76|||
4432741|NCT00129220|4257471|B3|||Height||centimeters (cm)|Mean|163.09|163.09|Standard Deviation|9.66|9.66|||
4432742|NCT00129220|4257472|B2|||Height||centimeters (cm)|Mean|162.10|162.1|Standard Deviation|7.87|7.87|||
4432743|NCT00129220|4257473|B1|||Height||centimeters (cm)|Mean|162.74|162.74|Standard Deviation|8.07|8.07|||
4432744|NCT00129220|4257470|B4|Overall Mood||Clinical Global Impression-Severity of Illness, Bipolar Version (CGI-BP)|A global rating scale for severity of patients adapted to bipolar disorder. Measures severity of the patient's overall severity of manic symptoms, depressive symptoms, and overall mood symptoms. Each of the three symptoms are on a scale of 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.1|4.1|Standard Deviation|1.1|1.1|||
4432745|NCT00129220|4257471|B3|Overall Mood||Clinical Global Impression-Severity of Illness, Bipolar Version (CGI-BP)|A global rating scale for severity of patients adapted to bipolar disorder. Measures severity of the patient's overall severity of manic symptoms, depressive symptoms, and overall mood symptoms. Each of the three symptoms are on a scale of 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.1|4.1|Standard Deviation|1.1|1.1|||
4432746|NCT00129220|4257472|B2|Overall Mood||Clinical Global Impression-Severity of Illness, Bipolar Version (CGI-BP)|A global rating scale for severity of patients adapted to bipolar disorder. Measures severity of the patient's overall severity of manic symptoms, depressive symptoms, and overall mood symptoms. Each of the three symptoms are on a scale of 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.4|4.4|Standard Deviation|1.2|1.2|||
4432747|NCT00129220|4257473|B1|Overall Mood||Clinical Global Impression-Severity of Illness, Bipolar Version (CGI-BP)|A global rating scale for severity of patients adapted to bipolar disorder. Measures severity of the patient's overall severity of manic symptoms, depressive symptoms, and overall mood symptoms. Each of the three symptoms are on a scale of 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.1|4.1|Standard Deviation|1.0|1.0|||
4432748|NCT00129220|4257470|B4|Depression||Clinical Global Impression-Severity of Illness, Bipolar Version (CGI-BP)|A global rating scale for severity of patients adapted to bipolar disorder. Measures severity of the patient's overall severity of manic symptoms, depressive symptoms, and overall mood symptoms. Each of the three symptoms are on a scale of 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|1.2|1.2|Standard Deviation|0.6|0.6|||
4432829|NCT00129116|4257722|B5||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4432749|NCT00129220|4257471|B3|Depression||Clinical Global Impression-Severity of Illness, Bipolar Version (CGI-BP)|A global rating scale for severity of patients adapted to bipolar disorder. Measures severity of the patient's overall severity of manic symptoms, depressive symptoms, and overall mood symptoms. Each of the three symptoms are on a scale of 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|1.3|1.3|Standard Deviation|0.7|0.7|||
4432750|NCT00129220|4257472|B2|Depression||Clinical Global Impression-Severity of Illness, Bipolar Version (CGI-BP)|A global rating scale for severity of patients adapted to bipolar disorder. Measures severity of the patient's overall severity of manic symptoms, depressive symptoms, and overall mood symptoms. Each of the three symptoms are on a scale of 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|1.1|1.1|Standard Deviation|0.2|0.2|||
4432751|NCT00129220|4257473|B1|Depression||Clinical Global Impression-Severity of Illness, Bipolar Version (CGI-BP)|A global rating scale for severity of patients adapted to bipolar disorder. Measures severity of the patient's overall severity of manic symptoms, depressive symptoms, and overall mood symptoms. Each of the three symptoms are on a scale of 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|1.3|1.3|Standard Deviation|0.6|0.6|||
4432752|NCT00129220|4257470|B4|Mania||Clinical Global Impression-Severity of Illness, Bipolar Version (CGI-BP)|A global rating scale for severity of patients adapted to bipolar disorder. Measures severity of the patient's overall severity of manic symptoms, depressive symptoms, and overall mood symptoms. Each of the three symptoms are on a scale of 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.2|4.2|Standard Deviation|1.0|1.0|||
4432753|NCT00129220|4257471|B3|Mania||Clinical Global Impression-Severity of Illness, Bipolar Version (CGI-BP)|A global rating scale for severity of patients adapted to bipolar disorder. Measures severity of the patient's overall severity of manic symptoms, depressive symptoms, and overall mood symptoms. Each of the three symptoms are on a scale of 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.1|4.1|Standard Deviation|1.1|1.1|||
4432754|NCT00129220|4257472|B2|Mania||Clinical Global Impression-Severity of Illness, Bipolar Version (CGI-BP)|A global rating scale for severity of patients adapted to bipolar disorder. Measures severity of the patient's overall severity of manic symptoms, depressive symptoms, and overall mood symptoms. Each of the three symptoms are on a scale of 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.6|4.6|Standard Deviation|0.8|0.8|||
4432755|NCT00129220|4257473|B1|Mania||Clinical Global Impression-Severity of Illness, Bipolar Version (CGI-BP)|A global rating scale for severity of patients adapted to bipolar disorder. Measures severity of the patient's overall severity of manic symptoms, depressive symptoms, and overall mood symptoms. Each of the three symptoms are on a scale of 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.2|4.2|Standard Deviation|1.0|1.0|||
4432756|NCT00129220|4257470|B4|||Age of Onset of Illness||years|Mean|31.6|31.6|Standard Deviation|11.4|11.4|||
4432757|NCT00129220|4257471|B3|||Age of Onset of Illness||years|Mean|30.9|30.9|Standard Deviation|10.7|10.7|||
4432758|NCT00129220|4257472|B2|||Age of Onset of Illness||years|Mean|37.7|37.7|Standard Deviation|12.5|12.5|||
4432759|NCT00129220|4257473|B1|||Age of Onset of Illness||years|Mean|31.2|31.2|Standard Deviation|11.6|11.6|||
4432760|NCT00129220|4257470|B4|||17-Item Hamilton Depression Rating Scale Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|4.7|4.7|Standard Deviation|4.1|4.1|||
4432761|NCT00129220|4257471|B3|||17-Item Hamilton Depression Rating Scale Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|4.9|4.9|Standard Deviation|4.5|4.5|||
4432762|NCT00129220|4257472|B2|||17-Item Hamilton Depression Rating Scale Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|4.1|4.1|Standard Deviation|3.7|3.7|||
4432763|NCT00129220|4257473|B1|||17-Item Hamilton Depression Rating Scale Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (e.g. absent, mild, moderate, severe, very severe) or a 3-point scale (e.g. absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|4.5|4.5|Standard Deviation|3.9|3.9|||
4432764|NCT00129220|4257470|B4|Mood-Incongruent||Psychosis|Type of psychosis for those participants who had a current illness episode of psychotic (total number of participants with data in this baseline measure will be less than the total in each arm)|participants|Number|1|1.0||||||
4432765|NCT00129220|4257471|B3|Mood-Incongruent||Psychosis|Type of psychosis for those participants who had a current illness episode of psychotic (total number of participants with data in this baseline measure will be less than the total in each arm)|participants|Number|0|0.0||||||
4432766|NCT00129220|4257472|B2|Mood-Incongruent||Psychosis|Type of psychosis for those participants who had a current illness episode of psychotic (total number of participants with data in this baseline measure will be less than the total in each arm)|participants|Number|0|0.0||||||
4432767|NCT00129220|4257473|B1|Mood-Incongruent||Psychosis|Type of psychosis for those participants who had a current illness episode of psychotic (total number of participants with data in this baseline measure will be less than the total in each arm)|participants|Number|1|1.0||||||
4432768|NCT00129220|4257470|B4|Mood-Congruent||Psychosis|Type of psychosis for those participants who had a current illness episode of psychotic (total number of participants with data in this baseline measure will be less than the total in each arm)|participants|Number|39|39.0||||||
4432769|NCT00129220|4257471|B3|Mood-Congruent||Psychosis|Type of psychosis for those participants who had a current illness episode of psychotic (total number of participants with data in this baseline measure will be less than the total in each arm)|participants|Number|19|19.0||||||
4432830|NCT00129116|4257723|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4432770|NCT00129220|4257472|B2|Mood-Congruent||Psychosis|Type of psychosis for those participants who had a current illness episode of psychotic (total number of participants with data in this baseline measure will be less than the total in each arm)|participants|Number|4|4.0||||||
4432771|NCT00129220|4257473|B1|Mood-Congruent||Psychosis|Type of psychosis for those participants who had a current illness episode of psychotic (total number of participants with data in this baseline measure will be less than the total in each arm)|participants|Number|16|16.0||||||
4432772|NCT00129220|4257470|B4|Out-Patients||Hospitalization Status||participants|Number|132|132.0||||||
4432773|NCT00129220|4257471|B3|Out-Patients||Hospitalization Status||participants|Number|59|59.0||||||
4432774|NCT00129220|4257472|B2|Out-Patients||Hospitalization Status||participants|Number|10|10.0||||||
4432775|NCT00129220|4257473|B1|Out-Patients||Hospitalization Status||participants|Number|63|63.0||||||
4432776|NCT00129220|4257470|B4|In-Patients||Hospitalization Status||participants|Number|89|89.0||||||
4432777|NCT00129220|4257471|B3|In-Patients||Hospitalization Status||participants|Number|38|38.0||||||
4432778|NCT00129220|4257472|B2|In-Patients||Hospitalization Status||participants|Number|10|10.0||||||
4432779|NCT00129220|4257473|B1|In-Patients||Hospitalization Status||participants|Number|41|41.0||||||
4432780|NCT00129220|4257470|B4|Nonpsychotic||Current Illness Episode: Psychotic versus Nonpsychotic||participants|Number|181|181.0||||||
4432781|NCT00129220|4257471|B3|Nonpsychotic||Current Illness Episode: Psychotic versus Nonpsychotic||participants|Number|78|78.0||||||
4432782|NCT00129220|4257472|B2|Nonpsychotic||Current Illness Episode: Psychotic versus Nonpsychotic||participants|Number|16|16.0||||||
4432783|NCT00129220|4257473|B1|Nonpsychotic||Current Illness Episode: Psychotic versus Nonpsychotic||participants|Number|87|87.0||||||
4432784|NCT00129220|4257470|B4|Psychotic||Current Illness Episode: Psychotic versus Nonpsychotic||participants|Number|40|40.0||||||
4432785|NCT00129220|4257471|B3|Psychotic||Current Illness Episode: Psychotic versus Nonpsychotic||participants|Number|19|19.0||||||
4432786|NCT00129220|4257472|B2|Psychotic||Current Illness Episode: Psychotic versus Nonpsychotic||participants|Number|4|4.0||||||
4432787|NCT00129220|4257473|B1|Psychotic||Current Illness Episode: Psychotic versus Nonpsychotic||participants|Number|17|17.0||||||
4432788|NCT00129220|4257470|B4|Mixed||Current Illness Episode: Manic versus Mixed||participants|Number|18|18.0||||||
4432789|NCT00129220|4257471|B3|Mixed||Current Illness Episode: Manic versus Mixed||participants|Number|8|8.0||||||
4432790|NCT00129220|4257472|B2|Mixed||Current Illness Episode: Manic versus Mixed||participants|Number|1|1.0||||||
4432791|NCT00129220|4257473|B1|Mixed||Current Illness Episode: Manic versus Mixed||participants|Number|9|9.0||||||
4432792|NCT00129220|4257470|B4|Manic||Current Illness Episode: Manic versus Mixed||participants|Number|203|203.0||||||
4432793|NCT00129220|4257471|B3|Manic||Current Illness Episode: Manic versus Mixed||participants|Number|89|89.0||||||
4432794|NCT00129220|4257472|B2|Manic||Current Illness Episode: Manic versus Mixed||participants|Number|19|19.0||||||
4432795|NCT00129220|4257473|B1|Manic||Current Illness Episode: Manic versus Mixed||participants|Number|95|95.0||||||
4432796|NCT00129220|4257470|B4|Japan||Region of Enrollment||participants|Number|221|221.0||||||
4432797|NCT00129220|4257471|B3|Japan||Region of Enrollment||participants|Number|97|97.0||||||
4432798|NCT00129220|4257472|B2|Japan||Region of Enrollment||participants|Number|20|20.0||||||
4432799|NCT00129220|4257473|B1|Japan||Region of Enrollment||participants|Number|104|104.0||||||
4432800|NCT00129220|4257470|B4|Japanese||Race/Ethnicity, Customized||participants|Number|221|221.0||||||
4432801|NCT00129220|4257471|B3|Japanese||Race/Ethnicity, Customized||participants|Number|97|97.0||||||
4432802|NCT00129220|4257472|B2|Japanese||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4432803|NCT00129220|4257473|B1|Japanese||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4432804|NCT00129220|4257470|B4||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4432805|NCT00129220|4257471|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4432806|NCT00129220|4257472|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4432807|NCT00129220|4257473|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4432808|NCT00129220|4257470|B4||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4432809|NCT00129220|4257471|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4432810|NCT00129220|4257472|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4432811|NCT00129220|4257473|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4432812|NCT00129220|4257470|B4|||Age||years|Mean|43.4|43.4|Standard Deviation|11.6|11.6|||
4432813|NCT00129220|4257471|B3|||Age||years|Mean|42.5|42.5|Standard Deviation|10.9|10.9|||
4432814|NCT00129220|4257472|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|11.9|11.9|||
4432815|NCT00129220|4257473|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|12.0|12.0|||
4432816|NCT00129129|4257512|B4||Male|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4432817|NCT00129129|4257513|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4432818|NCT00129129|4257514|B2||Male|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4432819|NCT00129129|4257515|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4432820|NCT00129129|4257512|B4||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4432821|NCT00129129|4257513|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4432822|NCT00129129|4257514|B2||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4432823|NCT00129129|4257515|B1||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4432824|NCT00129129|4257512|B4|||Age||Days|Mean|560.8|560.8|Standard Deviation|118.0|118.0|||
4432825|NCT00129129|4257513|B3|||Age||Days|Mean|1554.1|1554.1|Standard Deviation|338.4|338.4|||
4432826|NCT00129129|4257514|B2|||Age||Days|Mean|64.0|64.0|Standard Deviation|7.52|7.52|||
4432831|NCT00129116|4257724|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4432832|NCT00129116|4257725|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4432833|NCT00129116|4257726|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4432834|NCT00129116|4257721|B6||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4432835|NCT00129116|4257722|B5||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4432836|NCT00129116|4257723|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4432837|NCT00129116|4257724|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4432838|NCT00129116|4257725|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4432839|NCT00129116|4257726|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4432840|NCT00129116|4257721|B6|||Age||Weeks|Mean|8.7|8.7|Standard Deviation|1.65|1.65|||
4432841|NCT00129116|4257722|B5|||Age||Weeks|Mean|9.0|9.0|Standard Deviation|1.65|1.65|||
4432842|NCT00129116|4257723|B4|||Age||Weeks|Mean|8.3|8.3|Standard Deviation|1.63|1.63|||
4432843|NCT00129116|4257724|B3|||Age||Weeks|Mean|8.7|8.7|Standard Deviation|1.55|1.55|||
4432844|NCT00129116|4257725|B2|||Age||Weeks|Mean|8.8|8.8|Standard Deviation|1.72|1.72|||
4432845|NCT00129116|4257726|B1|||Age||Weeks|Mean|8.5|8.5|Standard Deviation|1.69|1.69|||
4432846|NCT00128921|4257992|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4432847|NCT00128921|4257994|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4432848|NCT00128921|4257995|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4432849|NCT00128921|4257992|B4|Male||Gender||participants|Number|9|9.0||||||
4432850|NCT00128921|4257994|B2|Male||Gender||participants|Number|4|4.0||||||
4432851|NCT00128921|4257995|B1|Male||Gender||participants|Number|5|5.0||||||
4432852|NCT00128921|4257992|B4|Female||Gender||participants|Number|9|9.0||||||
4432853|NCT00128921|4257994|B2|Female||Gender||participants|Number|4|4.0||||||
4432854|NCT00128921|4257995|B1|Female||Gender||participants|Number|5|5.0||||||
4432855|NCT00128921|4257992|B4|||Age||years|Mean|67.55|67.55|Standard Deviation|8.98|8.98|||
4432856|NCT00128921|4257994|B2|||Age||years|Mean|70.75|70.75|Standard Deviation|8.69|8.69|||
4432857|NCT00128921|4257995|B1|||Age||years|Mean|65|65.0|Standard Deviation|8.78|8.78|||
4432858|NCT00128921|4257992|B4|>=65 years||Age||participants|Number|9|9.0||||||
4432859|NCT00128921|4257994|B2|>=65 years||Age||participants|Number|5|5.0||||||
4432860|NCT00128921|4257995|B1|>=65 years||Age||participants|Number|4|4.0||||||
4432861|NCT00128921|4257992|B4|Between 18 and 65 years||Age||participants|Number|9|9.0||||||
4432862|NCT00128921|4257994|B2|Between 18 and 65 years||Age||participants|Number|3|3.0||||||
4432863|NCT00128921|4257995|B1|Between 18 and 65 years||Age||participants|Number|6|6.0||||||
4432864|NCT00128921|4257992|B4|<=18 years||Age||participants|Number|0|0.0||||||
4432865|NCT00128921|4257994|B2|<=18 years||Age||participants|Number|0|0.0||||||
4432866|NCT00128921|4257995|B1|<=18 years||Age||participants|Number|0|0.0||||||
4432867|NCT00128830|4258014|B1|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4432868|NCT00128830|4258014|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4432869|NCT00128830|4258014|B1|White||Race/Ethnicity, Customized||Participants|Number|164|164.0||||||
4432870|NCT00128830|4258014|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4432871|NCT00128830|4258014|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4432872|NCT00128830|4258014|B1||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4432873|NCT00128830|4258014|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4432874|NCT00128830|4258014|B1|||Age||years|Median|46.0|46.0|Full Range|7.56|7.56|32.0|70.0|
4432875|NCT00128713|4258029|B4|||Weight||kg|Mean|76.1|76.1|Standard Deviation|25.0|25.0|||
4432876|NCT00128713|4258030|B3|||Weight||kg|Mean|76.0|76.0|Standard Deviation|23.8|23.8|||
4432877|NCT00128713|4258031|B2|||Weight||kg|Mean|75.0|75.0|Standard Deviation|26.3|26.3|||
4432878|NCT00128713|4258032|B1|||Weight||kg|Mean|77.4|77.4|Standard Deviation|24.9|24.9|||
4432879|NCT00128713|4258029|B4|||Height||cm|Mean|165.2|165.2|Standard Deviation|20.8|20.8|||
4432880|NCT00128713|4258030|B3|||Height||cm|Mean|166.2|166.2|Standard Deviation|19.3|19.3|||
4432881|NCT00128713|4258031|B2|||Height||cm|Mean|164.0|164.0|Standard Deviation|21.7|21.7|||
4432882|NCT00128713|4258032|B1|||Height||cm|Mean|165.5|165.5|Standard Deviation|21.4|21.4|||
4432883|NCT00128713|4258029|B4|||Body Surface Area||m^2|Mean|1.8|1.8|Standard Deviation|0.4|0.4|||
4432884|NCT00128713|4258030|B3|||Body Surface Area||m^2|Mean|1.8|1.8|Standard Deviation|0.4|0.4|||
4432885|NCT00128713|4258031|B2|||Body Surface Area||m^2|Mean|1.8|1.8|Standard Deviation|0.4|0.4|||
4432886|NCT00128713|4258032|B1|||Body Surface Area||m^2|Mean|1.8|1.8|Standard Deviation|0.4|0.4|||
4432887|NCT00128713|4258029|B4|Chemotherapy for solid tumor||Treatment Regimen||Participants|Number|8|8.0||||||
4432888|NCT00128713|4258030|B3|Chemotherapy for solid tumor||Treatment Regimen||Participants|Number|2|2.0||||||
4432889|NCT00128713|4258031|B2|Chemotherapy for solid tumor||Treatment Regimen||Participants|Number|3|3.0||||||
4432890|NCT00128713|4258032|B1|Chemotherapy for solid tumor||Treatment Regimen||Participants|Number|3|3.0||||||
4432891|NCT00128713|4258029|B4|Chemotherapy for hematologic malignancy||Treatment Regimen||Participants|Number|333|333.0||||||
4432892|NCT00128713|4258030|B3|Chemotherapy for hematologic malignancy||Treatment Regimen||Participants|Number|110|110.0||||||
4432893|NCT00128713|4258031|B2|Chemotherapy for hematologic malignancy||Treatment Regimen||Participants|Number|112|112.0||||||
4432894|NCT00128713|4258032|B1|Chemotherapy for hematologic malignancy||Treatment Regimen||Participants|Number|111|111.0||||||
4432895|NCT00128713|4258029|B4|Allogeneic stem cell transplant||Treatment Regimen||Participants|Number|556|556.0||||||
4432896|NCT00128713|4258030|B3|Allogeneic stem cell transplant||Treatment Regimen||Participants|Number|186|186.0||||||
4432897|NCT00128713|4258031|B2|Allogeneic stem cell transplant||Treatment Regimen||Participants|Number|185|185.0||||||
4432898|NCT00128713|4258032|B1|Allogeneic stem cell transplant||Treatment Regimen||Participants|Number|185|185.0||||||
4432899|NCT00128713|4258029|B4|Autologous or syngeneic stem cell transplant||Treatment Regimen||Participants|Number|454|454.0||||||
4432900|NCT00128713|4258030|B3|Autologous or syngeneic stem cell transplant||Treatment Regimen||Participants|Number|151|151.0||||||
4432901|NCT00128713|4258031|B2|Autologous or syngeneic stem cell transplant||Treatment Regimen||Participants|Number|149|149.0||||||
4432902|NCT00128713|4258032|B1|Autologous or syngeneic stem cell transplant||Treatment Regimen||Participants|Number|154|154.0||||||
4432903|NCT00128713|4258029|B4|United States||Region of Enrollment||participants|Number|1351|1351.0||||||
4432904|NCT00128713|4258030|B3|United States||Region of Enrollment||participants|Number|449|449.0||||||
4432905|NCT00128713|4258031|B2|United States||Region of Enrollment||participants|Number|449|449.0||||||
4432906|NCT00128713|4258032|B1|United States||Region of Enrollment||participants|Number|453|453.0||||||
4432907|NCT00128713|4258029|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4432908|NCT00128713|4258030|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4432909|NCT00128713|4258031|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4432910|NCT00128713|4258032|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4432911|NCT00128713|4258029|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1281|1281.0||||||
4432912|NCT00128713|4258030|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|423|423.0||||||
4432913|NCT00128713|4258031|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|425|425.0||||||
4432914|NCT00128713|4258032|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|433|433.0||||||
4432915|NCT00128713|4258029|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4432916|NCT00128713|4258030|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4432917|NCT00128713|4258031|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4432918|NCT00128713|4258032|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4432919|NCT00128713|4258029|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4432920|NCT00128713|4258030|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4432921|NCT00128713|4258031|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4432922|NCT00128713|4258032|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4432923|NCT00128713|4258029|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4432924|NCT00128713|4258030|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4432925|NCT00128713|4258031|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4432926|NCT00128713|4258032|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4432927|NCT00128713|4258029|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1114|1114.0||||||
4432928|NCT00128713|4258030|B3||White|Race (NIH/OMB)||Participants|Count of Participants|378|378.0||||||
4432929|NCT00128713|4258031|B2||White|Race (NIH/OMB)||Participants|Count of Participants|374|374.0||||||
4432930|NCT00128713|4258032|B1||White|Race (NIH/OMB)||Participants|Count of Participants|362|362.0||||||
4432931|NCT00128713|4258029|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|130|130.0||||||
4432932|NCT00128713|4258030|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4432933|NCT00128713|4258031|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4432934|NCT00128713|4258032|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4432935|NCT00128713|4258029|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4432936|NCT00128713|4258030|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432937|NCT00128713|4258031|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4432938|NCT00128713|4258032|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4432939|NCT00128713|4258029|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4432940|NCT00128713|4258030|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4432941|NCT00128713|4258031|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4432942|NCT00128713|4258032|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4432943|NCT00128713|4258029|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4432944|NCT00128713|4258030|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4432945|NCT00128713|4258031|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4432946|NCT00128713|4258032|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4432947|NCT00128713|4258029|B4|Unknown/not reported||Sex/Gender, Customized||participants|Number|1|1.0||||||
4432948|NCT00128713|4258030|B3|Unknown/not reported||Sex/Gender, Customized||participants|Number|0|0.0||||||
4432949|NCT00128713|4258031|B2|Unknown/not reported||Sex/Gender, Customized||participants|Number|1|1.0||||||
4432950|NCT00128713|4258032|B1|Unknown/not reported||Sex/Gender, Customized||participants|Number|0|0.0||||||
4432951|NCT00128713|4258029|B4|Male||Sex/Gender, Customized||participants|Number|816|816.0||||||
4432952|NCT00128713|4258030|B3|Male||Sex/Gender, Customized||participants|Number|280|280.0||||||
4432953|NCT00128713|4258031|B2|Male||Sex/Gender, Customized||participants|Number|272|272.0||||||
4432954|NCT00128713|4258032|B1|Male||Sex/Gender, Customized||participants|Number|264|264.0||||||
4432955|NCT00128713|4258029|B4|Female||Sex/Gender, Customized||participants|Number|534|534.0||||||
4432956|NCT00128713|4258030|B3|Female||Sex/Gender, Customized||participants|Number|169|169.0||||||
4432957|NCT00128713|4258031|B2|Female||Sex/Gender, Customized||participants|Number|176|176.0||||||
4432958|NCT00128713|4258032|B1|Female||Sex/Gender, Customized||participants|Number|189|189.0||||||
4432959|NCT00128713|4258029|B4|Unknown/not reported||Age, Customized||participants|Number|1|1.0||||||
4432960|NCT00128713|4258030|B3|Unknown/not reported||Age, Customized||participants|Number|0|0.0||||||
4432961|NCT00128713|4258031|B2|Unknown/not reported||Age, Customized||participants|Number|1|1.0||||||
4432962|NCT00128713|4258032|B1|Unknown/not reported||Age, Customized||participants|Number|0|0.0||||||
4432963|NCT00128713|4258029|B4|>=21 years||Age, Customized||participants|Number|1128|1128.0||||||
4432964|NCT00128713|4258030|B3|>=21 years||Age, Customized||participants|Number|377|377.0||||||
4432965|NCT00128713|4258031|B2|>=21 years||Age, Customized||participants|Number|374|374.0||||||
4432966|NCT00128713|4258032|B1|>=21 years||Age, Customized||participants|Number|377|377.0||||||
4432967|NCT00128713|4258029|B4|18 - 20 years||Age, Customized||participants|Number|23|23.0||||||
4432968|NCT00128713|4258030|B3|18 - 20 years||Age, Customized||participants|Number|8|8.0||||||
4432969|NCT00128713|4258031|B2|18 - 20 years||Age, Customized||participants|Number|6|6.0||||||
4432970|NCT00128713|4258032|B1|18 - 20 years||Age, Customized||participants|Number|9|9.0||||||
4432971|NCT00128713|4258029|B4|0 - 17 years||Age, Customized||participants|Number|199|199.0||||||
4432972|NCT00128713|4258030|B3|0 - 17 years||Age, Customized||participants|Number|64|64.0||||||
4432973|NCT00128713|4258031|B2|0 - 17 years||Age, Customized||participants|Number|68|68.0||||||
4432974|NCT00128713|4258032|B1|0 - 17 years||Age, Customized||participants|Number|67|67.0||||||
4432975|NCT00128713|4258029|B4|||Age||years|Mean|44.6|44.6|Standard Deviation|19.4|19.4|||
4432976|NCT00128713|4258030|B3|||Age||years|Mean|45.5|45.5|Standard Deviation|19.7|19.7|||
4432977|NCT00128713|4258031|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|19.3|19.3|||
4432978|NCT00128713|4258032|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|19.3|19.3|||
4432979|NCT00128661|4258054|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432980|NCT00128661|4258055|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432981|NCT00128661|4258056|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4432982|NCT00128661|4258054|B3||Female|Sex: Female, Male||Participants|Count of Participants|7466|7466.0||||||
4432983|NCT00128661|4258055|B2||Female|Sex: Female, Male||Participants|Count of Participants|3739|3739.0||||||
4432984|NCT00128661|4258056|B1||Female|Sex: Female, Male||Participants|Count of Participants|3727|3727.0||||||
4432985|NCT00128661|4258054|B3|Years||Age||Years|Mean|21.1|21.1|Standard Deviation|2.3|2.3|||
4432986|NCT00128661|4258055|B2|Years||Age||Years|Mean|21.1|21.1|Standard Deviation|2.3|2.3|||
4432987|NCT00128661|4258056|B1|Years||Age||Years|Mean|21.1|21.1|Standard Deviation|2.3|2.3|||
4432988|NCT00128492|4258101|B3|||Weight||kg|Mean|59.36|59.36|Standard Deviation|15.05|15.05|||
4432989|NCT00128492|4258102|B2|||Weight||kg|Mean|59.28|59.28|Standard Deviation|15.81|15.81|||
4432990|NCT00128492|4258103|B1|||Weight||kg|Mean|59.52|59.52|Standard Deviation|13.28|13.28|||
4432991|NCT00128492|4258101|B3|||Log10 Pseudomonas aeruginosa (PA) Colony-Forming Units (CFUs) in Sputum||log10 CFUs/g|Mean|6.02|6.02|Standard Deviation|2.014|2.014|||
4432992|NCT00128492|4258102|B2|||Log10 Pseudomonas aeruginosa (PA) Colony-Forming Units (CFUs) in Sputum||log10 CFUs/g|Mean|6.16|6.16|Standard Deviation|1.894|1.894|||
4432993|NCT00128492|4258103|B1|||Log10 Pseudomonas aeruginosa (PA) Colony-Forming Units (CFUs) in Sputum||log10 CFUs/g|Mean|5.71|5.71|Standard Deviation|2.249|2.249|||
4432994|NCT00128492|4258101|B3|||Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height.|Percent|Mean|55.582|55.582|Standard Deviation|16.089|16.089|||
4432995|NCT00128492|4258102|B2|||Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height.|Percent|Mean|55.071|55.071|Standard Deviation|15.428|15.428|||
4432996|NCT00128492|4258103|B1|||Forced Expiratory Volume in 1 Second (FEV1) Percent Predicted|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height.|Percent|Mean|56.711|56.711|Standard Deviation|17.505|17.505|||
4432997|NCT00128492|4258101|B3|||Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Score (CFQ-R RSS)|CFQ-R RSS scale range 0-100, with higher scores indicating fewer CF symptoms.|Units on a scale|Mean|61.895|61.895|Standard Deviation|18.141|18.141|||
4432998|NCT00128492|4258102|B2|||Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Score (CFQ-R RSS)|CFQ-R RSS scale range 0-100, with higher scores indicating fewer CF symptoms.|Units on a scale|Mean|60.332|60.332|Standard Deviation|18.497|18.497|||
4432999|NCT00128492|4258103|B1|||Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Score (CFQ-R RSS)|CFQ-R RSS scale range 0-100, with higher scores indicating fewer CF symptoms.|Units on a scale|Mean|65.410|65.41|Standard Deviation|16.896|16.896|||
4433000|NCT00128492|4258101|B3|||Body Mass Index (BMI)||kg/m^2|Mean|21.40|21.4|Standard Deviation|3.75|3.75|||
4433001|NCT00128492|4258102|B2|||Body Mass Index (BMI)||kg/m^2|Mean|21.44|21.44|Standard Deviation|3.96|3.96|||
4433002|NCT00128492|4258103|B1|||Body Mass Index (BMI)||kg/m^2|Mean|21.30|21.3|Standard Deviation|3.25|3.25|||
4433003|NCT00128492|4258101|B3|Unknown||Disease severity as defined by FEV1 percent predicted category|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|Participants|Number|1|1.0||||||
4433004|NCT00128492|4258102|B2|Unknown||Disease severity as defined by FEV1 percent predicted category|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|Participants|Number|1|1.0||||||
4433005|NCT00128492|4258103|B1|Unknown||Disease severity as defined by FEV1 percent predicted category|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|Participants|Number|0|0.0||||||
4433006|NCT00128492|4258101|B3|FEV1 ≤ 50% predicted||Disease severity as defined by FEV1 percent predicted category|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|Participants|Number|110|110.0||||||
4433007|NCT00128492|4258102|B2|FEV1 ≤ 50% predicted||Disease severity as defined by FEV1 percent predicted category|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|Participants|Number|74|74.0||||||
4433008|NCT00128492|4258103|B1|FEV1 ≤ 50% predicted||Disease severity as defined by FEV1 percent predicted category|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|Participants|Number|36|36.0||||||
4433009|NCT00128492|4258101|B3|FEV1 > 50% predicted||Disease severity as defined by FEV1 percent predicted category|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|Participants|Number|163|163.0||||||
4433010|NCT00128492|4258102|B2|FEV1 > 50% predicted||Disease severity as defined by FEV1 percent predicted category|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|Participants|Number|114|114.0||||||
4433011|NCT00128492|4258103|B1|FEV1 > 50% predicted||Disease severity as defined by FEV1 percent predicted category|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|Participants|Number|49|49.0||||||
4433012|NCT00128492|4258101|B3|Unknown||Aztreonam Minimum Inhibitory Concentration (MIC) for Pseudomonas aeruginosa (PA)|Number of partipipants with an MIC of aztreonam ≤ 8 µg/mL or >8 µg/mL for PA are summarized.|participants|Number|27|27.0||||||
4433013|NCT00128492|4258102|B2|Unknown||Aztreonam Minimum Inhibitory Concentration (MIC) for Pseudomonas aeruginosa (PA)|Number of partipipants with an MIC of aztreonam ≤ 8 µg/mL or >8 µg/mL for PA are summarized.|participants|Number|18|18.0||||||
4433014|NCT00128492|4258103|B1|Unknown||Aztreonam Minimum Inhibitory Concentration (MIC) for Pseudomonas aeruginosa (PA)|Number of partipipants with an MIC of aztreonam ≤ 8 µg/mL or >8 µg/mL for PA are summarized.|participants|Number|9|9.0||||||
4433015|NCT00128492|4258101|B3|Aztreonam MIC < or = 8 µg/mL||Aztreonam Minimum Inhibitory Concentration (MIC) for Pseudomonas aeruginosa (PA)|Number of partipipants with an MIC of aztreonam ≤ 8 µg/mL or >8 µg/mL for PA are summarized.|participants|Number|145|145.0||||||
4433016|NCT00128492|4258102|B2|Aztreonam MIC < or = 8 µg/mL||Aztreonam Minimum Inhibitory Concentration (MIC) for Pseudomonas aeruginosa (PA)|Number of partipipants with an MIC of aztreonam ≤ 8 µg/mL or >8 µg/mL for PA are summarized.|participants|Number|99|99.0||||||
4433017|NCT00128492|4258103|B1|Aztreonam MIC < or = 8 µg/mL||Aztreonam Minimum Inhibitory Concentration (MIC) for Pseudomonas aeruginosa (PA)|Number of partipipants with an MIC of aztreonam ≤ 8 µg/mL or >8 µg/mL for PA are summarized.|participants|Number|46|46.0||||||
4433018|NCT00128492|4258101|B3|Aztreonam MIC > 8 µg/mL||Aztreonam Minimum Inhibitory Concentration (MIC) for Pseudomonas aeruginosa (PA)|Number of partipipants with an MIC of aztreonam ≤ 8 µg/mL or >8 µg/mL for PA are summarized.|participants|Number|102|102.0||||||
4433019|NCT00128492|4258102|B2|Aztreonam MIC > 8 µg/mL||Aztreonam Minimum Inhibitory Concentration (MIC) for Pseudomonas aeruginosa (PA)|Number of partipipants with an MIC of aztreonam ≤ 8 µg/mL or >8 µg/mL for PA are summarized.|participants|Number|72|72.0||||||
4433020|NCT00128492|4258103|B1|Aztreonam MIC > 8 µg/mL||Aztreonam Minimum Inhibitory Concentration (MIC) for Pseudomonas aeruginosa (PA)|Number of partipipants with an MIC of aztreonam ≤ 8 µg/mL or >8 µg/mL for PA are summarized.|participants|Number|30|30.0||||||
4433021|NCT00128492|4258101|B3|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4433022|NCT00128492|4258102|B2|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4433023|NCT00128492|4258103|B1|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4433024|NCT00128492|4258101|B3|Australia||Region of Enrollment||participants|Number|22|22.0||||||
4433025|NCT00128492|4258102|B2|Australia||Region of Enrollment||participants|Number|22|22.0||||||
4433026|NCT00128492|4258103|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4433027|NCT00128492|4258101|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4433028|NCT00128492|4258102|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4433029|NCT00128492|4258103|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4433030|NCT00128492|4258101|B3|United States||Region of Enrollment||participants|Number|242|242.0||||||
4433031|NCT00128492|4258102|B2|United States||Region of Enrollment||participants|Number|157|157.0||||||
4433032|NCT00128492|4258103|B1|United States||Region of Enrollment||participants|Number|85|85.0||||||
4433033|NCT00128492|4258101|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4433034|NCT00128492|4258102|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4433035|NCT00128492|4258103|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4433036|NCT00128492|4258101|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4433037|NCT00128492|4258102|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4433038|NCT00128492|4258103|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4433039|NCT00128492|4258101|B3|||Age||years|Mean|28.5|28.5|Standard Deviation|12.5|12.5|||
4433040|NCT00128492|4258102|B2|||Age||years|Mean|29.0|29.0|Standard Deviation|13.0|13.0|||
4433041|NCT00128492|4258103|B1|||Age||years|Mean|27.3|27.3|Standard Deviation|11.4|11.4|||
4433042|NCT00128492|4258101|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4433043|NCT00128492|4258102|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4433044|NCT00128492|4258103|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4433045|NCT00128492|4258101|B3||Between 18 and 65 years|Age||Participants|Count of Participants|216|216.0||||||
4433046|NCT00128492|4258102|B2||Between 18 and 65 years|Age||Participants|Count of Participants|151|151.0||||||
4433047|NCT00128492|4258103|B1||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4433048|NCT00128492|4258101|B3||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4433049|NCT00128492|4258102|B2||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4433050|NCT00128492|4258103|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4433051|NCT00128401|4258162|B3|||Liebowitz Social Anxiety Scale (LSAS) - baseline|"Social anxiety symptoms were assessed using the Liebowitz Social Anxiety Scale (LSAS). It is a 24-item self-report instrument that measures overall social anxiety fear and avoidance symptoms. This is the baseline assessment. The 24 items are each rated twice, from a 0 to 3 scale, with 0 indicated no level of symptom and 3 indicating a high level of the system. One rating is for anxiety, and the other is for avoidance. Thus, the lowest possible score is 0, and the highest possible score is 144. The total score represents the simple sum of all 48 ratings."|Units on a scale|Mean|83.725|83.725|Standard Deviation|25.910|25.91|||
4433052|NCT00128401|4258163|B2|||Liebowitz Social Anxiety Scale (LSAS) - baseline|"Social anxiety symptoms were assessed using the Liebowitz Social Anxiety Scale (LSAS). It is a 24-item self-report instrument that measures overall social anxiety fear and avoidance symptoms. This is the baseline assessment. The 24 items are each rated twice, from a 0 to 3 scale, with 0 indicated no level of symptom and 3 indicating a high level of the system. One rating is for anxiety, and the other is for avoidance. Thus, the lowest possible score is 0, and the highest possible score is 144. The total score represents the simple sum of all 48 ratings."|Units on a scale|Mean|75.588|75.588|Standard Deviation|25.063|25.063|||
4433053|NCT00128401|4258164|B1|||Liebowitz Social Anxiety Scale (LSAS) - baseline|"Social anxiety symptoms were assessed using the Liebowitz Social Anxiety Scale (LSAS). It is a 24-item self-report instrument that measures overall social anxiety fear and avoidance symptoms. This is the baseline assessment. The 24 items are each rated twice, from a 0 to 3 scale, with 0 indicated no level of symptom and 3 indicating a high level of the system. One rating is for anxiety, and the other is for avoidance. Thus, the lowest possible score is 0, and the highest possible score is 144. The total score represents the simple sum of all 48 ratings."|Units on a scale|Mean|89.9|89.9|Standard Deviation|27.028|27.028|||
4433054|NCT00128401|4258162|B3|||Clinical Global Impressions (CGI) - baseline|Symptom severity and improvement was assessed using the Clinical Global Impressions scale (CGI). It is a 2-item clinician-administered instrument that measures severity and improvement. One item characterizes subjects at baseline and at each post-baseline visit, based on severity. This is the CGI-S scale. This scale ranges from a score of 1 (normal, not all ill) to 7 (among the most extremely ill patients). The second item, the primary efficacy measure, is only rated after baseline, to quantify the amount of change. This ranges from 1 (completely recovered) to 8 (much worse).|Units on a scale|Mean|4.286|4.286|Standard Deviation|0.554|0.554|||
4433055|NCT00128401|4258163|B2|||Clinical Global Impressions (CGI) - baseline|Symptom severity and improvement was assessed using the Clinical Global Impressions scale (CGI). It is a 2-item clinician-administered instrument that measures severity and improvement. One item characterizes subjects at baseline and at each post-baseline visit, based on severity. This is the CGI-S scale. This scale ranges from a score of 1 (normal, not all ill) to 7 (among the most extremely ill patients). The second item, the primary efficacy measure, is only rated after baseline, to quantify the amount of change. This ranges from 1 (completely recovered) to 8 (much worse).|Units on a scale|Mean|4.278|4.278|Standard Deviation|0.576|0.576|||
4433056|NCT00128401|4258164|B1|||Clinical Global Impressions (CGI) - baseline|Symptom severity and improvement was assessed using the Clinical Global Impressions scale (CGI). It is a 2-item clinician-administered instrument that measures severity and improvement. One item characterizes subjects at baseline and at each post-baseline visit, based on severity. This is the CGI-S scale. This scale ranges from a score of 1 (normal, not all ill) to 7 (among the most extremely ill patients). The second item, the primary efficacy measure, is only rated after baseline, to quantify the amount of change. This ranges from 1 (completely recovered) to 8 (much worse).|Units on a scale|Mean|4.35|4.35|Standard Deviation|0.587|0.587|||
4433057|NCT00128401|4258162|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4433058|NCT00128401|4258163|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4433059|NCT00128401|4258164|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4433060|NCT00128401|4258162|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4433061|NCT00128401|4258163|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4433062|NCT00128401|4258164|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433063|NCT00128401|4258162|B3||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4433064|NCT00128401|4258163|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4433065|NCT00128401|4258164|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4433066|NCT00128401|4258162|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4433067|NCT00128401|4258163|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4433068|NCT00128401|4258164|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4433069|NCT00128401|4258162|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433070|NCT00128401|4258163|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433071|NCT00128401|4258164|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433072|NCT00128401|4258162|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4433073|NCT00128401|4258163|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4433074|NCT00128401|4258164|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4433075|NCT00128401|4258162|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433076|NCT00128401|4258163|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433077|NCT00128401|4258164|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433078|NCT00128401|4258162|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433079|NCT00128401|4258163|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433080|NCT00128401|4258164|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433081|NCT00128401|4258162|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4433082|NCT00128401|4258163|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4433083|NCT00128401|4258164|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4433084|NCT00128401|4258162|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4433085|NCT00128401|4258163|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4433086|NCT00128401|4258164|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433087|NCT00128401|4258162|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4433088|NCT00128401|4258163|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4433089|NCT00128401|4258164|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4433090|NCT00128401|4258162|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4433091|NCT00128401|4258163|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4433092|NCT00128401|4258164|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4433093|NCT00128401|4258162|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433094|NCT00128401|4258163|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433095|NCT00128401|4258164|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433096|NCT00128401|4258162|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4433097|NCT00128401|4258163|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4433098|NCT00128401|4258164|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4433099|NCT00128401|4258162|B3||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4433100|NCT00128401|4258163|B2||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4433101|NCT00128401|4258164|B1||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4433102|NCT00128219|4258174|B3|United States||Region of Enrollment||participants|Number|667|667.0||||||
4433103|NCT00128219|4258175|B2|United States||Region of Enrollment||participants|Number|334|334.0||||||
4433104|NCT00128219|4258176|B1|United States||Region of Enrollment||participants|Number|333|333.0||||||
4433105|NCT00128219|4258174|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4433106|NCT00128219|4258175|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4433107|NCT00128219|4258176|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4433108|NCT00128219|4258174|B3||Female|Sex: Female, Male||Participants|Count of Participants|667|667.0||||||
4433109|NCT00128219|4258175|B2||Female|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
4433110|NCT00128219|4258176|B1||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4433111|NCT00128219|4258174|B3|||Age||years|Mean|26.2|26.2|Standard Deviation|5.63|5.63|||
4433112|NCT00128219|4258175|B2|||Age||years|Mean|26.1|26.1|Standard Deviation|5.68|5.68|||
4433113|NCT00128219|4258176|B1|||Age||years|Mean|26.2|26.2|Standard Deviation|5.58|5.58|||
4433114|NCT00128219|4258174|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433115|NCT00128219|4258175|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433116|NCT00128219|4258176|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433117|NCT00128219|4258174|B3||Between 18 and 65 years|Age||Participants|Count of Participants|667|667.0||||||
4433118|NCT00128219|4258175|B2||Between 18 and 65 years|Age||Participants|Count of Participants|334|334.0||||||
4433119|NCT00128219|4258176|B1||Between 18 and 65 years|Age||Participants|Count of Participants|333|333.0||||||
4433120|NCT00128219|4258174|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433121|NCT00128219|4258175|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433122|NCT00128219|4258176|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433123|NCT00128206|4258259|B3|United States||Region of Enrollment||participants|Number|364|364.0||||||
4433124|NCT00128206|4258260|B2|United States||Region of Enrollment||participants|Number|180|180.0||||||
4433125|NCT00128206|4258261|B1|United States||Region of Enrollment||participants|Number|184|184.0||||||
4433126|NCT00128206|4258259|B3||Male|Sex: Female, Male||Participants|Count of Participants|339|339.0||||||
4433127|NCT00128206|4258260|B2||Male|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4433128|NCT00128206|4258261|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4433129|NCT00128206|4258259|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4433130|NCT00128206|4258260|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4433131|NCT00128206|4258261|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4433132|NCT00128206|4258259|B3|||Age||years|Mean|30.9|30.9|Standard Deviation|9.59|9.59|||
4433133|NCT00128206|4258260|B2|||Age||years|Mean|31.51|31.51|Standard Deviation|9.57|9.57|||
4433134|NCT00128206|4258261|B1|||Age||years|Mean|30.34|30.34|Standard Deviation|9.59|9.59|||
4433135|NCT00128206|4258259|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4433136|NCT00128206|4258260|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433137|NCT00128206|4258261|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4433138|NCT00128206|4258259|B3||Between 18 and 65 years|Age||Participants|Count of Participants|363|363.0||||||
4433139|NCT00128206|4258260|B2||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
4433140|NCT00128206|4258261|B1||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
4433141|NCT00128206|4258259|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433142|NCT00128206|4258260|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433143|NCT00128206|4258261|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433144|NCT00128193|4258268|B13|Nepal||Region of Enrollment||participants|Number|260|260.0||||||
4433145|NCT00128193|4258269|B12|Nepal||Region of Enrollment||participants|Number|20|20.0||||||
4433146|NCT00128193|4258270|B11|Nepal||Region of Enrollment||participants|Number|20|20.0||||||
4433147|NCT00128193|4258271|B10|Nepal||Region of Enrollment||participants|Number|20|20.0||||||
4433148|NCT00128193|4258272|B9|Nepal||Region of Enrollment||participants|Number|20|20.0||||||
4433149|NCT00128193|4258273|B8|Nepal||Region of Enrollment||participants|Number|20|20.0||||||
4433150|NCT00128193|4258274|B7|Nepal||Region of Enrollment||participants|Number|20|20.0||||||
4433151|NCT00128193|4258275|B6|Nepal||Region of Enrollment||participants|Number|20|20.0||||||
4433152|NCT00128193|4258276|B5|Nepal||Region of Enrollment||participants|Number|20|20.0||||||
4433153|NCT00128193|4258277|B4|Nepal||Region of Enrollment||participants|Number|45|45.0||||||
4433154|NCT00128193|4258278|B3|Nepal||Region of Enrollment||participants|Number|45|45.0||||||
4433155|NCT00128193|4258279|B2|Nepal||Region of Enrollment||participants|Number|5|5.0||||||
4433156|NCT00128193|4258280|B1|Nepal||Region of Enrollment||participants|Number|5|5.0||||||
4433157|NCT00128193|4258268|B13||Male|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4433158|NCT00128193|4258269|B12||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4433159|NCT00128193|4258270|B11||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4433160|NCT00128193|4258271|B10||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4433161|NCT00128193|4258272|B9||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4433162|NCT00128193|4258273|B8||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4433163|NCT00128193|4258274|B7||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4433164|NCT00128193|4258275|B6||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4433165|NCT00128193|4258276|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4433166|NCT00128193|4258277|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4433167|NCT00128193|4258278|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4433168|NCT00128193|4258279|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4433169|NCT00128193|4258280|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4433170|NCT00128193|4258268|B13||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4433171|NCT00128193|4258269|B12||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4433172|NCT00128193|4258270|B11||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4433173|NCT00128193|4258271|B10||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4433174|NCT00128193|4258272|B9||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4433175|NCT00128193|4258273|B8||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4433176|NCT00128193|4258274|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4433177|NCT00128193|4258275|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4433178|NCT00128193|4258276|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4433179|NCT00128193|4258277|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4433180|NCT00128193|4258278|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4433181|NCT00128193|4258279|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4433182|NCT00128193|4258280|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4433183|NCT00128193|4258268|B13|||Age||years|Mean|28.5|28.5|Standard Deviation|11.3|11.3|||
4433184|NCT00128193|4258269|B12|||Age||years|Mean|31.1|31.1|Standard Deviation|13.1|13.1|||
4433185|NCT00128193|4258270|B11|||Age||years|Mean|30.2|30.2|Standard Deviation|12.1|12.1|||
4433186|NCT00128193|4258271|B10|||Age||years|Mean|39.0|39.0|Standard Deviation|13.5|13.5|||
4433187|NCT00128193|4258272|B9|||Age||years|Mean|35.2|35.2|Standard Deviation|13.1|13.1|||
4433188|NCT00128193|4258273|B8|||Age||years|Mean|26.0|26.0|Standard Deviation|7.7|7.7|||
4433189|NCT00128193|4258274|B7|||Age||years|Mean|32.9|32.9|Standard Deviation|11.0|11.0|||
4433190|NCT00128193|4258275|B6|||Age||years|Mean|32.9|32.9|Standard Deviation|12.9|12.9|||
4433191|NCT00128193|4258276|B5|||Age||years|Mean|37.5|37.5|Standard Deviation|12.3|12.3|||
4433192|NCT00128193|4258277|B4|||Age||years|Mean|23.1|23.1|Standard Deviation|6.7|6.7|||
4433193|NCT00128193|4258278|B3|||Age||years|Mean|21.1|21.1|Standard Deviation|5.3|5.3|||
4433194|NCT00128193|4258279|B2|||Age||years|Mean|29.4|29.4|Standard Deviation|2.9|2.9|||
4433195|NCT00128193|4258280|B1|||Age||years|Mean|30.6|30.6|Standard Deviation|6.4|6.4|||
4433196|NCT00128193|4258268|B13||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433197|NCT00128193|4258269|B12||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433198|NCT00128193|4258270|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433199|NCT00128193|4258271|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433200|NCT00128193|4258272|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433201|NCT00128193|4258273|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433202|NCT00128193|4258274|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433203|NCT00128193|4258275|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433204|NCT00128193|4258276|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433205|NCT00128193|4258277|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433206|NCT00128193|4258278|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433207|NCT00128193|4258279|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433208|NCT00128193|4258280|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433209|NCT00128193|4258268|B13||Between 18 and 65 years|Age||Participants|Count of Participants|227|227.0||||||
4433210|NCT00128193|4258269|B12||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4433211|NCT00128193|4258270|B11||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4433212|NCT00128193|4258271|B10||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4433213|NCT00128193|4258272|B9||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4433214|NCT00128193|4258273|B8||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4433215|NCT00128193|4258274|B7||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4433216|NCT00128193|4258275|B6||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4433217|NCT00128193|4258276|B5||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4433218|NCT00128193|4258277|B4||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4433219|NCT00128193|4258278|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4433220|NCT00128193|4258279|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4433221|NCT00128193|4258280|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4433222|NCT00128193|4258268|B13||<=18 years|Age||Participants|Count of Participants|33|33.0||||||
4433223|NCT00128193|4258269|B12||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4433224|NCT00128193|4258270|B11||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4433225|NCT00128193|4258271|B10||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4433226|NCT00128193|4258272|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433227|NCT00128193|4258273|B8||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4433228|NCT00128193|4258274|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433229|NCT00128193|4258275|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433230|NCT00128193|4258276|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433231|NCT00128193|4258277|B4||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4433232|NCT00128193|4258278|B3||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4433233|NCT00128193|4258279|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433234|NCT00128193|4258280|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433235|NCT00128180|4258525|B3|Chile||Region of Enrollment||participants|Number|66|66.0||||||
4433236|NCT00128180|4258526|B2|Chile||Region of Enrollment||participants|Number|34|34.0||||||
4433237|NCT00128180|4258527|B1|Chile||Region of Enrollment||participants|Number|32|32.0||||||
4433238|NCT00128180|4258525|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4433239|NCT00128180|4258526|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4433240|NCT00128180|4258527|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4433241|NCT00128180|4258525|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4433242|NCT00128180|4258526|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4433243|NCT00128180|4258527|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4433244|NCT00128180|4258525|B3|||Age||years|Mean|38.53|38.53|Standard Deviation|15.37|15.37|||
4433245|NCT00128180|4258526|B2|||Age||years|Mean|36.26|36.26|Standard Deviation|15.13|15.13|||
4433246|NCT00128180|4258527|B1|||Age||years|Mean|40.94|40.94|Standard Deviation|15.49|15.49|||
4433247|NCT00128180|4258525|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4433248|NCT00128180|4258526|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4433249|NCT00128180|4258527|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4433250|NCT00128180|4258525|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4433251|NCT00128180|4258526|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4433252|NCT00128180|4258527|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4433253|NCT00128180|4258525|B3||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4433254|NCT00128180|4258526|B2||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4433255|NCT00128180|4258527|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4433256|NCT00127933|4258552|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4433257|NCT00127933|4258553|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4433258|NCT00127933|4258554|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4433259|NCT00127933|4258552|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4433260|NCT00127933|4258553|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4433261|NCT00127933|4258554|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4433262|NCT00127933|4258552|B3|||Age|Safety Population|years|Mean|51.3|51.3|Standard Deviation|10.79|10.79|||
4433263|NCT00127933|4258553|B2|||Age|Safety Population|years|Mean|52.2|52.2|Standard Deviation|9.36|9.36|||
4433264|NCT00127933|4258554|B1|||Age|Safety Population|years|Mean|51.0|51.0|Standard Deviation|11.20|11.2|||
4433265|NCT00127855|4258571|B6||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4433266|NCT00127855|4258572|B5||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4433267|NCT00127855|4258573|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4433268|NCT00127855|4258574|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4433269|NCT00127855|4258575|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4433270|NCT00127855|4258576|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4433271|NCT00127855|4258571|B6||Female|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4433272|NCT00127855|4258572|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4433273|NCT00127855|4258573|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4433274|NCT00127855|4258574|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4433275|NCT00127855|4258575|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4433276|NCT00127855|4258576|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4433277|NCT00127855|4258571|B6|||Age||Weeks|Mean|8.1|8.1|Standard Deviation|1.50|1.5|||
4433278|NCT00127855|4258572|B5|||Age||Weeks|Mean|8.1|8.1|Standard Deviation|1.43|1.43|||
4433279|NCT00127855|4258573|B4|||Age||Weeks|Mean|8.0|8.0|Standard Deviation|1.65|1.65|||
4433280|NCT00127855|4258574|B3|||Age||Weeks|Mean|8.2|8.2|Standard Deviation|1.65|1.65|||
4433281|NCT00127855|4258575|B2|||Age||Weeks|Mean|8.3|8.3|Standard Deviation|1.46|1.46|||
4433282|NCT00127855|4258576|B1|||Age||Weeks|Mean|8.1|8.1|Standard Deviation|1.39|1.39|||
4433283|NCT00127842|4258762|B1|||Patient Global Assessment|The patient global assessment of disease activity is a 5-point scale concerning disease activity that asks how the participant is doing since their last visit with regard to their rheumatoid arthritis. Participants answer on a scale from 1 (very good, asymptomatic, no limitation in normal activites) to 5 (very poor, very severe symptoms that are intolerable, inability to perform all normal activites).|Units on a scale|Mean|3.28|3.28|Standard Deviation|0.559|0.559|||
4433284|NCT00127842|4258762|B1|||Physician Global Assessment|The physician global assessment of disease activity asks the physician to assess how the participant is doing since their last visit on a scale from 1 (very good, asymptomatic, no limitations in normal activities) to 5 (very poor, severe symptoms that are intolerable, inability to carry out all normal activites).|Units on a scale|Mean|3.23|3.23|Standard Deviation|0.463|0.463|||
4433285|NCT00127842|4258762|B1|||HLQ Impediments to Work Module|The HLQ impediments to paid and unpaid labor module asks participants how much they were indered by health problems at work over the past 2 weeks on a scale from not at all (0), a little (1) to very (2). Participants were also asked whether they had performed unpaid activities (household work, shopping, odd jobs/chores, childcare) according to the following: Did do, hindered (1); Did do, not hindered (0); Did not do, due to health problems (2); Did not do, due to other reasons (0). The aggregated score ranges from 0 (no impediments) to 8 (unable to do any of the surveyed activities).|Units on a scale|Mean|3.0|3.0|Standard Deviation|1.33|1.33|||
4433286|NCT00127842|4258762|B1|Paid help||HLQ Unpaid Work Module: Help Received with Unpaid Work|"The Unpaid Labour Production Module of the HLQ assesses the amount of hours of unpaid work (including household work, shopping, caring for children and odd jobs around the house), normally performed by the participant, that were taken over by other members of the household, family or friends (unpaid help), and/or by paid workers due to health problems of the participant.~Analysis only includes participants who received unpaid help (103 participants) or paid help (51 participants)."|Hours|Mean|2.2|2.2|Standard Deviation|9.20|9.2|||
4433287|NCT00127842|4258762|B1|Unpaid help||HLQ Unpaid Work Module: Help Received with Unpaid Work|"The Unpaid Labour Production Module of the HLQ assesses the amount of hours of unpaid work (including household work, shopping, caring for children and odd jobs around the house), normally performed by the participant, that were taken over by other members of the household, family or friends (unpaid help), and/or by paid workers due to health problems of the participant.~Analysis only includes participants who received unpaid help (103 participants) or paid help (51 participants)."|Hours|Mean|7.7|7.7|Standard Deviation|10.20|10.2|||
4433345|NCT00127790|4258802|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4433346|NCT00127790|4258803|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4433288|NCT00127842|4258762|B1|||HLQ Reduced Productivity at Paid Work Module|The reduced productivity at work module of the HLQ asks participants to estimate the number of additional hours required to compensate for production losses due to illness on working days over the past 2 weeks.|Hours|Mean|2.3|2.3|Standard Deviation|8.22|8.22|||
4433289|NCT00127842|4258762|B1|||Health and Labour Questionnaire (HLQ) Absence from Work Module|The HLQ collects quantitative data on the relation between illness and treatment and work performance. The instrument is divided into 4 modules to collect data about absence from work, reduced productivity at paid work, unpaid labor production and impediments to paid and unpaid labor. The absence from work module asks participants to indicate how many days in the past 2 weeks they missed work due to health problems.|days|Mean|0.8|0.8|Standard Deviation|2.51|2.51|||
4433290|NCT00127842|4258762|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|103|103.0||||||
4433291|NCT00127842|4258762|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4433292|NCT00127842|4258762|B1|Canadian Aboriginal||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4433293|NCT00127842|4258762|B1|Other Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4433294|NCT00127842|4258762|B1|Chinese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4433295|NCT00127842|4258762|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4433296|NCT00127842|4258762|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4433297|NCT00127842|4258762|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4433298|NCT00127842|4258762|B1|||Age||Years|Mean|48.4|48.4|Standard Deviation|10.9|10.9|||
4433299|NCT00127803|4258776|B5|United States||Region of Enrollment||participants|Number|50|50.0||||||
4433300|NCT00127803|4258777|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4433301|NCT00127803|4258778|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4433302|NCT00127803|4258779|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4433303|NCT00127803|4258780|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4433304|NCT00127803|4258776|B5||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4433305|NCT00127803|4258777|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4433306|NCT00127803|4258778|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4433307|NCT00127803|4258779|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4433308|NCT00127803|4258780|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4433309|NCT00127803|4258776|B5||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4433310|NCT00127803|4258777|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4433311|NCT00127803|4258778|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4433312|NCT00127803|4258779|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4433313|NCT00127803|4258780|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4433314|NCT00127803|4258776|B5|||Age||Years|Mean|31.9|31.9|Standard Deviation|10.28|10.28|||
4433315|NCT00127803|4258777|B4|||Age||Years|Mean|32.6|32.6|Standard Deviation|9.07|9.07|||
4433316|NCT00127803|4258778|B3|||Age||Years|Mean|30.4|30.4|Standard Deviation|9.78|9.78|||
4433317|NCT00127803|4258779|B2|||Age||Years|Mean|30.8|30.8|Standard Deviation|10.26|10.26|||
4433318|NCT00127803|4258780|B1|||Age||Years|Mean|33.6|33.6|Standard Deviation|12.49|12.49|||
4433319|NCT00127803|4258776|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433320|NCT00127803|4258777|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433321|NCT00127803|4258778|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433322|NCT00127803|4258779|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433323|NCT00127803|4258780|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433324|NCT00127803|4258776|B5||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4433325|NCT00127803|4258777|B4||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4433326|NCT00127803|4258778|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4433327|NCT00127803|4258779|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4433328|NCT00127803|4258780|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4433329|NCT00127803|4258776|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433330|NCT00127803|4258777|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433331|NCT00127803|4258778|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433332|NCT00127803|4258779|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433333|NCT00127803|4258780|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433334|NCT00127790|4258801|B5|United States||Region of Enrollment||participants|Number|21|21.0||||||
4433335|NCT00127790|4258802|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4433336|NCT00127790|4258803|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4433337|NCT00127790|4258804|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4433338|NCT00127790|4258805|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4433339|NCT00127790|4258801|B5||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4433340|NCT00127790|4258802|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4433341|NCT00127790|4258803|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4433342|NCT00127790|4258804|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4433343|NCT00127790|4258805|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4433344|NCT00127790|4258801|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4433347|NCT00127790|4258804|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4433348|NCT00127790|4258805|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4433349|NCT00127790|4258801|B5|||Age||years|Mean|50.7|50.7|Standard Deviation|8.3|8.3|||
4433350|NCT00127790|4258802|B4|||Age||years|Mean|52.3|52.3|Standard Deviation|1.0|1.0|||
4433351|NCT00127790|4258803|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|8.5|8.5|||
4433352|NCT00127790|4258804|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|9.8|9.8|||
4433353|NCT00127790|4258805|B1|||Age||years|Mean|45.7|45.7|Standard Deviation|8.2|8.2|||
4433354|NCT00127790|4258801|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4433355|NCT00127790|4258802|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433356|NCT00127790|4258803|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433357|NCT00127790|4258804|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4433358|NCT00127790|4258805|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433359|NCT00127790|4258801|B5||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4433360|NCT00127790|4258802|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4433361|NCT00127790|4258803|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4433362|NCT00127790|4258804|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4433363|NCT00127790|4258805|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4433364|NCT00127790|4258801|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433365|NCT00127790|4258802|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433366|NCT00127790|4258803|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433367|NCT00127790|4258804|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433368|NCT00127790|4258805|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433369|NCT00127712|4258830|B3|United States||Region of Enrollment||participants|Number|130|130.0||||||
4433370|NCT00127712|4258831|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4433371|NCT00127712|4258832|B1|United States||Region of Enrollment||participants|Number|65|65.0||||||
4433372|NCT00127712|4258830|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4433373|NCT00127712|4258831|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4433374|NCT00127712|4258832|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4433375|NCT00127712|4258830|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4433376|NCT00127712|4258831|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4433377|NCT00127712|4258832|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4433378|NCT00127712|4258830|B3|||Age||years|Mean|62|62.0|Standard Deviation|9|9.0|||
4433379|NCT00127712|4258831|B2|||Age||years|Mean|63|63.0|Standard Deviation|9|9.0|||
4433380|NCT00127712|4258832|B1|||Age||years|Mean|61|61.0|Standard Deviation|8|8.0|||
4433381|NCT00127712|4258830|B3||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4433382|NCT00127712|4258831|B2||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4433383|NCT00127712|4258832|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4433384|NCT00127712|4258830|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4433385|NCT00127712|4258831|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4433386|NCT00127712|4258832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4433387|NCT00127712|4258830|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433388|NCT00127712|4258831|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433389|NCT00127712|4258832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433390|NCT00127660|4258845|B5|United States||Region of Enrollment||participants|Number|594|594.0||||||
4433391|NCT00127660|4258846|B4|United States||Region of Enrollment||participants|Number|150|150.0||||||
4433392|NCT00127660|4258847|B3|United States||Region of Enrollment||participants|Number|143|143.0||||||
4433393|NCT00127660|4258848|B2|United States||Region of Enrollment||participants|Number|151|151.0||||||
4433394|NCT00127660|4258849|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
4433395|NCT00127660|4258845|B5||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4433396|NCT00127660|4258846|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4433397|NCT00127660|4258847|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4433398|NCT00127660|4258848|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4433399|NCT00127660|4258849|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4433400|NCT00127660|4258845|B5||Female|Sex: Female, Male||Participants|Count of Participants|353|353.0||||||
4433401|NCT00127660|4258846|B4||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4433402|NCT00127660|4258847|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4433403|NCT00127660|4258848|B2||Female|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4433404|NCT00127660|4258849|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4433405|NCT00127660|4258845|B5||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
4433406|NCT00127660|4258846|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4433407|NCT00127660|4258847|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4433408|NCT00127660|4258848|B2||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4433409|NCT00127660|4258849|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4433410|NCT00127660|4258845|B5||Between 18 and 65 years|Age||Participants|Count of Participants|363|363.0||||||
4433411|NCT00127660|4258846|B4||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4433412|NCT00127660|4258847|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4433413|NCT00127660|4258848|B2||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4433414|NCT00127660|4258849|B1||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4433415|NCT00127660|4258845|B5||<=18 years|Age||Participants|Count of Participants|147|147.0||||||
4433416|NCT00127660|4258846|B4||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4433417|NCT00127660|4258847|B3||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
4433418|NCT00127660|4258848|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4433419|NCT00127660|4258849|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4433420|NCT00127530|4258862|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4433421|NCT00127530|4258863|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4433422|NCT00127530|4258864|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4433423|NCT00127530|4258862|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4433424|NCT00127530|4258863|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4433425|NCT00127530|4258864|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4433426|NCT00127530|4258862|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4433427|NCT00127530|4258863|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4433428|NCT00127530|4258864|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4433429|NCT00127530|4258862|B3|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4433430|NCT00127530|4258863|B2|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4433431|NCT00127530|4258864|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4433432|NCT00127530|4258862|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|278|278.0||||||
4433433|NCT00127530|4258863|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|211|211.0||||||
4433434|NCT00127530|4258864|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4433435|NCT00127530|4258862|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4433436|NCT00127530|4258863|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4433437|NCT00127530|4258864|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4433438|NCT00127530|4258862|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4433439|NCT00127530|4258863|B2||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4433440|NCT00127530|4258864|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4433441|NCT00127530|4258862|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|8.75|8.75|||
4433442|NCT00127530|4258863|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|8.72|8.72|||
4433443|NCT00127530|4258864|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|8.88|8.88|||
4433444|NCT00127439|4258871|B3|||Overground walking self-selected velocity|Overground walking Self-selected walking speed is provided in meters/sec with usual adult walking speed at 1.2 m/sec.|meters/sec|Mean|0.34|0.34|Standard Deviation|0.23|0.23|||
4433445|NCT00127439|4258872|B2|||Overground walking self-selected velocity|Overground walking Self-selected walking speed is provided in meters/sec with usual adult walking speed at 1.2 m/sec.|meters/sec|Mean|0.31|0.31|Standard Deviation|0.27|0.27|||
4433446|NCT00127439|4258873|B1|||Overground walking self-selected velocity|Overground walking Self-selected walking speed is provided in meters/sec with usual adult walking speed at 1.2 m/sec.|meters/sec|Mean|0.35|0.35|Standard Deviation|0.21|0.21|||
4433447|NCT00127439|4258871|B3|||Walking of SCI II (x/20)|Walking Index for SCI II - lowest score = 0 and highest score is 20. 0 is does not walk with equipment, bracing or assist and 20 is walks without a brace or device or physical assist for 10 meters.|units on a scale|Mean|12|12.0|Standard Deviation|4.41|4.41|||
4433448|NCT00127439|4258872|B2|||Walking of SCI II (x/20)|Walking Index for SCI II - lowest score = 0 and highest score is 20. 0 is does not walk with equipment, bracing or assist and 20 is walks without a brace or device or physical assist for 10 meters.|units on a scale|Mean|12|12.0|Standard Deviation|4.84|4.84|||
4433449|NCT00127439|4258873|B1|||Walking of SCI II (x/20)|Walking Index for SCI II - lowest score = 0 and highest score is 20. 0 is does not walk with equipment, bracing or assist and 20 is walks without a brace or device or physical assist for 10 meters.|units on a scale|Mean|12|12.0|Standard Deviation|4.41|4.41|||
4433450|NCT00127439|4258871|B3|||Lower Extremity Motor Score (X/50)|: Lower Extremity Motor Score = Strength based on bilateral leg muscle strength across 5 muscle groups: hip flexors, knee extensors, ankle dorsiflexors, long toe extensors, and ankle plantar flexors and scored 0-5 for each muscle group. 0 is the lowest score and 5 is the highest score. 0=total paralysis and 5= active movement, against gravity and normal resistance. Twenty-five (25) is the highest score possible for each lower extremity and thus 50 is the highest score for bilateral limbs.|units on a scale|Mean|38|38.0|Standard Deviation|10|10.0|||
4433451|NCT00127439|4258872|B2|||Lower Extremity Motor Score (X/50)|: Lower Extremity Motor Score = Strength based on bilateral leg muscle strength across 5 muscle groups: hip flexors, knee extensors, ankle dorsiflexors, long toe extensors, and ankle plantar flexors and scored 0-5 for each muscle group. 0 is the lowest score and 5 is the highest score. 0=total paralysis and 5= active movement, against gravity and normal resistance. Twenty-five (25) is the highest score possible for each lower extremity and thus 50 is the highest score for bilateral limbs.|units on a scale|Mean|37|37.0|Standard Deviation|13|13.0|||
4433506|NCT00127413|4258900|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433507|NCT00127413|4258896|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433508|NCT00127413|4258897|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433452|NCT00127439|4258873|B1|||Lower Extremity Motor Score (X/50)|: Lower Extremity Motor Score = Strength based on bilateral leg muscle strength across 5 muscle groups: hip flexors, knee extensors, ankle dorsiflexors, long toe extensors, and ankle plantar flexors and scored 0-5 for each muscle group. 0 is the lowest score and 5 is the highest score. 0=total paralysis and 5= active movement, against gravity and normal resistance. Twenty-five (25) is the highest score possible for each lower extremity and thus 50 is the highest score for bilateral limbs.|units on a scale|Mean|40|40.0|Standard Deviation|9|9.0|||
4433453|NCT00127439|4258871|B3|||Chronicity (months)|Chronicity = number of months since injury.|months|Mean|20.87|20.87|Standard Deviation|19.92|19.92|||
4433454|NCT00127439|4258872|B2|||Chronicity (months)|Chronicity = number of months since injury.|months|Mean|23.21|23.21|Standard Deviation|24.84|24.84|||
4433455|NCT00127439|4258873|B1|||Chronicity (months)|Chronicity = number of months since injury.|months|Mean|18.81|18.81|Standard Deviation|15.97|15.97|||
4433456|NCT00127439|4258871|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4433457|NCT00127439|4258872|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4433458|NCT00127439|4258873|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4433459|NCT00127439|4258871|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4433460|NCT00127439|4258872|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4433461|NCT00127439|4258873|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4433462|NCT00127439|4258871|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4433463|NCT00127439|4258872|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4433464|NCT00127439|4258873|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4433465|NCT00127439|4258871|B3|||Age||years|Mean|41.93|41.93|Standard Deviation|13.58|13.58|||
4433466|NCT00127439|4258872|B2|||Age||years|Mean|37.57|37.57|Standard Deviation|16.48|16.48|||
4433467|NCT00127439|4258873|B1|||Age||years|Mean|45.75|45.75|Standard Deviation|10.01|10.01|||
4433468|NCT00127439|4258871|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433469|NCT00127439|4258872|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433470|NCT00127439|4258873|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4433471|NCT00127439|4258871|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4433472|NCT00127439|4258872|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4433473|NCT00127439|4258873|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4433474|NCT00127439|4258871|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433475|NCT00127439|4258872|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433476|NCT00127439|4258873|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433477|NCT00127413|4258896|B5|United States||Region of Enrollment||participants|Number|42|42.0||||||
4433478|NCT00127413|4258897|B4|United States||Region of Enrollment||participants|Number|7|7.0||||||
4433479|NCT00127413|4258898|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4433480|NCT00127413|4258899|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4433481|NCT00127413|4258900|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4433482|NCT00127413|4258896|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433483|NCT00127413|4258897|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433484|NCT00127413|4258898|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433485|NCT00127413|4258899|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433486|NCT00127413|4258900|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433487|NCT00127413|4258896|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4433488|NCT00127413|4258897|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433489|NCT00127413|4258898|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4433490|NCT00127413|4258899|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4433491|NCT00127413|4258900|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4433492|NCT00127413|4258896|B5||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4433493|NCT00127413|4258897|B4||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4433494|NCT00127413|4258898|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4433495|NCT00127413|4258899|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4433496|NCT00127413|4258900|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4433497|NCT00127413|4258896|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4433498|NCT00127413|4258897|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4433499|NCT00127413|4258898|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4433500|NCT00127413|4258899|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4433501|NCT00127413|4258900|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4433502|NCT00127413|4258896|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4433503|NCT00127413|4258897|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433504|NCT00127413|4258898|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4433505|NCT00127413|4258899|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433509|NCT00127413|4258898|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433510|NCT00127413|4258899|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433511|NCT00127413|4258900|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433512|NCT00127413|4258896|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433513|NCT00127413|4258897|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433514|NCT00127413|4258898|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433515|NCT00127413|4258899|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433516|NCT00127413|4258900|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433517|NCT00127413|4258896|B5||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4433518|NCT00127413|4258897|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4433519|NCT00127413|4258898|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4433520|NCT00127413|4258899|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4433521|NCT00127413|4258900|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4433522|NCT00127413|4258896|B5||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4433523|NCT00127413|4258897|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4433524|NCT00127413|4258898|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4433525|NCT00127413|4258899|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4433526|NCT00127413|4258900|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4433527|NCT00127413|4258896|B5|||Age||years|Mean|52.80|52.8|Standard Deviation|6.23|6.23|||
4433528|NCT00127413|4258897|B4|||Age||years|Mean|52.40|52.4|Standard Deviation|4.67|4.67|||
4433529|NCT00127413|4258898|B3|||Age||years|Mean|54.18|54.18|Standard Deviation|7.82|7.82|||
4433530|NCT00127413|4258899|B2|||Age||years|Mean|49.20|49.2|Standard Deviation|5.27|5.27|||
4433531|NCT00127413|4258900|B1|||Age||years|Mean|54.13|54.13|Standard Deviation|5.6|5.6|||
4433532|NCT00127231|4258913|B3|||Number of participants with illicit drug use in past 6 months||Participants|Count of Participants|102|102.0||||||
4433533|NCT00127231|4258914|B2|||Number of participants with illicit drug use in past 6 months||Participants|Count of Participants|52|52.0||||||
4433534|NCT00127231|4258915|B1|||Number of participants with illicit drug use in past 6 months||Participants|Count of Participants|50|50.0||||||
4433535|NCT00127231|4258913|B3|||Number of standard drinks per episode, continuous|A standard drink is any drink that contains about 14 grams of pure alcohol. One standard drink is typically considered to be 12 fluid ounces of beer, 4 - 5 fluid ounces of wine, or 1.5 fluid ounces of 80 proof liquor.|standard drinks|Mean|9.62|9.62|Standard Deviation|7.78|7.78|||
4433536|NCT00127231|4258914|B2|||Number of standard drinks per episode, continuous|A standard drink is any drink that contains about 14 grams of pure alcohol. One standard drink is typically considered to be 12 fluid ounces of beer, 4 - 5 fluid ounces of wine, or 1.5 fluid ounces of 80 proof liquor.|standard drinks|Mean|9.55|9.55|Standard Deviation|6.42|6.42|||
4433537|NCT00127231|4258915|B1|||Number of standard drinks per episode, continuous|A standard drink is any drink that contains about 14 grams of pure alcohol. One standard drink is typically considered to be 12 fluid ounces of beer, 4 - 5 fluid ounces of wine, or 1.5 fluid ounces of 80 proof liquor.|standard drinks|Mean|9.69|9.69|Standard Deviation|9.13|9.13|||
4433538|NCT00127231|4258913|B3|||Total number of drinking days out of the past 90 days||days|Mean|32.24|32.24|Standard Deviation|28.52|28.52|||
4433539|NCT00127231|4258914|B2|||Total number of drinking days out of the past 90 days||days|Mean|30.45|30.45|Standard Deviation|27.57|27.57|||
4433540|NCT00127231|4258915|B1|||Total number of drinking days out of the past 90 days||days|Mean|34.03|34.03|Standard Deviation|29.47|29.47|||
4433541|NCT00127231|4258913|B3|||AUDIT score, continuous|Score on the Alcohol Use Disorders Identification Test (AUDIT) at baseline assessment. The AUDIT ranges from 0 (minimum) to 40 (maximum). The higher the score, the more likely it is that the individual has an alcohol use disorder.|units on a scale|Mean|12.1|12.1|Standard Deviation|8.8|8.8|||
4433542|NCT00127231|4258914|B2|||AUDIT score, continuous|Score on the Alcohol Use Disorders Identification Test (AUDIT) at baseline assessment. The AUDIT ranges from 0 (minimum) to 40 (maximum). The higher the score, the more likely it is that the individual has an alcohol use disorder.|units on a scale|Mean|12.3|12.3|Standard Deviation|8.9|8.9|||
4433543|NCT00127231|4258915|B1|||AUDIT score, continuous|Score on the Alcohol Use Disorders Identification Test (AUDIT) at baseline assessment. The AUDIT ranges from 0 (minimum) to 40 (maximum). The higher the score, the more likely it is that the individual has an alcohol use disorder.|units on a scale|Mean|11.9|11.9|Standard Deviation|8.7|8.7|||
4433544|NCT00127231|4258913|B3|||CD4 count, Continuous||cells/mm3|Mean|395.68|395.68|Standard Deviation|252.9|252.9|||
4433545|NCT00127231|4258914|B2|||CD4 count, Continuous||cells/mm3|Mean|393.24|393.24|Standard Deviation|236.78|236.78|||
4433546|NCT00127231|4258915|B1|||CD4 count, Continuous||cells/mm3|Mean|398.11|398.11|Standard Deviation|269.02|269.02|||
4433547|NCT00127231|4258913|B3||Detectable HIV-1 RNA|Undetectable HIV-1 RNA %||Participants|Count of Participants|88|88.0||||||
4433548|NCT00127231|4258914|B2||Detectable HIV-1 RNA|Undetectable HIV-1 RNA %||Participants|Count of Participants|43|43.0||||||
4433549|NCT00127231|4258915|B1||Detectable HIV-1 RNA|Undetectable HIV-1 RNA %||Participants|Count of Participants|45|45.0||||||
4433550|NCT00127231|4258913|B3||Undetectable HIV-1 RNA (<50 copies)|Undetectable HIV-1 RNA %||Participants|Count of Participants|60|60.0||||||
4433551|NCT00127231|4258914|B2||Undetectable HIV-1 RNA (<50 copies)|Undetectable HIV-1 RNA %||Participants|Count of Participants|31|31.0||||||
4433552|NCT00127231|4258915|B1||Undetectable HIV-1 RNA (<50 copies)|Undetectable HIV-1 RNA %||Participants|Count of Participants|29|29.0||||||
4433553|NCT00127231|4258913|B3|||Income, Continuous|Annual income at baseline assessment (US dollars)|dollars|Mean|8343.28|8343.28|Standard Deviation|7202.60|7202.6|||
4433554|NCT00127231|4258914|B2|||Income, Continuous|Annual income at baseline assessment (US dollars)|dollars|Mean|8189.19|8189.19|Standard Deviation|7239.17|7239.17|||
4433555|NCT00127231|4258915|B1|||Income, Continuous|Annual income at baseline assessment (US dollars)|dollars|Mean|8497.38|8497.38|Standard Deviation|7166.03|7166.03|||
4433556|NCT00127231|4258913|B3||Unemployed|Employment %|Current employment status at baseline assessment|Participants|Count of Participants|99|99.0||||||
4433557|NCT00127231|4258914|B2||Unemployed|Employment %|Current employment status at baseline assessment|Participants|Count of Participants|46|46.0||||||
4433558|NCT00127231|4258915|B1||Unemployed|Employment %|Current employment status at baseline assessment|Participants|Count of Participants|53|53.0||||||
4433559|NCT00127231|4258913|B3||Working part-time or full-time|Employment %|Current employment status at baseline assessment|Participants|Count of Participants|49|49.0||||||
4433560|NCT00127231|4258914|B2||Working part-time or full-time|Employment %|Current employment status at baseline assessment|Participants|Count of Participants|28|28.0||||||
4433561|NCT00127231|4258915|B1||Working part-time or full-time|Employment %|Current employment status at baseline assessment|Participants|Count of Participants|21|21.0||||||
4433562|NCT00127231|4258913|B3|United States||Region of Enrollment||participants|Number|148|148.0||||||
4433563|NCT00127231|4258914|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4433564|NCT00127231|4258915|B1|United States||Region of Enrollment||participants|Number|74|74.0||||||
4433565|NCT00127231|4258913|B3||Unknown or Not Reported|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433566|NCT00127231|4258914|B2||Unknown or Not Reported|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433567|NCT00127231|4258915|B1||Unknown or Not Reported|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433568|NCT00127231|4258913|B3||More than one race|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433569|NCT00127231|4258914|B2||More than one race|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433570|NCT00127231|4258915|B1||More than one race|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433571|NCT00127231|4258913|B3||White|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|19|19.0||||||
4433572|NCT00127231|4258914|B2||White|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|12|12.0||||||
4433573|NCT00127231|4258915|B1||White|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|7|7.0||||||
4433574|NCT00127231|4258913|B3||Black or African American|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|127|127.0||||||
4433575|NCT00127231|4258914|B2||Black or African American|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|60|60.0||||||
4433576|NCT00127231|4258915|B1||Black or African American|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|67|67.0||||||
4433577|NCT00127231|4258913|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433578|NCT00127231|4258914|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433579|NCT00127231|4258915|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433580|NCT00127231|4258913|B3||Asian|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433581|NCT00127231|4258914|B2||Asian|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433582|NCT00127231|4258915|B1||Asian|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433583|NCT00127231|4258913|B3||American Indian or Alaska Native|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|2|2.0||||||
4433584|NCT00127231|4258914|B2||American Indian or Alaska Native|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|2|2.0||||||
4433585|NCT00127231|4258915|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433586|NCT00127231|4258913|B3||Male|Sex: Female, Male|Sex at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433587|NCT00127231|4258914|B2||Male|Sex: Female, Male|Sex at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433588|NCT00127231|4258915|B1||Male|Sex: Female, Male|Sex at baseline assessment|Participants|Count of Participants|0|0.0||||||
4433589|NCT00127231|4258913|B3||Female|Sex: Female, Male|Sex at baseline assessment|Participants|Count of Participants|148|148.0||||||
4433590|NCT00127231|4258914|B2||Female|Sex: Female, Male|Sex at baseline assessment|Participants|Count of Participants|74|74.0||||||
4433591|NCT00127231|4258915|B1||Female|Sex: Female, Male|Sex at baseline assessment|Participants|Count of Participants|74|74.0||||||
4433592|NCT00127231|4258913|B3|||Age|Age at baseline assessment (Years)|years|Mean|45.56|45.56|Standard Deviation|8.08|8.08|||
4433593|NCT00127231|4258914|B2|||Age|Age at baseline assessment (Years)|years|Mean|44.86|44.86|Standard Deviation|9.1|9.1|||
4433594|NCT00127231|4258915|B1|||Age|Age at baseline assessment (Years)|years|Mean|46.27|46.27|Standard Deviation|7.07|7.07|||
4433595|NCT00127218|4258930|B3|United States||Region of Enrollment||participants|Number|145|145.0||||||
4433596|NCT00127218|4258931|B2|United States||Region of Enrollment||participants|Number|73|73.0||||||
4433597|NCT00127218|4258932|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4433598|NCT00127218|4258930|B3||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4433599|NCT00127218|4258931|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4433600|NCT00127218|4258932|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4433601|NCT00127218|4258930|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4433602|NCT00127218|4258931|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4433603|NCT00127218|4258932|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4433604|NCT00127218|4258930|B3|||Age||years|Median|73|73.0|Inter-Quartile Range|||69.0|77.0|
4433605|NCT00127218|4258931|B2|||Age||years|Median|72|72.0|Inter-Quartile Range|||69.0|77.0|
4433606|NCT00127218|4258932|B1|||Age||years|Median|73|73.0|Inter-Quartile Range|||69.0|77.0|
4433607|NCT00127192|4258941|B6|||Hemoglobin A1c (HbA1c)||percent|Mean|7.6|7.6|Standard Deviation|0.8|0.8|||
4433608|NCT00127192|4258942|B5|||Hemoglobin A1c (HbA1c)||percent|Mean|7.7|7.7|Standard Deviation|0.9|0.9|||
4433609|NCT00127192|4258943|B4|||Hemoglobin A1c (HbA1c)||percent|Mean|7.7|7.7|Standard Deviation|0.8|0.8|||
4433610|NCT00127192|4258944|B3|||Hemoglobin A1c (HbA1c)||percent|Mean|7.6|7.6|Standard Deviation|0.8|0.8|||
4433611|NCT00127192|4258945|B2|||Hemoglobin A1c (HbA1c)||percent|Mean|7.6|7.6|Standard Deviation|0.8|0.8|||
4433612|NCT00127192|4258946|B1|||Hemoglobin A1c (HbA1c)||percent|Mean|7.5|7.5|Standard Deviation|0.8|0.8|||
4433613|NCT00127192|4258941|B6|||Glycosylated albumin||percent|Mean|22.2|22.2|Standard Deviation|4.3|4.3|||
4433614|NCT00127192|4258942|B5|||Glycosylated albumin||percent|Mean|23.7|23.7|Standard Deviation|4.5|4.5|||
4433615|NCT00127192|4258943|B4|||Glycosylated albumin||percent|Mean|21.9|21.9|Standard Deviation|3.9|3.9|||
4433616|NCT00127192|4258944|B3|||Glycosylated albumin||percent|Mean|21.9|21.9|Standard Deviation|4.5|4.5|||
4433617|NCT00127192|4258945|B2|||Glycosylated albumin||percent|Mean|22.0|22.0|Standard Deviation|4.2|4.2|||
4433618|NCT00127192|4258946|B1|||Glycosylated albumin||percent|Mean|21.5|21.5|Standard Deviation|3.9|3.9|||
4433619|NCT00127192|4258941|B6|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|147.5|147.5|Standard Deviation|33.8|33.8|||
4433620|NCT00127192|4258942|B5|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|156.5|156.5|Standard Deviation|35.1|35.1|||
4433621|NCT00127192|4258943|B4|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|148.4|148.4|Standard Deviation|33.3|33.3|||
4433622|NCT00127192|4258944|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|142.6|142.6|Standard Deviation|31.8|31.8|||
4433623|NCT00127192|4258945|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|144.3|144.3|Standard Deviation|29.0|29.0|||
4433624|NCT00127192|4258946|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|145.7|145.7|Standard Deviation|37.6|37.6|||
4433625|NCT00127192|4258941|B6||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4433626|NCT00127192|4258942|B5||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4433627|NCT00127192|4258943|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4433628|NCT00127192|4258944|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4433629|NCT00127192|4258945|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4433630|NCT00127192|4258946|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4433631|NCT00127192|4258941|B6||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4433632|NCT00127192|4258942|B5||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4433633|NCT00127192|4258943|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4433634|NCT00127192|4258944|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4433635|NCT00127192|4258945|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4433636|NCT00127192|4258946|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4433637|NCT00127192|4258941|B6|||Age||years|Mean|59.8|59.8|Standard Deviation|8.5|8.5|||
4433638|NCT00127192|4258942|B5|||Age||years|Mean|60.2|60.2|Standard Deviation|8.0|8.0|||
4433639|NCT00127192|4258943|B4|||Age||years|Mean|60.6|60.6|Standard Deviation|7.7|7.7|||
4433640|NCT00127192|4258944|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|9.5|9.5|||
4433641|NCT00127192|4258945|B2|||Age||years|Mean|60.2|60.2|Standard Deviation|9.4|9.4|||
4433642|NCT00127192|4258946|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|7.9|7.9|||
4433643|NCT00127166|4258972|B3|||Time to recovery|Montelukast / Salmeterol, n=71; Salmeterol / Montelukast, n=70|Minutes|Mean|22.53|22.53|Standard Deviation|9.51|9.51|||
4433644|NCT00127166|4258973|B2|||Time to recovery|Montelukast / Salmeterol, n=71; Salmeterol / Montelukast, n=70|Minutes|Mean|21.51|21.51|Standard Deviation|8.30|8.3|||
4433645|NCT00127166|4258974|B1|||Time to recovery|Montelukast / Salmeterol, n=71; Salmeterol / Montelukast, n=70|Minutes|Mean|23.53|23.53|Standard Deviation|10.53|10.53|||
4433646|NCT00127166|4258972|B3|||Maximum percent fall in FEV1 after exercise||Percent change from baseline|Mean|25.09|25.09|Standard Deviation|9.65|9.65|||
4433647|NCT00127166|4258973|B2|||Maximum percent fall in FEV1 after exercise||Percent change from baseline|Mean|25.42|25.42|Standard Deviation|9.04|9.04|||
4433648|NCT00127166|4258974|B1|||Maximum percent fall in FEV1 after exercise||Percent change from baseline|Mean|24.77|24.77|Standard Deviation|10.25|10.25|||
4433649|NCT00127166|4258972|B3|||Maximum FEV1 percent predicted||Percent of predicted value|Mean|100.21|100.21|Standard Deviation|25.49|25.49|||
4433650|NCT00127166|4258973|B2|||Maximum FEV1 percent predicted||Percent of predicted value|Mean|100.54|100.54|Standard Deviation|15.61|15.61|||
4433651|NCT00127166|4258974|B1|||Maximum FEV1 percent predicted||Percent of predicted value|Mean|99.88|99.88|Standard Deviation|32.45|32.45|||
4433652|NCT00127166|4258972|B3|||Avg %-change from pre-exercise baseline FEV1 after 1st β-agonist use & prior to 2nd β-agonist use||Percent change from baseline|Mean|3.05|3.05|Standard Deviation|11.05|11.05|||
4433653|NCT00127166|4258973|B2|||Avg %-change from pre-exercise baseline FEV1 after 1st β-agonist use & prior to 2nd β-agonist use||Percent change from baseline|Mean|4.78|4.78|Standard Deviation|10.92|10.92|||
4433654|NCT00127166|4258974|B1|||Avg %-change from pre-exercise baseline FEV1 after 1st β-agonist use & prior to 2nd β-agonist use||Percent change from baseline|Mean|1.36|1.36|Standard Deviation|10.99|10.99|||
4433655|NCT00127166|4258972|B3|||Area Under the Curve from 0 to 20 minutes (AUC0-20)|Area Under the Curve for percent-change from pre-exercise baseline FEV1 in liters, from 0 to 20 minutes (AUC0-20)|Percent times Minutes|Mean|318.93|318.93|Standard Deviation|188.06|188.06|||
4433718|NCT00127101|4258993|B3|66-75 years of age||Age, Customized||participants|Number|0|0.0||||||
4433656|NCT00127166|4258973|B2|||Area Under the Curve from 0 to 20 minutes (AUC0-20)|Area Under the Curve for percent-change from pre-exercise baseline FEV1 in liters, from 0 to 20 minutes (AUC0-20)|Percent times Minutes|Mean|317.74|317.74|Standard Deviation|165.71|165.71|||
4433657|NCT00127166|4258974|B1|||Area Under the Curve from 0 to 20 minutes (AUC0-20)|Area Under the Curve for percent-change from pre-exercise baseline FEV1 in liters, from 0 to 20 minutes (AUC0-20)|Percent times Minutes|Mean|320.08|320.08|Standard Deviation|208.62|208.62|||
4433658|NCT00127166|4258972|B3|Other||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4433659|NCT00127166|4258973|B2|Other||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4433660|NCT00127166|4258974|B1|Other||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4433661|NCT00127166|4258972|B3|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4433662|NCT00127166|4258973|B2|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4433663|NCT00127166|4258974|B1|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4433664|NCT00127166|4258972|B3|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4433665|NCT00127166|4258973|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4433666|NCT00127166|4258974|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4433667|NCT00127166|4258972|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4433668|NCT00127166|4258973|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4433669|NCT00127166|4258974|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4433670|NCT00127166|4258972|B3||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4433671|NCT00127166|4258973|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4433672|NCT00127166|4258974|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4433673|NCT00127166|4258972|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4433674|NCT00127166|4258973|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4433675|NCT00127166|4258974|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4433676|NCT00127166|4258972|B3|||Age||years|Mean|10.0|10.0|Standard Deviation|2.0|2.0|||
4433677|NCT00127166|4258973|B2|||Age||years|Mean|9.8|9.8|Standard Deviation|2.0|2.0|||
4433678|NCT00127166|4258974|B1|||Age||years|Mean|10.2|10.2|Standard Deviation|2.0|2.0|||
4433679|NCT00127101|4258989|B7|White||Race/Ethnicity||participants|Number|22|22.0||||||
4433680|NCT00127101|4258990|B6|White||Race/Ethnicity||participants|Number|4|4.0||||||
4433681|NCT00127101|4258991|B5|White||Race/Ethnicity||participants|Number|5|5.0||||||
4433682|NCT00127101|4258992|B4|White||Race/Ethnicity||participants|Number|2|2.0||||||
4433683|NCT00127101|4258993|B3|White||Race/Ethnicity||participants|Number|3|3.0||||||
4433684|NCT00127101|4258994|B2|White||Race/Ethnicity||participants|Number|5|5.0||||||
4433685|NCT00127101|4258995|B1|White||Race/Ethnicity||participants|Number|3|3.0||||||
4433686|NCT00127101|4258989|B7|Turkish||Race/Ethnicity||participants|Number|1|1.0||||||
4433687|NCT00127101|4258990|B6|Turkish||Race/Ethnicity||participants|Number|0|0.0||||||
4433688|NCT00127101|4258991|B5|Turkish||Race/Ethnicity||participants|Number|0|0.0||||||
4433689|NCT00127101|4258992|B4|Turkish||Race/Ethnicity||participants|Number|1|1.0||||||
4433690|NCT00127101|4258993|B3|Turkish||Race/Ethnicity||participants|Number|0|0.0||||||
4433691|NCT00127101|4258994|B2|Turkish||Race/Ethnicity||participants|Number|0|0.0||||||
4433692|NCT00127101|4258995|B1|Turkish||Race/Ethnicity||participants|Number|0|0.0||||||
4433693|NCT00127101|4258989|B7||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4433694|NCT00127101|4258990|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4433695|NCT00127101|4258991|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4433696|NCT00127101|4258992|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4433697|NCT00127101|4258993|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4433698|NCT00127101|4258994|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4433699|NCT00127101|4258995|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4433700|NCT00127101|4258989|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4433701|NCT00127101|4258990|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4433702|NCT00127101|4258991|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4433703|NCT00127101|4258992|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4433704|NCT00127101|4258993|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4433705|NCT00127101|4258994|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4433706|NCT00127101|4258995|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4433707|NCT00127101|4258989|B7|Over 75 years of age||Age, Customized||participants|Number|2|2.0||||||
4433708|NCT00127101|4258990|B6|Over 75 years of age||Age, Customized||participants|Number|0|0.0||||||
4433709|NCT00127101|4258991|B5|Over 75 years of age||Age, Customized||participants|Number|0|0.0||||||
4433710|NCT00127101|4258992|B4|Over 75 years of age||Age, Customized||participants|Number|0|0.0||||||
4433711|NCT00127101|4258993|B3|Over 75 years of age||Age, Customized||participants|Number|0|0.0||||||
4433712|NCT00127101|4258994|B2|Over 75 years of age||Age, Customized||participants|Number|2|2.0||||||
4433713|NCT00127101|4258995|B1|Over 75 years of age||Age, Customized||participants|Number|0|0.0||||||
4433714|NCT00127101|4258989|B7|66-75 years of age||Age, Customized||participants|Number|4|4.0||||||
4433715|NCT00127101|4258990|B6|66-75 years of age||Age, Customized||participants|Number|2|2.0||||||
4433716|NCT00127101|4258991|B5|66-75 years of age||Age, Customized||participants|Number|0|0.0||||||
4433717|NCT00127101|4258992|B4|66-75 years of age||Age, Customized||participants|Number|0|0.0||||||
4433719|NCT00127101|4258994|B2|66-75 years of age||Age, Customized||participants|Number|1|1.0||||||
4433720|NCT00127101|4258995|B1|66-75 years of age||Age, Customized||participants|Number|1|1.0||||||
4433721|NCT00127101|4258989|B7|56-65 years of age||Age, Customized||participants|Number|9|9.0||||||
4433722|NCT00127101|4258990|B6|56-65 years of age||Age, Customized||participants|Number|1|1.0||||||
4433723|NCT00127101|4258991|B5|56-65 years of age||Age, Customized||participants|Number|3|3.0||||||
4433724|NCT00127101|4258992|B4|56-65 years of age||Age, Customized||participants|Number|2|2.0||||||
4433725|NCT00127101|4258993|B3|56-65 years of age||Age, Customized||participants|Number|1|1.0||||||
4433726|NCT00127101|4258994|B2|56-65 years of age||Age, Customized||participants|Number|1|1.0||||||
4433727|NCT00127101|4258995|B1|56-65 years of age||Age, Customized||participants|Number|1|1.0||||||
4433728|NCT00127101|4258989|B7|46-55 years of age||Age, Customized||participants|Number|4|4.0||||||
4433729|NCT00127101|4258990|B6|46-55 years of age||Age, Customized||participants|Number|1|1.0||||||
4433730|NCT00127101|4258991|B5|46-55 years of age||Age, Customized||participants|Number|1|1.0||||||
4433731|NCT00127101|4258992|B4|46-55 years of age||Age, Customized||participants|Number|1|1.0||||||
4433732|NCT00127101|4258993|B3|46-55 years of age||Age, Customized||participants|Number|1|1.0||||||
4433733|NCT00127101|4258994|B2|46-55 years of age||Age, Customized||participants|Number|0|0.0||||||
4433734|NCT00127101|4258995|B1|46-55 years of age||Age, Customized||participants|Number|0|0.0||||||
4433735|NCT00127101|4258989|B7|36-45 years of age||Age, Customized||participants|Number|2|2.0||||||
4433736|NCT00127101|4258990|B6|36-45 years of age||Age, Customized||participants|Number|0|0.0||||||
4433737|NCT00127101|4258991|B5|36-45 years of age||Age, Customized||participants|Number|0|0.0||||||
4433738|NCT00127101|4258992|B4|36-45 years of age||Age, Customized||participants|Number|0|0.0||||||
4433739|NCT00127101|4258993|B3|36-45 years of age||Age, Customized||participants|Number|0|0.0||||||
4433740|NCT00127101|4258994|B2|36-45 years of age||Age, Customized||participants|Number|1|1.0||||||
4433741|NCT00127101|4258995|B1|36-45 years of age||Age, Customized||participants|Number|1|1.0||||||
4433742|NCT00127101|4258989|B7|26-35 years of age||Age, Customized||participants|Number|2|2.0||||||
4433743|NCT00127101|4258990|B6|26-35 years of age||Age, Customized||participants|Number|0|0.0||||||
4433744|NCT00127101|4258991|B5|26-35 years of age||Age, Customized||participants|Number|1|1.0||||||
4433745|NCT00127101|4258992|B4|26-35 years of age||Age, Customized||participants|Number|0|0.0||||||
4433746|NCT00127101|4258993|B3|26-35 years of age||Age, Customized||participants|Number|1|1.0||||||
4433747|NCT00127101|4258994|B2|26-35 years of age||Age, Customized||participants|Number|0|0.0||||||
4433748|NCT00127101|4258995|B1|26-35 years of age||Age, Customized||participants|Number|0|0.0||||||
4433749|NCT00127036|4259020|B3|United States||Region of Enrollment||participants|Number|65|65.0||||||
4433750|NCT00127036|4259021|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4433751|NCT00127036|4259022|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4433752|NCT00127036|4259020|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4433753|NCT00127036|4259021|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4433754|NCT00127036|4259022|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4433755|NCT00127036|4259020|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4433756|NCT00127036|4259021|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4433757|NCT00127036|4259022|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4433758|NCT00127036|4259020|B3|||Age||years|Mean|63|63.0|Full Range|||38.0|88.0|
4433759|NCT00127036|4259021|B2|||Age||years|Mean|64|64.0|Full Range|||38.0|82.5|
4433760|NCT00127036|4259022|B1|||Age||years|Mean|62.5|62.5|Full Range|||39.0|88.0|
4433761|NCT00127036|4259020|B3||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4433762|NCT00127036|4259021|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4433763|NCT00127036|4259022|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4433764|NCT00127036|4259020|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4433765|NCT00127036|4259021|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4433766|NCT00127036|4259022|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4433767|NCT00127036|4259020|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433768|NCT00127036|4259021|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433769|NCT00127036|4259022|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433770|NCT00126776|4259033|B3|United States||Region of Enrollment||participants|Number|743|743.0||||||
4433771|NCT00126776|4259034|B2|United States||Region of Enrollment||participants|Number|371|371.0||||||
4433772|NCT00126776|4259035|B1|United States||Region of Enrollment||participants|Number|372|372.0||||||
4433773|NCT00126776|4259033|B3||Male|Sex: Female, Male||Participants|Count of Participants|728|728.0||||||
4433774|NCT00126776|4259034|B2||Male|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4433775|NCT00126776|4259035|B1||Male|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
4433776|NCT00126776|4259033|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4433777|NCT00126776|4259034|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4433778|NCT00126776|4259035|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4433779|NCT00126776|4259033|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|9.1|9.1|||
4433780|NCT00126776|4259034|B2|||Age||years|Mean|70.1|70.1|Standard Deviation|9.7|9.7|||
4433781|NCT00126776|4259035|B1|||Age||years|Mean|69.1|69.1|Standard Deviation|9.4|9.4|||
4433782|NCT00126776|4259033|B3||>=65 years|Age||Participants|Count of Participants|513|513.0||||||
4433783|NCT00126776|4259034|B2||>=65 years|Age||Participants|Count of Participants|268|268.0||||||
4433784|NCT00126776|4259035|B1||>=65 years|Age||Participants|Count of Participants|245|245.0||||||
4433785|NCT00126776|4259033|B3||Between 18 and 65 years|Age||Participants|Count of Participants|230|230.0||||||
4433786|NCT00126776|4259034|B2||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4433787|NCT00126776|4259035|B1||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4433788|NCT00126776|4259033|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433789|NCT00126776|4259034|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433790|NCT00126776|4259035|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433791|NCT00126750|4259040|B3|Gender||Sex/Gender, Customized|Gender data not collected||Number|0|0.0||||||
4433792|NCT00126750|4259041|B2|Gender||Sex/Gender, Customized|Gender data not collected||Number|0|0.0||||||
4433793|NCT00126750|4259042|B1|Gender||Sex/Gender, Customized|Gender data not collected||Number|0|0.0||||||
4433794|NCT00126750|4259040|B3|>=65 years||Age|Age data not collected||Number|0|0.0||||||
4433795|NCT00126750|4259041|B2|>=65 years||Age|Age data not collected||Number|0|0.0||||||
4433796|NCT00126750|4259042|B1|>=65 years||Age|Age data not collected||Number|0|0.0||||||
4433797|NCT00126750|4259040|B3|Between 18 and 65 years||Age|Age data not collected||Number|0|0.0||||||
4433798|NCT00126750|4259041|B2|Between 18 and 65 years||Age|Age data not collected||Number|0|0.0||||||
4433799|NCT00126750|4259042|B1|Between 18 and 65 years||Age|Age data not collected||Number|0|0.0||||||
4433800|NCT00126750|4259040|B3|<=18 years||Age|Age data not collected||Number|0|0.0||||||
4433801|NCT00126750|4259041|B2|<=18 years||Age|Age data not collected||Number|0|0.0||||||
4433802|NCT00126750|4259042|B1|<=18 years||Age|Age data not collected||Number|0|0.0||||||
4433803|NCT00126737|4259049|B5|Not-Married||Married||participants|Number|43|43.0||||||
4433804|NCT00126737|4259050|B4|Not-Married||Married||participants|Number|9|9.0||||||
4433805|NCT00126737|4259051|B3|Not-Married||Married||participants|Number|10|10.0||||||
4433806|NCT00126737|4259052|B2|Not-Married||Married||participants|Number|9|9.0||||||
4433807|NCT00126737|4259053|B1|Not-Married||Married||participants|Number|15|15.0||||||
4433808|NCT00126737|4259049|B5|Married||Married||participants|Number|67|67.0||||||
4433809|NCT00126737|4259050|B4|Married||Married||participants|Number|16|16.0||||||
4433810|NCT00126737|4259051|B3|Married||Married||participants|Number|20|20.0||||||
4433811|NCT00126737|4259052|B2|Married||Married||participants|Number|18|18.0||||||
4433812|NCT00126737|4259053|B1|Married||Married||participants|Number|13|13.0||||||
4433813|NCT00126737|4259049|B5|||Stair Total (climb, descend)|Total amount of stairs climbed and descended for three minutes. Subjects climbed four steps up and descended four steps down.|stairs|Mean|176.0|176.0|Standard Deviation|52.8|52.8|||
4433814|NCT00126737|4259050|B4|||Stair Total (climb, descend)|Total amount of stairs climbed and descended for three minutes. Subjects climbed four steps up and descended four steps down.|stairs|Mean|171.7|171.7|Standard Deviation|52.8|52.8|||
4433815|NCT00126737|4259051|B3|||Stair Total (climb, descend)|Total amount of stairs climbed and descended for three minutes. Subjects climbed four steps up and descended four steps down.|stairs|Mean|182.9|182.9|Standard Deviation|54.1|54.1|||
4433816|NCT00126737|4259052|B2|||Stair Total (climb, descend)|Total amount of stairs climbed and descended for three minutes. Subjects climbed four steps up and descended four steps down.|stairs|Mean|181.0|181.0|Standard Deviation|53.2|53.2|||
4433817|NCT00126737|4259053|B1|||Stair Total (climb, descend)|Total amount of stairs climbed and descended for three minutes. Subjects climbed four steps up and descended four steps down.|stairs|Mean|167.7|167.7|Standard Deviation|52.5|52.5|||
4433818|NCT00126737|4259049|B5|||SF-36v Physical Scale|The Rand Short Form-36 (SF-36). We used Physical Health component for self reporting of general physical health.Physical Health consists of 4 scales, Physical Function (10 items), Role Physical (4 items), Bodily Pain (2 items), General Health (5 items). The Physical Health component is a summary measure of scales, and the scores ranges from 0 to 100, a score of 50 is the normative average of general physical health. Lower scores correspond to worse physical health status, higher scores correspond to better physical health status.|score|Mean|36.9|36.9|Standard Deviation|8.3|8.3|||
4433819|NCT00126737|4259050|B4|||SF-36v Physical Scale|The Rand Short Form-36 (SF-36). We used Physical Health component for self reporting of general physical health.Physical Health consists of 4 scales, Physical Function (10 items), Role Physical (4 items), Bodily Pain (2 items), General Health (5 items). The Physical Health component is a summary measure of scales, and the scores ranges from 0 to 100, a score of 50 is the normative average of general physical health. Lower scores correspond to worse physical health status, higher scores correspond to better physical health status.|score|Mean|36.4|36.4|Standard Deviation|9.0|9.0|||
4433820|NCT00126737|4259051|B3|||SF-36v Physical Scale|The Rand Short Form-36 (SF-36). We used Physical Health component for self reporting of general physical health.Physical Health consists of 4 scales, Physical Function (10 items), Role Physical (4 items), Bodily Pain (2 items), General Health (5 items). The Physical Health component is a summary measure of scales, and the scores ranges from 0 to 100, a score of 50 is the normative average of general physical health. Lower scores correspond to worse physical health status, higher scores correspond to better physical health status.|score|Mean|35.7|35.7|Standard Deviation|8.2|8.2|||
4433821|NCT00126737|4259052|B2|||SF-36v Physical Scale|The Rand Short Form-36 (SF-36). We used Physical Health component for self reporting of general physical health.Physical Health consists of 4 scales, Physical Function (10 items), Role Physical (4 items), Bodily Pain (2 items), General Health (5 items). The Physical Health component is a summary measure of scales, and the scores ranges from 0 to 100, a score of 50 is the normative average of general physical health. Lower scores correspond to worse physical health status, higher scores correspond to better physical health status.|score|Mean|41.1|41.1|Standard Deviation|7.2|7.2|||
4433833|NCT00126737|4259049|B5|||Walking Distance|Average distance walked in six minutes.|meters|Mean|443.8|443.8|Standard Deviation|102.7|102.7|||
4433822|NCT00126737|4259053|B1|||SF-36v Physical Scale|The Rand Short Form-36 (SF-36). We used Physical Health component for self reporting of general physical health.Physical Health consists of 4 scales, Physical Function (10 items), Role Physical (4 items), Bodily Pain (2 items), General Health (5 items). The Physical Health component is a summary measure of scales, and the scores ranges from 0 to 100, a score of 50 is the normative average of general physical health. Lower scores correspond to worse physical health status, higher scores correspond to better physical health status.|score|Mean|34.7|34.7|Standard Deviation|7.8|7.8|||
4433823|NCT00126737|4259049|B5|||36 Items Short Form Survey Instrument (SF-36v) Mental Scale|The Rand Short Form-36 (SF-36). It has Physical Health and Mental Health components. Mental Health component consisted of 4 scales; they are: Vitality ( 4 items), Social functioning (2 items), Role Emotional (3 items), and Mental Health (5 items). The mental health summary measures is called the Mental health component of SF36v. It was used to measure health related quality of life. The total score ranged from 0 -100, a score of 50 is the normative average for general mental health. Lower scores correspond to worse mental health status, higher scores correspond to better mental health status.|score|Mean|50.1|50.1|Standard Deviation|10.8|10.8|||
4433824|NCT00126737|4259050|B4|||36 Items Short Form Survey Instrument (SF-36v) Mental Scale|The Rand Short Form-36 (SF-36). It has Physical Health and Mental Health components. Mental Health component consisted of 4 scales; they are: Vitality ( 4 items), Social functioning (2 items), Role Emotional (3 items), and Mental Health (5 items). The mental health summary measures is called the Mental health component of SF36v. It was used to measure health related quality of life. The total score ranged from 0 -100, a score of 50 is the normative average for general mental health. Lower scores correspond to worse mental health status, higher scores correspond to better mental health status.|score|Mean|48.3|48.3|Standard Deviation|11.5|11.5|||
4433825|NCT00126737|4259051|B3|||36 Items Short Form Survey Instrument (SF-36v) Mental Scale|The Rand Short Form-36 (SF-36). It has Physical Health and Mental Health components. Mental Health component consisted of 4 scales; they are: Vitality ( 4 items), Social functioning (2 items), Role Emotional (3 items), and Mental Health (5 items). The mental health summary measures is called the Mental health component of SF36v. It was used to measure health related quality of life. The total score ranged from 0 -100, a score of 50 is the normative average for general mental health. Lower scores correspond to worse mental health status, higher scores correspond to better mental health status.|score|Mean|48.2|48.2|Standard Deviation|11.4|11.4|||
4433826|NCT00126737|4259052|B2|||36 Items Short Form Survey Instrument (SF-36v) Mental Scale|The Rand Short Form-36 (SF-36). It has Physical Health and Mental Health components. Mental Health component consisted of 4 scales; they are: Vitality ( 4 items), Social functioning (2 items), Role Emotional (3 items), and Mental Health (5 items). The mental health summary measures is called the Mental health component of SF36v. It was used to measure health related quality of life. The total score ranged from 0 -100, a score of 50 is the normative average for general mental health. Lower scores correspond to worse mental health status, higher scores correspond to better mental health status.|score|Mean|51.9|51.9|Standard Deviation|9.8|9.8|||
4433827|NCT00126737|4259053|B1|||36 Items Short Form Survey Instrument (SF-36v) Mental Scale|The Rand Short Form-36 (SF-36). It has Physical Health and Mental Health components. Mental Health component consisted of 4 scales; they are: Vitality ( 4 items), Social functioning (2 items), Role Emotional (3 items), and Mental Health (5 items). The mental health summary measures is called the Mental health component of SF36v. It was used to measure health related quality of life. The total score ranged from 0 -100, a score of 50 is the normative average for general mental health. Lower scores correspond to worse mental health status, higher scores correspond to better mental health status.|score|Mean|52.1|52.1|Standard Deviation|10.6|10.6|||
4433828|NCT00126737|4259049|B5|||WOMAC Function|"Western Ontario and McMaster University Osteoarthritis Index (WOMAC) as a full scale, it consists of pain scale, function scale, and stiffness scale. It is used to measure pain, function, and stiffness in patients with Osteoarthritis (OA) of the knee.~We used the Function Scale only for this study. The Function Scale has 17 items, the responses are in Likert scale; namely 0=No difficulty, 1=Slight, 2=Moderate, 3= Very, 4=Extremely. The total score ranges from 0 to 68, a higher score means worse functioning. A score of 68 indicates extremely difficult in functioning."|Score|Mean|41.9|41.9|Standard Deviation|12.2|12.2|||
4433829|NCT00126737|4259050|B4|||WOMAC Function|"Western Ontario and McMaster University Osteoarthritis Index (WOMAC) as a full scale, it consists of pain scale, function scale, and stiffness scale. It is used to measure pain, function, and stiffness in patients with Osteoarthritis (OA) of the knee.~We used the Function Scale only for this study. The Function Scale has 17 items, the responses are in Likert scale; namely 0=No difficulty, 1=Slight, 2=Moderate, 3= Very, 4=Extremely. The total score ranges from 0 to 68, a higher score means worse functioning. A score of 68 indicates extremely difficult in functioning."|Score|Mean|44.4|44.4|Standard Deviation|14.8|14.8|||
4433830|NCT00126737|4259051|B3|||WOMAC Function|"Western Ontario and McMaster University Osteoarthritis Index (WOMAC) as a full scale, it consists of pain scale, function scale, and stiffness scale. It is used to measure pain, function, and stiffness in patients with Osteoarthritis (OA) of the knee.~We used the Function Scale only for this study. The Function Scale has 17 items, the responses are in Likert scale; namely 0=No difficulty, 1=Slight, 2=Moderate, 3= Very, 4=Extremely. The total score ranges from 0 to 68, a higher score means worse functioning. A score of 68 indicates extremely difficult in functioning."|Score|Mean|40.3|40.3|Standard Deviation|10.6|10.6|||
4433831|NCT00126737|4259052|B2|||WOMAC Function|"Western Ontario and McMaster University Osteoarthritis Index (WOMAC) as a full scale, it consists of pain scale, function scale, and stiffness scale. It is used to measure pain, function, and stiffness in patients with Osteoarthritis (OA) of the knee.~We used the Function Scale only for this study. The Function Scale has 17 items, the responses are in Likert scale; namely 0=No difficulty, 1=Slight, 2=Moderate, 3= Very, 4=Extremely. The total score ranges from 0 to 68, a higher score means worse functioning. A score of 68 indicates extremely difficult in functioning."|Score|Mean|39.2|39.2|Standard Deviation|12.0|12.0|||
4433832|NCT00126737|4259053|B1|||WOMAC Function|"Western Ontario and McMaster University Osteoarthritis Index (WOMAC) as a full scale, it consists of pain scale, function scale, and stiffness scale. It is used to measure pain, function, and stiffness in patients with Osteoarthritis (OA) of the knee.~We used the Function Scale only for this study. The Function Scale has 17 items, the responses are in Likert scale; namely 0=No difficulty, 1=Slight, 2=Moderate, 3= Very, 4=Extremely. The total score ranges from 0 to 68, a higher score means worse functioning. A score of 68 indicates extremely difficult in functioning."|Score|Mean|44.0|44.0|Standard Deviation|11.4|11.4|||
4433834|NCT00126737|4259050|B4|||Walking Distance|Average distance walked in six minutes.|meters|Mean|435.1|435.1|Standard Deviation|82.4|82.4|||
4433835|NCT00126737|4259051|B3|||Walking Distance|Average distance walked in six minutes.|meters|Mean|476.9|476.9|Standard Deviation|101.4|101.4|||
4433836|NCT00126737|4259052|B2|||Walking Distance|Average distance walked in six minutes.|meters|Mean|445.1|445.1|Standard Deviation|125.4|125.4|||
4433837|NCT00126737|4259053|B1|||Walking Distance|Average distance walked in six minutes.|meters|Mean|414.9|414.9|Standard Deviation|92.6|92.6|||
4433838|NCT00126737|4259049|B5|||Duration of OA|Duration of Osteoarthritis (OA) of the knee|years|Mean|10.0|10.0|Standard Deviation|10.1|10.1|||
4433839|NCT00126737|4259050|B4|||Duration of OA|Duration of Osteoarthritis (OA) of the knee|years|Mean|10.0|10.0|Standard Deviation|9.8|9.8|||
4433840|NCT00126737|4259051|B3|||Duration of OA|Duration of Osteoarthritis (OA) of the knee|years|Mean|11.5|11.5|Standard Deviation|13.2|13.2|||
4433841|NCT00126737|4259052|B2|||Duration of OA|Duration of Osteoarthritis (OA) of the knee|years|Mean|9.4|9.4|Standard Deviation|6.0|6.0|||
4433842|NCT00126737|4259053|B1|||Duration of OA|Duration of Osteoarthritis (OA) of the knee|years|Mean|9.1|9.1|Standard Deviation|10.4|10.4|||
4433843|NCT00126737|4259049|B5|||BMI at Baseline||kg/m^2|Mean|34.4|34.4|Standard Deviation|5.9|5.9|||
4433844|NCT00126737|4259050|B4|||BMI at Baseline||kg/m^2|Mean|32.8|32.8|Standard Deviation|5.1|5.1|||
4433845|NCT00126737|4259051|B3|||BMI at Baseline||kg/m^2|Mean|34.3|34.3|Standard Deviation|5.4|5.4|||
4433846|NCT00126737|4259052|B2|||BMI at Baseline||kg/m^2|Mean|36.8|36.8|Standard Deviation|6.2|6.2|||
4433847|NCT00126737|4259053|B1|||BMI at Baseline||kg/m^2|Mean|33.8|33.8|Standard Deviation|6.4|6.4|||
4433848|NCT00126737|4259049|B5|Non-white||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4433849|NCT00126737|4259050|B4|Non-white||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4433850|NCT00126737|4259051|B3|Non-white||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4433851|NCT00126737|4259052|B2|Non-white||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4433852|NCT00126737|4259053|B1|Non-white||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4433853|NCT00126737|4259049|B5|White||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
4433854|NCT00126737|4259050|B4|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4433855|NCT00126737|4259051|B3|White||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4433856|NCT00126737|4259052|B2|White||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4433857|NCT00126737|4259053|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4433858|NCT00126737|4259049|B5||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4433859|NCT00126737|4259050|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4433860|NCT00126737|4259051|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4433861|NCT00126737|4259052|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4433862|NCT00126737|4259053|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4433863|NCT00126737|4259049|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4433864|NCT00126737|4259050|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4433865|NCT00126737|4259051|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4433866|NCT00126737|4259052|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4433867|NCT00126737|4259053|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4433868|NCT00126737|4259049|B5|||Age||years|Mean|67.9|67.9|Standard Deviation|8.4|8.4|||
4433869|NCT00126737|4259050|B4|||Age||years|Mean|69.5|69.5|Standard Deviation|8.5|8.5|||
4433870|NCT00126737|4259051|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|7.6|7.6|||
4433871|NCT00126737|4259052|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|7.3|7.3|||
4433872|NCT00126737|4259053|B1|||Age||years|Mean|70.3|70.3|Standard Deviation|9.6|9.6|||
4433873|NCT00126659|4259082|B4|United States||Region of Enrollment||participants|Number|10|10.0||||||
4433874|NCT00126659|4259083|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4433875|NCT00126659|4259084|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4433876|NCT00126659|4259085|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4433877|NCT00126659|4259082|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4433878|NCT00126659|4259083|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4433879|NCT00126659|4259084|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4433880|NCT00126659|4259085|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4433881|NCT00126659|4259082|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4433882|NCT00126659|4259083|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4433883|NCT00126659|4259084|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4433884|NCT00126659|4259085|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4433885|NCT00126659|4259082|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4433886|NCT00126659|4259083|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4433887|NCT00126659|4259084|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4433888|NCT00126659|4259085|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4433889|NCT00126659|4259082|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4433890|NCT00126659|4259083|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4433891|NCT00126659|4259084|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4433892|NCT00126659|4259085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4433893|NCT00126659|4259082|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433894|NCT00126659|4259083|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433895|NCT00126659|4259084|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433896|NCT00126659|4259085|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4433897|NCT00126594|4259093|B3|Other||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|38|38.0||||||
4433898|NCT00126594|4259094|B2|Other||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|19|19.0||||||
4433899|NCT00126594|4259095|B1|Other||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|19|19.0||||||
4433900|NCT00126594|4259093|B3|Bone||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|11|11.0||||||
4433901|NCT00126594|4259094|B2|Bone||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|6|6.0||||||
4433902|NCT00126594|4259095|B1|Bone||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|5|5.0||||||
4433903|NCT00126594|4259093|B3|Liver||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|8|8.0||||||
4433904|NCT00126594|4259094|B2|Liver||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|5|5.0||||||
4433905|NCT00126594|4259095|B1|Liver||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|3|3.0||||||
4433906|NCT00126594|4259093|B3|Lymph Nodes||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|35|35.0||||||
4433907|NCT00126594|4259094|B2|Lymph Nodes||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|15|15.0||||||
4433908|NCT00126594|4259095|B1|Lymph Nodes||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|20|20.0||||||
4433909|NCT00126594|4259093|B3|Lung||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|63|63.0||||||
4433910|NCT00126594|4259094|B2|Lung||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|30|30.0||||||
4433911|NCT00126594|4259095|B1|Lung||Sites of Metastatic Disease|Number of participants with metastatic tumor sites in the noted locations for each study arm population.|participants|Number|33|33.0||||||
4433912|NCT00126594|4259093|B3|Three or More||Number of Metastatic Sites||participants|Number|16|16.0||||||
4433913|NCT00126594|4259094|B2|Three or More||Number of Metastatic Sites||participants|Number|6|6.0||||||
4433914|NCT00126594|4259095|B1|Three or More||Number of Metastatic Sites||participants|Number|10|10.0||||||
4433915|NCT00126594|4259093|B3|Two||Number of Metastatic Sites||participants|Number|37|37.0||||||
4433916|NCT00126594|4259094|B2|Two||Number of Metastatic Sites||participants|Number|20|20.0||||||
4433917|NCT00126594|4259095|B1|Two||Number of Metastatic Sites||participants|Number|17|17.0||||||
4433918|NCT00126594|4259093|B3|One||Number of Metastatic Sites||participants|Number|27|27.0||||||
4433919|NCT00126594|4259094|B2|One||Number of Metastatic Sites||participants|Number|14|14.0||||||
4433920|NCT00126594|4259095|B1|One||Number of Metastatic Sites||participants|Number|13|13.0||||||
4433921|NCT00126594|4259093|B3|Poor||Memorial Sloan–Kettering Cancer Center (MSKCC) Prognostic Risk|MSKCC risk system stratifies participants poor, intermediate and favorable-risk categories based on number of adverse clinical/laboratory parameters present. Poor prognostic factors include Karnofsky performance status <80, time from diagnosis to treatment <12 months, serum lactate dehydrogenase >1.5-times upper limit of normal, corrected serum calcium >10.0 mg/dl & hemoglobin <lower limit of normal. Favorable-risk group have no poor prognostic factors, intermediate-risk category have 1 or 2 adverse prognostic factors, & participants with poor-risk have >2 poor prognostic factors.|participants|Number|2|2.0||||||
4433922|NCT00126594|4259094|B2|Poor||Memorial Sloan–Kettering Cancer Center (MSKCC) Prognostic Risk|MSKCC risk system stratifies participants poor, intermediate and favorable-risk categories based on number of adverse clinical/laboratory parameters present. Poor prognostic factors include Karnofsky performance status <80, time from diagnosis to treatment <12 months, serum lactate dehydrogenase >1.5-times upper limit of normal, corrected serum calcium >10.0 mg/dl & hemoglobin <lower limit of normal. Favorable-risk group have no poor prognostic factors, intermediate-risk category have 1 or 2 adverse prognostic factors, & participants with poor-risk have >2 poor prognostic factors.|participants|Number|2|2.0||||||
4433923|NCT00126594|4259095|B1|Poor||Memorial Sloan–Kettering Cancer Center (MSKCC) Prognostic Risk|MSKCC risk system stratifies participants poor, intermediate and favorable-risk categories based on number of adverse clinical/laboratory parameters present. Poor prognostic factors include Karnofsky performance status <80, time from diagnosis to treatment <12 months, serum lactate dehydrogenase >1.5-times upper limit of normal, corrected serum calcium >10.0 mg/dl & hemoglobin <lower limit of normal. Favorable-risk group have no poor prognostic factors, intermediate-risk category have 1 or 2 adverse prognostic factors, & participants with poor-risk have >2 poor prognostic factors.|participants|Number|0|0.0||||||
4433924|NCT00126594|4259093|B3|Intermediate||Memorial Sloan–Kettering Cancer Center (MSKCC) Prognostic Risk|MSKCC risk system stratifies participants poor, intermediate and favorable-risk categories based on number of adverse clinical/laboratory parameters present. Poor prognostic factors include Karnofsky performance status <80, time from diagnosis to treatment <12 months, serum lactate dehydrogenase >1.5-times upper limit of normal, corrected serum calcium >10.0 mg/dl & hemoglobin <lower limit of normal. Favorable-risk group have no poor prognostic factors, intermediate-risk category have 1 or 2 adverse prognostic factors, & participants with poor-risk have >2 poor prognostic factors.|participants|Number|37|37.0||||||
4433925|NCT00126594|4259094|B2|Intermediate||Memorial Sloan–Kettering Cancer Center (MSKCC) Prognostic Risk|MSKCC risk system stratifies participants poor, intermediate and favorable-risk categories based on number of adverse clinical/laboratory parameters present. Poor prognostic factors include Karnofsky performance status <80, time from diagnosis to treatment <12 months, serum lactate dehydrogenase >1.5-times upper limit of normal, corrected serum calcium >10.0 mg/dl & hemoglobin <lower limit of normal. Favorable-risk group have no poor prognostic factors, intermediate-risk category have 1 or 2 adverse prognostic factors, & participants with poor-risk have >2 poor prognostic factors.|participants|Number|18|18.0||||||
4433926|NCT00126594|4259095|B1|Intermediate||Memorial Sloan–Kettering Cancer Center (MSKCC) Prognostic Risk|MSKCC risk system stratifies participants poor, intermediate and favorable-risk categories based on number of adverse clinical/laboratory parameters present. Poor prognostic factors include Karnofsky performance status <80, time from diagnosis to treatment <12 months, serum lactate dehydrogenase >1.5-times upper limit of normal, corrected serum calcium >10.0 mg/dl & hemoglobin <lower limit of normal. Favorable-risk group have no poor prognostic factors, intermediate-risk category have 1 or 2 adverse prognostic factors, & participants with poor-risk have >2 poor prognostic factors.|participants|Number|19|19.0||||||
4433927|NCT00126594|4259093|B3|Low||Memorial Sloan–Kettering Cancer Center (MSKCC) Prognostic Risk|MSKCC risk system stratifies participants poor, intermediate and favorable-risk categories based on number of adverse clinical/laboratory parameters present. Poor prognostic factors include Karnofsky performance status <80, time from diagnosis to treatment <12 months, serum lactate dehydrogenase >1.5-times upper limit of normal, corrected serum calcium >10.0 mg/dl & hemoglobin <lower limit of normal. Favorable-risk group have no poor prognostic factors, intermediate-risk category have 1 or 2 adverse prognostic factors, & participants with poor-risk have >2 poor prognostic factors.|participants|Number|41|41.0||||||
4433928|NCT00126594|4259094|B2|Low||Memorial Sloan–Kettering Cancer Center (MSKCC) Prognostic Risk|MSKCC risk system stratifies participants poor, intermediate and favorable-risk categories based on number of adverse clinical/laboratory parameters present. Poor prognostic factors include Karnofsky performance status <80, time from diagnosis to treatment <12 months, serum lactate dehydrogenase >1.5-times upper limit of normal, corrected serum calcium >10.0 mg/dl & hemoglobin <lower limit of normal. Favorable-risk group have no poor prognostic factors, intermediate-risk category have 1 or 2 adverse prognostic factors, & participants with poor-risk have >2 poor prognostic factors.|participants|Number|20|20.0||||||
4433929|NCT00126594|4259095|B1|Low||Memorial Sloan–Kettering Cancer Center (MSKCC) Prognostic Risk|MSKCC risk system stratifies participants poor, intermediate and favorable-risk categories based on number of adverse clinical/laboratory parameters present. Poor prognostic factors include Karnofsky performance status <80, time from diagnosis to treatment <12 months, serum lactate dehydrogenase >1.5-times upper limit of normal, corrected serum calcium >10.0 mg/dl & hemoglobin <lower limit of normal. Favorable-risk group have no poor prognostic factors, intermediate-risk category have 1 or 2 adverse prognostic factors, & participants with poor-risk have >2 poor prognostic factors.|participants|Number|21|21.0||||||
4433930|NCT00126594|4259093|B3|No||Nephrectomy|Number of participants who had nephrectomy|participants|Number|1|1.0||||||
4433931|NCT00126594|4259094|B2|No||Nephrectomy|Number of participants who had nephrectomy|participants|Number|1|1.0||||||
4433932|NCT00126594|4259095|B1|No||Nephrectomy|Number of participants who had nephrectomy|participants|Number|0|0.0||||||
4433933|NCT00126594|4259093|B3|Yes||Nephrectomy|Number of participants who had nephrectomy|participants|Number|79|79.0||||||
4433934|NCT00126594|4259094|B2|Yes||Nephrectomy|Number of participants who had nephrectomy|participants|Number|39|39.0||||||
4433935|NCT00126594|4259095|B1|Yes||Nephrectomy|Number of participants who had nephrectomy|participants|Number|40|40.0||||||
4433936|NCT00126594|4259093|B3|1||ECOG (Performance Status)|Eastern Cooperative Oncology Group (ECOG) Scale used to assess how a participant's disease is progressing, assess how the disease affects the daily living abilities of the participant, and determine appropriate treatment and prognosis. Scale runs from 0 to 5, with 0 denoting perfect health and 5 death.|participants|Number|30|30.0||||||
4433937|NCT00126594|4259094|B2|1||ECOG (Performance Status)|Eastern Cooperative Oncology Group (ECOG) Scale used to assess how a participant's disease is progressing, assess how the disease affects the daily living abilities of the participant, and determine appropriate treatment and prognosis. Scale runs from 0 to 5, with 0 denoting perfect health and 5 death.|participants|Number|15|15.0||||||
4433938|NCT00126594|4259095|B1|1||ECOG (Performance Status)|Eastern Cooperative Oncology Group (ECOG) Scale used to assess how a participant's disease is progressing, assess how the disease affects the daily living abilities of the participant, and determine appropriate treatment and prognosis. Scale runs from 0 to 5, with 0 denoting perfect health and 5 death.|participants|Number|15|15.0||||||
4433939|NCT00126594|4259093|B3|0||ECOG (Performance Status)|Eastern Cooperative Oncology Group (ECOG) Scale used to assess how a participant's disease is progressing, assess how the disease affects the daily living abilities of the participant, and determine appropriate treatment and prognosis. Scale runs from 0 to 5, with 0 denoting perfect health and 5 death.|participants|Number|50|50.0||||||
4433940|NCT00126594|4259094|B2|0||ECOG (Performance Status)|Eastern Cooperative Oncology Group (ECOG) Scale used to assess how a participant's disease is progressing, assess how the disease affects the daily living abilities of the participant, and determine appropriate treatment and prognosis. Scale runs from 0 to 5, with 0 denoting perfect health and 5 death.|participants|Number|25|25.0||||||
4433941|NCT00126594|4259095|B1|0||ECOG (Performance Status)|Eastern Cooperative Oncology Group (ECOG) Scale used to assess how a participant's disease is progressing, assess how the disease affects the daily living abilities of the participant, and determine appropriate treatment and prognosis. Scale runs from 0 to 5, with 0 denoting perfect health and 5 death.|participants|Number|25|25.0||||||
4433942|NCT00126594|4259093|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4433943|NCT00126594|4259094|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4433944|NCT00126594|4259095|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4433945|NCT00126594|4259093|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4433946|NCT00126594|4259094|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4433947|NCT00126594|4259095|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4433948|NCT00126594|4259093|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4433949|NCT00126594|4259094|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4433950|NCT00126594|4259095|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4433951|NCT00126594|4259093|B3|||Age||years|Mean|62.0|62.0|Full Range|||43.0|83.0|
4433952|NCT00126594|4259094|B2|||Age||years|Mean|60.7|60.7|Full Range|||43.0|81.0|
4433953|NCT00126594|4259095|B1|||Age||years|Mean|62.4|62.4|Full Range|||45.0|83.0|
4433954|NCT00126581|4259111|B3|Adenocarcinoma with bronchioloalveolar features||Histology||participants|Number|22|22.0||||||
4433955|NCT00126581|4259112|B2|Adenocarcinoma with bronchioloalveolar features||Histology||participants|Number|14|14.0||||||
4433956|NCT00126581|4259113|B1|Adenocarcinoma with bronchioloalveolar features||Histology||participants|Number|8|8.0||||||
4433957|NCT00126581|4259111|B3|Bronhioloalveolar cancer||Histology||participants|Number|4|4.0||||||
4433958|NCT00126581|4259112|B2|Bronhioloalveolar cancer||Histology||participants|Number|2|2.0||||||
4433959|NCT00126581|4259113|B1|Bronhioloalveolar cancer||Histology||participants|Number|2|2.0||||||
4433960|NCT00126581|4259111|B3|Adenocarcinoma||Histology||participants|Number|155|155.0||||||
4433961|NCT00126581|4259112|B2|Adenocarcinoma||Histology||participants|Number|84|84.0||||||
4433962|NCT00126581|4259113|B1|Adenocarcinoma||Histology||participants|Number|71|71.0||||||
4433963|NCT00126581|4259111|B3|Light former smoker||Smoking history||participants|Number|38|38.0||||||
4433964|NCT00126581|4259112|B2|Light former smoker||Smoking history||participants|Number|21|21.0||||||
4433965|NCT00126581|4259113|B1|Light former smoker||Smoking history||participants|Number|17|17.0||||||
4433966|NCT00126581|4259111|B3|Never smoker||Smoking history||participants|Number|143|143.0||||||
4433967|NCT00126581|4259112|B2|Never smoker||Smoking history||participants|Number|79|79.0||||||
4433968|NCT00126581|4259113|B1|Never smoker||Smoking history||participants|Number|64|64.0||||||
4433969|NCT00126581|4259111|B3|1 - minimal symptoms||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|83|83.0||||||
4433970|NCT00126581|4259112|B2|1 - minimal symptoms||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|52|52.0||||||
4433971|NCT00126581|4259113|B1|1 - minimal symptoms||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|31|31.0||||||
4433972|NCT00126581|4259111|B3|0 - fully active||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|98|98.0||||||
4433973|NCT00126581|4259112|B2|0 - fully active||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|48|48.0||||||
4433974|NCT00126581|4259113|B1|0 - fully active||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|50|50.0||||||
4433975|NCT00126581|4259111|B3|United States||Region of Enrollment||participants|Number|181|181.0||||||
4433976|NCT00126581|4259112|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
4433977|NCT00126581|4259113|B1|United States||Region of Enrollment||participants|Number|81|81.0||||||
4433978|NCT00126581|4259111|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4433979|NCT00126581|4259112|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4433980|NCT00126581|4259113|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4433981|NCT00126581|4259111|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4433982|NCT00126581|4259112|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4433983|NCT00126581|4259113|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4433984|NCT00126581|4259111|B3|||Age||years|Median|59|59.0|Full Range|||32.0|81.0|
4433985|NCT00126581|4259112|B2|||Age||years|Median|60|60.0|Full Range|||34.0|81.0|
4433986|NCT00126581|4259113|B1|||Age||years|Median|58|58.0|Full Range|||32.0|78.0|
4433987|NCT00126568|4259134|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4433988|NCT00126568|4259134|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433989|NCT00126568|4259134|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433990|NCT00126568|4259134|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4433991|NCT00126568|4259134|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433992|NCT00126568|4259134|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433993|NCT00126568|4259134|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433994|NCT00126568|4259134|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433995|NCT00126568|4259134|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4433996|NCT00126568|4259134|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4433997|NCT00126568|4259134|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4433998|NCT00126568|4259134|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4433999|NCT00126568|4259134|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4434000|NCT00126568|4259134|B1|||Age||years|Median|59|59.0|Full Range|||28.0|79.0|
4434001|NCT00126555|4259141|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4434002|NCT00126555|4259141|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4434003|NCT00126555|4259141|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4434004|NCT00126555|4259141|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4434005|NCT00126555|4259141|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4434006|NCT00126555|4259141|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4434007|NCT00126555|4259141|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4434008|NCT00126555|4259141|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4434009|NCT00126555|4259141|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4434010|NCT00126555|4259141|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4434011|NCT00126555|4259141|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4434012|NCT00126555|4259141|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4434013|NCT00126555|4259141|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4434014|NCT00126555|4259141|B1|||Age|Demographics are reported as consolidated information for both stratum.|years|Median|65|65.0|Full Range|||27.0|93.0|
4434015|NCT00126503|4259155|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4434016|NCT00126503|4259156|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4434017|NCT00126503|4259157|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4434018|NCT00126503|4259155|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4434019|NCT00126503|4259156|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4434020|NCT00126503|4259157|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4434021|NCT00126503|4259155|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4434022|NCT00126503|4259156|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4434023|NCT00126503|4259157|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4434024|NCT00126503|4259155|B3|||Age||years|Mean|62|62.0|Standard Deviation|1|1.0|||
4434025|NCT00126503|4259156|B2|||Age||years|Mean|58|58.0|Standard Deviation|1|1.0|||
4434026|NCT00126503|4259157|B1|||Age||years|Mean|65|65.0|Standard Deviation|1|1.0|||
4434027|NCT00126503|4259155|B3||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4434028|NCT00126503|4259156|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4434029|NCT00126503|4259157|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4434030|NCT00126503|4259155|B3||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4434031|NCT00126503|4259156|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4434032|NCT00126503|4259157|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4434033|NCT00126503|4259155|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434034|NCT00126503|4259156|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434035|NCT00126503|4259157|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434036|NCT00126490|4259170|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4434037|NCT00126490|4259170|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4434038|NCT00126490|4259170|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4434039|NCT00126490|4259170|B1|||Age||years|Median|66|66.0|Full Range|||41.0|84.0|
4434040|NCT00126490|4259170|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4434041|NCT00126490|4259170|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4434042|NCT00126490|4259170|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434043|NCT00126438|4259178|B3||Male|Sex: Female, Male||Participants|Count of Participants|394|394.0||||||
4434044|NCT00126438|4259179|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4434045|NCT00126438|4259180|B1||Male|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4434046|NCT00126438|4259178|B3||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4434047|NCT00126438|4259179|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4434048|NCT00126438|4259180|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4434049|NCT00126438|4259178|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|12.20|12.2|||
4434050|NCT00126438|4259179|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|10.84|10.84|||
4434051|NCT00126438|4259180|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|12.38|12.38|||
4434052|NCT00126425|4259187|B3||Male|Sex: Female, Male||Participants|Count of Participants|468|468.0||||||
4434053|NCT00126425|4259188|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4434054|NCT00126425|4259189|B1||Male|Sex: Female, Male||Participants|Count of Participants|440|440.0||||||
4434055|NCT00126425|4259187|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4434056|NCT00126425|4259188|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4434057|NCT00126425|4259189|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4434058|NCT00126425|4259187|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|11.37|11.37|||
4434059|NCT00126425|4259188|B2|||Age||years|Mean|56.4|56.4|Standard Deviation|11.97|11.97|||
4434060|NCT00126425|4259189|B1|||Age||years|Mean|63.0|63.0|Standard Deviation|11.33|11.33|||
4434061|NCT00126191|4259196|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4434062|NCT00126191|4259197|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4434063|NCT00126191|4259198|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4434064|NCT00126191|4259196|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4434065|NCT00126191|4259197|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4434066|NCT00126191|4259198|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4434067|NCT00126191|4259196|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4434068|NCT00126191|4259197|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4434069|NCT00126191|4259198|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4434070|NCT00126191|4259196|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4434071|NCT00126191|4259197|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4434072|NCT00126191|4259198|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4434073|NCT00126191|4259196|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4434074|NCT00126191|4259197|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4434075|NCT00126191|4259198|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4434076|NCT00126191|4259196|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4434077|NCT00126191|4259197|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434078|NCT00126191|4259198|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4434079|NCT00126191|4259196|B3||>=65 years|Age|IRB approved deviation to register 1 patient at age 17.|Participants|Count of Participants|0|0.0||||||
4434080|NCT00126191|4259197|B2||>=65 years|Age|IRB approved deviation to register 1 patient at age 17.|Participants|Count of Participants|0|0.0||||||
4434081|NCT00126191|4259198|B1||>=65 years|Age|IRB approved deviation to register 1 patient at age 17.|Participants|Count of Participants|0|0.0||||||
4434082|NCT00126191|4259196|B3||Between 18 and 65 years|Age|IRB approved deviation to register 1 patient at age 17.|Participants|Count of Participants|9|9.0||||||
4434083|NCT00126191|4259197|B2||Between 18 and 65 years|Age|IRB approved deviation to register 1 patient at age 17.|Participants|Count of Participants|8|8.0||||||
4434084|NCT00126191|4259198|B1||Between 18 and 65 years|Age|IRB approved deviation to register 1 patient at age 17.|Participants|Count of Participants|1|1.0||||||
4434085|NCT00126191|4259196|B3||<=18 years|Age|IRB approved deviation to register 1 patient at age 17.|Participants|Count of Participants|1|1.0||||||
4434086|NCT00126191|4259197|B2||<=18 years|Age|IRB approved deviation to register 1 patient at age 17.|Participants|Count of Participants|0|0.0||||||
4434087|NCT00126191|4259198|B1||<=18 years|Age|IRB approved deviation to register 1 patient at age 17.|Participants|Count of Participants|1|1.0||||||
4434088|NCT00126126|4259207|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4434089|NCT00126126|4259208|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4434090|NCT00126126|4259209|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4434091|NCT00126126|4259207|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4434092|NCT00126126|4259208|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4434093|NCT00126126|4259209|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4434094|NCT00126126|4259207|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4434095|NCT00126126|4259208|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4434096|NCT00126126|4259209|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4434097|NCT00126126|4259207|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|9.5|9.5|||
4434098|NCT00126126|4259208|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|7.1|7.1|||
4434099|NCT00126126|4259209|B1|||Age||years|Mean|63.4|63.4|Standard Deviation|11.4|11.4|||
4434100|NCT00126126|4259207|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4434101|NCT00126126|4259208|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4434102|NCT00126126|4259209|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4434103|NCT00126126|4259207|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4434104|NCT00126126|4259208|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4434105|NCT00126126|4259209|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4434106|NCT00126126|4259207|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434107|NCT00126126|4259208|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434108|NCT00126126|4259209|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434109|NCT00126113|4259218|B3|||Past hearing aid use||years|Mean|9.3|9.3|Standard Deviation|10.5|10.5|||
4434110|NCT00126113|4259219|B2|||Past hearing aid use||years|Mean|9.8|9.8|Standard Deviation|10.6|10.6|||
4434111|NCT00126113|4259220|B1|||Past hearing aid use||years|Mean|8.8|8.8|Standard Deviation|10.3|10.3|||
4434112|NCT00126113|4259218|B3|||Education level||years|Mean|15.3|15.3|Standard Deviation|2.8|2.8|||
4434113|NCT00126113|4259219|B2|||Education level||years|Mean|15.1|15.1|Standard Deviation|2.4|2.4|||
4434114|NCT00126113|4259220|B1|||Education level||years|Mean|15.4|15.4|Standard Deviation|3.1|3.1|||
4434115|NCT00126113|4259218|B3|||Hearing sensitivity (pure tone thresholds)||decibels|Mean|45.7|45.7|Standard Deviation|113|113.0|||
4434116|NCT00126113|4259219|B2|||Hearing sensitivity (pure tone thresholds)||decibels|Mean|46.4|46.4|Standard Deviation|11.0|11.0|||
4434117|NCT00126113|4259220|B1|||Hearing sensitivity (pure tone thresholds)||decibels|Mean|45.0|45.0|Standard Deviation|11.6|11.6|||
4434118|NCT00126113|4259218|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4434119|NCT00126113|4259219|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4434120|NCT00126113|4259220|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4434121|NCT00126113|4259218|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4434122|NCT00126113|4259219|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4434123|NCT00126113|4259220|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4434124|NCT00126113|4259218|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4434125|NCT00126113|4259219|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4434126|NCT00126113|4259220|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4434127|NCT00126113|4259218|B3|||Age||years|Mean|65.8|65.8|Standard Deviation|8.2|8.2|||
4434128|NCT00126113|4259219|B2|||Age||years|Mean|66.1|66.1|Standard Deviation|7.8|7.8|||
4434129|NCT00126113|4259220|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|8.6|8.6|||
4434130|NCT00125957|4259233|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4434131|NCT00125957|4259234|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4434132|NCT00125957|4259235|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4434133|NCT00125957|4259233|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4434134|NCT00125957|4259234|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4434135|NCT00125957|4259235|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4434136|NCT00125957|4259233|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4434137|NCT00125957|4259234|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4434138|NCT00125957|4259235|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4434139|NCT00125957|4259233|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4434140|NCT00125957|4259234|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4434141|NCT00125957|4259235|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4434142|NCT00125957|4259233|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4434143|NCT00125957|4259234|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4434144|NCT00125957|4259235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4434145|NCT00125957|4259233|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434146|NCT00125957|4259234|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434147|NCT00125957|4259235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434148|NCT00125957|4259233|B3|||Age||years|Mean|48|48.0|Full Range|||18.0|65.0|
4434149|NCT00125957|4259234|B2|||Age||years|Mean|47|47.0|Full Range|||22.0|63.0|
4434150|NCT00125957|4259235|B1|||Age||years|Mean|49|49.0|Full Range|||18.0|65.0|
4434151|NCT00125931|4259244|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4434152|NCT00125931|4259244|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4434153|NCT00125931|4259244|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4434154|NCT00125931|4259244|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4434155|NCT00125931|4259244|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434156|NCT00125762|4259249|B1|United States||Region of Enrollment||participants|Number|907|907.0||||||
4434157|NCT00125762|4259249|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|321|321.0||||||
4434158|NCT00125762|4259249|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4434159|NCT00125762|4259249|B1||White|Race (NIH/OMB)||Participants|Count of Participants|586|586.0||||||
4434160|NCT00125762|4259249|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4434161|NCT00125762|4259249|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4434162|NCT00125762|4259249|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4434163|NCT00125762|4259249|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4434164|NCT00125762|4259249|B1||Male|Sex: Female, Male||Participants|Count of Participants|491|491.0||||||
4434165|NCT00125762|4259249|B1||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4434166|NCT00125762|4259249|B1|||Age||years|Mean|49.9|49.9|Standard Deviation|8.8|8.8|||
4434167|NCT00125762|4259249|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4434168|NCT00125762|4259249|B1||Between 18 and 65 years|Age||Participants|Count of Participants|907|907.0||||||
4434169|NCT00125762|4259249|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434170|NCT00125658|4259254|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4434171|NCT00125658|4259255|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4434172|NCT00125658|4259256|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4434173|NCT00125658|4259254|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4434174|NCT00125658|4259255|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4434175|NCT00125658|4259256|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4434176|NCT00125658|4259254|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4434177|NCT00125658|4259255|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4434178|NCT00125658|4259256|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4434179|NCT00125658|4259254|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|15|15.0|||
4434180|NCT00125658|4259255|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|9.8|9.8|||
4434181|NCT00125658|4259256|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|17.9|17.9|||
4434182|NCT00125658|4259254|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4434183|NCT00125658|4259255|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4434184|NCT00125658|4259256|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4434185|NCT00125658|4259254|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4434186|NCT00125658|4259255|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4434187|NCT00125658|4259256|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4434188|NCT00125658|4259254|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434189|NCT00125658|4259255|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434190|NCT00125658|4259256|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434191|NCT00125619|4259275|B3|||Berg Balance Scale|The Berg Balance Scale is a standardized clinical assessment of balance function involving performance of 14 tasks ranging from sitting unsupported to standing on one leg with eyes closed. It is scored on a range of 0 - 56 points where 56 is the best score, which is generally equivalent to normal.|units on a scale|Mean|46.9|46.9|Standard Deviation|7.0|7.0|||
4434192|NCT00125619|4259276|B2|||Berg Balance Scale|The Berg Balance Scale is a standardized clinical assessment of balance function involving performance of 14 tasks ranging from sitting unsupported to standing on one leg with eyes closed. It is scored on a range of 0 - 56 points where 56 is the best score, which is generally equivalent to normal.|units on a scale|Mean|47|47.0|Standard Deviation|7.0|7.0|||
4434193|NCT00125619|4259277|B1|||Berg Balance Scale|The Berg Balance Scale is a standardized clinical assessment of balance function involving performance of 14 tasks ranging from sitting unsupported to standing on one leg with eyes closed. It is scored on a range of 0 - 56 points where 56 is the best score, which is generally equivalent to normal.|units on a scale|Mean|46.9|46.9|Standard Deviation|7.5|7.5|||
4434194|NCT00125619|4259275|B3|||Short Physical Performance Battery|The Short Physical Performance Battery measures 3 components of physical function: walking speed, strength - assessed through repeated sit-to-stand movements, and balance. The SPPB is scored over a range of 0-12 points, where 12 is the highest, or best, score. Each of the 3 components contributes 4 points to the total SPPB, although sub-scores are not typically calculated and/or interpreted.|units on a scale|Mean|7.31|7.31|Standard Deviation|3.1|3.1|||
4434195|NCT00125619|4259276|B2|||Short Physical Performance Battery|The Short Physical Performance Battery measures 3 components of physical function: walking speed, strength - assessed through repeated sit-to-stand movements, and balance. The SPPB is scored over a range of 0-12 points, where 12 is the highest, or best, score. Each of the 3 components contributes 4 points to the total SPPB, although sub-scores are not typically calculated and/or interpreted.|units on a scale|Mean|7.8|7.8|Standard Deviation|3.0|3.0|||
4434196|NCT00125619|4259277|B1|||Short Physical Performance Battery|The Short Physical Performance Battery measures 3 components of physical function: walking speed, strength - assessed through repeated sit-to-stand movements, and balance. The SPPB is scored over a range of 0-12 points, where 12 is the highest, or best, score. Each of the 3 components contributes 4 points to the total SPPB, although sub-scores are not typically calculated and/or interpreted.|units on a scale|Mean|6.9|6.9|Standard Deviation|3.4|3.4|||
4434197|NCT00125619|4259275|B3|||Lower Extremity Fugl-Meyer Motor Assessment|The Fugl-Meyer Motor Assessment is a standardized clinical assessment used to determine the magnitude of motor impairment (or severity) following stroke. There are separate scales for the upper and lower extremities. Here we used the lower extremity component which has a range of 36 points. Higher scores reflect better motor status than lower scores. Importantly, there is a remarkable ceiling effect with the FMA, thus a full score of 36 points does not indicate an individual post-stroke has fully recovered.|units on a scale|Mean|23|23.0|Standard Deviation|4.5|4.5|||
4434198|NCT00125619|4259276|B2|||Lower Extremity Fugl-Meyer Motor Assessment|The Fugl-Meyer Motor Assessment is a standardized clinical assessment used to determine the magnitude of motor impairment (or severity) following stroke. There are separate scales for the upper and lower extremities. Here we used the lower extremity component which has a range of 36 points. Higher scores reflect better motor status than lower scores. Importantly, there is a remarkable ceiling effect with the FMA, thus a full score of 36 points does not indicate an individual post-stroke has fully recovered.|units on a scale|Mean|21.4|21.4|Standard Deviation|5.1|5.1|||
4434199|NCT00125619|4259277|B1|||Lower Extremity Fugl-Meyer Motor Assessment|The Fugl-Meyer Motor Assessment is a standardized clinical assessment used to determine the magnitude of motor impairment (or severity) following stroke. There are separate scales for the upper and lower extremities. Here we used the lower extremity component which has a range of 36 points. Higher scores reflect better motor status than lower scores. Importantly, there is a remarkable ceiling effect with the FMA, thus a full score of 36 points does not indicate an individual post-stroke has fully recovered.|units on a scale|Mean|23.0|23.0|Standard Deviation|4.3|4.3|||
4434200|NCT00125619|4259275|B3|||Step-length Asymmetry|"Measure is a ratio of paretic/non-paretic step length calculated as follows:~= ABS[1-(paretic step length/non-paretic step length)]~Values approaching 0 reveal greater symmetry."|ratio|Mean|0.45|0.45|Standard Deviation|0.48|0.48|||
4434201|NCT00125619|4259276|B2|||Step-length Asymmetry|"Measure is a ratio of paretic/non-paretic step length calculated as follows:~= ABS[1-(paretic step length/non-paretic step length)]~Values approaching 0 reveal greater symmetry."|ratio|Mean|0.39|0.39|Standard Deviation|0.37|0.37|||
4434202|NCT00125619|4259277|B1|||Step-length Asymmetry|"Measure is a ratio of paretic/non-paretic step length calculated as follows:~= ABS[1-(paretic step length/non-paretic step length)]~Values approaching 0 reveal greater symmetry."|ratio|Mean|0.53|0.53|Standard Deviation|0.58|0.58|||
4434203|NCT00125619|4259275|B3|||Six Minute Walk Test||distance walked, meters|Mean|250.8|250.8|Standard Deviation|161.1|161.1|||
4434204|NCT00125619|4259276|B2|||Six Minute Walk Test||distance walked, meters|Mean|234.3|234.3|Standard Deviation|141.2|141.2|||
4434205|NCT00125619|4259277|B1|||Six Minute Walk Test||distance walked, meters|Mean|267.3|267.3|Standard Deviation|187.2|187.2|||
4434206|NCT00125619|4259275|B3|||Fast Walking Speed||meters per second|Mean|0.80|0.8|Standard Deviation|0.47|0.47|||
4434207|NCT00125619|4259276|B2|||Fast Walking Speed||meters per second|Mean|0.72|0.72|Standard Deviation|0.37|0.37|||
4434208|NCT00125619|4259277|B1|||Fast Walking Speed||meters per second|Mean|0.87|0.87|Standard Deviation|0.55|0.55|||
4434209|NCT00125619|4259275|B3|||Self-selected Overground Walking speed||meters per second|Mean|0.62|0.62|Standard Deviation|0.28|0.28|||
4434210|NCT00125619|4259276|B2|||Self-selected Overground Walking speed||meters per second|Mean|0.62|0.62|Standard Deviation|0.28|0.28|||
4434211|NCT00125619|4259277|B1|||Self-selected Overground Walking speed||meters per second|Mean|0.62|0.62|Standard Deviation|0.31|0.31|||
4434212|NCT00125619|4259275|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4434213|NCT00125619|4259276|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4434214|NCT00125619|4259277|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4434215|NCT00125619|4259275|B3||Male|Gender||Participants|Count of Participants|13|13.0||||||
4434216|NCT00125619|4259276|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
4434217|NCT00125619|4259277|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4434218|NCT00125619|4259275|B3||Female|Gender||Participants|Count of Participants|3|3.0||||||
4434219|NCT00125619|4259276|B2||Female|Gender||Participants|Count of Participants|1|1.0||||||
4434220|NCT00125619|4259277|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4434221|NCT00125619|4259275|B3|||Age||years|Mean|56.8|56.8|Standard Deviation|14.4|14.4|||
4434222|NCT00125619|4259276|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|13.6|13.6|||
4434223|NCT00125619|4259277|B1|||Age||years|Mean|58.6|58.6|Standard Deviation|16.9|16.9|||
4434224|NCT00125619|4259275|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4434225|NCT00125619|4259276|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4434226|NCT00125619|4259277|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4434227|NCT00125619|4259275|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4434228|NCT00125619|4259276|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4434229|NCT00125619|4259277|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4434230|NCT00125619|4259275|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434231|NCT00125619|4259276|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434232|NCT00125619|4259277|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434233|NCT00125593|4259296|B3|Not on dialysis||Renal status||Participants|Number|6247|6247.0||||||
4434234|NCT00125593|4259297|B2|Not on dialysis||Renal status||Participants|Number|3130|3130.0||||||
4434235|NCT00125593|4259298|B1|Not on dialysis||Renal status||Participants|Number|3117|3117.0||||||
4434236|NCT00125593|4259296|B3|On dialysis||Renal status||Participants|Number|3023|3023.0||||||
4434237|NCT00125593|4259297|B2|On dialysis||Renal status||Participants|Number|1490|1490.0||||||
4434238|NCT00125593|4259298|B1|On dialysis||Renal status||Participants|Number|1533|1533.0||||||
4434239|NCT00125593|4259296|B3||Male|Sex: Female, Male||Participants|Count of Participants|5800|5800.0||||||
4434240|NCT00125593|4259297|B2||Male|Sex: Female, Male||Participants|Count of Participants|2885|2885.0||||||
4434241|NCT00125593|4259298|B1||Male|Sex: Female, Male||Participants|Count of Participants|2915|2915.0||||||
4434242|NCT00125593|4259296|B3||Female|Sex: Female, Male||Participants|Count of Participants|3470|3470.0||||||
4434243|NCT00125593|4259297|B2||Female|Sex: Female, Male||Participants|Count of Participants|1735|1735.0||||||
4434244|NCT00125593|4259298|B1||Female|Sex: Female, Male||Participants|Count of Participants|1735|1735.0||||||
4434245|NCT00125593|4259296|B3|||Age||Years|Mean|62|62.0|Standard Deviation|12|12.0|||
4434246|NCT00125593|4259297|B2|||Age||Years|Mean|62|62.0|Standard Deviation|12|12.0|||
4434247|NCT00125593|4259298|B1|||Age||Years|Mean|62|62.0|Standard Deviation|12|12.0|||
4434248|NCT00125528|4259317|B3|||Numeric Rating Scale (NRS-11)|Numeric rating scale is an 11-point rating scale wherein participants rated their current lower back pain intensity on a scale from 0 to 10, with 0 meaning no pain and 10 being the worst pain possible. Thus, a lower score represents a better pain state at baseline.|units on a scale|Mean|6.54|6.54|Standard Deviation|1.45|1.45|||
4434249|NCT00125528|4259318|B2|||Numeric Rating Scale (NRS-11)|Numeric rating scale is an 11-point rating scale wherein participants rated their current lower back pain intensity on a scale from 0 to 10, with 0 meaning no pain and 10 being the worst pain possible. Thus, a lower score represents a better pain state at baseline.|units on a scale|Mean|6.6|6.6|Standard Deviation|1.50|1.5|||
4434250|NCT00125528|4259319|B1|||Numeric Rating Scale (NRS-11)|Numeric rating scale is an 11-point rating scale wherein participants rated their current lower back pain intensity on a scale from 0 to 10, with 0 meaning no pain and 10 being the worst pain possible. Thus, a lower score represents a better pain state at baseline.|units on a scale|Mean|6.47|6.47|Standard Deviation|1.40|1.4|||
4434251|NCT00125528|4259317|B3||Male|Gender||Participants|Count of Participants|16|16.0||||||
4434252|NCT00125528|4259318|B2||Male|Gender||Participants|Count of Participants|10|10.0||||||
4434253|NCT00125528|4259319|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4434254|NCT00125528|4259317|B3||Female|Gender||Participants|Count of Participants|25|25.0||||||
4434255|NCT00125528|4259318|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
4434256|NCT00125528|4259319|B1||Female|Gender||Participants|Count of Participants|14|14.0||||||
4434257|NCT00125528|4259317|B3|||Age||years|Mean|54.71|54.71|Standard Deviation|11.06|11.06|||
4434258|NCT00125528|4259318|B2|||Age||years|Mean|54.76|54.76|Standard Deviation|10.84|10.84|||
4434259|NCT00125528|4259319|B1|||Age||years|Mean|54.65|54.65|Standard Deviation|11.56|11.56|||
4434260|NCT00125515|4259328|B4|United States||Region of Enrollment||participants|Number|81|81.0||||||
4434261|NCT00125515|4259329|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4434262|NCT00125515|4259330|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4434263|NCT00125515|4259331|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4434264|NCT00125515|4259328|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4434265|NCT00125515|4259329|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4434266|NCT00125515|4259330|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4434267|NCT00125515|4259331|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4434268|NCT00125515|4259328|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4434269|NCT00125515|4259329|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4434270|NCT00125515|4259330|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4434271|NCT00125515|4259331|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4434272|NCT00125515|4259328|B4|||Age||years|Mean|41.3|41.3|Standard Deviation|9.8|9.8|||
4434273|NCT00125515|4259329|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|9.4|9.4|||
4434274|NCT00125515|4259330|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|10.3|10.3|||
4434275|NCT00125515|4259331|B1|||Age||years|Mean|40.5|40.5|Standard Deviation|9.6|9.6|||
4434276|NCT00125515|4259328|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4434277|NCT00125515|4259329|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4434278|NCT00125515|4259330|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4434279|NCT00125515|4259331|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4434280|NCT00125515|4259328|B4||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4434281|NCT00125515|4259329|B3||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4434282|NCT00125515|4259330|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4434283|NCT00125515|4259331|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4434284|NCT00125515|4259328|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434285|NCT00125515|4259329|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434286|NCT00125515|4259330|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434287|NCT00125515|4259331|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434288|NCT00125372|4259341|B1||Not assessed|KRAS Status||Participants|Count of Participants|1|1.0||||||
4434289|NCT00125372|4259341|B1||Mutant|KRAS Status||Participants|Count of Participants|5|5.0||||||
4434290|NCT00125372|4259341|B1||Wild type|KRAS Status||Participants|Count of Participants|4|4.0||||||
4434291|NCT00125372|4259341|B1||Not assessed|EGFR Status||Participants|Count of Participants|1|1.0||||||
4434292|NCT00125372|4259341|B1||Mutant|EGFR Status||Participants|Count of Participants|1|1.0||||||
4434293|NCT00125372|4259341|B1||Wild Type|EGFR Status||Participants|Count of Participants|8|8.0||||||
4434294|NCT00125372|4259341|B1||Basaloid carcinoma|Histology||Participants|Count of Participants|1|1.0||||||
4434295|NCT00125372|4259341|B1||Bronchioloalveolar carcinoma|Histology||Participants|Count of Participants|1|1.0||||||
4434296|NCT00125372|4259341|B1||Adenosquamous carcinoma|Histology||Participants|Count of Participants|1|1.0||||||
4434297|NCT00125372|4259341|B1||Adenocarcinoma|Histology||Participants|Count of Participants|6|6.0||||||
4434298|NCT00125372|4259341|B1||Sqamous Cell carcinoma|Histology||Participants|Count of Participants|1|1.0||||||
4434299|NCT00125372|4259341|B1||Former|Smoking status||Participants|Count of Participants|6|6.0||||||
4434300|NCT00125372|4259341|B1||Never|Smoking status||Participants|Count of Participants|1|1.0||||||
4434301|NCT00125372|4259341|B1||Current|Smoking status||Participants|Count of Participants|3|3.0||||||
4434302|NCT00125372|4259341|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4434303|NCT00125372|4259341|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4434304|NCT00125372|4259341|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4434305|NCT00125372|4259341|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4434306|NCT00125372|4259341|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4434307|NCT00125372|4259341|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434308|NCT00125359|4259349|B1||Former smoker|Smoking status||Participants|Count of Participants|29|29.0||||||
4434309|NCT00125359|4259349|B1||Current smoker|Smoking status||Participants|Count of Participants|6|6.0||||||
4434310|NCT00125359|4259349|B1||Never smoker|Smoking status||Participants|Count of Participants|7|7.0||||||
4434311|NCT00125359|4259349|B1|||Number of prior chemotherapies||chemotherapies|Median|2|2.0|Full Range|||0.0|5.0|
4434312|NCT00125359|4259349|B1||Did not receive prior anti-EGFR therapy|Prior anti-EGFR therapy||Participants|Count of Participants|33|33.0||||||
4434313|NCT00125359|4259349|B1||Received prior anti-EGFR therapy|Prior anti-EGFR therapy||Participants|Count of Participants|9|9.0||||||
4434314|NCT00125359|4259349|B1|Non-small cell carcinomas not otherwise specified||Histopathology|Includes multiple histopathology types (adenocarcinoma and brochioloalveolar type).|participants|Number|10|10.0||||||
4434315|NCT00125359|4259349|B1|Squamous cell carcinoma||Histopathology|Includes multiple histopathology types (adenocarcinoma and brochioloalveolar type).|participants|Number|2|2.0||||||
4434316|NCT00125359|4259349|B1|Bronchioloalveolar type||Histopathology|Includes multiple histopathology types (adenocarcinoma and brochioloalveolar type).|participants|Number|5|5.0||||||
4434317|NCT00125359|4259349|B1|Adenocarcinomas||Histopathology|Includes multiple histopathology types (adenocarcinoma and brochioloalveolar type).|participants|Number|28|28.0||||||
4434318|NCT00125359|4259349|B1|||Disease Stage IV|Clinically staged.|Participants|Count of Participants|42|42.0||||||
4434319|NCT00125359|4259349|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4434320|NCT00125359|4259349|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4434321|NCT00125359|4259349|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4434322|NCT00125359|4259349|B1|||Age||years|Median|67|67.0|Full Range|||46.0|77.0|
4434323|NCT00125268|4259356|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4434324|NCT00125268|4259357|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4434325|NCT00125268|4259358|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4434326|NCT00125268|4259356|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4434327|NCT00125268|4259357|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4434328|NCT00125268|4259358|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4434329|NCT00125268|4259356|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4434330|NCT00125268|4259357|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4434331|NCT00125268|4259358|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4434332|NCT00125268|4259356|B3|||Age||years|Mean|71|71.0|Standard Deviation|15|15.0|||
4434333|NCT00125268|4259357|B2|||Age||years|Mean|74|74.0|Standard Deviation|11|11.0|||
4434334|NCT00125268|4259358|B1|||Age||years|Mean|68|68.0|Standard Deviation|17|17.0|||
4434335|NCT00125242|4259369|B3||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4434336|NCT00125242|4259370|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4434337|NCT00125242|4259371|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4434338|NCT00125242|4259369|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4434339|NCT00125242|4259370|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4434340|NCT00125242|4259371|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4434341|NCT00125242|4259369|B3|21-80 Years||Age, Customized||participants|Number|110|110.0||||||
4434342|NCT00125242|4259370|B2|21-80 Years||Age, Customized||participants|Number|94|94.0||||||
4434343|NCT00125242|4259371|B1|21-80 Years||Age, Customized||participants|Number|16|16.0||||||
4434344|NCT00125190|4259377|B1|||Weight SD Score||SDs|Mean|-2.3|-2.3|Standard Deviation|0.7|0.7|||
4434345|NCT00125190|4259377|B1|||Maximum Stimulated GH||ng/mL|Mean|20.5|20.5|Standard Deviation|9.9|9.9|||
4434346|NCT00125190|4259377|B1|||IGF-1 SD Score||SDs|Mean|-2.6|-2.6|Standard Deviation|0.5|0.5|||
4434347|NCT00125190|4259377|B1|||IGF Binding Protein-3 SD Score||SDs|Mean|-0.7|-0.7|Standard Deviation|1.0|1.0|||
4434348|NCT00125190|4259377|B1|||Height SD Score||SDs|Mean|-2.7|-2.7|Standard Deviation|0.6|0.6|||
4434349|NCT00125190|4259377|B1|||Bone Age||years|Mean|7.2|7.2|Standard Deviation|2.6|2.6|||
4434350|NCT00125190|4259377|B1|||Body Mass Index SD Score||SDs|Mean|-0.4|-0.4|Standard Deviation|0.7|0.7|||
4434351|NCT00125190|4259377|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4434352|NCT00125190|4259377|B1|White||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4434353|NCT00125190|4259377|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4434354|NCT00125190|4259377|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4434355|NCT00125190|4259377|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4434356|NCT00125190|4259377|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4434357|NCT00125190|4259377|B1|||Age||years|Mean|8.7|8.7|Standard Deviation|2.8|2.8|||
4434358|NCT00125164|4259391|B5|||Weight||Kg|Mean|18.6|18.6|Standard Deviation|5.3|5.3|||
4434359|NCT00125164|4259392|B4|||Weight||Kg|Mean|18.5|18.5|Standard Deviation|5.7|5.7|||
4434360|NCT00125164|4259393|B3|||Weight||Kg|Mean|19.4|19.4|Standard Deviation|5.4|5.4|||
4434361|NCT00125164|4259394|B2|||Weight||Kg|Mean|18.5|18.5|Standard Deviation|4.7|4.7|||
4434362|NCT00125164|4259395|B1|||Weight||Kg|Mean|17.8|17.8|Standard Deviation|4.6|4.6|||
4434363|NCT00125164|4259391|B5|||Maximum Stimulated Growth Hormone|Growth Hormone Stimulation Test results expressed in ng/mL|ng/mL|Mean|18.6|18.6|Standard Deviation|12.1|12.1|||
4434364|NCT00125164|4259392|B4|||Maximum Stimulated Growth Hormone|Growth Hormone Stimulation Test results expressed in ng/mL|ng/mL|Mean|20.7|20.7|Standard Deviation|16.8|16.8|||
4434365|NCT00125164|4259393|B3|||Maximum Stimulated Growth Hormone|Growth Hormone Stimulation Test results expressed in ng/mL|ng/mL|Mean|17.8|17.8|Standard Deviation|9.0|9.0|||
4434366|NCT00125164|4259394|B2|||Maximum Stimulated Growth Hormone|Growth Hormone Stimulation Test results expressed in ng/mL|ng/mL|Mean|16.9|16.9|Standard Deviation|6.2|6.2|||
4434367|NCT00125164|4259395|B1|||Maximum Stimulated Growth Hormone|Growth Hormone Stimulation Test results expressed in ng/mL|ng/mL|Mean|17.0|17.0|Standard Deviation|6.5|6.5|||
4434368|NCT00125164|4259391|B5|||IGF-1 Standard Deviation (SD) Score|Please note that Standard Deviation (SD) Score is a term used in growth studies. The SD Score is calculated as the patient value minus the mean divided by the standard deviation. The mean and the standard deviation vary depending on the age and sex of the child.|SD|Mean|-2.8|-2.8|Standard Deviation|0.8|0.8|||
4434369|NCT00125164|4259392|B4|||IGF-1 Standard Deviation (SD) Score|Please note that Standard Deviation (SD) Score is a term used in growth studies. The SD Score is calculated as the patient value minus the mean divided by the standard deviation. The mean and the standard deviation vary depending on the age and sex of the child.|SD|Mean|-3.0|-3.0|Standard Deviation|0.8|0.8|||
4434370|NCT00125164|4259393|B3|||IGF-1 Standard Deviation (SD) Score|Please note that Standard Deviation (SD) Score is a term used in growth studies. The SD Score is calculated as the patient value minus the mean divided by the standard deviation. The mean and the standard deviation vary depending on the age and sex of the child.|SD|Mean|-2.6|-2.6|Standard Deviation|0.7|0.7|||
4434371|NCT00125164|4259394|B2|||IGF-1 Standard Deviation (SD) Score|Please note that Standard Deviation (SD) Score is a term used in growth studies. The SD Score is calculated as the patient value minus the mean divided by the standard deviation. The mean and the standard deviation vary depending on the age and sex of the child.|SD|Mean|-2.8|-2.8|Standard Deviation|0.8|0.8|||
4434372|NCT00125164|4259395|B1|||IGF-1 Standard Deviation (SD) Score|Please note that Standard Deviation (SD) Score is a term used in growth studies. The SD Score is calculated as the patient value minus the mean divided by the standard deviation. The mean and the standard deviation vary depending on the age and sex of the child.|SD|Mean|-2.6|-2.6|Standard Deviation|0.7|0.7|||
4434373|NCT00125164|4259391|B5|||Height Standard Deviation (SD) Score|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|SD|Mean|-2.8|-2.8|Standard Deviation|0.7|0.7|||
4434374|NCT00125164|4259392|B4|||Height Standard Deviation (SD) Score|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|SD|Mean|-2.9|-2.9|Standard Deviation|0.8|0.8|||
4434375|NCT00125164|4259393|B3|||Height Standard Deviation (SD) Score|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|SD|Mean|-2.7|-2.7|Standard Deviation|0.5|0.5|||
4434376|NCT00125164|4259394|B2|||Height Standard Deviation (SD) Score|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|SD|Mean|-2.6|-2.6|Standard Deviation|0.6|0.6|||
4434377|NCT00125164|4259395|B1|||Height Standard Deviation (SD) Score|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|SD|Mean|-2.8|-2.8|Standard Deviation|0.7|0.7|||
4434378|NCT00125164|4259391|B5|Height Standard Deviation Score >= -2.6||Stratum|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|participants|Number|60|60.0||||||
4434379|NCT00125164|4259392|B4|Height Standard Deviation Score >= -2.6||Stratum|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|participants|Number|21|21.0||||||
4434380|NCT00125164|4259393|B3|Height Standard Deviation Score >= -2.6||Stratum|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|participants|Number|19|19.0||||||
4434381|NCT00125164|4259394|B2|Height Standard Deviation Score >= -2.6||Stratum|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|participants|Number|8|8.0||||||
4434382|NCT00125164|4259395|B1|Height Standard Deviation Score >= -2.6||Stratum|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|participants|Number|12|12.0||||||
4434383|NCT00125164|4259391|B5|Height Standard Deviation Score < -2.6||Stratum|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|participants|Number|76|76.0||||||
4434384|NCT00125164|4259392|B4|Height Standard Deviation Score < -2.6||Stratum|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|participants|Number|30|30.0||||||
4434385|NCT00125164|4259393|B3|Height Standard Deviation Score < -2.6||Stratum|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|participants|Number|25|25.0||||||
4434386|NCT00125164|4259394|B2|Height Standard Deviation Score < -2.6||Stratum|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|participants|Number|8|8.0||||||
4434387|NCT00125164|4259395|B1|Height Standard Deviation Score < -2.6||Stratum|Please note that SD is a standard term used in growth studies and represents Standard Deviations calculated as the patient value minus the mean divided by the standard deviation. Standard Deviation Scores vary depending on the age and sex of the child.|participants|Number|13|13.0||||||
4434388|NCT00125164|4259391|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4434389|NCT00125164|4259392|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4434390|NCT00125164|4259393|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4434391|NCT00125164|4259394|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4434392|NCT00125164|4259395|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4434393|NCT00125164|4259391|B5|White||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4434394|NCT00125164|4259392|B4|White||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4434395|NCT00125164|4259393|B3|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4434396|NCT00125164|4259394|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4434397|NCT00125164|4259395|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4434398|NCT00125164|4259391|B5|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4434399|NCT00125164|4259392|B4|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4434400|NCT00125164|4259393|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4434401|NCT00125164|4259394|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4434402|NCT00125164|4259395|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4434403|NCT00125164|4259391|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4434404|NCT00125164|4259392|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4434405|NCT00125164|4259393|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4434406|NCT00125164|4259394|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4434407|NCT00125164|4259395|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4434408|NCT00125164|4259391|B5|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4434409|NCT00125164|4259392|B4|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4434410|NCT00125164|4259393|B3|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4434411|NCT00125164|4259394|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4434412|NCT00125164|4259395|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4434413|NCT00125164|4259391|B5|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4434414|NCT00125164|4259392|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4434415|NCT00125164|4259393|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4434416|NCT00125164|4259394|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4434417|NCT00125164|4259395|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4434418|NCT00125164|4259391|B5||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4434419|NCT00125164|4259392|B4||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4434420|NCT00125164|4259393|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4434421|NCT00125164|4259394|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4434422|NCT00125164|4259395|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4434423|NCT00125164|4259391|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4434424|NCT00125164|4259392|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4434425|NCT00125164|4259393|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4434426|NCT00125164|4259394|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4434427|NCT00125164|4259395|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4434428|NCT00125164|4259391|B5|||Age||years|Mean|7.5|7.5|Standard Deviation|2.5|2.5|||
4434429|NCT00125164|4259392|B4|||Age||years|Mean|7.6|7.6|Standard Deviation|2.7|2.7|||
4434430|NCT00125164|4259393|B3|||Age||years|Mean|7.7|7.7|Standard Deviation|2.4|2.4|||
4434431|NCT00125164|4259394|B2|||Age||years|Mean|7.6|7.6|Standard Deviation|2.4|2.4|||
4434432|NCT00125164|4259395|B1|||Age||years|Mean|7.0|7.0|Standard Deviation|2.4|2.4|||
4434433|NCT00125138|4259448|B5||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4434434|NCT00125138|4259449|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4434435|NCT00125138|4259450|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4434436|NCT00125138|4259451|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4434437|NCT00125138|4259452|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4434438|NCT00125138|4259448|B5||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4434439|NCT00125138|4259449|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4434440|NCT00125138|4259450|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4434441|NCT00125138|4259451|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4434442|NCT00125138|4259452|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4434443|NCT00125138|4259448|B5|||Age||years|Mean|68.4|68.4|Standard Deviation|10.0|10.0|||
4434444|NCT00125138|4259449|B4|||Age||years|Mean|68.5|68.5|Standard Deviation|9.6|9.6|||
4434445|NCT00125138|4259450|B3|||Age||years|Mean|67.4|67.4|Standard Deviation|11.2|11.2|||
4434446|NCT00125138|4259451|B2|||Age||years|Mean|69.0|69.0|Standard Deviation|11.8|11.8|||
4434447|NCT00125138|4259452|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|6.2|6.2|||
4434448|NCT00125034|4259469|B3|Germany||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|36|36.0||||||
4434449|NCT00125034|4259470|B2|Germany||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|22|22.0||||||
4434450|NCT00125034|4259471|B1|Germany||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|14|14.0||||||
4434451|NCT00125034|4259469|B3|Romania||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|31|31.0||||||
4434452|NCT00125034|4259470|B2|Romania||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|13|13.0||||||
4434453|NCT00125034|4259471|B1|Romania||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|18|18.0||||||
4434454|NCT00125034|4259469|B3|Poland||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|61|61.0||||||
4434455|NCT00125034|4259470|B2|Poland||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|31|31.0||||||
4434456|NCT00125034|4259471|B1|Poland||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|30|30.0||||||
4434457|NCT00125034|4259469|B3|Belgium||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|18|18.0||||||
4434458|NCT00125034|4259470|B2|Belgium||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|6|6.0||||||
4434459|NCT00125034|4259471|B1|Belgium||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|12|12.0||||||
4434460|NCT00125034|4259469|B3|France||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|15|15.0||||||
4434563|NCT00124943|4259587|B2|Insulin Dependent||Diabetes mellitis||participants|Number|5|5.0||||||
4434461|NCT00125034|4259470|B2|France||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|12|12.0||||||
4434462|NCT00125034|4259471|B1|France||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|3|3.0||||||
4434463|NCT00125034|4259469|B3|Italy||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|14|14.0||||||
4434464|NCT00125034|4259470|B2|Italy||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|6|6.0||||||
4434465|NCT00125034|4259471|B1|Italy||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|8|8.0||||||
4434466|NCT00125034|4259469|B3|Israel||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|1|1.0||||||
4434467|NCT00125034|4259470|B2|Israel||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|1|1.0||||||
4434468|NCT00125034|4259471|B1|Israel||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|0|0.0||||||
4434469|NCT00125034|4259469|B3|Russian Federation||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|49|49.0||||||
4434470|NCT00125034|4259470|B2|Russian Federation||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|24|24.0||||||
4434471|NCT00125034|4259471|B1|Russian Federation||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|25|25.0||||||
4434472|NCT00125034|4259469|B3|Austria||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|25|25.0||||||
4434473|NCT00125034|4259470|B2|Austria||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|9|9.0||||||
4434474|NCT00125034|4259471|B1|Austria||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|16|16.0||||||
4434475|NCT00125034|4259469|B3|Ukraine||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|49|49.0||||||
4434476|NCT00125034|4259470|B2|Ukraine||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|25|25.0||||||
4434477|NCT00125034|4259471|B1|Ukraine||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|24|24.0||||||
4434478|NCT00125034|4259469|B3|Spain||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|35|35.0||||||
4434479|NCT00125034|4259470|B2|Spain||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|16|16.0||||||
4434480|NCT00125034|4259471|B1|Spain||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|19|19.0||||||
4434481|NCT00125034|4259469|B3|Portugal||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|3|3.0||||||
4434482|NCT00125034|4259470|B2|Portugal||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|3|3.0||||||
4434483|NCT00125034|4259471|B1|Portugal||Region of Enrollment|Figures refer to randomized and treated participants|participants|Number|0|0.0||||||
4434484|NCT00125034|4259469|B3||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4434485|NCT00125034|4259470|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4434486|NCT00125034|4259471|B1||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4434487|NCT00125034|4259469|B3||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4434488|NCT00125034|4259470|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4434489|NCT00125034|4259471|B1||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4434490|NCT00125034|4259469|B3|||Age||years|Median|61.0|61.0|Full Range|||24.0|82.0|
4434491|NCT00125034|4259470|B2|||Age||years|Median|60.0|60.0|Full Range|||30.0|82.0|
4434492|NCT00125034|4259471|B1|||Age||years|Median|62.0|62.0|Full Range|||24.0|82.0|
4434493|NCT00125034|4259469|B3||>=65 years|Age||Participants|Count of Participants|132|132.0||||||
4434494|NCT00125034|4259470|B2||>=65 years|Age||Participants|Count of Participants|59|59.0||||||
4434495|NCT00125034|4259471|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4434496|NCT00125034|4259469|B3||Between 18 and 65 years|Age||Participants|Count of Participants|205|205.0||||||
4434497|NCT00125034|4259470|B2||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4434498|NCT00125034|4259471|B1||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4434499|NCT00125034|4259469|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434500|NCT00125034|4259470|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434501|NCT00125034|4259471|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434502|NCT00124982|4259502|B3|Data Not Available||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|52|52.0||||||
4434503|NCT00124982|4259503|B2|Data Not Available||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|33|33.0||||||
4434504|NCT00124982|4259504|B1|Data Not Available||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|19|19.0||||||
4434521|NCT00124982|4259503|B2|||Number of Swollen Joints|The mean number of swollen joints was evaluated based on the number of swollen joints in a standard 66 joint count.|swollen joints|Mean|13.5|13.5|Standard Deviation|5.4|5.4|||
4434564|NCT00124943|4259588|B1|Insulin Dependent||Diabetes mellitis||participants|Number|0|0.0||||||
4434505|NCT00124982|4259502|B3|Positive||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|641|641.0||||||
4434506|NCT00124982|4259503|B2|Positive||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|349|349.0||||||
4434507|NCT00124982|4259504|B1|Positive||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|292|292.0||||||
4434508|NCT00124982|4259502|B3|Negative||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|353|353.0||||||
4434509|NCT00124982|4259503|B2|Negative||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|215|215.0||||||
4434510|NCT00124982|4259504|B1|Negative||Rheumatoid Factor (RF) Status|Rheumatoid factor (RF or RhF) is an autoantibody (antibody directed against an organism's own tissues) most relevant in rheumatoid arthritis. It is an antibody against the Fc portion of Immunoglobulin (Ig)G, which is itself an antibody. RF and IgG join to form immune complexes which contribute to the disease process.|participants|Number|138|138.0||||||
4434511|NCT00124982|4259502|B3|||Disease Activity Score (DAS) 28 (Using CRP Levels)|The DAS28 (CRP) is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, serum CRP level, and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (> 5.1), low disease activity (< 3.2) and remission (< 2.6). A clinically significant response= decrease in DAS28 score of >1.2 from baseline.|units on a scale|Mean|6.2|6.2|Standard Deviation|0.7|0.7|||
4434512|NCT00124982|4259503|B2|||Disease Activity Score (DAS) 28 (Using CRP Levels)|The DAS28 (CRP) is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, serum CRP level, and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (> 5.1), low disease activity (< 3.2) and remission (< 2.6). A clinically significant response= decrease in DAS28 score of >1.2 from baseline.|units on a scale|Mean|6.2|6.2|Standard Deviation|0.7|0.7|||
4434513|NCT00124982|4259504|B1|||Disease Activity Score (DAS) 28 (Using CRP Levels)|The DAS28 (CRP) is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, serum CRP level, and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (> 5.1), low disease activity (< 3.2) and remission (< 2.6). A clinically significant response= decrease in DAS28 score of >1.2 from baseline.|units on a scale|Mean|6.2|6.2|Standard Deviation|0.7|0.7|||
4434514|NCT00124982|4259502|B3|||hs-C-Reactive Protein (hs-CRP) Serum Levels|hs-CRP is a acute phase reactant protein that is a clinical marker for Rheumatoid Arthritis (RA). Levels of hs-CRP can be used to determine DAS28.|mg/dL|Mean|2.1|2.1|Standard Deviation|3.0|3.0|||
4434515|NCT00124982|4259503|B2|||hs-C-Reactive Protein (hs-CRP) Serum Levels|hs-CRP is a acute phase reactant protein that is a clinical marker for Rheumatoid Arthritis (RA). Levels of hs-CRP can be used to determine DAS28.|mg/dL|Mean|2.1|2.1|Standard Deviation|3.0|3.0|||
4434516|NCT00124982|4259504|B1|||hs-C-Reactive Protein (hs-CRP) Serum Levels|hs-CRP is a acute phase reactant protein that is a clinical marker for Rheumatoid Arthritis (RA). Levels of hs-CRP can be used to determine DAS28.|mg/dL|Mean|2.2|2.2|Standard Deviation|3.0|3.0|||
4434517|NCT00124982|4259502|B3|||Physical Function, Health Assessment Questionnaire Disability Index (HAQ-DI)|The HAQ-DI includes 20 questions to assess physical functions in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip and common activities. The domain questions are evaluated on a 4-point scale: 0=without any difficulty, 1= with some difficulty, 2= with much difficulty, and 3= unable to do. HAQ-DI= sum of worst scores in each domain divided by the number of domains answered. HAQ-DI ranges from a minimum of 0 (no difficulty) to a maximum overall score of 3(unable to do).|units on a scale|Mean|1.7|1.7|Standard Deviation|0.6|0.6|||
4434518|NCT00124982|4259503|B2|||Physical Function, Health Assessment Questionnaire Disability Index (HAQ-DI)|The HAQ-DI includes 20 questions to assess physical functions in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip and common activities. The domain questions are evaluated on a 4-point scale: 0=without any difficulty, 1= with some difficulty, 2= with much difficulty, and 3= unable to do. HAQ-DI= sum of worst scores in each domain divided by the number of domains answered. HAQ-DI ranges from a minimum of 0 (no difficulty) to a maximum overall score of 3(unable to do).|units on a scale|Mean|1.7|1.7|Standard Deviation|0.6|0.6|||
4434519|NCT00124982|4259504|B1|||Physical Function, Health Assessment Questionnaire Disability Index (HAQ-DI)|The HAQ-DI includes 20 questions to assess physical functions in 8 domains: dressing, arising, eating, walking, hygiene, reach, grip and common activities. The domain questions are evaluated on a 4-point scale: 0=without any difficulty, 1= with some difficulty, 2= with much difficulty, and 3= unable to do. HAQ-DI= sum of worst scores in each domain divided by the number of domains answered. HAQ-DI ranges from a minimum of 0 (no difficulty) to a maximum overall score of 3(unable to do).|units on a scale|Mean|1.7|1.7|Standard Deviation|0.6|0.6|||
4434520|NCT00124982|4259502|B3|||Number of Swollen Joints|The mean number of swollen joints was evaluated based on the number of swollen joints in a standard 66 joint count.|swollen joints|Mean|13.6|13.6|Standard Deviation|5.5|5.5|||
4434562|NCT00124943|4259586|B3|Insulin Dependent||Diabetes mellitis||participants|Number|0|0.0||||||
4434522|NCT00124982|4259504|B1|||Number of Swollen Joints|The mean number of swollen joints was evaluated based on the number of swollen joints in a standard 66 joint count.|swollen joints|Mean|13.9|13.9|Standard Deviation|5.6|5.6|||
4434523|NCT00124982|4259502|B3|||Number of Tender Joints|The mean number of tender joints was evaluated based on the number of tender joints in a standard 68 joint count.|tender joints|Mean|17.8|17.8|Standard Deviation|6.0|6.0|||
4434524|NCT00124982|4259503|B2|||Number of Tender Joints|The mean number of tender joints was evaluated based on the number of tender joints in a standard 68 joint count.|tender joints|Mean|17.8|17.8|Standard Deviation|6.1|6.1|||
4434525|NCT00124982|4259504|B1|||Number of Tender Joints|The mean number of tender joints was evaluated based on the number of tender joints in a standard 68 joint count.|tender joints|Mean|17.8|17.8|Standard Deviation|5.9|5.9|||
4434526|NCT00124982|4259502|B3||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4434527|NCT00124982|4259503|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4434528|NCT00124982|4259504|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4434529|NCT00124982|4259502|B3||Female|Sex: Female, Male||Participants|Count of Participants|849|849.0||||||
4434530|NCT00124982|4259503|B2||Female|Sex: Female, Male||Participants|Count of Participants|490|490.0||||||
4434531|NCT00124982|4259504|B1||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4434532|NCT00124982|4259502|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|12.4|12.4|||
4434533|NCT00124982|4259503|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|12.3|12.3|||
4434534|NCT00124982|4259504|B1|||Age||years|Mean|56.1|56.1|Standard Deviation|12.5|12.5|||
4434535|NCT00124943|4259584|B5|||Diameter Stenosis|Participant population = 3, 51, 3, 54 (111 total). Measures were obtained from the angiographic evaluation.|% diameter stenosis|Mean|68.01|68.01|Standard Deviation|14.523|14.523|||
4434536|NCT00124943|4259585|B4|||Diameter Stenosis|Participant population = 3, 51, 3, 54 (111 total). Measures were obtained from the angiographic evaluation.|% diameter stenosis|Mean|66.28|66.28|Standard Deviation|14.253|14.253|||
4434537|NCT00124943|4259586|B3|||Diameter Stenosis|Participant population = 3, 51, 3, 54 (111 total). Measures were obtained from the angiographic evaluation.|% diameter stenosis|Mean|70.50|70.5|Standard Deviation|8.789|8.789|||
4434538|NCT00124943|4259587|B2|||Diameter Stenosis|Participant population = 3, 51, 3, 54 (111 total). Measures were obtained from the angiographic evaluation.|% diameter stenosis|Mean|68.94|68.94|Standard Deviation|15.083|15.083|||
4434539|NCT00124943|4259588|B1|||Diameter Stenosis|Participant population = 3, 51, 3, 54 (111 total). Measures were obtained from the angiographic evaluation.|% diameter stenosis|Mean|80.92|80.92|Standard Deviation|9.521|9.521|||
4434540|NCT00124943|4259584|B5|||Lesion Length|Participant population = 3, 50, 3, 54 (110 total). Measures were obtained from the angiographic evaluation.|mm|Mean|10.203|10.203|Standard Deviation|5.6932|5.6932|||
4434541|NCT00124943|4259585|B4|||Lesion Length|Participant population = 3, 50, 3, 54 (110 total). Measures were obtained from the angiographic evaluation.|mm|Mean|10.067|10.067|Standard Deviation|5.7097|5.7097|||
4434542|NCT00124943|4259586|B3|||Lesion Length|Participant population = 3, 50, 3, 54 (110 total). Measures were obtained from the angiographic evaluation.|mm|Mean|7.900|7.9|Standard Deviation|1.2630|1.263|||
4434543|NCT00124943|4259587|B2|||Lesion Length|Participant population = 3, 50, 3, 54 (110 total). Measures were obtained from the angiographic evaluation.|mm|Mean|10.720|10.72|Standard Deviation|5.9338|5.9338|||
4434544|NCT00124943|4259588|B1|||Lesion Length|Participant population = 3, 50, 3, 54 (110 total). Measures were obtained from the angiographic evaluation.|mm|Mean|6.342|6.342|Standard Deviation|0.9086|0.9086|||
4434545|NCT00124943|4259584|B5|||Reference Diameter|Participant population = 3, 50, 3, 54 (110 total). Measures were obtained from the angiographic evaluation.|mm|Mean|2.643|2.643|Standard Deviation|0.4259|0.4259|||
4434546|NCT00124943|4259585|B4|||Reference Diameter|Participant population = 3, 50, 3, 54 (110 total). Measures were obtained from the angiographic evaluation.|mm|Mean|2.703|2.703|Standard Deviation|0.4664|0.4664|||
4434547|NCT00124943|4259586|B3|||Reference Diameter|Participant population = 3, 50, 3, 54 (110 total). Measures were obtained from the angiographic evaluation.|mm|Mean|2.650|2.65|Standard Deviation|0.4290|0.429|||
4434548|NCT00124943|4259587|B2|||Reference Diameter|Participant population = 3, 50, 3, 54 (110 total). Measures were obtained from the angiographic evaluation.|mm|Mean|2.577|2.577|Standard Deviation|0.3899|0.3899|||
4434549|NCT00124943|4259588|B1|||Reference Diameter|Participant population = 3, 50, 3, 54 (110 total). Measures were obtained from the angiographic evaluation.|mm|Mean|2.668|2.668|Standard Deviation|0.0753|0.0753|||
4434550|NCT00124943|4259584|B5|||Minimum Lumen Diameter|Participant population = 3, 47, 3, 50 (103 total). Measures were obtained from the angiographic evaluation.|mm|Mean|0.908|0.908|Standard Deviation|0.3691|0.3691|||
4434551|NCT00124943|4259585|B4|||Minimum Lumen Diameter|Participant population = 3, 47, 3, 50 (103 total). Measures were obtained from the angiographic evaluation.|mm|Mean|0.986|0.986|Standard Deviation|0.3740|0.374|||
4434552|NCT00124943|4259586|B3|||Minimum Lumen Diameter|Participant population = 3, 47, 3, 50 (103 total). Measures were obtained from the angiographic evaluation.|mm|Mean|0.762|0.762|Standard Deviation|0.1804|0.1804|||
4434553|NCT00124943|4259587|B2|||Minimum Lumen Diameter|Participant population = 3, 47, 3, 50 (103 total). Measures were obtained from the angiographic evaluation.|mm|Mean|0.842|0.842|Standard Deviation|0.3628|0.3628|||
4434554|NCT00124943|4259588|B1|||Minimum Lumen Diameter|Participant population = 3, 47, 3, 50 (103 total). Measures were obtained from the angiographic evaluation.|mm|Mean|0.790|0.79|Standard Deviation|0.3941|0.3941|||
4434555|NCT00124943|4259584|B5|Non-Insulin Dependent||Diabetes mellitis||participants|Number|15|15.0||||||
4434556|NCT00124943|4259585|B4|Non-Insulin Dependent||Diabetes mellitis||participants|Number|8|8.0||||||
4434557|NCT00124943|4259586|B3|Non-Insulin Dependent||Diabetes mellitis||participants|Number|1|1.0||||||
4434558|NCT00124943|4259587|B2|Non-Insulin Dependent||Diabetes mellitis||participants|Number|6|6.0||||||
4434559|NCT00124943|4259588|B1|Non-Insulin Dependent||Diabetes mellitis||participants|Number|0|0.0||||||
4434560|NCT00124943|4259584|B5|Insulin Dependent||Diabetes mellitis||participants|Number|6|6.0||||||
4434561|NCT00124943|4259585|B4|Insulin Dependent||Diabetes mellitis||participants|Number|1|1.0||||||
4434565|NCT00124943|4259584|B5|No Diabetes||Diabetes mellitis||participants|Number|91|91.0||||||
4434566|NCT00124943|4259585|B4|No Diabetes||Diabetes mellitis||participants|Number|46|46.0||||||
4434567|NCT00124943|4259586|B3|No Diabetes||Diabetes mellitis||participants|Number|2|2.0||||||
4434568|NCT00124943|4259587|B2|No Diabetes||Diabetes mellitis||participants|Number|40|40.0||||||
4434569|NCT00124943|4259588|B1|No Diabetes||Diabetes mellitis||participants|Number|3|3.0||||||
4434570|NCT00124943|4259584|B5|Patients with In-Stent Restenosis Lesions||Lesion type||participants|Number|7|7.0||||||
4434571|NCT00124943|4259585|B4|Patients with In-Stent Restenosis Lesions||Lesion type||participants|Number|5|5.0||||||
4434572|NCT00124943|4259586|B3|Patients with In-Stent Restenosis Lesions||Lesion type||participants|Number|0|0.0||||||
4434573|NCT00124943|4259587|B2|Patients with In-Stent Restenosis Lesions||Lesion type||participants|Number|2|2.0||||||
4434574|NCT00124943|4259588|B1|Patients with In-Stent Restenosis Lesions||Lesion type||participants|Number|0|0.0||||||
4434575|NCT00124943|4259584|B5|Patients with de novo Lesions||Lesion type||participants|Number|105|105.0||||||
4434576|NCT00124943|4259585|B4|Patients with de novo Lesions||Lesion type||participants|Number|50|50.0||||||
4434577|NCT00124943|4259586|B3|Patients with de novo Lesions||Lesion type||participants|Number|3|3.0||||||
4434578|NCT00124943|4259587|B2|Patients with de novo Lesions||Lesion type||participants|Number|49|49.0||||||
4434579|NCT00124943|4259588|B1|Patients with de novo Lesions||Lesion type||participants|Number|3|3.0||||||
4434580|NCT00124943|4259584|B5|||Weight||kg|Mean|84.46|84.46|Standard Deviation|15.880|15.88|||
4434581|NCT00124943|4259585|B4|||Weight||kg|Mean|85.01|85.01|Standard Deviation|17.915|17.915|||
4434582|NCT00124943|4259586|B3|||Weight||kg|Mean|91.33|91.33|Standard Deviation|21.333|21.333|||
4434583|NCT00124943|4259587|B2|||Weight||kg|Mean|83.56|83.56|Standard Deviation|13.659|13.659|||
4434584|NCT00124943|4259588|B1|||Weight||kg|Mean|82.80|82.8|Standard Deviation|10.318|10.318|||
4434585|NCT00124943|4259584|B5|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4434586|NCT00124943|4259585|B4|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4434587|NCT00124943|4259586|B3|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4434588|NCT00124943|4259587|B2|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4434589|NCT00124943|4259588|B1|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4434590|NCT00124943|4259584|B5|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4434591|NCT00124943|4259585|B4|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4434592|NCT00124943|4259586|B3|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4434593|NCT00124943|4259587|B2|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4434594|NCT00124943|4259588|B1|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4434595|NCT00124943|4259584|B5|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4434596|NCT00124943|4259585|B4|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4434597|NCT00124943|4259586|B3|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4434598|NCT00124943|4259587|B2|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4434599|NCT00124943|4259588|B1|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4434600|NCT00124943|4259584|B5||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4434601|NCT00124943|4259585|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4434602|NCT00124943|4259586|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4434603|NCT00124943|4259587|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4434604|NCT00124943|4259588|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4434605|NCT00124943|4259584|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4434606|NCT00124943|4259585|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4434607|NCT00124943|4259586|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4434608|NCT00124943|4259587|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4434609|NCT00124943|4259588|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4434610|NCT00124943|4259584|B5|||Age||years|Mean|59.9|59.9|Standard Deviation|8.94|8.94|||
4434611|NCT00124943|4259585|B4|||Age||years|Mean|60.3|60.3|Standard Deviation|8.89|8.89|||
4434612|NCT00124943|4259586|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|6.81|6.81|||
4434613|NCT00124943|4259587|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|9.26|9.26|||
4434614|NCT00124943|4259588|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|6.51|6.51|||
4434615|NCT00124748|4259629|B3||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4434616|NCT00124748|4259630|B2||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4434617|NCT00124748|4259631|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4434618|NCT00124748|4259629|B3||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4434619|NCT00124748|4259630|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4434620|NCT00124748|4259631|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4434621|NCT00124748|4259629|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|14.25|14.25|||
4434622|NCT00124748|4259630|B2|||Age||years|Mean|48.2|48.2|Standard Deviation|13.89|13.89|||
4434623|NCT00124748|4259631|B1|||Age||years|Mean|46.2|46.2|Standard Deviation|14.90|14.9|||
4434801|NCT00124449|4259819|B2|||Age||years|Median|44.0|44.0|Full Range|||26.0|71.0|
4434624|NCT00124735|4259674|B11||Male|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|85|85.0||||||
4434625|NCT00124735|4259675|B10||Male|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|8|8.0||||||
4434626|NCT00124735|4259676|B9||Male|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|12|12.0||||||
4434627|NCT00124735|4259677|B8||Male|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|13|13.0||||||
4434628|NCT00124735|4259678|B7||Male|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|3|3.0||||||
4434629|NCT00124735|4259679|B6||Male|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|3|3.0||||||
4434630|NCT00124735|4259680|B5||Male|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|11|11.0||||||
4434631|NCT00124735|4259681|B4||Male|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|10|10.0||||||
4434632|NCT00124735|4259682|B3||Male|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|17|17.0||||||
4434633|NCT00124735|4259683|B2||Male|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|5|5.0||||||
4434634|NCT00124735|4259684|B1||Male|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|3|3.0||||||
4434635|NCT00124735|4259674|B11||Female|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|52|52.0||||||
4434636|NCT00124735|4259675|B10||Female|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|12|12.0||||||
4434637|NCT00124735|4259676|B9||Female|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|11|11.0||||||
4434638|NCT00124735|4259677|B8||Female|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|6|6.0||||||
4434639|NCT00124735|4259678|B7||Female|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|3|3.0||||||
4434640|NCT00124735|4259679|B6||Female|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|2|2.0||||||
4434641|NCT00124735|4259680|B5||Female|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|6|6.0||||||
4434642|NCT00124735|4259681|B4||Female|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|8|8.0||||||
4434643|NCT00124735|4259682|B3||Female|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|1|1.0||||||
4434644|NCT00124735|4259683|B2||Female|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|1|1.0||||||
4434645|NCT00124735|4259684|B1||Female|Sex: Female, Male|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|2|2.0||||||
4434646|NCT00124735|4259674|B11||>=65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434647|NCT00124735|4259675|B10||>=65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434648|NCT00124735|4259676|B9||>=65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434649|NCT00124735|4259677|B8||>=65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434650|NCT00124735|4259678|B7||>=65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434651|NCT00124735|4259679|B6||>=65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434652|NCT00124735|4259680|B5||>=65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434653|NCT00124735|4259681|B4||>=65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434654|NCT00124735|4259682|B3||>=65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434655|NCT00124735|4259683|B2||>=65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434656|NCT00124735|4259684|B1||>=65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434657|NCT00124735|4259674|B11||Between 18 and 65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434658|NCT00124735|4259675|B10||Between 18 and 65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434659|NCT00124735|4259676|B9||Between 18 and 65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434660|NCT00124735|4259677|B8||Between 18 and 65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434661|NCT00124735|4259678|B7||Between 18 and 65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434662|NCT00124735|4259679|B6||Between 18 and 65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434663|NCT00124735|4259680|B5||Between 18 and 65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434664|NCT00124735|4259681|B4||Between 18 and 65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434802|NCT00124449|4259820|B1|||Age||years|Median|43.5|43.5|Full Range|||23.0|74.0|
4434665|NCT00124735|4259682|B3||Between 18 and 65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434666|NCT00124735|4259683|B2||Between 18 and 65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434667|NCT00124735|4259684|B1||Between 18 and 65 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|0|0.0||||||
4434668|NCT00124735|4259674|B11||<=18 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|137|137.0||||||
4434669|NCT00124735|4259675|B10||<=18 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|20|20.0||||||
4434670|NCT00124735|4259676|B9||<=18 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|23|23.0||||||
4434671|NCT00124735|4259677|B8||<=18 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|19|19.0||||||
4434672|NCT00124735|4259678|B7||<=18 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|6|6.0||||||
4434673|NCT00124735|4259679|B6||<=18 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|5|5.0||||||
4434674|NCT00124735|4259680|B5||<=18 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|17|17.0||||||
4434675|NCT00124735|4259681|B4||<=18 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|18|18.0||||||
4434676|NCT00124735|4259682|B3||<=18 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|18|18.0||||||
4434677|NCT00124735|4259683|B2||<=18 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|6|6.0||||||
4434678|NCT00124735|4259684|B1||<=18 years|Age|Total of 137 subjects include all subjects who received rocuronium|Participants|Count of Participants|5|5.0||||||
4434679|NCT00124709|4259737|B3|||Parents' Index of Quality of Life - Atopic Dermatitis Score|Parents' Index Quality of Life - Atopic Dermatitis (PIQoL-AD) score = (sum of valid items/number of valid items)*28. Scores range from a total possible minimum value of 0 to a maximum value of 28, with a high total overall score indicating poor quality of life.|Scores on PIQoL-AD Scale|Mean|6.7|6.7|Standard Deviation|4.83|4.83|||
4434680|NCT00124709|4259738|B2|||Parents' Index of Quality of Life - Atopic Dermatitis Score|Parents' Index Quality of Life - Atopic Dermatitis (PIQoL-AD) score = (sum of valid items/number of valid items)*28. Scores range from a total possible minimum value of 0 to a maximum value of 28, with a high total overall score indicating poor quality of life.|Scores on PIQoL-AD Scale|Mean|6.9|6.9|Standard Deviation|4.92|4.92|||
4434681|NCT00124709|4259739|B1|||Parents' Index of Quality of Life - Atopic Dermatitis Score|Parents' Index Quality of Life - Atopic Dermatitis (PIQoL-AD) score = (sum of valid items/number of valid items)*28. Scores range from a total possible minimum value of 0 to a maximum value of 28, with a high total overall score indicating poor quality of life.|Scores on PIQoL-AD Scale|Mean|6.5|6.5|Standard Deviation|4.73|4.73|||
4434682|NCT00124709|4259737|B3||Male|Sex: Female, Male||Participants|Count of Participants|675|675.0||||||
4434683|NCT00124709|4259738|B2||Male|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4434684|NCT00124709|4259739|B1||Male|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4434685|NCT00124709|4259737|B3||Female|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
4434686|NCT00124709|4259738|B2||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4434687|NCT00124709|4259739|B1||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4434688|NCT00124709|4259737|B3|Greater than 18 months||Age, Customized||Participants|Number|0|0.0||||||
4434689|NCT00124709|4259738|B2|Greater than 18 months||Age, Customized||Participants|Number|0|0.0||||||
4434690|NCT00124709|4259739|B1|Greater than 18 months||Age, Customized||Participants|Number|0|0.0||||||
4434691|NCT00124709|4259737|B3|12 months to Less than or equal to 18 months||Age, Customized||Participants|Number|180|180.0||||||
4434692|NCT00124709|4259738|B2|12 months to Less than or equal to 18 months||Age, Customized||Participants|Number|99|99.0||||||
4434693|NCT00124709|4259739|B1|12 months to Less than or equal to 18 months||Age, Customized||Participants|Number|81|81.0||||||
4434694|NCT00124709|4259737|B3|6 months to Less than 12 months||Age, Customized||Participants|Number|451|451.0||||||
4434695|NCT00124709|4259738|B2|6 months to Less than 12 months||Age, Customized||Participants|Number|220|220.0||||||
4434696|NCT00124709|4259739|B1|6 months to Less than 12 months||Age, Customized||Participants|Number|231|231.0||||||
4434697|NCT00124709|4259737|B3|3 months to Less than 6 months||Age, Customized||Participants|Number|453|453.0||||||
4434698|NCT00124709|4259738|B2|3 months to Less than 6 months||Age, Customized||Participants|Number|223|223.0||||||
4434699|NCT00124709|4259739|B1|3 months to Less than 6 months||Age, Customized||Participants|Number|230|230.0||||||
4434700|NCT00124709|4259737|B3|Less than 3 months||Age, Customized||Participants|Number|3|3.0||||||
4434701|NCT00124709|4259738|B2|Less than 3 months||Age, Customized||Participants|Number|2|2.0||||||
4434702|NCT00124709|4259739|B1|Less than 3 months||Age, Customized||Participants|Number|1|1.0||||||
4434703|NCT00124709|4259737|B3|||Age||months|Mean|7.3|7.3|Standard Deviation|3.91|3.91|||
4434704|NCT00124709|4259738|B2|||Age||months|Mean|7.4|7.4|Standard Deviation|4.06|4.06|||
4434705|NCT00124709|4259739|B1|||Age||months|Mean|7.1|7.1|Standard Deviation|3.76|3.76|||
4434706|NCT00124657|4259754|B4|Spinal GBM||Diagnosis||participants|Number|1|1.0||||||
4434707|NCT00124657|4259755|B3|Spinal GBM||Diagnosis||participants|Number|1|1.0||||||
4434708|NCT00124657|4259756|B2|Spinal GBM||Diagnosis||participants|Number|0|0.0||||||
4434709|NCT00124657|4259757|B1|Spinal GBM||Diagnosis||participants|Number|0|0.0||||||
4434710|NCT00124657|4259754|B4|Unfavorable fibrillary astrocytoma||Diagnosis||participants|Number|1|1.0||||||
4434711|NCT00124657|4259755|B3|Unfavorable fibrillary astrocytoma||Diagnosis||participants|Number|1|1.0||||||
4434712|NCT00124657|4259756|B2|Unfavorable fibrillary astrocytoma||Diagnosis||participants|Number|0|0.0||||||
4434713|NCT00124657|4259757|B1|Unfavorable fibrillary astrocytoma||Diagnosis||participants|Number|0|0.0||||||
4434714|NCT00124657|4259754|B4|Anaplastic ganglioglioma||Diagnosis||participants|Number|1|1.0||||||
4434715|NCT00124657|4259755|B3|Anaplastic ganglioglioma||Diagnosis||participants|Number|0|0.0||||||
4434716|NCT00124657|4259756|B2|Anaplastic ganglioglioma||Diagnosis||participants|Number|0|0.0||||||
4434717|NCT00124657|4259757|B1|Anaplastic ganglioglioma||Diagnosis||participants|Number|1|1.0||||||
4434718|NCT00124657|4259754|B4|Anaplastic oligoastrocytoma||Diagnosis||participants|Number|3|3.0||||||
4434719|NCT00124657|4259755|B3|Anaplastic oligoastrocytoma||Diagnosis||participants|Number|1|1.0||||||
4434720|NCT00124657|4259756|B2|Anaplastic oligoastrocytoma||Diagnosis||participants|Number|0|0.0||||||
4434721|NCT00124657|4259757|B1|Anaplastic oligoastrocytoma||Diagnosis||participants|Number|2|2.0||||||
4434722|NCT00124657|4259754|B4|Glioblastoma multiforme (GBM)||Diagnosis||participants|Number|29|29.0||||||
4434723|NCT00124657|4259755|B3|Glioblastoma multiforme (GBM)||Diagnosis||participants|Number|17|17.0||||||
4434724|NCT00124657|4259756|B2|Glioblastoma multiforme (GBM)||Diagnosis||participants|Number|4|4.0||||||
4434725|NCT00124657|4259757|B1|Glioblastoma multiforme (GBM)||Diagnosis||participants|Number|8|8.0||||||
4434726|NCT00124657|4259754|B4|Anaplastic astrocytoma (AA)||Diagnosis||participants|Number|27|27.0||||||
4434727|NCT00124657|4259755|B3|Anaplastic astrocytoma (AA)||Diagnosis||participants|Number|19|19.0||||||
4434728|NCT00124657|4259756|B2|Anaplastic astrocytoma (AA)||Diagnosis||participants|Number|1|1.0||||||
4434729|NCT00124657|4259757|B1|Anaplastic astrocytoma (AA)||Diagnosis||participants|Number|7|7.0||||||
4434730|NCT00124657|4259754|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4434731|NCT00124657|4259755|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4434732|NCT00124657|4259756|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4434733|NCT00124657|4259757|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4434734|NCT00124657|4259754|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4434735|NCT00124657|4259755|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4434736|NCT00124657|4259756|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4434737|NCT00124657|4259757|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4434738|NCT00124657|4259754|B4|||Age||years|Mean|11.12|11.12|Standard Deviation|4.81|4.81|||
4434739|NCT00124657|4259755|B3|||Age||years|Mean|10.55|10.55|Standard Deviation|4.85|4.85|||
4434740|NCT00124657|4259756|B2|||Age||years|Mean|11.47|11.47|Standard Deviation|6.05|6.05|||
4434741|NCT00124657|4259757|B1|||Age||years|Mean|11.49|11.49|Standard Deviation|4.31|4.31|||
4434742|NCT00124618|4259794|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4434743|NCT00124618|4259794|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4434744|NCT00124618|4259794|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4434745|NCT00124618|4259794|B1|Median Age in years (Range)||Age, Customized||years|Median|77|77.0|Full Range|||60.0|87.0|
4434746|NCT00124579|4259801|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4434747|NCT00124579|4259801|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4434748|NCT00124579|4259801|B1|||Age||years|Median|63.7|63.7|Full Range|||37.6|81.4|
4434749|NCT00124462|4259807|B3|||WOMAC function score|The WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) is a self-administered health status measure for pain, stiffness, and function in patients with knee or hip OA. It measures Pain (5 questions), Stiffness (2 questions), and Function (17 questions). The WOMAC function score ranges from 0-68, all items are scored on a scale of 0-4 (0 = None, 1 = Slight, 2 = Moderate, 3 = Very, 4 = Extremely) for difficulty of specific functions. Lower overall function scores indicate higher levels of functioning or less difficulty performing a list of 17 specific activities.|units on a scale|Mean|33.9|33.9|Standard Deviation|11.1|11.1|||
4434750|NCT00124462|4259808|B2|||WOMAC function score|The WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) is a self-administered health status measure for pain, stiffness, and function in patients with knee or hip OA. It measures Pain (5 questions), Stiffness (2 questions), and Function (17 questions). The WOMAC function score ranges from 0-68, all items are scored on a scale of 0-4 (0 = None, 1 = Slight, 2 = Moderate, 3 = Very, 4 = Extremely) for difficulty of specific functions. Lower overall function scores indicate higher levels of functioning or less difficulty performing a list of 17 specific activities.|units on a scale|Mean|34.6|34.6|Standard Deviation|10.3|10.3|||
4434751|NCT00124462|4259809|B1|||WOMAC function score|The WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) is a self-administered health status measure for pain, stiffness, and function in patients with knee or hip OA. It measures Pain (5 questions), Stiffness (2 questions), and Function (17 questions). The WOMAC function score ranges from 0-68, all items are scored on a scale of 0-4 (0 = None, 1 = Slight, 2 = Moderate, 3 = Very, 4 = Extremely) for difficulty of specific functions. Lower overall function scores indicate higher levels of functioning or less difficulty performing a list of 17 specific activities.|units on a scale|Mean|33.3|33.3|Standard Deviation|11.8|11.8|||
4434752|NCT00124462|4259807|B3|||WOMAC pain score|The WOMAC (Western Ontario and McMaster Osteoarthritis Index) is a widely used self-administered health status measure used in assessing pain, stiffness, and function in patients with OA of the hip or knee. It measures Pain (5 questions), Stiffness (2 questions), and Function (17 questions). The WOMAC pain scale ranges from 0-20. All the items are scored on a scale of 0-4 (0 = None, 1 = Slight, 2 = Moderate, 3 = Very, 4 = Extremely). Lower scores indicate lower levels of pain.|units on a scale|Mean|9.15|9.15|Standard Deviation|3.4|3.4|||
4434803|NCT00124449|4259818|B3|||Age||years|Mean|44.8|44.8|Standard Deviation|11.4|11.4|||
4434804|NCT00124449|4259819|B2|||Age||years|Mean|44.7|44.7|Standard Deviation|12.1|12.1|||
4434805|NCT00124449|4259820|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|10.9|10.9|||
4434753|NCT00124462|4259808|B2|||WOMAC pain score|The WOMAC (Western Ontario and McMaster Osteoarthritis Index) is a widely used self-administered health status measure used in assessing pain, stiffness, and function in patients with OA of the hip or knee. It measures Pain (5 questions), Stiffness (2 questions), and Function (17 questions). The WOMAC pain scale ranges from 0-20. All the items are scored on a scale of 0-4 (0 = None, 1 = Slight, 2 = Moderate, 3 = Very, 4 = Extremely). Lower scores indicate lower levels of pain.|units on a scale|Mean|9.1|9.1|Standard Deviation|3.4|3.4|||
4434754|NCT00124462|4259809|B1|||WOMAC pain score|The WOMAC (Western Ontario and McMaster Osteoarthritis Index) is a widely used self-administered health status measure used in assessing pain, stiffness, and function in patients with OA of the hip or knee. It measures Pain (5 questions), Stiffness (2 questions), and Function (17 questions). The WOMAC pain scale ranges from 0-20. All the items are scored on a scale of 0-4 (0 = None, 1 = Slight, 2 = Moderate, 3 = Very, 4 = Extremely). Lower scores indicate lower levels of pain.|units on a scale|Mean|9.2|9.2|Standard Deviation|3.4|3.4|||
4434755|NCT00124462|4259807|B3|||BMI|Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. A BMI below 18.5 is underweight, between 18.5 and 24.9 is considered normal weight, 25 to 29.9 is overweight, a BMI 30-34.9 is moderately obese is, and a BMI 35 or greater is obese.|kg/m2|Mean|33.6|33.6|Standard Deviation|9.4|9.4|||
4434756|NCT00124462|4259808|B2|||BMI|Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. A BMI below 18.5 is underweight, between 18.5 and 24.9 is considered normal weight, 25 to 29.9 is overweight, a BMI 30-34.9 is moderately obese is, and a BMI 35 or greater is obese.|kg/m2|Mean|34.7|34.7|Standard Deviation|10.8|10.8|||
4434757|NCT00124462|4259809|B1|||BMI|Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. A BMI below 18.5 is underweight, between 18.5 and 24.9 is considered normal weight, 25 to 29.9 is overweight, a BMI 30-34.9 is moderately obese is, and a BMI 35 or greater is obese.|kg/m2|Mean|32.7|32.7|Standard Deviation|8.4|8.4|||
4434758|NCT00124462|4259807|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4434759|NCT00124462|4259808|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4434760|NCT00124462|4259809|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4434761|NCT00124462|4259807|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4434762|NCT00124462|4259808|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4434763|NCT00124462|4259809|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4434764|NCT00124462|4259807|B3|||Age||years|Mean|62|62.0|Standard Deviation|11.1|11.1|||
4434765|NCT00124462|4259808|B2|||Age||years|Mean|60|60.0|Standard Deviation|13.1|13.1|||
4434766|NCT00124462|4259809|B1|||Age||years|Mean|63|63.0|Standard Deviation|10.8|10.8|||
4434767|NCT00124449|4259818|B3|||Weight||Kilograms|Mean|73.4|73.4|Standard Deviation|18.7|18.7|||
4434768|NCT00124449|4259819|B2|||Weight||Kilograms|Mean|70.9|70.9|Standard Deviation|13.9|13.9|||
4434769|NCT00124449|4259820|B1|||Weight||Kilograms|Mean|75.9|75.9|Standard Deviation|22.5|22.5|||
4434770|NCT00124449|4259818|B3|||Months of Undifferentiated Inflammatory Arthritis (UA)||Months|Mean|7.9|7.9|Standard Deviation|4.3|4.3|||
4434771|NCT00124449|4259819|B2|||Months of Undifferentiated Inflammatory Arthritis (UA)||Months|Mean|7.1|7.1|Standard Deviation|4.4|4.4|||
4434772|NCT00124449|4259820|B1|||Months of Undifferentiated Inflammatory Arthritis (UA)||Months|Mean|8.8|8.8|Standard Deviation|4.2|4.2|||
4434773|NCT00124449|4259818|B3|Europe||Region of Enrollment||participants|Number|38|38.0||||||
4434774|NCT00124449|4259819|B2|Europe||Region of Enrollment||participants|Number|21|21.0||||||
4434775|NCT00124449|4259820|B1|Europe||Region of Enrollment||participants|Number|17|17.0||||||
4434776|NCT00124449|4259818|B3|South America||Region of Enrollment||participants|Number|7|7.0||||||
4434777|NCT00124449|4259819|B2|South America||Region of Enrollment||participants|Number|2|2.0||||||
4434778|NCT00124449|4259820|B1|South America||Region of Enrollment||participants|Number|5|5.0||||||
4434779|NCT00124449|4259818|B3|North America||Region of Enrollment||participants|Number|11|11.0||||||
4434780|NCT00124449|4259819|B2|North America||Region of Enrollment||participants|Number|5|5.0||||||
4434781|NCT00124449|4259820|B1|North America||Region of Enrollment||participants|Number|6|6.0||||||
4434782|NCT00124449|4259818|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4434783|NCT00124449|4259819|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4434784|NCT00124449|4259820|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4434785|NCT00124449|4259818|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4434786|NCT00124449|4259819|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4434787|NCT00124449|4259820|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4434788|NCT00124449|4259818|B3|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4434789|NCT00124449|4259819|B2|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4434790|NCT00124449|4259820|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4434791|NCT00124449|4259818|B3|White||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
4434792|NCT00124449|4259819|B2|White||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4434793|NCT00124449|4259820|B1|White||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4434794|NCT00124449|4259818|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4434795|NCT00124449|4259819|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4434796|NCT00124449|4259820|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4434797|NCT00124449|4259818|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4434798|NCT00124449|4259819|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4434799|NCT00124449|4259820|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4434800|NCT00124449|4259818|B3|||Age||years|Median|44.0|44.0|Full Range|||23.0|74.0|
4434806|NCT00124176|4259854|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4434807|NCT00124176|4259855|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4434808|NCT00124176|4259856|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4434809|NCT00124176|4259854|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4434810|NCT00124176|4259855|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4434811|NCT00124176|4259856|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4434812|NCT00124176|4259854|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4434813|NCT00124176|4259855|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4434814|NCT00124176|4259856|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4434815|NCT00124176|4259854|B3|||Age||years|Mean|10.6|10.6|Standard Deviation|3.4|3.4|||
4434816|NCT00124176|4259855|B2|||Age||years|Mean|10.7|10.7|Standard Deviation|3.3|3.3|||
4434817|NCT00124176|4259856|B1|||Age||years|Mean|10.4|10.4|Standard Deviation|3.5|3.5|||
4434818|NCT00124176|4259854|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4434819|NCT00124176|4259855|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4434820|NCT00124176|4259856|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4434821|NCT00124176|4259854|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4434822|NCT00124176|4259855|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4434823|NCT00124176|4259856|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4434824|NCT00124176|4259854|B3||<=18 years|Age||Participants|Count of Participants|81|81.0||||||
4434825|NCT00124176|4259855|B2||<=18 years|Age||Participants|Count of Participants|41|41.0||||||
4434826|NCT00124176|4259856|B1||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4434827|NCT00124072|4259871|B5|United Kingdom||Region of Enrollment||participants|Number|12064|12064.0||||||
4434828|NCT00124072|4259872|B4|United Kingdom||Region of Enrollment||participants|Number|3015|3015.0||||||
4434829|NCT00124072|4259873|B3|United Kingdom||Region of Enrollment||participants|Number|3016|3016.0||||||
4434830|NCT00124072|4259874|B2|United Kingdom||Region of Enrollment||participants|Number|3016|3016.0||||||
4434831|NCT00124072|4259875|B1|United Kingdom||Region of Enrollment||participants|Number|3017|3017.0||||||
4434832|NCT00124072|4259871|B5||Male|Sex: Female, Male||Participants|Count of Participants|10012|10012.0||||||
4434833|NCT00124072|4259872|B4||Male|Sex: Female, Male||Participants|Count of Participants|2503|2503.0||||||
4434834|NCT00124072|4259873|B3||Male|Sex: Female, Male||Participants|Count of Participants|2503|2503.0||||||
4434835|NCT00124072|4259874|B2||Male|Sex: Female, Male||Participants|Count of Participants|2502|2502.0||||||
4434836|NCT00124072|4259875|B1||Male|Sex: Female, Male||Participants|Count of Participants|2504|2504.0||||||
4434837|NCT00124072|4259871|B5||Female|Sex: Female, Male||Participants|Count of Participants|2052|2052.0||||||
4434838|NCT00124072|4259872|B4||Female|Sex: Female, Male||Participants|Count of Participants|512|512.0||||||
4434839|NCT00124072|4259873|B3||Female|Sex: Female, Male||Participants|Count of Participants|513|513.0||||||
4434840|NCT00124072|4259874|B2||Female|Sex: Female, Male||Participants|Count of Participants|514|514.0||||||
4434841|NCT00124072|4259875|B1||Female|Sex: Female, Male||Participants|Count of Participants|513|513.0||||||
4434842|NCT00124072|4259871|B5|||Age||years|Mean|64.2|64.2|Standard Deviation|8.9|8.9|||
4434843|NCT00124072|4259872|B4|||Age||years|Mean|64.2|64.2|Standard Deviation|8.9|8.9|||
4434844|NCT00124072|4259873|B3|||Age||years|Mean|64.2|64.2|Standard Deviation|8.9|8.9|||
4434845|NCT00124072|4259874|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|8.9|8.9|||
4434846|NCT00124072|4259875|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|8.9|8.9|||
4434847|NCT00124020|4259888|B3|Non-ventilated||Ventilator Status||participants|Number|407|407.0||||||
4434848|NCT00124020|4259889|B2|Non-ventilated||Ventilator Status||participants|Number|205|205.0||||||
4434849|NCT00124020|4259890|B1|Non-ventilated||Ventilator Status||participants|Number|202|202.0||||||
4434850|NCT00124020|4259888|B3|Ventilated||Ventilator Status||participants|Number|350|350.0||||||
4434851|NCT00124020|4259889|B2|Ventilated||Ventilator Status||participants|Number|175|175.0||||||
4434852|NCT00124020|4259890|B1|Ventilated||Ventilator Status||participants|Number|175|175.0||||||
4434853|NCT00124020|4259888|B3|No prior history of pneumonia||History of Pneumonia||participants|Number|675|675.0||||||
4434854|NCT00124020|4259889|B2|No prior history of pneumonia||History of Pneumonia||participants|Number|335|335.0||||||
4434855|NCT00124020|4259890|B1|No prior history of pneumonia||History of Pneumonia||participants|Number|340|340.0||||||
4434856|NCT00124020|4259888|B3|Prior history of pneumonia||History of Pneumonia||participants|Number|82|82.0||||||
4434857|NCT00124020|4259889|B2|Prior history of pneumonia||History of Pneumonia||participants|Number|45|45.0||||||
4434858|NCT00124020|4259890|B1|Prior history of pneumonia||History of Pneumonia||participants|Number|37|37.0||||||
4434859|NCT00124020|4259888|B3|Non-Diabetic||Diabetes Status||participants|Number|623|623.0||||||
4434860|NCT00124020|4259889|B2|Non-Diabetic||Diabetes Status||participants|Number|315|315.0||||||
4434861|NCT00124020|4259890|B1|Non-Diabetic||Diabetes Status||participants|Number|308|308.0||||||
4434862|NCT00124020|4259888|B3|Diabetic||Diabetes Status||participants|Number|134|134.0||||||
4434863|NCT00124020|4259889|B2|Diabetic||Diabetes Status||participants|Number|65|65.0||||||
4434864|NCT00124020|4259890|B1|Diabetic||Diabetes Status||participants|Number|69|69.0||||||
4434865|NCT00124020|4259888|B3|United States||Region of Enrollment||participants|Number|106|106.0||||||
4434866|NCT00124020|4259889|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4434867|NCT00124020|4259890|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4434868|NCT00124020|4259888|B3|Ukraine||Region of Enrollment||participants|Number|18|18.0||||||
4434869|NCT00124020|4259889|B2|Ukraine||Region of Enrollment||participants|Number|6|6.0||||||
4434870|NCT00124020|4259890|B1|Ukraine||Region of Enrollment||participants|Number|12|12.0||||||
4434871|NCT00124020|4259888|B3|Thailand||Region of Enrollment||participants|Number|33|33.0||||||
4434872|NCT00124020|4259889|B2|Thailand||Region of Enrollment||participants|Number|11|11.0||||||
4434873|NCT00124020|4259890|B1|Thailand||Region of Enrollment||participants|Number|22|22.0||||||
4434874|NCT00124020|4259888|B3|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4434875|NCT00124020|4259889|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4434876|NCT00124020|4259890|B1|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4434877|NCT00124020|4259888|B3|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4434878|NCT00124020|4259889|B2|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
4434879|NCT00124020|4259890|B1|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
4434880|NCT00124020|4259888|B3|Slovakia||Region of Enrollment||participants|Number|12|12.0||||||
4434881|NCT00124020|4259889|B2|Slovakia||Region of Enrollment||participants|Number|6|6.0||||||
4434882|NCT00124020|4259890|B1|Slovakia||Region of Enrollment||participants|Number|6|6.0||||||
4434883|NCT00124020|4259888|B3|Serbia||Region of Enrollment||participants|Number|17|17.0||||||
4434884|NCT00124020|4259889|B2|Serbia||Region of Enrollment||participants|Number|10|10.0||||||
4434885|NCT00124020|4259890|B1|Serbia||Region of Enrollment||participants|Number|7|7.0||||||
4434886|NCT00124020|4259888|B3|Russian Federation||Region of Enrollment||participants|Number|50|50.0||||||
4434887|NCT00124020|4259889|B2|Russian Federation||Region of Enrollment||participants|Number|29|29.0||||||
4434888|NCT00124020|4259890|B1|Russian Federation||Region of Enrollment||participants|Number|21|21.0||||||
4434889|NCT00124020|4259888|B3|Romania||Region of Enrollment||participants|Number|7|7.0||||||
4434890|NCT00124020|4259889|B2|Romania||Region of Enrollment||participants|Number|3|3.0||||||
4434891|NCT00124020|4259890|B1|Romania||Region of Enrollment||participants|Number|4|4.0||||||
4434892|NCT00124020|4259888|B3|Poland||Region of Enrollment||participants|Number|10|10.0||||||
4434893|NCT00124020|4259889|B2|Poland||Region of Enrollment||participants|Number|4|4.0||||||
4434894|NCT00124020|4259890|B1|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4434895|NCT00124020|4259888|B3|Philippines||Region of Enrollment||participants|Number|17|17.0||||||
4434896|NCT00124020|4259889|B2|Philippines||Region of Enrollment||participants|Number|9|9.0||||||
4434897|NCT00124020|4259890|B1|Philippines||Region of Enrollment||participants|Number|8|8.0||||||
4434898|NCT00124020|4259888|B3|Mexico||Region of Enrollment||participants|Number|60|60.0||||||
4434899|NCT00124020|4259889|B2|Mexico||Region of Enrollment||participants|Number|29|29.0||||||
4434900|NCT00124020|4259890|B1|Mexico||Region of Enrollment||participants|Number|31|31.0||||||
4434901|NCT00124020|4259888|B3|Lithuania||Region of Enrollment||participants|Number|17|17.0||||||
4434902|NCT00124020|4259889|B2|Lithuania||Region of Enrollment||participants|Number|10|10.0||||||
4434903|NCT00124020|4259890|B1|Lithuania||Region of Enrollment||participants|Number|7|7.0||||||
4434904|NCT00124020|4259888|B3|Lebanon||Region of Enrollment||participants|Number|9|9.0||||||
4434905|NCT00124020|4259889|B2|Lebanon||Region of Enrollment||participants|Number|4|4.0||||||
4434906|NCT00124020|4259890|B1|Lebanon||Region of Enrollment||participants|Number|5|5.0||||||
4434907|NCT00124020|4259888|B3|Korea, Republic of||Region of Enrollment||participants|Number|53|53.0||||||
4434908|NCT00124020|4259889|B2|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
4434909|NCT00124020|4259890|B1|Korea, Republic of||Region of Enrollment||participants|Number|23|23.0||||||
4434910|NCT00124020|4259888|B3|Israel||Region of Enrollment||participants|Number|76|76.0||||||
4434911|NCT00124020|4259889|B2|Israel||Region of Enrollment||participants|Number|38|38.0||||||
4434912|NCT00124020|4259890|B1|Israel||Region of Enrollment||participants|Number|38|38.0||||||
4434913|NCT00124020|4259888|B3|Greece||Region of Enrollment||participants|Number|2|2.0||||||
4434914|NCT00124020|4259889|B2|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4434915|NCT00124020|4259890|B1|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4434916|NCT00124020|4259888|B3|Georgia||Region of Enrollment||participants|Number|30|30.0||||||
4434917|NCT00124020|4259889|B2|Georgia||Region of Enrollment||participants|Number|13|13.0||||||
4434918|NCT00124020|4259890|B1|Georgia||Region of Enrollment||participants|Number|17|17.0||||||
4434919|NCT00124020|4259888|B3|France||Region of Enrollment||participants|Number|2|2.0||||||
4434920|NCT00124020|4259889|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4434921|NCT00124020|4259890|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4434922|NCT00124020|4259888|B3|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
4434923|NCT00124020|4259889|B2|Estonia||Region of Enrollment||participants|Number|1|1.0||||||
4434924|NCT00124020|4259890|B1|Estonia||Region of Enrollment||participants|Number|0|0.0||||||
4434925|NCT00124020|4259888|B3|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
4434926|NCT00124020|4259889|B2|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4434927|NCT00124020|4259890|B1|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4434928|NCT00124020|4259888|B3|Croatia||Region of Enrollment||participants|Number|4|4.0||||||
4434929|NCT00124020|4259889|B2|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
4434930|NCT00124020|4259890|B1|Croatia||Region of Enrollment||participants|Number|2|2.0||||||
4434931|NCT00124020|4259888|B3|China||Region of Enrollment||participants|Number|64|64.0||||||
4434932|NCT00124020|4259889|B2|China||Region of Enrollment||participants|Number|37|37.0||||||
4434933|NCT00124020|4259890|B1|China||Region of Enrollment||participants|Number|27|27.0||||||
4434934|NCT00124020|4259888|B3|Chile||Region of Enrollment||participants|Number|5|5.0||||||
4434935|NCT00124020|4259889|B2|Chile||Region of Enrollment||participants|Number|5|5.0||||||
4434936|NCT00124020|4259890|B1|Chile||Region of Enrollment||participants|Number|0|0.0||||||
4434937|NCT00124020|4259888|B3|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4434938|NCT00124020|4259889|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4434939|NCT00124020|4259890|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4434940|NCT00124020|4259888|B3|Bulgaria||Region of Enrollment||participants|Number|40|40.0||||||
4434941|NCT00124020|4259889|B2|Bulgaria||Region of Enrollment||participants|Number|20|20.0||||||
4434942|NCT00124020|4259890|B1|Bulgaria||Region of Enrollment||participants|Number|20|20.0||||||
4434943|NCT00124020|4259888|B3|Brazil||Region of Enrollment||participants|Number|33|33.0||||||
4434944|NCT00124020|4259889|B2|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
4434945|NCT00124020|4259890|B1|Brazil||Region of Enrollment||participants|Number|17|17.0||||||
4434946|NCT00124020|4259888|B3|Australia||Region of Enrollment||participants|Number|23|23.0||||||
4434947|NCT00124020|4259889|B2|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4434948|NCT00124020|4259890|B1|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4434949|NCT00124020|4259888|B3|Argentina||Region of Enrollment||participants|Number|39|39.0||||||
4434950|NCT00124020|4259889|B2|Argentina||Region of Enrollment||participants|Number|19|19.0||||||
4434951|NCT00124020|4259890|B1|Argentina||Region of Enrollment||participants|Number|20|20.0||||||
4434952|NCT00124020|4259888|B3||Male|Sex: Female, Male||Participants|Count of Participants|508|508.0||||||
4434953|NCT00124020|4259889|B2||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4434954|NCT00124020|4259890|B1||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4434955|NCT00124020|4259888|B3||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4434956|NCT00124020|4259889|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4434957|NCT00124020|4259890|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4434958|NCT00124020|4259888|B3|||Age||years|Mean|62|62.0|Standard Deviation|17.9|17.9|||
4434959|NCT00124020|4259889|B2|||Age||years|Mean|62|62.0|Standard Deviation|18.0|18.0|||
4434960|NCT00124020|4259890|B1|||Age||years|Mean|61|61.0|Standard Deviation|17.8|17.8|||
4434961|NCT00124020|4259888|B3||>=65 years|Age||Participants|Count of Participants|391|391.0||||||
4434962|NCT00124020|4259889|B2||>=65 years|Age||Participants|Count of Participants|196|196.0||||||
4434963|NCT00124020|4259890|B1||>=65 years|Age||Participants|Count of Participants|195|195.0||||||
4434964|NCT00124020|4259888|B3||Between 18 and 65 years|Age||Participants|Count of Participants|366|366.0||||||
4434965|NCT00124020|4259889|B2||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
4434966|NCT00124020|4259890|B1||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
4434967|NCT00124020|4259888|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434968|NCT00124020|4259889|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434969|NCT00124020|4259890|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4434970|NCT00123955|4259897|B3|||Workload (Watts)||Watts|Mean|62|62.0|Standard Deviation|26|26.0|||
4434971|NCT00123955|4259898|B2|||Workload (Watts)||Watts|Mean|60|60.0|Standard Deviation|26|26.0|||
4434972|NCT00123955|4259899|B1|||Workload (Watts)||Watts|Mean|63|63.0|Standard Deviation|26|26.0|||
4434973|NCT00123955|4259897|B3|||Peak VO2 (ml/kg/min)||ml/kg/min|Mean|13.4|13.4|Standard Deviation|2.9|2.9|||
4434974|NCT00123955|4259898|B2|||Peak VO2 (ml/kg/min)||ml/kg/min|Mean|13.3|13.3|Standard Deviation|2.9|2.9|||
4434975|NCT00123955|4259899|B1|||Peak VO2 (ml/kg/min)||ml/kg/min|Mean|13.5|13.5|Standard Deviation|2.9|2.9|||
4434976|NCT00123955|4259897|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4434977|NCT00123955|4259898|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4434978|NCT00123955|4259899|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4434979|NCT00123955|4259897|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4434980|NCT00123955|4259898|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4434981|NCT00123955|4259899|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4434982|NCT00123955|4259897|B3|||Age||years|Mean|70.8|70.8|Standard Deviation|7.3|7.3|||
4434983|NCT00123955|4259898|B2|||Age||years|Mean|71.7|71.7|Standard Deviation|7.3|7.3|||
4434984|NCT00123955|4259899|B1|||Age||years|Mean|70.0|70.0|Standard Deviation|7.3|7.3|||
4434985|NCT00123734|4259912|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4434986|NCT00123734|4259912|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4434987|NCT00123734|4259912|B1|||Age||years|Mean|55.12|55.12|Standard Deviation|15.148|15.148|||
4434988|NCT00123682|4259943|B5|||Cigarettes per day||cigarettes per day|Mean|18.0|18.0|Standard Deviation|10.0|10.0|||
4434989|NCT00123682|4259944|B4|||Cigarettes per day||cigarettes per day|Mean|20.1|20.1|Standard Deviation|11.4|11.4|||
4434990|NCT00123682|4259945|B3|||Cigarettes per day||cigarettes per day|Mean|17.6|17.6|Standard Deviation|10.2|10.2|||
4434991|NCT00123682|4259946|B2|||Cigarettes per day||cigarettes per day|Mean|18.3|18.3|Standard Deviation|10.3|10.3|||
4434992|NCT00123682|4259947|B1|||Cigarettes per day||cigarettes per day|Mean|17.7|17.7|Standard Deviation|9.9|9.9|||
4434993|NCT00123682|4259943|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|666|666.0||||||
4434994|NCT00123682|4259944|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
4434995|NCT00123682|4259945|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4434996|NCT00123682|4259946|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|170|170.0||||||
4434997|NCT00123682|4259947|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
4434998|NCT00123682|4259943|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4434999|NCT00123682|4259944|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435000|NCT00123682|4259945|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435001|NCT00123682|4259946|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435002|NCT00123682|4259947|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435003|NCT00123682|4259943|B5||White|Race (NIH/OMB)||Participants|Count of Participants|1779|1779.0||||||
4435004|NCT00123682|4259944|B4||White|Race (NIH/OMB)||Participants|Count of Participants|289|289.0||||||
4435005|NCT00123682|4259945|B3||White|Race (NIH/OMB)||Participants|Count of Participants|342|342.0||||||
4435006|NCT00123682|4259946|B2||White|Race (NIH/OMB)||Participants|Count of Participants|543|543.0||||||
4435007|NCT00123682|4259947|B1||White|Race (NIH/OMB)||Participants|Count of Participants|605|605.0||||||
4435008|NCT00123682|4259943|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|575|575.0||||||
4435009|NCT00123682|4259944|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4435010|NCT00123682|4259945|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4435011|NCT00123682|4259946|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
4435012|NCT00123682|4259947|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
4435013|NCT00123682|4259943|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435014|NCT00123682|4259944|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435015|NCT00123682|4259945|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435016|NCT00123682|4259946|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435017|NCT00123682|4259947|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435018|NCT00123682|4259943|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4435019|NCT00123682|4259944|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4435020|NCT00123682|4259945|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4435021|NCT00123682|4259946|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4435022|NCT00123682|4259947|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4435023|NCT00123682|4259943|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4435024|NCT00123682|4259944|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4435025|NCT00123682|4259945|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4435026|NCT00123682|4259946|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4435027|NCT00123682|4259947|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4435028|NCT00123682|4259943|B5||Male|Sex: Female, Male||Participants|Count of Participants|2935|2935.0||||||
4435029|NCT00123682|4259944|B4||Male|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4435030|NCT00123682|4259945|B3||Male|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
4435031|NCT00123682|4259946|B2||Male|Sex: Female, Male||Participants|Count of Participants|869|869.0||||||
4435032|NCT00123682|4259947|B1||Male|Sex: Female, Male||Participants|Count of Participants|1014|1014.0||||||
4435033|NCT00123682|4259943|B5||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4435034|NCT00123682|4259944|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4435035|NCT00123682|4259945|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4435036|NCT00123682|4259946|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4435037|NCT00123682|4259947|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4435038|NCT00123682|4259943|B5|||Age||years|Mean|54.0|54.0|Standard Deviation|11.0|11.0|||
4435039|NCT00123682|4259944|B4|||Age||years|Mean|55.1|55.1|Standard Deviation|11.4|11.4|||
4435040|NCT00123682|4259945|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|11.8|11.8|||
4435041|NCT00123682|4259946|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|11.1|11.1|||
4435042|NCT00123682|4259947|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|10.8|10.8|||
4435043|NCT00123643|4259968|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4435044|NCT00123643|4259969|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4435045|NCT00123643|4259970|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4435046|NCT00123643|4259968|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4435047|NCT00123643|4259969|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4435048|NCT00123643|4259970|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4435049|NCT00123643|4259968|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4435050|NCT00123643|4259969|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4435051|NCT00123643|4259970|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4435052|NCT00123643|4259968|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|8.5|8.5|||
4435053|NCT00123643|4259969|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|7.8|7.8|||
4435054|NCT00123643|4259970|B1|||Age||years|Mean|57.9|57.9|Standard Deviation|8.2|8.2|||
4435055|NCT00123643|4259968|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4435056|NCT00123643|4259969|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4435057|NCT00123643|4259970|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4435058|NCT00123643|4259968|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4435059|NCT00123643|4259969|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4435060|NCT00123643|4259970|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4435061|NCT00123643|4259968|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435062|NCT00123643|4259969|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435063|NCT00123643|4259970|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435064|NCT00123630|4259977|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4435065|NCT00123630|4259978|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4435066|NCT00123630|4259979|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4435067|NCT00123630|4259977|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4435068|NCT00123630|4259978|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4435069|NCT00123630|4259979|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4435070|NCT00123630|4259977|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4435071|NCT00123630|4259978|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4435072|NCT00123630|4259979|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4435073|NCT00123630|4259977|B3|||Age||years|Mean|30|30.0|Standard Deviation|10|10.0|||
4435074|NCT00123630|4259978|B2|||Age||years|Mean|32|32.0|Standard Deviation|12|12.0|||
4435075|NCT00123630|4259979|B1|||Age||years|Mean|28|28.0|Standard Deviation|6|6.0|||
4435076|NCT00123630|4259977|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4435077|NCT00123630|4259978|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4435078|NCT00123630|4259979|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4435079|NCT00123630|4259977|B3||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4435080|NCT00123630|4259978|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4435081|NCT00123630|4259979|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4435082|NCT00123630|4259977|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435083|NCT00123630|4259978|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435084|NCT00123630|4259979|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435085|NCT00123604|4259986|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4435086|NCT00123604|4259987|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4435087|NCT00123604|4259988|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4435088|NCT00123604|4259986|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4435089|NCT00123604|4259987|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4435090|NCT00123604|4259988|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4435091|NCT00123604|4259986|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4435092|NCT00123604|4259987|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4435093|NCT00123604|4259988|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4435094|NCT00123604|4259986|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|9.4|9.4|||
4435095|NCT00123604|4259987|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|8.5|8.5|||
4435096|NCT00123604|4259988|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|9.9|9.9|||
4435097|NCT00123604|4259986|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4435098|NCT00123604|4259987|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4435099|NCT00123604|4259988|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4435100|NCT00123604|4259986|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4435101|NCT00123604|4259987|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4435102|NCT00123604|4259988|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4435103|NCT00123604|4259986|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435104|NCT00123604|4259987|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435105|NCT00123604|4259988|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435106|NCT00123487|4259995|B3|Ph+ ALL||Participants by Disease Phase|Chronic Myelogenous Leukemia (CML) consists of a chronic phase lasting three to six years, followed by transformation to an accelerated phase (AP) and blast phases (myeloid and Lymphoid) of much shorter duration. The Philadelphia chromosome (Ph+) status was documented by cytogenetic analysis or by Fluorescent-In Situ Hybridization (FISH) for the presence of a protein kinase (BCR-ABL) on peripheral blood (PB) cells or bone marrow (BM) samples.|participants|Number|84|84.0||||||
4435107|NCT00123487|4259996|B2|Ph+ ALL||Participants by Disease Phase|Chronic Myelogenous Leukemia (CML) consists of a chronic phase lasting three to six years, followed by transformation to an accelerated phase (AP) and blast phases (myeloid and Lymphoid) of much shorter duration. The Philadelphia chromosome (Ph+) status was documented by cytogenetic analysis or by Fluorescent-In Situ Hybridization (FISH) for the presence of a protein kinase (BCR-ABL) on peripheral blood (PB) cells or bone marrow (BM) samples.|participants|Number|44|44.0||||||
4435169|NCT00123487|4259995|B3|Not Reported||Age, Customized||participants|Number|1|1.0||||||
4435108|NCT00123487|4259997|B1|Ph+ ALL||Participants by Disease Phase|Chronic Myelogenous Leukemia (CML) consists of a chronic phase lasting three to six years, followed by transformation to an accelerated phase (AP) and blast phases (myeloid and Lymphoid) of much shorter duration. The Philadelphia chromosome (Ph+) status was documented by cytogenetic analysis or by Fluorescent-In Situ Hybridization (FISH) for the presence of a protein kinase (BCR-ABL) on peripheral blood (PB) cells or bone marrow (BM) samples.|participants|Number|40|40.0||||||
4435109|NCT00123487|4259995|B3|Blast Phase CML - Lymphoid||Participants by Disease Phase|Chronic Myelogenous Leukemia (CML) consists of a chronic phase lasting three to six years, followed by transformation to an accelerated phase (AP) and blast phases (myeloid and Lymphoid) of much shorter duration. The Philadelphia chromosome (Ph+) status was documented by cytogenetic analysis or by Fluorescent-In Situ Hybridization (FISH) for the presence of a protein kinase (BCR-ABL) on peripheral blood (PB) cells or bone marrow (BM) samples.|participants|Number|61|61.0||||||
4435110|NCT00123487|4259996|B2|Blast Phase CML - Lymphoid||Participants by Disease Phase|Chronic Myelogenous Leukemia (CML) consists of a chronic phase lasting three to six years, followed by transformation to an accelerated phase (AP) and blast phases (myeloid and Lymphoid) of much shorter duration. The Philadelphia chromosome (Ph+) status was documented by cytogenetic analysis or by Fluorescent-In Situ Hybridization (FISH) for the presence of a protein kinase (BCR-ABL) on peripheral blood (PB) cells or bone marrow (BM) samples.|participants|Number|28|28.0||||||
4435111|NCT00123487|4259997|B1|Blast Phase CML - Lymphoid||Participants by Disease Phase|Chronic Myelogenous Leukemia (CML) consists of a chronic phase lasting three to six years, followed by transformation to an accelerated phase (AP) and blast phases (myeloid and Lymphoid) of much shorter duration. The Philadelphia chromosome (Ph+) status was documented by cytogenetic analysis or by Fluorescent-In Situ Hybridization (FISH) for the presence of a protein kinase (BCR-ABL) on peripheral blood (PB) cells or bone marrow (BM) samples.|participants|Number|33|33.0||||||
4435112|NCT00123487|4259995|B3|Blast Phase CML - Myeloid||Participants by Disease Phase|Chronic Myelogenous Leukemia (CML) consists of a chronic phase lasting three to six years, followed by transformation to an accelerated phase (AP) and blast phases (myeloid and Lymphoid) of much shorter duration. The Philadelphia chromosome (Ph+) status was documented by cytogenetic analysis or by Fluorescent-In Situ Hybridization (FISH) for the presence of a protein kinase (BCR-ABL) on peripheral blood (PB) cells or bone marrow (BM) samples.|participants|Number|149|149.0||||||
4435113|NCT00123487|4259996|B2|Blast Phase CML - Myeloid||Participants by Disease Phase|Chronic Myelogenous Leukemia (CML) consists of a chronic phase lasting three to six years, followed by transformation to an accelerated phase (AP) and blast phases (myeloid and Lymphoid) of much shorter duration. The Philadelphia chromosome (Ph+) status was documented by cytogenetic analysis or by Fluorescent-In Situ Hybridization (FISH) for the presence of a protein kinase (BCR-ABL) on peripheral blood (PB) cells or bone marrow (BM) samples.|participants|Number|74|74.0||||||
4435114|NCT00123487|4259997|B1|Blast Phase CML - Myeloid||Participants by Disease Phase|Chronic Myelogenous Leukemia (CML) consists of a chronic phase lasting three to six years, followed by transformation to an accelerated phase (AP) and blast phases (myeloid and Lymphoid) of much shorter duration. The Philadelphia chromosome (Ph+) status was documented by cytogenetic analysis or by Fluorescent-In Situ Hybridization (FISH) for the presence of a protein kinase (BCR-ABL) on peripheral blood (PB) cells or bone marrow (BM) samples.|participants|Number|75|75.0||||||
4435115|NCT00123487|4259995|B3|Accelerated Phase CML||Participants by Disease Phase|Chronic Myelogenous Leukemia (CML) consists of a chronic phase lasting three to six years, followed by transformation to an accelerated phase (AP) and blast phases (myeloid and Lymphoid) of much shorter duration. The Philadelphia chromosome (Ph+) status was documented by cytogenetic analysis or by Fluorescent-In Situ Hybridization (FISH) for the presence of a protein kinase (BCR-ABL) on peripheral blood (PB) cells or bone marrow (BM) samples.|participants|Number|317|317.0||||||
4435116|NCT00123487|4259996|B2|Accelerated Phase CML||Participants by Disease Phase|Chronic Myelogenous Leukemia (CML) consists of a chronic phase lasting three to six years, followed by transformation to an accelerated phase (AP) and blast phases (myeloid and Lymphoid) of much shorter duration. The Philadelphia chromosome (Ph+) status was documented by cytogenetic analysis or by Fluorescent-In Situ Hybridization (FISH) for the presence of a protein kinase (BCR-ABL) on peripheral blood (PB) cells or bone marrow (BM) samples.|participants|Number|159|159.0||||||
4435117|NCT00123487|4259997|B1|Accelerated Phase CML||Participants by Disease Phase|Chronic Myelogenous Leukemia (CML) consists of a chronic phase lasting three to six years, followed by transformation to an accelerated phase (AP) and blast phases (myeloid and Lymphoid) of much shorter duration. The Philadelphia chromosome (Ph+) status was documented by cytogenetic analysis or by Fluorescent-In Situ Hybridization (FISH) for the presence of a protein kinase (BCR-ABL) on peripheral blood (PB) cells or bone marrow (BM) samples.|participants|Number|158|158.0||||||
4435118|NCT00123487|4259995|B3|Missing||Imatinib Status|Failure on prior treatment with imatinib due to either resistance to or intolerance of imatinib. Resistance: no hematologic response after a ≥ 4-week treatment or a ≥ 50% increase in blasts after a 2-week treatment (primary resistance); achieved a hematologic response, no longer met criteria consistently on all assessments over a consecutive 2-week period while receiving an imatinib (acquired resistance); progressed while on treatment. Intolerance: Grade ≥ 3 non-hematologic toxicity or a Grade 4 hematologic toxicity lasting for > 2 weeks leading to discontinuation of therapy or dose decrease.|participants|Number|5|5.0||||||
4435119|NCT00123487|4259996|B2|Missing||Imatinib Status|Failure on prior treatment with imatinib due to either resistance to or intolerance of imatinib. Resistance: no hematologic response after a ≥ 4-week treatment or a ≥ 50% increase in blasts after a 2-week treatment (primary resistance); achieved a hematologic response, no longer met criteria consistently on all assessments over a consecutive 2-week period while receiving an imatinib (acquired resistance); progressed while on treatment. Intolerance: Grade ≥ 3 non-hematologic toxicity or a Grade 4 hematologic toxicity lasting for > 2 weeks leading to discontinuation of therapy or dose decrease.|participants|Number|1|1.0||||||
4435120|NCT00123487|4259997|B1|Missing||Imatinib Status|Failure on prior treatment with imatinib due to either resistance to or intolerance of imatinib. Resistance: no hematologic response after a ≥ 4-week treatment or a ≥ 50% increase in blasts after a 2-week treatment (primary resistance); achieved a hematologic response, no longer met criteria consistently on all assessments over a consecutive 2-week period while receiving an imatinib (acquired resistance); progressed while on treatment. Intolerance: Grade ≥ 3 non-hematologic toxicity or a Grade 4 hematologic toxicity lasting for > 2 weeks leading to discontinuation of therapy or dose decrease.|participants|Number|4|4.0||||||
4435121|NCT00123487|4259995|B3|Intolerance||Imatinib Status|Failure on prior treatment with imatinib due to either resistance to or intolerance of imatinib. Resistance: no hematologic response after a ≥ 4-week treatment or a ≥ 50% increase in blasts after a 2-week treatment (primary resistance); achieved a hematologic response, no longer met criteria consistently on all assessments over a consecutive 2-week period while receiving an imatinib (acquired resistance); progressed while on treatment. Intolerance: Grade ≥ 3 non-hematologic toxicity or a Grade 4 hematologic toxicity lasting for > 2 weeks leading to discontinuation of therapy or dose decrease.|participants|Number|132|132.0||||||
4435122|NCT00123487|4259996|B2|Intolerance||Imatinib Status|Failure on prior treatment with imatinib due to either resistance to or intolerance of imatinib. Resistance: no hematologic response after a ≥ 4-week treatment or a ≥ 50% increase in blasts after a 2-week treatment (primary resistance); achieved a hematologic response, no longer met criteria consistently on all assessments over a consecutive 2-week period while receiving an imatinib (acquired resistance); progressed while on treatment. Intolerance: Grade ≥ 3 non-hematologic toxicity or a Grade 4 hematologic toxicity lasting for > 2 weeks leading to discontinuation of therapy or dose decrease.|participants|Number|65|65.0||||||
4435123|NCT00123487|4259997|B1|Intolerance||Imatinib Status|Failure on prior treatment with imatinib due to either resistance to or intolerance of imatinib. Resistance: no hematologic response after a ≥ 4-week treatment or a ≥ 50% increase in blasts after a 2-week treatment (primary resistance); achieved a hematologic response, no longer met criteria consistently on all assessments over a consecutive 2-week period while receiving an imatinib (acquired resistance); progressed while on treatment. Intolerance: Grade ≥ 3 non-hematologic toxicity or a Grade 4 hematologic toxicity lasting for > 2 weeks leading to discontinuation of therapy or dose decrease.|participants|Number|67|67.0||||||
4435124|NCT00123487|4259995|B3|Acquired Resistance||Imatinib Status|Failure on prior treatment with imatinib due to either resistance to or intolerance of imatinib. Resistance: no hematologic response after a ≥ 4-week treatment or a ≥ 50% increase in blasts after a 2-week treatment (primary resistance); achieved a hematologic response, no longer met criteria consistently on all assessments over a consecutive 2-week period while receiving an imatinib (acquired resistance); progressed while on treatment. Intolerance: Grade ≥ 3 non-hematologic toxicity or a Grade 4 hematologic toxicity lasting for > 2 weeks leading to discontinuation of therapy or dose decrease.|participants|Number|382|382.0||||||
4435125|NCT00123487|4259996|B2|Acquired Resistance||Imatinib Status|Failure on prior treatment with imatinib due to either resistance to or intolerance of imatinib. Resistance: no hematologic response after a ≥ 4-week treatment or a ≥ 50% increase in blasts after a 2-week treatment (primary resistance); achieved a hematologic response, no longer met criteria consistently on all assessments over a consecutive 2-week period while receiving an imatinib (acquired resistance); progressed while on treatment. Intolerance: Grade ≥ 3 non-hematologic toxicity or a Grade 4 hematologic toxicity lasting for > 2 weeks leading to discontinuation of therapy or dose decrease.|participants|Number|190|190.0||||||
4435126|NCT00123487|4259997|B1|Acquired Resistance||Imatinib Status|Failure on prior treatment with imatinib due to either resistance to or intolerance of imatinib. Resistance: no hematologic response after a ≥ 4-week treatment or a ≥ 50% increase in blasts after a 2-week treatment (primary resistance); achieved a hematologic response, no longer met criteria consistently on all assessments over a consecutive 2-week period while receiving an imatinib (acquired resistance); progressed while on treatment. Intolerance: Grade ≥ 3 non-hematologic toxicity or a Grade 4 hematologic toxicity lasting for > 2 weeks leading to discontinuation of therapy or dose decrease.|participants|Number|192|192.0||||||
4435127|NCT00123487|4259995|B3|Primary Resistance||Imatinib Status|Failure on prior treatment with imatinib due to either resistance to or intolerance of imatinib. Resistance: no hematologic response after a ≥ 4-week treatment or a ≥ 50% increase in blasts after a 2-week treatment (primary resistance); achieved a hematologic response, no longer met criteria consistently on all assessments over a consecutive 2-week period while receiving an imatinib (acquired resistance); progressed while on treatment. Intolerance: Grade ≥ 3 non-hematologic toxicity or a Grade 4 hematologic toxicity lasting for > 2 weeks leading to discontinuation of therapy or dose decrease.|participants|Number|92|92.0||||||
4435128|NCT00123487|4259996|B2|Primary Resistance||Imatinib Status|Failure on prior treatment with imatinib due to either resistance to or intolerance of imatinib. Resistance: no hematologic response after a ≥ 4-week treatment or a ≥ 50% increase in blasts after a 2-week treatment (primary resistance); achieved a hematologic response, no longer met criteria consistently on all assessments over a consecutive 2-week period while receiving an imatinib (acquired resistance); progressed while on treatment. Intolerance: Grade ≥ 3 non-hematologic toxicity or a Grade 4 hematologic toxicity lasting for > 2 weeks leading to discontinuation of therapy or dose decrease.|participants|Number|49|49.0||||||
4435129|NCT00123487|4259997|B1|Primary Resistance||Imatinib Status|Failure on prior treatment with imatinib due to either resistance to or intolerance of imatinib. Resistance: no hematologic response after a ≥ 4-week treatment or a ≥ 50% increase in blasts after a 2-week treatment (primary resistance); achieved a hematologic response, no longer met criteria consistently on all assessments over a consecutive 2-week period while receiving an imatinib (acquired resistance); progressed while on treatment. Intolerance: Grade ≥ 3 non-hematologic toxicity or a Grade 4 hematologic toxicity lasting for > 2 weeks leading to discontinuation of therapy or dose decrease.|participants|Number|43|43.0||||||
4435130|NCT00123487|4259995|B3|Not Reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|2|2.0||||||
4435131|NCT00123487|4259996|B2|Not Reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|2|2.0||||||
4435132|NCT00123487|4259997|B1|Not Reported||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|0|0.0||||||
4435170|NCT00123487|4259996|B2|Not Reported||Age, Customized||participants|Number|1|1.0||||||
4435171|NCT00123487|4259997|B1|Not Reported||Age, Customized||participants|Number|0|0.0||||||
4435133|NCT00123487|4259995|B3|ECOG PS 3||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|9|9.0||||||
4435134|NCT00123487|4259996|B2|ECOG PS 3||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|2|2.0||||||
4435135|NCT00123487|4259997|B1|ECOG PS 3||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|7|7.0||||||
4435136|NCT00123487|4259995|B3|ECOG PS 2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|98|98.0||||||
4435137|NCT00123487|4259996|B2|ECOG PS 2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|58|58.0||||||
4435138|NCT00123487|4259997|B1|ECOG PS 2||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|40|40.0||||||
4435139|NCT00123487|4259995|B3|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|230|230.0||||||
4435140|NCT00123487|4259996|B2|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|109|109.0||||||
4435141|NCT00123487|4259997|B1|ECOG PS 1||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|121|121.0||||||
4435142|NCT00123487|4259995|B3|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|272|272.0||||||
4435143|NCT00123487|4259996|B2|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|134|134.0||||||
4435144|NCT00123487|4259997|B1|ECOG PS 0||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|ECOG PS, a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0= Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|participants|Number|138|138.0||||||
4435145|NCT00123487|4259995|B3|Unknown or Not reported||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4435146|NCT00123487|4259996|B2|Unknown or Not reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4435147|NCT00123487|4259997|B1|Unknown or Not reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4435148|NCT00123487|4259995|B3|Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4435149|NCT00123487|4259996|B2|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4435150|NCT00123487|4259997|B1|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4435151|NCT00123487|4259995|B3|White||Race/Ethnicity, Customized||participants|Number|471|471.0||||||
4435152|NCT00123487|4259996|B2|White||Race/Ethnicity, Customized||participants|Number|236|236.0||||||
4435153|NCT00123487|4259997|B1|White||Race/Ethnicity, Customized||participants|Number|235|235.0||||||
4435154|NCT00123487|4259995|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4435155|NCT00123487|4259996|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4435156|NCT00123487|4259997|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4435157|NCT00123487|4259995|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4435158|NCT00123487|4259996|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4435159|NCT00123487|4259997|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4435160|NCT00123487|4259995|B3|Asian||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4435161|NCT00123487|4259996|B2|Asian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4435162|NCT00123487|4259997|B1|Asian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4435163|NCT00123487|4259995|B3||Male|Sex: Female, Male||Participants|Count of Participants|344|344.0||||||
4435164|NCT00123487|4259996|B2||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4435165|NCT00123487|4259997|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4435166|NCT00123487|4259995|B3||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4435167|NCT00123487|4259996|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4435168|NCT00123487|4259997|B1||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4435172|NCT00123487|4259995|B3|Greater than (>) 75 years||Age, Customized||participants|Number|17|17.0||||||
4435173|NCT00123487|4259996|B2|Greater than (>) 75 years||Age, Customized||participants|Number|9|9.0||||||
4435174|NCT00123487|4259997|B1|Greater than (>) 75 years||Age, Customized||participants|Number|8|8.0||||||
4435175|NCT00123487|4259995|B3|66 - 75 years||Age, Customized||participants|Number|114|114.0||||||
4435176|NCT00123487|4259996|B2|66 - 75 years||Age, Customized||participants|Number|65|65.0||||||
4435177|NCT00123487|4259997|B1|66 - 75 years||Age, Customized||participants|Number|49|49.0||||||
4435178|NCT00123487|4259995|B3|46 - 65 years||Age, Customized||participants|Number|286|286.0||||||
4435179|NCT00123487|4259996|B2|46 - 65 years||Age, Customized||participants|Number|143|143.0||||||
4435180|NCT00123487|4259997|B1|46 - 65 years||Age, Customized||participants|Number|143|143.0||||||
4435181|NCT00123487|4259995|B3|21 - 45 years||Age, Customized||participants|Number|184|184.0||||||
4435182|NCT00123487|4259996|B2|21 - 45 years||Age, Customized||participants|Number|83|83.0||||||
4435183|NCT00123487|4259997|B1|21 - 45 years||Age, Customized||participants|Number|101|101.0||||||
4435184|NCT00123487|4259995|B3|Less than (<) 21 years||Age, Customized||participants|Number|9|9.0||||||
4435185|NCT00123487|4259996|B2|Less than (<) 21 years||Age, Customized||participants|Number|4|4.0||||||
4435186|NCT00123487|4259997|B1|Less than (<) 21 years||Age, Customized||participants|Number|5|5.0||||||
4435187|NCT00123474|4260038|B5|Intolerant to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|173|173.0||||||
4435188|NCT00123474|4260039|B4|Intolerant to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|42|42.0||||||
4435189|NCT00123474|4260040|B3|Intolerant to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|44|44.0||||||
4435190|NCT00123474|4260041|B2|Intolerant to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|44|44.0||||||
4435191|NCT00123474|4260042|B1|Intolerant to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|43|43.0||||||
4435192|NCT00123474|4260038|B5|Acquired Resistance to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|175|175.0||||||
4435193|NCT00123474|4260039|B4|Acquired Resistance to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|45|45.0||||||
4435194|NCT00123474|4260040|B3|Acquired Resistance to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|36|36.0||||||
4435262|NCT00123409|4260152|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435195|NCT00123474|4260041|B2|Acquired Resistance to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|45|45.0||||||
4435196|NCT00123474|4260042|B1|Acquired Resistance to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|49|49.0||||||
4435197|NCT00123474|4260038|B5|Primary Resistance to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|322|322.0||||||
4435198|NCT00123474|4260039|B4|Primary Resistance to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|81|81.0||||||
4435199|NCT00123474|4260040|B3|Primary Resistance to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|88|88.0||||||
4435200|NCT00123474|4260041|B2|Primary Resistance to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|78|78.0||||||
4435201|NCT00123474|4260042|B1|Primary Resistance to Imatinib||Imatinib Status|Primary Resistance: no decrease in white blood cell (WBC) count after ≥ 4 weeks imatinib or not achieved a complete hematologic response (CHR) after 3 months, a major cytogenetic response (MCyR) after 6 months, or a complete cytogenetic response (CCyR) after 12 months. Acquired resistance: achieved MCyR and no longer met the criteria for MCyR. Intolerance: Grade ≥ 3 toxicity considered at least possibly related to imatinib at a dose of ≤ 400 mg/day which led to discontinuation of therapy; tolerated the dose of 400 mg but did not achieve a CCyR and subsequently did not tolerate doses ≥ 600 mg.|participants|Number|75|75.0||||||
4435202|NCT00123474|4260038|B5||Male|Sex: Female, Male||Participants|Count of Participants|316|316.0||||||
4435203|NCT00123474|4260039|B4||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4435204|NCT00123474|4260040|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4435205|NCT00123474|4260041|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4435206|NCT00123474|4260042|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4435207|NCT00123474|4260038|B5||Female|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4435208|NCT00123474|4260039|B4||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4435209|NCT00123474|4260040|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4435210|NCT00123474|4260041|B2||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4435211|NCT00123474|4260042|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4435212|NCT00123474|4260038|B5|Greater than (>) 65 years||Age, Customized||participants|Number|166|166.0||||||
4435213|NCT00123474|4260039|B4|Greater than (>) 65 years||Age, Customized||participants|Number|43|43.0||||||
4435214|NCT00123474|4260040|B3|Greater than (>) 65 years||Age, Customized||participants|Number|38|38.0||||||
4435215|NCT00123474|4260041|B2|Greater than (>) 65 years||Age, Customized||participants|Number|39|39.0||||||
4435216|NCT00123474|4260042|B1|Greater than (>) 65 years||Age, Customized||participants|Number|46|46.0||||||
4435217|NCT00123474|4260038|B5|Less than, equal to (<=) 65 years||Age, Customized||participants|Number|504|504.0||||||
4435218|NCT00123474|4260039|B4|Less than, equal to (<=) 65 years||Age, Customized||participants|Number|125|125.0||||||
4435219|NCT00123474|4260040|B3|Less than, equal to (<=) 65 years||Age, Customized||participants|Number|130|130.0||||||
4435220|NCT00123474|4260041|B2|Less than, equal to (<=) 65 years||Age, Customized||participants|Number|128|128.0||||||
4435221|NCT00123474|4260042|B1|Less than, equal to (<=) 65 years||Age, Customized||participants|Number|121|121.0||||||
4435222|NCT00123422|4260136|B4|||RV/TLC percent predicted|The RV/TLC (residual volume/total lung capacity) is a pulmonary function measure. It is an indication of air-trapping in the lungs. In general, a value over 120 percent predicted indicates that there is significant air-trapping.|percent|Mean|161|161.0|Standard Deviation|25|25.0|||
4435223|NCT00123422|4260137|B3|||RV/TLC percent predicted|The RV/TLC (residual volume/total lung capacity) is a pulmonary function measure. It is an indication of air-trapping in the lungs. In general, a value over 120 percent predicted indicates that there is significant air-trapping.|percent|Mean|161|161.0|Standard Deviation|24|24.0|||
4435224|NCT00123422|4260138|B2|||RV/TLC percent predicted|The RV/TLC (residual volume/total lung capacity) is a pulmonary function measure. It is an indication of air-trapping in the lungs. In general, a value over 120 percent predicted indicates that there is significant air-trapping.|percent|Mean|158|158.0|Standard Deviation|24|24.0|||
4435225|NCT00123422|4260139|B1|||RV/TLC percent predicted|The RV/TLC (residual volume/total lung capacity) is a pulmonary function measure. It is an indication of air-trapping in the lungs. In general, a value over 120 percent predicted indicates that there is significant air-trapping.|percent|Mean|165|165.0|Standard Deviation|27|27.0|||
4435226|NCT00123422|4260136|B4|||FEV1 percent predicted|The FEV1 (forced expiratory volume in 1 second) is a measure of pulmonary function. It is the amount of air that a person can blow out in one second. This value is reported as the percentage of predicted normal.|percent|Mean|44|44.0|Standard Deviation|14|14.0|||
4435227|NCT00123422|4260137|B3|||FEV1 percent predicted|The FEV1 (forced expiratory volume in 1 second) is a measure of pulmonary function. It is the amount of air that a person can blow out in one second. This value is reported as the percentage of predicted normal.|percent|Mean|41|41.0|Standard Deviation|13|13.0|||
4435228|NCT00123422|4260138|B2|||FEV1 percent predicted|The FEV1 (forced expiratory volume in 1 second) is a measure of pulmonary function. It is the amount of air that a person can blow out in one second. This value is reported as the percentage of predicted normal.|percent|Mean|46|46.0|Standard Deviation|14|14.0|||
4435229|NCT00123422|4260139|B1|||FEV1 percent predicted|The FEV1 (forced expiratory volume in 1 second) is a measure of pulmonary function. It is the amount of air that a person can blow out in one second. This value is reported as the percentage of predicted normal.|percent|Mean|45|45.0|Standard Deviation|14|14.0|||
4435230|NCT00123422|4260136|B4|||Smoking history|Smoking history was measured in pack/years. This is the number of packs of cigarettes smoked per day multiplied by the number of years of smoking.|pack/years|Mean|64|64.0|Standard Deviation|42|42.0|||
4435231|NCT00123422|4260137|B3|||Smoking history|Smoking history was measured in pack/years. This is the number of packs of cigarettes smoked per day multiplied by the number of years of smoking.|pack/years|Mean|68|68.0|Standard Deviation|48|48.0|||
4435232|NCT00123422|4260138|B2|||Smoking history|Smoking history was measured in pack/years. This is the number of packs of cigarettes smoked per day multiplied by the number of years of smoking.|pack/years|Mean|67|67.0|Standard Deviation|40|40.0|||
4435233|NCT00123422|4260139|B1|||Smoking history|Smoking history was measured in pack/years. This is the number of packs of cigarettes smoked per day multiplied by the number of years of smoking.|pack/years|Mean|62|62.0|Standard Deviation|37|37.0|||
4435234|NCT00123422|4260136|B4|United States||Region of Enrollment||participants|Number|103|103.0||||||
4435235|NCT00123422|4260137|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4435236|NCT00123422|4260138|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4435237|NCT00123422|4260139|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4435238|NCT00123422|4260136|B4||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4435239|NCT00123422|4260137|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4435240|NCT00123422|4260138|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4435241|NCT00123422|4260139|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4435242|NCT00123422|4260136|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4435243|NCT00123422|4260137|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4435244|NCT00123422|4260138|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4435245|NCT00123422|4260139|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4435246|NCT00123422|4260136|B4|||Age||years|Mean|69|69.0|Standard Deviation|9|9.0|||
4435247|NCT00123422|4260137|B3|||Age||years|Mean|69|69.0|Standard Deviation|7|7.0|||
4435248|NCT00123422|4260138|B2|||Age||years|Mean|70|70.0|Standard Deviation|9|9.0|||
4435249|NCT00123422|4260139|B1|||Age||years|Mean|68|68.0|Standard Deviation|10|10.0|||
4435250|NCT00123409|4260152|B3|||Problems related to alcohol|Measure used was the Short Inventory of Problem Drinking (SIP)|# problems|Mean|4.5|4.5|Standard Deviation|5.52|5.52|||
4435251|NCT00123409|4260153|B2|||Problems related to alcohol|Measure used was the Short Inventory of Problem Drinking (SIP)|# problems|Mean|4.7|4.7|Standard Deviation|5.52|5.52|||
4435252|NCT00123409|4260154|B1|||Problems related to alcohol|Measure used was the Short Inventory of Problem Drinking (SIP)|# problems|Mean|4.31|4.31|Standard Deviation|5.52|5.52|||
4435253|NCT00123409|4260152|B3|||# of Days Drinking in last 28 days||# of days drinking|Mean|19.9|19.9|Standard Deviation|8.8|8.8|||
4435254|NCT00123409|4260153|B2|||# of Days Drinking in last 28 days||# of days drinking|Mean|20.2|20.2|Standard Deviation|8.12|8.12|||
4435255|NCT00123409|4260154|B1|||# of Days Drinking in last 28 days||# of days drinking|Mean|19.53|19.53|Standard Deviation|9.44|9.44|||
4435256|NCT00123409|4260152|B3|United States||Region of Enrollment||participants|Number|139|139.0||||||
4435257|NCT00123409|4260153|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4435258|NCT00123409|4260154|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4435259|NCT00123409|4260152|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435260|NCT00123409|4260153|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435261|NCT00123409|4260154|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435263|NCT00123409|4260153|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435264|NCT00123409|4260154|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435265|NCT00123409|4260152|B3||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4435266|NCT00123409|4260153|B2||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4435267|NCT00123409|4260154|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4435268|NCT00123409|4260152|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4435269|NCT00123409|4260153|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4435270|NCT00123409|4260154|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4435271|NCT00123409|4260152|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435272|NCT00123409|4260153|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435273|NCT00123409|4260154|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435274|NCT00123409|4260152|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435275|NCT00123409|4260153|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435276|NCT00123409|4260154|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435277|NCT00123409|4260152|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435278|NCT00123409|4260153|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435279|NCT00123409|4260154|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435280|NCT00123409|4260152|B3||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4435281|NCT00123409|4260153|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4435282|NCT00123409|4260154|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4435283|NCT00123409|4260152|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4435284|NCT00123409|4260153|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4435285|NCT00123409|4260154|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4435286|NCT00123409|4260152|B3|||Age||years|Mean|57.1|57.1|Standard Deviation|14|14.0|||
4435287|NCT00123409|4260153|B2|||Age||years|Mean|57|57.0|Standard Deviation|13.9|13.9|||
4435288|NCT00123409|4260154|B1|||Age||years|Mean|57.3|57.3|Standard Deviation|15.1|15.1|||
4435289|NCT00123162|4260163|B3|Croatia||Region of Enrollment||participants|Number|25|25.0||||||
4435290|NCT00123162|4260164|B2|Croatia||Region of Enrollment||participants|Number|12|12.0||||||
4435291|NCT00123162|4260165|B1|Croatia||Region of Enrollment||participants|Number|13|13.0||||||
4435292|NCT00123162|4260163|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435293|NCT00123162|4260164|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435294|NCT00123162|4260165|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435295|NCT00123162|4260163|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435296|NCT00123162|4260164|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435297|NCT00123162|4260165|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435298|NCT00123162|4260163|B3||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4435299|NCT00123162|4260164|B2||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4435300|NCT00123162|4260165|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4435301|NCT00123162|4260163|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435302|NCT00123162|4260164|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435303|NCT00123162|4260165|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435304|NCT00123162|4260163|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435305|NCT00123162|4260164|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435306|NCT00123162|4260165|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435307|NCT00123162|4260163|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435308|NCT00123162|4260164|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435309|NCT00123162|4260165|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435310|NCT00123162|4260163|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435311|NCT00123162|4260164|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435312|NCT00123162|4260165|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435313|NCT00123162|4260163|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435314|NCT00123162|4260164|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435315|NCT00123162|4260165|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435316|NCT00123162|4260163|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4435317|NCT00123162|4260164|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4435318|NCT00123162|4260165|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4435319|NCT00123162|4260163|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435320|NCT00123162|4260164|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435321|NCT00123162|4260165|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435322|NCT00123162|4260163|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435323|NCT00123162|4260164|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435324|NCT00123162|4260165|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435325|NCT00123162|4260163|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4435326|NCT00123162|4260164|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4435327|NCT00123162|4260165|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4435328|NCT00123162|4260163|B3|||Age||years|Mean|23.5|23.5|Standard Deviation|5.2|5.2|||
4435329|NCT00123162|4260164|B2|||Age||years|Mean|23.3|23.3|Standard Deviation|4.8|4.8|||
4435330|NCT00123162|4260165|B1|||Age||years|Mean|23.7|23.7|Standard Deviation|5.7|5.7|||
4435331|NCT00123123|4260174|B4|United States||Region of Enrollment||participants|Number|175|175.0||||||
4435332|NCT00123123|4260175|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4435333|NCT00123123|4260176|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4435334|NCT00123123|4260177|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4435335|NCT00123123|4260174|B4||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4435336|NCT00123123|4260175|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4435337|NCT00123123|4260176|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4435338|NCT00123123|4260177|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4435339|NCT00123123|4260174|B4||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4435340|NCT00123123|4260175|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4435341|NCT00123123|4260176|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4435342|NCT00123123|4260177|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4435343|NCT00123123|4260174|B4|||Age||years|Mean|48.0|48.0|Standard Deviation|20.8|20.8|||
4435344|NCT00123123|4260175|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|19.1|19.1|||
4435345|NCT00123123|4260176|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|19.9|19.9|||
4435346|NCT00123123|4260177|B1|||Age||years|Mean|50.0|50.0|Standard Deviation|22.5|22.5|||
4435347|NCT00123123|4260174|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4435348|NCT00123123|4260175|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4435349|NCT00123123|4260176|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4435350|NCT00123123|4260177|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4435351|NCT00123123|4260174|B4||Between 18 and 65 years|Age||Participants|Count of Participants|175|175.0||||||
4435352|NCT00123123|4260175|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4435353|NCT00123123|4260176|B2||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4435354|NCT00123123|4260177|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4435355|NCT00123123|4260174|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435356|NCT00123123|4260175|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435357|NCT00123123|4260176|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435358|NCT00123123|4260177|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435359|NCT00122980|4260190|B3|No||History of recurrent stroke|Recurrent stroke at baseline is defined as having had more than one stroke prior to study entry.|participants|Number|119|119.0||||||
4435360|NCT00122980|4260191|B2|No||History of recurrent stroke|Recurrent stroke at baseline is defined as having had more than one stroke prior to study entry.|participants|Number|62|62.0||||||
4435361|NCT00122980|4260192|B1|No||History of recurrent stroke|Recurrent stroke at baseline is defined as having had more than one stroke prior to study entry.|participants|Number|57|57.0||||||
4435362|NCT00122980|4260190|B3|Yes||History of recurrent stroke|Recurrent stroke at baseline is defined as having had more than one stroke prior to study entry.|participants|Number|14|14.0||||||
4435363|NCT00122980|4260191|B2|Yes||History of recurrent stroke|Recurrent stroke at baseline is defined as having had more than one stroke prior to study entry.|participants|Number|4|4.0||||||
4435364|NCT00122980|4260192|B1|Yes||History of recurrent stroke|Recurrent stroke at baseline is defined as having had more than one stroke prior to study entry.|participants|Number|10|10.0||||||
4435365|NCT00122980|4260190|B3|||Liver iron concentration|Participants were included in this trial if they had transfusional iron overload, defined as previously documented liver iron concentrations (LIC) ≥5.0 mg Fe per gram of dry weight liver or serum ferritin ≥500 ng/mL on 2 independent measurements. Part of the composite primary endpoint hypothesis of this study is that liver iron levels will decrease more in the Hydroxyurea/Phlebotomy group than in the Transfusion/Chelation group.|mg ferritin/gram dry weight liver|Median|14.5|14.5|Inter-Quartile Range|||9.0|23.0|
4435366|NCT00122980|4260191|B2|||Liver iron concentration|Participants were included in this trial if they had transfusional iron overload, defined as previously documented liver iron concentrations (LIC) ≥5.0 mg Fe per gram of dry weight liver or serum ferritin ≥500 ng/mL on 2 independent measurements. Part of the composite primary endpoint hypothesis of this study is that liver iron levels will decrease more in the Hydroxyurea/Phlebotomy group than in the Transfusion/Chelation group.|mg ferritin/gram dry weight liver|Median|13.9|13.9|Inter-Quartile Range|||8.7|22.9|
4435393|NCT00122980|4260191|B2|||Duration of Transfusion|Duration of Transfusions refers to the duration of chronic transfusion therapy (either simple, partial exchange, or erythrocytapheresis)for secondary stroke prevention.|years|Mean|7.0|7.0|Standard Deviation|3.61|3.61|||
4435424|NCT00122980|4260192|B1||Asian|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|0|0.0||||||
4435367|NCT00122980|4260192|B1|||Liver iron concentration|Participants were included in this trial if they had transfusional iron overload, defined as previously documented liver iron concentrations (LIC) ≥5.0 mg Fe per gram of dry weight liver or serum ferritin ≥500 ng/mL on 2 independent measurements. Part of the composite primary endpoint hypothesis of this study is that liver iron levels will decrease more in the Hydroxyurea/Phlebotomy group than in the Transfusion/Chelation group.|mg ferritin/gram dry weight liver|Median|14.5|14.5|Inter-Quartile Range|||9.5|23.3|
4435368|NCT00122980|4260190|B3|No||Prior use of hydroxyruea|Hydroxyurea, in combination with phlebotomy, is the Alternative Treatment to prevent secondary stroke in this study.|participants|Number|125|125.0||||||
4435369|NCT00122980|4260191|B2|No||Prior use of hydroxyruea|Hydroxyurea, in combination with phlebotomy, is the Alternative Treatment to prevent secondary stroke in this study.|participants|Number|63|63.0||||||
4435370|NCT00122980|4260192|B1|No||Prior use of hydroxyruea|Hydroxyurea, in combination with phlebotomy, is the Alternative Treatment to prevent secondary stroke in this study.|participants|Number|62|62.0||||||
4435371|NCT00122980|4260190|B3|Yes||Prior use of hydroxyruea|Hydroxyurea, in combination with phlebotomy, is the Alternative Treatment to prevent secondary stroke in this study.|participants|Number|8|8.0||||||
4435372|NCT00122980|4260191|B2|Yes||Prior use of hydroxyruea|Hydroxyurea, in combination with phlebotomy, is the Alternative Treatment to prevent secondary stroke in this study.|participants|Number|3|3.0||||||
4435373|NCT00122980|4260192|B1|Yes||Prior use of hydroxyruea|Hydroxyurea, in combination with phlebotomy, is the Alternative Treatment to prevent secondary stroke in this study.|participants|Number|5|5.0||||||
4435374|NCT00122980|4260190|B3|Missing||Prior use of Exjade (deferasirox)|Exjade (deferasirox) is a chelation treatment to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|4|4.0||||||
4435375|NCT00122980|4260191|B2|Missing||Prior use of Exjade (deferasirox)|Exjade (deferasirox) is a chelation treatment to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|3|3.0||||||
4435376|NCT00122980|4260192|B1|Missing||Prior use of Exjade (deferasirox)|Exjade (deferasirox) is a chelation treatment to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|1|1.0||||||
4435377|NCT00122980|4260190|B3|No||Prior use of Exjade (deferasirox)|Exjade (deferasirox) is a chelation treatment to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|17|17.0||||||
4435378|NCT00122980|4260191|B2|No||Prior use of Exjade (deferasirox)|Exjade (deferasirox) is a chelation treatment to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|8|8.0||||||
4435379|NCT00122980|4260192|B1|No||Prior use of Exjade (deferasirox)|Exjade (deferasirox) is a chelation treatment to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|9|9.0||||||
4435380|NCT00122980|4260190|B3|Yes||Prior use of Exjade (deferasirox)|Exjade (deferasirox) is a chelation treatment to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|112|112.0||||||
4435381|NCT00122980|4260191|B2|Yes||Prior use of Exjade (deferasirox)|Exjade (deferasirox) is a chelation treatment to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|55|55.0||||||
4435382|NCT00122980|4260192|B1|Yes||Prior use of Exjade (deferasirox)|Exjade (deferasirox) is a chelation treatment to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|57|57.0||||||
4435383|NCT00122980|4260190|B3|Missing||Prior use of Desferal (deferoxamine mesylate)|Desferal (deferoxamine mesylate) is a chelation therapy to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|4|4.0||||||
4435384|NCT00122980|4260191|B2|Missing||Prior use of Desferal (deferoxamine mesylate)|Desferal (deferoxamine mesylate) is a chelation therapy to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|3|3.0||||||
4435385|NCT00122980|4260192|B1|Missing||Prior use of Desferal (deferoxamine mesylate)|Desferal (deferoxamine mesylate) is a chelation therapy to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|1|1.0||||||
4435386|NCT00122980|4260190|B3|No||Prior use of Desferal (deferoxamine mesylate)|Desferal (deferoxamine mesylate) is a chelation therapy to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|38|38.0||||||
4435387|NCT00122980|4260191|B2|No||Prior use of Desferal (deferoxamine mesylate)|Desferal (deferoxamine mesylate) is a chelation therapy to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|19|19.0||||||
4435388|NCT00122980|4260192|B1|No||Prior use of Desferal (deferoxamine mesylate)|Desferal (deferoxamine mesylate) is a chelation therapy to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|19|19.0||||||
4435389|NCT00122980|4260190|B3|Yes||Prior use of Desferal (deferoxamine mesylate)|Desferal (deferoxamine mesylate) is a chelation therapy to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|91|91.0||||||
4435390|NCT00122980|4260191|B2|Yes||Prior use of Desferal (deferoxamine mesylate)|Desferal (deferoxamine mesylate) is a chelation therapy to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|44|44.0||||||
4435391|NCT00122980|4260192|B1|Yes||Prior use of Desferal (deferoxamine mesylate)|Desferal (deferoxamine mesylate) is a chelation therapy to reduce hepatic iron overload and was used in a subset of the Transfusion/Chelation treatment group of this study.|participants|Number|47|47.0||||||
4435392|NCT00122980|4260190|B3|||Duration of Transfusion|Duration of Transfusions refers to the duration of chronic transfusion therapy (either simple, partial exchange, or erythrocytapheresis)for secondary stroke prevention.|years|Mean|7.2|7.2|Standard Deviation|3.72|3.72|||
4435423|NCT00122980|4260191|B2||Asian|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|0|0.0||||||
4435394|NCT00122980|4260192|B1|||Duration of Transfusion|Duration of Transfusions refers to the duration of chronic transfusion therapy (either simple, partial exchange, or erythrocytapheresis)for secondary stroke prevention.|years|Mean|7.4|7.4|Standard Deviation|3.85|3.85|||
4435395|NCT00122980|4260190|B3|||Age at index stroke|Index Stroke is defined as an overt clinical stroke after the age of one year (12 months) with documented infarction on brain computed tomography (CT) or MRI.|years|Mean|5.9|5.9|Standard Deviation|2.87|2.87|||
4435396|NCT00122980|4260191|B2|||Age at index stroke|Index Stroke is defined as an overt clinical stroke after the age of one year (12 months) with documented infarction on brain computed tomography (CT) or MRI.|years|Mean|6.2|6.2|Standard Deviation|2.75|2.75|||
4435397|NCT00122980|4260192|B1|||Age at index stroke|Index Stroke is defined as an overt clinical stroke after the age of one year (12 months) with documented infarction on brain computed tomography (CT) or MRI.|years|Mean|5.6|5.6|Standard Deviation|2.97|2.97|||
4435398|NCT00122980|4260190|B3|No||History of splenomegaly|History of Splenomegaly is defined as participants who ever were diagnosed with splenomegaly. Splenomegaly includes hypersplenism (enlarged spleen with platelet count < 150 x 10^9/L), splenic sequestration (enlarged spleen with decrease in steady state hemoglobin of at least 2 gm/dL and/or platelet count < 150 x 10^9/L), and/or Splenomegaly without hypersplenism. Repeated dose-limiting toxicities may reflect the development of splenomegaly and hypersplenism. The size of the spleen was assessed monthly during the study|Participants|Number|95|95.0||||||
4435399|NCT00122980|4260191|B2|No||History of splenomegaly|History of Splenomegaly is defined as participants who ever were diagnosed with splenomegaly. Splenomegaly includes hypersplenism (enlarged spleen with platelet count < 150 x 10^9/L), splenic sequestration (enlarged spleen with decrease in steady state hemoglobin of at least 2 gm/dL and/or platelet count < 150 x 10^9/L), and/or Splenomegaly without hypersplenism. Repeated dose-limiting toxicities may reflect the development of splenomegaly and hypersplenism. The size of the spleen was assessed monthly during the study|Participants|Number|50|50.0||||||
4435400|NCT00122980|4260192|B1|No||History of splenomegaly|History of Splenomegaly is defined as participants who ever were diagnosed with splenomegaly. Splenomegaly includes hypersplenism (enlarged spleen with platelet count < 150 x 10^9/L), splenic sequestration (enlarged spleen with decrease in steady state hemoglobin of at least 2 gm/dL and/or platelet count < 150 x 10^9/L), and/or Splenomegaly without hypersplenism. Repeated dose-limiting toxicities may reflect the development of splenomegaly and hypersplenism. The size of the spleen was assessed monthly during the study|Participants|Number|45|45.0||||||
4435401|NCT00122980|4260190|B3|Yes||History of splenomegaly|History of Splenomegaly is defined as participants who ever were diagnosed with splenomegaly. Splenomegaly includes hypersplenism (enlarged spleen with platelet count < 150 x 10^9/L), splenic sequestration (enlarged spleen with decrease in steady state hemoglobin of at least 2 gm/dL and/or platelet count < 150 x 10^9/L), and/or Splenomegaly without hypersplenism. Repeated dose-limiting toxicities may reflect the development of splenomegaly and hypersplenism. The size of the spleen was assessed monthly during the study|Participants|Number|38|38.0||||||
4435402|NCT00122980|4260191|B2|Yes||History of splenomegaly|History of Splenomegaly is defined as participants who ever were diagnosed with splenomegaly. Splenomegaly includes hypersplenism (enlarged spleen with platelet count < 150 x 10^9/L), splenic sequestration (enlarged spleen with decrease in steady state hemoglobin of at least 2 gm/dL and/or platelet count < 150 x 10^9/L), and/or Splenomegaly without hypersplenism. Repeated dose-limiting toxicities may reflect the development of splenomegaly and hypersplenism. The size of the spleen was assessed monthly during the study|Participants|Number|16|16.0||||||
4435403|NCT00122980|4260192|B1|Yes||History of splenomegaly|History of Splenomegaly is defined as participants who ever were diagnosed with splenomegaly. Splenomegaly includes hypersplenism (enlarged spleen with platelet count < 150 x 10^9/L), splenic sequestration (enlarged spleen with decrease in steady state hemoglobin of at least 2 gm/dL and/or platelet count < 150 x 10^9/L), and/or Splenomegaly without hypersplenism. Repeated dose-limiting toxicities may reflect the development of splenomegaly and hypersplenism. The size of the spleen was assessed monthly during the study|Participants|Number|22|22.0||||||
4435404|NCT00122980|4260190|B3|United States||Region of Enrollment||participants|Number|133|133.0||||||
4435405|NCT00122980|4260191|B2|United States||Region of Enrollment||participants|Number|66|66.0||||||
4435406|NCT00122980|4260192|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4435407|NCT00122980|4260190|B3||Unknown or Not Reported|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|6|6.0||||||
4435408|NCT00122980|4260191|B2||Unknown or Not Reported|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|2|2.0||||||
4435409|NCT00122980|4260192|B1||Unknown or Not Reported|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|4|4.0||||||
4435410|NCT00122980|4260190|B3||More than one race|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|1|1.0||||||
4435411|NCT00122980|4260191|B2||More than one race|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|0|0.0||||||
4435412|NCT00122980|4260192|B1||More than one race|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|1|1.0||||||
4435413|NCT00122980|4260190|B3||White|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|0|0.0||||||
4435414|NCT00122980|4260191|B2||White|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|0|0.0||||||
4435415|NCT00122980|4260192|B1||White|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|0|0.0||||||
4435416|NCT00122980|4260190|B3||Black or African American|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|126|126.0||||||
4435417|NCT00122980|4260191|B2||Black or African American|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|64|64.0||||||
4435418|NCT00122980|4260192|B1||Black or African American|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|62|62.0||||||
4435419|NCT00122980|4260190|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|0|0.0||||||
4435420|NCT00122980|4260191|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|0|0.0||||||
4435421|NCT00122980|4260192|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|0|0.0||||||
4435422|NCT00122980|4260190|B3||Asian|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|0|0.0||||||
4435425|NCT00122980|4260190|B3||American Indian or Alaska Native|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|0|0.0||||||
4435426|NCT00122980|4260191|B2||American Indian or Alaska Native|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|0|0.0||||||
4435427|NCT00122980|4260192|B1||American Indian or Alaska Native|Race (NIH/OMB)|NIH race categories|Participants|Count of Participants|0|0.0||||||
4435428|NCT00122980|4260190|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435429|NCT00122980|4260191|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435430|NCT00122980|4260192|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435431|NCT00122980|4260190|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4435432|NCT00122980|4260191|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4435433|NCT00122980|4260192|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4435434|NCT00122980|4260190|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4435435|NCT00122980|4260191|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4435436|NCT00122980|4260192|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4435437|NCT00122980|4260190|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4435438|NCT00122980|4260191|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4435439|NCT00122980|4260192|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4435440|NCT00122980|4260190|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4435441|NCT00122980|4260191|B2||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4435442|NCT00122980|4260192|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4435443|NCT00122980|4260190|B3|||Age||years|Mean|13.1|13.1|Standard Deviation|3.89|3.89|||
4435444|NCT00122980|4260191|B2|||Age||years|Mean|13.3|13.3|Standard Deviation|3.76|3.76|||
4435445|NCT00122980|4260192|B1|||Age||years|Mean|13.0|13.0|Standard Deviation|4.05|4.05|||
4435446|NCT00122980|4260190|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4435447|NCT00122980|4260191|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4435448|NCT00122980|4260192|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4435449|NCT00122980|4260190|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4435450|NCT00122980|4260191|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4435451|NCT00122980|4260192|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4435452|NCT00122980|4260190|B3||<=18 years|Age||Participants|Count of Participants|120|120.0||||||
4435453|NCT00122980|4260191|B2||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4435454|NCT00122980|4260192|B1||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4435455|NCT00122954|4260215|B3|||Multiple sclerosis modifying therapy (MS DMT) use|MS DMT use includes: glatiramer acetate, interferon beta-1a, interferon beta-1b|Participants|Count of Participants|25|25.0||||||
4435456|NCT00122954|4260216|B2|||Multiple sclerosis modifying therapy (MS DMT) use|MS DMT use includes: glatiramer acetate, interferon beta-1a, interferon beta-1b|Participants|Count of Participants|13|13.0||||||
4435457|NCT00122954|4260217|B1|||Multiple sclerosis modifying therapy (MS DMT) use|MS DMT use includes: glatiramer acetate, interferon beta-1a, interferon beta-1b|Participants|Count of Participants|12|12.0||||||
4435458|NCT00122954|4260215|B3|||Adequate antidepressant use|Per protocol, all participants were on one antidepressant medication. Adequate antidepressant dose is defined as minimal clinical dose to two times minimal clinical dose.|Participants|Count of Participants|28|28.0||||||
4435459|NCT00122954|4260216|B2|||Adequate antidepressant use|Per protocol, all participants were on one antidepressant medication. Adequate antidepressant dose is defined as minimal clinical dose to two times minimal clinical dose.|Participants|Count of Participants|16|16.0||||||
4435460|NCT00122954|4260217|B1|||Adequate antidepressant use|Per protocol, all participants were on one antidepressant medication. Adequate antidepressant dose is defined as minimal clinical dose to two times minimal clinical dose.|Participants|Count of Participants|12|12.0||||||
4435461|NCT00122954|4260215|B3|||Docosahexaenoic Acid||% total fatty acids|Mean|4.0|4.0|Standard Deviation|1.0|1.0|||
4435462|NCT00122954|4260216|B2|||Docosahexaenoic Acid||% total fatty acids|Mean|4.0|4.0|Standard Deviation|1.0|1.0|||
4435463|NCT00122954|4260217|B1|||Docosahexaenoic Acid||% total fatty acids|Mean|3.9|3.9|Standard Deviation|1.2|1.2|||
4435464|NCT00122954|4260215|B3|||Eicosapentaenoic Acid||% total fatty acids|Mean|0.59|0.59|Standard Deviation|0.24|0.24|||
4435465|NCT00122954|4260216|B2|||Eicosapentaenoic Acid||% total fatty acids|Mean|0.58|0.58|Standard Deviation|0.2|0.2|||
4435466|NCT00122954|4260217|B1|||Eicosapentaenoic Acid||% total fatty acids|Mean|0.61|0.61|Standard Deviation|0.3|0.3|||
4435467|NCT00122954|4260215|B3|||Beck Depression Inventory (BDI)|The BDI is a 21-item self-report measure of depression, and is commonly used in MS studies. It is an easily administered measure for depression that is not clinician-depression. Scores range from 0-63 with a higher score indicating greater depression. A score > 19 indicates moderate to severe depression.|units on a scale|Mean|19.97|19.97|Standard Deviation|7.05|7.05|||
4435468|NCT00122954|4260216|B2|||Beck Depression Inventory (BDI)|The BDI is a 21-item self-report measure of depression, and is commonly used in MS studies. It is an easily administered measure for depression that is not clinician-depression. Scores range from 0-63 with a higher score indicating greater depression. A score > 19 indicates moderate to severe depression.|units on a scale|Mean|20.1|20.1|Standard Deviation|8.0|8.0|||
4435509|NCT00122681|4260226|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435510|NCT00122681|4260227|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435511|NCT00122681|4260228|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435469|NCT00122954|4260217|B1|||Beck Depression Inventory (BDI)|The BDI is a 21-item self-report measure of depression, and is commonly used in MS studies. It is an easily administered measure for depression that is not clinician-depression. Scores range from 0-63 with a higher score indicating greater depression. A score > 19 indicates moderate to severe depression.|units on a scale|Mean|19.6|19.6|Standard Deviation|5.7|5.7|||
4435470|NCT00122954|4260215|B3|||Montgomery-Asberg Depression Rating Scale (MADRS)|The MADRS is a structured interview assessment of depression, designed to be especially sensitive to changes in patients' depression symptoms after antidepressant therapy. The MADRS scale is more oriented towards psychic rather than somatic symptoms of depression. Scores between 11-30 indicate mild to moderate depression.|participants|Mean|18.75|18.75|Standard Deviation|4.82|4.82|||
4435471|NCT00122954|4260216|B2|||Montgomery-Asberg Depression Rating Scale (MADRS)|The MADRS is a structured interview assessment of depression, designed to be especially sensitive to changes in patients' depression symptoms after antidepressant therapy. The MADRS scale is more oriented towards psychic rather than somatic symptoms of depression. Scores between 11-30 indicate mild to moderate depression.|participants|Mean|18.4|18.4|Standard Deviation|5.3|5.3|||
4435472|NCT00122954|4260217|B1|||Montgomery-Asberg Depression Rating Scale (MADRS)|The MADRS is a structured interview assessment of depression, designed to be especially sensitive to changes in patients' depression symptoms after antidepressant therapy. The MADRS scale is more oriented towards psychic rather than somatic symptoms of depression. Scores between 11-30 indicate mild to moderate depression.|participants|Mean|19.1|19.1|Standard Deviation|4.0|4.0|||
4435473|NCT00122954|4260215|B3|||Expanded Disability Status Scale (EDSS)|The EDSS is an ordinal scale giving a measure of neurological impairment on a scale between 0 (normal) to 10 (dead). Patient with scores in the 0.5-4.0 range have mild disability and are able to walk at least 500 meters without aid or rest. Patients with scores > 7 cannot walk and have upper extremity dysfunction.|units on a scale|Mean|3.6|3.6|Standard Deviation|2.3|2.3|||
4435474|NCT00122954|4260216|B2|||Expanded Disability Status Scale (EDSS)|The EDSS is an ordinal scale giving a measure of neurological impairment on a scale between 0 (normal) to 10 (dead). Patient with scores in the 0.5-4.0 range have mild disability and are able to walk at least 500 meters without aid or rest. Patients with scores > 7 cannot walk and have upper extremity dysfunction.|units on a scale|Mean|3.2|3.2|Standard Deviation|2.1|2.1|||
4435475|NCT00122954|4260217|B1|||Expanded Disability Status Scale (EDSS)|The EDSS is an ordinal scale giving a measure of neurological impairment on a scale between 0 (normal) to 10 (dead). Patient with scores in the 0.5-4.0 range have mild disability and are able to walk at least 500 meters without aid or rest. Patients with scores > 7 cannot walk and have upper extremity dysfunction.|units on a scale|Mean|4.1|4.1|Standard Deviation|2.4|2.4|||
4435476|NCT00122954|4260215|B3|||Disease duration||years|Mean|17|17.0|Standard Deviation|10.42|10.42|||
4435477|NCT00122954|4260216|B2|||Disease duration||years|Mean|16.6|16.6|Standard Deviation|9.5|9.5|||
4435478|NCT00122954|4260217|B1|||Disease duration||years|Mean|17.2|17.2|Standard Deviation|10.0|10.0|||
4435479|NCT00122954|4260215|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435480|NCT00122954|4260216|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435481|NCT00122954|4260217|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435482|NCT00122954|4260215|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435483|NCT00122954|4260216|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435484|NCT00122954|4260217|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435485|NCT00122954|4260215|B3||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4435486|NCT00122954|4260216|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4435487|NCT00122954|4260217|B1||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4435488|NCT00122954|4260215|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435489|NCT00122954|4260216|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435490|NCT00122954|4260217|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435491|NCT00122954|4260215|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435492|NCT00122954|4260216|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435493|NCT00122954|4260217|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435494|NCT00122954|4260215|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435495|NCT00122954|4260216|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435496|NCT00122954|4260217|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435497|NCT00122954|4260215|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435498|NCT00122954|4260216|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435499|NCT00122954|4260217|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4435500|NCT00122954|4260215|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4435501|NCT00122954|4260216|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4435502|NCT00122954|4260217|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4435503|NCT00122954|4260215|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4435504|NCT00122954|4260216|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4435505|NCT00122954|4260217|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4435506|NCT00122954|4260215|B3|||Age||years|Mean|51.3|51.3|Standard Deviation|1.81|1.81|||
4435507|NCT00122954|4260216|B2|||Age||years|Mean|50.7|50.7|Standard Deviation|11.6|11.6|||
4435508|NCT00122954|4260217|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|10.0|10.0|||
4435512|NCT00122681|4260226|B3||Female|Sex: Female, Male||Participants|Count of Participants|18644|18644.0||||||
4435513|NCT00122681|4260227|B2||Female|Sex: Female, Male||Participants|Count of Participants|9319|9319.0||||||
4435514|NCT00122681|4260228|B1||Female|Sex: Female, Male||Participants|Count of Participants|9325|9325.0||||||
4435515|NCT00122681|4260226|B3|||Age||years|Mean|20.0|20.0|Standard Deviation|3.11|3.11|||
4435516|NCT00122681|4260227|B2|||Age||years|Mean|20.0|20.0|Standard Deviation|3.10|3.1|||
4435517|NCT00122681|4260228|B1|||Age||years|Mean|20.0|20.0|Standard Deviation|3.12|3.12|||
4435518|NCT00122460|4260301|B3|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
4435519|NCT00122460|4260302|B2|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4435520|NCT00122460|4260303|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4435521|NCT00122460|4260301|B3|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4435522|NCT00122460|4260302|B2|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4435523|NCT00122460|4260303|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4435524|NCT00122460|4260301|B3|Germany||Region of Enrollment||participants|Number|32|32.0||||||
4435525|NCT00122460|4260302|B2|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4435526|NCT00122460|4260303|B1|Germany||Region of Enrollment||participants|Number|18|18.0||||||
4435527|NCT00122460|4260301|B3|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4435528|NCT00122460|4260302|B2|Poland||Region of Enrollment||participants|Number|18|18.0||||||
4435529|NCT00122460|4260303|B1|Poland||Region of Enrollment||participants|Number|18|18.0||||||
4435530|NCT00122460|4260301|B3|Belgium||Region of Enrollment||participants|Number|30|30.0||||||
4435531|NCT00122460|4260302|B2|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4435532|NCT00122460|4260303|B1|Belgium||Region of Enrollment||participants|Number|14|14.0||||||
4435533|NCT00122460|4260301|B3|Hungary||Region of Enrollment||participants|Number|43|43.0||||||
4435534|NCT00122460|4260302|B2|Hungary||Region of Enrollment||participants|Number|24|24.0||||||
4435535|NCT00122460|4260303|B1|Hungary||Region of Enrollment||participants|Number|19|19.0||||||
4435536|NCT00122460|4260301|B3|Czech Republic||Region of Enrollment||participants|Number|9|9.0||||||
4435537|NCT00122460|4260302|B2|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4435538|NCT00122460|4260303|B1|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
4435539|NCT00122460|4260301|B3|France||Region of Enrollment||participants|Number|76|76.0||||||
4435540|NCT00122460|4260302|B2|France||Region of Enrollment||participants|Number|31|31.0||||||
4435541|NCT00122460|4260303|B1|France||Region of Enrollment||participants|Number|45|45.0||||||
4435542|NCT00122460|4260301|B3|Italy||Region of Enrollment||participants|Number|26|26.0||||||
4435543|NCT00122460|4260302|B2|Italy||Region of Enrollment||participants|Number|12|12.0||||||
4435544|NCT00122460|4260303|B1|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4435545|NCT00122460|4260301|B3|Switzerland||Region of Enrollment||participants|Number|8|8.0||||||
4435546|NCT00122460|4260302|B2|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4435547|NCT00122460|4260303|B1|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4435548|NCT00122460|4260301|B3|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4435549|NCT00122460|4260302|B2|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4435550|NCT00122460|4260303|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4435551|NCT00122460|4260301|B3|Russian Federation||Region of Enrollment||participants|Number|16|16.0||||||
4435552|NCT00122460|4260302|B2|Russian Federation||Region of Enrollment||participants|Number|7|7.0||||||
4435553|NCT00122460|4260303|B1|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4435554|NCT00122460|4260301|B3|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4435555|NCT00122460|4260302|B2|Austria||Region of Enrollment||participants|Number|10|10.0||||||
4435556|NCT00122460|4260303|B1|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4435557|NCT00122460|4260301|B3|Ukraine||Region of Enrollment||participants|Number|34|34.0||||||
4435558|NCT00122460|4260302|B2|Ukraine||Region of Enrollment||participants|Number|16|16.0||||||
4435559|NCT00122460|4260303|B1|Ukraine||Region of Enrollment||participants|Number|18|18.0||||||
4435560|NCT00122460|4260301|B3|Spain||Region of Enrollment||participants|Number|79|79.0||||||
4435561|NCT00122460|4260302|B2|Spain||Region of Enrollment||participants|Number|41|41.0||||||
4435562|NCT00122460|4260303|B1|Spain||Region of Enrollment||participants|Number|38|38.0||||||
4435563|NCT00122460|4260301|B3|Slovakia||Region of Enrollment||participants|Number|4|4.0||||||
4435564|NCT00122460|4260302|B2|Slovakia||Region of Enrollment||participants|Number|1|1.0||||||
4435565|NCT00122460|4260303|B1|Slovakia||Region of Enrollment||participants|Number|3|3.0||||||
4435566|NCT00122460|4260301|B3|Portugal||Region of Enrollment||participants|Number|9|9.0||||||
4435567|NCT00122460|4260302|B2|Portugal||Region of Enrollment||participants|Number|6|6.0||||||
4435568|NCT00122460|4260303|B1|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4435569|NCT00122460|4260301|B3||Male|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
4435570|NCT00122460|4260302|B2||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4435571|NCT00122460|4260303|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4435572|NCT00122460|4260301|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4435573|NCT00122460|4260302|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4435574|NCT00122460|4260303|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4435575|NCT00122460|4260301|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|8.3|8.3|||
4435576|NCT00122460|4260302|B2|||Age||years|Mean|56.7|56.7|Standard Deviation|8.7|8.7|||
4435577|NCT00122460|4260303|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|8.0|8.0|||
4435578|NCT00122460|4260301|B3||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
4435579|NCT00122460|4260302|B2||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4435580|NCT00122460|4260303|B1||>=65 years|Age||Participants|Count of Participants|39|39.0||||||
4435581|NCT00122460|4260301|B3||Between 18 and 65 years|Age||Participants|Count of Participants|365|365.0||||||
4435582|NCT00122460|4260302|B2||Between 18 and 65 years|Age||Participants|Count of Participants|182|182.0||||||
4435583|NCT00122460|4260303|B1||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
4435584|NCT00122460|4260301|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435585|NCT00122460|4260302|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435586|NCT00122460|4260303|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435587|NCT00122447|4260326|B5|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4435588|NCT00122447|4260327|B4|White||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4435589|NCT00122447|4260328|B3|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4435590|NCT00122447|4260329|B2|White||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4435591|NCT00122447|4260330|B1|White||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4435592|NCT00122447|4260326|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4435593|NCT00122447|4260327|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4435594|NCT00122447|4260328|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4435595|NCT00122447|4260329|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4435596|NCT00122447|4260330|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4435597|NCT00122447|4260326|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4435598|NCT00122447|4260327|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4435599|NCT00122447|4260328|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4435600|NCT00122447|4260329|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4435601|NCT00122447|4260330|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4435602|NCT00122447|4260326|B5||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4435603|NCT00122447|4260327|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4435604|NCT00122447|4260328|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4435605|NCT00122447|4260329|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4435606|NCT00122447|4260330|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4435607|NCT00122447|4260326|B5|||Age||years|Mean|52.6|52.6|Standard Deviation|10.2|10.2|||
4435608|NCT00122447|4260327|B4|||Age||years|Mean|51.3|51.3|Standard Deviation|11.7|11.7|||
4435609|NCT00122447|4260328|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|7.0|7.0|||
4435610|NCT00122447|4260329|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|8.5|8.5|||
4435611|NCT00122447|4260330|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|12.8|12.8|||
4435612|NCT00122382|4260351|B3|||Total Genant-modified Sharp score|To assess joint damage progression, the Genant-modified Sharp scoring method was used to evaluate radiographs of hands/wrists and feet for erosions and JSN. The total Genant-modified Sharp score ranges from 0 (no radiographic damage) to 290 (worst possible radiographic damage) and is the sum of the erosion score (range 0-145) and the joint space narrowing score (range 0-145). Higher scores indicated more damage. 3 participants in the abatacept group were not included in the measure.|units on a scale|Mean|7.1|7.1|Standard Deviation|9.2|9.2|||
4435613|NCT00122382|4260352|B2|||Total Genant-modified Sharp score|To assess joint damage progression, the Genant-modified Sharp scoring method was used to evaluate radiographs of hands/wrists and feet for erosions and JSN. The total Genant-modified Sharp score ranges from 0 (no radiographic damage) to 290 (worst possible radiographic damage) and is the sum of the erosion score (range 0-145) and the joint space narrowing score (range 0-145). Higher scores indicated more damage. 3 participants in the abatacept group were not included in the measure.|units on a scale|Mean|6.7|6.7|Standard Deviation|8.8|8.8|||
4435614|NCT00122382|4260353|B1|||Total Genant-modified Sharp score|To assess joint damage progression, the Genant-modified Sharp scoring method was used to evaluate radiographs of hands/wrists and feet for erosions and JSN. The total Genant-modified Sharp score ranges from 0 (no radiographic damage) to 290 (worst possible radiographic damage) and is the sum of the erosion score (range 0-145) and the joint space narrowing score (range 0-145). Higher scores indicated more damage. 3 participants in the abatacept group were not included in the measure.|units on a scale|Mean|7.5|7.5|Standard Deviation|9.7|9.7|||
4435615|NCT00122382|4260351|B3|||Tender Joints|Total number of joints analyzed=68|number of tender joints|Mean|31.0|31.0|Standard Deviation|14.4|14.4|||
4435616|NCT00122382|4260352|B2|||Tender Joints|Total number of joints analyzed=68|number of tender joints|Mean|30.8|30.8|Standard Deviation|14.0|14.0|||
4435617|NCT00122382|4260353|B1|||Tender Joints|Total number of joints analyzed=68|number of tender joints|Mean|31.3|31.3|Standard Deviation|14.8|14.8|||
4435618|NCT00122382|4260351|B3|||Swollen Joints|Total number of joints analyzed=66|number of swollen joints|Mean|22.4|22.4|Standard Deviation|10.8|10.8|||
4435619|NCT00122382|4260352|B2|||Swollen Joints|Total number of joints analyzed=66|number of swollen joints|Mean|21.9|21.9|Standard Deviation|10.1|10.1|||
4435620|NCT00122382|4260353|B1|||Swollen Joints|Total number of joints analyzed=66|number of swollen joints|Mean|22.9|22.9|Standard Deviation|11.3|11.3|||
4435653|NCT00122382|4260353|B1|unknown||Rheumatoid Factor (RF) Status|Rheumatoid Factor is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 IU/mL (>/= 15 IU/mL resulted in a positive result).|participants|Number|1|1.0||||||
4435621|NCT00122382|4260351|B3|||Subject Pain Assessment per VAS|Subject Pain Assessment measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower value signifies a better subject pain assessment. 1 participant in the Placebo group was not evaluated for this measure.|mm|Mean|66.8|66.8|Standard Deviation|22.5|22.5|||
4435622|NCT00122382|4260352|B2|||Subject Pain Assessment per VAS|Subject Pain Assessment measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower value signifies a better subject pain assessment. 1 participant in the Placebo group was not evaluated for this measure.|mm|Mean|67.1|67.1|Standard Deviation|22.6|22.6|||
4435623|NCT00122382|4260353|B1|||Subject Pain Assessment per VAS|Subject Pain Assessment measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower value signifies a better subject pain assessment. 1 participant in the Placebo group was not evaluated for this measure.|mm|Mean|66.6|66.6|Standard Deviation|22.5|22.5|||
4435624|NCT00122382|4260351|B3|||Subject Global Assessment per VAS|Subject Global Assessment is measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower score indicates a better Subject Assessment of Global Health. 1 participant in the Placebo group was not evaluated for this measure.|mm|Mean|64.8|64.8|Standard Deviation|22.9|22.9|||
4435625|NCT00122382|4260352|B2|||Subject Global Assessment per VAS|Subject Global Assessment is measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower score indicates a better Subject Assessment of Global Health. 1 participant in the Placebo group was not evaluated for this measure.|mm|Mean|63.7|63.7|Standard Deviation|24.0|24.0|||
4435626|NCT00122382|4260353|B1|||Subject Global Assessment per VAS|Subject Global Assessment is measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower score indicates a better Subject Assessment of Global Health. 1 participant in the Placebo group was not evaluated for this measure.|mm|Mean|65.8|65.8|Standard Deviation|21.8|21.8|||
4435627|NCT00122382|4260351|B3|||Physician Global Assessment per Visual Analogue Scale (VAS)|Physician Global Assessment is measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower score indicates a better Physician Assessment of Global Health. 1 participant in the abatacept group was not evaluated for this measure.|mm|Mean|66.4|66.4|Standard Deviation|18.5|18.5|||
4435628|NCT00122382|4260352|B2|||Physician Global Assessment per Visual Analogue Scale (VAS)|Physician Global Assessment is measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower score indicates a better Physician Assessment of Global Health. 1 participant in the abatacept group was not evaluated for this measure.|mm|Mean|65.7|65.7|Standard Deviation|18.9|18.9|||
4435629|NCT00122382|4260353|B1|||Physician Global Assessment per Visual Analogue Scale (VAS)|Physician Global Assessment is measured by VAS (100 mm). A Visual Analogue Scale (VAS) is a measurement instrument for characteristics that range across a continuum of values. Range is 1-100; a lower score indicates a better Physician Assessment of Global Health. 1 participant in the abatacept group was not evaluated for this measure.|mm|Mean|67.1|67.1|Standard Deviation|18.2|18.2|||
4435630|NCT00122382|4260351|B3|||Joint Space Narrowing (JSN) Score|To assess joint damage progression, the Genant-modified Sharp scoring method was used to evaluate radiographs of hands/wrists and feet for erosions and JSN. The joint space narrowing score range is 0 (no radiographic damage) to 145 (worst possible radiographic damage). Higher scores indicated more damage. 3 participants in the abatacept group were not included in the measure.|units on a scale|Mean|2.0|2.0|Standard Deviation|4.1|4.1|||
4435631|NCT00122382|4260352|B2|||Joint Space Narrowing (JSN) Score|To assess joint damage progression, the Genant-modified Sharp scoring method was used to evaluate radiographs of hands/wrists and feet for erosions and JSN. The joint space narrowing score range is 0 (no radiographic damage) to 145 (worst possible radiographic damage). Higher scores indicated more damage. 3 participants in the abatacept group were not included in the measure.|units on a scale|Mean|1.9|1.9|Standard Deviation|4.0|4.0|||
4435632|NCT00122382|4260353|B1|||Joint Space Narrowing (JSN) Score|To assess joint damage progression, the Genant-modified Sharp scoring method was used to evaluate radiographs of hands/wrists and feet for erosions and JSN. The joint space narrowing score range is 0 (no radiographic damage) to 145 (worst possible radiographic damage). Higher scores indicated more damage. 3 participants in the abatacept group were not included in the measure.|units on a scale|Mean|2.1|2.1|Standard Deviation|4.2|4.2|||
4435633|NCT00122382|4260351|B3|||Health Assessment Questionnaire - Disability Index (HAQ-DI)|HAQ-DI=self-reported measure of physical function calculated as a mean of 8 category scores: Dressing/Grooming, Rising, Eating, Walking, Hygiene, Reach, Grip, Activities. Each category score is calculated as the maximum of the scores for the questions within the category. HAQ-DI is expressed on a scale of 0 (without any difficulty) to 3 (unable to do) representing an average score across the category. Scores for at least 6 categories are needed to compute HAQ score. Changes to lower scores=improvement in physical function. 2 participants in the abatacept and placebo groups were not evaluated.|units on a scale|Mean|1.7|1.7|Standard Deviation|0.7|0.7|||
4435634|NCT00122382|4260352|B2|||Health Assessment Questionnaire - Disability Index (HAQ-DI)|HAQ-DI=self-reported measure of physical function calculated as a mean of 8 category scores: Dressing/Grooming, Rising, Eating, Walking, Hygiene, Reach, Grip, Activities. Each category score is calculated as the maximum of the scores for the questions within the category. HAQ-DI is expressed on a scale of 0 (without any difficulty) to 3 (unable to do) representing an average score across the category. Scores for at least 6 categories are needed to compute HAQ score. Changes to lower scores=improvement in physical function. 2 participants in the abatacept and placebo groups were not evaluated.|units on a scale|Mean|1.7|1.7|Standard Deviation|0.7|0.7|||
4435654|NCT00122382|4260351|B3|> 12 months||Duration of Rheumatoid Arthritis (RA) Disease||participants|Number|115|115.0||||||
4435655|NCT00122382|4260352|B2|> 12 months||Duration of Rheumatoid Arthritis (RA) Disease||participants|Number|62|62.0||||||
4435656|NCT00122382|4260353|B1|> 12 months||Duration of Rheumatoid Arthritis (RA) Disease||participants|Number|53|53.0||||||
4435635|NCT00122382|4260353|B1|||Health Assessment Questionnaire - Disability Index (HAQ-DI)|HAQ-DI=self-reported measure of physical function calculated as a mean of 8 category scores: Dressing/Grooming, Rising, Eating, Walking, Hygiene, Reach, Grip, Activities. Each category score is calculated as the maximum of the scores for the questions within the category. HAQ-DI is expressed on a scale of 0 (without any difficulty) to 3 (unable to do) representing an average score across the category. Scores for at least 6 categories are needed to compute HAQ score. Changes to lower scores=improvement in physical function. 2 participants in the abatacept and placebo groups were not evaluated.|units on a scale|Mean|1.7|1.7|Standard Deviation|0.7|0.7|||
4435636|NCT00122382|4260351|B3|||Erosion Score|To assess joint damage progression, the Genant-modified Sharp scoring method was used to evaluate radiographs of hands/wrists and feet for erosions and JSN. The erosion score range is 0 (no radiographic damage) to 145 (worst possible radiographic damage). Higher scores indicated more damage. 3 participants in the abatacept group were not included in the measure.|units on a scale|Mean|5.1|5.1|Standard Deviation|5.8|5.8|||
4435637|NCT00122382|4260352|B2|||Erosion Score|To assess joint damage progression, the Genant-modified Sharp scoring method was used to evaluate radiographs of hands/wrists and feet for erosions and JSN. The erosion score range is 0 (no radiographic damage) to 145 (worst possible radiographic damage). Higher scores indicated more damage. 3 participants in the abatacept group were not included in the measure.|units on a scale|Mean|4.8|4.8|Standard Deviation|5.4|5.4|||
4435638|NCT00122382|4260353|B1|||Erosion Score|To assess joint damage progression, the Genant-modified Sharp scoring method was used to evaluate radiographs of hands/wrists and feet for erosions and JSN. The erosion score range is 0 (no radiographic damage) to 145 (worst possible radiographic damage). Higher scores indicated more damage. 3 participants in the abatacept group were not included in the measure.|units on a scale|Mean|5.4|5.4|Standard Deviation|6.1|6.1|||
4435639|NCT00122382|4260351|B3|||Duration of RA||months|Mean|6.5|6.5|Standard Deviation|7.3|7.3|||
4435640|NCT00122382|4260352|B2|||Duration of RA||months|Mean|6.7|6.7|Standard Deviation|7.1|7.1|||
4435641|NCT00122382|4260353|B1|||Duration of RA||months|Mean|6.2|6.2|Standard Deviation|7.5|7.5|||
4435642|NCT00122382|4260351|B3|||Disease Activity Scale 28 (DAS 28) C-reactive Protein (CRP)|DAS 28-CRP=continuous composite of 4 variables: number of tender joints out of 28, number of swollen joints out of 28, CRP in milligrams/Liter (mg/L), and subject assessment of disease activity measured on a Visual Analogue Scale (VAS) of 100 millimeters (mm). Current disease activity is presented on a scale of 0 to 10, with a score above 5.1=high disease activity and below 3.2=low disease activity. VAS=a measurement instrument for characteristics that range across a continuum of values. Range is 1 to 100; a lower value signifies improvement. 1 participant in Placebo group was not evaluated.|units on a scale|Mean|6.3|6.3|Standard Deviation|1.0|1.0|||
4435643|NCT00122382|4260352|B2|||Disease Activity Scale 28 (DAS 28) C-reactive Protein (CRP)|DAS 28-CRP=continuous composite of 4 variables: number of tender joints out of 28, number of swollen joints out of 28, CRP in milligrams/Liter (mg/L), and subject assessment of disease activity measured on a Visual Analogue Scale (VAS) of 100 millimeters (mm). Current disease activity is presented on a scale of 0 to 10, with a score above 5.1=high disease activity and below 3.2=low disease activity. VAS=a measurement instrument for characteristics that range across a continuum of values. Range is 1 to 100; a lower value signifies improvement. 1 participant in Placebo group was not evaluated.|units on a scale|Mean|6.2|6.2|Standard Deviation|1.0|1.0|||
4435644|NCT00122382|4260353|B1|||Disease Activity Scale 28 (DAS 28) C-reactive Protein (CRP)|DAS 28-CRP=continuous composite of 4 variables: number of tender joints out of 28, number of swollen joints out of 28, CRP in milligrams/Liter (mg/L), and subject assessment of disease activity measured on a Visual Analogue Scale (VAS) of 100 millimeters (mm). Current disease activity is presented on a scale of 0 to 10, with a score above 5.1=high disease activity and below 3.2=low disease activity. VAS=a measurement instrument for characteristics that range across a continuum of values. Range is 1 to 100; a lower value signifies improvement. 1 participant in Placebo group was not evaluated.|units on a scale|Mean|6.3|6.3|Standard Deviation|1.0|1.0|||
4435645|NCT00122382|4260351|B3|negative||Rheumatoid Factor (RF) Status|Rheumatoid Factor is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 IU/mL (>/= 15 IU/mL resulted in a positive result).|participants|Number|16|16.0||||||
4435646|NCT00122382|4260352|B2|negative||Rheumatoid Factor (RF) Status|Rheumatoid Factor is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 IU/mL (>/= 15 IU/mL resulted in a positive result).|participants|Number|7|7.0||||||
4435647|NCT00122382|4260353|B1|negative||Rheumatoid Factor (RF) Status|Rheumatoid Factor is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 IU/mL (>/= 15 IU/mL resulted in a positive result).|participants|Number|9|9.0||||||
4435648|NCT00122382|4260351|B3|positive||Rheumatoid Factor (RF) Status|Rheumatoid Factor is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 IU/mL (>/= 15 IU/mL resulted in a positive result).|participants|Number|491|491.0||||||
4435649|NCT00122382|4260352|B2|positive||Rheumatoid Factor (RF) Status|Rheumatoid Factor is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 IU/mL (>/= 15 IU/mL resulted in a positive result).|participants|Number|245|245.0||||||
4435650|NCT00122382|4260353|B1|positive||Rheumatoid Factor (RF) Status|Rheumatoid Factor is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 IU/mL (>/= 15 IU/mL resulted in a positive result).|participants|Number|246|246.0||||||
4435651|NCT00122382|4260351|B3|unknown||Rheumatoid Factor (RF) Status|Rheumatoid Factor is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 IU/mL (>/= 15 IU/mL resulted in a positive result).|participants|Number|2|2.0||||||
4435652|NCT00122382|4260352|B2|unknown||Rheumatoid Factor (RF) Status|Rheumatoid Factor is an autoantibody that is usually present in the serum of people with rheumatoid arthritis. The cut-point value for seroconversion was 15 IU/mL (>/= 15 IU/mL resulted in a positive result).|participants|Number|1|1.0||||||
4435657|NCT00122382|4260351|B3|> 6 months - 12 months||Duration of Rheumatoid Arthritis (RA) Disease||participants|Number|70|70.0||||||
4435759|NCT00122109|4260541|B3|United States||Region of Enrollment||participants|Number|125|125.0||||||
4435658|NCT00122382|4260352|B2|> 6 months - 12 months||Duration of Rheumatoid Arthritis (RA) Disease||participants|Number|34|34.0||||||
4435659|NCT00122382|4260353|B1|> 6 months - 12 months||Duration of Rheumatoid Arthritis (RA) Disease||participants|Number|36|36.0||||||
4435660|NCT00122382|4260351|B3|</= 6 months||Duration of Rheumatoid Arthritis (RA) Disease||participants|Number|324|324.0||||||
4435661|NCT00122382|4260352|B2|</= 6 months||Duration of Rheumatoid Arthritis (RA) Disease||participants|Number|157|157.0||||||
4435662|NCT00122382|4260353|B1|</= 6 months||Duration of Rheumatoid Arthritis (RA) Disease||participants|Number|167|167.0||||||
4435663|NCT00122382|4260351|B3|negative||Anti-Cyclic Citrullinated Peptide 2 (CCP2) Status|Anti-CCP2 antibodies are autoantibodies that react with citrullinated proteins, are frequent in Rheumatoid Arthritis and are associated with erosive disease. > 5 units/mL is a positive result.|participants|Number|54|54.0||||||
4435664|NCT00122382|4260352|B2|negative||Anti-Cyclic Citrullinated Peptide 2 (CCP2) Status|Anti-CCP2 antibodies are autoantibodies that react with citrullinated proteins, are frequent in Rheumatoid Arthritis and are associated with erosive disease. > 5 units/mL is a positive result.|participants|Number|36|36.0||||||
4435665|NCT00122382|4260353|B1|negative||Anti-Cyclic Citrullinated Peptide 2 (CCP2) Status|Anti-CCP2 antibodies are autoantibodies that react with citrullinated proteins, are frequent in Rheumatoid Arthritis and are associated with erosive disease. > 5 units/mL is a positive result.|participants|Number|18|18.0||||||
4435666|NCT00122382|4260351|B3|positive||Anti-Cyclic Citrullinated Peptide 2 (CCP2) Status|Anti-CCP2 antibodies are autoantibodies that react with citrullinated proteins, are frequent in Rheumatoid Arthritis and are associated with erosive disease. > 5 units/mL is a positive result.|participants|Number|453|453.0||||||
4435667|NCT00122382|4260352|B2|positive||Anti-Cyclic Citrullinated Peptide 2 (CCP2) Status|Anti-CCP2 antibodies are autoantibodies that react with citrullinated proteins, are frequent in Rheumatoid Arthritis and are associated with erosive disease. > 5 units/mL is a positive result.|participants|Number|217|217.0||||||
4435668|NCT00122382|4260353|B1|positive||Anti-Cyclic Citrullinated Peptide 2 (CCP2) Status|Anti-CCP2 antibodies are autoantibodies that react with citrullinated proteins, are frequent in Rheumatoid Arthritis and are associated with erosive disease. > 5 units/mL is a positive result.|participants|Number|236|236.0||||||
4435669|NCT00122382|4260351|B3|unknown||Anti-Cyclic Citrullinated Peptide 2 (CCP2) Status|Anti-CCP2 antibodies are autoantibodies that react with citrullinated proteins, are frequent in Rheumatoid Arthritis and are associated with erosive disease. > 5 units/mL is a positive result.|participants|Number|2|2.0||||||
4435670|NCT00122382|4260352|B2|unknown||Anti-Cyclic Citrullinated Peptide 2 (CCP2) Status|Anti-CCP2 antibodies are autoantibodies that react with citrullinated proteins, are frequent in Rheumatoid Arthritis and are associated with erosive disease. > 5 units/mL is a positive result.|participants|Number|0|0.0||||||
4435671|NCT00122382|4260353|B1|unknown||Anti-Cyclic Citrullinated Peptide 2 (CCP2) Status|Anti-CCP2 antibodies are autoantibodies that react with citrullinated proteins, are frequent in Rheumatoid Arthritis and are associated with erosive disease. > 5 units/mL is a positive result.|participants|Number|2|2.0||||||
4435672|NCT00122382|4260351|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4435673|NCT00122382|4260352|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4435674|NCT00122382|4260353|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4435675|NCT00122382|4260351|B3||Female|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4435676|NCT00122382|4260352|B2||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4435677|NCT00122382|4260353|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4435678|NCT00122382|4260351|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|12.7|12.7|||
4435679|NCT00122382|4260352|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|13.0|13.0|||
4435680|NCT00122382|4260353|B1|||Age||years|Mean|50.1|50.1|Standard Deviation|12.4|12.4|||
4435681|NCT00122369|4260405|B4|United States||Region of Enrollment||participants|Number|236|236.0||||||
4435682|NCT00122369|4260406|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
4435683|NCT00122369|4260407|B2|United States||Region of Enrollment||participants|Number|82|82.0||||||
4435684|NCT00122369|4260408|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4435685|NCT00122369|4260405|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435686|NCT00122369|4260406|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435687|NCT00122369|4260407|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435688|NCT00122369|4260408|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435689|NCT00122369|4260405|B4||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4435690|NCT00122369|4260406|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4435691|NCT00122369|4260407|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4435692|NCT00122369|4260408|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4435693|NCT00122369|4260405|B4|||Age||years|Mean|48.3|48.3|Standard Deviation|13.4|13.4|||
4435694|NCT00122369|4260406|B3|||Age||years|Mean|47.8|47.8|Standard Deviation|13.7|13.7|||
4435695|NCT00122369|4260407|B2|||Age||years|Mean|48.0|48.0|Standard Deviation|13.22|13.22|||
4435696|NCT00122369|4260408|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|13.4|13.4|||
4435697|NCT00122369|4260405|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4435698|NCT00122369|4260406|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4435699|NCT00122369|4260407|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4435700|NCT00122369|4260408|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4435701|NCT00122369|4260405|B4||Between 18 and 65 years|Age||Participants|Count of Participants|216|216.0||||||
4435702|NCT00122369|4260406|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4435703|NCT00122369|4260407|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4435704|NCT00122369|4260408|B1||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4435705|NCT00122369|4260405|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435706|NCT00122369|4260406|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435707|NCT00122369|4260407|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435708|NCT00122369|4260408|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435709|NCT00122317|4260499|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4435710|NCT00122317|4260499|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|168|168.0||||||
4435711|NCT00122317|4260499|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4435712|NCT00122317|4260499|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4435713|NCT00122317|4260499|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4435714|NCT00122317|4260499|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4435715|NCT00122317|4260499|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|14.1|14.1|||
4435716|NCT00122278|4260506|B3|||Duration of headache Prior to Study||hours|Median|48|48.0|Inter-Quartile Range|||12.0|72.0|
4435717|NCT00122278|4260507|B2|||Duration of headache Prior to Study||hours|Median|48|48.0|Inter-Quartile Range|||12.0|72.0|
4435718|NCT00122278|4260508|B1|||Duration of headache Prior to Study||hours|Median|48|48.0|Inter-Quartile Range|||19.0|72.0|
4435719|NCT00122278|4260506|B3|United States||Region of Enrollment||Participants|Count of Participants|205|205.0||||||
4435720|NCT00122278|4260507|B2|United States||Region of Enrollment||Participants|Count of Participants|99|99.0||||||
4435721|NCT00122278|4260508|B1|United States||Region of Enrollment||Participants|Count of Participants|106|106.0||||||
4435722|NCT00122278|4260506|B3|||Race and Ethnicity Not Collected||Participants|Count of Participants|0|0.0||||||
4435723|NCT00122278|4260506|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4435724|NCT00122278|4260507|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4435725|NCT00122278|4260508|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4435726|NCT00122278|4260506|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4435727|NCT00122278|4260507|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4435728|NCT00122278|4260508|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4435729|NCT00122278|4260506|B3|||Age||years|Mean|37|37.0|Standard Deviation|10|10.0|||
4435730|NCT00122278|4260507|B2|||Age||years|Mean|37|37.0|Standard Deviation|11|11.0|||
4435731|NCT00122278|4260508|B1|||Age||years|Mean|36|36.0|Standard Deviation|10|10.0|||
4435732|NCT00122187|4260517|B3|Not collected||Sex/Gender, Customized|Participants in this study were VAMCs rather than human subjects. Gender of participants was not collected because it was not applicable.|participants|Number|8|8.0||||||
4435733|NCT00122187|4260518|B2|Not collected||Sex/Gender, Customized|Participants in this study were VAMCs rather than human subjects. Gender of participants was not collected because it was not applicable.|participants|Number|4|4.0||||||
4435734|NCT00122187|4260519|B1|Not collected||Sex/Gender, Customized|Participants in this study were VAMCs rather than human subjects. Gender of participants was not collected because it was not applicable.|participants|Number|4|4.0||||||
4435735|NCT00122187|4260517|B3|Not collected||Age, Customized|Participants in this study were VAMCs rather than human subjects. Age of participants was not collected because it was not applicable.|participants|Number|8|8.0||||||
4435736|NCT00122187|4260518|B2|Not collected||Age, Customized|Participants in this study were VAMCs rather than human subjects. Age of participants was not collected because it was not applicable.|participants|Number|4|4.0||||||
4435737|NCT00122187|4260519|B1|Not collected||Age, Customized|Participants in this study were VAMCs rather than human subjects. Age of participants was not collected because it was not applicable.|participants|Number|4|4.0||||||
4435738|NCT00122135|4260532|B3|United States||Region of Enrollment||participants|Number|120|120.0||||||
4435739|NCT00122135|4260533|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4435740|NCT00122135|4260534|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4435741|NCT00122135|4260532|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4435742|NCT00122135|4260533|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4435743|NCT00122135|4260534|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4435744|NCT00122135|4260532|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435745|NCT00122135|4260533|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435746|NCT00122135|4260534|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435747|NCT00122135|4260532|B3|||Age||years|Mean|67.4|67.4|Full Range|||55.0|85.0|
4435748|NCT00122135|4260533|B2|||Age||years|Mean|68.4|68.4|Full Range|||56.0|84.0|
4435749|NCT00122135|4260534|B1|||Age||years|Mean|66.4|66.4|Full Range|||55.0|85.0|
4435750|NCT00122135|4260532|B3||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4435751|NCT00122135|4260533|B2||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4435752|NCT00122135|4260534|B1||>=65 years|Age||Participants|Count of Participants|30|30.0||||||
4435753|NCT00122135|4260532|B3||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4435754|NCT00122135|4260533|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4435755|NCT00122135|4260534|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4435756|NCT00122135|4260532|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435757|NCT00122135|4260533|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435758|NCT00122135|4260534|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4435760|NCT00122109|4260542|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4435761|NCT00122109|4260543|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4435762|NCT00122109|4260541|B3||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4435763|NCT00122109|4260542|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4435764|NCT00122109|4260543|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4435765|NCT00122109|4260541|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435766|NCT00122109|4260542|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435767|NCT00122109|4260543|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435768|NCT00122109|4260541|B3|||Age||years|Mean|54.7|54.7|Full Range|||22.0|80.0|
4435769|NCT00122109|4260542|B2|||Age||years|Mean|54.6|54.6|Full Range|||22.0|75.0|
4435770|NCT00122109|4260543|B1|||Age||years|Mean|54.8|54.8|Full Range|||24.0|80.0|
4435771|NCT00121836|4260568|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435772|NCT00121836|4260568|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4435773|NCT00121836|4260568|B1|||Age||Years|Mean|56.7|56.7|Standard Deviation|12.03|12.03|||
4435774|NCT00121810|4260577|B3||Male|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|189|189.0||||||
4435775|NCT00121810|4260578|B2||Male|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|96|96.0||||||
4435776|NCT00121810|4260579|B1||Male|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|93|93.0||||||
4435777|NCT00121810|4260577|B3||Female|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|110|110.0||||||
4435778|NCT00121810|4260578|B2||Female|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|55|55.0||||||
4435779|NCT00121810|4260579|B1||Female|Sex: Female, Male|Intent-to-treat population|Participants|Count of Participants|55|55.0||||||
4435780|NCT00121810|4260577|B3|||Age|Intent-to-treat population|years|Mean|48.7|48.7|Standard Deviation|12.80|12.8|||
4435781|NCT00121810|4260578|B2|||Age|Intent-to-treat population|years|Mean|48.7|48.7|Standard Deviation|12.70|12.7|||
4435782|NCT00121810|4260579|B1|||Age|Intent-to-treat population|years|Mean|48.7|48.7|Standard Deviation|12.90|12.9|||
4435783|NCT00121719|4260594|B15||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4435784|NCT00121719|4260595|B14||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4435785|NCT00121719|4260596|B13||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4435786|NCT00121719|4260597|B12||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4435787|NCT00121719|4260598|B11||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4435788|NCT00121719|4260599|B10||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4435789|NCT00121719|4260600|B9||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4435790|NCT00121719|4260601|B8||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4435791|NCT00121719|4260602|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4435792|NCT00121719|4260603|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4435793|NCT00121719|4260604|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4435794|NCT00121719|4260605|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4435795|NCT00121719|4260606|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4435796|NCT00121719|4260607|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4435797|NCT00121719|4260608|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4435798|NCT00121719|4260594|B15||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4435799|NCT00121719|4260595|B14||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4435800|NCT00121719|4260596|B13||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4435801|NCT00121719|4260597|B12||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4435802|NCT00121719|4260598|B11||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4435803|NCT00121719|4260599|B10||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435804|NCT00121719|4260600|B9||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4435805|NCT00121719|4260601|B8||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4435806|NCT00121719|4260602|B7||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4435807|NCT00121719|4260603|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4435808|NCT00121719|4260604|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4435809|NCT00121719|4260605|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4435810|NCT00121719|4260606|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4435811|NCT00121719|4260607|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4435812|NCT00121719|4260608|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4435813|NCT00121719|4260594|B15|||Age||Years|Mean|53.4|53.4|Standard Deviation|12.32|12.32|||
4435814|NCT00121719|4260595|B14|||Age||Years|Mean|53.9|53.9|Standard Deviation|11.84|11.84|||
4435815|NCT00121719|4260596|B13|||Age||Years|Mean|52.2|52.2|Standard Deviation|9.65|9.65|||
4435816|NCT00121719|4260597|B12|||Age||Years|Mean|49.4|49.4|Standard Deviation|11.06|11.06|||
4435817|NCT00121719|4260598|B11|||Age||Years|Mean|52.3|52.3|Standard Deviation|9.99|9.99|||
4435818|NCT00121719|4260599|B10|||Age||Years|Mean|51.7|51.7|Standard Deviation|12.34|12.34|||
4435819|NCT00121719|4260600|B9|||Age||Years|Mean|55.7|55.7|Standard Deviation|13.32|13.32|||
4435820|NCT00121719|4260601|B8|||Age||Years|Mean|52.6|52.6|Standard Deviation|13.28|13.28|||
4435821|NCT00121719|4260602|B7|||Age||Years|Mean|46.3|46.3|Standard Deviation|13.25|13.25|||
4435822|NCT00121719|4260603|B6|||Age||Years|Mean|51.0|51.0|Standard Deviation|22.72|22.72|||
4435823|NCT00121719|4260604|B5|||Age||Years|Mean|65.0|65.0|Standard Deviation|19.00|19.0|||
4435824|NCT00121719|4260605|B4|||Age||Years|Mean|60.0|60.0|Standard Deviation|11.53|11.53|||
4435825|NCT00121719|4260606|B3|||Age||Years|Mean|64.0|64.0|Standard Deviation|6.48|6.48|||
4435826|NCT00121719|4260607|B2|||Age||Years|Mean|47.8|47.8|Standard Deviation|6.45|6.45|||
4435827|NCT00121719|4260608|B1|||Age||Years|Mean|64.5|64.5|Standard Deviation|7.94|7.94|||
4435828|NCT00121667|4260794|B5|>= 30||Body Mass Index Categorization||Participants|Number|426|426.0||||||
4435829|NCT00121667|4260795|B4|>= 30||Body Mass Index Categorization||Participants|Number|103|103.0||||||
4435830|NCT00121667|4260796|B3|>= 30||Body Mass Index Categorization||Participants|Number|99|99.0||||||
4435831|NCT00121667|4260797|B2|>= 30||Body Mass Index Categorization||Participants|Number|107|107.0||||||
4435832|NCT00121667|4260798|B1|>= 30||Body Mass Index Categorization||Participants|Number|117|117.0||||||
4435833|NCT00121667|4260794|B5|< 30||Body Mass Index Categorization||Participants|Number|317|317.0||||||
4435834|NCT00121667|4260795|B4|< 30||Body Mass Index Categorization||Participants|Number|76|76.0||||||
4435835|NCT00121667|4260796|B3|< 30||Body Mass Index Categorization||Participants|Number|82|82.0||||||
4435836|NCT00121667|4260797|B2|< 30||Body Mass Index Categorization||Participants|Number|84|84.0||||||
4435837|NCT00121667|4260798|B1|< 30||Body Mass Index Categorization||Participants|Number|75|75.0||||||
4435838|NCT00121667|4260794|B5|||Body Mass Index||kg/m^2|Mean|31.40|31.4|Standard Deviation|4.85|4.85|||
4435839|NCT00121667|4260795|B4|||Body Mass Index||kg/m^2|Mean|31.57|31.57|Standard Deviation|4.80|4.8|||
4435840|NCT00121667|4260796|B3|||Body Mass Index||kg/m^2|Mean|31.12|31.12|Standard Deviation|4.79|4.79|||
4435841|NCT00121667|4260797|B2|||Body Mass Index||kg/m^2|Mean|31.23|31.23|Standard Deviation|4.67|4.67|||
4435842|NCT00121667|4260798|B1|||Body Mass Index||kg/m^2|Mean|31.68|31.68|Standard Deviation|5.15|5.15|||
4435843|NCT00121667|4260794|B5|||Weight||kg|Mean|87.04|87.04|Standard Deviation|17.79|17.79|||
4435844|NCT00121667|4260795|B4|||Weight||kg|Mean|87.14|87.14|Standard Deviation|17.75|17.75|||
4435845|NCT00121667|4260796|B3|||Weight||kg|Mean|87.83|87.83|Standard Deviation|18.90|18.9|||
4435846|NCT00121667|4260797|B2|||Weight||kg|Mean|87.26|87.26|Standard Deviation|17.04|17.04|||
4435847|NCT00121667|4260798|B1|||Weight||kg|Mean|85.97|85.97|Standard Deviation|17.57|17.57|||
4435848|NCT00121667|4260794|B5|> 50 years||Age Characterization Female Only||participants|Number|254|254.0||||||
4435849|NCT00121667|4260795|B4|> 50 years||Age Characterization Female Only||participants|Number|62|62.0||||||
4435850|NCT00121667|4260796|B3|> 50 years||Age Characterization Female Only||participants|Number|62|62.0||||||
4435851|NCT00121667|4260797|B2|> 50 years||Age Characterization Female Only||participants|Number|54|54.0||||||
4435852|NCT00121667|4260798|B1|> 50 years||Age Characterization Female Only||participants|Number|76|76.0||||||
4435853|NCT00121667|4260794|B5|=< 50 years||Age Characterization Female Only||participants|Number|112|112.0||||||
4435854|NCT00121667|4260795|B4|=< 50 years||Age Characterization Female Only||participants|Number|21|21.0||||||
4435855|NCT00121667|4260796|B3|=< 50 years||Age Characterization Female Only||participants|Number|24|24.0||||||
4435856|NCT00121667|4260797|B2|=< 50 years||Age Characterization Female Only||participants|Number|34|34.0||||||
4435857|NCT00121667|4260798|B1|=< 50 years||Age Characterization Female Only||participants|Number|33|33.0||||||
4435858|NCT00121667|4260794|B5|Not Reported||Race/Ethnicity, Customized||participants|Number|406|406.0||||||
4435859|NCT00121667|4260795|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4435860|NCT00121667|4260796|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4435861|NCT00121667|4260797|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4435862|NCT00121667|4260798|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4435863|NCT00121667|4260794|B5|Not Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|229|229.0||||||
4435864|NCT00121667|4260795|B4|Not Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4435865|NCT00121667|4260796|B3|Not Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4435866|NCT00121667|4260797|B2|Not Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4435867|NCT00121667|4260798|B1|Not Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4435868|NCT00121667|4260794|B5|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|108|108.0||||||
4435869|NCT00121667|4260795|B4|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4435870|NCT00121667|4260796|B3|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4435871|NCT00121667|4260797|B2|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4435872|NCT00121667|4260798|B1|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4435873|NCT00121667|4260794|B5|Other||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4435874|NCT00121667|4260795|B4|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4435875|NCT00121667|4260796|B3|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4435876|NCT00121667|4260797|B2|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4435877|NCT00121667|4260798|B1|Other||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4435878|NCT00121667|4260794|B5|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4435879|NCT00121667|4260795|B4|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4435880|NCT00121667|4260796|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4435881|NCT00121667|4260797|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4435882|NCT00121667|4260798|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4435883|NCT00121667|4260794|B5|Black / African American||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4435884|NCT00121667|4260795|B4|Black / African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4435885|NCT00121667|4260796|B3|Black / African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4435886|NCT00121667|4260797|B2|Black / African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4435887|NCT00121667|4260798|B1|Black / African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4435888|NCT00121667|4260794|B5|White||Race/Ethnicity, Customized||participants|Number|606|606.0||||||
4435889|NCT00121667|4260795|B4|White||Race/Ethnicity, Customized||participants|Number|150|150.0||||||
4435890|NCT00121667|4260796|B3|White||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
4435891|NCT00121667|4260797|B2|White||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
4435892|NCT00121667|4260798|B1|White||Race/Ethnicity, Customized||participants|Number|153|153.0||||||
4435893|NCT00121667|4260794|B5||Male|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4435894|NCT00121667|4260795|B4||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4435895|NCT00121667|4260796|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4435896|NCT00121667|4260797|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4435897|NCT00121667|4260798|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4435898|NCT00121667|4260794|B5||Female|Sex: Female, Male||Participants|Count of Participants|366|366.0||||||
4435899|NCT00121667|4260795|B4||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4435900|NCT00121667|4260796|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4435901|NCT00121667|4260797|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4435902|NCT00121667|4260798|B1||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4435903|NCT00121667|4260794|B5|>= 75 years||Age, Customized||participants|Number|13|13.0||||||
4435904|NCT00121667|4260795|B4|>= 75 years||Age, Customized||participants|Number|3|3.0||||||
4435905|NCT00121667|4260796|B3|>= 75 years||Age, Customized||participants|Number|5|5.0||||||
4435906|NCT00121667|4260797|B2|>= 75 years||Age, Customized||participants|Number|2|2.0||||||
4435907|NCT00121667|4260798|B1|>= 75 years||Age, Customized||participants|Number|3|3.0||||||
4435908|NCT00121667|4260794|B5|>= 65 years||Age, Customized||participants|Number|117|117.0||||||
4435909|NCT00121667|4260795|B4|>= 65 years||Age, Customized||participants|Number|26|26.0||||||
4435910|NCT00121667|4260796|B3|>= 65 years||Age, Customized||participants|Number|26|26.0||||||
4435911|NCT00121667|4260797|B2|>= 65 years||Age, Customized||participants|Number|32|32.0||||||
4435912|NCT00121667|4260798|B1|>= 65 years||Age, Customized||participants|Number|33|33.0||||||
4435913|NCT00121667|4260794|B5|< 65 years||Age, Customized||participants|Number|626|626.0||||||
4435914|NCT00121667|4260795|B4|< 65 years||Age, Customized||participants|Number|153|153.0||||||
4435915|NCT00121667|4260796|B3|< 65 years||Age, Customized||participants|Number|155|155.0||||||
4435916|NCT00121667|4260797|B2|< 65 years||Age, Customized||participants|Number|159|159.0||||||
4435917|NCT00121667|4260798|B1|< 65 years||Age, Customized||participants|Number|159|159.0||||||
4435918|NCT00121667|4260794|B5|||Age||years|Mean|54.57|54.57|Standard Deviation|9.98|9.98|||
4435919|NCT00121667|4260795|B4|||Age||years|Mean|54.76|54.76|Standard Deviation|10.18|10.18|||
4435920|NCT00121667|4260796|B3|||Age||years|Mean|54.18|54.18|Standard Deviation|10.14|10.14|||
4435921|NCT00121667|4260797|B2|||Age||years|Mean|54.69|54.69|Standard Deviation|9.62|9.62|||
4435922|NCT00121667|4260798|B1|||Age||years|Mean|54.66|54.66|Standard Deviation|10.08|10.08|||
4435923|NCT00121641|4260895|B5|>= 30||Body Mass Index Categorization||Participants|Number|248|248.0||||||
4435924|NCT00121641|4260896|B4|>= 30||Body Mass Index Categorization||Participants|Number|53|53.0||||||
4435925|NCT00121641|4260897|B3|>= 30||Body Mass Index Categorization||Participants|Number|63|63.0||||||
4435926|NCT00121641|4260898|B2|>= 30||Body Mass Index Categorization||Participants|Number|66|66.0||||||
4435927|NCT00121641|4260899|B1|>= 30||Body Mass Index Categorization||Participants|Number|66|66.0||||||
4435928|NCT00121641|4260895|B5|< 30||Body Mass Index Categorization||Participants|Number|153|153.0||||||
4435929|NCT00121641|4260896|B4|< 30||Body Mass Index Categorization||Participants|Number|42|42.0||||||
4435930|NCT00121641|4260897|B3|< 30||Body Mass Index Categorization||Participants|Number|35|35.0||||||
4435931|NCT00121641|4260898|B2|< 30||Body Mass Index Categorization||Participants|Number|40|40.0||||||
4435932|NCT00121641|4260899|B1|< 30||Body Mass Index Categorization||Participants|Number|36|36.0||||||
4435933|NCT00121641|4260895|B5|||Body Mass Index||kg/m^2|Mean|31.73|31.73|Standard Deviation|4.60|4.6|||
4435934|NCT00121641|4260896|B4|||Body Mass Index||kg/m^2|Mean|30.93|30.93|Standard Deviation|4.26|4.26|||
4435935|NCT00121641|4260897|B3|||Body Mass Index||kg/m^2|Mean|31.71|31.71|Standard Deviation|4.71|4.71|||
4435936|NCT00121641|4260898|B2|||Body Mass Index||kg/m^2|Mean|32.30|32.3|Standard Deviation|4.53|4.53|||
4435937|NCT00121641|4260899|B1|||Body Mass Index||kg/m^2|Mean|31.90|31.9|Standard Deviation|4.82|4.82|||
4435938|NCT00121641|4260895|B5|||Weight||kg|Mean|89.84|89.84|Standard Deviation|17.96|17.96|||
4435939|NCT00121641|4260896|B4|||Weight||kg|Mean|86.56|86.56|Standard Deviation|16.90|16.9|||
4435940|NCT00121641|4260897|B3|||Weight||kg|Mean|89.30|89.3|Standard Deviation|17.67|17.67|||
4435941|NCT00121641|4260898|B2|||Weight||kg|Mean|91.09|91.09|Standard Deviation|18.53|18.53|||
4435942|NCT00121641|4260899|B1|||Weight||kg|Mean|92.10|92.1|Standard Deviation|18.39|18.39|||
4435943|NCT00121641|4260895|B5|> 50 years||Age Categorization, Female Only||Participants|Number|115|115.0||||||
4435944|NCT00121641|4260896|B4|> 50 years||Age Categorization, Female Only||Participants|Number|29|29.0||||||
4435945|NCT00121641|4260897|B3|> 50 years||Age Categorization, Female Only||Participants|Number|31|31.0||||||
4435946|NCT00121641|4260898|B2|> 50 years||Age Categorization, Female Only||Participants|Number|28|28.0||||||
4435947|NCT00121641|4260899|B1|> 50 years||Age Categorization, Female Only||Participants|Number|27|27.0||||||
4435948|NCT00121641|4260895|B5|=< 50 years||Age Categorization, Female Only||Participants|Number|82|82.0||||||
4435949|NCT00121641|4260896|B4|=< 50 years||Age Categorization, Female Only||Participants|Number|19|19.0||||||
4435950|NCT00121641|4260897|B3|=< 50 years||Age Categorization, Female Only||Participants|Number|22|22.0||||||
4435951|NCT00121641|4260898|B2|=< 50 years||Age Categorization, Female Only||Participants|Number|24|24.0||||||
4435952|NCT00121641|4260899|B1|=< 50 years||Age Categorization, Female Only||Participants|Number|17|17.0||||||
4435953|NCT00121641|4260895|B5|Not Reported||Race/Ethnicity, Customized||Partcipants|Number|168|168.0||||||
4435954|NCT00121641|4260896|B4|Not Reported||Race/Ethnicity, Customized||Partcipants|Number|42|42.0||||||
4435955|NCT00121641|4260897|B3|Not Reported||Race/Ethnicity, Customized||Partcipants|Number|42|42.0||||||
4435956|NCT00121641|4260898|B2|Not Reported||Race/Ethnicity, Customized||Partcipants|Number|43|43.0||||||
4435957|NCT00121641|4260899|B1|Not Reported||Race/Ethnicity, Customized||Partcipants|Number|41|41.0||||||
4435958|NCT00121641|4260895|B5|Not Hispanic / Latino||Race/Ethnicity, Customized||Partcipants|Number|174|174.0||||||
4435959|NCT00121641|4260896|B4|Not Hispanic / Latino||Race/Ethnicity, Customized||Partcipants|Number|38|38.0||||||
4435960|NCT00121641|4260897|B3|Not Hispanic / Latino||Race/Ethnicity, Customized||Partcipants|Number|42|42.0||||||
4435961|NCT00121641|4260898|B2|Not Hispanic / Latino||Race/Ethnicity, Customized||Partcipants|Number|49|49.0||||||
4435962|NCT00121641|4260899|B1|Not Hispanic / Latino||Race/Ethnicity, Customized||Partcipants|Number|45|45.0||||||
4435963|NCT00121641|4260895|B5|Hispanic / Latino||Race/Ethnicity, Customized||Partcipants|Number|59|59.0||||||
4435964|NCT00121641|4260896|B4|Hispanic / Latino||Race/Ethnicity, Customized||Partcipants|Number|15|15.0||||||
4435965|NCT00121641|4260897|B3|Hispanic / Latino||Race/Ethnicity, Customized||Partcipants|Number|14|14.0||||||
4435966|NCT00121641|4260898|B2|Hispanic / Latino||Race/Ethnicity, Customized||Partcipants|Number|14|14.0||||||
4435967|NCT00121641|4260899|B1|Hispanic / Latino||Race/Ethnicity, Customized||Partcipants|Number|16|16.0||||||
4435968|NCT00121641|4260895|B5|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4435969|NCT00121641|4260896|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4435970|NCT00121641|4260897|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4435971|NCT00121641|4260898|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4435972|NCT00121641|4260899|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4435973|NCT00121641|4260895|B5|Other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4435974|NCT00121641|4260896|B4|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4435975|NCT00121641|4260897|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4435976|NCT00121641|4260898|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4435977|NCT00121641|4260899|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4435978|NCT00121641|4260895|B5|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4435979|NCT00121641|4260896|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4435980|NCT00121641|4260897|B3|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4435981|NCT00121641|4260898|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4435982|NCT00121641|4260899|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4435983|NCT00121641|4260895|B5|Black/African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4435984|NCT00121641|4260896|B4|Black/African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4435985|NCT00121641|4260897|B3|Black/African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4435986|NCT00121641|4260898|B2|Black/African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4435987|NCT00121641|4260899|B1|Black/African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4435988|NCT00121641|4260895|B5|White||Race/Ethnicity, Customized||participants|Number|341|341.0||||||
4435989|NCT00121641|4260896|B4|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4435990|NCT00121641|4260897|B3|White||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4435991|NCT00121641|4260898|B2|White||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4435992|NCT00121641|4260899|B1|White||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4435993|NCT00121641|4260895|B5||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4435994|NCT00121641|4260896|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4435995|NCT00121641|4260897|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4435996|NCT00121641|4260898|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4435997|NCT00121641|4260899|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4435998|NCT00121641|4260895|B5||Female|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4435999|NCT00121641|4260896|B4||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4436000|NCT00121641|4260897|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4436001|NCT00121641|4260898|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4436002|NCT00121641|4260899|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4436003|NCT00121641|4260895|B5|>=75 years||Age, Customized||participants|Number|6|6.0||||||
4436004|NCT00121641|4260896|B4|>=75 years||Age, Customized||participants|Number|2|2.0||||||
4436005|NCT00121641|4260897|B3|>=75 years||Age, Customized||participants|Number|1|1.0||||||
4436006|NCT00121641|4260898|B2|>=75 years||Age, Customized||participants|Number|1|1.0||||||
4436007|NCT00121641|4260899|B1|>=75 years||Age, Customized||participants|Number|2|2.0||||||
4436008|NCT00121641|4260895|B5|>= 65 years||Age, Customized||participants|Number|63|63.0||||||
4436009|NCT00121641|4260896|B4|>= 65 years||Age, Customized||participants|Number|18|18.0||||||
4436010|NCT00121641|4260897|B3|>= 65 years||Age, Customized||participants|Number|14|14.0||||||
4436011|NCT00121641|4260898|B2|>= 65 years||Age, Customized||participants|Number|20|20.0||||||
4436012|NCT00121641|4260899|B1|>= 65 years||Age, Customized||participants|Number|11|11.0||||||
4436013|NCT00121641|4260895|B5|<65 years||Age, Customized||participants|Number|338|338.0||||||
4436014|NCT00121641|4260896|B4|<65 years||Age, Customized||participants|Number|77|77.0||||||
4436015|NCT00121641|4260897|B3|<65 years||Age, Customized||participants|Number|84|84.0||||||
4436016|NCT00121641|4260898|B2|<65 years||Age, Customized||participants|Number|86|86.0||||||
4436017|NCT00121641|4260899|B1|<65 years||Age, Customized||participants|Number|91|91.0||||||
4436018|NCT00121641|4260895|B5|||Age||years|Mean|53.46|53.46|Standard Deviation|11.29|11.29|||
4436019|NCT00121641|4260896|B4|||Age||years|Mean|53.91|53.91|Standard Deviation|12.32|12.32|||
4436020|NCT00121641|4260897|B3|||Age||years|Mean|52.73|52.73|Standard Deviation|11.27|11.27|||
4436021|NCT00121641|4260898|B2|||Age||years|Mean|53.91|53.91|Standard Deviation|11.57|11.57|||
4436022|NCT00121641|4260899|B1|||Age||years|Mean|53.27|53.27|Standard Deviation|10.06|10.06|||
4436023|NCT00121485|4261014|B3|Other, unknown||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4436024|NCT00121485|4261015|B2|Other, unknown||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4436025|NCT00121485|4261016|B1|Other, unknown||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4436026|NCT00121485|4261014|B3|White||Race/Ethnicity, Customized||Participants|Number|149|149.0||||||
4436027|NCT00121485|4261015|B2|White||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
4436028|NCT00121485|4261016|B1|White||Race/Ethnicity, Customized||Participants|Number|101|101.0||||||
4436029|NCT00121485|4261014|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4436030|NCT00121485|4261015|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4436031|NCT00121485|4261016|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4436032|NCT00121485|4261014|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4436033|NCT00121485|4261015|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4436034|NCT00121485|4261016|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4436035|NCT00121485|4261014|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4436036|NCT00121485|4261015|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4436037|NCT00121485|4261016|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4436038|NCT00121485|4261014|B3||Male|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4436039|NCT00121485|4261015|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4436040|NCT00121485|4261016|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4436041|NCT00121485|4261014|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4436042|NCT00121485|4261015|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4436043|NCT00121485|4261016|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4436044|NCT00121485|4261014|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|11.6|11.6|||
4436045|NCT00121485|4261015|B2|||Age||years|Mean|63|63.0|Standard Deviation|12|12.0|||
4436046|NCT00121485|4261016|B1|||Age||years|Mean|62|62.0|Standard Deviation|12|12.0|||
4436047|NCT00121472|4261051|B1|||PCWP|Pulmonary capillary wedge pressure|mmHg|Mean|26.0|26.0|Standard Deviation|7.7|7.7|||
4436048|NCT00121472|4261051|B1|||Cardiac Index||L/min/m^2|Mean|2.0|2.0|Standard Deviation|0.5|0.5|||
4436049|NCT00121472|4261051|B1|||Body Surface Area|Body Surface Area (BSA) calculated from patients height and weight|sq. meter|Mean|1.99|1.99|Standard Deviation|0.29|0.29|||
4436050|NCT00121472|4261051|B1||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4436051|NCT00121472|4261051|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4436052|NCT00121472|4261051|B1|||Age||years|Mean|50.6|50.6|Standard Deviation|13.0|13.0|||
4436053|NCT00121238|4261062|B1|||Median time since ADT initiation|Median time after initiation of Androgen Deprivation Treatment (ADT)|years|Median|4.7|4.7|Full Range|||1.0|10.6|
4436054|NCT00121238|4261062|B1|||No Local Treatment Modality|2 of the 13 patients analyzed had no local treatment modality.|participants|Number|2|2.0||||||
4436055|NCT00121238|4261062|B1|||Radical Prostatectomy|Surgery to manage prostate cancer by removal of the patient's prostate and vesicles.|participants|Number|6|6.0||||||
4436056|NCT00121238|4261062|B1|Salvage||Prior radiation to prostate|Of the 13 patients analyzed, only 11 patients had prior radiation.|participants|Number|3|3.0||||||
4436057|NCT00121238|4261062|B1|Adjuvant||Prior radiation to prostate|Of the 13 patients analyzed, only 11 patients had prior radiation.|participants|Number|3|3.0||||||
4436058|NCT00121238|4261062|B1|Definitive||Prior radiation to prostate|Of the 13 patients analyzed, only 11 patients had prior radiation.|participants|Number|5|5.0||||||
4436059|NCT00121238|4261062|B1|||Karnofsky Performance Score|A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky performance scores range from 0- 100. A higher score means the patient/participant is better able to conduct daily activities.|units on a scale|Median|90|90.0|Full Range|||80.0|100.0|
4436111|NCT00121173|4261086|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436112|NCT00121173|4261087|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436060|NCT00121238|4261062|B1|Gleason sum 9||Gleason sum|A Gleason score is given to prostate cancer based upon its microscopic appearance. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors (more favorable prognosis) and 10 the least-differentiated tumors (less favorable prognosis).|participants|Number|3|3.0||||||
4436061|NCT00121238|4261062|B1|Gleason sum 8||Gleason sum|A Gleason score is given to prostate cancer based upon its microscopic appearance. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors (more favorable prognosis) and 10 the least-differentiated tumors (less favorable prognosis).|participants|Number|2|2.0||||||
4436062|NCT00121238|4261062|B1|Gleason sum 7||Gleason sum|A Gleason score is given to prostate cancer based upon its microscopic appearance. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors (more favorable prognosis) and 10 the least-differentiated tumors (less favorable prognosis).|participants|Number|6|6.0||||||
4436063|NCT00121238|4261062|B1|Gleason sum 6||Gleason sum|A Gleason score is given to prostate cancer based upon its microscopic appearance. Gleason scores range from 2 to 10, with 2 representing the most well-differentiated tumors (more favorable prognosis) and 10 the least-differentiated tumors (less favorable prognosis).|participants|Number|2|2.0||||||
4436064|NCT00121238|4261062|B1|||Prostate Specific Antigen (PSA)||ng/mL|Median|8.4|8.4|Full Range|||2.2|77.0|
4436065|NCT00121238|4261062|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4436066|NCT00121238|4261062|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4436067|NCT00121238|4261062|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436068|NCT00121238|4261062|B1|age in years||Age, Customized||years|Median|65.5|65.5|Full Range|||53.8|78.1|
4436069|NCT00121225|4261070|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4436070|NCT00121225|4261070|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4436071|NCT00121225|4261070|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4436072|NCT00121225|4261070|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4436073|NCT00121225|4261070|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4436074|NCT00121225|4261070|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4436075|NCT00121225|4261070|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436076|NCT00121225|4261070|B1|||Age||years|Median|61|61.0|Full Range|||38.0|89.0|
4436077|NCT00121199|4261074|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436078|NCT00121199|4261074|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436079|NCT00121199|4261074|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4436080|NCT00121199|4261074|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4436081|NCT00121199|4261074|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436082|NCT00121199|4261074|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4436083|NCT00121199|4261074|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4436084|NCT00121199|4261074|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4436085|NCT00121199|4261074|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4436086|NCT00121199|4261074|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4436087|NCT00121199|4261074|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4436088|NCT00121199|4261074|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4436089|NCT00121199|4261074|B1|||Age||years|Median|67.6|67.6|Full Range|||21.8|84.9|
4436090|NCT00121186|4261081|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436091|NCT00121186|4261081|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436092|NCT00121186|4261081|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436093|NCT00121186|4261081|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436094|NCT00121186|4261081|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436095|NCT00121186|4261081|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436096|NCT00121186|4261081|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436097|NCT00121186|4261081|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436098|NCT00121186|4261081|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436099|NCT00121186|4261081|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436100|NCT00121186|4261081|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4436101|NCT00121186|4261081|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436102|NCT00121186|4261081|B1|||Age||years|Median|47.2|47.2|Full Range|||47.2|47.2|
4436103|NCT00121173|4261086|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4436104|NCT00121173|4261087|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4436105|NCT00121173|4261088|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4436106|NCT00121173|4261089|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4436107|NCT00121173|4261086|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4436108|NCT00121173|4261087|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436109|NCT00121173|4261088|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436110|NCT00121173|4261089|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436113|NCT00121173|4261088|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436114|NCT00121173|4261089|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436115|NCT00121173|4261086|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4436116|NCT00121173|4261087|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4436117|NCT00121173|4261088|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436118|NCT00121173|4261089|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436119|NCT00121173|4261086|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4436120|NCT00121173|4261087|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436121|NCT00121173|4261088|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436122|NCT00121173|4261089|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436123|NCT00121173|4261086|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436124|NCT00121173|4261087|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436125|NCT00121173|4261088|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436126|NCT00121173|4261089|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436127|NCT00121173|4261086|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436128|NCT00121173|4261087|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436129|NCT00121173|4261088|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436130|NCT00121173|4261089|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436131|NCT00121173|4261086|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436132|NCT00121173|4261087|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436133|NCT00121173|4261088|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436134|NCT00121173|4261089|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436135|NCT00121173|4261086|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436136|NCT00121173|4261087|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436137|NCT00121173|4261088|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436138|NCT00121173|4261089|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436139|NCT00121173|4261086|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4436140|NCT00121173|4261087|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4436141|NCT00121173|4261088|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4436142|NCT00121173|4261089|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4436143|NCT00121173|4261086|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4436144|NCT00121173|4261087|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436145|NCT00121173|4261088|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436146|NCT00121173|4261089|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436147|NCT00121173|4261086|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436148|NCT00121173|4261087|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436149|NCT00121173|4261088|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436150|NCT00121173|4261089|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436151|NCT00121173|4261086|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4436152|NCT00121173|4261087|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4436153|NCT00121173|4261088|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4436154|NCT00121173|4261089|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4436155|NCT00121173|4261086|B4|||Age|Participants ages 18 and older|years|Median|28.4|28.4|Full Range|||18.0|46.0|
4436156|NCT00121173|4261087|B3|||Age|Participants ages 18 and older|years|Median|30.3|30.3|Full Range|||20.0|45.0|
4436157|NCT00121173|4261088|B2|||Age|Participants ages 18 and older|years|Median|29|29.0|Full Range|||20.0|46.0|
4436158|NCT00121173|4261089|B1|||Age|Participants ages 18 and older|years|Median|26|26.0|Full Range|||18.0|36.0|
4436159|NCT00121173|4261086|B4||>=65 years|Age|Participants age 18 and older|Participants|Count of Participants|0|0.0||||||
4436160|NCT00121173|4261087|B3||>=65 years|Age|Participants age 18 and older|Participants|Count of Participants|0|0.0||||||
4436161|NCT00121173|4261088|B2||>=65 years|Age|Participants age 18 and older|Participants|Count of Participants|0|0.0||||||
4436162|NCT00121173|4261089|B1||>=65 years|Age|Participants age 18 and older|Participants|Count of Participants|0|0.0||||||
4436163|NCT00121173|4261086|B4||Between 18 and 65 years|Age|Participants age 18 and older|Participants|Count of Participants|14|14.0||||||
4436164|NCT00121173|4261087|B3||Between 18 and 65 years|Age|Participants age 18 and older|Participants|Count of Participants|9|9.0||||||
4436165|NCT00121173|4261088|B2||Between 18 and 65 years|Age|Participants age 18 and older|Participants|Count of Participants|3|3.0||||||
4436166|NCT00121173|4261089|B1||Between 18 and 65 years|Age|Participants age 18 and older|Participants|Count of Participants|2|2.0||||||
4436167|NCT00121173|4261086|B4||<=18 years|Age|Participants age 18 and older|Participants|Count of Participants|1|1.0||||||
4436168|NCT00121173|4261087|B3||<=18 years|Age|Participants age 18 and older|Participants|Count of Participants|0|0.0||||||
4436169|NCT00121173|4261088|B2||<=18 years|Age|Participants age 18 and older|Participants|Count of Participants|0|0.0||||||
4436170|NCT00121173|4261089|B1||<=18 years|Age|Participants age 18 and older|Participants|Count of Participants|1|1.0||||||
4436171|NCT00121134|4261114|B5|United States||Region of Enrollment||participants|Number|162|162.0||||||
4436172|NCT00121134|4261115|B4|United States||Region of Enrollment||participants|Number|40|40.0||||||
4436173|NCT00121134|4261116|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4436174|NCT00121134|4261117|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4436175|NCT00121134|4261118|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4436176|NCT00121134|4261114|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436177|NCT00121134|4261115|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436178|NCT00121134|4261116|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436179|NCT00121134|4261117|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436180|NCT00121134|4261118|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436181|NCT00121134|4261114|B5||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4436182|NCT00121134|4261115|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4436183|NCT00121134|4261116|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4436184|NCT00121134|4261117|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4436185|NCT00121134|4261118|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4436186|NCT00121134|4261114|B5|||Age||years|Mean|49.03|49.03|Standard Deviation|9.88|9.88|||
4436187|NCT00121134|4261115|B4|||Age||years|Mean|49.55|49.55|Standard Deviation|9.09|9.09|||
4436188|NCT00121134|4261116|B3|||Age||years|Mean|48.71|48.71|Standard Deviation|10.34|10.34|||
4436189|NCT00121134|4261117|B2|||Age||years|Mean|48.83|48.83|Standard Deviation|10.34|10.34|||
4436190|NCT00121134|4261118|B1|||Age||years|Mean|49.05|49.05|Standard Deviation|10.04|10.04|||
4436191|NCT00120874|4261131|B3|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4436192|NCT00120874|4261132|B2|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4436193|NCT00120874|4261133|B1|White, not of Hispanic-American Origin||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4436194|NCT00120874|4261131|B3|Hispanic-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4436195|NCT00120874|4261132|B2|Hispanic-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4436196|NCT00120874|4261133|B1|Hispanic-American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4436197|NCT00120874|4261131|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4436198|NCT00120874|4261132|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4436199|NCT00120874|4261133|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4436200|NCT00120874|4261131|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4436201|NCT00120874|4261132|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4436202|NCT00120874|4261133|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4436203|NCT00120874|4261131|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4436204|NCT00120874|4261132|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4436205|NCT00120874|4261133|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4436206|NCT00120874|4261131|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4436207|NCT00120874|4261132|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4436208|NCT00120874|4261133|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4436209|NCT00120874|4261131|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436210|NCT00120874|4261132|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436211|NCT00120874|4261133|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436212|NCT00120627|4261170|B3|United States||Region of Enrollment||participants|Number|146|146.0||||||
4436213|NCT00120627|4261171|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4436214|NCT00120627|4261172|B1|United States||Region of Enrollment||participants|Number|71|71.0||||||
4436215|NCT00120627|4261170|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4436216|NCT00120627|4261171|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4436217|NCT00120627|4261172|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4436218|NCT00120627|4261170|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4436219|NCT00120627|4261171|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4436220|NCT00120627|4261172|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4436221|NCT00120627|4261170|B3||White|Race (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4436222|NCT00120627|4261171|B2||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4436223|NCT00120627|4261172|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4436224|NCT00120627|4261170|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4436225|NCT00120627|4261171|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4436226|NCT00120627|4261172|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4436227|NCT00120627|4261170|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436291|NCT00120523|4261198|B2|Hungary||Region of Enrollment||participants|Number|40|40.0||||||
4436228|NCT00120627|4261171|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436229|NCT00120627|4261172|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436230|NCT00120627|4261170|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436231|NCT00120627|4261171|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436232|NCT00120627|4261172|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436233|NCT00120627|4261170|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436234|NCT00120627|4261171|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436235|NCT00120627|4261172|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436236|NCT00120627|4261170|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4436237|NCT00120627|4261171|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4436238|NCT00120627|4261172|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4436239|NCT00120627|4261170|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4436240|NCT00120627|4261171|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4436241|NCT00120627|4261172|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4436242|NCT00120627|4261170|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4436243|NCT00120627|4261171|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4436244|NCT00120627|4261172|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4436245|NCT00120627|4261170|B3||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4436246|NCT00120627|4261171|B2||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4436247|NCT00120627|4261172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4436248|NCT00120627|4261170|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436249|NCT00120627|4261171|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436250|NCT00120627|4261172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436251|NCT00120627|4261170|B3|||Age||years|Mean|57|57.0|Standard Deviation|10.10|10.1|||
4436252|NCT00120627|4261171|B2|||Age||years|Mean|58|58.0|Standard Deviation|9.86|9.86|||
4436253|NCT00120627|4261172|B1|||Age||years|Mean|56|56.0|Standard Deviation|10.31|10.31|||
4436254|NCT00120523|4261197|B3|South Africa||Region of Enrollment||participants|Number|104|104.0||||||
4436255|NCT00120523|4261198|B2|South Africa||Region of Enrollment||participants|Number|55|55.0||||||
4436256|NCT00120523|4261199|B1|South Africa||Region of Enrollment||participants|Number|49|49.0||||||
4436257|NCT00120523|4261197|B3|Venezuela||Region of Enrollment||participants|Number|78|78.0||||||
4436258|NCT00120523|4261198|B2|Venezuela||Region of Enrollment||participants|Number|39|39.0||||||
4436259|NCT00120523|4261199|B1|Venezuela||Region of Enrollment||participants|Number|39|39.0||||||
4436260|NCT00120523|4261197|B3|Taiwan||Region of Enrollment||participants|Number|60|60.0||||||
4436261|NCT00120523|4261198|B2|Taiwan||Region of Enrollment||participants|Number|30|30.0||||||
4436262|NCT00120523|4261199|B1|Taiwan||Region of Enrollment||participants|Number|30|30.0||||||
4436263|NCT00120523|4261197|B3|Turkey||Region of Enrollment||participants|Number|54|54.0||||||
4436264|NCT00120523|4261198|B2|Turkey||Region of Enrollment||participants|Number|28|28.0||||||
4436265|NCT00120523|4261199|B1|Turkey||Region of Enrollment||participants|Number|26|26.0||||||
4436266|NCT00120523|4261197|B3|Sweden||Region of Enrollment||participants|Number|58|58.0||||||
4436267|NCT00120523|4261198|B2|Sweden||Region of Enrollment||participants|Number|29|29.0||||||
4436268|NCT00120523|4261199|B1|Sweden||Region of Enrollment||participants|Number|29|29.0||||||
4436269|NCT00120523|4261197|B3|Singapore||Region of Enrollment||participants|Number|25|25.0||||||
4436270|NCT00120523|4261198|B2|Singapore||Region of Enrollment||participants|Number|13|13.0||||||
4436271|NCT00120523|4261199|B1|Singapore||Region of Enrollment||participants|Number|12|12.0||||||
4436272|NCT00120523|4261197|B3|Russian Federation||Region of Enrollment||participants|Number|107|107.0||||||
4436273|NCT00120523|4261198|B2|Russian Federation||Region of Enrollment||participants|Number|53|53.0||||||
4436274|NCT00120523|4261199|B1|Russian Federation||Region of Enrollment||participants|Number|54|54.0||||||
4436275|NCT00120523|4261197|B3|Portugal||Region of Enrollment||participants|Number|10|10.0||||||
4436276|NCT00120523|4261198|B2|Portugal||Region of Enrollment||participants|Number|5|5.0||||||
4436277|NCT00120523|4261199|B1|Portugal||Region of Enrollment||participants|Number|5|5.0||||||
4436278|NCT00120523|4261197|B3|Poland||Region of Enrollment||participants|Number|73|73.0||||||
4436279|NCT00120523|4261198|B2|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4436280|NCT00120523|4261199|B1|Poland||Region of Enrollment||participants|Number|37|37.0||||||
4436281|NCT00120523|4261197|B3|Peru||Region of Enrollment||participants|Number|106|106.0||||||
4436282|NCT00120523|4261198|B2|Peru||Region of Enrollment||participants|Number|51|51.0||||||
4436283|NCT00120523|4261199|B1|Peru||Region of Enrollment||participants|Number|55|55.0||||||
4436284|NCT00120523|4261197|B3|Netherlands||Region of Enrollment||participants|Number|106|106.0||||||
4436285|NCT00120523|4261198|B2|Netherlands||Region of Enrollment||participants|Number|55|55.0||||||
4436286|NCT00120523|4261199|B1|Netherlands||Region of Enrollment||participants|Number|51|51.0||||||
4436287|NCT00120523|4261197|B3|Iceland||Region of Enrollment||participants|Number|195|195.0||||||
4436288|NCT00120523|4261198|B2|Iceland||Region of Enrollment||participants|Number|98|98.0||||||
4436289|NCT00120523|4261199|B1|Iceland||Region of Enrollment||participants|Number|97|97.0||||||
4436290|NCT00120523|4261197|B3|Hungary||Region of Enrollment||participants|Number|79|79.0||||||
4436292|NCT00120523|4261199|B1|Hungary||Region of Enrollment||participants|Number|39|39.0||||||
4436293|NCT00120523|4261197|B3|Hong Kong||Region of Enrollment||participants|Number|9|9.0||||||
4436294|NCT00120523|4261198|B2|Hong Kong||Region of Enrollment||participants|Number|4|4.0||||||
4436295|NCT00120523|4261199|B1|Hong Kong||Region of Enrollment||participants|Number|5|5.0||||||
4436296|NCT00120523|4261197|B3|Guatemala||Region of Enrollment||participants|Number|109|109.0||||||
4436297|NCT00120523|4261198|B2|Guatemala||Region of Enrollment||participants|Number|56|56.0||||||
4436298|NCT00120523|4261199|B1|Guatemala||Region of Enrollment||participants|Number|53|53.0||||||
4436299|NCT00120523|4261197|B3|Greece||Region of Enrollment||participants|Number|35|35.0||||||
4436300|NCT00120523|4261198|B2|Greece||Region of Enrollment||participants|Number|16|16.0||||||
4436301|NCT00120523|4261199|B1|Greece||Region of Enrollment||participants|Number|19|19.0||||||
4436302|NCT00120523|4261197|B3|United Kingdom||Region of Enrollment||participants|Number|59|59.0||||||
4436303|NCT00120523|4261198|B2|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4436304|NCT00120523|4261199|B1|United Kingdom||Region of Enrollment||participants|Number|32|32.0||||||
4436305|NCT00120523|4261197|B3|Spain||Region of Enrollment||participants|Number|99|99.0||||||
4436306|NCT00120523|4261198|B2|Spain||Region of Enrollment||participants|Number|48|48.0||||||
4436307|NCT00120523|4261199|B1|Spain||Region of Enrollment||participants|Number|51|51.0||||||
4436308|NCT00120523|4261197|B3|Ecuador||Region of Enrollment||participants|Number|28|28.0||||||
4436309|NCT00120523|4261198|B2|Ecuador||Region of Enrollment||participants|Number|13|13.0||||||
4436310|NCT00120523|4261199|B1|Ecuador||Region of Enrollment||participants|Number|15|15.0||||||
4436311|NCT00120523|4261197|B3|Czech Republic||Region of Enrollment||participants|Number|49|49.0||||||
4436312|NCT00120523|4261198|B2|Czech Republic||Region of Enrollment||participants|Number|23|23.0||||||
4436313|NCT00120523|4261199|B1|Czech Republic||Region of Enrollment||participants|Number|26|26.0||||||
4436314|NCT00120523|4261197|B3|Colombia||Region of Enrollment||participants|Number|100|100.0||||||
4436315|NCT00120523|4261198|B2|Colombia||Region of Enrollment||participants|Number|52|52.0||||||
4436316|NCT00120523|4261199|B1|Colombia||Region of Enrollment||participants|Number|48|48.0||||||
4436317|NCT00120523|4261197|B3|China||Region of Enrollment||participants|Number|119|119.0||||||
4436318|NCT00120523|4261198|B2|China||Region of Enrollment||participants|Number|59|59.0||||||
4436319|NCT00120523|4261199|B1|China||Region of Enrollment||participants|Number|60|60.0||||||
4436320|NCT00120523|4261197|B3|Chile||Region of Enrollment||participants|Number|47|47.0||||||
4436321|NCT00120523|4261198|B2|Chile||Region of Enrollment||participants|Number|22|22.0||||||
4436322|NCT00120523|4261199|B1|Chile||Region of Enrollment||participants|Number|25|25.0||||||
4436323|NCT00120523|4261197|B3|Canada||Region of Enrollment||participants|Number|116|116.0||||||
4436324|NCT00120523|4261198|B2|Canada||Region of Enrollment||participants|Number|64|64.0||||||
4436325|NCT00120523|4261199|B1|Canada||Region of Enrollment||participants|Number|52|52.0||||||
4436326|NCT00120523|4261197|B3|Belgium||Region of Enrollment||participants|Number|36|36.0||||||
4436327|NCT00120523|4261198|B2|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4436328|NCT00120523|4261199|B1|Belgium||Region of Enrollment||participants|Number|20|20.0||||||
4436329|NCT00120523|4261197|B3|Argentina||Region of Enrollment||participants|Number|80|80.0||||||
4436330|NCT00120523|4261198|B2|Argentina||Region of Enrollment||participants|Number|40|40.0||||||
4436331|NCT00120523|4261199|B1|Argentina||Region of Enrollment||participants|Number|40|40.0||||||
4436332|NCT00120523|4261197|B3|Germany||Region of Enrollment||participants|Number|261|261.0||||||
4436333|NCT00120523|4261198|B2|Germany||Region of Enrollment||participants|Number|131|131.0||||||
4436334|NCT00120523|4261199|B1|Germany||Region of Enrollment||participants|Number|130|130.0||||||
4436335|NCT00120523|4261197|B3|United States||Region of Enrollment||participants|Number|216|216.0||||||
4436336|NCT00120523|4261198|B2|United States||Region of Enrollment||participants|Number|110|110.0||||||
4436337|NCT00120523|4261199|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
4436338|NCT00120523|4261197|B3||Male|Sex: Female, Male||Participants|Count of Participants|1486|1486.0||||||
4436339|NCT00120523|4261198|B2||Male|Sex: Female, Male||Participants|Count of Participants|742|742.0||||||
4436340|NCT00120523|4261199|B1||Male|Sex: Female, Male||Participants|Count of Participants|744|744.0||||||
4436341|NCT00120523|4261197|B3||Female|Sex: Female, Male||Participants|Count of Participants|932|932.0||||||
4436342|NCT00120523|4261198|B2||Female|Sex: Female, Male||Participants|Count of Participants|471|471.0||||||
4436343|NCT00120523|4261199|B1||Female|Sex: Female, Male||Participants|Count of Participants|461|461.0||||||
4436344|NCT00120523|4261197|B3|||Age||months|Mean|7.1|7.1|Standard Deviation|2.69|2.69|||
4436345|NCT00120523|4261198|B2|||Age||months|Mean|7.1|7.1|Standard Deviation|2.66|2.66|||
4436346|NCT00120523|4261199|B1|||Age||months|Mean|7.1|7.1|Standard Deviation|2.71|2.71|||
4436347|NCT00120523|4261197|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436348|NCT00120523|4261198|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436349|NCT00120523|4261199|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436350|NCT00120523|4261197|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4436351|NCT00120523|4261198|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4436352|NCT00120523|4261199|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4436353|NCT00120523|4261197|B3||<=18 years|Age||Participants|Count of Participants|2418|2418.0||||||
4436354|NCT00120523|4261198|B2||<=18 years|Age||Participants|Count of Participants|1213|1213.0||||||
4436355|NCT00120523|4261199|B1||<=18 years|Age||Participants|Count of Participants|1205|1205.0||||||
4436356|NCT00120406|4261222|B3|Severe||Calcification||lesions|Number|177|177.0||||||
4436357|NCT00120406|4261223|B2|Severe||Calcification||lesions|Number|87|87.0||||||
4436358|NCT00120406|4261224|B1|Severe||Calcification||lesions|Number|90|90.0||||||
4436359|NCT00120406|4261222|B3|Moderate||Calcification||lesions|Number|140|140.0||||||
4436360|NCT00120406|4261223|B2|Moderate||Calcification||lesions|Number|55|55.0||||||
4436361|NCT00120406|4261224|B1|Moderate||Calcification||lesions|Number|85|85.0||||||
4436362|NCT00120406|4261222|B3|Little||Calcification||lesions|Number|157|157.0||||||
4436363|NCT00120406|4261223|B2|Little||Calcification||lesions|Number|95|95.0||||||
4436364|NCT00120406|4261224|B1|Little||Calcification||lesions|Number|62|62.0||||||
4436365|NCT00120406|4261222|B3|None||Calcification||lesions|Number|16|16.0||||||
4436366|NCT00120406|4261223|B2|None||Calcification||lesions|Number|12|12.0||||||
4436367|NCT00120406|4261224|B1|None||Calcification||lesions|Number|4|4.0||||||
4436368|NCT00120406|4261222|B3|Lesions without total occlusion||Total Occlusion||lesions|Number|342|342.0||||||
4436369|NCT00120406|4261223|B2|Lesions without total occlusion||Total Occlusion||lesions|Number|180|180.0||||||
4436370|NCT00120406|4261224|B1|Lesions without total occlusion||Total Occlusion||lesions|Number|162|162.0||||||
4436371|NCT00120406|4261222|B3|Lesions with total occlusion||Total Occlusion||lesions|Number|147|147.0||||||
4436372|NCT00120406|4261223|B2|Lesions with total occlusion||Total Occlusion||lesions|Number|68|68.0||||||
4436373|NCT00120406|4261224|B1|Lesions with total occlusion||Total Occlusion||lesions|Number|79|79.0||||||
4436374|NCT00120406|4261222|B3|||Percent diameter stenosis|242 lesions in the PTX group and 249 lesions in the PTA group|percent of proximal ref. vessel diameter|Mean|79.1|79.1|Standard Deviation|17|17.0|||
4436375|NCT00120406|4261223|B2|||Percent diameter stenosis|242 lesions in the PTX group and 249 lesions in the PTA group|percent of proximal ref. vessel diameter|Mean|78.4|78.4|Standard Deviation|17.1|17.1|||
4436376|NCT00120406|4261224|B1|||Percent diameter stenosis|242 lesions in the PTX group and 249 lesions in the PTA group|percent of proximal ref. vessel diameter|Mean|79.8|79.8|Standard Deviation|17|17.0|||
4436377|NCT00120406|4261222|B3|||Normal-to-normal Lesion length|Site reported diseased lesion length (246 lesions in the PTX group and 251 lesions in the PTA group)|mm|Mean|64.8|64.8|Standard Deviation|39.7|39.7|||
4436378|NCT00120406|4261223|B2|||Normal-to-normal Lesion length|Site reported diseased lesion length (246 lesions in the PTX group and 251 lesions in the PTA group)|mm|Mean|63.2|63.2|Standard Deviation|40.5|40.5|||
4436379|NCT00120406|4261224|B1|||Normal-to-normal Lesion length|Site reported diseased lesion length (246 lesions in the PTX group and 251 lesions in the PTA group)|mm|Mean|66.4|66.4|Standard Deviation|38.9|38.9|||
4436380|NCT00120406|4261222|B3|||Stenosed lesion length|Region with > 20% diameter stenosis (242 lesions in the PTX group and 248 lesions in the PTA group)|mm|Mean|53.9|53.9|Standard Deviation|40.5|40.5|||
4436381|NCT00120406|4261223|B2|||Stenosed lesion length|Region with > 20% diameter stenosis (242 lesions in the PTX group and 248 lesions in the PTA group)|mm|Mean|53.2|53.2|Standard Deviation|40.3|40.3|||
4436382|NCT00120406|4261224|B1|||Stenosed lesion length|Region with > 20% diameter stenosis (242 lesions in the PTX group and 248 lesions in the PTA group)|mm|Mean|54.6|54.6|Standard Deviation|40.7|40.7|||
4436383|NCT00120406|4261222|B3|Unknown||Smoking status||participants|Number|1|1.0||||||
4436384|NCT00120406|4261223|B2|Unknown||Smoking status||participants|Number|1|1.0||||||
4436385|NCT00120406|4261224|B1|Unknown||Smoking status||participants|Number|0|0.0||||||
4436386|NCT00120406|4261222|B3|Still smokes||Smoking status||participants|Number|150|150.0||||||
4436387|NCT00120406|4261223|B2|Still smokes||Smoking status||participants|Number|77|77.0||||||
4436388|NCT00120406|4261224|B1|Still smokes||Smoking status||participants|Number|73|73.0||||||
4436389|NCT00120406|4261222|B3|Quit||Smoking status||participants|Number|254|254.0||||||
4436390|NCT00120406|4261223|B2|Quit||Smoking status||participants|Number|123|123.0||||||
4436391|NCT00120406|4261224|B1|Quit||Smoking status||participants|Number|131|131.0||||||
4436392|NCT00120406|4261222|B3|Never smoked||Smoking status||participants|Number|69|69.0||||||
4436393|NCT00120406|4261223|B2|Never smoked||Smoking status||participants|Number|37|37.0||||||
4436394|NCT00120406|4261224|B1|Never smoked||Smoking status||participants|Number|32|32.0||||||
4436395|NCT00120406|4261222|B3|Patients without hypertension||Hypertension||participants|Number|70|70.0||||||
4436396|NCT00120406|4261223|B2|Patients without hypertension||Hypertension||participants|Number|44|44.0||||||
4436397|NCT00120406|4261224|B1|Patients without hypertension||Hypertension||participants|Number|26|26.0||||||
4436398|NCT00120406|4261222|B3|Patients with hypertension||Hypertension||participants|Number|404|404.0||||||
4436399|NCT00120406|4261223|B2|Patients with hypertension||Hypertension||participants|Number|194|194.0||||||
4436400|NCT00120406|4261224|B1|Patients with hypertension||Hypertension||participants|Number|210|210.0||||||
4436401|NCT00120406|4261222|B3|Patients without hypercholesterolemia||Hypercholesterolemia||participants|Number|128|128.0||||||
4436402|NCT00120406|4261223|B2|Patients without hypercholesterolemia||Hypercholesterolemia||participants|Number|72|72.0||||||
4436403|NCT00120406|4261224|B1|Patients without hypercholesterolemia||Hypercholesterolemia||participants|Number|56|56.0||||||
4436404|NCT00120406|4261222|B3|Patients with hypercholesterolemia||Hypercholesterolemia||participants|Number|346|346.0||||||
4436405|NCT00120406|4261223|B2|Patients with hypercholesterolemia||Hypercholesterolemia||participants|Number|166|166.0||||||
4436406|NCT00120406|4261224|B1|Patients with hypercholesterolemia||Hypercholesterolemia||participants|Number|180|180.0||||||
4436407|NCT00120406|4261222|B3|Patients without diabetes||Diabetes||participants|Number|257|257.0||||||
4436408|NCT00120406|4261223|B2|Patients without diabetes||Diabetes||participants|Number|138|138.0||||||
4436409|NCT00120406|4261224|B1|Patients without diabetes||Diabetes||participants|Number|119|119.0||||||
4436410|NCT00120406|4261222|B3|Patients with diabetes||Diabetes||participants|Number|217|217.0||||||
4436411|NCT00120406|4261223|B2|Patients with diabetes||Diabetes||participants|Number|100|100.0||||||
4436412|NCT00120406|4261224|B1|Patients with diabetes||Diabetes||participants|Number|117|117.0||||||
4436413|NCT00120406|4261222|B3|||BMI|Body mass index|kg/m^2|Mean|28.3|28.3|Standard Deviation|5.4|5.4|||
4436414|NCT00120406|4261223|B2|||BMI|Body mass index|kg/m^2|Mean|28.2|28.2|Standard Deviation|5.6|5.6|||
4436415|NCT00120406|4261224|B1|||BMI|Body mass index|kg/m^2|Mean|28.4|28.4|Standard Deviation|5.3|5.3|||
4436416|NCT00120406|4261222|B3||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4436417|NCT00120406|4261223|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4436418|NCT00120406|4261224|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4436419|NCT00120406|4261222|B3||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4436420|NCT00120406|4261223|B2||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4436421|NCT00120406|4261224|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4436422|NCT00120406|4261222|B3|||Age||years|Mean|67.8|67.8|Standard Deviation|10.1|10.1|||
4436423|NCT00120406|4261223|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|10.6|10.6|||
4436424|NCT00120406|4261224|B1|||Age||years|Mean|67.9|67.9|Standard Deviation|9.6|9.6|||
4436425|NCT00120289|4261233|B3|Aspirin or other antiplatelet or anticoagulant||Concomitant Medications at Baseline||participants|Number|3334|3334.0||||||
4436426|NCT00120289|4261234|B2|Aspirin or other antiplatelet or anticoagulant||Concomitant Medications at Baseline||participants|Number|1654|1654.0||||||
4436427|NCT00120289|4261235|B1|Aspirin or other antiplatelet or anticoagulant||Concomitant Medications at Baseline||participants|Number|1680|1680.0||||||
4436428|NCT00120289|4261233|B3|ACE inhibitor or Angiotensin Receptor Blocker||Concomitant Medications at Baseline||participants|Number|2529|2529.0||||||
4436429|NCT00120289|4261234|B2|ACE inhibitor or Angiotensin Receptor Blocker||Concomitant Medications at Baseline||participants|Number|1271|1271.0||||||
4436430|NCT00120289|4261235|B1|ACE inhibitor or Angiotensin Receptor Blocker||Concomitant Medications at Baseline||participants|Number|1258|1258.0||||||
4436431|NCT00120289|4261233|B3|Beta-blockers||Concomitant Medications at Baseline||participants|Number|2719|2719.0||||||
4436432|NCT00120289|4261234|B2|Beta-blockers||Concomitant Medications at Baseline||participants|Number|1342|1342.0||||||
4436433|NCT00120289|4261235|B1|Beta-blockers||Concomitant Medications at Baseline||participants|Number|1377|1377.0||||||
4436434|NCT00120289|4261233|B3|Statins||Concomitant Medications at Baseline||participants|Number|3196|3196.0||||||
4436435|NCT00120289|4261234|B2|Statins||Concomitant Medications at Baseline||participants|Number|1601|1601.0||||||
4436436|NCT00120289|4261235|B1|Statins||Concomitant Medications at Baseline||participants|Number|1595|1595.0||||||
4436437|NCT00120289|4261233|B3|History of diabetes (Type 1 or 2)||Clinical History||participants|Number|1158|1158.0||||||
4436438|NCT00120289|4261234|B2|History of diabetes (Type 1 or 2)||Clinical History||participants|Number|570|570.0||||||
4436439|NCT00120289|4261235|B1|History of diabetes (Type 1 or 2)||Clinical History||participants|Number|588|588.0||||||
4436440|NCT00120289|4261233|B3|Metabolic syndrome||Clinical History||participants|Number|2767|2767.0||||||
4436441|NCT00120289|4261234|B2|Metabolic syndrome||Clinical History||participants|Number|1353|1353.0||||||
4436442|NCT00120289|4261235|B1|Metabolic syndrome||Clinical History||participants|Number|1414|1414.0||||||
4436443|NCT00120289|4261233|B3|History of peripheral vascular disease||Clinical History||participants|Number|465|465.0||||||
4436444|NCT00120289|4261234|B2|History of peripheral vascular disease||Clinical History||participants|Number|231|231.0||||||
4436445|NCT00120289|4261235|B1|History of peripheral vascular disease||Clinical History||participants|Number|234|234.0||||||
4436446|NCT00120289|4261233|B3|History of stroke or cerebrovascular disease||Clinical History||participants|Number|720|720.0||||||
4436447|NCT00120289|4261234|B2|History of stroke or cerebrovascular disease||Clinical History||participants|Number|362|362.0||||||
4436448|NCT00120289|4261235|B1|History of stroke or cerebrovascular disease||Clinical History||participants|Number|358|358.0||||||
4436449|NCT00120289|4261233|B3|History of Percutaneous Coronary Intervention||Clinical History||participants|Number|2101|2101.0||||||
4436450|NCT00120289|4261234|B2|History of Percutaneous Coronary Intervention||Clinical History||participants|Number|1044|1044.0||||||
4436451|NCT00120289|4261235|B1|History of Percutaneous Coronary Intervention||Clinical History||participants|Number|1057|1057.0||||||
4436452|NCT00120289|4261233|B3|History of CABG||Clinical History||participants|Number|1227|1227.0||||||
4436453|NCT00120289|4261234|B2|History of CABG||Clinical History||participants|Number|627|627.0||||||
4436454|NCT00120289|4261235|B1|History of CABG||Clinical History||participants|Number|600|600.0||||||
4436455|NCT00120289|4261233|B3|History of myocardial infarction (MI)||Clinical History||participants|Number|1923|1923.0||||||
4436456|NCT00120289|4261234|B2|History of myocardial infarction (MI)||Clinical History||participants|Number|955|955.0||||||
4436457|NCT00120289|4261235|B1|History of myocardial infarction (MI)||Clinical History||participants|Number|968|968.0||||||
4436458|NCT00120289|4261233|B3|Lipoprotein (a)||Lipids and Lipoproteins at Baseline||mg/dL|Mean|76.4|76.4|Standard Deviation|88.7|88.7|||
4436459|NCT00120289|4261234|B2|Lipoprotein (a)||Lipids and Lipoproteins at Baseline||mg/dL|Mean|75.5|75.5|Standard Deviation|89.6|89.6|||
4436460|NCT00120289|4261235|B1|Lipoprotein (a)||Lipids and Lipoproteins at Baseline||mg/dL|Mean|77.3|77.3|Standard Deviation|87.8|87.8|||
4436461|NCT00120289|4261233|B3|Apolipoprotein B||Lipids and Lipoproteins at Baseline||mg/dL|Mean|83|83.0|Standard Deviation|20.4|20.4|||
4436462|NCT00120289|4261234|B2|Apolipoprotein B||Lipids and Lipoproteins at Baseline||mg/dL|Mean|82.9|82.9|Standard Deviation|20.7|20.7|||
4436463|NCT00120289|4261235|B1|Apolipoprotein B||Lipids and Lipoproteins at Baseline||mg/dL|Mean|83.2|83.2|Standard Deviation|20.2|20.2|||
4436464|NCT00120289|4261233|B3|Apolipoprotein A-I||Lipids and Lipoproteins at Baseline||mg/dL|Mean|123.1|123.1|Standard Deviation|16.2|16.2|||
4436465|NCT00120289|4261234|B2|Apolipoprotein A-I||Lipids and Lipoproteins at Baseline||mg/dL|Mean|123.7|123.7|Standard Deviation|16.3|16.3|||
4436466|NCT00120289|4261235|B1|Apolipoprotein A-I||Lipids and Lipoproteins at Baseline||mg/dL|Mean|122.4|122.4|Standard Deviation|16.2|16.2|||
4436467|NCT00120289|4261233|B3|HDL3-C||Lipids and Lipoproteins at Baseline||mg/dL|Mean|28.6|28.6|Standard Deviation|4.1|4.1|||
4436468|NCT00120289|4261234|B2|HDL3-C||Lipids and Lipoproteins at Baseline||mg/dL|Mean|28.7|28.7|Standard Deviation|4.1|4.1|||
4436469|NCT00120289|4261235|B1|HDL3-C||Lipids and Lipoproteins at Baseline||mg/dL|Mean|28.5|28.5|Standard Deviation|4.2|4.2|||
4436470|NCT00120289|4261233|B3|HDL2-C||Lipids and Lipoproteins at Baseline||mg/dL|Mean|6.1|6.1|Standard Deviation|2.3|2.3|||
4436471|NCT00120289|4261234|B2|HDL2-C||Lipids and Lipoproteins at Baseline||mg/dL|Mean|6.2|6.2|Standard Deviation|2.4|2.4|||
4436472|NCT00120289|4261235|B1|HDL2-C||Lipids and Lipoproteins at Baseline||mg/dL|Mean|6|6.0|Standard Deviation|2.3|2.3|||
4436473|NCT00120289|4261233|B3|non-HDL cholesterol||Lipids and Lipoproteins at Baseline||mg/dL|Mean|110.6|110.6|Standard Deviation|26.8|26.8|||
4436474|NCT00120289|4261234|B2|non-HDL cholesterol||Lipids and Lipoproteins at Baseline||mg/dL|Mean|110.3|110.3|Standard Deviation|26|26.0|||
4436475|NCT00120289|4261235|B1|non-HDL cholesterol||Lipids and Lipoproteins at Baseline||mg/dL|Mean|110.8|110.8|Standard Deviation|27.5|27.5|||
4436476|NCT00120289|4261233|B3|Triglycerides||Lipids and Lipoproteins at Baseline||mg/dL|Mean|182.7|182.7|Standard Deviation|66.8|66.8|||
4436477|NCT00120289|4261234|B2|Triglycerides||Lipids and Lipoproteins at Baseline||mg/dL|Mean|181.9|181.9|Standard Deviation|66.9|66.9|||
4436478|NCT00120289|4261235|B1|Triglycerides||Lipids and Lipoproteins at Baseline||mg/dL|Mean|183.5|183.5|Standard Deviation|66.7|66.7|||
4436479|NCT00120289|4261233|B3|HDL-C||Lipids and Lipoproteins at Baseline||mg/dL|Mean|34.7|34.7|Standard Deviation|5.6|5.6|||
4436480|NCT00120289|4261234|B2|HDL-C||Lipids and Lipoproteins at Baseline||mg/dL|Mean|34.9|34.9|Standard Deviation|5.6|5.6|||
4436481|NCT00120289|4261235|B1|HDL-C||Lipids and Lipoproteins at Baseline||mg/dL|Mean|34.5|34.5|Standard Deviation|5.6|5.6|||
4436482|NCT00120289|4261233|B3|LDL-C||Lipids and Lipoproteins at Baseline||mg/dL|Mean|74.1|74.1|Standard Deviation|23|23.0|||
4436483|NCT00120289|4261234|B2|LDL-C||Lipids and Lipoproteins at Baseline||mg/dL|Mean|74.0|74.0|Standard Deviation|22.7|22.7|||
4436484|NCT00120289|4261235|B1|LDL-C||Lipids and Lipoproteins at Baseline||mg/dL|Mean|74.2|74.2|Standard Deviation|23.4|23.4|||
4436485|NCT00120289|4261233|B3|Canada||Region of Enrollment||participants|Number|1068|1068.0||||||
4436486|NCT00120289|4261234|B2|Canada||Region of Enrollment||participants|Number|529|529.0||||||
4436487|NCT00120289|4261235|B1|Canada||Region of Enrollment||participants|Number|539|539.0||||||
4436488|NCT00120289|4261233|B3|United States||Region of Enrollment||participants|Number|2346|2346.0||||||
4436489|NCT00120289|4261234|B2|United States||Region of Enrollment||participants|Number|1167|1167.0||||||
4436490|NCT00120289|4261235|B1|United States||Region of Enrollment||participants|Number|1179|1179.0||||||
4436491|NCT00120289|4261233|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436492|NCT00120289|4261234|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436493|NCT00120289|4261235|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436494|NCT00120289|4261233|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4436495|NCT00120289|4261234|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4436496|NCT00120289|4261235|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4436497|NCT00120289|4261233|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3148|3148.0||||||
4436498|NCT00120289|4261234|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1576|1576.0||||||
4436499|NCT00120289|4261235|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1572|1572.0||||||
4436500|NCT00120289|4261233|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4436501|NCT00120289|4261234|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4436502|NCT00120289|4261235|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4436503|NCT00120289|4261233|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4436504|NCT00120289|4261234|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4436505|NCT00120289|4261235|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4436506|NCT00120289|4261233|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4436507|NCT00120289|4261234|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4436508|NCT00120289|4261235|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4436509|NCT00120289|4261233|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4436510|NCT00120289|4261234|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4436511|NCT00120289|4261235|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4436512|NCT00120289|4261233|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436513|NCT00120289|4261234|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436514|NCT00120289|4261235|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436515|NCT00120289|4261233|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3273|3273.0||||||
4436516|NCT00120289|4261234|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1619|1619.0||||||
4436517|NCT00120289|4261235|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1654|1654.0||||||
4436518|NCT00120289|4261233|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4436519|NCT00120289|4261234|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4436520|NCT00120289|4261235|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4436521|NCT00120289|4261233|B3||Male|Sex: Female, Male||Participants|Count of Participants|2910|2910.0||||||
4436522|NCT00120289|4261234|B2||Male|Sex: Female, Male||Participants|Count of Participants|1445|1445.0||||||
4436523|NCT00120289|4261235|B1||Male|Sex: Female, Male||Participants|Count of Participants|1465|1465.0||||||
4436524|NCT00120289|4261233|B3||Female|Sex: Female, Male||Participants|Count of Participants|504|504.0||||||
4436525|NCT00120289|4261234|B2||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4436526|NCT00120289|4261235|B1||Female|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4436527|NCT00120289|4261233|B3|||Age||years|Mean|63.7|63.7|Standard Deviation|8.7|8.7|||
4436528|NCT00120289|4261234|B2|||Age||years|Mean|63.7|63.7|Standard Deviation|8.7|8.7|||
4436529|NCT00120289|4261235|B1|||Age||years|Mean|63.7|63.7|Standard Deviation|8.8|8.8|||
4436530|NCT00120289|4261233|B3||>=65 years|Age||Participants|Count of Participants|1582|1582.0||||||
4436531|NCT00120289|4261234|B2||>=65 years|Age||Participants|Count of Participants|781|781.0||||||
4436532|NCT00120289|4261235|B1||>=65 years|Age||Participants|Count of Participants|801|801.0||||||
4436533|NCT00120289|4261233|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1832|1832.0||||||
4436534|NCT00120289|4261234|B2||Between 18 and 65 years|Age||Participants|Count of Participants|915|915.0||||||
4436535|NCT00120289|4261235|B1||Between 18 and 65 years|Age||Participants|Count of Participants|917|917.0||||||
4436536|NCT00120289|4261233|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436537|NCT00120289|4261234|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436538|NCT00120289|4261235|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436539|NCT00120250|4261248|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4436540|NCT00120250|4261248|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4436541|NCT00120250|4261248|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4436542|NCT00120250|4261248|B1|||Age||years|Mean|19.0|19.0|Standard Deviation|14.3|14.3|||
4436543|NCT00120250|4261248|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436544|NCT00120250|4261248|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4436545|NCT00120250|4261248|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436546|NCT00120042|4261262|B4|Australia||Region of Enrollment||participants|Number|251.0|251.0||||||
4436547|NCT00120042|4261263|B3|Australia||Region of Enrollment||participants|Number|83|83.0||||||
4436548|NCT00120042|4261264|B2|Australia||Region of Enrollment||participants|Number|83|83.0||||||
4436549|NCT00120042|4261265|B1|Australia||Region of Enrollment||participants|Number|85|85.0||||||
4436550|NCT00120042|4261262|B4||Male|Sex: Female, Male||Participants|Count of Participants|0.0|0.0||||||
4436551|NCT00120042|4261263|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436552|NCT00120042|4261264|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436553|NCT00120042|4261265|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436554|NCT00120042|4261262|B4||Female|Sex: Female, Male||Participants|Count of Participants|251.0|251.0||||||
4436555|NCT00120042|4261263|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4436556|NCT00120042|4261264|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4436557|NCT00120042|4261265|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4436558|NCT00120042|4261262|B4|||Age||years|Median|32|32.0|Inter-Quartile Range|||26.0|36.0|
4436559|NCT00120042|4261263|B3|||Age||years|Median|30|30.0|Inter-Quartile Range|||24.0|36.0|
4436560|NCT00120042|4261264|B2|||Age||years|Median|32|32.0|Inter-Quartile Range|||27.0|36.0|
4436561|NCT00120042|4261265|B1|||Age||years|Median|32|32.0|Inter-Quartile Range|||25.5|35.0|
4436562|NCT00120042|4261262|B4||>=65 years|Age||Participants|Count of Participants|0.0|0.0||||||
4436563|NCT00120042|4261263|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436564|NCT00120042|4261264|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436565|NCT00120042|4261265|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436566|NCT00120042|4261262|B4||Between 18 and 65 years|Age||Participants|Count of Participants|251.0|251.0||||||
4436567|NCT00120042|4261263|B3||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4436568|NCT00120042|4261264|B2||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4436569|NCT00120042|4261265|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4436570|NCT00120042|4261262|B4||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4436571|NCT00120042|4261263|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436572|NCT00120042|4261264|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436573|NCT00120042|4261265|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436574|NCT00119847|4261275|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4436575|NCT00119847|4261276|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4436576|NCT00119847|4261277|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4436577|NCT00119847|4261275|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436578|NCT00119847|4261276|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436579|NCT00119847|4261277|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436580|NCT00119847|4261275|B3||White|Race (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
4436581|NCT00119847|4261276|B2||White|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4436582|NCT00119847|4261277|B1||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4436583|NCT00119847|4261275|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4436584|NCT00119847|4261276|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4436585|NCT00119847|4261277|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4436586|NCT00119847|4261275|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436587|NCT00119847|4261276|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436588|NCT00119847|4261277|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436589|NCT00119847|4261275|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436590|NCT00119847|4261276|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436591|NCT00119847|4261277|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436592|NCT00119847|4261275|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436593|NCT00119847|4261276|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436594|NCT00119847|4261277|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436595|NCT00119847|4261275|B3||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4436596|NCT00119847|4261276|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4436597|NCT00119847|4261277|B1||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4436598|NCT00119847|4261275|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4436599|NCT00119847|4261276|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4436600|NCT00119847|4261277|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4436601|NCT00119847|4261275|B3|||Age||years|Mean|57.4|57.4|Standard Deviation|10.5|10.5|||
4436602|NCT00119847|4261276|B2|||Age||years|Mean|57.6|57.6|Standard Deviation|10.5|10.5|||
4436603|NCT00119847|4261277|B1|||Age||years|Mean|57.2|57.2|Standard Deviation|10.5|10.5|||
4436604|NCT00119678|4261288|B3|Overall SLICC/ACR score unavailable||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|5|5.0||||||
4436605|NCT00119678|4261289|B2|Overall SLICC/ACR score unavailable||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|2|2.0||||||
4436606|NCT00119678|4261290|B1|Overall SLICC/ACR score unavailable||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|3|3.0||||||
4436607|NCT00119678|4261288|B3|Overall SLICC/ACR score >2||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|7|7.0||||||
4436608|NCT00119678|4261289|B2|Overall SLICC/ACR score >2||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|1|1.0||||||
4436643|NCT00119678|4261288|B3|||Age|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|years|Median|38.0|38.0|Full Range|||18.0|71.0|
4436644|NCT00119678|4261289|B2|||Age|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|years|Median|36.0|36.0|Full Range|||19.0|65.0|
4436650|NCT00119405|4261337|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436651|NCT00119405|4261337|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4436609|NCT00119678|4261290|B1|Overall SLICC/ACR score >2||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|6|6.0||||||
4436610|NCT00119678|4261288|B3|Overall SLICC/ACR score 2||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|20|20.0||||||
4436611|NCT00119678|4261289|B2|Overall SLICC/ACR score 2||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|5|5.0||||||
4436612|NCT00119678|4261290|B1|Overall SLICC/ACR score 2||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|15|15.0||||||
4436613|NCT00119678|4261288|B3|Overall SLICC/ACR score 1||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|23|23.0||||||
4436614|NCT00119678|4261289|B2|Overall SLICC/ACR score 1||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|11|11.0||||||
4436615|NCT00119678|4261290|B1|Overall SLICC/ACR score 1||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|12|12.0||||||
4436616|NCT00119678|4261288|B3|Overall SLICC/ACR score 0||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|120|120.0||||||
4436617|NCT00119678|4261289|B2|Overall SLICC/ACR score 0||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|38|38.0||||||
4436645|NCT00119678|4261290|B1|||Age|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|years|Median|38.0|38.0|Full Range|12.76|12.76|18.0|71.0|
4436646|NCT00119405|4261337|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4436647|NCT00119405|4261337|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4436648|NCT00119405|4261337|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4436618|NCT00119678|4261290|B1|Overall SLICC/ACR score 0||Systemic Lupus International Collaborative Clinics/American College of Rheumatology(SLICC/ACC) score|SLICC/ACR score or damage index is a measure of cumulative damage due to Systemic Lupus Erythematosus (SLE). Damage is defined as non-reversible change (not related to active inflammation) occurring since onset of lupus, ascertained by clinical assessment and present for at least 6 months. A score of 0=no damage, early damage is defined as ≥1. The total maximum score is 48, and increasing score indicates increasing disease severity. 183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|82|82.0||||||
4436619|NCT00119678|4261288|B3|||Weight|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|kilograms|Mean|68.750|68.75|Standard Deviation|17.493|17.493|||
4436620|NCT00119678|4261289|B2|||Weight|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|kilograms|Mean|69.000|69.0|Standard Deviation|14.790|14.79|||
4436621|NCT00119678|4261290|B1|||Weight|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|kilograms|Mean|68.630|68.63|Standard Deviation|18.717|18.717|||
4436622|NCT00119678|4261288|B3|Other races||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|4|4.0||||||
4436623|NCT00119678|4261289|B2|Other races||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|1|1.0||||||
4436624|NCT00119678|4261290|B1|Other races||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|3|3.0||||||
4436625|NCT00119678|4261288|B3|Asian||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|41|41.0||||||
4436626|NCT00119678|4261289|B2|Asian||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|13|13.0||||||
4436627|NCT00119678|4261290|B1|Asian||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|28|28.0||||||
4436628|NCT00119678|4261288|B3|American Indian/Alaska Native||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|1|1.0||||||
4436629|NCT00119678|4261289|B2|American Indian/Alaska Native||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|0|0.0||||||
4436630|NCT00119678|4261290|B1|American Indian/Alaska Native||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|1|1.0||||||
4436631|NCT00119678|4261288|B3|Black/African American||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|16|16.0||||||
4436632|NCT00119678|4261289|B2|Black/African American||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|4|4.0||||||
4436633|NCT00119678|4261290|B1|Black/African American||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|12|12.0||||||
4436634|NCT00119678|4261288|B3|White||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|113|113.0||||||
4436635|NCT00119678|4261289|B2|White||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|39|39.0||||||
4436636|NCT00119678|4261290|B1|White||Race/Ethnicity, Customized|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|participants|Number|74|74.0||||||
4436637|NCT00119678|4261288|B3||Male|Sex: Female, Male|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|Participants|Count of Participants|16|16.0||||||
4436638|NCT00119678|4261289|B2||Male|Sex: Female, Male|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|Participants|Count of Participants|2|2.0||||||
4436639|NCT00119678|4261290|B1||Male|Sex: Female, Male|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|Participants|Count of Participants|14|14.0||||||
4436640|NCT00119678|4261288|B3||Female|Sex: Female, Male|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|Participants|Count of Participants|159|159.0||||||
4436641|NCT00119678|4261289|B2||Female|Sex: Female, Male|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|Participants|Count of Participants|55|55.0||||||
4436642|NCT00119678|4261290|B1||Female|Sex: Female, Male|183 participants were randomized, 3 were not treated and 5 were treated but excluded due to site closure. Thus, Abatacept group n=118 and Placebo group n=57.|Participants|Count of Participants|104|104.0||||||
4436649|NCT00119405|4261337|B1|||Age||years|Mean|33.88|33.88|Standard Deviation|8.48|8.48|||
4436652|NCT00119405|4261337|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436653|NCT00119392|4261341|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436654|NCT00119392|4261341|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436655|NCT00119392|4261341|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4436656|NCT00119392|4261341|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436657|NCT00119392|4261341|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436658|NCT00119392|4261341|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436659|NCT00119392|4261341|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436660|NCT00119392|4261341|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436661|NCT00119392|4261341|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4436662|NCT00119392|4261341|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436663|NCT00119392|4261341|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4436664|NCT00119392|4261341|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4436665|NCT00119392|4261341|B1|||Age||years|Median|58|58.0|Full Range|||29.0|69.0|
4436666|NCT00119379|4261349|B3|United States||Region of Enrollment||Participants|Count of Participants|50|50.0||||||
4436667|NCT00119379|4261350|B2|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4436668|NCT00119379|4261351|B1|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4436669|NCT00119379|4261349|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4436670|NCT00119379|4261350|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4436671|NCT00119379|4261351|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4436672|NCT00119379|4261349|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4436673|NCT00119379|4261350|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4436674|NCT00119379|4261351|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4436675|NCT00119379|4261349|B3|||Age||years|Median|48|48.0|Full Range|||41.0|51.0|
4436676|NCT00119379|4261350|B2|||Age||years|Median|48|48.0|Full Range|||43.0|51.0|
4436677|NCT00119379|4261351|B1|||Age||years|Median|48|48.0|Full Range|||41.0|51.0|
4436678|NCT00119379|4261349|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436679|NCT00119379|4261350|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436680|NCT00119379|4261351|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436681|NCT00119379|4261349|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4436682|NCT00119379|4261350|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4436683|NCT00119379|4261351|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4436684|NCT00119379|4261349|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436685|NCT00119379|4261350|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436686|NCT00119379|4261351|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436687|NCT00119262|4261368|B3|United States||Region of Enrollment||participants|Number|223|223.0||||||
4436688|NCT00119262|4261369|B2|United States||Region of Enrollment||participants|Number|120|120.0||||||
4436689|NCT00119262|4261370|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
4436690|NCT00119262|4261368|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4436691|NCT00119262|4261369|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4436692|NCT00119262|4261370|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4436693|NCT00119262|4261368|B3||Female|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4436694|NCT00119262|4261369|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4436695|NCT00119262|4261370|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4436696|NCT00119262|4261368|B3|||Age||years|Median|50|50.0|Full Range|||27.0|76.0|
4436697|NCT00119262|4261369|B2|||Age||years|Median|50|50.0|Full Range|||27.0|76.0|
4436698|NCT00119262|4261370|B1|||Age||years|Median|50|50.0|Full Range|||33.0|76.0|
4436699|NCT00119158|4261381|B3|United States||Region of Enrollment||participants|Number|90|90.0||||||
4436700|NCT00119158|4261382|B2|United States||Region of Enrollment||participants|Number|45|45.0||||||
4436701|NCT00119158|4261383|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4436702|NCT00119158|4261381|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4436703|NCT00119158|4261382|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4436704|NCT00119158|4261383|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4436705|NCT00119158|4261381|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4436706|NCT00119158|4261382|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4436707|NCT00119158|4261383|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4436708|NCT00119158|4261381|B3|||Age||years|Mean|16.2|16.2|Standard Deviation|17.4|17.4|||
4436709|NCT00119158|4261382|B2|||Age||years|Mean|16.2|16.2|Standard Deviation|17.4|17.4|||
4436710|NCT00119158|4261383|B1|||Age||years|Mean|16.2|16.2|Standard Deviation|17.4|17.4|||
4436711|NCT00119158|4261381|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436712|NCT00119158|4261382|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436713|NCT00119158|4261383|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436714|NCT00119158|4261381|B3||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4436715|NCT00119158|4261382|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4436716|NCT00119158|4261383|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4436717|NCT00119158|4261381|B3||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
4436718|NCT00119158|4261382|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4436719|NCT00119158|4261383|B1||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4436720|NCT00119041|4261392|B4|||Sex/Gender, Customized||participants|Number|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4436721|NCT00119041|4261393|B3|||Sex/Gender, Customized||participants|Number|NA|||||||Gender was not collected for this study
4436722|NCT00119041|4261394|B2|||Sex/Gender, Customized||participants|Number|NA|||||||Gender was not collected for this study
4436723|NCT00119041|4261395|B1|||Sex/Gender, Customized||participants|Number|NA|||||||Gender was not collected for this study
4436724|NCT00119041|4261392|B4|18 years and older||Age, Customized||participants|Number|304|304.0||||||
4436725|NCT00119041|4261393|B3|18 years and older||Age, Customized||participants|Number|22|22.0||||||
4436726|NCT00119041|4261394|B2|18 years and older||Age, Customized||participants|Number|83|83.0||||||
4436727|NCT00119041|4261395|B1|18 years and older||Age, Customized||participants|Number|199|199.0||||||
4436728|NCT00119015|4261406|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4436729|NCT00119015|4261407|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4436730|NCT00119015|4261408|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4436731|NCT00119015|4261406|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4436732|NCT00119015|4261407|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4436733|NCT00119015|4261408|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4436734|NCT00119015|4261406|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4436735|NCT00119015|4261407|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4436736|NCT00119015|4261408|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4436737|NCT00119015|4261406|B3|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4436738|NCT00119015|4261407|B2|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4436739|NCT00119015|4261408|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4436740|NCT00119015|4261406|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4436741|NCT00119015|4261407|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4436742|NCT00119015|4261408|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4436743|NCT00119015|4261406|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4436744|NCT00119015|4261407|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4436745|NCT00119015|4261408|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4436746|NCT00119015|4261406|B3|||Age||years|Mean|34|34.0|Full Range|||18.0|56.0|
4436747|NCT00119015|4261407|B2|||Age||years|Mean|32|32.0|Full Range|||18.0|52.0|
4436748|NCT00119015|4261408|B1|||Age||years|Mean|35|35.0|Full Range|||19.0|56.0|
4436749|NCT00118911|4261424|B3|United States||Region of Enrollment||participants|Number|86|86.0||||||
4436750|NCT00118911|4261425|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4436751|NCT00118911|4261426|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4436752|NCT00118911|4261424|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4436753|NCT00118911|4261425|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4436754|NCT00118911|4261426|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4436755|NCT00118911|4261424|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4436756|NCT00118911|4261425|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4436757|NCT00118911|4261426|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4436758|NCT00118911|4261424|B3|||Age||years|Mean|43.15|43.15|Standard Deviation|11.25|11.25|||
4436759|NCT00118911|4261425|B2|||Age||years|Mean|44|44.0|Standard Deviation|12.2|12.2|||
4436760|NCT00118911|4261426|B1|||Age||years|Mean|42.3|42.3|Standard Deviation|10.3|10.3|||
4436761|NCT00118911|4261424|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436762|NCT00118911|4261425|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436763|NCT00118911|4261426|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4436764|NCT00118911|4261424|B3||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4436765|NCT00118911|4261425|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4436766|NCT00118911|4261426|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4436767|NCT00118911|4261424|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436768|NCT00118911|4261425|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436769|NCT00118911|4261426|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4436770|NCT00118898|4261435|B5|||Baseline CD4+ count|Baseline CD4 count is the average (mean) of 2 measures taken at pre-entry and entry visits.|cells/mm3|Median|229.5|229.5|Inter-Quartile Range|||89.5|333.8|
4436771|NCT00118898|4261436|B4|||Baseline CD4+ count|Baseline CD4 count is the average (mean) of 2 measures taken at pre-entry and entry visits.|cells/mm3|Median|236|236.0|Inter-Quartile Range|||71.5|345.5|
4436863|NCT00118898|4261438|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4436772|NCT00118898|4261437|B3|||Baseline CD4+ count|Baseline CD4 count is the average (mean) of 2 measures taken at pre-entry and entry visits.|cells/mm3|Median|224|224.0|Inter-Quartile Range|||87.0|326.5|
4436773|NCT00118898|4261438|B2|||Baseline CD4+ count|Baseline CD4 count is the average (mean) of 2 measures taken at pre-entry and entry visits.|cells/mm3|Median|225|225.0|Inter-Quartile Range|||103.0|324.0|
4436774|NCT00118898|4261439|B1|||Baseline CD4+ count|Baseline CD4 count is the average (mean) of 2 measures taken at pre-entry and entry visits.|cells/mm3|Median|233.5|233.5|Inter-Quartile Range|||102.5|333.5|
4436775|NCT00118898|4261435|B5|>=100,000 copies/mL||Screening HIV-1 RNA||participants|Number|797|797.0||||||
4436776|NCT00118898|4261436|B4|>=100,000 copies/mL||Screening HIV-1 RNA||participants|Number|199|199.0||||||
4436777|NCT00118898|4261437|B3|>=100,000 copies/mL||Screening HIV-1 RNA||participants|Number|200|200.0||||||
4436778|NCT00118898|4261438|B2|>=100,000 copies/mL||Screening HIV-1 RNA||participants|Number|199|199.0||||||
4436779|NCT00118898|4261439|B1|>=100,000 copies/mL||Screening HIV-1 RNA||participants|Number|199|199.0||||||
4436780|NCT00118898|4261435|B5|<100,000 copies/mL||Screening HIV-1 RNA||participants|Number|1060|1060.0||||||
4436781|NCT00118898|4261436|B4|<100,000 copies/mL||Screening HIV-1 RNA||participants|Number|264|264.0||||||
4436782|NCT00118898|4261437|B3|<100,000 copies/mL||Screening HIV-1 RNA||participants|Number|265|265.0||||||
4436783|NCT00118898|4261438|B2|<100,000 copies/mL||Screening HIV-1 RNA||participants|Number|266|266.0||||||
4436784|NCT00118898|4261439|B1|<100,000 copies/mL||Screening HIV-1 RNA||participants|Number|265|265.0||||||
4436785|NCT00118898|4261435|B5|||Baseline HIV-1 RNA|Baseline RNA is calculated as the mean of the log10 pre-entry and entry values|log10 copies/mL|Mean|4.7|4.7|Standard Deviation|0.7|0.7|||
4436786|NCT00118898|4261436|B4|||Baseline HIV-1 RNA|Baseline RNA is calculated as the mean of the log10 pre-entry and entry values|log10 copies/mL|Mean|4.7|4.7|Standard Deviation|0.7|0.7|||
4436787|NCT00118898|4261437|B3|||Baseline HIV-1 RNA|Baseline RNA is calculated as the mean of the log10 pre-entry and entry values|log10 copies/mL|Mean|4.7|4.7|Standard Deviation|0.7|0.7|||
4436788|NCT00118898|4261438|B2|||Baseline HIV-1 RNA|Baseline RNA is calculated as the mean of the log10 pre-entry and entry values|log10 copies/mL|Mean|4.7|4.7|Standard Deviation|0.7|0.7|||
4436789|NCT00118898|4261439|B1|||Baseline HIV-1 RNA|Baseline RNA is calculated as the mean of the log10 pre-entry and entry values|log10 copies/mL|Mean|4.7|4.7|Standard Deviation|0.7|0.7|||
4436790|NCT00118898|4261435|B5|Puerto Rico||Region of Enrollment||participants|Number|52|52.0||||||
4436791|NCT00118898|4261436|B4|Puerto Rico||Region of Enrollment||participants|Number|13|13.0||||||
4436792|NCT00118898|4261437|B3|Puerto Rico||Region of Enrollment||participants|Number|13|13.0||||||
4436793|NCT00118898|4261438|B2|Puerto Rico||Region of Enrollment||participants|Number|13|13.0||||||
4436794|NCT00118898|4261439|B1|Puerto Rico||Region of Enrollment||participants|Number|13|13.0||||||
4436795|NCT00118898|4261435|B5|United States||Region of Enrollment||participants|Number|1805|1805.0||||||
4436796|NCT00118898|4261436|B4|United States||Region of Enrollment||participants|Number|450|450.0||||||
4436797|NCT00118898|4261437|B3|United States||Region of Enrollment||participants|Number|452|452.0||||||
4436798|NCT00118898|4261438|B2|United States||Region of Enrollment||participants|Number|452|452.0||||||
4436799|NCT00118898|4261439|B1|United States||Region of Enrollment||participants|Number|451|451.0||||||
4436800|NCT00118898|4261435|B5|Unknown||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|5|5.0||||||
4436801|NCT00118898|4261436|B4|Unknown||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|0|0.0||||||
4436802|NCT00118898|4261437|B3|Unknown||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|1|1.0||||||
4436803|NCT00118898|4261438|B2|Unknown||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|3|3.0||||||
4436804|NCT00118898|4261439|B1|Unknown||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|1|1.0||||||
4436805|NCT00118898|4261435|B5|More than One Race||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|16|16.0||||||
4436806|NCT00118898|4261436|B4|More than One Race||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|4|4.0||||||
4436807|NCT00118898|4261437|B3|More than One Race||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|5|5.0||||||
4436808|NCT00118898|4261438|B2|More than One Race||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|5|5.0||||||
4436809|NCT00118898|4261439|B1|More than One Race||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|2|2.0||||||
4436810|NCT00118898|4261435|B5|Native American, Alaskan Native||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|14|14.0||||||
4436811|NCT00118898|4261436|B4|Native American, Alaskan Native||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|2|2.0||||||
4436812|NCT00118898|4261437|B3|Native American, Alaskan Native||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|3|3.0||||||
4436813|NCT00118898|4261438|B2|Native American, Alaskan Native||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|5|5.0||||||
4436814|NCT00118898|4261439|B1|Native American, Alaskan Native||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|4|4.0||||||
4436815|NCT00118898|4261435|B5|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|32|32.0||||||
4436816|NCT00118898|4261436|B4|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|7|7.0||||||
4436817|NCT00118898|4261437|B3|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|12|12.0||||||
4436818|NCT00118898|4261438|B2|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|8|8.0||||||
4436819|NCT00118898|4261439|B1|Asian, Pacific Islander||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|5|5.0||||||
4436820|NCT00118898|4261435|B5|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|429|429.0||||||
4436821|NCT00118898|4261436|B4|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|108|108.0||||||
4436822|NCT00118898|4261437|B3|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|111|111.0||||||
4436823|NCT00118898|4261438|B2|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|106|106.0||||||
4436824|NCT00118898|4261439|B1|Hispanic (Regardless of Race)||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|104|104.0||||||
4436825|NCT00118898|4261435|B5|Black Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|615|615.0||||||
4436826|NCT00118898|4261436|B4|Black Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|153|153.0||||||
4436827|NCT00118898|4261437|B3|Black Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|147|147.0||||||
4436828|NCT00118898|4261438|B2|Black Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|164|164.0||||||
4436829|NCT00118898|4261439|B1|Black Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|151|151.0||||||
4436830|NCT00118898|4261435|B5|White Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|746|746.0||||||
4436831|NCT00118898|4261436|B4|White Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|189|189.0||||||
4436832|NCT00118898|4261437|B3|White Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|186|186.0||||||
4436833|NCT00118898|4261438|B2|White Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|174|174.0||||||
4436834|NCT00118898|4261439|B1|White Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity is collected prior to study entry, participants may opt out of reporting.|participants|Number|197|197.0||||||
4436835|NCT00118898|4261435|B5||Male|Sex: Female, Male||Participants|Count of Participants|1535|1535.0||||||
4436836|NCT00118898|4261436|B4||Male|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
4436837|NCT00118898|4261437|B3||Male|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
4436838|NCT00118898|4261438|B2||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4436839|NCT00118898|4261439|B1||Male|Sex: Female, Male||Participants|Count of Participants|393|393.0||||||
4436840|NCT00118898|4261435|B5||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4436841|NCT00118898|4261436|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4436842|NCT00118898|4261437|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4436843|NCT00118898|4261438|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4436844|NCT00118898|4261439|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4436845|NCT00118898|4261435|B5|||Age||years|Mean|38.4|38.4|Standard Deviation|10.1|10.1|||
4436846|NCT00118898|4261436|B4|||Age||years|Mean|38.0|38.0|Standard Deviation|9.8|9.8|||
4436847|NCT00118898|4261437|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|10.4|10.4|||
4436848|NCT00118898|4261438|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|10.5|10.5|||
4436849|NCT00118898|4261439|B1|||Age||years|Mean|38.2|38.2|Standard Deviation|9.6|9.6|||
4436850|NCT00118898|4261435|B5||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4436851|NCT00118898|4261436|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4436852|NCT00118898|4261437|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4436853|NCT00118898|4261438|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4436854|NCT00118898|4261439|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4436855|NCT00118898|4261435|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1834|1834.0||||||
4436856|NCT00118898|4261436|B4||Between 18 and 65 years|Age||Participants|Count of Participants|458|458.0||||||
4436857|NCT00118898|4261437|B3||Between 18 and 65 years|Age||Participants|Count of Participants|461|461.0||||||
4436858|NCT00118898|4261438|B2||Between 18 and 65 years|Age||Participants|Count of Participants|454|454.0||||||
4436859|NCT00118898|4261439|B1||Between 18 and 65 years|Age||Participants|Count of Participants|461|461.0||||||
4436860|NCT00118898|4261435|B5||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4436861|NCT00118898|4261436|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4436862|NCT00118898|4261437|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4436864|NCT00118898|4261439|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4436865|NCT00118755|4261536|B3||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4436866|NCT00118755|4261537|B2||Male|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4436867|NCT00118755|4261538|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4436868|NCT00118755|4261536|B3||Female|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4436869|NCT00118755|4261537|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4436870|NCT00118755|4261538|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4436871|NCT00118755|4261536|B3|||Age||years|Mean|60.7|60.7|Standard Deviation|11.81|11.81|||
4436872|NCT00118755|4261537|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|12.17|12.17|||
4436873|NCT00118755|4261538|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|11.45|11.45|||
4436874|NCT00118742|4261551|B3|||Weight||kg|Mean|78.4|78.4|Standard Deviation|16.94|16.94|||
4436875|NCT00118742|4261552|B2|||Weight||kg|Mean|77.9|77.9|Standard Deviation|17.56|17.56|||
4436876|NCT00118742|4261553|B1|||Weight||kg|Mean|79|79.0|Standard Deviation|16.32|16.32|||
4436877|NCT00118742|4261551|B3|||Height||cm|Mean|173.3|173.3|Standard Deviation|10.14|10.14|||
4436878|NCT00118742|4261552|B2|||Height||cm|Mean|173.0|173.0|Standard Deviation|10.26|10.26|||
4436879|NCT00118742|4261553|B1|||Height||cm|Mean|173.6|173.6|Standard Deviation|10.04|10.04|||
4436880|NCT00118742|4261551|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4436881|NCT00118742|4261552|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4436882|NCT00118742|4261553|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4436883|NCT00118742|4261551|B3|White||Race/Ethnicity, Customized||participants|Number|251|251.0||||||
4436884|NCT00118742|4261552|B2|White||Race/Ethnicity, Customized||participants|Number|125|125.0||||||
4436885|NCT00118742|4261553|B1|White||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
4436886|NCT00118742|4261551|B3|Black||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4436887|NCT00118742|4261552|B2|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4436888|NCT00118742|4261553|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4436889|NCT00118742|4261551|B3|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4436890|NCT00118742|4261552|B2|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4436891|NCT00118742|4261553|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4436892|NCT00118742|4261551|B3|American Indian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4436893|NCT00118742|4261552|B2|American Indian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4436894|NCT00118742|4261553|B1|American Indian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4436895|NCT00118742|4261551|B3||Male|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4436896|NCT00118742|4261552|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4436897|NCT00118742|4261553|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4436898|NCT00118742|4261551|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4436899|NCT00118742|4261552|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4436900|NCT00118742|4261553|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4436901|NCT00118742|4261551|B3|||Age||years|Mean|53.3|53.3|Standard Deviation|8.36|8.36|||
4436902|NCT00118742|4261552|B2|||Age||years|Mean|53.2|53.2|Standard Deviation|8.83|8.83|||
4436903|NCT00118742|4261553|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|7.88|7.88|||
4436904|NCT00118703|4261566|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436905|NCT00118703|4261567|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436906|NCT00118703|4261568|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436907|NCT00118703|4261566|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4436908|NCT00118703|4261567|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436909|NCT00118703|4261568|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436910|NCT00118703|4261566|B3||White|Race (NIH/OMB)||Participants|Count of Participants|331|331.0||||||
4436911|NCT00118703|4261567|B2||White|Race (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4436912|NCT00118703|4261568|B1||White|Race (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4436913|NCT00118703|4261566|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4436914|NCT00118703|4261567|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4436915|NCT00118703|4261568|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4436916|NCT00118703|4261566|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436917|NCT00118703|4261567|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436918|NCT00118703|4261568|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436919|NCT00118703|4261566|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436920|NCT00118703|4261567|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436921|NCT00118703|4261568|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436922|NCT00118703|4261566|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436923|NCT00118703|4261567|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436924|NCT00118703|4261568|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436925|NCT00118703|4261566|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4436926|NCT00118703|4261567|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4436927|NCT00118703|4261568|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4436928|NCT00118703|4261566|B3||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4436929|NCT00118703|4261567|B2||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4436930|NCT00118703|4261568|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4436931|NCT00118703|4261566|B3|||Age||Years|Mean|43.9|43.9|Standard Deviation|15.06|15.06|||
4436932|NCT00118703|4261567|B2|||Age||Years|Mean|43.8|43.8|Standard Deviation|15.44|15.44|||
4436933|NCT00118703|4261568|B1|||Age||Years|Mean|44|44.0|Standard Deviation|14.72|14.72|||
4436934|NCT00118534|4261579|B3|United States||Region of Enrollment||participants|Number|943|943.0||||||
4436935|NCT00118534|4261580|B2|United States||Region of Enrollment||participants|Number|471|471.0||||||
4436936|NCT00118534|4261581|B1|United States||Region of Enrollment||participants|Number|472|472.0||||||
4436937|NCT00118534|4261579|B3||Male|Sex: Female, Male||Participants|Count of Participants|883|883.0||||||
4436938|NCT00118534|4261580|B2||Male|Sex: Female, Male||Participants|Count of Participants|439|439.0||||||
4436939|NCT00118534|4261581|B1||Male|Sex: Female, Male||Participants|Count of Participants|444|444.0||||||
4436940|NCT00118534|4261579|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4436941|NCT00118534|4261580|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4436942|NCT00118534|4261581|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4436943|NCT00118534|4261579|B3|||Age||years|Mean|54.56|54.56|Full Range|||22.0|81.0|
4436944|NCT00118534|4261580|B2|||Age||years|Mean|54.7|54.7|Full Range|||23.0|81.0|
4436945|NCT00118534|4261581|B1|||Age||years|Mean|54.4|54.4|Full Range|||22.0|80.0|
4436946|NCT00118482|4261664|B3|Canada||Region of Enrollment||participants|Number|170|170.0||||||
4436947|NCT00118482|4261665|B2|Canada||Region of Enrollment||participants|Number|85|85.0||||||
4436948|NCT00118482|4261666|B1|Canada||Region of Enrollment||participants|Number|85|85.0||||||
4436949|NCT00118482|4261664|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4436950|NCT00118482|4261665|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4436951|NCT00118482|4261666|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4436952|NCT00118482|4261664|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4436953|NCT00118482|4261665|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4436954|NCT00118482|4261666|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4436955|NCT00118482|4261664|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4436956|NCT00118482|4261665|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4436957|NCT00118482|4261666|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4436958|NCT00118482|4261664|B3|||Age||years|Median|30.5|30.5|Standard Deviation|12|12.0|||
4436959|NCT00118482|4261665|B2|||Age||years|Median|31|31.0|Standard Deviation|12|12.0|||
4436960|NCT00118482|4261666|B1|||Age||years|Median|28|28.0|Standard Deviation|11.5|11.5|||
4436961|NCT00118430|4261675|B4|||Brief Pain Inventory interference|The BPI interference scale consists of 7 items, each scored from 0 (no interference) to 10 (complete interference), and the total score is the average of the 7 individual item scores. Therefore, the BPI interference score can range from 0 (lowest pain) to 10 (worst or highest pain).|units on a scale|Mean|5.9|5.9|Standard Deviation|2.4|2.4|||
4436962|NCT00118430|4261676|B3|||Brief Pain Inventory interference|The BPI interference scale consists of 7 items, each scored from 0 (no interference) to 10 (complete interference), and the total score is the average of the 7 individual item scores. Therefore, the BPI interference score can range from 0 (lowest pain) to 10 (worst or highest pain).|units on a scale|Mean|4.8|4.8|Standard Deviation|2.2|2.2|||
4436963|NCT00118430|4261677|B2|||Brief Pain Inventory interference|The BPI interference scale consists of 7 items, each scored from 0 (no interference) to 10 (complete interference), and the total score is the average of the 7 individual item scores. Therefore, the BPI interference score can range from 0 (lowest pain) to 10 (worst or highest pain).|units on a scale|Mean|7.1|7.1|Standard Deviation|2.0|2.0|||
4436964|NCT00118430|4261678|B1|||Brief Pain Inventory interference|The BPI interference scale consists of 7 items, each scored from 0 (no interference) to 10 (complete interference), and the total score is the average of the 7 individual item scores. Therefore, the BPI interference score can range from 0 (lowest pain) to 10 (worst or highest pain).|units on a scale|Mean|6.8|6.8|Standard Deviation|2.2|2.2|||
4436965|NCT00118430|4261675|B4|||Brief Pain Inventory severity|The BPI severity scale is a 4-item scale with each item scored from 0 (no pain) to 10 (worst pain imaginable). The scale score is the average of the 4 items and thus can range from 0 (no pain) to 10 (worst or more severe pain)|units on a scale|Mean|5.8|5.8|Standard Deviation|1.8|1.8|||
4436966|NCT00118430|4261676|B3|||Brief Pain Inventory severity|The BPI severity scale is a 4-item scale with each item scored from 0 (no pain) to 10 (worst pain imaginable). The scale score is the average of the 4 items and thus can range from 0 (no pain) to 10 (worst or more severe pain)|units on a scale|Mean|5.4|5.4|Standard Deviation|1.8|1.8|||
4436967|NCT00118430|4261677|B2|||Brief Pain Inventory severity|The BPI severity scale is a 4-item scale with each item scored from 0 (no pain) to 10 (worst pain imaginable). The scale score is the average of the 4 items and thus can range from 0 (no pain) to 10 (worst or more severe pain)|units on a scale|Mean|6.1|6.1|Standard Deviation|1.8|1.8|||
4436968|NCT00118430|4261678|B1|||Brief Pain Inventory severity|The BPI severity scale is a 4-item scale with each item scored from 0 (no pain) to 10 (worst pain imaginable). The scale score is the average of the 4 items and thus can range from 0 (no pain) to 10 (worst or more severe pain)|units on a scale|Mean|6.2|6.2|Standard Deviation|1.8|1.8|||
4436969|NCT00118430|4261675|B4|||HSCL-20 depression severity|This scale consists of 20 items, each scored from 0 (lowest) to 4 (highest or worst). The scale score is the average of the 20 items. Therefore, the HSCL-20 depression severity score can range from 0 (no depression) to 4 (highest or worst depression)|units on a scale|Mean|1.3|1.3|Standard Deviation|0.8|0.8|||
4436970|NCT00118430|4261676|B3|||HSCL-20 depression severity|This scale consists of 20 items, each scored from 0 (lowest) to 4 (highest or worst). The scale score is the average of the 20 items. Therefore, the HSCL-20 depression severity score can range from 0 (no depression) to 4 (highest or worst depression)|units on a scale|Mean|0.7|0.7|Standard Deviation|0.5|0.5|||
4436971|NCT00118430|4261677|B2|||HSCL-20 depression severity|This scale consists of 20 items, each scored from 0 (lowest) to 4 (highest or worst). The scale score is the average of the 20 items. Therefore, the HSCL-20 depression severity score can range from 0 (no depression) to 4 (highest or worst depression)|units on a scale|Mean|1.9|1.9|Standard Deviation|0.6|0.6|||
4436972|NCT00118430|4261678|B1|||HSCL-20 depression severity|This scale consists of 20 items, each scored from 0 (lowest) to 4 (highest or worst). The scale score is the average of the 20 items. Therefore, the HSCL-20 depression severity score can range from 0 (no depression) to 4 (highest or worst depression)|units on a scale|Mean|1.8|1.8|Standard Deviation|0.7|0.7|||
4436973|NCT00118430|4261675|B4|United States||Region of Enrollment||participants|Number|500|500.0||||||
4436974|NCT00118430|4261676|B3|United States||Region of Enrollment||participants|Number|250|250.0||||||
4436975|NCT00118430|4261677|B2|United States||Region of Enrollment||participants|Number|127|127.0||||||
4436976|NCT00118430|4261678|B1|United States||Region of Enrollment||participants|Number|123|123.0||||||
4436977|NCT00118430|4261675|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4436978|NCT00118430|4261676|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4436979|NCT00118430|4261677|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4436980|NCT00118430|4261678|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4436981|NCT00118430|4261675|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436982|NCT00118430|4261676|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436983|NCT00118430|4261677|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436984|NCT00118430|4261678|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436985|NCT00118430|4261675|B4||White|Race (NIH/OMB)||Participants|Count of Participants|291|291.0||||||
4436986|NCT00118430|4261676|B3||White|Race (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4436987|NCT00118430|4261677|B2||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4436988|NCT00118430|4261678|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4436989|NCT00118430|4261675|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|191|191.0||||||
4436990|NCT00118430|4261676|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4436991|NCT00118430|4261677|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4436992|NCT00118430|4261678|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4436993|NCT00118430|4261675|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436994|NCT00118430|4261676|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436995|NCT00118430|4261677|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436996|NCT00118430|4261678|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436997|NCT00118430|4261675|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436998|NCT00118430|4261676|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4436999|NCT00118430|4261677|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437000|NCT00118430|4261678|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437001|NCT00118430|4261675|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4437002|NCT00118430|4261676|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437003|NCT00118430|4261677|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4437004|NCT00118430|4261678|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4437005|NCT00118430|4261675|B4||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4437006|NCT00118430|4261676|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4437007|NCT00118430|4261677|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4437008|NCT00118430|4261678|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4437009|NCT00118430|4261675|B4||Female|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4437010|NCT00118430|4261676|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4437011|NCT00118430|4261677|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4437012|NCT00118430|4261678|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4437013|NCT00118430|4261675|B4|||Age||years|Mean|59.0|59.0|Standard Deviation|13.4|13.4|||
4437014|NCT00118430|4261676|B3|||Age||years|Mean|62.5|62.5|Standard Deviation|14.1|14.1|||
4437015|NCT00118430|4261677|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|11.1|11.1|||
4437016|NCT00118430|4261678|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|12.6|12.6|||
4437017|NCT00118417|4261695|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4437018|NCT00118417|4261695|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4437019|NCT00118417|4261695|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4437020|NCT00118417|4261695|B1|||Age||years|Mean|37.7|37.7|Standard Deviation|11.2|11.2|||
4437021|NCT00118417|4261695|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4437022|NCT00118417|4261695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4437023|NCT00118417|4261695|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437024|NCT00118404|4261706|B4|United States||Region of Enrollment||participants|Number|241|241.0||||||
4437025|NCT00118404|4261707|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4437026|NCT00118404|4261708|B2|United States||Region of Enrollment||participants|Number|86|86.0||||||
4437027|NCT00118404|4261709|B1|United States||Region of Enrollment||participants|Number|86|86.0||||||
4437028|NCT00118404|4261706|B4||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4437029|NCT00118404|4261707|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4437030|NCT00118404|4261708|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4437031|NCT00118404|4261709|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4437032|NCT00118404|4261706|B4||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4437033|NCT00118404|4261707|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4437034|NCT00118404|4261708|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4437035|NCT00118404|4261709|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4437036|NCT00118404|4261706|B4|||Age||years|Mean|42.7|42.7|Standard Deviation|11.8|11.8|||
4437037|NCT00118404|4261707|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|12.3|12.3|||
4437038|NCT00118404|4261708|B2|||Age||years|Mean|43.1|43.1|Standard Deviation|11.5|11.5|||
4437039|NCT00118404|4261709|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|11.8|11.8|||
4437040|NCT00118404|4261706|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4437041|NCT00118404|4261707|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4437042|NCT00118404|4261708|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4437043|NCT00118404|4261709|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4437044|NCT00118404|4261706|B4||Between 18 and 65 years|Age||Participants|Count of Participants|241|241.0||||||
4437045|NCT00118404|4261707|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4437046|NCT00118404|4261708|B2||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4437047|NCT00118404|4261709|B1||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4437048|NCT00118404|4261706|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437049|NCT00118404|4261707|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437050|NCT00118404|4261708|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437051|NCT00118404|4261709|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437052|NCT00118378|4261725|B3|United States||Region of Enrollment||participants|Number|115|115.0||||||
4437053|NCT00118378|4261726|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
4437054|NCT00118378|4261727|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4437055|NCT00118378|4261725|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4437056|NCT00118378|4261726|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4437057|NCT00118378|4261727|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4437058|NCT00118378|4261725|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4437059|NCT00118378|4261726|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4437060|NCT00118378|4261727|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4437061|NCT00118378|4261725|B3|||Age||years|Mean|45.84|45.84|Standard Deviation|8.96|8.96|||
4437062|NCT00118378|4261726|B2|||Age||years|Mean|45.74|45.74|Standard Deviation|8.57|8.57|||
4437063|NCT00118378|4261727|B1|||Age||years|Mean|45.94|45.94|Standard Deviation|9.35|9.35|||
4437064|NCT00118378|4261725|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4437065|NCT00118378|4261726|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4437066|NCT00118378|4261727|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4437067|NCT00118378|4261725|B3||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4437068|NCT00118378|4261726|B2||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4437069|NCT00118378|4261727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4437070|NCT00118378|4261725|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437071|NCT00118378|4261726|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437072|NCT00118378|4261727|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437073|NCT00118365|4261740|B3||Male|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4437074|NCT00118365|4261741|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4437075|NCT00118365|4261742|B1||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4437076|NCT00118365|4261740|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4437077|NCT00118365|4261741|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4437078|NCT00118365|4261742|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4437079|NCT00118365|4261740|B3|||Age||years|Mean|60.5|60.5|Standard Deviation|8.40|8.4|||
4437080|NCT00118365|4261741|B2|||Age||years|Mean|61|61.0|Standard Deviation|8.4|8.4|||
4437081|NCT00118365|4261742|B1|||Age||years|Mean|60|60.0|Standard Deviation|8.6|8.6|||
4437082|NCT00118352|4261809|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4437083|NCT00118352|4261812|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4437084|NCT00118352|4261809|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4437085|NCT00118352|4261812|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4437086|NCT00118352|4261809|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4437087|NCT00118352|4261812|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4437088|NCT00118352|4261809|B4|||Age||years|Median|58.6|58.6|Full Range|||44.0|71.0|
4437089|NCT00118352|4261812|B1|||Age||years|Median|58.6|58.6|Full Range|||44.0|71.0|
4437090|NCT00118352|4261809|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4437091|NCT00118352|4261810|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4437092|NCT00118352|4261811|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4437093|NCT00118352|4261812|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4437094|NCT00118352|4261809|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4437095|NCT00118352|4261810|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4437096|NCT00118352|4261811|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4437097|NCT00118352|4261812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4437098|NCT00118352|4261809|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437099|NCT00118352|4261810|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437100|NCT00118352|4261811|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437101|NCT00118352|4261812|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437102|NCT00118287|4261840|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437103|NCT00118287|4261840|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437104|NCT00118287|4261840|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4437105|NCT00118287|4261840|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4437106|NCT00118287|4261840|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437107|NCT00118287|4261840|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4437108|NCT00118287|4261840|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437109|NCT00118287|4261840|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4437110|NCT00118287|4261840|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4437111|NCT00118287|4261840|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437112|NCT00118287|4261840|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4437113|NCT00118287|4261840|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4437114|NCT00118287|4261840|B1|||Age||years|Median|69|69.0|Full Range|||31.0|86.0|
4437115|NCT00118248|4261844|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4437116|NCT00118248|4261845|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4437117|NCT00118248|4261846|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4437118|NCT00118248|4261844|B3||Male|Gender||Participants|Count of Participants|25|25.0||||||
4437119|NCT00118248|4261845|B2||Male|Gender||Participants|Count of Participants|13|13.0||||||
4437120|NCT00118248|4261846|B1||Male|Gender||Participants|Count of Participants|12|12.0||||||
4437121|NCT00118248|4261844|B3||Female|Gender||Participants|Count of Participants|16|16.0||||||
4437122|NCT00118248|4261845|B2||Female|Gender||Participants|Count of Participants|11|11.0||||||
4437123|NCT00118248|4261846|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4437124|NCT00118248|4261844|B3|||Age||years|Median|60|60.0|Full Range|||33.0|80.0|
4437125|NCT00118248|4261845|B2|||Age||years|Median|61|61.0|Full Range|||34.0|80.0|
4437126|NCT00118248|4261846|B1|||Age||years|Median|56|56.0|Full Range|||33.0|70.0|
4437127|NCT00118157|4261860|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4437128|NCT00118157|4261860|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437129|NCT00118157|4261860|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4437130|NCT00118157|4261860|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4437131|NCT00118157|4261860|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4437132|NCT00118157|4261860|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437133|NCT00118157|4261860|B1|||Age||years|Median|57|57.0|Full Range|||32.0|84.0|
4437134|NCT00118144|4261865|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4437135|NCT00118144|4261865|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4437136|NCT00118144|4261865|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4437137|NCT00118144|4261865|B1|||Age||years|Median|68|68.0|Full Range|||54.0|75.0|
4437138|NCT00118131|4261871|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4437139|NCT00118131|4261871|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4437140|NCT00118131|4261871|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4437141|NCT00118131|4261871|B1|||Age||years|Mean|63|63.0|Standard Deviation|9.9|9.9|||
4437142|NCT00118131|4261871|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4437143|NCT00118131|4261871|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4437144|NCT00118131|4261871|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437145|NCT00118092|4261878|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4437146|NCT00118092|4261878|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4437147|NCT00118092|4261878|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437148|NCT00118092|4261878|B1|||Age||years|Median|68|68.0|Full Range|||52.0|78.0|
4437149|NCT00118053|4261886|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4437150|NCT00118053|4261886|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437151|NCT00118053|4261886|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4437152|NCT00118053|4261886|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|9.9|9.9|||
4437153|NCT00118053|4261886|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4437154|NCT00118053|4261886|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4437155|NCT00118053|4261886|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437156|NCT00118040|4261893|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
4437157|NCT00118040|4261894|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4437158|NCT00118040|4261895|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4437159|NCT00118040|4261896|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4437160|NCT00118040|4261893|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437161|NCT00118040|4261894|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437162|NCT00118040|4261895|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437163|NCT00118040|4261896|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437164|NCT00118040|4261893|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437165|NCT00118040|4261894|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437166|NCT00118040|4261895|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437167|NCT00118040|4261896|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437168|NCT00118040|4261893|B4||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4437169|NCT00118040|4261894|B3||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4437170|NCT00118040|4261895|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4437171|NCT00118040|4261896|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4437172|NCT00118040|4261893|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437173|NCT00118040|4261894|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437174|NCT00118040|4261895|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437175|NCT00118040|4261896|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437176|NCT00118040|4261893|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437177|NCT00118040|4261894|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437178|NCT00118040|4261895|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437179|NCT00118040|4261896|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437180|NCT00118040|4261893|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437181|NCT00118040|4261894|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437182|NCT00118040|4261895|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437183|NCT00118040|4261896|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437184|NCT00118040|4261893|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437185|NCT00118040|4261894|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437186|NCT00118040|4261895|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437187|NCT00118040|4261896|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437188|NCT00118040|4261893|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437189|NCT00118040|4261894|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437190|NCT00118040|4261895|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437191|NCT00118040|4261896|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437192|NCT00118040|4261893|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4437193|NCT00118040|4261894|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4437194|NCT00118040|4261895|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4437195|NCT00118040|4261896|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4437196|NCT00118040|4261893|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437197|NCT00118040|4261894|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437198|NCT00118040|4261895|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437199|NCT00118040|4261896|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437200|NCT00118040|4261893|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4437201|NCT00118040|4261894|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4437202|NCT00118040|4261895|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4437203|NCT00118040|4261896|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4437204|NCT00118040|4261893|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4437205|NCT00118040|4261894|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4437206|NCT00118040|4261895|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4437207|NCT00118040|4261896|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4437208|NCT00118040|4261893|B4|||Age||years|Mean|69.73|69.73|Standard Deviation|10.40|10.4|||
4437209|NCT00118040|4261894|B3|||Age||years|Mean|71.95|71.95|Standard Deviation|12.67|12.67|||
4437210|NCT00118040|4261895|B2|||Age||years|Mean|68.65|68.65|Standard Deviation|9.16|9.16|||
4437211|NCT00118040|4261896|B1|||Age||years|Mean|68.60|68.6|Standard Deviation|9.16|9.16|||
4437212|NCT00118040|4261893|B4||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4437213|NCT00118040|4261894|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4437214|NCT00118040|4261895|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4437215|NCT00118040|4261896|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4437216|NCT00118040|4261893|B4||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4437217|NCT00118040|4261894|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4437218|NCT00118040|4261895|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4437219|NCT00118040|4261896|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4437220|NCT00118040|4261893|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437221|NCT00118040|4261894|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437222|NCT00118040|4261895|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437223|NCT00118040|4261896|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437224|NCT00117988|4261959|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4437225|NCT00117988|4261959|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4437226|NCT00117988|4261959|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4437227|NCT00117988|4261959|B1|||Age||years|Median|49.5|49.5|Full Range|||25.0|76.0|
4437228|NCT00117962|4261963|B3|Not reported||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|3|3.0||||||
4437229|NCT00117962|4261964|B2|Not reported||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|2|2.0||||||
4437230|NCT00117962|4261965|B1|Not reported||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|1|1.0||||||
4437231|NCT00117962|4261963|B3|IIIB||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|42|42.0||||||
4437232|NCT00117962|4261964|B2|IIIB||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|24|24.0||||||
4437233|NCT00117962|4261965|B1|IIIB||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|18|18.0||||||
4437234|NCT00117962|4261963|B3|IIIA||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|56|56.0||||||
4437235|NCT00117962|4261964|B2|IIIA||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|27|27.0||||||
4437236|NCT00117962|4261965|B1|IIIA||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|29|29.0||||||
4437237|NCT00117962|4261963|B3|1 - Ambulatory, restricted strenuous activity||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|55|55.0||||||
4437238|NCT00117962|4261964|B2|1 - Ambulatory, restricted strenuous activity||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|35|35.0||||||
4437239|NCT00117962|4261965|B1|1 - Ambulatory, restricted strenuous activity||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|20|20.0||||||
4437240|NCT00117962|4261963|B3|0 - Fully Active||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|46|46.0||||||
4437241|NCT00117962|4261964|B2|0 - Fully Active||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|18|18.0||||||
4437242|NCT00117962|4261965|B1|0 - Fully Active||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|28|28.0||||||
4437243|NCT00117962|4261963|B3|Not reported||Histology||participants|Number|2|2.0||||||
4437244|NCT00117962|4261964|B2|Not reported||Histology||participants|Number|1|1.0||||||
4437245|NCT00117962|4261965|B1|Not reported||Histology||participants|Number|1|1.0||||||
4437246|NCT00117962|4261963|B3|Large cell||Histology||participants|Number|2|2.0||||||
4437247|NCT00117962|4261964|B2|Large cell||Histology||participants|Number|2|2.0||||||
4437248|NCT00117962|4261965|B1|Large cell||Histology||participants|Number|0|0.0||||||
4437249|NCT00117962|4261963|B3|NSCLC, undifferentiated||Histology||participants|Number|18|18.0||||||
4437250|NCT00117962|4261964|B2|NSCLC, undifferentiated||Histology||participants|Number|10|10.0||||||
4437251|NCT00117962|4261965|B1|NSCLC, undifferentiated||Histology||participants|Number|8|8.0||||||
4437252|NCT00117962|4261963|B3|Squamous||Histology||participants|Number|35|35.0||||||
4437253|NCT00117962|4261964|B2|Squamous||Histology||participants|Number|18|18.0||||||
4437254|NCT00117962|4261965|B1|Squamous||Histology||participants|Number|17|17.0||||||
4437255|NCT00117962|4261963|B3|Adenocarcinoma||Histology||participants|Number|44|44.0||||||
4437256|NCT00117962|4261964|B2|Adenocarcinoma||Histology||participants|Number|22|22.0||||||
4437257|NCT00117962|4261965|B1|Adenocarcinoma||Histology||participants|Number|22|22.0||||||
4437258|NCT00117962|4261963|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
4437259|NCT00117962|4261964|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
4437260|NCT00117962|4261965|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4437261|NCT00117962|4261963|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4437262|NCT00117962|4261964|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4437263|NCT00117962|4261965|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4437264|NCT00117962|4261963|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4437265|NCT00117962|4261964|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4437266|NCT00117962|4261965|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4437267|NCT00117962|4261963|B3|||Age||years|Median|66|66.0|Full Range|||32.0|81.0|
4437268|NCT00117962|4261964|B2|||Age||years|Median|66|66.0|Full Range|||32.0|81.0|
4437269|NCT00117962|4261965|B1|||Age||years|Median|65|65.0|Full Range|||41.0|79.0|
4437270|NCT00117949|4261978|B5|||Weight||kilogram|Mean|81.01|81.01|Standard Deviation|12.61|12.61|||
4437271|NCT00117949|4261979|B4|||Weight||kilogram|Mean|81.40|81.4|Standard Deviation|14.36|14.36|||
4437272|NCT00117949|4261980|B3|||Weight||kilogram|Mean|80.77|80.77|Standard Deviation|12.83|12.83|||
4437273|NCT00117949|4261981|B2|||Weight||kilogram|Mean|81.73|81.73|Standard Deviation|11.50|11.5|||
4437274|NCT00117949|4261982|B1|||Weight||kilogram|Mean|78.97|78.97|Standard Deviation|11.73|11.73|||
4437275|NCT00117949|4261978|B5|||Time since prostate cancer diagnosis|The mean number of days since a diagnosis of prostate cancer was made for the patients in each study group.|days|Mean|1181|1181.0|Standard Deviation|1494|1494.0|||
4437276|NCT00117949|4261979|B4|||Time since prostate cancer diagnosis|The mean number of days since a diagnosis of prostate cancer was made for the patients in each study group.|days|Mean|1095|1095.0|Standard Deviation|1385|1385.0|||
4437277|NCT00117949|4261980|B3|||Time since prostate cancer diagnosis|The mean number of days since a diagnosis of prostate cancer was made for the patients in each study group.|days|Mean|1609|1609.0|Standard Deviation|1836|1836.0|||
4437278|NCT00117949|4261981|B2|||Time since prostate cancer diagnosis|The mean number of days since a diagnosis of prostate cancer was made for the patients in each study group.|days|Mean|954|954.0|Standard Deviation|1328|1328.0|||
4437279|NCT00117949|4261982|B1|||Time since prostate cancer diagnosis|The mean number of days since a diagnosis of prostate cancer was made for the patients in each study group.|days|Mean|851|851.0|Standard Deviation|1077|1077.0|||
4437280|NCT00117949|4261978|B5|||Serum testosterone levels||nanogram per milliliter|Median|3.93|3.93|Full Range|||1.79|8.53|
4437281|NCT00117949|4261979|B4|||Serum testosterone levels||nanogram per milliliter|Median|3.89|3.89|Full Range|||1.79|8.53|
4437282|NCT00117949|4261980|B3|||Serum testosterone levels||nanogram per milliliter|Median|3.96|3.96|Full Range|||2.02|7.22|
4437283|NCT00117949|4261981|B2|||Serum testosterone levels||nanogram per milliliter|Median|4.10|4.1|Full Range|||1.79|8.53|
4437284|NCT00117949|4261982|B1|||Serum testosterone levels||nanogram per milliliter|Median|3.98|3.98|Full Range|||2.29|5.31|
4437285|NCT00117949|4261978|B5|||Serum prostate-specific antigen levels||nanogram per milliliter|Median|9.35|9.35|Full Range|||2.2|765.0|
4437286|NCT00117949|4261979|B4|||Serum prostate-specific antigen levels||nanogram per milliliter|Median|6.40|6.4|Full Range|||2.2|154.0|
4437287|NCT00117949|4261980|B3|||Serum prostate-specific antigen levels||nanogram per milliliter|Median|9.10|9.1|Full Range|||2.2|50.9|
4437288|NCT00117949|4261981|B2|||Serum prostate-specific antigen levels||nanogram per milliliter|Median|13.40|13.4|Full Range|||3.6|765.0|
4437289|NCT00117949|4261982|B1|||Serum prostate-specific antigen levels||nanogram per milliliter|Median|9.30|9.3|Full Range|||2.3|36.3|
4437290|NCT00117949|4261978|B5|||Body mass index|Body mass index is a measure of body fat based on height and weight.|kilogram per square meter|Mean|26.70|26.7|Standard Deviation|5.72|5.72|||
4437291|NCT00117949|4261979|B4|||Body mass index|Body mass index is a measure of body fat based on height and weight.|kilogram per square meter|Mean|26.64|26.64|Standard Deviation|3.38|3.38|||
4437292|NCT00117949|4261980|B3|||Body mass index|Body mass index is a measure of body fat based on height and weight.|kilogram per square meter|Mean|27.22|27.22|Standard Deviation|3.16|3.16|||
4437293|NCT00117949|4261981|B2|||Body mass index|Body mass index is a measure of body fat based on height and weight.|kilogram per square meter|Mean|26.61|26.61|Standard Deviation|3.55|3.55|||
4437294|NCT00117949|4261982|B1|||Body mass index|Body mass index is a measure of body fat based on height and weight.|kilogram per square meter|Mean|26.70|26.7|Standard Deviation|5.72|5.72|||
4437295|NCT00117949|4261978|B5|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|18|18.0||||||
4437296|NCT00117949|4261979|B4|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|7|7.0||||||
4437342|NCT00117949|4261980|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4437297|NCT00117949|4261980|B3|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4437298|NCT00117949|4261981|B2|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4437299|NCT00117949|4261982|B1|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4437300|NCT00117949|4261978|B5|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|10|10.0||||||
4437301|NCT00117949|4261979|B4|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4437302|NCT00117949|4261980|B3|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4437303|NCT00117949|4261981|B2|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|4|4.0||||||
4437304|NCT00117949|4261982|B1|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4437305|NCT00117949|4261978|B5|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|16|16.0||||||
4437306|NCT00117949|4261979|B4|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4437307|NCT00117949|4261980|B3|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4437308|NCT00117949|4261981|B2|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|6|6.0||||||
4437309|NCT00117949|4261982|B1|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|0|0.0||||||
4437310|NCT00117949|4261978|B5|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|38|38.0||||||
4437311|NCT00117949|4261979|B4|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|10|10.0||||||
4437312|NCT00117949|4261980|B3|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|12|12.0||||||
4437313|NCT00117949|4261981|B2|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|11|11.0||||||
4437343|NCT00117949|4261981|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4437344|NCT00117949|4261982|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4437345|NCT00117949|4261978|B5|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4437314|NCT00117949|4261982|B1|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4437315|NCT00117949|4261978|B5|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|36|36.0||||||
4437316|NCT00117949|4261979|B4|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|11|11.0||||||
4437317|NCT00117949|4261980|B3|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|11|11.0||||||
4437318|NCT00117949|4261981|B2|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|8|8.0||||||
4437319|NCT00117949|4261982|B1|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|6|6.0||||||
4437320|NCT00117949|4261978|B5|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|42|42.0||||||
4437321|NCT00117949|4261979|B4|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|13|13.0||||||
4437322|NCT00117949|4261980|B3|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|12|12.0||||||
4437323|NCT00117949|4261981|B2|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|14|14.0||||||
4437324|NCT00117949|4261982|B1|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|3|3.0||||||
4437325|NCT00117949|4261978|B5|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|3|3.0||||||
4437326|NCT00117949|4261979|B4|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4437327|NCT00117949|4261980|B3|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4437328|NCT00117949|4261981|B2|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4437329|NCT00117949|4261982|B1|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4437330|NCT00117949|4261978|B5|Unknown||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4437331|NCT00117949|4261979|B4|Unknown||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4437332|NCT00117949|4261980|B3|Unknown||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4437333|NCT00117949|4261981|B2|Unknown||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4437334|NCT00117949|4261982|B1|Unknown||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4437335|NCT00117949|4261978|B5|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4437336|NCT00117949|4261979|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4437337|NCT00117949|4261980|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4437338|NCT00117949|4261981|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4437339|NCT00117949|4261982|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4437340|NCT00117949|4261978|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4437341|NCT00117949|4261979|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4437346|NCT00117949|4261979|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4437347|NCT00117949|4261980|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4437348|NCT00117949|4261981|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4437349|NCT00117949|4261982|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4437350|NCT00117949|4261978|B5|Oriental/Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4437351|NCT00117949|4261979|B4|Oriental/Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4437352|NCT00117949|4261980|B3|Oriental/Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4437353|NCT00117949|4261981|B2|Oriental/Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4437354|NCT00117949|4261982|B1|Oriental/Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4437355|NCT00117949|4261978|B5||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4437356|NCT00117949|4261979|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4437357|NCT00117949|4261980|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4437358|NCT00117949|4261981|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4437359|NCT00117949|4261982|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4437360|NCT00117949|4261978|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437361|NCT00117949|4261979|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437362|NCT00117949|4261980|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437363|NCT00117949|4261981|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437364|NCT00117949|4261982|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437365|NCT00117949|4261978|B5|||Age||years|Mean|75.6|75.6|Standard Deviation|6.9|6.9|||
4437366|NCT00117949|4261979|B4|||Age||years|Mean|74.7|74.7|Standard Deviation|8.4|8.4|||
4437367|NCT00117949|4261980|B3|||Age||years|Mean|75.9|75.9|Standard Deviation|5.8|5.8|||
4437368|NCT00117949|4261981|B2|||Age||years|Mean|77.5|77.5|Standard Deviation|6.4|6.4|||
4437369|NCT00117949|4261982|B1|||Age||years|Mean|72.0|72.0|Standard Deviation|5.7|5.7|||
4437370|NCT00117949|4261978|B5||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4437371|NCT00117949|4261979|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4437372|NCT00117949|4261980|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4437373|NCT00117949|4261981|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4437374|NCT00117949|4261982|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4437375|NCT00117949|4261978|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4437376|NCT00117949|4261979|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4437377|NCT00117949|4261980|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4437378|NCT00117949|4261981|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4437379|NCT00117949|4261982|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4437380|NCT00117949|4261978|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437381|NCT00117949|4261979|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437382|NCT00117949|4261980|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437383|NCT00117949|4261981|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437384|NCT00117949|4261982|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437385|NCT00117845|4262019|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4437386|NCT00117845|4262019|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437387|NCT00117845|4262019|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437388|NCT00117845|4262019|B1||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437389|NCT00117845|4262019|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4437390|NCT00117845|4262019|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437391|NCT00117845|4262019|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4437392|NCT00117845|4262019|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437393|NCT00117845|4262019|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437394|NCT00117845|4262019|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4437395|NCT00117845|4262019|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437396|NCT00117845|4262019|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4437397|NCT00117845|4262019|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4437398|NCT00117845|4262019|B1|||Age||years|Mean|49.46|49.46|Standard Deviation|11.64|11.64|||
4437399|NCT00117845|4262019|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4437400|NCT00117845|4262019|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4437401|NCT00117845|4262019|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437402|NCT00117806|4262024|B3|||Neither Social Security Income/Social Security Disability Insurance recipient|Data were not available for all participants. Some veterans were neither recipients of SSI & SSDI.|participants|Number|46|46.0||||||
4437403|NCT00117806|4262025|B2|||Neither Social Security Income/Social Security Disability Insurance recipient|Data were not available for all participants. Some veterans were neither recipients of SSI & SSDI.|participants|Number|20|20.0||||||
4437447|NCT00117806|4262024|B3|Low tetraplegia, AIS A, B, C||AIS and neurological Level|Data were not available for all participants.|participants|Number|15|15.0||||||
4437404|NCT00117806|4262026|B1|||Neither Social Security Income/Social Security Disability Insurance recipient|Data were not available for all participants. Some veterans were neither recipients of SSI & SSDI.|participants|Number|26|26.0||||||
4437405|NCT00117806|4262024|B3|||Social Security Disability Insurance recipient|Data were not available for all participants. Not all veterans were recipients of SSDI.|participants|Number|91|91.0||||||
4437406|NCT00117806|4262025|B2|||Social Security Disability Insurance recipient|Data were not available for all participants. Not all veterans were recipients of SSDI.|participants|Number|46|46.0||||||
4437407|NCT00117806|4262026|B1|||Social Security Disability Insurance recipient|Data were not available for all participants. Not all veterans were recipients of SSDI.|participants|Number|45|45.0||||||
4437408|NCT00117806|4262024|B3|||Social Security Income recipient|Data were not available for all participants. Not all veterans received SSI.|participants|Number|21|21.0||||||
4437409|NCT00117806|4262025|B2|||Social Security Income recipient|Data were not available for all participants. Not all veterans received SSI.|participants|Number|11|11.0||||||
4437410|NCT00117806|4262026|B1|||Social Security Income recipient|Data were not available for all participants. Not all veterans received SSI.|participants|Number|10|10.0||||||
4437411|NCT00117806|4262024|B3|||Monthly non-service-connected amount||dollars|Mean|1005.7|1005.7|Standard Deviation|447.9|447.9|||
4437412|NCT00117806|4262025|B2|||Monthly non-service-connected amount||dollars|Mean|986|986.0|Standard Deviation|421|421.0|||
4437413|NCT00117806|4262026|B1|||Monthly non-service-connected amount||dollars|Mean|1024|1024.0|Standard Deviation|482|482.0|||
4437414|NCT00117806|4262024|B3|||Non-service-connected pension|Data were not available for all participants. Not all veterans received non-service-connected benefits.|participants|Number|36|36.0||||||
4437415|NCT00117806|4262025|B2|||Non-service-connected pension|Data were not available for all participants. Not all veterans received non-service-connected benefits.|participants|Number|18|18.0||||||
4437416|NCT00117806|4262026|B1|||Non-service-connected pension|Data were not available for all participants. Not all veterans received non-service-connected benefits.|participants|Number|18|18.0||||||
4437417|NCT00117806|4262024|B3|||No Service-connected/Non-service-connected benefits|Data were not available for all participants. Not all veterans received service-connected or non-service connected benefits.|participants|Number|46|46.0||||||
4437418|NCT00117806|4262025|B2|||No Service-connected/Non-service-connected benefits|Data were not available for all participants. Not all veterans received service-connected or non-service connected benefits.|participants|Number|20|20.0||||||
4437419|NCT00117806|4262026|B1|||No Service-connected/Non-service-connected benefits|Data were not available for all participants. Not all veterans received service-connected or non-service connected benefits.|participants|Number|26|26.0||||||
4437420|NCT00117806|4262024|B3|||Service-connected 100%|Data were not available for all participants. Not all veterans were 100% service-connected.|participants|Number|29|29.0||||||
4437421|NCT00117806|4262025|B2|||Service-connected 100%|Data were not available for all participants. Not all veterans were 100% service-connected.|participants|Number|13|13.0||||||
4437422|NCT00117806|4262026|B1|||Service-connected 100%|Data were not available for all participants. Not all veterans were 100% service-connected.|participants|Number|16|16.0||||||
4437423|NCT00117806|4262024|B3|||Service-connected benefits for SCI recipient|Data were not available for all participants. Not all veterans received service-connected benefits.|participants|Number|34|34.0||||||
4437424|NCT00117806|4262025|B2|||Service-connected benefits for SCI recipient|Data were not available for all participants. Not all veterans received service-connected benefits.|participants|Number|15|15.0||||||
4437425|NCT00117806|4262026|B1|||Service-connected benefits for SCI recipient|Data were not available for all participants. Not all veterans received service-connected benefits.|participants|Number|19|19.0||||||
4437426|NCT00117806|4262024|B3|||VA benefits recipient|Data were not available for all participants. Not all veterans were recipients of VA benefits.|participants|Number|93|93.0||||||
4437427|NCT00117806|4262025|B2|||VA benefits recipient|Data were not available for all participants. Not all veterans were recipients of VA benefits.|participants|Number|43|43.0||||||
4437428|NCT00117806|4262026|B1|||VA benefits recipient|Data were not available for all participants. Not all veterans were recipients of VA benefits.|participants|Number|50|50.0||||||
4437429|NCT00117806|4262024|B3|||Education Years||years|Mean|13.3|13.3|Standard Deviation|2.2|2.2|||
4437430|NCT00117806|4262025|B2|||Education Years||years|Mean|13.5|13.5|Standard Deviation|1.9|1.9|||
4437431|NCT00117806|4262026|B1|||Education Years||years|Mean|13.1|13.1|Standard Deviation|2.3|2.3|||
4437432|NCT00117806|4262024|B3|Other||Marital Status||participants|Number|50|50.0||||||
4437433|NCT00117806|4262025|B2|Other||Marital Status||participants|Number|27|27.0||||||
4437434|NCT00117806|4262026|B1|Other||Marital Status||participants|Number|23|23.0||||||
4437435|NCT00117806|4262024|B3|Divorced||Marital Status||participants|Number|62|62.0||||||
4437436|NCT00117806|4262025|B2|Divorced||Marital Status||participants|Number|34|34.0||||||
4437437|NCT00117806|4262026|B1|Divorced||Marital Status||participants|Number|28|28.0||||||
4437438|NCT00117806|4262024|B3|Married||Marital Status||participants|Number|45|45.0||||||
4437439|NCT00117806|4262025|B2|Married||Marital Status||participants|Number|15|15.0||||||
4437440|NCT00117806|4262026|B1|Married||Marital Status||participants|Number|30|30.0||||||
4437441|NCT00117806|4262024|B3|AIS D/E||AIS and neurological Level|Data were not available for all participants.|participants|Number|50|50.0||||||
4437442|NCT00117806|4262025|B2|AIS D/E||AIS and neurological Level|Data were not available for all participants.|participants|Number|25|25.0||||||
4437443|NCT00117806|4262026|B1|AIS D/E||AIS and neurological Level|Data were not available for all participants.|participants|Number|25|25.0||||||
4437444|NCT00117806|4262024|B3|Paraplegia, AIS A, B, C||AIS and neurological Level|Data were not available for all participants.|participants|Number|65|65.0||||||
4437445|NCT00117806|4262025|B2|Paraplegia, AIS A, B, C||AIS and neurological Level|Data were not available for all participants.|participants|Number|27|27.0||||||
4437446|NCT00117806|4262026|B1|Paraplegia, AIS A, B, C||AIS and neurological Level|Data were not available for all participants.|participants|Number|38|38.0||||||
4437597|NCT00117676|4262058|B3|France||Region of Enrollment||participants|Number|18|18.0||||||
4437448|NCT00117806|4262025|B2|Low tetraplegia, AIS A, B, C||AIS and neurological Level|Data were not available for all participants.|participants|Number|10|10.0||||||
4437449|NCT00117806|4262026|B1|Low tetraplegia, AIS A, B, C||AIS and neurological Level|Data were not available for all participants.|participants|Number|5|5.0||||||
4437450|NCT00117806|4262024|B3|High tetraplegia, AIS A, B,C||AIS and neurological Level|Data were not available for all participants.|participants|Number|25|25.0||||||
4437451|NCT00117806|4262025|B2|High tetraplegia, AIS A, B,C||AIS and neurological Level|Data were not available for all participants.|participants|Number|13|13.0||||||
4437452|NCT00117806|4262026|B1|High tetraplegia, AIS A, B,C||AIS and neurological Level|Data were not available for all participants.|participants|Number|12|12.0||||||
4437453|NCT00117806|4262024|B3|E-Normal||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|4|4.0||||||
4437454|NCT00117806|4262025|B2|E-Normal||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|4|4.0||||||
4437455|NCT00117806|4262026|B1|E-Normal||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|0|0.0||||||
4437456|NCT00117806|4262024|B3|D-Motor Incomplete||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|46|46.0||||||
4437457|NCT00117806|4262025|B2|D-Motor Incomplete||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|21|21.0||||||
4437458|NCT00117806|4262026|B1|D-Motor Incomplete||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|25|25.0||||||
4437459|NCT00117806|4262024|B3|C-Motor Incomplete||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|36|36.0||||||
4437460|NCT00117806|4262025|B2|C-Motor Incomplete||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|18|18.0||||||
4437461|NCT00117806|4262026|B1|C-Motor Incomplete||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|18|18.0||||||
4437542|NCT00117715|4262052|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437543|NCT00117715|4262052|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4437544|NCT00117715|4262052|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4437598|NCT00117676|4262059|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
4437462|NCT00117806|4262024|B3|B-Sensory Incomplete||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|24|24.0||||||
4437463|NCT00117806|4262025|B2|B-Sensory Incomplete||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|13|13.0||||||
4437464|NCT00117806|4262026|B1|B-Sensory Incomplete||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|11|11.0||||||
4437465|NCT00117806|4262024|B3|A-Complete||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|46|46.0||||||
4437466|NCT00117806|4262025|B2|A-Complete||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|20|20.0||||||
4437467|NCT00117806|4262026|B1|A-Complete||ASIA Impairment Scale (AIS)|"The ASIA Impairment Scale is a tool used to categorize motor & sensory impairment in individuals with SCI. A-Comp B-Incomp: Sensory but not motor function is preserved below the neurological level & includes the sacral segments S4-S5. C-Incomplete: Motor function is preserved below the neuro level & more than half of key muscles below the neuro level have a muscle grade < 3. D-Incomplete: Motor function is preserved below the neuro level, and at least half of key muscles below the neuro level have a muscle grade of >=3; E-Normal.~Data were not available for all participants. Incomplete data."|participants|Number|26|26.0||||||
4437468|NCT00117806|4262024|B3|Physical Component Score||Quality of Life VR-36|"The VR-36 is a 36-item instrument which assesses general health-related quality of life. The VR-36 assesses eight domains of a person’s health and functioning: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. The item responses are on a 3-point scale ranging from Yes, limited a lot to No, not limited at all. The items are summed and the range is from 0-100, 100 is equivalent to maximum health."|units on a scale|Mean|27.9|27.9|Standard Deviation|7.9|7.9|||
4437469|NCT00117806|4262025|B2|Physical Component Score||Quality of Life VR-36|"The VR-36 is a 36-item instrument which assesses general health-related quality of life. The VR-36 assesses eight domains of a person’s health and functioning: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. The item responses are on a 3-point scale ranging from Yes, limited a lot to No, not limited at all. The items are summed and the range is from 0-100, 100 is equivalent to maximum health."|units on a scale|Mean|28.1|28.1|Standard Deviation|8.4|8.4|||
4437470|NCT00117806|4262026|B1|Physical Component Score||Quality of Life VR-36|"The VR-36 is a 36-item instrument which assesses general health-related quality of life. The VR-36 assesses eight domains of a person’s health and functioning: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. The item responses are on a 3-point scale ranging from Yes, limited a lot to No, not limited at all. The items are summed and the range is from 0-100, 100 is equivalent to maximum health."|units on a scale|Mean|27.7|27.7|Standard Deviation|7.5|7.5|||
4437471|NCT00117806|4262024|B3|Mental Component Score||Quality of Life VR-36|"The VR-36 is a 36-item instrument which assesses general health-related quality of life. The VR-36 assesses eight domains of a person’s health and functioning: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. The item responses are on a 3-point scale ranging from Yes, limited a lot to No, not limited at all. The items are summed and the range is from 0-100, 100 is equivalent to maximum health."|units on a scale|Mean|55.1|55.1|Standard Deviation|13.3|13.3|||
4437472|NCT00117806|4262025|B2|Mental Component Score||Quality of Life VR-36|"The VR-36 is a 36-item instrument which assesses general health-related quality of life. The VR-36 assesses eight domains of a person’s health and functioning: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. The item responses are on a 3-point scale ranging from Yes, limited a lot to No, not limited at all. The items are summed and the range is from 0-100, 100 is equivalent to maximum health."|units on a scale|Mean|55.6|55.6|Standard Deviation|12.9|12.9|||
4437473|NCT00117806|4262026|B1|Mental Component Score||Quality of Life VR-36|"The VR-36 is a 36-item instrument which assesses general health-related quality of life. The VR-36 assesses eight domains of a person’s health and functioning: physical functioning, role limitations due to physical problems, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. The item responses are on a 3-point scale ranging from Yes, limited a lot to No, not limited at all. The items are summed and the range is from 0-100, 100 is equivalent to maximum health."|units on a scale|Mean|54.7|54.7|Standard Deviation|13.8|13.8|||
4437474|NCT00117806|4262024|B3|Economic Self Sufficiency||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|52.1|52.1|Standard Deviation|15.7|15.7|||
4437475|NCT00117806|4262025|B2|Economic Self Sufficiency||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|52.6|52.6|Standard Deviation|36.9|36.9|||
4437476|NCT00117806|4262026|B1|Economic Self Sufficiency||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|51.5|51.5|Standard Deviation|37.8|37.8|||
4437477|NCT00117806|4262024|B3|Physical||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|86.4|86.4|Standard Deviation|21.4|21.4|||
4437478|NCT00117806|4262025|B2|Physical||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|87.2|87.2|Standard Deviation|22.1|22.1|||
4437479|NCT00117806|4262026|B1|Physical||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|85.7|85.7|Standard Deviation|20.9|20.9|||
4437480|NCT00117806|4262024|B3|Occupation||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|51.0|51.0|Standard Deviation|31.7|31.7|||
4437481|NCT00117806|4262025|B2|Occupation||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|50.4|50.4|Standard Deviation|30.6|30.6|||
4437482|NCT00117806|4262026|B1|Occupation||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|51.5|51.5|Standard Deviation|32.9|32.9|||
4437483|NCT00117806|4262024|B3|Cognitive||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|90.1|90.1|Standard Deviation|15.7|15.7|||
4437484|NCT00117806|4262025|B2|Cognitive||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|90.8|90.8|Standard Deviation|14.9|14.9|||
4437545|NCT00117715|4262052|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4437546|NCT00117715|4262052|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437547|NCT00117715|4262052|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4437485|NCT00117806|4262026|B1|Cognitive||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|89.4|89.4|Standard Deviation|16.6|16.6|||
4437486|NCT00117806|4262024|B3|Mobility||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|80.4|80.4|Standard Deviation|19.7|19.7|||
4437487|NCT00117806|4262025|B2|Mobility||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|80.4|80.4|Standard Deviation|22.4|22.4|||
4437488|NCT00117806|4262026|B1|Mobility||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|80.4|80.4|Standard Deviation|17.0|17.0|||
4437489|NCT00117806|4262024|B3|Social Integration||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|83.3|83.3|Standard Deviation|13.1|13.1|||
4437490|NCT00117806|4262025|B2|Social Integration||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|84.7|84.7|Standard Deviation|12.7|12.7|||
4437491|NCT00117806|4262026|B1|Social Integration||Measures of Handicap (CHART)|The CHART contains 32 items assessing six dimensions of a person’s handicap: cognitive independence, physical independence, mobility, occupation, social integration, and economic self-sufficiency. A minimum score of 0 indicating full handicap in an individual's ability to sustain an individual existence and maximum score of 100 indicating no handicap in an individual's ability to sustain an individual existence , is permitted for each subscale.|units on a scale|Mean|82.0|82.0|Standard Deviation|13.6|13.6|||
4437492|NCT00117806|4262024|B3|Motor||Functional Independence Measure|The FIM is an 18-item instrument that assesses disability in terms of what level of assistance an individual needs to perform various activities. Each item is on a scale from 1 (total assistance) to 7 (complete independence). Motor subscale scores range from 13 (total dependence) to 91 (total independence) and cognitive subscale scores range from 5 (total dependence) to 35 (total independence). Motor and Cognitive are summed to create the Total FIM scores which range from 18 (totally dependent) to 126 (totally independent).|units on a scale|Mean|66.6|66.6|Standard Deviation|21.8|21.8|||
4437493|NCT00117806|4262025|B2|Motor||Functional Independence Measure|The FIM is an 18-item instrument that assesses disability in terms of what level of assistance an individual needs to perform various activities. Each item is on a scale from 1 (total assistance) to 7 (complete independence). Motor subscale scores range from 13 (total dependence) to 91 (total independence) and cognitive subscale scores range from 5 (total dependence) to 35 (total independence). Motor and Cognitive are summed to create the Total FIM scores which range from 18 (totally dependent) to 126 (totally independent).|units on a scale|Mean|66.4|66.4|Standard Deviation|22.2|22.2|||
4437494|NCT00117806|4262026|B1|Motor||Functional Independence Measure|The FIM is an 18-item instrument that assesses disability in terms of what level of assistance an individual needs to perform various activities. Each item is on a scale from 1 (total assistance) to 7 (complete independence). Motor subscale scores range from 13 (total dependence) to 91 (total independence) and cognitive subscale scores range from 5 (total dependence) to 35 (total independence). Motor and Cognitive are summed to create the Total FIM scores which range from 18 (totally dependent) to 126 (totally independent).|units on a scale|Mean|66.9|66.9|Standard Deviation|21.6|21.6|||
4437495|NCT00117806|4262024|B3|Cognitive||Functional Independence Measure|The FIM is an 18-item instrument that assesses disability in terms of what level of assistance an individual needs to perform various activities. Each item is on a scale from 1 (total assistance) to 7 (complete independence). Motor subscale scores range from 13 (total dependence) to 91 (total independence) and cognitive subscale scores range from 5 (total dependence) to 35 (total independence). Motor and Cognitive are summed to create the Total FIM scores which range from 18 (totally dependent) to 126 (totally independent).|units on a scale|Mean|33.8|33.8|Standard Deviation|2.5|2.5|||
4437496|NCT00117806|4262025|B2|Cognitive||Functional Independence Measure|The FIM is an 18-item instrument that assesses disability in terms of what level of assistance an individual needs to perform various activities. Each item is on a scale from 1 (total assistance) to 7 (complete independence). Motor subscale scores range from 13 (total dependence) to 91 (total independence) and cognitive subscale scores range from 5 (total dependence) to 35 (total independence). Motor and Cognitive are summed to create the Total FIM scores which range from 18 (totally dependent) to 126 (totally independent).|units on a scale|Mean|33.7|33.7|Standard Deviation|2.8|2.8|||
4437548|NCT00117715|4262052|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437599|NCT00117676|4262060|B1|France||Region of Enrollment||participants|Number|13|13.0||||||
4437497|NCT00117806|4262026|B1|Cognitive||Functional Independence Measure|The FIM is an 18-item instrument that assesses disability in terms of what level of assistance an individual needs to perform various activities. Each item is on a scale from 1 (total assistance) to 7 (complete independence). Motor subscale scores range from 13 (total dependence) to 91 (total independence) and cognitive subscale scores range from 5 (total dependence) to 35 (total independence). Motor and Cognitive are summed to create the Total FIM scores which range from 18 (totally dependent) to 126 (totally independent).|units on a scale|Mean|33.8|33.8|Standard Deviation|2.3|2.3|||
4437498|NCT00117806|4262024|B3|Total||Functional Independence Measure|The FIM is an 18-item instrument that assesses disability in terms of what level of assistance an individual needs to perform various activities. Each item is on a scale from 1 (total assistance) to 7 (complete independence). Motor subscale scores range from 13 (total dependence) to 91 (total independence) and cognitive subscale scores range from 5 (total dependence) to 35 (total independence). Motor and Cognitive are summed to create the Total FIM scores which range from 18 (totally dependent) to 126 (totally independent).|units on a scale|Mean|98.6|98.6|Standard Deviation|23.6|23.6|||
4437499|NCT00117806|4262025|B2|Total||Functional Independence Measure|The FIM is an 18-item instrument that assesses disability in terms of what level of assistance an individual needs to perform various activities. Each item is on a scale from 1 (total assistance) to 7 (complete independence). Motor subscale scores range from 13 (total dependence) to 91 (total independence) and cognitive subscale scores range from 5 (total dependence) to 35 (total independence). Motor and Cognitive are summed to create the Total FIM scores which range from 18 (totally dependent) to 126 (totally independent).|units on a scale|Mean|98.2|98.2|Standard Deviation|23.7|23.7|||
4437500|NCT00117806|4262026|B1|Total||Functional Independence Measure|The FIM is an 18-item instrument that assesses disability in terms of what level of assistance an individual needs to perform various activities. Each item is on a scale from 1 (total assistance) to 7 (complete independence). Motor subscale scores range from 13 (total dependence) to 91 (total independence) and cognitive subscale scores range from 5 (total dependence) to 35 (total independence). Motor and Cognitive are summed to create the Total FIM scores which range from 18 (totally dependent) to 126 (totally independent).|units on a scale|Mean|98.9|98.9|Standard Deviation|23.8|23.8|||
4437501|NCT00117806|4262024|B3|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4437502|NCT00117806|4262025|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4437503|NCT00117806|4262026|B1|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4437504|NCT00117806|4262024|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4437505|NCT00117806|4262025|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4437506|NCT00117806|4262026|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4437507|NCT00117806|4262024|B3|African American||Race/Ethnicity, Customized||participants|Number|66|66.0||||||
4437508|NCT00117806|4262025|B2|African American||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4437509|NCT00117806|4262026|B1|African American||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4437510|NCT00117806|4262024|B3|White||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4437511|NCT00117806|4262025|B2|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4437512|NCT00117806|4262026|B1|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4437513|NCT00117806|4262024|B3||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4437514|NCT00117806|4262025|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4437515|NCT00117806|4262026|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4437516|NCT00117806|4262024|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4437517|NCT00117806|4262025|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4437518|NCT00117806|4262026|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4437519|NCT00117806|4262024|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|9.8|9.8|||
4437520|NCT00117806|4262025|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|9.8|9.8|||
4437521|NCT00117806|4262026|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|9.8|9.8|||
4437522|NCT00117806|4262024|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4437523|NCT00117806|4262025|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4437524|NCT00117806|4262026|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4437525|NCT00117806|4262024|B3||Between 18 and 65 years|Age||Participants|Count of Participants|157|157.0||||||
4437526|NCT00117806|4262025|B2||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4437527|NCT00117806|4262026|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4437528|NCT00117806|4262024|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437529|NCT00117806|4262025|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437530|NCT00117806|4262026|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437531|NCT00117793|4262037|B1|||Height||m|Mean|1.78|1.78|Standard Deviation|0.11|0.11|||
4437532|NCT00117793|4262037|B1|||Weight||kg|Mean|84|84.0|Standard Deviation|11|11.0|||
4437533|NCT00117793|4262037|B1|||Years post-amputation||Years|Mean|13|13.0|Standard Deviation|15|15.0|||
4437534|NCT00117793|4262037|B1|Traumatic||Amputation etiology||Participants|Number|4|4.0||||||
4437535|NCT00117793|4262037|B1|Diabetic||Amputation etiology||Participants|Number|1|1.0||||||
4437536|NCT00117793|4262037|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4437537|NCT00117793|4262037|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437538|NCT00117793|4262037|B1|||Age||years|Mean|56|56.0|Standard Deviation|9|9.0|||
4437539|NCT00117793|4262037|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4437540|NCT00117793|4262037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4437541|NCT00117793|4262037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437549|NCT00117715|4262052|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437550|NCT00117715|4262052|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4437551|NCT00117715|4262052|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4437552|NCT00117715|4262052|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4437553|NCT00117715|4262052|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4437554|NCT00117715|4262052|B1|||Age||years|Mean|1.21|1.21|Standard Deviation|0.28|0.28|||
4437555|NCT00117676|4262058|B3|||Baseline Knodell Necroinflammatory Score|Based on Knodell numerical scoring of liver biopsy specimens. The Knodell necroinflammatory score is the combined necrosis and inflammation domain scores and ranges 0 (best) to 14 (worst).|units on a scale|Mean|7.8|7.8|Standard Deviation|2.37|2.37|||
4437556|NCT00117676|4262059|B2|||Baseline Knodell Necroinflammatory Score|Based on Knodell numerical scoring of liver biopsy specimens. The Knodell necroinflammatory score is the combined necrosis and inflammation domain scores and ranges 0 (best) to 14 (worst).|units on a scale|Mean|7.8|7.8|Standard Deviation|2.20|2.2|||
4437557|NCT00117676|4262060|B1|||Baseline Knodell Necroinflammatory Score|Based on Knodell numerical scoring of liver biopsy specimens. The Knodell necroinflammatory score is the combined necrosis and inflammation domain scores and ranges 0 (best) to 14 (worst).|units on a scale|Mean|7.8|7.8|Standard Deviation|2.45|2.45|||
4437558|NCT00117676|4262058|B3|||Baseline Hepatitis B Virus Deoxyribonucleic Acid (HBV DNA)||log10 copies/mL|Mean|6.90|6.9|Standard Deviation|1.294|1.294|||
4437559|NCT00117676|4262059|B2|||Baseline Hepatitis B Virus Deoxyribonucleic Acid (HBV DNA)||log10 copies/mL|Mean|6.98|6.98|Standard Deviation|1.266|1.266|||
4437560|NCT00117676|4262060|B1|||Baseline Hepatitis B Virus Deoxyribonucleic Acid (HBV DNA)||log10 copies/mL|Mean|6.86|6.86|Standard Deviation|1.308|1.308|||
4437561|NCT00117676|4262058|B3|No||Prior Lamivudine or FTC Treatment||participants|Number|309|309.0||||||
4437562|NCT00117676|4262059|B2|No||Prior Lamivudine or FTC Treatment||participants|Number|102|102.0||||||
4437563|NCT00117676|4262060|B1|No||Prior Lamivudine or FTC Treatment||participants|Number|207|207.0||||||
4437564|NCT00117676|4262058|B3|Yes||Prior Lamivudine or FTC Treatment||participants|Number|66|66.0||||||
4437565|NCT00117676|4262059|B2|Yes||Prior Lamivudine or FTC Treatment||participants|Number|23|23.0||||||
4437566|NCT00117676|4262060|B1|Yes||Prior Lamivudine or FTC Treatment||participants|Number|43|43.0||||||
4437567|NCT00117676|4262058|B3|No||Baseline Alanine Aminotransferase (ALT) Above the Upper Limit of the Normal (ULN) Range|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|21|21.0||||||
4437568|NCT00117676|4262059|B2|No||Baseline Alanine Aminotransferase (ALT) Above the Upper Limit of the Normal (ULN) Range|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|7|7.0||||||
4437569|NCT00117676|4262060|B1|No||Baseline Alanine Aminotransferase (ALT) Above the Upper Limit of the Normal (ULN) Range|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|14|14.0||||||
4437570|NCT00117676|4262058|B3|Yes||Baseline Alanine Aminotransferase (ALT) Above the Upper Limit of the Normal (ULN) Range|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|354|354.0||||||
4437571|NCT00117676|4262059|B2|Yes||Baseline Alanine Aminotransferase (ALT) Above the Upper Limit of the Normal (ULN) Range|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|118|118.0||||||
4437572|NCT00117676|4262060|B1|Yes||Baseline Alanine Aminotransferase (ALT) Above the Upper Limit of the Normal (ULN) Range|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|236|236.0||||||
4437573|NCT00117676|4262058|B3|New Zealand||Region of Enrollment||participants|Number|36|36.0||||||
4437574|NCT00117676|4262059|B2|New Zealand||Region of Enrollment||participants|Number|12|12.0||||||
4437575|NCT00117676|4262060|B1|New Zealand||Region of Enrollment||participants|Number|24|24.0||||||
4437576|NCT00117676|4262058|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4437577|NCT00117676|4262059|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4437578|NCT00117676|4262060|B1|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4437579|NCT00117676|4262058|B3|Germany||Region of Enrollment||participants|Number|30|30.0||||||
4437580|NCT00117676|4262059|B2|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4437581|NCT00117676|4262060|B1|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4437582|NCT00117676|4262058|B3|Bulgaria||Region of Enrollment||participants|Number|72|72.0||||||
4437583|NCT00117676|4262059|B2|Bulgaria||Region of Enrollment||participants|Number|23|23.0||||||
4437584|NCT00117676|4262060|B1|Bulgaria||Region of Enrollment||participants|Number|49|49.0||||||
4437585|NCT00117676|4262058|B3|Australia||Region of Enrollment||participants|Number|22|22.0||||||
4437586|NCT00117676|4262059|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4437587|NCT00117676|4262060|B1|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4437588|NCT00117676|4262058|B3|Poland||Region of Enrollment||participants|Number|24|24.0||||||
4437589|NCT00117676|4262059|B2|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4437590|NCT00117676|4262060|B1|Poland||Region of Enrollment||participants|Number|13|13.0||||||
4437591|NCT00117676|4262058|B3|Canada||Region of Enrollment||participants|Number|47|47.0||||||
4437592|NCT00117676|4262059|B2|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4437593|NCT00117676|4262060|B1|Canada||Region of Enrollment||participants|Number|29|29.0||||||
4437594|NCT00117676|4262058|B3|Czech Republic||Region of Enrollment||participants|Number|12|12.0||||||
4437595|NCT00117676|4262059|B2|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4437596|NCT00117676|4262060|B1|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4437600|NCT00117676|4262058|B3|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4437601|NCT00117676|4262059|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4437602|NCT00117676|4262060|B1|United Kingdom||Region of Enrollment||participants|Number|5|5.0||||||
4437603|NCT00117676|4262058|B3|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4437604|NCT00117676|4262059|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4437605|NCT00117676|4262060|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4437606|NCT00117676|4262058|B3|Turkey||Region of Enrollment||participants|Number|14|14.0||||||
4437607|NCT00117676|4262059|B2|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
4437608|NCT00117676|4262060|B1|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
4437609|NCT00117676|4262058|B3|Spain||Region of Enrollment||participants|Number|21|21.0||||||
4437610|NCT00117676|4262059|B2|Spain||Region of Enrollment||participants|Number|6|6.0||||||
4437611|NCT00117676|4262060|B1|Spain||Region of Enrollment||participants|Number|15|15.0||||||
4437612|NCT00117676|4262058|B3|Greece||Region of Enrollment||participants|Number|28|28.0||||||
4437613|NCT00117676|4262059|B2|Greece||Region of Enrollment||participants|Number|9|9.0||||||
4437614|NCT00117676|4262060|B1|Greece||Region of Enrollment||participants|Number|19|19.0||||||
4437615|NCT00117676|4262058|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4437616|NCT00117676|4262059|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4437617|NCT00117676|4262060|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4437618|NCT00117676|4262058|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4437619|NCT00117676|4262059|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4437620|NCT00117676|4262060|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4437621|NCT00117676|4262058|B3|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4437622|NCT00117676|4262059|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4437623|NCT00117676|4262060|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4437624|NCT00117676|4262058|B3|White||Race/Ethnicity, Customized||participants|Number|242|242.0||||||
4437625|NCT00117676|4262059|B2|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4437626|NCT00117676|4262060|B1|White||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
4437627|NCT00117676|4262058|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4437628|NCT00117676|4262059|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4437629|NCT00117676|4262060|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4437630|NCT00117676|4262058|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4437631|NCT00117676|4262059|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4437632|NCT00117676|4262060|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4437633|NCT00117676|4262058|B3|Asian||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4437634|NCT00117676|4262059|B2|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4437635|NCT00117676|4262060|B1|Asian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4437636|NCT00117676|4262058|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4437637|NCT00117676|4262059|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4437638|NCT00117676|4262060|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4437639|NCT00117676|4262058|B3||Male|Gender||Participants|Count of Participants|290|290.0||||||
4437640|NCT00117676|4262059|B2||Male|Gender||Participants|Count of Participants|97|97.0||||||
4437641|NCT00117676|4262060|B1||Male|Gender||Participants|Count of Participants|193|193.0||||||
4437642|NCT00117676|4262058|B3||Female|Gender||Participants|Count of Participants|85|85.0||||||
4437643|NCT00117676|4262059|B2||Female|Gender||Participants|Count of Participants|28|28.0||||||
4437644|NCT00117676|4262060|B1||Female|Gender||Participants|Count of Participants|57|57.0||||||
4437645|NCT00117676|4262058|B3|||Age||years|Mean|44|44.0|Standard Deviation|10.4|10.4|||
4437646|NCT00117676|4262059|B2|||Age||years|Mean|43|43.0|Standard Deviation|10.0|10.0|||
4437647|NCT00117676|4262060|B1|||Age||years|Mean|44|44.0|Standard Deviation|10.6|10.6|||
4437648|NCT00117676|4262058|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4437649|NCT00117676|4262059|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4437650|NCT00117676|4262060|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4437651|NCT00117676|4262058|B3||Between 18 and 65 years|Age||Participants|Count of Participants|370|370.0||||||
4437652|NCT00117676|4262059|B2||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4437653|NCT00117676|4262060|B1||Between 18 and 65 years|Age||Participants|Count of Participants|247|247.0||||||
4437654|NCT00117676|4262058|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4437655|NCT00117676|4262059|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4437656|NCT00117676|4262060|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437657|NCT00117637|4262148|B3|||Time since initial diagnosis||years|Median|1|1.0|Full Range|||0.1|20.2|
4437658|NCT00117637|4262149|B2|||Time since initial diagnosis||years|Median|1|1.0|Full Range|||0.1|20.2|
4437659|NCT00117637|4262150|B1|||Time since initial diagnosis||years|Median|0.9|0.9|Full Range|||0.1|13.7|
4437660|NCT00117637|4262148|B3|||Time since first progression||years|Median|0.2|0.2|Full Range|||0.0|12.4|
4437661|NCT00117637|4262149|B2|||Time since first progression||years|Median|0.2|0.2|Full Range|||0.0|12.4|
4437662|NCT00117637|4262150|B1|||Time since first progression||years|Median|0.2|0.2|Full Range|||0.0|4.5|
4437663|NCT00117637|4262148|B3|other variant||Renal Cell Carcinoma (RCC) subtype||participants|Number|23|23.0||||||
4437664|NCT00117637|4262149|B2|other variant||Renal Cell Carcinoma (RCC) subtype||participants|Number|11|11.0||||||
4437665|NCT00117637|4262150|B1|other variant||Renal Cell Carcinoma (RCC) subtype||participants|Number|12|12.0||||||
4437666|NCT00117637|4262148|B3|clear cell||Renal Cell Carcinoma (RCC) subtype||participants|Number|166|166.0||||||
4437667|NCT00117637|4262149|B2|clear cell||Renal Cell Carcinoma (RCC) subtype||participants|Number|81|81.0||||||
4437668|NCT00117637|4262150|B1|clear cell||Renal Cell Carcinoma (RCC) subtype||participants|Number|85|85.0||||||
4437669|NCT00117637|4262148|B3|Missing||Race||participants|Number|45|45.0||||||
4437670|NCT00117637|4262149|B2|Missing||Race||participants|Number|16|16.0||||||
4437671|NCT00117637|4262150|B1|Missing||Race||participants|Number|29|29.0||||||
4437672|NCT00117637|4262148|B3|Asian||Race||participants|Number|1|1.0||||||
4437673|NCT00117637|4262149|B2|Asian||Race||participants|Number|1|1.0||||||
4437674|NCT00117637|4262150|B1|Asian||Race||participants|Number|0|0.0||||||
4437675|NCT00117637|4262148|B3|White||Race||participants|Number|143|143.0||||||
4437676|NCT00117637|4262149|B2|White||Race||participants|Number|75|75.0||||||
4437677|NCT00117637|4262150|B1|White||Race||participants|Number|68|68.0||||||
4437678|NCT00117637|4262148|B3|missing||Motzer risk factors|Definition according to Motzer's score (predictive factor): low = no risk factor available; intermediate = 1 or 2 risk factors available; high = 3 or more risk factors available.|participants|Number|1|1.0||||||
4437679|NCT00117637|4262149|B2|missing||Motzer risk factors|Definition according to Motzer's score (predictive factor): low = no risk factor available; intermediate = 1 or 2 risk factors available; high = 3 or more risk factors available.|participants|Number|1|1.0||||||
4437680|NCT00117637|4262150|B1|missing||Motzer risk factors|Definition according to Motzer's score (predictive factor): low = no risk factor available; intermediate = 1 or 2 risk factors available; high = 3 or more risk factors available.|participants|Number|0|0.0||||||
4437681|NCT00117637|4262148|B3|high||Motzer risk factors|Definition according to Motzer's score (predictive factor): low = no risk factor available; intermediate = 1 or 2 risk factors available; high = 3 or more risk factors available.|participants|Number|1|1.0||||||
4437682|NCT00117637|4262149|B2|high||Motzer risk factors|Definition according to Motzer's score (predictive factor): low = no risk factor available; intermediate = 1 or 2 risk factors available; high = 3 or more risk factors available.|participants|Number|0|0.0||||||
4437683|NCT00117637|4262150|B1|high||Motzer risk factors|Definition according to Motzer's score (predictive factor): low = no risk factor available; intermediate = 1 or 2 risk factors available; high = 3 or more risk factors available.|participants|Number|1|1.0||||||
4437684|NCT00117637|4262148|B3|intermediate||Motzer risk factors|Definition according to Motzer's score (predictive factor): low = no risk factor available; intermediate = 1 or 2 risk factors available; high = 3 or more risk factors available.|participants|Number|88|88.0||||||
4437685|NCT00117637|4262149|B2|intermediate||Motzer risk factors|Definition according to Motzer's score (predictive factor): low = no risk factor available; intermediate = 1 or 2 risk factors available; high = 3 or more risk factors available.|participants|Number|44|44.0||||||
4437686|NCT00117637|4262150|B1|intermediate||Motzer risk factors|Definition according to Motzer's score (predictive factor): low = no risk factor available; intermediate = 1 or 2 risk factors available; high = 3 or more risk factors available.|participants|Number|44|44.0||||||
4437687|NCT00117637|4262148|B3|low||Motzer risk factors|Definition according to Motzer's score (predictive factor): low = no risk factor available; intermediate = 1 or 2 risk factors available; high = 3 or more risk factors available.|participants|Number|99|99.0||||||
4437688|NCT00117637|4262149|B2|low||Motzer risk factors|Definition according to Motzer's score (predictive factor): low = no risk factor available; intermediate = 1 or 2 risk factors available; high = 3 or more risk factors available.|participants|Number|47|47.0||||||
4437689|NCT00117637|4262150|B1|low||Motzer risk factors|Definition according to Motzer's score (predictive factor): low = no risk factor available; intermediate = 1 or 2 risk factors available; high = 3 or more risk factors available.|participants|Number|52|52.0||||||
4437690|NCT00117637|4262148|B3|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Category 0 = Fully active, able to carry on all pre-diseases performance without restriction; Category 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework, office work).|participants|Number|84|84.0||||||
4437691|NCT00117637|4262149|B2|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Category 0 = Fully active, able to carry on all pre-diseases performance without restriction; Category 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework, office work).|participants|Number|43|43.0||||||
4437692|NCT00117637|4262150|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Category 0 = Fully active, able to carry on all pre-diseases performance without restriction; Category 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework, office work).|participants|Number|41|41.0||||||
4437693|NCT00117637|4262148|B3|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Category 0 = Fully active, able to carry on all pre-diseases performance without restriction; Category 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework, office work).|participants|Number|105|105.0||||||
4437694|NCT00117637|4262149|B2|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Category 0 = Fully active, able to carry on all pre-diseases performance without restriction; Category 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework, office work).|participants|Number|49|49.0||||||
4437755|NCT00117559|4262295|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4437756|NCT00117559|4262296|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4437695|NCT00117637|4262150|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Category 0 = Fully active, able to carry on all pre-diseases performance without restriction; Category 1 = restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (e.g. light housework, office work).|participants|Number|56|56.0||||||
4437696|NCT00117637|4262148|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4437697|NCT00117637|4262149|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4437698|NCT00117637|4262150|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4437699|NCT00117637|4262148|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4437700|NCT00117637|4262149|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4437701|NCT00117637|4262150|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4437702|NCT00117637|4262148|B3|||Age||years|Median|62|62.0|Full Range|||18.0|80.0|
4437703|NCT00117637|4262149|B2|||Age||years|Median|62.5|62.5|Full Range|||18.0|80.0|
4437704|NCT00117637|4262150|B1|||Age||years|Median|62|62.0|Full Range|||34.0|78.0|
4437705|NCT00117598|4262223|B4||Male|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4437706|NCT00117598|4262224|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4437707|NCT00117598|4262225|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4437708|NCT00117598|4262226|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4437709|NCT00117598|4262223|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4437710|NCT00117598|4262224|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4437711|NCT00117598|4262225|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4437712|NCT00117598|4262226|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4437713|NCT00117598|4262223|B4|>=65 years||Age, Customized||years|Number|100|100.0||||||
4437714|NCT00117598|4262224|B3|>=65 years||Age, Customized||years|Number|28|28.0||||||
4437715|NCT00117598|4262225|B2|>=65 years||Age, Customized||years|Number|39|39.0||||||
4437716|NCT00117598|4262226|B1|>=65 years||Age, Customized||years|Number|33|33.0||||||
4437717|NCT00117598|4262223|B4|<65 years||Age, Customized||years|Number|69|69.0||||||
4437718|NCT00117598|4262224|B3|<65 years||Age, Customized||years|Number|28|28.0||||||
4437719|NCT00117598|4262225|B2|<65 years||Age, Customized||years|Number|17|17.0||||||
4437720|NCT00117598|4262226|B1|<65 years||Age, Customized||years|Number|24|24.0||||||
4437721|NCT00117585|4262258|B1|United States||Region of Enrollment||participants|Number|341|341.0||||||
4437722|NCT00117585|4262258|B1||Male|Sex: Female, Male||Participants|Count of Participants|300|300.0||||||
4437723|NCT00117585|4262258|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4437724|NCT00117585|4262258|B1|||Age||years|Mean|75|75.0|Standard Deviation|8|8.0|||
4437725|NCT00117585|4262258|B1||>=65 years|Age||Participants|Count of Participants|341|341.0||||||
4437726|NCT00117585|4262258|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4437727|NCT00117585|4262258|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437728|NCT00117572|4262262|B3|Russia||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4437729|NCT00117572|4262263|B2|Russia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4437730|NCT00117572|4262264|B1|Russia||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4437731|NCT00117572|4262262|B3|Croatia||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4437732|NCT00117572|4262263|B2|Croatia||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4437733|NCT00117572|4262264|B1|Croatia||Region of Enrollment||Participants|Count of Participants|5|5.0||||||
4437734|NCT00117572|4262262|B3|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4437735|NCT00117572|4262263|B2|Spain||Region of Enrollment||Participants|Count of Participants|0|0.0||||||
4437736|NCT00117572|4262264|B1|Spain||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4437737|NCT00117572|4262262|B3|United States||Region of Enrollment||Participants|Count of Participants|243|243.0||||||
4437738|NCT00117572|4262263|B2|United States||Region of Enrollment||Participants|Count of Participants|123|123.0||||||
4437739|NCT00117572|4262264|B1|United States||Region of Enrollment||Participants|Count of Participants|120|120.0||||||
4437740|NCT00117572|4262262|B3|France||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4437741|NCT00117572|4262263|B2|France||Region of Enrollment||Participants|Count of Participants|3|3.0||||||
4437742|NCT00117572|4262264|B1|France||Region of Enrollment||Participants|Count of Participants|4|4.0||||||
4437743|NCT00117572|4262262|B3||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4437744|NCT00117572|4262263|B2||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4437745|NCT00117572|4262264|B1||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4437746|NCT00117572|4262262|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4437747|NCT00117572|4262263|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4437748|NCT00117572|4262264|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4437749|NCT00117572|4262262|B3|||Age||years|Mean|56.8|56.8|Full Range|||31.0|82.0|
4437750|NCT00117572|4262263|B2|||Age||years|Mean|56.9|56.9|Full Range|||38.0|82.0|
4437751|NCT00117572|4262264|B1|||Age||years|Mean|56.7|56.7|Full Range|||31.0|75.0|
4437752|NCT00117559|4262295|B3|||BDI||units on a scale|Mean|12.61|12.61|Standard Deviation|9.14|9.14|||
4437753|NCT00117559|4262296|B2|||BDI||units on a scale|Mean|12.29|12.29|Standard Deviation|10.10|10.1|||
4437754|NCT00117559|4262297|B1|||BDI||units on a scale|Mean|12.93|12.93|Standard Deviation|8.17|8.17|||
4437757|NCT00117559|4262297|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4437758|NCT00117559|4262295|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4437759|NCT00117559|4262296|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4437760|NCT00117559|4262297|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4437761|NCT00117559|4262295|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437762|NCT00117559|4262296|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437763|NCT00117559|4262297|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437764|NCT00117559|4262295|B3|||Age||years|Mean|54.16|54.16|Standard Deviation|5.38|5.38|||
4437765|NCT00117559|4262296|B2|||Age||years|Mean|54.50|54.5|Standard Deviation|6.38|6.38|||
4437766|NCT00117559|4262297|B1|||Age||years|Mean|53.78|53.78|Standard Deviation|4.35|4.35|||
4437767|NCT00117338|4262304|B3|||Baseline FEV1 (Percent predicted)|"Percent of predicted baseline Forced Expiratory Volume in one second (FEV1)~A total of 4/276 (1—montelukast; 3—placebo) randomized patients were excluded from the Full Analysis Set (FAS) of the primary endpoint"|Percent|Mean|51.2|51.2|Standard Deviation|17.1|17.1|||
4437768|NCT00117338|4262305|B2|||Baseline FEV1 (Percent predicted)|"Percent of predicted baseline Forced Expiratory Volume in one second (FEV1)~A total of 4/276 (1—montelukast; 3—placebo) randomized patients were excluded from the Full Analysis Set (FAS) of the primary endpoint"|Percent|Mean|50.6|50.6|Standard Deviation|17.4|17.4|||
4437769|NCT00117338|4262306|B1|||Baseline FEV1 (Percent predicted)|"Percent of predicted baseline Forced Expiratory Volume in one second (FEV1)~A total of 4/276 (1—montelukast; 3—placebo) randomized patients were excluded from the Full Analysis Set (FAS) of the primary endpoint"|Percent|Mean|51.8|51.8|Standard Deviation|16.8|16.8|||
4437770|NCT00117338|4262304|B3|||Baseline FEV 1 (L)|"Forced Expiratory Volume in one second, measured in Liters (FEV 1 (L))~A total of 4/276 (1—montelukast; 3—placebo) randomized patients were excluded from the Full Analysis Set (FAS) of the primary endpoint"|Liters|Mean|1.0|1.0|Standard Deviation|0.5|0.5|||
4437771|NCT00117338|4262305|B2|||Baseline FEV 1 (L)|"Forced Expiratory Volume in one second, measured in Liters (FEV 1 (L))~A total of 4/276 (1—montelukast; 3—placebo) randomized patients were excluded from the Full Analysis Set (FAS) of the primary endpoint"|Liters|Mean|1.00|1.0|Standard Deviation|0.5|0.5|||
4437772|NCT00117338|4262306|B1|||Baseline FEV 1 (L)|"Forced Expiratory Volume in one second, measured in Liters (FEV 1 (L))~A total of 4/276 (1—montelukast; 3—placebo) randomized patients were excluded from the Full Analysis Set (FAS) of the primary endpoint"|Liters|Mean|1.06|1.06|Standard Deviation|0.5|0.5|||
4437773|NCT00117338|4262304|B3|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4437774|NCT00117338|4262305|B2|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4437775|NCT00117338|4262306|B1|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4437776|NCT00117338|4262304|B3|Multi-Racial||Race/Ethnicity||participants|Number|61|61.0||||||
4437777|NCT00117338|4262305|B2|Multi-Racial||Race/Ethnicity||participants|Number|27|27.0||||||
4437778|NCT00117338|4262306|B1|Multi-Racial||Race/Ethnicity||participants|Number|34|34.0||||||
4437779|NCT00117338|4262304|B3|Asian||Race/Ethnicity||participants|Number|36|36.0||||||
4437780|NCT00117338|4262305|B2|Asian||Race/Ethnicity||participants|Number|18|18.0||||||
4437781|NCT00117338|4262306|B1|Asian||Race/Ethnicity||participants|Number|18|18.0||||||
4437782|NCT00117338|4262304|B3|Hispanic||Race/Ethnicity||participants|Number|112|112.0||||||
4437783|NCT00117338|4262305|B2|Hispanic||Race/Ethnicity||participants|Number|53|53.0||||||
4437784|NCT00117338|4262306|B1|Hispanic||Race/Ethnicity||participants|Number|59|59.0||||||
4437785|NCT00117338|4262304|B3|Black||Race/Ethnicity||participants|Number|34|34.0||||||
4437786|NCT00117338|4262305|B2|Black||Race/Ethnicity||participants|Number|16|16.0||||||
4437787|NCT00117338|4262306|B1|Black||Race/Ethnicity||participants|Number|18|18.0||||||
4437788|NCT00117338|4262304|B3|White (Non-Hispanic)||Race/Ethnicity||participants|Number|32|32.0||||||
4437789|NCT00117338|4262305|B2|White (Non-Hispanic)||Race/Ethnicity||participants|Number|16|16.0||||||
4437790|NCT00117338|4262306|B1|White (Non-Hispanic)||Race/Ethnicity||participants|Number|16|16.0||||||
4437791|NCT00117338|4262304|B3||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4437792|NCT00117338|4262305|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4437793|NCT00117338|4262306|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4437794|NCT00117338|4262304|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4437795|NCT00117338|4262305|B2||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4437796|NCT00117338|4262306|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4437797|NCT00117338|4262304|B3|||Age||years|Mean|9.1|9.1|Standard Deviation|2.34|2.34|||
4437798|NCT00117338|4262305|B2|||Age||years|Mean|8.9|8.9|Standard Deviation|2.32|2.32|||
4437799|NCT00117338|4262306|B1|||Age||years|Mean|9.2|9.2|Standard Deviation|2.36|2.36|||
4437800|NCT00117325|4262325|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437801|NCT00117325|4262326|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437802|NCT00117325|4262327|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437803|NCT00117325|4262325|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4437804|NCT00117325|4262326|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4437805|NCT00117325|4262327|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4437806|NCT00117325|4262325|B3||White|Race (NIH/OMB)||Participants|Count of Participants|332|332.0||||||
4437807|NCT00117325|4262326|B2||White|Race (NIH/OMB)||Participants|Count of Participants|169|169.0||||||
4437808|NCT00117325|4262327|B1||White|Race (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
4437809|NCT00117325|4262325|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4437810|NCT00117325|4262326|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4437811|NCT00117325|4262327|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4437812|NCT00117325|4262325|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437813|NCT00117325|4262326|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437814|NCT00117325|4262327|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437815|NCT00117325|4262325|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4437816|NCT00117325|4262326|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4437817|NCT00117325|4262327|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4437818|NCT00117325|4262325|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4437819|NCT00117325|4262326|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4437820|NCT00117325|4262327|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4437821|NCT00117325|4262325|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4437822|NCT00117325|4262326|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4437823|NCT00117325|4262327|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4437824|NCT00117325|4262325|B3||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4437825|NCT00117325|4262326|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4437826|NCT00117325|4262327|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4437827|NCT00117325|4262325|B3|||Age||Years|Mean|45.8|45.8|Standard Deviation|15.77|15.77|||
4437828|NCT00117325|4262326|B2|||Age||Years|Mean|46.6|46.6|Standard Deviation|16.77|16.77|||
4437829|NCT00117325|4262327|B1|||Age||Years|Mean|45.0|45.0|Standard Deviation|14.66|14.66|||
4437830|NCT00117312|4262356|B5|||Weight||kilogram|Mean|81.0|81.0|Standard Deviation|12.6|12.6|||
4437831|NCT00117312|4262357|B4|||Weight||kilogram|Mean|81.4|81.4|Standard Deviation|14.4|14.4|||
4437832|NCT00117312|4262358|B3|||Weight||kilogram|Mean|80.8|80.8|Standard Deviation|12.8|12.8|||
4437833|NCT00117312|4262359|B2|||Weight||kilogram|Mean|81.7|81.7|Standard Deviation|11.5|11.5|||
4437834|NCT00117312|4262360|B1|||Weight||kilogram|Mean|79.0|79.0|Standard Deviation|11.7|11.7|||
4437835|NCT00117312|4262356|B5|||Time since prostate cancer diagnosis|Mean number of days since the participants in each treatment were diagnosed with prostate cancer.|days|Mean|1181|1181.0|Standard Deviation|1494|1494.0|||
4437836|NCT00117312|4262357|B4|||Time since prostate cancer diagnosis|Mean number of days since the participants in each treatment were diagnosed with prostate cancer.|days|Mean|1095|1095.0|Standard Deviation|1385|1385.0|||
4437837|NCT00117312|4262358|B3|||Time since prostate cancer diagnosis|Mean number of days since the participants in each treatment were diagnosed with prostate cancer.|days|Mean|1609|1609.0|Standard Deviation|1836|1836.0|||
4437838|NCT00117312|4262359|B2|||Time since prostate cancer diagnosis|Mean number of days since the participants in each treatment were diagnosed with prostate cancer.|days|Mean|954|954.0|Standard Deviation|1329|1329.0|||
4437839|NCT00117312|4262360|B1|||Time since prostate cancer diagnosis|Mean number of days since the participants in each treatment were diagnosed with prostate cancer.|days|Mean|851|851.0|Standard Deviation|1077|1077.0|||
4437840|NCT00117312|4262356|B5|||Body mass index|Body mass is a measure of body fat based on height and weight.|kilogram per square meter|Mean|26.8|26.8|Standard Deviation|3.64|3.64|||
4437841|NCT00117312|4262357|B4|||Body mass index|Body mass is a measure of body fat based on height and weight.|kilogram per square meter|Mean|26.6|26.6|Standard Deviation|3.39|3.39|||
4437842|NCT00117312|4262358|B3|||Body mass index|Body mass is a measure of body fat based on height and weight.|kilogram per square meter|Mean|27.2|27.2|Standard Deviation|3.15|3.15|||
4437843|NCT00117312|4262359|B2|||Body mass index|Body mass is a measure of body fat based on height and weight.|kilogram per square meter|Mean|26.6|26.6|Standard Deviation|3.54|3.54|||
4437844|NCT00117312|4262360|B1|||Body mass index|Body mass is a measure of body fat based on height and weight.|kilogram per square meter|Mean|26.7|26.7|Standard Deviation|5.66|5.66|||
4437845|NCT00117312|4262356|B5|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|18|18.0||||||
4437846|NCT00117312|4262357|B4|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|7|7.0||||||
4437847|NCT00117312|4262358|B3|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4437848|NCT00117312|4262359|B2|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4437901|NCT00117312|4262357|B4||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4437902|NCT00117312|4262358|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4437849|NCT00117312|4262360|B1|Not classifiable||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4437850|NCT00117312|4262356|B5|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|10|10.0||||||
4437851|NCT00117312|4262357|B4|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4437852|NCT00117312|4262358|B3|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4437853|NCT00117312|4262359|B2|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|4|4.0||||||
4437854|NCT00117312|4262360|B1|Metastatic||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|2|2.0||||||
4437855|NCT00117312|4262356|B5|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|16|16.0||||||
4437856|NCT00117312|4262357|B4|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4437857|NCT00117312|4262358|B3|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4437858|NCT00117312|4262359|B2|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|6|6.0||||||
4437859|NCT00117312|4262360|B1|Locally advanced||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|0|0.0||||||
4437860|NCT00117312|4262356|B5|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|38|38.0||||||
4437861|NCT00117312|4262357|B4|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|10|10.0||||||
4437862|NCT00117312|4262358|B3|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|12|12.0||||||
4437863|NCT00117312|4262359|B2|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|11|11.0||||||
4437864|NCT00117312|4262360|B1|Localized||Stage of prostate cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4437865|NCT00117312|4262356|B5|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|36|36.0||||||
4437866|NCT00117312|4262357|B4|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|11|11.0||||||
4437903|NCT00117312|4262359|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4437867|NCT00117312|4262358|B3|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|11|11.0||||||
4437868|NCT00117312|4262359|B2|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|8|8.0||||||
4437869|NCT00117312|4262360|B1|7-10||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|6|6.0||||||
4437870|NCT00117312|4262356|B5|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|42|42.0||||||
4437871|NCT00117312|4262357|B4|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|13|13.0||||||
4437872|NCT00117312|4262358|B3|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|12|12.0||||||
4437873|NCT00117312|4262359|B2|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|14|14.0||||||
4437874|NCT00117312|4262360|B1|5-6||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|3|3.0||||||
4437875|NCT00117312|4262356|B5|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|3|3.0||||||
4437876|NCT00117312|4262357|B4|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4437877|NCT00117312|4262358|B3|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4437878|NCT00117312|4262359|B2|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4437879|NCT00117312|4262360|B1|2-4||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4437880|NCT00117312|4262356|B5|Unknown||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4437881|NCT00117312|4262357|B4|Unknown||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4437882|NCT00117312|4262358|B3|Unknown||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4437883|NCT00117312|4262359|B2|Unknown||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4437884|NCT00117312|4262360|B1|Unknown||Gleason score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|0|0.0||||||
4437885|NCT00117312|4262356|B5|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4437886|NCT00117312|4262357|B4|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4437887|NCT00117312|4262358|B3|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4437888|NCT00117312|4262359|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4437889|NCT00117312|4262360|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4437890|NCT00117312|4262356|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4437891|NCT00117312|4262357|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4437892|NCT00117312|4262358|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4437893|NCT00117312|4262359|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4437894|NCT00117312|4262360|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4437895|NCT00117312|4262356|B5|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4437896|NCT00117312|4262357|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4437897|NCT00117312|4262358|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4437898|NCT00117312|4262359|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4437899|NCT00117312|4262360|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4437900|NCT00117312|4262356|B5||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4437904|NCT00117312|4262360|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4437905|NCT00117312|4262356|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437906|NCT00117312|4262357|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437907|NCT00117312|4262358|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437908|NCT00117312|4262359|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437909|NCT00117312|4262360|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4437910|NCT00117312|4262356|B5|||Age||years|Mean|75.6|75.6|Standard Deviation|6.90|6.9|||
4437911|NCT00117312|4262357|B4|||Age||years|Mean|74.7|74.7|Standard Deviation|8.37|8.37|||
4437912|NCT00117312|4262358|B3|||Age||years|Mean|75.9|75.9|Standard Deviation|5.79|5.79|||
4437913|NCT00117312|4262359|B2|||Age||years|Mean|77.5|77.5|Standard Deviation|6.38|6.38|||
4437914|NCT00117312|4262360|B1|||Age||years|Mean|72.0|72.0|Standard Deviation|5.72|5.72|||
4437915|NCT00117312|4262356|B5||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4437916|NCT00117312|4262357|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4437917|NCT00117312|4262358|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4437918|NCT00117312|4262359|B2||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4437919|NCT00117312|4262360|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4437920|NCT00117312|4262356|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4437921|NCT00117312|4262357|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4437922|NCT00117312|4262358|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4437923|NCT00117312|4262359|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4437924|NCT00117312|4262360|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4437925|NCT00117312|4262356|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437926|NCT00117312|4262357|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437927|NCT00117312|4262358|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437928|NCT00117312|4262359|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437929|NCT00117312|4262360|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4437930|NCT00117286|4262377|B3|||Time since Prostate Cancer Diagnosis|Safety analysis set|days|Mean|1299|1299.0|Standard Deviation|1580|1580.0|||
4437931|NCT00117286|4262378|B2|||Time since Prostate Cancer Diagnosis|Safety analysis set|days|Mean|1349|1349.0|Standard Deviation|1625|1625.0|||
4437932|NCT00117286|4262379|B1|||Time since Prostate Cancer Diagnosis|Safety analysis set|days|Mean|1253|1253.0|Standard Deviation|1565|1565.0|||
4437933|NCT00117286|4262377|B3|Not classifiable||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|18|18.0||||||
4437934|NCT00117286|4262378|B2|Not classifiable||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|10|10.0||||||
4437935|NCT00117286|4262379|B1|Not classifiable||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|8|8.0||||||
4437936|NCT00117286|4262377|B3|Metastatic||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|10|10.0||||||
4437937|NCT00117286|4262378|B2|Metastatic||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4437938|NCT00117286|4262379|B1|Metastatic||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4437939|NCT00117286|4262377|B3|Locally advanced||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|8|8.0||||||
4437940|NCT00117286|4262378|B2|Locally advanced||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4437969|NCT00117286|4262377|B3||More than one race|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437970|NCT00117286|4262378|B2||More than one race|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4438241|NCT00116779|4262598|B2||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4437941|NCT00117286|4262379|B1|Locally advanced||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|3|3.0||||||
4437942|NCT00117286|4262377|B3|Localized||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|21|21.0||||||
4437943|NCT00117286|4262378|B2|Localized||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|7|7.0||||||
4437944|NCT00117286|4262379|B1|Localized||Stage of Prostate Cancer|Safety analysis set. Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|14|14.0||||||
4437945|NCT00117286|4262377|B3|7-10||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|41|41.0||||||
4437946|NCT00117286|4262378|B2|7-10||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|18|18.0||||||
4437947|NCT00117286|4262379|B1|7-10||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|23|23.0||||||
4437948|NCT00117286|4262377|B3|5-6||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|13|13.0||||||
4437949|NCT00117286|4262378|B2|5-6||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|8|8.0||||||
4437950|NCT00117286|4262379|B1|5-6||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|5|5.0||||||
4437951|NCT00117286|4262377|B3|2-4||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|3|3.0||||||
4437952|NCT00117286|4262378|B2|2-4||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|1|1.0||||||
4437953|NCT00117286|4262379|B1|2-4||Gleason Score|Safety analysis set. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|2|2.0||||||
4437954|NCT00117286|4262377|B3|No||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|35|35.0||||||
4437955|NCT00117286|4262378|B2|No||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|16|16.0||||||
4437956|NCT00117286|4262379|B1|No||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|19|19.0||||||
4437957|NCT00117286|4262377|B3|Yes||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|22|22.0||||||
4437958|NCT00117286|4262378|B2|Yes||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|11|11.0||||||
4437959|NCT00117286|4262379|B1|Yes||Curative Intent|Safety analysis set. A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|11|11.0||||||
4437960|NCT00117286|4262377|B3|||Body mass index|Safety analysis set|kilogram per square meter|Mean|26.5|26.5|Standard Deviation|4.10|4.1|||
4437961|NCT00117286|4262378|B2|||Body mass index|Safety analysis set|kilogram per square meter|Mean|26.6|26.6|Standard Deviation|4.63|4.63|||
4437962|NCT00117286|4262379|B1|||Body mass index|Safety analysis set|kilogram per square meter|Mean|26.5|26.5|Standard Deviation|3.64|3.64|||
4437963|NCT00117286|4262377|B3|||Body weight|Safety analysis set|kilogram|Mean|80.1|80.1|Standard Deviation|12.2|12.2|||
4437964|NCT00117286|4262378|B2|||Body weight|Safety analysis set|kilogram|Mean|81.3|81.3|Standard Deviation|13.3|13.3|||
4437965|NCT00117286|4262379|B1|||Body weight|Safety analysis set|kilogram|Mean|79.0|79.0|Standard Deviation|11.4|11.4|||
4437966|NCT00117286|4262377|B3||Unknown or Not Reported|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437967|NCT00117286|4262378|B2||Unknown or Not Reported|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437968|NCT00117286|4262379|B1||Unknown or Not Reported|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437971|NCT00117286|4262379|B1||More than one race|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437972|NCT00117286|4262377|B3||White|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|49|49.0||||||
4437973|NCT00117286|4262378|B2||White|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|25|25.0||||||
4437974|NCT00117286|4262379|B1||White|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|24|24.0||||||
4437975|NCT00117286|4262377|B3||Black or African American|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|7|7.0||||||
4437976|NCT00117286|4262378|B2||Black or African American|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|2|2.0||||||
4437977|NCT00117286|4262379|B1||Black or African American|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|5|5.0||||||
4437978|NCT00117286|4262377|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437979|NCT00117286|4262378|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437980|NCT00117286|4262379|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437981|NCT00117286|4262377|B3||Asian|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|1|1.0||||||
4437982|NCT00117286|4262378|B2||Asian|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437983|NCT00117286|4262379|B1||Asian|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|1|1.0||||||
4437984|NCT00117286|4262377|B3||American Indian or Alaska Native|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437985|NCT00117286|4262378|B2||American Indian or Alaska Native|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437986|NCT00117286|4262379|B1||American Indian or Alaska Native|Race (NIH/OMB)|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437987|NCT00117286|4262377|B3||Male|Sex: Female, Male|Safety analysis set|Participants|Count of Participants|57|57.0||||||
4437988|NCT00117286|4262378|B2||Male|Sex: Female, Male|Safety analysis set|Participants|Count of Participants|27|27.0||||||
4437989|NCT00117286|4262379|B1||Male|Sex: Female, Male|Safety analysis set|Participants|Count of Participants|30|30.0||||||
4437990|NCT00117286|4262377|B3||Female|Sex: Female, Male|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437991|NCT00117286|4262378|B2||Female|Sex: Female, Male|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437992|NCT00117286|4262379|B1||Female|Sex: Female, Male|Safety analysis set|Participants|Count of Participants|0|0.0||||||
4437993|NCT00117286|4262377|B3|||Age|Safety analysis set|years|Mean|75.1|75.1|Standard Deviation|7.75|7.75|||
4437994|NCT00117286|4262378|B2|||Age|Safety analysis set|years|Mean|74.1|74.1|Standard Deviation|8.85|8.85|||
4437995|NCT00117286|4262379|B1|||Age|Safety analysis set|years|Mean|76.0|76.0|Standard Deviation|6.63|6.63|||
4437996|NCT00117156|4262388|B1|Splenic MZL||Histology||participants|Number|4|4.0||||||
4437997|NCT00117156|4262388|B1|MALT||Histology||participants|Number|8|8.0||||||
4437998|NCT00117156|4262388|B1|Nodal MZL||Histology||participants|Number|14|14.0||||||
4437999|NCT00117156|4262388|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4438000|NCT00117156|4262388|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4438001|NCT00117156|4262388|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4438002|NCT00117156|4262388|B1|||Age||years|Median|63.7|63.7|Full Range|||31.4|84.0|
4438003|NCT00116857|4262396|B3|United States||Region of Enrollment||participants|Number|122|122.0||||||
4438004|NCT00116857|4262397|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4438005|NCT00116857|4262398|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4438006|NCT00116857|4262396|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4438007|NCT00116857|4262397|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4438008|NCT00116857|4262398|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4438009|NCT00116857|4262396|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4438010|NCT00116857|4262397|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4438011|NCT00116857|4262398|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4438012|NCT00116857|4262396|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|9.0|9.0|||
4438013|NCT00116857|4262397|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|8.5|8.5|||
4438014|NCT00116857|4262398|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|9.4|9.4|||
4438015|NCT00116857|4262396|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4438016|NCT00116857|4262397|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4438017|NCT00116857|4262398|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4438018|NCT00116857|4262396|B3||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4438019|NCT00116857|4262397|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4438020|NCT00116857|4262398|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4438021|NCT00116857|4262396|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4438022|NCT00116857|4262397|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4438023|NCT00116857|4262398|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4438024|NCT00116844|4262405|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4438025|NCT00116844|4262406|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438026|NCT00116844|4262407|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4438027|NCT00116844|4262405|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4438028|NCT00116844|4262406|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4438029|NCT00116844|4262407|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4438030|NCT00116844|4262405|B3||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4438031|NCT00116844|4262406|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4438032|NCT00116844|4262407|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4438033|NCT00116844|4262405|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4438034|NCT00116844|4262406|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4438035|NCT00116844|4262407|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4438036|NCT00116844|4262405|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438037|NCT00116844|4262406|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438038|NCT00116844|4262407|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438039|NCT00116844|4262405|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4438040|NCT00116844|4262406|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4438041|NCT00116844|4262407|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438042|NCT00116844|4262405|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4438043|NCT00116844|4262406|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4438044|NCT00116844|4262407|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438045|NCT00116844|4262405|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4438046|NCT00116844|4262406|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4438047|NCT00116844|4262407|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4438048|NCT00116844|4262405|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4438049|NCT00116844|4262406|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4438050|NCT00116844|4262407|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4438051|NCT00116844|4262405|B3|||Age||Years|Mean|37.4|37.4|Standard Deviation|12.35|12.35|||
4438052|NCT00116844|4262406|B2|||Age||Years|Mean|35.8|35.8|Standard Deviation|11.69|11.69|||
4438053|NCT00116844|4262407|B1|||Age||Years|Mean|39.1|39.1|Standard Deviation|12.96|12.96|||
4438054|NCT00116831|4262424|B3|||Duration of diabetes|Duration of diabetes in the Safety Population|Years|Median|4.74|4.74|Full Range|||0.0|35.82|
4438055|NCT00116831|4262425|B2|||Duration of diabetes|Duration of diabetes in the Safety Population|Years|Median|4.96|4.96|Full Range|||0.02|31.66|
4438056|NCT00116831|4262426|B1|||Duration of diabetes|Duration of diabetes in the Safety Population|Years|Median|4.62|4.62|Full Range|||0.0|35.82|
4438057|NCT00116831|4262424|B3|||Duration of cardiovascular disease|Duration of cardiovascular disease in the Safety Population|Years|Mean|0.73|0.73|Full Range|||0.0|28.0|
4438058|NCT00116831|4262425|B2|||Duration of cardiovascular disease|Duration of cardiovascular disease in the Safety Population|Years|Mean|0.59|0.59|Full Range|||0.0|25.19|
4438059|NCT00116831|4262426|B1|||Duration of cardiovascular disease|Duration of cardiovascular disease in the Safety Population|Years|Mean|0.79|0.79|Full Range|||0.01|28.58|
4438060|NCT00116831|4262424|B3|||Body Mass Index (BMI)|Median BMI in the Safety Population|kilograms per square meter (kg/m2)|Median|29|29.0|Full Range|||17.0|58.0|
4438061|NCT00116831|4262425|B2|||Body Mass Index (BMI)|Median BMI in the Safety Population|kilograms per square meter (kg/m2)|Median|28|28.0|Full Range|||17.0|58.0|
4438062|NCT00116831|4262426|B1|||Body Mass Index (BMI)|Median BMI in the Safety Population|kilograms per square meter (kg/m2)|Median|29|29.0|Full Range|||19.0|52.0|
4438063|NCT00116831|4262424|B3|Missing||Smoking history|Smoking history in the Safety Population|Participants|Number|1|1.0||||||
4438064|NCT00116831|4262425|B2|Missing||Smoking history|Smoking history in the Safety Population|Participants|Number|1|1.0||||||
4438065|NCT00116831|4262426|B1|Missing||Smoking history|Smoking history in the Safety Population|Participants|Number|0|0.0||||||
4438066|NCT00116831|4262424|B3|Former smoker||Smoking history|Smoking history in the Safety Population|Participants|Number|252|252.0||||||
4438067|NCT00116831|4262425|B2|Former smoker||Smoking history|Smoking history in the Safety Population|Participants|Number|124|124.0||||||
4438068|NCT00116831|4262426|B1|Former smoker||Smoking history|Smoking history in the Safety Population|Participants|Number|128|128.0||||||
4438069|NCT00116831|4262424|B3|Current smoker||Smoking history|Smoking history in the Safety Population|Participants|Number|112|112.0||||||
4438070|NCT00116831|4262425|B2|Current smoker||Smoking history|Smoking history in the Safety Population|Participants|Number|55|55.0||||||
4438071|NCT00116831|4262426|B1|Current smoker||Smoking history|Smoking history in the Safety Population|Participants|Number|57|57.0||||||
4438072|NCT00116831|4262424|B3|Never smoked||Smoking history|Smoking history in the Safety Population|Participants|Number|303|303.0||||||
4438073|NCT00116831|4262425|B2|Never smoked||Smoking history|Smoking history in the Safety Population|Participants|Number|151|151.0||||||
4438074|NCT00116831|4262426|B1|Never smoked||Smoking history|Smoking history in the Safety Population|Participants|Number|152|152.0||||||
4438075|NCT00116831|4262424|B3|Oral anti-diabetic dual therapy||Pre-study Treatment|Pre-study treatment in the Safety Population|Participants|Number|183|183.0||||||
4438076|NCT00116831|4262425|B2|Oral anti-diabetic dual therapy||Pre-study Treatment|Pre-study treatment in the Safety Population|Participants|Number|93|93.0||||||
4438077|NCT00116831|4262426|B1|Oral anti-diabetic dual therapy||Pre-study Treatment|Pre-study treatment in the Safety Population|Participants|Number|90|90.0||||||
4438078|NCT00116831|4262424|B3|Oral anti-diabetic monotherapy||Pre-study Treatment|Pre-study treatment in the Safety Population|Participants|Number|365|365.0||||||
4438079|NCT00116831|4262425|B2|Oral anti-diabetic monotherapy||Pre-study Treatment|Pre-study treatment in the Safety Population|Participants|Number|182|182.0||||||
4438080|NCT00116831|4262426|B1|Oral anti-diabetic monotherapy||Pre-study Treatment|Pre-study treatment in the Safety Population|Participants|Number|183|183.0||||||
4438081|NCT00116831|4262424|B3|Diet and exercise regimen only||Pre-study Treatment|Pre-study treatment in the Safety Population|Participants|Number|120|120.0||||||
4438082|NCT00116831|4262425|B2|Diet and exercise regimen only||Pre-study Treatment|Pre-study treatment in the Safety Population|Participants|Number|56|56.0||||||
4438083|NCT00116831|4262426|B1|Diet and exercise regimen only||Pre-study Treatment|Pre-study treatment in the Safety Population|Participants|Number|64|64.0||||||
4438084|NCT00116831|4262424|B3|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4438085|NCT00116831|4262425|B2|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4438086|NCT00116831|4262426|B1|American Indian/Alaska native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4438087|NCT00116831|4262424|B3|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4438088|NCT00116831|4262425|B2|Missing||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4438089|NCT00116831|4262426|B1|Missing||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4438090|NCT00116831|4262424|B3|Mixed race||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4438091|NCT00116831|4262425|B2|Mixed race||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4438092|NCT00116831|4262426|B1|Mixed race||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4438093|NCT00116831|4262424|B3|Black||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4438094|NCT00116831|4262425|B2|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4438095|NCT00116831|4262426|B1|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4438096|NCT00116831|4262424|B3|Oriental||Race/Ethnicity, Customized||Participants|Number|152|152.0||||||
4438097|NCT00116831|4262425|B2|Oriental||Race/Ethnicity, Customized||Participants|Number|82|82.0||||||
4438098|NCT00116831|4262426|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|70|70.0||||||
4438099|NCT00116831|4262424|B3|White||Race/Ethnicity, Customized||Participants|Number|495|495.0||||||
4438100|NCT00116831|4262425|B2|White||Race/Ethnicity, Customized||Participants|Number|240|240.0||||||
4438101|NCT00116831|4262426|B1|White||Race/Ethnicity, Customized||Participants|Number|255|255.0||||||
4438102|NCT00116831|4262424|B3||Male|Sex: Female, Male||Participants|Count of Participants|454|454.0||||||
4438103|NCT00116831|4262425|B2||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4438104|NCT00116831|4262426|B1||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4438105|NCT00116831|4262424|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4438106|NCT00116831|4262425|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4438107|NCT00116831|4262426|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4438108|NCT00116831|4262424|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|8.76|8.76|||
4438109|NCT00116831|4262425|B2|||Age||years|Mean|61.8|61.8|Standard Deviation|8.38|8.38|||
4438110|NCT00116831|4262426|B1|||Age||years|Mean|60.2|60.2|Standard Deviation|9.05|9.05|0.0|65.0|
4438111|NCT00116805|4262503|B3|||Baseline Knodell Necroinflammatory Score|Based on Knodell numerical scoring of liver biopsy specimens. The Knodell necroinflammatory score is the combined necrosis and inflammation domain scores and ranges 0 (best) to 14 (worst).|units on a scale|Mean|8.4|8.4|Standard Deviation|2.09|2.09|||
4438112|NCT00116805|4262504|B2|||Baseline Knodell Necroinflammatory Score|Based on Knodell numerical scoring of liver biopsy specimens. The Knodell necroinflammatory score is the combined necrosis and inflammation domain scores and ranges 0 (best) to 14 (worst).|units on a scale|Mean|8.5|8.5|Standard Deviation|2.07|2.07|||
4438113|NCT00116805|4262505|B1|||Baseline Knodell Necroinflammatory Score|Based on Knodell numerical scoring of liver biopsy specimens. The Knodell necroinflammatory score is the combined necrosis and inflammation domain scores and ranges 0 (best) to 14 (worst).|units on a scale|Mean|8.3|8.3|Standard Deviation|2.11|2.11|||
4438114|NCT00116805|4262503|B3|||Baseline Hepatitis B Deoxyribonucleic Acid (HBV DNA)||log10 copies/mL|Mean|8.72|8.72|Standard Deviation|1.033|1.033|||
4438115|NCT00116805|4262504|B2|||Baseline Hepatitis B Deoxyribonucleic Acid (HBV DNA)||log10 copies/mL|Mean|8.88|8.88|Standard Deviation|0.930|0.93|||
4438116|NCT00116805|4262505|B1|||Baseline Hepatitis B Deoxyribonucleic Acid (HBV DNA)||log10 copies/mL|Mean|8.64|8.64|Standard Deviation|1.076|1.076|||
4438117|NCT00116805|4262503|B3|No||Prior Lamivudine or FTC Treatment||participants|Number|257|257.0||||||
4438118|NCT00116805|4262504|B2|No||Prior Lamivudine or FTC Treatment||participants|Number|89|89.0||||||
4438119|NCT00116805|4262505|B1|No||Prior Lamivudine or FTC Treatment||participants|Number|168|168.0||||||
4438120|NCT00116805|4262503|B3|Yes||Prior Lamivudine or FTC Treatment||participants|Number|9|9.0||||||
4438121|NCT00116805|4262504|B2|Yes||Prior Lamivudine or FTC Treatment||participants|Number|1|1.0||||||
4438122|NCT00116805|4262505|B1|Yes||Prior Lamivudine or FTC Treatment||participants|Number|8|8.0||||||
4438123|NCT00116805|4262503|B3|No||Baseline Alanine Aminotransferase (ALT) above the Upper Limit of the Normal (ULN) Range|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|7|7.0||||||
4438124|NCT00116805|4262504|B2|No||Baseline Alanine Aminotransferase (ALT) above the Upper Limit of the Normal (ULN) Range|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|0|0.0||||||
4438125|NCT00116805|4262505|B1|No||Baseline Alanine Aminotransferase (ALT) above the Upper Limit of the Normal (ULN) Range|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|7|7.0||||||
4438186|NCT00116805|4262503|B3||Between 18 and 65 years|Age||Participants|Count of Participants|262|262.0||||||
4438187|NCT00116805|4262504|B2||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4438126|NCT00116805|4262503|B3|Yes||Baseline Alanine Aminotransferase (ALT) above the Upper Limit of the Normal (ULN) Range|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|259|259.0||||||
4438127|NCT00116805|4262504|B2|Yes||Baseline Alanine Aminotransferase (ALT) above the Upper Limit of the Normal (ULN) Range|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|90|90.0||||||
4438128|NCT00116805|4262505|B1|Yes||Baseline Alanine Aminotransferase (ALT) above the Upper Limit of the Normal (ULN) Range|The ULN was 43 U/L for males and 34 U/L for females aged 18 to < 69, and 35 U/L for males and 32 U/L for females aged ≥ 69.|participants|Number|169|169.0||||||
4438129|NCT00116805|4262503|B3|New Zealand||Region of Enrollment||participants|Number|21|21.0||||||
4438130|NCT00116805|4262504|B2|New Zealand||Region of Enrollment||participants|Number|11|11.0||||||
4438131|NCT00116805|4262505|B1|New Zealand||Region of Enrollment||participants|Number|10|10.0||||||
4438132|NCT00116805|4262503|B3|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4438133|NCT00116805|4262504|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4438134|NCT00116805|4262505|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4438135|NCT00116805|4262503|B3|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4438136|NCT00116805|4262504|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4438137|NCT00116805|4262505|B1|Germany||Region of Enrollment||participants|Number|20|20.0||||||
4438138|NCT00116805|4262503|B3|Bulgaria||Region of Enrollment||participants|Number|28|28.0||||||
4438139|NCT00116805|4262504|B2|Bulgaria||Region of Enrollment||participants|Number|11|11.0||||||
4438140|NCT00116805|4262505|B1|Bulgaria||Region of Enrollment||participants|Number|17|17.0||||||
4438141|NCT00116805|4262503|B3|Australia||Region of Enrollment||participants|Number|28|28.0||||||
4438142|NCT00116805|4262504|B2|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4438143|NCT00116805|4262505|B1|Australia||Region of Enrollment||participants|Number|22|22.0||||||
4438144|NCT00116805|4262503|B3|Poland||Region of Enrollment||participants|Number|24|24.0||||||
4438145|NCT00116805|4262504|B2|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4438146|NCT00116805|4262505|B1|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4438147|NCT00116805|4262503|B3|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4438148|NCT00116805|4262504|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4438149|NCT00116805|4262505|B1|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4438150|NCT00116805|4262503|B3|Czech Republic||Region of Enrollment||participants|Number|8|8.0||||||
4438151|NCT00116805|4262504|B2|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4438152|NCT00116805|4262505|B1|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4438153|NCT00116805|4262503|B3|France||Region of Enrollment||participants|Number|14|14.0||||||
4438154|NCT00116805|4262504|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4438155|NCT00116805|4262505|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
4438156|NCT00116805|4262503|B3|United Kingdom||Region of Enrollment||participants|Number|7|7.0||||||
4438157|NCT00116805|4262504|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4438158|NCT00116805|4262505|B1|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4438159|NCT00116805|4262503|B3|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4438160|NCT00116805|4262504|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4438161|NCT00116805|4262505|B1|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4438162|NCT00116805|4262503|B3|Turkey||Region of Enrollment||participants|Number|14|14.0||||||
4438163|NCT00116805|4262504|B2|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
4438164|NCT00116805|4262505|B1|Turkey||Region of Enrollment||participants|Number|10|10.0||||||
4438165|NCT00116805|4262503|B3|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4438166|NCT00116805|4262504|B2|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4438167|NCT00116805|4262505|B1|Spain||Region of Enrollment||participants|Number|7|7.0||||||
4438168|NCT00116805|4262503|B3|Greece||Region of Enrollment||participants|Number|3|3.0||||||
4438169|NCT00116805|4262504|B2|Greece||Region of Enrollment||participants|Number|2|2.0||||||
4438170|NCT00116805|4262505|B1|Greece||Region of Enrollment||participants|Number|1|1.0||||||
4438171|NCT00116805|4262503|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4438172|NCT00116805|4262504|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4438173|NCT00116805|4262505|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4438174|NCT00116805|4262503|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4438175|NCT00116805|4262504|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4438176|NCT00116805|4262505|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4438177|NCT00116805|4262503|B3||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4438178|NCT00116805|4262504|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4438179|NCT00116805|4262505|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4438180|NCT00116805|4262503|B3|||Age||years|Mean|34|34.0|Standard Deviation|11.6|11.6|||
4438181|NCT00116805|4262504|B2|||Age||years|Mean|34|34.0|Standard Deviation|12.2|12.2|||
4438182|NCT00116805|4262505|B1|||Age||years|Mean|34|34.0|Standard Deviation|11.3|11.3|||
4438183|NCT00116805|4262503|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438184|NCT00116805|4262504|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438185|NCT00116805|4262505|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438188|NCT00116805|4262505|B1||Between 18 and 65 years|Age||Participants|Count of Participants|173|173.0||||||
4438189|NCT00116805|4262503|B3||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4438190|NCT00116805|4262504|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4438191|NCT00116805|4262505|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4438192|NCT00116779|4262597|B3|||Weight|Mean of Participants Weight in Kilograms|Kilograms|Mean|82.1|82.1|Standard Deviation|13.7|13.7|||
4438193|NCT00116779|4262598|B2|||Weight|Mean of Participants Weight in Kilograms|Kilograms|Mean|81.2|81.2|Standard Deviation|12.7|12.7|||
4438194|NCT00116779|4262599|B1|||Weight|Mean of Participants Weight in Kilograms|Kilograms|Mean|83|83.0|Standard Deviation|14.6|14.6|||
4438195|NCT00116779|4262597|B3|||Serum Testosterone level|Testosterone is a steroid hormone from the androgen group, and the principal male sex hormone. This test measures the amount of testosterone in the blood. Androgen deprivation is used to manage prostate cancer.|nanograms/milliliter|Median|4.13|4.13|Full Range|||0.2|11.0|
4438196|NCT00116779|4262598|B2|||Serum Testosterone level|Testosterone is a steroid hormone from the androgen group, and the principal male sex hormone. This test measures the amount of testosterone in the blood. Androgen deprivation is used to manage prostate cancer.|nanograms/milliliter|Median|4.23|4.23|Full Range|||0.2|8.68|
4438197|NCT00116779|4262599|B1|||Serum Testosterone level|Testosterone is a steroid hormone from the androgen group, and the principal male sex hormone. This test measures the amount of testosterone in the blood. Androgen deprivation is used to manage prostate cancer.|nanograms/milliliter|Median|4.1|4.1|Full Range|||1.51|11.0|
4438198|NCT00116779|4262597|B3|||Serum Prostate-Specific Antigen|Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. High PSA levels have a postive corrolation to prostate cancer.|nanograms/milliliter|Median|13.4|13.4|Full Range|||1.6|1942.0|
4438199|NCT00116779|4262598|B2|||Serum Prostate-Specific Antigen|Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. High PSA levels have a postive corrolation to prostate cancer.|nanograms/milliliter|Median|13.7|13.7|Full Range|||1.6|1942.0|
4438200|NCT00116779|4262599|B1|||Serum Prostate-Specific Antigen|Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. High PSA levels have a postive corrolation to prostate cancer.|nanograms/milliliter|Median|12.7|12.7|Full Range|||2.7|759.0|
4438201|NCT00116779|4262597|B3|||Days Since Diagnosis of Prostate Cancer|The number of days passed since a diagnosis of prostate cancer was made for each participant.|days|Mean|1234|1234.0|Standard Deviation|1568|1568.0|||
4438202|NCT00116779|4262598|B2|||Days Since Diagnosis of Prostate Cancer|The number of days passed since a diagnosis of prostate cancer was made for each participant.|days|Mean|1256|1256.0|Standard Deviation|1550|1550.0|||
4438203|NCT00116779|4262599|B1|||Days Since Diagnosis of Prostate Cancer|The number of days passed since a diagnosis of prostate cancer was made for each participant.|days|Mean|1213|1213.0|Standard Deviation|1597|1597.0|||
4438204|NCT00116779|4262597|B3|||Body Mass Index|Body mass index is a measure of body fat based on height and weight.|kilogram per square meter|Mean|27|27.0|Full Range|4.03|4.03|16.9|39.2|
4438205|NCT00116779|4262598|B2|||Body Mass Index|Body mass index is a measure of body fat based on height and weight.|kilogram per square meter|Mean|26.7|26.7|Full Range|3.98|3.98|16.9|36.4|
4438206|NCT00116779|4262599|B1|||Body Mass Index|Body mass index is a measure of body fat based on height and weight.|kilogram per square meter|Mean|27.3|27.3|Full Range|4.1|4.1|19.1|39.2|
4438207|NCT00116779|4262597|B3|Not classifiable||The Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|35|35.0||||||
4438208|NCT00116779|4262598|B2|Not classifiable||The Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|23|23.0||||||
4438209|NCT00116779|4262599|B1|Not classifiable||The Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|12|12.0||||||
4438210|NCT00116779|4262597|B3|Metastatic||The Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|24|24.0||||||
4438211|NCT00116779|4262598|B2|Metastatic||The Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|9|9.0||||||
4438212|NCT00116779|4262599|B1|Metastatic||The Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|15|15.0||||||
4438213|NCT00116779|4262597|B3|Locally advanced||The Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|14|14.0||||||
4438214|NCT00116779|4262598|B2|Locally advanced||The Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|9|9.0||||||
4438215|NCT00116779|4262599|B1|Locally advanced||The Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|5|5.0||||||
4438216|NCT00116779|4262597|B3|Localized||The Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|54|54.0||||||
4438217|NCT00116779|4262598|B2|Localized||The Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|23|23.0||||||
4438218|NCT00116779|4262599|B1|Localized||The Number of Participants at Each Stage of Prostate Cancer|Prostate cancer stage was classified to describe the extent of cancer. Localized refers to tumors without involvement of lymph nodes or metastasis. Advanced localized can be larger tumors that may involve the lymph nodes but no metastasis. Metastatic are more advanced cancers that are spreading beyond the original tumor.|participants|Number|31|31.0||||||
4438219|NCT00116779|4262597|B3|7-10||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|80|80.0||||||
4438220|NCT00116779|4262598|B2|7-10||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|39|39.0||||||
4438221|NCT00116779|4262599|B1|7-10||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|41|41.0||||||
4438222|NCT00116779|4262597|B3|5-6||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|41|41.0||||||
4438223|NCT00116779|4262598|B2|5-6||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|22|22.0||||||
4438224|NCT00116779|4262599|B1|5-6||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|19|19.0||||||
4438225|NCT00116779|4262597|B3|2-4||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|6|6.0||||||
4438226|NCT00116779|4262598|B2|2-4||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|3|3.0||||||
4438227|NCT00116779|4262599|B1|2-4||Participant Counts by Gleason Score|The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive.|participants|Number|3|3.0||||||
4438228|NCT00116779|4262597|B3|Yes||Curative Intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|46|46.0||||||
4438229|NCT00116779|4262598|B2|Yes||Curative Intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|24|24.0||||||
4438230|NCT00116779|4262599|B1|Yes||Curative Intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|22|22.0||||||
4438231|NCT00116779|4262597|B3|No||Curative Intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|81|81.0||||||
4438232|NCT00116779|4262598|B2|No||Curative Intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|40|40.0||||||
4438233|NCT00116779|4262599|B1|No||Curative Intent|A curative intent of Yes refers to participants who have been castrated via radical prostatectomy or radiotherapy.|participants|Number|41|41.0||||||
4438234|NCT00116779|4262597|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438235|NCT00116779|4262598|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438236|NCT00116779|4262599|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438237|NCT00116779|4262597|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438238|NCT00116779|4262598|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438239|NCT00116779|4262599|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438240|NCT00116779|4262597|B3||White|Race (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4438242|NCT00116779|4262599|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4438243|NCT00116779|4262597|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4438244|NCT00116779|4262598|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4438245|NCT00116779|4262599|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4438246|NCT00116779|4262597|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438247|NCT00116779|4262598|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438248|NCT00116779|4262599|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438249|NCT00116779|4262597|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4438250|NCT00116779|4262598|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4438251|NCT00116779|4262599|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4438252|NCT00116779|4262597|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438253|NCT00116779|4262598|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438254|NCT00116779|4262599|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438255|NCT00116779|4262597|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4438256|NCT00116779|4262598|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4438257|NCT00116779|4262599|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4438258|NCT00116779|4262597|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4438259|NCT00116779|4262598|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4438260|NCT00116779|4262599|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4438261|NCT00116779|4262597|B3|||Age||years|Mean|74.9|74.9|Standard Deviation|9.12|9.12|||
4438262|NCT00116779|4262598|B2|||Age||years|Mean|74.9|74.9|Standard Deviation|9.55|9.55|||
4438263|NCT00116779|4262599|B1|||Age||years|Mean|74.8|74.8|Standard Deviation|8.73|8.73|||
4438264|NCT00116779|4262597|B3||>=65 years|Age||Participants|Count of Participants|109|109.0||||||
4438265|NCT00116779|4262598|B2||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4438266|NCT00116779|4262599|B1||>=65 years|Age||Participants|Count of Participants|54|54.0||||||
4438267|NCT00116779|4262597|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4438268|NCT00116779|4262598|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4438269|NCT00116779|4262599|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4438270|NCT00116779|4262597|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4438271|NCT00116779|4262598|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4438272|NCT00116779|4262599|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4438273|NCT00116753|4262630|B4|||Serum Prostate Specific Antigen Levels|ITT population.|nanogram per milliliter|Median|15.6|15.6|Inter-Quartile Range|||7.3|40.5|
4438274|NCT00116753|4262631|B3|||Serum Prostate Specific Antigen Levels|ITT population.|nanogram per milliliter|Median|15.6|15.6|Inter-Quartile Range|||6.2|36.2|
4438275|NCT00116753|4262632|B2|||Serum Prostate Specific Antigen Levels|ITT population.|nanogram per milliliter|Median|16.6|16.6|Inter-Quartile Range|||9.0|40.5|
4438276|NCT00116753|4262633|B1|||Serum Prostate Specific Antigen Levels|ITT population.|nanogram per milliliter|Median|13.8|13.8|Inter-Quartile Range|||6.9|48.9|
4438277|NCT00116753|4262630|B4|||Serum Testosterone Levels|ITT population.|nanogram per milliliter|Median|4.23|4.23|Inter-Quartile Range|||3.08|5.45|
4438278|NCT00116753|4262631|B3|||Serum Testosterone Levels|ITT population.|nanogram per milliliter|Median|4.07|4.07|Inter-Quartile Range|||2.85|5.39|
4438279|NCT00116753|4262632|B2|||Serum Testosterone Levels|ITT population.|nanogram per milliliter|Median|4.00|4.0|Inter-Quartile Range|||3.21|5.06|
4438280|NCT00116753|4262633|B1|||Serum Testosterone Levels|ITT population.|nanogram per milliliter|Median|4.43|4.43|Inter-Quartile Range|||3.19|5.74|
4438281|NCT00116753|4262630|B4|||Body Mass Index|ITT population.|kilogram per square meter|Mean|26.0|26.0|Standard Deviation|4.30|4.3|||
4438282|NCT00116753|4262631|B3|||Body Mass Index|ITT population.|kilogram per square meter|Mean|26.0|26.0|Standard Deviation|4.24|4.24|||
4438283|NCT00116753|4262632|B2|||Body Mass Index|ITT population.|kilogram per square meter|Mean|26.3|26.3|Standard Deviation|4.42|4.42|||
4438284|NCT00116753|4262633|B1|||Body Mass Index|ITT population.|kilogram per square meter|Mean|25.9|25.9|Standard Deviation|4.25|4.25|||
4438285|NCT00116753|4262630|B4|||Body Weight|ITT population.|kilogram|Mean|78.1|78.1|Standard Deviation|13.8|13.8|||
4438286|NCT00116753|4262631|B3|||Body Weight|ITT population.|kilogram|Mean|77.4|77.4|Standard Deviation|12.9|12.9|||
4438287|NCT00116753|4262632|B2|||Body Weight|ITT population.|kilogram|Mean|78.4|78.4|Standard Deviation|13.9|13.9|||
4438288|NCT00116753|4262633|B1|||Body Weight|ITT population.|kilogram|Mean|78.5|78.5|Standard Deviation|14.6|14.6|||
4438289|NCT00116753|4262630|B4|||Time Since Prostate Cancer Diagnosis|ITT population.|days|Mean|400|400.0|Standard Deviation|925|925.0|||
4438290|NCT00116753|4262631|B3|||Time Since Prostate Cancer Diagnosis|ITT population.|days|Mean|346|346.0|Standard Deviation|738|738.0|||
4438291|NCT00116753|4262632|B2|||Time Since Prostate Cancer Diagnosis|ITT population.|days|Mean|388|388.0|Standard Deviation|968|968.0|||
4438292|NCT00116753|4262633|B1|||Time Since Prostate Cancer Diagnosis|ITT population.|days|Mean|465|465.0|Standard Deviation|1041|1041.0|||
4438309|NCT00116753|4262630|B4|7-10||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. The Gleason scores were missing for two participants.|participants|Number|249|249.0||||||
4438293|NCT00116753|4262630|B4|Not classifiable||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|74|74.0||||||
4438294|NCT00116753|4262631|B3|Not classifiable||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|21|21.0||||||
4438295|NCT00116753|4262632|B2|Not classifiable||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|27|27.0||||||
4438296|NCT00116753|4262633|B1|Not classifiable||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|26|26.0||||||
4438297|NCT00116753|4262630|B4|Metastatic||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|84|84.0||||||
4438298|NCT00116753|4262631|B3|Metastatic||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|26|26.0||||||
4438299|NCT00116753|4262632|B2|Metastatic||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|30|30.0||||||
4438300|NCT00116753|4262633|B1|Metastatic||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|28|28.0||||||
4438301|NCT00116753|4262630|B4|Locally advanced||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|105|105.0||||||
4438302|NCT00116753|4262631|B3|Locally advanced||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|34|34.0||||||
4438303|NCT00116753|4262632|B2|Locally advanced||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|31|31.0||||||
4438304|NCT00116753|4262633|B1|Locally advanced||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|40|40.0||||||
4438305|NCT00116753|4262630|B4|Localized||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|184|184.0||||||
4438306|NCT00116753|4262631|B3|Localized||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|66|66.0||||||
4438307|NCT00116753|4262632|B2|Localized||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|62|62.0||||||
4438308|NCT00116753|4262633|B1|Localized||Stage of Prostate Cancer|ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis.|participants|Number|56|56.0||||||
4438342|NCT00116753|4262631|B3||Black or African American|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|8|8.0||||||
4438343|NCT00116753|4262632|B2||Black or African American|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|15|15.0||||||
4438310|NCT00116753|4262631|B3|7-10||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. The Gleason scores were missing for two participants.|participants|Number|70|70.0||||||
4438311|NCT00116753|4262632|B2|7-10||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. The Gleason scores were missing for two participants.|participants|Number|97|97.0||||||
4438312|NCT00116753|4262633|B1|7-10||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. The Gleason scores were missing for two participants.|participants|Number|82|82.0||||||
4438313|NCT00116753|4262630|B4|5-6||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. The Gleason scores were missing for two participants.|participants|Number|156|156.0||||||
4438314|NCT00116753|4262631|B3|5-6||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. The Gleason scores were missing for two participants.|participants|Number|61|61.0||||||
4438315|NCT00116753|4262632|B2|5-6||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. The Gleason scores were missing for two participants.|participants|Number|43|43.0||||||
4438316|NCT00116753|4262633|B1|5-6||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. The Gleason scores were missing for two participants.|participants|Number|52|52.0||||||
4438317|NCT00116753|4262630|B4|2-4||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. The Gleason scores were missing for two participants.|participants|Number|40|40.0||||||
4438318|NCT00116753|4262631|B3|2-4||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. The Gleason scores were missing for two participants.|participants|Number|15|15.0||||||
4438319|NCT00116753|4262632|B2|2-4||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. The Gleason scores were missing for two participants.|participants|Number|9|9.0||||||
4438320|NCT00116753|4262633|B1|2-4||Gleason Score|ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. The Gleason scores were missing for two participants.|participants|Number|16|16.0||||||
4438321|NCT00116753|4262630|B4|No||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|Participants|Number|391|391.0||||||
4438322|NCT00116753|4262631|B3|No||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|Participants|Number|130|130.0||||||
4438323|NCT00116753|4262632|B2|No||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|Participants|Number|128|128.0||||||
4438324|NCT00116753|4262633|B1|No||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|Participants|Number|133|133.0||||||
4438325|NCT00116753|4262630|B4|Yes||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|Participants|Number|56|56.0||||||
4438326|NCT00116753|4262631|B3|Yes||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|Participants|Number|17|17.0||||||
4438327|NCT00116753|4262632|B2|Yes||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|Participants|Number|22|22.0||||||
4438328|NCT00116753|4262633|B1|Yes||Curative Intent|ITT population. Curative intent refers to radical prostatectomy or radiotherapy.|Participants|Number|17|17.0||||||
4438329|NCT00116753|4262630|B4||Unknown or Not Reported|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4438330|NCT00116753|4262631|B3||Unknown or Not Reported|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4438331|NCT00116753|4262632|B2||Unknown or Not Reported|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4438332|NCT00116753|4262633|B1||Unknown or Not Reported|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4438333|NCT00116753|4262630|B4||More than one race|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4438334|NCT00116753|4262631|B3||More than one race|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4438335|NCT00116753|4262632|B2||More than one race|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4438336|NCT00116753|4262633|B1||More than one race|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4438337|NCT00116753|4262630|B4||White|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|408|408.0||||||
4438338|NCT00116753|4262631|B3||White|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|136|136.0||||||
4438339|NCT00116753|4262632|B2||White|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|131|131.0||||||
4438340|NCT00116753|4262633|B1||White|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|141|141.0||||||
4438341|NCT00116753|4262630|B4||Black or African American|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|32|32.0||||||
4438344|NCT00116753|4262633|B1||Black or African American|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|9|9.0||||||
4438345|NCT00116753|4262630|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|1|1.0||||||
4438346|NCT00116753|4262631|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|1|1.0||||||
4438347|NCT00116753|4262632|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4438348|NCT00116753|4262633|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4438349|NCT00116753|4262630|B4||Asian|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|4|4.0||||||
4438350|NCT00116753|4262631|B3||Asian|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|1|1.0||||||
4438351|NCT00116753|4262632|B2||Asian|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|3|3.0||||||
4438352|NCT00116753|4262633|B1||Asian|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4438353|NCT00116753|4262630|B4||American Indian or Alaska Native|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|2|2.0||||||
4438354|NCT00116753|4262631|B3||American Indian or Alaska Native|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|1|1.0||||||
4438355|NCT00116753|4262632|B2||American Indian or Alaska Native|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|1|1.0||||||
4438356|NCT00116753|4262633|B1||American Indian or Alaska Native|Race (NIH/OMB)|ITT population.|Participants|Count of Participants|0|0.0||||||
4438357|NCT00116753|4262630|B4||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|447|447.0||||||
4438358|NCT00116753|4262631|B3||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|147|147.0||||||
4438359|NCT00116753|4262632|B2||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|150|150.0||||||
4438360|NCT00116753|4262633|B1||Male|Sex: Female, Male|ITT population.|Participants|Count of Participants|150|150.0||||||
4438361|NCT00116753|4262630|B4||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4438362|NCT00116753|4262631|B3||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4438363|NCT00116753|4262632|B2||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4438364|NCT00116753|4262633|B1||Female|Sex: Female, Male|ITT population.|Participants|Count of Participants|0|0.0||||||
4438365|NCT00116753|4262630|B4|||Age|ITT population.|years|Median|75|75.0|Full Range|||49.0|90.0|
4438366|NCT00116753|4262631|B3|||Age|ITT population.|years|Median|75|75.0|Full Range|||50.0|90.0|
4438367|NCT00116753|4262632|B2|||Age|ITT population.|years|Median|75|75.0|Full Range|||49.0|88.0|
4438368|NCT00116753|4262633|B1|||Age|ITT population.|years|Median|75|75.0|Full Range|||50.0|86.0|
4438369|NCT00116753|4262630|B4||>=65 years|Age|ITT population. ITT refers to the intent-to-treat population, which includes participants who were both randomized and treated.|Participants|Count of Participants|387|387.0||||||
4438370|NCT00116753|4262631|B3||>=65 years|Age|ITT population. ITT refers to the intent-to-treat population, which includes participants who were both randomized and treated.|Participants|Count of Participants|127|127.0||||||
4438371|NCT00116753|4262632|B2||>=65 years|Age|ITT population. ITT refers to the intent-to-treat population, which includes participants who were both randomized and treated.|Participants|Count of Participants|131|131.0||||||
4438372|NCT00116753|4262633|B1||>=65 years|Age|ITT population. ITT refers to the intent-to-treat population, which includes participants who were both randomized and treated.|Participants|Count of Participants|129|129.0||||||
4438373|NCT00116753|4262630|B4||Between 18 and 65 years|Age|ITT population. ITT refers to the intent-to-treat population, which includes participants who were both randomized and treated.|Participants|Count of Participants|60|60.0||||||
4438374|NCT00116753|4262631|B3||Between 18 and 65 years|Age|ITT population. ITT refers to the intent-to-treat population, which includes participants who were both randomized and treated.|Participants|Count of Participants|20|20.0||||||
4438375|NCT00116753|4262632|B2||Between 18 and 65 years|Age|ITT population. ITT refers to the intent-to-treat population, which includes participants who were both randomized and treated.|Participants|Count of Participants|19|19.0||||||
4438376|NCT00116753|4262633|B1||Between 18 and 65 years|Age|ITT population. ITT refers to the intent-to-treat population, which includes participants who were both randomized and treated.|Participants|Count of Participants|21|21.0||||||
4438377|NCT00116753|4262630|B4||<=18 years|Age|ITT population. ITT refers to the intent-to-treat population, which includes participants who were both randomized and treated.|Participants|Count of Participants|0|0.0||||||
4438378|NCT00116753|4262631|B3||<=18 years|Age|ITT population. ITT refers to the intent-to-treat population, which includes participants who were both randomized and treated.|Participants|Count of Participants|0|0.0||||||
4438379|NCT00116753|4262632|B2||<=18 years|Age|ITT population. ITT refers to the intent-to-treat population, which includes participants who were both randomized and treated.|Participants|Count of Participants|0|0.0||||||
4438380|NCT00116753|4262633|B1||<=18 years|Age|ITT population. ITT refers to the intent-to-treat population, which includes participants who were both randomized and treated.|Participants|Count of Participants|0|0.0||||||
4438381|NCT00116688|4262655|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4438382|NCT00116688|4262656|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4438383|NCT00116688|4262657|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4438384|NCT00116688|4262655|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4438385|NCT00116688|4262656|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4438386|NCT00116688|4262657|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4438387|NCT00116688|4262655|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4438388|NCT00116688|4262656|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4438389|NCT00116688|4262657|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4438390|NCT00116688|4262655|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4438391|NCT00116688|4262656|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4438392|NCT00116688|4262657|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4438393|NCT00116688|4262655|B3|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4438394|NCT00116688|4262656|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4438395|NCT00116688|4262657|B1|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4438396|NCT00116688|4262655|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4438397|NCT00116688|4262656|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4438398|NCT00116688|4262657|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4438399|NCT00116688|4262655|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|259|259.0||||||
4438400|NCT00116688|4262656|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4438401|NCT00116688|4262657|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|246|246.0||||||
4438402|NCT00116688|4262655|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4438403|NCT00116688|4262656|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4438404|NCT00116688|4262657|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4438405|NCT00116688|4262655|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4438406|NCT00116688|4262656|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4438407|NCT00116688|4262657|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4438408|NCT00116688|4262655|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4438409|NCT00116688|4262656|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4438410|NCT00116688|4262657|B1||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4438411|NCT00116688|4262655|B3|||Age||Years|Mean|51.3|51.3|Standard Deviation|19.7|19.7|||
4438412|NCT00116688|4262656|B2|||Age||Years|Mean|10.2|10.2|Standard Deviation|5.1|5.1|||
4438413|NCT00116688|4262657|B1|||Age||Years|Mean|54.2|54.2|Standard Deviation|16.9|16.9|||
4438414|NCT00116649|4262673|B1|||Baseline actinic keratosis lesion count||actinic keratosis lesions|Mean|45.5|45.5|Standard Deviation|2.36|2.36|||
4438415|NCT00116649|4262673|B1|United States||Region of Enrollment||participants|Number|551|551.0||||||
4438416|NCT00116649|4262673|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438417|NCT00116649|4262673|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438418|NCT00116649|4262673|B1||White|Race (NIH/OMB)||Participants|Count of Participants|551|551.0||||||
4438419|NCT00116649|4262673|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438420|NCT00116649|4262673|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438421|NCT00116649|4262673|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438422|NCT00116649|4262673|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438423|NCT00116649|4262673|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438424|NCT00116649|4262673|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|529|529.0||||||
4438425|NCT00116649|4262673|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4438426|NCT00116649|4262673|B1||Male|Sex: Female, Male||Participants|Count of Participants|437|437.0||||||
4438427|NCT00116649|4262673|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4438428|NCT00116649|4262673|B1|||Age||years|Mean|67.5|67.5|Standard Deviation|10.71|10.71|||
4438429|NCT00116649|4262673|B1||>=65 years|Age||Participants|Count of Participants|344|344.0||||||
4438430|NCT00116649|4262673|B1||Between 18 and 65 years|Age||Participants|Count of Participants|207|207.0||||||
4438431|NCT00116649|4262673|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4438432|NCT00116428|4262678|B3|||Number of documented symptomatic Atrial Fibrillation episodes|Number of symptomatic Atrial Fibrillation episodes during the last six months prior to study enrollment.|Number of episodes|Mean|63.24|63.24|Standard Deviation|93.0|93.0|||
4438433|NCT00116428|4262679|B2|||Number of documented symptomatic Atrial Fibrillation episodes|Number of symptomatic Atrial Fibrillation episodes during the last six months prior to study enrollment.|Number of episodes|Mean|64.9|64.9|Standard Deviation|98.0|98.0|||
4438434|NCT00116428|4262680|B1|||Number of documented symptomatic Atrial Fibrillation episodes|Number of symptomatic Atrial Fibrillation episodes during the last six months prior to study enrollment.|Number of episodes|Mean|62.3|62.3|Standard Deviation|89.2|89.2|||
4438435|NCT00116428|4262678|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4438436|NCT00116428|4262679|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4438437|NCT00116428|4262680|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4438438|NCT00116428|4262678|B3|Italy||Region of Enrollment||participants|Number|50|50.0||||||
4438439|NCT00116428|4262679|B2|Italy||Region of Enrollment||participants|Number|19|19.0||||||
4438440|NCT00116428|4262680|B1|Italy||Region of Enrollment||participants|Number|31|31.0||||||
4438441|NCT00116428|4262678|B3|Czech Republic||Region of Enrollment||participants|Number|27|27.0||||||
4438442|NCT00116428|4262679|B2|Czech Republic||Region of Enrollment||participants|Number|10|10.0||||||
4438443|NCT00116428|4262680|B1|Czech Republic||Region of Enrollment||participants|Number|17|17.0||||||
4438444|NCT00116428|4262678|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4438445|NCT00116428|4262679|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4438446|NCT00116428|4262680|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4438447|NCT00116428|4262678|B3|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4438448|NCT00116428|4262679|B2|Brazil||Region of Enrollment||participants|Number|5|5.0||||||
4438449|NCT00116428|4262680|B1|Brazil||Region of Enrollment||participants|Number|7|7.0||||||
4438450|NCT00116428|4262678|B3|Arab ethnicity||Race/Ethnicity, Customized|Ethnicity|Participants|Number|1|1.0||||||
4438451|NCT00116428|4262679|B2|Arab ethnicity||Race/Ethnicity, Customized|Ethnicity|Participants|Number|0|0.0||||||
4438452|NCT00116428|4262680|B1|Arab ethnicity||Race/Ethnicity, Customized|Ethnicity|Participants|Number|1|1.0||||||
4438453|NCT00116428|4262678|B3|White||Race/Ethnicity, Customized|Ethnicity|Participants|Number|164|164.0||||||
4438454|NCT00116428|4262679|B2|White||Race/Ethnicity, Customized|Ethnicity|Participants|Number|61|61.0||||||
4438455|NCT00116428|4262680|B1|White||Race/Ethnicity, Customized|Ethnicity|Participants|Number|103|103.0||||||
4438456|NCT00116428|4262678|B3|Native American||Race/Ethnicity, Customized|Ethnicity|Participants|Number|1|1.0||||||
4438457|NCT00116428|4262679|B2|Native American||Race/Ethnicity, Customized|Ethnicity|Participants|Number|0|0.0||||||
4438458|NCT00116428|4262680|B1|Native American||Race/Ethnicity, Customized|Ethnicity|Participants|Number|1|1.0||||||
4438459|NCT00116428|4262678|B3|Hispanic||Race/Ethnicity, Customized|Ethnicity|Participants|Number|1|1.0||||||
4438460|NCT00116428|4262679|B2|Hispanic||Race/Ethnicity, Customized|Ethnicity|Participants|Number|0|0.0||||||
4438461|NCT00116428|4262680|B1|Hispanic||Race/Ethnicity, Customized|Ethnicity|Participants|Number|1|1.0||||||
4438462|NCT00116428|4262678|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4438463|NCT00116428|4262679|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4438464|NCT00116428|4262680|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4438465|NCT00116428|4262678|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4438466|NCT00116428|4262679|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4438467|NCT00116428|4262680|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4438468|NCT00116428|4262678|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|10.7|10.7|||
4438469|NCT00116428|4262679|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|12.8|12.8|||
4438470|NCT00116428|4262680|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|9.3|9.3|||
4438471|NCT00116272|4262697|B3|Started Prior to DOC, End Date Unavailable||Exposed to Etanercept|the first trimester of pregnancy is defined as the period between the estimated date of conception (DOC) to the 11th week post-conception. The date of conception is defined as 14 days prior to the next expected menstrual period.|participants|Number|5|5.0||||||
4438472|NCT00116272|4262698|B2|Started Prior to DOC, End Date Unavailable||Exposed to Etanercept|the first trimester of pregnancy is defined as the period between the estimated date of conception (DOC) to the 11th week post-conception. The date of conception is defined as 14 days prior to the next expected menstrual period.|participants|Number|0|0.0||||||
4438473|NCT00116272|4262699|B1|Started Prior to DOC, End Date Unavailable||Exposed to Etanercept|the first trimester of pregnancy is defined as the period between the estimated date of conception (DOC) to the 11th week post-conception. The date of conception is defined as 14 days prior to the next expected menstrual period.|participants|Number|5|5.0||||||
4438474|NCT00116272|4262697|B3|2nd and/or 3rd Trimester Only||Exposed to Etanercept|the first trimester of pregnancy is defined as the period between the estimated date of conception (DOC) to the 11th week post-conception. The date of conception is defined as 14 days prior to the next expected menstrual period.|participants|Number|13|13.0||||||
4438475|NCT00116272|4262698|B2|2nd and/or 3rd Trimester Only||Exposed to Etanercept|the first trimester of pregnancy is defined as the period between the estimated date of conception (DOC) to the 11th week post-conception. The date of conception is defined as 14 days prior to the next expected menstrual period.|participants|Number|0|0.0||||||
4438476|NCT00116272|4262699|B1|2nd and/or 3rd Trimester Only||Exposed to Etanercept|the first trimester of pregnancy is defined as the period between the estimated date of conception (DOC) to the 11th week post-conception. The date of conception is defined as 14 days prior to the next expected menstrual period.|participants|Number|13|13.0||||||
4438477|NCT00116272|4262697|B3|Last Menstrual Period to Date of Conception||Exposed to Etanercept|the first trimester of pregnancy is defined as the period between the estimated date of conception (DOC) to the 11th week post-conception. The date of conception is defined as 14 days prior to the next expected menstrual period.|participants|Number|8|8.0||||||
4438478|NCT00116272|4262698|B2|Last Menstrual Period to Date of Conception||Exposed to Etanercept|the first trimester of pregnancy is defined as the period between the estimated date of conception (DOC) to the 11th week post-conception. The date of conception is defined as 14 days prior to the next expected menstrual period.|participants|Number|0|0.0||||||
4438479|NCT00116272|4262699|B1|Last Menstrual Period to Date of Conception||Exposed to Etanercept|the first trimester of pregnancy is defined as the period between the estimated date of conception (DOC) to the 11th week post-conception. The date of conception is defined as 14 days prior to the next expected menstrual period.|participants|Number|8|8.0||||||
4438480|NCT00116272|4262697|B3|First Trimester||Exposed to Etanercept|the first trimester of pregnancy is defined as the period between the estimated date of conception (DOC) to the 11th week post-conception. The date of conception is defined as 14 days prior to the next expected menstrual period.|participants|Number|344|344.0||||||
4438481|NCT00116272|4262698|B2|First Trimester||Exposed to Etanercept|the first trimester of pregnancy is defined as the period between the estimated date of conception (DOC) to the 11th week post-conception. The date of conception is defined as 14 days prior to the next expected menstrual period.|participants|Number|0|0.0||||||
4438482|NCT00116272|4262699|B1|First Trimester||Exposed to Etanercept|the first trimester of pregnancy is defined as the period between the estimated date of conception (DOC) to the 11th week post-conception. The date of conception is defined as 14 days prior to the next expected menstrual period.|participants|Number|344|344.0||||||
4438483|NCT00116272|4262697|B3|||Disease Severity Score - PsO|Maternal rating of overall severity of psoriasis measured using Global Assessment of Psoriasis, possible score 0-5 with higher score indicating more severe disease.|units on a scale|Mean|1.9|1.9|Standard Deviation|1.4|1.4|||
4438484|NCT00116272|4262698|B2|||Disease Severity Score - PsO|Maternal rating of overall severity of psoriasis measured using Global Assessment of Psoriasis, possible score 0-5 with higher score indicating more severe disease.|units on a scale|Mean|1.9|1.9|Standard Deviation|1.1|1.1|||
4438485|NCT00116272|4262699|B1|||Disease Severity Score - PsO|Maternal rating of overall severity of psoriasis measured using Global Assessment of Psoriasis, possible score 0-5 with higher score indicating more severe disease.|units on a scale|Mean|2.0|2.0|Standard Deviation|1.5|1.5|||
4438486|NCT00116272|4262697|B3|||Disease Severity Score - RA|"RA1 disease severity score expressed as the Health Assessment Questionnaire-Disability Index (HAQ-DI) summary score; possible score ranges from 0-3 with higher score representing higher severity/disability.~RA1 disease severity score at intake missing for 2 participants in the Etanercept-Exposed Group and 1 participant in the Diseased Controls Group."|units on a scale|Mean|0.5|0.5|Standard Deviation|0.6|0.6|||
4438487|NCT00116272|4262698|B2|||Disease Severity Score - RA|"RA1 disease severity score expressed as the Health Assessment Questionnaire-Disability Index (HAQ-DI) summary score; possible score ranges from 0-3 with higher score representing higher severity/disability.~RA1 disease severity score at intake missing for 2 participants in the Etanercept-Exposed Group and 1 participant in the Diseased Controls Group."|units on a scale|Mean|0.6|0.6|Standard Deviation|0.6|0.6|||
4438488|NCT00116272|4262699|B1|||Disease Severity Score - RA|"RA1 disease severity score expressed as the Health Assessment Questionnaire-Disability Index (HAQ-DI) summary score; possible score ranges from 0-3 with higher score representing higher severity/disability.~RA1 disease severity score at intake missing for 2 participants in the Etanercept-Exposed Group and 1 participant in the Diseased Controls Group."|units on a scale|Mean|0.5|0.5|Standard Deviation|0.6|0.6|||
4438489|NCT00116272|4262697|B3|No||Prednisone and/or Systemic Oral Corticosteroid||participants|Number|306|306.0||||||
4438490|NCT00116272|4262698|B2|No||Prednisone and/or Systemic Oral Corticosteroid||participants|Number|99|99.0||||||
4438491|NCT00116272|4262699|B1|No||Prednisone and/or Systemic Oral Corticosteroid||participants|Number|207|207.0||||||
4438492|NCT00116272|4262697|B3|Yes||Prednisone and/or Systemic Oral Corticosteroid||participants|Number|228|228.0||||||
4438493|NCT00116272|4262698|B2|Yes||Prednisone and/or Systemic Oral Corticosteroid||participants|Number|65|65.0||||||
4438494|NCT00116272|4262699|B1|Yes||Prednisone and/or Systemic Oral Corticosteroid||participants|Number|163|163.0||||||
4438495|NCT00116272|4262697|B3|||Duration of Disease|Year was known, but month and date were not known for all cases, therefore Jan 1 of the year of diagnosis through the 1st day of the last menstrual period for the index pregnancy was used to calculate duration of disease. In cases where the woman had multiple study diseases, the earliest known year of the “primary disease” diagnosis was used to calculate duration. Five participants in the Etanercept-Exposed Group were missing year of diagnosis.|years|Mean|9.9|9.9|Standard Deviation|8.3|8.3|||
4438496|NCT00116272|4262698|B2|||Duration of Disease|Year was known, but month and date were not known for all cases, therefore Jan 1 of the year of diagnosis through the 1st day of the last menstrual period for the index pregnancy was used to calculate duration of disease. In cases where the woman had multiple study diseases, the earliest known year of the “primary disease” diagnosis was used to calculate duration. Five participants in the Etanercept-Exposed Group were missing year of diagnosis.|years|Mean|10.0|10.0|Standard Deviation|9.1|9.1|||
4438497|NCT00116272|4262699|B1|||Duration of Disease|Year was known, but month and date were not known for all cases, therefore Jan 1 of the year of diagnosis through the 1st day of the last menstrual period for the index pregnancy was used to calculate duration of disease. In cases where the woman had multiple study diseases, the earliest known year of the “primary disease” diagnosis was used to calculate duration. Five participants in the Etanercept-Exposed Group were missing year of diagnosis.|years|Mean|9.8|9.8|Standard Deviation|7.9|7.9|||
4438498|NCT00116272|4262697|B3|No||Primary Disease (RA, JRA, PsA or AS)||participants|Number|106|106.0||||||
4438499|NCT00116272|4262698|B2|No||Primary Disease (RA, JRA, PsA or AS)||participants|Number|47|47.0||||||
4438500|NCT00116272|4262699|B1|No||Primary Disease (RA, JRA, PsA or AS)||participants|Number|59|59.0||||||
4438501|NCT00116272|4262697|B3|Yes||Primary Disease (RA, JRA, PsA or AS)||participants|Number|428|428.0||||||
4438502|NCT00116272|4262698|B2|Yes||Primary Disease (RA, JRA, PsA or AS)||participants|Number|117|117.0||||||
4438503|NCT00116272|4262699|B1|Yes||Primary Disease (RA, JRA, PsA or AS)||participants|Number|311|311.0||||||
4438504|NCT00116272|4262697|B3|No||Intended Pregnancy||participants|Number|147|147.0||||||
4438505|NCT00116272|4262698|B2|No||Intended Pregnancy||participants|Number|41|41.0||||||
4438506|NCT00116272|4262699|B1|No||Intended Pregnancy||participants|Number|106|106.0||||||
4438507|NCT00116272|4262697|B3|Yes||Intended Pregnancy||participants|Number|387|387.0||||||
4438508|NCT00116272|4262698|B2|Yes||Intended Pregnancy||participants|Number|123|123.0||||||
4438509|NCT00116272|4262699|B1|Yes||Intended Pregnancy||participants|Number|264|264.0||||||
4438510|NCT00116272|4262697|B3|No||Major Known or Suspected Human Teratogens||participants|Number|509|509.0||||||
4438511|NCT00116272|4262698|B2|No||Major Known or Suspected Human Teratogens||participants|Number|153|153.0||||||
4438512|NCT00116272|4262699|B1|No||Major Known or Suspected Human Teratogens||participants|Number|356|356.0||||||
4438513|NCT00116272|4262697|B3|Yes||Major Known or Suspected Human Teratogens||participants|Number|25|25.0||||||
4438514|NCT00116272|4262698|B2|Yes||Major Known or Suspected Human Teratogens||participants|Number|11|11.0||||||
4438515|NCT00116272|4262699|B1|Yes||Major Known or Suspected Human Teratogens||participants|Number|14|14.0||||||
4438516|NCT00116272|4262697|B3|No||Tobacco Use During Pregnancy||participants|Number|477|477.0||||||
4438517|NCT00116272|4262698|B2|No||Tobacco Use During Pregnancy||participants|Number|147|147.0||||||
4438518|NCT00116272|4262699|B1|No||Tobacco Use During Pregnancy||participants|Number|330|330.0||||||
4438519|NCT00116272|4262697|B3|Yes||Tobacco Use During Pregnancy||participants|Number|57|57.0||||||
4438520|NCT00116272|4262698|B2|Yes||Tobacco Use During Pregnancy||participants|Number|17|17.0||||||
4438521|NCT00116272|4262699|B1|Yes||Tobacco Use During Pregnancy||participants|Number|40|40.0||||||
4438522|NCT00116272|4262697|B3|No||Alcohol Use During Pregnancy||participants|Number|277|277.0||||||
4438523|NCT00116272|4262698|B2|No||Alcohol Use During Pregnancy||participants|Number|84|84.0||||||
4438524|NCT00116272|4262699|B1|No||Alcohol Use During Pregnancy||participants|Number|193|193.0||||||
4438525|NCT00116272|4262697|B3|Yes||Alcohol Use During Pregnancy||participants|Number|257|257.0||||||
4438526|NCT00116272|4262698|B2|Yes||Alcohol Use During Pregnancy||participants|Number|80|80.0||||||
4438527|NCT00116272|4262699|B1|Yes||Alcohol Use During Pregnancy||participants|Number|177|177.0||||||
4438528|NCT00116272|4262697|B3|Not Taken at All||Prenatal Multivitamin or Folic Acid Supplements||participants|Number|5|5.0||||||
4438529|NCT00116272|4262698|B2|Not Taken at All||Prenatal Multivitamin or Folic Acid Supplements||participants|Number|0|0.0||||||
4438530|NCT00116272|4262699|B1|Not Taken at All||Prenatal Multivitamin or Folic Acid Supplements||participants|Number|5|5.0||||||
4438531|NCT00116272|4262697|B3|Post-conception Only||Prenatal Multivitamin or Folic Acid Supplements||participants|Number|198|198.0||||||
4438532|NCT00116272|4262698|B2|Post-conception Only||Prenatal Multivitamin or Folic Acid Supplements||participants|Number|50|50.0||||||
4438533|NCT00116272|4262699|B1|Post-conception Only||Prenatal Multivitamin or Folic Acid Supplements||participants|Number|148|148.0||||||
4438534|NCT00116272|4262697|B3|Began Prior to Conception||Prenatal Multivitamin or Folic Acid Supplements||participants|Number|331|331.0||||||
4438535|NCT00116272|4262698|B2|Began Prior to Conception||Prenatal Multivitamin or Folic Acid Supplements||participants|Number|114|114.0||||||
4438536|NCT00116272|4262699|B1|Began Prior to Conception||Prenatal Multivitamin or Folic Acid Supplements||participants|Number|217|217.0||||||
4438537|NCT00116272|4262697|B3|Infections||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|388|388.0||||||
4438538|NCT00116272|4262698|B2|Infections||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|114|114.0||||||
4438539|NCT00116272|4262699|B1|Infections||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|274|274.0||||||
4438540|NCT00116272|4262697|B3|Other Psychiatric Conditions||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|96|96.0||||||
4438541|NCT00116272|4262698|B2|Other Psychiatric Conditions||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|32|32.0||||||
4438542|NCT00116272|4262699|B1|Other Psychiatric Conditions||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|64|64.0||||||
4438543|NCT00116272|4262697|B3|Preeclampsia||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|19|19.0||||||
4438544|NCT00116272|4262698|B2|Preeclampsia||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|8|8.0||||||
4438545|NCT00116272|4262699|B1|Preeclampsia||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|11|11.0||||||
4438546|NCT00116272|4262697|B3|Pre-gestational Hypertension||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|29|29.0||||||
4438547|NCT00116272|4262698|B2|Pre-gestational Hypertension||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|10|10.0||||||
4438548|NCT00116272|4262699|B1|Pre-gestational Hypertension||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|19|19.0||||||
4438549|NCT00116272|4262697|B3|Antidepressant Medication Use in Any Trimester||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|42|42.0||||||
4438550|NCT00116272|4262698|B2|Antidepressant Medication Use in Any Trimester||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|14|14.0||||||
4438551|NCT00116272|4262699|B1|Antidepressant Medication Use in Any Trimester||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|28|28.0||||||
4438552|NCT00116272|4262697|B3|Other Autoimmune Disease||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|60|60.0||||||
4438553|NCT00116272|4262698|B2|Other Autoimmune Disease||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|17|17.0||||||
4438554|NCT00116272|4262699|B1|Other Autoimmune Disease||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|43|43.0||||||
4438555|NCT00116272|4262697|B3|Asthma||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|81|81.0||||||
4438556|NCT00116272|4262698|B2|Asthma||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|33|33.0||||||
4438557|NCT00116272|4262699|B1|Asthma||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|48|48.0||||||
4438558|NCT00116272|4262697|B3|Thyroid Disease||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|68|68.0||||||
4438559|NCT00116272|4262698|B2|Thyroid Disease||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|23|23.0||||||
4438560|NCT00116272|4262699|B1|Thyroid Disease||Maternal Comorbidities|Participants could have more than one comorbidity|participants|Number|45|45.0||||||
4438561|NCT00116272|4262697|B3|Missing||Geographic Area of Residence||participants|Number|2|2.0||||||
4438562|NCT00116272|4262698|B2|Missing||Geographic Area of Residence||participants|Number|1|1.0||||||
4438563|NCT00116272|4262699|B1|Missing||Geographic Area of Residence||participants|Number|1|1.0||||||
4438564|NCT00116272|4262697|B3|Canada||Geographic Area of Residence||participants|Number|58|58.0||||||
4438565|NCT00116272|4262698|B2|Canada||Geographic Area of Residence||participants|Number|27|27.0||||||
4438566|NCT00116272|4262699|B1|Canada||Geographic Area of Residence||participants|Number|31|31.0||||||
4438567|NCT00116272|4262697|B3|United States||Geographic Area of Residence||participants|Number|474|474.0||||||
4438568|NCT00116272|4262698|B2|United States||Geographic Area of Residence||participants|Number|136|136.0||||||
4438569|NCT00116272|4262699|B1|United States||Geographic Area of Residence||participants|Number|338|338.0||||||
4438570|NCT00116272|4262697|B3|Missing||Referral Source Category||participants|Number|1|1.0||||||
4438571|NCT00116272|4262698|B2|Missing||Referral Source Category||participants|Number|0|0.0||||||
4438572|NCT00116272|4262699|B1|Missing||Referral Source Category||participants|Number|1|1.0||||||
4438573|NCT00116272|4262697|B3|Other||Referral Source Category||participants|Number|63|63.0||||||
4438574|NCT00116272|4262698|B2|Other||Referral Source Category||participants|Number|10|10.0||||||
4438575|NCT00116272|4262699|B1|Other||Referral Source Category||participants|Number|53|53.0||||||
4438576|NCT00116272|4262697|B3|OTIS Member Service||Referral Source Category||participants|Number|98|98.0||||||
4438577|NCT00116272|4262698|B2|OTIS Member Service||Referral Source Category||participants|Number|69|69.0||||||
4438578|NCT00116272|4262699|B1|OTIS Member Service||Referral Source Category||participants|Number|29|29.0||||||
4438579|NCT00116272|4262697|B3|Patient Support Group||Referral Source Category||participants|Number|4|4.0||||||
4438580|NCT00116272|4262698|B2|Patient Support Group||Referral Source Category||participants|Number|4|4.0||||||
4438581|NCT00116272|4262699|B1|Patient Support Group||Referral Source Category||participants|Number|0|0.0||||||
4438582|NCT00116272|4262697|B3|Internet||Referral Source Category||participants|Number|92|92.0||||||
4438583|NCT00116272|4262698|B2|Internet||Referral Source Category||participants|Number|27|27.0||||||
4438584|NCT00116272|4262699|B1|Internet||Referral Source Category||participants|Number|65|65.0||||||
4438585|NCT00116272|4262697|B3|Health-care Professional (HCP)||Referral Source Category||participants|Number|238|238.0||||||
4438586|NCT00116272|4262698|B2|Health-care Professional (HCP)||Referral Source Category||participants|Number|53|53.0||||||
4438587|NCT00116272|4262699|B1|Health-care Professional (HCP)||Referral Source Category||participants|Number|185|185.0||||||
4438588|NCT00116272|4262697|B3|Sponsor||Referral Source Category||participants|Number|38|38.0||||||
4438589|NCT00116272|4262698|B2|Sponsor||Referral Source Category||participants|Number|1|1.0||||||
4438590|NCT00116272|4262699|B1|Sponsor||Referral Source Category||participants|Number|37|37.0||||||
4438591|NCT00116272|4262697|B3|≥ 20 weeks||Gestational Age at Time of Enrollment||participants|Number|97|97.0||||||
4438592|NCT00116272|4262698|B2|≥ 20 weeks||Gestational Age at Time of Enrollment||participants|Number|22|22.0||||||
4438593|NCT00116272|4262699|B1|≥ 20 weeks||Gestational Age at Time of Enrollment||participants|Number|75|75.0||||||
4438594|NCT00116272|4262697|B3|13 - 19.9 weeks||Gestational Age at Time of Enrollment||participants|Number|157|157.0||||||
4438595|NCT00116272|4262698|B2|13 - 19.9 weeks||Gestational Age at Time of Enrollment||participants|Number|58|58.0||||||
4438596|NCT00116272|4262699|B1|13 - 19.9 weeks||Gestational Age at Time of Enrollment||participants|Number|99|99.0||||||
4438597|NCT00116272|4262697|B3|< 13 weeks||Gestational Age at Time of Enrollment||participants|Number|280|280.0||||||
4438598|NCT00116272|4262698|B2|< 13 weeks||Gestational Age at Time of Enrollment||participants|Number|84|84.0||||||
4438599|NCT00116272|4262699|B1|< 13 weeks||Gestational Age at Time of Enrollment||participants|Number|196|196.0||||||
4438600|NCT00116272|4262697|B3|No||In Vitro Fertilization (IVF) with This Pregnancy||participants|Number|502|502.0||||||
4438601|NCT00116272|4262698|B2|No||In Vitro Fertilization (IVF) with This Pregnancy||participants|Number|159|159.0||||||
4438602|NCT00116272|4262699|B1|No||In Vitro Fertilization (IVF) with This Pregnancy||participants|Number|343|343.0||||||
4438603|NCT00116272|4262697|B3|Yes||In Vitro Fertilization (IVF) with This Pregnancy||participants|Number|32|32.0||||||
4438604|NCT00116272|4262698|B2|Yes||In Vitro Fertilization (IVF) with This Pregnancy||participants|Number|5|5.0||||||
4438605|NCT00116272|4262699|B1|Yes||In Vitro Fertilization (IVF) with This Pregnancy||participants|Number|27|27.0||||||
4438606|NCT00116272|4262697|B3|No||Any Previous Child with Birth Defect||participants|Number|506|506.0||||||
4438607|NCT00116272|4262698|B2|No||Any Previous Child with Birth Defect||participants|Number|156|156.0||||||
4438608|NCT00116272|4262699|B1|No||Any Previous Child with Birth Defect||participants|Number|350|350.0||||||
4438609|NCT00116272|4262697|B3|Yes||Any Previous Child with Birth Defect||participants|Number|28|28.0||||||
4438610|NCT00116272|4262698|B2|Yes||Any Previous Child with Birth Defect||participants|Number|8|8.0||||||
4438611|NCT00116272|4262699|B1|Yes||Any Previous Child with Birth Defect||participants|Number|20|20.0||||||
4438612|NCT00116272|4262697|B3|No||Previous Preterm Delivery||participants|Number|491|491.0||||||
4438613|NCT00116272|4262698|B2|No||Previous Preterm Delivery||participants|Number|158|158.0||||||
4438614|NCT00116272|4262699|B1|No||Previous Preterm Delivery||participants|Number|333|333.0||||||
4438615|NCT00116272|4262697|B3|Yes||Previous Preterm Delivery||participants|Number|43|43.0||||||
4438616|NCT00116272|4262698|B2|Yes||Previous Preterm Delivery||participants|Number|6|6.0||||||
4438617|NCT00116272|4262699|B1|Yes||Previous Preterm Delivery||participants|Number|37|37.0||||||
4438618|NCT00116272|4262697|B3|≥ 3||Previous Elective Terminations||participants|Number|3|3.0||||||
4438619|NCT00116272|4262698|B2|≥ 3||Previous Elective Terminations||participants|Number|1|1.0||||||
4438620|NCT00116272|4262699|B1|≥ 3||Previous Elective Terminations||participants|Number|2|2.0||||||
4438621|NCT00116272|4262697|B3|2||Previous Elective Terminations||participants|Number|6|6.0||||||
4438622|NCT00116272|4262698|B2|2||Previous Elective Terminations||participants|Number|1|1.0||||||
4438623|NCT00116272|4262699|B1|2||Previous Elective Terminations||participants|Number|5|5.0||||||
4438624|NCT00116272|4262697|B3|1||Previous Elective Terminations||participants|Number|61|61.0||||||
4438625|NCT00116272|4262698|B2|1||Previous Elective Terminations||participants|Number|12|12.0||||||
4438626|NCT00116272|4262699|B1|1||Previous Elective Terminations||participants|Number|49|49.0||||||
4438627|NCT00116272|4262697|B3|0||Previous Elective Terminations||participants|Number|464|464.0||||||
4438628|NCT00116272|4262698|B2|0||Previous Elective Terminations||participants|Number|150|150.0||||||
4438629|NCT00116272|4262699|B1|0||Previous Elective Terminations||participants|Number|314|314.0||||||
4438630|NCT00116272|4262697|B3|≥ 3||Previous Spontaneous Abortion||participants|Number|16|16.0||||||
4438631|NCT00116272|4262698|B2|≥ 3||Previous Spontaneous Abortion||participants|Number|6|6.0||||||
4438632|NCT00116272|4262699|B1|≥ 3||Previous Spontaneous Abortion||participants|Number|10|10.0||||||
4438633|NCT00116272|4262697|B3|2||Previous Spontaneous Abortion||participants|Number|33|33.0||||||
4438634|NCT00116272|4262698|B2|2||Previous Spontaneous Abortion||participants|Number|11|11.0||||||
4438635|NCT00116272|4262699|B1|2||Previous Spontaneous Abortion||participants|Number|22|22.0||||||
4438636|NCT00116272|4262697|B3|1||Previous Spontaneous Abortion||participants|Number|103|103.0||||||
4438637|NCT00116272|4262698|B2|1||Previous Spontaneous Abortion||participants|Number|30|30.0||||||
4438638|NCT00116272|4262699|B1|1||Previous Spontaneous Abortion||participants|Number|73|73.0||||||
4438639|NCT00116272|4262697|B3|0||Previous Spontaneous Abortion||participants|Number|382|382.0||||||
4438640|NCT00116272|4262698|B2|0||Previous Spontaneous Abortion||participants|Number|117|117.0||||||
4438641|NCT00116272|4262699|B1|0||Previous Spontaneous Abortion||participants|Number|265|265.0||||||
4438642|NCT00116272|4262697|B3|≥ 5 births||Parity Category||participants|Number|2|2.0||||||
4438643|NCT00116272|4262698|B2|≥ 5 births||Parity Category||participants|Number|0|0.0||||||
4438644|NCT00116272|4262699|B1|≥ 5 births||Parity Category||participants|Number|2|2.0||||||
4438645|NCT00116272|4262697|B3|3 - 4 births||Parity Category||participants|Number|29|29.0||||||
4438646|NCT00116272|4262698|B2|3 - 4 births||Parity Category||participants|Number|7|7.0||||||
4438647|NCT00116272|4262699|B1|3 - 4 births||Parity Category||participants|Number|22|22.0||||||
4438648|NCT00116272|4262697|B3|1 -2 births||Parity Category||participants|Number|222|222.0||||||
4438649|NCT00116272|4262698|B2|1 -2 births||Parity Category||participants|Number|69|69.0||||||
4438650|NCT00116272|4262699|B1|1 -2 births||Parity Category||participants|Number|153|153.0||||||
4438651|NCT00116272|4262697|B3|0 births||Parity Category||participants|Number|281|281.0||||||
4438652|NCT00116272|4262698|B2|0 births||Parity Category||participants|Number|88|88.0||||||
4438653|NCT00116272|4262699|B1|0 births||Parity Category||participants|Number|193|193.0||||||
4438654|NCT00116272|4262697|B3|≥ 6 pregnancies||Gravidity Category||participants|Number|15|15.0||||||
4438655|NCT00116272|4262698|B2|≥ 6 pregnancies||Gravidity Category||participants|Number|3|3.0||||||
4438656|NCT00116272|4262699|B1|≥ 6 pregnancies||Gravidity Category||participants|Number|12|12.0||||||
4438657|NCT00116272|4262697|B3|4 -5 pregnancies||Gravidity Category||participants|Number|81|81.0||||||
4438658|NCT00116272|4262698|B2|4 -5 pregnancies||Gravidity Category||participants|Number|21|21.0||||||
4438659|NCT00116272|4262699|B1|4 -5 pregnancies||Gravidity Category||participants|Number|60|60.0||||||
4438660|NCT00116272|4262697|B3|2 -3 pregnancies||Gravidity Category||participants|Number|241|241.0||||||
4438661|NCT00116272|4262698|B2|2 -3 pregnancies||Gravidity Category||participants|Number|78|78.0||||||
4438662|NCT00116272|4262699|B1|2 -3 pregnancies||Gravidity Category||participants|Number|163|163.0||||||
4438663|NCT00116272|4262697|B3|1 pregnancy||Gravidity Category||participants|Number|197|197.0||||||
4438664|NCT00116272|4262698|B2|1 pregnancy||Gravidity Category||participants|Number|62|62.0||||||
4438665|NCT00116272|4262699|B1|1 pregnancy||Gravidity Category||participants|Number|135|135.0||||||
4438666|NCT00116272|4262697|B3|||Pre-pregnancy Body Weight||kg|Mean|69.6|69.6|Standard Deviation|17.8|17.8|||
4438667|NCT00116272|4262698|B2|||Pre-pregnancy Body Weight||kg|Mean|68.3|68.3|Standard Deviation|16.5|16.5|||
4438668|NCT00116272|4262699|B1|||Pre-pregnancy Body Weight||kg|Mean|70.2|70.2|Standard Deviation|18.14|18.14|||
4438669|NCT00116272|4262697|B3|||Pre-pregnancy Height||cm|Mean|165.3|165.3|Standard Deviation|7.1|7.1|||
4438670|NCT00116272|4262698|B2|||Pre-pregnancy Height||cm|Mean|166.7|166.7|Standard Deviation|7.0|7.0|||
4438671|NCT00116272|4262699|B1|||Pre-pregnancy Height||cm|Mean|164.7|164.7|Standard Deviation|7.1|7.1|||
4438672|NCT00116272|4262697|B3|Missing||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|2|2.0||||||
4438673|NCT00116272|4262698|B2|Missing||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|0|0.0||||||
4438674|NCT00116272|4262699|B1|Missing||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|2|2.0||||||
4438675|NCT00116272|4262697|B3|5||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|10|10.0||||||
4438676|NCT00116272|4262698|B2|5||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|3|3.0||||||
4438677|NCT00116272|4262699|B1|5||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|7|7.0||||||
4438678|NCT00116272|4262697|B3|4||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|29|29.0||||||
4438679|NCT00116272|4262698|B2|4||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|6|6.0||||||
4438787|NCT00115934|4262835|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438680|NCT00116272|4262699|B1|4||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|23|23.0||||||
4438681|NCT00116272|4262697|B3|3||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|78|78.0||||||
4438682|NCT00116272|4262698|B2|3||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|19|19.0||||||
4438683|NCT00116272|4262699|B1|3||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|59|59.0||||||
4438684|NCT00116272|4262697|B3|2||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|212|212.0||||||
4438685|NCT00116272|4262698|B2|2||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|67|67.0||||||
4438686|NCT00116272|4262699|B1|2||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|145|145.0||||||
4438687|NCT00116272|4262697|B3|1||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|203|203.0||||||
4438688|NCT00116272|4262698|B2|1||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|69|69.0||||||
4438689|NCT00116272|4262699|B1|1||Hollingshead Socioeconomic Category|Based on four-factor Hollingshead categories incorporating maternal and paternal education and occupation; highest socioeconomic status category = 1; lowest socioeconomic status category = 5.|participants|Number|134|134.0||||||
4438690|NCT00116272|4262697|B3|> 15 years||Maternal Education||participants|Number|361|361.0||||||
4438691|NCT00116272|4262698|B2|> 15 years||Maternal Education||participants|Number|118|118.0||||||
4438692|NCT00116272|4262699|B1|> 15 years||Maternal Education||participants|Number|243|243.0||||||
4438693|NCT00116272|4262697|B3|12 - 15 years||Maternal Education||participants|Number|160|160.0||||||
4438694|NCT00116272|4262698|B2|12 - 15 years||Maternal Education||participants|Number|42|42.0||||||
4438695|NCT00116272|4262699|B1|12 - 15 years||Maternal Education||participants|Number|118|118.0||||||
4438696|NCT00116272|4262697|B3|< 12 years||Maternal Education||participants|Number|13|13.0||||||
4438697|NCT00116272|4262698|B2|< 12 years||Maternal Education||participants|Number|4|4.0||||||
4438698|NCT00116272|4262699|B1|< 12 years||Maternal Education||participants|Number|9|9.0||||||
4438699|NCT00116272|4262697|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4438700|NCT00116272|4262698|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4438701|NCT00116272|4262699|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4438702|NCT00116272|4262697|B3|Native American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4438703|NCT00116272|4262698|B2|Native American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4438704|NCT00116272|4262699|B1|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4438705|NCT00116272|4262697|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4438706|NCT00116272|4262698|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4438707|NCT00116272|4262699|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4438708|NCT00116272|4262697|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4438709|NCT00116272|4262698|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4438710|NCT00116272|4262699|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4438711|NCT00116272|4262697|B3|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4438712|NCT00116272|4262698|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4438713|NCT00116272|4262699|B1|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4438714|NCT00116272|4262697|B3|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|430|430.0||||||
4438715|NCT00116272|4262698|B2|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
4438716|NCT00116272|4262699|B1|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|292|292.0||||||
4438717|NCT00116272|4262697|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4438718|NCT00116272|4262698|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4438719|NCT00116272|4262699|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4438720|NCT00116272|4262697|B3||Female|Sex: Female, Male||Participants|Count of Participants|534|534.0||||||
4438721|NCT00116272|4262698|B2||Female|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4438722|NCT00116272|4262699|B1||Female|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
4438723|NCT00116272|4262697|B3|> 34 years||Age, Customized|Maternal Age at Estimated Due Date|participants|Number|211|211.0||||||
4438724|NCT00116272|4262698|B2|> 34 years||Age, Customized|Maternal Age at Estimated Due Date|participants|Number|75|75.0||||||
4438725|NCT00116272|4262699|B1|> 34 years||Age, Customized|Maternal Age at Estimated Due Date|participants|Number|136|136.0||||||
4438726|NCT00116272|4262697|B3|30 - 34 years||Age, Customized|Maternal Age at Estimated Due Date|participants|Number|180|180.0||||||
4438727|NCT00116272|4262698|B2|30 - 34 years||Age, Customized|Maternal Age at Estimated Due Date|participants|Number|48|48.0||||||
4438728|NCT00116272|4262699|B1|30 - 34 years||Age, Customized|Maternal Age at Estimated Due Date|participants|Number|132|132.0||||||
4438729|NCT00116272|4262697|B3|25 - 29 years||Age, Customized|Maternal Age at Estimated Due Date|participants|Number|115|115.0||||||
4438730|NCT00116272|4262698|B2|25 - 29 years||Age, Customized|Maternal Age at Estimated Due Date|participants|Number|34|34.0||||||
4438731|NCT00116272|4262699|B1|25 - 29 years||Age, Customized|Maternal Age at Estimated Due Date|participants|Number|81|81.0||||||
4438732|NCT00116272|4262697|B3|< 25 years||Age, Customized|Maternal Age at Estimated Due Date|participants|Number|28|28.0||||||
4438733|NCT00116272|4262698|B2|< 25 years||Age, Customized|Maternal Age at Estimated Due Date|participants|Number|7|7.0||||||
4438734|NCT00116272|4262699|B1|< 25 years||Age, Customized|Maternal Age at Estimated Due Date|participants|Number|21|21.0||||||
4438735|NCT00116207|4262750|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4438736|NCT00116207|4262751|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4438737|NCT00116207|4262752|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4438738|NCT00116207|4262750|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4438739|NCT00116207|4262751|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4438740|NCT00116207|4262752|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4438741|NCT00116207|4262750|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4438742|NCT00116207|4262751|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4438743|NCT00116207|4262752|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4438744|NCT00116207|4262750|B3|||Age||years|Mean|46|46.0|Standard Deviation|11|11.0|||
4438745|NCT00116207|4262751|B2|||Age||years|Mean|47|47.0|Standard Deviation|10|10.0|||
4438746|NCT00116207|4262752|B1|||Age||years|Mean|44|44.0|Standard Deviation|12|12.0|||
4438747|NCT00116207|4262750|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438748|NCT00116207|4262751|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438749|NCT00116207|4262752|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438750|NCT00116207|4262750|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4438751|NCT00116207|4262751|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4438752|NCT00116207|4262752|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4438753|NCT00116207|4262750|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4438754|NCT00116207|4262751|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4438755|NCT00116207|4262752|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4438756|NCT00116168|4262765|B5||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4438757|NCT00116168|4262766|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4438758|NCT00116168|4262767|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4438759|NCT00116168|4262768|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4438760|NCT00116168|4262769|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4438761|NCT00116168|4262765|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4438762|NCT00116168|4262766|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4438763|NCT00116168|4262767|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4438764|NCT00116168|4262768|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4438765|NCT00116168|4262769|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4438766|NCT00116168|4262765|B5|||Age||Years|Mean|29.2|29.2|Standard Deviation|10.5|10.5|||
4438767|NCT00116168|4262766|B4|||Age||Years|Mean|33.2|33.2|Standard Deviation|13.9|13.9|||
4438768|NCT00116168|4262767|B3|||Age||Years|Mean|34.7|34.7|Standard Deviation|7.8|7.8|||
4438769|NCT00116168|4262768|B2|||Age||Years|Mean|25.2|25.2|Standard Deviation|9.7|9.7|||
4438770|NCT00116168|4262769|B1|||Age||Years|Mean|27.2|27.2|Standard Deviation|8.7|8.7|||
4438771|NCT00115934|4262834|B3|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4438772|NCT00115934|4262835|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4438773|NCT00115934|4262836|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4438774|NCT00115934|4262834|B3|United States||Region of Enrollment||participants|Number|534|534.0||||||
4438775|NCT00115934|4262835|B2|United States||Region of Enrollment||participants|Number|266|266.0||||||
4438776|NCT00115934|4262836|B1|United States||Region of Enrollment||participants|Number|268|268.0||||||
4438777|NCT00115934|4262834|B3||Male|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4438778|NCT00115934|4262835|B2||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4438779|NCT00115934|4262836|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4438780|NCT00115934|4262834|B3||Female|Sex: Female, Male||Participants|Count of Participants|209|209.0||||||
4438781|NCT00115934|4262835|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4438782|NCT00115934|4262836|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4438783|NCT00115934|4262834|B3|||Age||days|Mean|5.1|5.1|Standard Deviation|4.0|4.0|||
4438784|NCT00115934|4262835|B2|||Age||days|Mean|5.0|5.0|Standard Deviation|4.0|4.0|||
4438785|NCT00115934|4262836|B1|||Age||days|Mean|5.1|5.1|Standard Deviation|4.1|4.1|||
4438786|NCT00115934|4262834|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438788|NCT00115934|4262836|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438789|NCT00115934|4262834|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4438790|NCT00115934|4262835|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4438791|NCT00115934|4262836|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4438792|NCT00115934|4262834|B3||<=18 years|Age||Participants|Count of Participants|549|549.0||||||
4438793|NCT00115934|4262835|B2||<=18 years|Age||Participants|Count of Participants|274|274.0||||||
4438794|NCT00115934|4262836|B1||<=18 years|Age||Participants|Count of Participants|275|275.0||||||
4438795|NCT00115869|4262875|B3|United States||Region of Enrollment||participants|Number|8388|8388.0||||||
4438796|NCT00115869|4262876|B2|United States||Region of Enrollment||participants|Number|4177|4177.0||||||
4438797|NCT00115869|4262877|B1|United States||Region of Enrollment||participants|Number|4211|4211.0||||||
4438798|NCT00115869|4262875|B3||Male|Sex: Female, Male||Participants|Count of Participants|4257|4257.0||||||
4438799|NCT00115869|4262876|B2||Male|Sex: Female, Male||Participants|Count of Participants|2104|2104.0||||||
4438800|NCT00115869|4262877|B1||Male|Sex: Female, Male||Participants|Count of Participants|2153|2153.0||||||
4438801|NCT00115869|4262875|B3||Female|Sex: Female, Male||Participants|Count of Participants|4131|4131.0||||||
4438802|NCT00115869|4262876|B2||Female|Sex: Female, Male||Participants|Count of Participants|2073|2073.0||||||
4438803|NCT00115869|4262877|B1||Female|Sex: Female, Male||Participants|Count of Participants|2058|2058.0||||||
4438804|NCT00115869|4262875|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438805|NCT00115869|4262876|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438806|NCT00115869|4262877|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438807|NCT00115869|4262875|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4438808|NCT00115869|4262876|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4438809|NCT00115869|4262877|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4438810|NCT00115869|4262875|B3||<=18 years|Age||Participants|Count of Participants|8388|8388.0||||||
4438811|NCT00115869|4262876|B2||<=18 years|Age||Participants|Count of Participants|4177|4177.0||||||
4438812|NCT00115869|4262877|B1||<=18 years|Age||Participants|Count of Participants|4211|4211.0||||||
4438813|NCT00115804|4262886|B1|||Average Pain Severity|The average pain severity on the Pediatric Pain Questionnaire’s 100-mm visual analog scale. This is a 100-mm horizontal line on which the patient’s pain intensity is represented by a point between the extremes of zero “no pain at all” and 100 “worst pain imaginable.”|mm|Mean|62|62.0|Full Range|||47.0|76.0|
4438814|NCT00115804|4262886|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4438815|NCT00115804|4262886|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4438816|NCT00115804|4262886|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4438817|NCT00115804|4262886|B1|||Age||years|Mean|15.3|15.3|Standard Deviation|1.25|1.25|||
4438818|NCT00115804|4262886|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438819|NCT00115804|4262886|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4438820|NCT00115804|4262886|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4438821|NCT00115765|4262897|B5|No||Prior adjuvant chemotherapy||Participant|Number|822|822.0||||||
4438822|NCT00115765|4262898|B4|No||Prior adjuvant chemotherapy||Participant|Number|333|333.0||||||
4438823|NCT00115765|4262899|B3|No||Prior adjuvant chemotherapy||Participant|Number|79|79.0||||||
4438824|NCT00115765|4262900|B2|No||Prior adjuvant chemotherapy||Participant|Number|77|77.0||||||
4438825|NCT00115765|4262901|B1|No||Prior adjuvant chemotherapy||Participant|Number|333|333.0||||||
4438826|NCT00115765|4262897|B5|Yes||Prior adjuvant chemotherapy||Participant|Number|231|231.0||||||
4438827|NCT00115765|4262898|B4|Yes||Prior adjuvant chemotherapy||Participant|Number|80|80.0||||||
4438828|NCT00115765|4262899|B3|Yes||Prior adjuvant chemotherapy||Participant|Number|36|36.0||||||
4438829|NCT00115765|4262900|B2|Yes||Prior adjuvant chemotherapy||Participant|Number|38|38.0||||||
4438830|NCT00115765|4262901|B1|Yes||Prior adjuvant chemotherapy||Participant|Number|77|77.0||||||
4438831|NCT00115765|4262897|B5|Rectal||Primary Site of Disease||Participant|Number|218|218.0||||||
4438832|NCT00115765|4262898|B4|Rectal||Primary Site of Disease||Participant|Number|91|91.0||||||
4438833|NCT00115765|4262899|B3|Rectal||Primary Site of Disease||Participant|Number|20|20.0||||||
4438834|NCT00115765|4262900|B2|Rectal||Primary Site of Disease||Participant|Number|23|23.0||||||
4438835|NCT00115765|4262901|B1|Rectal||Primary Site of Disease||Participant|Number|84|84.0||||||
4438836|NCT00115765|4262897|B5|Colon||Primary Site of Disease||Participant|Number|835|835.0||||||
4438837|NCT00115765|4262898|B4|Colon||Primary Site of Disease||Participant|Number|322|322.0||||||
4438838|NCT00115765|4262899|B3|Colon||Primary Site of Disease||Participant|Number|95|95.0||||||
4438839|NCT00115765|4262900|B2|Colon||Primary Site of Disease||Participant|Number|92|92.0||||||
4438840|NCT00115765|4262901|B1|Colon||Primary Site of Disease||Participant|Number|326|326.0||||||
4438841|NCT00115765|4262897|B5|>1||Number of Metastatic Organs||Participant|Number|550|550.0||||||
4438842|NCT00115765|4262898|B4|>1||Number of Metastatic Organs||Participant|Number|208|208.0||||||
4438843|NCT00115765|4262899|B3|>1||Number of Metastatic Organs||Participant|Number|62|62.0||||||
4438844|NCT00115765|4262900|B2|>1||Number of Metastatic Organs||Participant|Number|69|69.0||||||
4438845|NCT00115765|4262901|B1|>1||Number of Metastatic Organs||Participant|Number|211|211.0||||||
4438846|NCT00115765|4262897|B5|1||Number of Metastatic Organs||Participant|Number|502|502.0||||||
4438847|NCT00115765|4262898|B4|1||Number of Metastatic Organs||Participant|Number|204|204.0||||||
4438848|NCT00115765|4262899|B3|1||Number of Metastatic Organs||Participant|Number|53|53.0||||||
4438849|NCT00115765|4262900|B2|1||Number of Metastatic Organs||Participant|Number|46|46.0||||||
4438850|NCT00115765|4262901|B1|1||Number of Metastatic Organs||Participant|Number|199|199.0||||||
4438851|NCT00115765|4262897|B5|None||Number of Metastatic Organs||Participant|Number|1|1.0||||||
4438852|NCT00115765|4262898|B4|None||Number of Metastatic Organs||Participant|Number|1|1.0||||||
4438853|NCT00115765|4262899|B3|None||Number of Metastatic Organs||Participant|Number|0|0.0||||||
4438854|NCT00115765|4262900|B2|None||Number of Metastatic Organs||Participant|Number|0|0.0||||||
4438855|NCT00115765|4262901|B1|None||Number of Metastatic Organs||Participant|Number|0|0.0||||||
4438856|NCT00115765|4262897|B5|1||ECOG Score|Eastern Cooperative Oncology Group (ECOG) Score|Participant|Number|419|419.0||||||
4438857|NCT00115765|4262898|B4|1||ECOG Score|Eastern Cooperative Oncology Group (ECOG) Score|Participant|Number|160|160.0||||||
4438858|NCT00115765|4262899|B3|1||ECOG Score|Eastern Cooperative Oncology Group (ECOG) Score|Participant|Number|41|41.0||||||
4438859|NCT00115765|4262900|B2|1||ECOG Score|Eastern Cooperative Oncology Group (ECOG) Score|Participant|Number|47|47.0||||||
4438860|NCT00115765|4262901|B1|1||ECOG Score|Eastern Cooperative Oncology Group (ECOG) Score|Participant|Number|171|171.0||||||
4438861|NCT00115765|4262897|B5|0||ECOG Score|Eastern Cooperative Oncology Group (ECOG) Score|Participant|Number|634|634.0||||||
4438862|NCT00115765|4262898|B4|0||ECOG Score|Eastern Cooperative Oncology Group (ECOG) Score|Participant|Number|253|253.0||||||
4438863|NCT00115765|4262899|B3|0||ECOG Score|Eastern Cooperative Oncology Group (ECOG) Score|Participant|Number|74|74.0||||||
4438864|NCT00115765|4262900|B2|0||ECOG Score|Eastern Cooperative Oncology Group (ECOG) Score|Participant|Number|68|68.0||||||
4438865|NCT00115765|4262901|B1|0||ECOG Score|Eastern Cooperative Oncology Group (ECOG) Score|Participant|Number|239|239.0||||||
4438866|NCT00115765|4262897|B5|Other||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4438867|NCT00115765|4262898|B4|Other||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4438868|NCT00115765|4262899|B3|Other||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4438869|NCT00115765|4262900|B2|Other||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4438870|NCT00115765|4262901|B1|Other||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4438871|NCT00115765|4262897|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4438872|NCT00115765|4262898|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4438873|NCT00115765|4262899|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4438874|NCT00115765|4262900|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4438875|NCT00115765|4262901|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4438876|NCT00115765|4262897|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|3|3.0||||||
4438877|NCT00115765|4262898|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4438878|NCT00115765|4262899|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4438879|NCT00115765|4262900|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|2|2.0||||||
4438880|NCT00115765|4262901|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participant|Number|1|1.0||||||
4438881|NCT00115765|4262897|B5|Japanese||Race/Ethnicity, Customized||Participant|Number|2|2.0||||||
4438882|NCT00115765|4262898|B4|Japanese||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4438883|NCT00115765|4262899|B3|Japanese||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4438884|NCT00115765|4262900|B2|Japanese||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4438885|NCT00115765|4262901|B1|Japanese||Race/Ethnicity, Customized||Participant|Number|2|2.0||||||
4438886|NCT00115765|4262897|B5|Asian||Race/Ethnicity, Customized||Participant|Number|22|22.0||||||
4438887|NCT00115765|4262898|B4|Asian||Race/Ethnicity, Customized||Participant|Number|10|10.0||||||
4438888|NCT00115765|4262899|B3|Asian||Race/Ethnicity, Customized||Participant|Number|0|0.0||||||
4438889|NCT00115765|4262900|B2|Asian||Race/Ethnicity, Customized||Participant|Number|2|2.0||||||
4438890|NCT00115765|4262901|B1|Asian||Race/Ethnicity, Customized||Participant|Number|10|10.0||||||
4438891|NCT00115765|4262897|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|70|70.0||||||
4438892|NCT00115765|4262898|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|25|25.0||||||
4438893|NCT00115765|4262899|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|14|14.0||||||
4438894|NCT00115765|4262900|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|6|6.0||||||
4438895|NCT00115765|4262901|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participant|Number|25|25.0||||||
4438896|NCT00115765|4262897|B5|Black or African American||Race/Ethnicity, Customized||Participant|Number|110|110.0||||||
4438897|NCT00115765|4262898|B4|Black or African American||Race/Ethnicity, Customized||Participant|Number|35|35.0||||||
4438898|NCT00115765|4262899|B3|Black or African American||Race/Ethnicity, Customized||Participant|Number|16|16.0||||||
4438899|NCT00115765|4262900|B2|Black or African American||Race/Ethnicity, Customized||Participant|Number|18|18.0||||||
4438900|NCT00115765|4262901|B1|Black or African American||Race/Ethnicity, Customized||Participant|Number|41|41.0||||||
4438901|NCT00115765|4262897|B5|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|844|844.0||||||
4438902|NCT00115765|4262898|B4|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|343|343.0||||||
4438903|NCT00115765|4262899|B3|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|85|85.0||||||
4438904|NCT00115765|4262900|B2|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|86|86.0||||||
4438905|NCT00115765|4262901|B1|White or Caucasian||Race/Ethnicity, Customized||Participant|Number|330|330.0||||||
4438906|NCT00115765|4262897|B5||Male|Sex: Female, Male||Participants|Count of Participants|598|598.0||||||
4438907|NCT00115765|4262898|B4||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4438908|NCT00115765|4262899|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4438909|NCT00115765|4262900|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4438910|NCT00115765|4262901|B1||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4438911|NCT00115765|4262897|B5||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4438912|NCT00115765|4262898|B4||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4438913|NCT00115765|4262899|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4438914|NCT00115765|4262900|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4438915|NCT00115765|4262901|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4438916|NCT00115765|4262897|B5|||Age||Year|Mean|60.4|60.4|Standard Deviation|11.8|11.8|||
4438917|NCT00115765|4262898|B4|||Age||Year|Mean|60.8|60.8|Standard Deviation|11.7|11.7|||
4438918|NCT00115765|4262899|B3|||Age||Year|Mean|57.8|57.8|Standard Deviation|12.0|12.0|||
4438919|NCT00115765|4262900|B2|||Age||Year|Mean|59.4|59.4|Standard Deviation|11.7|11.7|||
4438920|NCT00115765|4262901|B1|||Age||Year|Mean|61.0|61.0|Standard Deviation|11.9|11.9|||
4438921|NCT00115739|4262942|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4438922|NCT00115739|4262942|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4438923|NCT00115739|4262942|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4438924|NCT00115739|4262942|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|7.4|7.4|||
4438925|NCT00115739|4262942|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4438926|NCT00115739|4262942|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4438927|NCT00115739|4262942|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4438928|NCT00115349|4262949|B3|Lebanon||Region of Enrollment||participants|Number|4|4.0||||||
4438929|NCT00115349|4262950|B2|Lebanon||Region of Enrollment||participants|Number|2|2.0||||||
4438930|NCT00115349|4262951|B1|Lebanon||Region of Enrollment||participants|Number|2|2.0||||||
4438931|NCT00115349|4262949|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4438932|NCT00115349|4262950|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4438933|NCT00115349|4262951|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4438934|NCT00115349|4262949|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4438935|NCT00115349|4262950|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4438936|NCT00115349|4262951|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4438937|NCT00115349|4262949|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4438938|NCT00115349|4262950|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4438939|NCT00115349|4262951|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4438940|NCT00115349|4262949|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4438941|NCT00115349|4262950|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4438942|NCT00115349|4262951|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4438943|NCT00115349|4262949|B3|||Age||years|Mean|26.15|26.15|Standard Deviation|6.18|6.18|||
4438944|NCT00115349|4262950|B2|||Age||years|Mean|25.8|25.8|Standard Deviation|7.6|7.6|||
4438945|NCT00115349|4262951|B1|||Age||years|Mean|26.5|26.5|Standard Deviation|5.1|5.1|||
4438946|NCT00115349|4262949|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438947|NCT00115349|4262950|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438948|NCT00115349|4262951|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4438949|NCT00115349|4262949|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4438950|NCT00115349|4262950|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4438951|NCT00115349|4262951|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4438952|NCT00115349|4262949|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4438953|NCT00115349|4262950|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4438954|NCT00115349|4262951|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4438955|NCT00115297|4262958|B3|Turkey||Region of Enrollment||participants|Number|62|62.0||||||
4438956|NCT00115297|4262959|B2|Turkey||Region of Enrollment||participants|Number|32|32.0||||||
4438957|NCT00115297|4262960|B1|Turkey||Region of Enrollment||participants|Number|30|30.0||||||
4438958|NCT00115297|4262958|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438959|NCT00115297|4262959|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438960|NCT00115297|4262960|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438961|NCT00115297|4262958|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438962|NCT00115297|4262959|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438963|NCT00115297|4262960|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438964|NCT00115297|4262958|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4438965|NCT00115297|4262959|B2||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4438966|NCT00115297|4262960|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4438967|NCT00115297|4262958|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438968|NCT00115297|4262959|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438969|NCT00115297|4262960|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438970|NCT00115297|4262958|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438971|NCT00115297|4262959|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438972|NCT00115297|4262960|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438973|NCT00115297|4262958|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438974|NCT00115297|4262959|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438975|NCT00115297|4262960|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438976|NCT00115297|4262958|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438977|NCT00115297|4262959|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438978|NCT00115297|4262960|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438979|NCT00115297|4262958|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438980|NCT00115297|4262959|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438981|NCT00115297|4262960|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438982|NCT00115297|4262958|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4438983|NCT00115297|4262959|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4438984|NCT00115297|4262960|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4438985|NCT00115297|4262958|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438986|NCT00115297|4262959|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438987|NCT00115297|4262960|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4438988|NCT00115297|4262958|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4438989|NCT00115297|4262959|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4438990|NCT00115297|4262960|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4438991|NCT00115297|4262958|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4438992|NCT00115297|4262959|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4438993|NCT00115297|4262960|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4438994|NCT00115297|4262958|B3|||Age||Months|Median|13.0|13.0|Inter-Quartile Range|||9.0|20.0|
4438995|NCT00115297|4262959|B2|||Age||Months|Median|11.5|11.5|Inter-Quartile Range|||8.3|20.0|
4438996|NCT00115297|4262960|B1|||Age||Months|Median|13|13.0|Inter-Quartile Range|||8.5|19.3|
4438997|NCT00115063|4262971|B3|United States||Region of Enrollment||participants|Number|390|390.0||||||
4438998|NCT00115063|4262972|B2|United States||Region of Enrollment||participants|Number|190|190.0||||||
4438999|NCT00115063|4262973|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
4439000|NCT00115063|4262971|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4439001|NCT00115063|4262972|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4439002|NCT00115063|4262973|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4439003|NCT00115063|4262971|B3|White||Race/Ethnicity, Customized||participants|Number|296|296.0||||||
4439004|NCT00115063|4262972|B2|White||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
4439005|NCT00115063|4262973|B1|White||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
4439006|NCT00115063|4262971|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4439007|NCT00115063|4262972|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439008|NCT00115063|4262973|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4439009|NCT00115063|4262971|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4439010|NCT00115063|4262972|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4439011|NCT00115063|4262973|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4439012|NCT00115063|4262971|B3||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4439013|NCT00115063|4262972|B2||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4439014|NCT00115063|4262973|B1||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4439015|NCT00115063|4262971|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|0.6|0.6|||
4439016|NCT00115063|4262972|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|0.6|0.6|||
4439017|NCT00115063|4262973|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|0.6|0.6|||
4439018|NCT00115063|4262971|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4439019|NCT00115063|4262972|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4439020|NCT00115063|4262973|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4439021|NCT00115063|4262971|B3||Between 18 and 65 years|Age||Participants|Count of Participants|390|390.0||||||
4439022|NCT00115063|4262972|B2||Between 18 and 65 years|Age||Participants|Count of Participants|190|190.0||||||
4439023|NCT00115063|4262973|B1||Between 18 and 65 years|Age||Participants|Count of Participants|200|200.0||||||
4439024|NCT00115063|4262971|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4439025|NCT00115063|4262972|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4439026|NCT00115063|4262973|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4439044|NCT00114972|4262992|B1|Participants with Triglyceride Levels <150 mg/dL||Triglyceride levels ≥150 mg/dL|participants with Triglyceride levels ≥150 mg/dL as determined by a central chemistry laboratorium at baseline|participants|Number|593|593.0||||||
4439027|NCT00114972|4262990|B3|||Total Syntax Score|The SYNTAX score characterizes the coronary vasculature. It combines the importance of a diseased coronary artery segment (Leaman score), adverse characteristics of a lesion (ACC/AHA lesion classification) and the modified Duke/ICPS classification for bifurcation lesions. Higher SYNTAX scores are indicative of more complex lesions and disease; thus higher scores would predict worse short-term outcomes. Calculated from angiographic corelab analysis of baseline angiogram. (www.syntaxscore.com)|units on a scale|Mean|28.7|28.7|Standard Deviation|11.42|11.42|||
4439028|NCT00114972|4262991|B2|||Total Syntax Score|The SYNTAX score characterizes the coronary vasculature. It combines the importance of a diseased coronary artery segment (Leaman score), adverse characteristics of a lesion (ACC/AHA lesion classification) and the modified Duke/ICPS classification for bifurcation lesions. Higher SYNTAX scores are indicative of more complex lesions and disease; thus higher scores would predict worse short-term outcomes. Calculated from angiographic corelab analysis of baseline angiogram. (www.syntaxscore.com)|units on a scale|Mean|28.39|28.39|Standard Deviation|11.46|11.46|||
4439029|NCT00114972|4262992|B1|||Total Syntax Score|The SYNTAX score characterizes the coronary vasculature. It combines the importance of a diseased coronary artery segment (Leaman score), adverse characteristics of a lesion (ACC/AHA lesion classification) and the modified Duke/ICPS classification for bifurcation lesions. Higher SYNTAX scores are indicative of more complex lesions and disease; thus higher scores would predict worse short-term outcomes. Calculated from angiographic corelab analysis of baseline angiogram. (www.syntaxscore.com)|units on a scale|Mean|29.1|29.1|Standard Deviation|11.37|11.37|||
4439030|NCT00114972|4262990|B3|||Parsonnet Score|The first scoring system in cardiac surgery to calculate mortality risk and to become popular was the Parsonnet risk stratification system, which was developed in the United States in the 1980s. A predetermined weighted score is assigned for several specified patient-, cardiac-, and operation-related factors; for example, dialysis is assigned a score of 10. A score of greater than 15 is considered as being predictive of an increased mortality risk. Parsonette score is calculated from baseline information.|units on a scale|Mean|8.48|8.48|Standard Deviation|6.9|6.9|||
4439031|NCT00114972|4262991|B2|||Parsonnet Score|The first scoring system in cardiac surgery to calculate mortality risk and to become popular was the Parsonnet risk stratification system, which was developed in the United States in the 1980s. A predetermined weighted score is assigned for several specified patient-, cardiac-, and operation-related factors; for example, dialysis is assigned a score of 10. A score of greater than 15 is considered as being predictive of an increased mortality risk. Parsonette score is calculated from baseline information.|units on a scale|Mean|8.53|8.53|Standard Deviation|6.95|6.95|||
4439032|NCT00114972|4262992|B1|||Parsonnet Score|The first scoring system in cardiac surgery to calculate mortality risk and to become popular was the Parsonnet risk stratification system, which was developed in the United States in the 1980s. A predetermined weighted score is assigned for several specified patient-, cardiac-, and operation-related factors; for example, dialysis is assigned a score of 10. A score of greater than 15 is considered as being predictive of an increased mortality risk. Parsonette score is calculated from baseline information.|units on a scale|Mean|8.43|8.43|Standard Deviation|6.84|6.84|||
4439033|NCT00114972|4262990|B3|||Number of lesions per partipant|Average number of lesions per participant as determined by the investigator|Number of lesions/Participant|Mean|3.97|3.97|Standard Deviation|1.68|1.68|||
4439034|NCT00114972|4262991|B2|||Number of lesions per partipant|Average number of lesions per participant as determined by the investigator|Number of lesions/Participant|Mean|3.94|3.94|Standard Deviation|1.66|1.66|||
4439035|NCT00114972|4262992|B1|||Number of lesions per partipant|Average number of lesions per participant as determined by the investigator|Number of lesions/Participant|Mean|3.99|3.99|Standard Deviation|1.7|1.7|||
4439036|NCT00114972|4262990|B3|||Body Mass Index (BMI)|Body Mass Index calculated from participants heigth and weight.|kg/m2|Mean|28.01|28.01|Standard Deviation|4.67|4.67|||
4439037|NCT00114972|4262991|B2|||Body Mass Index (BMI)|Body Mass Index calculated from participants heigth and weight.|kg/m2|Mean|28.11|28.11|Standard Deviation|4.80|4.8|||
4439038|NCT00114972|4262992|B1|||Body Mass Index (BMI)|Body Mass Index calculated from participants heigth and weight.|kg/m2|Mean|27.91|27.91|Standard Deviation|4.54|4.54|||
4439039|NCT00114972|4262990|B3|||Additive Euroscore|Additive EuroSCORE is a prognostic scoring system calculating predicted operative mortality for patients undergoing cardiac surgery; it has been the most rigorously evaluated scoring system in cardiac surgery. A predetermined weighted score is assigned for specified patient-, cardiac-, and operation-related factors; for example, pulmonary hypertension is assigned a score of 2. The sum of scores is the additive EuroSCORE. EuroSCORE is calculated from site reported baseline data. A score of greater than 6 is considered as being predictive of an increased mortality risk. (www.euroscore.org)|units on a scale|Mean|3.77|3.77|Standard Deviation|2.66|2.66|||
4439040|NCT00114972|4262991|B2|||Additive Euroscore|Additive EuroSCORE is a prognostic scoring system calculating predicted operative mortality for patients undergoing cardiac surgery; it has been the most rigorously evaluated scoring system in cardiac surgery. A predetermined weighted score is assigned for specified patient-, cardiac-, and operation-related factors; for example, pulmonary hypertension is assigned a score of 2. The sum of scores is the additive EuroSCORE. EuroSCORE is calculated from site reported baseline data. A score of greater than 6 is considered as being predictive of an increased mortality risk. (www.euroscore.org)|units on a scale|Mean|3.75|3.75|Standard Deviation|2.62|2.62|||
4439041|NCT00114972|4262992|B1|||Additive Euroscore|Additive EuroSCORE is a prognostic scoring system calculating predicted operative mortality for patients undergoing cardiac surgery; it has been the most rigorously evaluated scoring system in cardiac surgery. A predetermined weighted score is assigned for specified patient-, cardiac-, and operation-related factors; for example, pulmonary hypertension is assigned a score of 2. The sum of scores is the additive EuroSCORE. EuroSCORE is calculated from site reported baseline data. A score of greater than 6 is considered as being predictive of an increased mortality risk. (www.euroscore.org)|units on a scale|Mean|3.79|3.79|Standard Deviation|2.69|2.69|||
4439042|NCT00114972|4262990|B3|Participants with Triglyceride Levels <150 mg/dL||Triglyceride levels ≥150 mg/dL|participants with Triglyceride levels ≥150 mg/dL as determined by a central chemistry laboratorium at baseline|participants|Number|1221.0|1221.0||||||
4439043|NCT00114972|4262991|B2|Participants with Triglyceride Levels <150 mg/dL||Triglyceride levels ≥150 mg/dL|participants with Triglyceride levels ≥150 mg/dL as determined by a central chemistry laboratorium at baseline|participants|Number|628|628.0||||||
4439045|NCT00114972|4262990|B3|Participants with Triglyceride Levels >= 150 mg/dL||Triglyceride levels ≥150 mg/dL|participants with Triglyceride levels ≥150 mg/dL as determined by a central chemistry laboratorium at baseline|participants|Number|579.0|579.0||||||
4439046|NCT00114972|4262991|B2|Participants with Triglyceride Levels >= 150 mg/dL||Triglyceride levels ≥150 mg/dL|participants with Triglyceride levels ≥150 mg/dL as determined by a central chemistry laboratorium at baseline|participants|Number|275|275.0||||||
4439047|NCT00114972|4262992|B1|Participants with Triglyceride Levels >= 150 mg/dL||Triglyceride levels ≥150 mg/dL|participants with Triglyceride levels ≥150 mg/dL as determined by a central chemistry laboratorium at baseline|participants|Number|304|304.0||||||
4439048|NCT00114972|4262990|B3|Participants with Partial Occlusion(s)||Total Occlusion (per patient)|Number of participants with at least one total occlusion as determined by the angiografic core laboratory on the baseline angiogram|participants|Number|1385.0|1385.0||||||
4439049|NCT00114972|4262991|B2|Participants with Partial Occlusion(s)||Total Occlusion (per patient)|Number of participants with at least one total occlusion as determined by the angiografic core laboratory on the baseline angiogram|participants|Number|686|686.0||||||
4439050|NCT00114972|4262992|B1|Participants with Partial Occlusion(s)||Total Occlusion (per patient)|Number of participants with at least one total occlusion as determined by the angiografic core laboratory on the baseline angiogram|participants|Number|699|699.0||||||
4439051|NCT00114972|4262990|B3|Participants with at least One Total Occlusion||Total Occlusion (per patient)|Number of participants with at least one total occlusion as determined by the angiografic core laboratory on the baseline angiogram|participants|Number|415.0|415.0||||||
4439052|NCT00114972|4262991|B2|Participants with at least One Total Occlusion||Total Occlusion (per patient)|Number of participants with at least one total occlusion as determined by the angiografic core laboratory on the baseline angiogram|participants|Number|217|217.0||||||
4439053|NCT00114972|4262992|B1|Participants with at least One Total Occlusion||Total Occlusion (per patient)|Number of participants with at least one total occlusion as determined by the angiografic core laboratory on the baseline angiogram|participants|Number|198|198.0||||||
4439054|NCT00114972|4262990|B3|No Transient Ischemic Attack before baseline||Prior TIA|number of partipants who had a Transient Ischemic Attack before baseline|participants|Number|1716.0|1716.0||||||
4439055|NCT00114972|4262991|B2|No Transient Ischemic Attack before baseline||Prior TIA|number of partipants who had a Transient Ischemic Attack before baseline|participants|Number|864|864.0||||||
4439056|NCT00114972|4262992|B1|No Transient Ischemic Attack before baseline||Prior TIA|number of partipants who had a Transient Ischemic Attack before baseline|participants|Number|852|852.0||||||
4439057|NCT00114972|4262990|B3|Transient Ischemic Attack Before Baseline||Prior TIA|number of partipants who had a Transient Ischemic Attack before baseline|participants|Number|84.0|84.0||||||
4439058|NCT00114972|4262991|B2|Transient Ischemic Attack Before Baseline||Prior TIA|number of partipants who had a Transient Ischemic Attack before baseline|participants|Number|39|39.0||||||
4439059|NCT00114972|4262992|B1|Transient Ischemic Attack Before Baseline||Prior TIA|number of partipants who had a Transient Ischemic Attack before baseline|participants|Number|45|45.0||||||
4439060|NCT00114972|4262990|B3|No Stroke Prior to Baseline||Prior Stroke|number of participants who had a stroke before baseline|participants|Number|1722.0|1722.0||||||
4439061|NCT00114972|4262991|B2|No Stroke Prior to Baseline||Prior Stroke|number of participants who had a stroke before baseline|participants|Number|868|868.0||||||
4439062|NCT00114972|4262992|B1|No Stroke Prior to Baseline||Prior Stroke|number of participants who had a stroke before baseline|participants|Number|854|854.0||||||
4439063|NCT00114972|4262990|B3|Stroke Prior to Baseline||Prior Stroke|number of participants who had a stroke before baseline|participants|Number|78.0|78.0||||||
4439064|NCT00114972|4262991|B2|Stroke Prior to Baseline||Prior Stroke|number of participants who had a stroke before baseline|participants|Number|35|35.0||||||
4439065|NCT00114972|4262992|B1|Stroke Prior to Baseline||Prior Stroke|number of participants who had a stroke before baseline|participants|Number|43|43.0||||||
4439066|NCT00114972|4262990|B3|No Myocardial Infarction Before Baseline||Prior MI|Number of participants who had a myocardial infarction before baseline|participants|Number|1215.0|1215.0||||||
4439067|NCT00114972|4262991|B2|No Myocardial Infarction Before Baseline||Prior MI|Number of participants who had a myocardial infarction before baseline|participants|Number|618|618.0||||||
4439068|NCT00114972|4262992|B1|No Myocardial Infarction Before Baseline||Prior MI|Number of participants who had a myocardial infarction before baseline|participants|Number|597|597.0||||||
4439069|NCT00114972|4262990|B3|Myocardial Infarction Before Baseline||Prior MI|Number of participants who had a myocardial infarction before baseline|participants|Number|585.0|585.0||||||
4439070|NCT00114972|4262991|B2|Myocardial Infarction Before Baseline||Prior MI|Number of participants who had a myocardial infarction before baseline|participants|Number|285|285.0||||||
4439071|NCT00114972|4262992|B1|Myocardial Infarction Before Baseline||Prior MI|Number of participants who had a myocardial infarction before baseline|participants|Number|300|300.0||||||
4439072|NCT00114972|4262990|B3|LVEF >=30% at Baseline||Poor LVEF|number of participants with left ventricular ejection fraction <30% at baseline|participants|Number|1766.0|1766.0||||||
4439073|NCT00114972|4262991|B2|LVEF >=30% at Baseline||Poor LVEF|number of participants with left ventricular ejection fraction <30% at baseline|participants|Number|891|891.0||||||
4439074|NCT00114972|4262992|B1|LVEF >=30% at Baseline||Poor LVEF|number of participants with left ventricular ejection fraction <30% at baseline|participants|Number|875|875.0||||||
4439075|NCT00114972|4262990|B3|LVEF <30% at Baseline||Poor LVEF|number of participants with left ventricular ejection fraction <30% at baseline|participants|Number|34.0|34.0||||||
4439076|NCT00114972|4262991|B2|LVEF <30% at Baseline||Poor LVEF|number of participants with left ventricular ejection fraction <30% at baseline|participants|Number|12|12.0||||||
4439077|NCT00114972|4262992|B1|LVEF <30% at Baseline||Poor LVEF|number of participants with left ventricular ejection fraction <30% at baseline|participants|Number|22|22.0||||||
4439078|NCT00114972|4262990|B3|Participants without a Metabolic Syndrome||Metabolic Syndrome|number of participants that met the criteria of metabolic syndrome defined by the American Heart Association|participants|Number|1144.0|1144.0||||||
4439196|NCT00114972|4262991|B2|Italy||Region of Enrollment||participants|Number|101|101.0||||||
4439079|NCT00114972|4262991|B2|Participants without a Metabolic Syndrome||Metabolic Syndrome|number of participants that met the criteria of metabolic syndrome defined by the American Heart Association|participants|Number|564|564.0||||||
4439080|NCT00114972|4262992|B1|Participants without a Metabolic Syndrome||Metabolic Syndrome|number of participants that met the criteria of metabolic syndrome defined by the American Heart Association|participants|Number|580|580.0||||||
4439081|NCT00114972|4262990|B3|Participants with a Metabolic Syndrome||Metabolic Syndrome|number of participants that met the criteria of metabolic syndrome defined by the American Heart Association|participants|Number|656.0|656.0||||||
4439082|NCT00114972|4262991|B2|Participants with a Metabolic Syndrome||Metabolic Syndrome|number of participants that met the criteria of metabolic syndrome defined by the American Heart Association|participants|Number|339|339.0||||||
4439083|NCT00114972|4262992|B1|Participants with a Metabolic Syndrome||Metabolic Syndrome|number of participants that met the criteria of metabolic syndrome defined by the American Heart Association|participants|Number|317|317.0||||||
4439084|NCT00114972|4262990|B3|Non-Diabetic Participants||Medically treated Diabetes|Number of participants with medically treated diabetes.Excludes participants with diabetes treated with diet only.|Participants|Number|1289.0|1289.0||||||
4439085|NCT00114972|4262991|B2|Non-Diabetic Participants||Medically treated Diabetes|Number of participants with medically treated diabetes.Excludes participants with diabetes treated with diet only.|Participants|Number|648|648.0||||||
4439086|NCT00114972|4262992|B1|Non-Diabetic Participants||Medically treated Diabetes|Number of participants with medically treated diabetes.Excludes participants with diabetes treated with diet only.|Participants|Number|641|641.0||||||
4439087|NCT00114972|4262990|B3|Diabetic Participants Treated through Diet only||Medically treated Diabetes|Number of participants with medically treated diabetes.Excludes participants with diabetes treated with diet only.|Participants|Number|59.0|59.0||||||
4439088|NCT00114972|4262991|B2|Diabetic Participants Treated through Diet only||Medically treated Diabetes|Number of participants with medically treated diabetes.Excludes participants with diabetes treated with diet only.|Participants|Number|24|24.0||||||
4439089|NCT00114972|4262992|B1|Diabetic Participants Treated through Diet only||Medically treated Diabetes|Number of participants with medically treated diabetes.Excludes participants with diabetes treated with diet only.|Participants|Number|35|35.0||||||
4439090|NCT00114972|4262990|B3|Diabetic Participants Medically Treated||Medically treated Diabetes|Number of participants with medically treated diabetes.Excludes participants with diabetes treated with diet only.|Participants|Number|452.0|452.0||||||
4439091|NCT00114972|4262991|B2|Diabetic Participants Medically Treated||Medically treated Diabetes|Number of participants with medically treated diabetes.Excludes participants with diabetes treated with diet only.|Participants|Number|231|231.0||||||
4439092|NCT00114972|4262992|B1|Diabetic Participants Medically Treated||Medically treated Diabetes|Number of participants with medically treated diabetes.Excludes participants with diabetes treated with diet only.|Participants|Number|221|221.0||||||
4439093|NCT00114972|4262990|B3|Nondiabetic Participants||Insulin requiring diabetes|Number of participants with diabetes treated with insulin|participants|Number|1289.0|1289.0||||||
4439094|NCT00114972|4262991|B2|Nondiabetic Participants||Insulin requiring diabetes|Number of participants with diabetes treated with insulin|participants|Number|648|648.0||||||
4439095|NCT00114972|4262992|B1|Nondiabetic Participants||Insulin requiring diabetes|Number of participants with diabetes treated with insulin|participants|Number|641|641.0||||||
4439096|NCT00114972|4262990|B3|Participants with non-Insulin independent Diabetes||Insulin requiring diabetes|Number of participants with diabetes treated with insulin|participants|Number|329.0|329.0||||||
4439097|NCT00114972|4262991|B2|Participants with non-Insulin independent Diabetes||Insulin requiring diabetes|Number of participants with diabetes treated with insulin|participants|Number|166|166.0||||||
4439098|NCT00114972|4262992|B1|Participants with non-Insulin independent Diabetes||Insulin requiring diabetes|Number of participants with diabetes treated with insulin|participants|Number|163|163.0||||||
4439099|NCT00114972|4262990|B3|Participants with Insulin dependent Diabetes||Insulin requiring diabetes|Number of participants with diabetes treated with insulin|participants|Number|182.0|182.0||||||
4439100|NCT00114972|4262991|B2|Participants with Insulin dependent Diabetes||Insulin requiring diabetes|Number of participants with diabetes treated with insulin|participants|Number|89|89.0||||||
4439101|NCT00114972|4262992|B1|Participants with Insulin dependent Diabetes||Insulin requiring diabetes|Number of participants with diabetes treated with insulin|participants|Number|93|93.0||||||
4439102|NCT00114972|4262990|B3|Participants without Hyperlipidemia at Baseline||Hyperlipidemia|participants with hyperlipidemia at baseline|participants|Number|409.0|409.0||||||
4439103|NCT00114972|4262991|B2|Participants without Hyperlipidemia at Baseline||Hyperlipidemia|participants with hyperlipidemia at baseline|participants|Number|198|198.0||||||
4439104|NCT00114972|4262992|B1|Participants without Hyperlipidemia at Baseline||Hyperlipidemia|participants with hyperlipidemia at baseline|participants|Number|211|211.0||||||
4439105|NCT00114972|4262990|B3|Participants with Hyperlipidemia at Baseline||Hyperlipidemia|participants with hyperlipidemia at baseline|participants|Number|1391.0|1391.0||||||
4439106|NCT00114972|4262991|B2|Participants with Hyperlipidemia at Baseline||Hyperlipidemia|participants with hyperlipidemia at baseline|participants|Number|705|705.0||||||
4439107|NCT00114972|4262992|B1|Participants with Hyperlipidemia at Baseline||Hyperlipidemia|participants with hyperlipidemia at baseline|participants|Number|686|686.0||||||
4439108|NCT00114972|4262990|B3|Participant HDL Greater Than Limit at Baseline||HDL cholesterol (<40 Male or <50 Female)|number of male participants with a high-density lipoprotein (HDL)<40 and female particpants with a HDL<50 determined by the central chemistry laboratory|participants|Number|1017.0|1017.0||||||
4439109|NCT00114972|4262991|B2|Participant HDL Greater Than Limit at Baseline||HDL cholesterol (<40 Male or <50 Female)|number of male participants with a high-density lipoprotein (HDL)<40 and female particpants with a HDL<50 determined by the central chemistry laboratory|participants|Number|524|524.0||||||
4439110|NCT00114972|4262992|B1|Participant HDL Greater Than Limit at Baseline||HDL cholesterol (<40 Male or <50 Female)|number of male participants with a high-density lipoprotein (HDL)<40 and female particpants with a HDL<50 determined by the central chemistry laboratory|participants|Number|493|493.0||||||
4439197|NCT00114972|4262992|B1|Italy||Region of Enrollment||participants|Number|96|96.0||||||
4439111|NCT00114972|4262990|B3|Participant HDL Less Than Limit at Baseline||HDL cholesterol (<40 Male or <50 Female)|number of male participants with a high-density lipoprotein (HDL)<40 and female particpants with a HDL<50 determined by the central chemistry laboratory|participants|Number|783.0|783.0||||||
4439112|NCT00114972|4262991|B2|Participant HDL Less Than Limit at Baseline||HDL cholesterol (<40 Male or <50 Female)|number of male participants with a high-density lipoprotein (HDL)<40 and female particpants with a HDL<50 determined by the central chemistry laboratory|participants|Number|379|379.0||||||
4439113|NCT00114972|4262992|B1|Participant HDL Less Than Limit at Baseline||HDL cholesterol (<40 Male or <50 Female)|number of male participants with a high-density lipoprotein (HDL)<40 and female particpants with a HDL<50 determined by the central chemistry laboratory|participants|Number|404|404.0||||||
4439114|NCT00114972|4262990|B3|No Diagnosed Diabetes at Baseline||Diabetes|All participants with diagnosed diabetes at baseline|participants|Number|1289.0|1289.0||||||
4439115|NCT00114972|4262991|B2|No Diagnosed Diabetes at Baseline||Diabetes|All participants with diagnosed diabetes at baseline|participants|Number|648|648.0||||||
4439116|NCT00114972|4262992|B1|No Diagnosed Diabetes at Baseline||Diabetes|All participants with diagnosed diabetes at baseline|participants|Number|641|641.0||||||
4439117|NCT00114972|4262990|B3|Diagnosed Diabetes at Baseline||Diabetes|All participants with diagnosed diabetes at baseline|participants|Number|511.0|511.0||||||
4439118|NCT00114972|4262991|B2|Diagnosed Diabetes at Baseline||Diabetes|All participants with diagnosed diabetes at baseline|participants|Number|255|255.0||||||
4439119|NCT00114972|4262992|B1|Diagnosed Diabetes at Baseline||Diabetes|All participants with diagnosed diabetes at baseline|participants|Number|256|256.0||||||
4439120|NCT00114972|4262990|B3|Non-Smokers at Baseline||Current smoking|Number of participants that were smoking at baseline|participants|Number|1437.0|1437.0||||||
4439121|NCT00114972|4262991|B2|Non-Smokers at Baseline||Current smoking|Number of participants that were smoking at baseline|participants|Number|736|736.0||||||
4439122|NCT00114972|4262992|B1|Non-Smokers at Baseline||Current smoking|Number of participants that were smoking at baseline|participants|Number|701|701.0||||||
4439123|NCT00114972|4262990|B3|Smokers at Baseline||Current smoking|Number of participants that were smoking at baseline|participants|Number|363.0|363.0||||||
4439124|NCT00114972|4262991|B2|Smokers at Baseline||Current smoking|Number of participants that were smoking at baseline|participants|Number|167|167.0||||||
4439125|NCT00114972|4262992|B1|Smokers at Baseline||Current smoking|Number of participants that were smoking at baseline|participants|Number|196|196.0||||||
4439126|NCT00114972|4262990|B3|No Congestive Heart Failure at Baseline||Congestive heart failure|number of particpants with congestive heart failure at baseline|participants|Number|1717.0|1717.0||||||
4439127|NCT00114972|4262991|B2|No Congestive Heart Failure at Baseline||Congestive heart failure|number of particpants with congestive heart failure at baseline|participants|Number|867|867.0||||||
4439128|NCT00114972|4262992|B1|No Congestive Heart Failure at Baseline||Congestive heart failure|number of particpants with congestive heart failure at baseline|participants|Number|850|850.0||||||
4439129|NCT00114972|4262990|B3|Congestive Heart Failure at Baseline||Congestive heart failure|number of particpants with congestive heart failure at baseline|participants|Number|83.0|83.0||||||
4439130|NCT00114972|4262991|B2|Congestive Heart Failure at Baseline||Congestive heart failure|number of particpants with congestive heart failure at baseline|participants|Number|36|36.0||||||
4439131|NCT00114972|4262992|B1|Congestive Heart Failure at Baseline||Congestive heart failure|number of particpants with congestive heart failure at baseline|participants|Number|47|47.0||||||
4439132|NCT00114972|4262990|B3|No Diagnosed Carotid Artery Disease at Baseline||Carotid artery disease|number of particpants with diagnosed carotid artery disease at baseline|participants|Number|1652.0|1652.0||||||
4439133|NCT00114972|4262991|B2|No Diagnosed Carotid Artery Disease at Baseline||Carotid artery disease|number of particpants with diagnosed carotid artery disease at baseline|participants|Number|830|830.0||||||
4439134|NCT00114972|4262992|B1|No Diagnosed Carotid Artery Disease at Baseline||Carotid artery disease|number of particpants with diagnosed carotid artery disease at baseline|participants|Number|822|822.0||||||
4439135|NCT00114972|4262990|B3|Diagnosed Carotid Artery Disease at Baseline||Carotid artery disease|number of particpants with diagnosed carotid artery disease at baseline|participants|Number|148.0|148.0||||||
4439136|NCT00114972|4262991|B2|Diagnosed Carotid Artery Disease at Baseline||Carotid artery disease|number of particpants with diagnosed carotid artery disease at baseline|participants|Number|73|73.0||||||
4439137|NCT00114972|4262992|B1|Diagnosed Carotid Artery Disease at Baseline||Carotid artery disease|number of particpants with diagnosed carotid artery disease at baseline|participants|Number|75|75.0||||||
4439138|NCT00114972|4262990|B3|Blood Pressure <130/85 mmHG||Blood pressure ≥130/85 mmHg|number of participants with blood pressure equal or higher than 130/85mmHg|participants|Number|604.0|604.0||||||
4439139|NCT00114972|4262991|B2|Blood Pressure <130/85 mmHG||Blood pressure ≥130/85 mmHg|number of participants with blood pressure equal or higher than 130/85mmHg|participants|Number|281|281.0||||||
4439140|NCT00114972|4262992|B1|Blood Pressure <130/85 mmHG||Blood pressure ≥130/85 mmHg|number of participants with blood pressure equal or higher than 130/85mmHg|participants|Number|323|323.0||||||
4439141|NCT00114972|4262990|B3|Blood Pressure >= 130/85 mmHG||Blood pressure ≥130/85 mmHg|number of participants with blood pressure equal or higher than 130/85mmHg|participants|Number|1196.0|1196.0||||||
4439142|NCT00114972|4262991|B2|Blood Pressure >= 130/85 mmHG||Blood pressure ≥130/85 mmHg|number of participants with blood pressure equal or higher than 130/85mmHg|participants|Number|622|622.0||||||
4439143|NCT00114972|4262992|B1|Blood Pressure >= 130/85 mmHG||Blood pressure ≥130/85 mmHg|number of participants with blood pressure equal or higher than 130/85mmHg|participants|Number|574|574.0||||||
4439144|NCT00114972|4262990|B3|No Bifurcated Lesions||Bifurcation lesion (per participant)|Number of participants with at least one bifurcation lesion as determined by the angiographic core laboratory on the baseline angiogram|participants|Number|499.0|499.0||||||
4439145|NCT00114972|4262991|B2|No Bifurcated Lesions||Bifurcation lesion (per participant)|Number of participants with at least one bifurcation lesion as determined by the angiographic core laboratory on the baseline angiogram|participants|Number|254|254.0||||||
4439198|NCT00114972|4262990|B3|United Kingdom||Region of Enrollment||participants|Number|267.0|267.0||||||
4439146|NCT00114972|4262992|B1|No Bifurcated Lesions||Bifurcation lesion (per participant)|Number of participants with at least one bifurcation lesion as determined by the angiographic core laboratory on the baseline angiogram|participants|Number|245|245.0||||||
4439147|NCT00114972|4262990|B3|One or more Bifurcated Lesion(s)||Bifurcation lesion (per participant)|Number of participants with at least one bifurcation lesion as determined by the angiographic core laboratory on the baseline angiogram|participants|Number|1301.0|1301.0||||||
4439148|NCT00114972|4262991|B2|One or more Bifurcated Lesion(s)||Bifurcation lesion (per participant)|Number of participants with at least one bifurcation lesion as determined by the angiographic core laboratory on the baseline angiogram|participants|Number|649|649.0||||||
4439149|NCT00114972|4262992|B1|One or more Bifurcated Lesion(s)||Bifurcation lesion (per participant)|Number of participants with at least one bifurcation lesion as determined by the angiographic core laboratory on the baseline angiogram|participants|Number|652|652.0||||||
4439150|NCT00114972|4262990|B3|Participants with No Angina at Baseline||Angina|number of particpiants with stable, unstable, or no angina at baseline|participants|Number|113.0|113.0||||||
4439151|NCT00114972|4262991|B2|Participants with No Angina at Baseline||Angina|number of particpiants with stable, unstable, or no angina at baseline|participants|Number|54|54.0||||||
4439152|NCT00114972|4262992|B1|Participants with No Angina at Baseline||Angina|number of particpiants with stable, unstable, or no angina at baseline|participants|Number|59|59.0||||||
4439153|NCT00114972|4262990|B3|Participants with Silent Ischemia at Baseline||Angina|number of particpiants with stable, unstable, or no angina at baseline|participants|Number|148.0|148.0||||||
4439154|NCT00114972|4262991|B2|Participants with Silent Ischemia at Baseline||Angina|number of particpiants with stable, unstable, or no angina at baseline|participants|Number|74|74.0||||||
4439155|NCT00114972|4262992|B1|Participants with Silent Ischemia at Baseline||Angina|number of particpiants with stable, unstable, or no angina at baseline|participants|Number|74|74.0||||||
4439156|NCT00114972|4262990|B3|Participants with Unstable Angina at Baseline||Angina|number of particpiants with stable, unstable, or no angina at baseline|participants|Number|512.0|512.0||||||
4439157|NCT00114972|4262991|B2|Participants with Unstable Angina at Baseline||Angina|number of particpiants with stable, unstable, or no angina at baseline|participants|Number|261|261.0||||||
4439158|NCT00114972|4262992|B1|Participants with Unstable Angina at Baseline||Angina|number of particpiants with stable, unstable, or no angina at baseline|participants|Number|251|251.0||||||
4439159|NCT00114972|4262990|B3|Participants with Stable Angina at Baseline||Angina|number of particpiants with stable, unstable, or no angina at baseline|participants|Number|1027.0|1027.0||||||
4439160|NCT00114972|4262991|B2|Participants with Stable Angina at Baseline||Angina|number of particpiants with stable, unstable, or no angina at baseline|participants|Number|514|514.0||||||
4439161|NCT00114972|4262992|B1|Participants with Stable Angina at Baseline||Angina|number of particpiants with stable, unstable, or no angina at baseline|participants|Number|513|513.0||||||
4439162|NCT00114972|4262990|B3|Sweden||Region of Enrollment||participants|Number|54.0|54.0||||||
4439163|NCT00114972|4262991|B2|Sweden||Region of Enrollment||participants|Number|26|26.0||||||
4439164|NCT00114972|4262992|B1|Sweden||Region of Enrollment||participants|Number|28|28.0||||||
4439165|NCT00114972|4262990|B3|Germany||Region of Enrollment||participants|Number|179.0|179.0||||||
4439166|NCT00114972|4262991|B2|Germany||Region of Enrollment||participants|Number|86|86.0||||||
4439167|NCT00114972|4262992|B1|Germany||Region of Enrollment||participants|Number|93|93.0||||||
4439168|NCT00114972|4262990|B3|Netherlands||Region of Enrollment||participants|Number|148.0|148.0||||||
4439169|NCT00114972|4262991|B2|Netherlands||Region of Enrollment||participants|Number|74|74.0||||||
4439170|NCT00114972|4262992|B1|Netherlands||Region of Enrollment||participants|Number|74|74.0||||||
4439171|NCT00114972|4262990|B3|Latvia||Region of Enrollment||participants|Number|40.0|40.0||||||
4439172|NCT00114972|4262991|B2|Latvia||Region of Enrollment||participants|Number|20|20.0||||||
4439173|NCT00114972|4262992|B1|Latvia||Region of Enrollment||participants|Number|20|20.0||||||
4439174|NCT00114972|4262990|B3|Norway||Region of Enrollment||participants|Number|8.0|8.0||||||
4439175|NCT00114972|4262991|B2|Norway||Region of Enrollment||participants|Number|4|4.0||||||
4439176|NCT00114972|4262992|B1|Norway||Region of Enrollment||participants|Number|4|4.0||||||
4439177|NCT00114972|4262990|B3|Denmark||Region of Enrollment||participants|Number|32.0|32.0||||||
4439178|NCT00114972|4262991|B2|Denmark||Region of Enrollment||participants|Number|17|17.0||||||
4439179|NCT00114972|4262992|B1|Denmark||Region of Enrollment||participants|Number|15|15.0||||||
4439180|NCT00114972|4262990|B3|Belgium||Region of Enrollment||participants|Number|91.0|91.0||||||
4439181|NCT00114972|4262991|B2|Belgium||Region of Enrollment||participants|Number|44|44.0||||||
4439182|NCT00114972|4262992|B1|Belgium||Region of Enrollment||participants|Number|47|47.0||||||
4439183|NCT00114972|4262990|B3|Poland||Region of Enrollment||participants|Number|66.0|66.0||||||
4439184|NCT00114972|4262991|B2|Poland||Region of Enrollment||participants|Number|33|33.0||||||
4439185|NCT00114972|4262992|B1|Poland||Region of Enrollment||participants|Number|33|33.0||||||
4439186|NCT00114972|4262990|B3|Czech Republic||Region of Enrollment||participants|Number|40.0|40.0||||||
4439187|NCT00114972|4262991|B2|Czech Republic||Region of Enrollment||participants|Number|20|20.0||||||
4439188|NCT00114972|4262992|B1|Czech Republic||Region of Enrollment||participants|Number|20|20.0||||||
4439189|NCT00114972|4262990|B3|Hungary||Region of Enrollment||participants|Number|83.0|83.0||||||
4439190|NCT00114972|4262991|B2|Hungary||Region of Enrollment||participants|Number|44|44.0||||||
4439191|NCT00114972|4262992|B1|Hungary||Region of Enrollment||participants|Number|39|39.0||||||
4439192|NCT00114972|4262990|B3|France||Region of Enrollment||participants|Number|208.0|208.0||||||
4439193|NCT00114972|4262991|B2|France||Region of Enrollment||participants|Number|103|103.0||||||
4439194|NCT00114972|4262992|B1|France||Region of Enrollment||participants|Number|105|105.0||||||
4439195|NCT00114972|4262990|B3|Italy||Region of Enrollment||participants|Number|197.0|197.0||||||
4439199|NCT00114972|4262991|B2|United Kingdom||Region of Enrollment||participants|Number|135|135.0||||||
4439200|NCT00114972|4262992|B1|United Kingdom||Region of Enrollment||participants|Number|132|132.0||||||
4439201|NCT00114972|4262990|B3|Austria||Region of Enrollment||participants|Number|52.0|52.0||||||
4439202|NCT00114972|4262991|B2|Austria||Region of Enrollment||participants|Number|28|28.0||||||
4439203|NCT00114972|4262992|B1|Austria||Region of Enrollment||participants|Number|24|24.0||||||
4439204|NCT00114972|4262990|B3|Spain||Region of Enrollment||participants|Number|53.0|53.0||||||
4439205|NCT00114972|4262991|B2|Spain||Region of Enrollment||participants|Number|27|27.0||||||
4439206|NCT00114972|4262992|B1|Spain||Region of Enrollment||participants|Number|26|26.0||||||
4439207|NCT00114972|4262990|B3|Finland||Region of Enrollment||participants|Number|24.0|24.0||||||
4439208|NCT00114972|4262991|B2|Finland||Region of Enrollment||participants|Number|12|12.0||||||
4439209|NCT00114972|4262992|B1|Finland||Region of Enrollment||participants|Number|12|12.0||||||
4439210|NCT00114972|4262990|B3|Portugal||Region of Enrollment||participants|Number|13.0|13.0||||||
4439211|NCT00114972|4262991|B2|Portugal||Region of Enrollment||participants|Number|6|6.0||||||
4439212|NCT00114972|4262992|B1|Portugal||Region of Enrollment||participants|Number|7|7.0||||||
4439213|NCT00114972|4262990|B3|United States||Region of Enrollment||participants|Number|245.0|245.0||||||
4439214|NCT00114972|4262991|B2|United States||Region of Enrollment||participants|Number|123|123.0||||||
4439215|NCT00114972|4262992|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
4439216|NCT00114972|4262990|B3||Male|Sex: Female, Male||Participants|Count of Participants|1398|1398.0||||||
4439217|NCT00114972|4262991|B2||Male|Sex: Female, Male||Participants|Count of Participants|690|690.0||||||
4439218|NCT00114972|4262992|B1||Male|Sex: Female, Male||Participants|Count of Participants|708|708.0||||||
4439219|NCT00114972|4262990|B3||Female|Sex: Female, Male||Participants|Count of Participants|402|402.0||||||
4439220|NCT00114972|4262991|B2||Female|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4439221|NCT00114972|4262992|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4439222|NCT00114972|4262990|B3|||Age||years|Mean|65.09|65.09|Standard Deviation|9.72|9.72|||
4439223|NCT00114972|4262991|B2|||Age||years|Mean|65.23|65.23|Standard Deviation|9.66|9.66|||
4439224|NCT00114972|4262992|B1|||Age||years|Mean|64.96|64.96|Standard Deviation|9.79|9.79|||
4439225|NCT00114972|4262990|B3||>=65 years|Age||Participants|Count of Participants|1003.0|1003.0||||||
4439226|NCT00114972|4262991|B2||>=65 years|Age||Participants|Count of Participants|506|506.0||||||
4439227|NCT00114972|4262992|B1||>=65 years|Age||Participants|Count of Participants|497|497.0||||||
4439228|NCT00114972|4262990|B3||Between 18 and 65 years|Age||Participants|Count of Participants|797.0|797.0||||||
4439229|NCT00114972|4262991|B2||Between 18 and 65 years|Age||Participants|Count of Participants|397|397.0||||||
4439230|NCT00114972|4262992|B1||Between 18 and 65 years|Age||Participants|Count of Participants|400|400.0||||||
4439231|NCT00114972|4262990|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4439232|NCT00114972|4262991|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4439233|NCT00114972|4262992|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4439234|NCT00114959|4263013|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4439235|NCT00114959|4263013|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4439236|NCT00114959|4263013|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4439237|NCT00114959|4263013|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4439238|NCT00114959|4263013|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4439239|NCT00114959|4263013|B1|||Age||years|Median|55|55.0|Full Range|||21.0|76.0|
4439240|NCT00114777|4263020|B4||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4439241|NCT00114777|4263021|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4439242|NCT00114777|4263022|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4439243|NCT00114777|4263023|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4439244|NCT00114777|4263020|B4||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4439245|NCT00114777|4263021|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4439246|NCT00114777|4263022|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4439247|NCT00114777|4263023|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4439248|NCT00114777|4263020|B4|more than 65 years||Age, Customized||participants|Number|137|137.0||||||
4439249|NCT00114777|4263021|B3|more than 65 years||Age, Customized||participants|Number|42|42.0||||||
4439250|NCT00114777|4263022|B2|more than 65 years||Age, Customized||participants|Number|43|43.0||||||
4439251|NCT00114777|4263023|B1|more than 65 years||Age, Customized||participants|Number|52|52.0||||||
4439252|NCT00114777|4263020|B4|46 to 65 years||Age, Customized||participants|Number|305|305.0||||||
4439253|NCT00114777|4263021|B3|46 to 65 years||Age, Customized||participants|Number|108|108.0||||||
4439254|NCT00114777|4263022|B2|46 to 65 years||Age, Customized||participants|Number|97|97.0||||||
4439255|NCT00114777|4263023|B1|46 to 65 years||Age, Customized||participants|Number|100|100.0||||||
4439256|NCT00114777|4263020|B4|18 to 45 years||Age, Customized||participants|Number|101|101.0||||||
4439257|NCT00114777|4263021|B3|18 to 45 years||Age, Customized||participants|Number|34|34.0||||||
4439258|NCT00114777|4263022|B2|18 to 45 years||Age, Customized||participants|Number|35|35.0||||||
4439259|NCT00114777|4263023|B1|18 to 45 years||Age, Customized||participants|Number|32|32.0||||||
4439260|NCT00114777|4263020|B4|||Age||years|Mean|56.2|56.2|Standard Deviation|12.4|12.4|||
4439261|NCT00114777|4263021|B3|||Age||years|Mean|55.7|55.7|Standard Deviation|12.2|12.2|||
4439262|NCT00114777|4263022|B2|||Age||years|Mean|56.1|56.1|Standard Deviation|12.4|12.4|||
4439263|NCT00114777|4263023|B1|||Age||years|Mean|56.7|56.7|Standard Deviation|12.6|12.6|||
4439264|NCT00114738|4263099|B1|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
4439265|NCT00114738|4263099|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439266|NCT00114738|4263099|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439267|NCT00114738|4263099|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4439268|NCT00114738|4263099|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4439269|NCT00114738|4263099|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439270|NCT00114738|4263099|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4439271|NCT00114738|4263099|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439272|NCT00114738|4263099|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4439273|NCT00114738|4263099|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4439274|NCT00114738|4263099|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4439275|NCT00114738|4263099|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4439276|NCT00114738|4263099|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4439277|NCT00114738|4263099|B1|||Age||years|Mean|58.85|58.85|Standard Deviation|8.7|8.7|||
4439278|NCT00114738|4263099|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4439279|NCT00114738|4263099|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4439280|NCT00114738|4263099|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4439281|NCT00114634|4263114|B1|||Severity score|Severity score ranges from 0-100; the higher the score the greater the severity|units on a scale|Median|17|17.0|Full Range|||6.0|28.0|
4439282|NCT00114634|4263114|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4439283|NCT00114634|4263114|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4439284|NCT00114634|4263114|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4439285|NCT00114634|4263114|B1|||Age||years|Mean|11.4|11.4|Standard Deviation|4.9|4.9|||
4439286|NCT00114634|4263114|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4439287|NCT00114634|4263114|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4439288|NCT00114634|4263114|B1||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4439289|NCT00114530|4263128|B3|||Disease-Modifying Anti-Rheumatic Drug (DMARD) Use|Any use of disease-modifying antirheumatic drugs (DMARDs) prior to randomization. DMARDS can include, but are not limited to, methotrexate, cyclophosphamide, azathioprine, leflunomide, mycophenolate mofetil, D-penicillamine, tacrolimus, cyclosporine, prednisone >10 mg, and TNF-blockers.|Participants|Count of Participants|59|59.0||||||
4439290|NCT00114530|4263129|B2|||Disease-Modifying Anti-Rheumatic Drug (DMARD) Use|Any use of disease-modifying antirheumatic drugs (DMARDs) prior to randomization. DMARDS can include, but are not limited to, methotrexate, cyclophosphamide, azathioprine, leflunomide, mycophenolate mofetil, D-penicillamine, tacrolimus, cyclosporine, prednisone >10 mg, and TNF-blockers.|Participants|Count of Participants|32|32.0||||||
4439291|NCT00114530|4263130|B1|||Disease-Modifying Anti-Rheumatic Drug (DMARD) Use|Any use of disease-modifying antirheumatic drugs (DMARDs) prior to randomization. DMARDS can include, but are not limited to, methotrexate, cyclophosphamide, azathioprine, leflunomide, mycophenolate mofetil, D-penicillamine, tacrolimus, cyclosporine, prednisone >10 mg, and TNF-blockers.|Participants|Count of Participants|27|27.0||||||
4439292|NCT00114530|4263128|B3|||Disease-Modifying Anti-Rheumatic Drug (DMARD) Use Within 6 Months of Randomization|Use of any disease-modifying antirheumatic drugs (DMARDs) within six months prior to randomization. DMARDS can include, but are not limited to, methotrexate, cyclophosphamide, azathioprine, leflunomide, mycophenolate mofetil, D-penicillamine, tacrolimus, cyclosporine, prednisone >10 mg, and TNF-blockers.|Participants|Count of Participants|51|51.0||||||
4439293|NCT00114530|4263129|B2|||Disease-Modifying Anti-Rheumatic Drug (DMARD) Use Within 6 Months of Randomization|Use of any disease-modifying antirheumatic drugs (DMARDs) within six months prior to randomization. DMARDS can include, but are not limited to, methotrexate, cyclophosphamide, azathioprine, leflunomide, mycophenolate mofetil, D-penicillamine, tacrolimus, cyclosporine, prednisone >10 mg, and TNF-blockers.|Participants|Count of Participants|25|25.0||||||
4439294|NCT00114530|4263130|B1|||Disease-Modifying Anti-Rheumatic Drug (DMARD) Use Within 6 Months of Randomization|Use of any disease-modifying antirheumatic drugs (DMARDs) within six months prior to randomization. DMARDS can include, but are not limited to, methotrexate, cyclophosphamide, azathioprine, leflunomide, mycophenolate mofetil, D-penicillamine, tacrolimus, cyclosporine, prednisone >10 mg, and TNF-blockers.|Participants|Count of Participants|26|26.0||||||
4439295|NCT00114530|4263128|B3|||Modified Rodnan Skin Score (mRSS)|The Modified Rodnan Skin Score (mRSS) is a measure of skin thickness. Skin thickness in 17 anatomic areas was rated on a 0-3 scale and scores are summed to obtain the mRSS (range from 0 - 51), with higher mRSS scores indicating worse disease activity.|units on a scale|Mean|29.7|29.7|Standard Deviation|9.72|9.72|||
4439296|NCT00114530|4263129|B2|||Modified Rodnan Skin Score (mRSS)|The Modified Rodnan Skin Score (mRSS) is a measure of skin thickness. Skin thickness in 17 anatomic areas was rated on a 0-3 scale and scores are summed to obtain the mRSS (range from 0 - 51), with higher mRSS scores indicating worse disease activity.|units on a scale|Mean|30.8|30.8|Standard Deviation|10.55|10.55|||
4439297|NCT00114530|4263130|B1|||Modified Rodnan Skin Score (mRSS)|The Modified Rodnan Skin Score (mRSS) is a measure of skin thickness. Skin thickness in 17 anatomic areas was rated on a 0-3 scale and scores are summed to obtain the mRSS (range from 0 - 51), with higher mRSS scores indicating worse disease activity.|units on a scale|Mean|28.5|28.5|Standard Deviation|8.72|8.72|||
4439320|NCT00114530|4263129|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439438|NCT00114231|4263279|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4439298|NCT00114530|4263128|B3|||Forced Vital Capacity (FVC) (Percent-Predicted)|Forced Vital Capacity (FVC) is the amount of air that can be forcibly exhaled after a full breath and is a measure of lung function. Predicted FVC was based on institutional standards.|percent predicted|Mean|74.2|74.2|Standard Deviation|15.86|15.86|||
4439299|NCT00114530|4263129|B2|||Forced Vital Capacity (FVC) (Percent-Predicted)|Forced Vital Capacity (FVC) is the amount of air that can be forcibly exhaled after a full breath and is a measure of lung function. Predicted FVC was based on institutional standards.|percent predicted|Mean|73.8|73.8|Standard Deviation|16.98|16.98|||
4439300|NCT00114530|4263130|B1|||Forced Vital Capacity (FVC) (Percent-Predicted)|Forced Vital Capacity (FVC) is the amount of air that can be forcibly exhaled after a full breath and is a measure of lung function. Predicted FVC was based on institutional standards.|percent predicted|Mean|74.5|74.5|Standard Deviation|14.77|14.77|||
4439301|NCT00114530|4263128|B3|||Diffusion in Liters of Carbon Monoxide (DLCO) (Percent-Predicted)|Diffusion in liters of carbon monoxide (DLCO) is a measure of lung function. Predicted values for DLCO were computed using the Crapo Morris equations and adjusted per the Cotes formula for anemia, if a participant’s hemoglobin was <13 or >17 gm/dL, and altitude (Calgary site only).|Percent predicted|Mean|53.3|53.3|Standard Deviation|7.90|7.9|||
4439302|NCT00114530|4263129|B2|||Diffusion in Liters of Carbon Monoxide (DLCO) (Percent-Predicted)|Diffusion in liters of carbon monoxide (DLCO) is a measure of lung function. Predicted values for DLCO were computed using the Crapo Morris equations and adjusted per the Cotes formula for anemia, if a participant’s hemoglobin was <13 or >17 gm/dL, and altitude (Calgary site only).|Percent predicted|Mean|52.7|52.7|Standard Deviation|8.19|8.19|||
4439303|NCT00114530|4263130|B1|||Diffusion in Liters of Carbon Monoxide (DLCO) (Percent-Predicted)|Diffusion in liters of carbon monoxide (DLCO) is a measure of lung function. Predicted values for DLCO were computed using the Crapo Morris equations and adjusted per the Cotes formula for anemia, if a participant’s hemoglobin was <13 or >17 gm/dL, and altitude (Calgary site only).|Percent predicted|Mean|53.9|53.9|Standard Deviation|7.63|7.63|||
4439304|NCT00114530|4263128|B3|Mental Component Score||Short Form 36 Health Survey (SF-36)|The SF-36 measures health-related quality of life. It has 36 items and 2 component scores, the Physical Component Score and the Mental Component Score. Each component was transformed into a 0-100 scale (higher numbers indicate greater quality of life) and normalized to have a mean of 50 and standard deviation of 10 for the 1998 general US population.|units on a scale|Mean|44.6|44.6|Standard Deviation|10.21|10.21|||
4439305|NCT00114530|4263129|B2|Mental Component Score||Short Form 36 Health Survey (SF-36)|The SF-36 measures health-related quality of life. It has 36 items and 2 component scores, the Physical Component Score and the Mental Component Score. Each component was transformed into a 0-100 scale (higher numbers indicate greater quality of life) and normalized to have a mean of 50 and standard deviation of 10 for the 1998 general US population.|units on a scale|Mean|44.6|44.6|Standard Deviation|9.86|9.86|||
4439306|NCT00114530|4263130|B1|Mental Component Score||Short Form 36 Health Survey (SF-36)|The SF-36 measures health-related quality of life. It has 36 items and 2 component scores, the Physical Component Score and the Mental Component Score. Each component was transformed into a 0-100 scale (higher numbers indicate greater quality of life) and normalized to have a mean of 50 and standard deviation of 10 for the 1998 general US population.|units on a scale|Mean|44.7|44.7|Standard Deviation|10.70|10.7|||
4439307|NCT00114530|4263128|B3|Physical Component Score||Short Form 36 Health Survey (SF-36)|The SF-36 measures health-related quality of life. It has 36 items and 2 component scores, the Physical Component Score and the Mental Component Score. Each component was transformed into a 0-100 scale (higher numbers indicate greater quality of life) and normalized to have a mean of 50 and standard deviation of 10 for the 1998 general US population.|units on a scale|Mean|29.2|29.2|Standard Deviation|9.27|9.27|||
4439308|NCT00114530|4263129|B2|Physical Component Score||Short Form 36 Health Survey (SF-36)|The SF-36 measures health-related quality of life. It has 36 items and 2 component scores, the Physical Component Score and the Mental Component Score. Each component was transformed into a 0-100 scale (higher numbers indicate greater quality of life) and normalized to have a mean of 50 and standard deviation of 10 for the 1998 general US population.|units on a scale|Mean|28.9|28.9|Standard Deviation|9.46|9.46|||
4439309|NCT00114530|4263130|B1|Physical Component Score||Short Form 36 Health Survey (SF-36)|The SF-36 measures health-related quality of life. It has 36 items and 2 component scores, the Physical Component Score and the Mental Component Score. Each component was transformed into a 0-100 scale (higher numbers indicate greater quality of life) and normalized to have a mean of 50 and standard deviation of 10 for the 1998 general US population.|units on a scale|Mean|29.5|29.5|Standard Deviation|9.20|9.2|||
4439310|NCT00114530|4263128|B3|||Health Assessment Questionnaire - Disability Index (HAQ-DI)|HAQ-DI is a self-reported questionnaire of functionality that includes questions in 8 domains (dressing/grooming, arising, eating, walking, hygiene, reach, grip, and activities). The final score ranges from 0 to 3, where a higher HAQ-DI score indicates a worse outcome.|units on a scale|Mean|1.3|1.3|Standard Deviation|0.77|0.77|||
4439311|NCT00114530|4263129|B2|||Health Assessment Questionnaire - Disability Index (HAQ-DI)|HAQ-DI is a self-reported questionnaire of functionality that includes questions in 8 domains (dressing/grooming, arising, eating, walking, hygiene, reach, grip, and activities). The final score ranges from 0 to 3, where a higher HAQ-DI score indicates a worse outcome.|units on a scale|Mean|1.4|1.4|Standard Deviation|0.86|0.86|||
4439312|NCT00114530|4263130|B1|||Health Assessment Questionnaire - Disability Index (HAQ-DI)|HAQ-DI is a self-reported questionnaire of functionality that includes questions in 8 domains (dressing/grooming, arising, eating, walking, hygiene, reach, grip, and activities). The final score ranges from 0 to 3, where a higher HAQ-DI score indicates a worse outcome.|units on a scale|Mean|1.2|1.2|Standard Deviation|0.65|0.65|||
4439313|NCT00114530|4263128|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4439314|NCT00114530|4263129|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4439315|NCT00114530|4263130|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4439316|NCT00114530|4263128|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4439317|NCT00114530|4263129|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4439318|NCT00114530|4263130|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4439319|NCT00114530|4263128|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4439321|NCT00114530|4263130|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4439322|NCT00114530|4263128|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4439323|NCT00114530|4263129|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4439324|NCT00114530|4263130|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4439325|NCT00114530|4263128|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4439326|NCT00114530|4263129|B2||White|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4439327|NCT00114530|4263130|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4439328|NCT00114530|4263128|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4439329|NCT00114530|4263129|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4439330|NCT00114530|4263130|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4439331|NCT00114530|4263128|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439332|NCT00114530|4263129|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439333|NCT00114530|4263130|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439334|NCT00114530|4263128|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4439335|NCT00114530|4263129|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4439336|NCT00114530|4263130|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4439337|NCT00114530|4263128|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439338|NCT00114530|4263129|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439339|NCT00114530|4263130|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439340|NCT00114530|4263128|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4439341|NCT00114530|4263129|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439342|NCT00114530|4263130|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4439343|NCT00114530|4263128|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4439344|NCT00114530|4263129|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4439345|NCT00114530|4263130|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4439346|NCT00114530|4263128|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4439347|NCT00114530|4263129|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4439348|NCT00114530|4263130|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4439349|NCT00114530|4263128|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4439350|NCT00114530|4263129|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4439351|NCT00114530|4263130|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4439352|NCT00114530|4263128|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4439353|NCT00114530|4263129|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4439354|NCT00114530|4263130|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4439355|NCT00114530|4263128|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|10.63|10.63|||
4439356|NCT00114530|4263129|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|10.43|10.43|||
4439357|NCT00114530|4263130|B1|||Age||years|Mean|44.9|44.9|Standard Deviation|10.90|10.9|||
4439358|NCT00114530|4263128|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4439359|NCT00114530|4263129|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4439360|NCT00114530|4263130|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4439361|NCT00114530|4263128|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4439362|NCT00114530|4263129|B2||Between 18 and 65 years|Age||Participants|Count of Participants|38|38.0||||||
4439363|NCT00114530|4263130|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4439364|NCT00114530|4263128|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4439365|NCT00114530|4263129|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4439366|NCT00114530|4263130|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4439367|NCT00114517|4263236|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4439368|NCT00114517|4263237|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4439369|NCT00114517|4263238|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4439370|NCT00114517|4263239|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4439371|NCT00114517|4263240|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4439372|NCT00114517|4263236|B5|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|79|79.0||||||
4439373|NCT00114517|4263237|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4439374|NCT00114517|4263238|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4439375|NCT00114517|4263239|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4439376|NCT00114517|4263240|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4439377|NCT00114517|4263236|B5|Black, non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
4439378|NCT00114517|4263237|B4|Black, non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4439379|NCT00114517|4263238|B3|Black, non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4439380|NCT00114517|4263239|B2|Black, non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4439381|NCT00114517|4263240|B1|Black, non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4439382|NCT00114517|4263236|B5|White, non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|415|415.0||||||
4439383|NCT00114517|4263237|B4|White, non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|127|127.0||||||
4439384|NCT00114517|4263238|B3|White, non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|127|127.0||||||
4439385|NCT00114517|4263239|B2|White, non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|73|73.0||||||
4439386|NCT00114517|4263240|B1|White, non-hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|88|88.0||||||
4439387|NCT00114517|4263236|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439388|NCT00114517|4263237|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439389|NCT00114517|4263238|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439390|NCT00114517|4263239|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439391|NCT00114517|4263240|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439392|NCT00114517|4263236|B5||Female|Sex: Female, Male||Participants|Count of Participants|596|596.0||||||
4439393|NCT00114517|4263237|B4||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4439394|NCT00114517|4263238|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4439395|NCT00114517|4263239|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4439396|NCT00114517|4263240|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4439397|NCT00114517|4263236|B5|||Age||years|Median|60.0|60.0|Inter-Quartile Range|||55.5|64.8|
4439398|NCT00114517|4263237|B4|||Age||years|Median|63.0|63.0|Inter-Quartile Range|||59.9|67.0|
4439399|NCT00114517|4263238|B3|||Age||years|Median|64.3|64.3|Inter-Quartile Range|||60.5|68.6|
4439400|NCT00114517|4263239|B2|||Age||years|Median|55.4|55.4|Inter-Quartile Range|||52.5|57.8|
4439401|NCT00114517|4263240|B1|||Age||years|Median|55.4|55.4|Inter-Quartile Range|||53.2|57.9|
4439402|NCT00114504|4263253|B3|Japan||Region of Enrollment||participants|Number|43|43.0||||||
4439403|NCT00114504|4263254|B2|Japan||Region of Enrollment||participants|Number|22|22.0||||||
4439404|NCT00114504|4263255|B1|Japan||Region of Enrollment||participants|Number|21|21.0||||||
4439405|NCT00114504|4263253|B3|No Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439406|NCT00114504|4263254|B2|No Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439407|NCT00114504|4263255|B1|No Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439408|NCT00114504|4263253|B3|Japanese||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4439409|NCT00114504|4263254|B2|Japanese||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4439410|NCT00114504|4263255|B1|Japanese||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4439411|NCT00114504|4263253|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4439412|NCT00114504|4263254|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4439413|NCT00114504|4263255|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4439414|NCT00114504|4263253|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4439415|NCT00114504|4263254|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4439416|NCT00114504|4263255|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4439417|NCT00114504|4263253|B3|||Age||years|Mean|63|63.0|Standard Deviation|8|8.0|||
4439418|NCT00114504|4263254|B2|||Age||years|Mean|62|62.0|Standard Deviation|6|6.0|||
4439419|NCT00114504|4263255|B1|||Age||years|Mean|65|65.0|Standard Deviation|9|9.0|||
4439420|NCT00114244|4263266|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4439421|NCT00114244|4263267|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4439422|NCT00114244|4263268|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4439423|NCT00114244|4263266|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4439424|NCT00114244|4263267|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4439425|NCT00114244|4263268|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4439426|NCT00114244|4263266|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4439427|NCT00114244|4263267|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4439428|NCT00114244|4263268|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4439429|NCT00114244|4263266|B3|||Age||years|Median|65|65.0|Full Range|||43.0|83.0|
4439430|NCT00114244|4263267|B2|||Age||years|Median|65|65.0|Full Range|||43.0|83.0|
4439431|NCT00114244|4263268|B1|||Age||years|Median|66|66.0|Full Range|||55.0|82.0|
4439432|NCT00114231|4263279|B3|United States||Region of Enrollment||Participants|Count of Participants|79|79.0||||||
4439433|NCT00114231|4263280|B2|United States||Region of Enrollment||Participants|Count of Participants|26|26.0||||||
4439434|NCT00114231|4263281|B1|United States||Region of Enrollment||Participants|Count of Participants|53|53.0||||||
4439435|NCT00114231|4263279|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4439436|NCT00114231|4263280|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4439437|NCT00114231|4263281|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4439439|NCT00114231|4263280|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4439440|NCT00114231|4263281|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4439441|NCT00114231|4263279|B3|||Age||years|Median|62|62.0|Full Range|||30.0|83.0|
4439442|NCT00114231|4263280|B2|||Age||years|Median|63|63.0|Full Range|||45.0|83.0|
4439443|NCT00114231|4263281|B1|||Age||years|Median|62|62.0|Full Range|||30.0|80.0|
4439444|NCT00114218|4263291|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439445|NCT00114218|4263291|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4439446|NCT00114218|4263291|B1|>79 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4439447|NCT00114218|4263291|B1|70-79 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
4439448|NCT00114218|4263291|B1|60-69 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
4439449|NCT00114218|4263291|B1|50-59 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4439450|NCT00114218|4263291|B1|<50 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4439451|NCT00114166|4263296|B3|Other Carcinoma||Cell Type||participants|Number|1|1.0||||||
4439452|NCT00114166|4263297|B2|Other Carcinoma||Cell Type||participants|Number|1|1.0||||||
4439453|NCT00114166|4263298|B1|Other Carcinoma||Cell Type||participants|Number|0|0.0||||||
4439454|NCT00114166|4263296|B3|Serous Adenocarcinoma||Cell Type||participants|Number|63|63.0||||||
4439455|NCT00114166|4263297|B2|Serous Adenocarcinoma||Cell Type||participants|Number|50|50.0||||||
4439456|NCT00114166|4263298|B1|Serous Adenocarcinoma||Cell Type||participants|Number|13|13.0||||||
4439457|NCT00114166|4263296|B3|Undifferentiated Carcinoma||Cell Type||participants|Number|1|1.0||||||
4439458|NCT00114166|4263297|B2|Undifferentiated Carcinoma||Cell Type||participants|Number|1|1.0||||||
4439459|NCT00114166|4263298|B1|Undifferentiated Carcinoma||Cell Type||participants|Number|0|0.0||||||
4439460|NCT00114166|4263296|B3|Mixed Epithelial Carcinoma||Cell Type||participants|Number|6|6.0||||||
4439461|NCT00114166|4263297|B2|Mixed Epithelial Carcinoma||Cell Type||participants|Number|5|5.0||||||
4439462|NCT00114166|4263298|B1|Mixed Epithelial Carcinoma||Cell Type||participants|Number|1|1.0||||||
4439463|NCT00114166|4263296|B3|Endometrioid Adenocarcinoma||Cell Type||participants|Number|2|2.0||||||
4439464|NCT00114166|4263297|B2|Endometrioid Adenocarcinoma||Cell Type||participants|Number|2|2.0||||||
4439465|NCT00114166|4263298|B1|Endometrioid Adenocarcinoma||Cell Type||participants|Number|0|0.0||||||
4439466|NCT00114166|4263296|B3|Clear Cell Carcinoma||Cell Type||participants|Number|2|2.0||||||
4439467|NCT00114166|4263297|B2|Clear Cell Carcinoma||Cell Type||participants|Number|1|1.0||||||
4439468|NCT00114166|4263298|B1|Clear Cell Carcinoma||Cell Type||participants|Number|1|1.0||||||
4439469|NCT00114166|4263296|B3|Adenocarcinoma, Unspecified||Cell Type||participants|Number|5|5.0||||||
4439470|NCT00114166|4263297|B2|Adenocarcinoma, Unspecified||Cell Type||participants|Number|5|5.0||||||
4439471|NCT00114166|4263298|B1|Adenocarcinoma, Unspecified||Cell Type||participants|Number|0|0.0||||||
4439472|NCT00114166|4263296|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4439473|NCT00114166|4263297|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4439474|NCT00114166|4263298|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4439475|NCT00114166|4263296|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439476|NCT00114166|4263297|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439477|NCT00114166|4263298|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439478|NCT00114166|4263296|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4439479|NCT00114166|4263297|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4439480|NCT00114166|4263298|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4439481|NCT00114166|4263296|B3|> 79 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4439482|NCT00114166|4263297|B2|> 79 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4439483|NCT00114166|4263298|B1|> 79 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4439484|NCT00114166|4263296|B3|70-79 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
4439485|NCT00114166|4263297|B2|70-79 years||Age, Customized||Participants|Count of Participants|12|12.0||||||
4439486|NCT00114166|4263298|B1|70-79 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4439487|NCT00114166|4263296|B3|60-69 years||Age, Customized||Participants|Count of Participants|21|21.0||||||
4439488|NCT00114166|4263297|B2|60-69 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
4439489|NCT00114166|4263298|B1|60-69 years||Age, Customized||Participants|Count of Participants|4|4.0||||||
4439490|NCT00114166|4263296|B3|50-59 years||Age, Customized||Participants|Count of Participants|32|32.0||||||
4439491|NCT00114166|4263297|B2|50-59 years||Age, Customized||Participants|Count of Participants|29|29.0||||||
4439492|NCT00114166|4263298|B1|50-59 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4439493|NCT00114166|4263296|B3|40-49 years||Age, Customized||Participants|Count of Participants|7|7.0||||||
4439494|NCT00114166|4263297|B2|40-49 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4439495|NCT00114166|4263298|B1|40-49 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4439496|NCT00114140|4263309|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4439497|NCT00114140|4263309|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4439498|NCT00114140|4263309|B1|||Age||years|Median|49|49.0|Full Range|||20.0|76.0|
4439532|NCT00114127|4263321|B3|No concurrent mood or anxiety disorders||At least one concurrent mood or anxiety disorder||Participants|Number|20|20.0||||||
4439499|NCT00114127|4263321|B3|||Liebowitz Self-Rated Disability Scale (LSDSR)|"The Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 1987) is a 24-item scale that provides separate scores for fear and avoidance in social and performance situations with higher scores representing increased social anxiety. The LSAS contains three total scores: 1) total fear score (0-72), 2) total avoidance score(0-72), 3) and total overall score (0-144). Suggested interpretations: 55-65 Moderate social phobia, 65-80 Marked social phobia, 80-95 Severe social phobia, Greater than 95 - Very severe social phobia.~Baseline was only collected for Phase 2 at week 6"|LSDSR Score|Mean|8.79|8.79|Standard Deviation|5.83|5.83|||
4439500|NCT00114127|4263322|B2|||Liebowitz Self-Rated Disability Scale (LSDSR)|"The Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 1987) is a 24-item scale that provides separate scores for fear and avoidance in social and performance situations with higher scores representing increased social anxiety. The LSAS contains three total scores: 1) total fear score (0-72), 2) total avoidance score(0-72), 3) and total overall score (0-144). Suggested interpretations: 55-65 Moderate social phobia, 65-80 Marked social phobia, 80-95 Severe social phobia, Greater than 95 - Very severe social phobia.~Baseline was only collected for Phase 2 at week 6"|LSDSR Score|Mean|10.0|10.0|Standard Deviation|5.41|5.41|||
4439501|NCT00114127|4263323|B1|||Liebowitz Self-Rated Disability Scale (LSDSR)|"The Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 1987) is a 24-item scale that provides separate scores for fear and avoidance in social and performance situations with higher scores representing increased social anxiety. The LSAS contains three total scores: 1) total fear score (0-72), 2) total avoidance score(0-72), 3) and total overall score (0-144). Suggested interpretations: 55-65 Moderate social phobia, 65-80 Marked social phobia, 80-95 Severe social phobia, Greater than 95 - Very severe social phobia.~Baseline was only collected for Phase 2 at week 6"|LSDSR Score|Mean|7.58|7.58|Standard Deviation|6.43|6.43|||
4439502|NCT00114127|4263321|B3|||Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q)|"Q-LES-Q; Endicott et al., 1993. This questionnaire rates 16 aspects of quality of life, including physical health, mood, activities of daily living, and overall life satisfaction. The scoring of the Q-LES-Q-SF involves summing only the first 14 items to yield a raw total score. The last two items are not included in the total score but are standalone items. The raw total score ranges from 14 to 70, with higher scores indicating higher satisfaction with quality of life.~Baseline QLESQ only collected in Phase 2 at week 6."|Q-LES-Q Score|Mean|47.5|47.5|Standard Deviation|9.12|9.12|||
4439503|NCT00114127|4263322|B2|||Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q)|"Q-LES-Q; Endicott et al., 1993. This questionnaire rates 16 aspects of quality of life, including physical health, mood, activities of daily living, and overall life satisfaction. The scoring of the Q-LES-Q-SF involves summing only the first 14 items to yield a raw total score. The last two items are not included in the total score but are standalone items. The raw total score ranges from 14 to 70, with higher scores indicating higher satisfaction with quality of life.~Baseline QLESQ only collected in Phase 2 at week 6."|Q-LES-Q Score|Mean|46.2|46.2|Standard Deviation|9.47|9.47|||
4439504|NCT00114127|4263323|B1|||Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q)|"Q-LES-Q; Endicott et al., 1993. This questionnaire rates 16 aspects of quality of life, including physical health, mood, activities of daily living, and overall life satisfaction. The scoring of the Q-LES-Q-SF involves summing only the first 14 items to yield a raw total score. The last two items are not included in the total score but are standalone items. The raw total score ranges from 14 to 70, with higher scores indicating higher satisfaction with quality of life.~Baseline QLESQ only collected in Phase 2 at week 6."|Q-LES-Q Score|Mean|49.1|49.1|Standard Deviation|8.83|8.83|||
4439505|NCT00114127|4263321|B3|||Sheehan Disability Scale (SDS)|"The SDS is a brief self-report questionnaire that was developed to assess functional impairment in three inter-related domains; work/school, social and family life. The patient rates the extent to which work/school, social and family responsibilities are impaired by his/her symptoms on a 10 point visual analog scale. The three items are summed into a single dimension measure of global function impairment that ranges from 0 (unimpaired) to 30 (highly impaired).~Baseline SDS only collected in Phase 2 at week 6."|SDS Score|Mean|12.9|12.9|Standard Deviation|5.71|5.71|||
4439506|NCT00114127|4263322|B2|||Sheehan Disability Scale (SDS)|"The SDS is a brief self-report questionnaire that was developed to assess functional impairment in three inter-related domains; work/school, social and family life. The patient rates the extent to which work/school, social and family responsibilities are impaired by his/her symptoms on a 10 point visual analog scale. The three items are summed into a single dimension measure of global function impairment that ranges from 0 (unimpaired) to 30 (highly impaired).~Baseline SDS only collected in Phase 2 at week 6."|SDS Score|Mean|14.1|14.1|Standard Deviation|5.52|5.52|||
4439507|NCT00114127|4263323|B1|||Sheehan Disability Scale (SDS)|"The SDS is a brief self-report questionnaire that was developed to assess functional impairment in three inter-related domains; work/school, social and family life. The patient rates the extent to which work/school, social and family responsibilities are impaired by his/her symptoms on a 10 point visual analog scale. The three items are summed into a single dimension measure of global function impairment that ranges from 0 (unimpaired) to 30 (highly impaired).~Baseline SDS only collected in Phase 2 at week 6."|SDS Score|Mean|11.2|11.2|Standard Deviation|6.06|6.06|||
4439508|NCT00114127|4263321|B3|||Montgomery Asberg Depression Rating Scale (MADRS)|"MADRS; Montgomery & Asberg, 1979. The MADRS is designed to measure the overall severity of depressive symptoms and has demonstrated good reliability and sensitivity to change with treatment. It includes 10 items and uses a 0-6 severity scale with higher scores indicating increasing depressive symptoms. Ratings can be added to form an overall score (range 0 to 60); no weights are used. Cut-off points include: 0 to 6 – symptom absent, 7 to 19 – mild depression, 30 to 34 – moderate, 35 to 60 – severe depression.~Baseline MADRS only collected in Phase 2 at week 6."|MADRS Score|Mean|9.17|9.17|Standard Deviation|6.60|6.6|||
4439509|NCT00114127|4263322|B2|||Montgomery Asberg Depression Rating Scale (MADRS)|"MADRS; Montgomery & Asberg, 1979. The MADRS is designed to measure the overall severity of depressive symptoms and has demonstrated good reliability and sensitivity to change with treatment. It includes 10 items and uses a 0-6 severity scale with higher scores indicating increasing depressive symptoms. Ratings can be added to form an overall score (range 0 to 60); no weights are used. Cut-off points include: 0 to 6 – symptom absent, 7 to 19 – mild depression, 30 to 34 – moderate, 35 to 60 – severe depression.~Baseline MADRS only collected in Phase 2 at week 6."|MADRS Score|Mean|10.3|10.3|Standard Deviation|7.79|7.79|||
4439533|NCT00114127|4263322|B2|No concurrent mood or anxiety disorders||At least one concurrent mood or anxiety disorder||Participants|Number|14|14.0||||||
4439510|NCT00114127|4263323|B1|||Montgomery Asberg Depression Rating Scale (MADRS)|"MADRS; Montgomery & Asberg, 1979. The MADRS is designed to measure the overall severity of depressive symptoms and has demonstrated good reliability and sensitivity to change with treatment. It includes 10 items and uses a 0-6 severity scale with higher scores indicating increasing depressive symptoms. Ratings can be added to form an overall score (range 0 to 60); no weights are used. Cut-off points include: 0 to 6 – symptom absent, 7 to 19 – mild depression, 30 to 34 – moderate, 35 to 60 – severe depression.~Baseline MADRS only collected in Phase 2 at week 6."|MADRS Score|Mean|8.08|8.08|Standard Deviation|5.00|5.0|||
4439511|NCT00114127|4263321|B3|||Clinical Global Impression-Improvement (CGI-I)|"The Clinician Global Impression-Improvement Scale (CGI-I) is a clinician-rated instrument used to assess global improvement of symptoms (Guy, 1976). The CGI ranges from 1 (very much improved) to 7 (very much worse).~Baseline CGI-I was not collected in Phase 1 as it is a measure of improvement. Baseline CGI-I was collected in Phase 2 because patients were transitioning from week 6 to 7."|CGI-I Score|Mean|3.31|3.31|Standard Deviation|1.09|1.09|||
4439512|NCT00114127|4263322|B2|||Clinical Global Impression-Improvement (CGI-I)|"The Clinician Global Impression-Improvement Scale (CGI-I) is a clinician-rated instrument used to assess global improvement of symptoms (Guy, 1976). The CGI ranges from 1 (very much improved) to 7 (very much worse).~Baseline CGI-I was not collected in Phase 1 as it is a measure of improvement. Baseline CGI-I was collected in Phase 2 because patients were transitioning from week 6 to 7."|CGI-I Score|Mean|3.36|3.36|Standard Deviation|1.22|1.22|||
4439513|NCT00114127|4263323|B1|||Clinical Global Impression-Improvement (CGI-I)|"The Clinician Global Impression-Improvement Scale (CGI-I) is a clinician-rated instrument used to assess global improvement of symptoms (Guy, 1976). The CGI ranges from 1 (very much improved) to 7 (very much worse).~Baseline CGI-I was not collected in Phase 1 as it is a measure of improvement. Baseline CGI-I was collected in Phase 2 because patients were transitioning from week 6 to 7."|CGI-I Score|Mean|3.25|3.25|Standard Deviation|0.97|0.97|||
4439514|NCT00114127|4263321|B3|||Clinical Global Impression-Severity (CGI-S)|"The Clinician Global Impression-Severity Scale (CGI-S) is a clinician-rated instrument used to assess global severity of symptoms (Guy, 1976). The CGI ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).~Baseline collected for Phase 1 at week 0 and for Phase 2 at week 6."|CGI-S Score|Mean|5.00|5.0|Standard Deviation|0.27|0.27|||
4439515|NCT00114127|4263322|B2|||Clinical Global Impression-Severity (CGI-S)|"The Clinician Global Impression-Severity Scale (CGI-S) is a clinician-rated instrument used to assess global severity of symptoms (Guy, 1976). The CGI ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).~Baseline collected for Phase 1 at week 0 and for Phase 2 at week 6."|CGI-S Score|Mean|4.93|4.93|Standard Deviation|0.36|0.36|||
4439516|NCT00114127|4263323|B1|||Clinical Global Impression-Severity (CGI-S)|"The Clinician Global Impression-Severity Scale (CGI-S) is a clinician-rated instrument used to assess global severity of symptoms (Guy, 1976). The CGI ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).~Baseline collected for Phase 1 at week 0 and for Phase 2 at week 6."|CGI-S Score|Mean|5.10|5.1|Standard Deviation|0.43|0.43|||
4439517|NCT00114127|4263321|B3|||Liebowitz Social Anxiety Scale (LSAS)|"The Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 1987) is a 24-item scale that provides separate scores for fear and avoidance in social and performance situations with higher scores representing increased social anxiety (55-65 Moderate social phobia, 65-80 Marked social phobia, 80-95 Severe social phobia, Greater than 95 - Very severe social phobia). It is widely used in treatment studies of SAD. The instrument shows very good psychometric properties (Heimberg et al., 1999; Safren et al., 1999).~Baseline collected for Phase 1 at week 0 and for Phase 2 at week 6."|LSAS Score|Mean|74.6|74.6|Standard Deviation|4.52|4.52|||
4439518|NCT00114127|4263322|B2|||Liebowitz Social Anxiety Scale (LSAS)|"The Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 1987) is a 24-item scale that provides separate scores for fear and avoidance in social and performance situations with higher scores representing increased social anxiety (55-65 Moderate social phobia, 65-80 Marked social phobia, 80-95 Severe social phobia, Greater than 95 - Very severe social phobia). It is widely used in treatment studies of SAD. The instrument shows very good psychometric properties (Heimberg et al., 1999; Safren et al., 1999).~Baseline collected for Phase 1 at week 0 and for Phase 2 at week 6."|LSAS Score|Mean|74.1|74.1|Standard Deviation|6.20|6.2|||
4439519|NCT00114127|4263323|B1|||Liebowitz Social Anxiety Scale (LSAS)|"The Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 1987) is a 24-item scale that provides separate scores for fear and avoidance in social and performance situations with higher scores representing increased social anxiety (55-65 Moderate social phobia, 65-80 Marked social phobia, 80-95 Severe social phobia, Greater than 95 - Very severe social phobia). It is widely used in treatment studies of SAD. The instrument shows very good psychometric properties (Heimberg et al., 1999; Safren et al., 1999).~Baseline collected for Phase 1 at week 0 and for Phase 2 at week 6."|LSAS Score|Mean|75.2|75.2|Standard Deviation|6.90|6.9|||
4439520|NCT00114127|4263321|B3|No Lifetime Alcohol/substance abuse/dependence||Lifetime alcohol or substance abuse or dependence||Participants|Number|22|22.0||||||
4439521|NCT00114127|4263322|B2|No Lifetime Alcohol/substance abuse/dependence||Lifetime alcohol or substance abuse or dependence||Participants|Number|12|12.0||||||
4439522|NCT00114127|4263323|B1|No Lifetime Alcohol/substance abuse/dependence||Lifetime alcohol or substance abuse or dependence||Participants|Number|10|10.0||||||
4439523|NCT00114127|4263321|B3|Lifetime Alcohol/substance abuse/dependence||Lifetime alcohol or substance abuse or dependence||Participants|Number|6|6.0||||||
4439524|NCT00114127|4263322|B2|Lifetime Alcohol/substance abuse/dependence||Lifetime alcohol or substance abuse or dependence||Participants|Number|3|3.0||||||
4439525|NCT00114127|4263323|B1|Lifetime Alcohol/substance abuse/dependence||Lifetime alcohol or substance abuse or dependence||Participants|Number|3|3.0||||||
4439526|NCT00114127|4263321|B3|No Lifetime depression||Lifetime depression||Participants|Number|18|18.0||||||
4439527|NCT00114127|4263322|B2|No Lifetime depression||Lifetime depression||Participants|Number|11|11.0||||||
4439528|NCT00114127|4263323|B1|No Lifetime depression||Lifetime depression||Participants|Number|7|7.0||||||
4439529|NCT00114127|4263321|B3|Lifetime depression||Lifetime depression||Participants|Number|10|10.0||||||
4439530|NCT00114127|4263322|B2|Lifetime depression||Lifetime depression||Participants|Number|4|4.0||||||
4439531|NCT00114127|4263323|B1|Lifetime depression||Lifetime depression||Participants|Number|6|6.0||||||
4439534|NCT00114127|4263323|B1|No concurrent mood or anxiety disorders||At least one concurrent mood or anxiety disorder||Participants|Number|6|6.0||||||
4439535|NCT00114127|4263321|B3|Concurrent mood or anxiety disorder||At least one concurrent mood or anxiety disorder||Participants|Number|8|8.0||||||
4439536|NCT00114127|4263322|B2|Concurrent mood or anxiety disorder||At least one concurrent mood or anxiety disorder||Participants|Number|1|1.0||||||
4439537|NCT00114127|4263323|B1|Concurrent mood or anxiety disorder||At least one concurrent mood or anxiety disorder||Participants|Number|7|7.0||||||
4439538|NCT00114127|4263321|B3|No Comorbid GAD||Current comorbidity, Generalized anxiety disorder (GAD)||Participants|Number|26|26.0||||||
4439539|NCT00114127|4263322|B2|No Comorbid GAD||Current comorbidity, Generalized anxiety disorder (GAD)||Participants|Number|15|15.0||||||
4439540|NCT00114127|4263323|B1|No Comorbid GAD||Current comorbidity, Generalized anxiety disorder (GAD)||Participants|Number|11|11.0||||||
4439541|NCT00114127|4263321|B3|Comorbid GAD||Current comorbidity, Generalized anxiety disorder (GAD)||Participants|Number|2|2.0||||||
4439542|NCT00114127|4263322|B2|Comorbid GAD||Current comorbidity, Generalized anxiety disorder (GAD)||Participants|Number|0|0.0||||||
4439543|NCT00114127|4263323|B1|Comorbid GAD||Current comorbidity, Generalized anxiety disorder (GAD)||Participants|Number|2|2.0||||||
4439544|NCT00114127|4263321|B3|No Comorbid PD||Current comorbidity, Panic Disorder (PD)||Participants|Number|27|27.0||||||
4439545|NCT00114127|4263322|B2|No Comorbid PD||Current comorbidity, Panic Disorder (PD)||Participants|Number|15|15.0||||||
4439546|NCT00114127|4263323|B1|No Comorbid PD||Current comorbidity, Panic Disorder (PD)||Participants|Number|12|12.0||||||
4439547|NCT00114127|4263321|B3|Comorbid PD||Current comorbidity, Panic Disorder (PD)||Participants|Number|1|1.0||||||
4439548|NCT00114127|4263322|B2|Comorbid PD||Current comorbidity, Panic Disorder (PD)||Participants|Number|0|0.0||||||
4439549|NCT00114127|4263323|B1|Comorbid PD||Current comorbidity, Panic Disorder (PD)||Participants|Number|1|1.0||||||
4439550|NCT00114127|4263321|B3|No Comorbid Dysthymia||Current comorbidity, Dysthymia||Participants|Number|26|26.0||||||
4439551|NCT00114127|4263322|B2|No Comorbid Dysthymia||Current comorbidity, Dysthymia||Participants|Number|15|15.0||||||
4439552|NCT00114127|4263323|B1|No Comorbid Dysthymia||Current comorbidity, Dysthymia||Participants|Number|11|11.0||||||
4439553|NCT00114127|4263321|B3|Comorbid Dysthymia||Current comorbidity, Dysthymia||Participants|Number|2|2.0||||||
4439554|NCT00114127|4263322|B2|Comorbid Dysthymia||Current comorbidity, Dysthymia||Participants|Number|0|0.0||||||
4439555|NCT00114127|4263323|B1|Comorbid Dysthymia||Current comorbidity, Dysthymia||Participants|Number|2|2.0||||||
4439556|NCT00114127|4263321|B3|No Comorbid MDD||Current comorbidity, Major depressive disorder (MDD)||Participants|Number|23|23.0||||||
4439557|NCT00114127|4263322|B2|No Comorbid MDD||Current comorbidity, Major depressive disorder (MDD)||Participants|Number|15|15.0||||||
4439558|NCT00114127|4263323|B1|No Comorbid MDD||Current comorbidity, Major depressive disorder (MDD)||Participants|Number|8|8.0||||||
4439559|NCT00114127|4263321|B3|Comorbid MDD||Current comorbidity, Major depressive disorder (MDD)||Participants|Number|5|5.0||||||
4439560|NCT00114127|4263322|B2|Comorbid MDD||Current comorbidity, Major depressive disorder (MDD)||Participants|Number|0|0.0||||||
4439561|NCT00114127|4263323|B1|Comorbid MDD||Current comorbidity, Major depressive disorder (MDD)||Participants|Number|5|5.0||||||
4439562|NCT00114127|4263321|B3|||Age of onset, mean age||Years|Mean|12.0|12.0|Standard Deviation|6.46|6.46|||
4439563|NCT00114127|4263322|B2|||Age of onset, mean age||Years|Mean|13.9|13.9|Standard Deviation|8.1|8.1|||
4439564|NCT00114127|4263323|B1|||Age of onset, mean age||Years|Mean|9.9|9.9|Standard Deviation|3.3|3.3|||
4439565|NCT00114127|4263321|B3|||Duration of illness, mean years (SD)||Years|Mean|23.7|23.7|Standard Deviation|14.9|14.9|||
4439566|NCT00114127|4263322|B2|||Duration of illness, mean years (SD)||Years|Mean|20.1|20.1|Standard Deviation|12.3|12.3|||
4439567|NCT00114127|4263323|B1|||Duration of illness, mean years (SD)||Years|Mean|27.6|27.6|Standard Deviation|17.0|17.0|||
4439568|NCT00114127|4263321|B3|Not College Graduate||Educational status, college graduate||Participants|Number|11|11.0||||||
4439569|NCT00114127|4263322|B2|Not College Graduate||Educational status, college graduate||Participants|Number|8|8.0||||||
4439570|NCT00114127|4263323|B1|Not College Graduate||Educational status, college graduate||Participants|Number|3|3.0||||||
4439571|NCT00114127|4263321|B3|College Graduate||Educational status, college graduate||Participants|Number|17|17.0||||||
4439572|NCT00114127|4263322|B2|College Graduate||Educational status, college graduate||Participants|Number|7|7.0||||||
4439573|NCT00114127|4263323|B1|College Graduate||Educational status, college graduate||Participants|Number|10|10.0||||||
4439574|NCT00114127|4263321|B3|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4439575|NCT00114127|4263322|B2|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4439576|NCT00114127|4263323|B1|Native Hawaiian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4439577|NCT00114127|4263321|B3|Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4439578|NCT00114127|4263322|B2|Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4439579|NCT00114127|4263323|B1|Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4439580|NCT00114127|4263321|B3|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4439581|NCT00114127|4263322|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4439582|NCT00114127|4263323|B1|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4439583|NCT00114127|4263321|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4439584|NCT00114127|4263322|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4439585|NCT00114127|4263323|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4439586|NCT00114127|4263321|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4439587|NCT00114127|4263322|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4439588|NCT00114127|4263323|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4439589|NCT00114127|4263321|B3|Male||Sex/Gender, Customized||Participants|Number|17|17.0||||||
4439590|NCT00114127|4263322|B2|Male||Sex/Gender, Customized||Participants|Number|11|11.0||||||
4439591|NCT00114127|4263323|B1|Male||Sex/Gender, Customized||Participants|Number|6|6.0||||||
4439592|NCT00114127|4263321|B3|Female||Sex/Gender, Customized||Participants|Number|11|11.0||||||
4439593|NCT00114127|4263322|B2|Female||Sex/Gender, Customized||Participants|Number|4|4.0||||||
4439594|NCT00114127|4263323|B1|Female||Sex/Gender, Customized||Participants|Number|7|7.0||||||
4439595|NCT00114127|4263321|B3|Age Baseline||Age, Customized||Years|Mean|36|36.0|Standard Deviation|12.6|12.6|||
4439596|NCT00114127|4263322|B2|Age Baseline||Age, Customized||Years|Mean|35.5|35.5|Standard Deviation|11.6|11.6|||
4439597|NCT00114127|4263323|B1|Age Baseline||Age, Customized||Years|Mean|36.6|36.6|Standard Deviation|14.2|14.2|||
4439598|NCT00114101|4263332|B3|No||Prior use of lenalidomide during induction therapy||participants|Number|300|300.0||||||
4439599|NCT00114101|4263333|B2|No||Prior use of lenalidomide during induction therapy||participants|Number|148|148.0||||||
4439600|NCT00114101|4263334|B1|No||Prior use of lenalidomide during induction therapy||participants|Number|152|152.0||||||
4439601|NCT00114101|4263332|B3|Yes||Prior use of lenalidomide during induction therapy||participants|Number|160|160.0||||||
4439602|NCT00114101|4263333|B2|Yes||Prior use of lenalidomide during induction therapy||participants|Number|81|81.0||||||
4439603|NCT00114101|4263334|B1|Yes||Prior use of lenalidomide during induction therapy||participants|Number|79|79.0||||||
4439604|NCT00114101|4263332|B3|No||Prior use of thalidomide during induction||participants|Number|255|255.0||||||
4439605|NCT00114101|4263333|B2|No||Prior use of thalidomide during induction||participants|Number|126|126.0||||||
4439606|NCT00114101|4263334|B1|No||Prior use of thalidomide during induction||participants|Number|129|129.0||||||
4439607|NCT00114101|4263332|B3|Yes||Prior use of thalidomide during induction||participants|Number|205|205.0||||||
4439608|NCT00114101|4263333|B2|Yes||Prior use of thalidomide during induction||participants|Number|103|103.0||||||
4439609|NCT00114101|4263334|B1|Yes||Prior use of thalidomide during induction||participants|Number|102|102.0||||||
4439610|NCT00114101|4263332|B3|Missing data||Beta 2 microglobulin at registration||participants|Number|22|22.0||||||
4439611|NCT00114101|4263333|B2|Missing data||Beta 2 microglobulin at registration||participants|Number|11|11.0||||||
4439612|NCT00114101|4263334|B1|Missing data||Beta 2 microglobulin at registration||participants|Number|11|11.0||||||
4439613|NCT00114101|4263332|B3|<= 2.5 mg/liter||Beta 2 microglobulin at registration||participants|Number|333|333.0||||||
4439614|NCT00114101|4263333|B2|<= 2.5 mg/liter||Beta 2 microglobulin at registration||participants|Number|163|163.0||||||
4439615|NCT00114101|4263334|B1|<= 2.5 mg/liter||Beta 2 microglobulin at registration||participants|Number|170|170.0||||||
4439616|NCT00114101|4263332|B3|> 2.5 mg/liter||Beta 2 microglobulin at registration||participants|Number|105|105.0||||||
4439617|NCT00114101|4263333|B2|> 2.5 mg/liter||Beta 2 microglobulin at registration||participants|Number|55|55.0||||||
4439618|NCT00114101|4263334|B1|> 2.5 mg/liter||Beta 2 microglobulin at registration||participants|Number|50|50.0||||||
4439619|NCT00114101|4263332|B3|United States||Region of Enrollment||participants|Number|460|460.0||||||
4439620|NCT00114101|4263333|B2|United States||Region of Enrollment||participants|Number|229|229.0||||||
4439621|NCT00114101|4263334|B1|United States||Region of Enrollment||participants|Number|231|231.0||||||
4439622|NCT00114101|4263332|B3||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4439623|NCT00114101|4263333|B2||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4439624|NCT00114101|4263334|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4439625|NCT00114101|4263332|B3||Female|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4439626|NCT00114101|4263333|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4439627|NCT00114101|4263334|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4439628|NCT00114101|4263332|B3|||Age||years|Median|59|59.0|Full Range|||29.0|71.0|
4439629|NCT00114101|4263333|B2|||Age||years|Median|58|58.0|Full Range|||40.0|71.0|
4439630|NCT00114101|4263334|B1|||Age||years|Median|59|59.0|Full Range|||29.0|71.0|
4439631|NCT00113919|4263347|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4439632|NCT00113919|4263347|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4439633|NCT00113919|4263347|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4439634|NCT00113919|4263347|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4439635|NCT00113919|4263347|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4439636|NCT00113880|4263351|B4|Male||Gender|Gender data was collected per dose of intervention and not per participant and that each participant could have received more than one dose.|dose|Number|95857|95857.0||||||
4439637|NCT00113880|4263352|B3|Male||Gender|Gender data was collected per dose of intervention and not per participant and that each participant could have received more than one dose.|dose|Number|29626|29626.0||||||
4439638|NCT00113880|4263353|B2|Male||Gender|Gender data was collected per dose of intervention and not per participant and that each participant could have received more than one dose.|dose|Number|33115|33115.0||||||
4439639|NCT00113880|4263354|B1|Male||Gender|Gender data was collected per dose of intervention and not per participant and that each participant could have received more than one dose.|dose|Number|33116|33116.0||||||
4439640|NCT00113880|4263351|B4|Female||Gender|Gender data was collected per dose of intervention and not per participant and that each participant could have received more than one dose.|dose|Number|120557|120557.0||||||
4439641|NCT00113880|4263352|B3|Female||Gender|Gender data was collected per dose of intervention and not per participant and that each participant could have received more than one dose.|dose|Number|37373|37373.0||||||
4439642|NCT00113880|4263353|B2|Female||Gender|Gender data was collected per dose of intervention and not per participant and that each participant could have received more than one dose.|dose|Number|41591|41591.0||||||
4439643|NCT00113880|4263354|B1|Female||Gender|Gender data was collected per dose of intervention and not per participant and that each participant could have received more than one dose.|dose|Number|41593|41593.0||||||
4439644|NCT00113880|4263351|B4|||Age||Years|Mean|17.1|17.1|Standard Deviation|12.8|12.8|||
4439645|NCT00113880|4263352|B3|||Age||Years|Mean|16.8|16.8|Standard Deviation|12.7|12.7|||
4439646|NCT00113880|4263353|B2|||Age||Years|Mean|17.1|17.1|Standard Deviation|12.8|12.8|||
4439647|NCT00113880|4263354|B1|||Age||Years|Mean|17.1|17.1|Standard Deviation|12.8|12.8|||
4439648|NCT00113841|4263413|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4439649|NCT00113841|4263414|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4439650|NCT00113841|4263415|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4439651|NCT00113841|4263413|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4439652|NCT00113841|4263414|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4439653|NCT00113841|4263415|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4439654|NCT00113841|4263413|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4439655|NCT00113841|4263414|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4439656|NCT00113841|4263415|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4439657|NCT00113841|4263413|B3|||Age||years|Median|59|59.0|Full Range|||41.0|78.0|
4439658|NCT00113841|4263414|B2|||Age||years|Median|62|62.0|Full Range|||41.0|78.0|
4439659|NCT00113841|4263415|B1|||Age||years|Median|59|59.0|Full Range|||46.0|78.0|
4439660|NCT00113763|4263422|B3|2||Eastern Cooperative Oncology Group (ECOG) performance status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|61|61.0||||||
4439661|NCT00113763|4263423|B2|2||Eastern Cooperative Oncology Group (ECOG) performance status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|30|30.0||||||
4439662|NCT00113763|4263424|B1|2||Eastern Cooperative Oncology Group (ECOG) performance status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|31|31.0||||||
4439663|NCT00113763|4263422|B3|0 or 1||Eastern Cooperative Oncology Group (ECOG) performance status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|402|402.0||||||
4439664|NCT00113763|4263423|B2|0 or 1||Eastern Cooperative Oncology Group (ECOG) performance status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|202|202.0||||||
4439665|NCT00113763|4263424|B1|0 or 1||Eastern Cooperative Oncology Group (ECOG) performance status|Scale used to assess how a patient's disease is progressing, how the disease affects the daily living abilities of the patient: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity, ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about > 50% of waking hours; 3 = Capable of only limited self care, confined to a bed or chair > 50% of waking hours; 4 = Completely disabled, confined to bed or chair; 5 = Dead.|participants|Number|200|200.0||||||
4439666|NCT00113763|4263422|B3|Rest of World||Region of Enrollment|Central and Eastern Europe includes the Czech Republic, Greece, Hungary, and the Slovak Republic. Rest of World includes Australia, Canada and New Zealand. Western Europe includes Austria, Belgium, France, Germany, Italy, Portugal, Spain, Switzerland, and the Netherlands.|participants|Number|66|66.0||||||
4439667|NCT00113763|4263423|B2|Rest of World||Region of Enrollment|Central and Eastern Europe includes the Czech Republic, Greece, Hungary, and the Slovak Republic. Rest of World includes Australia, Canada and New Zealand. Western Europe includes Austria, Belgium, France, Germany, Italy, Portugal, Spain, Switzerland, and the Netherlands.|participants|Number|33|33.0||||||
4439713|NCT00113607|4263451|B1|United States Of America||Region of Enrollment||participants|Number|63|63.0||||||
4439714|NCT00113607|4263449|B3|United Kingdom||Region of Enrollment||participants|Number|38|38.0||||||
4439668|NCT00113763|4263424|B1|Rest of World||Region of Enrollment|Central and Eastern Europe includes the Czech Republic, Greece, Hungary, and the Slovak Republic. Rest of World includes Australia, Canada and New Zealand. Western Europe includes Austria, Belgium, France, Germany, Italy, Portugal, Spain, Switzerland, and the Netherlands.|participants|Number|33|33.0||||||
4439669|NCT00113763|4263422|B3|Western Europe||Region of Enrollment|Central and Eastern Europe includes the Czech Republic, Greece, Hungary, and the Slovak Republic. Rest of World includes Australia, Canada and New Zealand. Western Europe includes Austria, Belgium, France, Germany, Italy, Portugal, Spain, Switzerland, and the Netherlands.|participants|Number|358|358.0||||||
4439670|NCT00113763|4263423|B2|Western Europe||Region of Enrollment|Central and Eastern Europe includes the Czech Republic, Greece, Hungary, and the Slovak Republic. Rest of World includes Australia, Canada and New Zealand. Western Europe includes Austria, Belgium, France, Germany, Italy, Portugal, Spain, Switzerland, and the Netherlands.|participants|Number|180|180.0||||||
4439671|NCT00113763|4263424|B1|Western Europe||Region of Enrollment|Central and Eastern Europe includes the Czech Republic, Greece, Hungary, and the Slovak Republic. Rest of World includes Australia, Canada and New Zealand. Western Europe includes Austria, Belgium, France, Germany, Italy, Portugal, Spain, Switzerland, and the Netherlands.|participants|Number|178|178.0||||||
4439672|NCT00113763|4263422|B3|Central and Eastern Europe||Region of Enrollment|Central and Eastern Europe includes the Czech Republic, Greece, Hungary, and the Slovak Republic. Rest of World includes Australia, Canada and New Zealand. Western Europe includes Austria, Belgium, France, Germany, Italy, Portugal, Spain, Switzerland, and the Netherlands.|participants|Number|39|39.0||||||
4439673|NCT00113763|4263423|B2|Central and Eastern Europe||Region of Enrollment|Central and Eastern Europe includes the Czech Republic, Greece, Hungary, and the Slovak Republic. Rest of World includes Australia, Canada and New Zealand. Western Europe includes Austria, Belgium, France, Germany, Italy, Portugal, Spain, Switzerland, and the Netherlands.|participants|Number|19|19.0||||||
4439674|NCT00113763|4263424|B1|Central and Eastern Europe||Region of Enrollment|Central and Eastern Europe includes the Czech Republic, Greece, Hungary, and the Slovak Republic. Rest of World includes Australia, Canada and New Zealand. Western Europe includes Austria, Belgium, France, Germany, Italy, Portugal, Spain, Switzerland, and the Netherlands.|participants|Number|20|20.0||||||
4439675|NCT00113763|4263422|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4439676|NCT00113763|4263423|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4439677|NCT00113763|4263424|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4439678|NCT00113763|4263422|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|457|457.0||||||
4439679|NCT00113763|4263423|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|228|228.0||||||
4439680|NCT00113763|4263424|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|229|229.0||||||
4439681|NCT00113763|4263422|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4439682|NCT00113763|4263423|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439683|NCT00113763|4263424|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4439684|NCT00113763|4263422|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439685|NCT00113763|4263423|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439686|NCT00113763|4263424|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439687|NCT00113763|4263422|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4439688|NCT00113763|4263423|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4439689|NCT00113763|4263424|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439690|NCT00113763|4263422|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439691|NCT00113763|4263423|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439692|NCT00113763|4263424|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439693|NCT00113763|4263422|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439694|NCT00113763|4263423|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439695|NCT00113763|4263424|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439696|NCT00113763|4263422|B3|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439697|NCT00113763|4263423|B2|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439698|NCT00113763|4263424|B1|Aborigine||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439699|NCT00113763|4263422|B3|Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4439700|NCT00113763|4263423|B2|Japanese||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4439701|NCT00113763|4263424|B1|Japanese||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439702|NCT00113763|4263422|B3||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4439703|NCT00113763|4263423|B2||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4439704|NCT00113763|4263424|B1||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4439705|NCT00113763|4263422|B3||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4439706|NCT00113763|4263423|B2||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4439707|NCT00113763|4263424|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4439708|NCT00113763|4263422|B3|||Age||years|Mean|61.3|61.3|Standard Deviation|10.5|10.5|||
4439709|NCT00113763|4263423|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|10.8|10.8|||
4439710|NCT00113763|4263424|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|10.3|10.3|||
4439711|NCT00113607|4263449|B3|United States Of America||Region of Enrollment||participants|Number|121|121.0||||||
4439712|NCT00113607|4263450|B2|United States Of America||Region of Enrollment||participants|Number|58|58.0||||||
4439715|NCT00113607|4263450|B2|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4439716|NCT00113607|4263451|B1|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4439717|NCT00113607|4263449|B3|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4439718|NCT00113607|4263450|B2|Taiwan||Region of Enrollment||participants|Number|2|2.0||||||
4439719|NCT00113607|4263451|B1|Taiwan||Region of Enrollment||participants|Number|7|7.0||||||
4439720|NCT00113607|4263449|B3|Sweden||Region of Enrollment||participants|Number|14|14.0||||||
4439721|NCT00113607|4263450|B2|Sweden||Region of Enrollment||participants|Number|8|8.0||||||
4439722|NCT00113607|4263451|B1|Sweden||Region of Enrollment||participants|Number|6|6.0||||||
4439723|NCT00113607|4263449|B3|Spain||Region of Enrollment||participants|Number|17|17.0||||||
4439724|NCT00113607|4263450|B2|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4439725|NCT00113607|4263451|B1|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4439726|NCT00113607|4263449|B3|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4439727|NCT00113607|4263450|B2|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4439728|NCT00113607|4263451|B1|Singapore||Region of Enrollment||participants|Number|0|0.0||||||
4439729|NCT00113607|4263449|B3|Russia||Region of Enrollment||participants|Number|108|108.0||||||
4439730|NCT00113607|4263450|B2|Russia||Region of Enrollment||participants|Number|56|56.0||||||
4439731|NCT00113607|4263451|B1|Russia||Region of Enrollment||participants|Number|52|52.0||||||
4439732|NCT00113607|4263449|B3|Republic Of Korea||Region of Enrollment||participants|Number|28|28.0||||||
4439733|NCT00113607|4263450|B2|Republic Of Korea||Region of Enrollment||participants|Number|11|11.0||||||
4439734|NCT00113607|4263451|B1|Republic Of Korea||Region of Enrollment||participants|Number|17|17.0||||||
4439735|NCT00113607|4263449|B3|Poland||Region of Enrollment||participants|Number|86|86.0||||||
4439736|NCT00113607|4263450|B2|Poland||Region of Enrollment||participants|Number|39|39.0||||||
4439737|NCT00113607|4263451|B1|Poland||Region of Enrollment||participants|Number|47|47.0||||||
4439738|NCT00113607|4263449|B3|China||Region of Enrollment||participants|Number|73|73.0||||||
4439739|NCT00113607|4263450|B2|China||Region of Enrollment||participants|Number|36|36.0||||||
4439740|NCT00113607|4263451|B1|China||Region of Enrollment||participants|Number|37|37.0||||||
4439741|NCT00113607|4263449|B3|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4439742|NCT00113607|4263450|B2|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4439743|NCT00113607|4263451|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4439744|NCT00113607|4263449|B3|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4439745|NCT00113607|4263450|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4439746|NCT00113607|4263451|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4439747|NCT00113607|4263449|B3|Hong Kong||Region of Enrollment||participants|Number|25|25.0||||||
4439748|NCT00113607|4263450|B2|Hong Kong||Region of Enrollment||participants|Number|15|15.0||||||
4439749|NCT00113607|4263451|B1|Hong Kong||Region of Enrollment||participants|Number|10|10.0||||||
4439750|NCT00113607|4263449|B3|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4439751|NCT00113607|4263450|B2|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4439752|NCT00113607|4263451|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4439753|NCT00113607|4263449|B3|France||Region of Enrollment||participants|Number|2|2.0||||||
4439754|NCT00113607|4263450|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4439755|NCT00113607|4263451|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4439756|NCT00113607|4263449|B3|Chile||Region of Enrollment||participants|Number|3|3.0||||||
4439757|NCT00113607|4263450|B2|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4439758|NCT00113607|4263451|B1|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4439759|NCT00113607|4263449|B3|Canada||Region of Enrollment||participants|Number|56|56.0||||||
4439760|NCT00113607|4263450|B2|Canada||Region of Enrollment||participants|Number|34|34.0||||||
4439761|NCT00113607|4263451|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4439762|NCT00113607|4263449|B3|Brazil||Region of Enrollment||participants|Number|21|21.0||||||
4439763|NCT00113607|4263450|B2|Brazil||Region of Enrollment||participants|Number|9|9.0||||||
4439764|NCT00113607|4263451|B1|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4439765|NCT00113607|4263449|B3|Belgium-Luxemburg||Region of Enrollment||participants|Number|25|25.0||||||
4439766|NCT00113607|4263450|B2|Belgium-Luxemburg||Region of Enrollment||participants|Number|13|13.0||||||
4439767|NCT00113607|4263451|B1|Belgium-Luxemburg||Region of Enrollment||participants|Number|12|12.0||||||
4439768|NCT00113607|4263449|B3|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4439769|NCT00113607|4263450|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4439770|NCT00113607|4263451|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4439771|NCT00113607|4263449|B3|Argentina||Region of Enrollment||participants|Number|7|7.0||||||
4439772|NCT00113607|4263450|B2|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4439773|NCT00113607|4263451|B1|Argentina||Region of Enrollment||participants|Number|5|5.0||||||
4439774|NCT00113607|4263449|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439775|NCT00113607|4263450|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439776|NCT00113607|4263451|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439777|NCT00113607|4263449|B3||Female|Sex: Female, Male||Participants|Count of Participants|672|672.0||||||
4439778|NCT00113607|4263450|B2||Female|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
4439779|NCT00113607|4263451|B1||Female|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4439780|NCT00113607|4263449|B3|||Age||years|Mean|57.5|57.5|Standard Deviation|10.63|10.63|||
4439781|NCT00113607|4263450|B2|||Age||years|Mean|56.8|56.8|Standard Deviation|10.48|10.48|||
4439782|NCT00113607|4263451|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|10.75|10.75|||
4439783|NCT00113568|4263466|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439784|NCT00113568|4263466|B1||Female|Sex: Female, Male||Participants|Count of Participants|723|723.0||||||
4439785|NCT00113568|4263466|B1|||Age||years|Mean|38|38.0|Standard Deviation|7|7.0|||
4439786|NCT00113555|4263478|B1|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4439787|NCT00113555|4263478|B1|United States||Region of Enrollment||participants|Number|137|137.0||||||
4439788|NCT00113555|4263478|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439789|NCT00113555|4263478|B1||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4439790|NCT00113555|4263478|B1|||Age||years|Mean|67.6|67.6|Standard Deviation|11.6|11.6|||
4439791|NCT00113555|4263478|B1||>=65 years|Age||Participants|Count of Participants|123|123.0||||||
4439792|NCT00113555|4263478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4439793|NCT00113555|4263478|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4439794|NCT00113529|4263488|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4439795|NCT00113529|4263488|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4439796|NCT00113529|4263488|B1|> = 65 years||Age, Customized||participants|Number|16|16.0||||||
4439797|NCT00113529|4263488|B1|< 65 years||Age, Customized||participants|Number|19|19.0||||||
4439798|NCT00113516|4263521|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4439799|NCT00113516|4263521|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4439800|NCT00113516|4263521|B1|> = 65 years||Age, Customized||participants|Number|31|31.0||||||
4439801|NCT00113516|4263521|B1|< 65 years||Age, Customized||participants|Number|53|53.0||||||
4439802|NCT00113490|4263563|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4439803|NCT00113490|4263564|B2|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4439804|NCT00113490|4263565|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4439805|NCT00113490|4263563|B3|White/Non-Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4439806|NCT00113490|4263564|B2|White/Non-Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4439807|NCT00113490|4263565|B1|White/Non-Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4439808|NCT00113490|4263563|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4439809|NCT00113490|4263564|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|62|62.0||||||
4439810|NCT00113490|4263565|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4439811|NCT00113490|4263563|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4439812|NCT00113490|4263564|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4439813|NCT00113490|4263565|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4439814|NCT00113490|4263563|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4439815|NCT00113490|4263564|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4439816|NCT00113490|4263565|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4439817|NCT00113490|4263563|B3|||Age||Months|Mean|13.43|13.43|Standard Deviation|3.00|3.0|||
4439818|NCT00113490|4263564|B2|||Age||Months|Mean|13.59|13.59|Standard Deviation|2.89|2.89|||
4439819|NCT00113490|4263565|B1|||Age||Months|Mean|13.25|13.25|Standard Deviation|3.13|3.13|||
4439820|NCT00113425|4263579|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4439821|NCT00113425|4263579|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4439822|NCT00113425|4263579|B1|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4439823|NCT00113425|4263579|B1|Middle Eastern||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4439824|NCT00113425|4263579|B1|Hispanic, Latina||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4439825|NCT00113425|4263579|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4439826|NCT00113425|4263579|B1|Black / African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4439827|NCT00113425|4263579|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4439828|NCT00113425|4263579|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4439829|NCT00113425|4263579|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4439830|NCT00113425|4263579|B1|||Age||years|Mean|25.41|25.41|Standard Deviation|8.46|8.46|||
4439831|NCT00113425|4263579|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4439832|NCT00113425|4263579|B1||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4439833|NCT00113425|4263579|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4439834|NCT00113399|4263597|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4439835|NCT00113399|4263598|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4439836|NCT00113399|4263599|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4439837|NCT00113399|4263597|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4439838|NCT00113399|4263598|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4439839|NCT00113399|4263599|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4439840|NCT00113399|4263597|B3|||Age||years|Median|57|57.0|Full Range|||44.0|80.0|
4439841|NCT00113399|4263598|B2|||Age||years|Median|57|57.0|Full Range|||48.0|68.0|
4439842|NCT00113399|4263599|B1|||Age||years|Median|56|56.0|Full Range|||44.0|80.0|
4439843|NCT00113386|4263606|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4439844|NCT00113386|4263607|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4439845|NCT00113386|4263608|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4439846|NCT00113386|4263606|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4439847|NCT00113386|4263607|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4439848|NCT00113386|4263608|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4439849|NCT00113386|4263606|B3|||Age||years|Median|63|63.0|Full Range|||43.0|77.0|
4439850|NCT00113386|4263607|B2|||Age||years|Median|57|57.0|Full Range|||45.0|72.0|
4439851|NCT00113386|4263608|B1|||Age||years|Median|66|66.0|Full Range|||43.0|77.0|
4439852|NCT00113373|4263615|B1|Serous Adenocarcinoma||Histologic Type||participants|Number|20|20.0||||||
4439853|NCT00113373|4263615|B1|Undifferentiated Carcinoma||Histologic Type||participants|Number|2|2.0||||||
4439854|NCT00113373|4263615|B1|Endometrioid Adenocarcinoma||Histologic Type||participants|Number|3|3.0||||||
4439855|NCT00113373|4263615|B1|||International Federation of Gynecology and Obstetrics (FIGO) Stage Recurrent/Persistent||participants|Number|25|25.0||||||
4439856|NCT00113373|4263615|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4439857|NCT00113373|4263615|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4439858|NCT00113373|4263615|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4439859|NCT00113373|4263615|B1|80-89 years||Age, Customized||participants|Number|2|2.0||||||
4439860|NCT00113373|4263615|B1|70-79 years||Age, Customized||participants|Number|4|4.0||||||
4439861|NCT00113373|4263615|B1|60-69 years||Age, Customized||participants|Number|12|12.0||||||
4439862|NCT00113373|4263615|B1|50-59 years||Age, Customized||participants|Number|4|4.0||||||
4439863|NCT00113373|4263615|B1|40-49 years||Age, Customized||participants|Number|3|3.0||||||
4439864|NCT00113373|4263615|B1|||Age||years|Median|63.4|63.4|Standard Deviation|9.3|9.3|||
4439865|NCT00113360|4263630|B1|United States||Region of Enrollment||participants|Number|67|67.0||||||
4439866|NCT00113360|4263630|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4439867|NCT00113360|4263630|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4439868|NCT00113360|4263630|B1|||Age||Years|Mean|55|55.0|Full Range|||44.0|67.0|
4439869|NCT00113334|4263634|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4439870|NCT00113334|4263634|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4439871|NCT00113334|4263634|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4439872|NCT00113334|4263634|B1|||Age||years|Mean|59|59.0|Full Range|||43.0|64.0|
4439873|NCT00113321|4263638|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4439874|NCT00113321|4263638|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4439875|NCT00113321|4263638|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4439876|NCT00113321|4263638|B1|||Age||years|Median|75|75.0|Full Range|||58.0|85.0|
4439877|NCT00113321|4263638|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4439878|NCT00113321|4263638|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4439879|NCT00113321|4263638|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4439880|NCT00113295|4263642|B3|||Q-LES-Q|The Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) measures the degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning.|units on a scale|Mean|45.51|45.51|Standard Deviation|9.77|9.77|||
4439881|NCT00113295|4263643|B2|||Q-LES-Q|The Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) measures the degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning.|units on a scale|Mean|45.89|45.89|Standard Deviation|8.88|8.88|||
4439882|NCT00113295|4263644|B1|||Q-LES-Q|The Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) measures the degree of enjoyment and satisfaction experienced by subjects in various areas of daily functioning.|units on a scale|Mean|45.13|45.13|Standard Deviation|10.6|10.6|||
4439883|NCT00113295|4263642|B3|||MADRS|The Montgomery–Asberg Depression Rating Scale (MADRS) measures depressive symptoms.|units on a scale|Mean|11.91|11.91|Standard Deviation|3.66|3.66|||
4439884|NCT00113295|4263643|B2|||MADRS|The Montgomery–Asberg Depression Rating Scale (MADRS) measures depressive symptoms.|units on a scale|Mean|12.36|12.36|Standard Deviation|4.80|4.8|||
4439885|NCT00113295|4263644|B1|||MADRS|The Montgomery–Asberg Depression Rating Scale (MADRS) measures depressive symptoms.|units on a scale|Mean|11.45|11.45|Standard Deviation|1.93|1.93|||
4439886|NCT00113295|4263642|B3|||CGI-S|The Clinical Global Impression of Improvement (CGI-I) measures illness severity and improvement. The patient's current condition is compared to the patient's baseline condition on a seven-point scale. The condition is rated as 1=very much improved since the initiation of treatment; 2=much improved; 3=minimally improved; 4=no change from baseline (the initiation of treatment); 5=minimally worse; 6= much worse; 7=very much worse since the initiation of treatment.|Units on a scale|Mean|3.77|3.77|Standard Deviation|0.75|0.75|||
4439887|NCT00113295|4263643|B2|||CGI-S|The Clinical Global Impression of Improvement (CGI-I) measures illness severity and improvement. The patient's current condition is compared to the patient's baseline condition on a seven-point scale. The condition is rated as 1=very much improved since the initiation of treatment; 2=much improved; 3=minimally improved; 4=no change from baseline (the initiation of treatment); 5=minimally worse; 6= much worse; 7=very much worse since the initiation of treatment.|Units on a scale|Mean|3.91|3.91|Standard Deviation|0.83|0.83|||
4439931|NCT00113269|4263664|B1|> 20% - 50%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|11|11.0||||||
4439932|NCT00113269|4263660|B5|> 0% - 20%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|93|93.0||||||
4439888|NCT00113295|4263644|B1|||CGI-S|The Clinical Global Impression of Improvement (CGI-I) measures illness severity and improvement. The patient's current condition is compared to the patient's baseline condition on a seven-point scale. The condition is rated as 1=very much improved since the initiation of treatment; 2=much improved; 3=minimally improved; 4=no change from baseline (the initiation of treatment); 5=minimally worse; 6= much worse; 7=very much worse since the initiation of treatment.|Units on a scale|Mean|3.64|3.64|Standard Deviation|0.67|0.67|||
4439889|NCT00113295|4263642|B3|||HAM-A|The 14-item Hamilton Anxiety Rating Scale (HAM-A) (Hamilton, 1959) was developed to assess anxiety in a clinical population. It is considered a measure of general anxiety across anxiety disorders, in addition to being a gold standard measure for GAD.|units on a scale|Mean|16.05|16.05|Standard Deviation|4.8|4.8|||
4439890|NCT00113295|4263643|B2|||HAM-A|The 14-item Hamilton Anxiety Rating Scale (HAM-A) (Hamilton, 1959) was developed to assess anxiety in a clinical population. It is considered a measure of general anxiety across anxiety disorders, in addition to being a gold standard measure for GAD.|units on a scale|Mean|15.82|15.82|Standard Deviation|4.77|4.77|||
4439891|NCT00113295|4263644|B1|||HAM-A|The 14-item Hamilton Anxiety Rating Scale (HAM-A) (Hamilton, 1959) was developed to assess anxiety in a clinical population. It is considered a measure of general anxiety across anxiety disorders, in addition to being a gold standard measure for GAD.|units on a scale|Mean|16.27|16.27|Standard Deviation|5.04|5.04|||
4439892|NCT00113295|4263642|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439893|NCT00113295|4263643|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439894|NCT00113295|4263644|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439895|NCT00113295|4263642|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439896|NCT00113295|4263643|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439897|NCT00113295|4263644|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439898|NCT00113295|4263642|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4439899|NCT00113295|4263643|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4439900|NCT00113295|4263644|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4439901|NCT00113295|4263642|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4439902|NCT00113295|4263643|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4439903|NCT00113295|4263644|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4439904|NCT00113295|4263642|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439905|NCT00113295|4263643|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439906|NCT00113295|4263644|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439907|NCT00113295|4263642|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439908|NCT00113295|4263643|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439909|NCT00113295|4263644|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439910|NCT00113295|4263642|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439911|NCT00113295|4263643|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439912|NCT00113295|4263644|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4439913|NCT00113295|4263642|B3|Phase 2 Baseline Males||Sex/Gender, Customized||participants|Number|11|11.0||||||
4439914|NCT00113295|4263643|B2|Phase 2 Baseline Males||Sex/Gender, Customized||participants|Number|4|4.0||||||
4439915|NCT00113295|4263644|B1|Phase 2 Baseline Males||Sex/Gender, Customized||participants|Number|7|7.0||||||
4439916|NCT00113295|4263642|B3|Phase 2 Baseline Females||Sex/Gender, Customized||participants|Number|11|11.0||||||
4439917|NCT00113295|4263643|B2|Phase 2 Baseline Females||Sex/Gender, Customized||participants|Number|7|7.0||||||
4439918|NCT00113295|4263644|B1|Phase 2 Baseline Females||Sex/Gender, Customized||participants|Number|4|4.0||||||
4439919|NCT00113295|4263642|B3|At Phase 2 Baseline||Age||years|Mean|42.2|42.2|Standard Deviation|11.7|11.7|||
4439920|NCT00113295|4263643|B2|At Phase 2 Baseline||Age||years|Mean|40.5|40.5|Standard Deviation|11.2|11.2|||
4439921|NCT00113295|4263644|B1|At Phase 2 Baseline||Age||years|Mean|43.8|43.8|Standard Deviation|12.5|12.5|||
4439922|NCT00113269|4263660|B5|> 50%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|28|28.0||||||
4439923|NCT00113269|4263661|B4|> 50%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|0|0.0||||||
4439924|NCT00113269|4263662|B3|> 50%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|3|3.0||||||
4439925|NCT00113269|4263663|B2|> 50%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|13|13.0||||||
4439926|NCT00113269|4263664|B1|> 50%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|12|12.0||||||
4439927|NCT00113269|4263660|B5|> 20% - 50%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|21|21.0||||||
4439928|NCT00113269|4263661|B4|> 20% - 50%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|1|1.0||||||
4439929|NCT00113269|4263662|B3|> 20% - 50%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|2|2.0||||||
4439930|NCT00113269|4263663|B2|> 20% - 50%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|7|7.0||||||
4439933|NCT00113269|4263661|B4|> 0% - 20%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|39|39.0||||||
4439934|NCT00113269|4263662|B3|> 0% - 20%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|24|24.0||||||
4439935|NCT00113269|4263663|B2|> 0% - 20%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|16|16.0||||||
4439936|NCT00113269|4263664|B1|> 0% - 20%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|14|14.0||||||
4439937|NCT00113269|4263660|B5|0%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|329|329.0||||||
4439938|NCT00113269|4263661|B4|0%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|130|130.0||||||
4439939|NCT00113269|4263662|B3|0%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|134|134.0||||||
4439940|NCT00113269|4263663|B2|0%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|32|32.0||||||
4439941|NCT00113269|4263664|B1|0%||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|33|33.0||||||
4439942|NCT00113269|4263660|B5|Missing||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|3|3.0||||||
4439943|NCT00113269|4263661|B4|Missing||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|1|1.0||||||
4439944|NCT00113269|4263662|B3|Missing||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|1|1.0||||||
4439945|NCT00113269|4263663|B2|Missing||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|1|1.0||||||
4439946|NCT00113269|4263664|B1|Missing||Panel Reactive Antibody (PRA) Group|PRA is defined as the highest level at time of transplant or 6 months prior to transplant.|Participants|Number|0|0.0||||||
4439947|NCT00113269|4263660|B5|Deceased||Type of Transplant||Participants|Number|189|189.0||||||
4439948|NCT00113269|4263661|B4|Deceased||Type of Transplant||Participants|Number|49|49.0||||||
4439949|NCT00113269|4263662|B3|Deceased||Type of Transplant||Participants|Number|55|55.0||||||
4439950|NCT00113269|4263663|B2|Deceased||Type of Transplant||Participants|Number|43|43.0||||||
4439951|NCT00113269|4263664|B1|Deceased||Type of Transplant||Participants|Number|42|42.0||||||
4439952|NCT00113269|4263660|B5|Living non-related||Type of Transplant||Participants|Number|111|111.0||||||
4439953|NCT00113269|4263661|B4|Living non-related||Type of Transplant||Participants|Number|48|48.0||||||
4439954|NCT00113269|4263662|B3|Living non-related||Type of Transplant||Participants|Number|45|45.0||||||
4439955|NCT00113269|4263663|B2|Living non-related||Type of Transplant||Participants|Number|11|11.0||||||
4439956|NCT00113269|4263664|B1|Living non-related||Type of Transplant||Participants|Number|7|7.0||||||
4439957|NCT00113269|4263660|B5|Living related||Type of Transplant||Participants|Number|174|174.0||||||
4439958|NCT00113269|4263661|B4|Living related||Type of Transplant||Participants|Number|74|74.0||||||
4439959|NCT00113269|4263662|B3|Living related||Type of Transplant||Participants|Number|64|64.0||||||
4439960|NCT00113269|4263663|B2|Living related||Type of Transplant||Participants|Number|15|15.0||||||
4439961|NCT00113269|4263664|B1|Living related||Type of Transplant||Participants|Number|21|21.0||||||
4439962|NCT00113269|4263660|B5|No||Previous Transplant||Participants|Number|445|445.0||||||
4439963|NCT00113269|4263661|B4|No||Previous Transplant||Participants|Number|168|168.0||||||
4439964|NCT00113269|4263662|B3|No||Previous Transplant||Participants|Number|162|162.0||||||
4439965|NCT00113269|4263663|B2|No||Previous Transplant||Participants|Number|59|59.0||||||
4439966|NCT00113269|4263664|B1|No||Previous Transplant||Participants|Number|56|56.0||||||
4439967|NCT00113269|4263660|B5|Yes||Previous Transplant||Participants|Number|29|29.0||||||
4439968|NCT00113269|4263661|B4|Yes||Previous Transplant||Participants|Number|3|3.0||||||
4439969|NCT00113269|4263662|B3|Yes||Previous Transplant||Participants|Number|2|2.0||||||
4439970|NCT00113269|4263663|B2|Yes||Previous Transplant||Participants|Number|10|10.0||||||
4439971|NCT00113269|4263664|B1|Yes||Previous Transplant||Participants|Number|14|14.0||||||
4439972|NCT00113269|4263660|B5|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4439973|NCT00113269|4263661|B4|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4439974|NCT00113269|4263662|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4439975|NCT00113269|4263663|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4439976|NCT00113269|4263664|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4439977|NCT00113269|4263660|B5|Asian||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4439978|NCT00113269|4263661|B4|Asian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4439979|NCT00113269|4263662|B3|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4439980|NCT00113269|4263663|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4439981|NCT00113269|4263664|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4439982|NCT00113269|4263660|B5|Black||Race/Ethnicity, Customized||Participants|Number|100|100.0||||||
4439983|NCT00113269|4263661|B4|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4439984|NCT00113269|4263662|B3|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4439985|NCT00113269|4263663|B2|Black||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4439986|NCT00113269|4263664|B1|Black||Race/Ethnicity, Customized||Participants|Number|50|50.0||||||
4439987|NCT00113269|4263660|B5|White||Race/Ethnicity, Customized||Participants|Number|354|354.0||||||
4439988|NCT00113269|4263661|B4|White||Race/Ethnicity, Customized||Participants|Number|161|161.0||||||
4439989|NCT00113269|4263662|B3|White||Race/Ethnicity, Customized||Participants|Number|155|155.0||||||
4439990|NCT00113269|4263663|B2|White||Race/Ethnicity, Customized||Participants|Number|20|20.0||||||
4439991|NCT00113269|4263664|B1|White||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4439992|NCT00113269|4263660|B5||Male|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4439993|NCT00113269|4263661|B4||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4439994|NCT00113269|4263662|B3||Male|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4439995|NCT00113269|4263663|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4439996|NCT00113269|4263664|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4439997|NCT00113269|4263660|B5||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4439998|NCT00113269|4263661|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4439999|NCT00113269|4263662|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4440000|NCT00113269|4263663|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4440001|NCT00113269|4263664|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4440002|NCT00113269|4263660|B5|>=65 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|52|52.0||||||
4440003|NCT00113269|4263661|B4|>=65 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|25|25.0||||||
4440004|NCT00113269|4263662|B3|>=65 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|18|18.0||||||
4440005|NCT00113269|4263663|B2|>=65 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|5|5.0||||||
4440006|NCT00113269|4263664|B1|>=65 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|4|4.0||||||
4440007|NCT00113269|4263660|B5|Between 18 and 64 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|421|421.0||||||
4440008|NCT00113269|4263661|B4|Between 18 and 64 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|146|146.0||||||
4440009|NCT00113269|4263662|B3|Between 18 and 64 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|145|145.0||||||
4440010|NCT00113269|4263663|B2|Between 18 and 64 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|64|64.0||||||
4440011|NCT00113269|4263664|B1|Between 18 and 64 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|66|66.0||||||
4440012|NCT00113269|4263660|B5|<18 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|1|1.0||||||
4440013|NCT00113269|4263661|B4|<18 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|0|0.0||||||
4440014|NCT00113269|4263662|B3|<18 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|1|1.0||||||
4440015|NCT00113269|4263663|B2|<18 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|0|0.0||||||
4440016|NCT00113269|4263664|B1|<18 years||Age, Customized|One patient turned 18 years of age during the study.|Participants|Number|0|0.0||||||
4440017|NCT00113230|4263717|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4440018|NCT00113230|4263717|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4440019|NCT00113230|4263717|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4440020|NCT00113230|4263717|B1|||Age||years|Mean|51|51.0|Full Range|||34.0|68.0|
4440021|NCT00113217|4263721|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4440022|NCT00113217|4263721|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4440023|NCT00113217|4263721|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4440024|NCT00113217|4263721|B1|||Age||years|Median|61|61.0|Full Range|||35.0|83.0|
4440025|NCT00113087|4263725|B3|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4440026|NCT00113087|4263726|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4440027|NCT00113087|4263727|B1|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4440028|NCT00113087|4263725|B3|United States||Region of Enrollment||participants|Number|209|209.0||||||
4440029|NCT00113087|4263726|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
4440030|NCT00113087|4263727|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
4440031|NCT00113087|4263725|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4440032|NCT00113087|4263726|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4440033|NCT00113087|4263727|B1|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4440034|NCT00113087|4263725|B3|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4440035|NCT00113087|4263726|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4440036|NCT00113087|4263727|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4440037|NCT00113087|4263725|B3|Black/African-American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4440038|NCT00113087|4263726|B2|Black/African-American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4440039|NCT00113087|4263727|B1|Black/African-American||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4440040|NCT00113087|4263725|B3|White||Race/Ethnicity, Customized||participants|Number|185|185.0||||||
4440041|NCT00113087|4263726|B2|White||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4440042|NCT00113087|4263727|B1|White||Race/Ethnicity, Customized||participants|Number|96|96.0||||||
4440043|NCT00113087|4263725|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4440044|NCT00113087|4263726|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4440045|NCT00113087|4263727|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4440046|NCT00113087|4263725|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4440047|NCT00113087|4263726|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4440048|NCT00113087|4263727|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4440049|NCT00113087|4263725|B3|||Age||days|Mean|20.4|20.4|Standard Deviation|9.0|9.0|||
4440050|NCT00113087|4263726|B2|||Age||days|Mean|20.7|20.7|Standard Deviation|9.1|9.1|||
4440051|NCT00113087|4263727|B1|||Age||days|Mean|20.1|20.1|Standard Deviation|8.9|8.9|||
4440052|NCT00113087|4263725|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4440053|NCT00113087|4263726|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4440054|NCT00113087|4263727|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4440055|NCT00113087|4263725|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4440056|NCT00113087|4263726|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4440057|NCT00113087|4263727|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4440058|NCT00113087|4263725|B3||<=18 years|Age||Participants|Count of Participants|230|230.0||||||
4440059|NCT00113087|4263726|B2||<=18 years|Age||Participants|Count of Participants|115|115.0||||||
4440060|NCT00113087|4263727|B1||<=18 years|Age||Participants|Count of Participants|115|115.0||||||
4440061|NCT00113022|4263790|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4440062|NCT00113022|4263791|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4440063|NCT00113022|4263792|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4440064|NCT00113022|4263790|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4440065|NCT00113022|4263791|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4440066|NCT00113022|4263792|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4440067|NCT00113022|4263790|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4440068|NCT00113022|4263791|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4440069|NCT00113022|4263792|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4440070|NCT00113022|4263790|B3|||Age||years|Mean|39.00|39.0|Standard Deviation|10.11|10.11|||
4440071|NCT00113022|4263791|B2|||Age||years|Mean|40.00|40.0|Standard Deviation|13.69|13.69|||
4440072|NCT00113022|4263792|B1|||Age||years|Mean|38.20|38.2|Standard Deviation|7.89|7.89|||
4440073|NCT00113022|4263790|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4440074|NCT00113022|4263791|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4440075|NCT00113022|4263792|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4440076|NCT00113022|4263790|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4440077|NCT00113022|4263791|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4440078|NCT00113022|4263792|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4440079|NCT00113022|4263790|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440080|NCT00113022|4263791|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440081|NCT00113022|4263792|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440082|NCT00112957|4263799|B1|||Body mass index||kg/m^2|Mean|29.5|29.5|Standard Deviation|4.7|4.7|||
4440083|NCT00112957|4263799|B1||100|Karnofsky Performance Status|Functional impairment is as follows: 100=normal, no complaints; 90=able to carry on normal activities with minor signs/symptoms of disease; 80=normal activity with effort; 70=care for self, unable to carry on normal activity or to do active work; 60=requires occasional assistance, but able to care for most needs; 50=requires considerable assistance & frequent medical care; 40=disabled, requires special care and assistance; 30=severly disabled, hospitalization indicated though death nonimminent; 20=very sick, hospitalization necessary, active supportive treatment necessary; 10=moribund; 0=dead|Participants|Count of Participants|16|16.0||||||
4440084|NCT00112957|4263799|B1||90|Karnofsky Performance Status|Functional impairment is as follows: 100=normal, no complaints; 90=able to carry on normal activities with minor signs/symptoms of disease; 80=normal activity with effort; 70=care for self, unable to carry on normal activity or to do active work; 60=requires occasional assistance, but able to care for most needs; 50=requires considerable assistance & frequent medical care; 40=disabled, requires special care and assistance; 30=severly disabled, hospitalization indicated though death nonimminent; 20=very sick, hospitalization necessary, active supportive treatment necessary; 10=moribund; 0=dead|Participants|Count of Participants|3|3.0||||||
4440085|NCT00112957|4263799|B1||80|Karnofsky Performance Status|Functional impairment is as follows: 100=normal, no complaints; 90=able to carry on normal activities with minor signs/symptoms of disease; 80=normal activity with effort; 70=care for self, unable to carry on normal activity or to do active work; 60=requires occasional assistance, but able to care for most needs; 50=requires considerable assistance & frequent medical care; 40=disabled, requires special care and assistance; 30=severly disabled, hospitalization indicated though death nonimminent; 20=very sick, hospitalization necessary, active supportive treatment necessary; 10=moribund; 0=dead|Participants|Count of Participants|3|3.0||||||
4440086|NCT00112957|4263799|B1||70|Karnofsky Performance Status|Functional impairment is as follows: 100=normal, no complaints; 90=able to carry on normal activities with minor signs/symptoms of disease; 80=normal activity with effort; 70=care for self, unable to carry on normal activity or to do active work; 60=requires occasional assistance, but able to care for most needs; 50=requires considerable assistance & frequent medical care; 40=disabled, requires special care and assistance; 30=severly disabled, hospitalization indicated though death nonimminent; 20=very sick, hospitalization necessary, active supportive treatment necessary; 10=moribund; 0=dead|Participants|Count of Participants|1|1.0||||||
4440087|NCT00112957|4263799|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4440088|NCT00112957|4263799|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440089|NCT00112957|4263799|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440090|NCT00112957|4263799|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4440091|NCT00112957|4263799|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440092|NCT00112957|4263799|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440093|NCT00112957|4263799|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440094|NCT00112957|4263799|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440095|NCT00112957|4263799|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440096|NCT00112957|4263799|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4440097|NCT00112957|4263799|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440098|NCT00112957|4263799|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440099|NCT00112957|4263799|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4440100|NCT00112957|4263799|B1|||Age||years|Median|55|55.0|Full Range|||37.0|89.0|
4440101|NCT00112918|4263811|B4|Other||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4440102|NCT00112918|4263812|B3|Other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4440103|NCT00112918|4263813|B2|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4440104|NCT00112918|4263814|B1|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4440105|NCT00112918|4263811|B4|White||Race/Ethnicity, Customized||participants|Number|2399|2399.0||||||
4440106|NCT00112918|4263812|B3|White||Race/Ethnicity, Customized||participants|Number|795|795.0||||||
4440107|NCT00112918|4263813|B2|White||Race/Ethnicity, Customized||participants|Number|813|813.0||||||
4440108|NCT00112918|4263814|B1|White||Race/Ethnicity, Customized||participants|Number|791|791.0||||||
4440109|NCT00112918|4263811|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4440110|NCT00112918|4263812|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4440111|NCT00112918|4263813|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4440112|NCT00112918|4263814|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4440113|NCT00112918|4263811|B4|Asian||Race/Ethnicity, Customized||participants|Number|377|377.0||||||
4440114|NCT00112918|4263812|B3|Asian||Race/Ethnicity, Customized||participants|Number|123|123.0||||||
4440115|NCT00112918|4263813|B2|Asian||Race/Ethnicity, Customized||participants|Number|115|115.0||||||
4440116|NCT00112918|4263814|B1|Asian||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
4440117|NCT00112918|4263811|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4440118|NCT00112918|4263812|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4440119|NCT00112918|4263813|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4440120|NCT00112918|4263814|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4440121|NCT00112918|4263811|B4||Male|Sex: Female, Male||Participants|Count of Participants|1537|1537.0||||||
4440122|NCT00112918|4263812|B3||Male|Sex: Female, Male||Participants|Count of Participants|520|520.0||||||
4440123|NCT00112918|4263813|B2||Male|Sex: Female, Male||Participants|Count of Participants|487|487.0||||||
4440124|NCT00112918|4263814|B1||Male|Sex: Female, Male||Participants|Count of Participants|530|530.0||||||
4440125|NCT00112918|4263811|B4||Female|Sex: Female, Male||Participants|Count of Participants|1330|1330.0||||||
4440126|NCT00112918|4263812|B3||Female|Sex: Female, Male||Participants|Count of Participants|432|432.0||||||
4440127|NCT00112918|4263813|B2||Female|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
4440128|NCT00112918|4263814|B1||Female|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4440129|NCT00112918|4263811|B4|>=65||Age, Customized||participants|Number|832|832.0||||||
4440130|NCT00112918|4263812|B3|>=65||Age, Customized||participants|Number|296|296.0||||||
4440131|NCT00112918|4263813|B2|>=65||Age, Customized||participants|Number|261|261.0||||||
4440132|NCT00112918|4263814|B1|>=65||Age, Customized||participants|Number|275|275.0||||||
4440133|NCT00112918|4263811|B4|40-65||Age, Customized||participants|Number|1816|1816.0||||||
4440134|NCT00112918|4263812|B3|40-65||Age, Customized||participants|Number|588|588.0||||||
4440135|NCT00112918|4263813|B2|40-65||Age, Customized||participants|Number|625|625.0||||||
4440136|NCT00112918|4263814|B1|40-65||Age, Customized||participants|Number|603|603.0||||||
4440137|NCT00112918|4263811|B4|<40||Age, Customized||participants|Number|219|219.0||||||
4440138|NCT00112918|4263812|B3|<40||Age, Customized||participants|Number|68|68.0||||||
4440139|NCT00112918|4263813|B2|<40||Age, Customized||participants|Number|74|74.0||||||
4440140|NCT00112918|4263814|B1|<40||Age, Customized||participants|Number|77|77.0||||||
4440141|NCT00112905|4263839|B1||Male|Sex: Female, Male|Gender of eligible participants who began treatment.|Participants|Count of Participants|14|14.0||||||
4440142|NCT00112905|4263839|B1||Female|Sex: Female, Male|Gender of eligible participants who began treatment.|Participants|Count of Participants|8|8.0||||||
4440143|NCT00112905|4263839|B1|||Age||years|Median|66|66.0|Full Range|||37.0|81.0|
4440144|NCT00112866|4263846|B3|no||Prior Biopsy Only||participants|Number|29|29.0||||||
4440145|NCT00112866|4263847|B2|no||Prior Biopsy Only||participants|Number|15|15.0||||||
4440146|NCT00112866|4263848|B1|no||Prior Biopsy Only||participants|Number|14|14.0||||||
4440147|NCT00112866|4263846|B3|yes||Prior Biopsy Only||participants|Number|1|1.0||||||
4440148|NCT00112866|4263847|B2|yes||Prior Biopsy Only||participants|Number|0|0.0||||||
4440149|NCT00112866|4263848|B1|yes||Prior Biopsy Only||participants|Number|1|1.0||||||
4440150|NCT00112866|4263846|B3|||Prior Radiotherapy||participants|Number|30|30.0||||||
4440151|NCT00112866|4263847|B2|||Prior Radiotherapy||participants|Number|15|15.0||||||
4440152|NCT00112866|4263848|B1|||Prior Radiotherapy||participants|Number|15|15.0||||||
4440153|NCT00112866|4263846|B3|No||Prior Immunotherapy||participants|Number|27|27.0||||||
4440154|NCT00112866|4263847|B2|No||Prior Immunotherapy||participants|Number|13|13.0||||||
4440155|NCT00112866|4263848|B1|No||Prior Immunotherapy||participants|Number|14|14.0||||||
4440156|NCT00112866|4263846|B3|Yes||Prior Immunotherapy||participants|Number|3|3.0||||||
4440157|NCT00112866|4263847|B2|Yes||Prior Immunotherapy||participants|Number|2|2.0||||||
4440158|NCT00112866|4263848|B1|Yes||Prior Immunotherapy||participants|Number|1|1.0||||||
4440159|NCT00112866|4263846|B3|||Prior Chemotherapy||participants|Number|30|30.0||||||
4440160|NCT00112866|4263847|B2|||Prior Chemotherapy||participants|Number|15|15.0||||||
4440161|NCT00112866|4263848|B1|||Prior Chemotherapy||participants|Number|15|15.0||||||
4440162|NCT00112866|4263846|B3|||Histology - Glioblastoma||participants|Number|30|30.0||||||
4440163|NCT00112866|4263847|B2|||Histology - Glioblastoma||participants|Number|15|15.0||||||
4440164|NCT00112866|4263848|B1|||Histology - Glioblastoma||participants|Number|15|15.0||||||
4440165|NCT00112866|4263846|B3|White||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4440166|NCT00112866|4263847|B2|White||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4440167|NCT00112866|4263848|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4440168|NCT00112866|4263846|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4440169|NCT00112866|4263847|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4440170|NCT00112866|4263848|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4440171|NCT00112866|4263846|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4440172|NCT00112866|4263847|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4440173|NCT00112866|4263848|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4440174|NCT00112866|4263846|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4440175|NCT00112866|4263847|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4440176|NCT00112866|4263848|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4440177|NCT00112866|4263846|B3|||Age||years|Median|55|55.0|Full Range|||42.0|68.0|
4440178|NCT00112866|4263847|B2|||Age||years|Median|56|56.0|Full Range|||42.0|68.0|
4440179|NCT00112866|4263848|B1|||Age||years|Median|51|51.0|Full Range|||42.0|63.0|
4440180|NCT00112840|4263868|B4|United States||Region of Enrollment||participants|Number|60|60.0||||||
4440181|NCT00112840|4263869|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4440182|NCT00112840|4263870|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4440183|NCT00112840|4263871|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4440184|NCT00112840|4263868|B4||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4440185|NCT00112840|4263869|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4440186|NCT00112840|4263870|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4440187|NCT00112840|4263871|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4440188|NCT00112840|4263868|B4||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4440189|NCT00112840|4263869|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4440190|NCT00112840|4263870|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4440191|NCT00112840|4263871|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4440192|NCT00112840|4263868|B4|||Age||years|Median|62.5|62.5|Full Range|||38.0|82.0|
4440193|NCT00112840|4263869|B3|||Age||years|Median|62|62.0|Full Range|||38.0|82.0|
4440194|NCT00112840|4263870|B2|||Age||years|Median|66|66.0|Full Range|||61.0|77.0|
4440195|NCT00112840|4263871|B1|||Age||years|Median|61|61.0|Full Range|||44.0|75.0|
4440196|NCT00112736|4263889|B4|glioblastoma||Histology||participants|Number|49|49.0||||||
4440197|NCT00112736|4263890|B3|glioblastoma||Histology||participants|Number|43|43.0||||||
4440198|NCT00112736|4263891|B2|glioblastoma||Histology||participants|Number|0|0.0||||||
4440199|NCT00112736|4263892|B1|glioblastoma||Histology||participants|Number|6|6.0||||||
4440200|NCT00112736|4263889|B4|anaplastic glioma||Histology||participants|Number|19|19.0||||||
4440201|NCT00112736|4263890|B3|anaplastic glioma||Histology||participants|Number|0|0.0||||||
4440202|NCT00112736|4263891|B2|anaplastic glioma||Histology||participants|Number|16|16.0||||||
4440203|NCT00112736|4263892|B1|anaplastic glioma||Histology||participants|Number|3|3.0||||||
4440204|NCT00112736|4263889|B4|||Prior Chemotherapy treatments||treatments|Median|1|1.0|Full Range|||0.0|3.0|
4440205|NCT00112736|4263890|B3|||Prior Chemotherapy treatments||treatments|Median|1|1.0|Full Range|||0.0|3.0|
4440206|NCT00112736|4263891|B2|||Prior Chemotherapy treatments||treatments|Median|1|1.0|Full Range|||1.0|3.0|
4440207|NCT00112736|4263892|B1|||Prior Chemotherapy treatments||treatments|Median|2|2.0|Full Range|||0.0|3.0|
4440208|NCT00112736|4263889|B4|||Karnofsky Performance Scale (KPS)|"The KPS scores range from 0 (lowest score) to 100 (highest score).~The higher the score the better able to carry out daily activities~100-80: able to carry on normal activity and to work; No special care~70-50: Unable to work; able to live at home and care for most personal needs; varying amount of assistance needed~40-10: unable to care for self, requires equivalent of institutional or hospital care; diseases may be progressing rapidly~0: dead"|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4440259|NCT00112463|4263960|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440209|NCT00112736|4263890|B3|||Karnofsky Performance Scale (KPS)|"The KPS scores range from 0 (lowest score) to 100 (highest score).~The higher the score the better able to carry out daily activities~100-80: able to carry on normal activity and to work; No special care~70-50: Unable to work; able to live at home and care for most personal needs; varying amount of assistance needed~40-10: unable to care for self, requires equivalent of institutional or hospital care; diseases may be progressing rapidly~0: dead"|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4440210|NCT00112736|4263891|B2|||Karnofsky Performance Scale (KPS)|"The KPS scores range from 0 (lowest score) to 100 (highest score).~The higher the score the better able to carry out daily activities~100-80: able to carry on normal activity and to work; No special care~70-50: Unable to work; able to live at home and care for most personal needs; varying amount of assistance needed~40-10: unable to care for self, requires equivalent of institutional or hospital care; diseases may be progressing rapidly~0: dead"|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4440211|NCT00112736|4263892|B1|||Karnofsky Performance Scale (KPS)|"The KPS scores range from 0 (lowest score) to 100 (highest score).~The higher the score the better able to carry out daily activities~100-80: able to carry on normal activity and to work; No special care~70-50: Unable to work; able to live at home and care for most personal needs; varying amount of assistance needed~40-10: unable to care for self, requires equivalent of institutional or hospital care; diseases may be progressing rapidly~0: dead"|units on a scale|Median|90|90.0|Full Range|||70.0|100.0|
4440212|NCT00112736|4263889|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4440213|NCT00112736|4263890|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4440214|NCT00112736|4263891|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4440215|NCT00112736|4263892|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4440216|NCT00112736|4263889|B4||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4440217|NCT00112736|4263890|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4440218|NCT00112736|4263891|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4440219|NCT00112736|4263892|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4440220|NCT00112736|4263889|B4|||Age||years|Median|51|51.0|Full Range|||20.0|74.0|
4440221|NCT00112736|4263890|B3|||Age||years|Median|50|50.0|Full Range|||20.0|69.0|
4440222|NCT00112736|4263891|B2|||Age||years|Median|47|47.0|Full Range|||29.0|72.0|
4440223|NCT00112736|4263892|B1|||Age||years|Median|57|57.0|Full Range|||33.0|74.0|
4440224|NCT00112723|4263906|B1|T/NK cell NHL||Diagnosis||patients|Number|7|7.0||||||
4440225|NCT00112723|4263906|B1|Mantle cell lymphoma||Diagnosis||patients|Number|7|7.0||||||
4440226|NCT00112723|4263906|B1|intermediate grade B-NHL||Diagnosis||patients|Number|17|17.0||||||
4440227|NCT00112723|4263906|B1|Indolent B-cell||Diagnosis||patients|Number|15|15.0||||||
4440228|NCT00112723|4263906|B1|2 (Ambulatory capable of all selfcare)||Eastern Cooperative Oncology Group (ECOG) Performance status||patients|Number|4|4.0||||||
4440229|NCT00112723|4263906|B1|1 (Restricted in physically strenuous activity)||Eastern Cooperative Oncology Group (ECOG) Performance status||patients|Number|34|34.0||||||
4440230|NCT00112723|4263906|B1|0 (Fully active)||Eastern Cooperative Oncology Group (ECOG) Performance status||patients|Number|8|8.0||||||
4440231|NCT00112723|4263906|B1|Canada||Region of Enrollment||patients|Number|1|1.0||||||
4440232|NCT00112723|4263906|B1|United States||Region of Enrollment||patients|Number|45|45.0||||||
4440233|NCT00112723|4263906|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4440234|NCT00112723|4263906|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4440235|NCT00112723|4263906|B1|||Age||years|Median|66|66.0|Full Range|||34.0|84.0|
4440236|NCT00112671|4263933|B1|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4440237|NCT00112671|4263933|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4440238|NCT00112671|4263933|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4440239|NCT00112671|4263933|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4440240|NCT00112671|4263933|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4440241|NCT00112671|4263933|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440242|NCT00112671|4263933|B1|||Age||years|Median|67|67.0|Full Range|||40.0|85.0|
4440243|NCT00112593|4263941|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4440244|NCT00112593|4263941|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440245|NCT00112593|4263941|B1|||Age||years|Mean|43|43.0|Full Range|||33.0|53.0|
4440246|NCT00112489|4263950|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440247|NCT00112489|4263950|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4440248|NCT00112489|4263950|B1|Age at Study Entry||Age, Customized||years|Mean|65.5|65.5|Standard Deviation|11.6|11.6|||
4440249|NCT00112463|4263960|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4440250|NCT00112463|4263960|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4440251|NCT00112463|4263960|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440252|NCT00112463|4263960|B1||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4440253|NCT00112463|4263960|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4440254|NCT00112463|4263960|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440255|NCT00112463|4263960|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4440256|NCT00112463|4263960|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440257|NCT00112463|4263960|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440258|NCT00112463|4263960|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4440260|NCT00112463|4263960|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4440261|NCT00112463|4263960|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4440262|NCT00112463|4263960|B1|||Age||years|Median|59|59.0|Full Range|||19.0|88.0|
4440263|NCT00112463|4263960|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4440264|NCT00112463|4263960|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4440265|NCT00112463|4263960|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440266|NCT00112437|4263967|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440267|NCT00112437|4263968|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440268|NCT00112437|4263969|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440269|NCT00112437|4263970|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440270|NCT00112437|4263971|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440271|NCT00112437|4263972|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440272|NCT00112437|4263967|B6||Female|Sex: Female, Male||Participants|Count of Participants|399|399.0||||||
4440273|NCT00112437|4263968|B5||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4440274|NCT00112437|4263969|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4440275|NCT00112437|4263970|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4440276|NCT00112437|4263971|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4440277|NCT00112437|4263972|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4440278|NCT00112437|4263967|B6|||Age||years|Mean|64.2|64.2|Standard Deviation|7.8|7.8|||
4440279|NCT00112437|4263968|B5|||Age||years|Mean|64.5|64.5|Standard Deviation|8.1|8.1|||
4440280|NCT00112437|4263969|B4|||Age||years|Mean|62.9|62.9|Standard Deviation|7.4|7.4|||
4440281|NCT00112437|4263970|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|8.0|8.0|||
4440282|NCT00112437|4263971|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|7.3|7.3|||
4440283|NCT00112437|4263972|B1|||Age||years|Mean|65.9|65.9|Standard Deviation|7.8|7.8|||
4440284|NCT00112385|4264275|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4440285|NCT00112385|4264276|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4440286|NCT00112385|4264277|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4440287|NCT00112385|4264275|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4440288|NCT00112385|4264276|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4440289|NCT00112385|4264277|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4440290|NCT00112385|4264275|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4440291|NCT00112385|4264276|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4440292|NCT00112385|4264277|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4440293|NCT00112385|4264275|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4440294|NCT00112385|4264276|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4440295|NCT00112385|4264277|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4440296|NCT00112385|4264275|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|13.39|13.39|||
4440297|NCT00112385|4264276|B2|||Age||years|Mean|44.2|44.2|Standard Deviation|11.9|11.9|||
4440298|NCT00112385|4264277|B1|||Age||years|Mean|43.36|43.36|Standard Deviation|14.8|14.8|||
4440299|NCT00112385|4264275|B3|>=65 years||Age||participants|Number|0|0.0||||||
4440300|NCT00112385|4264276|B2|>=65 years||Age||participants|Number|0|0.0||||||
4440301|NCT00112385|4264277|B1|>=65 years||Age||participants|Number|0|0.0||||||
4440302|NCT00112385|4264275|B3|Between 18 and 65 years||Age||participants|Number|16|16.0||||||
4440303|NCT00112385|4264276|B2|Between 18 and 65 years||Age||participants|Number|5|5.0||||||
4440304|NCT00112385|4264277|B1|Between 18 and 65 years||Age||participants|Number|11|11.0||||||
4440305|NCT00112385|4264275|B3|< 18 years||Age||participants|Number|0|0.0||||||
4440306|NCT00112385|4264276|B2|< 18 years||Age||participants|Number|0|0.0||||||
4440307|NCT00112385|4264277|B1|< 18 years||Age||participants|Number|0|0.0||||||
4440308|NCT00112359|4264366|B3|Disease severity: FEV1 <= 50% predicted||Disease severity based on forced expiratory volume in 1 second (FEV1) % predicted|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|participants|Number|60|60.0||||||
4440309|NCT00112359|4264367|B2|Disease severity: FEV1 <= 50% predicted||Disease severity based on forced expiratory volume in 1 second (FEV1) % predicted|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|participants|Number|30|30.0||||||
4440310|NCT00112359|4264368|B1|Disease severity: FEV1 <= 50% predicted||Disease severity based on forced expiratory volume in 1 second (FEV1) % predicted|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|participants|Number|30|30.0||||||
4440411|NCT00112151|4264435|B6|||Age||years|Mean|66.6|66.6|Standard Deviation|5.4|5.4|||
4440412|NCT00112151|4264436|B5|||Age||years|Mean|64.7|64.7|Standard Deviation|4.5|4.5|||
4440413|NCT00112151|4264437|B4|||Age||years|Mean|65.3|65.3|Standard Deviation|5.5|5.5|||
4440311|NCT00112359|4264366|B3|Disease severity: FEV1 > 50% predicted||Disease severity based on forced expiratory volume in 1 second (FEV1) % predicted|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|participants|Number|104|104.0||||||
4440312|NCT00112359|4264367|B2|Disease severity: FEV1 > 50% predicted||Disease severity based on forced expiratory volume in 1 second (FEV1) % predicted|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|participants|Number|50|50.0||||||
4440313|NCT00112359|4264368|B1|Disease severity: FEV1 > 50% predicted||Disease severity based on forced expiratory volume in 1 second (FEV1) % predicted|FEV1 percent predicted is a normalized value of FEV1 calculated using the Knudson equation and based upon participant age, gender, and height. This baseline measure indicates the number of subjects with FEV1 greater than 50% and less than or equal to 50% of the predicted value based on age, gender, and height at screening.|participants|Number|54|54.0||||||
4440314|NCT00112359|4264366|B3|Australia||Region of Enrollment||participants|Number|39|39.0||||||
4440315|NCT00112359|4264367|B2|Australia||Region of Enrollment||participants|Number|18|18.0||||||
4440316|NCT00112359|4264368|B1|Australia||Region of Enrollment||participants|Number|21|21.0||||||
4440317|NCT00112359|4264366|B3|North America||Region of Enrollment||participants|Number|125|125.0||||||
4440318|NCT00112359|4264367|B2|North America||Region of Enrollment||participants|Number|62|62.0||||||
4440319|NCT00112359|4264368|B1|North America||Region of Enrollment||participants|Number|63|63.0||||||
4440320|NCT00112359|4264366|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4440321|NCT00112359|4264367|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4440322|NCT00112359|4264368|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4440323|NCT00112359|4264366|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4440324|NCT00112359|4264367|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4440325|NCT00112359|4264368|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4440326|NCT00112359|4264366|B3|||Age||years|Mean|29.6|29.6|Standard Deviation|14.0|14.0|||
4440327|NCT00112359|4264367|B2|||Age||years|Mean|27.4|27.4|Standard Deviation|12.8|12.8|||
4440328|NCT00112359|4264368|B1|||Age||years|Mean|31.7|31.7|Standard Deviation|14.8|14.8|||
4440329|NCT00112359|4264366|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4440330|NCT00112359|4264367|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4440331|NCT00112359|4264368|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4440332|NCT00112359|4264366|B3||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4440333|NCT00112359|4264367|B2||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4440334|NCT00112359|4264368|B1||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4440335|NCT00112359|4264366|B3||<=18 years|Age||Participants|Count of Participants|37|37.0||||||
4440336|NCT00112359|4264367|B2||<=18 years|Age||Participants|Count of Participants|21|21.0||||||
4440337|NCT00112359|4264368|B1||<=18 years|Age||Participants|Count of Participants|16|16.0||||||
4440338|NCT00112294|4264393|B3|||Weight|3 participants in the C/T/C group did not have values for this measure. 1 participant in the C/T group did not have a value for this measure.|kg|Mean|75.1|75.1|Standard Deviation|17.6|17.6|||
4440339|NCT00112294|4264394|B2|||Weight|3 participants in the C/T/C group did not have values for this measure. 1 participant in the C/T group did not have a value for this measure.|kg|Mean|75.3|75.3|Standard Deviation|18.1|18.1|||
4440340|NCT00112294|4264395|B1|||Weight|3 participants in the C/T/C group did not have values for this measure. 1 participant in the C/T group did not have a value for this measure.|kg|Mean|75.0|75.0|Standard Deviation|17.1|17.1|||
4440341|NCT00112294|4264393|B3|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|4|4.0||||||
4440342|NCT00112294|4264394|B2|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|1|1.0||||||
4440343|NCT00112294|4264395|B1|Missing||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|3|3.0||||||
4440344|NCT00112294|4264393|B3|5=dead||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|0|0.0||||||
4440345|NCT00112294|4264394|B2|5=dead||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|0|0.0||||||
4440414|NCT00112151|4264438|B3|||Age||years|Mean|64.3|64.3|Standard Deviation|4.6|4.6|||
4440346|NCT00112294|4264395|B1|5=dead||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|0|0.0||||||
4440347|NCT00112294|4264393|B3|4=completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|0|0.0||||||
4440348|NCT00112294|4264394|B2|4=completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|0|0.0||||||
4440349|NCT00112294|4264395|B1|4=completely disabled||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|0|0.0||||||
4440350|NCT00112294|4264393|B3|3=capable of only limited self care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|1|1.0||||||
4440351|NCT00112294|4264394|B2|3=capable of only limited self care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|1|1.0||||||
4440352|NCT00112294|4264395|B1|3=capable of only limited self care||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|0|0.0||||||
4440353|NCT00112294|4264393|B3|2=ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|6|6.0||||||
4440354|NCT00112294|4264394|B2|2=ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|2|2.0||||||
4440355|NCT00112294|4264395|B1|2=ambulatory but unable to work||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|4|4.0||||||
4440356|NCT00112294|4264393|B3|1=restricted physically strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|441|441.0||||||
4440357|NCT00112294|4264394|B2|1=restricted physically strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|220|220.0||||||
4440358|NCT00112294|4264395|B1|1=restricted physically strenuous activity||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|221|221.0||||||
4440359|NCT00112294|4264393|B3|0=fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|224|224.0||||||
4440360|NCT00112294|4264394|B2|0=fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|114|114.0||||||
4440415|NCT00112151|4264439|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|4.5|4.5|||
4440416|NCT00112151|4264440|B1|||Age||years|Mean|67.3|67.3|Standard Deviation|7.6|7.6|||
4440417|NCT00112151|4264434|B7||>=65 years|Age||Participants|Count of Participants|85|85.0||||||
4440361|NCT00112294|4264395|B1|0=fully active||Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)|The ECOG PS is used to assess disease severity. A score of 0 is fully active; 1 is restricted physically strenuous activity; 2 is ambulatory but unable to work; 3 is capable of only limited self care; 4 is completely disabled; 5 is dead. Missing includes participants whose pre-treatment PS > 14 days prior to first dose.|Participants|Number|110|110.0||||||
4440362|NCT00112294|4264393|B3|Other race||Race/Ethnicity, Customized|'Other race' includes 1 American Indian or Alaska native and 3 native Hawaiian or other pacific islander.|Participants|Number|15|15.0||||||
4440363|NCT00112294|4264394|B2|Other race||Race/Ethnicity, Customized|'Other race' includes 1 American Indian or Alaska native and 3 native Hawaiian or other pacific islander.|Participants|Number|4|4.0||||||
4440364|NCT00112294|4264395|B1|Other race||Race/Ethnicity, Customized|'Other race' includes 1 American Indian or Alaska native and 3 native Hawaiian or other pacific islander.|Participants|Number|11|11.0||||||
4440365|NCT00112294|4264393|B3|White||Race/Ethnicity, Customized|'Other race' includes 1 American Indian or Alaska native and 3 native Hawaiian or other pacific islander.|Participants|Number|596|596.0||||||
4440366|NCT00112294|4264394|B2|White||Race/Ethnicity, Customized|'Other race' includes 1 American Indian or Alaska native and 3 native Hawaiian or other pacific islander.|Participants|Number|300|300.0||||||
4440367|NCT00112294|4264395|B1|White||Race/Ethnicity, Customized|'Other race' includes 1 American Indian or Alaska native and 3 native Hawaiian or other pacific islander.|Participants|Number|296|296.0||||||
4440368|NCT00112294|4264393|B3|Black||Race/Ethnicity, Customized|'Other race' includes 1 American Indian or Alaska native and 3 native Hawaiian or other pacific islander.|Participants|Number|49|49.0||||||
4440369|NCT00112294|4264394|B2|Black||Race/Ethnicity, Customized|'Other race' includes 1 American Indian or Alaska native and 3 native Hawaiian or other pacific islander.|Participants|Number|24|24.0||||||
4440370|NCT00112294|4264395|B1|Black||Race/Ethnicity, Customized|'Other race' includes 1 American Indian or Alaska native and 3 native Hawaiian or other pacific islander.|Participants|Number|25|25.0||||||
4440371|NCT00112294|4264393|B3|Asian||Race/Ethnicity, Customized|'Other race' includes 1 American Indian or Alaska native and 3 native Hawaiian or other pacific islander.|Participants|Number|16|16.0||||||
4440372|NCT00112294|4264394|B2|Asian||Race/Ethnicity, Customized|'Other race' includes 1 American Indian or Alaska native and 3 native Hawaiian or other pacific islander.|Participants|Number|10|10.0||||||
4440373|NCT00112294|4264395|B1|Asian||Race/Ethnicity, Customized|'Other race' includes 1 American Indian or Alaska native and 3 native Hawaiian or other pacific islander.|Participants|Number|6|6.0||||||
4440374|NCT00112294|4264393|B3||Male|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
4440375|NCT00112294|4264394|B2||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4440376|NCT00112294|4264395|B1||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4440377|NCT00112294|4264393|B3||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4440378|NCT00112294|4264394|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4440379|NCT00112294|4264395|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4440380|NCT00112294|4264393|B3|>= 65 years||Age, Customized||participants|Number|340|340.0||||||
4440381|NCT00112294|4264394|B2|>= 65 years||Age, Customized||participants|Number|173|173.0||||||
4440382|NCT00112294|4264395|B1|>= 65 years||Age, Customized||participants|Number|167|167.0||||||
4440383|NCT00112294|4264393|B3|<65 years||Age, Customized||participants|Number|336|336.0||||||
4440384|NCT00112294|4264394|B2|<65 years||Age, Customized||participants|Number|165|165.0||||||
4440385|NCT00112294|4264395|B1|<65 years||Age, Customized||participants|Number|171|171.0||||||
4440386|NCT00112294|4264393|B3|||Age||years|Mean|64.0|64.0|Standard Deviation|10.2|10.2|||
4440387|NCT00112294|4264394|B2|||Age||years|Mean|63.9|63.9|Standard Deviation|10.3|10.3|||
4440388|NCT00112294|4264395|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|10.0|10.0|||
4440389|NCT00112151|4264434|B7|United States||Region of Enrollment||participants|Number|167|167.0||||||
4440390|NCT00112151|4264435|B6|United States||Region of Enrollment||participants|Number|28|28.0||||||
4440391|NCT00112151|4264436|B5|United States||Region of Enrollment||participants|Number|28|28.0||||||
4440392|NCT00112151|4264437|B4|United States||Region of Enrollment||participants|Number|27|27.0||||||
4440393|NCT00112151|4264438|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4440394|NCT00112151|4264439|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4440395|NCT00112151|4264440|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4440396|NCT00112151|4264434|B7||Male|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4440397|NCT00112151|4264435|B6||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4440398|NCT00112151|4264436|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4440399|NCT00112151|4264437|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4440400|NCT00112151|4264438|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4440401|NCT00112151|4264439|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4440402|NCT00112151|4264440|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4440403|NCT00112151|4264434|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440404|NCT00112151|4264435|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440405|NCT00112151|4264436|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440406|NCT00112151|4264437|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440407|NCT00112151|4264438|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440408|NCT00112151|4264439|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440409|NCT00112151|4264440|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440410|NCT00112151|4264434|B7|||Age||years|Mean|65.7|65.7|Standard Deviation|5.5|5.5|||
4440418|NCT00112151|4264435|B6||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4440419|NCT00112151|4264436|B5||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4440420|NCT00112151|4264437|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4440421|NCT00112151|4264438|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4440422|NCT00112151|4264439|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4440423|NCT00112151|4264440|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4440424|NCT00112151|4264434|B7||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4440425|NCT00112151|4264435|B6||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4440426|NCT00112151|4264436|B5||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4440427|NCT00112151|4264437|B4||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4440428|NCT00112151|4264438|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4440429|NCT00112151|4264439|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4440430|NCT00112151|4264440|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4440431|NCT00112151|4264434|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440432|NCT00112151|4264435|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440433|NCT00112151|4264436|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440434|NCT00112151|4264437|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440435|NCT00112151|4264438|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440436|NCT00112151|4264439|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440437|NCT00112151|4264440|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440438|NCT00112112|4264474|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4440439|NCT00112112|4264475|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4440440|NCT00112112|4264476|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4440441|NCT00112112|4264474|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4440442|NCT00112112|4264475|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4440443|NCT00112112|4264476|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4440444|NCT00112112|4264474|B3|||Age||Years|Mean|12.2|12.2|Standard Deviation|3.8|3.8|||
4440445|NCT00112112|4264475|B2|||Age||Years|Mean|12.2|12.2|Standard Deviation|3.9|3.9|||
4440446|NCT00112112|4264476|B1|||Age||Years|Mean|12.2|12.2|Standard Deviation|3.8|3.8|||
4440447|NCT00112047|4264617|B3|||HIV-1 RNA||Log10 c/mL|Mean|5.01|5.01|Standard Deviation|0.52|0.52|||
4440448|NCT00112047|4264618|B2|||HIV-1 RNA||Log10 c/mL|Mean|5.00|5.0|Standard Deviation|0.51|0.51|||
4440449|NCT00112047|4264619|B1|||HIV-1 RNA||Log10 c/mL|Mean|5.03|5.03|Standard Deviation|0.54|0.54|||
4440450|NCT00112047|4264617|B3|||CD4 cell count||Cells/mm^3|Mean|245|245.0|Standard Deviation|164.2|164.2|||
4440451|NCT00112047|4264618|B2|||CD4 cell count||Cells/mm^3|Mean|245|245.0|Standard Deviation|156.6|156.6|||
4440452|NCT00112047|4264619|B1|||CD4 cell count||Cells/mm^3|Mean|246|246.0|Standard Deviation|171.9|171.9|||
4440453|NCT00112047|4264617|B3|AIDS||HIV Status||Participants|Number|206|206.0||||||
4440454|NCT00112047|4264618|B2|AIDS||HIV Status||Participants|Number|101|101.0||||||
4440455|NCT00112047|4264619|B1|AIDS||HIV Status||Participants|Number|105|105.0||||||
4440456|NCT00112047|4264617|B3|Symptomatic HIV Infection||HIV Status||Participants|Number|244|244.0||||||
4440457|NCT00112047|4264618|B2|Symptomatic HIV Infection||HIV Status||Participants|Number|127|127.0||||||
4440458|NCT00112047|4264619|B1|Symptomatic HIV Infection||HIV Status||Participants|Number|117|117.0||||||
4440459|NCT00112047|4264617|B3|Asymptomatic||HIV Status||Participants|Number|59|59.0||||||
4440460|NCT00112047|4264618|B2|Asymptomatic||HIV Status||Participants|Number|26|26.0||||||
4440461|NCT00112047|4264619|B1|Asymptomatic||HIV Status||Participants|Number|33|33.0||||||
4440462|NCT00112047|4264617|B3|Other||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4440463|NCT00112047|4264618|B2|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4440464|NCT00112047|4264619|B1|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4440465|NCT00112047|4264617|B3|Not allowed to report||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4440466|NCT00112047|4264618|B2|Not allowed to report||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4440467|NCT00112047|4264619|B1|Not allowed to report||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4440468|NCT00112047|4264617|B3|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4440469|NCT00112047|4264618|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4440470|NCT00112047|4264619|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4440471|NCT00112047|4264617|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|79|79.0||||||
4440472|NCT00112047|4264618|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4440473|NCT00112047|4264619|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4440474|NCT00112047|4264617|B3|Black||Race/Ethnicity, Customized||Participants|Number|116|116.0||||||
4440475|NCT00112047|4264618|B2|Black||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4440476|NCT00112047|4264619|B1|Black||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
4440477|NCT00112047|4264617|B3|White||Race/Ethnicity, Customized||Participants|Number|298|298.0||||||
4440478|NCT00112047|4264618|B2|White||Race/Ethnicity, Customized||Participants|Number|156|156.0||||||
4440479|NCT00112047|4264619|B1|White||Race/Ethnicity, Customized||Participants|Number|142|142.0||||||
4440480|NCT00112047|4264617|B3||Male|Sex: Female, Male||Participants|Count of Participants|440|440.0||||||
4440481|NCT00112047|4264618|B2||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4440482|NCT00112047|4264619|B1||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4440483|NCT00112047|4264617|B3||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4440484|NCT00112047|4264618|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4440485|NCT00112047|4264619|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4440486|NCT00112047|4264617|B3|||Age||years|Mean|38|38.0|Standard Deviation|9.5|9.5|||
4440487|NCT00112047|4264618|B2|||Age||years|Mean|38|38.0|Standard Deviation|9.0|9.0|||
4440488|NCT00112047|4264619|B1|||Age||years|Mean|38|38.0|Standard Deviation|9.9|9.9|||
4440489|NCT00111917|4264718|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4440490|NCT00111917|4264719|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4440491|NCT00111917|4264720|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4440492|NCT00111917|4264718|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4440493|NCT00111917|4264719|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4440494|NCT00111917|4264720|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4440495|NCT00111917|4264718|B3|||Age|patient reported age|years|Mean|56.5|56.5|Full Range|||46.0|74.0|
4440496|NCT00111917|4264719|B2|||Age|patient reported age|years|Mean|69.75|69.75|Full Range|||67.0|74.0|
4440497|NCT00111917|4264720|B1|||Age|patient reported age|years|Mean|54.63|54.63|Full Range|||46.0|65.0|
4440498|NCT00111839|4264733|B4||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4440499|NCT00111839|4264734|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4440500|NCT00111839|4264735|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4440501|NCT00111839|4264736|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4440502|NCT00111839|4264733|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4440503|NCT00111839|4264734|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4440504|NCT00111839|4264735|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4440505|NCT00111839|4264736|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4440506|NCT00111839|4264733|B4|||Age||years|Median|62|62.0|Full Range|||37.0|83.0|
4440507|NCT00111839|4264734|B3|||Age||years|Median|63|63.0|Full Range|||46.0|78.0|
4440508|NCT00111839|4264735|B2|||Age||years|Median|62|62.0|Full Range|||48.0|81.0|
4440509|NCT00111839|4264736|B1|||Age||years|Median|61|61.0|Full Range|||37.0|83.0|
4440510|NCT00111813|4264758|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4440511|NCT00111813|4264758|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4440512|NCT00111813|4264758|B1|||Age||years|Mean|60.6|60.6|Standard Deviation|8.1|8.1|||
4440513|NCT00111800|4264796|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440514|NCT00111800|4264797|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440515|NCT00111800|4264798|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440516|NCT00111800|4264799|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440517|NCT00111800|4264800|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440518|NCT00111800|4264801|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440519|NCT00111800|4264802|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440520|NCT00111800|4264796|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4440521|NCT00111800|4264797|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440522|NCT00111800|4264798|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440523|NCT00111800|4264799|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4440524|NCT00111800|4264800|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440525|NCT00111800|4264801|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440526|NCT00111800|4264802|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440527|NCT00111800|4264796|B7||White|Race (NIH/OMB)||Participants|Count of Participants|340|340.0||||||
4440528|NCT00111800|4264797|B6||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4440529|NCT00111800|4264798|B5||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4440530|NCT00111800|4264799|B4||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4440531|NCT00111800|4264800|B3||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4440532|NCT00111800|4264801|B2||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4440533|NCT00111800|4264802|B1||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4440534|NCT00111800|4264796|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4440535|NCT00111800|4264797|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4440536|NCT00111800|4264798|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4440537|NCT00111800|4264799|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4440538|NCT00111800|4264800|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4440539|NCT00111800|4264801|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4440540|NCT00111800|4264802|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4440541|NCT00111800|4264796|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4440542|NCT00111800|4264797|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440543|NCT00111800|4264798|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440544|NCT00111800|4264799|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440545|NCT00111800|4264800|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440546|NCT00111800|4264801|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4440547|NCT00111800|4264802|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440548|NCT00111800|4264796|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4440549|NCT00111800|4264797|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4440550|NCT00111800|4264798|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4440551|NCT00111800|4264799|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4440552|NCT00111800|4264800|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4440553|NCT00111800|4264801|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440554|NCT00111800|4264802|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4440555|NCT00111800|4264796|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440556|NCT00111800|4264797|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440557|NCT00111800|4264798|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440558|NCT00111800|4264799|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440559|NCT00111800|4264800|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440560|NCT00111800|4264801|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440561|NCT00111800|4264802|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440562|NCT00111800|4264796|B7||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4440563|NCT00111800|4264797|B6||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4440564|NCT00111800|4264798|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4440565|NCT00111800|4264799|B4||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4440566|NCT00111800|4264800|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4440567|NCT00111800|4264801|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4440568|NCT00111800|4264802|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4440569|NCT00111800|4264796|B7||Female|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4440570|NCT00111800|4264797|B6||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4440571|NCT00111800|4264798|B5||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4440572|NCT00111800|4264799|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4440573|NCT00111800|4264800|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4440574|NCT00111800|4264801|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4440575|NCT00111800|4264802|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4440576|NCT00111800|4264796|B7|||Age||Years|Mean|59.6|59.6|Standard Deviation|9.87|9.87|||
4440577|NCT00111800|4264797|B6|||Age||Years|Mean|59.2|59.2|Standard Deviation|7.85|7.85|||
4440578|NCT00111800|4264798|B5|||Age||Years|Mean|58.8|58.8|Standard Deviation|9.95|9.95|||
4440579|NCT00111800|4264799|B4|||Age||Years|Mean|59.9|59.9|Standard Deviation|7.97|7.97|||
4440580|NCT00111800|4264800|B3|||Age||Years|Mean|60.4|60.4|Standard Deviation|12.41|12.41|||
4440581|NCT00111800|4264801|B2|||Age||Years|Mean|58.6|58.6|Standard Deviation|9.54|9.54|||
4440582|NCT00111800|4264802|B1|||Age||Years|Mean|60.8|60.8|Standard Deviation|10.89|10.89|||
4440583|NCT00111761|4264975|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4440584|NCT00111761|4264976|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4440585|NCT00111761|4264977|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4440586|NCT00111761|4264975|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4440587|NCT00111761|4264976|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4440588|NCT00111761|4264977|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4440589|NCT00111761|4264975|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4440590|NCT00111761|4264976|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4440591|NCT00111761|4264977|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4440592|NCT00111761|4264975|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4440593|NCT00111761|4264976|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4440594|NCT00111761|4264977|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4440595|NCT00111761|4264975|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4440596|NCT00111761|4264976|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4440597|NCT00111761|4264977|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4440598|NCT00111761|4264975|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4440599|NCT00111761|4264976|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4440600|NCT00111761|4264977|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4440601|NCT00111761|4264975|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4440602|NCT00111761|4264976|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4440603|NCT00111761|4264977|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4440604|NCT00111761|4264975|B3|||Age||Years|Mean|58.9|58.9|Standard Deviation|13.8|13.8|||
4440605|NCT00111761|4264976|B2|||Age||Years|Mean|60.7|60.7|Standard Deviation|15.0|15.0|||
4440606|NCT00111761|4264977|B1|||Age||Years|Mean|56.6|56.6|Standard Deviation|12.1|12.1|||
4440607|NCT00111657|4264995|B1|||Baseline urate concentration (pUA)||mg/dL|Mean|10.8|10.8|Standard Deviation|1.2|1.2|||
4440608|NCT00111657|4264995|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4440609|NCT00111657|4264995|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4440610|NCT00111657|4264995|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4440611|NCT00111657|4264995|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|14.8|14.8|||
4440612|NCT00111657|4264995|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4440613|NCT00111657|4264995|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4440614|NCT00111657|4264995|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440615|NCT00111241|4265005|B3|Australia||Region of Enrollment||participants|Number|115|115.0||||||
4440616|NCT00111241|4265006|B2|Australia||Region of Enrollment||participants|Number|70|70.0||||||
4440617|NCT00111241|4265007|B1|Australia||Region of Enrollment||participants|Number|45|45.0||||||
4440618|NCT00111241|4265005|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440619|NCT00111241|4265006|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440620|NCT00111241|4265007|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4440621|NCT00111241|4265005|B3||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4440622|NCT00111241|4265006|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4440623|NCT00111241|4265007|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4440624|NCT00111241|4265005|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4440625|NCT00111241|4265006|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4440626|NCT00111241|4265007|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4440627|NCT00111241|4265005|B3||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4440628|NCT00111241|4265006|B2||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4440629|NCT00111241|4265007|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4440630|NCT00111241|4265005|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440631|NCT00111241|4265006|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440632|NCT00111241|4265007|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440633|NCT00111007|4265016|B3|Status 1||Baseline Eastern Cooperative Oncology Group (ECOG) Performance|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead. Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|124|124.0||||||
4440634|NCT00111007|4265017|B2|Status 1||Baseline Eastern Cooperative Oncology Group (ECOG) Performance|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead. Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|65|65.0||||||
4440635|NCT00111007|4265018|B1|Status 1||Baseline Eastern Cooperative Oncology Group (ECOG) Performance|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead. Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|59|59.0||||||
4440636|NCT00111007|4265016|B3|Status 0||Baseline Eastern Cooperative Oncology Group (ECOG) Performance|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead. Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|146|146.0||||||
4440637|NCT00111007|4265017|B2|Status 0||Baseline Eastern Cooperative Oncology Group (ECOG) Performance|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead. Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|70|70.0||||||
4440667|NCT00110994|4265034|B2|Missing||Lactate dehydrogenase (LDH) at study entry|Lactate dehydrogenase (LDH) was assessed at study entry as part of a battery of tests to assess liver function. A typical normal range is 105 to 333 Units/Liter (U/L), but may vary across laboratories.|participants|Number|2|2.0||||||
4440723|NCT00110890|4265060|B3|Vitamin D prescribed and Ca x P ≤ 55 mg^2/dL^2||Baseline Strata||Participants|Number|237|237.0||||||
4440638|NCT00111007|4265018|B1|Status 0||Baseline Eastern Cooperative Oncology Group (ECOG) Performance|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). 0=Fully active without restriction; 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead. Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|76|76.0||||||
4440639|NCT00111007|4265016|B3|Stage IV M1c||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|185|185.0||||||
4440640|NCT00111007|4265017|B2|Stage IV M1c||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|93|93.0||||||
4440641|NCT00111007|4265018|B1|Stage IV M1c||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|92|92.0||||||
4440642|NCT00111007|4265016|B3|Stage IV M1b||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|58|58.0||||||
4440643|NCT00111007|4265017|B2|Stage IV M1b||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|31|31.0||||||
4440644|NCT00111007|4265018|B1|Stage IV M1b||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|27|27.0||||||
4440645|NCT00111007|4265016|B3|Stage III or IV M1a||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|27|27.0||||||
4440646|NCT00111007|4265017|B2|Stage III or IV M1a||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|11|11.0||||||
4440647|NCT00111007|4265018|B1|Stage III or IV M1a||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|16|16.0||||||
4440648|NCT00111007|4265016|B3||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4440649|NCT00111007|4265017|B2||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4440650|NCT00111007|4265018|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4440651|NCT00111007|4265016|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4440652|NCT00111007|4265017|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4440653|NCT00111007|4265018|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4440654|NCT00111007|4265016|B3|>=75 years||Age, Customized||participants|Number|13|13.0||||||
4440655|NCT00111007|4265017|B2|>=75 years||Age, Customized||participants|Number|4|4.0||||||
4440656|NCT00111007|4265018|B1|>=75 years||Age, Customized||participants|Number|9|9.0||||||
4440657|NCT00111007|4265016|B3|65 to 74 years||Age, Customized||participants|Number|68|68.0||||||
4440658|NCT00111007|4265017|B2|65 to 74 years||Age, Customized||participants|Number|39|39.0||||||
4440659|NCT00111007|4265018|B1|65 to 74 years||Age, Customized||participants|Number|29|29.0||||||
4440660|NCT00111007|4265016|B3|<65 years||Age, Customized||participants|Number|189|189.0||||||
4440661|NCT00111007|4265017|B2|<65 years||Age, Customized||participants|Number|92|92.0||||||
4440662|NCT00111007|4265018|B1|<65 years||Age, Customized||participants|Number|97|97.0||||||
4440663|NCT00111007|4265016|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|57.0|57.0|||
4440664|NCT00111007|4265017|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|13.0|13.0|||
4440665|NCT00111007|4265018|B1|||Age||years|Mean|56.0|56.0|Standard Deviation|12.8|12.8|||
4440666|NCT00110994|4265033|B3|Missing||Lactate dehydrogenase (LDH) at study entry|Lactate dehydrogenase (LDH) was assessed at study entry as part of a battery of tests to assess liver function. A typical normal range is 105 to 333 Units/Liter (U/L), but may vary across laboratories.|participants|Number|7|7.0||||||
4440721|NCT00110890|4265061|B2|Vitamin D prescribed and Ca x P > 55 mg^2/dL^2||Baseline Strata||Participants|Number|47|47.0||||||
4440787|NCT00110812|4265077|B4|United States||Region of Enrollment||participants|Number|26|26.0||||||
4440668|NCT00110994|4265035|B1|Missing||Lactate dehydrogenase (LDH) at study entry|Lactate dehydrogenase (LDH) was assessed at study entry as part of a battery of tests to assess liver function. A typical normal range is 105 to 333 Units/Liter (U/L), but may vary across laboratories.|participants|Number|5|5.0||||||
4440669|NCT00110994|4265033|B3|High||Lactate dehydrogenase (LDH) at study entry|Lactate dehydrogenase (LDH) was assessed at study entry as part of a battery of tests to assess liver function. A typical normal range is 105 to 333 Units/Liter (U/L), but may vary across laboratories.|participants|Number|29|29.0||||||
4440670|NCT00110994|4265034|B2|High||Lactate dehydrogenase (LDH) at study entry|Lactate dehydrogenase (LDH) was assessed at study entry as part of a battery of tests to assess liver function. A typical normal range is 105 to 333 Units/Liter (U/L), but may vary across laboratories.|participants|Number|17|17.0||||||
4440671|NCT00110994|4265035|B1|High||Lactate dehydrogenase (LDH) at study entry|Lactate dehydrogenase (LDH) was assessed at study entry as part of a battery of tests to assess liver function. A typical normal range is 105 to 333 Units/Liter (U/L), but may vary across laboratories.|participants|Number|12|12.0||||||
4440672|NCT00110994|4265033|B3|Low||Lactate dehydrogenase (LDH) at study entry|Lactate dehydrogenase (LDH) was assessed at study entry as part of a battery of tests to assess liver function. A typical normal range is 105 to 333 Units/Liter (U/L), but may vary across laboratories.|participants|Number|3|3.0||||||
4440673|NCT00110994|4265034|B2|Low||Lactate dehydrogenase (LDH) at study entry|Lactate dehydrogenase (LDH) was assessed at study entry as part of a battery of tests to assess liver function. A typical normal range is 105 to 333 Units/Liter (U/L), but may vary across laboratories.|participants|Number|2|2.0||||||
4440674|NCT00110994|4265035|B1|Low||Lactate dehydrogenase (LDH) at study entry|Lactate dehydrogenase (LDH) was assessed at study entry as part of a battery of tests to assess liver function. A typical normal range is 105 to 333 Units/Liter (U/L), but may vary across laboratories.|participants|Number|1|1.0||||||
4440675|NCT00110994|4265033|B3|Normal||Lactate dehydrogenase (LDH) at study entry|Lactate dehydrogenase (LDH) was assessed at study entry as part of a battery of tests to assess liver function. A typical normal range is 105 to 333 Units/Liter (U/L), but may vary across laboratories.|participants|Number|62|62.0||||||
4440676|NCT00110994|4265034|B2|Normal||Lactate dehydrogenase (LDH) at study entry|Lactate dehydrogenase (LDH) was assessed at study entry as part of a battery of tests to assess liver function. A typical normal range is 105 to 333 Units/Liter (U/L), but may vary across laboratories.|participants|Number|29|29.0||||||
4440677|NCT00110994|4265035|B1|Normal||Lactate dehydrogenase (LDH) at study entry|Lactate dehydrogenase (LDH) was assessed at study entry as part of a battery of tests to assess liver function. A typical normal range is 105 to 333 Units/Liter (U/L), but may vary across laboratories.|participants|Number|33|33.0||||||
4440678|NCT00110994|4265033|B3|Status 1||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|39|39.0||||||
4440679|NCT00110994|4265034|B2|Status 1||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|19|19.0||||||
4440680|NCT00110994|4265035|B1|Status 1||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|20|20.0||||||
4440681|NCT00110994|4265033|B3|Status 0||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|62|62.0||||||
4440682|NCT00110994|4265034|B2|Status 0||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|31|31.0||||||
4440683|NCT00110994|4265035|B1|Status 0||Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study must have had an ECOG score of 0 or 1 (restricted in physically strenuous activity but ambulatory).|participants|Number|31|31.0||||||
4440684|NCT00110994|4265033|B3|Stage IV M1c||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|53|53.0||||||
4440685|NCT00110994|4265034|B2|Stage IV M1c||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|25|25.0||||||
4440686|NCT00110994|4265035|B1|Stage IV M1c||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|28|28.0||||||
4440722|NCT00110890|4265062|B1|Vitamin D prescribed and Ca x P > 55 mg^2/dL^2||Baseline Strata||Participants|Number|94|94.0||||||
4440788|NCT00110812|4265078|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4440687|NCT00110994|4265033|B3|Stage IV M1b||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|35|35.0||||||
4440688|NCT00110994|4265034|B2|Stage IV M1b||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|17|17.0||||||
4440689|NCT00110994|4265035|B1|Stage IV M1b||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|18|18.0||||||
4440690|NCT00110994|4265033|B3|Stage IV M1a||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|10|10.0||||||
4440691|NCT00110994|4265034|B2|Stage IV M1a||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|7|7.0||||||
4440692|NCT00110994|4265035|B1|Stage IV M1a||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|3|3.0||||||
4440693|NCT00110994|4265033|B3|Stage III||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|3|3.0||||||
4440694|NCT00110994|4265034|B2|Stage III||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|1|1.0||||||
4440695|NCT00110994|4265035|B1|Stage III||American Joint Committee on Cancer (AJCC) Stage at Study Entry|Stage III: Clinical or radiological evidence of regional metastases (M), in either the lymph nodes or intra-lymphatic. Stage IV: M at any distant site. M1a: M to the skin, subcutaneous tissue, or lymph nodes. M1b: M to the lung. M1c: M to all other visceral sites or at any site associated with an elevated serum lactate dehydrogenase.|participants|Number|2|2.0||||||
4440696|NCT00110994|4265033|B3||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4440697|NCT00110994|4265034|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4440698|NCT00110994|4265035|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4440699|NCT00110994|4265033|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4440700|NCT00110994|4265034|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4440701|NCT00110994|4265035|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4440702|NCT00110994|4265033|B3|>=75 years||Age, Customized||participants|Number|13|13.0||||||
4440703|NCT00110994|4265034|B2|>=75 years||Age, Customized||participants|Number|9|9.0||||||
4440704|NCT00110994|4265035|B1|>=75 years||Age, Customized||participants|Number|4|4.0||||||
4440705|NCT00110994|4265033|B3|>=65 and <75 years||Age, Customized||participants|Number|19|19.0||||||
4440706|NCT00110994|4265034|B2|>=65 and <75 years||Age, Customized||participants|Number|8|8.0||||||
4440707|NCT00110994|4265035|B1|>=65 and <75 years||Age, Customized||participants|Number|11|11.0||||||
4440708|NCT00110994|4265033|B3|<65 years||Age, Customized||participants|Number|69|69.0||||||
4440709|NCT00110994|4265034|B2|<65 years||Age, Customized||participants|Number|33|33.0||||||
4440710|NCT00110994|4265035|B1|<65 years||Age, Customized||participants|Number|36|36.0||||||
4440711|NCT00110994|4265033|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|13.3|13.3|||
4440712|NCT00110994|4265034|B2|||Age||years|Mean|60.1|60.1|Standard Deviation|13.8|13.8|||
4440713|NCT00110994|4265035|B1|||Age||years|Mean|56.5|56.5|Standard Deviation|12.7|12.7|||
4440714|NCT00110890|4265060|B3|Vitamin D not prescribed and Ca x P > 55 mg^2/dL^2||Baseline Strata||Participants|Number|71|71.0||||||
4440715|NCT00110890|4265061|B2|Vitamin D not prescribed and Ca x P > 55 mg^2/dL^2||Baseline Strata||Participants|Number|24|24.0||||||
4440716|NCT00110890|4265062|B1|Vitamin D not prescribed and Ca x P > 55 mg^2/dL^2||Baseline Strata||Participants|Number|47|47.0||||||
4440717|NCT00110890|4265060|B3|Vitamin D not prescribed and Ca x P ≤ 55 mg^2/dL^2||Baseline Strata||Participants|Number|103|103.0||||||
4440718|NCT00110890|4265061|B2|Vitamin D not prescribed and Ca x P ≤ 55 mg^2/dL^2||Baseline Strata||Participants|Number|34|34.0||||||
4440719|NCT00110890|4265062|B1|Vitamin D not prescribed and Ca x P ≤ 55 mg^2/dL^2||Baseline Strata||Participants|Number|69|69.0||||||
4440720|NCT00110890|4265060|B3|Vitamin D prescribed and Ca x P > 55 mg^2/dL^2||Baseline Strata||Participants|Number|141|141.0||||||
4440789|NCT00110812|4265079|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4440724|NCT00110890|4265061|B2|Vitamin D prescribed and Ca x P ≤ 55 mg^2/dL^2||Baseline Strata||Participants|Number|79|79.0||||||
4440725|NCT00110890|4265062|B1|Vitamin D prescribed and Ca x P ≤ 55 mg^2/dL^2||Baseline Strata||Participants|Number|158|158.0||||||
4440726|NCT00110890|4265060|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4440727|NCT00110890|4265061|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4440728|NCT00110890|4265062|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4440729|NCT00110890|4265060|B3|Other||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4440730|NCT00110890|4265061|B2|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4440731|NCT00110890|4265062|B1|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4440732|NCT00110890|4265060|B3|Black||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4440733|NCT00110890|4265061|B2|Black||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4440734|NCT00110890|4265062|B1|Black||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4440735|NCT00110890|4265060|B3|White||Race/Ethnicity, Customized||Participants|Number|521|521.0||||||
4440736|NCT00110890|4265061|B2|White||Race/Ethnicity, Customized||Participants|Number|172|172.0||||||
4440737|NCT00110890|4265062|B1|White||Race/Ethnicity, Customized||Participants|Number|349|349.0||||||
4440738|NCT00110890|4265060|B3||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4440739|NCT00110890|4265061|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4440740|NCT00110890|4265062|B1||Male|Sex: Female, Male||Participants|Count of Participants|224|224.0||||||
4440741|NCT00110890|4265060|B3||Female|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4440742|NCT00110890|4265061|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4440743|NCT00110890|4265062|B1||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4440744|NCT00110890|4265060|B3|||Age||Years|Mean|58.4|58.4|Standard Deviation|14.5|14.5|||
4440745|NCT00110890|4265061|B2|||Age||Years|Mean|58.3|58.3|Standard Deviation|14.5|14.5|||
4440746|NCT00110890|4265062|B1|||Age||Years|Mean|58.5|58.5|Standard Deviation|14.5|14.5|||
4440747|NCT00110812|4265077|B4|||CD4 cell count||cells/mm^3|Median|418|418.0|Inter-Quartile Range|||359.0|511.0|
4440748|NCT00110812|4265078|B3|||CD4 cell count||cells/mm^3|Median|425|425.0|Inter-Quartile Range|||365.0|535.0|
4440749|NCT00110812|4265079|B2|||CD4 cell count||cells/mm^3|Median|398|398.0|Inter-Quartile Range|||355.0|458.0|
4440750|NCT00110812|4265080|B1|||CD4 cell count||cells/mm^3|Median|432|432.0|Inter-Quartile Range|||375.0|507.0|
4440751|NCT00110812|4265077|B4|Italy||Region of Enrollment||participants|Number|21|21.0||||||
4440752|NCT00110812|4265078|B3|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4440753|NCT00110812|4265079|B2|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4440754|NCT00110812|4265080|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4440755|NCT00110812|4265077|B4|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4440756|NCT00110812|4265078|B3|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4440757|NCT00110812|4265079|B2|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4440758|NCT00110812|4265080|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4440759|NCT00110812|4265077|B4|Chile||Region of Enrollment||participants|Number|11|11.0||||||
4440760|NCT00110812|4265078|B3|Chile||Region of Enrollment||participants|Number|4|4.0||||||
4440761|NCT00110812|4265079|B2|Chile||Region of Enrollment||participants|Number|5|5.0||||||
4440762|NCT00110812|4265080|B1|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4440763|NCT00110812|4265077|B4|Australia||Region of Enrollment||participants|Number|26|26.0||||||
4440764|NCT00110812|4265078|B3|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4440765|NCT00110812|4265079|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4440766|NCT00110812|4265080|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4440767|NCT00110812|4265077|B4|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4440768|NCT00110812|4265078|B3|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4440769|NCT00110812|4265079|B2|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4440770|NCT00110812|4265080|B1|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4440771|NCT00110812|4265077|B4|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4440772|NCT00110812|4265078|B3|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4440773|NCT00110812|4265079|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4440774|NCT00110812|4265080|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4440775|NCT00110812|4265077|B4|Thailand||Region of Enrollment||participants|Number|64|64.0||||||
4440776|NCT00110812|4265078|B3|Thailand||Region of Enrollment||participants|Number|22|22.0||||||
4440777|NCT00110812|4265079|B2|Thailand||Region of Enrollment||participants|Number|21|21.0||||||
4440778|NCT00110812|4265080|B1|Thailand||Region of Enrollment||participants|Number|21|21.0||||||
4440779|NCT00110812|4265077|B4|Argentina||Region of Enrollment||participants|Number|70|70.0||||||
4440780|NCT00110812|4265078|B3|Argentina||Region of Enrollment||participants|Number|21|21.0||||||
4440781|NCT00110812|4265079|B2|Argentina||Region of Enrollment||participants|Number|24|24.0||||||
4440782|NCT00110812|4265080|B1|Argentina||Region of Enrollment||participants|Number|25|25.0||||||
4440783|NCT00110812|4265077|B4|Morocco||Region of Enrollment||participants|Number|1|1.0||||||
4440784|NCT00110812|4265078|B3|Morocco||Region of Enrollment||participants|Number|0|0.0||||||
4440785|NCT00110812|4265079|B2|Morocco||Region of Enrollment||participants|Number|0|0.0||||||
4440786|NCT00110812|4265080|B1|Morocco||Region of Enrollment||participants|Number|1|1.0||||||
4440790|NCT00110812|4265080|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4440791|NCT00110812|4265077|B4|Portugal||Region of Enrollment||participants|Number|10|10.0||||||
4440792|NCT00110812|4265078|B3|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4440793|NCT00110812|4265079|B2|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4440794|NCT00110812|4265080|B1|Portugal||Region of Enrollment||participants|Number|3|3.0||||||
4440795|NCT00110812|4265077|B4||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4440796|NCT00110812|4265078|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4440797|NCT00110812|4265079|B2||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4440798|NCT00110812|4265080|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4440799|NCT00110812|4265077|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4440800|NCT00110812|4265078|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4440801|NCT00110812|4265079|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4440802|NCT00110812|4265080|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4440803|NCT00110812|4265077|B4|||Age||years|Mean|37.4|37.4|Standard Deviation|9.5|9.5|||
4440804|NCT00110812|4265078|B3|||Age||years|Mean|37.8|37.8|Standard Deviation|11.0|11.0|||
4440805|NCT00110812|4265079|B2|||Age||years|Mean|37.3|37.3|Standard Deviation|9.6|9.6|||
4440806|NCT00110812|4265080|B1|||Age||years|Mean|37.1|37.1|Standard Deviation|7.7|7.7|||
4440807|NCT00110812|4265077|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4440808|NCT00110812|4265078|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4440809|NCT00110812|4265079|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4440810|NCT00110812|4265080|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4440811|NCT00110812|4265077|B4||Between 18 and 65 years|Age||Participants|Count of Participants|265|265.0||||||
4440812|NCT00110812|4265078|B3||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4440813|NCT00110812|4265079|B2||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4440814|NCT00110812|4265080|B1||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4440815|NCT00110812|4265077|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440816|NCT00110812|4265078|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440817|NCT00110812|4265079|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440818|NCT00110812|4265080|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440819|NCT00110617|4265125|B3|Missing||Weight Group||Participants|Number|3|3.0||||||
4440820|NCT00110617|4265126|B2|Missing||Weight Group||Participants|Number|2|2.0||||||
4440821|NCT00110617|4265127|B1|Missing||Weight Group||Participants|Number|1|1.0||||||
4440822|NCT00110617|4265125|B3|=75 kg||Weight Group||Participants|Number|13|13.0||||||
4440823|NCT00110617|4265126|B2|=75 kg||Weight Group||Participants|Number|3|3.0||||||
4440824|NCT00110617|4265127|B1|=75 kg||Weight Group||Participants|Number|10|10.0||||||
4440825|NCT00110617|4265125|B3|55- <75 kg||Weight Group||Participants|Number|64|64.0||||||
4440826|NCT00110617|4265126|B2|55- <75 kg||Weight Group||Participants|Number|22|22.0||||||
4440827|NCT00110617|4265127|B1|55- <75 kg||Weight Group||Participants|Number|42|42.0||||||
4440828|NCT00110617|4265125|B3|35- < 55 kg||Weight Group||Participants|Number|61|61.0||||||
4440829|NCT00110617|4265126|B2|35- < 55 kg||Weight Group||Participants|Number|18|18.0||||||
4440830|NCT00110617|4265127|B1|35- < 55 kg||Weight Group||Participants|Number|43|43.0||||||
4440831|NCT00110617|4265125|B3|15- <35 kg||Weight Group||Participants|Number|62|62.0||||||
4440832|NCT00110617|4265126|B2|15- <35 kg||Weight Group||Participants|Number|23|23.0||||||
4440833|NCT00110617|4265127|B1|15- <35 kg||Weight Group||Participants|Number|39|39.0||||||
4440834|NCT00110617|4265125|B3|<15 kg||Weight Group||Participants|Number|0|0.0||||||
4440835|NCT00110617|4265126|B2|<15 kg||Weight Group||Participants|Number|0|0.0||||||
4440836|NCT00110617|4265127|B1|<15 kg||Weight Group||Participants|Number|0|0.0||||||
4440837|NCT00110617|4265125|B3|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4440838|NCT00110617|4265126|B2|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4440839|NCT00110617|4265127|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4440840|NCT00110617|4265125|B3|Oriental||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4440841|NCT00110617|4265126|B2|Oriental||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4440842|NCT00110617|4265127|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4440843|NCT00110617|4265125|B3|Black||Race/Ethnicity, Customized||Participants|Number|195|195.0||||||
4440844|NCT00110617|4265126|B2|Black||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
4440845|NCT00110617|4265127|B1|Black||Race/Ethnicity, Customized||Participants|Number|130|130.0||||||
4440846|NCT00110617|4265125|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4440847|NCT00110617|4265126|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4440848|NCT00110617|4265127|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4440849|NCT00110617|4265125|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4440850|NCT00110617|4265126|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4440851|NCT00110617|4265127|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4440852|NCT00110617|4265125|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4440853|NCT00110617|4265126|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4440854|NCT00110617|4265127|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4440855|NCT00110617|4265125|B3|= 65 Years||Age, Customized||participants|Number|0|0.0||||||
4440856|NCT00110617|4265126|B2|= 65 Years||Age, Customized||participants|Number|0|0.0||||||
4440857|NCT00110617|4265127|B1|= 65 Years||Age, Customized||participants|Number|0|0.0||||||
4440858|NCT00110617|4265125|B3|50- <65 Years||Age, Customized||participants|Number|3|3.0||||||
4440859|NCT00110617|4265126|B2|50- <65 Years||Age, Customized||participants|Number|1|1.0||||||
4440860|NCT00110617|4265127|B1|50- <65 Years||Age, Customized||participants|Number|2|2.0||||||
4440861|NCT00110617|4265125|B3|16- < 50 Years||Age, Customized||participants|Number|74|74.0||||||
4440862|NCT00110617|4265126|B2|16- < 50 Years||Age, Customized||participants|Number|24|24.0||||||
4440863|NCT00110617|4265127|B1|16- < 50 Years||Age, Customized||participants|Number|50|50.0||||||
4440864|NCT00110617|4265125|B3|12- <16 Years||Age, Customized||participants|Number|53|53.0||||||
4440865|NCT00110617|4265126|B2|12- <16 Years||Age, Customized||participants|Number|18|18.0||||||
4440866|NCT00110617|4265127|B1|12- <16 Years||Age, Customized||participants|Number|35|35.0||||||
4440867|NCT00110617|4265125|B3|6- <12 Years||Age, Customized||participants|Number|63|63.0||||||
4440868|NCT00110617|4265126|B2|6- <12 Years||Age, Customized||participants|Number|21|21.0||||||
4440869|NCT00110617|4265127|B1|6- <12 Years||Age, Customized||participants|Number|42|42.0||||||
4440870|NCT00110617|4265125|B3|2- < 6 Years||Age, Customized||participants|Number|10|10.0||||||
4440871|NCT00110617|4265126|B2|2- < 6 Years||Age, Customized||participants|Number|4|4.0||||||
4440872|NCT00110617|4265127|B1|2- < 6 Years||Age, Customized||participants|Number|6|6.0||||||
4440873|NCT00110617|4265125|B3|||Age||years|Mean|16.3|16.3|Standard Deviation|10.23|10.23|||
4440874|NCT00110617|4265126|B2|||Age||years|Mean|16.2|16.2|Standard Deviation|10.15|10.15|||
4440875|NCT00110617|4265127|B1|||Age||years|Mean|16.4|16.4|Standard Deviation|10.31|10.31|||
4440876|NCT00110513|4265141|B1|||Antithrombin (AT) activity level <60%||Participants|Number|18|18.0||||||
4440877|NCT00110513|4265141|B1|||Prior history of thromboembolism||Participants|Number|18|18.0||||||
4440878|NCT00110513|4265141|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4440879|NCT00110513|4265141|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4440880|NCT00110513|4265141|B1|United Kingdom||Region of Enrollment||participants|Number|8|8.0||||||
4440881|NCT00110513|4265141|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4440882|NCT00110513|4265141|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4440883|NCT00110513|4265141|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4440884|NCT00110513|4265141|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4440885|NCT00110513|4265141|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4440886|NCT00110513|4265141|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4440887|NCT00110513|4265141|B1|||Age||years|Mean|37.2|37.2|Standard Deviation|12.2|12.2|||
4440888|NCT00110513|4265141|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4440889|NCT00110513|4265141|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4440890|NCT00110513|4265141|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440891|NCT00110461|4265145|B4|No||Treatment given for previous episodes||participants|Number|126|126.0||||||
4440892|NCT00110461|4265146|B3|No||Treatment given for previous episodes||participants|Number|36|36.0||||||
4440893|NCT00110461|4265147|B2|No||Treatment given for previous episodes||participants|Number|49|49.0||||||
4440894|NCT00110461|4265148|B1|No||Treatment given for previous episodes||participants|Number|41|41.0||||||
4440895|NCT00110461|4265145|B4|Yes||Treatment given for previous episodes||participants|Number|170|170.0||||||
4440896|NCT00110461|4265146|B3|Yes||Treatment given for previous episodes||participants|Number|63|63.0||||||
4440897|NCT00110461|4265147|B2|Yes||Treatment given for previous episodes||participants|Number|50|50.0||||||
4440898|NCT00110461|4265148|B1|Yes||Treatment given for previous episodes||participants|Number|57|57.0||||||
4440899|NCT00110461|4265145|B4|||Children's Depression Rating Scale - Revised (CDRS-R) Suicidal Ideation Score|The CDRS-R is used to diagnose depression and monitor treatment response. The interviewer rates 17 symptom areas (including those that sever as DSM-IV criteria for diagnosis of depression), among them suicidal ideation. Most of the 17 symptom areas are rated on a 7-point scale. The Suicide Ideation Score is rated on a 7-point scale, where the minimum score on the scale is 1 (better outcome) and the maximum score is 7 (worse outcome).|points|Mean|1.2|1.2|Standard Deviation|0.5|0.5|||
4440900|NCT00110461|4265146|B3|||Children's Depression Rating Scale - Revised (CDRS-R) Suicidal Ideation Score|The CDRS-R is used to diagnose depression and monitor treatment response. The interviewer rates 17 symptom areas (including those that sever as DSM-IV criteria for diagnosis of depression), among them suicidal ideation. Most of the 17 symptom areas are rated on a 7-point scale. The Suicide Ideation Score is rated on a 7-point scale, where the minimum score on the scale is 1 (better outcome) and the maximum score is 7 (worse outcome).|points|Mean|1.2|1.2|Standard Deviation|0.5|0.5|||
4440901|NCT00110461|4265147|B2|||Children's Depression Rating Scale - Revised (CDRS-R) Suicidal Ideation Score|The CDRS-R is used to diagnose depression and monitor treatment response. The interviewer rates 17 symptom areas (including those that sever as DSM-IV criteria for diagnosis of depression), among them suicidal ideation. Most of the 17 symptom areas are rated on a 7-point scale. The Suicide Ideation Score is rated on a 7-point scale, where the minimum score on the scale is 1 (better outcome) and the maximum score is 7 (worse outcome).|points|Mean|1.1|1.1|Standard Deviation|0.5|0.5|||
4440902|NCT00110461|4265148|B1|||Children's Depression Rating Scale - Revised (CDRS-R) Suicidal Ideation Score|The CDRS-R is used to diagnose depression and monitor treatment response. The interviewer rates 17 symptom areas (including those that sever as DSM-IV criteria for diagnosis of depression), among them suicidal ideation. Most of the 17 symptom areas are rated on a 7-point scale. The Suicide Ideation Score is rated on a 7-point scale, where the minimum score on the scale is 1 (better outcome) and the maximum score is 7 (worse outcome).|points|Mean|1.1|1.1|Standard Deviation|0.4|0.4|||
4440903|NCT00110461|4265145|B4|||Young Mania Rating Scale Score (Y-MRS)|The Y-MRS consists of 11 items assessing the core symptoms of mania. Each item has 5 defined grades of severity. Minimum score on the scale is 0 (absent or normal); maximum score on the scale is 60 (worse outcome or more severe symptoms).|points|Mean|30.0|30.0|Standard Deviation|6.5|6.5|||
4440904|NCT00110461|4265146|B3|||Young Mania Rating Scale Score (Y-MRS)|The Y-MRS consists of 11 items assessing the core symptoms of mania. Each item has 5 defined grades of severity. Minimum score on the scale is 0 (absent or normal); maximum score on the scale is 60 (worse outcome or more severe symptoms).|points|Mean|30.7|30.7|Standard Deviation|6.8|6.8|||
4440905|NCT00110461|4265147|B2|||Young Mania Rating Scale Score (Y-MRS)|The Y-MRS consists of 11 items assessing the core symptoms of mania. Each item has 5 defined grades of severity. Minimum score on the scale is 0 (absent or normal); maximum score on the scale is 60 (worse outcome or more severe symptoms).|points|Mean|29.5|29.5|Standard Deviation|6.3|6.3|||
4440906|NCT00110461|4265148|B1|||Young Mania Rating Scale Score (Y-MRS)|The Y-MRS consists of 11 items assessing the core symptoms of mania. Each item has 5 defined grades of severity. Minimum score on the scale is 0 (absent or normal); maximum score on the scale is 60 (worse outcome or more severe symptoms).|points|Mean|29.8|29.8|Standard Deviation|6.5|6.5|||
4440907|NCT00110461|4265145|B4|||Body Mass Index (BMI)||kg/m^2|Mean|23.83|23.83|Standard Deviation|5.72|5.72|||
4440908|NCT00110461|4265146|B3|||Body Mass Index (BMI)||kg/m^2|Mean|23.68|23.68|Standard Deviation|4.98|4.98|||
4440909|NCT00110461|4265147|B2|||Body Mass Index (BMI)||kg/m^2|Mean|23.66|23.66|Standard Deviation|6.70|6.7|||
4440910|NCT00110461|4265148|B1|||Body Mass Index (BMI)||kg/m^2|Mean|24.15|24.15|Standard Deviation|5.37|5.37|||
4440911|NCT00110461|4265145|B4|||Weight||kilograms (kg)|Mean|61.57|61.57|Standard Deviation|19.71|19.71|||
4440912|NCT00110461|4265146|B3|||Weight||kilograms (kg)|Mean|60.48|60.48|Standard Deviation|17.31|17.31|||
4440913|NCT00110461|4265147|B2|||Weight||kilograms (kg)|Mean|60.49|60.49|Standard Deviation|21.50|21.5|||
4440914|NCT00110461|4265148|B1|||Weight||kilograms (kg)|Mean|63.76|63.76|Standard Deviation|20.11|20.11|||
4440915|NCT00110461|4265145|B4|||Height||centimeters (cm)|Mean|159.36|159.36|Standard Deviation|12.12|12.12|||
4440916|NCT00110461|4265146|B3|||Height||centimeters (cm)|Mean|158.69|158.69|Standard Deviation|11.63|11.63|||
4440917|NCT00110461|4265147|B2|||Height||centimeters (cm)|Mean|158.37|158.37|Standard Deviation|12.21|12.21|||
4440918|NCT00110461|4265148|B1|||Height||centimeters (cm)|Mean|161.05|161.05|Standard Deviation|12.45|12.45|||
4440919|NCT00110461|4265145|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4440920|NCT00110461|4265146|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4440921|NCT00110461|4265147|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4440922|NCT00110461|4265148|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4440923|NCT00110461|4265145|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4440924|NCT00110461|4265146|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4440925|NCT00110461|4265147|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4440926|NCT00110461|4265148|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4440927|NCT00110461|4265145|B4||White|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4440928|NCT00110461|4265146|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4440929|NCT00110461|4265147|B2||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4440930|NCT00110461|4265148|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4440931|NCT00110461|4265145|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4440932|NCT00110461|4265146|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4440933|NCT00110461|4265147|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4440934|NCT00110461|4265148|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4440935|NCT00110461|4265145|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4440936|NCT00110461|4265146|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440937|NCT00110461|4265147|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440938|NCT00110461|4265148|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4440939|NCT00110461|4265145|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440940|NCT00110461|4265146|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440941|NCT00110461|4265147|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440942|NCT00110461|4265148|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440943|NCT00110461|4265145|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440944|NCT00110461|4265146|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440945|NCT00110461|4265147|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440946|NCT00110461|4265148|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440947|NCT00110461|4265145|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440948|NCT00110461|4265146|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440949|NCT00110461|4265147|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440950|NCT00110461|4265148|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4440951|NCT00110461|4265145|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|265|265.0||||||
4440952|NCT00110461|4265146|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4440953|NCT00110461|4265147|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4440954|NCT00110461|4265148|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4440955|NCT00110461|4265145|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4440956|NCT00110461|4265146|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4440957|NCT00110461|4265147|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4440958|NCT00110461|4265148|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4440959|NCT00110461|4265145|B4||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4440960|NCT00110461|4265146|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4440961|NCT00110461|4265147|B2||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4440962|NCT00110461|4265148|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4440963|NCT00110461|4265145|B4||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4440964|NCT00110461|4265146|B3||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4440965|NCT00110461|4265147|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4440966|NCT00110461|4265148|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4440967|NCT00110461|4265145|B4|||Age||years|Mean|13.43|13.43|Standard Deviation|2.21|2.21|||
4440968|NCT00110461|4265146|B3|||Age||years|Mean|13.28|13.28|Standard Deviation|2.12|2.12|||
4440969|NCT00110461|4265147|B2|||Age||years|Mean|13.31|13.31|Standard Deviation|2.32|2.32|||
4440970|NCT00110461|4265148|B1|||Age||years|Mean|13.70|13.7|Standard Deviation|2.17|2.17|||
4440971|NCT00110396|4265245|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4440972|NCT00110396|4265245|B1|United Kingdom||Region of Enrollment||participants|Number|23|23.0||||||
4440973|NCT00110396|4265245|B1|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4440974|NCT00110396|4265245|B1|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4440975|NCT00110396|4265245|B1|Russian Federation||Region of Enrollment||participants|Number|134|134.0||||||
4440976|NCT00110396|4265245|B1|Lithuania||Region of Enrollment||participants|Number|20|20.0||||||
4440977|NCT00110396|4265245|B1|Israel||Region of Enrollment||participants|Number|4|4.0||||||
4440978|NCT00110396|4265245|B1|Ireland||Region of Enrollment||participants|Number|4|4.0||||||
4440979|NCT00110396|4265245|B1|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4440980|NCT00110396|4265245|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4440981|NCT00110396|4265245|B1|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4440982|NCT00110396|4265245|B1|Argentina||Region of Enrollment||participants|Number|14|14.0||||||
4440983|NCT00110396|4265245|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4440984|NCT00110396|4265245|B1||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4440985|NCT00110396|4265245|B1|||Age||years|Mean|34.9|34.9|Standard Deviation|9.5|9.5|||
4440986|NCT00110396|4265245|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4440987|NCT00110396|4265245|B1||Between 18 and 65 years|Age||Participants|Count of Participants|260|260.0||||||
4440988|NCT00110396|4265245|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4440989|NCT00110357|4265251|B3|<50||Performance Status|"For participants ≤10 years of age, Lansky play scale is used; for participants >10 years of age, Karnofsky scale is used. The Lansky scale runs from 100 to 0, where 100 is fully active/normal and 0 is unresponsive. Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death."|Participants|Number|0|0.0||||||
4440990|NCT00110357|4265252|B2|<50||Performance Status|"For participants ≤10 years of age, Lansky play scale is used; for participants >10 years of age, Karnofsky scale is used. The Lansky scale runs from 100 to 0, where 100 is fully active/normal and 0 is unresponsive. Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death."|Participants|Number|0|0.0||||||
4440991|NCT00110357|4265253|B1|<50||Performance Status|"For participants ≤10 years of age, Lansky play scale is used; for participants >10 years of age, Karnofsky scale is used. The Lansky scale runs from 100 to 0, where 100 is fully active/normal and 0 is unresponsive. Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death."|Participants|Number|0|0.0||||||
4440992|NCT00110357|4265251|B3|≥50-70||Performance Status|"For participants ≤10 years of age, Lansky play scale is used; for participants >10 years of age, Karnofsky scale is used. The Lansky scale runs from 100 to 0, where 100 is fully active/normal and 0 is unresponsive. Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death."|Participants|Number|11|11.0||||||
4440993|NCT00110357|4265252|B2|≥50-70||Performance Status|"For participants ≤10 years of age, Lansky play scale is used; for participants >10 years of age, Karnofsky scale is used. The Lansky scale runs from 100 to 0, where 100 is fully active/normal and 0 is unresponsive. Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death."|Participants|Number|3|3.0||||||
4440994|NCT00110357|4265253|B1|≥50-70||Performance Status|"For participants ≤10 years of age, Lansky play scale is used; for participants >10 years of age, Karnofsky scale is used. The Lansky scale runs from 100 to 0, where 100 is fully active/normal and 0 is unresponsive. Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death."|Participants|Number|8|8.0||||||
4440995|NCT00110357|4265251|B3|>70-100||Performance Status|"For participants ≤10 years of age, Lansky play scale is used; for participants >10 years of age, Karnofsky scale is used. The Lansky scale runs from 100 to 0, where 100 is fully active/normal and 0 is unresponsive. Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death."|Participants|Number|35|35.0||||||
4441054|NCT00110305|4265342|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|8.9|8.9|||
4441055|NCT00110305|4265338|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4440996|NCT00110357|4265252|B2|>70-100||Performance Status|"For participants ≤10 years of age, Lansky play scale is used; for participants >10 years of age, Karnofsky scale is used. The Lansky scale runs from 100 to 0, where 100 is fully active/normal and 0 is unresponsive. Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death."|Participants|Number|16|16.0||||||
4440997|NCT00110357|4265253|B1|>70-100||Performance Status|"For participants ≤10 years of age, Lansky play scale is used; for participants >10 years of age, Karnofsky scale is used. The Lansky scale runs from 100 to 0, where 100 is fully active/normal and 0 is unresponsive. Karnofsky score runs from 100 to 0, where 100 is perfect health and 0 is death."|Participants|Number|19|19.0||||||
4440998|NCT00110357|4265251|B3|Non-CNS Primary Tumor||Disease diagnosis||Participants|Number|20|20.0||||||
4440999|NCT00110357|4265252|B2|Non-CNS Primary Tumor||Disease diagnosis||Participants|Number|10|10.0||||||
4441000|NCT00110357|4265253|B1|Non-CNS Primary Tumor||Disease diagnosis||Participants|Number|10|10.0||||||
4441001|NCT00110357|4265251|B3|CNS Primary Tumor||Disease diagnosis||Participants|Number|26|26.0||||||
4441002|NCT00110357|4265252|B2|CNS Primary Tumor||Disease diagnosis||Participants|Number|9|9.0||||||
4441003|NCT00110357|4265253|B1|CNS Primary Tumor||Disease diagnosis||Participants|Number|17|17.0||||||
4441004|NCT00110357|4265251|B3|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4441005|NCT00110357|4265252|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4441006|NCT00110357|4265253|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4441007|NCT00110357|4265251|B3|White||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4441008|NCT00110357|4265252|B2|White||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4441009|NCT00110357|4265253|B1|White||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4441010|NCT00110357|4265251|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4441011|NCT00110357|4265252|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4441012|NCT00110357|4265253|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4441013|NCT00110357|4265251|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4441014|NCT00110357|4265252|B2|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4441015|NCT00110357|4265253|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4441016|NCT00110357|4265251|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4441017|NCT00110357|4265252|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4441018|NCT00110357|4265253|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4441019|NCT00110357|4265251|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4441020|NCT00110357|4265252|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4441021|NCT00110357|4265253|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4441022|NCT00110357|4265251|B3|||Age||years|Median|10|10.0|Full Range|||1.0|18.0|
4441023|NCT00110357|4265252|B2|||Age||years|Median|16.0|16.0|Full Range|||13.0|18.0|
4441024|NCT00110357|4265253|B1|||Age||years|Median|8.0|8.0|Full Range|||1.0|12.0|
4441025|NCT00110305|4265338|B5|Latin America||Region Enroll||participants|Number|114|114.0||||||
4441026|NCT00110305|4265339|B4|Latin America||Region Enroll||participants|Number|28|28.0||||||
4441027|NCT00110305|4265340|B3|Latin America||Region Enroll||participants|Number|28|28.0||||||
4441028|NCT00110305|4265341|B2|Latin America||Region Enroll||participants|Number|30|30.0||||||
4441029|NCT00110305|4265342|B1|Latin America||Region Enroll||participants|Number|28|28.0||||||
4441030|NCT00110305|4265338|B5|Europe, USA and Russia||Region Enroll||participants|Number|130|130.0||||||
4441031|NCT00110305|4265339|B4|Europe, USA and Russia||Region Enroll||participants|Number|32|32.0||||||
4441032|NCT00110305|4265340|B3|Europe, USA and Russia||Region Enroll||participants|Number|32|32.0||||||
4441033|NCT00110305|4265341|B2|Europe, USA and Russia||Region Enroll||participants|Number|33|33.0||||||
4441034|NCT00110305|4265342|B1|Europe, USA and Russia||Region Enroll||participants|Number|33|33.0||||||
4441035|NCT00110305|4265338|B5|Asia, South Africa and Uganda||Region Enroll||participants|Number|124|124.0||||||
4441036|NCT00110305|4265339|B4|Asia, South Africa and Uganda||Region Enroll||participants|Number|29|29.0||||||
4441037|NCT00110305|4265340|B3|Asia, South Africa and Uganda||Region Enroll||participants|Number|31|31.0||||||
4441038|NCT00110305|4265341|B2|Asia, South Africa and Uganda||Region Enroll||participants|Number|32|32.0||||||
4441039|NCT00110305|4265342|B1|Asia, South Africa and Uganda||Region Enroll||participants|Number|32|32.0||||||
4441040|NCT00110305|4265338|B5||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4441041|NCT00110305|4265339|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4441042|NCT00110305|4265340|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4441043|NCT00110305|4265341|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4441044|NCT00110305|4265342|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4441045|NCT00110305|4265338|B5||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4441046|NCT00110305|4265339|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4441047|NCT00110305|4265340|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4441048|NCT00110305|4265341|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4441049|NCT00110305|4265342|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4441050|NCT00110305|4265338|B5|||Age||years|Mean|36.1|36.1|Standard Deviation|8.75|8.75|||
4441051|NCT00110305|4265339|B4|||Age||years|Mean|35.4|35.4|Standard Deviation|8.1|8.1|||
4441052|NCT00110305|4265340|B3|||Age||years|Mean|35.9|35.9|Standard Deviation|9.7|9.7|||
4441053|NCT00110305|4265341|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|8.3|8.3|||
4441056|NCT00110305|4265339|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441057|NCT00110305|4265340|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4441058|NCT00110305|4265341|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441059|NCT00110305|4265342|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4441060|NCT00110305|4265338|B5||Between 18 and 65 years|Age||Participants|Count of Participants|365|365.0||||||
4441061|NCT00110305|4265339|B4||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4441062|NCT00110305|4265340|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4441063|NCT00110305|4265341|B2||Between 18 and 65 years|Age||Participants|Count of Participants|95|95.0||||||
4441064|NCT00110305|4265342|B1||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4441065|NCT00110305|4265338|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441066|NCT00110305|4265339|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441067|NCT00110305|4265340|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441068|NCT00110305|4265341|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441069|NCT00110305|4265342|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441070|NCT00110214|4265394|B3|No||Prior history of arterial events||participants|Number|971|971.0||||||
4441071|NCT00110214|4265395|B2|No||Prior history of arterial events||participants|Number|487|487.0||||||
4441072|NCT00110214|4265396|B1|No||Prior history of arterial events||participants|Number|484|484.0||||||
4441073|NCT00110214|4265394|B3|Yes||Prior history of arterial events||participants|Number|79|79.0||||||
4441074|NCT00110214|4265395|B2|Yes||Prior history of arterial events||participants|Number|37|37.0||||||
4441075|NCT00110214|4265396|B1|Yes||Prior history of arterial events||participants|Number|42|42.0||||||
4441076|NCT00110214|4265394|B3|>=30%||24-month predicted survival probability||participants|Number|494|494.0||||||
4441077|NCT00110214|4265395|B2|>=30%||24-month predicted survival probability||participants|Number|247|247.0||||||
4441078|NCT00110214|4265396|B1|>=30%||24-month predicted survival probability||participants|Number|247|247.0||||||
4441079|NCT00110214|4265394|B3|10-29.9%||24-month predicted survival probability||participants|Number|367|367.0||||||
4441080|NCT00110214|4265395|B2|10-29.9%||24-month predicted survival probability||participants|Number|183|183.0||||||
4441081|NCT00110214|4265396|B1|10-29.9%||24-month predicted survival probability||participants|Number|184|184.0||||||
4441082|NCT00110214|4265394|B3|<10%||24-month predicted survival probability||participants|Number|189|189.0||||||
4441083|NCT00110214|4265395|B2|<10%||24-month predicted survival probability||participants|Number|94|94.0||||||
4441084|NCT00110214|4265396|B1|<10%||24-month predicted survival probability||participants|Number|95|95.0||||||
4441085|NCT00110214|4265394|B3|United States||Region of Enrollment||participants|Number|1050|1050.0||||||
4441086|NCT00110214|4265395|B2|United States||Region of Enrollment||participants|Number|524|524.0||||||
4441087|NCT00110214|4265396|B1|United States||Region of Enrollment||participants|Number|526|526.0||||||
4441088|NCT00110214|4265394|B3||Male|Sex: Female, Male||Participants|Count of Participants|1050|1050.0||||||
4441089|NCT00110214|4265395|B2||Male|Sex: Female, Male||Participants|Count of Participants|524|524.0||||||
4441090|NCT00110214|4265396|B1||Male|Sex: Female, Male||Participants|Count of Participants|526|526.0||||||
4441091|NCT00110214|4265394|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441092|NCT00110214|4265395|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441093|NCT00110214|4265396|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441094|NCT00110214|4265394|B3|>=65 years||Age, Customized||participants|Number|697|697.0||||||
4441095|NCT00110214|4265395|B2|>=65 years||Age, Customized||participants|Number|345|345.0||||||
4441096|NCT00110214|4265396|B1|>=65 years||Age, Customized||participants|Number|352|352.0||||||
4441097|NCT00110214|4265394|B3|< 65 years||Age, Customized||participants|Number|353|353.0||||||
4441098|NCT00110214|4265395|B2|< 65 years||Age, Customized||participants|Number|179|179.0||||||
4441099|NCT00110214|4265396|B1|< 65 years||Age, Customized||participants|Number|174|174.0||||||
4441100|NCT00110214|4265394|B3|||Age||years|Median|69.0|69.0|Inter-Quartile Range|||62.7|75.2|
4441101|NCT00110214|4265395|B2|||Age||years|Median|68.8|68.8|Inter-Quartile Range|||63.0|74.4|
4441102|NCT00110214|4265396|B1|||Age||years|Median|69.3|69.3|Inter-Quartile Range|||62.4|75.6|
4441103|NCT00110149|4265409|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441104|NCT00110149|4265409|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4441105|NCT00110149|4265409|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441106|NCT00110149|4265409|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4441107|NCT00110149|4265409|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4441108|NCT00110149|4265409|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4441109|NCT00110149|4265409|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4441110|NCT00110149|4265409|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441111|NCT00110136|4265414|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4441112|NCT00110136|4265414|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4441113|NCT00110136|4265414|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441114|NCT00110136|4265414|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4441115|NCT00110136|4265414|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4441116|NCT00110136|4265414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4441117|NCT00110136|4265414|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441118|NCT00110136|4265414|B1|||Age||years|Mean|55.2|55.2|Standard Deviation|7.0|7.0|||
4441119|NCT00110084|4265423|B1|Unknown||Progesterone receptor status|Using IHC (Immunohistochemistry): categorization is determined by individual institution standards.|participants|Number|2|2.0||||||
4441120|NCT00110084|4265423|B1|Negative||Progesterone receptor status|Using IHC (Immunohistochemistry): categorization is determined by individual institution standards.|participants|Number|20|20.0||||||
4441121|NCT00110084|4265423|B1|Positive||Progesterone receptor status|Using IHC (Immunohistochemistry): categorization is determined by individual institution standards.|participants|Number|28|28.0||||||
4441122|NCT00110084|4265423|B1|1 - Ambulatory, restricted strenuous activity||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|27|27.0||||||
4441123|NCT00110084|4265423|B1|0 - Fully Active||Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|23|23.0||||||
4441124|NCT00110084|4265423|B1|3+||Number of metastatic sites||participants|Number|30|30.0||||||
4441125|NCT00110084|4265423|B1|2||Number of metastatic sites||participants|Number|15|15.0||||||
4441126|NCT00110084|4265423|B1|1||Number of metastatic sites||participants|Number|5|5.0||||||
4441127|NCT00110084|4265423|B1|Negative||HER2 (human epidermal growth factor receptor 2) status||participants|Number|49|49.0||||||
4441128|NCT00110084|4265423|B1|Positive||HER2 (human epidermal growth factor receptor 2) status||participants|Number|1|1.0||||||
4441129|NCT00110084|4265423|B1|Unknown||Estrogen receptor status|Using IHC (Immunohistochemistry): categorization is determined by individual institution standards.|participants|Number|2|2.0||||||
4441130|NCT00110084|4265423|B1|Negative||Estrogen receptor status|Using IHC (Immunohistochemistry): categorization is determined by individual institution standards.|participants|Number|14|14.0||||||
4441131|NCT00110084|4265423|B1|Positive||Estrogen receptor status|Using IHC (Immunohistochemistry): categorization is determined by individual institution standards.|participants|Number|34|34.0||||||
4441132|NCT00110084|4265423|B1|Visceral||Dominant disease site||participants|Number|41|41.0||||||
4441133|NCT00110084|4265423|B1|Osseous||Dominant disease site||participants|Number|4|4.0||||||
4441134|NCT00110084|4265423|B1|Soft tissue||Dominant disease site||participants|Number|5|5.0||||||
4441135|NCT00110084|4265423|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4441136|NCT00110084|4265423|B1|Female||Sex/Gender, Customized||participants|Number|50|50.0||||||
4441137|NCT00110084|4265423|B1|||Age||years|Median|56|56.0|Full Range|||29.0|86.0|
4441138|NCT00110019|4265430|B3||Male|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
4441139|NCT00110019|4265431|B2||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4441140|NCT00110019|4265432|B1||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4441141|NCT00110019|4265430|B3||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4441142|NCT00110019|4265431|B2||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4441143|NCT00110019|4265432|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4441144|NCT00110019|4265430|B3|||Age||years|Median|59|59.0|Full Range|||18.0|86.0|
4441145|NCT00110019|4265431|B2|||Age||years|Median|58|58.0|Full Range|||18.0|84.0|
4441146|NCT00110019|4265432|B1|||Age||years|Median|60|60.0|Full Range|||19.0|86.0|
4441147|NCT00109967|4265443|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4441148|NCT00109967|4265444|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4441149|NCT00109967|4265445|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4441150|NCT00109967|4265443|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4441151|NCT00109967|4265444|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4441152|NCT00109967|4265445|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4441153|NCT00109967|4265443|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4441154|NCT00109967|4265444|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4441155|NCT00109967|4265445|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4441156|NCT00109967|4265443|B3|||Age||years|Median|67|67.0|Full Range|||44.0|86.0|
4441157|NCT00109967|4265444|B2|||Age||years|Median|66|66.0|Full Range|||44.0|85.0|
4441158|NCT00109967|4265445|B1|||Age||years|Median|67.5|67.5|Full Range|||51.0|86.0|
4441159|NCT00109928|4265460|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441160|NCT00109928|4265460|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441161|NCT00109928|4265460|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4441162|NCT00109928|4265460|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4441163|NCT00109928|4265460|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441164|NCT00109928|4265460|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4441165|NCT00109928|4265460|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441166|NCT00109928|4265460|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441167|NCT00109928|4265460|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4441168|NCT00109928|4265460|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4441169|NCT00109928|4265460|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4441170|NCT00109928|4265460|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4441171|NCT00109928|4265460|B1|||Age||years|Median|60|60.0|Full Range|||20.0|92.0|
4441172|NCT00109876|4265467|B1|||Baseline forced vital capacity||mL|Median|2070|2070.0|Full Range|||1090.0|3720.0|
4441173|NCT00109876|4265467|B1|||Baseline diffusing capacity of the lung for carbon monoxide (DLCO)||Percentage of predicted|Median|42|42.0|Full Range|||7.0|99.0|
4441174|NCT00109876|4265467|B1|||Baseline Forced Expiratory Volume in 1 second (FEV1)||Percentage of predicted|Median|48|48.0|Full Range|||13.0|102.0|
4441175|NCT00109876|4265467|B1||2= Symptomatic and ambulatory|Eastern Cooperative Oncology Group (ECOG)Performance Status||Participants|Count of Participants|13|13.0||||||
4441176|NCT00109876|4265467|B1||1= Symptomatic and fully ambulatory|Eastern Cooperative Oncology Group (ECOG)Performance Status||Participants|Count of Participants|29|29.0||||||
4441177|NCT00109876|4265467|B1||0 = Asymptomatic and fully active|Eastern Cooperative Oncology Group (ECOG)Performance Status||Participants|Count of Participants|9|9.0||||||
4441178|NCT00109876|4265467|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4441179|NCT00109876|4265467|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4441180|NCT00109876|4265467|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4441181|NCT00109876|4265467|B1|||Age||years|Median|76|76.0|Full Range|||60.0|89.0|
4441182|NCT00109850|4265477|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441183|NCT00109850|4265477|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441184|NCT00109850|4265477|B1||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4441185|NCT00109850|4265477|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4441186|NCT00109850|4265477|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441187|NCT00109850|4265477|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4441188|NCT00109850|4265477|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441189|NCT00109850|4265477|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4441190|NCT00109850|4265477|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4441191|NCT00109850|4265477|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441192|NCT00109850|4265477|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4441193|NCT00109850|4265477|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4441194|NCT00109850|4265477|B1|||Age||years|Median|61.4|61.4|Full Range|||43.0|83.1|
4441195|NCT00109837|4265484|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4441196|NCT00109837|4265484|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4441197|NCT00109837|4265484|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4441198|NCT00109837|4265484|B1|||Age||years|Median|42|42.0|Full Range|||18.0|63.0|
4441199|NCT00109772|4265492|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4441200|NCT00109772|4265493|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4441201|NCT00109772|4265494|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4441202|NCT00109772|4265492|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4441203|NCT00109772|4265493|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4441204|NCT00109772|4265494|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4441205|NCT00109772|4265492|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4441206|NCT00109772|4265493|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4441207|NCT00109772|4265494|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4441208|NCT00109772|4265492|B3|White||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
4441209|NCT00109772|4265493|B2|White||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4441210|NCT00109772|4265494|B1|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4441211|NCT00109772|4265492|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4441212|NCT00109772|4265493|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4441213|NCT00109772|4265494|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4441214|NCT00109772|4265492|B3||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4441215|NCT00109772|4265493|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4441216|NCT00109772|4265494|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4441217|NCT00109772|4265492|B3|||Age||years|Mean|44.5|44.5|Standard Deviation|11.20|11.2|||
4441218|NCT00109772|4265493|B2|||Age||years|Mean|45.1|45.1|Standard Deviation|11.06|11.06|||
4441219|NCT00109772|4265494|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|11.37|11.37|||
4441220|NCT00109733|4265533|B3|||Trunk to limb fat ratio||ratio|Mean|0.96|0.96|Standard Deviation|0.25|0.25|||
4441221|NCT00109733|4265534|B2|||Trunk to limb fat ratio||ratio|Mean|0.87|0.87|Standard Deviation|0.17|0.17|||
4441222|NCT00109733|4265535|B1|||Trunk to limb fat ratio||ratio|Mean|1.05|1.05|Standard Deviation|0.29|0.29|||
4441223|NCT00109733|4265533|B3|||Trunk fat||kg|Mean|11.56|11.56|Standard Deviation|7.47|7.47|||
4441224|NCT00109733|4265534|B2|||Trunk fat||kg|Mean|11.40|11.4|Standard Deviation|9.09|9.09|||
4441225|NCT00109733|4265535|B1|||Trunk fat||kg|Mean|11.73|11.73|Standard Deviation|5.58|5.58|||
4441226|NCT00109733|4265533|B3|||Total body fat||kg|Mean|24.58|24.58|Standard Deviation|14.90|14.9|||
4441227|NCT00109733|4265534|B2|||Total body fat||kg|Mean|25.11|25.11|Standard Deviation|18.29|18.29|||
4441228|NCT00109733|4265535|B1|||Total body fat||kg|Mean|24.02|24.02|Standard Deviation|10.81|10.81|||
4441229|NCT00109733|4265533|B3|||Limb fat||kg|Mean|12.22|12.22|Standard Deviation|7.59|7.59|||
4441230|NCT00109733|4265534|B2|||Limb fat||kg|Mean|12.92|12.92|Standard Deviation|9.28|9.28|||
4441231|NCT00109733|4265535|B1|||Limb fat||kg|Mean|11.47|11.47|Standard Deviation|5.49|5.49|||
4441232|NCT00109733|4265533|B3|||Lean body mass||kg|Mean|44.21|44.21|Standard Deviation|11.90|11.9|||
4441233|NCT00109733|4265534|B2|||Lean body mass||kg|Mean|44.38|44.38|Standard Deviation|12.98|12.98|||
4441234|NCT00109733|4265535|B1|||Lean body mass||kg|Mean|44.03|44.03|Standard Deviation|11.09|11.09|||
4441235|NCT00109733|4265533|B3|United States||Region of Enrollment||participants|Number|31|31.0||||||
4441236|NCT00109733|4265534|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4441237|NCT00109733|4265535|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4441238|NCT00109733|4265533|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4441239|NCT00109733|4265534|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4441240|NCT00109733|4265535|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4441241|NCT00109733|4265533|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4441242|NCT00109733|4265534|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4441243|NCT00109733|4265535|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4441244|NCT00109733|4265533|B3|||Age||years|Mean|17.8|17.8|Standard Deviation|1.9|1.9|||
4441245|NCT00109733|4265534|B2|||Age||years|Mean|18.1|18.1|Standard Deviation|1.9|1.9|||
4441246|NCT00109733|4265535|B1|||Age||years|Mean|17.4|17.4|Standard Deviation|1.8|1.8|||
4441247|NCT00109590|4265550|B4|||Plasma HIV-RNA at delivery||log10 copies/mL|Median|3.48|3.48|Full Range|||1.7|4.9|
4441248|NCT00109590|4265551|B3|||Plasma HIV-RNA at delivery||log10 copies/mL|Median|3.48|3.48|Full Range|||1.7|4.71|
4441249|NCT00109590|4265552|B2|||Plasma HIV-RNA at delivery||log10 copies/mL|Median|3.36|3.36|Full Range|||1.7|4.83|
4441250|NCT00109590|4265553|B1|||Plasma HIV-RNA at delivery||log10 copies/mL|Median|3.63|3.63|Full Range|||1.7|4.9|
4441251|NCT00109590|4265550|B4|||Plasma HIV RNA at entry||log10 copies/mL|Median|3.49|3.49|Full Range|||1.0|5.05|
4441252|NCT00109590|4265551|B3|||Plasma HIV RNA at entry||log10 copies/mL|Median|3.54|3.54|Full Range|||2.6|5.05|
4441253|NCT00109590|4265552|B2|||Plasma HIV RNA at entry||log10 copies/mL|Median|3.52|3.52|Full Range|||1.0|4.99|
4441254|NCT00109590|4265553|B1|||Plasma HIV RNA at entry||log10 copies/mL|Median|3.48|3.48|Full Range|||2.6|4.98|
4441255|NCT00109590|4265550|B4|||CD4 cell count at delivery||cells/uL|Median|513|513.0|Full Range|||70.0|1182.0|
4441256|NCT00109590|4265551|B3|||CD4 cell count at delivery||cells/uL|Median|566|566.0|Full Range|||222.0|1182.0|
4441257|NCT00109590|4265552|B2|||CD4 cell count at delivery||cells/uL|Median|517|517.0|Full Range|||198.0|1150.0|
4441258|NCT00109590|4265553|B1|||CD4 cell count at delivery||cells/uL|Median|484|484.0|Full Range|||70.0|1001.0|
4441259|NCT00109590|4265550|B4|||CD4 cell count at entry||cells/uL|Median|456|456.0|Full Range|||251.0|1233.0|
4441260|NCT00109590|4265551|B3|||CD4 cell count at entry||cells/uL|Median|481|481.0|Full Range|||262.0|1183.0|
4441261|NCT00109590|4265552|B2|||CD4 cell count at entry||cells/uL|Median|413|413.0|Full Range|||251.0|1024.0|
4441262|NCT00109590|4265553|B1|||CD4 cell count at entry||cells/uL|Median|431|431.0|Full Range|||262.0|1233.0|
4441263|NCT00109590|4265550|B4|||Duration of ZDV during pregnancy - At Delivery||weeks|Median|10|10.0|Full Range|||0.0|31.0|
4441264|NCT00109590|4265551|B3|||Duration of ZDV during pregnancy - At Delivery||weeks|Median|10|10.0|Full Range|||0.0|31.0|
4441265|NCT00109590|4265552|B2|||Duration of ZDV during pregnancy - At Delivery||weeks|Median|11|11.0|Full Range|||5.0|18.0|
4441266|NCT00109590|4265553|B1|||Duration of ZDV during pregnancy - At Delivery||weeks|Median|10|10.0|Full Range|||2.0|16.0|
4441267|NCT00109590|4265550|B4|||Duration of ZDV during pregnancy - At Entry||weeks|Median|3|3.0|Full Range|||0.0|27.0|
4441268|NCT00109590|4265551|B3|||Duration of ZDV during pregnancy - At Entry||weeks|Median|2|2.0|Full Range|||0.0|27.0|
4441269|NCT00109590|4265552|B2|||Duration of ZDV during pregnancy - At Entry||weeks|Median|2|2.0|Full Range|||0.0|10.0|
4441270|NCT00109590|4265553|B1|||Duration of ZDV during pregnancy - At Entry||weeks|Median|3|3.0|Full Range|||0.0|9.0|
4441271|NCT00109590|4265550|B4|||Gestational Age at Entry||weeks|Median|31|31.0|Full Range|||27.0|38.0|
4441272|NCT00109590|4265551|B3|||Gestational Age at Entry||weeks|Median|31|31.0|Full Range|||28.0|37.0|
4441273|NCT00109590|4265552|B2|||Gestational Age at Entry||weeks|Median|31|31.0|Full Range|||27.0|38.0|
4441274|NCT00109590|4265553|B1|||Gestational Age at Entry||weeks|Median|32|32.0|Full Range|||28.0|37.0|
4441275|NCT00109590|4265550|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441276|NCT00109590|4265551|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441277|NCT00109590|4265552|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441278|NCT00109590|4265553|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441279|NCT00109590|4265550|B4||Female|Sex: Female, Male||Participants|Count of Participants|169|169.0||||||
4441280|NCT00109590|4265551|B3||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4441281|NCT00109590|4265552|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4441282|NCT00109590|4265553|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4441283|NCT00109590|4265550|B4|>= 45 years||Age, Customized||participants|Number|1|1.0||||||
4441284|NCT00109590|4265551|B3|>= 45 years||Age, Customized||participants|Number|0|0.0||||||
4441285|NCT00109590|4265552|B2|>= 45 years||Age, Customized||participants|Number|0|0.0||||||
4441286|NCT00109590|4265553|B1|>= 45 years||Age, Customized||participants|Number|1|1.0||||||
4441287|NCT00109590|4265550|B4|>=30 to < 45 years||Age, Customized||participants|Number|61|61.0||||||
4441288|NCT00109590|4265551|B3|>=30 to < 45 years||Age, Customized||participants|Number|19|19.0||||||
4441289|NCT00109590|4265552|B2|>=30 to < 45 years||Age, Customized||participants|Number|21|21.0||||||
4441290|NCT00109590|4265553|B1|>=30 to < 45 years||Age, Customized||participants|Number|21|21.0||||||
4441291|NCT00109590|4265550|B4|18 to < 30years||Age, Customized||participants|Number|107|107.0||||||
4441292|NCT00109590|4265551|B3|18 to < 30years||Age, Customized||participants|Number|38|38.0||||||
4441293|NCT00109590|4265552|B2|18 to < 30years||Age, Customized||participants|Number|35|35.0||||||
4441294|NCT00109590|4265553|B1|18 to < 30years||Age, Customized||participants|Number|34|34.0||||||
4441295|NCT00109590|4265550|B4|||Age||years|Mean|28|28.0|Standard Deviation|5|5.0|||
4441296|NCT00109590|4265551|B3|||Age||years|Mean|27|27.0|Standard Deviation|5|5.0|||
4441297|NCT00109590|4265552|B2|||Age||years|Mean|28|28.0|Standard Deviation|5|5.0|||
4441298|NCT00109590|4265553|B1|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
4441299|NCT00109577|4265595|B3|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4441300|NCT00109577|4265596|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4441301|NCT00109577|4265597|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4441302|NCT00109577|4265595|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4441303|NCT00109577|4265596|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4441304|NCT00109577|4265597|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4441305|NCT00109577|4265595|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4441306|NCT00109577|4265596|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4441307|NCT00109577|4265597|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4441308|NCT00109577|4265595|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4441309|NCT00109577|4265596|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4441310|NCT00109577|4265597|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4441311|NCT00109577|4265595|B3|||Age||years|Mean|37.5|37.5|Standard Deviation|11|11.0|||
4441312|NCT00109577|4265596|B2|||Age||years|Mean|35|35.0|Standard Deviation|9|9.0|||
4441313|NCT00109577|4265597|B1|||Age||years|Mean|40|40.0|Standard Deviation|13|13.0|||
4441314|NCT00109577|4265595|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441315|NCT00109577|4265596|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441316|NCT00109577|4265597|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441317|NCT00109577|4265595|B3||Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4441318|NCT00109577|4265596|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4441319|NCT00109577|4265597|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4441320|NCT00109577|4265595|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441321|NCT00109577|4265596|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441322|NCT00109577|4265597|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441323|NCT00109473|4265604|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4441324|NCT00109473|4265605|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4441325|NCT00109473|4265606|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4441326|NCT00109473|4265604|B3||Male|Gender||Participants|Count of Participants|16|16.0||||||
4441327|NCT00109473|4265605|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
4441328|NCT00109473|4265606|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
4441329|NCT00109473|4265604|B3||Female|Gender||Participants|Count of Participants|4|4.0||||||
4441330|NCT00109473|4265605|B2||Female|Gender||Participants|Count of Participants|2|2.0||||||
4441331|NCT00109473|4265606|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4441332|NCT00109473|4265604|B3|||Age||years|Mean|13|13.0|Standard Deviation|3|3.0|||
4441333|NCT00109473|4265605|B2|||Age||years|Mean|13|13.0|Standard Deviation|3|3.0|||
4441334|NCT00109473|4265606|B1|||Age||years|Mean|12|12.0|Standard Deviation|3|3.0|||
4441335|NCT00109473|4265604|B3|<=18 years||Age, Customized||participants|Number|20|20.0||||||
4441336|NCT00109473|4265605|B2|<=18 years||Age, Customized||participants|Number|10|10.0||||||
4441337|NCT00109473|4265606|B1|<=18 years||Age, Customized||participants|Number|10|10.0||||||
4441338|NCT00109343|4265626|B4|Other||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4441339|NCT00109343|4265627|B3|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4441340|NCT00109343|4265628|B2|Other||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4441341|NCT00109343|4265629|B1|Other||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4441342|NCT00109343|4265626|B4|White||Race/Ethnicity, Customized||participants|Number|670|670.0||||||
4441343|NCT00109343|4265627|B3|White||Race/Ethnicity, Customized||participants|Number|174|174.0||||||
4441344|NCT00109343|4265628|B2|White||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
4441345|NCT00109343|4265629|B1|White||Race/Ethnicity, Customized||participants|Number|335|335.0||||||
4441346|NCT00109343|4265626|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4441347|NCT00109343|4265627|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4441348|NCT00109343|4265628|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4441349|NCT00109343|4265629|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4441350|NCT00109343|4265626|B4|Black||Race/Ethnicity, Customized||participants|Number|155|155.0||||||
4441351|NCT00109343|4265627|B3|Black||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4441352|NCT00109343|4265628|B2|Black||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4441353|NCT00109343|4265629|B1|Black||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4441354|NCT00109343|4265626|B4|Asian||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4441355|NCT00109343|4265627|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4441356|NCT00109343|4265628|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4441357|NCT00109343|4265629|B1|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4441358|NCT00109343|4265626|B4||Male|Sex: Female, Male||Participants|Count of Participants|560|560.0||||||
4441359|NCT00109343|4265627|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4441360|NCT00109343|4265628|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4441361|NCT00109343|4265629|B1||Male|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4441362|NCT00109343|4265626|B4||Female|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
4441363|NCT00109343|4265627|B3||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4441364|NCT00109343|4265628|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4441365|NCT00109343|4265629|B1||Female|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4441366|NCT00109343|4265626|B4|||Age||Months|Mean|12.6|12.6|Standard Deviation|0.96|0.96|||
4441367|NCT00109343|4265627|B3|||Age||Months|Mean|12.6|12.6|Standard Deviation|0.98|0.98|||
4441368|NCT00109343|4265628|B2|||Age||Months|Mean|12.5|12.5|Standard Deviation|0.93|0.93|||
4441369|NCT00109343|4265629|B1|||Age||Months|Mean|12.6|12.6|Standard Deviation|0.96|0.96|||
4441370|NCT00109031|4265672|B5|≥ 5 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|0|0.0||||||
4441371|NCT00109031|4265673|B4|≥ 5 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|0|0.0||||||
4441372|NCT00109031|4265674|B3|≥ 5 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|0|0.0||||||
4441373|NCT00109031|4265675|B2|≥ 5 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|0|0.0||||||
4441374|NCT00109031|4265676|B1|≥ 5 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|0|0.0||||||
4441375|NCT00109031|4265672|B5|4 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|26|26.0||||||
4441376|NCT00109031|4265673|B4|4 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|8|8.0||||||
4441377|NCT00109031|4265674|B3|4 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|6|6.0||||||
4441378|NCT00109031|4265675|B2|4 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|6|6.0||||||
4441379|NCT00109031|4265676|B1|4 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|6|6.0||||||
4441380|NCT00109031|4265672|B5|3 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|18|18.0||||||
4441381|NCT00109031|4265673|B4|3 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|4|4.0||||||
4441382|NCT00109031|4265674|B3|3 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|6|6.0||||||
4441383|NCT00109031|4265675|B2|3 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|4|4.0||||||
4441447|NCT00109031|4265674|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4441384|NCT00109031|4265676|B1|3 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|4|4.0||||||
4441385|NCT00109031|4265672|B5|≤ 2 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|2|2.0||||||
4441386|NCT00109031|4265673|B4|≤ 2 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|0|0.0||||||
4441387|NCT00109031|4265674|B3|≤ 2 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|1|1.0||||||
4441388|NCT00109031|4265675|B2|≤ 2 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|1|1.0||||||
4441389|NCT00109031|4265676|B1|≤ 2 days||Number of days of total body irradiation|Data are reported for the safety analysis set, as treated. Seven participants received the wrong sequence of placebo and palifermin in error in. Consequently, 10, 11, 13, and 12 participants actually received treatment according in each treatment arm respectively.|participants|Number|0|0.0||||||
4441390|NCT00109031|4265672|B5|No||Etoposide use||participants|Number|5|5.0||||||
4441391|NCT00109031|4265673|B4|No||Etoposide use||participants|Number|1|1.0||||||
4441392|NCT00109031|4265674|B3|No||Etoposide use||participants|Number|2|2.0||||||
4441393|NCT00109031|4265675|B2|No||Etoposide use||participants|Number|0|0.0||||||
4441394|NCT00109031|4265676|B1|No||Etoposide use||participants|Number|2|2.0||||||
4441395|NCT00109031|4265672|B5|Yes||Etoposide use||participants|Number|41|41.0||||||
4441396|NCT00109031|4265673|B4|Yes||Etoposide use||participants|Number|11|11.0||||||
4441397|NCT00109031|4265674|B3|Yes||Etoposide use||participants|Number|11|11.0||||||
4441398|NCT00109031|4265675|B2|Yes||Etoposide use||participants|Number|10|10.0||||||
4441399|NCT00109031|4265676|B1|Yes||Etoposide use||participants|Number|9|9.0||||||
4441400|NCT00109031|4265672|B5|Chronic myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441401|NCT00109031|4265673|B4|Chronic myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441402|NCT00109031|4265674|B3|Chronic myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441403|NCT00109031|4265675|B2|Chronic myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441404|NCT00109031|4265676|B1|Chronic myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441405|NCT00109031|4265672|B5|Chronic lymphocytic leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|1|1.0||||||
4441406|NCT00109031|4265673|B4|Chronic lymphocytic leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|1|1.0||||||
4441407|NCT00109031|4265674|B3|Chronic lymphocytic leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441408|NCT00109031|4265675|B2|Chronic lymphocytic leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441409|NCT00109031|4265676|B1|Chronic lymphocytic leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441410|NCT00109031|4265672|B5|Acute myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|2|2.0||||||
4441411|NCT00109031|4265673|B4|Acute myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|1|1.0||||||
4441412|NCT00109031|4265674|B3|Acute myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441413|NCT00109031|4265675|B2|Acute myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441414|NCT00109031|4265676|B1|Acute myelogenous leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|1|1.0||||||
4441448|NCT00109031|4265675|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4441415|NCT00109031|4265672|B5|Acute lymphoblastic leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|1|1.0||||||
4441416|NCT00109031|4265673|B4|Acute lymphoblastic leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441417|NCT00109031|4265674|B3|Acute lymphoblastic leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441418|NCT00109031|4265675|B2|Acute lymphoblastic leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441419|NCT00109031|4265676|B1|Acute lymphoblastic leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|1|1.0||||||
4441420|NCT00109031|4265672|B5|Leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|4|4.0||||||
4441421|NCT00109031|4265673|B4|Leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|2|2.0||||||
4441422|NCT00109031|4265674|B3|Leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441423|NCT00109031|4265675|B2|Leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441424|NCT00109031|4265676|B1|Leukemia||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|2|2.0||||||
4441425|NCT00109031|4265672|B5|Multiple Myeloma||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441426|NCT00109031|4265673|B4|Multiple Myeloma||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441427|NCT00109031|4265674|B3|Multiple Myeloma||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441428|NCT00109031|4265675|B2|Multiple Myeloma||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441429|NCT00109031|4265676|B1|Multiple Myeloma||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441430|NCT00109031|4265672|B5|Non-Hodgkin's lymphoma||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|33|33.0||||||
4441431|NCT00109031|4265673|B4|Non-Hodgkin's lymphoma||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|6|6.0||||||
4441432|NCT00109031|4265674|B3|Non-Hodgkin's lymphoma||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|9|9.0||||||
4441433|NCT00109031|4265675|B2|Non-Hodgkin's lymphoma||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|9|9.0||||||
4441434|NCT00109031|4265676|B1|Non-Hodgkin's lymphoma||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|9|9.0||||||
4441435|NCT00109031|4265672|B5|Hodgkin's disease||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|9|9.0||||||
4441436|NCT00109031|4265673|B4|Hodgkin's disease||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|4|4.0||||||
4441437|NCT00109031|4265674|B3|Hodgkin's disease||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|4|4.0||||||
4441438|NCT00109031|4265675|B2|Hodgkin's disease||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|1|1.0||||||
4441439|NCT00109031|4265676|B1|Hodgkin's disease||Type of diagnosis|Acute lymphoblastic leukemia., Acute myelogenous leukemia, Chronic lymphocytic leukemia, and1 ( 8) Chronic myelogenous leukemia are subsets of Leukemia.|participants|Number|0|0.0||||||
4441440|NCT00109031|4265672|B5|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4441441|NCT00109031|4265673|B4|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4441442|NCT00109031|4265674|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4441443|NCT00109031|4265675|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4441444|NCT00109031|4265676|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4441445|NCT00109031|4265672|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4441446|NCT00109031|4265673|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4441449|NCT00109031|4265676|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4441450|NCT00109031|4265672|B5|White or Caucasian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4441451|NCT00109031|4265673|B4|White or Caucasian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4441452|NCT00109031|4265674|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4441453|NCT00109031|4265675|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4441454|NCT00109031|4265676|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4441455|NCT00109031|4265672|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4441456|NCT00109031|4265673|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4441457|NCT00109031|4265674|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4441458|NCT00109031|4265675|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4441459|NCT00109031|4265676|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4441460|NCT00109031|4265672|B5||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4441461|NCT00109031|4265673|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4441462|NCT00109031|4265674|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4441463|NCT00109031|4265675|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441464|NCT00109031|4265676|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4441465|NCT00109031|4265672|B5|||Age||years|Mean|48.8|48.8|Standard Deviation|12.2|12.2|||
4441466|NCT00109031|4265673|B4|||Age||years|Mean|46.1|46.1|Standard Deviation|13.8|13.8|||
4441467|NCT00109031|4265674|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|14.2|14.2|||
4441468|NCT00109031|4265675|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|9.7|9.7|||
4441469|NCT00109031|4265676|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|9.9|9.9|||
4441470|NCT00109005|4265713|B3|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4441471|NCT00109005|4265714|B2|United States||Region of Enrollment||Participants|Count of Participants|9|9.0||||||
4441472|NCT00109005|4265715|B1|United States||Region of Enrollment||Participants|Count of Participants|8|8.0||||||
4441473|NCT00109005|4265713|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441474|NCT00109005|4265714|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441475|NCT00109005|4265715|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441476|NCT00109005|4265713|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441477|NCT00109005|4265714|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441478|NCT00109005|4265715|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441479|NCT00109005|4265713|B3||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4441480|NCT00109005|4265714|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4441481|NCT00109005|4265715|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4441482|NCT00109005|4265713|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441483|NCT00109005|4265714|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441484|NCT00109005|4265715|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441485|NCT00109005|4265713|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441486|NCT00109005|4265714|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441487|NCT00109005|4265715|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441488|NCT00109005|4265713|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4441489|NCT00109005|4265714|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441490|NCT00109005|4265715|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4441491|NCT00109005|4265713|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441492|NCT00109005|4265714|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441493|NCT00109005|4265715|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441494|NCT00109005|4265713|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441495|NCT00109005|4265714|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441496|NCT00109005|4265715|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441497|NCT00109005|4265713|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4441498|NCT00109005|4265714|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4441499|NCT00109005|4265715|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4441500|NCT00109005|4265713|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441501|NCT00109005|4265714|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441502|NCT00109005|4265715|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441503|NCT00109005|4265713|B3||Male|Gender||Participants|Count of Participants|4|4.0||||||
4441504|NCT00109005|4265714|B2||Male|Gender||Participants|Count of Participants|1|1.0||||||
4441505|NCT00109005|4265715|B1||Male|Gender||Participants|Count of Participants|3|3.0||||||
4441506|NCT00109005|4265713|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
4441507|NCT00109005|4265714|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
4441508|NCT00109005|4265715|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4441509|NCT00109005|4265713|B3|||Age||years|Mean|55.56|55.56|Standard Deviation|9.71|9.71|||
4441510|NCT00109005|4265714|B2|||Age||years|Mean|58.86|58.86|Standard Deviation|9.83|9.83|||
4441511|NCT00109005|4265715|B1|||Age||years|Mean|51.7|51.7|Standard Deviation|7.6|7.6|||
4441512|NCT00109005|4265713|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4441513|NCT00109005|4265714|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4441514|NCT00109005|4265715|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441515|NCT00109005|4265713|B3||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4441516|NCT00109005|4265714|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4441517|NCT00109005|4265715|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4441518|NCT00109005|4265713|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441519|NCT00109005|4265714|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441520|NCT00109005|4265715|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441521|NCT00108953|4265728|B3|missing||Tumor burden: Macroscopic vascular invasion|Tumor spread into the blood vessels as determined through radiological assessment (e.g., x-ray, imaging), which describes an aggressive and advanced tumor pattern.|participants|Number|2|2.0||||||
4441522|NCT00108953|4265729|B2|missing||Tumor burden: Macroscopic vascular invasion|Tumor spread into the blood vessels as determined through radiological assessment (e.g., x-ray, imaging), which describes an aggressive and advanced tumor pattern.|participants|Number|1|1.0||||||
4441523|NCT00108953|4265730|B1|missing||Tumor burden: Macroscopic vascular invasion|Tumor spread into the blood vessels as determined through radiological assessment (e.g., x-ray, imaging), which describes an aggressive and advanced tumor pattern.|participants|Number|1|1.0||||||
4441524|NCT00108953|4265728|B3|no||Tumor burden: Macroscopic vascular invasion|Tumor spread into the blood vessels as determined through radiological assessment (e.g., x-ray, imaging), which describes an aggressive and advanced tumor pattern.|participants|Number|65|65.0||||||
4441525|NCT00108953|4265729|B2|no||Tumor burden: Macroscopic vascular invasion|Tumor spread into the blood vessels as determined through radiological assessment (e.g., x-ray, imaging), which describes an aggressive and advanced tumor pattern.|participants|Number|32|32.0||||||
4441526|NCT00108953|4265730|B1|no||Tumor burden: Macroscopic vascular invasion|Tumor spread into the blood vessels as determined through radiological assessment (e.g., x-ray, imaging), which describes an aggressive and advanced tumor pattern.|participants|Number|33|33.0||||||
4441527|NCT00108953|4265728|B3|yes||Tumor burden: Macroscopic vascular invasion|Tumor spread into the blood vessels as determined through radiological assessment (e.g., x-ray, imaging), which describes an aggressive and advanced tumor pattern.|participants|Number|29|29.0||||||
4441528|NCT00108953|4265729|B2|yes||Tumor burden: Macroscopic vascular invasion|Tumor spread into the blood vessels as determined through radiological assessment (e.g., x-ray, imaging), which describes an aggressive and advanced tumor pattern.|participants|Number|16|16.0||||||
4441529|NCT00108953|4265730|B1|yes||Tumor burden: Macroscopic vascular invasion|Tumor spread into the blood vessels as determined through radiological assessment (e.g., x-ray, imaging), which describes an aggressive and advanced tumor pattern.|participants|Number|13|13.0||||||
4441530|NCT00108953|4265728|B3|no||Tumor burden: Extrahepatic spread|Tumor spread outside the liver, which describes an aggressive and advanced tumor pattern.|participants|Number|40|40.0||||||
4441531|NCT00108953|4265729|B2|no||Tumor burden: Extrahepatic spread|Tumor spread outside the liver, which describes an aggressive and advanced tumor pattern.|participants|Number|17|17.0||||||
4441532|NCT00108953|4265730|B1|no||Tumor burden: Extrahepatic spread|Tumor spread outside the liver, which describes an aggressive and advanced tumor pattern.|participants|Number|23|23.0||||||
4441533|NCT00108953|4265728|B3|yes||Tumor burden: Extrahepatic spread|Tumor spread outside the liver, which describes an aggressive and advanced tumor pattern.|participants|Number|56|56.0||||||
4441534|NCT00108953|4265729|B2|yes||Tumor burden: Extrahepatic spread|Tumor spread outside the liver, which describes an aggressive and advanced tumor pattern.|participants|Number|32|32.0||||||
4441535|NCT00108953|4265730|B1|yes||Tumor burden: Extrahepatic spread|Tumor spread outside the liver, which describes an aggressive and advanced tumor pattern.|participants|Number|24|24.0||||||
4441536|NCT00108953|4265728|B3|missing||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|7|7.0||||||
4441537|NCT00108953|4265729|B2|missing||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|4|4.0||||||
4441538|NCT00108953|4265730|B1|missing||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|3|3.0||||||
4441539|NCT00108953|4265728|B3|Grade 3||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|1|1.0||||||
4441540|NCT00108953|4265729|B2|Grade 3||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|1|1.0||||||
4441607|NCT00108862|4265753|B1|Botswana||Region of Enrollment||participants|Number|13|13.0||||||
4441541|NCT00108953|4265730|B1|Grade 3||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|0|0.0||||||
4441542|NCT00108953|4265728|B3|Grade 2||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|7|7.0||||||
4441543|NCT00108953|4265729|B2|Grade 2||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|3|3.0||||||
4441544|NCT00108953|4265730|B1|Grade 2||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|4|4.0||||||
4441545|NCT00108953|4265728|B3|Grade 1||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|43|43.0||||||
4441546|NCT00108953|4265729|B2|Grade 1||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|25|25.0||||||
4441547|NCT00108953|4265730|B1|Grade 1||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|18|18.0||||||
4441548|NCT00108953|4265728|B3|Grade 0||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|38|38.0||||||
4441549|NCT00108953|4265729|B2|Grade 0||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|16|16.0||||||
4441550|NCT00108953|4265730|B1|Grade 0||Eastern Cooperative Group performance status (ECOG PS) at study entry|ECOG PS is a rating of daily living abilities, from 0 to 5. 0=Fully active without restriction. 1= Restricted in physically strenuous activity; 2= Ambulatory, capable of all selfcare; 3= Capable of limited selfcare; 4= Completely disabled; 5= Dead.|participants|Number|22|22.0||||||
4441551|NCT00108953|4265728|B3|>7||Child Pugh Status|The Child-Pugh score is used to classify the stages of liver cirrhosis, based on clinical diagnosis and laboratory tests. Assessment of good operative risk (A) if 5 or 6 points, moderate risk (B) if 7 to 9 points, and poor operative risk (C) if 10 to 15 points. A “C” classification forecasts a survival of less than 12 months.|participants|Number|0|0.0||||||
4441552|NCT00108953|4265729|B2|>7||Child Pugh Status|The Child-Pugh score is used to classify the stages of liver cirrhosis, based on clinical diagnosis and laboratory tests. Assessment of good operative risk (A) if 5 or 6 points, moderate risk (B) if 7 to 9 points, and poor operative risk (C) if 10 to 15 points. A “C” classification forecasts a survival of less than 12 months.|participants|Number|0|0.0||||||
4441553|NCT00108953|4265730|B1|>7||Child Pugh Status|The Child-Pugh score is used to classify the stages of liver cirrhosis, based on clinical diagnosis and laboratory tests. Assessment of good operative risk (A) if 5 or 6 points, moderate risk (B) if 7 to 9 points, and poor operative risk (C) if 10 to 15 points. A “C” classification forecasts a survival of less than 12 months.|participants|Number|0|0.0||||||
4441554|NCT00108953|4265728|B3|7 (Child-Pugh B)||Child Pugh Status|The Child-Pugh score is used to classify the stages of liver cirrhosis, based on clinical diagnosis and laboratory tests. Assessment of good operative risk (A) if 5 or 6 points, moderate risk (B) if 7 to 9 points, and poor operative risk (C) if 10 to 15 points. A “C” classification forecasts a survival of less than 12 months.|participants|Number|2|2.0||||||
4441555|NCT00108953|4265729|B2|7 (Child-Pugh B)||Child Pugh Status|The Child-Pugh score is used to classify the stages of liver cirrhosis, based on clinical diagnosis and laboratory tests. Assessment of good operative risk (A) if 5 or 6 points, moderate risk (B) if 7 to 9 points, and poor operative risk (C) if 10 to 15 points. A “C” classification forecasts a survival of less than 12 months.|participants|Number|2|2.0||||||
4441556|NCT00108953|4265730|B1|7 (Child-Pugh B)||Child Pugh Status|The Child-Pugh score is used to classify the stages of liver cirrhosis, based on clinical diagnosis and laboratory tests. Assessment of good operative risk (A) if 5 or 6 points, moderate risk (B) if 7 to 9 points, and poor operative risk (C) if 10 to 15 points. A “C” classification forecasts a survival of less than 12 months.|participants|Number|0|0.0||||||
4441557|NCT00108953|4265728|B3|6 (Child-Pugh A)||Child Pugh Status|The Child-Pugh score is used to classify the stages of liver cirrhosis, based on clinical diagnosis and laboratory tests. Assessment of good operative risk (A) if 5 or 6 points, moderate risk (B) if 7 to 9 points, and poor operative risk (C) if 10 to 15 points. A “C” classification forecasts a survival of less than 12 months.|participants|Number|36|36.0||||||
4441558|NCT00108953|4265729|B2|6 (Child-Pugh A)||Child Pugh Status|The Child-Pugh score is used to classify the stages of liver cirrhosis, based on clinical diagnosis and laboratory tests. Assessment of good operative risk (A) if 5 or 6 points, moderate risk (B) if 7 to 9 points, and poor operative risk (C) if 10 to 15 points. A “C” classification forecasts a survival of less than 12 months.|participants|Number|19|19.0||||||
4441608|NCT00108862|4265751|B3|Uganda||Region of Enrollment||participants|Number|29|29.0||||||
4441559|NCT00108953|4265730|B1|6 (Child-Pugh A)||Child Pugh Status|The Child-Pugh score is used to classify the stages of liver cirrhosis, based on clinical diagnosis and laboratory tests. Assessment of good operative risk (A) if 5 or 6 points, moderate risk (B) if 7 to 9 points, and poor operative risk (C) if 10 to 15 points. A “C” classification forecasts a survival of less than 12 months.|participants|Number|17|17.0||||||
4441560|NCT00108953|4265728|B3|5 (Child-Pugh A)||Child Pugh Status|The Child-Pugh score is used to classify the stages of liver cirrhosis, based on clinical diagnosis and laboratory tests. Assessment of good operative risk (A) if 5 or 6 points, moderate risk (B) if 7 to 9 points, and poor operative risk (C) if 10 to 15 points. A “C” classification forecasts a survival of less than 12 months.|participants|Number|58|58.0||||||
4441561|NCT00108953|4265729|B2|5 (Child-Pugh A)||Child Pugh Status|The Child-Pugh score is used to classify the stages of liver cirrhosis, based on clinical diagnosis and laboratory tests. Assessment of good operative risk (A) if 5 or 6 points, moderate risk (B) if 7 to 9 points, and poor operative risk (C) if 10 to 15 points. A “C” classification forecasts a survival of less than 12 months.|participants|Number|28|28.0||||||
4441562|NCT00108953|4265730|B1|5 (Child-Pugh A)||Child Pugh Status|The Child-Pugh score is used to classify the stages of liver cirrhosis, based on clinical diagnosis and laboratory tests. Assessment of good operative risk (A) if 5 or 6 points, moderate risk (B) if 7 to 9 points, and poor operative risk (C) if 10 to 15 points. A “C” classification forecasts a survival of less than 12 months.|participants|Number|30|30.0||||||
4441563|NCT00108953|4265728|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4441564|NCT00108953|4265729|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4441565|NCT00108953|4265730|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4441566|NCT00108953|4265728|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4441567|NCT00108953|4265729|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4441568|NCT00108953|4265730|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4441569|NCT00108953|4265728|B3|Median (Full Range)||Age||years|Median|65|65.0|Full Range|||38.0|82.0|
4441570|NCT00108953|4265729|B2|Median (Full Range)||Age||years|Median|65|65.0|Full Range|||38.0|81.0|
4441571|NCT00108953|4265730|B1|Median (Full Range)||Age||years|Median|66|66.0|Full Range|||38.0|82.0|
4441572|NCT00108862|4265751|B3|||Time to ART Start from Start of TB Medications||days|Median|14|14.0|Inter-Quartile Range|||10.0|70.0|
4441573|NCT00108862|4265752|B2|||Time to ART Start from Start of TB Medications||days|Median|70|70.0|Inter-Quartile Range|||66.0|75.0|
4441574|NCT00108862|4265753|B1|||Time to ART Start from Start of TB Medications||days|Median|10|10.0|Inter-Quartile Range|||7.0|12.0|
4441575|NCT00108862|4265751|B3|RIF and INH Sensitive TB||Drug-Resistant TB Status at Entry||participants|Number|792|792.0||||||
4441576|NCT00108862|4265752|B2|RIF and INH Sensitive TB||Drug-Resistant TB Status at Entry||participants|Number|392|392.0||||||
4441577|NCT00108862|4265753|B1|RIF and INH Sensitive TB||Drug-Resistant TB Status at Entry||participants|Number|400|400.0||||||
4441578|NCT00108862|4265751|B3|RIF and INH Resistant TB (Multi-Drug Resistant TB)||Drug-Resistant TB Status at Entry||participants|Number|5|5.0||||||
4441579|NCT00108862|4265752|B2|RIF and INH Resistant TB (Multi-Drug Resistant TB)||Drug-Resistant TB Status at Entry||participants|Number|4|4.0||||||
4441580|NCT00108862|4265753|B1|RIF and INH Resistant TB (Multi-Drug Resistant TB)||Drug-Resistant TB Status at Entry||participants|Number|1|1.0||||||
4441581|NCT00108862|4265751|B3|Isoniazid (INH) Resistant TB||Drug-Resistant TB Status at Entry||participants|Number|8|8.0||||||
4441582|NCT00108862|4265752|B2|Isoniazid (INH) Resistant TB||Drug-Resistant TB Status at Entry||participants|Number|5|5.0||||||
4441583|NCT00108862|4265753|B1|Isoniazid (INH) Resistant TB||Drug-Resistant TB Status at Entry||participants|Number|3|3.0||||||
4441584|NCT00108862|4265751|B3|Rifampin (RIF) Resistant TB||Drug-Resistant TB Status at Entry||participants|Number|1|1.0||||||
4441585|NCT00108862|4265752|B2|Rifampin (RIF) Resistant TB||Drug-Resistant TB Status at Entry||participants|Number|0|0.0||||||
4441586|NCT00108862|4265753|B1|Rifampin (RIF) Resistant TB||Drug-Resistant TB Status at Entry||participants|Number|1|1.0||||||
4441587|NCT00108862|4265751|B3|Not TB||TB Diagnosis Level at Entry||participants|Number|6|6.0||||||
4441588|NCT00108862|4265752|B2|Not TB||TB Diagnosis Level at Entry||participants|Number|2|2.0||||||
4441589|NCT00108862|4265753|B1|Not TB||TB Diagnosis Level at Entry||participants|Number|4|4.0||||||
4441590|NCT00108862|4265751|B3|Probable TB||TB Diagnosis Level at Entry||participants|Number|426|426.0||||||
4441591|NCT00108862|4265752|B2|Probable TB||TB Diagnosis Level at Entry||participants|Number|218|218.0||||||
4441592|NCT00108862|4265753|B1|Probable TB||TB Diagnosis Level at Entry||participants|Number|208|208.0||||||
4441593|NCT00108862|4265751|B3|Confirmed TB||TB Diagnosis Level at Entry||participants|Number|374|374.0||||||
4441594|NCT00108862|4265752|B2|Confirmed TB||TB Diagnosis Level at Entry||participants|Number|181|181.0||||||
4441595|NCT00108862|4265753|B1|Confirmed TB||TB Diagnosis Level at Entry||participants|Number|193|193.0||||||
4441596|NCT00108862|4265751|B3|Thailand||Region of Enrollment||participants|Number|5|5.0||||||
4441597|NCT00108862|4265752|B2|Thailand||Region of Enrollment||participants|Number|2|2.0||||||
4441598|NCT00108862|4265753|B1|Thailand||Region of Enrollment||participants|Number|3|3.0||||||
4441599|NCT00108862|4265751|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4441600|NCT00108862|4265752|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4441601|NCT00108862|4265753|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4441602|NCT00108862|4265751|B3|Haiti||Region of Enrollment||participants|Number|20|20.0||||||
4441603|NCT00108862|4265752|B2|Haiti||Region of Enrollment||participants|Number|8|8.0||||||
4441604|NCT00108862|4265753|B1|Haiti||Region of Enrollment||participants|Number|12|12.0||||||
4441605|NCT00108862|4265751|B3|Botswana||Region of Enrollment||participants|Number|28|28.0||||||
4441606|NCT00108862|4265752|B2|Botswana||Region of Enrollment||participants|Number|15|15.0||||||
4441609|NCT00108862|4265752|B2|Uganda||Region of Enrollment||participants|Number|14|14.0||||||
4441610|NCT00108862|4265753|B1|Uganda||Region of Enrollment||participants|Number|15|15.0||||||
4441611|NCT00108862|4265751|B3|Zimbabwe||Region of Enrollment||participants|Number|33|33.0||||||
4441612|NCT00108862|4265752|B2|Zimbabwe||Region of Enrollment||participants|Number|17|17.0||||||
4441613|NCT00108862|4265753|B1|Zimbabwe||Region of Enrollment||participants|Number|16|16.0||||||
4441614|NCT00108862|4265751|B3|Zambia||Region of Enrollment||participants|Number|34|34.0||||||
4441615|NCT00108862|4265752|B2|Zambia||Region of Enrollment||participants|Number|17|17.0||||||
4441616|NCT00108862|4265753|B1|Zambia||Region of Enrollment||participants|Number|17|17.0||||||
4441617|NCT00108862|4265751|B3|India||Region of Enrollment||participants|Number|47|47.0||||||
4441618|NCT00108862|4265752|B2|India||Region of Enrollment||participants|Number|21|21.0||||||
4441619|NCT00108862|4265753|B1|India||Region of Enrollment||participants|Number|26|26.0||||||
4441620|NCT00108862|4265751|B3|Peru||Region of Enrollment||participants|Number|48|48.0||||||
4441621|NCT00108862|4265752|B2|Peru||Region of Enrollment||participants|Number|25|25.0||||||
4441622|NCT00108862|4265753|B1|Peru||Region of Enrollment||participants|Number|23|23.0||||||
4441623|NCT00108862|4265751|B3|Kenya||Region of Enrollment||participants|Number|72|72.0||||||
4441624|NCT00108862|4265752|B2|Kenya||Region of Enrollment||participants|Number|36|36.0||||||
4441625|NCT00108862|4265753|B1|Kenya||Region of Enrollment||participants|Number|36|36.0||||||
4441626|NCT00108862|4265751|B3|Brazil||Region of Enrollment||participants|Number|113|113.0||||||
4441627|NCT00108862|4265752|B2|Brazil||Region of Enrollment||participants|Number|56|56.0||||||
4441628|NCT00108862|4265753|B1|Brazil||Region of Enrollment||participants|Number|57|57.0||||||
4441629|NCT00108862|4265751|B3|Malawi||Region of Enrollment||participants|Number|137|137.0||||||
4441630|NCT00108862|4265752|B2|Malawi||Region of Enrollment||participants|Number|68|68.0||||||
4441631|NCT00108862|4265753|B1|Malawi||Region of Enrollment||participants|Number|69|69.0||||||
4441632|NCT00108862|4265751|B3|South Africa||Region of Enrollment||participants|Number|221|221.0||||||
4441633|NCT00108862|4265752|B2|South Africa||Region of Enrollment||participants|Number|112|112.0||||||
4441634|NCT00108862|4265753|B1|South Africa||Region of Enrollment||participants|Number|109|109.0||||||
4441635|NCT00108862|4265751|B3||Male|Sex: Female, Male||Participants|Count of Participants|501|501.0||||||
4441636|NCT00108862|4265752|B2||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4441637|NCT00108862|4265753|B1||Male|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4441638|NCT00108862|4265751|B3||Female|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4441639|NCT00108862|4265752|B2||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4441640|NCT00108862|4265753|B1||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4441641|NCT00108862|4265751|B3|||Age||years|Median|34|34.0|Inter-Quartile Range|||29.0|41.0|
4441642|NCT00108862|4265752|B2|||Age||years|Median|34|34.0|Inter-Quartile Range|||29.0|42.0|
4441643|NCT00108862|4265753|B1|||Age||years|Median|34|34.0|Inter-Quartile Range|||29.0|40.0|
4441644|NCT00108862|4265751|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4441645|NCT00108862|4265752|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4441646|NCT00108862|4265753|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4441647|NCT00108862|4265751|B3||Between 18 and 65 years|Age||Participants|Count of Participants|801|801.0||||||
4441648|NCT00108862|4265752|B2||Between 18 and 65 years|Age||Participants|Count of Participants|398|398.0||||||
4441649|NCT00108862|4265753|B1||Between 18 and 65 years|Age||Participants|Count of Participants|403|403.0||||||
4441650|NCT00108862|4265751|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4441651|NCT00108862|4265752|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4441652|NCT00108862|4265753|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441653|NCT00108732|4265782|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4441654|NCT00108732|4265782|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441655|NCT00108732|4265782|B1|||Age||years|Median|62.5|62.5|Full Range|||48.0|77.0|
4441656|NCT00108628|4265789|B3|United States||Region of Enrollment||participants|Number|124|124.0||||||
4441657|NCT00108628|4265790|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4441658|NCT00108628|4265791|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4441659|NCT00108628|4265789|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4441660|NCT00108628|4265790|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4441661|NCT00108628|4265791|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4441662|NCT00108628|4265789|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441663|NCT00108628|4265790|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441664|NCT00108628|4265791|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441665|NCT00108628|4265789|B3|||Age||years|Mean|59.42|59.42|Standard Deviation|3.55|3.55|||
4441666|NCT00108628|4265790|B2|||Age||years|Mean|59.06|59.06|Standard Deviation|3.86|3.86|||
4441667|NCT00108628|4265791|B1|||Age||years|Mean|59.79|59.79|Standard Deviation|3.18|3.18|||
4441668|NCT00108550|4265816|B3|United States||Region of Enrollment||participants|Number|108|108.0||||||
4441669|NCT00108550|4265817|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
4441670|NCT00108550|4265818|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4441671|NCT00108550|4265816|B3||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4441672|NCT00108550|4265817|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4441673|NCT00108550|4265818|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4441674|NCT00108550|4265816|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4441675|NCT00108550|4265817|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4441676|NCT00108550|4265818|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4441677|NCT00108550|4265816|B3|||Age||years|Mean|56.04|56.04|Standard Deviation|10.23|10.23|||
4441678|NCT00108550|4265817|B2|||Age||years|Mean|54.62|54.62|Standard Deviation|11.38|11.38|||
4441679|NCT00108550|4265818|B1|||Age||years|Mean|57.40|57.4|Standard Deviation|8.88|8.88|||
4441680|NCT00108524|4265827|B3|United States||Region of Enrollment||participants|Number|146|146.0||||||
4441681|NCT00108524|4265828|B2|United States||Region of Enrollment||participants|Number|74|74.0||||||
4441682|NCT00108524|4265829|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4441683|NCT00108524|4265827|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4441684|NCT00108524|4265828|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4441685|NCT00108524|4265829|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4441686|NCT00108524|4265827|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4441687|NCT00108524|4265828|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4441688|NCT00108524|4265829|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4441689|NCT00108524|4265827|B3|||Age||years|Mean|52|52.0|Standard Deviation|10|10.0|||
4441690|NCT00108524|4265828|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|9.2|9.2|||
4441691|NCT00108524|4265829|B1|||Age||years|Mean|52.9|52.9|Standard Deviation|10.2|10.2|||
4441692|NCT00108524|4265827|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441693|NCT00108524|4265828|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441694|NCT00108524|4265829|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441695|NCT00108524|4265827|B3||Between 18 and 65 years|Age||Participants|Count of Participants|146|146.0||||||
4441696|NCT00108524|4265828|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4441697|NCT00108524|4265829|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4441698|NCT00108524|4265827|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441699|NCT00108524|4265828|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441700|NCT00108524|4265829|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441701|NCT00108485|4265840|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4441702|NCT00108485|4265841|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4441703|NCT00108485|4265842|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4441704|NCT00108485|4265840|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4441705|NCT00108485|4265841|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4441706|NCT00108485|4265842|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4441707|NCT00108485|4265840|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4441708|NCT00108485|4265841|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4441709|NCT00108485|4265842|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4441710|NCT00108485|4265840|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4441711|NCT00108485|4265841|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4441712|NCT00108485|4265842|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4441713|NCT00108485|4265840|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4441714|NCT00108485|4265841|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4441715|NCT00108485|4265842|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4441716|NCT00108485|4265840|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441717|NCT00108485|4265841|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441718|NCT00108485|4265842|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441719|NCT00108433|4265849|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4441720|NCT00108433|4265850|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4441721|NCT00108433|4265851|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4441722|NCT00108433|4265849|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4441723|NCT00108433|4265850|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4441724|NCT00108433|4265851|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4441725|NCT00108433|4265849|B3|||Age||years|Mean|52.0|52.0|Standard Deviation|16.6|16.6|||
4441726|NCT00108433|4265850|B2|||Age||years|Mean|49.7|49.7|Standard Deviation|15.4|15.4|||
4441727|NCT00108433|4265851|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|17.7|17.7|||
4441728|NCT00108355|4265866|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4441729|NCT00108355|4265867|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4441730|NCT00108355|4265868|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4441731|NCT00108355|4265866|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4441732|NCT00108355|4265867|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4441733|NCT00108355|4265868|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4441734|NCT00108355|4265866|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4441735|NCT00108355|4265867|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441736|NCT00108355|4265868|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4441737|NCT00108355|4265866|B3|age median||Age||years|Median|58|58.0|Inter-Quartile Range|8|8.0|51.0|63.0|
4441738|NCT00108355|4265867|B2|age median||Age||years|Median|60|60.0|Inter-Quartile Range|8.4|8.4|51.0|65.0|
4441739|NCT00108355|4265868|B1|age median||Age||years|Median|55|55.0|Inter-Quartile Range|7.5|7.5|51.0|61.0|
4441740|NCT00108355|4265866|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4441741|NCT00108355|4265867|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4441742|NCT00108355|4265868|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4441743|NCT00108355|4265866|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4441744|NCT00108355|4265867|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4441745|NCT00108355|4265868|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4441746|NCT00108355|4265866|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441747|NCT00108355|4265867|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441748|NCT00108355|4265868|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441749|NCT00108342|4265877|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4441750|NCT00108342|4265878|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4441751|NCT00108342|4265879|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4441752|NCT00108342|4265877|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4441753|NCT00108342|4265878|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4441754|NCT00108342|4265879|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4441755|NCT00108342|4265877|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4441756|NCT00108342|4265878|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4441757|NCT00108342|4265879|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4441758|NCT00108342|4265877|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441759|NCT00108342|4265878|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441760|NCT00108342|4265879|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441761|NCT00108342|4265877|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4441762|NCT00108342|4265878|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4441763|NCT00108342|4265879|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4441764|NCT00108342|4265877|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441765|NCT00108342|4265878|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441766|NCT00108342|4265879|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441767|NCT00108303|4265886|B4|||Sensory gating ratio|Ratio of the positive 50 millisecond component amplitude of the vertex auditory evoked potential in response to the second of \paired auditory tones|percent|Mean|58|58.0|Standard Deviation|12|12.0|||
4441768|NCT00108303|4265887|B3|||Sensory gating ratio|Ratio of the positive 50 millisecond component amplitude of the vertex auditory evoked potential in response to the second of \paired auditory tones|percent|Mean|34|34.0|Standard Deviation|9|9.0|||
4441769|NCT00108303|4265888|B2|||Sensory gating ratio|Ratio of the positive 50 millisecond component amplitude of the vertex auditory evoked potential in response to the second of \paired auditory tones|percent|Mean|49|49.0|Standard Deviation|16|16.0|||
4441770|NCT00108303|4265889|B1|||Sensory gating ratio|Ratio of the positive 50 millisecond component amplitude of the vertex auditory evoked potential in response to the second of \paired auditory tones|percent|Mean|68|68.0|Standard Deviation|12|12.0|||
4441771|NCT00108303|4265886|B4|United States||Region of Enrollment||participants|Number|538|538.0||||||
4441772|NCT00108303|4265887|B3|United States||Region of Enrollment||participants|Number|180|180.0||||||
4441773|NCT00108303|4265888|B2|United States||Region of Enrollment||participants|Number|179|179.0||||||
4441774|NCT00108303|4265889|B1|United States||Region of Enrollment||participants|Number|179|179.0||||||
4441775|NCT00108303|4265886|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4441776|NCT00108303|4265887|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4441777|NCT00108303|4265888|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4441778|NCT00108303|4265889|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4441779|NCT00108303|4265886|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4441780|NCT00108303|4265887|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4441781|NCT00108303|4265888|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4441782|NCT00108303|4265889|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4441783|NCT00108303|4265886|B4||White|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4441784|NCT00108303|4265887|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4441785|NCT00108303|4265888|B2||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4441786|NCT00108303|4265889|B1||White|Race (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4441787|NCT00108303|4265886|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4441788|NCT00108303|4265887|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4441789|NCT00108303|4265888|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4441790|NCT00108303|4265889|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4441791|NCT00108303|4265886|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4441792|NCT00108303|4265887|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4441793|NCT00108303|4265888|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4441794|NCT00108303|4265889|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4441795|NCT00108303|4265886|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4441796|NCT00108303|4265887|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4441797|NCT00108303|4265888|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4441798|NCT00108303|4265889|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4441799|NCT00108303|4265886|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4441800|NCT00108303|4265887|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4441801|NCT00108303|4265888|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4441802|NCT00108303|4265889|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4441803|NCT00108303|4265886|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441804|NCT00108303|4265887|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441805|NCT00108303|4265888|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441806|NCT00108303|4265889|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441807|NCT00108303|4265886|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|466|466.0||||||
4441808|NCT00108303|4265887|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
4441809|NCT00108303|4265888|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|156|156.0||||||
4441810|NCT00108303|4265889|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4441811|NCT00108303|4265886|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4441812|NCT00108303|4265887|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4441813|NCT00108303|4265888|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4441814|NCT00108303|4265889|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4441815|NCT00108303|4265886|B4||Male|Sex: Female, Male||Participants|Count of Participants|263|263.0||||||
4441816|NCT00108303|4265887|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4441817|NCT00108303|4265888|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4441818|NCT00108303|4265889|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4441819|NCT00108303|4265886|B4||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4441820|NCT00108303|4265887|B3||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4441821|NCT00108303|4265888|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4441822|NCT00108303|4265889|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4441823|NCT00108303|4265886|B4|||Age|Age at study was taken by asking the subjects how old they were.|years|Mean|42|42.0|Inter-Quartile Range|||21.0|63.0|
4441824|NCT00108303|4265887|B3|||Age|Age at study was taken by asking the subjects how old they were.|years|Mean|42|42.0|Inter-Quartile Range|||20.0|63.0|
4441825|NCT00108303|4265888|B2|||Age|Age at study was taken by asking the subjects how old they were.|years|Mean|41|41.0|Inter-Quartile Range|||20.0|62.0|
4441826|NCT00108303|4265889|B1|||Age|Age at study was taken by asking the subjects how old they were.|years|Mean|42|42.0|Inter-Quartile Range|||21.0|63.0|
4441827|NCT00108303|4265886|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441828|NCT00108303|4265887|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441829|NCT00108303|4265888|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441830|NCT00108303|4265889|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441831|NCT00108303|4265886|B4||Between 18 and 65 years|Age||Participants|Count of Participants|538|538.0||||||
4441832|NCT00108303|4265887|B3||Between 18 and 65 years|Age||Participants|Count of Participants|180|180.0||||||
4441833|NCT00108303|4265888|B2||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
4441834|NCT00108303|4265889|B1||Between 18 and 65 years|Age||Participants|Count of Participants|179|179.0||||||
4441835|NCT00108303|4265886|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441836|NCT00108303|4265887|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441837|NCT00108303|4265888|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441838|NCT00108303|4265889|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441839|NCT00108277|4265903|B4|||Episodic Anxiety Scale|Episodic Anxiety Scale (EAS) is a modification of the Panic Disorder Severity Scale (Shear et al., 1997) that includes 2 additional questions regarding acute anxiety episodes that may not meet full criteria for a panic attack. The EAS consists of 9 questions, each ranging from 0 (none) to 4 (worst possible). The EAS total score is the sum of all 9 items, such that the minimum total score = 0 (no anxiety symptoms) and maximum total score = 36 (worst possible anxiety symptoms).|units on a scale|Mean|15.8|15.8|Standard Deviation|3.73|3.73|||
4441889|NCT00108082|4265932|B1|Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4441890|NCT00108082|4265929|B4|White/Caucasian||Race/Ethnicity, Customized||participants|Number|206|206.0||||||
4441840|NCT00108277|4265904|B3|||Episodic Anxiety Scale|Episodic Anxiety Scale (EAS) is a modification of the Panic Disorder Severity Scale (Shear et al., 1997) that includes 2 additional questions regarding acute anxiety episodes that may not meet full criteria for a panic attack. The EAS consists of 9 questions, each ranging from 0 (none) to 4 (worst possible). The EAS total score is the sum of all 9 items, such that the minimum total score = 0 (no anxiety symptoms) and maximum total score = 36 (worst possible anxiety symptoms).|units on a scale|Mean|16.1|16.1|Standard Deviation|3.23|3.23|||
4441841|NCT00108277|4265905|B2|||Episodic Anxiety Scale|Episodic Anxiety Scale (EAS) is a modification of the Panic Disorder Severity Scale (Shear et al., 1997) that includes 2 additional questions regarding acute anxiety episodes that may not meet full criteria for a panic attack. The EAS consists of 9 questions, each ranging from 0 (none) to 4 (worst possible). The EAS total score is the sum of all 9 items, such that the minimum total score = 0 (no anxiety symptoms) and maximum total score = 36 (worst possible anxiety symptoms).|units on a scale|Mean|15.7|15.7|Standard Deviation|4.53|4.53|||
4441842|NCT00108277|4265906|B1|||Episodic Anxiety Scale|Episodic Anxiety Scale (EAS) is a modification of the Panic Disorder Severity Scale (Shear et al., 1997) that includes 2 additional questions regarding acute anxiety episodes that may not meet full criteria for a panic attack. The EAS consists of 9 questions, each ranging from 0 (none) to 4 (worst possible). The EAS total score is the sum of all 9 items, such that the minimum total score = 0 (no anxiety symptoms) and maximum total score = 36 (worst possible anxiety symptoms).|units on a scale|Mean|15.5|15.5|Standard Deviation|3.44|3.44|||
4441843|NCT00108277|4265903|B4|Other||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4441844|NCT00108277|4265904|B3|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4441845|NCT00108277|4265905|B2|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4441846|NCT00108277|4265906|B1|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4441847|NCT00108277|4265903|B4|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4441848|NCT00108277|4265904|B3|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4441849|NCT00108277|4265905|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4441850|NCT00108277|4265906|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4441851|NCT00108277|4265903|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4441852|NCT00108277|4265904|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4441853|NCT00108277|4265905|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4441854|NCT00108277|4265906|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4441855|NCT00108277|4265903|B4||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4441856|NCT00108277|4265904|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4441857|NCT00108277|4265905|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4441858|NCT00108277|4265906|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4441859|NCT00108277|4265903|B4|||Age||years|Mean|45.9|45.9|Standard Deviation|12.1|12.1|||
4441860|NCT00108277|4265904|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|10.9|10.9|||
4441861|NCT00108277|4265905|B2|||Age||years|Mean|40.6|40.6|Standard Deviation|12.2|12.2|||
4441862|NCT00108277|4265906|B1|||Age||years|Mean|47.3|47.3|Standard Deviation|13.2|13.2|||
4441863|NCT00108160|4265916|B3|MSSA Infection at Baseline||Baseline S. aureus Infection Strain||participants|Number|50|50.0||||||
4441864|NCT00108160|4265917|B2|MSSA Infection at Baseline||Baseline S. aureus Infection Strain||participants|Number|20|20.0||||||
4441865|NCT00108160|4265918|B1|MSSA Infection at Baseline||Baseline S. aureus Infection Strain||participants|Number|30|30.0||||||
4441866|NCT00108160|4265916|B3|MRSA Infection at Baseline||Baseline S. aureus Infection Strain||participants|Number|96|96.0||||||
4441867|NCT00108160|4265917|B2|MRSA Infection at Baseline||Baseline S. aureus Infection Strain||participants|Number|43|43.0||||||
4441868|NCT00108160|4265918|B1|MRSA Infection at Baseline||Baseline S. aureus Infection Strain||participants|Number|53|53.0||||||
4441869|NCT00108160|4265916|B3||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4441870|NCT00108160|4265917|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4441871|NCT00108160|4265918|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4441872|NCT00108160|4265916|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4441873|NCT00108160|4265917|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4441874|NCT00108160|4265918|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4441875|NCT00108160|4265916|B3|||Age||years|Mean|57.2|57.2|Full Range|||22.0|88.0|
4441876|NCT00108160|4265917|B2|||Age||years|Mean|57.9|57.9|Full Range|||22.0|80.0|
4441877|NCT00108160|4265918|B1|||Age||years|Mean|56.7|56.7|Full Range|||25.0|88.0|
4441878|NCT00108082|4265929|B4|Not Reported||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4441879|NCT00108082|4265930|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4441880|NCT00108082|4265931|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4441881|NCT00108082|4265932|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4441882|NCT00108082|4265929|B4|Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4441883|NCT00108082|4265930|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4441884|NCT00108082|4265931|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4441885|NCT00108082|4265932|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4441886|NCT00108082|4265929|B4|Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4441887|NCT00108082|4265930|B3|Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4441888|NCT00108082|4265931|B2|Arabic/North African Heritage||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4442003|NCT00107978|4266007|B2|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4441891|NCT00108082|4265930|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4441892|NCT00108082|4265931|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4441893|NCT00108082|4265932|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4441894|NCT00108082|4265929|B4|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4441895|NCT00108082|4265930|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4441896|NCT00108082|4265931|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4441897|NCT00108082|4265932|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4441898|NCT00108082|4265929|B4|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4441899|NCT00108082|4265930|B3|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4441900|NCT00108082|4265931|B2|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4441901|NCT00108082|4265932|B1|American Indian/Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4441902|NCT00108082|4265929|B4|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4441903|NCT00108082|4265930|B3|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4441904|NCT00108082|4265931|B2|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4441905|NCT00108082|4265932|B1|African American/African Heritage||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4441906|NCT00108082|4265929|B4||Male|Gender||Participants|Count of Participants|159|159.0||||||
4441907|NCT00108082|4265930|B3||Male|Gender||Participants|Count of Participants|49|49.0||||||
4441908|NCT00108082|4265931|B2||Male|Gender||Participants|Count of Participants|59|59.0||||||
4441909|NCT00108082|4265932|B1||Male|Gender||Participants|Count of Participants|51|51.0||||||
4441910|NCT00108082|4265929|B4||Female|Gender||Participants|Count of Participants|128|128.0||||||
4441911|NCT00108082|4265930|B3||Female|Gender||Participants|Count of Participants|47|47.0||||||
4441912|NCT00108082|4265931|B2||Female|Gender||Participants|Count of Participants|41|41.0||||||
4441913|NCT00108082|4265932|B1||Female|Gender||Participants|Count of Participants|40|40.0||||||
4441914|NCT00108082|4265929|B4|||Age||years|Mean|56.7|56.7|Standard Deviation|10.52|10.52|||
4441915|NCT00108082|4265930|B3|||Age||years|Mean|55.9|55.9|Standard Deviation|10.09|10.09|||
4441916|NCT00108082|4265931|B2|||Age||years|Mean|57.4|57.4|Standard Deviation|10.95|10.95|||
4441917|NCT00108082|4265932|B1|||Age||years|Mean|56.6|56.6|Standard Deviation|10.53|10.53|||
4441918|NCT00108069|4265981|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4441919|NCT00108069|4265982|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4441920|NCT00108069|4265983|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4441921|NCT00108069|4265981|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4441922|NCT00108069|4265982|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4441923|NCT00108069|4265983|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4441924|NCT00108069|4265981|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441925|NCT00108069|4265982|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441926|NCT00108069|4265983|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441927|NCT00108069|4265981|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4441928|NCT00108069|4265982|B2||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4441929|NCT00108069|4265983|B1||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4441930|NCT00108069|4265981|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441931|NCT00108069|4265982|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441932|NCT00108069|4265983|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441933|NCT00108069|4265981|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441934|NCT00108069|4265982|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441935|NCT00108069|4265983|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441936|NCT00108069|4265981|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4441937|NCT00108069|4265982|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441938|NCT00108069|4265983|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4441939|NCT00108069|4265981|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441940|NCT00108069|4265982|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441941|NCT00108069|4265983|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441942|NCT00108069|4265981|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4441943|NCT00108069|4265982|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441944|NCT00108069|4265983|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4441945|NCT00108069|4265981|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4441946|NCT00108069|4265982|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4441947|NCT00108069|4265983|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4441948|NCT00108069|4265981|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4441949|NCT00108069|4265982|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4441950|NCT00108069|4265983|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441951|NCT00108069|4265981|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4441952|NCT00108069|4265982|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4441953|NCT00108069|4265983|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4441954|NCT00108069|4265981|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4441955|NCT00108069|4265982|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4441956|NCT00108069|4265983|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4441957|NCT00108069|4265981|B3|||Age||years|Mean|44|44.0|Standard Deviation|11|11.0|||
4441958|NCT00108069|4265982|B2|||Age||years|Mean|42|42.0|Standard Deviation|10|10.0|||
4441959|NCT00108069|4265983|B1|||Age||years|Mean|46|46.0|Standard Deviation|12|12.0|||
4441960|NCT00108069|4265981|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4441961|NCT00108069|4265982|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4441962|NCT00108069|4265983|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4441963|NCT00108069|4265981|B3||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4441964|NCT00108069|4265982|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4441965|NCT00108069|4265983|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4441966|NCT00108069|4265981|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441967|NCT00108069|4265982|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441968|NCT00108069|4265983|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4441969|NCT00107991|4265998|B1|||BMI|Body mass index in kg/meters squared|kg/m^2|Median|35.1|35.1|Full Range|||17.9|47.5|
4441970|NCT00107991|4265998|B1|Cimetidine||Prior systemic and intralesional therapies||participants|Number|1|1.0||||||
4441971|NCT00107991|4265998|B1|Spironolactone||Prior systemic and intralesional therapies||participants|Number|1|1.0||||||
4441972|NCT00107991|4265998|B1|Nicomide||Prior systemic and intralesional therapies||participants|Number|1|1.0||||||
4441973|NCT00107991|4265998|B1|Ketoconazole||Prior systemic and intralesional therapies||participants|Number|1|1.0||||||
4441974|NCT00107991|4265998|B1|Injected antibiotics||Prior systemic and intralesional therapies||participants|Number|1|1.0||||||
4441975|NCT00107991|4265998|B1|Oral corticosteroids||Prior systemic and intralesional therapies||participants|Number|1|1.0||||||
4441976|NCT00107991|4265998|B1|Oral contraceptives||Prior systemic and intralesional therapies||participants|Number|2|2.0||||||
4441977|NCT00107991|4265998|B1|Intralesional corticosteroids||Prior systemic and intralesional therapies||participants|Number|3|3.0||||||
4441978|NCT00107991|4265998|B1|Surgery||Prior systemic and intralesional therapies||participants|Number|8|8.0||||||
4441979|NCT00107991|4265998|B1|Accutane||Prior systemic and intralesional therapies||participants|Number|9|9.0||||||
4441980|NCT00107991|4265998|B1|Oral antibiotics||Prior systemic and intralesional therapies||participants|Number|14|14.0||||||
4441981|NCT00107991|4265998|B1|||Duration of disease|Duration of time patient had hidradenitis suppurativa prior to trial (in years)|years|Median|12|12.0|Full Range|||1.0|36.0|
4441982|NCT00107991|4265998|B1|||Patient Pain Score|Patient self-report of pain on a 100-mm visual analog scale with 0 corresponding to no pain and 100 mm corresponding to severe pain|units on a scale|Median|6.4|6.4|Inter-Quartile Range|||4.5|7.4|
4441983|NCT00107991|4265998|B1|||No. of lesions|numbers of lesions (nodules and abscesses) as assessed by a physician|lesions|Median|14|14.0|Inter-Quartile Range|||8.0|19.0|
4441984|NCT00107991|4265998|B1|||Physician's Global Assessment Score (PGA)|PGA score on a 100 mm visual analog scale, with 0 mm corresponding to no active disease and 100 mm corresponding to very severe disease with multiple, painful inflammatory lesions.|units on a scale|Median|4.35|4.35|Inter-Quartile Range|||3.1|4.8|
4441985|NCT00107991|4265998|B1|||Dermatology Life Quality Index (DLQI)|The DLQI is a dermatology-specific health-related quality of life measure. The effect on a patient's life is as follows: 0-1=none; 2-5=small; 6-10=moderate; 11-20=very large; and 21-30=extremely large|units on a scale|Median|19|19.0|Inter-Quartile Range|||14.0|29.0|
4441986|NCT00107991|4265998|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441987|NCT00107991|4265998|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441988|NCT00107991|4265998|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4441989|NCT00107991|4265998|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4441990|NCT00107991|4265998|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441991|NCT00107991|4265998|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441992|NCT00107991|4265998|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4441993|NCT00107991|4265998|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4441994|NCT00107991|4265998|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4441995|NCT00107991|4265998|B1|||Age||years|Median|45|45.0|Inter-Quartile Range|||30.0|50.0|
4441996|NCT00107978|4266006|B3|Not diabetic||Diabetes Status||Participants|Number|708|708.0||||||
4441997|NCT00107978|4266007|B2|Not diabetic||Diabetes Status||Participants|Number|363|363.0||||||
4441998|NCT00107978|4266008|B1|Not diabetic||Diabetes Status||Participants|Number|345|345.0||||||
4441999|NCT00107978|4266006|B3|Diabetic||Diabetes Status||Participants|Number|231|231.0||||||
4442000|NCT00107978|4266007|B2|Diabetic||Diabetes Status||Participants|Number|118|118.0||||||
4442001|NCT00107978|4266008|B1|Diabetic||Diabetes Status||Participants|Number|113|113.0||||||
4442002|NCT00107978|4266006|B3|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4442004|NCT00107978|4266008|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4442005|NCT00107978|4266006|B3|Taiwan||Region of Enrollment||participants|Number|45|45.0||||||
4442006|NCT00107978|4266007|B2|Taiwan||Region of Enrollment||participants|Number|25|25.0||||||
4442007|NCT00107978|4266008|B1|Taiwan||Region of Enrollment||participants|Number|20|20.0||||||
4442008|NCT00107978|4266006|B3|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4442009|NCT00107978|4266007|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4442010|NCT00107978|4266008|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4442011|NCT00107978|4266006|B3|Poland||Region of Enrollment||participants|Number|81|81.0||||||
4442012|NCT00107978|4266007|B2|Poland||Region of Enrollment||participants|Number|43|43.0||||||
4442013|NCT00107978|4266008|B1|Poland||Region of Enrollment||participants|Number|38|38.0||||||
4442014|NCT00107978|4266006|B3|Peru||Region of Enrollment||participants|Number|5|5.0||||||
4442015|NCT00107978|4266007|B2|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4442016|NCT00107978|4266008|B1|Peru||Region of Enrollment||participants|Number|4|4.0||||||
4442017|NCT00107978|4266006|B3|Lithuania||Region of Enrollment||participants|Number|18|18.0||||||
4442018|NCT00107978|4266007|B2|Lithuania||Region of Enrollment||participants|Number|6|6.0||||||
4442019|NCT00107978|4266008|B1|Lithuania||Region of Enrollment||participants|Number|12|12.0||||||
4442020|NCT00107978|4266006|B3|Korea, Republic of||Region of Enrollment||participants|Number|30|30.0||||||
4442021|NCT00107978|4266007|B2|Korea, Republic of||Region of Enrollment||participants|Number|16|16.0||||||
4442022|NCT00107978|4266008|B1|Korea, Republic of||Region of Enrollment||participants|Number|14|14.0||||||
4442023|NCT00107978|4266006|B3|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4442024|NCT00107978|4266007|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4442025|NCT00107978|4266008|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4442026|NCT00107978|4266006|B3|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4442027|NCT00107978|4266007|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4442028|NCT00107978|4266008|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4442029|NCT00107978|4266006|B3|France||Region of Enrollment||participants|Number|2|2.0||||||
4442030|NCT00107978|4266007|B2|France||Region of Enrollment||participants|Number|2|2.0||||||
4442031|NCT00107978|4266008|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4442032|NCT00107978|4266006|B3|Chile||Region of Enrollment||participants|Number|3|3.0||||||
4442033|NCT00107978|4266007|B2|Chile||Region of Enrollment||participants|Number|2|2.0||||||
4442034|NCT00107978|4266008|B1|Chile||Region of Enrollment||participants|Number|1|1.0||||||
4442035|NCT00107978|4266006|B3|Canada||Region of Enrollment||participants|Number|64|64.0||||||
4442036|NCT00107978|4266007|B2|Canada||Region of Enrollment||participants|Number|29|29.0||||||
4442037|NCT00107978|4266008|B1|Canada||Region of Enrollment||participants|Number|35|35.0||||||
4442038|NCT00107978|4266006|B3|Argentina||Region of Enrollment||participants|Number|68|68.0||||||
4442039|NCT00107978|4266007|B2|Argentina||Region of Enrollment||participants|Number|33|33.0||||||
4442040|NCT00107978|4266008|B1|Argentina||Region of Enrollment||participants|Number|35|35.0||||||
4442041|NCT00107978|4266006|B3|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
4442042|NCT00107978|4266007|B2|South Africa||Region of Enrollment||participants|Number|6|6.0||||||
4442043|NCT00107978|4266008|B1|South Africa||Region of Enrollment||participants|Number|6|6.0||||||
4442044|NCT00107978|4266006|B3|United States||Region of Enrollment||participants|Number|597|597.0||||||
4442045|NCT00107978|4266007|B2|United States||Region of Enrollment||participants|Number|310|310.0||||||
4442046|NCT00107978|4266008|B1|United States||Region of Enrollment||participants|Number|287|287.0||||||
4442047|NCT00107978|4266006|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442048|NCT00107978|4266007|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442049|NCT00107978|4266008|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442050|NCT00107978|4266006|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4442051|NCT00107978|4266007|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4442052|NCT00107978|4266008|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4442053|NCT00107978|4266006|B3||White|Race (NIH/OMB)||Participants|Count of Participants|679|679.0||||||
4442054|NCT00107978|4266007|B2||White|Race (NIH/OMB)||Participants|Count of Participants|343|343.0||||||
4442055|NCT00107978|4266008|B1||White|Race (NIH/OMB)||Participants|Count of Participants|336|336.0||||||
4442056|NCT00107978|4266006|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|143|143.0||||||
4442057|NCT00107978|4266007|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4442058|NCT00107978|4266008|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4442059|NCT00107978|4266006|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4442060|NCT00107978|4266007|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4442061|NCT00107978|4266008|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4442062|NCT00107978|4266006|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4442063|NCT00107978|4266007|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4442064|NCT00107978|4266008|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4442065|NCT00107978|4266006|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4442066|NCT00107978|4266007|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4442067|NCT00107978|4266008|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4442068|NCT00107978|4266006|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442069|NCT00107978|4266007|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442070|NCT00107978|4266008|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442071|NCT00107978|4266006|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|776|776.0||||||
4442072|NCT00107978|4266007|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|397|397.0||||||
4442073|NCT00107978|4266008|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|379|379.0||||||
4442074|NCT00107978|4266006|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|163|163.0||||||
4442075|NCT00107978|4266007|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4442076|NCT00107978|4266008|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4442077|NCT00107978|4266006|B3||Male|Sex: Female, Male||Participants|Count of Participants|552|552.0||||||
4442078|NCT00107978|4266007|B2||Male|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4442079|NCT00107978|4266008|B1||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4442080|NCT00107978|4266006|B3||Female|Sex: Female, Male||Participants|Count of Participants|387|387.0||||||
4442081|NCT00107978|4266007|B2||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4442082|NCT00107978|4266008|B1||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4442083|NCT00107978|4266006|B3|||Age||years|Mean|49.5|49.5|Standard Deviation|16.6|16.6|||
4442084|NCT00107978|4266007|B2|||Age||years|Mean|49.9|49.9|Standard Deviation|17.0|17.0|||
4442085|NCT00107978|4266008|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|16.1|16.1|||
4442086|NCT00107978|4266006|B3||>=65 years|Age||Participants|Count of Participants|183|183.0||||||
4442087|NCT00107978|4266007|B2||>=65 years|Age||Participants|Count of Participants|102|102.0||||||
4442088|NCT00107978|4266008|B1||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4442089|NCT00107978|4266006|B3||Between 18 and 65 years|Age||Participants|Count of Participants|756|756.0||||||
4442090|NCT00107978|4266007|B2||Between 18 and 65 years|Age||Participants|Count of Participants|379|379.0||||||
4442091|NCT00107978|4266008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|377|377.0||||||
4442092|NCT00107978|4266006|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442093|NCT00107978|4266007|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442094|NCT00107978|4266008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442095|NCT00107952|4266015|B3|Non-ventilated||Ventilator Status||Participants|Number|405|405.0||||||
4442096|NCT00107952|4266016|B2|Non-ventilated||Ventilator Status||Participants|Number|203|203.0||||||
4442097|NCT00107952|4266017|B1|Non-ventilated||Ventilator Status||Participants|Number|202|202.0||||||
4442098|NCT00107952|4266015|B3|Ventilated||Ventilator Status||Participants|Number|341|341.0||||||
4442099|NCT00107952|4266016|B2|Ventilated||Ventilator Status||Participants|Number|171|171.0||||||
4442100|NCT00107952|4266017|B1|Ventilated||Ventilator Status||Participants|Number|170|170.0||||||
4442101|NCT00107952|4266015|B3|No prior history of pneumonia||History of Pneumonia||participants|Number|631|631.0||||||
4442102|NCT00107952|4266016|B2|No prior history of pneumonia||History of Pneumonia||participants|Number|321|321.0||||||
4442103|NCT00107952|4266017|B1|No prior history of pneumonia||History of Pneumonia||participants|Number|310|310.0||||||
4442104|NCT00107952|4266015|B3|Prior history of pneumonia||History of Pneumonia||participants|Number|115|115.0||||||
4442105|NCT00107952|4266016|B2|Prior history of pneumonia||History of Pneumonia||participants|Number|53|53.0||||||
4442106|NCT00107952|4266017|B1|Prior history of pneumonia||History of Pneumonia||participants|Number|62|62.0||||||
4442107|NCT00107952|4266015|B3|Non-Diabetic||Diabetes Status||Participants|Number|546|546.0||||||
4442108|NCT00107952|4266016|B2|Non-Diabetic||Diabetes Status||Participants|Number|274|274.0||||||
4442109|NCT00107952|4266017|B1|Non-Diabetic||Diabetes Status||Participants|Number|272|272.0||||||
4442110|NCT00107952|4266015|B3|Diabetic||Diabetes Status||Participants|Number|200|200.0||||||
4442111|NCT00107952|4266016|B2|Diabetic||Diabetes Status||Participants|Number|100|100.0||||||
4442112|NCT00107952|4266017|B1|Diabetic||Diabetes Status||Participants|Number|100|100.0||||||
4442113|NCT00107952|4266015|B3|United States||Region of Enrollment||participants|Number|230|230.0||||||
4442114|NCT00107952|4266016|B2|United States||Region of Enrollment||participants|Number|113|113.0||||||
4442115|NCT00107952|4266017|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
4442116|NCT00107952|4266015|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4442117|NCT00107952|4266016|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4442118|NCT00107952|4266017|B1|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4442119|NCT00107952|4266015|B3|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
4442120|NCT00107952|4266016|B2|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4442121|NCT00107952|4266017|B1|Turkey||Region of Enrollment||participants|Number|2|2.0||||||
4442122|NCT00107952|4266015|B3|Taiwan||Region of Enrollment||participants|Number|63|63.0||||||
4442123|NCT00107952|4266016|B2|Taiwan||Region of Enrollment||participants|Number|34|34.0||||||
4442124|NCT00107952|4266017|B1|Taiwan||Region of Enrollment||participants|Number|29|29.0||||||
4442125|NCT00107952|4266015|B3|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4442126|NCT00107952|4266016|B2|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4442127|NCT00107952|4266017|B1|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4442128|NCT00107952|4266015|B3|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4442129|NCT00107952|4266016|B2|Poland||Region of Enrollment||participants|Number|2|2.0||||||
4442130|NCT00107952|4266017|B1|Poland||Region of Enrollment||participants|Number|0|0.0||||||
4442131|NCT00107952|4266015|B3|Peru||Region of Enrollment||participants|Number|5|5.0||||||
4442132|NCT00107952|4266016|B2|Peru||Region of Enrollment||participants|Number|3|3.0||||||
4442133|NCT00107952|4266017|B1|Peru||Region of Enrollment||participants|Number|2|2.0||||||
4442134|NCT00107952|4266015|B3|Malta||Region of Enrollment||participants|Number|3|3.0||||||
4442135|NCT00107952|4266016|B2|Malta||Region of Enrollment||participants|Number|1|1.0||||||
4442136|NCT00107952|4266017|B1|Malta||Region of Enrollment||participants|Number|2|2.0||||||
4442137|NCT00107952|4266015|B3|Malaysia||Region of Enrollment||participants|Number|20|20.0||||||
4442138|NCT00107952|4266016|B2|Malaysia||Region of Enrollment||participants|Number|7|7.0||||||
4442139|NCT00107952|4266017|B1|Malaysia||Region of Enrollment||participants|Number|13|13.0||||||
4442140|NCT00107952|4266015|B3|Italy||Region of Enrollment||participants|Number|7|7.0||||||
4442141|NCT00107952|4266016|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4442142|NCT00107952|4266017|B1|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4442143|NCT00107952|4266015|B3|Israel||Region of Enrollment||participants|Number|49|49.0||||||
4442144|NCT00107952|4266016|B2|Israel||Region of Enrollment||participants|Number|24|24.0||||||
4442145|NCT00107952|4266017|B1|Israel||Region of Enrollment||participants|Number|25|25.0||||||
4442146|NCT00107952|4266015|B3|India||Region of Enrollment||participants|Number|85|85.0||||||
4442147|NCT00107952|4266016|B2|India||Region of Enrollment||participants|Number|41|41.0||||||
4442148|NCT00107952|4266017|B1|India||Region of Enrollment||participants|Number|44|44.0||||||
4442149|NCT00107952|4266015|B3|Greece||Region of Enrollment||participants|Number|12|12.0||||||
4442150|NCT00107952|4266016|B2|Greece||Region of Enrollment||participants|Number|8|8.0||||||
4442151|NCT00107952|4266017|B1|Greece||Region of Enrollment||participants|Number|4|4.0||||||
4442152|NCT00107952|4266015|B3|France||Region of Enrollment||participants|Number|32|32.0||||||
4442153|NCT00107952|4266016|B2|France||Region of Enrollment||participants|Number|17|17.0||||||
4442154|NCT00107952|4266017|B1|France||Region of Enrollment||participants|Number|15|15.0||||||
4442155|NCT00107952|4266015|B3|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4442156|NCT00107952|4266016|B2|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4442157|NCT00107952|4266017|B1|Czech Republic||Region of Enrollment||participants|Number|0|0.0||||||
4442158|NCT00107952|4266015|B3|Croatia||Region of Enrollment||participants|Number|59|59.0||||||
4442159|NCT00107952|4266016|B2|Croatia||Region of Enrollment||participants|Number|31|31.0||||||
4442160|NCT00107952|4266017|B1|Croatia||Region of Enrollment||participants|Number|28|28.0||||||
4442161|NCT00107952|4266015|B3|Chile||Region of Enrollment||participants|Number|14|14.0||||||
4442162|NCT00107952|4266016|B2|Chile||Region of Enrollment||participants|Number|5|5.0||||||
4442163|NCT00107952|4266017|B1|Chile||Region of Enrollment||participants|Number|9|9.0||||||
4442164|NCT00107952|4266015|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4442165|NCT00107952|4266016|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4442166|NCT00107952|4266017|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4442167|NCT00107952|4266015|B3|Brazil||Region of Enrollment||participants|Number|26|26.0||||||
4442168|NCT00107952|4266016|B2|Brazil||Region of Enrollment||participants|Number|14|14.0||||||
4442169|NCT00107952|4266017|B1|Brazil||Region of Enrollment||participants|Number|12|12.0||||||
4442170|NCT00107952|4266015|B3|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4442171|NCT00107952|4266016|B2|Belgium||Region of Enrollment||participants|Number|5|5.0||||||
4442172|NCT00107952|4266017|B1|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4442173|NCT00107952|4266015|B3|Australia||Region of Enrollment||participants|Number|45|45.0||||||
4442174|NCT00107952|4266016|B2|Australia||Region of Enrollment||participants|Number|25|25.0||||||
4442175|NCT00107952|4266017|B1|Australia||Region of Enrollment||participants|Number|20|20.0||||||
4442176|NCT00107952|4266015|B3|Argentina||Region of Enrollment||participants|Number|48|48.0||||||
4442177|NCT00107952|4266016|B2|Argentina||Region of Enrollment||participants|Number|24|24.0||||||
4442178|NCT00107952|4266017|B1|Argentina||Region of Enrollment||participants|Number|24|24.0||||||
4442179|NCT00107952|4266015|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442180|NCT00107952|4266016|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442181|NCT00107952|4266017|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442182|NCT00107952|4266015|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4442183|NCT00107952|4266016|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442184|NCT00107952|4266017|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442185|NCT00107952|4266015|B3||White|Race (NIH/OMB)||Participants|Count of Participants|539|539.0||||||
4442186|NCT00107952|4266016|B2||White|Race (NIH/OMB)||Participants|Count of Participants|272|272.0||||||
4442187|NCT00107952|4266017|B1||White|Race (NIH/OMB)||Participants|Count of Participants|267|267.0||||||
4442188|NCT00107952|4266015|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4442189|NCT00107952|4266016|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4442190|NCT00107952|4266017|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4442191|NCT00107952|4266015|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442192|NCT00107952|4266016|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442193|NCT00107952|4266017|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442194|NCT00107952|4266015|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|178|178.0||||||
4442195|NCT00107952|4266016|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4442196|NCT00107952|4266017|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4442197|NCT00107952|4266015|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4442198|NCT00107952|4266016|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442199|NCT00107952|4266017|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4442200|NCT00107952|4266015|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442201|NCT00107952|4266016|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442202|NCT00107952|4266017|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442203|NCT00107952|4266015|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|602|602.0||||||
4442204|NCT00107952|4266016|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|308|308.0||||||
4442205|NCT00107952|4266017|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|294|294.0||||||
4442206|NCT00107952|4266015|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4442207|NCT00107952|4266016|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4442208|NCT00107952|4266017|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4442209|NCT00107952|4266015|B3||Male|Sex: Female, Male||Participants|Count of Participants|448|448.0||||||
4442210|NCT00107952|4266016|B2||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4442211|NCT00107952|4266017|B1||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4442212|NCT00107952|4266015|B3||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4442213|NCT00107952|4266016|B2||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4442214|NCT00107952|4266017|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4442215|NCT00107952|4266015|B3|||Age||years|Mean|64|64.0|Standard Deviation|18.3|18.3|||
4442216|NCT00107952|4266016|B2|||Age||years|Mean|64|64.0|Standard Deviation|17.3|17.3|||
4442217|NCT00107952|4266017|B1|||Age||years|Mean|63|63.0|Standard Deviation|19.2|19.2|||
4442218|NCT00107952|4266015|B3||>=65 years|Age||Participants|Count of Participants|414|414.0||||||
4442219|NCT00107952|4266016|B2||>=65 years|Age||Participants|Count of Participants|212|212.0||||||
4442220|NCT00107952|4266017|B1||>=65 years|Age||Participants|Count of Participants|202|202.0||||||
4442221|NCT00107952|4266015|B3||Between 18 and 65 years|Age||Participants|Count of Participants|332|332.0||||||
4442222|NCT00107952|4266016|B2||Between 18 and 65 years|Age||Participants|Count of Participants|162|162.0||||||
4442223|NCT00107952|4266017|B1||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
4442224|NCT00107952|4266015|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442225|NCT00107952|4266016|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442226|NCT00107952|4266017|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442227|NCT00107900|4266024|B7|Europe||Region of Enrollment||participants|Number|400|400.0||||||
4442228|NCT00107900|4266025|B6|Europe||Region of Enrollment||participants|Number|76|76.0||||||
4442229|NCT00107900|4266026|B5|Europe||Region of Enrollment||participants|Number|80|80.0||||||
4442230|NCT00107900|4266027|B4|Europe||Region of Enrollment||participants|Number|75|75.0||||||
4442231|NCT00107900|4266028|B3|Europe||Region of Enrollment||participants|Number|40|40.0||||||
4442232|NCT00107900|4266029|B2|Europe||Region of Enrollment||participants|Number|64|64.0||||||
4442233|NCT00107900|4266030|B1|Europe||Region of Enrollment||participants|Number|65|65.0||||||
4442234|NCT00107900|4266024|B7|United States||Region of Enrollment||participants|Number|206|206.0||||||
4442235|NCT00107900|4266025|B6|United States||Region of Enrollment||participants|Number|27|27.0||||||
4442236|NCT00107900|4266026|B5|United States||Region of Enrollment||participants|Number|35|35.0||||||
4442237|NCT00107900|4266027|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4442238|NCT00107900|4266028|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
4442239|NCT00107900|4266029|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4442240|NCT00107900|4266030|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4442241|NCT00107900|4266024|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|400|400.0||||||
4442242|NCT00107900|4266025|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4442243|NCT00107900|4266026|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4442244|NCT00107900|4266027|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4442245|NCT00107900|4266028|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4442246|NCT00107900|4266029|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4442247|NCT00107900|4266030|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4442248|NCT00107900|4266024|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
4442249|NCT00107900|4266025|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4442250|NCT00107900|4266026|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4442251|NCT00107900|4266027|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4442252|NCT00107900|4266028|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4442253|NCT00107900|4266029|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4442254|NCT00107900|4266030|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4442255|NCT00107900|4266024|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4442256|NCT00107900|4266025|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442257|NCT00107900|4266026|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4442258|NCT00107900|4266027|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4442259|NCT00107900|4266028|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4442260|NCT00107900|4266029|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442261|NCT00107900|4266030|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442262|NCT00107900|4266024|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4442263|NCT00107900|4266025|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442264|NCT00107900|4266026|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4442265|NCT00107900|4266027|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442266|NCT00107900|4266028|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4442267|NCT00107900|4266029|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442268|NCT00107900|4266030|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442269|NCT00107900|4266024|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442270|NCT00107900|4266025|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442271|NCT00107900|4266026|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442272|NCT00107900|4266027|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442273|NCT00107900|4266028|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442274|NCT00107900|4266029|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442275|NCT00107900|4266030|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442276|NCT00107900|4266024|B7||White|Race (NIH/OMB)||Participants|Count of Participants|578|578.0||||||
4442277|NCT00107900|4266025|B6||White|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4442278|NCT00107900|4266026|B5||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4442279|NCT00107900|4266027|B4||White|Race (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4442280|NCT00107900|4266028|B3||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4442281|NCT00107900|4266029|B2||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4442282|NCT00107900|4266030|B1||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4442283|NCT00107900|4266024|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4442284|NCT00107900|4266025|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4442285|NCT00107900|4266026|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4442286|NCT00107900|4266027|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442287|NCT00107900|4266028|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4442288|NCT00107900|4266029|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442289|NCT00107900|4266030|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442290|NCT00107900|4266024|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442291|NCT00107900|4266025|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442292|NCT00107900|4266026|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442293|NCT00107900|4266027|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442294|NCT00107900|4266028|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442295|NCT00107900|4266029|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442296|NCT00107900|4266030|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442297|NCT00107900|4266024|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442298|NCT00107900|4266025|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442299|NCT00107900|4266026|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442300|NCT00107900|4266027|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442301|NCT00107900|4266028|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442302|NCT00107900|4266029|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442303|NCT00107900|4266030|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442304|NCT00107900|4266024|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442305|NCT00107900|4266025|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442306|NCT00107900|4266026|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442307|NCT00107900|4266027|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442308|NCT00107900|4266028|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442309|NCT00107900|4266029|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442310|NCT00107900|4266030|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442311|NCT00107900|4266024|B7||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4442312|NCT00107900|4266025|B6||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4442313|NCT00107900|4266026|B5||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4442314|NCT00107900|4266027|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4442315|NCT00107900|4266028|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4442316|NCT00107900|4266029|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4442317|NCT00107900|4266030|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4442318|NCT00107900|4266024|B7||Female|Sex: Female, Male||Participants|Count of Participants|350|350.0||||||
4442319|NCT00107900|4266025|B6||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4442320|NCT00107900|4266026|B5||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4442321|NCT00107900|4266027|B4||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4442322|NCT00107900|4266028|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4442323|NCT00107900|4266029|B2||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4442324|NCT00107900|4266030|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4442325|NCT00107900|4266024|B7||>=65 years|Age||Participants|Count of Participants|210|210.0||||||
4442326|NCT00107900|4266025|B6||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4442327|NCT00107900|4266026|B5||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4442328|NCT00107900|4266027|B4||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4442329|NCT00107900|4266028|B3||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4442330|NCT00107900|4266029|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4442331|NCT00107900|4266030|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4442332|NCT00107900|4266024|B7||Between 18 and 65 years|Age||Participants|Count of Participants|396|396.0||||||
4442333|NCT00107900|4266025|B6||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4442334|NCT00107900|4266026|B5||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4442335|NCT00107900|4266027|B4||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4442336|NCT00107900|4266028|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4442337|NCT00107900|4266029|B2||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4442338|NCT00107900|4266030|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4442339|NCT00107900|4266024|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442340|NCT00107900|4266025|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442341|NCT00107900|4266026|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442342|NCT00107900|4266027|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442343|NCT00107900|4266028|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442344|NCT00107900|4266029|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442345|NCT00107900|4266030|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442346|NCT00107900|4266024|B7|||Age||years|Mean|58.5|58.5|Standard Deviation|12.25|12.25|||
4442347|NCT00107900|4266025|B6|||Age||years|Mean|56.5|56.5|Standard Deviation|12.83|12.83|||
4442348|NCT00107900|4266026|B5|||Age||years|Mean|58.8|58.8|Standard Deviation|12.80|12.8|||
4442349|NCT00107900|4266027|B4|||Age||years|Mean|58.6|58.6|Standard Deviation|11.90|11.9|||
4442350|NCT00107900|4266028|B3|||Age||years|Mean|60.1|60.1|Standard Deviation|13.09|13.09|||
4442351|NCT00107900|4266029|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|11.06|11.06|||
4442352|NCT00107900|4266030|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|10.71|10.71|||
4442353|NCT00107783|4266067|B3|||6 minute walk test|The 6MWT measures the distance that a patient can quickly walk on a flat hard surface in a period of six minutes.|ft|Mean|1457|1457.0|Standard Deviation|319|319.0|||
4442354|NCT00107783|4266068|B2|||6 minute walk test|The 6MWT measures the distance that a patient can quickly walk on a flat hard surface in a period of six minutes.|ft|Mean|1336|1336.0|Standard Deviation|369|369.0|||
4442355|NCT00107783|4266069|B1|||6 minute walk test|The 6MWT measures the distance that a patient can quickly walk on a flat hard surface in a period of six minutes.|ft|Mean|1578|1578.0|Standard Deviation|205|205.0|||
4442356|NCT00107783|4266067|B3|||Timed get up and go|In timed get up and go, the patient is asked to stand up from a standard chair and walk a distance of 3 meters, turn around and walk back to the chair and sit down. The examiner measures the time it takes for the patient to perform this series of tasks.|seconds|Mean|8.63|8.63|Standard Deviation|3.21|3.21|||
4442357|NCT00107783|4266068|B2|||Timed get up and go|In timed get up and go, the patient is asked to stand up from a standard chair and walk a distance of 3 meters, turn around and walk back to the chair and sit down. The examiner measures the time it takes for the patient to perform this series of tasks.|seconds|Mean|9.70|9.7|Standard Deviation|4.10|4.1|||
4442403|NCT00107744|4266086|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442358|NCT00107783|4266069|B1|||Timed get up and go|In timed get up and go, the patient is asked to stand up from a standard chair and walk a distance of 3 meters, turn around and walk back to the chair and sit down. The examiner measures the time it takes for the patient to perform this series of tasks.|seconds|Mean|7.56|7.56|Standard Deviation|1.40|1.4|||
4442359|NCT00107783|4266067|B3|||Functional Reach Assessment|Functional reach assessment measures the difference between the length of a person's outstretched arm and their maximal reach forward, while maintaining balance.|cm|Mean|9.60|9.6|Standard Deviation|3.04|3.04|||
4442360|NCT00107783|4266068|B2|||Functional Reach Assessment|Functional reach assessment measures the difference between the length of a person's outstretched arm and their maximal reach forward, while maintaining balance.|cm|Mean|8.98|8.98|Standard Deviation|3.10|3.1|||
4442361|NCT00107783|4266069|B1|||Functional Reach Assessment|Functional reach assessment measures the difference between the length of a person's outstretched arm and their maximal reach forward, while maintaining balance.|cm|Mean|10.22|10.22|Standard Deviation|2.92|2.92|||
4442362|NCT00107783|4266067|B3|||Schober's test|Schober's test measures a patient's ability to flex his/her lower back. The examiner makes a mark at L5 (fifth lumbar vertebra) and places one finger 5 cm below and another finger 10 cm above this mark. The patient is asked to touch his/her toes. The examiner measures the increase in distance between the two fingers.|cm|Mean|11.14|11.14|Standard Deviation|0.93|0.93|||
4442363|NCT00107783|4266068|B2|||Schober's test|Schober's test measures a patient's ability to flex his/her lower back. The examiner makes a mark at L5 (fifth lumbar vertebra) and places one finger 5 cm below and another finger 10 cm above this mark. The patient is asked to touch his/her toes. The examiner measures the increase in distance between the two fingers.|cm|Mean|10.86|10.86|Standard Deviation|0.73|0.73|||
4442364|NCT00107783|4266069|B1|||Schober's test|Schober's test measures a patient's ability to flex his/her lower back. The examiner makes a mark at L5 (fifth lumbar vertebra) and places one finger 5 cm below and another finger 10 cm above this mark. The patient is asked to touch his/her toes. The examiner measures the increase in distance between the two fingers.|cm|Mean|11.42|11.42|Standard Deviation|1.04|1.04|||
4442365|NCT00107783|4266067|B3|||Total Range of Motion (ROM) Worse Hip|The total (internal + external) range of motion (ROM) of the worse hip.|degrees|Mean|42.7|42.7|Standard Deviation|14.8|14.8|||
4442366|NCT00107783|4266068|B2|||Total Range of Motion (ROM) Worse Hip|The total (internal + external) range of motion (ROM) of the worse hip.|degrees|Mean|39.0|39.0|Standard Deviation|12.7|12.7|||
4442367|NCT00107783|4266069|B1|||Total Range of Motion (ROM) Worse Hip|The total (internal + external) range of motion (ROM) of the worse hip.|degrees|Mean|46.4|46.4|Standard Deviation|16.1|16.1|||
4442368|NCT00107783|4266067|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4442369|NCT00107783|4266068|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4442370|NCT00107783|4266069|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4442371|NCT00107783|4266067|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4442372|NCT00107783|4266068|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4442373|NCT00107783|4266069|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4442374|NCT00107783|4266067|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4442375|NCT00107783|4266068|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4442376|NCT00107783|4266069|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4442377|NCT00107783|4266067|B3|||Age||years|Mean|51.7|51.7|Standard Deviation|7.1|7.1|||
4442378|NCT00107783|4266068|B2|||Age||years|Mean|52.2|52.2|Standard Deviation|7.9|7.9|||
4442379|NCT00107783|4266069|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|6.5|6.5|||
4442380|NCT00107783|4266067|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4442381|NCT00107783|4266068|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4442382|NCT00107783|4266069|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4442383|NCT00107783|4266067|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4442384|NCT00107783|4266068|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4442385|NCT00107783|4266069|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4442386|NCT00107783|4266067|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442387|NCT00107783|4266068|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442388|NCT00107783|4266069|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442389|NCT00107744|4266084|B4|||Systolic Blood Pressure||mmHg|Mean|126.7|126.7|Standard Deviation|10.0|10.0|||
4442390|NCT00107744|4266085|B3|||Systolic Blood Pressure||mmHg|Mean|126.1|126.1|Standard Deviation|9.7|9.7|||
4442391|NCT00107744|4266086|B2|||Systolic Blood Pressure||mmHg|Mean|126.7|126.7|Standard Deviation|11.0|11.0|||
4442392|NCT00107744|4266087|B1|||Systolic Blood Pressure||mmHg|Mean|127.2|127.2|Standard Deviation|9.3|9.3|||
4442393|NCT00107744|4266084|B4|United States||Region of Enrollment||participants|Number|352|352.0||||||
4442394|NCT00107744|4266085|B3|United States||Region of Enrollment||participants|Number|118|118.0||||||
4442395|NCT00107744|4266086|B2|United States||Region of Enrollment||participants|Number|117|117.0||||||
4442396|NCT00107744|4266087|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
4442397|NCT00107744|4266084|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442398|NCT00107744|4266085|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442399|NCT00107744|4266086|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442400|NCT00107744|4266087|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442401|NCT00107744|4266084|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442402|NCT00107744|4266085|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442404|NCT00107744|4266087|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442405|NCT00107744|4266084|B4||White|Race (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
4442406|NCT00107744|4266085|B3||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4442407|NCT00107744|4266086|B2||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4442408|NCT00107744|4266087|B1||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4442409|NCT00107744|4266084|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4442410|NCT00107744|4266085|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4442411|NCT00107744|4266086|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4442412|NCT00107744|4266087|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4442413|NCT00107744|4266084|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442414|NCT00107744|4266085|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442415|NCT00107744|4266086|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442416|NCT00107744|4266087|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442417|NCT00107744|4266084|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442418|NCT00107744|4266085|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442419|NCT00107744|4266086|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442420|NCT00107744|4266087|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442421|NCT00107744|4266084|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442422|NCT00107744|4266085|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442423|NCT00107744|4266086|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442424|NCT00107744|4266087|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442425|NCT00107744|4266084|B4||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4442426|NCT00107744|4266085|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4442427|NCT00107744|4266086|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4442428|NCT00107744|4266087|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4442429|NCT00107744|4266084|B4||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4442430|NCT00107744|4266085|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4442431|NCT00107744|4266086|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4442432|NCT00107744|4266087|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4442433|NCT00107744|4266084|B4|||Age||years|Mean|47.7|47.7|Standard Deviation|10.3|10.3|||
4442434|NCT00107744|4266085|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|8.7|8.7|||
4442435|NCT00107744|4266086|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|10.7|10.7|||
4442436|NCT00107744|4266087|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|11.5|11.5|||
4442437|NCT00107653|4266103|B3||Male|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
4442438|NCT00107653|4266104|B2||Male|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4442439|NCT00107653|4266105|B1||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4442440|NCT00107653|4266103|B3||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4442441|NCT00107653|4266104|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4442442|NCT00107653|4266105|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4442443|NCT00107653|4266103|B3|||Age||Years|Mean|46.9|46.9|Standard Deviation|8.64|8.64|||
4442444|NCT00107653|4266104|B2|||Age||Years|Mean|48.1|48.1|Standard Deviation|8.34|8.34|||
4442445|NCT00107653|4266105|B1|||Age||Years|Mean|45.6|45.6|Standard Deviation|8.79|8.79|||
4442446|NCT00107614|4266152|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4442447|NCT00107614|4266152|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4442448|NCT00107614|4266152|B1|||Age||years|Mean|65|65.0|Standard Deviation|11.0|11.0|||
4442449|NCT00107614|4266152|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4442450|NCT00107614|4266152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4442451|NCT00107614|4266152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442452|NCT00107575|4266156|B3|United States||Region of Enrollment||participants|Number|236|236.0||||||
4442453|NCT00107575|4266157|B2|United States||Region of Enrollment||participants|Number|117|117.0||||||
4442454|NCT00107575|4266158|B1|United States||Region of Enrollment||participants|Number|119|119.0||||||
4442455|NCT00107575|4266156|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4442456|NCT00107575|4266157|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4442457|NCT00107575|4266158|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4442458|NCT00107575|4266156|B3||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4442459|NCT00107575|4266157|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4442460|NCT00107575|4266158|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4442461|NCT00107575|4266156|B3|||Age||years|Mean|41.5|41.5|Standard Deviation|12.0|12.0|||
4442462|NCT00107575|4266157|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|11.8|11.8|||
4442463|NCT00107575|4266158|B1|||Age||years|Mean|40.6|40.6|Standard Deviation|12.1|12.1|||
4442464|NCT00107575|4266156|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4442465|NCT00107575|4266157|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4442466|NCT00107575|4266158|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4442467|NCT00107575|4266156|B3||Between 18 and 65 years|Age||Participants|Count of Participants|225|225.0||||||
4442468|NCT00107575|4266157|B2||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4442469|NCT00107575|4266158|B1||Between 18 and 65 years|Age||Participants|Count of Participants|113|113.0||||||
4442470|NCT00107575|4266156|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4442471|NCT00107575|4266157|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442472|NCT00107575|4266158|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4442473|NCT00107536|4266173|B1|Unknown||Prior treatments||participants|Number|2|2.0||||||
4442474|NCT00107536|4266173|B1|Chemotherapy||Prior treatments||participants|Number|3|3.0||||||
4442475|NCT00107536|4266173|B1|Surgery||Prior treatments||participants|Number|16|16.0||||||
4442476|NCT00107536|4266173|B1|Chemo-embolization||Prior treatments||participants|Number|2|2.0||||||
4442477|NCT00107536|4266173|B1|X-ray treatment||Prior treatments||participants|Number|3|3.0||||||
4442478|NCT00107536|4266173|B1|Not available||Sites of metastasis||participants|Number|4|4.0||||||
4442479|NCT00107536|4266173|B1|Chest wall||Sites of metastasis||participants|Number|1|1.0||||||
4442480|NCT00107536|4266173|B1|Hepatic mets||Sites of metastasis||participants|Number|1|1.0||||||
4442481|NCT00107536|4266173|B1|Peritoneal mets||Sites of metastasis||participants|Number|1|1.0||||||
4442482|NCT00107536|4266173|B1|Adrenal gland||Sites of metastasis||participants|Number|1|1.0||||||
4442483|NCT00107536|4266173|B1|Bone||Sites of metastasis||participants|Number|1|1.0||||||
4442484|NCT00107536|4266173|B1|Spine||Sites of metastasis||participants|Number|1|1.0||||||
4442485|NCT00107536|4266173|B1|Lungs||Sites of metastasis||participants|Number|8|8.0||||||
4442486|NCT00107536|4266173|B1|Lymph nodes||Sites of metastasis||participants|Number|8|8.0||||||
4442487|NCT00107536|4266173|B1|Performance status 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG Performance status 0 is defined as fully active, able to carry on all pre-disease performance without restriction~ECOG Performance status 1 is defined as restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work"|participants|Number|14|14.0||||||
4442488|NCT00107536|4266173|B1|Performance status 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG Performance status 0 is defined as fully active, able to carry on all pre-disease performance without restriction~ECOG Performance status 1 is defined as restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work"|participants|Number|12|12.0||||||
4442489|NCT00107536|4266173|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4442490|NCT00107536|4266173|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442491|NCT00107536|4266173|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442492|NCT00107536|4266173|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4442493|NCT00107536|4266173|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4442494|NCT00107536|4266173|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442495|NCT00107536|4266173|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442496|NCT00107536|4266173|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442497|NCT00107536|4266173|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442498|NCT00107536|4266173|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4442499|NCT00107536|4266173|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442500|NCT00107536|4266173|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4442501|NCT00107536|4266173|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4442502|NCT00107536|4266173|B1|||Age||years|Median|58|58.0|Full Range|||29.0|81.0|
4442503|NCT00107380|4266183|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442504|NCT00107380|4266183|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442505|NCT00107380|4266183|B1||White|Race (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4442506|NCT00107380|4266183|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442507|NCT00107380|4266183|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442508|NCT00107380|4266183|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4442509|NCT00107380|4266183|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442510|NCT00107380|4266183|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4442511|NCT00107380|4266183|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4442512|NCT00107380|4266183|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4442513|NCT00107380|4266183|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4442514|NCT00107380|4266183|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4442515|NCT00107380|4266183|B1|||Age||years|Median|63.8|63.8|Full Range|||29.9|85.3|
4442516|NCT00107315|4266189|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4442517|NCT00107315|4266189|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4442518|NCT00107315|4266189|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4442519|NCT00107315|4266189|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4442520|NCT00107315|4266189|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442521|NCT00107315|4266189|B1|||Age||years|Mean|78|78.0|Standard Deviation|4.9|4.9|||
4442522|NCT00107276|4266196|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4442523|NCT00107276|4266196|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4442524|NCT00107276|4266196|B1|||Age||years|Median|59.7|59.7|Full Range|||34.3|88.1|
4442525|NCT00107198|4266202|B1|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4442526|NCT00107198|4266202|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4442527|NCT00107198|4266202|B1|Israel||Region of Enrollment||participants|Number|2|2.0||||||
4442528|NCT00107198|4266202|B1|United States||Region of Enrollment||participants|Number|162|162.0||||||
4442529|NCT00107198|4266202|B1|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4442530|NCT00107198|4266202|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4442531|NCT00107198|4266202|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442532|NCT00107198|4266202|B1||White|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4442533|NCT00107198|4266202|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4442534|NCT00107198|4266202|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4442535|NCT00107198|4266202|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4442536|NCT00107198|4266202|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442537|NCT00107198|4266202|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4442538|NCT00107198|4266202|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4442539|NCT00107198|4266202|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4442540|NCT00107198|4266202|B1||Male|Gender||Participants|Count of Participants|157|157.0||||||
4442541|NCT00107198|4266202|B1||Female|Gender||Participants|Count of Participants|31|31.0||||||
4442542|NCT00107198|4266202|B1|||Age||years|Median|13|13.0|Full Range|||4.0|20.0|
4442543|NCT00107198|4266202|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4442544|NCT00107198|4266202|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4442545|NCT00107198|4266202|B1||<=18 years|Age||Participants|Count of Participants|184|184.0||||||
4442546|NCT00107172|4266210|B3|||Baseline Forced Expiratory Volume in 1 second (FEV1)||Percentage of Predicted|Median|50|50.0|Full Range|||22.0|117.0|
4442547|NCT00107172|4266211|B2|||Baseline Forced Expiratory Volume in 1 second (FEV1)||Percentage of Predicted|Median|53|53.0|Full Range|||25.0|110.0|
4442548|NCT00107172|4266212|B1|||Baseline Forced Expiratory Volume in 1 second (FEV1)||Percentage of Predicted|Median|48|48.0|Full Range|||22.0|117.0|
4442549|NCT00107172|4266210|B3|||Baseline diffusing capacity of the lung for carbon monoxide (DLCO)||Percentage of predicted|Median|46|46.0|Full Range|||8.0|137.0|
4442550|NCT00107172|4266211|B2|||Baseline diffusing capacity of the lung for carbon monoxide (DLCO)||Percentage of predicted|Median|45|45.0|Full Range|||8.0|137.0|
4442551|NCT00107172|4266212|B1|||Baseline diffusing capacity of the lung for carbon monoxide (DLCO)||Percentage of predicted|Median|47|47.0|Full Range|||18.0|97.0|
4442552|NCT00107172|4266210|B3|||Nodal Stage, N0|Nodal stage refers to regional lymph node involvement. N0=No regional lymph node metastasis.|participants|Number|222|222.0||||||
4442553|NCT00107172|4266211|B2|||Nodal Stage, N0|Nodal stage refers to regional lymph node involvement. N0=No regional lymph node metastasis.|participants|Number|108|108.0||||||
4442554|NCT00107172|4266212|B1|||Nodal Stage, N0|Nodal stage refers to regional lymph node involvement. N0=No regional lymph node metastasis.|participants|Number|114|114.0||||||
4442555|NCT00107172|4266210|B3|||Metastatis stage, M0|Metastasis stage refers to which organs the cancer has spread. M0 = No distant metastasis|participants|Number|222|222.0||||||
4442556|NCT00107172|4266211|B2|||Metastatis stage, M0|Metastasis stage refers to which organs the cancer has spread. M0 = No distant metastasis|participants|Number|108|108.0||||||
4442557|NCT00107172|4266212|B1|||Metastatis stage, M0|Metastasis stage refers to which organs the cancer has spread. M0 = No distant metastasis|participants|Number|114|114.0||||||
4442558|NCT00107172|4266210|B3|T3=Tumor of any size||Tumor Stage|"Tumor staging was defined by tumor location and size. T1=surrounded by lung/visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus.~T2=tumor involves main bronchus, >=2cm distal to the carina; invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung.~T3=tumor directly invades chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina but without involvement of the carina;"|participants|Number|1|1.0||||||
4442559|NCT00107172|4266211|B2|T3=Tumor of any size||Tumor Stage|"Tumor staging was defined by tumor location and size. T1=surrounded by lung/visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus.~T2=tumor involves main bronchus, >=2cm distal to the carina; invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung.~T3=tumor directly invades chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina but without involvement of the carina;"|participants|Number|1|1.0||||||
4442560|NCT00107172|4266212|B1|T3=Tumor of any size||Tumor Stage|"Tumor staging was defined by tumor location and size. T1=surrounded by lung/visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus.~T2=tumor involves main bronchus, >=2cm distal to the carina; invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung.~T3=tumor directly invades chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina but without involvement of the carina;"|participants|Number|0|0.0||||||
4442561|NCT00107172|4266210|B3|T2=Tumor > 3cm||Tumor Stage|"Tumor staging was defined by tumor location and size. T1=surrounded by lung/visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus.~T2=tumor involves main bronchus, >=2cm distal to the carina; invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung.~T3=tumor directly invades chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina but without involvement of the carina;"|participants|Number|3|3.0||||||
4442562|NCT00107172|4266211|B2|T2=Tumor > 3cm||Tumor Stage|"Tumor staging was defined by tumor location and size. T1=surrounded by lung/visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus.~T2=tumor involves main bronchus, >=2cm distal to the carina; invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung.~T3=tumor directly invades chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina but without involvement of the carina;"|participants|Number|3|3.0||||||
4442563|NCT00107172|4266212|B1|T2=Tumor > 3cm||Tumor Stage|"Tumor staging was defined by tumor location and size. T1=surrounded by lung/visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus.~T2=tumor involves main bronchus, >=2cm distal to the carina; invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung.~T3=tumor directly invades chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina but without involvement of the carina;"|participants|Number|0|0.0||||||
4442564|NCT00107172|4266210|B3|T1=Tumor <=3cm||Tumor Stage|"Tumor staging was defined by tumor location and size. T1=surrounded by lung/visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus.~T2=tumor involves main bronchus, >=2cm distal to the carina; invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung.~T3=tumor directly invades chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina but without involvement of the carina;"|participants|Number|218|218.0||||||
4442565|NCT00107172|4266211|B2|T1=Tumor <=3cm||Tumor Stage|"Tumor staging was defined by tumor location and size. T1=surrounded by lung/visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus.~T2=tumor involves main bronchus, >=2cm distal to the carina; invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung.~T3=tumor directly invades chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina but without involvement of the carina;"|participants|Number|104|104.0||||||
4442566|NCT00107172|4266212|B1|T1=Tumor <=3cm||Tumor Stage|"Tumor staging was defined by tumor location and size. T1=surrounded by lung/visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus.~T2=tumor involves main bronchus, >=2cm distal to the carina; invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung.~T3=tumor directly invades chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina but without involvement of the carina;"|participants|Number|114|114.0||||||
4442567|NCT00107172|4266210|B3|> 2 cm||Clinical Nodule Size (cm)||participants|Number|82|82.0||||||
4442568|NCT00107172|4266211|B2|> 2 cm||Clinical Nodule Size (cm)||participants|Number|41|41.0||||||
4442569|NCT00107172|4266212|B1|> 2 cm||Clinical Nodule Size (cm)||participants|Number|41|41.0||||||
4442570|NCT00107172|4266210|B3|<= 2 cm||Clinical Nodule Size (cm)||participants|Number|140|140.0||||||
4442571|NCT00107172|4266211|B2|<= 2 cm||Clinical Nodule Size (cm)||participants|Number|67|67.0||||||
4442572|NCT00107172|4266212|B1|<= 2 cm||Clinical Nodule Size (cm)||participants|Number|73|73.0||||||
4442573|NCT00107172|4266210|B3|2= Symptomatic and ambulatory||Eastern Cooperative Oncology Group (ECOG)Performance Status||participants|Number|51|51.0||||||
4442574|NCT00107172|4266211|B2|2= Symptomatic and ambulatory||Eastern Cooperative Oncology Group (ECOG)Performance Status||participants|Number|23|23.0||||||
4442575|NCT00107172|4266212|B1|2= Symptomatic and ambulatory||Eastern Cooperative Oncology Group (ECOG)Performance Status||participants|Number|28|28.0||||||
4442576|NCT00107172|4266210|B3|1= Symptomatic and fully ambulatory||Eastern Cooperative Oncology Group (ECOG)Performance Status||participants|Number|126|126.0||||||
4442577|NCT00107172|4266211|B2|1= Symptomatic and fully ambulatory||Eastern Cooperative Oncology Group (ECOG)Performance Status||participants|Number|60|60.0||||||
4442578|NCT00107172|4266212|B1|1= Symptomatic and fully ambulatory||Eastern Cooperative Oncology Group (ECOG)Performance Status||participants|Number|66|66.0||||||
4442579|NCT00107172|4266210|B3|0 = Asymptomatic and fully active||Eastern Cooperative Oncology Group (ECOG)Performance Status||participants|Number|45|45.0||||||
4442580|NCT00107172|4266211|B2|0 = Asymptomatic and fully active||Eastern Cooperative Oncology Group (ECOG)Performance Status||participants|Number|25|25.0||||||
4442581|NCT00107172|4266212|B1|0 = Asymptomatic and fully active||Eastern Cooperative Oncology Group (ECOG)Performance Status||participants|Number|20|20.0||||||
4442582|NCT00107172|4266210|B3|United States||Region of Enrollment||participants|Number|221|221.0||||||
4442583|NCT00107172|4266211|B2|United States||Region of Enrollment||participants|Number|107|107.0||||||
4442584|NCT00107172|4266212|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4442585|NCT00107172|4266210|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4442586|NCT00107172|4266211|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4442587|NCT00107172|4266212|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4442588|NCT00107172|4266210|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4442589|NCT00107172|4266211|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4442590|NCT00107172|4266212|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4442591|NCT00107172|4266210|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4442592|NCT00107172|4266211|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4442593|NCT00107172|4266212|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4442594|NCT00107172|4266210|B3|||Age||years|Median|71|71.0|Full Range|||49.0|87.0|
4442595|NCT00107172|4266211|B2|||Age||years|Median|72|72.0|Full Range|||50.0|87.0|
4442596|NCT00107172|4266212|B1|||Age||years|Median|70|70.0|Full Range|||49.0|85.0|
4442597|NCT00107120|4266241|B3|United States||Region of Enrollment||participants|Number|312|312.0||||||
4442598|NCT00107120|4266242|B2|United States||Region of Enrollment||participants|Number|157|157.0||||||
4442599|NCT00107120|4266243|B1|United States||Region of Enrollment||participants|Number|155|155.0||||||
4442600|NCT00107120|4266241|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4442601|NCT00107120|4266242|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4442602|NCT00107120|4266243|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4442603|NCT00107120|4266241|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4442604|NCT00107120|4266242|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4442605|NCT00107120|4266243|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4442606|NCT00107120|4266241|B3|||Age||years|Mean|14.6|14.6|Standard Deviation|1.6|1.6|||
4442607|NCT00107120|4266242|B2|||Age||years|Mean|14.5|14.5|Standard Deviation|1.5|1.5|||
4442608|NCT00107120|4266243|B1|||Age||years|Mean|14.7|14.7|Standard Deviation|1.6|1.6|||
4442609|NCT00107120|4266241|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4442610|NCT00107120|4266242|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4442611|NCT00107120|4266243|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4442612|NCT00107120|4266241|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4442613|NCT00107120|4266242|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4442614|NCT00107120|4266243|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4442615|NCT00107120|4266241|B3||<=18 years|Age||Participants|Count of Participants|312|312.0||||||
4442616|NCT00107120|4266242|B2||<=18 years|Age||Participants|Count of Participants|157|157.0||||||
4442617|NCT00107120|4266243|B1||<=18 years|Age||Participants|Count of Participants|155|155.0||||||
4442618|NCT00107042|4266254|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442619|NCT00107042|4266255|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442620|NCT00107042|4266256|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442621|NCT00107042|4266254|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4442622|NCT00107042|4266255|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4442623|NCT00107042|4266256|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4442624|NCT00107042|4266254|B3||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4442625|NCT00107042|4266255|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4442626|NCT00107042|4266256|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4442627|NCT00107042|4266254|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4442628|NCT00107042|4266255|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4442629|NCT00107042|4266256|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4442630|NCT00107042|4266254|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442631|NCT00107042|4266255|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442632|NCT00107042|4266256|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442633|NCT00107042|4266254|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442634|NCT00107042|4266255|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442635|NCT00107042|4266256|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442636|NCT00107042|4266254|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442637|NCT00107042|4266255|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442638|NCT00107042|4266256|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4442639|NCT00107042|4266254|B3||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4442640|NCT00107042|4266255|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4442641|NCT00107042|4266256|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4442642|NCT00107042|4266254|B3||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4442643|NCT00107042|4266255|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4442644|NCT00107042|4266256|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4442645|NCT00107042|4266254|B3|15 - 17 years||Age, Customized||participants|Number|82|82.0||||||
4442646|NCT00107042|4266255|B2|15 - 17 years||Age, Customized||participants|Number|40|40.0||||||
4442647|NCT00107042|4266256|B1|15 - 17 years||Age, Customized||participants|Number|42|42.0||||||
4442648|NCT00107042|4266254|B3|12 - 14 years||Age, Customized||participants|Number|41|41.0||||||
4442649|NCT00107042|4266255|B2|12 - 14 years||Age, Customized||participants|Number|23|23.0||||||
4442650|NCT00107042|4266256|B1|12 - 14 years||Age, Customized||participants|Number|18|18.0||||||
4442651|NCT00107042|4266254|B3|||Age||years|Mean|15.12|15.12|Standard Deviation|1.58|1.58|||
4442652|NCT00107042|4266255|B2|||Age||years|Mean|15.22|15.22|Standard Deviation|1.71|1.71|||
4442653|NCT00107042|4266256|B1|||Age||years|Mean|15.02|15.02|Standard Deviation|1.43|1.43|||
4442654|NCT00106964|4266320|B4|Bahamas||Region of Enrollment||participants|Number|25|25.0||||||
4442655|NCT00106964|4266321|B3|Bahamas||Region of Enrollment||participants|Number|7|7.0||||||
4442656|NCT00106964|4266322|B2|Bahamas||Region of Enrollment||participants|Number|8|8.0||||||
4442657|NCT00106964|4266323|B1|Bahamas||Region of Enrollment||participants|Number|10|10.0||||||
4442658|NCT00106964|4266320|B4|Brazil||Region of Enrollment||participants|Number|168|168.0||||||
4442659|NCT00106964|4266321|B3|Brazil||Region of Enrollment||participants|Number|58|58.0||||||
4442660|NCT00106964|4266322|B2|Brazil||Region of Enrollment||participants|Number|58|58.0||||||
4442661|NCT00106964|4266323|B1|Brazil||Region of Enrollment||participants|Number|52|52.0||||||
4442662|NCT00106964|4266320|B4|South Africa||Region of Enrollment||participants|Number|23|23.0||||||
4442663|NCT00106964|4266321|B3|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
4442664|NCT00106964|4266322|B2|South Africa||Region of Enrollment||participants|Number|6|6.0||||||
4442665|NCT00106964|4266323|B1|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4442666|NCT00106964|4266320|B4|United States||Region of Enrollment||participants|Number|155|155.0||||||
4442667|NCT00106964|4266321|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4442668|NCT00106964|4266322|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4442669|NCT00106964|4266323|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4442670|NCT00106964|4266320|B4||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4442671|NCT00106964|4266321|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4442672|NCT00106964|4266322|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4442673|NCT00106964|4266323|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4442674|NCT00106964|4266320|B4||Female|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4442675|NCT00106964|4266321|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4442676|NCT00106964|4266322|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4442677|NCT00106964|4266323|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4442678|NCT00106964|4266320|B4|>20 years||Age, Customized||participants|Number|263|263.0||||||
4442679|NCT00106964|4266321|B3|>20 years||Age, Customized||participants|Number|89|89.0||||||
4442680|NCT00106964|4266322|B2|>20 years||Age, Customized||participants|Number|94|94.0||||||
4442681|NCT00106964|4266323|B1|>20 years||Age, Customized||participants|Number|80|80.0||||||
4442682|NCT00106964|4266320|B4|16-19 years||Age, Customized||participants|Number|63|63.0||||||
4442683|NCT00106964|4266321|B3|16-19 years||Age, Customized||participants|Number|20|20.0||||||
4442684|NCT00106964|4266322|B2|16-19 years||Age, Customized||participants|Number|18|18.0||||||
4442685|NCT00106964|4266323|B1|16-19 years||Age, Customized||participants|Number|25|25.0||||||
4442686|NCT00106964|4266320|B4|14-15 years||Age, Customized||participants|Number|26|26.0||||||
4442687|NCT00106964|4266321|B3|14-15 years||Age, Customized||participants|Number|10|10.0||||||
4442688|NCT00106964|4266322|B2|14-15 years||Age, Customized||participants|Number|11|11.0||||||
4442689|NCT00106964|4266323|B1|14-15 years||Age, Customized||participants|Number|5|5.0||||||
4442690|NCT00106964|4266320|B4|12-13 years||Age, Customized||participants|Number|19|19.0||||||
4442691|NCT00106964|4266321|B3|12-13 years||Age, Customized||participants|Number|8|8.0||||||
4442692|NCT00106964|4266322|B2|12-13 years||Age, Customized||participants|Number|3|3.0||||||
4442693|NCT00106964|4266323|B1|12-13 years||Age, Customized||participants|Number|8|8.0||||||
4442694|NCT00106964|4266320|B4|||Age||years|Mean|20.57|20.57|Standard Deviation|3.40|3.4|||
4442695|NCT00106964|4266321|B3|||Age||years|Mean|20.20|20.2|Standard Deviation|3.50|3.5|||
4442696|NCT00106964|4266322|B2|||Age||years|Mean|20.96|20.96|Standard Deviation|3.25|3.25|||
4442697|NCT00106964|4266323|B1|||Age||years|Mean|20.56|20.56|Standard Deviation|3.42|3.42|||
4442698|NCT00106938|4266348|B3|United States||Region of Enrollment||participants|Number|1453|1453.0||||||
4442699|NCT00106938|4266349|B2|United States||Region of Enrollment||participants|Number|364|364.0||||||
4442700|NCT00106938|4266350|B1|United States||Region of Enrollment||participants|Number|1089|1089.0||||||
4442701|NCT00106938|4266348|B3|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4442702|NCT00106938|4266349|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4442703|NCT00106938|4266350|B1|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4442704|NCT00106938|4266348|B3|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4442705|NCT00106938|4266349|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4442706|NCT00106938|4266350|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4442707|NCT00106938|4266348|B3|American Indian or Alaska||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4442708|NCT00106938|4266349|B2|American Indian or Alaska||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4442709|NCT00106938|4266350|B1|American Indian or Alaska||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4442710|NCT00106938|4266348|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4442711|NCT00106938|4266349|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4442712|NCT00106938|4266350|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4442713|NCT00106938|4266348|B3|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4442714|NCT00106938|4266349|B2|Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4442715|NCT00106938|4266350|B1|Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4442716|NCT00106938|4266348|B3|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4442717|NCT00106938|4266349|B2|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4442718|NCT00106938|4266350|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4442719|NCT00106938|4266348|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|1312|1312.0||||||
4442720|NCT00106938|4266349|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|327|327.0||||||
4442721|NCT00106938|4266350|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|985|985.0||||||
4442722|NCT00106938|4266348|B3||Male|Sex: Female, Male||Participants|Count of Participants|873|873.0||||||
4442723|NCT00106938|4266349|B2||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4442724|NCT00106938|4266350|B1||Male|Sex: Female, Male||Participants|Count of Participants|666|666.0||||||
4442725|NCT00106938|4266348|B3||Female|Sex: Female, Male||Participants|Count of Participants|580|580.0||||||
4442726|NCT00106938|4266349|B2||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4442727|NCT00106938|4266350|B1||Female|Sex: Female, Male||Participants|Count of Participants|423|423.0||||||
4442728|NCT00106938|4266348|B3|||Age||years|Mean|67.7|67.7|Standard Deviation|7.0|7.0|||
4442729|NCT00106938|4266349|B2|||Age||years|Mean|67.9|67.9|Standard Deviation|6.9|6.9|||
4442730|NCT00106938|4266350|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|7.0|7.0|||
4442731|NCT00106938|4266348|B3||>=65 years|Age||Participants|Count of Participants|1025|1025.0||||||
4442732|NCT00106938|4266349|B2||>=65 years|Age||Participants|Count of Participants|261|261.0||||||
4442733|NCT00106938|4266350|B1||>=65 years|Age||Participants|Count of Participants|764|764.0||||||
4442734|NCT00106938|4266348|B3||Between 18 and 65 years|Age||Participants|Count of Participants|428|428.0||||||
4442735|NCT00106938|4266349|B2||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4442736|NCT00106938|4266350|B1||Between 18 and 65 years|Age||Participants|Count of Participants|325|325.0||||||
4442737|NCT00106938|4266348|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442738|NCT00106938|4266349|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442739|NCT00106938|4266350|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442740|NCT00106704|4266418|B3|||Hemoglobin A1C (A1C)||Percent|Mean|8.34|8.34|Standard Deviation|0.75|0.75|||
4442741|NCT00106704|4266419|B2|||Hemoglobin A1C (A1C)||Percent|Mean|8.34|8.34|Standard Deviation|0.74|0.74|||
4442742|NCT00106704|4266420|B1|||Hemoglobin A1C (A1C)||Percent|Mean|8.34|8.34|Standard Deviation|0.76|0.76|||
4442743|NCT00106704|4266418|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|181.2|181.2|Standard Deviation|40.1|40.1|||
4442744|NCT00106704|4266419|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|181.6|181.6|Standard Deviation|42.5|42.5|||
4442745|NCT00106704|4266420|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|180.9|180.9|Standard Deviation|37.7|37.7|||
4442746|NCT00106704|4266418|B3|Other||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4442747|NCT00106704|4266419|B2|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4442748|NCT00106704|4266420|B1|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4442749|NCT00106704|4266418|B3|Asian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4442750|NCT00106704|4266419|B2|Asian||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4442751|NCT00106704|4266420|B1|Asian||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4442752|NCT00106704|4266418|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4442753|NCT00106704|4266419|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4442754|NCT00106704|4266420|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4442755|NCT00106704|4266418|B3|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4442756|NCT00106704|4266419|B2|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4442757|NCT00106704|4266420|B1|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4442758|NCT00106704|4266418|B3|White||Race/Ethnicity, Customized||participants|Number|276|276.0||||||
4442759|NCT00106704|4266419|B2|White||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4442760|NCT00106704|4266420|B1|White||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4442761|NCT00106704|4266418|B3||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4442762|NCT00106704|4266419|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4442763|NCT00106704|4266420|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4442764|NCT00106704|4266418|B3||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4442765|NCT00106704|4266419|B2||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4442766|NCT00106704|4266420|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4442767|NCT00106704|4266418|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|9.6|9.6|||
4442768|NCT00106704|4266419|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|9.6|9.6|||
4442769|NCT00106704|4266420|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|9.6|9.6|||
4442770|NCT00106639|4266429|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4442771|NCT00106639|4266430|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4442772|NCT00106639|4266431|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4442773|NCT00106639|4266432|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4442774|NCT00106639|4266429|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4442775|NCT00106639|4266430|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4442776|NCT00106639|4266431|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4442777|NCT00106639|4266432|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4442778|NCT00106639|4266429|B4|||Age||years|Mean|44.6|44.6|Standard Deviation|11.0|11.0|||
4442779|NCT00106639|4266430|B3|||Age||years|Mean|42.8|42.8|Standard Deviation|11.8|11.8|||
4442780|NCT00106639|4266431|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|12.3|12.3|||
4442781|NCT00106639|4266432|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|8.5|8.5|||
4442782|NCT00106626|4266557|B5|White||Race/Ethnicity||participants|Number|44|44.0||||||
4442783|NCT00106626|4266558|B4|White||Race/Ethnicity||participants|Number|12|12.0||||||
4442784|NCT00106626|4266559|B3|White||Race/Ethnicity||participants|Number|14|14.0||||||
4442785|NCT00106626|4266560|B2|White||Race/Ethnicity||participants|Number|6|6.0||||||
4442786|NCT00106626|4266561|B1|White||Race/Ethnicity||participants|Number|12|12.0||||||
4442787|NCT00106626|4266557|B5|Hispanic American||Race/Ethnicity||participants|Number|3|3.0||||||
4442788|NCT00106626|4266558|B4|Hispanic American||Race/Ethnicity||participants|Number|2|2.0||||||
4442789|NCT00106626|4266559|B3|Hispanic American||Race/Ethnicity||participants|Number|0|0.0||||||
4442790|NCT00106626|4266560|B2|Hispanic American||Race/Ethnicity||participants|Number|0|0.0||||||
4442791|NCT00106626|4266561|B1|Hispanic American||Race/Ethnicity||participants|Number|1|1.0||||||
4442792|NCT00106626|4266557|B5|European||Race/Ethnicity||participants|Number|1|1.0||||||
4442793|NCT00106626|4266558|B4|European||Race/Ethnicity||participants|Number|0|0.0||||||
4442794|NCT00106626|4266559|B3|European||Race/Ethnicity||participants|Number|0|0.0||||||
4442795|NCT00106626|4266560|B2|European||Race/Ethnicity||participants|Number|1|1.0||||||
4442796|NCT00106626|4266561|B1|European||Race/Ethnicity||participants|Number|0|0.0||||||
4442797|NCT00106626|4266557|B5|Black||Race/Ethnicity||participants|Number|3|3.0||||||
4442798|NCT00106626|4266558|B4|Black||Race/Ethnicity||participants|Number|1|1.0||||||
4442799|NCT00106626|4266559|B3|Black||Race/Ethnicity||participants|Number|0|0.0||||||
4442800|NCT00106626|4266560|B2|Black||Race/Ethnicity||participants|Number|2|2.0||||||
4442801|NCT00106626|4266561|B1|Black||Race/Ethnicity||participants|Number|0|0.0||||||
4442802|NCT00106626|4266557|B5|Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4442803|NCT00106626|4266558|B4|Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4442804|NCT00106626|4266559|B3|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4442805|NCT00106626|4266560|B2|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4442806|NCT00106626|4266561|B1|Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4442807|NCT00106626|4266557|B5||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4442808|NCT00106626|4266558|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4442809|NCT00106626|4266559|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4442810|NCT00106626|4266560|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4442811|NCT00106626|4266561|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4442812|NCT00106626|4266557|B5||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4442813|NCT00106626|4266558|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4442814|NCT00106626|4266559|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4442815|NCT00106626|4266560|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4442816|NCT00106626|4266561|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4442817|NCT00106626|4266557|B5|||Age||years|Mean|61|61.0|Full Range|||31.0|81.0|
4442818|NCT00106626|4266558|B4|||Age||years|Mean|63.63|63.63|Full Range|||39.0|81.0|
4442819|NCT00106626|4266559|B3|||Age||years|Mean|60.09|60.09|Full Range|||41.0|78.0|
4442820|NCT00106626|4266560|B2|||Age||years|Mean|58.23|58.23|Full Range|||31.0|74.0|
4442821|NCT00106626|4266561|B1|||Age||years|Mean|60.52|60.52|Full Range|||35.0|81.0|
4442822|NCT00106535|4266579|B4||Male|Sex: Female, Male||Participants|Count of Participants|201|201.0||||||
4442823|NCT00106535|4266580|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4442824|NCT00106535|4266581|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4442825|NCT00106535|4266582|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4442826|NCT00106535|4266579|B4||Female|Sex: Female, Male||Participants|Count of Participants|989|989.0||||||
4442827|NCT00106535|4266580|B3||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4442828|NCT00106535|4266581|B2||Female|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4442829|NCT00106535|4266582|B1||Female|Sex: Female, Male||Participants|Count of Participants|328|328.0||||||
4442830|NCT00106535|4266579|B4|||Age||years|Mean|52.0|52.0|Standard Deviation|12.24|12.24|||
4442831|NCT00106535|4266580|B3|||Age||years|Mean|53.4|53.4|Standard Deviation|11.72|11.72|||
4442832|NCT00106535|4266581|B2|||Age||years|Mean|51.4|51.4|Standard Deviation|12.59|12.59|||
4442833|NCT00106535|4266582|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|12.41|12.41|||
4442834|NCT00106431|4266878|B1|2, Ambulatory and capable of all selfcare but unab||Eastern Cooperative Oncology Group (ECOG) Performance status||Participants|Number|0|0.0||||||
4442835|NCT00106431|4266878|B1|1, Restricted in physically strenuous activity but||Eastern Cooperative Oncology Group (ECOG) Performance status||Participants|Number|49|49.0||||||
4442836|NCT00106431|4266878|B1|0, Fully active, able to carry on all pre-disease||Eastern Cooperative Oncology Group (ECOG) Performance status||Participants|Number|53|53.0||||||
4442837|NCT00106431|4266878|B1|Ukraine||Region of Enrollment||participants|Number|7|7.0||||||
4442838|NCT00106431|4266878|B1|Georgia||Region of Enrollment||participants|Number|3|3.0||||||
4442839|NCT00106431|4266878|B1|United Kingdom||Region of Enrollment||participants|Number|20|20.0||||||
4442840|NCT00106431|4266878|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4442841|NCT00106431|4266878|B1|Russian Federation||Region of Enrollment||participants|Number|17|17.0||||||
4442842|NCT00106431|4266878|B1|Poland||Region of Enrollment||participants|Number|24|24.0||||||
4442843|NCT00106431|4266878|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4442844|NCT00106431|4266878|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
4442845|NCT00106431|4266878|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4442846|NCT00106431|4266878|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4442847|NCT00106431|4266878|B1|||Age||years|Mean|57.0|57.0|Standard Deviation|11.93|11.93|||
4442848|NCT00106431|4266878|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4442849|NCT00106431|4266878|B1||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4442850|NCT00106431|4266878|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442851|NCT00106392|4266888|B3|White||Race/Ethnicity, Customized||Participants|Number|118|118.0||||||
4442852|NCT00106392|4266889|B2|White||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
4442853|NCT00106392|4266890|B1|White||Race/Ethnicity, Customized||Participants|Number|55|55.0||||||
4442854|NCT00106392|4266888|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4442855|NCT00106392|4266889|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4442856|NCT00106392|4266890|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4442857|NCT00106392|4266888|B3|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4442858|NCT00106392|4266889|B2|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4442859|NCT00106392|4266890|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4442860|NCT00106392|4266888|B3||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4442861|NCT00106392|4266889|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4442862|NCT00106392|4266890|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4442863|NCT00106392|4266888|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4442864|NCT00106392|4266889|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4442865|NCT00106392|4266890|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4442866|NCT00106392|4266888|B3|||Age||years|Mean|54.6|54.6|Standard Deviation|6.2|6.2|||
4442867|NCT00106392|4266889|B2|||Age||years|Mean|54.1|54.1|Standard Deviation|6.2|6.2|||
4442868|NCT00106392|4266890|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|6.2|6.2|||
4442869|NCT00106353|4266907|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4442870|NCT00106353|4266908|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4442871|NCT00106353|4266909|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4442872|NCT00106353|4266907|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4442873|NCT00106353|4266908|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4442874|NCT00106353|4266909|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4442875|NCT00106353|4266907|B3|>=18 to less than or equal to 21 years||Age, Customized||participants|Number|12|12.0||||||
4442876|NCT00106353|4266908|B2|>=18 to less than or equal to 21 years||Age, Customized||participants|Number|7|7.0||||||
4442877|NCT00106353|4266909|B1|>=18 to less than or equal to 21 years||Age, Customized||participants|Number|5|5.0||||||
4442878|NCT00106353|4266907|B3|>=16 to less than 18 years||Age, Customized||participants|Number|5|5.0||||||
4442879|NCT00106353|4266908|B2|>=16 to less than 18 years||Age, Customized||participants|Number|3|3.0||||||
4442880|NCT00106353|4266909|B1|>=16 to less than 18 years||Age, Customized||participants|Number|2|2.0||||||
4442881|NCT00106353|4266907|B3|Greater than or equal to(>=)1 to less than16 years||Age, Customized||participants|Number|54|54.0||||||
4442882|NCT00106353|4266908|B2|Greater than or equal to(>=)1 to less than16 years||Age, Customized||participants|Number|42|42.0||||||
4442883|NCT00106353|4266909|B1|Greater than or equal to(>=)1 to less than16 years||Age, Customized||participants|Number|12|12.0||||||
4442884|NCT00106249|4267040|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4442885|NCT00106249|4267041|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4442886|NCT00106249|4267042|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4442887|NCT00106249|4267040|B3||Male|Gender||Participants|Count of Participants|17|17.0||||||
4442888|NCT00106249|4267041|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
4442889|NCT00106249|4267042|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4442890|NCT00106249|4267040|B3||Female|Gender||Participants|Count of Participants|10|10.0||||||
4442891|NCT00106249|4267041|B2||Female|Gender||Participants|Count of Participants|5|5.0||||||
4442892|NCT00106249|4267042|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4442893|NCT00106249|4267040|B3|||Age||years|Mean|38.6|38.6|Standard Deviation|12.5|12.5|||
4442894|NCT00106249|4267041|B2|||Age||years|Mean|37.1|37.1|Standard Deviation|11.8|11.8|||
4442895|NCT00106249|4267042|B1|||Age||years|Mean|40.1|40.1|Standard Deviation|13.1|13.1|||
4442896|NCT00106184|4267053|B3|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4442897|NCT00106184|4267054|B2|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4442898|NCT00106184|4267055|B1|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4442899|NCT00106184|4267053|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4442900|NCT00106184|4267054|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4442901|NCT00106184|4267055|B1|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4442902|NCT00106184|4267053|B3|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4442903|NCT00106184|4267054|B2|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4442904|NCT00106184|4267055|B1|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
4442905|NCT00106184|4267053|B3|United States||Region of Enrollment||participants|Number|185|185.0||||||
4442906|NCT00106184|4267054|B2|United States||Region of Enrollment||participants|Number|98|98.0||||||
4442907|NCT00106184|4267055|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4442908|NCT00106184|4267053|B3||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4442909|NCT00106184|4267054|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4442910|NCT00106184|4267055|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4442911|NCT00106184|4267053|B3||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4442912|NCT00106184|4267054|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4442913|NCT00106184|4267055|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4442914|NCT00106184|4267053|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|18.3|18.3|||
4442915|NCT00106184|4267054|B2|||Age||years|Mean|40.7|40.7|Standard Deviation|18.4|18.4|||
4442916|NCT00106184|4267055|B1|||Age||years|Mean|43.1|43.1|Standard Deviation|18.23|18.23|||
4442917|NCT00106184|4267053|B3||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4442918|NCT00106184|4267054|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4442919|NCT00106184|4267055|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4442920|NCT00106184|4267053|B3||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4442921|NCT00106184|4267054|B2||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4442922|NCT00106184|4267055|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4442923|NCT00106184|4267053|B3||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4442924|NCT00106184|4267054|B2||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4442925|NCT00106184|4267055|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4442926|NCT00106119|4267066|B1|||Free thyroxine (T4)||ng/dl|Mean|1.76|1.76|Standard Deviation|0.46|0.46|||
4442927|NCT00106119|4267066|B1|||Triiodothyronine (T3)||ng/dl|Mean|99.0|99.0|Standard Deviation|24.2|24.2|||
4442928|NCT00106119|4267066|B1|||Thyroid stimulating hormone (TSH)||mU/liter|Mean|1.1|1.1|Standard Deviation|1.4|1.4|||
4442929|NCT00106119|4267066|B1|||Duration of hypothyroidism||years|Mean|8.6|8.6|Standard Deviation|13.1|13.1|||
4442930|NCT00106119|4267066|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4442931|NCT00106119|4267066|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4442932|NCT00106119|4267066|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4442933|NCT00106119|4267066|B1|||Age||years|Mean|49.3|49.3|Standard Deviation|8.0|8.0|||
4442934|NCT00106106|4267085|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4442935|NCT00106106|4267086|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4442936|NCT00106106|4267087|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4442937|NCT00106106|4267085|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4442938|NCT00106106|4267086|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4442939|NCT00106106|4267087|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4442940|NCT00106106|4267085|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4442941|NCT00106106|4267086|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4442942|NCT00106106|4267087|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4442943|NCT00106106|4267085|B3|||Age||years|Mean|35.1|35.1|Standard Deviation|6.5|6.5|||
4442944|NCT00106106|4267086|B2|||Age||years|Mean|35.0|35.0|Standard Deviation|5.8|5.8|||
4442945|NCT00106106|4267087|B1|||Age||years|Mean|35.1|35.1|Standard Deviation|6.1|6.1|||
4442946|NCT00106106|4267085|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4442947|NCT00106106|4267086|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4442948|NCT00106106|4267087|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4442949|NCT00106106|4267085|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4442950|NCT00106106|4267086|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4442951|NCT00106106|4267087|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4442952|NCT00106106|4267085|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442953|NCT00106106|4267086|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442954|NCT00106106|4267087|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4442955|NCT00106080|4267096|B3|Pulmonary||Clinician clinic|Clinician clinic reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|52.6|52.6||||||
4442956|NCT00106080|4267097|B2|Pulmonary||Clinician clinic|Clinician clinic reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|24.0|24.0||||||
4442957|NCT00106080|4267098|B1|Pulmonary||Clinician clinic|Clinician clinic reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|28.6|28.6||||||
4442958|NCT00106080|4267096|B3|Primary care/internal medicine||Clinician clinic|Clinician clinic reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|132.3|132.3||||||
4442959|NCT00106080|4267097|B2|Primary care/internal medicine||Clinician clinic|Clinician clinic reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|68.0|68.0||||||
4442960|NCT00106080|4267098|B1|Primary care/internal medicine||Clinician clinic|Clinician clinic reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|64.3|64.3||||||
4443011|NCT00106028|4267109|B1|Finland||Region of Enrollment||participants|Number|5|5.0||||||
4442961|NCT00106080|4267096|B3|Geriatric||Clinician clinic|Clinician clinic reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|15.1|15.1||||||
4442962|NCT00106080|4267097|B2|Geriatric||Clinician clinic|Clinician clinic reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|8.0|8.0||||||
4442963|NCT00106080|4267098|B1|Geriatric||Clinician clinic|Clinician clinic reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|7.1|7.1||||||
4442964|NCT00106080|4267096|B3|||Male Clinicians|Clinician gender reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|94|94.0||||||
4442965|NCT00106080|4267097|B2|||Male Clinicians|Clinician gender reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|44.0|44.0||||||
4442966|NCT00106080|4267098|B1|||Male Clinicians|Clinician gender reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|50.0|50.0||||||
4442967|NCT00106080|4267096|B3|Current smoker||Smoking Status|Patient smoking status reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|54.8|54.8||||||
4442968|NCT00106080|4267097|B2|Current smoker||Smoking Status|Patient smoking status reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|31.9|31.9||||||
4442969|NCT00106080|4267098|B1|Current smoker||Smoking Status|Patient smoking status reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|22.9|22.9||||||
4442970|NCT00106080|4267096|B3|Past smoker||Smoking Status|Patient smoking status reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|138.2|138.2||||||
4442971|NCT00106080|4267097|B2|Past smoker||Smoking Status|Patient smoking status reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|65.0|65.0||||||
4442972|NCT00106080|4267098|B1|Past smoker||Smoking Status|Patient smoking status reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|73.2|73.2||||||
4442973|NCT00106080|4267096|B3|Never smoked||Smoking Status|Patient smoking status reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|7|7.0||||||
4442974|NCT00106080|4267097|B2|Never smoked||Smoking Status|Patient smoking status reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|3.1|3.1||||||
4442975|NCT00106080|4267098|B1|Never smoked||Smoking Status|Patient smoking status reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|3.9|3.9||||||
4442976|NCT00106080|4267096|B3|White||Race/Ethnicity, Customized|Patient race reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|172.3|172.3||||||
4442977|NCT00106080|4267097|B2|White||Race/Ethnicity, Customized|Patient race reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|87.0|87.0||||||
4442978|NCT00106080|4267098|B1|White||Race/Ethnicity, Customized|Patient race reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|85.3|85.3||||||
4442979|NCT00106080|4267096|B3|Male||Sex/Gender, Customized|Patient gender reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|194.1|194.1||||||
4442980|NCT00106080|4267097|B2|Male||Sex/Gender, Customized|Patient gender reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|96.2|96.2||||||
4442981|NCT00106080|4267098|B1|Male||Sex/Gender, Customized|Patient gender reported as percent. *Total is incorrect due to auto-calculating field.|percent|Number|97.9|97.9||||||
4442982|NCT00106080|4267096|B3|||Age|Patient age in years|years|Mean|69.4|69.4|Standard Deviation|10.0|10.0|||
4442983|NCT00106080|4267097|B2|||Age|Patient age in years|years|Mean|69.4|69.4|Standard Deviation|10.0|10.0|||
4442984|NCT00106080|4267098|B1|||Age|Patient age in years|years|Mean|69.4|69.4|Standard Deviation|10.0|10.0|||
4442985|NCT00106028|4267107|B3|United States||Region of Enrollment||participants|Number|20.0|20.0||||||
4442986|NCT00106028|4267108|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4442987|NCT00106028|4267109|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4442988|NCT00106028|4267107|B3|United Kingdom||Region of Enrollment||participants|Number|30.0|30.0||||||
4442989|NCT00106028|4267108|B2|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4442990|NCT00106028|4267109|B1|United Kingdom||Region of Enrollment||participants|Number|9|9.0||||||
4442991|NCT00106028|4267107|B3|Spain||Region of Enrollment||participants|Number|2.0|2.0||||||
4442992|NCT00106028|4267108|B2|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4442993|NCT00106028|4267109|B1|Spain||Region of Enrollment||participants|Number|1|1.0||||||
4442994|NCT00106028|4267107|B3|South Africa||Region of Enrollment||participants|Number|1.0|1.0||||||
4442995|NCT00106028|4267108|B2|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4442996|NCT00106028|4267109|B1|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4442997|NCT00106028|4267107|B3|Poland||Region of Enrollment||participants|Number|14.0|14.0||||||
4442998|NCT00106028|4267108|B2|Poland||Region of Enrollment||participants|Number|9|9.0||||||
4442999|NCT00106028|4267109|B1|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4443000|NCT00106028|4267107|B3|Italy||Region of Enrollment||participants|Number|3.0|3.0||||||
4443001|NCT00106028|4267108|B2|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4443002|NCT00106028|4267109|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4443003|NCT00106028|4267107|B3|Hungary||Region of Enrollment||participants|Number|4.0|4.0||||||
4443004|NCT00106028|4267108|B2|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4443005|NCT00106028|4267109|B1|Hungary||Region of Enrollment||participants|Number|2|2.0||||||
4443006|NCT00106028|4267107|B3|Germany||Region of Enrollment||participants|Number|13.0|13.0||||||
4443007|NCT00106028|4267108|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4443008|NCT00106028|4267109|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4443009|NCT00106028|4267107|B3|Finland||Region of Enrollment||participants|Number|12.0|12.0||||||
4443010|NCT00106028|4267108|B2|Finland||Region of Enrollment||participants|Number|7|7.0||||||
4443012|NCT00106028|4267107|B3|Czech Republic||Region of Enrollment||participants|Number|5.0|5.0||||||
4443013|NCT00106028|4267108|B2|Czech Republic||Region of Enrollment||participants|Number|4|4.0||||||
4443014|NCT00106028|4267109|B1|Czech Republic||Region of Enrollment||participants|Number|1|1.0||||||
4443015|NCT00106028|4267107|B3|Chile||Region of Enrollment||participants|Number|13.0|13.0||||||
4443016|NCT00106028|4267108|B2|Chile||Region of Enrollment||participants|Number|9|9.0||||||
4443017|NCT00106028|4267109|B1|Chile||Region of Enrollment||participants|Number|4|4.0||||||
4443018|NCT00106028|4267107|B3|Belgium||Region of Enrollment||participants|Number|2.0|2.0||||||
4443019|NCT00106028|4267108|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4443020|NCT00106028|4267109|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4443021|NCT00106028|4267107|B3|Australia||Region of Enrollment||participants|Number|24.0|24.0||||||
4443022|NCT00106028|4267108|B2|Australia||Region of Enrollment||participants|Number|16|16.0||||||
4443023|NCT00106028|4267109|B1|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4443024|NCT00106028|4267107|B3||Male|Sex: Female, Male||Participants|Count of Participants|72.0|72.0||||||
4443025|NCT00106028|4267108|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4443026|NCT00106028|4267109|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4443027|NCT00106028|4267107|B3||Female|Sex: Female, Male||Participants|Count of Participants|71.0|71.0||||||
4443028|NCT00106028|4267108|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4443029|NCT00106028|4267109|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4443030|NCT00106028|4267107|B3|||Age||years|Mean|8.825|8.825|Standard Deviation|3.313|3.313|||
4443031|NCT00106028|4267108|B2|||Age||years|Mean|8.9|8.9|Standard Deviation|3.4|3.4|||
4443032|NCT00106028|4267109|B1|||Age||years|Mean|8.6|8.6|Standard Deviation|3.1|3.1|||
4443033|NCT00106028|4267107|B3||>=65 years|Age|There were 147 children enrolled in the study (stated in the protocol). However, 4 children were randomized but did not receive a dose of the study drug. Therefore, only 143 received at least 1 dose of study drug.|Participants|Count of Participants|0.0|0.0||||||
4443034|NCT00106028|4267108|B2||>=65 years|Age|There were 147 children enrolled in the study (stated in the protocol). However, 4 children were randomized but did not receive a dose of the study drug. Therefore, only 143 received at least 1 dose of study drug.|Participants|Count of Participants|0|0.0||||||
4443035|NCT00106028|4267109|B1||>=65 years|Age|There were 147 children enrolled in the study (stated in the protocol). However, 4 children were randomized but did not receive a dose of the study drug. Therefore, only 143 received at least 1 dose of study drug.|Participants|Count of Participants|0|0.0||||||
4443036|NCT00106028|4267107|B3||Between 18 and 65 years|Age|There were 147 children enrolled in the study (stated in the protocol). However, 4 children were randomized but did not receive a dose of the study drug. Therefore, only 143 received at least 1 dose of study drug.|Participants|Count of Participants|0.0|0.0||||||
4443037|NCT00106028|4267108|B2||Between 18 and 65 years|Age|There were 147 children enrolled in the study (stated in the protocol). However, 4 children were randomized but did not receive a dose of the study drug. Therefore, only 143 received at least 1 dose of study drug.|Participants|Count of Participants|0|0.0||||||
4443038|NCT00106028|4267109|B1||Between 18 and 65 years|Age|There were 147 children enrolled in the study (stated in the protocol). However, 4 children were randomized but did not receive a dose of the study drug. Therefore, only 143 received at least 1 dose of study drug.|Participants|Count of Participants|0|0.0||||||
4443039|NCT00106028|4267107|B3||<=18 years|Age|There were 147 children enrolled in the study (stated in the protocol). However, 4 children were randomized but did not receive a dose of the study drug. Therefore, only 143 received at least 1 dose of study drug.|Participants|Count of Participants|143.0|143.0||||||
4443040|NCT00106028|4267108|B2||<=18 years|Age|There were 147 children enrolled in the study (stated in the protocol). However, 4 children were randomized but did not receive a dose of the study drug. Therefore, only 143 received at least 1 dose of study drug.|Participants|Count of Participants|94|94.0||||||
4443041|NCT00106028|4267109|B1||<=18 years|Age|There were 147 children enrolled in the study (stated in the protocol). However, 4 children were randomized but did not receive a dose of the study drug. Therefore, only 143 received at least 1 dose of study drug.|Participants|Count of Participants|49|49.0||||||
4443042|NCT00106002|4267204|B1|4 - Completely Disabled||Eastern Cooperative Oncology Group Scale Performance Status||participants|Number|0|0.0||||||
4443043|NCT00106002|4267204|B1|3 - Partially Confined to Bed, Limited Self Care||Eastern Cooperative Oncology Group Scale Performance Status||participants|Number|0|0.0||||||
4443044|NCT00106002|4267204|B1|2 - Ambulatory, No Work Activities||Eastern Cooperative Oncology Group Scale Performance Status||participants|Number|0|0.0||||||
4443045|NCT00106002|4267204|B1|1 - Ambulatory, Restricted Strenuous Activity||Eastern Cooperative Oncology Group Scale Performance Status||participants|Number|18|18.0||||||
4443046|NCT00106002|4267204|B1|0 - Fully Active||Eastern Cooperative Oncology Group Scale Performance Status||participants|Number|19|19.0||||||
4443047|NCT00106002|4267204|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4443048|NCT00106002|4267204|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4443049|NCT00106002|4267204|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4443050|NCT00106002|4267204|B1|||Age||years|Median|61.4|61.4|Full Range|||39.0|82.0|
4443051|NCT00105989|4267212|B1|||Weight||kilograms|Mean|74.7|74.7|Standard Deviation|16.1|16.1|||
4443052|NCT00105989|4267212|B1|||Time Interval Between Episodes||months|Mean|8.38|8.38|Standard Deviation|6.78|6.78|||
4443053|NCT00105989|4267212|B1|||Number of Previous Episodes||previous episodes|Mean|4.22|4.22|Standard Deviation|3.48|3.48|||
4443054|NCT00105989|4267212|B1|||Height||centimeters|Mean|167.6|167.6|Standard Deviation|9.23|9.23|||
4443055|NCT00105989|4267212|B1|||Duration of Last Episode||months|Mean|6.14|6.14|Standard Deviation|5.29|5.29|||
4443056|NCT00105989|4267212|B1|||Duration of Current Episode||months|Mean|4.02|4.02|Standard Deviation|4.65|4.65|||
4443057|NCT00105989|4267212|B1|||Clinical Global Impressions - Severity (CGI-S) Total Score|Measures severity of illness at the time of assessment. Scores range from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).|units on a scale|Mean|4.49|4.49|Standard Deviation|0.6|0.6|||
4443058|NCT00105989|4267212|B1|||Age at First Episode||years|Mean|33.16|33.16|Standard Deviation|13.38|13.38|||
4443059|NCT00105989|4267212|B1|||17-item Hamilton Depression Rating Scale (HAMD-17) Total Score|The 17-item HAMD measures depression severity. Each item was evaluated and scored using either a 5-point scale (absent, mild, moderate, severe, very severe) or a 3-point scale (absent, mild, marked). The total score of HAMD-17 may range from 0 (normal) to 52 (severe).|units on a scale|Mean|23.07|23.07|Standard Deviation|3.57|3.57|||
4443060|NCT00105989|4267212|B1|East Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4443061|NCT00105989|4267212|B1|South Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4443062|NCT00105989|4267212|B1|African||Race/Ethnicity||participants|Number|3|3.0||||||
4443063|NCT00105989|4267212|B1|Hispanic||Race/Ethnicity||participants|Number|5|5.0||||||
4443064|NCT00105989|4267212|B1|Caucasian||Race/Ethnicity||participants|Number|504|504.0||||||
4443065|NCT00105989|4267212|B1|Sweden||Region of Enrollment||participants|Number|55|55.0||||||
4443066|NCT00105989|4267212|B1|Italy||Region of Enrollment||participants|Number|73|73.0||||||
4443067|NCT00105989|4267212|B1|Germany||Region of Enrollment||participants|Number|161|161.0||||||
4443068|NCT00105989|4267212|B1|Russian Federation||Region of Enrollment||participants|Number|99|99.0||||||
4443069|NCT00105989|4267212|B1|France||Region of Enrollment||participants|Number|65|65.0||||||
4443070|NCT00105989|4267212|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4443071|NCT00105989|4267212|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4443072|NCT00105989|4267212|B1||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4443073|NCT00105989|4267212|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|13.3|13.3|||
4443074|NCT00105586|4267327|B3|United States||Region of Enrollment||participants|Number|177.0|177.0||||||
4443075|NCT00105586|4267328|B2|United States||Region of Enrollment||participants|Number|85|85.0||||||
4443076|NCT00105586|4267329|B1|United States||Region of Enrollment||participants|Number|92|92.0||||||
4443077|NCT00105586|4267327|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4443078|NCT00105586|4267328|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4443079|NCT00105586|4267329|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4443080|NCT00105586|4267327|B3||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4443081|NCT00105586|4267328|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4443082|NCT00105586|4267329|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4443083|NCT00105586|4267327|B3|||Age||years|Mean|71.6|71.6|Standard Deviation|9.9999|9.9999|||
4443084|NCT00105586|4267328|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|7.4|7.4|||
4443085|NCT00105586|4267329|B1|||Age||years|Mean|72.2|72.2|Standard Deviation|8.2|8.2|||
4443086|NCT00105586|4267327|B3||>=65 years|Age||Participants|Count of Participants|177|177.0||||||
4443087|NCT00105586|4267328|B2||>=65 years|Age||Participants|Count of Participants|85|85.0||||||
4443088|NCT00105586|4267329|B1||>=65 years|Age||Participants|Count of Participants|92|92.0||||||
4443089|NCT00105586|4267327|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4443090|NCT00105586|4267328|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4443091|NCT00105586|4267329|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4443092|NCT00105586|4267327|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443093|NCT00105586|4267328|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443094|NCT00105586|4267329|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443095|NCT00105560|4267338|B1|No||Use of Photons for <20% radiation dose||Participants|Count of Participants|53|53.0||||||
4443096|NCT00105560|4267338|B1|Yes||Use of Photons for <20% radiation dose||Participants|Count of Participants|6|6.0||||||
4443097|NCT00105560|4267338|B1|>300 mg/m2||Cisplatin Cumulative Dose|Cisplatin cumulative dose information is not available for eight of the participants|participants|Number|34|34.0||||||
4443098|NCT00105560|4267338|B1|≤300 mg/m2||Cisplatin Cumulative Dose|Cisplatin cumulative dose information is not available for eight of the participants|participants|Number|17|17.0||||||
4443099|NCT00105560|4267338|B1|≥30 GyRBE||Cochlear Mean Dose to Each Ear (D50)||Ears|Number|57|57.0||||||
4443100|NCT00105560|4267338|B1|<30 GyRBE||Cochlear Mean Dose to Each Ear (D50)||Ears|Number|61|61.0||||||
4443101|NCT00105560|4267338|B1|≥40 GyRBE||Hypothalamus Mean Dose (D50)|D50 (the half maximal inhibitory dose) is the dose of radiation that is required for 50% inactivation of a tumor cell population.|Participants|Count of Participants|22|22.0||||||
4443102|NCT00105560|4267338|B1|<40 GyRBE||Hypothalamus Mean Dose (D50)|D50 (the half maximal inhibitory dose) is the dose of radiation that is required for 50% inactivation of a tumor cell population.|Participants|Count of Participants|37|37.0||||||
4443103|NCT00105560|4267338|B1|36 GyRBE||Craniospinal Radiation Doses||Participants|Count of Participants|14|14.0||||||
4443104|NCT00105560|4267338|B1|18-27 GyRBE||Craniospinal Radiation Doses||Participants|Count of Participants|45|45.0||||||
4443105|NCT00105560|4267338|B1|>54 GyRBE||Boost Dose|Dose measured as Gray (Gy) Relative Biological Effectiveness (RBE)|Participants|Count of Participants|2|2.0||||||
4443106|NCT00105560|4267338|B1|54 GyRBE||Boost Dose|Dose measured as Gray (Gy) Relative Biological Effectiveness (RBE)|Participants|Count of Participants|57|57.0||||||
4443107|NCT00105560|4267338|B1|Posterior Fossa||Boost Field||Participants|Count of Participants|23|23.0||||||
4443108|NCT00105560|4267338|B1|Tumor Bed Involved Field||Boost Field||Participants|Count of Participants|36|36.0||||||
4443109|NCT00105560|4267338|B1|No||Enrolled on a Children's Oncology Group Protocol|The alphanumeric codes next to the 'yes' represent Children's Oncology Group protocol numbers|participants|Number|47|47.0||||||
4443110|NCT00105560|4267338|B1|Yes : A9961||Enrolled on a Children's Oncology Group Protocol|The alphanumeric codes next to the 'yes' represent Children's Oncology Group protocol numbers|participants|Number|1|1.0||||||
4443111|NCT00105560|4267338|B1|Yes : ACNS0334||Enrolled on a Children's Oncology Group Protocol|The alphanumeric codes next to the 'yes' represent Children's Oncology Group protocol numbers|participants|Number|1|1.0||||||
4443112|NCT00105560|4267338|B1|Yes : ACNS0332||Enrolled on a Children's Oncology Group Protocol|The alphanumeric codes next to the 'yes' represent Children's Oncology Group protocol numbers|participants|Number|2|2.0||||||
4443113|NCT00105560|4267338|B1|Yes : ACNS0331||Enrolled on a Children's Oncology Group Protocol|The alphanumeric codes next to the 'yes' represent Children's Oncology Group protocol numbers|participants|Number|8|8.0||||||
4443114|NCT00105560|4267338|B1|No||Ventriculoperitoneal Shunt||Participants|Count of Participants|47|47.0||||||
4443115|NCT00105560|4267338|B1|Yes||Ventriculoperitoneal Shunt||Participants|Count of Participants|12|12.0||||||
4443116|NCT00105560|4267338|B1|No||Posterior Fossa Syndrome||Participants|Count of Participants|45|45.0||||||
4443117|NCT00105560|4267338|B1|Yes||Posterior Fossa Syndrome||Participants|Count of Participants|14|14.0||||||
4443118|NCT00105560|4267338|B1|High||Risk Group|Intermediate risk is defined as M0 patients with <1·5 cm² of residual disease but with anaplastic or large cell variant. If residual disease at the primary site was greater than or equal to 1·5 cm² on axial MRI, then they would be classified as high risk if they had no other evidence of metastatic disease.|Participants|Count of Participants|14|14.0||||||
4443119|NCT00105560|4267338|B1|Intermediate||Risk Group|Intermediate risk is defined as M0 patients with <1·5 cm² of residual disease but with anaplastic or large cell variant. If residual disease at the primary site was greater than or equal to 1·5 cm² on axial MRI, then they would be classified as high risk if they had no other evidence of metastatic disease.|Participants|Count of Participants|6|6.0||||||
4443120|NCT00105560|4267338|B1|Standard||Risk Group|Intermediate risk is defined as M0 patients with <1·5 cm² of residual disease but with anaplastic or large cell variant. If residual disease at the primary site was greater than or equal to 1·5 cm² on axial MRI, then they would be classified as high risk if they had no other evidence of metastatic disease.|Participants|Count of Participants|39|39.0||||||
4443121|NCT00105560|4267338|B1|Anaplastic or Large Cell Variant||Histological Subtype (Dominant Pattern)||Participants|Count of Participants|8|8.0||||||
4443122|NCT00105560|4267338|B1|Desmoplastic or Nodular Variant||Histological Subtype (Dominant Pattern)||Participants|Count of Participants|6|6.0||||||
4443123|NCT00105560|4267338|B1|Classic||Histological Subtype (Dominant Pattern)||Participants|Count of Participants|45|45.0||||||
4443124|NCT00105560|4267338|B1|United States||Region of Enrollment||Participants|Count of Participants|59|59.0||||||
4443125|NCT00105560|4267338|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4443126|NCT00105560|4267338|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4443127|NCT00105560|4267338|B1|≥ 8 Years||Age, Customized||Participants|Count of Participants|22|22.0||||||
4443128|NCT00105560|4267338|B1|< 8 Years||Age, Customized||Participants|Count of Participants|37|37.0||||||
4443129|NCT00105560|4267338|B1|||Age||years|Median|6.6|6.6|Inter-Quartile Range|||5.1|9.9|
4443130|NCT00105534|4267358|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4443131|NCT00105534|4267359|B2||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4443132|NCT00105534|4267360|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4443133|NCT00105534|4267358|B3||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4443134|NCT00105534|4267359|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4443135|NCT00105534|4267360|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4443136|NCT00105534|4267358|B3|||Age||years|Mean|28.4|28.4|Standard Deviation|26.54|26.54|||
4443137|NCT00105534|4267359|B2|||Age||years|Mean|30.8|30.8|Standard Deviation|28.07|28.07|||
4443138|NCT00105534|4267360|B1|||Age||years|Mean|25.6|25.6|Standard Deviation|24.49|24.49|||
4443139|NCT00105521|4267369|B5||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4443140|NCT00105521|4267370|B4||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4443141|NCT00105521|4267371|B3||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4443142|NCT00105521|4267372|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4443143|NCT00105521|4267373|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4443144|NCT00105521|4267369|B5||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4443145|NCT00105521|4267370|B4||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4443146|NCT00105521|4267371|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4443147|NCT00105521|4267372|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4443148|NCT00105521|4267373|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4443149|NCT00105521|4267369|B5|||Age||years|Mean|63.2|63.2|Standard Deviation|9.0|9.0|||
4443150|NCT00105521|4267370|B4|||Age||years|Mean|62.9|62.9|Standard Deviation|8.7|8.7|||
4443151|NCT00105521|4267371|B3|||Age||years|Mean|63.2|63.2|Standard Deviation|9.7|9.7|||
4443152|NCT00105521|4267372|B2|||Age||years|Mean|63.4|63.4|Standard Deviation|9.2|9.2|||
4443153|NCT00105521|4267373|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|8.3|8.3|||
4443154|NCT00105508|4267398|B3||Male|Sex: Female, Male||Participants|Count of Participants|268|268.0||||||
4443155|NCT00105508|4267399|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4443156|NCT00105508|4267400|B1||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4443157|NCT00105508|4267398|B3||Female|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4443158|NCT00105508|4267399|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4443159|NCT00105508|4267400|B1||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4443160|NCT00105508|4267398|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|9.56|9.56|||
4443161|NCT00105508|4267399|B2|||Age||years|Mean|65.0|65.0|Standard Deviation|9.11|9.11|||
4443162|NCT00105508|4267400|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|9.93|9.93|||
4443163|NCT00105482|4267413|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4443164|NCT00105482|4267414|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4443165|NCT00105482|4267415|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4443166|NCT00105482|4267413|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4443167|NCT00105482|4267414|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4443168|NCT00105482|4267415|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4443169|NCT00105482|4267413|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|10.7|10.7|||
4443170|NCT00105482|4267414|B2|||Age||years|Mean|45.5|45.5|Standard Deviation|11.3|11.3|||
4443171|NCT00105482|4267415|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|10.0|10.0|||
4443172|NCT00105469|4267430|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4443173|NCT00105469|4267431|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4443174|NCT00105469|4267432|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4443175|NCT00105469|4267430|B3||Female|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4443176|NCT00105469|4267431|B2||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4443177|NCT00105469|4267432|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4443178|NCT00105469|4267430|B3|||Age||years|Mean|20.4|20.4|Standard Deviation|21.55|21.55|||
4443179|NCT00105469|4267431|B2|||Age||years|Mean|22.8|22.8|Standard Deviation|22.61|22.61|||
4443180|NCT00105469|4267432|B1|||Age||years|Mean|17.9|17.9|Standard Deviation|20.23|20.23|||
4443181|NCT00105443|4267441|B3|Present||Tumor burden|"Tumor burden refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body and is also called the tumor load. Randomization was stratified by tumor burden assessment, ie, the presence of either macroscopic vascular invasion as determined by radiological assessment and/or extra-hepatic spread versus none."|participants|Number|421|421.0||||||
4443182|NCT00105443|4267442|B2|Present||Tumor burden|"Tumor burden refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body and is also called the tumor load. Randomization was stratified by tumor burden assessment, ie, the presence of either macroscopic vascular invasion as determined by radiological assessment and/or extra-hepatic spread versus none."|participants|Number|212|212.0||||||
4443183|NCT00105443|4267443|B1|Present||Tumor burden|"Tumor burden refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body and is also called the tumor load. Randomization was stratified by tumor burden assessment, ie, the presence of either macroscopic vascular invasion as determined by radiological assessment and/or extra-hepatic spread versus none."|participants|Number|209|209.0||||||
4443184|NCT00105443|4267441|B3|Absent||Tumor burden|"Tumor burden refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body and is also called the tumor load. Randomization was stratified by tumor burden assessment, ie, the presence of either macroscopic vascular invasion as determined by radiological assessment and/or extra-hepatic spread versus none."|participants|Number|181|181.0||||||
4443185|NCT00105443|4267442|B2|Absent||Tumor burden|"Tumor burden refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body and is also called the tumor load. Randomization was stratified by tumor burden assessment, ie, the presence of either macroscopic vascular invasion as determined by radiological assessment and/or extra-hepatic spread versus none."|participants|Number|91|91.0||||||
4443186|NCT00105443|4267443|B1|Absent||Tumor burden|"Tumor burden refers to the number of cancer cells, the size of a tumor, or the amount of cancer in the body and is also called the tumor load. Randomization was stratified by tumor burden assessment, ie, the presence of either macroscopic vascular invasion as determined by radiological assessment and/or extra-hepatic spread versus none."|participants|Number|90|90.0||||||
4443187|NCT00105443|4267441|B3|2 = capable of selfcare||Baseline Eastern Cooperative Oncology Group (ECOG)|Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study were to have an ECOG score of 0, 1 or 2.|participants|Number|46|46.0||||||
4443188|NCT00105443|4267442|B2|2 = capable of selfcare||Baseline Eastern Cooperative Oncology Group (ECOG)|Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study were to have an ECOG score of 0, 1 or 2.|participants|Number|22|22.0||||||
4443189|NCT00105443|4267443|B1|2 = capable of selfcare||Baseline Eastern Cooperative Oncology Group (ECOG)|Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study were to have an ECOG score of 0, 1 or 2.|participants|Number|24|24.0||||||
4443190|NCT00105443|4267441|B3|1 = restricted in physical activity but ambulatory||Baseline Eastern Cooperative Oncology Group (ECOG)|Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study were to have an ECOG score of 0, 1 or 2.|participants|Number|231|231.0||||||
4443191|NCT00105443|4267442|B2|1 = restricted in physical activity but ambulatory||Baseline Eastern Cooperative Oncology Group (ECOG)|Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study were to have an ECOG score of 0, 1 or 2.|participants|Number|117|117.0||||||
4443192|NCT00105443|4267443|B1|1 = restricted in physical activity but ambulatory||Baseline Eastern Cooperative Oncology Group (ECOG)|Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study were to have an ECOG score of 0, 1 or 2.|participants|Number|114|114.0||||||
4443193|NCT00105443|4267441|B3|0 = fully active||Baseline Eastern Cooperative Oncology Group (ECOG)|Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study were to have an ECOG score of 0, 1 or 2.|participants|Number|325|325.0||||||
4443194|NCT00105443|4267442|B2|0 = fully active||Baseline Eastern Cooperative Oncology Group (ECOG)|Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study were to have an ECOG score of 0, 1 or 2.|participants|Number|164|164.0||||||
4443195|NCT00105443|4267443|B1|0 = fully active||Baseline Eastern Cooperative Oncology Group (ECOG)|Baseline Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) is a scale that measures how cancer affects a patient. The scale ranges from 0 (fully active) to 5 (dead). Subjects entering this study were to have an ECOG score of 0, 1 or 2.|participants|Number|161|161.0||||||
4443196|NCT00105443|4267441|B3||Male|Sex: Female, Male||Participants|Count of Participants|524|524.0||||||
4443197|NCT00105443|4267442|B2||Male|Sex: Female, Male||Participants|Count of Participants|264|264.0||||||
4443198|NCT00105443|4267443|B1||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4443199|NCT00105443|4267441|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4443200|NCT00105443|4267442|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4443201|NCT00105443|4267443|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4443202|NCT00105443|4267441|B3|||Age||years|Mean|65.6|65.6|Standard Deviation|10.7|10.7|||
4443203|NCT00105443|4267442|B2|||Age||years|Mean|66.3|66.3|Standard Deviation|10.2|10.2|||
4443204|NCT00105443|4267443|B1|||Age||years|Mean|64.9|64.9|Standard Deviation|11.2|11.2|||
4443205|NCT00105235|4267473|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4443206|NCT00105235|4267473|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4443207|NCT00105235|4267473|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4443208|NCT00105235|4267473|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4443209|NCT00105235|4267473|B1|||Age||years|Mean|52.5|52.5|Standard Deviation|10.3|10.3|||
4443210|NCT00105235|4267473|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4443211|NCT00105235|4267473|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4443212|NCT00105235|4267473|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443213|NCT00105196|4267484|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4443214|NCT00105196|4267485|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4443215|NCT00105196|4267486|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4443216|NCT00105196|4267484|B3|White||Race/Ethnicity, Customized||participants|Number|304|304.0||||||
4443217|NCT00105196|4267485|B2|White||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
4443218|NCT00105196|4267486|B1|White||Race/Ethnicity, Customized||participants|Number|155|155.0||||||
4443219|NCT00105196|4267484|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4443220|NCT00105196|4267485|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4443221|NCT00105196|4267486|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4443222|NCT00105196|4267484|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443223|NCT00105196|4267485|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4443224|NCT00105196|4267486|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443225|NCT00105196|4267484|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4443226|NCT00105196|4267485|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4443227|NCT00105196|4267486|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4443228|NCT00105196|4267484|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443229|NCT00105196|4267485|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443230|NCT00105196|4267486|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4443231|NCT00105196|4267484|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4443232|NCT00105196|4267485|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4443233|NCT00105196|4267486|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4443234|NCT00105196|4267484|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|330|330.0||||||
4443235|NCT00105196|4267485|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|162|162.0||||||
4443236|NCT00105196|4267486|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
4443237|NCT00105196|4267484|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4443238|NCT00105196|4267485|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4443239|NCT00105196|4267486|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4443240|NCT00105196|4267484|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4443241|NCT00105196|4267485|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4443242|NCT00105196|4267486|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4443243|NCT00105196|4267484|B3||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4443244|NCT00105196|4267485|B2||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4443245|NCT00105196|4267486|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4443246|NCT00105196|4267484|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|10.9|10.9|||
4443247|NCT00105196|4267485|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|11.3|11.3|||
4443248|NCT00105196|4267486|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|10.6|10.6|||
4443249|NCT00105183|4267507|B4|Australia||Region of Enrollment||participants|Number|36|36.0||||||
4443250|NCT00105183|4267508|B3|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4443251|NCT00105183|4267509|B2|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4443252|NCT00105183|4267510|B1|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4443253|NCT00105183|4267507|B4|Austria||Region of Enrollment||participants|Number|50|50.0||||||
4443254|NCT00105183|4267508|B3|Austria||Region of Enrollment||participants|Number|14|14.0||||||
4443255|NCT00105183|4267509|B2|Austria||Region of Enrollment||participants|Number|18|18.0||||||
4443256|NCT00105183|4267510|B1|Austria||Region of Enrollment||participants|Number|18|18.0||||||
4443257|NCT00105183|4267507|B4|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4443258|NCT00105183|4267508|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4443259|NCT00105183|4267509|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4443260|NCT00105183|4267510|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4443261|NCT00105183|4267507|B4|United States||Region of Enrollment||participants|Number|122|122.0||||||
4443262|NCT00105183|4267508|B3|United States||Region of Enrollment||participants|Number|36|36.0||||||
4443263|NCT00105183|4267509|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4443264|NCT00105183|4267510|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4443265|NCT00105183|4267507|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4443266|NCT00105183|4267508|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4443267|NCT00105183|4267509|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4443268|NCT00105183|4267510|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4443269|NCT00105183|4267507|B4||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4443270|NCT00105183|4267508|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4443271|NCT00105183|4267509|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4443272|NCT00105183|4267510|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4443273|NCT00105183|4267507|B4||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4443274|NCT00105183|4267508|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4443275|NCT00105183|4267509|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4443276|NCT00105183|4267510|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4443277|NCT00105183|4267507|B4||Between 18 and 65 years|Age||Participants|Count of Participants|204|204.0||||||
4443278|NCT00105183|4267508|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4443279|NCT00105183|4267509|B2||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4443280|NCT00105183|4267510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4443281|NCT00105183|4267507|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443282|NCT00105183|4267508|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443283|NCT00105183|4267509|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443284|NCT00105183|4267510|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443285|NCT00105157|4267544|B5|||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA)||Copies/mL|Mean|49841.6|49841.6|Full Range|||3000.0|750000.0|
4443286|NCT00105157|4267545|B4|||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA)||Copies/mL|Mean|47432.6|47432.6|Full Range|||3630.0|611000.0|
4443287|NCT00105157|4267546|B3|||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA)||Copies/mL|Mean|49064.8|49064.8|Full Range|||7030.0|589000.0|
4443288|NCT00105157|4267547|B2|||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA)||Copies/mL|Mean|59107.9|59107.9|Full Range|||4770.0|750000.0|
4443289|NCT00105157|4267548|B1|||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA)||Copies/mL|Mean|44642.6|44642.6|Full Range|||3000.0|750000.0|
4443290|NCT00105157|4267544|B5|||Plasma HIV RNA||log10 copies/mL|Mean|4.7|4.7|Full Range|||3.5|5.9|
4443291|NCT00105157|4267545|B4|||Plasma HIV RNA||log10 copies/mL|Mean|4.7|4.7|Full Range|||3.6|5.8|
4443292|NCT00105157|4267546|B3|||Plasma HIV RNA||log10 copies/mL|Mean|4.7|4.7|Full Range|||3.8|5.8|
4443293|NCT00105157|4267547|B2|||Plasma HIV RNA||log10 copies/mL|Mean|4.8|4.8|Full Range|||3.7|5.9|
4443294|NCT00105157|4267548|B1|||Plasma HIV RNA||log10 copies/mL|Mean|4.6|4.6|Full Range|||3.5|5.9|
4443295|NCT00105157|4267544|B5|||Cluster of Differentiation 4 (CD4) Cell Count||Cells/mm3|Mean|239.9|239.9|Full Range|||30.0|1153.0|
4443296|NCT00105157|4267545|B4|||Cluster of Differentiation 4 (CD4) Cell Count||Cells/mm3|Mean|274.0|274.0|Full Range|||37.0|880.0|
4443297|NCT00105157|4267546|B3|||Cluster of Differentiation 4 (CD4) Cell Count||Cells/mm3|Mean|220.4|220.4|Full Range|||30.0|663.0|
4443298|NCT00105157|4267547|B2|||Cluster of Differentiation 4 (CD4) Cell Count||Cells/mm3|Mean|220.6|220.6|Full Range|||68.0|673.0|
4443299|NCT00105157|4267548|B1|||Cluster of Differentiation 4 (CD4) Cell Count||Cells/mm3|Mean|244.9|244.9|Full Range|||30.0|1153.0|
4443300|NCT00105157|4267544|B5|Others||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443301|NCT00105157|4267545|B4|Others||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443302|NCT00105157|4267546|B3|Others||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4443303|NCT00105157|4267547|B2|Others||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4443304|NCT00105157|4267548|B1|Others||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4443305|NCT00105157|4267544|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4443306|NCT00105157|4267545|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4443307|NCT00105157|4267546|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4443308|NCT00105157|4267547|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4443309|NCT00105157|4267548|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4443310|NCT00105157|4267544|B5|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4443311|NCT00105157|4267545|B4|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443312|NCT00105157|4267546|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4443313|NCT00105157|4267547|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4443314|NCT00105157|4267548|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4443315|NCT00105157|4267544|B5|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4443316|NCT00105157|4267545|B4|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4443317|NCT00105157|4267546|B3|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4443318|NCT00105157|4267547|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4443319|NCT00105157|4267548|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4443320|NCT00105157|4267544|B5|White||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4443321|NCT00105157|4267545|B4|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4443322|NCT00105157|4267546|B3|White||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4443323|NCT00105157|4267547|B2|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4443324|NCT00105157|4267548|B1|White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4443325|NCT00105157|4267544|B5||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4443326|NCT00105157|4267545|B4||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4443327|NCT00105157|4267546|B3||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4443328|NCT00105157|4267547|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4443329|NCT00105157|4267548|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4443330|NCT00105157|4267544|B5||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4443331|NCT00105157|4267545|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4443332|NCT00105157|4267546|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4443333|NCT00105157|4267547|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4443334|NCT00105157|4267548|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4443335|NCT00105157|4267544|B5|||Age||years|Mean|44.1|44.1|Full Range|||18.0|69.0|
4443336|NCT00105157|4267545|B4|||Age||years|Mean|43.3|43.3|Full Range|||29.0|59.0|
4443337|NCT00105157|4267546|B3|||Age||years|Mean|43.8|43.8|Full Range|||25.0|63.0|
4443338|NCT00105157|4267547|B2|||Age||years|Mean|45.1|45.1|Full Range|||32.0|69.0|
4443339|NCT00105157|4267548|B1|||Age||years|Mean|44.0|44.0|Full Range|||18.0|57.0|
4443340|NCT00105079|4267743|B3||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4443341|NCT00105079|4267744|B2||Male|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4443342|NCT00105079|4267745|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4443343|NCT00105079|4267743|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4443344|NCT00105079|4267744|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4443345|NCT00105079|4267745|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4443346|NCT00105079|4267743|B3|||Age||years|Mean|38.1|38.1|Standard Deviation|9.45|9.45|||
4443347|NCT00105079|4267744|B2|||Age||years|Mean|37.9|37.9|Standard Deviation|9.60|9.6|||
4443348|NCT00105079|4267745|B1|||Age||years|Mean|38.3|38.3|Standard Deviation|9.31|9.31|||
4443349|NCT00105066|4267762|B3|||HOMA-S|HOMA Insulin Sensitivity Index|HOMA Score|Mean|52.5|52.5|Standard Deviation|24.5|24.5|||
4443350|NCT00105066|4267763|B2|||HOMA-S|HOMA Insulin Sensitivity Index|HOMA Score|Mean|52.3|52.3|Standard Deviation|23.1|23.1|||
4443351|NCT00105066|4267764|B1|||HOMA-S|HOMA Insulin Sensitivity Index|HOMA Score|Mean|52.9|52.9|Standard Deviation|26.9|26.9|||
4443352|NCT00105066|4267762|B3|||FMD|Flow Mediated Dilation of brachial artery (percent change in blood flow after hyperemia)|percentage|Mean|8.5|8.5|Standard Deviation|5.3|5.3|||
4443353|NCT00105066|4267763|B2|||FMD|Flow Mediated Dilation of brachial artery (percent change in blood flow after hyperemia)|percentage|Mean|9.3|9.3|Standard Deviation|6.1|6.1|||
4443354|NCT00105066|4267764|B1|||FMD|Flow Mediated Dilation of brachial artery (percent change in blood flow after hyperemia)|percentage|Mean|7.6|7.6|Standard Deviation|4.4|4.4|||
4443355|NCT00105066|4267762|B3|||Carotid Femoral Pulse Wave Velocity||meters/second|Mean|6.8|6.8|Standard Deviation|2.1|2.1|||
4443356|NCT00105066|4267763|B2|||Carotid Femoral Pulse Wave Velocity||meters/second|Mean|6.8|6.8|Standard Deviation|2.1|2.1|||
4443357|NCT00105066|4267764|B1|||Carotid Femoral Pulse Wave Velocity||meters/second|Mean|6.8|6.8|Standard Deviation|2.1|2.1|||
4443358|NCT00105066|4267762|B3||Male|Gender||Participants|Count of Participants|23|23.0||||||
4443359|NCT00105066|4267763|B2||Male|Gender||Participants|Count of Participants|15|15.0||||||
4443360|NCT00105066|4267764|B1||Male|Gender||Participants|Count of Participants|8|8.0||||||
4443361|NCT00105066|4267762|B3||Female|Gender||Participants|Count of Participants|53|53.0||||||
4443362|NCT00105066|4267763|B2||Female|Gender||Participants|Count of Participants|34|34.0||||||
4443363|NCT00105066|4267764|B1||Female|Gender||Participants|Count of Participants|19|19.0||||||
4443364|NCT00105066|4267762|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|12.7|12.7|||
4443365|NCT00105066|4267763|B2|||Age||years|Mean|55.1|55.1|Standard Deviation|11.8|11.8|||
4443366|NCT00105066|4267764|B1|||Age||years|Mean|53.6|53.6|Standard Deviation|13.5|13.5|||
4443367|NCT00105027|4267775|B7|United States||Region of Enrollment||participants|Number|682|682.0||||||
4443368|NCT00105027|4267776|B6|United States||Region of Enrollment||participants|Number|138|138.0||||||
4443369|NCT00105027|4267777|B5|United States||Region of Enrollment||participants|Number|136|136.0||||||
4443370|NCT00105027|4267778|B4|United States||Region of Enrollment||participants|Number|137|137.0||||||
4443371|NCT00105027|4267779|B3|United States||Region of Enrollment||participants|Number|91|91.0||||||
4443372|NCT00105027|4267780|B2|United States||Region of Enrollment||participants|Number|92|92.0||||||
4443373|NCT00105027|4267781|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
4443374|NCT00105027|4267775|B7||Male|Sex: Female, Male||Participants|Count of Participants|357|357.0||||||
4443375|NCT00105027|4267776|B6||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4443376|NCT00105027|4267777|B5||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4443377|NCT00105027|4267778|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4443378|NCT00105027|4267779|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4443379|NCT00105027|4267780|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4443380|NCT00105027|4267781|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4443381|NCT00105027|4267775|B7||Female|Sex: Female, Male||Participants|Count of Participants|325|325.0||||||
4443382|NCT00105027|4267776|B6||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4443383|NCT00105027|4267777|B5||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4443384|NCT00105027|4267778|B4||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4443385|NCT00105027|4267779|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4443386|NCT00105027|4267780|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4443387|NCT00105027|4267781|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4443388|NCT00105027|4267775|B7|||Age||years|Mean|67.7|67.7|Standard Deviation|11.2|11.2|||
4443389|NCT00105027|4267776|B6|||Age||years|Mean|68.1|68.1|Standard Deviation|10.6|10.6|||
4443390|NCT00105027|4267777|B5|||Age||years|Mean|67.2|67.2|Standard Deviation|11.5|11.5|||
4443391|NCT00105027|4267778|B4|||Age||years|Mean|66.9|66.9|Standard Deviation|11.5|11.5|||
4443392|NCT00105027|4267779|B3|||Age||years|Mean|67.5|67.5|Standard Deviation|12.0|12.0|||
4443393|NCT00105027|4267780|B2|||Age||years|Mean|67.4|67.4|Standard Deviation|12.4|12.4|||
4443394|NCT00105027|4267781|B1|||Age||years|Mean|69.2|69.2|Standard Deviation|12.8|12.8|||
4443395|NCT00105027|4267775|B7||>=65 years|Age||Participants|Count of Participants|417|417.0||||||
4443396|NCT00105027|4267776|B6||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
4443397|NCT00105027|4267777|B5||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4443398|NCT00105027|4267778|B4||>=65 years|Age||Participants|Count of Participants|75|75.0||||||
4443399|NCT00105027|4267779|B3||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4443400|NCT00105027|4267780|B2||>=65 years|Age||Participants|Count of Participants|57|57.0||||||
4443401|NCT00105027|4267781|B1||>=65 years|Age||Participants|Count of Participants|63|63.0||||||
4443402|NCT00105027|4267775|B7||Between 18 and 65 years|Age||Participants|Count of Participants|265|265.0||||||
4443403|NCT00105027|4267776|B6||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4443404|NCT00105027|4267777|B5||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4443405|NCT00105027|4267778|B4||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4443406|NCT00105027|4267779|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4443407|NCT00105027|4267780|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4443408|NCT00105027|4267781|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4443409|NCT00105027|4267775|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443410|NCT00105027|4267776|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443411|NCT00105027|4267777|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443412|NCT00105027|4267778|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443413|NCT00105027|4267779|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443414|NCT00105027|4267780|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443415|NCT00105027|4267781|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443416|NCT00105001|4267818|B4|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4443417|NCT00105001|4267819|B3|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4443418|NCT00105001|4267820|B2|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4443419|NCT00105001|4267821|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4443420|NCT00105001|4267818|B4|Denmark||Region of Enrollment||participants|Number|15|15.0||||||
4443421|NCT00105001|4267819|B3|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4443422|NCT00105001|4267820|B2|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4443423|NCT00105001|4267821|B1|Denmark||Region of Enrollment||participants|Number|5|5.0||||||
4443424|NCT00105001|4267818|B4|United States||Region of Enrollment||participants|Number|176|176.0||||||
4443425|NCT00105001|4267819|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4443426|NCT00105001|4267820|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4443427|NCT00105001|4267821|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4443428|NCT00105001|4267818|B4||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4443429|NCT00105001|4267819|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4443430|NCT00105001|4267820|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4443431|NCT00105001|4267821|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4443432|NCT00105001|4267818|B4||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4443433|NCT00105001|4267819|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4443434|NCT00105001|4267820|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4443435|NCT00105001|4267821|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4443436|NCT00105001|4267818|B4|||Age||years|Median|60|60.0|Full Range|||13.0|75.0|
4443437|NCT00105001|4267819|B3|||Age||years|Median|60|60.0|Full Range|||15.0|75.0|
4443438|NCT00105001|4267820|B2|||Age||years|Median|60|60.0|Full Range|||13.0|72.0|
4443439|NCT00105001|4267821|B1|||Age||years|Median|60|60.0|Full Range|||26.0|74.0|
4443440|NCT00105001|4267818|B4||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4443441|NCT00105001|4267819|B3||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4443442|NCT00105001|4267820|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4443443|NCT00105001|4267821|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4443444|NCT00105001|4267818|B4||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4443445|NCT00105001|4267819|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4443446|NCT00105001|4267820|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4443447|NCT00105001|4267821|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4443448|NCT00105001|4267818|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4443449|NCT00105001|4267819|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4443450|NCT00105001|4267820|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4443451|NCT00105001|4267821|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443452|NCT00104884|4267843|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4443453|NCT00104884|4267843|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4443454|NCT00104884|4267843|B1|||Age||years|Median|53.5|53.5|Full Range|||51.0|66.0|
4443455|NCT00104871|4267847|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4443456|NCT00104871|4267847|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4443457|NCT00104871|4267847|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4443458|NCT00104871|4267847|B1|||Age||years|Median|62|62.0|Full Range|||36.0|83.0|
4443459|NCT00104728|4267853|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4443460|NCT00104728|4267853|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4443461|NCT00104728|4267853|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4443462|NCT00104728|4267853|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4443463|NCT00104728|4267853|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4443464|NCT00104728|4267853|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443465|NCT00104650|4267858|B4|||Serum C-Telopeptide (CTx)||ng/mL|Mean|1.28|1.28|Standard Deviation|1.48|1.48|||
4443466|NCT00104650|4267859|B3|||Serum C-Telopeptide (CTx)||ng/mL|Mean|1.34|1.34|Standard Deviation|1.27|1.27|||
4443467|NCT00104650|4267860|B2|||Serum C-Telopeptide (CTx)||ng/mL|Mean|1.40|1.4|Standard Deviation|1.93|1.93|||
4443468|NCT00104650|4267861|B1|||Serum C-Telopeptide (CTx)||ng/mL|Mean|1.12|1.12|Standard Deviation|1.18|1.18|||
4443469|NCT00104650|4267858|B4|||Urinary N-telopeptide (uNTx) Level|Corrected for urine creatinine (uNTx/Creatinine)|nmol/mmol|Mean|158.01|158.01|Standard Deviation|177.11|177.11|||
4443470|NCT00104650|4267859|B3|||Urinary N-telopeptide (uNTx) Level|Corrected for urine creatinine (uNTx/Creatinine)|nmol/mmol|Mean|175.15|175.15|Standard Deviation|208.87|208.87|||
4443471|NCT00104650|4267860|B2|||Urinary N-telopeptide (uNTx) Level|Corrected for urine creatinine (uNTx/Creatinine)|nmol/mmol|Mean|149.88|149.88|Standard Deviation|176.28|176.28|||
4443472|NCT00104650|4267861|B1|||Urinary N-telopeptide (uNTx) Level|Corrected for urine creatinine (uNTx/Creatinine)|nmol/mmol|Mean|149.94|149.94|Standard Deviation|147.20|147.2|||
4443473|NCT00104650|4267858|B4|Other solid tumor||Cancer Type Stratification Factor||Participants|Number|6|6.0||||||
4443474|NCT00104650|4267859|B3|Other solid tumor||Cancer Type Stratification Factor||Participants|Number|2|2.0||||||
4443475|NCT00104650|4267860|B2|Other solid tumor||Cancer Type Stratification Factor||Participants|Number|1|1.0||||||
4443476|NCT00104650|4267861|B1|Other solid tumor||Cancer Type Stratification Factor||Participants|Number|3|3.0||||||
4443477|NCT00104650|4267858|B4|Mutiple myeloma||Cancer Type Stratification Factor||Participants|Number|9|9.0||||||
4443478|NCT00104650|4267859|B3|Mutiple myeloma||Cancer Type Stratification Factor||Participants|Number|4|4.0||||||
4443479|NCT00104650|4267860|B2|Mutiple myeloma||Cancer Type Stratification Factor||Participants|Number|3|3.0||||||
4443480|NCT00104650|4267861|B1|Mutiple myeloma||Cancer Type Stratification Factor||Participants|Number|2|2.0||||||
4443481|NCT00104650|4267858|B4|Prostate cancer||Cancer Type Stratification Factor||Participants|Number|50|50.0||||||
4443482|NCT00104650|4267859|B3|Prostate cancer||Cancer Type Stratification Factor||Participants|Number|16|16.0||||||
4443483|NCT00104650|4267860|B2|Prostate cancer||Cancer Type Stratification Factor||Participants|Number|17|17.0||||||
4443484|NCT00104650|4267861|B1|Prostate cancer||Cancer Type Stratification Factor||Participants|Number|17|17.0||||||
4443485|NCT00104650|4267858|B4|Breast cancer||Cancer Type Stratification Factor||Participants|Number|46|46.0||||||
4443486|NCT00104650|4267859|B3|Breast cancer||Cancer Type Stratification Factor||Participants|Number|14|14.0||||||
4443487|NCT00104650|4267860|B2|Breast cancer||Cancer Type Stratification Factor||Participants|Number|16|16.0||||||
4443488|NCT00104650|4267861|B1|Breast cancer||Cancer Type Stratification Factor||Participants|Number|16|16.0||||||
4443489|NCT00104650|4267858|B4|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4443490|NCT00104650|4267859|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4443491|NCT00104650|4267860|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4443492|NCT00104650|4267861|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4443493|NCT00104650|4267858|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4443494|NCT00104650|4267859|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4443495|NCT00104650|4267860|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4443496|NCT00104650|4267861|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4443497|NCT00104650|4267858|B4|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4443498|NCT00104650|4267859|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4443499|NCT00104650|4267860|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4443500|NCT00104650|4267861|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4443501|NCT00104650|4267858|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4443502|NCT00104650|4267859|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4443503|NCT00104650|4267860|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4443504|NCT00104650|4267861|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4443505|NCT00104650|4267858|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4443506|NCT00104650|4267859|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4443507|NCT00104650|4267860|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4443508|NCT00104650|4267861|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4443509|NCT00104650|4267858|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
4443510|NCT00104650|4267859|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4443511|NCT00104650|4267860|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4443512|NCT00104650|4267861|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|22|22.0||||||
4443513|NCT00104650|4267858|B4||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4443514|NCT00104650|4267859|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4443515|NCT00104650|4267860|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4443516|NCT00104650|4267861|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4443517|NCT00104650|4267858|B4||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4443518|NCT00104650|4267859|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4443519|NCT00104650|4267860|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4443520|NCT00104650|4267861|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4443521|NCT00104650|4267858|B4|||Age||Years|Mean|62.5|62.5|Standard Deviation|11.8|11.8|||
4443522|NCT00104650|4267859|B3|||Age||Years|Mean|65.3|65.3|Standard Deviation|12.7|12.7|||
4443523|NCT00104650|4267860|B2|||Age||Years|Mean|61.6|61.6|Standard Deviation|11.7|11.7|||
4443524|NCT00104650|4267861|B1|||Age||Years|Mean|60.6|60.6|Standard Deviation|10.7|10.7|||
4443525|NCT00104637|4267895|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4443526|NCT00104637|4267895|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4443527|NCT00104637|4267895|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4443528|NCT00104637|4267895|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4443529|NCT00104637|4267895|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4443530|NCT00104637|4267895|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4443531|NCT00104572|4267922|B4|||knee strength||Nm|Mean|142.6|142.6|Standard Deviation|11.3|11.3|||
4443532|NCT00104572|4267923|B3|||knee strength||Nm|Mean|155.4|155.4|Standard Deviation|41.9|41.9|||
4443533|NCT00104572|4267924|B2|||knee strength||Nm|Mean|138.7|138.7|Standard Deviation|48.6|48.6|||
4443534|NCT00104572|4267925|B1|||knee strength||Nm|Mean|133.8|133.8|Standard Deviation|44.3|44.3|||
4443535|NCT00104572|4267922|B4|||hand grip||kg|Mean|39.9|39.9|Standard Deviation|1.1|1.1|||
4443536|NCT00104572|4267923|B3|||hand grip||kg|Mean|39.3|39.3|Standard Deviation|7.2|7.2|||
4443537|NCT00104572|4267924|B2|||hand grip||kg|Mean|39.2|39.2|Standard Deviation|9.9|9.9|||
4443538|NCT00104572|4267925|B1|||hand grip||kg|Mean|41.1|41.1|Standard Deviation|6.9|6.9|||
4443539|NCT00104572|4267922|B4|||Fat mass||kg|Mean|29.0|29.0|Standard Deviation|2.4|2.4|||
4443540|NCT00104572|4267923|B3|||Fat mass||kg|Mean|28.5|28.5|Standard Deviation|7.6|7.6|||
4443541|NCT00104572|4267924|B2|||Fat mass||kg|Mean|26.9|26.9|Standard Deviation|9.6|9.6|||
4443542|NCT00104572|4267925|B1|||Fat mass||kg|Mean|31.6|31.6|Standard Deviation|10.4|10.4|||
4443543|NCT00104572|4267922|B4|||lean body mass||kg|Mean|55.6|55.6|Standard Deviation|0.8|0.8|||
4443544|NCT00104572|4267923|B3|||lean body mass||kg|Mean|56.0|56.0|Standard Deviation|7.2|7.2|||
4443545|NCT00104572|4267924|B2|||lean body mass||kg|Mean|54.7|54.7|Standard Deviation|11.0|11.0|||
4443546|NCT00104572|4267925|B1|||lean body mass||kg|Mean|56.0|56.0|Standard Deviation|12|12.0|||
4443547|NCT00104572|4267922|B4|||Bone mineral density||g/cm2|Mean|1.3|1.3|Standard Deviation|0.1|0.1|||
4443548|NCT00104572|4267923|B3|||Bone mineral density||g/cm2|Mean|1.2|1.2|Standard Deviation|0.1|0.1|||
4443549|NCT00104572|4267924|B2|||Bone mineral density||g/cm2|Mean|1.3|1.3|Standard Deviation|0.2|0.2|||
4443550|NCT00104572|4267925|B1|||Bone mineral density||g/cm2|Mean|1.4|1.4|Standard Deviation|0.2|0.2|||
4443551|NCT00104572|4267922|B4|||follicle-stimulating hormone||mlU/ml|Mean|7.567|7.567|Standard Deviation|0.9|0.9|||
4443552|NCT00104572|4267923|B3|||follicle-stimulating hormone||mlU/ml|Mean|8.2|8.2|Standard Deviation|10.9|10.9|||
4443553|NCT00104572|4267924|B2|||follicle-stimulating hormone||mlU/ml|Mean|6.5|6.5|Standard Deviation|5.3|5.3|||
4443554|NCT00104572|4267925|B1|||follicle-stimulating hormone||mlU/ml|Mean|8.0|8.0|Standard Deviation|6.4|6.4|||
4443555|NCT00104572|4267922|B4|||luteinizing hormone||mlU/ml|Mean|10.00|10.0|Standard Deviation|3.1|3.1|||
4443556|NCT00104572|4267923|B3|||luteinizing hormone||mlU/ml|Mean|12.2|12.2|Standard Deviation|10.1|10.1|||
4443557|NCT00104572|4267924|B2|||luteinizing hormone||mlU/ml|Mean|6.4|6.4|Standard Deviation|2.7|2.7|||
4443558|NCT00104572|4267925|B1|||luteinizing hormone||mlU/ml|Mean|11.4|11.4|Standard Deviation|8.2|8.2|||
4443559|NCT00104572|4267922|B4|||Sex hormone-binding globulin||nmol/L|Mean|47.30|47.3|Standard Deviation|10.0|10.0|||
4443560|NCT00104572|4267923|B3|||Sex hormone-binding globulin||nmol/L|Mean|58.6|58.6|Standard Deviation|21.3|21.3|||
4443561|NCT00104572|4267924|B2|||Sex hormone-binding globulin||nmol/L|Mean|39.9|39.9|Standard Deviation|19.4|19.4|||
4443562|NCT00104572|4267925|B1|||Sex hormone-binding globulin||nmol/L|Mean|43.4|43.4|Standard Deviation|22.2|22.2|||
4443563|NCT00104572|4267922|B4|||Estradiol||ng/dL|Mean|1.700|1.7|Standard Deviation|0.3|0.3|||
4443564|NCT00104572|4267923|B3|||Estradiol||ng/dL|Mean|1.6|1.6|Standard Deviation|0.5|0.5|||
4443565|NCT00104572|4267924|B2|||Estradiol||ng/dL|Mean|1.5|1.5|Standard Deviation|0.6|0.6|||
4443566|NCT00104572|4267925|B1|||Estradiol||ng/dL|Mean|2.0|2.0|Standard Deviation|0.7|0.7|||
4443567|NCT00104572|4267922|B4|||Bioavailable Testosterone||ng/dL|Mean|106.8|106.8|Standard Deviation|13.5|13.5|||
4443568|NCT00104572|4267923|B3|||Bioavailable Testosterone||ng/dL|Mean|91.2|91.2|Standard Deviation|31.7|31.7|||
4443569|NCT00104572|4267924|B2|||Bioavailable Testosterone||ng/dL|Mean|114.8|114.8|Standard Deviation|36.3|36.3|||
4443570|NCT00104572|4267925|B1|||Bioavailable Testosterone||ng/dL|Mean|114.4|114.4|Standard Deviation|37.2|37.2|||
4443571|NCT00104572|4267922|B4|||Total Testosterone||ng/dL|Mean|291.8|291.8|Standard Deviation|17.6|17.6|||
4443572|NCT00104572|4267923|B3|||Total Testosterone||ng/dL|Mean|303.8|303.8|Standard Deviation|94.7|94.7|||
4443573|NCT00104572|4267924|B2|||Total Testosterone||ng/dL|Mean|271.6|271.6|Standard Deviation|85.6|85.6|||
4443574|NCT00104572|4267925|B1|||Total Testosterone||ng/dL|Mean|300.1|300.1|Standard Deviation|81.9|81.9|||
4443575|NCT00104572|4267922|B4|||Body mass index||kg/m2|Mean|28.5|28.5|Standard Deviation|1.4|1.4|||
4443576|NCT00104572|4267923|B3|||Body mass index||kg/m2|Mean|27.6|27.6|Standard Deviation|3.5|3.5|||
4443577|NCT00104572|4267924|B2|||Body mass index||kg/m2|Mean|27.8|27.8|Standard Deviation|4.1|4.1|||
4443578|NCT00104572|4267925|B1|||Body mass index||kg/m2|Mean|30.1|30.1|Standard Deviation|4.0|4.0|||
4443579|NCT00104572|4267922|B4|||Diastolic blood pressure||mmHg|Mean|72.9|72.9|Standard Deviation|0.5|0.5|||
4443580|NCT00104572|4267923|B3|||Diastolic blood pressure||mmHg|Mean|73.1|73.1|Standard Deviation|10.4|10.4|||
4443581|NCT00104572|4267924|B2|||Diastolic blood pressure||mmHg|Mean|72.4|72.4|Standard Deviation|9.4|9.4|||
4443582|NCT00104572|4267925|B1|||Diastolic blood pressure||mmHg|Mean|73.3|73.3|Standard Deviation|5.3|5.3|||
4443583|NCT00104572|4267922|B4|||Systolic blood pressure||mmHg|Mean|135.3|135.3|Standard Deviation|2.2|2.2|||
4443584|NCT00104572|4267923|B3|||Systolic blood pressure||mmHg|Mean|133.7|133.7|Standard Deviation|11.2|11.2|||
4443585|NCT00104572|4267924|B2|||Systolic blood pressure||mmHg|Mean|134.5|134.5|Standard Deviation|14.5|14.5|||
4443586|NCT00104572|4267925|B1|||Systolic blood pressure||mmHg|Mean|137.8|137.8|Standard Deviation|9.4|9.4|||
4443587|NCT00104572|4267922|B4|United States||Region of Enrollment||participants|Number|35|35.0||||||
4443588|NCT00104572|4267923|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4443589|NCT00104572|4267924|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4443590|NCT00104572|4267925|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4443591|NCT00104572|4267922|B4||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4443592|NCT00104572|4267923|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4443593|NCT00104572|4267924|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4443594|NCT00104572|4267925|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4443595|NCT00104572|4267922|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4443596|NCT00104572|4267923|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4443597|NCT00104572|4267924|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4443598|NCT00104572|4267925|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4443599|NCT00104572|4267922|B4|||Age||years|Mean|71|71.0|Standard Deviation|1.2|1.2|||
4443600|NCT00104572|4267923|B3|||Age||years|Mean|72|72.0|Standard Deviation|3.4|3.4|||
4443601|NCT00104572|4267924|B2|||Age||years|Mean|70|70.0|Standard Deviation|3.0|3.0|||
4443602|NCT00104572|4267925|B1|||Age||years|Mean|72|72.0|Standard Deviation|5.1|5.1|||
4443603|NCT00104520|4267944|B3|United States||Region of Enrollment||participants|Number|211|211.0||||||
4443604|NCT00104520|4267945|B2|United States||Region of Enrollment||participants|Number|135|135.0||||||
4443605|NCT00104520|4267946|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4443606|NCT00104520|4267944|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4443607|NCT00104520|4267945|B2||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4443608|NCT00104520|4267946|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4443609|NCT00104520|4267944|B3||Female|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4443610|NCT00104520|4267945|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4443611|NCT00104520|4267946|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4443612|NCT00104520|4267944|B3|||Age||years|Mean|26.2|26.2|Standard Deviation|10.4|10.4|||
4443613|NCT00104520|4267945|B2|||Age||years|Mean|25.3|25.3|Standard Deviation|10.2|10.2|||
4443614|NCT00104520|4267946|B1|||Age||years|Mean|27.9|27.9|Standard Deviation|10.4|10.4|||
4443615|NCT00104520|4267944|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4443616|NCT00104520|4267945|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4443617|NCT00104520|4267946|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4443618|NCT00104520|4267944|B3||Between 18 and 65 years|Age||Participants|Count of Participants|164|164.0||||||
4443619|NCT00104520|4267945|B2||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4443620|NCT00104520|4267946|B1||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4443621|NCT00104520|4267944|B3||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4443622|NCT00104520|4267945|B2||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4443623|NCT00104520|4267946|B1||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4443624|NCT00104416|4267965|B3|Asian and White||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|1|1.0||||||
4443625|NCT00104416|4267966|B2|Asian and White||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|0|0.0||||||
4443626|NCT00104416|4267967|B1|Asian and White||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|1|1.0||||||
4443627|NCT00104416|4267965|B3|American Indian or Alaskan Native and White||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|2|2.0||||||
4443628|NCT00104416|4267966|B2|American Indian or Alaskan Native and White||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|0|0.0||||||
4443629|NCT00104416|4267967|B1|American Indian or Alaskan Native and White||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|2|2.0||||||
4443630|NCT00104416|4267965|B3|White||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|75|75.0||||||
4443631|NCT00104416|4267966|B2|White||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|37|37.0||||||
4443632|NCT00104416|4267967|B1|White||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|38|38.0||||||
4443633|NCT00104416|4267965|B3|Asian||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|62|62.0||||||
4443634|NCT00104416|4267966|B2|Asian||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|31|31.0||||||
4443702|NCT00104234|4268046|B3|Portugal||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|6|6.0||||||
4443635|NCT00104416|4267967|B1|Asian||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|31|31.0||||||
4443636|NCT00104416|4267965|B3|African American/African Heritage||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|3|3.0||||||
4443637|NCT00104416|4267966|B2|African American/African Heritage||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|2|2.0||||||
4443638|NCT00104416|4267967|B1|African American/African Heritage||Race/Ethnicity, Customized|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|participants|Number|1|1.0||||||
4443639|NCT00104416|4267965|B3||Male|Gender|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|Participants|Count of Participants|73|73.0||||||
4443640|NCT00104416|4267966|B2||Male|Gender|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|Participants|Count of Participants|38|38.0||||||
4443641|NCT00104416|4267967|B1||Male|Gender|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|Participants|Count of Participants|35|35.0||||||
4443642|NCT00104416|4267965|B3||Female|Gender|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|Participants|Count of Participants|70|70.0||||||
4443643|NCT00104416|4267966|B2||Female|Gender|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|Participants|Count of Participants|32|32.0||||||
4443644|NCT00104416|4267967|B1||Female|Gender|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|Participants|Count of Participants|38|38.0||||||
4443645|NCT00104416|4267965|B3|||Age|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|years|Mean|28.9|28.9|Standard Deviation|12.10|12.1|||
4443646|NCT00104416|4267966|B2|||Age|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|years|Mean|29.4|29.4|Standard Deviation|12.78|12.78|||
4443647|NCT00104416|4267967|B1|||Age|Baseline measures are on the Intent-to-Treat (ITT) Population, participants who took at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. Four and six participants did not meet the ITT definition in the Double-Blind Treatment Phase Placebo Arm and the Double-Blind Treatment Phase LTG XR Arm, respectively.|years|Mean|28.4|28.4|Standard Deviation|11.48|11.48|||
4443648|NCT00104299|4268014|B3|||VDI|Vasculitis Damage Index. The VDI is a validated measure for damage assessment in vasculitis. The index comprises 64 items of damage (divided into 11 organ based systems) representative of damage incurred to patients with systemic vasculitis. Scores for this index range from 0 to 64, with higher scores indicating more severe damage.|score units|Mean|1.2|1.2|Standard Deviation|1.7|1.7|||
4443649|NCT00104299|4268015|B2|||VDI|Vasculitis Damage Index. The VDI is a validated measure for damage assessment in vasculitis. The index comprises 64 items of damage (divided into 11 organ based systems) representative of damage incurred to patients with systemic vasculitis. Scores for this index range from 0 to 64, with higher scores indicating more severe damage.|score units|Mean|1.0|1.0|Standard Deviation|1.4|1.4|||
4443650|NCT00104299|4268016|B1|||VDI|Vasculitis Damage Index. The VDI is a validated measure for damage assessment in vasculitis. The index comprises 64 items of damage (divided into 11 organ based systems) representative of damage incurred to patients with systemic vasculitis. Scores for this index range from 0 to 64, with higher scores indicating more severe damage.|score units|Mean|1.4|1.4|Standard Deviation|1.8|1.8|||
4443703|NCT00104234|4268047|B2|Portugal||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|2|2.0||||||
4443704|NCT00104234|4268048|B1|Portugal||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|4|4.0||||||
4443855|NCT00103857|4268080|B6|||Age||years|Mean|53.6|53.6|Standard Deviation|10.0|10.0|||
4443651|NCT00104299|4268014|B3|||BVAS/WG|The Birmingham Vasculitis Activity Score for Wegener’s Granulomatosis (WG) is a validated disease activity index. The BVAS/WG is designed to document new or worsening clinically active vasculitis and consists of a set of items divided into nine organ based systems. BVAS/WG scores range from 0 to 63, with higher scores indicating more active disease. In this study, the primary end point was a BVAS/WG score of 0 and successful completion of the prednisone taper at 6 months.|score units|Mean|8.0|8.0|Standard Deviation|3.1|3.1|||
4443652|NCT00104299|4268015|B2|||BVAS/WG|The Birmingham Vasculitis Activity Score for Wegener’s Granulomatosis (WG) is a validated disease activity index. The BVAS/WG is designed to document new or worsening clinically active vasculitis and consists of a set of items divided into nine organ based systems. BVAS/WG scores range from 0 to 63, with higher scores indicating more active disease. In this study, the primary end point was a BVAS/WG score of 0 and successful completion of the prednisone taper at 6 months.|score units|Mean|8.0|8.0|Standard Deviation|3.4|3.4|||
4443653|NCT00104299|4268016|B1|||BVAS/WG|The Birmingham Vasculitis Activity Score for Wegener’s Granulomatosis (WG) is a validated disease activity index. The BVAS/WG is designed to document new or worsening clinically active vasculitis and consists of a set of items divided into nine organ based systems. BVAS/WG scores range from 0 to 63, with higher scores indicating more active disease. In this study, the primary end point was a BVAS/WG score of 0 and successful completion of the prednisone taper at 6 months.|score units|Mean|8.1|8.1|Standard Deviation|2.8|2.8|||
4443654|NCT00104299|4268014|B3|Netherlands||Region of Enrollment||participants|Number|16|16.0||||||
4443655|NCT00104299|4268015|B2|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4443656|NCT00104299|4268016|B1|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4443657|NCT00104299|4268014|B3|United States||Region of Enrollment||participants|Number|181|181.0||||||
4443658|NCT00104299|4268015|B2|United States||Region of Enrollment||participants|Number|90|90.0||||||
4443659|NCT00104299|4268016|B1|United States||Region of Enrollment||participants|Number|91|91.0||||||
4443660|NCT00104299|4268014|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4443661|NCT00104299|4268015|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4443662|NCT00104299|4268016|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4443663|NCT00104299|4268014|B3||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4443664|NCT00104299|4268015|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4443665|NCT00104299|4268016|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4443666|NCT00104299|4268014|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|15.5|15.5|||
4443667|NCT00104299|4268015|B2|||Age||years|Mean|51.5|51.5|Standard Deviation|14.1|14.1|||
4443668|NCT00104299|4268016|B1|||Age||years|Mean|54.0|54.0|Standard Deviation|16.8|16.8|||
4443669|NCT00104299|4268014|B3||>=65 years|Age||Participants|Count of Participants|55|55.0||||||
4443670|NCT00104299|4268015|B2||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4443671|NCT00104299|4268016|B1||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4443672|NCT00104299|4268014|B3||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4443673|NCT00104299|4268015|B2||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4443674|NCT00104299|4268016|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4443675|NCT00104299|4268014|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4443676|NCT00104299|4268015|B2||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4443677|NCT00104299|4268016|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4443678|NCT00104247|4268037|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443679|NCT00104247|4268038|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4443680|NCT00104247|4268039|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443681|NCT00104247|4268037|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4443682|NCT00104247|4268038|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4443683|NCT00104247|4268039|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4443684|NCT00104247|4268037|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443685|NCT00104247|4268038|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4443686|NCT00104247|4268039|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443687|NCT00104247|4268037|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4443688|NCT00104247|4268038|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4443689|NCT00104247|4268039|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4443690|NCT00104247|4268037|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4443691|NCT00104247|4268038|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4443692|NCT00104247|4268039|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4443693|NCT00104247|4268037|B3|12 < Age||Age, Customized||Years|Number|71|71.0||||||
4443694|NCT00104247|4268038|B2|12 < Age||Age, Customized||Years|Number|36|36.0||||||
4443695|NCT00104247|4268039|B1|12 < Age||Age, Customized||Years|Number|35|35.0||||||
4443696|NCT00104247|4268037|B3|8 <= Age <= 12||Age, Customized||Years|Number|17|17.0||||||
4443697|NCT00104247|4268038|B2|8 <= Age <= 12||Age, Customized||Years|Number|11|11.0||||||
4443698|NCT00104247|4268039|B1|8 <= Age <= 12||Age, Customized||Years|Number|6|6.0||||||
4443699|NCT00104247|4268037|B3|||Age||years|Mean|20.4|20.4|Standard Deviation|9.7|9.7|||
4443700|NCT00104247|4268038|B2|||Age||years|Mean|19.5|19.5|Standard Deviation|9.8|9.8|||
4443701|NCT00104247|4268039|B1|||Age||years|Mean|21.5|21.5|Standard Deviation|9.5|9.5|||
4443791|NCT00103857|4268080|B6|||HbA1c (Hemoglobin A1c)||Percent|Mean|8.7|8.7|Standard Deviation|1.0|1.0|||
4443705|NCT00104234|4268046|B3|France||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|5|5.0||||||
4443706|NCT00104234|4268047|B2|France||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|3|3.0||||||
4443707|NCT00104234|4268048|B1|France||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|2|2.0||||||
4443708|NCT00104234|4268046|B3|Brazil||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|8|8.0||||||
4443709|NCT00104234|4268047|B2|Brazil||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|4|4.0||||||
4443710|NCT00104234|4268048|B1|Brazil||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|4|4.0||||||
4443711|NCT00104234|4268046|B3|United Kingdom||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|6|6.0||||||
4443712|NCT00104234|4268047|B2|United Kingdom||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|3|3.0||||||
4443713|NCT00104234|4268048|B1|United Kingdom||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|3|3.0||||||
4443714|NCT00104234|4268046|B3|Germany||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|8|8.0||||||
4443715|NCT00104234|4268047|B2|Germany||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|4|4.0||||||
4443716|NCT00104234|4268048|B1|Germany||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|4|4.0||||||
4443717|NCT00104234|4268046|B3|United States||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|6|6.0||||||
4443718|NCT00104234|4268047|B2|United States||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|4|4.0||||||
4443719|NCT00104234|4268048|B1|United States||Region of Enrollment|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|2|2.0||||||
4443720|NCT00104234|4268046|B3|Other||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|4|4.0||||||
4443721|NCT00104234|4268047|B2|Other||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|4|4.0||||||
4443722|NCT00104234|4268048|B1|Other||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|0|0.0||||||
4443723|NCT00104234|4268046|B3|Indigenous||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|2|2.0||||||
4443724|NCT00104234|4268047|B2|Indigenous||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|1|1.0||||||
4443725|NCT00104234|4268048|B1|Indigenous||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|1|1.0||||||
4443726|NCT00104234|4268046|B3|Asian||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|2|2.0||||||
4443727|NCT00104234|4268047|B2|Asian||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|1|1.0||||||
4443728|NCT00104234|4268048|B1|Asian||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|1|1.0||||||
4443729|NCT00104234|4268046|B3|Black||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|3|3.0||||||
4443730|NCT00104234|4268047|B2|Black||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|2|2.0||||||
4443731|NCT00104234|4268048|B1|Black||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|1|1.0||||||
4443732|NCT00104234|4268046|B3|Hispanic||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|4|4.0||||||
4443733|NCT00104234|4268047|B2|Hispanic||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|3|3.0||||||
4443734|NCT00104234|4268048|B1|Hispanic||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|1|1.0||||||
4443735|NCT00104234|4268046|B3|White, non-Hispanic||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|24|24.0||||||
4443736|NCT00104234|4268047|B2|White, non-Hispanic||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|9|9.0||||||
4443737|NCT00104234|4268048|B1|White, non-Hispanic||Race/Ethnicity, Customized|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|participants|Number|15|15.0||||||
4443738|NCT00104234|4268046|B3||Male|Sex: Female, Male|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|Participants|Count of Participants|13|13.0||||||
4443739|NCT00104234|4268047|B2||Male|Sex: Female, Male|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|Participants|Count of Participants|6|6.0||||||
4443740|NCT00104234|4268048|B1||Male|Sex: Female, Male|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|Participants|Count of Participants|7|7.0||||||
4443741|NCT00104234|4268046|B3||Female|Sex: Female, Male|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|Participants|Count of Participants|26|26.0||||||
4443742|NCT00104234|4268047|B2||Female|Sex: Female, Male|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|Participants|Count of Participants|14|14.0||||||
4443743|NCT00104234|4268048|B1||Female|Sex: Female, Male|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|Participants|Count of Participants|12|12.0||||||
4443744|NCT00104234|4268046|B3|Age||Age|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|years|Mean|12.2|12.2|Standard Deviation|5.62|5.62|||
4443745|NCT00104234|4268047|B2|Age||Age|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|years|Mean|10.7|10.7|Standard Deviation|4.35|4.35|||
4443746|NCT00104234|4268048|B1|Age||Age|Demographic and baseline characteristics were recorded at baseline in the double-blind study, ASB-03-05.|years|Mean|13.7|13.7|Standard Deviation|6.47|6.47|||
4443747|NCT00104104|4268057|B3|||Calculated creatinine clearance||mL/min|Mean|88.3|88.3|Standard Deviation|36.1|36.1|||
4443748|NCT00104104|4268058|B2|||Calculated creatinine clearance||mL/min|Mean|89.3|89.3|Standard Deviation|39.5|39.5|||
4443749|NCT00104104|4268059|B1|||Calculated creatinine clearance||mL/min|Mean|87.3|87.3|Standard Deviation|32.6|32.6|||
4443750|NCT00104104|4268057|B3|||Time since diagnosis|This baseline measurement was based on n=86, 87.|months|Mean|11.1|11.1|Standard Deviation|19.8|19.8|||
4443751|NCT00104104|4268058|B2|||Time since diagnosis|This baseline measurement was based on n=86, 87.|months|Mean|9.7|9.7|Standard Deviation|14.1|14.1|||
4443752|NCT00104104|4268059|B1|||Time since diagnosis|This baseline measurement was based on n=86, 87.|months|Mean|12.5|12.5|Standard Deviation|24.3|24.3|||
4443753|NCT00104104|4268057|B3|United States||Region of Enrollment||participants|Number|176|176.0||||||
4443754|NCT00104104|4268058|B2|United States||Region of Enrollment||participants|Number|88|88.0||||||
4443755|NCT00104104|4268059|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
4443756|NCT00104104|4268057|B3|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4443757|NCT00104104|4268058|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4443758|NCT00104104|4268059|B1|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4443759|NCT00104104|4268057|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4443760|NCT00104104|4268058|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443761|NCT00104104|4268059|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443762|NCT00104104|4268057|B3|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4443763|NCT00104104|4268058|B2|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4443764|NCT00104104|4268059|B1|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4443765|NCT00104104|4268057|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
4443766|NCT00104104|4268058|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4443767|NCT00104104|4268059|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4443768|NCT00104104|4268057|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4443769|NCT00104104|4268058|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4443770|NCT00104104|4268059|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4443771|NCT00104104|4268057|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4443772|NCT00104104|4268058|B2||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4443773|NCT00104104|4268059|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4443774|NCT00104104|4268057|B3|||Age||years|Mean|64.1|64.1|Standard Deviation|11.7|11.7|||
4443775|NCT00104104|4268058|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|11.54|11.54|||
4443776|NCT00104104|4268059|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|11.95|11.95|||
4443777|NCT00104104|4268057|B3||>=65 years|Age|Demographic data is provided for the entire Safety Population.|Participants|Count of Participants|90|90.0||||||
4443778|NCT00104104|4268058|B2||>=65 years|Age|Demographic data is provided for the entire Safety Population.|Participants|Count of Participants|41|41.0||||||
4443779|NCT00104104|4268059|B1||>=65 years|Age|Demographic data is provided for the entire Safety Population.|Participants|Count of Participants|49|49.0||||||
4443780|NCT00104104|4268057|B3||Between 18 and 65 years|Age|Demographic data is provided for the entire Safety Population.|Participants|Count of Participants|86|86.0||||||
4443781|NCT00104104|4268058|B2||Between 18 and 65 years|Age|Demographic data is provided for the entire Safety Population.|Participants|Count of Participants|47|47.0||||||
4443782|NCT00104104|4268059|B1||Between 18 and 65 years|Age|Demographic data is provided for the entire Safety Population.|Participants|Count of Participants|39|39.0||||||
4443783|NCT00104104|4268057|B3||<=18 years|Age|Demographic data is provided for the entire Safety Population.|Participants|Count of Participants|0|0.0||||||
4443784|NCT00104104|4268058|B2||<=18 years|Age|Demographic data is provided for the entire Safety Population.|Participants|Count of Participants|0|0.0||||||
4443785|NCT00104104|4268059|B1||<=18 years|Age|Demographic data is provided for the entire Safety Population.|Participants|Count of Participants|0|0.0||||||
4443786|NCT00104052|4268074|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4443787|NCT00104052|4268074|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4443788|NCT00104052|4268074|B1|||Age||years|Mean|9.7|9.7|Standard Deviation|4.0|4.0|||
4443789|NCT00103857|4268078|B8|||HbA1c (Hemoglobin A1c)||Percent|Mean|9.0|9.0|Standard Deviation|1.2|1.2|||
4443790|NCT00103857|4268079|B7|||HbA1c (Hemoglobin A1c)||Percent|Mean|11.2|11.2|Standard Deviation|1.2|1.2|||
4443792|NCT00103857|4268081|B5|||HbA1c (Hemoglobin A1c)||Percent|Mean|8.7|8.7|Standard Deviation|0.9|0.9|||
4443793|NCT00103857|4268082|B4|||HbA1c (Hemoglobin A1c)||Percent|Mean|8.8|8.8|Standard Deviation|1.0|1.0|||
4443794|NCT00103857|4268083|B3|||HbA1c (Hemoglobin A1c)||Percent|Mean|8.7|8.7|Standard Deviation|0.9|0.9|||
4443795|NCT00103857|4268084|B2|||HbA1c (Hemoglobin A1c)||Percent|Mean|8.9|8.9|Standard Deviation|1.0|1.0|||
4443796|NCT00103857|4268085|B1|||HbA1c (Hemoglobin A1c)||Percent|Mean|8.9|8.9|Standard Deviation|1.0|1.0|||
4443797|NCT00103857|4268078|B8|Other||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4443798|NCT00103857|4268079|B7|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4443799|NCT00103857|4268080|B6|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4443800|NCT00103857|4268081|B5|Other||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4443801|NCT00103857|4268082|B4|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4443802|NCT00103857|4268083|B3|Other||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4443803|NCT00103857|4268084|B2|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4443804|NCT00103857|4268085|B1|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4443805|NCT00103857|4268078|B8|Asian||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4443806|NCT00103857|4268079|B7|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443807|NCT00103857|4268080|B6|Asian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4443808|NCT00103857|4268081|B5|Asian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4443809|NCT00103857|4268082|B4|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4443810|NCT00103857|4268083|B3|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4443811|NCT00103857|4268084|B2|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4443812|NCT00103857|4268085|B1|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4443813|NCT00103857|4268078|B8|Hispanic||Race/Ethnicity, Customized||participants|Number|351|351.0||||||
4443814|NCT00103857|4268079|B7|Hispanic||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4443815|NCT00103857|4268080|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4443816|NCT00103857|4268081|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4443817|NCT00103857|4268082|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4443818|NCT00103857|4268083|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4443819|NCT00103857|4268084|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4443820|NCT00103857|4268085|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4443821|NCT00103857|4268078|B8|Black||Race/Ethnicity, Customized||participants|Number|85|85.0||||||
4443822|NCT00103857|4268079|B7|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4443823|NCT00103857|4268080|B6|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4443824|NCT00103857|4268081|B5|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4443825|NCT00103857|4268082|B4|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4443826|NCT00103857|4268083|B3|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4443827|NCT00103857|4268084|B2|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4443828|NCT00103857|4268085|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4443829|NCT00103857|4268078|B8|White||Race/Ethnicity, Customized||participants|Number|608|608.0||||||
4443830|NCT00103857|4268079|B7|White||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4443831|NCT00103857|4268080|B6|White||Race/Ethnicity, Customized||participants|Number|81|81.0||||||
4443832|NCT00103857|4268081|B5|White||Race/Ethnicity, Customized||participants|Number|95|95.0||||||
4443833|NCT00103857|4268082|B4|White||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4443834|NCT00103857|4268083|B3|White||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4443835|NCT00103857|4268084|B2|White||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4443836|NCT00103857|4268085|B1|White||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4443837|NCT00103857|4268078|B8||Male|Sex: Female, Male||Participants|Count of Participants|606|606.0||||||
4443838|NCT00103857|4268079|B7||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4443839|NCT00103857|4268080|B6||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4443840|NCT00103857|4268081|B5||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4443841|NCT00103857|4268082|B4||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4443842|NCT00103857|4268083|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4443843|NCT00103857|4268084|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4443844|NCT00103857|4268085|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4443845|NCT00103857|4268078|B8||Female|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
4443846|NCT00103857|4268079|B7||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4443847|NCT00103857|4268080|B6||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4443848|NCT00103857|4268081|B5||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4443849|NCT00103857|4268082|B4||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4443850|NCT00103857|4268083|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4443851|NCT00103857|4268084|B2||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4443852|NCT00103857|4268085|B1||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4443853|NCT00103857|4268078|B8|||Age||years|Mean|53.4|53.4|Standard Deviation|9.9|9.9|||
4443854|NCT00103857|4268079|B7|||Age||years|Mean|52.6|52.6|Standard Deviation|10.0|10.0|||
4443856|NCT00103857|4268081|B5|||Age||years|Mean|53.3|53.3|Standard Deviation|9.6|9.6|||
4443857|NCT00103857|4268082|B4|||Age||years|Mean|54.1|54.1|Standard Deviation|10.0|10.0|||
4443858|NCT00103857|4268083|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|9.6|9.6|||
4443859|NCT00103857|4268084|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|10.2|10.2|||
4443860|NCT00103857|4268085|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|10.2|10.2|||
4443861|NCT00103844|4268154|B3|Not Reported||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|6|6.0||||||
4443862|NCT00103844|4268155|B2|Not Reported||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|3|3.0||||||
4443863|NCT00103844|4268156|B1|Not Reported||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|3|3.0||||||
4443864|NCT00103844|4268154|B3|Score=5 (dead)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|0|0.0||||||
4443865|NCT00103844|4268155|B2|Score=5 (dead)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|0|0.0||||||
4443866|NCT00103844|4268156|B1|Score=5 (dead)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|0|0.0||||||
4443867|NCT00103844|4268154|B3|Score=4 (completely disabled)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|0|0.0||||||
4443868|NCT00103844|4268155|B2|Score=4 (completely disabled)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|0|0.0||||||
4443869|NCT00103844|4268156|B1|Score=4 (completely disabled)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|0|0.0||||||
4443870|NCT00103844|4268154|B3|Score=3 (limited selfcare, some bed confinement)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|0|0.0||||||
4443871|NCT00103844|4268155|B2|Score=3 (limited selfcare, some bed confinement)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|0|0.0||||||
4443872|NCT00103844|4268156|B1|Score=3 (limited selfcare, some bed confinement)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|0|0.0||||||
4443873|NCT00103844|4268154|B3|Score=2 (ambulatory, all selfcare, unable to work)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|0|0.0||||||
4443874|NCT00103844|4268155|B2|Score=2 (ambulatory, all selfcare, unable to work)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|0|0.0||||||
4443875|NCT00103844|4268156|B1|Score=2 (ambulatory, all selfcare, unable to work)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|0|0.0||||||
4443876|NCT00103844|4268154|B3|Score=1 (ambulatory, light/sedentary work)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|39|39.0||||||
4443877|NCT00103844|4268155|B2|Score=1 (ambulatory, light/sedentary work)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|12|12.0||||||
4443932|NCT00103662|4268219|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443933|NCT00103662|4268217|B3|African-American||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4443878|NCT00103844|4268156|B1|Score=1 (ambulatory, light/sedentary work)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|27|27.0||||||
4443879|NCT00103844|4268154|B3|Score=0 (fully active)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|105|105.0||||||
4443880|NCT00103844|4268155|B2|Score=0 (fully active)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|34|34.0||||||
4443881|NCT00103844|4268156|B1|Score=0 (fully active)||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS: a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction and 5=death.|Participants|Number|71|71.0||||||
4443882|NCT00103844|4268154|B3|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4443883|NCT00103844|4268155|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4443884|NCT00103844|4268156|B1|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4443885|NCT00103844|4268154|B3|White||Race/Ethnicity, Customized||Participants|Number|130|130.0||||||
4443886|NCT00103844|4268155|B2|White||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4443887|NCT00103844|4268156|B1|White||Race/Ethnicity, Customized||Participants|Number|87|87.0||||||
4443888|NCT00103844|4268154|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4443889|NCT00103844|4268155|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4443890|NCT00103844|4268156|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4443891|NCT00103844|4268154|B3|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4443892|NCT00103844|4268155|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4443893|NCT00103844|4268156|B1|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4443894|NCT00103844|4268154|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4443895|NCT00103844|4268155|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4443896|NCT00103844|4268156|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4443897|NCT00103844|4268154|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4443898|NCT00103844|4268155|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4443899|NCT00103844|4268156|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4443900|NCT00103844|4268154|B3|||Age||years|Mean|51|51.0|Standard Deviation|13.6|13.6|||
4443901|NCT00103844|4268155|B2|||Age||years|Mean|50|50.0|Standard Deviation|13.6|13.6|||
4443902|NCT00103844|4268156|B1|||Age||years|Mean|51|51.0|Standard Deviation|13.6|13.6|||
4443903|NCT00103844|4268154|B3|>75 years||Age, Customized||participants|Number|5|5.0||||||
4443904|NCT00103844|4268155|B2|>75 years||Age, Customized||participants|Number|1|1.0||||||
4443905|NCT00103844|4268156|B1|>75 years||Age, Customized||participants|Number|4|4.0||||||
4443906|NCT00103844|4268154|B3|Between 66 and 75 years||Age, Customized||participants|Number|18|18.0||||||
4443907|NCT00103844|4268155|B2|Between 66 and 75 years||Age, Customized||participants|Number|5|5.0||||||
4443908|NCT00103844|4268156|B1|Between 66 and 75 years||Age, Customized||participants|Number|13|13.0||||||
4443909|NCT00103844|4268154|B3|Between 46 and 65 years||Age, Customized||participants|Number|76|76.0||||||
4443910|NCT00103844|4268155|B2|Between 46 and 65 years||Age, Customized||participants|Number|28|28.0||||||
4443911|NCT00103844|4268156|B1|Between 46 and 65 years||Age, Customized||participants|Number|48|48.0||||||
4443912|NCT00103844|4268154|B3|Between 21 and 45 years||Age, Customized||participants|Number|51|51.0||||||
4443913|NCT00103844|4268155|B2|Between 21 and 45 years||Age, Customized||participants|Number|15|15.0||||||
4443914|NCT00103844|4268156|B1|Between 21 and 45 years||Age, Customized||participants|Number|36|36.0||||||
4443915|NCT00103740|4268188|B3||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4443916|NCT00103740|4268189|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4443917|NCT00103740|4268190|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4443918|NCT00103740|4268188|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4443919|NCT00103740|4268189|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4443920|NCT00103740|4268190|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4443921|NCT00103740|4268188|B3|||Age||years|Mean|69.8|69.8|Standard Deviation|10.41|10.41|||
4443922|NCT00103740|4268189|B2|||Age||years|Mean|68.2|68.2|Standard Deviation|11.15|11.15|||
4443923|NCT00103740|4268190|B1|||Age||years|Mean|71.3|71.3|Standard Deviation|9.42|9.42|||
4443924|NCT00103662|4268217|B3|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4443925|NCT00103662|4268218|B2|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4443926|NCT00103662|4268219|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443927|NCT00103662|4268217|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4443928|NCT00103662|4268218|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4443929|NCT00103662|4268219|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4443930|NCT00103662|4268217|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4443931|NCT00103662|4268218|B2|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4443934|NCT00103662|4268218|B2|African-American||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4443935|NCT00103662|4268219|B1|African-American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4443936|NCT00103662|4268217|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|245|245.0||||||
4443937|NCT00103662|4268218|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4443938|NCT00103662|4268219|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|117|117.0||||||
4443939|NCT00103662|4268217|B3||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4443940|NCT00103662|4268218|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4443941|NCT00103662|4268219|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4443942|NCT00103662|4268217|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4443943|NCT00103662|4268218|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4443944|NCT00103662|4268219|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4443945|NCT00103662|4268217|B3|||Age||years|Mean|58.3|58.3|Standard Deviation|8.5|8.5|||
4443946|NCT00103662|4268218|B2|||Age||years|Mean|58.4|58.4|Standard Deviation|8.6|8.6|||
4443947|NCT00103662|4268219|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|8.4|8.4|||
4443948|NCT00103610|4268244|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4443949|NCT00103610|4268245|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443950|NCT00103610|4268246|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443951|NCT00103610|4268244|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4443952|NCT00103610|4268245|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4443953|NCT00103610|4268246|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4443954|NCT00103610|4268244|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4443955|NCT00103610|4268245|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4443956|NCT00103610|4268246|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4443957|NCT00103610|4268244|B3|African-American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4443958|NCT00103610|4268245|B2|African-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4443959|NCT00103610|4268246|B1|African-American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4443960|NCT00103610|4268244|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|276|276.0||||||
4443961|NCT00103610|4268245|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4443962|NCT00103610|4268246|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4443963|NCT00103610|4268244|B3||Male|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4443964|NCT00103610|4268245|B2||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4443965|NCT00103610|4268246|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4443966|NCT00103610|4268244|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4443967|NCT00103610|4268245|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4443968|NCT00103610|4268246|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4443969|NCT00103610|4268244|B3|||Age||years|Mean|56.3|56.3|Standard Deviation|10.7|10.7|||
4443970|NCT00103610|4268245|B2|||Age||years|Mean|57.5|57.5|Standard Deviation|10.3|10.3|||
4443971|NCT00103610|4268246|B1|||Age||years|Mean|55.1|55.1|Standard Deviation|10.9|10.9|||
4443972|NCT00103506|4268269|B3|UNITED STATES OF AMERICA||Region of Enrollment||participants|Number|41|41.0||||||
4443973|NCT00103506|4268270|B2|UNITED STATES OF AMERICA||Region of Enrollment||participants|Number|23|23.0||||||
4443974|NCT00103506|4268271|B1|UNITED STATES OF AMERICA||Region of Enrollment||participants|Number|18|18.0||||||
4443975|NCT00103506|4268269|B3|SPAIN||Region of Enrollment||participants|Number|35|35.0||||||
4443976|NCT00103506|4268270|B2|SPAIN||Region of Enrollment||participants|Number|15|15.0||||||
4443977|NCT00103506|4268271|B1|SPAIN||Region of Enrollment||participants|Number|20|20.0||||||
4443978|NCT00103506|4268269|B3|SOUTH AFRICA||Region of Enrollment||participants|Number|28|28.0||||||
4443979|NCT00103506|4268270|B2|SOUTH AFRICA||Region of Enrollment||participants|Number|15|15.0||||||
4443980|NCT00103506|4268271|B1|SOUTH AFRICA||Region of Enrollment||participants|Number|13|13.0||||||
4443981|NCT00103506|4268269|B3|SINGAPORE||Region of Enrollment||participants|Number|5|5.0||||||
4443982|NCT00103506|4268270|B2|SINGAPORE||Region of Enrollment||participants|Number|2|2.0||||||
4443983|NCT00103506|4268271|B1|SINGAPORE||Region of Enrollment||participants|Number|3|3.0||||||
4443984|NCT00103506|4268269|B3|RUSSIA||Region of Enrollment||participants|Number|72|72.0||||||
4443985|NCT00103506|4268270|B2|RUSSIA||Region of Enrollment||participants|Number|34|34.0||||||
4443986|NCT00103506|4268271|B1|RUSSIA||Region of Enrollment||participants|Number|38|38.0||||||
4443987|NCT00103506|4268269|B3|PORTUGAL||Region of Enrollment||participants|Number|20|20.0||||||
4443988|NCT00103506|4268270|B2|PORTUGAL||Region of Enrollment||participants|Number|14|14.0||||||
4443989|NCT00103506|4268271|B1|PORTUGAL||Region of Enrollment||participants|Number|6|6.0||||||
4443990|NCT00103506|4268269|B3|POLAND||Region of Enrollment||participants|Number|52|52.0||||||
4443991|NCT00103506|4268270|B2|POLAND||Region of Enrollment||participants|Number|17|17.0||||||
4443992|NCT00103506|4268271|B1|POLAND||Region of Enrollment||participants|Number|35|35.0||||||
4443993|NCT00103506|4268269|B3|NETHERLANDS||Region of Enrollment||participants|Number|61|61.0||||||
4443994|NCT00103506|4268270|B2|NETHERLANDS||Region of Enrollment||participants|Number|32|32.0||||||
4443995|NCT00103506|4268271|B1|NETHERLANDS||Region of Enrollment||participants|Number|29|29.0||||||
4443996|NCT00103506|4268269|B3|ITALY||Region of Enrollment||participants|Number|28|28.0||||||
4443997|NCT00103506|4268270|B2|ITALY||Region of Enrollment||participants|Number|11|11.0||||||
4443998|NCT00103506|4268271|B1|ITALY||Region of Enrollment||participants|Number|17|17.0||||||
4443999|NCT00103506|4268269|B3|ISRAEL||Region of Enrollment||participants|Number|46|46.0||||||
4444000|NCT00103506|4268270|B2|ISRAEL||Region of Enrollment||participants|Number|21|21.0||||||
4444001|NCT00103506|4268271|B1|ISRAEL||Region of Enrollment||participants|Number|25|25.0||||||
4444002|NCT00103506|4268269|B3|GREAT BRITAIN||Region of Enrollment||participants|Number|15|15.0||||||
4444003|NCT00103506|4268270|B2|GREAT BRITAIN||Region of Enrollment||participants|Number|7|7.0||||||
4444004|NCT00103506|4268271|B1|GREAT BRITAIN||Region of Enrollment||participants|Number|8|8.0||||||
4444005|NCT00103506|4268269|B3|FRANCE||Region of Enrollment||participants|Number|49|49.0||||||
4444006|NCT00103506|4268270|B2|FRANCE||Region of Enrollment||participants|Number|28|28.0||||||
4444007|NCT00103506|4268271|B1|FRANCE||Region of Enrollment||participants|Number|21|21.0||||||
4444008|NCT00103506|4268269|B3|CZECH REPUBLIC||Region of Enrollment||participants|Number|36|36.0||||||
4444009|NCT00103506|4268270|B2|CZECH REPUBLIC||Region of Enrollment||participants|Number|22|22.0||||||
4444010|NCT00103506|4268271|B1|CZECH REPUBLIC||Region of Enrollment||participants|Number|14|14.0||||||
4444011|NCT00103506|4268269|B3|CANADA||Region of Enrollment||participants|Number|43|43.0||||||
4444012|NCT00103506|4268270|B2|CANADA||Region of Enrollment||participants|Number|23|23.0||||||
4444013|NCT00103506|4268271|B1|CANADA||Region of Enrollment||participants|Number|20|20.0||||||
4444014|NCT00103506|4268269|B3|BELGIUM-LUXEMBURG||Region of Enrollment||participants|Number|20|20.0||||||
4444015|NCT00103506|4268270|B2|BELGIUM-LUXEMBURG||Region of Enrollment||participants|Number|14|14.0||||||
4444016|NCT00103506|4268271|B1|BELGIUM-LUXEMBURG||Region of Enrollment||participants|Number|6|6.0||||||
4444017|NCT00103506|4268269|B3|AUSTRIA||Region of Enrollment||participants|Number|18|18.0||||||
4444018|NCT00103506|4268270|B2|AUSTRIA||Region of Enrollment||participants|Number|6|6.0||||||
4444019|NCT00103506|4268271|B1|AUSTRIA||Region of Enrollment||participants|Number|12|12.0||||||
4444020|NCT00103506|4268269|B3|AUSTRALIA||Region of Enrollment||participants|Number|62|62.0||||||
4444021|NCT00103506|4268270|B2|AUSTRALIA||Region of Enrollment||participants|Number|31|31.0||||||
4444022|NCT00103506|4268271|B1|AUSTRALIA||Region of Enrollment||participants|Number|31|31.0||||||
4444023|NCT00103506|4268269|B3|ARGENTINA||Region of Enrollment||participants|Number|15|15.0||||||
4444024|NCT00103506|4268270|B2|ARGENTINA||Region of Enrollment||participants|Number|9|9.0||||||
4444025|NCT00103506|4268271|B1|ARGENTINA||Region of Enrollment||participants|Number|6|6.0||||||
4444026|NCT00103506|4268269|B3||Male|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
4444027|NCT00103506|4268270|B2||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4444028|NCT00103506|4268271|B1||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4444029|NCT00103506|4268269|B3||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4444030|NCT00103506|4268270|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4444031|NCT00103506|4268271|B1||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4444032|NCT00103506|4268269|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|9.58|9.58|||
4444033|NCT00103506|4268270|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|9.61|9.61|||
4444034|NCT00103506|4268271|B1|||Age||years|Mean|61.5|61.5|Standard Deviation|9.56|9.56|||
4444035|NCT00103376|4268282|B4|United States||Region of Enrollment||participants|Number|23|23.0||||||
4444036|NCT00103376|4268283|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4444037|NCT00103376|4268284|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4444038|NCT00103376|4268285|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4444039|NCT00103376|4268282|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444040|NCT00103376|4268283|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444041|NCT00103376|4268284|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444042|NCT00103376|4268285|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444043|NCT00103376|4268282|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444044|NCT00103376|4268283|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444045|NCT00103376|4268284|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444046|NCT00103376|4268285|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444047|NCT00103376|4268282|B4||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4444048|NCT00103376|4268283|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4444049|NCT00103376|4268284|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4444050|NCT00103376|4268285|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4444051|NCT00103376|4268282|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4444052|NCT00103376|4268283|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4444053|NCT00103376|4268284|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4444054|NCT00103376|4268285|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4444055|NCT00103376|4268282|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444056|NCT00103376|4268283|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444057|NCT00103376|4268284|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444058|NCT00103376|4268285|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444059|NCT00103376|4268282|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444060|NCT00103376|4268283|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444061|NCT00103376|4268284|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444062|NCT00103376|4268285|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444063|NCT00103376|4268282|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444064|NCT00103376|4268283|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444065|NCT00103376|4268284|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444066|NCT00103376|4268285|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444067|NCT00103376|4268282|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4444068|NCT00103376|4268283|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4444069|NCT00103376|4268284|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4444070|NCT00103376|4268285|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4444071|NCT00103376|4268282|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4444072|NCT00103376|4268283|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4444073|NCT00103376|4268284|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4444074|NCT00103376|4268285|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4444075|NCT00103376|4268282|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4444076|NCT00103376|4268283|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4444077|NCT00103376|4268284|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4444078|NCT00103376|4268285|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4444079|NCT00103376|4268282|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4444080|NCT00103376|4268283|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4444081|NCT00103376|4268284|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4444082|NCT00103376|4268285|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4444083|NCT00103376|4268282|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444084|NCT00103376|4268283|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444085|NCT00103376|4268284|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444086|NCT00103376|4268285|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444087|NCT00103311|4268301|B3|United States||Region of Enrollment||participants|Number|64|64.0||||||
4444088|NCT00103311|4268302|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4444089|NCT00103311|4268303|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4444090|NCT00103311|4268301|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4444091|NCT00103311|4268302|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4444092|NCT00103311|4268303|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4444093|NCT00103311|4268301|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4444094|NCT00103311|4268302|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4444095|NCT00103311|4268303|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4444096|NCT00103311|4268301|B3|||Age||years|Median|59|59.0|Full Range|||28.0|82.0|
4444097|NCT00103311|4268302|B2|||Age||years|Median|60|60.0|Full Range|||35.0|80.0|
4444098|NCT00103311|4268303|B1|||Age||years|Median|59|59.0|Full Range|||28.0|82.0|
4444099|NCT00103285|4268314|B1|United States||Region of Enrollment||participants|Number|5377|5377.0||||||
4444100|NCT00103285|4268314|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|692|692.0||||||
4444101|NCT00103285|4268314|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444102|NCT00103285|4268314|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4046|4046.0||||||
4444103|NCT00103285|4268314|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|326|326.0||||||
4444104|NCT00103285|4268314|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4444105|NCT00103285|4268314|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|253|253.0||||||
4444106|NCT00103285|4268314|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4444107|NCT00103285|4268314|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
4444108|NCT00103285|4268314|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4038|4038.0||||||
4444109|NCT00103285|4268314|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1097|1097.0||||||
4444110|NCT00103285|4268314|B1||Male|Sex: Female, Male||Participants|Count of Participants|2888|2888.0||||||
4444111|NCT00103285|4268314|B1||Female|Sex: Female, Male||Participants|Count of Participants|2489|2489.0||||||
4444112|NCT00103285|4268314|B1|||Age||years|Mean|4.45|4.45|Standard Deviation|2.10|2.1|||
4444113|NCT00103285|4268314|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4444114|NCT00103285|4268314|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4444115|NCT00103285|4268314|B1||<=18 years|Age||Participants|Count of Participants|5377|5377.0||||||
4444116|NCT00103259|4268348|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4444117|NCT00103259|4268349|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4444118|NCT00103259|4268350|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4444119|NCT00103259|4268348|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4444120|NCT00103259|4268349|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4444121|NCT00103259|4268350|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4444122|NCT00103259|4268348|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4444123|NCT00103259|4268349|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4444124|NCT00103259|4268350|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4444125|NCT00103259|4268348|B3|||Age||years|Median|61|61.0|Full Range|||36.0|85.0|
4444126|NCT00103259|4268349|B2|||Age||years|Median|61|61.0|Full Range|||45.0|78.0|
4444127|NCT00103259|4268350|B1|||Age||years|Median|61|61.0|Full Range|||36.0|85.0|
4444128|NCT00103207|4268363|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4444129|NCT00103207|4268363|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4444130|NCT00103207|4268363|B1|||Age||years|Median|70|70.0|Full Range|||26.0|90.0|
4444131|NCT00103194|4268373|B1||Male|Sex: Female, Male|Gender of eligible patients who began treatment.|Participants|Count of Participants|35|35.0||||||
4444132|NCT00103194|4268373|B1||Female|Sex: Female, Male|Gender of eligible patients who began treatment.|Participants|Count of Participants|0|0.0||||||
4444133|NCT00103194|4268373|B1|||Age|Age of eligible patients who began treatment.|years|Median|65|65.0|Full Range|||48.0|81.0|
4444134|NCT00103142|4268380|B3|||Carcinoembryonic antigen (CEA)||mcg/L|Mean|1.9|1.9|Full Range|||0.5|15.0|
4444135|NCT00103142|4268381|B2|||Carcinoembryonic antigen (CEA)||mcg/L|Mean|1.8|1.8|Full Range|||0.5|15.0|
4444136|NCT00103142|4268382|B1|||Carcinoembryonic antigen (CEA)||mcg/L|Mean|2.0|2.0|Full Range|||0.6|13.0|
4444137|NCT00103142|4268380|B3|unknown||Number of nodules||participants|Number|9|9.0||||||
4444138|NCT00103142|4268381|B2|unknown||Number of nodules||participants|Number|3|3.0||||||
4444139|NCT00103142|4268382|B1|unknown||Number of nodules||participants|Number|6|6.0||||||
4444140|NCT00103142|4268380|B3|>4 nodules||Number of nodules||participants|Number|9|9.0||||||
4444141|NCT00103142|4268381|B2|>4 nodules||Number of nodules||participants|Number|5|5.0||||||
4444142|NCT00103142|4268382|B1|>4 nodules||Number of nodules||participants|Number|4|4.0||||||
4444143|NCT00103142|4268380|B3|2-4 nodules||Number of nodules||participants|Number|28|28.0||||||
4444144|NCT00103142|4268381|B2|2-4 nodules||Number of nodules||participants|Number|12|12.0||||||
4444145|NCT00103142|4268382|B1|2-4 nodules||Number of nodules||participants|Number|16|16.0||||||
4444146|NCT00103142|4268380|B3|1 nodules||Number of nodules||participants|Number|28|28.0||||||
4444147|NCT00103142|4268381|B2|1 nodules||Number of nodules||participants|Number|17|17.0||||||
4444148|NCT00103142|4268382|B1|1 nodules||Number of nodules||participants|Number|11|11.0||||||
4444149|NCT00103142|4268380|B3|Lung||Sites of metastasis||participants|Number|17|17.0||||||
4444150|NCT00103142|4268381|B2|Lung||Sites of metastasis||participants|Number|6|6.0||||||
4444151|NCT00103142|4268382|B1|Lung||Sites of metastasis||participants|Number|11|11.0||||||
4444152|NCT00103142|4268380|B3|Liver||Sites of metastasis||participants|Number|57|57.0||||||
4444153|NCT00103142|4268381|B2|Liver||Sites of metastasis||participants|Number|31|31.0||||||
4444154|NCT00103142|4268382|B1|Liver||Sites of metastasis||participants|Number|26|26.0||||||
4444155|NCT00103142|4268380|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4444156|NCT00103142|4268381|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4444157|NCT00103142|4268382|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4444158|NCT00103142|4268380|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4444159|NCT00103142|4268381|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4444160|NCT00103142|4268382|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4444161|NCT00103142|4268380|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4444162|NCT00103142|4268381|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4444163|NCT00103142|4268382|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4444164|NCT00103142|4268380|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4444165|NCT00103142|4268381|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4444166|NCT00103142|4268382|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4444167|NCT00103142|4268380|B3||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4444168|NCT00103142|4268381|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4444169|NCT00103142|4268382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4444170|NCT00103142|4268380|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444171|NCT00103142|4268381|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444172|NCT00103142|4268382|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444173|NCT00103142|4268380|B3|||Age||years|Median|53.5|53.5|Full Range|||25.0|77.0|
4444174|NCT00103142|4268381|B2|||Age||years|Median|52.0|52.0|Full Range|||33.0|74.0|
4444175|NCT00103142|4268382|B1|||Age||years|Median|53.6|53.6|Full Range|||25.0|77.0|
4444176|NCT00103116|4268391|B1|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4444177|NCT00103116|4268391|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4444178|NCT00103116|4268391|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4444179|NCT00103116|4268391|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4444180|NCT00103116|4268391|B1|||Age||years|Mean|60|60.0|Standard Deviation|5|5.0|||
4444181|NCT00103116|4268391|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4444182|NCT00103116|4268391|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4444183|NCT00103116|4268391|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444184|NCT00103012|4268396|B4|United States||Region of Enrollment||participants|Number|47|47.0||||||
4444185|NCT00103012|4268397|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4444186|NCT00103012|4268398|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4444187|NCT00103012|4268399|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4444188|NCT00103012|4268396|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4444189|NCT00103012|4268397|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4444190|NCT00103012|4268398|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4444191|NCT00103012|4268399|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4444192|NCT00103012|4268396|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4444193|NCT00103012|4268397|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4444194|NCT00103012|4268398|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4444195|NCT00103012|4268399|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4444196|NCT00103012|4268396|B4|||Age||years|Mean|33|33.0|Standard Deviation|8.0|8.0|||
4444197|NCT00103012|4268397|B3|||Age||years|Mean|32|32.0|Standard Deviation|6.4|6.4|||
4444198|NCT00103012|4268398|B2|||Age||years|Mean|33|33.0|Standard Deviation|8.5|8.5|||
4444199|NCT00103012|4268399|B1|||Age||years|Mean|33|33.0|Standard Deviation|9.3|9.3|||
4444200|NCT00103012|4268396|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4444201|NCT00103012|4268397|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4444202|NCT00103012|4268398|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4444203|NCT00103012|4268399|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4444204|NCT00103012|4268396|B4||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4444205|NCT00103012|4268397|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4444206|NCT00103012|4268398|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4444207|NCT00103012|4268399|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4444208|NCT00103012|4268396|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444209|NCT00103012|4268397|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444210|NCT00103012|4268398|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444211|NCT00103012|4268399|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444212|NCT00102960|4268409|B4|South Africa||Region of Enrollment||Participants|Number|377|377.0||||||
4444213|NCT00102960|4268410|B3|South Africa||Region of Enrollment||Participants|Number|126|126.0||||||
4444214|NCT00102960|4268411|B2|South Africa||Region of Enrollment||Participants|Number|126|126.0||||||
4444215|NCT00102960|4268412|B1|South Africa||Region of Enrollment||Participants|Number|125|125.0||||||
4444216|NCT00102960|4268409|B4||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4444217|NCT00102960|4268410|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4444218|NCT00102960|4268411|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4444219|NCT00102960|4268412|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4444220|NCT00102960|4268409|B4||Female|Sex: Female, Male||Participants|Count of Participants|220|220.0||||||
4444221|NCT00102960|4268410|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4444222|NCT00102960|4268411|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4444223|NCT00102960|4268412|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4444224|NCT00102960|4268409|B4|||Age||Weeks|Median|7.3|7.3|Inter-Quartile Range|||6.5|8.9|
4444225|NCT00102960|4268410|B3|||Age||Weeks|Median|7.5|7.5|Inter-Quartile Range|||6.6|9.0|
4444226|NCT00102960|4268411|B2|||Age||Weeks|Median|7.4|7.4|Inter-Quartile Range|||6.6|8.7|
4444227|NCT00102960|4268412|B1|||Age||Weeks|Median|7.1|7.1|Inter-Quartile Range|||6.4|8.9|
4444228|NCT00102804|4268461|B3|Korea, Republic of||Region of Enrollment||participants|Number|46|46.0||||||
4444229|NCT00102804|4268462|B2|Korea, Republic of||Region of Enrollment||participants|Number|9|9.0||||||
4444230|NCT00102804|4268463|B1|Korea, Republic of||Region of Enrollment||participants|Number|37|37.0||||||
4444231|NCT00102804|4268461|B3|China||Region of Enrollment||participants|Number|99|99.0||||||
4444232|NCT00102804|4268462|B2|China||Region of Enrollment||participants|Number|37|37.0||||||
4444233|NCT00102804|4268463|B1|China||Region of Enrollment||participants|Number|62|62.0||||||
4444234|NCT00102804|4268461|B3|Germany||Region of Enrollment||participants|Number|56|56.0||||||
4444235|NCT00102804|4268462|B2|Germany||Region of Enrollment||participants|Number|16|16.0||||||
4444236|NCT00102804|4268463|B1|Germany||Region of Enrollment||participants|Number|40|40.0||||||
4444237|NCT00102804|4268461|B3|Netherlands||Region of Enrollment||participants|Number|14|14.0||||||
4444238|NCT00102804|4268462|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4444239|NCT00102804|4268463|B1|Netherlands||Region of Enrollment||participants|Number|10|10.0||||||
4444240|NCT00102804|4268461|B3|Bulgaria||Region of Enrollment||participants|Number|19|19.0||||||
4444241|NCT00102804|4268462|B2|Bulgaria||Region of Enrollment||participants|Number|8|8.0||||||
4444242|NCT00102804|4268463|B1|Bulgaria||Region of Enrollment||participants|Number|11|11.0||||||
4444243|NCT00102804|4268461|B3|Australia||Region of Enrollment||participants|Number|27|27.0||||||
4444244|NCT00102804|4268462|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4444245|NCT00102804|4268463|B1|Australia||Region of Enrollment||participants|Number|19|19.0||||||
4444246|NCT00102804|4268461|B3|Romania||Region of Enrollment||participants|Number|77|77.0||||||
4444247|NCT00102804|4268462|B2|Romania||Region of Enrollment||participants|Number|26|26.0||||||
4444248|NCT00102804|4268463|B1|Romania||Region of Enrollment||participants|Number|51|51.0||||||
4444249|NCT00102804|4268461|B3|Croatia||Region of Enrollment||participants|Number|13|13.0||||||
4444250|NCT00102804|4268462|B2|Croatia||Region of Enrollment||participants|Number|3|3.0||||||
4444251|NCT00102804|4268463|B1|Croatia||Region of Enrollment||participants|Number|10|10.0||||||
4444252|NCT00102804|4268461|B3|Brazil||Region of Enrollment||participants|Number|34|34.0||||||
4444253|NCT00102804|4268462|B2|Brazil||Region of Enrollment||participants|Number|10|10.0||||||
4444254|NCT00102804|4268463|B1|Brazil||Region of Enrollment||participants|Number|24|24.0||||||
4444255|NCT00102804|4268461|B3|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4444256|NCT00102804|4268462|B2|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4444257|NCT00102804|4268463|B1|Poland||Region of Enrollment||participants|Number|25|25.0||||||
4444258|NCT00102804|4268461|B3|Czech Republic||Region of Enrollment||participants|Number|7|7.0||||||
4444259|NCT00102804|4268462|B2|Czech Republic||Region of Enrollment||participants|Number|2|2.0||||||
4444260|NCT00102804|4268463|B1|Czech Republic||Region of Enrollment||participants|Number|5|5.0||||||
4444261|NCT00102804|4268461|B3|Hungary||Region of Enrollment||participants|Number|14|14.0||||||
4444262|NCT00102804|4268462|B2|Hungary||Region of Enrollment||participants|Number|6|6.0||||||
4444263|NCT00102804|4268463|B1|Hungary||Region of Enrollment||participants|Number|8|8.0||||||
4444264|NCT00102804|4268461|B3|India||Region of Enrollment||participants|Number|55|55.0||||||
4444265|NCT00102804|4268462|B2|India||Region of Enrollment||participants|Number|16|16.0||||||
4444266|NCT00102804|4268463|B1|India||Region of Enrollment||participants|Number|39|39.0||||||
4444267|NCT00102804|4268461|B3|Italy||Region of Enrollment||participants|Number|34|34.0||||||
4444268|NCT00102804|4268462|B2|Italy||Region of Enrollment||participants|Number|16|16.0||||||
4444269|NCT00102804|4268463|B1|Italy||Region of Enrollment||participants|Number|18|18.0||||||
4444270|NCT00102804|4268461|B3|Austria||Region of Enrollment||participants|Number|4|4.0||||||
4444271|NCT00102804|4268462|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4444272|NCT00102804|4268463|B1|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4444273|NCT00102804|4268461|B3|Turkey||Region of Enrollment||participants|Number|11|11.0||||||
4444274|NCT00102804|4268462|B2|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
4444275|NCT00102804|4268463|B1|Turkey||Region of Enrollment||participants|Number|7|7.0||||||
4444276|NCT00102804|4268461|B3|Spain||Region of Enrollment||participants|Number|49|49.0||||||
4444277|NCT00102804|4268462|B2|Spain||Region of Enrollment||participants|Number|19|19.0||||||
4444278|NCT00102804|4268463|B1|Spain||Region of Enrollment||participants|Number|30|30.0||||||
4444279|NCT00102804|4268461|B3|Greece||Region of Enrollment||participants|Number|27|27.0||||||
4444280|NCT00102804|4268462|B2|Greece||Region of Enrollment||participants|Number|9|9.0||||||
4444281|NCT00102804|4268463|B1|Greece||Region of Enrollment||participants|Number|18|18.0||||||
4444282|NCT00102804|4268461|B3|Taiwan||Region of Enrollment||participants|Number|9|9.0||||||
4444283|NCT00102804|4268462|B2|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4444284|NCT00102804|4268463|B1|Taiwan||Region of Enrollment||participants|Number|5|5.0||||||
4444285|NCT00102804|4268461|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4444286|NCT00102804|4268462|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4444287|NCT00102804|4268463|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4444288|NCT00102804|4268461|B3|West Asian||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4444289|NCT00102804|4268462|B2|West Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4444290|NCT00102804|4268463|B1|West Asian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4444291|NCT00102804|4268461|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4444292|NCT00102804|4268462|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4444293|NCT00102804|4268463|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4444294|NCT00102804|4268461|B3|East Asian||Race/Ethnicity, Customized||participants|Number|154|154.0||||||
4444295|NCT00102804|4268462|B2|East Asian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4444296|NCT00102804|4268463|B1|East Asian||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4444297|NCT00102804|4268461|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|428|428.0||||||
4444298|NCT00102804|4268462|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
4444299|NCT00102804|4268463|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|279|279.0||||||
4444300|NCT00102804|4268461|B3|African||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4444301|NCT00102804|4268462|B2|African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4444302|NCT00102804|4268463|B1|African||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4444303|NCT00102804|4268461|B3|Aboriginal||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4444304|NCT00102804|4268462|B2|Aboriginal||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4444305|NCT00102804|4268463|B1|Aboriginal||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4444306|NCT00102804|4268461|B3||Male|Sex: Female, Male||Participants|Count of Participants|483|483.0||||||
4444307|NCT00102804|4268462|B2||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4444308|NCT00102804|4268463|B1||Male|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4444309|NCT00102804|4268461|B3||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4444310|NCT00102804|4268462|B2||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4444311|NCT00102804|4268463|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4444312|NCT00102804|4268461|B3|||Age||years|Median|60.6|60.6|Inter-Quartile Range|||54.1|67.4|
4444313|NCT00102804|4268462|B2|||Age||years|Median|60.4|60.4|Inter-Quartile Range|||53.8|67.0|
4444314|NCT00102804|4268463|B1|||Age||years|Median|60.6|60.6|Inter-Quartile Range|||54.3|67.5|
4444315|NCT00102687|4268482|B4|Not RBC transfusion dependent||Transfusion Dependence Status - RBCs|Does the participant's disease cause them to be dependent upon transfusions of red blood cells (RBCs)?|participants|Number|80|80.0||||||
4444316|NCT00102687|4268483|B3|Not RBC transfusion dependent||Transfusion Dependence Status - RBCs|Does the participant's disease cause them to be dependent upon transfusions of red blood cells (RBCs)?|participants|Number|29|29.0||||||
4444317|NCT00102687|4268484|B2|Not RBC transfusion dependent||Transfusion Dependence Status - RBCs|Does the participant's disease cause them to be dependent upon transfusions of red blood cells (RBCs)?|participants|Number|26|26.0||||||
4444318|NCT00102687|4268485|B1|Not RBC transfusion dependent||Transfusion Dependence Status - RBCs|Does the participant's disease cause them to be dependent upon transfusions of red blood cells (RBCs)?|participants|Number|25|25.0||||||
4444319|NCT00102687|4268482|B4|RBC transfusion dependent||Transfusion Dependence Status - RBCs|Does the participant's disease cause them to be dependent upon transfusions of red blood cells (RBCs)?|participants|Number|71|71.0||||||
4444320|NCT00102687|4268483|B3|RBC transfusion dependent||Transfusion Dependence Status - RBCs|Does the participant's disease cause them to be dependent upon transfusions of red blood cells (RBCs)?|participants|Number|22|22.0||||||
4444321|NCT00102687|4268484|B2|RBC transfusion dependent||Transfusion Dependence Status - RBCs|Does the participant's disease cause them to be dependent upon transfusions of red blood cells (RBCs)?|participants|Number|24|24.0||||||
4444322|NCT00102687|4268485|B1|RBC transfusion dependent||Transfusion Dependence Status - RBCs|Does the participant's disease cause them to be dependent upon transfusions of red blood cells (RBCs)?|participants|Number|25|25.0||||||
4444323|NCT00102687|4268482|B4|Not platelet transfusion dependent||Transfusion Dependence - Platelets|Does the participant's disease cause them to be dependent upon transfusions of platelets?|participants|Number|144|144.0||||||
4444324|NCT00102687|4268483|B3|Not platelet transfusion dependent||Transfusion Dependence - Platelets|Does the participant's disease cause them to be dependent upon transfusions of platelets?|participants|Number|50|50.0||||||
4444325|NCT00102687|4268484|B2|Not platelet transfusion dependent||Transfusion Dependence - Platelets|Does the participant's disease cause them to be dependent upon transfusions of platelets?|participants|Number|48|48.0||||||
4444326|NCT00102687|4268485|B1|Not platelet transfusion dependent||Transfusion Dependence - Platelets|Does the participant's disease cause them to be dependent upon transfusions of platelets?|participants|Number|46|46.0||||||
4444327|NCT00102687|4268482|B4|Platelet transfusion dependent||Transfusion Dependence - Platelets|Does the participant's disease cause them to be dependent upon transfusions of platelets?|participants|Number|7|7.0||||||
4444328|NCT00102687|4268483|B3|Platelet transfusion dependent||Transfusion Dependence - Platelets|Does the participant's disease cause them to be dependent upon transfusions of platelets?|participants|Number|1|1.0||||||
4444329|NCT00102687|4268484|B2|Platelet transfusion dependent||Transfusion Dependence - Platelets|Does the participant's disease cause them to be dependent upon transfusions of platelets?|participants|Number|2|2.0||||||
4444330|NCT00102687|4268485|B1|Platelet transfusion dependent||Transfusion Dependence - Platelets|Does the participant's disease cause them to be dependent upon transfusions of platelets?|participants|Number|4|4.0||||||
4444331|NCT00102687|4268482|B4|Other||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|0|0.0||||||
4444332|NCT00102687|4268483|B3|Other||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|0|0.0||||||
4444333|NCT00102687|4268484|B2|Other||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|0|0.0||||||
4444334|NCT00102687|4268485|B1|Other||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|0|0.0||||||
4444335|NCT00102687|4268482|B4|AML||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|0|0.0||||||
4444336|NCT00102687|4268483|B3|AML||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|0|0.0||||||
4444401|NCT00102687|4268484|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4444337|NCT00102687|4268484|B2|AML||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|0|0.0||||||
4444338|NCT00102687|4268485|B1|AML||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|0|0.0||||||
4444339|NCT00102687|4268482|B4|CMMoL with missing blasts||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|5|5.0||||||
4444340|NCT00102687|4268483|B3|CMMoL with missing blasts||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|3|3.0||||||
4444341|NCT00102687|4268484|B2|CMMoL with missing blasts||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|2|2.0||||||
4444342|NCT00102687|4268485|B1|CMMoL with missing blasts||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|0|0.0||||||
4444343|NCT00102687|4268482|B4|CMMoL with >=5% blasts||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|4|4.0||||||
4444344|NCT00102687|4268483|B3|CMMoL with >=5% blasts||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|1|1.0||||||
4444345|NCT00102687|4268484|B2|CMMoL with >=5% blasts||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|1|1.0||||||
4444346|NCT00102687|4268485|B1|CMMoL with >=5% blasts||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|2|2.0||||||
4444347|NCT00102687|4268482|B4|CMMoL with <5% blasts||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|7|7.0||||||
4444348|NCT00102687|4268483|B3|CMMoL with <5% blasts||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|1|1.0||||||
4444349|NCT00102687|4268484|B2|CMMoL with <5% blasts||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|3|3.0||||||
4444350|NCT00102687|4268485|B1|CMMoL with <5% blasts||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|3|3.0||||||
4444351|NCT00102687|4268482|B4|RAEB-T||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|4|4.0||||||
4444368|NCT00102687|4268483|B3|3=Capable/limited care||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|1|1.0||||||
4444352|NCT00102687|4268483|B3|RAEB-T||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|1|1.0||||||
4444353|NCT00102687|4268484|B2|RAEB-T||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|1|1.0||||||
4444354|NCT00102687|4268485|B1|RAEB-T||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|2|2.0||||||
4444355|NCT00102687|4268482|B4|RAEB||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|45|45.0||||||
4444356|NCT00102687|4268483|B3|RAEB||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|17|17.0||||||
4444357|NCT00102687|4268484|B2|RAEB||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|14|14.0||||||
4444358|NCT00102687|4268485|B1|RAEB||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|14|14.0||||||
4444359|NCT00102687|4268482|B4|RARS||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|21|21.0||||||
4444360|NCT00102687|4268483|B3|RARS||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|7|7.0||||||
4444361|NCT00102687|4268484|B2|RARS||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|7|7.0||||||
4444362|NCT00102687|4268485|B1|RARS||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|7|7.0||||||
4444363|NCT00102687|4268482|B4|RA||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|65|65.0||||||
4444364|NCT00102687|4268483|B3|RA||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|21|21.0||||||
4444365|NCT00102687|4268484|B2|RA||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|22|22.0||||||
4444366|NCT00102687|4268485|B1|RA||FAB Classification|The French-American-British (FAB) classification systems refers to a series of classifications of hematologic diseases. RA = Refractory anemia; RARS = Refractory anemia with ringed sideroblasts; RAEB = Refractory anemia with excess blasts; RAEB-T = Refractory anemia with excess blasts in transformation; CMMoL = Chronic myelomonocytic leukemia; AML = Acute myelogenous leukemia|participants|Number|22|22.0||||||
4444367|NCT00102687|4268482|B4|3=Capable/limited care||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|7|7.0||||||
4444400|NCT00102687|4268483|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4444369|NCT00102687|4268484|B2|3=Capable/limited care||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|3|3.0||||||
4444370|NCT00102687|4268485|B1|3=Capable/limited care||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|3|3.0||||||
4444371|NCT00102687|4268482|B4|2=Ambulatory/capable of self care||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|15|15.0||||||
4444372|NCT00102687|4268483|B3|2=Ambulatory/capable of self care||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|7|7.0||||||
4444373|NCT00102687|4268484|B2|2=Ambulatory/capable of self care||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|5|5.0||||||
4444374|NCT00102687|4268485|B1|2=Ambulatory/capable of self care||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|3|3.0||||||
4444375|NCT00102687|4268482|B4|1=Restricted||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|84|84.0||||||
4444376|NCT00102687|4268483|B3|1=Restricted||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|29|29.0||||||
4444377|NCT00102687|4268484|B2|1=Restricted||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|23|23.0||||||
4444378|NCT00102687|4268485|B1|1=Restricted||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|32|32.0||||||
4444379|NCT00102687|4268482|B4|0=Fully active||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|45|45.0||||||
4444380|NCT00102687|4268483|B3|0=Fully active||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|14|14.0||||||
4444381|NCT00102687|4268484|B2|0=Fully active||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|19|19.0||||||
4444382|NCT00102687|4268485|B1|0=Fully active||ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status is used by doctors and researchers to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.|participants|Number|12|12.0||||||
4444383|NCT00102687|4268482|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4444384|NCT00102687|4268483|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4444385|NCT00102687|4268484|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4444386|NCT00102687|4268485|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4444387|NCT00102687|4268482|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4444388|NCT00102687|4268483|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4444389|NCT00102687|4268484|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4444390|NCT00102687|4268485|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4444391|NCT00102687|4268482|B4|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4444392|NCT00102687|4268483|B3|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4444393|NCT00102687|4268484|B2|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4444394|NCT00102687|4268485|B1|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4444395|NCT00102687|4268482|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4444396|NCT00102687|4268483|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4444397|NCT00102687|4268484|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4444398|NCT00102687|4268485|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4444399|NCT00102687|4268482|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4444402|NCT00102687|4268485|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4444403|NCT00102687|4268482|B4||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4444404|NCT00102687|4268483|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4444405|NCT00102687|4268484|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4444406|NCT00102687|4268485|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4444407|NCT00102687|4268482|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4444408|NCT00102687|4268483|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4444409|NCT00102687|4268484|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4444410|NCT00102687|4268485|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4444411|NCT00102687|4268482|B4|||Age||years|Median|75.0|75.0|Full Range|||37.0|93.0|
4444412|NCT00102687|4268483|B3|||Age||years|Median|76.0|76.0|Full Range|||54.0|91.0|
4444413|NCT00102687|4268484|B2|||Age||years|Median|73.0|73.0|Full Range|||37.0|88.0|
4444414|NCT00102687|4268485|B1|||Age||years|Median|76.0|76.0|Full Range|||47.0|93.0|
4444415|NCT00102596|4268553|B1|||Fahn Tolosa Marin Tremor Rating Scale|"Only available for the 10 participants who entered Part B. The Fahn Tolosa Marin Tremor Rating Scale was used. Minimum of this scale is 0, maximum is 164 points. Higher scores indicate more tremor. See Fahn S, Tolosa E, and Marin C (1993) Clinical rating scale for tremor reference provided in Protocol for full information."|scores on a scale|Mean|41.6|41.6|Standard Deviation|17.6|17.6|||
4444416|NCT00102596|4268553|B1|||Family history of essential tremor||participants|Number|13|13.0||||||
4444417|NCT00102596|4268553|B1|||Number of alcohol servings required for tremor response|One serving of alcohol is 50 ml of 40% ethanol|servings|Mean|2.1|2.1|Standard Deviation|0.3|0.3|||
4444418|NCT00102596|4268553|B1|||History of alcohol-responsive tremors||participants|Number|15|15.0||||||
4444419|NCT00102596|4268553|B1|||Disease Duration||years|Mean|28.7|28.7|Standard Deviation|17.2|17.2|||
4444420|NCT00102596|4268553|B1|||Age of onset||years|Mean|39.5|39.5|Standard Deviation|18.6|18.6|||
4444421|NCT00102596|4268553|B1|||Body Mass Index||kg/m^2|Mean|28.6|28.6|Standard Deviation|4.7|4.7|||
4444422|NCT00102596|4268553|B1|||Weight||kg|Mean|82.9|82.9|Standard Deviation|20.1|20.1|||
4444423|NCT00102596|4268553|B1|||Height||centimeters|Mean|169.6|169.6|Standard Deviation|12.0|12.0|||
4444424|NCT00102596|4268553|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4444425|NCT00102596|4268553|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4444426|NCT00102596|4268553|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4444427|NCT00102596|4268553|B1|||Age||years|Mean|68.1|68.1|Standard Deviation|8.1|8.1|||
4444428|NCT00102531|4268563|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4444429|NCT00102531|4268564|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4444430|NCT00102531|4268565|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4444431|NCT00102531|4268563|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4444432|NCT00102531|4268564|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4444433|NCT00102531|4268565|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4444434|NCT00102531|4268563|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444435|NCT00102531|4268564|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444436|NCT00102531|4268565|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444437|NCT00102531|4268563|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4444438|NCT00102531|4268564|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4444439|NCT00102531|4268565|B1||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4444440|NCT00102531|4268563|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4444441|NCT00102531|4268564|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4444442|NCT00102531|4268565|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4444443|NCT00102531|4268563|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444444|NCT00102531|4268564|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444445|NCT00102531|4268565|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444446|NCT00102531|4268563|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4444447|NCT00102531|4268564|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444448|NCT00102531|4268565|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4444449|NCT00102531|4268563|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444450|NCT00102531|4268564|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444451|NCT00102531|4268565|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444452|NCT00102531|4268563|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4444453|NCT00102531|4268564|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4444454|NCT00102531|4268565|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4444455|NCT00102531|4268563|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4444456|NCT00102531|4268564|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4444457|NCT00102531|4268565|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4444458|NCT00102531|4268563|B3|||Age||years|Mean|18.2|18.2|Standard Deviation|3.4|3.4|||
4444459|NCT00102531|4268564|B2|||Age||years|Mean|17.8|17.8|Standard Deviation|2.3|2.3|||
4444460|NCT00102531|4268565|B1|||Age||years|Mean|19|19.0|Standard Deviation|4.8|4.8|||
4444461|NCT00102518|4268572|B1|||Body Mass Index (BMI)||kg/m^2|Mean|23.25|23.25|Standard Deviation|5.21|5.21|||
4444462|NCT00102518|4268572|B1|||Weight||kg|Mean|63.19|63.19|Standard Deviation|17.86|17.86|||
4444463|NCT00102518|4268572|B1|||Height||cm|Mean|164.09|164.09|Standard Deviation|11.22|11.22|||
4444464|NCT00102518|4268572|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444465|NCT00102518|4268572|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4444466|NCT00102518|4268572|B1||White|Race (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
4444467|NCT00102518|4268572|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4444468|NCT00102518|4268572|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4444469|NCT00102518|4268572|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4444470|NCT00102518|4268572|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4444471|NCT00102518|4268572|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444472|NCT00102518|4268572|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|281|281.0||||||
4444473|NCT00102518|4268572|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4444474|NCT00102518|4268572|B1||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4444475|NCT00102518|4268572|B1||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4444476|NCT00102518|4268572|B1|||Age||years|Mean|15.02|15.02|Standard Deviation|1.89|1.89|||
4444477|NCT00102440|4268578|B4|Other||Race/Ethnicity||subjects|Number|28|28.0||||||
4444478|NCT00102440|4268579|B3|Other||Race/Ethnicity||subjects|Number|15|15.0||||||
4444479|NCT00102440|4268580|B2|Other||Race/Ethnicity||subjects|Number|6|6.0||||||
4444480|NCT00102440|4268581|B1|Other||Race/Ethnicity||subjects|Number|7|7.0||||||
4444481|NCT00102440|4268578|B4|Asian||Race/Ethnicity||subjects|Number|25|25.0||||||
4444482|NCT00102440|4268579|B3|Asian||Race/Ethnicity||subjects|Number|6|6.0||||||
4444483|NCT00102440|4268580|B2|Asian||Race/Ethnicity||subjects|Number|9|9.0||||||
4444484|NCT00102440|4268581|B1|Asian||Race/Ethnicity||subjects|Number|10|10.0||||||
4444485|NCT00102440|4268578|B4|Hispanic||Race/Ethnicity||subjects|Number|58|58.0||||||
4444486|NCT00102440|4268579|B3|Hispanic||Race/Ethnicity||subjects|Number|19|19.0||||||
4444487|NCT00102440|4268580|B2|Hispanic||Race/Ethnicity||subjects|Number|17|17.0||||||
4444488|NCT00102440|4268581|B1|Hispanic||Race/Ethnicity||subjects|Number|22|22.0||||||
4444489|NCT00102440|4268578|B4|Black or African American||Race/Ethnicity||subjects|Number|62|62.0||||||
4444490|NCT00102440|4268579|B3|Black or African American||Race/Ethnicity||subjects|Number|18|18.0||||||
4444491|NCT00102440|4268580|B2|Black or African American||Race/Ethnicity||subjects|Number|20|20.0||||||
4444492|NCT00102440|4268581|B1|Black or African American||Race/Ethnicity||subjects|Number|24|24.0||||||
4444493|NCT00102440|4268578|B4|White||Race/Ethnicity||subjects|Number|587|587.0||||||
4444494|NCT00102440|4268579|B3|White||Race/Ethnicity||subjects|Number|195|195.0||||||
4444495|NCT00102440|4268580|B2|White||Race/Ethnicity||subjects|Number|199|199.0||||||
4444496|NCT00102440|4268581|B1|White||Race/Ethnicity||subjects|Number|193|193.0||||||
4444497|NCT00102440|4268578|B4|No and no other tophi present||Presence of Primary Palpable Tophus||subjects|Number|603|603.0||||||
4444498|NCT00102440|4268579|B3|No and no other tophi present||Presence of Primary Palpable Tophus||subjects|Number|204|204.0||||||
4444499|NCT00102440|4268580|B2|No and no other tophi present||Presence of Primary Palpable Tophus||subjects|Number|196|196.0||||||
4444500|NCT00102440|4268581|B1|No and no other tophi present||Presence of Primary Palpable Tophus||subjects|Number|203|203.0||||||
4444501|NCT00102440|4268578|B4|No, but other tophi present||Presence of Primary Palpable Tophus||subjects|Number|6|6.0||||||
4444502|NCT00102440|4268579|B3|No, but other tophi present||Presence of Primary Palpable Tophus||subjects|Number|3|3.0||||||
4444503|NCT00102440|4268580|B2|No, but other tophi present||Presence of Primary Palpable Tophus||subjects|Number|2|2.0||||||
4444504|NCT00102440|4268581|B1|No, but other tophi present||Presence of Primary Palpable Tophus||subjects|Number|1|1.0||||||
4444505|NCT00102440|4268578|B4|Yes||Presence of Primary Palpable Tophus||subjects|Number|151|151.0||||||
4444506|NCT00102440|4268579|B3|Yes||Presence of Primary Palpable Tophus||subjects|Number|46|46.0||||||
4444507|NCT00102440|4268580|B2|Yes||Presence of Primary Palpable Tophus||subjects|Number|53|53.0||||||
4444508|NCT00102440|4268581|B1|Yes||Presence of Primary Palpable Tophus||subjects|Number|52|52.0||||||
4444509|NCT00102440|4268578|B4|missing||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|3|3.0||||||
4444510|NCT00102440|4268579|B3|missing||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|3|3.0||||||
4444511|NCT00102440|4268580|B2|missing||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|0|0.0||||||
4444512|NCT00102440|4268581|B1|missing||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|0|0.0||||||
4444513|NCT00102440|4268578|B4|≥120 mL/min||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|80|80.0||||||
4444514|NCT00102440|4268579|B3|≥120 mL/min||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|29|29.0||||||
4444515|NCT00102440|4268580|B2|≥120 mL/min||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|23|23.0||||||
4444516|NCT00102440|4268581|B1|≥120 mL/min||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|28|28.0||||||
4444517|NCT00102440|4268578|B4|80 mL/min to <120 mL/min||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|408|408.0||||||
4444518|NCT00102440|4268579|B3|80 mL/min to <120 mL/min||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|140|140.0||||||
4444519|NCT00102440|4268580|B2|80 mL/min to <120 mL/min||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|130|130.0||||||
4444520|NCT00102440|4268581|B1|80 mL/min to <120 mL/min||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|138|138.0||||||
4444521|NCT00102440|4268578|B4|50 mL/min to <80 mL/min||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|235|235.0||||||
4444522|NCT00102440|4268579|B3|50 mL/min to <80 mL/min||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|68|68.0||||||
4444523|NCT00102440|4268580|B2|50 mL/min to <80 mL/min||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|90|90.0||||||
4444524|NCT00102440|4268581|B1|50 mL/min to <80 mL/min||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|77|77.0||||||
4444525|NCT00102440|4268578|B4|<50 milliliters per minute (mL/min)||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|34|34.0||||||
4444526|NCT00102440|4268579|B3|<50 milliliters per minute (mL/min)||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|13|13.0||||||
4444527|NCT00102440|4268580|B2|<50 milliliters per minute (mL/min)||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|8|8.0||||||
4444528|NCT00102440|4268581|B1|<50 milliliters per minute (mL/min)||Calculated Creatinine Clearance|Calculated creatinine clearance based on the Cockcroft-Gault equation using ideal body weight.|subjects|Number|13|13.0||||||
4444529|NCT00102440|4268578|B4|missing||Body Mass Index||subjects|Number|3|3.0||||||
4444530|NCT00102440|4268579|B3|missing||Body Mass Index||subjects|Number|3|3.0||||||
4444531|NCT00102440|4268580|B2|missing||Body Mass Index||subjects|Number|0|0.0||||||
4444532|NCT00102440|4268581|B1|missing||Body Mass Index||subjects|Number|0|0.0||||||
4444533|NCT00102440|4268578|B4|≥30 kg/m²||Body Mass Index||subjects|Number|472|472.0||||||
4444534|NCT00102440|4268579|B3|≥30 kg/m²||Body Mass Index||subjects|Number|154|154.0||||||
4444535|NCT00102440|4268580|B2|≥30 kg/m²||Body Mass Index||subjects|Number|152|152.0||||||
4444536|NCT00102440|4268581|B1|≥30 kg/m²||Body Mass Index||subjects|Number|166|166.0||||||
4444537|NCT00102440|4268578|B4|25 kg/m² to <30 kg/m²||Body Mass Index||subjects|Number|251|251.0||||||
4444538|NCT00102440|4268579|B3|25 kg/m² to <30 kg/m²||Body Mass Index||subjects|Number|89|89.0||||||
4444539|NCT00102440|4268580|B2|25 kg/m² to <30 kg/m²||Body Mass Index||subjects|Number|87|87.0||||||
4444540|NCT00102440|4268581|B1|25 kg/m² to <30 kg/m²||Body Mass Index||subjects|Number|75|75.0||||||
4444541|NCT00102440|4268578|B4|18.5 kg/m² to <25 kg/m²||Body Mass Index||subjects|Number|34|34.0||||||
4444542|NCT00102440|4268579|B3|18.5 kg/m² to <25 kg/m²||Body Mass Index||subjects|Number|7|7.0||||||
4444543|NCT00102440|4268580|B2|18.5 kg/m² to <25 kg/m²||Body Mass Index||subjects|Number|12|12.0||||||
4444544|NCT00102440|4268581|B1|18.5 kg/m² to <25 kg/m²||Body Mass Index||subjects|Number|15|15.0||||||
4444545|NCT00102440|4268578|B4|<18.5 kilogram per meter² (kg/m²)||Body Mass Index||subjects|Number|0|0.0||||||
4444546|NCT00102440|4268579|B3|<18.5 kilogram per meter² (kg/m²)||Body Mass Index||subjects|Number|0|0.0||||||
4444547|NCT00102440|4268580|B2|<18.5 kilogram per meter² (kg/m²)||Body Mass Index||subjects|Number|0|0.0||||||
4444548|NCT00102440|4268581|B1|<18.5 kilogram per meter² (kg/m²)||Body Mass Index||subjects|Number|0|0.0||||||
4444549|NCT00102440|4268578|B4||Male|Sex: Female, Male||Participants|Count of Participants|729|729.0||||||
4444550|NCT00102440|4268579|B3||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4444551|NCT00102440|4268580|B2||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4444552|NCT00102440|4268581|B1||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4444553|NCT00102440|4268578|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4444554|NCT00102440|4268579|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4444555|NCT00102440|4268580|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4444556|NCT00102440|4268581|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4444557|NCT00102440|4268578|B4|||Age||years|Mean|51.8|51.8|Standard Deviation|12.13|12.13|||
4444558|NCT00102440|4268579|B3|||Age||years|Mean|51.6|51.6|Standard Deviation|12.63|12.63|||
4444559|NCT00102440|4268580|B2|||Age||years|Mean|52.0|52.0|Standard Deviation|12.12|12.12|||
4444560|NCT00102440|4268581|B1|||Age||years|Mean|51.8|51.8|Standard Deviation|11.69|11.69|||
4444561|NCT00102440|4268578|B4|≥65 years||Age, Customized||subjects|Number|132|132.0||||||
4444562|NCT00102440|4268579|B3|≥65 years||Age, Customized||subjects|Number|44|44.0||||||
4444563|NCT00102440|4268580|B2|≥65 years||Age, Customized||subjects|Number|47|47.0||||||
4444564|NCT00102440|4268581|B1|≥65 years||Age, Customized||subjects|Number|41|41.0||||||
4444565|NCT00102440|4268578|B4|45 years to <65 years||Age, Customized||subjects|Number|398|398.0||||||
4444566|NCT00102440|4268579|B3|45 years to <65 years||Age, Customized||subjects|Number|125|125.0||||||
4444567|NCT00102440|4268580|B2|45 years to <65 years||Age, Customized||subjects|Number|133|133.0||||||
4444568|NCT00102440|4268581|B1|45 years to <65 years||Age, Customized||subjects|Number|140|140.0||||||
4444569|NCT00102440|4268578|B4|<45 years||Age, Customized||subjects|Number|230|230.0||||||
4444570|NCT00102440|4268579|B3|<45 years||Age, Customized||subjects|Number|84|84.0||||||
4444571|NCT00102440|4268580|B2|<45 years||Age, Customized||subjects|Number|71|71.0||||||
4444572|NCT00102440|4268581|B1|<45 years||Age, Customized||subjects|Number|75|75.0||||||
4444573|NCT00102063|4268630|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4444574|NCT00102063|4268631|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4444575|NCT00102063|4268632|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4444576|NCT00102063|4268633|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4444577|NCT00102063|4268630|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444578|NCT00102063|4268631|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444579|NCT00102063|4268632|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444580|NCT00102063|4268633|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444581|NCT00102063|4268630|B4||White|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4444582|NCT00102063|4268631|B3||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4444583|NCT00102063|4268632|B2||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4444584|NCT00102063|4268633|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4444585|NCT00102063|4268630|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4444586|NCT00102063|4268631|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4444587|NCT00102063|4268632|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4444588|NCT00102063|4268633|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4444589|NCT00102063|4268630|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444590|NCT00102063|4268631|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444591|NCT00102063|4268632|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444592|NCT00102063|4268633|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444593|NCT00102063|4268630|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4444594|NCT00102063|4268631|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4444595|NCT00102063|4268632|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4444596|NCT00102063|4268633|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4444597|NCT00102063|4268630|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4444598|NCT00102063|4268631|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4444599|NCT00102063|4268632|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444600|NCT00102063|4268633|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4444601|NCT00102063|4268630|B4||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4444602|NCT00102063|4268631|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4444603|NCT00102063|4268632|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4444604|NCT00102063|4268633|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4444605|NCT00102063|4268630|B4||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4444606|NCT00102063|4268631|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4444607|NCT00102063|4268632|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4444608|NCT00102063|4268633|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4444609|NCT00102063|4268630|B4|||Age||years|Mean|15.5|15.5|Standard Deviation|1.4|1.4|||
4444610|NCT00102063|4268631|B3|||Age||years|Mean|15.4|15.4|Standard Deviation|1.4|1.4|||
4444611|NCT00102063|4268632|B2|||Age||years|Mean|15.4|15.4|Standard Deviation|1.4|1.4|||
4444612|NCT00102063|4268633|B1|||Age||years|Mean|15.6|15.6|Standard Deviation|1.3|1.3|||
4444613|NCT00101933|4268664|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
4444614|NCT00101933|4268665|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4444615|NCT00101933|4268666|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4444616|NCT00101933|4268664|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4444617|NCT00101933|4268665|B2||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4444618|NCT00101933|4268666|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4444619|NCT00101933|4268664|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4444620|NCT00101933|4268665|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4444621|NCT00101933|4268666|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4444622|NCT00101933|4268664|B3|||Age||years|Mean|36.0|36.0|Standard Deviation|11.2|11.2|||
4444623|NCT00101933|4268665|B2|||Age||years|Mean|36.8|36.8|Standard Deviation|11.5|11.5|||
4444624|NCT00101933|4268666|B1|||Age||years|Mean|35.2|35.2|Standard Deviation|11.1|11.1|||
4444625|NCT00101933|4268664|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4444626|NCT00101933|4268665|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4444627|NCT00101933|4268666|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4444628|NCT00101933|4268664|B3||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4444629|NCT00101933|4268665|B2||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4444630|NCT00101933|4268666|B1||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4444631|NCT00101933|4268664|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444632|NCT00101933|4268665|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444633|NCT00101933|4268666|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444634|NCT00101907|4268687|B7|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4444635|NCT00101907|4268688|B6|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4444636|NCT00101907|4268689|B5|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4444637|NCT00101907|4268690|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4444638|NCT00101907|4268691|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4444639|NCT00101907|4268692|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4444640|NCT00101907|4268693|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4444641|NCT00101907|4268687|B7|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4444642|NCT00101907|4268688|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4444643|NCT00101907|4268689|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4444644|NCT00101907|4268690|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4444645|NCT00101907|4268691|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4444646|NCT00101907|4268692|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4444647|NCT00101907|4268693|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4444648|NCT00101907|4268687|B7|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4444649|NCT00101907|4268688|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4444650|NCT00101907|4268689|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4444651|NCT00101907|4268690|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4444652|NCT00101907|4268691|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4444653|NCT00101907|4268692|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4444654|NCT00101907|4268693|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4444655|NCT00101907|4268687|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4444656|NCT00101907|4268688|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4444657|NCT00101907|4268689|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4444658|NCT00101907|4268690|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4444659|NCT00101907|4268691|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4444660|NCT00101907|4268692|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4444661|NCT00101907|4268693|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4444662|NCT00101907|4268687|B7||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4444663|NCT00101907|4268688|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4444664|NCT00101907|4268689|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4444665|NCT00101907|4268690|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4444666|NCT00101907|4268691|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4444667|NCT00101907|4268692|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4444668|NCT00101907|4268693|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4444669|NCT00101907|4268687|B7|||Age||years|Mean|57.9|57.9|Standard Deviation|12.0|12.0|||
4444670|NCT00101907|4268688|B6|||Age||years|Mean|65.0|65.0|Standard Deviation|17.0|17.0|||
4444671|NCT00101907|4268689|B5|||Age||years|Mean|61.1|61.1|Standard Deviation|8.3|8.3|||
4444672|NCT00101907|4268690|B4|||Age||years|Mean|51.5|51.5|Standard Deviation|13.5|13.5|||
4444673|NCT00101907|4268691|B3|||Age||years|Mean|56.0|56.0|Standard Deviation|13.3|13.3|||
4444674|NCT00101907|4268692|B2|||Age||years|Mean|60.4|60.4|Standard Deviation|13.8|13.8|||
4444675|NCT00101907|4268693|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|12.4|12.4|||
4444676|NCT00101868|4268738|B3|absent||Heart failure|History of heart failure from patient interview or hospital record|participants|Number|484|484.0||||||
4444677|NCT00101868|4268739|B2|absent||Heart failure|History of heart failure from patient interview or hospital record|participants|Number|248|248.0||||||
4444678|NCT00101868|4268740|B1|absent||Heart failure|History of heart failure from patient interview or hospital record|participants|Number|236|236.0||||||
4444679|NCT00101868|4268738|B3|present||Heart failure|History of heart failure from patient interview or hospital record|participants|Number|147|147.0||||||
4444680|NCT00101868|4268739|B2|present||Heart failure|History of heart failure from patient interview or hospital record|participants|Number|67|67.0||||||
4444681|NCT00101868|4268740|B1|present||Heart failure|History of heart failure from patient interview or hospital record|participants|Number|80|80.0||||||
4444682|NCT00101868|4268738|B3|2 or more||Emergency department visits during 6 months before index admission||participants|Number|269|269.0||||||
4444683|NCT00101868|4268739|B2|2 or more||Emergency department visits during 6 months before index admission||participants|Number|147|147.0||||||
4444684|NCT00101868|4268740|B1|2 or more||Emergency department visits during 6 months before index admission||participants|Number|122|122.0||||||
4444685|NCT00101868|4268738|B3|zero or one||Emergency department visits during 6 months before index admission||participants|Number|362|362.0||||||
4444686|NCT00101868|4268739|B2|zero or one||Emergency department visits during 6 months before index admission||participants|Number|168|168.0||||||
4444687|NCT00101868|4268740|B1|zero or one||Emergency department visits during 6 months before index admission||participants|Number|194|194.0||||||
4444688|NCT00101868|4268738|B3|2 or more admissions||Hospital admissions during year prior to index admission||participants|Number|160|160.0||||||
4444689|NCT00101868|4268739|B2|2 or more admissions||Hospital admissions during year prior to index admission||participants|Number|91|91.0||||||
4444690|NCT00101868|4268740|B1|2 or more admissions||Hospital admissions during year prior to index admission||participants|Number|69|69.0||||||
4444691|NCT00101868|4268738|B3|zero or one admission||Hospital admissions during year prior to index admission||participants|Number|471|471.0||||||
4444692|NCT00101868|4268739|B2|zero or one admission||Hospital admissions during year prior to index admission||participants|Number|224|224.0||0.076|0.076|||
4444693|NCT00101868|4268740|B1|zero or one admission||Hospital admissions during year prior to index admission||participants|Number|247|247.0||0.072|0.072|||
4444694|NCT00101868|4268738|B3|United States||Region of Enrollment||participants|Number|631|631.0||||||
4444695|NCT00101868|4268739|B2|United States||Region of Enrollment||participants|Number|315|315.0||||||
4444696|NCT00101868|4268740|B1|United States||Region of Enrollment||participants|Number|316|316.0||||||
4444697|NCT00101868|4268738|B3||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4444698|NCT00101868|4268739|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4444699|NCT00101868|4268740|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4444700|NCT00101868|4268738|B3||Female|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
4444701|NCT00101868|4268739|B2||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4444702|NCT00101868|4268740|B1||Female|Sex: Female, Male||Participants|Count of Participants|180|180.0||||||
4444703|NCT00101868|4268738|B3||>=65 years|Age||Participants|Count of Participants|153|153.0||||||
4444704|NCT00101868|4268739|B2||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
4444705|NCT00101868|4268740|B1||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
4444706|NCT00101868|4268738|B3||Between 18 and 65 years|Age||Participants|Count of Participants|478|478.0||||||
4444707|NCT00101868|4268739|B2||Between 18 and 65 years|Age||Participants|Count of Participants|245|245.0||||||
4444708|NCT00101868|4268740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|233|233.0||||||
4444709|NCT00101868|4268738|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444710|NCT00101868|4268739|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444711|NCT00101868|4268740|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4444712|NCT00101816|4268751|B3|Functional Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|13.8|13.8|Standard Deviation|5.7|5.7|||
4444713|NCT00101816|4268752|B2|Functional Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|13.9|13.9|Standard Deviation|5.9|5.9|||
4444714|NCT00101816|4268753|B1|Functional Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|13.0|13.0|Standard Deviation|4.5|4.5|||
4444715|NCT00101816|4268751|B3|Emotional Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|16.7|16.7|Standard Deviation|5.2|5.2|||
4444716|NCT00101816|4268752|B2|Emotional Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|16.8|16.8|Standard Deviation|5.3|5.3|||
4444717|NCT00101816|4268753|B1|Emotional Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|15.3|15.3|Standard Deviation|2.1|2.1|||
4444764|NCT00101816|4268752|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4444718|NCT00101816|4268751|B3|Social/Family Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|21.9|21.9|Standard Deviation|4.7|4.7|||
4444719|NCT00101816|4268752|B2|Social/Family Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|22.1|22.1|Standard Deviation|4.7|4.7|||
4444720|NCT00101816|4268753|B1|Social/Family Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|20.1|20.1|Standard Deviation|23.6|23.6|||
4444721|NCT00101816|4268751|B3|Physical Well Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|16.5|16.5|Standard Deviation|6.1|6.1|||
4444722|NCT00101816|4268752|B2|Physical Well Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|16.4|16.4|Standard Deviation|6.3|6.3|||
4444723|NCT00101816|4268753|B1|Physical Well Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|17.2|17.2|Standard Deviation|3.8|3.8|||
4444724|NCT00101816|4268751|B3|Total FACT-G||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|68.9|68.9|Standard Deviation|15.4|15.4|||
4444725|NCT00101816|4268752|B2|Total FACT-G||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|69.2|69.2|Standard Deviation|16.0|16.0|||
4444726|NCT00101816|4268753|B1|Total FACT-G||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Score range: 0-108; higher scores=better health-related quality of life. 7 participants in the Imatinib-Intolerant group had baseline measurements; 80 participants in the Imatinib-Resistant group had baseline measurements for all 4 domains and 79 had baseline measurements for Total FACT-G scores.|units on a scale|Mean|65.6|65.6|Standard Deviation|7.1|7.1|||
4444727|NCT00101816|4268751|B3|Not Reported||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|5|5.0||||||
4444728|NCT00101816|4268752|B2|Not Reported||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|4|4.0||||||
4444729|NCT00101816|4268753|B1|Not Reported||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|1|1.0||||||
4444730|NCT00101816|4268751|B3|Score=5||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|0|0.0||||||
4444731|NCT00101816|4268752|B2|Score=5||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|0|0.0||||||
4444732|NCT00101816|4268753|B1|Score=5||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|0|0.0||||||
4444765|NCT00101816|4268753|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4444733|NCT00101816|4268751|B3|Score=4||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|0|0.0||||||
4444734|NCT00101816|4268752|B2|Score=4||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|0|0.0||||||
4444735|NCT00101816|4268753|B1|Score=4||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|0|0.0||||||
4444736|NCT00101816|4268751|B3|Score=3||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|2|2.0||||||
4444737|NCT00101816|4268752|B2|Score=3||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|2|2.0||||||
4444738|NCT00101816|4268753|B1|Score=3||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|0|0.0||||||
4444739|NCT00101816|4268751|B3|Score=2||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|35|35.0||||||
4444740|NCT00101816|4268752|B2|Score=2||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|33|33.0||||||
4444741|NCT00101816|4268753|B1|Score=2||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|2|2.0||||||
4444742|NCT00101816|4268751|B3|Score=1||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|45|45.0||||||
4444743|NCT00101816|4268752|B2|Score=1||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|39|39.0||||||
4444744|NCT00101816|4268753|B1|Score=1||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|6|6.0||||||
4444745|NCT00101816|4268751|B3|Score=0||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|22|22.0||||||
4444746|NCT00101816|4268752|B2|Score=0||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|21|21.0||||||
4444747|NCT00101816|4268753|B1|Score=0||Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS)|ECOG PS, a 6-item scale to assess disease progression, daily fuctioning, and appropriate treatment and prognosis. Scale: 0-5, with 0=Fully active, able to carry on all pre-disease performance without restriction and 5=Death.|Participants|Number|1|1.0||||||
4444748|NCT00101816|4268751|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4444749|NCT00101816|4268752|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4444750|NCT00101816|4268753|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4444751|NCT00101816|4268751|B3|White||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
4444752|NCT00101816|4268752|B2|White||Race/Ethnicity, Customized||Participants|Number|67|67.0||||||
4444753|NCT00101816|4268753|B1|White||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4444754|NCT00101816|4268751|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4444755|NCT00101816|4268752|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4444756|NCT00101816|4268753|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4444757|NCT00101816|4268751|B3|Asian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4444758|NCT00101816|4268752|B2|Asian||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4444759|NCT00101816|4268753|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4444760|NCT00101816|4268751|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4444761|NCT00101816|4268752|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4444762|NCT00101816|4268753|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4444763|NCT00101816|4268751|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4444766|NCT00101816|4268751|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|14.0|14.0|||
4444767|NCT00101816|4268752|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|14.0|14.0|||
4444768|NCT00101816|4268753|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|10.9|10.9|||
4444769|NCT00101816|4268751|B3|>75 years||Age, Customized||participants|Number|1|1.0||||||
4444770|NCT00101816|4268752|B2|>75 years||Age, Customized||participants|Number|0|0.0||||||
4444771|NCT00101816|4268753|B1|>75 years||Age, Customized||participants|Number|1|1.0||||||
4444772|NCT00101816|4268751|B3|Between 66 and 75 years||Age, Customized||participants|Number|19|19.0||||||
4444773|NCT00101816|4268752|B2|Between 66 and 75 years||Age, Customized||participants|Number|18|18.0||||||
4444774|NCT00101816|4268753|B1|Between 66 and 75 years||Age, Customized||participants|Number|1|1.0||||||
4444775|NCT00101816|4268751|B3|Between 46 and 65 years||Age, Customized||participants|Number|53|53.0||||||
4444776|NCT00101816|4268752|B2|Between 46 and 65 years||Age, Customized||participants|Number|46|46.0||||||
4444777|NCT00101816|4268753|B1|Between 46 and 65 years||Age, Customized||participants|Number|7|7.0||||||
4444778|NCT00101816|4268751|B3|Between 21 and 45 years||Age, Customized||participants|Number|36|36.0||||||
4444779|NCT00101816|4268752|B2|Between 21 and 45 years||Age, Customized||participants|Number|35|35.0||||||
4444780|NCT00101816|4268753|B1|Between 21 and 45 years||Age, Customized||participants|Number|1|1.0||||||
4444781|NCT00101686|4268801|B11||Male|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4444782|NCT00101686|4268802|B10||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4444783|NCT00101686|4268803|B9||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4444784|NCT00101686|4268804|B8||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4444785|NCT00101686|4268805|B7||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4444786|NCT00101686|4268806|B6||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4444787|NCT00101686|4268807|B5||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4444788|NCT00101686|4268808|B4||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4444789|NCT00101686|4268809|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4444790|NCT00101686|4268810|B2||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4444791|NCT00101686|4268811|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4444792|NCT00101686|4268801|B11||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4444793|NCT00101686|4268802|B10||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4444794|NCT00101686|4268803|B9||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4444795|NCT00101686|4268804|B8||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4444796|NCT00101686|4268805|B7||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4444797|NCT00101686|4268806|B6||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4444798|NCT00101686|4268807|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4444799|NCT00101686|4268808|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4444800|NCT00101686|4268809|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4444801|NCT00101686|4268810|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4444802|NCT00101686|4268811|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4444803|NCT00101686|4268801|B11|||Age||years|Median|61.0|61.0|Full Range|||20.0|87.0|
4444804|NCT00101686|4268802|B10|||Age||years|Median|59.0|59.0|Full Range|||35.0|84.0|
4444805|NCT00101686|4268803|B9|||Age||years|Median|61.0|61.0|Full Range|||45.0|84.0|
4444806|NCT00101686|4268804|B8|||Age||years|Median|59.5|59.5|Full Range|||32.0|80.0|
4444807|NCT00101686|4268805|B7|||Age||years|Median|59.0|59.0|Full Range|||37.0|81.0|
4444808|NCT00101686|4268806|B6|||Age||years|Median|62.5|62.5|Full Range|||33.0|85.0|
4444809|NCT00101686|4268807|B5|||Age||years|Median|62.0|62.0|Full Range|||20.0|78.0|
4444810|NCT00101686|4268808|B4|||Age||years|Median|62.0|62.0|Full Range|||29.0|80.0|
4444811|NCT00101686|4268809|B3|||Age||years|Median|61.0|61.0|Full Range|||34.0|78.0|
4444812|NCT00101686|4268810|B2|||Age||years|Median|62.0|62.0|Full Range|||31.0|87.0|
4444813|NCT00101686|4268811|B1|||Age||years|Median|61.0|61.0|Full Range|||35.0|81.0|
4444814|NCT00101660|4268865|B3|FWB||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|19.4|19.4|Standard Deviation|5.6|5.6|||
4444815|NCT00101660|4268866|B2|FWB||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|19.6|19.6|Standard Deviation|5.6|5.6|||
4444856|NCT00101660|4268865|B3|Asian||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4444857|NCT00101660|4268866|B2|Asian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4444858|NCT00101660|4268867|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4444816|NCT00101660|4268867|B1|FWB||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|18.7|18.7|Standard Deviation|5.5|5.5|||
4444817|NCT00101660|4268865|B3|EWB||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|18.1|18.1|Standard Deviation|3.8|3.8|||
4444818|NCT00101660|4268866|B2|EWB||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|18.4|18.4|Standard Deviation|3.7|3.7|||
4444819|NCT00101660|4268867|B1|EWB||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|17.3|17.3|Standard Deviation|4.0|4.0|||
4444820|NCT00101660|4268865|B3|SWB||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|23.0|23.0|Standard Deviation|4.4|4.4|||
4444821|NCT00101660|4268866|B2|SWB||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|23.0|23.0|Standard Deviation|4.5|4.5|||
4444822|NCT00101660|4268867|B1|SWB||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|23.0|23.0|Standard Deviation|4.4|4.4|||
4444823|NCT00101660|4268865|B3|PWB||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|21.7|21.7|Standard Deviation|5.2|5.2|||
4444824|NCT00101660|4268866|B2|PWB||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|21.6|21.6|Standard Deviation|5.2|5.2|||
4444825|NCT00101660|4268867|B1|PWB||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|22.0|22.0|Standard Deviation|5.1|5.1|||
4444859|NCT00101660|4268865|B3|Black/African American||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4444826|NCT00101660|4268865|B3|Total FACT-G||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|82.1|82.1|Standard Deviation|13.4|13.4|||
4444827|NCT00101660|4268866|B2|Total FACT-G||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|82.4|82.4|Standard Deviation|13.1|13.1|||
4444828|NCT00101660|4268867|B1|Total FACT-G||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 13 participants in imatinib-intolerant group had baseline measurements; 161 participants in imatinib-resistant group had baseline measurements for all 4 domains/79 had baseline measurements for total scores. Imatinib-intolerant participants assessed at baseline: n=78 for Total, EWB, FWB; n=80 for PWB, SWB. Imatinib-resistant participants assessed at baseline: n=234, Total; n=238, PWB, FWB; n=237, SWB, EWB.|Units on a scale|Mean|81.1|81.1|Standard Deviation|14.4|14.4|||
4444829|NCT00101660|4268865|B3|Not reported||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|3|3.0||||||
4444830|NCT00101660|4268866|B2|Not reported||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|3|3.0||||||
4444831|NCT00101660|4268867|B1|Not reported||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|0|0.0||||||
4444832|NCT00101660|4268865|B3|5||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|0|0.0||||||
4444833|NCT00101660|4268866|B2|5||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|0|0.0||||||
4444834|NCT00101660|4268867|B1|5||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|0|0.0||||||
4444835|NCT00101660|4268865|B3|4||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|0|0.0||||||
4444836|NCT00101660|4268866|B2|4||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|0|0.0||||||
4444837|NCT00101660|4268867|B1|4||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|0|0.0||||||
4444860|NCT00101660|4268866|B2|Black/African American||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4444949|NCT00101647|4268884|B3|21 to 45 years||Age, Customized||participants|Number|43|43.0||||||
4444838|NCT00101660|4268865|B3|3||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|0|0.0||||||
4444839|NCT00101660|4268866|B2|3||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|0|0.0||||||
4444840|NCT00101660|4268867|B1|3||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|0|0.0||||||
4444841|NCT00101660|4268865|B3|2||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|3|3.0||||||
4444842|NCT00101660|4268866|B2|2||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|3|3.0||||||
4444843|NCT00101660|4268867|B1|2||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|0|0.0||||||
4444844|NCT00101660|4268865|B3|1||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|105|105.0||||||
4444845|NCT00101660|4268866|B2|1||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|77|77.0||||||
4444846|NCT00101660|4268867|B1|1||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|28|28.0||||||
4444847|NCT00101660|4268865|B3|0||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|276|276.0||||||
4444848|NCT00101660|4268866|B2|0||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|205|205.0||||||
4444849|NCT00101660|4268867|B1|0||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG) Score|ECOG scale is a 6-item scale used to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 1-5, with 0=fully active, able to carry on all predisease performance without restriction, 1=physically strenous activity restricted, 2=capable of self-care, unable to work, 3=capable of only limited self-care, bed/chair confined for >50% of time, 4=completely disbled, bed/chair confined, and 5=death|Participants|Number|71|71.0||||||
4444850|NCT00101660|4268865|B3|Not reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4444851|NCT00101660|4268866|B2|Not reported||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4444852|NCT00101660|4268867|B1|Not reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4444853|NCT00101660|4268865|B3|Other||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4444854|NCT00101660|4268866|B2|Other||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4444855|NCT00101660|4268867|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4444861|NCT00101660|4268867|B1|Black/African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4444862|NCT00101660|4268865|B3|White||Race/Ethnicity, Customized||Participants|Number|345|345.0||||||
4444863|NCT00101660|4268866|B2|White||Race/Ethnicity, Customized||Participants|Number|252|252.0||||||
4444864|NCT00101660|4268867|B1|White||Race/Ethnicity, Customized||Participants|Number|93|93.0||||||
4444865|NCT00101660|4268865|B3||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4444866|NCT00101660|4268866|B2||Male|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4444867|NCT00101660|4268867|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4444868|NCT00101660|4268865|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4444869|NCT00101660|4268866|B2||Female|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4444870|NCT00101660|4268867|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4444871|NCT00101660|4268865|B3|> 75 years||Age, Customized||Participants|Number|16|16.0||||||
4444872|NCT00101660|4268866|B2|> 75 years||Age, Customized||Participants|Number|14|14.0||||||
4444873|NCT00101660|4268867|B1|> 75 years||Age, Customized||Participants|Number|2|2.0||||||
4444874|NCT00101660|4268865|B3|Between 66 and 75 years||Age, Customized||Participants|Number|82|82.0||||||
4444875|NCT00101660|4268866|B2|Between 66 and 75 years||Age, Customized||Participants|Number|65|65.0||||||
4444876|NCT00101660|4268867|B1|Between 66 and 75 years||Age, Customized||Participants|Number|17|17.0||||||
4444877|NCT00101660|4268865|B3|Between 46 and 65 years||Age, Customized||Participants|Number|186|186.0||||||
4444878|NCT00101660|4268866|B2|Between 46 and 65 years||Age, Customized||Participants|Number|131|131.0||||||
4444879|NCT00101660|4268867|B1|Between 46 and 65 years||Age, Customized||Participants|Number|55|55.0||||||
4444880|NCT00101660|4268865|B3|Between 21 and 45 years||Age, Customized||Participants|Number|103|103.0||||||
4444881|NCT00101660|4268866|B2|Between 21 and 45 years||Age, Customized||Participants|Number|78|78.0||||||
4444882|NCT00101660|4268867|B1|Between 21 and 45 years||Age, Customized||Participants|Number|25|25.0||||||
4444883|NCT00101660|4268865|B3|||Age||Years|Mean|55.4|55.4|Standard Deviation|13.3|13.3|||
4444884|NCT00101660|4268866|B2|||Age||Years|Mean|55.7|55.7|Standard Deviation|13.5|13.5|||
4444885|NCT00101660|4268867|B1|||Age||Years|Mean|54.6|54.6|Standard Deviation|12.5|12.5|||
4444886|NCT00101647|4268884|B3|Functional Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|17.1|17.1|Standard Deviation|6.8|6.8|||
4444887|NCT00101647|4268885|B2|Functional Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|16.9|16.9|Standard Deviation|6.7|6.7|||
4444888|NCT00101647|4268886|B1|Functional Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|19.2|19.2|Standard Deviation|6.9|6.9|||
4444889|NCT00101647|4268884|B3|Emotional Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|16.8|16.8|Standard Deviation|4.9|4.9|||
4444890|NCT00101647|4268885|B2|Emotional Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|16.7|16.7|Standard Deviation|4.9|4.9|||
4444891|NCT00101647|4268886|B1|Emotional Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|17.7|17.7|Standard Deviation|4.8|4.8|||
4444892|NCT00101647|4268884|B3|Social/Family Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|22.7|22.7|Standard Deviation|4.8|4.8|||
4444908|NCT00101647|4268885|B2|score=3 limited selfcare, bed/chair confined >50%||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|0|0.0||||||
4444893|NCT00101647|4268885|B2|Social/Family Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|22.7|22.7|Standard Deviation|4.8|4.8|||
4444894|NCT00101647|4268886|B1|Social/Family Well-Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|22.8|22.8|Standard Deviation|5.1|5.1|||
4444895|NCT00101647|4268884|B3|Physical Well Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|19.2|19.2|Standard Deviation|7.0|7.0|||
4444896|NCT00101647|4268885|B2|Physical Well Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|19.0|19.0|Standard Deviation|7.1|7.1|||
4444897|NCT00101647|4268886|B1|Physical Well Being||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|22.3|22.3|Standard Deviation|5.2|5.2|||
4444898|NCT00101647|4268884|B3|Total FACT-G||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|75.8|75.8|Standard Deviation|17.8|17.8|||
4444899|NCT00101647|4268885|B2|Total FACT-G||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|75.3|75.3|Standard Deviation|18.0|18.0|||
4444900|NCT00101647|4268886|B1|Total FACT-G||Functional Assessment of Cancer Therapy-General (FACT-G)|FACT-G=27 questions in 4 domains: physical, social/family, emotional, & functional well-being (PWB, SWB, EWB, FWB). Total score=0 to 108; higher score=better health-related quality of life. 12 participants in the Imatinib-Intolerant group had baseline measurements; 130 participants in the Imatinib-Resistant group had baseline measurements for Total FACT-G scores; 134 for PWB; 133 for FWB and SWB; 131 for EWB.|units on a scale|Mean|81.9|81.9|Standard Deviation|14.4|14.4|||
4444901|NCT00101647|4268884|B3|score=5 dead||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|0|0.0||||||
4444902|NCT00101647|4268885|B2|score=5 dead||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|0|0.0||||||
4444903|NCT00101647|4268886|B1|score=5 dead||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|0|0.0||||||
4444904|NCT00101647|4268884|B3|score=4 completely disabled, bed/chair confined||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|0|0.0||||||
4444905|NCT00101647|4268885|B2|score=4 completely disabled, bed/chair confined||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|0|0.0||||||
4444906|NCT00101647|4268886|B1|score=4 completely disabled, bed/chair confined||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|0|0.0||||||
4444907|NCT00101647|4268884|B3|score=3 limited selfcare, bed/chair confined >50%||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|0|0.0||||||
4444948|NCT00101647|4268886|B1|46 to 65 years||Age, Customized||participants|Number|6|6.0||||||
4444909|NCT00101647|4268886|B1|score=3 limited selfcare, bed/chair confined >50%||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|0|0.0||||||
4444910|NCT00101647|4268884|B3|score=2 capable of all selfcare, unable to work||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|24|24.0||||||
4444911|NCT00101647|4268885|B2|score=2 capable of all selfcare, unable to work||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|21|21.0||||||
4444912|NCT00101647|4268886|B1|score=2 capable of all selfcare, unable to work||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|3|3.0||||||
4444913|NCT00101647|4268884|B3|score=1 physically strenuous activity restricted||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|71|71.0||||||
4444914|NCT00101647|4268885|B2|score=1 physically strenuous activity restricted||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|67|67.0||||||
4444915|NCT00101647|4268886|B1|score=1 physically strenuous activity restricted||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|4|4.0||||||
4444916|NCT00101647|4268884|B3|score=0 fully active||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|79|79.0||||||
4444917|NCT00101647|4268885|B2|score=0 fully active||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|73|73.0||||||
4444918|NCT00101647|4268886|B1|score=0 fully active||Performance Status - Eastern Cooperative Oncology Group Scale (ECOG)|ECOG scale is a 6-item scale to assess disease progression, daily functioning, and appropriate treatment and prognosis. Scale 0-5, with 0=fully active, able to carry on all pre-disease performance without restriction, and 5=death|units on a scale|Number|6|6.0||||||
4444919|NCT00101647|4268884|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4444920|NCT00101647|4268885|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4444921|NCT00101647|4268886|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4444922|NCT00101647|4268884|B3|White||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
4444923|NCT00101647|4268885|B2|White||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4444924|NCT00101647|4268886|B1|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4444925|NCT00101647|4268884|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4444926|NCT00101647|4268885|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4444927|NCT00101647|4268886|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4444928|NCT00101647|4268884|B3|Asian||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4444929|NCT00101647|4268885|B2|Asian||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4444930|NCT00101647|4268886|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4444931|NCT00101647|4268884|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4444932|NCT00101647|4268885|B2||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4444933|NCT00101647|4268886|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4444934|NCT00101647|4268884|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4444935|NCT00101647|4268885|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4444936|NCT00101647|4268886|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4444937|NCT00101647|4268884|B3|||Age||years|Mean|54.8|54.8|Standard Deviation|13.7|13.7|||
4444938|NCT00101647|4268885|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|13.7|13.7|||
4444939|NCT00101647|4268886|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|14.2|14.2|||
4444940|NCT00101647|4268884|B3|>75 years||Age, Customized||participants|Number|9|9.0||||||
4444941|NCT00101647|4268885|B2|>75 years||Age, Customized||participants|Number|8|8.0||||||
4444942|NCT00101647|4268886|B1|>75 years||Age, Customized||participants|Number|1|1.0||||||
4444943|NCT00101647|4268884|B3|66 to 75 years||Age, Customized||participants|Number|29|29.0||||||
4444944|NCT00101647|4268885|B2|66 to 75 years||Age, Customized||participants|Number|25|25.0||||||
4444945|NCT00101647|4268886|B1|66 to 75 years||Age, Customized||participants|Number|4|4.0||||||
4444946|NCT00101647|4268884|B3|46 to 65 years||Age, Customized||participants|Number|93|93.0||||||
4444947|NCT00101647|4268885|B2|46 to 65 years||Age, Customized||participants|Number|87|87.0||||||
4444950|NCT00101647|4268885|B2|21 to 45 years||Age, Customized||participants|Number|41|41.0||||||
4444951|NCT00101647|4268886|B1|21 to 45 years||Age, Customized||participants|Number|2|2.0||||||
4444952|NCT00101582|4268935|B3|Hypopharynx||Tumor Site||participants|Number|36|36.0||||||
4444953|NCT00101582|4268936|B2|Hypopharynx||Tumor Site||participants|Number|14|14.0||||||
4444954|NCT00101582|4268937|B1|Hypopharynx||Tumor Site||participants|Number|22|22.0||||||
4444955|NCT00101582|4268935|B3|Larynx||Tumor Site||participants|Number|25|25.0||||||
4444956|NCT00101582|4268936|B2|Larynx||Tumor Site||participants|Number|16|16.0||||||
4444957|NCT00101582|4268937|B1|Larynx||Tumor Site||participants|Number|9|9.0||||||
4444958|NCT00101582|4268935|B3|Nasopharynx||Tumor Site||participants|Number|7|7.0||||||
4444959|NCT00101582|4268936|B2|Nasopharynx||Tumor Site||participants|Number|4|4.0||||||
4444960|NCT00101582|4268937|B1|Nasopharynx||Tumor Site||participants|Number|3|3.0||||||
4444961|NCT00101582|4268935|B3|Oropharynx||Tumor Site||participants|Number|106|106.0||||||
4444962|NCT00101582|4268936|B2|Oropharynx||Tumor Site||participants|Number|55|55.0||||||
4444963|NCT00101582|4268937|B1|Oropharynx||Tumor Site||participants|Number|51|51.0||||||
4444964|NCT00101582|4268935|B3|Oral Cavity||Tumor Site||participants|Number|14|14.0||||||
4444965|NCT00101582|4268936|B2|Oral Cavity||Tumor Site||participants|Number|5|5.0||||||
4444966|NCT00101582|4268937|B1|Oral Cavity||Tumor Site||participants|Number|9|9.0||||||
4444967|NCT00101582|4268935|B3|Stage IV B||Disease Stage|American Joint Committee on Cancer staging system.|participants|Number|19|19.0||||||
4444968|NCT00101582|4268936|B2|Stage IV B||Disease Stage|American Joint Committee on Cancer staging system.|participants|Number|8|8.0||||||
4444969|NCT00101582|4268937|B1|Stage IV B||Disease Stage|American Joint Committee on Cancer staging system.|participants|Number|11|11.0||||||
4444970|NCT00101582|4268935|B3|Stage IV A||Disease Stage|American Joint Committee on Cancer staging system.|participants|Number|114|114.0||||||
4444971|NCT00101582|4268936|B2|Stage IV A||Disease Stage|American Joint Committee on Cancer staging system.|participants|Number|60|60.0||||||
4444972|NCT00101582|4268937|B1|Stage IV A||Disease Stage|American Joint Committee on Cancer staging system.|participants|Number|54|54.0||||||
4444973|NCT00101582|4268935|B3|Stage III||Disease Stage|American Joint Committee on Cancer staging system.|participants|Number|55|55.0||||||
4444974|NCT00101582|4268936|B2|Stage III||Disease Stage|American Joint Committee on Cancer staging system.|participants|Number|26|26.0||||||
4444975|NCT00101582|4268937|B1|Stage III||Disease Stage|American Joint Committee on Cancer staging system.|participants|Number|29|29.0||||||
4444976|NCT00101582|4268935|B3|||Weight|Data available for 91 and 94 participants in each treatment group respectively.|kilograms|Mean|73.2|73.2|Standard Deviation|16.1|16.1|||
4444977|NCT00101582|4268936|B2|||Weight|Data available for 91 and 94 participants in each treatment group respectively.|kilograms|Mean|74.5|74.5|Standard Deviation|16.4|16.4|||
4444978|NCT00101582|4268937|B1|||Weight|Data available for 91 and 94 participants in each treatment group respectively.|kilograms|Mean|71.8|71.8|Standard Deviation|15.7|15.7|||
4444979|NCT00101582|4268935|B3|American Indian/ Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4444980|NCT00101582|4268936|B2|American Indian/ Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4444981|NCT00101582|4268937|B1|American Indian/ Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4444982|NCT00101582|4268935|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4444983|NCT00101582|4268936|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4444984|NCT00101582|4268937|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4444985|NCT00101582|4268935|B3|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4444986|NCT00101582|4268936|B2|Black||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4444987|NCT00101582|4268937|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4444988|NCT00101582|4268935|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|173|173.0||||||
4444989|NCT00101582|4268936|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4444990|NCT00101582|4268937|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
4444991|NCT00101582|4268935|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4444992|NCT00101582|4268936|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4444993|NCT00101582|4268937|B1||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4444994|NCT00101582|4268935|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4444995|NCT00101582|4268936|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4444996|NCT00101582|4268937|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4444997|NCT00101582|4268935|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|8.5|8.5|||
4444998|NCT00101582|4268936|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|8.6|8.6|||
4444999|NCT00101582|4268937|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|8.3|8.3|||
4445000|NCT00101452|4268958|B4|United States||Region of Enrollment|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|participants|Number|166|166.0||||||
4445001|NCT00101452|4268959|B3|United States||Region of Enrollment|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|participants|Number|52|52.0||||||
4445002|NCT00101452|4268960|B2|United States||Region of Enrollment|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|participants|Number|55|55.0||||||
4445003|NCT00101452|4268961|B1|United States||Region of Enrollment|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|participants|Number|59|59.0||||||
4445004|NCT00101452|4268958|B4||Male|Sex: Female, Male|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|80|80.0||||||
4445005|NCT00101452|4268959|B3||Male|Sex: Female, Male|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|25|25.0||||||
4445006|NCT00101452|4268960|B2||Male|Sex: Female, Male|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|28|28.0||||||
4445007|NCT00101452|4268961|B1||Male|Sex: Female, Male|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|27|27.0||||||
4445008|NCT00101452|4268958|B4||Female|Sex: Female, Male|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|86|86.0||||||
4445009|NCT00101452|4268959|B3||Female|Sex: Female, Male|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|27|27.0||||||
4445010|NCT00101452|4268960|B2||Female|Sex: Female, Male|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|27|27.0||||||
4445011|NCT00101452|4268961|B1||Female|Sex: Female, Male|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|32|32.0||||||
4445012|NCT00101452|4268958|B4|||Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|years|Mean|44.75|44.75|Standard Deviation|14.43|14.43|||
4445013|NCT00101452|4268959|B3|||Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|years|Mean|44.34|44.34|Standard Deviation|15.19|15.19|||
4445014|NCT00101452|4268960|B2|||Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|years|Mean|44.67|44.67|Standard Deviation|14.29|14.29|||
4445015|NCT00101452|4268961|B1|||Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|years|Mean|45.25|45.25|Standard Deviation|13.98|13.98|||
4445016|NCT00101452|4268958|B4||>=65 years|Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|9|9.0||||||
4445017|NCT00101452|4268959|B3||>=65 years|Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|2|2.0||||||
4445018|NCT00101452|4268960|B2||>=65 years|Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|4|4.0||||||
4445019|NCT00101452|4268961|B1||>=65 years|Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|3|3.0||||||
4445020|NCT00101452|4268958|B4||Between 18 and 65 years|Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|157|157.0||||||
4445021|NCT00101452|4268959|B3||Between 18 and 65 years|Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|50|50.0||||||
4445022|NCT00101452|4268960|B2||Between 18 and 65 years|Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|51|51.0||||||
4445023|NCT00101452|4268961|B1||Between 18 and 65 years|Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|56|56.0||||||
4445054|NCT00101400|4268994|B1|Grade 0: fully active||Eastern Cooperative Oncology Group (ECOG) performance status|5-point, ordinal scale specifying patient's ability to perform activities from 0 (fully active) to 4 (completely disabled, no self-care)|participants|Number|30|30.0||||||
4445024|NCT00101452|4268958|B4||<=18 years|Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|0|0.0||||||
4445025|NCT00101452|4268959|B3||<=18 years|Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|0|0.0||||||
4445026|NCT00101452|4268960|B2||<=18 years|Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|0|0.0||||||
4445027|NCT00101452|4268961|B1||<=18 years|Age|The number of patients originally enrolled does not match the number of patients who completed baseline assessments because some patients dropped out of the study after the screening visit and therefore never completed the baseline visit.|Participants|Count of Participants|0|0.0||||||
4445028|NCT00101439|4268975|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4445029|NCT00101439|4268976|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4445030|NCT00101439|4268977|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4445031|NCT00101439|4268975|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4445032|NCT00101439|4268976|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4445033|NCT00101439|4268977|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4445034|NCT00101439|4268975|B3|||Age||years|Mean|49.7|49.7|Standard Deviation|9.20|9.2|||
4445035|NCT00101439|4268976|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|9.48|9.48|||
4445036|NCT00101439|4268977|B1|||Age||years|Mean|51.0|51.0|Standard Deviation|8.84|8.84|||
4445037|NCT00101413|4268986|B1|Undifferentiated carcinoma||Histology|Measurable, histologically or cytologically documented stage IV non-small cell lung cancer (NSCLC). Subjects must have had disease progression at the time of study entry and have been treated with at least 1 but no more than 2 prior systemic agents or regimens (including gefitinib).|participants|Number|4|4.0||||||
4445038|NCT00101413|4268986|B1|Squamous cell (epidermoid) carcinoma||Histology|Measurable, histologically or cytologically documented stage IV non-small cell lung cancer (NSCLC). Subjects must have had disease progression at the time of study entry and have been treated with at least 1 but no more than 2 prior systemic agents or regimens (including gefitinib).|participants|Number|16|16.0||||||
4445039|NCT00101413|4268986|B1|Large cell carcinoma||Histology|Measurable, histologically or cytologically documented stage IV non-small cell lung cancer (NSCLC). Subjects must have had disease progression at the time of study entry and have been treated with at least 1 but no more than 2 prior systemic agents or regimens (including gefitinib).|participants|Number|4|4.0||||||
4445040|NCT00101413|4268986|B1|Adenocarcinoma NSCLC||Histology|Measurable, histologically or cytologically documented stage IV non-small cell lung cancer (NSCLC). Subjects must have had disease progression at the time of study entry and have been treated with at least 1 but no more than 2 prior systemic agents or regimens (including gefitinib).|participants|Number|28|28.0||||||
4445041|NCT00101413|4268986|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4445042|NCT00101413|4268986|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4445043|NCT00101413|4268986|B1|< 65 years||Age, Customized||participants|Number|31|31.0||||||
4445044|NCT00101413|4268986|B1|>=65 years||Age, Customized||participants|Number|21|21.0||||||
4445045|NCT00101413|4268986|B1|||Age||years|Median|62|62.0|Full Range|||26.0|85.0|
4445046|NCT00101400|4268994|B1|Stage IV -most advanced||Stage of disease at study entry (Tumor, Nodules, Metastasis (TNM) classification)|Categorized information on tumor size, lymph node involvement and metastases. Overall cancer staging (I – IV) is based on the TNM categories. The higher the overall stage, the more advanced the cancer is.|participants|Number|54|54.0||||||
4445047|NCT00101400|4268994|B1|Stage III||Stage of disease at study entry (Tumor, Nodules, Metastasis (TNM) classification)|Categorized information on tumor size, lymph node involvement and metastases. Overall cancer staging (I – IV) is based on the TNM categories. The higher the overall stage, the more advanced the cancer is.|participants|Number|0|0.0||||||
4445048|NCT00101400|4268994|B1|Stage II||Stage of disease at study entry (Tumor, Nodules, Metastasis (TNM) classification)|Categorized information on tumor size, lymph node involvement and metastases. Overall cancer staging (I – IV) is based on the TNM categories. The higher the overall stage, the more advanced the cancer is.|participants|Number|0|0.0||||||
4445049|NCT00101400|4268994|B1|Stage I||Stage of disease at study entry (Tumor, Nodules, Metastasis (TNM) classification)|Categorized information on tumor size, lymph node involvement and metastases. Overall cancer staging (I – IV) is based on the TNM categories. The higher the overall stage, the more advanced the cancer is.|participants|Number|0|0.0||||||
4445050|NCT00101400|4268994|B1|Grade 4: Completely disabled, no self-care||Eastern Cooperative Oncology Group (ECOG) performance status|5-point, ordinal scale specifying patient's ability to perform activities from 0 (fully active) to 4 (completely disabled, no self-care)|participants|Number|0|0.0||||||
4445051|NCT00101400|4268994|B1|Grade 3: Limited self-care, partly confined to bed||Eastern Cooperative Oncology Group (ECOG) performance status|5-point, ordinal scale specifying patient's ability to perform activities from 0 (fully active) to 4 (completely disabled, no self-care)|participants|Number|0|0.0||||||
4445052|NCT00101400|4268994|B1|Grade 2: Ambulatory, difficulty in walking||Eastern Cooperative Oncology Group (ECOG) performance status|5-point, ordinal scale specifying patient's ability to perform activities from 0 (fully active) to 4 (completely disabled, no self-care)|participants|Number|2|2.0||||||
4445053|NCT00101400|4268994|B1|Grade 1: Restricted strenous activity, ambulatory||Eastern Cooperative Oncology Group (ECOG) performance status|5-point, ordinal scale specifying patient's ability to perform activities from 0 (fully active) to 4 (completely disabled, no self-care)|participants|Number|22|22.0||||||
4445055|NCT00101400|4268994|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4445056|NCT00101400|4268994|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4445057|NCT00101400|4268994|B1|||Age||years|Mean|55.4|55.4|Standard Deviation|10.8|10.8|||
4445058|NCT00101361|4269003|B3|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4445059|NCT00101361|4269004|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4445060|NCT00101361|4269005|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4445061|NCT00101361|4269003|B3|United States||Region of Enrollment||participants|Number|210|210.0||||||
4445062|NCT00101361|4269004|B2|United States||Region of Enrollment||participants|Number|103|103.0||||||
4445063|NCT00101361|4269005|B1|United States||Region of Enrollment||participants|Number|107|107.0||||||
4445064|NCT00101361|4269003|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4445065|NCT00101361|4269004|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4445066|NCT00101361|4269005|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4445067|NCT00101361|4269003|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4445068|NCT00101361|4269004|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4445069|NCT00101361|4269005|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4445070|NCT00101361|4269003|B3|||Age||years|Mean|57.9|57.9|Standard Deviation|11.1|11.1|||
4445071|NCT00101361|4269004|B2|||Age||years|Mean|57.3|57.3|Standard Deviation|11.6|11.6|||
4445072|NCT00101361|4269005|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|10.4|10.4|||
4445073|NCT00101361|4269003|B3||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4445074|NCT00101361|4269004|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4445075|NCT00101361|4269005|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4445076|NCT00101361|4269003|B3||Between 18 and 65 years|Age||Participants|Count of Participants|165|165.0||||||
4445077|NCT00101361|4269004|B2||Between 18 and 65 years|Age||Participants|Count of Participants|83|83.0||||||
4445078|NCT00101361|4269005|B1||Between 18 and 65 years|Age||Participants|Count of Participants|82|82.0||||||
4445079|NCT00101361|4269003|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445080|NCT00101361|4269004|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445081|NCT00101361|4269005|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445082|NCT00101283|4269012|B3||Male|Sex: Female, Male|Gender of participants who began treatment.|Participants|Count of Participants|15|15.0||||||
4445083|NCT00101283|4269013|B2||Male|Sex: Female, Male|Gender of participants who began treatment.|Participants|Count of Participants|1|1.0||||||
4445084|NCT00101283|4269014|B1||Male|Sex: Female, Male|Gender of participants who began treatment.|Participants|Count of Participants|14|14.0||||||
4445085|NCT00101283|4269012|B3||Female|Sex: Female, Male|Gender of participants who began treatment.|Participants|Count of Participants|14|14.0||||||
4445086|NCT00101283|4269013|B2||Female|Sex: Female, Male|Gender of participants who began treatment.|Participants|Count of Participants|12|12.0||||||
4445087|NCT00101283|4269014|B1||Female|Sex: Female, Male|Gender of participants who began treatment.|Participants|Count of Participants|2|2.0||||||
4445088|NCT00101283|4269012|B3|||Age||years|Median|71|71.0|Full Range|||53.0|80.0|
4445089|NCT00101283|4269013|B2|||Age||years|Median|68|68.0|Full Range|||53.0|80.0|
4445090|NCT00101283|4269014|B1|||Age||years|Median|72|72.0|Full Range|||55.0|78.0|
4445091|NCT00101192|4269025|B1|Squamous Cell Carcinoma||Cell Type||participants|Number|41|41.0||||||
4445092|NCT00101192|4269025|B1|Adenosquamous||Cell Type||participants|Number|5|5.0||||||
4445093|NCT00101192|4269025|B1|Mucinous Adenocarcinoma||Cell Type||participants|Number|1|1.0||||||
4445094|NCT00101192|4269025|B1|Clear Cell Carcinoma||Cell Type||participants|Number|1|1.0||||||
4445095|NCT00101192|4269025|B1|Adenocarcinoma, Unspecified||Cell Type||participants|Number|21|21.0||||||
4445096|NCT00101192|4269025|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4445097|NCT00101192|4269025|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4445098|NCT00101192|4269025|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4445099|NCT00101192|4269025|B1|70-79 years||Age, Customized||participants|Number|4|4.0||||||
4445100|NCT00101192|4269025|B1|60-69 years||Age, Customized||participants|Number|9|9.0||||||
4445101|NCT00101192|4269025|B1|50-59 years||Age, Customized||participants|Number|26|26.0||||||
4445102|NCT00101192|4269025|B1|40-49 years||Age, Customized||participants|Number|18|18.0||||||
4445103|NCT00101192|4269025|B1|30-39 years||Age, Customized||participants|Number|11|11.0||||||
4445104|NCT00101192|4269025|B1|20-29 years||Age, Customized||participants|Number|1|1.0||||||
4445105|NCT00101192|4269025|B1|||Age||years|Mean|50.8|50.8|Standard Deviation|11.2|11.2|||
4445106|NCT00101166|4269029|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4445107|NCT00101166|4269029|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4445108|NCT00101166|4269029|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4445109|NCT00101166|4269029|B1|||Age||years|Median|60|60.0|Full Range|||24.0|87.0|
4445110|NCT00101101|4269037|B1|United States||Region of Enrollment||participants|Number|43|43.0||||||
4445111|NCT00101101|4269037|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4445112|NCT00101101|4269037|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4445113|NCT00101101|4269037|B1|||Age||participants|Median|65|65.0|Full Range|||47.0|81.0|
4445114|NCT00101101|4269037|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4445115|NCT00101101|4269037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4445116|NCT00101101|4269037|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445117|NCT00101036|4269043|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4445118|NCT00101036|4269044|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4445119|NCT00101036|4269045|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4445120|NCT00101036|4269043|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4445121|NCT00101036|4269044|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4445122|NCT00101036|4269045|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4445123|NCT00101036|4269043|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4445124|NCT00101036|4269044|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4445125|NCT00101036|4269045|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4445126|NCT00101036|4269043|B3|||Age||years|Median|62|62.0|Full Range|||19.0|82.0|
4445127|NCT00101036|4269044|B2|||Age||years|Median|62|62.0|Full Range|||19.0|82.0|
4445128|NCT00101036|4269045|B1|||Age||years|Median|58|58.0|Full Range|||44.0|76.0|
4445129|NCT00100932|4269058|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
4445130|NCT00100932|4269059|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4445131|NCT00100932|4269060|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
4445132|NCT00100932|4269058|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4445133|NCT00100932|4269059|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445134|NCT00100932|4269060|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4445135|NCT00100932|4269058|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445136|NCT00100932|4269059|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445137|NCT00100932|4269060|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445138|NCT00100932|4269058|B3||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4445139|NCT00100932|4269059|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4445140|NCT00100932|4269060|B1||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4445141|NCT00100932|4269058|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4445142|NCT00100932|4269059|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4445143|NCT00100932|4269060|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4445144|NCT00100932|4269058|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445145|NCT00100932|4269059|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445146|NCT00100932|4269060|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445147|NCT00100932|4269058|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4445148|NCT00100932|4269059|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4445149|NCT00100932|4269060|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4445150|NCT00100932|4269058|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445151|NCT00100932|4269059|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445152|NCT00100932|4269060|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445153|NCT00100932|4269058|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445154|NCT00100932|4269059|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445155|NCT00100932|4269060|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445156|NCT00100932|4269058|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4445157|NCT00100932|4269059|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4445158|NCT00100932|4269060|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4445159|NCT00100932|4269058|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4445160|NCT00100932|4269059|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445161|NCT00100932|4269060|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4445162|NCT00100932|4269058|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4445163|NCT00100932|4269059|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4445164|NCT00100932|4269060|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4445165|NCT00100932|4269058|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4445166|NCT00100932|4269059|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4445167|NCT00100932|4269060|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4445168|NCT00100932|4269058|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|10.28|10.28|||
4445169|NCT00100932|4269059|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|8.97|8.97|||
4445170|NCT00100932|4269060|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|10.59|10.59|||
4445171|NCT00100841|4269071|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4445172|NCT00100841|4269071|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4445173|NCT00100841|4269071|B1|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4445174|NCT00100841|4269071|B1|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4445175|NCT00100841|4269071|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4445176|NCT00100841|4269071|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4445177|NCT00100841|4269071|B1|||Age||years|Median|57|57.0|Full Range|||27.0|82.0|
4445178|NCT00100828|4269076|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4445179|NCT00100828|4269076|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4445180|NCT00100828|4269076|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4445181|NCT00100828|4269076|B1|||Age||years|Mean|71|71.0|Standard Deviation|10.94|10.94|||
4445182|NCT00100828|4269076|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4445183|NCT00100828|4269076|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4445184|NCT00100828|4269076|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445185|NCT00100815|4269080|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4445186|NCT00100815|4269080|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4445187|NCT00100815|4269080|B1|||Age||years|Mean|64.18|64.18|Standard Deviation|11.62|11.62|||
4445188|NCT00100802|4269088|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4445189|NCT00100802|4269088|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
4445190|NCT00100802|4269088|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4445191|NCT00100802|4269088|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4445192|NCT00100802|4269088|B1||Male|Gender||Participants|Count of Participants|63|63.0||||||
4445193|NCT00100802|4269088|B1||Female|Gender||Participants|Count of Participants|55|55.0||||||
4445194|NCT00100802|4269088|B1|||Age||years|Median|12|12.0|Full Range|||3.0|21.0|
4445195|NCT00100802|4269088|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4445196|NCT00100802|4269088|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4445197|NCT00100802|4269088|B1||<=18 years|Age||Participants|Count of Participants|110|110.0||||||
4445198|NCT00100789|4269093|B1|1||Performance Status|Performance status is graded according to the Zubrod Performance Status Scale. Patients with a performance status of 0 are fully active, able to carry on all pre-disease performance without restriction. Patients with a performance status of 1 are restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.|participants|Number|39|39.0||||||
4445199|NCT00100789|4269093|B1|0||Performance Status|Performance status is graded according to the Zubrod Performance Status Scale. Patients with a performance status of 0 are fully active, able to carry on all pre-disease performance without restriction. Patients with a performance status of 1 are restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.|participants|Number|24|24.0||||||
4445200|NCT00100789|4269093|B1|Not Reported||Disease Status||participants|Number|1|1.0||||||
4445201|NCT00100789|4269093|B1|Recurrent||Disease Status||participants|Number|50|50.0||||||
4445202|NCT00100789|4269093|B1|Persistent||Disease Status||participants|Number|7|7.0||||||
4445203|NCT00100789|4269093|B1|Newly Diagnosed||Disease Status||participants|Number|5|5.0||||||
4445204|NCT00100789|4269093|B1|Other/Unknown||Primary Site||participants|Number|5|5.0||||||
4445205|NCT00100789|4269093|B1|Paranasal Sinuses||Primary Site||participants|Number|3|3.0||||||
4445206|NCT00100789|4269093|B1|Larynx||Primary Site||participants|Number|16|16.0||||||
4445207|NCT00100789|4269093|B1|Hypopharynx||Primary Site||participants|Number|2|2.0||||||
4445208|NCT00100789|4269093|B1|Salivary glands||Primary Site||participants|Number|0|0.0||||||
4445209|NCT00100789|4269093|B1|Oropharynx||Primary Site||participants|Number|13|13.0||||||
4445210|NCT00100789|4269093|B1|Nasopharynx||Primary Site||participants|Number|4|4.0||||||
4445211|NCT00100789|4269093|B1|Lip/Oral Cavity||Primary Site||participants|Number|20|20.0||||||
4445212|NCT00100789|4269093|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4445213|NCT00100789|4269093|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4445214|NCT00100789|4269093|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4445215|NCT00100789|4269093|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4445216|NCT00100789|4269093|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445217|NCT00100789|4269093|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445218|NCT00100789|4269093|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445219|NCT00100789|4269093|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4445220|NCT00100789|4269093|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4445221|NCT00100789|4269093|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445222|NCT00100789|4269093|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4445223|NCT00100789|4269093|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4445224|NCT00100789|4269093|B1|||Age||years|Median|63.1|63.1|Full Range|||40.7|82.9|
4445225|NCT00100698|4269100|B3|United States||Region of Enrollment||participants|Number|56|56.0||||||
4445226|NCT00100698|4269101|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4445227|NCT00100698|4269102|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4445228|NCT00100698|4269100|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4445229|NCT00100698|4269101|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4445230|NCT00100698|4269102|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4445231|NCT00100698|4269100|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4445232|NCT00100698|4269101|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4445233|NCT00100698|4269102|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4445234|NCT00100698|4269100|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|6.9|6.9|||
4445235|NCT00100698|4269101|B2|||Age||years|Mean|47.4|47.4|Standard Deviation|6.1|6.1|||
4445236|NCT00100698|4269102|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|7.9|7.9|||
4445237|NCT00100698|4269100|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4445238|NCT00100698|4269101|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4445239|NCT00100698|4269102|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4445240|NCT00100698|4269100|B3||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4445241|NCT00100698|4269101|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4445242|NCT00100698|4269102|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4445243|NCT00100698|4269100|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445244|NCT00100698|4269101|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445245|NCT00100698|4269102|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445246|NCT00100659|4269143|B3|United States||Region of Enrollment||participants|Number|114|114.0||||||
4445247|NCT00100659|4269144|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4445248|NCT00100659|4269145|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4445249|NCT00100659|4269143|B3||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4445250|NCT00100659|4269144|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4445251|NCT00100659|4269145|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4445252|NCT00100659|4269143|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4445253|NCT00100659|4269144|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4445254|NCT00100659|4269145|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4445255|NCT00100659|4269143|B3|||Age||years|Mean|10.75|10.75|Standard Deviation|3.4|3.4|||
4445256|NCT00100659|4269144|B2|||Age||years|Mean|10.8|10.8|Standard Deviation|3.6|3.6|||
4445257|NCT00100659|4269145|B1|||Age||years|Mean|10.7|10.7|Standard Deviation|3.3|3.3|||
4445258|NCT00100659|4269143|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4445259|NCT00100659|4269144|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4445260|NCT00100659|4269145|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4445261|NCT00100659|4269143|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4445262|NCT00100659|4269144|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4445263|NCT00100659|4269145|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4445264|NCT00100659|4269143|B3||<=18 years|Age||Participants|Count of Participants|114|114.0||||||
4445265|NCT00100659|4269144|B2||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
4445266|NCT00100659|4269145|B1||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4445267|NCT00100230|4269154|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4445268|NCT00100230|4269155|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4445269|NCT00100230|4269156|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4445270|NCT00100230|4269154|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4445271|NCT00100230|4269155|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4445272|NCT00100230|4269156|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4445273|NCT00100230|4269154|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445274|NCT00100230|4269155|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445275|NCT00100230|4269156|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445276|NCT00100230|4269154|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|73|73.0||||||
4445277|NCT00100230|4269155|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4445278|NCT00100230|4269156|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4445279|NCT00100230|4269154|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4445280|NCT00100230|4269155|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4445281|NCT00100230|4269156|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4445282|NCT00100230|4269154|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445283|NCT00100230|4269155|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445284|NCT00100230|4269156|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445285|NCT00100230|4269154|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4445286|NCT00100230|4269155|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4445287|NCT00100230|4269156|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4445288|NCT00100230|4269154|B3||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4445289|NCT00100230|4269155|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4445290|NCT00100230|4269156|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4445291|NCT00100230|4269154|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4445292|NCT00100230|4269155|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445293|NCT00100230|4269156|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4445294|NCT00100230|4269154|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445295|NCT00100230|4269155|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445296|NCT00100230|4269156|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445297|NCT00100230|4269154|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445298|NCT00100230|4269155|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445299|NCT00100230|4269156|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445300|NCT00100230|4269154|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445301|NCT00100230|4269155|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445302|NCT00100230|4269156|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445303|NCT00100230|4269154|B3|male||Sex/Gender, Customized||participants|Number|78|78.0||||||
4445304|NCT00100230|4269155|B2|male||Sex/Gender, Customized||participants|Number|37|37.0||||||
4445305|NCT00100230|4269156|B1|male||Sex/Gender, Customized||participants|Number|41|41.0||||||
4445306|NCT00100230|4269154|B3|Age||Age, Customized|Ages 7 to 32 years|years|Mean|16.7|16.7|Standard Deviation|7.1|7.1|||
4445307|NCT00100230|4269155|B2|Age||Age, Customized|Ages 7 to 32 years|years|Mean|16.2|16.2|Standard Deviation|6.6|6.6|||
4445308|NCT00100230|4269156|B1|Age||Age, Customized|Ages 7 to 32 years|years|Mean|16.7|16.7|Standard Deviation|7.8|7.8|||
4445309|NCT00100178|4269167|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4445310|NCT00100178|4269168|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4445311|NCT00100178|4269169|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4445312|NCT00100178|4269170|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4445313|NCT00100178|4269167|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4445314|NCT00100178|4269168|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4445315|NCT00100178|4269169|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4445316|NCT00100178|4269170|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4445317|NCT00100178|4269167|B4|||Age||years|Mean|18.2|18.2|Standard Deviation|9.01|9.01|||
4445318|NCT00100178|4269168|B3|||Age||years|Mean|18.8|18.8|Standard Deviation|10.44|10.44|||
4445319|NCT00100178|4269169|B2|||Age||years|Mean|17.1|17.1|Standard Deviation|6.71|6.71|||
4445320|NCT00100178|4269170|B1|||Age||years|Mean|18.4|18.4|Standard Deviation|9.09|9.09|||
4445321|NCT00100048|4269180|B6|Cohort I and II Combined||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|57437|57437.0|Full Range|||2440.0|750000.0|
4445322|NCT00100048|4269181|B5|Cohort I and II Combined||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|67554|67554.0|Full Range|||3340.0|675000.0|
4445323|NCT00100048|4269182|B4|Cohort I and II Combined||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|57919|57919.0|Full Range|||3450.0|750000.0|
4445324|NCT00100048|4269183|B3|Cohort I and II Combined||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|43083|43083.0|Full Range|||2440.0|499000.0|
4445325|NCT00100048|4269184|B2|Cohort I and II Combined||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|64715|64715.0|Full Range|||7490.0|750000.0|
4445326|NCT00100048|4269185|B1|Cohort I and II Combined||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|58206|58206.0|Full Range|||4200.0|750000.0|
4445327|NCT00100048|4269180|B6|Cohort II||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|63965|63965.0|Full Range|||2440.0|750000.0|
4445328|NCT00100048|4269181|B5|Cohort II||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|76752|76752.0|Full Range|||7500.0|675000.0|
4445329|NCT00100048|4269182|B4|Cohort II||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|61929|61929.0|Full Range|||3450.0|750000.0|
4445330|NCT00100048|4269183|B3|Cohort II||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|47019|47019.0|Full Range|||2440.0|499000.0|
4445331|NCT00100048|4269184|B2|Cohort II||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|73646|73646.0|Full Range|||7490.0|750000.0|
4445332|NCT00100048|4269185|B1|Cohort II||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|65982|65982.0|Full Range|||4200.0|750000.0|
4445333|NCT00100048|4269180|B6|Cohort I||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|51496|51496.0|Full Range|||3890.0|456000.0|
4445334|NCT00100048|4269181|B5|Cohort I||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|58412|58412.0|Full Range|||7630.0|456000.0|
4445335|NCT00100048|4269182|B4|Cohort I||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|93911|93911.0|Full Range|||17100.0|388000.0|
4445336|NCT00100048|4269183|B3|Cohort I||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|37728|37728.0|Full Range|||6850.0|152000.0|
4445337|NCT00100048|4269184|B2|Cohort I||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|34143|34143.0|Full Range|||5420.0|168000.0|
4445350|NCT00100048|4269185|B1|Cohort II||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|293|293.0|Full Range|||76.0|736.0|
4445338|NCT00100048|4269185|B1|Cohort I||Plasma Human Immunodeficiency Virus (HIV) Ribonucleic acid (RNA)|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|copies/mL|Geometric Mean|44989|44989.0|Full Range|||3890.0|225000.0|
4445339|NCT00100048|4269180|B6|Cohort I and II Combined||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|266|266.0|Full Range|||70.0|1017.0|
4445340|NCT00100048|4269181|B5|Cohort I and II Combined||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|225|225.0|Full Range|||77.0|744.0|
4445341|NCT00100048|4269182|B4|Cohort I and II Combined||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|244|244.0|Full Range|||99.0|786.0|
4445342|NCT00100048|4269183|B3|Cohort I and II Combined||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|293|293.0|Full Range|||95.0|1017.0|
4445343|NCT00100048|4269184|B2|Cohort I and II Combined||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|277|277.0|Full Range|||70.0|723.0|
4445344|NCT00100048|4269185|B1|Cohort I and II Combined||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|272|272.0|Full Range|||76.0|758.0|
4445345|NCT00100048|4269180|B6|Cohort II||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|291|291.0|Full Range|||70.0|1017.0|
4445346|NCT00100048|4269181|B5|Cohort II||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|276|276.0|Full Range|||77.0|744.0|
4445347|NCT00100048|4269182|B4|Cohort II||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|245|245.0|Full Range|||99.0|734.0|
4445348|NCT00100048|4269183|B3|Cohort II||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|348|348.0|Full Range|||95.0|1017.0|
4445349|NCT00100048|4269184|B2|Cohort II||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|292|292.0|Full Range|||70.0|723.0|
4445387|NCT00100048|4269180|B6|White (Cohort II)||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4445388|NCT00100048|4269181|B5|White (Cohort II)||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4445351|NCT00100048|4269180|B6|Cohort I||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|394|394.0|Full Range|||96.0|1034.0|
4445352|NCT00100048|4269181|B5|Cohort I||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|343|343.0|Full Range|||115.0|599.0|
4445353|NCT00100048|4269182|B4|Cohort I||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|569|569.0|Full Range|||241.0|1034.0|
4445354|NCT00100048|4269183|B3|Cohort I||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|256|256.0|Full Range|||96.0|602.0|
4445355|NCT00100048|4269184|B2|Cohort I||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|343|343.0|Full Range|||149.0|624.0|
4445356|NCT00100048|4269185|B1|Cohort I||Cluster of differentiation 4 (CD4) Cell Count|Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7) Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34) Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)|cells/mm^3|Mean|415|415.0|Full Range|||138.0|745.0|
4445357|NCT00100048|4269180|B6|Never Treated (Cohort II)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4445358|NCT00100048|4269181|B5|Never Treated (Cohort II)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4445359|NCT00100048|4269182|B4|Never Treated (Cohort II)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4445360|NCT00100048|4269183|B3|Never Treated (Cohort II)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4445361|NCT00100048|4269184|B2|Never Treated (Cohort II)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4445362|NCT00100048|4269185|B1|Never Treated (Cohort II)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4445363|NCT00100048|4269180|B6|Other (Cohort II)||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4445364|NCT00100048|4269181|B5|Other (Cohort II)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4445365|NCT00100048|4269182|B4|Other (Cohort II)||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4445366|NCT00100048|4269183|B3|Other (Cohort II)||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4445367|NCT00100048|4269184|B2|Other (Cohort II)||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4445368|NCT00100048|4269185|B1|Other (Cohort II)||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4445369|NCT00100048|4269180|B6|Hispanic (Cohort II)||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4445370|NCT00100048|4269181|B5|Hispanic (Cohort II)||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4445371|NCT00100048|4269182|B4|Hispanic (Cohort II)||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4445372|NCT00100048|4269183|B3|Hispanic (Cohort II)||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4445373|NCT00100048|4269184|B2|Hispanic (Cohort II)||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4445374|NCT00100048|4269185|B1|Hispanic (Cohort II)||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4445375|NCT00100048|4269180|B6|Asian (Cohort II)||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4445376|NCT00100048|4269181|B5|Asian (Cohort II)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4445377|NCT00100048|4269182|B4|Asian (Cohort II)||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4445378|NCT00100048|4269183|B3|Asian (Cohort II)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4445379|NCT00100048|4269184|B2|Asian (Cohort II)||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4445380|NCT00100048|4269185|B1|Asian (Cohort II)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4445381|NCT00100048|4269180|B6|Black (Cohort II)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4445382|NCT00100048|4269181|B5|Black (Cohort II)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4445383|NCT00100048|4269182|B4|Black (Cohort II)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4445384|NCT00100048|4269183|B3|Black (Cohort II)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4445385|NCT00100048|4269184|B2|Black (Cohort II)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4445386|NCT00100048|4269185|B1|Black (Cohort II)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4445389|NCT00100048|4269182|B4|White (Cohort II)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4445390|NCT00100048|4269183|B3|White (Cohort II)||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4445391|NCT00100048|4269184|B2|White (Cohort II)||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4445392|NCT00100048|4269185|B1|White (Cohort II)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4445393|NCT00100048|4269180|B6|Hispanic (Cohort I)||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4445394|NCT00100048|4269181|B5|Hispanic (Cohort I)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4445395|NCT00100048|4269182|B4|Hispanic (Cohort I)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4445396|NCT00100048|4269183|B3|Hispanic (Cohort I)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4445397|NCT00100048|4269184|B2|Hispanic (Cohort I)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4445398|NCT00100048|4269185|B1|Hispanic (Cohort I)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4445399|NCT00100048|4269180|B6|Asian (Cohort I)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4445400|NCT00100048|4269181|B5|Asian (Cohort I)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4445401|NCT00100048|4269182|B4|Asian (Cohort I)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4445402|NCT00100048|4269183|B3|Asian (Cohort I)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4445403|NCT00100048|4269184|B2|Asian (Cohort I)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4445404|NCT00100048|4269185|B1|Asian (Cohort I)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4445405|NCT00100048|4269180|B6|Black (Cohort I)||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4445406|NCT00100048|4269181|B5|Black (Cohort I)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4445407|NCT00100048|4269182|B4|Black (Cohort I)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4445408|NCT00100048|4269183|B3|Black (Cohort I)||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4445409|NCT00100048|4269184|B2|Black (Cohort I)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4445410|NCT00100048|4269185|B1|Black (Cohort I)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4445411|NCT00100048|4269180|B6|White (Cohort I)||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4445412|NCT00100048|4269181|B5|White (Cohort I)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4445413|NCT00100048|4269182|B4|White (Cohort I)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4445414|NCT00100048|4269183|B3|White (Cohort I)||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4445415|NCT00100048|4269184|B2|White (Cohort I)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4445416|NCT00100048|4269185|B1|White (Cohort I)||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4445417|NCT00100048|4269180|B6|Never Treated Cohort II||Sex/Gender, Customized||participants|Number|2|2.0||||||
4445418|NCT00100048|4269181|B5|Never Treated Cohort II||Sex/Gender, Customized||participants|Number|1|1.0||||||
4445419|NCT00100048|4269182|B4|Never Treated Cohort II||Sex/Gender, Customized||participants|Number|0|0.0||||||
4445420|NCT00100048|4269183|B3|Never Treated Cohort II||Sex/Gender, Customized||participants|Number|0|0.0||||||
4445421|NCT00100048|4269184|B2|Never Treated Cohort II||Sex/Gender, Customized||participants|Number|0|0.0||||||
4445422|NCT00100048|4269185|B1|Never Treated Cohort II||Sex/Gender, Customized||participants|Number|1|1.0||||||
4445423|NCT00100048|4269180|B6|Male (Cohort II)||Sex/Gender, Customized||participants|Number|130|130.0||||||
4445424|NCT00100048|4269181|B5|Male (Cohort II)||Sex/Gender, Customized||participants|Number|26|26.0||||||
4445425|NCT00100048|4269182|B4|Male (Cohort II)||Sex/Gender, Customized||participants|Number|23|23.0||||||
4445426|NCT00100048|4269183|B3|Male (Cohort II)||Sex/Gender, Customized||participants|Number|31|31.0||||||
4445427|NCT00100048|4269184|B2|Male (Cohort II)||Sex/Gender, Customized||participants|Number|23|23.0||||||
4445428|NCT00100048|4269185|B1|Male (Cohort II)||Sex/Gender, Customized||participants|Number|27|27.0||||||
4445429|NCT00100048|4269180|B6|Female (Cohort II)||Sex/Gender, Customized||participants|Number|39|39.0||||||
4445430|NCT00100048|4269181|B5|Female (Cohort II)||Sex/Gender, Customized||participants|Number|8|8.0||||||
4445431|NCT00100048|4269182|B4|Female (Cohort II)||Sex/Gender, Customized||participants|Number|11|11.0||||||
4445432|NCT00100048|4269183|B3|Female (Cohort II)||Sex/Gender, Customized||participants|Number|4|4.0||||||
4445433|NCT00100048|4269184|B2|Female (Cohort II)||Sex/Gender, Customized||participants|Number|10|10.0||||||
4445434|NCT00100048|4269185|B1|Female (Cohort II)||Sex/Gender, Customized||participants|Number|6|6.0||||||
4445435|NCT00100048|4269180|B6|Male (Cohort I)||Sex/Gender, Customized||participants|Number|33|33.0||||||
4445436|NCT00100048|4269181|B5|Male (Cohort I)||Sex/Gender, Customized||participants|Number|6|6.0||||||
4445437|NCT00100048|4269182|B4|Male (Cohort I)||Sex/Gender, Customized||participants|Number|8|8.0||||||
4445438|NCT00100048|4269183|B3|Male (Cohort I)||Sex/Gender, Customized||participants|Number|6|6.0||||||
4445439|NCT00100048|4269184|B2|Male (Cohort I)||Sex/Gender, Customized||participants|Number|6|6.0||||||
4445440|NCT00100048|4269185|B1|Male (Cohort I)||Sex/Gender, Customized||participants|Number|7|7.0||||||
4445441|NCT00100048|4269180|B6|Female (Cohort I)||Sex/Gender, Customized||participants|Number|2|2.0||||||
4445442|NCT00100048|4269181|B5|Female (Cohort I)||Sex/Gender, Customized||participants|Number|1|1.0||||||
4445443|NCT00100048|4269182|B4|Female (Cohort I)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4445444|NCT00100048|4269183|B3|Female (Cohort I)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4445445|NCT00100048|4269184|B2|Female (Cohort I)||Sex/Gender, Customized||participants|Number|1|1.0||||||
4445446|NCT00100048|4269185|B1|Female (Cohort I)||Sex/Gender, Customized||participants|Number|0|0.0||||||
4445503|NCT00099632|4269309|B4|||Screening HIV-1 RNA Continuous||log10 copies/mL|Mean|3.50|3.5|Standard Deviation|0.88|0.88|||
4445447|NCT00100048|4269180|B6|Cohort I & II Combined||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|36|36.0|Full Range|||19.0|68.0|
4445448|NCT00100048|4269181|B5|Cohort I & II Combined||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|36|36.0|Full Range|||22.0|54.0|
4445449|NCT00100048|4269182|B4|Cohort I & II Combined||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|37|37.0|Full Range|||20.0|49.0|
4445450|NCT00100048|4269183|B3|Cohort I & II Combined||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|36|36.0|Full Range|||19.0|55.0|
4445451|NCT00100048|4269184|B2|Cohort I & II Combined||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|34|34.0|Full Range|||21.0|57.0|
4445452|NCT00100048|4269185|B1|Cohort I & II Combined||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|37|37.0|Full Range|||19.0|68.0|
4445453|NCT00100048|4269180|B6|Cohort II||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|35|35.0|Full Range|||19.0|58.0|
4445454|NCT00100048|4269181|B5|Cohort II||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|36|36.0|Full Range|||22.0|54.0|
4445455|NCT00100048|4269182|B4|Cohort II||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|36|36.0|Full Range|||20.0|49.0|
4445456|NCT00100048|4269183|B3|Cohort II||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|34|34.0|Full Range|||19.0|50.0|
4445457|NCT00100048|4269184|B2|Cohort II||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|31|31.0|Full Range|||21.0|56.0|
4445458|NCT00100048|4269185|B1|Cohort II||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|34|34.0|Full Range|||19.0|58.0|
4445459|NCT00100048|4269180|B6|Cohort I||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|40|40.0|Full Range|||21.0|68.0|
4445504|NCT00099632|4269310|B3|||Screening HIV-1 RNA Continuous||log10 copies/mL|Mean|3.54|3.54|Standard Deviation|0.82|0.82|||
4445460|NCT00100048|4269181|B5|Cohort I||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|36|36.0|Full Range|||21.0|51.0|
4445461|NCT00100048|4269182|B4|Cohort I||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|39|39.0|Full Range|||30.0|49.0|
4445462|NCT00100048|4269183|B3|Cohort I||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|41|41.0|Full Range|||25.0|55.0|
4445463|NCT00100048|4269184|B2|Cohort I||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|37|37.0|Full Range|||22.0|57.0|
4445464|NCT00100048|4269185|B1|Cohort I||Age|"Cohort I Participants: MK0518 100 mg b.i.d. (7); MK0518 200 mg b.i.d. (7); MK0518 400 mg b.i.d. (6); MK0518 600 mg b.i.d. (8); Placebo Cohort (7)~Cohort II Participants: MK0518 100 mg b.i.d. (33); MK0518 200 mg b.i.d. (33); MK0518 400 mg b.i.d. (35); MK0518 600 mg b.i.d. (34); Efavirenz 600 mg q.d. (34)~Cohort I & II Participants Combined: MK0518 100 mg b.i.d. (39); MK0518 200 mg b.i.d. (40); MK0518 400 mg b.i.d. (41); MK0518 600 mg b.i.d. (40); Efavirenz 600 mg q.d. (38)"|Years|Mean|46|46.0|Full Range|||31.0|68.0|
4445465|NCT00099983|4269297|B3|United States||Region of Enrollment||participants|Number|267|267.0||||||
4445466|NCT00099983|4269298|B2|United States||Region of Enrollment||participants|Number|134|134.0||||||
4445467|NCT00099983|4269299|B1|United States||Region of Enrollment||participants|Number|133|133.0||||||
4445468|NCT00099983|4269297|B3||Male|Sex: Female, Male||Participants|Count of Participants|258|258.0||||||
4445469|NCT00099983|4269298|B2||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4445470|NCT00099983|4269299|B1||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4445471|NCT00099983|4269297|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4445472|NCT00099983|4269298|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4445473|NCT00099983|4269299|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4445474|NCT00099983|4269297|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|10.7|10.7|||
4445475|NCT00099983|4269298|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|10.6|10.6|||
4445476|NCT00099983|4269299|B1|||Age||years|Mean|54.3|54.3|Standard Deviation|10.8|10.8|||
4445477|NCT00099983|4269297|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4445478|NCT00099983|4269298|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4445479|NCT00099983|4269299|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4445480|NCT00099983|4269297|B3||Between 18 and 65 years|Age||Participants|Count of Participants|267|267.0||||||
4445481|NCT00099983|4269298|B2||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
4445482|NCT00099983|4269299|B1||Between 18 and 65 years|Age||Participants|Count of Participants|133|133.0||||||
4445483|NCT00099983|4269297|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445484|NCT00099983|4269298|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445485|NCT00099983|4269299|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445486|NCT00099632|4269306|B7|no||Actual ZDV exposure during pregnancy||participants|Number|155|155.0||||||
4445487|NCT00099632|4269307|B6|no||Actual ZDV exposure during pregnancy||participants|Number|26|26.0||||||
4445488|NCT00099632|4269308|B5|no||Actual ZDV exposure during pregnancy||participants|Number|28|28.0||||||
4445489|NCT00099632|4269309|B4|no||Actual ZDV exposure during pregnancy||participants|Number|25|25.0||||||
4445490|NCT00099632|4269310|B3|no||Actual ZDV exposure during pregnancy||participants|Number|28|28.0||||||
4445491|NCT00099632|4269311|B2|no||Actual ZDV exposure during pregnancy||participants|Number|21|21.0||||||
4445492|NCT00099632|4269312|B1|no||Actual ZDV exposure during pregnancy||participants|Number|27|27.0||||||
4445493|NCT00099632|4269306|B7|yes||Actual ZDV exposure during pregnancy||participants|Number|267|267.0||||||
4445494|NCT00099632|4269307|B6|yes||Actual ZDV exposure during pregnancy||participants|Number|42|42.0||||||
4445495|NCT00099632|4269308|B5|yes||Actual ZDV exposure during pregnancy||participants|Number|43|43.0||||||
4445496|NCT00099632|4269309|B4|yes||Actual ZDV exposure during pregnancy||participants|Number|42|42.0||||||
4445497|NCT00099632|4269310|B3|yes||Actual ZDV exposure during pregnancy||participants|Number|47|47.0||||||
4445498|NCT00099632|4269311|B2|yes||Actual ZDV exposure during pregnancy||participants|Number|47|47.0||||||
4445499|NCT00099632|4269312|B1|yes||Actual ZDV exposure during pregnancy||participants|Number|46|46.0||||||
4445500|NCT00099632|4269306|B7|||Screening HIV-1 RNA Continuous||log10 copies/mL|Mean|3.56|3.56|Standard Deviation|0.90|0.9|||
4445501|NCT00099632|4269307|B6|||Screening HIV-1 RNA Continuous||log10 copies/mL|Mean|3.66|3.66|Standard Deviation|0.92|0.92|||
4445502|NCT00099632|4269308|B5|||Screening HIV-1 RNA Continuous||log10 copies/mL|Mean|3.63|3.63|Standard Deviation|0.90|0.9|||
4445505|NCT00099632|4269311|B2|||Screening HIV-1 RNA Continuous||log10 copies/mL|Mean|3.55|3.55|Standard Deviation|0.90|0.9|||
4445506|NCT00099632|4269312|B1|||Screening HIV-1 RNA Continuous||log10 copies/mL|Mean|3.50|3.5|Standard Deviation|1.01|1.01|||
4445507|NCT00099632|4269306|B7|Missing/Unknown||Screening HIV-1 RNA Categorical||participants|Number|2|2.0||||||
4445508|NCT00099632|4269307|B6|Missing/Unknown||Screening HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4445509|NCT00099632|4269308|B5|Missing/Unknown||Screening HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4445510|NCT00099632|4269309|B4|Missing/Unknown||Screening HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4445511|NCT00099632|4269310|B3|Missing/Unknown||Screening HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4445512|NCT00099632|4269311|B2|Missing/Unknown||Screening HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4445513|NCT00099632|4269312|B1|Missing/Unknown||Screening HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4445514|NCT00099632|4269306|B7|>=750000 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4445515|NCT00099632|4269307|B6|>=750000 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4445516|NCT00099632|4269308|B5|>=750000 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4445517|NCT00099632|4269309|B4|>=750000 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4445518|NCT00099632|4269310|B3|>=750000 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4445519|NCT00099632|4269311|B2|>=750000 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|0|0.0||||||
4445520|NCT00099632|4269312|B1|>=750000 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|1|1.0||||||
4445521|NCT00099632|4269306|B7|100000-749999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|28|28.0||||||
4445522|NCT00099632|4269307|B6|100000-749999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|4|4.0||||||
4445523|NCT00099632|4269308|B5|100000-749999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|4|4.0||||||
4445524|NCT00099632|4269309|B4|100000-749999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|5|5.0||||||
4445525|NCT00099632|4269310|B3|100000-749999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|4|4.0||||||
4445526|NCT00099632|4269311|B2|100000-749999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|3|3.0||||||
4445527|NCT00099632|4269312|B1|100000-749999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|8|8.0||||||
4445528|NCT00099632|4269306|B7|10000-99999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|112|112.0||||||
4445529|NCT00099632|4269307|B6|10000-99999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|26|26.0||||||
4445530|NCT00099632|4269308|B5|10000-99999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|20|20.0||||||
4445531|NCT00099632|4269309|B4|10000-99999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|14|14.0||||||
4445532|NCT00099632|4269310|B3|10000-99999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|18|18.0||||||
4445533|NCT00099632|4269311|B2|10000-99999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|17|17.0||||||
4445534|NCT00099632|4269312|B1|10000-99999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|17|17.0||||||
4445535|NCT00099632|4269306|B7|1000-9999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|148|148.0||||||
4445536|NCT00099632|4269307|B6|1000-9999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|18|18.0||||||
4445537|NCT00099632|4269308|B5|1000-9999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|29|29.0||||||
4445538|NCT00099632|4269309|B4|1000-9999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|25|25.0||||||
4445539|NCT00099632|4269310|B3|1000-9999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|33|33.0||||||
4445540|NCT00099632|4269311|B2|1000-9999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|26|26.0||||||
4445541|NCT00099632|4269312|B1|1000-9999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|17|17.0||||||
4445542|NCT00099632|4269306|B7|401-999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|48|48.0||||||
4445543|NCT00099632|4269307|B6|401-999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|4|4.0||||||
4445544|NCT00099632|4269308|B5|401-999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|6|6.0||||||
4445545|NCT00099632|4269309|B4|401-999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|11|11.0||||||
4445546|NCT00099632|4269310|B3|401-999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|7|7.0||||||
4445547|NCT00099632|4269311|B2|401-999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|8|8.0||||||
4445548|NCT00099632|4269312|B1|401-999 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|12|12.0||||||
4445549|NCT00099632|4269306|B7|<=400 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|83|83.0||||||
4445550|NCT00099632|4269307|B6|<=400 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|16|16.0||||||
4445551|NCT00099632|4269308|B5|<=400 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|12|12.0||||||
4445552|NCT00099632|4269309|B4|<=400 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|12|12.0||||||
4445553|NCT00099632|4269310|B3|<=400 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|13|13.0||||||
4445554|NCT00099632|4269311|B2|<=400 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|13|13.0||||||
4445555|NCT00099632|4269312|B1|<=400 copies/mL||Screening HIV-1 RNA Categorical||participants|Number|17|17.0||||||
4445556|NCT00099632|4269306|B7|||Screening CD4 count Continuous||cells/mm^3|Mean|545|545.0|Standard Deviation|216|216.0|||
4445557|NCT00099632|4269307|B6|||Screening CD4 count Continuous||cells/mm^3|Mean|566|566.0|Standard Deviation|249|249.0|||
4445558|NCT00099632|4269308|B5|||Screening CD4 count Continuous||cells/mm^3|Mean|505|505.0|Standard Deviation|205|205.0|||
4445559|NCT00099632|4269309|B4|||Screening CD4 count Continuous||cells/mm^3|Mean|545|545.0|Standard Deviation|191|191.0|||
4445560|NCT00099632|4269310|B3|||Screening CD4 count Continuous||cells/mm^3|Mean|537|537.0|Standard Deviation|186|186.0|||
4445561|NCT00099632|4269311|B2|||Screening CD4 count Continuous||cells/mm^3|Mean|585|585.0|Standard Deviation|215|215.0|||
4445562|NCT00099632|4269312|B1|||Screening CD4 count Continuous||cells/mm^3|Mean|538|538.0|Standard Deviation|244|244.0|||
4445563|NCT00099632|4269306|B7|>=500 cells/mm^3||Screening CD4 count Categorical||participants|Number|203|203.0||||||
4445564|NCT00099632|4269307|B6|>=500 cells/mm^3||Screening CD4 count Categorical||participants|Number|33|33.0||||||
4445565|NCT00099632|4269308|B5|>=500 cells/mm^3||Screening CD4 count Categorical||participants|Number|26|26.0||||||
4445566|NCT00099632|4269309|B4|>=500 cells/mm^3||Screening CD4 count Categorical||participants|Number|32|32.0||||||
4445567|NCT00099632|4269310|B3|>=500 cells/mm^3||Screening CD4 count Categorical||participants|Number|38|38.0||||||
4445568|NCT00099632|4269311|B2|>=500 cells/mm^3||Screening CD4 count Categorical||participants|Number|40|40.0||||||
4445569|NCT00099632|4269312|B1|>=500 cells/mm^3||Screening CD4 count Categorical||participants|Number|34|34.0||||||
4445570|NCT00099632|4269306|B7|350-499 cells/mm^3||Screening CD4 count Categorical||participants|Number|150|150.0||||||
4445571|NCT00099632|4269307|B6|350-499 cells/mm^3||Screening CD4 count Categorical||participants|Number|22|22.0||||||
4445572|NCT00099632|4269308|B5|350-499 cells/mm^3||Screening CD4 count Categorical||participants|Number|25|25.0||||||
4445573|NCT00099632|4269309|B4|350-499 cells/mm^3||Screening CD4 count Categorical||participants|Number|29|29.0||||||
4445574|NCT00099632|4269310|B3|350-499 cells/mm^3||Screening CD4 count Categorical||participants|Number|29|29.0||||||
4445575|NCT00099632|4269311|B2|350-499 cells/mm^3||Screening CD4 count Categorical||participants|Number|21|21.0||||||
4445576|NCT00099632|4269312|B1|350-499 cells/mm^3||Screening CD4 count Categorical||participants|Number|24|24.0||||||
4445577|NCT00099632|4269306|B7|250-349 cells/mm^3||Screening CD4 count Categorical||participants|Number|69|69.0||||||
4445578|NCT00099632|4269307|B6|250-349 cells/mm^3||Screening CD4 count Categorical||participants|Number|13|13.0||||||
4445579|NCT00099632|4269308|B5|250-349 cells/mm^3||Screening CD4 count Categorical||participants|Number|20|20.0||||||
4445580|NCT00099632|4269309|B4|250-349 cells/mm^3||Screening CD4 count Categorical||participants|Number|6|6.0||||||
4445581|NCT00099632|4269310|B3|250-349 cells/mm^3||Screening CD4 count Categorical||participants|Number|8|8.0||||||
4445582|NCT00099632|4269311|B2|250-349 cells/mm^3||Screening CD4 count Categorical||participants|Number|7|7.0||||||
4445583|NCT00099632|4269312|B1|250-349 cells/mm^3||Screening CD4 count Categorical||participants|Number|15|15.0||||||
4445584|NCT00099632|4269306|B7|||Gestational age at NVP dosing, Continuous||weeks|Mean|38|38.0|Standard Deviation|2|2.0|||
4445585|NCT00099632|4269307|B6|||Gestational age at NVP dosing, Continuous||weeks|Mean|38|38.0|Standard Deviation|2|2.0|||
4445586|NCT00099632|4269308|B5|||Gestational age at NVP dosing, Continuous||weeks|Mean|38|38.0|Standard Deviation|2|2.0|||
4445587|NCT00099632|4269309|B4|||Gestational age at NVP dosing, Continuous||weeks|Mean|38|38.0|Standard Deviation|3|3.0|||
4445588|NCT00099632|4269310|B3|||Gestational age at NVP dosing, Continuous||weeks|Mean|38|38.0|Standard Deviation|2|2.0|||
4445589|NCT00099632|4269311|B2|||Gestational age at NVP dosing, Continuous||weeks|Mean|39|39.0|Standard Deviation|2|2.0|||
4445590|NCT00099632|4269312|B1|||Gestational age at NVP dosing, Continuous||weeks|Mean|38|38.0|Standard Deviation|2|2.0|||
4445591|NCT00099632|4269306|B7|India||Region of Enrollment||participants|Number|104|104.0||||||
4445592|NCT00099632|4269307|B6|India||Region of Enrollment||participants|Number|16|16.0||||||
4445593|NCT00099632|4269308|B5|India||Region of Enrollment||participants|Number|16|16.0||||||
4445594|NCT00099632|4269309|B4|India||Region of Enrollment||participants|Number|19|19.0||||||
4445595|NCT00099632|4269310|B3|India||Region of Enrollment||participants|Number|20|20.0||||||
4445596|NCT00099632|4269311|B2|India||Region of Enrollment||participants|Number|18|18.0||||||
4445597|NCT00099632|4269312|B1|India||Region of Enrollment||participants|Number|15|15.0||||||
4445598|NCT00099632|4269306|B7|Malawi||Region of Enrollment||participants|Number|85|85.0||||||
4445599|NCT00099632|4269307|B6|Malawi||Region of Enrollment||participants|Number|15|15.0||||||
4445600|NCT00099632|4269308|B5|Malawi||Region of Enrollment||participants|Number|17|17.0||||||
4445601|NCT00099632|4269309|B4|Malawi||Region of Enrollment||participants|Number|12|12.0||||||
4445602|NCT00099632|4269310|B3|Malawi||Region of Enrollment||participants|Number|14|14.0||||||
4445603|NCT00099632|4269311|B2|Malawi||Region of Enrollment||participants|Number|14|14.0||||||
4445604|NCT00099632|4269312|B1|Malawi||Region of Enrollment||participants|Number|13|13.0||||||
4445605|NCT00099632|4269306|B7|South Africa||Region of Enrollment||participants|Number|60|60.0||||||
4445606|NCT00099632|4269307|B6|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4445607|NCT00099632|4269308|B5|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4445608|NCT00099632|4269309|B4|South Africa||Region of Enrollment||participants|Number|9|9.0||||||
4445609|NCT00099632|4269310|B3|South Africa||Region of Enrollment||participants|Number|10|10.0||||||
4445610|NCT00099632|4269311|B2|South Africa||Region of Enrollment||participants|Number|8|8.0||||||
4445611|NCT00099632|4269312|B1|South Africa||Region of Enrollment||participants|Number|13|13.0||||||
4445612|NCT00099632|4269306|B7|Uganda||Region of Enrollment||participants|Number|101|101.0||||||
4445613|NCT00099632|4269307|B6|Uganda||Region of Enrollment||participants|Number|16|16.0||||||
4445614|NCT00099632|4269308|B5|Uganda||Region of Enrollment||participants|Number|17|17.0||||||
4445615|NCT00099632|4269309|B4|Uganda||Region of Enrollment||participants|Number|17|17.0||||||
4445616|NCT00099632|4269310|B3|Uganda||Region of Enrollment||participants|Number|18|18.0||||||
4445617|NCT00099632|4269311|B2|Uganda||Region of Enrollment||participants|Number|16|16.0||||||
4445618|NCT00099632|4269312|B1|Uganda||Region of Enrollment||participants|Number|17|17.0||||||
4445619|NCT00099632|4269306|B7|Tanzania||Region of Enrollment||participants|Number|14|14.0||||||
4445620|NCT00099632|4269307|B6|Tanzania||Region of Enrollment||participants|Number|2|2.0||||||
4445621|NCT00099632|4269308|B5|Tanzania||Region of Enrollment||participants|Number|2|2.0||||||
4445622|NCT00099632|4269309|B4|Tanzania||Region of Enrollment||participants|Number|3|3.0||||||
4445623|NCT00099632|4269310|B3|Tanzania||Region of Enrollment||participants|Number|3|3.0||||||
4445624|NCT00099632|4269311|B2|Tanzania||Region of Enrollment||participants|Number|1|1.0||||||
4445625|NCT00099632|4269312|B1|Tanzania||Region of Enrollment||participants|Number|3|3.0||||||
4445626|NCT00099632|4269306|B7|Haiti||Region of Enrollment||participants|Number|58|58.0||||||
4445627|NCT00099632|4269307|B6|Haiti||Region of Enrollment||participants|Number|9|9.0||||||
4445628|NCT00099632|4269308|B5|Haiti||Region of Enrollment||participants|Number|9|9.0||||||
4445629|NCT00099632|4269309|B4|Haiti||Region of Enrollment||participants|Number|7|7.0||||||
4445630|NCT00099632|4269310|B3|Haiti||Region of Enrollment||participants|Number|10|10.0||||||
4445631|NCT00099632|4269311|B2|Haiti||Region of Enrollment||participants|Number|11|11.0||||||
4445632|NCT00099632|4269312|B1|Haiti||Region of Enrollment||participants|Number|12|12.0||||||
4445633|NCT00099632|4269306|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4445634|NCT00099632|4269307|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4445635|NCT00099632|4269308|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4445636|NCT00099632|4269309|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4445637|NCT00099632|4269310|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4445638|NCT00099632|4269311|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4445639|NCT00099632|4269312|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4445640|NCT00099632|4269306|B7||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4445641|NCT00099632|4269307|B6||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4445642|NCT00099632|4269308|B5||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4445643|NCT00099632|4269309|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4445644|NCT00099632|4269310|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4445645|NCT00099632|4269311|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4445646|NCT00099632|4269312|B1||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4445647|NCT00099632|4269306|B7|>= 40 years||Age, Customized||participants|Number|7|7.0||||||
4445648|NCT00099632|4269307|B6|>= 40 years||Age, Customized||participants|Number|1|1.0||||||
4445649|NCT00099632|4269308|B5|>= 40 years||Age, Customized||participants|Number|2|2.0||||||
4445650|NCT00099632|4269309|B4|>= 40 years||Age, Customized||participants|Number|0|0.0||||||
4445651|NCT00099632|4269310|B3|>= 40 years||Age, Customized||participants|Number|1|1.0||||||
4445652|NCT00099632|4269311|B2|>= 40 years||Age, Customized||participants|Number|1|1.0||||||
4445653|NCT00099632|4269312|B1|>= 40 years||Age, Customized||participants|Number|2|2.0||||||
4445654|NCT00099632|4269306|B7|Between 30 and 39 years||Age, Customized||participants|Number|109|109.0||||||
4445655|NCT00099632|4269307|B6|Between 30 and 39 years||Age, Customized||participants|Number|16|16.0||||||
4445656|NCT00099632|4269308|B5|Between 30 and 39 years||Age, Customized||participants|Number|19|19.0||||||
4445657|NCT00099632|4269309|B4|Between 30 and 39 years||Age, Customized||participants|Number|18|18.0||||||
4445658|NCT00099632|4269310|B3|Between 30 and 39 years||Age, Customized||participants|Number|16|16.0||||||
4445659|NCT00099632|4269311|B2|Between 30 and 39 years||Age, Customized||participants|Number|20|20.0||||||
4445660|NCT00099632|4269312|B1|Between 30 and 39 years||Age, Customized||participants|Number|20|20.0||||||
4445661|NCT00099632|4269306|B7|Between 20 and 29 years||Age, Customized||participants|Number|289|289.0||||||
4445662|NCT00099632|4269307|B6|Between 20 and 29 years||Age, Customized||participants|Number|48|48.0||||||
4445663|NCT00099632|4269308|B5|Between 20 and 29 years||Age, Customized||participants|Number|47|47.0||||||
4445664|NCT00099632|4269309|B4|Between 20 and 29 years||Age, Customized||participants|Number|46|46.0||||||
4445665|NCT00099632|4269310|B3|Between 20 and 29 years||Age, Customized||participants|Number|53|53.0||||||
4445666|NCT00099632|4269311|B2|Between 20 and 29 years||Age, Customized||participants|Number|46|46.0||||||
4445667|NCT00099632|4269312|B1|Between 20 and 29 years||Age, Customized||participants|Number|49|49.0||||||
4445668|NCT00099632|4269306|B7|Between 13 and 19 years||Age, Customized||participants|Number|17|17.0||||||
4445669|NCT00099632|4269307|B6|Between 13 and 19 years||Age, Customized||participants|Number|3|3.0||||||
4445670|NCT00099632|4269308|B5|Between 13 and 19 years||Age, Customized||participants|Number|3|3.0||||||
4445671|NCT00099632|4269309|B4|Between 13 and 19 years||Age, Customized||participants|Number|3|3.0||||||
4445672|NCT00099632|4269310|B3|Between 13 and 19 years||Age, Customized||participants|Number|5|5.0||||||
4445673|NCT00099632|4269311|B2|Between 13 and 19 years||Age, Customized||participants|Number|1|1.0||||||
4445674|NCT00099632|4269312|B1|Between 13 and 19 years||Age, Customized||participants|Number|2|2.0||||||
4445675|NCT00099632|4269306|B7|||Age||years|Mean|27|27.0|Standard Deviation|5|5.0|||
4445676|NCT00099632|4269307|B6|||Age||years|Mean|26|26.0|Standard Deviation|5|5.0|||
4445677|NCT00099632|4269308|B5|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
4445678|NCT00099632|4269309|B4|||Age||years|Mean|26|26.0|Standard Deviation|5|5.0|||
4445679|NCT00099632|4269310|B3|||Age||years|Mean|26|26.0|Standard Deviation|5|5.0|||
4445680|NCT00099632|4269311|B2|||Age||years|Mean|27|27.0|Standard Deviation|5|5.0|||
4445681|NCT00099632|4269312|B1|||Age||years|Mean|27|27.0|Standard Deviation|6|6.0|||
4445682|NCT00099437|4269355|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4445683|NCT00099437|4269356|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4445684|NCT00099437|4269357|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4445685|NCT00099437|4269355|B3||Female|Sex: Female, Male||Participants|Count of Participants|736|736.0||||||
4445686|NCT00099437|4269356|B2||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4445687|NCT00099437|4269357|B1||Female|Sex: Female, Male||Participants|Count of Participants|374|374.0||||||
4445688|NCT00099437|4269355|B3|||Age||Years|Mean|60.9|60.9|Standard Deviation|11.71|11.71|||
4445689|NCT00099437|4269356|B2|||Age||Years|Mean|61.0|61.0|Standard Deviation|11.47|11.47|||
4445690|NCT00099437|4269357|B1|||Age||Years|Mean|60.8|60.8|Standard Deviation|11.94|11.94|||
4445691|NCT00099359|4269378|B4|South Africa||Region of Enrollment||participants|Number|475|475.0||||||
4445692|NCT00099359|4269379|B3|South Africa||Region of Enrollment||participants|Number|156|156.0||||||
4445693|NCT00099359|4269380|B2|South Africa||Region of Enrollment||participants|Number|161|161.0||||||
4445694|NCT00099359|4269381|B1|South Africa||Region of Enrollment||participants|Number|158|158.0||||||
4445695|NCT00099359|4269378|B4|Brazil||Region of Enrollment||participants|Number|1219|1219.0||||||
4445696|NCT00099359|4269379|B3|Brazil||Region of Enrollment||participants|Number|402|402.0||||||
4445697|NCT00099359|4269380|B2|Brazil||Region of Enrollment||participants|Number|408|408.0||||||
4445698|NCT00099359|4269381|B1|Brazil||Region of Enrollment||participants|Number|409|409.0||||||
4445699|NCT00099359|4269378|B4|Argentina||Region of Enrollment||participants|Number|27|27.0||||||
4445700|NCT00099359|4269379|B3|Argentina||Region of Enrollment||participants|Number|11|11.0||||||
4445701|NCT00099359|4269380|B2|Argentina||Region of Enrollment||participants|Number|6|6.0||||||
4445702|NCT00099359|4269381|B1|Argentina||Region of Enrollment||participants|Number|10|10.0||||||
4445703|NCT00099359|4269378|B4|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4445704|NCT00099359|4269379|B3|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4445705|NCT00099359|4269380|B2|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4445706|NCT00099359|4269381|B1|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4445707|NCT00099359|4269378|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4445708|NCT00099359|4269379|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4445709|NCT00099359|4269380|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4445710|NCT00099359|4269381|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4445711|NCT00099359|4269378|B4||Male|Sex: Female, Male||Participants|Count of Participants|853|853.0||||||
4445712|NCT00099359|4269379|B3||Male|Sex: Female, Male||Participants|Count of Participants|293|293.0||||||
4445713|NCT00099359|4269380|B2||Male|Sex: Female, Male||Participants|Count of Participants|277|277.0||||||
4445714|NCT00099359|4269381|B1||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4445715|NCT00099359|4269378|B4||Female|Sex: Female, Male||Participants|Count of Participants|882|882.0||||||
4445716|NCT00099359|4269379|B3||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4445717|NCT00099359|4269380|B2||Female|Sex: Female, Male||Participants|Count of Participants|303|303.0||||||
4445718|NCT00099359|4269381|B1||Female|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4445719|NCT00099359|4269378|B4|Gestational Age in Weeks||Age||weeks|Mean|39|39.0|Standard Deviation|1.7|1.7|||
4445720|NCT00099359|4269379|B3|Gestational Age in Weeks||Age||weeks|Mean|39|39.0|Standard Deviation|1.7|1.7|||
4445721|NCT00099359|4269380|B2|Gestational Age in Weeks||Age||weeks|Mean|39|39.0|Standard Deviation|1.5|1.5|||
4445722|NCT00099359|4269381|B1|Gestational Age in Weeks||Age||weeks|Mean|39|39.0|Standard Deviation|1.7|1.7|||
4445723|NCT00099268|4269404|B3||Male|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
4445724|NCT00099268|4269405|B2||Male|Sex: Female, Male||Participants|Count of Participants|222|222.0||||||
4445725|NCT00099268|4269406|B1||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4445726|NCT00099268|4269404|B3||Female|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4445727|NCT00099268|4269405|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4445728|NCT00099268|4269406|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4445729|NCT00099268|4269404|B3|||Age|Baseline numbers represent the Intent-to-treat (ITT) population. Of the 747 randomized patients, one patient in each group discontinued the study without receiving a single dose of study drug and was excluded from the ITT population.|years|Mean|60.2|60.2|Standard Deviation|8.44|8.44|||
4445730|NCT00099268|4269405|B2|||Age|Baseline numbers represent the Intent-to-treat (ITT) population. Of the 747 randomized patients, one patient in each group discontinued the study without receiving a single dose of study drug and was excluded from the ITT population.|years|Mean|59.8|59.8|Standard Deviation|8.20|8.2|||
4445731|NCT00099268|4269406|B1|||Age|Baseline numbers represent the Intent-to-treat (ITT) population. Of the 747 randomized patients, one patient in each group discontinued the study without receiving a single dose of study drug and was excluded from the ITT population.|years|Mean|60.6|60.6|Standard Deviation|8.67|8.67|||
4445732|NCT00099047|4269423|B3|||serum monoclonal protein >1g/dL||participants|Number|23|23.0||||||
4445733|NCT00099047|4269424|B2|||serum monoclonal protein >1g/dL||participants|Number|12|12.0||||||
4445734|NCT00099047|4269425|B1|||serum monoclonal protein >1g/dL||participants|Number|11|11.0||||||
4445735|NCT00099047|4269423|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4445736|NCT00099047|4269424|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4445737|NCT00099047|4269425|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4445738|NCT00099047|4269423|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445739|NCT00099047|4269424|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445740|NCT00099047|4269425|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445741|NCT00099047|4269423|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445742|NCT00099047|4269424|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445743|NCT00099047|4269425|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445744|NCT00099047|4269423|B3||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4445745|NCT00099047|4269424|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4445746|NCT00099047|4269425|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4445747|NCT00099047|4269423|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4445748|NCT00099047|4269424|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4445749|NCT00099047|4269425|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445750|NCT00099047|4269423|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445751|NCT00099047|4269424|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445752|NCT00099047|4269425|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445753|NCT00099047|4269423|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445754|NCT00099047|4269424|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445755|NCT00099047|4269425|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445756|NCT00099047|4269423|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445757|NCT00099047|4269424|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445758|NCT00099047|4269425|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445759|NCT00099047|4269423|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445760|NCT00099047|4269424|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445761|NCT00099047|4269425|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445762|NCT00099047|4269423|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4445763|NCT00099047|4269424|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4445764|NCT00099047|4269425|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4445765|NCT00099047|4269423|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4445766|NCT00099047|4269424|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445767|NCT00099047|4269425|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4445768|NCT00099047|4269423|B3||Male|Gender||Participants|Count of Participants|14|14.0||||||
4445769|NCT00099047|4269424|B2||Male|Gender||Participants|Count of Participants|8|8.0||||||
4445770|NCT00099047|4269425|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4445771|NCT00099047|4269423|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
4445772|NCT00099047|4269424|B2||Female|Gender||Participants|Count of Participants|4|4.0||||||
4445773|NCT00099047|4269425|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4445774|NCT00099047|4269423|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4445775|NCT00099047|4269424|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4445776|NCT00099047|4269425|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4445777|NCT00099047|4269423|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4445778|NCT00099047|4269424|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4445779|NCT00099047|4269425|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4445780|NCT00099047|4269423|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445781|NCT00099047|4269424|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445782|NCT00099047|4269425|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445783|NCT00099021|4269432|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4445784|NCT00099021|4269432|B1||Male|Gender||Participants|Count of Participants|9|9.0||||||
4445785|NCT00099021|4269432|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
4445786|NCT00099021|4269432|B1|||Age||years|Median|56.1|56.1|Full Range|||27.0|75.0|
4445787|NCT00099021|4269432|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4445788|NCT00099021|4269432|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4445789|NCT00099021|4269432|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445790|NCT00098956|4269438|B1|Canada||Region of Enrollment||participants|Number|19|19.0||||||
4445791|NCT00098956|4269438|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4445792|NCT00098956|4269438|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4445793|NCT00098956|4269438|B1|||Age||years|Mean|59|59.0|Full Range|||51.0|73.0|
4445794|NCT00098956|4269438|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4445795|NCT00098956|4269438|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4445796|NCT00098956|4269438|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445797|NCT00098865|4269447|B1|Neuroblastoma||Disease Type||participants|Number|7|7.0||||||
4445798|NCT00098865|4269447|B1|Brain Tumor||Disease Type||participants|Number|8|8.0||||||
4445799|NCT00098865|4269447|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4445800|NCT00098865|4269447|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4445801|NCT00098865|4269447|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4445802|NCT00098865|4269447|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4445803|NCT00098865|4269447|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4445804|NCT00098865|4269447|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4445805|NCT00098839|4269453|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4445806|NCT00098839|4269454|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4445807|NCT00098839|4269455|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4445808|NCT00098839|4269453|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4445809|NCT00098839|4269454|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4445810|NCT00098839|4269455|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4445811|NCT00098839|4269453|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4445812|NCT00098839|4269454|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4445813|NCT00098839|4269455|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4445814|NCT00098839|4269453|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4445815|NCT00098839|4269454|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4445816|NCT00098839|4269455|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4445817|NCT00098839|4269453|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445818|NCT00098839|4269454|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445819|NCT00098839|4269455|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445820|NCT00098839|4269453|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4445821|NCT00098839|4269454|B2||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4445822|NCT00098839|4269455|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4445823|NCT00098839|4269453|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4445824|NCT00098839|4269454|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4445825|NCT00098839|4269455|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4445826|NCT00098839|4269453|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445827|NCT00098839|4269454|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445828|NCT00098839|4269455|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445829|NCT00098839|4269453|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4445830|NCT00098839|4269454|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4445831|NCT00098839|4269455|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445832|NCT00098839|4269453|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445833|NCT00098839|4269454|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445834|NCT00098839|4269455|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445835|NCT00098839|4269453|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4445836|NCT00098839|4269454|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4445837|NCT00098839|4269455|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4445838|NCT00098839|4269453|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4445839|NCT00098839|4269454|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4445840|NCT00098839|4269455|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4445841|NCT00098839|4269453|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4445842|NCT00098839|4269454|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4445843|NCT00098839|4269455|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4445844|NCT00098839|4269453|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4445845|NCT00098839|4269454|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4445846|NCT00098839|4269455|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4445847|NCT00098839|4269453|B3||<=18 years|Age||Participants|Count of Participants|103|103.0||||||
4445848|NCT00098839|4269454|B2||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4445849|NCT00098839|4269455|B1||<=18 years|Age||Participants|Count of Participants|48|48.0||||||
4445850|NCT00098839|4269453|B3|||Age||years|Mean|10.1|10.1|Standard Deviation|5.48|5.48|||
4445851|NCT00098839|4269454|B2|||Age||years|Mean|9.7|9.7|Standard Deviation|5.44|5.44|||
4445852|NCT00098839|4269455|B1|||Age||years|Mean|10.5|10.5|Standard Deviation|5.54|5.54|||
4445853|NCT00098813|4269467|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4445854|NCT00098813|4269467|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4445855|NCT00098813|4269467|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4445856|NCT00098813|4269467|B1|||Age||years|Mean|53.5|53.5|Standard Deviation|34.64823228|34.64823228|||
4445857|NCT00098813|4269467|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4445858|NCT00098813|4269467|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4445859|NCT00098813|4269467|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445860|NCT00098787|4269471|B4|Recurrence||Disease status||participants|Number|36|36.0||||||
4445861|NCT00098787|4269472|B3|Recurrence||Disease status||participants|Number|9|9.0||||||
4445862|NCT00098787|4269473|B2|Recurrence||Disease status||participants|Number|16|16.0||||||
4445863|NCT00098787|4269474|B1|Recurrence||Disease status||participants|Number|11|11.0||||||
4445864|NCT00098787|4269471|B4|Initial Diagnosis||Disease status||participants|Number|150|150.0||||||
4445865|NCT00098787|4269472|B3|Initial Diagnosis||Disease status||participants|Number|50|50.0||||||
4445866|NCT00098787|4269473|B2|Initial Diagnosis||Disease status||participants|Number|50|50.0||||||
4445867|NCT00098787|4269474|B1|Initial Diagnosis||Disease status||participants|Number|50|50.0||||||
4445868|NCT00098787|4269471|B4||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4445869|NCT00098787|4269472|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4445870|NCT00098787|4269473|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4445871|NCT00098787|4269474|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4445872|NCT00098787|4269471|B4||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4445873|NCT00098787|4269472|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4445874|NCT00098787|4269473|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4445875|NCT00098787|4269474|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4445876|NCT00098787|4269471|B4|||Age||years|Median|60|60.0|Full Range|||29.0|85.0|
4445877|NCT00098787|4269472|B3|||Age||years|Median|59|59.0|Full Range|||29.0|80.0|
4445878|NCT00098787|4269473|B2|||Age||years|Median|60|60.0|Full Range|||31.0|79.0|
4445879|NCT00098787|4269474|B1|||Age||years|Median|61|61.0|Full Range|||37.0|85.0|
4445880|NCT00098774|4269490|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4445881|NCT00098774|4269490|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445882|NCT00098774|4269490|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445883|NCT00098774|4269490|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4445884|NCT00098774|4269490|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445885|NCT00098774|4269490|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4445886|NCT00098774|4269490|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4445887|NCT00098774|4269490|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4445888|NCT00098774|4269490|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4445889|NCT00098774|4269490|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4445890|NCT00098774|4269490|B1|||Age||years|Median|61|61.0|Full Range|||12.0|76.0|
4445891|NCT00098748|4269497|B4||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4445892|NCT00098748|4269498|B3||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4445893|NCT00098748|4269499|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4445894|NCT00098748|4269500|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4445895|NCT00098748|4269497|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4445896|NCT00098748|4269498|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4445897|NCT00098748|4269499|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4445898|NCT00098748|4269500|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4445899|NCT00098748|4269497|B4|||Age||years|Mean|43.3|43.3|Full Range|8.2|8.2|16.0|65.0|
4445900|NCT00098748|4269498|B3|||Age||years|Mean|44.6|44.6|Full Range|8.3|8.3|23.0|65.0|
4445901|NCT00098748|4269499|B2|||Age||years|Mean|42.5|42.5|Full Range|8.0|8.0|16.0|62.0|
4445902|NCT00098748|4269500|B1|||Age||years|Mean|42.7|42.7|Full Range|8.4|8.4|16.0|59.0|
4445903|NCT00098748|4269497|B4|≥65 years||Age, Customized||participants|Number|1|1.0||||||
4445904|NCT00098748|4269498|B3|≥65 years||Age, Customized||participants|Number|1|1.0||||||
4445905|NCT00098748|4269499|B2|≥65 years||Age, Customized||participants|Number|0|0.0||||||
4445906|NCT00098748|4269500|B1|≥65 years||Age, Customized||participants|Number|0|0.0||||||
4445907|NCT00098748|4269497|B4|Between 55 and 64 years||Age, Customized||participants|Number|13|13.0||||||
4445908|NCT00098748|4269498|B3|Between 55 and 64 years||Age, Customized||participants|Number|7|7.0||||||
4445909|NCT00098748|4269499|B2|Between 55 and 64 years||Age, Customized||participants|Number|3|3.0||||||
4445910|NCT00098748|4269500|B1|Between 55 and 64 years||Age, Customized||participants|Number|3|3.0||||||
4445911|NCT00098748|4269497|B4|Between 45 and 54 years||Age, Customized||participants|Number|66|66.0||||||
4445912|NCT00098748|4269498|B3|Between 45 and 54 years||Age, Customized||participants|Number|20|20.0||||||
4445913|NCT00098748|4269499|B2|Between 45 and 54 years||Age, Customized||participants|Number|21|21.0||||||
4445914|NCT00098748|4269500|B1|Between 45 and 54 years||Age, Customized||participants|Number|25|25.0||||||
4445915|NCT00098748|4269497|B4|Between 35 and 44 years||Age, Customized||participants|Number|92|92.0||||||
4445916|NCT00098748|4269498|B3|Between 35 and 44 years||Age, Customized||participants|Number|31|31.0||||||
4445917|NCT00098748|4269499|B2|Between 35 and 44 years||Age, Customized||participants|Number|31|31.0||||||
4445918|NCT00098748|4269500|B1|Between 35 and 44 years||Age, Customized||participants|Number|30|30.0||||||
4445919|NCT00098748|4269497|B4|Between 25 and 34 years||Age, Customized||participants|Number|7|7.0||||||
4445920|NCT00098748|4269498|B3|Between 25 and 34 years||Age, Customized||participants|Number|2|2.0||||||
4445921|NCT00098748|4269499|B2|Between 25 and 34 years||Age, Customized||participants|Number|3|3.0||||||
4445922|NCT00098748|4269500|B1|Between 25 and 34 years||Age, Customized||participants|Number|2|2.0||||||
4445923|NCT00098748|4269497|B4|Between 18 and 24 years||Age, Customized||participants|Number|3|3.0||||||
4445924|NCT00098748|4269498|B3|Between 18 and 24 years||Age, Customized||participants|Number|1|1.0||||||
4445925|NCT00098748|4269499|B2|Between 18 and 24 years||Age, Customized||participants|Number|1|1.0||||||
4445926|NCT00098748|4269500|B1|Between 18 and 24 years||Age, Customized||participants|Number|1|1.0||||||
4445927|NCT00098748|4269497|B4|<18 years||Age, Customized||participants|Number|4|4.0||||||
4445928|NCT00098748|4269498|B3|<18 years||Age, Customized||participants|Number|0|0.0||||||
4445929|NCT00098748|4269499|B2|<18 years||Age, Customized||participants|Number|2|2.0||||||
4445930|NCT00098748|4269500|B1|<18 years||Age, Customized||participants|Number|2|2.0||||||
4445931|NCT00098722|4269555|B4||Male|Sex: Female, Male|Out of a total of 474 participants, data for baseline measure (gender) was available for 464 participants who were treated.|Participants|Count of Participants|402|402.0||||||
4445932|NCT00098722|4269556|B3||Male|Sex: Female, Male|Out of a total of 474 participants, data for baseline measure (gender) was available for 464 participants who were treated.|Participants|Count of Participants|79|79.0||||||
4445933|NCT00098722|4269557|B2||Male|Sex: Female, Male|Out of a total of 474 participants, data for baseline measure (gender) was available for 464 participants who were treated.|Participants|Count of Participants|170|170.0||||||
4445934|NCT00098722|4269558|B1||Male|Sex: Female, Male|Out of a total of 474 participants, data for baseline measure (gender) was available for 464 participants who were treated.|Participants|Count of Participants|153|153.0||||||
4445935|NCT00098722|4269555|B4||Female|Sex: Female, Male|Out of a total of 474 participants, data for baseline measure (gender) was available for 464 participants who were treated.|Participants|Count of Participants|62|62.0||||||
4445936|NCT00098722|4269556|B3||Female|Sex: Female, Male|Out of a total of 474 participants, data for baseline measure (gender) was available for 464 participants who were treated.|Participants|Count of Participants|12|12.0||||||
4445937|NCT00098722|4269557|B2||Female|Sex: Female, Male|Out of a total of 474 participants, data for baseline measure (gender) was available for 464 participants who were treated.|Participants|Count of Participants|21|21.0||||||
4445938|NCT00098722|4269558|B1||Female|Sex: Female, Male|Out of a total of 474 participants, data for baseline measure (gender) was available for 464 participants who were treated.|Participants|Count of Participants|29|29.0||||||
4445939|NCT00098722|4269555|B4|Greater than or equal to 65 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|10|10.0||||||
4445940|NCT00098722|4269556|B3|Greater than or equal to 65 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|2|2.0||||||
4445941|NCT00098722|4269557|B2|Greater than or equal to 65 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|3|3.0||||||
4445942|NCT00098722|4269558|B1|Greater than or equal to 65 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|5|5.0||||||
4445943|NCT00098722|4269555|B4|55 to 64 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|67|67.0||||||
4445944|NCT00098722|4269556|B3|55 to 64 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|11|11.0||||||
4445945|NCT00098722|4269557|B2|55 to 64 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|37|37.0||||||
4445946|NCT00098722|4269558|B1|55 to 64 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|19|19.0||||||
4445947|NCT00098722|4269555|B4|45 to 54 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|165|165.0||||||
4445948|NCT00098722|4269556|B3|45 to 54 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|32|32.0||||||
4445949|NCT00098722|4269557|B2|45 to 54 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|70|70.0||||||
4445950|NCT00098722|4269558|B1|45 to 54 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|63|63.0||||||
4445951|NCT00098722|4269555|B4|35 to 44 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|196|196.0||||||
4445952|NCT00098722|4269556|B3|35 to 44 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|40|40.0||||||
4445953|NCT00098722|4269557|B2|35 to 44 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|71|71.0||||||
4445954|NCT00098722|4269558|B1|35 to 44 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|85|85.0||||||
4445955|NCT00098722|4269555|B4|25 to 34 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|23|23.0||||||
4445956|NCT00098722|4269556|B3|25 to 34 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|6|6.0||||||
4445957|NCT00098722|4269557|B2|25 to 34 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|9|9.0||||||
4445958|NCT00098722|4269558|B1|25 to 34 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|8|8.0||||||
4445959|NCT00098722|4269555|B4|18 to 24 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|2|2.0||||||
4445960|NCT00098722|4269556|B3|18 to 24 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|0|0.0||||||
4445961|NCT00098722|4269557|B2|18 to 24 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|1|1.0||||||
4445962|NCT00098722|4269558|B1|18 to 24 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|1|1.0||||||
4445963|NCT00098722|4269555|B4|Less than 18 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|1|1.0||||||
4445964|NCT00098722|4269556|B3|Less than 18 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|0|0.0||||||
4445965|NCT00098722|4269557|B2|Less than 18 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|0|0.0||||||
4445966|NCT00098722|4269558|B1|Less than 18 years||Age, Customized|Out of a total of 474 participants, data for baseline measure (age) was available for 464 participants who were treated.|participants|Number|1|1.0||||||
4445967|NCT00098670|4269627|B1|Stage III-IV||Rai Stage|Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity. Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly, Rai Stage III: Lymphocytosis and anemia, Rai Stage IV: Lymphocytosis and thrombocytopenia|participants|Number|30|30.0||||||
4445968|NCT00098670|4269627|B1|Stage I-II||Rai Stage|Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity. Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly, Rai Stage III: Lymphocytosis and anemia, Rai Stage IV: Lymphocytosis and thrombocytopenia|participants|Number|71|71.0||||||
4445969|NCT00098670|4269627|B1|Stage 0||Rai Stage|Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity. Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis and lymphadenopathy, Rai Stage II: Lymphocytosis and hepatomegaly +/- splenomegaly, Rai Stage III: Lymphocytosis and anemia, Rai Stage IV: Lymphocytosis and thrombocytopenia|participants|Number|1|1.0||||||
4445970|NCT00098670|4269627|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4445971|NCT00098670|4269627|B1||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4445972|NCT00098670|4269627|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4445973|NCT00098670|4269627|B1|||Age||years|Median|61|61.0|Full Range|||23.0|82.0|
4445974|NCT00098475|4269636|B3||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4445975|NCT00098475|4269637|B2||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4445976|NCT00098475|4269638|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4445977|NCT00098475|4269636|B3||Female|Sex: Female, Male||Participants|Count of Participants|192|192.0||||||
4445978|NCT00098475|4269637|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4445979|NCT00098475|4269638|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4445980|NCT00098475|4269636|B3|||Age||years|Median|65|65.0|Full Range|||35.0|87.0|
4445981|NCT00098475|4269637|B2|||Age||years|Median|65|65.0|Full Range|||35.0|85.0|
4445982|NCT00098475|4269638|B1|||Age||years|Median|66|66.0|Full Range|||36.0|87.0|
4445983|NCT00098371|4269653|B1|United States||Region of Enrollment||participants|Number|64|64.0||||||
4445984|NCT00098371|4269653|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4445985|NCT00098371|4269653|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4445986|NCT00098371|4269653|B1|||Age||years|Median|60|60.0|Full Range|||31.0|82.0|
4445987|NCT00098371|4269653|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4445988|NCT00098371|4269653|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4445989|NCT00098371|4269653|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4445990|NCT00098345|4269678|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4445991|NCT00098345|4269678|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4445992|NCT00098345|4269678|B1|||Age||years|Mean|48.7|48.7|Full Range|||20.0|77.0|
4445993|NCT00098306|4269688|B4||Male|Sex: Female, Male|Out of a total of 601 participants, data for baseline measure (gender) was available for 585 participants who were treated.|Participants|Count of Participants|528|528.0||||||
4445994|NCT00098306|4269689|B3||Male|Sex: Female, Male|Out of a total of 601 participants, data for baseline measure (gender) was available for 585 participants who were treated.|Participants|Count of Participants|106|106.0||||||
4445995|NCT00098306|4269690|B2||Male|Sex: Female, Male|Out of a total of 601 participants, data for baseline measure (gender) was available for 585 participants who were treated.|Participants|Count of Participants|212|212.0||||||
4445996|NCT00098306|4269691|B1||Male|Sex: Female, Male|Out of a total of 601 participants, data for baseline measure (gender) was available for 585 participants who were treated.|Participants|Count of Participants|210|210.0||||||
4445997|NCT00098306|4269688|B4||Female|Sex: Female, Male|Out of a total of 601 participants, data for baseline measure (gender) was available for 585 participants who were treated.|Participants|Count of Participants|57|57.0||||||
4445998|NCT00098306|4269689|B3||Female|Sex: Female, Male|Out of a total of 601 participants, data for baseline measure (gender) was available for 585 participants who were treated.|Participants|Count of Participants|12|12.0||||||
4446034|NCT00098293|4269761|B3||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4445999|NCT00098306|4269690|B2||Female|Sex: Female, Male|Out of a total of 601 participants, data for baseline measure (gender) was available for 585 participants who were treated.|Participants|Count of Participants|23|23.0||||||
4446000|NCT00098306|4269691|B1||Female|Sex: Female, Male|Out of a total of 601 participants, data for baseline measure (gender) was available for 585 participants who were treated.|Participants|Count of Participants|22|22.0||||||
4446001|NCT00098306|4269688|B4|Greater than or equal to 65 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|8|8.0||||||
4446002|NCT00098306|4269689|B3|Greater than or equal to 65 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|1|1.0||||||
4446003|NCT00098306|4269690|B2|Greater than or equal to 65 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|2|2.0||||||
4446004|NCT00098306|4269691|B1|Greater than or equal to 65 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|5|5.0||||||
4446005|NCT00098306|4269688|B4|55 to 64 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|73|73.0||||||
4446006|NCT00098306|4269689|B3|55 to 64 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|19|19.0||||||
4446007|NCT00098306|4269690|B2|55 to 64 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|28|28.0||||||
4446008|NCT00098306|4269691|B1|55 to 64 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|26|26.0||||||
4446009|NCT00098306|4269688|B4|45 to 54 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|228|228.0||||||
4446010|NCT00098306|4269689|B3|45 to 54 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|45|45.0||||||
4446011|NCT00098306|4269690|B2|45 to 54 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|90|90.0||||||
4446012|NCT00098306|4269691|B1|45 to 54 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|93|93.0||||||
4446013|NCT00098306|4269688|B4|35 to 44 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|253|253.0||||||
4446014|NCT00098306|4269689|B3|35 to 44 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|48|48.0||||||
4446015|NCT00098306|4269690|B2|35 to 44 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|108|108.0||||||
4446016|NCT00098306|4269691|B1|35 to 44 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|97|97.0||||||
4446017|NCT00098306|4269688|B4|25 to 34 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|22|22.0||||||
4446018|NCT00098306|4269689|B3|25 to 34 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|5|5.0||||||
4446019|NCT00098306|4269690|B2|25 to 34 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|7|7.0||||||
4446020|NCT00098306|4269691|B1|25 to 34 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|10|10.0||||||
4446021|NCT00098306|4269688|B4|18 to 24 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|1|1.0||||||
4446022|NCT00098306|4269689|B3|18 to 24 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|0|0.0||||||
4446023|NCT00098306|4269690|B2|18 to 24 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|0|0.0||||||
4446024|NCT00098306|4269691|B1|18 to 24 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|1|1.0||||||
4446025|NCT00098306|4269688|B4|Less than 18 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|0|0.0||||||
4446026|NCT00098306|4269689|B3|Less than 18 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|0|0.0||||||
4446027|NCT00098306|4269690|B2|Less than 18 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|0|0.0||||||
4446028|NCT00098306|4269691|B1|Less than 18 years||Age, Customized|Out of a total of 601 participants, data for baseline measure (age) was available for 585 participants who were treated.|participants|Number|0|0.0||||||
4446029|NCT00098293|4269760|B4||Male|Sex: Female, Male||Participants|Count of Participants|645|645.0||||||
4446030|NCT00098293|4269761|B3||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4446031|NCT00098293|4269762|B2||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4446032|NCT00098293|4269763|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4446033|NCT00098293|4269760|B4||Female|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4446035|NCT00098293|4269762|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4446036|NCT00098293|4269763|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4446037|NCT00098293|4269760|B4|Greater than or equal to 65 years||Age, Customized||participants|Number|8|8.0||||||
4446038|NCT00098293|4269761|B3|Greater than or equal to 65 years||Age, Customized||participants|Number|5|5.0||||||
4446039|NCT00098293|4269762|B2|Greater than or equal to 65 years||Age, Customized||participants|Number|2|2.0||||||
4446040|NCT00098293|4269763|B1|Greater than or equal to 65 years||Age, Customized||participants|Number|1|1.0||||||
4446041|NCT00098293|4269760|B4|55 to 64 years||Age, Customized||participants|Number|36|36.0||||||
4446042|NCT00098293|4269761|B3|55 to 64 years||Age, Customized||participants|Number|15|15.0||||||
4446043|NCT00098293|4269762|B2|55 to 64 years||Age, Customized||participants|Number|14|14.0||||||
4446044|NCT00098293|4269763|B1|55 to 64 years||Age, Customized||participants|Number|7|7.0||||||
4446045|NCT00098293|4269760|B4|45 to 54 years||Age, Customized||participants|Number|140|140.0||||||
4446046|NCT00098293|4269761|B3|45 to 54 years||Age, Customized||participants|Number|55|55.0||||||
4446047|NCT00098293|4269762|B2|45 to 54 years||Age, Customized||participants|Number|56|56.0||||||
4446048|NCT00098293|4269763|B1|45 to 54 years||Age, Customized||participants|Number|29|29.0||||||
4446049|NCT00098293|4269760|B4|35 to 44 years||Age, Customized||participants|Number|331|331.0||||||
4446050|NCT00098293|4269761|B3|35 to 44 years||Age, Customized||participants|Number|141|141.0||||||
4446051|NCT00098293|4269762|B2|35 to 44 years||Age, Customized||participants|Number|117|117.0||||||
4446052|NCT00098293|4269763|B1|35 to 44 years||Age, Customized||participants|Number|73|73.0||||||
4446053|NCT00098293|4269760|B4|25 to 34 years||Age, Customized||participants|Number|314|314.0||||||
4446054|NCT00098293|4269761|B3|25 to 34 years||Age, Customized||participants|Number|120|120.0||||||
4446055|NCT00098293|4269762|B2|25 to 34 years||Age, Customized||participants|Number|147|147.0||||||
4446056|NCT00098293|4269763|B1|25 to 34 years||Age, Customized||participants|Number|47|47.0||||||
4446057|NCT00098293|4269760|B4|18 to 24 years||Age, Customized||participants|Number|66|66.0||||||
4446058|NCT00098293|4269761|B3|18 to 24 years||Age, Customized||participants|Number|25|25.0||||||
4446059|NCT00098293|4269762|B2|18 to 24 years||Age, Customized||participants|Number|24|24.0||||||
4446060|NCT00098293|4269763|B1|18 to 24 years||Age, Customized||participants|Number|17|17.0||||||
4446061|NCT00098293|4269760|B4|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4446062|NCT00098293|4269761|B3|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4446063|NCT00098293|4269762|B2|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4446064|NCT00098293|4269763|B1|Less than 18 years||Age, Customized||participants|Number|0|0.0||||||
4446065|NCT00098254|4269820|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4446066|NCT00098254|4269820|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4446067|NCT00098254|4269820|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446068|NCT00098254|4269820|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4446069|NCT00098254|4269820|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4446070|NCT00098254|4269820|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446071|NCT00098254|4269820|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4446072|NCT00098254|4269820|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446073|NCT00098254|4269820|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4446074|NCT00098254|4269820|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4446075|NCT00098254|4269820|B1|||Age||years|Mean|61.9|61.9|Standard Deviation|12.19|12.19|||
4446076|NCT00098254|4269820|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4446077|NCT00098254|4269820|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4446078|NCT00098254|4269820|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446079|NCT00098059|4269839|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4446080|NCT00098059|4269840|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4446081|NCT00098059|4269841|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4446082|NCT00098059|4269839|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4446083|NCT00098059|4269840|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4446084|NCT00098059|4269841|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4446085|NCT00098059|4269839|B3|13 to <=18 years||Age, Customized||participants|Number|2|2.0||||||
4446086|NCT00098059|4269840|B2|13 to <=18 years||Age, Customized||participants|Number|0|0.0||||||
4446087|NCT00098059|4269841|B1|13 to <=18 years||Age, Customized||participants|Number|2|2.0||||||
4446088|NCT00098059|4269839|B3|6 to <=12 years||Age, Customized||participants|Number|26|26.0||||||
4446089|NCT00098059|4269840|B2|6 to <=12 years||Age, Customized||participants|Number|18|18.0||||||
4446090|NCT00098059|4269841|B1|6 to <=12 years||Age, Customized||participants|Number|8|8.0||||||
4446091|NCT00098059|4269839|B3|2 to <6 years||Age, Customized||participants|Number|29|29.0||||||
4446092|NCT00098059|4269840|B2|2 to <6 years||Age, Customized||participants|Number|16|16.0||||||
4446093|NCT00098059|4269841|B1|2 to <6 years||Age, Customized||participants|Number|13|13.0||||||
4446094|NCT00098059|4269839|B3|1 to <2 years||Age, Customized||participants|Number|17|17.0||||||
4446095|NCT00098059|4269840|B2|1 to <2 years||Age, Customized||participants|Number|13|13.0||||||
4446096|NCT00098059|4269841|B1|1 to <2 years||Age, Customized||participants|Number|4|4.0||||||
4446097|NCT00098020|4269886|B1|||Protein/Creatinine Ratio, Urine||g/g|Mean|8.42|8.42|Standard Deviation|4.69|4.69|||
4446098|NCT00098020|4269886|B1|||Creatinine, Urine||mg/dL|Mean|71.37|71.37|Standard Deviation|43.36|43.36|||
4446099|NCT00098020|4269886|B1|||Protein, Urine||mg/dL|Mean|626.42|626.42|Standard Deviation|642.58|642.58|||
4446100|NCT00098020|4269886|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4446101|NCT00098020|4269886|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446102|NCT00098020|4269886|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4446103|NCT00098020|4269886|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4446104|NCT00098020|4269886|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446105|NCT00098020|4269886|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446106|NCT00098020|4269886|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446107|NCT00098020|4269886|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4446108|NCT00098020|4269886|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4446109|NCT00098020|4269886|B1|||Age||years|Mean|48|48.0|Standard Deviation|12.7|12.7|||
4446110|NCT00097981|4269891|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4446111|NCT00097981|4269892|B2||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4446112|NCT00097981|4269893|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4446113|NCT00097981|4269891|B3||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4446114|NCT00097981|4269892|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4446115|NCT00097981|4269893|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4446116|NCT00097981|4269891|B3|||Age||years|Mean|60.45|60.45|Standard Deviation|10.53|10.53|||
4446117|NCT00097981|4269892|B2|||Age||years|Mean|60.62|60.62|Standard Deviation|10.79|10.79|||
4446118|NCT00097981|4269893|B1|||Age||years|Mean|60.29|60.29|Standard Deviation|10.31|10.31|||
4446119|NCT00097786|4269912|B5||Male|Sex: Female, Male|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|Participants|Count of Participants|4595|4595.0||||||
4446120|NCT00097786|4269913|B4||Male|Sex: Female, Male|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|Participants|Count of Participants|1143|1143.0||||||
4446121|NCT00097786|4269914|B3||Male|Sex: Female, Male|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|Participants|Count of Participants|1135|1135.0||||||
4446122|NCT00097786|4269915|B2||Male|Sex: Female, Male|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|Participants|Count of Participants|1175|1175.0||||||
4446123|NCT00097786|4269916|B1||Male|Sex: Female, Male|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|Participants|Count of Participants|1142|1142.0||||||
4446124|NCT00097786|4269912|B5||Female|Sex: Female, Male|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|Participants|Count of Participants|4711|4711.0||||||
4446125|NCT00097786|4269913|B4||Female|Sex: Female, Male|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|Participants|Count of Participants|1203|1203.0||||||
4446126|NCT00097786|4269914|B3||Female|Sex: Female, Male|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|Participants|Count of Participants|1194|1194.0||||||
4446127|NCT00097786|4269915|B2||Female|Sex: Female, Male|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|Participants|Count of Participants|1140|1140.0||||||
4446128|NCT00097786|4269916|B1||Female|Sex: Female, Male|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|Participants|Count of Participants|1174|1174.0||||||
4446129|NCT00097786|4269912|B5|||Age|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|years|Mean|63.8|63.8|Standard Deviation|6.84|6.84|||
4446130|NCT00097786|4269913|B4|||Age|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|years|Mean|63.9|63.9|Standard Deviation|6.88|6.88|||
4446131|NCT00097786|4269914|B3|||Age|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|years|Mean|63.8|63.8|Standard Deviation|6.82|6.82|||
4446132|NCT00097786|4269915|B2|||Age|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|years|Mean|63.7|63.7|Standard Deviation|6.91|6.91|||
4446133|NCT00097786|4269916|B1|||Age|Originally 9518 patient were enrolled and 212 excluded. So this baseline measure is based on Full analysis Set(FAS)population.|years|Mean|63.7|63.7|Standard Deviation|6.75|6.75|||
4446134|NCT00097773|4269937|B5|United States||Region of Enrollment||participants|Number|304|304.0||||||
4446135|NCT00097773|4269938|B4|United States||Region of Enrollment||participants|Number|76|76.0||||||
4446136|NCT00097773|4269939|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
4446137|NCT00097773|4269940|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4446138|NCT00097773|4269941|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4446139|NCT00097773|4269937|B5||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4446140|NCT00097773|4269938|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4446141|NCT00097773|4269939|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4446142|NCT00097773|4269940|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4446143|NCT00097773|4269941|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4446144|NCT00097773|4269937|B5||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4446145|NCT00097773|4269938|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4446146|NCT00097773|4269939|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4446147|NCT00097773|4269940|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4446148|NCT00097773|4269941|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4446149|NCT00097773|4269937|B5|||Age||years|Mean|5.7|5.7|Standard Deviation|3.51|3.51|||
4446150|NCT00097773|4269938|B4|||Age||years|Mean|5.0|5.0|Standard Deviation|3.58|3.58|||
4446151|NCT00097773|4269939|B3|||Age||years|Mean|6.0|6.0|Standard Deviation|3.74|3.74|||
4446152|NCT00097773|4269940|B2|||Age||years|Mean|5.9|5.9|Standard Deviation|3.28|3.28|||
4446153|NCT00097773|4269941|B1|||Age||years|Mean|5.8|5.8|Standard Deviation|3.43|3.43|||
4446154|NCT00097773|4269937|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446155|NCT00097773|4269938|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446156|NCT00097773|4269939|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446157|NCT00097773|4269940|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446158|NCT00097773|4269941|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446159|NCT00097773|4269937|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4446160|NCT00097773|4269938|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4446161|NCT00097773|4269939|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4446162|NCT00097773|4269940|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4446163|NCT00097773|4269941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4446164|NCT00097773|4269937|B5||<=18 years|Age||Participants|Count of Participants|304|304.0||||||
4446165|NCT00097773|4269938|B4||<=18 years|Age||Participants|Count of Participants|76|76.0||||||
4446166|NCT00097773|4269939|B3||<=18 years|Age||Participants|Count of Participants|76|76.0||||||
4446167|NCT00097773|4269940|B2||<=18 years|Age||Participants|Count of Participants|76|76.0||||||
4446168|NCT00097773|4269941|B1||<=18 years|Age||Participants|Count of Participants|76|76.0||||||
4446169|NCT00097721|4269962|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4446170|NCT00097721|4269963|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4446171|NCT00097721|4269964|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4446172|NCT00097721|4269962|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4446173|NCT00097721|4269963|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4446174|NCT00097721|4269964|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4446175|NCT00097721|4269962|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4446176|NCT00097721|4269963|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4446177|NCT00097721|4269964|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4446178|NCT00097721|4269962|B3|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4446179|NCT00097721|4269963|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4446180|NCT00097721|4269964|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4446181|NCT00097721|4269962|B3|White||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4446182|NCT00097721|4269963|B2|White||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4446183|NCT00097721|4269964|B1|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4446184|NCT00097721|4269962|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4446185|NCT00097721|4269963|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4446186|NCT00097721|4269964|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4446187|NCT00097721|4269962|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4446188|NCT00097721|4269963|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4446189|NCT00097721|4269964|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4446190|NCT00097721|4269962|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4446191|NCT00097721|4269963|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4446192|NCT00097721|4269964|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4446193|NCT00097721|4269962|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4446194|NCT00097721|4269963|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4446195|NCT00097721|4269964|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4446196|NCT00097721|4269962|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446197|NCT00097721|4269963|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446198|NCT00097721|4269964|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446199|NCT00097721|4269962|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4446200|NCT00097721|4269963|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4446201|NCT00097721|4269964|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4446202|NCT00097721|4269962|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|10.76|10.76|||
4446203|NCT00097721|4269963|B2|||Age||years|Mean|54.5|54.5|Standard Deviation|10.99|10.99|||
4446204|NCT00097721|4269964|B1|||Age||years|Mean|55.9|55.9|Standard Deviation|10.7|10.7|||
4446205|NCT00097708|4269979|B4|United States||Region of Enrollment||participants|Number|483|483.0||||||
4446206|NCT00097708|4269980|B3|United States||Region of Enrollment||participants|Number|149|149.0||||||
4446207|NCT00097708|4269981|B2|United States||Region of Enrollment||participants|Number|169|169.0||||||
4446208|NCT00097708|4269982|B1|United States||Region of Enrollment||participants|Number|165|165.0||||||
4446209|NCT00097708|4269979|B4||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4446210|NCT00097708|4269980|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4446211|NCT00097708|4269981|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4446212|NCT00097708|4269982|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4446213|NCT00097708|4269979|B4||Female|Sex: Female, Male||Participants|Count of Participants|311|311.0||||||
4446214|NCT00097708|4269980|B3||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4446215|NCT00097708|4269981|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4446216|NCT00097708|4269982|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4446217|NCT00097708|4269979|B4|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4446218|NCT00097708|4269980|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4446219|NCT00097708|4269981|B2|>=65 years||Age, Customized||participants|Number|1|1.0||||||
4446220|NCT00097708|4269982|B1|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4446221|NCT00097708|4269979|B4|40 - < 65 years||Age, Customized||participants|Number|212|212.0||||||
4446222|NCT00097708|4269980|B3|40 - < 65 years||Age, Customized||participants|Number|58|58.0||||||
4446223|NCT00097708|4269981|B2|40 - < 65 years||Age, Customized||participants|Number|78|78.0||||||
4446224|NCT00097708|4269982|B1|40 - < 65 years||Age, Customized||participants|Number|76|76.0||||||
4446225|NCT00097708|4269979|B4|< 40 years||Age, Customized||participants|Number|268|268.0||||||
4446226|NCT00097708|4269980|B3|< 40 years||Age, Customized||participants|Number|91|91.0||||||
4446227|NCT00097708|4269981|B2|< 40 years||Age, Customized||participants|Number|90|90.0||||||
4446228|NCT00097708|4269982|B1|< 40 years||Age, Customized||participants|Number|87|87.0||||||
4446229|NCT00097708|4269979|B4|||Age||years|Mean|38.8|38.8|Standard Deviation|11.72|11.72|||
4446230|NCT00097708|4269980|B3|||Age||years|Mean|38.5|38.5|Standard Deviation|11.13|11.13|||
4446231|NCT00097708|4269981|B2|||Age||years|Mean|38.9|38.9|Standard Deviation|12.02|12.02|||
4446232|NCT00097708|4269982|B1|||Age||years|Mean|39.1|39.1|Standard Deviation|12.00|12.0|||
4446233|NCT00097695|4269992|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4446234|NCT00097695|4269993|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4446235|NCT00097695|4269994|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4446236|NCT00097695|4269995|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4446237|NCT00097695|4269996|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4446238|NCT00097695|4269992|B5||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4446239|NCT00097695|4269993|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4446240|NCT00097695|4269994|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4446241|NCT00097695|4269995|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4446242|NCT00097695|4269996|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4446243|NCT00097695|4269992|B5|||Age||Years|Mean|36.6|36.6|Standard Deviation|11.5|11.5|||
4446244|NCT00097695|4269993|B4|||Age||Years|Mean|37.4|37.4|Standard Deviation|11.48|11.48|||
4446245|NCT00097695|4269994|B3|||Age||Years|Mean|47.1|47.1|Standard Deviation|13.86|13.86|||
4446246|NCT00097695|4269995|B2|||Age||Years|Mean|34.9|34.9|Standard Deviation|11.37|11.37|||
4446247|NCT00097695|4269996|B1|||Age||Years|Mean|34.8|34.8|Standard Deviation|9.81|9.81|||
4446248|NCT00097591|4270013|B3|Pacifica||Region of Enrollment||participants|Number|266|266.0||||||
4446249|NCT00097591|4270014|B2|Pacifica||Region of Enrollment||participants|Number|133|133.0||||||
4446250|NCT00097591|4270015|B1|Pacifica||Region of Enrollment||participants|Number|133|133.0||||||
4446251|NCT00097591|4270013|B3|Africa||Region of Enrollment||participants|Number|404|404.0||||||
4446252|NCT00097591|4270014|B2|Africa||Region of Enrollment||participants|Number|200|200.0||||||
4446253|NCT00097591|4270015|B1|Africa||Region of Enrollment||participants|Number|204|204.0||||||
4446254|NCT00097591|4270013|B3|Middle East||Region of Enrollment||participants|Number|1219|1219.0||||||
4446255|NCT00097591|4270014|B2|Middle East||Region of Enrollment||participants|Number|613|613.0||||||
4446256|NCT00097591|4270015|B1|Middle East||Region of Enrollment||participants|Number|606|606.0||||||
4446257|NCT00097591|4270013|B3|Europe||Region of Enrollment||participants|Number|6875|6875.0||||||
4446258|NCT00097591|4270014|B2|Europe||Region of Enrollment||participants|Number|3439|3439.0||||||
4446259|NCT00097591|4270015|B1|Europe||Region of Enrollment||participants|Number|3436|3436.0||||||
4446260|NCT00097591|4270013|B3|South America||Region of Enrollment||participants|Number|534|534.0||||||
4446261|NCT00097591|4270014|B2|South America||Region of Enrollment||participants|Number|264|264.0||||||
4446262|NCT00097591|4270015|B1|South America||Region of Enrollment||participants|Number|270|270.0||||||
4446263|NCT00097591|4270013|B3|North America||Region of Enrollment||participants|Number|4310|4310.0||||||
4446264|NCT00097591|4270014|B2|North America||Region of Enrollment||participants|Number|2146|2146.0||||||
4446265|NCT00097591|4270015|B1|North America||Region of Enrollment||participants|Number|2164|2164.0||||||
4446266|NCT00097591|4270013|B3|Other||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4446267|NCT00097591|4270014|B2|Other||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4446268|NCT00097591|4270015|B1|Other||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4446269|NCT00097591|4270013|B3|Asian||Race/Ethnicity, Customized||Participants|Number|124|124.0||||||
4446270|NCT00097591|4270014|B2|Asian||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
4446271|NCT00097591|4270015|B1|Asian||Race/Ethnicity, Customized||Participants|Number|60|60.0||||||
4446272|NCT00097591|4270013|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|525|525.0||||||
4446273|NCT00097591|4270014|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|256|256.0||||||
4446274|NCT00097591|4270015|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|269|269.0||||||
4446275|NCT00097591|4270013|B3|African||Race/Ethnicity, Customized||Participants|Number|392|392.0||||||
4446276|NCT00097591|4270014|B2|African||Race/Ethnicity, Customized||Participants|Number|187|187.0||||||
4446277|NCT00097591|4270015|B1|African||Race/Ethnicity, Customized||Participants|Number|205|205.0||||||
4446278|NCT00097591|4270013|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|12537|12537.0||||||
4446279|NCT00097591|4270014|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|6274|6274.0||||||
4446280|NCT00097591|4270015|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|6263|6263.0||||||
4446281|NCT00097591|4270013|B3||Male|Sex: Female, Male||Participants|Count of Participants|10085|10085.0||||||
4446282|NCT00097591|4270014|B2||Male|Sex: Female, Male||Participants|Count of Participants|4977|4977.0||||||
4446283|NCT00097591|4270015|B1||Male|Sex: Female, Male||Participants|Count of Participants|5108|5108.0||||||
4446284|NCT00097591|4270013|B3||Female|Sex: Female, Male||Participants|Count of Participants|3523|3523.0||||||
4446285|NCT00097591|4270014|B2||Female|Sex: Female, Male||Participants|Count of Participants|1818|1818.0||||||
4446286|NCT00097591|4270015|B1||Female|Sex: Female, Male||Participants|Count of Participants|1705|1705.0||||||
4446287|NCT00097591|4270013|B3|||Age||years|Mean|60.9|60.9|Standard Deviation|11.3|11.3|||
4446288|NCT00097591|4270014|B2|||Age||years|Mean|60.9|60.9|Standard Deviation|11.4|11.4|||
4446289|NCT00097591|4270015|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|11.2|11.2|||
4446290|NCT00097539|4270032|B8||Male|Gender||Participants|Count of Participants|42483|42483.0||||||
4446291|NCT00097539|4270033|B7||Male|Gender||Participants|Count of Participants|158|158.0||||||
4446292|NCT00097539|4270034|B6||Male|Gender||Participants|Count of Participants|4993|4993.0||||||
4446293|NCT00097539|4270035|B5||Male|Gender||Participants|Count of Participants|1514|1514.0||||||
4446294|NCT00097539|4270036|B4||Male|Gender||Participants|Count of Participants|0|0.0||||||
4446295|NCT00097539|4270037|B3||Male|Gender||Participants|Count of Participants|9306|9306.0||||||
4446296|NCT00097539|4270038|B2||Male|Gender||Participants|Count of Participants|5930|5930.0||||||
4446297|NCT00097539|4270039|B1||Male|Gender||Participants|Count of Participants|20582|20582.0||||||
4446298|NCT00097539|4270032|B8||Female|Gender||Participants|Count of Participants|22722|22722.0||||||
4446299|NCT00097539|4270033|B7||Female|Gender||Participants|Count of Participants|81|81.0||||||
4446300|NCT00097539|4270034|B6||Female|Gender||Participants|Count of Participants|3017|3017.0||||||
4446301|NCT00097539|4270035|B5||Female|Gender||Participants|Count of Participants|630|630.0||||||
4446302|NCT00097539|4270036|B4||Female|Gender||Participants|Count of Participants|5651|5651.0||||||
4446303|NCT00097539|4270037|B3||Female|Gender||Participants|Count of Participants|3213|3213.0||||||
4446304|NCT00097539|4270038|B2||Female|Gender||Participants|Count of Participants|3426|3426.0||||||
4446305|NCT00097539|4270039|B1||Female|Gender||Participants|Count of Participants|6704|6704.0||||||
4446306|NCT00097539|4270032|B8|||Age|Age was calculated as first GH dose date minus birth date. Minimum ages shown as 0.0 are less than 19 days (0.05 × 365) and have been rounded to tenths. There were some cases when the birth date and the date of first GH dose were the same.|years|Median|11.1|11.1|Full Range|||0.0|41.9|
4446307|NCT00097539|4270033|B7|||Age|Age was calculated as first GH dose date minus birth date. Minimum ages shown as 0.0 are less than 19 days (0.05 × 365) and have been rounded to tenths. There were some cases when the birth date and the date of first GH dose were the same.|years|Median|10.7|10.7|Full Range|||0.0|17.9|
4446308|NCT00097539|4270034|B6|||Age|Age was calculated as first GH dose date minus birth date. Minimum ages shown as 0.0 are less than 19 days (0.05 × 365) and have been rounded to tenths. There were some cases when the birth date and the date of first GH dose were the same.|years|Median|10.1|10.1|Full Range|||0.0|37.8|
4446309|NCT00097539|4270035|B5|||Age|Age was calculated as first GH dose date minus birth date. Minimum ages shown as 0.0 are less than 19 days (0.05 × 365) and have been rounded to tenths. There were some cases when the birth date and the date of first GH dose were the same.|years|Median|10.2|10.2|Full Range|||0.0|28.8|
4446310|NCT00097539|4270036|B4|||Age|Age was calculated as first GH dose date minus birth date. Minimum ages shown as 0.0 are less than 19 days (0.05 × 365) and have been rounded to tenths. There were some cases when the birth date and the date of first GH dose were the same.|years|Median|10.2|10.2|Full Range|||0.1|21.2|
4446311|NCT00097539|4270037|B3|||Age|Age was calculated as first GH dose date minus birth date. Minimum ages shown as 0.0 are less than 19 days (0.05 × 365) and have been rounded to tenths. There were some cases when the birth date and the date of first GH dose were the same.|years|Median|11.8|11.8|Full Range|||0.0|24.2|
4446312|NCT00097539|4270038|B2|||Age|Age was calculated as first GH dose date minus birth date. Minimum ages shown as 0.0 are less than 19 days (0.05 × 365) and have been rounded to tenths. There were some cases when the birth date and the date of first GH dose were the same.|years|Median|10.0|10.0|Full Range|||0.0|38.6|
4446313|NCT00097539|4270039|B1|||Age|Age was calculated as first GH dose date minus birth date. Minimum ages shown as 0.0 are less than 19 days (0.05 × 365) and have been rounded to tenths. There were some cases when the birth date and the date of first GH dose were the same.|years|Median|11.6|11.6|Full Range|||0.0|41.9|
4446314|NCT00097500|4270089|B3|||Duration of diabetes||years|Mean|4.88|4.88|Standard Deviation|4.28|4.28|||
4446315|NCT00097500|4270090|B2|||Duration of diabetes||years|Mean|3.97|3.97|Standard Deviation|3.62|3.62|||
4446316|NCT00097500|4270091|B1|||Duration of diabetes||years|Mean|5.72|5.72|Standard Deviation|4.70|4.7|||
4446317|NCT00097500|4270089|B3|||Glycosylated hemoglobin (HbA1c)||percentage|Mean|7.50|7.5|Standard Deviation|0.85|0.85|||
4446318|NCT00097500|4270090|B2|||Glycosylated hemoglobin (HbA1c)||percentage|Mean|7.41|7.41|Standard Deviation|0.81|0.81|||
4446319|NCT00097500|4270091|B1|||Glycosylated hemoglobin (HbA1c)||percentage|Mean|7.58|7.58|Standard Deviation|0.89|0.89|||
4446320|NCT00097500|4270089|B3|||Body weight||kg|Mean|91.44|91.44|Standard Deviation|13.03|13.03|||
4446321|NCT00097500|4270090|B2|||Body weight||kg|Mean|92.39|92.39|Standard Deviation|13.56|13.56|||
4446322|NCT00097500|4270091|B1|||Body weight||kg|Mean|90.56|90.56|Standard Deviation|12.66|12.66|||
4446323|NCT00097500|4270089|B3|||Body Mass Index (BMI)||kg/m^2|Mean|30.52|30.52|Standard Deviation|3.84|3.84|||
4446324|NCT00097500|4270090|B2|||Body Mass Index (BMI)||kg/m^2|Mean|30.13|30.13|Standard Deviation|3.49|3.49|||
4446325|NCT00097500|4270091|B1|||Body Mass Index (BMI)||kg/m^2|Mean|30.87|30.87|Standard Deviation|4.15|4.15|||
4446326|NCT00097500|4270089|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4446327|NCT00097500|4270090|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4446328|NCT00097500|4270091|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4446329|NCT00097500|4270089|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4446330|NCT00097500|4270090|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4446331|NCT00097500|4270091|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4446332|NCT00097500|4270089|B3|||Age||years|Mean|58.4|58.4|Standard Deviation|7.8|7.8|||
4446333|NCT00097500|4270090|B2|||Age||years|Mean|58.3|58.3|Standard Deviation|7.3|7.3|||
4446334|NCT00097500|4270091|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|8.4|8.4|||
4446335|NCT00097448|4270114|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4446336|NCT00097448|4270115|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4446337|NCT00097448|4270116|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4446338|NCT00097448|4270114|B3|United States||Region of Enrollment||participants|Number|249|249.0||||||
4446339|NCT00097448|4270115|B2|United States||Region of Enrollment||participants|Number|127|127.0||||||
4446340|NCT00097448|4270116|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
4446341|NCT00097448|4270114|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4446342|NCT00097448|4270115|B2||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4446343|NCT00097448|4270116|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4446344|NCT00097448|4270114|B3||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4446345|NCT00097448|4270115|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4446346|NCT00097448|4270116|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4446347|NCT00097448|4270114|B3|||Age||years|Mean|50.5|50.5|Standard Deviation|14.5|14.5|||
4446348|NCT00097448|4270115|B2|||Age||years|Mean|51|51.0|Standard Deviation|15|15.0|||
4446349|NCT00097448|4270116|B1|||Age||years|Mean|50|50.0|Standard Deviation|14|14.0|||
4446350|NCT00097448|4270114|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446351|NCT00097448|4270115|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446352|NCT00097448|4270116|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446353|NCT00097448|4270114|B3||Between 18 and 65 years|Age||Participants|Count of Participants|255|255.0||||||
4446354|NCT00097448|4270115|B2||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4446355|NCT00097448|4270116|B1||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4446356|NCT00097448|4270114|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446357|NCT00097448|4270115|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446358|NCT00097448|4270116|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446359|NCT00097370|4270123|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|67|67.0||||||
4446360|NCT00097370|4270123|B1|South Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4446361|NCT00097370|4270123|B1|East and South East Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4446362|NCT00097370|4270123|B1|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4446363|NCT00097370|4270123|B1|Arabic/North African||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4446364|NCT00097370|4270123|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4446365|NCT00097370|4270123|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4446366|NCT00097370|4270123|B1|||Age||Years|Mean|49.2|49.2|Standard Deviation|14.89|14.89|||
4446367|NCT00097253|4270140|B1|United States||Region of Enrollment||participants|Number|56|56.0||||||
4446368|NCT00097253|4270140|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4446369|NCT00097253|4270140|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4446370|NCT00097253|4270140|B1|||Age||years|Mean|24.41|24.41|Standard Deviation|6.05|6.05|||
4446371|NCT00097253|4270140|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446372|NCT00097253|4270140|B1||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4446373|NCT00097253|4270140|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446374|NCT00096993|4270155|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446375|NCT00096993|4270156|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446376|NCT00096993|4270157|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446377|NCT00096993|4270155|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4446378|NCT00096993|4270156|B2||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4446379|NCT00096993|4270157|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4446380|NCT00096993|4270155|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|11.38|11.38|||
4446381|NCT00096993|4270156|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|10.79|10.79|||
4446382|NCT00096993|4270157|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|11.94|11.94|||
4446383|NCT00096954|4270172|B3||Male|Sex: Female, Male|Baseline characteristic numbers reflect the number of participants who received at least one dose of drug. Two participants in the Xolair group and three participants in the placebo group were not dosed.|Participants|Count of Participants|102|102.0||||||
4446384|NCT00096954|4270173|B2||Male|Sex: Female, Male|Baseline characteristic numbers reflect the number of participants who received at least one dose of drug. Two participants in the Xolair group and three participants in the placebo group were not dosed.|Participants|Count of Participants|55|55.0||||||
4446385|NCT00096954|4270174|B1||Male|Sex: Female, Male|Baseline characteristic numbers reflect the number of participants who received at least one dose of drug. Two participants in the Xolair group and three participants in the placebo group were not dosed.|Participants|Count of Participants|47|47.0||||||
4446386|NCT00096954|4270172|B3||Female|Sex: Female, Male|Baseline characteristic numbers reflect the number of participants who received at least one dose of drug. Two participants in the Xolair group and three participants in the placebo group were not dosed.|Participants|Count of Participants|226|226.0||||||
4446387|NCT00096954|4270173|B2||Female|Sex: Female, Male|Baseline characteristic numbers reflect the number of participants who received at least one dose of drug. Two participants in the Xolair group and three participants in the placebo group were not dosed.|Participants|Count of Participants|116|116.0||||||
4446388|NCT00096954|4270174|B1||Female|Sex: Female, Male|Baseline characteristic numbers reflect the number of participants who received at least one dose of drug. Two participants in the Xolair group and three participants in the placebo group were not dosed.|Participants|Count of Participants|110|110.0||||||
4446389|NCT00096954|4270172|B3|||Age||years|Mean|37.1|37.1|Standard Deviation|14.9|14.9|||
4446390|NCT00096954|4270173|B2|||Age||years|Mean|38.1|38.1|Standard Deviation|15.1|15.1|||
4446391|NCT00096954|4270174|B1|||Age||years|Mean|36.0|36.0|Standard Deviation|14.7|14.7|||
4446392|NCT00096941|4270187|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446393|NCT00096941|4270187|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4446394|NCT00096941|4270187|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446395|NCT00096941|4270187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4446396|NCT00096941|4270187|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446397|NCT00096785|4270192|B3|||Hepatitis B virus DNA (HBV DNA) by Polymerase Chain Reaction (PCR)||log10 copies/mL|Mean|10.18|10.18|Standard Deviation|1.742|1.742|||
4446398|NCT00096785|4270193|B2|||Hepatitis B virus DNA (HBV DNA) by Polymerase Chain Reaction (PCR)||log10 copies/mL|Mean|9.89|9.89|Standard Deviation|1.201|1.201|||
4446399|NCT00096785|4270194|B1|||Hepatitis B virus DNA (HBV DNA) by Polymerase Chain Reaction (PCR)||log10 copies/mL|Mean|10.45|10.45|Standard Deviation|2.125|2.125|||
4446400|NCT00096785|4270192|B3|||Alanine Aminotransferease (ALT)||U/L|Mean|142.4|142.4|Standard Deviation|159.12|159.12|||
4446401|NCT00096785|4270193|B2|||Alanine Aminotransferease (ALT)||U/L|Mean|176.4|176.4|Standard Deviation|207.22|207.22|||
4446402|NCT00096785|4270194|B1|||Alanine Aminotransferease (ALT)||U/L|Mean|109.4|109.4|Standard Deviation|81.76|81.76|||
4446403|NCT00096785|4270192|B3|No prior IFN||Prior interferon (IFN)||Participants|Number|67|67.0||||||
4446404|NCT00096785|4270193|B2|No prior IFN||Prior interferon (IFN)||Participants|Number|33|33.0||||||
4446405|NCT00096785|4270194|B1|No prior IFN||Prior interferon (IFN)||Participants|Number|34|34.0||||||
4446406|NCT00096785|4270192|B3|Prior IFN||Prior interferon (IFN)||Participants|Number|2|2.0||||||
4446407|NCT00096785|4270193|B2|Prior IFN||Prior interferon (IFN)||Participants|Number|1|1.0||||||
4446408|NCT00096785|4270194|B1|Prior IFN||Prior interferon (IFN)||Participants|Number|1|1.0||||||
4446409|NCT00096785|4270192|B3|East Asia||Region of Enrollment||participants|Number|47|47.0||||||
4446410|NCT00096785|4270193|B2|East Asia||Region of Enrollment||participants|Number|21|21.0||||||
4446411|NCT00096785|4270194|B1|East Asia||Region of Enrollment||participants|Number|26|26.0||||||
4446412|NCT00096785|4270192|B3|North America||Region of Enrollment||participants|Number|22|22.0||||||
4446413|NCT00096785|4270193|B2|North America||Region of Enrollment||participants|Number|13|13.0||||||
4446414|NCT00096785|4270194|B1|North America||Region of Enrollment||participants|Number|9|9.0||||||
4446415|NCT00096785|4270192|B3|White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4446416|NCT00096785|4270193|B2|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4446417|NCT00096785|4270194|B1|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4446418|NCT00096785|4270192|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4446419|NCT00096785|4270193|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4446420|NCT00096785|4270194|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4446421|NCT00096785|4270192|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4446422|NCT00096785|4270193|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4446423|NCT00096785|4270194|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4446424|NCT00096785|4270192|B3|Asian||Race/Ethnicity, Customized||Participants|Number|61|61.0||||||
4446425|NCT00096785|4270193|B2|Asian||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4446426|NCT00096785|4270194|B1|Asian||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4446427|NCT00096785|4270192|B3||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4446428|NCT00096785|4270193|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4446429|NCT00096785|4270194|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4446430|NCT00096785|4270192|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4446431|NCT00096785|4270193|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4446432|NCT00096785|4270194|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4446433|NCT00096785|4270192|B3|||Age||participants|Median|31|31.0|Full Range|||17.0|76.0|
4446434|NCT00096785|4270193|B2|||Age||participants|Median|28|28.0|Full Range|||17.0|57.0|
4446435|NCT00096785|4270194|B1|||Age||participants|Median|38|38.0|Full Range|||18.0|76.0|
4446436|NCT00096785|4270192|B3|||Age||years|Mean|34|34.0|Standard Deviation|1.5|1.5|||
4446437|NCT00096785|4270193|B2|||Age||years|Mean|32|32.0|Standard Deviation|1.9|1.9|||
4446438|NCT00096785|4270194|B1|||Age||years|Mean|37|37.0|Standard Deviation|2.3|2.3|||
4446439|NCT00096681|4270219|B1|South Africa||Region of Enrollment||participants|Number|762|762.0||||||
4446440|NCT00096681|4270219|B1||Male|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4446441|NCT00096681|4270219|B1||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4446442|NCT00096681|4270219|B1|||Age||years|Mean|30|30.0|Standard Deviation|11.1|11.1|||
4446443|NCT00096681|4270219|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4446444|NCT00096681|4270219|B1||Between 18 and 65 years|Age||Participants|Count of Participants|726|726.0||||||
4446445|NCT00096681|4270219|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4446446|NCT00096538|4270224|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4446447|NCT00096538|4270224|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4446448|NCT00096538|4270224|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446449|NCT00096538|4270224|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4446450|NCT00096538|4270224|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4446451|NCT00096538|4270224|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446452|NCT00096486|4270228|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4446453|NCT00096486|4270229|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4446454|NCT00096486|4270230|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4446455|NCT00096486|4270231|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4446456|NCT00096486|4270232|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4446457|NCT00096486|4270228|B5||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4446458|NCT00096486|4270229|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4446459|NCT00096486|4270230|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4446460|NCT00096486|4270231|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4446461|NCT00096486|4270232|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4446462|NCT00096486|4270228|B5||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4446463|NCT00096486|4270229|B4||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4446464|NCT00096486|4270230|B3||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4446465|NCT00096486|4270231|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4446466|NCT00096486|4270232|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4446467|NCT00096486|4270228|B5||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4446468|NCT00096486|4270229|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4446469|NCT00096486|4270230|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4446470|NCT00096486|4270231|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4446471|NCT00096486|4270232|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4446472|NCT00096486|4270228|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446473|NCT00096486|4270229|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446474|NCT00096486|4270230|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446475|NCT00096486|4270231|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446476|NCT00096486|4270232|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446477|NCT00096460|4270245|B3|||Months from diagnosis to transplant||months|Median|33.6|33.6|Full Range|||9.8|110.5|
4446478|NCT00096460|4270246|B2|||Months from diagnosis to transplant||months|Median|28.9|28.9|Full Range|||16.2|64.7|
4446479|NCT00096460|4270247|B1|||Months from diagnosis to transplant||months|Median|39.8|39.8|Full Range|||9.8|110.5|
4446480|NCT00096460|4270245|B3|||Number of Prior Therapies||Number of therapies|Median|2|2.0|Full Range|||1.0|3.0|
4446481|NCT00096460|4270246|B2|||Number of Prior Therapies||Number of therapies|Median|2|2.0|Full Range|||1.0|3.0|
4446482|NCT00096460|4270247|B1|||Number of Prior Therapies||Number of therapies|Median|2|2.0|Full Range|||1.0|3.0|
4446483|NCT00096460|4270245|B3|Third Complete Remission||Disease Status at Enrollment||Participants|Number|2|2.0||||||
4446484|NCT00096460|4270246|B2|Third Complete Remission||Disease Status at Enrollment||Participants|Number|1|1.0||||||
4446485|NCT00096460|4270247|B1|Third Complete Remission||Disease Status at Enrollment||Participants|Number|1|1.0||||||
4446486|NCT00096460|4270245|B3|Second Complete Remission||Disease Status at Enrollment||Participants|Number|9|9.0||||||
4446487|NCT00096460|4270246|B2|Second Complete Remission||Disease Status at Enrollment||Participants|Number|3|3.0||||||
4446488|NCT00096460|4270247|B1|Second Complete Remission||Disease Status at Enrollment||Participants|Number|6|6.0||||||
4446489|NCT00096460|4270245|B3|Third Partial Remission||Disease Status at Enrollment||Participants|Number|4|4.0||||||
4446490|NCT00096460|4270246|B2|Third Partial Remission||Disease Status at Enrollment||Participants|Number|1|1.0||||||
4446491|NCT00096460|4270247|B1|Third Partial Remission||Disease Status at Enrollment||Participants|Number|3|3.0||||||
4446492|NCT00096460|4270245|B3|Second Partial Remission||Disease Status at Enrollment||Participants|Number|11|11.0||||||
4446493|NCT00096460|4270246|B2|Second Partial Remission||Disease Status at Enrollment||Participants|Number|3|3.0||||||
4446494|NCT00096460|4270247|B1|Second Partial Remission||Disease Status at Enrollment||Participants|Number|8|8.0||||||
4446495|NCT00096460|4270245|B3|Third Relapse||Disease Status at Enrollment||Participants|Number|1|1.0||||||
4446496|NCT00096460|4270246|B2|Third Relapse||Disease Status at Enrollment||Participants|Number|0|0.0||||||
4446497|NCT00096460|4270247|B1|Third Relapse||Disease Status at Enrollment||Participants|Number|1|1.0||||||
4446498|NCT00096460|4270245|B3|Second Relapse||Disease Status at Enrollment||Participants|Number|1|1.0||||||
4446499|NCT00096460|4270246|B2|Second Relapse||Disease Status at Enrollment||Participants|Number|0|0.0||||||
4446500|NCT00096460|4270247|B1|Second Relapse||Disease Status at Enrollment||Participants|Number|1|1.0||||||
4446501|NCT00096460|4270245|B3|First Relapse||Disease Status at Enrollment||Participants|Number|2|2.0||||||
4446502|NCT00096460|4270246|B2|First Relapse||Disease Status at Enrollment||Participants|Number|0|0.0||||||
4446503|NCT00096460|4270247|B1|First Relapse||Disease Status at Enrollment||Participants|Number|2|2.0||||||
4446504|NCT00096460|4270245|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4446505|NCT00096460|4270246|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4446506|NCT00096460|4270247|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4446507|NCT00096460|4270245|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4446508|NCT00096460|4270246|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4446509|NCT00096460|4270247|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4446510|NCT00096460|4270245|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4446511|NCT00096460|4270246|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4446512|NCT00096460|4270247|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4446513|NCT00096460|4270245|B3|||Age||years|Median|49|49.0|Full Range|||36.0|66.0|
4446514|NCT00096460|4270246|B2|||Age||years|Median|48|48.0|Full Range|||40.0|64.0|
4446515|NCT00096460|4270247|B1|||Age||years|Median|50|50.0|Full Range|||36.0|66.0|
4446516|NCT00096447|4270254|B1|Serous Adenocarcinoma||Histologic Type||participants|Number|7|7.0||||||
4446517|NCT00096447|4270254|B1|Mixed Epithelial Carcinoma||Histologic Type||participants|Number|2|2.0||||||
4446518|NCT00096447|4270254|B1|Endometrioid Adenocarcinoma||Histologic Type||participants|Number|16|16.0||||||
4446519|NCT00096447|4270254|B1|Clear Cell Carcinoma||Histologic Type||participants|Number|3|3.0||||||
4446520|NCT00096447|4270254|B1|Adenocarcinoma, Unspecified||Histologic Type||participants|Number|2|2.0||||||
4446521|NCT00096447|4270254|B1|||International Federation of Gynecology and Obstetrics (FIGO) Stage - Recurrent/Persistent||participants|Number|30|30.0||||||
4446522|NCT00096447|4270254|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4446523|NCT00096447|4270254|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446524|NCT00096447|4270254|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4446525|NCT00096447|4270254|B1|70-79 years||Age, Customized||participants|Number|8|8.0||||||
4446526|NCT00096447|4270254|B1|60-69 years||Age, Customized||participants|Number|13|13.0||||||
4446527|NCT00096447|4270254|B1|50-59 years||Age, Customized||participants|Number|3|3.0||||||
4446528|NCT00096447|4270254|B1|40-49 years||Age, Customized||participants|Number|4|4.0||||||
4446529|NCT00096447|4270254|B1|30-39 years||Age, Customized||participants|Number|2|2.0||||||
4446530|NCT00096447|4270254|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|11.1|11.1|||
4446531|NCT00096382|4270268|B3|United States||Region of Enrollment||participants|Number|26|26.0||||||
4446532|NCT00096382|4270269|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4446533|NCT00096382|4270270|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4446534|NCT00096382|4270268|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446535|NCT00096382|4270269|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446536|NCT00096382|4270270|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446537|NCT00096382|4270268|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446538|NCT00096382|4270269|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446539|NCT00096382|4270270|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446540|NCT00096382|4270268|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4446541|NCT00096382|4270269|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4446542|NCT00096382|4270270|B1||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4446543|NCT00096382|4270268|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446544|NCT00096382|4270269|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446545|NCT00096382|4270270|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446546|NCT00096382|4270268|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446547|NCT00096382|4270269|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446548|NCT00096382|4270270|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446549|NCT00096382|4270268|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446550|NCT00096382|4270269|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446551|NCT00096382|4270270|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446552|NCT00096382|4270268|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446553|NCT00096382|4270269|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446554|NCT00096382|4270270|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446555|NCT00096382|4270268|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446556|NCT00096382|4270269|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446557|NCT00096382|4270270|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446558|NCT00096382|4270268|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4446559|NCT00096382|4270269|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4446560|NCT00096382|4270270|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4446561|NCT00096382|4270268|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446562|NCT00096382|4270269|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446563|NCT00096382|4270270|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446564|NCT00096382|4270268|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4446565|NCT00096382|4270269|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4446566|NCT00096382|4270270|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4446567|NCT00096382|4270268|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4446568|NCT00096382|4270269|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446569|NCT00096382|4270270|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4446570|NCT00096382|4270268|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|9.7|9.7|||
4446571|NCT00096382|4270269|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|12.0|12.0|||
4446572|NCT00096382|4270270|B1|||Age||years|Mean|43.9|43.9|Standard Deviation|9.6|9.6|||
4446573|NCT00096382|4270268|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446574|NCT00096382|4270269|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446575|NCT00096382|4270270|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446576|NCT00096382|4270268|B3||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4446577|NCT00096382|4270269|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4446578|NCT00096382|4270270|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4446579|NCT00096382|4270268|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446580|NCT00096382|4270269|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446581|NCT00096382|4270270|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446582|NCT00096356|4270279|B3|United States||Region of Enrollment||participants|Number|236|236.0||||||
4446583|NCT00096356|4270280|B2|United States||Region of Enrollment||participants|Number|114|114.0||||||
4446584|NCT00096356|4270281|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
4446585|NCT00096356|4270279|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|206|206.0||||||
4446586|NCT00096356|4270280|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4446587|NCT00096356|4270281|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|104|104.0||||||
4446588|NCT00096356|4270279|B3|African-American||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4446589|NCT00096356|4270280|B2|African-American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4446590|NCT00096356|4270281|B1|African-American||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4446591|NCT00096356|4270279|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4446592|NCT00096356|4270280|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4446593|NCT00096356|4270281|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4446594|NCT00096356|4270279|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446595|NCT00096356|4270280|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446596|NCT00096356|4270281|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446597|NCT00096356|4270279|B3||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4446598|NCT00096356|4270280|B2||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4446599|NCT00096356|4270281|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4446600|NCT00096356|4270279|B3|||Age||years|Mean|51.8|51.8|Standard Deviation|9.8|9.8|||
4446601|NCT00096356|4270280|B2|||Age||years|Mean|50.9|50.9|Standard Deviation|9.7|9.7|||
4446602|NCT00096356|4270281|B1|||Age||years|Mean|52.7|52.7|Standard Deviation|9.4|9.4|||
4446603|NCT00096356|4270279|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4446604|NCT00096356|4270280|B2||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4446605|NCT00096356|4270281|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4446606|NCT00096356|4270279|B3||Between 18 and 65 years|Age||Participants|Count of Participants|212|212.0||||||
4446607|NCT00096356|4270280|B2||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4446608|NCT00096356|4270281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4446609|NCT00096356|4270279|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446610|NCT00096356|4270280|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446611|NCT00096356|4270281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446612|NCT00096278|4270292|B3||Male|Sex: Female, Male||Participants|Count of Participants|1352|1352.0||||||
4446613|NCT00096278|4270293|B2||Male|Sex: Female, Male||Participants|Count of Participants|676|676.0||||||
4446614|NCT00096278|4270294|B1||Male|Sex: Female, Male||Participants|Count of Participants|676|676.0||||||
4446615|NCT00096278|4270292|B3||Female|Sex: Female, Male||Participants|Count of Participants|1358|1358.0||||||
4446616|NCT00096278|4270293|B2||Female|Sex: Female, Male||Participants|Count of Participants|678|678.0||||||
4446617|NCT00096278|4270294|B1||Female|Sex: Female, Male||Participants|Count of Participants|680|680.0||||||
4446618|NCT00096278|4270292|B3|||Age||years|Mean|57|57.0|Standard Deviation|11.4|11.4|||
4446619|NCT00096278|4270293|B2|||Age||years|Mean|56|56.0|Standard Deviation|11.3|11.3|||
4446620|NCT00096278|4270294|B1|||Age||years|Mean|57|57.0|Standard Deviation|11.6|11.6|||
4446621|NCT00096265|4270311|B4||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4446622|NCT00096265|4270312|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4446623|NCT00096265|4270313|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4446624|NCT00096265|4270314|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4446625|NCT00096265|4270311|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4446626|NCT00096265|4270312|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4446627|NCT00096265|4270313|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4446628|NCT00096265|4270314|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4446629|NCT00096265|4270311|B4|||Age||years|Median|63|63.0|Full Range|||39.0|89.0|
4446630|NCT00096265|4270312|B3|||Age||years|Median|61|61.0|Full Range|||46.0|85.0|
4446631|NCT00096265|4270313|B2|||Age||years|Median|63|63.0|Full Range|||39.0|83.0|
4446632|NCT00096265|4270314|B1|||Age||years|Median|63|63.0|Full Range|||42.0|89.0|
4446633|NCT00096226|4270342|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4446634|NCT00096226|4270342|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4446635|NCT00096226|4270342|B1|||Age||years|Median|59|59.0|Full Range|||41.0|79.0|
4446636|NCT00096200|4270346|B4|United States||Region of Enrollment||participants|Number|44|44.0||||||
4446637|NCT00096200|4270347|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4446638|NCT00096200|4270348|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4446639|NCT00096200|4270349|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4446640|NCT00096200|4270346|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4446641|NCT00096200|4270347|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446642|NCT00096200|4270348|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4446643|NCT00096200|4270349|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446644|NCT00096200|4270346|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4446645|NCT00096200|4270347|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446646|NCT00096200|4270348|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4446647|NCT00096200|4270349|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446648|NCT00096200|4270346|B4||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4446649|NCT00096200|4270347|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4446650|NCT00096200|4270348|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4446651|NCT00096200|4270349|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4446652|NCT00096200|4270346|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446653|NCT00096200|4270347|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446654|NCT00096200|4270348|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446655|NCT00096200|4270349|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446656|NCT00096200|4270346|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446657|NCT00096200|4270347|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446658|NCT00096200|4270348|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446659|NCT00096200|4270349|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446660|NCT00096200|4270346|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446661|NCT00096200|4270347|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446662|NCT00096200|4270348|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446663|NCT00096200|4270349|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446664|NCT00096200|4270346|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446665|NCT00096200|4270347|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446666|NCT00096200|4270348|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446667|NCT00096200|4270349|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446668|NCT00096200|4270346|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4446669|NCT00096200|4270347|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446670|NCT00096200|4270348|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4446671|NCT00096200|4270349|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4446672|NCT00096200|4270346|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4446673|NCT00096200|4270347|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4446674|NCT00096200|4270348|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4446675|NCT00096200|4270349|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4446676|NCT00096200|4270346|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446677|NCT00096200|4270347|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446678|NCT00096200|4270348|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446679|NCT00096200|4270349|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446680|NCT00096200|4270346|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446681|NCT00096200|4270347|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446682|NCT00096200|4270348|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446683|NCT00096200|4270349|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446684|NCT00096200|4270346|B4||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4446685|NCT00096200|4270347|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4446686|NCT00096200|4270348|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4446687|NCT00096200|4270349|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4446688|NCT00096200|4270346|B4|Age 70-79||Age, Customized|Age in years|participants|Number|6|6.0||||||
4446689|NCT00096200|4270347|B3|Age 70-79||Age, Customized|Age in years|participants|Number|0|0.0||||||
4446690|NCT00096200|4270348|B2|Age 70-79||Age, Customized|Age in years|participants|Number|5|5.0||||||
4446691|NCT00096200|4270349|B1|Age 70-79||Age, Customized|Age in years|participants|Number|1|1.0||||||
4446692|NCT00096200|4270346|B4|Age 60-69||Age, Customized|Age in years|participants|Number|17|17.0||||||
4446693|NCT00096200|4270347|B3|Age 60-69||Age, Customized|Age in years|participants|Number|5|5.0||||||
4446694|NCT00096200|4270348|B2|Age 60-69||Age, Customized|Age in years|participants|Number|8|8.0||||||
4446695|NCT00096200|4270349|B1|Age 60-69||Age, Customized|Age in years|participants|Number|4|4.0||||||
4446696|NCT00096200|4270346|B4|Age 50-59||Age, Customized|Age in years|participants|Number|19|19.0||||||
4446697|NCT00096200|4270347|B3|Age 50-59||Age, Customized|Age in years|participants|Number|0|0.0||||||
4446698|NCT00096200|4270348|B2|Age 50-59||Age, Customized|Age in years|participants|Number|15|15.0||||||
4446699|NCT00096200|4270349|B1|Age 50-59||Age, Customized|Age in years|participants|Number|4|4.0||||||
4446700|NCT00096200|4270346|B4|Age 40-49||Age, Customized|Age in years|participants|Number|2|2.0||||||
4446701|NCT00096200|4270347|B3|Age 40-49||Age, Customized|Age in years|participants|Number|0|0.0||||||
4446702|NCT00096200|4270348|B2|Age 40-49||Age, Customized|Age in years|participants|Number|2|2.0||||||
4446703|NCT00096200|4270349|B1|Age 40-49||Age, Customized|Age in years|participants|Number|0|0.0||||||
4446704|NCT00096174|4270365|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4446705|NCT00096174|4270365|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4446706|NCT00096174|4270365|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4446707|NCT00096174|4270365|B1|||Age||years|Median|54.8|54.8|Full Range|||42.0|78.5|
4446708|NCT00096161|4270371|B5|United States||Region of Enrollment||participants|Number|36|36.0||||||
4446709|NCT00096161|4270373|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4446710|NCT00096161|4270374|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4446711|NCT00096161|4270375|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4446712|NCT00096161|4270371|B5||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4446713|NCT00096161|4270373|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4446714|NCT00096161|4270374|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4446715|NCT00096161|4270375|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4446716|NCT00096161|4270371|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4446717|NCT00096161|4270373|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4446718|NCT00096161|4270374|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4446719|NCT00096161|4270375|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4446720|NCT00096161|4270371|B5|||Age||years|Median|56.9|56.9|Full Range|||35.0|72.0|
4446721|NCT00096161|4270373|B3|||Age||years|Median|60.3|60.3|Full Range|||47.0|69.0|
4446722|NCT00096161|4270374|B2|||Age||years|Median|59.3|59.3|Full Range|||35.0|72.0|
4446723|NCT00096161|4270375|B1|||Age||years|Median|55|55.0|Full Range|||44.0|67.0|
4446724|NCT00096161|4270371|B5||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4446725|NCT00096161|4270372|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446726|NCT00096161|4270373|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4446727|NCT00096161|4270374|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4446728|NCT00096161|4270375|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4446729|NCT00096161|4270371|B5||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4446730|NCT00096161|4270372|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4446731|NCT00096161|4270373|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4446732|NCT00096161|4270374|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4446733|NCT00096161|4270375|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4446734|NCT00096161|4270371|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446735|NCT00096161|4270372|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446736|NCT00096161|4270373|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446737|NCT00096161|4270374|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446738|NCT00096161|4270375|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446739|NCT00096135|4270408|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4446740|NCT00096135|4270409|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4446741|NCT00096135|4270410|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4446742|NCT00096135|4270408|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446743|NCT00096135|4270409|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446744|NCT00096135|4270410|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446745|NCT00096135|4270408|B3||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4446746|NCT00096135|4270409|B2||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4446747|NCT00096135|4270410|B1||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4446748|NCT00096135|4270408|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4446749|NCT00096135|4270409|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4446750|NCT00096135|4270410|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4446751|NCT00096135|4270408|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446752|NCT00096135|4270409|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446753|NCT00096135|4270410|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446754|NCT00096135|4270408|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4446755|NCT00096135|4270409|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4446756|NCT00096135|4270410|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4446757|NCT00096135|4270408|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446758|NCT00096135|4270409|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446759|NCT00096135|4270410|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446760|NCT00096135|4270408|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4446761|NCT00096135|4270409|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4446762|NCT00096135|4270410|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4446763|NCT00096135|4270408|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4446764|NCT00096135|4270409|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4446765|NCT00096135|4270410|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4446766|NCT00096135|4270408|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4446767|NCT00096135|4270409|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4446768|NCT00096135|4270410|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4446769|NCT00096135|4270408|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4446770|NCT00096135|4270409|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4446771|NCT00096135|4270410|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4446772|NCT00096135|4270408|B3||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4446773|NCT00096135|4270409|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446774|NCT00096135|4270410|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4446775|NCT00096135|4270408|B3|||Age||years|Mean|8.5|8.5|Standard Deviation|4.2|4.2|||
4446776|NCT00096135|4270409|B2|||Age||years|Mean|9.2|9.2|Standard Deviation|3.2|3.2|||
4446777|NCT00096135|4270410|B1|||Age||years|Mean|8.2|8.2|Standard Deviation|4.8|4.8|||
4446778|NCT00096135|4270408|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446779|NCT00096135|4270409|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446780|NCT00096135|4270410|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446781|NCT00096135|4270408|B3||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4446782|NCT00096135|4270409|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4446783|NCT00096135|4270410|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4446784|NCT00096135|4270408|B3||<=18 years|Age||Participants|Count of Participants|160|160.0||||||
4446785|NCT00096135|4270409|B2||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4446786|NCT00096135|4270410|B1||<=18 years|Age||Participants|Count of Participants|118|118.0||||||
4446787|NCT00096122|4270417|B1|United States||Region of Enrollment||participants|Number|95|95.0||||||
4446788|NCT00096122|4270417|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4446789|NCT00096122|4270417|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4446790|NCT00096122|4270417|B1|||Age||years|Median|50|50.0|Full Range|||17.0|61.0|
4446791|NCT00096109|4270421|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4446792|NCT00096109|4270421|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4446793|NCT00096109|4270421|B1||Female|Gender||Participants|Count of Participants|11|11.0||||||
4446794|NCT00096109|4270421|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4446795|NCT00096109|4270421|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4446796|NCT00096109|4270421|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446797|NCT00096044|4270427|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4446798|NCT00096044|4270427|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4446799|NCT00096044|4270427|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|7.9|7.9|||
4446800|NCT00096031|4270436|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446801|NCT00096031|4270436|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446802|NCT00096031|4270436|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4446803|NCT00096031|4270436|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446804|NCT00096031|4270436|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446805|NCT00096031|4270436|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446806|NCT00096031|4270436|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4446807|NCT00096031|4270436|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4446808|NCT00096031|4270436|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4446809|NCT00096031|4270436|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4446810|NCT00096031|4270436|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4446811|NCT00096031|4270436|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4446812|NCT00096031|4270436|B1|||Age||years|Median|61.2|61.2|Full Range|||30.7|88.5|
4446813|NCT00096018|4270442|B3|United States||Region of Enrollment||participants|Number|38|38.0||||||
4446814|NCT00096018|4270443|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4446815|NCT00096018|4270444|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4446816|NCT00096018|4270442|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4446817|NCT00096018|4270443|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4446818|NCT00096018|4270444|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4446819|NCT00096018|4270442|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4446820|NCT00096018|4270443|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4446821|NCT00096018|4270444|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4446822|NCT00096018|4270442|B3|70 - 79 years||Age, Customized||participants|Number|9|9.0||||||
4446823|NCT00096018|4270443|B2|70 - 79 years||Age, Customized||participants|Number|6|6.0||||||
4446824|NCT00096018|4270444|B1|70 - 79 years||Age, Customized||participants|Number|3|3.0||||||
4446825|NCT00096018|4270442|B3|60 - 69 years||Age, Customized||participants|Number|14|14.0||||||
4446826|NCT00096018|4270443|B2|60 - 69 years||Age, Customized||participants|Number|9|9.0||||||
4446827|NCT00096018|4270444|B1|60 - 69 years||Age, Customized||participants|Number|5|5.0||||||
4446828|NCT00096018|4270442|B3|50 - 59 years||Age, Customized||participants|Number|10|10.0||||||
4446829|NCT00096018|4270443|B2|50 - 59 years||Age, Customized||participants|Number|8|8.0||||||
4446830|NCT00096018|4270444|B1|50 - 59 years||Age, Customized||participants|Number|2|2.0||||||
4446831|NCT00096018|4270442|B3|40 - 49 years||Age, Customized||participants|Number|3|3.0||||||
4446832|NCT00096018|4270443|B2|40 - 49 years||Age, Customized||participants|Number|2|2.0||||||
4446833|NCT00096018|4270444|B1|40 - 49 years||Age, Customized||participants|Number|1|1.0||||||
4446834|NCT00096018|4270442|B3|30 - 39 years||Age, Customized||participants|Number|2|2.0||||||
4446835|NCT00096018|4270443|B2|30 - 39 years||Age, Customized||participants|Number|0|0.0||||||
4446836|NCT00096018|4270444|B1|30 - 39 years||Age, Customized||participants|Number|2|2.0||||||
4446837|NCT00095979|4270453|B1|Carcinosarcoma-homologous||Histologic Type||participants|Number|1|1.0||||||
4446838|NCT00095979|4270453|B1|Serous Adenocarcinoma||Histologic Type||participants|Number|21|21.0||||||
4446839|NCT00095979|4270453|B1|Mixed Epithelial Carcinoma||Histologic Type||participants|Number|4|4.0||||||
4446840|NCT00095979|4270453|B1|Endometrioid Adenocarcinoma||Histologic Type||participants|Number|22|22.0||||||
4446841|NCT00095979|4270453|B1|Clear Cell Carcinoma||Histologic Type||participants|Number|1|1.0||||||
4446842|NCT00095979|4270453|B1|Adenocarcinoma, Unspecified||Histologic Type||participants|Number|1|1.0||||||
4446843|NCT00095979|4270453|B1|||International Federation of Gynecology and Obstetrics (FIGO) Stage Recurrent/Persistent||participants|Number|50|50.0||||||
4446844|NCT00095979|4270453|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446845|NCT00095979|4270453|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4446846|NCT00095979|4270453|B1|80-89 years||Age, Customized||participants|Number|2|2.0||||||
4446847|NCT00095979|4270453|B1|70-79 years||Age, Customized||participants|Number|16|16.0||||||
4446848|NCT00095979|4270453|B1|60-69 years||Age, Customized||participants|Number|19|19.0||||||
4446849|NCT00095979|4270453|B1|50-59 years||Age, Customized||participants|Number|11|11.0||||||
4446850|NCT00095979|4270453|B1|40-49 years||Age, Customized||participants|Number|2|2.0||||||
4446851|NCT00095979|4270453|B1|30-39 years||Age, Customized||participants|Number|0|0.0||||||
4446852|NCT00095979|4270453|B1|20-29 years||Age, Customized||participants|Number|0|0.0||||||
4446853|NCT00095979|4270453|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|9.4|9.4|||
4446854|NCT00095940|4270464|B8|United States||Region of Enrollment||participants|Number|52|52.0||||||
4446855|NCT00095940|4270465|B7|United States||Region of Enrollment||participants|Number|14|14.0||||||
4446856|NCT00095940|4270466|B6|United States||Region of Enrollment||participants|Number|2|2.0||||||
4446857|NCT00095940|4270467|B5|United States||Region of Enrollment||participants|Number|2|2.0||||||
4446858|NCT00095940|4270468|B4|United States||Region of Enrollment||participants|Number|13|13.0||||||
4446859|NCT00095940|4270469|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4446860|NCT00095940|4270470|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4446861|NCT00095940|4270471|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4446862|NCT00095940|4270464|B8||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4446863|NCT00095940|4270465|B7||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4446864|NCT00095940|4270466|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4446865|NCT00095940|4270467|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4446866|NCT00095940|4270468|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4446867|NCT00095940|4270469|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4446868|NCT00095940|4270470|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4446869|NCT00095940|4270471|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4446870|NCT00095940|4270464|B8||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4446871|NCT00095940|4270465|B7||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4446872|NCT00095940|4270466|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446873|NCT00095940|4270467|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4446874|NCT00095940|4270468|B4||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4446875|NCT00095940|4270469|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4446876|NCT00095940|4270470|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4446877|NCT00095940|4270471|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4446878|NCT00095940|4270464|B8|||Age||years|Mean|11.6|11.6|Standard Deviation|5.6|5.6|||
4446879|NCT00095940|4270465|B7|||Age||years|Mean|8.0|8.0|Standard Deviation|4.1|4.1|||
4446880|NCT00095940|4270466|B6|||Age||years|Mean|9.9|9.9|Standard Deviation|1.8|1.8|||
4446881|NCT00095940|4270467|B5|||Age||years|Mean|7.1|7.1|Standard Deviation|1.8|1.8|||
4446882|NCT00095940|4270468|B4|||Age||years|Mean|13.5|13.5|Standard Deviation|4.5|4.5|||
4446883|NCT00095940|4270469|B3|||Age||years|Mean|14.2|14.2|Standard Deviation|5.9|5.9|||
4446884|NCT00095940|4270470|B2|||Age||years|Mean|8.7|8.7|Standard Deviation|.27|0.27|||
4446885|NCT00095940|4270471|B1|||Age||years|Mean|11.6|11.6|Standard Deviation|12.0|12.0|||
4446886|NCT00095940|4270464|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446887|NCT00095940|4270465|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446888|NCT00095940|4270466|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446889|NCT00095940|4270467|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446890|NCT00095940|4270468|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446891|NCT00095940|4270469|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446892|NCT00095940|4270470|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446893|NCT00095940|4270471|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4446894|NCT00095940|4270464|B8||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4446895|NCT00095940|4270465|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4446896|NCT00095940|4270466|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4446897|NCT00095940|4270467|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4446898|NCT00095940|4270468|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4446899|NCT00095940|4270469|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4446900|NCT00095940|4270470|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4446901|NCT00095940|4270471|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4446902|NCT00095940|4270464|B8||<=18 years|Age||Participants|Count of Participants|45|45.0||||||
4446903|NCT00095940|4270465|B7||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4446904|NCT00095940|4270466|B6||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4446905|NCT00095940|4270467|B5||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4446906|NCT00095940|4270468|B4||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4446907|NCT00095940|4270469|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4446908|NCT00095940|4270470|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4446909|NCT00095940|4270471|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4446910|NCT00095875|4270501|B3|Germany||Region of Enrollment||participants|Number|7|7.0||||||
4446911|NCT00095875|4270502|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4446912|NCT00095875|4270503|B1|Germany||Region of Enrollment||participants|Number|1|1.0||||||
4446913|NCT00095875|4270501|B3|United States||Region of Enrollment||participants|Number|138|138.0||||||
4446914|NCT00095875|4270502|B2|United States||Region of Enrollment||participants|Number|69|69.0||||||
4446915|NCT00095875|4270503|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4446916|NCT00095875|4270501|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4446917|NCT00095875|4270502|B2||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4446918|NCT00095875|4270503|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4446919|NCT00095875|4270501|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4446920|NCT00095875|4270502|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4446921|NCT00095875|4270503|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4446922|NCT00095875|4270501|B3|||Age||years|Mean|55|55.0|Standard Deviation|8.4|8.4|||
4446923|NCT00095875|4270502|B2|||Age||years|Mean|54|54.0|Standard Deviation|8|8.0|||
4446924|NCT00095875|4270503|B1|||Age||years|Mean|55|55.0|Standard Deviation|9|9.0|||
4446925|NCT00095875|4270501|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4446926|NCT00095875|4270502|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4446927|NCT00095875|4270503|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4446928|NCT00095875|4270501|B3||Between 18 and 65 years|Age||Participants|Count of Participants|125|125.0||||||
4446929|NCT00095875|4270502|B2||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4446930|NCT00095875|4270503|B1||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4446931|NCT00095875|4270501|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446932|NCT00095875|4270502|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446933|NCT00095875|4270503|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446934|NCT00095836|4270512|B1|Hürthle cell||Histology||Participants|Count of Participants|1|1.0||||||
4446935|NCT00095836|4270512|B1|Medullary||Histology||Participants|Count of Participants|4|4.0||||||
4446936|NCT00095836|4270512|B1|Anaplastic||Histology||Participants|Count of Participants|5|5.0||||||
4446937|NCT00095836|4270512|B1|Follicular||Histology||Participants|Count of Participants|6|6.0||||||
4446938|NCT00095836|4270512|B1|Papillary||Histology||Participants|Count of Participants|11|11.0||||||
4446939|NCT00095836|4270512|B1|External beam radiotherapy||Prior therapy||participants|Number|23|23.0||||||
4446940|NCT00095836|4270512|B1|Chemotherapy||Prior therapy||participants|Number|6|6.0||||||
4446941|NCT00095836|4270512|B1|Radioactive iodine||Prior therapy||participants|Number|17|17.0||||||
4446942|NCT00095836|4270512|B1|Lung + extra-pulmonary metastases||Metastatic sites||Participants|Count of Participants|15|15.0||||||
4446943|NCT00095836|4270512|B1|Lung-only||Metastatic sites||Participants|Count of Participants|10|10.0||||||
4446944|NCT00095836|4270512|B1|Metastatic||Stage||Participants|Count of Participants|25|25.0||||||
4446945|NCT00095836|4270512|B1|Locally Advanced||Stage||Participants|Count of Participants|2|2.0||||||
4446946|NCT00095836|4270512|B1|2||ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) performance status.~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~– Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)~– Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)"|Participants|Count of Participants|2|2.0||||||
4446947|NCT00095836|4270512|B1|0-1||ECOG Performance Status|"Eastern Cooperative Oncology Group (ECOG) performance status.~0 – Asymptomatic (Fully active, able to carry on all predisease activities without restriction)~– Symptomatic but completely ambulatory (Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. For example, light housework, office work)~– Symptomatic, <50% in bed during the day (Ambulatory and capable of all self care but unable to carry out any work activities. Up and about more than 50% of waking hours)"|Participants|Count of Participants|25|25.0||||||
4446948|NCT00095836|4270512|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4446949|NCT00095836|4270512|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4446950|NCT00095836|4270512|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4446951|NCT00095836|4270512|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|9.5|9.5|||
4446952|NCT00095836|4270512|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4446953|NCT00095836|4270512|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4446954|NCT00095836|4270512|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446955|NCT00095784|4270519|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4446956|NCT00095784|4270519|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4446957|NCT00095784|4270519|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4446958|NCT00095784|4270519|B1|||Age||years|Median|67|67.0|Full Range|||40.0|90.0|
4446959|NCT00095628|4270542|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4446960|NCT00095628|4270542|B1|Canada||Region of Enrollment||participants|Number|18|18.0||||||
4446961|NCT00095628|4270542|B1||Male|Gender||Participants|Count of Participants|17|17.0||||||
4446962|NCT00095628|4270542|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4446963|NCT00095628|4270542|B1|||Age||participants|Median|60|60.0|Full Range|||41.0|75.0|
4446964|NCT00095628|4270542|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4446965|NCT00095628|4270542|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4446966|NCT00095628|4270542|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446967|NCT00095576|4270551|B3||Male|Sex: Female, Male||Participants|Count of Participants|1844|1844.0||||||
4446968|NCT00095576|4270552|B2||Male|Sex: Female, Male||Participants|Count of Participants|925|925.0||||||
4446969|NCT00095576|4270553|B1||Male|Sex: Female, Male||Participants|Count of Participants|919|919.0||||||
4446970|NCT00095576|4270551|B3||Female|Sex: Female, Male||Participants|Count of Participants|1135|1135.0||||||
4446971|NCT00095576|4270552|B2||Female|Sex: Female, Male||Participants|Count of Participants|570|570.0||||||
4446972|NCT00095576|4270553|B1||Female|Sex: Female, Male||Participants|Count of Participants|565|565.0||||||
4446973|NCT00095576|4270551|B3|||Age||years|Mean|30.1|30.1|Standard Deviation|7.97|7.97|18.0|46.0|
4446974|NCT00095576|4270552|B2|||Age||years|Mean|30.2|30.2|Standard Deviation|8.13|8.13|18.0|45.0|
4446975|NCT00095576|4270553|B1|||Age||years|Mean|29.9|29.9|Standard Deviation|7.8|7.8|18.0|46.0|
4446976|NCT00095563|4270566|B1|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4446977|NCT00095563|4270566|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4446978|NCT00095563|4270566|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4446979|NCT00095563|4270566|B1|||Age||years|Median|57|57.0|Full Range|||39.0|80.0|
4446980|NCT00095563|4270566|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4446981|NCT00095563|4270566|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4446982|NCT00095563|4270566|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4446983|NCT00095498|4270575|B4|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4446984|NCT00095498|4270576|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4446985|NCT00095498|4270577|B2|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4446986|NCT00095498|4270578|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4446987|NCT00095498|4270575|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4446988|NCT00095498|4270576|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4446989|NCT00095498|4270577|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4446990|NCT00095498|4270578|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4446991|NCT00095498|4270575|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4446992|NCT00095498|4270576|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4446993|NCT00095498|4270577|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4446994|NCT00095498|4270578|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4446995|NCT00095498|4270575|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4446996|NCT00095498|4270576|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4446997|NCT00095498|4270577|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4446998|NCT00095498|4270578|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4446999|NCT00095498|4270575|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|187|187.0||||||
4447000|NCT00095498|4270576|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|62|62.0||||||
4447001|NCT00095498|4270577|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
4447002|NCT00095498|4270578|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|66|66.0||||||
4447003|NCT00095498|4270575|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4447004|NCT00095498|4270576|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447005|NCT00095498|4270577|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4447006|NCT00095498|4270578|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447007|NCT00095498|4270575|B4|Japanese||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4447008|NCT00095498|4270576|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447009|NCT00095498|4270577|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4447010|NCT00095498|4270578|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447011|NCT00095498|4270575|B4|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4447012|NCT00095498|4270576|B3|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4447013|NCT00095498|4270577|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447014|NCT00095498|4270578|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447015|NCT00095498|4270575|B4||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4447016|NCT00095498|4270576|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4447017|NCT00095498|4270577|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4447018|NCT00095498|4270578|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4447019|NCT00095498|4270575|B4||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4447020|NCT00095498|4270576|B3||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4447021|NCT00095498|4270577|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4447022|NCT00095498|4270578|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4447023|NCT00095498|4270575|B4|||Age||Years|Mean|57.4|57.4|Standard Deviation|11.2|11.2|||
4447024|NCT00095498|4270576|B3|||Age||Years|Mean|57|57.0|Standard Deviation|11.1|11.1|||
4447025|NCT00095498|4270577|B2|||Age||Years|Mean|57.3|57.3|Standard Deviation|11.4|11.4|||
4447026|NCT00095498|4270578|B1|||Age||Years|Mean|58|58.0|Standard Deviation|11|11.0|||
4447027|NCT00095303|4271005|B3|Unknown or Not Reported||Ethnicity (NIH/OMB)|Follow up study, ethnicity at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|0|0.0||||||
4447028|NCT00095303|4271006|B2|Unknown or Not Reported||Ethnicity (NIH/OMB)|Follow up study, ethnicity at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|0|0.0||||||
4447029|NCT00095303|4271007|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)|Follow up study, ethnicity at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|0|0.0||||||
4447030|NCT00095303|4271005|B3|Not Hispanic or Latino||Ethnicity (NIH/OMB)|Follow up study, ethnicity at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|146|146.0||||||
4447031|NCT00095303|4271006|B2|Not Hispanic or Latino||Ethnicity (NIH/OMB)|Follow up study, ethnicity at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|68|68.0||||||
4447032|NCT00095303|4271007|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)|Follow up study, ethnicity at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|78|78.0||||||
4447033|NCT00095303|4271005|B3|Hispanic or Latino||Ethnicity (NIH/OMB)|Follow up study, ethnicity at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|115|115.0||||||
4447034|NCT00095303|4271006|B2|Hispanic or Latino||Ethnicity (NIH/OMB)|Follow up study, ethnicity at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|53|53.0||||||
4447035|NCT00095303|4271007|B1|Hispanic or Latino||Ethnicity (NIH/OMB)|Follow up study, ethnicity at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|62|62.0||||||
4447036|NCT00095303|4271005|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)|Main study, ethnicity at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|9|9.0||||||
4447037|NCT00095303|4271006|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)|Main study, ethnicity at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|4|4.0||||||
4447038|NCT00095303|4271007|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Main study, ethnicity at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|5|5.0||||||
4447039|NCT00095303|4271005|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Main study, ethnicity at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|258|258.0||||||
4447040|NCT00095303|4271006|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Main study, ethnicity at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|125|125.0||||||
4447041|NCT00095303|4271007|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Main study, ethnicity at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|133|133.0||||||
4447042|NCT00095303|4271005|B3||Hispanic or Latino|Ethnicity (NIH/OMB)|Main study, ethnicity at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|213|213.0||||||
4447043|NCT00095303|4271006|B2||Hispanic or Latino|Ethnicity (NIH/OMB)|Main study, ethnicity at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|106|106.0||||||
4447044|NCT00095303|4271007|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Main study, ethnicity at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|107|107.0||||||
4447045|NCT00095303|4271005|B3|Male||Gender|Follow up study, gender at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|208|208.0||||||
4447046|NCT00095303|4271006|B2|Male||Gender|Follow up study, gender at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|94|94.0||||||
4447047|NCT00095303|4271007|B1|Male||Gender|Follow up study, gender at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|114|114.0||||||
4447048|NCT00095303|4271005|B3|Female||Gender|Follow up study, gender at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|53|53.0||||||
4447049|NCT00095303|4271006|B2|Female||Gender|Follow up study, gender at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|27|27.0||||||
4447050|NCT00095303|4271007|B1|Female||Gender|Follow up study, gender at follow up assessment. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|26|26.0||||||
4447051|NCT00095303|4271005|B3||Male|Sex: Female, Male|Main study, gender at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|377|377.0||||||
4447052|NCT00095303|4271006|B2||Male|Sex: Female, Male|Main study, gender at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|182|182.0||||||
4447053|NCT00095303|4271007|B1||Male|Sex: Female, Male|Main study, gender at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|195|195.0||||||
4447054|NCT00095303|4271005|B3||Female|Sex: Female, Male|Main study, gender at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|103|103.0||||||
4447055|NCT00095303|4271006|B2||Female|Sex: Female, Male|Main study, gender at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|53|53.0||||||
4447056|NCT00095303|4271007|B1||Female|Sex: Female, Male|Main study, gender at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|50|50.0||||||
4447057|NCT00095303|4271005|B3|>=65 years||Age|Follow up study, age at follow up assessment. The follow up study began 6 years after the baseline of the Main Study. All participants were over 18 at the time of the follow up study. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|0|0.0||||||
4447058|NCT00095303|4271006|B2|>=65 years||Age|Follow up study, age at follow up assessment. The follow up study began 6 years after the baseline of the Main Study. All participants were over 18 at the time of the follow up study. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|0|0.0||||||
4447059|NCT00095303|4271007|B1|>=65 years||Age|Follow up study, age at follow up assessment. The follow up study began 6 years after the baseline of the Main Study. All participants were over 18 at the time of the follow up study. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|0|0.0||||||
4447060|NCT00095303|4271005|B3|Between 18 and 65 years||Age|Follow up study, age at follow up assessment. The follow up study began 6 years after the baseline of the Main Study. All participants were over 18 at the time of the follow up study. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|261|261.0||||||
4447061|NCT00095303|4271006|B2|Between 18 and 65 years||Age|Follow up study, age at follow up assessment. The follow up study began 6 years after the baseline of the Main Study. All participants were over 18 at the time of the follow up study. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|121|121.0||||||
4447062|NCT00095303|4271007|B1|Between 18 and 65 years||Age|Follow up study, age at follow up assessment. The follow up study began 6 years after the baseline of the Main Study. All participants were over 18 at the time of the follow up study. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|140|140.0||||||
4447063|NCT00095303|4271005|B3|<=18 years||Age|Follow up study, age at follow up assessment. The follow up study began 6 years after the baseline of the Main Study. All participants were over 18 at the time of the follow up study. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|0|0.0||||||
4447064|NCT00095303|4271006|B2|<=18 years||Age|Follow up study, age at follow up assessment. The follow up study began 6 years after the baseline of the Main Study. All participants were over 18 at the time of the follow up study. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|0|0.0||||||
4447065|NCT00095303|4271007|B1|<=18 years||Age|Follow up study, age at follow up assessment. The follow up study began 6 years after the baseline of the Main Study. All participants were over 18 at the time of the follow up study. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|participants in follow up study|Number|0|0.0||||||
4447066|NCT00095303|4271005|B3||>=65 years|Age|Main Study, age at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|0|0.0||||||
4447067|NCT00095303|4271006|B2||>=65 years|Age|Main Study, age at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|0|0.0||||||
4447068|NCT00095303|4271007|B1||>=65 years|Age|Main Study, age at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|0|0.0||||||
4447122|NCT00095238|4271076|B1|Between 65 and 74 years||Age, Customized||participants|Number|994|994.0||||||
4447069|NCT00095303|4271005|B3||Between 18 and 65 years|Age|Main Study, age at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|0|0.0||||||
4447070|NCT00095303|4271006|B2||Between 18 and 65 years|Age|Main Study, age at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|0|0.0||||||
4447071|NCT00095303|4271007|B1||Between 18 and 65 years|Age|Main Study, age at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|0|0.0||||||
4447072|NCT00095303|4271005|B3||<=18 years|Age|Main Study, age at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|480|480.0||||||
4447073|NCT00095303|4271006|B2||<=18 years|Age|Main Study, age at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|235|235.0||||||
4447074|NCT00095303|4271007|B1||<=18 years|Age|Main Study, age at baseline. A self report, demographic questionnaire was used to gather information about household composition, household income, age, race and ethnicity, gender, and age.|Participants|Count of Participants|245|245.0||||||
4447075|NCT00095238|4271074|B3|||B-Type Natriuretic Peptide (Pro-BNP)|Participant population=those participants with a baseline Pro-BNP measurement. Irbesartan (n=1765), Placebo (n=1798), Total (n=3563)|pg/mL|Geometric Mean|353.9|353.9|Inter-Quartile Range|||135.0|974.0|
4447076|NCT00095238|4271075|B2|||B-Type Natriuretic Peptide (Pro-BNP)|Participant population=those participants with a baseline Pro-BNP measurement. Irbesartan (n=1765), Placebo (n=1798), Total (n=3563)|pg/mL|Geometric Mean|345.2|345.2|Inter-Quartile Range|||131.0|948.0|
4447077|NCT00095238|4271076|B1|||B-Type Natriuretic Peptide (Pro-BNP)|Participant population=those participants with a baseline Pro-BNP measurement. Irbesartan (n=1765), Placebo (n=1798), Total (n=3563)|pg/mL|Geometric Mean|363.0|363.0|Inter-Quartile Range|||140.0|994.0|
4447078|NCT00095238|4271074|B3|Class IV (Severe)||New York Heart Association (NYHA) Class|1 participant in Placebo was not classified. NYHA Classes: I=No limitation of physical activity (does not cause undue fatigue, palpitation, or dyspnea). II=Slight limitation of physical activity (comfortable at rest, ordinary physical activity results in fatigue, palpitation, or dyspnea). III=Marked limitation of physical activity (comfortable at rest, less than ordinary activity causes fatigue, palpitation, or dyspnea). IV=Unable to carry out any physical activity without discomfort (symptoms of cardiac insufficiency at rest; discomfort is increased if any physical activity is undertaken).|participants|Number|112|112.0||||||
4447079|NCT00095238|4271075|B2|Class IV (Severe)||New York Heart Association (NYHA) Class|1 participant in Placebo was not classified. NYHA Classes: I=No limitation of physical activity (does not cause undue fatigue, palpitation, or dyspnea). II=Slight limitation of physical activity (comfortable at rest, ordinary physical activity results in fatigue, palpitation, or dyspnea). III=Marked limitation of physical activity (comfortable at rest, less than ordinary activity causes fatigue, palpitation, or dyspnea). IV=Unable to carry out any physical activity without discomfort (symptoms of cardiac insufficiency at rest; discomfort is increased if any physical activity is undertaken).|participants|Number|53|53.0||||||
4447080|NCT00095238|4271076|B1|Class IV (Severe)||New York Heart Association (NYHA) Class|1 participant in Placebo was not classified. NYHA Classes: I=No limitation of physical activity (does not cause undue fatigue, palpitation, or dyspnea). II=Slight limitation of physical activity (comfortable at rest, ordinary physical activity results in fatigue, palpitation, or dyspnea). III=Marked limitation of physical activity (comfortable at rest, less than ordinary activity causes fatigue, palpitation, or dyspnea). IV=Unable to carry out any physical activity without discomfort (symptoms of cardiac insufficiency at rest; discomfort is increased if any physical activity is undertaken).|participants|Number|59|59.0||||||
4447081|NCT00095238|4271074|B3|Class III (Moderate)||New York Heart Association (NYHA) Class|1 participant in Placebo was not classified. NYHA Classes: I=No limitation of physical activity (does not cause undue fatigue, palpitation, or dyspnea). II=Slight limitation of physical activity (comfortable at rest, ordinary physical activity results in fatigue, palpitation, or dyspnea). III=Marked limitation of physical activity (comfortable at rest, less than ordinary activity causes fatigue, palpitation, or dyspnea). IV=Unable to carry out any physical activity without discomfort (symptoms of cardiac insufficiency at rest; discomfort is increased if any physical activity is undertaken).|participants|Number|3144|3144.0||||||
4447082|NCT00095238|4271075|B2|Class III (Moderate)||New York Heart Association (NYHA) Class|1 participant in Placebo was not classified. NYHA Classes: I=No limitation of physical activity (does not cause undue fatigue, palpitation, or dyspnea). II=Slight limitation of physical activity (comfortable at rest, ordinary physical activity results in fatigue, palpitation, or dyspnea). III=Marked limitation of physical activity (comfortable at rest, less than ordinary activity causes fatigue, palpitation, or dyspnea). IV=Unable to carry out any physical activity without discomfort (symptoms of cardiac insufficiency at rest; discomfort is increased if any physical activity is undertaken).|participants|Number|1562|1562.0||||||
4447083|NCT00095238|4271076|B1|Class III (Moderate)||New York Heart Association (NYHA) Class|1 participant in Placebo was not classified. NYHA Classes: I=No limitation of physical activity (does not cause undue fatigue, palpitation, or dyspnea). II=Slight limitation of physical activity (comfortable at rest, ordinary physical activity results in fatigue, palpitation, or dyspnea). III=Marked limitation of physical activity (comfortable at rest, less than ordinary activity causes fatigue, palpitation, or dyspnea). IV=Unable to carry out any physical activity without discomfort (symptoms of cardiac insufficiency at rest; discomfort is increased if any physical activity is undertaken).|participants|Number|1582|1582.0||||||
4447084|NCT00095238|4271074|B3|Class II (Mild)||New York Heart Association (NYHA) Class|1 participant in Placebo was not classified. NYHA Classes: I=No limitation of physical activity (does not cause undue fatigue, palpitation, or dyspnea). II=Slight limitation of physical activity (comfortable at rest, ordinary physical activity results in fatigue, palpitation, or dyspnea). III=Marked limitation of physical activity (comfortable at rest, less than ordinary activity causes fatigue, palpitation, or dyspnea). IV=Unable to carry out any physical activity without discomfort (symptoms of cardiac insufficiency at rest; discomfort is increased if any physical activity is undertaken).|participants|Number|870|870.0||||||
4447085|NCT00095238|4271075|B2|Class II (Mild)||New York Heart Association (NYHA) Class|1 participant in Placebo was not classified. NYHA Classes: I=No limitation of physical activity (does not cause undue fatigue, palpitation, or dyspnea). II=Slight limitation of physical activity (comfortable at rest, ordinary physical activity results in fatigue, palpitation, or dyspnea). III=Marked limitation of physical activity (comfortable at rest, less than ordinary activity causes fatigue, palpitation, or dyspnea). IV=Unable to carry out any physical activity without discomfort (symptoms of cardiac insufficiency at rest; discomfort is increased if any physical activity is undertaken).|participants|Number|444|444.0||||||
4447086|NCT00095238|4271076|B1|Class II (Mild)||New York Heart Association (NYHA) Class|1 participant in Placebo was not classified. NYHA Classes: I=No limitation of physical activity (does not cause undue fatigue, palpitation, or dyspnea). II=Slight limitation of physical activity (comfortable at rest, ordinary physical activity results in fatigue, palpitation, or dyspnea). III=Marked limitation of physical activity (comfortable at rest, less than ordinary activity causes fatigue, palpitation, or dyspnea). IV=Unable to carry out any physical activity without discomfort (symptoms of cardiac insufficiency at rest; discomfort is increased if any physical activity is undertaken).|participants|Number|426|426.0||||||
4447087|NCT00095238|4271074|B3|Class I (Mild)||New York Heart Association (NYHA) Class|1 participant in Placebo was not classified. NYHA Classes: I=No limitation of physical activity (does not cause undue fatigue, palpitation, or dyspnea). II=Slight limitation of physical activity (comfortable at rest, ordinary physical activity results in fatigue, palpitation, or dyspnea). III=Marked limitation of physical activity (comfortable at rest, less than ordinary activity causes fatigue, palpitation, or dyspnea). IV=Unable to carry out any physical activity without discomfort (symptoms of cardiac insufficiency at rest; discomfort is increased if any physical activity is undertaken).|participants|Number|1|1.0||||||
4447088|NCT00095238|4271075|B2|Class I (Mild)||New York Heart Association (NYHA) Class|1 participant in Placebo was not classified. NYHA Classes: I=No limitation of physical activity (does not cause undue fatigue, palpitation, or dyspnea). II=Slight limitation of physical activity (comfortable at rest, ordinary physical activity results in fatigue, palpitation, or dyspnea). III=Marked limitation of physical activity (comfortable at rest, less than ordinary activity causes fatigue, palpitation, or dyspnea). IV=Unable to carry out any physical activity without discomfort (symptoms of cardiac insufficiency at rest; discomfort is increased if any physical activity is undertaken).|participants|Number|1|1.0||||||
4447089|NCT00095238|4271076|B1|Class I (Mild)||New York Heart Association (NYHA) Class|1 participant in Placebo was not classified. NYHA Classes: I=No limitation of physical activity (does not cause undue fatigue, palpitation, or dyspnea). II=Slight limitation of physical activity (comfortable at rest, ordinary physical activity results in fatigue, palpitation, or dyspnea). III=Marked limitation of physical activity (comfortable at rest, less than ordinary activity causes fatigue, palpitation, or dyspnea). IV=Unable to carry out any physical activity without discomfort (symptoms of cardiac insufficiency at rest; discomfort is increased if any physical activity is undertaken).|participants|Number|0|0.0||||||
4447090|NCT00095238|4271074|B3|Other||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
4447091|NCT00095238|4271075|B2|Other||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4447092|NCT00095238|4271076|B1|Other||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4447093|NCT00095238|4271074|B3|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4447094|NCT00095238|4271075|B2|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4447095|NCT00095238|4271076|B1|Native Hawaiian or other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447096|NCT00095238|4271074|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447097|NCT00095238|4271075|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447098|NCT00095238|4271076|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447099|NCT00095238|4271074|B3|Asian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4447100|NCT00095238|4271075|B2|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4447101|NCT00095238|4271076|B1|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4447102|NCT00095238|4271074|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4447103|NCT00095238|4271075|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4447104|NCT00095238|4271076|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4447105|NCT00095238|4271074|B3|White||Race/Ethnicity, Customized||participants|Number|3859|3859.0||||||
4447106|NCT00095238|4271075|B2|White||Race/Ethnicity, Customized||participants|Number|1925|1925.0||||||
4447107|NCT00095238|4271076|B1|White||Race/Ethnicity, Customized||participants|Number|1934|1934.0||||||
4447108|NCT00095238|4271074|B3||Male|Sex: Female, Male||Participants|Count of Participants|1637|1637.0||||||
4447109|NCT00095238|4271075|B2||Male|Sex: Female, Male||Participants|Count of Participants|797|797.0||||||
4447110|NCT00095238|4271076|B1||Male|Sex: Female, Male||Participants|Count of Participants|840|840.0||||||
4447111|NCT00095238|4271074|B3||Female|Sex: Female, Male||Participants|Count of Participants|2491|2491.0||||||
4447112|NCT00095238|4271075|B2||Female|Sex: Female, Male||Participants|Count of Participants|1264|1264.0||||||
4447113|NCT00095238|4271076|B1||Female|Sex: Female, Male||Participants|Count of Participants|1227|1227.0||||||
4447114|NCT00095238|4271074|B3|||Age||years|Mean|71.6|71.6|Standard Deviation|6.95|6.95|||
4447115|NCT00095238|4271075|B2|||Age||years|Mean|71.7|71.7|Standard Deviation|7.00|7.0|||
4447116|NCT00095238|4271076|B1|||Age||years|Mean|71.6|71.6|Standard Deviation|6.90|6.9|||
4447117|NCT00095238|4271074|B3|>=75 years||Age, Customized||participants|Number|1413|1413.0||||||
4447118|NCT00095238|4271075|B2|>=75 years||Age, Customized||participants|Number|716|716.0||||||
4447119|NCT00095238|4271076|B1|>=75 years||Age, Customized||participants|Number|697|697.0||||||
4447120|NCT00095238|4271074|B3|Between 65 and 74 years||Age, Customized||participants|Number|1975|1975.0||||||
4447121|NCT00095238|4271075|B2|Between 65 and 74 years||Age, Customized||participants|Number|981|981.0||||||
4447123|NCT00095238|4271074|B3|< 65 years||Age, Customized||participants|Number|740|740.0||||||
4447124|NCT00095238|4271075|B2|< 65 years||Age, Customized||participants|Number|364|364.0||||||
4447125|NCT00095238|4271076|B1|< 65 years||Age, Customized||participants|Number|376|376.0||||||
4447126|NCT00095212|4271137|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4447127|NCT00095212|4271138|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4447128|NCT00095212|4271139|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4447129|NCT00095212|4271137|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4447130|NCT00095212|4271138|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4447131|NCT00095212|4271139|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4447132|NCT00095212|4271137|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4447133|NCT00095212|4271138|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4447134|NCT00095212|4271139|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4447135|NCT00095212|4271137|B3|||Age||years|Mean|44|44.0|Standard Deviation|1|1.0|||
4447136|NCT00095212|4271138|B2|||Age||years|Mean|43|43.0|Standard Deviation|1|1.0|||
4447137|NCT00095212|4271139|B1|||Age||years|Mean|45|45.0|Standard Deviation|2|2.0|||
4447138|NCT00095212|4271137|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4447139|NCT00095212|4271138|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4447140|NCT00095212|4271139|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4447141|NCT00095212|4271137|B3||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4447142|NCT00095212|4271138|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4447143|NCT00095212|4271139|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4447144|NCT00095212|4271137|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4447145|NCT00095212|4271138|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4447146|NCT00095212|4271139|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4447147|NCT00095199|4271166|B5|Squamous cell carcinoma||Pathological Diagnosis||participants|Number|239|239.0||||||
4447148|NCT00095199|4271167|B4|Squamous cell carcinoma||Pathological Diagnosis||participants|Number|51|51.0||||||
4447149|NCT00095199|4271168|B3|Squamous cell carcinoma||Pathological Diagnosis||participants|Number|41|41.0||||||
4447150|NCT00095199|4271169|B2|Squamous cell carcinoma||Pathological Diagnosis||participants|Number|71|71.0||||||
4447151|NCT00095199|4271170|B1|Squamous cell carcinoma||Pathological Diagnosis||participants|Number|76|76.0||||||
4447152|NCT00095199|4271166|B5|All other non-squamous diagnoses||Pathological Diagnosis||participants|Number|135|135.0||||||
4447153|NCT00095199|4271167|B4|All other non-squamous diagnoses||Pathological Diagnosis||participants|Number|29|29.0||||||
4447154|NCT00095199|4271168|B3|All other non-squamous diagnoses||Pathological Diagnosis||participants|Number|20|20.0||||||
4447155|NCT00095199|4271169|B2|All other non-squamous diagnoses||Pathological Diagnosis||participants|Number|41|41.0||||||
4447156|NCT00095199|4271170|B1|All other non-squamous diagnoses||Pathological Diagnosis||participants|Number|45|45.0||||||
4447157|NCT00095199|4271166|B5|Large cell carcinoma||Pathological Diagnosis||participants|Number|36|36.0||||||
4447158|NCT00095199|4271167|B4|Large cell carcinoma||Pathological Diagnosis||participants|Number|3|3.0||||||
4447159|NCT00095199|4271168|B3|Large cell carcinoma||Pathological Diagnosis||participants|Number|7|7.0||||||
4447160|NCT00095199|4271169|B2|Large cell carcinoma||Pathological Diagnosis||participants|Number|7|7.0||||||
4447161|NCT00095199|4271170|B1|Large cell carcinoma||Pathological Diagnosis||participants|Number|19|19.0||||||
4447162|NCT00095199|4271166|B5|Adenocarcinoma||Pathological Diagnosis||participants|Number|528|528.0||||||
4447163|NCT00095199|4271167|B4|Adenocarcinoma||Pathological Diagnosis||participants|Number|83|83.0||||||
4447164|NCT00095199|4271168|B3|Adenocarcinoma||Pathological Diagnosis||participants|Number|99|99.0||||||
4447165|NCT00095199|4271169|B2|Adenocarcinoma||Pathological Diagnosis||participants|Number|185|185.0||||||
4447166|NCT00095199|4271170|B1|Adenocarcinoma||Pathological Diagnosis||participants|Number|161|161.0||||||
4447167|NCT00095199|4271166|B5|Missing/unknown||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|6|6.0||||||
4447168|NCT00095199|4271167|B4|Missing/unknown||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|2|2.0||||||
4447169|NCT00095199|4271168|B3|Missing/unknown||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|1|1.0||||||
4447170|NCT00095199|4271169|B2|Missing/unknown||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|1|1.0||||||
4447171|NCT00095199|4271170|B1|Missing/unknown||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|2|2.0||||||
4447172|NCT00095199|4271166|B5|100||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|127|127.0||||||
4447173|NCT00095199|4271167|B4|100||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|18|18.0||||||
4447174|NCT00095199|4271168|B3|100||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|14|14.0||||||
4447175|NCT00095199|4271169|B2|100||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|47|47.0||||||
4447176|NCT00095199|4271170|B1|100||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|48|48.0||||||
4447177|NCT00095199|4271166|B5|90||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|355|355.0||||||
4447178|NCT00095199|4271167|B4|90||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|64|64.0||||||
4447179|NCT00095199|4271168|B3|90||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|74|74.0||||||
4447180|NCT00095199|4271169|B2|90||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|116|116.0||||||
4447248|NCT00095199|4271167|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4447249|NCT00095199|4271168|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4447181|NCT00095199|4271170|B1|90||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|101|101.0||||||
4447182|NCT00095199|4271166|B5|80||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|306|306.0||||||
4447183|NCT00095199|4271167|B4|80||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|57|57.0||||||
4447184|NCT00095199|4271168|B3|80||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|55|55.0||||||
4447185|NCT00095199|4271169|B2|80||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|91|91.0||||||
4447186|NCT00095199|4271170|B1|80||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|103|103.0||||||
4447187|NCT00095199|4271166|B5|70||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|105|105.0||||||
4447188|NCT00095199|4271167|B4|70||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|14|14.0||||||
4447189|NCT00095199|4271168|B3|70||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|21|21.0||||||
4447190|NCT00095199|4271169|B2|70||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|35|35.0||||||
4447191|NCT00095199|4271170|B1|70||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|35|35.0||||||
4447250|NCT00095199|4271169|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4447251|NCT00095199|4271170|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4447192|NCT00095199|4271166|B5|60||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|39|39.0||||||
4447193|NCT00095199|4271167|B4|60||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|11|11.0||||||
4447194|NCT00095199|4271168|B3|60||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|2|2.0||||||
4447195|NCT00095199|4271169|B2|60||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|14|14.0||||||
4447196|NCT00095199|4271170|B1|60||Karnofsky Performance Status|Karnofsky performance status was part of eligibility criteria and classifies participants according to their functional impairment. Scores range from 0-100, the lower the score, the worse the survival for most serious illnesses. 100=Normal. No complaints. No evidence of disease; 90=Able to carry on normal activity. Minor signs of disease; 80=Activity with effort. Some signs of disease; 70=Unable to carry on normal activity or to do active work; 60=Requires occasional assistance, but is able to care for most needs; <60=Needs increasing assistance, up to a score of 0=death.|participants|Number|12|12.0||||||
4447197|NCT00095199|4271166|B5|Missing||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|245|245.0||||||
4447198|NCT00095199|4271167|B4|Missing||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|45|45.0||||||
4447199|NCT00095199|4271168|B3|Missing||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|44|44.0||||||
4447200|NCT00095199|4271169|B2|Missing||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|76|76.0||||||
4447201|NCT00095199|4271170|B1|Missing||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|80|80.0||||||
4447202|NCT00095199|4271166|B5|0||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|75|75.0||||||
4447252|NCT00095199|4271166|B5|White||Race/Ethnicity, Customized||participants|Number|820|820.0||||||
4447253|NCT00095199|4271167|B4|White||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
4447254|NCT00095199|4271168|B3|White||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
4447255|NCT00095199|4271169|B2|White||Race/Ethnicity, Customized||participants|Number|265|265.0||||||
4447203|NCT00095199|4271167|B4|0||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|10|10.0||||||
4447204|NCT00095199|4271168|B3|0||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|12|12.0||||||
4447205|NCT00095199|4271169|B2|0||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|32|32.0||||||
4447206|NCT00095199|4271170|B1|0||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|21|21.0||||||
4447207|NCT00095199|4271166|B5|+3||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|356|356.0||||||
4447208|NCT00095199|4271167|B4|+3||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|58|58.0||||||
4447209|NCT00095199|4271168|B3|+3||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|72|72.0||||||
4447210|NCT00095199|4271169|B2|+3||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|108|108.0||||||
4447211|NCT00095199|4271170|B1|+3||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|118|118.0||||||
4447212|NCT00095199|4271166|B5|+2||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|159|159.0||||||
4447213|NCT00095199|4271167|B4|+2||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|34|34.0||||||
4447214|NCT00095199|4271168|B3|+2||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|26|26.0||||||
4447256|NCT00095199|4271170|B1|White||Race/Ethnicity, Customized||participants|Number|268|268.0||||||
4447215|NCT00095199|4271169|B2|+2||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|53|53.0||||||
4447216|NCT00095199|4271170|B1|+2||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|46|46.0||||||
4447217|NCT00095199|4271166|B5|+1||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|103|103.0||||||
4447218|NCT00095199|4271167|B4|+1||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|19|19.0||||||
4447219|NCT00095199|4271168|B3|+1||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|13|13.0||||||
4447220|NCT00095199|4271169|B2|+1||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|35|35.0||||||
4447221|NCT00095199|4271170|B1|+1||Epidermal growth factor receptor (EGFR) by immunohistochemistry|Immunohistochemical staining intensity of anti-EGFR antibody: Score 0=No staining is observed in membrane; Score +1=Staining in membrane is partial, weak and barely perceptible; Score +2=Staining is weak but is completely observed in membrane; Score +3=Strong complete membrane staining is observed. EGFR positive staining is a potential prognostic factor in non-small cell lung cancer. Presence of EGFR staining was not, however, an inclusion criteria or used to stratify participants in the trial.|participants|Number|36|36.0||||||
4447222|NCT00095199|4271166|B5|Canada||Region of Enrollment||participants|Number|100|100.0||||||
4447223|NCT00095199|4271167|B4|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4447224|NCT00095199|4271168|B3|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4447225|NCT00095199|4271169|B2|Canada||Region of Enrollment||participants|Number|34|34.0||||||
4447226|NCT00095199|4271170|B1|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4447227|NCT00095199|4271166|B5|United States||Region of Enrollment||participants|Number|838|838.0||||||
4447228|NCT00095199|4271167|B4|United States||Region of Enrollment||participants|Number|151|151.0||||||
4447229|NCT00095199|4271168|B3|United States||Region of Enrollment||participants|Number|152|152.0||||||
4447230|NCT00095199|4271169|B2|United States||Region of Enrollment||participants|Number|270|270.0||||||
4447231|NCT00095199|4271170|B1|United States||Region of Enrollment||participants|Number|265|265.0||||||
4447232|NCT00095199|4271166|B5|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4447233|NCT00095199|4271167|B4|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4447234|NCT00095199|4271168|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4447235|NCT00095199|4271169|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4447236|NCT00095199|4271170|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4447237|NCT00095199|4271166|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4447238|NCT00095199|4271167|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4447239|NCT00095199|4271168|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4447240|NCT00095199|4271169|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4447241|NCT00095199|4271170|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4447242|NCT00095199|4271166|B5|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4447243|NCT00095199|4271167|B4|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4447244|NCT00095199|4271168|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4447245|NCT00095199|4271169|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4447246|NCT00095199|4271170|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4447247|NCT00095199|4271166|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4447257|NCT00095199|4271166|B5||Male|Sex: Female, Male||Participants|Count of Participants|546|546.0||||||
4447258|NCT00095199|4271167|B4||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4447259|NCT00095199|4271168|B3||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4447260|NCT00095199|4271169|B2||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4447261|NCT00095199|4271170|B1||Male|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4447262|NCT00095199|4271166|B5||Female|Sex: Female, Male||Participants|Count of Participants|392|392.0||||||
4447263|NCT00095199|4271167|B4||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4447264|NCT00095199|4271168|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4447265|NCT00095199|4271169|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4447266|NCT00095199|4271170|B1||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4447267|NCT00095199|4271166|B5|||Age||years|Mean|63.5|63.5|Standard Deviation|9.5|9.5|||
4447268|NCT00095199|4271167|B4|||Age||years|Mean|63.9|63.9|Standard Deviation|9.2|9.2|||
4447269|NCT00095199|4271168|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|9.4|9.4|||
4447270|NCT00095199|4271169|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|9.4|9.4|||
4447271|NCT00095199|4271170|B1|||Age||years|Mean|62.8|62.8|Standard Deviation|10.0|10.0|||
4447272|NCT00095173|4271211|B1||Male|Gender||Participants|Count of Participants|53|53.0||||||
4447273|NCT00095173|4271211|B1||Female|Gender||Participants|Count of Participants|137|137.0||||||
4447274|NCT00095173|4271211|B1|||Age||years|Median|13.0|13.0|Full Range|||5.0|17.0|
4447275|NCT00095147|4271251|B4|||Baseline Disease Activity Score (DAS) 28 (Erythrocyte Sedimentation Rate [ESR])|The DAS28 is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, ESR or C-reactive protein (CRP), and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (> 5.1), low disease activity (< 3.2) and remission (< 2.6). A clinically significant response= decrease in DAS28 score of >1.2 from baseline.|units on a scale|Mean|6.8|6.8|Standard Deviation|1.0|1.0|||
4447276|NCT00095147|4271252|B3|||Baseline Disease Activity Score (DAS) 28 (Erythrocyte Sedimentation Rate [ESR])|The DAS28 is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, ESR or C-reactive protein (CRP), and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (> 5.1), low disease activity (< 3.2) and remission (< 2.6). A clinically significant response= decrease in DAS28 score of >1.2 from baseline.|units on a scale|Mean|6.8|6.8|Standard Deviation|1.0|1.0|||
4447277|NCT00095147|4271253|B2|||Baseline Disease Activity Score (DAS) 28 (Erythrocyte Sedimentation Rate [ESR])|The DAS28 is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, ESR or C-reactive protein (CRP), and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (> 5.1), low disease activity (< 3.2) and remission (< 2.6). A clinically significant response= decrease in DAS28 score of >1.2 from baseline.|units on a scale|Mean|6.8|6.8|Standard Deviation|0.9|0.9|||
4447278|NCT00095147|4271254|B1|||Baseline Disease Activity Score (DAS) 28 (Erythrocyte Sedimentation Rate [ESR])|The DAS28 is a continuous disease measure which is a composite of 4 variables: the 28 tender joint count, the 28 swollen joint count, ESR or C-reactive protein (CRP), and participant assessment of disease activity measure on a visual analogue scale. The DAS28 has numeric thresholds that define high disease activity (> 5.1), low disease activity (< 3.2) and remission (< 2.6). A clinically significant response= decrease in DAS28 score of >1.2 from baseline.|units on a scale|Mean|6.9|6.9|Standard Deviation|1.0|1.0|||
4447279|NCT00095147|4271251|B4||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4447280|NCT00095147|4271252|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4447281|NCT00095147|4271253|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4447282|NCT00095147|4271254|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4447283|NCT00095147|4271251|B4||Female|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4447284|NCT00095147|4271252|B3||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4447285|NCT00095147|4271253|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4447286|NCT00095147|4271254|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4447287|NCT00095147|4271251|B4|||Age||years|Mean|49.1|49.1|Standard Deviation|12.0|12.0|||
4447288|NCT00095147|4271252|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|11.5|11.5|||
4447289|NCT00095147|4271253|B2|||Age||years|Mean|49.1|49.1|Standard Deviation|12.0|12.0|||
4447290|NCT00095147|4271254|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|12.5|12.5|||
4447291|NCT00095121|4271451|B3|No||Prior Use of Other Hepatitis B Medications|"Other hepatitis B medications include any medications other than famciclovir, lamivudine, lobucavir, thymosin alpha, ganciclovir, interferon alpha, hepatitis B immune globulin (HBIG), entecavir, clevudine, emtricitabine, and ADV."|participants|Number|163|163.0||||||
4447292|NCT00095121|4271452|B2|No||Prior Use of Other Hepatitis B Medications|"Other hepatitis B medications include any medications other than famciclovir, lamivudine, lobucavir, thymosin alpha, ganciclovir, interferon alpha, hepatitis B immune globulin (HBIG), entecavir, clevudine, emtricitabine, and ADV."|participants|Number|56|56.0||||||
4447293|NCT00095121|4271453|B1|No||Prior Use of Other Hepatitis B Medications|"Other hepatitis B medications include any medications other than famciclovir, lamivudine, lobucavir, thymosin alpha, ganciclovir, interferon alpha, hepatitis B immune globulin (HBIG), entecavir, clevudine, emtricitabine, and ADV."|participants|Number|107|107.0||||||
4447294|NCT00095121|4271451|B3|Yes||Prior Use of Other Hepatitis B Medications|"Other hepatitis B medications include any medications other than famciclovir, lamivudine, lobucavir, thymosin alpha, ganciclovir, interferon alpha, hepatitis B immune globulin (HBIG), entecavir, clevudine, emtricitabine, and ADV."|participants|Number|10|10.0||||||
4447295|NCT00095121|4271452|B2|Yes||Prior Use of Other Hepatitis B Medications|"Other hepatitis B medications include any medications other than famciclovir, lamivudine, lobucavir, thymosin alpha, ganciclovir, interferon alpha, hepatitis B immune globulin (HBIG), entecavir, clevudine, emtricitabine, and ADV."|participants|Number|2|2.0||||||
4447296|NCT00095121|4271453|B1|Yes||Prior Use of Other Hepatitis B Medications|"Other hepatitis B medications include any medications other than famciclovir, lamivudine, lobucavir, thymosin alpha, ganciclovir, interferon alpha, hepatitis B immune globulin (HBIG), entecavir, clevudine, emtricitabine, and ADV."|participants|Number|8|8.0||||||
4447297|NCT00095121|4271451|B3|No||Prior Use of ADV||participants|Number|165|165.0||||||
4447298|NCT00095121|4271452|B2|No||Prior Use of ADV||participants|Number|54|54.0||||||
4447299|NCT00095121|4271453|B1|No||Prior Use of ADV||participants|Number|111|111.0||||||
4447300|NCT00095121|4271451|B3|Yes||Prior Use of ADV||participants|Number|8|8.0||||||
4447301|NCT00095121|4271452|B2|Yes||Prior Use of ADV||participants|Number|4|4.0||||||
4447302|NCT00095121|4271453|B1|Yes||Prior Use of ADV||participants|Number|4|4.0||||||
4447303|NCT00095121|4271451|B3|No||Prior Use of Interferon Alpha||participants|Number|93|93.0||||||
4447304|NCT00095121|4271452|B2|No||Prior Use of Interferon Alpha||participants|Number|30|30.0||||||
4447305|NCT00095121|4271453|B1|No||Prior Use of Interferon Alpha||participants|Number|63|63.0||||||
4447306|NCT00095121|4271451|B3|Yes||Prior Use of Interferon Alpha||participants|Number|80|80.0||||||
4447307|NCT00095121|4271452|B2|Yes||Prior Use of Interferon Alpha||participants|Number|28|28.0||||||
4447308|NCT00095121|4271453|B1|Yes||Prior Use of Interferon Alpha||participants|Number|52|52.0||||||
4447309|NCT00095121|4271451|B3|No||Prior Use of Lamivudine||participants|Number|104|104.0||||||
4447310|NCT00095121|4271452|B2|No||Prior Use of Lamivudine||participants|Number|35|35.0||||||
4447311|NCT00095121|4271453|B1|No||Prior Use of Lamivudine||participants|Number|69|69.0||||||
4447312|NCT00095121|4271451|B3|Yes||Prior Use of Lamivudine||participants|Number|69|69.0||||||
4447313|NCT00095121|4271452|B2|Yes||Prior Use of Lamivudine||participants|Number|23|23.0||||||
4447314|NCT00095121|4271453|B1|Yes||Prior Use of Lamivudine||participants|Number|46|46.0||||||
4447315|NCT00095121|4271451|B3|No||Prior Use of Famciclovir||participants|Number|172|172.0||||||
4447316|NCT00095121|4271452|B2|No||Prior Use of Famciclovir||participants|Number|57|57.0||||||
4447317|NCT00095121|4271453|B1|No||Prior Use of Famciclovir||participants|Number|115|115.0||||||
4447318|NCT00095121|4271451|B3|Yes||Prior Use of Famciclovir||participants|Number|1|1.0||||||
4447319|NCT00095121|4271452|B2|Yes||Prior Use of Famciclovir||participants|Number|1|1.0||||||
4447320|NCT00095121|4271453|B1|Yes||Prior Use of Famciclovir||participants|Number|0|0.0||||||
4447321|NCT00095121|4271451|B3|No||Any Prior Hepatitis B Medication||participants|Number|74|74.0||||||
4447322|NCT00095121|4271452|B2|No||Any Prior Hepatitis B Medication||participants|Number|25|25.0||||||
4447323|NCT00095121|4271453|B1|No||Any Prior Hepatitis B Medication||participants|Number|49|49.0||||||
4447324|NCT00095121|4271451|B3|Yes||Any Prior Hepatitis B Medication||participants|Number|99|99.0||||||
4447325|NCT00095121|4271452|B2|Yes||Any Prior Hepatitis B Medication||participants|Number|33|33.0||||||
4447326|NCT00095121|4271453|B1|Yes||Any Prior Hepatitis B Medication||participants|Number|66|66.0||||||
4447327|NCT00095121|4271451|B3|No||Current Alcohol Consumption||participants|Number|173|173.0||||||
4447328|NCT00095121|4271452|B2|No||Current Alcohol Consumption||participants|Number|58|58.0||||||
4447329|NCT00095121|4271453|B1|No||Current Alcohol Consumption||participants|Number|115|115.0||||||
4447330|NCT00095121|4271451|B3|Yes||Current Alcohol Consumption||participants|Number|0|0.0||||||
4447331|NCT00095121|4271452|B2|Yes||Current Alcohol Consumption||participants|Number|0|0.0||||||
4447332|NCT00095121|4271453|B1|Yes||Current Alcohol Consumption||participants|Number|0|0.0||||||
4447333|NCT00095121|4271451|B3|No||Hepatitis B Flares (Acute Exacerbation)|A hepatic flare was defined as a) serum ALT > 2 x study baseline and > 10 x ULN or b) an ALT 1-grade shift or ALT 2 x previous value and total bilirubin > 2.5 mg/dL or change from study baseline in total bilirubin = 1.0 mg/dL or change from study baseline in prothrombin time > 2 seconds or serum albumin < 3.0 g/dL or change from study baseline in serum albumin <= −1.0 g/dL.|participants|Number|157|157.0||||||
4447334|NCT00095121|4271452|B2|No||Hepatitis B Flares (Acute Exacerbation)|A hepatic flare was defined as a) serum ALT > 2 x study baseline and > 10 x ULN or b) an ALT 1-grade shift or ALT 2 x previous value and total bilirubin > 2.5 mg/dL or change from study baseline in total bilirubin = 1.0 mg/dL or change from study baseline in prothrombin time > 2 seconds or serum albumin < 3.0 g/dL or change from study baseline in serum albumin <= −1.0 g/dL.|participants|Number|54|54.0||||||
4447335|NCT00095121|4271453|B1|No||Hepatitis B Flares (Acute Exacerbation)|A hepatic flare was defined as a) serum ALT > 2 x study baseline and > 10 x ULN or b) an ALT 1-grade shift or ALT 2 x previous value and total bilirubin > 2.5 mg/dL or change from study baseline in total bilirubin = 1.0 mg/dL or change from study baseline in prothrombin time > 2 seconds or serum albumin < 3.0 g/dL or change from study baseline in serum albumin <= −1.0 g/dL.|participants|Number|103|103.0||||||
4447336|NCT00095121|4271451|B3|Yes||Hepatitis B Flares (Acute Exacerbation)|A hepatic flare was defined as a) serum ALT > 2 x study baseline and > 10 x ULN or b) an ALT 1-grade shift or ALT 2 x previous value and total bilirubin > 2.5 mg/dL or change from study baseline in total bilirubin = 1.0 mg/dL or change from study baseline in prothrombin time > 2 seconds or serum albumin < 3.0 g/dL or change from study baseline in serum albumin <= −1.0 g/dL.|participants|Number|16|16.0||||||
4447337|NCT00095121|4271452|B2|Yes||Hepatitis B Flares (Acute Exacerbation)|A hepatic flare was defined as a) serum ALT > 2 x study baseline and > 10 x ULN or b) an ALT 1-grade shift or ALT 2 x previous value and total bilirubin > 2.5 mg/dL or change from study baseline in total bilirubin = 1.0 mg/dL or change from study baseline in prothrombin time > 2 seconds or serum albumin < 3.0 g/dL or change from study baseline in serum albumin <= −1.0 g/dL.|participants|Number|4|4.0||||||
4447374|NCT00095121|4271453|B1|Not Done||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|1|1.0||||||
4447427|NCT00095121|4271452|B2|Positive||Antibody to HBeAg (HBeAb)||participants|Number|1|1.0||||||
4447338|NCT00095121|4271453|B1|Yes||Hepatitis B Flares (Acute Exacerbation)|A hepatic flare was defined as a) serum ALT > 2 x study baseline and > 10 x ULN or b) an ALT 1-grade shift or ALT 2 x previous value and total bilirubin > 2.5 mg/dL or change from study baseline in total bilirubin = 1.0 mg/dL or change from study baseline in prothrombin time > 2 seconds or serum albumin < 3.0 g/dL or change from study baseline in serum albumin <= −1.0 g/dL.|participants|Number|12|12.0||||||
4447339|NCT00095121|4271451|B3|No||Symptoms of Acute Hepatitis B|Symptoms of acute HBV infection include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay-colored bowel movements, joint pain, and jaundice. - cdc.gov [homepage on the Internet]. Atlanta: Centers for Disease Control and Prevention. Hepatitis B Information for Health Professionals; [updated 2011 April 4]. Available from: http://www.cdc.gov/hepatitis/HBV/HBVfaq.htm.|participants|Number|169|169.0||||||
4447340|NCT00095121|4271452|B2|No||Symptoms of Acute Hepatitis B|Symptoms of acute HBV infection include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay-colored bowel movements, joint pain, and jaundice. - cdc.gov [homepage on the Internet]. Atlanta: Centers for Disease Control and Prevention. Hepatitis B Information for Health Professionals; [updated 2011 April 4]. Available from: http://www.cdc.gov/hepatitis/HBV/HBVfaq.htm.|participants|Number|56|56.0||||||
4447341|NCT00095121|4271453|B1|No||Symptoms of Acute Hepatitis B|Symptoms of acute HBV infection include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay-colored bowel movements, joint pain, and jaundice. - cdc.gov [homepage on the Internet]. Atlanta: Centers for Disease Control and Prevention. Hepatitis B Information for Health Professionals; [updated 2011 April 4]. Available from: http://www.cdc.gov/hepatitis/HBV/HBVfaq.htm.|participants|Number|113|113.0||||||
4447342|NCT00095121|4271451|B3|Yes||Symptoms of Acute Hepatitis B|Symptoms of acute HBV infection include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay-colored bowel movements, joint pain, and jaundice. - cdc.gov [homepage on the Internet]. Atlanta: Centers for Disease Control and Prevention. Hepatitis B Information for Health Professionals; [updated 2011 April 4]. Available from: http://www.cdc.gov/hepatitis/HBV/HBVfaq.htm.|participants|Number|4|4.0||||||
4447343|NCT00095121|4271452|B2|Yes||Symptoms of Acute Hepatitis B|Symptoms of acute HBV infection include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay-colored bowel movements, joint pain, and jaundice. - cdc.gov [homepage on the Internet]. Atlanta: Centers for Disease Control and Prevention. Hepatitis B Information for Health Professionals; [updated 2011 April 4]. Available from: http://www.cdc.gov/hepatitis/HBV/HBVfaq.htm.|participants|Number|2|2.0||||||
4447344|NCT00095121|4271453|B1|Yes||Symptoms of Acute Hepatitis B|Symptoms of acute HBV infection include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay-colored bowel movements, joint pain, and jaundice. - cdc.gov [homepage on the Internet]. Atlanta: Centers for Disease Control and Prevention. Hepatitis B Information for Health Professionals; [updated 2011 April 4]. Available from: http://www.cdc.gov/hepatitis/HBV/HBVfaq.htm.|participants|Number|2|2.0||||||
4447345|NCT00095121|4271451|B3|Sexual contact with HBV infected person||Mode of HBV Acquisition||participants|Number|0|0.0||||||
4447346|NCT00095121|4271452|B2|Sexual contact with HBV infected person||Mode of HBV Acquisition||participants|Number|0|0.0||||||
4447347|NCT00095121|4271453|B1|Sexual contact with HBV infected person||Mode of HBV Acquisition||participants|Number|0|0.0||||||
4447348|NCT00095121|4271451|B3|Missing||Mode of HBV Acquisition||participants|Number|0|0.0||||||
4447349|NCT00095121|4271452|B2|Missing||Mode of HBV Acquisition||participants|Number|0|0.0||||||
4447350|NCT00095121|4271453|B1|Missing||Mode of HBV Acquisition||participants|Number|0|0.0||||||
4447351|NCT00095121|4271451|B3|Intravenous drug user||Mode of HBV Acquisition||participants|Number|0|0.0||||||
4447352|NCT00095121|4271452|B2|Intravenous drug user||Mode of HBV Acquisition||participants|Number|0|0.0||||||
4447353|NCT00095121|4271453|B1|Intravenous drug user||Mode of HBV Acquisition||participants|Number|0|0.0||||||
4447354|NCT00095121|4271451|B3|Other||Mode of HBV Acquisition||participants|Number|6|6.0||||||
4447355|NCT00095121|4271452|B2|Other||Mode of HBV Acquisition||participants|Number|2|2.0||||||
4447356|NCT00095121|4271453|B1|Other||Mode of HBV Acquisition||participants|Number|4|4.0||||||
4447357|NCT00095121|4271451|B3|Transfusion or exposure to infected blood products||Mode of HBV Acquisition||participants|Number|11|11.0||||||
4447358|NCT00095121|4271452|B2|Transfusion or exposure to infected blood products||Mode of HBV Acquisition||participants|Number|3|3.0||||||
4447359|NCT00095121|4271453|B1|Transfusion or exposure to infected blood products||Mode of HBV Acquisition||participants|Number|8|8.0||||||
4447360|NCT00095121|4271451|B3|Childhood acquisition after 1st year of life||Mode of HBV Acquisition||participants|Number|27|27.0||||||
4447361|NCT00095121|4271452|B2|Childhood acquisition after 1st year of life||Mode of HBV Acquisition||participants|Number|8|8.0||||||
4447362|NCT00095121|4271453|B1|Childhood acquisition after 1st year of life||Mode of HBV Acquisition||participants|Number|19|19.0||||||
4447363|NCT00095121|4271451|B3|Unknown||Mode of HBV Acquisition||participants|Number|58|58.0||||||
4447364|NCT00095121|4271452|B2|Unknown||Mode of HBV Acquisition||participants|Number|21|21.0||||||
4447365|NCT00095121|4271453|B1|Unknown||Mode of HBV Acquisition||participants|Number|37|37.0||||||
4447366|NCT00095121|4271451|B3|Perinatal transmission or within 1st year of life||Mode of HBV Acquisition||participants|Number|71|71.0||||||
4447367|NCT00095121|4271452|B2|Perinatal transmission or within 1st year of life||Mode of HBV Acquisition||participants|Number|24|24.0||||||
4447368|NCT00095121|4271453|B1|Perinatal transmission or within 1st year of life||Mode of HBV Acquisition||participants|Number|47|47.0||||||
4447369|NCT00095121|4271451|B3|||Time Since HBV Diagnosis||years until enrollment|Mean|6.8|6.8|Standard Deviation|4.09|4.09|||
4447370|NCT00095121|4271452|B2|||Time Since HBV Diagnosis||years until enrollment|Mean|6.8|6.8|Standard Deviation|4.06|4.06|||
4447371|NCT00095121|4271453|B1|||Time Since HBV Diagnosis||years until enrollment|Mean|6.8|6.8|Standard Deviation|4.12|4.12|||
4447372|NCT00095121|4271451|B3|Not Done||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|2|2.0||||||
4447373|NCT00095121|4271452|B2|Not Done||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|1|1.0||||||
4447375|NCT00095121|4271451|B3|HBV Genotype F||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|2|2.0||||||
4447376|NCT00095121|4271452|B2|HBV Genotype F||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|0|0.0||||||
4447377|NCT00095121|4271453|B1|HBV Genotype F||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|2|2.0||||||
4447378|NCT00095121|4271451|B3|HBV Genotype E||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|5|5.0||||||
4447379|NCT00095121|4271452|B2|HBV Genotype E||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|2|2.0||||||
4447380|NCT00095121|4271453|B1|HBV Genotype E||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|3|3.0||||||
4447381|NCT00095121|4271451|B3|HBV Genotype D||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|49|49.0||||||
4447382|NCT00095121|4271452|B2|HBV Genotype D||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|14|14.0||||||
4447383|NCT00095121|4271453|B1|HBV Genotype D||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|35|35.0||||||
4447384|NCT00095121|4271451|B3|HBV Genotype C||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|14|14.0||||||
4447385|NCT00095121|4271452|B2|HBV Genotype C||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|4|4.0||||||
4447386|NCT00095121|4271453|B1|HBV Genotype C||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|10|10.0||||||
4447387|NCT00095121|4271451|B3|HBV Genotype B||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|18|18.0||||||
4447388|NCT00095121|4271452|B2|HBV Genotype B||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|5|5.0||||||
4447389|NCT00095121|4271453|B1|HBV Genotype B||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|13|13.0||||||
4447390|NCT00095121|4271451|B3|HBV Genotype A||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|83|83.0||||||
4447391|NCT00095121|4271452|B2|HBV Genotype A||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|32|32.0||||||
4447392|NCT00095121|4271453|B1|HBV Genotype A||Genotype|Identification of specific HBV genotype (ie, Genotype A, B, C, D, E, or F).|participants|Number|51|51.0||||||
4447393|NCT00095121|4271451|B3|||ALT (Multiples of ULN)||multiples|Mean|2.8|2.8|Standard Deviation|1.85|1.85|||
4447394|NCT00095121|4271452|B2|||ALT (Multiples of ULN)||multiples|Mean|2.6|2.6|Standard Deviation|1.40|1.4|||
4447395|NCT00095121|4271453|B1|||ALT (Multiples of ULN)||multiples|Mean|2.9|2.9|Standard Deviation|2.03|2.03|||
4447396|NCT00095121|4271451|B3|Alanine aminotransferase >5*ULN||ALT Category||participants|Number|23|23.0||||||
4447397|NCT00095121|4271452|B2|Alanine aminotransferase >5*ULN||ALT Category||participants|Number|5|5.0||||||
4447398|NCT00095121|4271453|B1|Alanine aminotransferase >5*ULN||ALT Category||participants|Number|18|18.0||||||
4447399|NCT00095121|4271451|B3|2*ULN <alanine aminotransferase <=5*ULN||ALT Category||participants|Number|78|78.0||||||
4447400|NCT00095121|4271452|B2|2*ULN <alanine aminotransferase <=5*ULN||ALT Category||participants|Number|26|26.0||||||
4447401|NCT00095121|4271453|B1|2*ULN <alanine aminotransferase <=5*ULN||ALT Category||participants|Number|52|52.0||||||
4447402|NCT00095121|4271451|B3|ULN <alanine aminotransferase <=2*ULN||ALT Category||participants|Number|62|62.0||||||
4447403|NCT00095121|4271452|B2|ULN <alanine aminotransferase <=2*ULN||ALT Category||participants|Number|25|25.0||||||
4447404|NCT00095121|4271453|B1|ULN <alanine aminotransferase <=2*ULN||ALT Category||participants|Number|37|37.0||||||
4447405|NCT00095121|4271451|B3|Alanine aminotransferase <=ULN||ALT Category||participants|Number|10|10.0||||||
4447406|NCT00095121|4271452|B2|Alanine aminotransferase <=ULN||ALT Category||participants|Number|2|2.0||||||
4447407|NCT00095121|4271453|B1|Alanine aminotransferase <=ULN||ALT Category||participants|Number|8|8.0||||||
4447408|NCT00095121|4271451|B3|>median (2.265)||ALT as Multiple of ULN||participants|Number|86|86.0||||||
4447409|NCT00095121|4271452|B2|>median (2.265)||ALT as Multiple of ULN||participants|Number|28|28.0||||||
4447410|NCT00095121|4271453|B1|>median (2.265)||ALT as Multiple of ULN||participants|Number|58|58.0||||||
4447411|NCT00095121|4271451|B3|<=median (2.265)||ALT as Multiple of ULN||participants|Number|87|87.0||||||
4447412|NCT00095121|4271452|B2|<=median (2.265)||ALT as Multiple of ULN||participants|Number|30|30.0||||||
4447413|NCT00095121|4271453|B1|<=median (2.265)||ALT as Multiple of ULN||participants|Number|57|57.0||||||
4447414|NCT00095121|4271451|B3|<ULN||ALT||participants|Number|9|9.0||||||
4447415|NCT00095121|4271452|B2|<ULN||ALT||participants|Number|2|2.0||||||
4447416|NCT00095121|4271453|B1|<ULN||ALT||participants|Number|7|7.0||||||
4447417|NCT00095121|4271451|B3|>= Upper Limit of Normal (ULN)||ALT||participants|Number|164|164.0||||||
4447418|NCT00095121|4271452|B2|>= Upper Limit of Normal (ULN)||ALT||participants|Number|56|56.0||||||
4447419|NCT00095121|4271453|B1|>= Upper Limit of Normal (ULN)||ALT||participants|Number|108|108.0||||||
4447420|NCT00095121|4271451|B3|||ALT||U/L|Mean|107|107.0|Standard Deviation|73.3|73.3|||
4447421|NCT00095121|4271452|B2|||ALT||U/L|Mean|99|99.0|Standard Deviation|52.8|52.8|||
4447422|NCT00095121|4271453|B1|||ALT||U/L|Mean|111|111.0|Standard Deviation|81.6|81.6|||
4447423|NCT00095121|4271451|B3|Not Done||Antibody to HBeAg (HBeAb)||participants|Number|170|170.0||||||
4447424|NCT00095121|4271452|B2|Not Done||Antibody to HBeAg (HBeAb)||participants|Number|57|57.0||||||
4447425|NCT00095121|4271453|B1|Not Done||Antibody to HBeAg (HBeAb)||participants|Number|113|113.0||||||
4447426|NCT00095121|4271451|B3|Positive||Antibody to HBeAg (HBeAb)||participants|Number|3|3.0||||||
4447428|NCT00095121|4271453|B1|Positive||Antibody to HBeAg (HBeAb)||participants|Number|2|2.0||||||
4447429|NCT00095121|4271451|B3|Negative||Antibody to HBeAg (HBeAb)||participants|Number|0|0.0||||||
4447430|NCT00095121|4271452|B2|Negative||Antibody to HBeAg (HBeAb)||participants|Number|0|0.0||||||
4447431|NCT00095121|4271453|B1|Negative||Antibody to HBeAg (HBeAb)||participants|Number|0|0.0||||||
4447432|NCT00095121|4271451|B3|Positive||Hepatitis B e Antigen (HBeAg)||participants|Number|170|170.0||||||
4447433|NCT00095121|4271452|B2|Positive||Hepatitis B e Antigen (HBeAg)||participants|Number|57|57.0||||||
4447434|NCT00095121|4271453|B1|Positive||Hepatitis B e Antigen (HBeAg)||participants|Number|113|113.0||||||
4447435|NCT00095121|4271451|B3|Negative||Hepatitis B e Antigen (HBeAg)||participants|Number|3|3.0||||||
4447436|NCT00095121|4271452|B2|Negative||Hepatitis B e Antigen (HBeAg)||participants|Number|1|1.0||||||
4447437|NCT00095121|4271453|B1|Negative||Hepatitis B e Antigen (HBeAg)||participants|Number|2|2.0||||||
4447438|NCT00095121|4271451|B3|Not Done||Antibody to HBsAg (HBsAb)||participants|Number|173|173.0||||||
4447439|NCT00095121|4271452|B2|Not Done||Antibody to HBsAg (HBsAb)||participants|Number|58|58.0||||||
4447440|NCT00095121|4271453|B1|Not Done||Antibody to HBsAg (HBsAb)||participants|Number|115|115.0||||||
4447441|NCT00095121|4271451|B3|Positive||Antibody to HBsAg (HBsAb)||participants|Number|0|0.0||||||
4447442|NCT00095121|4271452|B2|Positive||Antibody to HBsAg (HBsAb)||participants|Number|0|0.0||||||
4447443|NCT00095121|4271453|B1|Positive||Antibody to HBsAg (HBsAb)||participants|Number|0|0.0||||||
4447444|NCT00095121|4271451|B3|Negative||Antibody to HBsAg (HBsAb)||participants|Number|0|0.0||||||
4447445|NCT00095121|4271452|B2|Negative||Antibody to HBsAg (HBsAb)||participants|Number|0|0.0||||||
4447446|NCT00095121|4271453|B1|Negative||Antibody to HBsAg (HBsAb)||participants|Number|0|0.0||||||
4447447|NCT00095121|4271451|B3|Positive||Hepatitis B Surface Antigen (HBsAg)||participants|Number|173|173.0||||||
4447448|NCT00095121|4271452|B2|Positive||Hepatitis B Surface Antigen (HBsAg)||participants|Number|58|58.0||||||
4447449|NCT00095121|4271453|B1|Positive||Hepatitis B Surface Antigen (HBsAg)||participants|Number|115|115.0||||||
4447450|NCT00095121|4271451|B3|Negative||Hepatitis B Surface Antigen (HBsAg)||participants|Number|0|0.0||||||
4447451|NCT00095121|4271452|B2|Negative||Hepatitis B Surface Antigen (HBsAg)||participants|Number|0|0.0||||||
4447452|NCT00095121|4271453|B1|Negative||Hepatitis B Surface Antigen (HBsAg)||participants|Number|0|0.0||||||
4447453|NCT00095121|4271451|B3|||HBV DNA||log10 copies/mL|Mean|8.71|8.71|Standard Deviation|0.935|0.935|||
4447454|NCT00095121|4271452|B2|||HBV DNA||log10 copies/mL|Mean|8.67|8.67|Standard Deviation|1.016|1.016|||
4447455|NCT00095121|4271453|B1|||HBV DNA||log10 copies/mL|Mean|8.74|8.74|Standard Deviation|0.894|0.894|||
4447456|NCT00095121|4271451|B3|No||Prior Exposure to Hepatitis B Treatment||participants|Number|76|76.0||||||
4447457|NCT00095121|4271452|B2|No||Prior Exposure to Hepatitis B Treatment||participants|Number|25|25.0||||||
4447458|NCT00095121|4271453|B1|No||Prior Exposure to Hepatitis B Treatment||participants|Number|51|51.0||||||
4447459|NCT00095121|4271451|B3|Yes||Prior Exposure to Hepatitis B Treatment||participants|Number|97|97.0||||||
4447460|NCT00095121|4271452|B2|Yes||Prior Exposure to Hepatitis B Treatment||participants|Number|33|33.0||||||
4447461|NCT00095121|4271453|B1|Yes||Prior Exposure to Hepatitis B Treatment||participants|Number|64|64.0||||||
4447462|NCT00095121|4271451|B3|||Body Mass Index (Females)||kg/cm^2|Mean|17.7|17.7|Standard Deviation|3.67|3.67|||
4447463|NCT00095121|4271452|B2|||Body Mass Index (Females)||kg/cm^2|Mean|17.7|17.7|Standard Deviation|3.76|3.76|||
4447464|NCT00095121|4271453|B1|||Body Mass Index (Females)||kg/cm^2|Mean|17.8|17.8|Standard Deviation|3.68|3.68|||
4447465|NCT00095121|4271451|B3|||Body Mass Index (Males)||kg/cm^2|Mean|19.4|19.4|Standard Deviation|4.33|4.33|||
4447466|NCT00095121|4271452|B2|||Body Mass Index (Males)||kg/cm^2|Mean|19.7|19.7|Standard Deviation|4.87|4.87|||
4447467|NCT00095121|4271453|B1|||Body Mass Index (Males)||kg/cm^2|Mean|19.3|19.3|Standard Deviation|4.04|4.04|||
4447468|NCT00095121|4271451|B3|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4447469|NCT00095121|4271452|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4447470|NCT00095121|4271453|B1|United Kingdom||Region of Enrollment||participants|Number|11|11.0||||||
4447471|NCT00095121|4271451|B3|Spain||Region of Enrollment||participants|Number|8|8.0||||||
4447472|NCT00095121|4271452|B2|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4447473|NCT00095121|4271453|B1|Spain||Region of Enrollment||participants|Number|4|4.0||||||
4447474|NCT00095121|4271451|B3|Poland||Region of Enrollment||participants|Number|75|75.0||||||
4447475|NCT00095121|4271452|B2|Poland||Region of Enrollment||participants|Number|27|27.0||||||
4447476|NCT00095121|4271453|B1|Poland||Region of Enrollment||participants|Number|48|48.0||||||
4447477|NCT00095121|4271451|B3|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4447478|NCT00095121|4271452|B2|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4447479|NCT00095121|4271453|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4447480|NCT00095121|4271451|B3|Belgium||Region of Enrollment||participants|Number|9|9.0||||||
4447481|NCT00095121|4271452|B2|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4447482|NCT00095121|4271453|B1|Belgium||Region of Enrollment||participants|Number|6|6.0||||||
4447483|NCT00095121|4271451|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4447484|NCT00095121|4271452|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4447485|NCT00095121|4271453|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4447486|NCT00095121|4271451|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447487|NCT00095121|4271452|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447488|NCT00095121|4271453|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447489|NCT00095121|4271451|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4447490|NCT00095121|4271452|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4447491|NCT00095121|4271453|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4447492|NCT00095121|4271451|B3||White|Race (NIH/OMB)||Participants|Count of Participants|111|111.0||||||
4447493|NCT00095121|4271452|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4447494|NCT00095121|4271453|B1||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4447495|NCT00095121|4271451|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4447496|NCT00095121|4271452|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4447497|NCT00095121|4271453|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4447498|NCT00095121|4271451|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447499|NCT00095121|4271452|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447500|NCT00095121|4271453|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447501|NCT00095121|4271451|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4447502|NCT00095121|4271452|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4447503|NCT00095121|4271453|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4447504|NCT00095121|4271451|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4447505|NCT00095121|4271452|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447506|NCT00095121|4271453|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4447507|NCT00095121|4271451|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447508|NCT00095121|4271452|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447509|NCT00095121|4271453|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447510|NCT00095121|4271451|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|172|172.0||||||
4447511|NCT00095121|4271452|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4447512|NCT00095121|4271453|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4447513|NCT00095121|4271451|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4447514|NCT00095121|4271452|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447515|NCT00095121|4271453|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4447516|NCT00095121|4271451|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4447517|NCT00095121|4271452|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4447518|NCT00095121|4271453|B1||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4447519|NCT00095121|4271451|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4447520|NCT00095121|4271452|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4447521|NCT00095121|4271453|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4447522|NCT00095121|4271451|B3|||Age||years|Mean|10.8|10.8|Standard Deviation|4.19|4.19|||
4447523|NCT00095121|4271452|B2|||Age||years|Mean|10.7|10.7|Standard Deviation|3.94|3.94|||
4447524|NCT00095121|4271453|B1|||Age||years|Mean|10.8|10.8|Standard Deviation|4.33|4.33|||
4447525|NCT00095121|4271451|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4447526|NCT00095121|4271452|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4447527|NCT00095121|4271453|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4447528|NCT00095121|4271451|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4447529|NCT00095121|4271452|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4447530|NCT00095121|4271453|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4447531|NCT00095121|4271451|B3||<=18 years|Age||Participants|Count of Participants|173|173.0||||||
4447532|NCT00095121|4271452|B2||<=18 years|Age||Participants|Count of Participants|58|58.0||||||
4447533|NCT00095121|4271453|B1||<=18 years|Age||Participants|Count of Participants|115|115.0||||||
4447534|NCT00095056|4271498|B3|||HbA1c (Hemoglobin A1c)||Percent|Mean|7.7|7.7|Standard Deviation|0.9|0.9|||
4447535|NCT00095056|4271499|B2|||HbA1c (Hemoglobin A1c)||Percent|Mean|7.8|7.8|Standard Deviation|0.9|0.9|||
4447536|NCT00095056|4271500|B1|||HbA1c (Hemoglobin A1c)||Percent|Mean|7.6|7.6|Standard Deviation|0.9|0.9|||
4447537|NCT00095056|4271498|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4447538|NCT00095056|4271499|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4447539|NCT00095056|4271500|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4447540|NCT00095056|4271498|B3|Asian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4447541|NCT00095056|4271499|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4447542|NCT00095056|4271500|B1|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4447543|NCT00095056|4271498|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4447544|NCT00095056|4271499|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4447545|NCT00095056|4271500|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4447546|NCT00095056|4271498|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4447547|NCT00095056|4271499|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4447548|NCT00095056|4271500|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4447549|NCT00095056|4271498|B3|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4447550|NCT00095056|4271499|B2|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4447551|NCT00095056|4271500|B1|White||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4447552|NCT00095056|4271498|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4447553|NCT00095056|4271499|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4447554|NCT00095056|4271500|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4447555|NCT00095056|4271498|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4447556|NCT00095056|4271499|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4447557|NCT00095056|4271500|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4447558|NCT00095056|4271498|B3|||Age||years|Mean|67.9|67.9|Standard Deviation|9.8|9.8|||
4447559|NCT00095056|4271499|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|9.7|9.7|||
4447560|NCT00095056|4271500|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|9.8|9.8|||
4447561|NCT00094900|4271509|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447562|NCT00094900|4271509|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447563|NCT00094900|4271509|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4447564|NCT00094900|4271509|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447565|NCT00094900|4271509|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447566|NCT00094900|4271509|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447567|NCT00094900|4271509|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447568|NCT00094900|4271509|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447569|NCT00094900|4271509|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4447570|NCT00094900|4271509|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4447571|NCT00094900|4271509|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4447572|NCT00094900|4271509|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4447573|NCT00094900|4271509|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4447574|NCT00094900|4271509|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4447575|NCT00094900|4271509|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4447576|NCT00094887|4271609|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4447577|NCT00094887|4271610|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4447578|NCT00094887|4271611|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4447579|NCT00094887|4271609|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4447580|NCT00094887|4271610|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4447581|NCT00094887|4271611|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4447582|NCT00094887|4271609|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4447583|NCT00094887|4271610|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4447584|NCT00094887|4271611|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4447585|NCT00094887|4271609|B3|||Age||years|Mean|26.3|26.3|Standard Deviation|10.75|10.75|||
4447586|NCT00094887|4271610|B2|||Age||years|Mean|26.0|26.0|Standard Deviation|10.49|10.49|||
4447587|NCT00094887|4271611|B1|||Age||years|Mean|26.6|26.6|Standard Deviation|11.06|11.06|||
4447588|NCT00094887|4271609|B3|>=16 years||Age, Customized||participants|Number|124|124.0||||||
4447589|NCT00094887|4271610|B2|>=16 years||Age, Customized||participants|Number|61|61.0||||||
4447590|NCT00094887|4271611|B1|>=16 years||Age, Customized||participants|Number|63|63.0||||||
4447591|NCT00094887|4271609|B3|< 16 years||Age, Customized||participants|Number|26|26.0||||||
4447592|NCT00094887|4271610|B2|< 16 years||Age, Customized||participants|Number|14|14.0||||||
4447593|NCT00094887|4271611|B1|< 16 years||Age, Customized||participants|Number|12|12.0||||||
4447594|NCT00094861|4271618|B3|3B, 2, 5-10%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|0|0.0||||||
4447595|NCT00094861|4271619|B2|3B, 2, 5-10%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|0|0.0||||||
4447596|NCT00094861|4271620|B1|3B, 2, 5-10%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|0|0.0||||||
4447597|NCT00094861|4271618|B3|3B, 2, <5%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|0|0.0||||||
4447598|NCT00094861|4271619|B2|3B, 2, <5%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|0|0.0||||||
4447599|NCT00094861|4271620|B1|3B, 2, <5%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|0|0.0||||||
4447600|NCT00094861|4271618|B3|3B, 0-1, 5-10%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|11|11.0||||||
4447659|NCT00094861|4271620|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4447601|NCT00094861|4271619|B2|3B, 0-1, 5-10%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|5|5.0||||||
4447602|NCT00094861|4271620|B1|3B, 0-1, 5-10%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|6|6.0||||||
4447603|NCT00094861|4271618|B3|3B, 0-1, <5%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|49|49.0||||||
4447604|NCT00094861|4271619|B2|3B, 0-1, <5%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|25|25.0||||||
4447605|NCT00094861|4271620|B1|3B, 0-1, <5%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|24|24.0||||||
4447606|NCT00094861|4271618|B3|3A, 2, 5-10%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|1|1.0||||||
4447607|NCT00094861|4271619|B2|3A, 2, 5-10%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|0|0.0||||||
4447608|NCT00094861|4271620|B1|3A, 2, 5-10%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|1|1.0||||||
4447609|NCT00094861|4271618|B3|3A, 2, <5%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|3|3.0||||||
4447610|NCT00094861|4271619|B2|3A, 2, <5%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|2|2.0||||||
4447611|NCT00094861|4271620|B1|3A, 2, <5%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|1|1.0||||||
4447612|NCT00094861|4271618|B3|3A, 0-1, 5-10%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|10|10.0||||||
4447613|NCT00094861|4271619|B2|3A, 0-1, 5-10%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|6|6.0||||||
4447614|NCT00094861|4271620|B1|3A, 0-1, 5-10%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|4|4.0||||||
4447615|NCT00094861|4271618|B3|3A, 0-1, <5%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|21|21.0||||||
4447616|NCT00094861|4271619|B2|3A, 0-1, <5%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|11|11.0||||||
4447617|NCT00094861|4271620|B1|3A, 0-1, <5%||Randomization Strata|Baseline disease stage (3A or 3B), Baseline ECOG performance status (0-1 or 2), Estimated weight loss in 3 months before study (<5% or 5-10%)|participants|Number|10|10.0||||||
4447618|NCT00094861|4271618|B3|5 - 10%||Weight Loss Over Last 3 Months||participants|Number|23|23.0||||||
4447619|NCT00094861|4271619|B2|5 - 10%||Weight Loss Over Last 3 Months||participants|Number|12|12.0||||||
4447620|NCT00094861|4271620|B1|5 - 10%||Weight Loss Over Last 3 Months||participants|Number|11|11.0||||||
4447621|NCT00094861|4271618|B3|< 5%||Weight Loss Over Last 3 Months||participants|Number|72|72.0||||||
4447622|NCT00094861|4271619|B2|< 5%||Weight Loss Over Last 3 Months||participants|Number|37|37.0||||||
4447623|NCT00094861|4271620|B1|< 5%||Weight Loss Over Last 3 Months||participants|Number|35|35.0||||||
4447624|NCT00094861|4271618|B3|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair; Grade 5: Dead.|participants|Number|4|4.0||||||
4447625|NCT00094861|4271619|B2|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair; Grade 5: Dead.|participants|Number|2|2.0||||||
4447626|NCT00094861|4271620|B1|Grade 2||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair; Grade 5: Dead.|participants|Number|2|2.0||||||
4447660|NCT00094861|4271618|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4447661|NCT00094861|4271619|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4447662|NCT00094861|4271620|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4447663|NCT00094861|4271618|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|8.9|8.9|||
4447627|NCT00094861|4271618|B3|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair; Grade 5: Dead.|participants|Number|49|49.0||||||
4447628|NCT00094861|4271619|B2|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair; Grade 5: Dead.|participants|Number|26|26.0||||||
4447629|NCT00094861|4271620|B1|Grade 1||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair; Grade 5: Dead.|participants|Number|23|23.0||||||
4447630|NCT00094861|4271618|B3|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair; Grade 5: Dead.|participants|Number|42|42.0||||||
4447631|NCT00094861|4271619|B2|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair; Grade 5: Dead.|participants|Number|21|21.0||||||
4447632|NCT00094861|4271620|B1|Grade 0||Eastern Cooperative Oncology Group (ECOG) Performance Status|Grade 0: Fully active, able to carry on all pre-disease performance without restriction; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature; Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; Grade 3: Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair; Grade 5: Dead.|participants|Number|21|21.0||||||
4447633|NCT00094861|4271618|B3|Stage 3B||Disease Stage|American Joint Committee on Cancer (AJCC) disease stage.|participants|Number|62|62.0||||||
4447634|NCT00094861|4271619|B2|Stage 3B||Disease Stage|American Joint Committee on Cancer (AJCC) disease stage.|participants|Number|30|30.0||||||
4447635|NCT00094861|4271620|B1|Stage 3B||Disease Stage|American Joint Committee on Cancer (AJCC) disease stage.|participants|Number|32|32.0||||||
4447636|NCT00094861|4271618|B3|Stage 3A||Disease Stage|American Joint Committee on Cancer (AJCC) disease stage.|participants|Number|33|33.0||||||
4447637|NCT00094861|4271619|B2|Stage 3A||Disease Stage|American Joint Committee on Cancer (AJCC) disease stage.|participants|Number|19|19.0||||||
4447638|NCT00094861|4271620|B1|Stage 3A||Disease Stage|American Joint Committee on Cancer (AJCC) disease stage.|participants|Number|14|14.0||||||
4447639|NCT00094861|4271618|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447640|NCT00094861|4271619|B2|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447641|NCT00094861|4271620|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4447642|NCT00094861|4271618|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447643|NCT00094861|4271619|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447644|NCT00094861|4271620|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4447645|NCT00094861|4271618|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447646|NCT00094861|4271619|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447647|NCT00094861|4271620|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4447648|NCT00094861|4271618|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4447649|NCT00094861|4271619|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447650|NCT00094861|4271620|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447651|NCT00094861|4271618|B3|Black or African-American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4447652|NCT00094861|4271619|B2|Black or African-American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4447653|NCT00094861|4271620|B1|Black or African-American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4447654|NCT00094861|4271618|B3|White or Causcasian||Race/Ethnicity, Customized||Participants|Number|86|86.0||||||
4447655|NCT00094861|4271619|B2|White or Causcasian||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4447656|NCT00094861|4271620|B1|White or Causcasian||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4447657|NCT00094861|4271618|B3||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4447658|NCT00094861|4271619|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4447664|NCT00094861|4271619|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|9.8|9.8|||
4447665|NCT00094861|4271620|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|7.7|7.7|||
4447666|NCT00094835|4271641|B8|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4447667|NCT00094835|4271642|B7|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447668|NCT00094835|4271643|B6|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4447669|NCT00094835|4271644|B5|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447670|NCT00094835|4271645|B4|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447671|NCT00094835|4271646|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4447672|NCT00094835|4271647|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447673|NCT00094835|4271648|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447674|NCT00094835|4271641|B8|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4447675|NCT00094835|4271642|B7|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4447676|NCT00094835|4271643|B6|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447677|NCT00094835|4271644|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4447678|NCT00094835|4271645|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447679|NCT00094835|4271646|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447680|NCT00094835|4271647|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447681|NCT00094835|4271648|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447682|NCT00094835|4271641|B8|White or Caucasian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4447683|NCT00094835|4271642|B7|White or Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4447684|NCT00094835|4271643|B6|White or Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4447685|NCT00094835|4271644|B5|White or Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4447686|NCT00094835|4271645|B4|White or Caucasian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4447687|NCT00094835|4271646|B3|White or Caucasian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4447688|NCT00094835|4271647|B2|White or Caucasian||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4447689|NCT00094835|4271648|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4447690|NCT00094835|4271641|B8||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4447691|NCT00094835|4271642|B7||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4447692|NCT00094835|4271643|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4447693|NCT00094835|4271644|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4447694|NCT00094835|4271645|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4447695|NCT00094835|4271646|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4447696|NCT00094835|4271647|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4447697|NCT00094835|4271648|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4447698|NCT00094835|4271641|B8||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4447699|NCT00094835|4271642|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4447700|NCT00094835|4271643|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4447701|NCT00094835|4271644|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4447702|NCT00094835|4271645|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4447703|NCT00094835|4271646|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4447704|NCT00094835|4271647|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4447705|NCT00094835|4271648|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4447706|NCT00094835|4271641|B8|||Age||years|Mean|59.9|59.9|Standard Deviation|10.8|10.8|||
4447707|NCT00094835|4271642|B7|||Age||years|Mean|59.0|59.0|Standard Deviation|5.5|5.5|||
4447708|NCT00094835|4271643|B6|||Age||years|Mean|51.6|51.6|Standard Deviation|14.6|14.6|||
4447709|NCT00094835|4271644|B5|||Age||years|Mean|64.0|64.0|Standard Deviation|9.6|9.6|||
4447710|NCT00094835|4271645|B4|||Age||years|Mean|57.5|57.5|Standard Deviation|9.9|9.9|||
4447711|NCT00094835|4271646|B3|||Age||years|Mean|64.5|64.5|Standard Deviation|6.1|6.1|||
4447712|NCT00094835|4271647|B2|||Age||years|Mean|55.7|55.7|Standard Deviation|12.7|12.7|||
4447713|NCT00094835|4271648|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|7.8|7.8|||
4447714|NCT00094809|4271730|B3|FOLFIRI||Chemotherapy Regimen|FOIL = 5-fluorouracil, oxaliplatin, irinotecan, and leucovorin; FOLFOX = 5-fluorouracil, oxaliplatin, and leucovorin; FOLFIRI = 5-fluorouracil, irinotecan, and leucovorin|Participants|Number|62|62.0||||||
4447715|NCT00094809|4271731|B2|FOLFIRI||Chemotherapy Regimen|FOIL = 5-fluorouracil, oxaliplatin, irinotecan, and leucovorin; FOLFOX = 5-fluorouracil, oxaliplatin, and leucovorin; FOLFIRI = 5-fluorouracil, irinotecan, and leucovorin|Participants|Number|30|30.0||||||
4447716|NCT00094809|4271732|B1|FOLFIRI||Chemotherapy Regimen|FOIL = 5-fluorouracil, oxaliplatin, irinotecan, and leucovorin; FOLFOX = 5-fluorouracil, oxaliplatin, and leucovorin; FOLFIRI = 5-fluorouracil, irinotecan, and leucovorin|Participants|Number|32|32.0||||||
4447717|NCT00094809|4271730|B3|FOLFOX||Chemotherapy Regimen|FOIL = 5-fluorouracil, oxaliplatin, irinotecan, and leucovorin; FOLFOX = 5-fluorouracil, oxaliplatin, and leucovorin; FOLFIRI = 5-fluorouracil, irinotecan, and leucovorin|Participants|Number|119|119.0||||||
4447718|NCT00094809|4271731|B2|FOLFOX||Chemotherapy Regimen|FOIL = 5-fluorouracil, oxaliplatin, irinotecan, and leucovorin; FOLFOX = 5-fluorouracil, oxaliplatin, and leucovorin; FOLFIRI = 5-fluorouracil, irinotecan, and leucovorin|Participants|Number|58|58.0||||||
4447719|NCT00094809|4271732|B1|FOLFOX||Chemotherapy Regimen|FOIL = 5-fluorouracil, oxaliplatin, irinotecan, and leucovorin; FOLFOX = 5-fluorouracil, oxaliplatin, and leucovorin; FOLFIRI = 5-fluorouracil, irinotecan, and leucovorin|Participants|Number|61|61.0||||||
4447720|NCT00094809|4271730|B3|FOIL||Chemotherapy Regimen|FOIL = 5-fluorouracil, oxaliplatin, irinotecan, and leucovorin; FOLFOX = 5-fluorouracil, oxaliplatin, and leucovorin; FOLFIRI = 5-fluorouracil, irinotecan, and leucovorin|Participants|Number|60|60.0||||||
4447721|NCT00094809|4271731|B2|FOIL||Chemotherapy Regimen|FOIL = 5-fluorouracil, oxaliplatin, irinotecan, and leucovorin; FOLFOX = 5-fluorouracil, oxaliplatin, and leucovorin; FOLFIRI = 5-fluorouracil, irinotecan, and leucovorin|Participants|Number|30|30.0||||||
4447722|NCT00094809|4271732|B1|FOIL||Chemotherapy Regimen|FOIL = 5-fluorouracil, oxaliplatin, irinotecan, and leucovorin; FOLFOX = 5-fluorouracil, oxaliplatin, and leucovorin; FOLFIRI = 5-fluorouracil, irinotecan, and leucovorin|Participants|Number|30|30.0||||||
4447723|NCT00094809|4271730|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447724|NCT00094809|4271731|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4447725|NCT00094809|4271732|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447726|NCT00094809|4271730|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4447727|NCT00094809|4271731|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4447728|NCT00094809|4271732|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4447729|NCT00094809|4271730|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447730|NCT00094809|4271731|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4447731|NCT00094809|4271732|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447732|NCT00094809|4271730|B3|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4447733|NCT00094809|4271731|B2|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4447734|NCT00094809|4271732|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4447735|NCT00094809|4271730|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4447736|NCT00094809|4271731|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4447737|NCT00094809|4271732|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4447738|NCT00094809|4271730|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|24|24.0||||||
4447739|NCT00094809|4271731|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4447740|NCT00094809|4271732|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4447741|NCT00094809|4271730|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|187|187.0||||||
4447742|NCT00094809|4271731|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|84|84.0||||||
4447743|NCT00094809|4271732|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|103|103.0||||||
4447744|NCT00094809|4271730|B3||Male|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4447745|NCT00094809|4271731|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4447746|NCT00094809|4271732|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4447747|NCT00094809|4271730|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4447748|NCT00094809|4271731|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4447749|NCT00094809|4271732|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4447750|NCT00094809|4271730|B3|||Age||Years|Mean|62.7|62.7|Standard Deviation|12.71|12.71|||
4447751|NCT00094809|4271731|B2|||Age||Years|Mean|62.9|62.9|Standard Deviation|13.21|13.21|||
4447752|NCT00094809|4271732|B1|||Age||Years|Mean|62.4|62.4|Standard Deviation|12.26|12.26|||
4447753|NCT00094770|4271757|B3|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.7|7.7|Standard Deviation|0.9|0.9|||
4447754|NCT00094770|4271758|B2|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.6|7.6|Standard Deviation|0.9|0.9|||
4447755|NCT00094770|4271759|B1|||Hemoglobin A1c (HbA1c)||Percent|Mean|7.7|7.7|Standard Deviation|0.9|0.9|||
4447756|NCT00094770|4271757|B3|Other||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4447757|NCT00094770|4271758|B2|Other||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4447758|NCT00094770|4271759|B1|Other||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4447759|NCT00094770|4271757|B3|White||Race/Ethnicity, Customized||participants|Number|866|866.0||||||
4447760|NCT00094770|4271758|B2|White||Race/Ethnicity, Customized||participants|Number|434|434.0||||||
4447761|NCT00094770|4271759|B1|White||Race/Ethnicity, Customized||participants|Number|432|432.0||||||
4447762|NCT00094770|4271757|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|89|89.0||||||
4447763|NCT00094770|4271758|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4447764|NCT00094770|4271759|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4447765|NCT00094770|4271757|B3|Black||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4447766|NCT00094770|4271758|B2|Black||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4447767|NCT00094770|4271759|B1|Black||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4447768|NCT00094770|4271757|B3|Asian||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
4447769|NCT00094770|4271758|B2|Asian||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4447770|NCT00094770|4271759|B1|Asian||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4447771|NCT00094770|4271757|B3||Male|Sex: Female, Male||Participants|Count of Participants|694|694.0||||||
4447772|NCT00094770|4271758|B2||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4447773|NCT00094770|4271759|B1||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4447774|NCT00094770|4271757|B3||Female|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
4447775|NCT00094770|4271758|B2||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4447776|NCT00094770|4271759|B1||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4447777|NCT00094770|4271757|B3|||Age||years|Mean|56.7|56.7|Standard Deviation|9.55|9.55|||
4447778|NCT00094770|4271758|B2|||Age||years|Mean|56.6|56.6|Standard Deviation|9.8|9.8|||
4447779|NCT00094770|4271759|B1|||Age||years|Mean|56.8|56.8|Standard Deviation|9.3|9.3|||
4447780|NCT00094757|4271788|B4|||Hemoglobin A1C (A1C)||Percent|Mean|8.1|8.1|Standard Deviation|0.9|0.9|||
4447781|NCT00094757|4271789|B3|||Hemoglobin A1C (A1C)||Percent|Mean|8.0|8.0|Standard Deviation|0.9|0.9|||
4447782|NCT00094757|4271790|B2|||Hemoglobin A1C (A1C)||Percent|Mean|8.1|8.1|Standard Deviation|0.9|0.9|||
4447783|NCT00094757|4271791|B1|||Hemoglobin A1C (A1C)||Percent|Mean|8.0|8.0|Standard Deviation|0.8|0.8|||
4447784|NCT00094757|4271788|B4|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4447785|NCT00094757|4271789|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4447786|NCT00094757|4271790|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4447787|NCT00094757|4271791|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4447788|NCT00094757|4271788|B4|Asian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4447789|NCT00094757|4271789|B3|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4447790|NCT00094757|4271790|B2|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4447791|NCT00094757|4271791|B1|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4447792|NCT00094757|4271788|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|98|98.0||||||
4447793|NCT00094757|4271789|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4447794|NCT00094757|4271790|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4447795|NCT00094757|4271791|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4447796|NCT00094757|4271788|B4|Black||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4447797|NCT00094757|4271789|B3|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4447798|NCT00094757|4271790|B2|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4447799|NCT00094757|4271791|B1|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4447800|NCT00094757|4271788|B4|White||Race/Ethnicity, Customized||participants|Number|356|356.0||||||
4447801|NCT00094757|4271789|B3|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4447802|NCT00094757|4271790|B2|White||Race/Ethnicity, Customized||participants|Number|146|146.0||||||
4447803|NCT00094757|4271791|B1|White||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
4447804|NCT00094757|4271788|B4||Male|Gender||Participants|Count of Participants|283|283.0||||||
4447805|NCT00094757|4271789|B3||Male|Gender||Participants|Count of Participants|69|69.0||||||
4447806|NCT00094757|4271790|B2||Male|Gender||Participants|Count of Participants|104|104.0||||||
4447807|NCT00094757|4271791|B1||Male|Gender||Participants|Count of Participants|110|110.0||||||
4447808|NCT00094757|4271788|B4||Female|Gender||Participants|Count of Participants|238|238.0||||||
4447809|NCT00094757|4271789|B3||Female|Gender||Participants|Count of Participants|41|41.0||||||
4447810|NCT00094757|4271790|B2||Female|Gender||Participants|Count of Participants|102|102.0||||||
4447811|NCT00094757|4271791|B1||Female|Gender||Participants|Count of Participants|95|95.0||||||
4447812|NCT00094757|4271788|B4|||Age||years|Mean|55.1|55.1|Standard Deviation|9.7|9.7|||
4447813|NCT00094757|4271789|B3|||Age||years|Mean|55.5|55.5|Standard Deviation|10.1|10.1|||
4447814|NCT00094757|4271790|B2|||Age||years|Mean|55.4|55.4|Standard Deviation|9.2|9.2|||
4447815|NCT00094757|4271791|B1|||Age||years|Mean|54.5|54.5|Standard Deviation|10.0|10.0|||
4447816|NCT00094653|4271810|B4|unknown||Lactate Dehydrogenase|Upper limit of normal (ULN) was 250 U/L for most assessments (some variation caused by tests performed at local laboratories).|Participants|Number|5|5.0||||||
4447817|NCT00094653|4271811|B3|unknown||Lactate Dehydrogenase|Upper limit of normal (ULN) was 250 U/L for most assessments (some variation caused by tests performed at local laboratories).|Participants|Number|3|3.0||||||
4447818|NCT00094653|4271812|B2|unknown||Lactate Dehydrogenase|Upper limit of normal (ULN) was 250 U/L for most assessments (some variation caused by tests performed at local laboratories).|Participants|Number|0|0.0||||||
4447819|NCT00094653|4271813|B1|unknown||Lactate Dehydrogenase|Upper limit of normal (ULN) was 250 U/L for most assessments (some variation caused by tests performed at local laboratories).|Participants|Number|2|2.0||||||
4447820|NCT00094653|4271810|B4|<=ULN||Lactate Dehydrogenase|Upper limit of normal (ULN) was 250 U/L for most assessments (some variation caused by tests performed at local laboratories).|Participants|Number|417|417.0||||||
4447821|NCT00094653|4271811|B3|<=ULN||Lactate Dehydrogenase|Upper limit of normal (ULN) was 250 U/L for most assessments (some variation caused by tests performed at local laboratories).|Participants|Number|81|81.0||||||
4447822|NCT00094653|4271812|B2|<=ULN||Lactate Dehydrogenase|Upper limit of normal (ULN) was 250 U/L for most assessments (some variation caused by tests performed at local laboratories).|Participants|Number|84|84.0||||||
4447823|NCT00094653|4271813|B1|<=ULN||Lactate Dehydrogenase|Upper limit of normal (ULN) was 250 U/L for most assessments (some variation caused by tests performed at local laboratories).|Participants|Number|252|252.0||||||
4447824|NCT00094653|4271810|B4|>upper limit of normal (ULN)||Lactate Dehydrogenase|Upper limit of normal (ULN) was 250 U/L for most assessments (some variation caused by tests performed at local laboratories).|Participants|Number|254|254.0||||||
4447825|NCT00094653|4271811|B3|>upper limit of normal (ULN)||Lactate Dehydrogenase|Upper limit of normal (ULN) was 250 U/L for most assessments (some variation caused by tests performed at local laboratories).|Participants|Number|52|52.0||||||
4447826|NCT00094653|4271812|B2|>upper limit of normal (ULN)||Lactate Dehydrogenase|Upper limit of normal (ULN) was 250 U/L for most assessments (some variation caused by tests performed at local laboratories).|Participants|Number|53|53.0||||||
4447827|NCT00094653|4271813|B1|>upper limit of normal (ULN)||Lactate Dehydrogenase|Upper limit of normal (ULN) was 250 U/L for most assessments (some variation caused by tests performed at local laboratories).|Participants|Number|149|149.0||||||
4447828|NCT00094653|4271810|B4|Yes||Prior Interleukin-2 Therapy||Participants|Number|154|154.0||||||
4447829|NCT00094653|4271811|B3|Yes||Prior Interleukin-2 Therapy||Participants|Number|33|33.0||||||
4447830|NCT00094653|4271812|B2|Yes||Prior Interleukin-2 Therapy||Participants|Number|32|32.0||||||
4447831|NCT00094653|4271813|B1|Yes||Prior Interleukin-2 Therapy||Participants|Number|89|89.0||||||
4447832|NCT00094653|4271810|B4|No||Prior Interleukin-2 Therapy||Participants|Number|522|522.0||||||
4447833|NCT00094653|4271811|B3|No||Prior Interleukin-2 Therapy||Participants|Number|103|103.0||||||
4447834|NCT00094653|4271812|B2|No||Prior Interleukin-2 Therapy||Participants|Number|105|105.0||||||
4447835|NCT00094653|4271813|B1|No||Prior Interleukin-2 Therapy||Participants|Number|314|314.0||||||
4447836|NCT00094653|4271810|B4|M1c||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|483|483.0||||||
4447837|NCT00094653|4271811|B3|M1c||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|98|98.0||||||
4447838|NCT00094653|4271812|B2|M1c||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|100|100.0||||||
4447839|NCT00094653|4271813|B1|M1c||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|285|285.0||||||
4447840|NCT00094653|4271810|B4|M1b||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|121|121.0||||||
4447841|NCT00094653|4271811|B3|M1b||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|23|23.0||||||
4447842|NCT00094653|4271812|B2|M1b||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|22|22.0||||||
4447843|NCT00094653|4271813|B1|M1b||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|76|76.0||||||
4447844|NCT00094653|4271810|B4|M1a||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|62|62.0||||||
4447845|NCT00094653|4271811|B3|M1a||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|11|11.0||||||
4447874|NCT00094653|4271812|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4447846|NCT00094653|4271812|B2|M1a||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|14|14.0||||||
4447847|NCT00094653|4271813|B1|M1a||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|37|37.0||||||
4447848|NCT00094653|4271810|B4|M0||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|10|10.0||||||
4447849|NCT00094653|4271811|B3|M0||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|4|4.0||||||
4447850|NCT00094653|4271812|B2|M0||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|1|1.0||||||
4447851|NCT00094653|4271813|B1|M0||Melanoma Stage|"The M in the TNM (tumor, node, metastasis) system refers to distant metastases—whether, and how far, the cancer has spread outside the original site. M0: There is no evidence that the cancer has spread beyond the original site. M1: The cancer has spread beyond the original site. M1a: The cancer has spread to other areas of skin, underneath the epidermis to the dermis (subcutaneous), or to lymph node(s). M1b: The cancer has spread to the lung(s) only. M1c: The cancer has spread to other organs and/or locations in the body with or without elevated LDH."|Participants|Number|5|5.0||||||
4447852|NCT00094653|4271810|B4|||Duration of Melanoma|Duration of melanoma is the number of years from date of initial diagnosis to the date of randomization. The randomization of 1 participant in the ipilumumab monotherapy cohort was prior to the initial diagnostic date. Data for 2 participants in the ipilimumab + gp100 cohort were missing.|years|Mean|5.05|5.05|Full Range|||0.0|38.9|
4447853|NCT00094653|4271811|B3|||Duration of Melanoma|Duration of melanoma is the number of years from date of initial diagnosis to the date of randomization. The randomization of 1 participant in the ipilumumab monotherapy cohort was prior to the initial diagnostic date. Data for 2 participants in the ipilimumab + gp100 cohort were missing.|years|Mean|5.65|5.65|Full Range|||0.3|31.2|
4447854|NCT00094653|4271812|B2|||Duration of Melanoma|Duration of melanoma is the number of years from date of initial diagnosis to the date of randomization. The randomization of 1 participant in the ipilumumab monotherapy cohort was prior to the initial diagnostic date. Data for 2 participants in the ipilimumab + gp100 cohort were missing.|years|Mean|4.34|4.34|Full Range|||0.0|35.9|
4447855|NCT00094653|4271813|B1|||Duration of Melanoma|Duration of melanoma is the number of years from date of initial diagnosis to the date of randomization. The randomization of 1 participant in the ipilumumab monotherapy cohort was prior to the initial diagnostic date. Data for 2 participants in the ipilimumab + gp100 cohort were missing.|years|Mean|5.09|5.09|Full Range|||0.2|38.9|
4447856|NCT00094653|4271810|B4|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4447857|NCT00094653|4271811|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447858|NCT00094653|4271812|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4447859|NCT00094653|4271813|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4447860|NCT00094653|4271810|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4447861|NCT00094653|4271811|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4447862|NCT00094653|4271812|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4447863|NCT00094653|4271813|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4447864|NCT00094653|4271810|B4|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4447865|NCT00094653|4271811|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447866|NCT00094653|4271812|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4447867|NCT00094653|4271813|B1|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4447868|NCT00094653|4271810|B4|White||Race/Ethnicity, Customized||Participants|Number|638|638.0||||||
4447869|NCT00094653|4271811|B3|White||Race/Ethnicity, Customized||Participants|Number|129|129.0||||||
4447870|NCT00094653|4271812|B2|White||Race/Ethnicity, Customized||Participants|Number|129|129.0||||||
4447871|NCT00094653|4271813|B1|White||Race/Ethnicity, Customized||Participants|Number|380|380.0||||||
4447872|NCT00094653|4271810|B4||Male|Sex: Female, Male||Participants|Count of Participants|401|401.0||||||
4447873|NCT00094653|4271811|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4447875|NCT00094653|4271813|B1||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4447876|NCT00094653|4271810|B4||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4447877|NCT00094653|4271811|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4447878|NCT00094653|4271812|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4447879|NCT00094653|4271813|B1||Female|Sex: Female, Male||Participants|Count of Participants|156|156.0||||||
4447880|NCT00094653|4271810|B4|>=65 years||Age, Customized||participants|Number|196|196.0||||||
4447881|NCT00094653|4271811|B3|>=65 years||Age, Customized||participants|Number|42|42.0||||||
4447882|NCT00094653|4271812|B2|>=65 years||Age, Customized||participants|Number|42|42.0||||||
4447883|NCT00094653|4271813|B1|>=65 years||Age, Customized||participants|Number|112|112.0||||||
4447884|NCT00094653|4271810|B4|< 65 years||Age, Customized||participants|Number|480|480.0||||||
4447885|NCT00094653|4271811|B3|< 65 years||Age, Customized||participants|Number|94|94.0||||||
4447886|NCT00094653|4271812|B2|< 65 years||Age, Customized||participants|Number|95|95.0||||||
4447887|NCT00094653|4271813|B1|< 65 years||Age, Customized||participants|Number|291|291.0||||||
4447888|NCT00094653|4271810|B4|||Age||years|Mean|56.2|56.2|Full Range|||19.0|90.0|
4447889|NCT00094653|4271811|B3|||Age||years|Mean|57.4|57.4|Full Range|||23.0|90.0|
4447890|NCT00094653|4271812|B2|||Age||years|Mean|56.8|56.8|Full Range|||19.0|88.0|
4447891|NCT00094653|4271813|B1|||Age||years|Mean|55.6|55.6|Full Range|||24.0|84.0|
4447892|NCT00094575|4271876|B3|||Maximum Aneurysm Diameter||Centimeter|Mean|5.7|5.7|Standard Deviation|0.9|0.9|||
4447893|NCT00094575|4271877|B2|||Maximum Aneurysm Diameter||Centimeter|Mean|5.7|5.7|Standard Deviation|1.0|1.0|||
4447894|NCT00094575|4271878|B1|||Maximum Aneurysm Diameter||Centimeter|Mean|5.7|5.7|Standard Deviation|.8|0.8|||
4447895|NCT00094575|4271876|B3|Not Assessed||Surgical Risk [RAND Score]||Participants|Number|9|9.0||||||
4447896|NCT00094575|4271877|B2|Not Assessed||Surgical Risk [RAND Score]||Participants|Number|5|5.0||||||
4447897|NCT00094575|4271878|B1|Not Assessed||Surgical Risk [RAND Score]||Participants|Number|4|4.0||||||
4447898|NCT00094575|4271876|B3|High||Surgical Risk [RAND Score]||Participants|Number|60|60.0||||||
4447899|NCT00094575|4271877|B2|High||Surgical Risk [RAND Score]||Participants|Number|29|29.0||||||
4447900|NCT00094575|4271878|B1|High||Surgical Risk [RAND Score]||Participants|Number|31|31.0||||||
4447901|NCT00094575|4271876|B3|Intermediate||Surgical Risk [RAND Score]||Participants|Number|344|344.0||||||
4447902|NCT00094575|4271877|B2|Intermediate||Surgical Risk [RAND Score]||Participants|Number|175|175.0||||||
4447903|NCT00094575|4271878|B1|Intermediate||Surgical Risk [RAND Score]||Participants|Number|169|169.0||||||
4447904|NCT00094575|4271876|B3|Low||Surgical Risk [RAND Score]||Participants|Number|468|468.0||||||
4447905|NCT00094575|4271877|B2|Low||Surgical Risk [RAND Score]||Participants|Number|228|228.0||||||
4447906|NCT00094575|4271878|B1|Low||Surgical Risk [RAND Score]||Participants|Number|240|240.0||||||
4447907|NCT00094575|4271876|B3|No||Currently Smoking||Participants|Number|518|518.0||||||
4447908|NCT00094575|4271877|B2|No||Currently Smoking||Participants|Number|244|244.0||||||
4447909|NCT00094575|4271878|B1|No||Currently Smoking||Participants|Number|274|274.0||||||
4447910|NCT00094575|4271876|B3|Yes||Currently Smoking||Participants|Number|363|363.0||||||
4447911|NCT00094575|4271877|B2|Yes||Currently Smoking||Participants|Number|193|193.0||||||
4447912|NCT00094575|4271878|B1|Yes||Currently Smoking||Participants|Number|170|170.0||||||
4447913|NCT00094575|4271876|B3|Never Smoked||Smoking Status||Participants|Number|40|40.0||||||
4447914|NCT00094575|4271877|B2|Never Smoked||Smoking Status||Participants|Number|24|24.0||||||
4447915|NCT00094575|4271878|B1|Never Smoked||Smoking Status||Participants|Number|16|16.0||||||
4447916|NCT00094575|4271876|B3|Ever Smoked||Smoking Status||Participants|Number|841|841.0||||||
4447917|NCT00094575|4271877|B2|Ever Smoked||Smoking Status||Participants|Number|413|413.0||||||
4447918|NCT00094575|4271878|B1|Ever Smoked||Smoking Status||Participants|Number|428|428.0||||||
4447919|NCT00094575|4271876|B3|||Body Mass Index [BMI]||Kg/m^2|Mean|28.6|28.6|Standard Deviation|5.4|5.4|||
4447920|NCT00094575|4271877|B2|||Body Mass Index [BMI]||Kg/m^2|Mean|28.7|28.7|Standard Deviation|5.6|5.6|||
4447921|NCT00094575|4271878|B1|||Body Mass Index [BMI]||Kg/m^2|Mean|28.6|28.6|Standard Deviation|5.2|5.2|||
4447922|NCT00094575|4271876|B3|||Weight in kilograms||Kilogram|Mean|89.8|89.8|Standard Deviation|17.3|17.3|||
4447923|NCT00094575|4271877|B2|||Weight in kilograms||Kilogram|Mean|89.7|89.7|Standard Deviation|17.8|17.8|||
4447924|NCT00094575|4271878|B1|||Weight in kilograms||Kilogram|Mean|89.9|89.9|Standard Deviation|16.8|16.8|||
4447925|NCT00094575|4271876|B3||Male|Sex: Female, Male||Participants|Count of Participants|876|876.0||||||
4447926|NCT00094575|4271877|B2||Male|Sex: Female, Male||Participants|Count of Participants|435|435.0||||||
4447927|NCT00094575|4271878|B1||Male|Sex: Female, Male||Participants|Count of Participants|441|441.0||||||
4447928|NCT00094575|4271876|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4447929|NCT00094575|4271877|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4447930|NCT00094575|4271878|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4447931|NCT00094575|4271876|B3|||Age||years|Mean|70.1|70.1|Standard Deviation|7.8|7.8|||
4447932|NCT00094575|4271877|B2|||Age||years|Mean|70.5|70.5|Standard Deviation|7.8|7.8|||
4447933|NCT00094575|4271878|B1|||Age||years|Mean|69.6|69.6|Standard Deviation|7.8|7.8|||
4447934|NCT00094536|4271899|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
4447935|NCT00094536|4271899|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4447936|NCT00094536|4271899|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447937|NCT00094536|4271899|B1|More than one race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4447938|NCT00094536|4271899|B1|White||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4447939|NCT00094536|4271899|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4447940|NCT00094536|4271899|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447941|NCT00094536|4271899|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447942|NCT00094536|4271899|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4447943|NCT00094536|4271899|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4447944|NCT00094536|4271899|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4447945|NCT00094536|4271899|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4447946|NCT00094536|4271899|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4447947|NCT00094536|4271899|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4447948|NCT00094536|4271899|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4447949|NCT00094536|4271899|B1||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4447950|NCT00094536|4271899|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4447951|NCT00094497|4271903|B3|4||ECOG|Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)|participants|Number|1|1.0||||||
4447952|NCT00094497|4271904|B2|4||ECOG|Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)|participants|Number|0|0.0||||||
4447953|NCT00094497|4271905|B1|4||ECOG|Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)|participants|Number|1|1.0||||||
4447954|NCT00094497|4271903|B3|2||ECOG|Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)|participants|Number|34|34.0||||||
4447955|NCT00094497|4271904|B2|2||ECOG|Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)|participants|Number|21|21.0||||||
4447956|NCT00094497|4271905|B1|2||ECOG|Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)|participants|Number|13|13.0||||||
4447957|NCT00094497|4271903|B3|1||ECOG|Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)|participants|Number|124|124.0||||||
4447958|NCT00094497|4271904|B2|1||ECOG|Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)|participants|Number|60|60.0||||||
4447959|NCT00094497|4271905|B1|1||ECOG|Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)|participants|Number|64|64.0||||||
4447960|NCT00094497|4271903|B3|0||ECOG|Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)|participants|Number|145|145.0||||||
4447961|NCT00094497|4271904|B2|0||ECOG|Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)|participants|Number|72|72.0||||||
4447962|NCT00094497|4271905|B1|0||ECOG|Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)|participants|Number|73|73.0||||||
4447963|NCT00094497|4271903|B3|IV||tumor stage||participants|Number|303|303.0||||||
4447964|NCT00094497|4271904|B2|IV||tumor stage||participants|Number|152|152.0||||||
4447965|NCT00094497|4271905|B1|IV||tumor stage||participants|Number|151|151.0||||||
4447966|NCT00094497|4271903|B3|III||tumor stage||participants|Number|1|1.0||||||
4447967|NCT00094497|4271904|B2|III||tumor stage||participants|Number|1|1.0||||||
4447968|NCT00094497|4271905|B1|III||tumor stage||participants|Number|0|0.0||||||
4447969|NCT00094497|4271903|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4447970|NCT00094497|4271904|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4447971|NCT00094497|4271905|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4447972|NCT00094497|4271903|B3||Female|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4447973|NCT00094497|4271904|B2||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4447974|NCT00094497|4271905|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4447975|NCT00094497|4271903|B3|>= 18 years||Age, Customized||participants|Number|304|304.0||||||
4447976|NCT00094497|4271904|B2|>= 18 years||Age, Customized||participants|Number|153|153.0||||||
4447977|NCT00094497|4271905|B1|>= 18 years||Age, Customized||participants|Number|151|151.0||||||
4447978|NCT00094458|4271920|B4|USA||Region of Enrollment||participants|Number|219|219.0||||||
4447979|NCT00094458|4271921|B3|USA||Region of Enrollment||participants|Number|70|70.0||||||
4447980|NCT00094458|4271922|B2|USA||Region of Enrollment||participants|Number|66|66.0||||||
4447981|NCT00094458|4271923|B1|USA||Region of Enrollment||participants|Number|83|83.0||||||
4447982|NCT00094458|4271920|B4|UK||Region of Enrollment||participants|Number|22|22.0||||||
4447983|NCT00094458|4271921|B3|UK||Region of Enrollment||participants|Number|7|7.0||||||
4447984|NCT00094458|4271922|B2|UK||Region of Enrollment||participants|Number|11|11.0||||||
4447985|NCT00094458|4271923|B1|UK||Region of Enrollment||participants|Number|4|4.0||||||
4447986|NCT00094458|4271920|B4|SWEDEN||Region of Enrollment||participants|Number|3|3.0||||||
4447987|NCT00094458|4271921|B3|SWEDEN||Region of Enrollment||participants|Number|2|2.0||||||
4447988|NCT00094458|4271922|B2|SWEDEN||Region of Enrollment||participants|Number|1|1.0||||||
4447989|NCT00094458|4271923|B1|SWEDEN||Region of Enrollment||participants|Number|0|0.0||||||
4447990|NCT00094458|4271920|B4|SPAIN||Region of Enrollment||participants|Number|6|6.0||||||
4447991|NCT00094458|4271921|B3|SPAIN||Region of Enrollment||participants|Number|2|2.0||||||
4447992|NCT00094458|4271922|B2|SPAIN||Region of Enrollment||participants|Number|2|2.0||||||
4447993|NCT00094458|4271923|B1|SPAIN||Region of Enrollment||participants|Number|2|2.0||||||
4447994|NCT00094458|4271920|B4|PORTUGAL||Region of Enrollment||participants|Number|2|2.0||||||
4447995|NCT00094458|4271921|B3|PORTUGAL||Region of Enrollment||participants|Number|0|0.0||||||
4447996|NCT00094458|4271922|B2|PORTUGAL||Region of Enrollment||participants|Number|2|2.0||||||
4447997|NCT00094458|4271923|B1|PORTUGAL||Region of Enrollment||participants|Number|0|0.0||||||
4447998|NCT00094458|4271920|B4|NORWAY||Region of Enrollment||participants|Number|1|1.0||||||
4447999|NCT00094458|4271921|B3|NORWAY||Region of Enrollment||participants|Number|0|0.0||||||
4448000|NCT00094458|4271922|B2|NORWAY||Region of Enrollment||participants|Number|1|1.0||||||
4448001|NCT00094458|4271923|B1|NORWAY||Region of Enrollment||participants|Number|0|0.0||||||
4448002|NCT00094458|4271920|B4|NETHERLANDS||Region of Enrollment||participants|Number|26|26.0||||||
4448003|NCT00094458|4271921|B3|NETHERLANDS||Region of Enrollment||participants|Number|8|8.0||||||
4448004|NCT00094458|4271922|B2|NETHERLANDS||Region of Enrollment||participants|Number|9|9.0||||||
4448005|NCT00094458|4271923|B1|NETHERLANDS||Region of Enrollment||participants|Number|9|9.0||||||
4448006|NCT00094458|4271920|B4|ISRAEL||Region of Enrollment||participants|Number|32|32.0||||||
4448007|NCT00094458|4271921|B3|ISRAEL||Region of Enrollment||participants|Number|12|12.0||||||
4448008|NCT00094458|4271922|B2|ISRAEL||Region of Enrollment||participants|Number|13|13.0||||||
4448009|NCT00094458|4271923|B1|ISRAEL||Region of Enrollment||participants|Number|7|7.0||||||
4448010|NCT00094458|4271920|B4|GREECE||Region of Enrollment||participants|Number|9|9.0||||||
4448011|NCT00094458|4271921|B3|GREECE||Region of Enrollment||participants|Number|3|3.0||||||
4448012|NCT00094458|4271922|B2|GREECE||Region of Enrollment||participants|Number|3|3.0||||||
4448013|NCT00094458|4271923|B1|GREECE||Region of Enrollment||participants|Number|3|3.0||||||
4448014|NCT00094458|4271920|B4|GERMANY||Region of Enrollment||participants|Number|38|38.0||||||
4448015|NCT00094458|4271921|B3|GERMANY||Region of Enrollment||participants|Number|13|13.0||||||
4448016|NCT00094458|4271922|B2|GERMANY||Region of Enrollment||participants|Number|8|8.0||||||
4448017|NCT00094458|4271923|B1|GERMANY||Region of Enrollment||participants|Number|17|17.0||||||
4448018|NCT00094458|4271920|B4|FRANCE||Region of Enrollment||participants|Number|39|39.0||||||
4448019|NCT00094458|4271921|B3|FRANCE||Region of Enrollment||participants|Number|18|18.0||||||
4448020|NCT00094458|4271922|B2|FRANCE||Region of Enrollment||participants|Number|12|12.0||||||
4448021|NCT00094458|4271923|B1|FRANCE||Region of Enrollment||participants|Number|9|9.0||||||
4448022|NCT00094458|4271920|B4|DENMARK||Region of Enrollment||participants|Number|17|17.0||||||
4448023|NCT00094458|4271921|B3|DENMARK||Region of Enrollment||participants|Number|4|4.0||||||
4448024|NCT00094458|4271922|B2|DENMARK||Region of Enrollment||participants|Number|8|8.0||||||
4448025|NCT00094458|4271923|B1|DENMARK||Region of Enrollment||participants|Number|5|5.0||||||
4448026|NCT00094458|4271920|B4|CANADA||Region of Enrollment||participants|Number|23|23.0||||||
4448027|NCT00094458|4271921|B3|CANADA||Region of Enrollment||participants|Number|7|7.0||||||
4448028|NCT00094458|4271922|B2|CANADA||Region of Enrollment||participants|Number|7|7.0||||||
4448029|NCT00094458|4271923|B1|CANADA||Region of Enrollment||participants|Number|9|9.0||||||
4448030|NCT00094458|4271920|B4|BELGIUM||Region of Enrollment||participants|Number|46|46.0||||||
4448031|NCT00094458|4271921|B3|BELGIUM||Region of Enrollment||participants|Number|15|15.0||||||
4448032|NCT00094458|4271922|B2|BELGIUM||Region of Enrollment||participants|Number|17|17.0||||||
4448033|NCT00094458|4271923|B1|BELGIUM||Region of Enrollment||participants|Number|14|14.0||||||
4448034|NCT00094458|4271920|B4|AUSTRIA||Region of Enrollment||participants|Number|25|25.0||||||
4448035|NCT00094458|4271921|B3|AUSTRIA||Region of Enrollment||participants|Number|8|8.0||||||
4448036|NCT00094458|4271922|B2|AUSTRIA||Region of Enrollment||participants|Number|9|9.0||||||
4448037|NCT00094458|4271923|B1|AUSTRIA||Region of Enrollment||participants|Number|8|8.0||||||
4448038|NCT00094458|4271920|B4||Male|Gender||Participants|Count of Participants|262|262.0||||||
4448039|NCT00094458|4271921|B3||Male|Gender||Participants|Count of Participants|88|88.0||||||
4448040|NCT00094458|4271922|B2||Male|Gender||Participants|Count of Participants|84|84.0||||||
4448041|NCT00094458|4271923|B1||Male|Gender||Participants|Count of Participants|90|90.0||||||
4448042|NCT00094458|4271920|B4||Female|Gender||Participants|Count of Participants|246|246.0||||||
4448043|NCT00094458|4271921|B3||Female|Gender||Participants|Count of Participants|81|81.0||||||
4448044|NCT00094458|4271922|B2||Female|Gender||Participants|Count of Participants|85|85.0||||||
4448045|NCT00094458|4271923|B1||Female|Gender||Participants|Count of Participants|80|80.0||||||
4448046|NCT00094458|4271920|B4|||Age||years|Mean|36.3|36.3|Standard Deviation|12.62|12.62|||
4448047|NCT00094458|4271921|B3|||Age||years|Mean|35.9|35.9|Standard Deviation|11.97|11.97|||
4448048|NCT00094458|4271922|B2|||Age||years|Mean|36.6|36.6|Standard Deviation|13|13.0|||
4448049|NCT00094458|4271923|B1|||Age||years|Mean|36.3|36.3|Standard Deviation|12.92|12.92|||
4448050|NCT00094328|4271966|B1|Ethnic group|Not Applicable|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4448051|NCT00094328|4271966|B1|Ethnic group|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4448052|NCT00094328|4271966|B1|Ethnic group|African/American|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4448053|NCT00094328|4271966|B1|Ethnic group|Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4448054|NCT00094328|4271966|B1|Race|Other|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4448055|NCT00094328|4271966|B1|Race|Black|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4448056|NCT00094328|4271966|B1|Race|Caucasian|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4448057|NCT00094328|4271966|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4448058|NCT00094328|4271966|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448059|NCT00094328|4271966|B1|||Age||Years|Median|3.5|3.5|Full Range|||2.0|9.0|
4448060|NCT00094302|4271978|B3|Elevated natriuretic peptide in previous 60 days||Eligibility Stratum|Eligible patients were assigned to one of two strata before randomization, according to whether they had at least one hospitalization within the previous 12 months in which management of heart failure was a major component of the care provided, or in absence of that criterion, an elevated brain natriuretic peptide (BNP) level within 60 days prior to randomization (a brain natriuretic peptide [BNP] level ≥100 pg per milliliter or an N-terminal pro-BNP [NTproBNP] level ≥360 pg per milliliter).|participants|Number|981|981.0||||||
4448061|NCT00094302|4271979|B2|Elevated natriuretic peptide in previous 60 days||Eligibility Stratum|Eligible patients were assigned to one of two strata before randomization, according to whether they had at least one hospitalization within the previous 12 months in which management of heart failure was a major component of the care provided, or in absence of that criterion, an elevated brain natriuretic peptide (BNP) level within 60 days prior to randomization (a brain natriuretic peptide [BNP] level ≥100 pg per milliliter or an N-terminal pro-BNP [NTproBNP] level ≥360 pg per milliliter).|participants|Number|490|490.0||||||
4448062|NCT00094302|4271980|B1|Elevated natriuretic peptide in previous 60 days||Eligibility Stratum|Eligible patients were assigned to one of two strata before randomization, according to whether they had at least one hospitalization within the previous 12 months in which management of heart failure was a major component of the care provided, or in absence of that criterion, an elevated brain natriuretic peptide (BNP) level within 60 days prior to randomization (a brain natriuretic peptide [BNP] level ≥100 pg per milliliter or an N-terminal pro-BNP [NTproBNP] level ≥360 pg per milliliter).|participants|Number|491|491.0||||||
4448063|NCT00094302|4271978|B3|Hospitalization in previous year for heart failure||Eligibility Stratum|Eligible patients were assigned to one of two strata before randomization, according to whether they had at least one hospitalization within the previous 12 months in which management of heart failure was a major component of the care provided, or in absence of that criterion, an elevated brain natriuretic peptide (BNP) level within 60 days prior to randomization (a brain natriuretic peptide [BNP] level ≥100 pg per milliliter or an N-terminal pro-BNP [NTproBNP] level ≥360 pg per milliliter).|participants|Number|2464|2464.0||||||
4448064|NCT00094302|4271979|B2|Hospitalization in previous year for heart failure||Eligibility Stratum|Eligible patients were assigned to one of two strata before randomization, according to whether they had at least one hospitalization within the previous 12 months in which management of heart failure was a major component of the care provided, or in absence of that criterion, an elevated brain natriuretic peptide (BNP) level within 60 days prior to randomization (a brain natriuretic peptide [BNP] level ≥100 pg per milliliter or an N-terminal pro-BNP [NTproBNP] level ≥360 pg per milliliter).|participants|Number|1232|1232.0||||||
4448065|NCT00094302|4271980|B1|Hospitalization in previous year for heart failure||Eligibility Stratum|Eligible patients were assigned to one of two strata before randomization, according to whether they had at least one hospitalization within the previous 12 months in which management of heart failure was a major component of the care provided, or in absence of that criterion, an elevated brain natriuretic peptide (BNP) level within 60 days prior to randomization (a brain natriuretic peptide [BNP] level ≥100 pg per milliliter or an N-terminal pro-BNP [NTproBNP] level ≥360 pg per milliliter).|participants|Number|1232|1232.0||||||
4448066|NCT00094302|4271978|B3|Georgia||Region of Enrollment||participants|Number|612|612.0||||||
4448067|NCT00094302|4271979|B2|Georgia||Region of Enrollment||participants|Number|307|307.0||||||
4448068|NCT00094302|4271980|B1|Georgia||Region of Enrollment||participants|Number|305|305.0||||||
4448069|NCT00094302|4271978|B3|Russian Federation||Region of Enrollment||participants|Number|1066|1066.0||||||
4448070|NCT00094302|4271979|B2|Russian Federation||Region of Enrollment||participants|Number|529|529.0||||||
4448071|NCT00094302|4271980|B1|Russian Federation||Region of Enrollment||participants|Number|537|537.0||||||
4448072|NCT00094302|4271978|B3|Brazil||Region of Enrollment||participants|Number|167|167.0||||||
4448073|NCT00094302|4271979|B2|Brazil||Region of Enrollment||participants|Number|85|85.0||||||
4448074|NCT00094302|4271980|B1|Brazil||Region of Enrollment||participants|Number|82|82.0||||||
4448075|NCT00094302|4271978|B3|Argentina||Region of Enrollment||participants|Number|123|123.0||||||
4448076|NCT00094302|4271979|B2|Argentina||Region of Enrollment||participants|Number|63|63.0||||||
4448077|NCT00094302|4271980|B1|Argentina||Region of Enrollment||participants|Number|60|60.0||||||
4448078|NCT00094302|4271978|B3|Canada||Region of Enrollment||participants|Number|326|326.0||||||
4448079|NCT00094302|4271979|B2|Canada||Region of Enrollment||participants|Number|166|166.0||||||
4448080|NCT00094302|4271980|B1|Canada||Region of Enrollment||participants|Number|160|160.0||||||
4448081|NCT00094302|4271978|B3|United States||Region of Enrollment||participants|Number|1151|1151.0||||||
4448082|NCT00094302|4271979|B2|United States||Region of Enrollment||participants|Number|572|572.0||||||
4448083|NCT00094302|4271980|B1|United States||Region of Enrollment||participants|Number|579|579.0||||||
4448084|NCT00094302|4271978|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4448085|NCT00094302|4271979|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4448086|NCT00094302|4271980|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4448087|NCT00094302|4271978|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4448088|NCT00094302|4271979|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4448089|NCT00094302|4271980|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448090|NCT00094302|4271978|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3062|3062.0||||||
4448091|NCT00094302|4271979|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1525|1525.0||||||
4448092|NCT00094302|4271980|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1537|1537.0||||||
4448093|NCT00094302|4271978|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|300|300.0||||||
4448094|NCT00094302|4271979|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|151|151.0||||||
4448095|NCT00094302|4271980|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4448096|NCT00094302|4271978|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448097|NCT00094302|4271979|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448098|NCT00094302|4271980|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448099|NCT00094302|4271978|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4448100|NCT00094302|4271979|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4448101|NCT00094302|4271980|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4448102|NCT00094302|4271978|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4448103|NCT00094302|4271979|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4448104|NCT00094302|4271980|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4448105|NCT00094302|4271978|B3||Male|Sex: Female, Male||Participants|Count of Participants|1670|1670.0||||||
4448106|NCT00094302|4271979|B2||Male|Sex: Female, Male||Participants|Count of Participants|834|834.0||||||
4448107|NCT00094302|4271980|B1||Male|Sex: Female, Male||Participants|Count of Participants|836|836.0||||||
4448108|NCT00094302|4271978|B3||Female|Sex: Female, Male||Participants|Count of Participants|1775|1775.0||||||
4448109|NCT00094302|4271979|B2||Female|Sex: Female, Male||Participants|Count of Participants|888|888.0||||||
4448110|NCT00094302|4271980|B1||Female|Sex: Female, Male||Participants|Count of Participants|887|887.0||||||
4448111|NCT00094302|4271978|B3|||Age||years|Median|68.7|68.7|Inter-Quartile Range|||60.9|75.9|
4448112|NCT00094302|4271979|B2|||Age||years|Median|68.7|68.7|Inter-Quartile Range|||61.0|76.4|
4448113|NCT00094302|4271980|B1|||Age||years|Median|68.7|68.7|Inter-Quartile Range|||60.7|75.5|
4448114|NCT00094302|4271978|B3||>=65 years|Age||Participants|Count of Participants|2142|2142.0||||||
4448115|NCT00094302|4271979|B2||>=65 years|Age||Participants|Count of Participants|1068|1068.0||||||
4448116|NCT00094302|4271980|B1||>=65 years|Age||Participants|Count of Participants|1074|1074.0||||||
4448117|NCT00094302|4271978|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1303|1303.0||||||
4448118|NCT00094302|4271979|B2||Between 18 and 65 years|Age||Participants|Count of Participants|654|654.0||||||
4448119|NCT00094302|4271980|B1||Between 18 and 65 years|Age||Participants|Count of Participants|649|649.0||||||
4448120|NCT00094302|4271978|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448121|NCT00094302|4271979|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448122|NCT00094302|4271980|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448123|NCT00094172|4272035|B3|||Number of Gd+ Lesions at Baseline|"Number of gadolinium-enhancing (Gd+)[1] lesions at baseline. A higher score indicates more severe disease.~[1]Gd+ lesions are measured on T1 weighted images after injection of 0.1 mM/kg of gadolinium pentate."|Lesion Count|Mean|0.5|0.5|Standard Deviation|2.1|2.1|||
4448124|NCT00094172|4272036|B2|||Number of Gd+ Lesions at Baseline|"Number of gadolinium-enhancing (Gd+)[1] lesions at baseline. A higher score indicates more severe disease.~[1]Gd+ lesions are measured on T1 weighted images after injection of 0.1 mM/kg of gadolinium pentate."|Lesion Count|Mean|0.2|0.2|Standard Deviation|0.5|0.5|||
4448125|NCT00094172|4272037|B1|||Number of Gd+ Lesions at Baseline|"Number of gadolinium-enhancing (Gd+)[1] lesions at baseline. A higher score indicates more severe disease.~[1]Gd+ lesions are measured on T1 weighted images after injection of 0.1 mM/kg of gadolinium pentate."|Lesion Count|Mean|0.7|0.7|Standard Deviation|2.7|2.7|||
4448126|NCT00094172|4272035|B3|||Number of T2 Lesions at Baseline|"Number of T2 lesions[1] at baseline. A higher score indicates more severe disease.~[1] A T2 lesion is defined as an abnormal, hyperintense white-matter area visible on T2 weighted images. Each T2 lesion is visible on at least one brain slice with a surface area ≥ 3mm^2 in plane"|Lesion Count|Mean|20.8|20.8|Standard Deviation|17.1|17.1|||
4448127|NCT00094172|4272036|B2|||Number of T2 Lesions at Baseline|"Number of T2 lesions[1] at baseline. A higher score indicates more severe disease.~[1] A T2 lesion is defined as an abnormal, hyperintense white-matter area visible on T2 weighted images. Each T2 lesion is visible on at least one brain slice with a surface area ≥ 3mm^2 in plane"|Lesion Count|Mean|19.5|19.5|Standard Deviation|16.5|16.5|||
4448128|NCT00094172|4272037|B1|||Number of T2 Lesions at Baseline|"Number of T2 lesions[1] at baseline. A higher score indicates more severe disease.~[1] A T2 lesion is defined as an abnormal, hyperintense white-matter area visible on T2 weighted images. Each T2 lesion is visible on at least one brain slice with a surface area ≥ 3mm^2 in plane"|Lesion Count|Mean|21.6|21.6|Standard Deviation|17.6|17.6|||
4448129|NCT00094172|4272035|B3|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4448130|NCT00094172|4272036|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4448131|NCT00094172|4272037|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4448132|NCT00094172|4272035|B3|United States||Region of Enrollment||participants|Number|75|75.0||||||
4448133|NCT00094172|4272036|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4448134|NCT00094172|4272037|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4448135|NCT00094172|4272035|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4448136|NCT00094172|4272036|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4448137|NCT00094172|4272037|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4448138|NCT00094172|4272035|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4448139|NCT00094172|4272036|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4448140|NCT00094172|4272037|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4448141|NCT00094172|4272035|B3|||Age||years|Mean|33.7|33.7|Standard Deviation|9.0|9.0|||
4448142|NCT00094172|4272036|B2|||Age||years|Mean|33.9|33.9|Standard Deviation|8.6|8.6|||
4448143|NCT00094172|4272037|B1|||Age||years|Mean|33.6|33.6|Standard Deviation|9.4|9.4|||
4448144|NCT00094107|4272048|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4448145|NCT00094107|4272048|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4448146|NCT00094107|4272048|B1|||Age||Years|Mean|62.40|62.4|Standard Deviation|15.56|15.56|||
4448147|NCT00094094|4272057|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4448148|NCT00094094|4272057|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4448149|NCT00094094|4272057|B1|||Age||Years|Mean|64.1|64.1|Standard Deviation|12.3|12.3|||
4448150|NCT00094055|4272066|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4448151|NCT00094055|4272066|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4448152|NCT00094055|4272066|B1|||Age||years|Mean|59.3|59.3|Standard Deviation|13.7|13.7|||
4448153|NCT00093847|4272075|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4448154|NCT00093847|4272076|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4448155|NCT00093847|4272077|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4448156|NCT00093847|4272075|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4448157|NCT00093847|4272076|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4448158|NCT00093847|4272077|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4448159|NCT00093847|4272075|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4448160|NCT00093847|4272076|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4448161|NCT00093847|4272077|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4448162|NCT00093847|4272075|B3|||Age||years|Mean|50.0|50.0|Standard Deviation|12.9|12.9|||
4448163|NCT00093847|4272076|B2|||Age||years|Mean|48.5|48.5|Standard Deviation|11.3|11.3|||
4448164|NCT00093847|4272077|B1|||Age||years|Mean|51.4|51.4|Standard Deviation|14.1|14.1|||
4448165|NCT00093847|4272075|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4448166|NCT00093847|4272076|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4448167|NCT00093847|4272077|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4448168|NCT00093847|4272075|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4448169|NCT00093847|4272076|B2||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4448170|NCT00093847|4272077|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4448171|NCT00093847|4272075|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448172|NCT00093847|4272076|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448173|NCT00093847|4272077|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448174|NCT00093808|4272086|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4448175|NCT00093808|4272086|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448176|NCT00093808|4272086|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4448177|NCT00093808|4272086|B1|||Age||years|Median|60|60.0|Full Range|||40.0|77.0|
4448178|NCT00093795|4272093|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448179|NCT00093795|4272094|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448180|NCT00093795|4272095|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448181|NCT00093795|4272096|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448182|NCT00093795|4272093|B4||Female|Sex: Female, Male||Participants|Count of Participants|4867|4867.0||||||
4448183|NCT00093795|4272094|B3||Female|Sex: Female, Male||Participants|Count of Participants|1621|1621.0||||||
4448184|NCT00093795|4272095|B2||Female|Sex: Female, Male||Participants|Count of Participants|1623|1623.0||||||
4448185|NCT00093795|4272096|B1||Female|Sex: Female, Male||Participants|Count of Participants|1623|1623.0||||||
4448186|NCT00093795|4272093|B4|||Age||years|Mean|51|51.0|Standard Deviation|9.5|9.5|||
4448187|NCT00093795|4272094|B3|||Age||years|Mean|51|51.0|Standard Deviation|9.4|9.4|||
4448188|NCT00093795|4272095|B2|||Age||years|Mean|51|51.0|Standard Deviation|9.5|9.5|||
4448189|NCT00093795|4272096|B1|||Age||years|Mean|51|51.0|Standard Deviation|9.5|9.5|||
4448190|NCT00093782|4272118|B1|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4448191|NCT00093782|4272118|B1||Male|Gender||Participants|Count of Participants|15|15.0||||||
4448192|NCT00093782|4272118|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
4448193|NCT00093782|4272118|B1|||Age||years|Median|58|58.0|Full Range|||36.0|78.0|
4448194|NCT00093782|4272118|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4448195|NCT00093782|4272118|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4448196|NCT00093782|4272118|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448197|NCT00093756|4272128|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4448198|NCT00093756|4272129|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4448199|NCT00093756|4272130|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4448200|NCT00093756|4272128|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4448201|NCT00093756|4272129|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4448202|NCT00093756|4272130|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4448203|NCT00093756|4272128|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4448204|NCT00093756|4272129|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4448205|NCT00093756|4272130|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4448206|NCT00093756|4272128|B3|||Age||years|Median|58|58.0|Full Range|||43.0|79.0|
4448207|NCT00093756|4272129|B2|||Age||years|Median|58|58.0|Full Range|||43.0|79.0|
4448208|NCT00093756|4272130|B1|||Age||years|Median|63|63.0|Full Range|||45.0|78.0|
4448209|NCT00093496|4272141|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4448210|NCT00093496|4272142|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4448211|NCT00093496|4272143|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4448212|NCT00093496|4272141|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448213|NCT00093496|4272142|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448214|NCT00093496|4272143|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448215|NCT00093496|4272141|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4448216|NCT00093496|4272142|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4448217|NCT00093496|4272143|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4448218|NCT00093496|4272141|B3|||Age||years|Median|64|64.0|Full Range|||28.0|87.0|
4448219|NCT00093496|4272142|B2|||Age||years|Median|63.5|63.5|Full Range|||51.0|87.0|
4448220|NCT00093496|4272143|B1|||Age||years|Median|64|64.0|Full Range|||28.0|79.0|
4448221|NCT00093470|4272155|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4448222|NCT00093470|4272156|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4448223|NCT00093470|4272157|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4448224|NCT00093470|4272155|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4448225|NCT00093470|4272156|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4448226|NCT00093470|4272157|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4448227|NCT00093470|4272155|B3|||Age||years|Median|69|69.0|Full Range|||28.0|86.0|
4448228|NCT00093470|4272156|B2|||Age||years|Median|69|69.0|Full Range|||28.0|80.0|
4448229|NCT00093470|4272157|B1|||Age||years|Median|70|70.0|Full Range|||30.0|86.0|
4448230|NCT00093379|4272166|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4448231|NCT00093379|4272166|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4448232|NCT00093379|4272166|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4448233|NCT00093379|4272166|B1|||Age||years|Median|55|55.0|Full Range|||39.0|66.0|
4448234|NCT00093145|4272172|B1|Non visceral||Dominant Lesion Site (Target + Non-Target)||participants|Number|7|7.0||||||
4448235|NCT00093145|4272172|B1|Visceral||Dominant Lesion Site (Target + Non-Target)||participants|Number|25|25.0||||||
4448236|NCT00093145|4272172|B1|> 3 lesions||Number of Lesions (Target + Non-Target)||participants|Number|22|22.0||||||
4448237|NCT00093145|4272172|B1|2 to 3 lesions||Number of Lesions (Target + Non-Target)||participants|Number|10|10.0||||||
4448238|NCT00093145|4272172|B1|0 or 1 lesion||Number of Lesions (Target + Non-Target)||participants|Number|0|0.0||||||
4448239|NCT00093145|4272172|B1|Non Visceral||Dominant site of metastasis/relapse||participants|Number|8|8.0||||||
4448240|NCT00093145|4272172|B1|Visceral||Dominant site of metastasis/relapse||participants|Number|24|24.0||||||
4448241|NCT00093145|4272172|B1|Other||Specific site(s) of metastasis/relapse|Participants can be in multiple sites of metastasis/relapse categories.|participants|Number|1|1.0||||||
4448242|NCT00093145|4272172|B1|Bone||Specific site(s) of metastasis/relapse|Participants can be in multiple sites of metastasis/relapse categories.|participants|Number|22|22.0||||||
4448243|NCT00093145|4272172|B1|Peritoneal||Specific site(s) of metastasis/relapse|Participants can be in multiple sites of metastasis/relapse categories.|participants|Number|1|1.0||||||
4448244|NCT00093145|4272172|B1|Liver||Specific site(s) of metastasis/relapse|Participants can be in multiple sites of metastasis/relapse categories.|participants|Number|15|15.0||||||
4448245|NCT00093145|4272172|B1|Lung||Specific site(s) of metastasis/relapse|Participants can be in multiple sites of metastasis/relapse categories.|participants|Number|19|19.0||||||
4448246|NCT00093145|4272172|B1|Lymph Nodes||Specific site(s) of metastasis/relapse|Participants can be in multiple sites of metastasis/relapse categories.|participants|Number|24|24.0||||||
4448247|NCT00093145|4272172|B1|Skin/Soft Tissue/Breast||Specific site(s) of metastasis/relapse|Participants can be in multiple sites of metastasis/relapse categories.|participants|Number|21|21.0||||||
4448248|NCT00093145|4272172|B1|Brain/Central Nervous System||Specific site(s) of metastasis/relapse|Participants can be in multiple sites of metastasis/relapse categories.|participants|Number|1|1.0||||||
4448249|NCT00093145|4272172|B1|||Time from first documented metastatic disease to study entry||years|Median|0.1|0.1|Full Range|||0.0|6.0|
4448250|NCT00093145|4272172|B1|Other||Histology of Primary Diagnosis||participants|Number|1|1.0||||||
4448251|NCT00093145|4272172|B1|Carcinoma/Adenocarcinoma||Histology of Primary Diagnosis||participants|Number|31|31.0||||||
4448252|NCT00093145|4272172|B1|Grade 1||Physician assessment of peripheral neuropathy|"The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of Neurology -- Neuropathy - Sensory. The scale is 0=normal and 1=asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function. Data available for 31 participants."|participants|Number|1|1.0||||||
4448253|NCT00093145|4272172|B1|Grade 0||Physician assessment of peripheral neuropathy|"The physician assessed sensory neuropathy using the National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE) of Neurology -- Neuropathy - Sensory. The scale is 0=normal and 1=asymptomatic; loss of deep tendon reflexes or paresthesia (including tingling) but not interfering with function. Data available for 31 participants."|participants|Number|30|30.0||||||
4448302|NCT00093041|4272186|B2|||Age||years|Median|59|59.0|Full Range|||49.0|63.0|
4448303|NCT00093041|4272187|B1|||Age||years|Median|54|54.0|Full Range|||49.0|62.0|
4448304|NCT00093041|4272181|B7||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4448305|NCT00093041|4272182|B6||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4448254|NCT00093145|4272172|B1|2 (Ambulatory, but Unable to Work)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale used to assess the progress of disease, how the disease affects the daily living abilities of the patient, and to determine appropriate treatment and prognosis.~0=Fully active, able to perform all pre-disease activity. 1=Restricted in physically strenuous activity, ambulatory, able to perform light work. 2=Ambulatory, capable of all selfcare, unable to carry out any work activities. Up and about >50% of waking hours. 3=Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4=Completely disabled. Cannot perform any selfcare. Confined to bed or chair. 5=Dead."|participants|Number|1|1.0||||||
4448255|NCT00093145|4272172|B1|1 (Restrictive but Ambulatory)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale used to assess the progress of disease, how the disease affects the daily living abilities of the patient, and to determine appropriate treatment and prognosis.~0=Fully active, able to perform all pre-disease activity. 1=Restricted in physically strenuous activity, ambulatory, able to perform light work. 2=Ambulatory, capable of all selfcare, unable to carry out any work activities. Up and about >50% of waking hours. 3=Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4=Completely disabled. Cannot perform any selfcare. Confined to bed or chair. 5=Dead."|participants|Number|12|12.0||||||
4448256|NCT00093145|4272172|B1|0 (Fully Active)||Eastern Cooperative Oncology Group (ECOG) Performance Status|"A scale used to assess the progress of disease, how the disease affects the daily living abilities of the patient, and to determine appropriate treatment and prognosis.~0=Fully active, able to perform all pre-disease activity. 1=Restricted in physically strenuous activity, ambulatory, able to perform light work. 2=Ambulatory, capable of all selfcare, unable to carry out any work activities. Up and about >50% of waking hours. 3=Capable of limited selfcare, confined to bed or chair >50% of waking hours. 4=Completely disabled. Cannot perform any selfcare. Confined to bed or chair. 5=Dead."|participants|Number|19|19.0||||||
4448257|NCT00093145|4272172|B1|Post-Menopausal||Menopausal Status||participants|Number|25|25.0||||||
4448258|NCT00093145|4272172|B1|Pre-Menopausal||Menopausal Status||participants|Number|7|7.0||||||
4448259|NCT00093145|4272172|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4448260|NCT00093145|4272172|B1|White, Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4448261|NCT00093145|4272172|B1|White, Non-Hispanic and Non-Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4448262|NCT00093145|4272172|B1|Black, of African Heritage||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4448263|NCT00093145|4272172|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448264|NCT00093145|4272172|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4448265|NCT00093145|4272172|B1|||Age||years|Median|52.0|52.0|Full Range|||29.0|76.0|
4448266|NCT00093145|4272172|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4448267|NCT00093145|4272172|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4448268|NCT00093145|4272172|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448269|NCT00093041|4272181|B7|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4448270|NCT00093041|4272182|B6|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4448271|NCT00093041|4272183|B5|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4448272|NCT00093041|4272184|B4|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4448273|NCT00093041|4272185|B3|Sweden||Region of Enrollment||participants|Number|2|2.0||||||
4448274|NCT00093041|4272186|B2|Sweden||Region of Enrollment||participants|Number|1|1.0||||||
4448275|NCT00093041|4272187|B1|Sweden||Region of Enrollment||participants|Number|0|0.0||||||
4448276|NCT00093041|4272181|B7|Denmark||Region of Enrollment||participants|Number|23|23.0||||||
4448277|NCT00093041|4272182|B6|Denmark||Region of Enrollment||participants|Number|6|6.0||||||
4448278|NCT00093041|4272183|B5|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4448279|NCT00093041|4272184|B4|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4448280|NCT00093041|4272185|B3|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4448281|NCT00093041|4272186|B2|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4448282|NCT00093041|4272187|B1|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4448283|NCT00093041|4272181|B7||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4448284|NCT00093041|4272182|B6||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4448285|NCT00093041|4272183|B5||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4448286|NCT00093041|4272184|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4448287|NCT00093041|4272185|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4448288|NCT00093041|4272186|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4448289|NCT00093041|4272187|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4448290|NCT00093041|4272181|B7||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4448291|NCT00093041|4272182|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4448292|NCT00093041|4272183|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448293|NCT00093041|4272184|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4448294|NCT00093041|4272185|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4448295|NCT00093041|4272186|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4448296|NCT00093041|4272187|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4448297|NCT00093041|4272181|B7|||Age||years|Median|57|57.0|Full Range|||47.0|79.0|
4448298|NCT00093041|4272182|B6|||Age||years|Median|58|58.0|Full Range|||52.0|67.0|
4448299|NCT00093041|4272183|B5|||Age||years|Median|53|53.0|Full Range|||47.0|61.0|
4448300|NCT00093041|4272184|B4|||Age||years|Median|55|55.0|Full Range|||50.0|76.0|
4448301|NCT00093041|4272185|B3|||Age||years|Median|57|57.0|Full Range|||56.0|68.0|
4448306|NCT00093041|4272183|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4448307|NCT00093041|4272184|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4448308|NCT00093041|4272185|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4448309|NCT00093041|4272186|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4448310|NCT00093041|4272187|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4448311|NCT00093041|4272181|B7||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4448312|NCT00093041|4272182|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4448313|NCT00093041|4272183|B5||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4448314|NCT00093041|4272184|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4448315|NCT00093041|4272185|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4448316|NCT00093041|4272186|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4448317|NCT00093041|4272187|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4448318|NCT00093041|4272181|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448319|NCT00093041|4272182|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448320|NCT00093041|4272183|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448321|NCT00093041|4272184|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448322|NCT00093041|4272185|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448323|NCT00093041|4272186|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448324|NCT00093041|4272187|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448325|NCT00093015|4272212|B3|< 1 g/g creat||Baseline proteinuria level|Baseline proteinuria level (g/g creat). Baseline proteinuria is defined as the last non-missing measurement prior or on the day of first investigational product.|Participants|Number|2639|2639.0||||||
4448326|NCT00093015|4272213|B2|< 1 g/g creat||Baseline proteinuria level|Baseline proteinuria level (g/g creat). Baseline proteinuria is defined as the last non-missing measurement prior or on the day of first investigational product.|Participants|Number|1315|1315.0||||||
4448327|NCT00093015|4272214|B1|< 1 g/g creat||Baseline proteinuria level|Baseline proteinuria level (g/g creat). Baseline proteinuria is defined as the last non-missing measurement prior or on the day of first investigational product.|Participants|Number|1324|1324.0||||||
4448328|NCT00093015|4272212|B3|>= 1 g/g creat||Baseline proteinuria level|Baseline proteinuria level (g/g creat). Baseline proteinuria is defined as the last non-missing measurement prior or on the day of first investigational product.|Participants|Number|1397|1397.0||||||
4448329|NCT00093015|4272213|B2|>= 1 g/g creat||Baseline proteinuria level|Baseline proteinuria level (g/g creat). Baseline proteinuria is defined as the last non-missing measurement prior or on the day of first investigational product.|Participants|Number|711|711.0||||||
4448330|NCT00093015|4272214|B1|>= 1 g/g creat||Baseline proteinuria level|Baseline proteinuria level (g/g creat). Baseline proteinuria is defined as the last non-missing measurement prior or on the day of first investigational product.|Participants|Number|686|686.0||||||
4448331|NCT00093015|4272212|B3|Without history of cardiovascular disease||History of cardiovascular disease|Cardiovascular disease history is based on the cardiovascular medical history case report form.|Participant|Number|1396|1396.0||||||
4448332|NCT00093015|4272213|B2|Without history of cardiovascular disease||History of cardiovascular disease|Cardiovascular disease history is based on the cardiovascular medical history case report form.|Participant|Number|671|671.0||||||
4448333|NCT00093015|4272214|B1|Without history of cardiovascular disease||History of cardiovascular disease|Cardiovascular disease history is based on the cardiovascular medical history case report form.|Participant|Number|725|725.0||||||
4448334|NCT00093015|4272212|B3|With history of cardiovascular disease||History of cardiovascular disease|Cardiovascular disease history is based on the cardiovascular medical history case report form.|Participant|Number|2642|2642.0||||||
4448335|NCT00093015|4272213|B2|With history of cardiovascular disease||History of cardiovascular disease|Cardiovascular disease history is based on the cardiovascular medical history case report form.|Participant|Number|1355|1355.0||||||
4448336|NCT00093015|4272214|B1|With history of cardiovascular disease||History of cardiovascular disease|Cardiovascular disease history is based on the cardiovascular medical history case report form.|Participant|Number|1287|1287.0||||||
4448337|NCT00093015|4272212|B3|Other||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4448338|NCT00093015|4272213|B2|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4448339|NCT00093015|4272214|B1|Other||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4448340|NCT00093015|4272212|B3|Aborigine||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4448341|NCT00093015|4272213|B2|Aborigine||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4448342|NCT00093015|4272214|B1|Aborigine||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4448343|NCT00093015|4272212|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4448344|NCT00093015|4272213|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4448345|NCT00093015|4272214|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4448346|NCT00093015|4272212|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4448347|NCT00093015|4272213|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4448348|NCT00093015|4272214|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4448349|NCT00093015|4272212|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4448350|NCT00093015|4272213|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4448351|NCT00093015|4272214|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4448352|NCT00093015|4272212|B3|Asian||Race/Ethnicity, Customized||Participants|Number|78|78.0||||||
4448353|NCT00093015|4272213|B2|Asian||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4448354|NCT00093015|4272214|B1|Asian||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4448355|NCT00093015|4272212|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|538|538.0||||||
4448356|NCT00093015|4272213|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|265|265.0||||||
4448357|NCT00093015|4272214|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|273|273.0||||||
4448358|NCT00093015|4272212|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|815|815.0||||||
4448359|NCT00093015|4272213|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|401|401.0||||||
4448360|NCT00093015|4272214|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|414|414.0||||||
4448361|NCT00093015|4272212|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|2570|2570.0||||||
4448362|NCT00093015|4272213|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|1300|1300.0||||||
4448363|NCT00093015|4272214|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|1270|1270.0||||||
4448364|NCT00093015|4272212|B3||Male|Sex: Female, Male||Participants|Count of Participants|1726|1726.0||||||
4448365|NCT00093015|4272213|B2||Male|Sex: Female, Male||Participants|Count of Participants|892|892.0||||||
4448366|NCT00093015|4272214|B1||Male|Sex: Female, Male||Participants|Count of Participants|834|834.0||||||
4448367|NCT00093015|4272212|B3||Female|Sex: Female, Male||Participants|Count of Participants|2312|2312.0||||||
4448368|NCT00093015|4272213|B2||Female|Sex: Female, Male||Participants|Count of Participants|1134|1134.0||||||
4448369|NCT00093015|4272214|B1||Female|Sex: Female, Male||Participants|Count of Participants|1178|1178.0||||||
4448370|NCT00093015|4272212|B3|||Age||Years|Mean|67.4|67.4|Standard Deviation|10.6|10.6|||
4448371|NCT00093015|4272213|B2|||Age||Years|Mean|67.5|67.5|Standard Deviation|10.6|10.6|||
4448372|NCT00093015|4272214|B1|||Age||Years|Mean|67.2|67.2|Standard Deviation|10.7|10.7|||
4448373|NCT00092677|4272241|B3|||Triglycerides (TG)||mmol/L|Mean|1.42|1.42|Standard Deviation|0.69|0.69|||
4448374|NCT00092677|4272242|B2|||Triglycerides (TG)||mmol/L|Mean|1.42|1.42|Standard Deviation|0.68|0.68|||
4448375|NCT00092677|4272243|B1|||Triglycerides (TG)||mmol/L|Mean|1.42|1.42|Standard Deviation|0.71|0.71|||
4448376|NCT00092677|4272241|B3|||Total Cholesterol||mmol/L|Mean|5.74|5.74|Standard Deviation|1.02|1.02|||
4448377|NCT00092677|4272242|B2|||Total Cholesterol||mmol/L|Mean|5.73|5.73|Standard Deviation|0.99|0.99|||
4448378|NCT00092677|4272243|B1|||Total Cholesterol||mmol/L|Mean|5.76|5.76|Standard Deviation|1.04|1.04|||
4448379|NCT00092677|4272241|B3|||Peak Transaortic Jet Velocity||m/sec|Mean|3.09|3.09|Standard Deviation|0.54|0.54|||
4448380|NCT00092677|4272242|B2|||Peak Transaortic Jet Velocity||m/sec|Mean|3.10|3.1|Standard Deviation|0.54|0.54|||
4448381|NCT00092677|4272243|B1|||Peak Transaortic Jet Velocity||m/sec|Mean|3.09|3.09|Standard Deviation|0.55|0.55|||
4448382|NCT00092677|4272241|B3|||Low-density Lipoprotein Cholesterol (LDL-C)||mmol/L|Mean|3.60|3.6|Standard Deviation|0.92|0.92|||
4448383|NCT00092677|4272242|B2|||Low-density Lipoprotein Cholesterol (LDL-C)||mmol/L|Mean|3.59|3.59|Standard Deviation|0.91|0.91|||
4448384|NCT00092677|4272243|B1|||Low-density Lipoprotein Cholesterol (LDL-C)||mmol/L|Mean|3.62|3.62|Standard Deviation|0.93|0.93|||
4448385|NCT00092677|4272241|B3|||High-density Lipoprotein Cholesterol (HDL-C)||mmol/L|Mean|1.49|1.49|Standard Deviation|0.43|0.43|||
4448386|NCT00092677|4272242|B2|||High-density Lipoprotein Cholesterol (HDL-C)||mmol/L|Mean|1.49|1.49|Standard Deviation|0.43|0.43|||
4448387|NCT00092677|4272243|B1|||High-density Lipoprotein Cholesterol (HDL-C)||mmol/L|Mean|1.49|1.49|Standard Deviation|0.43|0.43|||
4448388|NCT00092677|4272241|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4448389|NCT00092677|4272242|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4448390|NCT00092677|4272243|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4448391|NCT00092677|4272241|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4448392|NCT00092677|4272242|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4448393|NCT00092677|4272243|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4448394|NCT00092677|4272241|B3|White||Race/Ethnicity, Customized||participants|Number|1868|1868.0||||||
4448395|NCT00092677|4272242|B2|White||Race/Ethnicity, Customized||participants|Number|928|928.0||||||
4448396|NCT00092677|4272243|B1|White||Race/Ethnicity, Customized||participants|Number|940|940.0||||||
4448397|NCT00092677|4272241|B3||Male|Sex: Female, Male||Participants|Count of Participants|1150|1150.0||||||
4448398|NCT00092677|4272242|B2||Male|Sex: Female, Male||Participants|Count of Participants|569|569.0||||||
4448399|NCT00092677|4272243|B1||Male|Sex: Female, Male||Participants|Count of Participants|581|581.0||||||
4448400|NCT00092677|4272241|B3||Female|Sex: Female, Male||Participants|Count of Participants|723|723.0||||||
4448401|NCT00092677|4272242|B2||Female|Sex: Female, Male||Participants|Count of Participants|360|360.0||||||
4448402|NCT00092677|4272243|B1||Female|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
4448403|NCT00092677|4272241|B3|||Age||years|Mean|67.5|67.5|Full Range|||28.0|86.0|
4448404|NCT00092677|4272242|B2|||Age||years|Mean|67.4|67.4|Full Range|||28.0|85.0|
4448405|NCT00092677|4272243|B1|||Age||years|Mean|67.7|67.7|Full Range|||41.0|86.0|
4448406|NCT00092547|4272286|B3|Other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4448407|NCT00092547|4272287|B2|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4448408|NCT00092547|4272288|B1|Other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4448409|NCT00092547|4272286|B3|White||Race/Ethnicity, Customized||participants|Number|1085|1085.0||||||
4448410|NCT00092547|4272287|B2|White||Race/Ethnicity, Customized||participants|Number|369|369.0||||||
4448411|NCT00092547|4272288|B1|White||Race/Ethnicity, Customized||participants|Number|716|716.0||||||
4448584|NCT00092456|4272440|B2|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4448412|NCT00092547|4272286|B3|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4448413|NCT00092547|4272287|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4448414|NCT00092547|4272288|B1|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4448415|NCT00092547|4272286|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|390|390.0||||||
4448416|NCT00092547|4272287|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|130|130.0||||||
4448417|NCT00092547|4272288|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|260|260.0||||||
4448418|NCT00092547|4272286|B3|Black||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4448419|NCT00092547|4272287|B2|Black||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4448420|NCT00092547|4272288|B1|Black||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4448421|NCT00092547|4272286|B3|Asian||Race/Ethnicity, Customized||participants|Number|219|219.0||||||
4448422|NCT00092547|4272287|B2|Asian||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4448423|NCT00092547|4272288|B1|Asian||Race/Ethnicity, Customized||participants|Number|149|149.0||||||
4448424|NCT00092547|4272286|B3||Male|Sex: Female, Male||Participants|Count of Participants|843|843.0||||||
4448425|NCT00092547|4272287|B2||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4448426|NCT00092547|4272288|B1||Male|Sex: Female, Male||Participants|Count of Participants|568|568.0||||||
4448427|NCT00092547|4272286|B3||Female|Sex: Female, Male||Participants|Count of Participants|938|938.0||||||
4448428|NCT00092547|4272287|B2||Female|Sex: Female, Male||Participants|Count of Participants|322|322.0||||||
4448429|NCT00092547|4272288|B1||Female|Sex: Female, Male||Participants|Count of Participants|616|616.0||||||
4448430|NCT00092547|4272286|B3|17 Years of Age and Over||Age, Customized||Participants|Number|0|0.0||||||
4448431|NCT00092547|4272287|B2|17 Years of Age and Over||Age, Customized||Participants|Number|0|0.0||||||
4448432|NCT00092547|4272288|B1|17 Years of Age and Over||Age, Customized||Participants|Number|0|0.0||||||
4448433|NCT00092547|4272286|B3|9 to 16 Years of Age||Age, Customized||Participants|Number|1781|1781.0||||||
4448434|NCT00092547|4272287|B2|9 to 16 Years of Age||Age, Customized||Participants|Number|597|597.0||||||
4448435|NCT00092547|4272288|B1|9 to 16 Years of Age||Age, Customized||Participants|Number|1184|1184.0||||||
4448436|NCT00092547|4272286|B3|8 Years of Age and Under||Age, Customized||Participants|Number|0|0.0||||||
4448437|NCT00092547|4272287|B2|8 Years of Age and Under||Age, Customized||Participants|Number|0|0.0||||||
4448438|NCT00092547|4272288|B1|8 Years of Age and Under||Age, Customized||Participants|Number|0|0.0||||||
4448439|NCT00092547|4272286|B3|||Age||years|Mean|11.9|11.9|Standard Deviation|1.9|1.9|||
4448440|NCT00092547|4272287|B2|||Age||years|Mean|11.8|11.8|Standard Deviation|1.9|1.9|||
4448441|NCT00092547|4272288|B1|||Age||years|Mean|11.9|11.9|Standard Deviation|1.9|1.9|||
4448442|NCT00092534|4272332|B3|Other-Unspecified||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|1235|1235.0||||||
4448443|NCT00092534|4272333|B2|Other-Unspecified||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|610|610.0||||||
4448444|NCT00092534|4272334|B1|Other-Unspecified||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|625|625.0||||||
4448445|NCT00092534|4272332|B3|White||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|9134|9134.0||||||
4448446|NCT00092534|4272333|B2|White||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|4550|4550.0||||||
4448447|NCT00092534|4272334|B1|White||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|4584|4584.0||||||
4448448|NCT00092534|4272332|B3|Native American||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|2|2.0||||||
4448449|NCT00092534|4272333|B2|Native American||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|1|1.0||||||
4448450|NCT00092534|4272334|B1|Native American||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|1|1.0||||||
4448451|NCT00092534|4272332|B3|Hispanic American||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|1112|1112.0||||||
4448452|NCT00092534|4272333|B2|Hispanic American||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|557|557.0||||||
4448453|NCT00092534|4272334|B1|Hispanic American||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|555|555.0||||||
4448454|NCT00092534|4272332|B3|Black||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|398|398.0||||||
4448455|NCT00092534|4272333|B2|Black||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|227|227.0||||||
4448456|NCT00092534|4272334|B1|Black||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|171|171.0||||||
4448457|NCT00092534|4272332|B3|Asian||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|286|286.0||||||
4448458|NCT00092534|4272333|B2|Asian||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|135|135.0||||||
4448459|NCT00092534|4272334|B1|Asian||Race/Ethnicity|Subject race was determined at subject entry into the base study.|participants|Number|151|151.0||||||
4448460|NCT00092534|4272332|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448461|NCT00092534|4272333|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448462|NCT00092534|4272334|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448463|NCT00092534|4272332|B3||Female|Sex: Female, Male||Participants|Count of Participants|12167|12167.0||||||
4448464|NCT00092534|4272333|B2||Female|Sex: Female, Male||Participants|Count of Participants|6080|6080.0||||||
4448465|NCT00092534|4272334|B1||Female|Sex: Female, Male||Participants|Count of Participants|6087|6087.0||||||
4448466|NCT00092534|4272332|B3|Between 15 and 26 years||Age, Customized|Age for study subjects was recorded at the time of subject entry into the base study.|participants|Number|12167|12167.0||||||
4448467|NCT00092534|4272333|B2|Between 15 and 26 years||Age, Customized|Age for study subjects was recorded at the time of subject entry into the base study.|participants|Number|6080|6080.0||||||
4448468|NCT00092534|4272334|B1|Between 15 and 26 years||Age, Customized|Age for study subjects was recorded at the time of subject entry into the base study.|participants|Number|6087|6087.0||||||
4448469|NCT00092534|4272332|B3|||Age||years|Mean|19.9|19.9|Standard Deviation|2.1|2.1|||
4448470|NCT00092534|4272333|B2|||Age||years|Mean|19.9|19.9|Standard Deviation|2.1|2.1|||
4448471|NCT00092534|4272334|B1|||Age||years|Mean|20.0|20.0|Standard Deviation|2.2|2.2|||
4448472|NCT00092521|4272351|B4|Other - Unspecified||Race/Ethnicity, Customized||participants|Number|531|531.0||||||
4448473|NCT00092521|4272352|B3|Other - Unspecified||Race/Ethnicity, Customized||participants|Number|266|266.0||||||
4448474|NCT00092521|4272353|B2|Other - Unspecified||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4448475|NCT00092521|4272354|B1|Other - Unspecified||Race/Ethnicity, Customized||participants|Number|259|259.0||||||
4448476|NCT00092521|4272351|B4|White||Race/Ethnicity, Customized||participants|Number|3329|3329.0||||||
4448477|NCT00092521|4272352|B3|White||Race/Ethnicity, Customized||participants|Number|1558|1558.0||||||
4448478|NCT00092521|4272353|B2|White||Race/Ethnicity, Customized||participants|Number|171|171.0||||||
4448479|NCT00092521|4272354|B1|White||Race/Ethnicity, Customized||participants|Number|1600|1600.0||||||
4448480|NCT00092521|4272351|B4|Native American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4448481|NCT00092521|4272352|B3|Native American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4448482|NCT00092521|4272353|B2|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4448483|NCT00092521|4272354|B1|Native American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4448484|NCT00092521|4272351|B4|Hispanic American||Race/Ethnicity, Customized||participants|Number|1226|1226.0||||||
4448485|NCT00092521|4272352|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|566|566.0||||||
4448486|NCT00092521|4272353|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|93|93.0||||||
4448487|NCT00092521|4272354|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|567|567.0||||||
4448488|NCT00092521|4272351|B4|Black||Race/Ethnicity, Customized||participants|Number|308|308.0||||||
4448489|NCT00092521|4272352|B3|Black||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
4448490|NCT00092521|4272353|B2|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4448491|NCT00092521|4272354|B1|Black||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4448492|NCT00092521|4272351|B4|Asian||Race/Ethnicity, Customized||participants|Number|343|343.0||||||
4448493|NCT00092521|4272352|B3|Asian||Race/Ethnicity, Customized||participants|Number|165|165.0||||||
4448494|NCT00092521|4272353|B2|Asian||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4448495|NCT00092521|4272354|B1|Asian||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
4448496|NCT00092521|4272351|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448497|NCT00092521|4272352|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448498|NCT00092521|4272353|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448499|NCT00092521|4272354|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448500|NCT00092521|4272351|B4||Female|Sex: Female, Male||Participants|Count of Participants|5759|5759.0||||||
4448501|NCT00092521|4272352|B3||Female|Sex: Female, Male||Participants|Count of Participants|2732|2732.0||||||
4448502|NCT00092521|4272353|B2||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4448503|NCT00092521|4272354|B1||Female|Sex: Female, Male||Participants|Count of Participants|2723|2723.0||||||
4448504|NCT00092521|4272351|B4|16 to 24 Years of Age||Age, Customized|Although the upper age limit for this study was 23 years old, four subjects aged 24 were randomized into the study.|Participants|Number|5759|5759.0||||||
4448505|NCT00092521|4272352|B3|16 to 24 Years of Age||Age, Customized|Although the upper age limit for this study was 23 years old, four subjects aged 24 were randomized into the study.|Participants|Number|2732|2732.0||||||
4448506|NCT00092521|4272353|B2|16 to 24 Years of Age||Age, Customized|Although the upper age limit for this study was 23 years old, four subjects aged 24 were randomized into the study.|Participants|Number|304|304.0||||||
4448507|NCT00092521|4272354|B1|16 to 24 Years of Age||Age, Customized|Although the upper age limit for this study was 23 years old, four subjects aged 24 were randomized into the study.|Participants|Number|2723|2723.0||||||
4448508|NCT00092521|4272351|B4|||Age||Years|Median|20|20.0|Full Range|||16.0|24.0|
4448509|NCT00092521|4272352|B3|||Age||Years|Median|20|20.0|Full Range|||16.0|24.0|
4448510|NCT00092521|4272353|B2|||Age||Years|Median|20|20.0|Full Range|||16.0|24.0|
4448511|NCT00092521|4272354|B1|||Age||Years|Median|20|20.0|Full Range|||16.0|24.0|
4448512|NCT00092521|4272351|B4|||Age||years|Mean|20.3|20.3|Standard Deviation|1.8|1.8|||
4448513|NCT00092521|4272352|B3|||Age||years|Mean|20.3|20.3|Standard Deviation|1.8|1.8|||
4448514|NCT00092521|4272353|B2|||Age||years|Mean|20.2|20.2|Standard Deviation|1.74|1.74|||
4448515|NCT00092521|4272354|B1|||Age||years|Mean|20.2|20.2|Standard Deviation|1.8|1.8|||
4448516|NCT00092495|4272367|B5||Male|Sex: Female, Male||Participants|Count of Participants|510|510.0||||||
4448517|NCT00092495|4272368|B4||Male|Sex: Female, Male||Participants|Count of Participants|510|510.0||||||
4448518|NCT00092495|4272369|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448519|NCT00092495|4272370|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448520|NCT00092495|4272371|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448521|NCT00092495|4272367|B5||Female|Sex: Female, Male||Participants|Count of Participants|2545|2545.0||||||
4448522|NCT00092495|4272368|B4||Female|Sex: Female, Male||Participants|Count of Participants|1019|1019.0||||||
4448523|NCT00092495|4272369|B3||Female|Sex: Female, Male||Participants|Count of Participants|508|508.0||||||
4448524|NCT00092495|4272370|B2||Female|Sex: Female, Male||Participants|Count of Participants|514|514.0||||||
4448525|NCT00092495|4272371|B1||Female|Sex: Female, Male||Participants|Count of Participants|504|504.0||||||
4448526|NCT00092495|4272367|B5|Over 23 Years of Age||Age, Customized||participants|Number|1|1.0||||||
4448527|NCT00092495|4272368|B4|Over 23 Years of Age||Age, Customized||participants|Number|0|0.0||||||
4448528|NCT00092495|4272369|B3|Over 23 Years of Age||Age, Customized||participants|Number|0|0.0||||||
4448529|NCT00092495|4272370|B2|Over 23 Years of Age||Age, Customized||participants|Number|1|1.0||||||
4448530|NCT00092495|4272371|B1|Over 23 Years of Age||Age, Customized||participants|Number|0|0.0||||||
4448531|NCT00092495|4272367|B5|22 to 23 Years of Age||Age, Customized||participants|Number|353|353.0||||||
4448532|NCT00092495|4272368|B4|22 to 23 Years of Age||Age, Customized||participants|Number|146|146.0||||||
4448533|NCT00092495|4272369|B3|22 to 23 Years of Age||Age, Customized||participants|Number|57|57.0||||||
4448534|NCT00092495|4272370|B2|22 to 23 Years of Age||Age, Customized||participants|Number|86|86.0||||||
4448535|NCT00092495|4272371|B1|22 to 23 Years of Age||Age, Customized||participants|Number|64|64.0||||||
4448536|NCT00092495|4272367|B5|20 to 21 Years of Age||Age, Customized||participants|Number|434|434.0||||||
4448537|NCT00092495|4272368|B4|20 to 21 Years of Age||Age, Customized||participants|Number|165|165.0||||||
4448538|NCT00092495|4272369|B3|20 to 21 Years of Age||Age, Customized||participants|Number|93|93.0||||||
4448539|NCT00092495|4272370|B2|20 to 21 Years of Age||Age, Customized||participants|Number|86|86.0||||||
4448540|NCT00092495|4272371|B1|20 to 21 Years of Age||Age, Customized||participants|Number|90|90.0||||||
4448541|NCT00092495|4272367|B5|18 to 19 Years of Age||Age, Customized||participants|Number|316|316.0||||||
4448542|NCT00092495|4272368|B4|18 to 19 Years of Age||Age, Customized||participants|Number|125|125.0||||||
4448543|NCT00092495|4272369|B3|18 to 19 Years of Age||Age, Customized||participants|Number|71|71.0||||||
4448544|NCT00092495|4272370|B2|18 to 19 Years of Age||Age, Customized||participants|Number|62|62.0||||||
4448545|NCT00092495|4272371|B1|18 to 19 Years of Age||Age, Customized||participants|Number|58|58.0||||||
4448546|NCT00092495|4272367|B5|16 to 17 Years of Age||Age, Customized||participants|Number|176|176.0||||||
4448547|NCT00092495|4272368|B4|16 to 17 Years of Age||Age, Customized||participants|Number|77|77.0||||||
4448548|NCT00092495|4272369|B3|16 to 17 Years of Age||Age, Customized||participants|Number|35|35.0||||||
4448549|NCT00092495|4272370|B2|16 to 17 Years of Age||Age, Customized||participants|Number|24|24.0||||||
4448550|NCT00092495|4272371|B1|16 to 17 Years of Age||Age, Customized||participants|Number|40|40.0||||||
4448551|NCT00092495|4272367|B5|14 to 15 Years of Age||Age, Customized||participants|Number|571|571.0||||||
4448552|NCT00092495|4272368|B4|14 to 15 Years of Age||Age, Customized||participants|Number|344|344.0||||||
4448553|NCT00092495|4272369|B3|14 to 15 Years of Age||Age, Customized||participants|Number|77|77.0||||||
4448554|NCT00092495|4272370|B2|14 to 15 Years of Age||Age, Customized||participants|Number|83|83.0||||||
4448555|NCT00092495|4272371|B1|14 to 15 Years of Age||Age, Customized||participants|Number|67|67.0||||||
4448556|NCT00092495|4272367|B5|12 to 13 Years of Age||Age, Customized||participants|Number|676|676.0||||||
4448557|NCT00092495|4272368|B4|12 to 13 Years of Age||Age, Customized||participants|Number|370|370.0||||||
4448558|NCT00092495|4272369|B3|12 to 13 Years of Age||Age, Customized||participants|Number|101|101.0||||||
4448559|NCT00092495|4272370|B2|12 to 13 Years of Age||Age, Customized||participants|Number|95|95.0||||||
4448560|NCT00092495|4272371|B1|12 to 13 Years of Age||Age, Customized||participants|Number|110|110.0||||||
4448561|NCT00092495|4272367|B5|10 to 11 Years of Age||Age, Customized||participants|Number|528|528.0||||||
4448562|NCT00092495|4272368|B4|10 to 11 Years of Age||Age, Customized||participants|Number|302|302.0||||||
4448563|NCT00092495|4272369|B3|10 to 11 Years of Age||Age, Customized||participants|Number|74|74.0||||||
4448564|NCT00092495|4272370|B2|10 to 11 Years of Age||Age, Customized||participants|Number|77|77.0||||||
4448565|NCT00092495|4272371|B1|10 to 11 Years of Age||Age, Customized||participants|Number|75|75.0||||||
4448566|NCT00092495|4272367|B5|||Age||years|Mean|15.7|15.7|Full Range|10|10.0|10.0|24.0|
4448567|NCT00092495|4272368|B4|||Age||years|Mean|15.1|15.1|Full Range|||10.0|23.0|
4448568|NCT00092495|4272369|B3|||Age||years|Mean|16.2|16.2|Full Range|||10.0|23.0|
4448569|NCT00092495|4272370|B2|||Age||years|Mean|16.5|16.5|Full Range|||10.0|24.0|
4448570|NCT00092495|4272371|B1|||Age||years|Mean|16.2|16.2|Full Range|||10.0|23.0|
4448571|NCT00092456|4272437|B5|Other||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4448572|NCT00092456|4272438|B4|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4448573|NCT00092456|4272439|B3|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4448574|NCT00092456|4272440|B2|Other||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4448575|NCT00092456|4272441|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4448576|NCT00092456|4272437|B5|Multi-Racial||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4448577|NCT00092456|4272438|B4|Multi-Racial||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4448578|NCT00092456|4272439|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4448579|NCT00092456|4272440|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4448580|NCT00092456|4272441|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4448581|NCT00092456|4272437|B5|Black||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4448582|NCT00092456|4272438|B4|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4448583|NCT00092456|4272439|B3|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4448585|NCT00092456|4272441|B1|Black||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4448586|NCT00092456|4272437|B5|Hispanic American||Race/Ethnicity, Customized||participants|Number|186|186.0||||||
4448587|NCT00092456|4272438|B4|Hispanic American||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4448588|NCT00092456|4272439|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4448589|NCT00092456|4272440|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4448590|NCT00092456|4272441|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|57|57.0||||||
4448591|NCT00092456|4272437|B5|White||Race/Ethnicity, Customized||participants|Number|498|498.0||||||
4448592|NCT00092456|4272438|B4|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4448593|NCT00092456|4272439|B3|White||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
4448594|NCT00092456|4272440|B2|White||Race/Ethnicity, Customized||participants|Number|144|144.0||||||
4448595|NCT00092456|4272441|B1|White||Race/Ethnicity, Customized||participants|Number|139|139.0||||||
4448596|NCT00092456|4272437|B5||Male|Sex: Female, Male||Participants|Count of Participants|426|426.0||||||
4448597|NCT00092456|4272438|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4448598|NCT00092456|4272439|B3||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4448599|NCT00092456|4272440|B2||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4448600|NCT00092456|4272441|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4448601|NCT00092456|4272437|B5||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4448602|NCT00092456|4272438|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4448603|NCT00092456|4272439|B3||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4448604|NCT00092456|4272440|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4448605|NCT00092456|4272441|B1||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4448606|NCT00092456|4272437|B5|Over 12 Weeks||Age, Customized||participants|Number|3|3.0||||||
4448607|NCT00092456|4272438|B4|Over 12 Weeks||Age, Customized||participants|Number|0|0.0||||||
4448608|NCT00092456|4272439|B3|Over 12 Weeks||Age, Customized||participants|Number|1|1.0||||||
4448609|NCT00092456|4272440|B2|Over 12 Weeks||Age, Customized||participants|Number|1|1.0||||||
4448610|NCT00092456|4272441|B1|Over 12 Weeks||Age, Customized||participants|Number|1|1.0||||||
4448611|NCT00092456|4272437|B5|6 to 12 Weeks||Age, Customized||participants|Number|790|790.0||||||
4448612|NCT00092456|4272438|B4|6 to 12 Weeks||Age, Customized||participants|Number|113|113.0||||||
4448613|NCT00092456|4272439|B3|6 to 12 Weeks||Age, Customized||participants|Number|228|228.0||||||
4448614|NCT00092456|4272440|B2|6 to 12 Weeks||Age, Customized||participants|Number|224|224.0||||||
4448615|NCT00092456|4272441|B1|6 to 12 Weeks||Age, Customized||participants|Number|225|225.0||||||
4448616|NCT00092443|4272490|B3|Other||Race/Ethnicity||participants|Number|15|15.0||||||
4448617|NCT00092443|4272491|B2|Other||Race/Ethnicity||participants|Number|6|6.0||||||
4448618|NCT00092443|4272492|B1|Other||Race/Ethnicity||participants|Number|9|9.0||||||
4448619|NCT00092443|4272490|B3|Multi-Racial||Race/Ethnicity||participants|Number|32|32.0||||||
4448620|NCT00092443|4272491|B2|Multi-Racial||Race/Ethnicity||participants|Number|15|15.0||||||
4448621|NCT00092443|4272492|B1|Multi-Racial||Race/Ethnicity||participants|Number|17|17.0||||||
4448622|NCT00092443|4272490|B3|Black||Race/Ethnicity||participants|Number|44|44.0||||||
4448623|NCT00092443|4272491|B2|Black||Race/Ethnicity||participants|Number|23|23.0||||||
4448624|NCT00092443|4272492|B1|Black||Race/Ethnicity||participants|Number|21|21.0||||||
4448625|NCT00092443|4272490|B3|Hispanic American||Race/Ethnicity||participants|Number|156|156.0||||||
4448626|NCT00092443|4272491|B2|Hispanic American||Race/Ethnicity||participants|Number|77|77.0||||||
4448627|NCT00092443|4272492|B1|Hispanic American||Race/Ethnicity||participants|Number|79|79.0||||||
4448628|NCT00092443|4272490|B3|White||Race/Ethnicity||participants|Number|1065|1065.0||||||
4448629|NCT00092443|4272491|B2|White||Race/Ethnicity||participants|Number|540|540.0||||||
4448630|NCT00092443|4272492|B1|White||Race/Ethnicity||participants|Number|525|525.0||||||
4448631|NCT00092443|4272490|B3||Male|Sex: Female, Male||Participants|Count of Participants|685|685.0||||||
4448632|NCT00092443|4272491|B2||Male|Sex: Female, Male||Participants|Count of Participants|338|338.0||||||
4448633|NCT00092443|4272492|B1||Male|Sex: Female, Male||Participants|Count of Participants|347|347.0||||||
4448634|NCT00092443|4272490|B3||Female|Sex: Female, Male||Participants|Count of Participants|627|627.0||||||
4448635|NCT00092443|4272491|B2||Female|Sex: Female, Male||Participants|Count of Participants|323|323.0||||||
4448636|NCT00092443|4272492|B1||Female|Sex: Female, Male||Participants|Count of Participants|304|304.0||||||
4448637|NCT00092443|4272490|B3|Over 12 Weeks||Age, Customized||participants|Number|6|6.0||||||
4448638|NCT00092443|4272491|B2|Over 12 Weeks||Age, Customized||participants|Number|3|3.0||||||
4448639|NCT00092443|4272492|B1|Over 12 Weeks||Age, Customized||participants|Number|3|3.0||||||
4448640|NCT00092443|4272490|B3|6 to 12 Weeks||Age, Customized||participants|Number|1306|1306.0||||||
4448641|NCT00092443|4272491|B2|6 to 12 Weeks||Age, Customized||participants|Number|658|658.0||||||
4448642|NCT00092443|4272492|B1|6 to 12 Weeks||Age, Customized||participants|Number|648|648.0||||||
4448643|NCT00092417|4272509|B3|White||Race/Ethnicity, Customized||participants|Number|646|646.0||||||
4448644|NCT00092417|4272510|B2|White||Race/Ethnicity, Customized||participants|Number|214|214.0||||||
4448645|NCT00092417|4272511|B1|White||Race/Ethnicity, Customized||participants|Number|432|432.0||||||
4448646|NCT00092417|4272509|B3|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4448647|NCT00092417|4272510|B2|Native American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4448684|NCT00092118|4272555|B3||Male|Sex: Female, Male||Participants|Count of Participants|716|716.0||||||
4448648|NCT00092417|4272511|B1|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4448649|NCT00092417|4272509|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4448650|NCT00092417|4272510|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4448651|NCT00092417|4272511|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4448652|NCT00092417|4272509|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4448653|NCT00092417|4272510|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4448654|NCT00092417|4272511|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4448655|NCT00092417|4272509|B3|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4448656|NCT00092417|4272510|B2|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4448657|NCT00092417|4272511|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4448658|NCT00092417|4272509|B3|Asian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4448659|NCT00092417|4272510|B2|Asian||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4448660|NCT00092417|4272511|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4448661|NCT00092417|4272509|B3||Male|Sex: Female, Male||Participants|Count of Participants|279|279.0||||||
4448662|NCT00092417|4272510|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4448663|NCT00092417|4272511|B1||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4448664|NCT00092417|4272509|B3||Female|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
4448665|NCT00092417|4272510|B2||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4448666|NCT00092417|4272511|B1||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4448667|NCT00092417|4272509|B3|||Age||years|Mean|65.4|65.4|Standard Deviation|9.34|9.34|||
4448668|NCT00092417|4272510|B2|||Age||years|Mean|65.6|65.6|Standard Deviation|9.69|9.69|||
4448669|NCT00092417|4272511|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|9.16|9.16|||
4448670|NCT00092131|4272526|B1|||Time to recovery from maximal percent fall in FEV1 after exercise challenge|The duration between the time at which the maximum percent fall in FEV1 occurs and the time when the FEV1 returns to within 5% of the pre-exercise measurement for the first time after the exercise challenge|Minutes|Mean|45.15|45.15|Standard Deviation|29.70|29.7|||
4448671|NCT00092131|4272526|B1|||Maximum Percent Fall in forced expiratory volume in 1 second (FEV1) post-exercise challenge|Maximum percent fall in FEV1 from pre-exercise measurement occurring within the first 60 minutes after exercise challenge. Pre-exercise measurement FEV1 is the value (in liters) measured on the day of the exercise challenge, 5 minutes before exercise testing.|Percent change from pre-exercise measure|Mean|27.63|27.63|Standard Deviation|5.60|5.6|||
4448672|NCT00092131|4272526|B1|||AUC for percent change from pre-exercise measurement FEV1 in L 0-60 mins after exercise challenge|"Area under the curve (AUC) for FEV1 percent change from pre-exercise~measurement over the first hour after exercise challenge."|(percent change) *minutes|Mean|762.59|762.59|Standard Deviation|380.34|380.34|||
4448673|NCT00092131|4272526|B1|Yes||Need for β-agonist rescue medication following exercise challenge||Participants|Number|4|4.0||||||
4448674|NCT00092131|4272526|B1|No||Need for β-agonist rescue medication following exercise challenge||Participants|Number|47|47.0||||||
4448675|NCT00092131|4272526|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4448676|NCT00092131|4272526|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4448677|NCT00092131|4272526|B1|||Age||years|Mean|24.5|24.5|Standard Deviation|5.9|5.9|||
4448678|NCT00092118|4272555|B3|||Rhinoconjunctivitis Quality-of-Life Score|"Patients completed the validated, self-administered RQLQ which~included 28 items on a 7-point scale [Score 0 (best) to 6 (worst)] across 7 domains: activities, sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, and emotional. The scores within each domain were averaged, then the scores for the 7 domains were averaged to obtain the overall score. Baseline is the Visit 3 value."|Score on a scale|Mean|2.95|2.95|Standard Deviation|1.07|1.07|||
4448679|NCT00092118|4272556|B2|||Rhinoconjunctivitis Quality-of-Life Score|"Patients completed the validated, self-administered RQLQ which~included 28 items on a 7-point scale [Score 0 (best) to 6 (worst)] across 7 domains: activities, sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, and emotional. The scores within each domain were averaged, then the scores for the 7 domains were averaged to obtain the overall score. Baseline is the Visit 3 value."|Score on a scale|Mean|2.94|2.94|Standard Deviation|1.04|1.04|||
4448680|NCT00092118|4272557|B1|||Rhinoconjunctivitis Quality-of-Life Score|"Patients completed the validated, self-administered RQLQ which~included 28 items on a 7-point scale [Score 0 (best) to 6 (worst)] across 7 domains: activities, sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, and emotional. The scores within each domain were averaged, then the scores for the 7 domains were averaged to obtain the overall score. Baseline is the Visit 3 value."|Score on a scale|Mean|2.96|2.96|Standard Deviation|1.10|1.1|||
4448681|NCT00092118|4272555|B3|||Daytime nasal symptoms score|Computed using the average values of the 3 individual daytime nasal symptoms scores of congestion, rhinorrhea, and sneezing on a 4-point scale [Score 0 (best) to 3 (worst)]. Baseline is computed as the average daily value during the prerandomization run-in period (which included the 5-7 days prior to randomization at Visit 3).|Scores on a scale|Mean|2.10|2.1|Standard Deviation|0.41|0.41|||
4448682|NCT00092118|4272556|B2|||Daytime nasal symptoms score|Computed using the average values of the 3 individual daytime nasal symptoms scores of congestion, rhinorrhea, and sneezing on a 4-point scale [Score 0 (best) to 3 (worst)]. Baseline is computed as the average daily value during the prerandomization run-in period (which included the 5-7 days prior to randomization at Visit 3).|Scores on a scale|Mean|2.09|2.09|Standard Deviation|0.40|0.4|||
4448683|NCT00092118|4272557|B1|||Daytime nasal symptoms score|Computed using the average values of the 3 individual daytime nasal symptoms scores of congestion, rhinorrhea, and sneezing on a 4-point scale [Score 0 (best) to 3 (worst)]. Baseline is computed as the average daily value during the prerandomization run-in period (which included the 5-7 days prior to randomization at Visit 3).|Scores on a scale|Mean|2.10|2.1|Standard Deviation|0.41|0.41|||
4448685|NCT00092118|4272556|B2||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4448686|NCT00092118|4272557|B1||Male|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4448687|NCT00092118|4272555|B3||Female|Sex: Female, Male||Participants|Count of Participants|1276|1276.0||||||
4448688|NCT00092118|4272556|B2||Female|Sex: Female, Male||Participants|Count of Participants|644|644.0||||||
4448689|NCT00092118|4272557|B1||Female|Sex: Female, Male||Participants|Count of Participants|632|632.0||||||
4448690|NCT00092118|4272555|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|13.36|13.36|||
4448691|NCT00092118|4272556|B2|||Age||years|Mean|36.3|36.3|Standard Deviation|13.61|13.61|||
4448692|NCT00092118|4272557|B1|||Age||years|Mean|36.6|36.6|Standard Deviation|13.12|13.12|||
4448693|NCT00091962|4272568|B4|United States||Region of Enrollment||participants|Number|453|453.0||||||
4448694|NCT00091962|4272569|B3|United States||Region of Enrollment||participants|Number|151|151.0||||||
4448695|NCT00091962|4272570|B2|United States||Region of Enrollment||participants|Number|152|152.0||||||
4448696|NCT00091962|4272571|B1|United States||Region of Enrollment||participants|Number|150|150.0||||||
4448697|NCT00091962|4272568|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448698|NCT00091962|4272569|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448699|NCT00091962|4272570|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448700|NCT00091962|4272571|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448701|NCT00091962|4272568|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448702|NCT00091962|4272569|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448703|NCT00091962|4272570|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448704|NCT00091962|4272571|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448705|NCT00091962|4272568|B4||White|Race (NIH/OMB)||Participants|Count of Participants|396|396.0||||||
4448706|NCT00091962|4272569|B3||White|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4448707|NCT00091962|4272570|B2||White|Race (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
4448708|NCT00091962|4272571|B1||White|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4448709|NCT00091962|4272568|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4448710|NCT00091962|4272569|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4448711|NCT00091962|4272570|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4448712|NCT00091962|4272571|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4448713|NCT00091962|4272568|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4448714|NCT00091962|4272569|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4448715|NCT00091962|4272570|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448716|NCT00091962|4272571|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448717|NCT00091962|4272568|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4448718|NCT00091962|4272569|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4448719|NCT00091962|4272570|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448720|NCT00091962|4272571|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448721|NCT00091962|4272568|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4448722|NCT00091962|4272569|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4448723|NCT00091962|4272570|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448724|NCT00091962|4272571|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4448725|NCT00091962|4272568|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448726|NCT00091962|4272569|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448727|NCT00091962|4272570|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448728|NCT00091962|4272571|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448729|NCT00091962|4272568|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|448|448.0||||||
4448730|NCT00091962|4272569|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4448731|NCT00091962|4272570|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|152|152.0||||||
4448732|NCT00091962|4272571|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|147|147.0||||||
4448733|NCT00091962|4272568|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4448734|NCT00091962|4272569|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4448735|NCT00091962|4272570|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448736|NCT00091962|4272571|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4448737|NCT00091962|4272568|B4||Male|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4448738|NCT00091962|4272569|B3||Male|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4448739|NCT00091962|4272570|B2||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4448740|NCT00091962|4272571|B1||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4448741|NCT00091962|4272568|B4||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4448742|NCT00091962|4272569|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4448743|NCT00091962|4272570|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4448744|NCT00091962|4272571|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4448745|NCT00091962|4272568|B4|||Age||years|Mean|65|65.0|Standard Deviation|10|10.0|||
4448746|NCT00091962|4272569|B3|||Age||years|Mean|66|66.0|Standard Deviation|9.6|9.6|||
4448747|NCT00091962|4272570|B2|||Age||years|Mean|64|64.0|Standard Deviation|11.2|11.2|||
4448748|NCT00091962|4272571|B1|||Age||years|Mean|64|64.0|Standard Deviation|10.8|10.8|||
4448749|NCT00091962|4272568|B4||>=65 years|Age||Participants|Count of Participants|224|224.0||||||
4448750|NCT00091962|4272569|B3||>=65 years|Age||Participants|Count of Participants|91|91.0||||||
4448751|NCT00091962|4272570|B2||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
4448752|NCT00091962|4272571|B1||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
4448753|NCT00091962|4272568|B4||Between 18 and 65 years|Age||Participants|Count of Participants|229|229.0||||||
4448754|NCT00091962|4272569|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4448755|NCT00091962|4272570|B2||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4448756|NCT00091962|4272571|B1||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4448757|NCT00091962|4272568|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448758|NCT00091962|4272569|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448759|NCT00091962|4272570|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448760|NCT00091962|4272571|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448761|NCT00091949|4272590|B3|Germany||Region of Enrollment||participants|Number|151|151.0||||||
4448762|NCT00091949|4272591|B2|Germany||Region of Enrollment||participants|Number|77|77.0||||||
4448763|NCT00091949|4272592|B1|Germany||Region of Enrollment||participants|Number|74|74.0||||||
4448764|NCT00091949|4272590|B3|Australia||Region of Enrollment||participants|Number|108|108.0||||||
4448765|NCT00091949|4272591|B2|Australia||Region of Enrollment||participants|Number|55|55.0||||||
4448766|NCT00091949|4272592|B1|Australia||Region of Enrollment||participants|Number|53|53.0||||||
4448767|NCT00091949|4272590|B3|Israel||Region of Enrollment||participants|Number|178|178.0||||||
4448768|NCT00091949|4272591|B2|Israel||Region of Enrollment||participants|Number|88|88.0||||||
4448769|NCT00091949|4272592|B1|Israel||Region of Enrollment||participants|Number|90|90.0||||||
4448770|NCT00091949|4272590|B3|Italy||Region of Enrollment||participants|Number|48|48.0||||||
4448771|NCT00091949|4272591|B2|Italy||Region of Enrollment||participants|Number|26|26.0||||||
4448772|NCT00091949|4272592|B1|Italy||Region of Enrollment||participants|Number|22|22.0||||||
4448773|NCT00091949|4272590|B3|United Kingdom||Region of Enrollment||participants|Number|256|256.0||||||
4448774|NCT00091949|4272591|B2|United Kingdom||Region of Enrollment||participants|Number|133|133.0||||||
4448775|NCT00091949|4272592|B1|United Kingdom||Region of Enrollment||participants|Number|123|123.0||||||
4448776|NCT00091949|4272590|B3|United States||Region of Enrollment||participants|Number|2572|2572.0||||||
4448777|NCT00091949|4272591|B2|United States||Region of Enrollment||participants|Number|1276|1276.0||||||
4448778|NCT00091949|4272592|B1|United States||Region of Enrollment||participants|Number|1296|1296.0||||||
4448779|NCT00091949|4272590|B3|Puerto Rico||Region of Enrollment||participants|Number|20|20.0||||||
4448780|NCT00091949|4272591|B2|Puerto Rico||Region of Enrollment||participants|Number|11|11.0||||||
4448781|NCT00091949|4272592|B1|Puerto Rico||Region of Enrollment||participants|Number|9|9.0||||||
4448782|NCT00091949|4272590|B3|Canada||Region of Enrollment||participants|Number|543|543.0||||||
4448783|NCT00091949|4272591|B2|Canada||Region of Enrollment||participants|Number|271|271.0||||||
4448784|NCT00091949|4272592|B1|Canada||Region of Enrollment||participants|Number|272|272.0||||||
4448785|NCT00091949|4272590|B3||Male|Sex: Female, Male||Participants|Count of Participants|2538|2538.0||||||
4448786|NCT00091949|4272591|B2||Male|Sex: Female, Male||Participants|Count of Participants|1245|1245.0||||||
4448787|NCT00091949|4272592|B1||Male|Sex: Female, Male||Participants|Count of Participants|1293|1293.0||||||
4448788|NCT00091949|4272590|B3||Female|Sex: Female, Male||Participants|Count of Participants|1338|1338.0||||||
4448789|NCT00091949|4272591|B2||Female|Sex: Female, Male||Participants|Count of Participants|692|692.0||||||
4448790|NCT00091949|4272592|B1||Female|Sex: Female, Male||Participants|Count of Participants|646|646.0||||||
4448791|NCT00091949|4272590|B3|||Age||Years|Mean|63.5|63.5|Standard Deviation|10.7|10.7|||
4448792|NCT00091949|4272591|B2|||Age||Years|Mean|63.5|63.5|Standard Deviation|10.6|10.6|||
4448793|NCT00091949|4272592|B1|||Age||Years|Mean|63.5|63.5|Standard Deviation|10.7|10.7|||
4448794|NCT00091832|4272611|B7|||Osleocalcin||ng/mL|Mean|9.20|9.2|Standard Deviation|4.93|4.93|||
4448795|NCT00091832|4272612|B6|||Osleocalcin||ng/mL|Mean|9.31|9.31|Standard Deviation|4.06|4.06|||
4448796|NCT00091832|4272613|B5|||Osleocalcin||ng/mL|Mean|8.09|8.09|Standard Deviation|3.36|3.36|||
4448797|NCT00091832|4272614|B4|||Osleocalcin||ng/mL|Mean|8.96|8.96|Standard Deviation|5.03|5.03|||
4448798|NCT00091832|4272615|B3|||Osleocalcin||ng/mL|Mean|10.04|10.04|Standard Deviation|5.70|5.7|||
4448799|NCT00091832|4272616|B2|||Osleocalcin||ng/mL|Mean|9.25|9.25|Standard Deviation|4.98|4.98|||
4448800|NCT00091832|4272617|B1|||Osleocalcin||ng/mL|Mean|9.42|9.42|Standard Deviation|5.89|5.89|||
4448801|NCT00091832|4272611|B7|||P1NP|Procollagen 1 N-terminal peptide (P1NP)|µg/L|Mean|126.20|126.2|Standard Deviation|284.81|284.81|||
4448802|NCT00091832|4272612|B6|||P1NP|Procollagen 1 N-terminal peptide (P1NP)|µg/L|Mean|139.01|139.01|Standard Deviation|188.02|188.02|||
4448803|NCT00091832|4272613|B5|||P1NP|Procollagen 1 N-terminal peptide (P1NP)|µg/L|Mean|98.47|98.47|Standard Deviation|83.46|83.46|||
4448804|NCT00091832|4272614|B4|||P1NP|Procollagen 1 N-terminal peptide (P1NP)|µg/L|Mean|193.03|193.03|Standard Deviation|641.13|641.13|||
4448805|NCT00091832|4272615|B3|||P1NP|Procollagen 1 N-terminal peptide (P1NP)|µg/L|Mean|114.29|114.29|Standard Deviation|113.51|113.51|||
4448806|NCT00091832|4272616|B2|||P1NP|Procollagen 1 N-terminal peptide (P1NP)|µg/L|Mean|98.54|98.54|Standard Deviation|72.69|72.69|||
4448807|NCT00091832|4272617|B1|||P1NP|Procollagen 1 N-terminal peptide (P1NP)|µg/L|Mean|111.01|111.01|Standard Deviation|97.21|97.21|||
4448808|NCT00091832|4272611|B7|||BSAP|Bone specific alkaline phosphatase (BSAP)|U/L|Mean|50.75|50.75|Standard Deviation|55.04|55.04|||
4448809|NCT00091832|4272612|B6|||BSAP|Bone specific alkaline phosphatase (BSAP)|U/L|Mean|48.82|48.82|Standard Deviation|35.13|35.13|||
4448810|NCT00091832|4272613|B5|||BSAP|Bone specific alkaline phosphatase (BSAP)|U/L|Mean|47.89|47.89|Standard Deviation|30.46|30.46|||
4448811|NCT00091832|4272614|B4|||BSAP|Bone specific alkaline phosphatase (BSAP)|U/L|Mean|62.39|62.39|Standard Deviation|109.18|109.18|||
4448812|NCT00091832|4272615|B3|||BSAP|Bone specific alkaline phosphatase (BSAP)|U/L|Mean|45.62|45.62|Standard Deviation|26.02|26.02|||
4448813|NCT00091832|4272616|B2|||BSAP|Bone specific alkaline phosphatase (BSAP)|U/L|Mean|44.33|44.33|Standard Deviation|26.06|26.06|||
4448814|NCT00091832|4272617|B1|||BSAP|Bone specific alkaline phosphatase (BSAP)|U/L|Mean|54.84|54.84|Standard Deviation|51.69|51.69|||
4448815|NCT00091832|4272611|B7|||TRAP 5b|Tartrate-resistant acid phosphatase 5b (TRAP 5b)|U/L|Mean|7.057|7.057|Standard Deviation|4.358|4.358|||
4448816|NCT00091832|4272612|B6|||TRAP 5b|Tartrate-resistant acid phosphatase 5b (TRAP 5b)|U/L|Mean|7.009|7.009|Standard Deviation|4.217|4.217|||
4448817|NCT00091832|4272613|B5|||TRAP 5b|Tartrate-resistant acid phosphatase 5b (TRAP 5b)|U/L|Mean|6.765|6.765|Standard Deviation|4.340|4.34|||
4448818|NCT00091832|4272614|B4|||TRAP 5b|Tartrate-resistant acid phosphatase 5b (TRAP 5b)|U/L|Mean|7.628|7.628|Standard Deviation|6.830|6.83|||
4448819|NCT00091832|4272615|B3|||TRAP 5b|Tartrate-resistant acid phosphatase 5b (TRAP 5b)|U/L|Mean|7.116|7.116|Standard Deviation|3.493|3.493|||
4448820|NCT00091832|4272616|B2|||TRAP 5b|Tartrate-resistant acid phosphatase 5b (TRAP 5b)|U/L|Mean|6.879|6.879|Standard Deviation|2.878|2.878|||
4448821|NCT00091832|4272617|B1|||TRAP 5b|Tartrate-resistant acid phosphatase 5b (TRAP 5b)|U/L|Mean|6.907|6.907|Standard Deviation|3.280|3.28|||
4448822|NCT00091832|4272611|B7|||Serum CTx|Type I serum C-Telopeptide (CTx)|ng/mL|Mean|0.692|0.692|Standard Deviation|0.605|0.605|||
4448823|NCT00091832|4272612|B6|||Serum CTx|Type I serum C-Telopeptide (CTx)|ng/mL|Mean|0.846|0.846|Standard Deviation|0.892|0.892|||
4448824|NCT00091832|4272613|B5|||Serum CTx|Type I serum C-Telopeptide (CTx)|ng/mL|Mean|0.714|0.714|Standard Deviation|0.564|0.564|||
4448825|NCT00091832|4272614|B4|||Serum CTx|Type I serum C-Telopeptide (CTx)|ng/mL|Mean|0.647|0.647|Standard Deviation|0.703|0.703|||
4448826|NCT00091832|4272615|B3|||Serum CTx|Type I serum C-Telopeptide (CTx)|ng/mL|Mean|0.720|0.72|Standard Deviation|0.559|0.559|||
4448827|NCT00091832|4272616|B2|||Serum CTx|Type I serum C-Telopeptide (CTx)|ng/mL|Mean|0.632|0.632|Standard Deviation|0.430|0.43|||
4448828|NCT00091832|4272617|B1|||Serum CTx|Type I serum C-Telopeptide (CTx)|ng/mL|Mean|0.592|0.592|Standard Deviation|0.284|0.284|||
4448829|NCT00091832|4272611|B7|||uNTx/Cr|Urinary N-telopeptide corrected by creatinine (uNTx/Cr)|nmol/mmol|Mean|85.78|85.78|Standard Deviation|111.94|111.94|||
4448830|NCT00091832|4272612|B6|||uNTx/Cr|Urinary N-telopeptide corrected by creatinine (uNTx/Cr)|nmol/mmol|Mean|98.22|98.22|Standard Deviation|168.42|168.42|||
4448831|NCT00091832|4272613|B5|||uNTx/Cr|Urinary N-telopeptide corrected by creatinine (uNTx/Cr)|nmol/mmol|Mean|102.06|102.06|Standard Deviation|129.12|129.12|||
4448832|NCT00091832|4272614|B4|||uNTx/Cr|Urinary N-telopeptide corrected by creatinine (uNTx/Cr)|nmol/mmol|Mean|75.92|75.92|Standard Deviation|91.03|91.03|||
4448833|NCT00091832|4272615|B3|||uNTx/Cr|Urinary N-telopeptide corrected by creatinine (uNTx/Cr)|nmol/mmol|Mean|89.41|89.41|Standard Deviation|98.58|98.58|||
4448834|NCT00091832|4272616|B2|||uNTx/Cr|Urinary N-telopeptide corrected by creatinine (uNTx/Cr)|nmol/mmol|Mean|66.44|66.44|Standard Deviation|61.17|61.17|||
4448835|NCT00091832|4272617|B1|||uNTx/Cr|Urinary N-telopeptide corrected by creatinine (uNTx/Cr)|nmol/mmol|Mean|83.16|83.16|Standard Deviation|94.37|94.37|||
4448836|NCT00091832|4272611|B7|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4448837|NCT00091832|4272612|B6|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4448838|NCT00091832|4272613|B5|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4448839|NCT00091832|4272614|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4448840|NCT00091832|4272615|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4448841|NCT00091832|4272616|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4448842|NCT00091832|4272617|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4448843|NCT00091832|4272611|B7|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4448844|NCT00091832|4272612|B6|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4448845|NCT00091832|4272613|B5|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4448846|NCT00091832|4272614|B4|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4448847|NCT00091832|4272615|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4448848|NCT00091832|4272616|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4448849|NCT00091832|4272617|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4448850|NCT00091832|4272611|B7|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4448851|NCT00091832|4272612|B6|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4448852|NCT00091832|4272613|B5|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4448853|NCT00091832|4272614|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4448854|NCT00091832|4272615|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4448855|NCT00091832|4272616|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4448856|NCT00091832|4272617|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4448857|NCT00091832|4272611|B7|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
4448858|NCT00091832|4272612|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4448859|NCT00091832|4272613|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4448860|NCT00091832|4272614|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4448861|NCT00091832|4272615|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4448862|NCT00091832|4272616|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4448863|NCT00091832|4272617|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4448864|NCT00091832|4272611|B7|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|179|179.0||||||
4448865|NCT00091832|4272612|B6|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4448866|NCT00091832|4272613|B5|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4448867|NCT00091832|4272614|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4448868|NCT00091832|4272615|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4448869|NCT00091832|4272616|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|28|28.0||||||
4448870|NCT00091832|4272617|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4448871|NCT00091832|4272611|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448872|NCT00091832|4272612|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448873|NCT00091832|4272613|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448874|NCT00091832|4272614|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448875|NCT00091832|4272615|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448876|NCT00091832|4272616|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448877|NCT00091832|4272617|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448878|NCT00091832|4272611|B7||Female|Sex: Female, Male||Participants|Count of Participants|255|255.0||||||
4448879|NCT00091832|4272612|B6||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4448880|NCT00091832|4272613|B5||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4448881|NCT00091832|4272614|B4||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4448882|NCT00091832|4272615|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4448883|NCT00091832|4272616|B2||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4448884|NCT00091832|4272617|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4448885|NCT00091832|4272611|B7|||Age||Years|Mean|57.8|57.8|Standard Deviation|11.4|11.4|||
4448886|NCT00091832|4272612|B6|||Age||Years|Mean|57.6|57.6|Standard Deviation|13.9|13.9|||
4448887|NCT00091832|4272613|B5|||Age||Years|Mean|57.4|57.4|Standard Deviation|11.0|11.0|||
4448888|NCT00091832|4272614|B4|||Age||Years|Mean|58.2|58.2|Standard Deviation|9.1|9.1|||
4448889|NCT00091832|4272615|B3|||Age||Years|Mean|59.2|59.2|Standard Deviation|12.3|12.3|||
4448890|NCT00091832|4272616|B2|||Age||Years|Mean|56.5|56.5|Standard Deviation|10.8|10.8|||
4448891|NCT00091832|4272617|B1|||Age||Years|Mean|52.0|52.0|Standard Deviation|10.7|10.7|||
4448892|NCT00091819|4272738|B3|Not diabetic||Diabetes Status||Participants|Number|663|663.0||||||
4448893|NCT00091819|4272739|B2|Not diabetic||Diabetes Status||Participants|Number|331|331.0||||||
4448894|NCT00091819|4272740|B1|Not diabetic||Diabetes Status||Participants|Number|332|332.0||||||
4448895|NCT00091819|4272738|B3|Diabetic||Diabetes Status||Participants|Number|192|192.0||||||
4448896|NCT00091819|4272739|B2|Diabetic||Diabetes Status||Participants|Number|98|98.0||||||
4448897|NCT00091819|4272740|B1|Diabetic||Diabetes Status||Participants|Number|94|94.0||||||
4448898|NCT00091819|4272738|B3|Russian Federation||Region of Enrollment||participants|Number|39|39.0||||||
4448899|NCT00091819|4272739|B2|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
4448900|NCT00091819|4272740|B1|Russian Federation||Region of Enrollment||participants|Number|20|20.0||||||
4448901|NCT00091819|4272738|B3|Malaysia||Region of Enrollment||participants|Number|9|9.0||||||
4448902|NCT00091819|4272739|B2|Malaysia||Region of Enrollment||participants|Number|4|4.0||||||
4448903|NCT00091819|4272740|B1|Malaysia||Region of Enrollment||participants|Number|5|5.0||||||
4448904|NCT00091819|4272738|B3|Israel||Region of Enrollment||participants|Number|27|27.0||||||
4448905|NCT00091819|4272739|B2|Israel||Region of Enrollment||participants|Number|12|12.0||||||
4448906|NCT00091819|4272740|B1|Israel||Region of Enrollment||participants|Number|15|15.0||||||
4448907|NCT00091819|4272738|B3|Croatia||Region of Enrollment||participants|Number|100|100.0||||||
4448908|NCT00091819|4272739|B2|Croatia||Region of Enrollment||participants|Number|51|51.0||||||
4448909|NCT00091819|4272740|B1|Croatia||Region of Enrollment||participants|Number|49|49.0||||||
4448910|NCT00091819|4272738|B3|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4448911|NCT00091819|4272739|B2|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4448912|NCT00091819|4272740|B1|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4448913|NCT00091819|4272738|B3|Australia||Region of Enrollment||participants|Number|33|33.0||||||
4448914|NCT00091819|4272739|B2|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4448915|NCT00091819|4272740|B1|Australia||Region of Enrollment||participants|Number|18|18.0||||||
4448916|NCT00091819|4272738|B3|South Africa||Region of Enrollment||participants|Number|23|23.0||||||
4448917|NCT00091819|4272739|B2|South Africa||Region of Enrollment||participants|Number|12|12.0||||||
4448918|NCT00091819|4272740|B1|South Africa||Region of Enrollment||participants|Number|11|11.0||||||
4448919|NCT00091819|4272738|B3|United States||Region of Enrollment||participants|Number|622|622.0||||||
4448920|NCT00091819|4272739|B2|United States||Region of Enrollment||participants|Number|316|316.0||||||
4448921|NCT00091819|4272740|B1|United States||Region of Enrollment||participants|Number|306|306.0||||||
4448922|NCT00091819|4272738|B3||Unknown or Not Reported|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|2|2.0||||||
4448923|NCT00091819|4272739|B2||Unknown or Not Reported|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|1|1.0||||||
4448924|NCT00091819|4272740|B1||Unknown or Not Reported|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|1|1.0||||||
4448925|NCT00091819|4272738|B3||More than one race|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|7|7.0||||||
4448926|NCT00091819|4272739|B2||More than one race|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|3|3.0||||||
4448927|NCT00091819|4272740|B1||More than one race|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|4|4.0||||||
4448928|NCT00091819|4272738|B3||White|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|702|702.0||||||
4448929|NCT00091819|4272739|B2||White|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|353|353.0||||||
4448930|NCT00091819|4272740|B1||White|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|349|349.0||||||
4448931|NCT00091819|4272738|B3||Black or African American|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|111|111.0||||||
4448932|NCT00091819|4272739|B2||Black or African American|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|52|52.0||||||
4448933|NCT00091819|4272740|B1||Black or African American|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|59|59.0||||||
4448934|NCT00091819|4272738|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|12|12.0||||||
4448935|NCT00091819|4272739|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|9|9.0||||||
4448936|NCT00091819|4272740|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|3|3.0||||||
4448937|NCT00091819|4272738|B3||Asian|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|16|16.0||||||
4448938|NCT00091819|4272739|B2||Asian|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|9|9.0||||||
4448939|NCT00091819|4272740|B1||Asian|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|7|7.0||||||
4448940|NCT00091819|4272738|B3||American Indian or Alaska Native|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|5|5.0||||||
4448941|NCT00091819|4272739|B2||American Indian or Alaska Native|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|2|2.0||||||
4448942|NCT00091819|4272740|B1||American Indian or Alaska Native|Race (NIH/OMB)|Patients could indicate more than one racial category.|Participants|Count of Participants|3|3.0||||||
4448943|NCT00091819|4272738|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448944|NCT00091819|4272739|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448945|NCT00091819|4272740|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4448946|NCT00091819|4272738|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|644|644.0||||||
4448947|NCT00091819|4272739|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|332|332.0||||||
4448948|NCT00091819|4272740|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|312|312.0||||||
4448949|NCT00091819|4272738|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|211|211.0||||||
4448950|NCT00091819|4272739|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|97|97.0||||||
4448951|NCT00091819|4272740|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|114|114.0||||||
4448952|NCT00091819|4272738|B3||Male|Sex: Female, Male||Participants|Count of Participants|478|478.0||||||
4448953|NCT00091819|4272739|B2||Male|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4448954|NCT00091819|4272740|B1||Male|Sex: Female, Male||Participants|Count of Participants|230|230.0||||||
4448955|NCT00091819|4272738|B3||Female|Sex: Female, Male||Participants|Count of Participants|377|377.0||||||
4448956|NCT00091819|4272739|B2||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4448957|NCT00091819|4272740|B1||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4448958|NCT00091819|4272738|B3|||Age||years|Mean|48|48.0|Standard Deviation|16.7|16.7|||
4448959|NCT00091819|4272739|B2|||Age||years|Mean|48|48.0|Standard Deviation|16.1|16.1|||
4448960|NCT00091819|4272740|B1|||Age||years|Mean|49|49.0|Standard Deviation|17.3|17.3|||
4448961|NCT00091819|4272738|B3||>=65 years|Age||Participants|Count of Participants|161|161.0||||||
4448962|NCT00091819|4272739|B2||>=65 years|Age||Participants|Count of Participants|72|72.0||||||
4448963|NCT00091819|4272740|B1||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4448964|NCT00091819|4272738|B3||Between 18 and 65 years|Age||Participants|Count of Participants|694|694.0||||||
4448965|NCT00091819|4272739|B2||Between 18 and 65 years|Age||Participants|Count of Participants|357|357.0||||||
4448966|NCT00091819|4272740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|337|337.0||||||
4448967|NCT00091819|4272738|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448968|NCT00091819|4272739|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448969|NCT00091819|4272740|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448970|NCT00091793|4272747|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448971|NCT00091793|4272748|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448972|NCT00091793|4272749|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4448973|NCT00091793|4272747|B3||Female|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4448974|NCT00091793|4272748|B2||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4448975|NCT00091793|4272749|B1||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4448976|NCT00091793|4272747|B3|||Age||Years|Mean|59.4|59.4|Standard Deviation|7.5|7.5|||
4448977|NCT00091793|4272748|B2|||Age||Years|Mean|58.9|58.9|Standard Deviation|7.5|7.5|||
4448978|NCT00091793|4272749|B1|||Age||Years|Mean|59.8|59.8|Standard Deviation|7.4|7.4|||
4448979|NCT00091572|4272772|B3||Male|Sex: Female, Male||Participants|Count of Participants|503|503.0||||||
4448980|NCT00091572|4272773|B2||Male|Sex: Female, Male||Participants|Count of Participants|253|253.0||||||
4448981|NCT00091572|4272774|B1||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4448982|NCT00091572|4272772|B3||Female|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4448983|NCT00091572|4272773|B2||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4448984|NCT00091572|4272774|B1||Female|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4448985|NCT00091572|4272772|B3||>=65 years|Age||Participants|Count of Participants|322|322.0||||||
4448986|NCT00091572|4272773|B2||>=65 years|Age||Participants|Count of Participants|169|169.0||||||
4448987|NCT00091572|4272774|B1||>=65 years|Age||Participants|Count of Participants|153|153.0||||||
4448988|NCT00091572|4272772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|537|537.0||||||
4448989|NCT00091572|4272773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|261|261.0||||||
4448990|NCT00091572|4272774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|276|276.0||||||
4448991|NCT00091572|4272772|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448992|NCT00091572|4272773|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448993|NCT00091572|4272774|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4448994|NCT00091507|4272787|B3|United States||Region of Enrollment||participants|Number|911|911.0||||||
4448995|NCT00091507|4272788|B2|United States||Region of Enrollment||participants|Number|479|479.0||||||
4448996|NCT00091507|4272789|B1|United States||Region of Enrollment||participants|Number|432|432.0||||||
4448997|NCT00091507|4272787|B3||Male|Sex: Female, Male||Participants|Count of Participants|646|646.0||||||
4448998|NCT00091507|4272788|B2||Male|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4448999|NCT00091507|4272789|B1||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4449000|NCT00091507|4272787|B3||Female|Sex: Female, Male||Participants|Count of Participants|265|265.0||||||
4449001|NCT00091507|4272788|B2||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4449002|NCT00091507|4272789|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4449003|NCT00091507|4272787|B3|||Age||years|Mean|63.6|63.6|Standard Deviation|14.0|14.0|||
4449004|NCT00091507|4272788|B2|||Age||years|Mean|63.3|63.3|Standard Deviation|14.1|14.1|||
4449005|NCT00091507|4272789|B1|||Age||years|Mean|63.9|63.9|Standard Deviation|13.9|13.9|||
4449006|NCT00091442|4272804|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449007|NCT00091442|4272805|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449008|NCT00091442|4272806|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449009|NCT00091442|4272804|B3||Female|Sex: Female, Male||Participants|Count of Participants|751|751.0||||||
4449010|NCT00091442|4272805|B2||Female|Sex: Female, Male||Participants|Count of Participants|378|378.0||||||
4449011|NCT00091442|4272806|B1||Female|Sex: Female, Male||Participants|Count of Participants|373|373.0||||||
4449012|NCT00091442|4272804|B3|||Age||years|Mean|52.4|52.4|Standard Deviation|9.20|9.2|||
4449013|NCT00091442|4272805|B2|||Age||years|Mean|52.8|52.8|Standard Deviation|9.17|9.17|||
4449014|NCT00091442|4272806|B1|||Age||years|Mean|52.0|52.0|Standard Deviation|9.23|9.23|||
4449015|NCT00091390|4272817|B1||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4449016|NCT00091390|4272817|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449017|NCT00091390|4272817|B1|||Age||years|Median|68|68.0|Full Range|||49.0|81.0|
4449018|NCT00091273|4272821|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4449019|NCT00091273|4272821|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449020|NCT00091273|4272821|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4449021|NCT00091273|4272821|B1|||Age||years|Mean|57|57.0|Standard Deviation|13|13.0|||
4449022|NCT00091273|4272821|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4449023|NCT00091273|4272821|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4449024|NCT00091273|4272821|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449025|NCT00091260|4272827|B1||Not on dialysis|Dialysis y/n||Participants|Count of Participants|75|75.0||||||
4449026|NCT00091260|4272827|B1||on dialysis|Dialysis y/n||Participants|Count of Participants|7|7.0||||||
4449027|NCT00091260|4272827|B1||Male|Gender||Participants|Count of Participants|53|53.0||||||
4449028|NCT00091260|4272827|B1||Female|Gender||Participants|Count of Participants|29|29.0||||||
4449029|NCT00091260|4272827|B1||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4449030|NCT00091260|4272827|B1||Between 18 and 65 years|Age||Participants|Count of Participants|58|58.0||||||
4449031|NCT00091260|4272827|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449032|NCT00091169|4272833|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4449033|NCT00091169|4272834|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4449034|NCT00091169|4272835|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4449035|NCT00091169|4272833|B3||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4449036|NCT00091169|4272834|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4449037|NCT00091169|4272835|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4449038|NCT00091169|4272833|B3|||Age||years|Median|63|63.0|Full Range|||29.0|91.0|
4449039|NCT00091169|4272834|B2|||Age||years|Median|62|62.0|Full Range|||30.0|88.0|
4449040|NCT00091169|4272835|B1|||Age||years|Median|64|64.0|Full Range|||29.0|91.0|
4449041|NCT00091026|4272852|B3|2||ECOG Performance Status|"ECOG Performance Status~The scale ranges from 0-5:~0 Fully active, without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities.~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead"|Participants|Number|9|9.0||||||
4449042|NCT00091026|4272853|B2|2||ECOG Performance Status|"ECOG Performance Status~The scale ranges from 0-5:~0 Fully active, without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities.~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead"|Participants|Number|4|4.0||||||
4449043|NCT00091026|4272854|B1|2||ECOG Performance Status|"ECOG Performance Status~The scale ranges from 0-5:~0 Fully active, without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities.~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead"|Participants|Number|5|5.0||||||
4449044|NCT00091026|4272852|B3|1||ECOG Performance Status|"ECOG Performance Status~The scale ranges from 0-5:~0 Fully active, without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities.~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead"|Participants|Number|72|72.0||||||
4449045|NCT00091026|4272853|B2|1||ECOG Performance Status|"ECOG Performance Status~The scale ranges from 0-5:~0 Fully active, without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities.~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead"|Participants|Number|32|32.0||||||
4449046|NCT00091026|4272854|B1|1||ECOG Performance Status|"ECOG Performance Status~The scale ranges from 0-5:~0 Fully active, without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities.~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead"|Participants|Number|40|40.0||||||
4449047|NCT00091026|4272852|B3|0||ECOG Performance Status|"ECOG Performance Status~The scale ranges from 0-5:~0 Fully active, without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities.~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead"|Participants|Number|58|58.0||||||
4449048|NCT00091026|4272853|B2|0||ECOG Performance Status|"ECOG Performance Status~The scale ranges from 0-5:~0 Fully active, without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities.~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead"|Participants|Number|32|32.0||||||
4449049|NCT00091026|4272854|B1|0||ECOG Performance Status|"ECOG Performance Status~The scale ranges from 0-5:~0 Fully active, without restriction~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities.~Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair~Dead"|Participants|Number|26|26.0||||||
4449050|NCT00091026|4272852|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4449051|NCT00091026|4272853|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4449052|NCT00091026|4272854|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4449053|NCT00091026|4272852|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4449054|NCT00091026|4272853|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4449055|NCT00091026|4272854|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4449056|NCT00091026|4272852|B3|||Age||years|Median|63|63.0|Full Range|||36.0|86.0|
4449057|NCT00091026|4272853|B2|||Age||years|Median|63|63.0|Full Range|||39.0|86.0|
4449058|NCT00091026|4272854|B1|||Age||years|Median|63|63.0|Full Range|||36.0|83.0|
4449059|NCT00090987|4272865|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4449060|NCT00090987|4272865|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4449061|NCT00090987|4272865|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4449062|NCT00090987|4272865|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|9.5|9.5|||
4449063|NCT00090987|4272865|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4449064|NCT00090987|4272865|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4449065|NCT00090987|4272865|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449066|NCT00090870|4272869|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4449067|NCT00090870|4272869|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449068|NCT00090870|4272869|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449069|NCT00090870|4272869|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4449070|NCT00090870|4272869|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449071|NCT00090870|4272869|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449072|NCT00090870|4272869|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449073|NCT00090870|4272869|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449074|NCT00090870|4272869|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4449075|NCT00090870|4272869|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4449076|NCT00090870|4272869|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4449077|NCT00090870|4272869|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4449078|NCT00090870|4272869|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449079|NCT00090857|4272876|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4449080|NCT00090857|4272877|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4449081|NCT00090857|4272878|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4449082|NCT00090857|4272876|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449083|NCT00090857|4272877|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449084|NCT00090857|4272878|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449085|NCT00090857|4272876|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4449086|NCT00090857|4272877|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4449087|NCT00090857|4272878|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4449088|NCT00090857|4272876|B3|||Age||years|Median|54|54.0|Full Range|||45.0|72.0|
4449089|NCT00090857|4272877|B2|||Age||years|Median|52.5|52.5|Full Range|||48.0|72.0|
4449090|NCT00090857|4272878|B1|||Age||years|Median|56|56.0|Full Range|||45.0|66.0|
4449091|NCT00090844|4272907|B3|United States||Region of Enrollment||participants|Number|49|49.0||||||
4449092|NCT00090844|4272908|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4449093|NCT00090844|4272909|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4449094|NCT00090844|4272907|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449095|NCT00090844|4272908|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449096|NCT00090844|4272909|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449097|NCT00090844|4272907|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449098|NCT00090844|4272908|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449099|NCT00090844|4272909|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449100|NCT00090844|4272907|B3||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4449101|NCT00090844|4272908|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4449102|NCT00090844|4272909|B1||White|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4449103|NCT00090844|4272907|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4449104|NCT00090844|4272908|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4449105|NCT00090844|4272909|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4449106|NCT00090844|4272907|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449107|NCT00090844|4272908|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449108|NCT00090844|4272909|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449109|NCT00090844|4272907|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4449110|NCT00090844|4272908|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4449111|NCT00090844|4272909|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449112|NCT00090844|4272907|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449113|NCT00090844|4272908|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449114|NCT00090844|4272909|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449115|NCT00090844|4272907|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449116|NCT00090844|4272908|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449117|NCT00090844|4272909|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449118|NCT00090844|4272907|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4449119|NCT00090844|4272908|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4449120|NCT00090844|4272909|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4449121|NCT00090844|4272907|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4449122|NCT00090844|4272908|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4449123|NCT00090844|4272909|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4449124|NCT00090844|4272907|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449125|NCT00090844|4272908|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449126|NCT00090844|4272909|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449127|NCT00090844|4272907|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4449128|NCT00090844|4272908|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4449129|NCT00090844|4272909|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4449130|NCT00090844|4272907|B3|||Age||years|Median|39|39.0|Full Range|||21.0|44.0|
4449131|NCT00090844|4272908|B2|||Age||years|Median|38|38.0|Full Range|||26.0|44.0|
4449132|NCT00090844|4272909|B1|||Age||years|Median|39|39.0|Full Range|||21.0|44.0|
4449133|NCT00090844|4272907|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4449134|NCT00090844|4272908|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4449135|NCT00090844|4272909|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4449136|NCT00090844|4272907|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4449137|NCT00090844|4272908|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4449138|NCT00090844|4272909|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4449139|NCT00090844|4272907|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449140|NCT00090844|4272908|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449141|NCT00090844|4272909|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449142|NCT00090779|4272916|B3|>=10000 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|97|97.0||||||
4449143|NCT00090779|4272917|B2|>=10000 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|48|48.0||||||
4449144|NCT00090779|4272918|B1|>=10000 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|49|49.0||||||
4449145|NCT00090779|4272916|B3|1000-9999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|31|31.0||||||
4449146|NCT00090779|4272917|B2|1000-9999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|15|15.0||||||
4449147|NCT00090779|4272918|B1|1000-9999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|16|16.0||||||
4449148|NCT00090779|4272916|B3|400-999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|1|1.0||||||
4449149|NCT00090779|4272917|B2|400-999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|0|0.0||||||
4449150|NCT00090779|4272918|B1|400-999 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|1|1.0||||||
4449151|NCT00090779|4272916|B3|200-399 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|1|1.0||||||
4449152|NCT00090779|4272917|B2|200-399 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|1|1.0||||||
4449153|NCT00090779|4272918|B1|200-399 copies/mL||HIV-1 RNA Viral Load Category||participants|Number|0|0.0||||||
4449154|NCT00090779|4272916|B3|||Log10 HIV-1 RNA Viral Load||log10 copies/mL|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
4449155|NCT00090779|4272917|B2|||Log10 HIV-1 RNA Viral Load||log10 copies/mL|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
4449156|NCT00090779|4272918|B1|||Log10 HIV-1 RNA Viral Load||log10 copies/mL|Mean|4.4|4.4|Standard Deviation|0.6|0.6|||
4449157|NCT00090779|4272916|B3|>500 cells/mm^3||CD4 Count Category||participants|Number|74|74.0||||||
4449158|NCT00090779|4272917|B2|>500 cells/mm^3||CD4 Count Category||participants|Number|38|38.0||||||
4449159|NCT00090779|4272918|B1|>500 cells/mm^3||CD4 Count Category||participants|Number|36|36.0||||||
4449160|NCT00090779|4272916|B3|351-500 cells/mm^3||CD4 Count Category||participants|Number|50|50.0||||||
4449161|NCT00090779|4272917|B2|351-500 cells/mm^3||CD4 Count Category||participants|Number|24|24.0||||||
4449162|NCT00090779|4272918|B1|351-500 cells/mm^3||CD4 Count Category||participants|Number|26|26.0||||||
4449163|NCT00090779|4272916|B3|201-350 cells/mm^3||CD4 Count Category||participants|Number|6|6.0||||||
4449164|NCT00090779|4272917|B2|201-350 cells/mm^3||CD4 Count Category||participants|Number|2|2.0||||||
4449165|NCT00090779|4272918|B1|201-350 cells/mm^3||CD4 Count Category||participants|Number|4|4.0||||||
4449166|NCT00090779|4272916|B3|||CD4 Counts||cells/mm3|Mean|590|590.0|Standard Deviation|202|202.0|||
4449167|NCT00090779|4272917|B2|||CD4 Counts||cells/mm3|Mean|611|611.0|Standard Deviation|207|207.0|||
4449168|NCT00090779|4272918|B1|||CD4 Counts||cells/mm3|Mean|570|570.0|Standard Deviation|197|197.0|||
4449169|NCT00090779|4272916|B3|Not Hispanic or Latino||Ethnicity||participants|Number|107|107.0||||||
4449170|NCT00090779|4272917|B2|Not Hispanic or Latino||Ethnicity||participants|Number|55|55.0||||||
4449171|NCT00090779|4272918|B1|Not Hispanic or Latino||Ethnicity||participants|Number|52|52.0||||||
4449172|NCT00090779|4272916|B3|Hispanic or Latino||Ethnicity||participants|Number|23|23.0||||||
4449173|NCT00090779|4272917|B2|Hispanic or Latino||Ethnicity||participants|Number|9|9.0||||||
4449174|NCT00090779|4272918|B1|Hispanic or Latino||Ethnicity||participants|Number|14|14.0||||||
4449175|NCT00090779|4272916|B3|Unknown||Race||participants|Number|4|4.0||||||
4449176|NCT00090779|4272917|B2|Unknown||Race||participants|Number|1|1.0||||||
4449177|NCT00090779|4272918|B1|Unknown||Race||participants|Number|3|3.0||||||
4449178|NCT00090779|4272916|B3|Other||Race||participants|Number|8|8.0||||||
4449179|NCT00090779|4272917|B2|Other||Race||participants|Number|4|4.0||||||
4449180|NCT00090779|4272918|B1|Other||Race||participants|Number|4|4.0||||||
4449181|NCT00090779|4272916|B3|Black/ African American||Race||participants|Number|13|13.0||||||
4449182|NCT00090779|4272917|B2|Black/ African American||Race||participants|Number|3|3.0||||||
4449183|NCT00090779|4272918|B1|Black/ African American||Race||participants|Number|10|10.0||||||
4449184|NCT00090779|4272916|B3|White||Race||participants|Number|105|105.0||||||
4449185|NCT00090779|4272917|B2|White||Race||participants|Number|56|56.0||||||
4449186|NCT00090779|4272918|B1|White||Race||participants|Number|49|49.0||||||
4449187|NCT00090779|4272916|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4449188|NCT00090779|4272917|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4449189|NCT00090779|4272918|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4449190|NCT00090779|4272916|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4449191|NCT00090779|4272917|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4449192|NCT00090779|4272918|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4449193|NCT00090779|4272916|B3|60-69 years||Age, Customized||participants|Number|3|3.0||||||
4449194|NCT00090779|4272917|B2|60-69 years||Age, Customized||participants|Number|0|0.0||||||
4449195|NCT00090779|4272918|B1|60-69 years||Age, Customized||participants|Number|3|3.0||||||
4449196|NCT00090779|4272916|B3|50-59 years||Age, Customized||participants|Number|8|8.0||||||
4449197|NCT00090779|4272917|B2|50-59 years||Age, Customized||participants|Number|4|4.0||||||
4449198|NCT00090779|4272918|B1|50-59 years||Age, Customized||participants|Number|4|4.0||||||
4449199|NCT00090779|4272916|B3|40-49 years||Age, Customized||participants|Number|28|28.0||||||
4449200|NCT00090779|4272917|B2|40-49 years||Age, Customized||participants|Number|16|16.0||||||
4449201|NCT00090779|4272918|B1|40-49 years||Age, Customized||participants|Number|12|12.0||||||
4449202|NCT00090779|4272916|B3|30-39 years||Age, Customized||participants|Number|40|40.0||||||
4449203|NCT00090779|4272917|B2|30-39 years||Age, Customized||participants|Number|21|21.0||||||
4449204|NCT00090779|4272918|B1|30-39 years||Age, Customized||participants|Number|19|19.0||||||
4449205|NCT00090779|4272916|B3|20-29 years||Age, Customized||participants|Number|47|47.0||||||
4449206|NCT00090779|4272917|B2|20-29 years||Age, Customized||participants|Number|23|23.0||||||
4449207|NCT00090779|4272918|B1|20-29 years||Age, Customized||participants|Number|24|24.0||||||
4449208|NCT00090779|4272916|B3|<20 years||Age, Customized||participants|Number|4|4.0||||||
4449209|NCT00090779|4272917|B2|<20 years||Age, Customized||participants|Number|0|0.0||||||
4449210|NCT00090779|4272918|B1|<20 years||Age, Customized||participants|Number|4|4.0||||||
4449211|NCT00090779|4272916|B3|||Age||years|Mean|34.4|34.4|Standard Deviation|10.3|10.3|||
4449212|NCT00090779|4272917|B2|||Age||years|Mean|34.6|34.6|Standard Deviation|9.1|9.1|||
4449213|NCT00090779|4272918|B1|||Age||years|Mean|34.1|34.1|Standard Deviation|11.3|11.3|||
4449214|NCT00090766|4272940|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4449215|NCT00090766|4272941|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4449216|NCT00090766|4272942|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4449217|NCT00090766|4272943|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4449218|NCT00090766|4272940|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4449219|NCT00090766|4272941|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4449220|NCT00090766|4272942|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4449221|NCT00090766|4272943|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4449222|NCT00090766|4272940|B4|||Age||years|Mean|8.1|8.1|Standard Deviation|5.94|5.94|||
4449223|NCT00090766|4272941|B3|||Age||years|Mean|14.2|14.2|Standard Deviation|1.54|1.54|||
4449224|NCT00090766|4272942|B2|||Age||years|Mean|6.9|6.9|Standard Deviation|3.15|3.15|||
4449225|NCT00090766|4272943|B1|||Age||years|Mean|0.6|0.6|Standard Deviation|0.86|0.86|||
4449226|NCT00090753|4272985|B3||Male|Sex: Female, Male||Participants|Count of Participants|678|678.0||||||
4449227|NCT00090753|4272986|B2||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4449228|NCT00090753|4272987|B1||Male|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4449229|NCT00090753|4272985|B3||Female|Sex: Female, Male||Participants|Count of Participants|550|550.0||||||
4449230|NCT00090753|4272986|B2||Female|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4449231|NCT00090753|4272987|B1||Female|Sex: Female, Male||Participants|Count of Participants|327|327.0||||||
4449232|NCT00090753|4272985|B3|||Age||years|Mean|61.5|61.5|Standard Deviation|14.65|14.65|||
4449233|NCT00090753|4272986|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|14.42|14.42|||
4449234|NCT00090753|4272987|B1|||Age||years|Mean|61.2|61.2|Standard Deviation|14.80|14.8|||
4449235|NCT00090610|4272996|B3|United States||Region of Enrollment||participants|Number|150|150.0||||||
4449236|NCT00090610|4272997|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4449237|NCT00090610|4272998|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4449238|NCT00090610|4272996|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449239|NCT00090610|4272997|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449240|NCT00090610|4272998|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449241|NCT00090610|4272996|B3||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4449242|NCT00090610|4272997|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4449243|NCT00090610|4272998|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4449244|NCT00090610|4272996|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|10.08|10.08|||
4449245|NCT00090610|4272997|B2|||Age||years|Mean|64.9|64.9|Standard Deviation|10.04|10.04|||
4449246|NCT00090610|4272998|B1|||Age||years|Mean|63.8|63.8|Standard Deviation|10.17|10.17|||
4449247|NCT00090584|4273013|B3|United States||Region of Enrollment||participants|Number|307|307.0||||||
4449248|NCT00090584|4273014|B2|United States||Region of Enrollment||participants|Number|153|153.0||||||
4449249|NCT00090584|4273015|B1|United States||Region of Enrollment||participants|Number|154|154.0||||||
4449250|NCT00090584|4273013|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449251|NCT00090584|4273014|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449252|NCT00090584|4273015|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449253|NCT00090584|4273013|B3||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4449254|NCT00090584|4273014|B2||Female|Sex: Female, Male||Participants|Count of Participants|153|153.0||||||
4449255|NCT00090584|4273015|B1||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4449256|NCT00090584|4273013|B3|||Age||years|Mean|56.9|56.9|Standard Deviation|13.9|13.9|||
4449257|NCT00090584|4273014|B2|||Age||years|Mean|58.0|58.0|Standard Deviation|13.5|13.5|||
4449258|NCT00090584|4273015|B1|||Age||years|Mean|55.8|55.8|Standard Deviation|14.2|14.2|||
4449259|NCT00090584|4273013|B3||>=65 years|Age||Participants|Count of Participants|89|89.0||||||
4449260|NCT00090584|4273014|B2||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4449261|NCT00090584|4273015|B1||>=65 years|Age||Participants|Count of Participants|42|42.0||||||
4449262|NCT00090584|4273013|B3||Between 18 and 65 years|Age||Participants|Count of Participants|218|218.0||||||
4449263|NCT00090584|4273014|B2||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4449264|NCT00090584|4273015|B1||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4449265|NCT00090584|4273013|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449266|NCT00090584|4273014|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449267|NCT00090584|4273015|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449268|NCT00090519|4273046|B3|53||Diabetic Retinopathy (DR) Level|DR level is reported by number of DR study eyes for each level (722 DR study eyes in ruboxistaurin group and 696 DR study eyes in placebo group). EDTRS Final Retinopathy Severity Scale ranges from Level 10 (DR absent) to Level 65 (moderate proliferative diabetic retinopathy [PDR]), with a total of 12 levels based on the number of letters read incorrectly. Less than Level 47= mild to moderate nonproliferative diabetic retinopathy (NPDR). Level 47= moderately severe NPDR. Level 53=severe NPDR. Each level represents a change in DR (i.e., a change from Level 47 to >= Level 61 is >=2 steps worse).|DR study eyes for each level|Number|10|10.0||||||
4449269|NCT00090519|4273047|B2|53||Diabetic Retinopathy (DR) Level|DR level is reported by number of DR study eyes for each level (722 DR study eyes in ruboxistaurin group and 696 DR study eyes in placebo group). EDTRS Final Retinopathy Severity Scale ranges from Level 10 (DR absent) to Level 65 (moderate proliferative diabetic retinopathy [PDR]), with a total of 12 levels based on the number of letters read incorrectly. Less than Level 47= mild to moderate nonproliferative diabetic retinopathy (NPDR). Level 47= moderately severe NPDR. Level 53=severe NPDR. Each level represents a change in DR (i.e., a change from Level 47 to >= Level 61 is >=2 steps worse).|DR study eyes for each level|Number|3|3.0||||||
4449270|NCT00090519|4273048|B1|53||Diabetic Retinopathy (DR) Level|DR level is reported by number of DR study eyes for each level (722 DR study eyes in ruboxistaurin group and 696 DR study eyes in placebo group). EDTRS Final Retinopathy Severity Scale ranges from Level 10 (DR absent) to Level 65 (moderate proliferative diabetic retinopathy [PDR]), with a total of 12 levels based on the number of letters read incorrectly. Less than Level 47= mild to moderate nonproliferative diabetic retinopathy (NPDR). Level 47= moderately severe NPDR. Level 53=severe NPDR. Each level represents a change in DR (i.e., a change from Level 47 to >= Level 61 is >=2 steps worse).|DR study eyes for each level|Number|7|7.0||||||
4449271|NCT00090519|4273046|B3|47||Diabetic Retinopathy (DR) Level|DR level is reported by number of DR study eyes for each level (722 DR study eyes in ruboxistaurin group and 696 DR study eyes in placebo group). EDTRS Final Retinopathy Severity Scale ranges from Level 10 (DR absent) to Level 65 (moderate proliferative diabetic retinopathy [PDR]), with a total of 12 levels based on the number of letters read incorrectly. Less than Level 47= mild to moderate nonproliferative diabetic retinopathy (NPDR). Level 47= moderately severe NPDR. Level 53=severe NPDR. Each level represents a change in DR (i.e., a change from Level 47 to >= Level 61 is >=2 steps worse).|DR study eyes for each level|Number|522|522.0||||||
4449272|NCT00090519|4273047|B2|47||Diabetic Retinopathy (DR) Level|DR level is reported by number of DR study eyes for each level (722 DR study eyes in ruboxistaurin group and 696 DR study eyes in placebo group). EDTRS Final Retinopathy Severity Scale ranges from Level 10 (DR absent) to Level 65 (moderate proliferative diabetic retinopathy [PDR]), with a total of 12 levels based on the number of letters read incorrectly. Less than Level 47= mild to moderate nonproliferative diabetic retinopathy (NPDR). Level 47= moderately severe NPDR. Level 53=severe NPDR. Each level represents a change in DR (i.e., a change from Level 47 to >= Level 61 is >=2 steps worse).|DR study eyes for each level|Number|272|272.0||||||
4449273|NCT00090519|4273048|B1|47||Diabetic Retinopathy (DR) Level|DR level is reported by number of DR study eyes for each level (722 DR study eyes in ruboxistaurin group and 696 DR study eyes in placebo group). EDTRS Final Retinopathy Severity Scale ranges from Level 10 (DR absent) to Level 65 (moderate proliferative diabetic retinopathy [PDR]), with a total of 12 levels based on the number of letters read incorrectly. Less than Level 47= mild to moderate nonproliferative diabetic retinopathy (NPDR). Level 47= moderately severe NPDR. Level 53=severe NPDR. Each level represents a change in DR (i.e., a change from Level 47 to >= Level 61 is >=2 steps worse).|DR study eyes for each level|Number|250|250.0||||||
4449300|NCT00090519|4273048|B1|Type 1||Diabetes Type|Type 1 diabetes results from autoimmune mediated destruction of the beta cells of the pancreas. Participants require insulin treatment to survive. Type 2 diabetes is characterized by resistance to the action of insulin leading to relative insulin deficiency.|participants|Number|85|85.0||||||
4449301|NCT00090519|4273046|B3|||Glycosylated hemoglobin (HbA1c)||percent glycosylated hemoglobin|Mean|8.19|8.19|Standard Deviation|1.31|1.31|||
4449274|NCT00090519|4273046|B3|<47||Diabetic Retinopathy (DR) Level|DR level is reported by number of DR study eyes for each level (722 DR study eyes in ruboxistaurin group and 696 DR study eyes in placebo group). EDTRS Final Retinopathy Severity Scale ranges from Level 10 (DR absent) to Level 65 (moderate proliferative diabetic retinopathy [PDR]), with a total of 12 levels based on the number of letters read incorrectly. Less than Level 47= mild to moderate nonproliferative diabetic retinopathy (NPDR). Level 47= moderately severe NPDR. Level 53=severe NPDR. Each level represents a change in DR (i.e., a change from Level 47 to >= Level 61 is >=2 steps worse).|DR study eyes for each level|Number|886|886.0||||||
4449275|NCT00090519|4273047|B2|<47||Diabetic Retinopathy (DR) Level|DR level is reported by number of DR study eyes for each level (722 DR study eyes in ruboxistaurin group and 696 DR study eyes in placebo group). EDTRS Final Retinopathy Severity Scale ranges from Level 10 (DR absent) to Level 65 (moderate proliferative diabetic retinopathy [PDR]), with a total of 12 levels based on the number of letters read incorrectly. Less than Level 47= mild to moderate nonproliferative diabetic retinopathy (NPDR). Level 47= moderately severe NPDR. Level 53=severe NPDR. Each level represents a change in DR (i.e., a change from Level 47 to >= Level 61 is >=2 steps worse).|DR study eyes for each level|Number|421|421.0||||||
4449276|NCT00090519|4273048|B1|<47||Diabetic Retinopathy (DR) Level|DR level is reported by number of DR study eyes for each level (722 DR study eyes in ruboxistaurin group and 696 DR study eyes in placebo group). EDTRS Final Retinopathy Severity Scale ranges from Level 10 (DR absent) to Level 65 (moderate proliferative diabetic retinopathy [PDR]), with a total of 12 levels based on the number of letters read incorrectly. Less than Level 47= mild to moderate nonproliferative diabetic retinopathy (NPDR). Level 47= moderately severe NPDR. Level 53=severe NPDR. Each level represents a change in DR (i.e., a change from Level 47 to >= Level 61 is >=2 steps worse).|DR study eyes for each level|Number|465|465.0||||||
4449277|NCT00090519|4273046|B3|||Visual Acuity Score (Letters Correct)|Visual acuity by the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. Each participant starts at the top of the chart containing 5 letters per row and reads down the chart until reaching a row where a minimum of 3 letters on a line cannot be read. Each participant is scored by how many letters could be correctly identified. A higher number of letters correctly identified represents better visual acuity.|Letters read correctly|Mean|84.19|84.19|Standard Deviation|7.81|7.81|||
4449278|NCT00090519|4273047|B2|||Visual Acuity Score (Letters Correct)|Visual acuity by the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. Each participant starts at the top of the chart containing 5 letters per row and reads down the chart until reaching a row where a minimum of 3 letters on a line cannot be read. Each participant is scored by how many letters could be correctly identified. A higher number of letters correctly identified represents better visual acuity.|Letters read correctly|Mean|84.27|84.27|Standard Deviation|7.70|7.7|||
4449279|NCT00090519|4273048|B1|||Visual Acuity Score (Letters Correct)|Visual acuity by the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. Each participant starts at the top of the chart containing 5 letters per row and reads down the chart until reaching a row where a minimum of 3 letters on a line cannot be read. Each participant is scored by how many letters could be correctly identified. A higher number of letters correctly identified represents better visual acuity.|Letters read correctly|Mean|84.12|84.12|Standard Deviation|7.93|7.93|||
4449280|NCT00090519|4273046|B3|One||Number of diabetic retinopathy (DR) study eyes per participant||participants|Number|44|44.0||||||
4449281|NCT00090519|4273047|B2|One||Number of diabetic retinopathy (DR) study eyes per participant||participants|Number|24|24.0||||||
4449282|NCT00090519|4273048|B1|One||Number of diabetic retinopathy (DR) study eyes per participant||participants|Number|20|20.0||||||
4449283|NCT00090519|4273046|B3|Two||Number of diabetic retinopathy (DR) study eyes per participant||participants|Number|687|687.0||||||
4449284|NCT00090519|4273047|B2|Two||Number of diabetic retinopathy (DR) study eyes per participant||participants|Number|336|336.0||||||
4449285|NCT00090519|4273048|B1|Two||Number of diabetic retinopathy (DR) study eyes per participant||participants|Number|351|351.0||||||
4449286|NCT00090519|4273046|B3|No||Insulin use||participants|Number|262|262.0||||||
4449287|NCT00090519|4273047|B2|No||Insulin use||participants|Number|132|132.0||||||
4449288|NCT00090519|4273048|B1|No||Insulin use||participants|Number|130|130.0||||||
4449289|NCT00090519|4273046|B3|Yes||Insulin use||participants|Number|469|469.0||||||
4449290|NCT00090519|4273047|B2|Yes||Insulin use||participants|Number|228|228.0||||||
4449291|NCT00090519|4273048|B1|Yes||Insulin use||participants|Number|241|241.0||||||
4449292|NCT00090519|4273046|B3|||Duration of diabetes||years|Mean|15.70|15.7|Standard Deviation|7.75|7.75|||
4449293|NCT00090519|4273047|B2|||Duration of diabetes||years|Mean|15.57|15.57|Standard Deviation|7.48|7.48|||
4449294|NCT00090519|4273048|B1|||Duration of diabetes||years|Mean|15.82|15.82|Standard Deviation|8.00|8.0|||
4449295|NCT00090519|4273046|B3|Type 2||Diabetes Type|Type 1 diabetes results from autoimmune mediated destruction of the beta cells of the pancreas. Participants require insulin treatment to survive. Type 2 diabetes is characterized by resistance to the action of insulin leading to relative insulin deficiency.|participants|Number|570|570.0||||||
4449296|NCT00090519|4273047|B2|Type 2||Diabetes Type|Type 1 diabetes results from autoimmune mediated destruction of the beta cells of the pancreas. Participants require insulin treatment to survive. Type 2 diabetes is characterized by resistance to the action of insulin leading to relative insulin deficiency.|participants|Number|284|284.0||||||
4449297|NCT00090519|4273048|B1|Type 2||Diabetes Type|Type 1 diabetes results from autoimmune mediated destruction of the beta cells of the pancreas. Participants require insulin treatment to survive. Type 2 diabetes is characterized by resistance to the action of insulin leading to relative insulin deficiency.|participants|Number|286|286.0||||||
4449298|NCT00090519|4273046|B3|Type 1||Diabetes Type|Type 1 diabetes results from autoimmune mediated destruction of the beta cells of the pancreas. Participants require insulin treatment to survive. Type 2 diabetes is characterized by resistance to the action of insulin leading to relative insulin deficiency.|participants|Number|161|161.0||||||
4449299|NCT00090519|4273047|B2|Type 1||Diabetes Type|Type 1 diabetes results from autoimmune mediated destruction of the beta cells of the pancreas. Participants require insulin treatment to survive. Type 2 diabetes is characterized by resistance to the action of insulin leading to relative insulin deficiency.|participants|Number|76|76.0||||||
4449360|NCT00090519|4273048|B1|Portugal||Region of Enrollment||participants|Number|15|15.0||||||
4449302|NCT00090519|4273047|B2|||Glycosylated hemoglobin (HbA1c)||percent glycosylated hemoglobin|Mean|8.25|8.25|Standard Deviation|1.31|1.31|||
4449303|NCT00090519|4273048|B1|||Glycosylated hemoglobin (HbA1c)||percent glycosylated hemoglobin|Mean|8.14|8.14|Standard Deviation|1.31|1.31|||
4449304|NCT00090519|4273046|B3|Diastolic Blood Pressure||Blood Pressure||millimeters of mercury (mmHg)|Mean|77.73|77.73|Standard Deviation|8.86|8.86|||
4449305|NCT00090519|4273047|B2|Diastolic Blood Pressure||Blood Pressure||millimeters of mercury (mmHg)|Mean|77.77|77.77|Standard Deviation|9.05|9.05|||
4449306|NCT00090519|4273048|B1|Diastolic Blood Pressure||Blood Pressure||millimeters of mercury (mmHg)|Mean|77.68|77.68|Standard Deviation|8.68|8.68|||
4449307|NCT00090519|4273046|B3|Systolic Blood Pressure||Blood Pressure||millimeters of mercury (mmHg)|Mean|133.20|133.2|Standard Deviation|5.99|5.99|||
4449308|NCT00090519|4273047|B2|Systolic Blood Pressure||Blood Pressure||millimeters of mercury (mmHg)|Mean|133.50|133.5|Standard Deviation|15.58|15.58|||
4449309|NCT00090519|4273048|B1|Systolic Blood Pressure||Blood Pressure||millimeters of mercury (mmHg)|Mean|132.90|132.9|Standard Deviation|15.25|15.25|||
4449310|NCT00090519|4273046|B3|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|29.86|29.86|Standard Deviation|5.99|5.99|||
4449311|NCT00090519|4273047|B2|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|29.82|29.82|Standard Deviation|5.89|5.89|||
4449312|NCT00090519|4273048|B1|||Body Mass Index (BMI)|Body mass index is an estimate of body fat based on body weight divided by height squared.|kilograms/square meters (kg/m^2)|Mean|29.90|29.9|Standard Deviation|6.09|6.09|||
4449313|NCT00090519|4273046|B3|Germany||Region of Enrollment||participants|Number|41|41.0||||||
4449314|NCT00090519|4273047|B2|Germany||Region of Enrollment||participants|Number|19|19.0||||||
4449315|NCT00090519|4273048|B1|Germany||Region of Enrollment||participants|Number|22|22.0||||||
4449316|NCT00090519|4273046|B3|Netherlands||Region of Enrollment||participants|Number|17|17.0||||||
4449317|NCT00090519|4273047|B2|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4449318|NCT00090519|4273048|B1|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4449319|NCT00090519|4273046|B3|Denmark||Region of Enrollment||participants|Number|54|54.0||||||
4449320|NCT00090519|4273047|B2|Denmark||Region of Enrollment||participants|Number|28|28.0||||||
4449321|NCT00090519|4273048|B1|Denmark||Region of Enrollment||participants|Number|26|26.0||||||
4449322|NCT00090519|4273046|B3|Australia||Region of Enrollment||participants|Number|37|37.0||||||
4449323|NCT00090519|4273047|B2|Australia||Region of Enrollment||participants|Number|17|17.0||||||
4449324|NCT00090519|4273048|B1|Australia||Region of Enrollment||participants|Number|20|20.0||||||
4449325|NCT00090519|4273046|B3|Poland||Region of Enrollment||participants|Number|36|36.0||||||
4449326|NCT00090519|4273047|B2|Poland||Region of Enrollment||participants|Number|16|16.0||||||
4449327|NCT00090519|4273048|B1|Poland||Region of Enrollment||participants|Number|20|20.0||||||
4449328|NCT00090519|4273046|B3|Brazil||Region of Enrollment||participants|Number|29|29.0||||||
4449329|NCT00090519|4273047|B2|Brazil||Region of Enrollment||participants|Number|16|16.0||||||
4449330|NCT00090519|4273048|B1|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
4449331|NCT00090519|4273046|B3|Canada||Region of Enrollment||participants|Number|47|47.0||||||
4449332|NCT00090519|4273047|B2|Canada||Region of Enrollment||participants|Number|25|25.0||||||
4449333|NCT00090519|4273048|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4449334|NCT00090519|4273046|B3|Mexico||Region of Enrollment||participants|Number|44|44.0||||||
4449335|NCT00090519|4273047|B2|Mexico||Region of Enrollment||participants|Number|22|22.0||||||
4449336|NCT00090519|4273048|B1|Mexico||Region of Enrollment||participants|Number|22|22.0||||||
4449337|NCT00090519|4273046|B3|France||Region of Enrollment||participants|Number|21|21.0||||||
4449338|NCT00090519|4273047|B2|France||Region of Enrollment||participants|Number|10|10.0||||||
4449339|NCT00090519|4273048|B1|France||Region of Enrollment||participants|Number|11|11.0||||||
4449340|NCT00090519|4273046|B3|India||Region of Enrollment||participants|Number|51|51.0||||||
4449341|NCT00090519|4273047|B2|India||Region of Enrollment||participants|Number|26|26.0||||||
4449342|NCT00090519|4273048|B1|India||Region of Enrollment||participants|Number|25|25.0||||||
4449343|NCT00090519|4273046|B3|Italy||Region of Enrollment||participants|Number|14|14.0||||||
4449344|NCT00090519|4273047|B2|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4449345|NCT00090519|4273048|B1|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4449346|NCT00090519|4273046|B3|United Kingdom||Region of Enrollment||participants|Number|39|39.0||||||
4449347|NCT00090519|4273047|B2|United Kingdom||Region of Enrollment||participants|Number|18|18.0||||||
4449348|NCT00090519|4273048|B1|United Kingdom||Region of Enrollment||participants|Number|21|21.0||||||
4449349|NCT00090519|4273046|B3|Russian Federation||Region of Enrollment||participants|Number|52|52.0||||||
4449350|NCT00090519|4273047|B2|Russian Federation||Region of Enrollment||participants|Number|24|24.0||||||
4449351|NCT00090519|4273048|B1|Russian Federation||Region of Enrollment||participants|Number|28|28.0||||||
4449352|NCT00090519|4273046|B3|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4449353|NCT00090519|4273047|B2|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4449354|NCT00090519|4273048|B1|Spain||Region of Enrollment||participants|Number|13|13.0||||||
4449355|NCT00090519|4273046|B3|Taiwan||Region of Enrollment||participants|Number|4|4.0||||||
4449356|NCT00090519|4273047|B2|Taiwan||Region of Enrollment||participants|Number|1|1.0||||||
4449357|NCT00090519|4273048|B1|Taiwan||Region of Enrollment||participants|Number|3|3.0||||||
4449358|NCT00090519|4273046|B3|Portugal||Region of Enrollment||participants|Number|31|31.0||||||
4449359|NCT00090519|4273047|B2|Portugal||Region of Enrollment||participants|Number|16|16.0||||||
4449361|NCT00090519|4273046|B3|United States||Region of Enrollment||participants|Number|190|190.0||||||
4449362|NCT00090519|4273047|B2|United States||Region of Enrollment||participants|Number|97|97.0||||||
4449363|NCT00090519|4273048|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
4449364|NCT00090519|4273046|B3||Male|Sex: Female, Male||Participants|Count of Participants|456|456.0||||||
4449365|NCT00090519|4273047|B2||Male|Sex: Female, Male||Participants|Count of Participants|223|223.0||||||
4449366|NCT00090519|4273048|B1||Male|Sex: Female, Male||Participants|Count of Participants|233|233.0||||||
4449367|NCT00090519|4273046|B3||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4449368|NCT00090519|4273047|B2||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4449369|NCT00090519|4273048|B1||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4449370|NCT00090519|4273046|B3|||Age||years|Mean|55.17|55.17|Standard Deviation|11.01|11.01|||
4449371|NCT00090519|4273047|B2|||Age||years|Mean|55.15|55.15|Standard Deviation|11.18|11.18|||
4449372|NCT00090519|4273048|B1|||Age||years|Mean|55.20|55.2|Standard Deviation|10.85|10.85|||
4449373|NCT00090493|4273073|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4449374|NCT00090493|4273073|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4449375|NCT00090493|4273073|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4449376|NCT00090493|4273073|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4449377|NCT00090493|4273073|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4449378|NCT00090493|4273073|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449379|NCT00090363|4273077|B4|Other||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4449380|NCT00090363|4273078|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4449381|NCT00090363|4273079|B2|Other||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4449382|NCT00090363|4273080|B1|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4449383|NCT00090363|4273077|B4|Not a specific ethnic group||Race/Ethnicity, Customized||Participants|Number|281|281.0||||||
4449384|NCT00090363|4273078|B3|Not a specific ethnic group||Race/Ethnicity, Customized||Participants|Number|87|87.0||||||
4449385|NCT00090363|4273079|B2|Not a specific ethnic group||Race/Ethnicity, Customized||Participants|Number|95|95.0||||||
4449386|NCT00090363|4273080|B1|Not a specific ethnic group||Race/Ethnicity, Customized||Participants|Number|99|99.0||||||
4449387|NCT00090363|4273077|B4|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449388|NCT00090363|4273078|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449389|NCT00090363|4273079|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449390|NCT00090363|4273080|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449391|NCT00090363|4273077|B4|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4449392|NCT00090363|4273078|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4449393|NCT00090363|4273079|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449394|NCT00090363|4273080|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449395|NCT00090363|4273077|B4|African-American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449396|NCT00090363|4273078|B3|African-American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449397|NCT00090363|4273079|B2|African-American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449398|NCT00090363|4273080|B1|African-American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449399|NCT00090363|4273077|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4449400|NCT00090363|4273078|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4449401|NCT00090363|4273079|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4449402|NCT00090363|4273080|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4449403|NCT00090363|4273077|B4|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449404|NCT00090363|4273078|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449405|NCT00090363|4273079|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449406|NCT00090363|4273080|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449407|NCT00090363|4273077|B4|Oriental||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4449408|NCT00090363|4273078|B3|Oriental||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4449409|NCT00090363|4273079|B2|Oriental||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449410|NCT00090363|4273080|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449411|NCT00090363|4273077|B4|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449412|NCT00090363|4273078|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449413|NCT00090363|4273079|B2|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449414|NCT00090363|4273080|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449415|NCT00090363|4273077|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|306|306.0||||||
4449416|NCT00090363|4273078|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|93|93.0||||||
4449417|NCT00090363|4273079|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|107|107.0||||||
4449418|NCT00090363|4273080|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|106|106.0||||||
4449419|NCT00090363|4273077|B4||Male|Sex: Female, Male||Participants|Count of Participants|312|312.0||||||
4449420|NCT00090363|4273078|B3||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4449421|NCT00090363|4273079|B2||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4449422|NCT00090363|4273080|B1||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4449423|NCT00090363|4273077|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449424|NCT00090363|4273078|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449425|NCT00090363|4273079|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449426|NCT00090363|4273080|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449427|NCT00090363|4273077|B4|||Age||years|Mean|70|70.0|Standard Deviation|9|9.0|||
4449428|NCT00090363|4273078|B3|||Age||years|Mean|69|69.0|Standard Deviation|8|8.0|||
4449429|NCT00090363|4273079|B2|||Age||years|Mean|70|70.0|Standard Deviation|8|8.0|||
4449430|NCT00090363|4273080|B1|||Age||years|Mean|71|71.0|Standard Deviation|9|9.0|||
4449431|NCT00090545|4273102|B3|United States||Region of Enrollment||Participants|Count of Participants|46|46.0||||||
4449432|NCT00090545|4273103|B2|United States||Region of Enrollment||Participants|Count of Participants|24|24.0||||||
4449433|NCT00090545|4273104|B1|United States||Region of Enrollment||Participants|Count of Participants|22|22.0||||||
4449434|NCT00090545|4273102|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449435|NCT00090545|4273103|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449436|NCT00090545|4273104|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449437|NCT00090545|4273102|B3|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449438|NCT00090545|4273103|B2|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449439|NCT00090545|4273104|B1|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449440|NCT00090545|4273102|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|40|40.0||||||
4449441|NCT00090545|4273103|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4449442|NCT00090545|4273104|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4449443|NCT00090545|4273102|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4449444|NCT00090545|4273103|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4449445|NCT00090545|4273104|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4449446|NCT00090545|4273102|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449447|NCT00090545|4273103|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449448|NCT00090545|4273104|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449449|NCT00090545|4273102|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449450|NCT00090545|4273103|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449451|NCT00090545|4273104|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449452|NCT00090545|4273102|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449453|NCT00090545|4273103|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449454|NCT00090545|4273104|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4449455|NCT00090545|4273102|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449456|NCT00090545|4273103|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449457|NCT00090545|4273104|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449458|NCT00090545|4273102|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4449459|NCT00090545|4273103|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4449460|NCT00090545|4273104|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4449461|NCT00090545|4273102|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4449462|NCT00090545|4273103|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4449463|NCT00090545|4273104|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4449464|NCT00090545|4273102|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4449465|NCT00090545|4273103|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4449466|NCT00090545|4273104|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4449467|NCT00090545|4273102|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449468|NCT00090545|4273103|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449469|NCT00090545|4273104|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449470|NCT00090545|4273102|B3|||Age||years|Mean|66.52|66.52|Standard Deviation|8.87|8.87|||
4449471|NCT00090545|4273103|B2|||Age||years|Mean|68.08|68.08|Standard Deviation|10.17|10.17|||
4449472|NCT00090545|4273104|B1|||Age||years|Mean|64.8|64.8|Standard Deviation|7.04|7.04|||
4449473|NCT00090545|4273102|B3||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4449474|NCT00090545|4273103|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4449475|NCT00090545|4273104|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4449476|NCT00090545|4273102|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4449477|NCT00090545|4273103|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4449478|NCT00090545|4273104|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4449479|NCT00090545|4273102|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449480|NCT00090545|4273103|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449481|NCT00090545|4273104|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449482|NCT00090285|4273123|B3|Polynesian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4449483|NCT00090285|4273124|B2|Polynesian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4449484|NCT00090285|4273125|B1|Polynesian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4449485|NCT00090285|4273123|B3|Indian (subcontinent)||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4449486|NCT00090285|4273124|B2|Indian (subcontinent)||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4449487|NCT00090285|4273125|B1|Indian (subcontinent)||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4449488|NCT00090285|4273123|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|574|574.0||||||
4449489|NCT00090285|4273124|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|283|283.0||||||
4449490|NCT00090285|4273125|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|291|291.0||||||
4449491|NCT00090285|4273123|B3|White||Race/Ethnicity, Customized||participants|Number|1431|1431.0||||||
4449492|NCT00090285|4273124|B2|White||Race/Ethnicity, Customized||participants|Number|712|712.0||||||
4449493|NCT00090285|4273125|B1|White||Race/Ethnicity, Customized||participants|Number|719|719.0||||||
4449494|NCT00090285|4273123|B3|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4449495|NCT00090285|4273124|B2|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4449496|NCT00090285|4273125|B1|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4449497|NCT00090285|4273123|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|835|835.0||||||
4449498|NCT00090285|4273124|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|423|423.0||||||
4449499|NCT00090285|4273125|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|412|412.0||||||
4449500|NCT00090285|4273123|B3|Black||Race/Ethnicity, Customized||participants|Number|805|805.0||||||
4449501|NCT00090285|4273124|B2|Black||Race/Ethnicity, Customized||participants|Number|400|400.0||||||
4449502|NCT00090285|4273125|B1|Black||Race/Ethnicity, Customized||participants|Number|405|405.0||||||
4449503|NCT00090285|4273123|B3|Asian||Race/Ethnicity, Customized||participants|Number|406|406.0||||||
4449504|NCT00090285|4273124|B2|Asian||Race/Ethnicity, Customized||participants|Number|205|205.0||||||
4449505|NCT00090285|4273125|B1|Asian||Race/Ethnicity, Customized||participants|Number|201|201.0||||||
4449506|NCT00090285|4273123|B3||Male|Sex: Female, Male||Participants|Count of Participants|4065|4065.0||||||
4449507|NCT00090285|4273124|B2||Male|Sex: Female, Male||Participants|Count of Participants|2033|2033.0||||||
4449508|NCT00090285|4273125|B1||Male|Sex: Female, Male||Participants|Count of Participants|2032|2032.0||||||
4449509|NCT00090285|4273123|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449510|NCT00090285|4273124|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449511|NCT00090285|4273125|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449512|NCT00090285|4273123|B3|||Age|Although the upper age limit for this study was 26 years old, one subject age 27 was randomized into the study.|Years|Median|20|20.0|Full Range|||15.0|27.0|
4449513|NCT00090285|4273124|B2|||Age|Although the upper age limit for this study was 26 years old, one subject age 27 was randomized into the study.|Years|Median|20|20.0|Full Range|||15.0|27.0|
4449514|NCT00090285|4273125|B1|||Age|Although the upper age limit for this study was 26 years old, one subject age 27 was randomized into the study.|Years|Median|20|20.0|Full Range|||16.0|26.0|
4449515|NCT00090285|4273123|B3|||Age||years|Mean|20.5|20.5|Standard Deviation|2.0|2.0|||
4449516|NCT00090285|4273124|B2|||Age||years|Mean|20.5|20.5|Standard Deviation|2.0|2.0|||
4449517|NCT00090285|4273125|B1|||Age||years|Mean|20.6|20.6|Standard Deviation|2.0|2.0|||
4449518|NCT00090259|4273165|B3|Yes||β – Blocker therapy||Participants|Number|2758|2758.0||||||
4449519|NCT00090259|4273166|B2|Yes||β – Blocker therapy||Participants|Number|1388|1388.0||||||
4449520|NCT00090259|4273167|B1|Yes||β – Blocker therapy||Participants|Number|1370|1370.0||||||
4449521|NCT00090259|4273165|B3|No||β – Blocker therapy||Participants|Number|1076|1076.0||||||
4449522|NCT00090259|4273166|B2|No||β – Blocker therapy||Participants|Number|533|533.0||||||
4449523|NCT00090259|4273167|B1|No||β – Blocker therapy||Participants|Number|543|543.0||||||
4449524|NCT00090259|4273165|B3|West Europe||Region||participants|Number|1816|1816.0||||||
4449525|NCT00090259|4273166|B2|West Europe||Region||participants|Number|912|912.0||||||
4449526|NCT00090259|4273167|B1|West Europe||Region||participants|Number|904|904.0||||||
4449527|NCT00090259|4273165|B3|Latin America||Region||participants|Number|624|624.0||||||
4449528|NCT00090259|4273166|B2|Latin America||Region||participants|Number|315|315.0||||||
4449529|NCT00090259|4273167|B1|Latin America||Region||participants|Number|309|309.0||||||
4449530|NCT00090259|4273165|B3|Middle East and Africa||Region||participants|Number|194|194.0||||||
4449531|NCT00090259|4273166|B2|Middle East and Africa||Region||participants|Number|97|97.0||||||
4449532|NCT00090259|4273167|B1|Middle East and Africa||Region||participants|Number|97|97.0||||||
4449533|NCT00090259|4273165|B3|East Europe||Region||participants|Number|419|419.0||||||
4449534|NCT00090259|4273166|B2|East Europe||Region||participants|Number|207|207.0||||||
4449535|NCT00090259|4273167|B1|East Europe||Region||participants|Number|212|212.0||||||
4449536|NCT00090259|4273165|B3|Asia and Pacific Region||Region||participants|Number|781|781.0||||||
4449537|NCT00090259|4273166|B2|Asia and Pacific Region||Region||participants|Number|390|390.0||||||
4449538|NCT00090259|4273167|B1|Asia and Pacific Region||Region||participants|Number|391|391.0||||||
4449552|NCT00090259|4273166|B2|Yes||Angiotensin II antagonists||Participants|Number|1483|1483.0||||||
4449553|NCT00090259|4273167|B1|Yes||Angiotensin II antagonists||Participants|Number|1457|1457.0||||||
4449539|NCT00090259|4273165|B3|IV Severe limitations||New York Heart Association (NYHA) functional status|"NYHA Class Symptoms~I No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~II Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~III Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Number|22|22.0||||||
4449540|NCT00090259|4273166|B2|IV Severe limitations||New York Heart Association (NYHA) functional status|"NYHA Class Symptoms~I No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~II Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~III Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Number|10|10.0||||||
4449541|NCT00090259|4273167|B1|IV Severe limitations||New York Heart Association (NYHA) functional status|"NYHA Class Symptoms~I No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~II Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~III Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Number|12|12.0||||||
4449542|NCT00090259|4273165|B3|III Marked limitation||New York Heart Association (NYHA) functional status|"NYHA Class Symptoms~I No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~II Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~III Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Number|1152|1152.0||||||
4449543|NCT00090259|4273166|B2|III Marked limitation||New York Heart Association (NYHA) functional status|"NYHA Class Symptoms~I No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~II Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~III Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Number|583|583.0||||||
4449544|NCT00090259|4273167|B1|III Marked limitation||New York Heart Association (NYHA) functional status|"NYHA Class Symptoms~I No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~II Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~III Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Number|569|569.0||||||
4449545|NCT00090259|4273165|B3|II Mild symptoms||New York Heart Association (NYHA) functional status|"NYHA Class Symptoms~I No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~II Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~III Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Number|2657|2657.0||||||
4449546|NCT00090259|4273166|B2|II Mild symptoms||New York Heart Association (NYHA) functional status|"NYHA Class Symptoms~I No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~II Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~III Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Number|1327|1327.0||||||
4449547|NCT00090259|4273167|B1|II Mild symptoms||New York Heart Association (NYHA) functional status|"NYHA Class Symptoms~I No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~II Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~III Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Number|1330|1330.0||||||
4449548|NCT00090259|4273165|B3|I No symptoms||New York Heart Association (NYHA) functional status|"NYHA Class Symptoms~I No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~II Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~III Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Number|3|3.0||||||
4449549|NCT00090259|4273166|B2|I No symptoms||New York Heart Association (NYHA) functional status|"NYHA Class Symptoms~I No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~II Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~III Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Number|1|1.0||||||
4449550|NCT00090259|4273167|B1|I No symptoms||New York Heart Association (NYHA) functional status|"NYHA Class Symptoms~I No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc.~II Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity.~III Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m). Comfortable only at rest.~IV Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients."|Participants|Number|2|2.0||||||
4449551|NCT00090259|4273165|B3|Yes||Angiotensin II antagonists||Participants|Number|2940|2940.0||||||
4449554|NCT00090259|4273165|B3|No||Angiotensin II antagonists||Participants|Number|894|894.0||||||
4449555|NCT00090259|4273166|B2|No||Angiotensin II antagonists||Participants|Number|438|438.0||||||
4449556|NCT00090259|4273167|B1|No||Angiotensin II antagonists||Participants|Number|456|456.0||||||
4449557|NCT00090259|4273165|B3||Male|Sex: Female, Male||Participants|Count of Participants|2691|2691.0||||||
4449558|NCT00090259|4273166|B2||Male|Sex: Female, Male||Participants|Count of Participants|1338|1338.0||||||
4449559|NCT00090259|4273167|B1||Male|Sex: Female, Male||Participants|Count of Participants|1353|1353.0||||||
4449560|NCT00090259|4273165|B3||Female|Sex: Female, Male||Participants|Count of Participants|1143|1143.0||||||
4449561|NCT00090259|4273166|B2||Female|Sex: Female, Male||Participants|Count of Participants|583|583.0||||||
4449562|NCT00090259|4273167|B1||Female|Sex: Female, Male||Participants|Count of Participants|560|560.0||||||
4449563|NCT00090259|4273165|B3|>=65 years of Age||Age, Customized||participants|Number|2066|2066.0||||||
4449564|NCT00090259|4273166|B2|>=65 years of Age||Age, Customized||participants|Number|1042|1042.0||||||
4449565|NCT00090259|4273167|B1|>=65 years of Age||Age, Customized||participants|Number|1024|1024.0||||||
4449566|NCT00090259|4273165|B3|< 65 years of Age||Age, Customized||participants|Number|1768|1768.0||||||
4449567|NCT00090259|4273166|B2|< 65 years of Age||Age, Customized||participants|Number|879|879.0||||||
4449568|NCT00090259|4273167|B1|< 65 years of Age||Age, Customized||participants|Number|889|889.0||||||
4449569|NCT00090259|4273165|B3|||Age||years|Mean|64.2|64.2|Full Range|||18.0|98.0|
4449570|NCT00090259|4273166|B2|||Age||years|Mean|64.4|64.4|Full Range|||18.0|98.0|
4449571|NCT00090259|4273167|B1|||Age||years|Mean|64.1|64.1|Full Range|||19.0|95.0|
4449572|NCT00090233|4273182|B3|Other||Race/Ethnicity||participants|Number|226|226.0||||||
4449573|NCT00090233|4273183|B2|Other||Race/Ethnicity||participants|Number|107|107.0||||||
4449574|NCT00090233|4273184|B1|Other||Race/Ethnicity||participants|Number|119|119.0||||||
4449575|NCT00090233|4273182|B3|Native American||Race/Ethnicity||participants|Number|1045|1045.0||||||
4449576|NCT00090233|4273183|B2|Native American||Race/Ethnicity||participants|Number|514|514.0||||||
4449577|NCT00090233|4273184|B1|Native American||Race/Ethnicity||participants|Number|531|531.0||||||
4449578|NCT00090233|4273182|B3|Asian||Race/Ethnicity||participants|Number|1088|1088.0||||||
4449579|NCT00090233|4273183|B2|Asian||Race/Ethnicity||participants|Number|552|552.0||||||
4449580|NCT00090233|4273184|B1|Asian||Race/Ethnicity||participants|Number|536|536.0||||||
4449581|NCT00090233|4273182|B3|Multi Racial||Race/Ethnicity||participants|Number|3632|3632.0||||||
4449582|NCT00090233|4273183|B2|Multi Racial||Race/Ethnicity||participants|Number|1817|1817.0||||||
4449583|NCT00090233|4273184|B1|Multi Racial||Race/Ethnicity||participants|Number|1815|1815.0||||||
4449584|NCT00090233|4273182|B3|Black||Race/Ethnicity||participants|Number|5849|5849.0||||||
4449585|NCT00090233|4273183|B2|Black||Race/Ethnicity||participants|Number|2941|2941.0||||||
4449586|NCT00090233|4273184|B1|Black||Race/Ethnicity||participants|Number|2908|2908.0||||||
4449587|NCT00090233|4273182|B3|Hispanic American||Race/Ethnicity||participants|Number|9874|9874.0||||||
4449588|NCT00090233|4273183|B2|Hispanic American||Race/Ethnicity||participants|Number|4911|4911.0||||||
4449589|NCT00090233|4273184|B1|Hispanic American||Race/Ethnicity||participants|Number|4963|4963.0||||||
4449590|NCT00090233|4273182|B3|White||Race/Ethnicity||participants|Number|47560|47560.0||||||
4449591|NCT00090233|4273183|B2|White||Race/Ethnicity||participants|Number|23788|23788.0||||||
4449592|NCT00090233|4273184|B1|White||Race/Ethnicity||participants|Number|23772|23772.0||||||
4449593|NCT00090233|4273182|B3||Male|Sex: Female, Male||Participants|Count of Participants|35115|35115.0||||||
4449594|NCT00090233|4273183|B2||Male|Sex: Female, Male||Participants|Count of Participants|17529|17529.0||||||
4449595|NCT00090233|4273184|B1||Male|Sex: Female, Male||Participants|Count of Participants|17586|17586.0||||||
4449596|NCT00090233|4273182|B3||Female|Sex: Female, Male||Participants|Count of Participants|34159|34159.0||||||
4449597|NCT00090233|4273183|B2||Female|Sex: Female, Male||Participants|Count of Participants|17101|17101.0||||||
4449598|NCT00090233|4273184|B1||Female|Sex: Female, Male||Participants|Count of Participants|17058|17058.0||||||
4449599|NCT00090233|4273182|B3|Over 12 Weeks of Age||Age, Customized|The eligibility for this study was to enroll infants 6-12 weeks of age; however infants that were 5 weeks and under, and infants who were 12 weeks and over were inadvertently enrolled outside these ranges. Those infants who received at least 1 dose of study vaccine, were followed for safety.|Participants|Number|191|191.0||||||
4449600|NCT00090233|4273183|B2|Over 12 Weeks of Age||Age, Customized|The eligibility for this study was to enroll infants 6-12 weeks of age; however infants that were 5 weeks and under, and infants who were 12 weeks and over were inadvertently enrolled outside these ranges. Those infants who received at least 1 dose of study vaccine, were followed for safety.|Participants|Number|99|99.0||||||
4449601|NCT00090233|4273184|B1|Over 12 Weeks of Age||Age, Customized|The eligibility for this study was to enroll infants 6-12 weeks of age; however infants that were 5 weeks and under, and infants who were 12 weeks and over were inadvertently enrolled outside these ranges. Those infants who received at least 1 dose of study vaccine, were followed for safety.|Participants|Number|92|92.0||||||
4449602|NCT00090233|4273182|B3|6 to 12 Weeks of Age||Age, Customized|The eligibility for this study was to enroll infants 6-12 weeks of age; however infants that were 5 weeks and under, and infants who were 12 weeks and over were inadvertently enrolled outside these ranges. Those infants who received at least 1 dose of study vaccine, were followed for safety.|Participants|Number|69078|69078.0||||||
4449603|NCT00090233|4273183|B2|6 to 12 Weeks of Age||Age, Customized|The eligibility for this study was to enroll infants 6-12 weeks of age; however infants that were 5 weeks and under, and infants who were 12 weeks and over were inadvertently enrolled outside these ranges. Those infants who received at least 1 dose of study vaccine, were followed for safety.|Participants|Number|34527|34527.0||||||
4449654|NCT00090402|4273307|B3|||Age||years|Mean|76.7|76.7|Standard Deviation|10.6|10.6|||
4449655|NCT00090402|4273308|B2|||Age||years|Mean|75.9|75.9|Standard Deviation|8.1|8.1|||
4449604|NCT00090233|4273184|B1|6 to 12 Weeks of Age||Age, Customized|The eligibility for this study was to enroll infants 6-12 weeks of age; however infants that were 5 weeks and under, and infants who were 12 weeks and over were inadvertently enrolled outside these ranges. Those infants who received at least 1 dose of study vaccine, were followed for safety.|Participants|Number|34551|34551.0||||||
4449605|NCT00090233|4273182|B3|5 Weeks of Age and Under||Age, Customized|The eligibility for this study was to enroll infants 6-12 weeks of age; however infants that were 5 weeks and under, and infants who were 12 weeks and over were inadvertently enrolled outside these ranges. Those infants who received at least 1 dose of study vaccine, were followed for safety.|Participants|Number|5|5.0||||||
4449606|NCT00090233|4273183|B2|5 Weeks of Age and Under||Age, Customized|The eligibility for this study was to enroll infants 6-12 weeks of age; however infants that were 5 weeks and under, and infants who were 12 weeks and over were inadvertently enrolled outside these ranges. Those infants who received at least 1 dose of study vaccine, were followed for safety.|Participants|Number|4|4.0||||||
4449607|NCT00090233|4273184|B1|5 Weeks of Age and Under||Age, Customized|The eligibility for this study was to enroll infants 6-12 weeks of age; however infants that were 5 weeks and under, and infants who were 12 weeks and over were inadvertently enrolled outside these ranges. Those infants who received at least 1 dose of study vaccine, were followed for safety.|Participants|Number|1|1.0||||||
4449608|NCT00090220|4273207|B3|Polynesian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4449609|NCT00090220|4273208|B2|Polynesian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4449610|NCT00090220|4273209|B1|Polynesian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4449611|NCT00090220|4273207|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4449612|NCT00090220|4273208|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4449613|NCT00090220|4273209|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4449614|NCT00090220|4273207|B3|White||Race/Ethnicity, Customized||participants|Number|785|785.0||||||
4449615|NCT00090220|4273208|B2|White||Race/Ethnicity, Customized||participants|Number|397|397.0||||||
4449616|NCT00090220|4273209|B1|White||Race/Ethnicity, Customized||participants|Number|388|388.0||||||
4449617|NCT00090220|4273207|B3|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4449618|NCT00090220|4273208|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4449619|NCT00090220|4273209|B1|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4449620|NCT00090220|4273207|B3|Hispanic American||Race/Ethnicity, Customized||participants|Number|1649|1649.0||||||
4449621|NCT00090220|4273208|B2|Hispanic American||Race/Ethnicity, Customized||participants|Number|827|827.0||||||
4449622|NCT00090220|4273209|B1|Hispanic American||Race/Ethnicity, Customized||participants|Number|822|822.0||||||
4449623|NCT00090220|4273207|B3|Black||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
4449624|NCT00090220|4273208|B2|Black||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4449625|NCT00090220|4273209|B1|Black||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4449626|NCT00090220|4273207|B3|Asian||Race/Ethnicity, Customized||participants|Number|1192|1192.0||||||
4449627|NCT00090220|4273208|B2|Asian||Race/Ethnicity, Customized||participants|Number|596|596.0||||||
4449628|NCT00090220|4273209|B1|Asian||Race/Ethnicity, Customized||participants|Number|596|596.0||||||
4449629|NCT00090220|4273207|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449630|NCT00090220|4273208|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449631|NCT00090220|4273209|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449632|NCT00090220|4273207|B3||Female|Sex: Female, Male||Participants|Count of Participants|3819|3819.0||||||
4449633|NCT00090220|4273208|B2||Female|Sex: Female, Male||Participants|Count of Participants|1908|1908.0||||||
4449634|NCT00090220|4273209|B1||Female|Sex: Female, Male||Participants|Count of Participants|1911|1911.0||||||
4449635|NCT00090220|4273207|B3|||Age|Although the upper age limit for this study was 45 years old, one subject 46 years of age was randomized into the study.|Years|Median|34|34.0|Full Range|||21.0|46.0|
4449636|NCT00090220|4273208|B2|||Age|Although the upper age limit for this study was 45 years old, one subject 46 years of age was randomized into the study.|Years|Median|34|34.0|Full Range|||21.0|46.0|
4449637|NCT00090220|4273209|B1|||Age|Although the upper age limit for this study was 45 years old, one subject 46 years of age was randomized into the study.|Years|Median|35|35.0|Full Range|||24.0|45.0|
4449638|NCT00090220|4273207|B3|||Age||years|Mean|34.3|34.3|Standard Deviation|6.3|6.3|||
4449639|NCT00090220|4273208|B2|||Age||years|Mean|34.3|34.3|Standard Deviation|6.3|6.3|||
4449640|NCT00090220|4273209|B1|||Age||years|Mean|34.3|34.3|Standard Deviation|6.3|6.3|||
4449641|NCT00090402|4273306|B4|United States||Region of Enrollment||participants|Number|39|39.0||||||
4449642|NCT00090402|4273307|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4449643|NCT00090402|4273308|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4449644|NCT00090402|4273309|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4449645|NCT00090402|4273306|B4||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4449646|NCT00090402|4273307|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4449647|NCT00090402|4273308|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4449648|NCT00090402|4273309|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4449649|NCT00090402|4273306|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4449650|NCT00090402|4273307|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4449651|NCT00090402|4273308|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4449652|NCT00090402|4273309|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4449653|NCT00090402|4273306|B4|||Age||years|Mean|75.9|75.9|Standard Deviation|9.7|9.7|||
4449656|NCT00090402|4273309|B1|||Age||years|Mean|75.2|75.2|Standard Deviation|10.8|10.8|||
4449657|NCT00090402|4273306|B4||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4449658|NCT00090402|4273307|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4449659|NCT00090402|4273308|B2||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4449660|NCT00090402|4273309|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4449661|NCT00090402|4273306|B4||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4449662|NCT00090402|4273307|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4449663|NCT00090402|4273308|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4449664|NCT00090402|4273309|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4449665|NCT00090402|4273306|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449666|NCT00090402|4273307|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449667|NCT00090402|4273308|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449668|NCT00090402|4273309|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449669|NCT00090142|4273325|B1|||Time to recovery from maximal percent fall|The duration between the time at which the maximum percent fall in FEV1 occurs and the time when FEV1 returns to within 5% of the preexercise baseline for the first time.|Minutes|Mean|44.73|44.73|Standard Deviation|32.23|32.23|||
4449670|NCT00090142|4273325|B1|||Maximum percent fall in Forced Expiratory Volume in 1 second (FEV1) post-exercise challenge|Maximum percent fall in FEV1 from pre-exercise measurement occurring within the first 60 minutes after exercise challenge. Pre-exercise measurement FEV1 is the value [in liters (L)] measured on the day of the exercise challenge, 5 minutes before exercise testing.|percent change from pre-exercise measure|Mean|26.86|26.86|Standard Deviation|7.04|7.04|||
4449671|NCT00090142|4273325|B1|||AUC for percent change from pre-exercise measurement FEV1 in L 0-60 mins after exercise challenge|Area under the curve (AUC) for FEV1 percent change from pre-exercise measurement over the first hour after exercise challenge.|(percent change) *minutes|Mean|815.27|815.27|Standard Deviation|516.83|516.83|||
4449672|NCT00090142|4273325|B1|Yes||Need for β-agonist rescue medication following exercise challenge||Participants|Number|15|15.0||||||
4449673|NCT00090142|4273325|B1|No||Need for β-agonist rescue medication following exercise challenge||Participants|Number|47|47.0||||||
4449674|NCT00090142|4273325|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4449675|NCT00090142|4273325|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4449676|NCT00090142|4273325|B1|||Age||years|Mean|24.4|24.4|Standard Deviation|6.9|6.9|||
4449677|NCT00090103|4273354|B4|Unknown||Race/Ethnicity, Customized||participants|Number|50|50.0||||||
4449678|NCT00090103|4273355|B3|Unknown||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4449679|NCT00090103|4273356|B2|Unknown||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4449680|NCT00090103|4273357|B1|Unknown||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4449681|NCT00090103|4273354|B4|American Hispanic||Race/Ethnicity, Customized||participants|Number|147|147.0||||||
4449682|NCT00090103|4273355|B3|American Hispanic||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4449683|NCT00090103|4273356|B2|American Hispanic||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4449684|NCT00090103|4273357|B1|American Hispanic||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4449685|NCT00090103|4273354|B4|Asian||Race/Ethnicity, Customized||participants|Number|325|325.0||||||
4449686|NCT00090103|4273355|B3|Asian||Race/Ethnicity, Customized||participants|Number|112|112.0||||||
4449687|NCT00090103|4273356|B2|Asian||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4449688|NCT00090103|4273357|B1|Asian||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
4449689|NCT00090103|4273354|B4|Black||Race/Ethnicity, Customized||participants|Number|63|63.0||||||
4449690|NCT00090103|4273355|B3|Black||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4449691|NCT00090103|4273356|B2|Black||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4449692|NCT00090103|4273357|B1|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4449693|NCT00090103|4273354|B4|White||Race/Ethnicity, Customized||participants|Number|4259|4259.0||||||
4449694|NCT00090103|4273355|B3|White||Race/Ethnicity, Customized||participants|Number|1405|1405.0||||||
4449695|NCT00090103|4273356|B2|White||Race/Ethnicity, Customized||participants|Number|1433|1433.0||||||
4449696|NCT00090103|4273357|B1|White||Race/Ethnicity, Customized||participants|Number|1421|1421.0||||||
4449697|NCT00090103|4273354|B4||Male|Gender||Participants|Count of Participants|4844|4844.0||||||
4449698|NCT00090103|4273355|B3||Male|Gender||Participants|Count of Participants|1611|1611.0||||||
4449699|NCT00090103|4273356|B2||Male|Gender||Participants|Count of Participants|1623|1623.0||||||
4449700|NCT00090103|4273357|B1||Male|Gender||Participants|Count of Participants|1610|1610.0||||||
4449701|NCT00090103|4273354|B4||Female|Gender||Participants|Count of Participants|0|0.0||||||
4449702|NCT00090103|4273355|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4449703|NCT00090103|4273356|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4449704|NCT00090103|4273357|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4449705|NCT00090103|4273354|B4|||Age||years|Mean|66.1|66.1|Standard Deviation|7.01|7.01|||
4449706|NCT00090103|4273355|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|7.00|7.0|||
4449707|NCT00090103|4273356|B2|||Age||years|Mean|66.0|66.0|Standard Deviation|6.99|6.99|||
4449708|NCT00090103|4273357|B1|||Age||years|Mean|66.0|66.0|Standard Deviation|7.05|7.05|||
4449709|NCT00090051|4273457|B3||Male|Sex: Female, Male||Participants|Count of Participants|368|368.0||||||
4449710|NCT00090051|4273458|B2||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4449711|NCT00090051|4273459|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4449712|NCT00090051|4273457|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4449713|NCT00090051|4273458|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4449714|NCT00090051|4273459|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4449715|NCT00090051|4273457|B3|||Age||Years|Mean|61.7|61.7|Standard Deviation|9.14|9.14|||
4449716|NCT00090051|4273458|B2|||Age||Years|Mean|62.1|62.1|Standard Deviation|9.17|9.17|||
4449717|NCT00090051|4273459|B1|||Age||Years|Mean|61.3|61.3|Standard Deviation|9.11|9.11|||
4449718|NCT00003224|4273494|B7|United States||Region of Enrollment||participants|Number|22|22.0||||||
4449719|NCT00003224|4273495|B6|United States||Region of Enrollment||participants|Number|3|3.0||||||
4449720|NCT00003224|4273496|B5|United States||Region of Enrollment||participants|Number|4|4.0||||||
4449721|NCT00003224|4273497|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4449722|NCT00003224|4273498|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4449723|NCT00003224|4273499|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4449724|NCT00003224|4273500|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4449725|NCT00003224|4273494|B7||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4449726|NCT00003224|4273495|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4449727|NCT00003224|4273496|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4449728|NCT00003224|4273497|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4449729|NCT00003224|4273498|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4449730|NCT00003224|4273499|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4449731|NCT00003224|4273500|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4449732|NCT00003224|4273494|B7||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4449733|NCT00003224|4273495|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4449734|NCT00003224|4273496|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4449735|NCT00003224|4273497|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4449736|NCT00003224|4273498|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4449737|NCT00003224|4273499|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4449738|NCT00003224|4273500|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4449739|NCT00003224|4273494|B7|||Age||years|Mean|55.6|55.6|Standard Deviation|16.1|16.1|||
4449740|NCT00003224|4273495|B6|||Age||years|Mean|69.3|69.3|Standard Deviation|7.5|7.5|||
4449741|NCT00003224|4273496|B5|||Age||years|Mean|51.8|51.8|Standard Deviation|14.9|14.9|||
4449742|NCT00003224|4273497|B4|||Age||years|Mean|59.5|59.5|Standard Deviation|17.7|17.7|||
4449743|NCT00003224|4273498|B3|||Age||years|Mean|44.3|44.3|Standard Deviation|16.8|16.8|||
4449744|NCT00003224|4273499|B2|||Age||years|Mean|59.6|59.6|Standard Deviation|18.6|18.6|||
4449745|NCT00003224|4273500|B1|||Age||years|Mean|53.8|53.8|Standard Deviation|17.1|17.1|||
4449746|NCT00003224|4273494|B7||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4449747|NCT00003224|4273495|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4449748|NCT00003224|4273496|B5||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4449749|NCT00003224|4273497|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4449750|NCT00003224|4273498|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4449751|NCT00003224|4273499|B2||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4449752|NCT00003224|4273500|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4449753|NCT00003224|4273494|B7||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4449754|NCT00003224|4273495|B6||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4449755|NCT00003224|4273496|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4449756|NCT00003224|4273497|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4449757|NCT00003224|4273498|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4449758|NCT00003224|4273499|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4449759|NCT00003224|4273500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4449760|NCT00003224|4273494|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449761|NCT00003224|4273495|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449762|NCT00003224|4273496|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449763|NCT00003224|4273497|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449764|NCT00003224|4273498|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449765|NCT00003224|4273499|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449766|NCT00003224|4273500|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449767|NCT00089999|4273523|B3|American Hispanic||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
4449768|NCT00089999|4273524|B2|American Hispanic||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4449769|NCT00089999|4273525|B1|American Hispanic||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4449770|NCT00089999|4273523|B3|Asian||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
4449771|NCT00089999|4273524|B2|Asian||Race/Ethnicity, Customized||Participants|Number|35|35.0||||||
4449772|NCT00089999|4273525|B1|Asian||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4449773|NCT00089999|4273523|B3|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449774|NCT00089999|4273524|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449775|NCT00089999|4273525|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449776|NCT00089999|4273523|B3|White||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4449777|NCT00089999|4273524|B2|White||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449778|NCT00089999|4273525|B1|White||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4449779|NCT00089999|4273523|B3||Male|Gender||Participants|Count of Participants|0|0.0||||||
4449780|NCT00089999|4273524|B2||Male|Gender||Participants|Count of Participants|0|0.0||||||
4449781|NCT00089999|4273525|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4449782|NCT00089999|4273523|B3||Female|Gender||Participants|Count of Participants|138|138.0||||||
4449783|NCT00089999|4273524|B2||Female|Gender||Participants|Count of Participants|69|69.0||||||
4449784|NCT00089999|4273525|B1||Female|Gender||Participants|Count of Participants|69|69.0||||||
4449785|NCT00089999|4273523|B3|||Age||Years|Mean|53.3|53.3|Standard Deviation|13.92|13.92|||
4449786|NCT00089999|4273524|B2|||Age||Years|Mean|53.4|53.4|Standard Deviation|13.66|13.66|||
4449787|NCT00089999|4273525|B1|||Age||Years|Mean|53.2|53.2|Standard Deviation|14.27|14.27|||
4449788|NCT00089986|4273546|B4|Missing||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4449789|NCT00089986|4273547|B3|Missing||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4449790|NCT00089986|4273548|B2|Missing||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4449791|NCT00089986|4273549|B1|Missing||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4449792|NCT00089986|4273546|B4|Native Hawaiian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4449793|NCT00089986|4273547|B3|Native Hawaiian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449794|NCT00089986|4273548|B2|Native Hawaiian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449795|NCT00089986|4273549|B1|Native Hawaiian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4449796|NCT00089986|4273546|B4|American Indian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4449797|NCT00089986|4273547|B3|American Indian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449798|NCT00089986|4273548|B2|American Indian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4449799|NCT00089986|4273549|B1|American Indian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4449800|NCT00089986|4273546|B4|Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449801|NCT00089986|4273547|B3|Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449802|NCT00089986|4273548|B2|Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449803|NCT00089986|4273549|B1|Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449804|NCT00089986|4273546|B4|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|1139|1139.0||||||
4449805|NCT00089986|4273547|B3|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|161|161.0||||||
4449806|NCT00089986|4273548|B2|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|494|494.0||||||
4449807|NCT00089986|4273549|B1|White/Caucasian||Race/Ethnicity, Customized||Participants|Number|484|484.0||||||
4449808|NCT00089986|4273546|B4|South Asian||Race/Ethnicity, Customized||Participants|Number|63|63.0||||||
4449809|NCT00089986|4273547|B3|South Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4449810|NCT00089986|4273548|B2|South Asian||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4449811|NCT00089986|4273549|B1|South Asian||Race/Ethnicity, Customized||Participants|Number|29|29.0||||||
4449812|NCT00089986|4273546|B4|Japanese||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4449813|NCT00089986|4273547|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449814|NCT00089986|4273548|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4449815|NCT00089986|4273549|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4449816|NCT00089986|4273546|B4|East & South East Asian||Race/Ethnicity, Customized||Participants|Number|109|109.0||||||
4449817|NCT00089986|4273547|B3|East & South East Asian||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4449818|NCT00089986|4273548|B2|East & South East Asian||Race/Ethnicity, Customized||Participants|Number|44|44.0||||||
4449819|NCT00089986|4273549|B1|East & South East Asian||Race/Ethnicity, Customized||Participants|Number|51|51.0||||||
4449820|NCT00089986|4273546|B4|Black||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4449821|NCT00089986|4273547|B3|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4449822|NCT00089986|4273548|B2|Black||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4449823|NCT00089986|4273549|B1|Black||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4449824|NCT00089986|4273546|B4|Arabic/North African||Race/Ethnicity, Customized||Participants|Number|14|14.0||||||
4449825|NCT00089986|4273547|B3|Arabic/North African||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4449826|NCT00089986|4273548|B2|Arabic/North African||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4449827|NCT00089986|4273549|B1|Arabic/North African||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4449828|NCT00089986|4273546|B4||Male|Sex: Female, Male||Participants|Count of Participants|806|806.0||||||
4449829|NCT00089986|4273547|B3||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4449830|NCT00089986|4273548|B2||Male|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4449831|NCT00089986|4273549|B1||Male|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4449832|NCT00089986|4273546|B4||Female|Sex: Female, Male||Participants|Count of Participants|573|573.0||||||
4449833|NCT00089986|4273547|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4449834|NCT00089986|4273548|B2||Female|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4449835|NCT00089986|4273549|B1||Female|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4449836|NCT00089986|4273546|B4|||Age||Years|Mean|63.2|63.2|Standard Deviation|16.23|16.23|||
4449837|NCT00089986|4273547|B3|||Age||Years|Mean|64.8|64.8|Standard Deviation|15.47|15.47|||
4449838|NCT00089986|4273548|B2|||Age||Years|Mean|62.8|62.8|Standard Deviation|16.27|16.27|||
4449839|NCT00089986|4273549|B1|||Age||Years|Mean|63.1|63.1|Standard Deviation|16.41|16.41|||
4449840|NCT00089973|4273568|B1|White - White/Caucasian/European heritage||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4449841|NCT00089973|4273568|B1|White - Arabic/North African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4449842|NCT00089973|4273568|B1|Asian - South East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4449843|NCT00089973|4273568|B1|Asian - East Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4449844|NCT00089973|4273568|B1|Asian - Central/South Asian heritage||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4449845|NCT00089973|4273568|B1|African American/African heritage||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4449846|NCT00089973|4273568|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449847|NCT00089973|4273568|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4449848|NCT00089973|4273568|B1|||Age||Years|Mean|48.7|48.7|Standard Deviation|8.94|8.94|||
4449849|NCT00089895|4273581|B3||Male|Sex: Female, Male||Participants|Count of Participants|6431|6431.0||||||
4449850|NCT00089895|4273582|B2||Male|Sex: Female, Male||Participants|Count of Participants|3222|3222.0||||||
4449851|NCT00089895|4273583|B1||Male|Sex: Female, Male||Participants|Count of Participants|3209|3209.0||||||
4449852|NCT00089895|4273581|B3||Female|Sex: Female, Male||Participants|Count of Participants|2975|2975.0||||||
4449853|NCT00089895|4273582|B2||Female|Sex: Female, Male||Participants|Count of Participants|1462|1462.0||||||
4449854|NCT00089895|4273583|B1||Female|Sex: Female, Male||Participants|Count of Participants|1513|1513.0||||||
4449855|NCT00089895|4273581|B3|||Age||years|Mean|66.6|66.6|Standard Deviation|10.7|10.7|||
4449856|NCT00089895|4273582|B2|||Age||years|Mean|66.7|66.7|Standard Deviation|10.7|10.7|||
4449857|NCT00089895|4273583|B1|||Age||years|Mean|66.4|66.4|Standard Deviation|10.6|10.6|||
4449858|NCT00089843|4273592|B5|United States||Region of Enrollment||participants|Number|77|77.0||||||
4449859|NCT00089843|4273593|B4|United States||Region of Enrollment||participants|Number|18|18.0||||||
4449860|NCT00089843|4273594|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4449861|NCT00089843|4273595|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4449862|NCT00089843|4273596|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4449863|NCT00089843|4273592|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449864|NCT00089843|4273593|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449865|NCT00089843|4273594|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449866|NCT00089843|4273595|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449867|NCT00089843|4273596|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449868|NCT00089843|4273592|B5||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4449869|NCT00089843|4273593|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4449870|NCT00089843|4273594|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4449871|NCT00089843|4273595|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4449872|NCT00089843|4273596|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4449873|NCT00089843|4273592|B5|||Age||years|Mean|26.1|26.1|Standard Deviation|6.7|6.7|||
4449874|NCT00089843|4273593|B4|||Age||years|Mean|26.9|26.9|Standard Deviation|7.2|7.2|||
4449875|NCT00089843|4273594|B3|||Age||years|Mean|25.3|25.3|Standard Deviation|6.3|6.3|||
4449876|NCT00089843|4273595|B2|||Age||years|Mean|25.2|25.2|Standard Deviation|6.2|6.2|||
4449877|NCT00089843|4273596|B1|||Age||years|Mean|27.1|27.1|Standard Deviation|7.3|7.3|||
4449878|NCT00089843|4273592|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4449879|NCT00089843|4273593|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4449880|NCT00089843|4273594|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4449881|NCT00089843|4273595|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4449882|NCT00089843|4273596|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4449883|NCT00089843|4273592|B5||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4449884|NCT00089843|4273593|B4||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4449885|NCT00089843|4273594|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4449886|NCT00089843|4273595|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4449887|NCT00089843|4273596|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4449888|NCT00089843|4273592|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449889|NCT00089843|4273593|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449890|NCT00089843|4273594|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449891|NCT00089843|4273595|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449892|NCT00089843|4273596|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449893|NCT00089791|4273609|B3|Other||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4449894|NCT00089791|4273610|B2|Other||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4449895|NCT00089791|4273611|B1|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4449956|NCT00089778|4273643|B4||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4449896|NCT00089791|4273609|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4449897|NCT00089791|4273610|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4449898|NCT00089791|4273611|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4449899|NCT00089791|4273609|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4449900|NCT00089791|4273610|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4449901|NCT00089791|4273611|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4449902|NCT00089791|4273609|B3|Asian||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4449903|NCT00089791|4273610|B2|Asian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4449904|NCT00089791|4273611|B1|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4449905|NCT00089791|4273609|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|473|473.0||||||
4449906|NCT00089791|4273610|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|241|241.0||||||
4449907|NCT00089791|4273611|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|232|232.0||||||
4449908|NCT00089791|4273609|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4449909|NCT00089791|4273610|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4449910|NCT00089791|4273611|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|27|27.0||||||
4449911|NCT00089791|4273609|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|7238|7238.0||||||
4449912|NCT00089791|4273610|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|3609|3609.0||||||
4449913|NCT00089791|4273611|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|3629|3629.0||||||
4449914|NCT00089791|4273609|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449915|NCT00089791|4273610|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449916|NCT00089791|4273611|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449917|NCT00089791|4273609|B3||Female|Sex: Female, Male||Participants|Count of Participants|7808|7808.0||||||
4449918|NCT00089791|4273610|B2||Female|Sex: Female, Male||Participants|Count of Participants|3902|3902.0||||||
4449919|NCT00089791|4273611|B1||Female|Sex: Female, Male||Participants|Count of Participants|3906|3906.0||||||
4449920|NCT00089791|4273609|B3|||Age||Years|Mean|72.3|72.3|Standard Deviation|5.2|5.2|||
4449921|NCT00089791|4273610|B2|||Age||Years|Mean|72.3|72.3|Standard Deviation|5.2|5.2|||
4449922|NCT00089791|4273611|B1|||Age||Years|Mean|72.3|72.3|Standard Deviation|5.2|5.2|||
4449923|NCT00089752|4273622|B3|Canada||Region of Enrollment||participants|Number|103|103.0||||||
4449924|NCT00089752|4273623|B2|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4449925|NCT00089752|4273624|B1|Canada||Region of Enrollment||participants|Number|53|53.0||||||
4449926|NCT00089752|4273622|B3|United States||Region of Enrollment||participants|Number|136|136.0||||||
4449927|NCT00089752|4273623|B2|United States||Region of Enrollment||participants|Number|68|68.0||||||
4449928|NCT00089752|4273624|B1|United States||Region of Enrollment||participants|Number|68|68.0||||||
4449929|NCT00089752|4273622|B3||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4449930|NCT00089752|4273623|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4449931|NCT00089752|4273624|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4449932|NCT00089752|4273622|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4449933|NCT00089752|4273623|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4449934|NCT00089752|4273624|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4449935|NCT00089752|4273622|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4449936|NCT00089752|4273623|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4449937|NCT00089752|4273624|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4449938|NCT00089752|4273622|B3||Between 18 and 65 years|Age||Participants|Count of Participants|228|228.0||||||
4449939|NCT00089752|4273623|B2||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4449940|NCT00089752|4273624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|116|116.0||||||
4449941|NCT00089752|4273622|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449942|NCT00089752|4273623|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449943|NCT00089752|4273624|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4449944|NCT00089778|4273643|B4|United States||Region of Enrollment||participants|Number|11|11.0||||||
4449945|NCT00089778|4273644|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4449946|NCT00089778|4273645|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4449947|NCT00089778|4273646|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4449948|NCT00089778|4273643|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449949|NCT00089778|4273644|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449950|NCT00089778|4273645|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449951|NCT00089778|4273646|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449952|NCT00089778|4273643|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449953|NCT00089778|4273644|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449954|NCT00089778|4273645|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449955|NCT00089778|4273646|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449957|NCT00089778|4273644|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4449958|NCT00089778|4273645|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4449959|NCT00089778|4273646|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4449960|NCT00089778|4273643|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449961|NCT00089778|4273644|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449962|NCT00089778|4273645|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449963|NCT00089778|4273646|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449964|NCT00089778|4273643|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449965|NCT00089778|4273644|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449966|NCT00089778|4273645|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449967|NCT00089778|4273646|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449968|NCT00089778|4273643|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449969|NCT00089778|4273644|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449970|NCT00089778|4273645|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449971|NCT00089778|4273646|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449972|NCT00089778|4273643|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449973|NCT00089778|4273644|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449974|NCT00089778|4273645|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449975|NCT00089778|4273646|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449976|NCT00089778|4273643|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449977|NCT00089778|4273644|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449978|NCT00089778|4273645|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449979|NCT00089778|4273646|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449980|NCT00089778|4273643|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4449981|NCT00089778|4273644|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4449982|NCT00089778|4273645|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4449983|NCT00089778|4273646|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4449984|NCT00089778|4273643|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449985|NCT00089778|4273644|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449986|NCT00089778|4273645|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449987|NCT00089778|4273646|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4449988|NCT00089778|4273643|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4449989|NCT00089778|4273644|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4449990|NCT00089778|4273645|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4449991|NCT00089778|4273646|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4449992|NCT00089778|4273643|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4449993|NCT00089778|4273644|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4449994|NCT00089778|4273645|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449995|NCT00089778|4273646|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4449996|NCT00089778|4273643|B4|||Age||years|Mean|55.93|55.93|Standard Deviation|2.5|2.5|||
4449997|NCT00089778|4273644|B3|||Age||years|Mean|58.8|58.8|Standard Deviation|4.7|4.7|||
4449998|NCT00089778|4273645|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|0.0|0.0|||
4449999|NCT00089778|4273646|B1|||Age||years|Mean|55.0|55.0|Standard Deviation|2.8|2.8|||
4450000|NCT00089778|4273643|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4450001|NCT00089778|4273644|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4450002|NCT00089778|4273645|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4450003|NCT00089778|4273646|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4450004|NCT00089778|4273643|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4450005|NCT00089778|4273644|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4450006|NCT00089778|4273645|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4450007|NCT00089778|4273646|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4450008|NCT00089778|4273643|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450009|NCT00089778|4273644|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450010|NCT00089778|4273645|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450011|NCT00089778|4273646|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450012|NCT00089674|4273659|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|158|158.0||||||
4450013|NCT00089674|4273660|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|77|77.0||||||
4450014|NCT00089674|4273661|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|81|81.0||||||
4450015|NCT00089674|4273659|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|68|68.0||||||
4450016|NCT00089674|4273660|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4450017|NCT00089674|4273661|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|32|32.0||||||
4450018|NCT00089674|4273659|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|1224|1224.0||||||
4450019|NCT00089674|4273660|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|615|615.0||||||
4450020|NCT00089674|4273661|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|609|609.0||||||
4450021|NCT00089674|4273659|B3|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4450022|NCT00089674|4273660|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4450023|NCT00089674|4273661|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4450024|NCT00089674|4273659|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4450025|NCT00089674|4273660|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4450026|NCT00089674|4273661|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4450027|NCT00089674|4273659|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4450028|NCT00089674|4273660|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4450029|NCT00089674|4273661|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4450030|NCT00089674|4273659|B3|Asian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4450031|NCT00089674|4273660|B2|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4450032|NCT00089674|4273661|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4450033|NCT00089674|4273659|B3||Male|Sex: Female, Male||Participants|Count of Participants|1468|1468.0||||||
4450034|NCT00089674|4273660|B2||Male|Sex: Female, Male||Participants|Count of Participants|734|734.0||||||
4450035|NCT00089674|4273661|B1||Male|Sex: Female, Male||Participants|Count of Participants|734|734.0||||||
4450036|NCT00089674|4273659|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450037|NCT00089674|4273660|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450038|NCT00089674|4273661|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450039|NCT00089674|4273659|B3|||Age||Years|Mean|75.4|75.4|Standard Deviation|7.1|7.1|||
4450040|NCT00089674|4273660|B2|||Age||Years|Mean|75.3|75.3|Standard Deviation|7|7.0|||
4450041|NCT00089674|4273661|B1|||Age||Years|Mean|75.5|75.5|Standard Deviation|7.1|7.1|||
4450042|NCT00089661|4273686|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450043|NCT00089661|4273687|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450044|NCT00089661|4273688|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450045|NCT00089661|4273686|B3||Female|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4450046|NCT00089661|4273687|B2||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4450047|NCT00089661|4273688|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4450048|NCT00089661|4273686|B3|||Age||Years|Mean|59.5|59.5|Standard Deviation|9.3|9.3|||
4450049|NCT00089661|4273687|B2|||Age||Years|Mean|59.7|59.7|Standard Deviation|9.7|9.7|||
4450050|NCT00089661|4273688|B1|||Age||Years|Mean|59.2|59.2|Standard Deviation|8.9|8.9|||
4450051|NCT00089648|4273705|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4450052|NCT00089648|4273705|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4450053|NCT00089648|4273705|B1|> = 65 years||Age, Customized||participants|Number|18|18.0||||||
4450054|NCT00089648|4273705|B1|< 65 years||Age, Customized||participants|Number|43|43.0||||||
4450055|NCT00089635|4273721|B1|White or Caucasian||Race/Ethnicity, Customized||participants|Number|151|151.0||||||
4450056|NCT00089635|4273721|B1|Hispanic or Latino||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4450057|NCT00089635|4273721|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4450058|NCT00089635|4273721|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4450059|NCT00089635|4273721|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4450060|NCT00089635|4273721|B1||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4450061|NCT00089635|4273721|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4450062|NCT00089635|4273721|B1|||Age||years|Median|62|62.0|Inter-Quartile Range|||54.0|68.0|
4450063|NCT00089583|4273733|B3|>=13 yrs; not reported||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|2|2.0||||||
4450064|NCT00089583|4273734|B2|>=13 yrs; not reported||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|2|2.0||||||
4450122|NCT00089609|4273830|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4450065|NCT00089583|4273735|B1|>=13 yrs; not reported||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|0|0.0||||||
4450066|NCT00089583|4273733|B3|>=13 yrs; AIDS||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|5|5.0||||||
4450067|NCT00089583|4273734|B2|>=13 yrs; AIDS||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|5|5.0||||||
4450068|NCT00089583|4273735|B1|>=13 yrs; AIDS||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|0|0.0||||||
4450069|NCT00089583|4273733|B3|>=13 yrs; asymptomatic, not AIDS||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|14|14.0||||||
4450070|NCT00089583|4273734|B2|>=13 yrs; asymptomatic, not AIDS||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|14|14.0||||||
4450071|NCT00089583|4273735|B1|>=13 yrs; asymptomatic, not AIDS||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|0|0.0||||||
4450072|NCT00089583|4273733|B3|>=13 yrs; asymptomatic/lymphadenopathy/acute HIV||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|12|12.0||||||
4450073|NCT00089583|4273734|B2|>=13 yrs; asymptomatic/lymphadenopathy/acute HIV||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|12|12.0||||||
4450123|NCT00089609|4273828|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4450124|NCT00089609|4273829|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4450125|NCT00089609|4273830|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4450126|NCT00089609|4273828|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450074|NCT00089583|4273735|B1|>=13 yrs; asymptomatic/lymphadenopathy/acute HIV||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|0|0.0||||||
4450075|NCT00089583|4273733|B3|<13 yrs; non-S||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|6|6.0||||||
4450076|NCT00089583|4273734|B2|<13 yrs; non-S||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|5|5.0||||||
4450077|NCT00089583|4273735|B1|<13 yrs; non-S||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|1|1.0||||||
4450078|NCT00089583|4273733|B3|<13 yrs; severely S||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|10|10.0||||||
4450079|NCT00089583|4273734|B2|<13 yrs; severely S||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|10|10.0||||||
4450080|NCT00089583|4273735|B1|<13 yrs; severely S||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|0|0.0||||||
4450081|NCT00089583|4273733|B3|<13 yrs; moderately S||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|16|16.0||||||
4450082|NCT00089583|4273734|B2|<13 yrs; moderately S||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|15|15.0||||||
4450127|NCT00089609|4273829|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450128|NCT00089609|4273830|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450129|NCT00089609|4273828|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450130|NCT00089609|4273829|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450131|NCT00089609|4273830|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450083|NCT00089583|4273735|B1|<13 yrs; moderately S||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|1|1.0||||||
4450084|NCT00089583|4273733|B3|<13 years (yrs); mildly symptomatic (S)||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|44|44.0||||||
4450085|NCT00089583|4273734|B2|<13 years (yrs); mildly symptomatic (S)||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|26|26.0||||||
4450086|NCT00089583|4273735|B1|<13 years (yrs); mildly symptomatic (S)||Par with the Indicated 1993 Center for Disease Control and Prevention (CDC) Baseline Classification|The adult/adolescent (>=13 years) HIV infection CDC classification system was based on 3 categories (Cat). Cat A, asymptomatic acute/primary HIV infection or persistent generalized lymphadenopathy. Cat B, symptomatic conditions not included in Cat A or C but attributed to a cell-mediated immunity defect or for which the clinical course or management was complicated by HIV infection. Cat C, acquired immune deficiency syndrome (AIDS)-defining conditions. Infected children (<13 years) are classified into mutually exclusive categories per 3 parameters: infection, clinical, and immunologic status.|participants|Number|18|18.0||||||
4450087|NCT00089583|4273733|B3|Race Not Specified||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4450088|NCT00089583|4273734|B2|Race Not Specified||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4450089|NCT00089583|4273735|B1|Race Not Specified||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4450090|NCT00089583|4273733|B3|White/Caucasian||Race/Ethnicity, Customized||participants|Number|60|60.0||||||
4450091|NCT00089583|4273734|B2|White/Caucasian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4450092|NCT00089583|4273735|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4450093|NCT00089583|4273733|B3|South Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4450094|NCT00089583|4273734|B2|South Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4450095|NCT00089583|4273735|B1|South Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4450096|NCT00089583|4273733|B3|Black||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4450097|NCT00089583|4273734|B2|Black||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4450098|NCT00089583|4273735|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4450099|NCT00089583|4273733|B3|Arabic/North African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4450100|NCT00089583|4273734|B2|Arabic/North African||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4450101|NCT00089583|4273735|B1|Arabic/North African||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4450102|NCT00089583|4273733|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4450103|NCT00089583|4273734|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4450104|NCT00089583|4273735|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4450105|NCT00089583|4273733|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4450106|NCT00089583|4273734|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4450107|NCT00089583|4273735|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4450108|NCT00089583|4273733|B3|||Age||Years|Mean|8.7|8.7|Standard Deviation|4.93|4.93|||
4450109|NCT00089583|4273734|B2|||Age||Years|Mean|10.0|10.0|Standard Deviation|4.49|4.49|||
4450110|NCT00089583|4273735|B1|||Age||Years|Mean|2.9|2.9|Standard Deviation|1.07|1.07|||
4450111|NCT00089609|4273828|B3|United States||Region of Enrollment||Participants|Count of Participants|73|73.0||||||
4450112|NCT00089609|4273829|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4450113|NCT00089609|4273830|B1|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4450114|NCT00089609|4273828|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450115|NCT00089609|4273829|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450116|NCT00089609|4273830|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450117|NCT00089609|4273828|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450118|NCT00089609|4273829|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450119|NCT00089609|4273830|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450120|NCT00089609|4273828|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4450121|NCT00089609|4273829|B2||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4450132|NCT00089609|4273828|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450133|NCT00089609|4273829|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450134|NCT00089609|4273830|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450135|NCT00089609|4273828|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4450136|NCT00089609|4273829|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450137|NCT00089609|4273830|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4450138|NCT00089609|4273828|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4450139|NCT00089609|4273829|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4450140|NCT00089609|4273830|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4450141|NCT00089609|4273828|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4450142|NCT00089609|4273829|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4450143|NCT00089609|4273830|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4450144|NCT00089609|4273828|B3||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4450145|NCT00089609|4273829|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4450146|NCT00089609|4273830|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4450147|NCT00089609|4273828|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450148|NCT00089609|4273829|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450149|NCT00089609|4273830|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450150|NCT00089609|4273828|B3|||Age||years|Mean|64.98|64.98|Standard Deviation|7.96|7.96|||
4450151|NCT00089609|4273829|B2|||Age||years|Mean|63.31|63.31|Standard Deviation|8.74|8.74|||
4450152|NCT00089609|4273830|B1|||Age||years|Mean|65.35|65.35|Standard Deviation|7.81|7.81|||
4450153|NCT00089609|4273828|B3||>=65 years|Age||Participants|Count of Participants|36|36.0||||||
4450154|NCT00089609|4273829|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4450155|NCT00089609|4273830|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4450156|NCT00089609|4273828|B3||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4450157|NCT00089609|4273829|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4450158|NCT00089609|4273830|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4450159|NCT00089609|4273828|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450160|NCT00089609|4273829|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450161|NCT00089609|4273830|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450162|NCT00089544|4273848|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4450163|NCT00089544|4273849|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4450164|NCT00089544|4273850|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4450165|NCT00089544|4273848|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4450166|NCT00089544|4273849|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4450167|NCT00089544|4273850|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4450168|NCT00089544|4273848|B3|||Age||years|Median|48|48.0|Full Range|||20.0|81.0|
4450169|NCT00089544|4273849|B2|||Age||years|Median|47.0|47.0|Full Range|||39.0|81.0|
4450170|NCT00089544|4273850|B1|||Age||years|Median|49.0|49.0|Full Range|||20.0|75.0|
4450171|NCT00089505|4273861|B5|Clinical stage IV||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|24|24.0||||||
4450172|NCT00089505|4273862|B4|Clinical stage IV||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|11|11.0||||||
4450173|NCT00089505|4273863|B3|Clinical stage IV||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|7|7.0||||||
4450174|NCT00089505|4273864|B2|Clinical stage IV||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|1|1.0||||||
4450227|NCT00089505|4273862|B4|>=350 cells/mm^3||CD4 count Categorical||participants|Number|2|2.0||||||
4450228|NCT00089505|4273863|B3|>=350 cells/mm^3||CD4 count Categorical||participants|Number|2|2.0||||||
4450175|NCT00089505|4273865|B1|Clinical stage IV||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|5|5.0||||||
4450176|NCT00089505|4273861|B5|Clinical stage III||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|208|208.0||||||
4450177|NCT00089505|4273862|B4|Clinical stage III||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|80|80.0||||||
4450178|NCT00089505|4273863|B3|Clinical stage III||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|73|73.0||||||
4450179|NCT00089505|4273864|B2|Clinical stage III||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|25|25.0||||||
4450180|NCT00089505|4273865|B1|Clinical stage III||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|30|30.0||||||
4450181|NCT00089505|4273861|B5|Clinical stage II||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|219|219.0||||||
4450182|NCT00089505|4273862|B4|Clinical stage II||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|67|67.0||||||
4450183|NCT00089505|4273863|B3|Clinical stage II||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|72|72.0||||||
4450184|NCT00089505|4273864|B2|Clinical stage II||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|38|38.0||||||
4450185|NCT00089505|4273865|B1|Clinical stage II||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|42|42.0||||||
4450186|NCT00089505|4273861|B5|Clinical stage I||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|290|290.0||||||
4450229|NCT00089505|4273864|B2|>=350 cells/mm^3||CD4 count Categorical||participants|Number|0|0.0||||||
4450230|NCT00089505|4273865|B1|>=350 cells/mm^3||CD4 count Categorical||participants|Number|0|0.0||||||
4450231|NCT00089505|4273861|B5|Between 300 to 349 cells/mm^3||CD4 count Categorical||participants|Number|5|5.0||||||
4450187|NCT00089505|4273862|B4|Clinical stage I||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|93|93.0||||||
4450188|NCT00089505|4273863|B3|Clinical stage I||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|97|97.0||||||
4450189|NCT00089505|4273864|B2|Clinical stage I||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|56|56.0||||||
4450190|NCT00089505|4273865|B1|Clinical stage I||WHO stage|World Health Organization (WHO) produced WHO Disease Staging System for HIV Infection and Disease in Adults and Adolescents. It is an approach for use in resource limited settings in studies of progression to symptomatic HIV disease. There are 4 stages of disease staging, 1 being the least severe and 4 being the most severe disease stage based on the HIV related symptoms and diagnoses. Please refer to the following web page for detailed staging criteria: http://www.who.int/docstore/hiv/scaling/anex1.html|participants|Number|44|44.0||||||
4450191|NCT00089505|4273861|B5|||HIV-1 RNA Continuous||log 10 copies/mL|Median|5.2|5.2|Inter-Quartile Range|||4.7|5.5|
4450192|NCT00089505|4273862|B4|||HIV-1 RNA Continuous||log 10 copies/mL|Median|5.2|5.2|Inter-Quartile Range|||4.3|5.8|
4450193|NCT00089505|4273863|B3|||HIV-1 RNA Continuous||log 10 copies/mL|Median|5.2|5.2|Inter-Quartile Range|||4.2|5.9|
4450194|NCT00089505|4273864|B2|||HIV-1 RNA Continuous||log 10 copies/mL|Median|5.1|5.1|Inter-Quartile Range|||4.2|5.9|
4450195|NCT00089505|4273865|B1|||HIV-1 RNA Continuous||log 10 copies/mL|Median|5.2|5.2|Inter-Quartile Range|||4.3|5.8|
4450196|NCT00089505|4273861|B5|>=750,000 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|74|74.0||||||
4450197|NCT00089505|4273862|B4|>=750,000 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|22|22.0||||||
4450198|NCT00089505|4273863|B3|>=750,000 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|26|26.0||||||
4450199|NCT00089505|4273864|B2|>=750,000 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|15|15.0||||||
4450200|NCT00089505|4273865|B1|>=750,000 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|11|11.0||||||
4450201|NCT00089505|4273861|B5|Between 100,000 and 749,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|375|375.0||||||
4450202|NCT00089505|4273862|B4|Between 100,000 and 749,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|128|128.0||||||
4450203|NCT00089505|4273863|B3|Between 100,000 and 749,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|123|123.0||||||
4450204|NCT00089505|4273864|B2|Between 100,000 and 749,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|63|63.0||||||
4450205|NCT00089505|4273865|B1|Between 100,000 and 749,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|61|61.0||||||
4450206|NCT00089505|4273861|B5|Between 10,000 and 99,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|246|246.0||||||
4450207|NCT00089505|4273862|B4|Between 10,000 and 99,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|88|88.0||||||
4450208|NCT00089505|4273863|B3|Between 10,000 and 99,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|81|81.0||||||
4450209|NCT00089505|4273864|B2|Between 10,000 and 99,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|33|33.0||||||
4450210|NCT00089505|4273865|B1|Between 10,000 and 99,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|44|44.0||||||
4450211|NCT00089505|4273861|B5|Between 1000 and 9,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|42|42.0||||||
4450212|NCT00089505|4273862|B4|Between 1000 and 9,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|11|11.0||||||
4450213|NCT00089505|4273863|B3|Between 1000 and 9,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|18|18.0||||||
4450214|NCT00089505|4273864|B2|Between 1000 and 9,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|8|8.0||||||
4450215|NCT00089505|4273865|B1|Between 1000 and 9,999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|5|5.0||||||
4450216|NCT00089505|4273861|B5|Between 400 and 999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|4|4.0||||||
4450217|NCT00089505|4273862|B4|Between 400 and 999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|2|2.0||||||
4450218|NCT00089505|4273863|B3|Between 400 and 999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|1|1.0||||||
4450219|NCT00089505|4273864|B2|Between 400 and 999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|1|1.0||||||
4450220|NCT00089505|4273865|B1|Between 400 and 999 copies/mL||Baseline HIV-1 RNA Categorial||participants|Number|0|0.0||||||
4450221|NCT00089505|4273861|B5|||CD4 count Continuous||cell/mm^3|Mean|129|129.0|Standard Deviation|67|67.0|||
4450222|NCT00089505|4273862|B4|||CD4 count Continuous||cell/mm^3|Mean|125|125.0|Standard Deviation|71|71.0|||
4450223|NCT00089505|4273863|B3|||CD4 count Continuous||cell/mm^3|Mean|126|126.0|Standard Deviation|68|68.0|||
4450224|NCT00089505|4273864|B2|||CD4 count Continuous||cell/mm^3|Mean|135|135.0|Standard Deviation|61|61.0|||
4450225|NCT00089505|4273865|B1|||CD4 count Continuous||cell/mm^3|Mean|136|136.0|Standard Deviation|60|60.0|||
4450226|NCT00089505|4273861|B5|>=350 cells/mm^3||CD4 count Categorical||participants|Number|4|4.0||||||
4450232|NCT00089505|4273862|B4|Between 300 to 349 cells/mm^3||CD4 count Categorical||participants|Number|2|2.0||||||
4450233|NCT00089505|4273863|B3|Between 300 to 349 cells/mm^3||CD4 count Categorical||participants|Number|2|2.0||||||
4450234|NCT00089505|4273864|B2|Between 300 to 349 cells/mm^3||CD4 count Categorical||participants|Number|0|0.0||||||
4450235|NCT00089505|4273865|B1|Between 300 to 349 cells/mm^3||CD4 count Categorical||participants|Number|1|1.0||||||
4450236|NCT00089505|4273861|B5|Between 250 to 299 cells/mm^3||CD4 count Categorical||participants|Number|18|18.0||||||
4450237|NCT00089505|4273862|B4|Between 250 to 299 cells/mm^3||CD4 count Categorical||participants|Number|4|4.0||||||
4450238|NCT00089505|4273863|B3|Between 250 to 299 cells/mm^3||CD4 count Categorical||participants|Number|9|9.0||||||
4450239|NCT00089505|4273864|B2|Between 250 to 299 cells/mm^3||CD4 count Categorical||participants|Number|4|4.0||||||
4450240|NCT00089505|4273865|B1|Between 250 to 299 cells/mm^3||CD4 count Categorical||participants|Number|1|1.0||||||
4450241|NCT00089505|4273861|B5|Between 200 to 249 cells/mm^3||CD4 count Categorical||participants|Number|64|64.0||||||
4450242|NCT00089505|4273862|B4|Between 200 to 249 cells/mm^3||CD4 count Categorical||participants|Number|19|19.0||||||
4450243|NCT00089505|4273863|B3|Between 200 to 249 cells/mm^3||CD4 count Categorical||participants|Number|18|18.0||||||
4450244|NCT00089505|4273864|B2|Between 200 to 249 cells/mm^3||CD4 count Categorical||participants|Number|12|12.0||||||
4450245|NCT00089505|4273865|B1|Between 200 to 249 cells/mm^3||CD4 count Categorical||participants|Number|15|15.0||||||
4450246|NCT00089505|4273861|B5|Between 150 to 199 cells/mm^3||CD4 count Categorical||participants|Number|184|184.0||||||
4450247|NCT00089505|4273862|B4|Between 150 to 199 cells/mm^3||CD4 count Categorical||participants|Number|57|57.0||||||
4450248|NCT00089505|4273863|B3|Between 150 to 199 cells/mm^3||CD4 count Categorical||participants|Number|58|58.0||||||
4450249|NCT00089505|4273864|B2|Between 150 to 199 cells/mm^3||CD4 count Categorical||participants|Number|32|32.0||||||
4450250|NCT00089505|4273865|B1|Between 150 to 199 cells/mm^3||CD4 count Categorical||participants|Number|37|37.0||||||
4450251|NCT00089505|4273861|B5|Between 100 to 149 cells/mm^3||CD4 count Categorical||participants|Number|216|216.0||||||
4450252|NCT00089505|4273862|B4|Between 100 to 149 cells/mm^3||CD4 count Categorical||participants|Number|78|78.0||||||
4450253|NCT00089505|4273863|B3|Between 100 to 149 cells/mm^3||CD4 count Categorical||participants|Number|65|65.0||||||
4450254|NCT00089505|4273864|B2|Between 100 to 149 cells/mm^3||CD4 count Categorical||participants|Number|38|38.0||||||
4450255|NCT00089505|4273865|B1|Between 100 to 149 cells/mm^3||CD4 count Categorical||participants|Number|35|35.0||||||
4450256|NCT00089505|4273861|B5|Between 50 to 99 cells/mm^3||CD4 count Categorical||participants|Number|157|157.0||||||
4450257|NCT00089505|4273862|B4|Between 50 to 99 cells/mm^3||CD4 count Categorical||participants|Number|53|53.0||||||
4450258|NCT00089505|4273863|B3|Between 50 to 99 cells/mm^3||CD4 count Categorical||participants|Number|63|63.0||||||
4450259|NCT00089505|4273864|B2|Between 50 to 99 cells/mm^3||CD4 count Categorical||participants|Number|23|23.0||||||
4450260|NCT00089505|4273865|B1|Between 50 to 99 cells/mm^3||CD4 count Categorical||participants|Number|18|18.0||||||
4450261|NCT00089505|4273861|B5|<50 cells/mm^3||CD4 count Categorical||participants|Number|93|93.0||||||
4450262|NCT00089505|4273862|B4|<50 cells/mm^3||CD4 count Categorical||participants|Number|36|36.0||||||
4450263|NCT00089505|4273863|B3|<50 cells/mm^3||CD4 count Categorical||participants|Number|32|32.0||||||
4450264|NCT00089505|4273864|B2|<50 cells/mm^3||CD4 count Categorical||participants|Number|11|11.0||||||
4450265|NCT00089505|4273865|B1|<50 cells/mm^3||CD4 count Categorical||participants|Number|14|14.0||||||
4450266|NCT00089505|4273861|B5|Zimbabwe||Region of Enrollment||participants|Number|117|117.0||||||
4450267|NCT00089505|4273862|B4|Zimbabwe||Region of Enrollment||participants|Number|42|42.0||||||
4450268|NCT00089505|4273863|B3|Zimbabwe||Region of Enrollment||participants|Number|39|39.0||||||
4450269|NCT00089505|4273864|B2|Zimbabwe||Region of Enrollment||participants|Number|18|18.0||||||
4450270|NCT00089505|4273865|B1|Zimbabwe||Region of Enrollment||participants|Number|18|18.0||||||
4450271|NCT00089505|4273861|B5|South Africa||Region of Enrollment||participants|Number|207|207.0||||||
4450272|NCT00089505|4273862|B4|South Africa||Region of Enrollment||participants|Number|67|67.0||||||
4450273|NCT00089505|4273863|B3|South Africa||Region of Enrollment||participants|Number|69|69.0||||||
4450274|NCT00089505|4273864|B2|South Africa||Region of Enrollment||participants|Number|36|36.0||||||
4450275|NCT00089505|4273865|B1|South Africa||Region of Enrollment||participants|Number|35|35.0||||||
4450276|NCT00089505|4273861|B5|Malawi||Region of Enrollment||participants|Number|68|68.0||||||
4450277|NCT00089505|4273862|B4|Malawi||Region of Enrollment||participants|Number|22|22.0||||||
4450278|NCT00089505|4273863|B3|Malawi||Region of Enrollment||participants|Number|22|22.0||||||
4450279|NCT00089505|4273864|B2|Malawi||Region of Enrollment||participants|Number|10|10.0||||||
4450280|NCT00089505|4273865|B1|Malawi||Region of Enrollment||participants|Number|14|14.0||||||
4450281|NCT00089505|4273861|B5|Uganda||Region of Enrollment||participants|Number|60|60.0||||||
4450282|NCT00089505|4273862|B4|Uganda||Region of Enrollment||participants|Number|21|21.0||||||
4450283|NCT00089505|4273863|B3|Uganda||Region of Enrollment||participants|Number|22|22.0||||||
4450284|NCT00089505|4273864|B2|Uganda||Region of Enrollment||participants|Number|9|9.0||||||
4450285|NCT00089505|4273865|B1|Uganda||Region of Enrollment||participants|Number|8|8.0||||||
4450286|NCT00089505|4273861|B5|Botswana||Region of Enrollment||participants|Number|88|88.0||||||
4450287|NCT00089505|4273862|B4|Botswana||Region of Enrollment||participants|Number|30|30.0||||||
4450288|NCT00089505|4273863|B3|Botswana||Region of Enrollment||participants|Number|33|33.0||||||
4450289|NCT00089505|4273864|B2|Botswana||Region of Enrollment||participants|Number|12|12.0||||||
4450290|NCT00089505|4273865|B1|Botswana||Region of Enrollment||participants|Number|13|13.0||||||
4450291|NCT00089505|4273861|B5|Zambia||Region of Enrollment||participants|Number|64|64.0||||||
4450292|NCT00089505|4273862|B4|Zambia||Region of Enrollment||participants|Number|21|21.0||||||
4450293|NCT00089505|4273863|B3|Zambia||Region of Enrollment||participants|Number|19|19.0||||||
4450294|NCT00089505|4273864|B2|Zambia||Region of Enrollment||participants|Number|12|12.0||||||
4450295|NCT00089505|4273865|B1|Zambia||Region of Enrollment||participants|Number|12|12.0||||||
4450296|NCT00089505|4273861|B5|Kenya||Region of Enrollment||participants|Number|137|137.0||||||
4450297|NCT00089505|4273862|B4|Kenya||Region of Enrollment||participants|Number|48|48.0||||||
4450298|NCT00089505|4273863|B3|Kenya||Region of Enrollment||participants|Number|45|45.0||||||
4450299|NCT00089505|4273864|B2|Kenya||Region of Enrollment||participants|Number|23|23.0||||||
4450300|NCT00089505|4273865|B1|Kenya||Region of Enrollment||participants|Number|21|21.0||||||
4450301|NCT00089505|4273861|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450302|NCT00089505|4273862|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450303|NCT00089505|4273863|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450304|NCT00089505|4273864|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450305|NCT00089505|4273865|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450306|NCT00089505|4273861|B5||Female|Sex: Female, Male||Participants|Count of Participants|741|741.0||||||
4450307|NCT00089505|4273862|B4||Female|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4450308|NCT00089505|4273863|B3||Female|Sex: Female, Male||Participants|Count of Participants|249|249.0||||||
4450309|NCT00089505|4273864|B2||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4450310|NCT00089505|4273865|B1||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4450311|NCT00089505|4273861|B5|>=50 years||Age, Customized||participants|Number|20|20.0||||||
4450312|NCT00089505|4273862|B4|>=50 years||Age, Customized||participants|Number|12|12.0||||||
4450313|NCT00089505|4273863|B3|>=50 years||Age, Customized||participants|Number|7|7.0||||||
4450314|NCT00089505|4273864|B2|>=50 years||Age, Customized||participants|Number|0|0.0||||||
4450315|NCT00089505|4273865|B1|>=50 years||Age, Customized||participants|Number|1|1.0||||||
4450316|NCT00089505|4273861|B5|Between 40 and 49 years||Age, Customized||participants|Number|117|117.0||||||
4450317|NCT00089505|4273862|B4|Between 40 and 49 years||Age, Customized||participants|Number|49|49.0||||||
4450318|NCT00089505|4273863|B3|Between 40 and 49 years||Age, Customized||participants|Number|54|54.0||||||
4450319|NCT00089505|4273864|B2|Between 40 and 49 years||Age, Customized||participants|Number|9|9.0||||||
4450320|NCT00089505|4273865|B1|Between 40 and 49 years||Age, Customized||participants|Number|5|5.0||||||
4450321|NCT00089505|4273861|B5|Between 30 and 39 years||Age, Customized||participants|Number|370|370.0||||||
4450322|NCT00089505|4273862|B4|Between 30 and 39 years||Age, Customized||participants|Number|124|124.0||||||
4450323|NCT00089505|4273863|B3|Between 30 and 39 years||Age, Customized||participants|Number|125|125.0||||||
4450324|NCT00089505|4273864|B2|Between 30 and 39 years||Age, Customized||participants|Number|62|62.0||||||
4450325|NCT00089505|4273865|B1|Between 30 and 39 years||Age, Customized||participants|Number|59|59.0||||||
4450326|NCT00089505|4273861|B5|Between 20 and 29 years||Age, Customized||participants|Number|232|232.0||||||
4450327|NCT00089505|4273862|B4|Between 20 and 29 years||Age, Customized||participants|Number|64|64.0||||||
4450328|NCT00089505|4273863|B3|Between 20 and 29 years||Age, Customized||participants|Number|63|63.0||||||
4450329|NCT00089505|4273864|B2|Between 20 and 29 years||Age, Customized||participants|Number|49|49.0||||||
4450330|NCT00089505|4273865|B1|Between 20 and 29 years||Age, Customized||participants|Number|56|56.0||||||
4450331|NCT00089505|4273861|B5|Between 13 and 19 years||Age, Customized||participants|Number|2|2.0||||||
4450332|NCT00089505|4273862|B4|Between 13 and 19 years||Age, Customized||participants|Number|2|2.0||||||
4450333|NCT00089505|4273863|B3|Between 13 and 19 years||Age, Customized||participants|Number|0|0.0||||||
4450334|NCT00089505|4273864|B2|Between 13 and 19 years||Age, Customized||participants|Number|0|0.0||||||
4450335|NCT00089505|4273865|B1|Between 13 and 19 years||Age, Customized||participants|Number|0|0.0||||||
4450336|NCT00089505|4273861|B5|||Age||years|Mean|33|33.0|Standard Deviation|7|7.0|||
4450337|NCT00089505|4273862|B4|||Age||years|Mean|35|35.0|Standard Deviation|8|8.0|||
4450338|NCT00089505|4273863|B3|||Age||years|Mean|35|35.0|Standard Deviation|7|7.0|||
4450339|NCT00089505|4273864|B2|||Age||years|Mean|31|31.0|Standard Deviation|5|5.0|||
4450340|NCT00089505|4273865|B1|||Age||years|Mean|30|30.0|Standard Deviation|5|5.0|||
4450341|NCT00089479|4273910|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450342|NCT00089479|4273911|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450343|NCT00089479|4273912|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450344|NCT00089479|4273910|B3||Female|Sex: Female, Male||Participants|Count of Participants|2611|2611.0||||||
4450345|NCT00089479|4273911|B2||Female|Sex: Female, Male||Participants|Count of Participants|1307|1307.0||||||
4450346|NCT00089479|4273912|B1||Female|Sex: Female, Male||Participants|Count of Participants|1304|1304.0||||||
4450347|NCT00089479|4273910|B3|||Age||years|Mean|50.9|50.9|Standard Deviation|9.00|9.0|||
4450348|NCT00089479|4273911|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|9.19|9.19|||
4450349|NCT00089479|4273912|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|8.81|8.81|||
4450350|NCT00089414|4273937|B4|United States||Region of Enrollment||participants|Number|5|5.0||||||
4450351|NCT00089414|4273938|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4450352|NCT00089414|4273939|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4450353|NCT00089414|4273940|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4450354|NCT00089414|4273937|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450355|NCT00089414|4273938|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450356|NCT00089414|4273939|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450357|NCT00089414|4273940|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450358|NCT00089414|4273937|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4450359|NCT00089414|4273938|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4450360|NCT00089414|4273939|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4450361|NCT00089414|4273940|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4450362|NCT00089414|4273937|B4|||Age||years|Mean|34.6|34.6|Standard Deviation|3.8794|3.8794|||
4450363|NCT00089414|4273938|B3|||Age||years|Mean|34.5|34.5|Standard Deviation|2.121|2.121|||
4450364|NCT00089414|4273939|B2|||Age||years|Mean|41|41.0|Standard Deviation|0|0.0|||
4450365|NCT00089414|4273940|B1|||Age||years|Mean|31.5|31.5|Standard Deviation|6.364|6.364|||
4450366|NCT00089414|4273937|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4450367|NCT00089414|4273938|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4450368|NCT00089414|4273939|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4450369|NCT00089414|4273940|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4450370|NCT00089414|4273937|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4450371|NCT00089414|4273938|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4450372|NCT00089414|4273939|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4450373|NCT00089414|4273940|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4450374|NCT00089414|4273937|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450375|NCT00089414|4273938|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450376|NCT00089414|4273939|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450377|NCT00089414|4273940|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450378|NCT00089297|4273956|B1||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4450379|NCT00089297|4273956|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4450380|NCT00089297|4273956|B1|||Age||years|Median|57|57.0|Full Range|||31.0|76.0|
4450381|NCT00089141|4273963|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4450382|NCT00089141|4273964|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4450383|NCT00089141|4273965|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4450384|NCT00089141|4273963|B3|United States||Region of Enrollment||participants|Number|148|148.0||||||
4450385|NCT00089141|4273964|B2|United States||Region of Enrollment||participants|Number|75|75.0||||||
4450386|NCT00089141|4273965|B1|United States||Region of Enrollment||participants|Number|73|73.0||||||
4450387|NCT00089141|4273963|B3||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4450388|NCT00089141|4273964|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4450389|NCT00089141|4273965|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4450390|NCT00089141|4273963|B3||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4450391|NCT00089141|4273964|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4450392|NCT00089141|4273965|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4450393|NCT00089141|4273963|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|13.3|13.3|||
4450394|NCT00089141|4273964|B2|||Age||years|Mean|47.9|47.9|Standard Deviation|13.3|13.3|||
4450395|NCT00089141|4273965|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|13.3|13.3|||
4450396|NCT00089141|4273963|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4450397|NCT00089141|4273964|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4450398|NCT00089141|4273965|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4450399|NCT00089141|4273963|B3||Between 18 and 65 years|Age||Participants|Count of Participants|139|139.0||||||
4450400|NCT00089141|4273964|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4450401|NCT00089141|4273965|B1||Between 18 and 65 years|Age||Participants|Count of Participants|68|68.0||||||
4450402|NCT00089141|4273963|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4450403|NCT00089141|4273964|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4450404|NCT00089141|4273965|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4450405|NCT00089128|4273988|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4450406|NCT00089128|4273988|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450407|NCT00089128|4273988|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450408|NCT00089128|4273988|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4450409|NCT00089128|4273988|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4450410|NCT00089128|4273988|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450411|NCT00089128|4273988|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450412|NCT00089128|4273988|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450413|NCT00089128|4273988|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4450414|NCT00089128|4273988|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4450415|NCT00089128|4273988|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4450416|NCT00089128|4273988|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4450417|NCT00089128|4273988|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450418|NCT00089102|4273995|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4450419|NCT00089102|4273995|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450420|NCT00089102|4273995|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450421|NCT00089102|4273995|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4450422|NCT00089102|4273995|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4450423|NCT00089102|4273995|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450424|NCT00089102|4273995|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450425|NCT00089102|4273995|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450426|NCT00089102|4273995|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4450427|NCT00089102|4273995|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4450428|NCT00089102|4273995|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4450429|NCT00089102|4273995|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4450430|NCT00089102|4273995|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450431|NCT00089076|4274002|B1|3 mg/kg monthly x 4 doses||Dose Level||participants|Number|6|6.0||||||
4450432|NCT00089076|4274002|B1|3 mg/kg first dose, then 1 mg/kg monthly x 3 doses||Dose Level||participants|Number|12|12.0||||||
4450433|NCT00089076|4274002|B1|||Number of prior treatments||Treatments|Median|2|2.0|Full Range|||1.0|4.0|
4450434|NCT00089076|4274002|B1|Mantle cell lymphoma||Disease Histology||participants|Number|1|1.0||||||
4450435|NCT00089076|4274002|B1|Diffuse large B-cell lymphoma||Disease Histology||participants|Number|3|3.0||||||
4450436|NCT00089076|4274002|B1|Follicular grade 2 lymphoma||Disease Histology||participants|Number|5|5.0||||||
4450437|NCT00089076|4274002|B1|Follicular grade 1 lymphoma||Disease Histology||participants|Number|9|9.0||||||
4450438|NCT00089076|4274002|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4450439|NCT00089076|4274002|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4450440|NCT00089076|4274002|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4450441|NCT00089076|4274002|B1|||Age||years|Median|56|56.0|Full Range|||37.0|79.0|
4450442|NCT00089011|4274013|B3|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4450443|NCT00089011|4274014|B2|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4450444|NCT00089011|4274015|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4450445|NCT00089011|4274013|B3|United States||Region of Enrollment||participants|Number|144|144.0||||||
4450446|NCT00089011|4274014|B2|United States||Region of Enrollment||participants|Number|46|46.0||||||
4450447|NCT00089011|4274015|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
4450448|NCT00089011|4274013|B3||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4450449|NCT00089011|4274014|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4450450|NCT00089011|4274015|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4450451|NCT00089011|4274013|B3||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4450452|NCT00089011|4274014|B2||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4450453|NCT00089011|4274015|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4450454|NCT00089011|4274013|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4450455|NCT00089011|4274014|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4450456|NCT00089011|4274015|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4450457|NCT00089011|4274013|B3||Between 18 and 65 years|Age||Participants|Count of Participants|123|123.0||||||
4450458|NCT00089011|4274014|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4450459|NCT00089011|4274015|B1||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4450460|NCT00089011|4274013|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450461|NCT00089011|4274014|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450462|NCT00089011|4274015|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450463|NCT00088985|4274036|B1|United States||Region of Enrollment||Participants|Count of Participants|7|7.0||||||
4450464|NCT00088985|4274036|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450465|NCT00088985|4274036|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450466|NCT00088985|4274036|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4450467|NCT00088985|4274036|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4450468|NCT00088985|4274036|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450469|NCT00088985|4274036|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4450470|NCT00088985|4274036|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450471|NCT00088985|4274036|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450472|NCT00088985|4274036|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4450473|NCT00088985|4274036|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450474|NCT00088985|4274036|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450475|NCT00088985|4274036|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4450476|NCT00088985|4274036|B1|||Age||years|Mean|64.43|64.43|Full Range|||54.0|79.0|
4450477|NCT00088972|4274041|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4450478|NCT00088972|4274042|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4450479|NCT00088972|4274043|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4450480|NCT00088972|4274041|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450481|NCT00088972|4274042|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450482|NCT00088972|4274043|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450483|NCT00088972|4274041|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4450484|NCT00088972|4274042|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4450485|NCT00088972|4274043|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4450486|NCT00088972|4274041|B3|||Age||years|Mean|43.5|43.5|Standard Deviation|4.9|4.9|||
4450487|NCT00088972|4274042|B2|||Age||years|Mean|43.3|43.3|Standard Deviation|5.9|5.9|||
4450488|NCT00088972|4274043|B1|||Age||years|Mean|43.8|43.8|Standard Deviation|3.9|3.9|||
4450489|NCT00088972|4274041|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4450490|NCT00088972|4274042|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4450491|NCT00088972|4274043|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4450492|NCT00088972|4274041|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4450493|NCT00088972|4274042|B2||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4450494|NCT00088972|4274043|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4450495|NCT00088972|4274041|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450496|NCT00088972|4274042|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450497|NCT00088972|4274043|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450498|NCT00088907|4274052|B3||Male|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4450499|NCT00088907|4274053|B2||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4450500|NCT00088907|4274054|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4450501|NCT00088907|4274052|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4450502|NCT00088907|4274053|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4450503|NCT00088907|4274054|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4450504|NCT00088907|4274052|B3|||Age||years|Median|60|60.0|Full Range|||28.0|86.0|
4450505|NCT00088907|4274053|B2|||Age||years|Median|60|60.0|Full Range|||41.0|84.0|
4450506|NCT00088907|4274054|B1|||Age||years|Median|61|61.0|Full Range|||28.0|86.0|
4450507|NCT00088881|4274066|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4450508|NCT00088881|4274066|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4450509|NCT00088881|4274066|B1|||Age||years|Median|62|62.0|Full Range|||20.0|84.0|
4450510|NCT00088829|4274075|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4450511|NCT00088829|4274075|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450512|NCT00088829|4274075|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4450513|NCT00088829|4274075|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4450514|NCT00088829|4274075|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4450515|NCT00088829|4274075|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450516|NCT00088699|4274079|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4450517|NCT00088699|4274080|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450518|NCT00088699|4274081|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4450519|NCT00088699|4274079|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4450520|NCT00088699|4274080|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4450521|NCT00088699|4274081|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4450522|NCT00088699|4274079|B3||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4450523|NCT00088699|4274080|B2||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4450524|NCT00088699|4274081|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4450525|NCT00088699|4274079|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4450526|NCT00088699|4274080|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4450527|NCT00088699|4274081|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4450528|NCT00088699|4274079|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450529|NCT00088699|4274080|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450530|NCT00088699|4274081|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450531|NCT00088699|4274079|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4450532|NCT00088699|4274080|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4450533|NCT00088699|4274081|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4450534|NCT00088699|4274079|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450535|NCT00088699|4274080|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450536|NCT00088699|4274081|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450537|NCT00088699|4274079|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450538|NCT00088699|4274080|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450539|NCT00088699|4274081|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4450540|NCT00088699|4274079|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4450541|NCT00088699|4274080|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4450542|NCT00088699|4274081|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4450543|NCT00088699|4274079|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4450544|NCT00088699|4274080|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4450545|NCT00088699|4274081|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4450546|NCT00088699|4274079|B3||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4450547|NCT00088699|4274080|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4450548|NCT00088699|4274081|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4450549|NCT00088699|4274079|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4450550|NCT00088699|4274080|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4450551|NCT00088699|4274081|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4450552|NCT00088699|4274079|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4450553|NCT00088699|4274080|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4450554|NCT00088699|4274081|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4450555|NCT00088699|4274079|B3||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4450556|NCT00088699|4274080|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4450557|NCT00088699|4274081|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4450558|NCT00088699|4274079|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450559|NCT00088699|4274080|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450560|NCT00088699|4274081|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450561|NCT00088634|4274098|B3||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4450562|NCT00088634|4274099|B2||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4450563|NCT00088634|4274100|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4450564|NCT00088634|4274098|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4450565|NCT00088634|4274099|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4450566|NCT00088634|4274100|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4450567|NCT00088634|4274098|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|9.88|9.88|||
4450568|NCT00088634|4274099|B2|||Age||years|Mean|41.9|41.9|Standard Deviation|9.78|9.78|||
4450569|NCT00088634|4274100|B1|||Age||years|Mean|39.7|39.7|Standard Deviation|9.91|9.91|||
4450570|NCT00088621|4274113|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4450571|NCT00088621|4274113|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4450572|NCT00088621|4274113|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4450573|NCT00088621|4274113|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|11.05|11.05|||
4450574|NCT00088595|4274117|B1|France||Region of Enrollment||participants|Number|1|1.0||||||
4450575|NCT00088595|4274117|B1|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4450576|NCT00088595|4274117|B1|Germany||Region of Enrollment||participants|Number|11|11.0||||||
4450577|NCT00088595|4274117|B1|Sweden||Region of Enrollment||participants|Number|5|5.0||||||
4450578|NCT00088595|4274117|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4450579|NCT00088595|4274117|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4450580|NCT00088595|4274117|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4450581|NCT00088595|4274117|B1|||Age||years|Mean|61.0|61.0|Standard Deviation|8.72|8.72|||
4450582|NCT00088530|4274133|B3|3||Baseline ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status Grade as published in Oken MM, et al. ECOG PS grade 0- Fully active, able to carry on all predisease performance without restriction; 1 - restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2- ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3- capable of only limited self-care, confined to bed or chair more than 50% of waking hours.|Participants|Count of Participants|1|1.0||||||
4450583|NCT00088530|4274134|B2|3||Baseline ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status Grade as published in Oken MM, et al. ECOG PS grade 0- Fully active, able to carry on all predisease performance without restriction; 1 - restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2- ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3- capable of only limited self-care, confined to bed or chair more than 50% of waking hours.|Participants|Count of Participants|1|1.0||||||
4450596|NCT00088530|4274135|B1|Italy||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|8|8.0||||||
4450584|NCT00088530|4274135|B1|3||Baseline ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status Grade as published in Oken MM, et al. ECOG PS grade 0- Fully active, able to carry on all predisease performance without restriction; 1 - restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2- ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3- capable of only limited self-care, confined to bed or chair more than 50% of waking hours.|Participants|Count of Participants|0|0.0||||||
4450585|NCT00088530|4274133|B3|2||Baseline ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status Grade as published in Oken MM, et al. ECOG PS grade 0- Fully active, able to carry on all predisease performance without restriction; 1 - restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2- ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3- capable of only limited self-care, confined to bed or chair more than 50% of waking hours.|Participants|Count of Participants|28|28.0||||||
4450586|NCT00088530|4274134|B2|2||Baseline ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status Grade as published in Oken MM, et al. ECOG PS grade 0- Fully active, able to carry on all predisease performance without restriction; 1 - restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2- ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3- capable of only limited self-care, confined to bed or chair more than 50% of waking hours.|Participants|Count of Participants|14|14.0||||||
4450587|NCT00088530|4274135|B1|2||Baseline ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status Grade as published in Oken MM, et al. ECOG PS grade 0- Fully active, able to carry on all predisease performance without restriction; 1 - restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2- ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3- capable of only limited self-care, confined to bed or chair more than 50% of waking hours.|Participants|Count of Participants|14|14.0||||||
4450588|NCT00088530|4274133|B3|1||Baseline ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status Grade as published in Oken MM, et al. ECOG PS grade 0- Fully active, able to carry on all predisease performance without restriction; 1 - restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2- ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3- capable of only limited self-care, confined to bed or chair more than 50% of waking hours.|Participants|Count of Participants|62|62.0||||||
4450589|NCT00088530|4274134|B2|1||Baseline ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status Grade as published in Oken MM, et al. ECOG PS grade 0- Fully active, able to carry on all predisease performance without restriction; 1 - restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2- ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3- capable of only limited self-care, confined to bed or chair more than 50% of waking hours.|Participants|Count of Participants|32|32.0||||||
4450590|NCT00088530|4274135|B1|1||Baseline ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status Grade as published in Oken MM, et al. ECOG PS grade 0- Fully active, able to carry on all predisease performance without restriction; 1 - restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2- ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3- capable of only limited self-care, confined to bed or chair more than 50% of waking hours.|Participants|Count of Participants|30|30.0||||||
4450591|NCT00088530|4274133|B3|0||Baseline ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status Grade as published in Oken MM, et al. ECOG PS grade 0- Fully active, able to carry on all predisease performance without restriction; 1 - restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2- ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3- capable of only limited self-care, confined to bed or chair more than 50% of waking hours.|Participants|Count of Participants|49|49.0||||||
4450592|NCT00088530|4274134|B2|0||Baseline ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status Grade as published in Oken MM, et al. ECOG PS grade 0- Fully active, able to carry on all predisease performance without restriction; 1 - restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2- ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3- capable of only limited self-care, confined to bed or chair more than 50% of waking hours.|Participants|Count of Participants|23|23.0||||||
4450593|NCT00088530|4274135|B1|0||Baseline ECOG Performance Status|Eastern Cooperative Oncology Group (ECOG) Performance Status Grade as published in Oken MM, et al. ECOG PS grade 0- Fully active, able to carry on all predisease performance without restriction; 1 - restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work; 2- ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3- capable of only limited self-care, confined to bed or chair more than 50% of waking hours.|Participants|Count of Participants|26|26.0||||||
4450594|NCT00088530|4274133|B3|Italy||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|20|20.0||||||
4450595|NCT00088530|4274134|B2|Italy||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|12|12.0||||||
4450597|NCT00088530|4274133|B3|Germany||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|3|3.0||||||
4450598|NCT00088530|4274134|B2|Germany||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|0|0.0||||||
4450599|NCT00088530|4274135|B1|Germany||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|3|3.0||||||
4450600|NCT00088530|4274133|B3|United Kingdom||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|7|7.0||||||
4450601|NCT00088530|4274134|B2|United Kingdom||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|3|3.0||||||
4450602|NCT00088530|4274135|B1|United Kingdom||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|4|4.0||||||
4450603|NCT00088530|4274133|B3|France||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|8|8.0||||||
4450604|NCT00088530|4274134|B2|France||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|4|4.0||||||
4450605|NCT00088530|4274135|B1|France||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|4|4.0||||||
4450606|NCT00088530|4274133|B3|Uruguay||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|1|1.0||||||
4450607|NCT00088530|4274134|B2|Uruguay||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|1|1.0||||||
4450608|NCT00088530|4274135|B1|Uruguay||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|0|0.0||||||
4450609|NCT00088530|4274133|B3|Ukraine||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|4|4.0||||||
4450610|NCT00088530|4274134|B2|Ukraine||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|3|3.0||||||
4450611|NCT00088530|4274135|B1|Ukraine||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|1|1.0||||||
4450612|NCT00088530|4274133|B3|Russian Federation||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|9|9.0||||||
4450613|NCT00088530|4274134|B2|Russian Federation||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|5|5.0||||||
4450614|NCT00088530|4274135|B1|Russian Federation||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|4|4.0||||||
4450669|NCT00088530|4274133|B3|≥ 80||Age, Customized||Participants|Count of Participants|2|2.0||||||
4450670|NCT00088530|4274134|B2|≥ 80||Age, Customized||Participants|Count of Participants|1|1.0||||||
4450671|NCT00088530|4274135|B1|≥ 80||Age, Customized||Participants|Count of Participants|1|1.0||||||
4450615|NCT00088530|4274133|B3|Romania||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|2|2.0||||||
4450616|NCT00088530|4274134|B2|Romania||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|1|1.0||||||
4450617|NCT00088530|4274135|B1|Romania||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|1|1.0||||||
4450618|NCT00088530|4274133|B3|Poland||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|2|2.0||||||
4450619|NCT00088530|4274134|B2|Poland||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|0|0.0||||||
4450620|NCT00088530|4274135|B1|Poland||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|2|2.0||||||
4450621|NCT00088530|4274133|B3|Peru||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|17|17.0||||||
4450622|NCT00088530|4274134|B2|Peru||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|8|8.0||||||
4450623|NCT00088530|4274135|B1|Peru||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|9|9.0||||||
4450624|NCT00088530|4274133|B3|India||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|21|21.0||||||
4450625|NCT00088530|4274134|B2|India||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|12|12.0||||||
4450626|NCT00088530|4274135|B1|India||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|9|9.0||||||
4450627|NCT00088530|4274133|B3|Hungary||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|10|10.0||||||
4450628|NCT00088530|4274134|B2|Hungary||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|5|5.0||||||
4450629|NCT00088530|4274135|B1|Hungary||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|5|5.0||||||
4450630|NCT00088530|4274133|B3|Ecuador||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|7|7.0||||||
4450631|NCT00088530|4274134|B2|Ecuador||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|4|4.0||||||
4450632|NCT00088530|4274135|B1|Ecuador||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|3|3.0||||||
4450633|NCT00088530|4274133|B3|Colombia||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|1|1.0||||||
4450634|NCT00088530|4274134|B2|Colombia||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|0|0.0||||||
4450635|NCT00088530|4274135|B1|Colombia||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|1|1.0||||||
4450636|NCT00088530|4274133|B3|Bulgaria||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|9|9.0||||||
4450637|NCT00088530|4274134|B2|Bulgaria||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|3|3.0||||||
4450638|NCT00088530|4274135|B1|Bulgaria||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|6|6.0||||||
4450639|NCT00088530|4274133|B3|Argentina||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|11|11.0||||||
4450640|NCT00088530|4274134|B2|Argentina||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|5|5.0||||||
4450641|NCT00088530|4274135|B1|Argentina||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|6|6.0||||||
4450642|NCT00088530|4274133|B3|North America||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|8|8.0||||||
4450643|NCT00088530|4274134|B2|North America||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|4|4.0||||||
4450644|NCT00088530|4274135|B1|North America||Region of Enrollment|Demographic data will be displayed and summary statistics will be used to describe the study population (i.e., means, medians, and ranges of age, weight, and height, and frequencies for race, gender, baseline performance status, and tumor types and histology). No formal statistical tests will be done.|participants|Number|4|4.0||||||
4450645|NCT00088530|4274133|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4450646|NCT00088530|4274134|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4450647|NCT00088530|4274135|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4450648|NCT00088530|4274133|B3|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4450649|NCT00088530|4274134|B2|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4450650|NCT00088530|4274135|B1|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4450651|NCT00088530|4274133|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4450652|NCT00088530|4274134|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4450653|NCT00088530|4274135|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4450654|NCT00088530|4274133|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4450655|NCT00088530|4274134|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4450656|NCT00088530|4274135|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4450657|NCT00088530|4274133|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4450658|NCT00088530|4274134|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4450659|NCT00088530|4274135|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4450660|NCT00088530|4274133|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|90|90.0||||||
4450661|NCT00088530|4274134|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4450662|NCT00088530|4274135|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|46|46.0||||||
4450663|NCT00088530|4274133|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4450664|NCT00088530|4274134|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4450665|NCT00088530|4274135|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4450666|NCT00088530|4274133|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4450667|NCT00088530|4274134|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4450668|NCT00088530|4274135|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4450672|NCT00088530|4274133|B3|70 to < 80||Age, Customized||Participants|Count of Participants|24|24.0||||||
4450673|NCT00088530|4274134|B2|70 to < 80||Age, Customized||Participants|Count of Participants|9|9.0||||||
4450674|NCT00088530|4274135|B1|70 to < 80||Age, Customized||Participants|Count of Participants|15|15.0||||||
4450675|NCT00088530|4274133|B3|60 to < 70||Age, Customized||Participants|Count of Participants|41|41.0||||||
4450676|NCT00088530|4274134|B2|60 to < 70||Age, Customized||Participants|Count of Participants|21|21.0||||||
4450677|NCT00088530|4274135|B1|60 to < 70||Age, Customized||Participants|Count of Participants|20|20.0||||||
4450678|NCT00088530|4274133|B3|50 to < 60||Age, Customized||Participants|Count of Participants|39|39.0||||||
4450679|NCT00088530|4274134|B2|50 to < 60||Age, Customized||Participants|Count of Participants|21|21.0||||||
4450680|NCT00088530|4274135|B1|50 to < 60||Age, Customized||Participants|Count of Participants|18|18.0||||||
4450681|NCT00088530|4274133|B3|40 to < 50||Age, Customized||Participants|Count of Participants|16|16.0||||||
4450682|NCT00088530|4274134|B2|40 to < 50||Age, Customized||Participants|Count of Participants|7|7.0||||||
4450683|NCT00088530|4274135|B1|40 to < 50||Age, Customized||Participants|Count of Participants|9|9.0||||||
4450684|NCT00088530|4274133|B3|30 to < 40||Age, Customized||Participants|Count of Participants|11|11.0||||||
4450685|NCT00088530|4274134|B2|30 to < 40||Age, Customized||Participants|Count of Participants|9|9.0||||||
4450686|NCT00088530|4274135|B1|30 to < 40||Age, Customized||Participants|Count of Participants|2|2.0||||||
4450687|NCT00088530|4274133|B3|18 to < 30||Age, Customized||Participants|Count of Participants|7|7.0||||||
4450688|NCT00088530|4274134|B2|18 to < 30||Age, Customized||Participants|Count of Participants|2|2.0||||||
4450689|NCT00088530|4274135|B1|18 to < 30||Age, Customized||Participants|Count of Participants|5|5.0||||||
4450690|NCT00088530|4274133|B3|Age at Randomization (years)||Age||years|Mean|57.2|57.2|Standard Deviation|13.2|13.2|||
4450691|NCT00088530|4274134|B2|Age at Randomization (years)||Age||years|Mean|56.2|56.2|Standard Deviation|12.9|12.9|||
4450692|NCT00088530|4274135|B1|Age at Randomization (years)||Age||years|Mean|58.2|58.2|Standard Deviation|13.5|13.5|||
4450693|NCT00088465|4274148|B1|Greece||Region of Enrollment||participants|Number|3|3.0||||||
4450694|NCT00088465|4274148|B1|Sweden||Region of Enrollment||participants|Number|9|9.0||||||
4450695|NCT00088465|4274148|B1|Germany||Region of Enrollment||participants|Number|32|32.0||||||
4450696|NCT00088465|4274148|B1|Romania||Region of Enrollment||participants|Number|34|34.0||||||
4450697|NCT00088465|4274148|B1|Croatia||Region of Enrollment||participants|Number|16|16.0||||||
4450698|NCT00088465|4274148|B1|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
4450699|NCT00088465|4274148|B1|Brazil||Region of Enrollment||participants|Number|89|89.0||||||
4450700|NCT00088465|4274148|B1|Poland||Region of Enrollment||participants|Number|33|33.0||||||
4450701|NCT00088465|4274148|B1|Argentina||Region of Enrollment||participants|Number|73|73.0||||||
4450702|NCT00088465|4274148|B1|Mexico||Region of Enrollment||participants|Number|63|63.0||||||
4450703|NCT00088465|4274148|B1|Hungary||Region of Enrollment||participants|Number|13|13.0||||||
4450704|NCT00088465|4274148|B1|Czech Republic||Region of Enrollment||participants|Number|3|3.0||||||
4450705|NCT00088465|4274148|B1|Austria||Region of Enrollment||participants|Number|10|10.0||||||
4450706|NCT00088465|4274148|B1|Netherlands||Region of Enrollment||participants|Number|8|8.0||||||
4450707|NCT00088465|4274148|B1|South Africa||Region of Enrollment||participants|Number|28|28.0||||||
4450708|NCT00088465|4274148|B1|Australia||Region of Enrollment||participants|Number|11|11.0||||||
4450709|NCT00088465|4274148|B1|Puerto Rico||Region of Enrollment||participants|Number|27|27.0||||||
4450710|NCT00088465|4274148|B1|France||Region of Enrollment||participants|Number|55|55.0||||||
4450711|NCT00088465|4274148|B1|Italy||Region of Enrollment||participants|Number|6|6.0||||||
4450712|NCT00088465|4274148|B1|Israel||Region of Enrollment||participants|Number|29|29.0||||||
4450713|NCT00088465|4274148|B1|Russian Federation||Region of Enrollment||participants|Number|114|114.0||||||
4450714|NCT00088465|4274148|B1|Spain||Region of Enrollment||participants|Number|24|24.0||||||
4450715|NCT00088465|4274148|B1|Slovakia||Region of Enrollment||participants|Number|13|13.0||||||
4450716|NCT00088465|4274148|B1|Taiwan||Region of Enrollment||participants|Number|30|30.0||||||
4450717|NCT00088465|4274148|B1|Portugal||Region of Enrollment||participants|Number|18|18.0||||||
4450718|NCT00088465|4274148|B1|United States||Region of Enrollment||participants|Number|177|177.0||||||
4450719|NCT00088465|4274148|B1|West Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4450720|NCT00088465|4274148|B1|Native American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4450721|NCT00088465|4274148|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|140|140.0||||||
4450722|NCT00088465|4274148|B1|East Asian||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4450723|NCT00088465|4274148|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|629|629.0||||||
4450724|NCT00088465|4274148|B1|African||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4450725|NCT00088465|4274148|B1||Male|Sex: Female, Male||Participants|Count of Participants|621|621.0||||||
4450726|NCT00088465|4274148|B1||Female|Sex: Female, Male||Participants|Count of Participants|310|310.0||||||
4450727|NCT00088465|4274148|B1|||Age||years|Mean|39.32|39.32|Standard Deviation|11.67|11.67|||
4450728|NCT00088374|4274171|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4450729|NCT00088374|4274171|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4450730|NCT00088374|4274171|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4450731|NCT00088374|4274171|B1|||Age||years|Mean|48.32|48.32|Standard Deviation|10.82|10.82|||
4450732|NCT00088374|4274171|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4450733|NCT00088374|4274171|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4450734|NCT00088374|4274171|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450735|NCT00088218|4274180|B3|United States||Region of Enrollment||participants|Number|95|95.0||||||
4450736|NCT00088218|4274181|B2|United States||Region of Enrollment||participants|Number|79|79.0||||||
4450737|NCT00088218|4274182|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4450738|NCT00088218|4274180|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4450739|NCT00088218|4274181|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4450740|NCT00088218|4274182|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4450741|NCT00088218|4274180|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4450742|NCT00088218|4274181|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4450743|NCT00088218|4274182|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4450744|NCT00088218|4274180|B3|||Age||years|Median|70|70.0|Full Range|||60.0|83.0|
4450745|NCT00088218|4274181|B2|||Age||years|Median|70|70.0|Full Range|||60.0|82.0|
4450746|NCT00088218|4274182|B1|||Age||years|Median|72|72.0|Full Range|||60.0|83.0|
4450747|NCT00088218|4274180|B3||>=65 years|Age||Participants|Count of Participants|82|82.0||||||
4450748|NCT00088218|4274181|B2||>=65 years|Age||Participants|Count of Participants|67|67.0||||||
4450749|NCT00088218|4274182|B1||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4450750|NCT00088218|4274180|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4450751|NCT00088218|4274181|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4450752|NCT00088218|4274182|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4450753|NCT00088218|4274180|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450754|NCT00088218|4274181|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450755|NCT00088218|4274182|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450756|NCT00088166|4274189|B3|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4450757|NCT00088166|4274190|B2|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4450758|NCT00088166|4274191|B1|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4450759|NCT00088166|4274189|B3|Australia||Region of Enrollment||participants|Number|6|6.0||||||
4450760|NCT00088166|4274190|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4450761|NCT00088166|4274191|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4450762|NCT00088166|4274189|B3|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4450763|NCT00088166|4274190|B2|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4450764|NCT00088166|4274191|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4450765|NCT00088166|4274189|B3|United States||Region of Enrollment||participants|Number|171|171.0||||||
4450766|NCT00088166|4274190|B2|United States||Region of Enrollment||participants|Number|81|81.0||||||
4450767|NCT00088166|4274191|B1|United States||Region of Enrollment||participants|Number|90|90.0||||||
4450768|NCT00088166|4274189|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4450769|NCT00088166|4274190|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4450770|NCT00088166|4274191|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4450771|NCT00088166|4274189|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4450772|NCT00088166|4274190|B2||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4450773|NCT00088166|4274191|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4450774|NCT00088166|4274189|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|11.7|11.7|||
4450775|NCT00088166|4274190|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|11.6|11.6|||
4450776|NCT00088166|4274191|B1|||Age||years|Mean|51.9|51.9|Standard Deviation|11.8|11.8|||
4450777|NCT00088166|4274189|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4450778|NCT00088166|4274190|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4450779|NCT00088166|4274191|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4450780|NCT00088166|4274189|B3||Between 18 and 65 years|Age||Participants|Count of Participants|176|176.0||||||
4450781|NCT00088166|4274190|B2||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4450782|NCT00088166|4274191|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4450783|NCT00088166|4274189|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450784|NCT00088166|4274190|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450785|NCT00088166|4274191|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450786|NCT00088153|4274214|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
4450787|NCT00088153|4274215|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4450788|NCT00088153|4274216|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4450789|NCT00088153|4274214|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450790|NCT00088153|4274215|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450791|NCT00088153|4274216|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450792|NCT00088153|4274214|B3||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4450793|NCT00088153|4274215|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4450794|NCT00088153|4274216|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4450795|NCT00088153|4274214|B3|||Age||years|Mean|16.5|16.5|Standard Deviation|0.2|0.2|||
4450796|NCT00088153|4274215|B2|||Age||years|Mean|16.3|16.3|Standard Deviation|1.6|1.6|||
4450797|NCT00088153|4274216|B1|||Age||years|Mean|16.6|16.6|Standard Deviation|1.6|1.6|||
4450798|NCT00088153|4274214|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4450799|NCT00088153|4274215|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4450800|NCT00088153|4274216|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4450801|NCT00088153|4274214|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4450802|NCT00088153|4274215|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4450803|NCT00088153|4274216|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4450804|NCT00088153|4274214|B3||<=18 years|Age||Participants|Count of Participants|110|110.0||||||
4450805|NCT00088153|4274215|B2||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4450806|NCT00088153|4274216|B1||<=18 years|Age||Participants|Count of Participants|55|55.0||||||
4450807|NCT00087698|4274227|B1|||Time from Initial Pathological Diagnosis to Enrollment||months|Mean|2.19|2.19|Standard Deviation|2.909|2.909|||
4450808|NCT00087698|4274227|B1|Hispanic||Race/Ethnicity||participants|Number|2|2.0||||||
4450809|NCT00087698|4274227|B1|Western Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4450810|NCT00087698|4274227|B1|East/Southeast Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4450811|NCT00087698|4274227|B1|African||Race/Ethnicity||participants|Number|1|1.0||||||
4450812|NCT00087698|4274227|B1|Caucasian||Race/Ethnicity||participants|Number|71|71.0||||||
4450813|NCT00087698|4274227|B1|Other||Initial Pathological Diagnosis||participants|Number|12|12.0||||||
4450814|NCT00087698|4274227|B1|Sarcomatoid Mesothelioma||Initial Pathological Diagnosis||participants|Number|1|1.0||||||
4450815|NCT00087698|4274227|B1|Mixed Cell Mesothelioma||Initial Pathological Diagnosis||participants|Number|2|2.0||||||
4450816|NCT00087698|4274227|B1|Epithelial Mesothelioma||Initial Pathological Diagnosis||participants|Number|62|62.0||||||
4450817|NCT00087698|4274227|B1|2 - In bed < 50% of time||Eastern Cooperative Oncology Group Performance Status||participants|Number|2|2.0||||||
4450818|NCT00087698|4274227|B1|1 - Ambulatory with symptoms||Eastern Cooperative Oncology Group Performance Status||participants|Number|47|47.0||||||
4450819|NCT00087698|4274227|B1|0 - Fully active and asymptomatic||Eastern Cooperative Oncology Group Performance Status||participants|Number|28|28.0||||||
4450820|NCT00087698|4274227|B1|Unknown/Not Available||Disease Stage at Time of Study Entry||participants|Number|2|2.0||||||
4450821|NCT00087698|4274227|B1|Stage IV||Disease Stage at Time of Study Entry||participants|Number|1|1.0||||||
4450822|NCT00087698|4274227|B1|Stage III||Disease Stage at Time of Study Entry||participants|Number|35|35.0||||||
4450823|NCT00087698|4274227|B1|Stage II||Disease Stage at Time of Study Entry||participants|Number|33|33.0||||||
4450824|NCT00087698|4274227|B1|Stage IB||Disease Stage at Time of Study Entry||participants|Number|3|3.0||||||
4450825|NCT00087698|4274227|B1|Stage IA||Disease Stage at Time of Study Entry||participants|Number|3|3.0||||||
4450826|NCT00087698|4274227|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
4450827|NCT00087698|4274227|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4450828|NCT00087698|4274227|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4450829|NCT00087698|4274227|B1|||Age||years|Mean|61.1|61.1|Standard Deviation|9.38|9.38|||
4450830|NCT00087685|4274236|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4450831|NCT00087685|4274236|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4450832|NCT00087685|4274236|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4450833|NCT00087685|4274236|B1|||Age||years|Median|59|59.0|Full Range|||38.0|81.0|
4450834|NCT00087672|4274241|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4450835|NCT00087672|4274241|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4450836|NCT00087672|4274241|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4450837|NCT00087672|4274241|B1|||Age||years|Median|66|66.0|Full Range|||42.0|83.0|
4450838|NCT00087672|4274241|B1||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4450839|NCT00087672|4274241|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4450840|NCT00087672|4274241|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4450841|NCT00087646|4274245|B5||Male|Sex: Female, Male||Participants|Count of Participants|616|616.0||||||
4450842|NCT00087646|4274246|B4||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4450843|NCT00087646|4274247|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4450844|NCT00087646|4274248|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4450845|NCT00087646|4274249|B1||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4450846|NCT00087646|4274245|B5||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4450847|NCT00087646|4274246|B4||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4450848|NCT00087646|4274247|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4450849|NCT00087646|4274248|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4450850|NCT00087646|4274249|B1||Female|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4450851|NCT00087646|4274245|B5|||Age||years|Mean|48.6|48.6|Standard Deviation|8.97|8.97|||
4450852|NCT00087646|4274246|B4|||Age||years|Mean|48.5|48.5|Standard Deviation|8.97|8.97|||
4450853|NCT00087646|4274247|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|8.46|8.46|||
4450854|NCT00087646|4274248|B2|||Age||years|Mean|48.8|48.8|Standard Deviation|9.93|9.93|||
4450855|NCT00087646|4274249|B1|||Age||years|Mean|48.1|48.1|Standard Deviation|8.73|8.73|||
4450856|NCT00087633|4274278|B3|United States||Region of Enrollment||participants|Number|115|115.0||||||
4450857|NCT00087633|4274279|B2|United States||Region of Enrollment||participants|Number|60|60.0||||||
4450858|NCT00087633|4274280|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4450859|NCT00087633|4274278|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4450860|NCT00087633|4274279|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4450861|NCT00087633|4274280|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4450862|NCT00087633|4274278|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4450863|NCT00087633|4274279|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4450864|NCT00087633|4274280|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4450865|NCT00087633|4274278|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|5.82|5.82|||
4450866|NCT00087633|4274279|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|5.37|5.37|||
4450867|NCT00087633|4274280|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|6.09|6.09|||
4450868|NCT00087607|4274289|B3||Male|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4450869|NCT00087607|4274290|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4450870|NCT00087607|4274291|B1||Male|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4450871|NCT00087607|4274289|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4450872|NCT00087607|4274290|B2||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4450873|NCT00087607|4274291|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4450874|NCT00087607|4274289|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|7.52|7.52|||
4450875|NCT00087607|4274290|B2|||Age||years|Mean|48.4|48.4|Standard Deviation|7.80|7.8|||
4450876|NCT00087607|4274291|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|7.18|7.18|||
4450877|NCT00087594|4274330|B3||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4450878|NCT00087594|4274331|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4450879|NCT00087594|4274332|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4450880|NCT00087594|4274330|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4450881|NCT00087594|4274331|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4450882|NCT00087594|4274332|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4450883|NCT00087594|4274330|B3|||Age||years|Mean|47.4|47.4|Standard Deviation|9.90|9.9|||
4450884|NCT00087594|4274331|B2|||Age||years|Mean|46.8|46.8|Standard Deviation|9.45|9.45|||
4450885|NCT00087594|4274332|B1|||Age||years|Mean|47.9|47.9|Standard Deviation|10.50|10.5|||
4450886|NCT00087568|4274365|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4450887|NCT00087568|4274366|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4450888|NCT00087568|4274367|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4450889|NCT00087568|4274365|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4450890|NCT00087568|4274366|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4450891|NCT00087568|4274367|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4450892|NCT00087568|4274365|B3|||Age||years|Median|49.0|49.0|Full Range|||32.0|68.0|
4450893|NCT00087568|4274366|B2|||Age||years|Median|49.0|49.0|Full Range|||35.0|66.0|
4450894|NCT00087568|4274367|B1|||Age||years|Median|47.0|47.0|Full Range|||32.0|68.0|
4450895|NCT00087555|4274392|B4|United States||Region of Enrollment||participants|Number|195|195.0||||||
4450896|NCT00087555|4274393|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4450897|NCT00087555|4274394|B2|United States||Region of Enrollment||participants|Number|62|62.0||||||
4450898|NCT00087555|4274395|B1|United States||Region of Enrollment||participants|Number|66|66.0||||||
4450899|NCT00087555|4274392|B4|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4450900|NCT00087555|4274393|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4450901|NCT00087555|4274394|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4450902|NCT00087555|4274395|B1|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4450903|NCT00087555|4274392|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4450904|NCT00087555|4274393|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4450905|NCT00087555|4274394|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4450906|NCT00087555|4274395|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4450907|NCT00087555|4274392|B4|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4450908|NCT00087555|4274393|B3|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4450909|NCT00087555|4274394|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4450910|NCT00087555|4274395|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4450911|NCT00087555|4274392|B4|African American||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4450912|NCT00087555|4274393|B3|African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4450913|NCT00087555|4274394|B2|African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4450914|NCT00087555|4274395|B1|African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4450915|NCT00087555|4274392|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|180|180.0||||||
4450916|NCT00087555|4274393|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|65|65.0||||||
4450917|NCT00087555|4274394|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|56|56.0||||||
4450918|NCT00087555|4274395|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
4450919|NCT00087555|4274392|B4||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4450920|NCT00087555|4274393|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4450921|NCT00087555|4274394|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4450922|NCT00087555|4274395|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4450923|NCT00087555|4274392|B4||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4450924|NCT00087555|4274393|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4450925|NCT00087555|4274394|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4450926|NCT00087555|4274395|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4450927|NCT00087555|4274392|B4|>=65 years||Age, Customized||participants|Number|9|9.0||||||
4450928|NCT00087555|4274393|B3|>=65 years||Age, Customized||participants|Number|2|2.0||||||
4450929|NCT00087555|4274394|B2|>=65 years||Age, Customized||participants|Number|3|3.0||||||
4450930|NCT00087555|4274395|B1|>=65 years||Age, Customized||participants|Number|4|4.0||||||
4450931|NCT00087555|4274392|B4|50 - 64 Years||Age, Customized||participants|Number|73|73.0||||||
4450932|NCT00087555|4274393|B3|50 - 64 Years||Age, Customized||participants|Number|25|25.0||||||
4450933|NCT00087555|4274394|B2|50 - 64 Years||Age, Customized||participants|Number|26|26.0||||||
4450934|NCT00087555|4274395|B1|50 - 64 Years||Age, Customized||participants|Number|22|22.0||||||
4450935|NCT00087555|4274392|B4|40 - 49 Years||Age, Customized||participants|Number|60|60.0||||||
4450936|NCT00087555|4274393|B3|40 - 49 Years||Age, Customized||participants|Number|17|17.0||||||
4450937|NCT00087555|4274394|B2|40 - 49 Years||Age, Customized||participants|Number|19|19.0||||||
4450938|NCT00087555|4274395|B1|40 - 49 Years||Age, Customized||participants|Number|24|24.0||||||
4450939|NCT00087555|4274392|B4|18 - 39 Years||Age, Customized||participants|Number|53|53.0||||||
4450940|NCT00087555|4274393|B3|18 - 39 Years||Age, Customized||participants|Number|23|23.0||||||
4450941|NCT00087555|4274394|B2|18 - 39 Years||Age, Customized||participants|Number|14|14.0||||||
4450942|NCT00087555|4274395|B1|18 - 39 Years||Age, Customized||participants|Number|16|16.0||||||
4450943|NCT00087555|4274392|B4|||Age||years|Mean|46.5|46.5|Standard Deviation|11.35|11.35|||
4450944|NCT00087555|4274393|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|11.51|11.51|||
4450945|NCT00087555|4274394|B2|||Age||years|Mean|47.2|47.2|Standard Deviation|11.89|11.89|||
4450946|NCT00087555|4274395|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|10.69|10.69|||
4450947|NCT00087529|4274405|B3||Male|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4450948|NCT00087529|4274406|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4450949|NCT00087529|4274407|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4450950|NCT00087529|4274405|B3||Female|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4450951|NCT00087529|4274406|B2||Female|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4450952|NCT00087529|4274407|B1||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4450953|NCT00087529|4274405|B3|||Age||years|Mean|49.9|49.9|Standard Deviation|8.90|8.9|||
4450954|NCT00087529|4274406|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|9.02|9.02|||
4450955|NCT00087529|4274407|B1|||Age||years|Mean|49.6|49.6|Standard Deviation|8.69|8.69|||
4450956|NCT00087516|4274420|B4|||Hemoglobin A1c (A1C)||Percent|Mean|8.0|8.0|Standard Deviation|0.9|0.9|||
4450957|NCT00087516|4274421|B3|||Hemoglobin A1c (A1C)||Percent|Mean|8.0|8.0|Standard Deviation|0.8|0.8|||
4450958|NCT00087516|4274422|B2|||Hemoglobin A1c (A1C)||Percent|Mean|8.1|8.1|Standard Deviation|0.9|0.9|||
4450959|NCT00087516|4274423|B1|||Hemoglobin A1c (A1C)||Percent|Mean|8.0|8.0|Standard Deviation|0.9|0.9|||
4450960|NCT00087516|4274420|B4|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|173.7|173.7|Standard Deviation|43.7|43.7|||
4450961|NCT00087516|4274421|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|176.1|176.1|Standard Deviation|41.8|41.8|||
4450962|NCT00087516|4274422|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|174.2|174.2|Standard Deviation|46.2|46.2|||
4450963|NCT00087516|4274423|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|170.7|170.7|Standard Deviation|43.0|43.0|||
4450964|NCT00087516|4274420|B4|Other||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4450965|NCT00087516|4274421|B3|Other||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4450966|NCT00087516|4274422|B2|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4450967|NCT00087516|4274423|B1|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4450968|NCT00087516|4274420|B4|Asian||Race/Ethnicity, Customized||participants|Number|103|103.0||||||
4450969|NCT00087516|4274421|B3|Asian||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4450970|NCT00087516|4274422|B2|Asian||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4450971|NCT00087516|4274423|B1|Asian||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4450972|NCT00087516|4274420|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|175|175.0||||||
4450973|NCT00087516|4274421|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4450974|NCT00087516|4274422|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4450975|NCT00087516|4274423|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|58|58.0||||||
4450976|NCT00087516|4274420|B4|Black||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4450977|NCT00087516|4274421|B3|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4450978|NCT00087516|4274422|B2|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4450979|NCT00087516|4274423|B1|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4450980|NCT00087516|4274420|B4|White||Race/Ethnicity, Customized||participants|Number|381|381.0||||||
4450981|NCT00087516|4274421|B3|White||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4450982|NCT00087516|4274422|B2|White||Race/Ethnicity, Customized||participants|Number|132|132.0||||||
4450983|NCT00087516|4274423|B1|White||Race/Ethnicity, Customized||participants|Number|122|122.0||||||
4450984|NCT00087516|4274420|B4||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4450985|NCT00087516|4274421|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4450986|NCT00087516|4274422|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4450987|NCT00087516|4274423|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4450988|NCT00087516|4274420|B4||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4450989|NCT00087516|4274421|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4450990|NCT00087516|4274422|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4450991|NCT00087516|4274423|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4450992|NCT00087516|4274420|B4|||Age||years|Mean|54.2|54.2|Standard Deviation|9.9|9.9|||
4450993|NCT00087516|4274421|B3|||Age||years|Mean|54.3|54.3|Standard Deviation|10.1|10.1|||
4450994|NCT00087516|4274422|B2|||Age||years|Mean|54.9|54.9|Standard Deviation|10.1|10.1|||
4450995|NCT00087516|4274423|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|9.5|9.5|||
4450996|NCT00087490|4274453|B3||Male|Sex: Female, Male||Participants|Count of Participants|620|620.0||||||
4450997|NCT00087490|4274454|B2||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4450998|NCT00087490|4274455|B1||Male|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4450999|NCT00087490|4274453|B3||Female|Sex: Female, Male||Participants|Count of Participants|432|432.0||||||
4451000|NCT00087490|4274454|B2||Female|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4451001|NCT00087490|4274455|B1||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4451002|NCT00087490|4274453|B3|||Age||Years|Mean|49.5|49.5|Standard Deviation|17.4|17.4|||
4451003|NCT00087490|4274454|B2|||Age||Years|Mean|49.4|49.4|Standard Deviation|17.2|17.2|||
4451004|NCT00087490|4274455|B1|||Age||Years|Mean|49.7|49.7|Standard Deviation|17.6|17.6|||
4451005|NCT00087438|4274490|B1||Male|Gender||Participants|Count of Participants|21|21.0||||||
4451006|NCT00087438|4274490|B1||Female|Gender||Participants|Count of Participants|34|34.0||||||
4451007|NCT00087438|4274490|B1|||Age||years|Median|72|72.0|Full Range|||48.0|89.0|
4451008|NCT00087152|4274494|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4451009|NCT00087152|4274494|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451010|NCT00087152|4274494|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4451011|NCT00087152|4274494|B1|||Age||years|Mean|55.3|55.3|Standard Deviation|10.6|10.6|||
4451012|NCT00087152|4274494|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4451013|NCT00087152|4274494|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4451014|NCT00087152|4274494|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451015|NCT00087139|4274500|B4||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4451016|NCT00087139|4274501|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4451017|NCT00087139|4274502|B2||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4451018|NCT00087139|4274503|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4451019|NCT00087139|4274500|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451020|NCT00087139|4274501|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451021|NCT00087139|4274502|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451022|NCT00087139|4274503|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451023|NCT00087139|4274500|B4|||Age||years|Median|70|70.0|Full Range|||45.0|90.0|
4451024|NCT00087139|4274501|B3|||Age||years|Median|67.5|67.5|Full Range|||49.0|90.0|
4451025|NCT00087139|4274502|B2|||Age||years|Median|69|69.0|Full Range|||50.0|81.0|
4451026|NCT00087139|4274503|B1|||Age||years|Median|72|72.0|Full Range|||45.0|82.0|
4451027|NCT00087022|4274520|B3||Male|Sex: Female, Male||Participants|Count of Participants|574|574.0||||||
4451028|NCT00087022|4274521|B2||Male|Sex: Female, Male||Participants|Count of Participants|298|298.0||||||
4451029|NCT00087022|4274522|B1||Male|Sex: Female, Male||Participants|Count of Participants|276|276.0||||||
4451030|NCT00087022|4274520|B3||Female|Sex: Female, Male||Participants|Count of Participants|290|290.0||||||
4451031|NCT00087022|4274521|B2||Female|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4451032|NCT00087022|4274522|B1||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4451033|NCT00087022|4274520|B3|||Age||years|Mean|58.0|58.0|Standard Deviation|9.98|9.98|||
4451034|NCT00087022|4274521|B2|||Age||years|Mean|57.8|57.8|Standard Deviation|10.1|10.1|||
4451035|NCT00087022|4274522|B1|||Age||years|Mean|58.2|58.2|Standard Deviation|9.83|9.83|||
4451036|NCT00086996|4274536|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4451037|NCT00086996|4274536|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451038|NCT00086996|4274536|B1||White|Race (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4451039|NCT00086996|4274536|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4451040|NCT00086996|4274536|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451041|NCT00086996|4274536|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451042|NCT00086996|4274536|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4451043|NCT00086996|4274536|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4451044|NCT00086996|4274536|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4451045|NCT00086996|4274536|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4451046|NCT00086996|4274536|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4451047|NCT00086996|4274536|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4451048|NCT00086996|4274536|B1|||Age|Of eligible patients|participants|Median|62.2|62.2|Full Range|||41.6|83.1|
4451049|NCT00086957|4274543|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4451050|NCT00086957|4274543|B1||Male|Gender||Participants|Count of Participants|0|0.0||||||
4451051|NCT00086957|4274543|B1||Female|Gender||Participants|Count of Participants|31|31.0||||||
4451052|NCT00086957|4274543|B1|||Age||years|Mean|52|52.0|Full Range|||34.0|67.0|
4451053|NCT00086684|4274555|B4|||Baseline BMI||kg/cm2|Mean|26.9|26.9|Standard Deviation|9.18|9.18|||
4451054|NCT00086684|4274556|B3|||Baseline BMI||kg/cm2|Mean|27.1|27.1|Standard Deviation|11.02|11.02|||
4451055|NCT00086684|4274557|B2|||Baseline BMI||kg/cm2|Mean|26.8|26.8|Standard Deviation|9.42|9.42|||
4451056|NCT00086684|4274558|B1|||Baseline BMI||kg/cm2|Mean|27|27.0|Standard Deviation|6.50|6.5|||
4451057|NCT00086684|4274555|B4|>=75 YEARS||AgeCategorical||participants|Number|9|9.0||||||
4451058|NCT00086684|4274556|B3|>=75 YEARS||AgeCategorical||participants|Number|2|2.0||||||
4451059|NCT00086684|4274557|B2|>=75 YEARS||AgeCategorical||participants|Number|3|3.0||||||
4451060|NCT00086684|4274558|B1|>=75 YEARS||AgeCategorical||participants|Number|4|4.0||||||
4451061|NCT00086684|4274555|B4|65-<74 YEARS||AgeCategorical||participants|Number|38|38.0||||||
4451062|NCT00086684|4274556|B3|65-<74 YEARS||AgeCategorical||participants|Number|11|11.0||||||
4451063|NCT00086684|4274557|B2|65-<74 YEARS||AgeCategorical||participants|Number|17|17.0||||||
4451064|NCT00086684|4274558|B1|65-<74 YEARS||AgeCategorical||participants|Number|10|10.0||||||
4451065|NCT00086684|4274555|B4|18-<64 YEARS||AgeCategorical||participants|Number|322|322.0||||||
4451066|NCT00086684|4274556|B3|18-<64 YEARS||AgeCategorical||participants|Number|109|109.0||||||
4451067|NCT00086684|4274557|B2|18-<64 YEARS||AgeCategorical||participants|Number|109|109.0||||||
4451068|NCT00086684|4274558|B1|18-<64 YEARS||AgeCategorical||participants|Number|104|104.0||||||
4451069|NCT00086684|4274555|B4|<18 YEARS||AgeCategorical||participants|Number|0|0.0||||||
4451070|NCT00086684|4274556|B3|<18 YEARS||AgeCategorical||participants|Number|0|0.0||||||
4451071|NCT00086684|4274557|B2|<18 YEARS||AgeCategorical||participants|Number|0|0.0||||||
4451072|NCT00086684|4274558|B1|<18 YEARS||AgeCategorical||participants|Number|0|0.0||||||
4451073|NCT00086684|4274555|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4451074|NCT00086684|4274556|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4451075|NCT00086684|4274557|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4451076|NCT00086684|4274558|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4451077|NCT00086684|4274555|B4||Female|Sex: Female, Male||Participants|Count of Participants|333|333.0||||||
4451078|NCT00086684|4274556|B3||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4451079|NCT00086684|4274557|B2||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4451080|NCT00086684|4274558|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4451081|NCT00086684|4274555|B4|||Age||years|Mean|44.3|44.3|Standard Deviation|15.35|15.35|||
4451082|NCT00086684|4274556|B3|||Age||years|Mean|42.7|42.7|Standard Deviation|15.71|15.71|||
4451083|NCT00086684|4274557|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|15.68|15.68|||
4451084|NCT00086684|4274558|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|14.58|14.58|||
4451085|NCT00086684|4274555|B4||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4451086|NCT00086684|4274556|B3||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4451087|NCT00086684|4274557|B2||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4451088|NCT00086684|4274558|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4451089|NCT00086684|4274555|B4||Between 18 and 65 years|Age||Participants|Count of Participants|320|320.0||||||
4451090|NCT00086684|4274556|B3||Between 18 and 65 years|Age||Participants|Count of Participants|109|109.0||||||
4451091|NCT00086684|4274557|B2||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4451092|NCT00086684|4274558|B1||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4451093|NCT00086684|4274555|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4451094|NCT00086684|4274556|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451095|NCT00086684|4274557|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4451096|NCT00086684|4274558|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4451097|NCT00086619|4274571|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4451098|NCT00086619|4274572|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4451099|NCT00086619|4274573|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4451100|NCT00086619|4274571|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451101|NCT00086619|4274572|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451102|NCT00086619|4274573|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451103|NCT00086619|4274571|B3||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4451104|NCT00086619|4274572|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4451105|NCT00086619|4274573|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4451106|NCT00086619|4274571|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|8.2|8.2|||
4451107|NCT00086619|4274572|B2|||Age||years|Mean|62.1|62.1|Standard Deviation|8.9|8.9|||
4451108|NCT00086619|4274573|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|7.6|7.6|||
4451109|NCT00086619|4274571|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4451110|NCT00086619|4274572|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4451111|NCT00086619|4274573|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4451112|NCT00086619|4274571|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4451113|NCT00086619|4274572|B2||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4451114|NCT00086619|4274573|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4451115|NCT00086619|4274571|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451116|NCT00086619|4274572|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451117|NCT00086619|4274573|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451118|NCT00086580|4274582|B3|Non-fludarabine-containing therapy||Summary of Prior Therapy by Type of Therapy|Count of participants who had prior therapy categorized by type of therapy: fludarabine-containing therapy or non-fludarabine-containing therapy.|participants|Number|284|284.0||||||
4451119|NCT00086580|4274583|B2|Non-fludarabine-containing therapy||Summary of Prior Therapy by Type of Therapy|Count of participants who had prior therapy categorized by type of therapy: fludarabine-containing therapy or non-fludarabine-containing therapy.|participants|Number|141|141.0||||||
4451120|NCT00086580|4274584|B1|Non-fludarabine-containing therapy||Summary of Prior Therapy by Type of Therapy|Count of participants who had prior therapy categorized by type of therapy: fludarabine-containing therapy or non-fludarabine-containing therapy.|participants|Number|143|143.0||||||
4451121|NCT00086580|4274582|B3|Fludarabine-containing therapy||Summary of Prior Therapy by Type of Therapy|Count of participants who had prior therapy categorized by type of therapy: fludarabine-containing therapy or non-fludarabine-containing therapy.|participants|Number|51|51.0||||||
4451122|NCT00086580|4274583|B2|Fludarabine-containing therapy||Summary of Prior Therapy by Type of Therapy|Count of participants who had prior therapy categorized by type of therapy: fludarabine-containing therapy or non-fludarabine-containing therapy.|participants|Number|26|26.0||||||
4451123|NCT00086580|4274584|B1|Fludarabine-containing therapy||Summary of Prior Therapy by Type of Therapy|Count of participants who had prior therapy categorized by type of therapy: fludarabine-containing therapy or non-fludarabine-containing therapy.|participants|Number|25|25.0||||||
4451124|NCT00086580|4274582|B3|Refractory||Disease Status|Count of participants with refractory or relapsed disease at baseline (as reported by the investigator).|participants|Number|133|133.0||||||
4451125|NCT00086580|4274583|B2|Refractory||Disease Status|Count of participants with refractory or relapsed disease at baseline (as reported by the investigator).|participants|Number|66|66.0||||||
4451126|NCT00086580|4274584|B1|Refractory||Disease Status|Count of participants with refractory or relapsed disease at baseline (as reported by the investigator).|participants|Number|67|67.0||||||
4451127|NCT00086580|4274582|B3|Relapsed||Disease Status|Count of participants with refractory or relapsed disease at baseline (as reported by the investigator).|participants|Number|202|202.0||||||
4451128|NCT00086580|4274583|B2|Relapsed||Disease Status|Count of participants with refractory or relapsed disease at baseline (as reported by the investigator).|participants|Number|101|101.0||||||
4451129|NCT00086580|4274584|B1|Relapsed||Disease Status|Count of participants with refractory or relapsed disease at baseline (as reported by the investigator).|participants|Number|101|101.0||||||
4451130|NCT00086580|4274582|B3|Binet Stage C||Binet Stage|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of low red blood cell count (anemia) or low number of blood platelets (thrombocytopenia).~Binet Stage A: fewer than three areas of enlarged lymphoid tissue. Enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group, whether unilateral (one-sided) or bilateral (on both sides).~Binet Stage B: more than three areas of enlarged lymphoid tissue.~Binet Stage C: anemia plus thrombocytopenia (platelets <100 x 10^3/dL)."|participants|Number|105|105.0||||||
4451131|NCT00086580|4274583|B2|Binet Stage C||Binet Stage|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of low red blood cell count (anemia) or low number of blood platelets (thrombocytopenia).~Binet Stage A: fewer than three areas of enlarged lymphoid tissue. Enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group, whether unilateral (one-sided) or bilateral (on both sides).~Binet Stage B: more than three areas of enlarged lymphoid tissue.~Binet Stage C: anemia plus thrombocytopenia (platelets <100 x 10^3/dL)."|participants|Number|53|53.0||||||
4451132|NCT00086580|4274584|B1|Binet Stage C||Binet Stage|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of low red blood cell count (anemia) or low number of blood platelets (thrombocytopenia).~Binet Stage A: fewer than three areas of enlarged lymphoid tissue. Enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group, whether unilateral (one-sided) or bilateral (on both sides).~Binet Stage B: more than three areas of enlarged lymphoid tissue.~Binet Stage C: anemia plus thrombocytopenia (platelets <100 x 10^3/dL)."|participants|Number|52|52.0||||||
4451133|NCT00086580|4274582|B3|Binet Stage B||Binet Stage|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of low red blood cell count (anemia) or low number of blood platelets (thrombocytopenia).~Binet Stage A: fewer than three areas of enlarged lymphoid tissue. Enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group, whether unilateral (one-sided) or bilateral (on both sides).~Binet Stage B: more than three areas of enlarged lymphoid tissue.~Binet Stage C: anemia plus thrombocytopenia (platelets <100 x 10^3/dL)."|participants|Number|178|178.0||||||
4451134|NCT00086580|4274583|B2|Binet Stage B||Binet Stage|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of low red blood cell count (anemia) or low number of blood platelets (thrombocytopenia).~Binet Stage A: fewer than three areas of enlarged lymphoid tissue. Enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group, whether unilateral (one-sided) or bilateral (on both sides).~Binet Stage B: more than three areas of enlarged lymphoid tissue.~Binet Stage C: anemia plus thrombocytopenia (platelets <100 x 10^3/dL)."|participants|Number|89|89.0||||||
4451177|NCT00086580|4274584|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4451178|NCT00086580|4274582|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|9.29|9.29|||
4451135|NCT00086580|4274584|B1|Binet Stage B||Binet Stage|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of low red blood cell count (anemia) or low number of blood platelets (thrombocytopenia).~Binet Stage A: fewer than three areas of enlarged lymphoid tissue. Enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group, whether unilateral (one-sided) or bilateral (on both sides).~Binet Stage B: more than three areas of enlarged lymphoid tissue.~Binet Stage C: anemia plus thrombocytopenia (platelets <100 x 10^3/dL)."|participants|Number|89|89.0||||||
4451136|NCT00086580|4274582|B3|Binet Stage A||Binet Stage|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of low red blood cell count (anemia) or low number of blood platelets (thrombocytopenia).~Binet Stage A: fewer than three areas of enlarged lymphoid tissue. Enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group, whether unilateral (one-sided) or bilateral (on both sides).~Binet Stage B: more than three areas of enlarged lymphoid tissue.~Binet Stage C: anemia plus thrombocytopenia (platelets <100 x 10^3/dL)."|participants|Number|52|52.0||||||
4451137|NCT00086580|4274583|B2|Binet Stage A||Binet Stage|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of low red blood cell count (anemia) or low number of blood platelets (thrombocytopenia).~Binet Stage A: fewer than three areas of enlarged lymphoid tissue. Enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group, whether unilateral (one-sided) or bilateral (on both sides).~Binet Stage B: more than three areas of enlarged lymphoid tissue.~Binet Stage C: anemia plus thrombocytopenia (platelets <100 x 10^3/dL)."|participants|Number|25|25.0||||||
4451138|NCT00086580|4274584|B1|Binet Stage A||Binet Stage|"Binet staging classifies CLL according to the number of lymphoid tissues involved, as well as the presence of low red blood cell count (anemia) or low number of blood platelets (thrombocytopenia).~Binet Stage A: fewer than three areas of enlarged lymphoid tissue. Enlarged lymph nodes of the neck, underarms, and groin, as well as the spleen, are each considered one group, whether unilateral (one-sided) or bilateral (on both sides).~Binet Stage B: more than three areas of enlarged lymphoid tissue.~Binet Stage C: anemia plus thrombocytopenia (platelets <100 x 10^3/dL)."|participants|Number|27|27.0||||||
4451139|NCT00086580|4274582|B3|Rai Stage III - IV||Rai Stage Group|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia.~Per protocol, the 4 participants with Rai Stage 0 were eligible for the study because they had Binet Stage A."|participants|Number|125|125.0||||||
4451140|NCT00086580|4274583|B2|Rai Stage III - IV||Rai Stage Group|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia.~Per protocol, the 4 participants with Rai Stage 0 were eligible for the study because they had Binet Stage A."|participants|Number|63|63.0||||||
4451141|NCT00086580|4274584|B1|Rai Stage III - IV||Rai Stage Group|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia.~Per protocol, the 4 participants with Rai Stage 0 were eligible for the study because they had Binet Stage A."|participants|Number|62|62.0||||||
4451142|NCT00086580|4274582|B3|Rai Stage I - II||Rai Stage Group|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia.~Per protocol, the 4 participants with Rai Stage 0 were eligible for the study because they had Binet Stage A."|participants|Number|206|206.0||||||
4451143|NCT00086580|4274583|B2|Rai Stage I - II||Rai Stage Group|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia.~Per protocol, the 4 participants with Rai Stage 0 were eligible for the study because they had Binet Stage A."|participants|Number|102|102.0||||||
4451144|NCT00086580|4274584|B1|Rai Stage I - II||Rai Stage Group|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia.~Per protocol, the 4 participants with Rai Stage 0 were eligible for the study because they had Binet Stage A."|participants|Number|104|104.0||||||
4451145|NCT00086580|4274582|B3|Rai Stage 0||Rai Stage Group|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia.~Per protocol, the 4 participants with Rai Stage 0 were eligible for the study because they had Binet Stage A."|participants|Number|4|4.0||||||
4451146|NCT00086580|4274583|B2|Rai Stage 0||Rai Stage Group|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia.~Per protocol, the 4 participants with Rai Stage 0 were eligible for the study because they had Binet Stage A."|participants|Number|2|2.0||||||
4451179|NCT00086580|4274583|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|9.34|9.34|||
4451180|NCT00086580|4274584|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|9.25|9.25|||
4451181|NCT00086411|4274629|B5|United States||Region of Enrollment||participants|Number|260|260.0||||||
4451147|NCT00086580|4274584|B1|Rai Stage 0||Rai Stage Group|"Rai staging is a way to categorize the disease progression of chronic lymphocytic leukemia (CLL); higher stages reflect increasing severity.~Rai Stage 0: Lymphocytosis only, Rai Stage I: Lymphocytosis with lymphadenopathy, Rai Stage II: Lymphocytosis with hepatomegaly or splenomegaly, Rai Stage III: Lymphocytosis with anemia, Rai Stage IV: Lymphocytosis with thrombocytopenia.~Per protocol, the 4 participants with Rai Stage 0 were eligible for the study because they had Binet Stage A."|participants|Number|2|2.0||||||
4451148|NCT00086580|4274582|B3|WHO Performance Status = 1||World Health Organization (WHO) Performance Status|"Per protocol, all participants had a WHO performance status of 0 or 1. A WHO performance status of 0 is defined as patient is able to carry out all normal activity without restriction, and status of 1 is patient is ambulatory and capable of all self-care but unable to carry out any work; up and about more than 50% of waking hours."|participants|Number|182|182.0||||||
4451149|NCT00086580|4274583|B2|WHO Performance Status = 1||World Health Organization (WHO) Performance Status|"Per protocol, all participants had a WHO performance status of 0 or 1. A WHO performance status of 0 is defined as patient is able to carry out all normal activity without restriction, and status of 1 is patient is ambulatory and capable of all self-care but unable to carry out any work; up and about more than 50% of waking hours."|participants|Number|95|95.0||||||
4451150|NCT00086580|4274584|B1|WHO Performance Status = 1||World Health Organization (WHO) Performance Status|"Per protocol, all participants had a WHO performance status of 0 or 1. A WHO performance status of 0 is defined as patient is able to carry out all normal activity without restriction, and status of 1 is patient is ambulatory and capable of all self-care but unable to carry out any work; up and about more than 50% of waking hours."|participants|Number|87|87.0||||||
4451151|NCT00086580|4274582|B3|WHO Performance Status = 0||World Health Organization (WHO) Performance Status|"Per protocol, all participants had a WHO performance status of 0 or 1. A WHO performance status of 0 is defined as patient is able to carry out all normal activity without restriction, and status of 1 is patient is ambulatory and capable of all self-care but unable to carry out any work; up and about more than 50% of waking hours."|participants|Number|153|153.0||||||
4451152|NCT00086580|4274583|B2|WHO Performance Status = 0||World Health Organization (WHO) Performance Status|"Per protocol, all participants had a WHO performance status of 0 or 1. A WHO performance status of 0 is defined as patient is able to carry out all normal activity without restriction, and status of 1 is patient is ambulatory and capable of all self-care but unable to carry out any work; up and about more than 50% of waking hours."|participants|Number|72|72.0||||||
4451153|NCT00086580|4274584|B1|WHO Performance Status = 0||World Health Organization (WHO) Performance Status|"Per protocol, all participants had a WHO performance status of 0 or 1. A WHO performance status of 0 is defined as patient is able to carry out all normal activity without restriction, and status of 1 is patient is ambulatory and capable of all self-care but unable to carry out any work; up and about more than 50% of waking hours."|participants|Number|81|81.0||||||
4451154|NCT00086580|4274582|B3|>= 5 centimeters||Maximum Lymph Node Size|The number of participants whose largest lymph node by physical exam assessment during a baseline visit fell within two categories: <5 cm and >=5 cm. If there is no enlarged lymph node, then size is classified as <5 cm.|participants|Number|65|65.0||||||
4451155|NCT00086580|4274583|B2|>= 5 centimeters||Maximum Lymph Node Size|The number of participants whose largest lymph node by physical exam assessment during a baseline visit fell within two categories: <5 cm and >=5 cm. If there is no enlarged lymph node, then size is classified as <5 cm.|participants|Number|31|31.0||||||
4451156|NCT00086580|4274584|B1|>= 5 centimeters||Maximum Lymph Node Size|The number of participants whose largest lymph node by physical exam assessment during a baseline visit fell within two categories: <5 cm and >=5 cm. If there is no enlarged lymph node, then size is classified as <5 cm.|participants|Number|34|34.0||||||
4451157|NCT00086580|4274582|B3|<5 centimeters||Maximum Lymph Node Size|The number of participants whose largest lymph node by physical exam assessment during a baseline visit fell within two categories: <5 cm and >=5 cm. If there is no enlarged lymph node, then size is classified as <5 cm.|participants|Number|270|270.0||||||
4451158|NCT00086580|4274583|B2|<5 centimeters||Maximum Lymph Node Size|The number of participants whose largest lymph node by physical exam assessment during a baseline visit fell within two categories: <5 cm and >=5 cm. If there is no enlarged lymph node, then size is classified as <5 cm.|participants|Number|136|136.0||||||
4451159|NCT00086580|4274584|B1|<5 centimeters||Maximum Lymph Node Size|The number of participants whose largest lymph node by physical exam assessment during a baseline visit fell within two categories: <5 cm and >=5 cm. If there is no enlarged lymph node, then size is classified as <5 cm.|participants|Number|134|134.0||||||
4451160|NCT00086580|4274582|B3|||Body Surface Area (BSA)||meters^2|Mean|1.88|1.88|Standard Deviation|0.216|0.216|||
4451161|NCT00086580|4274583|B2|||Body Surface Area (BSA)||meters^2|Mean|1.90|1.9|Standard Deviation|0.218|0.218|||
4451162|NCT00086580|4274584|B1|||Body Surface Area (BSA)||meters^2|Mean|1.87|1.87|Standard Deviation|0.213|0.213|||
4451163|NCT00086580|4274582|B3|||Height||centimeters|Mean|169.2|169.2|Standard Deviation|9.08|9.08|||
4451164|NCT00086580|4274583|B2|||Height||centimeters|Mean|169.4|169.4|Standard Deviation|9.30|9.3|||
4451165|NCT00086580|4274584|B1|||Height||centimeters|Mean|169.0|169.0|Standard Deviation|8.88|8.88|||
4451166|NCT00086580|4274582|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4451167|NCT00086580|4274583|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4451168|NCT00086580|4274584|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4451169|NCT00086580|4274582|B3|White||Race/Ethnicity, Customized||participants|Number|334|334.0||||||
4451170|NCT00086580|4274583|B2|White||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
4451171|NCT00086580|4274584|B1|White||Race/Ethnicity, Customized||participants|Number|167|167.0||||||
4451172|NCT00086580|4274582|B3||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4451173|NCT00086580|4274583|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4451174|NCT00086580|4274584|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4451175|NCT00086580|4274582|B3||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4451176|NCT00086580|4274583|B2||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4451182|NCT00086411|4274630|B4|United States||Region of Enrollment||participants|Number|65|65.0||||||
4451183|NCT00086411|4274631|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4451184|NCT00086411|4274632|B2|United States||Region of Enrollment||participants|Number|63|63.0||||||
4451185|NCT00086411|4274633|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4451186|NCT00086411|4274629|B5||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4451187|NCT00086411|4274630|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4451188|NCT00086411|4274631|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4451189|NCT00086411|4274632|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4451190|NCT00086411|4274633|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4451191|NCT00086411|4274629|B5||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4451192|NCT00086411|4274630|B4||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4451193|NCT00086411|4274631|B3||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4451194|NCT00086411|4274632|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4451195|NCT00086411|4274633|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4451196|NCT00086411|4274629|B5|||Age||years|Mean|43.3|43.3|Standard Deviation|12.2|12.2|||
4451197|NCT00086411|4274630|B4|||Age||years|Mean|43.1|43.1|Standard Deviation|11.3|11.3|||
4451198|NCT00086411|4274631|B3|||Age||years|Mean|45.8|45.8|Standard Deviation|12.6|12.6|||
4451199|NCT00086411|4274632|B2|||Age||years|Mean|42.4|42.4|Standard Deviation|12.6|12.6|||
4451200|NCT00086411|4274633|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|12.5|12.5|||
4451201|NCT00086385|4274646|B5|United States||Region of Enrollment||participants|Number|402|402.0||||||
4451202|NCT00086385|4274647|B4|United States||Region of Enrollment||participants|Number|99|99.0||||||
4451203|NCT00086385|4274648|B3|United States||Region of Enrollment||participants|Number|104|104.0||||||
4451204|NCT00086385|4274649|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
4451205|NCT00086385|4274650|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4451206|NCT00086385|4274646|B5||Male|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4451207|NCT00086385|4274647|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4451208|NCT00086385|4274648|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4451209|NCT00086385|4274649|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4451210|NCT00086385|4274650|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4451211|NCT00086385|4274646|B5||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4451212|NCT00086385|4274647|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4451213|NCT00086385|4274648|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4451214|NCT00086385|4274649|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4451215|NCT00086385|4274650|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4451216|NCT00086385|4274646|B5|||Age||years|Mean|56.67|56.67|Standard Deviation|5.85|5.85|||
4451217|NCT00086385|4274647|B4|||Age||years|Mean|56.63|56.63|Standard Deviation|5.64|5.64|||
4451218|NCT00086385|4274648|B3|||Age||years|Mean|56.88|56.88|Standard Deviation|6.82|6.82|||
4451219|NCT00086385|4274649|B2|||Age||years|Mean|56.97|56.97|Standard Deviation|5.46|5.46|||
4451220|NCT00086385|4274650|B1|||Age||years|Mean|56.190|56.19|Standard Deviation|5.40|5.4|||
4451221|NCT00086385|4274646|B5||>=65 years|Age||Participants|Count of Participants|44|44.0||||||
4451222|NCT00086385|4274647|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4451223|NCT00086385|4274648|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4451224|NCT00086385|4274649|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4451225|NCT00086385|4274650|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4451226|NCT00086385|4274646|B5||Between 18 and 65 years|Age||Participants|Count of Participants|358|358.0||||||
4451227|NCT00086385|4274647|B4||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4451228|NCT00086385|4274648|B3||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4451229|NCT00086385|4274649|B2||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4451230|NCT00086385|4274650|B1||Between 18 and 65 years|Age||Participants|Count of Participants|93|93.0||||||
4451231|NCT00086385|4274646|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451232|NCT00086385|4274647|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451233|NCT00086385|4274648|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451234|NCT00086385|4274649|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451235|NCT00086385|4274650|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451236|NCT00086515|4274663|B3|||Hemoglobin A1C (A1C)||Percent|Mean|8.0|8.0|Standard Deviation|0.8|0.8|||
4451237|NCT00086515|4274664|B2|||Hemoglobin A1C (A1C)||Percent|Mean|8.0|8.0|Standard Deviation|0.8|0.8|||
4451238|NCT00086515|4274665|B1|||Hemoglobin A1C (A1C)||Percent|Mean|8.0|8.0|Standard Deviation|0.8|0.8|||
4451239|NCT00086515|4274663|B3|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|171.5|171.5|Standard Deviation|41.3|41.3|||
4451240|NCT00086515|4274664|B2|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|174.1|174.1|Standard Deviation|42.0|42.0|||
4451241|NCT00086515|4274665|B1|||Fasting Plasma Glucose (FPG)||mg/dL|Mean|170.2|170.2|Standard Deviation|40.2|40.2|||
4451242|NCT00086515|4274663|B3|Other||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4451243|NCT00086515|4274664|B2|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4451244|NCT00086515|4274665|B1|Other||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4451245|NCT00086515|4274663|B3|Asian||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4451246|NCT00086515|4274664|B2|Asian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4451247|NCT00086515|4274665|B1|Asian||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4451248|NCT00086515|4274663|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|100|100.0||||||
4451249|NCT00086515|4274664|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|28|28.0||||||
4451250|NCT00086515|4274665|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|72|72.0||||||
4451251|NCT00086515|4274663|B3|Black||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4451252|NCT00086515|4274664|B2|Black||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4451253|NCT00086515|4274665|B1|Black||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4451254|NCT00086515|4274663|B3|White||Race/Ethnicity, Customized||participants|Number|452|452.0||||||
4451255|NCT00086515|4274664|B2|White||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
4451256|NCT00086515|4274665|B1|White||Race/Ethnicity, Customized||participants|Number|293|293.0||||||
4451257|NCT00086515|4274663|B3||Male|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4451258|NCT00086515|4274664|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4451259|NCT00086515|4274665|B1||Male|Sex: Female, Male||Participants|Count of Participants|259|259.0||||||
4451260|NCT00086515|4274663|B3||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4451261|NCT00086515|4274664|B2||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4451262|NCT00086515|4274665|B1||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4451263|NCT00086515|4274663|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|10.2|10.2|||
4451264|NCT00086515|4274664|B2|||Age||years|Mean|54.7|54.7|Standard Deviation|9.7|9.7|||
4451265|NCT00086515|4274665|B1|||Age||years|Mean|54.4|54.4|Standard Deviation|10.4|10.4|||
4451266|NCT00086502|4274676|B3|||HbA1c (Hemoglobin A1c)||Percent|Mean|8.0|8.0|Standard Deviation|0.8|0.8|||
4451267|NCT00086502|4274677|B2|||HbA1c (Hemoglobin A1c)||Percent|Mean|8.0|8.0|Standard Deviation|0.8|0.8|||
4451268|NCT00086502|4274678|B1|||HbA1c (Hemoglobin A1c)||Percent|Mean|8.1|8.1|Standard Deviation|0.8|0.8|||
4451269|NCT00086502|4274676|B3|Other||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4451270|NCT00086502|4274677|B2|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4451271|NCT00086502|4274678|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4451272|NCT00086502|4274676|B3|Asian||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4451273|NCT00086502|4274677|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4451274|NCT00086502|4274678|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4451275|NCT00086502|4274676|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4451276|NCT00086502|4274677|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4451277|NCT00086502|4274678|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4451278|NCT00086502|4274676|B3|Black||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4451279|NCT00086502|4274677|B2|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4451280|NCT00086502|4274678|B1|Black||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4451281|NCT00086502|4274676|B3|White||Race/Ethnicity, Customized||participants|Number|256|256.0||||||
4451282|NCT00086502|4274677|B2|White||Race/Ethnicity, Customized||participants|Number|129|129.0||||||
4451283|NCT00086502|4274678|B1|White||Race/Ethnicity, Customized||participants|Number|127|127.0||||||
4451284|NCT00086502|4274676|B3||Male|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4451285|NCT00086502|4274677|B2||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4451286|NCT00086502|4274678|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4451287|NCT00086502|4274676|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4451288|NCT00086502|4274677|B2||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4451289|NCT00086502|4274678|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4451290|NCT00086502|4274676|B3|||Age||years|Mean|56.2|56.2|Standard Deviation|10.8|10.8|||
4451291|NCT00086502|4274677|B2|||Age||years|Mean|56.9|56.9|Standard Deviation|11.1|11.1|||
4451292|NCT00086502|4274678|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|10.4|10.4|||
4451293|NCT00086450|4274687|B3||Male|Gender||Participants|Count of Participants|1356|1356.0||||||
4451294|NCT00086450|4274688|B2||Male|Gender||Participants|Count of Participants|658|658.0||||||
4451295|NCT00086450|4274689|B1||Male|Gender||Participants|Count of Participants|698|698.0||||||
4451296|NCT00086450|4274687|B3||Female|Gender||Participants|Count of Participants|544|544.0||||||
4451297|NCT00086450|4274688|B2||Female|Gender||Participants|Count of Participants|289|289.0||||||
4451298|NCT00086450|4274689|B1||Female|Gender||Participants|Count of Participants|255|255.0||||||
4451299|NCT00086450|4274687|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|9.1|9.1|||
4451300|NCT00086450|4274688|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|9.2|9.2|||
4451301|NCT00086450|4274689|B1|||Age||years|Mean|63.2|63.2|Standard Deviation|8.9|8.9|||
4451302|NCT00086346|4274702|B3|||Mean serum creatinine levels||μmol/L|Mean|123.7|123.7|Standard Deviation|32.2|32.2|||
4451303|NCT00086346|4274703|B2|||Mean serum creatinine levels||μmol/L|Mean|125.2|125.2|Standard Deviation|31.9|31.9|||
4451304|NCT00086346|4274704|B1|||Mean serum creatinine levels||μmol/L|Mean|122.9|122.9|Standard Deviation|32.3|32.3|||
4451305|NCT00086346|4274702|B3||Male|Sex: Female, Male||Participants|Count of Participants|421.0|421.0||||||
4451306|NCT00086346|4274703|B2||Male|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4451307|NCT00086346|4274704|B1||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4451308|NCT00086346|4274702|B3||Female|Sex: Female, Male||Participants|Count of Participants|186.0|186.0||||||
4451309|NCT00086346|4274703|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4451310|NCT00086346|4274704|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4451311|NCT00086346|4274702|B3|||Age||years|Median|57.0|57.0|Full Range|||21.0|76.0|
4451312|NCT00086346|4274703|B2|||Age||years|Median|56.5|56.5|Full Range|||21.0|73.0|
4451313|NCT00086346|4274704|B1|||Age||years|Median|57.0|57.0|Full Range|||23.0|76.0|
4451314|NCT00086281|4274717|B16|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451315|NCT00086281|4274718|B15|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451316|NCT00086281|4274719|B14|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451317|NCT00086281|4274720|B13|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451318|NCT00086281|4274721|B12|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451319|NCT00086281|4274722|B11|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451320|NCT00086281|4274723|B10|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451321|NCT00086281|4274724|B9|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451322|NCT00086281|4274725|B8|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451323|NCT00086281|4274726|B7|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451324|NCT00086281|4274727|B6|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451325|NCT00086281|4274728|B5|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451326|NCT00086281|4274729|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451327|NCT00086281|4274730|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451328|NCT00086281|4274731|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451329|NCT00086281|4274732|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451330|NCT00086281|4274717|B16|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451331|NCT00086281|4274718|B15|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451332|NCT00086281|4274719|B14|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451333|NCT00086281|4274720|B13|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451334|NCT00086281|4274721|B12|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451335|NCT00086281|4274722|B11|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451336|NCT00086281|4274723|B10|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451337|NCT00086281|4274724|B9|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451338|NCT00086281|4274725|B8|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451339|NCT00086281|4274726|B7|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451340|NCT00086281|4274727|B6|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451341|NCT00086281|4274728|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451342|NCT00086281|4274729|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451343|NCT00086281|4274730|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451344|NCT00086281|4274731|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451345|NCT00086281|4274732|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451346|NCT00086281|4274717|B16|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4451347|NCT00086281|4274718|B15|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451348|NCT00086281|4274719|B14|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451349|NCT00086281|4274720|B13|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451350|NCT00086281|4274721|B12|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451351|NCT00086281|4274722|B11|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451352|NCT00086281|4274723|B10|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451353|NCT00086281|4274724|B9|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451354|NCT00086281|4274725|B8|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451355|NCT00086281|4274726|B7|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451356|NCT00086281|4274727|B6|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451357|NCT00086281|4274728|B5|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451358|NCT00086281|4274729|B4|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451359|NCT00086281|4274730|B3|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451360|NCT00086281|4274731|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451361|NCT00086281|4274732|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4451362|NCT00086281|4274717|B16|Caucasian||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
4451363|NCT00086281|4274718|B15|Caucasian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4451364|NCT00086281|4274719|B14|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451365|NCT00086281|4274720|B13|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451366|NCT00086281|4274721|B12|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451367|NCT00086281|4274722|B11|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4451368|NCT00086281|4274723|B10|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451369|NCT00086281|4274724|B9|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451370|NCT00086281|4274725|B8|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451371|NCT00086281|4274726|B7|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451372|NCT00086281|4274727|B6|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4451373|NCT00086281|4274728|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4451374|NCT00086281|4274729|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4451375|NCT00086281|4274730|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4451376|NCT00086281|4274731|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4451377|NCT00086281|4274732|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4451378|NCT00086281|4274717|B16||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4451379|NCT00086281|4274718|B15||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4451380|NCT00086281|4274719|B14||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4451381|NCT00086281|4274720|B13||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4451382|NCT00086281|4274721|B12||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451383|NCT00086281|4274722|B11||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4451384|NCT00086281|4274723|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451385|NCT00086281|4274724|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4451386|NCT00086281|4274725|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4451387|NCT00086281|4274726|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4451388|NCT00086281|4274727|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4451389|NCT00086281|4274728|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4451390|NCT00086281|4274729|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4451391|NCT00086281|4274730|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4451392|NCT00086281|4274731|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4451393|NCT00086281|4274732|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4451394|NCT00086281|4274717|B16||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4451395|NCT00086281|4274718|B15||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4451396|NCT00086281|4274719|B14||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451397|NCT00086281|4274720|B13||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451398|NCT00086281|4274721|B12||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4451399|NCT00086281|4274722|B11||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4451400|NCT00086281|4274723|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4451401|NCT00086281|4274724|B9||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451402|NCT00086281|4274725|B8||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451403|NCT00086281|4274726|B7||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451404|NCT00086281|4274727|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451405|NCT00086281|4274728|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451406|NCT00086281|4274729|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4451407|NCT00086281|4274730|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4451408|NCT00086281|4274731|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4451409|NCT00086281|4274732|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451410|NCT00086281|4274717|B16|||Age||years|Mean|50.2|50.2|Standard Deviation|9.59|9.59|||
4451411|NCT00086281|4274718|B15|||Age||years|Mean|48.0|48.0|Standard Deviation|7.00|7.0|||
4451412|NCT00086281|4274719|B14|||Age||years|Mean|36.0|36.0|Standard Deviation|0|0.0|||
4451413|NCT00086281|4274720|B13|||Age||years|Mean|61.0|61.0|Standard Deviation|0|0.0|||
4451414|NCT00086281|4274721|B12|||Age||years|Mean|63.0|63.0|Standard Deviation|0|0.0|||
4451415|NCT00086281|4274722|B11|||Age||years|Mean|59.3|59.3|Standard Deviation|7.77|7.77|||
4451416|NCT00086281|4274723|B10|||Age||years|Mean|43.0|43.0|Standard Deviation|0|0.0|||
4451417|NCT00086281|4274724|B9|||Age||years|Mean|64.0|64.0|Standard Deviation|18.38|18.38|||
4451418|NCT00086281|4274725|B8|||Age||years|Mean|42.0|42.0|Standard Deviation|0|0.0|||
4451419|NCT00086281|4274726|B7|||Age||years|Mean|61.0|61.0|Standard Deviation|0|0.0|||
4451420|NCT00086281|4274727|B6|||Age||years|Mean|47.3|47.3|Standard Deviation|6.11|6.11|||
4451421|NCT00086281|4274728|B5|||Age||years|Mean|49.0|49.0|Standard Deviation|0|0.0|||
4451422|NCT00086281|4274729|B4|||Age||years|Mean|50.5|50.5|Standard Deviation|8.45|8.45|||
4451423|NCT00086281|4274730|B3|||Age||years|Mean|49.4|49.4|Standard Deviation|4.44|4.44|||
4451424|NCT00086281|4274731|B2|||Age||years|Mean|46.3|46.3|Standard Deviation|11.39|11.39|||
4451425|NCT00086281|4274732|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|9.63|9.63|||
4451426|NCT00086307|4274756|B4|United States||Region of Enrollment||participants|Number|39|39.0||||||
4451427|NCT00086307|4274757|B3|United States||Region of Enrollment||participants|Number|13|13.0||||||
4451428|NCT00086307|4274758|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4451429|NCT00086307|4274759|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4451430|NCT00086307|4274756|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4451431|NCT00086307|4274757|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4451432|NCT00086307|4274758|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4451433|NCT00086307|4274759|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4451434|NCT00086307|4274756|B4||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4451435|NCT00086307|4274757|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4451436|NCT00086307|4274758|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4451437|NCT00086307|4274759|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4451438|NCT00086307|4274756|B4|||Age||years|Mean|45.3|45.3|Standard Deviation|11.9|11.9|||
4451439|NCT00086307|4274757|B3|||Age||years|Mean|45.3|45.3|Standard Deviation|12.7|12.7|||
4451440|NCT00086307|4274758|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|13.6|13.6|||
4451441|NCT00086307|4274759|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|10.1|10.1|||
4451442|NCT00086307|4274756|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451443|NCT00086307|4274757|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451444|NCT00086307|4274758|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451445|NCT00086307|4274759|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451446|NCT00086307|4274756|B4||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4451447|NCT00086307|4274757|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4451448|NCT00086307|4274758|B2||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4451449|NCT00086307|4274759|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4451450|NCT00086307|4274756|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451451|NCT00086307|4274757|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451452|NCT00086307|4274758|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451453|NCT00086307|4274759|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451454|NCT00086190|4274769|B4|Treatment - No||Treatment of PD - Anticholinergic|Participants taking Anticholinergic for treatment of Parkinson's Disease.|Participants|Number|105|105.0||||||
4451455|NCT00086190|4274770|B3|Treatment - No||Treatment of PD - Anticholinergic|Participants taking Anticholinergic for treatment of Parkinson's Disease.|Participants|Number|36|36.0||||||
4451456|NCT00086190|4274771|B2|Treatment - No||Treatment of PD - Anticholinergic|Participants taking Anticholinergic for treatment of Parkinson's Disease.|Participants|Number|30|30.0||||||
4451457|NCT00086190|4274772|B1|Treatment - No||Treatment of PD - Anticholinergic|Participants taking Anticholinergic for treatment of Parkinson's Disease.|Participants|Number|39|39.0||||||
4451458|NCT00086190|4274769|B4|Treatment - Yes||Treatment of PD - Anticholinergic|Participants taking Anticholinergic for treatment of Parkinson's Disease.|Participants|Number|10|10.0||||||
4451459|NCT00086190|4274770|B3|Treatment - Yes||Treatment of PD - Anticholinergic|Participants taking Anticholinergic for treatment of Parkinson's Disease.|Participants|Number|3|3.0||||||
4451460|NCT00086190|4274771|B2|Treatment - Yes||Treatment of PD - Anticholinergic|Participants taking Anticholinergic for treatment of Parkinson's Disease.|Participants|Number|4|4.0||||||
4451461|NCT00086190|4274772|B1|Treatment - Yes||Treatment of PD - Anticholinergic|Participants taking Anticholinergic for treatment of Parkinson's Disease.|Participants|Number|3|3.0||||||
4451462|NCT00086190|4274769|B4|Treatment - No||Treatment of PD - Amantadine|Participants taking Amantadine for treatment of Parkinson's Disease.|Participants|Number|99|99.0||||||
4451463|NCT00086190|4274770|B3|Treatment - No||Treatment of PD - Amantadine|Participants taking Amantadine for treatment of Parkinson's Disease.|Participants|Number|33|33.0||||||
4451464|NCT00086190|4274771|B2|Treatment - No||Treatment of PD - Amantadine|Participants taking Amantadine for treatment of Parkinson's Disease.|Participants|Number|30|30.0||||||
4451465|NCT00086190|4274772|B1|Treatment - No||Treatment of PD - Amantadine|Participants taking Amantadine for treatment of Parkinson's Disease.|Participants|Number|36|36.0||||||
4451466|NCT00086190|4274769|B4|Treatment - Yes||Treatment of PD - Amantadine|Participants taking Amantadine for treatment of Parkinson's Disease.|Participants|Number|16|16.0||||||
4451467|NCT00086190|4274770|B3|Treatment - Yes||Treatment of PD - Amantadine|Participants taking Amantadine for treatment of Parkinson's Disease.|Participants|Number|6|6.0||||||
4451468|NCT00086190|4274771|B2|Treatment - Yes||Treatment of PD - Amantadine|Participants taking Amantadine for treatment of Parkinson's Disease.|Participants|Number|4|4.0||||||
4451469|NCT00086190|4274772|B1|Treatment - Yes||Treatment of PD - Amantadine|Participants taking Amantadine for treatment of Parkinson's Disease.|Participants|Number|6|6.0||||||
4451470|NCT00086190|4274769|B4|Treatment - No||Treatment for PD - Catechol O-methyltransferase Inhibitor|Participants taking Catechol O-methyltransferase (COMT) Inhibitor for treatment of Parkinson's Disease.|Participants|Number|86|86.0||||||
4451471|NCT00086190|4274770|B3|Treatment - No||Treatment for PD - Catechol O-methyltransferase Inhibitor|Participants taking Catechol O-methyltransferase (COMT) Inhibitor for treatment of Parkinson's Disease.|Participants|Number|28|28.0||||||
4451472|NCT00086190|4274771|B2|Treatment - No||Treatment for PD - Catechol O-methyltransferase Inhibitor|Participants taking Catechol O-methyltransferase (COMT) Inhibitor for treatment of Parkinson's Disease.|Participants|Number|25|25.0||||||
4451473|NCT00086190|4274772|B1|Treatment - No||Treatment for PD - Catechol O-methyltransferase Inhibitor|Participants taking Catechol O-methyltransferase (COMT) Inhibitor for treatment of Parkinson's Disease.|Participants|Number|33|33.0||||||
4451474|NCT00086190|4274769|B4|Treatment - Yes||Treatment for PD - Catechol O-methyltransferase Inhibitor|Participants taking Catechol O-methyltransferase (COMT) Inhibitor for treatment of Parkinson's Disease.|Participants|Number|29|29.0||||||
4451475|NCT00086190|4274770|B3|Treatment - Yes||Treatment for PD - Catechol O-methyltransferase Inhibitor|Participants taking Catechol O-methyltransferase (COMT) Inhibitor for treatment of Parkinson's Disease.|Participants|Number|11|11.0||||||
4451476|NCT00086190|4274771|B2|Treatment - Yes||Treatment for PD - Catechol O-methyltransferase Inhibitor|Participants taking Catechol O-methyltransferase (COMT) Inhibitor for treatment of Parkinson's Disease.|Participants|Number|9|9.0||||||
4451477|NCT00086190|4274772|B1|Treatment - Yes||Treatment for PD - Catechol O-methyltransferase Inhibitor|Participants taking Catechol O-methyltransferase (COMT) Inhibitor for treatment of Parkinson's Disease.|Participants|Number|9|9.0||||||
4451478|NCT00086190|4274769|B4|Treatment - No||Treatment of PD - Agonist|Participants taking Agonist for treatment of Parkinson's Disease.|Participants|Number|73|73.0||||||
4451479|NCT00086190|4274770|B3|Treatment - No||Treatment of PD - Agonist|Participants taking Agonist for treatment of Parkinson's Disease.|Participants|Number|27|27.0||||||
4451480|NCT00086190|4274771|B2|Treatment - No||Treatment of PD - Agonist|Participants taking Agonist for treatment of Parkinson's Disease.|Participants|Number|21|21.0||||||
4451481|NCT00086190|4274772|B1|Treatment - No||Treatment of PD - Agonist|Participants taking Agonist for treatment of Parkinson's Disease.|Participants|Number|25|25.0||||||
4451482|NCT00086190|4274769|B4|Treatment - Yes||Treatment of PD - Agonist|Participants taking Agonist for treatment of Parkinson's Disease.|Participants|Number|42|42.0||||||
4451483|NCT00086190|4274770|B3|Treatment - Yes||Treatment of PD - Agonist|Participants taking Agonist for treatment of Parkinson's Disease.|Participants|Number|12|12.0||||||
4451484|NCT00086190|4274771|B2|Treatment - Yes||Treatment of PD - Agonist|Participants taking Agonist for treatment of Parkinson's Disease.|Participants|Number|13|13.0||||||
4451485|NCT00086190|4274772|B1|Treatment - Yes||Treatment of PD - Agonist|Participants taking Agonist for treatment of Parkinson's Disease.|Participants|Number|17|17.0||||||
4451486|NCT00086190|4274769|B4|Treatment - No||Treatment of PD - Levodopa|Participants taking Levodopa for treatment of Parkinson's Disease.|Participants|Number|18|18.0||||||
4451487|NCT00086190|4274770|B3|Treatment - No||Treatment of PD - Levodopa|Participants taking Levodopa for treatment of Parkinson's Disease.|Participants|Number|7|7.0||||||
4451488|NCT00086190|4274771|B2|Treatment - No||Treatment of PD - Levodopa|Participants taking Levodopa for treatment of Parkinson's Disease.|Participants|Number|7|7.0||||||
4451489|NCT00086190|4274772|B1|Treatment - No||Treatment of PD - Levodopa|Participants taking Levodopa for treatment of Parkinson's Disease.|Participants|Number|4|4.0||||||
4451490|NCT00086190|4274769|B4|Treatment - Yes||Treatment of PD - Levodopa|Participants taking Levodopa for treatment of Parkinson's Disease.|Participants|Number|97|97.0||||||
4451491|NCT00086190|4274770|B3|Treatment - Yes||Treatment of PD - Levodopa|Participants taking Levodopa for treatment of Parkinson's Disease.|Participants|Number|32|32.0||||||
4451492|NCT00086190|4274771|B2|Treatment - Yes||Treatment of PD - Levodopa|Participants taking Levodopa for treatment of Parkinson's Disease.|Participants|Number|27|27.0||||||
4451493|NCT00086190|4274772|B1|Treatment - Yes||Treatment of PD - Levodopa|Participants taking Levodopa for treatment of Parkinson's Disease.|Participants|Number|38|38.0||||||
4451494|NCT00086190|4274769|B4|||BPRS Score|Brief Psychiatric Rating Scale. Maximum score 126, minimum score 0. Higher score indicates greater psychiatric difficulties.|Score|Mean|34.6|34.6|Standard Deviation|9.6|9.6|||
4451495|NCT00086190|4274770|B3|||BPRS Score|Brief Psychiatric Rating Scale. Maximum score 126, minimum score 0. Higher score indicates greater psychiatric difficulties.|Score|Mean|34.4|34.4|Standard Deviation|9.3|9.3|||
4451496|NCT00086190|4274771|B2|||BPRS Score|Brief Psychiatric Rating Scale. Maximum score 126, minimum score 0. Higher score indicates greater psychiatric difficulties.|Score|Mean|35.7|35.7|Standard Deviation|8.9|8.9|||
4451497|NCT00086190|4274772|B1|||BPRS Score|Brief Psychiatric Rating Scale. Maximum score 126, minimum score 0. Higher score indicates greater psychiatric difficulties.|Score|Mean|33.6|33.6|Standard Deviation|10.7|10.7|||
4451498|NCT00086190|4274769|B4|||Mini Mental State Examination Score|Mini Mental State Examination (MMSE). Range 0-30. Higher score indicates better cognitive status. Score less than 9 = severe cognitive impairment, 10-20 moderate impairment, 21-24 mild impairment, 25 and greater considered normal.|Score|Mean|28.7|28.7|Standard Deviation|1.6|1.6|||
4451499|NCT00086190|4274770|B3|||Mini Mental State Examination Score|Mini Mental State Examination (MMSE). Range 0-30. Higher score indicates better cognitive status. Score less than 9 = severe cognitive impairment, 10-20 moderate impairment, 21-24 mild impairment, 25 and greater considered normal.|Score|Mean|28.5|28.5|Standard Deviation|1.5|1.5|||
4451500|NCT00086190|4274771|B2|||Mini Mental State Examination Score|Mini Mental State Examination (MMSE). Range 0-30. Higher score indicates better cognitive status. Score less than 9 = severe cognitive impairment, 10-20 moderate impairment, 21-24 mild impairment, 25 and greater considered normal.|Score|Mean|28.9|28.9|Standard Deviation|1.8|1.8|||
4451501|NCT00086190|4274772|B1|||Mini Mental State Examination Score|Mini Mental State Examination (MMSE). Range 0-30. Higher score indicates better cognitive status. Score less than 9 = severe cognitive impairment, 10-20 moderate impairment, 21-24 mild impairment, 25 and greater considered normal.|Score|Mean|28.7|28.7|Standard Deviation|1.4|1.4|||
4451502|NCT00086190|4274769|B4|||Snaith CAS|Snaith Clinical Anxiety Scale. Range 0-21. Higher scores indicate increased anxiety. Score greater than 8 indicates clinical anxiety.|Score|Mean|7.3|7.3|Standard Deviation|4.2|4.2|||
4451503|NCT00086190|4274770|B3|||Snaith CAS|Snaith Clinical Anxiety Scale. Range 0-21. Higher scores indicate increased anxiety. Score greater than 8 indicates clinical anxiety.|Score|Mean|7.5|7.5|Standard Deviation|4.3|4.3|||
4451504|NCT00086190|4274771|B2|||Snaith CAS|Snaith Clinical Anxiety Scale. Range 0-21. Higher scores indicate increased anxiety. Score greater than 8 indicates clinical anxiety.|Score|Mean|7.8|7.8|Standard Deviation|4.5|4.5|||
4451505|NCT00086190|4274772|B1|||Snaith CAS|Snaith Clinical Anxiety Scale. Range 0-21. Higher scores indicate increased anxiety. Score greater than 8 indicates clinical anxiety.|Score|Mean|6.7|6.7|Standard Deviation|3.9|3.9|||
4451506|NCT00086190|4274769|B4|Mental Component Summary||Short Form-36 Health Survey Scores|Short Form 36 Health Survey. Range 0-100. Higher score indicates a better perceived quality of life.|Score|Mean|39.9|39.9|Standard Deviation|9.4|9.4|||
4451507|NCT00086190|4274770|B3|Mental Component Summary||Short Form-36 Health Survey Scores|Short Form 36 Health Survey. Range 0-100. Higher score indicates a better perceived quality of life.|Score|Mean|40.0|40.0|Standard Deviation|9.3|9.3|||
4451508|NCT00086190|4274771|B2|Mental Component Summary||Short Form-36 Health Survey Scores|Short Form 36 Health Survey. Range 0-100. Higher score indicates a better perceived quality of life.|Score|Mean|38.3|38.3|Standard Deviation|10.1|10.1|||
4451509|NCT00086190|4274772|B1|Mental Component Summary||Short Form-36 Health Survey Scores|Short Form 36 Health Survey. Range 0-100. Higher score indicates a better perceived quality of life.|Score|Mean|41.4|41.4|Standard Deviation|8.8|8.8|||
4451615|NCT00086190|4274770|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451510|NCT00086190|4274769|B4|Physical Component Summary||Short Form-36 Health Survey Scores|Short Form 36 Health Survey. Range 0-100. Higher score indicates a better perceived quality of life.|Score|Mean|36.9|36.9|Standard Deviation|10|10.0|||
4451511|NCT00086190|4274770|B3|Physical Component Summary||Short Form-36 Health Survey Scores|Short Form 36 Health Survey. Range 0-100. Higher score indicates a better perceived quality of life.|Score|Mean|37.1|37.1|Standard Deviation|10.4|10.4|||
4451512|NCT00086190|4274771|B2|Physical Component Summary||Short Form-36 Health Survey Scores|Short Form 36 Health Survey. Range 0-100. Higher score indicates a better perceived quality of life.|Score|Mean|36.2|36.2|Standard Deviation|10.3|10.3|||
4451513|NCT00086190|4274772|B1|Physical Component Summary||Short Form-36 Health Survey Scores|Short Form 36 Health Survey. Range 0-100. Higher score indicates a better perceived quality of life.|Score|Mean|37.5|37.5|Standard Deviation|9.3|9.3|||
4451514|NCT00086190|4274769|B4|||PDQ-39 Total|Parkinson's Disease Questionnaire (PDQ-39) Total. Range 0-100. Lower score indicates a better perceived health status.|Score on PDQ-39 Questionnaire|Mean|37.9|37.9|Standard Deviation|15.6|15.6|||
4451515|NCT00086190|4274770|B3|||PDQ-39 Total|Parkinson's Disease Questionnaire (PDQ-39) Total. Range 0-100. Lower score indicates a better perceived health status.|Score on PDQ-39 Questionnaire|Mean|39.6|39.6|Standard Deviation|14.8|14.8|||
4451516|NCT00086190|4274771|B2|||PDQ-39 Total|Parkinson's Disease Questionnaire (PDQ-39) Total. Range 0-100. Lower score indicates a better perceived health status.|Score on PDQ-39 Questionnaire|Mean|37.2|37.2|Standard Deviation|15.6|15.6|||
4451517|NCT00086190|4274772|B1|||PDQ-39 Total|Parkinson's Disease Questionnaire (PDQ-39) Total. Range 0-100. Lower score indicates a better perceived health status.|Score on PDQ-39 Questionnaire|Mean|36.8|36.8|Standard Deviation|16.3|16.3|||
4451518|NCT00086190|4274769|B4|No||Motor Fluctuations||Participants|Number|46|46.0||||||
4451519|NCT00086190|4274770|B3|No||Motor Fluctuations||Participants|Number|15|15.0||||||
4451520|NCT00086190|4274771|B2|No||Motor Fluctuations||Participants|Number|14|14.0||||||
4451521|NCT00086190|4274772|B1|No||Motor Fluctuations||Participants|Number|17|17.0||||||
4451522|NCT00086190|4274769|B4|Yes||Motor Fluctuations||Participants|Number|69|69.0||||||
4451523|NCT00086190|4274770|B3|Yes||Motor Fluctuations||Participants|Number|24|24.0||||||
4451524|NCT00086190|4274771|B2|Yes||Motor Fluctuations||Participants|Number|20|20.0||||||
4451525|NCT00086190|4274772|B1|Yes||Motor Fluctuations||Participants|Number|25|25.0||||||
4451526|NCT00086190|4274769|B4|||"Schwab/England Activities of Daily Living Score (On)"|Schwab and England Activities of Daily Living Scale (S/E ADL). Range 0-100%. Higher percentage indicates higher level of function and lower impact of disease on life activities.|Score|Mean|81.3|81.3|Standard Deviation|13.1|13.1|||
4451527|NCT00086190|4274770|B3|||"Schwab/England Activities of Daily Living Score (On)"|Schwab and England Activities of Daily Living Scale (S/E ADL). Range 0-100%. Higher percentage indicates higher level of function and lower impact of disease on life activities.|Score|Mean|80.8|80.8|Standard Deviation|13.4|13.4|||
4451528|NCT00086190|4274771|B2|||"Schwab/England Activities of Daily Living Score (On)"|Schwab and England Activities of Daily Living Scale (S/E ADL). Range 0-100%. Higher percentage indicates higher level of function and lower impact of disease on life activities.|Score|Mean|80.3|80.3|Standard Deviation|14.6|14.6|||
4451529|NCT00086190|4274772|B1|||"Schwab/England Activities of Daily Living Score (On)"|Schwab and England Activities of Daily Living Scale (S/E ADL). Range 0-100%. Higher percentage indicates higher level of function and lower impact of disease on life activities.|Score|Mean|82.9|82.9|Standard Deviation|11.2|11.2|||
4451530|NCT00086190|4274769|B4|Total||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|42.5|42.5|Standard Deviation|16.6|16.6|||
4451531|NCT00086190|4274770|B3|Total||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|41.7|41.7|Standard Deviation|15.9|15.9|||
4451532|NCT00086190|4274771|B2|Total||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|43.1|43.1|Standard Deviation|19.0|19.0|||
4451533|NCT00086190|4274772|B1|Total||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|42.7|42.7|Standard Deviation|14.9|14.9|||
4451534|NCT00086190|4274769|B4|Motor||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|10.9|10.9|Standard Deviation|6.5|6.5|||
4451535|NCT00086190|4274770|B3|Motor||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|10.8|10.8|Standard Deviation|5.5|5.5|||
4451536|NCT00086190|4274771|B2|Motor||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|11.4|11.4|Standard Deviation|7.4|7.4|||
4451537|NCT00086190|4274772|B1|Motor||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|10.6|10.6|Standard Deviation|6.7|6.7|||
4451538|NCT00086190|4274769|B4|Activities of Daily Living||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|26.8|26.8|Standard Deviation|11.1|11.1|||
4451616|NCT00086190|4274771|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451539|NCT00086190|4274770|B3|Activities of Daily Living||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|26.4|26.4|Standard Deviation|11.5|11.5|||
4451540|NCT00086190|4274771|B2|Activities of Daily Living||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|26.8|26.8|Standard Deviation|12.3|12.3|||
4451541|NCT00086190|4274772|B1|Activities of Daily Living||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|27.3|27.3|Standard Deviation|9.6|9.6|||
4451542|NCT00086190|4274769|B4|Mental||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|4.9|4.9|Standard Deviation|2.1|2.1|||
4451543|NCT00086190|4274770|B3|Mental||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|4.6|4.6|Standard Deviation|2.0|2.0|||
4451544|NCT00086190|4274771|B2|Mental||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|5.2|5.2|Standard Deviation|1.9|1.9|||
4451545|NCT00086190|4274772|B1|Mental||UPDRS Score|Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum score = 0.|Score|Mean|4.8|4.8|Standard Deviation|2.4|2.4|||
4451546|NCT00086190|4274769|B4|3.0-4.0 (Moderate to Severe Bilateral Parkinson's)||Hoehn and Yahr Stage|As the stage rating increases, the severity of the disease increases. Ranges from 1.0 to 5.0.|Participants|Number|17|17.0||||||
4451547|NCT00086190|4274770|B3|3.0-4.0 (Moderate to Severe Bilateral Parkinson's)||Hoehn and Yahr Stage|As the stage rating increases, the severity of the disease increases. Ranges from 1.0 to 5.0.|Participants|Number|5|5.0||||||
4451548|NCT00086190|4274771|B2|3.0-4.0 (Moderate to Severe Bilateral Parkinson's)||Hoehn and Yahr Stage|As the stage rating increases, the severity of the disease increases. Ranges from 1.0 to 5.0.|Participants|Number|5|5.0||||||
4451549|NCT00086190|4274772|B1|3.0-4.0 (Moderate to Severe Bilateral Parkinson's)||Hoehn and Yahr Stage|As the stage rating increases, the severity of the disease increases. Ranges from 1.0 to 5.0.|Participants|Number|7|7.0||||||
4451550|NCT00086190|4274769|B4|2.0-2.5 (Mild Bilateral Parkinson's Disease)||Hoehn and Yahr Stage|As the stage rating increases, the severity of the disease increases. Ranges from 1.0 to 5.0.|Participants|Number|92|92.0||||||
4451551|NCT00086190|4274770|B3|2.0-2.5 (Mild Bilateral Parkinson's Disease)||Hoehn and Yahr Stage|As the stage rating increases, the severity of the disease increases. Ranges from 1.0 to 5.0.|Participants|Number|31|31.0||||||
4451552|NCT00086190|4274771|B2|2.0-2.5 (Mild Bilateral Parkinson's Disease)||Hoehn and Yahr Stage|As the stage rating increases, the severity of the disease increases. Ranges from 1.0 to 5.0.|Participants|Number|29|29.0||||||
4451553|NCT00086190|4274772|B1|2.0-2.5 (Mild Bilateral Parkinson's Disease)||Hoehn and Yahr Stage|As the stage rating increases, the severity of the disease increases. Ranges from 1.0 to 5.0.|Participants|Number|32|32.0||||||
4451554|NCT00086190|4274769|B4|1.0-1.5 (Unilateral Parkinson's Disease)||Hoehn and Yahr Stage|As the stage rating increases, the severity of the disease increases. Ranges from 1.0 to 5.0.|Participants|Number|6|6.0||||||
4451555|NCT00086190|4274770|B3|1.0-1.5 (Unilateral Parkinson's Disease)||Hoehn and Yahr Stage|As the stage rating increases, the severity of the disease increases. Ranges from 1.0 to 5.0.|Participants|Number|3|3.0||||||
4451556|NCT00086190|4274771|B2|1.0-1.5 (Unilateral Parkinson's Disease)||Hoehn and Yahr Stage|As the stage rating increases, the severity of the disease increases. Ranges from 1.0 to 5.0.|Participants|Number|0|0.0||||||
4451557|NCT00086190|4274772|B1|1.0-1.5 (Unilateral Parkinson's Disease)||Hoehn and Yahr Stage|As the stage rating increases, the severity of the disease increases. Ranges from 1.0 to 5.0.|Participants|Number|3|3.0||||||
4451558|NCT00086190|4274769|B4|||Years since PD Diagnosis||Years|Mean|4.9|4.9|Standard Deviation|4.4|4.4|||
4451559|NCT00086190|4274770|B3|||Years since PD Diagnosis||Years|Mean|4.9|4.9|Standard Deviation|3.6|3.6|||
4451560|NCT00086190|4274771|B2|||Years since PD Diagnosis||Years|Mean|4.7|4.7|Standard Deviation|3.7|3.7|||
4451561|NCT00086190|4274772|B1|||Years since PD Diagnosis||Years|Mean|5.2|5.2|Standard Deviation|5.9|5.9|||
4451562|NCT00086190|4274769|B4|||Years since PD Onset||Years|Mean|7.0|7.0|Standard Deviation|4.6|4.6|||
4451563|NCT00086190|4274770|B3|||Years since PD Onset||Years|Mean|7.0|7.0|Standard Deviation|3.8|3.8|||
4451564|NCT00086190|4274771|B2|||Years since PD Onset||Years|Mean|7.4|7.4|Standard Deviation|4.2|4.2|||
4451565|NCT00086190|4274772|B1|||Years since PD Onset||Years|Mean|6.7|6.7|Standard Deviation|5.8|5.8|||
4451566|NCT00086190|4274769|B4|||BDI-II Score|Beck Depression Inventory II. Range 0-63. Higher score indicates more severe depression. 0-13 minimal depression, 14-19 mild depression, 20-28 moderate depression, 29-63 severe depression.|Score|Mean|17.3|17.3|Standard Deviation|8.6|8.6|||
4451567|NCT00086190|4274770|B3|||BDI-II Score|Beck Depression Inventory II. Range 0-63. Higher score indicates more severe depression. 0-13 minimal depression, 14-19 mild depression, 20-28 moderate depression, 29-63 severe depression.|Score|Mean|17.5|17.5|Standard Deviation|7.4|7.4|||
4451568|NCT00086190|4274771|B2|||BDI-II Score|Beck Depression Inventory II. Range 0-63. Higher score indicates more severe depression. 0-13 minimal depression, 14-19 mild depression, 20-28 moderate depression, 29-63 severe depression.|Score|Mean|17.1|17.1|Standard Deviation|9.1|9.1|||
4451569|NCT00086190|4274772|B1|||BDI-II Score|Beck Depression Inventory II. Range 0-63. Higher score indicates more severe depression. 0-13 minimal depression, 14-19 mild depression, 20-28 moderate depression, 29-63 severe depression.|Score|Mean|17.2|17.2|Standard Deviation|9.2|9.2|||
4451570|NCT00086190|4274769|B4|||GDS Score|Geriatric Depression Scale. Range 0-30. Higher score indicates more severe depression. 0-9 normal, 10-19 mild depression, 20-30 severe depression.|Score|Mean|15.2|15.2|Standard Deviation|5.6|5.6|||
4451571|NCT00086190|4274770|B3|||GDS Score|Geriatric Depression Scale. Range 0-30. Higher score indicates more severe depression. 0-9 normal, 10-19 mild depression, 20-30 severe depression.|Score|Mean|15.0|15.0|Standard Deviation|4.9|4.9|||
4451572|NCT00086190|4274771|B2|||GDS Score|Geriatric Depression Scale. Range 0-30. Higher score indicates more severe depression. 0-9 normal, 10-19 mild depression, 20-30 severe depression.|Score|Mean|15.1|15.1|Standard Deviation|5.8|5.8|||
4451573|NCT00086190|4274772|B1|||GDS Score|Geriatric Depression Scale. Range 0-30. Higher score indicates more severe depression. 0-9 normal, 10-19 mild depression, 20-30 severe depression.|Score|Mean|15.5|15.5|Standard Deviation|6.2|6.2|||
4451574|NCT00086190|4274769|B4|||MADRS Score|Montgomery-Asberg Depression Rating Scale. Range 0-60. Higher score indicates more severe depression. 0-6 normal, 7-19 mild depression, 20-34 moderate depression, greater than 34 severe depression.|Score|Mean|20.1|20.1|Standard Deviation|6.9|6.9|||
4451575|NCT00086190|4274770|B3|||MADRS Score|Montgomery-Asberg Depression Rating Scale. Range 0-60. Higher score indicates more severe depression. 0-6 normal, 7-19 mild depression, 20-34 moderate depression, greater than 34 severe depression.|Score|Mean|19.9|19.9|Standard Deviation|5.9|5.9|||
4451576|NCT00086190|4274771|B2|||MADRS Score|Montgomery-Asberg Depression Rating Scale. Range 0-60. Higher score indicates more severe depression. 0-6 normal, 7-19 mild depression, 20-34 moderate depression, greater than 34 severe depression.|Score|Mean|19.4|19.4|Standard Deviation|7.9|7.9|||
4451577|NCT00086190|4274772|B1|||MADRS Score|Montgomery-Asberg Depression Rating Scale. Range 0-60. Higher score indicates more severe depression. 0-6 normal, 7-19 mild depression, 20-34 moderate depression, greater than 34 severe depression.|Score|Mean|21.0|21.0|Standard Deviation|6.8|6.8|||
4451578|NCT00086190|4274769|B4|||HAM-D Score|Hamilton Depression Rating Scale. Ranges from 0-50. Higher scores represent more significant depression. Mild depression ranges from 8-13, moderate depression from 14-18, severe 19-22 and very severe any score over 23.|Hamilton Depression Score|Mean|21.6|21.6|Standard Deviation|5.8|5.8|||
4451579|NCT00086190|4274770|B3|||HAM-D Score|Hamilton Depression Rating Scale. Ranges from 0-50. Higher scores represent more significant depression. Mild depression ranges from 8-13, moderate depression from 14-18, severe 19-22 and very severe any score over 23.|Hamilton Depression Score|Mean|21.4|21.4|Standard Deviation|4.8|4.8|||
4451580|NCT00086190|4274771|B2|||HAM-D Score|Hamilton Depression Rating Scale. Ranges from 0-50. Higher scores represent more significant depression. Mild depression ranges from 8-13, moderate depression from 14-18, severe 19-22 and very severe any score over 23.|Hamilton Depression Score|Mean|21.2|21.2|Standard Deviation|6.0|6.0|||
4451581|NCT00086190|4274772|B1|||HAM-D Score|Hamilton Depression Rating Scale. Ranges from 0-50. Higher scores represent more significant depression. Mild depression ranges from 8-13, moderate depression from 14-18, severe 19-22 and very severe any score over 23.|Hamilton Depression Score|Mean|22.2|22.2|Standard Deviation|6.5|6.5|||
4451582|NCT00086190|4274769|B4|No||Past Antidepressant Use||participants|Number|105|105.0||||||
4451583|NCT00086190|4274770|B3|No||Past Antidepressant Use||participants|Number|34|34.0||||||
4451584|NCT00086190|4274771|B2|No||Past Antidepressant Use||participants|Number|32|32.0||||||
4451585|NCT00086190|4274772|B1|No||Past Antidepressant Use||participants|Number|39|39.0||||||
4451586|NCT00086190|4274769|B4|Yes||Past Antidepressant Use||participants|Number|10|10.0||||||
4451587|NCT00086190|4274770|B3|Yes||Past Antidepressant Use||participants|Number|5|5.0||||||
4451588|NCT00086190|4274771|B2|Yes||Past Antidepressant Use||participants|Number|2|2.0||||||
4451589|NCT00086190|4274772|B1|Yes||Past Antidepressant Use||participants|Number|3|3.0||||||
4451590|NCT00086190|4274769|B4|No||Major Depression||participants|Number|42|42.0||||||
4451591|NCT00086190|4274770|B3|No||Major Depression||participants|Number|17|17.0||||||
4451592|NCT00086190|4274771|B2|No||Major Depression||participants|Number|12|12.0||||||
4451593|NCT00086190|4274772|B1|No||Major Depression||participants|Number|13|13.0||||||
4451594|NCT00086190|4274769|B4|Yes||Major Depression||participants|Number|73|73.0||||||
4451595|NCT00086190|4274770|B3|Yes||Major Depression||participants|Number|22|22.0||||||
4451596|NCT00086190|4274771|B2|Yes||Major Depression||participants|Number|22|22.0||||||
4451597|NCT00086190|4274772|B1|Yes||Major Depression||participants|Number|29|29.0||||||
4451598|NCT00086190|4274769|B4|Not married||Marriage||participants|Number|33|33.0||||||
4451599|NCT00086190|4274770|B3|Not married||Marriage||participants|Number|11|11.0||||||
4451600|NCT00086190|4274771|B2|Not married||Marriage||participants|Number|7|7.0||||||
4451601|NCT00086190|4274772|B1|Not married||Marriage||participants|Number|15|15.0||||||
4451602|NCT00086190|4274769|B4|Married||Marriage||participants|Number|82|82.0||||||
4451603|NCT00086190|4274770|B3|Married||Marriage||participants|Number|28|28.0||||||
4451604|NCT00086190|4274771|B2|Married||Marriage||participants|Number|27|27.0||||||
4451605|NCT00086190|4274772|B1|Married||Marriage||participants|Number|27|27.0||||||
4451606|NCT00086190|4274769|B4|Not beyond High School||Education beyond High School||participants|Number|26|26.0||||||
4451607|NCT00086190|4274770|B3|Not beyond High School||Education beyond High School||participants|Number|12|12.0||||||
4451608|NCT00086190|4274771|B2|Not beyond High School||Education beyond High School||participants|Number|7|7.0||||||
4451609|NCT00086190|4274772|B1|Not beyond High School||Education beyond High School||participants|Number|7|7.0||||||
4451610|NCT00086190|4274769|B4|Beyond High School||Education beyond High School||participants|Number|89|89.0||||||
4451611|NCT00086190|4274770|B3|Beyond High School||Education beyond High School||participants|Number|27|27.0||||||
4451612|NCT00086190|4274771|B2|Beyond High School||Education beyond High School||participants|Number|27|27.0||||||
4451613|NCT00086190|4274772|B1|Beyond High School||Education beyond High School||participants|Number|35|35.0||||||
4451614|NCT00086190|4274769|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451678|NCT00085917|4274851|B2|||Age||years|Mean|46|46.0|Standard Deviation|5.93|5.93|||
4451617|NCT00086190|4274772|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451618|NCT00086190|4274769|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4451619|NCT00086190|4274770|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4451620|NCT00086190|4274771|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4451621|NCT00086190|4274772|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4451622|NCT00086190|4274769|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4451623|NCT00086190|4274770|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4451624|NCT00086190|4274771|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4451625|NCT00086190|4274772|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4451626|NCT00086190|4274769|B4||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4451627|NCT00086190|4274770|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4451628|NCT00086190|4274771|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4451629|NCT00086190|4274772|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4451630|NCT00086190|4274769|B4||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4451631|NCT00086190|4274770|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4451632|NCT00086190|4274771|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4451633|NCT00086190|4274772|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4451634|NCT00086190|4274769|B4|||Age||years|Mean|63.5|63.5|Standard Deviation|10.7|10.7|||
4451635|NCT00086190|4274770|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|11.0|11.0|||
4451636|NCT00086190|4274771|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|11.4|11.4|||
4451637|NCT00086190|4274772|B1|||Age||years|Mean|65.2|65.2|Standard Deviation|9.8|9.8|||
4451638|NCT00086138|4274830|B3|Male||Sex/Gender, Customized||participants|Number|60|60.0||||||
4451639|NCT00086138|4274831|B2|Male||Sex/Gender, Customized||participants|Number|33|33.0||||||
4451640|NCT00086138|4274832|B1|Male||Sex/Gender, Customized||participants|Number|27|27.0||||||
4451641|NCT00086138|4274830|B3|Female||Sex/Gender, Customized||participants|Number|71|71.0||||||
4451642|NCT00086138|4274831|B2|Female||Sex/Gender, Customized||participants|Number|31|31.0||||||
4451643|NCT00086138|4274832|B1|Female||Sex/Gender, Customized||participants|Number|40|40.0||||||
4451644|NCT00086138|4274830|B3|Age||Age, Customized||years|Mean|77.3|77.3|Standard Deviation|8|8.0|||
4451645|NCT00086138|4274831|B2|Age||Age, Customized||years|Mean|78.2|78.2|Standard Deviation|8|8.0|||
4451646|NCT00086138|4274832|B1|Age||Age, Customized||years|Mean|76.5|76.5|Standard Deviation|8|8.0|||
4451647|NCT00086047|4274841|B3|United States||Region of Enrollment||participants|Number|114|114.0||||||
4451648|NCT00086047|4274842|B2|United States||Region of Enrollment||participants|Number|57|57.0||||||
4451649|NCT00086047|4274843|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4451650|NCT00086047|4274841|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4451651|NCT00086047|4274842|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4451652|NCT00086047|4274843|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4451653|NCT00086047|4274841|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4451654|NCT00086047|4274842|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4451655|NCT00086047|4274843|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4451656|NCT00086047|4274841|B3|||Age||years|Mean|15.0|15.0|Standard Deviation|1.8|1.8|||
4451657|NCT00086047|4274842|B2|||Age||years|Mean|14.9|14.9|Standard Deviation|1.7|1.7|||
4451658|NCT00086047|4274843|B1|||Age||years|Mean|15.2|15.2|Standard Deviation|1.8|1.8|||
4451659|NCT00086047|4274841|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451660|NCT00086047|4274842|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451661|NCT00086047|4274843|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451662|NCT00086047|4274841|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4451663|NCT00086047|4274842|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4451664|NCT00086047|4274843|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4451665|NCT00086047|4274841|B3||<=18 years|Age||Participants|Count of Participants|114|114.0||||||
4451666|NCT00086047|4274842|B2||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4451667|NCT00086047|4274843|B1||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4451668|NCT00085917|4274850|B3|United States||Region of Enrollment||participants|Number|29|29.0||||||
4451669|NCT00085917|4274851|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4451670|NCT00085917|4274852|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4451671|NCT00085917|4274850|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4451672|NCT00085917|4274851|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4451673|NCT00085917|4274852|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4451674|NCT00085917|4274850|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4451675|NCT00085917|4274851|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4451676|NCT00085917|4274852|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4451677|NCT00085917|4274850|B3|||Age||years|Mean|47|47.0|Standard Deviation|6.109|6.109|||
4451679|NCT00085917|4274852|B1|||Age||years|Mean|48|48.0|Standard Deviation|6.402|6.402|||
4451680|NCT00085917|4274850|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451681|NCT00085917|4274851|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451682|NCT00085917|4274852|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451683|NCT00085917|4274850|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4451684|NCT00085917|4274851|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4451685|NCT00085917|4274852|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4451686|NCT00085917|4274850|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451687|NCT00085917|4274851|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451688|NCT00085917|4274852|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451689|NCT00085839|4274863|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4451690|NCT00085839|4274864|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4451691|NCT00085839|4274865|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4451692|NCT00085839|4274863|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4451693|NCT00085839|4274864|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4451694|NCT00085839|4274865|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4451695|NCT00085839|4274863|B3|Black||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4451696|NCT00085839|4274864|B2|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4451697|NCT00085839|4274865|B1|Black||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4451698|NCT00085839|4274863|B3|White||Race/Ethnicity, Customized||participants|Number|68|68.0||||||
4451699|NCT00085839|4274864|B2|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4451700|NCT00085839|4274865|B1|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4451701|NCT00085839|4274863|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4451702|NCT00085839|4274864|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4451703|NCT00085839|4274865|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4451704|NCT00085839|4274863|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4451705|NCT00085839|4274864|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4451706|NCT00085839|4274865|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4451707|NCT00085839|4274863|B3|||Age||years|Median|68|68.0|Full Range|||47.0|84.0|
4451708|NCT00085839|4274864|B2|||Age||years|Median|67|67.0|Full Range|||47.0|84.0|
4451709|NCT00085839|4274865|B1|||Age||years|Median|69|69.0|Full Range|||47.0|82.0|
4451710|NCT00085735|4274876|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4451711|NCT00085735|4274877|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4451712|NCT00085735|4274878|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4451713|NCT00085735|4274879|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4451714|NCT00085735|4274880|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4451715|NCT00085735|4274881|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4451716|NCT00085735|4274882|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4451717|NCT00085735|4274876|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451718|NCT00085735|4274877|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451719|NCT00085735|4274878|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451720|NCT00085735|4274879|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451721|NCT00085735|4274880|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451722|NCT00085735|4274881|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451723|NCT00085735|4274882|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451724|NCT00085735|4274876|B7||White|Race (NIH/OMB)||Participants|Count of Participants|420|420.0||||||
4451725|NCT00085735|4274877|B6||White|Race (NIH/OMB)||Participants|Count of Participants|120|120.0||||||
4451726|NCT00085735|4274878|B5||White|Race (NIH/OMB)||Participants|Count of Participants|108|108.0||||||
4451727|NCT00085735|4274879|B4||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4451728|NCT00085735|4274880|B3||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4451729|NCT00085735|4274881|B2||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4451730|NCT00085735|4274882|B1||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4451731|NCT00085735|4274876|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4451732|NCT00085735|4274877|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4451733|NCT00085735|4274878|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4451734|NCT00085735|4274879|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4451735|NCT00085735|4274880|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4451736|NCT00085735|4274881|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4451737|NCT00085735|4274882|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4451738|NCT00085735|4274876|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4451739|NCT00085735|4274877|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451740|NCT00085735|4274878|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451741|NCT00085735|4274879|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4451742|NCT00085735|4274880|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4451743|NCT00085735|4274881|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4451744|NCT00085735|4274882|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4451745|NCT00085735|4274876|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4451746|NCT00085735|4274877|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4451747|NCT00085735|4274878|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4451748|NCT00085735|4274879|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4451749|NCT00085735|4274880|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4451750|NCT00085735|4274881|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451751|NCT00085735|4274882|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451752|NCT00085735|4274876|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4451753|NCT00085735|4274877|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451754|NCT00085735|4274878|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4451755|NCT00085735|4274879|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451756|NCT00085735|4274880|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4451757|NCT00085735|4274881|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451758|NCT00085735|4274882|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4451759|NCT00085735|4274876|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4451760|NCT00085735|4274877|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4451761|NCT00085735|4274878|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4451762|NCT00085735|4274879|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4451763|NCT00085735|4274880|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4451764|NCT00085735|4274881|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4451765|NCT00085735|4274882|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4451766|NCT00085735|4274876|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|410|410.0||||||
4451767|NCT00085735|4274877|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4451768|NCT00085735|4274878|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|110|110.0||||||
4451769|NCT00085735|4274879|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4451770|NCT00085735|4274880|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4451771|NCT00085735|4274881|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4451772|NCT00085735|4274882|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4451773|NCT00085735|4274876|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|87|87.0||||||
4451774|NCT00085735|4274877|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4451775|NCT00085735|4274878|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4451776|NCT00085735|4274879|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4451777|NCT00085735|4274880|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4451778|NCT00085735|4274881|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4451779|NCT00085735|4274882|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4451780|NCT00085735|4274876|B7||Male|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4451781|NCT00085735|4274877|B6||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4451782|NCT00085735|4274878|B5||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4451783|NCT00085735|4274879|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4451784|NCT00085735|4274880|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4451785|NCT00085735|4274881|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4451786|NCT00085735|4274882|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4451787|NCT00085735|4274876|B7||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4451788|NCT00085735|4274877|B6||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4451789|NCT00085735|4274878|B5||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4451790|NCT00085735|4274879|B4||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4451791|NCT00085735|4274880|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4451792|NCT00085735|4274881|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4451793|NCT00085735|4274882|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4451794|NCT00085735|4274876|B7|||Age||years|Median|8.3|8.3|Full Range|||3.0|21.8|
4451795|NCT00085735|4274877|B6|||Age||years|Median|11.8|11.8|Full Range|||8.0|21.8|
4451796|NCT00085735|4274878|B5|||Age||years|Median|12.4|12.4|Full Range|||8.0|19.8|
4451797|NCT00085735|4274879|B4|||Age||years|Median|5.4|5.4|Full Range|||3.1|7.7|
4451798|NCT00085735|4274880|B3|||Age||years|Median|5.9|5.9|Full Range|||3.0|8.0|
4451799|NCT00085735|4274881|B2|||Age||years|Median|5.9|5.9|Full Range|||3.3|7.9|
4451800|NCT00085735|4274882|B1|||Age||years|Median|5.9|5.9|Full Range|||3.2|7.8|
4451801|NCT00085735|4274876|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451802|NCT00085735|4274877|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451803|NCT00085735|4274878|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451804|NCT00085735|4274879|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451805|NCT00085735|4274880|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451806|NCT00085735|4274881|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451807|NCT00085735|4274882|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4451808|NCT00085735|4274876|B7||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4451809|NCT00085735|4274877|B6||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4451810|NCT00085735|4274878|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4451811|NCT00085735|4274879|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4451812|NCT00085735|4274880|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4451813|NCT00085735|4274881|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4451814|NCT00085735|4274882|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4451815|NCT00085735|4274876|B7||<=18 years|Age||Participants|Count of Participants|493|493.0||||||
4451816|NCT00085735|4274877|B6||<=18 years|Age||Participants|Count of Participants|128|128.0||||||
4451817|NCT00085735|4274878|B5||<=18 years|Age||Participants|Count of Participants|120|120.0||||||
4451818|NCT00085735|4274879|B4||<=18 years|Age||Participants|Count of Participants|58|58.0||||||
4451819|NCT00085735|4274880|B3||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4451820|NCT00085735|4274881|B2||<=18 years|Age||Participants|Count of Participants|64|64.0||||||
4451821|NCT00085735|4274882|B1||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
4451822|NCT00085709|4274913|B3||Male|Sex: Female, Male||Participants|Count of Participants|313|313.0||||||
4451823|NCT00085709|4274914|B2||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4451824|NCT00085709|4274915|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4451825|NCT00085709|4274913|B3||Female|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4451826|NCT00085709|4274914|B2||Female|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4451827|NCT00085709|4274915|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4451828|NCT00085709|4274913|B3|||Age||years|Median|47|47.0|Full Range|||18.0|60.0|
4451829|NCT00085709|4274914|B2|||Age||years|Median|48|48.0|Full Range|||18.0|60.0|
4451830|NCT00085709|4274915|B1|||Age||years|Median|47|47.0|Full Range|||18.0|60.0|
4451831|NCT00085644|4274930|B3|Europe||Region of Enrollment||participants|Number|167|167.0||||||
4451832|NCT00085644|4274931|B2|Europe||Region of Enrollment||participants|Number|59|59.0||||||
4451833|NCT00085644|4274932|B1|Europe||Region of Enrollment||participants|Number|108|108.0||||||
4451834|NCT00085644|4274930|B3|United States||Region of Enrollment||participants|Number|148|148.0||||||
4451835|NCT00085644|4274931|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4451836|NCT00085644|4274932|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4451837|NCT00085644|4274930|B3||Male|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4451838|NCT00085644|4274931|B2||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4451839|NCT00085644|4274932|B1||Male|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4451840|NCT00085644|4274930|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4451841|NCT00085644|4274931|B2||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4451842|NCT00085644|4274932|B1||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4451843|NCT00085644|4274930|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|11.57|11.57|||
4451844|NCT00085644|4274931|B2|||Age||years|Mean|43.4|43.4|Standard Deviation|11.32|11.32|||
4451845|NCT00085644|4274932|B1|||Age||years|Mean|41.7|41.7|Standard Deviation|11.69|11.69|||
4451846|NCT00085644|4274930|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4451847|NCT00085644|4274931|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4451848|NCT00085644|4274932|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4451849|NCT00085644|4274930|B3||Between 18 and 65 years|Age||Participants|Count of Participants|309|309.0||||||
4451850|NCT00085644|4274931|B2||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4451851|NCT00085644|4274932|B1||Between 18 and 65 years|Age||Participants|Count of Participants|205|205.0||||||
4451852|NCT00085644|4274930|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4451853|NCT00085644|4274931|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4451854|NCT00085644|4274932|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451855|NCT00085631|4274975|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451856|NCT00085631|4274975|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4451857|NCT00085631|4274975|B1|||Age||years|Mean|50.25|50.25|Standard Deviation|12.15|12.15|||
4451858|NCT00085566|4274984|B4||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4451859|NCT00085566|4274985|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4451860|NCT00085566|4274986|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4451861|NCT00085566|4274987|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4451862|NCT00085566|4274984|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4451863|NCT00085566|4274985|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4451864|NCT00085566|4274986|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451865|NCT00085566|4274987|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4451866|NCT00085566|4274984|B4||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4451867|NCT00085566|4274985|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4451868|NCT00085566|4274986|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4451869|NCT00085566|4274987|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4451870|NCT00085566|4274984|B4||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4451871|NCT00085566|4274985|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4451872|NCT00085566|4274986|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4451873|NCT00085566|4274987|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4451874|NCT00085566|4274984|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451875|NCT00085566|4274985|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451876|NCT00085566|4274986|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451877|NCT00085566|4274987|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451878|NCT00085540|4274997|B3|||Prior chemotherapy regimens||number of chemotherapy regimens|Median|1|1.0|Full Range|||1.0|3.0|
4451879|NCT00085540|4274998|B2|||Prior chemotherapy regimens||number of chemotherapy regimens|Median|1|1.0|Full Range|||1.0|3.0|
4451880|NCT00085540|4274999|B1|||Prior chemotherapy regimens||number of chemotherapy regimens|Median|1|1.0|Full Range|||1.0|2.0|
4451881|NCT00085540|4274997|B3|||Prior Radiotherapy||participants|Number|48|48.0||||||
4451882|NCT00085540|4274998|B2|||Prior Radiotherapy||participants|Number|40|40.0||||||
4451883|NCT00085540|4274999|B1|||Prior Radiotherapy||participants|Number|8|8.0||||||
4451884|NCT00085540|4274997|B3|Gliobastoma||Histology||participants|Number|41|41.0||||||
4451885|NCT00085540|4274998|B2|Gliobastoma||Histology||participants|Number|35|35.0||||||
4451886|NCT00085540|4274999|B1|Gliobastoma||Histology||participants|Number|6|6.0||||||
4451887|NCT00085540|4274997|B3|Anaplastic glioma||Histology||participants|Number|7|7.0||||||
4451888|NCT00085540|4274998|B2|Anaplastic glioma||Histology||participants|Number|5|5.0||||||
4451889|NCT00085540|4274999|B1|Anaplastic glioma||Histology||participants|Number|2|2.0||||||
4451890|NCT00085540|4274997|B3|60-80||Karnofsky Performance Status Scale (KPS)|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Number|25|25.0||||||
4451891|NCT00085540|4274998|B2|60-80||Karnofsky Performance Status Scale (KPS)|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Number|21|21.0||||||
4451892|NCT00085540|4274999|B1|60-80||Karnofsky Performance Status Scale (KPS)|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Number|4|4.0||||||
4451893|NCT00085540|4274997|B3|90-100||Karnofsky Performance Status Scale (KPS)|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Number|23|23.0||||||
4451894|NCT00085540|4274998|B2|90-100||Karnofsky Performance Status Scale (KPS)|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Number|19|19.0||||||
4451948|NCT00085254|4275042|B4|unmethylated||MGMT Statis|0-6-methylguanine-DNA methyltransferase|participants|Number|48|48.0||||||
4451949|NCT00085254|4275043|B3|unmethylated||MGMT Statis|0-6-methylguanine-DNA methyltransferase|participants|Number|18|18.0||||||
4451950|NCT00085254|4275044|B2|unmethylated||MGMT Statis|0-6-methylguanine-DNA methyltransferase|participants|Number|21|21.0||||||
4451895|NCT00085540|4274999|B1|90-100||Karnofsky Performance Status Scale (KPS)|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Number|4|4.0||||||
4451896|NCT00085540|4274997|B3||Male|Gender||Participants|Count of Participants|35|35.0||||||
4451897|NCT00085540|4274998|B2||Male|Gender||Participants|Count of Participants|30|30.0||||||
4451898|NCT00085540|4274999|B1||Male|Gender||Participants|Count of Participants|5|5.0||||||
4451899|NCT00085540|4274997|B3||Female|Gender||Participants|Count of Participants|13|13.0||||||
4451900|NCT00085540|4274998|B2||Female|Gender||Participants|Count of Participants|10|10.0||||||
4451901|NCT00085540|4274999|B1||Female|Gender||Participants|Count of Participants|3|3.0||||||
4451902|NCT00085540|4274997|B3|||Age||years|Median|54|54.0|Full Range|||37.0|79.0|
4451903|NCT00085540|4274998|B2|||Age||years|Median|55|55.0|Full Range|||37.0|79.0|
4451904|NCT00085540|4274999|B1|||Age||years|Median|52|52.0|Full Range|||44.0|57.0|
4451905|NCT00085436|4275007|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4451906|NCT00085436|4275007|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4451907|NCT00085436|4275007|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4451908|NCT00085436|4275007|B1|||Age||years|Mean|60.8|60.8|Standard Deviation|9.83126|9.83126|||
4451909|NCT00085436|4275007|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4451910|NCT00085436|4275007|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4451911|NCT00085436|4275007|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451912|NCT00085423|4275012|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4451913|NCT00085423|4275012|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4451914|NCT00085423|4275012|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4451915|NCT00085423|4275012|B1|||Age||years|Mean|52|52.0|Standard Deviation|11.3|11.3|||
4451916|NCT00085423|4275012|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4451917|NCT00085423|4275012|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4451918|NCT00085423|4275012|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451919|NCT00085410|4275018|B1|No||Previous Surgery||participants|Number|15|15.0||||||
4451920|NCT00085410|4275018|B1|Yes: Liver section||Previous Surgery||participants|Number|1|1.0||||||
4451921|NCT00085410|4275018|B1|Yes: Cholecystectomy||Previous Surgery||participants|Number|4|4.0||||||
4451922|NCT00085410|4275018|B1|Other||Previous Treatment||participants|Number|1|1.0||||||
4451923|NCT00085410|4275018|B1|Chemotherapy/radiation therapy||Previous Treatment||participants|Number|5|5.0||||||
4451924|NCT00085410|4275018|B1|Chemotherapy only||Previous Treatment||participants|Number|4|4.0||||||
4451925|NCT00085410|4275018|B1|None||Previous Treatment||participants|Number|10|10.0||||||
4451926|NCT00085410|4275018|B1|Grade 1||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease performance without restriction~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature"|participants|Number|13|13.0||||||
4451927|NCT00085410|4275018|B1|Grade 0||Eastern Cooperative Oncology Group Performance Status|"Grade 0: Fully active, able to carry on all pre-disease performance without restriction~Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature"|participants|Number|7|7.0||||||
4451928|NCT00085410|4275018|B1|Other||Site of Metastases|Multiple Metastases possible per patient|participants|Number|2|2.0||||||
4451929|NCT00085410|4275018|B1|Lung||Site of Metastases|Multiple Metastases possible per patient|participants|Number|5|5.0||||||
4451930|NCT00085410|4275018|B1|Lymph nodes||Site of Metastases|Multiple Metastases possible per patient|participants|Number|7|7.0||||||
4451931|NCT00085410|4275018|B1|Liver||Site of Metastases|Multiple Metastases possible per patient|participants|Number|14|14.0||||||
4451932|NCT00085410|4275018|B1|Intrahepatic or extrahepatic cholangiocarcinoma||Site of Primary Tumor||participants|Number|14|14.0||||||
4451933|NCT00085410|4275018|B1|Gallbladder||Site of Primary Tumor||participants|Number|6|6.0||||||
4451934|NCT00085410|4275018|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4451935|NCT00085410|4275018|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4451936|NCT00085410|4275018|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4451937|NCT00085410|4275018|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4451938|NCT00085410|4275018|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4451939|NCT00085410|4275018|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4451940|NCT00085293|4275032|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4451941|NCT00085293|4275032|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4451942|NCT00085293|4275032|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4451943|NCT00085293|4275032|B1|||Age||years|Median|53|53.0|Full Range|||31.0|71.0|
4451944|NCT00085254|4275042|B4|unknown||MGMT Statis|0-6-methylguanine-DNA methyltransferase|participants|Number|43|43.0||||||
4451945|NCT00085254|4275043|B3|unknown||MGMT Statis|0-6-methylguanine-DNA methyltransferase|participants|Number|23|23.0||||||
4451946|NCT00085254|4275044|B2|unknown||MGMT Statis|0-6-methylguanine-DNA methyltransferase|participants|Number|14|14.0||||||
4451947|NCT00085254|4275045|B1|unknown||MGMT Statis|0-6-methylguanine-DNA methyltransferase|participants|Number|6|6.0||||||
4451951|NCT00085254|4275045|B1|unmethylated||MGMT Statis|0-6-methylguanine-DNA methyltransferase|participants|Number|9|9.0||||||
4451952|NCT00085254|4275042|B4|methylated||MGMT Statis|0-6-methylguanine-DNA methyltransferase|participants|Number|21|21.0||||||
4451953|NCT00085254|4275043|B3|methylated||MGMT Statis|0-6-methylguanine-DNA methyltransferase|participants|Number|7|7.0||||||
4451954|NCT00085254|4275044|B2|methylated||MGMT Statis|0-6-methylguanine-DNA methyltransferase|participants|Number|11|11.0||||||
4451955|NCT00085254|4275045|B1|methylated||MGMT Statis|0-6-methylguanine-DNA methyltransferase|participants|Number|3|3.0||||||
4451956|NCT00085254|4275042|B4|missing data||Corticosteroid Therapy||participants|Number|2|2.0||||||
4451957|NCT00085254|4275043|B3|missing data||Corticosteroid Therapy||participants|Number|1|1.0||||||
4451958|NCT00085254|4275044|B2|missing data||Corticosteroid Therapy||participants|Number|0|0.0||||||
4451959|NCT00085254|4275045|B1|missing data||Corticosteroid Therapy||participants|Number|1|1.0||||||
4451960|NCT00085254|4275042|B4|No||Corticosteroid Therapy||participants|Number|28|28.0||||||
4451961|NCT00085254|4275043|B3|No||Corticosteroid Therapy||participants|Number|11|11.0||||||
4451962|NCT00085254|4275044|B2|No||Corticosteroid Therapy||participants|Number|13|13.0||||||
4451963|NCT00085254|4275045|B1|No||Corticosteroid Therapy||participants|Number|4|4.0||||||
4451964|NCT00085254|4275042|B4|Yes||Corticosteroid Therapy||participants|Number|82|82.0||||||
4451965|NCT00085254|4275043|B3|Yes||Corticosteroid Therapy||participants|Number|36|36.0||||||
4451966|NCT00085254|4275044|B2|Yes||Corticosteroid Therapy||participants|Number|33|33.0||||||
4451967|NCT00085254|4275045|B1|Yes||Corticosteroid Therapy||participants|Number|13|13.0||||||
4451968|NCT00085254|4275042|B4|other||Surgical Proceedure||participants|Number|1|1.0||||||
4451969|NCT00085254|4275043|B3|other||Surgical Proceedure||participants|Number|0|0.0||||||
4451970|NCT00085254|4275044|B2|other||Surgical Proceedure||participants|Number|1|1.0||||||
4451971|NCT00085254|4275045|B1|other||Surgical Proceedure||participants|Number|0|0.0||||||
4451972|NCT00085254|4275042|B4|craniotomy||Surgical Proceedure||participants|Number|86|86.0||||||
4451973|NCT00085254|4275043|B3|craniotomy||Surgical Proceedure||participants|Number|39|39.0||||||
4451974|NCT00085254|4275044|B2|craniotomy||Surgical Proceedure||participants|Number|35|35.0||||||
4451975|NCT00085254|4275045|B1|craniotomy||Surgical Proceedure||participants|Number|12|12.0||||||
4451976|NCT00085254|4275042|B4|biopsy||Surgical Proceedure||participants|Number|25|25.0||||||
4451977|NCT00085254|4275043|B3|biopsy||Surgical Proceedure||participants|Number|9|9.0||||||
4451978|NCT00085254|4275044|B2|biopsy||Surgical Proceedure||participants|Number|10|10.0||||||
4451979|NCT00085254|4275045|B1|biopsy||Surgical Proceedure||participants|Number|6|6.0||||||
4451980|NCT00085254|4275042|B4|60||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|4|4.0||||||
4451981|NCT00085254|4275043|B3|60||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|2|2.0||||||
4451982|NCT00085254|4275044|B2|60||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|2|2.0||||||
4451983|NCT00085254|4275045|B1|60||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|0|0.0||||||
4451984|NCT00085254|4275042|B4|70||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|15|15.0||||||
4451985|NCT00085254|4275043|B3|70||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|6|6.0||||||
4451986|NCT00085254|4275044|B2|70||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|6|6.0||||||
4451987|NCT00085254|4275045|B1|70||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|3|3.0||||||
4451988|NCT00085254|4275042|B4|80||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|15|15.0||||||
4451989|NCT00085254|4275043|B3|80||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|7|7.0||||||
4451990|NCT00085254|4275044|B2|80||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|3|3.0||||||
4451991|NCT00085254|4275045|B1|80||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|5|5.0||||||
4451992|NCT00085254|4275042|B4|90||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|51|51.0||||||
4451993|NCT00085254|4275043|B3|90||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|18|18.0||||||
4451994|NCT00085254|4275044|B2|90||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|27|27.0||||||
4451995|NCT00085254|4275045|B1|90||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|6|6.0||||||
4451996|NCT00085254|4275042|B4|100||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|27|27.0||||||
4451997|NCT00085254|4275043|B3|100||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|15|15.0||||||
4451998|NCT00085254|4275044|B2|100||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|8|8.0||||||
4451999|NCT00085254|4275045|B1|100||Karnofsky Performance Status|100 - Normal; no complaints; no evidence of disease 90 - Able to carry on normal activity; minor signs or symptoms of disease 80 - Normal activity with effort; some signs or symptoms of disease 70 - Cares for self; unable to carry on normal activity or to do active work 60 - Requires occasional assistance, but is able to care for most of his personal needs|participants|Number|4|4.0||||||
4452000|NCT00085254|4275042|B4||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4452001|NCT00085254|4275043|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4452002|NCT00085254|4275044|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4452003|NCT00085254|4275045|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4452004|NCT00085254|4275042|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4452005|NCT00085254|4275043|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4452006|NCT00085254|4275044|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4452007|NCT00085254|4275045|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4452008|NCT00085254|4275042|B4|||Age||years|Median|55.5|55.5|Full Range|||22.0|88.0|
4452009|NCT00085254|4275043|B3|||Age||years|Median|54.9|54.9|Full Range|||22.0|81.0|
4452010|NCT00085254|4275044|B2|||Age||years|Median|56.3|56.3|Full Range|||35.0|88.0|
4452011|NCT00085254|4275045|B1|||Age||years|Median|55.6|55.6|Full Range|||22.0|88.0|
4452012|NCT00085202|4275061|B3||Male|Sex: Female, Male||Participants|Count of Participants|252|252.0||||||
4452013|NCT00085202|4275062|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4452014|NCT00085202|4275063|B1||Male|Sex: Female, Male||Participants|Count of Participants|164|164.0||||||
4452015|NCT00085202|4275061|B3||Female|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4452016|NCT00085202|4275062|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4452017|NCT00085202|4275063|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4452018|NCT00085202|4275061|B3|||Age||years|Median|8.33|8.33|Full Range|||3.06|21.56|
4452019|NCT00085202|4275062|B2|||Age||years|Median|7.87|7.87|Full Range|||3.13|20.43|
4452020|NCT00085202|4275063|B1|||Age||years|Median|8.42|8.42|Full Range|||3.06|21.56|
4452021|NCT00085202|4275061|B3|||Age||Years|Mean|8.98|8.98|Standard Deviation|4.03|4.03|||
4452022|NCT00085202|4275062|B2|||Age||Years|Mean|8.66|8.66|Standard Deviation|3.93|3.93|||
4452023|NCT00085202|4275063|B1|||Age||Years|Mean|9.15|9.15|Standard Deviation|4.08|4.08|||
4452024|NCT00085098|4275083|B3|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4452025|NCT00085098|4275084|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4452026|NCT00085098|4275085|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4452027|NCT00085098|4275083|B3|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4452028|NCT00085098|4275084|B2|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4452029|NCT00085098|4275085|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4452030|NCT00085098|4275083|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4452031|NCT00085098|4275084|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4452032|NCT00085098|4275085|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4452033|NCT00085098|4275083|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4452034|NCT00085098|4275084|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4452035|NCT00085098|4275085|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4452036|NCT00085098|4275083|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4452037|NCT00085098|4275084|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4452038|NCT00085098|4275085|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4452039|NCT00085098|4275083|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4452040|NCT00085098|4275084|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4452041|NCT00085098|4275085|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4452042|NCT00085098|4275083|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4452043|NCT00085098|4275084|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4452044|NCT00085098|4275085|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4452045|NCT00085098|4275083|B3||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4452046|NCT00085098|4275084|B2||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4452047|NCT00085098|4275085|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4452048|NCT00084864|4275096|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4452049|NCT00084864|4275097|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4452050|NCT00084864|4275098|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4452051|NCT00084864|4275099|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4452052|NCT00084864|4275100|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4452053|NCT00084864|4275096|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452054|NCT00084864|4275097|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452055|NCT00084864|4275098|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452056|NCT00084864|4275099|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452057|NCT00084864|4275100|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452058|NCT00084864|4275096|B5|||Age||years|Mean|55.7|55.7|Standard Deviation|6.7|6.7|||
4452059|NCT00084864|4275097|B4|||Age||years|Mean|50.2|50.2|Standard Deviation|2.7|2.7|||
4452060|NCT00084864|4275098|B3|||Age||years|Mean|54.5|54.5|Standard Deviation|8.3|8.3|||
4452061|NCT00084864|4275099|B2|||Age||years|Mean|56.3|56.3|Standard Deviation|4.7|4.7|||
4452062|NCT00084864|4275100|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|7.8|7.8|||
4452063|NCT00084838|4275129|B1|M3||Chang Stage|Chang staging: M0 is non-metastatic disease. M1 is CSF +ve disease which means that the tumor cells are found floating in the spinal fluid, M2 is localized metastatic disease and M3 is disseminated bulk disease.|participants|Number|5|5.0||||||
4452064|NCT00084838|4275129|B1|M2||Chang Stage|Chang staging: M0 is non-metastatic disease. M1 is CSF +ve disease which means that the tumor cells are found floating in the spinal fluid, M2 is localized metastatic disease and M3 is disseminated bulk disease.|participants|Number|1|1.0||||||
4452065|NCT00084838|4275129|B1|M0||Chang Stage|Chang staging: M0 is non-metastatic disease. M1 is CSF +ve disease which means that the tumor cells are found floating in the spinal fluid, M2 is localized metastatic disease and M3 is disseminated bulk disease.|participants|Number|14|14.0||||||
4452066|NCT00084838|4275129|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4452067|NCT00084838|4275129|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4452068|NCT00084838|4275129|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4452069|NCT00084838|4275129|B1|||Age||years|Median|2.2|2.2|Full Range|||0.2|19.0|
4452070|NCT00084747|4275151|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4452071|NCT00084747|4275151|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4452072|NCT00084747|4275151|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4452073|NCT00084747|4275151|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4452074|NCT00084747|4275151|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4452075|NCT00084747|4275151|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452076|NCT00084682|4275156|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4452077|NCT00084682|4275156|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4452078|NCT00084682|4275156|B1|White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4452079|NCT00084682|4275156|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4452080|NCT00084682|4275156|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4452081|NCT00084682|4275156|B1|||Age||years|Median|59.0|59.0|Full Range|||46.0|75.0|
4452082|NCT00084617|4275160|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4452083|NCT00084617|4275160|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4452084|NCT00084617|4275160|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4452085|NCT00084617|4275160|B1|||Age||years|Median|57.8|57.8|Full Range|||31.0|79.0|
4452086|NCT00084487|4275166|B1|Radiation||Prior Therapy|Number of patients exceeds number on study as some patients had both chemo and radiation.|participants|Number|8|8.0||||||
4452087|NCT00084487|4275166|B1|Chemotherapy||Prior Therapy|Number of patients exceeds number on study as some patients had both chemo and radiation.|participants|Number|20|20.0||||||
4452088|NCT00084487|4275166|B1|2||ECOG Performance Status|Based on a scale of 0-4 with 0=100 Asymptomatic; 1=80-90 Symptomatic, fully ambulatory; 2=60-70 Symptomatic, in bed less than 50% of the day; 3=40-50 Symptomatic, in bed more than 50% of the day, but not bedridden; 4=20-30 Bedridden|participants|Number|5|5.0||||||
4452089|NCT00084487|4275166|B1|1||ECOG Performance Status|Based on a scale of 0-4 with 0=100 Asymptomatic; 1=80-90 Symptomatic, fully ambulatory; 2=60-70 Symptomatic, in bed less than 50% of the day; 3=40-50 Symptomatic, in bed more than 50% of the day, but not bedridden; 4=20-30 Bedridden|participants|Number|10|10.0||||||
4452090|NCT00084487|4275166|B1|0||ECOG Performance Status|Based on a scale of 0-4 with 0=100 Asymptomatic; 1=80-90 Symptomatic, fully ambulatory; 2=60-70 Symptomatic, in bed less than 50% of the day; 3=40-50 Symptomatic, in bed more than 50% of the day, but not bedridden; 4=20-30 Bedridden|participants|Number|5|5.0||||||
4452091|NCT00084487|4275166|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4452092|NCT00084487|4275166|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452093|NCT00084487|4275166|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452094|NCT00084487|4275166|B1||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4452095|NCT00084487|4275166|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4452096|NCT00084487|4275166|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452097|NCT00084487|4275166|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452098|NCT00084487|4275166|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452099|NCT00084487|4275166|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4452100|NCT00084487|4275166|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4452101|NCT00084487|4275166|B1|||Age||years|Median|61|61.0|Full Range|||45.0|72.0|
4452102|NCT00084409|4275174|B3|United States||Region of Enrollment||participants|Number|152|152.0||||||
4452103|NCT00084409|4275175|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4452104|NCT00084409|4275176|B1|United States||Region of Enrollment||participants|Number|75|75.0||||||
4452105|NCT00084409|4275174|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4452106|NCT00084409|4275175|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4452107|NCT00084409|4275176|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4452108|NCT00084409|4275174|B3||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4452109|NCT00084409|4275175|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4452110|NCT00084409|4275176|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4452111|NCT00084409|4275174|B3|||Age||years|Mean|58|58.0|Standard Deviation|10|10.0|||
4452112|NCT00084409|4275175|B2|||Age||years|Mean|58|58.0|Standard Deviation|9|9.0|||
4452113|NCT00084409|4275176|B1|||Age||years|Mean|58|58.0|Standard Deviation|11|11.0|||
4452114|NCT00084409|4275174|B3||>=65 years|Age||Participants|Count of Participants|33|33.0||||||
4452115|NCT00084409|4275175|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4452116|NCT00084409|4275176|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4452117|NCT00084409|4275174|B3||Between 18 and 65 years|Age||Participants|Count of Participants|119|119.0||||||
4452118|NCT00084409|4275175|B2||Between 18 and 65 years|Age||Participants|Count of Participants|62|62.0||||||
4452119|NCT00084409|4275176|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4452120|NCT00084409|4275174|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452121|NCT00084409|4275175|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452122|NCT00084409|4275176|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452123|NCT00084383|4275203|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4452124|NCT00084383|4275203|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4452125|NCT00084383|4275203|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4452126|NCT00084383|4275203|B1|||Age||years|Mean|62|62.0|Standard Deviation|9.375|9.375|||
4452127|NCT00084383|4275203|B1||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4452128|NCT00084383|4275203|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4452129|NCT00084383|4275203|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452130|NCT00084318|4275208|B3||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4452131|NCT00084318|4275209|B2||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4452132|NCT00084318|4275210|B1||Male|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4452133|NCT00084318|4275208|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4452134|NCT00084318|4275209|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4452135|NCT00084318|4275210|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4452136|NCT00084318|4275208|B3|||Age||years|Median|56|56.0|Full Range|||21.0|80.0|
4452137|NCT00084318|4275209|B2|||Age||years|Median|55|55.0|Full Range|||21.0|79.0|
4452138|NCT00084318|4275210|B1|||Age||years|Median|57|57.0|Full Range|||27.0|80.0|
4452139|NCT00084266|4275229|B3|Purulent Sputum||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|345|345.0||||||
4452140|NCT00084266|4275230|B2|Purulent Sputum||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|174|174.0||||||
4452141|NCT00084266|4275231|B1|Purulent Sputum||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|171|171.0||||||
4452142|NCT00084266|4275229|B3|Pleuritic Chest Pain||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|21|21.0||||||
4452143|NCT00084266|4275230|B2|Pleuritic Chest Pain||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|9|9.0||||||
4452144|NCT00084266|4275231|B1|Pleuritic Chest Pain||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|12|12.0||||||
4452145|NCT00084266|4275229|B3|Dyspnea||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|160|160.0||||||
4452146|NCT00084266|4275230|B2|Dyspnea||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|80|80.0||||||
4452147|NCT00084266|4275231|B1|Dyspnea||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|80|80.0||||||
4452148|NCT00084266|4275229|B3|Cough||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|191|191.0||||||
4452149|NCT00084266|4275230|B2|Cough||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|90|90.0||||||
4452150|NCT00084266|4275231|B1|Cough||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|101|101.0||||||
4452151|NCT00084266|4275229|B3|Chills/Rigors||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|27|27.0||||||
4452152|NCT00084266|4275230|B2|Chills/Rigors||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|9|9.0||||||
4452153|NCT00084266|4275231|B1|Chills/Rigors||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|18|18.0||||||
4452154|NCT00084266|4275229|B3|Tachypnea||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|247|247.0||||||
4452155|NCT00084266|4275230|B2|Tachypnea||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|123|123.0||||||
4452156|NCT00084266|4275231|B1|Tachypnea||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|124|124.0||||||
4452157|NCT00084266|4275229|B3|Rales||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|291|291.0||||||
4452158|NCT00084266|4275230|B2|Rales||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|149|149.0||||||
4452159|NCT00084266|4275231|B1|Rales||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|142|142.0||||||
4452160|NCT00084266|4275229|B3|Pulmonary Consolidation||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|303|303.0||||||
4452161|NCT00084266|4275230|B2|Pulmonary Consolidation||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|158|158.0||||||
4452162|NCT00084266|4275231|B1|Pulmonary Consolidation||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|145|145.0||||||
4452163|NCT00084266|4275229|B3|Hypoxia||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|260|260.0||||||
4452164|NCT00084266|4275230|B2|Hypoxia||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|127|127.0||||||
4452165|NCT00084266|4275231|B1|Hypoxia||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|133|133.0||||||
4452166|NCT00084266|4275229|B3|Decreased Breath Sounds||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|293|293.0||||||
4452167|NCT00084266|4275230|B2|Decreased Breath Sounds||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|155|155.0||||||
4452168|NCT00084266|4275231|B1|Decreased Breath Sounds||Clinical Signs and Symptoms for Per Protocol (PP) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with PaO2<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|138|138.0||||||
4452169|NCT00084266|4275229|B3|Purulent Sputum||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|376|376.0||||||
4452170|NCT00084266|4275230|B2|Purulent Sputum||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|209|209.0||||||
4452208|NCT00084149|4275266|B3|||Plasma log10 HIV viral load||log10(copies/mL)|Median|5.0|5.0|Inter-Quartile Range|||4.7|5.8|
4452171|NCT00084266|4275231|B1|Purulent Sputum||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|167|167.0||||||
4452172|NCT00084266|4275229|B3|Pleuritic Chest Pain||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|26|26.0||||||
4452173|NCT00084266|4275230|B2|Pleuritic Chest Pain||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|12|12.0||||||
4452174|NCT00084266|4275231|B1|Pleuritic Chest Pain||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|14|14.0||||||
4452175|NCT00084266|4275229|B3|Dyspnea||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|194|194.0||||||
4452176|NCT00084266|4275230|B2|Dyspnea||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|95|95.0||||||
4452177|NCT00084266|4275231|B1|Dyspnea||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|99|99.0||||||
4452178|NCT00084266|4275229|B3|Cough||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|229|229.0||||||
4452179|NCT00084266|4275230|B2|Cough||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|107|107.0||||||
4452180|NCT00084266|4275231|B1|Cough||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|122|122.0||||||
4452181|NCT00084266|4275229|B3|Chills/Rigors||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|33|33.0||||||
4452182|NCT00084266|4275230|B2|Chills/Rigors||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|11|11.0||||||
4452183|NCT00084266|4275231|B1|Chills/Rigors||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|22|22.0||||||
4452184|NCT00084266|4275229|B3|Tachypnea||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|295|295.0||||||
4452185|NCT00084266|4275230|B2|Tachypnea||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|143|143.0||||||
4452209|NCT00084149|4275267|B2|||Plasma log10 HIV viral load||log10(copies/mL)|Median|4.9|4.9|Inter-Quartile Range|||4.5|5.8|
4452186|NCT00084266|4275231|B1|Tachypnea||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|152|152.0||||||
4452187|NCT00084266|4275229|B3|Rales||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|349|349.0||||||
4452188|NCT00084266|4275230|B2|Rales||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|177|177.0||||||
4452189|NCT00084266|4275231|B1|Rales||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|172|172.0||||||
4452190|NCT00084266|4275229|B3|Pulmonary Consolidation||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|357|357.0||||||
4452191|NCT00084266|4275230|B2|Pulmonary Consolidation||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|184|184.0||||||
4452192|NCT00084266|4275231|B1|Pulmonary Consolidation||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|173|173.0||||||
4452193|NCT00084266|4275229|B3|Hypoxia||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|315|315.0||||||
4452194|NCT00084266|4275230|B2|Hypoxia||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|151|151.0||||||
4452195|NCT00084266|4275231|B1|Hypoxia||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|164|164.0||||||
4452196|NCT00084266|4275229|B3|Decreased Breath Sounds||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|351|351.0||||||
4452197|NCT00084266|4275230|B2|Decreased Breath Sounds||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|182|182.0||||||
4452198|NCT00084266|4275231|B1|Decreased Breath Sounds||Clinical Signs and Symptoms for modified intent-to-treat (mITT) Population|Clinical signs and symptoms (mild to severe):cough;production of purulent sputum;auscultatory finding on pulmonary examination of rales,pulmonary consolidation(dullness on percussion, bronchial breath sounds,egophony);dyspnea, tachypnea,hypoxemia with partial pressure of oxygen(PaO2)<60 mmHg/worsening gas exchange/increased O2 requirement.|Participants|Number|169|169.0||||||
4452199|NCT00084266|4275229|B3||Male|Sex: Female, Male||Participants|Count of Participants|775|775.0||||||
4452200|NCT00084266|4275230|B2||Male|Sex: Female, Male||Participants|Count of Participants|380|380.0||||||
4452201|NCT00084266|4275231|B1||Male|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4452202|NCT00084266|4275229|B3||Female|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
4452203|NCT00084266|4275230|B2||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4452204|NCT00084266|4275231|B1||Female|Sex: Female, Male||Participants|Count of Participants|202|202.0||||||
4452205|NCT00084266|4275229|B3|||Age||Years|Mean|60.5|60.5|Standard Deviation|18.4|18.4|||
4452206|NCT00084266|4275230|B2|||Age||Years|Mean|60.5|60.5|Standard Deviation|18.4|18.4|||
4452207|NCT00084266|4275231|B1|||Age||Years|Mean|60.5|60.5|Standard Deviation|18.4|18.4|||
4452210|NCT00084149|4275268|B1|||Plasma log10 HIV viral load||log10(copies/mL)|Median|5.0|5.0|Inter-Quartile Range|||4.9|5.8|
4452211|NCT00084149|4275266|B3|||Cluster of differentiation 4 (CD4+) T-cell count||cells/mm^3|Median|450|450.0|Inter-Quartile Range|||365.0|605.0|
4452212|NCT00084149|4275267|B2|||Cluster of differentiation 4 (CD4+) T-cell count||cells/mm^3|Median|490|490.0|Inter-Quartile Range|||399.0|623.0|
4452213|NCT00084149|4275268|B1|||Cluster of differentiation 4 (CD4+) T-cell count||cells/mm^3|Median|407|407.0|Inter-Quartile Range|||340.0|587.0|
4452214|NCT00084149|4275266|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4452215|NCT00084149|4275267|B2|United States||Region of Enrollment||participants|Number|13|13.0||||||
4452216|NCT00084149|4275268|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4452217|NCT00084149|4275266|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4452218|NCT00084149|4275267|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4452219|NCT00084149|4275268|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4452220|NCT00084149|4275266|B3|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4452221|NCT00084149|4275267|B2|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4452222|NCT00084149|4275268|B1|African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4452223|NCT00084149|4275266|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4452224|NCT00084149|4275267|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4452225|NCT00084149|4275268|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4452226|NCT00084149|4275266|B3|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4452227|NCT00084149|4275267|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4452228|NCT00084149|4275268|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4452229|NCT00084149|4275266|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4452230|NCT00084149|4275267|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4452231|NCT00084149|4275268|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4452232|NCT00084149|4275266|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4452233|NCT00084149|4275267|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452234|NCT00084149|4275268|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4452235|NCT00084149|4275266|B3|||Age||years|Median|36|36.0|Inter-Quartile Range|||30.0|42.0|
4452236|NCT00084149|4275267|B2|||Age||years|Median|35|35.0|Inter-Quartile Range|||30.0|43.0|
4452237|NCT00084149|4275268|B1|||Age||years|Median|36|36.0|Inter-Quartile Range|||30.0|40.0|
4452238|NCT00084136|4275287|B4|Missing||Plasma HIV-1 RNA, Categorical||participants|Number|1|1.0||||||
4452239|NCT00084136|4275288|B3|Missing||Plasma HIV-1 RNA, Categorical||participants|Number|0|0.0||||||
4452240|NCT00084136|4275289|B2|Missing||Plasma HIV-1 RNA, Categorical||participants|Number|1|1.0||||||
4452241|NCT00084136|4275290|B1|Missing||Plasma HIV-1 RNA, Categorical||participants|Number|0|0.0||||||
4452242|NCT00084136|4275287|B4|>= 750,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|121|121.0||||||
4452243|NCT00084136|4275288|B3|>= 750,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|46|46.0||||||
4452244|NCT00084136|4275289|B2|>= 750,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|40|40.0||||||
4452245|NCT00084136|4275290|B1|>= 750,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|35|35.0||||||
4452246|NCT00084136|4275287|B4|Between 400,001 and 749,999 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|158|158.0||||||
4452247|NCT00084136|4275288|B3|Between 400,001 and 749,999 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|55|55.0||||||
4452248|NCT00084136|4275289|B2|Between 400,001 and 749,999 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|58|58.0||||||
4452249|NCT00084136|4275290|B1|Between 400,001 and 749,999 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|45|45.0||||||
4452250|NCT00084136|4275287|B4|Between 40,001 and 400,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|878|878.0||||||
4452251|NCT00084136|4275288|B3|Between 40,001 and 400,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|284|284.0||||||
4452252|NCT00084136|4275289|B2|Between 40,001 and 400,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|283|283.0||||||
4452253|NCT00084136|4275290|B1|Between 40,001 and 400,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|311|311.0||||||
4452254|NCT00084136|4275287|B4|Between 4001 and 40,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|346|346.0||||||
4452255|NCT00084136|4275288|B3|Between 4001 and 40,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|124|124.0||||||
4452256|NCT00084136|4275289|B2|Between 4001 and 40,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|119|119.0||||||
4452257|NCT00084136|4275290|B1|Between 4001 and 40,000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|103|103.0||||||
4452258|NCT00084136|4275287|B4|Between 400 and 4000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|55|55.0||||||
4452259|NCT00084136|4275288|B3|Between 400 and 4000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|14|14.0||||||
4452260|NCT00084136|4275289|B2|Between 400 and 4000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|19|19.0||||||
4452261|NCT00084136|4275290|B1|Between 400 and 4000 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|22|22.0||||||
4452262|NCT00084136|4275287|B4|<= 400 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|12|12.0||||||
4452263|NCT00084136|4275288|B3|<= 400 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|3|3.0||||||
4452264|NCT00084136|4275289|B2|<= 400 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|6|6.0||||||
4452265|NCT00084136|4275290|B1|<= 400 copies/mL||Plasma HIV-1 RNA, Categorical||participants|Number|3|3.0||||||
4452307|NCT00084136|4275288|B3|South Africa||Region of Enrollment||participants|Number|70|70.0||||||
4452266|NCT00084136|4275287|B4|||Plasma HIV-1 RNA, Continuous||log10 copies/mL|Median|5.0|5.0|Inter-Quartile Range|||4.6|5.5|
4452267|NCT00084136|4275288|B3|||Plasma HIV-1 RNA, Continuous||log10 copies/mL|Median|5.0|5.0|Inter-Quartile Range|||4.5|5.5|
4452268|NCT00084136|4275289|B2|||Plasma HIV-1 RNA, Continuous||log10 copies/mL|Median|5.1|5.1|Inter-Quartile Range|||4.5|5.5|
4452269|NCT00084136|4275290|B1|||Plasma HIV-1 RNA, Continuous||log10 copies/mL|Median|5.0|5.0|Inter-Quartile Range|||4.6|5.4|
4452270|NCT00084136|4275287|B4|Between 250 and 299 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|275|275.0||||||
4452271|NCT00084136|4275288|B3|Between 250 and 299 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|75|75.0||||||
4452272|NCT00084136|4275289|B2|Between 250 and 299 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|97|97.0||||||
4452273|NCT00084136|4275290|B1|Between 250 and 299 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|103|103.0||||||
4452274|NCT00084136|4275287|B4|Between 200 and 249 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|339|339.0||||||
4452275|NCT00084136|4275288|B3|Between 200 and 249 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|107|107.0||||||
4452276|NCT00084136|4275289|B2|Between 200 and 249 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|128|128.0||||||
4452277|NCT00084136|4275290|B1|Between 200 and 249 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|104|104.0||||||
4452278|NCT00084136|4275287|B4|Between 100 and 199 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|528|528.0||||||
4452279|NCT00084136|4275288|B3|Between 100 and 199 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|193|193.0||||||
4452280|NCT00084136|4275289|B2|Between 100 and 199 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|161|161.0||||||
4452281|NCT00084136|4275290|B1|Between 100 and 199 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|174|174.0||||||
4452282|NCT00084136|4275287|B4|Between 50 and 99 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|229|229.0||||||
4452283|NCT00084136|4275288|B3|Between 50 and 99 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|82|82.0||||||
4452284|NCT00084136|4275289|B2|Between 50 and 99 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|77|77.0||||||
4452285|NCT00084136|4275290|B1|Between 50 and 99 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|70|70.0||||||
4452286|NCT00084136|4275287|B4|< 50 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|200|200.0||||||
4452287|NCT00084136|4275288|B3|< 50 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|69|69.0||||||
4452288|NCT00084136|4275289|B2|< 50 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|63|63.0||||||
4452289|NCT00084136|4275290|B1|< 50 cells/mm^3||CD4 count, Categorical|Screening CD4 count used for study eligibility as no other pre-randomization counts available.|participants|Number|68|68.0||||||
4452290|NCT00084136|4275287|B4|||CD4 count, Continuous|Screening value used for study eligibility as no other pre-randomization CD4 cell counts available|cells/mm^3|Mean|162|162.0|Standard Deviation|83|83.0|||
4452291|NCT00084136|4275288|B3|||CD4 count, Continuous|Screening value used for study eligibility as no other pre-randomization CD4 cell counts available|cells/mm^3|Mean|155|155.0|Standard Deviation|81|81.0|||
4452292|NCT00084136|4275289|B2|||CD4 count, Continuous|Screening value used for study eligibility as no other pre-randomization CD4 cell counts available|cells/mm^3|Mean|167|167.0|Standard Deviation|83|83.0|||
4452293|NCT00084136|4275290|B1|||CD4 count, Continuous|Screening value used for study eligibility as no other pre-randomization CD4 cell counts available|cells/mm^3|Mean|163|163.0|Standard Deviation|85|85.0|||
4452294|NCT00084136|4275287|B4|Zimbabwe||Region of Enrollment||participants|Number|110|110.0||||||
4452295|NCT00084136|4275288|B3|Zimbabwe||Region of Enrollment||participants|Number|37|37.0||||||
4452296|NCT00084136|4275289|B2|Zimbabwe||Region of Enrollment||participants|Number|37|37.0||||||
4452297|NCT00084136|4275290|B1|Zimbabwe||Region of Enrollment||participants|Number|36|36.0||||||
4452298|NCT00084136|4275287|B4|United States||Region of Enrollment||participants|Number|210|210.0||||||
4452299|NCT00084136|4275288|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4452300|NCT00084136|4275289|B2|United States||Region of Enrollment||participants|Number|70|70.0||||||
4452301|NCT00084136|4275290|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4452302|NCT00084136|4275287|B4|Thailand||Region of Enrollment||participants|Number|100|100.0||||||
4452303|NCT00084136|4275288|B3|Thailand||Region of Enrollment||participants|Number|35|35.0||||||
4452304|NCT00084136|4275289|B2|Thailand||Region of Enrollment||participants|Number|33|33.0||||||
4452305|NCT00084136|4275290|B1|Thailand||Region of Enrollment||participants|Number|32|32.0||||||
4452306|NCT00084136|4275287|B4|South Africa||Region of Enrollment||participants|Number|210|210.0||||||
4452308|NCT00084136|4275289|B2|South Africa||Region of Enrollment||participants|Number|70|70.0||||||
4452309|NCT00084136|4275290|B1|South Africa||Region of Enrollment||participants|Number|70|70.0||||||
4452310|NCT00084136|4275287|B4|Peru||Region of Enrollment||participants|Number|134|134.0||||||
4452311|NCT00084136|4275288|B3|Peru||Region of Enrollment||participants|Number|44|44.0||||||
4452312|NCT00084136|4275289|B2|Peru||Region of Enrollment||participants|Number|48|48.0||||||
4452313|NCT00084136|4275290|B1|Peru||Region of Enrollment||participants|Number|42|42.0||||||
4452314|NCT00084136|4275287|B4|Malawi||Region of Enrollment||participants|Number|221|221.0||||||
4452315|NCT00084136|4275288|B3|Malawi||Region of Enrollment||participants|Number|73|73.0||||||
4452316|NCT00084136|4275289|B2|Malawi||Region of Enrollment||participants|Number|74|74.0||||||
4452317|NCT00084136|4275290|B1|Malawi||Region of Enrollment||participants|Number|74|74.0||||||
4452318|NCT00084136|4275287|B4|India||Region of Enrollment||participants|Number|255|255.0||||||
4452319|NCT00084136|4275288|B3|India||Region of Enrollment||participants|Number|88|88.0||||||
4452320|NCT00084136|4275289|B2|India||Region of Enrollment||participants|Number|86|86.0||||||
4452321|NCT00084136|4275290|B1|India||Region of Enrollment||participants|Number|81|81.0||||||
4452322|NCT00084136|4275287|B4|Haiti||Region of Enrollment||participants|Number|100|100.0||||||
4452323|NCT00084136|4275288|B3|Haiti||Region of Enrollment||participants|Number|33|33.0||||||
4452324|NCT00084136|4275289|B2|Haiti||Region of Enrollment||participants|Number|32|32.0||||||
4452325|NCT00084136|4275290|B1|Haiti||Region of Enrollment||participants|Number|35|35.0||||||
4452326|NCT00084136|4275287|B4|Brazil||Region of Enrollment||participants|Number|231|231.0||||||
4452327|NCT00084136|4275288|B3|Brazil||Region of Enrollment||participants|Number|76|76.0||||||
4452328|NCT00084136|4275289|B2|Brazil||Region of Enrollment||participants|Number|76|76.0||||||
4452329|NCT00084136|4275290|B1|Brazil||Region of Enrollment||participants|Number|79|79.0||||||
4452330|NCT00084136|4275287|B4||Male|Sex: Female, Male||Participants|Count of Participants|832|832.0||||||
4452331|NCT00084136|4275288|B3||Male|Sex: Female, Male||Participants|Count of Participants|284|284.0||||||
4452332|NCT00084136|4275289|B2||Male|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4452333|NCT00084136|4275290|B1||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4452334|NCT00084136|4275287|B4||Female|Sex: Female, Male||Participants|Count of Participants|739|739.0||||||
4452335|NCT00084136|4275288|B3||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4452336|NCT00084136|4275289|B2||Female|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4452337|NCT00084136|4275290|B1||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4452338|NCT00084136|4275287|B4|At least 50 years||Age, Customized||participants|Number|103|103.0||||||
4452339|NCT00084136|4275288|B3|At least 50 years||Age, Customized||participants|Number|39|39.0||||||
4452340|NCT00084136|4275289|B2|At least 50 years||Age, Customized||participants|Number|30|30.0||||||
4452341|NCT00084136|4275290|B1|At least 50 years||Age, Customized||participants|Number|34|34.0||||||
4452342|NCT00084136|4275287|B4|Between 40 and 49 years||Age, Customized||participants|Number|345|345.0||||||
4452343|NCT00084136|4275288|B3|Between 40 and 49 years||Age, Customized||participants|Number|116|116.0||||||
4452344|NCT00084136|4275289|B2|Between 40 and 49 years||Age, Customized||participants|Number|129|129.0||||||
4452345|NCT00084136|4275290|B1|Between 40 and 49 years||Age, Customized||participants|Number|100|100.0||||||
4452346|NCT00084136|4275287|B4|Between 30 and 39 years||Age, Customized||participants|Number|690|690.0||||||
4452347|NCT00084136|4275288|B3|Between 30 and 39 years||Age, Customized||participants|Number|225|225.0||||||
4452348|NCT00084136|4275289|B2|Between 30 and 39 years||Age, Customized||participants|Number|221|221.0||||||
4452349|NCT00084136|4275290|B1|Between 30 and 39 years||Age, Customized||participants|Number|244|244.0||||||
4452350|NCT00084136|4275287|B4|Between 18 and 29 years||Age, Customized||participants|Number|433|433.0||||||
4452351|NCT00084136|4275288|B3|Between 18 and 29 years||Age, Customized||participants|Number|146|146.0||||||
4452352|NCT00084136|4275289|B2|Between 18 and 29 years||Age, Customized||participants|Number|146|146.0||||||
4452353|NCT00084136|4275290|B1|Between 18 and 29 years||Age, Customized||participants|Number|141|141.0||||||
4452354|NCT00084136|4275287|B4|||Age||years|Mean|35|35.0|Standard Deviation|9|9.0|||
4452355|NCT00084136|4275288|B3|||Age||years|Mean|35|35.0|Standard Deviation|9|9.0|||
4452356|NCT00084136|4275289|B2|||Age||years|Mean|35|35.0|Standard Deviation|8|8.0|||
4452357|NCT00084136|4275290|B1|||Age||years|Mean|35|35.0|Standard Deviation|9|9.0|||
4452358|NCT00084084|4275351|B1|||Baseline Heart Rate Variability (SDNN)||msec|Mean|98.947|98.947|Standard Deviation|32.324|32.324|||
4452359|NCT00084084|4275351|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4452360|NCT00084084|4275351|B1|White||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4452361|NCT00084084|4275351|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4452362|NCT00084084|4275351|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4452363|NCT00084084|4275351|B1|||Age||years|Mean|11.99|11.99|Standard Deviation|3.2464|3.2464|||
4452364|NCT00083915|4275359|B3||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4452365|NCT00083915|4275360|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4452366|NCT00083915|4275361|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4452367|NCT00083915|4275359|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4452368|NCT00083915|4275360|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4452369|NCT00083915|4275361|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4452370|NCT00083915|4275359|B3|||Age||years|Mean|65.14|65.14|Standard Deviation|8.55|8.55|||
4452371|NCT00083915|4275360|B2|||Age||years|Mean|65.5|65.5|Standard Deviation|8.36|8.36|||
4452372|NCT00083915|4275361|B1|||Age||years|Mean|64.83|64.83|Standard Deviation|8.77|8.77|||
4452373|NCT00083915|4275359|B3||>=65 years|Age||Participants|Count of Participants|46|46.0||||||
4452374|NCT00083915|4275360|B2||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4452375|NCT00083915|4275361|B1||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4452376|NCT00083915|4275359|B3||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4452377|NCT00083915|4275360|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4452378|NCT00083915|4275361|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4452379|NCT00083915|4275359|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452380|NCT00083915|4275360|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452381|NCT00083915|4275361|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452382|NCT00083889|4275368|B3||Male|Sex: Female, Male||Participants|Count of Participants|536|536.0||||||
4452383|NCT00083889|4275369|B2||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4452384|NCT00083889|4275370|B1||Male|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4452385|NCT00083889|4275368|B3||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4452386|NCT00083889|4275369|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4452387|NCT00083889|4275370|B1||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4452388|NCT00083889|4275368|B3||>=65 years|Age||Participants|Count of Participants|275|275.0||||||
4452389|NCT00083889|4275369|B2||>=65 years|Age||Participants|Count of Participants|123|123.0||||||
4452390|NCT00083889|4275370|B1||>=65 years|Age||Participants|Count of Participants|152|152.0||||||
4452391|NCT00083889|4275368|B3||Between 18 and 65 years|Age||Participants|Count of Participants|475|475.0||||||
4452392|NCT00083889|4275369|B2||Between 18 and 65 years|Age||Participants|Count of Participants|252|252.0||||||
4452393|NCT00083889|4275370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|223|223.0||||||
4452394|NCT00083889|4275368|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452395|NCT00083889|4275369|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452396|NCT00083889|4275370|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452397|NCT00004146|4275420|B1|Performance Status 60||Karnofsky Performance Status|performance status is an attempt to quantify patients' general well-being and activities of daily life. The scale is in intervals of 10. 100 being normal and 0 dead. For ABTC studies you had to have a KPS of at least 60 (Requires occasional assistance, but is able to care for most of his personal needs) to be eligible for the study.|participants|Number|2|2.0||||||
4452398|NCT00004146|4275420|B1|Performance Status 70||Karnofsky Performance Status|performance status is an attempt to quantify patients' general well-being and activities of daily life. The scale is in intervals of 10. 100 being normal and 0 dead. For ABTC studies you had to have a KPS of at least 60 (Requires occasional assistance, but is able to care for most of his personal needs) to be eligible for the study.|participants|Number|10|10.0||||||
4452399|NCT00004146|4275420|B1|Performance Status 80||Karnofsky Performance Status|performance status is an attempt to quantify patients' general well-being and activities of daily life. The scale is in intervals of 10. 100 being normal and 0 dead. For ABTC studies you had to have a KPS of at least 60 (Requires occasional assistance, but is able to care for most of his personal needs) to be eligible for the study.|participants|Number|10|10.0||||||
4452400|NCT00004146|4275420|B1|Performance Status 90||Karnofsky Performance Status|performance status is an attempt to quantify patients' general well-being and activities of daily life. The scale is in intervals of 10. 100 being normal and 0 dead. For ABTC studies you had to have a KPS of at least 60 (Requires occasional assistance, but is able to care for most of his personal needs) to be eligible for the study.|participants|Number|24|24.0||||||
4452401|NCT00004146|4275420|B1|Performance Status 100||Karnofsky Performance Status|performance status is an attempt to quantify patients' general well-being and activities of daily life. The scale is in intervals of 10. 100 being normal and 0 dead. For ABTC studies you had to have a KPS of at least 60 (Requires occasional assistance, but is able to care for most of his personal needs) to be eligible for the study.|participants|Number|9|9.0||||||
4452402|NCT00004146|4275420|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452403|NCT00004146|4275420|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452404|NCT00004146|4275420|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4452405|NCT00004146|4275420|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4452406|NCT00004146|4275420|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452407|NCT00004146|4275420|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452408|NCT00004146|4275420|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452409|NCT00004146|4275420|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4452410|NCT00004146|4275420|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4452411|NCT00004146|4275420|B1|||Age, Customized||years|Median|59|59.0|Full Range|||31.0|79.4|
4452412|NCT00083759|4275427|B3|>20||Baseline Count of Painful/Tender Joints||participants|Number|186|186.0||||||
4452413|NCT00083759|4275428|B2|>20||Baseline Count of Painful/Tender Joints||participants|Number|93|93.0||||||
4452414|NCT00083759|4275429|B1|>20||Baseline Count of Painful/Tender Joints||participants|Number|93|93.0||||||
4452415|NCT00083759|4275427|B3|<20||Baseline Count of Painful/Tender Joints||participants|Number|87|87.0||||||
4452416|NCT00083759|4275428|B2|<20||Baseline Count of Painful/Tender Joints||participants|Number|43|43.0||||||
4452417|NCT00083759|4275429|B1|<20||Baseline Count of Painful/Tender Joints||participants|Number|44|44.0||||||
4452418|NCT00083759|4275427|B3||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4452419|NCT00083759|4275428|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4452420|NCT00083759|4275429|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4452421|NCT00083759|4275427|B3||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4452422|NCT00083759|4275428|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4452423|NCT00083759|4275429|B1||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4452424|NCT00083759|4275427|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|10.5|10.5|||
4452425|NCT00083759|4275428|B2|||Age||years|Mean|53.6|53.6|Standard Deviation|10.4|10.4|||
4452426|NCT00083759|4275429|B1|||Age||years|Mean|50.9|50.9|Standard Deviation|10.5|10.5|||
4452427|NCT00083720|4275438|B1|Canada||Region of Enrollment||participants|Number|65|65.0||||||
4452428|NCT00083720|4275438|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4452429|NCT00083720|4275438|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4452430|NCT00083720|4275438|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4452431|NCT00083720|4275438|B1|||Age||years|Mean|64.2|64.2|Standard Deviation|11.41|11.41|||
4452432|NCT00083720|4275438|B1||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4452433|NCT00083720|4275438|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4452434|NCT00083720|4275438|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452435|NCT00083616|4275448|B1|Aborigine||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4452436|NCT00083616|4275448|B1|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4452437|NCT00083616|4275448|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|144|144.0||||||
4452438|NCT00083616|4275448|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4452439|NCT00083616|4275448|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4452440|NCT00083616|4275448|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|19|19.0||||||
4452441|NCT00083616|4275448|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4452442|NCT00083616|4275448|B1|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4452443|NCT00083616|4275448|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4452444|NCT00083616|4275448|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4452445|NCT00083616|4275448|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4452446|NCT00083616|4275448|B1|||Age||Years|Mean|59.6|59.6|Standard Deviation|10.6|10.6|||
4452447|NCT00083551|4275460|B3||Male|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
4452448|NCT00083551|4275461|B2||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4452449|NCT00083551|4275462|B1||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4452450|NCT00083551|4275460|B3||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4452451|NCT00083551|4275461|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4452452|NCT00083551|4275462|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4452453|NCT00083551|4275460|B3|< 60 years||Age, Customized||participants|Number|273|273.0||||||
4452454|NCT00083551|4275461|B2|< 60 years||Age, Customized||participants|Number|144|144.0||||||
4452455|NCT00083551|4275462|B1|< 60 years||Age, Customized||participants|Number|129|129.0||||||
4452456|NCT00083551|4275460|B3|>/= 65 years||Age, Customized||participants|Number|136|136.0||||||
4452457|NCT00083551|4275461|B2|>/= 65 years||Age, Customized||participants|Number|72|72.0||||||
4452458|NCT00083551|4275462|B1|>/= 65 years||Age, Customized||participants|Number|64|64.0||||||
4452459|NCT00083551|4275460|B3|>/= 60 to < 65 years||Age, Customized||participants|Number|259|259.0||||||
4452460|NCT00083551|4275461|B2|>/= 60 to < 65 years||Age, Customized||participants|Number|129|129.0||||||
4452461|NCT00083551|4275462|B1|>/= 60 to < 65 years||Age, Customized||participants|Number|130|130.0||||||
4452462|NCT00083382|4275469|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4452463|NCT00083382|4275469|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4452464|NCT00083382|4275469|B1|||Age||years|Mean|60.0|60.0|Standard Deviation|9.2|9.2|||
4452465|NCT00082888|4275473|B1|Uncommon||Relapsed or Refractory Lymphoma||participants|Number|36|36.0||||||
4452466|NCT00082888|4275473|B1|Indolent||Relapsed or Refractory Lymphoma||participants|Number|15|15.0||||||
4452467|NCT00082888|4275473|B1|Aggressive||Relapsed or Refractory Lymphoma||participants|Number|42|42.0||||||
4452468|NCT00082888|4275473|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
4452469|NCT00082888|4275473|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4452470|NCT00082888|4275473|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4452471|NCT00082888|4275473|B1|||Age||years|Median|62|62.0|Full Range|||18.0|91.0|
4452472|NCT00082810|4275477|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4452473|NCT00082810|4275477|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4452474|NCT00082810|4275477|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4452475|NCT00082810|4275477|B1|Whites||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4452476|NCT00082810|4275477|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452477|NCT00082810|4275477|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4452478|NCT00082810|4275477|B1|||Age||years|Median|61.0|61.0|Full Range|||39.0|77.0|
4452479|NCT00082758|4275485|B4|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4452480|NCT00082758|4275487|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4452481|NCT00082758|4275488|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4452482|NCT00082758|4275485|B4|United States||Region of Enrollment||participants|Number|36|36.0||||||
4452483|NCT00082758|4275487|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4452484|NCT00082758|4275488|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4452485|NCT00082758|4275485|B4|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|2|2.0||||||
4452486|NCT00082758|4275487|B2|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|1|1.0||||||
4452487|NCT00082758|4275488|B1|Unknown or Not Reported||Race (NIH/OMB)||participants|Number|1|1.0||||||
4452488|NCT00082758|4275485|B4|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4452489|NCT00082758|4275487|B2|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4452490|NCT00082758|4275488|B1|More than one race||Race (NIH/OMB)||participants|Number|0|0.0||||||
4452491|NCT00082758|4275485|B4|White||Race (NIH/OMB)||participants|Number|27|27.0||||||
4452492|NCT00082758|4275487|B2|White||Race (NIH/OMB)||participants|Number|18|18.0||||||
4452493|NCT00082758|4275488|B1|White||Race (NIH/OMB)||participants|Number|9|9.0||||||
4452494|NCT00082758|4275485|B4|Black or African American||Race (NIH/OMB)||participants|Number|8|8.0||||||
4452495|NCT00082758|4275487|B2|Black or African American||Race (NIH/OMB)||participants|Number|3|3.0||||||
4452496|NCT00082758|4275488|B1|Black or African American||Race (NIH/OMB)||participants|Number|5|5.0||||||
4452497|NCT00082758|4275485|B4|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4452498|NCT00082758|4275487|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4452499|NCT00082758|4275488|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)||participants|Number|0|0.0||||||
4452500|NCT00082758|4275485|B4|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4452501|NCT00082758|4275487|B2|Asian||Race (NIH/OMB)||participants|Number|1|1.0||||||
4452502|NCT00082758|4275488|B1|Asian||Race (NIH/OMB)||participants|Number|0|0.0||||||
4452503|NCT00082758|4275485|B4|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|1|1.0||||||
4452504|NCT00082758|4275487|B2|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|1|1.0||||||
4452505|NCT00082758|4275488|B1|American Indian or Alaska Native||Race (NIH/OMB)||participants|Number|0|0.0||||||
4452506|NCT00082758|4275485|B4|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
4452507|NCT00082758|4275487|B2|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|1|1.0||||||
4452508|NCT00082758|4275488|B1|Unknown or Not Reported||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4452509|NCT00082758|4275485|B4|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|36|36.0||||||
4452510|NCT00082758|4275487|B2|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|21|21.0||||||
4452511|NCT00082758|4275488|B1|Not Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|15|15.0||||||
4452512|NCT00082758|4275485|B4|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
4452513|NCT00082758|4275487|B2|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|2|2.0||||||
4452514|NCT00082758|4275488|B1|Hispanic or Latino||Ethnicity (NIH/OMB)||participants|Number|0|0.0||||||
4452515|NCT00082758|4275485|B4|Male||Gender||participants|Number|22|22.0||||||
4452516|NCT00082758|4275487|B2|Male||Gender||participants|Number|14|14.0||||||
4452517|NCT00082758|4275488|B1|Male||Gender||participants|Number|8|8.0||||||
4452518|NCT00082758|4275485|B4|Female||Gender||participants|Number|17|17.0||||||
4452519|NCT00082758|4275487|B2|Female||Gender||participants|Number|10|10.0||||||
4452520|NCT00082758|4275488|B1|Female||Gender||participants|Number|7|7.0||||||
4452521|NCT00082758|4275485|B4|||Age||years|Median|6.16|6.16|Inter-Quartile Range|||4.78|9.4|
4452522|NCT00082758|4275487|B2|||Age||years|Median|6.28|6.28|Inter-Quartile Range|||5.32|9.09|
4452523|NCT00082758|4275488|B1|||Age||years|Median|5.98|5.98|Inter-Quartile Range|||4.74|10.89|
4452524|NCT00082758|4275485|B4|>=65 years||Age||participants|Number|0|0.0||||||
4452525|NCT00082758|4275487|B2|>=65 years||Age||participants|Number|0|0.0||||||
4452526|NCT00082758|4275488|B1|>=65 years||Age||participants|Number|0|0.0||||||
4452527|NCT00082758|4275485|B4|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4452528|NCT00082758|4275487|B2|Between 18 and 65 years||Age||participants|Number|1|1.0||||||
4452529|NCT00082758|4275488|B1|Between 18 and 65 years||Age||participants|Number|0|0.0||||||
4452530|NCT00082758|4275485|B4|<=18 years||Age||participants|Number|38|38.0||||||
4452531|NCT00082758|4275487|B2|<=18 years||Age||participants|Number|23|23.0||||||
4452532|NCT00082758|4275488|B1|<=18 years||Age||participants|Number|15|15.0||||||
4452533|NCT00082641|4275498|B3|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4452534|NCT00082641|4275499|B2|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4452535|NCT00082641|4275500|B1|Caucasian||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4452536|NCT00082641|4275498|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452537|NCT00082641|4275499|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452538|NCT00082641|4275500|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452539|NCT00082641|4275498|B3||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4452540|NCT00082641|4275499|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4452541|NCT00082641|4275500|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4452542|NCT00082641|4275498|B3|Participant >= 19 years of age||Age, Customized||Participants|Count of Participants|23|23.0||||||
4452543|NCT00082641|4275499|B2|Participant >= 19 years of age||Age, Customized||Participants|Count of Participants|12|12.0||||||
4452544|NCT00082641|4275500|B1|Participant >= 19 years of age||Age, Customized||Participants|Count of Participants|11|11.0||||||
4452545|NCT00083226|4275510|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4452546|NCT00083226|4275510|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4452547|NCT00083226|4275510|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4452548|NCT00083226|4275510|B1|||Age||years|Mean|57.1|57.1|Standard Deviation|11.1|11.1|||
4452549|NCT00083174|4275516|B3|Spain||Region of Enrollment||participants|Number|432|432.0||||||
4452550|NCT00083174|4275517|B2|Spain||Region of Enrollment||participants|Number|215|215.0||||||
4452551|NCT00083174|4275518|B1|Spain||Region of Enrollment||participants|Number|217|217.0||||||
4452552|NCT00083174|4275516|B3|Canada||Region of Enrollment||participants|Number|1285|1285.0||||||
4452553|NCT00083174|4275517|B2|Canada||Region of Enrollment||participants|Number|642|642.0||||||
4452554|NCT00083174|4275518|B1|Canada||Region of Enrollment||participants|Number|643|643.0||||||
4452555|NCT00083174|4275516|B3|France||Region of Enrollment||participants|Number|19|19.0||||||
4452556|NCT00083174|4275517|B2|France||Region of Enrollment||participants|Number|10|10.0||||||
4452557|NCT00083174|4275518|B1|France||Region of Enrollment||participants|Number|9|9.0||||||
4452558|NCT00083174|4275516|B3|United States||Region of Enrollment||participants|Number|2824|2824.0||||||
4452559|NCT00083174|4275517|B2|United States||Region of Enrollment||participants|Number|1408|1408.0||||||
4452560|NCT00083174|4275518|B1|United States||Region of Enrollment||participants|Number|1416|1416.0||||||
4452561|NCT00083174|4275516|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452562|NCT00083174|4275517|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452563|NCT00083174|4275518|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452564|NCT00083174|4275516|B3||Female|Sex: Female, Male||Participants|Count of Participants|4560|4560.0||||||
4452565|NCT00083174|4275517|B2||Female|Sex: Female, Male||Participants|Count of Participants|2275|2275.0||||||
4452566|NCT00083174|4275518|B1||Female|Sex: Female, Male||Participants|Count of Participants|2285|2285.0||||||
4452567|NCT00083174|4275516|B3|||Age||years|Mean|63.1|63.1|Standard Deviation|7.1|7.1|||
4452568|NCT00083174|4275517|B2|||Age||years|Mean|63.1|63.1|Standard Deviation|7.0|7.0|||
4452569|NCT00083174|4275518|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|7.2|7.2|||
4452570|NCT00083174|4275516|B3||>=65 years|Age||Participants|Count of Participants|1621|1621.0||||||
4452571|NCT00083174|4275517|B2||>=65 years|Age||Participants|Count of Participants|794|794.0||||||
4452572|NCT00083174|4275518|B1||>=65 years|Age||Participants|Count of Participants|827|827.0||||||
4452573|NCT00083174|4275516|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2939|2939.0||||||
4452574|NCT00083174|4275517|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1481|1481.0||||||
4452575|NCT00083174|4275518|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1458|1458.0||||||
4452576|NCT00083174|4275516|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452577|NCT00083174|4275517|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452578|NCT00083174|4275518|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452579|NCT00083122|4275540|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4452580|NCT00083122|4275541|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4452581|NCT00083122|4275542|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4452582|NCT00083122|4275540|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452583|NCT00083122|4275541|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452584|NCT00083122|4275542|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452585|NCT00083122|4275540|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4452586|NCT00083122|4275541|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4452587|NCT00083122|4275542|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4452588|NCT00083122|4275540|B3|||Age||years|Median|59|59.0|Full Range|||29.0|79.0|
4452589|NCT00083122|4275541|B2|||Age||years|Median|61|61.0|Full Range|||41.0|73.0|
4452590|NCT00083122|4275542|B1|||Age||years|Median|59|59.0|Full Range|||29.0|79.0|
4452591|NCT00082628|4275552|B3||Male|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4452592|NCT00082628|4275553|B2||Male|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4452593|NCT00082628|4275554|B1||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4452594|NCT00082628|4275552|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4452595|NCT00082628|4275553|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4452596|NCT00082628|4275554|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4452597|NCT00082628|4275552|B3|||Age||Years|Mean|44.8|44.8|Standard Deviation|7.1|7.1|||
4452598|NCT00082628|4275553|B2|||Age||Years|Mean|44.5|44.5|Standard Deviation|7.0|7.0|||
4452599|NCT00082628|4275554|B1|||Age||Years|Mean|45.5|45.5|Standard Deviation|7.5|7.5|||
4452600|NCT00082433|4275576|B3|||Presence with at least 1 lesion||participants|Number|1218|1218.0||||||
4452601|NCT00082433|4275577|B2|||Presence with at least 1 lesion||participants|Number|612|612.0||||||
4452602|NCT00082433|4275578|B1|||Presence with at least 1 lesion||participants|Number|606|606.0||||||
4452603|NCT00082433|4275576|B3|Visceral, Other||Organ Sites||participants|Number|50|50.0||||||
4452604|NCT00082433|4275577|B2|Visceral, Other||Organ Sites||participants|Number|26|26.0||||||
4452605|NCT00082433|4275578|B1|Visceral, Other||Organ Sites||participants|Number|24|24.0||||||
4452606|NCT00082433|4275576|B3|Visceral, Lung||Organ Sites||participants|Number|438|438.0||||||
4452607|NCT00082433|4275577|B2|Visceral, Lung||Organ Sites||participants|Number|217|217.0||||||
4452608|NCT00082433|4275578|B1|Visceral, Lung||Organ Sites||participants|Number|221|221.0||||||
4452609|NCT00082433|4275576|B3|Visceral, Liver||Organ Sites||participants|Number|549|549.0||||||
4452610|NCT00082433|4275577|B2|Visceral, Liver||Organ Sites||participants|Number|276|276.0||||||
4452611|NCT00082433|4275578|B1|Visceral, Liver||Organ Sites||participants|Number|273|273.0||||||
4452612|NCT00082433|4275576|B3|Subcutaneous||Organ Sites||participants|Number|47|47.0||||||
4452613|NCT00082433|4275577|B2|Subcutaneous||Organ Sites||participants|Number|24|24.0||||||
4452614|NCT00082433|4275578|B1|Subcutaneous||Organ Sites||participants|Number|23|23.0||||||
4452615|NCT00082433|4275576|B3|Pleura||Organ Sites||participants|Number|170|170.0||||||
4452616|NCT00082433|4275577|B2|Pleura||Organ Sites||participants|Number|84|84.0||||||
4452617|NCT00082433|4275578|B1|Pleura||Organ Sites||participants|Number|86|86.0||||||
4452618|NCT00082433|4275576|B3|Other||Organ Sites||participants|Number|47|47.0||||||
4452619|NCT00082433|4275577|B2|Other||Organ Sites||participants|Number|30|30.0||||||
4452620|NCT00082433|4275578|B1|Other||Organ Sites||participants|Number|17|17.0||||||
4452621|NCT00082433|4275576|B3|Mediastinum||Organ Sites||participants|Number|106|106.0||||||
4452622|NCT00082433|4275577|B2|Mediastinum||Organ Sites||participants|Number|52|52.0||||||
4452623|NCT00082433|4275578|B1|Mediastinum||Organ Sites||participants|Number|54|54.0||||||
4452624|NCT00082433|4275576|B3|Lymph Node||Organ Sites||participants|Number|469|469.0||||||
4452625|NCT00082433|4275577|B2|Lymph Node||Organ Sites||participants|Number|233|233.0||||||
4452626|NCT00082433|4275578|B1|Lymph Node||Organ Sites||participants|Number|236|236.0||||||
4452627|NCT00082433|4275576|B3|Intestine||Organ Sites||participants|Number|2|2.0||||||
4452628|NCT00082433|4275577|B2|Intestine||Organ Sites||participants|Number|1|1.0||||||
4452629|NCT00082433|4275578|B1|Intestine||Organ Sites||participants|Number|1|1.0||||||
4452630|NCT00082433|4275576|B3|Effusion||Organ Sites||participants|Number|14|14.0||||||
4452631|NCT00082433|4275577|B2|Effusion||Organ Sites||participants|Number|7|7.0||||||
4452632|NCT00082433|4275578|B1|Effusion||Organ Sites||participants|Number|7|7.0||||||
4452633|NCT00082433|4275576|B3|Cutaneous||Organ Sites||participants|Number|121|121.0||||||
4452634|NCT00082433|4275577|B2|Cutaneous||Organ Sites||participants|Number|57|57.0||||||
4452635|NCT00082433|4275578|B1|Cutaneous||Organ Sites||participants|Number|64|64.0||||||
4452636|NCT00082433|4275576|B3|CNS||Organ Sites||participants|Number|1|1.0||||||
4452637|NCT00082433|4275577|B2|CNS||Organ Sites||participants|Number|0|0.0||||||
4452638|NCT00082433|4275578|B1|CNS||Organ Sites||participants|Number|1|1.0||||||
4452639|NCT00082433|4275576|B3|Chest Wall Mass||Organ Sites||participants|Number|85|85.0||||||
4452640|NCT00082433|4275577|B2|Chest Wall Mass||Organ Sites||participants|Number|38|38.0||||||
4452641|NCT00082433|4275578|B1|Chest Wall Mass||Organ Sites||participants|Number|47|47.0||||||
4452642|NCT00082433|4275576|B3|Breast||Organ Sites||participants|Number|95|95.0||||||
4452643|NCT00082433|4275577|B2|Breast||Organ Sites||participants|Number|54|54.0||||||
4452644|NCT00082433|4275578|B1|Breast||Organ Sites||participants|Number|41|41.0||||||
4452645|NCT00082433|4275576|B3|Brain||Organ Sites||participants|Number|1|1.0||||||
4452646|NCT00082433|4275577|B2|Brain||Organ Sites||participants|Number|1|1.0||||||
4452647|NCT00082433|4275578|B1|Brain||Organ Sites||participants|Number|0|0.0||||||
4452648|NCT00082433|4275576|B3|Bone||Organ Sites||participants|Number|570|570.0||||||
4452649|NCT00082433|4275577|B2|Bone||Organ Sites||participants|Number|287|287.0||||||
4452650|NCT00082433|4275578|B1|Bone||Organ Sites||participants|Number|283|283.0||||||
4452651|NCT00082433|4275576|B3|Ascites||Organ Sites||participants|Number|29|29.0||||||
4452652|NCT00082433|4275577|B2|Ascites||Organ Sites||participants|Number|16|16.0||||||
4452653|NCT00082433|4275578|B1|Ascites||Organ Sites||participants|Number|13|13.0||||||
4452654|NCT00082433|4275576|B3|Not Reported||Menopausal Status||participants|Number|18|18.0||||||
4452655|NCT00082433|4275577|B2|Not Reported||Menopausal Status||participants|Number|9|9.0||||||
4452656|NCT00082433|4275578|B1|Not Reported||Menopausal Status||participants|Number|9|9.0||||||
4452657|NCT00082433|4275576|B3|Postmenopausal||Menopausal Status||participants|Number|956|956.0||||||
4452658|NCT00082433|4275577|B2|Postmenopausal||Menopausal Status||participants|Number|481|481.0||||||
4452659|NCT00082433|4275578|B1|Postmenopausal||Menopausal Status||participants|Number|475|475.0||||||
4452660|NCT00082433|4275576|B3|Perimenopausal||Menopausal Status||participants|Number|64|64.0||||||
4452661|NCT00082433|4275577|B2|Perimenopausal||Menopausal Status||participants|Number|32|32.0||||||
4452662|NCT00082433|4275578|B1|Perimenopausal||Menopausal Status||participants|Number|32|32.0||||||
4452663|NCT00082433|4275576|B3|Premenopausal||Menopausal Status||participants|Number|183|183.0||||||
4452664|NCT00082433|4275577|B2|Premenopausal||Menopausal Status||participants|Number|90|90.0||||||
4452665|NCT00082433|4275578|B1|Premenopausal||Menopausal Status||participants|Number|93|93.0||||||
4452666|NCT00082433|4275576|B3|not reported||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|7|7.0||||||
4452667|NCT00082433|4275577|B2|not reported||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|1|1.0||||||
4452687|NCT00082433|4275576|B3|White||Race/Ethnicity, Customized||participants|Number|982|982.0||||||
4452668|NCT00082433|4275578|B1|not reported||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|6|6.0||||||
4452669|NCT00082433|4275576|B3|<70||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|4|4.0||||||
4452670|NCT00082433|4275577|B2|<70||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|2|2.0||||||
4452671|NCT00082433|4275578|B1|<70||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|2|2.0||||||
4452672|NCT00082433|4275576|B3|70||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|70|70.0||||||
4452673|NCT00082433|4275577|B2|70||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|26|26.0||||||
4452674|NCT00082433|4275578|B1|70||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|44|44.0||||||
4452675|NCT00082433|4275576|B3|80||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|281|281.0||||||
4452676|NCT00082433|4275577|B2|80||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|130|130.0||||||
4452677|NCT00082433|4275578|B1|80||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|151|151.0||||||
4452678|NCT00082433|4275576|B3|90||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|375|375.0||||||
4452679|NCT00082433|4275577|B2|90||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|188|188.0||||||
4452680|NCT00082433|4275578|B1|90||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|187|187.0||||||
4452681|NCT00082433|4275576|B3|100||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|484|484.0||||||
4452682|NCT00082433|4275577|B2|100||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|265|265.0||||||
4452683|NCT00082433|4275578|B1|100||Karnofsky performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=able to carry on normal activity and work, no special care; 70-50=unable to work; able to live at home and care for most personal needs with assistance; 40=unable to care for self; requires institutional or hospital care. Score reported in multiples of 10.|units on a scale|Number|219|219.0||||||
4452684|NCT00082433|4275576|B3|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4452685|NCT00082433|4275577|B2|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4452686|NCT00082433|4275578|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4452688|NCT00082433|4275577|B2|White||Race/Ethnicity, Customized||participants|Number|502|502.0||||||
4452689|NCT00082433|4275578|B1|White||Race/Ethnicity, Customized||participants|Number|480|480.0||||||
4452690|NCT00082433|4275576|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4452691|NCT00082433|4275577|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4452692|NCT00082433|4275578|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4452693|NCT00082433|4275576|B3|Asian||Race/Ethnicity, Customized||participants|Number|159|159.0||||||
4452694|NCT00082433|4275577|B2|Asian||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4452695|NCT00082433|4275578|B1|Asian||Race/Ethnicity, Customized||participants|Number|90|90.0||||||
4452696|NCT00082433|4275576|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4452697|NCT00082433|4275577|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4452698|NCT00082433|4275578|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4452699|NCT00082433|4275576|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452700|NCT00082433|4275577|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452701|NCT00082433|4275578|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452702|NCT00082433|4275576|B3||Female|Sex: Female, Male||Participants|Count of Participants|1221|1221.0||||||
4452703|NCT00082433|4275577|B2||Female|Sex: Female, Male||Participants|Count of Participants|612|612.0||||||
4452704|NCT00082433|4275578|B1||Female|Sex: Female, Male||Participants|Count of Participants|609|609.0||||||
4452705|NCT00082433|4275576|B3|||Age||years|Median|53.0|53.0|Full Range|||23.0|81.0|
4452706|NCT00082433|4275577|B2|||Age||years|Median|53.0|53.0|Full Range|||24.0|81.0|
4452707|NCT00082433|4275578|B1|||Age||years|Median|53.0|53.0|Full Range|||23.0|78.0|
4452708|NCT00082433|4275576|B3|≥50 years||Age, Customized||participants|Number|761|761.0||||||
4452709|NCT00082433|4275577|B2|≥50 years||Age, Customized||participants|Number|377|377.0||||||
4452710|NCT00082433|4275578|B1|≥50 years||Age, Customized||participants|Number|384|384.0||||||
4452711|NCT00082433|4275576|B3|<50 years||Age, Customized||participants|Number|460|460.0||||||
4452712|NCT00082433|4275577|B2|<50 years||Age, Customized||participants|Number|235|235.0||||||
4452713|NCT00082433|4275578|B1|<50 years||Age, Customized||participants|Number|225|225.0||||||
4452714|NCT00082433|4275576|B3|≥65 years||Age, Customized||participants|Number|158|158.0||||||
4452715|NCT00082433|4275577|B2|≥65 years||Age, Customized||participants|Number|81|81.0||||||
4452716|NCT00082433|4275578|B1|≥65 years||Age, Customized||participants|Number|77|77.0||||||
4452717|NCT00082433|4275576|B3|<65 years||Age, Customized||participants|Number|1063|1063.0||||||
4452718|NCT00082433|4275577|B2|<65 years||Age, Customized||participants|Number|531|531.0||||||
4452719|NCT00082433|4275578|B1|<65 years||Age, Customized||participants|Number|532|532.0||||||
4452720|NCT00082381|4275597|B3||Male|Sex: Female, Male||Participants|Count of Participants|306|306.0||||||
4452721|NCT00082381|4275598|B2||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4452722|NCT00082381|4275599|B1||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4452723|NCT00082381|4275597|B3||Female|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4452724|NCT00082381|4275598|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4452725|NCT00082381|4275599|B1||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4452726|NCT00082381|4275597|B3|||Age||years|Mean|58.91|58.91|Standard Deviation|9.13|9.13|||
4452727|NCT00082381|4275598|B2|||Age||years|Mean|57.96|57.96|Standard Deviation|9.46|9.46|||
4452728|NCT00082381|4275599|B1|||Age||years|Mean|59.80|59.8|Standard Deviation|8.82|8.82|||
4452729|NCT00082407|4275618|B3||Male|Sex: Female, Male||Participants|Count of Participants|244|244.0||||||
4452730|NCT00082407|4275619|B2||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4452731|NCT00082407|4275620|B1||Male|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4452732|NCT00082407|4275618|B3||Female|Sex: Female, Male||Participants|Count of Participants|257|257.0||||||
4452733|NCT00082407|4275619|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4452734|NCT00082407|4275620|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4452735|NCT00082407|4275618|B3|||Age||years|Mean|58.7|58.7|Standard Deviation|9.0|9.0|||
4452736|NCT00082407|4275619|B2|||Age||years|Mean|58.5|58.5|Standard Deviation|9.2|9.2|||
4452737|NCT00082407|4275620|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|8.7|8.7|||
4452738|NCT00082407|4275618|B3||>=65 years|Age||Participants|Count of Participants|143|143.0||||||
4452739|NCT00082407|4275619|B2||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4452740|NCT00082407|4275620|B1||>=65 years|Age||Participants|Count of Participants|69|69.0||||||
4452741|NCT00082407|4275618|B3||Between 18 and 65 years|Age||Participants|Count of Participants|358|358.0||||||
4452742|NCT00082407|4275619|B2||Between 18 and 65 years|Age||Participants|Count of Participants|174|174.0||||||
4452743|NCT00082407|4275620|B1||Between 18 and 65 years|Age||Participants|Count of Participants|184|184.0||||||
4452744|NCT00082407|4275618|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452745|NCT00082407|4275619|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452746|NCT00082407|4275620|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452747|NCT00082368|4275639|B1|||Prior Chemotherapy||prior therapies|Mean|3.5|3.5|Full Range|||1.0|6.0|
4452748|NCT00082368|4275639|B1|Ovarian cancer||Histology||Participants|Count of Participants|1|1.0||||||
4452749|NCT00082368|4275639|B1|Prostate cancer||Histology||Participants|Count of Participants|1|1.0||||||
4452750|NCT00082368|4275639|B1|Esophageal cancer||Histology||Participants|Count of Participants|1|1.0||||||
4452751|NCT00082368|4275639|B1|Non-small cell lung cancer||Histology||Participants|Count of Participants|1|1.0||||||
4452752|NCT00082368|4275639|B1|Small cell lung cancer||Histology||Participants|Count of Participants|2|2.0||||||
4452753|NCT00082368|4275639|B1|Pancreatic cancer||Histology||Participants|Count of Participants|2|2.0||||||
4452754|NCT00082368|4275639|B1|Colorectal cancer||Histology||Participants|Count of Participants|4|4.0||||||
4452755|NCT00082368|4275639|B1|Performance status: 3||Performance Status: Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Grade 3 is in bed >50% of the time. Capable of only limited self-care. Grade 4 is 100% bedridden. Completely disabled. Grade 5 is dead.|Participants|Count of Participants|0|0.0||||||
4452756|NCT00082368|4275639|B1|Performance status: 2||Performance Status: Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Grade 3 is in bed >50% of the time. Capable of only limited self-care. Grade 4 is 100% bedridden. Completely disabled. Grade 5 is dead.|Participants|Count of Participants|1|1.0||||||
4452757|NCT00082368|4275639|B1|Performance status: 1||Performance Status: Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Grade 3 is in bed >50% of the time. Capable of only limited self-care. Grade 4 is 100% bedridden. Completely disabled. Grade 5 is dead.|Participants|Count of Participants|9|9.0||||||
4452758|NCT00082368|4275639|B1|Performance status: 0||Performance Status: Eastern Cooperative Oncology Group (ECOG)|ECOG Performance Status: Grade 0 is normal activity. Fully active, able to carry on all pre-disease performance without restriction. Grade 1 is symptoms, but ambulatory. Restricted in physically strenuous activity, but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). Grade 2 is in bed <50% of the time. Ambulatory and capable of all self-care, but unable to carry out any work activities. Grade 3 is in bed >50% of the time. Capable of only limited self-care. Grade 4 is 100% bedridden. Completely disabled. Grade 5 is dead.|Participants|Count of Participants|2|2.0||||||
4452759|NCT00082368|4275639|B1|United States||Region of Enrollment||Participants|Count of Participants|12|12.0||||||
4452760|NCT00082368|4275639|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452761|NCT00082368|4275639|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452762|NCT00082368|4275639|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4452763|NCT00082368|4275639|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4452764|NCT00082368|4275639|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4452765|NCT00082368|4275639|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4452766|NCT00082368|4275639|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452767|NCT00082368|4275639|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452768|NCT00082368|4275639|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4452769|NCT00082368|4275639|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4452770|NCT00082368|4275639|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4452771|NCT00082368|4275639|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4452772|NCT00082368|4275639|B1|||Age||years|Mean|54.82|54.82|Standard Deviation|8.11|8.11|||
4452773|NCT00082368|4275639|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4452774|NCT00082368|4275639|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4452775|NCT00082368|4275639|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452776|NCT00082355|4275644|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4452777|NCT00082355|4275644|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4452778|NCT00082355|4275644|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4452779|NCT00082355|4275644|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|12|12.0|||
4452780|NCT00082355|4275644|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4452781|NCT00082355|4275644|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4452782|NCT00082355|4275644|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452783|NCT00082342|4275649|B3|||Hoehn-Yahr off medication|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The measurement on the Hoehn and Yahr was taken while the subject was off medication.|units on scale|Mean|2.8|2.8|Standard Deviation|0.4|0.4|||
4452831|NCT00081939|4275691|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4452832|NCT00081939|4275691|B1||>=65 years|Age||Participants|Count of Participants|84|84.0||||||
4452833|NCT00081939|4275691|B1||Between 18 and 65 years|Age||Participants|Count of Participants|219|219.0||||||
4452784|NCT00082342|4275650|B2|||Hoehn-Yahr off medication|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The measurement on the Hoehn and Yahr was taken while the subject was off medication.|units on scale|Mean|2.9|2.9|Standard Deviation|0.4|0.4|||
4452785|NCT00082342|4275651|B1|||Hoehn-Yahr off medication|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The measurement on the Hoehn and Yahr was taken while the subject was off medication.|units on scale|Mean|2.7|2.7|Standard Deviation|0.3|0.3|||
4452786|NCT00082342|4275649|B3|||Hoehn-Yahr on medication|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The measurement on the Hoehn and Yahr was taken while the subject was on medication.|units on a scale|Mean|2.42|2.42|Standard Deviation|0.2|0.2|||
4452787|NCT00082342|4275650|B2|||Hoehn-Yahr on medication|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The measurement on the Hoehn and Yahr was taken while the subject was on medication.|units on a scale|Mean|2.4|2.4|Standard Deviation|0.2|0.2|||
4452788|NCT00082342|4275651|B1|||Hoehn-Yahr on medication|The Hoehn and Yahr scale is a system used to describe how the symptoms of Parkinson's disease progress. The scale ranges from 1-5 with 1 representing unilateral involvement with minimal or no functional disability and 5 representing confinement to bed or wheelchair unless aided. The measurement on the Hoehn and Yahr was taken while the subject was on medication.|units on a scale|Mean|2.5|2.5|Standard Deviation|0.1|0.1|||
4452789|NCT00082342|4275649|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4452790|NCT00082342|4275650|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4452791|NCT00082342|4275651|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4452792|NCT00082342|4275649|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4452793|NCT00082342|4275650|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4452794|NCT00082342|4275651|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4452795|NCT00082342|4275649|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|8.5|8.5|||
4452796|NCT00082342|4275650|B2|||Age||years|Mean|64.2|64.2|Standard Deviation|8.8|8.8|||
4452797|NCT00082342|4275651|B1|||Age||years|Mean|63.6|63.6|Standard Deviation|9.0|9.0|||
4452798|NCT00082329|4275672|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4452799|NCT00082329|4275672|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4452800|NCT00082329|4275672|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4452801|NCT00082329|4275672|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4452802|NCT00082329|4275672|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4452803|NCT00082329|4275672|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452804|NCT00082173|4275676|B3|Brazil||Region of Enrollment||participants|Number|146|146.0||||||
4452805|NCT00082173|4275677|B2|Brazil||Region of Enrollment||participants|Number|72|72.0||||||
4452806|NCT00082173|4275678|B1|Brazil||Region of Enrollment||participants|Number|74|74.0||||||
4452807|NCT00082173|4275676|B3||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4452808|NCT00082173|4275677|B2||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4452809|NCT00082173|4275678|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4452810|NCT00082173|4275676|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4452811|NCT00082173|4275677|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4452812|NCT00082173|4275678|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4452813|NCT00082173|4275676|B3|||Age||years|Mean|34.1|34.1|Standard Deviation|11.9|11.9|||
4452814|NCT00082173|4275677|B2|||Age||years|Mean|35.7|35.7|Standard Deviation|12.0|12.0|||
4452815|NCT00082173|4275678|B1|||Age||years|Mean|32.5|32.5|Standard Deviation|11.7|11.7|||
4452816|NCT00082173|4275676|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4452817|NCT00082173|4275677|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4452818|NCT00082173|4275678|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4452819|NCT00082173|4275676|B3||Between 18 and 65 years|Age||Participants|Count of Participants|143|143.0||||||
4452820|NCT00082173|4275677|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4452821|NCT00082173|4275678|B1||Between 18 and 65 years|Age||Participants|Count of Participants|72|72.0||||||
4452822|NCT00082173|4275676|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452823|NCT00082173|4275677|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452824|NCT00082173|4275678|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452825|NCT00003726|4275687|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4452826|NCT00003726|4275687|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452827|NCT00003726|4275687|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4452828|NCT00003726|4275687|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4452829|NCT00003726|4275687|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452830|NCT00081939|4275691|B1||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4452834|NCT00081939|4275691|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452835|NCT00082017|4275695|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4452836|NCT00082017|4275695|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452837|NCT00082017|4275695|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452838|NCT00082017|4275695|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4452839|NCT00082017|4275695|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4452840|NCT00082017|4275695|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452841|NCT00082017|4275695|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4452842|NCT00082017|4275695|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4452843|NCT00082017|4275695|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4452844|NCT00082017|4275695|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4452845|NCT00082017|4275695|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4452846|NCT00082017|4275695|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4452847|NCT00082017|4275695|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4452848|NCT00082017|4275695|B1|||Age||years|Mean|35.29|35.29|Standard Deviation|18.89|18.89|||
4452849|NCT00082017|4275695|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4452850|NCT00082017|4275695|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4452851|NCT00082017|4275695|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4452852|NCT00081861|4275712|B1|United States||Region of Enrollment||Participants|Number|13|13.0||||||
4452853|NCT00081861|4275712|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4452854|NCT00081861|4275712|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4452855|NCT00081861|4275712|B1|||Age||years|Median|67|67.0|Full Range|||34.0|79.0|
4452856|NCT00081770|4275716|B4||Male|Sex: Female, Male||Participants|Count of Participants|1833|1833.0||||||
4452857|NCT00081770|4275717|B3||Male|Sex: Female, Male||Participants|Count of Participants|613|613.0||||||
4452858|NCT00081770|4275718|B2||Male|Sex: Female, Male||Participants|Count of Participants|607|607.0||||||
4452859|NCT00081770|4275719|B1||Male|Sex: Female, Male||Participants|Count of Participants|613|613.0||||||
4452860|NCT00081770|4275716|B4||Female|Sex: Female, Male||Participants|Count of Participants|1237|1237.0||||||
4452861|NCT00081770|4275717|B3||Female|Sex: Female, Male||Participants|Count of Participants|422|422.0||||||
4452862|NCT00081770|4275718|B2||Female|Sex: Female, Male||Participants|Count of Participants|409|409.0||||||
4452863|NCT00081770|4275719|B1||Female|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
4452864|NCT00081770|4275716|B4|||Age||years|Mean|47.5|47.5|Standard Deviation|8.0|8.0|||
4452865|NCT00081770|4275717|B3|||Age||years|Mean|47.6|47.6|Standard Deviation|8.2|8.2|||
4452866|NCT00081770|4275718|B2|||Age||years|Mean|47.5|47.5|Standard Deviation|8.1|8.1|||
4452867|NCT00081770|4275719|B1|||Age||years|Mean|47.5|47.5|Standard Deviation|7.8|7.8|||
4452868|NCT00081731|4275738|B3|United States||Region of Enrollment||participants|Number|772|772.0||||||
4452869|NCT00081731|4275739|B2|United States||Region of Enrollment||participants|Number|385|385.0||||||
4452870|NCT00081731|4275740|B1|United States||Region of Enrollment||participants|Number|387|387.0||||||
4452871|NCT00081731|4275738|B3||Male|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
4452872|NCT00081731|4275739|B2||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4452873|NCT00081731|4275740|B1||Male|Sex: Female, Male||Participants|Count of Participants|231|231.0||||||
4452874|NCT00081731|4275738|B3||Female|Sex: Female, Male||Participants|Count of Participants|466|466.0||||||
4452875|NCT00081731|4275739|B2||Female|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4452876|NCT00081731|4275740|B1||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4452877|NCT00081731|4275738|B3||>=65 years|Age||Participants|Count of Participants|664|664.0||||||
4452878|NCT00081731|4275739|B2||>=65 years|Age||Participants|Count of Participants|332|332.0||||||
4452879|NCT00081731|4275740|B1||>=65 years|Age||Participants|Count of Participants|332|332.0||||||
4452880|NCT00081731|4275738|B3||Between 18 and 65 years|Age||Participants|Count of Participants|267|267.0||||||
4452881|NCT00081731|4275739|B2||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4452882|NCT00081731|4275740|B1||Between 18 and 65 years|Age||Participants|Count of Participants|140|140.0||||||
4452883|NCT00081731|4275738|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452884|NCT00081731|4275739|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452885|NCT00081731|4275740|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4452886|NCT00081731|4275738|B3|||Age||years|Mean|69.15|69.15|Standard Deviation|9.2|9.2|||
4452887|NCT00081731|4275739|B2|||Age||years|Mean|69.3|69.3|Standard Deviation|9.4|9.4|||
4452888|NCT00081731|4275740|B1|||Age||years|Mean|69|69.0|Standard Deviation|9.0|9.0|||
4452889|NCT00081653|4275759|B3|Other||Race, Customized||participants|Number|1|1.0||||||
4452890|NCT00081653|4275760|B2|Other||Race, Customized||participants|Number|1|1.0||||||
4452891|NCT00081653|4275761|B1|Other||Race, Customized||participants|Number|0|0.0||||||
4452892|NCT00081653|4275759|B3|Hispanic||Race, Customized||participants|Number|37|37.0||||||
4452893|NCT00081653|4275760|B2|Hispanic||Race, Customized||participants|Number|20|20.0||||||
4452894|NCT00081653|4275761|B1|Hispanic||Race, Customized||participants|Number|17|17.0||||||
4452895|NCT00081653|4275759|B3|Oriental||Race, Customized||participants|Number|1|1.0||||||
4452896|NCT00081653|4275760|B2|Oriental||Race, Customized||participants|Number|1|1.0||||||
4452897|NCT00081653|4275761|B1|Oriental||Race, Customized||participants|Number|0|0.0||||||
4452898|NCT00081653|4275759|B3|Black||Race, Customized||participants|Number|1|1.0||||||
4452899|NCT00081653|4275760|B2|Black||Race, Customized||participants|Number|1|1.0||||||
4452900|NCT00081653|4275761|B1|Black||Race, Customized||participants|Number|0|0.0||||||
4452901|NCT00081653|4275759|B3|Caucasian/White||Race, Customized||participants|Number|679|679.0||||||
4452902|NCT00081653|4275760|B2|Caucasian/White||Race, Customized||participants|Number|338|338.0||||||
4452903|NCT00081653|4275761|B1|Caucasian/White||Race, Customized||participants|Number|341|341.0||||||
4452904|NCT00081653|4275759|B3|||BMI (kg/m^2)||kg/m^2|Mean|25.96|25.96|Standard Deviation|4.489|4.489|||
4452905|NCT00081653|4275760|B2|||BMI (kg/m^2)||kg/m^2|Mean|26.04|26.04|Standard Deviation|3.976|3.976|||
4452906|NCT00081653|4275761|B1|||BMI (kg/m^2)||kg/m^2|Mean|25.87|25.87|Standard Deviation|4.957|4.957|||
4452907|NCT00081653|4275759|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452908|NCT00081653|4275760|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452909|NCT00081653|4275761|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4452910|NCT00081653|4275759|B3||Female|Sex: Female, Male||Participants|Count of Participants|719|719.0||||||
4452911|NCT00081653|4275760|B2||Female|Sex: Female, Male||Participants|Count of Participants|361|361.0||||||
4452912|NCT00081653|4275761|B1||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4452913|NCT00081653|4275759|B3|||Age||years|Mean|67.7|67.7|Standard Deviation|6.7|6.7|||
4452914|NCT00081653|4275760|B2|||Age||years|Mean|67.7|67.7|Standard Deviation|6.8|6.8|||
4452915|NCT00081653|4275761|B1|||Age||years|Mean|67.8|67.8|Standard Deviation|6.55|6.55|||
4452916|NCT00081497|4275778|B3|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4452917|NCT00081497|4275779|B2|Other||Race/Ethnicity||participants|Number|0|0.0||||||
4452918|NCT00081497|4275780|B1|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4452919|NCT00081497|4275778|B3|Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4452920|NCT00081497|4275779|B2|Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4452921|NCT00081497|4275780|B1|Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4452922|NCT00081497|4275778|B3|Hispanic||Race/Ethnicity||participants|Number|5|5.0||||||
4452923|NCT00081497|4275779|B2|Hispanic||Race/Ethnicity||participants|Number|3|3.0||||||
4452924|NCT00081497|4275780|B1|Hispanic||Race/Ethnicity||participants|Number|2|2.0||||||
4452925|NCT00081497|4275778|B3|Black||Race/Ethnicity||participants|Number|0|0.0||||||
4452926|NCT00081497|4275779|B2|Black||Race/Ethnicity||participants|Number|0|0.0||||||
4452927|NCT00081497|4275780|B1|Black||Race/Ethnicity||participants|Number|0|0.0||||||
4452928|NCT00081497|4275778|B3|Caucasian||Race/Ethnicity||participants|Number|59|59.0||||||
4452929|NCT00081497|4275779|B2|Caucasian||Race/Ethnicity||participants|Number|35|35.0||||||
4452930|NCT00081497|4275780|B1|Caucasian||Race/Ethnicity||participants|Number|24|24.0||||||
4452931|NCT00081497|4275778|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4452932|NCT00081497|4275779|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4452933|NCT00081497|4275780|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4452934|NCT00081497|4275778|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4452935|NCT00081497|4275779|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4452936|NCT00081497|4275780|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4452937|NCT00081497|4275778|B3|||Age||years|Mean|45.3|45.3|Standard Deviation|9.60|9.6|||
4452938|NCT00081497|4275779|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|9.72|9.72|||
4452939|NCT00081497|4275780|B1|||Age||years|Mean|43.5|43.5|Standard Deviation|9.31|9.31|||
4452940|NCT00081497|4275778|B3|≥40 years||Age, Customized||participants|Number|52|52.0||||||
4452941|NCT00081497|4275779|B2|≥40 years||Age, Customized||participants|Number|32|32.0||||||
4452942|NCT00081497|4275780|B1|≥40 years||Age, Customized||participants|Number|20|20.0||||||
4452943|NCT00081497|4275778|B3|<40 years||Age, Customized||participants|Number|15|15.0||||||
4452944|NCT00081497|4275779|B2|<40 years||Age, Customized||participants|Number|7|7.0||||||
4452945|NCT00081497|4275780|B1|<40 years||Age, Customized||participants|Number|8|8.0||||||
4452946|NCT00081458|4275796|B4|United States||Region of Enrollment||participants|Number|28|28.0||||||
4452947|NCT00081458|4275797|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4452948|NCT00081458|4275798|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4452949|NCT00081458|4275799|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4452950|NCT00081458|4275796|B4|United Kingdom||Region of Enrollment||participants|Number|4|4.0||||||
4452951|NCT00081458|4275797|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4452952|NCT00081458|4275798|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4452953|NCT00081458|4275799|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4452954|NCT00081458|4275796|B4|Poland||Region of Enrollment||participants|Number|17|17.0||||||
4452955|NCT00081458|4275797|B3|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4452956|NCT00081458|4275798|B2|Poland||Region of Enrollment||participants|Number|6|6.0||||||
4452957|NCT00081458|4275799|B1|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4452958|NCT00081458|4275796|B4|Netherlands||Region of Enrollment||participants|Number|5|5.0||||||
4452959|NCT00081458|4275797|B3|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4452960|NCT00081458|4275798|B2|Netherlands||Region of Enrollment||participants|Number|4|4.0||||||
4452961|NCT00081458|4275799|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4452962|NCT00081458|4275796|B4|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4452963|NCT00081458|4275797|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4452964|NCT00081458|4275798|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4452965|NCT00081458|4275799|B1|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4452966|NCT00081458|4275796|B4|France||Region of Enrollment||participants|Number|9|9.0||||||
4452967|NCT00081458|4275797|B3|France||Region of Enrollment||participants|Number|2|2.0||||||
4452968|NCT00081458|4275798|B2|France||Region of Enrollment||participants|Number|5|5.0||||||
4452969|NCT00081458|4275799|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4452970|NCT00081458|4275796|B4|Denmark||Region of Enrollment||participants|Number|8|8.0||||||
4452971|NCT00081458|4275797|B3|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4452972|NCT00081458|4275798|B2|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4452973|NCT00081458|4275799|B1|Denmark||Region of Enrollment||participants|Number|2|2.0||||||
4452974|NCT00081458|4275796|B4|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4452975|NCT00081458|4275797|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4452976|NCT00081458|4275798|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4452977|NCT00081458|4275799|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4452978|NCT00081458|4275796|B4|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4452979|NCT00081458|4275797|B3|Belgium||Region of Enrollment||participants|Number|0|0.0||||||
4452980|NCT00081458|4275798|B2|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4452981|NCT00081458|4275799|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4452982|NCT00081458|4275796|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4452983|NCT00081458|4275797|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4452984|NCT00081458|4275798|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4452985|NCT00081458|4275799|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4452986|NCT00081458|4275796|B4||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4452987|NCT00081458|4275797|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4452988|NCT00081458|4275798|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4452989|NCT00081458|4275799|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4452990|NCT00081458|4275796|B4|> 55 years||Age, Customized||participants|Number|32|32.0||||||
4452991|NCT00081458|4275797|B3|> 55 years||Age, Customized||participants|Number|13|13.0||||||
4452992|NCT00081458|4275798|B2|> 55 years||Age, Customized||participants|Number|11|11.0||||||
4452993|NCT00081458|4275799|B1|> 55 years||Age, Customized||participants|Number|8|8.0||||||
4452994|NCT00081458|4275796|B4|45 - 54 years||Age, Customized||participants|Number|25|25.0||||||
4452995|NCT00081458|4275797|B3|45 - 54 years||Age, Customized||participants|Number|10|10.0||||||
4452996|NCT00081458|4275798|B2|45 - 54 years||Age, Customized||participants|Number|12|12.0||||||
4452997|NCT00081458|4275799|B1|45 - 54 years||Age, Customized||participants|Number|3|3.0||||||
4452998|NCT00081458|4275796|B4|35-44 years||Age, Customized||participants|Number|11|11.0||||||
4452999|NCT00081458|4275797|B3|35-44 years||Age, Customized||participants|Number|4|4.0||||||
4453000|NCT00081458|4275798|B2|35-44 years||Age, Customized||participants|Number|5|5.0||||||
4453001|NCT00081458|4275799|B1|35-44 years||Age, Customized||participants|Number|2|2.0||||||
4453002|NCT00081458|4275796|B4|< 35 years||Age, Customized||participants|Number|15|15.0||||||
4453003|NCT00081458|4275797|B3|< 35 years||Age, Customized||participants|Number|5|5.0||||||
4453004|NCT00081458|4275798|B2|< 35 years||Age, Customized||participants|Number|7|7.0||||||
4453005|NCT00081458|4275799|B1|< 35 years||Age, Customized||participants|Number|3|3.0||||||
4453006|NCT00081458|4275796|B4|||Age||years|Mean|48.8|48.8|Standard Deviation|14.2|14.2|||
4453007|NCT00081458|4275797|B3|||Age||years|Mean|50.3|50.3|Standard Deviation|14.0|14.0|||
4453008|NCT00081458|4275798|B2|||Age||years|Mean|47.1|47.1|Standard Deviation|14.2|14.2|||
4453009|NCT00081458|4275799|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|15.1|15.1|||
4453010|NCT00081328|4275812|B4|||Bone density from DXA||g per cm squared|Mean|1.09|1.09|Standard Deviation|.13|0.13|||
4453011|NCT00081328|4275813|B3|||Bone density from DXA||g per cm squared|Mean|1.08|1.08|Standard Deviation|.12|0.12|||
4453012|NCT00081328|4275814|B2|||Bone density from DXA||g per cm squared|Mean|1.10|1.1|Standard Deviation|.13|0.13|||
4453013|NCT00081328|4275815|B1|||Bone density from DXA||g per cm squared|Mean|1.09|1.09|Standard Deviation|.12|0.12|||
4453014|NCT00081328|4275812|B4|||Fat mass from DXA||kg|Mean|33.3|33.3|Standard Deviation|10.0|10.0|||
4453015|NCT00081328|4275813|B3|||Fat mass from DXA||kg|Mean|32.6|32.6|Standard Deviation|9.8|9.8|||
4453016|NCT00081328|4275814|B2|||Fat mass from DXA||kg|Mean|33.5|33.5|Standard Deviation|10.2|10.2|||
4453017|NCT00081328|4275815|B1|||Fat mass from DXA||kg|Mean|33.7|33.7|Standard Deviation|9.9|9.9|||
4453018|NCT00081328|4275812|B4|||Waist circumference||cm|Mean|108.6|108.6|Standard Deviation|16.7|16.7|||
4453019|NCT00081328|4275813|B3|||Waist circumference||cm|Mean|106.6|106.6|Standard Deviation|16.2|16.2|||
4453020|NCT00081328|4275814|B2|||Waist circumference||cm|Mean|109.0|109.0|Standard Deviation|17.0|17.0|||
4453021|NCT00081328|4275815|B1|||Waist circumference||cm|Mean|110.4|110.4|Standard Deviation|16.6|16.6|||
4453022|NCT00081328|4275812|B4|||Body mass index (BMI)||kg per m squared|Mean|34.9|34.9|Standard Deviation|7.6|7.6|||
4453023|NCT00081328|4275813|B3|||Body mass index (BMI)||kg per m squared|Mean|34.1|34.1|Standard Deviation|7.1|7.1|||
4453024|NCT00081328|4275814|B2|||Body mass index (BMI)||kg per m squared|Mean|35.0|35.0|Standard Deviation|7.7|7.7|||
4453025|NCT00081328|4275815|B1|||Body mass index (BMI)||kg per m squared|Mean|35.8|35.8|Standard Deviation|8.1|8.1|||
4453026|NCT00081328|4275812|B4|||Insulinogenic index from OGTT||uU/mL divided by mg/dL|Median|.93|0.93|Inter-Quartile Range|||0.47|1.85|
4453027|NCT00081328|4275813|B3|||Insulinogenic index from OGTT||uU/mL divided by mg/dL|Median|.87|0.87|Inter-Quartile Range|||0.47|1.89|
4453028|NCT00081328|4275814|B2|||Insulinogenic index from OGTT||uU/mL divided by mg/dL|Median|.92|0.92|Inter-Quartile Range|||0.47|1.58|
4453029|NCT00081328|4275815|B1|||Insulinogenic index from OGTT||uU/mL divided by mg/dL|Median|1.02|1.02|Inter-Quartile Range|||0.47|1.98|
4453030|NCT00081328|4275812|B4|||Insulin sensitivity (inverse of fasting insulin from OGTT)||mL/uU|Median|.039|0.039|Inter-Quartile Range|||0.027|0.06|
4453031|NCT00081328|4275813|B3|||Insulin sensitivity (inverse of fasting insulin from OGTT)||mL/uU|Median|.040|0.04|Inter-Quartile Range|||0.027|0.067|
4453032|NCT00081328|4275814|B2|||Insulin sensitivity (inverse of fasting insulin from OGTT)||mL/uU|Median|.040|0.04|Inter-Quartile Range|||0.028|0.064|
4453033|NCT00081328|4275815|B1|||Insulin sensitivity (inverse of fasting insulin from OGTT)||mL/uU|Median|.036|0.036|Inter-Quartile Range|||0.025|0.05|
4453034|NCT00081328|4275812|B4|Unknown||Nuclear family + grandparents history of diabetes||participants|Number|16|16.0||||||
4453035|NCT00081328|4275813|B3|Unknown||Nuclear family + grandparents history of diabetes||participants|Number|5|5.0||||||
4453036|NCT00081328|4275814|B2|Unknown||Nuclear family + grandparents history of diabetes||participants|Number|7|7.0||||||
4453037|NCT00081328|4275815|B1|Unknown||Nuclear family + grandparents history of diabetes||participants|Number|4|4.0||||||
4453038|NCT00081328|4275812|B4|Yes||Nuclear family + grandparents history of diabetes||participants|Number|611|611.0||||||
4453039|NCT00081328|4275813|B3|Yes||Nuclear family + grandparents history of diabetes||participants|Number|200|200.0||||||
4453040|NCT00081328|4275814|B2|Yes||Nuclear family + grandparents history of diabetes||participants|Number|200|200.0||||||
4453041|NCT00081328|4275815|B1|Yes||Nuclear family + grandparents history of diabetes||participants|Number|211|211.0||||||
4453042|NCT00081328|4275812|B4|No||Nuclear family + grandparents history of diabetes||participants|Number|72|72.0||||||
4453043|NCT00081328|4275813|B3|No||Nuclear family + grandparents history of diabetes||participants|Number|29|29.0||||||
4453044|NCT00081328|4275814|B2|No||Nuclear family + grandparents history of diabetes||participants|Number|26|26.0||||||
4453045|NCT00081328|4275815|B1|No||Nuclear family + grandparents history of diabetes||participants|Number|17|17.0||||||
4453046|NCT00081328|4275812|B4|Unknown||Nuclear family history of diabetes||participants|Number|16|16.0||||||
4453047|NCT00081328|4275813|B3|Unknown||Nuclear family history of diabetes||participants|Number|5|5.0||||||
4453048|NCT00081328|4275814|B2|Unknown||Nuclear family history of diabetes||participants|Number|7|7.0||||||
4453049|NCT00081328|4275815|B1|Unknown||Nuclear family history of diabetes||participants|Number|4|4.0||||||
4453050|NCT00081328|4275812|B4|Yes||Nuclear family history of diabetes||participants|Number|407|407.0||||||
4453051|NCT00081328|4275813|B3|Yes||Nuclear family history of diabetes||participants|Number|143|143.0||||||
4453052|NCT00081328|4275814|B2|Yes||Nuclear family history of diabetes||participants|Number|133|133.0||||||
4453053|NCT00081328|4275815|B1|Yes||Nuclear family history of diabetes||participants|Number|131|131.0||||||
4453054|NCT00081328|4275812|B4|No||Nuclear family history of diabetes||participants|Number|276|276.0||||||
4453055|NCT00081328|4275813|B3|No||Nuclear family history of diabetes||participants|Number|86|86.0||||||
4453056|NCT00081328|4275814|B2|No||Nuclear family history of diabetes||participants|Number|93|93.0||||||
4453057|NCT00081328|4275815|B1|No||Nuclear family history of diabetes||participants|Number|97|97.0||||||
4453058|NCT00081328|4275812|B4|1, 2, or 3||Tanner stage by physical examination|Tanner stage is a standard 5-point scale of pubertal maturity from 1 (pre-pubertal) to 5 (post-pubertal).|participants|Number|79|79.0||||||
4453059|NCT00081328|4275813|B3|1, 2, or 3||Tanner stage by physical examination|Tanner stage is a standard 5-point scale of pubertal maturity from 1 (pre-pubertal) to 5 (post-pubertal).|participants|Number|30|30.0||||||
4453060|NCT00081328|4275814|B2|1, 2, or 3||Tanner stage by physical examination|Tanner stage is a standard 5-point scale of pubertal maturity from 1 (pre-pubertal) to 5 (post-pubertal).|participants|Number|26|26.0||||||
4453061|NCT00081328|4275815|B1|1, 2, or 3||Tanner stage by physical examination|Tanner stage is a standard 5-point scale of pubertal maturity from 1 (pre-pubertal) to 5 (post-pubertal).|participants|Number|23|23.0||||||
4453062|NCT00081328|4275812|B4|4 or 5||Tanner stage by physical examination|Tanner stage is a standard 5-point scale of pubertal maturity from 1 (pre-pubertal) to 5 (post-pubertal).|participants|Number|620|620.0||||||
4453063|NCT00081328|4275813|B3|4 or 5||Tanner stage by physical examination|Tanner stage is a standard 5-point scale of pubertal maturity from 1 (pre-pubertal) to 5 (post-pubertal).|participants|Number|204|204.0||||||
4453064|NCT00081328|4275814|B2|4 or 5||Tanner stage by physical examination|Tanner stage is a standard 5-point scale of pubertal maturity from 1 (pre-pubertal) to 5 (post-pubertal).|participants|Number|207|207.0||||||
4453065|NCT00081328|4275815|B1|4 or 5||Tanner stage by physical examination|Tanner stage is a standard 5-point scale of pubertal maturity from 1 (pre-pubertal) to 5 (post-pubertal).|participants|Number|209|209.0||||||
4453066|NCT00081328|4275812|B4|Unknown||Highest household education level||participants|Number|13|13.0||||||
4453067|NCT00081328|4275813|B3|Unknown||Highest household education level||participants|Number|5|5.0||||||
4453068|NCT00081328|4275814|B2|Unknown||Highest household education level||participants|Number|5|5.0||||||
4453069|NCT00081328|4275815|B1|Unknown||Highest household education level||participants|Number|3|3.0||||||
4453070|NCT00081328|4275812|B4|Graduate degree||Highest household education level||participants|Number|114|114.0||||||
4453071|NCT00081328|4275813|B3|Graduate degree||Highest household education level||participants|Number|38|38.0||||||
4453072|NCT00081328|4275814|B2|Graduate degree||Highest household education level||participants|Number|41|41.0||||||
4453073|NCT00081328|4275815|B1|Graduate degree||Highest household education level||participants|Number|35|35.0||||||
4453074|NCT00081328|4275812|B4|College no degree||Highest household education level||participants|Number|218|218.0||||||
4453075|NCT00081328|4275813|B3|College no degree||Highest household education level||participants|Number|63|63.0||||||
4453076|NCT00081328|4275814|B2|College no degree||Highest household education level||participants|Number|78|78.0||||||
4453077|NCT00081328|4275815|B1|College no degree||Highest household education level||participants|Number|77|77.0||||||
4453078|NCT00081328|4275812|B4|High school, GED, business or technical||Highest household education level||participants|Number|172|172.0||||||
4453079|NCT00081328|4275813|B3|High school, GED, business or technical||Highest household education level||participants|Number|66|66.0||||||
4453080|NCT00081328|4275814|B2|High school, GED, business or technical||Highest household education level||participants|Number|49|49.0||||||
4453081|NCT00081328|4275815|B1|High school, GED, business or technical||Highest household education level||participants|Number|57|57.0||||||
4453082|NCT00081328|4275812|B4|Less than high school||Highest household education level||participants|Number|182|182.0||||||
4453083|NCT00081328|4275813|B3|Less than high school||Highest household education level||participants|Number|62|62.0||||||
4453084|NCT00081328|4275814|B2|Less than high school||Highest household education level||participants|Number|60|60.0||||||
4453085|NCT00081328|4275815|B1|Less than high school||Highest household education level||participants|Number|60|60.0||||||
4453086|NCT00081328|4275812|B4|unknown||Total annual household income||participants|Number|75|75.0||||||
4453087|NCT00081328|4275813|B3|unknown||Total annual household income||participants|Number|23|23.0||||||
4453088|NCT00081328|4275814|B2|unknown||Total annual household income||participants|Number|28|28.0||||||
4453089|NCT00081328|4275815|B1|unknown||Total annual household income||participants|Number|24|24.0||||||
4453090|NCT00081328|4275812|B4|>=$50,000||Total annual household income||participants|Number|155|155.0||||||
4453091|NCT00081328|4275813|B3|>=$50,000||Total annual household income||participants|Number|53|53.0||||||
4453092|NCT00081328|4275814|B2|>=$50,000||Total annual household income||participants|Number|58|58.0||||||
4453093|NCT00081328|4275815|B1|>=$50,000||Total annual household income||participants|Number|44|44.0||||||
4453094|NCT00081328|4275812|B4|$25,000-49,999||Total annual household income||participants|Number|210|210.0||||||
4453095|NCT00081328|4275813|B3|$25,000-49,999||Total annual household income||participants|Number|66|66.0||||||
4453096|NCT00081328|4275814|B2|$25,000-49,999||Total annual household income||participants|Number|61|61.0||||||
4453097|NCT00081328|4275815|B1|$25,000-49,999||Total annual household income||participants|Number|83|83.0||||||
4453098|NCT00081328|4275812|B4|< $25,000||Total annual household income||participants|Number|259|259.0||||||
4453099|NCT00081328|4275813|B3|< $25,000||Total annual household income||participants|Number|92|92.0||||||
4453100|NCT00081328|4275814|B2|< $25,000||Total annual household income||participants|Number|86|86.0||||||
4453101|NCT00081328|4275815|B1|< $25,000||Total annual household income||participants|Number|81|81.0||||||
4453102|NCT00081328|4275812|B4|||Duration of diabetes||months|Mean|7.8|7.8|Standard Deviation|5.8|5.8|||
4453103|NCT00081328|4275813|B3|||Duration of diabetes||months|Mean|7.6|7.6|Standard Deviation|5.8|5.8|||
4453104|NCT00081328|4275814|B2|||Duration of diabetes||months|Mean|8.0|8.0|Standard Deviation|5.7|5.7|||
4453105|NCT00081328|4275815|B1|||Duration of diabetes||months|Mean|7.8|7.8|Standard Deviation|6.0|6.0|||
4453106|NCT00081328|4275812|B4|||Percent overweight||100% X (BMI-50th %ile)/50th %ile|Mean|78.9|78.9|Standard Deviation|37.3|37.3|||
4453107|NCT00081328|4275813|B3|||Percent overweight||100% X (BMI-50th %ile)/50th %ile|Mean|75.6|75.6|Standard Deviation|35.3|35.3|||
4453108|NCT00081328|4275814|B2|||Percent overweight||100% X (BMI-50th %ile)/50th %ile|Mean|79.1|79.1|Standard Deviation|38.1|38.1|||
4453109|NCT00081328|4275815|B1|||Percent overweight||100% X (BMI-50th %ile)/50th %ile|Mean|82.1|82.1|Standard Deviation|38.3|38.3|||
4453110|NCT00081328|4275812|B4|||Body mass index z-score||z-score|Mean|2.23|2.23|Standard Deviation|0.47|0.47|||
4453111|NCT00081328|4275813|B3|||Body mass index z-score||z-score|Mean|2.18|2.18|Standard Deviation|0.46|0.46|||
4453112|NCT00081328|4275814|B2|||Body mass index z-score||z-score|Mean|2.22|2.22|Standard Deviation|0.49|0.49|||
4453113|NCT00081328|4275815|B1|||Body mass index z-score||z-score|Mean|2.27|2.27|Standard Deviation|0.45|0.45|||
4453114|NCT00081328|4275812|B4|United States||Region of Enrollment||participants|Number|699|699.0||||||
4453115|NCT00081328|4275813|B3|United States||Region of Enrollment||participants|Number|234|234.0||||||
4453116|NCT00081328|4275814|B2|United States||Region of Enrollment||participants|Number|233|233.0||||||
4453117|NCT00081328|4275815|B1|United States||Region of Enrollment||participants|Number|232|232.0||||||
4453118|NCT00081328|4275812|B4|Asian Non-Hispanic||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4453119|NCT00081328|4275813|B3|Asian Non-Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4453120|NCT00081328|4275814|B2|Asian Non-Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4453121|NCT00081328|4275815|B1|Asian Non-Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4453122|NCT00081328|4275812|B4|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
4453123|NCT00081328|4275813|B3|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4453124|NCT00081328|4275814|B2|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|47|47.0||||||
4453125|NCT00081328|4275815|B1|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4453126|NCT00081328|4275812|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|278|278.0||||||
4453127|NCT00081328|4275813|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4453128|NCT00081328|4275814|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|101|101.0||||||
4453129|NCT00081328|4275815|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4453130|NCT00081328|4275812|B4|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|227|227.0||||||
4453131|NCT00081328|4275813|B3|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|86|86.0||||||
4453132|NCT00081328|4275814|B2|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|64|64.0||||||
4453133|NCT00081328|4275815|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4453134|NCT00081328|4275812|B4|American Indian||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4453135|NCT00081328|4275813|B3|American Indian||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4453136|NCT00081328|4275814|B2|American Indian||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4453137|NCT00081328|4275815|B1|American Indian||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4453138|NCT00081328|4275812|B4||Male|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4453139|NCT00081328|4275813|B3||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4453140|NCT00081328|4275814|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4453141|NCT00081328|4275815|B1||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4453142|NCT00081328|4275812|B4||Female|Sex: Female, Male||Participants|Count of Participants|452|452.0||||||
4453143|NCT00081328|4275813|B3||Female|Sex: Female, Male||Participants|Count of Participants|154|154.0||||||
4453144|NCT00081328|4275814|B2||Female|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4453145|NCT00081328|4275815|B1||Female|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4453146|NCT00081328|4275812|B4|||Age||years|Mean|14.0|14.0|Standard Deviation|2.0|2.0|||
4453147|NCT00081328|4275813|B3|||Age||years|Mean|13.8|13.8|Standard Deviation|2.0|2.0|||
4453148|NCT00081328|4275814|B2|||Age||years|Mean|14.1|14.1|Standard Deviation|2.1|2.1|||
4453149|NCT00081328|4275815|B1|||Age||years|Mean|14.1|14.1|Standard Deviation|1.9|1.9|||
4453150|NCT00081289|4275855|B3||Male|Gender||Participants|Count of Participants|71|71.0||||||
4453151|NCT00081289|4275856|B2||Male|Gender||Participants|Count of Participants|38|38.0||||||
4453152|NCT00081289|4275857|B1||Male|Gender||Participants|Count of Participants|33|33.0||||||
4453153|NCT00081289|4275855|B3||Female|Gender||Participants|Count of Participants|33|33.0||||||
4453154|NCT00081289|4275856|B2||Female|Gender||Participants|Count of Participants|14|14.0||||||
4453155|NCT00081289|4275857|B1||Female|Gender||Participants|Count of Participants|19|19.0||||||
4453156|NCT00081289|4275855|B3|||Age||years|Median|57|57.0|Full Range|||27.0|78.0|
4453157|NCT00081289|4275856|B2|||Age||years|Median|56|56.0|Full Range|||30.0|76.0|
4453158|NCT00081289|4275857|B1|||Age||years|Median|57|57.0|Full Range|||27.0|78.0|
4453159|NCT00081263|4275864|B3|Cervical Intraepithelial Neoplasia 3||Cell Type|"Cell Type Definitions:~Cervical Intraepithelial Neoplasia 2/3 is defined as moderate-severe dysplasia or moderate-severe dyskaryosis.~Cervical Intraepithelial Neoplasia 3 is defined as severe dysplasia or severe dyskaryosis."|Participants|Count of Participants|66|66.0||||||
4453160|NCT00081263|4275865|B2|Cervical Intraepithelial Neoplasia 3||Cell Type|"Cell Type Definitions:~Cervical Intraepithelial Neoplasia 2/3 is defined as moderate-severe dysplasia or moderate-severe dyskaryosis.~Cervical Intraepithelial Neoplasia 3 is defined as severe dysplasia or severe dyskaryosis."|Participants|Count of Participants|30|30.0||||||
4453161|NCT00081263|4275866|B1|Cervical Intraepithelial Neoplasia 3||Cell Type|"Cell Type Definitions:~Cervical Intraepithelial Neoplasia 2/3 is defined as moderate-severe dysplasia or moderate-severe dyskaryosis.~Cervical Intraepithelial Neoplasia 3 is defined as severe dysplasia or severe dyskaryosis."|Participants|Count of Participants|36|36.0||||||
4453162|NCT00081263|4275864|B3|Cervical Intraepithelial Neoplasia 2/3||Cell Type|"Cell Type Definitions:~Cervical Intraepithelial Neoplasia 2/3 is defined as moderate-severe dysplasia or moderate-severe dyskaryosis.~Cervical Intraepithelial Neoplasia 3 is defined as severe dysplasia or severe dyskaryosis."|Participants|Count of Participants|25|25.0||||||
4453163|NCT00081263|4275865|B2|Cervical Intraepithelial Neoplasia 2/3||Cell Type|"Cell Type Definitions:~Cervical Intraepithelial Neoplasia 2/3 is defined as moderate-severe dysplasia or moderate-severe dyskaryosis.~Cervical Intraepithelial Neoplasia 3 is defined as severe dysplasia or severe dyskaryosis."|Participants|Count of Participants|11|11.0||||||
4453164|NCT00081263|4275866|B1|Cervical Intraepithelial Neoplasia 2/3||Cell Type|"Cell Type Definitions:~Cervical Intraepithelial Neoplasia 2/3 is defined as moderate-severe dysplasia or moderate-severe dyskaryosis.~Cervical Intraepithelial Neoplasia 3 is defined as severe dysplasia or severe dyskaryosis."|Participants|Count of Participants|14|14.0||||||
4453165|NCT00081263|4275864|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453166|NCT00081263|4275865|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453167|NCT00081263|4275866|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453168|NCT00081263|4275864|B3||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4453169|NCT00081263|4275865|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4453170|NCT00081263|4275866|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4453171|NCT00081263|4275864|B3|40-49 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4453172|NCT00081263|4275865|B2|40-49 years||Age, Customized||Participants|Count of Participants|3|3.0||||||
4453173|NCT00081263|4275866|B1|40-49 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4453174|NCT00081263|4275864|B3|30-39 years||Age, Customized||Participants|Count of Participants|23|23.0||||||
4453175|NCT00081263|4275865|B2|30-39 years||Age, Customized||Participants|Count of Participants|10|10.0||||||
4453176|NCT00081263|4275866|B1|30-39 years||Age, Customized||Participants|Count of Participants|13|13.0||||||
4453177|NCT00081263|4275864|B3|20-29 years||Age, Customized||Participants|Count of Participants|53|53.0||||||
4453178|NCT00081263|4275865|B2|20-29 years||Age, Customized||Participants|Count of Participants|23|23.0||||||
4453179|NCT00081263|4275866|B1|20-29 years||Age, Customized||Participants|Count of Participants|30|30.0||||||
4453180|NCT00081263|4275864|B3|18-19 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4453181|NCT00081263|4275865|B2|18-19 years||Age, Customized||Participants|Count of Participants|5|5.0||||||
4453182|NCT00081263|4275866|B1|18-19 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4453183|NCT00081159|4275875|B3|United States||Region of Enrollment||participants|Number|79|79.0||||||
4453184|NCT00081159|4275876|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4453185|NCT00081159|4275877|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4453186|NCT00081159|4275875|B3|Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4453187|NCT00081159|4275876|B2|Not Reported||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4453188|NCT00081159|4275877|B1|Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4453189|NCT00081159|4275875|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4453190|NCT00081159|4275876|B2|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4453191|NCT00081159|4275877|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4453192|NCT00081159|4275875|B3|White||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4453193|NCT00081159|4275876|B2|White||Race/Ethnicity, Customized||participants|Number|34|34.0||||||
4453194|NCT00081159|4275877|B1|White||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4453195|NCT00081159|4275875|B3||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4453196|NCT00081159|4275876|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4453197|NCT00081159|4275877|B1||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4453198|NCT00081159|4275875|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453199|NCT00081159|4275876|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453200|NCT00081159|4275877|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453201|NCT00081159|4275875|B3|||Age||years|Median|63|63.0|Full Range|||46.0|82.0|
4453202|NCT00081159|4275876|B2|||Age||years|Median|63|63.0|Full Range|||46.0|82.0|
4453203|NCT00081159|4275877|B1|||Age||years|Median|62|62.0|Full Range|||46.0|77.0|
4453204|NCT00080938|4275888|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4453205|NCT00080938|4275888|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4453206|NCT00080938|4275888|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4453207|NCT00080938|4275888|B1|||Age||years|Median|61|61.0|Full Range|||40.0|85.0|
4453208|NCT00080912|4275895|B3||Male|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
4453209|NCT00080912|4275896|B2||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4453210|NCT00080912|4275897|B1||Male|Sex: Female, Male||Participants|Count of Participants|243|243.0||||||
4453211|NCT00080912|4275895|B3||Female|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
4453212|NCT00080912|4275896|B2||Female|Sex: Female, Male||Participants|Count of Participants|167|167.0||||||
4453213|NCT00080912|4275897|B1||Female|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4453214|NCT00080912|4275895|B3|||Age||years|Median|65.1|65.1|Full Range|||18.4|94.5|
4453215|NCT00080912|4275896|B2|||Age||years|Median|65.3|65.3|Full Range|||32.0|93.0|
4453216|NCT00080912|4275897|B1|||Age||years|Median|64.6|64.6|Full Range|||18.4|94.5|
4453217|NCT00080899|4275904|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4453218|NCT00080899|4275904|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4453219|NCT00080899|4275904|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453220|NCT00080899|4275904|B1|||Age||years|Median|69|69.0|Full Range|||53.0|85.0|
4453221|NCT00080535|4275909|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4453222|NCT00080535|4275909|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453223|NCT00080535|4275909|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453224|NCT00080535|4275909|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4453225|NCT00080535|4275909|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4453226|NCT00080535|4275909|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453227|NCT00080535|4275909|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453228|NCT00080535|4275909|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453229|NCT00080535|4275909|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453230|NCT00080535|4275909|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4453231|NCT00080535|4275909|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4453232|NCT00080535|4275909|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4453233|NCT00080535|4275909|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4453234|NCT00080535|4275909|B1|||Age||years|Mean|55.85|55.85|Standard Deviation|17.18|17.18|||
4453235|NCT00080535|4275909|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4453236|NCT00080535|4275909|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4453237|NCT00080535|4275909|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4453238|NCT00080483|4275914|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4453239|NCT00080483|4275915|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4453240|NCT00080483|4275916|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4453241|NCT00080483|4275914|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4453242|NCT00080483|4275915|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4453243|NCT00080483|4275916|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4453244|NCT00080483|4275914|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453245|NCT00080483|4275915|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453246|NCT00080483|4275916|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453247|NCT00080483|4275914|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4453248|NCT00080483|4275915|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4453249|NCT00080483|4275916|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4453250|NCT00080483|4275914|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4453251|NCT00080483|4275915|B2||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4453252|NCT00080483|4275916|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4453253|NCT00080483|4275914|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4453254|NCT00080483|4275915|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4453255|NCT00080483|4275916|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4453256|NCT00002525|4275923|B3|Male||Gender|"1 patient on No perioperative 5-FU arm had missing information about sex"|participants|Number|195|195.0||||||
4453257|NCT00002525|4275924|B2|Male||Gender|"1 patient on No perioperative 5-FU arm had missing information about sex"|participants|Number|96|96.0||||||
4453258|NCT00002525|4275925|B1|Male||Gender|"1 patient on No perioperative 5-FU arm had missing information about sex"|participants|Number|99|99.0||||||
4453259|NCT00002525|4275923|B3|Female||Gender|"1 patient on No perioperative 5-FU arm had missing information about sex"|participants|Number|118|118.0||||||
4453260|NCT00002525|4275924|B2|Female||Gender|"1 patient on No perioperative 5-FU arm had missing information about sex"|participants|Number|61|61.0||||||
4453261|NCT00002525|4275925|B1|Female||Gender|"1 patient on No perioperative 5-FU arm had missing information about sex"|participants|Number|57|57.0||||||
4453262|NCT00002525|4275923|B3|||Age||Years|Median|65|65.0|Full Range|||25.0|89.0|
4453263|NCT00002525|4275924|B2|||Age||Years|Median|66|66.0|Full Range|||25.0|86.0|
4453264|NCT00002525|4275925|B1|||Age||Years|Median|63|63.0|Full Range|||30.0|89.0|
4453265|NCT00080470|4275940|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4453266|NCT00080470|4275941|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4453267|NCT00080470|4275942|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4453268|NCT00080470|4275940|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4453269|NCT00080470|4275941|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4453270|NCT00080470|4275942|B1||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4453271|NCT00080470|4275940|B3|||Age, Customized||Years|Mean|56.97|56.97|Standard Deviation|14.99|14.99|||
4453272|NCT00080470|4275941|B2|||Age, Customized||Years|Mean|54.82|54.82|Standard Deviation|16.73|16.73|||
4453273|NCT00080470|4275942|B1|||Age, Customized||Years|Mean|59.26|59.26|Standard Deviation|12.66|12.66|||
4453274|NCT00080301|4275951|B3|Missing||Visceral Disease in Liver and/or Lung||participants|Number|6|6.0||||||
4453275|NCT00080301|4275952|B2|Missing||Visceral Disease in Liver and/or Lung||participants|Number|2|2.0||||||
4453276|NCT00080301|4275953|B1|Missing||Visceral Disease in Liver and/or Lung||participants|Number|4|4.0||||||
4453277|NCT00080301|4275951|B3|No||Visceral Disease in Liver and/or Lung||participants|Number|115|115.0||||||
4453278|NCT00080301|4275952|B2|No||Visceral Disease in Liver and/or Lung||participants|Number|60|60.0||||||
4453279|NCT00080301|4275953|B1|No||Visceral Disease in Liver and/or Lung||participants|Number|55|55.0||||||
4453280|NCT00080301|4275951|B3|Yes||Visceral Disease in Liver and/or Lung||participants|Number|631|631.0||||||
4453281|NCT00080301|4275952|B2|Yes||Visceral Disease in Liver and/or Lung||participants|Number|315|315.0||||||
4453282|NCT00080301|4275953|B1|Yes||Visceral Disease in Liver and/or Lung||participants|Number|316|316.0||||||
4453283|NCT00080301|4275951|B3|Subjects with no lesions||Presence of All Lesions||participants|Number|6|6.0||||||
4453284|NCT00080301|4275952|B2|Subjects with no lesions||Presence of All Lesions||participants|Number|2|2.0||||||
4453285|NCT00080301|4275953|B1|Subjects with no lesions||Presence of All Lesions||participants|Number|4|4.0||||||
4453286|NCT00080301|4275951|B3|Subjects with at least 1 lesion||Presence of All Lesions||participants|Number|746|746.0||||||
4453287|NCT00080301|4275952|B2|Subjects with at least 1 lesion||Presence of All Lesions||participants|Number|375|375.0||||||
4453288|NCT00080301|4275953|B1|Subjects with at least 1 lesion||Presence of All Lesions||participants|Number|371|371.0||||||
4453289|NCT00080301|4275951|B3|≥5 disease sites||Number of Disease Sites||participants|Number|111|111.0||||||
4453290|NCT00080301|4275952|B2|≥5 disease sites||Number of Disease Sites||participants|Number|53|53.0||||||
4453291|NCT00080301|4275953|B1|≥5 disease sites||Number of Disease Sites||participants|Number|58|58.0||||||
4453292|NCT00080301|4275951|B3|4 disease sites||Number of Disease Sites||participants|Number|148|148.0||||||
4453293|NCT00080301|4275952|B2|4 disease sites||Number of Disease Sites||participants|Number|69|69.0||||||
4453294|NCT00080301|4275953|B1|4 disease sites||Number of Disease Sites||participants|Number|79|79.0||||||
4453295|NCT00080301|4275951|B3|3 disease sites||Number of Disease Sites||participants|Number|231|231.0||||||
4453296|NCT00080301|4275952|B2|3 disease sites||Number of Disease Sites||participants|Number|121|121.0||||||
4453297|NCT00080301|4275953|B1|3 disease sites||Number of Disease Sites||participants|Number|110|110.0||||||
4453298|NCT00080301|4275951|B3|2 disease sites||Number of Disease Sites||participants|Number|183|183.0||||||
4453299|NCT00080301|4275952|B2|2 disease sites||Number of Disease Sites||participants|Number|98|98.0||||||
4453300|NCT00080301|4275953|B1|2 disease sites||Number of Disease Sites||participants|Number|85|85.0||||||
4453301|NCT00080301|4275951|B3|1 disease site||Number of Disease Sites||participants|Number|73|73.0||||||
4453302|NCT00080301|4275952|B2|1 disease site||Number of Disease Sites||participants|Number|34|34.0||||||
4453303|NCT00080301|4275953|B1|1 disease site||Number of Disease Sites||participants|Number|39|39.0||||||
4453304|NCT00080301|4275951|B3|Not reported||Menopausal Status||participants|Number|28|28.0||||||
4453305|NCT00080301|4275952|B2|Not reported||Menopausal Status||participants|Number|14|14.0||||||
4453306|NCT00080301|4275953|B1|Not reported||Menopausal Status||participants|Number|14|14.0||||||
4453307|NCT00080301|4275951|B3|Postmenopausal||Menopausal Status||participants|Number|577|577.0||||||
4453308|NCT00080301|4275952|B2|Postmenopausal||Menopausal Status||participants|Number|289|289.0||||||
4453309|NCT00080301|4275953|B1|Postmenopausal||Menopausal Status||participants|Number|288|288.0||||||
4453310|NCT00080301|4275951|B3|Perimenopausal||Menopausal Status||participants|Number|42|42.0||||||
4453311|NCT00080301|4275952|B2|Perimenopausal||Menopausal Status||participants|Number|23|23.0||||||
4453312|NCT00080301|4275953|B1|Perimenopausal||Menopausal Status||participants|Number|19|19.0||||||
4453313|NCT00080301|4275951|B3|Premenopausal||Menopausal Status||participants|Number|105|105.0||||||
4453314|NCT00080301|4275952|B2|Premenopausal||Menopausal Status||participants|Number|51|51.0||||||
4453315|NCT00080301|4275953|B1|Premenopausal||Menopausal Status||participants|Number|54|54.0||||||
4453316|NCT00080301|4275951|B3|Not reported||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|6|6.0||||||
4453317|NCT00080301|4275952|B2|Not reported||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|3|3.0||||||
4453318|NCT00080301|4275953|B1|Not reported||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|3|3.0||||||
4453319|NCT00080301|4275951|B3|<70||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|1|1.0||||||
4453320|NCT00080301|4275952|B2|<70||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|1|1.0||||||
4453321|NCT00080301|4275953|B1|<70||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|0|0.0||||||
4453322|NCT00080301|4275951|B3|70||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|67|67.0||||||
4453323|NCT00080301|4275952|B2|70||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|34|34.0||||||
4453324|NCT00080301|4275953|B1|70||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|33|33.0||||||
4453325|NCT00080301|4275951|B3|80||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|188|188.0||||||
4453326|NCT00080301|4275952|B2|80||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|102|102.0||||||
4453327|NCT00080301|4275953|B1|80||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|86|86.0||||||
4453375|NCT00080301|4275953|B1|Effusion||Disease Sites||participants|Number|57|57.0||||||
4453376|NCT00080301|4275951|B3|Chest Wall||Disease Sites||participants|Number|106|106.0||||||
4453328|NCT00080301|4275951|B3|90||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|277|277.0||||||
4453329|NCT00080301|4275952|B2|90||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|132|132.0||||||
4453330|NCT00080301|4275953|B1|90||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|145|145.0||||||
4453331|NCT00080301|4275951|B3|100||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|213|213.0||||||
4453332|NCT00080301|4275952|B2|100||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|105|105.0||||||
4453333|NCT00080301|4275953|B1|100||Karnofsky Performance Status|Karnofsky Performance Scale Index measures a patient's functional impairment: 100-80=Able to carry on normal activity and work, no special care; 70-50=Unable to work; able to live at home and care for most personal needs with assistance; 40-0=Unable to care for self; institutional or hospital care needed. Score reported in multiples of 10.|Units on a scale|Number|108|108.0||||||
4453334|NCT00080301|4275951|B3|Other||Disease Sites at Baseline||participants|Number|11|11.0||||||
4453335|NCT00080301|4275952|B2|Other||Disease Sites at Baseline||participants|Number|5|5.0||||||
4453336|NCT00080301|4275953|B1|Other||Disease Sites at Baseline||participants|Number|6|6.0||||||
4453337|NCT00080301|4275951|B3|Bone||Disease Sites at Baseline||participants|Number|3|3.0||||||
4453338|NCT00080301|4275952|B2|Bone||Disease Sites at Baseline||participants|Number|3|3.0||||||
4453339|NCT00080301|4275953|B1|Bone||Disease Sites at Baseline||participants|Number|0|0.0||||||
4453340|NCT00080301|4275951|B3|Skin/Soft Tissue ± Bone||Disease Sites at Baseline||participants|Number|101|101.0||||||
4453341|NCT00080301|4275952|B2|Skin/Soft Tissue ± Bone||Disease Sites at Baseline||participants|Number|52|52.0||||||
4453342|NCT00080301|4275953|B1|Skin/Soft Tissue ± Bone||Disease Sites at Baseline||participants|Number|49|49.0||||||
4453343|NCT00080301|4275951|B3|Lung ± Skin/Soft Tissue ± Bone||Disease Sites at Baseline||participants|Number|158|158.0||||||
4453344|NCT00080301|4275952|B2|Lung ± Skin/Soft Tissue ± Bone||Disease Sites at Baseline||participants|Number|87|87.0||||||
4453345|NCT00080301|4275953|B1|Lung ± Skin/Soft Tissue ± Bone||Disease Sites at Baseline||participants|Number|71|71.0||||||
4453346|NCT00080301|4275951|B3|Liver ± Lung ± Skin/Soft Tissue ± Bone||Disease Sites at Baseline||participants|Number|473|473.0||||||
4453347|NCT00080301|4275952|B2|Liver ± Lung ± Skin/Soft Tissue ± Bone||Disease Sites at Baseline||participants|Number|228|228.0||||||
4453348|NCT00080301|4275953|B1|Liver ± Lung ± Skin/Soft Tissue ± Bone||Disease Sites at Baseline||participants|Number|245|245.0||||||
4453349|NCT00080301|4275951|B3|Visceral, Other||Disease Sites||participants|Number|62|62.0||||||
4453350|NCT00080301|4275952|B2|Visceral, Other||Disease Sites||participants|Number|28|28.0||||||
4453351|NCT00080301|4275953|B1|Visceral, Other||Disease Sites||participants|Number|34|34.0||||||
4453352|NCT00080301|4275951|B3|Visceral, Lung||Disease Sites||participants|Number|354|354.0||||||
4453353|NCT00080301|4275952|B2|Visceral, Lung||Disease Sites||participants|Number|174|174.0||||||
4453354|NCT00080301|4275953|B1|Visceral, Lung||Disease Sites||participants|Number|180|180.0||||||
4453355|NCT00080301|4275951|B3|Visceral, Liver||Disease Sites||participants|Number|473|473.0||||||
4453356|NCT00080301|4275952|B2|Visceral, Liver||Disease Sites||participants|Number|228|228.0||||||
4453357|NCT00080301|4275953|B1|Visceral, Liver||Disease Sites||participants|Number|245|245.0||||||
4453358|NCT00080301|4275951|B3|Skin/Soft Tissue||Disease Sites||participants|Number|122|122.0||||||
4453359|NCT00080301|4275952|B2|Skin/Soft Tissue||Disease Sites||participants|Number|62|62.0||||||
4453360|NCT00080301|4275953|B1|Skin/Soft Tissue||Disease Sites||participants|Number|60|60.0||||||
4453361|NCT00080301|4275951|B3|Pleura||Disease Sites||participants|Number|64|64.0||||||
4453362|NCT00080301|4275952|B2|Pleura||Disease Sites||participants|Number|35|35.0||||||
4453363|NCT00080301|4275953|B1|Pleura||Disease Sites||participants|Number|29|29.0||||||
4453364|NCT00080301|4275951|B3|Peritoneum||Disease Sites||participants|Number|21|21.0||||||
4453365|NCT00080301|4275952|B2|Peritoneum||Disease Sites||participants|Number|14|14.0||||||
4453366|NCT00080301|4275953|B1|Peritoneum||Disease Sites||participants|Number|7|7.0||||||
4453367|NCT00080301|4275951|B3|Other||Disease Sites||participants|Number|38|38.0||||||
4453368|NCT00080301|4275952|B2|Other||Disease Sites||participants|Number|18|18.0||||||
4453369|NCT00080301|4275953|B1|Other||Disease Sites||participants|Number|20|20.0||||||
4453370|NCT00080301|4275951|B3|Lymph Node||Disease Sites||participants|Number|499|499.0||||||
4453371|NCT00080301|4275952|B2|Lymph Node||Disease Sites||participants|Number|249|249.0||||||
4453372|NCT00080301|4275953|B1|Lymph Node||Disease Sites||participants|Number|250|250.0||||||
4453373|NCT00080301|4275951|B3|Effusion||Disease Sites||participants|Number|112|112.0||||||
4453374|NCT00080301|4275952|B2|Effusion||Disease Sites||participants|Number|55|55.0||||||
4453377|NCT00080301|4275952|B2|Chest Wall||Disease Sites||participants|Number|53|53.0||||||
4453378|NCT00080301|4275953|B1|Chest Wall||Disease Sites||participants|Number|53|53.0||||||
4453379|NCT00080301|4275951|B3|Breast||Disease Sites||participants|Number|124|124.0||||||
4453380|NCT00080301|4275952|B2|Breast||Disease Sites||participants|Number|63|63.0||||||
4453381|NCT00080301|4275953|B1|Breast||Disease Sites||participants|Number|61|61.0||||||
4453382|NCT00080301|4275951|B3|Bone||Disease Sites||participants|Number|330|330.0||||||
4453383|NCT00080301|4275952|B2|Bone||Disease Sites||participants|Number|162|162.0||||||
4453384|NCT00080301|4275953|B1|Bone||Disease Sites||participants|Number|168|168.0||||||
4453385|NCT00080301|4275951|B3|Ascites||Disease Sites||participants|Number|28|28.0||||||
4453386|NCT00080301|4275952|B2|Ascites||Disease Sites||participants|Number|14|14.0||||||
4453387|NCT00080301|4275953|B1|Ascites||Disease Sites||participants|Number|14|14.0||||||
4453388|NCT00080301|4275951|B3|Other||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4453389|NCT00080301|4275952|B2|Other||Race/Ethnicity, Customized||participants|Number|32|32.0||||||
4453390|NCT00080301|4275953|B1|Other||Race/Ethnicity, Customized||participants|Number|23|23.0||||||
4453391|NCT00080301|4275951|B3|White||Race/Ethnicity, Customized||participants|Number|504|504.0||||||
4453392|NCT00080301|4275952|B2|White||Race/Ethnicity, Customized||participants|Number|247|247.0||||||
4453393|NCT00080301|4275953|B1|White||Race/Ethnicity, Customized||participants|Number|257|257.0||||||
4453394|NCT00080301|4275951|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4453395|NCT00080301|4275952|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4453396|NCT00080301|4275953|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4453397|NCT00080301|4275951|B3|Asian||Race/Ethnicity, Customized||participants|Number|170|170.0||||||
4453398|NCT00080301|4275952|B2|Asian||Race/Ethnicity, Customized||participants|Number|87|87.0||||||
4453399|NCT00080301|4275953|B1|Asian||Race/Ethnicity, Customized||participants|Number|83|83.0||||||
4453400|NCT00080301|4275951|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4453401|NCT00080301|4275952|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4453402|NCT00080301|4275953|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4453403|NCT00080301|4275951|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4453404|NCT00080301|4275952|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4453405|NCT00080301|4275953|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453406|NCT00080301|4275951|B3||Female|Sex: Female, Male||Participants|Count of Participants|751|751.0||||||
4453407|NCT00080301|4275952|B2||Female|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
4453408|NCT00080301|4275953|B1||Female|Sex: Female, Male||Participants|Count of Participants|375|375.0||||||
4453409|NCT00080301|4275951|B3|||Age||years|Median|53.0|53.0|Full Range|||25.0|79.0|
4453410|NCT00080301|4275952|B2|||Age||years|Median|52.0|52.0|Full Range|||25.0|79.0|
4453411|NCT00080301|4275953|B1|||Age||years|Median|53.0|53.0|Full Range|||25.0|76.0|
4453412|NCT00080301|4275951|B3|Unknown||Age, Customized||participants|Number|1|1.0||||||
4453413|NCT00080301|4275952|B2|Unknown||Age, Customized||participants|Number|1|1.0||||||
4453414|NCT00080301|4275953|B1|Unknown||Age, Customized||participants|Number|0|0.0||||||
4453415|NCT00080301|4275951|B3|>= 50 years||Age, Customized||participants|Number|471|471.0||||||
4453416|NCT00080301|4275952|B2|>= 50 years||Age, Customized||participants|Number|231|231.0||||||
4453417|NCT00080301|4275953|B1|>= 50 years||Age, Customized||participants|Number|240|240.0||||||
4453418|NCT00080301|4275951|B3|<50 years||Age, Customized||participants|Number|280|280.0||||||
4453419|NCT00080301|4275952|B2|<50 years||Age, Customized||participants|Number|145|145.0||||||
4453420|NCT00080301|4275953|B1|<50 years||Age, Customized||participants|Number|135|135.0||||||
4453421|NCT00080301|4275951|B3|>= 65 years||Age, Customized||participants|Number|93|93.0||||||
4453422|NCT00080301|4275952|B2|>= 65 years||Age, Customized||participants|Number|54|54.0||||||
4453423|NCT00080301|4275953|B1|>= 65 years||Age, Customized||participants|Number|39|39.0||||||
4453424|NCT00080301|4275951|B3|<65 years||Age, Customized||participants|Number|658|658.0||||||
4453425|NCT00080301|4275952|B2|<65 years||Age, Customized||participants|Number|322|322.0||||||
4453426|NCT00080301|4275953|B1|<65 years||Age, Customized||participants|Number|336|336.0||||||
4453427|NCT00080288|4275972|B3|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4453428|NCT00080288|4275973|B2|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4453429|NCT00080288|4275974|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4453430|NCT00080288|4275972|B3|United States||Region of Enrollment||participants|Number|234|234.0||||||
4453431|NCT00080288|4275973|B2|United States||Region of Enrollment||participants|Number|117|117.0||||||
4453432|NCT00080288|4275974|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
4453433|NCT00080288|4275972|B3|Male||Gender|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|130|130.0||||||
4453434|NCT00080288|4275973|B2|Male||Gender|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|64|64.0||||||
4453435|NCT00080288|4275974|B1|Male||Gender|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|66|66.0||||||
4453436|NCT00080288|4275972|B3|Female||Gender|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|115|115.0||||||
4453437|NCT00080288|4275973|B2|Female||Gender|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|58|58.0||||||
4453438|NCT00080288|4275974|B1|Female||Gender|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|57|57.0||||||
4453439|NCT00080288|4275972|B3|||Age||years|Mean|39.6|39.6|Standard Deviation|10.76|10.76|||
4453440|NCT00080288|4275973|B2|||Age||years|Mean|40.3|40.3|Standard Deviation|10.76|10.76|||
4453441|NCT00080288|4275974|B1|||Age||years|Mean|38.9|38.9|Standard Deviation|10.75|10.75|||
4453442|NCT00080288|4275972|B3|>=65 years||Age|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|0|0.0||||||
4453443|NCT00080288|4275973|B2|>=65 years||Age|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|0|0.0||||||
4453444|NCT00080288|4275974|B1|>=65 years||Age|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|0|0.0||||||
4453445|NCT00080288|4275972|B3|Between 18 and 65 years||Age|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|245|245.0||||||
4453446|NCT00080288|4275973|B2|Between 18 and 65 years||Age|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|122|122.0||||||
4453447|NCT00080288|4275974|B1|Between 18 and 65 years||Age|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|123|123.0||||||
4453448|NCT00080288|4275972|B3|<=18 years||Age|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|0|0.0||||||
4453449|NCT00080288|4275973|B2|<=18 years||Age|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|0|0.0||||||
4453450|NCT00080288|4275974|B1|<=18 years||Age|9 participants (3 female ; 6 male) withdrew after randomization but prior to receiving study drug|participants|Number|0|0.0||||||
4453451|NCT00080223|4275983|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4453452|NCT00080223|4275983|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4453453|NCT00080223|4275983|B1|||Age||years|Mean|68.5|68.5|Standard Deviation|9.15|9.15|||
4453454|NCT00002540|4275991|B3|United States||Region of Enrollment||participants|Number|76685|76685.0||||||
4453455|NCT00002540|4275992|B2|United States||Region of Enrollment||participants|Number|38340|38340.0||||||
4453456|NCT00002540|4275993|B1|United States||Region of Enrollment||participants|Number|38345|38345.0||||||
4453457|NCT00002540|4275991|B3||Male|Sex: Female, Male||Participants|Count of Participants|76685|76685.0||||||
4453458|NCT00002540|4275992|B2||Male|Sex: Female, Male||Participants|Count of Participants|38340|38340.0||||||
4453459|NCT00002540|4275993|B1||Male|Sex: Female, Male||Participants|Count of Participants|38345|38345.0||||||
4453460|NCT00002540|4275991|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453461|NCT00002540|4275992|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453462|NCT00002540|4275993|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453463|NCT00002540|4275991|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|5.3|5.3|||
4453464|NCT00002540|4275992|B2|||Age||years|Mean|62.7|62.7|Standard Deviation|5.3|5.3|||
4453465|NCT00002540|4275993|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|5.3|5.3|||
4453466|NCT00002540|4275991|B3||>=65 years|Age||Participants|Count of Participants|27895|27895.0||||||
4453467|NCT00002540|4275992|B2||>=65 years|Age||Participants|Count of Participants|13940|13940.0||||||
4453468|NCT00002540|4275993|B1||>=65 years|Age||Participants|Count of Participants|13955|13955.0||||||
4453469|NCT00002540|4275991|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48790|48790.0||||||
4453470|NCT00002540|4275992|B2||Between 18 and 65 years|Age||Participants|Count of Participants|24400|24400.0||||||
4453471|NCT00002540|4275993|B1||Between 18 and 65 years|Age||Participants|Count of Participants|24390|24390.0||||||
4453472|NCT00002540|4275991|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4453473|NCT00002540|4275992|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4453474|NCT00002540|4275993|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4453475|NCT00080119|4276020|B5|Gaborone, Botswana||Site of enrollment||participants|Number|4|4.0||||||
4453476|NCT00080119|4276021|B4|Gaborone, Botswana||Site of enrollment||participants|Number|3|3.0||||||
4453477|NCT00080119|4276022|B3|Gaborone, Botswana||Site of enrollment||participants|Number|1|1.0||||||
4453478|NCT00080119|4276023|B2|Gaborone, Botswana||Site of enrollment||participants|Number|0|0.0||||||
4453479|NCT00080119|4276024|B1|Gaborone, Botswana||Site of enrollment||participants|Number|0|0.0||||||
4453480|NCT00080119|4276020|B5|Durban, S Africa||Site of enrollment||participants|Number|60|60.0||||||
4453481|NCT00080119|4276021|B4|Durban, S Africa||Site of enrollment||participants|Number|27|27.0||||||
4453482|NCT00080119|4276022|B3|Durban, S Africa||Site of enrollment||participants|Number|26|26.0||||||
4453483|NCT00080119|4276023|B2|Durban, S Africa||Site of enrollment||participants|Number|3|3.0||||||
4453484|NCT00080119|4276024|B1|Durban, S Africa||Site of enrollment||participants|Number|4|4.0||||||
4453485|NCT00080119|4276020|B5|Cape Town, S Africa||Site of enrollment||participants|Number|409|409.0||||||
4453486|NCT00080119|4276021|B4|Cape Town, S Africa||Site of enrollment||participants|Number|65|65.0||||||
4453487|NCT00080119|4276022|B3|Cape Town, S Africa||Site of enrollment||participants|Number|66|66.0||||||
4453488|NCT00080119|4276023|B2|Cape Town, S Africa||Site of enrollment||participants|Number|138|138.0||||||
4453489|NCT00080119|4276024|B1|Cape Town, S Africa||Site of enrollment||participants|Number|140|140.0||||||
4453490|NCT00080119|4276020|B5|Johannesburg, S Africa||Site of enrollment||participants|Number|878|878.0||||||
4453491|NCT00080119|4276021|B4|Johannesburg, S Africa||Site of enrollment||participants|Number|179|179.0||||||
4453492|NCT00080119|4276022|B3|Johannesburg, S Africa||Site of enrollment||participants|Number|180|180.0||||||
4453493|NCT00080119|4276023|B2|Johannesburg, S Africa||Site of enrollment||participants|Number|260|260.0||||||
4453494|NCT00080119|4276024|B1|Johannesburg, S Africa||Site of enrollment||participants|Number|259|259.0||||||
4453495|NCT00080119|4276020|B5|Not applicable||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|808|808.0||||||
4453496|NCT00080119|4276021|B4|Not applicable||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|3|3.0||||||
4453497|NCT00080119|4276022|B3|Not applicable||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|1|1.0||||||
4453498|NCT00080119|4276023|B2|Not applicable||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|401|401.0||||||
4453499|NCT00080119|4276024|B1|Not applicable||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|403|403.0||||||
4453500|NCT00080119|4276020|B5|No||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|372|372.0||||||
4453501|NCT00080119|4276021|B4|No||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|178|178.0||||||
4453502|NCT00080119|4276022|B3|No||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|194|194.0||||||
4453503|NCT00080119|4276023|B2|No||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453504|NCT00080119|4276024|B1|No||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453505|NCT00080119|4276020|B5|Yes||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|171|171.0||||||
4453506|NCT00080119|4276021|B4|Yes||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|93|93.0||||||
4453507|NCT00080119|4276022|B3|Yes||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|78|78.0||||||
4453508|NCT00080119|4276023|B2|Yes||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453509|NCT00080119|4276024|B1|Yes||On antiretrovirals at entry|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453510|NCT00080119|4276020|B5|Missing||Housing||participants|Number|2|2.0||||||
4453511|NCT00080119|4276021|B4|Missing||Housing||participants|Number|2|2.0||||||
4453512|NCT00080119|4276022|B3|Missing||Housing||participants|Number|0|0.0||||||
4453513|NCT00080119|4276023|B2|Missing||Housing||participants|Number|0|0.0||||||
4453514|NCT00080119|4276024|B1|Missing||Housing||participants|Number|0|0.0||||||
4453515|NCT00080119|4276020|B5|Hostel||Housing||participants|Number|2|2.0||||||
4453516|NCT00080119|4276021|B4|Hostel||Housing||participants|Number|0|0.0||||||
4453517|NCT00080119|4276022|B3|Hostel||Housing||participants|Number|2|2.0||||||
4453518|NCT00080119|4276023|B2|Hostel||Housing||participants|Number|0|0.0||||||
4453519|NCT00080119|4276024|B1|Hostel||Housing||participants|Number|0|0.0||||||
4453520|NCT00080119|4276020|B5|Informal (shack/wooden)||Housing||participants|Number|534|534.0||||||
4453521|NCT00080119|4276021|B4|Informal (shack/wooden)||Housing||participants|Number|89|89.0||||||
4453522|NCT00080119|4276022|B3|Informal (shack/wooden)||Housing||participants|Number|109|109.0||||||
4453523|NCT00080119|4276023|B2|Informal (shack/wooden)||Housing||participants|Number|168|168.0||||||
4453524|NCT00080119|4276024|B1|Informal (shack/wooden)||Housing||participants|Number|168|168.0||||||
4453525|NCT00080119|4276020|B5|Formal (brick) house||Housing||participants|Number|813|813.0||||||
4453526|NCT00080119|4276021|B4|Formal (brick) house||Housing||participants|Number|183|183.0||||||
4453527|NCT00080119|4276022|B3|Formal (brick) house||Housing||participants|Number|162|162.0||||||
4453528|NCT00080119|4276023|B2|Formal (brick) house||Housing||participants|Number|233|233.0||||||
4453529|NCT00080119|4276024|B1|Formal (brick) house||Housing||participants|Number|235|235.0||||||
4453530|NCT00080119|4276020|B5|No||History of tuberculosis (TB) in mother||participants|Number|1254|1254.0||||||
4453531|NCT00080119|4276021|B4|No||History of tuberculosis (TB) in mother||participants|Number|249|249.0||||||
4453532|NCT00080119|4276022|B3|No||History of tuberculosis (TB) in mother||participants|Number|259|259.0||||||
4453533|NCT00080119|4276023|B2|No||History of tuberculosis (TB) in mother||participants|Number|376|376.0||||||
4453534|NCT00080119|4276024|B1|No||History of tuberculosis (TB) in mother||participants|Number|370|370.0||||||
4453535|NCT00080119|4276020|B5|Yes||History of tuberculosis (TB) in mother||participants|Number|97|97.0||||||
4453536|NCT00080119|4276021|B4|Yes||History of tuberculosis (TB) in mother||participants|Number|25|25.0||||||
4453537|NCT00080119|4276022|B3|Yes||History of tuberculosis (TB) in mother||participants|Number|14|14.0||||||
4453538|NCT00080119|4276023|B2|Yes||History of tuberculosis (TB) in mother||participants|Number|25|25.0||||||
4453539|NCT00080119|4276024|B1|Yes||History of tuberculosis (TB) in mother||participants|Number|33|33.0||||||
4453540|NCT00080119|4276020|B5|Not applicable||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|808|808.0||||||
4453541|NCT00080119|4276021|B4|Not applicable||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|3|3.0||||||
4453542|NCT00080119|4276022|B3|Not applicable||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|1|1.0||||||
4453543|NCT00080119|4276023|B2|Not applicable||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|401|401.0||||||
4453544|NCT00080119|4276024|B1|Not applicable||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|403|403.0||||||
4453545|NCT00080119|4276020|B5|Missing||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|14|14.0||||||
4453546|NCT00080119|4276021|B4|Missing||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|6|6.0||||||
4453547|NCT00080119|4276022|B3|Missing||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|8|8.0||||||
4453548|NCT00080119|4276023|B2|Missing||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453549|NCT00080119|4276024|B1|Missing||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453550|NCT00080119|4276020|B5|>= 750,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|245|245.0||||||
4453551|NCT00080119|4276021|B4|>= 750,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|116|116.0||||||
4453552|NCT00080119|4276022|B3|>= 750,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|129|129.0||||||
4453553|NCT00080119|4276023|B2|>= 750,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453554|NCT00080119|4276024|B1|>= 750,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453555|NCT00080119|4276020|B5|20,000 - < 750,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|177|177.0||||||
4453556|NCT00080119|4276021|B4|20,000 - < 750,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|86|86.0||||||
4453557|NCT00080119|4276022|B3|20,000 - < 750,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|91|91.0||||||
4453558|NCT00080119|4276023|B2|20,000 - < 750,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453559|NCT00080119|4276024|B1|20,000 - < 750,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453560|NCT00080119|4276020|B5|401 - <20,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|87|87.0||||||
4453561|NCT00080119|4276021|B4|401 - <20,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|51|51.0||||||
4453562|NCT00080119|4276022|B3|401 - <20,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|36|36.0||||||
4453563|NCT00080119|4276023|B2|401 - <20,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453564|NCT00080119|4276024|B1|401 - <20,000 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453565|NCT00080119|4276020|B5|<= 400 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|20|20.0||||||
4453566|NCT00080119|4276021|B4|<= 400 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|12|12.0||||||
4453567|NCT00080119|4276022|B3|<= 400 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|8|8.0||||||
4453568|NCT00080119|4276023|B2|<= 400 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453569|NCT00080119|4276024|B1|<= 400 copies/ml||HIV-1 RNA (copies/ml)|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453570|NCT00080119|4276020|B5|No||Ever breastfed||participants|Number|1230|1230.0||||||
4453571|NCT00080119|4276021|B4|No||Ever breastfed||participants|Number|238|238.0||||||
4453572|NCT00080119|4276022|B3|No||Ever breastfed||participants|Number|236|236.0||||||
4453573|NCT00080119|4276023|B2|No||Ever breastfed||participants|Number|377|377.0||||||
4453574|NCT00080119|4276024|B1|No||Ever breastfed||participants|Number|379|379.0||||||
4453575|NCT00080119|4276020|B5|Yes||Ever breastfed||participants|Number|121|121.0||||||
4453576|NCT00080119|4276021|B4|Yes||Ever breastfed||participants|Number|36|36.0||||||
4453577|NCT00080119|4276022|B3|Yes||Ever breastfed||participants|Number|37|37.0||||||
4453578|NCT00080119|4276023|B2|Yes||Ever breastfed||participants|Number|24|24.0||||||
4453579|NCT00080119|4276024|B1|Yes||Ever breastfed||participants|Number|24|24.0||||||
4453580|NCT00080119|4276020|B5|No||Caregiver currently smokes||participants|Number|1289|1289.0||||||
4453581|NCT00080119|4276021|B4|No||Caregiver currently smokes||participants|Number|264|264.0||||||
4453582|NCT00080119|4276022|B3|No||Caregiver currently smokes||participants|Number|257|257.0||||||
4453583|NCT00080119|4276023|B2|No||Caregiver currently smokes||participants|Number|376|376.0||||||
4453584|NCT00080119|4276024|B1|No||Caregiver currently smokes||participants|Number|392|392.0||||||
4453585|NCT00080119|4276020|B5|Yes||Caregiver currently smokes||participants|Number|62|62.0||||||
4453586|NCT00080119|4276021|B4|Yes||Caregiver currently smokes||participants|Number|10|10.0||||||
4453587|NCT00080119|4276022|B3|Yes||Caregiver currently smokes||participants|Number|16|16.0||||||
4453588|NCT00080119|4276023|B2|Yes||Caregiver currently smokes||participants|Number|25|25.0||||||
4453589|NCT00080119|4276024|B1|Yes||Caregiver currently smokes||participants|Number|11|11.0||||||
4453590|NCT00080119|4276020|B5|Not applicable (HIV-uninfected)||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|804|804.0||||||
4453591|NCT00080119|4276021|B4|Not applicable (HIV-uninfected)||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|0|0.0||||||
4453592|NCT00080119|4276022|B3|Not applicable (HIV-uninfected)||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|0|0.0||||||
4453593|NCT00080119|4276023|B2|Not applicable (HIV-uninfected)||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|401|401.0||||||
4453594|NCT00080119|4276024|B1|Not applicable (HIV-uninfected)||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|403|403.0||||||
4453595|NCT00080119|4276020|B5|Missing||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|5|5.0||||||
4453596|NCT00080119|4276021|B4|Missing||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|3|3.0||||||
4453597|NCT00080119|4276022|B3|Missing||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|2|2.0||||||
4453598|NCT00080119|4276023|B2|Missing||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|0|0.0||||||
4453599|NCT00080119|4276024|B1|Missing||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|0|0.0||||||
4453600|NCT00080119|4276020|B5|HIV-uninfected on repeat test||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|4|4.0||||||
4453601|NCT00080119|4276021|B4|HIV-uninfected on repeat test||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|3|3.0||||||
4453602|NCT00080119|4276022|B3|HIV-uninfected on repeat test||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|1|1.0||||||
4453603|NCT00080119|4276023|B2|HIV-uninfected on repeat test||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|0|0.0||||||
4453604|NCT00080119|4276024|B1|HIV-uninfected on repeat test||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|0|0.0||||||
4453605|NCT00080119|4276020|B5|Category C||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|5|5.0||||||
4453606|NCT00080119|4276021|B4|Category C||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|3|3.0||||||
4453607|NCT00080119|4276022|B3|Category C||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|2|2.0||||||
4453608|NCT00080119|4276023|B2|Category C||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|0|0.0||||||
4453609|NCT00080119|4276024|B1|Category C||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|0|0.0||||||
4453610|NCT00080119|4276020|B5|Category B||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|37|37.0||||||
4453611|NCT00080119|4276021|B4|Category B||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|21|21.0||||||
4453612|NCT00080119|4276022|B3|Category B||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|16|16.0||||||
4453613|NCT00080119|4276023|B2|Category B||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|0|0.0||||||
4453614|NCT00080119|4276024|B1|Category B||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|0|0.0||||||
4453615|NCT00080119|4276020|B5|Category N or A||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|496|496.0||||||
4453616|NCT00080119|4276021|B4|Category N or A||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|244|244.0||||||
4453617|NCT00080119|4276022|B3|Category N or A||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|252|252.0||||||
4453618|NCT00080119|4276023|B2|Category N or A||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|0|0.0||||||
4453619|NCT00080119|4276024|B1|Category N or A||Centers for Disease Control (CDC) Disease Category|Only for HIV-infected participants.|participants|Number|0|0.0||||||
4453620|NCT00080119|4276020|B5|Not applicable||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|808|808.0||||||
4453621|NCT00080119|4276021|B4|Not applicable||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|3|3.0||||||
4453622|NCT00080119|4276022|B3|Not applicable||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|1|1.0||||||
4453623|NCT00080119|4276023|B2|Not applicable||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|401|401.0||||||
4453624|NCT00080119|4276024|B1|Not applicable||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|403|403.0||||||
4453625|NCT00080119|4276020|B5|Missing||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|27|27.0||||||
4453626|NCT00080119|4276021|B4|Missing||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|13|13.0||||||
4453627|NCT00080119|4276022|B3|Missing||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|14|14.0||||||
4453628|NCT00080119|4276023|B2|Missing||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453629|NCT00080119|4276024|B1|Missing||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453630|NCT00080119|4276020|B5|>= 25%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|319|319.0||||||
4453631|NCT00080119|4276021|B4|>= 25%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|157|157.0||||||
4453632|NCT00080119|4276022|B3|>= 25%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|162|162.0||||||
4453633|NCT00080119|4276023|B2|>= 25%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453634|NCT00080119|4276024|B1|>= 25%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453635|NCT00080119|4276020|B5|20%-<25%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|86|86.0||||||
4453636|NCT00080119|4276021|B4|20%-<25%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|46|46.0||||||
4453637|NCT00080119|4276022|B3|20%-<25%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|40|40.0||||||
4453638|NCT00080119|4276023|B2|20%-<25%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453639|NCT00080119|4276024|B1|20%-<25%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453640|NCT00080119|4276020|B5|<20%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|111|111.0||||||
4453641|NCT00080119|4276021|B4|<20%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|55|55.0||||||
4453642|NCT00080119|4276022|B3|<20%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|56|56.0||||||
4453643|NCT00080119|4276023|B2|<20%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453644|NCT00080119|4276024|B1|<20%||CD4%|Only for HIV-infected participants. Those in the HIV-infected stratum that were later determined to be HIV-uninfected are recorded as not applicable.|participants|Number|0|0.0||||||
4453645|NCT00080119|4276020|B5|>= 2500 grams||Birth weight (grams)||participants|Number|1129|1129.0||||||
4453646|NCT00080119|4276021|B4|>= 2500 grams||Birth weight (grams)||participants|Number|218|218.0||||||
4453647|NCT00080119|4276022|B3|>= 2500 grams||Birth weight (grams)||participants|Number|205|205.0||||||
4453648|NCT00080119|4276023|B2|>= 2500 grams||Birth weight (grams)||participants|Number|352|352.0||||||
4453649|NCT00080119|4276024|B1|>= 2500 grams||Birth weight (grams)||participants|Number|354|354.0||||||
4453650|NCT00080119|4276020|B5|<2500 grams||Birth weight (grams)||participants|Number|222|222.0||||||
4453651|NCT00080119|4276021|B4|<2500 grams||Birth weight (grams)||participants|Number|56|56.0||||||
4453652|NCT00080119|4276022|B3|<2500 grams||Birth weight (grams)||participants|Number|68|68.0||||||
4453653|NCT00080119|4276023|B2|<2500 grams||Birth weight (grams)||participants|Number|49|49.0||||||
4453654|NCT00080119|4276024|B1|<2500 grams||Birth weight (grams)||participants|Number|49|49.0||||||
4453655|NCT00080119|4276020|B5|Missing||Any smoker in household||participants|Number|3|3.0||||||
4453656|NCT00080119|4276021|B4|Missing||Any smoker in household||participants|Number|2|2.0||||||
4453657|NCT00080119|4276022|B3|Missing||Any smoker in household||participants|Number|0|0.0||||||
4453658|NCT00080119|4276023|B2|Missing||Any smoker in household||participants|Number|0|0.0||||||
4453659|NCT00080119|4276024|B1|Missing||Any smoker in household||participants|Number|1|1.0||||||
4453660|NCT00080119|4276020|B5|No||Any smoker in household||participants|Number|729|729.0||||||
4453661|NCT00080119|4276021|B4|No||Any smoker in household||participants|Number|141|141.0||||||
4453662|NCT00080119|4276022|B3|No||Any smoker in household||participants|Number|153|153.0||||||
4453663|NCT00080119|4276023|B2|No||Any smoker in household||participants|Number|224|224.0||||||
4453664|NCT00080119|4276024|B1|No||Any smoker in household||participants|Number|211|211.0||||||
4453665|NCT00080119|4276020|B5|Yes||Any smoker in household||participants|Number|619|619.0||||||
4453666|NCT00080119|4276021|B4|Yes||Any smoker in household||participants|Number|131|131.0||||||
4453667|NCT00080119|4276022|B3|Yes||Any smoker in household||participants|Number|120|120.0||||||
4453668|NCT00080119|4276023|B2|Yes||Any smoker in household||participants|Number|177|177.0||||||
4453669|NCT00080119|4276024|B1|Yes||Any smoker in household||participants|Number|191|191.0||||||
4453670|NCT00080119|4276020|B5|8-29 days||Age at receipt of Bacille Calmette-Guerin (BCG) vaccination (days)||participants|Number|51|51.0||||||
4453671|NCT00080119|4276021|B4|8-29 days||Age at receipt of Bacille Calmette-Guerin (BCG) vaccination (days)||participants|Number|16|16.0||||||
4453672|NCT00080119|4276022|B3|8-29 days||Age at receipt of Bacille Calmette-Guerin (BCG) vaccination (days)||participants|Number|18|18.0||||||
4453673|NCT00080119|4276023|B2|8-29 days||Age at receipt of Bacille Calmette-Guerin (BCG) vaccination (days)||participants|Number|9|9.0||||||
4453674|NCT00080119|4276024|B1|8-29 days||Age at receipt of Bacille Calmette-Guerin (BCG) vaccination (days)||participants|Number|8|8.0||||||
4453675|NCT00080119|4276020|B5|<= 7 days||Age at receipt of Bacille Calmette-Guerin (BCG) vaccination (days)||participants|Number|1300|1300.0||||||
4453676|NCT00080119|4276021|B4|<= 7 days||Age at receipt of Bacille Calmette-Guerin (BCG) vaccination (days)||participants|Number|258|258.0||||||
4453677|NCT00080119|4276022|B3|<= 7 days||Age at receipt of Bacille Calmette-Guerin (BCG) vaccination (days)||participants|Number|255|255.0||||||
4453678|NCT00080119|4276023|B2|<= 7 days||Age at receipt of Bacille Calmette-Guerin (BCG) vaccination (days)||participants|Number|392|392.0||||||
4453679|NCT00080119|4276024|B1|<= 7 days||Age at receipt of Bacille Calmette-Guerin (BCG) vaccination (days)||participants|Number|395|395.0||||||
4453680|NCT00080119|4276020|B5|Mixed ancestry/other||Race/Ethnicity, Customized||participants|Number|40|40.0||||||
4453681|NCT00080119|4276021|B4|Mixed ancestry/other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4453682|NCT00080119|4276022|B3|Mixed ancestry/other||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4453683|NCT00080119|4276023|B2|Mixed ancestry/other||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4453684|NCT00080119|4276024|B1|Mixed ancestry/other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4453685|NCT00080119|4276020|B5|Indigenous African||Race/Ethnicity, Customized||participants|Number|1311|1311.0||||||
4453686|NCT00080119|4276021|B4|Indigenous African||Race/Ethnicity, Customized||participants|Number|272|272.0||||||
4453687|NCT00080119|4276022|B3|Indigenous African||Race/Ethnicity, Customized||participants|Number|264|264.0||||||
4453688|NCT00080119|4276023|B2|Indigenous African||Race/Ethnicity, Customized||participants|Number|386|386.0||||||
4453689|NCT00080119|4276024|B1|Indigenous African||Race/Ethnicity, Customized||participants|Number|389|389.0||||||
4453690|NCT00080119|4276020|B5||Male|Sex: Female, Male||Participants|Count of Participants|648|648.0||||||
4453691|NCT00080119|4276021|B4||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4453692|NCT00080119|4276022|B3||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4453693|NCT00080119|4276023|B2||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4453694|NCT00080119|4276024|B1||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4453695|NCT00080119|4276020|B5||Female|Sex: Female, Male||Participants|Count of Participants|703|703.0||||||
4453696|NCT00080119|4276021|B4||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4453697|NCT00080119|4276022|B3||Female|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4453698|NCT00080119|4276023|B2||Female|Sex: Female, Male||Participants|Count of Participants|190|190.0||||||
4453699|NCT00080119|4276024|B1||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4453700|NCT00080119|4276020|B5|111-120 days||Age, Customized||participants|Number|233|233.0||||||
4453701|NCT00080119|4276021|B4|111-120 days||Age, Customized||participants|Number|49|49.0||||||
4453702|NCT00080119|4276022|B3|111-120 days||Age, Customized||participants|Number|46|46.0||||||
4453703|NCT00080119|4276023|B2|111-120 days||Age, Customized||participants|Number|64|64.0||||||
4453704|NCT00080119|4276024|B1|111-120 days||Age, Customized||participants|Number|74|74.0||||||
4453705|NCT00080119|4276020|B5|101-110 days||Age, Customized||participants|Number|244|244.0||||||
4453706|NCT00080119|4276021|B4|101-110 days||Age, Customized||participants|Number|33|33.0||||||
4453707|NCT00080119|4276022|B3|101-110 days||Age, Customized||participants|Number|56|56.0||||||
4453708|NCT00080119|4276023|B2|101-110 days||Age, Customized||participants|Number|84|84.0||||||
4453709|NCT00080119|4276024|B1|101-110 days||Age, Customized||participants|Number|71|71.0||||||
4453710|NCT00080119|4276020|B5|91-100 days||Age, Customized||participants|Number|874|874.0||||||
4453711|NCT00080119|4276021|B4|91-100 days||Age, Customized||participants|Number|192|192.0||||||
4453712|NCT00080119|4276022|B3|91-100 days||Age, Customized||participants|Number|171|171.0||||||
4453713|NCT00080119|4276023|B2|91-100 days||Age, Customized||participants|Number|253|253.0||||||
4453714|NCT00080119|4276024|B1|91-100 days||Age, Customized||participants|Number|258|258.0||||||
4453715|NCT00079937|4276059|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
4453716|NCT00079937|4276060|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4453717|NCT00079937|4276061|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4453718|NCT00079937|4276059|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453719|NCT00079937|4276060|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453720|NCT00079937|4276061|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453721|NCT00079937|4276059|B3||White|Race (NIH/OMB)||Participants|Count of Participants|377|377.0||||||
4453722|NCT00079937|4276060|B2||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4453723|NCT00079937|4276061|B1||White|Race (NIH/OMB)||Participants|Count of Participants|249|249.0||||||
4453724|NCT00079937|4276059|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4453725|NCT00079937|4276060|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4453726|NCT00079937|4276061|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4453727|NCT00079937|4276059|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453728|NCT00079937|4276060|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453729|NCT00079937|4276061|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453730|NCT00079937|4276059|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4453731|NCT00079937|4276060|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4453732|NCT00079937|4276061|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453733|NCT00079937|4276059|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453734|NCT00079937|4276060|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453735|NCT00079937|4276061|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453736|NCT00079937|4276059|B3||Male|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4453737|NCT00079937|4276060|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4453738|NCT00079937|4276061|B1||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4453739|NCT00079937|4276059|B3||Female|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4453740|NCT00079937|4276060|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4453741|NCT00079937|4276061|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4453742|NCT00079937|4276059|B3|||Age||years|Mean|8.6|8.6|Standard Deviation|1.7|1.7|||
4453743|NCT00079937|4276060|B2|||Age||years|Mean|8.4|8.4|Standard Deviation|1.7|1.7|||
4453744|NCT00079937|4276061|B1|||Age||years|Mean|8.7|8.7|Standard Deviation|1.7|1.7|||
4453745|NCT00009737|4276078|B3|Missing||Sex/Gender, Customized||Participants|Number|1|1.0||||||
4453746|NCT00009737|4276079|B2|Missing||Sex/Gender, Customized||Participants|Number|0|0.0||||||
4453747|NCT00009737|4276080|B1|Missing||Sex/Gender, Customized||Participants|Number|1|1.0||||||
4453748|NCT00009737|4276078|B3|Male||Sex/Gender, Customized||Participants|Number|1074|1074.0||||||
4453749|NCT00009737|4276079|B2|Male||Sex/Gender, Customized||Participants|Number|532|532.0||||||
4453750|NCT00009737|4276080|B1|Male||Sex/Gender, Customized||Participants|Number|542|542.0||||||
4453751|NCT00009737|4276078|B3|Female||Sex/Gender, Customized||Participants|Number|912|912.0||||||
4453752|NCT00009737|4276079|B2|Female||Sex/Gender, Customized||Participants|Number|451|451.0||||||
4453753|NCT00009737|4276080|B1|Female||Sex/Gender, Customized||Participants|Number|461|461.0||||||
4453754|NCT00009737|4276078|B3|||Age|For median age, summary is based on n=1985|Years|Median|62.0|62.0|Full Range|||22.0|82.0|
4453755|NCT00009737|4276079|B2|||Age|For median age, summary is based on n=1985|Years|Median|63.0|63.0|Full Range|||22.0|82.0|
4453756|NCT00009737|4276080|B1|||Age|For median age, summary is based on n=1985|Years|Median|62.0|62.0|Full Range|||25.0|80.0|
4453757|NCT00079781|4276097|B4|No||Anatomical brain abnormality (by neuroimaging)||participants|Number|34|34.0||||||
4453758|NCT00079781|4276098|B3|No||Anatomical brain abnormality (by neuroimaging)||participants|Number|7|7.0||||||
4453759|NCT00079781|4276099|B2|No||Anatomical brain abnormality (by neuroimaging)||participants|Number|3|3.0||||||
4453760|NCT00079781|4276100|B1|No||Anatomical brain abnormality (by neuroimaging)||participants|Number|24|24.0||||||
4453761|NCT00079781|4276097|B4|Yes||Anatomical brain abnormality (by neuroimaging)||participants|Number|31|31.0||||||
4453762|NCT00079781|4276098|B3|Yes||Anatomical brain abnormality (by neuroimaging)||participants|Number|7|7.0||||||
4453763|NCT00079781|4276099|B2|Yes||Anatomical brain abnormality (by neuroimaging)||participants|Number|6|6.0||||||
4453764|NCT00079781|4276100|B1|Yes||Anatomical brain abnormality (by neuroimaging)||participants|Number|18|18.0||||||
4453765|NCT00079781|4276097|B4|No||Prior vagal nerve stimulator (VNS)||participants|Number|47|47.0||||||
4453766|NCT00079781|4276098|B3|No||Prior vagal nerve stimulator (VNS)||participants|Number|12|12.0||||||
4453767|NCT00079781|4276099|B2|No||Prior vagal nerve stimulator (VNS)||participants|Number|9|9.0||||||
4453768|NCT00079781|4276100|B1|No||Prior vagal nerve stimulator (VNS)||participants|Number|26|26.0||||||
4453769|NCT00079781|4276097|B4|Yes||Prior vagal nerve stimulator (VNS)||participants|Number|18|18.0||||||
4453770|NCT00079781|4276098|B3|Yes||Prior vagal nerve stimulator (VNS)||participants|Number|2|2.0||||||
4453771|NCT00079781|4276099|B2|Yes||Prior vagal nerve stimulator (VNS)||participants|Number|0|0.0||||||
4453772|NCT00079781|4276100|B1|Yes||Prior vagal nerve stimulator (VNS)||participants|Number|16|16.0||||||
4453773|NCT00079781|4276097|B4|NO prior therapeutic surgery for epilepsy||Prior therapeutic surgery for epilepsy||participants|Number|41|41.0||||||
4453774|NCT00079781|4276098|B3|NO prior therapeutic surgery for epilepsy||Prior therapeutic surgery for epilepsy||participants|Number|10|10.0||||||
4453775|NCT00079781|4276099|B2|NO prior therapeutic surgery for epilepsy||Prior therapeutic surgery for epilepsy||participants|Number|7|7.0||||||
4453776|NCT00079781|4276100|B1|NO prior therapeutic surgery for epilepsy||Prior therapeutic surgery for epilepsy||participants|Number|24|24.0||||||
4453777|NCT00079781|4276097|B4|Prior therapeutic surgery for epilepsy||Prior therapeutic surgery for epilepsy||participants|Number|24|24.0||||||
4453778|NCT00079781|4276098|B3|Prior therapeutic surgery for epilepsy||Prior therapeutic surgery for epilepsy||participants|Number|4|4.0||||||
4453779|NCT00079781|4276099|B2|Prior therapeutic surgery for epilepsy||Prior therapeutic surgery for epilepsy||participants|Number|2|2.0||||||
4453780|NCT00079781|4276100|B1|Prior therapeutic surgery for epilepsy||Prior therapeutic surgery for epilepsy||participants|Number|18|18.0||||||
4453781|NCT00079781|4276097|B4|NO prior intracranial monitoring||Prior intracranial monitoring for seizure localization||participants|Number|12|12.0||||||
4453782|NCT00079781|4276098|B3|NO prior intracranial monitoring||Prior intracranial monitoring for seizure localization||participants|Number|1|1.0||||||
4453783|NCT00079781|4276099|B2|NO prior intracranial monitoring||Prior intracranial monitoring for seizure localization||participants|Number|1|1.0||||||
4453784|NCT00079781|4276100|B1|NO prior intracranial monitoring||Prior intracranial monitoring for seizure localization||participants|Number|10|10.0||||||
4453785|NCT00079781|4276097|B4|Prior intracranial monitoring||Prior intracranial monitoring for seizure localization||participants|Number|53|53.0||||||
4453786|NCT00079781|4276098|B3|Prior intracranial monitoring||Prior intracranial monitoring for seizure localization||participants|Number|13|13.0||||||
4453787|NCT00079781|4276099|B2|Prior intracranial monitoring||Prior intracranial monitoring for seizure localization||participants|Number|8|8.0||||||
4453788|NCT00079781|4276100|B1|Prior intracranial monitoring||Prior intracranial monitoring for seizure localization||participants|Number|32|32.0||||||
4453789|NCT00079781|4276097|B4|Unifocal||Number of seizure foci||participants|Number|39|39.0||||||
4453790|NCT00079781|4276098|B3|Unifocal||Number of seizure foci||participants|Number|8|8.0||||||
4453791|NCT00079781|4276099|B2|Unifocal||Number of seizure foci||participants|Number|4|4.0||||||
4453792|NCT00079781|4276100|B1|Unifocal||Number of seizure foci||participants|Number|27|27.0||||||
4453793|NCT00079781|4276097|B4|Bifocal||Number of seizure foci||participants|Number|26|26.0||||||
4453794|NCT00079781|4276098|B3|Bifocal||Number of seizure foci||participants|Number|6|6.0||||||
4453795|NCT00079781|4276099|B2|Bifocal||Number of seizure foci||participants|Number|5|5.0||||||
4453796|NCT00079781|4276100|B1|Bifocal||Number of seizure foci||participants|Number|15|15.0||||||
4453797|NCT00079781|4276097|B4|Other||Seizure onset location||participants|Number|49|49.0||||||
4453798|NCT00079781|4276098|B3|Other||Seizure onset location||participants|Number|8|8.0||||||
4453799|NCT00079781|4276099|B2|Other||Seizure onset location||participants|Number|7|7.0||||||
4453800|NCT00079781|4276100|B1|Other||Seizure onset location||participants|Number|34|34.0||||||
4453801|NCT00079781|4276097|B4|Mesial temporal lobe ONLY||Seizure onset location||participants|Number|16|16.0||||||
4453802|NCT00079781|4276098|B3|Mesial temporal lobe ONLY||Seizure onset location||participants|Number|6|6.0||||||
4453803|NCT00079781|4276099|B2|Mesial temporal lobe ONLY||Seizure onset location||participants|Number|2|2.0||||||
4453804|NCT00079781|4276100|B1|Mesial temporal lobe ONLY||Seizure onset location||participants|Number|8|8.0||||||
4453805|NCT00079781|4276097|B4|||Number of antiepileptic drugs (AEDs) used over lifetime||AEDs|Mean|7.6|7.6|Standard Deviation|2.6|2.6|||
4453806|NCT00079781|4276098|B3|||Number of antiepileptic drugs (AEDs) used over lifetime||AEDs|Mean|6.6|6.6|Standard Deviation|2.7|2.7|||
4453807|NCT00079781|4276099|B2|||Number of antiepileptic drugs (AEDs) used over lifetime||AEDs|Mean|7.3|7.3|Standard Deviation|2.4|2.4|||
4453808|NCT00079781|4276100|B1|||Number of antiepileptic drugs (AEDs) used over lifetime||AEDs|Mean|8.0|8.0|Standard Deviation|2.6|2.6|||
4453809|NCT00079781|4276097|B4|||Duration of epilepsy||years|Mean|17.5|17.5|Standard Deviation|10.1|10.1|||
4453810|NCT00079781|4276098|B3|||Duration of epilepsy||years|Mean|17.1|17.1|Standard Deviation|10.3|10.3|||
4453811|NCT00079781|4276099|B2|||Duration of epilepsy||years|Mean|17.4|17.4|Standard Deviation|8.9|8.9|||
4453812|NCT00079781|4276100|B1|||Duration of epilepsy||years|Mean|17.6|17.6|Standard Deviation|10.4|10.4|||
4453813|NCT00079781|4276097|B4|United States||Region of Enrollment||participants|Number|65|65.0||||||
4453814|NCT00079781|4276098|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4453815|NCT00079781|4276099|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4453816|NCT00079781|4276100|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4453817|NCT00079781|4276097|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4453818|NCT00079781|4276098|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4453819|NCT00079781|4276099|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4453820|NCT00079781|4276100|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4453821|NCT00079781|4276097|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4453822|NCT00079781|4276098|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4453823|NCT00079781|4276099|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4453824|NCT00079781|4276100|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4453825|NCT00079781|4276097|B4|||Age||years|Mean|31.9|31.9|Standard Deviation|10.3|10.3|||
4453826|NCT00079781|4276098|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|12.7|12.7|||
4453827|NCT00079781|4276099|B2|||Age||years|Mean|27.5|27.5|Standard Deviation|7.6|7.6|||
4453828|NCT00079781|4276100|B1|||Age||years|Mean|31.2|31.2|Standard Deviation|9.5|9.5|||
4453829|NCT00079781|4276097|B4|>=65 years||Age||participants|Number|0|0.0||||||
4453830|NCT00079781|4276098|B3|>=65 years||Age||participants|Number|0|0.0||||||
4453831|NCT00079781|4276099|B2|>=65 years||Age||participants|Number|0|0.0||||||
4453832|NCT00079781|4276100|B1|>=65 years||Age||participants|Number|0|0.0||||||
4453833|NCT00079781|4276097|B4|Between 18 and 65 years||Age||participants|Number|58|58.0||||||
4453834|NCT00079781|4276098|B3|Between 18 and 65 years||Age||participants|Number|13|13.0||||||
4453835|NCT00079781|4276099|B2|Between 18 and 65 years||Age||participants|Number|7|7.0||||||
4453836|NCT00079781|4276100|B1|Between 18 and 65 years||Age||participants|Number|38|38.0||||||
4453837|NCT00079781|4276097|B4|<=18 years||Age||participants|Number|2|2.0||||||
4453838|NCT00079781|4276098|B3|<=18 years||Age||participants|Number|1|1.0||||||
4453839|NCT00079781|4276099|B2|<=18 years||Age||participants|Number|1|1.0||||||
4453840|NCT00079781|4276100|B1|<=18 years||Age||participants|Number|0|0.0||||||
4453841|NCT00079677|4276109|B3|Australia||Region of Enrollment||participants|Number|41|41.0||||||
4453842|NCT00079677|4276110|B2|Australia||Region of Enrollment||participants|Number|21|21.0||||||
4453843|NCT00079677|4276111|B1|Australia||Region of Enrollment||participants|Number|20|20.0||||||
4453844|NCT00079677|4276109|B3|Russian Federation||Region of Enrollment||participants|Number|19|19.0||||||
4453845|NCT00079677|4276110|B2|Russian Federation||Region of Enrollment||participants|Number|9|9.0||||||
4453846|NCT00079677|4276111|B1|Russian Federation||Region of Enrollment||participants|Number|10|10.0||||||
4453847|NCT00079677|4276109|B3|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4453848|NCT00079677|4276110|B2|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4453849|NCT00079677|4276111|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4453850|NCT00079677|4276109|B3|France||Region of Enrollment||participants|Number|1|1.0||||||
4453851|NCT00079677|4276110|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4453852|NCT00079677|4276111|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4453853|NCT00079677|4276109|B3|United States||Region of Enrollment||participants|Number|198|198.0||||||
4453854|NCT00079677|4276110|B2|United States||Region of Enrollment||participants|Number|99|99.0||||||
4453855|NCT00079677|4276111|B1|United States||Region of Enrollment||participants|Number|99|99.0||||||
4453856|NCT00079677|4276109|B3|Male||Gender|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|190|190.0||||||
4453857|NCT00079677|4276110|B2|Male||Gender|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|93|93.0||||||
4453858|NCT00079677|4276111|B1|Male||Gender|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|97|97.0||||||
4453859|NCT00079677|4276109|B3|Female||Gender|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|69|69.0||||||
4453860|NCT00079677|4276110|B2|Female||Gender|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|37|37.0||||||
4453861|NCT00079677|4276111|B1|Female||Gender|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|32|32.0||||||
4453862|NCT00079677|4276109|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|8.99|8.99|||
4453863|NCT00079677|4276110|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|8.85|8.85|||
4453864|NCT00079677|4276111|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|9.17|9.17|||
4453865|NCT00079677|4276109|B3|>=65 years||Age|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|3|3.0||||||
4453866|NCT00079677|4276110|B2|>=65 years||Age|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|1|1.0||||||
4453867|NCT00079677|4276111|B1|>=65 years||Age|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|2|2.0||||||
4453868|NCT00079677|4276109|B3|Between 18 and 65 years||Age|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|256|256.0||||||
4453869|NCT00079677|4276110|B2|Between 18 and 65 years||Age|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|129|129.0||||||
4453870|NCT00079677|4276111|B1|Between 18 and 65 years||Age|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|127|127.0||||||
4453871|NCT00079677|4276109|B3|<=18 years||Age|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|0|0.0||||||
4453872|NCT00079677|4276110|B2|<=18 years||Age|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|0|0.0||||||
4453873|NCT00079677|4276111|B1|<=18 years||Age|4 male participants withdrew after randomization but prior to receiving study drug|participants|Number|0|0.0||||||
4453874|NCT00002601|4276120|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4453875|NCT00002601|4276120|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4453876|NCT00002601|4276120|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4453877|NCT00002601|4276120|B1|||Age||years|Median|31|31.0|Full Range|||21.0|41.0|
4453878|NCT00079417|4276128|B1|Barbados||Region of Enrollment||participants|Number|1|1.0||||||
4453879|NCT00079417|4276128|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4453880|NCT00079417|4276128|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4453881|NCT00079417|4276128|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453882|NCT00079417|4276128|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4453883|NCT00079417|4276128|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4453884|NCT00079417|4276128|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4453885|NCT00079417|4276128|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453886|NCT00079417|4276128|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4453887|NCT00079417|4276128|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4453888|NCT00079417|4276128|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4453889|NCT00079417|4276128|B1|||Age||Years|Median|0.3|0.3|Full Range|||0.0|2.0|
4453890|NCT00079391|4276136|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4453891|NCT00079391|4276136|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4453892|NCT00079391|4276136|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4453893|NCT00079391|4276136|B1|||Age||years|Mean|33|33.0|Standard Deviation|10|10.0|||
4453894|NCT00079391|4276136|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4453895|NCT00079391|4276136|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4453896|NCT00079391|4276136|B1||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4453897|NCT00079339|4276145|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
4453898|NCT00079339|4276146|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4453899|NCT00079339|4276147|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4453900|NCT00079339|4276148|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4453901|NCT00079339|4276145|B4||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4453902|NCT00079339|4276146|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4453903|NCT00079339|4276147|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4453904|NCT00079339|4276148|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4453905|NCT00079339|4276145|B4||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4453906|NCT00079339|4276146|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4453907|NCT00079339|4276147|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4453908|NCT00079339|4276148|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4453909|NCT00079339|4276145|B4|||Age||years|Median|5.72|5.72|Full Range|||3.33|16.7|
4453910|NCT00079339|4276146|B3|||Age||years|Median|5.84|5.84|Full Range|||4.55|13.75|
4453911|NCT00079339|4276147|B2|||Age||years|Median|5.48|5.48|Full Range|||3.33|16.47|
4453912|NCT00079339|4276148|B1|||Age||years|Median|5.87|5.87|Full Range|||4.68|8.23|
4453913|NCT00079339|4276145|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4453914|NCT00079339|4276146|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4453915|NCT00079339|4276147|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4453916|NCT00079339|4276148|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4453917|NCT00079339|4276145|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4453918|NCT00079339|4276146|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4453919|NCT00079339|4276147|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4453920|NCT00079339|4276148|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4453921|NCT00079339|4276145|B4||<=18 years|Age||Participants|Count of Participants|51|51.0||||||
4453922|NCT00079339|4276146|B3||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4453923|NCT00079339|4276147|B2||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4453924|NCT00079339|4276148|B1||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4453925|NCT00079326|4276164|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4453926|NCT00079326|4276165|B2|United States||Region of Enrollment||participants|Number|24|24.0||||||
4453927|NCT00079326|4276166|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4453928|NCT00079326|4276164|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453929|NCT00079326|4276165|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453930|NCT00079326|4276166|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4453931|NCT00079326|4276164|B3||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4453932|NCT00079326|4276165|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4453933|NCT00079326|4276166|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4453934|NCT00079326|4276164|B3|||Age, Customized||years|Mean|51.67|51.67|Standard Deviation|11.29|11.29|||
4453935|NCT00079326|4276165|B2|||Age, Customized||years|Mean|52.67|52.67|Standard Deviation|11.28|11.28|29.0|74.0|
4453936|NCT00079326|4276166|B1|||Age, Customized||years|Mean|50.07|50.07|Standard Deviation|11.5|11.5|32.0|67.0|
4453937|NCT00079274|4276174|B8|Wildtype||KRAS Status||participants|Number|2099|2099.0||||||
4453938|NCT00079274|4276175|B7|Wildtype||KRAS Status||participants|Number|0|0.0||||||
4453939|NCT00079274|4276176|B6|Wildtype||KRAS Status||participants|Number|29|29.0||||||
4453940|NCT00079274|4276177|B5|Wildtype||KRAS Status||participants|Number|27|27.0||||||
4453941|NCT00079274|4276178|B4|Wildtype||KRAS Status||participants|Number|954|954.0||||||
4453942|NCT00079274|4276179|B3|Wildtype||KRAS Status||participants|Number|62|62.0||||||
4453943|NCT00079274|4276180|B2|Wildtype||KRAS Status||participants|Number|72|72.0||||||
4453944|NCT00079274|4276181|B1|Wildtype||KRAS Status||participants|Number|955|955.0||||||
4453945|NCT00079274|4276174|B8|Mutant||KRAS Status||participants|Number|1166|1166.0||||||
4453946|NCT00079274|4276175|B7|Mutant||KRAS Status||participants|Number|326|326.0||||||
4453947|NCT00079274|4276176|B6|Mutant||KRAS Status||participants|Number|13|13.0||||||
4453948|NCT00079274|4276177|B5|Mutant||KRAS Status||participants|Number|15|15.0||||||
4453949|NCT00079274|4276178|B4|Mutant||KRAS Status||participants|Number|345|345.0||||||
4453950|NCT00079274|4276179|B3|Mutant||KRAS Status||participants|Number|43|43.0||||||
4453951|NCT00079274|4276180|B2|Mutant||KRAS Status||participants|Number|33|33.0||||||
4453952|NCT00079274|4276181|B1|Mutant||KRAS Status||participants|Number|391|391.0||||||
4453953|NCT00079274|4276174|B8|Unknown||KRAS Status||participants|Number|132|132.0||||||
4453954|NCT00079274|4276175|B7|Unknown||KRAS Status||participants|Number|6|6.0||||||
4453955|NCT00079274|4276176|B6|Unknown||KRAS Status||participants|Number|4|4.0||||||
4453956|NCT00079274|4276177|B5|Unknown||KRAS Status||participants|Number|3|3.0||||||
4453957|NCT00079274|4276178|B4|Unknown||KRAS Status||participants|Number|51|51.0||||||
4453958|NCT00079274|4276179|B3|Unknown||KRAS Status||participants|Number|6|6.0||||||
4453959|NCT00079274|4276180|B2|Unknown||KRAS Status||participants|Number|6|6.0||||||
4453960|NCT00079274|4276181|B1|Unknown||KRAS Status||participants|Number|56|56.0||||||
4453961|NCT00079274|4276174|B8|Low||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|2560|2560.0||||||
4453962|NCT00079274|4276175|B7|Low||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|272|272.0||||||
4453963|NCT00079274|4276176|B6|Low||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|34|34.0||||||
4453964|NCT00079274|4276177|B5|Low||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|35|35.0||||||
4453965|NCT00079274|4276178|B4|Low||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|1005|1005.0||||||
4453966|NCT00079274|4276179|B3|Low||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|83|83.0||||||
4453967|NCT00079274|4276180|B2|Low||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|86|86.0||||||
4453968|NCT00079274|4276181|B1|Low||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|1045|1045.0||||||
4453969|NCT00079274|4276174|B8|High||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|837|837.0||||||
4453970|NCT00079274|4276175|B7|High||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|60|60.0||||||
4453971|NCT00079274|4276176|B6|High||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|12|12.0||||||
4453972|NCT00079274|4276177|B5|High||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|10|10.0||||||
4453973|NCT00079274|4276178|B4|High||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|345|345.0||||||
4453974|NCT00079274|4276179|B3|High||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|28|28.0||||||
4453975|NCT00079274|4276180|B2|High||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|25|25.0||||||
4453976|NCT00079274|4276181|B1|High||Histologic Grade|High=poorly differentiated or undifferentiated > Low=well or moderately differentiated|participants|Number|357|357.0||||||
4453977|NCT00079274|4276174|B8|Not Availabe||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|2|2.0||||||
4453978|NCT00079274|4276175|B7|Not Availabe||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|0|0.0||||||
4453979|NCT00079274|4276176|B6|Not Availabe||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|0|0.0||||||
4453980|NCT00079274|4276177|B5|Not Availabe||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|1|1.0||||||
4453981|NCT00079274|4276178|B4|Not Availabe||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|1|1.0||||||
4453982|NCT00079274|4276179|B3|Not Availabe||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|0|0.0||||||
4453983|NCT00079274|4276180|B2|Not Availabe||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|0|0.0||||||
4453984|NCT00079274|4276181|B1|Not Availabe||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|0|0.0||||||
4453985|NCT00079274|4276174|B8|T4||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|398|398.0||||||
4453986|NCT00079274|4276175|B7|T4||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|62|62.0||||||
4453987|NCT00079274|4276176|B6|T4||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|2|2.0||||||
4453988|NCT00079274|4276177|B5|T4||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|4|4.0||||||
4453989|NCT00079274|4276178|B4|T4||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|153|153.0||||||
4453990|NCT00079274|4276179|B3|T4||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|4|4.0||||||
4453991|NCT00079274|4276180|B2|T4||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|15|15.0||||||
4453992|NCT00079274|4276181|B1|T4||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|158|158.0||||||
4453993|NCT00079274|4276174|B8|T3||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|2488|2488.0||||||
4453994|NCT00079274|4276175|B7|T3||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|214|214.0||||||
4453995|NCT00079274|4276176|B6|T3||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|39|39.0||||||
4453996|NCT00079274|4276177|B5|T3||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|35|35.0||||||
4453997|NCT00079274|4276178|B4|T3||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|983|983.0||||||
4453998|NCT00079274|4276179|B3|T3||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|93|93.0||||||
4454032|NCT00079274|4276181|B1|Puerto Rico||Region of Enrollment||participants|Number|5|5.0||||||
4453999|NCT00079274|4276180|B2|T3||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|78|78.0||||||
4454000|NCT00079274|4276181|B1|T3||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|1046|1046.0||||||
4454001|NCT00079274|4276174|B8|T1 or T2||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|509|509.0||||||
4454002|NCT00079274|4276175|B7|T1 or T2||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|56|56.0||||||
4454003|NCT00079274|4276176|B6|T1 or T2||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|5|5.0||||||
4454004|NCT00079274|4276177|B5|T1 or T2||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|5|5.0||||||
4454005|NCT00079274|4276178|B4|T1 or T2||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|213|213.0||||||
4454006|NCT00079274|4276179|B3|T1 or T2||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|14|14.0||||||
4454007|NCT00079274|4276180|B2|T1 or T2||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|18|18.0||||||
4454008|NCT00079274|4276181|B1|T1 or T2||Tumor Stage|"T1: Tumor invades submucosa~T2: Tumor invades muscularis propria~T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues~T4: (T4a+) Tumor perforates the visceral peritoneum without adherence to or invasion of other organs or structures or (T4b) Tumor is adherent to or directly invades other organs or structures"|participants|Number|198|198.0||||||
4454009|NCT00079274|4276174|B8|4+||Positive Nodes|Number of positive nodes|participants|Number|1390|1390.0||||||
4454010|NCT00079274|4276175|B7|4+||Positive Nodes|Number of positive nodes|participants|Number|129|129.0||||||
4454011|NCT00079274|4276176|B6|4+||Positive Nodes|Number of positive nodes|participants|Number|18|18.0||||||
4454012|NCT00079274|4276177|B5|4+||Positive Nodes|Number of positive nodes|participants|Number|16|16.0||||||
4454013|NCT00079274|4276178|B4|4+||Positive Nodes|Number of positive nodes|participants|Number|560|560.0||||||
4454014|NCT00079274|4276179|B3|4+||Positive Nodes|Number of positive nodes|participants|Number|41|41.0||||||
4454015|NCT00079274|4276180|B2|4+||Positive Nodes|Number of positive nodes|participants|Number|40|40.0||||||
4454016|NCT00079274|4276181|B1|4+||Positive Nodes|Number of positive nodes|participants|Number|586|586.0||||||
4454017|NCT00079274|4276174|B8|1-3||Positive Nodes|Number of positive nodes|participants|Number|2007|2007.0||||||
4454018|NCT00079274|4276175|B7|1-3||Positive Nodes|Number of positive nodes|participants|Number|203|203.0||||||
4454019|NCT00079274|4276176|B6|1-3||Positive Nodes|Number of positive nodes|participants|Number|28|28.0||||||
4454020|NCT00079274|4276177|B5|1-3||Positive Nodes|Number of positive nodes|participants|Number|29|29.0||||||
4454021|NCT00079274|4276178|B4|1-3||Positive Nodes|Number of positive nodes|participants|Number|790|790.0||||||
4454022|NCT00079274|4276179|B3|1-3||Positive Nodes|Number of positive nodes|participants|Number|70|70.0||||||
4454023|NCT00079274|4276180|B2|1-3||Positive Nodes|Number of positive nodes|participants|Number|71|71.0||||||
4454024|NCT00079274|4276181|B1|1-3||Positive Nodes|Number of positive nodes|participants|Number|816|816.0||||||
4454025|NCT00079274|4276174|B8|Puerto Rico||Region of Enrollment||participants|Number|8|8.0||||||
4454026|NCT00079274|4276175|B7|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4454027|NCT00079274|4276176|B6|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4454028|NCT00079274|4276177|B5|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4454029|NCT00079274|4276178|B4|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4454030|NCT00079274|4276179|B3|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4454031|NCT00079274|4276180|B2|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4454033|NCT00079274|4276174|B8|Jamaica||Region of Enrollment||participants|Number|1|1.0||||||
4454034|NCT00079274|4276175|B7|Jamaica||Region of Enrollment||participants|Number|0|0.0||||||
4454035|NCT00079274|4276176|B6|Jamaica||Region of Enrollment||participants|Number|0|0.0||||||
4454036|NCT00079274|4276177|B5|Jamaica||Region of Enrollment||participants|Number|0|0.0||||||
4454037|NCT00079274|4276178|B4|Jamaica||Region of Enrollment||participants|Number|0|0.0||||||
4454038|NCT00079274|4276179|B3|Jamaica||Region of Enrollment||participants|Number|0|0.0||||||
4454039|NCT00079274|4276180|B2|Jamaica||Region of Enrollment||participants|Number|0|0.0||||||
4454040|NCT00079274|4276181|B1|Jamaica||Region of Enrollment||participants|Number|1|1.0||||||
4454041|NCT00079274|4276174|B8|Canada||Region of Enrollment||participants|Number|295|295.0||||||
4454042|NCT00079274|4276175|B7|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4454043|NCT00079274|4276176|B6|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4454044|NCT00079274|4276177|B5|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4454045|NCT00079274|4276178|B4|Canada||Region of Enrollment||participants|Number|124|124.0||||||
4454046|NCT00079274|4276179|B3|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4454047|NCT00079274|4276180|B2|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4454048|NCT00079274|4276181|B1|Canada||Region of Enrollment||participants|Number|138|138.0||||||
4454049|NCT00079274|4276174|B8|United States||Region of Enrollment||participants|Number|3093|3093.0||||||
4454050|NCT00079274|4276175|B7|United States||Region of Enrollment||participants|Number|303|303.0||||||
4454051|NCT00079274|4276176|B6|United States||Region of Enrollment||participants|Number|46|46.0||||||
4454052|NCT00079274|4276177|B5|United States||Region of Enrollment||participants|Number|44|44.0||||||
4454053|NCT00079274|4276178|B4|United States||Region of Enrollment||participants|Number|1224|1224.0||||||
4454054|NCT00079274|4276179|B3|United States||Region of Enrollment||participants|Number|109|109.0||||||
4454055|NCT00079274|4276180|B2|United States||Region of Enrollment||participants|Number|109|109.0||||||
4454056|NCT00079274|4276181|B1|United States||Region of Enrollment||participants|Number|1258|1258.0||||||
4454057|NCT00079274|4276174|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4454058|NCT00079274|4276175|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4454059|NCT00079274|4276176|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454060|NCT00079274|4276177|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454061|NCT00079274|4276178|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4454062|NCT00079274|4276179|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454063|NCT00079274|4276180|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454064|NCT00079274|4276181|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4454065|NCT00079274|4276174|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4454066|NCT00079274|4276175|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454067|NCT00079274|4276176|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454068|NCT00079274|4276177|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454069|NCT00079274|4276178|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4454070|NCT00079274|4276179|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454071|NCT00079274|4276180|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454072|NCT00079274|4276181|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4454073|NCT00079274|4276174|B8||White|Race (NIH/OMB)||Participants|Count of Participants|2909|2909.0||||||
4454074|NCT00079274|4276175|B7||White|Race (NIH/OMB)||Participants|Count of Participants|275|275.0||||||
4454075|NCT00079274|4276176|B6||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4454076|NCT00079274|4276177|B5||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4454077|NCT00079274|4276178|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1154|1154.0||||||
4454078|NCT00079274|4276179|B3||White|Race (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4454079|NCT00079274|4276180|B2||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4454080|NCT00079274|4276181|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1202|1202.0||||||
4454081|NCT00079274|4276174|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|239|239.0||||||
4454082|NCT00079274|4276175|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4454083|NCT00079274|4276176|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454084|NCT00079274|4276177|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4454085|NCT00079274|4276178|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4454086|NCT00079274|4276179|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4454087|NCT00079274|4276180|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4454088|NCT00079274|4276181|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4454089|NCT00079274|4276174|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4454090|NCT00079274|4276175|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454091|NCT00079274|4276176|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454092|NCT00079274|4276177|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454093|NCT00079274|4276178|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4454094|NCT00079274|4276179|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454095|NCT00079274|4276180|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454096|NCT00079274|4276181|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4454097|NCT00079274|4276174|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|149|149.0||||||
4454098|NCT00079274|4276175|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4454099|NCT00079274|4276176|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454100|NCT00079274|4276177|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4454101|NCT00079274|4276178|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4454102|NCT00079274|4276179|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454103|NCT00079274|4276180|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4454104|NCT00079274|4276181|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4454105|NCT00079274|4276174|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4454106|NCT00079274|4276175|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454107|NCT00079274|4276176|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454108|NCT00079274|4276177|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454109|NCT00079274|4276178|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4454110|NCT00079274|4276179|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454111|NCT00079274|4276180|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454112|NCT00079274|4276181|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4454113|NCT00079274|4276174|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|562|562.0||||||
4454114|NCT00079274|4276175|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4454115|NCT00079274|4276176|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4454116|NCT00079274|4276177|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4454117|NCT00079274|4276178|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
4454118|NCT00079274|4276179|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4454119|NCT00079274|4276180|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4454120|NCT00079274|4276181|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|231|231.0||||||
4454121|NCT00079274|4276174|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2677|2677.0||||||
4454122|NCT00079274|4276175|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|225|225.0||||||
4454123|NCT00079274|4276176|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4454124|NCT00079274|4276177|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4454125|NCT00079274|4276178|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1060|1060.0||||||
4454126|NCT00079274|4276179|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4454127|NCT00079274|4276180|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4454128|NCT00079274|4276181|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1107|1107.0||||||
4454129|NCT00079274|4276174|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|158|158.0||||||
4454130|NCT00079274|4276175|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4454131|NCT00079274|4276176|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454132|NCT00079274|4276177|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4454133|NCT00079274|4276178|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4454134|NCT00079274|4276179|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4454135|NCT00079274|4276180|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4454136|NCT00079274|4276181|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4454137|NCT00079274|4276174|B8||Male|Sex: Female, Male||Participants|Count of Participants|1784|1784.0||||||
4454138|NCT00079274|4276175|B7||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4454139|NCT00079274|4276176|B6||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4454140|NCT00079274|4276177|B5||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4454141|NCT00079274|4276178|B4||Male|Sex: Female, Male||Participants|Count of Participants|703|703.0||||||
4454142|NCT00079274|4276179|B3||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4454143|NCT00079274|4276180|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4454144|NCT00079274|4276181|B1||Male|Sex: Female, Male||Participants|Count of Participants|740|740.0||||||
4454145|NCT00079274|4276174|B8||Female|Sex: Female, Male||Participants|Count of Participants|1613|1613.0||||||
4454146|NCT00079274|4276175|B7||Female|Sex: Female, Male||Participants|Count of Participants|160|160.0||||||
4454147|NCT00079274|4276176|B6||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4454148|NCT00079274|4276177|B5||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4454149|NCT00079274|4276178|B4||Female|Sex: Female, Male||Participants|Count of Participants|647|647.0||||||
4454150|NCT00079274|4276179|B3||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4454151|NCT00079274|4276180|B2||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4454152|NCT00079274|4276181|B1||Female|Sex: Female, Male||Participants|Count of Participants|662|662.0||||||
4454153|NCT00079274|4276174|B8|||Age||years|Median|58|58.0|Full Range|||19.0|86.0|
4454154|NCT00079274|4276175|B7|||Age||years|Median|56|56.0|Full Range|||22.0|84.0|
4454155|NCT00079274|4276176|B6|||Age||years|Median|60.5|60.5|Full Range|||30.0|81.0|
4454156|NCT00079274|4276177|B5|||Age||years|Median|59|59.0|Full Range|||30.0|82.0|
4454157|NCT00079274|4276178|B4|||Age||years|Median|58|58.0|Full Range|||22.0|86.0|
4454158|NCT00079274|4276179|B3|||Age||years|Median|60|60.0|Full Range|||24.0|82.0|
4454159|NCT00079274|4276180|B2|||Age||years|Median|57|57.0|Full Range|||25.0|82.0|
4454160|NCT00079274|4276181|B1|||Age||years|Median|58|58.0|Full Range|||19.0|85.0|
4454161|NCT00079183|4276208|B1|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4454162|NCT00079183|4276208|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454163|NCT00079183|4276208|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454164|NCT00079183|4276208|B1||White|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4454165|NCT00079183|4276208|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454166|NCT00079183|4276208|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454167|NCT00079183|4276208|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454168|NCT00079183|4276208|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454169|NCT00079183|4276208|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454170|NCT00079183|4276208|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4454171|NCT00079183|4276208|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454172|NCT00079183|4276208|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4454173|NCT00079183|4276208|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4454174|NCT00079183|4276208|B1|||Age||years|Median|40.55|40.55|Full Range|||1.4|72.4|
4454175|NCT00079183|4276208|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4454176|NCT00079183|4276208|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4454177|NCT00079183|4276208|B1||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4454178|NCT00079040|4276223|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4454179|NCT00079040|4276223|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4454180|NCT00079040|4276223|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4454181|NCT00079040|4276223|B1|||Age||Years|Median|65|65.0|Full Range|||45.0|83.0|
4454182|NCT00079001|4276229|B3|No||Prior Skeletal Related Event||participants|Number|563|563.0||||||
4454183|NCT00079001|4276230|B2|No||Prior Skeletal Related Event||participants|Number|282|282.0||||||
4454184|NCT00079001|4276231|B1|No||Prior Skeletal Related Event||participants|Number|281|281.0||||||
4454185|NCT00079001|4276229|B3|Yes||Prior Skeletal Related Event||participants|Number|82|82.0||||||
4454186|NCT00079001|4276230|B2|Yes||Prior Skeletal Related Event||participants|Number|40|40.0||||||
4454187|NCT00079001|4276231|B1|Yes||Prior Skeletal Related Event||participants|Number|42|42.0||||||
4454188|NCT00079001|4276229|B3|2||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|25|25.0||||||
4454189|NCT00079001|4276230|B2|2||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|12|12.0||||||
4454190|NCT00079001|4276231|B1|2||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|13|13.0||||||
4454191|NCT00079001|4276229|B3|1||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|210|210.0||||||
4454192|NCT00079001|4276230|B2|1||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|105|105.0||||||
4454193|NCT00079001|4276231|B1|1||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|105|105.0||||||
4454194|NCT00079001|4276229|B3|0||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|410|410.0||||||
4454195|NCT00079001|4276230|B2|0||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|205|205.0||||||
4454196|NCT00079001|4276231|B1|0||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|205|205.0||||||
4454197|NCT00079001|4276229|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4454198|NCT00079001|4276230|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4454199|NCT00079001|4276231|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4454200|NCT00079001|4276229|B3|United States||Region of Enrollment||participants|Number|644|644.0||||||
4454201|NCT00079001|4276230|B2|United States||Region of Enrollment||participants|Number|321|321.0||||||
4454202|NCT00079001|4276231|B1|United States||Region of Enrollment||participants|Number|323|323.0||||||
4454203|NCT00079001|4276229|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4454204|NCT00079001|4276230|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4454205|NCT00079001|4276231|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4454206|NCT00079001|4276229|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454207|NCT00079001|4276230|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454208|NCT00079001|4276231|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454209|NCT00079001|4276229|B3||White|Race (NIH/OMB)||Participants|Count of Participants|517|517.0||||||
4454210|NCT00079001|4276230|B2||White|Race (NIH/OMB)||Participants|Count of Participants|256|256.0||||||
4454211|NCT00079001|4276231|B1||White|Race (NIH/OMB)||Participants|Count of Participants|261|261.0||||||
4454212|NCT00079001|4276229|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|92|92.0||||||
4454213|NCT00079001|4276230|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4454214|NCT00079001|4276231|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4454215|NCT00079001|4276229|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4454216|NCT00079001|4276230|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454217|NCT00079001|4276231|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454218|NCT00079001|4276229|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4454219|NCT00079001|4276230|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4454220|NCT00079001|4276231|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4454221|NCT00079001|4276229|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454222|NCT00079001|4276230|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454223|NCT00079001|4276231|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454224|NCT00079001|4276229|B3||Male|Gender||Participants|Count of Participants|645|645.0||||||
4454225|NCT00079001|4276230|B2||Male|Gender||Participants|Count of Participants|322|322.0||||||
4454226|NCT00079001|4276231|B1||Male|Gender||Participants|Count of Participants|323|323.0||||||
4454227|NCT00079001|4276229|B3||Female|Gender||Participants|Count of Participants|0|0.0||||||
4454228|NCT00079001|4276230|B2||Female|Gender||Participants|Count of Participants|0|0.0||||||
4454229|NCT00079001|4276231|B1||Female|Gender||Participants|Count of Participants|0|0.0||||||
4454230|NCT00079001|4276229|B3|||Age||years|Median|66.3|66.3|Inter-Quartile Range|||60.0|73.0|
4454231|NCT00079001|4276230|B2|||Age||years|Median|66.7|66.7|Inter-Quartile Range|||60.2|73.6|
4454232|NCT00079001|4276231|B1|||Age||years|Median|66.1|66.1|Inter-Quartile Range|||60.0|72.5|
4454233|NCT00078949|4276242|B5||Male|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4454234|NCT00078949|4276245|B2||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4454235|NCT00078949|4276246|B1||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4454236|NCT00078949|4276242|B5||Female|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4454237|NCT00078949|4276245|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4454238|NCT00078949|4276246|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4454239|NCT00078949|4276242|B5|||Age||years|Median|55|55.0|Full Range|||19.0|74.0|
4454240|NCT00078949|4276245|B2|||Age||years|Median|55|55.0|Full Range|||23.0|74.0|
4454241|NCT00078949|4276246|B1|||Age||years|Median|55|55.0|Full Range|||19.0|71.0|
4454242|NCT00078767|4276261|B3|United States||Region of Enrollment||participants|Number|22|22.0||||||
4454243|NCT00078767|4276262|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4454244|NCT00078767|4276263|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4454245|NCT00078767|4276261|B3||African American|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4454246|NCT00078767|4276262|B2||African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4454247|NCT00078767|4276263|B1||African American|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4454248|NCT00078767|4276261|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4454249|NCT00078767|4276262|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4454250|NCT00078767|4276263|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4454251|NCT00078767|4276261|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4454252|NCT00078767|4276262|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4454253|NCT00078767|4276263|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4454254|NCT00078767|4276261|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4454255|NCT00078767|4276262|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4454256|NCT00078767|4276263|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4454257|NCT00078767|4276261|B3|||Age||years|Mean|14|14.0|Full Range|||10.0|17.0|
4454258|NCT00078767|4276262|B2|||Age||years|Mean|14|14.0|Full Range|||10.0|17.0|
4454259|NCT00078767|4276263|B1|||Age||years|Mean|14|14.0|Full Range|||10.0|17.0|
4454260|NCT00078767|4276261|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454261|NCT00078767|4276262|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454262|NCT00078767|4276263|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454263|NCT00078767|4276261|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4454264|NCT00078767|4276262|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4454265|NCT00078767|4276263|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4454266|NCT00078767|4276261|B3||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4454267|NCT00078767|4276262|B2||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4454268|NCT00078767|4276263|B1||<=18 years|Age||Participants|Count of Participants|11|11.0||||||
4454269|NCT00078754|4276278|B4|||overt aggression scale-modified (OAS-M).|OAS-M is a validated instrument that measures aggression. Possible scores for aggression range from 0 (no aggression) to infinity (because the score is calculated by the number of times an aggressive behavior occurred, which theoretically has no possible maximum). Therefore the bigger number, the more aggression. OAS-M score was calculated for the past week before the visit.|units on a scale|Mean|47.30|47.3|Standard Deviation|56.68|56.68|||
4454270|NCT00078754|4276279|B3|||overt aggression scale-modified (OAS-M).|OAS-M is a validated instrument that measures aggression. Possible scores for aggression range from 0 (no aggression) to infinity (because the score is calculated by the number of times an aggressive behavior occurred, which theoretically has no possible maximum). Therefore the bigger number, the more aggression. OAS-M score was calculated for the past week before the visit.|units on a scale|Mean|66.08|66.08|Standard Deviation|77.99|77.99|||
4454271|NCT00078754|4276280|B2|||overt aggression scale-modified (OAS-M).|OAS-M is a validated instrument that measures aggression. Possible scores for aggression range from 0 (no aggression) to infinity (because the score is calculated by the number of times an aggressive behavior occurred, which theoretically has no possible maximum). Therefore the bigger number, the more aggression. OAS-M score was calculated for the past week before the visit.|units on a scale|Mean|36.96|36.96|Standard Deviation|26.42|26.42|||
4454272|NCT00078754|4276281|B1|||overt aggression scale-modified (OAS-M).|OAS-M is a validated instrument that measures aggression. Possible scores for aggression range from 0 (no aggression) to infinity (because the score is calculated by the number of times an aggressive behavior occurred, which theoretically has no possible maximum). Therefore the bigger number, the more aggression. OAS-M score was calculated for the past week before the visit.|units on a scale|Mean|36.75|36.75|Standard Deviation|46.88|46.88|||
4454273|NCT00078754|4276278|B4||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4454274|NCT00078754|4276279|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4454275|NCT00078754|4276280|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4454276|NCT00078754|4276281|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4454277|NCT00078754|4276278|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4454278|NCT00078754|4276279|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4454279|NCT00078754|4276280|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4454280|NCT00078754|4276281|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4454281|NCT00078754|4276278|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454282|NCT00078754|4276279|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454283|NCT00078754|4276280|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454284|NCT00078754|4276281|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454285|NCT00078754|4276278|B4||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4454286|NCT00078754|4276279|B3||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4454287|NCT00078754|4276280|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4454288|NCT00078754|4276281|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4454289|NCT00078754|4276278|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454290|NCT00078754|4276279|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454291|NCT00078754|4276280|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454292|NCT00078754|4276281|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454293|NCT00078728|4276291|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4454294|NCT00078728|4276292|B2|United States||Region of Enrollment||participants|Number|20|20.0||||||
4454295|NCT00078728|4276293|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4454296|NCT00078728|4276291|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4454297|NCT00078728|4276292|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4454298|NCT00078728|4276293|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4454299|NCT00078728|4276291|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4454300|NCT00078728|4276292|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4454301|NCT00078728|4276293|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4454302|NCT00078728|4276291|B3|||Age||years|Mean|8.94|8.94|Standard Deviation|1.85|1.85|||
4454303|NCT00078728|4276292|B2|||Age||years|Mean|8.68|8.68|Standard Deviation|1.81|1.81|||
4454304|NCT00078728|4276293|B1|||Age||years|Mean|9.20|9.2|Standard Deviation|1.91|1.91|||
4454305|NCT00078728|4276291|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454306|NCT00078728|4276292|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454307|NCT00078728|4276293|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454308|NCT00078728|4276291|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4454309|NCT00078728|4276292|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4454310|NCT00078728|4276293|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4454311|NCT00078728|4276291|B3||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4454312|NCT00078728|4276292|B2||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4454313|NCT00078728|4276293|B1||<=18 years|Age||Participants|Count of Participants|20|20.0||||||
4454314|NCT00078715|4276302|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4454315|NCT00078715|4276302|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4454316|NCT00078715|4276302|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4454317|NCT00078715|4276302|B1|||Age||years|Mean|43.17|43.17|Standard Deviation|11.85|11.85|||
4454318|NCT00078715|4276302|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454319|NCT00078715|4276302|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4454320|NCT00078715|4276302|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454321|NCT00005947|4276309|B3||Male|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4454322|NCT00005947|4276310|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4454323|NCT00005947|4276311|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4454324|NCT00005947|4276309|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4454325|NCT00005947|4276310|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4454326|NCT00005947|4276311|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4454327|NCT00005947|4276309|B3|||Age, Customized||Years (Min, Max)|Median|73.0|73.0|Full Range|||47.0|86.0|
4454328|NCT00005947|4276310|B2|||Age, Customized||Years (Min, Max)|Median|71.0|71.0|Full Range|||50.0|86.0|
4454329|NCT00005947|4276311|B1|||Age, Customized||Years (Min, Max)|Median|73.0|73.0|Full Range|||47.0|85.0|
4454330|NCT00005947|4276309|B3|||Age||years|Mean|71.7|71.7|Standard Deviation|8.1|8.1|||
4454331|NCT00005947|4276310|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|8.3|8.3|||
4454332|NCT00005947|4276311|B1|||Age||years|Mean|72.1|72.1|Standard Deviation|8.1|8.1|||
4454333|NCT00078559|4276320|B1|Participants without pre-transplant dialysis||Pre-Transplant Dialysis|Whether or not participant received dialysis pre-transplant and if they did, the type they received.|Participants|Number|5|5.0||||||
4454334|NCT00078559|4276320|B1|Dialysis - Unknown Type||Pre-Transplant Dialysis|Whether or not participant received dialysis pre-transplant and if they did, the type they received.|Participants|Number|0|0.0||||||
4454335|NCT00078559|4276320|B1|Peritoneal Dialysis||Pre-Transplant Dialysis|Whether or not participant received dialysis pre-transplant and if they did, the type they received.|Participants|Number|0|0.0||||||
4454336|NCT00078559|4276320|B1|Hemodialysis||Pre-Transplant Dialysis|Whether or not participant received dialysis pre-transplant and if they did, the type they received.|Participants|Number|5|5.0||||||
4454337|NCT00078559|4276320|B1|Hemodialysis and Peritoneal Dialysis||Pre-Transplant Dialysis|Whether or not participant received dialysis pre-transplant and if they did, the type they received.|Participants|Number|0|0.0||||||
4454338|NCT00078559|4276320|B1|Other||Primary Cause of Renal Failure||Participants|Number|0|0.0||||||
4454339|NCT00078559|4276320|B1|Etiology Uncertain||Primary Cause of Renal Failure||Participants|Number|2|2.0||||||
4454340|NCT00078559|4276320|B1|Systemic Lupus Erythematosus||Primary Cause of Renal Failure||Participants|Number|0|0.0||||||
4454341|NCT00078559|4276320|B1|Post-streptococcal Glomerular Nephritis||Primary Cause of Renal Failure||Participants|Number|0|0.0||||||
4454342|NCT00078559|4276320|B1|IgA Nephropathy||Primary Cause of Renal Failure||Participants|Number|2|2.0||||||
4454343|NCT00078559|4276320|B1|Obstructive/Reflux Nephropathy||Primary Cause of Renal Failure||Participants|Number|1|1.0||||||
4454344|NCT00078559|4276320|B1|Diabetes Mellitus||Primary Cause of Renal Failure||Participants|Number|1|1.0||||||
4454345|NCT00078559|4276320|B1|Hypertension||Primary Cause of Renal Failure||Participants|Number|0|0.0||||||
4454346|NCT00078559|4276320|B1|Cystic/Polycystic Kidney Disease||Primary Cause of Renal Failure||Participants|Number|4|4.0||||||
4454347|NCT00078559|4276320|B1|Pyelonephritis/Interstitial Nephritis||Primary Cause of Renal Failure||Participants|Number|0|0.0||||||
4454348|NCT00078559|4276320|B1|Glomerulonephritis||Primary Cause of Renal Failure||Participants|Number|0|0.0||||||
4454349|NCT00078559|4276320|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4454350|NCT00078559|4276320|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4454351|NCT00078559|4276320|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4454352|NCT00078559|4276320|B1|||Age||years|Mean|45.3|45.3|Standard Deviation|10.5|10.5|||
4454353|NCT00078559|4276320|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454354|NCT00078559|4276320|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4454355|NCT00078559|4276320|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454356|NCT00002597|4276346|B3||Male|Sex: Female, Male||Participants|Count of Participants|1979|1979.0||||||
4454357|NCT00002597|4276347|B2||Male|Sex: Female, Male||Participants|Count of Participants|992|992.0||||||
4454358|NCT00002597|4276348|B1||Male|Sex: Female, Male||Participants|Count of Participants|987|987.0||||||
4454359|NCT00002597|4276346|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4454360|NCT00002597|4276347|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4454361|NCT00002597|4276348|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4454362|NCT00002597|4276346|B3|||Age||years|Median|71|71.0|Full Range|||47.0|91.0|
4454363|NCT00002597|4276347|B2|||Age||years|Median|71|71.0|Full Range|||47.0|88.0|
4454364|NCT00002597|4276348|B1|||Age||years|Median|70|70.0|Full Range|||47.0|91.0|
4454365|NCT00078377|4276371|B4|Australia||Region of Enrollment||participants|Number|14|14.0||||||
4454366|NCT00078377|4276372|B3|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4454367|NCT00078377|4276373|B2|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4454368|NCT00078377|4276374|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4454369|NCT00078377|4276371|B4|Russian Federation||Region of Enrollment||participants|Number|13|13.0||||||
4454370|NCT00078377|4276372|B3|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
4454371|NCT00078377|4276373|B2|Russian Federation||Region of Enrollment||participants|Number|4|4.0||||||
4454372|NCT00078377|4276374|B1|Russian Federation||Region of Enrollment||participants|Number|5|5.0||||||
4454373|NCT00078377|4276371|B4|Germany||Region of Enrollment||participants|Number|13|13.0||||||
4454374|NCT00078377|4276372|B3|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4454375|NCT00078377|4276373|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4454376|NCT00078377|4276374|B1|Germany||Region of Enrollment||participants|Number|5|5.0||||||
4454377|NCT00078377|4276371|B4|France||Region of Enrollment||participants|Number|9|9.0||||||
4454378|NCT00078377|4276372|B3|France||Region of Enrollment||participants|Number|3|3.0||||||
4454379|NCT00078377|4276373|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4454380|NCT00078377|4276374|B1|France||Region of Enrollment||participants|Number|3|3.0||||||
4454381|NCT00078377|4276371|B4|Canada||Region of Enrollment||participants|Number|36|36.0||||||
4454382|NCT00078377|4276372|B3|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4454383|NCT00078377|4276373|B2|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4454384|NCT00078377|4276374|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4454385|NCT00078377|4276371|B4|United States||Region of Enrollment||participants|Number|111|111.0||||||
4454386|NCT00078377|4276372|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4454387|NCT00078377|4276373|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4454388|NCT00078377|4276374|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4454389|NCT00078377|4276371|B4|Male||Gender|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|85|85.0||||||
4454390|NCT00078377|4276372|B3|Male||Gender|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|32|32.0||||||
4454391|NCT00078377|4276373|B2|Male||Gender|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|28|28.0||||||
4454392|NCT00078377|4276374|B1|Male||Gender|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|25|25.0||||||
4454393|NCT00078377|4276371|B4|Female||Gender|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|109|109.0||||||
4454394|NCT00078377|4276372|B3|Female||Gender|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|31|31.0||||||
4454395|NCT00078377|4276373|B2|Female||Gender|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|36|36.0||||||
4454396|NCT00078377|4276374|B1|Female||Gender|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|42|42.0||||||
4454397|NCT00078377|4276371|B4|||Age||years|Mean|38.1|38.1|Standard Deviation|12.50|12.5|||
4454398|NCT00078377|4276372|B3|||Age||years|Mean|39.2|39.2|Standard Deviation|11.98|11.98|||
4454399|NCT00078377|4276373|B2|||Age||years|Mean|40.4|40.4|Standard Deviation|12.52|12.52|||
4454400|NCT00078377|4276374|B1|||Age||years|Mean|35.0|35.0|Standard Deviation|12.52|12.52|||
4454401|NCT00078377|4276371|B4|>=65 years||Age|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|1|1.0||||||
4454402|NCT00078377|4276372|B3|>=65 years||Age|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|0|0.0||||||
4454403|NCT00078377|4276373|B2|>=65 years||Age|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|0|0.0||||||
4454404|NCT00078377|4276374|B1|>=65 years||Age|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|1|1.0||||||
4454405|NCT00078377|4276371|B4|Between 18 and 65 years||Age|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|193|193.0||||||
4454406|NCT00078377|4276372|B3|Between 18 and 65 years||Age|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|63|63.0||||||
4454407|NCT00078377|4276373|B2|Between 18 and 65 years||Age|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|64|64.0||||||
4454408|NCT00078377|4276374|B1|Between 18 and 65 years||Age|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|66|66.0||||||
4454409|NCT00078377|4276371|B4|<=18 years||Age|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|0|0.0||||||
4454410|NCT00078377|4276372|B3|<=18 years||Age|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|0|0.0||||||
4454411|NCT00078377|4276373|B2|<=18 years||Age|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|0|0.0||||||
4454412|NCT00078377|4276374|B1|<=18 years||Age|2 female patients withdrew after randomization but prior to receiving study drug (1 withdrew consent and 1 was lost to follow-up)|participants|Number|0|0.0||||||
4454413|NCT00078338|4276389|B3||Male|Sex: Female, Male||Participants|Count of Participants|225|225.0||||||
4454414|NCT00078338|4276390|B2||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4454415|NCT00078338|4276391|B1||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4454416|NCT00078338|4276389|B3||Female|Sex: Female, Male||Participants|Count of Participants|539|539.0||||||
4454417|NCT00078338|4276390|B2||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4454418|NCT00078338|4276391|B1||Female|Sex: Female, Male||Participants|Count of Participants|267|267.0||||||
4454419|NCT00078338|4276389|B3|Greater than 64 years||Age, Customized||Participants|Number|0|0.0||||||
4454420|NCT00078338|4276390|B2|Greater than 64 years||Age, Customized||Participants|Number|0|0.0||||||
4454421|NCT00078338|4276391|B1|Greater than 64 years||Age, Customized||Participants|Number|0|0.0||||||
4454422|NCT00078338|4276389|B3|18 years to 64 years||Age, Customized||Participants|Number|764|764.0||||||
4454423|NCT00078338|4276390|B2|18 years to 64 years||Age, Customized||Participants|Number|378|378.0||||||
4454424|NCT00078338|4276391|B1|18 years to 64 years||Age, Customized||Participants|Number|386|386.0||||||
4454425|NCT00078338|4276389|B3|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
4454426|NCT00078338|4276390|B2|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
4454427|NCT00078338|4276391|B1|Less than 18 years||Age, Customized||Participants|Number|0|0.0||||||
4454428|NCT00076687|4276398|B4||Male|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4454429|NCT00076687|4276399|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4454430|NCT00076687|4276400|B2||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4454431|NCT00076687|4276401|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4454432|NCT00076687|4276398|B4||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4454433|NCT00076687|4276399|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4454434|NCT00076687|4276400|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4454435|NCT00076687|4276401|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4454436|NCT00076687|4276398|B4|||Age||years|Mean|56.4|56.4|Full Range|||18.0|83.0|
4454437|NCT00076687|4276399|B3|||Age||years|Mean|55.8|55.8|Full Range|||19.0|81.0|
4454438|NCT00076687|4276400|B2|||Age||years|Mean|55.5|55.5|Full Range|||21.0|83.0|
4454439|NCT00076687|4276401|B1|||Age||years|Mean|58|58.0|Full Range|||18.0|80.0|
4454440|NCT00078403|4276420|B4|Puerto Rico||Region of Enrollment||participants|Number|6|6.0||||||
4454441|NCT00078403|4276421|B3|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4454442|NCT00078403|4276422|B2|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4454443|NCT00078403|4276423|B1|Puerto Rico||Region of Enrollment||participants|Number|3|3.0||||||
4454444|NCT00078403|4276420|B4|United States||Region of Enrollment||participants|Number|249|249.0||||||
4454445|NCT00078403|4276421|B3|United States||Region of Enrollment||participants|Number|168|168.0||||||
4454446|NCT00078403|4276422|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4454447|NCT00078403|4276423|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4454448|NCT00078403|4276420|B4||Male|Gender||Participants|Count of Participants|212|212.0||||||
4454449|NCT00078403|4276421|B3||Male|Gender||Participants|Count of Participants|150|150.0||||||
4454450|NCT00078403|4276422|B2||Male|Gender||Participants|Count of Participants|30|30.0||||||
4454451|NCT00078403|4276423|B1||Male|Gender||Participants|Count of Participants|32|32.0||||||
4454452|NCT00078403|4276420|B4||Female|Gender||Participants|Count of Participants|43|43.0||||||
4454453|NCT00078403|4276421|B3||Female|Gender||Participants|Count of Participants|19|19.0||||||
4454454|NCT00078403|4276422|B2||Female|Gender||Participants|Count of Participants|12|12.0||||||
4454455|NCT00078403|4276423|B1||Female|Gender||Participants|Count of Participants|12|12.0||||||
4454456|NCT00078403|4276420|B4|||Age||years|Mean|47.6|47.6|Standard Deviation|6.8|6.8|||
4454457|NCT00078403|4276421|B3|||Age||years|Mean|47.2|47.2|Standard Deviation|7.1|7.1|||
4454458|NCT00078403|4276422|B2|||Age||years|Mean|48.1|48.1|Standard Deviation|5.8|5.8|||
4454459|NCT00078403|4276423|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|6.7|6.7|||
4454460|NCT00078403|4276420|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454461|NCT00078403|4276421|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454462|NCT00078403|4276422|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454463|NCT00078403|4276423|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454464|NCT00078403|4276420|B4||Between 18 and 65 years|Age||Participants|Count of Participants|255|255.0||||||
4454465|NCT00078403|4276421|B3||Between 18 and 65 years|Age||Participants|Count of Participants|169|169.0||||||
4454466|NCT00078403|4276422|B2||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4454467|NCT00078403|4276423|B1||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4454468|NCT00078403|4276420|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454469|NCT00078403|4276421|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454470|NCT00078403|4276422|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454471|NCT00078403|4276423|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454472|NCT00078325|4276482|B4|Canada||Region of Enrollment||participants|Number|42|42.0||||||
4454473|NCT00078325|4276483|B3|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4454474|NCT00078325|4276484|B2|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4454475|NCT00078325|4276485|B1|Canada||Region of Enrollment||participants|Number|14|14.0||||||
4454476|NCT00078325|4276482|B4|United States||Region of Enrollment||participants|Number|353|353.0||||||
4454477|NCT00078325|4276483|B3|United States||Region of Enrollment||participants|Number|117|117.0||||||
4454478|NCT00078325|4276484|B2|United States||Region of Enrollment||participants|Number|119|119.0||||||
4454479|NCT00078325|4276485|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
4454480|NCT00078325|4276482|B4||Male|Sex: Female, Male|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|276|276.0||||||
4454481|NCT00078325|4276483|B3||Male|Sex: Female, Male|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|90|90.0||||||
4454482|NCT00078325|4276484|B2||Male|Sex: Female, Male|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|97|97.0||||||
4454483|NCT00078325|4276485|B1||Male|Sex: Female, Male|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|89|89.0||||||
4454484|NCT00078325|4276482|B4||Female|Sex: Female, Male|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|116|116.0||||||
4454485|NCT00078325|4276483|B3||Female|Sex: Female, Male|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|40|40.0||||||
4454486|NCT00078325|4276484|B2||Female|Sex: Female, Male|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|34|34.0||||||
4454487|NCT00078325|4276485|B1||Female|Sex: Female, Male|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|42|42.0||||||
4454488|NCT00078325|4276482|B4|||Age||years|Mean|49.5|49.5|Standard Deviation|9.10|9.1|||
4454489|NCT00078325|4276483|B3|||Age||years|Mean|50.1|50.1|Standard Deviation|9.43|9.43|||
4454490|NCT00078325|4276484|B2|||Age||years|Mean|49.3|49.3|Standard Deviation|9.17|9.17|||
4454491|NCT00078325|4276485|B1|||Age||years|Mean|49.1|49.1|Standard Deviation|8.74|8.74|||
4454492|NCT00078325|4276482|B4||>=65 years|Age|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|2|2.0||||||
4454493|NCT00078325|4276483|B3||>=65 years|Age|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|1|1.0||||||
4454494|NCT00078325|4276484|B2||>=65 years|Age|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|0|0.0||||||
4454495|NCT00078325|4276485|B1||>=65 years|Age|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|1|1.0||||||
4454496|NCT00078325|4276482|B4||Between 18 and 65 years|Age|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|390|390.0||||||
4454497|NCT00078325|4276483|B3||Between 18 and 65 years|Age|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|129|129.0||||||
4454498|NCT00078325|4276484|B2||Between 18 and 65 years|Age|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|131|131.0||||||
4454499|NCT00078325|4276485|B1||Between 18 and 65 years|Age|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|130|130.0||||||
4454500|NCT00078325|4276482|B4||<=18 years|Age|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|0|0.0||||||
4454501|NCT00078325|4276483|B3||<=18 years|Age|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|0|0.0||||||
4454502|NCT00078325|4276484|B2||<=18 years|Age|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|0|0.0||||||
4454503|NCT00078325|4276485|B1||<=18 years|Age|3 female patients withdrew after randomization but prior to receiving study drug (1 had a protocol violation and 2 were lost to follow-up)|Participants|Count of Participants|0|0.0||||||
4454504|NCT00078312|4276498|B1|Russian Federation||Region of Enrollment||participants|Number|61|61.0||||||
4454505|NCT00078312|4276498|B1|United States||Region of Enrollment||participants|Number|267|267.0||||||
4454506|NCT00078312|4276498|B1|Male||Gender|5 male participants withdrew after enrollment but prior to receiving study drug (1 withdrew consent, 3 were lost to follow-up, and 1 was noncompliant)|participants|Number|212|212.0||||||
4454507|NCT00078312|4276498|B1|Female||Gender|5 male participants withdrew after enrollment but prior to receiving study drug (1 withdrew consent, 3 were lost to follow-up, and 1 was noncompliant)|participants|Number|111|111.0||||||
4454508|NCT00078312|4276498|B1|||Age||years|Mean|45.2|45.2|Standard Deviation|11.27|11.27|||
4454509|NCT00078312|4276498|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4454510|NCT00078312|4276498|B1||Between 18 and 65 years|Age||Participants|Count of Participants|326|326.0||||||
4454511|NCT00078312|4276498|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454512|NCT00078286|4276502|B3||Male|Sex: Female, Male||Participants|Count of Participants|279.0|279.0||||||
4454513|NCT00078286|4276503|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4454514|NCT00078286|4276504|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4454515|NCT00078286|4276502|B3||Female|Sex: Female, Male||Participants|Count of Participants|190.0|190.0||||||
4454516|NCT00078286|4276503|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4454517|NCT00078286|4276504|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4454518|NCT00078286|4276502|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|10.8|10.8|||
4454519|NCT00078286|4276503|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|11.1|11.1|||
4454520|NCT00078286|4276504|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|10.5|10.5|||
4454521|NCT00078286|4276502|B3||>=65 years|Age||Participants|Count of Participants|191.0|191.0||||||
4454522|NCT00078286|4276503|B2||>=65 years|Age||Participants|Count of Participants|88|88.0||||||
4454523|NCT00078286|4276504|B1||>=65 years|Age||Participants|Count of Participants|103|103.0||||||
4454524|NCT00078286|4276502|B3||Between 18 and 65 years|Age||Participants|Count of Participants|278.0|278.0||||||
4454525|NCT00078286|4276503|B2||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4454526|NCT00078286|4276504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|131|131.0||||||
4454527|NCT00078286|4276502|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4454528|NCT00078286|4276503|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454529|NCT00078286|4276504|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454530|NCT00077974|4276513|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4454531|NCT00077974|4276513|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4454532|NCT00077974|4276513|B1|>= 65 years||Age, Customized||participants|Number|19|19.0||||||
4454533|NCT00077974|4276513|B1|< 65 years||Age, Customized||participants|Number|87|87.0||||||
4454534|NCT00077857|4276528|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4454535|NCT00077857|4276529|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4454536|NCT00077857|4276530|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4454537|NCT00077857|4276528|B3||Female|Sex: Female, Male||Participants|Count of Participants|470|470.0||||||
4454538|NCT00077857|4276529|B2||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4454539|NCT00077857|4276530|B1||Female|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4454540|NCT00077857|4276528|B3|||Age||years|Mean|50.75|50.75|Full Range|||22.0|75.0|
4454541|NCT00077857|4276529|B2|||Age||years|Mean|50.6|50.6|Full Range|||28.0|75.0|
4454542|NCT00077857|4276530|B1|||Age||years|Mean|50.9|50.9|Full Range|||22.0|75.0|
4454543|NCT00077766|4276549|B3||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4454544|NCT00077766|4276550|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4454545|NCT00077766|4276551|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4454546|NCT00077766|4276549|B3||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4454547|NCT00077766|4276550|B2||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4454548|NCT00077766|4276551|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4454549|NCT00077766|4276549|B3|||Age||Years|Mean|62.2|62.2|Standard Deviation|15.21|15.21|||
4454550|NCT00077766|4276550|B2|||Age||Years|Mean|61.9|61.9|Standard Deviation|14.74|14.74|||
4454551|NCT00077766|4276551|B1|||Age||Years|Mean|62.5|62.5|Standard Deviation|15.72|15.72|||
4454552|NCT00077922|4276570|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4454553|NCT00077922|4276570|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454554|NCT00077922|4276570|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454555|NCT00077922|4276570|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4454556|NCT00077922|4276570|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454557|NCT00077922|4276570|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454558|NCT00077922|4276570|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454559|NCT00077922|4276570|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454560|NCT00077922|4276570|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454561|NCT00077922|4276570|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4454562|NCT00077922|4276570|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454563|NCT00077922|4276570|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4454564|NCT00077922|4276570|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4454565|NCT00077922|4276570|B1|||Age||years|Mean|61.36|61.36|Standard Deviation|7.6|7.6|||
4454566|NCT00077922|4276570|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4454567|NCT00077922|4276570|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4454568|NCT00077922|4276570|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454569|NCT00077675|4276575|B3|Not Diabetic||Diabetes Status||participants|Number|163|163.0||||||
4454570|NCT00077675|4276576|B2|Not Diabetic||Diabetes Status||participants|Number|81|81.0||||||
4454571|NCT00077675|4276577|B1|Not Diabetic||Diabetes Status||participants|Number|82|82.0||||||
4454572|NCT00077675|4276575|B3|Diabetic||Diabetes Status||participants|Number|32|32.0||||||
4454573|NCT00077675|4276576|B2|Diabetic||Diabetes Status||participants|Number|14|14.0||||||
4454574|NCT00077675|4276577|B1|Diabetic||Diabetes Status||participants|Number|18|18.0||||||
4454575|NCT00077675|4276575|B3|South Africa||Region of Enrollment||participants|Number|83|83.0||||||
4454576|NCT00077675|4276576|B2|South Africa||Region of Enrollment||participants|Number|41|41.0||||||
4454577|NCT00077675|4276577|B1|South Africa||Region of Enrollment||participants|Number|42|42.0||||||
4454578|NCT00077675|4276575|B3|United States||Region of Enrollment||participants|Number|112|112.0||||||
4454579|NCT00077675|4276576|B2|United States||Region of Enrollment||participants|Number|54|54.0||||||
4454580|NCT00077675|4276577|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4454581|NCT00077675|4276575|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454582|NCT00077675|4276576|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454583|NCT00077675|4276577|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454584|NCT00077675|4276575|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4454585|NCT00077675|4276576|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4454586|NCT00077675|4276577|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4454587|NCT00077675|4276575|B3||White|Race (NIH/OMB)||Participants|Count of Participants|84|84.0||||||
4454588|NCT00077675|4276576|B2||White|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4454589|NCT00077675|4276577|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4454590|NCT00077675|4276575|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4454591|NCT00077675|4276576|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4454592|NCT00077675|4276577|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4454593|NCT00077675|4276575|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4454594|NCT00077675|4276576|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454595|NCT00077675|4276577|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4454596|NCT00077675|4276575|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4454597|NCT00077675|4276576|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454598|NCT00077675|4276577|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454599|NCT00077675|4276575|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454600|NCT00077675|4276576|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454601|NCT00077675|4276577|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454602|NCT00077675|4276575|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454603|NCT00077675|4276576|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454604|NCT00077675|4276577|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454605|NCT00077675|4276575|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|164|164.0||||||
4454606|NCT00077675|4276576|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4454607|NCT00077675|4276577|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4454608|NCT00077675|4276575|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4454609|NCT00077675|4276576|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4454610|NCT00077675|4276577|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4454611|NCT00077675|4276575|B3||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4454612|NCT00077675|4276576|B2||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4454613|NCT00077675|4276577|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4454614|NCT00077675|4276575|B3||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4454615|NCT00077675|4276576|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4454616|NCT00077675|4276577|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4454617|NCT00077675|4276575|B3|||Age||years|Mean|43.6|43.6|Standard Deviation|12.4|12.4|||
4454618|NCT00077675|4276576|B2|||Age||years|Mean|42.3|42.3|Standard Deviation|10.8|10.8|||
4454619|NCT00077675|4276577|B1|||Age||years|Mean|44.7|44.7|Standard Deviation|13.7|13.7|||
4454620|NCT00077675|4276575|B3||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4454621|NCT00077675|4276576|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4454622|NCT00077675|4276577|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4454623|NCT00077675|4276575|B3||Between 18 and 65 years|Age||Participants|Count of Participants|183|183.0||||||
4454624|NCT00077675|4276576|B2||Between 18 and 65 years|Age||Participants|Count of Participants|91|91.0||||||
4454625|NCT00077675|4276577|B1||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4454626|NCT00077675|4276575|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454627|NCT00077675|4276576|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454628|NCT00077675|4276577|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454629|NCT00077649|4276584|B5||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4454630|NCT00077649|4276585|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4454631|NCT00077649|4276586|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4454632|NCT00077649|4276587|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4454633|NCT00077649|4276588|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4454634|NCT00077649|4276584|B5||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4454635|NCT00077649|4276585|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4454636|NCT00077649|4276586|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4454637|NCT00077649|4276587|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4454638|NCT00077649|4276588|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4454639|NCT00077649|4276584|B5|||Age||years|Mean|48.1|48.1|Standard Deviation|7.33|7.33|||
4454640|NCT00077649|4276585|B4|||Age||years|Mean|48.5|48.5|Standard Deviation|6.78|6.78|||
4454641|NCT00077649|4276586|B3|||Age||years|Mean|47.1|47.1|Standard Deviation|6.37|6.37|||
4454642|NCT00077649|4276587|B2|||Age||years|Mean|49.6|49.6|Standard Deviation|8.46|8.46|||
4454643|NCT00077649|4276588|B1|||Age||years|Mean|47.2|47.2|Standard Deviation|7.48|7.48|||
4454644|NCT00077636|4276637|B3||Male|Sex: Female, Male||Participants|Count of Participants|913|913.0||||||
4454645|NCT00077636|4276638|B2||Male|Sex: Female, Male||Participants|Count of Participants|462|462.0||||||
4454646|NCT00077636|4276639|B1||Male|Sex: Female, Male||Participants|Count of Participants|451|451.0||||||
4454647|NCT00077636|4276637|B3||Female|Sex: Female, Male||Participants|Count of Participants|556|556.0||||||
4454648|NCT00077636|4276638|B2||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4454649|NCT00077636|4276639|B1||Female|Sex: Female, Male||Participants|Count of Participants|285|285.0||||||
4454650|NCT00077636|4276637|B3|||Age||Years|Mean|45.8|45.8|Standard Deviation|9.90|9.9|||
4454651|NCT00077636|4276638|B2|||Age||Years|Mean|45.6|45.6|Standard Deviation|9.98|9.98|||
4454652|NCT00077636|4276639|B1|||Age||Years|Mean|46.1|46.1|Standard Deviation|9.83|9.83|||
4454653|NCT00077623|4276658|B4||Male|Sex: Female, Male||Participants|Count of Participants|335|335.0||||||
4454654|NCT00077623|4276659|B3||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4454655|NCT00077623|4276660|B2||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4454656|NCT00077623|4276661|B1||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4454657|NCT00077623|4276658|B4||Female|Sex: Female, Male||Participants|Count of Participants|236|236.0||||||
4454658|NCT00077623|4276659|B3||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4454659|NCT00077623|4276660|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4454660|NCT00077623|4276661|B1||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4454661|NCT00077623|4276658|B4|||Age||years|Mean|61.1|61.1|Standard Deviation|15.10|15.1|||
4454662|NCT00077623|4276659|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|14.70|14.7|||
4454663|NCT00077623|4276660|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|15.16|15.16|||
4454664|NCT00077623|4276661|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|15.40|15.4|||
4454665|NCT00077610|4276695|B4||Male|Gender||Participants|Count of Participants|390|390.0||||||
4454666|NCT00077610|4276696|B3||Male|Gender||Participants|Count of Participants|133|133.0||||||
4454667|NCT00077610|4276697|B2||Male|Gender||Participants|Count of Participants|125|125.0||||||
4454668|NCT00077610|4276698|B1||Male|Gender||Participants|Count of Participants|132|132.0||||||
4454669|NCT00077610|4276695|B4||Female|Gender||Participants|Count of Participants|276|276.0||||||
4454670|NCT00077610|4276696|B3||Female|Gender||Participants|Count of Participants|92|92.0||||||
4454671|NCT00077610|4276697|B2||Female|Gender||Participants|Count of Participants|95|95.0||||||
4454672|NCT00077610|4276698|B1||Female|Gender||Participants|Count of Participants|89|89.0||||||
4454673|NCT00077610|4276695|B4|||Age||years|Mean|58.9|58.9|Standard Deviation|15.05|15.05|||
4454674|NCT00077610|4276696|B3|||Age||years|Mean|58.5|58.5|Standard Deviation|15.16|15.16|||
4454675|NCT00077610|4276697|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|15.00|15.0|||
4454676|NCT00077610|4276698|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|15.05|15.05|||
4454677|NCT00077376|4276729|B1||Male|Sex: Female, Male|All treated patients|Participants|Count of Participants|0|0.0||||||
4454678|NCT00077376|4276729|B1||Female|Sex: Female, Male|All treated patients|Participants|Count of Participants|59|59.0||||||
4454679|NCT00077376|4276729|B1|||Age|HER2+ patients only|years|Median|54|54.0|Full Range|||24.0|81.0|
4454680|NCT00077376|4276729|B1|||Age|All treated patients|years|Median|51|51.0|Full Range|||24.0|81.0|
4454681|NCT00077207|4276740|B1|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4454682|NCT00077207|4276740|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4454683|NCT00077207|4276740|B1|United States||Region of Enrollment||participants|Number|61|61.0||||||
4454684|NCT00077207|4276740|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4454685|NCT00077207|4276740|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4454686|NCT00077207|4276740|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4454687|NCT00077207|4276740|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4454688|NCT00077207|4276740|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454689|NCT00077207|4276740|B1||White|Race (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4454690|NCT00077207|4276740|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4454691|NCT00077207|4276740|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454692|NCT00077207|4276740|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454693|NCT00077207|4276740|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454694|NCT00077207|4276740|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4454695|NCT00077207|4276740|B1||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4454696|NCT00077207|4276740|B1|||Age||years|Median|4|4.0|Full Range|||0.0|9.0|
4454697|NCT00077064|4276750|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4454698|NCT00077064|4276751|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4454699|NCT00077064|4276752|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4454700|NCT00077064|4276750|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4454701|NCT00077064|4276751|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4454702|NCT00077064|4276752|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4454703|NCT00077064|4276750|B3|||Age||years|Median|65|65.0|Full Range|||42.0|87.0|
4454704|NCT00077064|4276751|B2|||Age||years|Median|64|64.0|Full Range|||46.0|75.0|
4454705|NCT00077064|4276752|B1|||Age||years|Median|67|67.0|Full Range|||42.0|87.0|
4454706|NCT00076999|4276765|B5|No||Antiretroviral Experienced||participants|Number|3|3.0||||||
4454707|NCT00076999|4276766|B4|No||Antiretroviral Experienced||participants|Number|1|1.0||||||
4454708|NCT00076999|4276767|B3|No||Antiretroviral Experienced||participants|Number|0|0.0||||||
4454709|NCT00076999|4276768|B2|No||Antiretroviral Experienced||participants|Number|1|1.0||||||
4454710|NCT00076999|4276769|B1|No||Antiretroviral Experienced||participants|Number|1|1.0||||||
4454711|NCT00076999|4276765|B5|Yes||Antiretroviral Experienced||participants|Number|112|112.0||||||
4454712|NCT00076999|4276766|B4|Yes||Antiretroviral Experienced||participants|Number|28|28.0||||||
4454713|NCT00076999|4276767|B3|Yes||Antiretroviral Experienced||participants|Number|24|24.0||||||
4454714|NCT00076999|4276768|B2|Yes||Antiretroviral Experienced||participants|Number|36|36.0||||||
4454715|NCT00076999|4276769|B1|Yes||Antiretroviral Experienced||participants|Number|24|24.0||||||
4454716|NCT00076999|4276765|B5|Europe||Region of Enrollment||participants|Number|29|29.0||||||
4454717|NCT00076999|4276766|B4|Europe||Region of Enrollment||participants|Number|13|13.0||||||
4454718|NCT00076999|4276767|B3|Europe||Region of Enrollment||participants|Number|7|7.0||||||
4454719|NCT00076999|4276768|B2|Europe||Region of Enrollment||participants|Number|9|9.0||||||
4454720|NCT00076999|4276769|B1|Europe||Region of Enrollment||participants|Number|0|0.0||||||
4454721|NCT00076999|4276765|B5|South America and Mexico||Region of Enrollment||participants|Number|45|45.0||||||
4454722|NCT00076999|4276766|B4|South America and Mexico||Region of Enrollment||participants|Number|5|5.0||||||
4454723|NCT00076999|4276767|B3|South America and Mexico||Region of Enrollment||participants|Number|4|4.0||||||
4454724|NCT00076999|4276768|B2|South America and Mexico||Region of Enrollment||participants|Number|14|14.0||||||
4454725|NCT00076999|4276769|B1|South America and Mexico||Region of Enrollment||participants|Number|22|22.0||||||
4454726|NCT00076999|4276765|B5|North America||Region of Enrollment||participants|Number|41|41.0||||||
4454727|NCT00076999|4276766|B4|North America||Region of Enrollment||participants|Number|11|11.0||||||
4454728|NCT00076999|4276767|B3|North America||Region of Enrollment||participants|Number|13|13.0||||||
4454729|NCT00076999|4276768|B2|North America||Region of Enrollment||participants|Number|14|14.0||||||
4454730|NCT00076999|4276769|B1|North America||Region of Enrollment||participants|Number|3|3.0||||||
4454731|NCT00076999|4276765|B5|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4454732|NCT00076999|4276766|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4454733|NCT00076999|4276767|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4454734|NCT00076999|4276768|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4454735|NCT00076999|4276769|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4454736|NCT00076999|4276765|B5|Black||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4454737|NCT00076999|4276766|B4|Black||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4454738|NCT00076999|4276767|B3|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4454739|NCT00076999|4276768|B2|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4454740|NCT00076999|4276769|B1|Black||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4454741|NCT00076999|4276765|B5|White||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4454742|NCT00076999|4276766|B4|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4454743|NCT00076999|4276767|B3|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4454744|NCT00076999|4276768|B2|White||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4454745|NCT00076999|4276769|B1|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4454746|NCT00076999|4276765|B5|Unknown||Race/Ethnicity, Customized||participants|Number|49|49.0||||||
4454747|NCT00076999|4276766|B4|Unknown||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4454748|NCT00076999|4276767|B3|Unknown||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4454749|NCT00076999|4276768|B2|Unknown||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4454750|NCT00076999|4276769|B1|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4454751|NCT00076999|4276765|B5|Mixed Race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4454752|NCT00076999|4276766|B4|Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4454753|NCT00076999|4276767|B3|Mixed Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4454754|NCT00076999|4276768|B2|Mixed Race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4454755|NCT00076999|4276769|B1|Mixed Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4454756|NCT00076999|4276765|B5|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|61|61.0||||||
4454757|NCT00076999|4276766|B4|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4454758|NCT00076999|4276767|B3|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4454759|NCT00076999|4276768|B2|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4454760|NCT00076999|4276769|B1|Hispanic / Latino||Race/Ethnicity, Customized||participants|Number|22|22.0||||||
4454761|NCT00076999|4276765|B5||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4454762|NCT00076999|4276766|B4||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4454763|NCT00076999|4276767|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4454764|NCT00076999|4276768|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4454765|NCT00076999|4276769|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4454766|NCT00076999|4276765|B5||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4454767|NCT00076999|4276766|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4454768|NCT00076999|4276767|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4454769|NCT00076999|4276768|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4454770|NCT00076999|4276769|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4454771|NCT00076999|4276765|B5|||Age||years|Mean|10.8|10.8|Standard Deviation|4.5|4.5|||
4454772|NCT00076999|4276766|B4|||Age||years|Mean|15.1|15.1|Standard Deviation|1.7|1.7|||
4454773|NCT00076999|4276767|B3|||Age||years|Mean|14.4|14.4|Standard Deviation|1.7|1.7|||
4454774|NCT00076999|4276768|B2|||Age||years|Mean|9.5|9.5|Standard Deviation|1.4|1.4|||
4454775|NCT00076999|4276769|B1|||Age||years|Mean|4.1|4.1|Standard Deviation|1.1|1.1|||
4454776|NCT00003222|4276890|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4454777|NCT00003222|4276891|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4454778|NCT00003222|4276892|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4454779|NCT00003222|4276890|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4454780|NCT00003222|4276891|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4454781|NCT00003222|4276892|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4454782|NCT00003222|4276890|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4454783|NCT00003222|4276891|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4454784|NCT00003222|4276892|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4454785|NCT00003222|4276890|B3|||Age||years|Mean|55|55.0|Standard Deviation|12|12.0|||
4454786|NCT00003222|4276891|B2|||Age||years|Mean|55|55.0|Standard Deviation|11|11.0|||
4454787|NCT00003222|4276892|B1|||Age||years|Mean|57|57.0|Standard Deviation|13|13.0|||
4454788|NCT00003222|4276890|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4454789|NCT00003222|4276891|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4454790|NCT00003222|4276892|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4454791|NCT00003222|4276890|B3||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4454792|NCT00003222|4276891|B2||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4454793|NCT00003222|4276892|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4454794|NCT00003222|4276890|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454795|NCT00003222|4276891|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454796|NCT00003222|4276892|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454797|NCT00076804|4276903|B3|South Africa||Region of Enrollment||participants|Number|274|274.0||||||
4454798|NCT00076804|4276904|B2|South Africa||Region of Enrollment||participants|Number|137|137.0||||||
4454799|NCT00076804|4276905|B1|South Africa||Region of Enrollment||participants|Number|137|137.0||||||
4454800|NCT00076804|4276903|B3||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4454801|NCT00076804|4276904|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4454802|NCT00076804|4276905|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4454803|NCT00076804|4276903|B3||Female|Sex: Female, Male||Participants|Count of Participants|158|158.0||||||
4454804|NCT00076804|4276904|B2||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4454805|NCT00076804|4276905|B1||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4454806|NCT00076804|4276903|B3|||Age||years|Mean|36.2|36.2|Standard Deviation|9.1|9.1|||
4454807|NCT00076804|4276904|B2|||Age||years|Mean|36.7|36.7|Standard Deviation|9.2|9.2|||
4454808|NCT00076804|4276905|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|9.7|9.7|||
4454809|NCT00076804|4276903|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4454810|NCT00076804|4276904|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4454811|NCT00076804|4276905|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4454812|NCT00076804|4276903|B3||Between 18 and 65 years|Age||Participants|Count of Participants|270|270.0||||||
4454813|NCT00076804|4276904|B2||Between 18 and 65 years|Age||Participants|Count of Participants|136|136.0||||||
4454814|NCT00076804|4276905|B1||Between 18 and 65 years|Age||Participants|Count of Participants|134|134.0||||||
4454815|NCT00076804|4276903|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454816|NCT00076804|4276904|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454817|NCT00076804|4276905|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454818|NCT00076752|4276918|B1|United States||Region of Enrollment||participants|Number|9|9.0||||||
4454819|NCT00076752|4276918|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454820|NCT00076752|4276918|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454821|NCT00076752|4276918|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4454822|NCT00076752|4276918|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4454823|NCT00076752|4276918|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454824|NCT00076752|4276918|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454825|NCT00076752|4276918|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454826|NCT00076752|4276918|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454827|NCT00076752|4276918|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4454828|NCT00076752|4276918|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454829|NCT00076752|4276918|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4454830|NCT00076752|4276918|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4454831|NCT00076752|4276918|B1|||Age||years|Mean|25.85|25.85|Standard Deviation|7.67|7.67|||
4454832|NCT00076752|4276918|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4454833|NCT00076752|4276918|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4454834|NCT00076752|4276918|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4454835|NCT00076622|4276937|B5|||Cognitive function (MMSE)|The Mini Mental State Examination (MMSE) measures cognitive function in multiple domains, including memory, orientation, language, and executive function. Scores range from zero (severe cognitive impairment) to thirty (intact cognitive function).|units on a scale|Mean|24.1|24.1|Standard Deviation|4.1|4.1|||
4454836|NCT00076622|4276938|B4|||Cognitive function (MMSE)|The Mini Mental State Examination (MMSE) measures cognitive function in multiple domains, including memory, orientation, language, and executive function. Scores range from zero (severe cognitive impairment) to thirty (intact cognitive function).|units on a scale|Mean|24.3|24.3|Standard Deviation|4.5|4.5|||
4454837|NCT00076622|4276939|B3|||Cognitive function (MMSE)|The Mini Mental State Examination (MMSE) measures cognitive function in multiple domains, including memory, orientation, language, and executive function. Scores range from zero (severe cognitive impairment) to thirty (intact cognitive function).|units on a scale|Mean|24.4|24.4|Standard Deviation|3.7|3.7|||
4454838|NCT00076622|4276940|B2|||Cognitive function (MMSE)|The Mini Mental State Examination (MMSE) measures cognitive function in multiple domains, including memory, orientation, language, and executive function. Scores range from zero (severe cognitive impairment) to thirty (intact cognitive function).|units on a scale|Mean|24.9|24.9|Standard Deviation|4.0|4.0|||
4454839|NCT00076622|4276941|B1|||Cognitive function (MMSE)|The Mini Mental State Examination (MMSE) measures cognitive function in multiple domains, including memory, orientation, language, and executive function. Scores range from zero (severe cognitive impairment) to thirty (intact cognitive function).|units on a scale|Mean|23.1|23.1|Standard Deviation|4.4|4.4|||
4454840|NCT00076622|4276937|B5|||Geriatric Depression Scale|The Geriatric Depression Scale (GDS) measures presence and severity of depressive symptoms in older adults. Scores range from zero (no depression symptoms) to thirty (severe depression symptoms).|units on a scale|Mean|4.3|4.3|Standard Deviation|2.7|2.7|||
4454841|NCT00076622|4276938|B4|||Geriatric Depression Scale|The Geriatric Depression Scale (GDS) measures presence and severity of depressive symptoms in older adults. Scores range from zero (no depression symptoms) to thirty (severe depression symptoms).|units on a scale|Mean|2.6|2.6|Standard Deviation|1.5|1.5|||
4454842|NCT00076622|4276939|B3|||Geriatric Depression Scale|The Geriatric Depression Scale (GDS) measures presence and severity of depressive symptoms in older adults. Scores range from zero (no depression symptoms) to thirty (severe depression symptoms).|units on a scale|Mean|4.5|4.5|Standard Deviation|2.4|2.4|||
4454843|NCT00076622|4276940|B2|||Geriatric Depression Scale|The Geriatric Depression Scale (GDS) measures presence and severity of depressive symptoms in older adults. Scores range from zero (no depression symptoms) to thirty (severe depression symptoms).|units on a scale|Mean|4.6|4.6|Standard Deviation|2.9|2.9|||
4454844|NCT00076622|4276941|B1|||Geriatric Depression Scale|The Geriatric Depression Scale (GDS) measures presence and severity of depressive symptoms in older adults. Scores range from zero (no depression symptoms) to thirty (severe depression symptoms).|units on a scale|Mean|4.3|4.3|Standard Deviation|3.1|3.1|||
4454845|NCT00076622|4276937|B5|United States||Region of Enrollment||Participants|Count of Participants|94|94.0||||||
4454846|NCT00076622|4276938|B4|United States||Region of Enrollment||Participants|Count of Participants|18|18.0||||||
4454847|NCT00076622|4276939|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4454848|NCT00076622|4276940|B2|United States||Region of Enrollment||Participants|Count of Participants|13|13.0||||||
4454849|NCT00076622|4276941|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4454850|NCT00076622|4276937|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454851|NCT00076622|4276938|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454852|NCT00076622|4276939|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454853|NCT00076622|4276940|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454854|NCT00076622|4276941|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454855|NCT00076622|4276937|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454856|NCT00076622|4276938|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454857|NCT00076622|4276939|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454858|NCT00076622|4276940|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454859|NCT00076622|4276941|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454860|NCT00076622|4276937|B5||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4454861|NCT00076622|4276938|B4||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4454862|NCT00076622|4276939|B3||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4454863|NCT00076622|4276940|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4454864|NCT00076622|4276941|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4454865|NCT00076622|4276937|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4454866|NCT00076622|4276938|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454867|NCT00076622|4276939|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4454868|NCT00076622|4276940|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454869|NCT00076622|4276941|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4454870|NCT00076622|4276937|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454871|NCT00076622|4276938|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454872|NCT00076622|4276939|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454873|NCT00076622|4276940|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454874|NCT00076622|4276941|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454875|NCT00076622|4276937|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454876|NCT00076622|4276938|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454877|NCT00076622|4276939|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454878|NCT00076622|4276940|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454879|NCT00076622|4276941|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454880|NCT00076622|4276937|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454881|NCT00076622|4276938|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454882|NCT00076622|4276939|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454883|NCT00076622|4276940|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454884|NCT00076622|4276941|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454885|NCT00076622|4276937|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4454886|NCT00076622|4276938|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4454887|NCT00076622|4276939|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4454888|NCT00076622|4276940|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4454889|NCT00076622|4276941|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4454890|NCT00076622|4276937|B5||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4454891|NCT00076622|4276938|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4454892|NCT00076622|4276939|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4454893|NCT00076622|4276940|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4454894|NCT00076622|4276941|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4454895|NCT00076622|4276937|B5||>=65 years|Age||Participants|Count of Participants|94|94.0||||||
4454896|NCT00076622|4276938|B4||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4454897|NCT00076622|4276939|B3||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4454898|NCT00076622|4276940|B2||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4454899|NCT00076622|4276941|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4454900|NCT00076622|4276937|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4454901|NCT00076622|4276938|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4454902|NCT00076622|4276939|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4454903|NCT00076622|4276940|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4454904|NCT00076622|4276941|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4454905|NCT00076622|4276937|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454906|NCT00076622|4276938|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454907|NCT00076622|4276939|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454908|NCT00076622|4276940|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454909|NCT00076622|4276941|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4454910|NCT00076570|4276962|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4454911|NCT00076570|4276963|B2|United States||Region of Enrollment||participants|Number|8|8.0||||||
4454912|NCT00076570|4276964|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4454913|NCT00076570|4276962|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454914|NCT00076570|4276963|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454915|NCT00076570|4276964|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454916|NCT00076570|4276962|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454917|NCT00076570|4276963|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454918|NCT00076570|4276964|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454919|NCT00076570|4276962|B3||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4454920|NCT00076570|4276963|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4454921|NCT00076570|4276964|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4454922|NCT00076570|4276962|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454923|NCT00076570|4276963|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454924|NCT00076570|4276964|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454925|NCT00076570|4276962|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454926|NCT00076570|4276963|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454927|NCT00076570|4276964|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454928|NCT00076570|4276962|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454929|NCT00076570|4276963|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454930|NCT00076570|4276964|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454931|NCT00076570|4276962|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454932|NCT00076570|4276963|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454933|NCT00076570|4276964|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454934|NCT00076570|4276962|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4454935|NCT00076570|4276963|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4454936|NCT00076570|4276964|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4454937|NCT00076570|4276962|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4454938|NCT00076570|4276963|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4454939|NCT00076570|4276964|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4454940|NCT00076570|4276962|B3|||Age||years|Mean|44.7|44.7|Standard Deviation|13.8|13.8|||
4454941|NCT00076570|4276963|B2|||Age||years|Mean|45.0|45.0|Standard Deviation|15.2|15.2|||
4454942|NCT00076570|4276964|B1|||Age||years|Mean|44.4|44.4|Standard Deviation|13.1|13.1|||
4454943|NCT00003298|4276973|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4454944|NCT00003298|4276973|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4454945|NCT00003298|4276973|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4454946|NCT00003298|4276973|B1|||Age||years|Median|57|57.0|Full Range|||34.0|78.0|
4454947|NCT00076336|4276981|B3||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4454948|NCT00076336|4276982|B2||Male|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4454949|NCT00076336|4276983|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4454950|NCT00076336|4276981|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4454951|NCT00076336|4276982|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4454952|NCT00076336|4276983|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4454953|NCT00076336|4276981|B3|> 50 years||Age, Customized||Participants|Number|132|132.0||||||
4454954|NCT00076336|4276982|B2|> 50 years||Age, Customized||Participants|Number|68|68.0||||||
4454955|NCT00076336|4276983|B1|> 50 years||Age, Customized||Participants|Number|64|64.0||||||
4454956|NCT00076336|4276981|B3|Between 30 and 50 years||Age, Customized||Participants|Number|88|88.0||||||
4454957|NCT00076336|4276982|B2|Between 30 and 50 years||Age, Customized||Participants|Number|44|44.0||||||
4454958|NCT00076336|4276983|B1|Between 30 and 50 years||Age, Customized||Participants|Number|44|44.0||||||
4454959|NCT00076336|4276981|B3|< 30 years||Age, Customized||Participants|Number|8|8.0||||||
4454960|NCT00076336|4276982|B2|< 30 years||Age, Customized||Participants|Number|2|2.0||||||
4454961|NCT00076336|4276983|B1|< 30 years||Age, Customized||Participants|Number|6|6.0||||||
4454962|NCT00076336|4276981|B3|||Age|Baseline measures are based on intention to treat (ITT) population.|years|Mean|50.8|50.8|Standard Deviation|10.48|10.48|||
4454963|NCT00076336|4276982|B2|||Age|Baseline measures are based on intention to treat (ITT) population.|years|Mean|51.9|51.9|Standard Deviation|9.98|9.98|||
4454964|NCT00076336|4276983|B1|||Age|Baseline measures are based on intention to treat (ITT) population.|years|Mean|49.6|49.6|Standard Deviation|10.88|10.88|||
4454965|NCT00076258|4276998|B3|||Hamilton Depression Rating Scale (17 item)|Hamilton Depression rating scale (17 item) is a clinical interview with scores that can range from 0-52. Higher scores indicate higher levels of depression symptoms.|units on a scale|Mean|17.9|17.9|Standard Deviation|3.8|3.8|||
4454966|NCT00076258|4276999|B2|||Hamilton Depression Rating Scale (17 item)|Hamilton Depression rating scale (17 item) is a clinical interview with scores that can range from 0-52. Higher scores indicate higher levels of depression symptoms.|units on a scale|Mean|17.8|17.8|Standard Deviation|3.8|3.8|||
4454967|NCT00076258|4277000|B1|||Hamilton Depression Rating Scale (17 item)|Hamilton Depression rating scale (17 item) is a clinical interview with scores that can range from 0-52. Higher scores indicate higher levels of depression symptoms.|units on a scale|Mean|18.1|18.1|Standard Deviation|3.8|3.8|||
4454968|NCT00076258|4276998|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454969|NCT00076258|4276999|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454970|NCT00076258|4277000|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454971|NCT00076258|4276998|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454972|NCT00076258|4276999|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454973|NCT00076258|4277000|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454974|NCT00076258|4276998|B3||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4454975|NCT00076258|4276999|B2||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4454976|NCT00076258|4277000|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4454977|NCT00076258|4276998|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4454978|NCT00076258|4276999|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4454979|NCT00076258|4277000|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4454980|NCT00076258|4276998|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4454981|NCT00076258|4276999|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454982|NCT00076258|4277000|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454983|NCT00076258|4276998|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454984|NCT00076258|4276999|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454985|NCT00076258|4277000|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454986|NCT00076258|4276998|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454987|NCT00076258|4276999|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454988|NCT00076258|4277000|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454989|NCT00076258|4276998|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454990|NCT00076258|4276999|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454991|NCT00076258|4277000|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454992|NCT00076258|4276998|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|121|121.0||||||
4454993|NCT00076258|4276999|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4454994|NCT00076258|4277000|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4454995|NCT00076258|4276998|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454996|NCT00076258|4276999|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4454997|NCT00076258|4277000|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4454998|NCT00076258|4276998|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4454999|NCT00076258|4276999|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4455000|NCT00076258|4277000|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4455001|NCT00076258|4276998|B3||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4455002|NCT00076258|4276999|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4455003|NCT00076258|4277000|B1||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4455004|NCT00076258|4276998|B3|||Age||years|Mean|47.05|47.05|Standard Deviation|9.9|9.9|||
4455005|NCT00076258|4276999|B2|||Age||years|Mean|45.6|45.6|Standard Deviation|10.4|10.4|||
4455006|NCT00076258|4277000|B1|||Age||years|Mean|48.5|48.5|Standard Deviation|9.4|9.4|||
4455007|NCT00076245|4277007|B5|United States||Region of Enrollment||participants|Number|61|61.0||||||
4455008|NCT00076245|4277008|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4455009|NCT00076245|4277009|B3|United States||Region of Enrollment||participants|Number|15|15.0||||||
4455010|NCT00076245|4277010|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4455011|NCT00076245|4277011|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4455012|NCT00076245|4277007|B5|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4455013|NCT00076245|4277008|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4455014|NCT00076245|4277009|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4455015|NCT00076245|4277010|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4455016|NCT00076245|4277011|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4455017|NCT00076245|4277007|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4455018|NCT00076245|4277008|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4455019|NCT00076245|4277009|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4455020|NCT00076245|4277010|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4455021|NCT00076245|4277011|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4455022|NCT00076245|4277007|B5|African American||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4455023|NCT00076245|4277008|B4|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4455024|NCT00076245|4277009|B3|African American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4455025|NCT00076245|4277010|B2|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4455026|NCT00076245|4277011|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4455027|NCT00076245|4277007|B5|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4455028|NCT00076245|4277008|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4455029|NCT00076245|4277009|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4455030|NCT00076245|4277010|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4455031|NCT00076245|4277011|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4455032|NCT00076245|4277007|B5|White||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4455033|NCT00076245|4277008|B4|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4455034|NCT00076245|4277009|B3|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4455035|NCT00076245|4277010|B2|White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4455036|NCT00076245|4277011|B1|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4455037|NCT00076245|4277007|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4455038|NCT00076245|4277008|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4455039|NCT00076245|4277009|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4455040|NCT00076245|4277010|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455041|NCT00076245|4277011|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4455042|NCT00076245|4277007|B5||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4455043|NCT00076245|4277008|B4||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4455044|NCT00076245|4277009|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4455045|NCT00076245|4277010|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4455046|NCT00076245|4277011|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4455047|NCT00076245|4277007|B5|||Age||years|Mean|45.0|45.0|Standard Deviation|5.8|5.8|||
4455048|NCT00076245|4277008|B4|||Age||years|Mean|43.3|43.3|Standard Deviation|7.7|7.7|||
4455049|NCT00076245|4277009|B3|||Age||years|Mean|43.0|43.0|Standard Deviation|12.8|12.8|||
4455050|NCT00076245|4277010|B2|||Age||years|Mean|45.9|45.9|Standard Deviation|15.5|15.5|||
4455051|NCT00076245|4277011|B1|||Age||years|Mean|47.6|47.6|Standard Deviation|9.7|9.7|||
4455052|NCT00076219|4277028|B3|Male||Gender|One subject has missing gender.|participants|Number|793|793.0||||||
4455053|NCT00076219|4277029|B2|Male||Gender|One subject has missing gender.|participants|Number|384|384.0||||||
4455054|NCT00076219|4277030|B1|Male||Gender|One subject has missing gender.|participants|Number|409|409.0||||||
4455055|NCT00076219|4277028|B3|Female||Gender|One subject has missing gender.|participants|Number|330|330.0||||||
4455056|NCT00076219|4277029|B2|Female||Gender|One subject has missing gender.|participants|Number|176|176.0||||||
4455057|NCT00076219|4277030|B1|Female||Gender|One subject has missing gender.|participants|Number|154|154.0||||||
4455058|NCT00076219|4277028|B3|||Age||years|Mean|59.7|59.7|Standard Deviation|15.3|15.3|||
4455059|NCT00076219|4277029|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|15.2|15.2|||
4455060|NCT00076219|4277030|B1|||Age||years|Mean|59.6|59.6|Standard Deviation|15.3|15.3|||
4455061|NCT00076219|4277028|B3||>=65 years|Age||Participants|Count of Participants|448|448.0||||||
4455062|NCT00076219|4277029|B2||>=65 years|Age||Participants|Count of Participants|226|226.0||||||
4455063|NCT00076219|4277030|B1||>=65 years|Age||Participants|Count of Participants|222|222.0||||||
4455064|NCT00076219|4277028|B3||Between 18 and 65 years|Age||Participants|Count of Participants|676|676.0||||||
4455065|NCT00076219|4277029|B2||Between 18 and 65 years|Age||Participants|Count of Participants|335|335.0||||||
4455066|NCT00076219|4277030|B1||Between 18 and 65 years|Age||Participants|Count of Participants|341|341.0||||||
4455067|NCT00076219|4277028|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4455068|NCT00076219|4277029|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4455069|NCT00076219|4277030|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4455070|NCT00076102|4277037|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4455071|NCT00076102|4277037|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4455072|NCT00076102|4277037|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455073|NCT00076102|4277037|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4455074|NCT00076102|4277037|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4455075|NCT00076102|4277037|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455076|NCT00076102|4277037|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455077|NCT00076102|4277037|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455078|NCT00076102|4277037|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455079|NCT00076102|4277037|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4455080|NCT00076102|4277037|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4455081|NCT00076102|4277037|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4455082|NCT00076102|4277037|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4455083|NCT00076102|4277037|B1|||Age||years|Mean|9.81|9.81|Standard Deviation|4.52|4.52|||
4455084|NCT00076102|4277037|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455085|NCT00076102|4277037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4455086|NCT00076102|4277037|B1||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4455087|NCT00076050|4277049|B3|United States||Region of Enrollment||participants|Number|248|248.0||||||
4455088|NCT00076050|4277050|B2|United States||Region of Enrollment||participants|Number|126|126.0||||||
4455089|NCT00076050|4277051|B1|United States||Region of Enrollment||participants|Number|122|122.0||||||
4455090|NCT00076050|4277049|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455091|NCT00076050|4277050|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455092|NCT00076050|4277051|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455093|NCT00076050|4277049|B3||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4455094|NCT00076050|4277050|B2||Female|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4455095|NCT00076050|4277051|B1||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4455096|NCT00076050|4277049|B3|||Age||years|Mean|52.5|52.5|Standard Deviation|3.3|3.3|||
4455097|NCT00076050|4277050|B2|||Age||years|Mean|52|52.0|Standard Deviation|3.3|3.3|||
4455098|NCT00076050|4277051|B1|||Age||years|Mean|53|53.0|Standard Deviation|3.3|3.3|||
4455099|NCT00076050|4277049|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455100|NCT00076050|4277050|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455101|NCT00076050|4277051|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455102|NCT00076050|4277049|B3||Between 18 and 65 years|Age||Participants|Count of Participants|248|248.0||||||
4455103|NCT00076050|4277050|B2||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4455104|NCT00076050|4277051|B1||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4455105|NCT00076050|4277049|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4455106|NCT00076050|4277050|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4455107|NCT00076050|4277051|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4455108|NCT00076024|4277062|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455109|NCT00076024|4277063|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455110|NCT00076024|4277064|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455111|NCT00076024|4277065|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455112|NCT00076024|4277062|B4||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4455113|NCT00076024|4277063|B3||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4455114|NCT00076024|4277064|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4455115|NCT00076024|4277065|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4455116|NCT00076024|4277062|B4|||Age||Years|Mean|54.2|54.2|Standard Deviation|10.3|10.3|||
4455117|NCT00076024|4277063|B3|||Age||Years|Mean|54.70|54.7|Standard Deviation|10.12|10.12|||
4455118|NCT00076024|4277064|B2|||Age||Years|Mean|54.10|54.1|Standard Deviation|10.43|10.43|||
4455119|NCT00076024|4277065|B1|||Age||Years|Mean|50.80|50.8|Standard Deviation|9.68|9.68|||
4455120|NCT00076011|4277082|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4455121|NCT00076011|4277082|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4455122|NCT00076011|4277082|B1|||Age||Years|Mean|58.8|58.8|Standard Deviation|11.25|11.25|||
4455123|NCT00075946|4277090|B5||Male|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4455124|NCT00075946|4277091|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4455125|NCT00075946|4277092|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4455126|NCT00075946|4277093|B2||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4455127|NCT00075946|4277094|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4455128|NCT00075946|4277090|B5||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4455129|NCT00075946|4277091|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4455130|NCT00075946|4277092|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4455131|NCT00075946|4277093|B2||Female|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4455132|NCT00075946|4277094|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4455133|NCT00075946|4277090|B5|||Age||years|Median|60|60.0|Full Range|||25.0|86.0|
4455134|NCT00075946|4277091|B4|||Age||years|Median|65|65.0|Full Range|||38.0|85.0|
4455135|NCT00075946|4277092|B3|||Age||years|Median|61|61.0|Full Range|||47.0|86.0|
4455136|NCT00075946|4277093|B2|||Age||years|Median|58|58.0|Full Range|||25.0|86.0|
4455137|NCT00075946|4277094|B1|||Age||years|Median|59|59.0|Full Range|||25.0|86.0|
4455138|NCT00075881|4277113|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4455139|NCT00075881|4277113|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4455140|NCT00075881|4277113|B1|||Age||years|Median|63|63.0|Full Range|||44.0|81.0|
4455141|NCT00075829|4277120|B5|Unknown||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|11|11.0||||||
4455142|NCT00075829|4277121|B4|Unknown||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|0|0.0||||||
4455143|NCT00075829|4277122|B3|Unknown||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|0|0.0||||||
4455144|NCT00075829|4277123|B2|Unknown||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|0|0.0||||||
4455145|NCT00075829|4277124|B1|Unknown||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|11|11.0||||||
4455146|NCT00075829|4277120|B5|Not Evaluable||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|54|54.0||||||
4455147|NCT00075829|4277121|B4|Not Evaluable||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|4|4.0||||||
4455223|NCT00075829|4277122|B3|African American||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4455148|NCT00075829|4277122|B3|Not Evaluable||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|8|8.0||||||
4455149|NCT00075829|4277123|B2|Not Evaluable||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|12|12.0||||||
4455150|NCT00075829|4277124|B1|Not Evaluable||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|30|30.0||||||
4455151|NCT00075829|4277120|B5|SD||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|37|37.0||||||
4455152|NCT00075829|4277121|B4|SD||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|4|4.0||||||
4455153|NCT00075829|4277122|B3|SD||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|6|6.0||||||
4455154|NCT00075829|4277123|B2|SD||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|6|6.0||||||
4455155|NCT00075829|4277124|B1|SD||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|21|21.0||||||
4455156|NCT00075829|4277120|B5|MR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|61|61.0||||||
4455157|NCT00075829|4277121|B4|MR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|3|3.0||||||
4455158|NCT00075829|4277122|B3|MR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|10|10.0||||||
4455159|NCT00075829|4277123|B2|MR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|17|17.0||||||
4455160|NCT00075829|4277124|B1|MR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|31|31.0||||||
4455161|NCT00075829|4277120|B5|PR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|269|269.0||||||
4455162|NCT00075829|4277121|B4|PR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|14|14.0||||||
4455163|NCT00075829|4277122|B3|PR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|21|21.0||||||
4455164|NCT00075829|4277123|B2|PR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|76|76.0||||||
4455165|NCT00075829|4277124|B1|PR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|158|158.0||||||
4455166|NCT00075829|4277120|B5|Very Good PR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|119|119.0||||||
4455167|NCT00075829|4277121|B4|Very Good PR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|7|7.0||||||
4455168|NCT00075829|4277122|B3|Very Good PR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|1|1.0||||||
4455169|NCT00075829|4277123|B2|Very Good PR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|32|32.0||||||
4455170|NCT00075829|4277124|B1|Very Good PR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|79|79.0||||||
4455171|NCT00075829|4277120|B5|Near CR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|90|90.0||||||
4455172|NCT00075829|4277121|B4|Near CR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|2|2.0||||||
4455173|NCT00075829|4277122|B3|Near CR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|1|1.0||||||
4455174|NCT00075829|4277123|B2|Near CR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|22|22.0||||||
4455175|NCT00075829|4277124|B1|Near CR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|65|65.0||||||
4455176|NCT00075829|4277120|B5|CR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|69|69.0||||||
4455177|NCT00075829|4277121|B4|CR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|3|3.0||||||
4455178|NCT00075829|4277122|B3|CR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|1|1.0||||||
4455179|NCT00075829|4277123|B2|CR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|24|24.0||||||
4455180|NCT00075829|4277124|B1|CR||Disease status|Disease status at time of first autologous transplantation represents the results from initial multiple myeloma therapy received prior to trial enrollment: Complete Response (CR), Partial Response (PR), Minimal Response (MR), Stable Disease (SD)|participants|Number|41|41.0||||||
4455181|NCT00075829|4277120|B5|||Interval from diagnosis to transplantation||months|Median|7|7.0|Full Range|||3.0|55.0|
4455182|NCT00075829|4277121|B4|||Interval from diagnosis to transplantation||months|Median|7|7.0|Full Range|||3.0|38.0|
4455183|NCT00075829|4277122|B3|||Interval from diagnosis to transplantation||months|Median|7|7.0|Full Range|||5.0|22.0|
4455184|NCT00075829|4277123|B2|||Interval from diagnosis to transplantation||months|Median|7|7.0|Full Range|||4.0|35.0|
4455185|NCT00075829|4277124|B1|||Interval from diagnosis to transplantation||months|Median|7|7.0|Full Range|||3.0|55.0|
4455186|NCT00075829|4277120|B5|Stage III||Durie-Salmon|The Durie and Salmon classification uses three multiple myeloma stages. Stage I has all of the following: Hemoglobin greater than 10 g/dL, Serum calcium less than 12 mg/dL, Normal bone structure or solitary plasmacytoma on radiographs, and Low M component. Stage II does not fit either Stage I or Stage III. Stage III has one or more of the following: Hemoglobin less than 8.5 g/dL, Serum calcium greater than 12 mg/dL, Advanced lytic bone lesions, and/or Hyper M component.|participants|Number|490|490.0||||||
4455187|NCT00075829|4277121|B4|Stage III||Durie-Salmon|The Durie and Salmon classification uses three multiple myeloma stages. Stage I has all of the following: Hemoglobin greater than 10 g/dL, Serum calcium less than 12 mg/dL, Normal bone structure or solitary plasmacytoma on radiographs, and Low M component. Stage II does not fit either Stage I or Stage III. Stage III has one or more of the following: Hemoglobin less than 8.5 g/dL, Serum calcium greater than 12 mg/dL, Advanced lytic bone lesions, and/or Hyper M component.|participants|Number|28|28.0||||||
4455188|NCT00075829|4277122|B3|Stage III||Durie-Salmon|The Durie and Salmon classification uses three multiple myeloma stages. Stage I has all of the following: Hemoglobin greater than 10 g/dL, Serum calcium less than 12 mg/dL, Normal bone structure or solitary plasmacytoma on radiographs, and Low M component. Stage II does not fit either Stage I or Stage III. Stage III has one or more of the following: Hemoglobin less than 8.5 g/dL, Serum calcium greater than 12 mg/dL, Advanced lytic bone lesions, and/or Hyper M component.|participants|Number|38|38.0||||||
4455189|NCT00075829|4277123|B2|Stage III||Durie-Salmon|The Durie and Salmon classification uses three multiple myeloma stages. Stage I has all of the following: Hemoglobin greater than 10 g/dL, Serum calcium less than 12 mg/dL, Normal bone structure or solitary plasmacytoma on radiographs, and Low M component. Stage II does not fit either Stage I or Stage III. Stage III has one or more of the following: Hemoglobin less than 8.5 g/dL, Serum calcium greater than 12 mg/dL, Advanced lytic bone lesions, and/or Hyper M component.|participants|Number|130|130.0||||||
4455190|NCT00075829|4277124|B1|Stage III||Durie-Salmon|The Durie and Salmon classification uses three multiple myeloma stages. Stage I has all of the following: Hemoglobin greater than 10 g/dL, Serum calcium less than 12 mg/dL, Normal bone structure or solitary plasmacytoma on radiographs, and Low M component. Stage II does not fit either Stage I or Stage III. Stage III has one or more of the following: Hemoglobin less than 8.5 g/dL, Serum calcium greater than 12 mg/dL, Advanced lytic bone lesions, and/or Hyper M component.|participants|Number|294|294.0||||||
4455224|NCT00075829|4277123|B2|African American||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4455225|NCT00075829|4277124|B1|African American||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4455226|NCT00075829|4277120|B5||Male|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
4455191|NCT00075829|4277120|B5|Stages I-II||Durie-Salmon|The Durie and Salmon classification uses three multiple myeloma stages. Stage I has all of the following: Hemoglobin greater than 10 g/dL, Serum calcium less than 12 mg/dL, Normal bone structure or solitary plasmacytoma on radiographs, and Low M component. Stage II does not fit either Stage I or Stage III. Stage III has one or more of the following: Hemoglobin less than 8.5 g/dL, Serum calcium greater than 12 mg/dL, Advanced lytic bone lesions, and/or Hyper M component.|participants|Number|220|220.0||||||
4455192|NCT00075829|4277121|B4|Stages I-II||Durie-Salmon|The Durie and Salmon classification uses three multiple myeloma stages. Stage I has all of the following: Hemoglobin greater than 10 g/dL, Serum calcium less than 12 mg/dL, Normal bone structure or solitary plasmacytoma on radiographs, and Low M component. Stage II does not fit either Stage I or Stage III. Stage III has one or more of the following: Hemoglobin less than 8.5 g/dL, Serum calcium greater than 12 mg/dL, Advanced lytic bone lesions, and/or Hyper M component.|participants|Number|9|9.0||||||
4455193|NCT00075829|4277122|B3|Stages I-II||Durie-Salmon|The Durie and Salmon classification uses three multiple myeloma stages. Stage I has all of the following: Hemoglobin greater than 10 g/dL, Serum calcium less than 12 mg/dL, Normal bone structure or solitary plasmacytoma on radiographs, and Low M component. Stage II does not fit either Stage I or Stage III. Stage III has one or more of the following: Hemoglobin less than 8.5 g/dL, Serum calcium greater than 12 mg/dL, Advanced lytic bone lesions, and/or Hyper M component.|participants|Number|10|10.0||||||
4455194|NCT00075829|4277123|B2|Stages I-II||Durie-Salmon|The Durie and Salmon classification uses three multiple myeloma stages. Stage I has all of the following: Hemoglobin greater than 10 g/dL, Serum calcium less than 12 mg/dL, Normal bone structure or solitary plasmacytoma on radiographs, and Low M component. Stage II does not fit either Stage I or Stage III. Stage III has one or more of the following: Hemoglobin less than 8.5 g/dL, Serum calcium greater than 12 mg/dL, Advanced lytic bone lesions, and/or Hyper M component.|participants|Number|59|59.0||||||
4455195|NCT00075829|4277124|B1|Stages I-II||Durie-Salmon|The Durie and Salmon classification uses three multiple myeloma stages. Stage I has all of the following: Hemoglobin greater than 10 g/dL, Serum calcium less than 12 mg/dL, Normal bone structure or solitary plasmacytoma on radiographs, and Low M component. Stage II does not fit either Stage I or Stage III. Stage III has one or more of the following: Hemoglobin less than 8.5 g/dL, Serum calcium greater than 12 mg/dL, Advanced lytic bone lesions, and/or Hyper M component.|participants|Number|142|142.0||||||
4455196|NCT00075829|4277120|B5|||β-2 Microglobulin||mg/L|Median|3.025|3.025|Full Range|||0.004|9.8|
4455197|NCT00075829|4277121|B4|||β-2 Microglobulin||mg/L|Median|3.7|3.7|Full Range|||1.2|6.6|
4455198|NCT00075829|4277122|B3|||β-2 Microglobulin||mg/L|Median|4.4|4.4|Full Range|||0.9|9.8|
4455199|NCT00075829|4277123|B2|||β-2 Microglobulin||mg/L|Median|2.0|2.0|Full Range|||0.9|4.0|
4455200|NCT00075829|4277124|B1|||β-2 Microglobulin||mg/L|Median|2.0|2.0|Full Range|||0.004|4.0|
4455201|NCT00075829|4277120|B5|< 90||Karnofsky Performance score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|165|165.0||||||
4455202|NCT00075829|4277121|B4|< 90||Karnofsky Performance score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|11|11.0||||||
4455203|NCT00075829|4277122|B3|< 90||Karnofsky Performance score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|21|21.0||||||
4455204|NCT00075829|4277123|B2|< 90||Karnofsky Performance score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|41|41.0||||||
4455205|NCT00075829|4277124|B1|< 90||Karnofsky Performance score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|92|92.0||||||
4455206|NCT00075829|4277120|B5|100 - 90||Karnofsky Performance score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|545|545.0||||||
4455207|NCT00075829|4277121|B4|100 - 90||Karnofsky Performance score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|26|26.0||||||
4455208|NCT00075829|4277122|B3|100 - 90||Karnofsky Performance score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|27|27.0||||||
4455209|NCT00075829|4277123|B2|100 - 90||Karnofsky Performance score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|148|148.0||||||
4455210|NCT00075829|4277124|B1|100 - 90||Karnofsky Performance score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|344|344.0||||||
4455211|NCT00075829|4277120|B5|Other||Race/Ethnicity, Customized||participants|Number|37|37.0||||||
4455212|NCT00075829|4277121|B4|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4455213|NCT00075829|4277122|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4455214|NCT00075829|4277123|B2|Other||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4455215|NCT00075829|4277124|B1|Other||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4455216|NCT00075829|4277120|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|567|567.0||||||
4455217|NCT00075829|4277121|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4455218|NCT00075829|4277122|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4455219|NCT00075829|4277123|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|161|161.0||||||
4455220|NCT00075829|4277124|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|335|335.0||||||
4455221|NCT00075829|4277120|B5|African American||Race/Ethnicity, Customized||participants|Number|106|106.0||||||
4455222|NCT00075829|4277121|B4|African American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4455227|NCT00075829|4277121|B4||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4455228|NCT00075829|4277122|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4455229|NCT00075829|4277123|B2||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4455230|NCT00075829|4277124|B1||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4455231|NCT00075829|4277120|B5||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4455232|NCT00075829|4277121|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4455233|NCT00075829|4277122|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4455234|NCT00075829|4277123|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4455235|NCT00075829|4277124|B1||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4455236|NCT00075829|4277120|B5|||Age||years|Median|53.2|53.2|Inter-Quartile Range|||22.0|68.0|
4455237|NCT00075829|4277121|B4|||Age||years|Median|51|51.0|Inter-Quartile Range|||32.0|66.0|
4455238|NCT00075829|4277122|B3|||Age||years|Median|57|57.0|Inter-Quartile Range|||32.0|70.0|
4455239|NCT00075829|4277123|B2|||Age||years|Median|53|53.0|Inter-Quartile Range|||29.0|68.0|
4455240|NCT00075829|4277124|B1|||Age||years|Median|55|55.0|Inter-Quartile Range|||22.0|70.0|
4455241|NCT00075816|4277155|B3|||CD34+ cell dose per kilogram (x10^-6)|Data on CD34+ cell dose were missing for 121 patients in the bone marrow group and 25 in the peripheral-blood group.|cell dose per kilogram (x10^-6)|Median|5.23|5.23|Inter-Quartile Range|||1.94|11.28|
4455242|NCT00075816|4277156|B2|||CD34+ cell dose per kilogram (x10^-6)|Data on CD34+ cell dose were missing for 121 patients in the bone marrow group and 25 in the peripheral-blood group.|cell dose per kilogram (x10^-6)|Median|7.70|7.7|Inter-Quartile Range|||5.43|11.28|
4455243|NCT00075816|4277157|B1|||CD34+ cell dose per kilogram (x10^-6)|Data on CD34+ cell dose were missing for 121 patients in the bone marrow group and 25 in the peripheral-blood group.|cell dose per kilogram (x10^-6)|Median|2.75|2.75|Inter-Quartile Range|||1.94|4.53|
4455244|NCT00075816|4277155|B3|Missing||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|25|25.0||||||
4455245|NCT00075816|4277156|B2|Missing||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|11|11.0||||||
4455246|NCT00075816|4277157|B1|Missing||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|14|14.0||||||
4455247|NCT00075816|4277155|B3|3||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|2|2.0||||||
4455248|NCT00075816|4277156|B2|3||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|0|0.0||||||
4455249|NCT00075816|4277157|B1|3||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|2|2.0||||||
4455250|NCT00075816|4277155|B3|2||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|10|10.0||||||
4455251|NCT00075816|4277156|B2|2||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|3|3.0||||||
4455252|NCT00075816|4277157|B1|2||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|7|7.0||||||
4455253|NCT00075816|4277155|B3|1||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|105|105.0||||||
4455254|NCT00075816|4277156|B2|1||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|50|50.0||||||
4455255|NCT00075816|4277157|B1|1||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|55|55.0||||||
4455256|NCT00075816|4277155|B3|0||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|409|409.0||||||
4455257|NCT00075816|4277156|B2|0||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|209|209.0||||||
4455258|NCT00075816|4277157|B1|0||Number of donor mismatches at HLA-A, B, C, and DRB1|Data on donor HLA mismatch were not collected for patients who did not undergo transplantation.|participants|Number|200|200.0||||||
4455259|NCT00075816|4277155|B3|Unknown||Antithymocyte globulin treatment|Data on antithymocyte globulin treatment was not collected for patients who did not undergo transplantation. Data were also missing for several patients who did undergo transplantation.|participants|Number|38|38.0||||||
4455260|NCT00075816|4277156|B2|Unknown||Antithymocyte globulin treatment|Data on antithymocyte globulin treatment was not collected for patients who did not undergo transplantation. Data were also missing for several patients who did undergo transplantation.|participants|Number|18|18.0||||||
4455261|NCT00075816|4277157|B1|Unknown||Antithymocyte globulin treatment|Data on antithymocyte globulin treatment was not collected for patients who did not undergo transplantation. Data were also missing for several patients who did undergo transplantation.|participants|Number|20|20.0||||||
4455262|NCT00075816|4277155|B3|No Antithymocyte globulin treatment||Antithymocyte globulin treatment|Data on antithymocyte globulin treatment was not collected for patients who did not undergo transplantation. Data were also missing for several patients who did undergo transplantation.|participants|Number|376|376.0||||||
4455263|NCT00075816|4277156|B2|No Antithymocyte globulin treatment||Antithymocyte globulin treatment|Data on antithymocyte globulin treatment was not collected for patients who did not undergo transplantation. Data were also missing for several patients who did undergo transplantation.|participants|Number|183|183.0||||||
4455264|NCT00075816|4277157|B1|No Antithymocyte globulin treatment||Antithymocyte globulin treatment|Data on antithymocyte globulin treatment was not collected for patients who did not undergo transplantation. Data were also missing for several patients who did undergo transplantation.|participants|Number|193|193.0||||||
4455265|NCT00075816|4277155|B3|Antithymocyte globulin treatment||Antithymocyte globulin treatment|Data on antithymocyte globulin treatment was not collected for patients who did not undergo transplantation. Data were also missing for several patients who did undergo transplantation.|participants|Number|137|137.0||||||
4455266|NCT00075816|4277156|B2|Antithymocyte globulin treatment||Antithymocyte globulin treatment|Data on antithymocyte globulin treatment was not collected for patients who did not undergo transplantation. Data were also missing for several patients who did undergo transplantation.|participants|Number|72|72.0||||||
4455267|NCT00075816|4277157|B1|Antithymocyte globulin treatment||Antithymocyte globulin treatment|Data on antithymocyte globulin treatment was not collected for patients who did not undergo transplantation. Data were also missing for several patients who did undergo transplantation.|participants|Number|65|65.0||||||
4455268|NCT00075816|4277155|B3|Did not undergo transplantation||Transplantation patients||participants|Number|25|25.0||||||
4455269|NCT00075816|4277156|B2|Did not undergo transplantation||Transplantation patients||participants|Number|11|11.0||||||
4455270|NCT00075816|4277157|B1|Did not undergo transplantation||Transplantation patients||participants|Number|14|14.0||||||
4455271|NCT00075816|4277155|B3|Underwent transplantation||Transplantation patients||participants|Number|526|526.0||||||
4455272|NCT00075816|4277156|B2|Underwent transplantation||Transplantation patients||participants|Number|262|262.0||||||
4455273|NCT00075816|4277157|B1|Underwent transplantation||Transplantation patients||participants|Number|264|264.0||||||
4455274|NCT00075816|4277155|B3|Other||GVHD prophylaxis||participants|Number|46|46.0||||||
4455275|NCT00075816|4277156|B2|Other||GVHD prophylaxis||participants|Number|18|18.0||||||
4455276|NCT00075816|4277157|B1|Other||GVHD prophylaxis||participants|Number|28|28.0||||||
4455277|NCT00075816|4277155|B3|Tacrolimus and methotrexate||GVHD prophylaxis||participants|Number|379|379.0||||||
4455278|NCT00075816|4277156|B2|Tacrolimus and methotrexate||GVHD prophylaxis||participants|Number|196|196.0||||||
4455279|NCT00075816|4277157|B1|Tacrolimus and methotrexate||GVHD prophylaxis||participants|Number|183|183.0||||||
4455280|NCT00075816|4277155|B3|Cyclosporine and methotrexate||GVHD prophylaxis||participants|Number|126|126.0||||||
4455281|NCT00075816|4277156|B2|Cyclosporine and methotrexate||GVHD prophylaxis||participants|Number|59|59.0||||||
4455282|NCT00075816|4277157|B1|Cyclosporine and methotrexate||GVHD prophylaxis||participants|Number|67|67.0||||||
4455283|NCT00075816|4277155|B3|Fludarabine and melphalan||Conditioning regimen||participants|Number|41|41.0||||||
4455284|NCT00075816|4277156|B2|Fludarabine and melphalan||Conditioning regimen||participants|Number|25|25.0||||||
4455285|NCT00075816|4277157|B1|Fludarabine and melphalan||Conditioning regimen||participants|Number|16|16.0||||||
4455286|NCT00075816|4277155|B3|Fludarabine, busulfan, and antithymocyte globulin||Conditioning regimen||participants|Number|79|79.0||||||
4455287|NCT00075816|4277156|B2|Fludarabine, busulfan, and antithymocyte globulin||Conditioning regimen||participants|Number|40|40.0||||||
4455288|NCT00075816|4277157|B1|Fludarabine, busulfan, and antithymocyte globulin||Conditioning regimen||participants|Number|39|39.0||||||
4455289|NCT00075816|4277155|B3|Cyclophosphamide and busulfan||Conditioning regimen||participants|Number|165|165.0||||||
4455290|NCT00075816|4277156|B2|Cyclophosphamide and busulfan||Conditioning regimen||participants|Number|75|75.0||||||
4455291|NCT00075816|4277157|B1|Cyclophosphamide and busulfan||Conditioning regimen||participants|Number|90|90.0||||||
4455292|NCT00075816|4277155|B3|Cyclophosphamide and total-body irradiation||Conditioning regimen||participants|Number|266|266.0||||||
4455293|NCT00075816|4277156|B2|Cyclophosphamide and total-body irradiation||Conditioning regimen||participants|Number|133|133.0||||||
4455294|NCT00075816|4277157|B1|Cyclophosphamide and total-body irradiation||Conditioning regimen||participants|Number|133|133.0||||||
4455295|NCT00075816|4277155|B3|Unknown||Cytomegalovirus serologic testing||participants|Number|27|27.0||||||
4455296|NCT00075816|4277156|B2|Unknown||Cytomegalovirus serologic testing||participants|Number|12|12.0||||||
4455297|NCT00075816|4277157|B1|Unknown||Cytomegalovirus serologic testing||participants|Number|15|15.0||||||
4455298|NCT00075816|4277155|B3|Seronegativity for CMV||Cytomegalovirus serologic testing||participants|Number|259|259.0||||||
4455299|NCT00075816|4277156|B2|Seronegativity for CMV||Cytomegalovirus serologic testing||participants|Number|138|138.0||||||
4455300|NCT00075816|4277157|B1|Seronegativity for CMV||Cytomegalovirus serologic testing||participants|Number|121|121.0||||||
4455301|NCT00075816|4277155|B3|Seropositivity for CMV||Cytomegalovirus serologic testing||participants|Number|265|265.0||||||
4455302|NCT00075816|4277156|B2|Seropositivity for CMV||Cytomegalovirus serologic testing||participants|Number|123|123.0||||||
4455303|NCT00075816|4277157|B1|Seropositivity for CMV||Cytomegalovirus serologic testing||participants|Number|142|142.0||||||
4455304|NCT00075816|4277155|B3|Unknown||Karnofsky performance-status score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|83|83.0||||||
4455305|NCT00075816|4277156|B2|Unknown||Karnofsky performance-status score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|45|45.0||||||
4455306|NCT00075816|4277157|B1|Unknown||Karnofsky performance-status score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|38|38.0||||||
4455307|NCT00075816|4277155|B3|<90%||Karnofsky performance-status score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|142|142.0||||||
4455308|NCT00075816|4277156|B2|<90%||Karnofsky performance-status score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|74|74.0||||||
4455309|NCT00075816|4277157|B1|<90%||Karnofsky performance-status score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|68|68.0||||||
4455310|NCT00075816|4277155|B3|90-100%||Karnofsky performance-status score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|326|326.0||||||
4455311|NCT00075816|4277156|B2|90-100%||Karnofsky performance-status score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|154|154.0||||||
4455312|NCT00075816|4277157|B1|90-100%||Karnofsky performance-status score|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|172|172.0||||||
4455313|NCT00075816|4277155|B3|Myelofibrosis||Diagnosis||participants|Number|6|6.0||||||
4455314|NCT00075816|4277156|B2|Myelofibrosis||Diagnosis||participants|Number|4|4.0||||||
4455315|NCT00075816|4277157|B1|Myelofibrosis||Diagnosis||participants|Number|2|2.0||||||
4455316|NCT00075816|4277155|B3|Chronic myelomonocytic leukemia||Diagnosis||participants|Number|8|8.0||||||
4455317|NCT00075816|4277156|B2|Chronic myelomonocytic leukemia||Diagnosis||participants|Number|4|4.0||||||
4455318|NCT00075816|4277157|B1|Chronic myelomonocytic leukemia||Diagnosis||participants|Number|4|4.0||||||
4455319|NCT00075816|4277155|B3|Myelodysplastic syndrome||Diagnosis||participants|Number|93|93.0||||||
4455320|NCT00075816|4277156|B2|Myelodysplastic syndrome||Diagnosis||participants|Number|41|41.0||||||
4455321|NCT00075816|4277157|B1|Myelodysplastic syndrome||Diagnosis||participants|Number|52|52.0||||||
4455322|NCT00075816|4277155|B3|Chronic myeloid leukemia||Diagnosis||participants|Number|66|66.0||||||
4455323|NCT00075816|4277156|B2|Chronic myeloid leukemia||Diagnosis||participants|Number|37|37.0||||||
4455324|NCT00075816|4277157|B1|Chronic myeloid leukemia||Diagnosis||participants|Number|29|29.0||||||
4455325|NCT00075816|4277155|B3|Acute lymphoblastic leukemia||Diagnosis||participants|Number|117|117.0||||||
4455326|NCT00075816|4277156|B2|Acute lymphoblastic leukemia||Diagnosis||participants|Number|56|56.0||||||
4455327|NCT00075816|4277157|B1|Acute lymphoblastic leukemia||Diagnosis||participants|Number|61|61.0||||||
4455328|NCT00075816|4277155|B3|Acute myeloid leukemia||Diagnosis||participants|Number|261|261.0||||||
4455329|NCT00075816|4277156|B2|Acute myeloid leukemia||Diagnosis||participants|Number|131|131.0||||||
4455330|NCT00075816|4277157|B1|Acute myeloid leukemia||Diagnosis||participants|Number|130|130.0||||||
4455331|NCT00075816|4277155|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4455332|NCT00075816|4277156|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4455333|NCT00075816|4277157|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4455334|NCT00075816|4277155|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4455335|NCT00075816|4277156|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455336|NCT00075816|4277157|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4455337|NCT00075816|4277155|B3||White|Race (NIH/OMB)||Participants|Count of Participants|498|498.0||||||
4455338|NCT00075816|4277156|B2||White|Race (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
4455339|NCT00075816|4277157|B1||White|Race (NIH/OMB)||Participants|Count of Participants|250|250.0||||||
4455340|NCT00075816|4277155|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4455341|NCT00075816|4277156|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4455342|NCT00075816|4277157|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4455343|NCT00075816|4277155|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455344|NCT00075816|4277156|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455345|NCT00075816|4277157|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455346|NCT00075816|4277155|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4455347|NCT00075816|4277156|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4455348|NCT00075816|4277157|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4455349|NCT00075816|4277155|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455350|NCT00075816|4277156|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455351|NCT00075816|4277157|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455352|NCT00075816|4277155|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4455353|NCT00075816|4277156|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4455354|NCT00075816|4277157|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4455355|NCT00075816|4277155|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|502|502.0||||||
4455356|NCT00075816|4277156|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|244|244.0||||||
4455357|NCT00075816|4277157|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|258|258.0||||||
4455358|NCT00075816|4277155|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4455359|NCT00075816|4277156|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4455360|NCT00075816|4277157|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4455361|NCT00075816|4277155|B3||Male|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4455362|NCT00075816|4277156|B2||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4455363|NCT00075816|4277157|B1||Male|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4455364|NCT00075816|4277155|B3||Female|Sex: Female, Male||Participants|Count of Participants|237|237.0||||||
4455365|NCT00075816|4277156|B2||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4455366|NCT00075816|4277157|B1||Female|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4455367|NCT00075816|4277155|B3|>=61 years||Age, Customized||participants|Number|67|67.0||||||
4455368|NCT00075816|4277156|B2|>=61 years||Age, Customized||participants|Number|29|29.0||||||
4455369|NCT00075816|4277157|B1|>=61 years||Age, Customized||participants|Number|38|38.0||||||
4455370|NCT00075816|4277155|B3|51-60 years||Age, Customized||participants|Number|144|144.0||||||
4455371|NCT00075816|4277156|B2|51-60 years||Age, Customized||participants|Number|75|75.0||||||
4455372|NCT00075816|4277157|B1|51-60 years||Age, Customized||participants|Number|69|69.0||||||
4455373|NCT00075816|4277155|B3|41-50 years||Age, Customized||participants|Number|107|107.0||||||
4455374|NCT00075816|4277156|B2|41-50 years||Age, Customized||participants|Number|55|55.0||||||
4455375|NCT00075816|4277157|B1|41-50 years||Age, Customized||participants|Number|52|52.0||||||
4455376|NCT00075816|4277155|B3|31-40 years||Age, Customized||participants|Number|91|91.0||||||
4455377|NCT00075816|4277156|B2|31-40 years||Age, Customized||participants|Number|49|49.0||||||
4455378|NCT00075816|4277157|B1|31-40 years||Age, Customized||participants|Number|42|42.0||||||
4455379|NCT00075816|4277155|B3|21-30 years||Age, Customized||participants|Number|87|87.0||||||
4455380|NCT00075816|4277156|B2|21-30 years||Age, Customized||participants|Number|45|45.0||||||
4455381|NCT00075816|4277157|B1|21-30 years||Age, Customized||participants|Number|42|42.0||||||
4455382|NCT00075816|4277155|B3|11-20 years||Age, Customized||participants|Number|37|37.0||||||
4455383|NCT00075816|4277156|B2|11-20 years||Age, Customized||participants|Number|11|11.0||||||
4455384|NCT00075816|4277157|B1|11-20 years||Age, Customized||participants|Number|26|26.0||||||
4455385|NCT00075816|4277155|B3|0-10 years||Age, Customized||participants|Number|18|18.0||||||
4455386|NCT00075816|4277156|B2|0-10 years||Age, Customized||participants|Number|9|9.0||||||
4455387|NCT00075816|4277157|B1|0-10 years||Age, Customized||participants|Number|9|9.0||||||
4455388|NCT00075803|4277196|B3|< 90%||Karnofsky/Lansky Performance Status|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|83|83.0||||||
4455389|NCT00075803|4277197|B2|< 90%||Karnofsky/Lansky Performance Status|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|37|37.0||||||
4455390|NCT00075803|4277198|B1|< 90%||Karnofsky/Lansky Performance Status|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|46|46.0||||||
4455391|NCT00075803|4277196|B3|90% - 100%||Karnofsky/Lansky Performance Status|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|517|517.0||||||
4455392|NCT00075803|4277197|B2|90% - 100%||Karnofsky/Lansky Performance Status|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|268|268.0||||||
4455393|NCT00075803|4277198|B1|90% - 100%||Karnofsky/Lansky Performance Status|Assesses patient self-perceived global quality of life and functioning (excellent, very good, good, fair, poor), where 100 equals perfect quality of life.|participants|Number|249|249.0||||||
4455394|NCT00075803|4277196|B3|5 of 6||Human Leukocyte Antigen (HLA) Match|Patients must have a 5 or 6 of 6 HLA-matched donor. The match may be determined at serologic level for HLA-A and HLA-B loci.|participants|Number|25|25.0||||||
4455395|NCT00075803|4277197|B2|5 of 6||Human Leukocyte Antigen (HLA) Match|Patients must have a 5 or 6 of 6 HLA-matched donor. The match may be determined at serologic level for HLA-A and HLA-B loci.|participants|Number|12|12.0||||||
4455396|NCT00075803|4277198|B1|5 of 6||Human Leukocyte Antigen (HLA) Match|Patients must have a 5 or 6 of 6 HLA-matched donor. The match may be determined at serologic level for HLA-A and HLA-B loci.|participants|Number|13|13.0||||||
4455397|NCT00075803|4277196|B3|6 of 6||Human Leukocyte Antigen (HLA) Match|Patients must have a 5 or 6 of 6 HLA-matched donor. The match may be determined at serologic level for HLA-A and HLA-B loci.|participants|Number|575|575.0||||||
4455398|NCT00075803|4277197|B2|6 of 6||Human Leukocyte Antigen (HLA) Match|Patients must have a 5 or 6 of 6 HLA-matched donor. The match may be determined at serologic level for HLA-A and HLA-B loci.|participants|Number|293|293.0||||||
4455399|NCT00075803|4277198|B1|6 of 6||Human Leukocyte Antigen (HLA) Match|Patients must have a 5 or 6 of 6 HLA-matched donor. The match may be determined at serologic level for HLA-A and HLA-B loci.|participants|Number|282|282.0||||||
4455400|NCT00075803|4277196|B3|Non-Hodgkin lymphoma||Primary Disease||participants|Number|43|43.0||||||
4455401|NCT00075803|4277197|B2|Non-Hodgkin lymphoma||Primary Disease||participants|Number|22|22.0||||||
4455402|NCT00075803|4277198|B1|Non-Hodgkin lymphoma||Primary Disease||participants|Number|21|21.0||||||
4455403|NCT00075803|4277196|B3|Myelodysplastic syndrome||Primary Disease||participants|Number|98|98.0||||||
4455404|NCT00075803|4277197|B2|Myelodysplastic syndrome||Primary Disease||participants|Number|49|49.0||||||
4455405|NCT00075803|4277198|B1|Myelodysplastic syndrome||Primary Disease||participants|Number|49|49.0||||||
4455406|NCT00075803|4277196|B3|Chronic myelogenous leukemia||Primary Disease||participants|Number|103|103.0||||||
4455407|NCT00075803|4277197|B2|Chronic myelogenous leukemia||Primary Disease||participants|Number|43|43.0||||||
4455408|NCT00075803|4277198|B1|Chronic myelogenous leukemia||Primary Disease||participants|Number|60|60.0||||||
4455409|NCT00075803|4277196|B3|Acute lymphoblastic leukemia||Primary Disease||participants|Number|122|122.0||||||
4455410|NCT00075803|4277197|B2|Acute lymphoblastic leukemia||Primary Disease||participants|Number|58|58.0||||||
4455411|NCT00075803|4277198|B1|Acute lymphoblastic leukemia||Primary Disease||participants|Number|64|64.0||||||
4455412|NCT00075803|4277196|B3|Acute myeloid leukemia||Primary Disease||participants|Number|234|234.0||||||
4455413|NCT00075803|4277197|B2|Acute myeloid leukemia||Primary Disease||participants|Number|133|133.0||||||
4455414|NCT00075803|4277198|B1|Acute myeloid leukemia||Primary Disease||participants|Number|101|101.0||||||
4455415|NCT00075803|4277196|B3|Cord blood||Graft Source||participants|Number|2|2.0||||||
4455416|NCT00075803|4277197|B2|Cord blood||Graft Source||participants|Number|2|2.0||||||
4455417|NCT00075803|4277198|B1|Cord blood||Graft Source||participants|Number|0|0.0||||||
4455418|NCT00075803|4277196|B3|Peripheral blood||Graft Source||participants|Number|383|383.0||||||
4455419|NCT00075803|4277197|B2|Peripheral blood||Graft Source||participants|Number|197|197.0||||||
4455420|NCT00075803|4277198|B1|Peripheral blood||Graft Source||participants|Number|186|186.0||||||
4455421|NCT00075803|4277196|B3|Bone marrow||Graft Source||participants|Number|215|215.0||||||
4455422|NCT00075803|4277197|B2|Bone marrow||Graft Source||participants|Number|106|106.0||||||
4455423|NCT00075803|4277198|B1|Bone marrow||Graft Source||participants|Number|109|109.0||||||
4455424|NCT00075803|4277196|B3|Other||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4455425|NCT00075803|4277197|B2|Other||Race/Ethnicity, Customized||participants|Number|29|29.0||||||
4455426|NCT00075803|4277198|B1|Other||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4455427|NCT00075803|4277196|B3|White||Race/Ethnicity, Customized||participants|Number|541|541.0||||||
4455428|NCT00075803|4277197|B2|White||Race/Ethnicity, Customized||participants|Number|276|276.0||||||
4455429|NCT00075803|4277198|B1|White||Race/Ethnicity, Customized||participants|Number|265|265.0||||||
4455430|NCT00075803|4277196|B3||Male|Sex: Female, Male||Participants|Count of Participants|331|331.0||||||
4455431|NCT00075803|4277197|B2||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4455432|NCT00075803|4277198|B1||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4455433|NCT00075803|4277196|B3||Female|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4455434|NCT00075803|4277197|B2||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4455435|NCT00075803|4277198|B1||Female|Sex: Female, Male||Participants|Count of Participants|134|134.0||||||
4455436|NCT00075803|4277196|B3|≥18 years||Age, Customized||participants|Number|549|549.0||||||
4455437|NCT00075803|4277197|B2|≥18 years||Age, Customized||participants|Number|278|278.0||||||
4455438|NCT00075803|4277198|B1|≥18 years||Age, Customized||participants|Number|271|271.0||||||
4455439|NCT00075803|4277196|B3|<18 years||Age, Customized||participants|Number|51|51.0||||||
4455440|NCT00075803|4277197|B2|<18 years||Age, Customized||participants|Number|27|27.0||||||
4455441|NCT00075803|4277198|B1|<18 years||Age, Customized||participants|Number|24|24.0||||||
4455442|NCT00075803|4277196|B3|||Age, Customized||years|Median|43|43.0|Full Range|||3.0|66.0|
4455443|NCT00075803|4277197|B2|||Age, Customized||years|Median|43|43.0|Full Range|||3.0|66.0|
4455444|NCT00075803|4277198|B1|||Age, Customized||years|Median|43|43.0|Full Range|||9.0|65.0|
4455445|NCT00075764|4277225|B3|Negative||HER2 status|HER2 denotes human epidermal growth factor receptor type 2.|participants|Number|536|536.0||||||
4455446|NCT00075764|4277226|B2|Negative||HER2 status|HER2 denotes human epidermal growth factor receptor type 2.|participants|Number|266|266.0||||||
4455447|NCT00075764|4277227|B1|Negative||HER2 status|HER2 denotes human epidermal growth factor receptor type 2.|participants|Number|270|270.0||||||
4455448|NCT00075764|4277225|B3|Positive||HER2 status|HER2 denotes human epidermal growth factor receptor type 2.|participants|Number|56|56.0||||||
4455449|NCT00075764|4277226|B2|Positive||HER2 status|HER2 denotes human epidermal growth factor receptor type 2.|participants|Number|31|31.0||||||
4455450|NCT00075764|4277227|B1|Positive||HER2 status|HER2 denotes human epidermal growth factor receptor type 2.|participants|Number|25|25.0||||||
4455451|NCT00075764|4277225|B3|>= 10 yr||Time between diagnosis of primary and metastatic disease||participants|Number|192|192.0||||||
4455452|NCT00075764|4277226|B2|>= 10 yr||Time between diagnosis of primary and metastatic disease||participants|Number|104|104.0||||||
4455453|NCT00075764|4277227|B1|>= 10 yr||Time between diagnosis of primary and metastatic disease||participants|Number|88|88.0||||||
4455454|NCT00075764|4277225|B3|5 to < 10 yr||Time between diagnosis of primary and metastatic disease||participants|Number|134|134.0||||||
4455455|NCT00075764|4277226|B2|5 to < 10 yr||Time between diagnosis of primary and metastatic disease||participants|Number|66|66.0||||||
4455456|NCT00075764|4277227|B1|5 to < 10 yr||Time between diagnosis of primary and metastatic disease||participants|Number|68|68.0||||||
4455457|NCT00075764|4277225|B3|3 mo to < 5 yr||Time between diagnosis of primary and metastatic disease||participants|Number|87|87.0||||||
4455458|NCT00075764|4277226|B2|3 mo to < 5 yr||Time between diagnosis of primary and metastatic disease||participants|Number|47|47.0||||||
4455459|NCT00075764|4277227|B1|3 mo to < 5 yr||Time between diagnosis of primary and metastatic disease||participants|Number|40|40.0||||||
4455460|NCT00075764|4277225|B3|None||Time between diagnosis of primary and metastatic disease||participants|Number|263|263.0||||||
4455461|NCT00075764|4277226|B2|None||Time between diagnosis of primary and metastatic disease||participants|Number|122|122.0||||||
4455462|NCT00075764|4277227|B1|None||Time between diagnosis of primary and metastatic disease||participants|Number|141|141.0||||||
4455463|NCT00075764|4277225|B3|Nonvisceral||Disease site||participants|Number|195|195.0||||||
4455464|NCT00075764|4277226|B2|Nonvisceral||Disease site||participants|Number|93|93.0||||||
4455465|NCT00075764|4277227|B1|Nonvisceral||Disease site||participants|Number|102|102.0||||||
4455466|NCT00075764|4277225|B3|Visceral||Disease site||participants|Number|348|348.0||||||
4455467|NCT00075764|4277226|B2|Visceral||Disease site||participants|Number|181|181.0||||||
4455468|NCT00075764|4277227|B1|Visceral||Disease site||participants|Number|167|167.0||||||
4455469|NCT00075764|4277225|B3|Bone only||Disease site||participants|Number|151|151.0||||||
4455470|NCT00075764|4277226|B2|Bone only||Disease site||participants|Number|75|75.0||||||
4455471|NCT00075764|4277227|B1|Bone only||Disease site||participants|Number|76|76.0||||||
4455472|NCT00075764|4277225|B3|No||Measurable disease||participants|Number|318|318.0||||||
4455473|NCT00075764|4277226|B2|No||Measurable disease||participants|Number|161|161.0||||||
4455474|NCT00075764|4277227|B1|No||Measurable disease||participants|Number|157|157.0||||||
4455475|NCT00075764|4277225|B3|Yes||Measurable disease||participants|Number|376|376.0||||||
4455476|NCT00075764|4277226|B2|Yes||Measurable disease||participants|Number|188|188.0||||||
4455477|NCT00075764|4277227|B1|Yes||Measurable disease||participants|Number|188|188.0||||||
4455478|NCT00075764|4277225|B3|No||Prior adjuvant chemotherapy||participants|Number|462|462.0||||||
4455479|NCT00075764|4277226|B2|No||Prior adjuvant chemotherapy||participants|Number|220|220.0||||||
4455480|NCT00075764|4277227|B1|No||Prior adjuvant chemotherapy||participants|Number|242|242.0||||||
4455481|NCT00075764|4277225|B3|Yes||Prior adjuvant chemotherapy||participants|Number|232|232.0||||||
4455482|NCT00075764|4277226|B2|Yes||Prior adjuvant chemotherapy||participants|Number|129|129.0||||||
4455483|NCT00075764|4277227|B1|Yes||Prior adjuvant chemotherapy||participants|Number|103|103.0||||||
4455484|NCT00075764|4277225|B3|No||Prior adjuvant tamoxifen||participants|Number|414|414.0||||||
4455485|NCT00075764|4277226|B2|No||Prior adjuvant tamoxifen||participants|Number|208|208.0||||||
4455486|NCT00075764|4277227|B1|No||Prior adjuvant tamoxifen||participants|Number|206|206.0||||||
4455487|NCT00075764|4277225|B3|Yes||Prior adjuvant tamoxifen||participants|Number|280|280.0||||||
4455488|NCT00075764|4277226|B2|Yes||Prior adjuvant tamoxifen||participants|Number|141|141.0||||||
4455489|NCT00075764|4277227|B1|Yes||Prior adjuvant tamoxifen||participants|Number|139|139.0||||||
4455490|NCT00075764|4277225|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455491|NCT00075764|4277226|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455492|NCT00075764|4277227|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455493|NCT00075764|4277225|B3||Female|Sex: Female, Male||Participants|Count of Participants|694|694.0||||||
4455494|NCT00075764|4277226|B2||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4455495|NCT00075764|4277227|B1||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4455496|NCT00075764|4277225|B3|||Age||years|Median|65|65.0|Full Range|||27.0|92.0|
4455497|NCT00075764|4277226|B2|||Age||years|Median|65|65.0|Full Range|||27.0|92.0|
4455498|NCT00075764|4277227|B1|||Age||years|Median|65|65.0|Full Range|||36.0|91.0|
4455499|NCT00075725|4277240|B13||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|340|340.0||||||
4455500|NCT00075725|4277241|B12||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4455501|NCT00075725|4277242|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455502|NCT00075725|4277243|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4455503|NCT00075725|4277244|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4455504|NCT00075725|4277245|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4455505|NCT00075725|4277246|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4455506|NCT00075725|4277247|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|83|83.0||||||
4455507|NCT00075725|4277248|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4455508|NCT00075725|4277249|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4455509|NCT00075725|4277250|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4455510|NCT00075725|4277251|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4455511|NCT00075725|4277252|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4455512|NCT00075725|4277240|B13||More than one race|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4455513|NCT00075725|4277241|B12||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455514|NCT00075725|4277242|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455515|NCT00075725|4277243|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455516|NCT00075725|4277244|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4455517|NCT00075725|4277245|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4455518|NCT00075725|4277246|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4455519|NCT00075725|4277247|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4455520|NCT00075725|4277248|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4455521|NCT00075725|4277249|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4455522|NCT00075725|4277250|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455523|NCT00075725|4277251|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4455524|NCT00075725|4277252|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4455525|NCT00075725|4277240|B13||White|Race (NIH/OMB)||Participants|Count of Participants|2395|2395.0||||||
4455526|NCT00075725|4277241|B12||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4455527|NCT00075725|4277242|B11||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4455528|NCT00075725|4277243|B10||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4455529|NCT00075725|4277244|B9||White|Race (NIH/OMB)||Participants|Count of Participants|227|227.0||||||
4455530|NCT00075725|4277245|B8||White|Race (NIH/OMB)||Participants|Count of Participants|519|519.0||||||
4455531|NCT00075725|4277246|B7||White|Race (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
4455532|NCT00075725|4277247|B6||White|Race (NIH/OMB)||Participants|Count of Participants|534|534.0||||||
4455533|NCT00075725|4277248|B5||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
4455534|NCT00075725|4277249|B4||White|Race (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
4455535|NCT00075725|4277250|B3||White|Race (NIH/OMB)||Participants|Count of Participants|235|235.0||||||
4455536|NCT00075725|4277251|B2||White|Race (NIH/OMB)||Participants|Count of Participants|76|76.0||||||
4455537|NCT00075725|4277252|B1||White|Race (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
4455538|NCT00075725|4277240|B13||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
4455539|NCT00075725|4277241|B12||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455540|NCT00075725|4277242|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455541|NCT00075725|4277243|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4455542|NCT00075725|4277244|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4455543|NCT00075725|4277245|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4455544|NCT00075725|4277246|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4455545|NCT00075725|4277247|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4455546|NCT00075725|4277248|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4455547|NCT00075725|4277249|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4455548|NCT00075725|4277250|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4455549|NCT00075725|4277251|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4455550|NCT00075725|4277252|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4455551|NCT00075725|4277240|B13||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4455552|NCT00075725|4277241|B12||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455553|NCT00075725|4277242|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455554|NCT00075725|4277243|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455555|NCT00075725|4277244|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4455556|NCT00075725|4277245|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4455557|NCT00075725|4277246|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4455558|NCT00075725|4277247|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4455559|NCT00075725|4277248|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455560|NCT00075725|4277249|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4455561|NCT00075725|4277250|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455562|NCT00075725|4277251|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455563|NCT00075725|4277252|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4455564|NCT00075725|4277240|B13||Asian|Race (NIH/OMB)||Participants|Count of Participants|117|117.0||||||
4455565|NCT00075725|4277241|B12||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455566|NCT00075725|4277242|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455567|NCT00075725|4277243|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4455568|NCT00075725|4277244|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4455569|NCT00075725|4277245|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4455570|NCT00075725|4277246|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4455571|NCT00075725|4277247|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4455572|NCT00075725|4277248|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4455573|NCT00075725|4277249|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4455574|NCT00075725|4277250|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4455575|NCT00075725|4277251|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4455576|NCT00075725|4277252|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4455577|NCT00075725|4277240|B13||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4455578|NCT00075725|4277241|B12||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455579|NCT00075725|4277242|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4455580|NCT00075725|4277243|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455581|NCT00075725|4277244|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4455582|NCT00075725|4277245|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4455583|NCT00075725|4277246|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455584|NCT00075725|4277247|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4455585|NCT00075725|4277248|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455586|NCT00075725|4277249|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455587|NCT00075725|4277250|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455588|NCT00075725|4277251|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455589|NCT00075725|4277252|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455590|NCT00075725|4277240|B13||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4455591|NCT00075725|4277241|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455592|NCT00075725|4277242|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4455593|NCT00075725|4277243|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455594|NCT00075725|4277244|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4455595|NCT00075725|4277245|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4455596|NCT00075725|4277246|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4455597|NCT00075725|4277247|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4455598|NCT00075725|4277248|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4455599|NCT00075725|4277249|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4455600|NCT00075725|4277250|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4455601|NCT00075725|4277251|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4455602|NCT00075725|4277252|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4455603|NCT00075725|4277240|B13||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2299|2299.0||||||
4455604|NCT00075725|4277241|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4455605|NCT00075725|4277242|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4455606|NCT00075725|4277243|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4455607|NCT00075725|4277244|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
4455608|NCT00075725|4277245|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|504|504.0||||||
4455609|NCT00075725|4277246|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
4455610|NCT00075725|4277247|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|516|516.0||||||
4455611|NCT00075725|4277248|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|165|165.0||||||
4455612|NCT00075725|4277249|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
4455613|NCT00075725|4277250|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|217|217.0||||||
4455614|NCT00075725|4277251|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4455615|NCT00075725|4277252|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|179|179.0||||||
4455616|NCT00075725|4277240|B13||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|733|733.0||||||
4455617|NCT00075725|4277241|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4455618|NCT00075725|4277242|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455619|NCT00075725|4277243|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4455620|NCT00075725|4277244|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|69|69.0||||||
4455621|NCT00075725|4277245|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|168|168.0||||||
4455622|NCT00075725|4277246|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|61|61.0||||||
4455623|NCT00075725|4277247|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|167|167.0||||||
4455624|NCT00075725|4277248|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4455625|NCT00075725|4277249|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4455626|NCT00075725|4277250|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4455627|NCT00075725|4277251|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4455628|NCT00075725|4277252|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4455629|NCT00075725|4277240|B13||Male|Sex: Female, Male||Participants|Count of Participants|1755|1755.0||||||
4455630|NCT00075725|4277241|B12||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4455631|NCT00075725|4277242|B11||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4455632|NCT00075725|4277243|B10||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4455633|NCT00075725|4277244|B9||Male|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4455634|NCT00075725|4277245|B8||Male|Sex: Female, Male||Participants|Count of Participants|408|408.0||||||
4455635|NCT00075725|4277246|B7||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4455636|NCT00075725|4277247|B6||Male|Sex: Female, Male||Participants|Count of Participants|389|389.0||||||
4455637|NCT00075725|4277248|B5||Male|Sex: Female, Male||Participants|Count of Participants|126|126.0||||||
4455638|NCT00075725|4277249|B4||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4455639|NCT00075725|4277250|B3||Male|Sex: Female, Male||Participants|Count of Participants|161|161.0||||||
4455640|NCT00075725|4277251|B2||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4455641|NCT00075725|4277252|B1||Male|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4455642|NCT00075725|4277240|B13||Female|Sex: Female, Male||Participants|Count of Participants|1399|1399.0||||||
4455643|NCT00075725|4277241|B12||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4455644|NCT00075725|4277242|B11||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4455645|NCT00075725|4277243|B10||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4455646|NCT00075725|4277244|B9||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4455647|NCT00075725|4277245|B8||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4455648|NCT00075725|4277246|B7||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4455649|NCT00075725|4277247|B6||Female|Sex: Female, Male||Participants|Count of Participants|321|321.0||||||
4455650|NCT00075725|4277248|B5||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4455651|NCT00075725|4277249|B4||Female|Sex: Female, Male||Participants|Count of Participants|117|117.0||||||
4455652|NCT00075725|4277250|B3||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4455653|NCT00075725|4277251|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4455654|NCT00075725|4277252|B1||Female|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4455655|NCT00075725|4277240|B13|||Age||years|Mean|10.8|10.8|Standard Deviation|5.7|5.7|||
4455656|NCT00075725|4277241|B12|||Age||years|Mean|14.4|14.4|Standard Deviation|2.9|2.9|||
4455657|NCT00075725|4277242|B11|||Age||years|Mean|12.3|12.3|Standard Deviation|6.6|6.6|||
4455658|NCT00075725|4277243|B10|||Age||years|Mean|10.5|10.5|Standard Deviation|5.7|5.7|||
4455659|NCT00075725|4277244|B9|||Age||years|Mean|14.6|14.6|Standard Deviation|2.9|2.9|||
4455660|NCT00075725|4277245|B8|||Age||years|Mean|14.5|14.5|Standard Deviation|3.2|3.2|||
4455661|NCT00075725|4277246|B7|||Age||years|Mean|4.2|4.2|Standard Deviation|2.2|2.2|||
4455662|NCT00075725|4277247|B6|||Age||years|Mean|14.7|14.7|Standard Deviation|3.3|3.3|||
4455663|NCT00075725|4277248|B5|||Age||years|Mean|4.2|4.2|Standard Deviation|2.2|2.2|||
4455664|NCT00075725|4277249|B4|||Age||years|Mean|4.1|4.1|Standard Deviation|2.2|2.2|||
4455665|NCT00075725|4277250|B3|||Age||years|Mean|14.1|14.1|Standard Deviation|2.8|2.8|||
4455666|NCT00075725|4277251|B2|||Age||years|Mean|9.3|9.3|Standard Deviation|6.0|6.0|||
4455667|NCT00075725|4277252|B1|||Age||years|Mean|4.0|4.0|Standard Deviation|2.3|2.3|||
4455668|NCT00075725|4277240|B13||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455669|NCT00075725|4277241|B12||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455670|NCT00075725|4277242|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455671|NCT00075725|4277243|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455672|NCT00075725|4277244|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455673|NCT00075725|4277245|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455674|NCT00075725|4277246|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455675|NCT00075725|4277247|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455676|NCT00075725|4277248|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455677|NCT00075725|4277249|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455678|NCT00075725|4277250|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455679|NCT00075725|4277251|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455680|NCT00075725|4277252|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455681|NCT00075725|4277240|B13||Between 18 and 65 years|Age||Participants|Count of Participants|230|230.0||||||
4455682|NCT00075725|4277241|B12||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4455683|NCT00075725|4277242|B11||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4455684|NCT00075725|4277243|B10||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4455685|NCT00075725|4277244|B9||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4455686|NCT00075725|4277245|B8||Between 18 and 65 years|Age||Participants|Count of Participants|86|86.0||||||
4455687|NCT00075725|4277246|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4455688|NCT00075725|4277247|B6||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4455689|NCT00075725|4277248|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4455690|NCT00075725|4277249|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4455691|NCT00075725|4277250|B3||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4455692|NCT00075725|4277251|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4455693|NCT00075725|4277252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4455694|NCT00075725|4277240|B13||<=18 years|Age||Participants|Count of Participants|2924|2924.0||||||
4455695|NCT00075725|4277241|B12||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4455696|NCT00075725|4277242|B11||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4455697|NCT00075725|4277243|B10||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4455698|NCT00075725|4277244|B9||<=18 years|Age||Participants|Count of Participants|266|266.0||||||
4455699|NCT00075725|4277245|B8||<=18 years|Age||Participants|Count of Participants|610|610.0||||||
4455700|NCT00075725|4277246|B7||<=18 years|Age||Participants|Count of Participants|246|246.0||||||
4455701|NCT00075725|4277247|B6||<=18 years|Age||Participants|Count of Participants|641|641.0||||||
4455702|NCT00075725|4277248|B5||<=18 years|Age||Participants|Count of Participants|232|232.0||||||
4455703|NCT00075725|4277249|B4||<=18 years|Age||Participants|Count of Participants|246|246.0||||||
4455704|NCT00075725|4277250|B3||<=18 years|Age||Participants|Count of Participants|275|275.0||||||
4455705|NCT00075725|4277251|B2||<=18 years|Age||Participants|Count of Participants|96|96.0||||||
4455706|NCT00075725|4277252|B1||<=18 years|Age||Participants|Count of Participants|246|246.0||||||
4455707|NCT00075608|4277352|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4455708|NCT00075608|4277352|B1||Male|Gender||Participants|Count of Participants|7|7.0||||||
4455709|NCT00075608|4277352|B1||Female|Gender||Participants|Count of Participants|5|5.0||||||
4455710|NCT00075608|4277352|B1|||Age||years|Mean|54.25|54.25|Standard Deviation|1|1.0|||
4455711|NCT00075608|4277352|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455712|NCT00075608|4277352|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4455713|NCT00075608|4277352|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4455714|NCT00075582|4277358|B3|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4455715|NCT00075582|4277359|B2|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4455716|NCT00075582|4277360|B1|Switzerland||Region of Enrollment||participants|Number|3|3.0||||||
4455717|NCT00075582|4277358|B3|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4455718|NCT00075582|4277359|B2|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4455719|NCT00075582|4277360|B1|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4455720|NCT00075582|4277358|B3|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4455721|NCT00075582|4277359|B2|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4455722|NCT00075582|4277360|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4455723|NCT00075582|4277358|B3|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4455724|NCT00075582|4277359|B2|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4455725|NCT00075582|4277360|B1|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4455726|NCT00075582|4277358|B3|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4455727|NCT00075582|4277359|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4455728|NCT00075582|4277360|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4455729|NCT00075582|4277358|B3|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4455730|NCT00075582|4277359|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4455731|NCT00075582|4277360|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4455732|NCT00075582|4277358|B3|United States||Region of Enrollment||participants|Number|346|346.0||||||
4455733|NCT00075582|4277359|B2|United States||Region of Enrollment||participants|Number|77|77.0||||||
4455734|NCT00075582|4277360|B1|United States||Region of Enrollment||participants|Number|269|269.0||||||
4455735|NCT00075582|4277358|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4455736|NCT00075582|4277359|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4455737|NCT00075582|4277360|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4455738|NCT00075582|4277358|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|326|326.0||||||
4455739|NCT00075582|4277359|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4455740|NCT00075582|4277360|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|255|255.0||||||
4455741|NCT00075582|4277358|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4455742|NCT00075582|4277359|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4455743|NCT00075582|4277360|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4455744|NCT00075582|4277358|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4455745|NCT00075582|4277359|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4455746|NCT00075582|4277360|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4455747|NCT00075582|4277358|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455748|NCT00075582|4277359|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455749|NCT00075582|4277360|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455750|NCT00075582|4277358|B3||White|Race (NIH/OMB)||Participants|Count of Participants|293|293.0||||||
4455751|NCT00075582|4277359|B2||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4455752|NCT00075582|4277360|B1||White|Race (NIH/OMB)||Participants|Count of Participants|228|228.0||||||
4455753|NCT00075582|4277358|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4455754|NCT00075582|4277359|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4455755|NCT00075582|4277360|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4455756|NCT00075582|4277358|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455757|NCT00075582|4277359|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455758|NCT00075582|4277360|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4455759|NCT00075582|4277358|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4455760|NCT00075582|4277359|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4455761|NCT00075582|4277360|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4455762|NCT00075582|4277358|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4455763|NCT00075582|4277359|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4455764|NCT00075582|4277360|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4455765|NCT00075582|4277358|B3||Male|Gender||Participants|Count of Participants|247|247.0||||||
4455766|NCT00075582|4277359|B2||Male|Gender||Participants|Count of Participants|30|30.0||||||
4455767|NCT00075582|4277360|B1||Male|Gender||Participants|Count of Participants|217|217.0||||||
4455768|NCT00075582|4277358|B3||Female|Gender||Participants|Count of Participants|143|143.0||||||
4455769|NCT00075582|4277359|B2||Female|Gender||Participants|Count of Participants|55|55.0||||||
4455770|NCT00075582|4277360|B1||Female|Gender||Participants|Count of Participants|88|88.0||||||
4455771|NCT00075582|4277358|B3|||Age||years|Mean|7.11|7.11|Standard Deviation|6.13|6.13|||
4455772|NCT00075582|4277359|B2|||Age||years|Mean|5.02|5.02|Standard Deviation|6.78|6.78|||
4455773|NCT00075582|4277360|B1|||Age||years|Mean|7.69|7.69|Standard Deviation|5.81|5.81|||
4455774|NCT00075504|4277369|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4455775|NCT00075504|4277370|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4455776|NCT00075504|4277371|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4455777|NCT00075504|4277369|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4455778|NCT00075504|4277370|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4455779|NCT00075504|4277371|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4455780|NCT00075504|4277369|B3|White||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4455781|NCT00075504|4277370|B2|White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4455782|NCT00075504|4277371|B1|White||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4455783|NCT00075504|4277369|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4455784|NCT00075504|4277370|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4455785|NCT00075504|4277371|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4455786|NCT00075504|4277369|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4455787|NCT00075504|4277370|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4455788|NCT00075504|4277371|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4455789|NCT00075504|4277369|B3|||Age||years|Median|62.3|62.3|Full Range|||35.0|85.0|
4455790|NCT00075504|4277370|B2|||Age||years|Median|67.5|67.5|Full Range|||55.0|75.0|
4455791|NCT00075504|4277371|B1|||Age||years|Median|57|57.0|Full Range|||35.0|85.0|
4455792|NCT00075478|4277382|B3|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4455793|NCT00075478|4277383|B2|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4455794|NCT00075478|4277384|B1|Italy||Region of Enrollment||participants|Number|2|2.0||||||
4455795|NCT00075478|4277382|B3|Germany||Region of Enrollment||participants|Number|12|12.0||||||
4455796|NCT00075478|4277383|B2|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4455797|NCT00075478|4277384|B1|Germany||Region of Enrollment||participants|Number|6|6.0||||||
4455798|NCT00075478|4277382|B3|United States||Region of Enrollment||participants|Number|70|70.0||||||
4455799|NCT00075478|4277383|B2|United States||Region of Enrollment||participants|Number|37|37.0||||||
4455800|NCT00075478|4277384|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4455801|NCT00075478|4277382|B3||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4455802|NCT00075478|4277383|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4455803|NCT00075478|4277384|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4455804|NCT00075478|4277382|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4455805|NCT00075478|4277383|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4455806|NCT00075478|4277384|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4455807|NCT00075478|4277382|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4455808|NCT00075478|4277383|B2||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4455809|NCT00075478|4277384|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4455810|NCT00075478|4277382|B3||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4455811|NCT00075478|4277383|B2||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4455812|NCT00075478|4277384|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4455813|NCT00075478|4277382|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4455814|NCT00075478|4277383|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4455815|NCT00075478|4277384|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4455816|NCT00075478|4277382|B3|||Age||years|Median|56|56.0|Full Range|||18.0|74.0|
4455817|NCT00075478|4277383|B2|||Age||years|Median|54.5|54.5|Full Range|||18.0|74.0|
4455818|NCT00075478|4277384|B1|||Age||years|Median|57|57.0|Full Range|||18.0|72.0|
4455819|NCT00075400|4277405|B1|Carcinosarcoma, Malignant Mixed Mullerian Tumor||Histologic Type||participants|Number|12|12.0||||||
4455820|NCT00075400|4277405|B1|Carcinosarcoma-heterologous||Histologic Type||participants|Number|8|8.0||||||
4455821|NCT00075400|4277405|B1|Carcinosarcoma-homologous||Histologic Type||participants|Number|3|3.0||||||
4455822|NCT00075400|4277405|B1|||FIGO (International Federation of Gynecology and Obstetrics) Stage Recurrent/Persistent||participants|Number|23|23.0||||||
4455823|NCT00075400|4277405|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4455824|NCT00075400|4277405|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455825|NCT00075400|4277405|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4455826|NCT00075400|4277405|B1|80-89 years||Age, Customized||participants|Number|2|2.0||||||
4455827|NCT00075400|4277405|B1|70-79 years||Age, Customized||participants|Number|4|4.0||||||
4455828|NCT00075400|4277405|B1|60-69 years||Age, Customized||participants|Number|11|11.0||||||
4455829|NCT00075400|4277405|B1|50-59 years||Age, Customized||participants|Number|3|3.0||||||
4455830|NCT00075400|4277405|B1|40-49 years||Age, Customized||participants|Number|3|3.0||||||
4455831|NCT00075400|4277405|B1|||Age||years|Mean|64.5|64.5|Standard Deviation|10.2|10.2|||
4455832|NCT00075335|4277419|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4455833|NCT00075335|4277419|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4455834|NCT00075335|4277419|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4455835|NCT00075335|4277419|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455836|NCT00075335|4277419|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4455837|NCT00075335|4277419|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4455838|NCT00075270|4277424|B3|Unknown||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4455839|NCT00075270|4277425|B2|Unknown||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4455840|NCT00075270|4277426|B1|Unknown||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4455841|NCT00075270|4277424|B3|American Hispanic||Race/Ethnicity, Customized||participants|Number|107|107.0||||||
4455842|NCT00075270|4277425|B2|American Hispanic||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4455843|NCT00075270|4277426|B1|American Hispanic||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4455844|NCT00075270|4277424|B3|Asian||Race/Ethnicity, Customized||participants|Number|65|65.0||||||
4455845|NCT00075270|4277425|B2|Asian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4455846|NCT00075270|4277426|B1|Asian||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4455847|NCT00075270|4277424|B3|Black||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4455848|NCT00075270|4277425|B2|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4455849|NCT00075270|4277426|B1|Black||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4455850|NCT00075270|4277424|B3|White||Race/Ethnicity, Customized||participants|Number|372|372.0||||||
4455851|NCT00075270|4277425|B2|White||Race/Ethnicity, Customized||participants|Number|182|182.0||||||
4455852|NCT00075270|4277426|B1|White||Race/Ethnicity, Customized||participants|Number|190|190.0||||||
4455853|NCT00075270|4277424|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455854|NCT00075270|4277425|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455855|NCT00075270|4277426|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4455856|NCT00075270|4277424|B3||Female|Sex: Female, Male||Participants|Count of Participants|579|579.0||||||
4455857|NCT00075270|4277425|B2||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4455858|NCT00075270|4277426|B1||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4455859|NCT00075270|4277424|B3|||Age||Years|Mean|51.8|51.8|Standard Deviation|10.72|10.72|||
4455860|NCT00075270|4277425|B2|||Age||Years|Mean|52.4|52.4|Standard Deviation|10.98|10.98|||
4455861|NCT00075270|4277426|B1|||Age||Years|Mean|51.3|51.3|Standard Deviation|10.45|10.45|||
4455862|NCT00075218|4277471|B3||Male|Sex: Female, Male||Participants|Count of Participants|199.0|199.0||||||
4455863|NCT00075218|4277472|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4455864|NCT00075218|4277473|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4455865|NCT00075218|4277471|B3||Female|Sex: Female, Male||Participants|Count of Participants|162.0|162.0||||||
4455866|NCT00075218|4277472|B2||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4455867|NCT00075218|4277473|B1||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4455868|NCT00075218|4277471|B3||>=65 years|Age||Participants|Count of Participants|110.0|110.0||||||
4455869|NCT00075218|4277472|B2||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4455870|NCT00075218|4277473|B1||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4455871|NCT00075218|4277471|B3||Between 18 and 65 years|Age||Participants|Count of Participants|251.0|251.0||||||
4455872|NCT00075218|4277472|B2||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4455873|NCT00075218|4277473|B1||Between 18 and 65 years|Age||Participants|Count of Participants|170|170.0||||||
4455874|NCT00075218|4277471|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4455875|NCT00075218|4277472|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4455876|NCT00075218|4277473|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4455877|NCT00075088|4277508|B3|United States||Region of Enrollment||participants|Number|794|794.0||||||
4455878|NCT00075088|4277509|B2|United States||Region of Enrollment||participants|Number|391|391.0||||||
4455879|NCT00075088|4277510|B1|United States||Region of Enrollment||participants|Number|403|403.0||||||
4455880|NCT00075088|4277508|B3||Male|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
4455881|NCT00075088|4277509|B2||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4455882|NCT00075088|4277510|B1||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4455883|NCT00075088|4277508|B3||Female|Sex: Female, Male||Participants|Count of Participants|382|382.0||||||
4455884|NCT00075088|4277509|B2||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4455885|NCT00075088|4277510|B1||Female|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4455886|NCT00075088|4277508|B3|||Age||years|Mean|70|70.0|Standard Deviation|14|14.0|||
4455887|NCT00075088|4277509|B2|||Age||years|Mean|71|71.0|Standard Deviation|14|14.0|||
4455888|NCT00075088|4277510|B1|||Age||years|Mean|70|70.0|Standard Deviation|15|15.0|||
4455889|NCT00075023|4277522|B3|United States||Region of Enrollment||participants|Number|10|10.0||||||
4455890|NCT00075023|4277523|B2|United States||Region of Enrollment||participants|Number|5|5.0||||||
4455891|NCT00075023|4277524|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4455892|NCT00075023|4277522|B3||Male|Sex: Female, Male|Total enrollment of 7 males and 3 females. Gender data not available for each arm.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4455893|NCT00075023|4277523|B2||Male|Sex: Female, Male|Total enrollment of 7 males and 3 females. Gender data not available for each arm.|Participants|Count of Participants|NA|||||||Data not available per group
4455894|NCT00075023|4277524|B1||Male|Sex: Female, Male|Total enrollment of 7 males and 3 females. Gender data not available for each arm.|Participants|Count of Participants|NA|||||||Data not available per group
4455895|NCT00075023|4277522|B3||Female|Sex: Female, Male|Total enrollment of 7 males and 3 females. Gender data not available for each arm.|Participants|Count of Participants|NA|||||||Total not calculated because data are not available (NA) in one or more arms.
4455896|NCT00075023|4277523|B2||Female|Sex: Female, Male|Total enrollment of 7 males and 3 females. Gender data not available for each arm.|Participants|Count of Participants|NA|||||||Data not available per group
4455897|NCT00075023|4277524|B1||Female|Sex: Female, Male|Total enrollment of 7 males and 3 females. Gender data not available for each arm.|Participants|Count of Participants|NA|||||||Data not available per group
4455898|NCT00075023|4277522|B3|27-60 yrs||Age, Customized||participants|Number|10|10.0||||||
4455899|NCT00075023|4277523|B2|27-60 yrs||Age, Customized||participants|Number|5|5.0||||||
4455900|NCT00075023|4277524|B1|27-60 yrs||Age, Customized||participants|Number|5|5.0||||||
4455901|NCT00074984|4277532|B3|Other||Race/Ethnicity||participants|Number|2|2.0||||||
4455902|NCT00074984|4277533|B2|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4455903|NCT00074984|4277534|B1|Other||Race/Ethnicity||participants|Number|1|1.0||||||
4455904|NCT00074984|4277532|B3|Asian||Race/Ethnicity||participants|Number|2|2.0||||||
4455905|NCT00074984|4277533|B2|Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4455906|NCT00074984|4277534|B1|Asian||Race/Ethnicity||participants|Number|1|1.0||||||
4455907|NCT00074984|4277532|B3|Hispanic||Race/Ethnicity||participants|Number|5|5.0||||||
4455908|NCT00074984|4277533|B2|Hispanic||Race/Ethnicity||participants|Number|3|3.0||||||
4455909|NCT00074984|4277534|B1|Hispanic||Race/Ethnicity||participants|Number|2|2.0||||||
4455910|NCT00074984|4277532|B3|Black||Race/Ethnicity||participants|Number|1|1.0||||||
4455911|NCT00074984|4277533|B2|Black||Race/Ethnicity||participants|Number|1|1.0||||||
4455912|NCT00074984|4277534|B1|Black||Race/Ethnicity||participants|Number|0|0.0||||||
4455913|NCT00074984|4277532|B3|Caucasian||Race/Ethnicity||participants|Number|72|72.0||||||
4455914|NCT00074984|4277533|B2|Caucasian||Race/Ethnicity||participants|Number|45|45.0||||||
4455915|NCT00074984|4277534|B1|Caucasian||Race/Ethnicity||participants|Number|27|27.0||||||
4455916|NCT00074984|4277532|B3||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4455917|NCT00074984|4277533|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4455918|NCT00074984|4277534|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4455919|NCT00074984|4277532|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4455920|NCT00074984|4277533|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4455921|NCT00074984|4277534|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4455922|NCT00074984|4277532|B3|||Age||years|Mean|45.9|45.9|Standard Deviation|9.58|9.58|||
4455923|NCT00074984|4277533|B2|||Age||years|Mean|46.9|46.9|Standard Deviation|9.75|9.75|||
4455924|NCT00074984|4277534|B1|||Age||years|Mean|44.3|44.3|Standard Deviation|9.23|9.23|||
4455925|NCT00074984|4277532|B3|≥40 years||Age, Customized||participants|Number|63|63.0||||||
4455926|NCT00074984|4277533|B2|≥40 years||Age, Customized||participants|Number|40|40.0||||||
4455927|NCT00074984|4277534|B1|≥40 years||Age, Customized||participants|Number|23|23.0||||||
4455928|NCT00074984|4277532|B3|<40 years||Age, Customized||participants|Number|19|19.0||||||
4455929|NCT00074984|4277533|B2|<40 years||Age, Customized||participants|Number|11|11.0||||||
4455930|NCT00074984|4277534|B1|<40 years||Age, Customized||participants|Number|8|8.0||||||
4455931|NCT00074984|4277532|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4455932|NCT00074984|4277533|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4455933|NCT00074984|4277534|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455934|NCT00074984|4277532|B3||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4455935|NCT00074984|4277533|B2||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4455936|NCT00074984|4277534|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4455937|NCT00074984|4277532|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4455938|NCT00074984|4277533|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4455939|NCT00074984|4277534|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4455940|NCT00074958|4277550|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4455941|NCT00074958|4277550|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4455942|NCT00074958|4277550|B1|||Age||years|Mean|12.1|12.1|Standard Deviation|2.52|2.52|||
4455943|NCT00074815|4277555|B4|United States||Region of Enrollment||participants|Number|124|124.0||||||
4455944|NCT00074815|4277556|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4455945|NCT00074815|4277557|B2|United States||Region of Enrollment||participants|Number|40|40.0||||||
4455946|NCT00074815|4277558|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4455947|NCT00074815|4277555|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4455948|NCT00074815|4277556|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4455949|NCT00074815|4277557|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4455950|NCT00074815|4277558|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4455951|NCT00074815|4277555|B4||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4455952|NCT00074815|4277556|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4455953|NCT00074815|4277557|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4455954|NCT00074815|4277558|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4455955|NCT00074815|4277555|B4|||Age||years|Mean|13.6|13.6|Standard Deviation|2.77|2.77|||
4455956|NCT00074815|4277556|B3|||Age||years|Mean|14.34|14.34|Standard Deviation|2.51|2.51|||
4455957|NCT00074815|4277557|B2|||Age||years|Mean|13.76|13.76|Standard Deviation|2.72|2.72|||
4455958|NCT00074815|4277558|B1|||Age||years|Mean|12.71|12.71|Standard Deviation|2.88|2.88|||
4455959|NCT00074815|4277555|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455960|NCT00074815|4277556|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455961|NCT00074815|4277557|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455962|NCT00074815|4277558|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4455963|NCT00074815|4277555|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4455964|NCT00074815|4277556|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4455965|NCT00074815|4277557|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4455966|NCT00074815|4277558|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4455967|NCT00074815|4277555|B4||<=18 years|Age||Participants|Count of Participants|124|124.0||||||
4455968|NCT00074815|4277556|B3||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4455969|NCT00074815|4277557|B2||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4455970|NCT00074815|4277558|B1||<=18 years|Age||Participants|Count of Participants|42|42.0||||||
4455971|NCT00074802|4277568|B3|||Quality of Life Inventory|The Quality of Life Inventory is a 16-item self-report measure of life satisfaction. Each item is rated for importance (0-2) and satisfaction (-3 to +3), and these ratings are multiplied, summed, and divided by the number of non-zero entries to yield an average item score, which can range from -6 to +6. Higher scores represent a higher quality of life.|units on a scale|Mean|0.48|0.48|Standard Deviation|1.66|1.66|||
4455972|NCT00074802|4277569|B2|||Quality of Life Inventory|The Quality of Life Inventory is a 16-item self-report measure of life satisfaction. Each item is rated for importance (0-2) and satisfaction (-3 to +3), and these ratings are multiplied, summed, and divided by the number of non-zero entries to yield an average item score, which can range from -6 to +6. Higher scores represent a higher quality of life.|units on a scale|Mean|0.31|0.31|Standard Deviation|1.67|1.67|||
4455973|NCT00074802|4277570|B1|||Quality of Life Inventory|The Quality of Life Inventory is a 16-item self-report measure of life satisfaction. Each item is rated for importance (0-2) and satisfaction (-3 to +3), and these ratings are multiplied, summed, and divided by the number of non-zero entries to yield an average item score, which can range from -6 to +6. Higher scores represent a higher quality of life.|units on a scale|Mean|0.67|0.67|Standard Deviation|1.65|1.65|||
4455974|NCT00074802|4277568|B3|||Liebowitz Self-Rated Disability Scale|The Liebowitz Self-Report Disability Scale is an 11-item self-report measure of the degree to which one's emotional problems limit one's ability to function in a variety of domains. Items are rated on a 0-3 scale of severity, and 10 of the 11 items (choosing either school or work as one area and omitting the other) are summed to produce a total score, ranging from 0-30. Higher scores represent greater disability.|units on a scale|Mean|7.42|7.42|Standard Deviation|4.52|4.52|||
4455975|NCT00074802|4277569|B2|||Liebowitz Self-Rated Disability Scale|The Liebowitz Self-Report Disability Scale is an 11-item self-report measure of the degree to which one's emotional problems limit one's ability to function in a variety of domains. Items are rated on a 0-3 scale of severity, and 10 of the 11 items (choosing either school or work as one area and omitting the other) are summed to produce a total score, ranging from 0-30. Higher scores represent greater disability.|units on a scale|Mean|6.58|6.58|Standard Deviation|4.40|4.4|||
4455976|NCT00074802|4277570|B1|||Liebowitz Self-Rated Disability Scale|The Liebowitz Self-Report Disability Scale is an 11-item self-report measure of the degree to which one's emotional problems limit one's ability to function in a variety of domains. Items are rated on a 0-3 scale of severity, and 10 of the 11 items (choosing either school or work as one area and omitting the other) are summed to produce a total score, ranging from 0-30. Higher scores represent greater disability.|units on a scale|Mean|8.42|8.42|Standard Deviation|4.56|4.56|||
4455977|NCT00074802|4277568|B3|||Brief Fear of Negative Evaluation Scale|The Brief Fear of Negative Evaluation Scale is a 12-item self-report measure of concern about negative evaluation by others. Items are rated on a 1-5 scale, yielding scores ranging from 12-60, with higher scores indicating greater fear of negative evaluation.|units on a scale|Mean|23.82|23.82|Standard Deviation|7.13|7.13|||
4455978|NCT00074802|4277569|B2|||Brief Fear of Negative Evaluation Scale|The Brief Fear of Negative Evaluation Scale is a 12-item self-report measure of concern about negative evaluation by others. Items are rated on a 1-5 scale, yielding scores ranging from 12-60, with higher scores indicating greater fear of negative evaluation.|units on a scale|Mean|21.83|21.83|Standard Deviation|6.41|6.41|||
4455979|NCT00074802|4277570|B1|||Brief Fear of Negative Evaluation Scale|The Brief Fear of Negative Evaluation Scale is a 12-item self-report measure of concern about negative evaluation by others. Items are rated on a 1-5 scale, yielding scores ranging from 12-60, with higher scores indicating greater fear of negative evaluation.|units on a scale|Mean|26.20|26.2|Standard Deviation|7.34|7.34|||
4455980|NCT00074802|4277568|B3|||Social Phobia Scale|The Social Phobia Scale is a 20-item self-report measure of anxiety experienced when being observed by others. Items are rated on a 0-4 scale, yielding a range of scores from 0-80, with higher scores representing greater anxiety.|units on a scale|Mean|18.62|18.62|Standard Deviation|11.29|11.29|||
4456020|NCT00074802|4277569|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4455981|NCT00074802|4277569|B2|||Social Phobia Scale|The Social Phobia Scale is a 20-item self-report measure of anxiety experienced when being observed by others. Items are rated on a 0-4 scale, yielding a range of scores from 0-80, with higher scores representing greater anxiety.|units on a scale|Mean|17.43|17.43|Standard Deviation|10.85|10.85|||
4455982|NCT00074802|4277570|B1|||Social Phobia Scale|The Social Phobia Scale is a 20-item self-report measure of anxiety experienced when being observed by others. Items are rated on a 0-4 scale, yielding a range of scores from 0-80, with higher scores representing greater anxiety.|units on a scale|Mean|20.04|20.04|Standard Deviation|11.87|11.87|||
4455983|NCT00074802|4277568|B3|||Social Interaction Anxiety Scale|The Social Interaction Anxiety Scale is a 20-item self-report measure of anxiety experienced while interacting in dyads or groups. Items are rated on a 0-4 scale, yielding a range of scores from 0-80, with higher scores representing greater anxiety.|units on a scale|Mean|37.19|37.19|Standard Deviation|11.85|11.85|||
4455984|NCT00074802|4277569|B2|||Social Interaction Anxiety Scale|The Social Interaction Anxiety Scale is a 20-item self-report measure of anxiety experienced while interacting in dyads or groups. Items are rated on a 0-4 scale, yielding a range of scores from 0-80, with higher scores representing greater anxiety.|units on a scale|Mean|35.43|35.43|Standard Deviation|12.35|12.35|||
4455985|NCT00074802|4277570|B1|||Social Interaction Anxiety Scale|The Social Interaction Anxiety Scale is a 20-item self-report measure of anxiety experienced while interacting in dyads or groups. Items are rated on a 0-4 scale, yielding a range of scores from 0-80, with higher scores representing greater anxiety.|units on a scale|Mean|39.30|39.3|Standard Deviation|11.08|11.08|||
4455986|NCT00074802|4277568|B3|||Liebowitz Social Anxiety Scale|The Liebowitz Social Anxiety Scale is a 24-item clinician-administered measure, which provides 0-3 ratings for anxiety and avoidance of social and performance situations. Anxiety and avoidance ratings are summed across items, yielding a range of scores from 0-144, with higher scores representing greater severity of social anxiety symptoms.|units on a scale|Mean|46.92|46.92|Standard Deviation|16.55|16.55|||
4455987|NCT00074802|4277569|B2|||Liebowitz Social Anxiety Scale|The Liebowitz Social Anxiety Scale is a 24-item clinician-administered measure, which provides 0-3 ratings for anxiety and avoidance of social and performance situations. Anxiety and avoidance ratings are summed across items, yielding a range of scores from 0-144, with higher scores representing greater severity of social anxiety symptoms.|units on a scale|Mean|44.63|44.63|Standard Deviation|13.60|13.6|||
4455988|NCT00074802|4277570|B1|||Liebowitz Social Anxiety Scale|The Liebowitz Social Anxiety Scale is a 24-item clinician-administered measure, which provides 0-3 ratings for anxiety and avoidance of social and performance situations. Anxiety and avoidance ratings are summed across items, yielding a range of scores from 0-144, with higher scores representing greater severity of social anxiety symptoms.|units on a scale|Mean|49.45|49.45|Standard Deviation|19.23|19.23|||
4455989|NCT00074802|4277568|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4455990|NCT00074802|4277569|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4455991|NCT00074802|4277570|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4455992|NCT00074802|4277568|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455993|NCT00074802|4277569|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455994|NCT00074802|4277570|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4455995|NCT00074802|4277568|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4455996|NCT00074802|4277569|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4455997|NCT00074802|4277570|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4455998|NCT00074802|4277568|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4455999|NCT00074802|4277569|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4456000|NCT00074802|4277570|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4456001|NCT00074802|4277568|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456002|NCT00074802|4277569|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456003|NCT00074802|4277570|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456004|NCT00074802|4277568|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4456005|NCT00074802|4277569|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4456006|NCT00074802|4277570|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4456007|NCT00074802|4277568|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456008|NCT00074802|4277569|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456009|NCT00074802|4277570|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456010|NCT00074802|4277568|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456011|NCT00074802|4277569|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456012|NCT00074802|4277570|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456013|NCT00074802|4277568|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4456014|NCT00074802|4277569|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4456015|NCT00074802|4277570|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4456016|NCT00074802|4277568|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4456017|NCT00074802|4277569|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4456018|NCT00074802|4277570|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4456019|NCT00074802|4277568|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4456021|NCT00074802|4277570|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4456022|NCT00074802|4277568|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4456023|NCT00074802|4277569|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4456024|NCT00074802|4277570|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4456025|NCT00074802|4277568|B3|||Age||years|Mean|33.72|33.72|Standard Deviation|11.05|11.05|||
4456026|NCT00074802|4277569|B2|||Age||years|Mean|32.22|32.22|Standard Deviation|9.73|9.73|||
4456027|NCT00074802|4277570|B1|||Age||years|Mean|35.38|35.38|Standard Deviation|12.30|12.3|||
4456028|NCT00074711|4277589|B3|United States||Region of Enrollment||participants|Number|241|241.0||||||
4456029|NCT00074711|4277590|B2|United States||Region of Enrollment||participants|Number|121|121.0||||||
4456030|NCT00074711|4277591|B1|United States||Region of Enrollment||participants|Number|120|120.0||||||
4456031|NCT00074711|4277589|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456032|NCT00074711|4277590|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456033|NCT00074711|4277591|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456034|NCT00074711|4277589|B3||Female|Sex: Female, Male||Participants|Count of Participants|241|241.0||||||
4456035|NCT00074711|4277590|B2||Female|Sex: Female, Male||Participants|Count of Participants|121|121.0||||||
4456036|NCT00074711|4277591|B1||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4456037|NCT00074711|4277589|B3|||Age||years|Mean|70.07|70.07|Standard Deviation|6.38|6.38|||
4456038|NCT00074711|4277590|B2|||Age||years|Mean|70.07|70.07|Standard Deviation|6.34|6.34|||
4456039|NCT00074711|4277591|B1|||Age||years|Mean|70.09|70.09|Standard Deviation|7.02|7.02|||
4456040|NCT00074711|4277589|B3||>=65 years|Age||Participants|Count of Participants|230|230.0||||||
4456041|NCT00074711|4277590|B2||>=65 years|Age||Participants|Count of Participants|115|115.0||||||
4456042|NCT00074711|4277591|B1||>=65 years|Age||Participants|Count of Participants|115|115.0||||||
4456043|NCT00074711|4277589|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4456044|NCT00074711|4277590|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4456045|NCT00074711|4277591|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4456046|NCT00074711|4277589|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456047|NCT00074711|4277590|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456048|NCT00074711|4277591|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456049|NCT00074581|4277608|B3|Africa||Region||participants|Number|1921|1921.0||||||
4456050|NCT00074581|4277609|B2|Africa||Region||participants|Number|960|960.0||||||
4456051|NCT00074581|4277610|B1|Africa||Region||participants|Number|961|961.0||||||
4456052|NCT00074581|4277608|B3|Asia||Region||participants|Number|1063|1063.0||||||
4456053|NCT00074581|4277609|B2|Asia||Region||participants|Number|528|528.0||||||
4456054|NCT00074581|4277610|B1|Asia||Region||participants|Number|535|535.0||||||
4456055|NCT00074581|4277608|B3|North or South America||Region||participants|Number|572|572.0||||||
4456056|NCT00074581|4277609|B2|North or South America||Region||participants|Number|279|279.0||||||
4456057|NCT00074581|4277610|B1|North or South America||Region||participants|Number|293|293.0||||||
4456058|NCT00074581|4277608|B3||Male|Gender||Participants|Count of Participants|1819|1819.0||||||
4456059|NCT00074581|4277609|B2||Male|Gender||Participants|Count of Participants|907|907.0||||||
4456060|NCT00074581|4277610|B1||Male|Gender||Participants|Count of Participants|912|912.0||||||
4456061|NCT00074581|4277608|B3||Female|Gender||Participants|Count of Participants|1737|1737.0||||||
4456062|NCT00074581|4277609|B2||Female|Gender||Participants|Count of Participants|860|860.0||||||
4456063|NCT00074581|4277610|B1||Female|Gender||Participants|Count of Participants|877|877.0||||||
4456064|NCT00074581|4277608|B3|>40 yr||Age, Customized||participants|Number|741|741.0||||||
4456065|NCT00074581|4277609|B2|>40 yr||Age, Customized||participants|Number|353|353.0||||||
4456066|NCT00074581|4277610|B1|>40 yr||Age, Customized||participants|Number|388|388.0||||||
4456067|NCT00074581|4277608|B3|26-40 yr||Age, Customized||participants|Number|2180|2180.0||||||
4456068|NCT00074581|4277609|B2|26-40 yr||Age, Customized||participants|Number|1079|1079.0||||||
4456069|NCT00074581|4277610|B1|26-40 yr||Age, Customized||participants|Number|1101|1101.0||||||
4456070|NCT00074581|4277608|B3|18-25 yr||Age, Customized||participants|Number|635|635.0||||||
4456071|NCT00074581|4277609|B2|18-25 yr||Age, Customized||participants|Number|335|335.0||||||
4456072|NCT00074581|4277610|B1|18-25 yr||Age, Customized||participants|Number|300|300.0||||||
4456073|NCT00074490|4277619|B6|United States||Region of Enrollment||Participants|Count of Participants|164|164.0||||||
4456074|NCT00074490|4277620|B5|United States||Region of Enrollment||Participants|Count of Participants|45|45.0||||||
4456075|NCT00074490|4277621|B4|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4456076|NCT00074490|4277622|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4456077|NCT00074490|4277623|B2|United States||Region of Enrollment||Participants|Count of Participants|34|34.0||||||
4456078|NCT00074490|4277624|B1|United States||Region of Enrollment||Participants|Count of Participants|1|1.0||||||
4456079|NCT00074490|4277619|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4456080|NCT00074490|4277620|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4456081|NCT00074490|4277621|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4456082|NCT00074490|4277622|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4456083|NCT00074490|4277623|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4456084|NCT00074490|4277624|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456085|NCT00074490|4277619|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456086|NCT00074490|4277620|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456087|NCT00074490|4277621|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456088|NCT00074490|4277622|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456089|NCT00074490|4277623|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456090|NCT00074490|4277624|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456091|NCT00074490|4277619|B6||White|Race (NIH/OMB)||Participants|Count of Participants|115|115.0||||||
4456092|NCT00074490|4277620|B5||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4456093|NCT00074490|4277621|B4||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4456094|NCT00074490|4277622|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4456095|NCT00074490|4277623|B2||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4456096|NCT00074490|4277624|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4456097|NCT00074490|4277619|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4456098|NCT00074490|4277620|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4456099|NCT00074490|4277621|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4456100|NCT00074490|4277622|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4456101|NCT00074490|4277623|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4456102|NCT00074490|4277624|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456103|NCT00074490|4277619|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456104|NCT00074490|4277620|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456105|NCT00074490|4277621|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456106|NCT00074490|4277622|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456107|NCT00074490|4277623|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456108|NCT00074490|4277624|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456109|NCT00074490|4277619|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4456110|NCT00074490|4277620|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4456111|NCT00074490|4277621|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4456112|NCT00074490|4277622|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456113|NCT00074490|4277623|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4456114|NCT00074490|4277624|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456115|NCT00074490|4277619|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456116|NCT00074490|4277620|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456117|NCT00074490|4277621|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456118|NCT00074490|4277622|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456119|NCT00074490|4277623|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456120|NCT00074490|4277624|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456121|NCT00074490|4277619|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456122|NCT00074490|4277620|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456123|NCT00074490|4277621|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456124|NCT00074490|4277622|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456125|NCT00074490|4277623|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456126|NCT00074490|4277624|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456127|NCT00074490|4277619|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|131|131.0||||||
4456128|NCT00074490|4277620|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4456129|NCT00074490|4277621|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4456130|NCT00074490|4277622|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4456131|NCT00074490|4277623|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4456132|NCT00074490|4277624|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4456133|NCT00074490|4277619|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4456134|NCT00074490|4277620|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4456135|NCT00074490|4277621|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4456136|NCT00074490|4277622|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4456137|NCT00074490|4277623|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4456138|NCT00074490|4277624|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456139|NCT00074490|4277619|B6||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4456140|NCT00074490|4277620|B5||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4456141|NCT00074490|4277621|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4456142|NCT00074490|4277622|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4456143|NCT00074490|4277623|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4456144|NCT00074490|4277624|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4456145|NCT00074490|4277619|B6||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4456146|NCT00074490|4277620|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4456147|NCT00074490|4277621|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4456148|NCT00074490|4277622|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4456149|NCT00074490|4277623|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4456150|NCT00074490|4277624|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456151|NCT00074490|4277619|B6|||Age||years|Mean|49.44|49.44|Standard Deviation|13.12|13.12|||
4456152|NCT00074490|4277620|B5|||Age||years|Mean|50.19|50.19|Standard Deviation|13.50|13.5|||
4456153|NCT00074490|4277621|B4|||Age||years|Mean|47.66|47.66|Standard Deviation|12.45|12.45|||
4456154|NCT00074490|4277622|B3|||Age||years|Mean|49.68|49.68|Standard Deviation|12.92|12.92|||
4456155|NCT00074490|4277623|B2|||Age||years|Mean|45.96|45.96|Standard Deviation|12.41|12.41|||
4456156|NCT00074490|4277624|B1|||Age||years|Mean|56|56.0|Standard Deviation|||||
4456157|NCT00074490|4277619|B6||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4456158|NCT00074490|4277620|B5||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4456159|NCT00074490|4277621|B4||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4456160|NCT00074490|4277622|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4456161|NCT00074490|4277623|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4456162|NCT00074490|4277624|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456163|NCT00074490|4277619|B6||Between 18 and 65 years|Age||Participants|Count of Participants|153|153.0||||||
4456164|NCT00074490|4277620|B5||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4456165|NCT00074490|4277621|B4||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4456166|NCT00074490|4277622|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4456167|NCT00074490|4277623|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4456168|NCT00074490|4277624|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4456169|NCT00074490|4277619|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456170|NCT00074490|4277620|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456171|NCT00074490|4277621|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456172|NCT00074490|4277622|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456173|NCT00074490|4277623|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456174|NCT00074490|4277624|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456175|NCT00074412|4277661|B3|>=3500||Categorical Infant Birthweight (g)||participants|Number|329|329.0||||||
4456176|NCT00074412|4277662|B2|>=3500||Categorical Infant Birthweight (g)||participants|Number|163|163.0||||||
4456177|NCT00074412|4277663|B1|>=3500||Categorical Infant Birthweight (g)||participants|Number|166|166.0||||||
4456178|NCT00074412|4277661|B3|3000-3499||Categorical Infant Birthweight (g)||participants|Number|665|665.0||||||
4456179|NCT00074412|4277662|B2|3000-3499||Categorical Infant Birthweight (g)||participants|Number|336|336.0||||||
4456180|NCT00074412|4277663|B1|3000-3499||Categorical Infant Birthweight (g)||participants|Number|329|329.0||||||
4456181|NCT00074412|4277661|B3|2500-2999||Categorical Infant Birthweight (g)||participants|Number|425|425.0||||||
4456182|NCT00074412|4277662|B2|2500-2999||Categorical Infant Birthweight (g)||participants|Number|211|211.0||||||
4456183|NCT00074412|4277663|B1|2500-2999||Categorical Infant Birthweight (g)||participants|Number|214|214.0||||||
4456184|NCT00074412|4277661|B3|2000-2499||Categorical Infant Birthweight (g)||participants|Number|102|102.0||||||
4456185|NCT00074412|4277662|B2|2000-2499||Categorical Infant Birthweight (g)||participants|Number|52|52.0||||||
4456186|NCT00074412|4277663|B1|2000-2499||Categorical Infant Birthweight (g)||participants|Number|50|50.0||||||
4456187|NCT00074412|4277661|B3|Missing||Categorical Infant Birthweight (g)||participants|Number|1|1.0||||||
4456188|NCT00074412|4277662|B2|Missing||Categorical Infant Birthweight (g)||participants|Number|1|1.0||||||
4456189|NCT00074412|4277663|B1|Missing||Categorical Infant Birthweight (g)||participants|Number|0|0.0||||||
4456190|NCT00074412|4277661|B3|Zimbabwe||Region of Enrollment||participants|Number|463|463.0||||||
4456191|NCT00074412|4277662|B2|Zimbabwe||Region of Enrollment||participants|Number|232|232.0||||||
4456192|NCT00074412|4277663|B1|Zimbabwe||Region of Enrollment||participants|Number|231|231.0||||||
4456193|NCT00074412|4277661|B3|South Africa||Region of Enrollment||participants|Number|342|342.0||||||
4456194|NCT00074412|4277662|B2|South Africa||Region of Enrollment||participants|Number|171|171.0||||||
4456195|NCT00074412|4277663|B1|South Africa||Region of Enrollment||participants|Number|171|171.0||||||
4456196|NCT00074412|4277661|B3|Uganda||Region of Enrollment||participants|Number|520|520.0||||||
4456197|NCT00074412|4277662|B2|Uganda||Region of Enrollment||participants|Number|261|261.0||||||
4456198|NCT00074412|4277663|B1|Uganda||Region of Enrollment||participants|Number|259|259.0||||||
4456199|NCT00074412|4277661|B3|Tanzania||Region of Enrollment||participants|Number|197|197.0||||||
4456200|NCT00074412|4277662|B2|Tanzania||Region of Enrollment||participants|Number|99|99.0||||||
4456201|NCT00074412|4277663|B1|Tanzania||Region of Enrollment||participants|Number|98|98.0||||||
4456202|NCT00074412|4277661|B3|Female||Sex/Gender, Customized||participants|Number|760|760.0||||||
4456203|NCT00074412|4277662|B2|Female||Sex/Gender, Customized||participants|Number|365|365.0||||||
4456204|NCT00074412|4277663|B1|Female||Sex/Gender, Customized||participants|Number|395|395.0||||||
4456205|NCT00074412|4277661|B3|Male||Sex/Gender, Customized||participants|Number|761|761.0||||||
4456206|NCT00074412|4277662|B2|Male||Sex/Gender, Customized||participants|Number|398|398.0||||||
4456207|NCT00074412|4277663|B1|Male||Sex/Gender, Customized||participants|Number|363|363.0||||||
4456208|NCT00074412|4277661|B3|Ambiguous||Sex/Gender, Customized||participants|Number|1|1.0||||||
4456209|NCT00074412|4277662|B2|Ambiguous||Sex/Gender, Customized||participants|Number|0|0.0||||||
4456210|NCT00074412|4277663|B1|Ambiguous||Sex/Gender, Customized||participants|Number|1|1.0||||||
4456211|NCT00074412|4277661|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456212|NCT00074412|4277662|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456213|NCT00074412|4277663|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456214|NCT00074412|4277661|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4456215|NCT00074412|4277662|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4456216|NCT00074412|4277663|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4456217|NCT00074412|4277661|B3||<=18 years|Age||Participants|Count of Participants|1522|1522.0||||||
4456218|NCT00074412|4277662|B2||<=18 years|Age||Participants|Count of Participants|763|763.0||||||
4456219|NCT00074412|4277663|B1||<=18 years|Age||Participants|Count of Participants|759|759.0||||||
4456220|NCT00074308|4277678|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4456221|NCT00074308|4277679|B2|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4456222|NCT00074308|4277680|B1|United States||Region of Enrollment||Participants|Count of Participants|17|17.0||||||
4456223|NCT00074308|4277678|B3|Arm 1|Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4456224|NCT00074308|4277679|B2|Arm 1|Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4456225|NCT00074308|4277680|B1|Arm 1|Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4456226|NCT00074308|4277678|B3|Arm 1|Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4456227|NCT00074308|4277679|B2|Arm 1|Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4456228|NCT00074308|4277680|B1|Arm 1|Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4456229|NCT00074308|4277678|B3|Arm 1|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456230|NCT00074308|4277679|B2|Arm 1|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456231|NCT00074308|4277680|B1|Arm 1|>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456232|NCT00074308|4277678|B3|Arm 1|Between 18 and 65 years|Age||Participants|Count of Participants|40|40.0||||||
4456233|NCT00074308|4277679|B2|Arm 1|Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4456234|NCT00074308|4277680|B1|Arm 1|Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4456235|NCT00074308|4277678|B3|Arm 1|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456236|NCT00074308|4277679|B2|Arm 1|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456237|NCT00074308|4277680|B1|Arm 1|<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456238|NCT00074269|4277695|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456239|NCT00074269|4277695|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4456240|NCT00074269|4277695|B1|||Age||years|Median|45|45.0|Full Range|||40.0|57.0|
4456241|NCT00074165|4277705|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4456242|NCT00074165|4277705|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4456243|NCT00074165|4277705|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4456244|NCT00074165|4277705|B1|||Age||years|Mean|55.235|55.235|Standard Deviation|12.799|12.799|||
4456245|NCT00074165|4277705|B1||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4456246|NCT00074165|4277705|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4456247|NCT00074165|4277705|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456248|NCT00074152|4277710|B3|unknown||Estrogen receptor (ER) status of primary tumor||participants|Number|19|19.0||||||
4456249|NCT00074152|4277711|B2|unknown||Estrogen receptor (ER) status of primary tumor||participants|Number|9|9.0||||||
4456250|NCT00074152|4277712|B1|unknown||Estrogen receptor (ER) status of primary tumor||participants|Number|10|10.0||||||
4456251|NCT00074152|4277710|B3|positive||Estrogen receptor (ER) status of primary tumor||participants|Number|96|96.0||||||
4456252|NCT00074152|4277711|B2|positive||Estrogen receptor (ER) status of primary tumor||participants|Number|49|49.0||||||
4456253|NCT00074152|4277712|B1|positive||Estrogen receptor (ER) status of primary tumor||participants|Number|47|47.0||||||
4456254|NCT00074152|4277710|B3|negative||Estrogen receptor (ER) status of primary tumor||participants|Number|47|47.0||||||
4456255|NCT00074152|4277711|B2|negative||Estrogen receptor (ER) status of primary tumor||participants|Number|27|27.0||||||
4456256|NCT00074152|4277712|B1|negative||Estrogen receptor (ER) status of primary tumor||participants|Number|20|20.0||||||
4456257|NCT00074152|4277710|B3|||Time from primary surgery to isolated loco-regional recurrence (ILRR) surgery||years|Median|5.5|5.5|Full Range|||2.9|11.3|
4456258|NCT00074152|4277711|B2|||Time from primary surgery to isolated loco-regional recurrence (ILRR) surgery||years|Median|5.0|5.0|Full Range|||2.9|9.5|
4456259|NCT00074152|4277712|B1|||Time from primary surgery to isolated loco-regional recurrence (ILRR) surgery||years|Median|6.2|6.2|Full Range|||2.9|11.3|
4456313|NCT00074152|4277712|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4456260|NCT00074152|4277710|B3|post||Menopausal Status at isolated loco-regional recurrence (ILRR)||participants|Number|128|128.0||||||
4456261|NCT00074152|4277711|B2|post||Menopausal Status at isolated loco-regional recurrence (ILRR)||participants|Number|65|65.0||||||
4456262|NCT00074152|4277712|B1|post||Menopausal Status at isolated loco-regional recurrence (ILRR)||participants|Number|63|63.0||||||
4456263|NCT00074152|4277710|B3|pre||Menopausal Status at isolated loco-regional recurrence (ILRR)||participants|Number|34|34.0||||||
4456264|NCT00074152|4277711|B2|pre||Menopausal Status at isolated loco-regional recurrence (ILRR)||participants|Number|20|20.0||||||
4456265|NCT00074152|4277712|B1|pre||Menopausal Status at isolated loco-regional recurrence (ILRR)||participants|Number|14|14.0||||||
4456266|NCT00074152|4277710|B3|Regional lymph nodes||Location of isolated loco-regional recurrence (ILRR)||participants|Number|21|21.0||||||
4456267|NCT00074152|4277711|B2|Regional lymph nodes||Location of isolated loco-regional recurrence (ILRR)||participants|Number|11|11.0||||||
4456268|NCT00074152|4277712|B1|Regional lymph nodes||Location of isolated loco-regional recurrence (ILRR)||participants|Number|10|10.0||||||
4456269|NCT00074152|4277710|B3|Mx scar/chest wall||Location of isolated loco-regional recurrence (ILRR)||participants|Number|53|53.0||||||
4456270|NCT00074152|4277711|B2|Mx scar/chest wall||Location of isolated loco-regional recurrence (ILRR)||participants|Number|27|27.0||||||
4456271|NCT00074152|4277712|B1|Mx scar/chest wall||Location of isolated loco-regional recurrence (ILRR)||participants|Number|26|26.0||||||
4456272|NCT00074152|4277710|B3|Breast||Location of isolated loco-regional recurrence (ILRR)||participants|Number|88|88.0||||||
4456273|NCT00074152|4277711|B2|Breast||Location of isolated loco-regional recurrence (ILRR)||participants|Number|47|47.0||||||
4456274|NCT00074152|4277712|B1|Breast||Location of isolated loco-regional recurrence (ILRR)||participants|Number|41|41.0||||||
4456275|NCT00074152|4277710|B3|not available||Progesterone receptor (PgR) status of the isolated local or regional recurrence||participants|Number|4|4.0||||||
4456276|NCT00074152|4277711|B2|not available||Progesterone receptor (PgR) status of the isolated local or regional recurrence||participants|Number|2|2.0||||||
4456277|NCT00074152|4277712|B1|not available||Progesterone receptor (PgR) status of the isolated local or regional recurrence||participants|Number|2|2.0||||||
4456278|NCT00074152|4277710|B3|negative||Progesterone receptor (PgR) status of the isolated local or regional recurrence||participants|Number|79|79.0||||||
4456279|NCT00074152|4277711|B2|negative||Progesterone receptor (PgR) status of the isolated local or regional recurrence||participants|Number|39|39.0||||||
4456280|NCT00074152|4277712|B1|negative||Progesterone receptor (PgR) status of the isolated local or regional recurrence||participants|Number|40|40.0||||||
4456281|NCT00074152|4277710|B3|positive||Progesterone receptor (PgR) status of the isolated local or regional recurrence||participants|Number|79|79.0||||||
4456282|NCT00074152|4277711|B2|positive||Progesterone receptor (PgR) status of the isolated local or regional recurrence||participants|Number|44|44.0||||||
4456283|NCT00074152|4277712|B1|positive||Progesterone receptor (PgR) status of the isolated local or regional recurrence||participants|Number|35|35.0||||||
4456284|NCT00074152|4277710|B3|Negative||Estrogen receptor (ER) status of the isolated local or regional recurrence||participants|Number|58|58.0||||||
4456285|NCT00074152|4277711|B2|Negative||Estrogen receptor (ER) status of the isolated local or regional recurrence||participants|Number|29|29.0||||||
4456286|NCT00074152|4277712|B1|Negative||Estrogen receptor (ER) status of the isolated local or regional recurrence||participants|Number|29|29.0||||||
4456287|NCT00074152|4277710|B3|Positive||Estrogen receptor (ER) status of the isolated local or regional recurrence||participants|Number|104|104.0||||||
4456288|NCT00074152|4277711|B2|Positive||Estrogen receptor (ER) status of the isolated local or regional recurrence||participants|Number|56|56.0||||||
4456289|NCT00074152|4277712|B1|Positive||Estrogen receptor (ER) status of the isolated local or regional recurrence||participants|Number|48|48.0||||||
4456290|NCT00074152|4277710|B3|Breast conserving||Surgery for primary tumor||participants|Number|98|98.0||||||
4456291|NCT00074152|4277711|B2|Breast conserving||Surgery for primary tumor||participants|Number|52|52.0||||||
4456292|NCT00074152|4277712|B1|Breast conserving||Surgery for primary tumor||participants|Number|46|46.0||||||
4456293|NCT00074152|4277710|B3|Mastectomy||Surgery for primary tumor||participants|Number|64|64.0||||||
4456294|NCT00074152|4277711|B2|Mastectomy||Surgery for primary tumor||participants|Number|33|33.0||||||
4456295|NCT00074152|4277712|B1|Mastectomy||Surgery for primary tumor||participants|Number|31|31.0||||||
4456296|NCT00074152|4277710|B3|No||Prior chemotherapy||participants|Number|61|61.0||||||
4456297|NCT00074152|4277711|B2|No||Prior chemotherapy||participants|Number|36|36.0||||||
4456298|NCT00074152|4277712|B1|No||Prior chemotherapy||participants|Number|25|25.0||||||
4456299|NCT00074152|4277710|B3|Yes||Prior chemotherapy||participants|Number|101|101.0||||||
4456300|NCT00074152|4277711|B2|Yes||Prior chemotherapy||participants|Number|49|49.0||||||
4456301|NCT00074152|4277712|B1|Yes||Prior chemotherapy||participants|Number|52|52.0||||||
4456302|NCT00074152|4277710|B3|Switzerland||Region of Enrollment||participants|Number|16|16.0||||||
4456303|NCT00074152|4277711|B2|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
4456304|NCT00074152|4277712|B1|Switzerland||Region of Enrollment||participants|Number|6|6.0||||||
4456305|NCT00074152|4277710|B3|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
4456306|NCT00074152|4277711|B2|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4456307|NCT00074152|4277712|B1|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4456308|NCT00074152|4277710|B3|South Africa||Region of Enrollment||participants|Number|5|5.0||||||
4456309|NCT00074152|4277711|B2|South Africa||Region of Enrollment||participants|Number|2|2.0||||||
4456310|NCT00074152|4277712|B1|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
4456311|NCT00074152|4277710|B3|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4456312|NCT00074152|4277711|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4456314|NCT00074152|4277710|B3|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4456315|NCT00074152|4277711|B2|Peru||Region of Enrollment||participants|Number|0|0.0||||||
4456316|NCT00074152|4277712|B1|Peru||Region of Enrollment||participants|Number|1|1.0||||||
4456317|NCT00074152|4277710|B3|Spain||Region of Enrollment||participants|Number|20|20.0||||||
4456318|NCT00074152|4277711|B2|Spain||Region of Enrollment||participants|Number|11|11.0||||||
4456319|NCT00074152|4277712|B1|Spain||Region of Enrollment||participants|Number|9|9.0||||||
4456320|NCT00074152|4277710|B3|Canada||Region of Enrollment||participants|Number|31|31.0||||||
4456321|NCT00074152|4277711|B2|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4456322|NCT00074152|4277712|B1|Canada||Region of Enrollment||participants|Number|15|15.0||||||
4456323|NCT00074152|4277710|B3|Hungary||Region of Enrollment||participants|Number|33|33.0||||||
4456324|NCT00074152|4277711|B2|Hungary||Region of Enrollment||participants|Number|16|16.0||||||
4456325|NCT00074152|4277712|B1|Hungary||Region of Enrollment||participants|Number|17|17.0||||||
4456326|NCT00074152|4277710|B3|United States||Region of Enrollment||participants|Number|42|42.0||||||
4456327|NCT00074152|4277711|B2|United States||Region of Enrollment||participants|Number|23|23.0||||||
4456328|NCT00074152|4277712|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4456329|NCT00074152|4277710|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456330|NCT00074152|4277711|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456331|NCT00074152|4277712|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456332|NCT00074152|4277710|B3||Female|Sex: Female, Male||Participants|Count of Participants|162|162.0||||||
4456333|NCT00074152|4277711|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4456334|NCT00074152|4277712|B1||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4456335|NCT00074152|4277710|B3||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4456336|NCT00074152|4277711|B2||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4456337|NCT00074152|4277712|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4456338|NCT00074152|4277710|B3||Between 18 and 65 years|Age||Participants|Count of Participants|131|131.0||||||
4456339|NCT00074152|4277711|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4456340|NCT00074152|4277712|B1||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4456341|NCT00074152|4277710|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456342|NCT00074152|4277711|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456343|NCT00074152|4277712|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456344|NCT00074035|4277723|B1|United States||Region of Enrollment||count of participants|Number|38|38.0||||||
4456345|NCT00074035|4277723|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4456346|NCT00074035|4277723|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4456347|NCT00074035|4277723|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4456348|NCT00074035|4277723|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4456349|NCT00074035|4277723|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456350|NCT00074035|4277723|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4456351|NCT00074035|4277723|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456352|NCT00074035|4277723|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4456353|NCT00074035|4277723|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4456354|NCT00074035|4277723|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4456355|NCT00074035|4277723|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4456356|NCT00074035|4277723|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4456357|NCT00074035|4277723|B1|||Age||years|Median|48|48.0|Full Range|||28.0|79.0|
4456358|NCT00073983|4277730|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4456359|NCT00073983|4277730|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4456360|NCT00073983|4277730|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4456361|NCT00073983|4277730|B1|||Age||years|Mean|43|43.0|Standard Deviation|19|19.0|||
4456362|NCT00073983|4277730|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4456363|NCT00073983|4277730|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4456364|NCT00073983|4277730|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4456365|NCT00073957|4277745|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4456366|NCT00073957|4277745|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456367|NCT00073957|4277745|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4456368|NCT00073957|4277745|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4456369|NCT00073957|4277745|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4456370|NCT00073957|4277745|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4456371|NCT00073957|4277745|B1|||Age||years|Mean|70|70.0|Full Range|||60.0|82.0|
4456372|NCT00073918|4277751|B1|United States||Region of Enrollment||participants|Number|111|111.0||||||
4456373|NCT00073918|4277751|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4456374|NCT00073918|4277751|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456375|NCT00073918|4277751|B1||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4456376|NCT00073918|4277751|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4456377|NCT00073918|4277751|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456378|NCT00073918|4277751|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4456379|NCT00073918|4277751|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4456380|NCT00073918|4277751|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4456381|NCT00073918|4277751|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4456382|NCT00073918|4277751|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4456383|NCT00073918|4277751|B1||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4456384|NCT00073918|4277751|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4456385|NCT00073918|4277751|B1|||Age||years|Median|52.3|52.3|Full Range|||32.0|59.0|
4456386|NCT00073918|4277751|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456387|NCT00073918|4277751|B1||Between 18 and 65 years|Age||Participants|Count of Participants|111|111.0||||||
4456388|NCT00073918|4277751|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456389|NCT00073749|4277758|B8||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4456390|NCT00073749|4277759|B7||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4456391|NCT00073749|4277760|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4456392|NCT00073749|4277761|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4456393|NCT00073749|4277762|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4456394|NCT00073749|4277763|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4456395|NCT00073749|4277764|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4456396|NCT00073749|4277765|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4456397|NCT00073749|4277758|B8||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4456398|NCT00073749|4277759|B7||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4456399|NCT00073749|4277760|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4456400|NCT00073749|4277761|B5||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4456401|NCT00073749|4277762|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456402|NCT00073749|4277763|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4456403|NCT00073749|4277764|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4456404|NCT00073749|4277765|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456405|NCT00073749|4277758|B8|||Age||years|Mean|59.46|59.46|Standard Deviation|11.29|11.29|||
4456406|NCT00073749|4277759|B7|||Age||years|Mean|57.30|57.3|Standard Deviation|10.91|10.91|||
4456407|NCT00073749|4277760|B6|||Age||years|Mean|57.17|57.17|Standard Deviation|12.25|12.25|||
4456408|NCT00073749|4277761|B5|||Age||years|Mean|60.00|60.0|Standard Deviation|12.82|12.82|||
4456409|NCT00073749|4277762|B4|||Age||years|Mean|56.67|56.67|Standard Deviation|5.96|5.96|||
4456410|NCT00073749|4277763|B3|||Age||years|Mean|65.45|65.45|Standard Deviation|10.56|10.56|||
4456411|NCT00073749|4277764|B2|||Age||years|Mean|73.80|73.8|Standard Deviation|2.59|2.59|||
4456412|NCT00073749|4277765|B1|||Age||years|Mean|50.50|50.5|Standard Deviation|13.44|13.44|||
4456413|NCT00073528|4277800|B3||Other|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4456414|NCT00073528|4277801|B2||Other|Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4456415|NCT00073528|4277802|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4456416|NCT00073528|4277800|B3||American Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|101|101.0||||||
4456417|NCT00073528|4277801|B2||American Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|57|57.0||||||
4456418|NCT00073528|4277802|B1||American Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|44|44.0||||||
4456419|NCT00073528|4277800|B3||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
4456420|NCT00073528|4277801|B2||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4456421|NCT00073528|4277802|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4456422|NCT00073528|4277800|B3||Black|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4456423|NCT00073528|4277801|B2||Black|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4456424|NCT00073528|4277802|B1||Black|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4456425|NCT00073528|4277800|B3||White|Race/Ethnicity, Customized||Participants|Count of Participants|1086|1086.0||||||
4456426|NCT00073528|4277801|B2||White|Race/Ethnicity, Customized||Participants|Count of Participants|529|529.0||||||
4456427|NCT00073528|4277802|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|557|557.0||||||
4456428|NCT00073528|4277800|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456429|NCT00073528|4277801|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456430|NCT00073528|4277802|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456431|NCT00073528|4277800|B3||Female|Sex: Female, Male||Participants|Count of Participants|1286|1286.0||||||
4456432|NCT00073528|4277801|B2||Female|Sex: Female, Male||Participants|Count of Participants|642|642.0||||||
4456433|NCT00073528|4277802|B1||Female|Sex: Female, Male||Participants|Count of Participants|644|644.0||||||
4456434|NCT00073528|4277800|B3|||Age||Years|Mean|63.1|63.1|Standard Deviation|9.83|9.83|||
4456435|NCT00073528|4277801|B2|||Age||Years|Mean|62.8|62.8|Standard Deviation|9.70|9.7|||
4456436|NCT00073528|4277802|B1|||Age||Years|Mean|63.3|63.3|Standard Deviation|9.95|9.95|||
4456437|NCT00073333|4277877|B4|United States||Region of Enrollment||participants|Number|106|106.0||||||
4456438|NCT00073333|4277878|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4456439|NCT00073333|4277879|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4456440|NCT00073333|4277880|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4456441|NCT00073333|4277877|B4||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4456442|NCT00073333|4277878|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4456443|NCT00073333|4277879|B2||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4456444|NCT00073333|4277880|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4456445|NCT00073333|4277877|B4||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4456446|NCT00073333|4277878|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4456447|NCT00073333|4277879|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4456448|NCT00073333|4277880|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4456449|NCT00073333|4277877|B4|||Age||years|Mean|36.3|36.3|Standard Deviation|13.9|13.9|||
4456450|NCT00073333|4277878|B3|||Age||years|Mean|36.4|36.4|Standard Deviation|14.2|14.2|||
4456451|NCT00073333|4277879|B2|||Age||years|Mean|36.1|36.1|Standard Deviation|13.8|13.8|||
4456452|NCT00073333|4277880|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|14.4|14.4|||
4456453|NCT00073333|4277877|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4456454|NCT00073333|4277878|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456455|NCT00073333|4277879|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456456|NCT00073333|4277880|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4456457|NCT00073333|4277877|B4||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4456458|NCT00073333|4277878|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4456459|NCT00073333|4277879|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4456460|NCT00073333|4277880|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4456461|NCT00073333|4277877|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456462|NCT00073333|4277878|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456463|NCT00073333|4277879|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456464|NCT00073333|4277880|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456465|NCT00073307|4277890|B3|Granular||Cancer Subtypes|"Histopathological characterization of renal cell carcinomas that subjects had included clear cell, papillary or granular carcinomas. Clear cell renal cell carcinoma is a renal cortical tumor typically characterized by malignant epithelial cells with clear cytoplasm and a compact-alveolar (nested) or acinar growth pattern interspersed with intricate, arborizing vasculature.~Tumors in which eosinophilic cells predominate were classified as granular cell carcinoma.~Papillary renal cell carcinoma is an uncommon subtype that has distinctive gross, histologic, and cytogenetic features."|Participants with carcinoma type|Number|3|3.0||||||
4456466|NCT00073307|4277891|B2|Granular||Cancer Subtypes|"Histopathological characterization of renal cell carcinomas that subjects had included clear cell, papillary or granular carcinomas. Clear cell renal cell carcinoma is a renal cortical tumor typically characterized by malignant epithelial cells with clear cytoplasm and a compact-alveolar (nested) or acinar growth pattern interspersed with intricate, arborizing vasculature.~Tumors in which eosinophilic cells predominate were classified as granular cell carcinoma.~Papillary renal cell carcinoma is an uncommon subtype that has distinctive gross, histologic, and cytogenetic features."|Participants with carcinoma type|Number|2|2.0||||||
4456467|NCT00073307|4277892|B1|Granular||Cancer Subtypes|"Histopathological characterization of renal cell carcinomas that subjects had included clear cell, papillary or granular carcinomas. Clear cell renal cell carcinoma is a renal cortical tumor typically characterized by malignant epithelial cells with clear cytoplasm and a compact-alveolar (nested) or acinar growth pattern interspersed with intricate, arborizing vasculature.~Tumors in which eosinophilic cells predominate were classified as granular cell carcinoma.~Papillary renal cell carcinoma is an uncommon subtype that has distinctive gross, histologic, and cytogenetic features."|Participants with carcinoma type|Number|1|1.0||||||
4456468|NCT00073307|4277890|B3|Papillary||Cancer Subtypes|"Histopathological characterization of renal cell carcinomas that subjects had included clear cell, papillary or granular carcinomas. Clear cell renal cell carcinoma is a renal cortical tumor typically characterized by malignant epithelial cells with clear cytoplasm and a compact-alveolar (nested) or acinar growth pattern interspersed with intricate, arborizing vasculature.~Tumors in which eosinophilic cells predominate were classified as granular cell carcinoma.~Papillary renal cell carcinoma is an uncommon subtype that has distinctive gross, histologic, and cytogenetic features."|Participants with carcinoma type|Number|4|4.0||||||
4456469|NCT00073307|4277891|B2|Papillary||Cancer Subtypes|"Histopathological characterization of renal cell carcinomas that subjects had included clear cell, papillary or granular carcinomas. Clear cell renal cell carcinoma is a renal cortical tumor typically characterized by malignant epithelial cells with clear cytoplasm and a compact-alveolar (nested) or acinar growth pattern interspersed with intricate, arborizing vasculature.~Tumors in which eosinophilic cells predominate were classified as granular cell carcinoma.~Papillary renal cell carcinoma is an uncommon subtype that has distinctive gross, histologic, and cytogenetic features."|Participants with carcinoma type|Number|3|3.0||||||
4456481|NCT00073307|4277891|B2|Missing||ECOG Performance Status (PS)|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants by scale|Number|2|2.0||||||
4456470|NCT00073307|4277892|B1|Papillary||Cancer Subtypes|"Histopathological characterization of renal cell carcinomas that subjects had included clear cell, papillary or granular carcinomas. Clear cell renal cell carcinoma is a renal cortical tumor typically characterized by malignant epithelial cells with clear cytoplasm and a compact-alveolar (nested) or acinar growth pattern interspersed with intricate, arborizing vasculature.~Tumors in which eosinophilic cells predominate were classified as granular cell carcinoma.~Papillary renal cell carcinoma is an uncommon subtype that has distinctive gross, histologic, and cytogenetic features."|Participants with carcinoma type|Number|1|1.0||||||
4456471|NCT00073307|4277890|B3|Clear Cell||Cancer Subtypes|"Histopathological characterization of renal cell carcinomas that subjects had included clear cell, papillary or granular carcinomas. Clear cell renal cell carcinoma is a renal cortical tumor typically characterized by malignant epithelial cells with clear cytoplasm and a compact-alveolar (nested) or acinar growth pattern interspersed with intricate, arborizing vasculature.~Tumors in which eosinophilic cells predominate were classified as granular cell carcinoma.~Papillary renal cell carcinoma is an uncommon subtype that has distinctive gross, histologic, and cytogenetic features."|Participants with carcinoma type|Number|896|896.0||||||
4456472|NCT00073307|4277891|B2|Clear Cell||Cancer Subtypes|"Histopathological characterization of renal cell carcinomas that subjects had included clear cell, papillary or granular carcinomas. Clear cell renal cell carcinoma is a renal cortical tumor typically characterized by malignant epithelial cells with clear cytoplasm and a compact-alveolar (nested) or acinar growth pattern interspersed with intricate, arborizing vasculature.~Tumors in which eosinophilic cells predominate were classified as granular cell carcinoma.~Papillary renal cell carcinoma is an uncommon subtype that has distinctive gross, histologic, and cytogenetic features."|Participants with carcinoma type|Number|447|447.0||||||
4456473|NCT00073307|4277892|B1|Clear Cell||Cancer Subtypes|"Histopathological characterization of renal cell carcinomas that subjects had included clear cell, papillary or granular carcinomas. Clear cell renal cell carcinoma is a renal cortical tumor typically characterized by malignant epithelial cells with clear cytoplasm and a compact-alveolar (nested) or acinar growth pattern interspersed with intricate, arborizing vasculature.~Tumors in which eosinophilic cells predominate were classified as granular cell carcinoma.~Papillary renal cell carcinoma is an uncommon subtype that has distinctive gross, histologic, and cytogenetic features."|Participants with carcinoma type|Number|449|449.0||||||
4456474|NCT00073307|4277890|B3|Stage IV||TNM Classification at study entry|TNM=Tumor, primary (T); Nodes, regional lymph nodes (N); Metastasis, distant (M). T0/N0/M0=no evidence of aspect. N1=metastasis in single regional lymph node, M1=distant metastasis. T1=tumor 7 cm or less in greatest dimension limited to kidney. T2= tumor >7 cm in greatest dimension limited to kidney. T3=tumor extends into major veins, invades adrenal gland, or peripheric tissues but not beyond Gerota's fascia. T4=tumor invades beyond Gerota's fascia. [Stage I: T1, N0, M0][Stage II=T2, N0, M0][Stage IV=T4, N0, M0; T4, N1, M0; any T, N2, M0; any T, any N, M1][Stage III=remaining combinations]|Participants|Number|871|871.0||||||
4456475|NCT00073307|4277891|B2|Stage IV||TNM Classification at study entry|TNM=Tumor, primary (T); Nodes, regional lymph nodes (N); Metastasis, distant (M). T0/N0/M0=no evidence of aspect. N1=metastasis in single regional lymph node, M1=distant metastasis. T1=tumor 7 cm or less in greatest dimension limited to kidney. T2= tumor >7 cm in greatest dimension limited to kidney. T3=tumor extends into major veins, invades adrenal gland, or peripheric tissues but not beyond Gerota's fascia. T4=tumor invades beyond Gerota's fascia. [Stage I: T1, N0, M0][Stage II=T2, N0, M0][Stage IV=T4, N0, M0; T4, N1, M0; any T, N2, M0; any T, any N, M1][Stage III=remaining combinations]|Participants|Number|438|438.0||||||
4456476|NCT00073307|4277892|B1|Stage IV||TNM Classification at study entry|TNM=Tumor, primary (T); Nodes, regional lymph nodes (N); Metastasis, distant (M). T0/N0/M0=no evidence of aspect. N1=metastasis in single regional lymph node, M1=distant metastasis. T1=tumor 7 cm or less in greatest dimension limited to kidney. T2= tumor >7 cm in greatest dimension limited to kidney. T3=tumor extends into major veins, invades adrenal gland, or peripheric tissues but not beyond Gerota's fascia. T4=tumor invades beyond Gerota's fascia. [Stage I: T1, N0, M0][Stage II=T2, N0, M0][Stage IV=T4, N0, M0; T4, N1, M0; any T, N2, M0; any T, any N, M1][Stage III=remaining combinations]|Participants|Number|433|433.0||||||
4456477|NCT00073307|4277890|B3|Stage III||TNM Classification at study entry|TNM=Tumor, primary (T); Nodes, regional lymph nodes (N); Metastasis, distant (M). T0/N0/M0=no evidence of aspect. N1=metastasis in single regional lymph node, M1=distant metastasis. T1=tumor 7 cm or less in greatest dimension limited to kidney. T2= tumor >7 cm in greatest dimension limited to kidney. T3=tumor extends into major veins, invades adrenal gland, or peripheric tissues but not beyond Gerota's fascia. T4=tumor invades beyond Gerota's fascia. [Stage I: T1, N0, M0][Stage II=T2, N0, M0][Stage IV=T4, N0, M0; T4, N1, M0; any T, N2, M0; any T, any N, M1][Stage III=remaining combinations]|Participants|Number|32|32.0||||||
4456478|NCT00073307|4277891|B2|Stage III||TNM Classification at study entry|TNM=Tumor, primary (T); Nodes, regional lymph nodes (N); Metastasis, distant (M). T0/N0/M0=no evidence of aspect. N1=metastasis in single regional lymph node, M1=distant metastasis. T1=tumor 7 cm or less in greatest dimension limited to kidney. T2= tumor >7 cm in greatest dimension limited to kidney. T3=tumor extends into major veins, invades adrenal gland, or peripheric tissues but not beyond Gerota's fascia. T4=tumor invades beyond Gerota's fascia. [Stage I: T1, N0, M0][Stage II=T2, N0, M0][Stage IV=T4, N0, M0; T4, N1, M0; any T, N2, M0; any T, any N, M1][Stage III=remaining combinations]|Participants|Number|14|14.0||||||
4456479|NCT00073307|4277892|B1|Stage III||TNM Classification at study entry|TNM=Tumor, primary (T); Nodes, regional lymph nodes (N); Metastasis, distant (M). T0/N0/M0=no evidence of aspect. N1=metastasis in single regional lymph node, M1=distant metastasis. T1=tumor 7 cm or less in greatest dimension limited to kidney. T2= tumor >7 cm in greatest dimension limited to kidney. T3=tumor extends into major veins, invades adrenal gland, or peripheric tissues but not beyond Gerota's fascia. T4=tumor invades beyond Gerota's fascia. [Stage I: T1, N0, M0][Stage II=T2, N0, M0][Stage IV=T4, N0, M0; T4, N1, M0; any T, N2, M0; any T, any N, M1][Stage III=remaining combinations]|Participants|Number|18|18.0||||||
4456480|NCT00073307|4277890|B3|Missing||ECOG Performance Status (PS)|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants by scale|Number|4|4.0||||||
4456585|NCT00073008|4277956|B1|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4456482|NCT00073307|4277892|B1|Missing||ECOG Performance Status (PS)|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants by scale|Number|2|2.0||||||
4456483|NCT00073307|4277890|B3|PS 2||ECOG Performance Status (PS)|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants by scale|Number|11|11.0||||||
4456484|NCT00073307|4277891|B2|PS 2||ECOG Performance Status (PS)|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants by scale|Number|4|4.0||||||
4456485|NCT00073307|4277892|B1|PS 2||ECOG Performance Status (PS)|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants by scale|Number|7|7.0||||||
4456486|NCT00073307|4277890|B3|PS 1||ECOG Performance Status (PS)|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants by scale|Number|458|458.0||||||
4456487|NCT00073307|4277891|B2|PS 1||ECOG Performance Status (PS)|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants by scale|Number|235|235.0||||||
4456488|NCT00073307|4277892|B1|PS 1||ECOG Performance Status (PS)|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants by scale|Number|223|223.0||||||
4456489|NCT00073307|4277890|B3|PS 0||ECOG Performance Status (PS)|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants by scale|Number|430|430.0||||||
4456490|NCT00073307|4277891|B2|PS 0||ECOG Performance Status (PS)|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants by scale|Number|211|211.0||||||
4456491|NCT00073307|4277892|B1|PS 0||ECOG Performance Status (PS)|ECOG = Eastern cooperative oncology group PS levels are 0 (Fully active, able to carry on all pre-disease performance), 1 (ambulatory and able to carry out work of a light or sedentary), 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities), 3 (Capable of only limited selfcare, confined to bed or chair more than 50% of awake time), 4 (Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair) and 5 (death).|Participants by scale|Number|219|219.0||||||
4456492|NCT00073307|4277890|B3|Missing||Motzer Category (Low, intermediate or high)|The Motzer score risk factors predicting survival in participants with metastatic RCC are as following: • Low ECOG performance status (PS>2) • High lactate dehydrogenase (>1.5 times upper limit of normal) • Low serum hemoglobin (<lower limit of normal) • High corrected serum calcium (>10 mg/dL) • Absence of prior nephrectomy factors.|Participants|Number|1|1.0||||||
4456493|NCT00073307|4277891|B2|Missing||Motzer Category (Low, intermediate or high)|The Motzer score risk factors predicting survival in participants with metastatic RCC are as following: • Low ECOG performance status (PS>2) • High lactate dehydrogenase (>1.5 times upper limit of normal) • Low serum hemoglobin (<lower limit of normal) • High corrected serum calcium (>10 mg/dL) • Absence of prior nephrectomy factors.|Participants|Number|1|1.0||||||
4456494|NCT00073307|4277892|B1|Missing||Motzer Category (Low, intermediate or high)|The Motzer score risk factors predicting survival in participants with metastatic RCC are as following: • Low ECOG performance status (PS>2) • High lactate dehydrogenase (>1.5 times upper limit of normal) • Low serum hemoglobin (<lower limit of normal) • High corrected serum calcium (>10 mg/dL) • Absence of prior nephrectomy factors.|Participants|Number|0|0.0||||||
4456495|NCT00073307|4277890|B3|Intermediate||Motzer Category (Low, intermediate or high)|The Motzer score risk factors predicting survival in participants with metastatic RCC are as following: • Low ECOG performance status (PS>2) • High lactate dehydrogenase (>1.5 times upper limit of normal) • Low serum hemoglobin (<lower limit of normal) • High corrected serum calcium (>10 mg/dL) • Absence of prior nephrectomy factors.|Participants|Number|449|449.0||||||
4456496|NCT00073307|4277891|B2|Intermediate||Motzer Category (Low, intermediate or high)|The Motzer score risk factors predicting survival in participants with metastatic RCC are as following: • Low ECOG performance status (PS>2) • High lactate dehydrogenase (>1.5 times upper limit of normal) • Low serum hemoglobin (<lower limit of normal) • High corrected serum calcium (>10 mg/dL) • Absence of prior nephrectomy factors.|Participants|Number|232|232.0||||||
4456497|NCT00073307|4277892|B1|Intermediate||Motzer Category (Low, intermediate or high)|The Motzer score risk factors predicting survival in participants with metastatic RCC are as following: • Low ECOG performance status (PS>2) • High lactate dehydrogenase (>1.5 times upper limit of normal) • Low serum hemoglobin (<lower limit of normal) • High corrected serum calcium (>10 mg/dL) • Absence of prior nephrectomy factors.|Participants|Number|217|217.0||||||
4456498|NCT00073307|4277890|B3|Low||Motzer Category (Low, intermediate or high)|The Motzer score risk factors predicting survival in participants with metastatic RCC are as following: • Low ECOG performance status (PS>2) • High lactate dehydrogenase (>1.5 times upper limit of normal) • Low serum hemoglobin (<lower limit of normal) • High corrected serum calcium (>10 mg/dL) • Absence of prior nephrectomy factors.|Participants|Number|453|453.0||||||
4456499|NCT00073307|4277891|B2|Low||Motzer Category (Low, intermediate or high)|The Motzer score risk factors predicting survival in participants with metastatic RCC are as following: • Low ECOG performance status (PS>2) • High lactate dehydrogenase (>1.5 times upper limit of normal) • Low serum hemoglobin (<lower limit of normal) • High corrected serum calcium (>10 mg/dL) • Absence of prior nephrectomy factors.|Participants|Number|219|219.0||||||
4456500|NCT00073307|4277892|B1|Low||Motzer Category (Low, intermediate or high)|The Motzer score risk factors predicting survival in participants with metastatic RCC are as following: • Low ECOG performance status (PS>2) • High lactate dehydrogenase (>1.5 times upper limit of normal) • Low serum hemoglobin (<lower limit of normal) • High corrected serum calcium (>10 mg/dL) • Absence of prior nephrectomy factors.|Participants|Number|234|234.0||||||
4456501|NCT00073307|4277890|B3||Male|Sex: Female, Male||Participants|Count of Participants|655|655.0||||||
4456502|NCT00073307|4277891|B2||Male|Sex: Female, Male||Participants|Count of Participants|340|340.0||||||
4456503|NCT00073307|4277892|B1||Male|Sex: Female, Male||Participants|Count of Participants|315|315.0||||||
4456504|NCT00073307|4277890|B3||Female|Sex: Female, Male||Participants|Count of Participants|248|248.0||||||
4456505|NCT00073307|4277891|B2||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4456506|NCT00073307|4277892|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4456507|NCT00073307|4277890|B3|>= 65 years||Age, Customized||Participants|Number|271|271.0||||||
4456508|NCT00073307|4277891|B2|>= 65 years||Age, Customized||Participants|Number|124|124.0||||||
4456509|NCT00073307|4277892|B1|>= 65 years||Age, Customized||Participants|Number|147|147.0||||||
4456510|NCT00073307|4277890|B3|<65 years||Age, Customized||Participants|Number|632|632.0||||||
4456511|NCT00073307|4277891|B2|<65 years||Age, Customized||Participants|Number|328|328.0||||||
4456512|NCT00073307|4277892|B1|<65 years||Age, Customized||Participants|Number|304|304.0||||||
4456513|NCT00073307|4277890|B3|||Age||Years|Median|59.0|59.0|Full Range|||19.0|86.0|
4456514|NCT00073307|4277891|B2|||Age||Years|Median|59.0|59.0|Full Range|||29.0|84.0|
4456515|NCT00073307|4277892|B1|||Age||Years|Median|58.0|58.0|Full Range|||19.0|86.0|
4456516|NCT00073073|4277912|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4456517|NCT00073073|4277912|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456518|NCT00073073|4277912|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4456519|NCT00073073|4277912|B1|||Age||years|Mean|59.1|59.1|Full Range|||45.0|75.0|
4456520|NCT00073021|4277923|B3|Multi-racial/other||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|5|5.0||||||
4456521|NCT00073021|4277924|B2|Multi-racial/other||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|3|3.0||||||
4456522|NCT00073021|4277925|B1|Multi-racial/other||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|2|2.0||||||
4456523|NCT00073021|4277923|B3|Hispanic||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|27|27.0||||||
4456524|NCT00073021|4277924|B2|Hispanic||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|11|11.0||||||
4456525|NCT00073021|4277925|B1|Hispanic||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|16|16.0||||||
4456526|NCT00073021|4277923|B3|Asian (Oriental)||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|4|4.0||||||
4456527|NCT00073021|4277924|B2|Asian (Oriental)||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|3|3.0||||||
4456528|NCT00073021|4277925|B1|Asian (Oriental)||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|1|1.0||||||
4456529|NCT00073021|4277923|B3|Asian (Indian)||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|3|3.0||||||
4456530|NCT00073021|4277924|B2|Asian (Indian)||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|2|2.0||||||
4456531|NCT00073021|4277925|B1|Asian (Indian)||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|1|1.0||||||
4456532|NCT00073021|4277923|B3|Black or African American||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|25|25.0||||||
4456533|NCT00073021|4277924|B2|Black or African American||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|14|14.0||||||
4456534|NCT00073021|4277925|B1|Black or African American||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|11|11.0||||||
4456535|NCT00073021|4277923|B3|Caucasian||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|204|204.0||||||
4456536|NCT00073021|4277924|B2|Caucasian||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|96|96.0||||||
4456537|NCT00073021|4277925|B1|Caucasian||Race/Ethnicity, Customized|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Number|108|108.0||||||
4456538|NCT00073021|4277923|B3||Male|Sex: Female, Male|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Count of Participants|116|116.0||||||
4456539|NCT00073021|4277924|B2||Male|Sex: Female, Male|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Count of Participants|54|54.0||||||
4456540|NCT00073021|4277925|B1||Male|Sex: Female, Male|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Count of Participants|62|62.0||||||
4456541|NCT00073021|4277923|B3||Female|Sex: Female, Male|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Count of Participants|152|152.0||||||
4456542|NCT00073021|4277924|B2||Female|Sex: Female, Male|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Count of Participants|75|75.0||||||
4456543|NCT00073021|4277925|B1||Female|Sex: Female, Male|All Randomized Patients with Moderate Disease [PGA = 2] at Baseline|Participants|Count of Participants|77|77.0||||||
4456544|NCT00073021|4277923|B3|>= 65 years||Age, Customized|All Randomized Patients with Moderate Disease [PGA (Physician's Global Assessment) = 2] at Baseline|Participants|Number|24|24.0||||||
4456545|NCT00073021|4277924|B2|>= 65 years||Age, Customized|All Randomized Patients with Moderate Disease [PGA (Physician's Global Assessment) = 2] at Baseline|Participants|Number|11|11.0||||||
4456546|NCT00073021|4277925|B1|>= 65 years||Age, Customized|All Randomized Patients with Moderate Disease [PGA (Physician's Global Assessment) = 2] at Baseline|Participants|Number|13|13.0||||||
4456547|NCT00073021|4277923|B3|18 - 64 years||Age, Customized|All Randomized Patients with Moderate Disease [PGA (Physician's Global Assessment) = 2] at Baseline|Participants|Number|244|244.0||||||
4456548|NCT00073021|4277924|B2|18 - 64 years||Age, Customized|All Randomized Patients with Moderate Disease [PGA (Physician's Global Assessment) = 2] at Baseline|Participants|Number|118|118.0||||||
4456549|NCT00073021|4277925|B1|18 - 64 years||Age, Customized|All Randomized Patients with Moderate Disease [PGA (Physician's Global Assessment) = 2] at Baseline|Participants|Number|126|126.0||||||
4456550|NCT00073008|4277954|B3|Missing||Histology at diagnosis|Type of lung cancer|Participants|Number|4|4.0||||||
4456551|NCT00073008|4277955|B2|Missing||Histology at diagnosis|Type of lung cancer|Participants|Number|2|2.0||||||
4456552|NCT00073008|4277956|B1|Missing||Histology at diagnosis|Type of lung cancer|Participants|Number|2|2.0||||||
4456553|NCT00073008|4277954|B3|Other||Histology at diagnosis|Type of lung cancer|Participants|Number|6|6.0||||||
4456554|NCT00073008|4277955|B2|Other||Histology at diagnosis|Type of lung cancer|Participants|Number|2|2.0||||||
4456555|NCT00073008|4277956|B1|Other||Histology at diagnosis|Type of lung cancer|Participants|Number|4|4.0||||||
4456556|NCT00073008|4277954|B3|Other non-small cell lung cancer type||Histology at diagnosis|Type of lung cancer|Participants|Number|6|6.0||||||
4456557|NCT00073008|4277955|B2|Other non-small cell lung cancer type||Histology at diagnosis|Type of lung cancer|Participants|Number|1|1.0||||||
4456558|NCT00073008|4277956|B1|Other non-small cell lung cancer type||Histology at diagnosis|Type of lung cancer|Participants|Number|5|5.0||||||
4456559|NCT00073008|4277954|B3|Adenocarcinoma without BAC features||Histology at diagnosis|Type of lung cancer|Participants|Number|77|77.0||||||
4456560|NCT00073008|4277955|B2|Adenocarcinoma without BAC features||Histology at diagnosis|Type of lung cancer|Participants|Number|43|43.0||||||
4456561|NCT00073008|4277956|B1|Adenocarcinoma without BAC features||Histology at diagnosis|Type of lung cancer|Participants|Number|34|34.0||||||
4456562|NCT00073008|4277954|B3|Adenocarcinoma with BAC features||Histology at diagnosis|Type of lung cancer|Participants|Number|21|21.0||||||
4456563|NCT00073008|4277955|B2|Adenocarcinoma with BAC features||Histology at diagnosis|Type of lung cancer|Participants|Number|13|13.0||||||
4456564|NCT00073008|4277956|B1|Adenocarcinoma with BAC features||Histology at diagnosis|Type of lung cancer|Participants|Number|8|8.0||||||
4456565|NCT00073008|4277954|B3|Bronchioloalveolar carcinoma (BAC)||Histology at diagnosis|Type of lung cancer|Participants|Number|5|5.0||||||
4456566|NCT00073008|4277955|B2|Bronchioloalveolar carcinoma (BAC)||Histology at diagnosis|Type of lung cancer|Participants|Number|2|2.0||||||
4456567|NCT00073008|4277956|B1|Bronchioloalveolar carcinoma (BAC)||Histology at diagnosis|Type of lung cancer|Participants|Number|3|3.0||||||
4456568|NCT00073008|4277954|B3|Squamous cell||Histology at diagnosis|Type of lung cancer|Participants|Number|12|12.0||||||
4456569|NCT00073008|4277955|B2|Squamous cell||Histology at diagnosis|Type of lung cancer|Participants|Number|3|3.0||||||
4456570|NCT00073008|4277956|B1|Squamous cell||Histology at diagnosis|Type of lung cancer|Participants|Number|9|9.0||||||
4456571|NCT00073008|4277954|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4456572|NCT00073008|4277955|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4456573|NCT00073008|4277956|B1|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4456574|NCT00073008|4277954|B3|American Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4456575|NCT00073008|4277955|B2|American Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4456576|NCT00073008|4277956|B1|American Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4456577|NCT00073008|4277954|B3|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4456578|NCT00073008|4277955|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4456579|NCT00073008|4277956|B1|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4456580|NCT00073008|4277954|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4456581|NCT00073008|4277955|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4456582|NCT00073008|4277956|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4456583|NCT00073008|4277954|B3|White||Race/Ethnicity, Customized||participants|Number|110|110.0||||||
4456584|NCT00073008|4277955|B2|White||Race/Ethnicity, Customized||participants|Number|56|56.0||||||
4456586|NCT00073008|4277954|B3||Male|Gender||Participants|Count of Participants|58|58.0||||||
4456587|NCT00073008|4277955|B2||Male|Gender||Participants|Count of Participants|26|26.0||||||
4456588|NCT00073008|4277956|B1||Male|Gender||Participants|Count of Participants|32|32.0||||||
4456589|NCT00073008|4277954|B3||Female|Gender||Participants|Count of Participants|73|73.0||||||
4456590|NCT00073008|4277955|B2||Female|Gender||Participants|Count of Participants|40|40.0||||||
4456591|NCT00073008|4277956|B1||Female|Gender||Participants|Count of Participants|33|33.0||||||
4456592|NCT00073008|4277954|B3|||Age||years|Mean|65.1|65.1|Standard Deviation|11.27|11.27|||
4456593|NCT00073008|4277955|B2|||Age||years|Mean|65.2|65.2|Standard Deviation|10.56|10.56|||
4456594|NCT00073008|4277956|B1|||Age||years|Mean|65.1|65.1|Standard Deviation|12.03|12.03|||
4456595|NCT00072761|4277987|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4456596|NCT00072761|4277988|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4456597|NCT00072761|4277989|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4456598|NCT00072761|4277987|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456599|NCT00072761|4277988|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456600|NCT00072761|4277989|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456601|NCT00072761|4277987|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4456602|NCT00072761|4277988|B2||White|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456603|NCT00072761|4277989|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4456604|NCT00072761|4277987|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4456605|NCT00072761|4277988|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4456606|NCT00072761|4277989|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4456607|NCT00072761|4277987|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456608|NCT00072761|4277988|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456609|NCT00072761|4277989|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456610|NCT00072761|4277987|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456611|NCT00072761|4277988|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456612|NCT00072761|4277989|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456613|NCT00072761|4277987|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456614|NCT00072761|4277988|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456615|NCT00072761|4277989|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456616|NCT00072761|4277987|B3||Male|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4456617|NCT00072761|4277988|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4456618|NCT00072761|4277989|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4456619|NCT00072761|4277987|B3||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4456620|NCT00072761|4277988|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4456621|NCT00072761|4277989|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4456622|NCT00072761|4277987|B3|||Age||years|Median|10|10.0|Full Range|||5.0|15.0|
4456623|NCT00072761|4277988|B2|||Age||years|Median|10|10.0|Full Range|||5.0|15.0|
4456624|NCT00072761|4277989|B1|||Age||years|Median|10|10.0|Full Range|||5.0|15.0|
4456625|NCT00072761|4277987|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456626|NCT00072761|4277988|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456627|NCT00072761|4277989|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456628|NCT00072761|4277987|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4456629|NCT00072761|4277988|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4456630|NCT00072761|4277989|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4456631|NCT00072761|4277987|B3||<=18 years|Age||Participants|Count of Participants|196|196.0||||||
4456632|NCT00072761|4277988|B2||<=18 years|Age||Participants|Count of Participants|97|97.0||||||
4456633|NCT00072761|4277989|B1||<=18 years|Age||Participants|Count of Participants|99|99.0||||||
4456634|NCT00072475|4277996|B1|United States||Region of Enrollment||participants|Number|142|142.0||||||
4456635|NCT00072475|4277996|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4456636|NCT00072475|4277996|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4456637|NCT00072475|4277996|B1||White|Race (NIH/OMB)||Participants|Count of Participants|133|133.0||||||
4456638|NCT00072475|4277996|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4456639|NCT00072475|4277996|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456640|NCT00072475|4277996|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4456641|NCT00072475|4277996|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456642|NCT00072475|4277996|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4456643|NCT00072475|4277996|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4456644|NCT00072475|4277996|B1|||Age||years|Median|71|71.0|Full Range|||27.0|91.0|
4456696|NCT00072280|4278037|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456645|NCT00072449|4278004|B1|||Mini-Mental State Examination (MMSE)|The mini–mental state examination (MMSE) is a 30-point questionnaire test used to screen for cognitive impairment. Commonly used to screen for dementia. It is also used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time. The MMSE test includes simple questions and problems in a number of areas: the time and place of the test, repeating lists of words, arithmetic such as the serial sevens, language use and comprehension, and basic motor skills. The Higher your score, the higher your function.|Score|Median|29|29.0|Full Range|||18.0|30.0|
4456646|NCT00072449|4278004|B1|||Karnofsky Performance Status Scale|100 normal no complaints no disease 90 capable of normal activity few symptoms/disease 80 normal activity with some difficulty some symptoms or signs 70 caring for self not capable of normal activity or work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care and help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures or treatment 10 moribund rapidly progressive fatal disease processes 0 death|Score|Median|85|85.0|Full Range|||60.0|100.0|
4456647|NCT00072449|4278004|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4456648|NCT00072449|4278004|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4456649|NCT00072449|4278004|B1|age, years||Age||years|Median|64|64.0|Full Range|31-81|31.0|31.0|81.0|
4456650|NCT00072384|4278011|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4456651|NCT00072384|4278011|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4456652|NCT00072384|4278011|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456653|NCT00072384|4278011|B1||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4456654|NCT00072384|4278011|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4456655|NCT00072384|4278011|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456656|NCT00072384|4278011|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4456657|NCT00072384|4278011|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456658|NCT00072384|4278011|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456659|NCT00072384|4278011|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4456660|NCT00072384|4278011|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4456661|NCT00072384|4278011|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4456662|NCT00072384|4278011|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4456663|NCT00072384|4278011|B1|||Age||months|Median|7.5|7.5|Full Range|||1.0|52.0|
4456664|NCT00072293|4278022|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456665|NCT00072293|4278023|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456666|NCT00072293|4278024|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456667|NCT00072293|4278022|B3||Female|Sex: Female, Male||Participants|Count of Participants|931|931.0||||||
4456668|NCT00072293|4278023|B2||Female|Sex: Female, Male||Participants|Count of Participants|467|467.0||||||
4456669|NCT00072293|4278024|B1||Female|Sex: Female, Male||Participants|Count of Participants|464|464.0||||||
4456670|NCT00072293|4278022|B3|||Age||years|Median|54|54.0|Inter-Quartile Range|||26.0|81.0|
4456671|NCT00072293|4278023|B2|||Age||years|Median|54|54.0|Inter-Quartile Range|||26.0|81.0|
4456672|NCT00072293|4278024|B1|||Age||years|Median|53|53.0|Inter-Quartile Range|||28.0|81.0|
4456673|NCT00072280|4278035|B3|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4456674|NCT00072280|4278036|B2|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4456675|NCT00072280|4278037|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4456676|NCT00072280|4278035|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4456677|NCT00072280|4278036|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4456678|NCT00072280|4278037|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4456679|NCT00072280|4278035|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4456680|NCT00072280|4278036|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4456681|NCT00072280|4278037|B1|United States||Region of Enrollment||participants|Number|1|1.0||||||
4456682|NCT00072280|4278035|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456683|NCT00072280|4278036|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456684|NCT00072280|4278037|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456685|NCT00072280|4278035|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456686|NCT00072280|4278036|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456687|NCT00072280|4278037|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456688|NCT00072280|4278035|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4456689|NCT00072280|4278036|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4456690|NCT00072280|4278037|B1||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4456691|NCT00072280|4278035|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4456692|NCT00072280|4278036|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456693|NCT00072280|4278037|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4456694|NCT00072280|4278035|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456695|NCT00072280|4278036|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456697|NCT00072280|4278035|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456698|NCT00072280|4278036|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456699|NCT00072280|4278037|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456700|NCT00072280|4278035|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456701|NCT00072280|4278036|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456702|NCT00072280|4278037|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456703|NCT00072280|4278035|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456704|NCT00072280|4278036|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456705|NCT00072280|4278037|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456706|NCT00072280|4278035|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4456707|NCT00072280|4278036|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4456708|NCT00072280|4278037|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4456709|NCT00072280|4278035|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4456710|NCT00072280|4278036|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4456711|NCT00072280|4278037|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4456712|NCT00072280|4278035|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4456713|NCT00072280|4278036|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4456714|NCT00072280|4278037|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4456715|NCT00072280|4278035|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4456716|NCT00072280|4278036|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4456717|NCT00072280|4278037|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4456718|NCT00072280|4278035|B3|6 months or more||Age, Customized||participants|Number|3|3.0||||||
4456719|NCT00072280|4278036|B2|6 months or more||Age, Customized||participants|Number|2|2.0||||||
4456720|NCT00072280|4278037|B1|6 months or more||Age, Customized||participants|Number|1|1.0||||||
4456721|NCT00072280|4278035|B3|Less than 6 months||Age, Customized||participants|Number|4|4.0||||||
4456722|NCT00072280|4278036|B2|Less than 6 months||Age, Customized||participants|Number|2|2.0||||||
4456723|NCT00072280|4278037|B1|Less than 6 months||Age, Customized||participants|Number|2|2.0||||||
4456724|NCT00072280|4278035|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456725|NCT00072280|4278036|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456726|NCT00072280|4278037|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456727|NCT00072280|4278035|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4456728|NCT00072280|4278036|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4456729|NCT00072280|4278037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4456730|NCT00072280|4278035|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4456731|NCT00072280|4278036|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4456732|NCT00072280|4278037|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4456733|NCT00072189|4278043|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4456734|NCT00072189|4278043|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4456735|NCT00072189|4278043|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4456736|NCT00072189|4278043|B1|||Age||years|Median|53|53.0|Full Range|||34.0|85.0|
4456737|NCT00072176|4278049|B3|Canada||Region of Enrollment||participants|Number|60|60.0||||||
4456738|NCT00072176|4278050|B2|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4456739|NCT00072176|4278051|B1|Canada||Region of Enrollment||participants|Number|33|33.0||||||
4456740|NCT00072176|4278049|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456741|NCT00072176|4278050|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456742|NCT00072176|4278051|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456743|NCT00072176|4278049|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4456744|NCT00072176|4278050|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4456745|NCT00072176|4278051|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4456746|NCT00072176|4278049|B3|||Age||years|Median|63|63.0|Full Range|||41.0|81.0|
4456747|NCT00072176|4278050|B2|||Age||years|Median|60|60.0|Full Range|||41.0|81.0|
4456748|NCT00072176|4278051|B1|||Age||years|Median|66|66.0|Full Range|||52.0|80.0|
4456749|NCT00071981|4278060|B5|United States||Region of Enrollment||participants|Number|148|148.0||||||
4456750|NCT00071981|4278061|B4|United States||Region of Enrollment||participants|Number|42|42.0||||||
4456751|NCT00071981|4278062|B3|United States||Region of Enrollment||participants|Number|32|32.0||||||
4456752|NCT00071981|4278063|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4456753|NCT00071981|4278064|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4456754|NCT00071981|4278060|B5||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4456755|NCT00071981|4278061|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4456756|NCT00071981|4278062|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4456757|NCT00071981|4278063|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4456758|NCT00071981|4278064|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4456759|NCT00071981|4278060|B5||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4456760|NCT00071981|4278061|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4456761|NCT00071981|4278062|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4456762|NCT00071981|4278063|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4456763|NCT00071981|4278064|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4456764|NCT00071981|4278060|B5|||Age||years|Median|66|66.0|Full Range|||31.0|89.0|
4456765|NCT00071981|4278061|B4|||Age||years|Median|64|64.0|Full Range|||40.0|82.0|
4456766|NCT00071981|4278062|B3|||Age||years|Median|66|66.0|Full Range|||32.0|89.0|
4456767|NCT00071981|4278063|B2|||Age||years|Median|69|69.0|Full Range|||31.0|88.0|
4456768|NCT00071981|4278064|B1|||Age||years|Median|65|65.0|Full Range|||35.0|86.0|
4456769|NCT00072566|4278093|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4456770|NCT00072566|4278093|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4456771|NCT00072566|4278093|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4456772|NCT00072566|4278093|B1|||Age||years|Median|60|60.0|Full Range|||31.0|83.0|
4456773|NCT00072514|4278099|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4456774|NCT00072514|4278099|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4456775|NCT00072514|4278099|B1|||Age||years|Median|58|58.0|Full Range|||19.0|79.0|
4456776|NCT00071812|4278106|B5|Poland||Region of Enrollment||participants|Number|49|49.0||||||
4456777|NCT00071812|4278107|B4|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4456778|NCT00071812|4278108|B3|Poland||Region of Enrollment||participants|Number|12|12.0||||||
4456779|NCT00071812|4278109|B2|Poland||Region of Enrollment||participants|Number|11|11.0||||||
4456780|NCT00071812|4278110|B1|Poland||Region of Enrollment||participants|Number|14|14.0||||||
4456781|NCT00071812|4278106|B5|United States||Region of Enrollment||participants|Number|234|234.0||||||
4456782|NCT00071812|4278107|B4|United States||Region of Enrollment||participants|Number|59|59.0||||||
4456783|NCT00071812|4278108|B3|United States||Region of Enrollment||participants|Number|59|59.0||||||
4456784|NCT00071812|4278109|B2|United States||Region of Enrollment||participants|Number|61|61.0||||||
4456785|NCT00071812|4278110|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4456786|NCT00071812|4278106|B5||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4456787|NCT00071812|4278107|B4||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4456788|NCT00071812|4278108|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4456789|NCT00071812|4278109|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4456790|NCT00071812|4278110|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4456791|NCT00071812|4278106|B5||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4456792|NCT00071812|4278107|B4||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4456793|NCT00071812|4278108|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4456794|NCT00071812|4278109|B2||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4456795|NCT00071812|4278110|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4456796|NCT00071812|4278106|B5|||Age||years|Mean|50.4|50.4|Standard Deviation|9.1|9.1|||
4456797|NCT00071812|4278107|B4|||Age||years|Mean|49.5|49.5|Standard Deviation|9.3|9.3|||
4456798|NCT00071812|4278108|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|10.2|10.2|||
4456799|NCT00071812|4278109|B2|||Age||years|Mean|50.6|50.6|Standard Deviation|8.3|8.3|||
4456800|NCT00071812|4278110|B1|||Age||years|Mean|50.7|50.7|Standard Deviation|8.8|8.8|||
4456801|NCT00071799|4278153|B3|||Weight||kilograms|Mean|75.6|75.6|Standard Deviation|13.85|13.85|||
4456802|NCT00071799|4278154|B2|||Weight||kilograms|Mean|74.6|74.6|Standard Deviation|13.58|13.58|||
4456803|NCT00071799|4278155|B1|||Weight||kilograms|Mean|76.5|76.5|Standard Deviation|14.08|14.08|||
4456804|NCT00071799|4278153|B3|||Body Surface Area||meters squared|Mean|1.9|1.9|Standard Deviation|0.19|0.19|||
4456805|NCT00071799|4278154|B2|||Body Surface Area||meters squared|Mean|1.8|1.8|Standard Deviation|0.19|0.19|||
4456806|NCT00071799|4278155|B1|||Body Surface Area||meters squared|Mean|1.9|1.9|Standard Deviation|0.19|0.19|||
4456807|NCT00071799|4278153|B3|Indeterminate||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|5|5.0||||||
4456808|NCT00071799|4278154|B2|Indeterminate||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|4|4.0||||||
4456809|NCT00071799|4278155|B1|Indeterminate||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|1|1.0||||||
4456810|NCT00071799|4278153|B3|Acute myeloid leukemia||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|113|113.0||||||
4456811|NCT00071799|4278154|B2|Acute myeloid leukemia||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|58|58.0||||||
4456812|NCT00071799|4278155|B1|Acute myeloid leukemia||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|55|55.0||||||
4456813|NCT00071799|4278153|B3|Chronic myelomonocytic leukemia - 2 (CMMoL-2)||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|15|15.0||||||
4456860|NCT00071799|4278155|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4456814|NCT00071799|4278154|B2|Chronic myelomonocytic leukemia - 2 (CMMoL-2)||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|5|5.0||||||
4456815|NCT00071799|4278155|B1|Chronic myelomonocytic leukemia - 2 (CMMoL-2)||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|10|10.0||||||
4456816|NCT00071799|4278153|B3|Chronic myelomonocytic leukemia - 1 (CMMoL-1)||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|1|1.0||||||
4456817|NCT00071799|4278154|B2|Chronic myelomonocytic leukemia - 1 (CMMoL-1)||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|0|0.0||||||
4456818|NCT00071799|4278155|B1|Chronic myelomonocytic leukemia - 1 (CMMoL-1)||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|1|1.0||||||
4456819|NCT00071799|4278153|B3|Refractory anemia with excess blasts - 2||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|193|193.0||||||
4456820|NCT00071799|4278154|B2|Refractory anemia with excess blasts - 2||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|95|95.0||||||
4456821|NCT00071799|4278155|B1|Refractory anemia with excess blasts - 2||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|98|98.0||||||
4456822|NCT00071799|4278153|B3|Refractory anemia with excess blasts - 1||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|31|31.0||||||
4456823|NCT00071799|4278154|B2|Refractory anemia with excess blasts - 1||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|17|17.0||||||
4456824|NCT00071799|4278155|B1|Refractory anemia with excess blasts - 1||World Health Organization (WHO) Classification|WHO classifications were determined by the Independent Review Committee|participants|Number|14|14.0||||||
4456825|NCT00071799|4278153|B3|Indeterminate||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|19|19.0||||||
4456826|NCT00071799|4278154|B2|Indeterminate||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|8|8.0||||||
4456827|NCT00071799|4278155|B1|Indeterminate||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|11|11.0||||||
4456828|NCT00071799|4278153|B3|Not applicable||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|8|8.0||||||
4456829|NCT00071799|4278154|B2|Not applicable||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|3|3.0||||||
4456830|NCT00071799|4278155|B1|Not applicable||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|5|5.0||||||
4456831|NCT00071799|4278153|B3|High risk (2.5-3.5)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|167|167.0||||||
4456832|NCT00071799|4278154|B2|High risk (2.5-3.5)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|85|85.0||||||
4456833|NCT00071799|4278155|B1|High risk (2.5-3.5)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|82|82.0||||||
4456861|NCT00071799|4278153|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4456862|NCT00071799|4278154|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4456834|NCT00071799|4278153|B3|Intermediate risk level 2 (1.5-2.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|146|146.0||||||
4456835|NCT00071799|4278154|B2|Intermediate risk level 2 (1.5-2.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|70|70.0||||||
4456836|NCT00071799|4278155|B1|Intermediate risk level 2 (1.5-2.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|76|76.0||||||
4456837|NCT00071799|4278153|B3|Intermediate risk level 1 (0.5-1.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|18|18.0||||||
4456838|NCT00071799|4278154|B2|Intermediate risk level 1 (0.5-1.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|13|13.0||||||
4456839|NCT00071799|4278155|B1|Intermediate risk level 1 (0.5-1.0)||International Prognostic Scoring System (IPSS)|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The scale is 0-3.5 at .5 increments. Scores of 2.5-3.5 represent high risk which corresponds to poorer prognosis. The assessment was performed by the Independent Review Committee.|participants|Number|5|5.0||||||
4456840|NCT00071799|4278153|B3|Indeterminate||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|9|9.0||||||
4456841|NCT00071799|4278154|B2|Indeterminate||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|6|6.0||||||
4456842|NCT00071799|4278155|B1|Indeterminate||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|3|3.0||||||
4456843|NCT00071799|4278153|B3|Myeloproliferative disease||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|6|6.0||||||
4456844|NCT00071799|4278154|B2|Myeloproliferative disease||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|2|2.0||||||
4456845|NCT00071799|4278155|B1|Myeloproliferative disease||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|4|4.0||||||
4456846|NCT00071799|4278153|B3|Acute myeloid leukemia||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|2|2.0||||||
4456847|NCT00071799|4278154|B2|Acute myeloid leukemia||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|1|1.0||||||
4456848|NCT00071799|4278155|B1|Acute myeloid leukemia||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|1|1.0||||||
4456849|NCT00071799|4278153|B3|Modified chronic myelomonocytic leukemia||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|11|11.0||||||
4456850|NCT00071799|4278154|B2|Modified chronic myelomonocytic leukemia||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|5|5.0||||||
4456851|NCT00071799|4278155|B1|Modified chronic myelomonocytic leukemia||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|6|6.0||||||
4456852|NCT00071799|4278153|B3|RAEB in transformation||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|123|123.0||||||
4456853|NCT00071799|4278154|B2|RAEB in transformation||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|62|62.0||||||
4456854|NCT00071799|4278155|B1|RAEB in transformation||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|61|61.0||||||
4456855|NCT00071799|4278153|B3|Refractory anemia with excess blasts (RAEB)||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|207|207.0||||||
4456856|NCT00071799|4278154|B2|Refractory anemia with excess blasts (RAEB)||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|103|103.0||||||
4456857|NCT00071799|4278155|B1|Refractory anemia with excess blasts (RAEB)||French-American-British (FAB) Classification|FAB classifications were determined by the Independent Review Committee|participants|Number|104|104.0||||||
4456858|NCT00071799|4278153|B3|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4456859|NCT00071799|4278154|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4456863|NCT00071799|4278155|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4456864|NCT00071799|4278153|B3|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4456865|NCT00071799|4278154|B2|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4456866|NCT00071799|4278155|B1|Asian/Oriental||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4456867|NCT00071799|4278153|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4456868|NCT00071799|4278154|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4456869|NCT00071799|4278155|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4456870|NCT00071799|4278153|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|352|352.0||||||
4456871|NCT00071799|4278154|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|175|175.0||||||
4456872|NCT00071799|4278155|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|177|177.0||||||
4456873|NCT00071799|4278153|B3||Male|Sex: Female, Male||Participants|Count of Participants|251|251.0||||||
4456874|NCT00071799|4278154|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4456875|NCT00071799|4278155|B1||Male|Sex: Female, Male||Participants|Count of Participants|132|132.0||||||
4456876|NCT00071799|4278153|B3||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4456877|NCT00071799|4278154|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4456878|NCT00071799|4278155|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4456879|NCT00071799|4278153|B3|||Age||years|Mean|68.6|68.6|Standard Deviation|7.73|7.73|||
4456880|NCT00071799|4278154|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|7.87|7.87|||
4456881|NCT00071799|4278155|B1|||Age||years|Mean|68.0|68.0|Standard Deviation|7.57|7.57|||
4456882|NCT00071890|4278196|B3|||CD4 nadir||cells per mm3|Median|326|326.0|Inter-Quartile Range|||263.0|411.0|
4456883|NCT00071890|4278197|B2|||CD4 nadir||cells per mm3|Median|328|328.0|Inter-Quartile Range|||259.0|355.0|
4456884|NCT00071890|4278198|B1|||CD4 nadir||cells per mm3|Median|326|326.0|Inter-Quartile Range|||264.0|438.0|
4456885|NCT00071890|4278196|B3|||CD4 at inclusion||cells per mm3|Median|747|747.0|Inter-Quartile Range|||637.0|851.0|
4456886|NCT00071890|4278197|B2|||CD4 at inclusion||cells per mm3|Median|735|735.0|Inter-Quartile Range|||625.0|834.0|
4456887|NCT00071890|4278198|B1|||CD4 at inclusion||cells per mm3|Median|770|770.0|Inter-Quartile Range|||646.0|876.0|
4456888|NCT00071890|4278196|B3|United States||Region of Enrollment||participants|Number|8|8.0||||||
4456889|NCT00071890|4278197|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4456890|NCT00071890|4278198|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4456891|NCT00071890|4278196|B3|France||Region of Enrollment||participants|Number|140|140.0||||||
4456892|NCT00071890|4278197|B2|France||Region of Enrollment||participants|Number|63|63.0||||||
4456893|NCT00071890|4278198|B1|France||Region of Enrollment||participants|Number|77|77.0||||||
4456894|NCT00071890|4278196|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4456895|NCT00071890|4278197|B2||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4456896|NCT00071890|4278198|B1||Male|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4456897|NCT00071890|4278196|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4456898|NCT00071890|4278197|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4456899|NCT00071890|4278198|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4456900|NCT00071890|4278196|B3|||Age||years|Mean|43|43.0|Standard Deviation|8|8.0|||
4456901|NCT00071890|4278197|B2|||Age||years|Mean|44|44.0|Standard Deviation|9|9.0|||
4456902|NCT00071890|4278198|B1|||Age||years|Mean|42|42.0|Standard Deviation|8|8.0|||
4456903|NCT00071890|4278196|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4456904|NCT00071890|4278197|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4456905|NCT00071890|4278198|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456906|NCT00071890|4278196|B3||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4456907|NCT00071890|4278197|B2||Between 18 and 65 years|Age||Participants|Count of Participants|66|66.0||||||
4456908|NCT00071890|4278198|B1||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4456909|NCT00071890|4278196|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456910|NCT00071890|4278197|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456911|NCT00071890|4278198|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4456912|NCT00071760|4278209|B1|American Indian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4456913|NCT00071760|4278209|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4456914|NCT00071760|4278209|B1|Black||Race/Ethnicity, Customized||participants|Number|44|44.0||||||
4456915|NCT00071760|4278209|B1||Male|Gender||Participants|Count of Participants|23|23.0||||||
4456916|NCT00071760|4278209|B1||Female|Gender||Participants|Count of Participants|31|31.0||||||
4456917|NCT00071760|4278209|B1|||Age||Months|Mean|8.6|8.6|Standard Deviation|6.43|6.43|||
4456918|NCT00071721|4278268|B3|||NPI|The Neuropsychiatric Inventory (NPI) quantifies behavioral changes in dementia, including depression, anxiety, psychosis, agitation, sleep change, appetite change, and others. This is a structured questionnaire administered to the subject's caregiver/study partner. The range of this instrument is 0 to 120 with higher numbers indicating greater impairment.|Units on a scale|Mean|2.9|2.9|Standard Deviation|2.6|2.6|||
4456949|NCT00071513|4278288|B2||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4456950|NCT00071513|4278289|B1||Male|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4456951|NCT00071513|4278287|B3||Female|Sex: Female, Male||Participants|Count of Participants|314|314.0||||||
4456919|NCT00071721|4278269|B2|||NPI|The Neuropsychiatric Inventory (NPI) quantifies behavioral changes in dementia, including depression, anxiety, psychosis, agitation, sleep change, appetite change, and others. This is a structured questionnaire administered to the subject's caregiver/study partner. The range of this instrument is 0 to 120 with higher numbers indicating greater impairment.|Units on a scale|Mean|3.1|3.1|Standard Deviation|2.6|2.6|||
4456920|NCT00071721|4278270|B1|||NPI|The Neuropsychiatric Inventory (NPI) quantifies behavioral changes in dementia, including depression, anxiety, psychosis, agitation, sleep change, appetite change, and others. This is a structured questionnaire administered to the subject's caregiver/study partner. The range of this instrument is 0 to 120 with higher numbers indicating greater impairment.|Units on a scale|Mean|2.6|2.6|Standard Deviation|2.6|2.6|||
4456921|NCT00071721|4278268|B3|||CMAI|The Cohen-Mansfield Agitation Inventory (CMAI) is a 29-item caregiver rating questionnaire for the assessment of agitation in older persons. It includes descriptions of 29 agitated behaviors, each rated on a 7-point scale of frequency. The range of this instrument is 29 to 203 with higher numbers indicating greater impairment.|Units on a scale|Mean|11.4|11.4|Standard Deviation|9.7|9.7|||
4456922|NCT00071721|4278269|B2|||CMAI|The Cohen-Mansfield Agitation Inventory (CMAI) is a 29-item caregiver rating questionnaire for the assessment of agitation in older persons. It includes descriptions of 29 agitated behaviors, each rated on a 7-point scale of frequency. The range of this instrument is 29 to 203 with higher numbers indicating greater impairment.|Units on a scale|Mean|11.9|11.9|Standard Deviation|10.4|10.4|||
4456923|NCT00071721|4278270|B1|||CMAI|The Cohen-Mansfield Agitation Inventory (CMAI) is a 29-item caregiver rating questionnaire for the assessment of agitation in older persons. It includes descriptions of 29 agitated behaviors, each rated on a 7-point scale of frequency. The range of this instrument is 29 to 203 with higher numbers indicating greater impairment.|Units on a scale|Mean|10.9|10.9|Standard Deviation|8.9|8.9|||
4456924|NCT00071721|4278268|B3|||CDR-SOB|Clinical Dementia Rating, Sum of Boxes (CDR-SOB) is a global rating of dementia severity based on the clinician's interpretation of the history and examination. The range of this instrument is 0 to 18 with higher numbers indicating greater impairment.|Units on a scale|Mean|7.3|7.3|Standard Deviation|2.9|2.9|||
4456925|NCT00071721|4278269|B2|||CDR-SOB|Clinical Dementia Rating, Sum of Boxes (CDR-SOB) is a global rating of dementia severity based on the clinician's interpretation of the history and examination. The range of this instrument is 0 to 18 with higher numbers indicating greater impairment.|Units on a scale|Mean|7.5|7.5|Standard Deviation|3.1|3.1|||
4456926|NCT00071721|4278270|B1|||CDR-SOB|Clinical Dementia Rating, Sum of Boxes (CDR-SOB) is a global rating of dementia severity based on the clinician's interpretation of the history and examination. The range of this instrument is 0 to 18 with higher numbers indicating greater impairment.|Units on a scale|Mean|7.1|7.1|Standard Deviation|2.7|2.7|||
4456927|NCT00071721|4278268|B3|||ADCS-ADL|Alzheimer's Disease Cooperative Study Activities of Daily Living Score (ADCS-ADL) is a structured questionnaire about activities of daily living, administered to the subject's caregiver/study partner. The range of this instrument is 0 to 78 with lower numbers indicating greater impairment.|Units on a scale|Mean|55.9|55.9|Standard Deviation|12.4|12.4|||
4456928|NCT00071721|4278269|B2|||ADCS-ADL|Alzheimer's Disease Cooperative Study Activities of Daily Living Score (ADCS-ADL) is a structured questionnaire about activities of daily living, administered to the subject's caregiver/study partner. The range of this instrument is 0 to 78 with lower numbers indicating greater impairment.|Units on a scale|Mean|54.9|54.9|Standard Deviation|13|13.0|||
4456929|NCT00071721|4278270|B1|||ADCS-ADL|Alzheimer's Disease Cooperative Study Activities of Daily Living Score (ADCS-ADL) is a structured questionnaire about activities of daily living, administered to the subject's caregiver/study partner. The range of this instrument is 0 to 78 with lower numbers indicating greater impairment.|Units on a scale|Mean|56.9|56.9|Standard Deviation|11.8|11.8|||
4456930|NCT00071721|4278268|B3|||ADAScog|Alzheimer's Disease Assessment Scale, cognitive sub-scale in points per year (ADAS-cog) is a psychometric measure sensitive to change in mild to moderate AD. The range of this instrument is 0 to 70 with higher numbers indicating greater impairment.|Units on a scale|Mean|29.8|29.8|Standard Deviation|9.4|9.4|||
4456931|NCT00071721|4278269|B2|||ADAScog|Alzheimer's Disease Assessment Scale, cognitive sub-scale in points per year (ADAS-cog) is a psychometric measure sensitive to change in mild to moderate AD. The range of this instrument is 0 to 70 with higher numbers indicating greater impairment.|Units on a scale|Mean|30.1|30.1|Standard Deviation|9.8|9.8|||
4456932|NCT00071721|4278270|B1|||ADAScog|Alzheimer's Disease Assessment Scale, cognitive sub-scale in points per year (ADAS-cog) is a psychometric measure sensitive to change in mild to moderate AD. The range of this instrument is 0 to 70 with higher numbers indicating greater impairment.|Units on a scale|Mean|29.4|29.4|Standard Deviation|8.9|8.9|||
4456933|NCT00071721|4278268|B3|United States||Region of Enrollment||participants|Number|313|313.0||||||
4456934|NCT00071721|4278269|B2|United States||Region of Enrollment||participants|Number|160|160.0||||||
4456935|NCT00071721|4278270|B1|United States||Region of Enrollment||participants|Number|153|153.0||||||
4456936|NCT00071721|4278268|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4456937|NCT00071721|4278269|B2||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4456938|NCT00071721|4278270|B1||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4456939|NCT00071721|4278268|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4456940|NCT00071721|4278269|B2||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4456941|NCT00071721|4278270|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4456942|NCT00071721|4278268|B3|||Age||years|Mean|75.7|75.7|Standard Deviation|7.8|7.8|||
4456943|NCT00071721|4278269|B2|||Age||years|Mean|76.6|76.6|Standard Deviation|7.4|7.4|||
4456944|NCT00071721|4278270|B1|||Age||years|Mean|74.9|74.9|Standard Deviation|8.2|8.2|||
4456945|NCT00071513|4278287|B3|United States||Region of Enrollment||participants|Number|497|497.0||||||
4456946|NCT00071513|4278288|B2|United States||Region of Enrollment||participants|Number|256|256.0||||||
4456947|NCT00071513|4278289|B1|United States||Region of Enrollment||participants|Number|241|241.0||||||
4456948|NCT00071513|4278287|B3||Male|Sex: Female, Male||Participants|Count of Participants|183|183.0||||||
4456952|NCT00071513|4278288|B2||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4456953|NCT00071513|4278289|B1||Female|Sex: Female, Male||Participants|Count of Participants|149|149.0||||||
4456954|NCT00071513|4278287|B3|||Age||years|Mean|13.57|13.57|Standard Deviation|0.75|0.75|||
4456955|NCT00071513|4278288|B2|||Age||years|Mean|13.65|13.65|Standard Deviation|0.67|0.67|||
4456956|NCT00071513|4278289|B1|||Age||years|Mean|13.5|13.5|Standard Deviation|0.83|0.83|||
4456957|NCT00071513|4278287|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456958|NCT00071513|4278288|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456959|NCT00071513|4278289|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4456960|NCT00071513|4278287|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4456961|NCT00071513|4278288|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4456962|NCT00071513|4278289|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4456963|NCT00071513|4278287|B3||<=18 years|Age||Participants|Count of Participants|497|497.0||||||
4456964|NCT00071513|4278288|B2||<=18 years|Age||Participants|Count of Participants|256|256.0||||||
4456965|NCT00071513|4278289|B1||<=18 years|Age||Participants|Count of Participants|241|241.0||||||
4456966|NCT00071487|4278298|B5|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4456967|NCT00071487|4278299|B4|Canada||Region of Enrollment||participants|Number|2|2.0||||||
4456968|NCT00071487|4278300|B3|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4456969|NCT00071487|4278301|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4456970|NCT00071487|4278302|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4456971|NCT00071487|4278298|B5|United States||Region of Enrollment||participants|Number|446|446.0||||||
4456972|NCT00071487|4278299|B4|United States||Region of Enrollment||participants|Number|109|109.0||||||
4456973|NCT00071487|4278300|B3|United States||Region of Enrollment||participants|Number|111|111.0||||||
4456974|NCT00071487|4278301|B2|United States||Region of Enrollment||participants|Number|113|113.0||||||
4456975|NCT00071487|4278302|B1|United States||Region of Enrollment||participants|Number|113|113.0||||||
4456976|NCT00071487|4278298|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4456977|NCT00071487|4278299|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4456978|NCT00071487|4278300|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4456979|NCT00071487|4278301|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4456980|NCT00071487|4278302|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4456981|NCT00071487|4278298|B5||Female|Sex: Female, Male||Participants|Count of Participants|419|419.0||||||
4456982|NCT00071487|4278299|B4||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4456983|NCT00071487|4278300|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4456984|NCT00071487|4278301|B2||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4456985|NCT00071487|4278302|B1||Female|Sex: Female, Male||Participants|Count of Participants|102|102.0||||||
4456986|NCT00071487|4278298|B5|||Age||years|Mean|42.2|42.2|Standard Deviation|11.2|11.2|||
4456987|NCT00071487|4278299|B4|||Age||years|Mean|41.8|41.8|Standard Deviation|11.7|11.7|||
4456988|NCT00071487|4278300|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|10.7|10.7|||
4456989|NCT00071487|4278301|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|11.7|11.7|||
4456990|NCT00071487|4278302|B1|||Age||years|Mean|42.2|42.2|Standard Deviation|10.9|10.9|||
4456991|NCT00071396|4278349|B1|United States||Region of Enrollment||participants|Number|44|44.0||||||
4456992|NCT00071396|4278349|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4456993|NCT00071396|4278349|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4456994|NCT00071396|4278349|B1|||Age||years|Median|59|59.0|Full Range|||39.0|78.0|
4456995|NCT00071110|4278353|B3|United States||Region of Enrollment||participants|Number|57.0|57.0||||||
4456996|NCT00071110|4278354|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4456997|NCT00071110|4278355|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4456998|NCT00071110|4278353|B3||Male|Sex: Female, Male||Participants|Count of Participants|18.0|18.0||||||
4456999|NCT00071110|4278354|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4457000|NCT00071110|4278355|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4457001|NCT00071110|4278353|B3||Female|Sex: Female, Male||Participants|Count of Participants|39.0|39.0||||||
4457002|NCT00071110|4278354|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4457003|NCT00071110|4278355|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4457004|NCT00071110|4278353|B3|||Age||years|Mean|47.47|47.47|Standard Deviation|12.35|12.35|||
4457005|NCT00071110|4278354|B2|||Age||years|Mean|48.86|48.86|Standard Deviation|13.12|13.12|||
4457006|NCT00071110|4278355|B1|||Age||years|Mean|46.04|46.04|Standard Deviation|11.32|11.32|||
4457007|NCT00071110|4278353|B3||>=65 years|Age||Participants|Count of Participants|4.0|4.0||||||
4457008|NCT00071110|4278354|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4457009|NCT00071110|4278355|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4457010|NCT00071110|4278353|B3||Between 18 and 65 years|Age||Participants|Count of Participants|53.0|53.0||||||
4457011|NCT00071110|4278354|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4457012|NCT00071110|4278355|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4457013|NCT00071110|4278353|B3||<=18 years|Age||Participants|Count of Participants|0.0|0.0||||||
4457014|NCT00071110|4278354|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457015|NCT00071110|4278355|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457016|NCT00071032|4278368|B3|No History of Cardiovascular Disease||Cardiovascular Disease|History of coronary artery disease, congestive heart failure, cardiovascular disease, or peripheral vascular disease|participants|Number|748|748.0||||||
4457017|NCT00071032|4278369|B2|No History of Cardiovascular Disease||Cardiovascular Disease|History of coronary artery disease, congestive heart failure, cardiovascular disease, or peripheral vascular disease|participants|Number|378|378.0||||||
4457018|NCT00071032|4278370|B1|No History of Cardiovascular Disease||Cardiovascular Disease|History of coronary artery disease, congestive heart failure, cardiovascular disease, or peripheral vascular disease|participants|Number|370|370.0||||||
4457019|NCT00071032|4278368|B3|History of Cardiovascular Disease||Cardiovascular Disease|History of coronary artery disease, congestive heart failure, cardiovascular disease, or peripheral vascular disease|participants|Number|1268|1268.0||||||
4457020|NCT00071032|4278369|B2|History of Cardiovascular Disease||Cardiovascular Disease|History of coronary artery disease, congestive heart failure, cardiovascular disease, or peripheral vascular disease|participants|Number|631|631.0||||||
4457021|NCT00071032|4278370|B1|History of Cardiovascular Disease||Cardiovascular Disease|History of coronary artery disease, congestive heart failure, cardiovascular disease, or peripheral vascular disease|participants|Number|637|637.0||||||
4457022|NCT00071032|4278368|B3|Canada||Region of Enrollment||participants|Number|794|794.0||||||
4457023|NCT00071032|4278369|B2|Canada||Region of Enrollment||participants|Number|396|396.0||||||
4457024|NCT00071032|4278370|B1|Canada||Region of Enrollment||participants|Number|398|398.0||||||
4457025|NCT00071032|4278368|B3|United States||Region of Enrollment||participants|Number|1222|1222.0||||||
4457026|NCT00071032|4278369|B2|United States||Region of Enrollment||participants|Number|613|613.0||||||
4457027|NCT00071032|4278370|B1|United States||Region of Enrollment||participants|Number|609|609.0||||||
4457028|NCT00071032|4278368|B3||Male|Sex: Female, Male||Participants|Count of Participants|489|489.0||||||
4457029|NCT00071032|4278369|B2||Male|Sex: Female, Male||Participants|Count of Participants|239|239.0||||||
4457030|NCT00071032|4278370|B1||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4457031|NCT00071032|4278368|B3||Female|Sex: Female, Male||Participants|Count of Participants|1527|1527.0||||||
4457032|NCT00071032|4278369|B2||Female|Sex: Female, Male||Participants|Count of Participants|770|770.0||||||
4457033|NCT00071032|4278370|B1||Female|Sex: Female, Male||Participants|Count of Participants|757|757.0||||||
4457034|NCT00071032|4278368|B3|||Age||years|Mean|81.6|81.6|Standard Deviation|8.9|8.9|||
4457035|NCT00071032|4278369|B2|||Age||years|Mean|81.5|81.5|Standard Deviation|9.0|9.0|||
4457036|NCT00071032|4278370|B1|||Age||years|Mean|81.8|81.8|Standard Deviation|8.8|8.8|||
4457037|NCT00071006|4278379|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4457038|NCT00071006|4278379|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4457039|NCT00071006|4278379|B1|||Age||Years|Mean|77.42|77.42|Standard Deviation|8.53|8.53|||
4457040|NCT00070941|4278389|B4|United States||Region of Enrollment||participants|Number|29|29.0||||||
4457041|NCT00070941|4278390|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4457042|NCT00070941|4278391|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4457043|NCT00070941|4278392|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4457044|NCT00070941|4278389|B4||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4457045|NCT00070941|4278390|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4457046|NCT00070941|4278391|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4457047|NCT00070941|4278392|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4457048|NCT00070941|4278389|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4457049|NCT00070941|4278390|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4457050|NCT00070941|4278391|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4457051|NCT00070941|4278392|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4457052|NCT00070941|4278389|B4||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4457053|NCT00070941|4278390|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4457054|NCT00070941|4278391|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4457055|NCT00070941|4278392|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4457056|NCT00070941|4278389|B4||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4457057|NCT00070941|4278390|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4457058|NCT00070941|4278391|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4457059|NCT00070941|4278392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4457060|NCT00070941|4278389|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457061|NCT00070941|4278390|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457062|NCT00070941|4278391|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457063|NCT00070941|4278392|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457064|NCT00071058|4278402|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4457065|NCT00071058|4278402|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457066|NCT00071058|4278402|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457067|NCT00071058|4278402|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4457068|NCT00071058|4278402|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4457069|NCT00071058|4278402|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457070|NCT00071058|4278402|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457071|NCT00071058|4278402|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457072|NCT00071058|4278402|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457073|NCT00071058|4278402|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4457074|NCT00071058|4278402|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457075|NCT00071058|4278402|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4457076|NCT00071058|4278402|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4457077|NCT00071058|4278402|B1|||Age||years|Mean|45.56|45.56|Standard Deviation|12.2|12.2|||
4457078|NCT00071058|4278402|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4457079|NCT00071058|4278402|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4457080|NCT00071058|4278402|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457081|NCT00003907|4278407|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4457082|NCT00003907|4278408|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4457083|NCT00003907|4278409|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4457084|NCT00003907|4278407|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4457085|NCT00003907|4278408|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4457086|NCT00003907|4278409|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4457087|NCT00003907|4278407|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4457088|NCT00003907|4278408|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4457089|NCT00003907|4278409|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4457090|NCT00003907|4278407|B3|||Age||years|Median|62|62.0|Full Range|||28.0|83.0|
4457091|NCT00003907|4278408|B2|||Age||years|Median|62|62.0|Full Range|||28.0|83.0|
4457092|NCT00003907|4278409|B1|||Age||years|Median|62|62.0|Full Range|||41.0|81.0|
4457093|NCT00070564|4278420|B7||Unknown|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|31|31.0||||||
4457094|NCT00070564|4278421|B6||Unknown|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|2|2.0||||||
4457095|NCT00070564|4278422|B5||Unknown|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|0|0.0||||||
4457096|NCT00070564|4278423|B4||Unknown|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|5|5.0||||||
4457097|NCT00070564|4278424|B3||Unknown|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|9|9.0||||||
4457098|NCT00070564|4278425|B2||Unknown|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|4|4.0||||||
4457099|NCT00070564|4278426|B1||Unknown|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|11|11.0||||||
4457100|NCT00070564|4278420|B7||Positive|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|601|601.0||||||
4457101|NCT00070564|4278421|B6||Positive|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|57|57.0||||||
4457102|NCT00070564|4278422|B5||Positive|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|69|69.0||||||
4457103|NCT00070564|4278423|B4||Positive|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|109|109.0||||||
4457104|NCT00070564|4278424|B3||Positive|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|118|118.0||||||
4457105|NCT00070564|4278425|B2||Positive|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|123|123.0||||||
4457106|NCT00070564|4278426|B1||Positive|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|125|125.0||||||
4457107|NCT00070564|4278420|B7||Negative|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|2606|2606.0||||||
4457108|NCT00070564|4278421|B6||Negative|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|235|235.0||||||
4457109|NCT00070564|4278422|B5||Negative|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|208|208.0||||||
4457110|NCT00070564|4278423|B4||Negative|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|525|525.0||||||
4457111|NCT00070564|4278424|B3||Negative|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|554|554.0||||||
4457112|NCT00070564|4278425|B2||Negative|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|556|556.0||||||
4457113|NCT00070564|4278426|B1||Negative|HER2|HER2, human epidermal growth factor receptor 2.|Participants|Count of Participants|528|528.0||||||
4457114|NCT00070564|4278420|B7||Unknown|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|10|10.0||||||
4457115|NCT00070564|4278421|B6||Unknown|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|1|1.0||||||
4457116|NCT00070564|4278422|B5||Unknown|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|0|0.0||||||
4457117|NCT00070564|4278423|B4||Unknown|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|3|3.0||||||
4457118|NCT00070564|4278424|B3||Unknown|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|3|3.0||||||
4457119|NCT00070564|4278425|B2||Unknown|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|1|1.0||||||
4457120|NCT00070564|4278426|B1||Unknown|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|2|2.0||||||
4457121|NCT00070564|4278420|B7||Positive (either or both positive)|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|2145|2145.0||||||
4457122|NCT00070564|4278421|B6||Positive (either or both positive)|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|185|185.0||||||
4457123|NCT00070564|4278422|B5||Positive (either or both positive)|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|178|178.0||||||
4457124|NCT00070564|4278423|B4||Positive (either or both positive)|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|430|430.0||||||
4457125|NCT00070564|4278424|B3||Positive (either or both positive)|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|446|446.0||||||
4457126|NCT00070564|4278425|B2||Positive (either or both positive)|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|456|456.0||||||
4457127|NCT00070564|4278426|B1||Positive (either or both positive)|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|450|450.0||||||
4457128|NCT00070564|4278420|B7||Negative (both negative)|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|1083|1083.0||||||
4457129|NCT00070564|4278421|B6||Negative (both negative)|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|108|108.0||||||
4457130|NCT00070564|4278422|B5||Negative (both negative)|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|99|99.0||||||
4457131|NCT00070564|4278423|B4||Negative (both negative)|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|206|206.0||||||
4457132|NCT00070564|4278424|B3||Negative (both negative)|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|232|232.0||||||
4457133|NCT00070564|4278425|B2||Negative (both negative)|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|226|226.0||||||
4457134|NCT00070564|4278426|B1||Negative (both negative)|ER/PgR|ER, estrogen receptor; PgR, progesterone receptor|Participants|Count of Participants|212|212.0||||||
4457135|NCT00070564|4278420|B7||unknown|Nodal status||Participants|Count of Participants|10|10.0||||||
4457136|NCT00070564|4278421|B6||unknown|Nodal status||Participants|Count of Participants|0|0.0||||||
4457137|NCT00070564|4278422|B5||unknown|Nodal status||Participants|Count of Participants|1|1.0||||||
4457138|NCT00070564|4278423|B4||unknown|Nodal status||Participants|Count of Participants|4|4.0||||||
4457139|NCT00070564|4278424|B3||unknown|Nodal status||Participants|Count of Participants|3|3.0||||||
4457140|NCT00070564|4278425|B2||unknown|Nodal status||Participants|Count of Participants|0|0.0||||||
4457141|NCT00070564|4278426|B1||unknown|Nodal status||Participants|Count of Participants|2|2.0||||||
4457142|NCT00070564|4278420|B7||>= 4 positive nodes|Nodal status||Participants|Count of Participants|1147|1147.0||||||
4457143|NCT00070564|4278421|B6||>= 4 positive nodes|Nodal status||Participants|Count of Participants|87|87.0||||||
4457144|NCT00070564|4278422|B5||>= 4 positive nodes|Nodal status||Participants|Count of Participants|68|68.0||||||
4457145|NCT00070564|4278423|B4||>= 4 positive nodes|Nodal status||Participants|Count of Participants|244|244.0||||||
4457146|NCT00070564|4278424|B3||>= 4 positive nodes|Nodal status||Participants|Count of Participants|243|243.0||||||
4457147|NCT00070564|4278425|B2||>= 4 positive nodes|Nodal status||Participants|Count of Participants|264|264.0||||||
4457148|NCT00070564|4278426|B1||>= 4 positive nodes|Nodal status||Participants|Count of Participants|241|241.0||||||
4457149|NCT00070564|4278420|B7||1-3 positive nodes|Nodal status||Participants|Count of Participants|1248|1248.0||||||
4457150|NCT00070564|4278421|B6||1-3 positive nodes|Nodal status||Participants|Count of Participants|98|98.0||||||
4457151|NCT00070564|4278422|B5||1-3 positive nodes|Nodal status||Participants|Count of Participants|103|103.0||||||
4457152|NCT00070564|4278423|B4||1-3 positive nodes|Nodal status||Participants|Count of Participants|245|245.0||||||
4457153|NCT00070564|4278424|B3||1-3 positive nodes|Nodal status||Participants|Count of Participants|276|276.0||||||
4457154|NCT00070564|4278425|B2||1-3 positive nodes|Nodal status||Participants|Count of Participants|266|266.0||||||
4457155|NCT00070564|4278426|B1||1-3 positive nodes|Nodal status||Participants|Count of Participants|260|260.0||||||
4457156|NCT00070564|4278420|B7||Negative|Nodal status||Participants|Count of Participants|833|833.0||||||
4457157|NCT00070564|4278421|B6||Negative|Nodal status||Participants|Count of Participants|109|109.0||||||
4457158|NCT00070564|4278422|B5||Negative|Nodal status||Participants|Count of Participants|105|105.0||||||
4457159|NCT00070564|4278423|B4||Negative|Nodal status||Participants|Count of Participants|146|146.0||||||
4457160|NCT00070564|4278424|B3||Negative|Nodal status||Participants|Count of Participants|159|159.0||||||
4457161|NCT00070564|4278425|B2||Negative|Nodal status||Participants|Count of Participants|153|153.0||||||
4457162|NCT00070564|4278426|B1||Negative|Nodal status||Participants|Count of Participants|161|161.0||||||
4457163|NCT00070564|4278420|B7||Unknown|Menopausal status (females)||Participants|Count of Participants|5|5.0||||||
4457164|NCT00070564|4278421|B6||Unknown|Menopausal status (females)||Participants|Count of Participants|2|2.0||||||
4457165|NCT00070564|4278422|B5||Unknown|Menopausal status (females)||Participants|Count of Participants|3|3.0||||||
4457166|NCT00070564|4278423|B4||Unknown|Menopausal status (females)||Participants|Count of Participants|0|0.0||||||
4457167|NCT00070564|4278424|B3||Unknown|Menopausal status (females)||Participants|Count of Participants|0|0.0||||||
4457168|NCT00070564|4278425|B2||Unknown|Menopausal status (females)||Participants|Count of Participants|0|0.0||||||
4457169|NCT00070564|4278426|B1||Unknown|Menopausal status (females)||Participants|Count of Participants|0|0.0||||||
4457170|NCT00070564|4278420|B7||Postmenopausal|Menopausal status (females)||Participants|Count of Participants|1705|1705.0||||||
4457171|NCT00070564|4278421|B6||Postmenopausal|Menopausal status (females)||Participants|Count of Participants|166|166.0||||||
4457172|NCT00070564|4278422|B5||Postmenopausal|Menopausal status (females)||Participants|Count of Participants|148|148.0||||||
4457173|NCT00070564|4278423|B4||Postmenopausal|Menopausal status (females)||Participants|Count of Participants|337|337.0||||||
4457174|NCT00070564|4278424|B3||Postmenopausal|Menopausal status (females)||Participants|Count of Participants|368|368.0||||||
4457175|NCT00070564|4278425|B2||Postmenopausal|Menopausal status (females)||Participants|Count of Participants|354|354.0||||||
4457176|NCT00070564|4278426|B1||Postmenopausal|Menopausal status (females)||Participants|Count of Participants|332|332.0||||||
4457177|NCT00070564|4278420|B7||Premenopausal|Menopausal status (females)||Participants|Count of Participants|1505|1505.0||||||
4457178|NCT00070564|4278421|B6||Premenopausal|Menopausal status (females)||Participants|Count of Participants|123|123.0||||||
4457179|NCT00070564|4278422|B5||Premenopausal|Menopausal status (females)||Participants|Count of Participants|124|124.0||||||
4457180|NCT00070564|4278423|B4||Premenopausal|Menopausal status (females)||Participants|Count of Participants|299|299.0||||||
4457181|NCT00070564|4278424|B3||Premenopausal|Menopausal status (females)||Participants|Count of Participants|308|308.0||||||
4457182|NCT00070564|4278425|B2||Premenopausal|Menopausal status (females)||Participants|Count of Participants|325|325.0||||||
4457183|NCT00070564|4278426|B1||Premenopausal|Menopausal status (females)||Participants|Count of Participants|326|326.0||||||
4457184|NCT00070564|4278420|B7|||Black Race||Participants|Count of Participants|377|377.0||||||
4457185|NCT00070564|4278421|B6|||Black Race||Participants|Count of Participants|44|44.0||||||
4457186|NCT00070564|4278422|B5|||Black Race||Participants|Count of Participants|31|31.0||||||
4457187|NCT00070564|4278423|B4|||Black Race||Participants|Count of Participants|78|78.0||||||
4457188|NCT00070564|4278424|B3|||Black Race||Participants|Count of Participants|74|74.0||||||
4457189|NCT00070564|4278425|B2|||Black Race||Participants|Count of Participants|77|77.0||||||
4457190|NCT00070564|4278426|B1|||Black Race||Participants|Count of Participants|73|73.0||||||
4457191|NCT00070564|4278420|B7||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4457192|NCT00070564|4278421|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4457193|NCT00070564|4278422|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4457194|NCT00070564|4278423|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4457195|NCT00070564|4278424|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4457196|NCT00070564|4278425|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4457197|NCT00070564|4278426|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4457198|NCT00070564|4278420|B7||Female|Sex: Female, Male||Participants|Count of Participants|3215|3215.0||||||
4457199|NCT00070564|4278421|B6||Female|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4457200|NCT00070564|4278422|B5||Female|Sex: Female, Male||Participants|Count of Participants|275|275.0||||||
4457201|NCT00070564|4278423|B4||Female|Sex: Female, Male||Participants|Count of Participants|636|636.0||||||
4457202|NCT00070564|4278424|B3||Female|Sex: Female, Male||Participants|Count of Participants|676|676.0||||||
4457203|NCT00070564|4278425|B2||Female|Sex: Female, Male||Participants|Count of Participants|679|679.0||||||
4457204|NCT00070564|4278426|B1||Female|Sex: Female, Male||Participants|Count of Participants|658|658.0||||||
4457205|NCT00070564|4278420|B7|||Age||years|Median|52.7|52.7|Full Range|||21.0|86.0|
4457206|NCT00070564|4278421|B6|||Age||years|Median|53.2|53.2|Full Range|||23.0|76.0|
4457207|NCT00070564|4278422|B5|||Age||years|Median|52.7|52.7|Full Range|||31.0|79.0|
4457208|NCT00070564|4278423|B4|||Age||years|Median|50.7|50.7|Full Range|||21.0|76.0|
4457209|NCT00070564|4278424|B3|||Age||years|Median|51.8|51.8|Full Range|||23.0|86.0|
4457210|NCT00070564|4278425|B2|||Age||years|Median|50.9|50.9|Full Range|||23.0|79.0|
4457211|NCT00070564|4278426|B1|||Age||years|Median|50.5|50.5|Full Range|||25.0|77.0|
4457212|NCT00070499|4278481|B5|United States||Region of Enrollment||participants|Number|391|391.0||||||
4457213|NCT00070499|4278482|B4|United States||Region of Enrollment||participants|Number|123|123.0||||||
4457214|NCT00070499|4278483|B3|United States||Region of Enrollment||participants|Number|123|123.0||||||
4457215|NCT00070499|4278484|B2|United States||Region of Enrollment||participants|Number|73|73.0||||||
4457216|NCT00070499|4278485|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4457217|NCT00070499|4278481|B5||Male|Sex: Female, Male||Participants|Count of Participants|240|240.0||||||
4457218|NCT00070499|4278482|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4457219|NCT00070499|4278483|B3||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4457220|NCT00070499|4278484|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4457221|NCT00070499|4278485|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4457222|NCT00070499|4278481|B5||Female|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4457223|NCT00070499|4278482|B4||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4457224|NCT00070499|4278483|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4457225|NCT00070499|4278484|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4457226|NCT00070499|4278485|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4457227|NCT00070499|4278481|B5|||Age||years|Median|50|50.0|Full Range|||18.0|90.0|
4457228|NCT00070499|4278482|B4|||Age||years|Median|50|50.0|Full Range|||19.0|89.0|
4457229|NCT00070499|4278483|B3|||Age||years|Median|47|47.0|Full Range|||18.0|90.0|
4457230|NCT00070499|4278484|B2|||Age||years|Median|52|52.0|Full Range|||20.0|82.0|
4457231|NCT00070499|4278485|B1|||Age||years|Median|50|50.0|Full Range|||23.0|80.0|
4457232|NCT00070317|4278514|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4457233|NCT00070317|4278514|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457234|NCT00070317|4278514|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4457235|NCT00070317|4278514|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4457236|NCT00070317|4278514|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457237|NCT00070317|4278514|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4457238|NCT00070317|4278514|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4457239|NCT00070317|4278514|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4457240|NCT00070317|4278514|B1||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4457241|NCT00070317|4278514|B1|80-89 years||Age, Customized||Participants|Count of Participants|1|1.0||||||
4457242|NCT00070317|4278514|B1|70-79 years||Age, Customized||Participants|Count of Participants|2|2.0||||||
4457243|NCT00070317|4278514|B1|60-69 years||Age, Customized||Participants|Count of Participants|9|9.0||||||
4457244|NCT00070317|4278514|B1|50-59 years||Age, Customized||Participants|Count of Participants|17|17.0||||||
4457245|NCT00070317|4278514|B1|40-49 years||Age, Customized||Participants|Count of Participants|31|31.0||||||
4457246|NCT00070317|4278514|B1|30-39 years||Age, Customized||Participants|Count of Participants|23|23.0||||||
4457247|NCT00070317|4278514|B1|20-29 years||Age, Customized||Participants|Count of Participants|6|6.0||||||
4457248|NCT00070291|4278519|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4457249|NCT00070291|4278519|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4457250|NCT00070291|4278519|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4457251|NCT00070291|4278519|B1|||Age||years|Median|62|62.0|Full Range|||42.0|65.0|
4457252|NCT00070135|4278524|B1|Matched related donor||Transplant Donor Type||participants|Number|55|55.0||||||
4457253|NCT00070135|4278524|B1|Matched unrelated donor||Transplant Donor Type||participants|Number|59|59.0||||||
4457254|NCT00070135|4278524|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4457255|NCT00070135|4278524|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4457256|NCT00070135|4278524|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457257|NCT00070135|4278524|B1||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4457258|NCT00070135|4278524|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4457259|NCT00070135|4278524|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457260|NCT00070135|4278524|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457261|NCT00070135|4278524|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457262|NCT00070135|4278524|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4457263|NCT00070135|4278524|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|102|102.0||||||
4457264|NCT00070135|4278524|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4457265|NCT00070135|4278524|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4457266|NCT00070135|4278524|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4457267|NCT00070135|4278524|B1|||Age||years|Median|65|65.0|Full Range|||60.0|74.0|
4457268|NCT00070109|4278530|B6|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4457269|NCT00070109|4278531|B5|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4457270|NCT00070109|4278532|B4|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4457271|NCT00070109|4278533|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4457272|NCT00070109|4278534|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4457273|NCT00070109|4278535|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4457274|NCT00070109|4278530|B6|United States||Region of Enrollment||participants|Number|43|43.0||||||
4457275|NCT00070109|4278531|B5|United States||Region of Enrollment||participants|Number|8|8.0||||||
4457276|NCT00070109|4278532|B4|United States||Region of Enrollment||participants|Number|19|19.0||||||
4457277|NCT00070109|4278533|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4457278|NCT00070109|4278534|B2|United States||Region of Enrollment||participants|Number|6|6.0||||||
4457279|NCT00070109|4278535|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4457280|NCT00070109|4278530|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4457281|NCT00070109|4278531|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457282|NCT00070109|4278532|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4457283|NCT00070109|4278533|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457284|NCT00070109|4278534|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457285|NCT00070109|4278535|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457286|NCT00070109|4278530|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457287|NCT00070109|4278531|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457288|NCT00070109|4278532|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457289|NCT00070109|4278533|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457290|NCT00070109|4278534|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457291|NCT00070109|4278535|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457292|NCT00070109|4278530|B6||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4457293|NCT00070109|4278531|B5||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4457294|NCT00070109|4278532|B4||White|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4457295|NCT00070109|4278533|B3||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4457296|NCT00070109|4278534|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4457297|NCT00070109|4278535|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4457298|NCT00070109|4278530|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4457299|NCT00070109|4278531|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457300|NCT00070109|4278532|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4457301|NCT00070109|4278533|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457302|NCT00070109|4278534|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457303|NCT00070109|4278535|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457304|NCT00070109|4278530|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457305|NCT00070109|4278531|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457306|NCT00070109|4278532|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457307|NCT00070109|4278533|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457308|NCT00070109|4278534|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457309|NCT00070109|4278535|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457310|NCT00070109|4278530|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4457311|NCT00070109|4278531|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457312|NCT00070109|4278532|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457313|NCT00070109|4278533|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457314|NCT00070109|4278534|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457315|NCT00070109|4278535|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457316|NCT00070109|4278530|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457317|NCT00070109|4278531|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457318|NCT00070109|4278532|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457319|NCT00070109|4278533|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457320|NCT00070109|4278534|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457321|NCT00070109|4278535|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457322|NCT00070109|4278530|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4457323|NCT00070109|4278531|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457324|NCT00070109|4278532|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457325|NCT00070109|4278533|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4457326|NCT00070109|4278534|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457327|NCT00070109|4278535|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457328|NCT00070109|4278530|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4457329|NCT00070109|4278531|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4457330|NCT00070109|4278532|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4457331|NCT00070109|4278533|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457332|NCT00070109|4278534|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4457333|NCT00070109|4278535|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4457334|NCT00070109|4278530|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4457335|NCT00070109|4278531|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4457336|NCT00070109|4278532|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4457337|NCT00070109|4278533|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457338|NCT00070109|4278534|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457339|NCT00070109|4278535|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457340|NCT00070109|4278530|B6||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4457341|NCT00070109|4278531|B5||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4457342|NCT00070109|4278532|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4457343|NCT00070109|4278533|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4457344|NCT00070109|4278534|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4457345|NCT00070109|4278535|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4457346|NCT00070109|4278530|B6||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4457347|NCT00070109|4278531|B5||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4457348|NCT00070109|4278532|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4457349|NCT00070109|4278533|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4457350|NCT00070109|4278534|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4457351|NCT00070109|4278535|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4457352|NCT00070109|4278530|B6|||Age||years|Median|15.5|15.5|Full Range|||4.0|24.0|
4457353|NCT00070109|4278531|B5|||Age||years|Median|16|16.0|Full Range|||8.0|21.0|
4457354|NCT00070109|4278532|B4|||Age||years|Median|14.5|14.5|Full Range|||4.0|22.0|
4457355|NCT00070109|4278533|B3|||Age||years|Median|16|16.0|Full Range|||8.0|20.0|
4457356|NCT00070109|4278534|B2|||Age||years|Median|15.5|15.5|Full Range|||8.0|21.0|
4457357|NCT00070109|4278535|B1|||Age||years|Median|18.5|18.5|Full Range|||8.0|24.0|
4457358|NCT00070018|4278567|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457359|NCT00070018|4278567|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457360|NCT00070018|4278567|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4457361|NCT00070018|4278567|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4457362|NCT00070018|4278567|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457363|NCT00070018|4278567|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457364|NCT00070018|4278567|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457365|NCT00070018|4278567|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4457366|NCT00070018|4278567|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4457367|NCT00070018|4278567|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4457368|NCT00070018|4278567|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4457369|NCT00070018|4278567|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4457370|NCT00070018|4278567|B1|||Age||years|Median|61.2|61.2|Full Range|||23.5|84.6|
4457371|NCT00069953|4278571|B1||Male|Gender||Participants|Count of Participants|34|34.0||||||
4457372|NCT00069953|4278571|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
4457373|NCT00069953|4278571|B1|||Age||years|Median|59|59.0|Full Range|||42.0|81.0|
4457374|NCT00069784|4278575|B3|||Fasting Plasma Glucose|Due to missing values, N=6248 for insulin glargine and N=6266 for standard care.|mmol/L|Median|6.94|6.94|Inter-Quartile Range|||6.05|8.2|
4457375|NCT00069784|4278576|B2|||Fasting Plasma Glucose|Due to missing values, N=6248 for insulin glargine and N=6266 for standard care.|mmol/L|Median|6.90|6.9|Inter-Quartile Range|||6.0|8.2|
4457376|NCT00069784|4278577|B1|||Fasting Plasma Glucose|Due to missing values, N=6248 for insulin glargine and N=6266 for standard care.|mmol/L|Median|6.94|6.94|Inter-Quartile Range|||6.05|8.2|
4457377|NCT00069784|4278575|B3|||Glycated Hemoglobin A1c (HbA1c)|Due to missing values, N=6175 for insulin glargine and N=6189 for standard care.|percent|Median|6.40|6.4|Inter-Quartile Range|||5.81|7.18|
4457378|NCT00069784|4278576|B2|||Glycated Hemoglobin A1c (HbA1c)|Due to missing values, N=6175 for insulin glargine and N=6189 for standard care.|percent|Median|6.40|6.4|Inter-Quartile Range|||5.81|7.16|
4457379|NCT00069784|4278577|B1|||Glycated Hemoglobin A1c (HbA1c)|Due to missing values, N=6175 for insulin glargine and N=6189 for standard care.|percent|Median|6.41|6.41|Inter-Quartile Range|||5.81|7.18|
4457380|NCT00069784|4278575|B3|||Duration of diabetes for established diabetes patients|Population of patients with established diabetes. Due to missing values, N=5148 for insulin glargine and N=5141 for standard care.|years|Median|3.50|3.5|Inter-Quartile Range|||1.5|7.5|
4457381|NCT00069784|4278576|B2|||Duration of diabetes for established diabetes patients|Population of patients with established diabetes. Due to missing values, N=5148 for insulin glargine and N=5141 for standard care.|years|Median|3.50|3.5|Inter-Quartile Range|||1.5|7.5|
4457382|NCT00069784|4278577|B1|||Duration of diabetes for established diabetes patients|Population of patients with established diabetes. Due to missing values, N=5148 for insulin glargine and N=5141 for standard care.|years|Median|3.50|3.5|Inter-Quartile Range|||1.5|7.5|
4457383|NCT00069784|4278575|B3|Unclear diabetes status||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|4|4.0||||||
4457384|NCT00069784|4278576|B2|Unclear diabetes status||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|2|2.0||||||
4457385|NCT00069784|4278577|B1|Unclear diabetes status||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|2|2.0||||||
4457386|NCT00069784|4278575|B3|Established diabetes with one OAD treatment||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|7440|7440.0||||||
4457409|NCT00069784|4278577|B1|||Baseline Weight|Due to missing values, N=6256 for insulin glargine and N=6271 for standard care.|kg|Mean|83.33|83.33|Standard Deviation|16.77|16.77|||
4457410|NCT00069784|4278575|B3|Missing value||Sex/Gender, Customized||participants|Number|1|1.0||||||
4457411|NCT00069784|4278576|B2|Missing value||Sex/Gender, Customized||participants|Number|0|0.0||||||
4457387|NCT00069784|4278576|B2|Established diabetes with one OAD treatment||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|3692|3692.0||||||
4457388|NCT00069784|4278577|B1|Established diabetes with one OAD treatment||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|3748|3748.0||||||
4457389|NCT00069784|4278575|B3|Established diabetes with no OAD treatment||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|2881|2881.0||||||
4457390|NCT00069784|4278576|B2|Established diabetes with no OAD treatment||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|1467|1467.0||||||
4457391|NCT00069784|4278577|B1|Established diabetes with no OAD treatment||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|1414|1414.0||||||
4457392|NCT00069784|4278575|B3|Newly diagnosed diabetic||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|760|760.0||||||
4457393|NCT00069784|4278576|B2|Newly diagnosed diabetic||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|395|395.0||||||
4457394|NCT00069784|4278577|B1|Newly diagnosed diabetic||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|365|365.0||||||
4457395|NCT00069784|4278575|B3|IFG and/or IGT||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|1452|1452.0||||||
4457396|NCT00069784|4278576|B2|IFG and/or IGT||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|717|717.0||||||
4457397|NCT00069784|4278577|B1|IFG and/or IGT||Diabetes diagnosis at time of screening|"IFG = Impaired Fasting Glucose defined as a Postprandial Plasma Glucose (PPG) value ≥140 and <200 mg/dL (ie, ≥7.8 and <11.1 mmol/L), with a Fasting Plasma Glucose (FPG) <126 mg/dL (7.0 mmol/L)~IGT = Impaired Glucose Tolerance defined as an FPG ≥110 and <126 mg/dL (≥6.1 and <7 mmol/L), without diabetes mellitus (PPG must be <200 mg/dL [11.1 mmol/L])~OAD = oral antidiabetic drug"|participants|Number|735|735.0||||||
4457398|NCT00069784|4278575|B3|Yes||Any previous cardiovascular event||participants|Number|7378|7378.0||||||
4457399|NCT00069784|4278576|B2|Yes||Any previous cardiovascular event||participants|Number|3666|3666.0||||||
4457400|NCT00069784|4278577|B1|Yes||Any previous cardiovascular event||participants|Number|3712|3712.0||||||
4457401|NCT00069784|4278575|B3|No||Any previous cardiovascular event||participants|Number|5159|5159.0||||||
4457402|NCT00069784|4278576|B2|No||Any previous cardiovascular event||participants|Number|2607|2607.0||||||
4457403|NCT00069784|4278577|B1|No||Any previous cardiovascular event||participants|Number|2552|2552.0||||||
4457404|NCT00069784|4278575|B3|||Baseline Body Mass Index|Due to missing values, N=6251 for insulin glargine and N=6270 for standard care.|kg/m²|Mean|29.82|29.82|Standard Deviation|5.25|5.25|||
4457405|NCT00069784|4278576|B2|||Baseline Body Mass Index|Due to missing values, N=6251 for insulin glargine and N=6270 for standard care.|kg/m²|Mean|29.88|29.88|Standard Deviation|5.33|5.33|||
4457406|NCT00069784|4278577|B1|||Baseline Body Mass Index|Due to missing values, N=6251 for insulin glargine and N=6270 for standard care.|kg/m²|Mean|29.77|29.77|Standard Deviation|5.17|5.17|||
4457407|NCT00069784|4278575|B3|||Baseline Weight|Due to missing values, N=6256 for insulin glargine and N=6271 for standard care.|kg|Mean|83.23|83.23|Standard Deviation|17.03|17.03|||
4457408|NCT00069784|4278576|B2|||Baseline Weight|Due to missing values, N=6256 for insulin glargine and N=6271 for standard care.|kg|Mean|83.13|83.13|Standard Deviation|17.28|17.28|||
4457412|NCT00069784|4278577|B1|Missing value||Sex/Gender, Customized||participants|Number|1|1.0||||||
4457413|NCT00069784|4278575|B3|Female||Sex/Gender, Customized||participants|Number|4386|4386.0||||||
4457414|NCT00069784|4278576|B2|Female||Sex/Gender, Customized||participants|Number|2304|2304.0||||||
4457415|NCT00069784|4278577|B1|Female||Sex/Gender, Customized||participants|Number|2082|2082.0||||||
4457416|NCT00069784|4278575|B3|Male||Sex/Gender, Customized||participants|Number|8150|8150.0||||||
4457417|NCT00069784|4278576|B2|Male||Sex/Gender, Customized||participants|Number|3969|3969.0||||||
4457418|NCT00069784|4278577|B1|Male||Sex/Gender, Customized||participants|Number|4181|4181.0||||||
4457419|NCT00069784|4278575|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|7.8|7.8|||
4457420|NCT00069784|4278576|B2|||Age||years|Mean|63.5|63.5|Standard Deviation|7.9|7.9|||
4457421|NCT00069784|4278577|B1|||Age||years|Mean|63.5|63.5|Standard Deviation|7.8|7.8|||
4457422|NCT00069823|4278596|B3|||Percent change in FEV1 after bronchodilator|The percent difference in FEV1 before and after using a bronchodilator (albuterol) divided by the value before bronchodilation.|Percent change|Mean|11|11.0|Standard Deviation|13|13.0|||
4457423|NCT00069823|4278597|B2|||Percent change in FEV1 after bronchodilator|The percent difference in FEV1 before and after using a bronchodilator (albuterol) divided by the value before bronchodilation.|Percent change|Mean|11|11.0|Standard Deviation|16|16.0|||
4457424|NCT00069823|4278598|B1|||Percent change in FEV1 after bronchodilator|The percent difference in FEV1 before and after using a bronchodilator (albuterol) divided by the value before bronchodilation.|Percent change|Mean|10|10.0|Standard Deviation|10|10.0|||
4457425|NCT00069823|4278596|B3|mini asthma quality of life questionnaire||Asthma scores|Asthma Control Score (ACS)ranges from 0 to 6, lower scores indicating better asthma control and 0.5 as the minimal clinically important difference; Asthma Symptom Utility Index (ASUI) score ranges from 0 to 1, higher scores indicating less severe asthma; Mini-Asthma Quality of Life Questionnaire (mini-AQLQ) score range from 1 to 7, higher scores indicating better quality of life and 0.5 as the minimal clinically important difference.|score|Mean|4.7|4.7|Standard Deviation|1.2|1.2|||
4457426|NCT00069823|4278597|B2|mini asthma quality of life questionnaire||Asthma scores|Asthma Control Score (ACS)ranges from 0 to 6, lower scores indicating better asthma control and 0.5 as the minimal clinically important difference; Asthma Symptom Utility Index (ASUI) score ranges from 0 to 1, higher scores indicating less severe asthma; Mini-Asthma Quality of Life Questionnaire (mini-AQLQ) score range from 1 to 7, higher scores indicating better quality of life and 0.5 as the minimal clinically important difference.|score|Mean|4.7|4.7|Standard Deviation|1.2|1.2|||
4457427|NCT00069823|4278598|B1|mini asthma quality of life questionnaire||Asthma scores|Asthma Control Score (ACS)ranges from 0 to 6, lower scores indicating better asthma control and 0.5 as the minimal clinically important difference; Asthma Symptom Utility Index (ASUI) score ranges from 0 to 1, higher scores indicating less severe asthma; Mini-Asthma Quality of Life Questionnaire (mini-AQLQ) score range from 1 to 7, higher scores indicating better quality of life and 0.5 as the minimal clinically important difference.|score|Mean|4.7|4.7|Standard Deviation|1.2|1.2|||
4457428|NCT00069823|4278596|B3|ASUI||Asthma scores|Asthma Control Score (ACS)ranges from 0 to 6, lower scores indicating better asthma control and 0.5 as the minimal clinically important difference; Asthma Symptom Utility Index (ASUI) score ranges from 0 to 1, higher scores indicating less severe asthma; Mini-Asthma Quality of Life Questionnaire (mini-AQLQ) score range from 1 to 7, higher scores indicating better quality of life and 0.5 as the minimal clinically important difference.|score|Mean|0.75|0.75|Standard Deviation|0.15|0.15|||
4457429|NCT00069823|4278597|B2|ASUI||Asthma scores|Asthma Control Score (ACS)ranges from 0 to 6, lower scores indicating better asthma control and 0.5 as the minimal clinically important difference; Asthma Symptom Utility Index (ASUI) score ranges from 0 to 1, higher scores indicating less severe asthma; Mini-Asthma Quality of Life Questionnaire (mini-AQLQ) score range from 1 to 7, higher scores indicating better quality of life and 0.5 as the minimal clinically important difference.|score|Mean|0.76|0.76|Standard Deviation|0.15|0.15|||
4457430|NCT00069823|4278598|B1|ASUI||Asthma scores|Asthma Control Score (ACS)ranges from 0 to 6, lower scores indicating better asthma control and 0.5 as the minimal clinically important difference; Asthma Symptom Utility Index (ASUI) score ranges from 0 to 1, higher scores indicating less severe asthma; Mini-Asthma Quality of Life Questionnaire (mini-AQLQ) score range from 1 to 7, higher scores indicating better quality of life and 0.5 as the minimal clinically important difference.|score|Mean|0.74|0.74|Standard Deviation|0.18|0.18|||
4457431|NCT00069823|4278596|B3|ACQ||Asthma scores|Asthma Control Score (ACS)ranges from 0 to 6, lower scores indicating better asthma control and 0.5 as the minimal clinically important difference; Asthma Symptom Utility Index (ASUI) score ranges from 0 to 1, higher scores indicating less severe asthma; Mini-Asthma Quality of Life Questionnaire (mini-AQLQ) score range from 1 to 7, higher scores indicating better quality of life and 0.5 as the minimal clinically important difference.|score|Mean|1.8|1.8|Standard Deviation|0.8|0.8|||
4457432|NCT00069823|4278597|B2|ACQ||Asthma scores|Asthma Control Score (ACS)ranges from 0 to 6, lower scores indicating better asthma control and 0.5 as the minimal clinically important difference; Asthma Symptom Utility Index (ASUI) score ranges from 0 to 1, higher scores indicating less severe asthma; Mini-Asthma Quality of Life Questionnaire (mini-AQLQ) score range from 1 to 7, higher scores indicating better quality of life and 0.5 as the minimal clinically important difference.|score|Mean|1.8|1.8|Standard Deviation|0.8|0.8|||
4457433|NCT00069823|4278598|B1|ACQ||Asthma scores|Asthma Control Score (ACS)ranges from 0 to 6, lower scores indicating better asthma control and 0.5 as the minimal clinically important difference; Asthma Symptom Utility Index (ASUI) score ranges from 0 to 1, higher scores indicating less severe asthma; Mini-Asthma Quality of Life Questionnaire (mini-AQLQ) score range from 1 to 7, higher scores indicating better quality of life and 0.5 as the minimal clinically important difference.|score|Mean|1.9|1.9|Standard Deviation|0.8|0.8|||
4457434|NCT00069823|4278596|B3|at onset of asthma||Age of participants||years|Mean|17|17.0|Standard Deviation|16|16.0|||
4457435|NCT00069823|4278597|B2|at onset of asthma||Age of participants||years|Mean|17|17.0|Standard Deviation|16|16.0|||
4457436|NCT00069823|4278598|B1|at onset of asthma||Age of participants||years|Mean|17|17.0|Standard Deviation|17|17.0|||
4457437|NCT00069823|4278596|B3|at randomization||Age of participants||years|Mean|42|42.0|Standard Deviation|13|13.0|||
4457438|NCT00069823|4278597|B2|at randomization||Age of participants||years|Mean|42|42.0|Standard Deviation|13|13.0|||
4457439|NCT00069823|4278598|B1|at randomization||Age of participants||years|Mean|42|42.0|Standard Deviation|13|13.0|||
4457440|NCT00069823|4278596|B3|||Age of onset of asthma||years|Mean|17|17.0|Standard Deviation|16|16.0|||
4457441|NCT00069823|4278597|B2|||Age of onset of asthma||years|Mean|17|17.0|Standard Deviation|16|16.0|||
4457442|NCT00069823|4278598|B1|||Age of onset of asthma||years|Mean|17|17.0|Standard Deviation|17|17.0|||
4457443|NCT00069823|4278596|B3|||%Predicted amount of air expired in the first second during a forced expiration pre broncho-dilator|Percent of the predicted value for the amount of air expired in the first second during a forced expiratory maneuver (FEV1) based on gender, age and ethnicity that the measured value is.|Percent|Mean|77|77.0|Standard Deviation|16|16.0|||
4457444|NCT00069823|4278597|B2|||%Predicted amount of air expired in the first second during a forced expiration pre broncho-dilator|Percent of the predicted value for the amount of air expired in the first second during a forced expiratory maneuver (FEV1) based on gender, age and ethnicity that the measured value is.|Percent|Mean|76|76.0|Standard Deviation|16|16.0|||
4457445|NCT00069823|4278598|B1|||%Predicted amount of air expired in the first second during a forced expiration pre broncho-dilator|Percent of the predicted value for the amount of air expired in the first second during a forced expiratory maneuver (FEV1) based on gender, age and ethnicity that the measured value is.|Percent|Mean|78|78.0|Standard Deviation|15|15.0|||
4457446|NCT00069823|4278596|B3|Missing result||potential Hydrogen (pH) monitoring|Results of ambulatory measure of esophageal potential Hydrogen (pH) for 16 to 24 hours. Test were considered positive if pH was less than 4 for more than 5.8% of the total tiem, 8.2% of upright time, or 3.5% of supine time.|participants|Number|98|98.0||||||
4457447|NCT00069823|4278597|B2|Missing result||potential Hydrogen (pH) monitoring|Results of ambulatory measure of esophageal potential Hydrogen (pH) for 16 to 24 hours. Test were considered positive if pH was less than 4 for more than 5.8% of the total tiem, 8.2% of upright time, or 3.5% of supine time.|participants|Number|50|50.0||||||
4457448|NCT00069823|4278598|B1|Missing result||potential Hydrogen (pH) monitoring|Results of ambulatory measure of esophageal potential Hydrogen (pH) for 16 to 24 hours. Test were considered positive if pH was less than 4 for more than 5.8% of the total tiem, 8.2% of upright time, or 3.5% of supine time.|participants|Number|48|48.0||||||
4457449|NCT00069823|4278596|B3|Negative result||potential Hydrogen (pH) monitoring|Results of ambulatory measure of esophageal potential Hydrogen (pH) for 16 to 24 hours. Test were considered positive if pH was less than 4 for more than 5.8% of the total tiem, 8.2% of upright time, or 3.5% of supine time.|participants|Number|181|181.0||||||
4457450|NCT00069823|4278597|B2|Negative result||potential Hydrogen (pH) monitoring|Results of ambulatory measure of esophageal potential Hydrogen (pH) for 16 to 24 hours. Test were considered positive if pH was less than 4 for more than 5.8% of the total tiem, 8.2% of upright time, or 3.5% of supine time.|participants|Number|92|92.0||||||
4457451|NCT00069823|4278598|B1|Negative result||potential Hydrogen (pH) monitoring|Results of ambulatory measure of esophageal potential Hydrogen (pH) for 16 to 24 hours. Test were considered positive if pH was less than 4 for more than 5.8% of the total tiem, 8.2% of upright time, or 3.5% of supine time.|participants|Number|89|89.0||||||
4457452|NCT00069823|4278596|B3|Positive result||potential Hydrogen (pH) monitoring|Results of ambulatory measure of esophageal potential Hydrogen (pH) for 16 to 24 hours. Test were considered positive if pH was less than 4 for more than 5.8% of the total tiem, 8.2% of upright time, or 3.5% of supine time.|participants|Number|123|123.0||||||
4457453|NCT00069823|4278597|B2|Positive result||potential Hydrogen (pH) monitoring|Results of ambulatory measure of esophageal potential Hydrogen (pH) for 16 to 24 hours. Test were considered positive if pH was less than 4 for more than 5.8% of the total tiem, 8.2% of upright time, or 3.5% of supine time.|participants|Number|61|61.0||||||
4457454|NCT00069823|4278598|B1|Positive result||potential Hydrogen (pH) monitoring|Results of ambulatory measure of esophageal potential Hydrogen (pH) for 16 to 24 hours. Test were considered positive if pH was less than 4 for more than 5.8% of the total tiem, 8.2% of upright time, or 3.5% of supine time.|participants|Number|62|62.0||||||
4457455|NCT00069823|4278596|B3|Missing||Pulmonary function||participants|Number|8|8.0||||||
4457456|NCT00069823|4278597|B2|Missing||Pulmonary function||participants|Number|3|3.0||||||
4457457|NCT00069823|4278598|B1|Missing||Pulmonary function||participants|Number|5|5.0||||||
4457458|NCT00069823|4278596|B3|20% from post-diluent contraindicated||Pulmonary function||participants|Number|219|219.0||||||
4457459|NCT00069823|4278597|B2|20% from post-diluent contraindicated||Pulmonary function||participants|Number|117|117.0||||||
4457460|NCT00069823|4278598|B1|20% from post-diluent contraindicated||Pulmonary function||participants|Number|102|102.0||||||
4457461|NCT00069823|4278596|B3|Participants with 20% post-diluent measurement||Pulmonary function||participants|Number|175|175.0||||||
4457462|NCT00069823|4278597|B2|Participants with 20% post-diluent measurement||Pulmonary function||participants|Number|83|83.0||||||
4457463|NCT00069823|4278598|B1|Participants with 20% post-diluent measurement||Pulmonary function||participants|Number|92|92.0||||||
4457464|NCT00069823|4278596|B3|No visit||Health Care Visits|Unscheduled health care visit for asthma in previous year|participants|Number|167|167.0||||||
4457465|NCT00069823|4278597|B2|No visit||Health Care Visits|Unscheduled health care visit for asthma in previous year|participants|Number|94|94.0||||||
4457466|NCT00069823|4278598|B1|No visit||Health Care Visits|Unscheduled health care visit for asthma in previous year|participants|Number|73|73.0||||||
4457467|NCT00069823|4278596|B3|Health care visit for asthma exacerbation||Health Care Visits|Unscheduled health care visit for asthma in previous year|participants|Number|235|235.0||||||
4457468|NCT00069823|4278597|B2|Health care visit for asthma exacerbation||Health Care Visits|Unscheduled health care visit for asthma in previous year|participants|Number|109|109.0||||||
4457469|NCT00069823|4278598|B1|Health care visit for asthma exacerbation||Health Care Visits|Unscheduled health care visit for asthma in previous year|participants|Number|126|126.0||||||
4457470|NCT00069823|4278596|B3|Never smoked||Former smoker||participants|Number|331|331.0||||||
4457471|NCT00069823|4278597|B2|Never smoked||Former smoker||participants|Number|172|172.0||||||
4457472|NCT00069823|4278598|B1|Never smoked||Former smoker||participants|Number|159|159.0||||||
4457473|NCT00069823|4278596|B3|Former Smoker||Former smoker||participants|Number|71|71.0||||||
4457474|NCT00069823|4278597|B2|Former Smoker||Former smoker||participants|Number|31|31.0||||||
4457475|NCT00069823|4278598|B1|Former Smoker||Former smoker||participants|Number|40|40.0||||||
4457476|NCT00069823|4278596|B3|No GER reported||Conditions other than asthma|These conditions were self-reported.|participants|Number|343|343.0||||||
4457477|NCT00069823|4278597|B2|No GER reported||Conditions other than asthma|These conditions were self-reported.|participants|Number|182|182.0||||||
4457478|NCT00069823|4278598|B1|No GER reported||Conditions other than asthma|These conditions were self-reported.|participants|Number|161|161.0||||||
4457479|NCT00069823|4278596|B3|Gastroesophageal reflux disease||Conditions other than asthma|These conditions were self-reported.|participants|Number|59|59.0||||||
4457480|NCT00069823|4278597|B2|Gastroesophageal reflux disease||Conditions other than asthma|These conditions were self-reported.|participants|Number|21|21.0||||||
4457481|NCT00069823|4278598|B1|Gastroesophageal reflux disease||Conditions other than asthma|These conditions were self-reported.|participants|Number|38|38.0||||||
4457482|NCT00069823|4278596|B3|BMI <30||Body-mass index >=30|The body-mass index is the weight in kilograms divided by the square of the height in meters.|participants|Number|193|193.0||||||
4457483|NCT00069823|4278597|B2|BMI <30||Body-mass index >=30|The body-mass index is the weight in kilograms divided by the square of the height in meters.|participants|Number|101|101.0||||||
4457484|NCT00069823|4278598|B1|BMI <30||Body-mass index >=30|The body-mass index is the weight in kilograms divided by the square of the height in meters.|participants|Number|92|92.0||||||
4457485|NCT00069823|4278596|B3|BMI >=30||Body-mass index >=30|The body-mass index is the weight in kilograms divided by the square of the height in meters.|participants|Number|209|209.0||||||
4457486|NCT00069823|4278597|B2|BMI >=30||Body-mass index >=30|The body-mass index is the weight in kilograms divided by the square of the height in meters.|participants|Number|102|102.0||||||
4457487|NCT00069823|4278598|B1|BMI >=30||Body-mass index >=30|The body-mass index is the weight in kilograms divided by the square of the height in meters.|participants|Number|107|107.0||||||
4457488|NCT00069823|4278596|B3|Combination of fluticasone and salmeterol||Asthma medication use||participants|Number|308|308.0||||||
4457489|NCT00069823|4278597|B2|Combination of fluticasone and salmeterol||Asthma medication use||participants|Number|159|159.0||||||
4457490|NCT00069823|4278598|B1|Combination of fluticasone and salmeterol||Asthma medication use||participants|Number|149|149.0||||||
4457491|NCT00069823|4278596|B3|Inhaled corticosteroids||Asthma medication use||participants|Number|94|94.0||||||
4457492|NCT00069823|4278597|B2|Inhaled corticosteroids||Asthma medication use||participants|Number|44|44.0||||||
4457493|NCT00069823|4278598|B1|Inhaled corticosteroids||Asthma medication use||participants|Number|50|50.0||||||
4457494|NCT00069823|4278596|B3|Other||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|participants|Number|10|10.0||||||
4457495|NCT00069823|4278597|B2|Other||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|participants|Number|4|4.0||||||
4457496|NCT00069823|4278598|B1|Other||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|participants|Number|6|6.0||||||
4457497|NCT00069823|4278596|B3|Hispanic||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|participants|Number|35|35.0||||||
4457498|NCT00069823|4278597|B2|Hispanic||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|participants|Number|18|18.0||||||
4457499|NCT00069823|4278598|B1|Hispanic||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|participants|Number|17|17.0||||||
4457500|NCT00069823|4278596|B3|Black||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|participants|Number|152|152.0||||||
4457501|NCT00069823|4278597|B2|Black||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|participants|Number|79|79.0||||||
4457502|NCT00069823|4278598|B1|Black||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|participants|Number|73|73.0||||||
4457503|NCT00069823|4278596|B3|White||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|participants|Number|205|205.0||||||
4457504|NCT00069823|4278597|B2|White||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|participants|Number|102|102.0||||||
4457505|NCT00069823|4278598|B1|White||Race/Ethnicity, Customized|Race or ethnic group was self-reported.|participants|Number|103|103.0||||||
4457506|NCT00069823|4278596|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4457507|NCT00069823|4278597|B2||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4457508|NCT00069823|4278598|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4457509|NCT00069823|4278596|B3||Female|Sex: Female, Male||Participants|Count of Participants|273|273.0||||||
4457510|NCT00069823|4278597|B2||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4457511|NCT00069823|4278598|B1||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4457512|NCT00069823|4278596|B3|||Age||years|Mean|42|42.0|Standard Deviation|13|13.0|||
4457513|NCT00069823|4278597|B2|||Age||years|Mean|42|42.0|Standard Deviation|13|13.0|||
4457514|NCT00069823|4278598|B1|||Age||years|Mean|42|42.0|Standard Deviation|13|13.0|||
4457515|NCT00069641|4278639|B4|Europe||Region of Enrollment||participants|Number|41|41.0||||||
4457516|NCT00069641|4278640|B3|Europe||Region of Enrollment||participants|Number|13|13.0||||||
4457517|NCT00069641|4278641|B2|Europe||Region of Enrollment||participants|Number|14|14.0||||||
4457518|NCT00069641|4278642|B1|Europe||Region of Enrollment||participants|Number|14|14.0||||||
4457519|NCT00069641|4278639|B4|South America||Region of Enrollment||participants|Number|21|21.0||||||
4457520|NCT00069641|4278640|B3|South America||Region of Enrollment||participants|Number|7|7.0||||||
4457521|NCT00069641|4278641|B2|South America||Region of Enrollment||participants|Number|7|7.0||||||
4457522|NCT00069641|4278642|B1|South America||Region of Enrollment||participants|Number|7|7.0||||||
4457523|NCT00069641|4278639|B4|North America||Region of Enrollment||participants|Number|34|34.0||||||
4457524|NCT00069641|4278640|B3|North America||Region of Enrollment||participants|Number|12|12.0||||||
4457525|NCT00069641|4278641|B2|North America||Region of Enrollment||participants|Number|11|11.0||||||
4457526|NCT00069641|4278642|B1|North America||Region of Enrollment||participants|Number|11|11.0||||||
4457527|NCT00069641|4278639|B4||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4457528|NCT00069641|4278640|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4457529|NCT00069641|4278641|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4457530|NCT00069641|4278642|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4457531|NCT00069641|4278639|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4457532|NCT00069641|4278640|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4457533|NCT00069641|4278641|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4457534|NCT00069641|4278642|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4457535|NCT00069641|4278639|B4|greater than equal to (>=) 26 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|5|5.0||||||
4457536|NCT00069641|4278640|B3|greater than equal to (>=) 26 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|2|2.0||||||
4457537|NCT00069641|4278641|B2|greater than equal to (>=) 26 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|2|2.0||||||
4457538|NCT00069641|4278642|B1|greater than equal to (>=) 26 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|1|1.0||||||
4457539|NCT00069641|4278639|B4|19 to 25 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|19|19.0||||||
4457540|NCT00069641|4278640|B3|19 to 25 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|5|5.0||||||
4457541|NCT00069641|4278641|B2|19 to 25 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|7|7.0||||||
4457542|NCT00069641|4278642|B1|19 to 25 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|7|7.0||||||
4457543|NCT00069641|4278639|B4|12 to 18 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|29|29.0||||||
4457544|NCT00069641|4278640|B3|12 to 18 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|10|10.0||||||
4457545|NCT00069641|4278641|B2|12 to 18 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|9|9.0||||||
4457546|NCT00069641|4278642|B1|12 to 18 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|10|10.0||||||
4457547|NCT00069641|4278639|B4|5 to 11 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|43|43.0||||||
4457548|NCT00069641|4278640|B3|5 to 11 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|15|15.0||||||
4457549|NCT00069641|4278641|B2|5 to 11 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|14|14.0||||||
4457550|NCT00069641|4278642|B1|5 to 11 years||Age, Customized|"Age at randomization. The participant who was less than (<) 5 years old was considered for randomization to be in 5 to 11 years category.~Participants who were greater than (>) 25 years old were considered for randomization to be in 19 to 25 years category."|participants|Number|14|14.0||||||
4457551|NCT00069641|4278639|B4|||Age|Age at randomization.|years|Mean|14.22|14.22|Standard Deviation|6.729|6.729|||
4457552|NCT00069641|4278640|B3|||Age|Age at randomization.|years|Mean|13.12|13.12|Standard Deviation|6.908|6.908|||
4457553|NCT00069641|4278641|B2|||Age|Age at randomization.|years|Mean|14.40|14.4|Standard Deviation|7.019|7.019|||
4457554|NCT00069641|4278642|B1|||Age|Age at randomization.|years|Mean|15.14|15.14|Standard Deviation|6.293|6.293|||
4457555|NCT00069277|4278669|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4457556|NCT00069277|4278669|B1|Unknown or Not Reported||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4457557|NCT00069277|4278669|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4457558|NCT00069277|4278669|B1|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4457559|NCT00069277|4278669|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4457560|NCT00069277|4278669|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4457561|NCT00069277|4278669|B1|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4457562|NCT00069277|4278669|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4457563|NCT00069277|4278669|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4457564|NCT00069277|4278669|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4457565|NCT00069277|4278669|B1|Mean (+/- Standard Deviation)||Age, Customized||participants|Mean|59.0|59.0|Standard Deviation|11.2|11.2|||
4457566|NCT00069264|4278673|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4457567|NCT00069264|4278673|B1||Unknown or Not Reported|Race (NIH/OMB)|Please note: 8 subjects in unknown category were Hispanic/Latino|Participants|Count of Participants|8|8.0||||||
4457568|NCT00069264|4278673|B1||More than one race|Race (NIH/OMB)|Please note: 8 subjects in unknown category were Hispanic/Latino|Participants|Count of Participants|0|0.0||||||
4457569|NCT00069264|4278673|B1||White|Race (NIH/OMB)|Please note: 8 subjects in unknown category were Hispanic/Latino|Participants|Count of Participants|16|16.0||||||
4457570|NCT00069264|4278673|B1||Black or African American|Race (NIH/OMB)|Please note: 8 subjects in unknown category were Hispanic/Latino|Participants|Count of Participants|7|7.0||||||
4457571|NCT00069264|4278673|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Please note: 8 subjects in unknown category were Hispanic/Latino|Participants|Count of Participants|0|0.0||||||
4457572|NCT00069264|4278673|B1||Asian|Race (NIH/OMB)|Please note: 8 subjects in unknown category were Hispanic/Latino|Participants|Count of Participants|1|1.0||||||
4457573|NCT00069264|4278673|B1||American Indian or Alaska Native|Race (NIH/OMB)|Please note: 8 subjects in unknown category were Hispanic/Latino|Participants|Count of Participants|0|0.0||||||
4457574|NCT00069264|4278673|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457575|NCT00069264|4278673|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4457576|NCT00069264|4278673|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4457577|NCT00069264|4278673|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4457578|NCT00069264|4278673|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4457579|NCT00069264|4278673|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|11.29|11.29|||
4457580|NCT00069329|4278677|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4457581|NCT00069329|4278677|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457582|NCT00069329|4278677|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4457583|NCT00069329|4278677|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457584|NCT00069329|4278677|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457585|NCT00069329|4278677|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4457586|NCT00069329|4278677|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457587|NCT00069329|4278677|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4457588|NCT00069329|4278677|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4457589|NCT00069329|4278677|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4457590|NCT00069329|4278677|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4457591|NCT00069329|4278677|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4457592|NCT00069329|4278677|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4457593|NCT00069329|4278677|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4457594|NCT00069329|4278677|B1||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4457595|NCT00069238|4278701|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4457596|NCT00069238|4278701|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457597|NCT00069238|4278701|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457598|NCT00069238|4278701|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4457599|NCT00069238|4278701|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4457600|NCT00069238|4278701|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457601|NCT00069238|4278701|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4457602|NCT00069238|4278701|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457603|NCT00069238|4278701|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457604|NCT00069238|4278701|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4457605|NCT00069238|4278701|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457606|NCT00069238|4278701|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4457607|NCT00069238|4278701|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4457608|NCT00069238|4278701|B1|||Age||years|Mean|49.52|49.52|Standard Deviation|15.5|15.5|||
4457609|NCT00069238|4278701|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4457610|NCT00069238|4278701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4457611|NCT00069238|4278701|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4457612|NCT00069121|4278709|B3||Male|Sex: Female, Male||Participants|Count of Participants|1013|1013.0||||||
4457613|NCT00069121|4278710|B2||Male|Sex: Female, Male||Participants|Count of Participants|513|513.0||||||
4457614|NCT00069121|4278711|B1||Male|Sex: Female, Male||Participants|Count of Participants|500|500.0||||||
4457615|NCT00069121|4278709|B3||Female|Sex: Female, Male||Participants|Count of Participants|873|873.0||||||
4457616|NCT00069121|4278710|B2||Female|Sex: Female, Male||Participants|Count of Participants|431|431.0||||||
4457617|NCT00069121|4278711|B1||Female|Sex: Female, Male||Participants|Count of Participants|442|442.0||||||
4457618|NCT00069121|4278709|B3|||Age||years|Mean|60.2|60.2|Standard Deviation|10.86|10.86|||
4457619|NCT00069121|4278710|B2|||Age||years|Mean|59.8|59.8|Standard Deviation|10.95|10.95|||
4457620|NCT00069121|4278711|B1|||Age||years|Mean|60.5|60.5|Standard Deviation|10.76|10.76|||
4457621|NCT00069108|4278732|B3||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
4457622|NCT00069108|4278733|B2||Male|Sex: Female, Male||Participants|Count of Participants|191|191.0||||||
4457623|NCT00069108|4278734|B1||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4457624|NCT00069108|4278732|B3||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4457625|NCT00069108|4278733|B2||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4457626|NCT00069108|4278734|B1||Female|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4457627|NCT00069108|4278732|B3|||Age||Years|Mean|60.2|60.2|Standard Deviation|10.24|10.24|||
4457628|NCT00069108|4278733|B2|||Age||Years|Mean|59.7|59.7|Standard Deviation|10.55|10.55|||
4457629|NCT00069108|4278734|B1|||Age||Years|Mean|60.7|60.7|Standard Deviation|9.91|9.91|||
4457630|NCT00069095|4278761|B7||Male|Sex: Female, Male||Participants|Count of Participants|1207|1207.0||||||
4457631|NCT00069095|4278762|B6||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4457632|NCT00069095|4278763|B5||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4457633|NCT00069095|4278764|B4||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4457634|NCT00069095|4278765|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4457635|NCT00069095|4278766|B2||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4457636|NCT00069095|4278767|B1||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4457637|NCT00069095|4278761|B7||Female|Sex: Female, Male||Participants|Count of Participants|827|827.0||||||
4457638|NCT00069095|4278762|B6||Female|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4457639|NCT00069095|4278763|B5||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4457640|NCT00069095|4278764|B4||Female|Sex: Female, Male||Participants|Count of Participants|165|165.0||||||
4457641|NCT00069095|4278765|B3||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4457642|NCT00069095|4278766|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4457643|NCT00069095|4278767|B1||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4457644|NCT00069095|4278761|B7|||Age||years|Mean|59.7|59.7|Standard Deviation|11.14|11.14|||
4457645|NCT00069095|4278762|B6|||Age||years|Mean|59.7|59.7|Standard Deviation|10.74|10.74|||
4457646|NCT00069095|4278763|B5|||Age||years|Mean|59.7|59.7|Standard Deviation|11.28|11.28|||
4457647|NCT00069095|4278764|B4|||Age||years|Mean|58.8|58.8|Standard Deviation|10.87|10.87|||
4457648|NCT00069095|4278765|B3|||Age||years|Mean|59.1|59.1|Standard Deviation|12.14|12.14|||
4457649|NCT00069095|4278766|B2|||Age||years|Mean|60.6|60.6|Standard Deviation|10.94|10.94|||
4457650|NCT00069095|4278767|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|10.76|10.76|||
4457651|NCT00069160|4278824|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4457652|NCT00069160|4278825|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4457653|NCT00069160|4278826|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4457654|NCT00069160|4278824|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4457655|NCT00069160|4278825|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4457656|NCT00069160|4278826|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4457657|NCT00069160|4278824|B3||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4457658|NCT00069160|4278825|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4457659|NCT00069160|4278826|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4457660|NCT00069160|4278824|B3|||Age||years|Mean|53.37|53.37|Standard Deviation|9.79|9.79|||
4457661|NCT00069160|4278825|B2|||Age||years|Mean|55.77|55.77|Standard Deviation|9.57|9.57|||
4457662|NCT00069160|4278826|B1|||Age||years|Mean|50.76|50.76|Standard Deviation|9.54|9.54|||
4457663|NCT00069160|4278824|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4457664|NCT00069160|4278825|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4457665|NCT00069160|4278826|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4457666|NCT00069160|4278824|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4457667|NCT00069160|4278825|B2||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4457668|NCT00069160|4278826|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4457669|NCT00069160|4278824|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457670|NCT00069160|4278825|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457671|NCT00069160|4278826|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457672|NCT00068822|4278840|B3|||SOF-ADL Score at baseline|Study of Osteoporotic Fractures - Activities of Daily Living (SOF-ADL) scale range from 0 to 18, with higher scores indicating more back-related disability|Units on a scale|Mean|10.14|10.14|Standard Deviation|3.23|3.23|||
4457673|NCT00068822|4278841|B2|||SOF-ADL Score at baseline|Study of Osteoporotic Fractures - Activities of Daily Living (SOF-ADL) scale range from 0 to 18, with higher scores indicating more back-related disability|Units on a scale|Mean|10.3|10.3|Standard Deviation|2.8|2.8|||
4457674|NCT00068822|4278842|B1|||SOF-ADL Score at baseline|Study of Osteoporotic Fractures - Activities of Daily Living (SOF-ADL) scale range from 0 to 18, with higher scores indicating more back-related disability|Units on a scale|Mean|10.0|10.0|Standard Deviation|3.6|3.6|||
4457675|NCT00068822|4278840|B3|||EQ-SD Score at baseline|European Quality of Life - 5 Dimensions (EQ-SD) scale range from -0.1 to 1.0, with higher scores indicating a better quality of life.|Units on a scale|Mean|0.55|0.55|Standard Deviation|0.20|0.2|||
4457676|NCT00068822|4278841|B2|||EQ-SD Score at baseline|European Quality of Life - 5 Dimensions (EQ-SD) scale range from -0.1 to 1.0, with higher scores indicating a better quality of life.|Units on a scale|Mean|0.54|0.54|Standard Deviation|0.23|0.23|||
4457677|NCT00068822|4278842|B1|||EQ-SD Score at baseline|European Quality of Life - 5 Dimensions (EQ-SD) scale range from -0.1 to 1.0, with higher scores indicating a better quality of life.|Units on a scale|Mean|0.57|0.57|Standard Deviation|0.18|0.18|||
4457678|NCT00068822|4278840|B3|||Pain Bothersome Index score at baseline|Scores on the Pain Bothersome Index range from 0 to 4, with higher scores indicating more severe pain|Units on a scale|Mean|2.98|2.98|Standard Deviation|0.75|0.75|||
4457679|NCT00068822|4278841|B2|||Pain Bothersome Index score at baseline|Scores on the Pain Bothersome Index range from 0 to 4, with higher scores indicating more severe pain|Units on a scale|Mean|3.1|3.1|Standard Deviation|0.8|0.8|||
4457680|NCT00068822|4278842|B1|||Pain Bothersome Index score at baseline|Scores on the Pain Bothersome Index range from 0 to 4, with higher scores indicating more severe pain|Units on a scale|Mean|2.9|2.9|Standard Deviation|0.7|0.7|||
4457681|NCT00068822|4278840|B3|||Pain Frequency Index Score at baseline|Scores on the Pain Frequency Index range from 0 to 4, with higher scores indicating more severe pain|Units on a scale|Mean|3.04|3.04|Standard Deviation|0.8|0.8|||
4457682|NCT00068822|4278841|B2|||Pain Frequency Index Score at baseline|Scores on the Pain Frequency Index range from 0 to 4, with higher scores indicating more severe pain|Units on a scale|Mean|3.1|3.1|Standard Deviation|0.8|0.8|||
4457683|NCT00068822|4278842|B1|||Pain Frequency Index Score at baseline|Scores on the Pain Frequency Index range from 0 to 4, with higher scores indicating more severe pain|Units on a scale|Mean|3.0|3.0|Standard Deviation|0.8|0.8|||
4457684|NCT00068822|4278840|B3|||SF-36 score; summary mental component at baseline|Scores on the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36), version 2. Subjects completed the SF-36 which consists of 8 sub-scales which are additionally summarized into 2 summary components (physical and mental). The subscales and the summary scales both range from 0 to 100, with (0 = worst imaginable, 100 = best imaginable).|Units on a scale|Mean|43.21|43.21|Standard Deviation|13.03|13.03|||
4457685|NCT00068822|4278841|B2|||SF-36 score; summary mental component at baseline|Scores on the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36), version 2. Subjects completed the SF-36 which consists of 8 sub-scales which are additionally summarized into 2 summary components (physical and mental). The subscales and the summary scales both range from 0 to 100, with (0 = worst imaginable, 100 = best imaginable).|Units on a scale|Mean|41.5|41.5|Standard Deviation|14.1|14.1|||
4457686|NCT00068822|4278842|B1|||SF-36 score; summary mental component at baseline|Scores on the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36), version 2. Subjects completed the SF-36 which consists of 8 sub-scales which are additionally summarized into 2 summary components (physical and mental). The subscales and the summary scales both range from 0 to 100, with (0 = worst imaginable, 100 = best imaginable).|Units on a scale|Mean|44.8|44.8|Standard Deviation|11.8|11.8|||
4457687|NCT00068822|4278840|B3|||SF-36 score; summary physical component at baseline|Scores on the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36), version 2. Subjects completed the SF-36 which consists of 8 sub-scales which are additionally summarized into 2 summary components (physical and mental). The subscales and the summary scales both range from 0 to 100, with (0 = worst imaginable, 100 = best imaginable).|Units on a scale|Mean|25.3|25.3|Standard Deviation|7.55|7.55|||
4457688|NCT00068822|4278841|B2|||SF-36 score; summary physical component at baseline|Scores on the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36), version 2. Subjects completed the SF-36 which consists of 8 sub-scales which are additionally summarized into 2 summary components (physical and mental). The subscales and the summary scales both range from 0 to 100, with (0 = worst imaginable, 100 = best imaginable).|Units on a scale|Mean|25.3|25.3|Standard Deviation|7.3|7.3|||
4457689|NCT00068822|4278842|B1|||SF-36 score; summary physical component at baseline|Scores on the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36), version 2. Subjects completed the SF-36 which consists of 8 sub-scales which are additionally summarized into 2 summary components (physical and mental). The subscales and the summary scales both range from 0 to 100, with (0 = worst imaginable, 100 = best imaginable).|Units on a scale|Mean|25.3|25.3|Standard Deviation|7.8|7.8|||
4457690|NCT00068822|4278840|B3|||Average pain intensity during past 24 hours at baseline|The pain intensity rating ranges from 0 (no pain) to 10 (worst pain)|Units on a scale|Mean|7.02|7.02|Standard Deviation|1.9|1.9|||
4457691|NCT00068822|4278841|B2|||Average pain intensity during past 24 hours at baseline|The pain intensity rating ranges from 0 (no pain) to 10 (worst pain)|Units on a scale|Mean|7.2|7.2|Standard Deviation|1.8|1.8|||
4457692|NCT00068822|4278842|B1|||Average pain intensity during past 24 hours at baseline|The pain intensity rating ranges from 0 (no pain) to 10 (worst pain)|Units on a scale|Mean|6.9|6.9|Standard Deviation|2.0|2.0|||
4457693|NCT00068822|4278840|B3|||RDQ Score at baseline|Scores on the Roland-Morris Disability Questionnaire (RDQ) range from 0-23, with higher scores indicating more severe disability|Units on a scale|Mean|17.05|17.05|Standard Deviation|3.98|3.98|||
4457694|NCT00068822|4278841|B2|||RDQ Score at baseline|Scores on the Roland-Morris Disability Questionnaire (RDQ) range from 0-23, with higher scores indicating more severe disability|Units on a scale|Mean|17.5|17.5|Standard Deviation|4.1|4.1|||
4457786|NCT00068692|4278875|B3|||Age||years|Median|58|58.0|Full Range|||36.0|79.0|
4457695|NCT00068822|4278842|B1|||RDQ Score at baseline|Scores on the Roland-Morris Disability Questionnaire (RDQ) range from 0-23, with higher scores indicating more severe disability|Units on a scale|Mean|16.6|16.6|Standard Deviation|3.8|3.8|||
4457696|NCT00068822|4278840|B3|Australia||Region of Enrollment||participants|Number|22|22.0||||||
4457697|NCT00068822|4278841|B2|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4457698|NCT00068822|4278842|B1|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4457699|NCT00068822|4278840|B3|United Kingdom||Region of Enrollment||participants|Number|52|52.0||||||
4457700|NCT00068822|4278841|B2|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
4457701|NCT00068822|4278842|B1|United Kingdom||Region of Enrollment||participants|Number|26|26.0||||||
4457702|NCT00068822|4278840|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4457703|NCT00068822|4278841|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4457704|NCT00068822|4278842|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4457705|NCT00068822|4278840|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4457706|NCT00068822|4278841|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4457707|NCT00068822|4278842|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4457708|NCT00068822|4278840|B3||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4457709|NCT00068822|4278841|B2||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4457710|NCT00068822|4278842|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4457711|NCT00068822|4278840|B3|||Age||years|Mean|73.84|73.84|Standard Deviation|9.48|9.48|||
4457712|NCT00068822|4278841|B2|||Age||years|Mean|74.3|74.3|Standard Deviation|9.6|9.6|||
4457713|NCT00068822|4278842|B1|||Age||years|Mean|73.4|73.4|Standard Deviation|9.4|9.4|||
4457714|NCT00068770|4278853|B3|Biopsy||Prior Surgery|Whether pt had Craniotomy or Biopsy|Participant|Number|4|4.0||||||
4457715|NCT00068770|4278854|B2|Biopsy||Prior Surgery|Whether pt had Craniotomy or Biopsy|Participant|Number|3|3.0||||||
4457716|NCT00068770|4278855|B1|Biopsy||Prior Surgery|Whether pt had Craniotomy or Biopsy|Participant|Number|1|1.0||||||
4457717|NCT00068770|4278853|B3|Craniotomy||Prior Surgery|Whether pt had Craniotomy or Biopsy|Participant|Number|31|31.0||||||
4457718|NCT00068770|4278854|B2|Craniotomy||Prior Surgery|Whether pt had Craniotomy or Biopsy|Participant|Number|10|10.0||||||
4457719|NCT00068770|4278855|B1|Craniotomy||Prior Surgery|Whether pt had Craniotomy or Biopsy|Participant|Number|21|21.0||||||
4457720|NCT00068770|4278853|B3|No||Corticosteroid therapy|Patients on corticpsteroid therapy|Participants|Number|6|6.0||||||
4457721|NCT00068770|4278854|B2|No||Corticosteroid therapy|Patients on corticpsteroid therapy|Participants|Number|2|2.0||||||
4457722|NCT00068770|4278855|B1|No||Corticosteroid therapy|Patients on corticpsteroid therapy|Participants|Number|4|4.0||||||
4457723|NCT00068770|4278853|B3|Yes||Corticosteroid therapy|Patients on corticpsteroid therapy|Participants|Number|29|29.0||||||
4457724|NCT00068770|4278854|B2|Yes||Corticosteroid therapy|Patients on corticpsteroid therapy|Participants|Number|11|11.0||||||
4457725|NCT00068770|4278855|B1|Yes||Corticosteroid therapy|Patients on corticpsteroid therapy|Participants|Number|18|18.0||||||
4457726|NCT00068770|4278853|B3|||Mini Mental State Exam Score|The mini–mental state examination (MMSE) is a 30-point questionnaire test used to screen for cognitive impairment. Commonly used to screen for dementia. It is also used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time. The MMSE test includes simple questions and problems in a number of areas: the time and place of the test, repeating lists of words, arithmetic such as the serial sevens, language use and comprehension, and basic motor skills. The Higher your score, the higher your function.|scores on a scale|Mean|28|28.0|Standard Deviation|3|3.0|||
4457727|NCT00068770|4278854|B2|||Mini Mental State Exam Score|The mini–mental state examination (MMSE) is a 30-point questionnaire test used to screen for cognitive impairment. Commonly used to screen for dementia. It is also used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time. The MMSE test includes simple questions and problems in a number of areas: the time and place of the test, repeating lists of words, arithmetic such as the serial sevens, language use and comprehension, and basic motor skills. The Higher your score, the higher your function.|scores on a scale|Mean|28|28.0|Standard Deviation|3|3.0|||
4457728|NCT00068770|4278855|B1|||Mini Mental State Exam Score|The mini–mental state examination (MMSE) is a 30-point questionnaire test used to screen for cognitive impairment. Commonly used to screen for dementia. It is also used to estimate the severity of cognitive impairment and to follow the course of cognitive changes in an individual over time. The MMSE test includes simple questions and problems in a number of areas: the time and place of the test, repeating lists of words, arithmetic such as the serial sevens, language use and comprehension, and basic motor skills. The Higher your score, the higher your function.|scores on a scale|Mean|28|28.0|Standard Deviation|4|4.0|||
4457729|NCT00068770|4278853|B3|||Karnofsky Perfomance Status (KPS)|100 normal no complaints no disease 90 capable of normal activity few symptoms/disease 80 normal activity with some difficulty some symptoms or signs 70 caring for self not capable of normal activity or work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care and help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures or treatment 10 moribund rapidly progressive fatal disease processes 0 death|scores on a scale|Mean|86|86.0|Standard Deviation|10|10.0|||
4457730|NCT00068770|4278854|B2|||Karnofsky Perfomance Status (KPS)|100 normal no complaints no disease 90 capable of normal activity few symptoms/disease 80 normal activity with some difficulty some symptoms or signs 70 caring for self not capable of normal activity or work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care and help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures or treatment 10 moribund rapidly progressive fatal disease processes 0 death|scores on a scale|Mean|83|83.0|Standard Deviation|9|9.0|||
4457731|NCT00068770|4278855|B1|||Karnofsky Perfomance Status (KPS)|100 normal no complaints no disease 90 capable of normal activity few symptoms/disease 80 normal activity with some difficulty some symptoms or signs 70 caring for self not capable of normal activity or work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care and help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures or treatment 10 moribund rapidly progressive fatal disease processes 0 death|scores on a scale|Mean|88|88.0|Standard Deviation|11|11.0|||
4457732|NCT00068770|4278853|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4457733|NCT00068770|4278854|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4457734|NCT00068770|4278855|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4457735|NCT00068770|4278853|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4457736|NCT00068770|4278854|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4457737|NCT00068770|4278855|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4457738|NCT00068770|4278853|B3|||Age||years|Mean|57|57.0|Standard Deviation|26|26.0|||
4457739|NCT00068770|4278854|B2|||Age||years|Mean|56|56.0|Standard Deviation|17|17.0|||
4457740|NCT00068770|4278855|B1|||Age||years|Mean|58|58.0|Standard Deviation|12|12.0|||
4457741|NCT00068718|4278864|B1|Italy||Region of Enrollment||participants|Number|9|9.0||||||
4457742|NCT00068718|4278864|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4457743|NCT00068718|4278864|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4457744|NCT00068718|4278864|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4457745|NCT00068718|4278864|B1|||Age||years|Median|59.2|59.2|Full Range|||21.0|74.0|
4457746|NCT00068718|4278864|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4457747|NCT00068718|4278864|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4457748|NCT00068718|4278864|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457749|NCT00068692|4278874|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457750|NCT00068692|4278875|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457751|NCT00068692|4278876|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457752|NCT00068692|4278877|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457753|NCT00068692|4278874|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457754|NCT00068692|4278875|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457755|NCT00068692|4278876|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457756|NCT00068692|4278877|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457757|NCT00068692|4278874|B4||White|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
4457758|NCT00068692|4278875|B3||White|Race (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4457759|NCT00068692|4278876|B2||White|Race (NIH/OMB)||Participants|Count of Participants|57|57.0||||||
4457760|NCT00068692|4278877|B1||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4457761|NCT00068692|4278874|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4457762|NCT00068692|4278875|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4457763|NCT00068692|4278876|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457764|NCT00068692|4278877|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4457765|NCT00068692|4278874|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457766|NCT00068692|4278875|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457767|NCT00068692|4278876|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457768|NCT00068692|4278877|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457769|NCT00068692|4278874|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4457770|NCT00068692|4278875|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4457771|NCT00068692|4278876|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457772|NCT00068692|4278877|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457773|NCT00068692|4278874|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457774|NCT00068692|4278875|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457775|NCT00068692|4278876|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457776|NCT00068692|4278877|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457777|NCT00068692|4278874|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4457778|NCT00068692|4278875|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4457779|NCT00068692|4278876|B2||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4457780|NCT00068692|4278877|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4457781|NCT00068692|4278874|B4||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4457782|NCT00068692|4278875|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4457783|NCT00068692|4278876|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4457784|NCT00068692|4278877|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4457785|NCT00068692|4278874|B4|||Age||years|Median|57|57.0|Full Range|||33.0|82.0|
4457787|NCT00068692|4278876|B2|||Age||years|Median|56|56.0|Full Range|||35.0|79.0|
4457788|NCT00068692|4278877|B1|||Age||years|Median|58|58.0|Full Range|||33.0|82.0|
4457789|NCT00068601|4278905|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4457790|NCT00068601|4278906|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4457791|NCT00068601|4278907|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4457792|NCT00068601|4278905|B3||Female|Sex: Female, Male||Participants|Count of Participants|218|218.0||||||
4457793|NCT00068601|4278906|B2||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4457794|NCT00068601|4278907|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4457795|NCT00068601|4278905|B3|||Age||years|Median|37.7|37.7|Full Range|||25.1|49.9|
4457796|NCT00068601|4278906|B2|||Age||years|Median|37.6|37.6|Full Range|||26.1|48.6|
4457797|NCT00068601|4278907|B1|||Age||years|Median|38.7|38.7|Full Range|||25.1|49.9|
4457798|NCT00068588|4278918|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4457799|NCT00068588|4278919|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4457800|NCT00068588|4278920|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4457801|NCT00068588|4278918|B4|Male||Gender||participants|Number|0|0.0||||||
4457802|NCT00068588|4278919|B3|Male||Gender||participants|Number|0|0.0||||||
4457803|NCT00068588|4278920|B2|Male||Gender||participants|Number|0|0.0||||||
4457804|NCT00068588|4278918|B4|Female||Gender||participants|Number|24|24.0||||||
4457805|NCT00068588|4278919|B3|Female||Gender||participants|Number|21|21.0||||||
4457806|NCT00068588|4278920|B2|Female||Gender||participants|Number|3|3.0||||||
4457807|NCT00068588|4278918|B4|||Age||years|Median|53|53.0|Full Range|||39.0|74.0|
4457808|NCT00068588|4278919|B3|||Age||years|Median|52|52.0|Full Range|||39.0|74.0|
4457809|NCT00068588|4278920|B2|||Age||years|Median|63|63.0|Full Range|||42.0|64.0|
4457810|NCT00068575|4278933|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4457811|NCT00068575|4278933|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4457812|NCT00068575|4278933|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4457813|NCT00068575|4278933|B1|||Age||years|Median|60.5|60.5|Full Range|||39.0|69.0|
4457814|NCT00068445|4278937|B3|United States||Region of Enrollment||Participants|Count of Participants|125|125.0||||||
4457815|NCT00068445|4278938|B2|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
4457816|NCT00068445|4278939|B1|United States||Region of Enrollment||Participants|Count of Participants|63|63.0||||||
4457817|NCT00068445|4278937|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4457818|NCT00068445|4278938|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4457819|NCT00068445|4278939|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4457820|NCT00068445|4278937|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4457821|NCT00068445|4278938|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4457822|NCT00068445|4278939|B1||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4457823|NCT00068445|4278937|B3|||Age||years|Mean|61|61.0|Full Range|||29.0|84.0|
4457824|NCT00068445|4278938|B2|||Age||years|Mean|59|59.0|Full Range|||34.0|82.0|
4457825|NCT00068445|4278939|B1|||Age||years|Mean|62|62.0|Full Range|||29.0|84.0|
4457826|NCT00068419|4278964|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4457827|NCT00068419|4278964|B1|United States||Region of Enrollment||participants|Number|63|63.0||||||
4457828|NCT00068419|4278964|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4457829|NCT00068419|4278964|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457830|NCT00068419|4278964|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4457831|NCT00068419|4278964|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4457832|NCT00068419|4278964|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4457833|NCT00068419|4278964|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4457834|NCT00068419|4278964|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457835|NCT00068419|4278964|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4457836|NCT00068419|4278964|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4457837|NCT00068419|4278964|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4457838|NCT00068419|4278964|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4457839|NCT00068419|4278964|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4457840|NCT00068419|4278964|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4457841|NCT00068419|4278964|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4457842|NCT00068419|4278964|B1||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
4457843|NCT00068406|4278968|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457844|NCT00068406|4278968|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457845|NCT00068406|4278968|B1||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4457846|NCT00068406|4278968|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4457847|NCT00068406|4278968|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457848|NCT00068406|4278968|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4457849|NCT00068406|4278968|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4457850|NCT00068406|4278968|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4457851|NCT00068406|4278968|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4457852|NCT00068406|4278968|B1|Age of participants|>=70 years|Age, Customized||Participants|Count of Participants|14|14.0||||||
4457853|NCT00068406|4278968|B1|Age of participants|60-69 years|Age, Customized||Participants|Count of Participants|13|13.0||||||
4457854|NCT00068406|4278968|B1|Age of participants|50-59 years|Age, Customized||Participants|Count of Participants|17|17.0||||||
4457855|NCT00068406|4278968|B1|Age of participants|40-49 years|Age, Customized||Participants|Count of Participants|9|9.0||||||
4457856|NCT00068406|4278968|B1|Age of participants|<40 years|Age, Customized||Participants|Count of Participants|5|5.0||||||
4457857|NCT00068393|4278973|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4457858|NCT00068393|4278973|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4457859|NCT00068393|4278973|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4457860|NCT00068393|4278973|B1|||Age||years|Median|59|59.0|Full Range|||36.0|77.0|
4457861|NCT00068380|4278979|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4457862|NCT00068380|4278979|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4457863|NCT00068380|4278979|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4457864|NCT00068380|4278979|B1|||Age||years|Median|60|60.0|Full Range|||38.0|84.0|
4457865|NCT00068367|4278988|B1||No|Prior multi-agent chemotherapy||Participants|Count of Participants|6|6.0||||||
4457866|NCT00068367|4278988|B1||Yes|Prior multi-agent chemotherapy||Participants|Count of Participants|14|14.0||||||
4457867|NCT00068367|4278988|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4457868|NCT00068367|4278988|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4457869|NCT00068367|4278988|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4457870|NCT00068367|4278988|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4457871|NCT00068367|4278988|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4457872|NCT00068367|4278988|B1|||Age||years|Median|45.3|45.3|Full Range|||19.8|76.4|
4457873|NCT00068341|4278994|B4|United States||Region of Enrollment||participants|Number|74|74.0||||||
4457874|NCT00068341|4278995|B3|United States||Region of Enrollment||participants|Number|44|44.0||||||
4457875|NCT00068341|4278996|B2|United States||Region of Enrollment||participants|Number|15|15.0||||||
4457876|NCT00068341|4278997|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4457877|NCT00068341|4278994|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4457878|NCT00068341|4278995|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4457879|NCT00068341|4278996|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4457880|NCT00068341|4278997|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4457881|NCT00068341|4278994|B4||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4457882|NCT00068341|4278995|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4457883|NCT00068341|4278996|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4457884|NCT00068341|4278997|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4457885|NCT00068341|4278994|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4457886|NCT00068341|4278995|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4457887|NCT00068341|4278996|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4457888|NCT00068341|4278997|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4457889|NCT00068341|4278994|B4||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4457890|NCT00068341|4278995|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4457891|NCT00068341|4278996|B2||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4457892|NCT00068341|4278997|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4457893|NCT00068341|4278994|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457894|NCT00068341|4278995|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457895|NCT00068341|4278996|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457896|NCT00068341|4278997|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457897|NCT00068250|4279020|B4||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4457898|NCT00068250|4279021|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4457899|NCT00068250|4279022|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4457900|NCT00068250|4279023|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4457901|NCT00068250|4279020|B4||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4457902|NCT00068250|4279021|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4457903|NCT00068250|4279022|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4457904|NCT00068250|4279023|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4457905|NCT00068250|4279020|B4|||Age||years|Median|57|57.0|Full Range|||24.0|73.0|
4457906|NCT00068250|4279021|B3|||Age||years|Median|57|57.0|Full Range|||24.0|73.0|
4457907|NCT00068250|4279022|B2|||Age||years|Median|62|62.0|Full Range|||47.0|72.0|
4457908|NCT00068250|4279023|B1|||Age||years|Median|57|57.0|Full Range|||43.0|70.0|
4457909|NCT00068237|4279036|B1||Male|Gender||Participants|Count of Participants|36|36.0||||||
4457910|NCT00068237|4279036|B1||Female|Gender||Participants|Count of Participants|8|8.0||||||
4457911|NCT00068237|4279036|B1|||Age||years|Median|56.5|56.5|Full Range|||42.0|74.0|
4457912|NCT00068107|4279040|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4457913|NCT00068107|4279040|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4457914|NCT00068107|4279040|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4457915|NCT00068107|4279040|B1|||Age||years|Mean|41|41.0|Standard Deviation|9|9.0|||
4457916|NCT00068107|4279040|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4457917|NCT00068107|4279040|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4457918|NCT00068107|4279040|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457919|NCT00067990|4279051|B3|Other||Cause of Native Kidney Disease||Participants|Count of Participants|63|63.0||||||
4457920|NCT00067990|4279052|B2|Other||Cause of Native Kidney Disease||Participants|Count of Participants|35|35.0||||||
4457921|NCT00067990|4279053|B1|Other||Cause of Native Kidney Disease||Participants|Count of Participants|28|28.0||||||
4457922|NCT00067990|4279051|B3|Polycystic kidney disease||Cause of Native Kidney Disease||Participants|Count of Participants|23|23.0||||||
4457923|NCT00067990|4279052|B2|Polycystic kidney disease||Cause of Native Kidney Disease||Participants|Count of Participants|10|10.0||||||
4457924|NCT00067990|4279053|B1|Polycystic kidney disease||Cause of Native Kidney Disease||Participants|Count of Participants|13|13.0||||||
4457925|NCT00067990|4279051|B3|Hypertension||Cause of Native Kidney Disease||Participants|Count of Participants|10|10.0||||||
4457926|NCT00067990|4279052|B2|Hypertension||Cause of Native Kidney Disease||Participants|Count of Participants|2|2.0||||||
4457927|NCT00067990|4279053|B1|Hypertension||Cause of Native Kidney Disease||Participants|Count of Participants|8|8.0||||||
4457928|NCT00067990|4279051|B3|Diabetes mellitus||Cause of Native Kidney Disease||Participants|Count of Participants|57|57.0||||||
4457929|NCT00067990|4279052|B2|Diabetes mellitus||Cause of Native Kidney Disease||Participants|Count of Participants|29|29.0||||||
4457930|NCT00067990|4279053|B1|Diabetes mellitus||Cause of Native Kidney Disease||Participants|Count of Participants|28|28.0||||||
4457931|NCT00067990|4279051|B3|Cadaver Donor||Donor Type||Participants|Count of Participants|45|45.0||||||
4457932|NCT00067990|4279052|B2|Cadaver Donor||Donor Type||Participants|Count of Participants|21|21.0||||||
4457933|NCT00067990|4279053|B1|Cadaver Donor||Donor Type||Participants|Count of Participants|24|24.0||||||
4457934|NCT00067990|4279051|B3|Live Donor||Donor Type||Participants|Count of Participants|108|108.0||||||
4457935|NCT00067990|4279052|B2|Live Donor||Donor Type||Participants|Count of Participants|55|55.0||||||
4457936|NCT00067990|4279053|B1|Live Donor||Donor Type||Participants|Count of Participants|53|53.0||||||
4457937|NCT00067990|4279051|B3|Not Available||Race/Ethnicity, Customized||Participants|Count of Participants|20|20.0||||||
4457938|NCT00067990|4279052|B2|Not Available||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4457939|NCT00067990|4279053|B1|Not Available||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4457940|NCT00067990|4279051|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|133|133.0||||||
4457941|NCT00067990|4279052|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|67|67.0||||||
4457942|NCT00067990|4279053|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
4457943|NCT00067990|4279051|B3||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4457944|NCT00067990|4279052|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4457945|NCT00067990|4279053|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4457946|NCT00067990|4279051|B3||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4457947|NCT00067990|4279052|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4457948|NCT00067990|4279053|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4457949|NCT00067990|4279051|B3|||Age||years|Mean|48.7|48.7|Standard Deviation|12.4|12.4|||
4457950|NCT00067990|4279052|B2|||Age||years|Mean|48.0|48.0|Standard Deviation|13.6|13.6|||
4457951|NCT00067990|4279053|B1|||Age||years|Mean|49.4|49.4|Standard Deviation|11.1|11.1|||
4457952|NCT00067808|4279062|B4|United States||Region of Enrollment||participants|Number|124|124.0||||||
4457953|NCT00067808|4279063|B3|United States||Region of Enrollment||participants|Number|14|14.0||||||
4457954|NCT00067808|4279064|B2|United States||Region of Enrollment||participants|Number|93|93.0||||||
4457955|NCT00067808|4279065|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4457956|NCT00067808|4279062|B4||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4457957|NCT00067808|4279063|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4457958|NCT00067808|4279064|B2||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4457959|NCT00067808|4279065|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4457960|NCT00067808|4279062|B4||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4457961|NCT00067808|4279063|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4457962|NCT00067808|4279064|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4457963|NCT00067808|4279065|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4457964|NCT00067808|4279062|B4|||Age||years|Median|65|65.0|Full Range|||37.0|90.0|
4457965|NCT00067808|4279063|B3|||Age||years|Median|64|64.0|Full Range|||51.0|79.0|
4457966|NCT00067808|4279064|B2|||Age||years|Median|65|65.0|Full Range|||37.0|83.0|
4457967|NCT00067808|4279065|B1|||Age||years|Median|67|67.0|Full Range|||44.0|90.0|
4457968|NCT00067808|4279062|B4||>=65 years|Age||Participants|Count of Participants|65|65.0||||||
4457969|NCT00067808|4279063|B3||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4457970|NCT00067808|4279064|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4457971|NCT00067808|4279065|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4457972|NCT00067808|4279062|B4||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4457973|NCT00067808|4279063|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4457974|NCT00067808|4279064|B2||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4457975|NCT00067808|4279065|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4457976|NCT00067808|4279062|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457977|NCT00067808|4279063|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457978|NCT00067808|4279064|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457979|NCT00067808|4279065|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4457980|NCT00067470|4279075|B3|Portugal||Region of Enrollment||participants|Number|6|6.0||||||
4457981|NCT00067470|4279076|B2|Portugal||Region of Enrollment||participants|Number|2|2.0||||||
4457982|NCT00067470|4279077|B1|Portugal||Region of Enrollment||participants|Number|4|4.0||||||
4457983|NCT00067470|4279075|B3|France||Region of Enrollment||participants|Number|5|5.0||||||
4457984|NCT00067470|4279076|B2|France||Region of Enrollment||participants|Number|3|3.0||||||
4457985|NCT00067470|4279077|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4457986|NCT00067470|4279075|B3|Brazil||Region of Enrollment||participants|Number|8|8.0||||||
4457987|NCT00067470|4279076|B2|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4457988|NCT00067470|4279077|B1|Brazil||Region of Enrollment||participants|Number|4|4.0||||||
4457989|NCT00067470|4279075|B3|United Kingdom||Region of Enrollment||participants|Number|6|6.0||||||
4457990|NCT00067470|4279076|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4457991|NCT00067470|4279077|B1|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4457992|NCT00067470|4279075|B3|Germany||Region of Enrollment||participants|Number|8|8.0||||||
4457993|NCT00067470|4279076|B2|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4457994|NCT00067470|4279077|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4457995|NCT00067470|4279075|B3|United States||Region of Enrollment||participants|Number|6|6.0||||||
4457996|NCT00067470|4279076|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4457997|NCT00067470|4279077|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4457998|NCT00067470|4279075|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4457999|NCT00067470|4279076|B2|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4458000|NCT00067470|4279077|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4458001|NCT00067470|4279075|B3|Indigenous||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4458002|NCT00067470|4279076|B2|Indigenous||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4458003|NCT00067470|4279077|B1|Indigenous||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4458004|NCT00067470|4279075|B3|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4458005|NCT00067470|4279076|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4458006|NCT00067470|4279077|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4458007|NCT00067470|4279075|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4458008|NCT00067470|4279076|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4458009|NCT00067470|4279077|B1|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4458010|NCT00067470|4279075|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4458011|NCT00067470|4279076|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4458012|NCT00067470|4279077|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4458013|NCT00067470|4279075|B3|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4458014|NCT00067470|4279076|B2|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4458015|NCT00067470|4279077|B1|White, non-Hispanic||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4458016|NCT00067470|4279075|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4458017|NCT00067470|4279076|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4458018|NCT00067470|4279077|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4458019|NCT00067470|4279075|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4458020|NCT00067470|4279076|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4458021|NCT00067470|4279077|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4458022|NCT00067470|4279075|B3|||Age||years|Mean|12.2|12.2|Standard Deviation|5.62|5.62|||
4458023|NCT00067470|4279076|B2|||Age||years|Mean|10.7|10.7|Standard Deviation|4.35|4.35|||
4458024|NCT00067470|4279077|B1|||Age||years|Mean|13.7|13.7|Standard Deviation|6.47|6.47|||
4458025|NCT00067236|4279088|B3|Poland||Region of Enrollment||participants|Number|173|173.0||||||
4458026|NCT00067236|4279089|B2|Poland||Region of Enrollment||participants|Number|86|86.0||||||
4458027|NCT00067236|4279090|B1|Poland||Region of Enrollment||participants|Number|87|87.0||||||
4458028|NCT00067236|4279088|B3|Canada||Region of Enrollment||participants|Number|45|45.0||||||
4458029|NCT00067236|4279089|B2|Canada||Region of Enrollment||participants|Number|23|23.0||||||
4458030|NCT00067236|4279090|B1|Canada||Region of Enrollment||participants|Number|22|22.0||||||
4458031|NCT00067236|4279088|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4458032|NCT00067236|4279089|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4458033|NCT00067236|4279090|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4458034|NCT00067236|4279088|B3||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4458035|NCT00067236|4279089|B2||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4458036|NCT00067236|4279090|B1||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4458037|NCT00067236|4279088|B3||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4458038|NCT00067236|4279089|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4458039|NCT00067236|4279090|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4458040|NCT00067236|4279088|B3|||Age||years|Mean|59.8|59.8|Standard Deviation|10.96|10.96|||
4458041|NCT00067236|4279089|B2|||Age||years|Mean|59.7|59.7|Standard Deviation|11.71|11.71|||
4458042|NCT00067236|4279090|B1|||Age||years|Mean|59.9|59.9|Standard Deviation|10.22|10.22|||
4458043|NCT00066963|4279097|B4|United States||Region of Enrollment||participants|Number|376|376.0||||||
4458044|NCT00066963|4279098|B3|United States||Region of Enrollment||participants|Number|126|126.0||||||
4458045|NCT00066963|4279099|B2|United States||Region of Enrollment||participants|Number|124|124.0||||||
4458046|NCT00066963|4279100|B1|United States||Region of Enrollment||participants|Number|126|126.0||||||
4458047|NCT00066963|4279097|B4||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4458048|NCT00066963|4279098|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4458049|NCT00066963|4279099|B2||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4458050|NCT00066963|4279100|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4458051|NCT00066963|4279097|B4||Female|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4458052|NCT00066963|4279098|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4458053|NCT00066963|4279099|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4458054|NCT00066963|4279100|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4458055|NCT00066963|4279097|B4|||Age||Year|Mean|1.8|1.8|Standard Deviation|0.6|0.6|||
4458056|NCT00066963|4279098|B3|||Age||Year|Mean|1.8|1.8|Standard Deviation|0.6|0.6|||
4458057|NCT00066963|4279099|B2|||Age||Year|Mean|1.8|1.8|Standard Deviation|0.5|0.5|||
4458058|NCT00066963|4279100|B1|||Age||Year|Mean|1.8|1.8|Standard Deviation|0.6|0.6|||
4458059|NCT00066963|4279097|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458060|NCT00066963|4279098|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458061|NCT00066963|4279099|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458062|NCT00066963|4279100|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458063|NCT00066963|4279097|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4458064|NCT00066963|4279098|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4458065|NCT00066963|4279099|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4458066|NCT00066963|4279100|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4458067|NCT00066963|4279097|B4||<=18 years|Age||Participants|Count of Participants|376|376.0||||||
4458068|NCT00066963|4279098|B3||<=18 years|Age||Participants|Count of Participants|126|126.0||||||
4458069|NCT00066963|4279099|B2||<=18 years|Age||Participants|Count of Participants|124|124.0||||||
4458070|NCT00066963|4279100|B1||<=18 years|Age||Participants|Count of Participants|126|126.0||||||
4458071|NCT00066937|4279110|B5|United States||Region of Enrollment||participants|Number|140|140.0||||||
4458072|NCT00066937|4279111|B4|United States||Region of Enrollment||participants|Number|24|24.0||||||
4458073|NCT00066937|4279112|B3|United States||Region of Enrollment||participants|Number|37|37.0||||||
4458074|NCT00066937|4279113|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4458075|NCT00066937|4279114|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4458076|NCT00066937|4279110|B5||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4458077|NCT00066937|4279111|B4||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4458078|NCT00066937|4279112|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4458079|NCT00066937|4279113|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4458080|NCT00066937|4279114|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4458081|NCT00066937|4279110|B5||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4458082|NCT00066937|4279111|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4458083|NCT00066937|4279112|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4458084|NCT00066937|4279113|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4458085|NCT00066937|4279114|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4458086|NCT00066937|4279110|B5|||Age||years|Mean|36.4|36.4|Standard Deviation|11.9|11.9|||
4458087|NCT00066937|4279111|B4|||Age||years|Mean|33.3|33.3|Standard Deviation|11.3|11.3|||
4458088|NCT00066937|4279112|B3|||Age||years|Mean|37.2|37.2|Standard Deviation|11.5|11.5|||
4458089|NCT00066937|4279113|B2|||Age||years|Mean|38.4|38.4|Standard Deviation|12.5|12.5|||
4458090|NCT00066937|4279114|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|12.0|12.0|||
4458091|NCT00066807|4279139|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458092|NCT00066807|4279140|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458093|NCT00066807|4279141|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458094|NCT00066807|4279139|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4458095|NCT00066807|4279140|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4458096|NCT00066807|4279141|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4458097|NCT00066807|4279139|B3|||Age||years|Mean|45|45.0|Inter-Quartile Range|||42.0|48.0|
4458098|NCT00066807|4279140|B2|||Age||years|Mean|45|45.0|Inter-Quartile Range|||42.0|48.0|
4458099|NCT00066807|4279141|B1|||Age||years|Mean|45|45.0|Inter-Quartile Range|||42.0|48.0|
4458100|NCT00066781|4279154|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458101|NCT00066781|4279155|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458102|NCT00066781|4279156|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458103|NCT00066781|4279154|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458104|NCT00066781|4279155|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458105|NCT00066781|4279156|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458106|NCT00066781|4279154|B3||White|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4458107|NCT00066781|4279155|B2||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4458108|NCT00066781|4279156|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4458109|NCT00066781|4279154|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458110|NCT00066781|4279155|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458111|NCT00066781|4279156|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458112|NCT00066781|4279154|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458113|NCT00066781|4279155|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458114|NCT00066781|4279156|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458115|NCT00066781|4279154|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458116|NCT00066781|4279155|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458117|NCT00066781|4279156|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458118|NCT00066781|4279154|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458119|NCT00066781|4279155|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458120|NCT00066781|4279156|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458121|NCT00066781|4279154|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4458122|NCT00066781|4279155|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4458123|NCT00066781|4279156|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4458124|NCT00066781|4279154|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4458125|NCT00066781|4279155|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4458126|NCT00066781|4279156|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4458127|NCT00066781|4279154|B3|||Age||years|Mean|62|62.0|Standard Deviation|12|12.0|||
4458128|NCT00066781|4279155|B2|||Age||years|Mean|61|61.0|Standard Deviation|15|15.0|||
4458129|NCT00066781|4279156|B1|||Age||years|Mean|62|62.0|Standard Deviation|9|9.0|||
4458130|NCT00066742|4279167|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458131|NCT00066742|4279167|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458132|NCT00066742|4279167|B1||White|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4458133|NCT00066742|4279167|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4458134|NCT00066742|4279167|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458135|NCT00066742|4279167|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4458136|NCT00066742|4279167|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458137|NCT00066742|4279167|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4458138|NCT00066742|4279167|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4458139|NCT00066742|4279167|B1|||Age||years|Median|63|63.0|Full Range|||39.0|85.0|
4458140|NCT00066703|4279174|B3|Unknown||HER2 status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|2|2.0||||||
4458141|NCT00066703|4279175|B2|Unknown||HER2 status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|1|1.0||||||
4458142|NCT00066703|4279176|B1|Unknown||HER2 status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|1|1.0||||||
4458143|NCT00066703|4279174|B3|Positive||HER2 status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|24|24.0||||||
4458144|NCT00066703|4279175|B2|Positive||HER2 status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|12|12.0||||||
4458287|NCT00066365|4279225|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4458145|NCT00066703|4279176|B1|Positive||HER2 status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|12|12.0||||||
4458146|NCT00066703|4279174|B3|Negative||HER2 status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|174|174.0||||||
4458147|NCT00066703|4279175|B2|Negative||HER2 status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|87|87.0||||||
4458148|NCT00066703|4279176|B1|Negative||HER2 status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|87|87.0||||||
4458149|NCT00066703|4279174|B3|unknown||Tumor grade|Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis. Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|2|2.0||||||
4458150|NCT00066703|4279175|B2|unknown||Tumor grade|Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis. Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|1|1.0||||||
4458151|NCT00066703|4279176|B1|unknown||Tumor grade|Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis. Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|1|1.0||||||
4458152|NCT00066703|4279174|B3|3||Tumor grade|Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis. Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|53|53.0||||||
4458153|NCT00066703|4279175|B2|3||Tumor grade|Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis. Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|27|27.0||||||
4458154|NCT00066703|4279176|B1|3||Tumor grade|Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis. Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|26|26.0||||||
4458155|NCT00066703|4279174|B3|2||Tumor grade|Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis. Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|111|111.0||||||
4458156|NCT00066703|4279175|B2|2||Tumor grade|Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis. Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|55|55.0||||||
4458157|NCT00066703|4279176|B1|2||Tumor grade|Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis. Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|56|56.0||||||
4458158|NCT00066703|4279174|B3|1||Tumor grade|Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis. Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|34|34.0||||||
4458159|NCT00066703|4279175|B2|1||Tumor grade|Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis. Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|17|17.0||||||
4458160|NCT00066703|4279176|B1|1||Tumor grade|Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis. Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|17|17.0||||||
4458161|NCT00066703|4279174|B3|unknown||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|2|2.0||||||
4458162|NCT00066703|4279175|B2|unknown||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|1|1.0||||||
4458163|NCT00066703|4279176|B1|unknown||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|1|1.0||||||
4458164|NCT00066703|4279174|B3|>=2 cm||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|79|79.0||||||
4458165|NCT00066703|4279175|B2|>=2 cm||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|40|40.0||||||
4458166|NCT00066703|4279176|B1|>=2 cm||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|39|39.0||||||
4458167|NCT00066703|4279174|B3|<=2 cm||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|119|119.0||||||
4458168|NCT00066703|4279175|B2|<=2 cm||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|59|59.0||||||
4458169|NCT00066703|4279176|B1|<=2 cm||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|60|60.0||||||
4458170|NCT00066703|4279174|B3|Positive||Lymph-node status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|96|96.0||||||
4458171|NCT00066703|4279175|B2|Positive||Lymph-node status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|48|48.0||||||
4458172|NCT00066703|4279176|B1|Positive||Lymph-node status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|48|48.0||||||
4458173|NCT00066703|4279174|B3|Negative||Lymph-node status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|104|104.0||||||
4458174|NCT00066703|4279175|B2|Negative||Lymph-node status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|52|52.0||||||
4458175|NCT00066703|4279176|B1|Negative||Lymph-node status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|52|52.0||||||
4458176|NCT00066703|4279174|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458177|NCT00066703|4279175|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458178|NCT00066703|4279176|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458179|NCT00066703|4279174|B3||Female|Sex: Female, Male||Participants|Count of Participants|2660|2660.0||||||
4458180|NCT00066703|4279175|B2||Female|Sex: Female, Male||Participants|Count of Participants|1332|1332.0||||||
4458181|NCT00066703|4279176|B1||Female|Sex: Female, Male||Participants|Count of Participants|1328|1328.0||||||
4458182|NCT00066703|4279174|B3|Age||Age||years|Median|43|43.0|Inter-Quartile Range|||40.0|46.0|
4458183|NCT00066703|4279175|B2|Age||Age||years|Median|43|43.0|Inter-Quartile Range|||39.0|46.0|
4458184|NCT00066703|4279176|B1|Age||Age||years|Median|44|44.0|Inter-Quartile Range|||40.0|46.0|
4458185|NCT00066690|4279187|B4|Positive||HER2-status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|36.03|36.03||||||
4458186|NCT00066690|4279188|B3|Positive||HER2-status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|12.82|12.82||||||
4458187|NCT00066690|4279189|B2|Positive||HER2-status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|11.72|11.72||||||
4458188|NCT00066690|4279190|B1|Positive||HER2-status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|11.49|11.49||||||
4458189|NCT00066690|4279187|B4|Negative||HER2-status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|254.12|254.12||||||
4458190|NCT00066690|4279188|B3|Negative||HER2-status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|84.52|84.52||||||
4458191|NCT00066690|4279189|B2|Negative||HER2-status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|85.42|85.42||||||
4458192|NCT00066690|4279190|B1|Negative||HER2-status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|84.18|84.18||||||
4458193|NCT00066690|4279187|B4|Unknown||HER2-status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|9.84|9.84||||||
4458194|NCT00066690|4279188|B3|Unknown||HER2-status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|2.66|2.66||||||
4458195|NCT00066690|4279189|B2|Unknown||HER2-status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|2.86|2.86||||||
4458196|NCT00066690|4279190|B1|Unknown||HER2-status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|4.32|4.32||||||
4458197|NCT00066690|4279187|B4|3||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|63.01|63.01||||||
4458198|NCT00066690|4279188|B3|3||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|19.82|19.82||||||
4458199|NCT00066690|4279189|B2|3||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|20.89|20.89||||||
4458200|NCT00066690|4279190|B1|3||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|22.30|22.3||||||
4458201|NCT00066690|4279187|B4|2||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|152.62|152.62||||||
4458288|NCT00066365|4279226|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458202|NCT00066690|4279188|B3|2||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|53.65|53.65||||||
4458203|NCT00066690|4279189|B2|2||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|50.64|50.64||||||
4458204|NCT00066690|4279190|B1|2||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|48.33|48.33||||||
4458205|NCT00066690|4279187|B4|1||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|77.48|77.48||||||
4458206|NCT00066690|4279188|B3|1||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|24.36|24.36||||||
4458207|NCT00066690|4279189|B2|1||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|26.11|26.11||||||
4458208|NCT00066690|4279190|B1|1||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|27.01|27.01||||||
4458209|NCT00066690|4279187|B4|Unknown||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|6.89|6.89||||||
4458210|NCT00066690|4279188|B3|Unknown||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|2.17|2.17||||||
4458211|NCT00066690|4279189|B2|Unknown||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|2.36|2.36||||||
4458212|NCT00066690|4279190|B1|Unknown||Tumor grade|"Tumor grade is the histologic grade according to the BRE method. The method involves assessment of tumor morphology, including tubule formation, nuclear pleomorphism and frequency of mitoses. Grades are recorded according to criteria as 1,2 or 3. Grade 3 is associated with poor prognosis.~Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants."|percent of participants|Number|2.36|2.36||||||
4458213|NCT00066690|4279187|B4|>2cm||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|94.92|94.92||||||
4458214|NCT00066690|4279188|B3|>2cm||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|31.07|31.07||||||
4458215|NCT00066690|4279189|B2|>2cm||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|32.91|32.91||||||
4458216|NCT00066690|4279190|B1|>2cm||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|30.94|30.94||||||
4458217|NCT00066690|4279187|B4|<=2 cm||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|197.89|197.89||||||
4458218|NCT00066690|4279188|B3|<=2 cm||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|66.86|66.86||||||
4458219|NCT00066690|4279189|B2|<=2 cm||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|64.63|64.63||||||
4458220|NCT00066690|4279190|B1|<=2 cm||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|66.40|66.4||||||
4458221|NCT00066690|4279187|B4|Unknown||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|7.18|7.18||||||
4458222|NCT00066690|4279188|B3|Unknown||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|2.07|2.07||||||
4458223|NCT00066690|4279189|B2|Unknown||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|2.46|2.46||||||
4458224|NCT00066690|4279190|B1|Unknown||Tumor size|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|2.65|2.65||||||
4458225|NCT00066690|4279187|B4|Positive||Lymph-node status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|103.58|103.58||||||
4458226|NCT00066690|4279188|B3|Positive||Lymph-node status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|33.83|33.83||||||
4458227|NCT00066690|4279189|B2|Positive||Lymph-node status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|34.78|34.78||||||
4458228|NCT00066690|4279190|B1|Positive||Lymph-node status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|34.97|34.97||||||
4458229|NCT00066690|4279187|B4|Negative||Lymph-node status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|196.42|196.42||||||
4458230|NCT00066690|4279188|B3|Negative||Lymph-node status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|66.17|66.17||||||
4458231|NCT00066690|4279189|B2|Negative||Lymph-node status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|65.22|65.22||||||
4458232|NCT00066690|4279190|B1|Negative||Lymph-node status|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|65.03|65.03||||||
4458233|NCT00066690|4279187|B4|Male||Gender|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|0|0.0||||||
4458234|NCT00066690|4279188|B3|Male||Gender|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|0|0.0||||||
4458235|NCT00066690|4279189|B2|Male||Gender|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|0|0.0||||||
4458289|NCT00066365|4279227|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4458236|NCT00066690|4279190|B1|Male||Gender|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|0|0.0||||||
4458237|NCT00066690|4279187|B4|Female||Gender|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|300|300.0||||||
4458238|NCT00066690|4279188|B3|Female||Gender|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|100|100.0||||||
4458239|NCT00066690|4279189|B2|Female||Gender|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|100|100.0||||||
4458240|NCT00066690|4279190|B1|Female||Gender|Units in this baseline measure reflect the percentage of total participants, rather than number of participants. The total provided does not equal the total number of participants and should not be interpreted as an accurate total of participants.|percent of participants|Number|100|100.0||||||
4458241|NCT00066690|4279187|B4|||Age||years|Median|43|43.0|Inter-Quartile Range|||38.0|47.0|
4458242|NCT00066690|4279188|B3|||Age||years|Median|43|43.0|Inter-Quartile Range|||38.0|47.0|
4458243|NCT00066690|4279189|B2|||Age||years|Median|43|43.0|Inter-Quartile Range|||38.0|47.0|
4458244|NCT00066690|4279190|B1|||Age||years|Median|43|43.0|Inter-Quartile Range|||38.0|46.0|
4458245|NCT00066573|4279206|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458246|NCT00066573|4279207|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458247|NCT00066573|4279208|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458248|NCT00066573|4279206|B3||Female|Sex: Female, Male||Participants|Count of Participants|7576|7576.0||||||
4458249|NCT00066573|4279207|B2||Female|Sex: Female, Male||Participants|Count of Participants|3787|3787.0||||||
4458250|NCT00066573|4279208|B1||Female|Sex: Female, Male||Participants|Count of Participants|3789|3789.0||||||
4458251|NCT00066573|4279206|B3|||Age||years|Median|64.1|64.1|Full Range|||32.3|95.1|
4458252|NCT00066573|4279207|B2|||Age||years|Median|64.3|64.3|Full Range|||32.3|95.1|
4458253|NCT00066573|4279208|B1|||Age||years|Median|63.9|63.9|Full Range|||35.9|93.6|
4458254|NCT00066469|4279221|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4458255|NCT00066469|4279221|B1|Canada||Region of Enrollment||participants|Number|7|7.0||||||
4458256|NCT00066469|4279221|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4458257|NCT00066469|4279221|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4458258|NCT00066469|4279221|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458259|NCT00066469|4279221|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4458260|NCT00066469|4279221|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4458261|NCT00066469|4279221|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458262|NCT00066469|4279221|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458263|NCT00066469|4279221|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458264|NCT00066469|4279221|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4458265|NCT00066469|4279221|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4458266|NCT00066469|4279221|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4458267|NCT00066469|4279221|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4458268|NCT00066469|4279221|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4458269|NCT00066469|4279221|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458270|NCT00066469|4279221|B1||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4458271|NCT00066469|4279221|B1||<=18 years|Age||Participants|Count of Participants|54|54.0||||||
4458272|NCT00066365|4279225|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4458273|NCT00066365|4279226|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4458274|NCT00066365|4279227|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4458275|NCT00066365|4279225|B3|United States||Region of Enrollment||participants|Number|48|48.0||||||
4458276|NCT00066365|4279226|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4458277|NCT00066365|4279227|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4458278|NCT00066365|4279225|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4458279|NCT00066365|4279226|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4458280|NCT00066365|4279227|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458281|NCT00066365|4279225|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458282|NCT00066365|4279226|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458283|NCT00066365|4279227|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458284|NCT00066365|4279225|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4458285|NCT00066365|4279226|B2||White|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4458286|NCT00066365|4279227|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4458290|NCT00066365|4279225|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458291|NCT00066365|4279226|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458292|NCT00066365|4279227|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458293|NCT00066365|4279225|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458294|NCT00066365|4279226|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458295|NCT00066365|4279227|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458296|NCT00066365|4279225|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458297|NCT00066365|4279226|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458298|NCT00066365|4279227|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458299|NCT00066365|4279225|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4458300|NCT00066365|4279226|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4458301|NCT00066365|4279227|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458302|NCT00066365|4279225|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4458303|NCT00066365|4279226|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4458304|NCT00066365|4279227|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4458305|NCT00066365|4279225|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4458306|NCT00066365|4279226|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458307|NCT00066365|4279227|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4458308|NCT00066365|4279225|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4458309|NCT00066365|4279226|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4458310|NCT00066365|4279227|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4458311|NCT00066365|4279225|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4458312|NCT00066365|4279226|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4458313|NCT00066365|4279227|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4458314|NCT00066365|4279225|B3|||Age||years|Median|16|16.0|Full Range|||7.0|29.0|
4458315|NCT00066365|4279226|B2|||Age||years|Median|17|17.0|Full Range|||14.0|20.0|
4458316|NCT00066365|4279227|B1|||Age||years|Median|16|16.0|Full Range|||7.0|29.0|
4458317|NCT00066365|4279225|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458318|NCT00066365|4279226|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458319|NCT00066365|4279227|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458320|NCT00066365|4279225|B3||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4458321|NCT00066365|4279226|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4458322|NCT00066365|4279227|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4458323|NCT00066365|4279225|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4458324|NCT00066365|4279226|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4458325|NCT00066365|4279227|B1||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4458326|NCT00066222|4279256|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4458327|NCT00066222|4279256|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4458328|NCT00066222|4279256|B1|||Age||years|Median|71|71.0|Full Range|||43.0|84.0|
4458329|NCT00066170|4279265|B5|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4458330|NCT00066170|4279266|B4|Other||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4458331|NCT00066170|4279267|B3|Other||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4458332|NCT00066170|4279268|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4458333|NCT00066170|4279269|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4458334|NCT00066170|4279265|B5|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4458335|NCT00066170|4279266|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4458336|NCT00066170|4279267|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4458337|NCT00066170|4279268|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4458338|NCT00066170|4279269|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4458339|NCT00066170|4279265|B5|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4458340|NCT00066170|4279266|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4458341|NCT00066170|4279267|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4458342|NCT00066170|4279268|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4458343|NCT00066170|4279269|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4458344|NCT00066170|4279265|B5|Black||Race/Ethnicity, Customized||Participants|Number|21|21.0||||||
4458345|NCT00066170|4279266|B4|Black||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4458346|NCT00066170|4279267|B3|Black||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4458347|NCT00066170|4279268|B2|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4458348|NCT00066170|4279269|B1|Black||Race/Ethnicity, Customized||Participants|Number|11|11.0||||||
4458349|NCT00066170|4279265|B5|Caucasian||Race/Ethnicity, Customized||Participants|Number|195|195.0||||||
4458350|NCT00066170|4279266|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|48|48.0||||||
4458351|NCT00066170|4279267|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4458352|NCT00066170|4279268|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|47|47.0||||||
4458353|NCT00066170|4279269|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|43|43.0||||||
4458354|NCT00066170|4279265|B5||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4458355|NCT00066170|4279266|B4||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4458356|NCT00066170|4279267|B3||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4458357|NCT00066170|4279268|B2||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4458358|NCT00066170|4279269|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4458359|NCT00066170|4279265|B5||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4458360|NCT00066170|4279266|B4||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4458361|NCT00066170|4279267|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4458362|NCT00066170|4279268|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4458363|NCT00066170|4279269|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4458364|NCT00066170|4279265|B5|||Age||years|Mean|38.6|38.6|Standard Deviation|14.60|14.6|||
4458365|NCT00066170|4279266|B4|||Age||years|Mean|38.9|38.9|Standard Deviation|15.87|15.87|||
4458366|NCT00066170|4279267|B3|||Age||years|Mean|38.9|38.9|Standard Deviation|15.62|15.62|||
4458367|NCT00066170|4279268|B2|||Age||years|Mean|35.1|35.1|Standard Deviation|12.86|12.86|||
4458368|NCT00066170|4279269|B1|||Age||years|Mean|41.0|41.0|Standard Deviation|13.35|13.35|||
4458369|NCT00066066|4279282|B4|United States||Region of Enrollment||participants|Number|146|146.0||||||
4458370|NCT00066066|4279283|B3|United States||Region of Enrollment||participants|Number|47|47.0||||||
4458371|NCT00066066|4279284|B2|United States||Region of Enrollment||participants|Number|50|50.0||||||
4458372|NCT00066066|4279285|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4458373|NCT00066066|4279282|B4||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4458374|NCT00066066|4279283|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4458375|NCT00066066|4279284|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4458376|NCT00066066|4279285|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4458377|NCT00066066|4279282|B4||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4458378|NCT00066066|4279283|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4458379|NCT00066066|4279284|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4458380|NCT00066066|4279285|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4458381|NCT00066066|4279282|B4|||Age||years|Mean|49.5|49.5|Standard Deviation|11.5|11.5|||
4458382|NCT00066066|4279283|B3|||Age||years|Mean|48.0|48.0|Standard Deviation|11.1|11.1|||
4458383|NCT00066066|4279284|B2|||Age||years|Mean|50.3|50.3|Standard Deviation|11.6|11.6|||
4458384|NCT00066066|4279285|B1|||Age||years|Mean|50.3|50.3|Standard Deviation|11.8|11.8|||
4458385|NCT00066066|4279282|B4||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4458386|NCT00066066|4279283|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4458387|NCT00066066|4279284|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4458388|NCT00066066|4279285|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4458389|NCT00066066|4279282|B4||Between 18 and 65 years|Age||Participants|Count of Participants|132|132.0||||||
4458390|NCT00066066|4279283|B3||Between 18 and 65 years|Age||Participants|Count of Participants|44|44.0||||||
4458391|NCT00066066|4279284|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4458392|NCT00066066|4279285|B1||Between 18 and 65 years|Age||Participants|Count of Participants|42|42.0||||||
4458393|NCT00066066|4279282|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4458394|NCT00066066|4279283|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4458395|NCT00066066|4279284|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4458396|NCT00066066|4279285|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4458397|NCT00065806|4279304|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4458398|NCT00065806|4279305|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4458399|NCT00065806|4279306|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4458400|NCT00065806|4279304|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4458401|NCT00065806|4279305|B2||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4458402|NCT00065806|4279306|B1||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4458403|NCT00065806|4279304|B3|||Age||years|Mean|15.7|15.7|Standard Deviation|2.6|2.6|||
4458404|NCT00065806|4279305|B2|||Age||years|Mean|15.8|15.8|Standard Deviation|2.5|2.5|||
4458405|NCT00065806|4279306|B1|||Age||years|Mean|15.7|15.7|Standard Deviation|2.8|2.8|||
4458406|NCT00065806|4279304|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458407|NCT00065806|4279305|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458408|NCT00065806|4279306|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458409|NCT00065806|4279304|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4458410|NCT00065806|4279305|B2||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4458411|NCT00065806|4279306|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4458412|NCT00065806|4279304|B3||<=18 years|Age||Participants|Count of Participants|174|174.0||||||
4458413|NCT00065806|4279305|B2||<=18 years|Age||Participants|Count of Participants|87|87.0||||||
4458414|NCT00065806|4279306|B1||<=18 years|Age||Participants|Count of Participants|87|87.0||||||
4458415|NCT00014560|4279349|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4458416|NCT00014560|4279349|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4458417|NCT00014560|4279349|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4458418|NCT00014560|4279349|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458419|NCT00014560|4279349|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4458420|NCT00014560|4279349|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4458421|NCT00065611|4279353|B3|||CKD-EPI eGFR|estimate glomerular filtration rate (GFR) using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formula|ml/min/1.73m^2|Mean|66.6|66.6|Standard Deviation|18.1|18.1|||
4458422|NCT00065611|4279354|B2|||CKD-EPI eGFR|estimate glomerular filtration rate (GFR) using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formula|ml/min/1.73m^2|Mean|76.3|76.3|Standard Deviation|21.4|21.4|||
4458423|NCT00065611|4279355|B1|||CKD-EPI eGFR|estimate glomerular filtration rate (GFR) using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formula|ml/min/1.73m^2|Mean|59.2|59.2|Standard Deviation|13.4|13.4|||
4458424|NCT00065611|4279353|B3|||Urine Protein||g/d|Mean|10.8|10.8|Standard Deviation|5.1|5.1|||
4458425|NCT00065611|4279354|B2|||Urine Protein||g/d|Mean|10.0|10.0|Standard Deviation|1.9|1.9|||
4458426|NCT00065611|4279355|B1|||Urine Protein||g/d|Mean|11.2|11.2|Standard Deviation|7.0|7.0|||
4458427|NCT00065611|4279353|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4458428|NCT00065611|4279354|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4458429|NCT00065611|4279355|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4458430|NCT00065611|4279353|B3|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4458431|NCT00065611|4279354|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4458432|NCT00065611|4279355|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4458433|NCT00065611|4279353|B3|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4458434|NCT00065611|4279354|B2|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4458435|NCT00065611|4279355|B1|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4458436|NCT00065611|4279353|B3|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4458437|NCT00065611|4279354|B2|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4458438|NCT00065611|4279355|B1|White||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4458439|NCT00065611|4279353|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4458440|NCT00065611|4279354|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4458441|NCT00065611|4279355|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4458442|NCT00065611|4279353|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4458443|NCT00065611|4279354|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4458444|NCT00065611|4279355|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4458445|NCT00065611|4279353|B3|||Age||years|Mean|35|35.0|Standard Deviation|8|8.0|31.0|38.0|
4458446|NCT00065611|4279354|B2|||Age||years|Mean|30|30.0|Standard Deviation|5|5.0|||
4458447|NCT00065611|4279355|B1|||Age||years|Mean|38|38.0|Standard Deviation|9|9.0|||
4458448|NCT00065507|4279366|B3|||Mayo End-Stage Liver Disease (MELD) score|The Model for End-Stage Liver Disease (MELD), is a scoring system for assessing the severity of chronic liver disease. MELD uses the patient's values for serum bilirubin, serum creatinine, and the international normalized ratio for prothrombin time (INR) to predict survival. In interpreting the MELD Score in hospitalized patients, the 3 month mortality is: 40 or more=100% mortality; 30-39=83% mortality; 20-29=76% mortality; 10-19=27% mortality; <10=4% mortality. As-randomized population.|units on a scale|Mean|16.23|16.23|Standard Deviation|4.89|4.89|||
4458449|NCT00065507|4279367|B2|||Mayo End-Stage Liver Disease (MELD) score|The Model for End-Stage Liver Disease (MELD), is a scoring system for assessing the severity of chronic liver disease. MELD uses the patient's values for serum bilirubin, serum creatinine, and the international normalized ratio for prothrombin time (INR) to predict survival. In interpreting the MELD Score in hospitalized patients, the 3 month mortality is: 40 or more=100% mortality; 30-39=83% mortality; 20-29=76% mortality; 10-19=27% mortality; <10=4% mortality. As-randomized population.|units on a scale|Mean|15.30|15.3|Standard Deviation|4.61|4.61|||
4458450|NCT00065507|4279368|B1|||Mayo End-Stage Liver Disease (MELD) score|The Model for End-Stage Liver Disease (MELD), is a scoring system for assessing the severity of chronic liver disease. MELD uses the patient's values for serum bilirubin, serum creatinine, and the international normalized ratio for prothrombin time (INR) to predict survival. In interpreting the MELD Score in hospitalized patients, the 3 month mortality is: 40 or more=100% mortality; 30-39=83% mortality; 20-29=76% mortality; 10-19=27% mortality; <10=4% mortality. As-randomized population.|units on a scale|Mean|17.07|17.07|Standard Deviation|5.00|5.0|||
4458451|NCT00065507|4279366|B3|||HBV DNA by PCR|HBV=hepatitis B virus, PCR=polymerase chain reaction. As-Randomized population.|log10 copies/mL|Mean|7.83|7.83|Standard Deviation|2.023|2.023|||
4458452|NCT00065507|4279367|B2|||HBV DNA by PCR|HBV=hepatitis B virus, PCR=polymerase chain reaction. As-Randomized population.|log10 copies/mL|Mean|8.16|8.16|Standard Deviation|2.179|2.179|||
4458453|NCT00065507|4279368|B1|||HBV DNA by PCR|HBV=hepatitis B virus, PCR=polymerase chain reaction. As-Randomized population.|log10 copies/mL|Mean|7.53|7.53|Standard Deviation|1.829|1.829|||
4458477|NCT00065507|4279368|B1|South Africa||Region of Enrollment||participants|Number|3|3.0||||||
4458478|NCT00065507|4279366|B3|Singapore||Region of Enrollment||participants|Number|8|8.0||||||
4458479|NCT00065507|4279367|B2|Singapore||Region of Enrollment||participants|Number|5|5.0||||||
4458454|NCT00065507|4279366|B3|||Child-Pugh Score|The Child-Pugh classification is used to assess the prognosis of chronic liver disease. The score employs 5 clinical measures of liver disease; each measure is scored 1-3, with 3 indicating most severe derangement. Total possible score is 15. Chronic liver disease is classified into Child-Pugh class A to C, employing the added score from above: 5-6=Class A; 7-9=Class B; 10-15=Class C. As-Randomized population.|units on a scale|Mean|8.59|8.59|Standard Deviation|1.91|1.91|||
4458455|NCT00065507|4279367|B2|||Child-Pugh Score|The Child-Pugh classification is used to assess the prognosis of chronic liver disease. The score employs 5 clinical measures of liver disease; each measure is scored 1-3, with 3 indicating most severe derangement. Total possible score is 15. Chronic liver disease is classified into Child-Pugh class A to C, employing the added score from above: 5-6=Class A; 7-9=Class B; 10-15=Class C. As-Randomized population.|units on a scale|Mean|8.35|8.35|Standard Deviation|1.82|1.82|||
4458456|NCT00065507|4279368|B1|||Child-Pugh Score|The Child-Pugh classification is used to assess the prognosis of chronic liver disease. The score employs 5 clinical measures of liver disease; each measure is scored 1-3, with 3 indicating most severe derangement. Total possible score is 15. Chronic liver disease is classified into Child-Pugh class A to C, employing the added score from above: 5-6=Class A; 7-9=Class B; 10-15=Class C. As-Randomized population.|units on a scale|Mean|8.81|8.81|Standard Deviation|1.98|1.98|||
4458457|NCT00065507|4279366|B3|||Alanine Aminotransferase (ALT)|As-randomized population|U/L|Mean|99.6|99.6|Standard Deviation|98.01|98.01|||
4458458|NCT00065507|4279367|B2|||Alanine Aminotransferase (ALT)|As-randomized population|U/L|Mean|100.0|100.0|Standard Deviation|81.68|81.68|||
4458459|NCT00065507|4279368|B1|||Alanine Aminotransferase (ALT)|As-randomized population|U/L|Mean|99.2|99.2|Standard Deviation|111.23|111.23|||
4458460|NCT00065507|4279366|B3|Class C||Child-Pugh Class|The Child-Pugh classification is used to assess the prognosis of chronic liver disease. The score employs 5 clinical measures of liver disease; each measure is scored 1-3, with 3 indicating most severe derangement. Total possible score is 15. Chronic liver disease is classified into Child-Pugh class A to C, employing the added score from above: 5-6=Class A; 7-9=Class B; 10-15=Class C. As-Randomized population.|Participants|Number|50|50.0||||||
4458461|NCT00065507|4279367|B2|Class C||Child-Pugh Class|The Child-Pugh classification is used to assess the prognosis of chronic liver disease. The score employs 5 clinical measures of liver disease; each measure is scored 1-3, with 3 indicating most severe derangement. Total possible score is 15. Chronic liver disease is classified into Child-Pugh class A to C, employing the added score from above: 5-6=Class A; 7-9=Class B; 10-15=Class C. As-Randomized population.|Participants|Number|20|20.0||||||
4458462|NCT00065507|4279368|B1|Class C||Child-Pugh Class|The Child-Pugh classification is used to assess the prognosis of chronic liver disease. The score employs 5 clinical measures of liver disease; each measure is scored 1-3, with 3 indicating most severe derangement. Total possible score is 15. Chronic liver disease is classified into Child-Pugh class A to C, employing the added score from above: 5-6=Class A; 7-9=Class B; 10-15=Class C. As-Randomized population.|Participants|Number|30|30.0||||||
4458463|NCT00065507|4279366|B3|Class B||Child-Pugh Class|The Child-Pugh classification is used to assess the prognosis of chronic liver disease. The score employs 5 clinical measures of liver disease; each measure is scored 1-3, with 3 indicating most severe derangement. Total possible score is 15. Chronic liver disease is classified into Child-Pugh class A to C, employing the added score from above: 5-6=Class A; 7-9=Class B; 10-15=Class C. As-Randomized population.|Participants|Number|124|124.0||||||
4458464|NCT00065507|4279367|B2|Class B||Child-Pugh Class|The Child-Pugh classification is used to assess the prognosis of chronic liver disease. The score employs 5 clinical measures of liver disease; each measure is scored 1-3, with 3 indicating most severe derangement. Total possible score is 15. Chronic liver disease is classified into Child-Pugh class A to C, employing the added score from above: 5-6=Class A; 7-9=Class B; 10-15=Class C. As-Randomized population.|Participants|Number|61|61.0||||||
4458465|NCT00065507|4279368|B1|Class B||Child-Pugh Class|The Child-Pugh classification is used to assess the prognosis of chronic liver disease. The score employs 5 clinical measures of liver disease; each measure is scored 1-3, with 3 indicating most severe derangement. Total possible score is 15. Chronic liver disease is classified into Child-Pugh class A to C, employing the added score from above: 5-6=Class A; 7-9=Class B; 10-15=Class C. As-Randomized population.|Participants|Number|63|63.0||||||
4458466|NCT00065507|4279366|B3|Class A||Child-Pugh Class|The Child-Pugh classification is used to assess the prognosis of chronic liver disease. The score employs 5 clinical measures of liver disease; each measure is scored 1-3, with 3 indicating most severe derangement. Total possible score is 15. Chronic liver disease is classified into Child-Pugh class A to C, employing the added score from above: 5-6=Class A; 7-9=Class B; 10-15=Class C. As-Randomized population.|Participants|Number|17|17.0||||||
4458467|NCT00065507|4279367|B2|Class A||Child-Pugh Class|The Child-Pugh classification is used to assess the prognosis of chronic liver disease. The score employs 5 clinical measures of liver disease; each measure is scored 1-3, with 3 indicating most severe derangement. Total possible score is 15. Chronic liver disease is classified into Child-Pugh class A to C, employing the added score from above: 5-6=Class A; 7-9=Class B; 10-15=Class C. As-Randomized population.|Participants|Number|10|10.0||||||
4458468|NCT00065507|4279368|B1|Class A||Child-Pugh Class|The Child-Pugh classification is used to assess the prognosis of chronic liver disease. The score employs 5 clinical measures of liver disease; each measure is scored 1-3, with 3 indicating most severe derangement. Total possible score is 15. Chronic liver disease is classified into Child-Pugh class A to C, employing the added score from above: 5-6=Class A; 7-9=Class B; 10-15=Class C. As-Randomized population.|Participants|Number|7|7.0||||||
4458469|NCT00065507|4279366|B3|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4458470|NCT00065507|4279367|B2|United Kingdom||Region of Enrollment||participants|Number|1|1.0||||||
4458471|NCT00065507|4279368|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4458472|NCT00065507|4279366|B3|France||Region of Enrollment||participants|Number|2|2.0||||||
4458473|NCT00065507|4279367|B2|France||Region of Enrollment||participants|Number|0|0.0||||||
4458474|NCT00065507|4279368|B1|France||Region of Enrollment||participants|Number|2|2.0||||||
4458475|NCT00065507|4279366|B3|South Africa||Region of Enrollment||participants|Number|7|7.0||||||
4458476|NCT00065507|4279367|B2|South Africa||Region of Enrollment||participants|Number|4|4.0||||||
4458480|NCT00065507|4279368|B1|Singapore||Region of Enrollment||participants|Number|3|3.0||||||
4458481|NCT00065507|4279366|B3|Poland||Region of Enrollment||participants|Number|8|8.0||||||
4458482|NCT00065507|4279367|B2|Poland||Region of Enrollment||participants|Number|5|5.0||||||
4458483|NCT00065507|4279368|B1|Poland||Region of Enrollment||participants|Number|3|3.0||||||
4458484|NCT00065507|4279366|B3|Brazil||Region of Enrollment||participants|Number|26|26.0||||||
4458485|NCT00065507|4279367|B2|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
4458486|NCT00065507|4279368|B1|Brazil||Region of Enrollment||participants|Number|13|13.0||||||
4458487|NCT00065507|4279366|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4458488|NCT00065507|4279367|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4458489|NCT00065507|4279368|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4458490|NCT00065507|4279366|B3|India||Region of Enrollment||participants|Number|29|29.0||||||
4458491|NCT00065507|4279367|B2|India||Region of Enrollment||participants|Number|14|14.0||||||
4458492|NCT00065507|4279368|B1|India||Region of Enrollment||participants|Number|15|15.0||||||
4458493|NCT00065507|4279366|B3|Russian Federation||Region of Enrollment||participants|Number|2|2.0||||||
4458494|NCT00065507|4279367|B2|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4458495|NCT00065507|4279368|B1|Russian Federation||Region of Enrollment||participants|Number|1|1.0||||||
4458496|NCT00065507|4279366|B3|Turkey||Region of Enrollment||participants|Number|4|4.0||||||
4458497|NCT00065507|4279367|B2|Turkey||Region of Enrollment||participants|Number|1|1.0||||||
4458498|NCT00065507|4279368|B1|Turkey||Region of Enrollment||participants|Number|3|3.0||||||
4458499|NCT00065507|4279366|B3|Indonesia||Region of Enrollment||participants|Number|2|2.0||||||
4458500|NCT00065507|4279367|B2|Indonesia||Region of Enrollment||participants|Number|0|0.0||||||
4458501|NCT00065507|4279368|B1|Indonesia||Region of Enrollment||participants|Number|2|2.0||||||
4458502|NCT00065507|4279366|B3|Thailand||Region of Enrollment||participants|Number|19|19.0||||||
4458503|NCT00065507|4279367|B2|Thailand||Region of Enrollment||participants|Number|9|9.0||||||
4458504|NCT00065507|4279368|B1|Thailand||Region of Enrollment||participants|Number|10|10.0||||||
4458505|NCT00065507|4279366|B3|Greece||Region of Enrollment||participants|Number|13|13.0||||||
4458506|NCT00065507|4279367|B2|Greece||Region of Enrollment||participants|Number|5|5.0||||||
4458507|NCT00065507|4279368|B1|Greece||Region of Enrollment||participants|Number|8|8.0||||||
4458508|NCT00065507|4279366|B3|Hong Kong||Region of Enrollment||participants|Number|10|10.0||||||
4458509|NCT00065507|4279367|B2|Hong Kong||Region of Enrollment||participants|Number|5|5.0||||||
4458510|NCT00065507|4279368|B1|Hong Kong||Region of Enrollment||participants|Number|5|5.0||||||
4458511|NCT00065507|4279366|B3|Taiwan||Region of Enrollment||participants|Number|22|22.0||||||
4458512|NCT00065507|4279367|B2|Taiwan||Region of Enrollment||participants|Number|11|11.0||||||
4458513|NCT00065507|4279368|B1|Taiwan||Region of Enrollment||participants|Number|11|11.0||||||
4458514|NCT00065507|4279366|B3|Philippines||Region of Enrollment||participants|Number|9|9.0||||||
4458515|NCT00065507|4279367|B2|Philippines||Region of Enrollment||participants|Number|5|5.0||||||
4458516|NCT00065507|4279368|B1|Philippines||Region of Enrollment||participants|Number|4|4.0||||||
4458517|NCT00065507|4279366|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4458518|NCT00065507|4279367|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4458519|NCT00065507|4279368|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4458520|NCT00065507|4279366|B3|Black/African American||Race/Ethnicity, Customized|"Other category includes Asian Indian, South African color, mixed ancestry, and mixed race"|participants|Number|10|10.0||||||
4458521|NCT00065507|4279367|B2|Black/African American||Race/Ethnicity, Customized|"Other category includes Asian Indian, South African color, mixed ancestry, and mixed race"|participants|Number|5|5.0||||||
4458522|NCT00065507|4279368|B1|Black/African American||Race/Ethnicity, Customized|"Other category includes Asian Indian, South African color, mixed ancestry, and mixed race"|participants|Number|5|5.0||||||
4458523|NCT00065507|4279366|B3|Other||Race/Ethnicity, Customized|"Other category includes Asian Indian, South African color, mixed ancestry, and mixed race"|participants|Number|14|14.0||||||
4458524|NCT00065507|4279367|B2|Other||Race/Ethnicity, Customized|"Other category includes Asian Indian, South African color, mixed ancestry, and mixed race"|participants|Number|9|9.0||||||
4458525|NCT00065507|4279368|B1|Other||Race/Ethnicity, Customized|"Other category includes Asian Indian, South African color, mixed ancestry, and mixed race"|participants|Number|5|5.0||||||
4458526|NCT00065507|4279366|B3|White||Race/Ethnicity, Customized|"Other category includes Asian Indian, South African color, mixed ancestry, and mixed race"|participants|Number|63|63.0||||||
4458527|NCT00065507|4279367|B2|White||Race/Ethnicity, Customized|"Other category includes Asian Indian, South African color, mixed ancestry, and mixed race"|participants|Number|28|28.0||||||
4458528|NCT00065507|4279368|B1|White||Race/Ethnicity, Customized|"Other category includes Asian Indian, South African color, mixed ancestry, and mixed race"|participants|Number|35|35.0||||||
4458529|NCT00065507|4279366|B3|Asian||Race/Ethnicity, Customized|"Other category includes Asian Indian, South African color, mixed ancestry, and mixed race"|participants|Number|104|104.0||||||
4458530|NCT00065507|4279367|B2|Asian||Race/Ethnicity, Customized|"Other category includes Asian Indian, South African color, mixed ancestry, and mixed race"|participants|Number|49|49.0||||||
4458531|NCT00065507|4279368|B1|Asian||Race/Ethnicity, Customized|"Other category includes Asian Indian, South African color, mixed ancestry, and mixed race"|participants|Number|55|55.0||||||
4458532|NCT00065507|4279366|B3||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4458533|NCT00065507|4279367|B2||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4458534|NCT00065507|4279368|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4458535|NCT00065507|4279366|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4458536|NCT00065507|4279367|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4458537|NCT00065507|4279368|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4458538|NCT00065507|4279366|B3|||Age||years|Mean|52|52.0|Standard Deviation|11|11.0|||
4458539|NCT00065507|4279367|B2|||Age||years|Mean|53|53.0|Standard Deviation|11|11.0|||
4458540|NCT00065507|4279368|B1|||Age||years|Mean|51|51.0|Standard Deviation|12|12.0|||
4458541|NCT00065468|4279431|B4||Male|Sex: Female, Male||Participants|Count of Participants|432|432.0||||||
4458542|NCT00065468|4279432|B3||Male|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4458543|NCT00065468|4279433|B2||Male|Sex: Female, Male||Participants|Count of Participants|139|139.0||||||
4458544|NCT00065468|4279434|B1||Male|Sex: Female, Male||Participants|Count of Participants|148|148.0||||||
4458545|NCT00065468|4279431|B4||Female|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4458546|NCT00065468|4279432|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4458547|NCT00065468|4279433|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4458548|NCT00065468|4279434|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4458549|NCT00065468|4279431|B4|||Age||years|Mean|59.1|59.1|Standard Deviation|10.1|10.1|||
4458550|NCT00065468|4279432|B3|||Age||years|Mean|59.3|59.3|Standard Deviation|9.8|9.8|||
4458551|NCT00065468|4279433|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|10.0|10.0|||
4458552|NCT00065468|4279434|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|10.4|10.4|||
4458553|NCT00065442|4279465|B3||Male|Sex: Female, Male||Participants|Count of Participants|512|512.0||||||
4458554|NCT00065442|4279466|B2||Male|Sex: Female, Male||Participants|Count of Participants|341|341.0||||||
4458555|NCT00065442|4279467|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4458556|NCT00065442|4279465|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458557|NCT00065442|4279466|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458558|NCT00065442|4279467|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458559|NCT00065442|4279465|B3|||Age, Customized||years|Median|71|71.0|Full Range|||40.0|91.0|
4458560|NCT00065442|4279466|B2|||Age, Customized||years|Median|72|72.0|Full Range|||49.0|91.0|
4458561|NCT00065442|4279467|B1|||Age, Customized||years|Median|70|70.0|Full Range|||40.0|89.0|
4458562|NCT00065442|4279465|B3|||Age||years|Mean|70.8|70.8|Standard Deviation|8.9|8.9|||
4458563|NCT00065442|4279466|B2|||Age||years|Mean|71.1|71.1|Standard Deviation|8.9|8.9|||
4458564|NCT00065442|4279467|B1|||Age||years|Mean|70.1|70.1|Standard Deviation|9.0|9.0|||
4458565|NCT00065429|4279476|B8|United States||Region of Enrollment||participants|Number|64|64.0||||||
4458566|NCT00065429|4279477|B7|United States||Region of Enrollment||participants|Number|4|4.0||||||
4458567|NCT00065429|4279478|B6|United States||Region of Enrollment||participants|Number|4|4.0||||||
4458568|NCT00065429|4279479|B5|United States||Region of Enrollment||participants|Number|41|41.0||||||
4458569|NCT00065429|4279480|B4|United States||Region of Enrollment||participants|Number|4|4.0||||||
4458570|NCT00065429|4279481|B3|United States||Region of Enrollment||participants|Number|4|4.0||||||
4458571|NCT00065429|4279482|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4458572|NCT00065429|4279483|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4458573|NCT00065429|4279476|B8||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4458574|NCT00065429|4279477|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458575|NCT00065429|4279478|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4458576|NCT00065429|4279479|B5||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4458577|NCT00065429|4279480|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4458578|NCT00065429|4279481|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4458579|NCT00065429|4279482|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4458580|NCT00065429|4279483|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4458581|NCT00065429|4279476|B8||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4458582|NCT00065429|4279477|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4458583|NCT00065429|4279478|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4458584|NCT00065429|4279479|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4458585|NCT00065429|4279480|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4458586|NCT00065429|4279481|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4458587|NCT00065429|4279482|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4458588|NCT00065429|4279483|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458589|NCT00065429|4279476|B8|>=18 years||Age, Customized||participants|Number|64|64.0||||||
4458590|NCT00065429|4279477|B7|>=18 years||Age, Customized||participants|Number|4|4.0||||||
4458591|NCT00065429|4279478|B6|>=18 years||Age, Customized||participants|Number|4|4.0||||||
4458592|NCT00065429|4279479|B5|>=18 years||Age, Customized||participants|Number|41|41.0||||||
4458593|NCT00065429|4279480|B4|>=18 years||Age, Customized||participants|Number|4|4.0||||||
4458594|NCT00065429|4279481|B3|>=18 years||Age, Customized||participants|Number|4|4.0||||||
4458595|NCT00065429|4279482|B2|>=18 years||Age, Customized||participants|Number|3|3.0||||||
4458596|NCT00065429|4279483|B1|>=18 years||Age, Customized||participants|Number|4|4.0||||||
4458597|NCT00065429|4279476|B8|||Age||years|Mean|62.67|62.67|Standard Deviation|10.01|10.01|||
4458598|NCT00065429|4279477|B7|||Age||years|Mean|54.5|54.5|Standard Deviation|9.5|9.5|||
4458599|NCT00065429|4279478|B6|||Age||years|Mean|59.5|59.5|Standard Deviation|4.8|4.8|||
4458600|NCT00065429|4279479|B5|||Age||years|Mean|61.2|61.2|Standard Deviation|10.1|10.1|||
4458601|NCT00065429|4279480|B4|||Age||years|Mean|59.8|59.8|Standard Deviation|9.07|9.07|||
4458602|NCT00065429|4279481|B3|||Age||years|Mean|60.0|60.0|Standard Deviation|12.65|12.65|||
4458603|NCT00065429|4279482|B2|||Age||years|Mean|59.0|59.0|Standard Deviation|13.08|13.08|||
4458604|NCT00065429|4279483|B1|||Age||years|Mean|64.0|64.0|Standard Deviation|10.86|10.86|||
4458605|NCT00065260|4279501|B3|United States||Region of Enrollment||participants|Number|54|54.0||||||
4458606|NCT00065260|4279502|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4458607|NCT00065260|4279503|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4458608|NCT00065260|4279501|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4458609|NCT00065260|4279502|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4458610|NCT00065260|4279503|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4458611|NCT00065260|4279501|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4458612|NCT00065260|4279502|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4458613|NCT00065260|4279503|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4458614|NCT00065260|4279501|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4458615|NCT00065260|4279502|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4458616|NCT00065260|4279503|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4458617|NCT00065260|4279501|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4458618|NCT00065260|4279502|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4458619|NCT00065260|4279503|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4458620|NCT00065260|4279501|B3||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4458621|NCT00065260|4279502|B2||<=18 years|Age||Participants|Count of Participants|9|9.0||||||
4458622|NCT00065260|4279503|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4458623|NCT00065156|4279510|B1|3 - 5||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG indicates a person's ability to perform life's functions on a scale of 0-5:~0= fully active and no restrictions~restricted but ambulatory and capable of light work~ambulatory and capable of self-care but unable to work~3-4= increasingly restricted~5= dead"|participants|Number|0|0.0||||||
4458624|NCT00065156|4279510|B1|2||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG indicates a person's ability to perform life's functions on a scale of 0-5:~0= fully active and no restrictions~restricted but ambulatory and capable of light work~ambulatory and capable of self-care but unable to work~3-4= increasingly restricted~5= dead"|participants|Number|14|14.0||||||
4458625|NCT00065156|4279510|B1|1||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG indicates a person's ability to perform life's functions on a scale of 0-5:~0= fully active and no restrictions~restricted but ambulatory and capable of light work~ambulatory and capable of self-care but unable to work~3-4= increasingly restricted~5= dead"|participants|Number|75|75.0||||||
4458626|NCT00065156|4279510|B1|0||Eastern Cooperative Oncology Group (ECOG) Performance Status|"ECOG indicates a person's ability to perform life's functions on a scale of 0-5:~0= fully active and no restrictions~restricted but ambulatory and capable of light work~ambulatory and capable of self-care but unable to work~3-4= increasingly restricted~5= dead"|participants|Number|59|59.0||||||
4458627|NCT00065156|4279510|B1|Unknown||Cytogenetic Complexity||participants|Number|1|1.0||||||
4458628|NCT00065156|4279510|B1|Complex||Cytogenetic Complexity||participants|Number|12|12.0||||||
4458629|NCT00065156|4279510|B1|Intermediate (5q + 1 abnormality)||Cytogenetic Complexity||participants|Number|25|25.0||||||
4458630|NCT00065156|4279510|B1|Isolated 5q||Cytogenetic Complexity||participants|Number|110|110.0||||||
4458631|NCT00065156|4279510|B1|Unable to classify||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|20|20.0||||||
4458632|NCT00065156|4279510|B1|Acute leukemia||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|1|1.0||||||
4458633|NCT00065156|4279510|B1|Chronic myelomonocytic leukemia (CMML)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|3|3.0||||||
4458634|NCT00065156|4279510|B1|Refractory anemia with excess blasts (RAEB)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|30|30.0||||||
4458635|NCT00065156|4279510|B1|Refractory anemia with ringed sideroblasts (RARS)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|16|16.0||||||
4458636|NCT00065156|4279510|B1|Refractory anemia (RA)||French-American-British (FAB) Classification|FAB is a classification system for five (5) subtypes of myelodysplastic syndrome that are distinguished by the percentage of myeloblasts, presence or absence of ringed sideroblasts or a monocytosis. Classification was made by the Central Reviewer.|participants|Number|78|78.0||||||
4458675|NCT00065065|4279525|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458637|NCT00065156|4279510|B1|Missing (unable to assign)||International Prognostic Scoring System (IPSS) Score|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|21|21.0||||||
4458638|NCT00065156|4279510|B1|High (>=2.5)||International Prognostic Scoring System (IPSS) Score|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|2|2.0||||||
4458639|NCT00065156|4279510|B1|Intermediate-2 (1.5 to 2.0)||International Prognostic Scoring System (IPSS) Score|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|7|7.0||||||
4458640|NCT00065156|4279510|B1|Intermediate-1 (0.5 to 1.0)||International Prognostic Scoring System (IPSS) Score|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|69|69.0||||||
4458641|NCT00065156|4279510|B1|Low (0)||International Prognostic Scoring System (IPSS) Score|The international prognostic scoring system (IPSS) is a standard for risk assessment in primary myelodysplastic syndromes (MDS) that categorizes prognoses taking into account cytogenetics, cytopenias, blasts and blood counts. The IPSS prognostic subgroups consist of low-, intermediate-1-, intermediate-2-, and high-risk groups. The scale is 0-3.5 at 0.5 increments. Scores of 0=Low; 0.5-1.0=Int-1; 1.5-2.0=Int-2; 2.5-3.5=High risk which corresponds to poorer prognosis. The assessment was performed by the Central Reviewer.|participants|Number|49|49.0||||||
4458642|NCT00065156|4279510|B1|||Participants with 5q(-) (31-33) Chromosomal Abnormality||participants|Number|148|148.0||||||
4458643|NCT00065156|4279510|B1|||Duration of Myelodysplastic Syndrome (MDS)|Time from diagnosis of MDS until study start.|years|Mean|3.4|3.4|Standard Deviation|3.29|3.29|||
4458644|NCT00065156|4279510|B1|Germany||Region of Enrollment||participants|Number|36|36.0||||||
4458645|NCT00065156|4279510|B1|United States||Region of Enrollment||participants|Number|112|112.0||||||
4458646|NCT00065156|4279510|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4458647|NCT00065156|4279510|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4458648|NCT00065156|4279510|B1|White||Race/Ethnicity, Customized||participants|Number|143|143.0||||||
4458649|NCT00065156|4279510|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4458650|NCT00065156|4279510|B1||Female|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4458651|NCT00065156|4279510|B1|>65 years||Age, Customized||participants|Number|100|100.0||||||
4458652|NCT00065156|4279510|B1|<= 65 years||Age, Customized||participants|Number|48|48.0||||||
4458653|NCT00065156|4279510|B1|||Age||years|Mean|70.0|70.0|Standard Deviation|10.50|10.5|||
4458654|NCT00065065|4279525|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
4458655|NCT00065065|4279526|B2|United States||Region of Enrollment||participants|Number|53|53.0||||||
4458656|NCT00065065|4279527|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4458657|NCT00065065|4279525|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458658|NCT00065065|4279526|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458659|NCT00065065|4279527|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458660|NCT00065065|4279525|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458661|NCT00065065|4279526|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458662|NCT00065065|4279527|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458663|NCT00065065|4279525|B3||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4458664|NCT00065065|4279526|B2||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4458665|NCT00065065|4279527|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4458666|NCT00065065|4279525|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4458667|NCT00065065|4279526|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4458668|NCT00065065|4279527|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4458669|NCT00065065|4279525|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458670|NCT00065065|4279526|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458671|NCT00065065|4279527|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458672|NCT00065065|4279525|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4458673|NCT00065065|4279526|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458674|NCT00065065|4279527|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4458676|NCT00065065|4279526|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458677|NCT00065065|4279527|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458678|NCT00065065|4279525|B3||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4458679|NCT00065065|4279526|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4458680|NCT00065065|4279527|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4458681|NCT00065065|4279525|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4458682|NCT00065065|4279526|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4458683|NCT00065065|4279527|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4458684|NCT00065065|4279525|B3|||Age||years|Median|43|43.0|Inter-Quartile Range|||31.0|51.0|
4458685|NCT00065065|4279526|B2|||Age||years|Median|46|46.0|Inter-Quartile Range|||34.0|55.0|
4458686|NCT00065065|4279527|B1|||Age||years|Median|42|42.0|Inter-Quartile Range|||31.0|49.0|
4458687|NCT00003895|4279538|B3||Male|Gender||Participants|Count of Participants|20|20.0||||||
4458688|NCT00003895|4279539|B2||Male|Gender||Participants|Count of Participants|9|9.0||||||
4458689|NCT00003895|4279540|B1||Male|Gender||Participants|Count of Participants|11|11.0||||||
4458690|NCT00003895|4279538|B3||Female|Gender||Participants|Count of Participants|16|16.0||||||
4458691|NCT00003895|4279539|B2||Female|Gender||Participants|Count of Participants|9|9.0||||||
4458692|NCT00003895|4279540|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
4458693|NCT00003895|4279538|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4458694|NCT00003895|4279539|B2||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4458695|NCT00003895|4279540|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4458696|NCT00003895|4279538|B3||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4458697|NCT00003895|4279539|B2||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4458698|NCT00003895|4279540|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4458699|NCT00003895|4279538|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4458700|NCT00003895|4279539|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4458701|NCT00003895|4279540|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4458702|NCT00064987|4279547|B3|United States||Region of Enrollment||Participants|Count of Participants|16|16.0||||||
4458703|NCT00064987|4279548|B2|United States||Region of Enrollment||Participants|Count of Participants|6|6.0||||||
4458704|NCT00064987|4279549|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4458705|NCT00064987|4279547|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458706|NCT00064987|4279548|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458707|NCT00064987|4279549|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458708|NCT00064987|4279547|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458709|NCT00064987|4279548|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458710|NCT00064987|4279549|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458711|NCT00064987|4279547|B3||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4458712|NCT00064987|4279548|B2||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4458713|NCT00064987|4279549|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4458714|NCT00064987|4279547|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4458715|NCT00064987|4279548|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458716|NCT00064987|4279549|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4458717|NCT00064987|4279547|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458718|NCT00064987|4279548|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458719|NCT00064987|4279549|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458720|NCT00064987|4279547|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458721|NCT00064987|4279548|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458722|NCT00064987|4279549|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458723|NCT00064987|4279547|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458724|NCT00064987|4279548|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458725|NCT00064987|4279549|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458726|NCT00064987|4279547|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458727|NCT00064987|4279548|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458728|NCT00064987|4279549|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458729|NCT00064987|4279547|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4458730|NCT00064987|4279548|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4458731|NCT00064987|4279549|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4458732|NCT00064987|4279547|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458733|NCT00064987|4279548|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458734|NCT00064987|4279549|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458735|NCT00064987|4279547|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4458736|NCT00064987|4279548|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4458737|NCT00064987|4279549|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4458738|NCT00064987|4279547|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458739|NCT00064987|4279548|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458740|NCT00064987|4279549|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458741|NCT00064987|4279547|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458742|NCT00064987|4279548|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458743|NCT00064987|4279549|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458744|NCT00064987|4279547|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4458745|NCT00064987|4279548|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4458746|NCT00064987|4279549|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4458747|NCT00064987|4279547|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4458748|NCT00064987|4279548|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4458749|NCT00064987|4279549|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4458750|NCT00064844|4279568|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
4458751|NCT00064844|4279569|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4458752|NCT00064844|4279570|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4458753|NCT00064844|4279568|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4458754|NCT00064844|4279569|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4458755|NCT00064844|4279570|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4458756|NCT00064844|4279568|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4458757|NCT00064844|4279569|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4458758|NCT00064844|4279570|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4458759|NCT00064844|4279568|B3|||Age||years|Mean|44.9|44.9|Standard Deviation|10.1|10.1|||
4458760|NCT00064844|4279569|B2|||Age||years|Mean|44.8|44.8|Standard Deviation|10.1|10.1|||
4458761|NCT00064844|4279570|B1|||Age||years|Mean|45.1|45.1|Standard Deviation|10.2|10.2|||
4458762|NCT00064753|4279579|B3|||Triglycerides levels||mmol/L|Mean|2.2|2.2|Standard Deviation|2.1|2.1|||
4458763|NCT00064753|4279580|B2|||Triglycerides levels||mmol/L|Mean|2.2|2.2|Standard Deviation|1.6|1.6|||
4458764|NCT00064753|4279581|B1|||Triglycerides levels||mmol/L|Mean|2.3|2.3|Standard Deviation|2.5|2.5|||
4458765|NCT00064753|4279579|B3|||Calculated or direct low-density lipoprotein cholesterol||mmol/L|Mean|2.6|2.6|Standard Deviation|0.9|0.9|||
4458766|NCT00064753|4279580|B2|||Calculated or direct low-density lipoprotein cholesterol||mmol/L|Mean|2.6|2.6|Standard Deviation|0.9|0.9|||
4458767|NCT00064753|4279581|B1|||Calculated or direct low-density lipoprotein cholesterol||mmol/L|Mean|2.6|2.6|Standard Deviation|0.9|0.9|||
4458768|NCT00064753|4279579|B3|||High-density lipoprotein cholesterol||mmol/L|Mean|1.2|1.2|Standard Deviation|0.4|0.4|||
4458769|NCT00064753|4279580|B2|||High-density lipoprotein cholesterol||mmol/L|Mean|1.2|1.2|Standard Deviation|0.4|0.4|||
4458770|NCT00064753|4279581|B1|||High-density lipoprotein cholesterol||mmol/L|Mean|1.2|1.2|Standard Deviation|0.4|0.4|||
4458771|NCT00064753|4279579|B3|||Total cholesterol||mmol/L|Mean|4.8|4.8|Standard Deviation|1.1|1.1|||
4458772|NCT00064753|4279580|B2|||Total cholesterol||mmol/L|Mean|4.8|4.8|Standard Deviation|1.1|1.1|||
4458773|NCT00064753|4279581|B1|||Total cholesterol||mmol/L|Mean|4.8|4.8|Standard Deviation|1.2|1.2|||
4458774|NCT00064753|4279579|B3|Not current smoker||Current smoker||participants|Number|3659|3659.0||||||
4458775|NCT00064753|4279580|B2|Not current smoker||Current smoker||participants|Number|1833|1833.0||||||
4458776|NCT00064753|4279581|B1|Not current smoker||Current smoker||participants|Number|1826|1826.0||||||
4458777|NCT00064753|4279579|B3|Current smoker||Current smoker||participants|Number|451|451.0||||||
4458778|NCT00064753|4279580|B2|Current smoker||Current smoker||participants|Number|221|221.0||||||
4458779|NCT00064753|4279581|B1|Current smoker||Current smoker||participants|Number|230|230.0||||||
4458780|NCT00064753|4279579|B3|||Body mass index||kg/m^2|Mean|29|29.0|Standard Deviation|6.2|6.2|||
4458781|NCT00064753|4279580|B2|||Body mass index||kg/m^2|Mean|29|29.0|Standard Deviation|6.3|6.3|||
4458782|NCT00064753|4279581|B1|||Body mass index||kg/m^2|Mean|29|29.0|Standard Deviation|6.2|6.2|||
4458783|NCT00064753|4279579|B3|Non-prevalent hypertension||Prevalent hypertension||participants|Number|332|332.0||||||
4458784|NCT00064753|4279580|B2|Non-prevalent hypertension||Prevalent hypertension||participants|Number|155|155.0||||||
4458785|NCT00064753|4279581|B1|Non-prevalent hypertension||Prevalent hypertension||participants|Number|177|177.0||||||
4458786|NCT00064753|4279579|B3|Prevalent hypertension||Prevalent hypertension||participants|Number|3778|3778.0||||||
4458787|NCT00064753|4279580|B2|Prevalent hypertension||Prevalent hypertension||participants|Number|1899|1899.0||||||
4458788|NCT00064753|4279581|B1|Prevalent hypertension||Prevalent hypertension||participants|Number|1879|1879.0||||||
4458789|NCT00064753|4279579|B3|No history of diabetes mellitus||History of diabetes mellitus||participants|Number|2447|2447.0||||||
4458790|NCT00064753|4279580|B2|No history of diabetes mellitus||History of diabetes mellitus||participants|Number|1204|1204.0||||||
4458791|NCT00064753|4279581|B1|No history of diabetes mellitus||History of diabetes mellitus||participants|Number|1243|1243.0||||||
4458792|NCT00064753|4279579|B3|History of diabetes mellitus||History of diabetes mellitus||participants|Number|1663|1663.0||||||
4458793|NCT00064753|4279580|B2|History of diabetes mellitus||History of diabetes mellitus||participants|Number|850|850.0||||||
4458794|NCT00064753|4279581|B1|History of diabetes mellitus||History of diabetes mellitus||participants|Number|813|813.0||||||
4458795|NCT00064753|4279579|B3|No History of CVD||History of CVD||participants|Number|3290|3290.0||||||
4458796|NCT00064753|4279580|B2|No History of CVD||History of CVD||participants|Number|1640|1640.0||||||
4458797|NCT00064753|4279581|B1|No History of CVD||History of CVD||participants|Number|1650|1650.0||||||
4458798|NCT00064753|4279579|B3|History of CVD||History of CVD||participants|Number|820|820.0||||||
4458799|NCT00064753|4279580|B2|History of CVD||History of CVD||participants|Number|414|414.0||||||
4458800|NCT00064753|4279581|B1|History of CVD||History of CVD||participants|Number|406|406.0||||||
4458801|NCT00064753|4279579|B3|||Graft vintage||years|Mean|5|5.0|Standard Deviation|5.0|5.0|||
4458802|NCT00064753|4279580|B2|||Graft vintage||years|Mean|5|5.0|Standard Deviation|5.0|5.0|||
4458803|NCT00064753|4279581|B1|||Graft vintage||years|Mean|6|6.0|Standard Deviation|5.1|5.1|||
4458804|NCT00064753|4279579|B3|Brazil||Region of Enrollment||participants|Number|612|612.0||||||
4458805|NCT00064753|4279580|B2|Brazil||Region of Enrollment||participants|Number|305|305.0||||||
4458806|NCT00064753|4279581|B1|Brazil||Region of Enrollment||participants|Number|307|307.0||||||
4458807|NCT00064753|4279579|B3|United States||Region of Enrollment||participants|Number|3000|3000.0||||||
4458808|NCT00064753|4279580|B2|United States||Region of Enrollment||participants|Number|1500|1500.0||||||
4458809|NCT00064753|4279581|B1|United States||Region of Enrollment||participants|Number|1500|1500.0||||||
4458810|NCT00064753|4279579|B3|Canada||Region of Enrollment||participants|Number|498|498.0||||||
4458811|NCT00064753|4279580|B2|Canada||Region of Enrollment||participants|Number|249|249.0||||||
4458812|NCT00064753|4279581|B1|Canada||Region of Enrollment||participants|Number|249|249.0||||||
4458813|NCT00064753|4279579|B3||Male|Sex: Female, Male||Participants|Count of Participants|2582|2582.0||||||
4458814|NCT00064753|4279580|B2||Male|Sex: Female, Male||Participants|Count of Participants|1293|1293.0||||||
4458815|NCT00064753|4279581|B1||Male|Sex: Female, Male||Participants|Count of Participants|1289|1289.0||||||
4458816|NCT00064753|4279579|B3||Female|Sex: Female, Male||Participants|Count of Participants|1528|1528.0||||||
4458817|NCT00064753|4279580|B2||Female|Sex: Female, Male||Participants|Count of Participants|761|761.0||||||
4458818|NCT00064753|4279581|B1||Female|Sex: Female, Male||Participants|Count of Participants|767|767.0||||||
4458819|NCT00064753|4279579|B3|||Age||years|Mean|52|52.0|Standard Deviation|9.4|9.4|||
4458820|NCT00064753|4279580|B2|||Age||years|Mean|52|52.0|Standard Deviation|9.5|9.5|||
4458821|NCT00064753|4279581|B1|||Age||years|Mean|52|52.0|Standard Deviation|9.4|9.4|||
4458822|NCT00064792|4279610|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4458823|NCT00064792|4279611|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4458824|NCT00064792|4279612|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4458825|NCT00064792|4279610|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4458826|NCT00064792|4279611|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4458827|NCT00064792|4279612|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4458828|NCT00064792|4279610|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4458829|NCT00064792|4279611|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4458830|NCT00064792|4279612|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4458831|NCT00064792|4279610|B3|||Age||years|Mean|8.175694444|8.175694444|Standard Deviation|3.58400024|3.58400024|||
4458832|NCT00064792|4279611|B2|||Age||years|Mean|7.775|7.775|Standard Deviation|2.286247802|2.286247802|||
4458833|NCT00064792|4279612|B1|||Age||years|Mean|8.576388889|8.576388889|Standard Deviation|4.464005643|4.464005643|||
4458834|NCT00064792|4279610|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458835|NCT00064792|4279611|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458836|NCT00064792|4279612|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4458837|NCT00064792|4279610|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4458838|NCT00064792|4279611|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4458839|NCT00064792|4279612|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4458840|NCT00064792|4279610|B3||<=18 years|Age||Participants|Count of Participants|23|23.0||||||
4458841|NCT00064792|4279611|B2||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4458842|NCT00064792|4279612|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4458843|NCT00064701|4279621|B4|Yes||Previous Transplant||participants|Number|24|24.0||||||
4458844|NCT00064701|4279622|B3|Yes||Previous Transplant||participants|Number|9|9.0||||||
4458845|NCT00064701|4279623|B2|Yes||Previous Transplant||participants|Number|8|8.0||||||
4458846|NCT00064701|4279624|B1|Yes||Previous Transplant||participants|Number|7|7.0||||||
4458847|NCT00064701|4279621|B4|No||Previous Transplant||participants|Number|614|614.0||||||
4458848|NCT00064701|4279622|B3|No||Previous Transplant||participants|Number|203|203.0||||||
4458849|NCT00064701|4279623|B2|No||Previous Transplant||participants|Number|206|206.0||||||
4458850|NCT00064701|4279624|B1|No||Previous Transplant||participants|Number|205|205.0||||||
4458851|NCT00064701|4279621|B4|Other||Primary Diagnosis||participants|Number|16|16.0||||||
4458852|NCT00064701|4279622|B3|Other||Primary Diagnosis||participants|Number|6|6.0||||||
4458853|NCT00064701|4279623|B2|Other||Primary Diagnosis||participants|Number|5|5.0||||||
4458854|NCT00064701|4279624|B1|Other||Primary Diagnosis||participants|Number|5|5.0||||||
4458855|NCT00064701|4279621|B4|Unknown||Primary Diagnosis||participants|Number|58|58.0||||||
4458856|NCT00064701|4279622|B3|Unknown||Primary Diagnosis||participants|Number|17|17.0||||||
4458857|NCT00064701|4279623|B2|Unknown||Primary Diagnosis||participants|Number|24|24.0||||||
4458858|NCT00064701|4279624|B1|Unknown||Primary Diagnosis||participants|Number|17|17.0||||||
4458859|NCT00064701|4279621|B4|Reflux||Primary Diagnosis||participants|Number|2|2.0||||||
4458860|NCT00064701|4279622|B3|Reflux||Primary Diagnosis||participants|Number|1|1.0||||||
4458861|NCT00064701|4279623|B2|Reflux||Primary Diagnosis||participants|Number|0|0.0||||||
4458862|NCT00064701|4279624|B1|Reflux||Primary Diagnosis||participants|Number|1|1.0||||||
4458863|NCT00064701|4279621|B4|Congenital/ Hereditary Nephropathy||Primary Diagnosis||participants|Number|27|27.0||||||
4458864|NCT00064701|4279622|B3|Congenital/ Hereditary Nephropathy||Primary Diagnosis||participants|Number|13|13.0||||||
4458865|NCT00064701|4279623|B2|Congenital/ Hereditary Nephropathy||Primary Diagnosis||participants|Number|7|7.0||||||
4458866|NCT00064701|4279624|B1|Congenital/ Hereditary Nephropathy||Primary Diagnosis||participants|Number|7|7.0||||||
4458867|NCT00064701|4279621|B4|Systemic Vasculitis||Primary Diagnosis||participants|Number|26|26.0||||||
4458868|NCT00064701|4279622|B3|Systemic Vasculitis||Primary Diagnosis||participants|Number|7|7.0||||||
4458869|NCT00064701|4279623|B2|Systemic Vasculitis||Primary Diagnosis||participants|Number|10|10.0||||||
4458870|NCT00064701|4279624|B1|Systemic Vasculitis||Primary Diagnosis||participants|Number|9|9.0||||||
4458871|NCT00064701|4279621|B4|Tubular/ Interstitial Disease||Primary Diagnosis||participants|Number|30|30.0||||||
4458872|NCT00064701|4279622|B3|Tubular/ Interstitial Disease||Primary Diagnosis||participants|Number|16|16.0||||||
4458873|NCT00064701|4279623|B2|Tubular/ Interstitial Disease||Primary Diagnosis||participants|Number|5|5.0||||||
4458874|NCT00064701|4279624|B1|Tubular/ Interstitial Disease||Primary Diagnosis||participants|Number|9|9.0||||||
4458875|NCT00064701|4279621|B4|Polycycstic Kidney Disease||Primary Diagnosis||participants|Number|66|66.0||||||
4458876|NCT00064701|4279622|B3|Polycycstic Kidney Disease||Primary Diagnosis||participants|Number|20|20.0||||||
4458877|NCT00064701|4279623|B2|Polycycstic Kidney Disease||Primary Diagnosis||participants|Number|26|26.0||||||
4458878|NCT00064701|4279624|B1|Polycycstic Kidney Disease||Primary Diagnosis||participants|Number|20|20.0||||||
4458879|NCT00064701|4279621|B4|Glomerulonephritis||Primary Diagnosis||participants|Number|130|130.0||||||
4458880|NCT00064701|4279622|B3|Glomerulonephritis||Primary Diagnosis||participants|Number|43|43.0||||||
4458881|NCT00064701|4279623|B2|Glomerulonephritis||Primary Diagnosis||participants|Number|43|43.0||||||
4458882|NCT00064701|4279624|B1|Glomerulonephritis||Primary Diagnosis||participants|Number|44|44.0||||||
4458883|NCT00064701|4279621|B4|Diabetic Nephropathy||Primary Diagnosis||participants|Number|130|130.0||||||
4458884|NCT00064701|4279622|B3|Diabetic Nephropathy||Primary Diagnosis||participants|Number|46|46.0||||||
4458885|NCT00064701|4279623|B2|Diabetic Nephropathy||Primary Diagnosis||participants|Number|38|38.0||||||
4458886|NCT00064701|4279624|B1|Diabetic Nephropathy||Primary Diagnosis||participants|Number|46|46.0||||||
4458887|NCT00064701|4279621|B4|Nephrosclerosis/ Hypertensive Nephropathy||Primary Diagnosis||participants|Number|153|153.0||||||
4458888|NCT00064701|4279622|B3|Nephrosclerosis/ Hypertensive Nephropathy||Primary Diagnosis||participants|Number|43|43.0||||||
4458889|NCT00064701|4279623|B2|Nephrosclerosis/ Hypertensive Nephropathy||Primary Diagnosis||participants|Number|56|56.0||||||
4458890|NCT00064701|4279624|B1|Nephrosclerosis/ Hypertensive Nephropathy||Primary Diagnosis||participants|Number|54|54.0||||||
4458891|NCT00064701|4279621|B4|Other||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4458892|NCT00064701|4279622|B3|Other||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4458893|NCT00064701|4279623|B2|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4458894|NCT00064701|4279624|B1|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4458895|NCT00064701|4279621|B4|Asian||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4458896|NCT00064701|4279622|B3|Asian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4458897|NCT00064701|4279623|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4458898|NCT00064701|4279624|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4458899|NCT00064701|4279621|B4|Black||Race/Ethnicity, Customized||participants|Number|128|128.0||||||
4458900|NCT00064701|4279622|B3|Black||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4458901|NCT00064701|4279623|B2|Black||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4458902|NCT00064701|4279624|B1|Black||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4458903|NCT00064701|4279621|B4|White||Race/Ethnicity, Customized||participants|Number|475|475.0||||||
4458904|NCT00064701|4279622|B3|White||Race/Ethnicity, Customized||participants|Number|163|163.0||||||
4458905|NCT00064701|4279623|B2|White||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
4458906|NCT00064701|4279624|B1|White||Race/Ethnicity, Customized||participants|Number|152|152.0||||||
4458907|NCT00064701|4279621|B4||Male|Sex: Female, Male||Participants|Count of Participants|404|404.0||||||
4458908|NCT00064701|4279622|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4458909|NCT00064701|4279623|B2||Male|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4458910|NCT00064701|4279624|B1||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4458911|NCT00064701|4279621|B4||Female|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4458912|NCT00064701|4279622|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4458913|NCT00064701|4279623|B2||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4458914|NCT00064701|4279624|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4458915|NCT00064701|4279621|B4|||Age|Demographic data provided for the full analysis set, defined as all randomized patients who received at least one dose of study drug.|years|Mean|48.03|48.03|Standard Deviation|12.921|12.921|||
4458974|NCT00064298|4279714|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458916|NCT00064701|4279622|B3|||Age|Demographic data provided for the full analysis set, defined as all randomized patients who received at least one dose of study drug.|years|Mean|47.63|47.63|Standard Deviation|12.953|12.953|||
4458917|NCT00064701|4279623|B2|||Age|Demographic data provided for the full analysis set, defined as all randomized patients who received at least one dose of study drug.|years|Mean|47.84|47.84|Standard Deviation|12.995|12.995|||
4458918|NCT00064701|4279624|B1|||Age|Demographic data provided for the full analysis set, defined as all randomized patients who received at least one dose of study drug.|years|Mean|48.62|48.62|Standard Deviation|12.855|12.855|||
4458919|NCT00064662|4279676|B3|United States||Region of Enrollment||participants|Number|655|655.0||||||
4458920|NCT00064662|4279677|B2|United States||Region of Enrollment||participants|Number|326|326.0||||||
4458921|NCT00064662|4279678|B1|United States||Region of Enrollment||participants|Number|329|329.0||||||
4458922|NCT00064662|4279676|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458923|NCT00064662|4279677|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458924|NCT00064662|4279678|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4458925|NCT00064662|4279676|B3||Female|Sex: Female, Male||Participants|Count of Participants|655|655.0||||||
4458926|NCT00064662|4279677|B2||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4458927|NCT00064662|4279678|B1||Female|Sex: Female, Male||Participants|Count of Participants|329|329.0||||||
4458928|NCT00064662|4279676|B3|||Age||years|Mean|51.9|51.9|Standard Deviation|10.3|10.3|||
4458929|NCT00064662|4279677|B2|||Age||years|Mean|51.6|51.6|Standard Deviation|10.1|10.1|||
4458930|NCT00064662|4279678|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|10.5|10.5|||
4458931|NCT00064662|4279676|B3||>=65 years|Age||Participants|Count of Participants|81|81.0||||||
4458932|NCT00064662|4279677|B2||>=65 years|Age||Participants|Count of Participants|41|41.0||||||
4458933|NCT00064662|4279678|B1||>=65 years|Age||Participants|Count of Participants|40|40.0||||||
4458934|NCT00064662|4279676|B3||Between 18 and 65 years|Age||Participants|Count of Participants|574|574.0||||||
4458935|NCT00064662|4279677|B2||Between 18 and 65 years|Age||Participants|Count of Participants|285|285.0||||||
4458936|NCT00064662|4279678|B1||Between 18 and 65 years|Age||Participants|Count of Participants|289|289.0||||||
4458937|NCT00064662|4279676|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4458938|NCT00064662|4279677|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4458939|NCT00064662|4279678|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4458940|NCT00064350|4279687|B4|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4458941|NCT00064350|4279688|B3|Unknown||Sex/Gender, Customized||participants|Number|1|1.0||||||
4458942|NCT00064350|4279689|B2|Unknown||Sex/Gender, Customized||participants|Number|0|0.0||||||
4458943|NCT00064350|4279690|B1|Unknown||Sex/Gender, Customized||participants|Number|0|0.0||||||
4458944|NCT00064350|4279687|B4|Male||Sex/Gender, Customized||participants|Number|168|168.0||||||
4458945|NCT00064350|4279688|B3|Male||Sex/Gender, Customized||participants|Number|127|127.0||||||
4458946|NCT00064350|4279689|B2|Male||Sex/Gender, Customized||participants|Number|18|18.0||||||
4458947|NCT00064350|4279690|B1|Male||Sex/Gender, Customized||participants|Number|23|23.0||||||
4458948|NCT00064350|4279687|B4|Female||Sex/Gender, Customized||participants|Number|130|130.0||||||
4458949|NCT00064350|4279688|B3|Female||Sex/Gender, Customized||participants|Number|90|90.0||||||
4458950|NCT00064350|4279689|B2|Female||Sex/Gender, Customized||participants|Number|13|13.0||||||
4458951|NCT00064350|4279690|B1|Female||Sex/Gender, Customized||participants|Number|27|27.0||||||
4458952|NCT00064350|4279687|B4|||Age||years|Median|64|64.0|Full Range|||33.0|86.0|
4458953|NCT00064350|4279688|B3|||Age||years|Median|63|63.0|Full Range|||33.0|85.0|
4458954|NCT00064350|4279689|B2|||Age||years|Median|69|69.0|Full Range|||40.0|86.0|
4458955|NCT00064350|4279690|B1|||Age||years|Median|64.5|64.5|Full Range|||42.0|80.0|
4458956|NCT00064337|4279707|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4458957|NCT00064337|4279707|B1||Female|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4458958|NCT00064337|4279707|B1|||Age||years|Median|65|65.0|Full Range|||33.0|80.0|
4458959|NCT00064298|4279714|B3|United States||Region of Enrollment||Participants|Count of Participants|134|134.0||||||
4458960|NCT00064298|4279715|B2|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
4458961|NCT00064298|4279716|B1|United States||Region of Enrollment||Participants|Count of Participants|72|72.0||||||
4458962|NCT00064298|4279714|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4458963|NCT00064298|4279715|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458964|NCT00064298|4279716|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4458965|NCT00064298|4279714|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458966|NCT00064298|4279715|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458967|NCT00064298|4279716|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458968|NCT00064298|4279714|B3||White|Race (NIH/OMB)||Participants|Count of Participants|119|119.0||||||
4458969|NCT00064298|4279715|B2||White|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4458970|NCT00064298|4279716|B1||White|Race (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4458971|NCT00064298|4279714|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4458972|NCT00064298|4279715|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4458973|NCT00064298|4279716|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4459091|NCT00064025|4279783|B1|60-69 years||Age, Customized||participants|Number|30|30.0||||||
4458975|NCT00064298|4279715|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458976|NCT00064298|4279716|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458977|NCT00064298|4279714|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458978|NCT00064298|4279715|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458979|NCT00064298|4279716|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458980|NCT00064298|4279714|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458981|NCT00064298|4279715|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458982|NCT00064298|4279716|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458983|NCT00064298|4279714|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458984|NCT00064298|4279715|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4458985|NCT00064298|4279716|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4458986|NCT00064298|4279714|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4458987|NCT00064298|4279715|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4458988|NCT00064298|4279716|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4458989|NCT00064298|4279714|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4458990|NCT00064298|4279715|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4458991|NCT00064298|4279716|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4458992|NCT00064298|4279714|B3||Male|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4458993|NCT00064298|4279715|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4458994|NCT00064298|4279716|B1||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4458995|NCT00064298|4279714|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4458996|NCT00064298|4279715|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4458997|NCT00064298|4279716|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4458998|NCT00064298|4279714|B3|||Age||years|Median|58|58.0|Full Range|||30.0|82.0|
4458999|NCT00064298|4279715|B2|||Age||years|Median|59|59.0|Full Range|||41.0|82.0|
4459000|NCT00064298|4279716|B1|||Age||years|Median|58|58.0|Full Range|||30.0|82.0|
4459001|NCT00064298|4279714|B3||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4459002|NCT00064298|4279715|B2||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4459003|NCT00064298|4279716|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4459004|NCT00064298|4279714|B3||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4459005|NCT00064298|4279715|B2||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4459006|NCT00064298|4279716|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4459007|NCT00064298|4279714|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459008|NCT00064298|4279715|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459009|NCT00064298|4279716|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459010|NCT00064259|4279725|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4459011|NCT00064259|4279725|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4459012|NCT00064259|4279725|B1|||Age||years|Median|55.0|55.0|Full Range|||36.0|65.0|
4459013|NCT00064077|4279732|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4459014|NCT00064077|4279733|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4459015|NCT00064077|4279734|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4459016|NCT00064077|4279735|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459017|NCT00064077|4279736|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4459018|NCT00064077|4279732|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459019|NCT00064077|4279733|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459020|NCT00064077|4279734|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459021|NCT00064077|4279735|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459022|NCT00064077|4279736|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459023|NCT00064077|4279732|B5||White|Race (NIH/OMB)||Participants|Count of Participants|316|316.0||||||
4459024|NCT00064077|4279733|B4||White|Race (NIH/OMB)||Participants|Count of Participants|82|82.0||||||
4459025|NCT00064077|4279734|B3||White|Race (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4459026|NCT00064077|4279735|B2||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4459027|NCT00064077|4279736|B1||White|Race (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4459028|NCT00064077|4279732|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4459029|NCT00064077|4279733|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4459030|NCT00064077|4279734|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4459031|NCT00064077|4279735|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4459032|NCT00064077|4279736|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4459033|NCT00064077|4279732|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459034|NCT00064077|4279733|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459035|NCT00064077|4279734|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459036|NCT00064077|4279735|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459037|NCT00064077|4279736|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459038|NCT00064077|4279732|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4459039|NCT00064077|4279733|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4459040|NCT00064077|4279734|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4459041|NCT00064077|4279735|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4459042|NCT00064077|4279736|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4459043|NCT00064077|4279732|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4459044|NCT00064077|4279733|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459045|NCT00064077|4279734|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459046|NCT00064077|4279735|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459047|NCT00064077|4279736|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459048|NCT00064077|4279732|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4459049|NCT00064077|4279733|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4459050|NCT00064077|4279734|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4459051|NCT00064077|4279735|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4459052|NCT00064077|4279736|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4459053|NCT00064077|4279732|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|329|329.0||||||
4459054|NCT00064077|4279733|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|78|78.0||||||
4459055|NCT00064077|4279734|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|86|86.0||||||
4459056|NCT00064077|4279735|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|90|90.0||||||
4459057|NCT00064077|4279736|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4459058|NCT00064077|4279732|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4459059|NCT00064077|4279733|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4459060|NCT00064077|4279734|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4459061|NCT00064077|4279735|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4459062|NCT00064077|4279736|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4459063|NCT00064077|4279732|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459064|NCT00064077|4279733|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459065|NCT00064077|4279734|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459066|NCT00064077|4279735|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459067|NCT00064077|4279736|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459068|NCT00064077|4279732|B5||Female|Sex: Female, Male||Participants|Count of Participants|434|434.0||||||
4459069|NCT00064077|4279733|B4||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4459070|NCT00064077|4279734|B3||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4459071|NCT00064077|4279735|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4459072|NCT00064077|4279736|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4459073|NCT00064077|4279732|B5|||Age||years|Median|48|48.0|Full Range|||20.0|89.0|
4459074|NCT00064077|4279733|B4|||Age||years|Median|48|48.0|Full Range|||25.0|75.0|
4459075|NCT00064077|4279734|B3|||Age||years|Median|45|45.0|Full Range|||20.0|89.0|
4459076|NCT00064077|4279735|B2|||Age||years|Median|49|49.0|Full Range|||24.0|76.0|
4459077|NCT00064077|4279736|B1|||Age||years|Median|50|50.0|Full Range|||29.0|81.0|
4459078|NCT00064038|4279769|B3||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4459079|NCT00064038|4279770|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4459080|NCT00064038|4279771|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4459081|NCT00064038|4279769|B3||Female|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4459082|NCT00064038|4279770|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4459083|NCT00064038|4279771|B1||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4459084|NCT00064038|4279769|B3|Overall||Age||years|Median|64.6|64.6|Full Range|||36.9|89.0|
4459085|NCT00064038|4279770|B2|Overall||Age||years|Median|63.1|63.1|Full Range|||37.6|87.0|
4459086|NCT00064038|4279771|B1|Overall||Age||years|Median|64.9|64.9|Full Range|||36.9|89.0|
4459087|NCT00064025|4279783|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459088|NCT00064025|4279783|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4459089|NCT00064025|4279783|B1|80-89 years||Age, Customized||participants|Number|3|3.0||||||
4459090|NCT00064025|4279783|B1|70-79 years||Age, Customized||participants|Number|3|3.0||||||
4459092|NCT00064025|4279783|B1|50-59 years||Age, Customized||participants|Number|28|28.0||||||
4459093|NCT00064025|4279783|B1|40-49 years||Age, Customized||participants|Number|3|3.0||||||
4459094|NCT00064025|4279783|B1|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4459095|NCT00063999|4279790|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459096|NCT00063999|4279791|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459097|NCT00063999|4279792|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459098|NCT00063999|4279790|B3||Female|Sex: Female, Male||Participants|Count of Participants|1312|1312.0||||||
4459099|NCT00063999|4279791|B2||Female|Sex: Female, Male||Participants|Count of Participants|665|665.0||||||
4459100|NCT00063999|4279792|B1||Female|Sex: Female, Male||Participants|Count of Participants|647|647.0||||||
4459101|NCT00063999|4279790|B3||>=70 years|Age, Customized||Participants|Count of Participants|227|227.0||||||
4459102|NCT00063999|4279791|B2||>=70 years|Age, Customized||Participants|Count of Participants|114|114.0||||||
4459103|NCT00063999|4279792|B1||>=70 years|Age, Customized||Participants|Count of Participants|113|113.0||||||
4459104|NCT00063999|4279790|B3||60-60 years|Age, Customized||Participants|Count of Participants|500|500.0||||||
4459105|NCT00063999|4279791|B2||60-60 years|Age, Customized||Participants|Count of Participants|244|244.0||||||
4459106|NCT00063999|4279792|B1||60-60 years|Age, Customized||Participants|Count of Participants|256|256.0||||||
4459107|NCT00063999|4279790|B3||50-59 years|Age, Customized||Participants|Count of Participants|411|411.0||||||
4459108|NCT00063999|4279791|B2||50-59 years|Age, Customized||Participants|Count of Participants|219|219.0||||||
4459109|NCT00063999|4279792|B1||50-59 years|Age, Customized||Participants|Count of Participants|192|192.0||||||
4459110|NCT00063999|4279790|B3||40 -49 years|Age, Customized||Participants|Count of Participants|137|137.0||||||
4459111|NCT00063999|4279791|B2||40 -49 years|Age, Customized||Participants|Count of Participants|70|70.0||||||
4459112|NCT00063999|4279792|B1||40 -49 years|Age, Customized||Participants|Count of Participants|67|67.0||||||
4459113|NCT00063999|4279790|B3||<40 years|Age, Customized||Participants|Count of Participants|37|37.0||||||
4459114|NCT00063999|4279791|B2||<40 years|Age, Customized||Participants|Count of Participants|18|18.0||||||
4459115|NCT00063999|4279792|B1||<40 years|Age, Customized||Participants|Count of Participants|19|19.0||||||
4459116|NCT00063986|4279809|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
4459117|NCT00063986|4279809|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4459118|NCT00063986|4279809|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4459119|NCT00063986|4279809|B1|||Age||years|Median|65|65.0|Full Range|||36.0|83.0|
4459120|NCT00063934|4279821|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4459121|NCT00063934|4279821|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459122|NCT00063934|4279821|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4459123|NCT00063934|4279821|B1|||Age||years|Median|49|49.0|Full Range|||24.0|71.0|
4459124|NCT00063635|4279827|B4|||NAFLD activity score|Total nonalcoholic fatty liver disease (NAFLD) activity was assessed on a scale of 0 to 8, with higher scores indicating more severe disease; the components of this measure include steatosis (assessed on a scale of 0 to 3), lobular inflammation (assessed on a scale of 0 to 3), and hepatocellular ballooning (assessed on a scale of 0 to 2).|scores on a scale|Mean|4.6|4.6|Standard Deviation|1.4|1.4|||
4459125|NCT00063635|4279828|B3|||NAFLD activity score|Total nonalcoholic fatty liver disease (NAFLD) activity was assessed on a scale of 0 to 8, with higher scores indicating more severe disease; the components of this measure include steatosis (assessed on a scale of 0 to 3), lobular inflammation (assessed on a scale of 0 to 3), and hepatocellular ballooning (assessed on a scale of 0 to 2).|scores on a scale|Mean|4.6|4.6|Standard Deviation|1.3|1.3|||
4459126|NCT00063635|4279829|B2|||NAFLD activity score|Total nonalcoholic fatty liver disease (NAFLD) activity was assessed on a scale of 0 to 8, with higher scores indicating more severe disease; the components of this measure include steatosis (assessed on a scale of 0 to 3), lobular inflammation (assessed on a scale of 0 to 3), and hepatocellular ballooning (assessed on a scale of 0 to 2).|scores on a scale|Mean|4.8|4.8|Standard Deviation|1.6|1.6|||
4459127|NCT00063635|4279830|B1|||NAFLD activity score|Total nonalcoholic fatty liver disease (NAFLD) activity was assessed on a scale of 0 to 8, with higher scores indicating more severe disease; the components of this measure include steatosis (assessed on a scale of 0 to 3), lobular inflammation (assessed on a scale of 0 to 3), and hepatocellular ballooning (assessed on a scale of 0 to 2).|scores on a scale|Mean|4.5|4.5|Standard Deviation|1.2|1.2|||
4459128|NCT00063635|4279827|B4|United States||Region of Enrollment||participants|Number|173|173.0||||||
4459129|NCT00063635|4279828|B3|United States||Region of Enrollment||participants|Number|58|58.0||||||
4459130|NCT00063635|4279829|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4459131|NCT00063635|4279830|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4459132|NCT00063635|4279827|B4||Male|Sex: Female, Male||Participants|Count of Participants|140|140.0||||||
4459133|NCT00063635|4279828|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4459134|NCT00063635|4279829|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4459135|NCT00063635|4279830|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4459136|NCT00063635|4279827|B4||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4459137|NCT00063635|4279828|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4459138|NCT00063635|4279829|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4459139|NCT00063635|4279830|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4459140|NCT00063635|4279827|B4|||Age||years|Mean|13.1|13.1|Standard Deviation|2.4|2.4|||
4459141|NCT00063635|4279828|B3|||Age||years|Mean|12.9|12.9|Standard Deviation|2.6|2.6|||
4459142|NCT00063635|4279829|B2|||Age||years|Mean|13.4|13.4|Standard Deviation|2.3|2.3|||
4459143|NCT00063635|4279830|B1|||Age||years|Mean|13.1|13.1|Standard Deviation|2.4|2.4|||
4459144|NCT00063622|4279870|B4|||Total nonalcoholic fatty liver disease (NAFLD) activity score|Total nonalcoholic fatty liver disease (NAFLD) activity was assessed on a scale of 0 to 8, with higher scores indicating more severe disease; the components of this measure include steatosis (assessed on a scale of 0 to 3), lobular inflammation (assessed on a scale of 0 to 3), and hepatocellular ballooning (assessed on a scale of 0 to 2).|scores on a scale|Mean|4.9|4.9|Standard Deviation|1.4|1.4|||
4459145|NCT00063622|4279871|B3|||Total nonalcoholic fatty liver disease (NAFLD) activity score|Total nonalcoholic fatty liver disease (NAFLD) activity was assessed on a scale of 0 to 8, with higher scores indicating more severe disease; the components of this measure include steatosis (assessed on a scale of 0 to 3), lobular inflammation (assessed on a scale of 0 to 3), and hepatocellular ballooning (assessed on a scale of 0 to 2).|scores on a scale|Mean|4.8|4.8|Standard Deviation|1.4|1.4|||
4459146|NCT00063622|4279872|B2|||Total nonalcoholic fatty liver disease (NAFLD) activity score|Total nonalcoholic fatty liver disease (NAFLD) activity was assessed on a scale of 0 to 8, with higher scores indicating more severe disease; the components of this measure include steatosis (assessed on a scale of 0 to 3), lobular inflammation (assessed on a scale of 0 to 3), and hepatocellular ballooning (assessed on a scale of 0 to 2).|scores on a scale|Mean|5.1|5.1|Standard Deviation|1.4|1.4|||
4459147|NCT00063622|4279873|B1|||Total nonalcoholic fatty liver disease (NAFLD) activity score|Total nonalcoholic fatty liver disease (NAFLD) activity was assessed on a scale of 0 to 8, with higher scores indicating more severe disease; the components of this measure include steatosis (assessed on a scale of 0 to 3), lobular inflammation (assessed on a scale of 0 to 3), and hepatocellular ballooning (assessed on a scale of 0 to 2).|scores on a scale|Mean|5.0|5.0|Standard Deviation|1.4|1.4|||
4459148|NCT00063622|4279870|B4|United States||Region of Enrollment||participants|Number|247|247.0||||||
4459149|NCT00063622|4279871|B3|United States||Region of Enrollment||participants|Number|83|83.0||||||
4459150|NCT00063622|4279872|B2|United States||Region of Enrollment||participants|Number|84|84.0||||||
4459151|NCT00063622|4279873|B1|United States||Region of Enrollment||participants|Number|80|80.0||||||
4459152|NCT00063622|4279870|B4||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4459153|NCT00063622|4279871|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4459154|NCT00063622|4279872|B2||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4459155|NCT00063622|4279873|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4459156|NCT00063622|4279870|B4||Female|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4459157|NCT00063622|4279871|B3||Female|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4459158|NCT00063622|4279872|B2||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4459159|NCT00063622|4279873|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4459160|NCT00063622|4279870|B4|||Age||years|Mean|46.3|46.3|Standard Deviation|11.9|11.9|||
4459161|NCT00063622|4279871|B3|||Age||years|Mean|45.4|45.4|Standard Deviation|11.2|11.2|||
4459162|NCT00063622|4279872|B2|||Age||years|Mean|46.6|46.6|Standard Deviation|12.1|12.1|||
4459163|NCT00063622|4279873|B1|||Age||years|Mean|47.0|47.0|Standard Deviation|12.6|12.6|||
4459164|NCT00063570|4279898|B3|||Time (in months) from Current Pathological Diagnosis to Enrollment||Months|Median|14.29|14.29|Full Range|||0.4|134.2|
4459165|NCT00063570|4279899|B2|||Time (in months) from Current Pathological Diagnosis to Enrollment||Months|Median|14.31|14.31|Full Range|||0.5|57.1|
4459166|NCT00063570|4279900|B1|||Time (in months) from Current Pathological Diagnosis to Enrollment||Months|Median|13.08|13.08|Full Range|||0.4|134.2|
4459167|NCT00063570|4279898|B3|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4459168|NCT00063570|4279899|B2|Hispanic||Race/Ethnicity||participants|Number|0|0.0||||||
4459169|NCT00063570|4279900|B1|Hispanic||Race/Ethnicity||participants|Number|1|1.0||||||
4459170|NCT00063570|4279898|B3|East/Southeast Asian||Race/Ethnicity||participants|Number|3|3.0||||||
4459171|NCT00063570|4279899|B2|East/Southeast Asian||Race/Ethnicity||participants|Number|0|0.0||||||
4459172|NCT00063570|4279900|B1|East/Southeast Asian||Race/Ethnicity||participants|Number|3|3.0||||||
4459173|NCT00063570|4279898|B3|African||Race/Ethnicity||participants|Number|5|5.0||||||
4459174|NCT00063570|4279899|B2|African||Race/Ethnicity||participants|Number|1|1.0||||||
4459175|NCT00063570|4279900|B1|African||Race/Ethnicity||participants|Number|4|4.0||||||
4459176|NCT00063570|4279898|B3|Caucasian||Race/Ethnicity||participants|Number|64|64.0||||||
4459177|NCT00063570|4279899|B2|Caucasian||Race/Ethnicity||participants|Number|20|20.0||||||
4459178|NCT00063570|4279900|B1|Caucasian||Race/Ethnicity||participants|Number|44|44.0||||||
4459179|NCT00063570|4279898|B3|No||Patients with Current Pathological Diagnosis||participants|Number|2|2.0||||||
4459180|NCT00063570|4279899|B2|No||Patients with Current Pathological Diagnosis||participants|Number|0|0.0||||||
4459181|NCT00063570|4279900|B1|No||Patients with Current Pathological Diagnosis||participants|Number|2|2.0||||||
4459182|NCT00063570|4279898|B3|Yes||Patients with Current Pathological Diagnosis||participants|Number|71|71.0||||||
4459183|NCT00063570|4279899|B2|Yes||Patients with Current Pathological Diagnosis||participants|Number|21|21.0||||||
4459184|NCT00063570|4279900|B1|Yes||Patients with Current Pathological Diagnosis||participants|Number|50|50.0||||||
4459185|NCT00063570|4279898|B3|Post-Menopausal||Menopausal Status at Cycle 0||participants|Number|56|56.0||||||
4459186|NCT00063570|4279899|B2|Post-Menopausal||Menopausal Status at Cycle 0||participants|Number|15|15.0||||||
4459187|NCT00063570|4279900|B1|Post-Menopausal||Menopausal Status at Cycle 0||participants|Number|41|41.0||||||
4459188|NCT00063570|4279898|B3|Menopausal||Menopausal Status at Cycle 0||participants|Number|7|7.0||||||
4459189|NCT00063570|4279899|B2|Menopausal||Menopausal Status at Cycle 0||participants|Number|3|3.0||||||
4459190|NCT00063570|4279900|B1|Menopausal||Menopausal Status at Cycle 0||participants|Number|4|4.0||||||
4459191|NCT00063570|4279898|B3|Pre-Menopausal||Menopausal Status at Cycle 0||participants|Number|10|10.0||||||
4459192|NCT00063570|4279899|B2|Pre-Menopausal||Menopausal Status at Cycle 0||participants|Number|3|3.0||||||
4459193|NCT00063570|4279900|B1|Pre-Menopausal||Menopausal Status at Cycle 0||participants|Number|7|7.0||||||
4459194|NCT00063570|4279898|B3|unknown||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|1|1.0||||||
4459195|NCT00063570|4279899|B2|unknown||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|0|0.0||||||
4459196|NCT00063570|4279900|B1|unknown||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|1|1.0||||||
4459197|NCT00063570|4279898|B3|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|23|23.0||||||
4459198|NCT00063570|4279899|B2|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|6|6.0||||||
4459199|NCT00063570|4279900|B1|100 - Normal no complaints; no evidence of disease||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|17|17.0||||||
4459200|NCT00063570|4279898|B3|90 - Normal activity; minor signs of disease||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|28|28.0||||||
4459201|NCT00063570|4279899|B2|90 - Normal activity; minor signs of disease||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|9|9.0||||||
4459202|NCT00063570|4279900|B1|90 - Normal activity; minor signs of disease||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|19|19.0||||||
4459203|NCT00063570|4279898|B3|80 - Activity with effort; some signs of disease||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|16|16.0||||||
4459204|NCT00063570|4279899|B2|80 - Activity with effort; some signs of disease||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|5|5.0||||||
4459205|NCT00063570|4279900|B1|80 - Activity with effort; some signs of disease||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|11|11.0||||||
4459206|NCT00063570|4279898|B3|70 - Unable to carry on normal activity||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|5|5.0||||||
4459207|NCT00063570|4279899|B2|70 - Unable to carry on normal activity||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|1|1.0||||||
4459208|NCT00063570|4279900|B1|70 - Unable to carry on normal activity||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|4|4.0||||||
4459209|NCT00063570|4279898|B3|<=60 - Needs increasing assistance up to Death (0)||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|0|0.0||||||
4459210|NCT00063570|4279899|B2|<=60 - Needs increasing assistance up to Death (0)||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|0|0.0||||||
4459211|NCT00063570|4279900|B1|<=60 - Needs increasing assistance up to Death (0)||Karnofsky Performance Status (KPS)|The Karnofsky Performance Status Index classifies functional impairment. Scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities.|participants|Number|0|0.0||||||
4459212|NCT00063570|4279898|B3|No current pathological diagnosis||Current Pathological Diagnosis||paticipants|Number|2|2.0||||||
4459213|NCT00063570|4279899|B2|No current pathological diagnosis||Current Pathological Diagnosis||paticipants|Number|0|0.0||||||
4459214|NCT00063570|4279900|B1|No current pathological diagnosis||Current Pathological Diagnosis||paticipants|Number|2|2.0||||||
4459215|NCT00063570|4279898|B3|Unknown||Current Pathological Diagnosis||paticipants|Number|2|2.0||||||
4459216|NCT00063570|4279899|B2|Unknown||Current Pathological Diagnosis||paticipants|Number|1|1.0||||||
4459217|NCT00063570|4279900|B1|Unknown||Current Pathological Diagnosis||paticipants|Number|1|1.0||||||
4459218|NCT00063570|4279898|B3|Other||Current Pathological Diagnosis||paticipants|Number|10|10.0||||||
4459219|NCT00063570|4279899|B2|Other||Current Pathological Diagnosis||paticipants|Number|3|3.0||||||
4459220|NCT00063570|4279900|B1|Other||Current Pathological Diagnosis||paticipants|Number|7|7.0||||||
4459221|NCT00063570|4279898|B3|Breast carcinoma||Current Pathological Diagnosis||paticipants|Number|8|8.0||||||
4459222|NCT00063570|4279899|B2|Breast carcinoma||Current Pathological Diagnosis||paticipants|Number|4|4.0||||||
4459223|NCT00063570|4279900|B1|Breast carcinoma||Current Pathological Diagnosis||paticipants|Number|4|4.0||||||
4459224|NCT00063570|4279898|B3|Adenocystic breast carcinoma||Current Pathological Diagnosis||paticipants|Number|1|1.0||||||
4459225|NCT00063570|4279899|B2|Adenocystic breast carcinoma||Current Pathological Diagnosis||paticipants|Number|1|1.0||||||
4459226|NCT00063570|4279900|B1|Adenocystic breast carcinoma||Current Pathological Diagnosis||paticipants|Number|0|0.0||||||
4459227|NCT00063570|4279898|B3|Lobular breast carcinoma||Current Pathological Diagnosis||paticipants|Number|2|2.0||||||
4459228|NCT00063570|4279899|B2|Lobular breast carcinoma||Current Pathological Diagnosis||paticipants|Number|0|0.0||||||
4459229|NCT00063570|4279900|B1|Lobular breast carcinoma||Current Pathological Diagnosis||paticipants|Number|2|2.0||||||
4459230|NCT00063570|4279898|B3|Ductal breast carcinoma||Current Pathological Diagnosis||paticipants|Number|48|48.0||||||
4459231|NCT00063570|4279899|B2|Ductal breast carcinoma||Current Pathological Diagnosis||paticipants|Number|12|12.0||||||
4459232|NCT00063570|4279900|B1|Ductal breast carcinoma||Current Pathological Diagnosis||paticipants|Number|36|36.0||||||
4459233|NCT00063570|4279898|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4459234|NCT00063570|4279899|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4459235|NCT00063570|4279900|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4459236|NCT00063570|4279898|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459237|NCT00063570|4279899|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459238|NCT00063570|4279900|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459239|NCT00063570|4279898|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4459240|NCT00063570|4279899|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4459241|NCT00063570|4279900|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4459242|NCT00063570|4279898|B3|||Age||years|Median|51.9|51.9|Full Range|||28.0|73.0|
4459243|NCT00063570|4279899|B2|||Age||years|Median|50.7|50.7|Full Range|||28.0|73.0|
4459244|NCT00063570|4279900|B1|||Age||years|Median|53.5|53.5|Full Range|||33.0|73.0|
4459245|NCT00063362|4279915|B3|Bipolar II disorder||Bipolar Subtype|"Bipolar I Disorder is mainly defined by manic or mixed episodes that last at least seven days, or by manic symptoms that are so severe that the person needs immediate hospital care.~Bipolar II Disorder is defined by a pattern of depressive episodes shifting back and forth with hypomanic episodes, but no full manic or mixed episodes"|participants|Number|22|22.0||||||
4459246|NCT00063362|4279916|B2|Bipolar II disorder||Bipolar Subtype|"Bipolar I Disorder is mainly defined by manic or mixed episodes that last at least seven days, or by manic symptoms that are so severe that the person needs immediate hospital care.~Bipolar II Disorder is defined by a pattern of depressive episodes shifting back and forth with hypomanic episodes, but no full manic or mixed episodes"|participants|Number|10|10.0||||||
4459247|NCT00063362|4279917|B1|Bipolar II disorder||Bipolar Subtype|"Bipolar I Disorder is mainly defined by manic or mixed episodes that last at least seven days, or by manic symptoms that are so severe that the person needs immediate hospital care.~Bipolar II Disorder is defined by a pattern of depressive episodes shifting back and forth with hypomanic episodes, but no full manic or mixed episodes"|participants|Number|12|12.0||||||
4459248|NCT00063362|4279915|B3|Bipolar I disorder||Bipolar Subtype|"Bipolar I Disorder is mainly defined by manic or mixed episodes that last at least seven days, or by manic symptoms that are so severe that the person needs immediate hospital care.~Bipolar II Disorder is defined by a pattern of depressive episodes shifting back and forth with hypomanic episodes, but no full manic or mixed episodes"|participants|Number|27|27.0||||||
4459249|NCT00063362|4279916|B2|Bipolar I disorder||Bipolar Subtype|"Bipolar I Disorder is mainly defined by manic or mixed episodes that last at least seven days, or by manic symptoms that are so severe that the person needs immediate hospital care.~Bipolar II Disorder is defined by a pattern of depressive episodes shifting back and forth with hypomanic episodes, but no full manic or mixed episodes"|participants|Number|16|16.0||||||
4459250|NCT00063362|4279917|B1|Bipolar I disorder||Bipolar Subtype|"Bipolar I Disorder is mainly defined by manic or mixed episodes that last at least seven days, or by manic symptoms that are so severe that the person needs immediate hospital care.~Bipolar II Disorder is defined by a pattern of depressive episodes shifting back and forth with hypomanic episodes, but no full manic or mixed episodes"|participants|Number|11|11.0||||||
4459251|NCT00063362|4279915|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459252|NCT00063362|4279916|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459253|NCT00063362|4279917|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459254|NCT00063362|4279915|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459255|NCT00063362|4279916|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459256|NCT00063362|4279917|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459257|NCT00063362|4279915|B3||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4459258|NCT00063362|4279916|B2||White|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4459259|NCT00063362|4279917|B1||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4459260|NCT00063362|4279915|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4459261|NCT00063362|4279916|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459262|NCT00063362|4279917|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459263|NCT00063362|4279915|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459264|NCT00063362|4279916|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459265|NCT00063362|4279917|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459266|NCT00063362|4279915|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459267|NCT00063362|4279916|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459268|NCT00063362|4279917|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459269|NCT00063362|4279915|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459270|NCT00063362|4279916|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459271|NCT00063362|4279917|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459272|NCT00063362|4279915|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4459273|NCT00063362|4279916|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4459274|NCT00063362|4279917|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4459275|NCT00063362|4279915|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4459276|NCT00063362|4279916|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4459277|NCT00063362|4279917|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4459278|NCT00063362|4279915|B3|||Age||years|Mean|37.9|37.9|Standard Deviation|11.1|11.1|||
4459279|NCT00063362|4279916|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|9.6|9.6|||
4459280|NCT00063362|4279917|B1|||Age||years|Mean|35.7|35.7|Standard Deviation|11.0|11.0|||
4459281|NCT00063258|4279924|B3|United States||Region of Enrollment||participants|Number|5|5.0||||||
4459282|NCT00063258|4279926|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4459283|NCT00063258|4279924|B3|Male||Gender||participants|Number|4|4.0||||||
4459284|NCT00063258|4279926|B1|Male||Gender||participants|Number|4|4.0||||||
4459285|NCT00063258|4279924|B3|Female||Gender||participants|Number|1|1.0||||||
4459286|NCT00063258|4279926|B1|Female||Gender||participants|Number|1|1.0||||||
4459287|NCT00063258|4279924|B3|||Age||years|Median|64|64.0|Full Range|||56.0|71.0|
4459288|NCT00063258|4279926|B1|||Age||years|Median|64|64.0|Full Range|||56.0|71.0|
4459289|NCT00063154|4279933|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4459290|NCT00063154|4279933|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4459291|NCT00063154|4279933|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|9.1|9.1|||
4459292|NCT00063232|4279940|B1|No||Diabetes|Diabetes is defined by a fasting glucose greater or equal to 125 or greater or equal to 200 mg per dL aftera 2-h glucose load.|participants|Number|19|19.0||||||
4459293|NCT00063232|4279940|B1|Yes||Diabetes|Diabetes is defined by a fasting glucose greater or equal to 125 or greater or equal to 200 mg per dL aftera 2-h glucose load.|participants|Number|7|7.0||||||
4459294|NCT00063232|4279940|B1|not impaired||Glucose tolerance|Impaired glucose tolerance is defined by fasting glucose 110–125 or >=160 mg⁄ dL after 2-h glucose load|partcipants|Number|18|18.0||||||
4459295|NCT00063232|4279940|B1|impaired||Glucose tolerance|Impaired glucose tolerance is defined by fasting glucose 110–125 or >=160 mg⁄ dL after 2-h glucose load|partcipants|Number|8|8.0||||||
4459296|NCT00063232|4279940|B1|Severely Obese (BMI greater than 40 kg/m^2)||Body Mass Index||participants|Number|5|5.0||||||
4459297|NCT00063232|4279940|B1|Obese (BMI=30-40 kg/m^2)||Body Mass Index||participants|Number|13|13.0||||||
4459298|NCT00063232|4279940|B1|Overweight (BMI=25-30 kg/m^2)||Body Mass Index||participants|Number|8|8.0||||||
4459299|NCT00063232|4279940|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4459300|NCT00063232|4279940|B1|African-American||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4459301|NCT00063232|4279940|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4459302|NCT00063232|4279940|B1|Hispanic White||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4459303|NCT00063232|4279940|B1|Non-Hispanic White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4459304|NCT00063232|4279940|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4459305|NCT00063232|4279940|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4459306|NCT00063232|4279940|B1|||Age||years|Mean|44|44.0|Standard Deviation|14|14.0|||
4459307|NCT00062764|4279946|B1|other||Fasting glucose||participant|Number|16|16.0||||||
4459308|NCT00062764|4279946|B1|110-125 mg/dL||Fasting glucose||participant|Number|2|2.0||||||
4459309|NCT00062764|4279946|B1|No||Metabolic syndrome||participants|Number|11|11.0||||||
4459310|NCT00062764|4279946|B1|Yes||Metabolic syndrome||participants|Number|7|7.0||||||
4459311|NCT00062764|4279946|B1|other||2-hr glucose (Impaired glucose tolerance)||participants|Number|7|7.0||||||
4459312|NCT00062764|4279946|B1|140-199 mg/dL||2-hr glucose (Impaired glucose tolerance)||participants|Number|11|11.0||||||
4459313|NCT00062764|4279946|B1|<=200 mg/dL||2-hr glucose diabetes mellitus||participants|Number|16|16.0||||||
4459314|NCT00062764|4279946|B1|>200 mg/dL||2-hr glucose diabetes mellitus||participants|Number|2|2.0||||||
4459315|NCT00062764|4279946|B1|BMI<=30||Obesity Distribution||participants|Number|7|7.0||||||
4459316|NCT00062764|4279946|B1|BMI>30||Obesity Distribution||participants|Number|11|11.0||||||
4459317|NCT00062764|4279946|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4459318|NCT00062764|4279946|B1|Mixed||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4459319|NCT00062764|4279946|B1|White||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4459320|NCT00062764|4279946|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4459321|NCT00062764|4279946|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4459322|NCT00062764|4279946|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4459323|NCT00062764|4279946|B1|||Age||years|Mean|46|46.0|Standard Deviation|11|11.0|||
4459324|NCT00062751|4279954|B6|Female||Sex/Gender, Customized||participants|Number|108|108.0||||||
4459325|NCT00062751|4279955|B5|Female||Sex/Gender, Customized||participants|Number|6|6.0||||||
4459326|NCT00062751|4279956|B4|Female||Sex/Gender, Customized||participants|Number|6|6.0||||||
4459327|NCT00062751|4279957|B3|Female||Sex/Gender, Customized||participants|Number|33|33.0||||||
4459328|NCT00062751|4279958|B2|Female||Sex/Gender, Customized||participants|Number|30|30.0||||||
4459329|NCT00062751|4279959|B1|Female||Sex/Gender, Customized||participants|Number|33|33.0||||||
4459330|NCT00062751|4279954|B6|||Age||years|Mean|61.82|61.82|Standard Deviation|9.98|9.98|||
4459331|NCT00062751|4279955|B5|||Age||years|Mean|60.00|60.0|Standard Deviation|9.65|9.65|||
4459332|NCT00062751|4279956|B4|||Age||years|Mean|61.83|61.83|Standard Deviation|9.83|9.83|||
4459333|NCT00062751|4279957|B3|||Age||years|Mean|60.85|60.85|Standard Deviation|9.79|9.79|||
4459334|NCT00062751|4279958|B2|||Age||years|Mean|62.83|62.83|Standard Deviation|8.39|8.39|||
4459335|NCT00062751|4279959|B1|||Age||years|Mean|62.21|62.21|Standard Deviation|11.87|11.87|||
4459336|NCT00062738|4280031|B4|United States||Region of Enrollment||participants|Number|52|52.0||||||
4459337|NCT00062738|4280032|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4459338|NCT00062738|4280033|B2|United States||Region of Enrollment||participants|Number|18|18.0||||||
4459339|NCT00062738|4280034|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4459340|NCT00062738|4280031|B4||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4459341|NCT00062738|4280032|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4459342|NCT00062738|4280033|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4459343|NCT00062738|4280034|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4459344|NCT00062738|4280031|B4||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4459345|NCT00062738|4280032|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4459346|NCT00062738|4280033|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4459347|NCT00062738|4280034|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4459348|NCT00062738|4280031|B4|||Age||years|Mean|62.2|62.2|Standard Deviation|8.7|8.7|||
4459349|NCT00062738|4280032|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|9.2|9.2|||
4459350|NCT00062738|4280033|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|8.1|8.1|||
4459351|NCT00062738|4280034|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|9.3|9.3|||
4459352|NCT00062738|4280031|B4||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4459353|NCT00062738|4280032|B3||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4459354|NCT00062738|4280033|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4459355|NCT00062738|4280034|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4459356|NCT00062738|4280031|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4459357|NCT00062738|4280032|B3||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4459358|NCT00062738|4280033|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4459359|NCT00062738|4280034|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4459360|NCT00062738|4280031|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459361|NCT00062738|4280032|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459362|NCT00062738|4280033|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459363|NCT00062738|4280034|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459364|NCT00062647|4280047|B3|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4459365|NCT00062647|4280048|B2|Hong Kong||Region of Enrollment||participants|Number|0|0.0||||||
4459366|NCT00062647|4280049|B1|Hong Kong||Region of Enrollment||participants|Number|1|1.0||||||
4459367|NCT00062647|4280047|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4459368|NCT00062647|4280048|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4459369|NCT00062647|4280049|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4459370|NCT00062647|4280047|B3|Spain||Region of Enrollment||participants|Number|5|5.0||||||
4459371|NCT00062647|4280048|B2|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4459372|NCT00062647|4280049|B1|Spain||Region of Enrollment||participants|Number|2|2.0||||||
4459373|NCT00062647|4280047|B3|Singapore||Region of Enrollment||participants|Number|4|4.0||||||
4459374|NCT00062647|4280048|B2|Singapore||Region of Enrollment||participants|Number|3|3.0||||||
4459375|NCT00062647|4280049|B1|Singapore||Region of Enrollment||participants|Number|1|1.0||||||
4459376|NCT00062647|4280047|B3|Argentina||Region of Enrollment||participants|Number|5|5.0||||||
4459377|NCT00062647|4280048|B2|Argentina||Region of Enrollment||participants|Number|2|2.0||||||
4459378|NCT00062647|4280049|B1|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4459379|NCT00062647|4280047|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459380|NCT00062647|4280048|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459381|NCT00062647|4280049|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459382|NCT00062647|4280047|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459383|NCT00062647|4280048|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459384|NCT00062647|4280049|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459385|NCT00062647|4280047|B3||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4459386|NCT00062647|4280048|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4459387|NCT00062647|4280049|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4459388|NCT00062647|4280047|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4459389|NCT00062647|4280048|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4459390|NCT00062647|4280049|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4459391|NCT00062647|4280047|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459392|NCT00062647|4280048|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459393|NCT00062647|4280049|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459394|NCT00062647|4280047|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4459395|NCT00062647|4280048|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4459396|NCT00062647|4280049|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459397|NCT00062647|4280047|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459398|NCT00062647|4280048|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459399|NCT00062647|4280049|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459400|NCT00062647|4280047|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459401|NCT00062647|4280048|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459402|NCT00062647|4280049|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459403|NCT00062647|4280047|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4459404|NCT00062647|4280048|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4459405|NCT00062647|4280049|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4459406|NCT00062647|4280047|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4459407|NCT00062647|4280048|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4459408|NCT00062647|4280049|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4459409|NCT00062647|4280047|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4459410|NCT00062647|4280048|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4459411|NCT00062647|4280049|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4459412|NCT00062647|4280047|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4459413|NCT00062647|4280048|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4459414|NCT00062647|4280049|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4459415|NCT00062647|4280047|B3|||Age||years|Mean|60|60.0|Standard Deviation|17.9|17.9|||
4459416|NCT00062647|4280048|B2|||Age||years|Mean|60|60.0|Standard Deviation|17.9|17.9|||
4459417|NCT00062647|4280049|B1|||Age||years|Mean|60|60.0|Standard Deviation|19|19.0|||
4459418|NCT00062647|4280047|B3||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4459419|NCT00062647|4280048|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4459420|NCT00062647|4280049|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4459421|NCT00062647|4280047|B3||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4459422|NCT00062647|4280048|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4459423|NCT00062647|4280049|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4459424|NCT00062647|4280047|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459425|NCT00062647|4280048|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459426|NCT00062647|4280049|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459427|NCT00062439|4280056|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459428|NCT00062439|4280056|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459429|NCT00062439|4280056|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4459430|NCT00062439|4280056|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459431|NCT00062439|4280056|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459432|NCT00062439|4280056|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4459433|NCT00062439|4280056|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459434|NCT00062439|4280056|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4459435|NCT00062439|4280056|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4459436|NCT00062439|4280056|B1|||Age||years|Median|59|59.0|Full Range|||44.0|75.0|
4459437|NCT00062374|4280068|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4459438|NCT00062374|4280068|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4459439|NCT00062374|4280068|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4459440|NCT00062374|4280068|B1||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4459441|NCT00062374|4280068|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4459442|NCT00062374|4280068|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459443|NCT00062166|4280073|B1|United States||Region of Enrollment||Participants|Count of Participants|340|340.0||||||
4459444|NCT00062166|4280073|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4459445|NCT00062166|4280073|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459446|NCT00062166|4280073|B1||White|Race (NIH/OMB)||Participants|Count of Participants|287|287.0||||||
4459447|NCT00062166|4280073|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4459448|NCT00062166|4280073|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459449|NCT00062166|4280073|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4459450|NCT00062166|4280073|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459451|NCT00062166|4280073|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459452|NCT00062166|4280073|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|310|310.0||||||
4459453|NCT00062166|4280073|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4459454|NCT00062166|4280073|B1||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4459455|NCT00062166|4280073|B1||Female|Sex: Female, Male||Participants|Count of Participants|168|168.0||||||
4459456|NCT00062166|4280073|B1|||Age||years|Mean|43|43.0|Standard Deviation|13|13.0|||
4459457|NCT00062166|4280073|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4459458|NCT00062166|4280073|B1||Between 18 and 65 years|Age||Participants|Count of Participants|327|327.0||||||
4459459|NCT00062166|4280073|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459460|NCT00062010|4280081|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4459461|NCT00062010|4280081|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4459462|NCT00062010|4280081|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4459463|NCT00062010|4280081|B1|||Age||years|Median|60|60.0|Full Range|||39.0|74.0|
4459464|NCT00062010|4280081|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4459465|NCT00062010|4280081|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4459466|NCT00062010|4280081|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459467|NCT00061945|4280087|B3|United States||Region of Enrollment||participants|Number|300|300.0||||||
4459468|NCT00061945|4280088|B2|United States||Region of Enrollment||participants|Number|181|181.0||||||
4459469|NCT00061945|4280089|B1|United States||Region of Enrollment||participants|Number|119|119.0||||||
4459470|NCT00061945|4280087|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4459471|NCT00061945|4280088|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4459472|NCT00061945|4280089|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459473|NCT00061945|4280087|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459474|NCT00061945|4280088|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459475|NCT00061945|4280089|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459476|NCT00061945|4280087|B3||White|Race (NIH/OMB)||Participants|Count of Participants|251|251.0||||||
4459477|NCT00061945|4280088|B2||White|Race (NIH/OMB)||Participants|Count of Participants|150|150.0||||||
4459478|NCT00061945|4280089|B1||White|Race (NIH/OMB)||Participants|Count of Participants|101|101.0||||||
4459479|NCT00061945|4280087|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4459480|NCT00061945|4280088|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4459481|NCT00061945|4280089|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4459482|NCT00061945|4280087|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459483|NCT00061945|4280088|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459484|NCT00061945|4280089|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459485|NCT00061945|4280087|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4459486|NCT00061945|4280088|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4459487|NCT00061945|4280089|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4459488|NCT00061945|4280087|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459489|NCT00061945|4280088|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459490|NCT00061945|4280089|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459491|NCT00061945|4280087|B3||Male|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4459492|NCT00061945|4280088|B2||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4459493|NCT00061945|4280089|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4459494|NCT00061945|4280087|B3||Female|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4459495|NCT00061945|4280088|B2||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4459496|NCT00061945|4280089|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4459497|NCT00061945|4280087|B3|||Age||years|Median|46.8|46.8|Full Range|||29.0|59.8|
4459498|NCT00061945|4280088|B2|||Age||years|Median|46.5|46.5|Full Range|||29.0|58.4|
4459499|NCT00061945|4280089|B1|||Age||years|Median|48.3|48.3|Full Range|||30.5|59.8|
4459500|NCT00061932|4280098|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4459501|NCT00061932|4280099|B2|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4459502|NCT00061932|4280100|B1|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4459503|NCT00061932|4280098|B3|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4459504|NCT00061932|4280099|B2|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4459505|NCT00061932|4280100|B1|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4459506|NCT00061932|4280098|B3|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4459507|NCT00061932|4280099|B2|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4459508|NCT00061932|4280100|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4459509|NCT00061932|4280098|B3|White||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4459510|NCT00061932|4280099|B2|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4459511|NCT00061932|4280100|B1|White||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4459512|NCT00061932|4280098|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4459513|NCT00061932|4280099|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4459514|NCT00061932|4280100|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4459515|NCT00061932|4280098|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4459516|NCT00061932|4280099|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4459517|NCT00061932|4280100|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4459518|NCT00061932|4280098|B3|||Age||years|Median|56.5|56.5|Full Range|||33.0|87.0|
4459519|NCT00061932|4280099|B2|||Age||years|Median|54.5|54.5|Full Range|||33.0|77.0|
4459520|NCT00061932|4280100|B1|||Age||years|Median|58.5|58.5|Full Range|||33.0|87.0|
4459521|NCT00061893|4280107|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4459522|NCT00061893|4280107|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4459523|NCT00061893|4280107|B1|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4459524|NCT00061893|4280107|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4459525|NCT00061893|4280107|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4459526|NCT00061893|4280107|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459527|NCT00061893|4280107|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4459528|NCT00061893|4280107|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459529|NCT00061893|4280107|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459530|NCT00061893|4280107|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459531|NCT00061893|4280107|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459532|NCT00061893|4280107|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459533|NCT00061893|4280107|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4459534|NCT00061893|4280107|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4459535|NCT00061893|4280107|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4459536|NCT00061893|4280107|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4459537|NCT00061893|4280107|B1|||Age||years|Mean|12.97|12.97|Standard Deviation|5.81|5.81|||
4459538|NCT00061633|4280112|B3|Non-Diabetic||Diabetes Status||participants|Number|123|123.0||||||
4459539|NCT00061633|4280113|B2|Non-Diabetic||Diabetes Status||participants|Number|64|64.0||||||
4459540|NCT00061633|4280114|B1|Non-Diabetic||Diabetes Status||participants|Number|59|59.0||||||
4459541|NCT00061633|4280112|B3|Diabetic||Diabetes Status||participants|Number|44|44.0||||||
4459542|NCT00061633|4280113|B2|Diabetic||Diabetes Status||participants|Number|19|19.0||||||
4459543|NCT00061633|4280114|B1|Diabetic||Diabetes Status||participants|Number|25|25.0||||||
4459544|NCT00061633|4280112|B3|South Africa||Region of Enrollment||participants|Number|50|50.0||||||
4459545|NCT00061633|4280113|B2|South Africa||Region of Enrollment||participants|Number|25|25.0||||||
4459546|NCT00061633|4280114|B1|South Africa||Region of Enrollment||participants|Number|25|25.0||||||
4459547|NCT00061633|4280112|B3|United States||Region of Enrollment||participants|Number|117|117.0||||||
4459548|NCT00061633|4280113|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4459549|NCT00061633|4280114|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4459550|NCT00061633|4280112|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4459551|NCT00061633|4280113|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459552|NCT00061633|4280114|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459553|NCT00061633|4280112|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4459554|NCT00061633|4280113|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4459555|NCT00061633|4280114|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4459556|NCT00061633|4280112|B3||White|Race (NIH/OMB)||Participants|Count of Participants|79|79.0||||||
4459557|NCT00061633|4280113|B2||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4459558|NCT00061633|4280114|B1||White|Race (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4459559|NCT00061633|4280112|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4459560|NCT00061633|4280113|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4459561|NCT00061633|4280114|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4459562|NCT00061633|4280112|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4459563|NCT00061633|4280113|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4459564|NCT00061633|4280114|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4459565|NCT00061633|4280112|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4459566|NCT00061633|4280113|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459567|NCT00061633|4280114|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4459568|NCT00061633|4280112|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459569|NCT00061633|4280113|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459570|NCT00061633|4280114|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459571|NCT00061633|4280112|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459572|NCT00061633|4280113|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459573|NCT00061633|4280114|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459574|NCT00061633|4280112|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|140|140.0||||||
4459575|NCT00061633|4280113|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4459576|NCT00061633|4280114|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4459577|NCT00061633|4280112|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|25|25.0||||||
4459578|NCT00061633|4280113|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4459579|NCT00061633|4280114|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4459580|NCT00061633|4280112|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4459581|NCT00061633|4280113|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4459582|NCT00061633|4280114|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4459583|NCT00061633|4280112|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4459584|NCT00061633|4280113|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4459585|NCT00061633|4280114|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4459586|NCT00061633|4280112|B3|||Age||years|Mean|44.4|44.4|Standard Deviation|13.7|13.7|||
4459587|NCT00061633|4280113|B2|||Age||years|Mean|44.3|44.3|Standard Deviation|13.5|13.5|||
4459588|NCT00061633|4280114|B1|||Age||years|Mean|44.6|44.6|Standard Deviation|13.9|13.9|||
4459589|NCT00061633|4280112|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4459590|NCT00061633|4280113|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4459591|NCT00061633|4280114|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4459592|NCT00061633|4280112|B3||Between 18 and 65 years|Age||Participants|Count of Participants|158|158.0||||||
4459593|NCT00061633|4280113|B2||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4459594|NCT00061633|4280114|B1||Between 18 and 65 years|Age||Participants|Count of Participants|80|80.0||||||
4459595|NCT00061633|4280112|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459596|NCT00061633|4280113|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459597|NCT00061633|4280114|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459598|NCT00061373|4280121|B3|United States||Region of Enrollment||participants|Number|18|18.0||||||
4459599|NCT00061373|4280122|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4459600|NCT00061373|4280123|B1|United States||Region of Enrollment||participants|Number|15|15.0||||||
4459601|NCT00061373|4280121|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4459602|NCT00061373|4280122|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4459603|NCT00061373|4280123|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4459604|NCT00061373|4280121|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4459605|NCT00061373|4280122|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4459606|NCT00061373|4280123|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4459607|NCT00061373|4280121|B3|||Age||years|Mean|68|68.0|Standard Deviation|9|9.0|||
4459608|NCT00061373|4280122|B2|||Age||years|Mean|59|59.0|Standard Deviation|7|7.0|||
4459609|NCT00061373|4280123|B1|||Age||years|Mean|70|70.0|Standard Deviation|9|9.0|||
4459610|NCT00061373|4280121|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4459611|NCT00061373|4280122|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4459612|NCT00061373|4280123|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4459613|NCT00061373|4280121|B3||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4459614|NCT00061373|4280122|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4459615|NCT00061373|4280123|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4459616|NCT00061373|4280121|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459617|NCT00061373|4280122|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459618|NCT00061373|4280123|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459619|NCT00061048|4280140|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4459620|NCT00061048|4280140|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4459621|NCT00061048|4280140|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4459622|NCT00061048|4280140|B1|||Age||years|Mean|52.54|52.54|Standard Deviation|13.39|13.39|||
4459623|NCT00061048|4280140|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4459624|NCT00061048|4280140|B1||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4459625|NCT00061048|4280140|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459626|NCT00060944|4280148|B3|United States Of America||Region of Enrollment||participants|Number|181|181.0||||||
4459627|NCT00060944|4280149|B2|United States Of America||Region of Enrollment||participants|Number|92|92.0||||||
4459628|NCT00060944|4280150|B1|United States Of America||Region of Enrollment||participants|Number|89|89.0||||||
4459629|NCT00060944|4280148|B3|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4459630|NCT00060944|4280149|B2|Spain||Region of Enrollment||participants|Number|0|0.0||||||
4459631|NCT00060944|4280150|B1|Spain||Region of Enrollment||participants|Number|3|3.0||||||
4459632|NCT00060944|4280148|B3|Russia||Region of Enrollment||participants|Number|28|28.0||||||
4459633|NCT00060944|4280149|B2|Russia||Region of Enrollment||participants|Number|13|13.0||||||
4459634|NCT00060944|4280150|B1|Russia||Region of Enrollment||participants|Number|15|15.0||||||
4459635|NCT00060944|4280148|B3|Italy||Region of Enrollment||participants|Number|8|8.0||||||
4459636|NCT00060944|4280149|B2|Italy||Region of Enrollment||participants|Number|3|3.0||||||
4459637|NCT00060944|4280150|B1|Italy||Region of Enrollment||participants|Number|5|5.0||||||
4459638|NCT00060944|4280148|B3|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4459639|NCT00060944|4280149|B2|Germany||Region of Enrollment||participants|Number|0|0.0||||||
4459640|NCT00060944|4280150|B1|Germany||Region of Enrollment||participants|Number|2|2.0||||||
4459641|NCT00060944|4280148|B3|France||Region of Enrollment||participants|Number|17|17.0||||||
4459642|NCT00060944|4280149|B2|France||Region of Enrollment||participants|Number|12|12.0||||||
4459643|NCT00060944|4280150|B1|France||Region of Enrollment||participants|Number|5|5.0||||||
4459644|NCT00060944|4280148|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4459645|NCT00060944|4280149|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4459646|NCT00060944|4280150|B1|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4459647|NCT00060944|4280148|B3|Belgium||Region of Enrollment||participants|Number|3|3.0||||||
4459648|NCT00060944|4280149|B2|Belgium||Region of Enrollment||participants|Number|2|2.0||||||
4459649|NCT00060944|4280150|B1|Belgium||Region of Enrollment||participants|Number|1|1.0||||||
4459650|NCT00060944|4280148|B3|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4459651|NCT00060944|4280149|B2|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4459652|NCT00060944|4280150|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4459653|NCT00060944|4280148|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4459654|NCT00060944|4280149|B2||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4459655|NCT00060944|4280150|B1||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4459656|NCT00060944|4280148|B3||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4459657|NCT00060944|4280149|B2||Female|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4459658|NCT00060944|4280150|B1||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4459659|NCT00060944|4280148|B3|||Age||years|Mean|53.1|53.1|Standard Deviation|10.32|10.32|||
4459660|NCT00060944|4280149|B2|||Age||years|Mean|53.4|53.4|Standard Deviation|10.7|10.7|||
4459661|NCT00060944|4280150|B1|||Age||years|Mean|52.8|52.8|Standard Deviation|9.95|9.95|||
4459662|NCT00060840|4280165|B3|Germany||Region of Enrollment||participants|Number|70|70.0||||||
4459663|NCT00060840|4280166|B2|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4459664|NCT00060840|4280167|B1|Germany||Region of Enrollment||participants|Number|35|35.0||||||
4459665|NCT00060840|4280165|B3|United States||Region of Enrollment||participants|Number|80|80.0||||||
4459666|NCT00060840|4280166|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4459667|NCT00060840|4280167|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4459668|NCT00060840|4280165|B3||Male|Sex: Female, Male||Participants|Count of Participants|129|129.0||||||
4459669|NCT00060840|4280166|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4459670|NCT00060840|4280167|B1||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4459671|NCT00060840|4280165|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4459672|NCT00060840|4280166|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4459673|NCT00060840|4280167|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4459674|NCT00060840|4280165|B3|||Age||years|Mean|55.8|55.8|Standard Deviation|11.04|11.04|||
4459675|NCT00060840|4280166|B2|||Age||years|Mean|54.0|54.0|Standard Deviation|11.95|11.95|||
4459676|NCT00060840|4280167|B1|||Age||years|Mean|57.6|57.6|Standard Deviation|9.75|9.75|||
4459677|NCT00060840|4280165|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4459678|NCT00060840|4280166|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4459679|NCT00060840|4280167|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4459680|NCT00060840|4280165|B3||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4459681|NCT00060840|4280166|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4459682|NCT00060840|4280167|B1||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4459683|NCT00060840|4280165|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459684|NCT00060840|4280166|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459685|NCT00060840|4280167|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459686|NCT00060528|4280174|B1|United States||Region of Enrollment||Participants|Count of Participants|32|32.0||||||
4459687|NCT00060528|4280174|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4459688|NCT00060528|4280174|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459689|NCT00060528|4280174|B1|||Age||years|Mean|64.1|64.1|Standard Deviation|8.85|8.85|||
4459690|NCT00060528|4280174|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4459691|NCT00060528|4280174|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4459692|NCT00060528|4280174|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459693|NCT00060424|4280191|B1|Italy||Region of Enrollment||participants|Number|1|1.0||||||
4459694|NCT00060424|4280191|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4459695|NCT00060424|4280191|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459696|NCT00060424|4280191|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459697|NCT00060424|4280191|B1||White|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4459698|NCT00060424|4280191|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459699|NCT00060424|4280191|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459700|NCT00060424|4280191|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459701|NCT00060424|4280191|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459702|NCT00060424|4280191|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4459703|NCT00060424|4280191|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4459704|NCT00060424|4280191|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459705|NCT00060424|4280191|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4459706|NCT00060424|4280191|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4459707|NCT00060424|4280191|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4459708|NCT00060424|4280191|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4459709|NCT00060424|4280191|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459710|NCT00060346|4280199|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4459711|NCT00060346|4280199|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4459712|NCT00060346|4280199|B1|||Age||years|Median|59.5|59.5|Full Range|||44.1|78.6|
4459713|NCT00060333|4280203|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4459714|NCT00060333|4280203|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4459715|NCT00060333|4280203|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4459716|NCT00060333|4280203|B1|||Age||years|Median|68.0|68.0|Full Range|||49.0|76.0|
4459717|NCT00060008|4280214|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4459718|NCT00060008|4280214|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4459719|NCT00060008|4280214|B1|||Age, Customized||years|Mean|14.4|14.4|Full Range|||6.0|27.0|
4459720|NCT00059839|4280219|B3|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4459721|NCT00059839|4280220|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4459722|NCT00059839|4280221|B1|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4459723|NCT00059839|4280219|B3|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4459724|NCT00059839|4280220|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4459725|NCT00059839|4280221|B1|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4459726|NCT00059839|4280219|B3|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4459727|NCT00059839|4280220|B2|Canada||Region of Enrollment||participants|Number|9|9.0||||||
4459728|NCT00059839|4280221|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4459729|NCT00059839|4280219|B3|United States||Region of Enrollment||participants|Number|111|111.0||||||
4459730|NCT00059839|4280220|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4459731|NCT00059839|4280221|B1|United States||Region of Enrollment||participants|Number|59|59.0||||||
4459732|NCT00059839|4280219|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4459733|NCT00059839|4280220|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4459734|NCT00059839|4280221|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4459735|NCT00059839|4280219|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459736|NCT00059839|4280220|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459737|NCT00059839|4280221|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459738|NCT00059839|4280219|B3||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4459739|NCT00059839|4280220|B2||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4459740|NCT00059839|4280221|B1||White|Race (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4459741|NCT00059839|4280219|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4459742|NCT00059839|4280220|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4459743|NCT00059839|4280221|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4459744|NCT00059839|4280219|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459745|NCT00059839|4280220|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459746|NCT00059839|4280221|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459747|NCT00059839|4280219|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4459748|NCT00059839|4280220|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4459749|NCT00059839|4280221|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4459750|NCT00059839|4280219|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459751|NCT00059839|4280220|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459752|NCT00059839|4280221|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459753|NCT00059839|4280219|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4459754|NCT00059839|4280220|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459755|NCT00059839|4280221|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4459756|NCT00059839|4280219|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|107|107.0||||||
4459757|NCT00059839|4280220|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4459758|NCT00059839|4280221|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4459759|NCT00059839|4280219|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4459760|NCT00059839|4280220|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4459761|NCT00059839|4280221|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4459762|NCT00059839|4280219|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4459763|NCT00059839|4280220|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4459764|NCT00059839|4280221|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4459765|NCT00059839|4280219|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4459766|NCT00059839|4280220|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4459767|NCT00059839|4280221|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4459768|NCT00059839|4280219|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4459769|NCT00059839|4280220|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4459770|NCT00059839|4280221|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4459771|NCT00059839|4280219|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4459772|NCT00059839|4280220|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4459773|NCT00059839|4280221|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4459774|NCT00059839|4280219|B3||<=18 years|Age||Participants|Count of Participants|124|124.0||||||
4459775|NCT00059839|4280220|B2||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
4459776|NCT00059839|4280221|B1||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
4459777|NCT00059787|4280228|B1|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4459778|NCT00059787|4280228|B1|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4459779|NCT00059787|4280228|B1|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4459780|NCT00059787|4280228|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4459781|NCT00059787|4280228|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459782|NCT00059787|4280228|B1||Female|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4459783|NCT00059787|4280228|B1|||Age||years|Median|55.5|55.5|Full Range|||22.0|79.0|
4459784|NCT00059475|4280236|B9|United States||Region of Enrollment||participants|Number|138|138.0||||||
4459785|NCT00059475|4280237|B8|United States||Region of Enrollment||participants|Number|7|7.0||||||
4459786|NCT00059475|4280238|B7|United States||Region of Enrollment||participants|Number|34|34.0||||||
4459787|NCT00059475|4280239|B6|United States||Region of Enrollment||participants|Number|2|2.0||||||
4459788|NCT00059475|4280240|B5|United States||Region of Enrollment||participants|Number|33|33.0||||||
4459789|NCT00059475|4280241|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4459790|NCT00059475|4280242|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4459791|NCT00059475|4280243|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4459792|NCT00059475|4280244|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4459793|NCT00059475|4280236|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459794|NCT00059475|4280237|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459795|NCT00059475|4280238|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459796|NCT00059475|4280239|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459797|NCT00059475|4280240|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459798|NCT00059475|4280241|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459799|NCT00059475|4280242|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459800|NCT00059475|4280243|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459801|NCT00059475|4280244|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459802|NCT00059475|4280236|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459803|NCT00059475|4280237|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459804|NCT00059475|4280238|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459805|NCT00059475|4280239|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459806|NCT00059475|4280240|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459962|NCT00059332|4280278|B2|Tobacco use||Medical History||participants|Number|139|139.0||||||
4459807|NCT00059475|4280241|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459808|NCT00059475|4280242|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459809|NCT00059475|4280243|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459810|NCT00059475|4280244|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459811|NCT00059475|4280236|B9||White|Race (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4459812|NCT00059475|4280237|B8||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4459813|NCT00059475|4280238|B7||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4459814|NCT00059475|4280239|B6||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459815|NCT00059475|4280240|B5||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4459816|NCT00059475|4280241|B4||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4459817|NCT00059475|4280242|B3||White|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4459818|NCT00059475|4280243|B2||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459819|NCT00059475|4280244|B1||White|Race (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4459820|NCT00059475|4280236|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459821|NCT00059475|4280237|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459822|NCT00059475|4280238|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459823|NCT00059475|4280239|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459824|NCT00059475|4280240|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459825|NCT00059475|4280241|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459826|NCT00059475|4280242|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459827|NCT00059475|4280243|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459828|NCT00059475|4280244|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459829|NCT00059475|4280236|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459830|NCT00059475|4280237|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459831|NCT00059475|4280238|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459832|NCT00059475|4280239|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459833|NCT00059475|4280240|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459834|NCT00059475|4280241|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459835|NCT00059475|4280242|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459836|NCT00059475|4280243|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459837|NCT00059475|4280244|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459838|NCT00059475|4280236|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459839|NCT00059475|4280237|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459840|NCT00059475|4280238|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459841|NCT00059475|4280239|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459842|NCT00059475|4280240|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459843|NCT00059475|4280241|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459844|NCT00059475|4280242|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459845|NCT00059475|4280243|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459846|NCT00059475|4280244|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459847|NCT00059475|4280236|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459848|NCT00059475|4280237|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459849|NCT00059475|4280238|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459850|NCT00059475|4280239|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459851|NCT00059475|4280240|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459852|NCT00059475|4280241|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459853|NCT00059475|4280242|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459854|NCT00059475|4280243|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459855|NCT00059475|4280244|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459856|NCT00059475|4280236|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459857|NCT00059475|4280237|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459858|NCT00059475|4280238|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459859|NCT00059475|4280239|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459860|NCT00059475|4280240|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459861|NCT00059475|4280241|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459862|NCT00059475|4280242|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459863|NCT00059475|4280243|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459864|NCT00059475|4280244|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459865|NCT00059475|4280236|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|137|137.0||||||
4459866|NCT00059475|4280237|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4459867|NCT00059475|4280238|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4459868|NCT00059475|4280239|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459869|NCT00059475|4280240|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4459870|NCT00059475|4280241|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4459871|NCT00059475|4280242|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4459872|NCT00059475|4280243|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459873|NCT00059475|4280244|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4459874|NCT00059475|4280236|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459875|NCT00059475|4280237|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459876|NCT00059475|4280238|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459877|NCT00059475|4280239|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459878|NCT00059475|4280240|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4459879|NCT00059475|4280241|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459880|NCT00059475|4280242|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459881|NCT00059475|4280243|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459882|NCT00059475|4280244|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459883|NCT00059475|4280236|B9||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4459884|NCT00059475|4280237|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4459885|NCT00059475|4280238|B7||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4459886|NCT00059475|4280239|B6||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4459887|NCT00059475|4280240|B5||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4459888|NCT00059475|4280241|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4459889|NCT00059475|4280242|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4459890|NCT00059475|4280243|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459891|NCT00059475|4280244|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4459892|NCT00059475|4280236|B9||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4459893|NCT00059475|4280237|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4459894|NCT00059475|4280238|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4459895|NCT00059475|4280239|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459896|NCT00059475|4280240|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4459897|NCT00059475|4280241|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4459898|NCT00059475|4280242|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4459899|NCT00059475|4280243|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4459900|NCT00059475|4280244|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4459901|NCT00059475|4280236|B9|||Age||years|Mean|47.55|47.55|Standard Deviation|10.18|10.18|||
4459902|NCT00059475|4280237|B8|||Age||years|Mean|48.0|48.0|Standard Deviation|8.5|8.5|||
4459903|NCT00059475|4280238|B7|||Age||years|Mean|44.9|44.9|Standard Deviation|11.4|11.4|||
4459904|NCT00059475|4280239|B6|||Age||years|Mean|52.0|52.0|Standard Deviation|8.5|8.5|||
4459905|NCT00059475|4280240|B5|||Age||years|Mean|47.5|47.5|Standard Deviation|13.0|13.0|||
4459906|NCT00059475|4280241|B4|||Age||years|Mean|52.7|52.7|Standard Deviation|3.8|3.8|||
4459907|NCT00059475|4280242|B3|||Age||years|Mean|48.5|48.5|Standard Deviation|12.9|12.9|||
4459908|NCT00059475|4280243|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|8.5|8.5|||
4459909|NCT00059475|4280244|B1|||Age||years|Mean|44.8|44.8|Standard Deviation|14.9|14.9|||
4459910|NCT00059475|4280236|B9||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4459911|NCT00059475|4280237|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4459912|NCT00059475|4280238|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4459913|NCT00059475|4280239|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4459914|NCT00059475|4280240|B5||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4459915|NCT00059475|4280241|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4459916|NCT00059475|4280242|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4459917|NCT00059475|4280243|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4459918|NCT00059475|4280244|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4459919|NCT00059475|4280236|B9||Between 18 and 65 years|Age||Participants|Count of Participants|126|126.0||||||
4459920|NCT00059475|4280237|B8||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4459921|NCT00059475|4280238|B7||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4459922|NCT00059475|4280239|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4459923|NCT00059475|4280240|B5||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4459924|NCT00059475|4280241|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4459925|NCT00059475|4280242|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4459926|NCT00059475|4280243|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4459927|NCT00059475|4280244|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4459928|NCT00059475|4280236|B9||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4459929|NCT00059475|4280237|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459930|NCT00059475|4280238|B7||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4459931|NCT00059475|4280239|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459932|NCT00059475|4280240|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459933|NCT00059475|4280241|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459934|NCT00059475|4280242|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459935|NCT00059475|4280243|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459936|NCT00059475|4280244|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4459937|NCT00059332|4280277|B3|Cerebrovascular-mimicking condition||Final Diagnosis||participants|Number|67|67.0||||||
4459938|NCT00059332|4280278|B2|Cerebrovascular-mimicking condition||Final Diagnosis||participants|Number|30|30.0||||||
4459939|NCT00059332|4280279|B1|Cerebrovascular-mimicking condition||Final Diagnosis||participants|Number|37|37.0||||||
4459940|NCT00059332|4280277|B3|Intracranial Hemorrhage||Final Diagnosis||participants|Number|387|387.0||||||
4459941|NCT00059332|4280278|B2|Intracranial Hemorrhage||Final Diagnosis||participants|Number|195|195.0||||||
4459942|NCT00059332|4280279|B1|Intracranial Hemorrhage||Final Diagnosis||participants|Number|192|192.0||||||
4459943|NCT00059332|4280277|B3|Cerebral Ischemia||Final Diagnosis||participants|Number|1245|1245.0||||||
4459944|NCT00059332|4280278|B2|Cerebral Ischemia||Final Diagnosis||participants|Number|632|632.0||||||
4459945|NCT00059332|4280279|B1|Cerebral Ischemia||Final Diagnosis||participants|Number|613|613.0||||||
4459946|NCT00059332|4280277|B3|||Intravenous tissue plasminogen activator (t-PA) in patients with cerebral ischemia||participants|Number|447|447.0||||||
4459947|NCT00059332|4280278|B2|||Intravenous tissue plasminogen activator (t-PA) in patients with cerebral ischemia||participants|Number|242|242.0||||||
4459948|NCT00059332|4280279|B1|||Intravenous tissue plasminogen activator (t-PA) in patients with cerebral ischemia||participants|Number|205|205.0||||||
4459949|NCT00059332|4280277|B3|||National Institute of Health Stroke Scale (NIHSS) at hospital arrival|"The National Institute of Health Stroke Scale (NIHSS) is a measure of neurologic deficit. Total Score range 0-42, with higher scores indicating greater severity. The 11 domains assessed are:~1a-c Level of consciousness 2. Best Gaze 3. Visual 4. Facial Palsy 5a. Motor left arm 5b. Motor right arm 6a. Motor left leg 6b. Motor right leg 7. Limb Ataxia 8. Sensory 9. Best Language 10. Dysarthria 11. Extinction and Inattention"|units on a scale|Mean|11.3|11.3|Standard Deviation|9.9|9.9|||
4459950|NCT00059332|4280278|B2|||National Institute of Health Stroke Scale (NIHSS) at hospital arrival|"The National Institute of Health Stroke Scale (NIHSS) is a measure of neurologic deficit. Total Score range 0-42, with higher scores indicating greater severity. The 11 domains assessed are:~1a-c Level of consciousness 2. Best Gaze 3. Visual 4. Facial Palsy 5a. Motor left arm 5b. Motor right arm 6a. Motor left leg 6b. Motor right leg 7. Limb Ataxia 8. Sensory 9. Best Language 10. Dysarthria 11. Extinction and Inattention"|units on a scale|Mean|11.5|11.5|Standard Deviation|9.9|9.9|||
4459951|NCT00059332|4280279|B1|||National Institute of Health Stroke Scale (NIHSS) at hospital arrival|"The National Institute of Health Stroke Scale (NIHSS) is a measure of neurologic deficit. Total Score range 0-42, with higher scores indicating greater severity. The 11 domains assessed are:~1a-c Level of consciousness 2. Best Gaze 3. Visual 4. Facial Palsy 5a. Motor left arm 5b. Motor right arm 6a. Motor left leg 6b. Motor right leg 7. Limb Ataxia 8. Sensory 9. Best Language 10. Dysarthria 11. Extinction and Inattention"|units on a scale|Mean|11.2|11.2|Standard Deviation|9.8|9.8|||
4459952|NCT00059332|4280277|B3|||Los Angeles Motor Scale at hospital arrival|The Los Angeles Motor Scale (LAMS) Facial droop (sub score is 0-1) Absent 0 Present 1 Arm drift (sub score range is 0-2) Absent 0 Drifts down 1 Falls rapidly 2 Grip strength (sub score range is 0-2) Normal 0 Weak grip 1 No grip 2 The sub scales are summed to obtain a total score. Total Score Range is 0-5. Lower values on the scale represent better outcomes and Higher values on the scale represent worse outcomes.|units on a scale|Mean|3.4|3.4|Standard Deviation|2.3|2.3|||
4459953|NCT00059332|4280278|B2|||Los Angeles Motor Scale at hospital arrival|The Los Angeles Motor Scale (LAMS) Facial droop (sub score is 0-1) Absent 0 Present 1 Arm drift (sub score range is 0-2) Absent 0 Drifts down 1 Falls rapidly 2 Grip strength (sub score range is 0-2) Normal 0 Weak grip 1 No grip 2 The sub scales are summed to obtain a total score. Total Score Range is 0-5. Lower values on the scale represent better outcomes and Higher values on the scale represent worse outcomes.|units on a scale|Mean|3.4|3.4|Standard Deviation|2.3|2.3|||
4459954|NCT00059332|4280279|B1|||Los Angeles Motor Scale at hospital arrival|The Los Angeles Motor Scale (LAMS) Facial droop (sub score is 0-1) Absent 0 Present 1 Arm drift (sub score range is 0-2) Absent 0 Drifts down 1 Falls rapidly 2 Grip strength (sub score range is 0-2) Normal 0 Weak grip 1 No grip 2 The sub scales are summed to obtain a total score. Total Score Range is 0-5. Lower values on the scale represent better outcomes and Higher values on the scale represent worse outcomes.|units on a scale|Mean|3.3|3.3|Standard Deviation|2.2|2.2|||
4459955|NCT00059332|4280277|B3|||Prestroke function - Living at home||participants|Number|1657|1657.0||||||
4459956|NCT00059332|4280278|B2|||Prestroke function - Living at home||participants|Number|834|834.0||||||
4459957|NCT00059332|4280279|B1|||Prestroke function - Living at home||participants|Number|823|823.0||||||
4459958|NCT00059332|4280277|B3|Alcohol use||Medical History||participants|Number|654|654.0||||||
4459959|NCT00059332|4280278|B2|Alcohol use||Medical History||participants|Number|326|326.0||||||
4459960|NCT00059332|4280279|B1|Alcohol use||Medical History||participants|Number|328|328.0||||||
4459961|NCT00059332|4280277|B3|Tobacco use||Medical History||participants|Number|297|297.0||||||
4459963|NCT00059332|4280279|B1|Tobacco use||Medical History||participants|Number|158|158.0||||||
4459964|NCT00059332|4280277|B3|Myocardial infarction||Medical History||participants|Number|176|176.0||||||
4459965|NCT00059332|4280278|B2|Myocardial infarction||Medical History||participants|Number|94|94.0||||||
4459966|NCT00059332|4280279|B1|Myocardial infarction||Medical History||participants|Number|82|82.0||||||
4459967|NCT00059332|4280277|B3|Atrial fibrillation||Medical History||participants|Number|369|369.0||||||
4459968|NCT00059332|4280278|B2|Atrial fibrillation||Medical History||participants|Number|194|194.0||||||
4459969|NCT00059332|4280279|B1|Atrial fibrillation||Medical History||participants|Number|175|175.0||||||
4459970|NCT00059332|4280277|B3|Hyperlipidimia||Medical History||participants|Number|805|805.0||||||
4459971|NCT00059332|4280278|B2|Hyperlipidimia||Medical History||participants|Number|398|398.0||||||
4459972|NCT00059332|4280279|B1|Hyperlipidimia||Medical History||participants|Number|407|407.0||||||
4459973|NCT00059332|4280277|B3|Diabetes||Medical History||participants|Number|377|377.0||||||
4459974|NCT00059332|4280278|B2|Diabetes||Medical History||participants|Number|189|189.0||||||
4459975|NCT00059332|4280279|B1|Diabetes||Medical History||participants|Number|188|188.0||||||
4459976|NCT00059332|4280277|B3|Hypertension||Medical History||participants|Number|1319|1319.0||||||
4459977|NCT00059332|4280278|B2|Hypertension||Medical History||participants|Number|671|671.0||||||
4459978|NCT00059332|4280279|B1|Hypertension||Medical History||participants|Number|648|648.0||||||
4459979|NCT00059332|4280277|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459980|NCT00059332|4280278|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459981|NCT00059332|4280279|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459982|NCT00059332|4280277|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459983|NCT00059332|4280278|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459984|NCT00059332|4280279|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4459985|NCT00059332|4280277|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1325|1325.0||||||
4459986|NCT00059332|4280278|B2||White|Race (NIH/OMB)||Participants|Count of Participants|664|664.0||||||
4459987|NCT00059332|4280279|B1||White|Race (NIH/OMB)||Participants|Count of Participants|661|661.0||||||
4459988|NCT00059332|4280277|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
4459989|NCT00059332|4280278|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4459990|NCT00059332|4280279|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|113|113.0||||||
4459991|NCT00059332|4280277|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4459992|NCT00059332|4280278|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4459993|NCT00059332|4280279|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4459994|NCT00059332|4280277|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|139|139.0||||||
4459995|NCT00059332|4280278|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|77|77.0||||||
4459996|NCT00059332|4280279|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4459997|NCT00059332|4280277|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4459998|NCT00059332|4280278|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4459999|NCT00059332|4280279|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4460000|NCT00059332|4280277|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460001|NCT00059332|4280278|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460002|NCT00059332|4280279|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460003|NCT00059332|4280277|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1298|1298.0||||||
4460004|NCT00059332|4280278|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|661|661.0||||||
4460005|NCT00059332|4280279|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|637|637.0||||||
4460006|NCT00059332|4280277|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|402|402.0||||||
4460007|NCT00059332|4280278|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|196|196.0||||||
4460008|NCT00059332|4280279|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|206|206.0||||||
4460009|NCT00059332|4280277|B3||Male|Sex: Female, Male||Participants|Count of Participants|975|975.0||||||
4460010|NCT00059332|4280278|B2||Male|Sex: Female, Male||Participants|Count of Participants|499|499.0||||||
4460011|NCT00059332|4280279|B1||Male|Sex: Female, Male||Participants|Count of Participants|476|476.0||||||
4460012|NCT00059332|4280277|B3||Female|Sex: Female, Male||Participants|Count of Participants|725|725.0||||||
4460013|NCT00059332|4280278|B2||Female|Sex: Female, Male||Participants|Count of Participants|358|358.0||||||
4460014|NCT00059332|4280279|B1||Female|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4460015|NCT00059332|4280277|B3|>75 years of age||Age, Customized||participants|Number|657|657.0||||||
4460016|NCT00059332|4280278|B2|>75 years of age||Age, Customized||participants|Number|337|337.0||||||
4460017|NCT00059332|4280279|B1|>75 years of age||Age, Customized||participants|Number|320|320.0||||||
4460018|NCT00059332|4280277|B3|60-75 years of age||Age, Customized||participants|Number|562|562.0||||||
4460019|NCT00059332|4280278|B2|60-75 years of age||Age, Customized||participants|Number|278|278.0||||||
4460020|NCT00059332|4280279|B1|60-75 years of age||Age, Customized||participants|Number|284|284.0||||||
4460021|NCT00059332|4280277|B3|<60 years of age||Age, Customized||participants|Number|481|481.0||||||
4460022|NCT00059332|4280278|B2|<60 years of age||Age, Customized||participants|Number|242|242.0||||||
4460023|NCT00059332|4280279|B1|<60 years of age||Age, Customized||participants|Number|239|239.0||||||
4460024|NCT00059332|4280277|B3|||Age||years|Mean|69|69.0|Standard Deviation|13.5|13.5|||
4460025|NCT00059332|4280278|B2|||Age||years|Mean|69|69.0|Standard Deviation|13.4|13.4|||
4460026|NCT00059332|4280279|B1|||Age||years|Mean|69|69.0|Standard Deviation|13.6|13.6|||
4460027|NCT00059215|4280302|B5|United States||Region of Enrollment||participants|Number|723|723.0||||||
4460028|NCT00059215|4280303|B4|United States||Region of Enrollment||participants|Number|208|208.0||||||
4460029|NCT00059215|4280304|B3|United States||Region of Enrollment||participants|Number|203|203.0||||||
4460030|NCT00059215|4280305|B2|United States||Region of Enrollment||participants|Number|156|156.0||||||
4460031|NCT00059215|4280306|B1|United States||Region of Enrollment||participants|Number|156|156.0||||||
4460032|NCT00059215|4280302|B5|Canada||Region of Enrollment||participants|Number|181|181.0||||||
4460033|NCT00059215|4280303|B4|Canada||Region of Enrollment||participants|Number|46|46.0||||||
4460034|NCT00059215|4280304|B3|Canada||Region of Enrollment||participants|Number|48|48.0||||||
4460035|NCT00059215|4280305|B2|Canada||Region of Enrollment||participants|Number|44|44.0||||||
4460036|NCT00059215|4280306|B1|Canada||Region of Enrollment||participants|Number|43|43.0||||||
4460037|NCT00059215|4280302|B5|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4460038|NCT00059215|4280303|B4|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4460039|NCT00059215|4280304|B3|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4460040|NCT00059215|4280305|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4460041|NCT00059215|4280306|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4460042|NCT00059215|4280302|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4460043|NCT00059215|4280303|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4460044|NCT00059215|4280304|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4460045|NCT00059215|4280305|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4460046|NCT00059215|4280306|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4460047|NCT00059215|4280302|B5|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4460048|NCT00059215|4280303|B4|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4460049|NCT00059215|4280304|B3|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4460050|NCT00059215|4280305|B2|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4460051|NCT00059215|4280306|B1|East/Southeast Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4460052|NCT00059215|4280302|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|824|824.0||||||
4460053|NCT00059215|4280303|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|238|238.0||||||
4460054|NCT00059215|4280304|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|226|226.0||||||
4460055|NCT00059215|4280305|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|180|180.0||||||
4460056|NCT00059215|4280306|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|180|180.0||||||
4460057|NCT00059215|4280302|B5|Western Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4460058|NCT00059215|4280303|B4|Western Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4460059|NCT00059215|4280304|B3|Western Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4460060|NCT00059215|4280305|B2|Western Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4460061|NCT00059215|4280306|B1|Western Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4460062|NCT00059215|4280302|B5|African descent||Race/Ethnicity, Customized||participants|Number|48|48.0||||||
4460063|NCT00059215|4280303|B4|African descent||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4460064|NCT00059215|4280304|B3|African descent||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4460065|NCT00059215|4280305|B2|African descent||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4460066|NCT00059215|4280306|B1|African descent||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4460067|NCT00059215|4280302|B5||Male|Sex: Female, Male||Participants|Count of Participants|696|696.0||||||
4460068|NCT00059215|4280303|B4||Male|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4460069|NCT00059215|4280304|B3||Male|Sex: Female, Male||Participants|Count of Participants|198|198.0||||||
4460070|NCT00059215|4280305|B2||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4460071|NCT00059215|4280306|B1||Male|Sex: Female, Male||Participants|Count of Participants|152|152.0||||||
4460072|NCT00059215|4280302|B5||Female|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4460073|NCT00059215|4280303|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4460074|NCT00059215|4280304|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4460075|NCT00059215|4280305|B2||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4460076|NCT00059215|4280306|B1||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4460077|NCT00059215|4280302|B5|||Age||years|Mean|59.2|59.2|Standard Deviation|9.03|9.03|||
4460078|NCT00059215|4280303|B4|||Age||years|Mean|58.4|58.4|Standard Deviation|9.17|9.17|||
4460079|NCT00059215|4280304|B3|||Age||years|Mean|59.4|59.4|Standard Deviation|8.97|8.97|||
4460080|NCT00059215|4280305|B2|||Age||years|Mean|58.7|58.7|Standard Deviation|9.15|9.15|||
4460081|NCT00059215|4280306|B1|||Age||years|Mean|60.4|60.4|Standard Deviation|8.72|8.72|||
4460082|NCT00059215|4280302|B5|> 65 years||Age, Customized||participants|Number|243|243.0||||||
4460083|NCT00059215|4280303|B4|> 65 years||Age, Customized||participants|Number|59|59.0||||||
4460084|NCT00059215|4280304|B3|> 65 years||Age, Customized||participants|Number|66|66.0||||||
4460085|NCT00059215|4280305|B2|> 65 years||Age, Customized||participants|Number|48|48.0||||||
4460086|NCT00059215|4280306|B1|> 65 years||Age, Customized||participants|Number|70|70.0||||||
4460087|NCT00059215|4280302|B5|>18 and <= 65 years||Age, Customized||participants|Number|661|661.0||||||
4460088|NCT00059215|4280303|B4|>18 and <= 65 years||Age, Customized||participants|Number|195|195.0||||||
4460089|NCT00059215|4280304|B3|>18 and <= 65 years||Age, Customized||participants|Number|185|185.0||||||
4460090|NCT00059215|4280305|B2|>18 and <= 65 years||Age, Customized||participants|Number|152|152.0||||||
4460091|NCT00059215|4280306|B1|>18 and <= 65 years||Age, Customized||participants|Number|129|129.0||||||
4460092|NCT00059215|4280302|B5|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4460093|NCT00059215|4280303|B4|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4460094|NCT00059215|4280304|B3|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4460095|NCT00059215|4280305|B2|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4460096|NCT00059215|4280306|B1|<=18 years||Age, Customized||participants|Number|0|0.0||||||
4460097|NCT00059228|4280335|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4460098|NCT00059228|4280336|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460099|NCT00059228|4280337|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460100|NCT00059228|4280335|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460101|NCT00059228|4280336|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460102|NCT00059228|4280337|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460103|NCT00059228|4280335|B3||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4460104|NCT00059228|4280336|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4460105|NCT00059228|4280337|B1||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4460106|NCT00059228|4280335|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4460107|NCT00059228|4280336|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4460108|NCT00059228|4280337|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4460109|NCT00059228|4280335|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460110|NCT00059228|4280336|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460111|NCT00059228|4280337|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460112|NCT00059228|4280335|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460113|NCT00059228|4280336|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460114|NCT00059228|4280337|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460115|NCT00059228|4280335|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460116|NCT00059228|4280336|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460117|NCT00059228|4280337|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460118|NCT00059228|4280335|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460119|NCT00059228|4280336|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460120|NCT00059228|4280337|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460121|NCT00059228|4280335|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4460122|NCT00059228|4280336|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4460123|NCT00059228|4280337|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4460124|NCT00059228|4280335|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4460125|NCT00059228|4280336|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460126|NCT00059228|4280337|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460127|NCT00059228|4280335|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460128|NCT00059228|4280336|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460129|NCT00059228|4280337|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460130|NCT00059228|4280335|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4460131|NCT00059228|4280336|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4460132|NCT00059228|4280337|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4460133|NCT00059228|4280335|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460134|NCT00059228|4280336|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460135|NCT00059228|4280337|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460136|NCT00059228|4280335|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4460137|NCT00059228|4280336|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4460138|NCT00059228|4280337|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4460139|NCT00059228|4280335|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460140|NCT00059228|4280336|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460141|NCT00059228|4280337|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460142|NCT00058825|4280346|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460143|NCT00058825|4280346|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4460144|NCT00058825|4280346|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4460145|NCT00058825|4280346|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4460146|NCT00058825|4280346|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4460147|NCT00058825|4280346|B1|||Age||years|Median|15|15.0|Full Range|||2.0|65.0|
4460148|NCT00058552|4280360|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460149|NCT00058552|4280361|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460150|NCT00058552|4280362|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460151|NCT00058552|4280360|B3||Female|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4460152|NCT00058552|4280361|B2||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4460153|NCT00058552|4280362|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4460154|NCT00058552|4280360|B3|||Age||years|Mean|57.3|57.3|Standard Deviation|10.5|10.5|||
4460155|NCT00058552|4280361|B2|||Age||years|Mean|56.5|56.5|Standard Deviation|11.2|11.2|||
4460156|NCT00058552|4280362|B1|||Age||years|Mean|58.1|58.1|Standard Deviation|9.9|9.9|||
4460157|NCT00058539|4280381|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4460158|NCT00058539|4280381|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460159|NCT00058539|4280381|B1|||Age||years|Mean|67.7|67.7|Standard Deviation|8.8|8.8|||
4460160|NCT00058240|4280391|B5|United States||Region of Enrollment||patients|Number|52|52.0||||||
4460161|NCT00058240|4280392|B4|United States||Region of Enrollment||patients|Number|12|12.0||||||
4460162|NCT00058240|4280393|B3|United States||Region of Enrollment||patients|Number|17|17.0||||||
4460163|NCT00058240|4280394|B2|United States||Region of Enrollment||patients|Number|3|3.0||||||
4460164|NCT00058240|4280395|B1|United States||Region of Enrollment||patients|Number|20|20.0||||||
4460165|NCT00058240|4280391|B5||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4460166|NCT00058240|4280392|B4||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4460167|NCT00058240|4280393|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4460168|NCT00058240|4280394|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4460169|NCT00058240|4280395|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4460170|NCT00058240|4280391|B5||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4460171|NCT00058240|4280392|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4460172|NCT00058240|4280393|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4460173|NCT00058240|4280394|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4460174|NCT00058240|4280395|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4460175|NCT00058240|4280391|B5|||Age||years|Median|60|60.0|Full Range|||38.0|84.0|
4460176|NCT00058240|4280392|B4|||Age||years|Median|60|60.0|Full Range|||38.0|75.0|
4460177|NCT00058240|4280393|B3|||Age||years|Median|55|55.0|Full Range|||39.0|69.0|
4460178|NCT00058240|4280394|B2|||Age||years|Median|52|52.0|Full Range|||44.0|62.0|
4460179|NCT00058240|4280395|B1|||Age||years|Median|61.5|61.5|Full Range|||44.0|84.0|
4460180|NCT00058214|4280408|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4460181|NCT00058214|4280408|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4460182|NCT00058214|4280408|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460183|NCT00058214|4280408|B1|||Age||years|Median|67|67.0|Full Range|||52.0|78.0|
4460184|NCT00058123|4280413|B1|Anaplastic Mixed Oligoastrocytoma||Histology|WHO Classification|participants|Number|3|3.0||||||
4460185|NCT00058123|4280413|B1|Anaplastic Oligodendroglioma||Histology|WHO Classification|participants|Number|10|10.0||||||
4460186|NCT00058123|4280413|B1|Anaplastic Astrocytoma||Histology|WHO Classification|participants|Number|32|32.0||||||
4460187|NCT00058123|4280413|B1|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4460188|NCT00058123|4280413|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460189|NCT00058123|4280413|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460190|NCT00058123|4280413|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4460191|NCT00058123|4280413|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4460192|NCT00058123|4280413|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460193|NCT00058123|4280413|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4460194|NCT00058123|4280413|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460195|NCT00058123|4280413|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4460196|NCT00058123|4280413|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4460197|NCT00058123|4280413|B1|||Age, Customized||years|Median|43|43.0|Full Range|||25.0|70.0|
4460198|NCT00058058|4280420|B1|Unknown||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4460199|NCT00058058|4280420|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|887|887.0||||||
4460200|NCT00058058|4280420|B1|Native Hawaiian Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4460201|NCT00058058|4280420|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|48|48.0||||||
4460202|NCT00058058|4280420|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|23|23.0||||||
4460203|NCT00058058|4280420|B1|American Indian or Alaskan Native||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4460204|NCT00058058|4280420|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4460205|NCT00058058|4280420|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|925|925.0||||||
4460206|NCT00058058|4280420|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4460207|NCT00058058|4280420|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460208|NCT00058058|4280420|B1||Female|Sex: Female, Male||Participants|Count of Participants|969|969.0||||||
4460209|NCT00058058|4280420|B1|||Age||years|Mean|53.3|53.3|Standard Deviation|11.4|11.4|||
4460210|NCT00058019|4280429|B3|No||Prior rituximab||Participants|Number|6|6.0||||||
4460211|NCT00058019|4280430|B2|No||Prior rituximab||Participants|Number|1|1.0||||||
4460212|NCT00058019|4280431|B1|No||Prior rituximab||Participants|Number|5|5.0||||||
4460213|NCT00058019|4280429|B3|Yes||Prior rituximab||Participants|Number|45|45.0||||||
4460214|NCT00058019|4280430|B2|Yes||Prior rituximab||Participants|Number|11|11.0||||||
4460215|NCT00058019|4280431|B1|Yes||Prior rituximab||Participants|Number|34|34.0||||||
4460216|NCT00058019|4280429|B3|4 or more||Prior therapies||Participants|Number|15|15.0||||||
4460217|NCT00058019|4280430|B2|4 or more||Prior therapies||Participants|Number|3|3.0||||||
4460218|NCT00058019|4280431|B1|4 or more||Prior therapies||Participants|Number|12|12.0||||||
4460219|NCT00058019|4280429|B3|2-3||Prior therapies||Participants|Number|22|22.0||||||
4460220|NCT00058019|4280430|B2|2-3||Prior therapies||Participants|Number|5|5.0||||||
4460221|NCT00058019|4280431|B1|2-3||Prior therapies||Participants|Number|17|17.0||||||
4460222|NCT00058019|4280429|B3|1||Prior therapies||Participants|Number|14|14.0||||||
4460223|NCT00058019|4280430|B2|1||Prior therapies||Participants|Number|4|4.0||||||
4460224|NCT00058019|4280431|B1|1||Prior therapies||Participants|Number|10|10.0||||||
4460225|NCT00058019|4280429|B3|No||LDH elevation||Participants|Number|29|29.0||||||
4460226|NCT00058019|4280430|B2|No||LDH elevation||Participants|Number|6|6.0||||||
4460227|NCT00058019|4280431|B1|No||LDH elevation||Participants|Number|23|23.0||||||
4460228|NCT00058019|4280429|B3|Yes||LDH elevation||Participants|Number|22|22.0||||||
4460229|NCT00058019|4280430|B2|Yes||LDH elevation||Participants|Number|6|6.0||||||
4460230|NCT00058019|4280431|B1|Yes||LDH elevation||Participants|Number|16|16.0||||||
4460231|NCT00058019|4280429|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4460232|NCT00058019|4280430|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4460233|NCT00058019|4280431|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4460234|NCT00058019|4280429|B3|African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4460235|NCT00058019|4280430|B2|African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4460236|NCT00058019|4280431|B1|African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4460237|NCT00058019|4280429|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|46|46.0||||||
4460238|NCT00058019|4280430|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4460239|NCT00058019|4280431|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|34|34.0||||||
4460240|NCT00058019|4280429|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4460241|NCT00058019|4280430|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4460242|NCT00058019|4280431|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4460243|NCT00058019|4280429|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4460244|NCT00058019|4280430|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4460245|NCT00058019|4280431|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4460246|NCT00058019|4280429|B3|||Age||years|Median|66|66.0|Full Range|||44.0|90.0|
4460247|NCT00058019|4280430|B2|||Age||years|Median|73|73.0|Full Range|||53.0|87.0|
4460248|NCT00058019|4280431|B1|||Age||years|Median|64|64.0|Full Range|||44.0|90.0|
4460249|NCT00057954|4280445|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4460250|NCT00057954|4280445|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4460251|NCT00057954|4280445|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4460252|NCT00057954|4280445|B1|||Age||years|Median|47|47.0|Full Range|||21.0|60.0|
4460253|NCT00057941|4280451|B3|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4460254|NCT00057941|4280452|B2|South Africa||Region of Enrollment||participants|Number|1|1.0||||||
4460255|NCT00057941|4280453|B1|South Africa||Region of Enrollment||participants|Number|0|0.0||||||
4460256|NCT00057941|4280451|B3|Peru||Region of Enrollment||participants|Number|62|62.0||||||
4460257|NCT00057941|4280452|B2|Peru||Region of Enrollment||participants|Number|29|29.0||||||
4460258|NCT00057941|4280453|B1|Peru||Region of Enrollment||participants|Number|33|33.0||||||
4460259|NCT00057941|4280451|B3|United States||Region of Enrollment||participants|Number|78|78.0||||||
4460260|NCT00057941|4280452|B2|United States||Region of Enrollment||participants|Number|39|39.0||||||
4460261|NCT00057941|4280453|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4460262|NCT00057941|4280451|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460263|NCT00057941|4280452|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460264|NCT00057941|4280453|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460265|NCT00057941|4280451|B3||Female|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4460266|NCT00057941|4280452|B2||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4460267|NCT00057941|4280453|B1||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4460268|NCT00057941|4280451|B3|||Age||years|Median|59|59.0|Full Range|||34.0|91.0|
4460269|NCT00057941|4280452|B2|||Age||years|Median|63|63.0|Full Range|||35.0|91.0|
4460270|NCT00057941|4280453|B1|||Age||years|Median|58|58.0|Full Range|||34.0|90.0|
4460271|NCT00057876|4280460|B3|United States||Region of Enrollment||participants|Number|71|71.0||||||
4460272|NCT00057876|4280461|B2|United States||Region of Enrollment||participants|Number|34|34.0||||||
4460273|NCT00057876|4280462|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4460274|NCT00057876|4280460|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4460275|NCT00057876|4280461|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4460276|NCT00057876|4280462|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4460277|NCT00057876|4280460|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4460278|NCT00057876|4280461|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4460279|NCT00057876|4280462|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4460280|NCT00057876|4280460|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|9.5|9.5|||
4460281|NCT00057876|4280461|B2|||Age||years|Mean|65.3|65.3|Standard Deviation|10.3|10.3|||
4460282|NCT00057876|4280462|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|8.7|8.7|||
4460283|NCT00057863|4280473|B1|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4460284|NCT00057863|4280473|B1|Black||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4460285|NCT00057863|4280473|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4460286|NCT00057863|4280473|B1|White||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4460287|NCT00057863|4280473|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460288|NCT00057863|4280473|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4460289|NCT00057863|4280473|B1|||Age||years|Median|56|56.0|Full Range|||27.0|78.0|
4460290|NCT00057837|4280480|B3||Male|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4460291|NCT00057837|4280481|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4460292|NCT00057837|4280482|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4460293|NCT00057837|4280480|B3||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4460294|NCT00057837|4280481|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4460295|NCT00057837|4280482|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4460296|NCT00057837|4280480|B3|||Age||years|Median|63|63.0|Full Range|||37.0|83.0|
4460297|NCT00057837|4280481|B2|||Age||years|Median|64|64.0|Full Range|||44.0|83.0|
4460298|NCT00057837|4280482|B1|||Age||years|Median|60|60.0|Full Range|||37.0|76.0|
4460299|NCT00057811|4280493|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4460300|NCT00057811|4280494|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4460301|NCT00057811|4280495|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4460302|NCT00057811|4280493|B3|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4460303|NCT00057811|4280494|B2|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4460304|NCT00057811|4280495|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4460305|NCT00057811|4280493|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
4460306|NCT00057811|4280494|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4460307|NCT00057811|4280495|B1|United States||Region of Enrollment||participants|Number|47|47.0||||||
4460308|NCT00057811|4280493|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4460309|NCT00057811|4280494|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4460310|NCT00057811|4280495|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4460311|NCT00057811|4280493|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460312|NCT00057811|4280494|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460313|NCT00057811|4280495|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460314|NCT00057811|4280493|B3||White|Race (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4460315|NCT00057811|4280494|B2||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4460316|NCT00057811|4280495|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4460317|NCT00057811|4280493|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4460318|NCT00057811|4280494|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4460319|NCT00057811|4280495|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4460320|NCT00057811|4280493|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460321|NCT00057811|4280494|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460322|NCT00057811|4280495|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460323|NCT00057811|4280493|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4460324|NCT00057811|4280494|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4460325|NCT00057811|4280495|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4460326|NCT00057811|4280493|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460327|NCT00057811|4280494|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460328|NCT00057811|4280495|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460329|NCT00057811|4280493|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4460330|NCT00057811|4280494|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4460331|NCT00057811|4280495|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460332|NCT00057811|4280493|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|75|75.0||||||
4460333|NCT00057811|4280494|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4460334|NCT00057811|4280495|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4460335|NCT00057811|4280493|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4460336|NCT00057811|4280494|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4460337|NCT00057811|4280495|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4460338|NCT00057811|4280493|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4460339|NCT00057811|4280494|B2||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4460340|NCT00057811|4280495|B1||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4460341|NCT00057811|4280493|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4460342|NCT00057811|4280494|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4460343|NCT00057811|4280495|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4460344|NCT00057811|4280493|B3|||Age||days|Median|3853.5|3853.5|Inter-Quartile Range|||2218.5|5028.5|
4460345|NCT00057811|4280494|B2|||Age||days|Median|3132|3132.0|Inter-Quartile Range|||1940.0|4419.0|
4460346|NCT00057811|4280495|B1|||Age||days|Median|4575|4575.0|Inter-Quartile Range|||2497.0|5638.0|
4460347|NCT00057811|4280493|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460348|NCT00057811|4280494|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460349|NCT00057811|4280495|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460350|NCT00057811|4280493|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4460351|NCT00057811|4280494|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4460352|NCT00057811|4280495|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4460353|NCT00057811|4280493|B3||<=18 years|Age||Participants|Count of Participants|93|93.0||||||
4460354|NCT00057811|4280494|B2||<=18 years|Age||Participants|Count of Participants|44|44.0||||||
4460355|NCT00057811|4280495|B1||<=18 years|Age||Participants|Count of Participants|49|49.0||||||
4460356|NCT00057785|4280508|B1||Male|Gender||Participants|Count of Participants|51|51.0||||||
4460357|NCT00057785|4280508|B1||Female|Gender||Participants|Count of Participants|17|17.0||||||
4460358|NCT00057785|4280508|B1|||Age||years|Median|48.5|48.5|Full Range|||18.0|73.0|
4460359|NCT00057746|4280512|B4||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4460360|NCT00057746|4280513|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4460361|NCT00057746|4280514|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4460362|NCT00057746|4280515|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4460363|NCT00057746|4280512|B4||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4460364|NCT00057746|4280513|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4460365|NCT00057746|4280514|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4460366|NCT00057746|4280515|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4460367|NCT00057746|4280512|B4|||Age||years|Median|62|62.0|Full Range|||39.0|86.0|
4460368|NCT00057746|4280513|B3|||Age||years|Median|61|61.0|Full Range|||44.0|77.0|
4460369|NCT00057746|4280514|B2|||Age||years|Median|62|62.0|Full Range|||39.0|78.0|
4460370|NCT00057746|4280515|B1|||Age||years|Median|62|62.0|Full Range|||39.0|86.0|
4460371|NCT00023673|4280525|B4||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4460372|NCT00023673|4280526|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4460373|NCT00023673|4280527|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4460374|NCT00023673|4280528|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4460375|NCT00023673|4280525|B4||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4460376|NCT00023673|4280526|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4460377|NCT00023673|4280527|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4460378|NCT00023673|4280528|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4460379|NCT00023673|4280525|B4|||Age||years|Median|67|67.0|Full Range|||43.0|83.0|
4460380|NCT00023673|4280526|B3|||Age||years|Median|67|67.0|Full Range|||43.0|83.0|
4460381|NCT00023673|4280527|B2|||Age||years|Median|68|68.0|Full Range|||52.0|81.0|
4460382|NCT00023673|4280528|B1|||Age||years|Median|65.5|65.5|Full Range|||48.0|77.0|
4460383|NCT00057681|4280544|B4|United States||Region of Enrollment||participants|Number|379|379.0||||||
4460384|NCT00057681|4280545|B3|United States||Region of Enrollment||participants|Number|103|103.0||||||
4460385|NCT00057681|4280546|B2|United States||Region of Enrollment||participants|Number|139|139.0||||||
4460386|NCT00057681|4280547|B1|United States||Region of Enrollment||participants|Number|137|137.0||||||
4460387|NCT00057681|4280544|B4||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4460388|NCT00057681|4280545|B3||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4460389|NCT00057681|4280546|B2||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4460390|NCT00057681|4280547|B1||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4460391|NCT00057681|4280544|B4||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4460392|NCT00057681|4280545|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4460393|NCT00057681|4280546|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4460394|NCT00057681|4280547|B1||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4460395|NCT00057681|4280544|B4|||Age||years|Mean|10.19|10.19|Standard Deviation|2.73|2.73|||
4460396|NCT00057681|4280545|B3|||Age||years|Mean|10.99|10.99|Standard Deviation|2.95|2.95|||
4460397|NCT00057681|4280546|B2|||Age||years|Mean|9.85|9.85|Standard Deviation|2.37|2.37|||
4460398|NCT00057681|4280547|B1|||Age||years|Mean|9.92|9.92|Standard Deviation|2.79|2.79|||
4460399|NCT00057681|4280544|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460400|NCT00057681|4280545|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460401|NCT00057681|4280546|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460402|NCT00057681|4280547|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460403|NCT00057681|4280544|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4460404|NCT00057681|4280545|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4460405|NCT00057681|4280546|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4460406|NCT00057681|4280547|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4460407|NCT00057681|4280544|B4||<=18 years|Age||Participants|Count of Participants|379|379.0||||||
4460408|NCT00057681|4280545|B3||<=18 years|Age||Participants|Count of Participants|103|103.0||||||
4460409|NCT00057681|4280546|B2||<=18 years|Age||Participants|Count of Participants|139|139.0||||||
4460410|NCT00057681|4280547|B1||<=18 years|Age||Participants|Count of Participants|137|137.0||||||
4460411|NCT00057577|4280563|B3|||Number of participants who met criteria for Major Depressive Disorder via SCID-MDD||participants|Number|452|452.0||||||
4460412|NCT00057577|4280564|B2|||Number of participants who met criteria for Major Depressive Disorder via SCID-MDD||participants|Number|225|225.0||||||
4460413|NCT00057577|4280565|B1|||Number of participants who met criteria for Major Depressive Disorder via SCID-MDD||participants|Number|227|227.0||||||
4460414|NCT00057577|4280563|B3|United States||Region of Enrollment||participants|Number|452|452.0||||||
4460415|NCT00057577|4280564|B2|United States||Region of Enrollment||participants|Number|225|225.0||||||
4460416|NCT00057577|4280565|B1|United States||Region of Enrollment||participants|Number|227|227.0||||||
4460417|NCT00057577|4280563|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460418|NCT00057577|4280564|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460419|NCT00057577|4280565|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460420|NCT00057577|4280563|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|425|425.0||||||
4460421|NCT00057577|4280564|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|215|215.0||||||
4460422|NCT00057577|4280565|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|210|210.0||||||
4460423|NCT00057577|4280563|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4460424|NCT00057577|4280564|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4460425|NCT00057577|4280565|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4460426|NCT00057577|4280563|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460427|NCT00057577|4280564|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460428|NCT00057577|4280565|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460429|NCT00057577|4280563|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460430|NCT00057577|4280564|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460431|NCT00057577|4280565|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460432|NCT00057577|4280563|B3||White|Race (NIH/OMB)||Participants|Count of Participants|387|387.0||||||
4460433|NCT00057577|4280564|B2||White|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4460434|NCT00057577|4280565|B1||White|Race (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
4460435|NCT00057577|4280563|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4460436|NCT00057577|4280564|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4460437|NCT00057577|4280565|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4460438|NCT00057577|4280563|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460439|NCT00057577|4280564|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460440|NCT00057577|4280565|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460441|NCT00057577|4280563|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4460442|NCT00057577|4280564|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4460443|NCT00057577|4280565|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4460444|NCT00057577|4280563|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4460445|NCT00057577|4280564|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460446|NCT00057577|4280565|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4460447|NCT00057577|4280563|B3||Male|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4460448|NCT00057577|4280564|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4460449|NCT00057577|4280565|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4460450|NCT00057577|4280563|B3||Female|Sex: Female, Male||Participants|Count of Participants|266|266.0||||||
4460451|NCT00057577|4280564|B2||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4460452|NCT00057577|4280565|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4460453|NCT00057577|4280563|B3||>=65 years|Age||Participants|Count of Participants|24|24.0||||||
4460454|NCT00057577|4280564|B2||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4460455|NCT00057577|4280565|B1||>=65 years|Age||Participants|Count of Participants|13|13.0||||||
4460456|NCT00057577|4280563|B3||Between 18 and 65 years|Age||Participants|Count of Participants|428|428.0||||||
4460457|NCT00057577|4280564|B2||Between 18 and 65 years|Age||Participants|Count of Participants|214|214.0||||||
4460458|NCT00057577|4280565|B1||Between 18 and 65 years|Age||Participants|Count of Participants|214|214.0||||||
4460459|NCT00057577|4280563|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460460|NCT00057577|4280564|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460461|NCT00057577|4280565|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460462|NCT00057577|4280563|B3|||Age||years|Mean|43.2|43.2|Standard Deviation|13.1|13.1|||
4460463|NCT00057577|4280564|B2|||Age||years|Mean|43.0|43.0|Standard Deviation|13.4|13.4|||
4460464|NCT00057577|4280565|B1|||Age||years|Mean|43.3|43.3|Standard Deviation|12.9|12.9|||
4460465|NCT00057551|4280580|B4|||Hamilton Depression Scale|Scores range from 0-72 with higher scores indicating more severe depression|units on a scale|Mean|19.48|19.48|Standard Deviation|8.27|8.27|||
4460466|NCT00057551|4280581|B3|||Hamilton Depression Scale|Scores range from 0-72 with higher scores indicating more severe depression|units on a scale|Mean|18.4|18.4|Standard Deviation|8.8|8.8|||
4460467|NCT00057551|4280582|B2|||Hamilton Depression Scale|Scores range from 0-72 with higher scores indicating more severe depression|units on a scale|Mean|19.44|19.44|Standard Deviation|8.31|8.31|||
4460468|NCT00057551|4280583|B1|||Hamilton Depression Scale|Scores range from 0-72 with higher scores indicating more severe depression|units on a scale|Mean|19.52|19.52|Standard Deviation|8.26|8.26|||
4460469|NCT00057551|4280580|B4|United States||Region of Enrollment||participants|Number|491|491.0||||||
4460470|NCT00057551|4280581|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
4460471|NCT00057551|4280582|B2|United States||Region of Enrollment||participants|Number|195|195.0||||||
4460472|NCT00057551|4280583|B1|United States||Region of Enrollment||participants|Number|200|200.0||||||
4460473|NCT00057551|4280580|B4||Male|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4460474|NCT00057551|4280581|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4460475|NCT00057551|4280582|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4460476|NCT00057551|4280583|B1||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4460477|NCT00057551|4280580|B4||Female|Sex: Female, Male||Participants|Count of Participants|272|272.0||||||
4460478|NCT00057551|4280581|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4460479|NCT00057551|4280582|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4460480|NCT00057551|4280583|B1||Female|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4460481|NCT00057551|4280580|B4|||Age||years|Mean|45.9|45.9|Standard Deviation|11.8|11.8|||
4460482|NCT00057551|4280581|B3|||Age||years|Mean|45.3|45.3|Standard Deviation|11.9|11.9|||
4460483|NCT00057551|4280582|B2|||Age||years|Mean|46.4|46.4|Standard Deviation|11.7|11.7|||
4460484|NCT00057551|4280583|B1|||Age||years|Mean|43.2|43.2|Standard Deviation|13.4|13.4|||
4460485|NCT00057330|4280593|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460486|NCT00057330|4280594|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460487|NCT00057330|4280595|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460488|NCT00057330|4280593|B3||Female|Sex: Female, Male||Participants|Count of Participants|8323|8323.0||||||
4460489|NCT00057330|4280594|B2||Female|Sex: Female, Male||Participants|Count of Participants|3746|3746.0||||||
4460490|NCT00057330|4280595|B1||Female|Sex: Female, Male||Participants|Count of Participants|4577|4577.0||||||
4460491|NCT00057330|4280593|B3|||Age||Years|Mean|22.3|22.3|Standard Deviation|3.27|3.27|||
4460492|NCT00057330|4280594|B2|||Age||Years|Mean|22.3|22.3|Standard Deviation|3.23|3.23|||
4460493|NCT00057330|4280595|B1|||Age||Years|Mean|22.3|22.3|Standard Deviation|3.30|3.3|||
4460494|NCT00056862|4280624|B3|HCV Genotype 3||Genotype||participants|Number|23|23.0||||||
4460495|NCT00056862|4280625|B2|HCV Genotype 3||Genotype||participants|Number|14|14.0||||||
4460496|NCT00056862|4280626|B1|HCV Genotype 3||Genotype||participants|Number|9|9.0||||||
4460497|NCT00056862|4280624|B3|HCV Genotype 2||Genotype||participants|Number|34|34.0||||||
4460498|NCT00056862|4280625|B2|HCV Genotype 2||Genotype||participants|Number|13|13.0||||||
4460499|NCT00056862|4280626|B1|HCV Genotype 2||Genotype||participants|Number|21|21.0||||||
4460500|NCT00056862|4280624|B3|||HCV RNA||log IU/mL|Mean|6.1|6.1|Standard Deviation|0.92|0.92|||
4460501|NCT00056862|4280625|B2|||HCV RNA||log IU/mL|Mean|5.9|5.9|Standard Deviation|1.02|1.02|||
4460502|NCT00056862|4280626|B1|||HCV RNA||log IU/mL|Mean|6.3|6.3|Standard Deviation|0.82|0.82|||
4460503|NCT00056862|4280624|B3|||ALT||U/L|Mean|94|94.0|Standard Deviation|77|77.0|||
4460504|NCT00056862|4280625|B2|||ALT||U/L|Mean|97|97.0|Standard Deviation|85|85.0|||
4460505|NCT00056862|4280626|B1|||ALT||U/L|Mean|91|91.0|Standard Deviation|69|69.0|||
4460506|NCT00056862|4280624|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4460507|NCT00056862|4280625|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4460508|NCT00056862|4280626|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4460509|NCT00056862|4280624|B3|African-American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4460510|NCT00056862|4280625|B2|African-American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4460511|NCT00056862|4280626|B1|African-American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4460512|NCT00056862|4280624|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4460513|NCT00056862|4280625|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4460514|NCT00056862|4280626|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4460515|NCT00056862|4280624|B3|Asian||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4460516|NCT00056862|4280625|B2|Asian||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4460517|NCT00056862|4280626|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4460518|NCT00056862|4280624|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|46|46.0||||||
4460519|NCT00056862|4280625|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4460520|NCT00056862|4280626|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4460521|NCT00056862|4280624|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4460522|NCT00056862|4280625|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4460523|NCT00056862|4280626|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4460524|NCT00056862|4280624|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4460525|NCT00056862|4280625|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4460526|NCT00056862|4280626|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4460527|NCT00056862|4280624|B3|||Age||years|Mean|48|48.0|Full Range|||26.0|69.0|
4460528|NCT00056862|4280625|B2|||Age||years|Mean|47|47.0|Full Range|||26.0|69.0|
4460529|NCT00056862|4280626|B1|||Age||years|Mean|48|48.0|Full Range|||29.0|62.0|
4460530|NCT00056563|4280641|B3|United States||Region of Enrollment||participants|Number|255|255.0||||||
4460531|NCT00056563|4280642|B2|United States||Region of Enrollment||participants|Number|134|134.0||||||
4460532|NCT00056563|4280643|B1|United States||Region of Enrollment||participants|Number|121|121.0||||||
4460533|NCT00056563|4280641|B3||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4460534|NCT00056563|4280642|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4460535|NCT00056563|4280643|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4460536|NCT00056563|4280641|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4460537|NCT00056563|4280642|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4460538|NCT00056563|4280643|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4460539|NCT00056563|4280641|B3|||Age||years|Mean|62.3|62.3|Standard Deviation|8.9|8.9|||
4460540|NCT00056563|4280642|B2|||Age||years|Mean|62.3|62.3|Standard Deviation|9.0|9.0|||
4460541|NCT00056563|4280643|B1|||Age||years|Mean|62.4|62.4|Standard Deviation|8.8|8.8|||
4460542|NCT00056563|4280641|B3||>=65 years|Age||Participants|Count of Participants|68|68.0||||||
4460543|NCT00056563|4280642|B2||>=65 years|Age||Participants|Count of Participants|37|37.0||||||
4460544|NCT00056563|4280643|B1||>=65 years|Age||Participants|Count of Participants|31|31.0||||||
4460545|NCT00056563|4280641|B3||Between 18 and 65 years|Age||Participants|Count of Participants|187|187.0||||||
4460546|NCT00056563|4280642|B2||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4460547|NCT00056563|4280643|B1||Between 18 and 65 years|Age||Participants|Count of Participants|90|90.0||||||
4460548|NCT00056563|4280641|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460549|NCT00056563|4280642|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460550|NCT00056563|4280643|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460551|NCT00056550|4280652|B1|||Antithrombin (AT) activity level < or equal to 60%|Inclusion criteria states that the patients must have a history of congenital antithrombin (AT) deficiency that includes two or more plasma AT activity levels < or equal to 60% of normal|Participants|Number|14|14.0||||||
4460552|NCT00056550|4280652|B1|||Prior history of venous thrombotic events|Inclusion criteria states that patients had to have congenital antithrombin (AT) deficiency with a personal or family history of venous thrombotic events.|Participants|Number|14|14.0||||||
4460553|NCT00056550|4280652|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4460554|NCT00056550|4280652|B1|Europe||Region of Enrollment||participants|Number|12|12.0||||||
4460555|NCT00056550|4280652|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460556|NCT00056550|4280652|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460557|NCT00056550|4280652|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4460558|NCT00056550|4280652|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460559|NCT00056550|4280652|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460560|NCT00056550|4280652|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460561|NCT00056550|4280652|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460562|NCT00056550|4280652|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4460563|NCT00056550|4280652|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4460564|NCT00056550|4280652|B1|||Age||years|Mean|36.7|36.7|Standard Deviation|13.6|13.6|||
4460565|NCT00056550|4280652|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4460566|NCT00056550|4280652|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4460567|NCT00056550|4280652|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460568|NCT00056498|4280657|B3|United States||Region of Enrollment||participants|Number|65.0|65.0||||||
4460569|NCT00056498|4280658|B2|United States||Region of Enrollment||participants|Number|35|35.0||||||
4460570|NCT00056498|4280659|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4460571|NCT00056498|4280657|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4460572|NCT00056498|4280658|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4460573|NCT00056498|4280659|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4460574|NCT00056498|4280657|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4460575|NCT00056498|4280658|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4460576|NCT00056498|4280659|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4460577|NCT00056498|4280657|B3|||Age||years|Mean|46.1|46.1|Standard Deviation|8.6|8.6|||
4460578|NCT00056498|4280658|B2|||Age||years|Mean|44.1|44.1|Standard Deviation|9.3|9.3|||
4460579|NCT00056498|4280659|B1|||Age||years|Mean|48.3|48.3|Standard Deviation|7.2|7.2|||
4460580|NCT00056498|4280657|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460581|NCT00056498|4280658|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460582|NCT00056498|4280659|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460583|NCT00056498|4280657|B3||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4460584|NCT00056498|4280658|B2||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4460585|NCT00056498|4280659|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4460586|NCT00056498|4280657|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460587|NCT00056498|4280658|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460588|NCT00056498|4280659|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460589|NCT00056472|4280670|B3|Canada||Region of Enrollment||participants|Number|81|81.0||||||
4460590|NCT00056472|4280671|B2|Canada||Region of Enrollment||participants|Number|41|41.0||||||
4460591|NCT00056472|4280672|B1|Canada||Region of Enrollment||participants|Number|40|40.0||||||
4460592|NCT00056472|4280670|B3|United States||Region of Enrollment||participants|Number|178|178.0||||||
4460593|NCT00056472|4280671|B2|United States||Region of Enrollment||participants|Number|89|89.0||||||
4460594|NCT00056472|4280672|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
4460595|NCT00056472|4280670|B3||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4460596|NCT00056472|4280671|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4460597|NCT00056472|4280672|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4460598|NCT00056472|4280670|B3||Female|Sex: Female, Male||Participants|Count of Participants|166|166.0||||||
4460599|NCT00056472|4280671|B2||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4460600|NCT00056472|4280672|B1||Female|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4460601|NCT00056472|4280670|B3||>=65 years|Age||Participants|Count of Participants|108|108.0||||||
4460602|NCT00056472|4280671|B2||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4460603|NCT00056472|4280672|B1||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4460604|NCT00056472|4280670|B3||Between 18 and 65 years|Age||Participants|Count of Participants|150|150.0||||||
4460605|NCT00056472|4280671|B2||Between 18 and 65 years|Age||Participants|Count of Participants|73|73.0||||||
4460606|NCT00056472|4280672|B1||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4460607|NCT00056472|4280670|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4460608|NCT00056472|4280671|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4460609|NCT00056472|4280672|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460610|NCT00056407|4280683|B3|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4460611|NCT00056407|4280684|B2|Missing||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4460612|NCT00056407|4280685|B1|Missing||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4460613|NCT00056407|4280683|B3|Other||Race/Ethnicity, Customized||participants|Number|82|82.0||||||
4460614|NCT00056407|4280684|B2|Other||Race/Ethnicity, Customized||participants|Number|43|43.0||||||
4460615|NCT00056407|4280685|B1|Other||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4460616|NCT00056407|4280683|B3|American Hispanic||Race/Ethnicity, Customized||participants|Number|333|333.0||||||
4460617|NCT00056407|4280684|B2|American Hispanic||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
4460618|NCT00056407|4280685|B1|American Hispanic||Race/Ethnicity, Customized||participants|Number|173|173.0||||||
4460619|NCT00056407|4280683|B3|Asian||Race/Ethnicity, Customized||participants|Number|134|134.0||||||
4460620|NCT00056407|4280684|B2|Asian||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4460621|NCT00056407|4280685|B1|Asian||Race/Ethnicity, Customized||participants|Number|67|67.0||||||
4460622|NCT00056407|4280683|B3|Black||Race/Ethnicity, Customized||participants|Number|190|190.0||||||
4460623|NCT00056407|4280684|B2|Black||Race/Ethnicity, Customized||participants|Number|91|91.0||||||
4460624|NCT00056407|4280685|B1|Black||Race/Ethnicity, Customized||participants|Number|99|99.0||||||
4460625|NCT00056407|4280683|B3|White||Race/Ethnicity, Customized||participants|Number|7491|7491.0||||||
4460626|NCT00056407|4280684|B2|White||Race/Ethnicity, Customized||participants|Number|3744|3744.0||||||
4460627|NCT00056407|4280685|B1|White||Race/Ethnicity, Customized||participants|Number|3747|3747.0||||||
4460628|NCT00056407|4280683|B3||Male|Sex: Female, Male||Participants|Count of Participants|8231|8231.0||||||
4460629|NCT00056407|4280684|B2||Male|Sex: Female, Male||Participants|Count of Participants|4105|4105.0||||||
4460630|NCT00056407|4280685|B1||Male|Sex: Female, Male||Participants|Count of Participants|4126|4126.0||||||
4460631|NCT00056407|4280683|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460632|NCT00056407|4280684|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460633|NCT00056407|4280685|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460634|NCT00056407|4280683|B3|||Age||years|Mean|62.8|62.8|Standard Deviation|6.06|6.06|||
4460635|NCT00056407|4280684|B2|||Age||years|Mean|62.8|62.8|Standard Deviation|6.04|6.04|||
4460636|NCT00056407|4280685|B1|||Age||years|Mean|62.7|62.7|Standard Deviation|6.08|6.08|||
4460637|NCT00056316|4280742|B3|United States||Region of Enrollment||participants|Number|74|74.0||||||
4460638|NCT00056316|4280743|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4460639|NCT00056316|4280744|B1|United States||Region of Enrollment||participants|Number|33|33.0||||||
4460640|NCT00056316|4280742|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460641|NCT00056316|4280743|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460642|NCT00056316|4280744|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460643|NCT00056316|4280742|B3||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4460644|NCT00056316|4280743|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4460645|NCT00056316|4280744|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4460646|NCT00056316|4280742|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|11.1|11.1|||
4460647|NCT00056316|4280743|B2|||Age||years|Mean|62.9|62.9|Standard Deviation|9.6|9.6|||
4460648|NCT00056316|4280744|B1|||Age||years|Mean|58.4|58.4|Standard Deviation|11.9|11.9|||
4460649|NCT00056316|4280742|B3||>=65 years|Age||Participants|Count of Participants|25|25.0||||||
4460650|NCT00056316|4280743|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4460651|NCT00056316|4280744|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4460652|NCT00056316|4280742|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4460653|NCT00056316|4280743|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4460654|NCT00056316|4280744|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4460655|NCT00056316|4280742|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460656|NCT00056316|4280743|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460657|NCT00056316|4280744|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460658|NCT00056160|4280757|B3|Canada||Region of Enrollment||participants|Number|61|61.0||||||
4460659|NCT00056160|4280758|B2|Canada||Region of Enrollment||participants|Number|26|26.0||||||
4460660|NCT00056160|4280759|B1|Canada||Region of Enrollment||participants|Number|35|35.0||||||
4460661|NCT00056160|4280757|B3|United States||Region of Enrollment||participants|Number|292|292.0||||||
4460662|NCT00056160|4280758|B2|United States||Region of Enrollment||participants|Number|150|150.0||||||
4460663|NCT00056160|4280759|B1|United States||Region of Enrollment||participants|Number|142|142.0||||||
4460664|NCT00056160|4280757|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4460665|NCT00056160|4280758|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4460666|NCT00056160|4280759|B1||Male|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4460667|NCT00056160|4280757|B3||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4460668|NCT00056160|4280758|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4460669|NCT00056160|4280759|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4460670|NCT00056160|4280757|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|9.81|9.81|||
4460671|NCT00056160|4280758|B2|||Age||years|Mean|62.5|62.5|Standard Deviation|9.81|9.81|||
4460672|NCT00056160|4280759|B1|||Age||years|Mean|63.3|63.3|Standard Deviation|9.84|9.84|||
4460673|NCT00056160|4280757|B3||>=65 years|Age||Participants|Count of Participants|156|156.0||||||
4460674|NCT00056160|4280758|B2||>=65 years|Age||Participants|Count of Participants|73|73.0||||||
4460675|NCT00056160|4280759|B1||>=65 years|Age||Participants|Count of Participants|83|83.0||||||
4460676|NCT00056160|4280757|B3||Between 18 and 65 years|Age||Participants|Count of Participants|197|197.0||||||
4460677|NCT00056160|4280758|B2||Between 18 and 65 years|Age||Participants|Count of Participants|103|103.0||||||
4460678|NCT00056160|4280759|B1||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4460679|NCT00056160|4280757|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460680|NCT00056160|4280758|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460681|NCT00056160|4280759|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460682|NCT00055692|4280772|B1|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4460683|NCT00055692|4280772|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4460684|NCT00055692|4280772|B1|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4460685|NCT00055692|4280772|B1|White||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4460686|NCT00055692|4280772|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4460687|NCT00055692|4280772|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4460688|NCT00055692|4280772|B1|||Age||years|Median|58|58.0|Full Range|||21.0|81.0|
4460689|NCT00055601|4280781|B3||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4460690|NCT00055601|4280782|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4460691|NCT00055601|4280783|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4460692|NCT00055601|4280781|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4460693|NCT00055601|4280782|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4460694|NCT00055601|4280783|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4460695|NCT00055601|4280781|B3|||Age||years|Median|66|66.0|Full Range|||44.0|83.0|
4460696|NCT00055601|4280782|B2|||Age||years|Median|67|67.0|Full Range|||44.0|83.0|
4460697|NCT00055601|4280783|B1|||Age||years|Median|65|65.0|Full Range|||48.0|82.0|
4460698|NCT00055497|4280794|B5||Male|Sex: Female, Male|Baseline data were collected in the lead-in study (NCT00055523) and are reported by treatment group determined at Week 4 of NCT00055497.|Participants|Count of Participants|122|122.0||||||
4460699|NCT00055497|4280795|B4||Male|Sex: Female, Male|Baseline data were collected in the lead-in study (NCT00055523) and are reported by treatment group determined at Week 4 of NCT00055497.|Participants|Count of Participants|100|100.0||||||
4460700|NCT00055497|4280796|B3||Male|Sex: Female, Male|Baseline data were collected in the lead-in study (NCT00055523) and are reported by treatment group determined at Week 4 of NCT00055497.|Participants|Count of Participants|9|9.0||||||
4460701|NCT00055497|4280797|B2||Male|Sex: Female, Male|Baseline data were collected in the lead-in study (NCT00055523) and are reported by treatment group determined at Week 4 of NCT00055497.|Participants|Count of Participants|7|7.0||||||
4460702|NCT00055497|4280798|B1||Male|Sex: Female, Male|Baseline data were collected in the lead-in study (NCT00055523) and are reported by treatment group determined at Week 4 of NCT00055497.|Participants|Count of Participants|6|6.0||||||
4460703|NCT00055497|4280794|B5||Female|Sex: Female, Male|Baseline data were collected in the lead-in study (NCT00055523) and are reported by treatment group determined at Week 4 of NCT00055497.|Participants|Count of Participants|137|137.0||||||
4460704|NCT00055497|4280795|B4||Female|Sex: Female, Male|Baseline data were collected in the lead-in study (NCT00055523) and are reported by treatment group determined at Week 4 of NCT00055497.|Participants|Count of Participants|104|104.0||||||
4460705|NCT00055497|4280796|B3||Female|Sex: Female, Male|Baseline data were collected in the lead-in study (NCT00055523) and are reported by treatment group determined at Week 4 of NCT00055497.|Participants|Count of Participants|9|9.0||||||
4460706|NCT00055497|4280797|B2||Female|Sex: Female, Male|Baseline data were collected in the lead-in study (NCT00055523) and are reported by treatment group determined at Week 4 of NCT00055497.|Participants|Count of Participants|12|12.0||||||
4460707|NCT00055497|4280798|B1||Female|Sex: Female, Male|Baseline data were collected in the lead-in study (NCT00055523) and are reported by treatment group determined at Week 4 of NCT00055497.|Participants|Count of Participants|12|12.0||||||
4460708|NCT00055497|4280794|B5||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4460709|NCT00055497|4280795|B4||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4460710|NCT00055497|4280796|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460711|NCT00055497|4280797|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460712|NCT00055497|4280798|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4460713|NCT00055497|4280794|B5||Between 18 and 65 years|Age||Participants|Count of Participants|249|249.0||||||
4460714|NCT00055497|4280795|B4||Between 18 and 65 years|Age||Participants|Count of Participants|195|195.0||||||
4460715|NCT00055497|4280796|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4460716|NCT00055497|4280797|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4460717|NCT00055497|4280798|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4460718|NCT00055497|4280794|B5||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4460719|NCT00055497|4280795|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4460720|NCT00055497|4280796|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460721|NCT00055497|4280797|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460722|NCT00055497|4280798|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460723|NCT00055471|4280843|B4|||Weight||Kilograms (kg)|Mean|103.06|103.06|Standard Deviation|23.405|23.405|||
4460724|NCT00055471|4280844|B3|||Weight||Kilograms (kg)|Mean|103.00|103.0|Standard Deviation|35.595|35.595|||
4460725|NCT00055471|4280845|B2|||Weight||Kilograms (kg)|Mean|107.8|107.8|Standard Deviation|21.060|21.06|||
4460726|NCT00055471|4280846|B1|||Weight||Kilograms (kg)|Mean|87.33|87.33|Standard Deviation|19.035|19.035|||
4460727|NCT00055471|4280843|B4|||Height||Centimeters (cm)|Mean|177|177.0|Standard Deviation|6.69|6.69|||
4460728|NCT00055471|4280844|B3|||Height||Centimeters (cm)|Mean|176.33|176.33|Standard Deviation|5.03|5.03|||
4460729|NCT00055471|4280845|B2|||Height||Centimeters (cm)|Mean|177.10|177.1|Standard Deviation|8.02|8.02|||
4460730|NCT00055471|4280846|B1|||Height||Centimeters (cm)|Mean|177.33|177.33|Standard Deviation|4.51|4.51|||
4460731|NCT00055471|4280843|B4|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4460732|NCT00055471|4280844|B3|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4460733|NCT00055471|4280845|B2|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4460734|NCT00055471|4280846|B1|Other||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4460735|NCT00055471|4280843|B4|Oriental||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4460736|NCT00055471|4280844|B3|Oriental||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4460737|NCT00055471|4280845|B2|Oriental||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4460738|NCT00055471|4280846|B1|Oriental||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4460739|NCT00055471|4280843|B4|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4460740|NCT00055471|4280844|B3|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4460741|NCT00055471|4280845|B2|Black||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4460742|NCT00055471|4280846|B1|Black||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4460743|NCT00055471|4280843|B4|Caucasian||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4460744|NCT00055471|4280844|B3|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4460745|NCT00055471|4280845|B2|Caucasian||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4460746|NCT00055471|4280846|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4460747|NCT00055471|4280843|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4460748|NCT00055471|4280844|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4460749|NCT00055471|4280845|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4460750|NCT00055471|4280846|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4460751|NCT00055471|4280843|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460752|NCT00055471|4280844|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460753|NCT00055471|4280845|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460754|NCT00055471|4280846|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460755|NCT00055471|4280843|B4|Overall||Age||Years|Mean|66.4|66.4|Standard Deviation|8.72|8.72|||
4460756|NCT00055471|4280844|B3|Overall||Age||Years|Mean|66.3|66.3|Standard Deviation|8.08|8.08|||
4460757|NCT00055471|4280845|B2|Overall||Age||Years|Mean|64.6|64.6|Standard Deviation|9.72|9.72|||
4460758|NCT00055471|4280846|B1|Overall||Age||Years|Mean|72.3|72.3|Standard Deviation|3.21|3.21|||
4460759|NCT00055237|4280874|B3|United States||Region of Enrollment||participants|Number|19|19.0||||||
4460760|NCT00055237|4280875|B2|United States||Region of Enrollment||participants|Number|2|2.0||||||
4460761|NCT00055237|4280876|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4460762|NCT00055237|4280874|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460763|NCT00055237|4280875|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460764|NCT00055237|4280876|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460765|NCT00055237|4280874|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4460766|NCT00055237|4280875|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4460767|NCT00055237|4280876|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4460768|NCT00055237|4280874|B3||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4460769|NCT00055237|4280875|B2||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460770|NCT00055237|4280876|B1||Hispanic|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4460771|NCT00055237|4280874|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4460772|NCT00055237|4280875|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4460773|NCT00055237|4280876|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4460774|NCT00055237|4280874|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4460775|NCT00055237|4280875|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460776|NCT00055237|4280876|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4460777|NCT00055237|4280874|B3|||Age||years|Mean|50|50.0|Standard Deviation|11|11.0|||
4460778|NCT00055237|4280875|B2|||Age||years|Mean|58|58.0|Standard Deviation|12.7|12.7|||
4460779|NCT00055237|4280876|B1|||Age||years|Mean|42|42.0|Standard Deviation|9.3|9.3|||
4460780|NCT00055237|4280874|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4460781|NCT00055237|4280875|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4460782|NCT00055237|4280876|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4460783|NCT00055237|4280874|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4460784|NCT00055237|4280875|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4460785|NCT00055237|4280876|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4460786|NCT00055237|4280874|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460787|NCT00055237|4280875|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460788|NCT00055237|4280876|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460789|NCT00054847|4280882|B3|||Triglycerides|Triglycerides level missing for 33 SV and 18 RA patients.|mg/dL|Mean|189.7|189.7|Standard Deviation|131.8|131.8|||
4460790|NCT00054847|4280883|B2|||Triglycerides|Triglycerides level missing for 33 SV and 18 RA patients.|mg/dL|Mean|193.0|193.0|Standard Deviation|143.6|143.6|||
4460791|NCT00054847|4280884|B1|||Triglycerides|Triglycerides level missing for 33 SV and 18 RA patients.|mg/dL|Mean|186.4|186.4|Standard Deviation|118.4|118.4|||
4460792|NCT00054847|4280882|B3|||LDL|LDL level missing for 43 SV and 31 RA patients|mg/dL|Mean|104.9|104.9|Standard Deviation|39.0|39.0|||
4460793|NCT00054847|4280883|B2|||LDL|LDL level missing for 43 SV and 31 RA patients|mg/dL|Mean|104.2|104.2|Standard Deviation|38.4|38.4|||
4460794|NCT00054847|4280884|B1|||LDL|LDL level missing for 43 SV and 31 RA patients|mg/dL|Mean|105.6|105.6|Standard Deviation|39.6|39.6|||
4460795|NCT00054847|4280882|B3|||HDL|HDL level was missing for 34 SV patients and 19 RA patients.|mg/dL|Mean|38.9|38.9|Standard Deviation|11.2|11.2|||
4460796|NCT00054847|4280883|B2|||HDL|HDL level was missing for 34 SV patients and 19 RA patients.|mg/dL|Mean|38.5|38.5|Standard Deviation|10.2|10.2|||
4460797|NCT00054847|4280884|B1|||HDL|HDL level was missing for 34 SV patients and 19 RA patients.|mg/dL|Mean|39.3|39.3|Standard Deviation|12.2|12.2|||
4460798|NCT00054847|4280882|B3|||Total Cholesterol|Total cholesterol level was missing for 26 patients in the saphenous vein (SV) group and 12 patients in the radial artery (RA) group.|mg/dL|Mean|177.7|177.7|Standard Deviation|44.2|44.2|||
4460799|NCT00054847|4280883|B2|||Total Cholesterol|Total cholesterol level was missing for 26 patients in the saphenous vein (SV) group and 12 patients in the radial artery (RA) group.|mg/dL|Mean|178.8|178.8|Standard Deviation|46.8|46.8|||
4460800|NCT00054847|4280884|B1|||Total Cholesterol|Total cholesterol level was missing for 26 patients in the saphenous vein (SV) group and 12 patients in the radial artery (RA) group.|mg/dL|Mean|177.2|177.2|Standard Deviation|41.4|41.4|||
4460801|NCT00054847|4280882|B3|Missing data||Smoking History||participants|Number|3|3.0||||||
4460802|NCT00054847|4280883|B2|Missing data||Smoking History||participants|Number|1|1.0||||||
4460803|NCT00054847|4280884|B1|Missing data||Smoking History||participants|Number|2|2.0||||||
4460804|NCT00054847|4280882|B3|Current smoker||Smoking History||participants|Number|185|185.0||||||
4460805|NCT00054847|4280883|B2|Current smoker||Smoking History||participants|Number|86|86.0||||||
4460806|NCT00054847|4280884|B1|Current smoker||Smoking History||participants|Number|99|99.0||||||
4460807|NCT00054847|4280882|B3|Ex-smoker||Smoking History||participants|Number|437|437.0||||||
4460808|NCT00054847|4280883|B2|Ex-smoker||Smoking History||participants|Number|220|220.0||||||
4460809|NCT00054847|4280884|B1|Ex-smoker||Smoking History||participants|Number|217|217.0||||||
4460810|NCT00054847|4280882|B3|Never smoked||Smoking History||participants|Number|108|108.0||||||
4460811|NCT00054847|4280883|B2|Never smoked||Smoking History||participants|Number|59|59.0||||||
4460812|NCT00054847|4280884|B1|Never smoked||Smoking History||participants|Number|49|49.0||||||
4460813|NCT00054847|4280882|B3|No Previous Myocardial Infarction||Previous Myocardial Infarction|Represents the number of patients who had a previous myocardial infarction.|participants|Number|444|444.0||||||
4460814|NCT00054847|4280883|B2|No Previous Myocardial Infarction||Previous Myocardial Infarction|Represents the number of patients who had a previous myocardial infarction.|participants|Number|220|220.0||||||
4460815|NCT00054847|4280884|B1|No Previous Myocardial Infarction||Previous Myocardial Infarction|Represents the number of patients who had a previous myocardial infarction.|participants|Number|224|224.0||||||
4460816|NCT00054847|4280882|B3|Previous Myocardial Infarction||Previous Myocardial Infarction|Represents the number of patients who had a previous myocardial infarction.|participants|Number|289|289.0||||||
4460817|NCT00054847|4280883|B2|Previous Myocardial Infarction||Previous Myocardial Infarction|Represents the number of patients who had a previous myocardial infarction.|participants|Number|146|146.0||||||
4460818|NCT00054847|4280884|B1|Previous Myocardial Infarction||Previous Myocardial Infarction|Represents the number of patients who had a previous myocardial infarction.|participants|Number|143|143.0||||||
4460819|NCT00054847|4280882|B3|Heart Failure||Comorbidities|Participants may have more than one comorbidity.|participants|Number|43|43.0||||||
4460820|NCT00054847|4280883|B2|Heart Failure||Comorbidities|Participants may have more than one comorbidity.|participants|Number|28|28.0||||||
4460821|NCT00054847|4280884|B1|Heart Failure||Comorbidities|Participants may have more than one comorbidity.|participants|Number|15|15.0||||||
4460822|NCT00054847|4280882|B3|Hypertension||Comorbidities|Participants may have more than one comorbidity.|participants|Number|576|576.0||||||
4460823|NCT00054847|4280883|B2|Hypertension||Comorbidities|Participants may have more than one comorbidity.|participants|Number|289|289.0||||||
4460824|NCT00054847|4280884|B1|Hypertension||Comorbidities|Participants may have more than one comorbidity.|participants|Number|287|287.0||||||
4460825|NCT00054847|4280882|B3|Diabetes mellitus||Comorbidities|Participants may have more than one comorbidity.|participants|Number|307|307.0||||||
4460826|NCT00054847|4280883|B2|Diabetes mellitus||Comorbidities|Participants may have more than one comorbidity.|participants|Number|154|154.0||||||
4460827|NCT00054847|4280884|B1|Diabetes mellitus||Comorbidities|Participants may have more than one comorbidity.|participants|Number|153|153.0||||||
4460828|NCT00054847|4280882|B3|Right Coronary Artery||Target Vessel||participants|Number|211|211.0||||||
4460829|NCT00054847|4280883|B2|Right Coronary Artery||Target Vessel||participants|Number|112|112.0||||||
4460830|NCT00054847|4280884|B1|Right Coronary Artery||Target Vessel||participants|Number|99|99.0||||||
4460831|NCT00054847|4280882|B3|Circumflex||Target Vessel||participants|Number|418|418.0||||||
4460832|NCT00054847|4280883|B2|Circumflex||Target Vessel||participants|Number|203|203.0||||||
4460833|NCT00054847|4280884|B1|Circumflex||Target Vessel||participants|Number|215|215.0||||||
4460834|NCT00054847|4280882|B3|Left Anterior Descending||Target Vessel||participants|Number|104|104.0||||||
4460835|NCT00054847|4280883|B2|Left Anterior Descending||Target Vessel||participants|Number|51|51.0||||||
4460836|NCT00054847|4280884|B1|Left Anterior Descending||Target Vessel||participants|Number|53|53.0||||||
4460837|NCT00054847|4280882|B3|Missing||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|2|2.0||||||
4460838|NCT00054847|4280883|B2|Missing||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|1|1.0||||||
4460839|NCT00054847|4280884|B1|Missing||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|1|1.0||||||
4460840|NCT00054847|4280882|B3|IV||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|88|88.0||||||
4460841|NCT00054847|4280883|B2|IV||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|44|44.0||||||
4460842|NCT00054847|4280884|B1|IV||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|44|44.0||||||
4460843|NCT00054847|4280882|B3|III||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|259|259.0||||||
4460844|NCT00054847|4280883|B2|III||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|127|127.0||||||
4460845|NCT00054847|4280884|B1|III||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|132|132.0||||||
4460846|NCT00054847|4280882|B3|II||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|230|230.0||||||
4460847|NCT00054847|4280883|B2|II||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|115|115.0||||||
4460848|NCT00054847|4280884|B1|II||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|115|115.0||||||
4460849|NCT00054847|4280882|B3|I||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|154|154.0||||||
4460850|NCT00054847|4280883|B2|I||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|79|79.0||||||
4460851|NCT00054847|4280884|B1|I||Canadian Functional Class|Represents increasing angina from minimal (I) to severe incapacitating angina (IV).|participants|Number|75|75.0||||||
4460852|NCT00054847|4280882|B3|Did not specify||Race/Ethnicity, Customized|Race classification was based on prespecified categories and obtained from the patient. One patient did not specify race.|participants|Number|1|1.0||||||
4460853|NCT00054847|4280883|B2|Did not specify||Race/Ethnicity, Customized|Race classification was based on prespecified categories and obtained from the patient. One patient did not specify race.|participants|Number|0|0.0||||||
4460854|NCT00054847|4280884|B1|Did not specify||Race/Ethnicity, Customized|Race classification was based on prespecified categories and obtained from the patient. One patient did not specify race.|participants|Number|1|1.0||||||
4460855|NCT00054847|4280882|B3|Other||Race/Ethnicity, Customized|Race classification was based on prespecified categories and obtained from the patient. One patient did not specify race.|participants|Number|11|11.0||||||
4460856|NCT00054847|4280883|B2|Other||Race/Ethnicity, Customized|Race classification was based on prespecified categories and obtained from the patient. One patient did not specify race.|participants|Number|4|4.0||||||
4460857|NCT00054847|4280884|B1|Other||Race/Ethnicity, Customized|Race classification was based on prespecified categories and obtained from the patient. One patient did not specify race.|participants|Number|7|7.0||||||
4460858|NCT00054847|4280882|B3|Black or African American||Race/Ethnicity, Customized|Race classification was based on prespecified categories and obtained from the patient. One patient did not specify race.|participants|Number|61|61.0||||||
4460859|NCT00054847|4280883|B2|Black or African American||Race/Ethnicity, Customized|Race classification was based on prespecified categories and obtained from the patient. One patient did not specify race.|participants|Number|31|31.0||||||
4460860|NCT00054847|4280884|B1|Black or African American||Race/Ethnicity, Customized|Race classification was based on prespecified categories and obtained from the patient. One patient did not specify race.|participants|Number|30|30.0||||||
4460861|NCT00054847|4280882|B3|White||Race/Ethnicity, Customized|Race classification was based on prespecified categories and obtained from the patient. One patient did not specify race.|participants|Number|660|660.0||||||
4460862|NCT00054847|4280883|B2|White||Race/Ethnicity, Customized|Race classification was based on prespecified categories and obtained from the patient. One patient did not specify race.|participants|Number|331|331.0||||||
4460863|NCT00054847|4280884|B1|White||Race/Ethnicity, Customized|Race classification was based on prespecified categories and obtained from the patient. One patient did not specify race.|participants|Number|329|329.0||||||
4460864|NCT00054847|4280882|B3||Male|Sex: Female, Male||Participants|Count of Participants|727|727.0||||||
4460865|NCT00054847|4280883|B2||Male|Sex: Female, Male||Participants|Count of Participants|365|365.0||||||
4460866|NCT00054847|4280884|B1||Male|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4460867|NCT00054847|4280882|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4460868|NCT00054847|4280883|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4460869|NCT00054847|4280884|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4460870|NCT00054847|4280882|B3|||Age||years|Mean|61.6|61.6|Standard Deviation|8.1|8.1|||
4460871|NCT00054847|4280883|B2|||Age||years|Mean|61|61.0|Standard Deviation|8|8.0|||
4460872|NCT00054847|4280884|B1|||Age||years|Mean|62|62.0|Standard Deviation|8|8.0|||
4460873|NCT00054756|4280897|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4460874|NCT00054756|4280897|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460875|NCT00054756|4280897|B1||White|Race (NIH/OMB)||Participants|Count of Participants|68|68.0||||||
4460876|NCT00054756|4280897|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4460877|NCT00054756|4280897|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460878|NCT00054756|4280897|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4460879|NCT00054756|4280897|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460880|NCT00054756|4280897|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4460881|NCT00054756|4280897|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4460882|NCT00054756|4280897|B1|||Age||years|Mean|38|38.0|Full Range|||9.0|75.0|
4460883|NCT00054756|4280897|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4460884|NCT00054756|4280897|B1||Between 18 and 65 years|Age||Participants|Count of Participants|92|92.0||||||
4460885|NCT00054756|4280897|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4460886|NCT00054717|4280901|B3||Male|Sex: Female, Male||Participants|Count of Participants|565|565.0||||||
4460887|NCT00054717|4280902|B2||Male|Sex: Female, Male||Participants|Count of Participants|287|287.0||||||
4460888|NCT00054717|4280903|B1||Male|Sex: Female, Male||Participants|Count of Participants|278|278.0||||||
4460889|NCT00054717|4280901|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4460890|NCT00054717|4280902|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4460891|NCT00054717|4280903|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4460892|NCT00054717|4280901|B3|||Age||years|Mean|45.1|45.1|Standard Deviation|7.5|7.5|||
4460893|NCT00054717|4280902|B2|||Age||years|Mean|44.5|44.5|Standard Deviation|7.1|7.1|||
4460894|NCT00054717|4280903|B1|||Age||years|Mean|45.6|45.6|Standard Deviation|7.9|7.9|||
4460895|NCT00054704|4281090|B3|United States||Region of Enrollment||Participants|Number|20|20.0||||||
4460896|NCT00054704|4281091|B2|United States||Region of Enrollment||Participants|Number|11|11.0||||||
4460897|NCT00054704|4281092|B1|United States||Region of Enrollment||Participants|Number|9|9.0||||||
4460898|NCT00054704|4281090|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4460899|NCT00054704|4281091|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4460900|NCT00054704|4281092|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4460901|NCT00054704|4281090|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4460902|NCT00054704|4281091|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4460903|NCT00054704|4281092|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4460904|NCT00054704|4281090|B3|||Age||Years|Mean|47.60|47.6|Standard Deviation|12.75|12.75|||
4460905|NCT00054704|4281091|B2|||Age||Years|Mean|48.27|48.27|Standard Deviation|11.15|11.15|||
4460906|NCT00054704|4281092|B1|||Age||Years|Mean|46.78|46.78|Standard Deviation|15.14|15.14|||
4460907|NCT00054691|4281099|B1|United States||Region of Enrollment||participants|Number|40|40.0||||||
4460908|NCT00054691|4281099|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4460909|NCT00054691|4281099|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4460910|NCT00054691|4281099|B1|||Age, Customized||years|Median|67|67.0|Full Range|||37.0|95.0|
4460911|NCT00054665|4281104|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4460912|NCT00054665|4281104|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460913|NCT00054665|4281104|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460914|NCT00054665|4281104|B1||White|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4460915|NCT00054665|4281104|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4460916|NCT00054665|4281104|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460917|NCT00054665|4281104|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460918|NCT00054665|4281104|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460919|NCT00054665|4281104|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460920|NCT00054665|4281104|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4460921|NCT00054665|4281104|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4460922|NCT00054665|4281104|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4460923|NCT00054665|4281104|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4460924|NCT00054665|4281104|B1|||Age||years|Mean|53.04|53.04|Standard Deviation|16.46|16.46|||
4460925|NCT00054665|4281104|B1||>=65 years|Age||Participants|Count of Participants|14|14.0||||||
4460926|NCT00054665|4281104|B1||Between 18 and 65 years|Age||Participants|Count of Participants|36|36.0||||||
4460927|NCT00054665|4281104|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460928|NCT00054639|4281113|B1|United States||Region of Enrollment||participants|Number|46|46.0||||||
4460929|NCT00054639|4281113|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4460930|NCT00054639|4281113|B1||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4460931|NCT00054639|4281113|B1|||Age||years|Median|59|59.0|Full Range|||35.0|82.0|
4460932|NCT00054353|4281117|B3|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4460933|NCT00054353|4281118|B2|Italy||Region of Enrollment||participants|Number|0|0.0||||||
4460934|NCT00054353|4281119|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4460935|NCT00054353|4281117|B3|United States||Region of Enrollment||participants|Number|12|12.0||||||
4460936|NCT00054353|4281118|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4460937|NCT00054353|4281119|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4460938|NCT00054353|4281117|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4460939|NCT00054353|4281118|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4460940|NCT00054353|4281119|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4460941|NCT00054353|4281117|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460942|NCT00054353|4281118|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460943|NCT00054353|4281119|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4460944|NCT00054353|4281117|B3||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4460945|NCT00054353|4281118|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4460946|NCT00054353|4281119|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4460947|NCT00054353|4281117|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4460948|NCT00054353|4281118|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4460949|NCT00054353|4281119|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4460950|NCT00054353|4281117|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460951|NCT00054353|4281118|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460952|NCT00054353|4281119|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4460953|NCT00054327|4281140|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460954|NCT00054327|4281141|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460955|NCT00054327|4281142|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460956|NCT00054327|4281143|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460957|NCT00054327|4281144|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460958|NCT00054327|4281145|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460959|NCT00054327|4281146|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460960|NCT00054327|4281140|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460961|NCT00054327|4281141|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460962|NCT00054327|4281142|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460963|NCT00054327|4281143|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460964|NCT00054327|4281144|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460965|NCT00054327|4281145|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460966|NCT00054327|4281146|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460967|NCT00054327|4281140|B7||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4460968|NCT00054327|4281141|B6||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4460969|NCT00054327|4281142|B5||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4460970|NCT00054327|4281143|B4||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4460971|NCT00054327|4281144|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4460972|NCT00054327|4281145|B2||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4460973|NCT00054327|4281146|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4460974|NCT00054327|4281140|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460975|NCT00054327|4281141|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460976|NCT00054327|4281142|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460977|NCT00054327|4281143|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460978|NCT00054327|4281144|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460979|NCT00054327|4281145|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460980|NCT00054327|4281146|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460981|NCT00054327|4281140|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460982|NCT00054327|4281141|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460983|NCT00054327|4281142|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460984|NCT00054327|4281143|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460985|NCT00054327|4281144|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460986|NCT00054327|4281145|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460987|NCT00054327|4281146|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460988|NCT00054327|4281140|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460989|NCT00054327|4281141|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460990|NCT00054327|4281142|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460991|NCT00054327|4281143|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460992|NCT00054327|4281144|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460993|NCT00054327|4281145|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460994|NCT00054327|4281146|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460995|NCT00054327|4281140|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460996|NCT00054327|4281141|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460997|NCT00054327|4281142|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460998|NCT00054327|4281143|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4460999|NCT00054327|4281144|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461000|NCT00054327|4281145|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461001|NCT00054327|4281146|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461002|NCT00054327|4281140|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461003|NCT00054327|4281141|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461004|NCT00054327|4281142|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461005|NCT00054327|4281143|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461006|NCT00054327|4281144|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461007|NCT00054327|4281145|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461008|NCT00054327|4281146|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461009|NCT00054327|4281140|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|33|33.0||||||
4461010|NCT00054327|4281141|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4461011|NCT00054327|4281142|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4461012|NCT00054327|4281143|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4461013|NCT00054327|4281144|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4461014|NCT00054327|4281145|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4461015|NCT00054327|4281146|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4461016|NCT00054327|4281140|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461017|NCT00054327|4281141|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461018|NCT00054327|4281142|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461019|NCT00054327|4281143|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461020|NCT00054327|4281144|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461021|NCT00054327|4281145|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461022|NCT00054327|4281146|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461023|NCT00054327|4281140|B7||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4461024|NCT00054327|4281141|B6||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4461025|NCT00054327|4281142|B5||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4461026|NCT00054327|4281143|B4||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4461027|NCT00054327|4281144|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4461028|NCT00054327|4281145|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4461029|NCT00054327|4281146|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4461030|NCT00054327|4281140|B7||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4461031|NCT00054327|4281141|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4461032|NCT00054327|4281142|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4461033|NCT00054327|4281143|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4461034|NCT00054327|4281144|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4461035|NCT00054327|4281145|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4461036|NCT00054327|4281146|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4461037|NCT00054327|4281140|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461038|NCT00054327|4281141|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461039|NCT00054327|4281142|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461040|NCT00054327|4281143|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461041|NCT00054327|4281144|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461042|NCT00054327|4281145|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461043|NCT00054327|4281146|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461044|NCT00054327|4281140|B7||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4461045|NCT00054327|4281141|B6||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4461046|NCT00054327|4281142|B5||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4461047|NCT00054327|4281143|B4||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4461048|NCT00054327|4281144|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4461049|NCT00054327|4281145|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4461050|NCT00054327|4281146|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4461051|NCT00054327|4281140|B7||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4461052|NCT00054327|4281141|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461053|NCT00054327|4281142|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461054|NCT00054327|4281143|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4461055|NCT00054327|4281144|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461056|NCT00054327|4281145|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4461057|NCT00054327|4281146|B1||<=18 years|Age||Participants|Count of Participants|8|8.0||||||
4461058|NCT00054275|4281189|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4461059|NCT00054275|4281189|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461060|NCT00054275|4281189|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4461061|NCT00054275|4281189|B1|||Age||years|Median|51|51.0|Full Range|||28.0|78.0|
4461062|NCT00054132|4281195|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4461063|NCT00054132|4281195|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461064|NCT00054132|4281195|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4461065|NCT00054132|4281195|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4461066|NCT00054132|4281195|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4461067|NCT00054132|4281195|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461068|NCT00054028|4281204|B3|3 Prior chemo therapies||Prior chemotherapy (metastatic setting)||patients|Number|2|2.0||||||
4461069|NCT00054028|4281205|B2|3 Prior chemo therapies||Prior chemotherapy (metastatic setting)||patients|Number|2|2.0||||||
4461070|NCT00054028|4281206|B1|3 Prior chemo therapies||Prior chemotherapy (metastatic setting)||patients|Number|0|0.0||||||
4461071|NCT00054028|4281204|B3|2 Prior chemo therapies||Prior chemotherapy (metastatic setting)||patients|Number|10|10.0||||||
4461072|NCT00054028|4281205|B2|2 Prior chemo therapies||Prior chemotherapy (metastatic setting)||patients|Number|3|3.0||||||
4461073|NCT00054028|4281206|B1|2 Prior chemo therapies||Prior chemotherapy (metastatic setting)||patients|Number|7|7.0||||||
4461074|NCT00054028|4281204|B3|1 Prior chemo therapies||Prior chemotherapy (metastatic setting)||patients|Number|14|14.0||||||
4461075|NCT00054028|4281205|B2|1 Prior chemo therapies||Prior chemotherapy (metastatic setting)||patients|Number|4|4.0||||||
4461076|NCT00054028|4281206|B1|1 Prior chemo therapies||Prior chemotherapy (metastatic setting)||patients|Number|10|10.0||||||
4461077|NCT00054028|4281204|B3|0 Prior chemo therapies||Prior chemotherapy (metastatic setting)||patients|Number|5|5.0||||||
4461078|NCT00054028|4281205|B2|0 Prior chemo therapies||Prior chemotherapy (metastatic setting)||patients|Number|0|0.0||||||
4461079|NCT00054028|4281206|B1|0 Prior chemo therapies||Prior chemotherapy (metastatic setting)||patients|Number|5|5.0||||||
4461080|NCT00054028|4281204|B3|Paclitaxel and docetaxel||Prior taxane therapy||patients|Number|2|2.0||||||
4461081|NCT00054028|4281205|B2|Paclitaxel and docetaxel||Prior taxane therapy||patients|Number|2|2.0||||||
4461082|NCT00054028|4281206|B1|Paclitaxel and docetaxel||Prior taxane therapy||patients|Number|0|0.0||||||
4461083|NCT00054028|4281204|B3|Nab-paclitaxel||Prior taxane therapy||patients|Number|1|1.0||||||
4461084|NCT00054028|4281205|B2|Nab-paclitaxel||Prior taxane therapy||patients|Number|1|1.0||||||
4461085|NCT00054028|4281206|B1|Nab-paclitaxel||Prior taxane therapy||patients|Number|0|0.0||||||
4461086|NCT00054028|4281204|B3|Docetaxel||Prior taxane therapy||patients|Number|15|15.0||||||
4461087|NCT00054028|4281205|B2|Docetaxel||Prior taxane therapy||patients|Number|10|10.0||||||
4461088|NCT00054028|4281206|B1|Docetaxel||Prior taxane therapy||patients|Number|5|5.0||||||
4461089|NCT00054028|4281204|B3|Paclitaxel||Prior taxane therapy||patients|Number|13|13.0||||||
4461090|NCT00054028|4281205|B2|Paclitaxel||Prior taxane therapy||patients|Number|9|9.0||||||
4461091|NCT00054028|4281206|B1|Paclitaxel||Prior taxane therapy||patients|Number|4|4.0||||||
4461092|NCT00054028|4281204|B3|Bone||Sites of metastases||patients|Number|17|17.0||||||
4461093|NCT00054028|4281205|B2|Bone||Sites of metastases||patients|Number|11|11.0||||||
4461094|NCT00054028|4281206|B1|Bone||Sites of metastases||patients|Number|6|6.0||||||
4461095|NCT00054028|4281204|B3|Lung||Sites of metastases||patients|Number|16|16.0||||||
4461096|NCT00054028|4281205|B2|Lung||Sites of metastases||patients|Number|10|10.0||||||
4461097|NCT00054028|4281206|B1|Lung||Sites of metastases||patients|Number|6|6.0||||||
4461098|NCT00054028|4281204|B3|Liver||Sites of metastases||patients|Number|15|15.0||||||
4461099|NCT00054028|4281205|B2|Liver||Sites of metastases||patients|Number|12|12.0||||||
4461100|NCT00054028|4281206|B1|Liver||Sites of metastases||patients|Number|3|3.0||||||
4461101|NCT00054028|4281204|B3|≥3||Number of sites of metastastic||patients|Number|9|9.0||||||
4461102|NCT00054028|4281205|B2|≥3||Number of sites of metastastic||patients|Number|6|6.0||||||
4461103|NCT00054028|4281206|B1|≥3||Number of sites of metastastic||patients|Number|3|3.0||||||
4461104|NCT00054028|4281204|B3|2||Number of sites of metastastic||patients|Number|12|12.0||||||
4461105|NCT00054028|4281205|B2|2||Number of sites of metastastic||patients|Number|7|7.0||||||
4461106|NCT00054028|4281206|B1|2||Number of sites of metastastic||patients|Number|5|5.0||||||
4461107|NCT00054028|4281204|B3|1||Number of sites of metastastic||patients|Number|10|10.0||||||
4461108|NCT00054028|4281205|B2|1||Number of sites of metastastic||patients|Number|9|9.0||||||
4461109|NCT00054028|4281206|B1|1||Number of sites of metastastic||patients|Number|1|1.0||||||
4461110|NCT00054028|4281204|B3|Triple negative Status||ER/PR/HER 2 neu status||patients|Number|11|11.0||||||
4461111|NCT00054028|4281205|B2|Triple negative Status||ER/PR/HER 2 neu status||patients|Number|8|8.0||||||
4461112|NCT00054028|4281206|B1|Triple negative Status||ER/PR/HER 2 neu status||patients|Number|3|3.0||||||
4461113|NCT00054028|4281204|B3|HER2 neu+ Status||ER/PR/HER 2 neu status||patients|Number|0|0.0||||||
4461114|NCT00054028|4281205|B2|HER2 neu+ Status||ER/PR/HER 2 neu status||patients|Number|0|0.0||||||
4461115|NCT00054028|4281206|B1|HER2 neu+ Status||ER/PR/HER 2 neu status||patients|Number|0|0.0||||||
4461116|NCT00054028|4281204|B3|ER+ or PR+ Status||ER/PR/HER 2 neu status||patients|Number|20|20.0||||||
4461117|NCT00054028|4281205|B2|ER+ or PR+ Status||ER/PR/HER 2 neu status||patients|Number|14|14.0||||||
4461118|NCT00054028|4281206|B1|ER+ or PR+ Status||ER/PR/HER 2 neu status||patients|Number|6|6.0||||||
4461119|NCT00054028|4281204|B3|Postmenopausal||Menopausal status||patients|Number|30|30.0||||||
4461120|NCT00054028|4281205|B2|Postmenopausal||Menopausal status||patients|Number|21|21.0||||||
4461121|NCT00054028|4281206|B1|Postmenopausal||Menopausal status||patients|Number|9|9.0||||||
4461122|NCT00054028|4281204|B3|Premenopausal||Menopausal status||patients|Number|1|1.0||||||
4461123|NCT00054028|4281205|B2|Premenopausal||Menopausal status||patients|Number|1|1.0||||||
4461124|NCT00054028|4281206|B1|Premenopausal||Menopausal status||patients|Number|0|0.0||||||
4461125|NCT00054028|4281204|B3|ECOG PS 2||ECOG performance status (PS)|"0=Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|patients|Number|3|3.0||||||
4461163|NCT00054028|4281206|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4461126|NCT00054028|4281205|B2|ECOG PS 2||ECOG performance status (PS)|"0=Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|patients|Number|3|3.0||||||
4461127|NCT00054028|4281206|B1|ECOG PS 2||ECOG performance status (PS)|"0=Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|patients|Number|0|0.0||||||
4461128|NCT00054028|4281204|B3|ECOG PS 1||ECOG performance status (PS)|"0=Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|patients|Number|12|12.0||||||
4461129|NCT00054028|4281205|B2|ECOG PS 1||ECOG performance status (PS)|"0=Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|patients|Number|8|8.0||||||
4461130|NCT00054028|4281206|B1|ECOG PS 1||ECOG performance status (PS)|"0=Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|patients|Number|4|4.0||||||
4461131|NCT00054028|4281204|B3|ECOG PS 0||ECOG performance status (PS)|"0=Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|patients|Number|16|16.0||||||
4461132|NCT00054028|4281205|B2|ECOG PS 0||ECOG performance status (PS)|"0=Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|patients|Number|11|11.0||||||
4461133|NCT00054028|4281206|B1|ECOG PS 0||ECOG performance status (PS)|"0=Fully active, able to carry on all pre-disease performance without restriction.~Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours."|patients|Number|5|5.0||||||
4461134|NCT00054028|4281204|B3|United States||Region of Enrollment||patients|Number|31|31.0||||||
4461135|NCT00054028|4281205|B2|United States||Region of Enrollment||patients|Number|22|22.0||||||
4461136|NCT00054028|4281206|B1|United States||Region of Enrollment||patients|Number|9|9.0||||||
4461137|NCT00054028|4281204|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461138|NCT00054028|4281205|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461139|NCT00054028|4281206|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461140|NCT00054028|4281204|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461141|NCT00054028|4281205|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461142|NCT00054028|4281206|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461143|NCT00054028|4281204|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4461144|NCT00054028|4281205|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4461145|NCT00054028|4281206|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4461146|NCT00054028|4281204|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4461147|NCT00054028|4281205|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4461148|NCT00054028|4281206|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461149|NCT00054028|4281204|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461150|NCT00054028|4281205|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461151|NCT00054028|4281206|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461152|NCT00054028|4281204|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461153|NCT00054028|4281205|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461154|NCT00054028|4281206|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461155|NCT00054028|4281204|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461156|NCT00054028|4281205|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461157|NCT00054028|4281206|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461158|NCT00054028|4281204|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461159|NCT00054028|4281205|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461160|NCT00054028|4281206|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461161|NCT00054028|4281204|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4461162|NCT00054028|4281205|B2||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4461164|NCT00054028|4281204|B3|||Age||years|Median|56|56.0|Full Range|||35.0|73.0|
4461165|NCT00054028|4281205|B2|||Age||years|Median|56|56.0|Full Range|||35.0|70.0|
4461166|NCT00054028|4281206|B1|||Age||years|Median|56|56.0|Full Range|||44.0|73.0|
4461167|NCT00053898|4281212|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461168|NCT00053898|4281213|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461169|NCT00053898|4281214|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461170|NCT00053898|4281212|B3||Female|Sex: Female, Male||Participants|Count of Participants|3104|3104.0||||||
4461171|NCT00053898|4281213|B2||Female|Sex: Female, Male||Participants|Count of Participants|1552|1552.0||||||
4461172|NCT00053898|4281214|B1||Female|Sex: Female, Male||Participants|Count of Participants|1552|1552.0||||||
4461173|NCT00053898|4281212|B3|||Age||years|Mean|61.0|61.0|Standard Deviation|7.8|7.8|||
4461174|NCT00053898|4281213|B2|||Age||years|Mean|61.1|61.1|Standard Deviation|7.8|7.8|||
4461175|NCT00053898|4281214|B1|||Age||years|Mean|60.9|60.9|Standard Deviation|7.8|7.8|||
4461176|NCT00053846|4281239|B3|Unknown||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|3|3.0||||||
4461177|NCT00053846|4281240|B2|Unknown||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|1|1.0||||||
4461178|NCT00053846|4281241|B1|Unknown||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|2|2.0||||||
4461179|NCT00053846|4281239|B3|4||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|54|54.0||||||
4461180|NCT00053846|4281240|B2|4||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|32|32.0||||||
4461181|NCT00053846|4281241|B1|4||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|22|22.0||||||
4461182|NCT00053846|4281239|B3|3||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|115|115.0||||||
4461183|NCT00053846|4281240|B2|3||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|54|54.0||||||
4461184|NCT00053846|4281241|B1|3||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|61|61.0||||||
4461185|NCT00053846|4281239|B3|2||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|157|157.0||||||
4461186|NCT00053846|4281240|B2|2||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|80|80.0||||||
4461187|NCT00053846|4281241|B1|2||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|77|77.0||||||
4461188|NCT00053846|4281239|B3|1||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|44|44.0||||||
4461189|NCT00053846|4281240|B2|1||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|23|23.0||||||
4461234|NCT00053846|4281240|B2|Beyond High School||Education||participants|Number|78|78.0||||||
4461190|NCT00053846|4281241|B1|1||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|21|21.0||||||
4461191|NCT00053846|4281239|B3|0||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|6|6.0||||||
4461192|NCT00053846|4281240|B2|0||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|2|2.0||||||
4461193|NCT00053846|4281241|B1|0||Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade|The Modified Medical Research Council Dyspnea Scale (MMRCDS) Grade is assessed on a 5-point scale with a range of 0 to 4. Grade 0 (I only get breathless with strenuous exercise) to Grade 4 (I am too breathless to leave the house or I am breathless when dressing). Higher scores are less favorable.|participants|Number|4|4.0||||||
4461194|NCT00053846|4281239|B3|||O2 Cost Diagram (OCD)|Oxygen Cost Diagram (OCD) is used to evaluate dyspnea on exertion and activities of daily living. OCD is a visual analog scale for quantifying a patient's evaluation of tolerance for exertion. It corresponds to the oxygen requirements at different activity levels. It is presented as a score ranging from 2 (i.e.; even sleeping induces exertion) to 14 (i.e., unable to walk briskly uphill). Higher scores indicate fewer limitations due to dyspnea.|units on a scale|Mean|8.56|8.56|Standard Deviation|2.6|2.6|||
4461195|NCT00053846|4281240|B2|||O2 Cost Diagram (OCD)|Oxygen Cost Diagram (OCD) is used to evaluate dyspnea on exertion and activities of daily living. OCD is a visual analog scale for quantifying a patient's evaluation of tolerance for exertion. It corresponds to the oxygen requirements at different activity levels. It is presented as a score ranging from 2 (i.e.; even sleeping induces exertion) to 14 (i.e., unable to walk briskly uphill). Higher scores indicate fewer limitations due to dyspnea.|units on a scale|Mean|8.43|8.43|Standard Deviation|2.6|2.6|||
4461196|NCT00053846|4281241|B1|||O2 Cost Diagram (OCD)|Oxygen Cost Diagram (OCD) is used to evaluate dyspnea on exertion and activities of daily living. OCD is a visual analog scale for quantifying a patient's evaluation of tolerance for exertion. It corresponds to the oxygen requirements at different activity levels. It is presented as a score ranging from 2 (i.e.; even sleeping induces exertion) to 14 (i.e., unable to walk briskly uphill). Higher scores indicate fewer limitations due to dyspnea.|units on a scale|Mean|8.70|8.7|Standard Deviation|2.6|2.6|||
4461197|NCT00053846|4281239|B3|Unknown||Tumor Stage||participants|Number|15|15.0||||||
4461198|NCT00053846|4281240|B2|Unknown||Tumor Stage||participants|Number|7|7.0||||||
4461199|NCT00053846|4281241|B1|Unknown||Tumor Stage||participants|Number|8|8.0||||||
4461200|NCT00053846|4281239|B3|IV||Tumor Stage||participants|Number|205|205.0||||||
4461201|NCT00053846|4281240|B2|IV||Tumor Stage||participants|Number|102|102.0||||||
4461202|NCT00053846|4281241|B1|IV||Tumor Stage||participants|Number|103|103.0||||||
4461203|NCT00053846|4281239|B3|III||Tumor Stage||participants|Number|102|102.0||||||
4461204|NCT00053846|4281240|B2|III||Tumor Stage||participants|Number|53|53.0||||||
4461205|NCT00053846|4281241|B1|III||Tumor Stage||participants|Number|49|49.0||||||
4461206|NCT00053846|4281239|B3|II||Tumor Stage||participants|Number|35|35.0||||||
4461207|NCT00053846|4281240|B2|II||Tumor Stage||participants|Number|18|18.0||||||
4461208|NCT00053846|4281241|B1|II||Tumor Stage||participants|Number|17|17.0||||||
4461209|NCT00053846|4281239|B3|I||Tumor Stage||participants|Number|22|22.0||||||
4461210|NCT00053846|4281240|B2|I||Tumor Stage||participants|Number|12|12.0||||||
4461211|NCT00053846|4281241|B1|I||Tumor Stage||participants|Number|10|10.0||||||
4461212|NCT00053846|4281239|B3|Other||Tumor Site||participants|Number|60|60.0||||||
4461213|NCT00053846|4281240|B2|Other||Tumor Site||participants|Number|30|30.0||||||
4461214|NCT00053846|4281241|B1|Other||Tumor Site||participants|Number|30|30.0||||||
4461215|NCT00053846|4281239|B3|Gastrointestinal||Tumor Site||participants|Number|35|35.0||||||
4461216|NCT00053846|4281240|B2|Gastrointestinal||Tumor Site||participants|Number|17|17.0||||||
4461217|NCT00053846|4281241|B1|Gastrointestinal||Tumor Site||participants|Number|18|18.0||||||
4461218|NCT00053846|4281239|B3|Breast||Tumor Site||participants|Number|52|52.0||||||
4461219|NCT00053846|4281240|B2|Breast||Tumor Site||participants|Number|27|27.0||||||
4461220|NCT00053846|4281241|B1|Breast||Tumor Site||participants|Number|25|25.0||||||
4461221|NCT00053846|4281239|B3|Lung||Tumor Site||participants|Number|232|232.0||||||
4461222|NCT00053846|4281240|B2|Lung||Tumor Site||participants|Number|118|118.0||||||
4461223|NCT00053846|4281241|B1|Lung||Tumor Site||participants|Number|114|114.0||||||
4461224|NCT00053846|4281239|B3|No||History of chronic obstructive pulmonary disease (COPD)||participants|Number|282|282.0||||||
4461225|NCT00053846|4281240|B2|No||History of chronic obstructive pulmonary disease (COPD)||participants|Number|123|123.0||||||
4461226|NCT00053846|4281241|B1|No||History of chronic obstructive pulmonary disease (COPD)||participants|Number|159|159.0||||||
4461227|NCT00053846|4281239|B3|Yes||History of chronic obstructive pulmonary disease (COPD)||participants|Number|97|97.0||||||
4461228|NCT00053846|4281240|B2|Yes||History of chronic obstructive pulmonary disease (COPD)||participants|Number|69|69.0||||||
4461229|NCT00053846|4281241|B1|Yes||History of chronic obstructive pulmonary disease (COPD)||participants|Number|28|28.0||||||
4461230|NCT00053846|4281239|B3|High School or Less||Education||participants|Number|225|225.0||||||
4461231|NCT00053846|4281240|B2|High School or Less||Education||participants|Number|114|114.0||||||
4461232|NCT00053846|4281241|B1|High School or Less||Education||participants|Number|111|111.0||||||
4461233|NCT00053846|4281239|B3|Beyond High School||Education||participants|Number|154|154.0||||||
4461235|NCT00053846|4281241|B1|Beyond High School||Education||participants|Number|76|76.0||||||
4461236|NCT00053846|4281239|B3|Not Married||Marital Status||participants|Number|126|126.0||||||
4461237|NCT00053846|4281240|B2|Not Married||Marital Status||participants|Number|66|66.0||||||
4461238|NCT00053846|4281241|B1|Not Married||Marital Status||participants|Number|60|60.0||||||
4461239|NCT00053846|4281239|B3|Married||Marital Status||participants|Number|253|253.0||||||
4461240|NCT00053846|4281240|B2|Married||Marital Status||participants|Number|126|126.0||||||
4461241|NCT00053846|4281241|B1|Married||Marital Status||participants|Number|127|127.0||||||
4461242|NCT00053846|4281239|B3|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4461243|NCT00053846|4281240|B2|Other||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4461244|NCT00053846|4281241|B1|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4461245|NCT00053846|4281239|B3|African American||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4461246|NCT00053846|4281240|B2|African American||Race/Ethnicity, Customized||participants|Number|20|20.0||||||
4461247|NCT00053846|4281241|B1|African American||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4461248|NCT00053846|4281239|B3|White||Race/Ethnicity, Customized||participants|Number|337|337.0||||||
4461249|NCT00053846|4281240|B2|White||Race/Ethnicity, Customized||participants|Number|171|171.0||||||
4461250|NCT00053846|4281241|B1|White||Race/Ethnicity, Customized||participants|Number|166|166.0||||||
4461251|NCT00053846|4281239|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4461252|NCT00053846|4281240|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461253|NCT00053846|4281241|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4461254|NCT00053846|4281239|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|370|370.0||||||
4461255|NCT00053846|4281240|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
4461256|NCT00053846|4281241|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|181|181.0||||||
4461257|NCT00053846|4281239|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4461258|NCT00053846|4281240|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4461259|NCT00053846|4281241|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461260|NCT00053846|4281239|B3||Male|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4461261|NCT00053846|4281240|B2||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4461262|NCT00053846|4281241|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4461263|NCT00053846|4281239|B3||Female|Sex: Female, Male||Participants|Count of Participants|195|195.0||||||
4461264|NCT00053846|4281240|B2||Female|Sex: Female, Male||Participants|Count of Participants|95|95.0||||||
4461265|NCT00053846|4281241|B1||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4461266|NCT00053846|4281239|B3|||Age||years|Mean|63.5|63.5|Standard Deviation|9.9|9.9|||
4461267|NCT00053846|4281240|B2|||Age||years|Mean|64.0|64.0|Standard Deviation|9.4|9.4|||
4461268|NCT00053846|4281241|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|10.3|10.3|||
4461269|NCT00053703|4281248|B4|United States||Region of Enrollment||participants|Number|116|116.0||||||
4461270|NCT00053703|4281249|B3|United States||Region of Enrollment||participants|Number|40|40.0||||||
4461271|NCT00053703|4281250|B2|United States||Region of Enrollment||participants|Number|41|41.0||||||
4461272|NCT00053703|4281251|B1|United States||Region of Enrollment||participants|Number|35|35.0||||||
4461273|NCT00053703|4281248|B4||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4461274|NCT00053703|4281249|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4461275|NCT00053703|4281250|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4461276|NCT00053703|4281251|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4461277|NCT00053703|4281248|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4461278|NCT00053703|4281249|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4461279|NCT00053703|4281250|B2||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4461280|NCT00053703|4281251|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4461281|NCT00053703|4281248|B4|||Age||years|Mean|14.25|14.25|Standard Deviation|2.39|2.39|||
4461282|NCT00053703|4281249|B3|||Age||years|Mean|14.3|14.3|Standard Deviation|2.4|2.4|||
4461283|NCT00053703|4281250|B2|||Age||years|Mean|14.54|14.54|Standard Deviation|2.38|2.38|||
4461284|NCT00053703|4281251|B1|||Age||years|Mean|13.84|13.84|Standard Deviation|2.41|2.41|||
4461285|NCT00053703|4281248|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461286|NCT00053703|4281249|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461287|NCT00053703|4281250|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461288|NCT00053703|4281251|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461289|NCT00053703|4281248|B4||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4461290|NCT00053703|4281249|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4461291|NCT00053703|4281250|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4461292|NCT00053703|4281251|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4461293|NCT00053703|4281248|B4||<=18 years|Age||Participants|Count of Participants|114|114.0||||||
4461294|NCT00053703|4281249|B3||<=18 years|Age||Participants|Count of Participants|39|39.0||||||
4461295|NCT00053703|4281250|B2||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4461296|NCT00053703|4281251|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4461297|NCT00053677|4281276|B3|United States||Region of Enrollment||participants|Number|77|77.0||||||
4461298|NCT00053677|4281277|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4461299|NCT00053677|4281278|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4461300|NCT00053677|4281276|B3|Race/Ethnicity|Other Race|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4461301|NCT00053677|4281277|B2|Race/Ethnicity|Other Race|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4461302|NCT00053677|4281278|B1|Race/Ethnicity|Other Race|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4461303|NCT00053677|4281276|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|70|70.0||||||
4461304|NCT00053677|4281277|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4461305|NCT00053677|4281278|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|54|54.0||||||
4461306|NCT00053677|4281276|B3||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4461307|NCT00053677|4281277|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4461308|NCT00053677|4281278|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4461309|NCT00053677|4281276|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4461310|NCT00053677|4281277|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4461311|NCT00053677|4281278|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4461312|NCT00053677|4281276|B3|||Age||Years|Mean|46.3|46.3|Standard Deviation|9.66|9.66|||
4461313|NCT00053677|4281277|B2|||Age||Years|Mean|44.7|44.7|Standard Deviation|9.67|9.67|||
4461314|NCT00053677|4281278|B1|||Age||Years|Mean|47.8|47.8|Standard Deviation|9.65|9.65|||
4461315|NCT00053495|4281285|B6|United States||Region of Enrollment||participants|Number|353|353.0||||||
4461316|NCT00053495|4281286|B5|United States||Region of Enrollment||participants|Number|49|49.0||||||
4461317|NCT00053495|4281287|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
4461318|NCT00053495|4281288|B3|United States||Region of Enrollment||participants|Number|101|101.0||||||
4461319|NCT00053495|4281289|B2|United States||Region of Enrollment||participants|Number|101|101.0||||||
4461320|NCT00053495|4281290|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4461321|NCT00053495|4281285|B6||Male|Sex: Female, Male||Participants|Count of Participants|238|238.0||||||
4461322|NCT00053495|4281286|B5||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4461323|NCT00053495|4281287|B4||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4461324|NCT00053495|4281288|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4461325|NCT00053495|4281289|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4461326|NCT00053495|4281290|B1||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4461327|NCT00053495|4281285|B6||Female|Sex: Female, Male||Participants|Count of Participants|115|115.0||||||
4461328|NCT00053495|4281286|B5||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4461329|NCT00053495|4281287|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4461330|NCT00053495|4281288|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4461331|NCT00053495|4281289|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4461332|NCT00053495|4281290|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4461333|NCT00053495|4281285|B6|||Age||Years|Mean|22|22.0|Standard Deviation|3|3.0|||
4461334|NCT00053495|4281286|B5|||Age||Years|Mean|22|22.0|Standard Deviation|3.1|3.1|||
4461335|NCT00053495|4281287|B4|||Age||Years|Mean|22|22.0|Standard Deviation|3.0|3.0|||
4461336|NCT00053495|4281288|B3|||Age||Years|Mean|22|22.0|Standard Deviation|3.2|3.2|||
4461337|NCT00053495|4281289|B2|||Age||Years|Mean|22|22.0|Standard Deviation|3.1|3.1|||
4461338|NCT00053495|4281290|B1|||Age||Years|Mean|23|23.0|Standard Deviation|2.4|2.4|||
4461339|NCT00053495|4281285|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461340|NCT00053495|4281286|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461341|NCT00053495|4281287|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461342|NCT00053495|4281288|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461343|NCT00053495|4281289|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461344|NCT00053495|4281290|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461345|NCT00053495|4281285|B6||Between 18 and 65 years|Age||Participants|Count of Participants|353|353.0||||||
4461346|NCT00053495|4281286|B5||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4461347|NCT00053495|4281287|B4||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4461348|NCT00053495|4281288|B3||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4461349|NCT00053495|4281289|B2||Between 18 and 65 years|Age||Participants|Count of Participants|101|101.0||||||
4461350|NCT00053495|4281290|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4461351|NCT00053495|4281285|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461352|NCT00053495|4281286|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461353|NCT00053495|4281287|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461354|NCT00053495|4281288|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461355|NCT00053495|4281289|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461356|NCT00053495|4281290|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461357|NCT00053482|4281341|B6|United States||Region of Enrollment||participants|Number|357|357.0||||||
4461358|NCT00053482|4281342|B5|United States||Region of Enrollment||participants|Number|52|52.0||||||
4461359|NCT00053482|4281343|B4|United States||Region of Enrollment||participants|Number|50|50.0||||||
4461360|NCT00053482|4281344|B3|United States||Region of Enrollment||participants|Number|102|102.0||||||
4461361|NCT00053482|4281345|B2|United States||Region of Enrollment||participants|Number|102|102.0||||||
4461362|NCT00053482|4281346|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4461363|NCT00053482|4281341|B6||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4461364|NCT00053482|4281342|B5||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4461365|NCT00053482|4281343|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4461366|NCT00053482|4281344|B3||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4461367|NCT00053482|4281345|B2||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4461368|NCT00053482|4281346|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4461369|NCT00053482|4281341|B6||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4461370|NCT00053482|4281342|B5||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4461371|NCT00053482|4281343|B4||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4461372|NCT00053482|4281344|B3||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4461373|NCT00053482|4281345|B2||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4461374|NCT00053482|4281346|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4461375|NCT00053482|4281341|B6|||Age||Years|Mean|48|48.0|Standard Deviation|10.5|10.5|||
4461376|NCT00053482|4281342|B5|||Age||Years|Mean|48|48.0|Standard Deviation|9.2|9.2|||
4461377|NCT00053482|4281343|B4|||Age||Years|Mean|47|47.0|Standard Deviation|9.1|9.1|||
4461378|NCT00053482|4281344|B3|||Age||Years|Mean|50|50.0|Standard Deviation|11.7|11.7|||
4461379|NCT00053482|4281345|B2|||Age||Years|Mean|48|48.0|Standard Deviation|10.1|10.1|||
4461380|NCT00053482|4281346|B1|||Age||Years|Mean|48|48.0|Standard Deviation|9.7|9.7|||
4461381|NCT00053482|4281341|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461382|NCT00053482|4281342|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461383|NCT00053482|4281343|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461384|NCT00053482|4281344|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461385|NCT00053482|4281345|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461386|NCT00053482|4281346|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461387|NCT00053482|4281341|B6||Between 18 and 65 years|Age||Participants|Count of Participants|357|357.0||||||
4461388|NCT00053482|4281342|B5||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4461389|NCT00053482|4281343|B4||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4461390|NCT00053482|4281344|B3||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4461391|NCT00053482|4281345|B2||Between 18 and 65 years|Age||Participants|Count of Participants|102|102.0||||||
4461392|NCT00053482|4281346|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4461393|NCT00053482|4281341|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461394|NCT00053482|4281342|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461395|NCT00053482|4281343|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461396|NCT00053482|4281344|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461397|NCT00053482|4281345|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461398|NCT00053482|4281346|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461399|NCT00053417|4281397|B5|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4461400|NCT00053417|4281398|B4|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4461401|NCT00053417|4281399|B3|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4461402|NCT00053417|4281400|B2|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4461403|NCT00053417|4281401|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4461404|NCT00053417|4281397|B5|United States||Region of Enrollment||participants|Number|185|185.0||||||
4461405|NCT00053417|4281398|B4|United States||Region of Enrollment||participants|Number|51|51.0||||||
4461406|NCT00053417|4281399|B3|United States||Region of Enrollment||participants|Number|45|45.0||||||
4461407|NCT00053417|4281400|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4461408|NCT00053417|4281401|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4461409|NCT00053417|4281397|B5||Male|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4461410|NCT00053417|4281398|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4461411|NCT00053417|4281399|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4461412|NCT00053417|4281400|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4461413|NCT00053417|4281401|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4461414|NCT00053417|4281397|B5||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4461415|NCT00053417|4281398|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4461416|NCT00053417|4281399|B3||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4461417|NCT00053417|4281400|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4461418|NCT00053417|4281401|B1||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4461419|NCT00053417|4281397|B5|||Age||years|Mean|49.8|49.8|Standard Deviation|8.73|8.73|||
4461420|NCT00053417|4281398|B4|||Age||years|Mean|52.2|52.2|Standard Deviation|8.33|8.33|||
4461421|NCT00053417|4281399|B3|||Age||years|Mean|47.7|47.7|Standard Deviation|8.93|8.93|||
4461422|NCT00053417|4281400|B2|||Age||years|Mean|49.8|49.8|Standard Deviation|8.34|8.34|||
4461423|NCT00053417|4281401|B1|||Age||years|Mean|49.0|49.0|Standard Deviation|8.99|8.99|||
4461424|NCT00053417|4281397|B5||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4461425|NCT00053417|4281398|B4||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4461426|NCT00053417|4281399|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4461427|NCT00053417|4281400|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4461428|NCT00053417|4281401|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4461429|NCT00053417|4281397|B5||Between 18 and 65 years|Age||Participants|Count of Participants|199|199.0||||||
4461430|NCT00053417|4281398|B4||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4461431|NCT00053417|4281399|B3||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4461432|NCT00053417|4281400|B2||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4461433|NCT00053417|4281401|B1||Between 18 and 65 years|Age||Participants|Count of Participants|45|45.0||||||
4461434|NCT00053417|4281397|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461435|NCT00053417|4281398|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461436|NCT00053417|4281399|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461437|NCT00053417|4281400|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461438|NCT00053417|4281401|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461439|NCT00053365|4281414|B1|Undifferentiated Carcinoma||Cell Type||participants|Number|3|3.0||||||
4461440|NCT00053365|4281414|B1|Serous Adenocarcinoma||Cell Type||participants|Number|47|47.0||||||
4461441|NCT00053365|4281414|B1|Mixed Epithelial Carcinoma||Cell Type||participants|Number|3|3.0||||||
4461442|NCT00053365|4281414|B1|Endometrioid Adenocarcinoma||Cell Type||participants|Number|2|2.0||||||
4461443|NCT00053365|4281414|B1|||Recurrent/Persistent Disease|FIGO (International Federation of Gynecology and Obestetrics) Stage Grouping for Primary Carcinoma of the Ovary(1985)|participants|Number|55|55.0||||||
4461444|NCT00053365|4281414|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4461445|NCT00053365|4281414|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461446|NCT00053365|4281414|B1||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4461447|NCT00053365|4281414|B1|80-89 years||Age, Customized||participants|Number|2|2.0||||||
4461448|NCT00053365|4281414|B1|70-79 years||Age, Customized||participants|Number|4|4.0||||||
4461449|NCT00053365|4281414|B1|60-69 years||Age, Customized||participants|Number|21|21.0||||||
4461450|NCT00053365|4281414|B1|50-59 years||Age, Customized||participants|Number|17|17.0||||||
4461451|NCT00053365|4281414|B1|40-49 years||Age, Customized||participants|Number|10|10.0||||||
4461452|NCT00053365|4281414|B1|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4461453|NCT00053365|4281414|B1|||Age||years|Mean|59.2|59.2|Standard Deviation|9.7|9.7|||
4461454|NCT00053352|4281421|B3|Guam||Region of Enrollment||participants|Number|1|1.0||||||
4461455|NCT00053352|4281422|B2|Guam||Region of Enrollment||participants|Number|0|0.0||||||
4461456|NCT00053352|4281423|B1|Guam||Region of Enrollment||participants|Number|1|1.0||||||
4461457|NCT00053352|4281421|B3|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4461458|NCT00053352|4281422|B2|Switzerland||Region of Enrollment||participants|Number|2|2.0||||||
4461459|NCT00053352|4281423|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4461460|NCT00053352|4281421|B3|Australia||Region of Enrollment||participants|Number|9|9.0||||||
4461461|NCT00053352|4281422|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4461462|NCT00053352|4281423|B1|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4461463|NCT00053352|4281421|B3|United States||Region of Enrollment||participants|Number|261|261.0||||||
4461464|NCT00053352|4281422|B2|United States||Region of Enrollment||participants|Number|91|91.0||||||
4461465|NCT00053352|4281423|B1|United States||Region of Enrollment||participants|Number|170|170.0||||||
4461466|NCT00053352|4281421|B3|Canada||Region of Enrollment||participants|Number|24|24.0||||||
4461467|NCT00053352|4281422|B2|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4461468|NCT00053352|4281423|B1|Canada||Region of Enrollment||participants|Number|16|16.0||||||
4461469|NCT00053352|4281421|B3|New Zealand||Region of Enrollment||participants|Number|5|5.0||||||
4461470|NCT00053352|4281422|B2|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4461471|NCT00053352|4281423|B1|New Zealand||Region of Enrollment||participants|Number|2|2.0||||||
4461472|NCT00053352|4281421|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4461473|NCT00053352|4281422|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4461474|NCT00053352|4281423|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4461475|NCT00053352|4281421|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461476|NCT00053352|4281422|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461477|NCT00053352|4281423|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461478|NCT00053352|4281421|B3||White|Race (NIH/OMB)||Participants|Count of Participants|200|200.0||||||
4461479|NCT00053352|4281422|B2||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4461480|NCT00053352|4281423|B1||White|Race (NIH/OMB)||Participants|Count of Participants|128|128.0||||||
4461481|NCT00053352|4281421|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4461482|NCT00053352|4281422|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4461483|NCT00053352|4281423|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4461484|NCT00053352|4281421|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4461485|NCT00053352|4281422|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4461486|NCT00053352|4281423|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461487|NCT00053352|4281421|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4461488|NCT00053352|4281422|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4461489|NCT00053352|4281423|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4461490|NCT00053352|4281421|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4461491|NCT00053352|4281422|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461492|NCT00053352|4281423|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461493|NCT00053352|4281421|B3||Male|Sex: Female, Male||Participants|Count of Participants|128|128.0||||||
4461494|NCT00053352|4281422|B2||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4461495|NCT00053352|4281423|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4461496|NCT00053352|4281421|B3||Female|Sex: Female, Male||Participants|Count of Participants|174|174.0||||||
4461497|NCT00053352|4281422|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4461498|NCT00053352|4281423|B1||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4461499|NCT00053352|4281421|B3|||Age||years|Mean|8.02|8.02|Standard Deviation|6.09|6.09|||
4461500|NCT00053352|4281422|B2|||Age||years|Mean|5.41|5.41|Standard Deviation|5.93|5.93|||
4461501|NCT00053352|4281423|B1|||Age||years|Mean|9.57|9.57|Standard Deviation|5.65|5.65|||
4461502|NCT00053014|4281433|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4461503|NCT00053014|4281433|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4461504|NCT00053014|4281433|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4461505|NCT00053014|4281433|B1|||Age||years|Median|62|62.0|Full Range|||56.0|65.0|
4461506|NCT00003830|4281438|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461507|NCT00003830|4281439|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461508|NCT00003830|4281440|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461509|NCT00003830|4281438|B3||Female|Sex: Female, Male||Participants|Count of Participants|5611|5611.0||||||
4461510|NCT00003830|4281439|B2||Female|Sex: Female, Male||Participants|Count of Participants|2804|2804.0||||||
4461511|NCT00003830|4281440|B1||Female|Sex: Female, Male||Participants|Count of Participants|2807|2807.0||||||
4461512|NCT00003830|4281438|B3|||Age||years|Mean|56|56.0|Standard Deviation|11.1|11.1|||
4461513|NCT00003830|4281439|B2|||Age||years|Mean|56|56.0|Standard Deviation|11.0|11.0|||
4461514|NCT00003830|4281440|B1|||Age||years|Mean|56|56.0|Standard Deviation|11.2|11.2|||
4461515|NCT00052962|4281465|B3|United States||Region of Enrollment||participants|Number|30|30.0||||||
4461516|NCT00052962|4281466|B2|United States||Region of Enrollment||participants|Number|17|17.0||||||
4461517|NCT00052962|4281467|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4461518|NCT00052962|4281465|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4461519|NCT00052962|4281466|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4461520|NCT00052962|4281467|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4461521|NCT00052962|4281465|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461522|NCT00052962|4281466|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461523|NCT00052962|4281467|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461524|NCT00052962|4281465|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461525|NCT00052962|4281466|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461526|NCT00052962|4281467|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461527|NCT00052962|4281465|B3|White||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4461528|NCT00052962|4281466|B2|White||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4461529|NCT00052962|4281467|B1|White||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4461530|NCT00052962|4281465|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4461531|NCT00052962|4281466|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4461532|NCT00052962|4281467|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4461533|NCT00052962|4281465|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461534|NCT00052962|4281466|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461535|NCT00052962|4281467|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461536|NCT00052962|4281465|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461537|NCT00052962|4281466|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461538|NCT00052962|4281467|B1|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461539|NCT00052962|4281465|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461540|NCT00052962|4281466|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461541|NCT00052962|4281467|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4461542|NCT00052962|4281465|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461543|NCT00052962|4281466|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461544|NCT00052962|4281467|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461545|NCT00052962|4281465|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4461546|NCT00052962|4281466|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4461547|NCT00052962|4281467|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4461548|NCT00052962|4281465|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4461549|NCT00052962|4281466|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461550|NCT00052962|4281467|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4461551|NCT00052962|4281465|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4461552|NCT00052962|4281466|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4461553|NCT00052962|4281467|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4461554|NCT00052962|4281465|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4461555|NCT00052962|4281466|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4461556|NCT00052962|4281467|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4461557|NCT00052962|4281465|B3|||Age|Mean values were not calculated for all participants who started the study because one participant was not randomized/not evaluable, two were not evaluable, and/or information is not known.|years|Mean|50.55|50.55|Standard Deviation|13.14|13.14|||
4461558|NCT00052962|4281466|B2|||Age|Mean values were not calculated for all participants who started the study because one participant was not randomized/not evaluable, two were not evaluable, and/or information is not known.|years|Mean|48.64|48.64|Standard Deviation|11.21|11.21|||
4461559|NCT00052962|4281467|B1|||Age|Mean values were not calculated for all participants who started the study because one participant was not randomized/not evaluable, two were not evaluable, and/or information is not known.|years|Mean|51.08|51.08|Standard Deviation|15.58|15.58|||
4461560|NCT00052962|4281465|B3|>=65 years||Age|Two subject's were not evaluable, and/or information is not known for Arm 2.|Participants|Number|2|2.0||||||
4461561|NCT00052962|4281466|B2|>=65 years||Age|Two subject's were not evaluable, and/or information is not known for Arm 2.|Participants|Number|0|0.0||||||
4461562|NCT00052962|4281467|B1|>=65 years||Age|Two subject's were not evaluable, and/or information is not known for Arm 2.|Participants|Number|2|2.0||||||
4461563|NCT00052962|4281465|B3|Between 18 and 65 years||Age|Two subject's were not evaluable, and/or information is not known for Arm 2.|Participants|Number|26|26.0||||||
4461564|NCT00052962|4281466|B2|Between 18 and 65 years||Age|Two subject's were not evaluable, and/or information is not known for Arm 2.|Participants|Number|15|15.0||||||
4461565|NCT00052962|4281467|B1|Between 18 and 65 years||Age|Two subject's were not evaluable, and/or information is not known for Arm 2.|Participants|Number|11|11.0||||||
4461566|NCT00052962|4281465|B3|<=18 years||Age|Two subject's were not evaluable, and/or information is not known for Arm 2.|Participants|Number|0|0.0||||||
4461567|NCT00052962|4281466|B2|<=18 years||Age|Two subject's were not evaluable, and/or information is not known for Arm 2.|Participants|Number|0|0.0||||||
4461568|NCT00052962|4281467|B1|<=18 years||Age|Two subject's were not evaluable, and/or information is not known for Arm 2.|Participants|Number|0|0.0||||||
4461569|NCT00052910|4281476|B3|United States||Region of Enrollment||participants|Number|508|508.0||||||
4461570|NCT00052910|4281477|B2|United States||Region of Enrollment||participants|Number|249|249.0||||||
4461571|NCT00052910|4281478|B1|United States||Region of Enrollment||participants|Number|259|259.0||||||
4461572|NCT00052910|4281476|B3|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4461573|NCT00052910|4281477|B2|Canada||Region of Enrollment||participants|Number|17|17.0||||||
4461574|NCT00052910|4281478|B1|Canada||Region of Enrollment||participants|Number|21|21.0||||||
4461575|NCT00052910|4281476|B3||Male|Sex: Female, Male||Participants|Count of Participants|371|371.0||||||
4461576|NCT00052910|4281477|B2||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4461577|NCT00052910|4281478|B1||Male|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4461578|NCT00052910|4281476|B3||Female|Sex: Female, Male||Participants|Count of Participants|175|175.0||||||
4461579|NCT00052910|4281477|B2||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4461580|NCT00052910|4281478|B1||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4461581|NCT00052910|4281476|B3|||Age||years|Median|58.6|58.6|Full Range|||23.0|83.0|
4461582|NCT00052910|4281477|B2|||Age||years|Median|58|58.0|Full Range|||29.0|83.0|
4461583|NCT00052910|4281478|B1|||Age||years|Median|59|59.0|Full Range|||23.0|81.0|
4461584|NCT00052715|4281487|B1||Gross Total resection|Extent of Resection||Participants|Count of Participants|11|11.0||||||
4461585|NCT00052715|4281487|B1||Subtotal resection|Extent of Resection||Participants|Count of Participants|17|17.0||||||
4461586|NCT00052715|4281487|B1||Biopsy|Extent of Resection||Participants|Count of Participants|2|2.0||||||
4461587|NCT00052715|4281487|B1|||Histology Glioblastoma|WHO Classification|participants|Number|30|30.0||||||
4461588|NCT00052715|4281487|B1|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4461589|NCT00052715|4281487|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461590|NCT00052715|4281487|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461591|NCT00052715|4281487|B1||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4461592|NCT00052715|4281487|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461593|NCT00052715|4281487|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461594|NCT00052715|4281487|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461595|NCT00052715|4281487|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461596|NCT00052715|4281487|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4461597|NCT00052715|4281487|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4461598|NCT00052715|4281487|B1|||Age||years|Median|53|53.0|Full Range|||26.0|76.0|
4461599|NCT00052429|4281496|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4461600|NCT00052429|4281496|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4461601|NCT00052429|4281496|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4461602|NCT00052429|4281496|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4461603|NCT00052429|4281496|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4461604|NCT00052429|4281496|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461605|NCT00049543|4281501|B3|United States||Region of Enrollment||participants|Number|401|401.0||||||
4461606|NCT00049543|4281502|B2|United States||Region of Enrollment||participants|Number|202|202.0||||||
4461607|NCT00049543|4281503|B1|United States||Region of Enrollment||participants|Number|199|199.0||||||
4461608|NCT00049543|4281501|B3|Canada||Region of Enrollment||participants|Number|102|102.0||||||
4461609|NCT00049543|4281502|B2|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4461610|NCT00049543|4281503|B1|Canada||Region of Enrollment||participants|Number|52|52.0||||||
4461611|NCT00049543|4281501|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4461612|NCT00049543|4281502|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4461613|NCT00049543|4281503|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461614|NCT00049543|4281501|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461615|NCT00049543|4281502|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461616|NCT00049543|4281503|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461617|NCT00049543|4281501|B3||White|Race (NIH/OMB)||Participants|Count of Participants|468|468.0||||||
4461618|NCT00049543|4281502|B2||White|Race (NIH/OMB)||Participants|Count of Participants|235|235.0||||||
4461619|NCT00049543|4281503|B1||White|Race (NIH/OMB)||Participants|Count of Participants|233|233.0||||||
4461620|NCT00049543|4281501|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4461621|NCT00049543|4281502|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4461622|NCT00049543|4281503|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4461623|NCT00049543|4281501|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461624|NCT00049543|4281502|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461625|NCT00049543|4281503|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461626|NCT00049543|4281501|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4461627|NCT00049543|4281502|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4461628|NCT00049543|4281503|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4461629|NCT00049543|4281501|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4461630|NCT00049543|4281502|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4461631|NCT00049543|4281503|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4461632|NCT00049543|4281501|B3||Male|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4461633|NCT00049543|4281502|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4461634|NCT00049543|4281503|B1||Male|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4461635|NCT00049543|4281501|B3||Female|Sex: Female, Male||Participants|Count of Participants|232|232.0||||||
4461636|NCT00049543|4281502|B2||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4461637|NCT00049543|4281503|B1||Female|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4461638|NCT00049543|4281501|B3|||Age||years|Median|66.7|66.7|Full Range|||30.4|88.0|
4461639|NCT00049543|4281502|B2|||Age||years|Median|65.9|65.9|Full Range|||30.4|86.9|
4461640|NCT00049543|4281503|B1|||Age||years|Median|67.3|67.3|Full Range|||38.9|88.0|
4461641|NCT00049543|4281501|B3||>=65 years|Age||Participants|Count of Participants|278|278.0||||||
4461642|NCT00049543|4281502|B2||>=65 years|Age||Participants|Count of Participants|132|132.0||||||
4461643|NCT00049543|4281503|B1||>=65 years|Age||Participants|Count of Participants|146|146.0||||||
4461644|NCT00049543|4281501|B3||Between 18 and 65 years|Age||Participants|Count of Participants|225|225.0||||||
4461645|NCT00049543|4281502|B2||Between 18 and 65 years|Age||Participants|Count of Participants|120|120.0||||||
4461646|NCT00049543|4281503|B1||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4461647|NCT00049543|4281501|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461648|NCT00049543|4281502|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461649|NCT00049543|4281503|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461650|NCT00049530|4281514|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4461651|NCT00049530|4281514|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4461652|NCT00049530|4281514|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4461653|NCT00049530|4281514|B1|||Age||years|Median|64|64.0|Full Range|||39.0|84.0|
4461654|NCT00049517|4281521|B3||Male|Gender||Participants|Count of Participants|335|335.0||||||
4461655|NCT00049517|4281522|B2||Male|Gender||Participants|Count of Participants|163|163.0||||||
4461656|NCT00049517|4281523|B1||Male|Gender||Participants|Count of Participants|172|172.0||||||
4461657|NCT00049517|4281521|B3||Female|Gender||Participants|Count of Participants|322|322.0||||||
4461658|NCT00049517|4281522|B2||Female|Gender||Participants|Count of Participants|164|164.0||||||
4461659|NCT00049517|4281523|B1||Female|Gender||Participants|Count of Participants|158|158.0||||||
4461660|NCT00049517|4281521|B3|||Age||years|Median|48|48.0|Full Range|||17.0|60.0|
4461661|NCT00049517|4281522|B2|||Age||years|Median|48|48.0|Full Range|||18.0|60.0|
4461662|NCT00049517|4281523|B1|||Age||years|Median|47|47.0|Full Range|||17.0|60.0|
4461663|NCT00049504|4281538|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4461664|NCT00049504|4281538|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4461665|NCT00049504|4281538|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4461666|NCT00049504|4281538|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4461667|NCT00049504|4281538|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4461668|NCT00049504|4281538|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461669|NCT00049504|4281538|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4461670|NCT00049504|4281538|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461671|NCT00049504|4281538|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4461672|NCT00049504|4281538|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4461673|NCT00049504|4281538|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4461674|NCT00049504|4281538|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4461675|NCT00049504|4281538|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4461676|NCT00049504|4281538|B1|||Age||years|Median|40|40.0|Full Range|||18.0|73.0|
4461677|NCT00049322|4281544|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4461678|NCT00049322|4281545|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4461679|NCT00049322|4281546|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4461680|NCT00049322|4281544|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4461681|NCT00049322|4281545|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4461682|NCT00049322|4281546|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4461683|NCT00049322|4281544|B3|Median age||Age, Customized||years|Median|59.5|59.5|Full Range|||49.0|79.0|
4461684|NCT00049322|4281545|B2|Median age||Age, Customized||years|Median|58|58.0|Full Range|||49.0|75.0|
4461685|NCT00049322|4281546|B1|Median age||Age, Customized||years|Median|61|61.0|Full Range|||50.0|79.0|
4461686|NCT00049257|4281559|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461687|NCT00049257|4281559|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461688|NCT00049257|4281559|B1||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4461689|NCT00049257|4281559|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4461690|NCT00049257|4281559|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461691|NCT00049257|4281559|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4461692|NCT00049257|4281559|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461693|NCT00049257|4281559|B1||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4461694|NCT00049257|4281559|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461695|NCT00049257|4281559|B1|||Age||years|Median|71|71.0|Full Range|||49.0|85.0|
4461696|NCT00049127|4281566|B6|2||Performance Score|"Eastern Cooperative Oncology Group (ECOG) PERFORMANCE STATUS:~0=Asymptomatic and fully active~1=Symptomatic; fully ambulatory; restricted in physically strenuous activity~2=Symptomatic; ambulatory; capable of self-care; more than 50% of waking hours are spent out of bed~3=Symptomatic; limited self-care; spends more than 50% of time in bed, but not bedridden~4=Completely disabled; no self-care; bedridden"|participants|Number|9|9.0||||||
4461697|NCT00049127|4281567|B5|2||Performance Score|"Eastern Cooperative Oncology Group (ECOG) PERFORMANCE STATUS:~0=Asymptomatic and fully active~1=Symptomatic; fully ambulatory; restricted in physically strenuous activity~2=Symptomatic; ambulatory; capable of self-care; more than 50% of waking hours are spent out of bed~3=Symptomatic; limited self-care; spends more than 50% of time in bed, but not bedridden~4=Completely disabled; no self-care; bedridden"|participants|Number|2|2.0||||||
4461698|NCT00049127|4281569|B3|2||Performance Score|"Eastern Cooperative Oncology Group (ECOG) PERFORMANCE STATUS:~0=Asymptomatic and fully active~1=Symptomatic; fully ambulatory; restricted in physically strenuous activity~2=Symptomatic; ambulatory; capable of self-care; more than 50% of waking hours are spent out of bed~3=Symptomatic; limited self-care; spends more than 50% of time in bed, but not bedridden~4=Completely disabled; no self-care; bedridden"|participants|Number|6|6.0||||||
4461734|NCT00049036|4281604|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4461699|NCT00049127|4281571|B1|2||Performance Score|"Eastern Cooperative Oncology Group (ECOG) PERFORMANCE STATUS:~0=Asymptomatic and fully active~1=Symptomatic; fully ambulatory; restricted in physically strenuous activity~2=Symptomatic; ambulatory; capable of self-care; more than 50% of waking hours are spent out of bed~3=Symptomatic; limited self-care; spends more than 50% of time in bed, but not bedridden~4=Completely disabled; no self-care; bedridden"|participants|Number|1|1.0||||||
4461700|NCT00049127|4281566|B6|1||Performance Score|"Eastern Cooperative Oncology Group (ECOG) PERFORMANCE STATUS:~0=Asymptomatic and fully active~1=Symptomatic; fully ambulatory; restricted in physically strenuous activity~2=Symptomatic; ambulatory; capable of self-care; more than 50% of waking hours are spent out of bed~3=Symptomatic; limited self-care; spends more than 50% of time in bed, but not bedridden~4=Completely disabled; no self-care; bedridden"|participants|Number|31|31.0||||||
4461701|NCT00049127|4281567|B5|1||Performance Score|"Eastern Cooperative Oncology Group (ECOG) PERFORMANCE STATUS:~0=Asymptomatic and fully active~1=Symptomatic; fully ambulatory; restricted in physically strenuous activity~2=Symptomatic; ambulatory; capable of self-care; more than 50% of waking hours are spent out of bed~3=Symptomatic; limited self-care; spends more than 50% of time in bed, but not bedridden~4=Completely disabled; no self-care; bedridden"|participants|Number|4|4.0||||||
4461702|NCT00049127|4281569|B3|1||Performance Score|"Eastern Cooperative Oncology Group (ECOG) PERFORMANCE STATUS:~0=Asymptomatic and fully active~1=Symptomatic; fully ambulatory; restricted in physically strenuous activity~2=Symptomatic; ambulatory; capable of self-care; more than 50% of waking hours are spent out of bed~3=Symptomatic; limited self-care; spends more than 50% of time in bed, but not bedridden~4=Completely disabled; no self-care; bedridden"|participants|Number|23|23.0||||||
4461703|NCT00049127|4281571|B1|1||Performance Score|"Eastern Cooperative Oncology Group (ECOG) PERFORMANCE STATUS:~0=Asymptomatic and fully active~1=Symptomatic; fully ambulatory; restricted in physically strenuous activity~2=Symptomatic; ambulatory; capable of self-care; more than 50% of waking hours are spent out of bed~3=Symptomatic; limited self-care; spends more than 50% of time in bed, but not bedridden~4=Completely disabled; no self-care; bedridden"|participants|Number|4|4.0||||||
4461704|NCT00049127|4281566|B6|0||Performance Score|"Eastern Cooperative Oncology Group (ECOG) PERFORMANCE STATUS:~0=Asymptomatic and fully active~1=Symptomatic; fully ambulatory; restricted in physically strenuous activity~2=Symptomatic; ambulatory; capable of self-care; more than 50% of waking hours are spent out of bed~3=Symptomatic; limited self-care; spends more than 50% of time in bed, but not bedridden~4=Completely disabled; no self-care; bedridden"|participants|Number|23|23.0||||||
4461705|NCT00049127|4281567|B5|0||Performance Score|"Eastern Cooperative Oncology Group (ECOG) PERFORMANCE STATUS:~0=Asymptomatic and fully active~1=Symptomatic; fully ambulatory; restricted in physically strenuous activity~2=Symptomatic; ambulatory; capable of self-care; more than 50% of waking hours are spent out of bed~3=Symptomatic; limited self-care; spends more than 50% of time in bed, but not bedridden~4=Completely disabled; no self-care; bedridden"|participants|Number|6|6.0||||||
4461706|NCT00049127|4281569|B3|0||Performance Score|"Eastern Cooperative Oncology Group (ECOG) PERFORMANCE STATUS:~0=Asymptomatic and fully active~1=Symptomatic; fully ambulatory; restricted in physically strenuous activity~2=Symptomatic; ambulatory; capable of self-care; more than 50% of waking hours are spent out of bed~3=Symptomatic; limited self-care; spends more than 50% of time in bed, but not bedridden~4=Completely disabled; no self-care; bedridden"|participants|Number|10|10.0||||||
4461707|NCT00049127|4281571|B1|0||Performance Score|"Eastern Cooperative Oncology Group (ECOG) PERFORMANCE STATUS:~0=Asymptomatic and fully active~1=Symptomatic; fully ambulatory; restricted in physically strenuous activity~2=Symptomatic; ambulatory; capable of self-care; more than 50% of waking hours are spent out of bed~3=Symptomatic; limited self-care; spends more than 50% of time in bed, but not bedridden~4=Completely disabled; no self-care; bedridden"|participants|Number|7|7.0||||||
4461708|NCT00049127|4281566|B6||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4461709|NCT00049127|4281567|B5||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4461710|NCT00049127|4281569|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4461711|NCT00049127|4281571|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4461712|NCT00049127|4281566|B6||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4461713|NCT00049127|4281567|B5||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4461714|NCT00049127|4281569|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4461715|NCT00049127|4281571|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4461716|NCT00049127|4281566|B6|participants||Age||years|Median|46|46.0|Full Range|||22.0|83.0|
4461717|NCT00049127|4281567|B5|participants||Age||years|Median|47|47.0|Full Range|||22.0|59.0|
4461718|NCT00049127|4281569|B3|participants||Age||years|Median|46|46.0|Full Range|||22.0|83.0|
4461719|NCT00049127|4281571|B1|participants||Age||years|Median|45|45.0|Full Range|||34.0|65.0|
4461720|NCT00049036|4281602|B3|United States||Region of Enrollment||participants|Number|106|106.0||||||
4461721|NCT00049036|4281603|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4461722|NCT00049036|4281604|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4461723|NCT00049036|4281602|B3||Male|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4461724|NCT00049036|4281603|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4461725|NCT00049036|4281604|B1||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4461726|NCT00049036|4281602|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4461727|NCT00049036|4281603|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4461728|NCT00049036|4281604|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4461729|NCT00049036|4281602|B3|||Age||years|Mean|42.6|42.6|Standard Deviation|8.9|8.9|||
4461730|NCT00049036|4281603|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|9.4|9.4|||
4461731|NCT00049036|4281604|B1|||Age||years|Mean|42.6|42.6|Standard Deviation|8.4|8.4|||
4461732|NCT00049036|4281602|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4461733|NCT00049036|4281603|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4461735|NCT00049036|4281602|B3||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4461736|NCT00049036|4281603|B2||Between 18 and 65 years|Age||Participants|Count of Participants|54|54.0||||||
4461737|NCT00049036|4281604|B1||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4461738|NCT00049036|4281602|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461739|NCT00049036|4281603|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461740|NCT00049036|4281604|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461741|NCT00048997|4281611|B3||Male|Sex: Female, Male||Participants|Count of Participants|213|213.0||||||
4461742|NCT00048997|4281612|B2||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4461743|NCT00048997|4281613|B1||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4461744|NCT00048997|4281611|B3||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4461745|NCT00048997|4281612|B2||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4461746|NCT00048997|4281613|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4461747|NCT00048997|4281611|B3|||Age||years|Median|61|61.0|Full Range|||38.0|81.0|
4461748|NCT00048997|4281612|B2|||Age||years|Median|60|60.0|Full Range|||38.0|81.0|
4461749|NCT00048997|4281613|B1|||Age||years|Median|62|62.0|Full Range|||38.0|81.0|
4461750|NCT00047385|4281635|B3|United States||Region of Enrollment||participants|Number|53454|53454.0||||||
4461751|NCT00047385|4281636|B2|United States||Region of Enrollment||participants|Number|26,732|26.0||||||
4461752|NCT00047385|4281637|B1|United States||Region of Enrollment||participants|Number|26,722|26.0||||||
4461753|NCT00047385|4281635|B3||Male|Sex: Female, Male||Participants|Count of Participants|31532|31532.0||||||
4461754|NCT00047385|4281636|B2||Male|Sex: Female, Male||Participants|Count of Participants|15762|15762.0||||||
4461755|NCT00047385|4281637|B1||Male|Sex: Female, Male||Participants|Count of Participants|15770|15770.0||||||
4461756|NCT00047385|4281635|B3||Female|Sex: Female, Male||Participants|Count of Participants|21922|21922.0||||||
4461757|NCT00047385|4281636|B2||Female|Sex: Female, Male||Participants|Count of Participants|10970|10970.0||||||
4461758|NCT00047385|4281637|B1||Female|Sex: Female, Male||Participants|Count of Participants|10952|10952.0||||||
4461759|NCT00047385|4281635|B3|||Age||years|Mean|61.4|61.4|Standard Deviation|5.0|5.0|||
4461760|NCT00047385|4281636|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|5.0|5.0|||
4461761|NCT00047385|4281637|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|5.0|5.0|||
4461762|NCT00047385|4281635|B3||>=65 years|Age||Participants|Count of Participants|14220|14220.0||||||
4461763|NCT00047385|4281636|B2||>=65 years|Age||Participants|Count of Participants|7110|7110.0||||||
4461764|NCT00047385|4281637|B1||>=65 years|Age||Participants|Count of Participants|7110|7110.0||||||
4461765|NCT00047385|4281635|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39234|39234.0||||||
4461766|NCT00047385|4281636|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19622|19622.0||||||
4461767|NCT00047385|4281637|B1||Between 18 and 65 years|Age||Participants|Count of Participants|19612|19612.0||||||
4461768|NCT00047385|4281635|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461769|NCT00047385|4281636|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461770|NCT00047385|4281637|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461771|NCT00047320|4281656|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4461772|NCT00047320|4281656|B1|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4461773|NCT00047320|4281656|B1|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4461774|NCT00047320|4281656|B1|United States||Region of Enrollment||participants|Number|88|88.0||||||
4461775|NCT00047320|4281656|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4461776|NCT00047320|4281656|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|85|85.0||||||
4461777|NCT00047320|4281656|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4461778|NCT00047320|4281656|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4461779|NCT00047320|4281656|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461780|NCT00047320|4281656|B1||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4461781|NCT00047320|4281656|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4461782|NCT00047320|4281656|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4461783|NCT00047320|4281656|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4461784|NCT00047320|4281656|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461785|NCT00047320|4281656|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4461786|NCT00047320|4281656|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4461787|NCT00047320|4281656|B1|||Age||years|Median|12|12.0|Full Range|||3.0|23.0|
4461788|NCT00047008|4281665|B3||Male|Sex: Female, Male||Participants|Count of Participants|597|597.0||||||
4461789|NCT00047008|4281666|B2||Male|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4461790|NCT00047008|4281667|B1||Male|Sex: Female, Male||Participants|Count of Participants|309|309.0||||||
4461791|NCT00047008|4281665|B3||Female|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4461792|NCT00047008|4281666|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4461793|NCT00047008|4281667|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4461794|NCT00047008|4281665|B3|||Age||years|Median|56|56.0|Full Range|||26.0|82.0|
4461795|NCT00047008|4281666|B2|||Age||years|Median|55|55.0|Full Range|||26.0|82.0|
4461796|NCT00047008|4281667|B1|||Age||years|Median|56|56.0|Full Range|||34.0|82.0|
4461797|NCT00046930|4281674|B3||Male|Sex: Female, Male||Participants|Count of Participants|245|245.0||||||
4461798|NCT00046930|4281675|B2||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4461799|NCT00046930|4281676|B1||Male|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4461800|NCT00046930|4281674|B3||Female|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4461801|NCT00046930|4281675|B2||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4461802|NCT00046930|4281676|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4461803|NCT00046930|4281674|B3|||Age||years|Mean|69.3|69.3|Standard Deviation|5.4|5.4|||
4461804|NCT00046930|4281675|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|5.3|5.3|||
4461805|NCT00046930|4281676|B1|||Age||years|Mean|69.4|69.4|Standard Deviation|5.5|5.5|||
4461806|NCT00046891|4281690|B3|United States||Region of Enrollment||participants|Number|226|226.0||||||
4461807|NCT00046891|4281691|B2|United States||Region of Enrollment||participants|Number|113|113.0||||||
4461808|NCT00046891|4281692|B1|United States||Region of Enrollment||participants|Number|113|113.0||||||
4461809|NCT00046891|4281690|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461810|NCT00046891|4281691|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461811|NCT00046891|4281692|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4461812|NCT00046891|4281690|B3||Female|Sex: Female, Male||Participants|Count of Participants|226|226.0||||||
4461813|NCT00046891|4281691|B2||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4461814|NCT00046891|4281692|B1||Female|Sex: Female, Male||Participants|Count of Participants|113|113.0||||||
4461815|NCT00046891|4281690|B3|Age >= 50||Age, Customized||participants|Number|117|117.0||||||
4461816|NCT00046891|4281691|B2|Age >= 50||Age, Customized||participants|Number|59|59.0||||||
4461817|NCT00046891|4281692|B1|Age >= 50||Age, Customized||participants|Number|58|58.0||||||
4461818|NCT00046891|4281690|B3|Age < 50||Age, Customized||participants|Number|109|109.0||||||
4461819|NCT00046891|4281691|B2|Age < 50||Age, Customized||participants|Number|54|54.0||||||
4461820|NCT00046891|4281692|B1|Age < 50||Age, Customized||participants|Number|55|55.0||||||
4461821|NCT00046839|4281711|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4461822|NCT00046839|4281712|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4461823|NCT00046839|4281713|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4461824|NCT00046839|4281711|B3||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4461825|NCT00046839|4281712|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4461826|NCT00046839|4281713|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4461827|NCT00046839|4281711|B3|||Age||years|Median|72|72.0|Full Range|||47.0|88.0|
4461828|NCT00046839|4281712|B2|||Age||years|Median|71|71.0|Full Range|||47.0|82.0|
4461829|NCT00046839|4281713|B1|||Age||years|Median|73|73.0|Full Range|||65.0|88.0|
4461830|NCT00045734|4281721|B1|||Prior Chemotherapy Regimens||Chemotherapy Regimens|Median|0|0.0|Full Range|||0.0|2.0|
4461831|NCT00045734|4281721|B1|||Prior Radiation Therapies||Radiation Therapies|Median|1|1.0|Full Range|||0.0|5.0|
4461832|NCT00045734|4281721|B1|||Prior Surgeries||surgeries|Median|3|3.0|Full Range|||1.0|8.0|
4461833|NCT00045734|4281721|B1|Anaplastic (WHO grade III)||Histology|"using the WHO classification histology code which is the International classification for Oncology~Benign (WHO grade I) Atypical (WHO grade II) Anaplastic (WHO grade III)"|participants|Number|5|5.0||||||
4461834|NCT00045734|4281721|B1|Atypical (WHO grade II)||Histology|"using the WHO classification histology code which is the International classification for Oncology~Benign (WHO grade I) Atypical (WHO grade II) Anaplastic (WHO grade III)"|participants|Number|5|5.0||||||
4461835|NCT00045734|4281721|B1|Benign (WHO grade I)||Histology|"using the WHO classification histology code which is the International classification for Oncology~Benign (WHO grade I) Atypical (WHO grade II) Anaplastic (WHO grade III)"|participants|Number|13|13.0||||||
4461836|NCT00045734|4281721|B1|||Karnofsky Performance Status Scale (KPS)|High best 100 normal no complaints no disease 90 capable of normal activity few symptoms/disease 80 normal activity w/ some difficulty some symptoms/signs 70 caring for self not capable of normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|80|80.0|Full Range|||60.0|100.0|
4461837|NCT00045734|4281721|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4461838|NCT00045734|4281721|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4461839|NCT00045734|4281721|B1|||Age||years|Median|58|58.0|Full Range|||26.0|75.0|
4461840|NCT00045708|4281733|B4|None||Anticonvulsant Use|subjects were either on an anticonvulsant (EIAED) enzyme inducing antiepileptic drug or on an anticonvulsant that was not enzyme inducing (-EIAED) or on NO anticonvulsant|participants|Number|15|15.0||||||
4461841|NCT00045708|4281734|B3|None||Anticonvulsant Use|subjects were either on an anticonvulsant (EIAED) enzyme inducing antiepileptic drug or on an anticonvulsant that was not enzyme inducing (-EIAED) or on NO anticonvulsant|participants|Number|9|9.0||||||
4461842|NCT00045708|4281735|B2|None||Anticonvulsant Use|subjects were either on an anticonvulsant (EIAED) enzyme inducing antiepileptic drug or on an anticonvulsant that was not enzyme inducing (-EIAED) or on NO anticonvulsant|participants|Number|5|5.0||||||
4461843|NCT00045708|4281736|B1|None||Anticonvulsant Use|subjects were either on an anticonvulsant (EIAED) enzyme inducing antiepileptic drug or on an anticonvulsant that was not enzyme inducing (-EIAED) or on NO anticonvulsant|participants|Number|0|0.0||||||
4461885|NCT00045708|4281734|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4461844|NCT00045708|4281733|B4|-EIAED||Anticonvulsant Use|subjects were either on an anticonvulsant (EIAED) enzyme inducing antiepileptic drug or on an anticonvulsant that was not enzyme inducing (-EIAED) or on NO anticonvulsant|participants|Number|25|25.0||||||
4461845|NCT00045708|4281734|B3|-EIAED||Anticonvulsant Use|subjects were either on an anticonvulsant (EIAED) enzyme inducing antiepileptic drug or on an anticonvulsant that was not enzyme inducing (-EIAED) or on NO anticonvulsant|participants|Number|10|10.0||||||
4461846|NCT00045708|4281735|B2|-EIAED||Anticonvulsant Use|subjects were either on an anticonvulsant (EIAED) enzyme inducing antiepileptic drug or on an anticonvulsant that was not enzyme inducing (-EIAED) or on NO anticonvulsant|participants|Number|12|12.0||||||
4461847|NCT00045708|4281736|B1|-EIAED||Anticonvulsant Use|subjects were either on an anticonvulsant (EIAED) enzyme inducing antiepileptic drug or on an anticonvulsant that was not enzyme inducing (-EIAED) or on NO anticonvulsant|participants|Number|0|0.0||||||
4461848|NCT00045708|4281733|B4|+EIAED||Anticonvulsant Use|subjects were either on an anticonvulsant (EIAED) enzyme inducing antiepileptic drug or on an anticonvulsant that was not enzyme inducing (-EIAED) or on NO anticonvulsant|participants|Number|21|21.0||||||
4461849|NCT00045708|4281734|B3|+EIAED||Anticonvulsant Use|subjects were either on an anticonvulsant (EIAED) enzyme inducing antiepileptic drug or on an anticonvulsant that was not enzyme inducing (-EIAED) or on NO anticonvulsant|participants|Number|0|0.0||||||
4461850|NCT00045708|4281735|B2|+EIAED||Anticonvulsant Use|subjects were either on an anticonvulsant (EIAED) enzyme inducing antiepileptic drug or on an anticonvulsant that was not enzyme inducing (-EIAED) or on NO anticonvulsant|participants|Number|0|0.0||||||
4461851|NCT00045708|4281736|B1|+EIAED||Anticonvulsant Use|subjects were either on an anticonvulsant (EIAED) enzyme inducing antiepileptic drug or on an anticonvulsant that was not enzyme inducing (-EIAED) or on NO anticonvulsant|participants|Number|21|21.0||||||
4461852|NCT00045708|4281733|B4|Anaplastic astrocytoma||Histology|pathology at time of study entry|participants|Number|13|13.0||||||
4461853|NCT00045708|4281734|B3|Anaplastic astrocytoma||Histology|pathology at time of study entry|participants|Number|4|4.0||||||
4461854|NCT00045708|4281735|B2|Anaplastic astrocytoma||Histology|pathology at time of study entry|participants|Number|3|3.0||||||
4461855|NCT00045708|4281736|B1|Anaplastic astrocytoma||Histology|pathology at time of study entry|participants|Number|5|5.0||||||
4461856|NCT00045708|4281733|B4|Malignant glioma||Histology|pathology at time of study entry|participants|Number|2|2.0||||||
4461857|NCT00045708|4281734|B3|Malignant glioma||Histology|pathology at time of study entry|participants|Number|1|1.0||||||
4461858|NCT00045708|4281735|B2|Malignant glioma||Histology|pathology at time of study entry|participants|Number|0|0.0||||||
4461859|NCT00045708|4281736|B1|Malignant glioma||Histology|pathology at time of study entry|participants|Number|1|1.0||||||
4461860|NCT00045708|4281733|B4|Glioblastoma multiforme||Histology|pathology at time of study entry|participants|Number|46|46.0||||||
4461861|NCT00045708|4281734|B3|Glioblastoma multiforme||Histology|pathology at time of study entry|participants|Number|14|14.0||||||
4461862|NCT00045708|4281735|B2|Glioblastoma multiforme||Histology|pathology at time of study entry|participants|Number|14|14.0||||||
4461863|NCT00045708|4281736|B1|Glioblastoma multiforme||Histology|pathology at time of study entry|participants|Number|15|15.0||||||
4461864|NCT00045708|4281733|B4|100%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|7|7.0||||||
4461865|NCT00045708|4281734|B3|100%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|6|6.0||||||
4461866|NCT00045708|4281735|B2|100%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|0|0.0||||||
4461867|NCT00045708|4281736|B1|100%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|1|1.0||||||
4461868|NCT00045708|4281733|B4|90%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|26|26.0||||||
4461869|NCT00045708|4281734|B3|90%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|6|6.0||||||
4461886|NCT00045708|4281735|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4461887|NCT00045708|4281736|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4461888|NCT00045708|4281733|B4||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4461870|NCT00045708|4281735|B2|90%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|8|8.0||||||
4461871|NCT00045708|4281736|B1|90%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|10|10.0||||||
4461872|NCT00045708|4281733|B4|80%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|14|14.0||||||
4461873|NCT00045708|4281734|B3|80%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|5|5.0||||||
4461874|NCT00045708|4281735|B2|80%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|3|3.0||||||
4461875|NCT00045708|4281736|B1|80%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|6|6.0||||||
4461876|NCT00045708|4281733|B4|70%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|9|9.0||||||
4461877|NCT00045708|4281734|B3|70%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|2|2.0||||||
4461878|NCT00045708|4281735|B2|70%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|3|3.0||||||
4461879|NCT00045708|4281736|B1|70%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|2|2.0||||||
4461880|NCT00045708|4281733|B4|60%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|5|5.0||||||
4461881|NCT00045708|4281734|B3|60%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|0|0.0||||||
4461882|NCT00045708|4281735|B2|60%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|3|3.0||||||
4461883|NCT00045708|4281736|B1|60%||Karnofsky Performance Status (KPS)|"Performance status is a range where the higher score is the better score:~100 - Normal; no complaints; no evidence of disease; 90 - Able to carry on normal activity; minor signs or symptoms of disease, 80 - Normal activity with effort; some signs or symptoms of disease; 70 - Cares for self; unable to carry on normal activity or to do active work; 60 - Requires occasional assistance, but is able to care for most of his personal needs"|participants|Number|2|2.0||||||
4461884|NCT00045708|4281733|B4||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4461889|NCT00045708|4281734|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4461890|NCT00045708|4281735|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4461891|NCT00045708|4281736|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4461892|NCT00045708|4281733|B4|||Age||years|Median|54|54.0|Full Range|||22.0|75.0|
4461893|NCT00045708|4281734|B3|||Age||years|Median|53|53.0|Full Range|||32.0|73.0|
4461894|NCT00045708|4281735|B2|||Age||years|Median|56|56.0|Full Range|||22.0|75.0|
4461895|NCT00045708|4281736|B1|||Age||years|Median|53|53.0|Full Range|||23.0|65.0|
4461896|NCT00045630|4281763|B1|Missing||Prior Intravesical Therapy||participants|Number|4|4.0||||||
4461897|NCT00045630|4281763|B1|No||Prior Intravesical Therapy||participants|Number|59|59.0||||||
4461898|NCT00045630|4281763|B1|Yes||Prior Intravesical Therapy||participants|Number|11|11.0||||||
4461899|NCT00045630|4281763|B1|T4a||Clinical T Stage|"Primary Tumor (T): TX Primary tumor cannot be assessed, T0 No evidence of primary tumor, Ta Non-invasive papillary carcinoma, Tis Carcinoma in situ: flat tumor, T1 Tumor invades subepithelial connective tissue, T2 Tumor invades muscle, pT2a Tumor invades superficial muscle (inner half), pT2b Tumor invades deep muscle (outer half), T3 Tumor invades perivesical tissue, pT3a Microscopically, pT3b Macroscopically (extravesical mass), T4 Tumor invades any of the following: prostate, uterus, vagina, pelvic wall, abdominal wall, T4a Tumor invades prostate, uterus, vagina."|participants|Number|5|5.0||||||
4461900|NCT00045630|4281763|B1|T3||Clinical T Stage|"Primary Tumor (T): TX Primary tumor cannot be assessed, T0 No evidence of primary tumor, Ta Non-invasive papillary carcinoma, Tis Carcinoma in situ: flat tumor, T1 Tumor invades subepithelial connective tissue, T2 Tumor invades muscle, pT2a Tumor invades superficial muscle (inner half), pT2b Tumor invades deep muscle (outer half), T3 Tumor invades perivesical tissue, pT3a Microscopically, pT3b Macroscopically (extravesical mass), T4 Tumor invades any of the following: prostate, uterus, vagina, pelvic wall, abdominal wall, T4a Tumor invades prostate, uterus, vagina."|participants|Number|17|17.0||||||
4461901|NCT00045630|4281763|B1|T2||Clinical T Stage|"Primary Tumor (T): TX Primary tumor cannot be assessed, T0 No evidence of primary tumor, Ta Non-invasive papillary carcinoma, Tis Carcinoma in situ: flat tumor, T1 Tumor invades subepithelial connective tissue, T2 Tumor invades muscle, pT2a Tumor invades superficial muscle (inner half), pT2b Tumor invades deep muscle (outer half), T3 Tumor invades perivesical tissue, pT3a Microscopically, pT3b Macroscopically (extravesical mass), T4 Tumor invades any of the following: prostate, uterus, vagina, pelvic wall, abdominal wall, T4a Tumor invades prostate, uterus, vagina."|participants|Number|52|52.0||||||
4461902|NCT00045630|4281763|B1|Missing||Performance Status|Patients will be graded according to the Zubrod performance status scale. 0: Fully active, able to carry all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed or chair.|participants|Number|8|8.0||||||
4461903|NCT00045630|4281763|B1|1||Performance Status|Patients will be graded according to the Zubrod performance status scale. 0: Fully active, able to carry all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed or chair.|participants|Number|16|16.0||||||
4461904|NCT00045630|4281763|B1|0||Performance Status|Patients will be graded according to the Zubrod performance status scale. 0: Fully active, able to carry all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed or chair.|participants|Number|50|50.0||||||
4461905|NCT00045630|4281763|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461906|NCT00045630|4281763|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461907|NCT00045630|4281763|B1||White|Race (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4461908|NCT00045630|4281763|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4461909|NCT00045630|4281763|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4461910|NCT00045630|4281763|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461911|NCT00045630|4281763|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4461912|NCT00045630|4281763|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4461913|NCT00045630|4281763|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4461914|NCT00045630|4281763|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4461915|NCT00045630|4281763|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4461916|NCT00045630|4281763|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4461917|NCT00045630|4281763|B1|||Age||years|Median|69|69.0|Full Range|||49.0|83.0|
4461918|NCT00045487|4281769|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4461919|NCT00045487|4281769|B1||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4461920|NCT00045487|4281769|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4461921|NCT00045487|4281769|B1|||Age||years|Mean|57|57.0|Standard Deviation|2|2.0|||
4461922|NCT00045487|4281769|B1||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4461923|NCT00045487|4281769|B1||Between 18 and 65 years|Age||Participants|Count of Participants|15|15.0||||||
4461924|NCT00045487|4281769|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461925|NCT00045435|4281773|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4461926|NCT00045435|4281773|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4461927|NCT00045435|4281773|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4461928|NCT00045435|4281773|B1|||Age||years|Median|64.8|64.8|Full Range|||56.0|72.7|
4461929|NCT00045435|4281773|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4461930|NCT00045435|4281773|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4461931|NCT00045435|4281773|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4461932|NCT00045305|4281782|B1|United States||Region of Enrollment||participants|Number|17|17.0||||||
4461933|NCT00045305|4281782|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4461934|NCT00045305|4281782|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4461935|NCT00045305|4281782|B1|||Age||years|Median|58|58.0|Full Range|||31.0|64.0|
4461936|NCT00045162|4281791|B3|Unknown or Not Reported||Race/Ethnicity, Customized||particpants|Number|6|6.0||||||
4461937|NCT00045162|4281792|B2|Unknown or Not Reported||Race/Ethnicity, Customized||particpants|Number|4|4.0||||||
4461938|NCT00045162|4281793|B1|Unknown or Not Reported||Race/Ethnicity, Customized||particpants|Number|2|2.0||||||
4461939|NCT00045162|4281791|B3|More than one race||Race/Ethnicity, Customized||particpants|Number|2|2.0||||||
4461940|NCT00045162|4281792|B2|More than one race||Race/Ethnicity, Customized||particpants|Number|0|0.0||||||
4461941|NCT00045162|4281793|B1|More than one race||Race/Ethnicity, Customized||particpants|Number|2|2.0||||||
4461942|NCT00045162|4281791|B3|White||Race/Ethnicity, Customized||particpants|Number|604|604.0||||||
4461943|NCT00045162|4281792|B2|White||Race/Ethnicity, Customized||particpants|Number|304|304.0||||||
4461944|NCT00045162|4281793|B1|White||Race/Ethnicity, Customized||particpants|Number|300|300.0||||||
4461945|NCT00045162|4281791|B3|Black or African American||Race/Ethnicity, Customized||particpants|Number|32|32.0||||||
4461946|NCT00045162|4281792|B2|Black or African American||Race/Ethnicity, Customized||particpants|Number|18|18.0||||||
4461947|NCT00045162|4281793|B1|Black or African American||Race/Ethnicity, Customized||particpants|Number|14|14.0||||||
4461948|NCT00045162|4281791|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||particpants|Number|0|0.0||||||
4461949|NCT00045162|4281792|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||particpants|Number|0|0.0||||||
4461950|NCT00045162|4281793|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||particpants|Number|0|0.0||||||
4461951|NCT00045162|4281791|B3|Asian||Race/Ethnicity, Customized||particpants|Number|5|5.0||||||
4461952|NCT00045162|4281792|B2|Asian||Race/Ethnicity, Customized||particpants|Number|1|1.0||||||
4461953|NCT00045162|4281793|B1|Asian||Race/Ethnicity, Customized||particpants|Number|4|4.0||||||
4461954|NCT00045162|4281791|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||particpants|Number|2|2.0||||||
4461955|NCT00045162|4281792|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||particpants|Number|0|0.0||||||
4461956|NCT00045162|4281793|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||particpants|Number|2|2.0||||||
4461957|NCT00045162|4281791|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4461958|NCT00045162|4281792|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4461959|NCT00045162|4281793|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4461960|NCT00045162|4281791|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|577|577.0||||||
4461961|NCT00045162|4281792|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|288|288.0||||||
4461962|NCT00045162|4281793|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|289|289.0||||||
4461963|NCT00045162|4281791|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4461964|NCT00045162|4281792|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4461965|NCT00045162|4281793|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4461966|NCT00045162|4281791|B3||Male|Sex: Female, Male||Participants|Count of Participants|370|370.0||||||
4461967|NCT00045162|4281792|B2||Male|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4461968|NCT00045162|4281793|B1||Male|Sex: Female, Male||Participants|Count of Participants|188|188.0||||||
4461969|NCT00045162|4281791|B3||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4461970|NCT00045162|4281792|B2||Female|Sex: Female, Male||Participants|Count of Participants|145|145.0||||||
4461971|NCT00045162|4281793|B1||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4461972|NCT00045162|4281791|B3|||Age||years|Median|62|62.0|Full Range|||22.0|88.0|
4461973|NCT00045162|4281792|B2|||Age||years|Median|63|63.0|Full Range|||35.0|88.0|
4461974|NCT00045162|4281793|B1|||Age||years|Median|62|62.0|Full Range|||22.0|85.0|
4461975|NCT00045110|4281806|B4|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|80|80.0|Full Range|||60.0|100.0|
4462023|NCT00045110|4281806|B4|Glioblastoma||Histology||participants|Number|107|107.0||||||
4462024|NCT00045110|4281807|B3|Glioblastoma||Histology||participants|Number|44|44.0||||||
4462025|NCT00045110|4281808|B2|Glioblastoma||Histology||participants|Number|42|42.0||||||
4461976|NCT00045110|4281807|B3|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4461977|NCT00045110|4281808|B2|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|80|80.0|Full Range|||60.0|100.0|
4461978|NCT00045110|4281809|B1|||Karnofsky Performance Status Scale|Higher score better 100 normal no complaints/disease 90 capable normal activity few symptoms/disease 80 normal activity, some difficulty some symptoms/signs 70 caring for self not capable normal activity/work 60 requiring some help can take care of most personal requirements 50 requires help often requires frequent medical care 40 disabled requires special care/help 30 severely disabled hospital admission indicated but no risk of death 20 very ill urgently requiring admission requires supportive measures/treatment 10 moribund rapidly progressive fatal disease processes 0 death|units on a scale|Median|90|90.0|Full Range|||60.0|100.0|
4461979|NCT00045110|4281806|B4|3 treatments||Prior Number of Chemotherapy Regimens||participants|Number|5|5.0||||||
4461980|NCT00045110|4281807|B3|3 treatments||Prior Number of Chemotherapy Regimens||participants|Number|0|0.0||||||
4461981|NCT00045110|4281808|B2|3 treatments||Prior Number of Chemotherapy Regimens||participants|Number|3|3.0||||||
4461982|NCT00045110|4281809|B1|3 treatments||Prior Number of Chemotherapy Regimens||participants|Number|2|2.0||||||
4461983|NCT00045110|4281806|B4|2 treatments||Prior Number of Chemotherapy Regimens||participants|Number|35|35.0||||||
4461984|NCT00045110|4281807|B3|2 treatments||Prior Number of Chemotherapy Regimens||participants|Number|0|0.0||||||
4461985|NCT00045110|4281808|B2|2 treatments||Prior Number of Chemotherapy Regimens||participants|Number|21|21.0||||||
4461986|NCT00045110|4281809|B1|2 treatments||Prior Number of Chemotherapy Regimens||participants|Number|14|14.0||||||
4461987|NCT00045110|4281806|B4|1 treatment||Prior Number of Chemotherapy Regimens||participants|Number|89|89.0||||||
4461988|NCT00045110|4281807|B3|1 treatment||Prior Number of Chemotherapy Regimens||participants|Number|45|45.0||||||
4461989|NCT00045110|4281808|B2|1 treatment||Prior Number of Chemotherapy Regimens||participants|Number|31|31.0||||||
4461990|NCT00045110|4281809|B1|1 treatment||Prior Number of Chemotherapy Regimens||participants|Number|13|13.0||||||
4461991|NCT00045110|4281806|B4|0 treatments||Prior Number of Chemotherapy Regimens||participants|Number|7|7.0||||||
4461992|NCT00045110|4281807|B3|0 treatments||Prior Number of Chemotherapy Regimens||participants|Number|0|0.0||||||
4461993|NCT00045110|4281808|B2|0 treatments||Prior Number of Chemotherapy Regimens||participants|Number|4|4.0||||||
4461994|NCT00045110|4281809|B1|0 treatments||Prior Number of Chemotherapy Regimens||participants|Number|3|3.0||||||
4461995|NCT00045110|4281806|B4|No||Prior Radiation Treatment||participants|Number|4|4.0||||||
4461996|NCT00045110|4281807|B3|No||Prior Radiation Treatment||participants|Number|0|0.0||||||
4461997|NCT00045110|4281808|B2|No||Prior Radiation Treatment||participants|Number|4|4.0||||||
4461998|NCT00045110|4281809|B1|No||Prior Radiation Treatment||participants|Number|0|0.0||||||
4461999|NCT00045110|4281806|B4|Yes||Prior Radiation Treatment||participants|Number|132|132.0||||||
4462000|NCT00045110|4281807|B3|Yes||Prior Radiation Treatment||participants|Number|45|45.0||||||
4462001|NCT00045110|4281808|B2|Yes||Prior Radiation Treatment||participants|Number|55|55.0||||||
4462002|NCT00045110|4281809|B1|Yes||Prior Radiation Treatment||participants|Number|32|32.0||||||
4462003|NCT00045110|4281806|B4|Oligodendroglioma||Histology||participants|Number|1|1.0||||||
4462004|NCT00045110|4281807|B3|Oligodendroglioma||Histology||participants|Number|0|0.0||||||
4462005|NCT00045110|4281808|B2|Oligodendroglioma||Histology||participants|Number|1|1.0||||||
4462006|NCT00045110|4281809|B1|Oligodendroglioma||Histology||participants|Number|0|0.0||||||
4462007|NCT00045110|4281806|B4|Pleomorphic Xanthoastrocytoma||Histology||participants|Number|1|1.0||||||
4462008|NCT00045110|4281807|B3|Pleomorphic Xanthoastrocytoma||Histology||participants|Number|0|0.0||||||
4462009|NCT00045110|4281808|B2|Pleomorphic Xanthoastrocytoma||Histology||participants|Number|1|1.0||||||
4462010|NCT00045110|4281809|B1|Pleomorphic Xanthoastrocytoma||Histology||participants|Number|0|0.0||||||
4462011|NCT00045110|4281806|B4|Atypical meningioma||Histology||participants|Number|1|1.0||||||
4462012|NCT00045110|4281807|B3|Atypical meningioma||Histology||participants|Number|0|0.0||||||
4462013|NCT00045110|4281808|B2|Atypical meningioma||Histology||participants|Number|0|0.0||||||
4462014|NCT00045110|4281809|B1|Atypical meningioma||Histology||participants|Number|1|1.0||||||
4462015|NCT00045110|4281806|B4|Anaplastic oligodendroglioma||Histology||participants|Number|3|3.0||||||
4462016|NCT00045110|4281807|B3|Anaplastic oligodendroglioma||Histology||participants|Number|0|0.0||||||
4462017|NCT00045110|4281808|B2|Anaplastic oligodendroglioma||Histology||participants|Number|1|1.0||||||
4462018|NCT00045110|4281809|B1|Anaplastic oligodendroglioma||Histology||participants|Number|2|2.0||||||
4462019|NCT00045110|4281806|B4|Anaplastic Astrocytoma||Histology||participants|Number|23|23.0||||||
4462020|NCT00045110|4281807|B3|Anaplastic Astrocytoma||Histology||participants|Number|1|1.0||||||
4462021|NCT00045110|4281808|B2|Anaplastic Astrocytoma||Histology||participants|Number|14|14.0||||||
4462022|NCT00045110|4281809|B1|Anaplastic Astrocytoma||Histology||participants|Number|8|8.0||||||
4462026|NCT00045110|4281809|B1|Glioblastoma||Histology||participants|Number|21|21.0||||||
4462027|NCT00045110|4281806|B4||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4462028|NCT00045110|4281807|B3||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4462029|NCT00045110|4281808|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4462030|NCT00045110|4281809|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4462031|NCT00045110|4281806|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4462032|NCT00045110|4281807|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4462033|NCT00045110|4281808|B2||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4462034|NCT00045110|4281809|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4462035|NCT00045110|4281806|B4|||Age||years|Median|52|52.0|Full Range|||19.0|78.0|
4462036|NCT00045110|4281807|B3|||Age||years|Median|52|52.0|Full Range|||19.0|72.0|
4462037|NCT00045110|4281808|B2|||Age||years|Median|54|54.0|Full Range|||29.0|78.0|
4462038|NCT00045110|4281809|B1|||Age||years|Median|45|45.0|Full Range|||19.0|76.0|
4462039|NCT00045032|4281857|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462040|NCT00045032|4281858|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462041|NCT00045032|4281859|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462042|NCT00045032|4281860|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462043|NCT00045032|4281857|B4||Female|Sex: Female, Male||Participants|Count of Participants|5099|5099.0||||||
4462044|NCT00045032|4281858|B3||Female|Sex: Female, Male||Participants|Count of Participants|1700|1700.0||||||
4462045|NCT00045032|4281859|B2||Female|Sex: Female, Male||Participants|Count of Participants|1702|1702.0||||||
4462046|NCT00045032|4281860|B1||Female|Sex: Female, Male||Participants|Count of Participants|1697|1697.0||||||
4462047|NCT00045032|4281857|B4|||Age||years|Mean|49.1|49.1|Standard Deviation|10.08|10.08|||
4462048|NCT00045032|4281858|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|10.09|10.09|||
4462049|NCT00045032|4281859|B2|||Age||years|Mean|49.0|49.0|Standard Deviation|10.06|10.06|||
4462050|NCT00045032|4281860|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|10.08|10.08|||
4462051|NCT00042991|4281989|B8|United States||Region of Enrollment||participants|Number|69|69.0||||||
4462052|NCT00042991|4281990|B7|United States||Region of Enrollment||participants|Number|3|3.0||||||
4462053|NCT00042991|4281991|B6|United States||Region of Enrollment||participants|Number|5|5.0||||||
4462054|NCT00042991|4281992|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
4462055|NCT00042991|4281993|B4|United States||Region of Enrollment||participants|Number|2|2.0||||||
4462056|NCT00042991|4281994|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4462057|NCT00042991|4281995|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4462058|NCT00042991|4281996|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4462059|NCT00042991|4281989|B8||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4462060|NCT00042991|4281990|B7||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4462061|NCT00042991|4281991|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4462062|NCT00042991|4281992|B5||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4462063|NCT00042991|4281993|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4462064|NCT00042991|4281994|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4462065|NCT00042991|4281995|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4462066|NCT00042991|4281996|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4462067|NCT00042991|4281989|B8||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4462068|NCT00042991|4281990|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4462069|NCT00042991|4281991|B6||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4462070|NCT00042991|4281992|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462071|NCT00042991|4281993|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462072|NCT00042991|4281994|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4462073|NCT00042991|4281995|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4462074|NCT00042991|4281996|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4462075|NCT00042991|4281989|B8|||Age||years|Mean|9.01|9.01|Standard Deviation|4.47|4.47|||
4462076|NCT00042991|4281990|B7|||Age||years|Mean|12.82|12.82|Standard Deviation|2.37|2.37|||
4462077|NCT00042991|4281991|B6|||Age||years|Mean|11.69|11.69|Standard Deviation|5.40|5.4|||
4462078|NCT00042991|4281992|B5|||Age||years|Mean|15.91|15.91|Standard Deviation|5.61|5.61|||
4462079|NCT00042991|4281993|B4|||Age||years|Mean|9.17|9.17|Standard Deviation|8.56|8.56|||
4462080|NCT00042991|4281994|B3|||Age||years|Mean|10.07|10.07|Standard Deviation|4.71|4.71|||
4462081|NCT00042991|4281995|B2|||Age||years|Mean|8.02|8.02|Standard Deviation|3.87|3.87|||
4462082|NCT00042991|4281996|B1|||Age||years|Mean|7.25|7.25|Standard Deviation|2.92|2.92|||
4462083|NCT00042991|4281989|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462084|NCT00042991|4281990|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462085|NCT00042991|4281991|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462086|NCT00042991|4281992|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462087|NCT00042991|4281993|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462088|NCT00042991|4281994|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462089|NCT00042991|4281995|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462090|NCT00042991|4281996|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462091|NCT00042991|4281989|B8||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4462092|NCT00042991|4281990|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4462093|NCT00042991|4281991|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4462094|NCT00042991|4281992|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4462095|NCT00042991|4281993|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4462096|NCT00042991|4281994|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4462097|NCT00042991|4281995|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4462098|NCT00042991|4281996|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4462099|NCT00042991|4281989|B8||<=18 years|Age||Participants|Count of Participants|68|68.0||||||
4462100|NCT00042991|4281990|B7||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4462101|NCT00042991|4281991|B6||<=18 years|Age||Participants|Count of Participants|5|5.0||||||
4462102|NCT00042991|4281992|B5||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4462103|NCT00042991|4281993|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4462104|NCT00042991|4281994|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4462105|NCT00042991|4281995|B2||<=18 years|Age||Participants|Count of Participants|43|43.0||||||
4462106|NCT00042991|4281996|B1||<=18 years|Age||Participants|Count of Participants|6|6.0||||||
4462107|NCT00042939|4282043|B3||Male|Sex: Female, Male|Gender of eligible patients who began treatment.|Participants|Count of Participants|61|61.0||||||
4462108|NCT00042939|4282044|B2||Male|Sex: Female, Male|Gender of eligible patients who began treatment.|Participants|Count of Participants|37|37.0||||||
4462109|NCT00042939|4282045|B1||Male|Sex: Female, Male|Gender of eligible patients who began treatment.|Participants|Count of Participants|24|24.0||||||
4462110|NCT00042939|4282043|B3||Female|Sex: Female, Male|Gender of eligible patients who began treatment.|Participants|Count of Participants|26|26.0||||||
4462111|NCT00042939|4282044|B2||Female|Sex: Female, Male|Gender of eligible patients who began treatment.|Participants|Count of Participants|6|6.0||||||
4462112|NCT00042939|4282045|B1||Female|Sex: Female, Male|Gender of eligible patients who began treatment.|Participants|Count of Participants|20|20.0||||||
4462113|NCT00042939|4282043|B3|||Age|Age of eligible patients who began treatment.|years|Median|60.4|60.4|Full Range|||41.0|77.1|
4462114|NCT00042939|4282044|B2|||Age|Age of eligible patients who began treatment.|years|Median|60.6|60.6|Full Range|||41.0|74.2|
4462115|NCT00042939|4282045|B1|||Age|Age of eligible patients who began treatment.|years|Median|60.2|60.2|Full Range|||41.0|77.1|
4462116|NCT00041132|4282060|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462117|NCT00041132|4282060|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462118|NCT00041132|4282060|B1||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4462119|NCT00041132|4282060|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462120|NCT00041132|4282060|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462121|NCT00041132|4282060|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462122|NCT00041132|4282060|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462123|NCT00041132|4282060|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462124|NCT00041132|4282060|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4462125|NCT00041132|4282060|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462126|NCT00041132|4282060|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4462127|NCT00041132|4282060|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4462128|NCT00041132|4282060|B1|||Age||years|Median|57.4|57.4|Full Range|||35.0|69.8|
4462129|NCT00041119|4282066|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462130|NCT00041119|4282067|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462131|NCT00041119|4282068|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462132|NCT00041119|4282069|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462133|NCT00041119|4282070|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462134|NCT00041119|4282066|B5||Female|Sex: Female, Male||Participants|Count of Participants|3871|3871.0||||||
4462135|NCT00041119|4282067|B4||Female|Sex: Female, Male||Participants|Count of Participants|789|789.0||||||
4462136|NCT00041119|4282068|B3||Female|Sex: Female, Male||Participants|Count of Participants|1151|1151.0||||||
4462137|NCT00041119|4282069|B2||Female|Sex: Female, Male||Participants|Count of Participants|789|789.0||||||
4462138|NCT00041119|4282070|B1||Female|Sex: Female, Male||Participants|Count of Participants|1142|1142.0||||||
4462139|NCT00041119|4282066|B5|||Age||years|Mean|53.4|53.4|Standard Deviation|9.6|9.6|||
4462140|NCT00041119|4282067|B4|||Age||years|Mean|52.7|52.7|Standard Deviation|9.2|9.2|||
4462141|NCT00041119|4282068|B3|||Age||years|Mean|54.0|54.0|Standard Deviation|9.9|9.9|||
4462142|NCT00041119|4282069|B2|||Age||years|Mean|52.6|52.6|Standard Deviation|9.1|9.1|||
4462143|NCT00041119|4282070|B1|||Age||years|Mean|53.7|53.7|Standard Deviation|9.9|9.9|||
4462144|NCT00041119|4282066|B5||>=65 years|Age||Participants|Count of Participants|472|472.0||||||
4462145|NCT00041119|4282067|B4||>=65 years|Age||Participants|Count of Participants|74|74.0||||||
4462146|NCT00041119|4282068|B3||>=65 years|Age||Participants|Count of Participants|164|164.0||||||
4462147|NCT00041119|4282069|B2||>=65 years|Age||Participants|Count of Participants|70|70.0||||||
4462148|NCT00041119|4282070|B1||>=65 years|Age||Participants|Count of Participants|164|164.0||||||
4462149|NCT00041119|4282066|B5||Between 18 and 65 years|Age||Participants|Count of Participants|3399|3399.0||||||
4462150|NCT00041119|4282067|B4||Between 18 and 65 years|Age||Participants|Count of Participants|715|715.0||||||
4462151|NCT00041119|4282068|B3||Between 18 and 65 years|Age||Participants|Count of Participants|987|987.0||||||
4462152|NCT00041119|4282069|B2||Between 18 and 65 years|Age||Participants|Count of Participants|719|719.0||||||
4462153|NCT00041119|4282070|B1||Between 18 and 65 years|Age||Participants|Count of Participants|978|978.0||||||
4462154|NCT00041119|4282066|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462155|NCT00041119|4282067|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462156|NCT00041119|4282068|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462157|NCT00041119|4282069|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462158|NCT00041119|4282070|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462159|NCT00041080|4282093|B3|Fallopian Tube||Primary Site of Disease||participants|Number|1|1.0||||||
4462160|NCT00041080|4282094|B2|Fallopian Tube||Primary Site of Disease||participants|Number|1|1.0||||||
4462161|NCT00041080|4282095|B1|Fallopian Tube||Primary Site of Disease||participants|Number|0|0.0||||||
4462162|NCT00041080|4282093|B3|Peritoneum||Primary Site of Disease||participants|Number|20|20.0||||||
4462163|NCT00041080|4282094|B2|Peritoneum||Primary Site of Disease||participants|Number|10|10.0||||||
4462164|NCT00041080|4282095|B1|Peritoneum||Primary Site of Disease||participants|Number|10|10.0||||||
4462165|NCT00041080|4282093|B3|Ovary||Primary Site of Disease||participants|Number|117|117.0||||||
4462166|NCT00041080|4282094|B2|Ovary||Primary Site of Disease||participants|Number|59|59.0||||||
4462167|NCT00041080|4282095|B1|Ovary||Primary Site of Disease||participants|Number|58|58.0||||||
4462168|NCT00041080|4282093|B3|1 - symptomatic||Gynecologic Oncology Group (GOG) Performance Status||participants|Number|8|8.0||||||
4462169|NCT00041080|4282094|B2|1 - symptomatic||Gynecologic Oncology Group (GOG) Performance Status||participants|Number|3|3.0||||||
4462170|NCT00041080|4282095|B1|1 - symptomatic||Gynecologic Oncology Group (GOG) Performance Status||participants|Number|5|5.0||||||
4462171|NCT00041080|4282093|B3|0 - asymptomatic||Gynecologic Oncology Group (GOG) Performance Status||participants|Number|130|130.0||||||
4462172|NCT00041080|4282094|B2|0 - asymptomatic||Gynecologic Oncology Group (GOG) Performance Status||participants|Number|67|67.0||||||
4462173|NCT00041080|4282095|B1|0 - asymptomatic||Gynecologic Oncology Group (GOG) Performance Status||participants|Number|63|63.0||||||
4462174|NCT00041080|4282093|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462175|NCT00041080|4282094|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462176|NCT00041080|4282095|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462177|NCT00041080|4282093|B3||Female|Sex: Female, Male||Participants|Count of Participants|138|138.0||||||
4462178|NCT00041080|4282094|B2||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4462179|NCT00041080|4282095|B1||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4462180|NCT00041080|4282093|B3|80-89 years||Age, Customized||participants|Number|6|6.0||||||
4462181|NCT00041080|4282094|B2|80-89 years||Age, Customized||participants|Number|1|1.0||||||
4462182|NCT00041080|4282095|B1|80-89 years||Age, Customized||participants|Number|5|5.0||||||
4462183|NCT00041080|4282093|B3|70-79 years||Age, Customized||participants|Number|32|32.0||||||
4462184|NCT00041080|4282094|B2|70-79 years||Age, Customized||participants|Number|15|15.0||||||
4462185|NCT00041080|4282095|B1|70-79 years||Age, Customized||participants|Number|17|17.0||||||
4462186|NCT00041080|4282093|B3|60-69 years||Age, Customized||participants|Number|50|50.0||||||
4462187|NCT00041080|4282094|B2|60-69 years||Age, Customized||participants|Number|28|28.0||||||
4462188|NCT00041080|4282095|B1|60-69 years||Age, Customized||participants|Number|22|22.0||||||
4462189|NCT00041080|4282093|B3|50-59 years||Age, Customized||participants|Number|31|31.0||||||
4462190|NCT00041080|4282094|B2|50-59 years||Age, Customized||participants|Number|14|14.0||||||
4462191|NCT00041080|4282095|B1|50-59 years||Age, Customized||participants|Number|17|17.0||||||
4462192|NCT00041080|4282093|B3|< 50 years||Age, Customized||participants|Number|19|19.0||||||
4462193|NCT00041080|4282094|B2|< 50 years||Age, Customized||participants|Number|12|12.0||||||
4462194|NCT00041080|4282095|B1|< 50 years||Age, Customized||participants|Number|7|7.0||||||
4462195|NCT00041080|4282093|B3|||Age||years|Mean|62.9|62.9|Standard Deviation|10.7|10.7|||
4462196|NCT00041080|4282094|B2|||Age||years|Mean|61.6|61.6|Standard Deviation|10.5|10.5|||
4462197|NCT00041080|4282095|B1|||Age||years|Mean|64.3|64.3|Standard Deviation|10.8|10.8|||
4462198|NCT00041067|4282102|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462199|NCT00041067|4282102|B1||Female|Sex: Female, Male||Participants|Count of Participants|74|74.0||||||
4462200|NCT00041067|4282102|B1|70-79||Age, Customized||participants|Number|3|3.0||||||
4462201|NCT00041067|4282102|B1|60-69||Age, Customized||participants|Number|15|15.0||||||
4462202|NCT00041067|4282102|B1|50-59||Age, Customized||participants|Number|19|19.0||||||
4462203|NCT00041067|4282102|B1|40-49||Age, Customized||participants|Number|26|26.0||||||
4462204|NCT00041067|4282102|B1|30-39||Age, Customized||participants|Number|11|11.0||||||
4462205|NCT00040937|4282109|B1|United States||Region of Enrollment||participants|Number|142|142.0||||||
4462206|NCT00040937|4282109|B1||Male|Gender||Participants|Count of Participants|86|86.0||||||
4462207|NCT00040937|4282109|B1||Female|Gender||Participants|Count of Participants|56|56.0||||||
4462208|NCT00040937|4282109|B1|||Age||years|Median|57|57.0|Full Range|23-66|23.0|23.0|66.0|
4462209|NCT00040846|4282116|B7|United States||Region of Enrollment||participants|Number|60|60.0||||||
4462210|NCT00040846|4282122|B1|United States||Region of Enrollment||participants|Number|60|60.0||||||
4462211|NCT00040846|4282116|B7||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4462212|NCT00040846|4282122|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4462213|NCT00040846|4282116|B7||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4462214|NCT00040846|4282122|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4462215|NCT00040846|4282116|B7|||Age||years|Median|56.7|56.7|Full Range|||13.0|72.0|
4462216|NCT00040846|4282122|B1|||Age||years|Median|56.7|56.7|Full Range|||13.0|72.0|
4462217|NCT00040846|4282116|B7||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4462218|NCT00040846|4282122|B1||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4462219|NCT00040846|4282116|B7||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4462220|NCT00040846|4282122|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4462221|NCT00040846|4282116|B7||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4462222|NCT00040846|4282122|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4462223|NCT00040742|4282165|B5|||Quality of life(FACT-G)|Quality of life is evaluated using the Functional Assessment of Cancer Therapy-General (FACT-G), a 27-item compilation of questions divided into 4 primary domains: Physical Well-Being (PWB)[range 0 - 28], Social Well-Being (SWB)[range 0 - 28], Emotional Well-Being (EWB) [range 0 - 24], and Functional Well-Being (FWB) [range 0 - 28]. Total FACT-G score is a sum of the 4 primary domains [range 0 - 108]. The higher the score, the better.|units on a scale|Mean|72|72.0|Standard Deviation|15.6|15.6|||
4462224|NCT00040742|4282166|B4|||Quality of life(FACT-G)|Quality of life is evaluated using the Functional Assessment of Cancer Therapy-General (FACT-G), a 27-item compilation of questions divided into 4 primary domains: Physical Well-Being (PWB)[range 0 - 28], Social Well-Being (SWB)[range 0 - 28], Emotional Well-Being (EWB) [range 0 - 24], and Functional Well-Being (FWB) [range 0 - 28]. Total FACT-G score is a sum of the 4 primary domains [range 0 - 108]. The higher the score, the better.|units on a scale|Mean|72|72.0|Standard Deviation|16.0|16.0|||
4462225|NCT00040742|4282167|B3|||Quality of life(FACT-G)|Quality of life is evaluated using the Functional Assessment of Cancer Therapy-General (FACT-G), a 27-item compilation of questions divided into 4 primary domains: Physical Well-Being (PWB)[range 0 - 28], Social Well-Being (SWB)[range 0 - 28], Emotional Well-Being (EWB) [range 0 - 24], and Functional Well-Being (FWB) [range 0 - 28]. Total FACT-G score is a sum of the 4 primary domains [range 0 - 108]. The higher the score, the better.|units on a scale|Mean|71|71.0|Standard Deviation|15.4|15.4|||
4462226|NCT00040742|4282168|B2|||Quality of life(FACT-G)|Quality of life is evaluated using the Functional Assessment of Cancer Therapy-General (FACT-G), a 27-item compilation of questions divided into 4 primary domains: Physical Well-Being (PWB)[range 0 - 28], Social Well-Being (SWB)[range 0 - 28], Emotional Well-Being (EWB) [range 0 - 24], and Functional Well-Being (FWB) [range 0 - 28]. Total FACT-G score is a sum of the 4 primary domains [range 0 - 108]. The higher the score, the better.|units on a scale|Mean|72|72.0|Standard Deviation|15.0|15.0|||
4462227|NCT00040742|4282169|B1|||Quality of life(FACT-G)|Quality of life is evaluated using the Functional Assessment of Cancer Therapy-General (FACT-G), a 27-item compilation of questions divided into 4 primary domains: Physical Well-Being (PWB)[range 0 - 28], Social Well-Being (SWB)[range 0 - 28], Emotional Well-Being (EWB) [range 0 - 24], and Functional Well-Being (FWB) [range 0 - 28]. Total FACT-G score is a sum of the 4 primary domains [range 0 - 108]. The higher the score, the better.|units on a scale|Mean|72|72.0|Standard Deviation|15.9|15.9|||
4462228|NCT00040742|4282165|B5|||Baseline nausea at its worst|"Maximum nausea evaluated using a 7-point semantic rating scale anchored by 1 =  Not at all nauseated and by 7 = Extremely nauseated."|units on a scale|Mean|2.7|2.7|Standard Deviation|2.0|2.0|||
4462229|NCT00040742|4282166|B4|||Baseline nausea at its worst|"Maximum nausea evaluated using a 7-point semantic rating scale anchored by 1 =  Not at all nauseated and by 7 = Extremely nauseated."|units on a scale|Mean|2.7|2.7|Standard Deviation|2.0|2.0|||
4462230|NCT00040742|4282167|B3|||Baseline nausea at its worst|"Maximum nausea evaluated using a 7-point semantic rating scale anchored by 1 =  Not at all nauseated and by 7 = Extremely nauseated."|units on a scale|Mean|2.8|2.8|Standard Deviation|2.0|2.0|||
4462231|NCT00040742|4282168|B2|||Baseline nausea at its worst|"Maximum nausea evaluated using a 7-point semantic rating scale anchored by 1 =  Not at all nauseated and by 7 = Extremely nauseated."|units on a scale|Mean|2.9|2.9|Standard Deviation|2.1|2.1|||
4462232|NCT00040742|4282169|B1|||Baseline nausea at its worst|"Maximum nausea evaluated using a 7-point semantic rating scale anchored by 1 =  Not at all nauseated and by 7 = Extremely nauseated."|units on a scale|Mean|2.5|2.5|Standard Deviation|1.7|1.7|||
4462233|NCT00040742|4282165|B5|||Baseline average nausea, Day1|"Average nausea evaluated using a 7-point semantic rating scale anchored by 1 =  Not at all nauseated and by 7 = Extremely nauseated."|units on a scale|Mean|2.4|2.4|Standard Deviation|1.8|1.8|||
4462234|NCT00040742|4282166|B4|||Baseline average nausea, Day1|"Average nausea evaluated using a 7-point semantic rating scale anchored by 1 =  Not at all nauseated and by 7 = Extremely nauseated."|units on a scale|Mean|2.4|2.4|Standard Deviation|1.7|1.7|||
4462235|NCT00040742|4282167|B3|||Baseline average nausea, Day1|"Average nausea evaluated using a 7-point semantic rating scale anchored by 1 =  Not at all nauseated and by 7 = Extremely nauseated."|units on a scale|Mean|2.5|2.5|Standard Deviation|1.8|1.8|||
4462236|NCT00040742|4282168|B2|||Baseline average nausea, Day1|"Average nausea evaluated using a 7-point semantic rating scale anchored by 1 =  Not at all nauseated and by 7 = Extremely nauseated."|units on a scale|Mean|2.6|2.6|Standard Deviation|1.9|1.9|||
4462237|NCT00040742|4282169|B1|||Baseline average nausea, Day1|"Average nausea evaluated using a 7-point semantic rating scale anchored by 1 =  Not at all nauseated and by 7 = Extremely nauseated."|units on a scale|Mean|2.2|2.2|Standard Deviation|1.6|1.6|||
4462238|NCT00040742|4282165|B5|Not Married||Marital status||participants|Number|156|156.0||||||
4462239|NCT00040742|4282166|B4|Not Married||Marital status||participants|Number|38|38.0||||||
4462240|NCT00040742|4282167|B3|Not Married||Marital status||participants|Number|38|38.0||||||
4462241|NCT00040742|4282168|B2|Not Married||Marital status||participants|Number|38|38.0||||||
4462242|NCT00040742|4282169|B1|Not Married||Marital status||participants|Number|42|42.0||||||
4462243|NCT00040742|4282165|B5|Married||Marital status||participants|Number|420|420.0||||||
4462244|NCT00040742|4282166|B4|Married||Marital status||participants|Number|114|114.0||||||
4462245|NCT00040742|4282167|B3|Married||Marital status||participants|Number|103|103.0||||||
4462246|NCT00040742|4282168|B2|Married||Marital status||participants|Number|96|96.0||||||
4462247|NCT00040742|4282169|B1|Married||Marital status||participants|Number|107|107.0||||||
4462248|NCT00040742|4282165|B5|Other||Tumor site||participants|Number|8|8.0||||||
4462249|NCT00040742|4282166|B4|Other||Tumor site||participants|Number|2|2.0||||||
4462250|NCT00040742|4282167|B3|Other||Tumor site||participants|Number|1|1.0||||||
4462251|NCT00040742|4282168|B2|Other||Tumor site||participants|Number|3|3.0||||||
4462252|NCT00040742|4282169|B1|Other||Tumor site||participants|Number|2|2.0||||||
4462253|NCT00040742|4282165|B5|Lung||Tumor site||participants|Number|33|33.0||||||
4462254|NCT00040742|4282166|B4|Lung||Tumor site||participants|Number|10|10.0||||||
4462255|NCT00040742|4282167|B3|Lung||Tumor site||participants|Number|6|6.0||||||
4462256|NCT00040742|4282168|B2|Lung||Tumor site||participants|Number|7|7.0||||||
4462257|NCT00040742|4282169|B1|Lung||Tumor site||participants|Number|10|10.0||||||
4462258|NCT00040742|4282165|B5|Hematologic||Tumor site||participants|Number|24|24.0||||||
4462259|NCT00040742|4282166|B4|Hematologic||Tumor site||participants|Number|8|8.0||||||
4462260|NCT00040742|4282167|B3|Hematologic||Tumor site||participants|Number|9|9.0||||||
4462261|NCT00040742|4282168|B2|Hematologic||Tumor site||participants|Number|4|4.0||||||
4462262|NCT00040742|4282169|B1|Hematologic||Tumor site||participants|Number|3|3.0||||||
4462263|NCT00040742|4282165|B5|Gynecologic||Tumor site||participants|Number|31|31.0||||||
4462264|NCT00040742|4282166|B4|Gynecologic||Tumor site||participants|Number|5|5.0||||||
4462265|NCT00040742|4282167|B3|Gynecologic||Tumor site||participants|Number|9|9.0||||||
4462266|NCT00040742|4282168|B2|Gynecologic||Tumor site||participants|Number|6|6.0||||||
4462267|NCT00040742|4282169|B1|Gynecologic||Tumor site||participants|Number|11|11.0||||||
4462268|NCT00040742|4282165|B5|Genitourinary||Tumor site||participants|Number|10|10.0||||||
4462269|NCT00040742|4282166|B4|Genitourinary||Tumor site||participants|Number|2|2.0||||||
4462270|NCT00040742|4282167|B3|Genitourinary||Tumor site||participants|Number|3|3.0||||||
4462271|NCT00040742|4282168|B2|Genitourinary||Tumor site||participants|Number|3|3.0||||||
4462272|NCT00040742|4282169|B1|Genitourinary||Tumor site||participants|Number|2|2.0||||||
4462273|NCT00040742|4282165|B5|Breast||Tumor site||participants|Number|427|427.0||||||
4462274|NCT00040742|4282166|B4|Breast||Tumor site||participants|Number|117|117.0||||||
4462275|NCT00040742|4282167|B3|Breast||Tumor site||participants|Number|103|103.0||||||
4462276|NCT00040742|4282168|B2|Breast||Tumor site||participants|Number|100|100.0||||||
4462277|NCT00040742|4282169|B1|Breast||Tumor site||participants|Number|107|107.0||||||
4462278|NCT00040742|4282165|B5|Alimentary||Tumor site||participants|Number|43|43.0||||||
4462279|NCT00040742|4282166|B4|Alimentary||Tumor site||participants|Number|8|8.0||||||
4462280|NCT00040742|4282167|B3|Alimentary||Tumor site||participants|Number|10|10.0||||||
4462281|NCT00040742|4282168|B2|Alimentary||Tumor site||participants|Number|11|11.0||||||
4462282|NCT00040742|4282169|B1|Alimentary||Tumor site||participants|Number|14|14.0||||||
4462283|NCT00040742|4282165|B5|Unknown||Previous radiation therapy||participants|Number|2|2.0||||||
4462284|NCT00040742|4282166|B4|Unknown||Previous radiation therapy||participants|Number|0|0.0||||||
4462285|NCT00040742|4282167|B3|Unknown||Previous radiation therapy||participants|Number|0|0.0||||||
4462286|NCT00040742|4282168|B2|Unknown||Previous radiation therapy||participants|Number|2|2.0||||||
4462287|NCT00040742|4282169|B1|Unknown||Previous radiation therapy||participants|Number|0|0.0||||||
4462288|NCT00040742|4282165|B5|No||Previous radiation therapy||participants|Number|533|533.0||||||
4462289|NCT00040742|4282166|B4|No||Previous radiation therapy||participants|Number|144|144.0||||||
4462290|NCT00040742|4282167|B3|No||Previous radiation therapy||participants|Number|128|128.0||||||
4462291|NCT00040742|4282168|B2|No||Previous radiation therapy||participants|Number|125|125.0||||||
4462292|NCT00040742|4282169|B1|No||Previous radiation therapy||participants|Number|136|136.0||||||
4462293|NCT00040742|4282165|B5|Yes||Previous radiation therapy||participants|Number|41|41.0||||||
4462294|NCT00040742|4282166|B4|Yes||Previous radiation therapy||participants|Number|8|8.0||||||
4462295|NCT00040742|4282167|B3|Yes||Previous radiation therapy||participants|Number|13|13.0||||||
4462296|NCT00040742|4282168|B2|Yes||Previous radiation therapy||participants|Number|7|7.0||||||
4462297|NCT00040742|4282169|B1|Yes||Previous radiation therapy||participants|Number|13|13.0||||||
4462298|NCT00040742|4282165|B5|Unknown||Previous chemotherapy||participants|Number|2|2.0||||||
4462299|NCT00040742|4282166|B4|Unknown||Previous chemotherapy||participants|Number|0|0.0||||||
4462300|NCT00040742|4282167|B3|Unknown||Previous chemotherapy||participants|Number|0|0.0||||||
4462301|NCT00040742|4282168|B2|Unknown||Previous chemotherapy||participants|Number|2|2.0||||||
4462302|NCT00040742|4282169|B1|Unknown||Previous chemotherapy||participants|Number|0|0.0||||||
4462303|NCT00040742|4282165|B5|No||Previous chemotherapy||participants|Number|251|251.0||||||
4462304|NCT00040742|4282166|B4|No||Previous chemotherapy||participants|Number|70|70.0||||||
4462305|NCT00040742|4282167|B3|No||Previous chemotherapy||participants|Number|56|56.0||||||
4462306|NCT00040742|4282168|B2|No||Previous chemotherapy||participants|Number|57|57.0||||||
4462307|NCT00040742|4282169|B1|No||Previous chemotherapy||participants|Number|68|68.0||||||
4462308|NCT00040742|4282165|B5|Yes||Previous chemotherapy||participants|Number|323|323.0||||||
4462309|NCT00040742|4282166|B4|Yes||Previous chemotherapy||participants|Number|82|82.0||||||
4462310|NCT00040742|4282167|B3|Yes||Previous chemotherapy||participants|Number|85|85.0||||||
4462311|NCT00040742|4282168|B2|Yes||Previous chemotherapy||participants|Number|75|75.0||||||
4462312|NCT00040742|4282169|B1|Yes||Previous chemotherapy||participants|Number|81|81.0||||||
4462313|NCT00040742|4282165|B5|No||Previous surgery||participants|Number|75|75.0||||||
4462314|NCT00040742|4282166|B4|No||Previous surgery||participants|Number|23|23.0||||||
4462315|NCT00040742|4282167|B3|No||Previous surgery||participants|Number|15|15.0||||||
4462316|NCT00040742|4282168|B2|No||Previous surgery||participants|Number|19|19.0||||||
4462317|NCT00040742|4282169|B1|No||Previous surgery||participants|Number|18|18.0||||||
4462318|NCT00040742|4282165|B5|Yes||Previous surgery||participants|Number|501|501.0||||||
4462319|NCT00040742|4282166|B4|Yes||Previous surgery||participants|Number|129|129.0||||||
4462320|NCT00040742|4282167|B3|Yes||Previous surgery||participants|Number|126|126.0||||||
4462321|NCT00040742|4282168|B2|Yes||Previous surgery||participants|Number|115|115.0||||||
4462322|NCT00040742|4282169|B1|Yes||Previous surgery||participants|Number|131|131.0||||||
4462323|NCT00040742|4282165|B5|Unknown||Education||participants|Number|1|1.0||||||
4462324|NCT00040742|4282166|B4|Unknown||Education||participants|Number|0|0.0||||||
4462325|NCT00040742|4282167|B3|Unknown||Education||participants|Number|0|0.0||||||
4462326|NCT00040742|4282168|B2|Unknown||Education||participants|Number|0|0.0||||||
4462327|NCT00040742|4282169|B1|Unknown||Education||participants|Number|1|1.0||||||
4462328|NCT00040742|4282165|B5|Some/No HS||Education||participants|Number|23|23.0||||||
4462329|NCT00040742|4282166|B4|Some/No HS||Education||participants|Number|3|3.0||||||
4462330|NCT00040742|4282167|B3|Some/No HS||Education||participants|Number|5|5.0||||||
4462331|NCT00040742|4282168|B2|Some/No HS||Education||participants|Number|9|9.0||||||
4462332|NCT00040742|4282169|B1|Some/No HS||Education||participants|Number|6|6.0||||||
4462333|NCT00040742|4282165|B5|H.S. Grad||Education||participants|Number|336|336.0||||||
4462334|NCT00040742|4282166|B4|H.S. Grad||Education||participants|Number|95|95.0||||||
4462335|NCT00040742|4282167|B3|H.S. Grad||Education||participants|Number|81|81.0||||||
4462336|NCT00040742|4282168|B2|H.S. Grad||Education||participants|Number|78|78.0||||||
4462337|NCT00040742|4282169|B1|H.S. Grad||Education||participants|Number|82|82.0||||||
4462338|NCT00040742|4282165|B5|College Grad||Education||participants|Number|216|216.0||||||
4462339|NCT00040742|4282166|B4|College Grad||Education||participants|Number|54|54.0||||||
4462340|NCT00040742|4282167|B3|College Grad||Education||participants|Number|55|55.0||||||
4462341|NCT00040742|4282168|B2|College Grad||Education||participants|Number|47|47.0||||||
4462342|NCT00040742|4282169|B1|College Grad||Education||participants|Number|60|60.0||||||
4462343|NCT00040742|4282165|B5|Unknown||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4462344|NCT00040742|4282166|B4|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4462345|NCT00040742|4282167|B3|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4462346|NCT00040742|4282168|B2|Unknown||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4462347|NCT00040742|4282169|B1|Unknown||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4462348|NCT00040742|4282165|B5|Non-White||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4462349|NCT00040742|4282166|B4|Non-White||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4462350|NCT00040742|4282167|B3|Non-White||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4462351|NCT00040742|4282168|B2|Non-White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4462352|NCT00040742|4282169|B1|Non-White||Race/Ethnicity, Customized||participants|Number|11|11.0||||||
4462353|NCT00040742|4282165|B5|White||Race/Ethnicity, Customized||participants|Number|538|538.0||||||
4462354|NCT00040742|4282166|B4|White||Race/Ethnicity, Customized||participants|Number|142|142.0||||||
4462355|NCT00040742|4282167|B3|White||Race/Ethnicity, Customized||participants|Number|133|133.0||||||
4462356|NCT00040742|4282168|B2|White||Race/Ethnicity, Customized||participants|Number|126|126.0||||||
4462357|NCT00040742|4282169|B1|White||Race/Ethnicity, Customized||participants|Number|137|137.0||||||
4462358|NCT00040742|4282165|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4462359|NCT00040742|4282166|B4||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4462360|NCT00040742|4282167|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4462361|NCT00040742|4282168|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4462362|NCT00040742|4282169|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4462363|NCT00040742|4282165|B5||Female|Sex: Female, Male||Participants|Count of Participants|521|521.0||||||
4462364|NCT00040742|4282166|B4||Female|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4462365|NCT00040742|4282167|B3||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4462366|NCT00040742|4282168|B2||Female|Sex: Female, Male||Participants|Count of Participants|122|122.0||||||
4462367|NCT00040742|4282169|B1||Female|Sex: Female, Male||Participants|Count of Participants|135|135.0||||||
4462368|NCT00040742|4282165|B5|||Age||years|Mean|52.75|52.75|Standard Deviation|10.68|10.68|||
4462369|NCT00040742|4282166|B4|||Age||years|Mean|52|52.0|Standard Deviation|9.86|9.86|||
4462370|NCT00040742|4282167|B3|||Age||years|Mean|52|52.0|Standard Deviation|10.69|10.69|||
4462371|NCT00040742|4282168|B2|||Age||years|Mean|54|54.0|Standard Deviation|11.58|11.58|||
4462372|NCT00040742|4282169|B1|||Age||years|Mean|53|53.0|Standard Deviation|10.62|10.62|||
4462373|NCT00039377|4282186|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4462374|NCT00039377|4282186|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4462375|NCT00039377|4282186|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4462376|NCT00039377|4282186|B1|||Age||years|Median|44|44.0|Full Range|||25.0|58.0|
4462377|NCT00039195|4282201|B1|United States||Region of Enrollment||participants|Number|98|98.0||||||
4462378|NCT00039195|4282201|B1||Male|Sex: Female, Male||Participants|Count of Participants|56|56.0||||||
4462379|NCT00039195|4282201|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4462380|NCT00039195|4282201|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4462381|NCT00039195|4282201|B1||Between 18 and 65 years|Age||Participants|Count of Participants|97|97.0||||||
4462382|NCT00039195|4282201|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462383|NCT00039130|4282205|B1|United States||Region of Enrollment||participants|Number|105|105.0||||||
4462384|NCT00039130|4282205|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462385|NCT00039130|4282205|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462386|NCT00039130|4282205|B1||White|Race (NIH/OMB)||Participants|Count of Participants|98|98.0||||||
4462387|NCT00039130|4282205|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4462388|NCT00039130|4282205|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462389|NCT00039130|4282205|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462390|NCT00039130|4282205|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462391|NCT00039130|4282205|B1||Male|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4462392|NCT00039130|4282205|B1||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4462393|NCT00039130|4282205|B1|||Age||years|Median|43|43.0|Full Range|||19.0|79.0|
4462394|NCT00036738|4282211|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4462395|NCT00036738|4282211|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4462396|NCT00036738|4282211|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4462397|NCT00036738|4282211|B1|||Age||years|Median|57.6|57.6|Full Range|||33.8|69.8|
4462398|NCT00036738|4282211|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4462399|NCT00036738|4282211|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4462400|NCT00036738|4282211|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462401|NCT00033657|4282219|B3|United States||Region of Enrollment||participants|Number|81|81.0||||||
4462402|NCT00033657|4282220|B2|United States||Region of Enrollment||participants|Number|42|42.0||||||
4462403|NCT00033657|4282221|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4462404|NCT00033657|4282219|B3||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4462405|NCT00033657|4282220|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4462406|NCT00033657|4282221|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4462407|NCT00033657|4282219|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4462408|NCT00033657|4282220|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4462409|NCT00033657|4282221|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4462410|NCT00033657|4282219|B3|||Age||years|Mean|58.1|58.1|Standard Deviation|10.3|10.3|||
4462411|NCT00033657|4282220|B2|||Age||years|Mean|59.9|59.9|Standard Deviation|10.7|10.7|||
4462412|NCT00033657|4282221|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|9.7|9.7|||
4462413|NCT00033631|4282234|B3||Male|Sex: Female, Male||Participants|Count of Participants|1499|1499.0||||||
4462414|NCT00033631|4282235|B2||Male|Sex: Female, Male||Participants|Count of Participants|748|748.0||||||
4462415|NCT00033631|4282236|B1||Male|Sex: Female, Male||Participants|Count of Participants|751|751.0||||||
4462416|NCT00033631|4282234|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462417|NCT00033631|4282235|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462418|NCT00033631|4282236|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462419|NCT00033631|4282234|B3|||Age||years|Median|71|71.0|Full Range|||33.0|87.0|
4462420|NCT00033631|4282235|B2|||Age||years|Median|71|71.0|Full Range|||49.0|87.0|
4462421|NCT00033631|4282236|B1|||Age||years|Median|71|71.0|Full Range|||33.0|86.0|
4462422|NCT00033540|4282255|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462423|NCT00033540|4282255|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462424|NCT00033540|4282255|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4462425|NCT00033540|4282255|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4462426|NCT00033540|4282255|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462427|NCT00033540|4282255|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4462428|NCT00033540|4282255|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462429|NCT00033540|4282255|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462430|NCT00033540|4282255|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4462431|NCT00033540|4282255|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4462432|NCT00033540|4282255|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4462433|NCT00033540|4282255|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4462434|NCT00033540|4282255|B1|||Age||years|Median|58.8|58.8|Full Range|||29.5|85.6|
4462435|NCT00033514|4282263|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4462436|NCT00033514|4282264|B2|United States||Region of Enrollment||participants|Number|11|11.0||||||
4462437|NCT00033514|4282265|B1|United States||Region of Enrollment||participants|Number|16|16.0||||||
4462438|NCT00033514|4282263|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4462439|NCT00033514|4282264|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462440|NCT00033514|4282265|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462441|NCT00033514|4282263|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462442|NCT00033514|4282264|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462443|NCT00033514|4282265|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462444|NCT00033514|4282263|B3||White|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4462445|NCT00033514|4282264|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4462446|NCT00033514|4282265|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4462447|NCT00033514|4282263|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4462448|NCT00033514|4282264|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462449|NCT00033514|4282265|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462450|NCT00033514|4282263|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462451|NCT00033514|4282264|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462452|NCT00033514|4282265|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462453|NCT00033514|4282263|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462454|NCT00033514|4282264|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462455|NCT00033514|4282265|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462456|NCT00033514|4282263|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462457|NCT00033514|4282264|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462458|NCT00033514|4282265|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462459|NCT00033514|4282263|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462460|NCT00033514|4282264|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462461|NCT00033514|4282265|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462462|NCT00033514|4282263|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4462463|NCT00033514|4282264|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4462464|NCT00033514|4282265|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4462465|NCT00033514|4282263|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4462466|NCT00033514|4282264|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4462467|NCT00033514|4282265|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4462468|NCT00033514|4282263|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4462469|NCT00033514|4282264|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4462470|NCT00033514|4282265|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4462471|NCT00033514|4282263|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462472|NCT00033514|4282264|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462473|NCT00033514|4282265|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462474|NCT00033371|4282274|B3|Not Evaulable Participant||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|40|40.0||||||
4462475|NCT00033371|4282275|B2|Not Evaulable Participant||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|22|22.0||||||
4462476|NCT00033371|4282276|B1|Not Evaulable Participant||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|18|18.0||||||
4462477|NCT00033371|4282274|B3|No Baseline Screen||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|4|4.0||||||
4462478|NCT00033371|4282275|B2|No Baseline Screen||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|0|0.0||||||
4462479|NCT00033371|4282276|B1|No Baseline Screen||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|4|4.0||||||
4462480|NCT00033371|4282274|B3|10 or more||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|4|4.0||||||
4462481|NCT00033371|4282275|B2|10 or more||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|4|4.0||||||
4462482|NCT00033371|4282276|B1|10 or more||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|0|0.0||||||
4462483|NCT00033371|4282274|B3|5-9||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|18|18.0||||||
4462484|NCT00033371|4282275|B2|5-9||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|5|5.0||||||
4462485|NCT00033371|4282276|B1|5-9||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|13|13.0||||||
4462486|NCT00033371|4282274|B3|2-4||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|24|24.0||||||
4462487|NCT00033371|4282275|B2|2-4||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|13|13.0||||||
4462488|NCT00033371|4282276|B1|2-4||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|11|11.0||||||
4462489|NCT00033371|4282274|B3|0-1||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|22|22.0||||||
4462490|NCT00033371|4282275|B2|0-1||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|13|13.0||||||
4462491|NCT00033371|4282276|B1|0-1||Number Landmark Polyps at least 2 mm at Baseline Screen for Evaluable polyps, Evaluable Participants||participants|Number|9|9.0||||||
4462492|NCT00033371|4282274|B3|No Baseline Screen||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|4|4.0||||||
4462493|NCT00033371|4282275|B2|No Baseline Screen||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|0|0.0||||||
4462494|NCT00033371|4282276|B1|No Baseline Screen||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|4|4.0||||||
4462495|NCT00033371|4282274|B3|10 or more||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|10|10.0||||||
4462496|NCT00033371|4282275|B2|10 or more||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|6|6.0||||||
4462497|NCT00033371|4282276|B1|10 or more||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|4|4.0||||||
4462498|NCT00033371|4282274|B3|5-9||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|30|30.0||||||
4462499|NCT00033371|4282275|B2|5-9||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|8|8.0||||||
4462500|NCT00033371|4282276|B1|5-9||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|22|22.0||||||
4462501|NCT00033371|4282274|B3|2-4||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|35|35.0||||||
4462502|NCT00033371|4282275|B2|2-4||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|23|23.0||||||
4462503|NCT00033371|4282276|B1|2-4||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|12|12.0||||||
4462504|NCT00033371|4282274|B3|0-1||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|33|33.0||||||
4462505|NCT00033371|4282275|B2|0-1||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|20|20.0||||||
4462506|NCT00033371|4282276|B1|0-1||Number of Landmark Polyps at least 2 mm at Baseline Screen||participants|Number|13|13.0||||||
4462507|NCT00033371|4282274|B3|No Baseline Screen||Number of Landmark Polyps at Baseline Sceen||participants|Number|4|4.0||||||
4462508|NCT00033371|4282275|B2|No Baseline Screen||Number of Landmark Polyps at Baseline Sceen||participants|Number|0|0.0||||||
4462509|NCT00033371|4282276|B1|No Baseline Screen||Number of Landmark Polyps at Baseline Sceen||participants|Number|4|4.0||||||
4462510|NCT00033371|4282274|B3|10 or more||Number of Landmark Polyps at Baseline Sceen||participants|Number|41|41.0||||||
4462511|NCT00033371|4282275|B2|10 or more||Number of Landmark Polyps at Baseline Sceen||participants|Number|19|19.0||||||
4462512|NCT00033371|4282276|B1|10 or more||Number of Landmark Polyps at Baseline Sceen||participants|Number|22|22.0||||||
4462513|NCT00033371|4282274|B3|5-9||Number of Landmark Polyps at Baseline Sceen||participants|Number|40|40.0||||||
4462514|NCT00033371|4282275|B2|5-9||Number of Landmark Polyps at Baseline Sceen||participants|Number|21|21.0||||||
4462515|NCT00033371|4282276|B1|5-9||Number of Landmark Polyps at Baseline Sceen||participants|Number|19|19.0||||||
4462516|NCT00033371|4282274|B3|2-4||Number of Landmark Polyps at Baseline Sceen||participants|Number|19|19.0||||||
4462517|NCT00033371|4282275|B2|2-4||Number of Landmark Polyps at Baseline Sceen||participants|Number|12|12.0||||||
4462518|NCT00033371|4282276|B1|2-4||Number of Landmark Polyps at Baseline Sceen||participants|Number|7|7.0||||||
4462519|NCT00033371|4282274|B3|0-1||Number of Landmark Polyps at Baseline Sceen||participants|Number|8|8.0||||||
4462520|NCT00033371|4282275|B2|0-1||Number of Landmark Polyps at Baseline Sceen||participants|Number|5|5.0||||||
4462521|NCT00033371|4282276|B1|0-1||Number of Landmark Polyps at Baseline Sceen||participants|Number|3|3.0||||||
4462522|NCT00033371|4282274|B3|Rectum Only||Colon versus Rectum|Number of participants with intact colon (Colon); or those with rectum only (Rectum Only).|participants|Number|66|66.0||||||
4462523|NCT00033371|4282275|B2|Rectum Only||Colon versus Rectum|Number of participants with intact colon (Colon); or those with rectum only (Rectum Only).|participants|Number|30|30.0||||||
4462524|NCT00033371|4282276|B1|Rectum Only||Colon versus Rectum|Number of participants with intact colon (Colon); or those with rectum only (Rectum Only).|participants|Number|36|36.0||||||
4462525|NCT00033371|4282274|B3|Colon||Colon versus Rectum|Number of participants with intact colon (Colon); or those with rectum only (Rectum Only).|participants|Number|46|46.0||||||
4462526|NCT00033371|4282275|B2|Colon||Colon versus Rectum|Number of participants with intact colon (Colon); or those with rectum only (Rectum Only).|participants|Number|27|27.0||||||
4462527|NCT00033371|4282276|B1|Colon||Colon versus Rectum|Number of participants with intact colon (Colon); or those with rectum only (Rectum Only).|participants|Number|19|19.0||||||
4462528|NCT00033371|4282274|B3|>25 Polyps and age >40||Basis of FAP Diagnosis|Eligible participants aged 18-65 years required to have clinical diagnosis of FAP based on personal history of one of following a)>100 adenomas; b)>10 adenomas before age 40 years; c)>25 adenomas and, if age>40 years, a characteristic family history (autosomal dominant pattern) including >100 polyps in first degree family member, >25 polyps in 2 relatives in two generations, genetic diagnosis in a relative, or d) genetic diagnosis by sequencing/similar assay. Participants required to have an evaluable colon and/or rectal segment, and 5 or more colorectal polyps’ ≥2mm at baseline examination.|participants|Number|17|17.0||||||
4462529|NCT00033371|4282275|B2|>25 Polyps and age >40||Basis of FAP Diagnosis|Eligible participants aged 18-65 years required to have clinical diagnosis of FAP based on personal history of one of following a)>100 adenomas; b)>10 adenomas before age 40 years; c)>25 adenomas and, if age>40 years, a characteristic family history (autosomal dominant pattern) including >100 polyps in first degree family member, >25 polyps in 2 relatives in two generations, genetic diagnosis in a relative, or d) genetic diagnosis by sequencing/similar assay. Participants required to have an evaluable colon and/or rectal segment, and 5 or more colorectal polyps’ ≥2mm at baseline examination.|participants|Number|11|11.0||||||
4462530|NCT00033371|4282276|B1|>25 Polyps and age >40||Basis of FAP Diagnosis|Eligible participants aged 18-65 years required to have clinical diagnosis of FAP based on personal history of one of following a)>100 adenomas; b)>10 adenomas before age 40 years; c)>25 adenomas and, if age>40 years, a characteristic family history (autosomal dominant pattern) including >100 polyps in first degree family member, >25 polyps in 2 relatives in two generations, genetic diagnosis in a relative, or d) genetic diagnosis by sequencing/similar assay. Participants required to have an evaluable colon and/or rectal segment, and 5 or more colorectal polyps’ ≥2mm at baseline examination.|participants|Number|6|6.0||||||
4462531|NCT00033371|4282274|B3|>10 Polyps and age <40||Basis of FAP Diagnosis|Eligible participants aged 18-65 years required to have clinical diagnosis of FAP based on personal history of one of following a)>100 adenomas; b)>10 adenomas before age 40 years; c)>25 adenomas and, if age>40 years, a characteristic family history (autosomal dominant pattern) including >100 polyps in first degree family member, >25 polyps in 2 relatives in two generations, genetic diagnosis in a relative, or d) genetic diagnosis by sequencing/similar assay. Participants required to have an evaluable colon and/or rectal segment, and 5 or more colorectal polyps’ ≥2mm at baseline examination.|participants|Number|51|51.0||||||
4462532|NCT00033371|4282275|B2|>10 Polyps and age <40||Basis of FAP Diagnosis|Eligible participants aged 18-65 years required to have clinical diagnosis of FAP based on personal history of one of following a)>100 adenomas; b)>10 adenomas before age 40 years; c)>25 adenomas and, if age>40 years, a characteristic family history (autosomal dominant pattern) including >100 polyps in first degree family member, >25 polyps in 2 relatives in two generations, genetic diagnosis in a relative, or d) genetic diagnosis by sequencing/similar assay. Participants required to have an evaluable colon and/or rectal segment, and 5 or more colorectal polyps’ ≥2mm at baseline examination.|participants|Number|23|23.0||||||
4462533|NCT00033371|4282276|B1|>10 Polyps and age <40||Basis of FAP Diagnosis|Eligible participants aged 18-65 years required to have clinical diagnosis of FAP based on personal history of one of following a)>100 adenomas; b)>10 adenomas before age 40 years; c)>25 adenomas and, if age>40 years, a characteristic family history (autosomal dominant pattern) including >100 polyps in first degree family member, >25 polyps in 2 relatives in two generations, genetic diagnosis in a relative, or d) genetic diagnosis by sequencing/similar assay. Participants required to have an evaluable colon and/or rectal segment, and 5 or more colorectal polyps’ ≥2mm at baseline examination.|participants|Number|28|28.0||||||
4462534|NCT00033371|4282274|B3|>100 Polyps||Basis of FAP Diagnosis|Eligible participants aged 18-65 years required to have clinical diagnosis of FAP based on personal history of one of following a)>100 adenomas; b)>10 adenomas before age 40 years; c)>25 adenomas and, if age>40 years, a characteristic family history (autosomal dominant pattern) including >100 polyps in first degree family member, >25 polyps in 2 relatives in two generations, genetic diagnosis in a relative, or d) genetic diagnosis by sequencing/similar assay. Participants required to have an evaluable colon and/or rectal segment, and 5 or more colorectal polyps’ ≥2mm at baseline examination.|participants|Number|44|44.0||||||
4462535|NCT00033371|4282275|B2|>100 Polyps||Basis of FAP Diagnosis|Eligible participants aged 18-65 years required to have clinical diagnosis of FAP based on personal history of one of following a)>100 adenomas; b)>10 adenomas before age 40 years; c)>25 adenomas and, if age>40 years, a characteristic family history (autosomal dominant pattern) including >100 polyps in first degree family member, >25 polyps in 2 relatives in two generations, genetic diagnosis in a relative, or d) genetic diagnosis by sequencing/similar assay. Participants required to have an evaluable colon and/or rectal segment, and 5 or more colorectal polyps’ ≥2mm at baseline examination.|participants|Number|23|23.0||||||
4462536|NCT00033371|4282276|B1|>100 Polyps||Basis of FAP Diagnosis|Eligible participants aged 18-65 years required to have clinical diagnosis of FAP based on personal history of one of following a)>100 adenomas; b)>10 adenomas before age 40 years; c)>25 adenomas and, if age>40 years, a characteristic family history (autosomal dominant pattern) including >100 polyps in first degree family member, >25 polyps in 2 relatives in two generations, genetic diagnosis in a relative, or d) genetic diagnosis by sequencing/similar assay. Participants required to have an evaluable colon and/or rectal segment, and 5 or more colorectal polyps’ ≥2mm at baseline examination.|participants|Number|21|21.0||||||
4462537|NCT00033371|4282274|B3|United Kingdom||Region of Enrollment||participants|Number|27|27.0||||||
4462538|NCT00033371|4282275|B2|United Kingdom||Region of Enrollment||participants|Number|14|14.0||||||
4462539|NCT00033371|4282276|B1|United Kingdom||Region of Enrollment||participants|Number|13|13.0||||||
4462540|NCT00033371|4282274|B3|United States||Region of Enrollment||participants|Number|85|85.0||||||
4462541|NCT00033371|4282275|B2|United States||Region of Enrollment||participants|Number|43|43.0||||||
4462542|NCT00033371|4282276|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4462543|NCT00033371|4282274|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4462544|NCT00033371|4282275|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462545|NCT00033371|4282276|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462546|NCT00033371|4282274|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462547|NCT00033371|4282275|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462548|NCT00033371|4282276|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462549|NCT00033371|4282274|B3||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4462550|NCT00033371|4282275|B2||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4462551|NCT00033371|4282276|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4462552|NCT00033371|4282274|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462553|NCT00033371|4282275|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462554|NCT00033371|4282276|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462555|NCT00033371|4282274|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462556|NCT00033371|4282275|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462675|NCT00030901|4282308|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4462557|NCT00033371|4282276|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462558|NCT00033371|4282274|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462559|NCT00033371|4282275|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462560|NCT00033371|4282276|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462561|NCT00033371|4282274|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462562|NCT00033371|4282275|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462563|NCT00033371|4282276|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462564|NCT00033371|4282274|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4462565|NCT00033371|4282275|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4462566|NCT00033371|4282276|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462567|NCT00033371|4282274|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|96|96.0||||||
4462568|NCT00033371|4282275|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4462569|NCT00033371|4282276|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4462570|NCT00033371|4282274|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4462571|NCT00033371|4282275|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4462572|NCT00033371|4282276|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4462573|NCT00033371|4282274|B3||Male|Gender||Participants|Count of Participants|60|60.0||||||
4462574|NCT00033371|4282275|B2||Male|Gender||Participants|Count of Participants|30|30.0||||||
4462575|NCT00033371|4282276|B1||Male|Gender||Participants|Count of Participants|30|30.0||||||
4462576|NCT00033371|4282274|B3||Female|Gender||Participants|Count of Participants|52|52.0||||||
4462577|NCT00033371|4282275|B2||Female|Gender||Participants|Count of Participants|27|27.0||||||
4462578|NCT00033371|4282276|B1||Female|Gender||Participants|Count of Participants|25|25.0||||||
4462579|NCT00033371|4282274|B3|||Age||years|Median|38|38.0|Full Range|||18.0|63.0|
4462580|NCT00033371|4282275|B2|||Age||years|Median|38|38.0|Full Range|||19.0|59.0|
4462581|NCT00033371|4282276|B1|||Age||years|Median|38|38.0|Full Range|||18.0|63.0|
4462582|NCT00033293|4282283|B3|United States||Region of Enrollment||participants|Number|53|53.0||||||
4462583|NCT00033293|4282284|B2|United States||Region of Enrollment||participants|Number|27|27.0||||||
4462584|NCT00033293|4282285|B1|United States||Region of Enrollment||participants|Number|26|26.0||||||
4462585|NCT00033293|4282283|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4462586|NCT00033293|4282284|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4462587|NCT00033293|4282285|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462588|NCT00033293|4282283|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462589|NCT00033293|4282284|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462590|NCT00033293|4282285|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462591|NCT00033293|4282283|B3||White|Race (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4462592|NCT00033293|4282284|B2||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4462593|NCT00033293|4282285|B1||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4462594|NCT00033293|4282283|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4462595|NCT00033293|4282284|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4462596|NCT00033293|4282285|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4462597|NCT00033293|4282283|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462598|NCT00033293|4282284|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462599|NCT00033293|4282285|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462600|NCT00033293|4282283|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462601|NCT00033293|4282284|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462602|NCT00033293|4282285|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462603|NCT00033293|4282283|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462604|NCT00033293|4282284|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462605|NCT00033293|4282285|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462606|NCT00033293|4282283|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462607|NCT00033293|4282284|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462608|NCT00033293|4282285|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462609|NCT00033293|4282283|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4462610|NCT00033293|4282284|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4462611|NCT00033293|4282285|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4462612|NCT00033293|4282283|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4462613|NCT00033293|4282284|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4462614|NCT00033293|4282285|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4462615|NCT00033293|4282283|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4462616|NCT00033293|4282284|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4462617|NCT00033293|4282285|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4462618|NCT00033293|4282283|B3||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4462619|NCT00033293|4282284|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4462620|NCT00033293|4282285|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4462621|NCT00033293|4282283|B3|||Age||years|Mean|1.3|1.3|Standard Deviation|0.7|0.7|||
4462622|NCT00033293|4282284|B2|||Age||years|Mean|1.2|1.2|Standard Deviation|0.5|0.5|||
4462623|NCT00033293|4282285|B1|||Age||years|Mean|1.4|1.4|Standard Deviation|0.9|0.9|||
4462624|NCT00033293|4282283|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462625|NCT00033293|4282284|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462626|NCT00033293|4282285|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462627|NCT00033293|4282283|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4462628|NCT00033293|4282284|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4462629|NCT00033293|4282285|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4462630|NCT00033293|4282283|B3||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
4462631|NCT00033293|4282284|B2||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4462632|NCT00033293|4282285|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4462633|NCT00031694|4282304|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4462634|NCT00031694|4282304|B1|Non-Hispanic black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4462635|NCT00031694|4282304|B1|Non-Hispanic whites||Race/Ethnicity, Customized||participants|Number|13|13.0||||||
4462636|NCT00031694|4282304|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4462637|NCT00031694|4282304|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4462638|NCT00031694|4282304|B1|||Age||years|Median|56.0|56.0|Full Range|||21.0|81.0|
4462639|NCT00030901|4282308|B3|4-10 ng/mL||Baseline Prostate-Specific Antigen (PSA) - reported by site||participants|Number|252|252.0||||||
4462640|NCT00030901|4282309|B2|4-10 ng/mL||Baseline Prostate-Specific Antigen (PSA) - reported by site||participants|Number|121|121.0||||||
4462641|NCT00030901|4282310|B1|4-10 ng/mL||Baseline Prostate-Specific Antigen (PSA) - reported by site||participants|Number|131|131.0||||||
4462642|NCT00030901|4282308|B3|<4 ng/mL||Baseline Prostate-Specific Antigen (PSA) - reported by site||participants|Number|171|171.0||||||
4462643|NCT00030901|4282309|B2|<4 ng/mL||Baseline Prostate-Specific Antigen (PSA) - reported by site||participants|Number|90|90.0||||||
4462644|NCT00030901|4282310|B1|<4 ng/mL||Baseline Prostate-Specific Antigen (PSA) - reported by site||participants|Number|81|81.0||||||
4462645|NCT00030901|4282308|B3|>70 years||Age||participants|Number|110|110.0||||||
4462646|NCT00030901|4282309|B2|>70 years||Age||participants|Number|51|51.0||||||
4462647|NCT00030901|4282310|B1|>70 years||Age||participants|Number|59|59.0||||||
4462648|NCT00030901|4282308|B3|61-70 years||Age||participants|Number|194|194.0||||||
4462649|NCT00030901|4282309|B2|61-70 years||Age||participants|Number|98|98.0||||||
4462650|NCT00030901|4282310|B1|61-70 years||Age||participants|Number|96|96.0||||||
4462651|NCT00030901|4282308|B3|55-60 years||Age||participants|Number|63|63.0||||||
4462652|NCT00030901|4282309|B2|55-60 years||Age||participants|Number|35|35.0||||||
4462653|NCT00030901|4282310|B1|55-60 years||Age||participants|Number|28|28.0||||||
4462654|NCT00030901|4282308|B3|50-54 years||Age||participants|Number|40|40.0||||||
4462655|NCT00030901|4282309|B2|50-54 years||Age||participants|Number|20|20.0||||||
4462656|NCT00030901|4282310|B1|50-54 years||Age||participants|Number|20|20.0||||||
4462657|NCT00030901|4282308|B3|<50 years||Age||participants|Number|16|16.0||||||
4462658|NCT00030901|4282309|B2|<50 years||Age||participants|Number|7|7.0||||||
4462659|NCT00030901|4282310|B1|<50 years||Age||participants|Number|9|9.0||||||
4462660|NCT00030901|4282308|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4462661|NCT00030901|4282309|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4462662|NCT00030901|4282310|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462663|NCT00030901|4282308|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462664|NCT00030901|4282309|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462665|NCT00030901|4282310|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462666|NCT00030901|4282308|B3||White|Race (NIH/OMB)||Participants|Count of Participants|353|353.0||||||
4462667|NCT00030901|4282309|B2||White|Race (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
4462668|NCT00030901|4282310|B1||White|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4462669|NCT00030901|4282308|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4462670|NCT00030901|4282309|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4462671|NCT00030901|4282310|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4462672|NCT00030901|4282308|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462673|NCT00030901|4282309|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462674|NCT00030901|4282310|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462676|NCT00030901|4282309|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4462677|NCT00030901|4282310|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4462678|NCT00030901|4282308|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4462679|NCT00030901|4282309|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462680|NCT00030901|4282310|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462681|NCT00030901|4282308|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|24|24.0||||||
4462682|NCT00030901|4282309|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4462683|NCT00030901|4282310|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4462684|NCT00030901|4282308|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|382|382.0||||||
4462685|NCT00030901|4282309|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
4462686|NCT00030901|4282310|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|195|195.0||||||
4462687|NCT00030901|4282308|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4462688|NCT00030901|4282309|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4462689|NCT00030901|4282310|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4462690|NCT00030901|4282308|B3||Male|Sex: Female, Male||Participants|Count of Participants|423|423.0||||||
4462691|NCT00030901|4282309|B2||Male|Sex: Female, Male||Participants|Count of Participants|211|211.0||||||
4462692|NCT00030901|4282310|B1||Male|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4462693|NCT00030901|4282308|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462694|NCT00030901|4282309|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462695|NCT00030901|4282310|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462696|NCT00030901|4282308|B3|||Age||years|Median|65.65|65.65|Full Range|||42.2|82.7|
4462697|NCT00030901|4282309|B2|||Age||years|Median|65.30|65.3|Full Range|||44.9|82.7|
4462698|NCT00030901|4282310|B1|||Age||years|Median|65.90|65.9|Full Range|||42.2|80.1|
4462699|NCT00030823|4282320|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462700|NCT00030823|4282320|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4462701|NCT00030823|4282320|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462702|NCT00030823|4282320|B1||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4462703|NCT00030823|4282320|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462704|NCT00030264|4282324|B1|United States||Region of Enrollment||Participants|Count of Participants|23|23.0||||||
4462705|NCT00030264|4282324|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462706|NCT00030264|4282324|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462707|NCT00030264|4282324|B1||White|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4462708|NCT00030264|4282324|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462709|NCT00030264|4282324|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462710|NCT00030264|4282324|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462711|NCT00030264|4282324|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462712|NCT00030264|4282324|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4462713|NCT00030264|4282324|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4462714|NCT00030264|4282324|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462715|NCT00030264|4282324|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4462716|NCT00030264|4282324|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4462717|NCT00030264|4282324|B1|||Age||years|Median|5.56|5.56|Full Range|||0.34|23.99|
4462718|NCT00030264|4282324|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462719|NCT00030264|4282324|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4462720|NCT00030264|4282324|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4462721|NCT00028769|4282328|B1|9-10||Gleason Score||participants|Number|14|14.0||||||
4462722|NCT00028769|4282328|B1|8||Gleason Score||participants|Number|6|6.0||||||
4462723|NCT00028769|4282328|B1|7||Gleason Score||participants|Number|12|12.0||||||
4462724|NCT00028769|4282328|B1|6||Gleason Score||participants|Number|2|2.0||||||
4462725|NCT00028769|4282328|B1|Missing||Gleason Score||participants|Number|1|1.0||||||
4462726|NCT00028769|4282328|B1|No/Unknown||Previous Prostatectomy||participants|Number|29|29.0||||||
4462727|NCT00028769|4282328|B1|Yes||Previous Prostatectomy||participants|Number|6|6.0||||||
4462728|NCT00028769|4282328|B1|>=2||Bone Pain Grade (CTC version 2.0)|0 - none, 1 - mild pain not interfering with function, 2 - moderate pain: pain or analgesics interfering with function, but not interfering with activities of daily living, 3 - severe pain: pain or analgesics severely interfering with activities of daily living, 4 - disabling|participants|Number|7|7.0||||||
4462729|NCT00028769|4282328|B1|<2||Bone Pain Grade (CTC version 2.0)|0 - none, 1 - mild pain not interfering with function, 2 - moderate pain: pain or analgesics interfering with function, but not interfering with activities of daily living, 3 - severe pain: pain or analgesics severely interfering with activities of daily living, 4 - disabling|participants|Number|26|26.0||||||
4462779|NCT00027846|4282343|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4462730|NCT00028769|4282328|B1|Missing||Bone Pain Grade (CTC version 2.0)|0 - none, 1 - mild pain not interfering with function, 2 - moderate pain: pain or analgesics interfering with function, but not interfering with activities of daily living, 3 - severe pain: pain or analgesics severely interfering with activities of daily living, 4 - disabling|participants|Number|2|2.0||||||
4462731|NCT00028769|4282328|B1|1||Southwestern Oncology Group Performance Status|Patients will be graded according to the Zubrod performance status scale. 0: Fully active, able to carry all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed or chair.|participants|Number|15|15.0||||||
4462732|NCT00028769|4282328|B1|0||Southwestern Oncology Group Performance Status|Patients will be graded according to the Zubrod performance status scale. 0: Fully active, able to carry all pre-disease performance without restriction. 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature. 2: Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours. 3: Capable of limited self-care, confined to bed or chair more than 50% of waking hours. 4: Completely disabled; cannot carry on any self-care; totally confined to bed or chair.|participants|Number|20|20.0||||||
4462733|NCT00028769|4282328|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462734|NCT00028769|4282328|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462735|NCT00028769|4282328|B1||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4462736|NCT00028769|4282328|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4462737|NCT00028769|4282328|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462738|NCT00028769|4282328|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462739|NCT00028769|4282328|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462740|NCT00028769|4282328|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462741|NCT00028769|4282328|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4462742|NCT00028769|4282328|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4462743|NCT00028769|4282328|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4462744|NCT00028769|4282328|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462745|NCT00028769|4282328|B1|||Age||years|Median|60|60.0|Full Range|||45.0|79.0|
4462746|NCT00028002|4282334|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4462747|NCT00028002|4282334|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4462748|NCT00028002|4282334|B1|||Age||years|Median|58.5|58.5|Full Range|||24.0|84.0|
4462749|NCT00027846|4282341|B4|Australia||Region of Enrollment||participants|Number|15|15.0||||||
4462750|NCT00027846|4282342|B3|Australia||Region of Enrollment||participants|Number|5|5.0||||||
4462751|NCT00027846|4282343|B2|Australia||Region of Enrollment||participants|Number|10|10.0||||||
4462752|NCT00027846|4282344|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4462753|NCT00027846|4282341|B4|United States||Region of Enrollment||participants|Number|317|317.0||||||
4462754|NCT00027846|4282342|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4462755|NCT00027846|4282343|B2|United States||Region of Enrollment||participants|Number|243|243.0||||||
4462756|NCT00027846|4282344|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4462757|NCT00027846|4282341|B4|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4462758|NCT00027846|4282342|B3|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4462759|NCT00027846|4282343|B2|Netherlands||Region of Enrollment||participants|Number|6|6.0||||||
4462760|NCT00027846|4282344|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4462761|NCT00027846|4282341|B4|Canada||Region of Enrollment||participants|Number|37|37.0||||||
4462762|NCT00027846|4282342|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4462763|NCT00027846|4282343|B2|Canada||Region of Enrollment||participants|Number|28|28.0||||||
4462764|NCT00027846|4282344|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4462765|NCT00027846|4282341|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4462766|NCT00027846|4282342|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4462767|NCT00027846|4282343|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4462768|NCT00027846|4282344|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4462769|NCT00027846|4282341|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4462770|NCT00027846|4282342|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462771|NCT00027846|4282343|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4462772|NCT00027846|4282344|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462773|NCT00027846|4282341|B4||White|Race (NIH/OMB)||Participants|Count of Participants|290|290.0||||||
4462774|NCT00027846|4282342|B3||White|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4462775|NCT00027846|4282343|B2||White|Race (NIH/OMB)||Participants|Count of Participants|219|219.0||||||
4462776|NCT00027846|4282344|B1||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4462777|NCT00027846|4282341|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4462778|NCT00027846|4282342|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4462780|NCT00027846|4282344|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462781|NCT00027846|4282341|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462782|NCT00027846|4282342|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462783|NCT00027846|4282343|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462784|NCT00027846|4282344|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462785|NCT00027846|4282341|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4462786|NCT00027846|4282342|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4462787|NCT00027846|4282343|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4462788|NCT00027846|4282344|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462789|NCT00027846|4282341|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462790|NCT00027846|4282342|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4462791|NCT00027846|4282343|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462792|NCT00027846|4282344|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462793|NCT00027846|4282341|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4462794|NCT00027846|4282342|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4462795|NCT00027846|4282343|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4462796|NCT00027846|4282344|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4462797|NCT00027846|4282341|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|311|311.0||||||
4462798|NCT00027846|4282342|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4462799|NCT00027846|4282343|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|242|242.0||||||
4462800|NCT00027846|4282344|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4462801|NCT00027846|4282341|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4462802|NCT00027846|4282342|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4462803|NCT00027846|4282343|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|36|36.0||||||
4462804|NCT00027846|4282344|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462805|NCT00027846|4282341|B4||Male|Gender||Participants|Count of Participants|219|219.0||||||
4462806|NCT00027846|4282342|B3||Male|Gender||Participants|Count of Participants|40|40.0||||||
4462807|NCT00027846|4282343|B2||Male|Gender||Participants|Count of Participants|173|173.0||||||
4462808|NCT00027846|4282344|B1||Male|Gender||Participants|Count of Participants|6|6.0||||||
4462809|NCT00027846|4282341|B4||Female|Gender||Participants|Count of Participants|159|159.0||||||
4462810|NCT00027846|4282342|B3||Female|Gender||Participants|Count of Participants|38|38.0||||||
4462811|NCT00027846|4282343|B2||Female|Gender||Participants|Count of Participants|114|114.0||||||
4462812|NCT00027846|4282344|B1||Female|Gender||Participants|Count of Participants|7|7.0||||||
4462813|NCT00027846|4282341|B4|||Age||years|Median|5.60|5.6|Full Range|||1.01|21.01|
4462814|NCT00027846|4282342|B3|||Age||years|Median|5.18|5.18|Full Range|||1.01|19.6|
4462815|NCT00027846|4282343|B2|||Age||years|Median|5.58|5.58|Full Range|||1.01|21.01|
4462816|NCT00027846|4282344|B1|||Age||years|Median|10.78|10.78|Full Range|||1.49|16.71|
4462817|NCT00027846|4282341|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462818|NCT00027846|4282342|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462819|NCT00027846|4282343|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462820|NCT00027846|4282344|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462821|NCT00027846|4282341|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4462822|NCT00027846|4282342|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4462823|NCT00027846|4282343|B2||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4462824|NCT00027846|4282344|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4462825|NCT00027846|4282341|B4||<=18 years|Age||Participants|Count of Participants|370|370.0||||||
4462826|NCT00027846|4282342|B3||<=18 years|Age||Participants|Count of Participants|76|76.0||||||
4462827|NCT00027846|4282343|B2||<=18 years|Age||Participants|Count of Participants|281|281.0||||||
4462828|NCT00027846|4282344|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4462829|NCT00027560|4282364|B1|United States||Region of Enrollment||participants|Number|51|51.0||||||
4462830|NCT00027560|4282364|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4462831|NCT00027560|4282364|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4462832|NCT00027560|4282364|B1|||Age||years|Mean|42.9|42.9|Standard Deviation|15|15.0|||
4462833|NCT00027560|4282364|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4462834|NCT00027560|4282364|B1||Between 18 and 65 years|Age||Participants|Count of Participants|46|46.0||||||
4462835|NCT00027560|4282364|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4462836|NCT00026494|4282373|B5||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4462837|NCT00026494|4282374|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4462838|NCT00026494|4282375|B3||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4462839|NCT00026494|4282376|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4462840|NCT00026494|4282377|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4462841|NCT00026494|4282373|B5||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4462842|NCT00026494|4282374|B4||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4462843|NCT00026494|4282375|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4462844|NCT00026494|4282376|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4462845|NCT00026494|4282377|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4462846|NCT00026494|4282373|B5||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4462847|NCT00026494|4282374|B4||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4462848|NCT00026494|4282375|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4462849|NCT00026494|4282376|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4462850|NCT00026494|4282377|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4462851|NCT00026494|4282373|B5||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4462852|NCT00026494|4282374|B4||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4462853|NCT00026494|4282375|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4462854|NCT00026494|4282376|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4462855|NCT00026494|4282377|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4462856|NCT00026494|4282373|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462857|NCT00026494|4282374|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462858|NCT00026494|4282375|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462859|NCT00026494|4282376|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462860|NCT00026494|4282377|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462861|NCT00026312|4282390|B3|Australia||Region of Enrollment||participants|Number|92|92.0||||||
4462862|NCT00026312|4282391|B2|Australia||Region of Enrollment||participants|Number|89|89.0||||||
4462863|NCT00026312|4282392|B1|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4462864|NCT00026312|4282390|B3|United States||Region of Enrollment||participants|Number|1192|1192.0||||||
4462865|NCT00026312|4282391|B2|United States||Region of Enrollment||participants|Number|1092|1092.0||||||
4462866|NCT00026312|4282392|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4462867|NCT00026312|4282390|B3|Canada||Region of Enrollment||participants|Number|148|148.0||||||
4462868|NCT00026312|4282391|B2|Canada||Region of Enrollment||participants|Number|135|135.0||||||
4462869|NCT00026312|4282392|B1|Canada||Region of Enrollment||participants|Number|13|13.0||||||
4462870|NCT00026312|4282390|B3|New Zealand||Region of Enrollment||participants|Number|17|17.0||||||
4462871|NCT00026312|4282391|B2|New Zealand||Region of Enrollment||participants|Number|17|17.0||||||
4462872|NCT00026312|4282392|B1|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4462873|NCT00026312|4282390|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
4462874|NCT00026312|4282391|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|171|171.0||||||
4462875|NCT00026312|4282392|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4462876|NCT00026312|4282390|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462877|NCT00026312|4282391|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462878|NCT00026312|4282392|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462879|NCT00026312|4282390|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1031|1031.0||||||
4462880|NCT00026312|4282391|B2||White|Race (NIH/OMB)||Participants|Count of Participants|942|942.0||||||
4462881|NCT00026312|4282392|B1||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4462882|NCT00026312|4282390|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|161|161.0||||||
4462883|NCT00026312|4282391|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4462884|NCT00026312|4282392|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4462885|NCT00026312|4282390|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4462886|NCT00026312|4282391|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462887|NCT00026312|4282392|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4462888|NCT00026312|4282390|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4462889|NCT00026312|4282391|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|62|62.0||||||
4462890|NCT00026312|4282392|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4462891|NCT00026312|4282390|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4462892|NCT00026312|4282391|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4462893|NCT00026312|4282392|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4462894|NCT00026312|4282390|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4462895|NCT00026312|4282391|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4462896|NCT00026312|4282392|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4462897|NCT00026312|4282390|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1258|1258.0||||||
4462898|NCT00026312|4282391|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1159|1159.0||||||
4462899|NCT00026312|4282392|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|99|99.0||||||
4462900|NCT00026312|4282390|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|153|153.0||||||
4462901|NCT00026312|4282391|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|142|142.0||||||
4462902|NCT00026312|4282392|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4462903|NCT00026312|4282390|B3||Male|Sex: Female, Male||Participants|Count of Participants|866|866.0||||||
4462904|NCT00026312|4282391|B2||Male|Sex: Female, Male||Participants|Count of Participants|799|799.0||||||
4462905|NCT00026312|4282392|B1||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4462906|NCT00026312|4282390|B3||Female|Sex: Female, Male||Participants|Count of Participants|583|583.0||||||
4462907|NCT00026312|4282391|B2||Female|Sex: Female, Male||Participants|Count of Participants|534|534.0||||||
4462908|NCT00026312|4282392|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4462909|NCT00026312|4282390|B3|||Age||Years|Mean|3.61|3.61|Standard Deviation|2.73|2.73|||
4462910|NCT00026312|4282391|B2|||Age||Years|Mean|3.64|3.64|Standard Deviation|2.77|2.77|||
4462911|NCT00026312|4282392|B1|||Age||Years|Mean|3.22|3.22|Standard Deviation|2.12|2.12|||
4462912|NCT00026312|4282390|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462913|NCT00026312|4282391|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462914|NCT00026312|4282392|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462915|NCT00026312|4282390|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4462916|NCT00026312|4282391|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4462917|NCT00026312|4282392|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4462918|NCT00026312|4282390|B3||<=18 years|Age||Participants|Count of Participants|1441|1441.0||||||
4462919|NCT00026312|4282391|B2||<=18 years|Age||Participants|Count of Participants|1325|1325.0||||||
4462920|NCT00026312|4282392|B1||<=18 years|Age||Participants|Count of Participants|116|116.0||||||
4462921|NCT00026221|4282408|B4|United States||Region of Enrollment||patients|Number|57|57.0||||||
4462922|NCT00026221|4282409|B3|United States||Region of Enrollment||patients|Number|25|25.0||||||
4462923|NCT00026221|4282410|B2|United States||Region of Enrollment||patients|Number|16|16.0||||||
4462924|NCT00026221|4282411|B1|United States||Region of Enrollment||patients|Number|16|16.0||||||
4462925|NCT00026221|4282408|B4||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4462926|NCT00026221|4282409|B3||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4462927|NCT00026221|4282410|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4462928|NCT00026221|4282411|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4462929|NCT00026221|4282408|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4462930|NCT00026221|4282409|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4462931|NCT00026221|4282410|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4462932|NCT00026221|4282411|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4462933|NCT00026221|4282408|B4|||Age||years|Median|57|57.0|Full Range|||28.0|83.0|
4462934|NCT00026221|4282409|B3|||Age||years|Median|58.4|58.4|Full Range|||31.0|79.0|
4462935|NCT00026221|4282410|B2|||Age||years|Median|54|54.0|Full Range|||39.0|83.0|
4462936|NCT00026221|4282411|B1|||Age||years|Median|64|64.0|Full Range|||28.0|74.0|
4462937|NCT00026208|4282430|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
4462938|NCT00026208|4282431|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4462939|NCT00026208|4282432|B1|United States||Region of Enrollment||participants|Number|72|72.0||||||
4462940|NCT00026208|4282430|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4462941|NCT00026208|4282431|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4462942|NCT00026208|4282432|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4462943|NCT00026208|4282430|B3||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4462944|NCT00026208|4282431|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4462945|NCT00026208|4282432|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4462946|NCT00026208|4282430|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4462947|NCT00026208|4282431|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4462948|NCT00026208|4282432|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4462949|NCT00026208|4282430|B3||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4462950|NCT00026208|4282431|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4462951|NCT00026208|4282432|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4462952|NCT00026208|4282430|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462953|NCT00026208|4282431|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462954|NCT00026208|4282432|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462955|NCT00025662|4282451|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4462956|NCT00025662|4282451|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4462957|NCT00025662|4282451|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4462958|NCT00025662|4282451|B1|||Age||years|Mean|63|63.0|Standard Deviation|6.6|6.6|||
4462959|NCT00025662|4282451|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4462960|NCT00025662|4282451|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4462961|NCT00025662|4282451|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4462962|NCT00025506|4282459|B1|Carcinosarcoma, MMT||Histologic type||participants|Number|7|7.0||||||
4462963|NCT00025506|4282459|B1|Carcinosarcoma-heterologous||Histologic type||participants|Number|16|16.0||||||
4462964|NCT00025506|4282459|B1|Carcinosarcoma-homologous||Histologic type||participants|Number|22|22.0||||||
4462965|NCT00025506|4282459|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4462966|NCT00025506|4282459|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4462967|NCT00025506|4282459|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4462968|NCT00025506|4282459|B1|80-89 years||Age, Customized||participants|Number|2|2.0||||||
4462969|NCT00025506|4282459|B1|70-79 years||Age, Customized||participants|Number|11|11.0||||||
4462970|NCT00025506|4282459|B1|60-69 years||Age, Customized||participants|Number|23|23.0||||||
4462971|NCT00025506|4282459|B1|50-59 years||Age, Customized||participants|Number|7|7.0||||||
4462972|NCT00025506|4282459|B1|40-49 years||Age, Customized||participants|Number|1|1.0||||||
4462973|NCT00025506|4282459|B1|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4462974|NCT00025506|4282459|B1|||Age||years|Mean|65.6|65.6|Standard Deviation|8.9|8.9|||
4462975|NCT00025259|4282473|B8|French Polynesia||Region of Enrollment||participants|Number|1|1.0||||||
4462976|NCT00025259|4282474|B7|French Polynesia||Region of Enrollment||participants|Number|0|0.0||||||
4462977|NCT00025259|4282475|B6|French Polynesia||Region of Enrollment||participants|Number|0|0.0||||||
4462978|NCT00025259|4282476|B5|French Polynesia||Region of Enrollment||participants|Number|1|1.0||||||
4462979|NCT00025259|4282477|B4|French Polynesia||Region of Enrollment||participants|Number|0|0.0||||||
4462980|NCT00025259|4282478|B3|French Polynesia||Region of Enrollment||participants|Number|0|0.0||||||
4462981|NCT00025259|4282479|B2|French Polynesia||Region of Enrollment||participants|Number|0|0.0||||||
4462982|NCT00025259|4282480|B1|French Polynesia||Region of Enrollment||participants|Number|0|0.0||||||
4462983|NCT00025259|4282473|B8|Bermuda||Region of Enrollment||participants|Number|1|1.0||||||
4462984|NCT00025259|4282474|B7|Bermuda||Region of Enrollment||participants|Number|0|0.0||||||
4462985|NCT00025259|4282475|B6|Bermuda||Region of Enrollment||participants|Number|0|0.0||||||
4462986|NCT00025259|4282476|B5|Bermuda||Region of Enrollment||participants|Number|0|0.0||||||
4462987|NCT00025259|4282477|B4|Bermuda||Region of Enrollment||participants|Number|1|1.0||||||
4462988|NCT00025259|4282478|B3|Bermuda||Region of Enrollment||participants|Number|0|0.0||||||
4462989|NCT00025259|4282479|B2|Bermuda||Region of Enrollment||participants|Number|0|0.0||||||
4462990|NCT00025259|4282480|B1|Bermuda||Region of Enrollment||participants|Number|0|0.0||||||
4462991|NCT00025259|4282473|B8|Puerto Rico||Region of Enrollment||participants|Number|13|13.0||||||
4462992|NCT00025259|4282474|B7|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4462993|NCT00025259|4282475|B6|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4462994|NCT00025259|4282476|B5|Puerto Rico||Region of Enrollment||participants|Number|0|0.0||||||
4462995|NCT00025259|4282477|B4|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4462996|NCT00025259|4282478|B3|Puerto Rico||Region of Enrollment||participants|Number|2|2.0||||||
4462997|NCT00025259|4282479|B2|Puerto Rico||Region of Enrollment||participants|Number|4|4.0||||||
4462998|NCT00025259|4282480|B1|Puerto Rico||Region of Enrollment||participants|Number|1|1.0||||||
4462999|NCT00025259|4282473|B8|Netherlands||Region of Enrollment||participants|Number|22|22.0||||||
4463000|NCT00025259|4282474|B7|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4463001|NCT00025259|4282475|B6|Netherlands||Region of Enrollment||participants|Number|3|3.0||||||
4463002|NCT00025259|4282476|B5|Netherlands||Region of Enrollment||participants|Number|1|1.0||||||
4463003|NCT00025259|4282477|B4|Netherlands||Region of Enrollment||participants|Number|7|7.0||||||
4463004|NCT00025259|4282478|B3|Netherlands||Region of Enrollment||participants|Number|9|9.0||||||
4463005|NCT00025259|4282479|B2|Netherlands||Region of Enrollment||participants|Number|2|2.0||||||
4463006|NCT00025259|4282480|B1|Netherlands||Region of Enrollment||participants|Number|0|0.0||||||
4463007|NCT00025259|4282473|B8|France||Region of Enrollment||participants|Number|1|1.0||||||
4463008|NCT00025259|4282474|B7|France||Region of Enrollment||participants|Number|0|0.0||||||
4463009|NCT00025259|4282475|B6|France||Region of Enrollment||participants|Number|0|0.0||||||
4463010|NCT00025259|4282476|B5|France||Region of Enrollment||participants|Number|0|0.0||||||
4463011|NCT00025259|4282477|B4|France||Region of Enrollment||participants|Number|0|0.0||||||
4463012|NCT00025259|4282478|B3|France||Region of Enrollment||participants|Number|0|0.0||||||
4463013|NCT00025259|4282479|B2|France||Region of Enrollment||participants|Number|1|1.0||||||
4463014|NCT00025259|4282480|B1|France||Region of Enrollment||participants|Number|0|0.0||||||
4463015|NCT00025259|4282473|B8|Kuwait||Region of Enrollment||participants|Number|1|1.0||||||
4463016|NCT00025259|4282474|B7|Kuwait||Region of Enrollment||participants|Number|0|0.0||||||
4463017|NCT00025259|4282475|B6|Kuwait||Region of Enrollment||participants|Number|0|0.0||||||
4463018|NCT00025259|4282476|B5|Kuwait||Region of Enrollment||participants|Number|0|0.0||||||
4463019|NCT00025259|4282477|B4|Kuwait||Region of Enrollment||participants|Number|0|0.0||||||
4463020|NCT00025259|4282478|B3|Kuwait||Region of Enrollment||participants|Number|0|0.0||||||
4463021|NCT00025259|4282479|B2|Kuwait||Region of Enrollment||participants|Number|0|0.0||||||
4463022|NCT00025259|4282480|B1|Kuwait||Region of Enrollment||participants|Number|1|1.0||||||
4463023|NCT00025259|4282473|B8|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4463024|NCT00025259|4282474|B7|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4463025|NCT00025259|4282475|B6|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4463026|NCT00025259|4282476|B5|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4463027|NCT00025259|4282477|B4|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4463028|NCT00025259|4282478|B3|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4463029|NCT00025259|4282479|B2|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4463030|NCT00025259|4282480|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4463031|NCT00025259|4282473|B8|Australia||Region of Enrollment||participants|Number|40|40.0||||||
4463032|NCT00025259|4282474|B7|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4463033|NCT00025259|4282475|B6|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4463034|NCT00025259|4282476|B5|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4463035|NCT00025259|4282477|B4|Australia||Region of Enrollment||participants|Number|12|12.0||||||
4463036|NCT00025259|4282478|B3|Australia||Region of Enrollment||participants|Number|13|13.0||||||
4463037|NCT00025259|4282479|B2|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4463038|NCT00025259|4282480|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4463039|NCT00025259|4282473|B8|Israel||Region of Enrollment||participants|Number|6|6.0||||||
4463040|NCT00025259|4282474|B7|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4463041|NCT00025259|4282475|B6|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4463042|NCT00025259|4282476|B5|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4463043|NCT00025259|4282477|B4|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4463044|NCT00025259|4282478|B3|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4463045|NCT00025259|4282479|B2|Israel||Region of Enrollment||participants|Number|3|3.0||||||
4463046|NCT00025259|4282480|B1|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4463047|NCT00025259|4282473|B8|United States||Region of Enrollment||participants|Number|1469|1469.0||||||
4463048|NCT00025259|4282474|B7|United States||Region of Enrollment||participants|Number|128|128.0||||||
4463049|NCT00025259|4282475|B6|United States||Region of Enrollment||participants|Number|125|125.0||||||
4463050|NCT00025259|4282476|B5|United States||Region of Enrollment||participants|Number|39|39.0||||||
4463051|NCT00025259|4282477|B4|United States||Region of Enrollment||participants|Number|491|491.0||||||
4463052|NCT00025259|4282478|B3|United States||Region of Enrollment||participants|Number|312|312.0||||||
4463053|NCT00025259|4282479|B2|United States||Region of Enrollment||participants|Number|333|333.0||||||
4463054|NCT00025259|4282480|B1|United States||Region of Enrollment||participants|Number|41|41.0||||||
4463055|NCT00025259|4282473|B8|Canada||Region of Enrollment||participants|Number|175|175.0||||||
4463056|NCT00025259|4282474|B7|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4463057|NCT00025259|4282475|B6|Canada||Region of Enrollment||participants|Number|20|20.0||||||
4463058|NCT00025259|4282476|B5|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4463059|NCT00025259|4282477|B4|Canada||Region of Enrollment||participants|Number|51|51.0||||||
4463060|NCT00025259|4282478|B3|Canada||Region of Enrollment||participants|Number|45|45.0||||||
4463061|NCT00025259|4282479|B2|Canada||Region of Enrollment||participants|Number|30|30.0||||||
4463062|NCT00025259|4282480|B1|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4463063|NCT00025259|4282473|B8|New Zealand||Region of Enrollment||participants|Number|4|4.0||||||
4463064|NCT00025259|4282474|B7|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4463065|NCT00025259|4282475|B6|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4463066|NCT00025259|4282476|B5|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4463067|NCT00025259|4282477|B4|New Zealand||Region of Enrollment||participants|Number|3|3.0||||||
4463068|NCT00025259|4282478|B3|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4463069|NCT00025259|4282479|B2|New Zealand||Region of Enrollment||participants|Number|0|0.0||||||
4463070|NCT00025259|4282480|B1|New Zealand||Region of Enrollment||participants|Number|1|1.0||||||
4463071|NCT00025259|4282473|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|132|132.0||||||
4463072|NCT00025259|4282474|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4463073|NCT00025259|4282475|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4463074|NCT00025259|4282476|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4463075|NCT00025259|4282477|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4463076|NCT00025259|4282478|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4463077|NCT00025259|4282479|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|31|31.0||||||
4463078|NCT00025259|4282480|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4463079|NCT00025259|4282473|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463080|NCT00025259|4282474|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463081|NCT00025259|4282475|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463082|NCT00025259|4282476|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463083|NCT00025259|4282477|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463084|NCT00025259|4282478|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463085|NCT00025259|4282479|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463086|NCT00025259|4282480|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463087|NCT00025259|4282473|B8||White|Race (NIH/OMB)||Participants|Count of Participants|1348|1348.0||||||
4463088|NCT00025259|4282474|B7||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4463089|NCT00025259|4282475|B6||White|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4463090|NCT00025259|4282476|B5||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4463091|NCT00025259|4282477|B4||White|Race (NIH/OMB)||Participants|Count of Participants|444|444.0||||||
4463092|NCT00025259|4282478|B3||White|Race (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
4463093|NCT00025259|4282479|B2||White|Race (NIH/OMB)||Participants|Count of Participants|290|290.0||||||
4463094|NCT00025259|4282480|B1||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4463095|NCT00025259|4282473|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|194|194.0||||||
4463096|NCT00025259|4282474|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4463097|NCT00025259|4282475|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4463098|NCT00025259|4282476|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4463099|NCT00025259|4282477|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4463100|NCT00025259|4282478|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|43|43.0||||||
4463101|NCT00025259|4282479|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|45|45.0||||||
4463102|NCT00025259|4282480|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4463103|NCT00025259|4282473|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4463104|NCT00025259|4282474|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463105|NCT00025259|4282475|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463106|NCT00025259|4282476|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463107|NCT00025259|4282477|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4463108|NCT00025259|4282478|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4463109|NCT00025259|4282479|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463110|NCT00025259|4282480|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463111|NCT00025259|4282473|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4463112|NCT00025259|4282474|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4463113|NCT00025259|4282475|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4463114|NCT00025259|4282476|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463115|NCT00025259|4282477|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4463116|NCT00025259|4282478|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4463117|NCT00025259|4282479|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4463118|NCT00025259|4282480|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463119|NCT00025259|4282473|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4463120|NCT00025259|4282474|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463121|NCT00025259|4282475|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463122|NCT00025259|4282476|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463123|NCT00025259|4282477|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4463124|NCT00025259|4282478|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463125|NCT00025259|4282479|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463126|NCT00025259|4282480|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463127|NCT00025259|4282473|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4463128|NCT00025259|4282474|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4463129|NCT00025259|4282475|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4463130|NCT00025259|4282476|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4463131|NCT00025259|4282477|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4463132|NCT00025259|4282478|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4463133|NCT00025259|4282479|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4463134|NCT00025259|4282480|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463135|NCT00025259|4282473|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1425|1425.0||||||
4463136|NCT00025259|4282474|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|134|134.0||||||
4463137|NCT00025259|4282475|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|127|127.0||||||
4463138|NCT00025259|4282476|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4463139|NCT00025259|4282477|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|487|487.0||||||
4463140|NCT00025259|4282478|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|306|306.0||||||
4463141|NCT00025259|4282479|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|293|293.0||||||
4463142|NCT00025259|4282480|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4463143|NCT00025259|4282473|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|259|259.0||||||
4463144|NCT00025259|4282474|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4463145|NCT00025259|4282475|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4463146|NCT00025259|4282476|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4463147|NCT00025259|4282477|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|74|74.0||||||
4463148|NCT00025259|4282478|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|67|67.0||||||
4463149|NCT00025259|4282479|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4463150|NCT00025259|4282480|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4463151|NCT00025259|4282473|B8||Male|Sex: Female, Male||Participants|Count of Participants|919|919.0||||||
4463152|NCT00025259|4282474|B7||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4463153|NCT00025259|4282475|B6||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4463154|NCT00025259|4282476|B5||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4463155|NCT00025259|4282477|B4||Male|Sex: Female, Male||Participants|Count of Participants|283|283.0||||||
4463156|NCT00025259|4282478|B3||Male|Sex: Female, Male||Participants|Count of Participants|227|227.0||||||
4463157|NCT00025259|4282479|B2||Male|Sex: Female, Male||Participants|Count of Participants|204|204.0||||||
4463158|NCT00025259|4282480|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4463159|NCT00025259|4282473|B8||Female|Sex: Female, Male||Participants|Count of Participants|815|815.0||||||
4463160|NCT00025259|4282474|B7||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4463161|NCT00025259|4282475|B6||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4463162|NCT00025259|4282476|B5||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4463163|NCT00025259|4282477|B4||Female|Sex: Female, Male||Participants|Count of Participants|288|288.0||||||
4463164|NCT00025259|4282478|B3||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4463165|NCT00025259|4282479|B2||Female|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4463166|NCT00025259|4282480|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4463167|NCT00025259|4282473|B8|||Age||Years|Median|15|15.0|Full Range|||1.0|21.0|
4463168|NCT00025259|4282474|B7|||Age||Years|Median|15|15.0|Full Range|||5.0|21.0|
4463169|NCT00025259|4282475|B6|||Age||Years|Median|15|15.0|Full Range|||5.0|21.0|
4463170|NCT00025259|4282476|B5|||Age||Years|Median|15|15.0|Full Range|||5.0|19.0|
4463171|NCT00025259|4282477|B4|||Age||Years|Median|15|15.0|Full Range|||1.0|21.0|
4463172|NCT00025259|4282478|B3|||Age||Years|Median|14|14.0|Full Range|||3.0|21.0|
4463173|NCT00025259|4282479|B2|||Age||Years|Median|14|14.0|Full Range|||2.0|21.0|
4463174|NCT00025259|4282480|B1|||Age||Years|Median|16|16.0|Full Range|||5.0|20.0|
4463175|NCT00025259|4282473|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4463176|NCT00025259|4282474|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4463177|NCT00025259|4282475|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4463178|NCT00025259|4282476|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4463179|NCT00025259|4282477|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4463180|NCT00025259|4282478|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4463181|NCT00025259|4282479|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4463182|NCT00025259|4282480|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4463183|NCT00025259|4282473|B8||Between 18 and 65 years|Age||Participants|Count of Participants|85|85.0||||||
4463184|NCT00025259|4282474|B7||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4463185|NCT00025259|4282475|B6||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4463186|NCT00025259|4282476|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4463187|NCT00025259|4282477|B4||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4463188|NCT00025259|4282478|B3||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4463189|NCT00025259|4282479|B2||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4463190|NCT00025259|4282480|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4463191|NCT00025259|4282473|B8||<=18 years|Age||Participants|Count of Participants|1649|1649.0||||||
4463192|NCT00025259|4282474|B7||<=18 years|Age||Participants|Count of Participants|148|148.0||||||
4463193|NCT00025259|4282475|B6||<=18 years|Age||Participants|Count of Participants|143|143.0||||||
4463194|NCT00025259|4282476|B5||<=18 years|Age||Participants|Count of Participants|40|40.0||||||
4463195|NCT00025259|4282477|B4||<=18 years|Age||Participants|Count of Participants|540|540.0||||||
4463196|NCT00025259|4282478|B3||<=18 years|Age||Participants|Count of Participants|369|369.0||||||
4463197|NCT00025259|4282479|B2||<=18 years|Age||Participants|Count of Participants|363|363.0||||||
4463198|NCT00025259|4282480|B1||<=18 years|Age||Participants|Count of Participants|46|46.0||||||
4463199|NCT00025233|4282522|B1|Recurrent/Persistent||International Federation of Gynecology and Obstetrics (FIGO) Stage||participants|Number|45|45.0||||||
4463200|NCT00025233|4282522|B1|Unspecified||International Federation of Gynecology and Obstetrics (FIGO) Stage||participants|Number|1|1.0||||||
4463201|NCT00025233|4282522|B1|Squamous Cell Carcinoma||Histologic Type||participants|Number|43|43.0||||||
4463202|NCT00025233|4282522|B1|Adenosquamous||Histologic Type||participants|Number|3|3.0||||||
4463203|NCT00025233|4282522|B1|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4463204|NCT00025233|4282522|B1|United States||Region of Enrollment||participants|Number|45|45.0||||||
4463205|NCT00025233|4282522|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463206|NCT00025233|4282522|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4463207|NCT00025233|4282522|B1|60-69 years||Age, Customized||participants|Number|5|5.0||||||
4463208|NCT00025233|4282522|B1|50-59 years||Age, Customized||participants|Number|12|12.0||||||
4463209|NCT00025233|4282522|B1|40-49 years||Age, Customized||participants|Number|17|17.0||||||
4463210|NCT00025233|4282522|B1|30-39 years||Age, Customized||participants|Number|11|11.0||||||
4463211|NCT00025233|4282522|B1|20-29 years||Age, Customized||participants|Number|1|1.0||||||
4463212|NCT00025233|4282522|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|9.3|9.3|||
4463213|NCT00025155|4282537|B1|Serous Adenocarcinoma||Histologic Type||participants|Number|38|38.0||||||
4463214|NCT00025155|4282537|B1|Mucinous Adenocarcinoma||Histologic Type||participants|Number|1|1.0||||||
4463215|NCT00025155|4282537|B1|Mixed Epithelial Carcinoma||Histologic Type||participants|Number|3|3.0||||||
4463216|NCT00025155|4282537|B1|Endometrioid Adenocarcinoma||Histologic Type||participants|Number|2|2.0||||||
4463217|NCT00025155|4282537|B1|Clear Cell Carcinoma||Histologic Type||participants|Number|4|4.0||||||
4463218|NCT00025155|4282537|B1|Adenocarcinoma, unspecified||Histologic Type||participants|Number|1|1.0||||||
4463219|NCT00025155|4282537|B1|||International Federation of Gynecology and Obstetrics (FIGO) Stage - Recurrent/Persistent|International Federation of Gynecology and Obstetrics, stage grouping for primary carcinoma of the ovary (1985)|participants|Number|49|49.0||||||
4463220|NCT00025155|4282537|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4463221|NCT00025155|4282537|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463222|NCT00025155|4282537|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4463223|NCT00025155|4282537|B1|80-89 years||Age, Customized||participants|Number|1|1.0||||||
4463224|NCT00025155|4282537|B1|70-79 years||Age, Customized||participants|Number|13|13.0||||||
4463225|NCT00025155|4282537|B1|60-69 years||Age, Customized||participants|Number|15|15.0||||||
4463226|NCT00025155|4282537|B1|50-59 years||Age, Customized||participants|Number|13|13.0||||||
4463227|NCT00025155|4282537|B1|40-49 years||Age, Customized||participants|Number|6|6.0||||||
4463228|NCT00025155|4282537|B1|30-39 years||Age, Customized||participants|Number|0|0.0||||||
4463229|NCT00025155|4282537|B1|20-29 years||Age, Customized||participants|Number|1|1.0||||||
4463230|NCT00024258|4282548|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4463231|NCT00024258|4282548|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4463232|NCT00024258|4282548|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4463233|NCT00024258|4282548|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4463234|NCT00024258|4282548|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4463235|NCT00024258|4282548|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4463236|NCT00024167|4282552|B4|United States||Region of Enrollment||participants|Number|260|260.0||||||
4463237|NCT00024167|4282553|B3|United States||Region of Enrollment||participants|Number|62|62.0||||||
4463238|NCT00024167|4282554|B2|United States||Region of Enrollment||participants|Number|65|65.0||||||
4463239|NCT00024167|4282555|B1|United States||Region of Enrollment||participants|Number|133|133.0||||||
4463240|NCT00024167|4282552|B4||Male|Sex: Female, Male||Participants|Count of Participants|260|260.0||||||
4463241|NCT00024167|4282553|B3||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4463242|NCT00024167|4282554|B2||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4463243|NCT00024167|4282555|B1||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4463244|NCT00024167|4282552|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463245|NCT00024167|4282553|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463246|NCT00024167|4282554|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463247|NCT00024167|4282555|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463248|NCT00024167|4282552|B4|||Age||years|Median|67|67.0|Full Range|||8.0|85.0|
4463249|NCT00024167|4282553|B3|||Age||years|Median|67|67.0|Full Range|||8.0|80.0|
4463250|NCT00024167|4282554|B2|||Age||years|Median|68|68.0|Full Range|||48.0|85.0|
4463251|NCT00024167|4282555|B1|||Age||years|Median|67|67.0|Full Range|||44.0|85.0|
4463252|NCT00024167|4282552|B4||>=65 years|Age||Participants|Count of Participants|161|161.0||||||
4463253|NCT00024167|4282553|B3||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4463254|NCT00024167|4282554|B2||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4463255|NCT00024167|4282555|B1||>=65 years|Age||Participants|Count of Participants|80|80.0||||||
4463256|NCT00024167|4282552|B4||Between 18 and 65 years|Age||Participants|Count of Participants|98|98.0||||||
4463257|NCT00024167|4282553|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4463258|NCT00024167|4282554|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4463259|NCT00024167|4282555|B1||Between 18 and 65 years|Age||Participants|Count of Participants|53|53.0||||||
4463260|NCT00024167|4282552|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4463261|NCT00024167|4282553|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4463262|NCT00024167|4282554|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463263|NCT00024167|4282555|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463264|NCT00024102|4282565|B3|Unknown||HER2 Status||participants|Number|90|90.0||||||
4463265|NCT00024102|4282566|B2|Unknown||HER2 Status||participants|Number|45|45.0||||||
4463266|NCT00024102|4282567|B1|Unknown||HER2 Status||participants|Number|45|45.0||||||
4463267|NCT00024102|4282565|B3|Positive||HER2 Status||participants|Number|65|65.0||||||
4463268|NCT00024102|4282566|B2|Positive||HER2 Status||participants|Number|30|30.0||||||
4463269|NCT00024102|4282567|B1|Positive||HER2 Status||participants|Number|35|35.0||||||
4463270|NCT00024102|4282565|B3|Negative||HER2 Status||participants|Number|478|478.0||||||
4463271|NCT00024102|4282566|B2|Negative||HER2 Status||participants|Number|232|232.0||||||
4463272|NCT00024102|4282567|B1|Negative||HER2 Status||participants|Number|246|246.0||||||
4463273|NCT00024102|4282565|B3|2 (symptoms, but active > 50% of the time)||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|21|21.0||||||
4463274|NCT00024102|4282566|B2|2 (symptoms, but active > 50% of the time)||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|12|12.0||||||
4463275|NCT00024102|4282567|B1|2 (symptoms, but active > 50% of the time)||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|9|9.0||||||
4463276|NCT00024102|4282565|B3|0 or 1 (fully active or minimal symptoms)||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|612|612.0||||||
4463277|NCT00024102|4282566|B2|0 or 1 (fully active or minimal symptoms)||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|295|295.0||||||
4463278|NCT00024102|4282567|B1|0 or 1 (fully active or minimal symptoms)||ECOG Performance Status|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|participants|Number|317|317.0||||||
4463279|NCT00024102|4282565|B3|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4463280|NCT00024102|4282566|B2|Australia||Region of Enrollment||participants|Number|2|2.0||||||
4463281|NCT00024102|4282567|B1|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4463282|NCT00024102|4282565|B3|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4463283|NCT00024102|4282566|B2|Argentina||Region of Enrollment||participants|Number|3|3.0||||||
4463284|NCT00024102|4282567|B1|Argentina||Region of Enrollment||participants|Number|0|0.0||||||
4463285|NCT00024102|4282565|B3|United States||Region of Enrollment||participants|Number|628|628.0||||||
4463286|NCT00024102|4282566|B2|United States||Region of Enrollment||participants|Number|302|302.0||||||
4463287|NCT00024102|4282567|B1|United States||Region of Enrollment||participants|Number|326|326.0||||||
4463288|NCT00024102|4282565|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463289|NCT00024102|4282566|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463290|NCT00024102|4282567|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463291|NCT00024102|4282565|B3||Female|Sex: Female, Male||Participants|Count of Participants|633|633.0||||||
4463292|NCT00024102|4282566|B2||Female|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4463293|NCT00024102|4282567|B1||Female|Sex: Female, Male||Participants|Count of Participants|326|326.0||||||
4463294|NCT00024102|4282565|B3|>=80 years||Age, Customized||participants|Number|28|28.0||||||
4463295|NCT00024102|4282566|B2|>=80 years||Age, Customized||participants|Number|14|14.0||||||
4463296|NCT00024102|4282567|B1|>=80 years||Age, Customized||participants|Number|14|14.0||||||
4463297|NCT00024102|4282565|B3|70-79 years||Age, Customized||participants|Number|383|383.0||||||
4463298|NCT00024102|4282566|B2|70-79 years||Age, Customized||participants|Number|183|183.0||||||
4463299|NCT00024102|4282567|B1|70-79 years||Age, Customized||participants|Number|200|200.0||||||
4463300|NCT00024102|4282565|B3|65-69 years||Age, Customized||participants|Number|222|222.0||||||
4463301|NCT00024102|4282566|B2|65-69 years||Age, Customized||participants|Number|110|110.0||||||
4463302|NCT00024102|4282567|B1|65-69 years||Age, Customized||participants|Number|112|112.0||||||
4463303|NCT00023764|4282580|B1|United States||Region of Enrollment||participants|Number|103|103.0||||||
4463304|NCT00023764|4282580|B1||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4463305|NCT00023764|4282580|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4463306|NCT00023764|4282580|B1||>=65 years|Age||Participants|Count of Participants|56|56.0||||||
4463307|NCT00023764|4282580|B1||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4463308|NCT00023764|4282580|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463309|NCT00023712|4282585|B3|Undifferentiated Carcinoma||Cell Type||participants|Number|1|1.0||||||
4463310|NCT00023712|4282586|B2|Undifferentiated Carcinoma||Cell Type||participants|Number|1|1.0||||||
4463311|NCT00023712|4282587|B1|Undifferentiated Carcinoma||Cell Type||participants|Number|0|0.0||||||
4463312|NCT00023712|4282585|B3|Transitional Cell Carcinoma||Cell Type||participants|Number|2|2.0||||||
4463313|NCT00023712|4282586|B2|Transitional Cell Carcinoma||Cell Type||participants|Number|1|1.0||||||
4463314|NCT00023712|4282587|B1|Transitional Cell Carcinoma||Cell Type||participants|Number|1|1.0||||||
4463315|NCT00023712|4282585|B3|Serous Adenocarcinoma||Cell Type||participants|Number|46|46.0||||||
4463316|NCT00023712|4282586|B2|Serous Adenocarcinoma||Cell Type||participants|Number|25|25.0||||||
4463317|NCT00023712|4282587|B1|Serous Adenocarcinoma||Cell Type||participants|Number|21|21.0||||||
4463318|NCT00023712|4282585|B3|Mixed Epithelial Carcinoma||Cell Type||participants|Number|3|3.0||||||
4463319|NCT00023712|4282586|B2|Mixed Epithelial Carcinoma||Cell Type||participants|Number|1|1.0||||||
4463320|NCT00023712|4282587|B1|Mixed Epithelial Carcinoma||Cell Type||participants|Number|2|2.0||||||
4463321|NCT00023712|4282585|B3|Endometrioid Adenocarcinoma||Cell Type||participants|Number|2|2.0||||||
4463322|NCT00023712|4282586|B2|Endometrioid Adenocarcinoma||Cell Type||participants|Number|1|1.0||||||
4463323|NCT00023712|4282587|B1|Endometrioid Adenocarcinoma||Cell Type||participants|Number|1|1.0||||||
4463324|NCT00023712|4282585|B3|Adenocarcinoma, Unspecified||Cell Type||participants|Number|1|1.0||||||
4463325|NCT00023712|4282586|B2|Adenocarcinoma, Unspecified||Cell Type||participants|Number|0|0.0||||||
4463326|NCT00023712|4282587|B1|Adenocarcinoma, Unspecified||Cell Type||participants|Number|1|1.0||||||
4463327|NCT00023712|4282585|B3|United States||Region of Enrollment||participants|Number|52|52.0||||||
4463328|NCT00023712|4282586|B2|United States||Region of Enrollment||participants|Number|29|29.0||||||
4463329|NCT00023712|4282587|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4463330|NCT00023712|4282585|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4463331|NCT00023712|4282586|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4463332|NCT00023712|4282587|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4463333|NCT00023712|4282585|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463334|NCT00023712|4282586|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463335|NCT00023712|4282587|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463336|NCT00023712|4282585|B3||Female|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4463337|NCT00023712|4282586|B2||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4463338|NCT00023712|4282587|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4463339|NCT00023712|4282585|B3|80-89 years||Age, Customized||participants|Number|1|1.0||||||
4463340|NCT00023712|4282586|B2|80-89 years||Age, Customized||participants|Number|1|1.0||||||
4463341|NCT00023712|4282587|B1|80-89 years||Age, Customized||participants|Number|0|0.0||||||
4463342|NCT00023712|4282585|B3|70-79 years||Age, Customized||participants|Number|6|6.0||||||
4463343|NCT00023712|4282586|B2|70-79 years||Age, Customized||participants|Number|1|1.0||||||
4463344|NCT00023712|4282587|B1|70-79 years||Age, Customized||participants|Number|5|5.0||||||
4463345|NCT00023712|4282585|B3|60-69 years||Age, Customized||participants|Number|17|17.0||||||
4463346|NCT00023712|4282586|B2|60-69 years||Age, Customized||participants|Number|11|11.0||||||
4463347|NCT00023712|4282587|B1|60-69 years||Age, Customized||participants|Number|6|6.0||||||
4463348|NCT00023712|4282585|B3|50-59 years||Age, Customized||participants|Number|18|18.0||||||
4463349|NCT00023712|4282586|B2|50-59 years||Age, Customized||participants|Number|10|10.0||||||
4463350|NCT00023712|4282587|B1|50-59 years||Age, Customized||participants|Number|8|8.0||||||
4463351|NCT00023712|4282585|B3|40-49 years||Age, Customized||participants|Number|10|10.0||||||
4463352|NCT00023712|4282586|B2|40-49 years||Age, Customized||participants|Number|4|4.0||||||
4463353|NCT00023712|4282587|B1|40-49 years||Age, Customized||participants|Number|6|6.0||||||
4463354|NCT00023712|4282585|B3|30-39 years||Age, Customized||participants|Number|2|2.0||||||
4463355|NCT00023712|4282586|B2|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4463356|NCT00023712|4282587|B1|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4463357|NCT00023712|4282585|B3|20-29 years||Age, Customized||participants|Number|1|1.0||||||
4463358|NCT00023712|4282586|B2|20-29 years||Age, Customized||participants|Number|1|1.0||||||
4463359|NCT00023712|4282587|B1|20-29 years||Age, Customized||participants|Number|0|0.0||||||
4463360|NCT00023712|4282585|B3|||Age||years|Mean|57.2|57.2|Standard Deviation|11.2|11.2|||
4463361|NCT00023712|4282586|B2|||Age||years|Mean|55.8|55.8|Standard Deviation|11.4|11.4|||
4463362|NCT00023712|4282587|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|11.1|11.1|||
4463363|NCT00022698|4282610|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4463364|NCT00022698|4282611|B2||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4463365|NCT00022698|4282612|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4463366|NCT00022698|4282610|B3||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4463367|NCT00022698|4282611|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4463368|NCT00022698|4282612|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4463369|NCT00022698|4282610|B3|||Age||years|Mean|61.8|61.8|Standard Deviation|10.5|10.5|||
4463370|NCT00022698|4282611|B2|||Age||years|Mean|61.4|61.4|Standard Deviation|11.1|11.1|||
4463371|NCT00022698|4282612|B1|||Age||years|Mean|63.1|63.1|Standard Deviation|8.3|8.3|||
4463372|NCT00022672|4282636|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463373|NCT00022672|4282637|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463374|NCT00022672|4282638|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463375|NCT00022672|4282636|B3||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4463376|NCT00022672|4282637|B2||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4463377|NCT00022672|4282638|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4463378|NCT00022672|4282636|B3|||Age||years|Mean|56.5|56.5|Standard Deviation|10.7|10.7|||
4463379|NCT00022672|4282637|B2|||Age||years|Mean|55.5|55.5|Standard Deviation|10.7|10.7|||
4463380|NCT00022672|4282638|B1|||Age||years|Mean|57.4|57.4|Standard Deviation|10.6|10.6|||
4463381|NCT00022659|4282672|B1|Serous Adenocarcinoma||Histologic Type||participants|Number|51|51.0||||||
4463382|NCT00022659|4282672|B1|Mixed Epithelial Carcinoma||Histologic Type||participants|Number|6|6.0||||||
4463383|NCT00022659|4282672|B1|Endometrioid Adenocarcinoma||Histologic Type||participants|Number|2|2.0||||||
4463384|NCT00022659|4282672|B1|Clear Cell Carcinoma||Histologic Type||participants|Number|2|2.0||||||
4463385|NCT00022659|4282672|B1|Adenocarcinoma, Unspecified||Histologic Type||participants|Number|1|1.0||||||
4463386|NCT00022659|4282672|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4463387|NCT00022659|4282672|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463388|NCT00022659|4282672|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4463389|NCT00022659|4282672|B1|70-79 years||Age, Customized||participants|Number|10|10.0||||||
4463390|NCT00022659|4282672|B1|60-69 years||Age, Customized||participants|Number|13|13.0||||||
4463391|NCT00022659|4282672|B1|50-59 years||Age, Customized||participants|Number|21|21.0||||||
4463392|NCT00022659|4282672|B1|40-49 years||Age, Customized||participants|Number|13|13.0||||||
4463393|NCT00022659|4282672|B1|30-39 years||Age, Customized||participants|Number|3|3.0||||||
4463394|NCT00022659|4282672|B1|20-29 years||Age, Customized||participants|Number|1|1.0||||||
4463395|NCT00022659|4282672|B1|10-19 years||Age, Customized||participants|Number|1|1.0||||||
4463396|NCT00022659|4282672|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|12.5|12.5|||
4463397|NCT00022633|4282683|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463398|NCT00022633|4282684|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463399|NCT00022633|4282685|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463400|NCT00022633|4282683|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463401|NCT00022633|4282684|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463402|NCT00022633|4282685|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463403|NCT00022633|4282683|B3||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4463404|NCT00022633|4282684|B2||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4463405|NCT00022633|4282685|B1||White|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4463406|NCT00022633|4282683|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4463407|NCT00022633|4282684|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463408|NCT00022633|4282685|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4463409|NCT00022633|4282683|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463410|NCT00022633|4282684|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463411|NCT00022633|4282685|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463412|NCT00022633|4282683|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463413|NCT00022633|4282684|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463414|NCT00022633|4282685|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463415|NCT00022633|4282683|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463416|NCT00022633|4282684|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463417|NCT00022633|4282685|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463418|NCT00022633|4282683|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463419|NCT00022633|4282684|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463420|NCT00022633|4282685|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463421|NCT00022633|4282683|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4463422|NCT00022633|4282684|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4463423|NCT00022633|4282685|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4463424|NCT00022633|4282683|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4463425|NCT00022633|4282684|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463426|NCT00022633|4282685|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4463427|NCT00022633|4282683|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4463428|NCT00022633|4282684|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4463429|NCT00022633|4282685|B1||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4463430|NCT00022633|4282683|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4463431|NCT00022633|4282684|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4463432|NCT00022633|4282685|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4463433|NCT00022633|4282683|B3|||Age||years|Median|74.6|74.6|Full Range|||31.2|85.2|
4463434|NCT00022633|4282684|B2|||Age||years|Median|53.8|53.8|Full Range|||31.2|59.7|
4463435|NCT00022633|4282685|B1|||Age||years|Median|76.1|76.1|Full Range|||70.1|85.2|
4463436|NCT00022516|4282697|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463437|NCT00022516|4282698|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463438|NCT00022516|4282699|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463439|NCT00022516|4282697|B3||Female|Sex: Female, Male||Participants|Count of Participants|1086|1086.0||||||
4463440|NCT00022516|4282698|B2||Female|Sex: Female, Male||Participants|Count of Participants|544|544.0||||||
4463441|NCT00022516|4282699|B1||Female|Sex: Female, Male||Participants|Count of Participants|542|542.0||||||
4463442|NCT00022516|4282697|B3|||Age||years|Median|52|52.0|Full Range|||23.0|80.0|
4463443|NCT00022516|4282698|B2|||Age||years|Median|52|52.0|Full Range|||28.0|79.0|
4463444|NCT00022516|4282699|B1|||Age||years|Median|52|52.0|Full Range|||28.0|80.0|
4463445|NCT00022490|4282712|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4463446|NCT00022490|4282712|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4463447|NCT00022490|4282712|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4463448|NCT00022490|4282712|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4463449|NCT00022490|4282712|B1||Between 18 and 65 years|Age||Participants|Count of Participants|21|21.0||||||
4463450|NCT00022490|4282712|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463451|NCT00021255|4282716|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463452|NCT00021255|4282717|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463453|NCT00021255|4282718|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463454|NCT00021255|4282719|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463455|NCT00021255|4282716|B4||Female|Sex: Female, Male||Participants|Count of Participants|3222|3222.0||||||
4463456|NCT00021255|4282717|B3||Female|Sex: Female, Male||Participants|Count of Participants|1075|1075.0||||||
4463457|NCT00021255|4282718|B2||Female|Sex: Female, Male||Participants|Count of Participants|1074|1074.0||||||
4463458|NCT00021255|4282719|B1||Female|Sex: Female, Male||Participants|Count of Participants|1073|1073.0||||||
4463459|NCT00021255|4282716|B4|||Age||years|Mean|48.7|48.7|Standard Deviation|9.8|9.8|||
4463460|NCT00021255|4282717|B3|||Age||years|Mean|48.6|48.6|Standard Deviation|9.9|9.9|||
4463461|NCT00021255|4282718|B2|||Age||years|Mean|48.7|48.7|Standard Deviation|9.7|9.7|||
4463462|NCT00021255|4282719|B1|||Age||years|Mean|48.8|48.8|Standard Deviation|9.7|9.7|||
4463463|NCT00021229|4282735|B4|United States||Region of Enrollment||participants|Number|85|85.0||||||
4463464|NCT00021229|4282736|B3|United States||Region of Enrollment||participants|Number|16|16.0||||||
4463465|NCT00021229|4282737|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4463466|NCT00021229|4282738|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4463467|NCT00021229|4282735|B4||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4463468|NCT00021229|4282736|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4463469|NCT00021229|4282737|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4463470|NCT00021229|4282738|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4463471|NCT00021229|4282735|B4||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4463472|NCT00021229|4282736|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4463473|NCT00021229|4282737|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4463474|NCT00021229|4282738|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4463475|NCT00021229|4282735|B4|||Age||years|Mean|10.3|10.3|Standard Deviation|5.3|5.3|||
4463476|NCT00021229|4282736|B3|||Age||years|Mean|14.1|14.1|Standard Deviation|4.7|4.7|||
4463477|NCT00021229|4282737|B2|||Age||years|Mean|10.9|10.9|Standard Deviation|5.4|5.4|||
4463478|NCT00021229|4282738|B1|||Age||years|Mean|8.05|8.05|Standard Deviation|4.3|4.3|||
4463479|NCT00021229|4282735|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4463480|NCT00021229|4282736|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4463481|NCT00021229|4282737|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4463482|NCT00021229|4282738|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4463483|NCT00021229|4282735|B4||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4463484|NCT00021229|4282736|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4463485|NCT00021229|4282737|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4463486|NCT00021229|4282738|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4463487|NCT00021229|4282735|B4||<=18 years|Age||Participants|Count of Participants|81|81.0||||||
4463488|NCT00021229|4282736|B3||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4463489|NCT00021229|4282737|B2||<=18 years|Age||Participants|Count of Participants|30|30.0||||||
4463490|NCT00021229|4282738|B1||<=18 years|Age||Participants|Count of Participants|36|36.0||||||
4463491|NCT00020722|4282766|B1|United States||Region of Enrollment||participants|Number|7|7.0||||||
4463492|NCT00020722|4282766|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463493|NCT00020722|4282766|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4463494|NCT00020722|4282766|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4463495|NCT00020722|4282766|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4463496|NCT00020722|4282766|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463497|NCT00019747|4282771|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4463498|NCT00019747|4282772|B2|United States||Region of Enrollment||participants|Number|16|16.0||||||
4463499|NCT00019747|4282773|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4463500|NCT00019747|4282771|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4463501|NCT00019747|4282772|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4463502|NCT00019747|4282773|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4463503|NCT00019747|4282771|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4463504|NCT00019747|4282772|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4463505|NCT00019747|4282773|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4463506|NCT00019747|4282771|B3|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4463507|NCT00019747|4282772|B2|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4463508|NCT00019747|4282773|B1|More than one race||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4463509|NCT00019747|4282771|B3|White||Race/Ethnicity, Customized||Participants|Number|30|30.0||||||
4463510|NCT00019747|4282772|B2|White||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4463511|NCT00019747|4282773|B1|White||Race/Ethnicity, Customized||Participants|Number|17|17.0||||||
4463512|NCT00019747|4282771|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4463513|NCT00019747|4282772|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4463514|NCT00019747|4282773|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4463515|NCT00019747|4282771|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4463516|NCT00019747|4282772|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4463517|NCT00019747|4282773|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4463518|NCT00019747|4282771|B3|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4463519|NCT00019747|4282772|B2|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4463520|NCT00019747|4282773|B1|Asian||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4463521|NCT00019747|4282771|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4463522|NCT00019747|4282772|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4463523|NCT00019747|4282773|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4463524|NCT00019747|4282771|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463525|NCT00019747|4282772|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463526|NCT00019747|4282773|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463527|NCT00019747|4282771|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|38|38.0||||||
4463528|NCT00019747|4282772|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4463529|NCT00019747|4282773|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4463530|NCT00019747|4282771|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463531|NCT00019747|4282772|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463532|NCT00019747|4282773|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463533|NCT00019747|4282771|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4463534|NCT00019747|4282772|B2||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4463535|NCT00019747|4282773|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4463536|NCT00019747|4282771|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4463537|NCT00019747|4282772|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4463538|NCT00019747|4282773|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4463539|NCT00019747|4282771|B3|||Age||years|Mean|67.47|67.47|Standard Deviation|10.54|10.54|||
4463540|NCT00019747|4282772|B2|||Age||years|Mean|71.19|71.19|Standard Deviation|11.76|11.76|||
4463541|NCT00019747|4282773|B1|||Age||years|Mean|64.89|64.89|Standard Deviation|8.70|8.7|||
4463542|NCT00019747|4282771|B3||>=65 years|Age||Participants|Count of Participants|20|20.0||||||
4463543|NCT00019747|4282772|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4463544|NCT00019747|4282773|B1||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4463545|NCT00019747|4282771|B3||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4463546|NCT00019747|4282772|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4463547|NCT00019747|4282773|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4463548|NCT00019747|4282771|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463549|NCT00019747|4282772|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463550|NCT00019747|4282773|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463551|NCT00019682|4282780|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463552|NCT00019682|4282781|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463553|NCT00019682|4282782|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463554|NCT00019682|4282780|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463555|NCT00019682|4282781|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463556|NCT00019682|4282782|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463557|NCT00019682|4282780|B3||White|Race (NIH/OMB)||Participants|Count of Participants|184|184.0||||||
4463558|NCT00019682|4282781|B2||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4463559|NCT00019682|4282782|B1||White|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4463560|NCT00019682|4282780|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463561|NCT00019682|4282781|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463562|NCT00019682|4282782|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463563|NCT00019682|4282780|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463564|NCT00019682|4282781|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463565|NCT00019682|4282782|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463566|NCT00019682|4282780|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463567|NCT00019682|4282781|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463568|NCT00019682|4282782|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463569|NCT00019682|4282780|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463570|NCT00019682|4282781|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463571|NCT00019682|4282782|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463572|NCT00019682|4282780|B3||Male|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4463573|NCT00019682|4282781|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4463574|NCT00019682|4282782|B1||Male|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4463575|NCT00019682|4282780|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4463576|NCT00019682|4282781|B2||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4463577|NCT00019682|4282782|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4463578|NCT00019682|4282780|B3|||Age||years|Mean|48.6|48.6|Full Range|||18.0|65.0|
4463579|NCT00019682|4282781|B2|||Age||years|Mean|46.9|46.9|Full Range|||18.0|65.0|
4463580|NCT00019682|4282782|B1|||Age||years|Mean|50.3|50.3|Full Range|||18.0|65.0|
4463581|NCT00019604|4282795|B1|United States||Region of Enrollment||Participants|Count of Participants|44|44.0||||||
4463582|NCT00019604|4282795|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463583|NCT00019604|4282795|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463584|NCT00019604|4282795|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4463585|NCT00019604|4282795|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4463586|NCT00019604|4282795|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463587|NCT00019604|4282795|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4463588|NCT00019604|4282795|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463589|NCT00019604|4282795|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463590|NCT00019604|4282795|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4463591|NCT00019604|4282795|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463592|NCT00019604|4282795|B1||Male|Gender||Participants|Count of Participants|23|23.0||||||
4463593|NCT00019604|4282795|B1||Female|Gender||Participants|Count of Participants|21|21.0||||||
4463594|NCT00019604|4282795|B1|||Age||years|Mean|59.18|59.18|Standard Deviation|13.19|13.19|||
4463595|NCT00019604|4282795|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4463596|NCT00019604|4282795|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4463597|NCT00019604|4282795|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463598|NCT00017563|4282808|B1|United States||Region of Enrollment||participants|Number|57|57.0||||||
4463599|NCT00017563|4282808|B1||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4463600|NCT00017563|4282808|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463601|NCT00017563|4282808|B1|||Age||years|Mean|61.56|61.56|Standard Deviation|6.279|6.279|||
4463602|NCT00017563|4282808|B1||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4463603|NCT00017563|4282808|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4463604|NCT00017563|4282808|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463605|NCT00016913|4282812|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4463606|NCT00016913|4282812|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4463607|NCT00016913|4282812|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463608|NCT00016913|4282812|B1|||Age||years|Median|61|61.0|Full Range|||52.0|75.0|
4463609|NCT00016354|4282818|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4463610|NCT00016354|4282818|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4463611|NCT00016354|4282818|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4463612|NCT00016354|4282818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4463613|NCT00016354|4282818|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463614|NCT00015847|4282829|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4463615|NCT00015847|4282829|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4463616|NCT00015847|4282829|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4463617|NCT00015847|4282829|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4463618|NCT00015847|4282829|B1||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4463619|NCT00015847|4282829|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463620|NCT00014495|4282835|B5|United States||Region of Enrollment||participants|Number|32|32.0||||||
4463621|NCT00014495|4282836|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4463622|NCT00014495|4282837|B3|United States||Region of Enrollment||participants|Number|20|20.0||||||
4463623|NCT00014495|4282838|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4463624|NCT00014495|4282839|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4463625|NCT00014495|4282835|B5||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4463626|NCT00014495|4282836|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4463627|NCT00014495|4282837|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4463628|NCT00014495|4282838|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4463629|NCT00014495|4282839|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4463630|NCT00014495|4282835|B5||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4463631|NCT00014495|4282836|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4463632|NCT00014495|4282837|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4463633|NCT00014495|4282838|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4463634|NCT00014495|4282839|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463635|NCT00014495|4282835|B5||>=65 years|Age||Participants|Count of Participants|18|18.0||||||
4463636|NCT00014495|4282836|B4||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4463637|NCT00014495|4282837|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4463638|NCT00014495|4282838|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4463639|NCT00014495|4282839|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4463640|NCT00014495|4282835|B5||Between 18 and 65 years|Age||Participants|Count of Participants|14|14.0||||||
4463641|NCT00014495|4282836|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4463642|NCT00014495|4282837|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4463643|NCT00014495|4282838|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4463644|NCT00014495|4282839|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4463645|NCT00014495|4282835|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463646|NCT00014495|4282836|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463647|NCT00014495|4282837|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463648|NCT00014495|4282838|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463649|NCT00014495|4282839|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463650|NCT00012298|4282849|B8|United States||Region of Enrollment||participants|Number|79|79.0||||||
4463651|NCT00012298|4282850|B7|United States||Region of Enrollment||participants|Number|39|39.0||||||
4463652|NCT00012298|4282851|B6|United States||Region of Enrollment||participants|Number|6|6.0||||||
4463653|NCT00012298|4282852|B5|United States||Region of Enrollment||participants|Number|5|5.0||||||
4463654|NCT00012298|4282853|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4463655|NCT00012298|4282854|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4463656|NCT00012298|4282855|B2|United States||Region of Enrollment||participants|Number|7|7.0||||||
4463657|NCT00012298|4282856|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4463658|NCT00012298|4282849|B8|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
4463659|NCT00012298|4282850|B7|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4463660|NCT00012298|4282851|B6|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4463661|NCT00012298|4282852|B5|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4463662|NCT00012298|4282853|B4|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4463663|NCT00012298|4282854|B3|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4463664|NCT00012298|4282855|B2|Croatia||Region of Enrollment||participants|Number|0|0.0||||||
4463665|NCT00012298|4282856|B1|Croatia||Region of Enrollment||participants|Number|1|1.0||||||
4463666|NCT00012298|4282849|B8|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
4463667|NCT00012298|4282850|B7|Saudi Arabia||Region of Enrollment||participants|Number|0|0.0||||||
4463668|NCT00012298|4282851|B6|Saudi Arabia||Region of Enrollment||participants|Number|0|0.0||||||
4463669|NCT00012298|4282852|B5|Saudi Arabia||Region of Enrollment||participants|Number|0|0.0||||||
4463670|NCT00012298|4282853|B4|Saudi Arabia||Region of Enrollment||participants|Number|1|1.0||||||
4463671|NCT00012298|4282854|B3|Saudi Arabia||Region of Enrollment||participants|Number|0|0.0||||||
4463672|NCT00012298|4282855|B2|Saudi Arabia||Region of Enrollment||participants|Number|0|0.0||||||
4463673|NCT00012298|4282856|B1|Saudi Arabia||Region of Enrollment||participants|Number|0|0.0||||||
4463674|NCT00012298|4282849|B8||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4463675|NCT00012298|4282850|B7||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4463676|NCT00012298|4282851|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4463677|NCT00012298|4282852|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4463678|NCT00012298|4282853|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4463679|NCT00012298|4282854|B3||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4463680|NCT00012298|4282855|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4463681|NCT00012298|4282856|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4463682|NCT00012298|4282849|B8||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4463683|NCT00012298|4282850|B7||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4463684|NCT00012298|4282851|B6||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4463685|NCT00012298|4282852|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4463686|NCT00012298|4282853|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4463687|NCT00012298|4282854|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4463688|NCT00012298|4282855|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4463689|NCT00012298|4282856|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4463690|NCT00012298|4282849|B8|||Age||years|Median|58|58.0|Full Range|||28.0|76.0|
4463691|NCT00012298|4282850|B7|||Age||years|Median|58|58.0|Full Range|||36.0|76.0|
4463692|NCT00012298|4282851|B6|||Age||years|Median|59|59.0|Full Range|||28.0|62.0|
4463693|NCT00012298|4282852|B5|||Age||years|Median|46|46.0|Full Range|||42.0|60.0|
4463694|NCT00012298|4282853|B4|||Age||years|Median|51|51.0|Full Range|||30.0|67.0|
4463695|NCT00012298|4282854|B3|||Age||years|Median|52|52.0|Full Range|||37.0|70.0|
4463696|NCT00012298|4282855|B2|||Age||years|Median|56|56.0|Full Range|||31.0|65.0|
4463697|NCT00012298|4282856|B1|||Age||years|Median|60|60.0|Full Range|||39.0|70.0|
4463698|NCT00012012|4282890|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463699|NCT00012012|4282891|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463700|NCT00012012|4282892|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463701|NCT00012012|4282890|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4463702|NCT00012012|4282891|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4463703|NCT00012012|4282892|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4463704|NCT00012012|4282890|B3|||Age||years|Median|55|55.0|Full Range|||25.0|76.0|
4463705|NCT00012012|4282891|B2|||Age||years|Median|56|56.0|Full Range|||25.0|75.0|
4463706|NCT00012012|4282892|B1|||Age||years|Median|54|54.0|Full Range|||30.0|76.0|
4463707|NCT00011986|4282899|B6|> 1 cm gross disease||Size of Residual Disease||participants|Number|1319|1319.0||||||
4463708|NCT00011986|4282900|B5|> 1 cm gross disease||Size of Residual Disease||participants|Number|260|260.0||||||
4463709|NCT00011986|4282901|B4|> 1 cm gross disease||Size of Residual Disease||participants|Number|283|283.0||||||
4463710|NCT00011986|4282902|B3|> 1 cm gross disease||Size of Residual Disease||participants|Number|251|251.0||||||
4463711|NCT00011986|4282903|B2|> 1 cm gross disease||Size of Residual Disease||participants|Number|262|262.0||||||
4463712|NCT00011986|4282904|B1|> 1 cm gross disease||Size of Residual Disease||participants|Number|263|263.0||||||
4463713|NCT00011986|4282899|B6|≤ 1 cm gross disease||Size of Residual Disease||participants|Number|1949|1949.0||||||
4463714|NCT00011986|4282900|B5|≤ 1 cm gross disease||Size of Residual Disease||participants|Number|398|398.0||||||
4463715|NCT00011986|4282901|B4|≤ 1 cm gross disease||Size of Residual Disease||participants|Number|358|358.0||||||
4463716|NCT00011986|4282902|B3|≤ 1 cm gross disease||Size of Residual Disease||participants|Number|405|405.0||||||
4463717|NCT00011986|4282903|B2|≤ 1 cm gross disease||Size of Residual Disease||participants|Number|384|384.0||||||
4463718|NCT00011986|4282904|B1|≤ 1 cm gross disease||Size of Residual Disease||participants|Number|404|404.0||||||
4463719|NCT00011986|4282899|B6|Microscopic only||Size of Residual Disease||participants|Number|1044|1044.0||||||
4463720|NCT00011986|4282900|B5|Microscopic only||Size of Residual Disease||participants|Number|203|203.0||||||
4463721|NCT00011986|4282901|B4|Microscopic only||Size of Residual Disease||participants|Number|220|220.0||||||
4463722|NCT00011986|4282902|B3|Microscopic only||Size of Residual Disease||participants|Number|206|206.0||||||
4463723|NCT00011986|4282903|B2|Microscopic only||Size of Residual Disease||participants|Number|218|218.0||||||
4463724|NCT00011986|4282904|B1|Microscopic only||Size of Residual Disease||participants|Number|197|197.0||||||
4463725|NCT00011986|4282899|B6|Peritoneum||Primary Site of Disease||participants|Number|572|572.0||||||
4463726|NCT00011986|4282900|B5|Peritoneum||Primary Site of Disease||participants|Number|110|110.0||||||
4463727|NCT00011986|4282901|B4|Peritoneum||Primary Site of Disease||participants|Number|109|109.0||||||
4463728|NCT00011986|4282902|B3|Peritoneum||Primary Site of Disease||participants|Number|125|125.0||||||
4463729|NCT00011986|4282903|B2|Peritoneum||Primary Site of Disease||participants|Number|112|112.0||||||
4463730|NCT00011986|4282904|B1|Peritoneum||Primary Site of Disease||participants|Number|116|116.0||||||
4463731|NCT00011986|4282899|B6|Ovary||Primary Site of Disease||participants|Number|3740|3740.0||||||
4463732|NCT00011986|4282900|B5|Ovary||Primary Site of Disease||participants|Number|751|751.0||||||
4463733|NCT00011986|4282901|B4|Ovary||Primary Site of Disease||participants|Number|752|752.0||||||
4463734|NCT00011986|4282902|B3|Ovary||Primary Site of Disease||participants|Number|737|737.0||||||
4463735|NCT00011986|4282903|B2|Ovary||Primary Site of Disease||participants|Number|752|752.0||||||
4463736|NCT00011986|4282904|B1|Ovary||Primary Site of Disease||participants|Number|748|748.0||||||
4463737|NCT00011986|4282899|B6|Stage IV:see description for details||International Federation of Gynecology and Obstetrics (FIGO) Stage|"FIGO Staging Classification: 1985.~Stage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum.~Stage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV."|participants|Number|631|631.0||||||
4463806|NCT00008138|4282961|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463807|NCT00008138|4282961|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463808|NCT00008138|4282961|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4463809|NCT00008138|4282961|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463810|NCT00008138|4282961|B1||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4463738|NCT00011986|4282900|B5|Stage IV:see description for details||International Federation of Gynecology and Obstetrics (FIGO) Stage|"FIGO Staging Classification: 1985.~Stage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum.~Stage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV."|participants|Number|140|140.0||||||
4463739|NCT00011986|4282901|B4|Stage IV:see description for details||International Federation of Gynecology and Obstetrics (FIGO) Stage|"FIGO Staging Classification: 1985.~Stage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum.~Stage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV."|participants|Number|117|117.0||||||
4463740|NCT00011986|4282902|B3|Stage IV:see description for details||International Federation of Gynecology and Obstetrics (FIGO) Stage|"FIGO Staging Classification: 1985.~Stage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum.~Stage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV."|participants|Number|119|119.0||||||
4463741|NCT00011986|4282903|B2|Stage IV:see description for details||International Federation of Gynecology and Obstetrics (FIGO) Stage|"FIGO Staging Classification: 1985.~Stage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum.~Stage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV."|participants|Number|115|115.0||||||
4463742|NCT00011986|4282904|B1|Stage IV:see description for details||International Federation of Gynecology and Obstetrics (FIGO) Stage|"FIGO Staging Classification: 1985.~Stage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum.~Stage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV."|participants|Number|140|140.0||||||
4463743|NCT00011986|4282899|B6|Stage III:see description for details||International Federation of Gynecology and Obstetrics (FIGO) Stage|"FIGO Staging Classification: 1985.~Stage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum.~Stage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV."|participants|Number|3681|3681.0||||||
4463744|NCT00011986|4282900|B5|Stage III:see description for details||International Federation of Gynecology and Obstetrics (FIGO) Stage|"FIGO Staging Classification: 1985.~Stage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum.~Stage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV."|participants|Number|721|721.0||||||
4463745|NCT00011986|4282901|B4|Stage III:see description for details||International Federation of Gynecology and Obstetrics (FIGO) Stage|"FIGO Staging Classification: 1985.~Stage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum.~Stage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV."|participants|Number|744|744.0||||||
4463746|NCT00011986|4282902|B3|Stage III:see description for details||International Federation of Gynecology and Obstetrics (FIGO) Stage|"FIGO Staging Classification: 1985.~Stage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum.~Stage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV."|participants|Number|743|743.0||||||
4463747|NCT00011986|4282903|B2|Stage III:see description for details||International Federation of Gynecology and Obstetrics (FIGO) Stage|"FIGO Staging Classification: 1985.~Stage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum.~Stage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV."|participants|Number|749|749.0||||||
4463811|NCT00008138|4282961|B1|||Age||years|Median|62|62.0|Full Range|||31.0|79.0|
4463812|NCT00006916|4282967|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4463813|NCT00006916|4282967|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4463748|NCT00011986|4282904|B1|Stage III:see description for details||International Federation of Gynecology and Obstetrics (FIGO) Stage|"FIGO Staging Classification: 1985.~Stage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum.~Stage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV."|participants|Number|724|724.0||||||
4463749|NCT00011986|4282899|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463750|NCT00011986|4282900|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463751|NCT00011986|4282901|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463752|NCT00011986|4282902|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463753|NCT00011986|4282903|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463754|NCT00011986|4282904|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463755|NCT00011986|4282899|B6||Female|Sex: Female, Male||Participants|Count of Participants|4312|4312.0||||||
4463756|NCT00011986|4282900|B5||Female|Sex: Female, Male||Participants|Count of Participants|861|861.0||||||
4463757|NCT00011986|4282901|B4||Female|Sex: Female, Male||Participants|Count of Participants|861|861.0||||||
4463758|NCT00011986|4282902|B3||Female|Sex: Female, Male||Participants|Count of Participants|862|862.0||||||
4463759|NCT00011986|4282903|B2||Female|Sex: Female, Male||Participants|Count of Participants|864|864.0||||||
4463760|NCT00011986|4282904|B1||Female|Sex: Female, Male||Participants|Count of Participants|864|864.0||||||
4463761|NCT00011986|4282899|B6|||Age||years|Mean|58.6|58.6|Standard Deviation|10.9|10.9|||
4463762|NCT00011986|4282900|B5|||Age||years|Mean|58.9|58.9|Standard Deviation|10.7|10.7|||
4463763|NCT00011986|4282901|B4|||Age||years|Mean|58.2|58.2|Standard Deviation|11.0|11.0|||
4463764|NCT00011986|4282902|B3|||Age||years|Mean|59.0|59.0|Standard Deviation|11.1|11.1|||
4463765|NCT00011986|4282903|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|10.8|10.8|||
4463766|NCT00011986|4282904|B1|||Age||years|Mean|57.8|57.8|Standard Deviation|11.1|11.1|||
4463767|NCT00010257|4282920|B3|United States||Region of Enrollment||participants|Number|46|46.0||||||
4463768|NCT00010257|4282921|B2|United States||Region of Enrollment||participants|Number|21|21.0||||||
4463769|NCT00010257|4282922|B1|United States||Region of Enrollment||participants|Number|25|25.0||||||
4463770|NCT00010257|4282920|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4463771|NCT00010257|4282921|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4463772|NCT00010257|4282922|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4463773|NCT00010257|4282920|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4463774|NCT00010257|4282921|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4463775|NCT00010257|4282922|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4463776|NCT00010257|4282920|B3|||Age||Years|Median|50.7|50.7|Full Range|||20.8|76.7|
4463777|NCT00010257|4282921|B2|||Age||Years|Median|49.2|49.2|Full Range|||20.8|67.1|
4463778|NCT00010257|4282922|B1|||Age||Years|Median|50.8|50.8|Full Range|||32.7|76.7|
4463779|NCT00009945|4282931|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463780|NCT00009945|4282932|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463781|NCT00009945|4282933|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463782|NCT00009945|4282931|B3||Female|Sex: Female, Male||Participants|Count of Participants|3323|3323.0||||||
4463783|NCT00009945|4282932|B2||Female|Sex: Female, Male||Participants|Count of Participants|1661|1661.0||||||
4463784|NCT00009945|4282933|B1||Female|Sex: Female, Male||Participants|Count of Participants|1662|1662.0||||||
4463785|NCT00009945|4282931|B3|||Age||years|Mean|54|54.0|Standard Deviation|10.4|10.4|||
4463786|NCT00009945|4282932|B2|||Age||years|Mean|53|53.0|Standard Deviation|10.4|10.4|||
4463787|NCT00009945|4282933|B1|||Age||years|Mean|54|54.0|Standard Deviation|10.5|10.5|||
4463788|NCT00008385|4282948|B3||Male|Sex: Female, Male||Participants|Count of Participants|759|759.0||||||
4463789|NCT00008385|4282949|B2||Male|Sex: Female, Male||Participants|Count of Participants|509|509.0||||||
4463790|NCT00008385|4282950|B1||Male|Sex: Female, Male||Participants|Count of Participants|250|250.0||||||
4463791|NCT00008385|4282948|B3||Female|Sex: Female, Male||Participants|Count of Participants|802|802.0||||||
4463792|NCT00008385|4282949|B2||Female|Sex: Female, Male||Participants|Count of Participants|531|531.0||||||
4463793|NCT00008385|4282950|B1||Female|Sex: Female, Male||Participants|Count of Participants|271|271.0||||||
4463794|NCT00008385|4282948|B3|||Age||Years|Median|66|66.0|Full Range|||22.0|93.0|
4463795|NCT00008385|4282949|B2|||Age||Years|Median|66|66.0|Full Range|||22.0|93.0|
4463796|NCT00008385|4282950|B1|||Age||Years|Median|66|66.0|Full Range|||38.0|86.0|
4463797|NCT00008138|4282961|B1|Not reported||Primary Site||participants|Number|1|1.0||||||
4463798|NCT00008138|4282961|B1|Peritoneal||Primary Site||participants|Number|14|14.0||||||
4463799|NCT00008138|4282961|B1|Ovary||Primary Site||participants|Number|43|43.0||||||
4463800|NCT00008138|4282961|B1|Stage IV||Stage||participants|Number|15|15.0||||||
4463801|NCT00008138|4282961|B1|Stage III||Stage||participants|Number|43|43.0||||||
4463802|NCT00008138|4282961|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4463803|NCT00008138|4282961|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463804|NCT00008138|4282961|B1||White|Race (NIH/OMB)||Participants|Count of Participants|51|51.0||||||
4463805|NCT00008138|4282961|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463814|NCT00006916|4282967|B1|||Age||years|Median|59|59.0|Full Range|||24.0|81.0|
4463815|NCT00006903|4282971|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463816|NCT00006903|4282972|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463817|NCT00006903|4282973|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4463818|NCT00006903|4282971|B3||Female|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4463819|NCT00006903|4282972|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4463820|NCT00006903|4282973|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4463821|NCT00006903|4282971|B3|||Age, Customized||years|Mean|64.6|64.6|Standard Deviation|10.4|10.4|||
4463822|NCT00006903|4282972|B2|||Age, Customized||years|Mean|65.9|65.9|Standard Deviation|10.4|10.4|||
4463823|NCT00006903|4282973|B1|||Age, Customized||years|Mean|62.9|62.9|Standard Deviation|10.2|10.2|||
4463824|NCT00006721|4282985|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4463825|NCT00006721|4282986|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463826|NCT00006721|4282987|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4463827|NCT00006721|4282988|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4463828|NCT00006721|4282985|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463829|NCT00006721|4282986|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463830|NCT00006721|4282987|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463831|NCT00006721|4282988|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463832|NCT00006721|4282985|B4||White|Race (NIH/OMB)||Participants|Count of Participants|492|492.0||||||
4463833|NCT00006721|4282986|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4463834|NCT00006721|4282987|B2||White|Race (NIH/OMB)||Participants|Count of Participants|238|238.0||||||
4463835|NCT00006721|4282988|B1||White|Race (NIH/OMB)||Participants|Count of Participants|241|241.0||||||
4463836|NCT00006721|4282985|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4463837|NCT00006721|4282986|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463838|NCT00006721|4282987|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4463839|NCT00006721|4282988|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4463840|NCT00006721|4282985|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463841|NCT00006721|4282986|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463842|NCT00006721|4282987|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463843|NCT00006721|4282988|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463844|NCT00006721|4282985|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4463845|NCT00006721|4282986|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463846|NCT00006721|4282987|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4463847|NCT00006721|4282988|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4463848|NCT00006721|4282985|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4463849|NCT00006721|4282986|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463850|NCT00006721|4282987|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4463851|NCT00006721|4282988|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4463852|NCT00006721|4282985|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|64|64.0||||||
4463853|NCT00006721|4282986|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463854|NCT00006721|4282987|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4463855|NCT00006721|4282988|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4463856|NCT00006721|4282985|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|466|466.0||||||
4463857|NCT00006721|4282986|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4463858|NCT00006721|4282987|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|220|220.0||||||
4463859|NCT00006721|4282988|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|232|232.0||||||
4463860|NCT00006721|4282985|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4463861|NCT00006721|4282986|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4463862|NCT00006721|4282987|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4463863|NCT00006721|4282988|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4463864|NCT00006721|4282985|B4||Male|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4463865|NCT00006721|4282986|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4463866|NCT00006721|4282987|B2||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4463867|NCT00006721|4282988|B1||Male|Sex: Female, Male||Participants|Count of Participants|142|142.0||||||
4463868|NCT00006721|4282985|B4||Female|Sex: Female, Male||Participants|Count of Participants|247|247.0||||||
4463869|NCT00006721|4282986|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4463870|NCT00006721|4282987|B2||Female|Sex: Female, Male||Participants|Count of Participants|118|118.0||||||
4463871|NCT00006721|4282988|B1||Female|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4463872|NCT00006721|4282985|B4|||Age||years|Median|54|54.0|Full Range|||23.5|86.9|
4463873|NCT00006721|4282986|B3|||Age||years|Median|54.5|54.5|Full Range|||32.6|75.5|
4463874|NCT00006721|4282987|B2|||Age||years|Median|53.3|53.3|Full Range|||23.6|81.8|
4463875|NCT00006721|4282988|B1|||Age||years|Median|54.5|54.5|Full Range|||23.5|86.9|
4463876|NCT00006478|4283008|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4463877|NCT00006478|4283008|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4463878|NCT00006478|4283008|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4463879|NCT00006478|4283008|B1|||Age||years|Mean|46.7|46.7|Standard Deviation|10.68|10.68|||
4463880|NCT00006478|4283008|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4463881|NCT00006478|4283008|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4463882|NCT00006478|4283008|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4463883|NCT00006392|4283015|B5|Unknown||Smoking status||Participant|Number|300|300.0||||||
4463884|NCT00006392|4283016|B4|Unknown||Smoking status||Participant|Number|88|88.0||||||
4463885|NCT00006392|4283017|B3|Unknown||Smoking status||Participant|Number|69|69.0||||||
4463886|NCT00006392|4283018|B2|Unknown||Smoking status||Participant|Number|66|66.0||||||
4463887|NCT00006392|4283019|B1|Unknown||Smoking status||Participant|Number|77|77.0||||||
4463888|NCT00006392|4283015|B5|Ever (unknown status)||Smoking status||Participant|Number|235|235.0||||||
4463889|NCT00006392|4283016|B4|Ever (unknown status)||Smoking status||Participant|Number|63|63.0||||||
4463890|NCT00006392|4283017|B3|Ever (unknown status)||Smoking status||Participant|Number|56|56.0||||||
4463891|NCT00006392|4283018|B2|Ever (unknown status)||Smoking status||Participant|Number|61|61.0||||||
4463892|NCT00006392|4283019|B1|Ever (unknown status)||Smoking status||Participant|Number|55|55.0||||||
4463893|NCT00006392|4283015|B5|Former||Smoking status||Participant|Number|16858|16858.0||||||
4463894|NCT00006392|4283016|B4|Former||Smoking status||Participant|Number|4208|4208.0||||||
4463895|NCT00006392|4283017|B3|Former||Smoking status||Participant|Number|4242|4242.0||||||
4463896|NCT00006392|4283018|B2|Former||Smoking status||Participant|Number|4214|4214.0||||||
4463897|NCT00006392|4283019|B1|Former||Smoking status||Participant|Number|4194|4194.0||||||
4463898|NCT00006392|4283015|B5|Current||Smoking status||Participant|Number|2615|2615.0||||||
4463899|NCT00006392|4283016|B4|Current||Smoking status||Participant|Number|655|655.0||||||
4463900|NCT00006392|4283017|B3|Current||Smoking status||Participant|Number|670|670.0||||||
4463901|NCT00006392|4283018|B2|Current||Smoking status||Participant|Number|631|631.0||||||
4463902|NCT00006392|4283019|B1|Current||Smoking status||Participant|Number|659|659.0||||||
4463903|NCT00006392|4283015|B5|Never||Smoking status||Participant|Number|14880|14880.0||||||
4463904|NCT00006392|4283016|B4|Never||Smoking status||Participant|Number|3682|3682.0||||||
4463905|NCT00006392|4283017|B3|Never||Smoking status||Participant|Number|3666|3666.0||||||
4463906|NCT00006392|4283018|B2|Never||Smoking status||Participant|Number|3780|3780.0||||||
4463907|NCT00006392|4283019|B1|Never||Smoking status||Participant|Number|3752|3752.0||||||
4463908|NCT00006392|4283015|B5|Unknown/missing||PSA (ng/ml)||Participant|Number|41|41.0||||||
4463909|NCT00006392|4283016|B4|Unknown/missing||PSA (ng/ml)||Participant|Number|7|7.0||||||
4463910|NCT00006392|4283017|B3|Unknown/missing||PSA (ng/ml)||Participant|Number|15|15.0||||||
4463911|NCT00006392|4283018|B2|Unknown/missing||PSA (ng/ml)||Participant|Number|8|8.0||||||
4463912|NCT00006392|4283019|B1|Unknown/missing||PSA (ng/ml)||Participant|Number|11|11.0||||||
4463913|NCT00006392|4283015|B5|> 4.0||PSA (ng/ml)||Participant|Number|11|11.0||||||
4463914|NCT00006392|4283016|B4|> 4.0||PSA (ng/ml)||Participant|Number|5|5.0||||||
4463915|NCT00006392|4283017|B3|> 4.0||PSA (ng/ml)||Participant|Number|1|1.0||||||
4463916|NCT00006392|4283018|B2|> 4.0||PSA (ng/ml)||Participant|Number|2|2.0||||||
4463917|NCT00006392|4283019|B1|> 4.0||PSA (ng/ml)||Participant|Number|3|3.0||||||
4463918|NCT00006392|4283015|B5|3.1 - 4.0||PSA (ng/ml)||Participant|Number|2611|2611.0||||||
4463919|NCT00006392|4283016|B4|3.1 - 4.0||PSA (ng/ml)||Participant|Number|666|666.0||||||
4463920|NCT00006392|4283017|B3|3.1 - 4.0||PSA (ng/ml)||Participant|Number|659|659.0||||||
4463921|NCT00006392|4283018|B2|3.1 - 4.0||PSA (ng/ml)||Participant|Number|652|652.0||||||
4463922|NCT00006392|4283019|B1|3.1 - 4.0||PSA (ng/ml)||Participant|Number|634|634.0||||||
4463923|NCT00006392|4283015|B5|2.1 - 3.0||PSA (ng/ml)||Participant|Number|4756|4756.0||||||
4463924|NCT00006392|4283016|B4|2.1 - 3.0||PSA (ng/ml)||Participant|Number|1168|1168.0||||||
4463925|NCT00006392|4283017|B3|2.1 - 3.0||PSA (ng/ml)||Participant|Number|1149|1149.0||||||
4463926|NCT00006392|4283018|B2|2.1 - 3.0||PSA (ng/ml)||Participant|Number|1211|1211.0||||||
4463927|NCT00006392|4283019|B1|2.1 - 3.0||PSA (ng/ml)||Participant|Number|1228|1228.0||||||
4463928|NCT00006392|4283015|B5|1.1 - 2.0||PSA (ng/ml)||Participant|Number|10708|10708.0||||||
4463929|NCT00006392|4283016|B4|1.1 - 2.0||PSA (ng/ml)||Participant|Number|2728|2728.0||||||
4463930|NCT00006392|4283017|B3|1.1 - 2.0||PSA (ng/ml)||Participant|Number|2666|2666.0||||||
4463931|NCT00006392|4283018|B2|1.1 - 2.0||PSA (ng/ml)||Participant|Number|2661|2661.0||||||
4463932|NCT00006392|4283019|B1|1.1 - 2.0||PSA (ng/ml)||Participant|Number|2653|2653.0||||||
4463933|NCT00006392|4283015|B5|0.1 - 1.0||PSA (ng/ml)||Participant|Number|16761|16761.0||||||
4463934|NCT00006392|4283016|B4|0.1 - 1.0||PSA (ng/ml)||Participant|Number|4122|4122.0||||||
4463935|NCT00006392|4283017|B3|0.1 - 1.0||PSA (ng/ml)||Participant|Number|4213|4213.0||||||
4463936|NCT00006392|4283018|B2|0.1 - 1.0||PSA (ng/ml)||Participant|Number|4218|4218.0||||||
4463937|NCT00006392|4283019|B1|0.1 - 1.0||PSA (ng/ml)||Participant|Number|4208|4208.0||||||
4463938|NCT00006392|4283015|B5|Unknown/missing||Education (highest)||Participant|Number|339|339.0||||||
4463939|NCT00006392|4283016|B4|Unknown/missing||Education (highest)||Participant|Number|95|95.0||||||
4463940|NCT00006392|4283017|B3|Unknown/missing||Education (highest)||Participant|Number|85|85.0||||||
4463941|NCT00006392|4283018|B2|Unknown/missing||Education (highest)||Participant|Number|78|78.0||||||
4463942|NCT00006392|4283019|B1|Unknown/missing||Education (highest)||Participant|Number|81|81.0||||||
4463943|NCT00006392|4283015|B5|>= College graduate||Education (highest)||Participant|Number|17513|17513.0||||||
4463944|NCT00006392|4283016|B4|>= College graduate||Education (highest)||Participant|Number|4317|4317.0||||||
4463945|NCT00006392|4283017|B3|>= College graduate||Education (highest)||Participant|Number|4372|4372.0||||||
4463946|NCT00006392|4283018|B2|>= College graduate||Education (highest)||Participant|Number|4430|4430.0||||||
4463947|NCT00006392|4283019|B1|>= College graduate||Education (highest)||Participant|Number|4394|4394.0||||||
4463948|NCT00006392|4283015|B5|Some college/vocational school||Education (highest)||Participant|Number|9353|9353.0||||||
4463949|NCT00006392|4283016|B4|Some college/vocational school||Education (highest)||Participant|Number|2291|2291.0||||||
4463950|NCT00006392|4283017|B3|Some college/vocational school||Education (highest)||Participant|Number|2348|2348.0||||||
4463951|NCT00006392|4283018|B2|Some college/vocational school||Education (highest)||Participant|Number|2327|2327.0||||||
4463952|NCT00006392|4283019|B1|Some college/vocational school||Education (highest)||Participant|Number|2387|2387.0||||||
4463953|NCT00006392|4283015|B5|<= High school graduate or GED||Education (highest)||Participant|Number|7683|7683.0||||||
4463954|NCT00006392|4283016|B4|<= High school graduate or GED||Education (highest)||Participant|Number|1993|1993.0||||||
4463955|NCT00006392|4283017|B3|<= High school graduate or GED||Education (highest)||Participant|Number|1898|1898.0||||||
4463956|NCT00006392|4283018|B2|<= High school graduate or GED||Education (highest)||Participant|Number|1917|1917.0||||||
4463957|NCT00006392|4283019|B1|<= High school graduate or GED||Education (highest)||Participant|Number|1875|1875.0||||||
4463958|NCT00006392|4283015|B5|>= 75 years||Age (categorical)||participants|Number|2253|2253.0||||||
4463959|NCT00006392|4283016|B4|>= 75 years||Age (categorical)||participants|Number|561|561.0||||||
4463960|NCT00006392|4283017|B3|>= 75 years||Age (categorical)||participants|Number|535|535.0||||||
4463961|NCT00006392|4283018|B2|>= 75 years||Age (categorical)||participants|Number|606|606.0||||||
4463962|NCT00006392|4283019|B1|>= 75 years||Age (categorical)||participants|Number|551|551.0||||||
4463963|NCT00006392|4283015|B5|65 - 74 years||Age (categorical)||participants|Number|10807|10807.0||||||
4463964|NCT00006392|4283016|B4|65 - 74 years||Age (categorical)||participants|Number|2702|2702.0||||||
4463965|NCT00006392|4283017|B3|65 - 74 years||Age (categorical)||participants|Number|2731|2731.0||||||
4463966|NCT00006392|4283018|B2|65 - 74 years||Age (categorical)||participants|Number|2733|2733.0||||||
4463967|NCT00006392|4283019|B1|65 - 74 years||Age (categorical)||participants|Number|2641|2641.0||||||
4463968|NCT00006392|4283015|B5|55 - 64 years||Age (categorical)||participants|Number|20349|20349.0||||||
4463969|NCT00006392|4283016|B4|55 - 64 years||Age (categorical)||participants|Number|5078|5078.0||||||
4463970|NCT00006392|4283017|B3|55 - 64 years||Age (categorical)||participants|Number|5052|5052.0||||||
4463971|NCT00006392|4283018|B2|55 - 64 years||Age (categorical)||participants|Number|5076|5076.0||||||
4463972|NCT00006392|4283019|B1|55 - 64 years||Age (categorical)||participants|Number|5143|5143.0||||||
4463973|NCT00006392|4283015|B5|50 - 54 years||Age (categorical)||participants|Number|1479|1479.0||||||
4463974|NCT00006392|4283016|B4|50 - 54 years||Age (categorical)||participants|Number|355|355.0||||||
4463975|NCT00006392|4283017|B3|50 - 54 years||Age (categorical)||participants|Number|385|385.0||||||
4463976|NCT00006392|4283018|B2|50 - 54 years||Age (categorical)||participants|Number|337|337.0||||||
4463977|NCT00006392|4283019|B1|50 - 54 years||Age (categorical)||participants|Number|402|402.0||||||
4463978|NCT00006392|4283015|B5|Puerto Rico||Region of Enrollment||participants|Number|1460|1460.0||||||
4463979|NCT00006392|4283016|B4|Puerto Rico||Region of Enrollment||participants|Number|364|364.0||||||
4463980|NCT00006392|4283017|B3|Puerto Rico||Region of Enrollment||participants|Number|365|365.0||||||
4463981|NCT00006392|4283018|B2|Puerto Rico||Region of Enrollment||participants|Number|366|366.0||||||
4463982|NCT00006392|4283019|B1|Puerto Rico||Region of Enrollment||participants|Number|365|365.0||||||
4463983|NCT00006392|4283015|B5|Canada||Region of Enrollment||participants|Number|3639|3639.0||||||
4463984|NCT00006392|4283016|B4|Canada||Region of Enrollment||participants|Number|904|904.0||||||
4463985|NCT00006392|4283017|B3|Canada||Region of Enrollment||participants|Number|911|911.0||||||
4463986|NCT00006392|4283018|B2|Canada||Region of Enrollment||participants|Number|915|915.0||||||
4463987|NCT00006392|4283019|B1|Canada||Region of Enrollment||participants|Number|909|909.0||||||
4463988|NCT00006392|4283015|B5|United States||Region of Enrollment||participants|Number|29789|29789.0||||||
4463989|NCT00006392|4283016|B4|United States||Region of Enrollment||participants|Number|7428|7428.0||||||
4463990|NCT00006392|4283017|B3|United States||Region of Enrollment||participants|Number|7427|7427.0||||||
4463991|NCT00006392|4283018|B2|United States||Region of Enrollment||participants|Number|7471|7471.0||||||
4463992|NCT00006392|4283019|B1|United States||Region of Enrollment||participants|Number|7463|7463.0||||||
4463993|NCT00006392|4283015|B5|Other||Race/Ethnicity, Customized||Participant|Number|711|711.0||||||
4463994|NCT00006392|4283016|B4|Other||Race/Ethnicity, Customized||Participant|Number|187|187.0||||||
4463995|NCT00006392|4283017|B3|Other||Race/Ethnicity, Customized||Participant|Number|174|174.0||||||
4463996|NCT00006392|4283018|B2|Other||Race/Ethnicity, Customized||Participant|Number|190|190.0||||||
4463997|NCT00006392|4283019|B1|Other||Race/Ethnicity, Customized||Participant|Number|160|160.0||||||
4463998|NCT00006392|4283015|B5|Hispanic (African American)||Race/Ethnicity, Customized||Participant|Number|360|360.0||||||
4463999|NCT00006392|4283016|B4|Hispanic (African American)||Race/Ethnicity, Customized||Participant|Number|76|76.0||||||
4464000|NCT00006392|4283017|B3|Hispanic (African American)||Race/Ethnicity, Customized||Participant|Number|95|95.0||||||
4464001|NCT00006392|4283018|B2|Hispanic (African American)||Race/Ethnicity, Customized||Participant|Number|86|86.0||||||
4464002|NCT00006392|4283019|B1|Hispanic (African American)||Race/Ethnicity, Customized||Participant|Number|103|103.0||||||
4464003|NCT00006392|4283015|B5|Hispanic (non-African American)||Race/Ethnicity, Customized||Participant|Number|1934|1934.0||||||
4464004|NCT00006392|4283016|B4|Hispanic (non-African American)||Race/Ethnicity, Customized||Participant|Number|492|492.0||||||
4464005|NCT00006392|4283017|B3|Hispanic (non-African American)||Race/Ethnicity, Customized||Participant|Number|484|484.0||||||
4464006|NCT00006392|4283018|B2|Hispanic (non-African American)||Race/Ethnicity, Customized||Participant|Number|481|481.0||||||
4464007|NCT00006392|4283019|B1|Hispanic (non-African American)||Race/Ethnicity, Customized||Participant|Number|477|477.0||||||
4464008|NCT00006392|4283015|B5|African American||Race/Ethnicity, Customized||Participant|Number|4314|4314.0||||||
4464009|NCT00006392|4283016|B4|African American||Race/Ethnicity, Customized||Participant|Number|1078|1078.0||||||
4464010|NCT00006392|4283017|B3|African American||Race/Ethnicity, Customized||Participant|Number|1076|1076.0||||||
4464011|NCT00006392|4283018|B2|African American||Race/Ethnicity, Customized||Participant|Number|1053|1053.0||||||
4464012|NCT00006392|4283019|B1|African American||Race/Ethnicity, Customized||Participant|Number|1107|1107.0||||||
4464013|NCT00006392|4283015|B5|White||Race/Ethnicity, Customized||Participant|Number|27569|27569.0||||||
4464014|NCT00006392|4283016|B4|White||Race/Ethnicity, Customized||Participant|Number|6863|6863.0||||||
4464015|NCT00006392|4283017|B3|White||Race/Ethnicity, Customized||Participant|Number|6874|6874.0||||||
4464016|NCT00006392|4283018|B2|White||Race/Ethnicity, Customized||Participant|Number|6942|6942.0||||||
4464017|NCT00006392|4283019|B1|White||Race/Ethnicity, Customized||Participant|Number|6890|6890.0||||||
4464018|NCT00006392|4283015|B5||Male|Sex: Female, Male||Participants|Count of Participants|34888|34888.0||||||
4464019|NCT00006392|4283016|B4||Male|Sex: Female, Male||Participants|Count of Participants|8696|8696.0||||||
4464020|NCT00006392|4283017|B3||Male|Sex: Female, Male||Participants|Count of Participants|8703|8703.0||||||
4464021|NCT00006392|4283018|B2||Male|Sex: Female, Male||Participants|Count of Participants|8752|8752.0||||||
4464022|NCT00006392|4283019|B1||Male|Sex: Female, Male||Participants|Count of Participants|8737|8737.0||||||
4464023|NCT00006392|4283015|B5||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464024|NCT00006392|4283016|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464025|NCT00006392|4283017|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464026|NCT00006392|4283018|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464027|NCT00006392|4283019|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464028|NCT00006392|4283015|B5|||Age||years|Median|62.3|62.3|Inter-Quartile Range|||58.1|67.8|
4464029|NCT00006392|4283016|B4|||Age||years|Median|62.6|62.6|Inter-Quartile Range|||58.2|68.0|
4464030|NCT00006392|4283017|B3|||Age||years|Median|62.3|62.3|Inter-Quartile Range|||58.0|67.8|
4464031|NCT00006392|4283018|B2|||Age||years|Median|62.6|62.6|Inter-Quartile Range|||58.1|67.8|
4464032|NCT00006392|4283019|B1|||Age||years|Median|62.4|62.4|Inter-Quartile Range|||58.1|67.8|
4464033|NCT00006389|4283052|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4464034|NCT00006389|4283052|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4464035|NCT00006389|4283052|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4464036|NCT00006389|4283052|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4464037|NCT00006389|4283052|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4464038|NCT00006389|4283052|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464039|NCT00006244|4283058|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4464040|NCT00006244|4283058|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464041|NCT00006244|4283058|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464042|NCT00006244|4283058|B1||White|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4464043|NCT00006244|4283058|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464044|NCT00006244|4283058|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464045|NCT00006244|4283058|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4464046|NCT00006244|4283058|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464047|NCT00006244|4283058|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464048|NCT00006244|4283058|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4464049|NCT00006244|4283058|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4464050|NCT00006244|4283058|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4464051|NCT00006244|4283058|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4464052|NCT00006244|4283058|B1|||Age||Years|Mean|53.56|53.56|Full Range|||36.2|69.4|
4464053|NCT00006244|4283058|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4464054|NCT00006244|4283058|B1||Between 18 and 65 years|Age||Participants|Count of Participants|32|32.0||||||
4464055|NCT00006244|4283058|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464056|NCT00006237|4283067|B3|United States||Region of Enrollment||participants|Number|402|402.0||||||
4464057|NCT00006237|4283068|B2|United States||Region of Enrollment||participants|Number|199|199.0||||||
4464058|NCT00006237|4283069|B1|United States||Region of Enrollment||participants|Number|203|203.0||||||
4464059|NCT00006237|4283067|B3||Male|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4464060|NCT00006237|4283068|B2||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4464061|NCT00006237|4283069|B1||Male|Sex: Female, Male||Participants|Count of Participants|141|141.0||||||
4464062|NCT00006237|4283067|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4464063|NCT00006237|4283068|B2||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4464064|NCT00006237|4283069|B1||Female|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4464065|NCT00006237|4283067|B3|||Age||years|Median|47|47.0|Full Range|||10.0|74.0|
4464066|NCT00006237|4283068|B2|||Age||years|Median|46|46.0|Full Range|||10.0|74.0|
4464067|NCT00006237|4283069|B1|||Age||years|Median|47|47.0|Full Range|||12.0|73.0|
4464068|NCT00006110|4283080|B3|IV||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|13|13.0||||||
4464069|NCT00006110|4283081|B2|IV||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|3|3.0||||||
4464070|NCT00006110|4283082|B1|IV||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|10|10.0||||||
4464071|NCT00006110|4283080|B3|IIIC||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|8|8.0||||||
4464072|NCT00006110|4283081|B2|IIIC||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|0|0.0||||||
4464073|NCT00006110|4283082|B1|IIIC||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|8|8.0||||||
4464074|NCT00006110|4283080|B3|IIIB||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|14|14.0||||||
4464075|NCT00006110|4283081|B2|IIIB||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|6|6.0||||||
4464076|NCT00006110|4283082|B1|IIIB||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|8|8.0||||||
4464131|NCT00006110|4283080|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464132|NCT00006110|4283081|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464133|NCT00006110|4283082|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464134|NCT00006110|4283080|B3||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4464077|NCT00006110|4283080|B3|IIIA||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|32|32.0||||||
4464078|NCT00006110|4283081|B2|IIIA||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|12|12.0||||||
4464079|NCT00006110|4283082|B1|IIIA||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|20|20.0||||||
4464080|NCT00006110|4283080|B3|IIB||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|15|15.0||||||
4464081|NCT00006110|4283081|B2|IIB||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|9|9.0||||||
4464082|NCT00006110|4283082|B1|IIB||Clinical Stage|Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. The grading system is as follows: grade I - cancer cells that resemble normal cells and aren't growing rapidly. grade II - cancer cells that don't look like normal cells and are growing faster than normal cells. grade III - cancer cells that look abnormal and may grow or spread more aggressively. Grade IV- They tend to grow quicker, spread more often and have a worse prognosis.|Participants|Count of Participants|6|6.0||||||
4464083|NCT00006110|4283080|B3|FISH +||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|1|1.0||||||
4464084|NCT00006110|4283081|B2|FISH +||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|0|0.0||||||
4464085|NCT00006110|4283082|B1|FISH +||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|1|1.0||||||
4464086|NCT00006110|4283080|B3|fluorescence in-situ hybridization (FISH) Negative||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|11|11.0||||||
4464087|NCT00006110|4283081|B2|fluorescence in-situ hybridization (FISH) Negative||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|11|11.0||||||
4464135|NCT00006110|4283081|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4464136|NCT00006110|4283082|B1||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4464137|NCT00006110|4283080|B3|||Age||years|Median|48|48.0|Full Range|||24.0|70.0|
4464088|NCT00006110|4283082|B1|fluorescence in-situ hybridization (FISH) Negative||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|0|0.0||||||
4464089|NCT00006110|4283080|B3|0||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|4|4.0||||||
4464090|NCT00006110|4283081|B2|0||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|4|4.0||||||
4464091|NCT00006110|4283082|B1|0||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|0|0.0||||||
4464092|NCT00006110|4283080|B3|+3||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|48|48.0||||||
4464093|NCT00006110|4283081|B2|+3||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|3|3.0||||||
4464094|NCT00006110|4283082|B1|+3||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|45|45.0||||||
4464095|NCT00006110|4283080|B3|+2||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|9|9.0||||||
4464096|NCT00006110|4283081|B2|+2||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|3|3.0||||||
4464097|NCT00006110|4283082|B1|+2||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|6|6.0||||||
4464098|NCT00006110|4283080|B3|+1||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|9|9.0||||||
4464099|NCT00006110|4283081|B2|+1||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|9|9.0||||||
4464100|NCT00006110|4283082|B1|+1||Estrogen Receptor Status|Fluorescence in situ hybridization (FISH) is a test that “maps” the genetic material in a person’s cells. This test can be used to visualize specific genes or portions of genes. FISH testing is done on breast cancer tissue removed during biopsy to see if the cells have extra copies of the human epidermal growth factor receptor 2 (HER2) gene. The more copies of the HER2 gene that are present, the more HER2 receptors the cells have. These HER2 receptors receive signals that stimulate the growth of breast cancer cells.|Participants|Count of Participants|0|0.0||||||
4464101|NCT00006110|4283080|B3||Adjuvant|Type of Therapy|"Neoadjuvant Patients: Eligible will receive four cycles of conventional dose 4AC (doxorubicin at 60 mg/m2, Cyclophosphamide at 600 mg/m2). Patients will then receive 12 weeks of weekly Taxol® (90 mg/m2) plus Herceptin® followed by surgery.~Adjuvant Patients:~patients will undergo surgery followed by four cycles of conventional dose 4AC (doxorubicin at 60 mg/m2, Cyclophosphamide at 600 mg/m2). Patients will then receive 12 weeks of weekly Taxol® (90 mg/m2) plus Herceptin® ( 4 mg/kg load week 1; 2 mg/kg weekly thereafter)."|Participants|Count of Participants|15|15.0||||||
4464102|NCT00006110|4283081|B2||Adjuvant|Type of Therapy|"Neoadjuvant Patients: Eligible will receive four cycles of conventional dose 4AC (doxorubicin at 60 mg/m2, Cyclophosphamide at 600 mg/m2). Patients will then receive 12 weeks of weekly Taxol® (90 mg/m2) plus Herceptin® followed by surgery.~Adjuvant Patients:~patients will undergo surgery followed by four cycles of conventional dose 4AC (doxorubicin at 60 mg/m2, Cyclophosphamide at 600 mg/m2). Patients will then receive 12 weeks of weekly Taxol® (90 mg/m2) plus Herceptin® ( 4 mg/kg load week 1; 2 mg/kg weekly thereafter)."|Participants|Count of Participants|0|0.0||||||
4464103|NCT00006110|4283082|B1||Adjuvant|Type of Therapy|"Neoadjuvant Patients: Eligible will receive four cycles of conventional dose 4AC (doxorubicin at 60 mg/m2, Cyclophosphamide at 600 mg/m2). Patients will then receive 12 weeks of weekly Taxol® (90 mg/m2) plus Herceptin® followed by surgery.~Adjuvant Patients:~patients will undergo surgery followed by four cycles of conventional dose 4AC (doxorubicin at 60 mg/m2, Cyclophosphamide at 600 mg/m2). Patients will then receive 12 weeks of weekly Taxol® (90 mg/m2) plus Herceptin® ( 4 mg/kg load week 1; 2 mg/kg weekly thereafter)."|Participants|Count of Participants|15|15.0||||||
4464104|NCT00006110|4283080|B3||Neoadjuvant|Type of Therapy|"Neoadjuvant Patients: Eligible will receive four cycles of conventional dose 4AC (doxorubicin at 60 mg/m2, Cyclophosphamide at 600 mg/m2). Patients will then receive 12 weeks of weekly Taxol® (90 mg/m2) plus Herceptin® followed by surgery.~Adjuvant Patients:~patients will undergo surgery followed by four cycles of conventional dose 4AC (doxorubicin at 60 mg/m2, Cyclophosphamide at 600 mg/m2). Patients will then receive 12 weeks of weekly Taxol® (90 mg/m2) plus Herceptin® ( 4 mg/kg load week 1; 2 mg/kg weekly thereafter)."|Participants|Count of Participants|67|67.0||||||
4464105|NCT00006110|4283081|B2||Neoadjuvant|Type of Therapy|"Neoadjuvant Patients: Eligible will receive four cycles of conventional dose 4AC (doxorubicin at 60 mg/m2, Cyclophosphamide at 600 mg/m2). Patients will then receive 12 weeks of weekly Taxol® (90 mg/m2) plus Herceptin® followed by surgery.~Adjuvant Patients:~patients will undergo surgery followed by four cycles of conventional dose 4AC (doxorubicin at 60 mg/m2, Cyclophosphamide at 600 mg/m2). Patients will then receive 12 weeks of weekly Taxol® (90 mg/m2) plus Herceptin® ( 4 mg/kg load week 1; 2 mg/kg weekly thereafter)."|Participants|Count of Participants|30|30.0||||||
4464106|NCT00006110|4283082|B1||Neoadjuvant|Type of Therapy|"Neoadjuvant Patients: Eligible will receive four cycles of conventional dose 4AC (doxorubicin at 60 mg/m2, Cyclophosphamide at 600 mg/m2). Patients will then receive 12 weeks of weekly Taxol® (90 mg/m2) plus Herceptin® followed by surgery.~Adjuvant Patients:~patients will undergo surgery followed by four cycles of conventional dose 4AC (doxorubicin at 60 mg/m2, Cyclophosphamide at 600 mg/m2). Patients will then receive 12 weeks of weekly Taxol® (90 mg/m2) plus Herceptin® ( 4 mg/kg load week 1; 2 mg/kg weekly thereafter)."|Participants|Count of Participants|37|37.0||||||
4464107|NCT00006110|4283080|B3|United States||Region of Enrollment||participants|Number|82|82.0||||||
4464108|NCT00006110|4283081|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4464109|NCT00006110|4283082|B1|United States||Region of Enrollment||participants|Number|52|52.0||||||
4464110|NCT00006110|4283080|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464111|NCT00006110|4283081|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464112|NCT00006110|4283082|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464113|NCT00006110|4283080|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4464114|NCT00006110|4283081|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4464115|NCT00006110|4283082|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464116|NCT00006110|4283080|B3||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4464117|NCT00006110|4283081|B2||White|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4464118|NCT00006110|4283082|B1||White|Race (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4464119|NCT00006110|4283080|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4464120|NCT00006110|4283081|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4464121|NCT00006110|4283082|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4464122|NCT00006110|4283080|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464123|NCT00006110|4283081|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464124|NCT00006110|4283082|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464125|NCT00006110|4283080|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464126|NCT00006110|4283081|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464127|NCT00006110|4283082|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464128|NCT00006110|4283080|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464129|NCT00006110|4283081|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464130|NCT00006110|4283082|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464138|NCT00006110|4283081|B2|||Age||years|Median|48|48.0|Full Range|||30.0|70.0|
4464139|NCT00006110|4283082|B1|||Age||years|Median|48|48.0|Full Range|||24.0|69.0|
4464140|NCT00006101|4283095|B3|United States||Region of Enrollment||participants|Number|76|76.0||||||
4464141|NCT00006101|4283096|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4464142|NCT00006101|4283097|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4464143|NCT00006101|4283095|B3||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4464144|NCT00006101|4283096|B2||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4464145|NCT00006101|4283097|B1||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4464146|NCT00006101|4283095|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464147|NCT00006101|4283096|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464148|NCT00006101|4283097|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464149|NCT00006101|4283095|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4464150|NCT00006101|4283096|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4464151|NCT00006101|4283097|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4464152|NCT00006101|4283095|B3||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4464153|NCT00006101|4283096|B2||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4464154|NCT00006101|4283097|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4464155|NCT00006101|4283095|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464156|NCT00006101|4283096|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464157|NCT00006101|4283097|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464158|NCT00006011|4283104|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464159|NCT00006011|4283105|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464160|NCT00006011|4283106|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464161|NCT00006011|4283107|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464162|NCT00006011|4283104|B4||Female|Sex: Female, Male||Participants|Count of Participants|616|616.0||||||
4464163|NCT00006011|4283105|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4464164|NCT00006011|4283106|B2||Female|Sex: Female, Male||Participants|Count of Participants|282|282.0||||||
4464165|NCT00006011|4283107|B1||Female|Sex: Female, Male||Participants|Count of Participants|270|270.0||||||
4464166|NCT00006011|4283104|B4|||Age||years|Mean|59.3|59.3|Standard Deviation|10.5|10.5|||
4464167|NCT00006011|4283105|B3|||Age||years|Mean|63.9|63.9|Standard Deviation|10.7|10.7|||
4464168|NCT00006011|4283106|B2|||Age||years|Mean|58.8|58.8|Standard Deviation|9.5|9.5|||
4464169|NCT00006011|4283107|B1|||Age||years|Mean|58.8|58.8|Standard Deviation|11.1|11.1|||
4464170|NCT00005957|4283115|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464171|NCT00005957|4283116|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464172|NCT00005957|4283117|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464173|NCT00005957|4283115|B3||Female|Sex: Female, Male||Participants|Count of Participants|1832|1832.0||||||
4464174|NCT00005957|4283116|B2||Female|Sex: Female, Male||Participants|Count of Participants|916|916.0||||||
4464175|NCT00005957|4283117|B1||Female|Sex: Female, Male||Participants|Count of Participants|916|916.0||||||
4464176|NCT00005957|4283115|B3|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
4464177|NCT00005957|4283116|B2|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
4464178|NCT00005957|4283117|B1|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
4464179|NCT00005879|4283126|B3|3 Relatives||Number relatives with Breast Cancer||Participants|Count of Participants|4|4.0||||||
4464180|NCT00005879|4283127|B2|3 Relatives||Number relatives with Breast Cancer||Participants|Count of Participants|2|2.0||||||
4464181|NCT00005879|4283128|B1|3 Relatives||Number relatives with Breast Cancer||Participants|Count of Participants|2|2.0||||||
4464182|NCT00005879|4283126|B3|2 Relatives||Number relatives with Breast Cancer||Participants|Count of Participants|40|40.0||||||
4464183|NCT00005879|4283127|B2|2 Relatives||Number relatives with Breast Cancer||Participants|Count of Participants|17|17.0||||||
4464184|NCT00005879|4283128|B1|2 Relatives||Number relatives with Breast Cancer||Participants|Count of Participants|23|23.0||||||
4464185|NCT00005879|4283126|B3|1 Relative||Number relatives with Breast Cancer||Participants|Count of Participants|105|105.0||||||
4464186|NCT00005879|4283127|B2|1 Relative||Number relatives with Breast Cancer||Participants|Count of Participants|52|52.0||||||
4464187|NCT00005879|4283128|B1|1 Relative||Number relatives with Breast Cancer||Participants|Count of Participants|53|53.0||||||
4464188|NCT00005879|4283126|B3|0 Relatives||Number relatives with Breast Cancer||Participants|Count of Participants|50|50.0||||||
4464189|NCT00005879|4283127|B2|0 Relatives||Number relatives with Breast Cancer||Participants|Count of Participants|27|27.0||||||
4464190|NCT00005879|4283128|B1|0 Relatives||Number relatives with Breast Cancer||Participants|Count of Participants|23|23.0||||||
4464191|NCT00005879|4283126|B3|||Prior Biopsy||Participants|Count of Participants|34|34.0||||||
4464192|NCT00005879|4283127|B2|||Prior Biopsy||Participants|Count of Participants|17|17.0||||||
4464193|NCT00005879|4283128|B1|||Prior Biopsy||Participants|Count of Participants|17|17.0||||||
4464194|NCT00005879|4283126|B3|||Age at First Live Birth||years|Mean|20.4|20.4|Standard Deviation|11.2|11.2|||
4464195|NCT00005879|4283127|B2|||Age at First Live Birth||years|Mean|20.2|20.2|Standard Deviation|12.1|12.1|||
4464196|NCT00005879|4283128|B1|||Age at First Live Birth||years|Mean|20.6|20.6|Standard Deviation|10.4|10.4|||
4464197|NCT00005879|4283126|B3|||Age at Menarche||years|Mean|12.79|12.79|Standard Deviation|1.43|1.43|||
4464198|NCT00005879|4283127|B2|||Age at Menarche||years|Mean|12.82|12.82|Standard Deviation|1.45|1.45|||
4464199|NCT00005879|4283128|B1|||Age at Menarche||years|Mean|12.78|12.78|Standard Deviation|1.42|1.42|||
4464200|NCT00005879|4283126|B3||OC or HRT Use|Hormone Use||Participants|Count of Participants|64|64.0||||||
4464201|NCT00005879|4283127|B2||OC or HRT Use|Hormone Use||Participants|Count of Participants|29|29.0||||||
4464202|NCT00005879|4283128|B1||OC or HRT Use|Hormone Use||Participants|Count of Participants|35|35.0||||||
4464203|NCT00005879|4283126|B3||None|Hormone Use||Participants|Count of Participants|135|135.0||||||
4464204|NCT00005879|4283127|B2||None|Hormone Use||Participants|Count of Participants|69|69.0||||||
4464205|NCT00005879|4283128|B1||None|Hormone Use||Participants|Count of Participants|66|66.0||||||
4464206|NCT00005879|4283126|B3||Post|Menopause Status||Participants|Count of Participants|96|96.0||||||
4464207|NCT00005879|4283127|B2||Post|Menopause Status||Participants|Count of Participants|47|47.0||||||
4464208|NCT00005879|4283128|B1||Post|Menopause Status||Participants|Count of Participants|49|49.0||||||
4464209|NCT00005879|4283126|B3||Pre|Menopause Status||Participants|Count of Participants|103|103.0||||||
4464210|NCT00005879|4283127|B2||Pre|Menopause Status||Participants|Count of Participants|51|51.0||||||
4464211|NCT00005879|4283128|B1||Pre|Menopause Status||Participants|Count of Participants|52|52.0||||||
4464212|NCT00005879|4283126|B3|||BMI||kg/m^2|Mean|26.1|26.1|Standard Deviation|5.6|5.6|||
4464213|NCT00005879|4283127|B2|||BMI||kg/m^2|Mean|26.0|26.0|Standard Deviation|5.8|5.8|||
4464214|NCT00005879|4283128|B1|||BMI||kg/m^2|Mean|26.3|26.3|Standard Deviation|5.5|5.5|||
4464215|NCT00005879|4283126|B3|||Weight||lb|Mean|156|156.0|Standard Deviation|36|36.0|||
4464216|NCT00005879|4283127|B2|||Weight||lb|Mean|157|157.0|Standard Deviation|40|40.0|||
4464217|NCT00005879|4283128|B1|||Weight||lb|Mean|156|156.0|Standard Deviation|32|32.0|||
4464218|NCT00005879|4283126|B3|||Height||inches|Mean|65.0|65.0|Standard Deviation|2.5|2.5|||
4464219|NCT00005879|4283127|B2|||Height||inches|Mean|65.1|65.1|Standard Deviation|2.4|2.4|||
4464220|NCT00005879|4283128|B1|||Height||inches|Mean|64.8|64.8|Standard Deviation|2.6|2.6|||
4464221|NCT00005879|4283126|B3|United States||Region of Enrollment||participants|Number|199|199.0||||||
4464222|NCT00005879|4283127|B2|United States||Region of Enrollment||participants|Number|98|98.0||||||
4464223|NCT00005879|4283128|B1|United States||Region of Enrollment||participants|Number|101|101.0||||||
4464224|NCT00005879|4283126|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464225|NCT00005879|4283127|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464226|NCT00005879|4283128|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464227|NCT00005879|4283126|B3||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4464228|NCT00005879|4283127|B2||Female|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4464229|NCT00005879|4283128|B1||Female|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4464230|NCT00005879|4283126|B3|||Age||years|Mean|46.6|46.6|Standard Deviation|6.9|6.9|||
4464231|NCT00005879|4283127|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|6.6|6.6|||
4464232|NCT00005879|4283128|B1|||Age||years|Mean|46.5|46.5|Standard Deviation|7.1|7.1|||
4464233|NCT00005803|4283137|B1|United States||Region of Enrollment||participants|Number|76|76.0||||||
4464234|NCT00005803|4283137|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464235|NCT00005803|4283137|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464236|NCT00005803|4283137|B1||White|Race (NIH/OMB)||Participants|Count of Participants|72|72.0||||||
4464237|NCT00005803|4283137|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464238|NCT00005803|4283137|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464239|NCT00005803|4283137|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4464240|NCT00005803|4283137|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464241|NCT00005803|4283137|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464242|NCT00005803|4283137|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|71|71.0||||||
4464243|NCT00005803|4283137|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4464244|NCT00005803|4283137|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4464245|NCT00005803|4283137|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4464246|NCT00005803|4283137|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4464247|NCT00005803|4283137|B1||Between 18 and 65 years|Age||Participants|Count of Participants|75|75.0||||||
4464248|NCT00005803|4283137|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464249|NCT00005047|4283148|B5|Unknown||Bladder carcinoma in situ||Participants|Count of Participants|73|73.0||||||
4464250|NCT00005047|4283149|B4|Unknown||Bladder carcinoma in situ||Participants|Count of Participants|23|23.0||||||
4464251|NCT00005047|4283150|B3|Unknown||Bladder carcinoma in situ||Participants|Count of Participants|30|30.0||||||
4464252|NCT00005047|4283151|B2|Unknown||Bladder carcinoma in situ||Participants|Count of Participants|12|12.0||||||
4464253|NCT00005047|4283152|B1|Unknown||Bladder carcinoma in situ||Participants|Count of Participants|8|8.0||||||
4464254|NCT00005047|4283148|B5|Yes||Bladder carcinoma in situ||Participants|Count of Participants|302|302.0||||||
4464255|NCT00005047|4283149|B4|Yes||Bladder carcinoma in situ||Participants|Count of Participants|99|99.0||||||
4464256|NCT00005047|4283150|B3|Yes||Bladder carcinoma in situ||Participants|Count of Participants|137|137.0||||||
4464257|NCT00005047|4283151|B2|Yes||Bladder carcinoma in situ||Participants|Count of Participants|32|32.0||||||
4464258|NCT00005047|4283152|B1|Yes||Bladder carcinoma in situ||Participants|Count of Participants|34|34.0||||||
4464259|NCT00005047|4283148|B5|No||Bladder carcinoma in situ||Participants|Count of Participants|124|124.0||||||
4464260|NCT00005047|4283149|B4|No||Bladder carcinoma in situ||Participants|Count of Participants|36|36.0||||||
4464261|NCT00005047|4283150|B3|No||Bladder carcinoma in situ||Participants|Count of Participants|60|60.0||||||
4464262|NCT00005047|4283151|B2|No||Bladder carcinoma in situ||Participants|Count of Participants|12|12.0||||||
4464263|NCT00005047|4283152|B1|No||Bladder carcinoma in situ||Participants|Count of Participants|16|16.0||||||
4464264|NCT00005047|4283148|B5|Unknown||Lymphovascular invasion||Participants|Count of Participants|138|138.0||||||
4464265|NCT00005047|4283149|B4|Unknown||Lymphovascular invasion||Participants|Count of Participants|45|45.0||||||
4464266|NCT00005047|4283150|B3|Unknown||Lymphovascular invasion||Participants|Count of Participants|64|64.0||||||
4464267|NCT00005047|4283151|B2|Unknown||Lymphovascular invasion||Participants|Count of Participants|17|17.0||||||
4464268|NCT00005047|4283152|B1|Unknown||Lymphovascular invasion||Participants|Count of Participants|12|12.0||||||
4464269|NCT00005047|4283148|B5|Yes||Lymphovascular invasion||Participants|Count of Participants|102|102.0||||||
4464270|NCT00005047|4283149|B4|Yes||Lymphovascular invasion||Participants|Count of Participants|29|29.0||||||
4464271|NCT00005047|4283150|B3|Yes||Lymphovascular invasion||Participants|Count of Participants|46|46.0||||||
4464272|NCT00005047|4283151|B2|Yes||Lymphovascular invasion||Participants|Count of Participants|14|14.0||||||
4464273|NCT00005047|4283152|B1|Yes||Lymphovascular invasion||Participants|Count of Participants|13|13.0||||||
4464274|NCT00005047|4283148|B5|No||Lymphovascular invasion||Participants|Count of Participants|259|259.0||||||
4464275|NCT00005047|4283149|B4|No||Lymphovascular invasion||Participants|Count of Participants|84|84.0||||||
4464276|NCT00005047|4283150|B3|No||Lymphovascular invasion||Participants|Count of Participants|117|117.0||||||
4464277|NCT00005047|4283151|B2|No||Lymphovascular invasion||Participants|Count of Participants|25|25.0||||||
4464278|NCT00005047|4283152|B1|No||Lymphovascular invasion||Participants|Count of Participants|33|33.0||||||
4464279|NCT00005047|4283148|B5|missing||p21 status||Participants|Count of Participants|4|4.0||||||
4464280|NCT00005047|4283149|B4|missing||p21 status||Participants|Count of Participants|2|2.0||||||
4464281|NCT00005047|4283150|B3|missing||p21 status||Participants|Count of Participants|2|2.0||||||
4464282|NCT00005047|4283151|B2|missing||p21 status||Participants|Count of Participants|0|0.0||||||
4464283|NCT00005047|4283152|B1|missing||p21 status||Participants|Count of Participants|0|0.0||||||
4464284|NCT00005047|4283148|B5|Present||p21 status||Participants|Count of Participants|350|350.0||||||
4464285|NCT00005047|4283149|B4|Present||p21 status||Participants|Count of Participants|92|92.0||||||
4464286|NCT00005047|4283150|B3|Present||p21 status||Participants|Count of Participants|190|190.0||||||
4464287|NCT00005047|4283151|B2|Present||p21 status||Participants|Count of Participants|34|34.0||||||
4464288|NCT00005047|4283152|B1|Present||p21 status||Participants|Count of Participants|34|34.0||||||
4464289|NCT00005047|4283148|B5|Absent||p21 status||Participants|Count of Participants|145|145.0||||||
4464290|NCT00005047|4283149|B4|Absent||p21 status||Participants|Count of Participants|64|64.0||||||
4464291|NCT00005047|4283150|B3|Absent||p21 status||Participants|Count of Participants|35|35.0||||||
4464292|NCT00005047|4283151|B2|Absent||p21 status||Participants|Count of Participants|22|22.0||||||
4464293|NCT00005047|4283152|B1|Absent||p21 status||Participants|Count of Participants|24|24.0||||||
4464294|NCT00005047|4283148|B5|>= 15 nodes||No. of nodes identified||Participants|Count of Participants|331|331.0||||||
4464295|NCT00005047|4283149|B4|>= 15 nodes||No. of nodes identified||Participants|Count of Participants|94|94.0||||||
4464296|NCT00005047|4283150|B3|>= 15 nodes||No. of nodes identified||Participants|Count of Participants|159|159.0||||||
4464297|NCT00005047|4283151|B2|>= 15 nodes||No. of nodes identified||Participants|Count of Participants|42|42.0||||||
4464298|NCT00005047|4283152|B1|>= 15 nodes||No. of nodes identified||Participants|Count of Participants|36|36.0||||||
4464299|NCT00005047|4283148|B5|<15 nodes||No. of nodes identified||Participants|Count of Participants|168|168.0||||||
4464300|NCT00005047|4283149|B4|<15 nodes||No. of nodes identified||Participants|Count of Participants|64|64.0||||||
4464301|NCT00005047|4283150|B3|<15 nodes||No. of nodes identified||Participants|Count of Participants|68|68.0||||||
4464302|NCT00005047|4283151|B2|<15 nodes||No. of nodes identified||Participants|Count of Participants|14|14.0||||||
4464303|NCT00005047|4283152|B1|<15 nodes||No. of nodes identified||Participants|Count of Participants|22|22.0||||||
4464304|NCT00005047|4283148|B5|missing||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|2|2.0||||||
4464305|NCT00005047|4283149|B4|missing||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|1|1.0||||||
4464306|NCT00005047|4283150|B3|missing||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|1|1.0||||||
4464354|NCT00005047|4283148|B5||Male|Sex: Female, Male||Participants|Count of Participants|400|400.0||||||
4464355|NCT00005047|4283149|B4||Male|Sex: Female, Male||Participants|Count of Participants|124|124.0||||||
4464307|NCT00005047|4283151|B2|missing||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|0|0.0||||||
4464308|NCT00005047|4283152|B1|missing||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|0|0.0||||||
4464309|NCT00005047|4283148|B5|3 or 4||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|473|473.0||||||
4464310|NCT00005047|4283149|B4|3 or 4||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|152|152.0||||||
4464311|NCT00005047|4283150|B3|3 or 4||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|210|210.0||||||
4464312|NCT00005047|4283151|B2|3 or 4||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|55|55.0||||||
4464313|NCT00005047|4283152|B1|3 or 4||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|56|56.0||||||
4464314|NCT00005047|4283148|B5|1 or 2||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|24|24.0||||||
4464315|NCT00005047|4283149|B4|1 or 2||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|5|5.0||||||
4464316|NCT00005047|4283150|B3|1 or 2||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|16|16.0||||||
4464317|NCT00005047|4283151|B2|1 or 2||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|1|1.0||||||
4464318|NCT00005047|4283152|B1|1 or 2||Grade|Grade 1: Increased umber of urothelial cell layers, no mitotoc cells identified, slight cytologic atypia Grade 2: Rare mitotic cells identified, mild cytologic atypia with uniform appearing cells Grade 3: Moderate cellular atypia, mitotic cells easily identifiable, variation in cellular appearance Grade 4: Severe cellular atypia, frequent mitotic cells, cellular pleomorphisms, difficult to identify cell of origin|Participants|Count of Participants|2|2.0||||||
4464319|NCT00005047|4283148|B5|pT2 and pT2a||Stage|"The TNM classification for pathologic (p) staging of bladder cancer Primary tumor (T):~TX Primary tumor cannot be assessed T0 No evidence of primary tumor Ta Noninvasive papillary carcinoma Tis Carcinoma in situ: “flat tumor” T1 Tumor invades subepithelial connective tissue T2 Tumor invades muscularis propria T2a The tumor has spread to the inner half of the muscle of the bladder wall, which may be called the superficial muscle."|Participants|Count of Participants|314|314.0||||||
4464320|NCT00005047|4283149|B4|pT2 and pT2a||Stage|"The TNM classification for pathologic (p) staging of bladder cancer Primary tumor (T):~TX Primary tumor cannot be assessed T0 No evidence of primary tumor Ta Noninvasive papillary carcinoma Tis Carcinoma in situ: “flat tumor” T1 Tumor invades subepithelial connective tissue T2 Tumor invades muscularis propria T2a The tumor has spread to the inner half of the muscle of the bladder wall, which may be called the superficial muscle."|Participants|Count of Participants|97|97.0||||||
4464356|NCT00005047|4283150|B3||Male|Sex: Female, Male||Participants|Count of Participants|178|178.0||||||
4464357|NCT00005047|4283151|B2||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4464358|NCT00005047|4283152|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4464321|NCT00005047|4283150|B3|pT2 and pT2a||Stage|"The TNM classification for pathologic (p) staging of bladder cancer Primary tumor (T):~TX Primary tumor cannot be assessed T0 No evidence of primary tumor Ta Noninvasive papillary carcinoma Tis Carcinoma in situ: “flat tumor” T1 Tumor invades subepithelial connective tissue T2 Tumor invades muscularis propria T2a The tumor has spread to the inner half of the muscle of the bladder wall, which may be called the superficial muscle."|Participants|Count of Participants|140|140.0||||||
4464322|NCT00005047|4283151|B2|pT2 and pT2a||Stage|"The TNM classification for pathologic (p) staging of bladder cancer Primary tumor (T):~TX Primary tumor cannot be assessed T0 No evidence of primary tumor Ta Noninvasive papillary carcinoma Tis Carcinoma in situ: “flat tumor” T1 Tumor invades subepithelial connective tissue T2 Tumor invades muscularis propria T2a The tumor has spread to the inner half of the muscle of the bladder wall, which may be called the superficial muscle."|Participants|Count of Participants|40|40.0||||||
4464323|NCT00005047|4283152|B1|pT2 and pT2a||Stage|"The TNM classification for pathologic (p) staging of bladder cancer Primary tumor (T):~TX Primary tumor cannot be assessed T0 No evidence of primary tumor Ta Noninvasive papillary carcinoma Tis Carcinoma in situ: “flat tumor” T1 Tumor invades subepithelial connective tissue T2 Tumor invades muscularis propria T2a The tumor has spread to the inner half of the muscle of the bladder wall, which may be called the superficial muscle."|Participants|Count of Participants|37|37.0||||||
4464324|NCT00005047|4283148|B5|pT1||Stage|"The TNM classification for pathologic (p) staging of bladder cancer Primary tumor (T):~TX Primary tumor cannot be assessed T0 No evidence of primary tumor Ta Noninvasive papillary carcinoma Tis Carcinoma in situ: “flat tumor” T1 Tumor invades subepithelial connective tissue T2 Tumor invades muscularis propria T2a The tumor has spread to the inner half of the muscle of the bladder wall, which may be called the superficial muscle."|Participants|Count of Participants|185|185.0||||||
4464325|NCT00005047|4283149|B4|pT1||Stage|"The TNM classification for pathologic (p) staging of bladder cancer Primary tumor (T):~TX Primary tumor cannot be assessed T0 No evidence of primary tumor Ta Noninvasive papillary carcinoma Tis Carcinoma in situ: “flat tumor” T1 Tumor invades subepithelial connective tissue T2 Tumor invades muscularis propria T2a The tumor has spread to the inner half of the muscle of the bladder wall, which may be called the superficial muscle."|Participants|Count of Participants|61|61.0||||||
4464326|NCT00005047|4283150|B3|pT1||Stage|"The TNM classification for pathologic (p) staging of bladder cancer Primary tumor (T):~TX Primary tumor cannot be assessed T0 No evidence of primary tumor Ta Noninvasive papillary carcinoma Tis Carcinoma in situ: “flat tumor” T1 Tumor invades subepithelial connective tissue T2 Tumor invades muscularis propria T2a The tumor has spread to the inner half of the muscle of the bladder wall, which may be called the superficial muscle."|Participants|Count of Participants|87|87.0||||||
4464327|NCT00005047|4283151|B2|pT1||Stage|"The TNM classification for pathologic (p) staging of bladder cancer Primary tumor (T):~TX Primary tumor cannot be assessed T0 No evidence of primary tumor Ta Noninvasive papillary carcinoma Tis Carcinoma in situ: “flat tumor” T1 Tumor invades subepithelial connective tissue T2 Tumor invades muscularis propria T2a The tumor has spread to the inner half of the muscle of the bladder wall, which may be called the superficial muscle."|Participants|Count of Participants|16|16.0||||||
4464328|NCT00005047|4283152|B1|pT1||Stage|"The TNM classification for pathologic (p) staging of bladder cancer Primary tumor (T):~TX Primary tumor cannot be assessed T0 No evidence of primary tumor Ta Noninvasive papillary carcinoma Tis Carcinoma in situ: “flat tumor” T1 Tumor invades subepithelial connective tissue T2 Tumor invades muscularis propria T2a The tumor has spread to the inner half of the muscle of the bladder wall, which may be called the superficial muscle."|Participants|Count of Participants|21|21.0||||||
4464329|NCT00005047|4283148|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4464330|NCT00005047|4283149|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4464331|NCT00005047|4283150|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4464332|NCT00005047|4283151|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4464333|NCT00005047|4283152|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4464334|NCT00005047|4283148|B5|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4464335|NCT00005047|4283149|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4464336|NCT00005047|4283150|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4464337|NCT00005047|4283151|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4464338|NCT00005047|4283152|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4464339|NCT00005047|4283148|B5|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4464340|NCT00005047|4283149|B4|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4464341|NCT00005047|4283150|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4464342|NCT00005047|4283151|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4464343|NCT00005047|4283152|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4464344|NCT00005047|4283148|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|22|22.0||||||
4464345|NCT00005047|4283149|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4464346|NCT00005047|4283150|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|13|13.0||||||
4464347|NCT00005047|4283151|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4464348|NCT00005047|4283152|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4464349|NCT00005047|4283148|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|454|454.0||||||
4464350|NCT00005047|4283149|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|150|150.0||||||
4464351|NCT00005047|4283150|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|203|203.0||||||
4464352|NCT00005047|4283151|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|49|49.0||||||
4464353|NCT00005047|4283152|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|52|52.0||||||
4464359|NCT00005047|4283148|B5||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4464360|NCT00005047|4283149|B4||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4464361|NCT00005047|4283150|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4464362|NCT00005047|4283151|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4464363|NCT00005047|4283152|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4464364|NCT00005047|4283148|B5||>=65 years|Age||Participants|Count of Participants|213|213.0||||||
4464365|NCT00005047|4283149|B4||>=65 years|Age||Participants|Count of Participants|77|77.0||||||
4464366|NCT00005047|4283150|B3||>=65 years|Age||Participants|Count of Participants|100|100.0||||||
4464367|NCT00005047|4283151|B2||>=65 years|Age||Participants|Count of Participants|15|15.0||||||
4464368|NCT00005047|4283152|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4464369|NCT00005047|4283148|B5||Between 18 and 65 years|Age||Participants|Count of Participants|286|286.0||||||
4464370|NCT00005047|4283149|B4||Between 18 and 65 years|Age||Participants|Count of Participants|81|81.0||||||
4464371|NCT00005047|4283150|B3||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4464372|NCT00005047|4283151|B2||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4464373|NCT00005047|4283152|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4464374|NCT00005047|4283148|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464375|NCT00005047|4283149|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464376|NCT00005047|4283150|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464377|NCT00005047|4283151|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464378|NCT00005047|4283152|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464379|NCT00005044|4283169|B3||Male|Sex: Female, Male||Participants|Count of Participants|1489|1489.0||||||
4464380|NCT00005044|4283170|B2||Male|Sex: Female, Male||Participants|Count of Participants|737|737.0||||||
4464381|NCT00005044|4283171|B1||Male|Sex: Female, Male||Participants|Count of Participants|752|752.0||||||
4464382|NCT00005044|4283169|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464383|NCT00005044|4283170|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464384|NCT00005044|4283171|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464385|NCT00005044|4283169|B3|||Age||years|Median|71|71.0|Full Range|||45.0|88.0|
4464386|NCT00005044|4283170|B2|||Age||years|Median|71|71.0|Full Range|||46.0|88.0|
4464387|NCT00005044|4283171|B1|||Age||years|Median|71|71.0|Full Range|||45.0|84.0|
4464388|NCT00004888|4283190|B3|Female||Sex/Gender, Customized|All participants are female.|participants|Number|84|84.0||||||
4464389|NCT00004888|4283191|B2|Female||Sex/Gender, Customized|All participants are female.|participants|Number|46|46.0||||||
4464390|NCT00004888|4283192|B1|Female||Sex/Gender, Customized|All participants are female.|participants|Number|38|38.0||||||
4464391|NCT00004888|4283190|B3|||Age||years|Median|53|53.0|Full Range|||23.0|80.0|
4464392|NCT00004888|4283191|B2|||Age||years|Median|53|53.0|Full Range|||23.0|80.0|
4464393|NCT00004888|4283192|B1|||Age||years|Median|53|53.0|Full Range|||33.0|80.0|
4464394|NCT00004859|4283209|B3||Male|Sex: Female, Male||Participants|Count of Participants|334|334.0||||||
4464395|NCT00004859|4283210|B2||Male|Sex: Female, Male||Participants|Count of Participants|163|163.0||||||
4464396|NCT00004859|4283211|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4464397|NCT00004859|4283209|B3||Female|Sex: Female, Male||Participants|Count of Participants|212|212.0||||||
4464398|NCT00004859|4283210|B2||Female|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4464399|NCT00004859|4283211|B1||Female|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4464400|NCT00004859|4283209|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|9.8|9.8|||
4464401|NCT00004859|4283210|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|10.5|10.5|||
4464402|NCT00004859|4283211|B1|||Age||years|Mean|62.9|62.9|Standard Deviation|9.0|9.0|||
4464403|NCT00004259|4283222|B5||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4464404|NCT00004259|4283223|B4||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4464405|NCT00004259|4283224|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4464406|NCT00004259|4283225|B2||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4464407|NCT00004259|4283226|B1||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4464408|NCT00004259|4283222|B5||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4464409|NCT00004259|4283223|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4464410|NCT00004259|4283224|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4464411|NCT00004259|4283225|B2||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4464412|NCT00004259|4283226|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4464413|NCT00004259|4283222|B5|||Age||years|Median|43|43.0|Full Range|||18.0|80.0|
4464414|NCT00004259|4283223|B4|||Age||years|Median|41|41.0|Full Range|||25.0|74.0|
4464415|NCT00004259|4283224|B3|||Age||years|Median|48|48.0|Full Range|||26.0|80.0|
4464416|NCT00004259|4283225|B2|||Age||years|Median|43|43.0|Full Range|||19.0|80.0|
4464417|NCT00004259|4283226|B1|||Age||years|Median|42|42.0|Full Range|||18.0|73.0|
4464418|NCT00004228|4283243|B8|Switzerland||Region of Enrollment||participants|Number|4|4.0||||||
4464419|NCT00004228|4283244|B7|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4464420|NCT00004228|4283245|B6|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4464421|NCT00004228|4283246|B5|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4464422|NCT00004228|4283247|B4|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4464423|NCT00004228|4283248|B3|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4464424|NCT00004228|4283249|B2|Switzerland||Region of Enrollment||participants|Number|1|1.0||||||
4464425|NCT00004228|4283250|B1|Switzerland||Region of Enrollment||participants|Number|0|0.0||||||
4464426|NCT00004228|4283243|B8|Australia||Region of Enrollment||participants|Number|16|16.0||||||
4464427|NCT00004228|4283244|B7|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4464428|NCT00004228|4283245|B6|Australia||Region of Enrollment||participants|Number|3|3.0||||||
4464429|NCT00004228|4283246|B5|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4464430|NCT00004228|4283247|B4|Australia||Region of Enrollment||participants|Number|0|0.0||||||
4464431|NCT00004228|4283248|B3|Australia||Region of Enrollment||participants|Number|1|1.0||||||
4464432|NCT00004228|4283249|B2|Australia||Region of Enrollment||participants|Number|4|4.0||||||
4464433|NCT00004228|4283250|B1|Australia||Region of Enrollment||participants|Number|7|7.0||||||
4464434|NCT00004228|4283243|B8|Canada||Region of Enrollment||participants|Number|27|27.0||||||
4464435|NCT00004228|4283244|B7|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4464436|NCT00004228|4283245|B6|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4464437|NCT00004228|4283246|B5|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4464438|NCT00004228|4283247|B4|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4464439|NCT00004228|4283248|B3|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4464440|NCT00004228|4283249|B2|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4464441|NCT00004228|4283250|B1|Canada||Region of Enrollment||participants|Number|5|5.0||||||
4464442|NCT00004228|4283243|B8|United States||Region of Enrollment||participants|Number|346|346.0||||||
4464443|NCT00004228|4283244|B7|United States||Region of Enrollment||participants|Number|51|51.0||||||
4464444|NCT00004228|4283245|B6|United States||Region of Enrollment||participants|Number|58|58.0||||||
4464445|NCT00004228|4283246|B5|United States||Region of Enrollment||participants|Number|62|62.0||||||
4464446|NCT00004228|4283247|B4|United States||Region of Enrollment||participants|Number|12|12.0||||||
4464447|NCT00004228|4283248|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4464448|NCT00004228|4283249|B2|United States||Region of Enrollment||participants|Number|58|58.0||||||
4464449|NCT00004228|4283250|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4464450|NCT00004228|4283243|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4464451|NCT00004228|4283244|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4464452|NCT00004228|4283245|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4464453|NCT00004228|4283246|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4464454|NCT00004228|4283247|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464455|NCT00004228|4283248|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4464456|NCT00004228|4283249|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4464457|NCT00004228|4283250|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4464458|NCT00004228|4283243|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4464459|NCT00004228|4283244|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|02|2.0||||||
4464460|NCT00004228|4283245|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464461|NCT00004228|4283246|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464462|NCT00004228|4283247|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464463|NCT00004228|4283248|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464464|NCT00004228|4283249|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464465|NCT00004228|4283250|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464466|NCT00004228|4283243|B8||White|Race (NIH/OMB)||Participants|Count of Participants|315|315.0||||||
4464467|NCT00004228|4283244|B7||White|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4464468|NCT00004228|4283245|B6||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4464469|NCT00004228|4283246|B5||White|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4464470|NCT00004228|4283247|B4||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4464471|NCT00004228|4283248|B3||White|Race (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4464472|NCT00004228|4283249|B2||White|Race (NIH/OMB)||Participants|Count of Participants|56|56.0||||||
4464473|NCT00004228|4283250|B1||White|Race (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4464474|NCT00004228|4283243|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|41|41.0||||||
4464475|NCT00004228|4283244|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4464476|NCT00004228|4283245|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4464477|NCT00004228|4283246|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4464478|NCT00004228|4283247|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4464479|NCT00004228|4283248|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4464480|NCT00004228|4283249|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4464481|NCT00004228|4283250|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4464482|NCT00004228|4283243|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4464483|NCT00004228|4283244|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464484|NCT00004228|4283245|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464485|NCT00004228|4283246|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464486|NCT00004228|4283247|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464487|NCT00004228|4283248|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464488|NCT00004228|4283249|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4464489|NCT00004228|4283250|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464490|NCT00004228|4283243|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4464491|NCT00004228|4283244|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464492|NCT00004228|4283245|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464493|NCT00004228|4283246|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4464494|NCT00004228|4283247|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464495|NCT00004228|4283248|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4464496|NCT00004228|4283249|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464497|NCT00004228|4283250|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464498|NCT00004228|4283243|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464499|NCT00004228|4283244|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464500|NCT00004228|4283245|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464501|NCT00004228|4283246|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464502|NCT00004228|4283247|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464503|NCT00004228|4283248|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464504|NCT00004228|4283249|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464505|NCT00004228|4283250|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464506|NCT00004228|4283243|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4464507|NCT00004228|4283244|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4464508|NCT00004228|4283245|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4464509|NCT00004228|4283246|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464510|NCT00004228|4283247|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464511|NCT00004228|4283248|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4464512|NCT00004228|4283249|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464513|NCT00004228|4283250|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4464514|NCT00004228|4283243|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|325|325.0||||||
4464515|NCT00004228|4283244|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4464516|NCT00004228|4283245|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4464517|NCT00004228|4283246|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4464518|NCT00004228|4283247|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4464519|NCT00004228|4283248|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4464520|NCT00004228|4283249|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|53|53.0||||||
4464521|NCT00004228|4283250|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|47|47.0||||||
4464522|NCT00004228|4283243|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4464523|NCT00004228|4283244|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4464524|NCT00004228|4283245|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4464525|NCT00004228|4283246|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4464526|NCT00004228|4283247|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4464527|NCT00004228|4283248|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4464528|NCT00004228|4283249|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4464529|NCT00004228|4283250|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4464530|NCT00004228|4283243|B8||Male|Gender||Participants|Count of Participants|285|285.0||||||
4464531|NCT00004228|4283244|B7||Male|Gender||Participants|Count of Participants|40|40.0||||||
4464532|NCT00004228|4283245|B6||Male|Gender||Participants|Count of Participants|49|49.0||||||
4464533|NCT00004228|4283246|B5||Male|Gender||Participants|Count of Participants|47|47.0||||||
4464534|NCT00004228|4283247|B4||Male|Gender||Participants|Count of Participants|9|9.0||||||
4464535|NCT00004228|4283248|B3||Male|Gender||Participants|Count of Participants|56|56.0||||||
4464536|NCT00004228|4283249|B2||Male|Gender||Participants|Count of Participants|47|47.0||||||
4464537|NCT00004228|4283250|B1||Male|Gender||Participants|Count of Participants|37|37.0||||||
4464538|NCT00004228|4283243|B8||Female|Gender||Participants|Count of Participants|108|108.0||||||
4464539|NCT00004228|4283244|B7||Female|Gender||Participants|Count of Participants|17|17.0||||||
4464540|NCT00004228|4283245|B6||Female|Gender||Participants|Count of Participants|16|16.0||||||
4464541|NCT00004228|4283246|B5||Female|Gender||Participants|Count of Participants|20|20.0||||||
4464542|NCT00004228|4283247|B4||Female|Gender||Participants|Count of Participants|4|4.0||||||
4464543|NCT00004228|4283248|B3||Female|Gender||Participants|Count of Participants|9|9.0||||||
4464544|NCT00004228|4283249|B2||Female|Gender||Participants|Count of Participants|19|19.0||||||
4464545|NCT00004228|4283250|B1||Female|Gender||Participants|Count of Participants|23|23.0||||||
4464546|NCT00004228|4283243|B8|||Age||years|Mean|10.3|10.3|Standard Deviation|5.1|5.1|||
4464547|NCT00004228|4283244|B7|||Age||years|Mean|11.5|11.5|Standard Deviation|5.1|5.1|||
4464548|NCT00004228|4283245|B6|||Age||years|Mean|10.6|10.6|Standard Deviation|5.1|5.1|||
4464549|NCT00004228|4283246|B5|||Age||years|Mean|10.2|10.2|Standard Deviation|5.1|5.1|||
4464550|NCT00004228|4283247|B4|||Age||years|Mean|11.4|11.4|Standard Deviation|5.3|5.3|||
4464551|NCT00004228|4283248|B3|||Age||years|Mean|10|10.0|Standard Deviation|4.8|4.8|||
4464552|NCT00004228|4283249|B2|||Age||years|Mean|10.5|10.5|Standard Deviation|5.2|5.2|||
4464553|NCT00004228|4283250|B1|||Age||years|Mean|8.7|8.7|Standard Deviation|4.9|4.9|||
4464554|NCT00004228|4283243|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4464555|NCT00004228|4283244|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4464556|NCT00004228|4283245|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4464557|NCT00004228|4283246|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4464558|NCT00004228|4283247|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4464559|NCT00004228|4283248|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4464560|NCT00004228|4283249|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4464561|NCT00004228|4283250|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4464562|NCT00004228|4283243|B8||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4464563|NCT00004228|4283244|B7||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4464564|NCT00004228|4283245|B6||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4464565|NCT00004228|4283246|B5||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4464566|NCT00004228|4283247|B4||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4464567|NCT00004228|4283248|B3||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4464568|NCT00004228|4283249|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4464569|NCT00004228|4283250|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4464570|NCT00004228|4283243|B8||<=18 years|Age||Participants|Count of Participants|373|373.0||||||
4464571|NCT00004228|4283244|B7||<=18 years|Age||Participants|Count of Participants|52|52.0||||||
4464572|NCT00004228|4283245|B6||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
4464573|NCT00004228|4283246|B5||<=18 years|Age||Participants|Count of Participants|65|65.0||||||
4464574|NCT00004228|4283247|B4||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4464575|NCT00004228|4283248|B3||<=18 years|Age||Participants|Count of Participants|63|63.0||||||
4464576|NCT00004228|4283249|B2||<=18 years|Age||Participants|Count of Participants|62|62.0||||||
4464577|NCT00004228|4283250|B1||<=18 years|Age||Participants|Count of Participants|57|57.0||||||
4464578|NCT00004143|4283279|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4464579|NCT00004143|4283279|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4464580|NCT00004143|4283279|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464581|NCT00004143|4283279|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4464582|NCT00004143|4283279|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4464583|NCT00004143|4283279|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464584|NCT00004124|4283288|B3||Gleason Score<8 w/Positive Margins or PSA>10 ng/mL|Risk Groups|"Node Positive-- Prostate Cancer with metastases to lymph nodes~pT3b - The pathological grade of the primary tumor where the tumor presents with extraprostatic extension with seminal vesicle invasion. Defined by the Manual for Staging of Cancer, AJCC, Fifth Edition.~Positive Margins -- cancer cells detected on edge of tissue removed from patient during radical prostatectomy.~PSA -- Prostate Specific Antigen -- a blood test that used to screen for cancer of the prostate and to monitor treatment of the disease."|Participants|Count of Participants|227|227.0||||||
4464585|NCT00004124|4283289|B2||Gleason Score<8 w/Positive Margins or PSA>10 ng/mL|Risk Groups|"Node Positive-- Prostate Cancer with metastases to lymph nodes~pT3b - The pathological grade of the primary tumor where the tumor presents with extraprostatic extension with seminal vesicle invasion. Defined by the Manual for Staging of Cancer, AJCC, Fifth Edition.~Positive Margins -- cancer cells detected on edge of tissue removed from patient during radical prostatectomy.~PSA -- Prostate Specific Antigen -- a blood test that used to screen for cancer of the prostate and to monitor treatment of the disease."|Participants|Count of Participants|101|101.0||||||
4464586|NCT00004124|4283290|B1||Gleason Score<8 w/Positive Margins or PSA>10 ng/mL|Risk Groups|"Node Positive-- Prostate Cancer with metastases to lymph nodes~pT3b - The pathological grade of the primary tumor where the tumor presents with extraprostatic extension with seminal vesicle invasion. Defined by the Manual for Staging of Cancer, AJCC, Fifth Edition.~Positive Margins -- cancer cells detected on edge of tissue removed from patient during radical prostatectomy.~PSA -- Prostate Specific Antigen -- a blood test that used to screen for cancer of the prostate and to monitor treatment of the disease."|Participants|Count of Participants|126|126.0||||||
4464587|NCT00004124|4283288|B3||Gleason Score >= 8 or pT3b|Risk Groups|"Node Positive-- Prostate Cancer with metastases to lymph nodes~pT3b - The pathological grade of the primary tumor where the tumor presents with extraprostatic extension with seminal vesicle invasion. Defined by the Manual for Staging of Cancer, AJCC, Fifth Edition.~Positive Margins -- cancer cells detected on edge of tissue removed from patient during radical prostatectomy.~PSA -- Prostate Specific Antigen -- a blood test that used to screen for cancer of the prostate and to monitor treatment of the disease."|Participants|Count of Participants|572|572.0||||||
4464588|NCT00004124|4283289|B2||Gleason Score >= 8 or pT3b|Risk Groups|"Node Positive-- Prostate Cancer with metastases to lymph nodes~pT3b - The pathological grade of the primary tumor where the tumor presents with extraprostatic extension with seminal vesicle invasion. Defined by the Manual for Staging of Cancer, AJCC, Fifth Edition.~Positive Margins -- cancer cells detected on edge of tissue removed from patient during radical prostatectomy.~PSA -- Prostate Specific Antigen -- a blood test that used to screen for cancer of the prostate and to monitor treatment of the disease."|Participants|Count of Participants|296|296.0||||||
4464589|NCT00004124|4283290|B1||Gleason Score >= 8 or pT3b|Risk Groups|"Node Positive-- Prostate Cancer with metastases to lymph nodes~pT3b - The pathological grade of the primary tumor where the tumor presents with extraprostatic extension with seminal vesicle invasion. Defined by the Manual for Staging of Cancer, AJCC, Fifth Edition.~Positive Margins -- cancer cells detected on edge of tissue removed from patient during radical prostatectomy.~PSA -- Prostate Specific Antigen -- a blood test that used to screen for cancer of the prostate and to monitor treatment of the disease."|Participants|Count of Participants|276|276.0||||||
4464590|NCT00004124|4283288|B3||Node Positive|Risk Groups|"Node Positive-- Prostate Cancer with metastases to lymph nodes~pT3b - The pathological grade of the primary tumor where the tumor presents with extraprostatic extension with seminal vesicle invasion. Defined by the Manual for Staging of Cancer, AJCC, Fifth Edition.~Positive Margins -- cancer cells detected on edge of tissue removed from patient during radical prostatectomy.~PSA -- Prostate Specific Antigen -- a blood test that used to screen for cancer of the prostate and to monitor treatment of the disease."|Participants|Count of Participants|162|162.0||||||
4464591|NCT00004124|4283289|B2||Node Positive|Risk Groups|"Node Positive-- Prostate Cancer with metastases to lymph nodes~pT3b - The pathological grade of the primary tumor where the tumor presents with extraprostatic extension with seminal vesicle invasion. Defined by the Manual for Staging of Cancer, AJCC, Fifth Edition.~Positive Margins -- cancer cells detected on edge of tissue removed from patient during radical prostatectomy.~PSA -- Prostate Specific Antigen -- a blood test that used to screen for cancer of the prostate and to monitor treatment of the disease."|Participants|Count of Participants|83|83.0||||||
4464592|NCT00004124|4283290|B1||Node Positive|Risk Groups|"Node Positive-- Prostate Cancer with metastases to lymph nodes~pT3b - The pathological grade of the primary tumor where the tumor presents with extraprostatic extension with seminal vesicle invasion. Defined by the Manual for Staging of Cancer, AJCC, Fifth Edition.~Positive Margins -- cancer cells detected on edge of tissue removed from patient during radical prostatectomy.~PSA -- Prostate Specific Antigen -- a blood test that used to screen for cancer of the prostate and to monitor treatment of the disease."|Participants|Count of Participants|79|79.0||||||
4464593|NCT00004124|4283288|B3||8 - 10|Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|Participants|Count of Participants|504|504.0||||||
4464594|NCT00004124|4283289|B2||8 - 10|Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|Participants|Count of Participants|248|248.0||||||
4464595|NCT00004124|4283290|B1||8 - 10|Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|Participants|Count of Participants|256|256.0||||||
4464596|NCT00004124|4283288|B3||7|Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|Participants|Count of Participants|435|435.0||||||
4464597|NCT00004124|4283289|B2||7|Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|Participants|Count of Participants|220|220.0||||||
4464616|NCT00004124|4283290|B1||N1|Disease Extent|"Disease Staging Criteria from the Manual for Staging of Cancer, AJCC, Fifth Edition~Regional Lymph Nodes (N) N0 - No regional lymph node metastasis N1 - Metastasis in a single lymph node or nodes.~Primary Tumor, Clinical (T) T3 - Tumor extends through the prostatic capsule. Note: Invasion of disease into the prostatic apex or into (but not beyond) the prostatic capsule is not classified as T3 but as T2."|Participants|Count of Participants|79|79.0||||||
4464598|NCT00004124|4283290|B1||7|Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|Participants|Count of Participants|215|215.0||||||
4464599|NCT00004124|4283288|B3||<= 6|Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|Participants|Count of Participants|22|22.0||||||
4464600|NCT00004124|4283289|B2||<= 6|Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|Participants|Count of Participants|12|12.0||||||
4464601|NCT00004124|4283290|B1||<= 6|Gleason Score|This is a 2 to 10 grading system for prostate carcinoma devised by Dr. Donald Gleason in 1977 as a method for predicting the behavior of prostate cancer. Tumors with a low Gleason score are less likely to show aggressive behavior and therefore are less likely to have spread outside of the gland to lymph nodes. To obtain a Gleason score, the dominant tumor pattern is added to the second most prevalent pattern to obtain a number between 2 and 10. If a tumor has patterns 3 and 2, the score would be 5. If the tumor has only one pattern, then the single pattern is added to itself (e.g. 3+3=6).|Participants|Count of Participants|10|10.0||||||
4464602|NCT00004124|4283288|B3|||Intent to Receive Adjuvant RT||Participants|Count of Participants|257|257.0||||||
4464603|NCT00004124|4283289|B2|||Intent to Receive Adjuvant RT||Participants|Count of Participants|127|127.0||||||
4464604|NCT00004124|4283290|B1|||Intent to Receive Adjuvant RT||Participants|Count of Participants|130|130.0||||||
4464605|NCT00004124|4283288|B3|||Positive Margins from Prostatectomy||Participants|Count of Participants|609|609.0||||||
4464606|NCT00004124|4283289|B2|||Positive Margins from Prostatectomy||Participants|Count of Participants|293|293.0||||||
4464607|NCT00004124|4283290|B1|||Positive Margins from Prostatectomy||Participants|Count of Participants|316|316.0||||||
4464608|NCT00004124|4283288|B3||Organ Confined|Disease Extent|"Disease Staging Criteria from the Manual for Staging of Cancer, AJCC, Fifth Edition~Regional Lymph Nodes (N) N0 - No regional lymph node metastasis N1 - Metastasis in a single lymph node or nodes.~Primary Tumor, Clinical (T) T3 - Tumor extends through the prostatic capsule. Note: Invasion of disease into the prostatic apex or into (but not beyond) the prostatic capsule is not classified as T3 but as T2."|Participants|Count of Participants|200|200.0||||||
4464609|NCT00004124|4283289|B2||Organ Confined|Disease Extent|"Disease Staging Criteria from the Manual for Staging of Cancer, AJCC, Fifth Edition~Regional Lymph Nodes (N) N0 - No regional lymph node metastasis N1 - Metastasis in a single lymph node or nodes.~Primary Tumor, Clinical (T) T3 - Tumor extends through the prostatic capsule. Note: Invasion of disease into the prostatic apex or into (but not beyond) the prostatic capsule is not classified as T3 but as T2."|Participants|Count of Participants|91|91.0||||||
4464610|NCT00004124|4283290|B1||Organ Confined|Disease Extent|"Disease Staging Criteria from the Manual for Staging of Cancer, AJCC, Fifth Edition~Regional Lymph Nodes (N) N0 - No regional lymph node metastasis N1 - Metastasis in a single lymph node or nodes.~Primary Tumor, Clinical (T) T3 - Tumor extends through the prostatic capsule. Note: Invasion of disease into the prostatic apex or into (but not beyond) the prostatic capsule is not classified as T3 but as T2."|Participants|Count of Participants|109|109.0||||||
4464611|NCT00004124|4283288|B3||>= T3 but N0|Disease Extent|"Disease Staging Criteria from the Manual for Staging of Cancer, AJCC, Fifth Edition~Regional Lymph Nodes (N) N0 - No regional lymph node metastasis N1 - Metastasis in a single lymph node or nodes.~Primary Tumor, Clinical (T) T3 - Tumor extends through the prostatic capsule. Note: Invasion of disease into the prostatic apex or into (but not beyond) the prostatic capsule is not classified as T3 but as T2."|Participants|Count of Participants|599|599.0||||||
4464612|NCT00004124|4283289|B2||>= T3 but N0|Disease Extent|"Disease Staging Criteria from the Manual for Staging of Cancer, AJCC, Fifth Edition~Regional Lymph Nodes (N) N0 - No regional lymph node metastasis N1 - Metastasis in a single lymph node or nodes.~Primary Tumor, Clinical (T) T3 - Tumor extends through the prostatic capsule. Note: Invasion of disease into the prostatic apex or into (but not beyond) the prostatic capsule is not classified as T3 but as T2."|Participants|Count of Participants|306|306.0||||||
4464613|NCT00004124|4283290|B1||>= T3 but N0|Disease Extent|"Disease Staging Criteria from the Manual for Staging of Cancer, AJCC, Fifth Edition~Regional Lymph Nodes (N) N0 - No regional lymph node metastasis N1 - Metastasis in a single lymph node or nodes.~Primary Tumor, Clinical (T) T3 - Tumor extends through the prostatic capsule. Note: Invasion of disease into the prostatic apex or into (but not beyond) the prostatic capsule is not classified as T3 but as T2."|Participants|Count of Participants|293|293.0||||||
4464614|NCT00004124|4283288|B3||N1|Disease Extent|"Disease Staging Criteria from the Manual for Staging of Cancer, AJCC, Fifth Edition~Regional Lymph Nodes (N) N0 - No regional lymph node metastasis N1 - Metastasis in a single lymph node or nodes.~Primary Tumor, Clinical (T) T3 - Tumor extends through the prostatic capsule. Note: Invasion of disease into the prostatic apex or into (but not beyond) the prostatic capsule is not classified as T3 but as T2."|Participants|Count of Participants|162|162.0||||||
4464615|NCT00004124|4283289|B2||N1|Disease Extent|"Disease Staging Criteria from the Manual for Staging of Cancer, AJCC, Fifth Edition~Regional Lymph Nodes (N) N0 - No regional lymph node metastasis N1 - Metastasis in a single lymph node or nodes.~Primary Tumor, Clinical (T) T3 - Tumor extends through the prostatic capsule. Note: Invasion of disease into the prostatic apex or into (but not beyond) the prostatic capsule is not classified as T3 but as T2."|Participants|Count of Participants|83|83.0||||||
4464617|NCT00004124|4283288|B3|||Hispanic||Participants|Count of Participants|55|55.0||||||
4464618|NCT00004124|4283289|B2|||Hispanic||Participants|Count of Participants|30|30.0||||||
4464619|NCT00004124|4283290|B1|||Hispanic||Participants|Count of Participants|25|25.0||||||
4464620|NCT00004124|4283288|B3|||PSA at Prostatectomy||ng/mL|Median|7.7|7.7|Inter-Quartile Range|||5.1|12.5|
4464621|NCT00004124|4283289|B2|||PSA at Prostatectomy||ng/mL|Median|7.4|7.4|Inter-Quartile Range|||5.1|12.7|
4464622|NCT00004124|4283290|B1|||PSA at Prostatectomy||ng/mL|Median|7.9|7.9|Inter-Quartile Range|||5.1|12.3|
4464623|NCT00004124|4283288|B3|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|18|18.0||||||
4464624|NCT00004124|4283289|B2|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4464625|NCT00004124|4283290|B1|Race/Ethnicity|Other|Race/Ethnicity, Customized||Participants|Count of Participants|10|10.0||||||
4464626|NCT00004124|4283288|B3|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|17|17.0||||||
4464627|NCT00004124|4283289|B2|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4464628|NCT00004124|4283290|B1|Race/Ethnicity|Asian|Race/Ethnicity, Customized||Participants|Count of Participants|6|6.0||||||
4464629|NCT00004124|4283288|B3|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|116|116.0||||||
4464630|NCT00004124|4283289|B2|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4464631|NCT00004124|4283290|B1|Race/Ethnicity|Black|Race/Ethnicity, Customized||Participants|Count of Participants|66|66.0||||||
4464632|NCT00004124|4283288|B3|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|810|810.0||||||
4464633|NCT00004124|4283289|B2|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|411|411.0||||||
4464634|NCT00004124|4283290|B1|Race/Ethnicity|White|Race/Ethnicity, Customized||Participants|Count of Participants|399|399.0||||||
4464635|NCT00004124|4283288|B3||Male|Sex: Female, Male||Participants|Count of Participants|961|961.0||||||
4464636|NCT00004124|4283289|B2||Male|Sex: Female, Male||Participants|Count of Participants|480|480.0||||||
4464637|NCT00004124|4283290|B1||Male|Sex: Female, Male||Participants|Count of Participants|481|481.0||||||
4464638|NCT00004124|4283288|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464639|NCT00004124|4283289|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464640|NCT00004124|4283290|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464641|NCT00004124|4283288|B3|||Age||years|Median|60|60.0|Full Range|||40.0|86.0|
4464642|NCT00004124|4283289|B2|||Age||years|Median|60|60.0|Full Range|||40.0|86.0|
4464643|NCT00004124|4283290|B1|||Age||years|Median|60|60.0|Full Range|||40.0|82.0|
4464644|NCT00004092|4283305|B3|United States||Region of Enrollment||participants|Number|72|72.0||||||
4464645|NCT00004092|4283306|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4464646|NCT00004092|4283307|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4464647|NCT00004092|4283305|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464648|NCT00004092|4283306|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464649|NCT00004092|4283307|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464650|NCT00004092|4283305|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4464651|NCT00004092|4283306|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4464652|NCT00004092|4283307|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4464653|NCT00004092|4283305|B3|||Age||years|Median|50|50.0|Full Range|||28.0|61.0|
4464654|NCT00004092|4283306|B2|||Age||years|Median|51|51.0|Full Range|||28.0|61.0|
4464655|NCT00004092|4283307|B1|||Age||years|Median|42|42.0|Full Range|||29.0|56.0|
4464656|NCT00004054|4283316|B3||Male|Sex: Female, Male||Participants|Count of Participants|397|397.0||||||
4464657|NCT00004054|4283317|B2||Male|Sex: Female, Male||Participants|Count of Participants|200|200.0||||||
4464658|NCT00004054|4283318|B1||Male|Sex: Female, Male||Participants|Count of Participants|197|197.0||||||
4464659|NCT00004054|4283316|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464660|NCT00004054|4283317|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464661|NCT00004054|4283318|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464662|NCT00004054|4283316|B3|||Age||years|Median|66|66.0|Full Range|||42.0|81.0|
4464663|NCT00004054|4283317|B2|||Age||years|Median|67|67.0|Full Range|||42.0|81.0|
4464664|NCT00004054|4283318|B1|||Age||years|Median|65|65.0|Full Range|||42.0|79.0|
4464665|NCT00003910|4283333|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4464666|NCT00003910|4283333|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4464667|NCT00003910|4283333|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4464668|NCT00003910|4283333|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|17.8|17.8|||
4464669|NCT00003910|4283333|B1||>=65 years|Age||Participants|Count of Participants|35|35.0||||||
4464670|NCT00003910|4283333|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4464671|NCT00003910|4283333|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464672|NCT00003901|4283339|B1||IIIB|Overall Pathologic Stage|"Stage grouping was defined by T stage, N stage and M Stage. M stage: M0=Distant metastasis (DM) cannot be assessed, M0=No DM, M1=DM present.~Overall Stage: IA=T1N0M0; IB=T2N0M0, IIA=T1N1M0, IIB=T2N1M0, T3N0M0; IIIA=T1N2M0, T2N2M0, T3N1M0, T3N2M0; IIIB=Any T, N3M0 or T4, Any N and M0; IV=Any T, Any N and M1"|Participants|Count of Participants|29|29.0||||||
4464732|NCT00003875|4283356|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4464733|NCT00003875|4283356|B1|||Age||years|Median|52|52.0|Full Range|||26.0|65.0|
4464673|NCT00003901|4283339|B1||IIIA|Overall Pathologic Stage|"Stage grouping was defined by T stage, N stage and M Stage. M stage: M0=Distant metastasis (DM) cannot be assessed, M0=No DM, M1=DM present.~Overall Stage: IA=T1N0M0; IB=T2N0M0, IIA=T1N1M0, IIB=T2N1M0, T3N0M0; IIIA=T1N2M0, T2N2M0, T3N1M0, T3N2M0; IIIB=Any T, N3M0 or T4, Any N and M0; IV=Any T, Any N and M1"|Participants|Count of Participants|137|137.0||||||
4464674|NCT00003901|4283339|B1||IIB|Overall Pathologic Stage|"Stage grouping was defined by T stage, N stage and M Stage. M stage: M0=Distant metastasis (DM) cannot be assessed, M0=No DM, M1=DM present.~Overall Stage: IA=T1N0M0; IB=T2N0M0, IIA=T1N1M0, IIB=T2N1M0, T3N0M0; IIIA=T1N2M0, T2N2M0, T3N1M0, T3N2M0; IIIB=Any T, N3M0 or T4, Any N and M0; IV=Any T, Any N and M1"|Participants|Count of Participants|158|158.0||||||
4464675|NCT00003901|4283339|B1||IIA|Overall Pathologic Stage|"Stage grouping was defined by T stage, N stage and M Stage. M stage: M0=Distant metastasis (DM) cannot be assessed, M0=No DM, M1=DM present.~Overall Stage: IA=T1N0M0; IB=T2N0M0, IIA=T1N1M0, IIB=T2N1M0, T3N0M0; IIIA=T1N2M0, T2N2M0, T3N1M0, T3N2M0; IIIB=Any T, N3M0 or T4, Any N and M0; IV=Any T, Any N and M1"|Participants|Count of Participants|32|32.0||||||
4464676|NCT00003901|4283339|B1||IB|Overall Pathologic Stage|"Stage grouping was defined by T stage, N stage and M Stage. M stage: M0=Distant metastasis (DM) cannot be assessed, M0=No DM, M1=DM present.~Overall Stage: IA=T1N0M0; IB=T2N0M0, IIA=T1N1M0, IIB=T2N1M0, T3N0M0; IIIA=T1N2M0, T2N2M0, T3N1M0, T3N2M0; IIIB=Any T, N3M0 or T4, Any N and M0; IV=Any T, Any N and M1"|Participants|Count of Participants|367|367.0||||||
4464677|NCT00003901|4283339|B1||IA|Overall Pathologic Stage|"Stage grouping was defined by T stage, N stage and M Stage. M stage: M0=Distant metastasis (DM) cannot be assessed, M0=No DM, M1=DM present.~Overall Stage: IA=T1N0M0; IB=T2N0M0, IIA=T1N1M0, IIB=T2N1M0, T3N0M0; IIIA=T1N2M0, T2N2M0, T3N1M0, T3N2M0; IIIB=Any T, N3M0 or T4, Any N and M0; IV=Any T, Any N and M1"|Participants|Count of Participants|324|324.0||||||
4464678|NCT00003901|4283339|B1||NX|Pathologic N Stage|"Nodal Involvement (N) was defined as:~NX=Regional lymph nodes (LN) cannot be assessed, N0=No regional LN metastasis, N1=Metastasis to ipsilateral peribronchial and/or ipsilateral hilar LN and intrapulmonary nodes involved by direct extension of the primary tumor, N2= Metastasis to ipsilateral mediastinal and/or subcarinal LN, N3=Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular LN."|Participants|Count of Participants|8|8.0||||||
4464679|NCT00003901|4283339|B1||N2|Pathologic N Stage|"Nodal Involvement (N) was defined as:~NX=Regional lymph nodes (LN) cannot be assessed, N0=No regional LN metastasis, N1=Metastasis to ipsilateral peribronchial and/or ipsilateral hilar LN and intrapulmonary nodes involved by direct extension of the primary tumor, N2= Metastasis to ipsilateral mediastinal and/or subcarinal LN, N3=Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular LN."|Participants|Count of Participants|129|129.0||||||
4464680|NCT00003901|4283339|B1||N1|Pathologic N Stage|"Nodal Involvement (N) was defined as:~NX=Regional lymph nodes (LN) cannot be assessed, N0=No regional LN metastasis, N1=Metastasis to ipsilateral peribronchial and/or ipsilateral hilar LN and intrapulmonary nodes involved by direct extension of the primary tumor, N2= Metastasis to ipsilateral mediastinal and/or subcarinal LN, N3=Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular LN."|Participants|Count of Participants|171|171.0||||||
4464681|NCT00003901|4283339|B1||N0|Pathologic N Stage|"Nodal Involvement (N) was defined as:~NX=Regional lymph nodes (LN) cannot be assessed, N0=No regional LN metastasis, N1=Metastasis to ipsilateral peribronchial and/or ipsilateral hilar LN and intrapulmonary nodes involved by direct extension of the primary tumor, N2= Metastasis to ipsilateral mediastinal and/or subcarinal LN, N3=Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular LN."|Participants|Count of Participants|739|739.0||||||
4464682|NCT00003901|4283339|B1||TX=Primary tumor cannot be assessed|Pathologic T Stage|Staging was defined by tumor location and size. T1: w/o bronchoscopic evidence of invasion more proximal than the lobar bronchus. T2: invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. T3: chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina (ca) but w/o involvement of the ca; T4: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, ca, separate tumor nodule in the same lobe or tumor w malignant pleural effusion.|Participants|Count of Participants|2|2.0||||||
4464683|NCT00003901|4283339|B1||T4=Tumor of any size that invades certain area|Pathologic T Stage|Staging was defined by tumor location and size. T1: w/o bronchoscopic evidence of invasion more proximal than the lobar bronchus. T2: invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. T3: chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina (ca) but w/o involvement of the ca; T4: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, ca, separate tumor nodule in the same lobe or tumor w malignant pleural effusion.|Participants|Count of Participants|29|29.0||||||
4464684|NCT00003901|4283339|B1||T3=Tumor of any size directly invades certain area|Pathologic T Stage|Staging was defined by tumor location and size. T1: w/o bronchoscopic evidence of invasion more proximal than the lobar bronchus. T2: invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. T3: chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina (ca) but w/o involvement of the ca; T4: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, ca, separate tumor nodule in the same lobe or tumor w malignant pleural effusion.|Participants|Count of Participants|55|55.0||||||
4464685|NCT00003901|4283339|B1||T2=Tumor > 3 cm, main bronchus, >=2cm distal to ca|Pathologic T Stage|Staging was defined by tumor location and size. T1: w/o bronchoscopic evidence of invasion more proximal than the lobar bronchus. T2: invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. T3: chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina (ca) but w/o involvement of the ca; T4: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, ca, separate tumor nodule in the same lobe or tumor w malignant pleural effusion.|Participants|Count of Participants|575|575.0||||||
4464734|NCT00003875|4283356|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4464735|NCT00003875|4283356|B1||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4464736|NCT00003875|4283356|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464686|NCT00003901|4283339|B1||T1=Tumor<=3cm, surrounded by lung/visceral pleura|Pathologic T Stage|Staging was defined by tumor location and size. T1: w/o bronchoscopic evidence of invasion more proximal than the lobar bronchus. T2: invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. T3: chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina (ca) but w/o involvement of the ca; T4: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, ca, separate tumor nodule in the same lobe or tumor w malignant pleural effusion.|Participants|Count of Participants|384|384.0||||||
4464687|NCT00003901|4283339|B1||Not available|Pathologic T Stage|Staging was defined by tumor location and size. T1: w/o bronchoscopic evidence of invasion more proximal than the lobar bronchus. T2: invades the visceral pleura; associated with atelectasis/obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. T3: chest wall, diaphragm, mediastinal pleura, parietal pericardium; tumor in the main bronchus <2cm distal to the carina (ca) but w/o involvement of the ca; T4: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, ca, separate tumor nodule in the same lobe or tumor w malignant pleural effusion.|Participants|Count of Participants|2|2.0||||||
4464688|NCT00003901|4283339|B1||Non-small-cell lung cancer, other subtype or other|Tumor histology||Participants|Count of Participants|137|137.0||||||
4464689|NCT00003901|4283339|B1||Adenosquamous|Tumor histology||Participants|Count of Participants|14|14.0||||||
4464690|NCT00003901|4283339|B1||Large cell|Tumor histology||Participants|Count of Participants|54|54.0||||||
4464691|NCT00003901|4283339|B1||Squamous cell carcinoma|Tumor histology||Participants|Count of Participants|318|318.0||||||
4464692|NCT00003901|4283339|B1||Adenocarcinoma|Tumor histology||Participants|Count of Participants|524|524.0||||||
4464693|NCT00003901|4283339|B1||R2|Extent of resection||Participants|Count of Participants|20|20.0||||||
4464694|NCT00003901|4283339|B1||R1|Extent of resection||Participants|Count of Participants|31|31.0||||||
4464695|NCT00003901|4283339|B1||R0|Extent of resection||Participants|Count of Participants|996|996.0||||||
4464696|NCT00003901|4283339|B1|Intrapericardial resection||Additional components of resection||Participants|Count of Participants|20|20.0||||||
4464697|NCT00003901|4283339|B1|Vascular sleeve resection/arterioplasty||Additional components of resection||Participants|Count of Participants|13|13.0||||||
4464698|NCT00003901|4283339|B1|Bronchial sleeve resection||Additional components of resection||Participants|Count of Participants|33|33.0||||||
4464699|NCT00003901|4283339|B1|Chest wall resection +/- reconstruction||Additional components of resection||Participants|Count of Participants|33|33.0||||||
4464700|NCT00003901|4283339|B1|Pneumonectomy||Operation performed (pulmonary resection)||Participants|Count of Participants|71|71.0||||||
4464701|NCT00003901|4283339|B1|Bilobectomy||Operation performed (pulmonary resection)||Participants|Count of Participants|51|51.0||||||
4464702|NCT00003901|4283339|B1|Lobectomy||Operation performed (pulmonary resection)||Participants|Count of Participants|832|832.0||||||
4464703|NCT00003901|4283339|B1|Segmentectomy||Operation performed (pulmonary resection)||Participants|Count of Participants|79|79.0||||||
4464704|NCT00003901|4283339|B1|Wedge resection||Operation performed (pulmonary resection)||Participants|Count of Participants|24|24.0||||||
4464705|NCT00003901|4283339|B1|Exploration, no resection||Operation performed (pulmonary resection)||Participants|Count of Participants|16|16.0||||||
4464706|NCT00003901|4283339|B1|United States||Region of Enrollment||participants|Number|870|870.0||||||
4464707|NCT00003901|4283339|B1|Canada||Region of Enrollment||participants|Number|177|177.0||||||
4464708|NCT00003901|4283339|B1||Other|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4464709|NCT00003901|4283339|B1||American Indian/Alaska Native|Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4464710|NCT00003901|4283339|B1||Asian|Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4464711|NCT00003901|4283339|B1||Black/African American|Race/Ethnicity, Customized||Participants|Count of Participants|60|60.0||||||
4464712|NCT00003901|4283339|B1||Hispanic/Latino|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4464713|NCT00003901|4283339|B1||White|Race/Ethnicity, Customized||Participants|Count of Participants|959|959.0||||||
4464714|NCT00003901|4283339|B1||Male|Gender||Participants|Count of Participants|538|538.0||||||
4464715|NCT00003901|4283339|B1||Female|Gender||Participants|Count of Participants|509|509.0||||||
4464716|NCT00003901|4283339|B1|||Age||years|Median|67.2|67.2|Full Range|||33.6|89.5|
4464717|NCT00003896|4283350|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464718|NCT00003896|4283350|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464719|NCT00003896|4283350|B1||White|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4464720|NCT00003896|4283350|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464721|NCT00003896|4283350|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464722|NCT00003896|4283350|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464723|NCT00003896|4283350|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4464724|NCT00003896|4283350|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464725|NCT00003896|4283350|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4464726|NCT00003896|4283350|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4464727|NCT00003896|4283350|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464728|NCT00003896|4283350|B1||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4464729|NCT00003896|4283350|B1|||Age||years|Median|59|59.0|Full Range|||33.0|79.0|
4464730|NCT00003875|4283356|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4464731|NCT00003875|4283356|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4464737|NCT00003869|4283363|B3|IV||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|145|145.0||||||
4464738|NCT00003869|4283364|B2|IV||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|73|73.0||||||
4464739|NCT00003869|4283365|B1|IV||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|72|72.0||||||
4464740|NCT00003869|4283363|B3|IIIA/IIIB||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|41|41.0||||||
4464741|NCT00003869|4283364|B2|IIIA/IIIB||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|19|19.0||||||
4464742|NCT00003869|4283365|B1|IIIA/IIIB||TNM Stage|American Joint Committee on Cancer, Cancer Staging Manual http://www.cancerstaging.org/products/pasteditions.html|participants|Number|22|22.0||||||
4464743|NCT00003869|4283363|B3|Not Reported||Smoking Status||participants|Number|19|19.0||||||
4464744|NCT00003869|4283364|B2|Not Reported||Smoking Status||participants|Number|10|10.0||||||
4464745|NCT00003869|4283365|B1|Not Reported||Smoking Status||participants|Number|9|9.0||||||
4464746|NCT00003869|4283363|B3|Current||Smoking Status||participants|Number|35|35.0||||||
4464747|NCT00003869|4283364|B2|Current||Smoking Status||participants|Number|15|15.0||||||
4464748|NCT00003869|4283365|B1|Current||Smoking Status||participants|Number|20|20.0||||||
4464749|NCT00003869|4283363|B3|Former (quit >= 6 months)||Smoking Status||participants|Number|111|111.0||||||
4464750|NCT00003869|4283364|B2|Former (quit >= 6 months)||Smoking Status||participants|Number|57|57.0||||||
4464751|NCT00003869|4283365|B1|Former (quit >= 6 months)||Smoking Status||participants|Number|54|54.0||||||
4464752|NCT00003869|4283363|B3|Never||Smoking Status||participants|Number|21|21.0||||||
4464753|NCT00003869|4283364|B2|Never||Smoking Status||participants|Number|10|10.0||||||
4464754|NCT00003869|4283365|B1|Never||Smoking Status||participants|Number|11|11.0||||||
4464755|NCT00003869|4283363|B3|Stable||Prior Response to Chemotherapy||participants|Number|77|77.0||||||
4464756|NCT00003869|4283364|B2|Stable||Prior Response to Chemotherapy||participants|Number|35|35.0||||||
4464757|NCT00003869|4283365|B1|Stable||Prior Response to Chemotherapy||participants|Number|42|42.0||||||
4464758|NCT00003869|4283363|B3|Regression||Prior Response to Chemotherapy||participants|Number|17|17.0||||||
4464759|NCT00003869|4283364|B2|Regression||Prior Response to Chemotherapy||participants|Number|8|8.0||||||
4464760|NCT00003869|4283365|B1|Regression||Prior Response to Chemotherapy||participants|Number|9|9.0||||||
4464761|NCT00003869|4283363|B3|Partial||Prior Response to Chemotherapy||participants|Number|83|83.0||||||
4464762|NCT00003869|4283364|B2|Partial||Prior Response to Chemotherapy||participants|Number|45|45.0||||||
4464763|NCT00003869|4283365|B1|Partial||Prior Response to Chemotherapy||participants|Number|38|38.0||||||
4464764|NCT00003869|4283363|B3|Complete||Prior Response to Chemotherapy||participants|Number|9|9.0||||||
4464765|NCT00003869|4283364|B2|Complete||Prior Response to Chemotherapy||participants|Number|4|4.0||||||
4464766|NCT00003869|4283365|B1|Complete||Prior Response to Chemotherapy||participants|Number|5|5.0||||||
4464767|NCT00003869|4283363|B3|2 - Ambulatory, unable to perform work activities||Eastern Cooperative Oncology Group Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|16|16.0||||||
4464768|NCT00003869|4283364|B2|2 - Ambulatory, unable to perform work activities||Eastern Cooperative Oncology Group Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|6|6.0||||||
4464769|NCT00003869|4283365|B1|2 - Ambulatory, unable to perform work activities||Eastern Cooperative Oncology Group Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|10|10.0||||||
4464770|NCT00003869|4283363|B3|1 - Ambulatory, restricted strenuous activity||Eastern Cooperative Oncology Group Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|95|95.0||||||
4464771|NCT00003869|4283364|B2|1 - Ambulatory, restricted strenuous activity||Eastern Cooperative Oncology Group Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|48|48.0||||||
4464772|NCT00003869|4283365|B1|1 - Ambulatory, restricted strenuous activity||Eastern Cooperative Oncology Group Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|47|47.0||||||
4464773|NCT00003869|4283363|B3|0 - Fully Active||Eastern Cooperative Oncology Group Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|75|75.0||||||
4464774|NCT00003869|4283364|B2|0 - Fully Active||Eastern Cooperative Oncology Group Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|38|38.0||||||
4464775|NCT00003869|4283365|B1|0 - Fully Active||Eastern Cooperative Oncology Group Performance Score|Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).|Participants|Number|37|37.0||||||
4464776|NCT00003869|4283363|B3|Squamous||Histology||participants|Number|34|34.0||||||
4464777|NCT00003869|4283364|B2|Squamous||Histology||participants|Number|13|13.0||||||
4464778|NCT00003869|4283365|B1|Squamous||Histology||participants|Number|21|21.0||||||
4464779|NCT00003869|4283363|B3|Adenocarcinoma||Histology||participants|Number|106|106.0||||||
4464780|NCT00003869|4283364|B2|Adenocarcinoma||Histology||participants|Number|55|55.0||||||
4464781|NCT00003869|4283365|B1|Adenocarcinoma||Histology||participants|Number|51|51.0||||||
4464782|NCT00003869|4283363|B3|NOS (not otherwise specified) NSCLC/not avaliable||Histology||participants|Number|27|27.0||||||
4464783|NCT00003869|4283364|B2|NOS (not otherwise specified) NSCLC/not avaliable||Histology||participants|Number|11|11.0||||||
4464784|NCT00003869|4283365|B1|NOS (not otherwise specified) NSCLC/not avaliable||Histology||participants|Number|16|16.0||||||
4464785|NCT00003869|4283363|B3|Bronchoalveolar/large cell||Histology||participants|Number|19|19.0||||||
4464786|NCT00003869|4283364|B2|Bronchoalveolar/large cell||Histology||participants|Number|13|13.0||||||
4464787|NCT00003869|4283365|B1|Bronchoalveolar/large cell||Histology||participants|Number|6|6.0||||||
4464788|NCT00003869|4283363|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4464789|NCT00003869|4283364|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464790|NCT00003869|4283365|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4464791|NCT00003869|4283363|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464792|NCT00003869|4283364|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464793|NCT00003869|4283365|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464794|NCT00003869|4283363|B3||White|Race (NIH/OMB)||Participants|Count of Participants|180|180.0||||||
4464795|NCT00003869|4283364|B2||White|Race (NIH/OMB)||Participants|Count of Participants|89|89.0||||||
4464796|NCT00003869|4283365|B1||White|Race (NIH/OMB)||Participants|Count of Participants|91|91.0||||||
4464797|NCT00003869|4283363|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464798|NCT00003869|4283364|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464799|NCT00003869|4283365|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464800|NCT00003869|4283363|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464801|NCT00003869|4283364|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464802|NCT00003869|4283365|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464803|NCT00003869|4283363|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464804|NCT00003869|4283364|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464805|NCT00003869|4283365|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4464806|NCT00003869|4283363|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4464807|NCT00003869|4283364|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464808|NCT00003869|4283365|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4464809|NCT00003869|4283363|B3||Male|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4464810|NCT00003869|4283364|B2||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4464811|NCT00003869|4283365|B1||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4464812|NCT00003869|4283363|B3||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4464813|NCT00003869|4283364|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4464814|NCT00003869|4283365|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4464815|NCT00003869|4283363|B3|> 65 years||Age, Customized||participants|Number|99|99.0||||||
4464816|NCT00003869|4283364|B2|> 65 years||Age, Customized||participants|Number|42|42.0||||||
4464817|NCT00003869|4283365|B1|> 65 years||Age, Customized||participants|Number|57|57.0||||||
4464818|NCT00003869|4283363|B3|<= 65 years||Age, Customized||participants|Number|87|87.0||||||
4464819|NCT00003869|4283364|B2|<= 65 years||Age, Customized||participants|Number|50|50.0||||||
4464820|NCT00003869|4283365|B1|<= 65 years||Age, Customized||participants|Number|37|37.0||||||
4464821|NCT00003820|4283382|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4464822|NCT00003820|4283382|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4464823|NCT00003820|4283382|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4464824|NCT00003820|4283382|B1|||Age||years|Mean|42.0|42.0|Standard Deviation|13.0|13.0|||
4464825|NCT00003820|4283382|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4464826|NCT00003820|4283382|B1||Between 18 and 65 years|Age||Participants|Count of Participants|37|37.0||||||
4464827|NCT00003820|4283382|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4464828|NCT00003782|4283389|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464829|NCT00003782|4283390|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464830|NCT00003782|4283391|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464831|NCT00003782|4283392|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464832|NCT00003782|4283389|B4||Female|Sex: Female, Male||Participants|Count of Participants|5351|5351.0||||||
4464833|NCT00003782|4283390|B3||Female|Sex: Female, Male||Participants|Count of Participants|1784|1784.0||||||
4464834|NCT00003782|4283391|B2||Female|Sex: Female, Male||Participants|Count of Participants|1784|1784.0||||||
4464835|NCT00003782|4283392|B1||Female|Sex: Female, Male||Participants|Count of Participants|1783|1783.0||||||
4464836|NCT00003782|4283389|B4|||Age||years|Mean|51|51.0|Standard Deviation|9.7|9.7|||
4464837|NCT00003782|4283390|B3|||Age||years|Mean|51|51.0|Standard Deviation|9.9|9.9|||
4464838|NCT00003782|4283391|B2|||Age||years|Mean|50|50.0|Standard Deviation|9.5|9.5|||
4464839|NCT00003782|4283392|B1|||Age||years|Mean|50|50.0|Standard Deviation|9.8|9.8|||
4464840|NCT00003702|4283402|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464841|NCT00003702|4283403|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464842|NCT00003702|4283404|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4464843|NCT00003702|4283402|B3||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4464844|NCT00003702|4283403|B2||Female|Sex: Female, Male||Participants|Count of Participants|109|109.0||||||
4464845|NCT00003702|4283404|B1||Female|Sex: Female, Male||Participants|Count of Participants|107|107.0||||||
4464846|NCT00003702|4283402|B3|||Age||years|Mean|29.6|29.6|Standard Deviation|8.3|8.3|||
4464847|NCT00003702|4283403|B2|||Age||years|Mean|30.4|30.4|Standard Deviation|8.6|8.6|||
4464848|NCT00003702|4283404|B1|||Age||years|Mean|28.8|28.8|Standard Deviation|7.9|7.9|||
4464849|NCT00003659|4283414|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4464850|NCT00003659|4283414|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4464851|NCT00003659|4283414|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4464852|NCT00003659|4283414|B1|||Age||years|Mean|57.7|57.7|Standard Deviation|8.8|8.8|||
4464853|NCT00003659|4283414|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4464854|NCT00003659|4283414|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4464855|NCT00003659|4283414|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464856|NCT00003641|4283420|B3|Male||Gender|1 patient on arm I and 1 patient on arm II had missing information about sex|participants|Number|656|656.0||||||
4464857|NCT00003641|4283421|B2|Male||Gender|1 patient on arm I and 1 patient on arm II had missing information about sex|participants|Number|336|336.0||||||
4464858|NCT00003641|4283422|B1|Male||Gender|1 patient on arm I and 1 patient on arm II had missing information about sex|participants|Number|320|320.0||||||
4464859|NCT00003641|4283420|B3|Female||Gender|1 patient on arm I and 1 patient on arm II had missing information about sex|participants|Number|492|492.0||||||
4464860|NCT00003641|4283421|B2|Female||Gender|1 patient on arm I and 1 patient on arm II had missing information about sex|participants|Number|244|244.0||||||
4464861|NCT00003641|4283422|B1|Female||Gender|1 patient on arm I and 1 patient on arm II had missing information about sex|participants|Number|248|248.0||||||
4464862|NCT00003641|4283420|B3|||Age||years|Median|52|52.0|Full Range|||10.0|85.0|
4464863|NCT00003641|4283421|B2|||Age||years|Median|52|52.0|Full Range|||10.0|85.0|
4464864|NCT00003641|4283422|B1|||Age||years|Median|52|52.0|Full Range|||19.0|81.0|
4464865|NCT00003631|4283431|B4||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4464866|NCT00003631|4283432|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4464867|NCT00003631|4283433|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4464868|NCT00003631|4283434|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4464869|NCT00003631|4283431|B4||Female|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4464870|NCT00003631|4283432|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4464871|NCT00003631|4283433|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4464872|NCT00003631|4283434|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4464873|NCT00003631|4283431|B4||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4464874|NCT00003631|4283432|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4464875|NCT00003631|4283433|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4464876|NCT00003631|4283434|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4464877|NCT00003631|4283431|B4||Between 18 and 65 years|Age||Participants|Count of Participants|115|115.0||||||
4464878|NCT00003631|4283432|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4464879|NCT00003631|4283433|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4464880|NCT00003631|4283434|B1||Between 18 and 65 years|Age||Participants|Count of Participants|49|49.0||||||
4464881|NCT00003631|4283431|B4||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4464882|NCT00003631|4283432|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4464883|NCT00003631|4283433|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4464884|NCT00003631|4283434|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4464885|NCT00003590|4283444|B1|United States||Region of Enrollment||participants|Number|28|28.0||||||
4464886|NCT00003590|4283444|B1||Unknown or Not Reported|Race (NIH/OMB)|Race of participant was collected at baseline and is reported per the NIH/OMB categorization.|Participants|Count of Participants|0|0.0||||||
4464887|NCT00003590|4283444|B1||More than one race|Race (NIH/OMB)|Race of participant was collected at baseline and is reported per the NIH/OMB categorization.|Participants|Count of Participants|0|0.0||||||
4464888|NCT00003590|4283444|B1||White|Race (NIH/OMB)|Race of participant was collected at baseline and is reported per the NIH/OMB categorization.|Participants|Count of Participants|28|28.0||||||
4464889|NCT00003590|4283444|B1||Black or African American|Race (NIH/OMB)|Race of participant was collected at baseline and is reported per the NIH/OMB categorization.|Participants|Count of Participants|0|0.0||||||
4464890|NCT00003590|4283444|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)|Race of participant was collected at baseline and is reported per the NIH/OMB categorization.|Participants|Count of Participants|0|0.0||||||
4464891|NCT00003590|4283444|B1||Asian|Race (NIH/OMB)|Race of participant was collected at baseline and is reported per the NIH/OMB categorization.|Participants|Count of Participants|0|0.0||||||
4464892|NCT00003590|4283444|B1||American Indian or Alaska Native|Race (NIH/OMB)|Race of participant was collected at baseline and is reported per the NIH/OMB categorization.|Participants|Count of Participants|0|0.0||||||
4464893|NCT00003590|4283444|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)|Ethnicity was captured at baseline and is reported per NIH/OMB categorization.|Participants|Count of Participants|0|0.0||||||
4464894|NCT00003590|4283444|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was captured at baseline and is reported per NIH/OMB categorization.|Participants|Count of Participants|27|27.0||||||
4464895|NCT00003590|4283444|B1||Hispanic or Latino|Ethnicity (NIH/OMB)|Ethnicity was captured at baseline and is reported per NIH/OMB categorization.|Participants|Count of Participants|1|1.0||||||
4464896|NCT00003590|4283444|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4464897|NCT00003590|4283444|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4464898|NCT00003590|4283444|B1|||Age||years|Median|62|62.0|Full Range|||24.0|84.0|
4464899|NCT00003537|4283449|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4464900|NCT00003537|4283449|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4464901|NCT00003537|4283449|B1|||Age||Years|Median|44.0|44.0|Full Range|||22.4|60.0|
4464902|NCT00003535|4283454|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4464903|NCT00003535|4283454|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4464904|NCT00003535|4283454|B1|||Age||Years|Median|9.7|9.7|Full Range|||4.8|17.5|
4464905|NCT00003483|4283459|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4464906|NCT00003483|4283459|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4464907|NCT00003483|4283459|B1|||Age||Years|Median|41.8|41.8|Full Range|||30.2|49.8|
4464908|NCT00003479|4283464|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4464909|NCT00003479|4283464|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4464910|NCT00003479|4283464|B1|||Age||Years|Median|7.3|7.3|Full Range|||1.6|35.7|
4464911|NCT00003477|4283469|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4464912|NCT00003477|4283469|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4464913|NCT00003477|4283469|B1|||Age||Years|Median|4.5|4.5|Full Range|||0.6|16.6|
4464914|NCT00003476|4283474|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4464915|NCT00003476|4283474|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4464916|NCT00003476|4283474|B1|||Age||Years|Median|9.1|9.1|Full Range|||2.6|16.4|
4464917|NCT00003475|4283479|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4464918|NCT00003475|4283479|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4464919|NCT00003475|4283479|B1|||Age||Years|Median|48.2|48.2|Full Range|||19.7|68.2|
4464920|NCT00003474|4283484|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4464921|NCT00003474|4283484|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4464922|NCT00003474|4283484|B1|||Age||Years|Median|48.8|48.8|Full Range|||26.7|71.4|
4464923|NCT00003473|4283489|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4464924|NCT00003473|4283489|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4464925|NCT00003473|4283489|B1|||Age||Years|Median|37.3|37.3|Full Range|||26.7|54.3|
4464926|NCT00003472|4283494|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4464927|NCT00003472|4283494|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4464928|NCT00003472|4283494|B1|||Age||Years|Median|41.5|41.5|Full Range|||29.3|53.5|
4464929|NCT00003471|4283499|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4464930|NCT00003471|4283499|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4464931|NCT00003471|4283499|B1|||Age||Years|Median|43.1|43.1|Full Range|||35.2|51.1|
4464932|NCT00003470|4283504|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4464933|NCT00003470|4283504|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4464934|NCT00003470|4283504|B1|||Age||Years|Median|41.5|41.5|Full Range|||19.9|57.8|
4464935|NCT00003469|4283509|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4464936|NCT00003469|4283509|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4464937|NCT00003469|4283509|B1|||Age||Years|Median|3.7|3.7|Full Range|||2.0|6.8|
4464938|NCT00003468|4283514|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4464939|NCT00003468|4283514|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4464940|NCT00003468|4283514|B1|||Age||Years|Median|9.3|9.3|Full Range|||3.7|17.4|
4464941|NCT00003460|4283519|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4464942|NCT00003460|4283519|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4464943|NCT00003460|4283519|B1|||Age||Years|Median|6.1|6.1|Full Range|||1.0|12.2|
4464944|NCT00003459|4283524|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4464945|NCT00003459|4283524|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4464946|NCT00003459|4283524|B1|||Age||Years|Median|11.2|11.2|Full Range|||3.5|43.8|
4464947|NCT00003458|4283529|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4464948|NCT00003458|4283529|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4464949|NCT00003458|4283529|B1|||Age||Years|Median|10.4|10.4|Full Range|||0.8|17.8|
4464950|NCT00003457|4283534|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4464951|NCT00003457|4283534|B1||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4464952|NCT00003457|4283534|B1|||Age||Years|Median|36.0|36.0|Full Range|||18.1|64.2|
4464953|NCT00003456|4283539|B1||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4464954|NCT00003456|4283539|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4464955|NCT00003456|4283539|B1|||Age||Years|Median|52.4|52.4|Full Range|||26.3|76.2|
4464956|NCT00003453|4283544|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4464957|NCT00003453|4283544|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4464958|NCT00003453|4283544|B1|||Age||years|Median|45.0|45.0|Full Range|||0.67|64.75|
4464959|NCT00003389|4283549|B3|United States||Region of Enrollment||participants|Number|698|698.0||||||
4464960|NCT00003389|4283550|B2|United States||Region of Enrollment||participants|Number|349|349.0||||||
4464961|NCT00003389|4283551|B1|United States||Region of Enrollment||participants|Number|349|349.0||||||
4464962|NCT00003389|4283549|B3|Canada||Region of Enrollment||participants|Number|96|96.0||||||
4464963|NCT00003389|4283550|B2|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4464964|NCT00003389|4283551|B1|Canada||Region of Enrollment||participants|Number|46|46.0||||||
4464965|NCT00003389|4283549|B3||Male|Sex: Female, Male||Participants|Count of Participants|425|425.0||||||
4464966|NCT00003389|4283550|B2||Male|Sex: Female, Male||Participants|Count of Participants|217|217.0||||||
4464967|NCT00003389|4283551|B1||Male|Sex: Female, Male||Participants|Count of Participants|208|208.0||||||
4464968|NCT00003389|4283549|B3||Female|Sex: Female, Male||Participants|Count of Participants|369|369.0||||||
4464969|NCT00003389|4283550|B2||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4464970|NCT00003389|4283551|B1||Female|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4464971|NCT00003389|4283549|B3|||Age||years|Median|33|33.0|Full Range|||16.0|83.0|
4464972|NCT00003389|4283550|B2|||Age||years|Median|33|33.0|Full Range|||16.0|83.0|
4464973|NCT00003389|4283551|B1|||Age||years|Median|33|33.0|Full Range|||18.0|83.0|
4464974|NCT00003377|4283562|B6|Squamous cell||Cell Type||participants|Number|26|26.0||||||
4464975|NCT00003377|4283563|B5|Squamous cell||Cell Type||participants|Number|3|3.0||||||
4464976|NCT00003377|4283564|B4|Squamous cell||Cell Type||participants|Number|2|2.0||||||
4464977|NCT00003377|4283565|B3|Squamous cell||Cell Type||participants|Number|16|16.0||||||
4464978|NCT00003377|4283566|B2|Squamous cell||Cell Type||participants|Number|2|2.0||||||
4464979|NCT00003377|4283567|B1|Squamous cell||Cell Type||participants|Number|3|3.0||||||
4464980|NCT00003377|4283562|B6|Clear cell||Cell Type||participants|Number|1|1.0||||||
4464981|NCT00003377|4283563|B5|Clear cell||Cell Type||participants|Number|0|0.0||||||
4464982|NCT00003377|4283564|B4|Clear cell||Cell Type||participants|Number|1|1.0||||||
4464983|NCT00003377|4283565|B3|Clear cell||Cell Type||participants|Number|0|0.0||||||
4464984|NCT00003377|4283566|B2|Clear cell||Cell Type||participants|Number|0|0.0||||||
4464985|NCT00003377|4283567|B1|Clear cell||Cell Type||participants|Number|0|0.0||||||
4464986|NCT00003377|4283562|B6|Adenocarcinoma NOS(not otherwise specified)||Cell Type||participants|Number|2|2.0||||||
4464987|NCT00003377|4283563|B5|Adenocarcinoma NOS(not otherwise specified)||Cell Type||participants|Number|0|0.0||||||
4464988|NCT00003377|4283564|B4|Adenocarcinoma NOS(not otherwise specified)||Cell Type||participants|Number|0|0.0||||||
4464989|NCT00003377|4283565|B3|Adenocarcinoma NOS(not otherwise specified)||Cell Type||participants|Number|1|1.0||||||
4464990|NCT00003377|4283566|B2|Adenocarcinoma NOS(not otherwise specified)||Cell Type||participants|Number|1|1.0||||||
4464991|NCT00003377|4283567|B1|Adenocarcinoma NOS(not otherwise specified)||Cell Type||participants|Number|0|0.0||||||
4464992|NCT00003377|4283562|B6|4B - disease spread to distant organs||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4464993|NCT00003377|4283563|B5|4B - disease spread to distant organs||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4464994|NCT00003377|4283564|B4|4B - disease spread to distant organs||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4464995|NCT00003377|4283565|B3|4B - disease spread to distant organs||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4464996|NCT00003377|4283566|B2|4B - disease spread to distant organs||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4464997|NCT00003377|4283567|B1|4B - disease spread to distant organs||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4464998|NCT00003377|4283562|B6|4A - disease spread to adjacent organs||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|4|4.0||||||
4464999|NCT00003377|4283563|B5|4A - disease spread to adjacent organs||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465000|NCT00003377|4283564|B4|4A - disease spread to adjacent organs||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465100|NCT00003199|4283585|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4465001|NCT00003377|4283565|B3|4A - disease spread to adjacent organs||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|4|4.0||||||
4465002|NCT00003377|4283566|B2|4A - disease spread to adjacent organs||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465003|NCT00003377|4283567|B1|4A - disease spread to adjacent organs||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465004|NCT00003377|4283562|B6|3B - disease extended to pelvic wall||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|12|12.0||||||
4465005|NCT00003377|4283563|B5|3B - disease extended to pelvic wall||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|2|2.0||||||
4465006|NCT00003377|4283564|B4|3B - disease extended to pelvic wall||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|1|1.0||||||
4465007|NCT00003377|4283565|B3|3B - disease extended to pelvic wall||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|7|7.0||||||
4465008|NCT00003377|4283566|B2|3B - disease extended to pelvic wall||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|2|2.0||||||
4465009|NCT00003377|4283567|B1|3B - disease extended to pelvic wall||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465010|NCT00003377|4283562|B6|3A -disease in lower 3rd of vagina not pelvic wall||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465011|NCT00003377|4283563|B5|3A -disease in lower 3rd of vagina not pelvic wall||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465012|NCT00003377|4283564|B4|3A -disease in lower 3rd of vagina not pelvic wall||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465013|NCT00003377|4283565|B3|3A -disease in lower 3rd of vagina not pelvic wall||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465014|NCT00003377|4283566|B2|3A -disease in lower 3rd of vagina not pelvic wall||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465015|NCT00003377|4283567|B1|3A -disease in lower 3rd of vagina not pelvic wall||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465016|NCT00003377|4283562|B6|2B - obvious parametrial involvement||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|7|7.0||||||
4465017|NCT00003377|4283563|B5|2B - obvious parametrial involvement||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|1|1.0||||||
4465018|NCT00003377|4283564|B4|2B - obvious parametrial involvement||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465019|NCT00003377|4283565|B3|2B - obvious parametrial involvement||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|4|4.0||||||
4465101|NCT00003199|4283585|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465020|NCT00003377|4283566|B2|2B - obvious parametrial involvement||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465021|NCT00003377|4283567|B1|2B - obvious parametrial involvement||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|2|2.0||||||
4465022|NCT00003377|4283562|B6|2A - no obvious parametrial involvement||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465023|NCT00003377|4283563|B5|2A - no obvious parametrial involvement||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465024|NCT00003377|4283564|B4|2A - no obvious parametrial involvement||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465025|NCT00003377|4283565|B3|2A - no obvious parametrial involvement||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465026|NCT00003377|4283566|B2|2A - no obvious parametrial involvement||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465027|NCT00003377|4283567|B1|2A - no obvious parametrial involvement||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465028|NCT00003377|4283562|B6|1B - disease confined to cervix||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|6|6.0||||||
4465029|NCT00003377|4283563|B5|1B - disease confined to cervix||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465030|NCT00003377|4283564|B4|1B - disease confined to cervix||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|2|2.0||||||
4465031|NCT00003377|4283565|B3|1B - disease confined to cervix||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|2|2.0||||||
4465032|NCT00003377|4283566|B2|1B - disease confined to cervix||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|1|1.0||||||
4465033|NCT00003377|4283567|B1|1B - disease confined to cervix||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|1|1.0||||||
4465034|NCT00003377|4283562|B6|1A - disease identified only microscopically||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465035|NCT00003377|4283563|B5|1A - disease identified only microscopically||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465036|NCT00003377|4283564|B4|1A - disease identified only microscopically||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465037|NCT00003377|4283565|B3|1A - disease identified only microscopically||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465038|NCT00003377|4283566|B2|1A - disease identified only microscopically||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465102|NCT00003199|4283585|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4465039|NCT00003377|4283567|B1|1A - disease identified only microscopically||FIGO (International Federation of Gynecology and Obstetrics) Stage|Clinical staging - Carcinoma of the Cervix Uteri FIGO Classification 1995 specifying invasive carcinoma from Stage 1A (confined to the cervix, identified only microscopically) to Stage 4B (spread to distant organs).|participants|Number|0|0.0||||||
4465040|NCT00003377|4283562|B6|United States||Region of Enrollment||participants|Number|29|29.0||||||
4465041|NCT00003377|4283563|B5|United States||Region of Enrollment||participants|Number|3|3.0||||||
4465042|NCT00003377|4283564|B4|United States||Region of Enrollment||participants|Number|3|3.0||||||
4465043|NCT00003377|4283565|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4465044|NCT00003377|4283566|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4465045|NCT00003377|4283567|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4465046|NCT00003377|4283562|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465047|NCT00003377|4283563|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465048|NCT00003377|4283564|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465049|NCT00003377|4283565|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465050|NCT00003377|4283566|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465051|NCT00003377|4283567|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465052|NCT00003377|4283562|B6||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4465053|NCT00003377|4283563|B5||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4465054|NCT00003377|4283564|B4||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4465055|NCT00003377|4283565|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4465056|NCT00003377|4283566|B2||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4465057|NCT00003377|4283567|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4465058|NCT00003377|4283562|B6|60-69 years||Age, Customized||participants|Number|6|6.0||||||
4465059|NCT00003377|4283563|B5|60-69 years||Age, Customized||participants|Number|0|0.0||||||
4465060|NCT00003377|4283564|B4|60-69 years||Age, Customized||participants|Number|0|0.0||||||
4465061|NCT00003377|4283565|B3|60-69 years||Age, Customized||participants|Number|4|4.0||||||
4465062|NCT00003377|4283566|B2|60-69 years||Age, Customized||participants|Number|1|1.0||||||
4465063|NCT00003377|4283567|B1|60-69 years||Age, Customized||participants|Number|1|1.0||||||
4465064|NCT00003377|4283562|B6|50-59 years||Age, Customized||participants|Number|5|5.0||||||
4465065|NCT00003377|4283563|B5|50-59 years||Age, Customized||participants|Number|1|1.0||||||
4465066|NCT00003377|4283564|B4|50-59 years||Age, Customized||participants|Number|1|1.0||||||
4465067|NCT00003377|4283565|B3|50-59 years||Age, Customized||participants|Number|2|2.0||||||
4465068|NCT00003377|4283566|B2|50-59 years||Age, Customized||participants|Number|1|1.0||||||
4465069|NCT00003377|4283567|B1|50-59 years||Age, Customized||participants|Number|0|0.0||||||
4465070|NCT00003377|4283562|B6|40-49 years||Age, Customized||participants|Number|15|15.0||||||
4465071|NCT00003377|4283563|B5|40-49 years||Age, Customized||participants|Number|2|2.0||||||
4465072|NCT00003377|4283564|B4|40-49 years||Age, Customized||participants|Number|2|2.0||||||
4465073|NCT00003377|4283565|B3|40-49 years||Age, Customized||participants|Number|9|9.0||||||
4465074|NCT00003377|4283566|B2|40-49 years||Age, Customized||participants|Number|1|1.0||||||
4465075|NCT00003377|4283567|B1|40-49 years||Age, Customized||participants|Number|1|1.0||||||
4465076|NCT00003377|4283562|B6|30-39 years||Age, Customized||participants|Number|2|2.0||||||
4465077|NCT00003377|4283563|B5|30-39 years||Age, Customized||participants|Number|0|0.0||||||
4465078|NCT00003377|4283564|B4|30-39 years||Age, Customized||participants|Number|0|0.0||||||
4465079|NCT00003377|4283565|B3|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4465080|NCT00003377|4283566|B2|30-39 years||Age, Customized||participants|Number|0|0.0||||||
4465081|NCT00003377|4283567|B1|30-39 years||Age, Customized||participants|Number|1|1.0||||||
4465082|NCT00003377|4283562|B6|20-29 years||Age, Customized||participants|Number|1|1.0||||||
4465083|NCT00003377|4283563|B5|20-29 years||Age, Customized||participants|Number|0|0.0||||||
4465084|NCT00003377|4283564|B4|20-29 years||Age, Customized||participants|Number|0|0.0||||||
4465085|NCT00003377|4283565|B3|20-29 years||Age, Customized||participants|Number|1|1.0||||||
4465086|NCT00003377|4283566|B2|20-29 years||Age, Customized||participants|Number|0|0.0||||||
4465087|NCT00003377|4283567|B1|20-29 years||Age, Customized||participants|Number|0|0.0||||||
4465088|NCT00003377|4283562|B6|||Age||years|Mean|49.5|49.5|Standard Deviation|10.1|10.1|||
4465089|NCT00003377|4283563|B5|||Age||years|Mean|47.7|47.7|Standard Deviation|4.0|4.0|||
4465090|NCT00003377|4283564|B4|||Age||years|Mean|47.6|47.6|Standard Deviation|8.4|8.4|||
4465091|NCT00003377|4283565|B3|||Age||years|Mean|49.8|49.8|Standard Deviation|11.0|11.0|||
4465092|NCT00003377|4283566|B2|||Age||years|Mean|54.2|54.2|Standard Deviation|10.7|10.7|||
4465093|NCT00003377|4283567|B1|||Age||years|Mean|46.4|46.4|Standard Deviation|13.7|13.7|||
4465094|NCT00003199|4283585|B1|United States||Region of Enrollment||participants|Number|50|50.0||||||
4465095|NCT00003199|4283585|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465096|NCT00003199|4283585|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465097|NCT00003199|4283585|B1||White|Race (NIH/OMB)||Participants|Count of Participants|37|37.0||||||
4465098|NCT00003199|4283585|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465099|NCT00003199|4283585|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4465103|NCT00003199|4283585|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465104|NCT00003199|4283585|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465105|NCT00003199|4283585|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465106|NCT00003199|4283585|B1||Female|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4465107|NCT00003199|4283585|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4465108|NCT00003199|4283585|B1||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4465109|NCT00003199|4283585|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465110|NCT00003138|4283591|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4465111|NCT00003138|4283592|B2||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4465112|NCT00003138|4283593|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4465113|NCT00003138|4283591|B3||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4465114|NCT00003138|4283592|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4465115|NCT00003138|4283593|B1||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4465116|NCT00003138|4283591|B3||>=65 years|Age||Participants|Count of Participants|93|93.0||||||
4465117|NCT00003138|4283592|B2||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4465118|NCT00003138|4283593|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4465119|NCT00003138|4283591|B3||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4465120|NCT00003138|4283592|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4465121|NCT00003138|4283593|B1||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4465122|NCT00003138|4283591|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465123|NCT00003138|4283592|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465124|NCT00003138|4283593|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465125|NCT00002975|4283607|B1||Male|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4465126|NCT00002975|4283607|B1||Female|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4465127|NCT00002975|4283607|B1|||Age||years|Mean|58.0|58.0|Standard Deviation|16.0|16.0|||
4465128|NCT00002931|4283611|B1|United States||Region of Enrollment||participants|Number|48|48.0||||||
4465129|NCT00002931|4283611|B1||Male|Gender||Participants|Count of Participants|47|47.0||||||
4465130|NCT00002931|4283611|B1||Female|Gender||Participants|Count of Participants|1|1.0||||||
4465131|NCT00002931|4283611|B1|||Age||years|Median|29|29.0|Full Range|||16.0|49.0|
4465132|NCT00002874|4283617|B3||Male|Sex: Female, Male||Participants|Count of Participants|760|760.0||||||
4465133|NCT00002874|4283618|B2||Male|Sex: Female, Male||Participants|Count of Participants|384|384.0||||||
4465134|NCT00002874|4283619|B1||Male|Sex: Female, Male||Participants|Count of Participants|376|376.0||||||
4465135|NCT00002874|4283617|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465136|NCT00002874|4283618|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465137|NCT00002874|4283619|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465138|NCT00002874|4283617|B3|||Age||years|Median|65|65.0|Full Range|||40.0|83.0|
4465139|NCT00002874|4283618|B2|||Age||years|Median|65|65.0|Full Range|||40.0|83.0|
4465140|NCT00002874|4283619|B1|||Age||years|Median|65|65.0|Full Range|||45.0|81.0|
4465141|NCT00002850|4283642|B4|||Eastern Cooperative Oncology Group (ECOG) performance status|"ECOG PERFORMANCE STATUS: Used by doctors and researchers to assess how a patient's disease is progressing.~0: Fully active, able to carry on pre-disease performance~Restricted in physically strenuous activity but ambulatory; able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Confined to bed or chair~Dead"|units on a scale|Mean|1.0|1.0|Full Range|||0.0|4.0|
4465142|NCT00002850|4283643|B3|||Eastern Cooperative Oncology Group (ECOG) performance status|"ECOG PERFORMANCE STATUS: Used by doctors and researchers to assess how a patient's disease is progressing.~0: Fully active, able to carry on pre-disease performance~Restricted in physically strenuous activity but ambulatory; able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Confined to bed or chair~Dead"|units on a scale|Mean|0.8|0.8|Full Range|||0.0|4.0|
4465143|NCT00002850|4283644|B2|||Eastern Cooperative Oncology Group (ECOG) performance status|"ECOG PERFORMANCE STATUS: Used by doctors and researchers to assess how a patient's disease is progressing.~0: Fully active, able to carry on pre-disease performance~Restricted in physically strenuous activity but ambulatory; able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Confined to bed or chair~Dead"|units on a scale|Mean|1.1|1.1|Full Range|||0.0|4.0|
4465144|NCT00002850|4283645|B1|||Eastern Cooperative Oncology Group (ECOG) performance status|"ECOG PERFORMANCE STATUS: Used by doctors and researchers to assess how a patient's disease is progressing.~0: Fully active, able to carry on pre-disease performance~Restricted in physically strenuous activity but ambulatory; able to carry out work of a light or sedentary nature~Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours~Capable of limited selfcare, confined to bed or chair more than 50% of waking hours~Completely disabled. Cannot carry on selfcare. Confined to bed or chair~Dead"|units on a scale|Mean|1.0|1.0|Full Range|||0.0|3.0|
4465145|NCT00002850|4283642|B4|Other||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|93|93.0||||||
4465146|NCT00002850|4283643|B3|Other||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|27|27.0||||||
4465147|NCT00002850|4283644|B2|Other||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|38|38.0||||||
4465148|NCT00002850|4283645|B1|Other||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|28|28.0||||||
4465149|NCT00002850|4283642|B4|Vincristine, Adriamycin, Dexamethasone||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|63|63.0||||||
4465150|NCT00002850|4283643|B3|Vincristine, Adriamycin, Dexamethasone||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|22|22.0||||||
4465151|NCT00002850|4283644|B2|Vincristine, Adriamycin, Dexamethasone||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|17|17.0||||||
4465152|NCT00002850|4283645|B1|Vincristine, Adriamycin, Dexamethasone||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|24|24.0||||||
4465153|NCT00002850|4283642|B4|VBMCP||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|22|22.0||||||
4465154|NCT00002850|4283643|B3|VBMCP||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|8|8.0||||||
4465155|NCT00002850|4283644|B2|VBMCP||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|8|8.0||||||
4465156|NCT00002850|4283645|B1|VBMCP||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|6|6.0||||||
4465157|NCT00002850|4283642|B4|Melphalan, Prednisone||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|34|34.0||||||
4465158|NCT00002850|4283643|B3|Melphalan, Prednisone||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|10|10.0||||||
4465159|NCT00002850|4283644|B2|Melphalan, Prednisone||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|13|13.0||||||
4465160|NCT00002850|4283645|B1|Melphalan, Prednisone||Chemotherapy regimen|VBMCP=vincristine, carmustine, melphalan, cyclophosphamide, and prednisone|participants|Number|11|11.0||||||
4465161|NCT00002850|4283642|B4|Unknown||Infection in last 6 months||participants|Number|184|184.0||||||
4465162|NCT00002850|4283643|B3|Unknown||Infection in last 6 months||participants|Number|59|59.0||||||
4465163|NCT00002850|4283644|B2|Unknown||Infection in last 6 months||participants|Number|69|69.0||||||
4465164|NCT00002850|4283645|B1|Unknown||Infection in last 6 months||participants|Number|56|56.0||||||
4465165|NCT00002850|4283642|B4|Yes||Infection in last 6 months||participants|Number|28|28.0||||||
4465166|NCT00002850|4283643|B3|Yes||Infection in last 6 months||participants|Number|8|8.0||||||
4465167|NCT00002850|4283644|B2|Yes||Infection in last 6 months||participants|Number|7|7.0||||||
4465168|NCT00002850|4283645|B1|Yes||Infection in last 6 months||participants|Number|13|13.0||||||
4465169|NCT00002850|4283642|B4|United States||Region of Enrollment||participants|Number|212|212.0||||||
4465170|NCT00002850|4283643|B3|United States||Region of Enrollment||participants|Number|67|67.0||||||
4465171|NCT00002850|4283644|B2|United States||Region of Enrollment||participants|Number|76|76.0||||||
4465172|NCT00002850|4283645|B1|United States||Region of Enrollment||participants|Number|69|69.0||||||
4465173|NCT00002850|4283642|B4|Unknown||Race/Ethnicity, Customized||participants|Number|52|52.0||||||
4465174|NCT00002850|4283643|B3|Unknown||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4465175|NCT00002850|4283644|B2|Unknown||Race/Ethnicity, Customized||participants|Number|25|25.0||||||
4465176|NCT00002850|4283645|B1|Unknown||Race/Ethnicity, Customized||participants|Number|15|15.0||||||
4465177|NCT00002850|4283642|B4|White||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
4465178|NCT00002850|4283643|B3|White||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4465179|NCT00002850|4283644|B2|White||Race/Ethnicity, Customized||participants|Number|51|51.0||||||
4465180|NCT00002850|4283645|B1|White||Race/Ethnicity, Customized||participants|Number|54|54.0||||||
4465181|NCT00002850|4283642|B4||Male|Sex: Female, Male||Participants|Count of Participants|133|133.0||||||
4465182|NCT00002850|4283643|B3||Male|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4465183|NCT00002850|4283644|B2||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4465184|NCT00002850|4283645|B1||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4465185|NCT00002850|4283642|B4||Female|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4465186|NCT00002850|4283643|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4465187|NCT00002850|4283644|B2||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4465188|NCT00002850|4283645|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4465189|NCT00002850|4283642|B4|||Age||years|Mean|63.2|63.2|Full Range|||32.4|89.3|
4465190|NCT00002850|4283643|B3|||Age||years|Mean|65.0|65.0|Full Range|||36.7|89.3|
4465191|NCT00002850|4283644|B2|||Age||years|Mean|62.6|62.6|Full Range|||36.7|85.7|
4465192|NCT00002850|4283645|B1|||Age||years|Mean|63.7|63.7|Full Range|||32.4|86.0|
4465193|NCT00002842|4283655|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4465194|NCT00002842|4283655|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4465195|NCT00002842|4283655|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4465196|NCT00002842|4283655|B1|||Age||years|Median|56|56.0|Full Range|||38.0|77.0|
4465197|NCT00002766|4283659|B3||Male|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4465198|NCT00002766|4283660|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4465199|NCT00002766|4283661|B1||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4465200|NCT00002766|4283659|B3||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4465201|NCT00002766|4283660|B2||Female|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4465202|NCT00002766|4283661|B1||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4465203|NCT00002766|4283659|B3||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4465204|NCT00002766|4283660|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4465205|NCT00002766|4283661|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4465206|NCT00002766|4283659|B3||Between 18 and 65 years|Age||Participants|Count of Participants|153|153.0||||||
4465207|NCT00002766|4283660|B2||Between 18 and 65 years|Age||Participants|Count of Participants|77|77.0||||||
4465208|NCT00002766|4283661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4465209|NCT00002766|4283659|B3||<=18 years|Age||Participants|Count of Participants|7|7.0||||||
4465210|NCT00002766|4283660|B2||<=18 years|Age||Participants|Count of Participants|4|4.0||||||
4465211|NCT00002766|4283661|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4465212|NCT00002651|4283668|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|298|298.0||||||
4465213|NCT00002651|4283669|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|144|144.0||||||
4465214|NCT00002651|4283670|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|154|154.0||||||
4465215|NCT00002651|4283668|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4465216|NCT00002651|4283669|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465217|NCT00002651|4283670|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4465218|NCT00002651|4283668|B3||White|Race (NIH/OMB)||Participants|Count of Participants|1026|1026.0||||||
4465219|NCT00002651|4283669|B2||White|Race (NIH/OMB)||Participants|Count of Participants|519|519.0||||||
4465220|NCT00002651|4283670|B1||White|Race (NIH/OMB)||Participants|Count of Participants|507|507.0||||||
4465221|NCT00002651|4283668|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|187|187.0||||||
4465222|NCT00002651|4283669|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4465223|NCT00002651|4283670|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|93|93.0||||||
4465224|NCT00002651|4283668|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4465225|NCT00002651|4283669|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465226|NCT00002651|4283670|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4465227|NCT00002651|4283668|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4465228|NCT00002651|4283669|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4465229|NCT00002651|4283670|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4465230|NCT00002651|4283668|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4465231|NCT00002651|4283669|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4465232|NCT00002651|4283670|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4465233|NCT00002651|4283668|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|360|360.0||||||
4465234|NCT00002651|4283669|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|183|183.0||||||
4465235|NCT00002651|4283670|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|177|177.0||||||
4465236|NCT00002651|4283668|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1135|1135.0||||||
4465237|NCT00002651|4283669|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|564|564.0||||||
4465238|NCT00002651|4283670|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|571|571.0||||||
4465239|NCT00002651|4283668|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4465240|NCT00002651|4283669|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4465241|NCT00002651|4283670|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4465242|NCT00002651|4283668|B3||Male|Sex: Female, Male||Participants|Count of Participants|1535|1535.0||||||
4465243|NCT00002651|4283669|B2||Male|Sex: Female, Male||Participants|Count of Participants|770|770.0||||||
4465244|NCT00002651|4283670|B1||Male|Sex: Female, Male||Participants|Count of Participants|765|765.0||||||
4465245|NCT00002651|4283668|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465246|NCT00002651|4283669|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465247|NCT00002651|4283670|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465248|NCT00002651|4283668|B3|||Age||years|Median|70|70.0|Full Range|||39.0|97.0|
4465249|NCT00002651|4283669|B2|||Age||years|Median|70|70.0|Full Range|||39.0|97.0|
4465250|NCT00002651|4283670|B1|||Age||years|Median|70|70.0|Full Range|||39.0|92.0|
4465251|NCT00002558|4283688|B3||Male|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4465252|NCT00002558|4283689|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4465253|NCT00002558|4283690|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4465254|NCT00002558|4283688|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4465255|NCT00002558|4283689|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4465256|NCT00002558|4283690|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4465257|NCT00002558|4283688|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4465258|NCT00002558|4283689|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4465259|NCT00002558|4283690|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4465260|NCT00002558|4283688|B3||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4465261|NCT00002558|4283689|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4465262|NCT00002558|4283690|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4465263|NCT00002558|4283688|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4465264|NCT00002558|4283689|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465265|NCT00002558|4283690|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4465266|NCT00052078|4283697|B5|United States||Region of Enrollment||participants|Number|488|488.0||||||
4465267|NCT00052078|4283698|B4|United States||Region of Enrollment||participants|Number|76|76.0||||||
4465268|NCT00052078|4283699|B3|United States||Region of Enrollment||participants|Number|140|140.0||||||
4465269|NCT00052078|4283700|B2|United States||Region of Enrollment||participants|Number|139|139.0||||||
4465270|NCT00052078|4283701|B1|United States||Region of Enrollment||participants|Number|133|133.0||||||
4465271|NCT00052078|4283697|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465272|NCT00052078|4283698|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465273|NCT00052078|4283699|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465274|NCT00052078|4283700|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465275|NCT00052078|4283701|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465276|NCT00052078|4283697|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|39|39.0||||||
4465277|NCT00052078|4283698|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4465278|NCT00052078|4283699|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4465279|NCT00052078|4283700|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4465280|NCT00052078|4283701|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4465281|NCT00052078|4283697|B5||White|Race (NIH/OMB)||Participants|Count of Participants|385|385.0||||||
4465282|NCT00052078|4283698|B4||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4465283|NCT00052078|4283699|B3||White|Race (NIH/OMB)||Participants|Count of Participants|116|116.0||||||
4465284|NCT00052078|4283700|B2||White|Race (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4465285|NCT00052078|4283701|B1||White|Race (NIH/OMB)||Participants|Count of Participants|103|103.0||||||
4465286|NCT00052078|4283697|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4465287|NCT00052078|4283698|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4465288|NCT00052078|4283699|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4465289|NCT00052078|4283700|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4465290|NCT00052078|4283701|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4465291|NCT00052078|4283697|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4465292|NCT00052078|4283698|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465293|NCT00052078|4283699|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465294|NCT00052078|4283700|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465295|NCT00052078|4283701|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465296|NCT00052078|4283697|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4465297|NCT00052078|4283698|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465298|NCT00052078|4283699|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4465299|NCT00052078|4283700|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465300|NCT00052078|4283701|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4465301|NCT00052078|4283697|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4465302|NCT00052078|4283698|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465303|NCT00052078|4283699|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465304|NCT00052078|4283700|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4465305|NCT00052078|4283701|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4465306|NCT00052078|4283697|B5||Male|Sex: Female, Male||Participants|Count of Participants|246|246.0||||||
4465307|NCT00052078|4283698|B4||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4465308|NCT00052078|4283699|B3||Male|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4465309|NCT00052078|4283700|B2||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4465310|NCT00052078|4283701|B1||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4465311|NCT00052078|4283697|B5||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4465312|NCT00052078|4283698|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4465313|NCT00052078|4283699|B3||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4465314|NCT00052078|4283700|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4465315|NCT00052078|4283701|B1||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4465316|NCT00052078|4283697|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4465317|NCT00052078|4283698|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4465318|NCT00052078|4283699|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4465319|NCT00052078|4283700|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4465320|NCT00052078|4283701|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4465321|NCT00052078|4283697|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4465322|NCT00052078|4283698|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4465323|NCT00052078|4283699|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4465324|NCT00052078|4283700|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4465325|NCT00052078|4283701|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4465326|NCT00052078|4283697|B5||<=18 years|Age||Participants|Count of Participants|488|488.0||||||
4465327|NCT00052078|4283698|B4||<=18 years|Age||Participants|Count of Participants|76|76.0||||||
4465328|NCT00052078|4283699|B3||<=18 years|Age||Participants|Count of Participants|140|140.0||||||
4465329|NCT00052078|4283700|B2||<=18 years|Age||Participants|Count of Participants|139|139.0||||||
4465330|NCT00052078|4283701|B1||<=18 years|Age||Participants|Count of Participants|133|133.0||||||
4465331|NCT00051636|4283714|B3||Male|Sex: Female, Male||Participants|Count of Participants|123|123.0||||||
4465332|NCT00051636|4283715|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4465333|NCT00051636|4283716|B1||Male|Sex: Female, Male||Participants|Count of Participants|62|62.0||||||
4465334|NCT00051636|4283714|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4465335|NCT00051636|4283715|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4465336|NCT00051636|4283716|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4465337|NCT00051636|4283714|B3|||Age||years|Mean|71.2|71.2|Standard Deviation|10.10|10.1|||
4465338|NCT00051636|4283715|B2|||Age||years|Mean|72.1|72.1|Standard Deviation|9.91|9.91|||
4465339|NCT00051636|4283716|B1|||Age||years|Mean|70.4|70.4|Standard Deviation|10.25|10.25|||
4465340|NCT00051558|4283743|B3|||C-terminal telopeptide of type I collagen||pmol/L|Mean|4185.328|4185.328|Standard Deviation|3907.204|3907.204|||
4465341|NCT00051558|4283744|B2|||C-terminal telopeptide of type I collagen||pmol/L|Mean|4543.156|4543.156|Standard Deviation|4838.919|4838.919|||
4465342|NCT00051558|4283745|B1|||C-terminal telopeptide of type I collagen||pmol/L|Mean|3790.483|3790.483|Standard Deviation|2478.189|2478.189|||
4465343|NCT00051558|4283743|B3|Femoral Neck Bone Mineral Density||Baseline Bone Mineral Density||grams per square centimeters|Mean|0.689|0.689|Standard Deviation|0.116|0.116|||
4465344|NCT00051558|4283744|B2|Femoral Neck Bone Mineral Density||Baseline Bone Mineral Density||grams per square centimeters|Mean|0.697|0.697|Standard Deviation|0.119|0.119|||
4465345|NCT00051558|4283745|B1|Femoral Neck Bone Mineral Density||Baseline Bone Mineral Density||grams per square centimeters|Mean|0.682|0.682|Standard Deviation|0.114|0.114|||
4465346|NCT00051558|4283743|B3|Total Hip Bone Mineral Density||Baseline Bone Mineral Density||grams per square centimeters|Mean|0.750|0.75|Standard Deviation|0.119|0.119|||
4465347|NCT00051558|4283744|B2|Total Hip Bone Mineral Density||Baseline Bone Mineral Density||grams per square centimeters|Mean|0.757|0.757|Standard Deviation|0.124|0.124|||
4465348|NCT00051558|4283745|B1|Total Hip Bone Mineral Density||Baseline Bone Mineral Density||grams per square centimeters|Mean|0.744|0.744|Standard Deviation|0.113|0.113|||
4465349|NCT00051558|4283743|B3|Lumbar Spine Bone Mineral Density||Baseline Bone Mineral Density||grams per square centimeters|Mean|0.845|0.845|Standard Deviation|0.129|0.129|||
4465350|NCT00051558|4283744|B2|Lumbar Spine Bone Mineral Density||Baseline Bone Mineral Density||grams per square centimeters|Mean|0.844|0.844|Standard Deviation|0.128|0.128|||
4465351|NCT00051558|4283745|B1|Lumbar Spine Bone Mineral Density||Baseline Bone Mineral Density||grams per square centimeters|Mean|0.845|0.845|Standard Deviation|0.131|0.131|||
4465352|NCT00051558|4283743|B3|Osteocalcin||Baseline Biochemical Markers of Bone Metabolism||ug/L|Mean|16.492|16.492|Standard Deviation|12.468|12.468|||
4465353|NCT00051558|4283744|B2|Osteocalcin||Baseline Biochemical Markers of Bone Metabolism||ug/L|Mean|15.878|15.878|Standard Deviation|10.286|10.286|||
4465354|NCT00051558|4283745|B1|Osteocalcin||Baseline Biochemical Markers of Bone Metabolism||ug/L|Mean|17.130|17.13|Standard Deviation|14.422|14.422|||
4465355|NCT00051558|4283743|B3|Bone-specific alkaline phosphatase||Baseline Biochemical Markers of Bone Metabolism||ug/L|Mean|9.595|9.595|Standard Deviation|4.513|4.513|||
4465356|NCT00051558|4283744|B2|Bone-specific alkaline phosphatase||Baseline Biochemical Markers of Bone Metabolism||ug/L|Mean|9.711|9.711|Standard Deviation|4.527|4.527|||
4465357|NCT00051558|4283745|B1|Bone-specific alkaline phosphatase||Baseline Biochemical Markers of Bone Metabolism||ug/L|Mean|9.465|9.465|Standard Deviation|4.522|4.522|||
4465358|NCT00051558|4283743|B3|Procollagen I carboxy-terminal propeptide||Baseline Biochemical Markers of Bone Metabolism||ug/L|Mean|158.845|158.845|Standard Deviation|79.910|79.91|||
4465359|NCT00051558|4283744|B2|Procollagen I carboxy-terminal propeptide||Baseline Biochemical Markers of Bone Metabolism||ug/L|Mean|152.109|152.109|Standard Deviation|56.637|56.637|||
4465360|NCT00051558|4283745|B1|Procollagen I carboxy-terminal propeptide||Baseline Biochemical Markers of Bone Metabolism||ug/L|Mean|166.402|166.402|Standard Deviation|99.625|99.625|||
4465361|NCT00051558|4283743|B3|Serum N-terminal propeptide of type 1 procollagen||Baseline Biochemical Markers of Bone Metabolism||ug/L|Mean|46.704|46.704|Standard Deviation|32.562|32.562|||
4465362|NCT00051558|4283744|B2|Serum N-terminal propeptide of type 1 procollagen||Baseline Biochemical Markers of Bone Metabolism||ug/L|Mean|47.235|47.235|Standard Deviation|29.606|29.606|||
4465363|NCT00051558|4283745|B1|Serum N-terminal propeptide of type 1 procollagen||Baseline Biochemical Markers of Bone Metabolism||ug/L|Mean|46.161|46.161|Standard Deviation|35.471|35.471|||
4465364|NCT00051558|4283743|B3|No||Prior Bisphosphonate User||participants|Number|388|388.0||||||
4465365|NCT00051558|4283744|B2|No||Prior Bisphosphonate User||participants|Number|194|194.0||||||
4465366|NCT00051558|4283745|B1|No||Prior Bisphosphonate User||participants|Number|194|194.0||||||
4465367|NCT00051558|4283743|B3|Yes||Prior Bisphosphonate User||participants|Number|40|40.0||||||
4465368|NCT00051558|4283744|B2|Yes||Prior Bisphosphonate User||participants|Number|20|20.0||||||
4465369|NCT00051558|4283745|B1|Yes||Prior Bisphosphonate User||participants|Number|20|20.0||||||
4465370|NCT00051558|4283743|B3|Non-Caucasian||Origin||participants|Number|127|127.0||||||
4465371|NCT00051558|4283744|B2|Non-Caucasian||Origin||participants|Number|66|66.0||||||
4465372|NCT00051558|4283745|B1|Non-Caucasian||Origin||participants|Number|61|61.0||||||
4465373|NCT00051558|4283743|B3|Caucasian||Origin||participants|Number|301|301.0||||||
4465374|NCT00051558|4283744|B2|Caucasian||Origin||participants|Number|148|148.0||||||
4465375|NCT00051558|4283745|B1|Caucasian||Origin||participants|Number|153|153.0||||||
4465376|NCT00051558|4283743|B3|Germany||Region of Enrollment||participants|Number|28|28.0||||||
4465377|NCT00051558|4283744|B2|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4465378|NCT00051558|4283745|B1|Germany||Region of Enrollment||participants|Number|14|14.0||||||
4465379|NCT00051558|4283743|B3|Finland||Region of Enrollment||participants|Number|3|3.0||||||
4465380|NCT00051558|4283744|B2|Finland||Region of Enrollment||participants|Number|2|2.0||||||
4465381|NCT00051558|4283745|B1|Finland||Region of Enrollment||participants|Number|1|1.0||||||
4465382|NCT00051558|4283743|B3|Mexico||Region of Enrollment||participants|Number|29|29.0||||||
4465383|NCT00051558|4283744|B2|Mexico||Region of Enrollment||participants|Number|15|15.0||||||
4465384|NCT00051558|4283745|B1|Mexico||Region of Enrollment||participants|Number|14|14.0||||||
4465385|NCT00051558|4283743|B3|Venezuela||Region of Enrollment||participants|Number|7|7.0||||||
4465386|NCT00051558|4283744|B2|Venezuela||Region of Enrollment||participants|Number|3|3.0||||||
4465387|NCT00051558|4283745|B1|Venezuela||Region of Enrollment||participants|Number|4|4.0||||||
4465388|NCT00051558|4283743|B3|Colombia||Region of Enrollment||participants|Number|19|19.0||||||
4465389|NCT00051558|4283744|B2|Colombia||Region of Enrollment||participants|Number|9|9.0||||||
4465390|NCT00051558|4283745|B1|Colombia||Region of Enrollment||participants|Number|10|10.0||||||
4465391|NCT00051558|4283743|B3|Brazil||Region of Enrollment||participants|Number|145|145.0||||||
4465392|NCT00051558|4283744|B2|Brazil||Region of Enrollment||participants|Number|73|73.0||||||
4465393|NCT00051558|4283745|B1|Brazil||Region of Enrollment||participants|Number|72|72.0||||||
4465394|NCT00051558|4283743|B3|Argentina||Region of Enrollment||participants|Number|43|43.0||||||
4465395|NCT00051558|4283744|B2|Argentina||Region of Enrollment||participants|Number|20|20.0||||||
4465396|NCT00051558|4283745|B1|Argentina||Region of Enrollment||participants|Number|23|23.0||||||
4465397|NCT00051558|4283743|B3|Norway||Region of Enrollment||participants|Number|2|2.0||||||
4465398|NCT00051558|4283744|B2|Norway||Region of Enrollment||participants|Number|1|1.0||||||
4465399|NCT00051558|4283745|B1|Norway||Region of Enrollment||participants|Number|1|1.0||||||
4465400|NCT00051558|4283743|B3|Austria||Region of Enrollment||participants|Number|3|3.0||||||
4465401|NCT00051558|4283744|B2|Austria||Region of Enrollment||participants|Number|2|2.0||||||
4465402|NCT00051558|4283745|B1|Austria||Region of Enrollment||participants|Number|1|1.0||||||
4465403|NCT00051558|4283743|B3|Denmark||Region of Enrollment||participants|Number|7|7.0||||||
4465404|NCT00051558|4283744|B2|Denmark||Region of Enrollment||participants|Number|3|3.0||||||
4465405|NCT00051558|4283745|B1|Denmark||Region of Enrollment||participants|Number|4|4.0||||||
4465406|NCT00051558|4283743|B3|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4465407|NCT00051558|4283744|B2|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4465408|NCT00051558|4283745|B1|Belgium||Region of Enrollment||participants|Number|8|8.0||||||
4465409|NCT00051558|4283743|B3|United States||Region of Enrollment||participants|Number|126|126.0||||||
4465410|NCT00051558|4283744|B2|United States||Region of Enrollment||participants|Number|64|64.0||||||
4465411|NCT00051558|4283745|B1|United States||Region of Enrollment||participants|Number|62|62.0||||||
4465412|NCT00051558|4283743|B3||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4465413|NCT00051558|4283744|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4465414|NCT00051558|4283745|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4465415|NCT00051558|4283743|B3||Female|Sex: Female, Male||Participants|Count of Participants|345|345.0||||||
4465416|NCT00051558|4283744|B2||Female|Sex: Female, Male||Participants|Count of Participants|173|173.0||||||
4465417|NCT00051558|4283745|B1||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4465418|NCT00051558|4283743|B3|Age >= 65 years||Age, Customized||participants|Number|127|127.0||||||
4465419|NCT00051558|4283744|B2|Age >= 65 years||Age, Customized||participants|Number|67|67.0||1.528|1.528|||
4465420|NCT00051558|4283745|B1|Age >= 65 years||Age, Customized||participants|Number|60|60.0||1.518|1.518|||
4465421|NCT00051558|4283743|B3|50 <= Age < 65 years||Age, Customized||participants|Number|179|179.0||||||
4465422|NCT00051558|4283744|B2|50 <= Age < 65 years||Age, Customized||participants|Number|93|93.0||||||
4465423|NCT00051558|4283745|B1|50 <= Age < 65 years||Age, Customized||participants|Number|86|86.0||||||
4465424|NCT00051558|4283743|B3|35 <= Age < 50 years||Age, Customized||participants|Number|90|90.0||||||
4465425|NCT00051558|4283744|B2|35 <= Age < 50 years||Age, Customized||participants|Number|35|35.0||||||
4465426|NCT00051558|4283745|B1|35 <= Age < 50 years||Age, Customized||participants|Number|55|55.0||||||
4465427|NCT00051558|4283743|B3|Age < 35 years||Age, Customized||participants|Number|32|32.0||||||
4465428|NCT00051558|4283744|B2|Age < 35 years||Age, Customized||participants|Number|19|19.0||||||
4465429|NCT00051558|4283745|B1|Age < 35 years||Age, Customized||participants|Number|13|13.0||||||
4465430|NCT00051363|4283780|B3|United States||Region of Enrollment||participants|Number|1098|1098.0||||||
4465431|NCT00051363|4283781|B2|United States||Region of Enrollment||participants|Number|542|542.0||||||
4465432|NCT00051363|4283782|B1|United States||Region of Enrollment||participants|Number|556|556.0||||||
4465433|NCT00051363|4283780|B3||Male|Sex: Female, Male||Participants|Count of Participants|719|719.0||||||
4465434|NCT00051363|4283781|B2||Male|Sex: Female, Male||Participants|Count of Participants|356|356.0||||||
4465435|NCT00051363|4283782|B1||Male|Sex: Female, Male||Participants|Count of Participants|363|363.0||||||
4465436|NCT00051363|4283780|B3||Female|Sex: Female, Male||Participants|Count of Participants|379|379.0||||||
4465437|NCT00051363|4283781|B2||Female|Sex: Female, Male||Participants|Count of Participants|186|186.0||||||
4465438|NCT00051363|4283782|B1||Female|Sex: Female, Male||Participants|Count of Participants|193|193.0||||||
4465439|NCT00051363|4283780|B3|||Age||years|Mean|51.5|51.5|Standard Deviation|12.2|12.2|||
4465440|NCT00051363|4283781|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|12.2|12.2|||
4465441|NCT00051363|4283782|B1|||Age||years|Mean|52.2|52.2|Standard Deviation|12.2|12.2|||
4465442|NCT00051363|4283780|B3||>=65 years|Age||Participants|Count of Participants|174|174.0||||||
4465443|NCT00051363|4283781|B2||>=65 years|Age||Participants|Count of Participants|78|78.0||||||
4465444|NCT00051363|4283782|B1||>=65 years|Age||Participants|Count of Participants|96|96.0||||||
4465445|NCT00051363|4283780|B3||Between 18 and 65 years|Age||Participants|Count of Participants|923|923.0||||||
4465446|NCT00051363|4283781|B2||Between 18 and 65 years|Age||Participants|Count of Participants|464|464.0||||||
4465447|NCT00051363|4283782|B1||Between 18 and 65 years|Age||Participants|Count of Participants|459|459.0||||||
4465448|NCT00051363|4283780|B3||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4465449|NCT00051363|4283781|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465450|NCT00051363|4283782|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4465451|NCT00051168|4283817|B1||Male|Sex: Female, Male||Participants|Count of Participants|221|221.0||||||
4465452|NCT00051168|4283817|B1||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4465453|NCT00051168|4283817|B1||>=65 years|Age||Participants|Count of Participants|265|265.0||||||
4465454|NCT00051168|4283817|B1||Between 18 and 65 years|Age||Participants|Count of Participants|237|237.0||||||
4465455|NCT00051168|4283817|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465456|NCT00051025|4283821|B3|United States||Region of Enrollment||participants|Number|9|9.0||||||
4465457|NCT00051025|4283822|B2|United States||Region of Enrollment||participants|Number|4|4.0||||||
4465458|NCT00051025|4283823|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4465459|NCT00051025|4283821|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465460|NCT00051025|4283822|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465461|NCT00051025|4283823|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465462|NCT00051025|4283821|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465463|NCT00051025|4283822|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465464|NCT00051025|4283823|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465465|NCT00051025|4283821|B3||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4465466|NCT00051025|4283822|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4465467|NCT00051025|4283823|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4465468|NCT00051025|4283821|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465469|NCT00051025|4283822|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465470|NCT00051025|4283823|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465471|NCT00051025|4283821|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465472|NCT00051025|4283822|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465473|NCT00051025|4283823|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465474|NCT00051025|4283821|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465475|NCT00051025|4283822|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465476|NCT00051025|4283823|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465477|NCT00051025|4283821|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465478|NCT00051025|4283822|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465479|NCT00051025|4283823|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465480|NCT00051025|4283821|B3||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4465481|NCT00051025|4283822|B2||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4465482|NCT00051025|4283823|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4465483|NCT00051025|4283821|B3||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4465484|NCT00051025|4283822|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4465485|NCT00051025|4283823|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4465486|NCT00051025|4283821|B3|||Age||years|Mean|63.3|63.3|Standard Deviation|11.5|11.5|||
4465487|NCT00051025|4283822|B2|||Age||years|Mean|60.8|60.8|Standard Deviation|15.5|15.5|||
4465488|NCT00051025|4283823|B1|||Age||years|Mean|65.4|65.4|Standard Deviation|8.4|8.4|||
4465489|NCT00051025|4283821|B3||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4465490|NCT00051025|4283822|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4465491|NCT00051025|4283823|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4465492|NCT00051025|4283821|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4465493|NCT00051025|4283822|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2|2.0||||||
4465494|NCT00051025|4283823|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4465495|NCT00051025|4283821|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465496|NCT00051025|4283822|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465497|NCT00051025|4283823|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465498|NCT00050986|4283832|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4465499|NCT00050986|4283832|B1||Male|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4465500|NCT00050986|4283832|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4465501|NCT00050986|4283832|B1|||Age||years|Median|52|52.0|Full Range|||21.0|84.0|
4465502|NCT00050986|4283832|B1||>=65 years|Age||Participants|Count of Participants|3|3.0||||||
4465503|NCT00050986|4283832|B1||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4465504|NCT00050986|4283832|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465505|NCT00050960|4283836|B3|Unknown or Not Reported||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|7|7.0||||||
4465506|NCT00050960|4283837|B2|Unknown or Not Reported||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|2|2.0||||||
4465507|NCT00050960|4283838|B1|Unknown or Not Reported||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|5|5.0||||||
4465508|NCT00050960|4283836|B3|More than one race||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|0|0.0||||||
4465509|NCT00050960|4283837|B2|More than one race||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|0|0.0||||||
4465510|NCT00050960|4283838|B1|More than one race||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|0|0.0||||||
4465511|NCT00050960|4283836|B3|White||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|541|541.0||||||
4465512|NCT00050960|4283837|B2|White||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|272|272.0||||||
4465513|NCT00050960|4283838|B1|White||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|269|269.0||||||
4465514|NCT00050960|4283836|B3|Black or African American||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|43|43.0||||||
4465515|NCT00050960|4283837|B2|Black or African American||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|20|20.0||||||
4465516|NCT00050960|4283838|B1|Black or African American||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|23|23.0||||||
4465517|NCT00050960|4283836|B3|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|0|0.0||||||
4465518|NCT00050960|4283837|B2|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|0|0.0||||||
4465519|NCT00050960|4283838|B1|Native Hawaiian or Other Pacific Islander||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|0|0.0||||||
4465520|NCT00050960|4283836|B3|Asian||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|10|10.0||||||
4465521|NCT00050960|4283837|B2|Asian||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|3|3.0||||||
4465522|NCT00050960|4283838|B1|Asian||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|7|7.0||||||
4465523|NCT00050960|4283836|B3|American Indian or Alaska Native||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|0|0.0||||||
4465597|NCT00050778|4283845|B4|||Age||years|Mean|32.3|32.3|Standard Deviation|8.52|8.52|||
4465598|NCT00050778|4283846|B3|||Age||years|Mean|32.2|32.2|Standard Deviation|8.76|8.76|||
4465524|NCT00050960|4283837|B2|American Indian or Alaska Native||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|0|0.0||||||
4465525|NCT00050960|4283838|B1|American Indian or Alaska Native||Race (NIH/OMB)|"Counts are correct as reported. The BL measure title of race does not include counts of Hispanic or Latino population- which are reported in the BL measure title of Ethnicity."|Participants|Number|0|0.0||||||
4465526|NCT00050960|4283836|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465527|NCT00050960|4283837|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465528|NCT00050960|4283838|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465529|NCT00050960|4283836|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|601|601.0||||||
4465530|NCT00050960|4283837|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|297|297.0||||||
4465531|NCT00050960|4283838|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|304|304.0||||||
4465532|NCT00050960|4283836|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4465533|NCT00050960|4283837|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4465534|NCT00050960|4283838|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4465535|NCT00050960|4283836|B3||Male|Sex: Female, Male||Participants|Count of Participants|406|406.0||||||
4465536|NCT00050960|4283837|B2||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4465537|NCT00050960|4283838|B1||Male|Sex: Female, Male||Participants|Count of Participants|203|203.0||||||
4465538|NCT00050960|4283836|B3||Female|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4465539|NCT00050960|4283837|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4465540|NCT00050960|4283838|B1||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4465541|NCT00050960|4283836|B3|||Age||years|Mean|62.1|62.1|Standard Deviation|10.0|10.0|||
4465542|NCT00050960|4283837|B2|||Age||years|Mean|61.7|61.7|Standard Deviation|10.3|10.3|||
4465543|NCT00050960|4283838|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|9.6|9.6|||
4465544|NCT00050960|4283836|B3||>=65 years|Age||Participants|Count of Participants|272|272.0||||||
4465545|NCT00050960|4283837|B2||>=65 years|Age||Participants|Count of Participants|132|132.0||||||
4465546|NCT00050960|4283838|B1||>=65 years|Age||Participants|Count of Participants|140|140.0||||||
4465547|NCT00050960|4283836|B3||Between 18 and 65 years|Age||Participants|Count of Participants|340|340.0||||||
4465548|NCT00050960|4283837|B2||Between 18 and 65 years|Age||Participants|Count of Participants|174|174.0||||||
4465549|NCT00050960|4283838|B1||Between 18 and 65 years|Age||Participants|Count of Participants|166|166.0||||||
4465550|NCT00050960|4283836|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465551|NCT00050960|4283837|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465552|NCT00050960|4283838|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465553|NCT00050778|4283845|B4|||Time Constant 2 (T2) Lesion Volume|Number of participants evaluable for this Baseline characteristic were 102, 106 and 107 in Interferon Beta-1a, Alemtuzumab 12 mg and Alemtuzumab 24 mg arm, respectively.|cubic centimeter|Mean|17.0|17.0|Standard Deviation|19.19|19.19|||
4465554|NCT00050778|4283846|B3|||Time Constant 2 (T2) Lesion Volume|Number of participants evaluable for this Baseline characteristic were 102, 106 and 107 in Interferon Beta-1a, Alemtuzumab 12 mg and Alemtuzumab 24 mg arm, respectively.|cubic centimeter|Mean|17.8|17.8|Standard Deviation|17.45|17.45|||
4465555|NCT00050778|4283847|B2|||Time Constant 2 (T2) Lesion Volume|Number of participants evaluable for this Baseline characteristic were 102, 106 and 107 in Interferon Beta-1a, Alemtuzumab 12 mg and Alemtuzumab 24 mg arm, respectively.|cubic centimeter|Mean|17.2|17.2|Standard Deviation|23.84|23.84|||
4465556|NCT00050778|4283848|B1|||Time Constant 2 (T2) Lesion Volume|Number of participants evaluable for this Baseline characteristic were 102, 106 and 107 in Interferon Beta-1a, Alemtuzumab 12 mg and Alemtuzumab 24 mg arm, respectively.|cubic centimeter|Mean|15.8|15.8|Standard Deviation|15.23|15.23|||
4465557|NCT00050778|4283845|B4|||Time Constant 1 (T1) Cerebral Volume|Number of participants evaluable for this Baseline characteristic were 103, 107 and 107 in Interferon Beta-1a, Alemtuzumab 12 mg and Alemtuzumab 24 mg arm, respectively. Partial brain volumes were measured using the technique of Losseff et al. (1996).|cubic centimeter|Mean|319.6|319.6|Standard Deviation|25.61|25.61|||
4465558|NCT00050778|4283846|B3|||Time Constant 1 (T1) Cerebral Volume|Number of participants evaluable for this Baseline characteristic were 103, 107 and 107 in Interferon Beta-1a, Alemtuzumab 12 mg and Alemtuzumab 24 mg arm, respectively. Partial brain volumes were measured using the technique of Losseff et al. (1996).|cubic centimeter|Mean|320.5|320.5|Standard Deviation|24.99|24.99|||
4465559|NCT00050778|4283847|B2|||Time Constant 1 (T1) Cerebral Volume|Number of participants evaluable for this Baseline characteristic were 103, 107 and 107 in Interferon Beta-1a, Alemtuzumab 12 mg and Alemtuzumab 24 mg arm, respectively. Partial brain volumes were measured using the technique of Losseff et al. (1996).|cubic centimeter|Mean|320.8|320.8|Standard Deviation|27.15|27.15|||
4465560|NCT00050778|4283848|B1|||Time Constant 1 (T1) Cerebral Volume|Number of participants evaluable for this Baseline characteristic were 103, 107 and 107 in Interferon Beta-1a, Alemtuzumab 12 mg and Alemtuzumab 24 mg arm, respectively. Partial brain volumes were measured using the technique of Losseff et al. (1996).|cubic centimeter|Mean|317.5|317.5|Standard Deviation|24.70|24.7|||
4465561|NCT00050778|4283845|B4|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that quantifies disability in participants with MS. It assesses the 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS). Number of participants evaluable for this Baseline characteristic were 110, 112 and 110 in Interferon Beta-1a, Alemtuzumab 12 mg and Alemtuzumab 24 mg arm, respectively.|units on a scale|Mean|1.9|1.9|Standard Deviation|0.76|0.76|||
4465562|NCT00050778|4283846|B3|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that quantifies disability in participants with MS. It assesses the 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS). Number of participants evaluable for this Baseline characteristic were 110, 112 and 110 in Interferon Beta-1a, Alemtuzumab 12 mg and Alemtuzumab 24 mg arm, respectively.|units on a scale|Mean|2.0|2.0|Standard Deviation|0.73|0.73|||
4465563|NCT00050778|4283847|B2|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that quantifies disability in participants with MS. It assesses the 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS). Number of participants evaluable for this Baseline characteristic were 110, 112 and 110 in Interferon Beta-1a, Alemtuzumab 12 mg and Alemtuzumab 24 mg arm, respectively.|units on a scale|Mean|2.0|2.0|Standard Deviation|0.73|0.73|||
4465564|NCT00050778|4283848|B1|||Expanded Disability Status Scale (EDSS) Score|EDSS is an ordinal scale in half-point increments that quantifies disability in participants with MS. It assesses the 7 functional systems (visual, brainstem, pyramidal, cerebellar, sensory, bowel/bladder and cerebral) as well as ambulation. EDSS total score ranges from 0 (normal neurological examination) to 10 (death due to MS). Number of participants evaluable for this Baseline characteristic were 110, 112 and 110 in Interferon Beta-1a, Alemtuzumab 12 mg and Alemtuzumab 24 mg arm, respectively.|units on a scale|Mean|1.9|1.9|Standard Deviation|0.81|0.81|||
4465565|NCT00050778|4283845|B4|||Total Number of Relapses||relapses|Number|884|884.0||||||
4465566|NCT00050778|4283846|B3|||Total Number of Relapses||relapses|Number|290|290.0||||||
4465567|NCT00050778|4283847|B2|||Total Number of Relapses||relapses|Number|301|301.0||||||
4465568|NCT00050778|4283848|B1|||Total Number of Relapses||relapses|Number|293|293.0||||||
4465569|NCT00050778|4283845|B4|Greater than or equal to 3 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|117|117.0||||||
4465570|NCT00050778|4283846|B3|Greater than or equal to 3 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|40|40.0||||||
4465571|NCT00050778|4283847|B2|Greater than or equal to 3 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|47|47.0||||||
4465572|NCT00050778|4283848|B1|Greater than or equal to 3 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|30|30.0||||||
4465573|NCT00050778|4283845|B4|2 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|187|187.0||||||
4465574|NCT00050778|4283846|B3|2 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|56|56.0||||||
4465575|NCT00050778|4283847|B2|2 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|58|58.0||||||
4465576|NCT00050778|4283848|B1|2 Relapses||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|73|73.0||||||
4465577|NCT00050778|4283845|B4|1 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|26|26.0||||||
4465578|NCT00050778|4283846|B3|1 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|13|13.0||||||
4465579|NCT00050778|4283847|B2|1 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|5|5.0||||||
4465580|NCT00050778|4283848|B1|1 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|8|8.0||||||
4465581|NCT00050778|4283845|B4|0 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|3|3.0||||||
4465582|NCT00050778|4283846|B3|0 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|1|1.0||||||
4465583|NCT00050778|4283847|B2|0 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|2|2.0||||||
4465584|NCT00050778|4283848|B1|0 Relapse||Number of Relapse Episodes in the Preceding 2 Years|Number of participants with 0, 1, 2 or greater than or equal to 3 relapses are reported.|participants|Number|0|0.0||||||
4465585|NCT00050778|4283845|B4|||Time Since First Relapse||years|Median|1.3|1.3|Full Range|||0.1|6.3|
4465586|NCT00050778|4283846|B3|||Time Since First Relapse||years|Median|1.2|1.2|Full Range|||0.3|3.2|
4465587|NCT00050778|4283847|B2|||Time Since First Relapse||years|Median|1.3|1.3|Full Range|||0.1|3.5|
4465588|NCT00050778|4283848|B1|||Time Since First Relapse||years|Median|1.4|1.4|Full Range|||0.2|6.3|
4465589|NCT00050778|4283845|B4||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4465590|NCT00050778|4283846|B3||Male|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4465591|NCT00050778|4283847|B2||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4465592|NCT00050778|4283848|B1||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4465593|NCT00050778|4283845|B4||Female|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4465594|NCT00050778|4283846|B3||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4465595|NCT00050778|4283847|B2||Female|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4465596|NCT00050778|4283848|B1||Female|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4465599|NCT00050778|4283847|B2|||Age||years|Mean|31.9|31.9|Standard Deviation|8.01|8.01|||
4465600|NCT00050778|4283848|B1|||Age||years|Mean|32.8|32.8|Standard Deviation|8.82|8.82|||
4465601|NCT00050622|4283876|B1|United States||Region of Enrollment||participants|Number|154|154.0||||||
4465602|NCT00050622|4283876|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465603|NCT00050622|4283876|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4465604|NCT00050622|4283876|B1||White|Race (NIH/OMB)||Participants|Count of Participants|122|122.0||||||
4465605|NCT00050622|4283876|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4465606|NCT00050622|4283876|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465607|NCT00050622|4283876|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4465608|NCT00050622|4283876|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465609|NCT00050622|4283876|B1||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4465610|NCT00050622|4283876|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4465611|NCT00050622|4283876|B1|||Age||Years|Mean|9.15|9.15|Standard Deviation|2.02|2.02|||
4465612|NCT00050622|4283876|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4465613|NCT00050622|4283876|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4465614|NCT00050622|4283876|B1||<=18 years|Age||Participants|Count of Participants|154|154.0||||||
4465615|NCT00050167|4283912|B3|United States||Region of Enrollment||participants|Number|603|603.0||||||
4465616|NCT00050167|4283913|B2|United States||Region of Enrollment||participants|Number|301|301.0||||||
4465617|NCT00050167|4283914|B1|United States||Region of Enrollment||participants|Number|302|302.0||||||
4465618|NCT00050167|4283912|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465619|NCT00050167|4283913|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465620|NCT00050167|4283914|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465621|NCT00050167|4283912|B3||Female|Sex: Female, Male||Participants|Count of Participants|603|603.0||||||
4465622|NCT00050167|4283913|B2||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4465623|NCT00050167|4283914|B1||Female|Sex: Female, Male||Participants|Count of Participants|302|302.0||||||
4465624|NCT00050167|4283912|B3|||Age||years|Median|50|50.0|Full Range|||42.0|57.0|
4465625|NCT00050167|4283913|B2|||Age||years|Median|50|50.0|Full Range|||42.0|57.0|
4465626|NCT00050167|4283914|B1|||Age||years|Median|50|50.0|Full Range|||42.0|57.0|
4465627|NCT00050089|4283921|B5|Other antiviral||Concomitant Medications|Not all study participants were on other Concomitant Medications. Numbers provided represent participants on those medications at baseline.|participants|Number|136|136.0||||||
4465628|NCT00050089|4283922|B4|Other antiviral||Concomitant Medications|Not all study participants were on other Concomitant Medications. Numbers provided represent participants on those medications at baseline.|participants|Number|33|33.0||||||
4465629|NCT00050089|4283923|B3|Other antiviral||Concomitant Medications|Not all study participants were on other Concomitant Medications. Numbers provided represent participants on those medications at baseline.|participants|Number|30|30.0||||||
4465630|NCT00050089|4283924|B2|Other antiviral||Concomitant Medications|Not all study participants were on other Concomitant Medications. Numbers provided represent participants on those medications at baseline.|participants|Number|30|30.0||||||
4465631|NCT00050089|4283925|B1|Other antiviral||Concomitant Medications|Not all study participants were on other Concomitant Medications. Numbers provided represent participants on those medications at baseline.|participants|Number|43|43.0||||||
4465632|NCT00050089|4283921|B5|Lipid Lowering||Concomitant Medications|Not all study participants were on other Concomitant Medications. Numbers provided represent participants on those medications at baseline.|participants|Number|98|98.0||||||
4465633|NCT00050089|4283922|B4|Lipid Lowering||Concomitant Medications|Not all study participants were on other Concomitant Medications. Numbers provided represent participants on those medications at baseline.|participants|Number|21|21.0||||||
4465634|NCT00050089|4283923|B3|Lipid Lowering||Concomitant Medications|Not all study participants were on other Concomitant Medications. Numbers provided represent participants on those medications at baseline.|participants|Number|33|33.0||||||
4465635|NCT00050089|4283924|B2|Lipid Lowering||Concomitant Medications|Not all study participants were on other Concomitant Medications. Numbers provided represent participants on those medications at baseline.|participants|Number|20|20.0||||||
4465636|NCT00050089|4283925|B1|Lipid Lowering||Concomitant Medications|Not all study participants were on other Concomitant Medications. Numbers provided represent participants on those medications at baseline.|participants|Number|24|24.0||||||
4465637|NCT00050089|4283921|B5|Antifungal||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|86|86.0||||||
4465638|NCT00050089|4283922|B4|Antifungal||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|19|19.0||||||
4465639|NCT00050089|4283923|B3|Antifungal||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|22|22.0||||||
4465640|NCT00050089|4283924|B2|Antifungal||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|23|23.0||||||
4465641|NCT00050089|4283925|B1|Antifungal||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|22|22.0||||||
4465642|NCT00050089|4283921|B5|Antibacterial||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|152|152.0||||||
4465643|NCT00050089|4283922|B4|Antibacterial||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|37|37.0||||||
4465644|NCT00050089|4283923|B3|Antibacterial||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|33|33.0||||||
4465645|NCT00050089|4283924|B2|Antibacterial||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|39|39.0||||||
4465646|NCT00050089|4283925|B1|Antibacterial||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|43|43.0||||||
4465647|NCT00050089|4283921|B5|Anti-CMV||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|4|4.0||||||
4465648|NCT00050089|4283922|B4|Anti-CMV||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|0|0.0||||||
4465649|NCT00050089|4283923|B3|Anti-CMV||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|2|2.0||||||
4465650|NCT00050089|4283924|B2|Anti-CMV||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|0|0.0||||||
4465651|NCT00050089|4283925|B1|Anti-CMV||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|2|2.0||||||
4465652|NCT00050089|4283921|B5|Anti-PCP||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|275|275.0||||||
4465653|NCT00050089|4283922|B4|Anti-PCP||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|62|62.0||||||
4465654|NCT00050089|4283923|B3|Anti-PCP||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|71|71.0||||||
4465655|NCT00050089|4283924|B2|Anti-PCP||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|67|67.0||||||
4465656|NCT00050089|4283925|B1|Anti-PCP||OI medications for prophylaxis|Opportunistic Infections medications for prophylaxis at study entry|participants|Number|75|75.0||||||
4465657|NCT00050089|4283921|B5|No||Hepatitis C (Hep C anti-HCV)||participants|Number|262|262.0||||||
4465658|NCT00050089|4283922|B4|No||Hepatitis C (Hep C anti-HCV)||participants|Number|66|66.0||||||
4465659|NCT00050089|4283923|B3|No||Hepatitis C (Hep C anti-HCV)||participants|Number|59|59.0||||||
4465660|NCT00050089|4283924|B2|No||Hepatitis C (Hep C anti-HCV)||participants|Number|63|63.0||||||
4465661|NCT00050089|4283925|B1|No||Hepatitis C (Hep C anti-HCV)||participants|Number|74|74.0||||||
4465662|NCT00050089|4283921|B5|Yes||Hepatitis C (Hep C anti-HCV)||participants|Number|77|77.0||||||
4465663|NCT00050089|4283922|B4|Yes||Hepatitis C (Hep C anti-HCV)||participants|Number|12|12.0||||||
4465664|NCT00050089|4283923|B3|Yes||Hepatitis C (Hep C anti-HCV)||participants|Number|27|27.0||||||
4465665|NCT00050089|4283924|B2|Yes||Hepatitis C (Hep C anti-HCV)||participants|Number|21|21.0||||||
4465666|NCT00050089|4283925|B1|Yes||Hepatitis C (Hep C anti-HCV)||participants|Number|17|17.0||||||
4465667|NCT00050089|4283921|B5|No||Hepatitis B (HBsAg)||participants|Number|302|302.0||||||
4465668|NCT00050089|4283922|B4|No||Hepatitis B (HBsAg)||participants|Number|70|70.0||||||
4465669|NCT00050089|4283923|B3|No||Hepatitis B (HBsAg)||participants|Number|71|71.0||||||
4465670|NCT00050089|4283924|B2|No||Hepatitis B (HBsAg)||participants|Number|80|80.0||||||
4465671|NCT00050089|4283925|B1|No||Hepatitis B (HBsAg)||participants|Number|81|81.0||||||
4465672|NCT00050089|4283921|B5|Yes||Hepatitis B (HBsAg)||participants|Number|37|37.0||||||
4465673|NCT00050089|4283922|B4|Yes||Hepatitis B (HBsAg)||participants|Number|8|8.0||||||
4465674|NCT00050089|4283923|B3|Yes||Hepatitis B (HBsAg)||participants|Number|15|15.0||||||
4465675|NCT00050089|4283924|B2|Yes||Hepatitis B (HBsAg)||participants|Number|4|4.0||||||
4465676|NCT00050089|4283925|B1|Yes||Hepatitis B (HBsAg)||participants|Number|10|10.0||||||
4465677|NCT00050089|4283921|B5|No||AIDS at entry|History of AIDS event at study entry|participants|Number|139|139.0||||||
4465678|NCT00050089|4283922|B4|No||AIDS at entry|History of AIDS event at study entry|participants|Number|27|27.0||||||
4465679|NCT00050089|4283923|B3|No||AIDS at entry|History of AIDS event at study entry|participants|Number|42|42.0||||||
4465680|NCT00050089|4283924|B2|No||AIDS at entry|History of AIDS event at study entry|participants|Number|38|38.0||||||
4465681|NCT00050089|4283925|B1|No||AIDS at entry|History of AIDS event at study entry|participants|Number|32|32.0||||||
4465682|NCT00050089|4283921|B5|Yes||AIDS at entry|History of AIDS event at study entry|participants|Number|200|200.0||||||
4465683|NCT00050089|4283922|B4|Yes||AIDS at entry|History of AIDS event at study entry|participants|Number|51|51.0||||||
4465684|NCT00050089|4283923|B3|Yes||AIDS at entry|History of AIDS event at study entry|participants|Number|44|44.0||||||
4465685|NCT00050089|4283924|B2|Yes||AIDS at entry|History of AIDS event at study entry|participants|Number|46|46.0||||||
4465686|NCT00050089|4283925|B1|Yes||AIDS at entry|History of AIDS event at study entry|participants|Number|59|59.0||||||
4465687|NCT00050089|4283921|B5|Unknown||Mode of HIV Infection||participants|Number|2|2.0||||||
4465688|NCT00050089|4283922|B4|Unknown||Mode of HIV Infection||participants|Number|0|0.0||||||
4465689|NCT00050089|4283923|B3|Unknown||Mode of HIV Infection||participants|Number|2|2.0||||||
4465690|NCT00050089|4283924|B2|Unknown||Mode of HIV Infection||participants|Number|0|0.0||||||
4465691|NCT00050089|4283925|B1|Unknown||Mode of HIV Infection||participants|Number|0|0.0||||||
4465692|NCT00050089|4283921|B5|Other||Mode of HIV Infection||participants|Number|17|17.0||||||
4465693|NCT00050089|4283922|B4|Other||Mode of HIV Infection||participants|Number|4|4.0||||||
4465694|NCT00050089|4283923|B3|Other||Mode of HIV Infection||participants|Number|2|2.0||||||
4465695|NCT00050089|4283924|B2|Other||Mode of HIV Infection||participants|Number|5|5.0||||||
4465696|NCT00050089|4283925|B1|Other||Mode of HIV Infection||participants|Number|6|6.0||||||
4465697|NCT00050089|4283921|B5|Men who have Sex with Men (MSM)||Mode of HIV Infection||participants|Number|155|155.0||||||
4465698|NCT00050089|4283922|B4|Men who have Sex with Men (MSM)||Mode of HIV Infection||participants|Number|39|39.0||||||
4465699|NCT00050089|4283923|B3|Men who have Sex with Men (MSM)||Mode of HIV Infection||participants|Number|37|37.0||||||
4465700|NCT00050089|4283924|B2|Men who have Sex with Men (MSM)||Mode of HIV Infection||participants|Number|37|37.0||||||
4465701|NCT00050089|4283925|B1|Men who have Sex with Men (MSM)||Mode of HIV Infection||participants|Number|42|42.0||||||
4465702|NCT00050089|4283921|B5|Intravenous Drug Use (IVDU)||Mode of HIV Infection||participants|Number|51|51.0||||||
4465703|NCT00050089|4283922|B4|Intravenous Drug Use (IVDU)||Mode of HIV Infection||participants|Number|9|9.0||||||
4465704|NCT00050089|4283923|B3|Intravenous Drug Use (IVDU)||Mode of HIV Infection||participants|Number|15|15.0||||||
4465705|NCT00050089|4283924|B2|Intravenous Drug Use (IVDU)||Mode of HIV Infection||participants|Number|16|16.0||||||
4465706|NCT00050089|4283925|B1|Intravenous Drug Use (IVDU)||Mode of HIV Infection||participants|Number|11|11.0||||||
4465707|NCT00050089|4283921|B5|Heterosexual||Mode of HIV Infection||participants|Number|80|80.0||||||
4465708|NCT00050089|4283922|B4|Heterosexual||Mode of HIV Infection||participants|Number|19|19.0||||||
4465709|NCT00050089|4283923|B3|Heterosexual||Mode of HIV Infection||participants|Number|22|22.0||||||
4465710|NCT00050089|4283924|B2|Heterosexual||Mode of HIV Infection||participants|Number|19|19.0||||||
4465711|NCT00050089|4283925|B1|Heterosexual||Mode of HIV Infection||participants|Number|20|20.0||||||
4465712|NCT00050089|4283921|B5|Blood||Mode of HIV Infection||participants|Number|34|34.0||||||
4465713|NCT00050089|4283922|B4|Blood||Mode of HIV Infection||participants|Number|7|7.0||||||
4465714|NCT00050089|4283923|B3|Blood||Mode of HIV Infection||participants|Number|8|8.0||||||
4465715|NCT00050089|4283924|B2|Blood||Mode of HIV Infection||participants|Number|7|7.0||||||
4465716|NCT00050089|4283925|B1|Blood||Mode of HIV Infection||participants|Number|12|12.0||||||
4465717|NCT00050089|4283921|B5|CD4 >100 cells/mm^3||CD4 level||participants|Number|194|194.0||||||
4465718|NCT00050089|4283922|B4|CD4 >100 cells/mm^3||CD4 level||participants|Number|45|45.0||||||
4465719|NCT00050089|4283923|B3|CD4 >100 cells/mm^3||CD4 level||participants|Number|50|50.0||||||
4465720|NCT00050089|4283924|B2|CD4 >100 cells/mm^3||CD4 level||participants|Number|46|46.0||||||
4465721|NCT00050089|4283925|B1|CD4 >100 cells/mm^3||CD4 level||participants|Number|53|53.0||||||
4465722|NCT00050089|4283921|B5|CD4 <=100 cells/mm^3||CD4 level||participants|Number|145|145.0||||||
4465723|NCT00050089|4283922|B4|CD4 <=100 cells/mm^3||CD4 level||participants|Number|33|33.0||||||
4465724|NCT00050089|4283923|B3|CD4 <=100 cells/mm^3||CD4 level||participants|Number|36|36.0||||||
4465725|NCT00050089|4283924|B2|CD4 <=100 cells/mm^3||CD4 level||participants|Number|38|38.0||||||
4465726|NCT00050089|4283925|B1|CD4 <=100 cells/mm^3||CD4 level||participants|Number|38|38.0||||||
4465727|NCT00050089|4283921|B5|||CD4 cells/mm3||cells/mm^3|Mean|130|130.0|Standard Deviation|108|108.0|||
4465728|NCT00050089|4283922|B4|||CD4 cells/mm3||cells/mm^3|Mean|127|127.0|Standard Deviation|106|106.0|||
4465729|NCT00050089|4283923|B3|||CD4 cells/mm3||cells/mm^3|Mean|130|130.0|Standard Deviation|106|106.0|||
4465730|NCT00050089|4283924|B2|||CD4 cells/mm3||cells/mm^3|Mean|127|127.0|Standard Deviation|107|107.0|||
4465731|NCT00050089|4283925|B1|||CD4 cells/mm3||cells/mm^3|Mean|136|136.0|Standard Deviation|112|112.0|||
4465732|NCT00050089|4283921|B5|||log10 Viral Load||log10 copies/mL|Mean|4.71|4.71|Standard Deviation|0.68|0.68|||
4465733|NCT00050089|4283922|B4|||log10 Viral Load||log10 copies/mL|Mean|4.7|4.7|Standard Deviation|0.75|0.75|||
4465734|NCT00050089|4283923|B3|||log10 Viral Load||log10 copies/mL|Mean|4.64|4.64|Standard Deviation|0.67|0.67|||
4465735|NCT00050089|4283924|B2|||log10 Viral Load||log10 copies/mL|Mean|4.75|4.75|Standard Deviation|0.76|0.76|||
4465736|NCT00050089|4283925|B1|||log10 Viral Load||log10 copies/mL|Mean|4.76|4.76|Standard Deviation|0.55|0.55|||
4465737|NCT00050089|4283921|B5|Canada||Region of Enrollment||participants|Number|41|41.0||||||
4465738|NCT00050089|4283922|B4|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4465739|NCT00050089|4283923|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4465740|NCT00050089|4283924|B2|Canada||Region of Enrollment||participants|Number|11|11.0||||||
4465741|NCT00050089|4283925|B1|Canada||Region of Enrollment||participants|Number|12|12.0||||||
4465742|NCT00050089|4283921|B5|United Kingdom||Region of Enrollment||participants|Number|10|10.0||||||
4465743|NCT00050089|4283922|B4|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4465744|NCT00050089|4283923|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4465745|NCT00050089|4283924|B2|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4465746|NCT00050089|4283925|B1|United Kingdom||Region of Enrollment||participants|Number|2|2.0||||||
4465747|NCT00050089|4283921|B5|United States||Region of Enrollment||participants|Number|288|288.0||||||
4465748|NCT00050089|4283922|B4|United States||Region of Enrollment||participants|Number|67|67.0||||||
4465749|NCT00050089|4283923|B3|United States||Region of Enrollment||participants|Number|73|73.0||||||
4465750|NCT00050089|4283924|B2|United States||Region of Enrollment||participants|Number|71|71.0||||||
4465751|NCT00050089|4283925|B1|United States||Region of Enrollment||participants|Number|77|77.0||||||
4465752|NCT00050089|4283921|B5|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4465753|NCT00050089|4283922|B4|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4465754|NCT00050089|4283923|B3|Other||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4465755|NCT00050089|4283924|B2|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4465756|NCT00050089|4283925|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4465757|NCT00050089|4283921|B5|Aboriginal||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4465758|NCT00050089|4283922|B4|Aboriginal||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4465759|NCT00050089|4283923|B3|Aboriginal||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4465760|NCT00050089|4283924|B2|Aboriginal||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4465761|NCT00050089|4283925|B1|Aboriginal||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4465762|NCT00050089|4283921|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4465763|NCT00050089|4283922|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|12|12.0||||||
4465764|NCT00050089|4283923|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4465765|NCT00050089|4283924|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4465766|NCT00050089|4283925|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4465767|NCT00050089|4283921|B5|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4465768|NCT00050089|4283922|B4|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4465769|NCT00050089|4283923|B3|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4465770|NCT00050089|4283924|B2|Asian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4465771|NCT00050089|4283925|B1|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4465772|NCT00050089|4283921|B5|Black||Race/Ethnicity, Customized||participants|Number|138|138.0||||||
4465773|NCT00050089|4283922|B4|Black||Race/Ethnicity, Customized||participants|Number|31|31.0||||||
4465774|NCT00050089|4283923|B3|Black||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4465775|NCT00050089|4283924|B2|Black||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4465776|NCT00050089|4283925|B1|Black||Race/Ethnicity, Customized||participants|Number|41|41.0||||||
4465777|NCT00050089|4283921|B5|White||Race/Ethnicity, Customized||participants|Number|160|160.0||||||
4465778|NCT00050089|4283922|B4|White||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4465779|NCT00050089|4283923|B3|White||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4465780|NCT00050089|4283924|B2|White||Race/Ethnicity, Customized||participants|Number|45|45.0||||||
4465781|NCT00050089|4283925|B1|White||Race/Ethnicity, Customized||participants|Number|42|42.0||||||
4465782|NCT00050089|4283921|B5||Male|Sex: Female, Male||Participants|Count of Participants|332|332.0||||||
4465783|NCT00050089|4283922|B4||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4465784|NCT00050089|4283923|B3||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4465785|NCT00050089|4283924|B2||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4465786|NCT00050089|4283925|B1||Male|Sex: Female, Male||Participants|Count of Participants|90|90.0||||||
4465787|NCT00050089|4283921|B5||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4465788|NCT00050089|4283922|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4465789|NCT00050089|4283923|B3||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4465790|NCT00050089|4283924|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4465791|NCT00050089|4283925|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4465792|NCT00050089|4283921|B5|>60 years||Age, Customized||participants|Number|23|23.0||||||
4465793|NCT00050089|4283922|B4|>60 years||Age, Customized||participants|Number|5|5.0||||||
4465794|NCT00050089|4283923|B3|>60 years||Age, Customized||participants|Number|7|7.0||||||
4465795|NCT00050089|4283924|B2|>60 years||Age, Customized||participants|Number|4|4.0||||||
4465796|NCT00050089|4283925|B1|>60 years||Age, Customized||participants|Number|7|7.0||||||
4465797|NCT00050089|4283921|B5|51-60 years||Age, Customized||participants|Number|120|120.0||||||
4465798|NCT00050089|4283922|B4|51-60 years||Age, Customized||participants|Number|28|28.0||||||
4465799|NCT00050089|4283923|B3|51-60 years||Age, Customized||participants|Number|31|31.0||||||
4465800|NCT00050089|4283924|B2|51-60 years||Age, Customized||participants|Number|28|28.0||||||
4465801|NCT00050089|4283925|B1|51-60 years||Age, Customized||participants|Number|33|33.0||||||
4465802|NCT00050089|4283921|B5|41-50 years||Age, Customized||participants|Number|142|142.0||||||
4465803|NCT00050089|4283922|B4|41-50 years||Age, Customized||participants|Number|30|30.0||||||
4465804|NCT00050089|4283923|B3|41-50 years||Age, Customized||participants|Number|36|36.0||||||
4465805|NCT00050089|4283924|B2|41-50 years||Age, Customized||participants|Number|41|41.0||||||
4465806|NCT00050089|4283925|B1|41-50 years||Age, Customized||participants|Number|35|35.0||||||
4465807|NCT00050089|4283921|B5|31-40 years||Age, Customized||participants|Number|54|54.0||||||
4465808|NCT00050089|4283922|B4|31-40 years||Age, Customized||participants|Number|15|15.0||||||
4465809|NCT00050089|4283923|B3|31-40 years||Age, Customized||participants|Number|12|12.0||||||
4465810|NCT00050089|4283924|B2|31-40 years||Age, Customized||participants|Number|11|11.0||||||
4465811|NCT00050089|4283925|B1|31-40 years||Age, Customized||participants|Number|16|16.0||||||
4465812|NCT00050089|4283921|B5|||Age||years|Mean|48.6|48.6|Standard Deviation|8.39|8.39|||
4465813|NCT00050089|4283922|B4|||Age||years|Mean|48.2|48.2|Standard Deviation|8.58|8.58|||
4465814|NCT00050089|4283923|B3|||Age||years|Mean|49.2|49.2|Standard Deviation|8.1|8.1|||
4465815|NCT00050089|4283924|B2|||Age||years|Mean|48.3|48.3|Standard Deviation|7.92|7.92|||
4465816|NCT00050089|4283925|B1|||Age||years|Mean|48.7|48.7|Standard Deviation|8.99|8.99|||
4465817|NCT00050011|4283946|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465818|NCT00050011|4283947|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465819|NCT00050011|4283948|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465820|NCT00050011|4283946|B3||Female|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
4465821|NCT00050011|4283947|B2||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4465822|NCT00050011|4283948|B1||Female|Sex: Female, Male||Participants|Count of Participants|301|301.0||||||
4465823|NCT00050011|4283946|B3|||Age||years|Mean|61.2|61.2|Standard Deviation|9.1|9.1|||
4465824|NCT00050011|4283947|B2|||Age||years|Mean|61.0|61.0|Standard Deviation|8.92|8.92|||
4465825|NCT00050011|4283948|B1|||Age||years|Mean|61.4|61.4|Standard Deviation|9.28|9.28|||
4465826|NCT00049842|4283969|B3||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4465827|NCT00049842|4283970|B2||Male|Sex: Female, Male||Participants|Count of Participants|189|189.0||||||
4465828|NCT00049842|4283971|B1||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4465829|NCT00049842|4283969|B3||Female|Sex: Female, Male||Participants|Count of Participants|157|157.0||||||
4465830|NCT00049842|4283970|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4465831|NCT00049842|4283971|B1||Female|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4465832|NCT00049842|4283969|B3|>50 years||Age, Customized||participants|Number|247|247.0||||||
4465833|NCT00049842|4283970|B2|>50 years||Age, Customized||participants|Number|122|122.0||||||
4465834|NCT00049842|4283971|B1|>50 years||Age, Customized||participants|Number|125|125.0||||||
4465835|NCT00049842|4283969|B3|<=50 years||Age, Customized||participants|Number|293|293.0||||||
4465836|NCT00049842|4283970|B2|<=50 years||Age, Customized||participants|Number|148|148.0||||||
4465837|NCT00049842|4283971|B1|<=50 years||Age, Customized||participants|Number|145|145.0||||||
4465838|NCT00048932|4283988|B3||Male|Sex: Female, Male||Participants|Count of Participants|254|254.0||||||
4465839|NCT00048932|4283989|B2||Male|Sex: Female, Male||Participants|Count of Participants|84|84.0||||||
4465840|NCT00048932|4283990|B1||Male|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4465841|NCT00048932|4283988|B3||Female|Sex: Female, Male||Participants|Count of Participants|1187|1187.0||||||
4465842|NCT00048932|4283989|B2||Female|Sex: Female, Male||Participants|Count of Participants|398|398.0||||||
4465843|NCT00048932|4283990|B1||Female|Sex: Female, Male||Participants|Count of Participants|789|789.0||||||
4465844|NCT00048932|4283988|B3|||Age||years|Mean|52.3|52.3|Standard Deviation|11.8|11.8|||
4465845|NCT00048932|4283989|B2|||Age||years|Mean|52.1|52.1|Standard Deviation|12.0|12.0|||
4465846|NCT00048932|4283990|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|11.7|11.7|||
4465847|NCT00048815|4284016|B4|United States||Region of Enrollment||participants|Number|73|73.0||||||
4465848|NCT00048815|4284017|B3|United States||Region of Enrollment||participants|Number|23|23.0||||||
4465849|NCT00048815|4284018|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4465850|NCT00048815|4284019|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4465851|NCT00048815|4284016|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465852|NCT00048815|4284017|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465853|NCT00048815|4284018|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465854|NCT00048815|4284019|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465855|NCT00048815|4284016|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|70|70.0||||||
4465856|NCT00048815|4284017|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4465857|NCT00048815|4284018|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4465858|NCT00048815|4284019|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4465859|NCT00048815|4284016|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4465860|NCT00048815|4284017|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465861|NCT00048815|4284018|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465862|NCT00048815|4284019|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4465863|NCT00048815|4284016|B4||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4465864|NCT00048815|4284017|B3||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4465865|NCT00048815|4284018|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4465866|NCT00048815|4284019|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4465867|NCT00048815|4284016|B4||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4465868|NCT00048815|4284017|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4465869|NCT00048815|4284018|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4465870|NCT00048815|4284019|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4465871|NCT00048815|4284016|B4|||Age||years|Mean|48.1|48.1|Standard Deviation|15.0|15.0|||
4465872|NCT00048815|4284017|B3|||Age||years|Mean|51.4|51.4|Standard Deviation|16.6|16.6|||
4465873|NCT00048815|4284018|B2|||Age||years|Mean|42.2|42.2|Standard Deviation|14.1|14.1|||
4465874|NCT00048815|4284019|B1|||Age||years|Mean|51.3|51.3|Standard Deviation|12.5|12.5|||
4465875|NCT00048581|4284032|B3|||Weight||kg|Mean|78.2|78.2|Standard Deviation|19.7|19.7|||
4465876|NCT00048581|4284033|B2|||Weight||kg|Mean|78.2|78.2|Standard Deviation|21.0|21.0|||
4465877|NCT00048581|4284034|B1|||Weight||kg|Mean|78.2|78.2|Standard Deviation|19.0|19.0|||
4465878|NCT00048581|4284032|B3|Europe||Region of Enrollment||participants|Number|103|103.0||||||
4465879|NCT00048581|4284033|B2|Europe||Region of Enrollment||participants|Number|34|34.0||||||
4465880|NCT00048581|4284034|B1|Europe||Region of Enrollment||participants|Number|69|69.0||||||
4465881|NCT00048581|4284032|B3|North America||Region of Enrollment||participants|Number|288|288.0||||||
4465882|NCT00048581|4284033|B2|North America||Region of Enrollment||participants|Number|99|99.0||||||
4465883|NCT00048581|4284034|B1|North America||Region of Enrollment||participants|Number|189|189.0||||||
4465884|NCT00048581|4284032|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465885|NCT00048581|4284033|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465886|NCT00048581|4284034|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465887|NCT00048581|4284032|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465888|NCT00048581|4284033|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465889|NCT00048581|4284034|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465890|NCT00048581|4284032|B3||White|Race (NIH/OMB)||Participants|Count of Participants|372|372.0||||||
4465891|NCT00048581|4284033|B2||White|Race (NIH/OMB)||Participants|Count of Participants|124|124.0||||||
4465892|NCT00048581|4284034|B1||White|Race (NIH/OMB)||Participants|Count of Participants|248|248.0||||||
4465893|NCT00048581|4284032|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4465894|NCT00048581|4284033|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4465895|NCT00048581|4284034|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4465896|NCT00048581|4284032|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465897|NCT00048581|4284033|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465898|NCT00048581|4284034|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465899|NCT00048581|4284032|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4465900|NCT00048581|4284033|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4465901|NCT00048581|4284034|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465902|NCT00048581|4284032|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4465903|NCT00048581|4284033|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465904|NCT00048581|4284034|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465905|NCT00048581|4284032|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4465906|NCT00048581|4284033|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4465907|NCT00048581|4284034|B1||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4465908|NCT00048581|4284032|B3||Female|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4465909|NCT00048581|4284033|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4465910|NCT00048581|4284034|B1||Female|Sex: Female, Male||Participants|Count of Participants|199|199.0||||||
4465911|NCT00048581|4284032|B3|||Age||years|Mean|53.2|53.2|Standard Deviation|12.1|12.1|||
4465912|NCT00048581|4284033|B2|||Age||years|Mean|52.7|52.7|Standard Deviation|11.3|11.3|||
4465913|NCT00048581|4284034|B1|||Age||years|Mean|53.4|53.4|Standard Deviation|12.4|12.4|||
4465914|NCT00048568|4284201|B3|> 10 years||Duration of Rheumatoid Arthritis (RA) Disease|Number of participants with RA duration <= 2 years, > 2 years to <= 5 years, > 5 years to <= 10 years, and > 10 years as evaluated at baseline.|Participants|Number|209|209.0||||||
4465915|NCT00048568|4284202|B2|> 10 years||Duration of Rheumatoid Arthritis (RA) Disease|Number of participants with RA duration <= 2 years, > 2 years to <= 5 years, > 5 years to <= 10 years, and > 10 years as evaluated at baseline.|Participants|Number|74|74.0||||||
4465916|NCT00048568|4284203|B1|> 10 years||Duration of Rheumatoid Arthritis (RA) Disease|Number of participants with RA duration <= 2 years, > 2 years to <= 5 years, > 5 years to <= 10 years, and > 10 years as evaluated at baseline.|Participants|Number|135|135.0||||||
4465917|NCT00048568|4284201|B3|> 5 years to <=10 years||Duration of Rheumatoid Arthritis (RA) Disease|Number of participants with RA duration <= 2 years, > 2 years to <= 5 years, > 5 years to <= 10 years, and > 10 years as evaluated at baseline.|Participants|Number|160|160.0||||||
4465918|NCT00048568|4284202|B2|> 5 years to <=10 years||Duration of Rheumatoid Arthritis (RA) Disease|Number of participants with RA duration <= 2 years, > 2 years to <= 5 years, > 5 years to <= 10 years, and > 10 years as evaluated at baseline.|Participants|Number|54|54.0||||||
4465919|NCT00048568|4284203|B1|> 5 years to <=10 years||Duration of Rheumatoid Arthritis (RA) Disease|Number of participants with RA duration <= 2 years, > 2 years to <= 5 years, > 5 years to <= 10 years, and > 10 years as evaluated at baseline.|Participants|Number|106|106.0||||||
4465920|NCT00048568|4284201|B3|> 2 years to <= 5 years||Duration of Rheumatoid Arthritis (RA) Disease|Number of participants with RA duration <= 2 years, > 2 years to <= 5 years, > 5 years to <= 10 years, and > 10 years as evaluated at baseline.|Participants|Number|139|139.0||||||
4465921|NCT00048568|4284202|B2|> 2 years to <= 5 years||Duration of Rheumatoid Arthritis (RA) Disease|Number of participants with RA duration <= 2 years, > 2 years to <= 5 years, > 5 years to <= 10 years, and > 10 years as evaluated at baseline.|Participants|Number|46|46.0||||||
4465922|NCT00048568|4284203|B1|> 2 years to <= 5 years||Duration of Rheumatoid Arthritis (RA) Disease|Number of participants with RA duration <= 2 years, > 2 years to <= 5 years, > 5 years to <= 10 years, and > 10 years as evaluated at baseline.|Participants|Number|93|93.0||||||
4465923|NCT00048568|4284201|B3|<= 2 years||Duration of Rheumatoid Arthritis (RA) Disease|Number of participants with RA duration <= 2 years, > 2 years to <= 5 years, > 5 years to <= 10 years, and > 10 years as evaluated at baseline.|Participants|Number|144|144.0||||||
4465924|NCT00048568|4284202|B2|<= 2 years||Duration of Rheumatoid Arthritis (RA) Disease|Number of participants with RA duration <= 2 years, > 2 years to <= 5 years, > 5 years to <= 10 years, and > 10 years as evaluated at baseline.|Participants|Number|45|45.0||||||
4465925|NCT00048568|4284203|B1|<= 2 years||Duration of Rheumatoid Arthritis (RA) Disease|Number of participants with RA duration <= 2 years, > 2 years to <= 5 years, > 5 years to <= 10 years, and > 10 years as evaluated at baseline.|Participants|Number|99|99.0||||||
4465926|NCT00048568|4284201|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|34|34.0||||||
4465927|NCT00048568|4284202|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4465928|NCT00048568|4284203|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|23|23.0||||||
4465929|NCT00048568|4284201|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465930|NCT00048568|4284202|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465931|NCT00048568|4284203|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465932|NCT00048568|4284201|B3||White|Race (NIH/OMB)||Participants|Count of Participants|572|572.0||||||
4465933|NCT00048568|4284202|B2||White|Race (NIH/OMB)||Participants|Count of Participants|193|193.0||||||
4465934|NCT00048568|4284203|B1||White|Race (NIH/OMB)||Participants|Count of Participants|379|379.0||||||
4465935|NCT00048568|4284201|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4465936|NCT00048568|4284202|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4465937|NCT00048568|4284203|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4465938|NCT00048568|4284201|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465939|NCT00048568|4284202|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465940|NCT00048568|4284203|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4465941|NCT00048568|4284201|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4465942|NCT00048568|4284202|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4465943|NCT00048568|4284203|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4465944|NCT00048568|4284201|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4465945|NCT00048568|4284202|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465946|NCT00048568|4284203|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4465947|NCT00048568|4284201|B3||Male|Sex: Female, Male||Participants|Count of Participants|516|516.0||||||
4465948|NCT00048568|4284202|B2||Male|Sex: Female, Male||Participants|Count of Participants|179|179.0||||||
4465949|NCT00048568|4284203|B1||Male|Sex: Female, Male||Participants|Count of Participants|337|337.0||||||
4465950|NCT00048568|4284201|B3||Female|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4465951|NCT00048568|4284202|B2||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4465952|NCT00048568|4284203|B1||Female|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4465953|NCT00048568|4284201|B3|||Age||years|Mean|51.1|51.1|Standard Deviation|12.7|12.7|||
4465954|NCT00048568|4284202|B2|||Age||years|Mean|50.4|50.4|Standard Deviation|12.4|12.4|||
4465955|NCT00048568|4284203|B1|||Age||years|Mean|51.5|51.5|Standard Deviation|12.9|12.9|||
4465956|NCT00048893|4284493|B1|United States||Region of Enrollment||participants|Number|37|37.0||||||
4465957|NCT00048893|4284493|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4465958|NCT00048893|4284493|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4465959|NCT00048893|4284493|B1|White||Race/Ethnicity, Customized||Participants|Number|26|26.0||||||
4465960|NCT00048893|4284493|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4465961|NCT00048893|4284493|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465962|NCT00048893|4284493|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|35|35.0||||||
4465963|NCT00048893|4284493|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4465964|NCT00048893|4284493|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4465965|NCT00048893|4284493|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4465966|NCT00048893|4284493|B1|||Age||years|Mean|52|52.0|Standard Deviation|7.92|7.92|||
4465967|NCT00048893|4284493|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4465968|NCT00048893|4284493|B1||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4465969|NCT00048893|4284493|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465970|NCT00048737|4284504|B1|United States||Region of Enrollment||participants|Number|70|70.0||||||
4465971|NCT00048737|4284504|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4465972|NCT00048737|4284504|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4465973|NCT00048737|4284504|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4465974|NCT00048737|4284504|B1||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4465975|NCT00048737|4284504|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4465976|NCT00048724|4284508|B3||Male|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4465977|NCT00048724|4284509|B2||Male|Sex: Female, Male||Participants|Count of Participants|215|215.0||||||
4465978|NCT00048724|4284510|B1||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4465979|NCT00048724|4284508|B3||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4465980|NCT00048724|4284509|B2||Female|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4465981|NCT00048724|4284510|B1||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4465982|NCT00048724|4284508|B3|>50 years||Age, Customized||Participants|Number|364|364.0||||||
4465983|NCT00048724|4284509|B2|>50 years||Age, Customized||Participants|Number|183|183.0||||||
4465984|NCT00048724|4284510|B1|>50 years||Age, Customized||Participants|Number|181|181.0||||||
4465985|NCT00048724|4284508|B3|<=50 years||Age, Customized||Participants|Number|262|262.0||||||
4465986|NCT00048724|4284509|B2|<=50 years||Age, Customized||Participants|Number|132|132.0||||||
4465987|NCT00048724|4284510|B1|<=50 years||Age, Customized||Participants|Number|130|130.0||||||
4465988|NCT00048542|4284519|B5||Male|Sex: Female, Male|Numbers represent participants in the Double-Blind Phase only.|Participants|Count of Participants|30|30.0||||||
4465989|NCT00048542|4284520|B4||Male|Sex: Female, Male|Numbers represent participants in the Double-Blind Phase only.|Participants|Count of Participants|8|8.0||||||
4465990|NCT00048542|4284521|B3||Male|Sex: Female, Male|Numbers represent participants in the Double-Blind Phase only.|Participants|Count of Participants|7|7.0||||||
4465991|NCT00048542|4284522|B2||Male|Sex: Female, Male|Numbers represent participants in the Double-Blind Phase only.|Participants|Count of Participants|7|7.0||||||
4465992|NCT00048542|4284523|B1||Male|Sex: Female, Male|Numbers represent participants in the Double-Blind Phase only.|Participants|Count of Participants|8|8.0||||||
4465993|NCT00048542|4284519|B5||Female|Sex: Female, Male|Numbers represent participants in the Double-Blind Phase only.|Participants|Count of Participants|103|103.0||||||
4465994|NCT00048542|4284520|B4||Female|Sex: Female, Male|Numbers represent participants in the Double-Blind Phase only.|Participants|Count of Participants|20|20.0||||||
4465995|NCT00048542|4284521|B3||Female|Sex: Female, Male|Numbers represent participants in the Double-Blind Phase only.|Participants|Count of Participants|23|23.0||||||
4465996|NCT00048542|4284522|B2||Female|Sex: Female, Male|Numbers represent participants in the Double-Blind Phase only.|Participants|Count of Participants|30|30.0||||||
4465997|NCT00048542|4284523|B1||Female|Sex: Female, Male|Numbers represent participants in the Double-Blind Phase only.|Participants|Count of Participants|30|30.0||||||
4465998|NCT00048542|4284519|B5|||Age|Age for participants in the Double-Blind Phase only.|years|Mean|11.2|11.2|Standard Deviation|3.64|3.64|||
4465999|NCT00048542|4284520|B4|||Age|Age for participants in the Double-Blind Phase only.|years|Mean|11.3|11.3|Standard Deviation|3.77|3.77|||
4466000|NCT00048542|4284521|B3|||Age|Age for participants in the Double-Blind Phase only.|years|Mean|11.1|11.1|Standard Deviation|4.13|4.13|||
4466001|NCT00048542|4284522|B2|||Age|Age for participants in the Double-Blind Phase only.|years|Mean|10.8|10.8|Standard Deviation|3.36|3.36|||
4466002|NCT00048542|4284523|B1|||Age|Age for participants in the Double-Blind Phase only.|years|Mean|11.7|11.7|Standard Deviation|3.29|3.29|||
4466003|NCT00048347|4284596|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4466004|NCT00048347|4284596|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4466005|NCT00048347|4284596|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4466006|NCT00048347|4284596|B1|||Age||years|Mean|39.4|39.4|Standard Deviation|4.3|4.3|||
4466007|NCT00048347|4284596|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4466008|NCT00048347|4284596|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4466009|NCT00048347|4284596|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4466010|NCT00048165|4284600|B3||Male|Sex: Female, Male||Participants|Count of Participants|348|348.0||||||
4466011|NCT00048165|4284601|B2||Male|Sex: Female, Male||Participants|Count of Participants|177|177.0||||||
4466012|NCT00048165|4284602|B1||Male|Sex: Female, Male||Participants|Count of Participants|171|171.0||||||
4466013|NCT00048165|4284600|B3||Female|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4466014|NCT00048165|4284601|B2||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4466015|NCT00048165|4284602|B1||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4466016|NCT00048165|4284600|B3|||Age||years|Mean|52.8|52.8|Standard Deviation|11.81|11.81|||
4466017|NCT00048165|4284601|B2|||Age||years|Mean|53.1|53.1|Standard Deviation|11.89|11.89|||
4466018|NCT00048165|4284602|B1|||Age||years|Mean|52.4|52.4|Standard Deviation|11.75|11.75|||
4466019|NCT00048074|4284635|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466020|NCT00048074|4284636|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466021|NCT00048074|4284637|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466022|NCT00048074|4284638|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466023|NCT00048074|4284635|B4||Female|Sex: Female, Male||Participants|Count of Participants|1382|1382.0||||||
4466024|NCT00048074|4284636|B3||Female|Sex: Female, Male||Participants|Count of Participants|469|469.0||||||
4466025|NCT00048074|4284637|B2||Female|Sex: Female, Male||Participants|Count of Participants|448|448.0||||||
4466026|NCT00048074|4284638|B1||Female|Sex: Female, Male||Participants|Count of Participants|465|465.0||||||
4466027|NCT00048074|4284635|B4|||Age||Years|Mean|66.0|66.0|Standard Deviation|6.22|6.22|||
4466028|NCT00048074|4284636|B3|||Age||Years|Mean|65.8|65.8|Standard Deviation|6.30|6.3|||
4466029|NCT00048074|4284637|B2|||Age||Years|Mean|66.6|66.6|Standard Deviation|6.26|6.26|||
4466030|NCT00048074|4284638|B1|||Age||Years|Mean|65.7|65.7|Standard Deviation|6.08|6.08|||
4466031|NCT00048061|4284693|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466032|NCT00048061|4284694|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466033|NCT00048061|4284695|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466034|NCT00048061|4284696|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466035|NCT00048061|4284697|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466036|NCT00048061|4284693|B5||Female|Sex: Female, Male||Participants|Count of Participants|1583|1583.0||||||
4466037|NCT00048061|4284694|B4||Female|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
4466038|NCT00048061|4284695|B3||Female|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
4466039|NCT00048061|4284696|B2||Female|Sex: Female, Male||Participants|Count of Participants|396|396.0||||||
4466040|NCT00048061|4284697|B1||Female|Sex: Female, Male||Participants|Count of Participants|395|395.0||||||
4466041|NCT00048061|4284693|B5|||Age||years|Mean|66.0|66.0|Standard Deviation|6.58|6.58|||
4466042|NCT00048061|4284694|B4|||Age||years|Mean|66.2|66.2|Standard Deviation|6.64|6.64|||
4466043|NCT00048061|4284695|B3|||Age||years|Mean|66.2|66.2|Standard Deviation|6.38|6.38|||
4466044|NCT00048061|4284696|B2|||Age||years|Mean|66.0|66.0|Standard Deviation|6.71|6.71|||
4466045|NCT00048061|4284697|B1|||Age||years|Mean|65.8|65.8|Standard Deviation|6.61|6.61|||
4466046|NCT00048048|4284770|B10||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4466047|NCT00048048|4284771|B9||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4466048|NCT00048048|4284772|B8||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4466049|NCT00048048|4284773|B7||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4466050|NCT00048048|4284774|B6||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4466051|NCT00048048|4284775|B5||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4466052|NCT00048048|4284776|B4||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4466053|NCT00048048|4284777|B3||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4466054|NCT00048048|4284778|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4466055|NCT00048048|4284779|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4466056|NCT00048048|4284770|B10||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4466057|NCT00048048|4284771|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4466058|NCT00048048|4284772|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4466059|NCT00048048|4284773|B7||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4466060|NCT00048048|4284774|B6||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4466061|NCT00048048|4284775|B5||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4466062|NCT00048048|4284776|B4||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4466063|NCT00048048|4284777|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4466064|NCT00048048|4284778|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4466065|NCT00048048|4284779|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4466066|NCT00048048|4284770|B10|||Age||Years|Mean|60.9|60.9|Standard Deviation|16.20|16.2|||
4466067|NCT00048048|4284771|B9|||Age||Years|Mean|58.3|58.3|Standard Deviation|18.42|18.42|||
4466068|NCT00048048|4284772|B8|||Age||Years|Mean|54.5|54.5|Standard Deviation|16.85|16.85|||
4466069|NCT00048048|4284773|B7|||Age||Years|Mean|66.5|66.5|Standard Deviation|9.42|9.42|||
4466070|NCT00048048|4284774|B6|||Age||Years|Mean|62.3|62.3|Standard Deviation|12.63|12.63|||
4466071|NCT00048048|4284775|B5|||Age||Years|Mean|62.7|62.7|Standard Deviation|21.29|21.29|||
4466072|NCT00048048|4284776|B4|||Age||Years|Mean|60.3|60.3|Standard Deviation|16.80|16.8|||
4466073|NCT00048048|4284777|B3|||Age||Years|Mean|58.0|58.0|Standard Deviation|16.55|16.55|||
4466074|NCT00048048|4284778|B2|||Age||Years|Mean|70.0|70.0|Standard Deviation|13.75|13.75|||
4466075|NCT00048048|4284779|B1|||Age||Years|Mean|58.2|58.2|Standard Deviation|21.66|21.66|||
4466076|NCT00048035|4284840|B7||Male|Gender||Participants|Count of Participants|60|60.0||||||
4466077|NCT00048035|4284841|B6||Male|Gender||Participants|Count of Participants|12|12.0||||||
4466078|NCT00048035|4284842|B5||Male|Gender||Participants|Count of Participants|10|10.0||||||
4466079|NCT00048035|4284843|B4||Male|Gender||Participants|Count of Participants|9|9.0||||||
4466080|NCT00048035|4284844|B3||Male|Gender||Participants|Count of Participants|9|9.0||||||
4466081|NCT00048035|4284845|B2||Male|Gender||Participants|Count of Participants|7|7.0||||||
4466082|NCT00048035|4284846|B1||Male|Gender||Participants|Count of Participants|13|13.0||||||
4466083|NCT00048035|4284840|B7||Female|Gender||Participants|Count of Participants|31|31.0||||||
4466084|NCT00048035|4284841|B6||Female|Gender||Participants|Count of Participants|3|3.0||||||
4466085|NCT00048035|4284842|B5||Female|Gender||Participants|Count of Participants|6|6.0||||||
4466086|NCT00048035|4284843|B4||Female|Gender||Participants|Count of Participants|6|6.0||||||
4466087|NCT00048035|4284844|B3||Female|Gender||Participants|Count of Participants|6|6.0||||||
4466088|NCT00048035|4284845|B2||Female|Gender||Participants|Count of Participants|8|8.0||||||
4466089|NCT00048035|4284846|B1||Female|Gender||Participants|Count of Participants|2|2.0||||||
4466090|NCT00048035|4284840|B7|||Age||years|Mean|58.00|58.0|Standard Deviation|12.91|12.91|||
4466091|NCT00048035|4284841|B6|||Age||years|Mean|62.5|62.5|Standard Deviation|10.77|10.77|||
4466092|NCT00048035|4284842|B5|||Age||years|Mean|60.1|60.1|Standard Deviation|11.89|11.89|||
4466093|NCT00048035|4284843|B4|||Age||years|Mean|62.8|62.8|Standard Deviation|15.76|15.76|||
4466094|NCT00048035|4284844|B3|||Age||years|Mean|53.8|53.8|Standard Deviation|12.72|12.72|||
4466095|NCT00048035|4284845|B2|||Age||years|Mean|58.6|58.6|Standard Deviation|12.64|12.64|||
4466096|NCT00048035|4284846|B1|||Age||years|Mean|50.2|50.2|Standard Deviation|9.90|9.9|||
4466097|NCT00047879|4284889|B3|United States||Region of Enrollment||participants|Number|7|7.0||||||
4466098|NCT00047879|4284890|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4466099|NCT00047879|4284891|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4466100|NCT00047879|4284889|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4466101|NCT00047879|4284890|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4466102|NCT00047879|4284891|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4466103|NCT00047879|4284889|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4466104|NCT00047879|4284890|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4466105|NCT00047879|4284891|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466106|NCT00047879|4284889|B3|||Age||years|Mean|54.71|54.71|Standard Deviation|10.36|10.36|||
4466107|NCT00047879|4284890|B2|||Age||years|Mean|53.67|53.67|Standard Deviation|11.93|11.93|||
4466108|NCT00047879|4284891|B1|||Age||years|Mean|55.5|55.5|Standard Deviation|10.85|10.85|||
4466109|NCT00047879|4284889|B3||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4466110|NCT00047879|4284890|B2||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4466111|NCT00047879|4284891|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466112|NCT00047879|4284889|B3||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4466113|NCT00047879|4284890|B2||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4466114|NCT00047879|4284891|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4466115|NCT00047879|4284889|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466116|NCT00047879|4284890|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466117|NCT00047879|4284891|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466118|NCT00047697|4284902|B3|||Cognitive Assessment: CVLT|California Verbal Learning Test (percent of correct answers) Range: 0-100. Higher = better|Correct answers, percentage|Mean|43.7|43.7|Standard Deviation|12.3|12.3|||
4466119|NCT00047697|4284903|B2|||Cognitive Assessment: CVLT|California Verbal Learning Test (percent of correct answers) Range: 0-100. Higher = better|Correct answers, percentage|Mean|47.1|47.1|Standard Deviation|10.3|10.3|||
4466120|NCT00047697|4284904|B1|||Cognitive Assessment: CVLT|California Verbal Learning Test (percent of correct answers) Range: 0-100. Higher = better|Correct answers, percentage|Mean|40.7|40.7|Standard Deviation|14.1|14.1|||
4466121|NCT00047697|4284902|B3|||Cognitive Assessment: EOWVT Standard score|Expressive One Word Vocabulary Test (standard score) Range: 55-140. Higher = better|units on a scale|Mean|106.5|106.5|Standard Deviation|19.9|19.9|||
4466122|NCT00047697|4284903|B2|||Cognitive Assessment: EOWVT Standard score|Expressive One Word Vocabulary Test (standard score) Range: 55-140. Higher = better|units on a scale|Mean|108.7|108.7|Standard Deviation|17.0|17.0|||
4466123|NCT00047697|4284904|B1|||Cognitive Assessment: EOWVT Standard score|Expressive One Word Vocabulary Test (standard score) Range: 55-140. Higher = better|units on a scale|Mean|104.6|104.6|Standard Deviation|22.4|22.4|||
4466124|NCT00047697|4284902|B3|||Cognitive Assessment: TMT|TMT: Trial-Making Test. Time (sec) Range: 0 - 300. Lower = better|Seconds|Mean|138.3|138.3|Standard Deviation|66.5|66.5|||
4466125|NCT00047697|4284903|B2|||Cognitive Assessment: TMT|TMT: Trial-Making Test. Time (sec) Range: 0 - 300. Lower = better|Seconds|Mean|154.9|154.9|Standard Deviation|77.8|77.8|||
4466126|NCT00047697|4284904|B1|||Cognitive Assessment: TMT|TMT: Trial-Making Test. Time (sec) Range: 0 - 300. Lower = better|Seconds|Mean|123.6|123.6|Standard Deviation|56.5|56.5|||
4466127|NCT00047697|4284902|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4466128|NCT00047697|4284903|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4466129|NCT00047697|4284904|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4466130|NCT00047697|4284902|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4466131|NCT00047697|4284903|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4466132|NCT00047697|4284904|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4466133|NCT00047697|4284902|B3|||Age||years|Mean|11.7|11.7|Full Range|||8.1|16.8|
4466134|NCT00047697|4284903|B2|||Age||years|Mean|11.8|11.8|Full Range|||8.1|16.6|
4466135|NCT00047697|4284904|B1|||Age||years|Mean|11.6|11.6|Full Range|||8.7|16.8|
4466136|NCT00047619|4284915|B3|male gender||Sex/Gender, Customized|Both male and female subjects are eligible, though recruitment in the veterans affairs medical center spinal cord injury service resulted in only males being recruited as there were very few females with spinal cord injury in the veterans affairs medical center spinal cord injury service.|participants|Number|28|28.0||||||
4466137|NCT00047619|4284916|B2|male gender||Sex/Gender, Customized|Both male and female subjects are eligible, though recruitment in the veterans affairs medical center spinal cord injury service resulted in only males being recruited as there were very few females with spinal cord injury in the veterans affairs medical center spinal cord injury service.|participants|Number|14|14.0||||||
4466138|NCT00047619|4284917|B1|male gender||Sex/Gender, Customized|Both male and female subjects are eligible, though recruitment in the veterans affairs medical center spinal cord injury service resulted in only males being recruited as there were very few females with spinal cord injury in the veterans affairs medical center spinal cord injury service.|participants|Number|14|14.0||||||
4466139|NCT00047619|4284915|B3|Number of subjects >=18 years||Age, Customized|Age above 18 who can give appropriate consent to the study|participants|Number|28|28.0||||||
4466140|NCT00047619|4284916|B2|Number of subjects >=18 years||Age, Customized|Age above 18 who can give appropriate consent to the study|participants|Number|14|14.0||||||
4466141|NCT00047619|4284917|B1|Number of subjects >=18 years||Age, Customized|Age above 18 who can give appropriate consent to the study|participants|Number|14|14.0||||||
4466142|NCT00047463|4284926|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4466143|NCT00047463|4284927|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4466144|NCT00047463|4284928|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4466145|NCT00047463|4284926|B3||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4466146|NCT00047463|4284927|B2||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4466147|NCT00047463|4284928|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4466148|NCT00047463|4284926|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4466149|NCT00047463|4284927|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4466150|NCT00047463|4284928|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4466151|NCT00047463|4284926|B3|||Age||years|Mean|41.8|41.8|Standard Deviation|12.9|12.9|||
4466152|NCT00047463|4284927|B2|||Age||years|Mean|42.7|42.7|Standard Deviation|12.3|12.3|||
4466153|NCT00047463|4284928|B1|||Age||years|Mean|40.2|40.2|Standard Deviation|14.3|14.3|||
4466154|NCT00047463|4284926|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466155|NCT00047463|4284927|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466156|NCT00047463|4284928|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466157|NCT00047463|4284926|B3||Between 18 and 65 years|Age||Participants|Count of Participants|35|35.0||||||
4466158|NCT00047463|4284927|B2||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4466159|NCT00047463|4284928|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4466160|NCT00047463|4284926|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466161|NCT00047463|4284927|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466162|NCT00047463|4284928|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466163|NCT00046475|4284938|B3||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4466164|NCT00046475|4284939|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4466165|NCT00046475|4284940|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4466166|NCT00046475|4284938|B3||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4466167|NCT00046475|4284939|B2||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4466168|NCT00046475|4284940|B1||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4466169|NCT00046475|4284938|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|14.27|14.27|||
4466170|NCT00046475|4284939|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|14.43|14.43|||
4466171|NCT00046475|4284940|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|14.22|14.22|||
4466172|NCT00046566|4284978|B4|United States||Region of Enrollment||participants|Number|352|352.0||||||
4466173|NCT00046566|4284979|B3|United States||Region of Enrollment||participants|Number|118|118.0||||||
4466174|NCT00046566|4284980|B2|United States||Region of Enrollment||participants|Number|117|117.0||||||
4466175|NCT00046566|4284981|B1|United States||Region of Enrollment||participants|Number|117|117.0||||||
4466176|NCT00046566|4284978|B4||Male|Sex: Female, Male||Participants|Count of Participants|147|147.0||||||
4466177|NCT00046566|4284979|B3||Male|Sex: Female, Male||Participants|Count of Participants|50|50.0||||||
4466178|NCT00046566|4284980|B2||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4466179|NCT00046566|4284981|B1||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4466180|NCT00046566|4284978|B4||Female|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4466181|NCT00046566|4284979|B3||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4466182|NCT00046566|4284980|B2||Female|Sex: Female, Male||Participants|Count of Participants|68|68.0||||||
4466183|NCT00046566|4284981|B1||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4466184|NCT00046566|4284978|B4|||Age||years|Mean|47.7|47.7|Standard Deviation|10.3|10.3|||
4466185|NCT00046566|4284979|B3|||Age||years|Mean|48.1|48.1|Standard Deviation|8.7|8.7|||
4466186|NCT00046566|4284980|B2|||Age||years|Mean|46.7|46.7|Standard Deviation|10.7|10.7|||
4466187|NCT00046566|4284981|B1|||Age||years|Mean|48.4|48.4|Standard Deviation|11.5|11.5|||
4466188|NCT00046228|4284997|B4||Male|Sex: Female, Male||Participants|Count of Participants|1810|1810.0||||||
4466189|NCT00046228|4284998|B3||Male|Sex: Female, Male||Participants|Count of Participants|609|609.0||||||
4466190|NCT00046228|4284999|B2||Male|Sex: Female, Male||Participants|Count of Participants|602|602.0||||||
4466191|NCT00046228|4285000|B1||Male|Sex: Female, Male||Participants|Count of Participants|599|599.0||||||
4466192|NCT00046228|4284997|B4||Female|Sex: Female, Male||Participants|Count of Participants|642|642.0||||||
4466193|NCT00046228|4284998|B3||Female|Sex: Female, Male||Participants|Count of Participants|219|219.0||||||
4466194|NCT00046228|4284999|B2||Female|Sex: Female, Male||Participants|Count of Participants|216|216.0||||||
4466195|NCT00046228|4285000|B1||Female|Sex: Female, Male||Participants|Count of Participants|207|207.0||||||
4466196|NCT00046228|4284997|B4|||Age||years|Mean|62.4|62.4|Standard Deviation|11.5|11.5|||
4466197|NCT00046228|4284998|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|11.4|11.4|||
4466198|NCT00046228|4284999|B2|||Age||years|Mean|61.9|61.9|Standard Deviation|11.8|11.8|||
4466199|NCT00046228|4285000|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|11.4|11.4|||
4466200|NCT00045942|4285037|B10||Male|Sex: Female, Male||Participants|Count of Participants|76|76.0||||||
4466201|NCT00045942|4285038|B9||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4466202|NCT00045942|4285039|B8||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4466203|NCT00045942|4285040|B7||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4466204|NCT00045942|4285041|B6||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4466205|NCT00045942|4285042|B5||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4466206|NCT00045942|4285043|B4||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4466207|NCT00045942|4285044|B3||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4466208|NCT00045942|4285045|B2||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4466209|NCT00045942|4285046|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4466210|NCT00045942|4285037|B10||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4466211|NCT00045942|4285038|B9||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4466212|NCT00045942|4285039|B8||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4466213|NCT00045942|4285040|B7||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4466214|NCT00045942|4285041|B6||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4466215|NCT00045942|4285042|B5||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4466216|NCT00045942|4285043|B4||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4466217|NCT00045942|4285044|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4466218|NCT00045942|4285045|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4466219|NCT00045942|4285046|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4466220|NCT00045942|4285037|B10||>=65 years|Age||Participants|Count of Participants|86|86.0||||||
4466221|NCT00045942|4285038|B9||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4466222|NCT00045942|4285039|B8||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4466223|NCT00045942|4285040|B7||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4466224|NCT00045942|4285041|B6||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4466225|NCT00045942|4285042|B5||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4466226|NCT00045942|4285043|B4||>=65 years|Age||Participants|Count of Participants|26|26.0||||||
4466227|NCT00045942|4285044|B3||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4466228|NCT00045942|4285045|B2||>=65 years|Age||Participants|Count of Participants|7|7.0||||||
4466229|NCT00045942|4285046|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4466230|NCT00045942|4285037|B10||Between 18 and 65 years|Age||Participants|Count of Participants|56|56.0||||||
4466231|NCT00045942|4285038|B9||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4466232|NCT00045942|4285039|B8||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4466233|NCT00045942|4285040|B7||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4466234|NCT00045942|4285041|B6||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4466235|NCT00045942|4285042|B5||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4466236|NCT00045942|4285043|B4||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4466237|NCT00045942|4285044|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4466238|NCT00045942|4285045|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4466239|NCT00045942|4285046|B1||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4466240|NCT00045942|4285037|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466241|NCT00045942|4285038|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466242|NCT00045942|4285039|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466243|NCT00045942|4285040|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466244|NCT00045942|4285041|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466245|NCT00045942|4285042|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466246|NCT00045942|4285043|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466247|NCT00045942|4285044|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466248|NCT00045942|4285045|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466249|NCT00045942|4285046|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466250|NCT00044655|4285134|B3|United States||Region of Enrollment||participants|Number|219|219.0||||||
4466251|NCT00044655|4285135|B2|United States||Region of Enrollment||participants|Number|117|117.0||||||
4466252|NCT00044655|4285136|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4466253|NCT00044655|4285134|B3||Male|Sex: Female, Male||Participants|Count of Participants|146|146.0||||||
4466254|NCT00044655|4285135|B2||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4466255|NCT00044655|4285136|B1||Male|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4466256|NCT00044655|4285134|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4466257|NCT00044655|4285135|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4466258|NCT00044655|4285136|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4466259|NCT00044655|4285134|B3|||Age||years|Mean|46.9|46.9|Standard Deviation|11.0|11.0|||
4466260|NCT00044655|4285135|B2|||Age||years|Mean|47.7|47.7|Standard Deviation|11.3|11.3|||
4466261|NCT00044655|4285136|B1|||Age||years|Mean|46.9|46.9|Standard Deviation|10.4|10.4|||
4466262|NCT00044655|4285134|B3||>=65 years|Age||Participants|Count of Participants|11|11.0||||||
4466263|NCT00044655|4285135|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4466264|NCT00044655|4285136|B1||>=65 years|Age||Participants|Count of Participants|6|6.0||||||
4466265|NCT00044655|4285134|B3||Between 18 and 65 years|Age||Participants|Count of Participants|208|208.0||||||
4466266|NCT00044655|4285135|B2||Between 18 and 65 years|Age||Participants|Count of Participants|112|112.0||||||
4466267|NCT00044655|4285136|B1||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4466268|NCT00044655|4285134|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466269|NCT00044655|4285135|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466270|NCT00044655|4285136|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466271|NCT00044512|4285143|B1|Stage 4||Stage of Disease at study entry (TNM Classification)|TNM (Tumor, Nodes, Metastasis) is a solid tumor classification system. T1-T4 = size and degree of spreading. N0-N3 = degree of spreading into lymph nodes. M0-M1 = whether the cancer has metastazied beyond the lymph nodes or not. Bigger numbers are worse. One of the inclusion criteria for this study was inoperable tumor T2-T4, any N, M0 or M1.|participants|Number|91|91.0||||||
4466272|NCT00044512|4285143|B1|Stage 3||Stage of Disease at study entry (TNM Classification)|TNM (Tumor, Nodes, Metastasis) is a solid tumor classification system. T1-T4 = size and degree of spreading. N0-N3 = degree of spreading into lymph nodes. M0-M1 = whether the cancer has metastazied beyond the lymph nodes or not. Bigger numbers are worse. One of the inclusion criteria for this study was inoperable tumor T2-T4, any N, M0 or M1.|participants|Number|42|42.0||||||
4466309|NCT00044044|4285175|B6||Female|Sex: Female, Male||Participants|Count of Participants|91|91.0||||||
4466310|NCT00044044|4285176|B5||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4466273|NCT00044512|4285143|B1|Stage 2||Stage of Disease at study entry (TNM Classification)|TNM (Tumor, Nodes, Metastasis) is a solid tumor classification system. T1-T4 = size and degree of spreading. N0-N3 = degree of spreading into lymph nodes. M0-M1 = whether the cancer has metastazied beyond the lymph nodes or not. Bigger numbers are worse. One of the inclusion criteria for this study was inoperable tumor T2-T4, any N, M0 or M1.|participants|Number|4|4.0||||||
4466274|NCT00044512|4285143|B1|Stage 1||Stage of Disease at study entry (TNM Classification)|TNM (Tumor, Nodes, Metastasis) is a solid tumor classification system. T1-T4 = size and degree of spreading. N0-N3 = degree of spreading into lymph nodes. M0-M1 = whether the cancer has metastazied beyond the lymph nodes or not. Bigger numbers are worse. One of the inclusion criteria for this study was inoperable tumor T2-T4, any N, M0 or M1.|participants|Number|0|0.0||||||
4466275|NCT00044512|4285143|B1|Grade 4||Eastern Cooperative Group performance status (ECOG PS) at study entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|participants|Number|0|0.0||||||
4466276|NCT00044512|4285143|B1|Grade 3||Eastern Cooperative Group performance status (ECOG PS) at study entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|participants|Number|0|0.0||||||
4466277|NCT00044512|4285143|B1|Grade 2||Eastern Cooperative Group performance status (ECOG PS) at study entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|participants|Number|0|0.0||||||
4466278|NCT00044512|4285143|B1|Grade 1||Eastern Cooperative Group performance status (ECOG PS) at study entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|participants|Number|69|69.0||||||
4466279|NCT00044512|4285143|B1|Grade 0||Eastern Cooperative Group performance status (ECOG PS) at study entry|Eastern Cooperative Oncology Group (ECOG) Performance Status is a scale that measures how cancer affects a patient. 0 = fully active, 1 = restricted strenuous activity, 2 = ambulatory, 3 = limited selfcare, 4 = completely disabled, 5 = dead. Subjects entering this study must have had an ECOG score of 0 or 1.|participants|Number|68|68.0||||||
4466280|NCT00044512|4285143|B1|Missing||Child Pugh Status|A Child-Pugh (CP) score (determined by encephalopathy grade, ascites, serum bilirubin and albumin, prothrombin time) is used to assess the prognosis of chronic liver disease, mainly cirrhosis. One of the inclusion criterion for this study was a CP class A (good operative risk) or B (moderate risk) score; class C (poor operative risk) was excluded.|participants|Number|1|1.0||||||
4466281|NCT00044512|4285143|B1|Status B||Child Pugh Status|A Child-Pugh (CP) score (determined by encephalopathy grade, ascites, serum bilirubin and albumin, prothrombin time) is used to assess the prognosis of chronic liver disease, mainly cirrhosis. One of the inclusion criterion for this study was a CP class A (good operative risk) or B (moderate risk) score; class C (poor operative risk) was excluded.|participants|Number|38|38.0||||||
4466282|NCT00044512|4285143|B1|Status A||Child Pugh Status|A Child-Pugh (CP) score (determined by encephalopathy grade, ascites, serum bilirubin and albumin, prothrombin time) is used to assess the prognosis of chronic liver disease, mainly cirrhosis. One of the inclusion criterion for this study was a CP class A (good operative risk) or B (moderate risk) score; class C (poor operative risk) was excluded.|participants|Number|98|98.0||||||
4466283|NCT00044512|4285143|B1||Male|Sex: Female, Male||Participants|Count of Participants|97|97.0||||||
4466284|NCT00044512|4285143|B1||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4466285|NCT00044512|4285143|B1||>=65 years|Age||Participants|Count of Participants|53|53.0||||||
4466286|NCT00044512|4285143|B1||Between 18 and 65 years|Age||Participants|Count of Participants|84|84.0||||||
4466287|NCT00044512|4285143|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466288|NCT00044213|4285154|B5||Male|Sex: Female, Male||Participants|Count of Participants|1409|1409.0||||||
4466289|NCT00044213|4285155|B4||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4466290|NCT00044213|4285156|B3||Male|Sex: Female, Male||Participants|Count of Participants|355|355.0||||||
4466291|NCT00044213|4285157|B2||Male|Sex: Female, Male||Participants|Count of Participants|336|336.0||||||
4466292|NCT00044213|4285158|B1||Male|Sex: Female, Male||Participants|Count of Participants|351|351.0||||||
4466293|NCT00044213|4285154|B5||Female|Sex: Female, Male||Participants|Count of Participants|299|299.0||||||
4466294|NCT00044213|4285155|B4||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4466295|NCT00044213|4285156|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4466296|NCT00044213|4285157|B2||Female|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4466297|NCT00044213|4285158|B1||Female|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4466298|NCT00044213|4285154|B5|||Age||Years|Mean|65.5|65.5|Full Range|||59.0|72.0|
4466299|NCT00044213|4285155|B4|||Age||Years|Mean|66|66.0|Full Range|||59.0|72.0|
4466300|NCT00044213|4285156|B3|||Age||Years|Mean|66|66.0|Full Range|||59.0|72.0|
4466301|NCT00044213|4285157|B2|||Age||Years|Mean|65|65.0|Full Range|||60.0|72.0|
4466302|NCT00044213|4285158|B1|||Age||Years|Mean|65|65.0|Full Range|||59.0|71.0|
4466303|NCT00044044|4285175|B6||Male|Sex: Female, Male||Participants|Count of Participants|262|262.0||||||
4466304|NCT00044044|4285176|B5||Male|Sex: Female, Male||Participants|Count of Participants|55|55.0||||||
4466305|NCT00044044|4285177|B4||Male|Sex: Female, Male||Participants|Count of Participants|58|58.0||||||
4466306|NCT00044044|4285178|B3||Male|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4466307|NCT00044044|4285179|B2||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4466308|NCT00044044|4285180|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4466311|NCT00044044|4285177|B4||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4466312|NCT00044044|4285178|B3||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4466313|NCT00044044|4285179|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4466314|NCT00044044|4285180|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4466315|NCT00044044|4285175|B6|||Age||years|Mean|41.2|41.2|Standard Deviation|10.0|10.0|||
4466316|NCT00044044|4285176|B5|||Age||years|Mean|41.0|41.0|Standard Deviation|9.7|9.7|||
4466317|NCT00044044|4285177|B4|||Age||years|Mean|40.0|40.0|Standard Deviation|10.5|10.5|||
4466318|NCT00044044|4285178|B3|||Age||years|Mean|42.2|42.2|Standard Deviation|8.3|8.3|||
4466319|NCT00044044|4285179|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|10.9|10.9|||
4466320|NCT00044044|4285180|B1|||Age||years|Mean|40.7|40.7|Standard Deviation|10.5|10.5|||
4466321|NCT00044005|4285211|B4|United States||Region of Enrollment||participants|Number|98|98.0||||||
4466322|NCT00044005|4285212|B3|United States||Region of Enrollment||participants|Number|33|33.0||||||
4466323|NCT00044005|4285213|B2|United States||Region of Enrollment||participants|Number|33|33.0||||||
4466324|NCT00044005|4285214|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4466325|NCT00044005|4285211|B4||Male|Sex: Female, Male||Participants|Count of Participants|70|70.0||||||
4466326|NCT00044005|4285212|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4466327|NCT00044005|4285213|B2||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4466328|NCT00044005|4285214|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4466329|NCT00044005|4285211|B4||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4466330|NCT00044005|4285212|B3||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4466331|NCT00044005|4285213|B2||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4466332|NCT00044005|4285214|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4466333|NCT00044005|4285211|B4|||Age||years|Mean|41.3|41.3|Standard Deviation|10.4|10.4|||
4466334|NCT00044005|4285212|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|10.7|10.7|||
4466335|NCT00044005|4285213|B2|||Age||years|Mean|42.2|42.2|Standard Deviation|12.4|12.4|||
4466336|NCT00044005|4285214|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|7.8|7.8|||
4466337|NCT00044083|4285224|B3|United States||Region of Enrollment||participants|Number|189|189.0||||||
4466338|NCT00044083|4285225|B2|United States||Region of Enrollment||participants|Number|59|59.0||||||
4466339|NCT00044083|4285226|B1|United States||Region of Enrollment||participants|Number|130|130.0||||||
4466340|NCT00044083|4285224|B3||Male|Sex: Female, Male||Participants|Count of Participants|112|112.0||||||
4466341|NCT00044083|4285225|B2||Male|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4466342|NCT00044083|4285226|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4466343|NCT00044083|4285224|B3||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4466344|NCT00044083|4285225|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4466345|NCT00044083|4285226|B1||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4466346|NCT00044083|4285224|B3|||Age||years|Mean|32.1|32.1|Standard Deviation|9.1|9.1|||
4466347|NCT00044083|4285225|B2|||Age||years|Mean|26.9|26.9|Standard Deviation|6.8|6.8|||
4466348|NCT00044083|4285226|B1|||Age||years|Mean|34.5|34.5|Standard Deviation|9.1|9.1|||
4466349|NCT00044083|4285224|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466350|NCT00044083|4285225|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466351|NCT00044083|4285226|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466352|NCT00044083|4285224|B3||Between 18 and 65 years|Age||Participants|Count of Participants|189|189.0||||||
4466353|NCT00044083|4285225|B2||Between 18 and 65 years|Age||Participants|Count of Participants|59|59.0||||||
4466354|NCT00044083|4285226|B1||Between 18 and 65 years|Age||Participants|Count of Participants|130|130.0||||||
4466355|NCT00044083|4285224|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466356|NCT00044083|4285225|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466357|NCT00044083|4285226|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466358|NCT00043979|4285263|B3|PP||High-Risk Features (Participants that Did Not Receive Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|2|2.0||||||
4466359|NCT00043979|4285264|B2|PP||High-Risk Features (Participants that Did Not Receive Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|2|2.0||||||
4466360|NCT00043979|4285263|B3|ER||High-Risk Features (Participants that Did Not Receive Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|3|3.0||||||
4466361|NCT00043979|4285264|B2|ER||High-Risk Features (Participants that Did Not Receive Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|3|3.0||||||
4466362|NCT00043979|4285263|B3|PP, B/BM||High-Risk Features (Participants that Did Not Receive Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|1|1.0||||||
4466363|NCT00043979|4285264|B2|PP, B/BM||High-Risk Features (Participants that Did Not Receive Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|1|1.0||||||
4466508|NCT00043979|4285263|B3||Female|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4466364|NCT00043979|4285263|B3|ER, B/BM||High-Risk Features (Participants that Did Not Receive Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|1|1.0||||||
4466365|NCT00043979|4285264|B2|ER, B/BM||High-Risk Features (Participants that Did Not Receive Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|1|1.0||||||
4466366|NCT00043979|4285263|B3|PP, B/BM||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|1|1.0||||||
4466367|NCT00043979|4285264|B2|PP, B/BM||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|1|1.0||||||
4466368|NCT00043979|4285263|B3|PP/Metastatic||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|1|1.0||||||
4466369|NCT00043979|4285264|B2|PP/Metastatic||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|1|1.0||||||
4466370|NCT00043979|4285263|B3|Metastatic||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|4|4.0||||||
4466371|NCT00043979|4285264|B2|Metastatic||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|4|4.0||||||
4466372|NCT00043979|4285263|B3|B/BM||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|7|7.0||||||
4466373|NCT00043979|4285264|B2|B/BM||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|7|7.0||||||
4466374|NCT00043979|4285263|B3|PP||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|1|1.0||||||
4466375|NCT00043979|4285264|B2|PP||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|1|1.0||||||
4466376|NCT00043979|4285263|B3|ER, B/BM, MR||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|1|1.0||||||
4466377|NCT00043979|4285264|B2|ER, B/BM, MR||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|1|1.0||||||
4466378|NCT00043979|4285263|B3|ER||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|2|2.0||||||
4466379|NCT00043979|4285264|B2|ER||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|2|2.0||||||
4466380|NCT00043979|4285263|B3|MR||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|6|6.0||||||
4466381|NCT00043979|4285264|B2|MR||High-Risk Features (Participants that Received Stem Cell Transplant)|B/BM indicates bone or bone marrow metastases; ER, early recurrence; MR, multiply recurrent; PP, primary progressive disease.|Participants|Count of Participants|6|6.0||||||
4466382|NCT00043979|4285263|B3|DSRCT||Diagnosis (Participants that Did Not Receive Stem Cell Transplant)|ESRT, Ewings sarcoma; DSRCT, desmoplastic small round cell tumor.|Participants|Count of Participants|1|1.0||||||
4466383|NCT00043979|4285264|B2|DSRCT||Diagnosis (Participants that Did Not Receive Stem Cell Transplant)|ESRT, Ewings sarcoma; DSRCT, desmoplastic small round cell tumor.|Participants|Count of Participants|1|1.0||||||
4466384|NCT00043979|4285263|B3|ESFT||Diagnosis (Participants that Did Not Receive Stem Cell Transplant)|ESRT, Ewings sarcoma; DSRCT, desmoplastic small round cell tumor.|Participants|Count of Participants|6|6.0||||||
4466385|NCT00043979|4285264|B2|ESFT||Diagnosis (Participants that Did Not Receive Stem Cell Transplant)|ESRT, Ewings sarcoma; DSRCT, desmoplastic small round cell tumor.|Participants|Count of Participants|6|6.0||||||
4466386|NCT00043979|4285263|B3|DSRCT||Diagnosis (Participants that Received Stem Cell Transplant)|aRMS indicates alveolar rhabdomyosarcoma; ESRT, Ewings sarcoma; DSRCT, desmoplastic small round cell tumor.|Participants|Count of Participants|11|11.0||||||
4466387|NCT00043979|4285264|B2|DSRCT||Diagnosis (Participants that Received Stem Cell Transplant)|aRMS indicates alveolar rhabdomyosarcoma; ESRT, Ewings sarcoma; DSRCT, desmoplastic small round cell tumor.|Participants|Count of Participants|11|11.0||||||
4466388|NCT00043979|4285263|B3|ESFT||Diagnosis (Participants that Received Stem Cell Transplant)|aRMS indicates alveolar rhabdomyosarcoma; ESRT, Ewings sarcoma; DSRCT, desmoplastic small round cell tumor.|Participants|Count of Participants|5|5.0||||||
4466389|NCT00043979|4285264|B2|ESFT||Diagnosis (Participants that Received Stem Cell Transplant)|aRMS indicates alveolar rhabdomyosarcoma; ESRT, Ewings sarcoma; DSRCT, desmoplastic small round cell tumor.|Participants|Count of Participants|5|5.0||||||
4466390|NCT00043979|4285263|B3|aRMS||Diagnosis (Participants that Received Stem Cell Transplant)|aRMS indicates alveolar rhabdomyosarcoma; ESRT, Ewings sarcoma; DSRCT, desmoplastic small round cell tumor.|Participants|Count of Participants|7|7.0||||||
4466509|NCT00043979|4285264|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4466391|NCT00043979|4285264|B2|aRMS||Diagnosis (Participants that Received Stem Cell Transplant)|aRMS indicates alveolar rhabdomyosarcoma; ESRT, Ewings sarcoma; DSRCT, desmoplastic small round cell tumor.|Participants|Count of Participants|7|7.0||||||
4466392|NCT00043979|4285263|B3|||Disease Status (Progressive Disease) at Hematopoietic Stem Cell Transplant|This list includes the disease status of participants who did not receive stem cell transplant.|Participants|Count of Participants|7|7.0||||||
4466393|NCT00043979|4285264|B2|||Disease Status (Progressive Disease) at Hematopoietic Stem Cell Transplant|This list includes the disease status of participants who did not receive stem cell transplant.|Participants|Count of Participants|7|7.0||||||
4466394|NCT00043979|4285263|B3|Complete Response (CR)/(NED)||Disease Status at Hematopoietic Stem Cell Transplant|This list includes the disease status of participants who received stem cell transplant.|Participants|Count of Participants|3|3.0||||||
4466395|NCT00043979|4285264|B2|Complete Response (CR)/(NED)||Disease Status at Hematopoietic Stem Cell Transplant|This list includes the disease status of participants who received stem cell transplant.|Participants|Count of Participants|3|3.0||||||
4466396|NCT00043979|4285263|B3|Progressive Disease (PD)||Disease Status at Hematopoietic Stem Cell Transplant|This list includes the disease status of participants who received stem cell transplant.|Participants|Count of Participants|3|3.0||||||
4466397|NCT00043979|4285264|B2|Progressive Disease (PD)||Disease Status at Hematopoietic Stem Cell Transplant|This list includes the disease status of participants who received stem cell transplant.|Participants|Count of Participants|3|3.0||||||
4466398|NCT00043979|4285263|B3|No Evidence of Disease (NED)||Disease Status at Hematopoietic Stem Cell Transplant|This list includes the disease status of participants who received stem cell transplant.|Participants|Count of Participants|4|4.0||||||
4466399|NCT00043979|4285264|B2|No Evidence of Disease (NED)||Disease Status at Hematopoietic Stem Cell Transplant|This list includes the disease status of participants who received stem cell transplant.|Participants|Count of Participants|4|4.0||||||
4466400|NCT00043979|4285263|B3|Stable Disease (SD)||Disease Status at Hematopoietic Stem Cell Transplant|This list includes the disease status of participants who received stem cell transplant.|Participants|Count of Participants|9|9.0||||||
4466401|NCT00043979|4285264|B2|Stable Disease (SD)||Disease Status at Hematopoietic Stem Cell Transplant|This list includes the disease status of participants who received stem cell transplant.|Participants|Count of Participants|9|9.0||||||
4466402|NCT00043979|4285263|B3|Partial Response (PR)||Disease Status at Hematopoietic Stem Cell Transplant|This list includes the disease status of participants who received stem cell transplant.|Participants|Count of Participants|4|4.0||||||
4466403|NCT00043979|4285264|B2|Partial Response (PR)||Disease Status at Hematopoietic Stem Cell Transplant|This list includes the disease status of participants who received stem cell transplant.|Participants|Count of Participants|4|4.0||||||
4466404|NCT00043979|4285263|B3|||Participants who Did Not Receive Stem Cell Transplant Disease Status(Progressive Disease)/Enrollment||Participants|Count of Participants|7|7.0||||||
4466405|NCT00043979|4285264|B2|||Participants who Did Not Receive Stem Cell Transplant Disease Status(Progressive Disease)/Enrollment||Participants|Count of Participants|7|7.0||||||
4466406|NCT00043979|4285263|B3|Stable Disease (SD)||Participants who Received Stem Cell Transplant Disease Status at Enrollment||Participants|Count of Participants|1|1.0||||||
4466407|NCT00043979|4285264|B2|Stable Disease (SD)||Participants who Received Stem Cell Transplant Disease Status at Enrollment||Participants|Count of Participants|1|1.0||||||
4466408|NCT00043979|4285263|B3|No Evidence of Disease (NED)||Participants who Received Stem Cell Transplant Disease Status at Enrollment||Participants|Count of Participants|4|4.0||||||
4466409|NCT00043979|4285264|B2|No Evidence of Disease (NED)||Participants who Received Stem Cell Transplant Disease Status at Enrollment||Participants|Count of Participants|4|4.0||||||
4466410|NCT00043979|4285263|B3|Progressive Disease (PD)||Participants who Received Stem Cell Transplant Disease Status at Enrollment||Participants|Count of Participants|18|18.0||||||
4466411|NCT00043979|4285264|B2|Progressive Disease (PD)||Participants who Received Stem Cell Transplant Disease Status at Enrollment||Participants|Count of Participants|18|18.0||||||
4466412|NCT00043979|4285263|B3|Patient # 26||Number of Prior Regimens of Participants that Did Not Receive Stem Cell Transplant||regimens|Number|3|3.0||||||
4466413|NCT00043979|4285264|B2|Patient # 26||Number of Prior Regimens of Participants that Did Not Receive Stem Cell Transplant||regimens|Number|3|3.0||||||
4466414|NCT00043979|4285263|B3|Patient # 23||Number of Prior Regimens of Participants that Did Not Receive Stem Cell Transplant||regimens|Number|4|4.0||||||
4466415|NCT00043979|4285264|B2|Patient # 23||Number of Prior Regimens of Participants that Did Not Receive Stem Cell Transplant||regimens|Number|4|4.0||||||
4466416|NCT00043979|4285263|B3|Patient # 19||Number of Prior Regimens of Participants that Did Not Receive Stem Cell Transplant||regimens|Number|2|2.0||||||
4466417|NCT00043979|4285264|B2|Patient # 19||Number of Prior Regimens of Participants that Did Not Receive Stem Cell Transplant||regimens|Number|2|2.0||||||
4466418|NCT00043979|4285263|B3|Patient # 16||Number of Prior Regimens of Participants that Did Not Receive Stem Cell Transplant||regimens|Number|2|2.0||||||
4466419|NCT00043979|4285264|B2|Patient # 16||Number of Prior Regimens of Participants that Did Not Receive Stem Cell Transplant||regimens|Number|2|2.0||||||
4466420|NCT00043979|4285263|B3|Patient # 11||Number of Prior Regimens of Participants that Did Not Receive Stem Cell Transplant||regimens|Number|3|3.0||||||
4466421|NCT00043979|4285264|B2|Patient # 11||Number of Prior Regimens of Participants that Did Not Receive Stem Cell Transplant||regimens|Number|3|3.0||||||
4466422|NCT00043979|4285263|B3|Patient # 7||Number of Prior Regimens of Participants that Did Not Receive Stem Cell Transplant||regimens|Number|1|1.0||||||
4466423|NCT00043979|4285264|B2|Patient # 7||Number of Prior Regimens of Participants that Did Not Receive Stem Cell Transplant||regimens|Number|1|1.0||||||
4466424|NCT00043979|4285263|B3|Patient # 5||Number of Prior Regimens of Participants that Did Not Receive Stem Cell Transplant||regimens|Number|2|2.0||||||
4466425|NCT00043979|4285264|B2|Patient # 5||Number of Prior Regimens of Participants that Did Not Receive Stem Cell Transplant||regimens|Number|2|2.0||||||
4466426|NCT00043979|4285263|B3|Patient # 30||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|1|1.0||||||
4466427|NCT00043979|4285264|B2|Patient # 30||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|1|1.0||||||
4466428|NCT00043979|4285263|B3|Patient # 29||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466429|NCT00043979|4285264|B2|Patient # 29||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466430|NCT00043979|4285263|B3|Patient # 28 (c)||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|1|1.0||||||
4466431|NCT00043979|4285264|B2|Patient # 28 (c)||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|1|1.0||||||
4466432|NCT00043979|4285263|B3|Patient # 27||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|1|1.0||||||
4466433|NCT00043979|4285264|B2|Patient # 27||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|1|1.0||||||
4466434|NCT00043979|4285263|B3|Patient # 25||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466435|NCT00043979|4285264|B2|Patient # 25||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466436|NCT00043979|4285263|B3|Patient # 24||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466437|NCT00043979|4285264|B2|Patient # 24||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466438|NCT00043979|4285263|B3|Patient # 22||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|1|1.0||||||
4466439|NCT00043979|4285264|B2|Patient # 22||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|1|1.0||||||
4466440|NCT00043979|4285263|B3|Patient # 21||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|1|1.0||||||
4466441|NCT00043979|4285264|B2|Patient # 21||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|1|1.0||||||
4466442|NCT00043979|4285263|B3|Patient # 20||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|3|3.0||||||
4466443|NCT00043979|4285264|B2|Patient # 20||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|3|3.0||||||
4466444|NCT00043979|4285263|B3|Patient # 18||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466445|NCT00043979|4285264|B2|Patient # 18||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466446|NCT00043979|4285263|B3|Patient # 17||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466447|NCT00043979|4285264|B2|Patient # 17||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466448|NCT00043979|4285263|B3|Patient # 15||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466449|NCT00043979|4285264|B2|Patient # 15||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466450|NCT00043979|4285263|B3|Patient # 14||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|1|1.0||||||
4466451|NCT00043979|4285264|B2|Patient # 14||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|1|1.0||||||
4466452|NCT00043979|4285263|B3|Patient # 13||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|3|3.0||||||
4466453|NCT00043979|4285264|B2|Patient # 13||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|3|3.0||||||
4466454|NCT00043979|4285263|B3|Patient # 12||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466455|NCT00043979|4285264|B2|Patient # 12||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466456|NCT00043979|4285263|B3|Patient # 10||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466457|NCT00043979|4285264|B2|Patient # 10||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466458|NCT00043979|4285263|B3|Patient # 9||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466459|NCT00043979|4285264|B2|Patient # 9||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466460|NCT00043979|4285263|B3|Patient # 8||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|1|1.0||||||
4466461|NCT00043979|4285264|B2|Patient # 8||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|1|1.0||||||
4466462|NCT00043979|4285263|B3|Patient # 6||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466463|NCT00043979|4285264|B2|Patient # 6||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466464|NCT00043979|4285263|B3|Patient # 4||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|3|3.0||||||
4466465|NCT00043979|4285264|B2|Patient # 4||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|3|3.0||||||
4466466|NCT00043979|4285263|B3|Patient # 3||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466467|NCT00043979|4285264|B2|Patient # 3||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|2|2.0||||||
4466468|NCT00043979|4285263|B3|Patient # 2||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|3|3.0||||||
4466469|NCT00043979|4285264|B2|Patient # 2||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|3|3.0||||||
4466470|NCT00043979|4285263|B3|Patient # 1||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|5|5.0||||||
4466471|NCT00043979|4285264|B2|Patient # 1||Number of Prior Regimens of Participants that Received Stem Cell Transplant|(c) Up-front regimen included autologous stem cell transplantation.|regimens|Number|5|5.0||||||
4466472|NCT00043979|4285263|B3|United States||Region of Enrollment||Participants|Count of Participants|60|60.0||||||
4466473|NCT00043979|4285264|B2|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4466474|NCT00043979|4285265|B1|United States||Region of Enrollment||Participants|Count of Participants|30|30.0||||||
4466475|NCT00043979|4285263|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466476|NCT00043979|4285264|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466477|NCT00043979|4285265|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466478|NCT00043979|4285263|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466479|NCT00043979|4285264|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466480|NCT00043979|4285265|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466481|NCT00043979|4285263|B3||White|Race (NIH/OMB)||Participants|Count of Participants|60|60.0||||||
4466482|NCT00043979|4285264|B2||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4466483|NCT00043979|4285265|B1||White|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4466484|NCT00043979|4285263|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466485|NCT00043979|4285264|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466486|NCT00043979|4285265|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466487|NCT00043979|4285263|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466488|NCT00043979|4285264|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466489|NCT00043979|4285265|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466490|NCT00043979|4285263|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466491|NCT00043979|4285264|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466492|NCT00043979|4285265|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466493|NCT00043979|4285263|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466494|NCT00043979|4285264|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466495|NCT00043979|4285265|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466496|NCT00043979|4285263|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466497|NCT00043979|4285264|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466498|NCT00043979|4285265|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466499|NCT00043979|4285263|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|58|58.0||||||
4466500|NCT00043979|4285264|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4466501|NCT00043979|4285265|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4466502|NCT00043979|4285263|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4466503|NCT00043979|4285264|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4466504|NCT00043979|4285265|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4466505|NCT00043979|4285263|B3||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4466506|NCT00043979|4285264|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4466507|NCT00043979|4285265|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4466510|NCT00043979|4285265|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4466511|NCT00043979|4285263|B3|||Age||years|Mean|20.55|20.55|Standard Deviation|8.35|8.35|||
4466512|NCT00043979|4285264|B2|||Age||years|Mean|19.98|19.98|Standard Deviation|5.8|5.8|||
4466513|NCT00043979|4285265|B1|||Age||years|Mean|21.12|21.12|Standard Deviation|10.9|10.9|||
4466514|NCT00043979|4285263|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466515|NCT00043979|4285264|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466516|NCT00043979|4285265|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466517|NCT00043979|4285263|B3||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4466518|NCT00043979|4285264|B2||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4466519|NCT00043979|4285265|B1||Between 18 and 65 years|Age||Participants|Count of Participants|13|13.0||||||
4466520|NCT00043979|4285263|B3||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4466521|NCT00043979|4285264|B2||<=18 years|Age||Participants|Count of Participants|14|14.0||||||
4466522|NCT00043979|4285265|B1||<=18 years|Age||Participants|Count of Participants|17|17.0||||||
4466523|NCT00043550|4285285|B4|United States||Region of Enrollment||participants|Number|156|156.0||||||
4466524|NCT00043550|4285286|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4466525|NCT00043550|4285287|B2|United States||Region of Enrollment||participants|Number|51|51.0||||||
4466526|NCT00043550|4285288|B1|United States||Region of Enrollment||participants|Number|55|55.0||||||
4466527|NCT00043550|4285285|B4||Male|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4466528|NCT00043550|4285286|B3||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4466529|NCT00043550|4285287|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4466530|NCT00043550|4285288|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4466531|NCT00043550|4285285|B4||Female|Sex: Female, Male||Participants|Count of Participants|92|92.0||||||
4466532|NCT00043550|4285286|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4466533|NCT00043550|4285287|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4466534|NCT00043550|4285288|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4466535|NCT00043550|4285285|B4|||Age||years|Mean|37.5|37.5|Standard Deviation|12.2|12.2|||
4466536|NCT00043550|4285286|B3|||Age||years|Mean|38.3|38.3|Standard Deviation|12.0|12.0|||
4466537|NCT00043550|4285287|B2|||Age||years|Mean|36.2|36.2|Standard Deviation|12.2|12.2|||
4466538|NCT00043550|4285288|B1|||Age||years|Mean|38.0|38.0|Standard Deviation|12.5|12.5|||
4466539|NCT00043550|4285285|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466540|NCT00043550|4285286|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466541|NCT00043550|4285287|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466542|NCT00043550|4285288|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466543|NCT00043550|4285285|B4||Between 18 and 65 years|Age||Participants|Count of Participants|156|156.0||||||
4466544|NCT00043550|4285286|B3||Between 18 and 65 years|Age||Participants|Count of Participants|50|50.0||||||
4466545|NCT00043550|4285287|B2||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4466546|NCT00043550|4285288|B1||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4466547|NCT00043550|4285285|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466548|NCT00043550|4285286|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466549|NCT00043550|4285287|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466550|NCT00043550|4285288|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466551|NCT00043186|4285298|B10|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4466552|NCT00043186|4285299|B9|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466553|NCT00043186|4285300|B8|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466554|NCT00043186|4285301|B7|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466555|NCT00043186|4285302|B6|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466556|NCT00043186|4285303|B5|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466557|NCT00043186|4285304|B4|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466558|NCT00043186|4285305|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466559|NCT00043186|4285306|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4466560|NCT00043186|4285307|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466561|NCT00043186|4285298|B10|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4466562|NCT00043186|4285299|B9|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466563|NCT00043186|4285300|B8|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466564|NCT00043186|4285301|B7|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466565|NCT00043186|4285302|B6|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466566|NCT00043186|4285303|B5|Japanese||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4466567|NCT00043186|4285304|B4|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466568|NCT00043186|4285305|B3|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466569|NCT00043186|4285306|B2|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466570|NCT00043186|4285307|B1|Japanese||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466571|NCT00043186|4285298|B10|Asian||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4466572|NCT00043186|4285299|B9|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466573|NCT00043186|4285300|B8|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466574|NCT00043186|4285301|B7|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466575|NCT00043186|4285302|B6|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4466576|NCT00043186|4285303|B5|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466577|NCT00043186|4285304|B4|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466578|NCT00043186|4285305|B3|Asian||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466579|NCT00043186|4285306|B2|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4466580|NCT00043186|4285307|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4466581|NCT00043186|4285298|B10|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4466582|NCT00043186|4285299|B9|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4466583|NCT00043186|4285300|B8|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4466584|NCT00043186|4285301|B7|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4466585|NCT00043186|4285302|B6|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4466586|NCT00043186|4285303|B5|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4466587|NCT00043186|4285304|B4|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4466588|NCT00043186|4285305|B3|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4466589|NCT00043186|4285306|B2|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4466590|NCT00043186|4285307|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4466591|NCT00043186|4285298|B10|Black or African American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4466592|NCT00043186|4285299|B9|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4466593|NCT00043186|4285300|B8|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466594|NCT00043186|4285301|B7|Black or African American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4466595|NCT00043186|4285302|B6|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4466596|NCT00043186|4285303|B5|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4466597|NCT00043186|4285304|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4466598|NCT00043186|4285305|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4466599|NCT00043186|4285306|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4466600|NCT00043186|4285307|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4466601|NCT00043186|4285298|B10|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|355|355.0||||||
4466602|NCT00043186|4285299|B9|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|40|40.0||||||
4466603|NCT00043186|4285300|B8|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4466604|NCT00043186|4285301|B7|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4466605|NCT00043186|4285302|B6|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|39|39.0||||||
4466606|NCT00043186|4285303|B5|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|49|49.0||||||
4466607|NCT00043186|4285304|B4|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|36|36.0||||||
4466608|NCT00043186|4285305|B3|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|42|42.0||||||
4466609|NCT00043186|4285306|B2|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|33|33.0||||||
4466610|NCT00043186|4285307|B1|White or Caucasian||Race/Ethnicity, Customized||Participants|Number|37|37.0||||||
4466611|NCT00043186|4285298|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466612|NCT00043186|4285299|B9||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466613|NCT00043186|4285300|B8||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466614|NCT00043186|4285301|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466615|NCT00043186|4285302|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466616|NCT00043186|4285303|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466617|NCT00043186|4285304|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466618|NCT00043186|4285305|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466619|NCT00043186|4285306|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466620|NCT00043186|4285307|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466621|NCT00043186|4285298|B10||Female|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
4466622|NCT00043186|4285299|B9||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4466623|NCT00043186|4285300|B8||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4466624|NCT00043186|4285301|B7||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4466625|NCT00043186|4285302|B6||Female|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4466626|NCT00043186|4285303|B5||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4466627|NCT00043186|4285304|B4||Female|Sex: Female, Male||Participants|Count of Participants|41|41.0||||||
4466628|NCT00043186|4285305|B3||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4466629|NCT00043186|4285306|B2||Female|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4466630|NCT00043186|4285307|B1||Female|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4466631|NCT00043186|4285298|B10|||Age||Years|Mean|62.5|62.5|Standard Deviation|8.1|8.1|||
4466632|NCT00043186|4285299|B9|||Age||Years|Mean|62.8|62.8|Standard Deviation|8.2|8.2|||
4466633|NCT00043186|4285300|B8|||Age||Years|Mean|60.5|60.5|Standard Deviation|7.8|7.8|||
4466634|NCT00043186|4285301|B7|||Age||Years|Mean|64.9|64.9|Standard Deviation|8.2|8.2|||
4466635|NCT00043186|4285302|B6|||Age||Years|Mean|63.1|63.1|Standard Deviation|8.1|8.1|||
4466636|NCT00043186|4285303|B5|||Age||Years|Mean|61.4|61.4|Standard Deviation|8.1|8.1|||
4466637|NCT00043186|4285304|B4|||Age||Years|Mean|61.2|61.2|Standard Deviation|8.5|8.5|||
4466638|NCT00043186|4285305|B3|||Age||Years|Mean|62.3|62.3|Standard Deviation|6|6.0|||
4466639|NCT00043186|4285306|B2|||Age||Years|Mean|62.8|62.8|Standard Deviation|8.6|8.6|||
4466640|NCT00043186|4285307|B1|||Age||Years|Mean|63.7|63.7|Standard Deviation|9.1|9.1|||
4466641|NCT00042432|4285641|B3|||Intact Parathyroid Hormone (iPTH)||pg/mL|Mean|239.7|239.7|Standard Deviation|164.9|164.9|||
4466642|NCT00042432|4285642|B2|||Intact Parathyroid Hormone (iPTH)||pg/mL|Mean|236.1|236.1|Standard Deviation|189.5|189.5|||
4466643|NCT00042432|4285643|B1|||Intact Parathyroid Hormone (iPTH)||pg/mL|Mean|243.3|243.3|Standard Deviation|139.5|139.5|||
4466644|NCT00042432|4285641|B3|GFR ≥ 25 and ≤ 50 ml/min/1.73 m^2||Glomerular Filtration Rate (GFR) Stratification Factor||Participants|Number|15|15.0||||||
4466645|NCT00042432|4285642|B2|GFR ≥ 25 and ≤ 50 ml/min/1.73 m^2||Glomerular Filtration Rate (GFR) Stratification Factor||Participants|Number|8|8.0||||||
4466646|NCT00042432|4285643|B1|GFR ≥ 25 and ≤ 50 ml/min/1.73 m^2||Glomerular Filtration Rate (GFR) Stratification Factor||Participants|Number|7|7.0||||||
4466647|NCT00042432|4285641|B3|GFR ≥ 15 and < 25 ml/min/1.73 m^2||Glomerular Filtration Rate (GFR) Stratification Factor||Participants|Number|39|39.0||||||
4466648|NCT00042432|4285642|B2|GFR ≥ 15 and < 25 ml/min/1.73 m^2||Glomerular Filtration Rate (GFR) Stratification Factor||Participants|Number|19|19.0||||||
4466649|NCT00042432|4285643|B1|GFR ≥ 15 and < 25 ml/min/1.73 m^2||Glomerular Filtration Rate (GFR) Stratification Factor||Participants|Number|20|20.0||||||
4466650|NCT00042432|4285641|B3|Other||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4466651|NCT00042432|4285642|B2|Other||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4466652|NCT00042432|4285643|B1|Other||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4466653|NCT00042432|4285641|B3|Black||Race/Ethnicity, Customized||Participants|Number|16|16.0||||||
4466654|NCT00042432|4285642|B2|Black||Race/Ethnicity, Customized||Participants|Number|10|10.0||||||
4466655|NCT00042432|4285643|B1|Black||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4466656|NCT00042432|4285641|B3|White||Race/Ethnicity, Customized||Participants|Number|31|31.0||||||
4466657|NCT00042432|4285642|B2|White||Race/Ethnicity, Customized||Participants|Number|13|13.0||||||
4466658|NCT00042432|4285643|B1|White||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4466659|NCT00042432|4285641|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4466660|NCT00042432|4285642|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4466661|NCT00042432|4285643|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4466662|NCT00042432|4285641|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4466663|NCT00042432|4285642|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4466664|NCT00042432|4285643|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4466665|NCT00042432|4285641|B3|||Age||Years|Mean|61.2|61.2|Standard Deviation|15.2|15.2|||
4466666|NCT00042432|4285642|B2|||Age||Years|Mean|61.9|61.9|Standard Deviation|15.2|15.2|||
4466667|NCT00042432|4285643|B1|||Age||Years|Mean|60.6|60.6|Standard Deviation|15.5|15.5|||
4466668|NCT00042224|4285652|B3|United States||Region of Enrollment||participants|Number|39|39.0||||||
4466669|NCT00042224|4285653|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4466670|NCT00042224|4285654|B1|United States||Region of Enrollment||participants|Number|20|20.0||||||
4466671|NCT00042224|4285652|B3||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4466672|NCT00042224|4285653|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4466673|NCT00042224|4285654|B1||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4466674|NCT00042224|4285652|B3||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4466675|NCT00042224|4285653|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4466676|NCT00042224|4285654|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4466677|NCT00042224|4285652|B3|||Age||years|Mean|39.24|39.24|Standard Deviation|2.05|2.05|||
4466678|NCT00042224|4285653|B2|||Age||years|Mean|42.78|42.78|Standard Deviation|1.82|1.82|||
4466679|NCT00042224|4285654|B1|||Age||years|Mean|35.70|35.7|Standard Deviation|2.27|2.27|||
4466680|NCT00042224|4285652|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466681|NCT00042224|4285653|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466682|NCT00042224|4285654|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4466683|NCT00042224|4285652|B3||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4466684|NCT00042224|4285653|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4466685|NCT00042224|4285654|B1||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4466686|NCT00042224|4285652|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466687|NCT00042224|4285653|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466688|NCT00042224|4285654|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466689|NCT00041938|4285661|B3|Argentina||Region of Enrollment||participants|Number|92|92.0||||||
4466690|NCT00041938|4285662|B2|Argentina||Region of Enrollment||participants|Number|42|42.0||||||
4466691|NCT00041938|4285663|B1|Argentina||Region of Enrollment||participants|Number|50|50.0||||||
4466692|NCT00041938|4285661|B3|Europe||Region of Enrollment||participants|Number|1094|1094.0||||||
4466693|NCT00041938|4285662|B2|Europe||Region of Enrollment||participants|Number|527|527.0||||||
4466694|NCT00041938|4285663|B1|Europe||Region of Enrollment||participants|Number|567|567.0||||||
4466695|NCT00041938|4285661|B3|North America||Region of Enrollment||participants|Number|1119|1119.0||||||
4466696|NCT00041938|4285662|B2|North America||Region of Enrollment||participants|Number|573|573.0||||||
4466697|NCT00041938|4285663|B1|North America||Region of Enrollment||participants|Number|546|546.0||||||
4466698|NCT00041938|4285661|B3|Unknown||Sex/Gender, Customized||participants|Number|5|5.0||||||
4466699|NCT00041938|4285662|B2|Unknown||Sex/Gender, Customized||participants|Number|2|2.0||||||
4466700|NCT00041938|4285663|B1|Unknown||Sex/Gender, Customized||participants|Number|3|3.0||||||
4466701|NCT00041938|4285661|B3|Female||Sex/Gender, Customized||participants|Number|460|460.0||||||
4466702|NCT00041938|4285662|B2|Female||Sex/Gender, Customized||participants|Number|236|236.0||||||
4466703|NCT00041938|4285663|B1|Female||Sex/Gender, Customized||participants|Number|224|224.0||||||
4466704|NCT00041938|4285661|B3|Male||Sex/Gender, Customized||participants|Number|1840|1840.0||||||
4466705|NCT00041938|4285662|B2|Male||Sex/Gender, Customized||participants|Number|904|904.0||||||
4466706|NCT00041938|4285663|B1|Male||Sex/Gender, Customized||participants|Number|936|936.0||||||
4466707|NCT00041938|4285661|B3|||Age||years|Mean|61|61.0|Standard Deviation|11.3|11.3|||
4466708|NCT00041938|4285662|B2|||Age||years|Mean|61|61.0|Standard Deviation|11.6|11.6|||
4466709|NCT00041938|4285663|B1|||Age||years|Mean|61|61.0|Standard Deviation|11.1|11.1|||
4466710|NCT00041938|4285661|B3||>=65 years|Age||Participants|Count of Participants|867|867.0||||||
4466711|NCT00041938|4285662|B2||>=65 years|Age||Participants|Count of Participants|436|436.0||||||
4466712|NCT00041938|4285663|B1||>=65 years|Age||Participants|Count of Participants|431|431.0||||||
4466713|NCT00041938|4285661|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1438|1438.0||||||
4466714|NCT00041938|4285662|B2||Between 18 and 65 years|Age||Participants|Count of Participants|706|706.0||||||
4466715|NCT00041938|4285663|B1||Between 18 and 65 years|Age||Participants|Count of Participants|732|732.0||||||
4466716|NCT00041938|4285661|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466717|NCT00041938|4285662|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466718|NCT00041938|4285663|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466719|NCT00041756|4285692|B6|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466720|NCT00041756|4285693|B5|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466721|NCT00041756|4285694|B4|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466722|NCT00041756|4285695|B3|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466723|NCT00041756|4285696|B2|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466724|NCT00041756|4285697|B1|Multi-Racial||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466725|NCT00041756|4285692|B6|Asian Indian||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4466726|NCT00041756|4285693|B5|Asian Indian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4466727|NCT00041756|4285694|B4|Asian Indian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4466728|NCT00041756|4285695|B3|Asian Indian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4466729|NCT00041756|4285696|B2|Asian Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466730|NCT00041756|4285697|B1|Asian Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466731|NCT00041756|4285692|B6|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466732|NCT00041756|4285693|B5|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466733|NCT00041756|4285694|B4|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466734|NCT00041756|4285695|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466735|NCT00041756|4285696|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466736|NCT00041756|4285697|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466737|NCT00041756|4285692|B6|Caucasian||Race/Ethnicity, Customized||participants|Number|384|384.0||||||
4466738|NCT00041756|4285693|B5|Caucasian||Race/Ethnicity, Customized||participants|Number|76|76.0||||||
4466739|NCT00041756|4285694|B4|Caucasian||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4466740|NCT00041756|4285695|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4466741|NCT00041756|4285696|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|79|79.0||||||
4466742|NCT00041756|4285697|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|77|77.0||||||
4466743|NCT00041756|4285692|B6|Black||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4466744|NCT00041756|4285693|B5|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466745|NCT00041756|4285694|B4|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4466746|NCT00041756|4285695|B3|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4466747|NCT00041756|4285696|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4466748|NCT00041756|4285697|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466749|NCT00041756|4285692|B6|Asian Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466750|NCT00041756|4285693|B5|Asian Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466751|NCT00041756|4285694|B4|Asian Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466752|NCT00041756|4285695|B3|Asian Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466753|NCT00041756|4285696|B2|Asian Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466754|NCT00041756|4285697|B1|Asian Oriental||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466755|NCT00041756|4285692|B6|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466756|NCT00041756|4285693|B5|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466757|NCT00041756|4285694|B4|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466758|NCT00041756|4285695|B3|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466759|NCT00041756|4285696|B2|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466760|NCT00041756|4285697|B1|American Indian||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4466761|NCT00041756|4285692|B6||Male|Sex: Female, Male||Participants|Count of Participants|114|114.0||||||
4466762|NCT00041756|4285693|B5||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4466763|NCT00041756|4285694|B4||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4466764|NCT00041756|4285695|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4466765|NCT00041756|4285696|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4466766|NCT00041756|4285697|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4466767|NCT00041756|4285692|B6||Female|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4466768|NCT00041756|4285693|B5||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4466769|NCT00041756|4285694|B4||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4466770|NCT00041756|4285695|B3||Female|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4466771|NCT00041756|4285696|B2||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4466772|NCT00041756|4285697|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4466773|NCT00041756|4285692|B6|||Age||years|Mean|62.6|62.6|Standard Deviation|0.40|0.4|||
4466774|NCT00041756|4285693|B5|||Age||years|Mean|63.1|63.1|Standard Deviation|0.80|0.8|||
4466775|NCT00041756|4285694|B4|||Age||years|Mean|62.9|62.9|Standard Deviation|0.95|0.95|||
4466776|NCT00041756|4285695|B3|||Age||years|Mean|62.6|62.6|Standard Deviation|0.92|0.92|||
4466777|NCT00041756|4285696|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|0.86|0.86|||
4466778|NCT00041756|4285697|B1|||Age||years|Mean|62.0|62.0|Standard Deviation|0.92|0.92|||
4466779|NCT00041717|4285718|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4466780|NCT00041717|4285719|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4466781|NCT00041717|4285720|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4466782|NCT00041717|4285718|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466783|NCT00041717|4285719|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466784|NCT00041717|4285720|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466785|NCT00041717|4285718|B3||White|Race (NIH/OMB)||Participants|Count of Participants|175|175.0||||||
4466786|NCT00041717|4285719|B2||White|Race (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4466787|NCT00041717|4285720|B1||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4466788|NCT00041717|4285718|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4466789|NCT00041717|4285719|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4466790|NCT00041717|4285720|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|18|18.0||||||
4466791|NCT00041717|4285718|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466792|NCT00041717|4285719|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466793|NCT00041717|4285720|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466794|NCT00041717|4285718|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4466795|NCT00041717|4285719|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4466796|NCT00041717|4285720|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466797|NCT00041717|4285718|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4466798|NCT00041717|4285719|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4466799|NCT00041717|4285720|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4466800|NCT00041717|4285718|B3||Male|Sex: Female, Male||Participants|Count of Participants|185|185.0||||||
4466801|NCT00041717|4285719|B2||Male|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4466802|NCT00041717|4285720|B1||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4466803|NCT00041717|4285718|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4466804|NCT00041717|4285719|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4466805|NCT00041717|4285720|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4466806|NCT00041717|4285718|B3|||Age||years|Mean|40.9|40.9|Standard Deviation|12.54|12.54|||
4466807|NCT00041717|4285719|B2|||Age||years|Mean|40.1|40.1|Standard Deviation|13.10|13.1|||
4466808|NCT00041717|4285720|B1|||Age||years|Mean|41.6|41.6|Standard Deviation|12.05|12.05|||
4466809|NCT00041470|4285729|B1|||Baseline Participants||participants|Number|38|38.0||||||
4466810|NCT00041470|4285729|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466811|NCT00041470|4285729|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4466812|NCT00041470|4285729|B1|||Age||years|Median|46.5|46.5|Full Range|||27.0|73.0|
4466813|NCT00040664|4285734|B1|African Heritage||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4466814|NCT00040664|4285734|B1|American Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4466815|NCT00040664|4285734|B1|East and South East Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4466816|NCT00040664|4285734|B1|Black||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4466817|NCT00040664|4285734|B1|White/Caucasian||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4466818|NCT00040664|4285734|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4466819|NCT00040664|4285734|B1||Female|Sex: Female, Male||Participants|Count of Participants|39|39.0||||||
4466820|NCT00040664|4285734|B1|||Age||years|Mean|10.2|10.2|Standard Deviation|4.6|4.6|||
4466821|NCT00041392|4285785|B3|United States||Region of Enrollment||participants|Number|389|389.0||||||
4466822|NCT00041392|4285786|B2|United States||Region of Enrollment||participants|Number|191|191.0||||||
4466823|NCT00041392|4285787|B1|United States||Region of Enrollment||participants|Number|198|198.0||||||
4466824|NCT00041392|4285785|B3||Male|Sex: Female, Male||Participants|Count of Participants|269|269.0||||||
4466825|NCT00041392|4285786|B2||Male|Sex: Female, Male||Participants|Count of Participants|125|125.0||||||
4466826|NCT00041392|4285787|B1||Male|Sex: Female, Male||Participants|Count of Participants|144|144.0||||||
4466827|NCT00041392|4285785|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4466828|NCT00041392|4285786|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4466829|NCT00041392|4285787|B1||Female|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4466830|NCT00041392|4285785|B3|||Age||years|Mean|68.5|68.5|Standard Deviation|8.2|8.2|||
4466831|NCT00041392|4285786|B2|||Age||years|Mean|68.4|68.4|Standard Deviation|8.0|8.0|||
4466832|NCT00041392|4285787|B1|||Age||years|Mean|68.6|68.6|Standard Deviation|8.4|8.4|||
4466833|NCT00041392|4285785|B3||>=65 years|Age||Participants|Count of Participants|237|237.0||||||
4466834|NCT00041392|4285786|B2||>=65 years|Age||Participants|Count of Participants|117|117.0||||||
4466835|NCT00041392|4285787|B1||>=65 years|Age||Participants|Count of Participants|120|120.0||||||
4466836|NCT00041392|4285785|B3||Between 18 and 65 years|Age||Participants|Count of Participants|152|152.0||||||
4466837|NCT00041392|4285786|B2||Between 18 and 65 years|Age||Participants|Count of Participants|74|74.0||||||
4466838|NCT00041392|4285787|B1||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4466839|NCT00041392|4285785|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466840|NCT00041392|4285786|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466841|NCT00041392|4285787|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466842|NCT00040443|4285794|B3||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4466843|NCT00040443|4285795|B2||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4466844|NCT00040443|4285796|B1||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4466845|NCT00040443|4285794|B3||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4466846|NCT00040443|4285795|B2||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4466847|NCT00040443|4285796|B1||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4466848|NCT00040443|4285794|B3|||Age||years|Mean|71.1|71.1|Standard Deviation|8.1|8.1|||
4466849|NCT00040443|4285795|B2|||Age||years|Mean|70.3|70.3|Standard Deviation|8.5|8.5|||
4466850|NCT00040443|4285796|B1|||Age||years|Mean|72.0|72.0|Standard Deviation|7.7|7.7|||
4466851|NCT00040365|4285803|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4466852|NCT00040365|4285803|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4466853|NCT00040365|4285803|B1|White||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4466854|NCT00040365|4285803|B1|Black||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4466855|NCT00040365|4285803|B1|Asian||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4466856|NCT00040365|4285803|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4466857|NCT00040365|4285803|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4466858|NCT00040365|4285803|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4466859|NCT00040365|4285803|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4466860|NCT00040365|4285803|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4466861|NCT00040365|4285803|B1|||Age||years|Mean|65.63|65.63|Standard Deviation|7.06|7.06|||
4466862|NCT00040365|4285803|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4466863|NCT00040365|4285803|B1||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4466864|NCT00040365|4285803|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466865|NCT00039871|4285812|B1|Missing||METAVIR Fibrosis score|"The METAVIR scoring system for hepatic fibrosis is as follows:~F0= no fibrosis~F1 = portal fibrosis without septa~F2 = portal fibrosis with few septa~F3= septal fibrosis without cirrhosis~F4= cirrhosis"|number of participants|Number|2|2.0||||||
4466866|NCT00039871|4285812|B1|F4||METAVIR Fibrosis score|"The METAVIR scoring system for hepatic fibrosis is as follows:~F0= no fibrosis~F1 = portal fibrosis without septa~F2 = portal fibrosis with few septa~F3= septal fibrosis without cirrhosis~F4= cirrhosis"|number of participants|Number|974|974.0||||||
4466867|NCT00039871|4285812|B1|F3||METAVIR Fibrosis score|"The METAVIR scoring system for hepatic fibrosis is as follows:~F0= no fibrosis~F1 = portal fibrosis without septa~F2 = portal fibrosis with few septa~F3= septal fibrosis without cirrhosis~F4= cirrhosis"|number of participants|Number|676|676.0||||||
4466868|NCT00039871|4285812|B1|F2||METAVIR Fibrosis score|"The METAVIR scoring system for hepatic fibrosis is as follows:~F0= no fibrosis~F1 = portal fibrosis without septa~F2 = portal fibrosis with few septa~F3= septal fibrosis without cirrhosis~F4= cirrhosis"|number of participants|Number|658|658.0||||||
4466869|NCT00039871|4285812|B1|F1||METAVIR Fibrosis score|"The METAVIR scoring system for hepatic fibrosis is as follows:~F0= no fibrosis~F1 = portal fibrosis without septa~F2 = portal fibrosis with few septa~F3= septal fibrosis without cirrhosis~F4= cirrhosis"|number of participants|Number|2|2.0||||||
4466870|NCT00039871|4285812|B1|Missing||Hepatitis C Virus (HCV) Genotype||number of participants|Number|9|9.0||||||
4466871|NCT00039871|4285812|B1|Nontypable||Hepatitis C Virus (HCV) Genotype||number of participants|Number|8|8.0||||||
4466872|NCT00039871|4285812|B1|Genotype 4||Hepatitis C Virus (HCV) Genotype||number of participants|Number|68|68.0||||||
4466873|NCT00039871|4285812|B1|Genotype 3||Hepatitis C Virus (HCV) Genotype||number of participants|Number|293|293.0||||||
4466874|NCT00039871|4285812|B1|Genotype 2||Hepatitis C Virus (HCV) Genotype||number of participants|Number|75|75.0||||||
4466875|NCT00039871|4285812|B1|Genotype 1||Hepatitis C Virus (HCV) Genotype||number of participants|Number|1859|1859.0||||||
4466876|NCT00039871|4285812|B1||Male|Sex: Female, Male||Participants|Count of Participants|1650|1650.0||||||
4466877|NCT00039871|4285812|B1||Female|Sex: Female, Male||Participants|Count of Participants|662|662.0||||||
4466878|NCT00039871|4285812|B1|||Age||years|Mean|49.2|49.2|Standard Deviation|8.1|8.1|||
4466879|NCT00039871|4285812|B1||>=65 years|Age||Participants|Count of Participants|45|45.0||||||
4466880|NCT00039871|4285812|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2267|2267.0||||||
4466881|NCT00039871|4285812|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4466882|NCT00039741|4285818|B5|||CD4 percent (percentage of total lymphocytes that are CD4 cells)||CD4%|Mean|18|18.0|Standard Deviation|11|11.0|||
4466883|NCT00039741|4285819|B4|||CD4 percent (percentage of total lymphocytes that are CD4 cells)||CD4%|Mean|17|17.0|Standard Deviation|12|12.0|||
4466884|NCT00039741|4285820|B3|||CD4 percent (percentage of total lymphocytes that are CD4 cells)||CD4%|Mean|18|18.0|Standard Deviation|11|11.0|||
4466885|NCT00039741|4285821|B2|||CD4 percent (percentage of total lymphocytes that are CD4 cells)||CD4%|Mean|18|18.0|Standard Deviation|10|10.0|||
4466886|NCT00039741|4285822|B1|||CD4 percent (percentage of total lymphocytes that are CD4 cells)||CD4%|Mean|18|18.0|Standard Deviation|12|12.0|||
4466887|NCT00039741|4285818|B5|PACTG||PENTA/PACTG site||participants|Number|75|75.0||||||
4466888|NCT00039741|4285819|B4|PACTG||PENTA/PACTG site||participants|Number|18|18.0||||||
4466889|NCT00039741|4285820|B3|PACTG||PENTA/PACTG site||participants|Number|17|17.0||||||
4466890|NCT00039741|4285821|B2|PACTG||PENTA/PACTG site||participants|Number|21|21.0||||||
4466891|NCT00039741|4285822|B1|PACTG||PENTA/PACTG site||participants|Number|19|19.0||||||
4466892|NCT00039741|4285818|B5|PENTA||PENTA/PACTG site||participants|Number|188|188.0||||||
4466893|NCT00039741|4285819|B4|PENTA||PENTA/PACTG site||participants|Number|46|46.0||||||
4466894|NCT00039741|4285820|B3|PENTA||PENTA/PACTG site||participants|Number|48|48.0||||||
4466895|NCT00039741|4285821|B2|PENTA||PENTA/PACTG site||participants|Number|47|47.0||||||
4466896|NCT00039741|4285822|B1|PENTA||PENTA/PACTG site||participants|Number|47|47.0||||||
4466897|NCT00039741|4285818|B5|||Viral Load|Log10 HIV-1 RNA (copies/ml)|Log10 copies/ml|Mean|5.1|5.1|Standard Deviation|0.8|0.8|||
4466898|NCT00039741|4285819|B4|||Viral Load|Log10 HIV-1 RNA (copies/ml)|Log10 copies/ml|Mean|5.1|5.1|Standard Deviation|0.8|0.8|||
4466899|NCT00039741|4285820|B3|||Viral Load|Log10 HIV-1 RNA (copies/ml)|Log10 copies/ml|Mean|5.0|5.0|Standard Deviation|0.8|0.8|||
4466900|NCT00039741|4285821|B2|||Viral Load|Log10 HIV-1 RNA (copies/ml)|Log10 copies/ml|Mean|5.0|5.0|Standard Deviation|0.8|0.8|||
4466901|NCT00039741|4285822|B1|||Viral Load|Log10 HIV-1 RNA (copies/ml)|Log10 copies/ml|Mean|5.2|5.2|Standard Deviation|0.8|0.8|||
4466902|NCT00039741|4285818|B5|Ireland||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|4|4.0||||||
4466903|NCT00039741|4285819|B4|Ireland||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|1|1.0||||||
4466904|NCT00039741|4285820|B3|Ireland||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|2|2.0||||||
4466905|NCT00039741|4285821|B2|Ireland||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|1|1.0||||||
4466906|NCT00039741|4285822|B1|Ireland||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|0|0.0||||||
4466907|NCT00039741|4285818|B5|United Kingdom||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|33|33.0||||||
4466908|NCT00039741|4285819|B4|United Kingdom||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|6|6.0||||||
4466909|NCT00039741|4285820|B3|United Kingdom||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|9|9.0||||||
4466910|NCT00039741|4285821|B2|United Kingdom||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|11|11.0||||||
4466911|NCT00039741|4285822|B1|United Kingdom||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|7|7.0||||||
4466912|NCT00039741|4285818|B5|Spain||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|2|2.0||||||
4466913|NCT00039741|4285819|B4|Spain||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|0|0.0||||||
4466914|NCT00039741|4285820|B3|Spain||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|1|1.0||||||
4466915|NCT00039741|4285821|B2|Spain||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|0|0.0||||||
4466916|NCT00039741|4285822|B1|Spain||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|1|1.0||||||
4466917|NCT00039741|4285818|B5|Romania||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|31|31.0||||||
4466918|NCT00039741|4285819|B4|Romania||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|7|7.0||||||
4466919|NCT00039741|4285820|B3|Romania||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|9|9.0||||||
4466920|NCT00039741|4285821|B2|Romania||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|7|7.0||||||
4466921|NCT00039741|4285822|B1|Romania||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|8|8.0||||||
4466922|NCT00039741|4285818|B5|Italy||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|22|22.0||||||
4466923|NCT00039741|4285819|B4|Italy||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|6|6.0||||||
4466924|NCT00039741|4285820|B3|Italy||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|5|5.0||||||
4466925|NCT00039741|4285821|B2|Italy||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|4|4.0||||||
4466926|NCT00039741|4285822|B1|Italy||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|7|7.0||||||
4466927|NCT00039741|4285818|B5|Germany||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|21|21.0||||||
4466928|NCT00039741|4285819|B4|Germany||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|7|7.0||||||
4466929|NCT00039741|4285820|B3|Germany||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|3|3.0||||||
4466930|NCT00039741|4285821|B2|Germany||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|6|6.0||||||
4466931|NCT00039741|4285822|B1|Germany||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|5|5.0||||||
4466932|NCT00039741|4285818|B5|France||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|17|17.0||||||
4466933|NCT00039741|4285819|B4|France||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|6|6.0||||||
4466934|NCT00039741|4285820|B3|France||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|5|5.0||||||
4466935|NCT00039741|4285821|B2|France||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|3|3.0||||||
4466936|NCT00039741|4285822|B1|France||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|3|3.0||||||
4466937|NCT00039741|4285818|B5|Brazil||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|41|41.0||||||
4466938|NCT00039741|4285819|B4|Brazil||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|9|9.0||||||
4466939|NCT00039741|4285820|B3|Brazil||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|9|9.0||||||
4466940|NCT00039741|4285821|B2|Brazil||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|11|11.0||||||
4466941|NCT00039741|4285822|B1|Brazil||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|12|12.0||||||
4466942|NCT00039741|4285818|B5|Bahamas||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|4|4.0||||||
4466943|NCT00039741|4285819|B4|Bahamas||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|0|0.0||||||
4466944|NCT00039741|4285820|B3|Bahamas||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|2|2.0||||||
4466945|NCT00039741|4285821|B2|Bahamas||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|0|0.0||||||
4466946|NCT00039741|4285822|B1|Bahamas||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|2|2.0||||||
4466947|NCT00039741|4285818|B5|Austria||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|2|2.0||||||
4466948|NCT00039741|4285819|B4|Austria||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|1|1.0||||||
4466949|NCT00039741|4285820|B3|Austria||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|0|0.0||||||
4466950|NCT00039741|4285821|B2|Austria||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|0|0.0||||||
4467001|NCT00039741|4285822|B1|>30 days to <=12 months||Age, Customized||participants|Number|10|10.0||||||
4466951|NCT00039741|4285822|B1|Austria||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|1|1.0||||||
4466952|NCT00039741|4285818|B5|Argentina||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|11|11.0||||||
4466953|NCT00039741|4285819|B4|Argentina||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|3|3.0||||||
4466954|NCT00039741|4285820|B3|Argentina||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|3|3.0||||||
4466955|NCT00039741|4285821|B2|Argentina||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|4|4.0||||||
4466956|NCT00039741|4285822|B1|Argentina||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|1|1.0||||||
4466957|NCT00039741|4285818|B5|Puerto Rico||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|3|3.0||||||
4466958|NCT00039741|4285819|B4|Puerto Rico||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|0|0.0||||||
4466959|NCT00039741|4285820|B3|Puerto Rico||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|1|1.0||||||
4466960|NCT00039741|4285821|B2|Puerto Rico||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|1|1.0||||||
4466961|NCT00039741|4285822|B1|Puerto Rico||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|1|1.0||||||
4466962|NCT00039741|4285818|B5|United States||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|72|72.0||||||
4466963|NCT00039741|4285819|B4|United States||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|18|18.0||||||
4466964|NCT00039741|4285820|B3|United States||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|16|16.0||||||
4466965|NCT00039741|4285821|B2|United States||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|20|20.0||||||
4466966|NCT00039741|4285822|B1|United States||Region of Enrollment|Sites in the US and Puerto Rico were enrolled through PACTG, and other sites were enrolled through PENTA|participants|Number|18|18.0||||||
4466967|NCT00039741|4285818|B5||Male|Sex: Female, Male||Participants|Count of Participants|136|136.0||||||
4466968|NCT00039741|4285819|B4||Male|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4466969|NCT00039741|4285820|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4466970|NCT00039741|4285821|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4466971|NCT00039741|4285822|B1||Male|Sex: Female, Male||Participants|Count of Participants|36|36.0||||||
4466972|NCT00039741|4285818|B5||Female|Sex: Female, Male||Participants|Count of Participants|127|127.0||||||
4466973|NCT00039741|4285819|B4||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4466974|NCT00039741|4285820|B3||Female|Sex: Female, Male||Participants|Count of Participants|32|32.0||||||
4466975|NCT00039741|4285821|B2||Female|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4466976|NCT00039741|4285822|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4466977|NCT00039741|4285818|B5|>14 years to <18 years||Age, Customized||participants|Number|46|46.0||||||
4466978|NCT00039741|4285819|B4|>14 years to <18 years||Age, Customized||participants|Number|9|9.0||||||
4466979|NCT00039741|4285820|B3|>14 years to <18 years||Age, Customized||participants|Number|13|13.0||||||
4466980|NCT00039741|4285821|B2|>14 years to <18 years||Age, Customized||participants|Number|9|9.0||||||
4466981|NCT00039741|4285822|B1|>14 years to <18 years||Age, Customized||participants|Number|15|15.0||||||
4466982|NCT00039741|4285818|B5|>9 to <=14 years||Age, Customized||participants|Number|50|50.0||||||
4466983|NCT00039741|4285819|B4|>9 to <=14 years||Age, Customized||participants|Number|10|10.0||||||
4466984|NCT00039741|4285820|B3|>9 to <=14 years||Age, Customized||participants|Number|13|13.0||||||
4466985|NCT00039741|4285821|B2|>9 to <=14 years||Age, Customized||participants|Number|13|13.0||||||
4466986|NCT00039741|4285822|B1|>9 to <=14 years||Age, Customized||participants|Number|14|14.0||||||
4466987|NCT00039741|4285818|B5|>3 to <=9 years||Age, Customized||participants|Number|99|99.0||||||
4466988|NCT00039741|4285819|B4|>3 to <=9 years||Age, Customized||participants|Number|29|29.0||||||
4466989|NCT00039741|4285820|B3|>3 to <=9 years||Age, Customized||participants|Number|24|24.0||||||
4466990|NCT00039741|4285821|B2|>3 to <=9 years||Age, Customized||participants|Number|27|27.0||||||
4466991|NCT00039741|4285822|B1|>3 to <=9 years||Age, Customized||participants|Number|19|19.0||||||
4466992|NCT00039741|4285818|B5|>12 months to <=3 years||Age, Customized||participants|Number|28|28.0||||||
4466993|NCT00039741|4285819|B4|>12 months to <=3 years||Age, Customized||participants|Number|5|5.0||||||
4466994|NCT00039741|4285820|B3|>12 months to <=3 years||Age, Customized||participants|Number|8|8.0||||||
4466995|NCT00039741|4285821|B2|>12 months to <=3 years||Age, Customized||participants|Number|7|7.0||||||
4466996|NCT00039741|4285822|B1|>12 months to <=3 years||Age, Customized||participants|Number|8|8.0||||||
4466997|NCT00039741|4285818|B5|>30 days to <=12 months||Age, Customized||participants|Number|40|40.0||||||
4466998|NCT00039741|4285819|B4|>30 days to <=12 months||Age, Customized||participants|Number|11|11.0||||||
4466999|NCT00039741|4285820|B3|>30 days to <=12 months||Age, Customized||participants|Number|7|7.0||||||
4467000|NCT00039741|4285821|B2|>30 days to <=12 months||Age, Customized||participants|Number|12|12.0||||||
4467002|NCT00039741|4285818|B5|||Age||years|Mean|7.5|7.5|Standard Deviation|5.4|5.4|||
4467003|NCT00039741|4285819|B4|||Age||years|Mean|6.9|6.9|Standard Deviation|5.0|5.0|||
4467004|NCT00039741|4285820|B3|||Age||years|Mean|7.9|7.9|Standard Deviation|5.4|5.4|||
4467005|NCT00039741|4285821|B2|||Age||years|Mean|7.0|7.0|Standard Deviation|5.4|5.4|||
4467006|NCT00039741|4285822|B1|||Age||years|Mean|8.0|8.0|Standard Deviation|5.7|5.7|||
4467007|NCT00038948|4285867|B3||Male|Sex: Female, Male||Participants|Count of Participants|579.0|579.0||||||
4467008|NCT00038948|4285868|B2||Male|Sex: Female, Male||Participants|Count of Participants|194|194.0||||||
4467009|NCT00038948|4285869|B1||Male|Sex: Female, Male||Participants|Count of Participants|385|385.0||||||
4467010|NCT00038948|4285867|B3||Female|Sex: Female, Male||Participants|Count of Participants|251.0|251.0||||||
4467011|NCT00038948|4285868|B2||Female|Sex: Female, Male||Participants|Count of Participants|81|81.0||||||
4467012|NCT00038948|4285869|B1||Female|Sex: Female, Male||Participants|Count of Participants|170|170.0||||||
4467013|NCT00038948|4285867|B3|||Age||years|Median|44.50|44.5|Full Range|||12.8|75.1|
4467014|NCT00038948|4285868|B2|||Age||years|Median|43.50|43.5|Full Range|||12.8|74.0|
4467015|NCT00038948|4285869|B1|||Age||years|Median|45.00|45.0|Full Range|||13.2|75.1|
4467016|NCT00038857|4285882|B1|United States||Region of Enrollment||participants|Number|29|29.0||||||
4467017|NCT00038857|4285882|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4467018|NCT00038857|4285882|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4467019|NCT00038857|4285882|B1|||Age||years|Mean|36|36.0|Standard Deviation|11|11.0|||
4467020|NCT00038727|4285886|B4|||BMI||kg/m2|Mean|33.8|33.8|Standard Deviation|6.5|6.5|||
4467021|NCT00038727|4285887|B3|||BMI||kg/m2|Mean|34.0|34.0|Standard Deviation|6.5|6.5|||
4467022|NCT00038727|4285888|B2|||BMI||kg/m2|Mean|33.8|33.8|Standard Deviation|6.5|6.5|||
4467023|NCT00038727|4285889|B1|||BMI||kg/m2|Mean|33.7|33.7|Standard Deviation|6.5|6.5|||
4467024|NCT00038727|4285886|B4|United States||Region of Enrollment||participants|Number|2779|2779.0||||||
4467025|NCT00038727|4285887|B3|United States||Region of Enrollment||participants|Number|936|936.0||||||
4467026|NCT00038727|4285888|B2|United States||Region of Enrollment||participants|Number|927|927.0||||||
4467027|NCT00038727|4285889|B1|United States||Region of Enrollment||participants|Number|916|916.0||||||
4467028|NCT00038727|4285886|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|63|63.0||||||
4467029|NCT00038727|4285887|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|20|20.0||||||
4467030|NCT00038727|4285888|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4467031|NCT00038727|4285889|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4467032|NCT00038727|4285886|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4467033|NCT00038727|4285887|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4467034|NCT00038727|4285888|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4467035|NCT00038727|4285889|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4467036|NCT00038727|4285886|B4||White|Race (NIH/OMB)||Participants|Count of Participants|1836|1836.0||||||
4467037|NCT00038727|4285887|B3||White|Race (NIH/OMB)||Participants|Count of Participants|612|612.0||||||
4467038|NCT00038727|4285888|B2||White|Race (NIH/OMB)||Participants|Count of Participants|628|628.0||||||
4467039|NCT00038727|4285889|B1||White|Race (NIH/OMB)||Participants|Count of Participants|596|596.0||||||
4467040|NCT00038727|4285886|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|544|544.0||||||
4467041|NCT00038727|4285887|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|189|189.0||||||
4467042|NCT00038727|4285888|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|182|182.0||||||
4467043|NCT00038727|4285889|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|173|173.0||||||
4467044|NCT00038727|4285886|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4467045|NCT00038727|4285887|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4467046|NCT00038727|4285888|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4467047|NCT00038727|4285889|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4467048|NCT00038727|4285886|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|112|112.0||||||
4467049|NCT00038727|4285887|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4467050|NCT00038727|4285888|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|28|28.0||||||
4467051|NCT00038727|4285889|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4467052|NCT00038727|4285886|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|155|155.0||||||
4467053|NCT00038727|4285887|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4467054|NCT00038727|4285888|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4467055|NCT00038727|4285889|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4467056|NCT00038727|4285886|B4||Male|Sex: Female, Male||Participants|Count of Participants|890|890.0||||||
4467057|NCT00038727|4285887|B3||Male|Sex: Female, Male||Participants|Count of Participants|291|291.0||||||
4467058|NCT00038727|4285888|B2||Male|Sex: Female, Male||Participants|Count of Participants|307|307.0||||||
4467059|NCT00038727|4285889|B1||Male|Sex: Female, Male||Participants|Count of Participants|292|292.0||||||
4467060|NCT00038727|4285886|B4||Female|Sex: Female, Male||Participants|Count of Participants|1889|1889.0||||||
4467061|NCT00038727|4285887|B3||Female|Sex: Female, Male||Participants|Count of Participants|645|645.0||||||
4467062|NCT00038727|4285888|B2||Female|Sex: Female, Male||Participants|Count of Participants|620|620.0||||||
4467063|NCT00038727|4285889|B1||Female|Sex: Female, Male||Participants|Count of Participants|624|624.0||||||
4467064|NCT00038727|4285886|B4|||Age||years|Mean|51.1|51.1|Standard Deviation|10.4|10.4|||
4467065|NCT00038727|4285887|B3|||Age||years|Mean|50.7|50.7|Standard Deviation|10.0|10.0|||
4467066|NCT00038727|4285888|B2|||Age||years|Mean|51.3|51.3|Standard Deviation|10.1|10.1|||
4467067|NCT00038727|4285889|B1|||Age||years|Mean|51.2|51.2|Standard Deviation|11.1|11.1|||
4467068|NCT00038727|4285886|B4|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
4467069|NCT00038727|4285887|B3|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
4467070|NCT00038727|4285888|B2|||Age||years|Mean|54|54.0|Standard Deviation|10|10.0|||
4467071|NCT00038727|4285889|B1|||Age||years|Mean|54|54.0|Standard Deviation|11|11.0|||
4467072|NCT00038649|4285902|B1|United States||Region of Enrollment||participants|Number|114|114.0||||||
4467073|NCT00038649|4285902|B1||Male|Sex: Female, Male||Participants|Count of Participants|71|71.0||||||
4467074|NCT00038649|4285902|B1||Female|Sex: Female, Male||Participants|Count of Participants|43|43.0||||||
4467075|NCT00038649|4285902|B1|||Age||years|Median|48|48.0|Full Range|||17.0|84.0|
4467076|NCT00038610|4285907|B1|United States||Region of Enrollment||participants|Number|54|54.0||||||
4467077|NCT00038610|4285907|B1||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4467078|NCT00038610|4285907|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4467079|NCT00038610|4285907|B1|||Age||years|Median|51|51.0|Full Range|||17.0|84.0|
4467080|NCT00038467|4285913|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467081|NCT00038467|4285914|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467082|NCT00038467|4285915|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467083|NCT00038467|4285913|B3||Female|Sex: Female, Male||Participants|Count of Participants|4724|4724.0||||||
4467084|NCT00038467|4285914|B2||Female|Sex: Female, Male||Participants|Count of Participants|2372|2372.0||||||
4467085|NCT00038467|4285915|B1||Female|Sex: Female, Male||Participants|Count of Participants|2352|2352.0||||||
4467086|NCT00038467|4285913|B3|||Age||years|Mean|63.73|63.73|Standard Deviation|8.17|8.17|||
4467087|NCT00038467|4285914|B2|||Age||years|Mean|63.69|63.69|Standard Deviation|8.22|8.22|||
4467088|NCT00038467|4285915|B1|||Age||years|Mean|63.78|63.78|Standard Deviation|8.12|8.12|||
4467089|NCT00038103|4285976|B3||Male|Sex: Female, Male|All participants were female|Participants|Count of Participants|0.0|0.0||||||
4467090|NCT00038103|4285977|B2||Male|Sex: Female, Male|All participants were female|Participants|Count of Participants|0|0.0||||||
4467091|NCT00038103|4285978|B1||Male|Sex: Female, Male|All participants were female|Participants|Count of Participants|0|0.0||||||
4467092|NCT00038103|4285976|B3||Female|Sex: Female, Male|All participants were female|Participants|Count of Participants|111.0|111.0||||||
4467093|NCT00038103|4285977|B2||Female|Sex: Female, Male|All participants were female|Participants|Count of Participants|56|56.0||||||
4467094|NCT00038103|4285978|B1||Female|Sex: Female, Male|All participants were female|Participants|Count of Participants|55|55.0||||||
4467095|NCT00038103|4285976|B3|=> 80 years||Age, Customized||Participants|Number|1.0|1.0||||||
4467096|NCT00038103|4285977|B2|=> 80 years||Age, Customized||Participants|Number|1.0|1.0||||||
4467097|NCT00038103|4285978|B1|=> 80 years||Age, Customized||Participants|Number|0.0|0.0||||||
4467098|NCT00038103|4285976|B3|65-79 years||Age, Customized||Participants|Number|27.0|27.0||||||
4467099|NCT00038103|4285977|B2|65-79 years||Age, Customized||Participants|Number|12.0|12.0||||||
4467100|NCT00038103|4285978|B1|65-79 years||Age, Customized||Participants|Number|15.0|15.0||||||
4467101|NCT00038103|4285976|B3|50-64 years||Age, Customized||Participants|Number|47.0|47.0||||||
4467102|NCT00038103|4285977|B2|50-64 years||Age, Customized||Participants|Number|27.0|27.0||||||
4467103|NCT00038103|4285978|B1|50-64 years||Age, Customized||Participants|Number|20.0|20.0||||||
4467104|NCT00038103|4285976|B3|< 50 years||Age, Customized||Participants|Number|36.0|36.0||||||
4467105|NCT00038103|4285977|B2|< 50 years||Age, Customized||Participants|Number|16.0|16.0||||||
4467106|NCT00038103|4285978|B1|< 50 years||Age, Customized||Participants|Number|20.0|20.0||||||
4467107|NCT00037830|4285999|B4|United States||Region of Enrollment||participants|Number|94|94.0||||||
4467108|NCT00037830|4286000|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4467109|NCT00037830|4286001|B2|United States||Region of Enrollment||participants|Number|38|38.0||||||
4467110|NCT00037830|4286002|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4467111|NCT00037830|4285999|B4||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4467112|NCT00037830|4286000|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4467113|NCT00037830|4286001|B2||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4467114|NCT00037830|4286002|B1||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4467115|NCT00037830|4285999|B4||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4467116|NCT00037830|4286000|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4467117|NCT00037830|4286001|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4467118|NCT00037830|4286002|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4467119|NCT00037830|4285999|B4|||Age||years|Mean|59.5|59.5|Standard Deviation|9.6|9.6|||
4467120|NCT00037830|4286000|B3|||Age||years|Mean|61.1|61.1|Standard Deviation|11.8|11.8|||
4467121|NCT00037830|4286001|B2|||Age||years|Mean|57.7|57.7|Standard Deviation|8.7|8.7|||
4467122|NCT00037830|4286002|B1|||Age||years|Mean|59.7|59.7|Standard Deviation|8.4|8.4|||
4467123|NCT00037830|4285999|B4||>=65 years|Age||Participants|Count of Participants|29|29.0||||||
4467124|NCT00037830|4286000|B3||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4467125|NCT00037830|4286001|B2||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4467126|NCT00037830|4286002|B1||>=65 years|Age||Participants|Count of Participants|12|12.0||||||
4467127|NCT00037830|4285999|B4||Between 18 and 65 years|Age||Participants|Count of Participants|65|65.0||||||
4467128|NCT00037830|4286000|B3||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4467129|NCT00037830|4286001|B2||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4467130|NCT00037830|4286002|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4467131|NCT00037830|4285999|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467132|NCT00037830|4286000|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467133|NCT00037830|4286001|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467134|NCT00037830|4286002|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467135|NCT00036569|4286025|B1|United States||Region of Enrollment||participants|Number|32|32.0||||||
4467136|NCT00036569|4286025|B1|Native Hawaiian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4467137|NCT00036569|4286025|B1|Asian or Pacific Islander||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4467138|NCT00036569|4286025|B1|Black||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4467139|NCT00036569|4286025|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4467140|NCT00036569|4286025|B1|Not Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|23|23.0||||||
4467141|NCT00036569|4286025|B1|Hispanic or Latino||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4467142|NCT00036569|4286025|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4467143|NCT00036569|4286025|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4467144|NCT00036569|4286025|B1|||Age||years|Mean|6.28|6.28|Standard Deviation|3.16|3.16|||
4467145|NCT00036569|4286025|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4467146|NCT00036569|4286025|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4467147|NCT00036569|4286025|B1||<=18 years|Age||Participants|Count of Participants|32|32.0||||||
4467148|NCT00036270|4286034|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467149|NCT00036270|4286035|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467150|NCT00036270|4286036|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467151|NCT00036270|4286034|B3||Female|Sex: Female, Male||Participants|Count of Participants|9766|9766.0||||||
4467152|NCT00036270|4286035|B2||Female|Sex: Female, Male||Participants|Count of Participants|4868|4868.0||||||
4467153|NCT00036270|4286036|B1||Female|Sex: Female, Male||Participants|Count of Participants|4898|4898.0||||||
4467154|NCT00036270|4286034|B3|Greater than and equal to 70 years||Age, Customized||Participants|Number|2687|2687.0||||||
4467155|NCT00036270|4286035|B2|Greater than and equal to 70 years||Age, Customized||Participants|Number|1305|1305.0||||||
4467156|NCT00036270|4286036|B1|Greater than and equal to 70 years||Age, Customized||Participants|Number|1382|1382.0||||||
4467157|NCT00036270|4286034|B3|60 to 69 years||Age, Customized||Participants|Number|3731|3731.0||||||
4467158|NCT00036270|4286035|B2|60 to 69 years||Age, Customized||Participants|Number|1896|1896.0||||||
4467159|NCT00036270|4286036|B1|60 to 69 years||Age, Customized||Participants|Number|1835|1835.0||||||
4467160|NCT00036270|4286034|B3|50 to 59 years||Age, Customized||Participants|Number|3017|3017.0||||||
4467161|NCT00036270|4286035|B2|50 to 59 years||Age, Customized||Participants|Number|1507|1507.0||||||
4467162|NCT00036270|4286036|B1|50 to 59 years||Age, Customized||Participants|Number|1510|1510.0||||||
4467163|NCT00036270|4286034|B3|Less than 50 years||Age, Customized||Participants|Number|331|331.0||||||
4467164|NCT00036270|4286035|B2|Less than 50 years||Age, Customized||Participants|Number|160|160.0||||||
4467165|NCT00036270|4286036|B1|Less than 50 years||Age, Customized||Participants|Number|171|171.0||||||
4467166|NCT00036270|4286034|B3|||Age||Years|Mean|64|64.0|Standard Deviation|9|9.0|||
4467167|NCT00036270|4286035|B2|||Age||Years|Mean|64|64.0|Standard Deviation|9|9.0|||
4467168|NCT00036270|4286036|B1|||Age||Years|Mean|65|65.0|Standard Deviation|9|9.0|||
4467169|NCT00035932|4286053|B4|||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA)||log10 c/mL|Median|4.45|4.45|Full Range|||2.6|5.88|
4467170|NCT00035932|4286054|B3|||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA)||log10 c/mL|Median|4.47|4.47|Full Range|||2.6|5.88|
4467171|NCT00035932|4286055|B2|||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA)||log10 c/mL|Median|4.42|4.42|Full Range|||2.6|5.88|
4467172|NCT00035932|4286056|B1|||Human Immunodeficiency Virus Ribonucleic Acid (HIV RNA)||log10 c/mL|Median|4.44|4.44|Full Range|||2.6|5.88|
4467173|NCT00035932|4286053|B4|||Cluster of Differentiation 4 (CD4) cell count||cells/mm^3|Median|297|297.0|Full Range|||14.0|1543.0|
4467174|NCT00035932|4286054|B3|||Cluster of Differentiation 4 (CD4) cell count||cells/mm^3|Median|283|283.0|Full Range|||14.0|1238.0|
4467175|NCT00035932|4286055|B2|||Cluster of Differentiation 4 (CD4) cell count||cells/mm^3|Median|286|286.0|Full Range|||42.0|1543.0|
4467176|NCT00035932|4286056|B1|||Cluster of Differentiation 4 (CD4) cell count||cells/mm^3|Median|317|317.0|Full Range|||40.0|1025.0|
4467177|NCT00035932|4286053|B4|No||Intravenous (IV) Drug Use||participants|Number|335|335.0||||||
4467178|NCT00035932|4286054|B3|No||Intravenous (IV) Drug Use||participants|Number|115|115.0||||||
4467179|NCT00035932|4286055|B2|No||Intravenous (IV) Drug Use||participants|Number|108|108.0||||||
4467180|NCT00035932|4286056|B1|No||Intravenous (IV) Drug Use||participants|Number|112|112.0||||||
4467181|NCT00035932|4286053|B4|Yes||Intravenous (IV) Drug Use||participants|Number|23|23.0||||||
4467182|NCT00035932|4286054|B3|Yes||Intravenous (IV) Drug Use||participants|Number|8|8.0||||||
4467183|NCT00035932|4286055|B2|Yes||Intravenous (IV) Drug Use||participants|Number|7|7.0||||||
4467184|NCT00035932|4286056|B1|Yes||Intravenous (IV) Drug Use||participants|Number|8|8.0||||||
4467185|NCT00035932|4286053|B4|No||Acquired Immunodeficiency Virus (AIDS)||participants|Number|256|256.0||||||
4467186|NCT00035932|4286054|B3|No||Acquired Immunodeficiency Virus (AIDS)||participants|Number|87|87.0||||||
4467187|NCT00035932|4286055|B2|No||Acquired Immunodeficiency Virus (AIDS)||participants|Number|82|82.0||||||
4467188|NCT00035932|4286056|B1|No||Acquired Immunodeficiency Virus (AIDS)||participants|Number|87|87.0||||||
4467189|NCT00035932|4286053|B4|Yes||Acquired Immunodeficiency Virus (AIDS)||participants|Number|102|102.0||||||
4467190|NCT00035932|4286054|B3|Yes||Acquired Immunodeficiency Virus (AIDS)||participants|Number|36|36.0||||||
4467191|NCT00035932|4286055|B2|Yes||Acquired Immunodeficiency Virus (AIDS)||participants|Number|33|33.0||||||
4467192|NCT00035932|4286056|B1|Yes||Acquired Immunodeficiency Virus (AIDS)||participants|Number|33|33.0||||||
4467193|NCT00035932|4286053|B4|Europe||Region of Enrollment||participants|Number|69|69.0||||||
4467194|NCT00035932|4286054|B3|Europe||Region of Enrollment||participants|Number|22|22.0||||||
4467195|NCT00035932|4286055|B2|Europe||Region of Enrollment||participants|Number|22|22.0||||||
4467196|NCT00035932|4286056|B1|Europe||Region of Enrollment||participants|Number|25|25.0||||||
4467197|NCT00035932|4286053|B4|North America||Region of Enrollment||participants|Number|124|124.0||||||
4467198|NCT00035932|4286054|B3|North America||Region of Enrollment||participants|Number|47|47.0||||||
4467199|NCT00035932|4286055|B2|North America||Region of Enrollment||participants|Number|38|38.0||||||
4467200|NCT00035932|4286056|B1|North America||Region of Enrollment||participants|Number|39|39.0||||||
4467201|NCT00035932|4286053|B4|South America||Region of Enrollment||participants|Number|165|165.0||||||
4467202|NCT00035932|4286054|B3|South America||Region of Enrollment||participants|Number|54|54.0||||||
4467203|NCT00035932|4286055|B2|South America||Region of Enrollment||participants|Number|55|55.0||||||
4467204|NCT00035932|4286056|B1|South America||Region of Enrollment||participants|Number|56|56.0||||||
4467205|NCT00035932|4286053|B4|Other||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4467206|NCT00035932|4286054|B3|Other||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4467207|NCT00035932|4286055|B2|Other||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4467208|NCT00035932|4286056|B1|Other||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4467209|NCT00035932|4286053|B4|Black||Race/Ethnicity, Customized||participants|Number|55|55.0||||||
4467210|NCT00035932|4286054|B3|Black||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4467211|NCT00035932|4286055|B2|Black||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4467212|NCT00035932|4286056|B1|Black||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4467213|NCT00035932|4286053|B4|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|80|80.0||||||
4467214|NCT00035932|4286054|B3|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4467215|NCT00035932|4286055|B2|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|26|26.0||||||
4467216|NCT00035932|4286056|B1|Hispanic/Latino||Race/Ethnicity, Customized||participants|Number|27|27.0||||||
4467217|NCT00035932|4286053|B4|White||Race/Ethnicity, Customized||participants|Number|216|216.0||||||
4467218|NCT00035932|4286054|B3|White||Race/Ethnicity, Customized||participants|Number|71|71.0||||||
4467219|NCT00035932|4286055|B2|White||Race/Ethnicity, Customized||participants|Number|70|70.0||||||
4467220|NCT00035932|4286056|B1|White||Race/Ethnicity, Customized||participants|Number|75|75.0||||||
4467221|NCT00035932|4286053|B4||Male|Sex: Female, Male||Participants|Count of Participants|281|281.0||||||
4467222|NCT00035932|4286054|B3||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4467223|NCT00035932|4286055|B2||Male|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4467224|NCT00035932|4286056|B1||Male|Sex: Female, Male||Participants|Count of Participants|96|96.0||||||
4467225|NCT00035932|4286053|B4||Female|Sex: Female, Male||Participants|Count of Participants|77|77.0||||||
4467226|NCT00035932|4286054|B3||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4467227|NCT00035932|4286055|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4467228|NCT00035932|4286056|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4467229|NCT00035932|4286053|B4|||Age||years|Median|40|40.0|Full Range|||24.0|74.0|
4467230|NCT00035932|4286054|B3|||Age||years|Median|39|39.0|Full Range|||25.0|72.0|
4467231|NCT00035932|4286055|B2|||Age||years|Median|41|41.0|Full Range|||26.0|74.0|
4467232|NCT00035932|4286056|B1|||Age||years|Median|39|39.0|Full Range|||24.0|71.0|
4467233|NCT00035815|4286182|B3|United States||Region of Enrollment||participants|Number|330|330.0||||||
4467234|NCT00035815|4286183|B2|United States||Region of Enrollment||participants|Number|163|163.0||||||
4467235|NCT00035815|4286184|B1|United States||Region of Enrollment||participants|Number|167|167.0||||||
4467236|NCT00035815|4286182|B3||Male|Sex: Female, Male||Participants|Count of Participants|210|210.0||||||
4467237|NCT00035815|4286183|B2||Male|Sex: Female, Male||Participants|Count of Participants|100|100.0||||||
4467238|NCT00035815|4286184|B1||Male|Sex: Female, Male||Participants|Count of Participants|110|110.0||||||
4467239|NCT00035815|4286182|B3||Female|Sex: Female, Male||Participants|Count of Participants|120|120.0||||||
4467240|NCT00035815|4286183|B2||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4467241|NCT00035815|4286184|B1||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4467242|NCT00035815|4286182|B3|||Age||years|Mean|54.4|54.4|Standard Deviation|11.7|11.7|||
4467243|NCT00035815|4286183|B2|||Age||years|Mean|54.8|54.8|Standard Deviation|11.2|11.2|||
4467244|NCT00035815|4286184|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|12.2|12.2|||
4467245|NCT00035815|4286182|B3||>=65 years|Age||Participants|Count of Participants|66|66.0||||||
4467246|NCT00035815|4286183|B2||>=65 years|Age||Participants|Count of Participants|34|34.0||||||
4467247|NCT00035815|4286184|B1||>=65 years|Age||Participants|Count of Participants|32|32.0||||||
4467248|NCT00035815|4286182|B3||Between 18 and 65 years|Age||Participants|Count of Participants|264|264.0||||||
4467249|NCT00035815|4286183|B2||Between 18 and 65 years|Age||Participants|Count of Participants|129|129.0||||||
4467250|NCT00035815|4286184|B1||Between 18 and 65 years|Age||Participants|Count of Participants|135|135.0||||||
4467251|NCT00035815|4286182|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467252|NCT00035815|4286183|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467253|NCT00035815|4286184|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467254|NCT00035555|4286195|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|8|8.0||||||
4467255|NCT00035555|4286196|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4467256|NCT00035555|4286197|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4467257|NCT00035555|4286198|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4467258|NCT00035555|4286195|B4|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4467259|NCT00035555|4286196|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4467260|NCT00035555|4286197|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4467261|NCT00035555|4286198|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4467262|NCT00035555|4286195|B4|Black or African American||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4467263|NCT00035555|4286196|B3|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4467264|NCT00035555|4286197|B2|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4467265|NCT00035555|4286198|B1|Black or African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4467266|NCT00035555|4286195|B4|White||Race/Ethnicity, Customized||Participants|Number|180|180.0||||||
4467267|NCT00035555|4286196|B3|White||Race/Ethnicity, Customized||Participants|Number|59|59.0||||||
4467268|NCT00035555|4286197|B2|White||Race/Ethnicity, Customized||Participants|Number|57|57.0||||||
4467269|NCT00035555|4286198|B1|White||Race/Ethnicity, Customized||Participants|Number|64|64.0||||||
4467270|NCT00035555|4286195|B4||Male|Sex: Female, Male||Participants|Count of Participants|151|151.0||||||
4467271|NCT00035555|4286196|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4467272|NCT00035555|4286197|B2||Male|Sex: Female, Male||Participants|Count of Participants|48|48.0||||||
4467273|NCT00035555|4286198|B1||Male|Sex: Female, Male||Participants|Count of Participants|54|54.0||||||
4467274|NCT00035555|4286195|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4467275|NCT00035555|4286196|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4467276|NCT00035555|4286197|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4467277|NCT00035555|4286198|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4467278|NCT00035555|4286195|B4|Older than 60 years||Age, Customized||Participants|Number|13|13.0||||||
4467279|NCT00035555|4286196|B3|Older than 60 years||Age, Customized||Participants|Number|4|4.0||||||
4467280|NCT00035555|4286197|B2|Older than 60 years||Age, Customized||Participants|Number|3|3.0||||||
4467281|NCT00035555|4286198|B1|Older than 60 years||Age, Customized||Participants|Number|6|6.0||||||
4467282|NCT00035555|4286195|B4|Between 46 and 60 years||Age, Customized||Participants|Number|90|90.0||||||
4467283|NCT00035555|4286196|B3|Between 46 and 60 years||Age, Customized||Participants|Number|33|33.0||||||
4467284|NCT00035555|4286197|B2|Between 46 and 60 years||Age, Customized||Participants|Number|26|26.0||||||
4467285|NCT00035555|4286198|B1|Between 46 and 60 years||Age, Customized||Participants|Number|31|31.0||||||
4467286|NCT00035555|4286195|B4|Between 18 and 45 years||Age, Customized||Participants|Number|115|115.0||||||
4467287|NCT00035555|4286196|B3|Between 18 and 45 years||Age, Customized||Participants|Number|36|36.0||||||
4467288|NCT00035555|4286197|B2|Between 18 and 45 years||Age, Customized||Participants|Number|42|42.0||||||
4467289|NCT00035555|4286198|B1|Between 18 and 45 years||Age, Customized||Participants|Number|37|37.0||||||
4467290|NCT00035555|4286195|B4|||Age||Years|Median|45.0|45.0|Full Range|||18.0|71.0|
4467291|NCT00035555|4286196|B3|||Age||Years|Median|46.0|46.0|Full Range|||23.0|66.0|
4467292|NCT00035555|4286197|B2|||Age||Years|Median|43.0|43.0|Full Range|||18.0|71.0|
4467293|NCT00035555|4286198|B1|||Age||Years|Median|45.5|45.5|Full Range|||23.0|70.0|
4467294|NCT00035555|4286195|B4|||Age||Years|Mean|44.9|44.9|Standard Deviation|11.2|11.2|||
4467295|NCT00035555|4286196|B3|||Age||Years|Mean|46.1|46.1|Standard Deviation|10.9|10.9|||
4467296|NCT00035555|4286197|B2|||Age||Years|Mean|42.1|42.1|Standard Deviation|11.6|11.6|||
4467297|NCT00035555|4286198|B1|||Age||Years|Mean|46.5|46.5|Standard Deviation|10.8|10.8|||
4467298|NCT00033917|4286241|B3|United States||Region of Enrollment||participants|Number|431|431.0||||||
4467299|NCT00033917|4286242|B2|United States||Region of Enrollment||participants|Number|222|222.0||||||
4467300|NCT00033917|4286243|B1|United States||Region of Enrollment||participants|Number|209|209.0||||||
4467301|NCT00033917|4286241|B3||Male|Sex: Female, Male||Participants|Count of Participants|235|235.0||||||
4467302|NCT00033917|4286242|B2||Male|Sex: Female, Male||Participants|Count of Participants|119|119.0||||||
4467303|NCT00033917|4286243|B1||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4467304|NCT00033917|4286241|B3||Female|Sex: Female, Male||Participants|Count of Participants|196|196.0||||||
4467305|NCT00033917|4286242|B2||Female|Sex: Female, Male||Participants|Count of Participants|103|103.0||||||
4467306|NCT00033917|4286243|B1||Female|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4467307|NCT00033917|4286241|B3|||Age|Age is expressed in postnatal hours|hours|Mean|7.8|7.8|Standard Deviation|2.3|2.3|||
4467308|NCT00033917|4286242|B2|||Age|Age is expressed in postnatal hours|hours|Mean|7.9|7.9|Standard Deviation|2.4|2.4|||
4467309|NCT00033917|4286243|B1|||Age|Age is expressed in postnatal hours|hours|Mean|7.8|7.8|Standard Deviation|2.3|2.3|||
4467310|NCT00032630|4286254|B3|United States||Region of Enrollment||participants|Number|2203|2203.0||||||
4467311|NCT00032630|4286255|B2|United States||Region of Enrollment||participants|Number|1104|1104.0||||||
4467312|NCT00032630|4286256|B1|United States||Region of Enrollment||participants|Number|1099|1099.0||||||
4467313|NCT00032630|4286254|B3||Male|Sex: Female, Male||Participants|Count of Participants|2190|2190.0||||||
4467314|NCT00032630|4286255|B2||Male|Sex: Female, Male||Participants|Count of Participants|1097|1097.0||||||
4467315|NCT00032630|4286256|B1||Male|Sex: Female, Male||Participants|Count of Participants|1093|1093.0||||||
4467316|NCT00032630|4286254|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4467317|NCT00032630|4286255|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4467318|NCT00032630|4286256|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4467319|NCT00032630|4286254|B3|||Age||years|Mean|62.74|62.74|Standard Deviation|8.49|8.49|||
4467320|NCT00032630|4286255|B2|||Age||years|Mean|63.0|63.0|Standard Deviation|8.5|8.5|||
4467321|NCT00032630|4286256|B1|||Age||years|Mean|62.5|62.5|Standard Deviation|8.5|8.5|||
4467322|NCT00032630|4286254|B3||>=65 years|Age||Participants|Count of Participants|833|833.0||||||
4467323|NCT00032630|4286255|B2||>=65 years|Age||Participants|Count of Participants|433|433.0||||||
4467324|NCT00032630|4286256|B1||>=65 years|Age||Participants|Count of Participants|400|400.0||||||
4467325|NCT00032630|4286254|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1370|1370.0||||||
4467326|NCT00032630|4286255|B2||Between 18 and 65 years|Age||Participants|Count of Participants|671|671.0||||||
4467327|NCT00032630|4286256|B1||Between 18 and 65 years|Age||Participants|Count of Participants|699|699.0||||||
4467328|NCT00032630|4286254|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467329|NCT00032630|4286255|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467330|NCT00032630|4286256|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467331|NCT00032591|4286265|B3||Male|Sex: Female, Male||Participants|Count of Participants|2871|2871.0||||||
4467332|NCT00032591|4286266|B2||Male|Sex: Female, Male||Participants|Count of Participants|1431|1431.0||||||
4467333|NCT00032591|4286267|B1||Male|Sex: Female, Male||Participants|Count of Participants|1440|1440.0||||||
4467334|NCT00032591|4286265|B3||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4467335|NCT00032591|4286266|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4467336|NCT00032591|4286267|B1||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4467337|NCT00032591|4286265|B3|Total study population||Age||years|Mean|67|67.0|Standard Deviation|9.6|9.6|||
4467338|NCT00032591|4286266|B2|Total study population||Age||years|Mean|67.4|67.4|Standard Deviation|9.4|9.4|||
4467339|NCT00032591|4286267|B1|Total study population||Age||years|Mean|66.6|66.6|Standard Deviation|9.7|9.7|||
4467340|NCT00032487|4286282|B3|United States||Region of Enrollment||participants|Number|1791|1791.0||||||
4467341|NCT00032487|4286283|B2|United States||Region of Enrollment||participants|Number|892|892.0||||||
4467342|NCT00032487|4286284|B1|United States||Region of Enrollment||participants|Number|899|899.0||||||
4467343|NCT00032487|4286282|B3||Male|Sex: Female, Male||Participants|Count of Participants|1739|1739.0||||||
4467344|NCT00032487|4286283|B2||Male|Sex: Female, Male||Participants|Count of Participants|866|866.0||||||
4467345|NCT00032487|4286284|B1||Male|Sex: Female, Male||Participants|Count of Participants|873|873.0||||||
4467346|NCT00032487|4286282|B3||Female|Sex: Female, Male||Participants|Count of Participants|52|52.0||||||
4467347|NCT00032487|4286283|B2||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4467348|NCT00032487|4286284|B1||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4467349|NCT00032487|4286282|B3|||Age||years|Mean|60.4|60.4|Standard Deviation|9.0|9.0|||
4467350|NCT00032487|4286283|B2|||Age||years|Mean|60.5|60.5|Standard Deviation|9.0|9.0|||
4467351|NCT00032487|4286284|B1|||Age||years|Mean|60.3|60.3|Standard Deviation|9.0|9.0|||
4467352|NCT00032487|4286282|B3||>=65 years|Age||Participants|Count of Participants|573|573.0||||||
4467353|NCT00032487|4286283|B2||>=65 years|Age||Participants|Count of Participants|280|280.0||||||
4467354|NCT00032487|4286284|B1||>=65 years|Age||Participants|Count of Participants|293|293.0||||||
4467355|NCT00032487|4286282|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1218|1218.0||||||
4467356|NCT00032487|4286283|B2||Between 18 and 65 years|Age||Participants|Count of Participants|612|612.0||||||
4467357|NCT00032487|4286284|B1||Between 18 and 65 years|Age||Participants|Count of Participants|606|606.0||||||
4467358|NCT00032487|4286282|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467359|NCT00032487|4286283|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467360|NCT00032487|4286284|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467361|NCT00031551|4286293|B3|Unknown||Cancer stage||participants|Number|3|3.0||||||
4467362|NCT00031551|4286294|B2|Unknown||Cancer stage||participants|Number|2|2.0||||||
4467363|NCT00031551|4286295|B1|Unknown||Cancer stage||participants|Number|1|1.0||||||
4467364|NCT00031551|4286293|B3|Accelerated Phase||Cancer stage||participants|Number|1|1.0||||||
4467365|NCT00031551|4286294|B2|Accelerated Phase||Cancer stage||participants|Number|1|1.0||||||
4467366|NCT00031551|4286295|B1|Accelerated Phase||Cancer stage||participants|Number|0|0.0||||||
4467367|NCT00031551|4286293|B3|Second Remission||Cancer stage||participants|Number|1|1.0||||||
4467368|NCT00031551|4286294|B2|Second Remission||Cancer stage||participants|Number|1|1.0||||||
4467369|NCT00031551|4286295|B1|Second Remission||Cancer stage||participants|Number|0|0.0||||||
4467370|NCT00031551|4286293|B3|First Remission||Cancer stage||participants|Number|1|1.0||||||
4467371|NCT00031551|4286294|B2|First Remission||Cancer stage||participants|Number|1|1.0||||||
4467372|NCT00031551|4286295|B1|First Remission||Cancer stage||participants|Number|0|0.0||||||
4467373|NCT00031551|4286293|B3|Unstaged||Cancer stage||participants|Number|1|1.0||||||
4467374|NCT00031551|4286294|B2|Unstaged||Cancer stage||participants|Number|1|1.0||||||
4467375|NCT00031551|4286295|B1|Unstaged||Cancer stage||participants|Number|0|0.0||||||
4467376|NCT00031551|4286293|B3|Stage IV||Cancer stage||participants|Number|5|5.0||||||
4467377|NCT00031551|4286294|B2|Stage IV||Cancer stage||participants|Number|5|5.0||||||
4467378|NCT00031551|4286295|B1|Stage IV||Cancer stage||participants|Number|0|0.0||||||
4467379|NCT00031551|4286293|B3|Stage III||Cancer stage||participants|Number|14|14.0||||||
4467380|NCT00031551|4286294|B2|Stage III||Cancer stage||participants|Number|13|13.0||||||
4467381|NCT00031551|4286295|B1|Stage III||Cancer stage||participants|Number|1|1.0||||||
4467382|NCT00031551|4286293|B3|Stage II||Cancer stage||participants|Number|1|1.0||||||
4467383|NCT00031551|4286294|B2|Stage II||Cancer stage||participants|Number|1|1.0||||||
4467384|NCT00031551|4286295|B1|Stage II||Cancer stage||participants|Number|0|0.0||||||
4467385|NCT00031551|4286293|B3|Leukemia||Cancer Diagnosis||participants|Number|4|4.0||||||
4467386|NCT00031551|4286294|B2|Leukemia||Cancer Diagnosis||participants|Number|4|4.0||||||
4467387|NCT00031551|4286295|B1|Leukemia||Cancer Diagnosis||participants|Number|0|0.0||||||
4467388|NCT00031551|4286293|B3|Multiple Myeloma||Cancer Diagnosis||participants|Number|3|3.0||||||
4467389|NCT00031551|4286294|B2|Multiple Myeloma||Cancer Diagnosis||participants|Number|2|2.0||||||
4467390|NCT00031551|4286295|B1|Multiple Myeloma||Cancer Diagnosis||participants|Number|1|1.0||||||
4467391|NCT00031551|4286293|B3|Hodgkin's Lymphoma||Cancer Diagnosis||participants|Number|4|4.0||||||
4467392|NCT00031551|4286294|B2|Hodgkin's Lymphoma||Cancer Diagnosis||participants|Number|4|4.0||||||
4467393|NCT00031551|4286295|B1|Hodgkin's Lymphoma||Cancer Diagnosis||participants|Number|0|0.0||||||
4467394|NCT00031551|4286293|B3|Non-Hodgkin's Lymphoma||Cancer Diagnosis||participants|Number|9|9.0||||||
4467395|NCT00031551|4286294|B2|Non-Hodgkin's Lymphoma||Cancer Diagnosis||participants|Number|8|8.0||||||
4467396|NCT00031551|4286295|B1|Non-Hodgkin's Lymphoma||Cancer Diagnosis||participants|Number|1|1.0||||||
4467397|NCT00031551|4286293|B3|Breast Cancer||Cancer Diagnosis||participants|Number|7|7.0||||||
4467398|NCT00031551|4286294|B2|Breast Cancer||Cancer Diagnosis||participants|Number|7|7.0||||||
4467399|NCT00031551|4286295|B1|Breast Cancer||Cancer Diagnosis||participants|Number|0|0.0||||||
4467400|NCT00031551|4286293|B3|Graduate School||Education||participants|Number|5|5.0||||||
4467401|NCT00031551|4286294|B2|Graduate School||Education||participants|Number|4|4.0||||||
4467402|NCT00031551|4286295|B1|Graduate School||Education||participants|Number|1|1.0||||||
4467403|NCT00031551|4286293|B3|College Graduate||Education||participants|Number|8|8.0||||||
4467404|NCT00031551|4286294|B2|College Graduate||Education||participants|Number|7|7.0||||||
4467405|NCT00031551|4286295|B1|College Graduate||Education||participants|Number|1|1.0||||||
4467406|NCT00031551|4286293|B3|Some College||Education||participants|Number|7|7.0||||||
4467407|NCT00031551|4286294|B2|Some College||Education||participants|Number|7|7.0||||||
4467408|NCT00031551|4286295|B1|Some College||Education||participants|Number|0|0.0||||||
4467409|NCT00031551|4286293|B3|High School||Education||participants|Number|5|5.0||||||
4467410|NCT00031551|4286294|B2|High School||Education||participants|Number|5|5.0||||||
4467411|NCT00031551|4286295|B1|High School||Education||participants|Number|0|0.0||||||
4467412|NCT00031551|4286293|B3|Grade School||Education||participants|Number|2|2.0||||||
4467413|NCT00031551|4286294|B2|Grade School||Education||participants|Number|2|2.0||||||
4467414|NCT00031551|4286295|B1|Grade School||Education||participants|Number|0|0.0||||||
4467415|NCT00031551|4286293|B3|United States||Region of Enrollment||participants|Number|27|27.0||||||
4467416|NCT00031551|4286294|B2|United States||Region of Enrollment||participants|Number|25|25.0||||||
4467417|NCT00031551|4286295|B1|United States||Region of Enrollment||participants|Number|2|2.0||||||
4467418|NCT00031551|4286293|B3|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4467419|NCT00031551|4286294|B2|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4467420|NCT00031551|4286295|B1|Asian/Pacific Islander||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4467421|NCT00031551|4286293|B3|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4467422|NCT00031551|4286294|B2|Black||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4467423|NCT00031551|4286295|B1|Black||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4467424|NCT00031551|4286293|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4467425|NCT00031551|4286294|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4467426|NCT00031551|4286295|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4467427|NCT00031551|4286293|B3|White||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4467428|NCT00031551|4286294|B2|White||Race/Ethnicity, Customized||participants|Number|16|16.0||||||
4467429|NCT00031551|4286295|B1|White||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4467430|NCT00031551|4286293|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4467431|NCT00031551|4286294|B2||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4467432|NCT00031551|4286295|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4467433|NCT00031551|4286293|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4467434|NCT00031551|4286294|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4467435|NCT00031551|4286295|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467436|NCT00031551|4286293|B3|||Age||years|Mean|NA||Full Range|||0.0|0.0|These numbers reflect two different populations in two different studies and were not analyzed together.
4467437|NCT00031551|4286294|B2|||Age||years|Mean|46|46.0|Full Range|||32.0|68.0|
4467438|NCT00031551|4286295|B1|||Age||years|Mean|59|59.0|Full Range|||54.0|64.0|
4467439|NCT00031486|4286306|B3|Sweden||Region of Enrollment||participants|Number|57|57.0||||||
4467440|NCT00031486|4286307|B2|Sweden||Region of Enrollment||participants|Number|31|31.0||||||
4467441|NCT00031486|4286308|B1|Sweden||Region of Enrollment||participants|Number|26|26.0||||||
4467442|NCT00031486|4286306|B3|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4467443|NCT00031486|4286307|B2|United Kingdom||Region of Enrollment||participants|Number|3|3.0||||||
4467444|NCT00031486|4286308|B1|United Kingdom||Region of Enrollment||participants|Number|0|0.0||||||
4467445|NCT00031486|4286306|B3|Canada||Region of Enrollment||participants|Number|10|10.0||||||
4467446|NCT00031486|4286307|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4467447|NCT00031486|4286308|B1|Canada||Region of Enrollment||participants|Number|6|6.0||||||
4467448|NCT00031486|4286306|B3|United States||Region of Enrollment||participants|Number|17|17.0||||||
4467449|NCT00031486|4286307|B2|United States||Region of Enrollment||participants|Number|9|9.0||||||
4467450|NCT00031486|4286308|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4467451|NCT00031486|4286306|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4467452|NCT00031486|4286307|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4467453|NCT00031486|4286308|B1||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4467454|NCT00031486|4286306|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4467455|NCT00031486|4286307|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4467456|NCT00031486|4286308|B1||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4467457|NCT00031486|4286306|B3|61 years or older||Age, Customized||participants|Number|33|33.0||||||
4467458|NCT00031486|4286307|B2|61 years or older||Age, Customized||participants|Number|20|20.0||||||
4467459|NCT00031486|4286308|B1|61 years or older||Age, Customized||participants|Number|13|13.0||||||
4467460|NCT00031486|4286306|B3|41-60 years||Age, Customized||participants|Number|40|40.0||||||
4467461|NCT00031486|4286307|B2|41-60 years||Age, Customized||participants|Number|22|22.0||||||
4467462|NCT00031486|4286308|B1|41-60 years||Age, Customized||participants|Number|18|18.0||||||
4467463|NCT00031486|4286306|B3|19-40 years||Age, Customized||participants|Number|12|12.0||||||
4467464|NCT00031486|4286307|B2|19-40 years||Age, Customized||participants|Number|5|5.0||||||
4467465|NCT00031486|4286308|B1|19-40 years||Age, Customized||participants|Number|7|7.0||||||
4467466|NCT00031486|4286306|B3|12-18 years||Age, Customized||participants|Number|2|2.0||||||
4467467|NCT00031486|4286307|B2|12-18 years||Age, Customized||participants|Number|0|0.0||||||
4467468|NCT00031486|4286308|B1|12-18 years||Age, Customized||participants|Number|2|2.0||||||
4467469|NCT00031486|4286306|B3|||Age||years|Mean|55|55.0|Inter-Quartile Range|||14.0|83.0|
4467470|NCT00031486|4286307|B2|||Age||years|Mean|56|56.0|Inter-Quartile Range|||26.0|83.0|
4467471|NCT00031486|4286308|B1|||Age||years|Mean|53.5|53.5|Inter-Quartile Range|||14.0|77.0|
4467472|NCT00031460|4286333|B3|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4467473|NCT00031460|4286334|B2|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4467474|NCT00031460|4286335|B1|Canada||Region of Enrollment||participants|Number|3|3.0||||||
4467475|NCT00031460|4286333|B3|United States||Region of Enrollment||participants|Number|43|43.0||||||
4467476|NCT00031460|4286334|B2|United States||Region of Enrollment||participants|Number|22|22.0||||||
4467477|NCT00031460|4286335|B1|United States||Region of Enrollment||participants|Number|21|21.0||||||
4467478|NCT00031460|4286333|B3||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4467479|NCT00031460|4286334|B2||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4467480|NCT00031460|4286335|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4467481|NCT00031460|4286333|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4467482|NCT00031460|4286334|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4467483|NCT00031460|4286335|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4467484|NCT00031460|4286333|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4467485|NCT00031460|4286334|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4467486|NCT00031460|4286335|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4467487|NCT00031460|4286333|B3|Between 18 and 65 years||Age, Customized||participants|Number|0|0.0||||||
4467488|NCT00031460|4286334|B2|Between 18 and 65 years||Age, Customized||participants|Number|0|0.0||||||
4467489|NCT00031460|4286335|B1|Between 18 and 65 years||Age, Customized||participants|Number|0|0.0||||||
4467490|NCT00031460|4286333|B3|<=28 days||Age, Customized||participants|Number|46|46.0||||||
4467491|NCT00031460|4286334|B2|<=28 days||Age, Customized||participants|Number|22|22.0||||||
4467492|NCT00031460|4286335|B1|<=28 days||Age, Customized||participants|Number|24|24.0||||||
4467493|NCT00031460|4286333|B3|||Age, Customized||days|Median|13|13.0|Full Range|1.13|1.13|1.0|42.0|
4467494|NCT00031460|4286334|B2|||Age, Customized||days|Median|15.5|15.5|Full Range|1.42|1.42|5.0|29.0|
4467495|NCT00031460|4286335|B1|||Age, Customized||days|Median|11|11.0|Full Range|1.71|1.71|1.0|42.0|
4467496|NCT00031447|4286348|B3|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4467497|NCT00031447|4286349|B2|Canada||Region of Enrollment||participants|Number|1|1.0||||||
4467498|NCT00031447|4286350|B1|Canada||Region of Enrollment||participants|Number|0|0.0||||||
4467499|NCT00031447|4286348|B3|United States||Region of Enrollment||participants|Number|28|28.0||||||
4467500|NCT00031447|4286349|B2|United States||Region of Enrollment||participants|Number|14|14.0||||||
4467501|NCT00031447|4286350|B1|United States||Region of Enrollment||participants|Number|14|14.0||||||
4467502|NCT00031447|4286348|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4467503|NCT00031447|4286349|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4467504|NCT00031447|4286350|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4467505|NCT00031447|4286348|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4467506|NCT00031447|4286349|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4467507|NCT00031447|4286350|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4467508|NCT00031447|4286348|B3|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4467509|NCT00031447|4286349|B2|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4467510|NCT00031447|4286350|B1|>=65 years||Age, Customized||participants|Number|0|0.0||||||
4467511|NCT00031447|4286348|B3|Between 29 days and 65 years||Age, Customized||participants|Number|0|0.0||||||
4467512|NCT00031447|4286349|B2|Between 29 days and 65 years||Age, Customized||participants|Number|0|0.0||||||
4467513|NCT00031447|4286350|B1|Between 29 days and 65 years||Age, Customized||participants|Number|0|0.0||||||
4467514|NCT00031447|4286348|B3|< = 28 days||Age, Customized||participants|Number|29|29.0||||||
4467515|NCT00031447|4286349|B2|< = 28 days||Age, Customized||participants|Number|15|15.0||||||
4467516|NCT00031447|4286350|B1|< = 28 days||Age, Customized||participants|Number|14|14.0||||||
4467517|NCT00031447|4286348|B3|||Age, Customized||days|Median|15|15.0|Full Range|2.23|2.23|2.0|55.0|
4467518|NCT00031447|4286349|B2|||Age, Customized||days|Median|15|15.0|Full Range|2.51|2.51|2.0|35.0|
4467519|NCT00031447|4286350|B1|||Age, Customized||days|Median|15|15.0|Full Range|3.76|3.76|5.0|55.0|
4467520|NCT00030992|4286363|B1|United States||Region of Enrollment||participants|Number|102|102.0||||||
4467521|NCT00030992|4286363|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4467522|NCT00030992|4286363|B1|Asian||Race/Ethnicity, Customized||Participants|Number|5|5.0||||||
4467523|NCT00030992|4286363|B1|African American||Race/Ethnicity, Customized||Participants|Number|12|12.0||||||
4467524|NCT00030992|4286363|B1|Caucasian||Race/Ethnicity, Customized||Participants|Number|84|84.0||||||
4467525|NCT00030992|4286363|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467526|NCT00030992|4286363|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|100|100.0||||||
4467527|NCT00030992|4286363|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4467528|NCT00030992|4286363|B1||Male|Sex: Female, Male||Participants|Count of Participants|78|78.0||||||
4467529|NCT00030992|4286363|B1||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4467530|NCT00030992|4286363|B1|||Age||years|Mean|57.21|57.21|Standard Deviation|10.81|10.81|||
4467531|NCT00030992|4286363|B1||>=65 years|Age||Participants|Count of Participants|23|23.0||||||
4467532|NCT00030992|4286363|B1||Between 18 and 65 years|Age||Participants|Count of Participants|79|79.0||||||
4467533|NCT00030992|4286363|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467534|NCT00030147|4286368|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4467535|NCT00030147|4286369|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4467536|NCT00030147|4286370|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4467537|NCT00030147|4286371|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4467538|NCT00030147|4286372|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467539|NCT00030147|4286368|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467540|NCT00030147|4286369|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467541|NCT00030147|4286370|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467542|NCT00030147|4286371|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467543|NCT00030147|4286372|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467544|NCT00030147|4286368|B5||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4467545|NCT00030147|4286369|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4467546|NCT00030147|4286370|B3||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4467547|NCT00030147|4286371|B2||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4467548|NCT00030147|4286372|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4467549|NCT00030147|4286368|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|12|12.0||||||
4467550|NCT00030147|4286369|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467551|NCT00030147|4286370|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4467552|NCT00030147|4286371|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4467553|NCT00030147|4286372|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4467554|NCT00030147|4286368|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467555|NCT00030147|4286369|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467556|NCT00030147|4286370|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467557|NCT00030147|4286371|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467558|NCT00030147|4286372|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467559|NCT00030147|4286368|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4467560|NCT00030147|4286369|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4467561|NCT00030147|4286370|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467562|NCT00030147|4286371|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4467563|NCT00030147|4286372|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467564|NCT00030147|4286368|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467565|NCT00030147|4286369|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467566|NCT00030147|4286370|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467567|NCT00030147|4286371|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467568|NCT00030147|4286372|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467569|NCT00030147|4286368|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4467570|NCT00030147|4286369|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4467571|NCT00030147|4286370|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467572|NCT00030147|4286371|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467573|NCT00030147|4286372|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4467574|NCT00030147|4286368|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4467575|NCT00030147|4286369|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4467576|NCT00030147|4286370|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4467577|NCT00030147|4286371|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4467578|NCT00030147|4286372|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4467579|NCT00030147|4286368|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4467580|NCT00030147|4286369|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467581|NCT00030147|4286370|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4467582|NCT00030147|4286371|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4467583|NCT00030147|4286372|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4467584|NCT00030147|4286368|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467585|NCT00030147|4286369|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467586|NCT00030147|4286370|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467587|NCT00030147|4286371|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467588|NCT00030147|4286372|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467589|NCT00030147|4286368|B5||Female|Sex: Female, Male||Participants|Count of Participants|63|63.0||||||
4467590|NCT00030147|4286369|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4467591|NCT00030147|4286370|B3||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4467592|NCT00030147|4286371|B2||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4467593|NCT00030147|4286372|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4467594|NCT00030147|4286368|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4467595|NCT00030147|4286369|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4467596|NCT00030147|4286370|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4467597|NCT00030147|4286371|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4467598|NCT00030147|4286372|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4467599|NCT00030147|4286368|B5||Between 18 and 65 years|Age||Participants|Count of Participants|63|63.0||||||
4467600|NCT00030147|4286369|B4||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4467601|NCT00030147|4286370|B3||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4467602|NCT00030147|4286371|B2||Between 18 and 65 years|Age||Participants|Count of Participants|19|19.0||||||
4467603|NCT00030147|4286372|B1||Between 18 and 65 years|Age||Participants|Count of Participants|17|17.0||||||
4467604|NCT00030147|4286368|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467605|NCT00030147|4286369|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467606|NCT00030147|4286370|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467607|NCT00030147|4286371|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467608|NCT00030147|4286372|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467609|NCT00029536|4286389|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467610|NCT00029536|4286390|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467611|NCT00029536|4286391|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467612|NCT00029536|4286392|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467613|NCT00029536|4286393|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467614|NCT00029536|4286389|B5||Female|Sex: Female, Male||Participants|Count of Participants|294|294.0||||||
4467615|NCT00029536|4286390|B4||Female|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4467616|NCT00029536|4286391|B3||Female|Sex: Female, Male||Participants|Count of Participants|105|105.0||||||
4467617|NCT00029536|4286392|B2||Female|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4467618|NCT00029536|4286393|B1||Female|Sex: Female, Male||Participants|Count of Participants|85|85.0||||||
4467619|NCT00029536|4286389|B5|||Age||years|Mean|31.71|31.71|Standard Deviation|8.30|8.3|||
4467620|NCT00029536|4286390|B4|||Age||years|Mean|32.42|32.42|Standard Deviation|7.87|7.87|||
4467621|NCT00029536|4286391|B3|||Age||years|Mean|30.71|30.71|Standard Deviation|8.16|8.16|||
4467622|NCT00029536|4286392|B2|||Age||years|Mean|32.31|32.31|Standard Deviation|8.5|8.5|||
4467623|NCT00029536|4286393|B1|||Age||years|Mean|31.4|31.4|Standard Deviation|8.68|8.68|||
4467624|NCT00029172|4286420|B1|United States||Region of Enrollment||participants|Number|182|182.0||||||
4467625|NCT00029172|4286420|B1||Male|Sex: Female, Male||Participants|Count of Participants|83|83.0||||||
4467626|NCT00029172|4286420|B1||Female|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4467627|NCT00029172|4286420|B1|||Age||years|Mean|61|61.0|Standard Deviation|3|3.0|||
4467628|NCT00029146|4286424|B3|Canada||Region of Enrollment||participants|Number|8|8.0||||||
4467629|NCT00029146|4286425|B2|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4467630|NCT00029146|4286426|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4467631|NCT00029146|4286424|B3|United States||Region of Enrollment||participants|Number|187|187.0||||||
4467632|NCT00029146|4286425|B2|United States||Region of Enrollment||participants|Number|94|94.0||||||
4467633|NCT00029146|4286426|B1|United States||Region of Enrollment||participants|Number|93|93.0||||||
4467634|NCT00029146|4286424|B3||Male|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4467635|NCT00029146|4286425|B2||Male|Sex: Female, Male||Participants|Count of Participants|61|61.0||||||
4467636|NCT00029146|4286426|B1||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4467637|NCT00029146|4286424|B3||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4467638|NCT00029146|4286425|B2||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4467639|NCT00029146|4286426|B1||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4467640|NCT00029146|4286424|B3|||Age||years|Mean|58|58.0|Standard Deviation|9|9.0|||
4467641|NCT00029146|4286425|B2|||Age||years|Mean|58|58.0|Standard Deviation|9|9.0|||
4467642|NCT00029146|4286426|B1|||Age||years|Mean|58|58.0|Standard Deviation|9|9.0|||
4467643|NCT00029146|4286424|B3||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4467644|NCT00029146|4286425|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4467645|NCT00029146|4286426|B1||>=65 years|Age||Participants|Count of Participants|21|21.0||||||
4467646|NCT00029146|4286424|B3||Between 18 and 65 years|Age||Participants|Count of Participants|147|147.0||||||
4467647|NCT00029146|4286425|B2||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4467648|NCT00029146|4286426|B1||Between 18 and 65 years|Age||Participants|Count of Participants|76|76.0||||||
4467649|NCT00029146|4286424|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467650|NCT00029146|4286425|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467651|NCT00029146|4286426|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467652|NCT00029107|4286454|B3|United States||Region of Enrollment||participants|Number|24|24.0||||||
4467653|NCT00029107|4286455|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4467654|NCT00029107|4286456|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4467655|NCT00029107|4286454|B3||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4467656|NCT00029107|4286455|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4467657|NCT00029107|4286456|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4467658|NCT00029107|4286454|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4467659|NCT00029107|4286455|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4467660|NCT00029107|4286456|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4467661|NCT00029107|4286454|B3|||Age||years|Mean|51|51.0|Standard Deviation|4.8|4.8|||
4467662|NCT00029107|4286455|B2|||Age||years|Mean|51|51.0|Standard Deviation|4|4.0|||
4467663|NCT00029107|4286456|B1|||Age||years|Mean|52|52.0|Standard Deviation|5.6|5.6|||
4467664|NCT00029107|4286454|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4467665|NCT00029107|4286455|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4467666|NCT00029107|4286456|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4467667|NCT00029107|4286454|B3||Between 18 and 65 years|Age||Participants|Count of Participants|24|24.0||||||
4467668|NCT00029107|4286455|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4467669|NCT00029107|4286456|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4467670|NCT00029107|4286454|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467671|NCT00029107|4286455|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467672|NCT00029107|4286456|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4467673|NCT00028262|4286463|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467674|NCT00028262|4286463|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467675|NCT00028262|4286463|B1||White|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4467676|NCT00028262|4286463|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467677|NCT00028262|4286463|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467678|NCT00028262|4286463|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467679|NCT00028262|4286463|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467680|NCT00028262|4286463|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4467681|NCT00028262|4286463|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4467682|NCT00028262|4286463|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4467683|NCT00028262|4286463|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4467684|NCT00028262|4286463|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4467685|NCT00028262|4286463|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4467686|NCT00028262|4286463|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4467687|NCT00028262|4286463|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4467688|NCT00028093|4286467|B3|||Hepatitis C Virus RNA level||log(IU/mL)|Mean|6.2|6.2|Standard Deviation|0.56|0.56|||
4467689|NCT00028093|4286468|B2|||Hepatitis C Virus RNA level||log(IU/mL)|Mean|6.2|6.2|Standard Deviation|0.58|0.58|||
4467690|NCT00028093|4286469|B1|||Hepatitis C Virus RNA level||log(IU/mL)|Mean|6.2|6.2|Standard Deviation|0.53|0.53|||
4467691|NCT00028093|4286467|B3|||Histology activity index|Possible range 0-18. Higher values represent a worse outcome.|Units on a scale|Median|8|8.0|Full Range|||3.0|15.0|
4467692|NCT00028093|4286468|B2|||Histology activity index|Possible range 0-18. Higher values represent a worse outcome.|Units on a scale|Median|8|8.0|Full Range|||3.0|15.0|
4467693|NCT00028093|4286469|B1|||Histology activity index|Possible range 0-18. Higher values represent a worse outcome.|Units on a scale|Median|8|8.0|Full Range|||5.0|13.0|
4467694|NCT00028093|4286467|B3|3-6||Ishak fibrosis|Fibrosis was staged with the Ishak scale (ranging from 0 = no fibrosis to 6 = cirrhosis). Higher values represent a worse outcome.|participant|Number|19|19.0||||||
4467695|NCT00028093|4286468|B2|3-6||Ishak fibrosis|Fibrosis was staged with the Ishak scale (ranging from 0 = no fibrosis to 6 = cirrhosis). Higher values represent a worse outcome.|participant|Number|9|9.0||||||
4467696|NCT00028093|4286469|B1|3-6||Ishak fibrosis|Fibrosis was staged with the Ishak scale (ranging from 0 = no fibrosis to 6 = cirrhosis). Higher values represent a worse outcome.|participant|Number|10|10.0||||||
4467697|NCT00028093|4286467|B3|0-2||Ishak fibrosis|Fibrosis was staged with the Ishak scale (ranging from 0 = no fibrosis to 6 = cirrhosis). Higher values represent a worse outcome.|participant|Number|31|31.0||||||
4467698|NCT00028093|4286468|B2|0-2||Ishak fibrosis|Fibrosis was staged with the Ishak scale (ranging from 0 = no fibrosis to 6 = cirrhosis). Higher values represent a worse outcome.|participant|Number|16|16.0||||||
4467699|NCT00028093|4286469|B1|0-2||Ishak fibrosis|Fibrosis was staged with the Ishak scale (ranging from 0 = no fibrosis to 6 = cirrhosis). Higher values represent a worse outcome.|participant|Number|15|15.0||||||
4467700|NCT00028093|4286467|B3|||Alanine transaminase||U/L|Mean|83|83.0|Standard Deviation|71|71.0|||
4467701|NCT00028093|4286468|B2|||Alanine transaminase||U/L|Mean|96|96.0|Standard Deviation|79|79.0|||
4467702|NCT00028093|4286469|B1|||Alanine transaminase||U/L|Mean|69|69.0|Standard Deviation|61|61.0|||
4467703|NCT00028093|4286467|B3|||Body Mass Index||kg/(m^2)|Mean|27.0|27.0|Standard Deviation|4.9|4.9|||
4467704|NCT00028093|4286468|B2|||Body Mass Index||kg/(m^2)|Mean|27.0|27.0|Standard Deviation|4.8|4.8|||
4467705|NCT00028093|4286469|B1|||Body Mass Index||kg/(m^2)|Mean|26.9|26.9|Standard Deviation|4.9|4.9|||
4467706|NCT00028093|4286467|B3|||Weight||kg|Mean|77.5|77.5|Standard Deviation|18.0|18.0|||
4467707|NCT00028093|4286468|B2|||Weight||kg|Mean|76.8|76.8|Standard Deviation|19|19.0|||
4467708|NCT00028093|4286469|B1|||Weight||kg|Mean|78.1|78.1|Standard Deviation|17|17.0|||
4467709|NCT00028093|4286467|B3|Unknown||Mode of infection||participants|Number|4|4.0||||||
4467710|NCT00028093|4286468|B2|Unknown||Mode of infection||participants|Number|2|2.0||||||
4467711|NCT00028093|4286469|B1|Unknown||Mode of infection||participants|Number|2|2.0||||||
4467712|NCT00028093|4286467|B3|Other||Mode of infection||participants|Number|11|11.0||||||
4467713|NCT00028093|4286468|B2|Other||Mode of infection||participants|Number|6|6.0||||||
4467714|NCT00028093|4286469|B1|Other||Mode of infection||participants|Number|5|5.0||||||
4467715|NCT00028093|4286467|B3|Blood transfusion||Mode of infection||participants|Number|17|17.0||||||
4467716|NCT00028093|4286468|B2|Blood transfusion||Mode of infection||participants|Number|9|9.0||||||
4467717|NCT00028093|4286469|B1|Blood transfusion||Mode of infection||participants|Number|8|8.0||||||
4467718|NCT00028093|4286467|B3|Injection drug use||Mode of infection||participants|Number|18|18.0||||||
4467719|NCT00028093|4286468|B2|Injection drug use||Mode of infection||participants|Number|8|8.0||||||
4467720|NCT00028093|4286469|B1|Injection drug use||Mode of infection||participants|Number|10|10.0||||||
4467721|NCT00028093|4286467|B3|||Duration of infection||year|Mean|23|23.0|Standard Deviation|8.4|8.4|||
4467722|NCT00028093|4286468|B2|||Duration of infection||year|Mean|23|23.0|Standard Deviation|7.7|7.7|||
4467723|NCT00028093|4286469|B1|||Duration of infection||year|Mean|23|23.0|Standard Deviation|9.0|9.0|||
4467724|NCT00028093|4286467|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4467725|NCT00028093|4286468|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4467726|NCT00028093|4286469|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4467727|NCT00028093|4286467|B3|Asian||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4467728|NCT00028093|4286468|B2|Asian||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4467729|NCT00028093|4286469|B1|Asian||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4467730|NCT00028093|4286467|B3|African American||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4467731|NCT00028093|4286468|B2|African American||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4467732|NCT00028093|4286469|B1|African American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4467733|NCT00028093|4286467|B3|Caucasian||Race/Ethnicity, Customized||participants|Number|38|38.0||||||
4467734|NCT00028093|4286468|B2|Caucasian||Race/Ethnicity, Customized||participants|Number|21|21.0||||||
4467735|NCT00028093|4286469|B1|Caucasian||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4467736|NCT00028093|4286467|B3||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4467737|NCT00028093|4286468|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4467738|NCT00028093|4286469|B1||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4467739|NCT00028093|4286467|B3||Female|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4467740|NCT00028093|4286468|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4467741|NCT00028093|4286469|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4467742|NCT00028093|4286467|B3|||Age||years|Median|51|51.0|Full Range|||28.0|68.0|
4467743|NCT00028093|4286468|B2|||Age||years|Median|52|52.0|Full Range|||28.0|67.0|
4467744|NCT00028093|4286469|B1|||Age||years|Median|49|49.0|Full Range|||35.0|68.0|
4467745|NCT00027378|4286476|B3|United States||Region of Enrollment||participants|Number|50|50.0||||||
4467746|NCT00027378|4286477|B2|United States||Region of Enrollment||participants|Number|26|26.0||||||
4467747|NCT00027378|4286478|B1|United States||Region of Enrollment||participants|Number|24|24.0||||||
4467748|NCT00027378|4286476|B3||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4467749|NCT00027378|4286477|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4467750|NCT00027378|4286478|B1||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4467751|NCT00027378|4286476|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4467752|NCT00027378|4286477|B2||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4467753|NCT00027378|4286478|B1||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4467754|NCT00027378|4286476|B3|||Age||years|Mean|19.4|19.4|Standard Deviation|.92|0.92|||
4467755|NCT00027378|4286477|B2|||Age||years|Mean|19.4|19.4|Standard Deviation|.91|0.91|||
4467756|NCT00027378|4286478|B1|||Age||years|Mean|19.5|19.5|Standard Deviation|.94|0.94|||
4467757|NCT00027378|4286476|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4467758|NCT00027378|4286477|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4467759|NCT00027378|4286478|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4467760|NCT00027378|4286476|B3||Between 18 and 65 years|Age||Participants|Count of Participants|47|47.0||||||
4467761|NCT00027378|4286477|B2||Between 18 and 65 years|Age||Participants|Count of Participants|25|25.0||||||
4467762|NCT00027378|4286478|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4467763|NCT00027378|4286476|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4467764|NCT00027378|4286477|B2||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4467765|NCT00027378|4286478|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4467766|NCT00027027|4286487|B6||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4467767|NCT00027027|4286488|B5||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4467768|NCT00027027|4286489|B4||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4467769|NCT00027027|4286490|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4467770|NCT00027027|4286491|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4467771|NCT00027027|4286492|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4467772|NCT00027027|4286487|B6||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4467773|NCT00027027|4286488|B5||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4467774|NCT00027027|4286489|B4||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467775|NCT00027027|4286490|B3||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4467776|NCT00027027|4286491|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4467777|NCT00027027|4286492|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4467778|NCT00027027|4286487|B6|||Age||years|Mean|56.7|56.7|Standard Deviation|12.7|12.7|||
4467779|NCT00027027|4286488|B5|||Age||years|Mean|60|60.0|Standard Deviation|8.2|8.2|||
4467780|NCT00027027|4286489|B4|||Age||years|Mean|61|61.0|Standard Deviation|17.1|17.1|||
4467781|NCT00027027|4286490|B3|||Age||years|Mean|48|48.0|Standard Deviation|13.8|13.8|||
4467782|NCT00027027|4286491|B2|||Age||years|Mean|55|55.0|Standard Deviation|13.6|13.6|||
4467783|NCT00027027|4286492|B1|||Age||years|Mean|58|58.0|Standard Deviation|20.4|20.4|||
4467784|NCT00025883|4286541|B3|||Daily total insulin units per patient||insulin units|Mean|362|362.0|Standard Deviation|620|620.0|||
4467785|NCT00025883|4286542|B2|||Daily total insulin units per patient||insulin units|Mean|278|278.0|Standard Deviation|214|214.0|||
4467786|NCT00025883|4286543|B1|||Daily total insulin units per patient||insulin units|Mean|625|625.0|Standard Deviation|1099|1099.0|||
4467787|NCT00025883|4286541|B3|||International Normalized Ratio (INR)||ratio|Mean|1.05|1.05|Standard Deviation|0.13|0.13|||
4467788|NCT00025883|4286542|B2|||International Normalized Ratio (INR)||ratio|Mean|0.98|0.98|Standard Deviation|0.06|0.06|||
4467789|NCT00025883|4286543|B1|||International Normalized Ratio (INR)||ratio|Mean|1.10|1.1|Standard Deviation|0.14|0.14|||
4467790|NCT00025883|4286541|B3|||PT|prothrombin time|sec|Mean|13.8|13.8|Standard Deviation|1.1|1.1|||
4467791|NCT00025883|4286542|B2|||PT|prothrombin time|sec|Mean|13.2|13.2|Standard Deviation|0.6|0.6|||
4467792|NCT00025883|4286543|B1|||PT|prothrombin time|sec|Mean|14.2|14.2|Standard Deviation|1.2|1.2|||
4467793|NCT00025883|4286541|B3|||25-Hydroxyvitamin D||ng/mL|Mean|19|19.0|Standard Deviation|12|12.0|||
4467794|NCT00025883|4286542|B2|||25-Hydroxyvitamin D||ng/mL|Mean|23|23.0|Standard Deviation|13|13.0|||
4467795|NCT00025883|4286543|B1|||25-Hydroxyvitamin D||ng/mL|Mean|16|16.0|Standard Deviation|11|11.0|||
4467796|NCT00025883|4286541|B3|||Vitamin E||mg/dL|Mean|31|31.0|Standard Deviation|28|28.0|||
4467797|NCT00025883|4286542|B2|||Vitamin E||mg/dL|Mean|34|34.0|Standard Deviation|21|21.0|||
4467798|NCT00025883|4286543|B1|||Vitamin E||mg/dL|Mean|26|26.0|Standard Deviation|32|32.0|||
4467799|NCT00025883|4286541|B3|||Vitamin A||µg/dL|Mean|61|61.0|Standard Deviation|25|25.0|||
4467800|NCT00025883|4286542|B2|||Vitamin A||µg/dL|Mean|73|73.0|Standard Deviation|20|20.0|||
4467801|NCT00025883|4286543|B1|||Vitamin A||µg/dL|Mean|57|57.0|Standard Deviation|33|33.0|||
4467802|NCT00025883|4286541|B3|||LDL-C|low-density lipoprotein cholesterol|mg/dL|Mean|103|103.0|Standard Deviation|46|46.0|||
4467803|NCT00025883|4286542|B2|||LDL-C|low-density lipoprotein cholesterol|mg/dL|Mean|101|101.0|Standard Deviation|36|36.0|||
4467804|NCT00025883|4286543|B1|||LDL-C|low-density lipoprotein cholesterol|mg/dL|Mean|104|104.0|Standard Deviation|50|50.0|||
4467805|NCT00025883|4286541|B3|||HDL-C|high-density lipoprotein cholesterol|mg/dL|Mean|30|30.0|Standard Deviation|9|9.0|||
4467806|NCT00025883|4286542|B2|||HDL-C|high-density lipoprotein cholesterol|mg/dL|Mean|31|31.0|Standard Deviation|9|9.0|||
4467807|NCT00025883|4286543|B1|||HDL-C|high-density lipoprotein cholesterol|mg/dL|Mean|29|29.0|Standard Deviation|9|9.0|||
4467808|NCT00025883|4286541|B3|||Triglycerides||mg/dL|Geometric Mean|473|473.0|Inter-Quartile Range|||200.0|898.0|
4467809|NCT00025883|4286542|B2|||Triglycerides||mg/dL|Geometric Mean|483|483.0|Inter-Quartile Range|||232.0|856.0|
4467810|NCT00025883|4286543|B1|||Triglycerides||mg/dL|Geometric Mean|467|467.0|Inter-Quartile Range|||200.0|847.0|
4467811|NCT00025883|4286541|B3|||Total cholesterol||mg/dL|Mean|222|222.0|Standard Deviation|126|126.0|||
4467812|NCT00025883|4286542|B2|||Total cholesterol||mg/dL|Mean|235|235.0|Standard Deviation|147|147.0|||
4467813|NCT00025883|4286543|B1|||Total cholesterol||mg/dL|Mean|214|214.0|Standard Deviation|110|110.0|||
4467814|NCT00025883|4286541|B3|||Lipid-lowering medications per patient||lipid-lowering medications|Mean|0.82|0.82|Standard Deviation|0.93|0.93|||
4467815|NCT00025883|4286542|B2|||Lipid-lowering medications per patient||lipid-lowering medications|Mean|1.07|1.07|Standard Deviation|1.04|1.04|||
4467816|NCT00025883|4286543|B1|||Lipid-lowering medications per patient||lipid-lowering medications|Mean|0.61|0.61|Standard Deviation|0.84|0.84|||
4467817|NCT00025883|4286541|B3|not known||Insulin users||participants|Number|3|3.0||||||
4467818|NCT00025883|4286542|B2|not known||Insulin users||participants|Number|2|2.0||||||
4467819|NCT00025883|4286543|B1|not known||Insulin users||participants|Number|1|1.0||||||
4467820|NCT00025883|4286541|B3|No||Insulin users||participants|Number|38|38.0||||||
4467821|NCT00025883|4286542|B2|No||Insulin users||participants|Number|14|14.0||||||
4467822|NCT00025883|4286543|B1|No||Insulin users||participants|Number|24|24.0||||||
4467823|NCT00025883|4286541|B3|Yes||Insulin users||participants|Number|45|45.0||||||
4467824|NCT00025883|4286542|B2|Yes||Insulin users||participants|Number|15|15.0||||||
4467825|NCT00025883|4286543|B1|Yes||Insulin users||participants|Number|30|30.0||||||
4467826|NCT00025883|4286541|B3|||Antidiabetic medications per patient||antidiabetic medications|Mean|1.36|1.36|Standard Deviation|0.81|0.81|||
4467827|NCT00025883|4286542|B2|||Antidiabetic medications per patient||antidiabetic medications|Mean|1.79|1.79|Standard Deviation|0.68|0.68|||
4467828|NCT00025883|4286543|B1|||Antidiabetic medications per patient||antidiabetic medications|Mean|1.13|1.13|Standard Deviation|0.7|0.7|||
4467829|NCT00025883|4286541|B3|||C-peptide||ng/mL|Mean|4.82|4.82|Standard Deviation|3.62|3.62|||
4467830|NCT00025883|4286542|B2|||C-peptide||ng/mL|Mean|3.56|3.56|Standard Deviation|2.27|2.27|||
4467831|NCT00025883|4286543|B1|||C-peptide||ng/mL|Mean|5.61|5.61|Standard Deviation|4.03|4.03|||
4467832|NCT00025883|4286541|B3|||Fasting insulin||µU/mL|Mean|108|108.0|Standard Deviation|273|273.0|||
4467833|NCT00025883|4286542|B2|||Fasting insulin||µU/mL|Mean|82|82.0|Standard Deviation|157|157.0|||
4467834|NCT00025883|4286543|B1|||Fasting insulin||µU/mL|Mean|122|122.0|Standard Deviation|318|318.0|||
4467835|NCT00025883|4286541|B3|||HbA1c||percentage of glycated hemoglobin|Mean|8.3|8.3|Standard Deviation|2.3|2.3|||
4467836|NCT00025883|4286542|B2|||HbA1c||percentage of glycated hemoglobin|Mean|8.1|8.1|Standard Deviation|2.2|2.2|||
4467837|NCT00025883|4286543|B1|||HbA1c||percentage of glycated hemoglobin|Mean|8.4|8.4|Standard Deviation|2.3|2.3|||
4467838|NCT00025883|4286541|B3|||Glucose||mg/dL|Mean|181|181.0|Standard Deviation|83|83.0|||
4467839|NCT00025883|4286542|B2|||Glucose||mg/dL|Mean|182|182.0|Standard Deviation|87|87.0|||
4467840|NCT00025883|4286543|B1|||Glucose||mg/dL|Mean|180|180.0|Standard Deviation|80|80.0|||
4467841|NCT00025883|4286541|B3|||Leptin||ng/mL|Mean|3.03|3.03|Standard Deviation|3.44|3.44|||
4467842|NCT00025883|4286542|B2|||Leptin||ng/mL|Mean|6.23|6.23|Standard Deviation|3.96|3.96|||
4467843|NCT00025883|4286543|B1|||Leptin||ng/mL|Mean|1.13|1.13|Standard Deviation|0.74|0.74|||
4467844|NCT00025883|4286541|B3|||Percentage body fat|percentage of body fat|percentage of body fat|Mean|15|15.0|Standard Deviation|7|7.0|||
4467845|NCT00025883|4286542|B2|||Percentage body fat|percentage of body fat|percentage of body fat|Mean|22|22.0|Standard Deviation|4|4.0|||
4467846|NCT00025883|4286543|B1|||Percentage body fat|percentage of body fat|percentage of body fat|Mean|9|9.0|Standard Deviation|2|2.0|||
4467847|NCT00025883|4286541|B3|||Body mass index-standard deviation score (BMI-SDS)|Body mass index -standard deviation score (BMI-SDS) represents a measure of weight, adjusted for height, sex, and age. sample range of BMI-SDS is (-3.23, 1.91). Higher value indicates more body fat.|units on a scale|Mean|0.41|0.41|Standard Deviation|0.9|0.9|||
4467848|NCT00025883|4286542|B2|||Body mass index-standard deviation score (BMI-SDS)|Body mass index -standard deviation score (BMI-SDS) represents a measure of weight, adjusted for height, sex, and age. sample range of BMI-SDS is (-3.23, 1.91). Higher value indicates more body fat.|units on a scale|Mean|0.66|0.66|Standard Deviation|0.7|0.7|||
4467849|NCT00025883|4286543|B1|||Body mass index-standard deviation score (BMI-SDS)|Body mass index -standard deviation score (BMI-SDS) represents a measure of weight, adjusted for height, sex, and age. sample range of BMI-SDS is (-3.23, 1.91). Higher value indicates more body fat.|units on a scale|Mean|0.26|0.26|Standard Deviation|0.98|0.98|||
4467850|NCT00025883|4286541|B3|aged >=20 years||Pediatric patients||participants|Number|37|37.0||||||
4467851|NCT00025883|4286542|B2|aged >=20 years||Pediatric patients||participants|Number|24|24.0||||||
4467852|NCT00025883|4286543|B1|aged >=20 years||Pediatric patients||participants|Number|13|13.0||||||
4467853|NCT00025883|4286541|B3|aged <20 years||Pediatric patients||participants|Number|49|49.0||||||
4467854|NCT00025883|4286542|B2|aged <20 years||Pediatric patients||participants|Number|7|7.0||||||
4467855|NCT00025883|4286543|B1|aged <20 years||Pediatric patients||participants|Number|42|42.0||||||
4467856|NCT00025883|4286541|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4467857|NCT00025883|4286542|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4467858|NCT00025883|4286543|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4467859|NCT00025883|4286541|B3||Female|Sex: Female, Male||Participants|Count of Participants|73|73.0||||||
4467860|NCT00025883|4286542|B2||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4467861|NCT00025883|4286543|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4467862|NCT00025883|4286541|B3|||Age||years|Mean|24|24.0|Standard Deviation|15|15.0|||
4467863|NCT00025883|4286542|B2|||Age||years|Mean|35|35.0|Standard Deviation|14|14.0|||
4467864|NCT00025883|4286543|B1|||Age||years|Mean|18|18.0|Standard Deviation|12|12.0|||
4467865|NCT00023595|4286550|B6||Male|Sex: Female, Male||Participants|Count of Participants|1850|1850.0||||||
4467866|NCT00023595|4286551|B5||Male|Sex: Female, Male||Participants|Count of Participants|432|432.0||||||
4467867|NCT00023595|4286552|B4||Male|Sex: Female, Male||Participants|Count of Participants|354|354.0||||||
4467868|NCT00023595|4286553|B3||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4467869|NCT00023595|4286554|B2||Male|Sex: Female, Male||Participants|Count of Participants|470|470.0||||||
4467870|NCT00023595|4286555|B1||Male|Sex: Female, Male||Participants|Count of Participants|527|527.0||||||
4467871|NCT00023595|4286550|B6||Female|Sex: Female, Male||Participants|Count of Participants|286|286.0||||||
4467872|NCT00023595|4286551|B5||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4467873|NCT00023595|4286552|B4||Female|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4467874|NCT00023595|4286553|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4467875|NCT00023595|4286554|B2||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4467876|NCT00023595|4286555|B1||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4467877|NCT00023595|4286550|B6|||Age||years|Median|60|60.0|Inter-Quartile Range|||54.0|68.0|
4467878|NCT00023595|4286551|B5|||Age||years|Median|62|62.0|Inter-Quartile Range|||55.0|69.0|
4467879|NCT00023595|4286552|B4|||Age||years|Median|62|62.0|Inter-Quartile Range|||55.0|69.0|
4467880|NCT00023595|4286553|B3|||Age||years|Median|61|61.0|Inter-Quartile Range|||54.0|68.0|
4467881|NCT00023595|4286554|B2|||Age||years|Median|60|60.0|Inter-Quartile Range|||54.0|68.0|
4467882|NCT00023595|4286555|B1|||Age||years|Median|59|59.0|Inter-Quartile Range|||53.0|67.0|
4467883|NCT00023452|4286768|B3|Missing||Sex/Gender, Customized||participants|Number|1|1.0||||||
4467884|NCT00023452|4286769|B2|Missing||Sex/Gender, Customized||participants|Number|1|1.0||||||
4467885|NCT00023452|4286770|B1|Missing||Sex/Gender, Customized||participants|Number|0|0.0||||||
4467886|NCT00023452|4286768|B3|Male||Sex/Gender, Customized||participants|Number|4393|4393.0||||||
4467887|NCT00023452|4286769|B2|Male||Sex/Gender, Customized||participants|Number|2297|2297.0||||||
4467888|NCT00023452|4286770|B1|Male||Sex/Gender, Customized||participants|Number|2096|2096.0||||||
4467889|NCT00023452|4286768|B3|Female||Sex/Gender, Customized||participants|Number|3659|3659.0||||||
4467890|NCT00023452|4286769|B2|Female||Sex/Gender, Customized||participants|Number|1847|1847.0||||||
4467891|NCT00023452|4286770|B1|Female||Sex/Gender, Customized||participants|Number|1812|1812.0||||||
4467892|NCT00023452|4286768|B3|||Age||years|Median|35|35.0|Inter-Quartile Range|||25.0|47.0|
4467893|NCT00023452|4286769|B2|||Age||years|Median|36|36.0|Inter-Quartile Range|||25.0|47.0|
4467894|NCT00023452|4286770|B1|||Age||years|Median|35|35.0|Inter-Quartile Range|||25.0|46.0|
4467895|NCT00023322|4286795|B1|||Fibrosis (Ishak score)|Possible range of Ishak score is 0 to 6. Higher values indicate worse outcome.|Scores on a scale|Median|3|3.0|Full Range|||3.0|6.0|
4467896|NCT00023322|4286795|B1|||HBV-DNA|hepatitis B virus DNA|Log10 IU/ml|Median|2.9|2.9|Full Range|||2.0|49.0|
4467897|NCT00023322|4286795|B1|||HBsAg||Log10 IU/ml|Mean|3.7|3.7|Standard Deviation|0.6|0.6|||
4467898|NCT00023322|4286795|B1|||HDV-RNA|hepatitis D virus RNA|Log10 Genome Equivalent/ml|Mean|6.7|6.7|Standard Deviation|1.2|1.2|||
4467899|NCT00023322|4286795|B1|Endemic Region||Infection source||participants|Number|5|5.0||||||
4467900|NCT00023322|4286795|B1|Transfusion||Infection source||participants|Number|2|2.0||||||
4467901|NCT00023322|4286795|B1|Sexual||Infection source||participants|Number|2|2.0||||||
4467902|NCT00023322|4286795|B1|IV Drug Abuse||Infection source||participants|Number|6|6.0||||||
4467903|NCT00023322|4286795|B1|||ALT|alanine aminotransferase|IU/L|Median|141|141.0|Full Range|||31.0|506.0|
4467904|NCT00023322|4286795|B1|||Estimated duration of the disease|Estimated duration of the HDV infection|years|Median|25|25.0|Full Range|||7.0|35.0|
4467905|NCT00023322|4286795|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4467906|NCT00023322|4286795|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467907|NCT00023322|4286795|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467908|NCT00023322|4286795|B1||White|Race (NIH/OMB)||Participants|Count of Participants|11|11.0||||||
4467909|NCT00023322|4286795|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467910|NCT00023322|4286795|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467911|NCT00023322|4286795|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4467912|NCT00023322|4286795|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4467913|NCT00023322|4286795|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4467914|NCT00023322|4286795|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4467915|NCT00023322|4286795|B1|||Age||years|Median|42|42.0|Full Range|||18.0|58.0|
4467916|NCT00023309|4286800|B3|No||Cirrhosis||participants|Number|34|34.0||||||
4467917|NCT00023309|4286801|B2|No||Cirrhosis||participants|Number|17|17.0||||||
4467918|NCT00023309|4286802|B1|No||Cirrhosis||participants|Number|17|17.0||||||
4467919|NCT00023309|4286800|B3|Yes||Cirrhosis||participants|Number|7|7.0||||||
4467920|NCT00023309|4286801|B2|Yes||Cirrhosis||participants|Number|2|2.0||||||
4467921|NCT00023309|4286802|B1|Yes||Cirrhosis||participants|Number|5|5.0||||||
4467922|NCT00023309|4286800|B3|||Ishak|Ishak Fibrosis Score, (range 0–6, where 0 = no fibrosis and 6 = cirrhosis)|Units on a scale|Mean|2.9|2.9|Standard Deviation|1.6|1.6|||
4467923|NCT00023309|4286801|B2|||Ishak|Ishak Fibrosis Score, (range 0–6, where 0 = no fibrosis and 6 = cirrhosis)|Units on a scale|Mean|2.4|2.4|Standard Deviation|1.5|1.5|||
4467924|NCT00023309|4286802|B1|||Ishak|Ishak Fibrosis Score, (range 0–6, where 0 = no fibrosis and 6 = cirrhosis)|Units on a scale|Mean|3.3|3.3|Standard Deviation|1.7|1.7|||
4467925|NCT00023309|4286800|B3|||HAI|HAI Fibrosis score for liver histology, which has a range 0–18 and higher values represent a worse outcome|Units on a scale|Mean|8.0|8.0|Standard Deviation|2.6|2.6|||
4467926|NCT00023309|4286801|B2|||HAI|HAI Fibrosis score for liver histology, which has a range 0–18 and higher values represent a worse outcome|Units on a scale|Mean|7.9|7.9|Standard Deviation|2.4|2.4|||
4467927|NCT00023309|4286802|B1|||HAI|HAI Fibrosis score for liver histology, which has a range 0–18 and higher values represent a worse outcome|Units on a scale|Mean|8.1|8.1|Standard Deviation|2.7|2.7|||
4467928|NCT00023309|4286800|B3|||HBV DNA Log 10 copies per ml|Hepatitis B virus DNA logarithm 10 copies per ml|log10(copies/ml)|Mean|8.0|8.0|Standard Deviation|1.4|1.4|||
4467929|NCT00023309|4286801|B2|||HBV DNA Log 10 copies per ml|Hepatitis B virus DNA logarithm 10 copies per ml|log10(copies/ml)|Mean|7.8|7.8|Standard Deviation|1.6|1.6|||
4467930|NCT00023309|4286802|B1|||HBV DNA Log 10 copies per ml|Hepatitis B virus DNA logarithm 10 copies per ml|log10(copies/ml)|Mean|8.1|8.1|Standard Deviation|1.3|1.3|||
4467931|NCT00023309|4286800|B3|||ALT|Alanine transaminase|IU/ml|Mean|139|139.0|Standard Deviation|187|187.0|||
4467932|NCT00023309|4286801|B2|||ALT|Alanine transaminase|IU/ml|Mean|87|87.0|Standard Deviation|56|56.0|||
4467933|NCT00023309|4286802|B1|||ALT|Alanine transaminase|IU/ml|Mean|183|183.0|Standard Deviation|250|250.0|||
4467934|NCT00023309|4286800|B3|No||HBeAg positive||participants|Number|10|10.0||||||
4467935|NCT00023309|4286801|B2|No||HBeAg positive||participants|Number|5|5.0||||||
4467936|NCT00023309|4286802|B1|No||HBeAg positive||participants|Number|5|5.0||||||
4467937|NCT00023309|4286800|B3|Yes||HBeAg positive||participants|Number|31|31.0||||||
4467938|NCT00023309|4286801|B2|Yes||HBeAg positive||participants|Number|14|14.0||||||
4467939|NCT00023309|4286802|B1|Yes||HBeAg positive||participants|Number|17|17.0||||||
4467940|NCT00023309|4286800|B3|No||Treatment Naive||participants|Number|10|10.0||||||
4467941|NCT00023309|4286801|B2|No||Treatment Naive||participants|Number|5|5.0||||||
4467942|NCT00023309|4286802|B1|No||Treatment Naive||participants|Number|5|5.0||||||
4467943|NCT00023309|4286800|B3|Yes||Treatment Naive||participants|Number|31|31.0||||||
4467944|NCT00023309|4286801|B2|Yes||Treatment Naive||participants|Number|14|14.0||||||
4467945|NCT00023309|4286802|B1|Yes||Treatment Naive||participants|Number|17|17.0||||||
4467946|NCT00023309|4286800|B3|United States||Region of Enrollment||participants|Number|41|41.0||||||
4467947|NCT00023309|4286801|B2|United States||Region of Enrollment||participants|Number|19|19.0||||||
4467948|NCT00023309|4286802|B1|United States||Region of Enrollment||participants|Number|22|22.0||||||
4467949|NCT00023309|4286800|B3|Black||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4467950|NCT00023309|4286801|B2|Black||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4467951|NCT00023309|4286802|B1|Black||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4467952|NCT00023309|4286800|B3|Asian||Race/Ethnicity, Customized||participants|Number|19|19.0||||||
4467953|NCT00023309|4286801|B2|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4467954|NCT00023309|4286802|B1|Asian||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4467955|NCT00023309|4286800|B3|White||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4467956|NCT00023309|4286801|B2|White||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4467957|NCT00023309|4286802|B1|White||Race/Ethnicity, Customized||participants|Number|9|9.0||||||
4467958|NCT00023309|4286800|B3||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4467959|NCT00023309|4286801|B2||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4467960|NCT00023309|4286802|B1||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4467961|NCT00023309|4286800|B3||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4467962|NCT00023309|4286801|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4467963|NCT00023309|4286802|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4467964|NCT00023309|4286800|B3|||Age||years|Mean|45|45.0|Standard Deviation|14|14.0|||
4467965|NCT00023309|4286801|B2|||Age||years|Mean|45|45.0|Standard Deviation|13|13.0|||
4467966|NCT00023309|4286802|B1|||Age||years|Mean|46|46.0|Standard Deviation|14|14.0|||
4467967|NCT00022763|4286817|B3||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4467968|NCT00022763|4286818|B2||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4467969|NCT00022763|4286819|B1||Male|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4467970|NCT00022763|4286817|B3||Female|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4467971|NCT00022763|4286818|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4467972|NCT00022763|4286819|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4467973|NCT00022763|4286817|B3|||Age||years|Mean|11.5|11.5|Standard Deviation|3.1|3.1|||
4467974|NCT00022763|4286818|B2|||Age||years|Mean|13.9|13.9|Standard Deviation|1.6|1.6|||
4467975|NCT00022763|4286819|B1|||Age||years|Mean|8.7|8.7|Standard Deviation|1.8|1.8|||
4467976|NCT00016718|4286843|B4||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4467977|NCT00016718|4286844|B3||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4467978|NCT00016718|4286845|B2||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4467979|NCT00016718|4286846|B1||Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4467980|NCT00016718|4286843|B4||Black non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|27|27.0||||||
4467981|NCT00016718|4286844|B3||Black non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|12|12.0||||||
4467982|NCT00016718|4286845|B2||Black non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|11|11.0||||||
4467983|NCT00016718|4286846|B1||Black non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4467984|NCT00016718|4286843|B4||White non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|5|5.0||||||
4467985|NCT00016718|4286844|B3||White non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4467986|NCT00016718|4286845|B2||White non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4467987|NCT00016718|4286846|B1||White non-Hispanic|Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4467988|NCT00016718|4286843|B4||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4467989|NCT00016718|4286844|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4467990|NCT00016718|4286845|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4467991|NCT00016718|4286846|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4467992|NCT00016718|4286843|B4||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4467993|NCT00016718|4286844|B3||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4467994|NCT00016718|4286845|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4467995|NCT00016718|4286846|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4467996|NCT00016718|4286843|B4|||Age||years|Median|9.6|9.6|Full Range|||0.3|21.1|
4467997|NCT00016718|4286844|B3|||Age||years|Median|17.5|17.5|Full Range|||14.5|21.1|
4467998|NCT00016718|4286845|B2|||Age||years|Median|5.7|5.7|Full Range|||3.2|11.7|
4467999|NCT00016718|4286846|B1|||Age||years|Median|0.5|0.5|Full Range|||0.3|2.6|
4468000|NCT00014911|4286862|B1|||Daily Insulin Usage|Average daily insulin usage at baseline visit|Units of Insulin/kilogram/day (U/kg/day)|Mean|0.5|0.5|Standard Deviation|0.1|0.1|||
4468001|NCT00014911|4286862|B1|||Number of Years with Diabetes|Average number of years at baseline visit since the participant was physician-diagnosed with Type 1 diabetes mellitus (T1DM)|Years|Mean|27|27.0|Standard Deviation|10.4|10.4|||
4468002|NCT00014911|4286862|B1|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4468003|NCT00014911|4286862|B1|Italy||Region of Enrollment||participants|Number|4|4.0||||||
4468004|NCT00014911|4286862|B1|Germany||Region of Enrollment||participants|Number|4|4.0||||||
4468005|NCT00014911|4286862|B1|Canada||Region of Enrollment||participants|Number|4|4.0||||||
4468006|NCT00014911|4286862|B1|United States||Region of Enrollment||participants|Number|19|19.0||||||
4468007|NCT00014911|4286862|B1|Ethnicity: Non-Hispanic||Race/Ethnicity, Customized|Race/Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|36|36.0||||||
4468008|NCT00014911|4286862|B1|Race: Unspecified||Race/Ethnicity, Customized|Race/Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|1|1.0||||||
4468009|NCT00014911|4286862|B1|Race: White||Race/Ethnicity, Customized|Race/Ethnicity (Reference: Public Health Service [PHS] 398/2590, Revised 6/2009)|Participants|Number|35|35.0||||||
4468010|NCT00014911|4286862|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4468011|NCT00014911|4286862|B1||Female|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4468012|NCT00014911|4286862|B1|||Age||years|Mean|40.9|40.9|Standard Deviation|9.2|9.2|||
4468013|NCT00006604|4286871|B8|||HIV-RNA||log10 copies/ml|Median|4.8|4.8|Full Range|||3.4|6.5|
4468014|NCT00006604|4286872|B7|||HIV-RNA||log10 copies/ml|Median|4.3|4.3|Full Range|||3.5|5.0|
4468015|NCT00006604|4286873|B6|||HIV-RNA||log10 copies/ml|Median|4.5|4.5|Full Range|||3.4|5.0|
4468016|NCT00006604|4286874|B5|||HIV-RNA||log10 copies/ml|Median|4.8|4.8|Full Range|||4.1|5.1|
4468017|NCT00006604|4286875|B4|||HIV-RNA||log10 copies/ml|Median|5|5.0|Full Range|||5.0|6.5|
4468018|NCT00006604|4286876|B3|||HIV-RNA||log10 copies/ml|Median|5|5.0|Full Range|||4.4|5.6|
4468019|NCT00006604|4286877|B2|||HIV-RNA||log10 copies/ml|Median|4.7|4.7|Full Range|||3.6|6.5|
4468020|NCT00006604|4286878|B1|||HIV-RNA||log10 copies/ml|Median|4.4|4.4|Full Range|||3.5|5.0|
4468021|NCT00006604|4286871|B8|||CD4 Percent||percentage of total lymphocytes|Median|18|18.0|Full Range|||0.0|53.0|
4468022|NCT00006604|4286872|B7|||CD4 Percent||percentage of total lymphocytes|Median|19|19.0|Full Range|||0.0|40.0|
4468082|NCT00006604|4286876|B3||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4468023|NCT00006604|4286873|B6|||CD4 Percent||percentage of total lymphocytes|Median|21|21.0|Full Range|||1.0|43.0|
4468024|NCT00006604|4286874|B5|||CD4 Percent||percentage of total lymphocytes|Median|16|16.0|Full Range|||2.0|34.0|
4468025|NCT00006604|4286875|B4|||CD4 Percent||percentage of total lymphocytes|Median|35|35.0|Full Range|||10.0|46.0|
4468026|NCT00006604|4286876|B3|||CD4 Percent||percentage of total lymphocytes|Median|19|19.0|Full Range|||7.0|53.0|
4468027|NCT00006604|4286877|B2|||CD4 Percent||percentage of total lymphocytes|Median|14|14.0|Full Range|||1.0|39.0|
4468028|NCT00006604|4286878|B1|||CD4 Percent||percentage of total lymphocytes|Median|18|18.0|Full Range|||7.0|36.0|
4468029|NCT00006604|4286871|B8|||CD4 Count||cells/mm^3|Median|457|457.0|Full Range|||1.0|4875.0|
4468030|NCT00006604|4286872|B7|||CD4 Count||cells/mm^3|Median|334|334.0|Full Range|||1.0|548.0|
4468031|NCT00006604|4286873|B6|||CD4 Count||cells/mm^3|Median|540|540.0|Full Range|||24.0|1800.0|
4468032|NCT00006604|4286874|B5|||CD4 Count||cells/mm^3|Median|466|466.0|Full Range|||62.0|1537.0|
4468033|NCT00006604|4286875|B4|||CD4 Count||cells/mm^3|Median|2125|2125.0|Full Range|||583.0|2715.0|
4468034|NCT00006604|4286876|B3|||CD4 Count||cells/mm^3|Median|1306|1306.0|Full Range|||392.0|4875.0|
4468035|NCT00006604|4286877|B2|||CD4 Count||cells/mm^3|Median|286|286.0|Full Range|||11.0|476.0|
4468036|NCT00006604|4286878|B1|||CD4 Count||cells/mm^3|Median|374|374.0|Full Range|||105.0|963.0|
4468037|NCT00006604|4286871|B8|Unavailable||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4468038|NCT00006604|4286872|B7|Unavailable||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4468039|NCT00006604|4286873|B6|Unavailable||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4468040|NCT00006604|4286874|B5|Unavailable||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4468041|NCT00006604|4286875|B4|Unavailable||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4468042|NCT00006604|4286876|B3|Unavailable||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4468043|NCT00006604|4286877|B2|Unavailable||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4468044|NCT00006604|4286878|B1|Unavailable||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4468045|NCT00006604|4286871|B8|More than one race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4468046|NCT00006604|4286872|B7|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4468047|NCT00006604|4286873|B6|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4468048|NCT00006604|4286874|B5|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4468049|NCT00006604|4286875|B4|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4468050|NCT00006604|4286876|B3|More than one race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4468051|NCT00006604|4286877|B2|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4468052|NCT00006604|4286878|B1|More than one race||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4468053|NCT00006604|4286871|B8|Hisp-Regardless of Race||Race/Ethnicity, Customized||participants|Number|30|30.0||||||
4468054|NCT00006604|4286872|B7|Hisp-Regardless of Race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4468055|NCT00006604|4286873|B6|Hisp-Regardless of Race||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4468056|NCT00006604|4286874|B5|Hisp-Regardless of Race||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4468057|NCT00006604|4286875|B4|Hisp-Regardless of Race||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4468058|NCT00006604|4286876|B3|Hisp-Regardless of Race||Race/Ethnicity, Customized||participants|Number|2|2.0||||||
4468059|NCT00006604|4286877|B2|Hisp-Regardless of Race||Race/Ethnicity, Customized||participants|Number|7|7.0||||||
4468060|NCT00006604|4286878|B1|Hisp-Regardless of Race||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4468061|NCT00006604|4286871|B8|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|102|102.0||||||
4468062|NCT00006604|4286872|B7|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4468063|NCT00006604|4286873|B6|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4468064|NCT00006604|4286874|B5|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4468065|NCT00006604|4286875|B4|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4468066|NCT00006604|4286876|B3|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|18|18.0||||||
4468067|NCT00006604|4286877|B2|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|17|17.0||||||
4468068|NCT00006604|4286878|B1|Black Non-Hispanic||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4468069|NCT00006604|4286871|B8|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|5|5.0||||||
4468070|NCT00006604|4286872|B7|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4468071|NCT00006604|4286873|B6|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4468072|NCT00006604|4286874|B5|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4468073|NCT00006604|4286875|B4|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4468074|NCT00006604|4286876|B3|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4468075|NCT00006604|4286877|B2|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|0|0.0||||||
4468076|NCT00006604|4286878|B1|White Non-Hispanic||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4468077|NCT00006604|4286871|B8||Male|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4468078|NCT00006604|4286872|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4468079|NCT00006604|4286873|B6||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4468080|NCT00006604|4286874|B5||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4468081|NCT00006604|4286875|B4||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4468083|NCT00006604|4286877|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4468084|NCT00006604|4286878|B1||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4468085|NCT00006604|4286871|B8||Female|Sex: Female, Male||Participants|Count of Participants|75|75.0||||||
4468086|NCT00006604|4286872|B7||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4468087|NCT00006604|4286873|B6||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4468088|NCT00006604|4286874|B5||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4468089|NCT00006604|4286875|B4||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4468090|NCT00006604|4286876|B3||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4468091|NCT00006604|4286877|B2||Female|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4468092|NCT00006604|4286878|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4468093|NCT00006604|4286871|B8|||Age||years|Median|7|7.0|Full Range|||0.3|21.0|
4468094|NCT00006604|4286872|B7|||Age||years|Median|17|17.0|Full Range|||13.9|21.0|
4468095|NCT00006604|4286873|B6|||Age||years|Median|9|9.0|Full Range|||5.6|12.7|
4468096|NCT00006604|4286874|B5|||Age||years|Median|4.4|4.4|Full Range|||2.0|12.0|
4468097|NCT00006604|4286875|B4|||Age||years|Median|0.4|0.4|Full Range|||0.3|0.5|
4468098|NCT00006604|4286876|B3|||Age||years|Median|1.2|1.2|Full Range|||0.3|2.0|
4468099|NCT00006604|4286877|B2|||Age||years|Median|14.3|14.3|Full Range|||13.1|20.2|
4468100|NCT00006604|4286878|B1|||Age||years|Median|8.6|8.6|Full Range|||6.3|12.5|
4468101|NCT00004978|4287008|B3|||CD4+ cell count||cells/mm^3|Median|458|458.0|Inter-Quartile Range|||373.0|586.0|
4468102|NCT00004978|4287009|B2|||CD4+ cell count||cells/mm^3|Median|451|451.0|Inter-Quartile Range|||370.0|578.0|
4468103|NCT00004978|4287010|B1|||CD4+ cell count||cells/mm^3|Median|465|465.0|Inter-Quartile Range|||374.0|592.0|
4468104|NCT00004978|4287008|B3|United States||Region of Enrollment||participants|Number|988|988.0||||||
4468105|NCT00004978|4287009|B2|United States||Region of Enrollment||participants|Number|477|477.0||||||
4468106|NCT00004978|4287010|B1|United States||Region of Enrollment||participants|Number|511|511.0||||||
4468107|NCT00004978|4287008|B3|United Kingdom||Region of Enrollment||participants|Number|328|328.0||||||
4468108|NCT00004978|4287009|B2|United Kingdom||Region of Enrollment||participants|Number|163|163.0||||||
4468109|NCT00004978|4287010|B1|United Kingdom||Region of Enrollment||participants|Number|165|165.0||||||
4468110|NCT00004978|4287008|B3|Thailand||Region of Enrollment||participants|Number|365|365.0||||||
4468111|NCT00004978|4287009|B2|Thailand||Region of Enrollment||participants|Number|183|183.0||||||
4468112|NCT00004978|4287010|B1|Thailand||Region of Enrollment||participants|Number|182|182.0||||||
4468113|NCT00004978|4287008|B3|Switzerland||Region of Enrollment||participants|Number|10|10.0||||||
4468114|NCT00004978|4287009|B2|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4468115|NCT00004978|4287010|B1|Switzerland||Region of Enrollment||participants|Number|5|5.0||||||
4468116|NCT00004978|4287008|B3|Sweden||Region of Enrollment||participants|Number|7|7.0||||||
4468117|NCT00004978|4287009|B2|Sweden||Region of Enrollment||participants|Number|3|3.0||||||
4468118|NCT00004978|4287010|B1|Sweden||Region of Enrollment||participants|Number|4|4.0||||||
4468119|NCT00004978|4287008|B3|Spain||Region of Enrollment||participants|Number|308|308.0||||||
4468120|NCT00004978|4287009|B2|Spain||Region of Enrollment||participants|Number|157|157.0||||||
4468121|NCT00004978|4287010|B1|Spain||Region of Enrollment||participants|Number|151|151.0||||||
4468122|NCT00004978|4287008|B3|Singapore||Region of Enrollment||participants|Number|20|20.0||||||
4468123|NCT00004978|4287009|B2|Singapore||Region of Enrollment||participants|Number|10|10.0||||||
4468124|NCT00004978|4287010|B1|Singapore||Region of Enrollment||participants|Number|10|10.0||||||
4468125|NCT00004978|4287008|B3|Portugal||Region of Enrollment||participants|Number|107|107.0||||||
4468126|NCT00004978|4287009|B2|Portugal||Region of Enrollment||participants|Number|56|56.0||||||
4468127|NCT00004978|4287010|B1|Portugal||Region of Enrollment||participants|Number|51|51.0||||||
4468128|NCT00004978|4287008|B3|Poland||Region of Enrollment||participants|Number|100|100.0||||||
4468129|NCT00004978|4287009|B2|Poland||Region of Enrollment||participants|Number|52|52.0||||||
4468130|NCT00004978|4287010|B1|Poland||Region of Enrollment||participants|Number|48|48.0||||||
4468131|NCT00004978|4287008|B3|Norway||Region of Enrollment||participants|Number|8|8.0||||||
4468132|NCT00004978|4287009|B2|Norway||Region of Enrollment||participants|Number|5|5.0||||||
4468133|NCT00004978|4287010|B1|Norway||Region of Enrollment||participants|Number|3|3.0||||||
4468134|NCT00004978|4287008|B3|Netherlands||Region of Enrollment||participants|Number|54|54.0||||||
4468135|NCT00004978|4287009|B2|Netherlands||Region of Enrollment||participants|Number|25|25.0||||||
4468136|NCT00004978|4287010|B1|Netherlands||Region of Enrollment||participants|Number|29|29.0||||||
4468137|NCT00004978|4287008|B3|Morocco||Region of Enrollment||participants|Number|26|26.0||||||
4468138|NCT00004978|4287009|B2|Morocco||Region of Enrollment||participants|Number|14|14.0||||||
4468139|NCT00004978|4287010|B1|Morocco||Region of Enrollment||participants|Number|12|12.0||||||
4468140|NCT00004978|4287008|B3|Japan||Region of Enrollment||participants|Number|25|25.0||||||
4468141|NCT00004978|4287009|B2|Japan||Region of Enrollment||participants|Number|11|11.0||||||
4468142|NCT00004978|4287010|B1|Japan||Region of Enrollment||participants|Number|14|14.0||||||
4468143|NCT00004978|4287008|B3|Italy||Region of Enrollment||participants|Number|104|104.0||||||
4468144|NCT00004978|4287009|B2|Italy||Region of Enrollment||participants|Number|54|54.0||||||
4468145|NCT00004978|4287010|B1|Italy||Region of Enrollment||participants|Number|50|50.0||||||
4468146|NCT00004978|4287008|B3|Israel||Region of Enrollment||participants|Number|64|64.0||||||
4468147|NCT00004978|4287009|B2|Israel||Region of Enrollment||participants|Number|33|33.0||||||
4468148|NCT00004978|4287010|B1|Israel||Region of Enrollment||participants|Number|31|31.0||||||
4468149|NCT00004978|4287008|B3|Ireland||Region of Enrollment||participants|Number|4|4.0||||||
4468150|NCT00004978|4287009|B2|Ireland||Region of Enrollment||participants|Number|1|1.0||||||
4468151|NCT00004978|4287010|B1|Ireland||Region of Enrollment||participants|Number|3|3.0||||||
4468152|NCT00004978|4287008|B3|Germany||Region of Enrollment||participants|Number|266|266.0||||||
4468153|NCT00004978|4287009|B2|Germany||Region of Enrollment||participants|Number|130|130.0||||||
4468154|NCT00004978|4287010|B1|Germany||Region of Enrollment||participants|Number|136|136.0||||||
4468155|NCT00004978|4287008|B3|France||Region of Enrollment||participants|Number|182|182.0||||||
4468156|NCT00004978|4287009|B2|France||Region of Enrollment||participants|Number|96|96.0||||||
4468157|NCT00004978|4287010|B1|France||Region of Enrollment||participants|Number|86|86.0||||||
4468158|NCT00004978|4287008|B3|Denmark||Region of Enrollment||participants|Number|72|72.0||||||
4468159|NCT00004978|4287009|B2|Denmark||Region of Enrollment||participants|Number|33|33.0||||||
4468160|NCT00004978|4287010|B1|Denmark||Region of Enrollment||participants|Number|39|39.0||||||
4468161|NCT00004978|4287008|B3|Canada||Region of Enrollment||participants|Number|141|141.0||||||
4468162|NCT00004978|4287009|B2|Canada||Region of Enrollment||participants|Number|67|67.0||||||
4468163|NCT00004978|4287010|B1|Canada||Region of Enrollment||participants|Number|74|74.0||||||
4468164|NCT00004978|4287008|B3|Brazil||Region of Enrollment||participants|Number|98|98.0||||||
4468165|NCT00004978|4287009|B2|Brazil||Region of Enrollment||participants|Number|50|50.0||||||
4468166|NCT00004978|4287010|B1|Brazil||Region of Enrollment||participants|Number|48|48.0||||||
4468167|NCT00004978|4287008|B3|Belgium||Region of Enrollment||participants|Number|80|80.0||||||
4468168|NCT00004978|4287009|B2|Belgium||Region of Enrollment||participants|Number|41|41.0||||||
4468169|NCT00004978|4287010|B1|Belgium||Region of Enrollment||participants|Number|39|39.0||||||
4468170|NCT00004978|4287008|B3|Austria||Region of Enrollment||participants|Number|34|34.0||||||
4468171|NCT00004978|4287009|B2|Austria||Region of Enrollment||participants|Number|18|18.0||||||
4468172|NCT00004978|4287010|B1|Austria||Region of Enrollment||participants|Number|16|16.0||||||
4468173|NCT00004978|4287008|B3|Australia||Region of Enrollment||participants|Number|205|205.0||||||
4468174|NCT00004978|4287009|B2|Australia||Region of Enrollment||participants|Number|98|98.0||||||
4468175|NCT00004978|4287010|B1|Australia||Region of Enrollment||participants|Number|107|107.0||||||
4468176|NCT00004978|4287008|B3|Argentina||Region of Enrollment||participants|Number|554|554.0||||||
4468177|NCT00004978|4287009|B2|Argentina||Region of Enrollment||participants|Number|278|278.0||||||
4468178|NCT00004978|4287010|B1|Argentina||Region of Enrollment||participants|Number|276|276.0||||||
4468179|NCT00004978|4287008|B3||Male|Sex: Female, Male||Participants|Count of Participants|3381|3381.0||||||
4468180|NCT00004978|4287009|B2||Male|Sex: Female, Male||Participants|Count of Participants|1679|1679.0||||||
4468181|NCT00004978|4287010|B1||Male|Sex: Female, Male||Participants|Count of Participants|1702|1702.0||||||
4468182|NCT00004978|4287008|B3||Female|Sex: Female, Male||Participants|Count of Participants|769|769.0||||||
4468183|NCT00004978|4287009|B2||Female|Sex: Female, Male||Participants|Count of Participants|381|381.0||||||
4468184|NCT00004978|4287010|B1||Female|Sex: Female, Male||Participants|Count of Participants|388|388.0||||||
4468185|NCT00004978|4287008|B3|||Age||years|Mean|40.8|40.8|Standard Deviation|9.0|9.0|||
4468186|NCT00004978|4287009|B2|||Age||years|Mean|40.9|40.9|Standard Deviation|9.1|9.1|||
4468187|NCT00004978|4287010|B1|||Age||years|Mean|40.8|40.8|Standard Deviation|8.8|8.8|||
4468188|NCT00004978|4287008|B3||>=65 years|Age||Participants|Count of Participants|47|47.0||||||
4468189|NCT00004978|4287009|B2||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4468190|NCT00004978|4287010|B1||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4468191|NCT00004978|4287008|B3||Between 18 and 65 years|Age||Participants|Count of Participants|4103|4103.0||||||
4468192|NCT00004978|4287009|B2||Between 18 and 65 years|Age||Participants|Count of Participants|2032|2032.0||||||
4468193|NCT00004978|4287010|B1||Between 18 and 65 years|Age||Participants|Count of Participants|2071|2071.0||||||
4468194|NCT00004978|4287008|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468195|NCT00004978|4287009|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468196|NCT00004978|4287010|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468197|NCT00021541|4287035|B3|United States||Region of Enrollment||Participants|Count of Participants|62|62.0||||||
4468198|NCT00021541|4287036|B2|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4468199|NCT00021541|4287037|B1|United States||Region of Enrollment||Participants|Count of Participants|31|31.0||||||
4468200|NCT00021541|4287035|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4468201|NCT00021541|4287036|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468202|NCT00021541|4287037|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4468203|NCT00021541|4287035|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468204|NCT00021541|4287036|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468205|NCT00021541|4287037|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468206|NCT00021541|4287035|B3|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468207|NCT00021541|4287036|B2|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468208|NCT00021541|4287037|B1|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468209|NCT00021541|4287035|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4468210|NCT00021541|4287036|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4468211|NCT00021541|4287037|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|25|25.0||||||
4468212|NCT00021541|4287035|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4468213|NCT00021541|4287036|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|4|4.0||||||
4468214|NCT00021541|4287037|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4468215|NCT00021541|4287035|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468216|NCT00021541|4287036|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468217|NCT00021541|4287037|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468218|NCT00021541|4287035|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468219|NCT00021541|4287036|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468220|NCT00021541|4287037|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468221|NCT00021541|4287035|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468222|NCT00021541|4287036|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468223|NCT00021541|4287037|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468224|NCT00021541|4287035|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468225|NCT00021541|4287036|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468226|NCT00021541|4287037|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468227|NCT00021541|4287035|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|59|59.0||||||
4468228|NCT00021541|4287036|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4468229|NCT00021541|4287037|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4468230|NCT00021541|4287035|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4468231|NCT00021541|4287036|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4468232|NCT00021541|4287037|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4468233|NCT00021541|4287035|B3||Male|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4468234|NCT00021541|4287036|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4468235|NCT00021541|4287037|B1||Male|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4468236|NCT00021541|4287035|B3||Female|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4468237|NCT00021541|4287036|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4468238|NCT00021541|4287037|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4468239|NCT00021541|4287035|B3|||Age||years|Mean|10.|0.0|Standard Deviation|4.87|4.87|||
4468240|NCT00021541|4287036|B2|||Age||years|Mean|9.8|9.8|Standard Deviation|4.69|4.69|||
4468241|NCT00021541|4287037|B1|||Age||years|Mean|10.2|10.2|Standard Deviation|5.13|5.13|||
4468242|NCT00021541|4287035|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468243|NCT00021541|4287036|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468244|NCT00021541|4287037|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468245|NCT00021541|4287035|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4468246|NCT00021541|4287036|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468247|NCT00021541|4287037|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4468248|NCT00021541|4287035|B3||<=18 years|Age||Participants|Count of Participants|59|59.0||||||
4468249|NCT00021541|4287036|B2||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4468250|NCT00021541|4287037|B1||<=18 years|Age||Participants|Count of Participants|28|28.0||||||
4468251|NCT00018031|4287048|B1|United States||Region of Enrollment||participants|Number|36|36.0||||||
4468252|NCT00018031|4287048|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4468253|NCT00018031|4287048|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4468254|NCT00018031|4287048|B1||>=65 years|Age||Participants|Count of Participants|2|2.0||||||
4468255|NCT00018031|4287048|B1||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4468256|NCT00018031|4287048|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468257|NCT00015457|4287052|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4468258|NCT00015457|4287052|B1||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4468259|NCT00015457|4287052|B1||>=65 years|Age|age >18|Participants|Count of Participants|1|1.0||||||
4468260|NCT00015457|4287052|B1||Between 18 and 65 years|Age|age >18|Participants|Count of Participants|15|15.0||||||
4468261|NCT00015457|4287052|B1||<=18 years|Age|age >18|Participants|Count of Participants|0|0.0||||||
4468262|NCT00013611|4287061|B3|Brazil||Region of Enrollment||participants|Number|75|75.0||||||
4468263|NCT00013611|4287062|B2|Brazil||Region of Enrollment||participants|Number|38|38.0||||||
4468264|NCT00013611|4287063|B1|Brazil||Region of Enrollment||participants|Number|37|37.0||||||
4468265|NCT00013611|4287061|B3|Canada||Region of Enrollment||participants|Number|130|130.0||||||
4468266|NCT00013611|4287062|B2|Canada||Region of Enrollment||participants|Number|62|62.0||||||
4468267|NCT00013611|4287063|B1|Canada||Region of Enrollment||participants|Number|68|68.0||||||
4468268|NCT00013611|4287061|B3|United States||Region of Enrollment||participants|Number|406|406.0||||||
4468269|NCT00013611|4287062|B2|United States||Region of Enrollment||participants|Number|203|203.0||||||
4468270|NCT00013611|4287063|B1|United States||Region of Enrollment||participants|Number|203|203.0||||||
4468271|NCT00013611|4287061|B3|Australia||Region of Enrollment||participants|Number|126|126.0||||||
4468272|NCT00013611|4287062|B2|Australia||Region of Enrollment||participants|Number|64|64.0||||||
4468273|NCT00013611|4287063|B1|Australia||Region of Enrollment||participants|Number|62|62.0||||||
4468274|NCT00013611|4287061|B3|Argentina||Region of Enrollment||participants|Number|170|170.0||||||
4468275|NCT00013611|4287062|B2|Argentina||Region of Enrollment||participants|Number|85|85.0||||||
4468276|NCT00013611|4287063|B1|Argentina||Region of Enrollment||participants|Number|85|85.0||||||
4468277|NCT00013611|4287061|B3|Netherlands||Region of Enrollment||participants|Number|23|23.0||||||
4468278|NCT00013611|4287062|B2|Netherlands||Region of Enrollment||participants|Number|12|12.0||||||
4468279|NCT00013611|4287063|B1|Netherlands||Region of Enrollment||participants|Number|11|11.0||||||
4468280|NCT00013611|4287061|B3|Italy||Region of Enrollment||participants|Number|273|273.0||||||
4468281|NCT00013611|4287062|B2|Italy||Region of Enrollment||participants|Number|142|142.0||||||
4468282|NCT00013611|4287063|B1|Italy||Region of Enrollment||participants|Number|131|131.0||||||
4468283|NCT00013611|4287061|B3|France||Region of Enrollment||participants|Number|97|97.0||||||
4468284|NCT00013611|4287062|B2|France||Region of Enrollment||participants|Number|50|50.0||||||
4468285|NCT00013611|4287063|B1|France||Region of Enrollment||participants|Number|47|47.0||||||
4468286|NCT00013611|4287061|B3|Spain||Region of Enrollment||participants|Number|270|270.0||||||
4468287|NCT00013611|4287062|B2|Spain||Region of Enrollment||participants|Number|131|131.0||||||
4468288|NCT00013611|4287063|B1|Spain||Region of Enrollment||participants|Number|139|139.0||||||
4468289|NCT00013611|4287061|B3|Germany||Region of Enrollment||participants|Number|96|96.0||||||
4468290|NCT00013611|4287062|B2|Germany||Region of Enrollment||participants|Number|46|46.0||||||
4468291|NCT00013611|4287063|B1|Germany||Region of Enrollment||participants|Number|50|50.0||||||
4468292|NCT00013611|4287061|B3|Belgium||Region of Enrollment||participants|Number|29|29.0||||||
4468293|NCT00013611|4287062|B2|Belgium||Region of Enrollment||participants|Number|13|13.0||||||
4468294|NCT00013611|4287063|B1|Belgium||Region of Enrollment||participants|Number|16|16.0||||||
4468295|NCT00013611|4287061|B3||Male|Sex: Female, Male||Participants|Count of Participants|1415|1415.0||||||
4468296|NCT00013611|4287062|B2||Male|Sex: Female, Male||Participants|Count of Participants|703|703.0||||||
4468297|NCT00013611|4287063|B1||Male|Sex: Female, Male||Participants|Count of Participants|712|712.0||||||
4468298|NCT00013611|4287061|B3||Female|Sex: Female, Male||Participants|Count of Participants|280|280.0||||||
4468299|NCT00013611|4287062|B2||Female|Sex: Female, Male||Participants|Count of Participants|143|143.0||||||
4468300|NCT00013611|4287063|B1||Female|Sex: Female, Male||Participants|Count of Participants|137|137.0||||||
4468301|NCT00013611|4287061|B3|||Age||years|Mean|41.9|41.9|Standard Deviation|8.7|8.7|||
4468302|NCT00013611|4287062|B2|||Age||years|Mean|42.0|42.0|Standard Deviation|8.8|8.8|||
4468303|NCT00013611|4287063|B1|||Age||years|Mean|41.8|41.8|Standard Deviation|8.7|8.7|||
4468304|NCT00013611|4287061|B3||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4468305|NCT00013611|4287062|B2||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4468306|NCT00013611|4287063|B1||>=65 years|Age||Participants|Count of Participants|8|8.0||||||
4468307|NCT00013611|4287061|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1679|1679.0||||||
4468308|NCT00013611|4287062|B2||Between 18 and 65 years|Age||Participants|Count of Participants|838|838.0||||||
4468309|NCT00013611|4287063|B1||Between 18 and 65 years|Age||Participants|Count of Participants|841|841.0||||||
4468310|NCT00013611|4287061|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468311|NCT00013611|4287062|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468312|NCT00013611|4287063|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468313|NCT00010803|4287080|B3|United States||Region of Enrollment||participants|Number|3069|3069.0||||||
4468314|NCT00010803|4287081|B2|United States||Region of Enrollment||participants|Number|1524|1524.0||||||
4468315|NCT00010803|4287082|B1|United States||Region of Enrollment||participants|Number|1545|1545.0||||||
4468316|NCT00010803|4287080|B3||Male|Sex: Female, Male||Participants|Count of Participants|1651|1651.0||||||
4468317|NCT00010803|4287081|B2||Male|Sex: Female, Male||Participants|Count of Participants|808|808.0||||||
4468318|NCT00010803|4287082|B1||Male|Sex: Female, Male||Participants|Count of Participants|843|843.0||||||
4468319|NCT00010803|4287080|B3||Female|Sex: Female, Male||Participants|Count of Participants|1418|1418.0||||||
4468320|NCT00010803|4287081|B2||Female|Sex: Female, Male||Participants|Count of Participants|716|716.0||||||
4468321|NCT00010803|4287082|B1||Female|Sex: Female, Male||Participants|Count of Participants|702|702.0||||||
4468322|NCT00010803|4287080|B3|||Age||years|Mean|79.1|79.1|Standard Deviation|3.3|3.3|||
4468323|NCT00010803|4287081|B2|||Age||years|Mean|79.1|79.1|Standard Deviation|3.3|3.3|||
4468324|NCT00010803|4287082|B1|||Age||years|Mean|79.1|79.1|Standard Deviation|3.3|3.3|||
4468325|NCT00010803|4287080|B3||>=65 years|Age||Participants|Count of Participants|3069|3069.0||||||
4468326|NCT00010803|4287081|B2||>=65 years|Age||Participants|Count of Participants|1524|1524.0||||||
4468327|NCT00010803|4287082|B1||>=65 years|Age||Participants|Count of Participants|1545|1545.0||||||
4468328|NCT00010803|4287080|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468329|NCT00010803|4287081|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468330|NCT00010803|4287082|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468331|NCT00010803|4287080|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468332|NCT00010803|4287081|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468333|NCT00010803|4287082|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468334|NCT00010439|4287093|B1|United States||Region of Enrollment||participants|Number|10|10.0||||||
4468335|NCT00010439|4287093|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4468336|NCT00010439|4287093|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4468337|NCT00010439|4287093|B1|Post Treatment||Age||years|Mean|10.6|10.6|Standard Deviation|2.3|2.3|||
4468338|NCT00010439|4287093|B1|Pre-Treatment (Baseline)||Age||years|Mean|9.4|9.4|Standard Deviation|2.3|2.3|||
4468339|NCT00010439|4287093|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468340|NCT00010439|4287093|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468341|NCT00010439|4287093|B1||<=18 years|Age||Participants|Count of Participants|10|10.0||||||
4468342|NCT00007644|4287098|B3|United States||Region of Enrollment||participants|Number|731|731.0||||||
4468343|NCT00007644|4287099|B2|United States||Region of Enrollment||participants|Number|367|367.0||||||
4468344|NCT00007644|4287100|B1|United States||Region of Enrollment||participants|Number|364|364.0||||||
4468345|NCT00007644|4287098|B3||Male|Sex: Female, Male||Participants|Count of Participants|731|731.0||||||
4468346|NCT00007644|4287099|B2||Male|Sex: Female, Male||Participants|Count of Participants|367|367.0||||||
4468347|NCT00007644|4287100|B1||Male|Sex: Female, Male||Participants|Count of Participants|364|364.0||||||
4468348|NCT00007644|4287098|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468349|NCT00007644|4287099|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468350|NCT00007644|4287100|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468351|NCT00007644|4287098|B3|||Age||years|Mean|66.9|66.9|Standard Deviation|5.4|5.4|||
4468352|NCT00007644|4287099|B2|||Age||years|Mean|66.8|66.8|Standard Deviation|5.6|5.6|||
4468353|NCT00007644|4287100|B1|||Age||years|Mean|67.0|67.0|Standard Deviation|5.2|5.2|||
4468354|NCT00007644|4287098|B3||>=65 years|Age||Participants|Count of Participants|478|478.0||||||
4468355|NCT00007644|4287099|B2||>=65 years|Age||Participants|Count of Participants|236|236.0||||||
4468356|NCT00007644|4287100|B1||>=65 years|Age||Participants|Count of Participants|242|242.0||||||
4468357|NCT00007644|4287098|B3||Between 18 and 65 years|Age||Participants|Count of Participants|253|253.0||||||
4468358|NCT00007644|4287099|B2||Between 18 and 65 years|Age||Participants|Count of Participants|131|131.0||||||
4468359|NCT00007644|4287100|B1||Between 18 and 65 years|Age||Participants|Count of Participants|122|122.0||||||
4468360|NCT00007644|4287098|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468361|NCT00007644|4287099|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468362|NCT00007644|4287100|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468363|NCT00007475|4287107|B4|||Time from onset/diagnosis of Focal Segmental Glomerulosclerosis to study enrollment/consent|Note: calculated in terms of whole years, subject to coarsening due to integer subtraction (whole-year age at consent - whole-year age at onset)|years|Median|8|8.0|Inter-Quartile Range|||4.0|13.5|
4468364|NCT00007475|4287108|B3|||Time from onset/diagnosis of Focal Segmental Glomerulosclerosis to study enrollment/consent|Note: calculated in terms of whole years, subject to coarsening due to integer subtraction (whole-year age at consent - whole-year age at onset)|years|Median|1.5|1.5|Inter-Quartile Range|||1.25|1.75|
4468365|NCT00007475|4287109|B2|||Time from onset/diagnosis of Focal Segmental Glomerulosclerosis to study enrollment/consent|Note: calculated in terms of whole years, subject to coarsening due to integer subtraction (whole-year age at consent - whole-year age at onset)|years|Median|6|6.0|Inter-Quartile Range|||6.0|6.0|
4468366|NCT00007475|4287110|B1|||Time from onset/diagnosis of Focal Segmental Glomerulosclerosis to study enrollment/consent|Note: calculated in terms of whole years, subject to coarsening due to integer subtraction (whole-year age at consent - whole-year age at onset)|years|Median|10|10.0|Inter-Quartile Range|||7.75|14.75|
4468367|NCT00007475|4287107|B4|No||Treated for Prior Recurrence||participants|Number|12|12.0||||||
4468368|NCT00007475|4287108|B3|No||Treated for Prior Recurrence||participants|Number|2|2.0||||||
4468369|NCT00007475|4287109|B2|No||Treated for Prior Recurrence||participants|Number|0|0.0||||||
4468370|NCT00007475|4287110|B1|No||Treated for Prior Recurrence||participants|Number|10|10.0||||||
4468371|NCT00007475|4287107|B4|Yes||Treated for Prior Recurrence||participants|Number|3|3.0||||||
4468372|NCT00007475|4287108|B3|Yes||Treated for Prior Recurrence||participants|Number|0|0.0||||||
4468373|NCT00007475|4287109|B2|Yes||Treated for Prior Recurrence||participants|Number|1|1.0||||||
4468374|NCT00007475|4287110|B1|Yes||Treated for Prior Recurrence||participants|Number|2|2.0||||||
4468375|NCT00007475|4287107|B4|United States||Region of Enrollment||participants|Number|15|15.0||||||
4468376|NCT00007475|4287108|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4468377|NCT00007475|4287109|B2|United States||Region of Enrollment||participants|Number|1|1.0||||||
4468378|NCT00007475|4287110|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4468379|NCT00007475|4287107|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468380|NCT00007475|4287108|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468381|NCT00007475|4287109|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468382|NCT00007475|4287110|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468383|NCT00007475|4287107|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468384|NCT00007475|4287108|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468385|NCT00007475|4287109|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468386|NCT00007475|4287110|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468387|NCT00007475|4287107|B4||White|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4468388|NCT00007475|4287108|B3||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4468389|NCT00007475|4287109|B2||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4468390|NCT00007475|4287110|B1||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4468391|NCT00007475|4287107|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4468392|NCT00007475|4287108|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468393|NCT00007475|4287109|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468394|NCT00007475|4287110|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4468395|NCT00007475|4287107|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468396|NCT00007475|4287108|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468397|NCT00007475|4287109|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468398|NCT00007475|4287110|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468399|NCT00007475|4287107|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4468400|NCT00007475|4287108|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468401|NCT00007475|4287109|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468402|NCT00007475|4287110|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4468403|NCT00007475|4287107|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468404|NCT00007475|4287108|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468405|NCT00007475|4287109|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468406|NCT00007475|4287110|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468407|NCT00007475|4287107|B4||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4468408|NCT00007475|4287108|B3||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4468409|NCT00007475|4287109|B2||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4468410|NCT00007475|4287110|B1||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4468411|NCT00007475|4287107|B4||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4468412|NCT00007475|4287108|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4468413|NCT00007475|4287109|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468414|NCT00007475|4287110|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4468415|NCT00007475|4287107|B4|||Age||years at consent|Median|37|37.0|Inter-Quartile Range|||25.0|48.5|
4468416|NCT00007475|4287108|B3|||Age||years at consent|Median|19|19.0|Inter-Quartile Range|||18.5|19.5|
4468417|NCT00007475|4287109|B2|||Age||years at consent|Median|63|63.0|Inter-Quartile Range|||63.0|63.0|
4468418|NCT00007475|4287110|B1|||Age||years at consent|Median|39.5|39.5|Inter-Quartile Range|||32.25|47.25|
4468419|NCT00007345|4287133|B3|Australia||Region of Enrollment||participants|Number|37|37.0||||||
4468420|NCT00007345|4287134|B2|Australia||Region of Enrollment||participants|Number|29|29.0||||||
4468421|NCT00007345|4287135|B1|Australia||Region of Enrollment||participants|Number|8|8.0||||||
4468422|NCT00007345|4287133|B3|United States||Region of Enrollment||participants|Number|94|94.0||||||
4468423|NCT00007345|4287134|B2|United States||Region of Enrollment||participants|Number|55|55.0||||||
4468424|NCT00007345|4287135|B1|United States||Region of Enrollment||participants|Number|39|39.0||||||
4468425|NCT00007345|4287133|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4468426|NCT00007345|4287134|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4468427|NCT00007345|4287135|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468428|NCT00007345|4287133|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468429|NCT00007345|4287134|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468430|NCT00007345|4287135|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468431|NCT00007345|4287133|B3||White|Race (NIH/OMB)||Participants|Count of Participants|105|105.0||||||
4468432|NCT00007345|4287134|B2||White|Race (NIH/OMB)||Participants|Count of Participants|65|65.0||||||
4468433|NCT00007345|4287135|B1||White|Race (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4468434|NCT00007345|4287133|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4468435|NCT00007345|4287134|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|17|17.0||||||
4468436|NCT00007345|4287135|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4468437|NCT00007345|4287133|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468438|NCT00007345|4287134|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468439|NCT00007345|4287135|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468440|NCT00007345|4287133|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4468441|NCT00007345|4287134|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468442|NCT00007345|4287135|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4468443|NCT00007345|4287133|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468444|NCT00007345|4287134|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468445|NCT00007345|4287135|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468446|NCT00007345|4287133|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468447|NCT00007345|4287134|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468448|NCT00007345|4287135|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468449|NCT00007345|4287133|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|126|126.0||||||
4468450|NCT00007345|4287134|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|80|80.0||||||
4468451|NCT00007345|4287135|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|46|46.0||||||
4468452|NCT00007345|4287133|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4468453|NCT00007345|4287134|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4468454|NCT00007345|4287135|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4468455|NCT00007345|4287133|B3||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4468456|NCT00007345|4287134|B2||Male|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4468457|NCT00007345|4287135|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4468458|NCT00007345|4287133|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4468459|NCT00007345|4287134|B2||Female|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4468460|NCT00007345|4287135|B1||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4468461|NCT00007345|4287133|B3|||Age||years|Mean|58.25|58.25|Standard Deviation|12.86|12.86|||
4468462|NCT00007345|4287134|B2|||Age||years|Mean|57.85|57.85|Standard Deviation|13.08|13.08|||
4468463|NCT00007345|4287135|B1|||Age||years|Mean|58.97|58.97|Standard Deviation|12.56|12.56|||
4468464|NCT00007345|4287133|B3||>=65 years|Age||Participants|Count of Participants|43|43.0||||||
4468465|NCT00007345|4287134|B2||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4468466|NCT00007345|4287135|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4468467|NCT00007345|4287133|B3||Between 18 and 65 years|Age||Participants|Count of Participants|88|88.0||||||
4468468|NCT00007345|4287134|B2||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4468469|NCT00007345|4287135|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4468470|NCT00007345|4287133|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468471|NCT00007345|4287134|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468472|NCT00007345|4287135|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468473|NCT00006489|4287154|B5|Other||Types of trauma||Participants|Count of Participants|42|42.0||||||
4468474|NCT00006489|4287155|B4|Other||Types of trauma||Participants|Count of Participants|15|15.0||||||
4468475|NCT00006489|4287156|B3|Other||Types of trauma||Participants|Count of Participants|10|10.0||||||
4468476|NCT00006489|4287157|B2|Other||Types of trauma||Participants|Count of Participants|8|8.0||||||
4468477|NCT00006489|4287158|B1|Other||Types of trauma||Participants|Count of Participants|9|9.0||||||
4468478|NCT00006489|4287154|B5|Combat||Types of trauma||Participants|Count of Participants|19|19.0||||||
4468479|NCT00006489|4287155|B4|Combat||Types of trauma||Participants|Count of Participants|4|4.0||||||
4468480|NCT00006489|4287156|B3|Combat||Types of trauma||Participants|Count of Participants|7|7.0||||||
4468481|NCT00006489|4287157|B2|Combat||Types of trauma||Participants|Count of Participants|4|4.0||||||
4468482|NCT00006489|4287158|B1|Combat||Types of trauma||Participants|Count of Participants|4|4.0||||||
4468483|NCT00006489|4287154|B5|Physical Assault||Types of trauma||Participants|Count of Participants|62|62.0||||||
4468484|NCT00006489|4287155|B4|Physical Assault||Types of trauma||Participants|Count of Participants|16|16.0||||||
4468485|NCT00006489|4287156|B3|Physical Assault||Types of trauma||Participants|Count of Participants|12|12.0||||||
4468486|NCT00006489|4287157|B2|Physical Assault||Types of trauma||Participants|Count of Participants|16|16.0||||||
4468487|NCT00006489|4287158|B1|Physical Assault||Types of trauma||Participants|Count of Participants|18|18.0||||||
4468488|NCT00006489|4287154|B5|Sexual Assault||Types of trauma||Participants|Count of Participants|42|42.0||||||
4468489|NCT00006489|4287155|B4|Sexual Assault||Types of trauma||Participants|Count of Participants|8|8.0||||||
4468490|NCT00006489|4287156|B3|Sexual Assault||Types of trauma||Participants|Count of Participants|11|11.0||||||
4468491|NCT00006489|4287157|B2|Sexual Assault||Types of trauma||Participants|Count of Participants|12|12.0||||||
4468492|NCT00006489|4287158|B1|Sexual Assault||Types of trauma||Participants|Count of Participants|11|11.0||||||
4468493|NCT00006489|4287154|B5|United States||Region of Enrollment||Participants|Count of Participants|165|165.0||||||
4468494|NCT00006489|4287155|B4|United States||Region of Enrollment||Participants|Count of Participants|43|43.0||||||
4468495|NCT00006489|4287156|B3|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4468496|NCT00006489|4287157|B2|United States||Region of Enrollment||Participants|Count of Participants|40|40.0||||||
4468497|NCT00006489|4287158|B1|United States||Region of Enrollment||Participants|Count of Participants|42|42.0||||||
4468498|NCT00006489|4287154|B5|Other||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4468499|NCT00006489|4287155|B4|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468500|NCT00006489|4287156|B3|Other||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468501|NCT00006489|4287157|B2|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468502|NCT00006489|4287158|B1|Other||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468503|NCT00006489|4287154|B5|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468504|NCT00006489|4287155|B4|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468505|NCT00006489|4287156|B3|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468506|NCT00006489|4287157|B2|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468507|NCT00006489|4287158|B1|Native American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468508|NCT00006489|4287154|B5|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|7|7.0||||||
4468509|NCT00006489|4287155|B4|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468510|NCT00006489|4287156|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|3|3.0||||||
4468511|NCT00006489|4287157|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468512|NCT00006489|4287158|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4468513|NCT00006489|4287154|B5|White||Race/Ethnicity, Customized||Participants|Count of Participants|50|50.0||||||
4468514|NCT00006489|4287155|B4|White||Race/Ethnicity, Customized||Participants|Count of Participants|14|14.0||||||
4468515|NCT00006489|4287156|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4468516|NCT00006489|4287157|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|9|9.0||||||
4468517|NCT00006489|4287158|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|19|19.0||||||
4468518|NCT00006489|4287154|B5|Black||Race/Ethnicity, Customized||Participants|Count of Participants|105|105.0||||||
4468519|NCT00006489|4287155|B4|Black||Race/Ethnicity, Customized||Participants|Count of Participants|26|26.0||||||
4468520|NCT00006489|4287156|B3|Black||Race/Ethnicity, Customized||Participants|Count of Participants|28|28.0||||||
4468521|NCT00006489|4287157|B2|Black||Race/Ethnicity, Customized||Participants|Count of Participants|30|30.0||||||
4468522|NCT00006489|4287158|B1|Black||Race/Ethnicity, Customized||Participants|Count of Participants|21|21.0||||||
4468523|NCT00006489|4287154|B5||Male|Sex: Female, Male||Participants|Count of Participants|108|108.0||||||
4468524|NCT00006489|4287155|B4||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4468525|NCT00006489|4287156|B3||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4468526|NCT00006489|4287157|B2||Male|Sex: Female, Male||Participants|Count of Participants|27|27.0||||||
4468527|NCT00006489|4287158|B1||Male|Sex: Female, Male||Participants|Count of Participants|26|26.0||||||
4468528|NCT00006489|4287154|B5||Female|Sex: Female, Male||Participants|Count of Participants|57|57.0||||||
4468529|NCT00006489|4287155|B4||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4468530|NCT00006489|4287156|B3||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4468531|NCT00006489|4287157|B2||Female|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4468532|NCT00006489|4287158|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4468533|NCT00006489|4287154|B5|||Age||years|Mean|42.7|42.7|Full Range|||19.0|64.0|
4468534|NCT00006489|4287155|B4|||Age||years|Mean|41.2|41.2|Full Range|||24.0|58.0|
4468535|NCT00006489|4287156|B3|||Age||years|Mean|44.7|44.7|Full Range|||23.0|62.0|
4468536|NCT00006489|4287157|B2|||Age||years|Mean|40.1|40.1|Full Range|||19.0|64.0|
4468537|NCT00006489|4287158|B1|||Age||years|Mean|44.9|44.9|Full Range|||24.0|63.0|
4468538|NCT00006409|4287179|B7||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468539|NCT00006409|4287180|B6||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468540|NCT00006409|4287181|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468541|NCT00006409|4287182|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468542|NCT00006409|4287183|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468543|NCT00006409|4287184|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468544|NCT00006409|4287185|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468545|NCT00006409|4287179|B7||Female|Sex: Female, Male||Participants|Count of Participants|8727|8727.0||||||
4468546|NCT00006409|4287180|B6||Female|Sex: Female, Male||Participants|Count of Participants|1776|1776.0||||||
4468547|NCT00006409|4287181|B5||Female|Sex: Female, Male||Participants|Count of Participants|1726|1726.0||||||
4468548|NCT00006409|4287182|B4||Female|Sex: Female, Male||Participants|Count of Participants|1713|1713.0||||||
4468549|NCT00006409|4287183|B3||Female|Sex: Female, Male||Participants|Count of Participants|1791|1791.0||||||
4468550|NCT00006409|4287184|B2||Female|Sex: Female, Male||Participants|Count of Participants|856|856.0||||||
4468551|NCT00006409|4287185|B1||Female|Sex: Female, Male||Participants|Count of Participants|865|865.0||||||
4468552|NCT00006409|4287179|B7|||Age||years|Mean|11.96|11.96|Standard Deviation|0.52|0.52|||
4468553|NCT00006409|4287180|B6|||Age||years|Mean|13.99|13.99|Standard Deviation|0.49|0.49|||
4468554|NCT00006409|4287181|B5|||Age||years|Mean|13.97|13.97|Standard Deviation|0.49|0.49|||
4468555|NCT00006409|4287182|B4|||Age||years|Mean|13.99|13.99|Standard Deviation|0.52|0.52|||
4468556|NCT00006409|4287183|B3|||Age||years|Mean|14.00|14.0|Standard Deviation|0.53|0.53|||
4468557|NCT00006409|4287184|B2|||Age||years|Mean|11.98|11.98|Standard Deviation|0.55|0.55|||
4468558|NCT00006409|4287185|B1|||Age||years|Mean|11.94|11.94|Standard Deviation|0.49|0.49|||
4468559|NCT00006409|4287179|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468560|NCT00006409|4287180|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468561|NCT00006409|4287181|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468562|NCT00006409|4287182|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468563|NCT00006409|4287183|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468564|NCT00006409|4287184|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468565|NCT00006409|4287185|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468566|NCT00006409|4287179|B7||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468567|NCT00006409|4287180|B6||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468568|NCT00006409|4287181|B5||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468569|NCT00006409|4287182|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468570|NCT00006409|4287183|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468571|NCT00006409|4287184|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468572|NCT00006409|4287185|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468573|NCT00006409|4287179|B7||<=18 years|Age||Participants|Count of Participants|8727|8727.0||||||
4468574|NCT00006409|4287180|B6||<=18 years|Age||Participants|Count of Participants|1776|1776.0||||||
4468575|NCT00006409|4287181|B5||<=18 years|Age||Participants|Count of Participants|1726|1726.0||||||
4468576|NCT00006409|4287182|B4||<=18 years|Age||Participants|Count of Participants|1713|1713.0||||||
4468577|NCT00006409|4287183|B3||<=18 years|Age||Participants|Count of Participants|1791|1791.0||||||
4468578|NCT00006409|4287184|B2||<=18 years|Age||Participants|Count of Participants|856|856.0||||||
4468579|NCT00006409|4287185|B1||<=18 years|Age||Participants|Count of Participants|865|865.0||||||
4468580|NCT00006305|4287210|B5|Europe||Region of Enrollment||participants|Number|75|75.0||||||
4468581|NCT00006305|4287211|B4|Europe||Region of Enrollment||participants|Number|20|20.0||||||
4468582|NCT00006305|4287212|B3|Europe||Region of Enrollment||participants|Number|17|17.0||||||
4468583|NCT00006305|4287213|B2|Europe||Region of Enrollment||participants|Number|19|19.0||||||
4468584|NCT00006305|4287214|B1|Europe||Region of Enrollment||participants|Number|19|19.0||||||
4468585|NCT00006305|4287210|B5|Mexico||Region of Enrollment||participants|Number|85|85.0||||||
4468586|NCT00006305|4287211|B4|Mexico||Region of Enrollment||participants|Number|21|21.0||||||
4468587|NCT00006305|4287212|B3|Mexico||Region of Enrollment||participants|Number|22|22.0||||||
4468588|NCT00006305|4287213|B2|Mexico||Region of Enrollment||participants|Number|21|21.0||||||
4468589|NCT00006305|4287214|B1|Mexico||Region of Enrollment||participants|Number|21|21.0||||||
4468590|NCT00006305|4287210|B5|Brazil||Region of Enrollment||participants|Number|356|356.0||||||
4468591|NCT00006305|4287211|B4|Brazil||Region of Enrollment||participants|Number|89|89.0||||||
4468592|NCT00006305|4287212|B3|Brazil||Region of Enrollment||participants|Number|89|89.0||||||
4468593|NCT00006305|4287213|B2|Brazil||Region of Enrollment||participants|Number|89|89.0||||||
4468594|NCT00006305|4287214|B1|Brazil||Region of Enrollment||participants|Number|89|89.0||||||
4468595|NCT00006305|4287210|B5|Canada||Region of Enrollment||participants|Number|353|353.0||||||
4468596|NCT00006305|4287211|B4|Canada||Region of Enrollment||participants|Number|89|89.0||||||
4468597|NCT00006305|4287212|B3|Canada||Region of Enrollment||participants|Number|89|89.0||||||
4468598|NCT00006305|4287213|B2|Canada||Region of Enrollment||participants|Number|88|88.0||||||
4468599|NCT00006305|4287214|B1|Canada||Region of Enrollment||participants|Number|87|87.0||||||
4468600|NCT00006305|4287210|B5|United States||Region of Enrollment||participants|Number|1499|1499.0||||||
4468601|NCT00006305|4287211|B4|United States||Region of Enrollment||participants|Number|380|380.0||||||
4468602|NCT00006305|4287212|B3|United States||Region of Enrollment||participants|Number|376|376.0||||||
4468603|NCT00006305|4287213|B2|United States||Region of Enrollment||participants|Number|367|367.0||||||
4468604|NCT00006305|4287214|B1|United States||Region of Enrollment||participants|Number|376|376.0||||||
4468605|NCT00006305|4287210|B5||Male|Sex: Female, Male||Participants|Count of Participants|1666|1666.0||||||
4468606|NCT00006305|4287211|B4||Male|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
4468607|NCT00006305|4287212|B3||Male|Sex: Female, Male||Participants|Count of Participants|421|421.0||||||
4468608|NCT00006305|4287213|B2||Male|Sex: Female, Male||Participants|Count of Participants|412|412.0||||||
4468609|NCT00006305|4287214|B1||Male|Sex: Female, Male||Participants|Count of Participants|416|416.0||||||
4468610|NCT00006305|4287210|B5||Female|Sex: Female, Male||Participants|Count of Participants|702|702.0||||||
4468611|NCT00006305|4287211|B4||Female|Sex: Female, Male||Participants|Count of Participants|182|182.0||||||
4468612|NCT00006305|4287212|B3||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4468613|NCT00006305|4287213|B2||Female|Sex: Female, Male||Participants|Count of Participants|172|172.0||||||
4468614|NCT00006305|4287214|B1||Female|Sex: Female, Male||Participants|Count of Participants|176|176.0||||||
4468615|NCT00006305|4287210|B5|||Age||years|Mean|62.4|62.4|Standard Deviation|8.9|8.9|||
4468616|NCT00006305|4287211|B4|||Age||years|Mean|62.2|62.2|Standard Deviation|9.3|9.3|||
4468617|NCT00006305|4287212|B3|||Age||years|Mean|62.7|62.7|Standard Deviation|8.8|8.8|||
4468618|NCT00006305|4287213|B2|||Age||years|Mean|62.4|62.4|Standard Deviation|9.1|9.1|||
4468619|NCT00006305|4287214|B1|||Age||years|Mean|62.3|62.3|Standard Deviation|8.5|8.5|||
4468620|NCT00006305|4287210|B5||>=65 years|Age||Participants|Count of Participants|929|929.0||||||
4468621|NCT00006305|4287211|B4||>=65 years|Age||Participants|Count of Participants|226|226.0||||||
4468622|NCT00006305|4287212|B3||>=65 years|Age||Participants|Count of Participants|243|243.0||||||
4468623|NCT00006305|4287213|B2||>=65 years|Age||Participants|Count of Participants|230|230.0||||||
4468624|NCT00006305|4287214|B1||>=65 years|Age||Participants|Count of Participants|230|230.0||||||
4468625|NCT00006305|4287210|B5||Between 18 and 65 years|Age||Participants|Count of Participants|1439|1439.0||||||
4468626|NCT00006305|4287211|B4||Between 18 and 65 years|Age||Participants|Count of Participants|373|373.0||||||
4468627|NCT00006305|4287212|B3||Between 18 and 65 years|Age||Participants|Count of Participants|350|350.0||||||
4468628|NCT00006305|4287213|B2||Between 18 and 65 years|Age||Participants|Count of Participants|354|354.0||||||
4468629|NCT00006305|4287214|B1||Between 18 and 65 years|Age||Participants|Count of Participants|362|362.0||||||
4468630|NCT00006305|4287210|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468631|NCT00006305|4287211|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468632|NCT00006305|4287212|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468633|NCT00006305|4287213|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468634|NCT00006305|4287214|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468635|NCT00006289|4287231|B3|United States||Region of Enrollment||participants|Number|21|21.0||||||
4468636|NCT00006289|4287232|B2|United States||Region of Enrollment||participants|Number|10|10.0||||||
4468637|NCT00006289|4287233|B1|United States||Region of Enrollment||participants|Number|11|11.0||||||
4468638|NCT00006289|4287231|B3||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4468639|NCT00006289|4287232|B2||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4468640|NCT00006289|4287233|B1||Male|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4468641|NCT00006289|4287231|B3||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4468642|NCT00006289|4287232|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4468643|NCT00006289|4287233|B1||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4468644|NCT00006289|4287231|B3|||Age||years|Mean|41.7|41.7|Standard Deviation|13.7|13.7|||
4468645|NCT00006289|4287232|B2|||Age||years|Mean|46.5|46.5|Standard Deviation|13.2|13.2|||
4468646|NCT00006289|4287233|B1|||Age||years|Mean|37.3|37.3|Standard Deviation|13.2|13.2|||
4468647|NCT00006289|4287231|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4468648|NCT00006289|4287232|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4468649|NCT00006289|4287233|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468650|NCT00006289|4287231|B3||Between 18 and 65 years|Age||Participants|Count of Participants|18|18.0||||||
4468651|NCT00006289|4287232|B2||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4468652|NCT00006289|4287233|B1||Between 18 and 65 years|Age||Participants|Count of Participants|9|9.0||||||
4468653|NCT00006289|4287231|B3||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4468654|NCT00006289|4287232|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468655|NCT00006289|4287233|B1||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4468656|NCT00006184|4287250|B3|United States||Region of Enrollment||Participants|Count of Participants|20|20.0||||||
4468657|NCT00006184|4287251|B2|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4468658|NCT00006184|4287252|B1|United States||Region of Enrollment||Participants|Count of Participants|10|10.0||||||
4468659|NCT00006184|4287250|B3|Non Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468660|NCT00006184|4287251|B2|Non Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468661|NCT00006184|4287252|B1|Non Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468662|NCT00006184|4287250|B3|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4468663|NCT00006184|4287251|B2|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468664|NCT00006184|4287252|B1|Hispanic||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468665|NCT00006184|4287250|B3|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|16|16.0||||||
4468666|NCT00006184|4287251|B2|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4468667|NCT00006184|4287252|B1|Unknown or Not Reported||Race/Ethnicity, Customized||Participants|Count of Participants|8|8.0||||||
4468668|NCT00006184|4287250|B3|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468669|NCT00006184|4287251|B2|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468670|NCT00006184|4287252|B1|More than one race||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468671|NCT00006184|4287250|B3|White||Race/Ethnicity, Customized||Participants|Count of Participants|2|2.0||||||
4468672|NCT00006184|4287251|B2|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468673|NCT00006184|4287252|B1|White||Race/Ethnicity, Customized||Participants|Count of Participants|1|1.0||||||
4468674|NCT00006184|4287250|B3|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468675|NCT00006184|4287251|B2|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468676|NCT00006184|4287252|B1|Black or African American||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468677|NCT00006184|4287250|B3|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468678|NCT00006184|4287251|B2|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468679|NCT00006184|4287252|B1|Native Hawaiian or Other Pacific Islander||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468680|NCT00006184|4287250|B3|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468681|NCT00006184|4287251|B2|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468682|NCT00006184|4287252|B1|Asian||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468683|NCT00006184|4287250|B3|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468684|NCT00006184|4287251|B2|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468685|NCT00006184|4287252|B1|American Indian or Alaska Native||Race/Ethnicity, Customized||Participants|Count of Participants|0|0.0||||||
4468686|NCT00006184|4287250|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4468687|NCT00006184|4287251|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4468688|NCT00006184|4287252|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4468689|NCT00006184|4287250|B3||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4468690|NCT00006184|4287251|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4468691|NCT00006184|4287252|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4468692|NCT00006184|4287250|B3|||Age||years|Mean|52.|0.0|Standard Deviation|5.37|5.37|||
4468693|NCT00006184|4287251|B2|||Age||years|Mean|50.8|50.8|Standard Deviation|6.05|6.05|||
4468694|NCT00006184|4287252|B1|||Age||years|Mean|53.2|53.2|Standard Deviation|4.59|4.59|||
4468695|NCT00006184|4287250|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468696|NCT00006184|4287251|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468697|NCT00006184|4287252|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468698|NCT00006184|4287250|B3||Between 18 and 65 years|Age||Participants|Count of Participants|20|20.0||||||
4468699|NCT00006184|4287251|B2||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4468700|NCT00006184|4287252|B1||Between 18 and 65 years|Age||Participants|Count of Participants|10|10.0||||||
4468701|NCT00006184|4287250|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468702|NCT00006184|4287251|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468703|NCT00006184|4287252|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468704|NCT00006178|4287260|B1|United States||Region of Enrollment||participants|Number|12|12.0||||||
4468705|NCT00006178|4287260|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4468706|NCT00006178|4287260|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4468707|NCT00006178|4287260|B1|||Age||years|Mean|45.0|45.0|Standard Deviation|12.7|12.7|||
4468708|NCT00006178|4287260|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468709|NCT00006178|4287260|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4468710|NCT00006178|4287260|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468711|NCT00006170|4287267|B5|United States||Region of Enrollment||participants|Number|349|349.0||||||
4468712|NCT00006170|4287268|B4|United States||Region of Enrollment||participants|Number|67|67.0||||||
4468713|NCT00006170|4287269|B3|United States||Region of Enrollment||participants|Number|89|89.0||||||
4468714|NCT00006170|4287270|B2|United States||Region of Enrollment||participants|Number|87|87.0||||||
4468715|NCT00006170|4287271|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
4468716|NCT00006170|4287267|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468717|NCT00006170|4287268|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468718|NCT00006170|4287269|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468719|NCT00006170|4287270|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468720|NCT00006170|4287271|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468721|NCT00006170|4287267|B5||Female|Sex: Female, Male||Participants|Count of Participants|349|349.0||||||
4468722|NCT00006170|4287268|B4||Female|Sex: Female, Male||Participants|Count of Participants|67|67.0||||||
4468723|NCT00006170|4287269|B3||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4468724|NCT00006170|4287270|B2||Female|Sex: Female, Male||Participants|Count of Participants|87|87.0||||||
4468725|NCT00006170|4287271|B1||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4468726|NCT00006170|4287267|B5|||Age||years|Mean|42.0|42.0|Standard Deviation|10.1|10.1|||
4468727|NCT00006170|4287268|B4|||Age||years|Mean|42.3|42.3|Standard Deviation|10.4|10.4|||
4468728|NCT00006170|4287269|B3|||Age||years|Mean|41.0|41.0|Standard Deviation|11.2|11.2|||
4468729|NCT00006170|4287270|B2|||Age||years|Mean|42.6|42.6|Standard Deviation|10.0|10.0|||
4468730|NCT00006170|4287271|B1|||Age||years|Mean|42.1|42.1|Standard Deviation|9.2|9.2|||
4468731|NCT00006170|4287267|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468732|NCT00006170|4287268|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468733|NCT00006170|4287269|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468734|NCT00006170|4287270|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468735|NCT00006170|4287271|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468736|NCT00006170|4287267|B5||Between 18 and 65 years|Age||Participants|Count of Participants|349|349.0||||||
4468737|NCT00006170|4287268|B4||Between 18 and 65 years|Age||Participants|Count of Participants|67|67.0||||||
4468738|NCT00006170|4287269|B3||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4468739|NCT00006170|4287270|B2||Between 18 and 65 years|Age||Participants|Count of Participants|87|87.0||||||
4468740|NCT00006170|4287271|B1||Between 18 and 65 years|Age||Participants|Count of Participants|106|106.0||||||
4468741|NCT00006170|4287267|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468742|NCT00006170|4287268|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468743|NCT00006170|4287269|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468744|NCT00006170|4287270|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468745|NCT00006170|4287271|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468746|NCT00006156|4287292|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4468747|NCT00006156|4287293|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4468748|NCT00006156|4287294|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4468749|NCT00006156|4287292|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468750|NCT00006156|4287293|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468751|NCT00006156|4287294|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468752|NCT00006156|4287292|B3||White|Race (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4468753|NCT00006156|4287293|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4468754|NCT00006156|4287294|B1||White|Race (NIH/OMB)||Participants|Count of Participants|29|29.0||||||
4468755|NCT00006156|4287292|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4468756|NCT00006156|4287293|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4468757|NCT00006156|4287294|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4468758|NCT00006156|4287292|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468759|NCT00006156|4287293|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468760|NCT00006156|4287294|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468761|NCT00006156|4287292|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4468762|NCT00006156|4287293|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468763|NCT00006156|4287294|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4468764|NCT00006156|4287292|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468765|NCT00006156|4287293|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468766|NCT00006156|4287294|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468767|NCT00006156|4287292|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4468768|NCT00006156|4287293|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468769|NCT00006156|4287294|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4468770|NCT00006156|4287292|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4468771|NCT00006156|4287293|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4468772|NCT00006156|4287294|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4468773|NCT00006156|4287292|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4468774|NCT00006156|4287293|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4468775|NCT00006156|4287294|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4468776|NCT00006156|4287292|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468777|NCT00006156|4287293|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468778|NCT00006156|4287294|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468779|NCT00006156|4287292|B3||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4468780|NCT00006156|4287293|B2||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4468781|NCT00006156|4287294|B1||Female|Sex: Female, Male||Participants|Count of Participants|42|42.0||||||
4468782|NCT00006156|4287292|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4468783|NCT00006156|4287293|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468784|NCT00006156|4287294|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4468785|NCT00006156|4287292|B3||Between 18 and 65 years|Age||Participants|Count of Participants|48|48.0||||||
4468786|NCT00006156|4287293|B2||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4468787|NCT00006156|4287294|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4468788|NCT00006156|4287292|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468789|NCT00006156|4287293|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468790|NCT00006156|4287294|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468791|NCT00006164|4287302|B3|United States||Region of Enrollment||participants|Number|1050|1050.0||||||
4468792|NCT00006164|4287303|B2|United States||Region of Enrollment||participants|Number|533|533.0||||||
4468793|NCT00006164|4287304|B1|United States||Region of Enrollment||participants|Number|517|517.0||||||
4468794|NCT00006164|4287302|B3||Male|Sex: Female, Male||Participants|Count of Participants|745|745.0||||||
4468795|NCT00006164|4287303|B2||Male|Sex: Female, Male||Participants|Count of Participants|383|383.0||||||
4468796|NCT00006164|4287304|B1||Male|Sex: Female, Male||Participants|Count of Participants|362|362.0||||||
4468797|NCT00006164|4287302|B3||Female|Sex: Female, Male||Participants|Count of Participants|305|305.0||||||
4468798|NCT00006164|4287303|B2||Female|Sex: Female, Male||Participants|Count of Participants|150|150.0||||||
4468799|NCT00006164|4287304|B1||Female|Sex: Female, Male||Participants|Count of Participants|155|155.0||||||
4468800|NCT00006164|4287302|B3|||Age||years|Mean|50.6|50.6|Standard Deviation|7.2|7.2|||
4468801|NCT00006164|4287303|B2|||Age||years|Mean|50.1|50.1|Standard Deviation|7.0|7.0|||
4468802|NCT00006164|4287304|B1|||Age||years|Mean|51.1|51.1|Standard Deviation|7.3|7.3|||
4468803|NCT00006164|4287302|B3||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4468804|NCT00006164|4287303|B2||>=65 years|Age||Participants|Count of Participants|22|22.0||||||
4468805|NCT00006164|4287304|B1||>=65 years|Age||Participants|Count of Participants|28|28.0||||||
4468806|NCT00006164|4287302|B3||Between 18 and 65 years|Age||Participants|Count of Participants|1000|1000.0||||||
4468807|NCT00006164|4287303|B2||Between 18 and 65 years|Age||Participants|Count of Participants|511|511.0||||||
4468808|NCT00006164|4287304|B1||Between 18 and 65 years|Age||Participants|Count of Participants|489|489.0||||||
4468809|NCT00006164|4287302|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468810|NCT00006164|4287303|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468811|NCT00006164|4287304|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468812|NCT00006151|4287339|B3|United States||Region of Enrollment||participants|Number|60|60.0||||||
4468813|NCT00006151|4287340|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4468814|NCT00006151|4287341|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4468815|NCT00006151|4287339|B3||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4468816|NCT00006151|4287340|B2||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4468817|NCT00006151|4287341|B1||Male|Sex: Female, Male||Participants|Count of Participants|13|13.0||||||
4468818|NCT00006151|4287339|B3||Female|Sex: Female, Male||Participants|Count of Participants|37|37.0||||||
4468819|NCT00006151|4287340|B2||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4468820|NCT00006151|4287341|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4468821|NCT00006151|4287339|B3|||Age||years|Mean|45.29|45.29|Standard Deviation|11.7|11.7|||
4468822|NCT00006151|4287340|B2|||Age||years|Mean|43.50|43.5|Standard Deviation|12|12.0|||
4468823|NCT00006151|4287341|B1|||Age||years|Mean|47.07|47.07|Standard Deviation|11.4|11.4|||
4468824|NCT00006151|4287339|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468825|NCT00006151|4287340|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468826|NCT00006151|4287341|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468827|NCT00006151|4287339|B3||Between 18 and 65 years|Age||Participants|Count of Participants|60|60.0||||||
4468828|NCT00006151|4287340|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4468829|NCT00006151|4287341|B1||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4468830|NCT00006151|4287339|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468831|NCT00006151|4287340|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468832|NCT00006151|4287341|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468833|NCT00005937|4287348|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4468834|NCT00005937|4287348|B1||Male|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4468835|NCT00005937|4287348|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4468836|NCT00005937|4287348|B1|||Age||years|Mean|54|54.0|Standard Deviation|14|14.0|||
4468837|NCT00005937|4287348|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4468838|NCT00005937|4287348|B1||Between 18 and 65 years|Age||Participants|Count of Participants|33|33.0||||||
4468839|NCT00005937|4287348|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468840|NCT00005908|4287352|B1|United States||Region of Enrollment||participants|Number|30|30.0||||||
4468841|NCT00005908|4287352|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4468842|NCT00005908|4287352|B1|Asian||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4468843|NCT00005908|4287352|B1|African American||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4468844|NCT00005908|4287352|B1|White||Race/Ethnicity, Customized||Participants|Number|15|15.0||||||
4468845|NCT00005908|4287352|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468846|NCT00005908|4287352|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4468847|NCT00005908|4287352|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4468848|NCT00005908|4287352|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468849|NCT00005908|4287352|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4468850|NCT00005908|4287352|B1|||Age||years|Mean|50|50.0|Standard Deviation|9.80|9.8|||
4468851|NCT00005908|4287352|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4468852|NCT00005908|4287352|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4468853|NCT00005908|4287352|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468854|NCT00005906|4287362|B1|United States||Region of Enrollment||participants|Number|4|4.0||||||
4468855|NCT00005906|4287362|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4468856|NCT00005906|4287362|B1||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4468857|NCT00005906|4287362|B1|||Age||years|Mean|43|43.0|Standard Deviation|5.5|5.5|||
4468858|NCT00005906|4287362|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468859|NCT00005906|4287362|B1||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4468860|NCT00005906|4287362|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4468861|NCT00005901|4287368|B3|||Bone Mineral Density in Response to Pamidronate|Dual-energy X-ray Absorptiometry (DXA) measurements were obtained using a Hologic QDR 4500 densitometer and low density software package. Measurements have a precision of 0.011 SD. Raw measurements were converted to Z-scores for analysis using the manufacturer's reference standards for age and pubertal status.|Z-score|Mean|-5.32|-5.32|Standard Deviation|1.47|1.47|||
4468915|NCT00005669|4287387|B3||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4468916|NCT00005669|4287388|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4468917|NCT00005669|4287389|B1||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4468862|NCT00005901|4287369|B2|||Bone Mineral Density in Response to Pamidronate|Dual-energy X-ray Absorptiometry (DXA) measurements were obtained using a Hologic QDR 4500 densitometer and low density software package. Measurements have a precision of 0.011 SD. Raw measurements were converted to Z-scores for analysis using the manufacturer's reference standards for age and pubertal status.|Z-score|Mean|-5.68|-5.68|Standard Deviation|0.96|0.96|||
4468863|NCT00005901|4287370|B1|||Bone Mineral Density in Response to Pamidronate|Dual-energy X-ray Absorptiometry (DXA) measurements were obtained using a Hologic QDR 4500 densitometer and low density software package. Measurements have a precision of 0.011 SD. Raw measurements were converted to Z-scores for analysis using the manufacturer's reference standards for age and pubertal status.|Z-score|Mean|-5.01|-5.01|Standard Deviation|1.79|1.79|||
4468864|NCT00005901|4287368|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4468865|NCT00005901|4287369|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4468866|NCT00005901|4287370|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4468867|NCT00005901|4287368|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468868|NCT00005901|4287369|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468869|NCT00005901|4287370|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468870|NCT00005901|4287368|B3||White|Race (NIH/OMB)||Participants|Count of Participants|27|27.0||||||
4468871|NCT00005901|4287369|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4468872|NCT00005901|4287370|B1||White|Race (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4468873|NCT00005901|4287368|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4468874|NCT00005901|4287369|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4468875|NCT00005901|4287370|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4468876|NCT00005901|4287368|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468877|NCT00005901|4287369|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468878|NCT00005901|4287370|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468879|NCT00005901|4287368|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468880|NCT00005901|4287369|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468881|NCT00005901|4287370|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468882|NCT00005901|4287368|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468883|NCT00005901|4287369|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468884|NCT00005901|4287370|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468885|NCT00005901|4287368|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468886|NCT00005901|4287369|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468887|NCT00005901|4287370|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4468888|NCT00005901|4287368|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4468889|NCT00005901|4287369|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|14|14.0||||||
4468890|NCT00005901|4287370|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|16|16.0||||||
4468891|NCT00005901|4287368|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4468892|NCT00005901|4287369|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4468893|NCT00005901|4287370|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4468894|NCT00005901|4287368|B3||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4468895|NCT00005901|4287369|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4468896|NCT00005901|4287370|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4468897|NCT00005901|4287368|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4468898|NCT00005901|4287369|B2||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4468899|NCT00005901|4287370|B1||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4468900|NCT00005901|4287368|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468901|NCT00005901|4287369|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468902|NCT00005901|4287370|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468903|NCT00005901|4287368|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468904|NCT00005901|4287369|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468905|NCT00005901|4287370|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468906|NCT00005901|4287368|B3||<=18 years|Age||Participants|Count of Participants|34|34.0||||||
4468907|NCT00005901|4287369|B2||<=18 years|Age||Participants|Count of Participants|15|15.0||||||
4468908|NCT00005901|4287370|B1||<=18 years|Age||Participants|Count of Participants|19|19.0||||||
4468909|NCT00005669|4287387|B3|United States||Region of Enrollment||participants|Number|100|100.0||||||
4468910|NCT00005669|4287388|B2|United States||Region of Enrollment||participants|Number|47|47.0||||||
4468911|NCT00005669|4287389|B1|United States||Region of Enrollment||participants|Number|53|53.0||||||
4468912|NCT00005669|4287387|B3||Male|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4468913|NCT00005669|4287388|B2||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4468914|NCT00005669|4287389|B1||Male|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4468918|NCT00005669|4287387|B3|||Age||years|Mean|10.2|10.2|Standard Deviation|1.5|1.5|||
4468919|NCT00005669|4287388|B2|||Age||years|Mean|10.4|10.4|Standard Deviation|1.4|1.4|||
4468920|NCT00005669|4287389|B1|||Age||years|Mean|10.1|10.1|Standard Deviation|1.6|1.6|||
4468921|NCT00005669|4287387|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468922|NCT00005669|4287388|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468923|NCT00005669|4287389|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4468924|NCT00005669|4287387|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468925|NCT00005669|4287388|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468926|NCT00005669|4287389|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4468927|NCT00005669|4287387|B3||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4468928|NCT00005669|4287388|B2||<=18 years|Age||Participants|Count of Participants|47|47.0||||||
4468929|NCT00005669|4287389|B1||<=18 years|Age||Participants|Count of Participants|53|53.0||||||
4468930|NCT00004980|4287404|B3|||Total Auditory Hallucination Rate Scale (AHRS) score|Sum of 7 variables: frequency of hallucinations, reality of hallucinations, loudness of hallucinations, number of acoustically distinct voices, length of hallucinations, attentional salience of hallucinations, level of distress induced by hallucinations; higher score connotes more severe hallucinations; lowest score is 4, highest score is 37|Scores on a scale|Mean|25.6|25.6|Standard Deviation|5.3|5.3|||
4468931|NCT00004980|4287405|B2|||Total Auditory Hallucination Rate Scale (AHRS) score|Sum of 7 variables: frequency of hallucinations, reality of hallucinations, loudness of hallucinations, number of acoustically distinct voices, length of hallucinations, attentional salience of hallucinations, level of distress induced by hallucinations; higher score connotes more severe hallucinations; lowest score is 4, highest score is 37|Scores on a scale|Mean|26.1|26.1|Standard Deviation|5.7|5.7|||
4468932|NCT00004980|4287406|B1|||Total Auditory Hallucination Rate Scale (AHRS) score|Sum of 7 variables: frequency of hallucinations, reality of hallucinations, loudness of hallucinations, number of acoustically distinct voices, length of hallucinations, attentional salience of hallucinations, level of distress induced by hallucinations; higher score connotes more severe hallucinations; lowest score is 4, highest score is 37|Scores on a scale|Mean|25.1|25.1|Standard Deviation|5.0|5.0|||
4468933|NCT00004980|4287404|B3|Not Medication Resistant||Medication Resistance|Number of participants who were medication resistant|Participants|Number|11|11.0||||||
4468934|NCT00004980|4287405|B2|Not Medication Resistant||Medication Resistance|Number of participants who were medication resistant|Participants|Number|5|5.0||||||
4468935|NCT00004980|4287406|B1|Not Medication Resistant||Medication Resistance|Number of participants who were medication resistant|Participants|Number|6|6.0||||||
4468936|NCT00004980|4287404|B3|Medication Resistant||Medication Resistance|Number of participants who were medication resistant|Participants|Number|39|39.0||||||
4468937|NCT00004980|4287405|B2|Medication Resistant||Medication Resistance|Number of participants who were medication resistant|Participants|Number|18|18.0||||||
4468938|NCT00004980|4287406|B1|Medication Resistant||Medication Resistance|Number of participants who were medication resistant|Participants|Number|21|21.0||||||
4468939|NCT00004980|4287404|B3||Male|Sex: Female, Male||Participants|Count of Participants|33|33.0||||||
4468940|NCT00004980|4287405|B2||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4468941|NCT00004980|4287406|B1||Male|Sex: Female, Male||Participants|Count of Participants|18|18.0||||||
4468942|NCT00004980|4287404|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4468943|NCT00004980|4287405|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4468944|NCT00004980|4287406|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4468945|NCT00004980|4287404|B3|||Age||Years|Mean|35.3|35.3|Standard Deviation|10.8|10.8|||
4468946|NCT00004980|4287405|B2|||Age||Years|Mean|35.5|35.5|Standard Deviation|9.5|9.5|||
4468947|NCT00004980|4287406|B1|||Age||Years|Mean|35.1|35.1|Standard Deviation|11.9|11.9|||
4468948|NCT00004732|4287419|B3|Severe (>=70%)||Percent Stenosis at Randomization||Participants|Number|2151|2151.0||||||
4468949|NCT00004732|4287420|B2|Severe (>=70%)||Percent Stenosis at Randomization||Participants|Number|1054|1054.0||||||
4468950|NCT00004732|4287421|B1|Severe (>=70%)||Percent Stenosis at Randomization||Participants|Number|1097|1097.0||||||
4468951|NCT00004732|4287419|B3|Moderate (<70%)||Percent Stenosis at Randomization||Participants|Number|351|351.0||||||
4468952|NCT00004732|4287420|B2|Moderate (<70%)||Percent Stenosis at Randomization||Participants|Number|186|186.0||||||
4468953|NCT00004732|4287421|B1|Moderate (<70%)||Percent Stenosis at Randomization||Participants|Number|165|165.0||||||
4468954|NCT00004732|4287419|B3|||Diastolic Blood Pressure||mmHg|Mean|74.0|74.0|Standard Deviation|11.5|11.5|||
4468955|NCT00004732|4287420|B2|||Diastolic Blood Pressure||mmHg|Mean|73.9|73.9|Standard Deviation|11.5|11.5|||
4468956|NCT00004732|4287421|B1|||Diastolic Blood Pressure||mmHg|Mean|74.0|74.0|Standard Deviation|11.6|11.6|||
4468957|NCT00004732|4287419|B3|||Systolic Blood Pressure||mmHg|Mean|141.4|141.4|Standard Deviation|20.3|20.3|||
4468958|NCT00004732|4287420|B2|||Systolic Blood Pressure||mmHg|Mean|141.2|141.2|Standard Deviation|20.5|20.5|||
4468959|NCT00004732|4287421|B1|||Systolic Blood Pressure||mmHg|Mean|141.6|141.6|Standard Deviation|20.2|20.2|||
4468960|NCT00004732|4287419|B3|Right||Lesion Location||Participants|Number|1215|1215.0||||||
4468961|NCT00004732|4287420|B2|Right||Lesion Location||Participants|Number|592|592.0||||||
4468962|NCT00004732|4287421|B1|Right||Lesion Location||Participants|Number|623|623.0||||||
4468963|NCT00004732|4287419|B3|Left||Lesion Location||Participants|Number|1287|1287.0||||||
4468964|NCT00004732|4287420|B2|Left||Lesion Location||Participants|Number|648|648.0||||||
4468965|NCT00004732|4287421|B1|Left||Lesion Location||Participants|Number|639|639.0||||||
4468966|NCT00004732|4287419|B3|Unknown||Present Smoker||Participant|Number|42|42.0||||||
4468967|NCT00004732|4287420|B2|Unknown||Present Smoker||Participant|Number|24|24.0||||||
4468968|NCT00004732|4287421|B1|Unknown||Present Smoker||Participant|Number|18|18.0||||||
4468969|NCT00004732|4287419|B3|No||Present Smoker||Participant|Number|1814|1814.0||||||
4468970|NCT00004732|4287420|B2|No||Present Smoker||Participant|Number|899|899.0||||||
4468971|NCT00004732|4287421|B1|No||Present Smoker||Participant|Number|915|915.0||||||
4468972|NCT00004732|4287419|B3|Yes||Present Smoker||Participant|Number|646|646.0||||||
4468973|NCT00004732|4287420|B2|Yes||Present Smoker||Participant|Number|317|317.0||||||
4468974|NCT00004732|4287421|B1|Yes||Present Smoker||Participant|Number|329|329.0||||||
4468975|NCT00004732|4287419|B3|Unknown||Dyslipidemia||Participants|Number|21|21.0||||||
4468976|NCT00004732|4287420|B2|Unknown||Dyslipidemia||Participants|Number|13|13.0||||||
4468977|NCT00004732|4287421|B1|Unknown||Dyslipidemia||Participants|Number|8|8.0||||||
4468978|NCT00004732|4287419|B3|No||Dyslipidemia||Participants|Number|388|388.0||||||
4468979|NCT00004732|4287420|B2|No||Dyslipidemia||Participants|Number|174|174.0||||||
4468980|NCT00004732|4287421|B1|No||Dyslipidemia||Participants|Number|214|214.0||||||
4468981|NCT00004732|4287419|B3|Yes||Dyslipidemia||Participants|Number|2093|2093.0||||||
4468982|NCT00004732|4287420|B2|Yes||Dyslipidemia||Participants|Number|1053|1053.0||||||
4468983|NCT00004732|4287421|B1|Yes||Dyslipidemia||Participants|Number|1040|1040.0||||||
4468984|NCT00004732|4287419|B3|Unknown||Diabetes Status||Participants|Number|13|13.0||||||
4468985|NCT00004732|4287420|B2|Unknown||Diabetes Status||Participants|Number|8|8.0||||||
4468986|NCT00004732|4287421|B1|Unknown||Diabetes Status||Participants|Number|5|5.0||||||
4468987|NCT00004732|4287419|B3|No||Diabetes Status||Participants|Number|1730|1730.0||||||
4468988|NCT00004732|4287420|B2|No||Diabetes Status||Participants|Number|857|857.0||||||
4468989|NCT00004732|4287421|B1|No||Diabetes Status||Participants|Number|873|873.0||||||
4468990|NCT00004732|4287419|B3|Yes||Diabetes Status||Participants|Number|759|759.0||||||
4468991|NCT00004732|4287420|B2|Yes||Diabetes Status||Participants|Number|375|375.0||||||
4468992|NCT00004732|4287421|B1|Yes||Diabetes Status||Participants|Number|384|384.0||||||
4468993|NCT00004732|4287419|B3|Unknown||Baseline Hypertension||Participants|Number|10|10.0||||||
4468994|NCT00004732|4287420|B2|Unknown||Baseline Hypertension||Participants|Number|7|7.0||||||
4468995|NCT00004732|4287421|B1|Unknown||Baseline Hypertension||Participants|Number|3|3.0||||||
4468996|NCT00004732|4287419|B3|No||Baseline Hypertension||Participants|Number|351|351.0||||||
4468997|NCT00004732|4287420|B2|No||Baseline Hypertension||Participants|Number|172|172.0||||||
4468998|NCT00004732|4287421|B1|No||Baseline Hypertension||Participants|Number|179|179.0||||||
4468999|NCT00004732|4287419|B3|Yes||Baseline Hypertension||Participants|Number|2141|2141.0||||||
4469000|NCT00004732|4287420|B2|Yes||Baseline Hypertension||Participants|Number|1061|1061.0||||||
4469001|NCT00004732|4287421|B1|Yes||Baseline Hypertension||Participants|Number|1080|1080.0||||||
4469002|NCT00004732|4287419|B3|Symptomatic||Symptomatic Status||Participants|Number|1321|1321.0||||||
4469003|NCT00004732|4287420|B2|Symptomatic||Symptomatic Status||Participants|Number|653|653.0||||||
4469004|NCT00004732|4287421|B1|Symptomatic||Symptomatic Status||Participants|Number|668|668.0||||||
4469005|NCT00004732|4287419|B3|Asymptomatic||Symptomatic Status||Participants|Number|1181|1181.0||||||
4469006|NCT00004732|4287420|B2|Asymptomatic||Symptomatic Status||Participants|Number|587|587.0||||||
4469007|NCT00004732|4287421|B1|Asymptomatic||Symptomatic Status||Participants|Number|594|594.0||||||
4469008|NCT00004732|4287419|B3|Not Specified||Race/Ethnicity, Customized||Participants|Number|18|18.0||||||
4469009|NCT00004732|4287420|B2|Not Specified||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4469010|NCT00004732|4287421|B1|Not Specified||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4469011|NCT00004732|4287419|B3|Non-White||Race/Ethnicity, Customized||Participants|Number|152|152.0||||||
4469012|NCT00004732|4287420|B2|Non-White||Race/Ethnicity, Customized||Participants|Number|71|71.0||||||
4469013|NCT00004732|4287421|B1|Non-White||Race/Ethnicity, Customized||Participants|Number|81|81.0||||||
4469014|NCT00004732|4287419|B3|White||Race/Ethnicity, Customized||Participants|Number|2332|2332.0||||||
4469015|NCT00004732|4287420|B2|White||Race/Ethnicity, Customized||Participants|Number|1160|1160.0||||||
4469016|NCT00004732|4287421|B1|White||Race/Ethnicity, Customized||Participants|Number|1172|1172.0||||||
4469017|NCT00004732|4287419|B3||Male|Sex: Female, Male||Participants|Count of Participants|1630|1630.0||||||
4469018|NCT00004732|4287420|B2||Male|Sex: Female, Male||Participants|Count of Participants|823|823.0||||||
4469019|NCT00004732|4287421|B1||Male|Sex: Female, Male||Participants|Count of Participants|807|807.0||||||
4469020|NCT00004732|4287419|B3||Female|Sex: Female, Male||Participants|Count of Participants|872|872.0||||||
4469021|NCT00004732|4287420|B2||Female|Sex: Female, Male||Participants|Count of Participants|417|417.0||||||
4469022|NCT00004732|4287421|B1||Female|Sex: Female, Male||Participants|Count of Participants|455|455.0||||||
4469023|NCT00004732|4287419|B3|||Age||years|Mean|69.0|69.0|Standard Deviation|8.9|8.9|||
4469024|NCT00004732|4287420|B2|||Age||years|Mean|69.2|69.2|Standard Deviation|8.7|8.7|||
4469025|NCT00004732|4287421|B1|||Age||years|Mean|68.9|68.9|Standard Deviation|9.0|9.0|||
4469026|NCT00004635|4287430|B3|United States||Region of Enrollment||participants|Number|159|159.0||||||
4469027|NCT00004635|4287431|B2|United States||Region of Enrollment||participants|Number|80|80.0||||||
4469028|NCT00004635|4287432|B1|United States||Region of Enrollment||participants|Number|79|79.0||||||
4469029|NCT00004635|4287430|B3||Male|Sex: Female, Male||Participants|Count of Participants|159|159.0||||||
4469030|NCT00004635|4287431|B2||Male|Sex: Female, Male||Participants|Count of Participants|80|80.0||||||
4469031|NCT00004635|4287432|B1||Male|Sex: Female, Male||Participants|Count of Participants|79|79.0||||||
4469032|NCT00004635|4287430|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4469033|NCT00004635|4287431|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4469034|NCT00004635|4287432|B1||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4469035|NCT00004635|4287430|B3|||Age||years|Mean|66.91|66.91|Standard Deviation|7.98|7.98|||
4469036|NCT00004635|4287431|B2|||Age||years|Mean|68.46|68.46|Standard Deviation|8.54|8.54|||
4469037|NCT00004635|4287432|B1|||Age||years|Mean|65.35|65.35|Standard Deviation|7.43|7.43|||
4469038|NCT00004635|4287430|B3||>=65 years|Age||Participants|Count of Participants|90|90.0||||||
4469039|NCT00004635|4287431|B2||>=65 years|Age||Participants|Count of Participants|52|52.0||||||
4469040|NCT00004635|4287432|B1||>=65 years|Age||Participants|Count of Participants|38|38.0||||||
4469041|NCT00004635|4287430|B3||Between 18 and 65 years|Age||Participants|Count of Participants|69|69.0||||||
4469042|NCT00004635|4287431|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4469043|NCT00004635|4287432|B1||Between 18 and 65 years|Age||Participants|Count of Participants|41|41.0||||||
4469044|NCT00004635|4287430|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469045|NCT00004635|4287431|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469046|NCT00004635|4287432|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469047|NCT00004563|4287443|B3||Male|Sex: Female, Male||Participants|Count of Participants|47|47.0||||||
4469048|NCT00004563|4287444|B2||Male|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4469049|NCT00004563|4287445|B1||Male|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4469050|NCT00004563|4287443|B3||Female|Sex: Female, Male||Participants|Count of Participants|111|111.0||||||
4469051|NCT00004563|4287444|B2||Female|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4469052|NCT00004563|4287445|B1||Female|Sex: Female, Male||Participants|Count of Participants|60|60.0||||||
4469053|NCT00004563|4287443|B3|||Age||Years|Mean|47.9|47.9|Standard Deviation|1|1.0|||
4469054|NCT00004563|4287444|B2|||Age||Years|Mean|47.5|47.5|Standard Deviation|1.4|1.4|||
4469055|NCT00004563|4287445|B1|||Age||Years|Mean|48.2|48.2|Standard Deviation|1.4|1.4|||
4469056|NCT00004562|4287456|B3|||Interval between MI and randomization||days|Median|8|8.0|Inter-Quartile Range|||5.0|17.0|
4469057|NCT00004562|4287457|B2|||Interval between MI and randomization||days|Median|8|8.0|Inter-Quartile Range|||5.0|17.0|
4469058|NCT00004562|4287458|B1|||Interval between MI and randomization||days|Median|8|8.0|Inter-Quartile Range|||5.0|16.0|
4469059|NCT00004562|4287456|B3|Right coronary artery||Infarct-related artery|Angiographic characteristic|participants|Number|1073|1073.0||||||
4469060|NCT00004562|4287457|B2|Right coronary artery||Infarct-related artery|Angiographic characteristic|participants|Number|532|532.0||||||
4469061|NCT00004562|4287458|B1|Right coronary artery||Infarct-related artery|Angiographic characteristic|participants|Number|541|541.0||||||
4469062|NCT00004562|4287456|B3|Left circumflex coronary artery||Infarct-related artery|Angiographic characteristic|participants|Number|335|335.0||||||
4469063|NCT00004562|4287457|B2|Left circumflex coronary artery||Infarct-related artery|Angiographic characteristic|participants|Number|158|158.0||||||
4469064|NCT00004562|4287458|B1|Left circumflex coronary artery||Infarct-related artery|Angiographic characteristic|participants|Number|177|177.0||||||
4469065|NCT00004562|4287456|B3|Left anterior descending coronary artery||Infarct-related artery|Angiographic characteristic|participants|Number|793|793.0||||||
4469066|NCT00004562|4287457|B2|Left anterior descending coronary artery||Infarct-related artery|Angiographic characteristic|participants|Number|410|410.0||||||
4469067|NCT00004562|4287458|B1|Left anterior descending coronary artery||Infarct-related artery|Angiographic characteristic|participants|Number|383|383.0||||||
4469068|NCT00004562|4287456|B3|Hypertension||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|1071|1071.0||||||
4469069|NCT00004562|4287457|B2|Hypertension||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|543|543.0||||||
4469070|NCT00004562|4287458|B1|Hypertension||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|528|528.0||||||
4469071|NCT00004562|4287456|B3|Diabetes - Insulin Use||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|124|124.0||||||
4469072|NCT00004562|4287457|B2|Diabetes - Insulin Use||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|61|61.0||||||
4469073|NCT00004562|4287458|B1|Diabetes - Insulin Use||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|63|63.0||||||
4469074|NCT00004562|4287456|B3|Diabetes||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|454|454.0||||||
4469075|NCT00004562|4287457|B2|Diabetes||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|251|251.0||||||
4469076|NCT00004562|4287458|B1|Diabetes||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|203|203.0||||||
4469077|NCT00004562|4287456|B3|CABG||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|9|9.0||||||
4469078|NCT00004562|4287457|B2|CABG||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|4|4.0||||||
4469079|NCT00004562|4287458|B1|CABG||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|5|5.0||||||
4469123|NCT00004562|4287457|B2||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4469080|NCT00004562|4287456|B3|PCI||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|105|105.0||||||
4469081|NCT00004562|4287457|B2|PCI||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|54|54.0||||||
4469082|NCT00004562|4287458|B1|PCI||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|51|51.0||||||
4469083|NCT00004562|4287456|B3|Heart Failure||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|52|52.0||||||
4469084|NCT00004562|4287457|B2|Heart Failure||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|25|25.0||||||
4469085|NCT00004562|4287458|B1|Heart Failure||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|27|27.0||||||
4469086|NCT00004562|4287456|B3|Peripheral-vessel disease||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|83|83.0||||||
4469087|NCT00004562|4287457|B2|Peripheral-vessel disease||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|39|39.0||||||
4469088|NCT00004562|4287458|B1|Peripheral-vessel disease||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|44|44.0||||||
4469089|NCT00004562|4287456|B3|Cerebrovascular disease||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|82|82.0||||||
4469090|NCT00004562|4287457|B2|Cerebrovascular disease||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|34|34.0||||||
4469091|NCT00004562|4287458|B1|Cerebrovascular disease||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|48|48.0||||||
4469092|NCT00004562|4287456|B3|Myocardial infarction||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|247|247.0||||||
4469093|NCT00004562|4287457|B2|Myocardial infarction||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|118|118.0||||||
4469094|NCT00004562|4287458|B1|Myocardial infarction||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|129|129.0||||||
4469095|NCT00004562|4287456|B3|Angina||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|495|495.0||||||
4469096|NCT00004562|4287457|B2|Angina||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|255|255.0||||||
4469097|NCT00004562|4287458|B1|Angina||Prior History of Characteristics and Risk Factors|Some study participants had more than one characteristic/risk factor and may be counted more than once.|participants|Number|240|240.0||||||
4469098|NCT00004562|4287456|B3|Unknown||Current cigarette smoker||participants|Number|18|18.0||||||
4469099|NCT00004562|4287457|B2|Unknown||Current cigarette smoker||participants|Number|9|9.0||||||
4469100|NCT00004562|4287458|B1|Unknown||Current cigarette smoker||participants|Number|9|9.0||||||
4469101|NCT00004562|4287456|B3|Non-Smoker||Current cigarette smoker||participants|Number|1324|1324.0||||||
4469102|NCT00004562|4287457|B2|Non-Smoker||Current cigarette smoker||participants|Number|660|660.0||||||
4469103|NCT00004562|4287458|B1|Non-Smoker||Current cigarette smoker||participants|Number|664|664.0||||||
4469104|NCT00004562|4287456|B3|Current Cigaratte Smoker||Current cigarette smoker||participants|Number|859|859.0||||||
4469105|NCT00004562|4287457|B2|Current Cigaratte Smoker||Current cigarette smoker||participants|Number|431|431.0||||||
4469106|NCT00004562|4287458|B1|Current Cigaratte Smoker||Current cigarette smoker||participants|Number|428|428.0||||||
4469107|NCT00004562|4287456|B3|Other||Race/Ethnicity, Customized||participants|Number|92|92.0||||||
4469108|NCT00004562|4287457|B2|Other||Race/Ethnicity, Customized||participants|Number|53|53.0||||||
4469109|NCT00004562|4287458|B1|Other||Race/Ethnicity, Customized||participants|Number|39|39.0||||||
4469110|NCT00004562|4287456|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|277|277.0||||||
4469111|NCT00004562|4287457|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|136|136.0||||||
4469112|NCT00004562|4287458|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|141|141.0||||||
4469113|NCT00004562|4287456|B3|Black or African American||Race/Ethnicity, Customized||participants|Number|69|69.0||||||
4469114|NCT00004562|4287457|B2|Black or African American||Race/Ethnicity, Customized||participants|Number|36|36.0||||||
4469115|NCT00004562|4287458|B1|Black or African American||Race/Ethnicity, Customized||participants|Number|33|33.0||||||
4469116|NCT00004562|4287456|B3|White||Race/Ethnicity, Customized||participants|Number|1763|1763.0||||||
4469117|NCT00004562|4287457|B2|White||Race/Ethnicity, Customized||participants|Number|875|875.0||||||
4469118|NCT00004562|4287458|B1|White||Race/Ethnicity, Customized||participants|Number|888|888.0||||||
4469119|NCT00004562|4287456|B3||Male|Sex: Female, Male||Participants|Count of Participants|1717|1717.0||||||
4469120|NCT00004562|4287457|B2||Male|Sex: Female, Male||Participants|Count of Participants|858|858.0||||||
4469121|NCT00004562|4287458|B1||Male|Sex: Female, Male||Participants|Count of Participants|859|859.0||||||
4469122|NCT00004562|4287456|B3||Female|Sex: Female, Male||Participants|Count of Participants|484|484.0||||||
4469124|NCT00004562|4287458|B1||Female|Sex: Female, Male||Participants|Count of Participants|242|242.0||||||
4469125|NCT00004562|4287456|B3|||Age||Years|Mean|58.7|58.7|Standard Deviation|10.9|10.9|||
4469126|NCT00004562|4287457|B2|||Age||Years|Mean|58.7|58.7|Standard Deviation|11.1|11.1|||
4469127|NCT00004562|4287458|B1|||Age||Years|Mean|58.6|58.6|Standard Deviation|10.9|10.9|||
4469128|NCT00004547|4287467|B4|United States||Region of Enrollment||participants|Number|188|188.0||||||
4469129|NCT00004547|4287468|B3|United States||Region of Enrollment||participants|Number|57|57.0||||||
4469130|NCT00004547|4287469|B2|United States||Region of Enrollment||participants|Number|48|48.0||||||
4469131|NCT00004547|4287470|B1|United States||Region of Enrollment||participants|Number|83|83.0||||||
4469132|NCT00004547|4287467|B4|Unknown||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4469133|NCT00004547|4287468|B3|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4469134|NCT00004547|4287469|B2|Unknown||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4469135|NCT00004547|4287470|B1|Unknown||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4469136|NCT00004547|4287467|B4|Asian American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4469137|NCT00004547|4287468|B3|Asian American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4469138|NCT00004547|4287469|B2|Asian American||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4469139|NCT00004547|4287470|B1|Asian American||Race/Ethnicity, Customized||Participants|Number|4|4.0||||||
4469140|NCT00004547|4287467|B4|African American||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4469141|NCT00004547|4287468|B3|African American||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4469142|NCT00004547|4287469|B2|African American||Race/Ethnicity, Customized||Participants|Number|7|7.0||||||
4469143|NCT00004547|4287470|B1|African American||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4469144|NCT00004547|4287467|B4|Hispanic||Race/Ethnicity, Customized||Participants|Number|9|9.0||||||
4469145|NCT00004547|4287468|B3|Hispanic||Race/Ethnicity, Customized||Participants|Number|3|3.0||||||
4469146|NCT00004547|4287469|B2|Hispanic||Race/Ethnicity, Customized||Participants|Number|0|0.0||||||
4469147|NCT00004547|4287470|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4469148|NCT00004547|4287467|B4|White||Race/Ethnicity, Customized||Participants|Number|161|161.0||||||
4469149|NCT00004547|4287468|B3|White||Race/Ethnicity, Customized||Participants|Number|54|54.0||||||
4469150|NCT00004547|4287469|B2|White||Race/Ethnicity, Customized||Participants|Number|38|38.0||||||
4469151|NCT00004547|4287470|B1|White||Race/Ethnicity, Customized||Participants|Number|69|69.0||||||
4469152|NCT00004547|4287467|B4||Male|Sex: Female, Male||Participants|Count of Participants|99|99.0||||||
4469153|NCT00004547|4287468|B3||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4469154|NCT00004547|4287469|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4469155|NCT00004547|4287470|B1||Male|Sex: Female, Male||Participants|Count of Participants|45|45.0||||||
4469156|NCT00004547|4287467|B4||Female|Sex: Female, Male||Participants|Count of Participants|89|89.0||||||
4469157|NCT00004547|4287468|B3||Female|Sex: Female, Male||Participants|Count of Participants|28|28.0||||||
4469158|NCT00004547|4287469|B2||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4469159|NCT00004547|4287470|B1||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4469160|NCT00004547|4287467|B4|||Age||years|Mean|50.01|50.01|Standard Deviation|12.61|12.61|||
4469161|NCT00004547|4287468|B3|||Age||years|Mean|49.70|49.7|Standard Deviation|11.78|11.78|||
4469162|NCT00004547|4287469|B2|||Age||years|Mean|50.48|50.48|Standard Deviation|10.85|10.85|||
4469163|NCT00004547|4287470|B1|||Age||years|Mean|49.95|49.95|Standard Deviation|14.12|14.12|||
4469164|NCT00004547|4287467|B4||>=65 years|Age||Participants|Count of Participants|19|19.0||||||
4469165|NCT00004547|4287468|B3||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4469166|NCT00004547|4287469|B2||>=65 years|Age||Participants|Count of Participants|5|5.0||||||
4469167|NCT00004547|4287470|B1||>=65 years|Age||Participants|Count of Participants|9|9.0||||||
4469168|NCT00004547|4287467|B4||Between 18 and 65 years|Age||Participants|Count of Participants|166|166.0||||||
4469169|NCT00004547|4287468|B3||Between 18 and 65 years|Age||Participants|Count of Participants|52|52.0||||||
4469170|NCT00004547|4287469|B2||Between 18 and 65 years|Age||Participants|Count of Participants|43|43.0||||||
4469171|NCT00004547|4287470|B1||Between 18 and 65 years|Age||Participants|Count of Participants|71|71.0||||||
4469172|NCT00004547|4287467|B4||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4469173|NCT00004547|4287468|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469174|NCT00004547|4287469|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469175|NCT00004547|4287470|B1||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4469176|NCT00001984|4287490|B1|Obstructive uropathy||Cause of end-stage renal disease||participants|Number|1|1.0||||||
4469177|NCT00001984|4287490|B1|Medullary cystic disease||Cause of end-stage renal disease||participants|Number|1|1.0||||||
4469178|NCT00001984|4287490|B1|Polycystic kidney disease||Cause of end-stage renal disease||participants|Number|1|1.0||||||
4469179|NCT00001984|4287490|B1|IgA nephropathy||Cause of end-stage renal disease||participants|Number|1|1.0||||||
4469180|NCT00001984|4287490|B1|Membranous glomerulonephritis||Cause of end-stage renal disease||participants|Number|1|1.0||||||
4469181|NCT00001984|4287490|B1|Living unrelated||Relationship between Donor and Recepient||participants|Number|2|2.0||||||
4469182|NCT00001984|4287490|B1|Living related||Relationship between Donor and Recepient||participants|Number|3|3.0||||||
4469183|NCT00001984|4287490|B1|United States||Region of Enrollment||participants|Number|5|5.0||||||
4469184|NCT00001984|4287490|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469185|NCT00001984|4287490|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469186|NCT00001984|4287490|B1||White|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4469187|NCT00001984|4287490|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469188|NCT00001984|4287490|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469189|NCT00001984|4287490|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469190|NCT00001984|4287490|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469191|NCT00001984|4287490|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4469192|NCT00001984|4287490|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4469193|NCT00001984|4287490|B1|||Age||years|Median|40|40.0|Full Range|||28.0|54.0|
4469194|NCT00001984|4287490|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469195|NCT00001984|4287490|B1||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4469196|NCT00001984|4287490|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469197|NCT00001962|4287500|B1||Male|Sex: Female, Male||Participants|Count of Participants|51|51.0||||||
4469198|NCT00001962|4287500|B1||Female|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4469199|NCT00001962|4287500|B1||>=65 years|Age||Participants|Count of Participants|16|16.0||||||
4469200|NCT00001962|4287500|B1||Between 18 and 65 years|Age||Participants|Count of Participants|57|57.0||||||
4469201|NCT00001962|4287500|B1||<=18 years|Age||Participants|Count of Participants|27|27.0||||||
4469202|NCT00001959|4287504|B1|||Duration of angiotensin antagonist therapy before treatment|2 patients did not receive angiotensin antagonist therapy during the baseline periods because of angioedema and hypotension.|month|Median|15|15.0|Inter-Quartile Range|||8.4|33.0|
4469203|NCT00001959|4287504|B1|||Decrease in GFR during baseline period||ml/min/1.73 m^2|Median|-0.61|-0.61|Inter-Quartile Range|||-1.31|-0.41|
4469204|NCT00001959|4287504|B1|||Baseline period proteinuria||g/d|Median|3.2|3.2|Inter-Quartile Range|||1.6|4.4|
4469205|NCT00001959|4287504|B1|||Baseline GFR||ml/min/1.73 m^2|Mean|26.0|26.0|Standard Deviation|9.4|9.4|||
4469206|NCT00001959|4287504|B1|United States||Region of Enrollment||participants|Number|18|18.0||||||
4469207|NCT00001959|4287504|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469208|NCT00001959|4287504|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469209|NCT00001959|4287504|B1||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4469210|NCT00001959|4287504|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4469211|NCT00001959|4287504|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469212|NCT00001959|4287504|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4469213|NCT00001959|4287504|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469214|NCT00001959|4287504|B1||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4469215|NCT00001959|4287504|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4469216|NCT00001959|4287504|B1|||Age||years|Mean|47|47.0|Standard Deviation|10|10.0|||
4469217|NCT00001941|4287510|B1|United States||Region of Enrollment||participants|Number|34|34.0||||||
4469218|NCT00001941|4287510|B1|Asian||Race/Ethnicity, Customized||Participants|Number|1|1.0||||||
4469219|NCT00001941|4287510|B1|White||Race/Ethnicity, Customized||Participants|Number|6|6.0||||||
4469220|NCT00001941|4287510|B1|Hispanic||Race/Ethnicity, Customized||Participants|Number|2|2.0||||||
4469221|NCT00001941|4287510|B1|Black||Race/Ethnicity, Customized||Participants|Number|25|25.0||||||
4469222|NCT00001941|4287510|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469223|NCT00001941|4287510|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|32|32.0||||||
4469224|NCT00001941|4287510|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4469225|NCT00001941|4287510|B1||Male|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4469226|NCT00001941|4287510|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4469227|NCT00001941|4287510|B1|||Age||years|Mean|47.37|47.37|Standard Deviation|14.6|14.6|||
4469228|NCT00001941|4287510|B1||>=65 years|Age||Participants|Count of Participants|4|4.0||||||
4469229|NCT00001941|4287510|B1||Between 18 and 65 years|Age||Participants|Count of Participants|29|29.0||||||
4469230|NCT00001941|4287510|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4469231|NCT00000392|4287521|B3|United States||Region of Enrollment||participants|Number|215|215.0||||||
4469232|NCT00000392|4287522|B2|United States||Region of Enrollment||participants|Number|109|109.0||||||
4469233|NCT00000392|4287523|B1|United States||Region of Enrollment||participants|Number|106|106.0||||||
4469234|NCT00000392|4287521|B3|Black||Race/Ethnicity, Customized|Information is not available for all participants.|Participants|Number|10|10.0||||||
4469235|NCT00000392|4287522|B2|Black||Race/Ethnicity, Customized|Information is not available for all participants.|Participants|Number|5|5.0||||||
4469236|NCT00000392|4287523|B1|Black||Race/Ethnicity, Customized|Information is not available for all participants.|Participants|Number|5|5.0||||||
4469237|NCT00000392|4287521|B3|Hispanic||Race/Ethnicity, Customized|Information is not available for all participants.|Participants|Number|25|25.0||||||
4469238|NCT00000392|4287522|B2|Hispanic||Race/Ethnicity, Customized|Information is not available for all participants.|Participants|Number|9|9.0||||||
4469239|NCT00000392|4287523|B1|Hispanic||Race/Ethnicity, Customized|Information is not available for all participants.|Participants|Number|16|16.0||||||
4469240|NCT00000392|4287521|B3|White||Race/Ethnicity, Customized|Information is not available for all participants.|Participants|Number|177|177.0||||||
4469241|NCT00000392|4287522|B2|White||Race/Ethnicity, Customized|Information is not available for all participants.|Participants|Number|94|94.0||||||
4469242|NCT00000392|4287523|B1|White||Race/Ethnicity, Customized|Information is not available for all participants.|Participants|Number|83|83.0||||||
4469243|NCT00000392|4287521|B3||Male|Sex: Female, Male||Participants|Count of Participants|205|205.0||||||
4469244|NCT00000392|4287522|B2||Male|Sex: Female, Male||Participants|Count of Participants|104|104.0||||||
4469245|NCT00000392|4287523|B1||Male|Sex: Female, Male||Participants|Count of Participants|101|101.0||||||
4469246|NCT00000392|4287521|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4469247|NCT00000392|4287522|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4469248|NCT00000392|4287523|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4469249|NCT00000392|4287521|B3|18-39 years||Age, Customized|Information is not available for all participants.|Participants|Number|122|122.0||||||
4469250|NCT00000392|4287522|B2|18-39 years||Age, Customized|Information is not available for all participants.|Participants|Number|62|62.0||||||
4469251|NCT00000392|4287523|B1|18-39 years||Age, Customized|Information is not available for all participants.|Participants|Number|60|60.0||||||
4469252|NCT00001832|4287532|B15|United States||Region of Enrollment||participants|Number|110|110.0||||||
4469253|NCT00001832|4287533|B14|United States||Region of Enrollment||participants|Number|2|2.0||||||
4469254|NCT00001832|4287534|B13|United States||Region of Enrollment||participants|Number|3|3.0||||||
4469255|NCT00001832|4287535|B12|United States||Region of Enrollment||participants|Number|6|6.0||||||
4469256|NCT00001832|4287536|B11|United States||Region of Enrollment||participants|Number|7|7.0||||||
4469257|NCT00001832|4287537|B10|United States||Region of Enrollment||participants|Number|1|1.0||||||
4469258|NCT00001832|4287538|B9|United States||Region of Enrollment||participants|Number|6|6.0||||||
4469259|NCT00001832|4287539|B8|United States||Region of Enrollment||participants|Number|8|8.0||||||
4469260|NCT00001832|4287540|B7|United States||Region of Enrollment||participants|Number|7|7.0||||||
4469261|NCT00001832|4287541|B6|United States||Region of Enrollment||participants|Number|4|4.0||||||
4469262|NCT00001832|4287542|B5|United States||Region of Enrollment||participants|Number|51|51.0||||||
4469263|NCT00001832|4287543|B4|United States||Region of Enrollment||participants|Number|6|6.0||||||
4469264|NCT00001832|4287544|B3|United States||Region of Enrollment||participants|Number|3|3.0||||||
4469265|NCT00001832|4287545|B2|United States||Region of Enrollment||participants|Number|3|3.0||||||
4469266|NCT00001832|4287546|B1|United States||Region of Enrollment||participants|Number|3|3.0||||||
4469267|NCT00001832|4287532|B15||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469268|NCT00001832|4287533|B14||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469269|NCT00001832|4287534|B13||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469270|NCT00001832|4287535|B12||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469271|NCT00001832|4287536|B11||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469272|NCT00001832|4287537|B10||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469273|NCT00001832|4287538|B9||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469274|NCT00001832|4287539|B8||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469275|NCT00001832|4287540|B7||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469276|NCT00001832|4287541|B6||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469277|NCT00001832|4287542|B5||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469278|NCT00001832|4287543|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469279|NCT00001832|4287544|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469280|NCT00001832|4287545|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469281|NCT00001832|4287546|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469282|NCT00001832|4287532|B15||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469283|NCT00001832|4287533|B14||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469284|NCT00001832|4287534|B13||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469285|NCT00001832|4287535|B12||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469286|NCT00001832|4287536|B11||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469287|NCT00001832|4287537|B10||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469288|NCT00001832|4287538|B9||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469289|NCT00001832|4287539|B8||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469290|NCT00001832|4287540|B7||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469291|NCT00001832|4287541|B6||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469292|NCT00001832|4287542|B5||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469293|NCT00001832|4287543|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469294|NCT00001832|4287544|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469295|NCT00001832|4287545|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469296|NCT00001832|4287546|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469297|NCT00001832|4287532|B15||White|Race (NIH/OMB)||Participants|Count of Participants|109|109.0||||||
4469298|NCT00001832|4287533|B14||White|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4469299|NCT00001832|4287534|B13||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469300|NCT00001832|4287535|B12||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4469301|NCT00001832|4287536|B11||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4469302|NCT00001832|4287537|B10||White|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469303|NCT00001832|4287538|B9||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4469304|NCT00001832|4287539|B8||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4469305|NCT00001832|4287540|B7||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4469306|NCT00001832|4287541|B6||White|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4469307|NCT00001832|4287542|B5||White|Race (NIH/OMB)||Participants|Count of Participants|50|50.0||||||
4469308|NCT00001832|4287543|B4||White|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4469309|NCT00001832|4287544|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469310|NCT00001832|4287545|B2||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469311|NCT00001832|4287546|B1||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469312|NCT00001832|4287532|B15||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469313|NCT00001832|4287533|B14||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469314|NCT00001832|4287534|B13||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469315|NCT00001832|4287535|B12||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469316|NCT00001832|4287536|B11||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469317|NCT00001832|4287537|B10||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469318|NCT00001832|4287538|B9||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469319|NCT00001832|4287539|B8||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469320|NCT00001832|4287540|B7||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469321|NCT00001832|4287541|B6||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469322|NCT00001832|4287542|B5||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469323|NCT00001832|4287543|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469324|NCT00001832|4287544|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469325|NCT00001832|4287545|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469326|NCT00001832|4287546|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469327|NCT00001832|4287532|B15||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469328|NCT00001832|4287533|B14||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469329|NCT00001832|4287534|B13||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469330|NCT00001832|4287535|B12||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469331|NCT00001832|4287536|B11||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469332|NCT00001832|4287537|B10||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469333|NCT00001832|4287538|B9||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469334|NCT00001832|4287539|B8||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469335|NCT00001832|4287540|B7||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469336|NCT00001832|4287541|B6||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469337|NCT00001832|4287542|B5||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469338|NCT00001832|4287543|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469339|NCT00001832|4287544|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469340|NCT00001832|4287545|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469341|NCT00001832|4287546|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469342|NCT00001832|4287532|B15||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469343|NCT00001832|4287533|B14||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469344|NCT00001832|4287534|B13||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469345|NCT00001832|4287535|B12||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469346|NCT00001832|4287536|B11||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469347|NCT00001832|4287537|B10||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469348|NCT00001832|4287538|B9||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469349|NCT00001832|4287539|B8||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469350|NCT00001832|4287540|B7||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469351|NCT00001832|4287541|B6||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469352|NCT00001832|4287542|B5||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469353|NCT00001832|4287543|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469354|NCT00001832|4287544|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469355|NCT00001832|4287545|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469356|NCT00001832|4287546|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469357|NCT00001832|4287532|B15||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469358|NCT00001832|4287533|B14||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469359|NCT00001832|4287534|B13||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469360|NCT00001832|4287535|B12||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469361|NCT00001832|4287536|B11||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469362|NCT00001832|4287537|B10||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469363|NCT00001832|4287538|B9||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469364|NCT00001832|4287539|B8||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469365|NCT00001832|4287540|B7||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469366|NCT00001832|4287541|B6||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469367|NCT00001832|4287542|B5||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469368|NCT00001832|4287543|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469369|NCT00001832|4287544|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469370|NCT00001832|4287545|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469371|NCT00001832|4287546|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469372|NCT00001832|4287532|B15||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469373|NCT00001832|4287533|B14||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469374|NCT00001832|4287534|B13||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469375|NCT00001832|4287535|B12||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469376|NCT00001832|4287536|B11||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469377|NCT00001832|4287537|B10||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469378|NCT00001832|4287538|B9||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469379|NCT00001832|4287539|B8||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469380|NCT00001832|4287540|B7||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469381|NCT00001832|4287541|B6||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469382|NCT00001832|4287542|B5||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469383|NCT00001832|4287543|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469384|NCT00001832|4287544|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469385|NCT00001832|4287545|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469386|NCT00001832|4287546|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469387|NCT00001832|4287532|B15||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|106|106.0||||||
4469388|NCT00001832|4287533|B14||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4469389|NCT00001832|4287534|B13||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469390|NCT00001832|4287535|B12||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4469391|NCT00001832|4287536|B11||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4469392|NCT00001832|4287537|B10||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469393|NCT00001832|4287538|B9||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4469394|NCT00001832|4287539|B8||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4469395|NCT00001832|4287540|B7||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4469396|NCT00001832|4287541|B6||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4469397|NCT00001832|4287542|B5||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|48|48.0||||||
4469398|NCT00001832|4287543|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4469399|NCT00001832|4287544|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469400|NCT00001832|4287545|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469401|NCT00001832|4287546|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469402|NCT00001832|4287532|B15||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4469403|NCT00001832|4287533|B14||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469404|NCT00001832|4287534|B13||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469405|NCT00001832|4287535|B12||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469406|NCT00001832|4287536|B11||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469407|NCT00001832|4287537|B10||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469408|NCT00001832|4287538|B9||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469409|NCT00001832|4287539|B8||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469410|NCT00001832|4287540|B7||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469411|NCT00001832|4287541|B6||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469412|NCT00001832|4287542|B5||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469413|NCT00001832|4287543|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469414|NCT00001832|4287544|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469415|NCT00001832|4287545|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469416|NCT00001832|4287546|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469417|NCT00001832|4287532|B15||Male|Sex: Female, Male||Participants|Count of Participants|72|72.0||||||
4469418|NCT00001832|4287533|B14||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4469419|NCT00001832|4287534|B13||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4469420|NCT00001832|4287535|B12||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4469421|NCT00001832|4287536|B11||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4469422|NCT00001832|4287537|B10||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4469423|NCT00001832|4287538|B9||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4469424|NCT00001832|4287539|B8||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4469425|NCT00001832|4287540|B7||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4469426|NCT00001832|4287541|B6||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4469427|NCT00001832|4287542|B5||Male|Sex: Female, Male||Participants|Count of Participants|29|29.0||||||
4469428|NCT00001832|4287543|B4||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4469429|NCT00001832|4287544|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4469430|NCT00001832|4287545|B2||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4469431|NCT00001832|4287546|B1||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4469432|NCT00001832|4287532|B15||Female|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4469433|NCT00001832|4287533|B14||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4469434|NCT00001832|4287534|B13||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4469435|NCT00001832|4287535|B12||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4469436|NCT00001832|4287536|B11||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4469437|NCT00001832|4287537|B10||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4469438|NCT00001832|4287538|B9||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4469439|NCT00001832|4287539|B8||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4469440|NCT00001832|4287540|B7||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4469441|NCT00001832|4287541|B6||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4469442|NCT00001832|4287542|B5||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4469443|NCT00001832|4287543|B4||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4469444|NCT00001832|4287544|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4469445|NCT00001832|4287545|B2||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4469446|NCT00001832|4287546|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4469447|NCT00001832|4287532|B15|||Age||years|Mean|45.0|45.0|Standard Deviation|11.4|11.4|||
4469448|NCT00001832|4287533|B14|||Age||years|Mean|58.5|58.5|Standard Deviation|10.6|10.6|||
4469449|NCT00001832|4287534|B13|||Age||years|Mean|37.7|37.7|Standard Deviation|7.1|7.1|||
4469450|NCT00001832|4287535|B12|||Age||years|Mean|44.2|44.2|Standard Deviation|11.2|11.2|||
4469451|NCT00001832|4287536|B11|||Age||years|Mean|40.7|40.7|Standard Deviation|9.9|9.9|||
4469452|NCT00001832|4287537|B10|||Age||years|Mean|62.0|62.0|Standard Deviation|||||
4469453|NCT00001832|4287538|B9|||Age||years|Mean|49.0|49.0|Standard Deviation|10.3|10.3|||
4469454|NCT00001832|4287539|B8|||Age||years|Mean|41.8|41.8|Standard Deviation|11.6|11.6|||
4469455|NCT00001832|4287540|B7|||Age||years|Mean|39.7|39.7|Standard Deviation|11.1|11.1|||
4469456|NCT00001832|4287541|B6|||Age||years|Mean|38.0|38.0|Standard Deviation|14.3|14.3|||
4469457|NCT00001832|4287542|B5|||Age||years|Mean|41.9|41.9|Standard Deviation|12.7|12.7|||
4469458|NCT00001832|4287543|B4|||Age||years|Mean|37.8|37.8|Standard Deviation|14.7|14.7|||
4469459|NCT00001832|4287544|B3|||Age||years|Mean|42.3|42.3|Standard Deviation|13.3|13.3|||
4469460|NCT00001832|4287545|B2|||Age||years|Mean|52.3|52.3|Standard Deviation|4.5|4.5|||
4469461|NCT00001832|4287546|B1|||Age||years|Mean|41.3|41.3|Standard Deviation|9.3|9.3|||
4469462|NCT00001832|4287532|B15||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4469463|NCT00001832|4287533|B14||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4469464|NCT00001832|4287534|B13||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469465|NCT00001832|4287535|B12||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469466|NCT00001832|4287536|B11||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469467|NCT00001832|4287537|B10||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469468|NCT00001832|4287538|B9||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469469|NCT00001832|4287539|B8||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469470|NCT00001832|4287540|B7||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469471|NCT00001832|4287541|B6||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469472|NCT00001832|4287542|B5||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469473|NCT00001832|4287543|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469474|NCT00001832|4287544|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469475|NCT00001832|4287545|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469476|NCT00001832|4287546|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469477|NCT00001832|4287532|B15||Between 18 and 65 years|Age||Participants|Count of Participants|108|108.0||||||
4469478|NCT00001832|4287533|B14||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4469479|NCT00001832|4287534|B13||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4469480|NCT00001832|4287535|B12||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4469481|NCT00001832|4287536|B11||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4469482|NCT00001832|4287537|B10||Between 18 and 65 years|Age||Participants|Count of Participants|1|1.0||||||
4469483|NCT00001832|4287538|B9||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4469484|NCT00001832|4287539|B8||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4469485|NCT00001832|4287540|B7||Between 18 and 65 years|Age||Participants|Count of Participants|7|7.0||||||
4469486|NCT00001832|4287541|B6||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4469487|NCT00001832|4287542|B5||Between 18 and 65 years|Age||Participants|Count of Participants|51|51.0||||||
4469488|NCT00001832|4287543|B4||Between 18 and 65 years|Age||Participants|Count of Participants|5|5.0||||||
4469489|NCT00001832|4287544|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4469490|NCT00001832|4287545|B2||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4469491|NCT00001832|4287546|B1||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4469492|NCT00001832|4287532|B15||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4469493|NCT00001832|4287533|B14||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469494|NCT00001832|4287534|B13||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469495|NCT00001832|4287535|B12||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469496|NCT00001832|4287536|B11||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469497|NCT00001832|4287537|B10||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469498|NCT00001832|4287538|B9||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469499|NCT00001832|4287539|B8||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469500|NCT00001832|4287540|B7||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469501|NCT00001832|4287541|B6||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469502|NCT00001832|4287542|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469503|NCT00001832|4287543|B4||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4469504|NCT00001832|4287544|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469505|NCT00001832|4287545|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469506|NCT00001832|4287546|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469507|NCT00001723|4287604|B3|United States||Region of Enrollment||participants|Number|200|200.0||||||
4469508|NCT00001723|4287605|B2|United States||Region of Enrollment||participants|Number|100|100.0||||||
4469509|NCT00001723|4287606|B1|United States||Region of Enrollment||participants|Number|100|100.0||||||
4469510|NCT00001723|4287604|B3||Male|Sex: Female, Male||Participants|Count of Participants|69|69.0||||||
4469511|NCT00001723|4287605|B2||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4469512|NCT00001723|4287606|B1||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4469513|NCT00001723|4287604|B3||Female|Sex: Female, Male||Participants|Count of Participants|131|131.0||||||
4469514|NCT00001723|4287605|B2||Female|Sex: Female, Male||Participants|Count of Participants|66|66.0||||||
4469515|NCT00001723|4287606|B1||Female|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4469516|NCT00001723|4287604|B3|||Age||years|Mean|14.59|14.59|Standard Deviation|1.41|1.41|||
4469517|NCT00001723|4287605|B2|||Age||years|Mean|14.52|14.52|Standard Deviation|1.46|1.46|||
4469518|NCT00001723|4287606|B1|||Age||years|Mean|14.65|14.65|Standard Deviation|1.38|1.38|||
4469519|NCT00001723|4287604|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469520|NCT00001723|4287605|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469521|NCT00001723|4287606|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469522|NCT00001723|4287604|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469523|NCT00001723|4287605|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469524|NCT00001723|4287606|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469525|NCT00001723|4287604|B3||<=18 years|Age||Participants|Count of Participants|200|200.0||||||
4469526|NCT00001723|4287605|B2||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4469527|NCT00001723|4287606|B1||<=18 years|Age||Participants|Count of Participants|100|100.0||||||
4469528|NCT00001703|4287623|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4469529|NCT00001703|4287623|B1||Male|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4469530|NCT00001703|4287623|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4469531|NCT00001703|4287623|B1|||Age||years|Mean|62|62.0|Standard Deviation|11.31|11.31|||
4469532|NCT00001703|4287623|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469533|NCT00001703|4287623|B1||Between 18 and 65 years|Age||Participants|Count of Participants|6|6.0||||||
4469534|NCT00001703|4287623|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469535|NCT00001656|4287628|B3|United States||Region of Enrollment||participants|Number|25|25.0||||||
4469536|NCT00001656|4287629|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4469537|NCT00001656|4287630|B1|United States||Region of Enrollment||participants|Number|13|13.0||||||
4469538|NCT00001656|4287628|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469539|NCT00001656|4287629|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469540|NCT00001656|4287630|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469541|NCT00001656|4287628|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469542|NCT00001656|4287629|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469543|NCT00001656|4287630|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469544|NCT00001656|4287628|B3||White|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4469545|NCT00001656|4287629|B2||White|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4469546|NCT00001656|4287630|B1||White|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4469547|NCT00001656|4287628|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|7|7.0||||||
4469548|NCT00001656|4287629|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469549|NCT00001656|4287630|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4469550|NCT00001656|4287628|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469551|NCT00001656|4287629|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469552|NCT00001656|4287630|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469553|NCT00001656|4287628|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469554|NCT00001656|4287629|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469555|NCT00001656|4287630|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469556|NCT00001656|4287628|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469557|NCT00001656|4287629|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469558|NCT00001656|4287630|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469559|NCT00001656|4287628|B3||Male|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4469560|NCT00001656|4287629|B2||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4469561|NCT00001656|4287630|B1||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4469562|NCT00001656|4287628|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4469563|NCT00001656|4287629|B2||Female|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4469564|NCT00001656|4287630|B1||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4469565|NCT00001656|4287628|B3|||Age||years|Mean|12.2|12.2|Standard Deviation|2.1|2.1|||
4469566|NCT00001656|4287629|B2|||Age||years|Mean|11.7|11.7|Standard Deviation|2.3|2.3|||
4469567|NCT00001656|4287630|B1|||Age||years|Mean|12.8|12.8|Standard Deviation|2.4|2.4|||
4469568|NCT00001656|4287628|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469569|NCT00001656|4287629|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469570|NCT00001656|4287630|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469571|NCT00001656|4287628|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469572|NCT00001656|4287629|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469573|NCT00001656|4287630|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469574|NCT00001656|4287628|B3||<=18 years|Age||Participants|Count of Participants|25|25.0||||||
4469575|NCT00001656|4287629|B2||<=18 years|Age||Participants|Count of Participants|12|12.0||||||
4469576|NCT00001656|4287630|B1||<=18 years|Age||Participants|Count of Participants|13|13.0||||||
4469577|NCT00001596|4287659|B3|||6 Minute Walk Test|6 minute walk test (6MWT) measures the distance that a patient can quickly walk on a flat hard surface in a period of six minutes.|meters|Mean|520.65|520.65|Standard Deviation|107.94|107.94|||
4469578|NCT00001596|4287660|B2|||6 Minute Walk Test|6 minute walk test (6MWT) measures the distance that a patient can quickly walk on a flat hard surface in a period of six minutes.|meters|Mean|526.87|526.87|Standard Deviation|103.00|103.0|||
4469579|NCT00001596|4287661|B1|||6 Minute Walk Test|6 minute walk test (6MWT) measures the distance that a patient can quickly walk on a flat hard surface in a period of six minutes.|meters|Mean|517.39|517.39|Standard Deviation|112.79|112.79|||
4469580|NCT00001596|4287659|B3|||Adjusted Diffusing Capacity of the Lung for Carbon Monoxide|Adjusted Diffusing Capacity of the lung for carbon monoxide (DLCOa) measures gas uptake during a single inspiration in a standard time, adjusted for subject's hemoglobin levels. DLCOa is recorded as a percentage of predicted volume, and normal range is 75-125% of predicted.|% of predicted volume|Mean|67.48|67.48|Standard Deviation|15.93|15.93|||
4469581|NCT00001596|4287660|B2|||Adjusted Diffusing Capacity of the Lung for Carbon Monoxide|Adjusted Diffusing Capacity of the lung for carbon monoxide (DLCOa) measures gas uptake during a single inspiration in a standard time, adjusted for subject's hemoglobin levels. DLCOa is recorded as a percentage of predicted volume, and normal range is 75-125% of predicted.|% of predicted volume|Mean|66.83|66.83|Standard Deviation|16.60|16.6|||
4469627|NCT00001586|4287684|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469582|NCT00001596|4287661|B1|||Adjusted Diffusing Capacity of the Lung for Carbon Monoxide|Adjusted Diffusing Capacity of the lung for carbon monoxide (DLCOa) measures gas uptake during a single inspiration in a standard time, adjusted for subject's hemoglobin levels. DLCOa is recorded as a percentage of predicted volume, and normal range is 75-125% of predicted.|% of predicted volume|Mean|67.82|67.82|Standard Deviation|15.94|15.94|||
4469583|NCT00001596|4287659|B3|||Total Lung Capacity|Total Lung Capacity (TLC) is the volume in the lungs at maximal inflation. TLC is recorded as the percentage of predicted volume based on subject's height, age, sex, and weight. TLC normal range is 80-120% of predicted.|% of predicted volume|Mean|73.65|73.65|Standard Deviation|11.28|11.28|||
4469584|NCT00001596|4287660|B2|||Total Lung Capacity|Total Lung Capacity (TLC) is the volume in the lungs at maximal inflation. TLC is recorded as the percentage of predicted volume based on subject's height, age, sex, and weight. TLC normal range is 80-120% of predicted.|% of predicted volume|Mean|73.28|73.28|Standard Deviation|10.09|10.09|||
4469585|NCT00001596|4287661|B1|||Total Lung Capacity|Total Lung Capacity (TLC) is the volume in the lungs at maximal inflation. TLC is recorded as the percentage of predicted volume based on subject's height, age, sex, and weight. TLC normal range is 80-120% of predicted.|% of predicted volume|Mean|73.84|73.84|Standard Deviation|12.07|12.07|||
4469586|NCT00001596|4287659|B3|||Forced Vital Capacity|Forced Vital Capacity (FVC) is the volume of air that can be forcibly blown out from the lungs after full inspiration. It is recorded as the percentage of predicted volume (predicted FVC volume is calculated based on subject's height, age, sex, and weight). FVC normal range is 80-120% of predicted.|% of predicted|Mean|73.03|73.03|Standard Deviation|8.70|8.7|||
4469587|NCT00001596|4287660|B2|||Forced Vital Capacity|Forced Vital Capacity (FVC) is the volume of air that can be forcibly blown out from the lungs after full inspiration. It is recorded as the percentage of predicted volume (predicted FVC volume is calculated based on subject's height, age, sex, and weight). FVC normal range is 80-120% of predicted.|% of predicted|Mean|73.53|73.53|Standard Deviation|10.09|10.09|||
4469588|NCT00001596|4287661|B1|||Forced Vital Capacity|Forced Vital Capacity (FVC) is the volume of air that can be forcibly blown out from the lungs after full inspiration. It is recorded as the percentage of predicted volume (predicted FVC volume is calculated based on subject's height, age, sex, and weight). FVC normal range is 80-120% of predicted.|% of predicted|Mean|72.77|72.77|Standard Deviation|8.12|8.12|||
4469589|NCT00001596|4287659|B3|United States||Region of Enrollment||participants|Number|35|35.0||||||
4469590|NCT00001596|4287660|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4469591|NCT00001596|4287661|B1|United States||Region of Enrollment||participants|Number|23|23.0||||||
4469592|NCT00001596|4287659|B3||Male|Sex: Female, Male||Participants|Count of Participants|14|14.0||||||
4469593|NCT00001596|4287660|B2||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4469594|NCT00001596|4287661|B1||Male|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4469595|NCT00001596|4287659|B3||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4469596|NCT00001596|4287660|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4469597|NCT00001596|4287661|B1||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4469598|NCT00001596|4287659|B3|||Age||years|Mean|41.05|41.05|Standard Deviation|10.18|10.18|||
4469599|NCT00001596|4287660|B2|||Age||years|Mean|43.97|43.97|Standard Deviation|8.02|8.02|||
4469600|NCT00001596|4287661|B1|||Age||years|Mean|39.53|39.53|Standard Deviation|11.00|11.0|||
4469601|NCT00001596|4287659|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4469602|NCT00001596|4287660|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469603|NCT00001596|4287661|B1||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4469604|NCT00001596|4287659|B3||Between 18 and 65 years|Age||Participants|Count of Participants|34|34.0||||||
4469605|NCT00001596|4287660|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4469606|NCT00001596|4287661|B1||Between 18 and 65 years|Age||Participants|Count of Participants|22|22.0||||||
4469607|NCT00001596|4287659|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469608|NCT00001596|4287660|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469609|NCT00001596|4287661|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469610|NCT00001586|4287682|B3|United States||Region of Enrollment||participants|Number|105|105.0||||||
4469611|NCT00001586|4287683|B2|United States||Region of Enrollment||participants|Number|56|56.0||||||
4469612|NCT00001586|4287684|B1|United States||Region of Enrollment||participants|Number|49|49.0||||||
4469613|NCT00001586|4287682|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469614|NCT00001586|4287683|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469615|NCT00001586|4287684|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469616|NCT00001586|4287682|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469617|NCT00001586|4287683|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469618|NCT00001586|4287684|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469619|NCT00001586|4287682|B3||White|Race (NIH/OMB)||Participants|Count of Participants|94|94.0||||||
4469620|NCT00001586|4287683|B2||White|Race (NIH/OMB)||Participants|Count of Participants|52|52.0||||||
4469621|NCT00001586|4287684|B1||White|Race (NIH/OMB)||Participants|Count of Participants|42|42.0||||||
4469622|NCT00001586|4287682|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|8|8.0||||||
4469623|NCT00001586|4287683|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4469624|NCT00001586|4287684|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4469625|NCT00001586|4287682|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469626|NCT00001586|4287683|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469628|NCT00001586|4287682|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4469629|NCT00001586|4287683|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469630|NCT00001586|4287684|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469631|NCT00001586|4287682|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469632|NCT00001586|4287683|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469633|NCT00001586|4287684|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469634|NCT00001586|4287682|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469635|NCT00001586|4287683|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469636|NCT00001586|4287684|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469637|NCT00001586|4287682|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|104|104.0||||||
4469638|NCT00001586|4287683|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|55|55.0||||||
4469639|NCT00001586|4287684|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|49|49.0||||||
4469640|NCT00001586|4287682|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469641|NCT00001586|4287683|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469642|NCT00001586|4287684|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469643|NCT00001586|4287682|B3||Male|Sex: Female, Male||Participants|Count of Participants|65|65.0||||||
4469644|NCT00001586|4287683|B2||Male|Sex: Female, Male||Participants|Count of Participants|35|35.0||||||
4469645|NCT00001586|4287684|B1||Male|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4469646|NCT00001586|4287682|B3||Female|Sex: Female, Male||Participants|Count of Participants|40|40.0||||||
4469647|NCT00001586|4287683|B2||Female|Sex: Female, Male||Participants|Count of Participants|21|21.0||||||
4469648|NCT00001586|4287684|B1||Female|Sex: Female, Male||Participants|Count of Participants|19|19.0||||||
4469649|NCT00001586|4287682|B3|||Age||years|Mean|57.98|57.98|Standard Deviation|11.11|11.11|||
4469650|NCT00001586|4287683|B2|||Age||years|Mean|58.42|58.42|Standard Deviation|11.32|11.32|||
4469651|NCT00001586|4287684|B1|||Age||years|Mean|56.2|56.2|Standard Deviation|9.34|9.34|||
4469652|NCT00001586|4287682|B3||>=65 years|Age||Participants|Count of Participants|27|27.0||||||
4469653|NCT00001586|4287683|B2||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4469654|NCT00001586|4287684|B1||>=65 years|Age||Participants|Count of Participants|10|10.0||||||
4469655|NCT00001586|4287682|B3||Between 18 and 65 years|Age||Participants|Count of Participants|78|78.0||||||
4469656|NCT00001586|4287683|B2||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4469657|NCT00001586|4287684|B1||Between 18 and 65 years|Age||Participants|Count of Participants|39|39.0||||||
4469658|NCT00001586|4287682|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469659|NCT00001586|4287683|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469660|NCT00001586|4287684|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469661|NCT00001575|4287693|B1|United States||Region of Enrollment||participants|Number|87|87.0||||||
4469662|NCT00001575|4287693|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|5|5.0||||||
4469663|NCT00001575|4287693|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469664|NCT00001575|4287693|B1||White|Race (NIH/OMB)||Participants|Count of Participants|66|66.0||||||
4469665|NCT00001575|4287693|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|15|15.0||||||
4469666|NCT00001575|4287693|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469667|NCT00001575|4287693|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469668|NCT00001575|4287693|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469669|NCT00001575|4287693|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469670|NCT00001575|4287693|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|81|81.0||||||
4469671|NCT00001575|4287693|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|6|6.0||||||
4469672|NCT00001575|4287693|B1||Male|Sex: Female, Male||Participants|Count of Participants|53|53.0||||||
4469673|NCT00001575|4287693|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4469674|NCT00001575|4287693|B1|||Age||years|Mean|36|36.0|Standard Deviation|16|16.0|||
4469675|NCT00001575|4287693|B1||>=65 years|Age||Participants|Count of Participants|17|17.0||||||
4469676|NCT00001575|4287693|B1||Between 18 and 65 years|Age||Participants|Count of Participants|70|70.0||||||
4469677|NCT00001575|4287693|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469678|NCT00001566|4287699|B1|United States||Region of Enrollment||participants|Number|42|42.0||||||
4469679|NCT00001566|4287699|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469680|NCT00001566|4287699|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|40|40.0||||||
4469681|NCT00001566|4287699|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4469682|NCT00001566|4287699|B1||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4469683|NCT00001566|4287699|B1||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4469684|NCT00001566|4287699|B1|||Age||years|Mean|18.67|18.67|Standard Deviation|8.59|8.59|||
4469685|NCT00001566|4287699|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469686|NCT00001566|4287699|B1||Between 18 and 65 years|Age||Participants|Count of Participants|16|16.0||||||
4469687|NCT00001566|4287699|B1||<=18 years|Age||Participants|Count of Participants|26|26.0||||||
4469688|NCT00001304|4287711|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469689|NCT00001304|4287712|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469690|NCT00001304|4287713|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469691|NCT00001304|4287711|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469692|NCT00001304|4287712|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469693|NCT00001304|4287713|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469694|NCT00001304|4287711|B3||White|Race (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4469695|NCT00001304|4287712|B2||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4469696|NCT00001304|4287713|B1||White|Race (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4469697|NCT00001304|4287711|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469698|NCT00001304|4287712|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469699|NCT00001304|4287713|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469700|NCT00001304|4287711|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469701|NCT00001304|4287712|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469702|NCT00001304|4287713|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469703|NCT00001304|4287711|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469704|NCT00001304|4287712|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469705|NCT00001304|4287713|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469706|NCT00001304|4287711|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469707|NCT00001304|4287712|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469708|NCT00001304|4287713|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469709|NCT00001304|4287711|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469710|NCT00001304|4287712|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469711|NCT00001304|4287713|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469712|NCT00001304|4287711|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|26|26.0||||||
4469713|NCT00001304|4287712|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4469714|NCT00001304|4287713|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|13|13.0||||||
4469715|NCT00001304|4287711|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469716|NCT00001304|4287712|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469717|NCT00001304|4287713|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469718|NCT00001304|4287711|B3||Male|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4469719|NCT00001304|4287712|B2||Male|Sex: Female, Male||Participants|Count of Participants|4|4.0||||||
4469720|NCT00001304|4287713|B1||Male|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4469721|NCT00001304|4287711|B3||Female|Sex: Female, Male||Participants|Count of Participants|17|17.0||||||
4469722|NCT00001304|4287712|B2||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4469723|NCT00001304|4287713|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4469724|NCT00001304|4287711|B3||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4469725|NCT00001304|4287712|B2||>=65 years|Age||Participants|Count of Participants|1|1.0||||||
4469726|NCT00001304|4287713|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469727|NCT00001304|4287711|B3||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4469728|NCT00001304|4287712|B2||Between 18 and 65 years|Age||Participants|Count of Participants|11|11.0||||||
4469729|NCT00001304|4287713|B1||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4469730|NCT00001304|4287711|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4469731|NCT00001304|4287712|B2||<=18 years|Age||Participants|Count of Participants|2|2.0||||||
4469732|NCT00001304|4287713|B1||<=18 years|Age||Participants|Count of Participants|1|1.0||||||
4469733|NCT00001262|4287732|B4||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|4|4.0||||||
4469734|NCT00001262|4287733|B3||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469735|NCT00001262|4287734|B2||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469736|NCT00001262|4287735|B1||Unknown or Not Reported|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469737|NCT00001262|4287732|B4||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469738|NCT00001262|4287733|B3||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469739|NCT00001262|4287734|B2||More than one race|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469740|NCT00001262|4287735|B1||More than one race|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469741|NCT00001262|4287732|B4||White|Race (NIH/OMB)||Participants|Count of Participants|44|44.0||||||
4469742|NCT00001262|4287733|B3||White|Race (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469743|NCT00001262|4287734|B2||White|Race (NIH/OMB)||Participants|Count of Participants|19|19.0||||||
4469744|NCT00001262|4287735|B1||White|Race (NIH/OMB)||Participants|Count of Participants|22|22.0||||||
4469745|NCT00001262|4287732|B4||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|10|10.0||||||
4469746|NCT00001262|4287733|B3||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469747|NCT00001262|4287734|B2||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469748|NCT00001262|4287735|B1||Black or African American|Race (NIH/OMB)||Participants|Count of Participants|9|9.0||||||
4469749|NCT00001262|4287732|B4||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469750|NCT00001262|4287733|B3||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469751|NCT00001262|4287734|B2||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469752|NCT00001262|4287735|B1||Native Hawaiian or Other Pacific Islander|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469753|NCT00001262|4287732|B4||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469754|NCT00001262|4287733|B3||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469755|NCT00001262|4287734|B2||Asian|Race (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469756|NCT00001262|4287735|B1||Asian|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469757|NCT00001262|4287732|B4||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469758|NCT00001262|4287733|B3||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469759|NCT00001262|4287734|B2||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469760|NCT00001262|4287735|B1||American Indian or Alaska Native|Race (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469761|NCT00001262|4287732|B4||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469762|NCT00001262|4287733|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469763|NCT00001262|4287734|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|1|1.0||||||
4469764|NCT00001262|4287735|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|2|2.0||||||
4469765|NCT00001262|4287732|B4||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|54|54.0||||||
4469766|NCT00001262|4287733|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469767|NCT00001262|4287734|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|21|21.0||||||
4469768|NCT00001262|4287735|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|30|30.0||||||
4469769|NCT00001262|4287732|B4||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469770|NCT00001262|4287733|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469771|NCT00001262|4287734|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469772|NCT00001262|4287735|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|3|3.0||||||
4469773|NCT00001262|4287732|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4469774|NCT00001262|4287733|B3||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4469775|NCT00001262|4287734|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4469776|NCT00001262|4287735|B1||Male|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4469777|NCT00001262|4287732|B4||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4469778|NCT00001262|4287733|B3||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4469779|NCT00001262|4287734|B2||Female|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4469780|NCT00001262|4287735|B1||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4469781|NCT00001262|4287732|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469782|NCT00001262|4287733|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469783|NCT00001262|4287734|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469784|NCT00001262|4287735|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469785|NCT00001262|4287732|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469786|NCT00001262|4287733|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469787|NCT00001262|4287734|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469788|NCT00001262|4287735|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469789|NCT00001262|4287732|B4||<=18 years|Age||Participants|Count of Participants|60|60.0||||||
4469790|NCT00001262|4287733|B3||<=18 years|Age||Participants|Count of Participants|3|3.0||||||
4469791|NCT00001262|4287734|B2||<=18 years|Age||Participants|Count of Participants|22|22.0||||||
4469792|NCT00001262|4287735|B1||<=18 years|Age||Participants|Count of Participants|35|35.0||||||
4469793|NCT00001213|4287763|B1|Male||Gender|Gender was captured for 326 out of 328 participants, the gender of two participants is unknown.|participants|Number|173|173.0||||||
4469794|NCT00001213|4287763|B1|Female||Gender|Gender was captured for 326 out of 328 participants, the gender of two participants is unknown.|participants|Number|153|153.0||||||
4469795|NCT00001213|4287763|B1|||Age|Although 328 participants were initially enrolled, the mean and standard deviation were only obtained for 322 participants.|years|Mean|13.1|13.1|Standard Deviation|10.04|10.04|||
4469796|NCT00001151|4287768|B1|United States||Region of Enrollment||participants|Number|6|6.0||||||
4469797|NCT00001151|4287768|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4469798|NCT00001151|4287768|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4469799|NCT00001151|4287768|B1|||Age||years|Mean|15|15.0|Full Range|||5.0|50.0|
4469800|NCT00000378|4287772|B3|United States||Region of Enrollment||participants|Number|110|110.0||||||
4469801|NCT00000378|4287773|B2|United States||Region of Enrollment||participants|Number|52|52.0||||||
4469802|NCT00000378|4287774|B1|United States||Region of Enrollment||participants|Number|58|58.0||||||
4469803|NCT00000378|4287772|B3||Male|Sex: Female, Male||Participants|Count of Participants|46|46.0||||||
4469804|NCT00000378|4287773|B2||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4469805|NCT00000378|4287774|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4469806|NCT00000378|4287772|B3||Female|Sex: Female, Male||Participants|Count of Participants|64|64.0||||||
4469807|NCT00000378|4287773|B2||Female|Sex: Female, Male||Participants|Count of Participants|30|30.0||||||
4469808|NCT00000378|4287774|B1||Female|Sex: Female, Male||Participants|Count of Participants|34|34.0||||||
4469809|NCT00000378|4287772|B3||>=65 years|Age||Participants|Count of Participants|98|98.0||||||
4469810|NCT00000378|4287773|B2||>=65 years|Age||Participants|Count of Participants|48|48.0||||||
4469811|NCT00000378|4287774|B1||>=65 years|Age||Participants|Count of Participants|50|50.0||||||
4469812|NCT00000378|4287772|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4469813|NCT00000378|4287773|B2||Between 18 and 65 years|Age||Participants|Count of Participants|4|4.0||||||
4469814|NCT00000378|4287774|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4469815|NCT00000378|4287772|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469816|NCT00000378|4287773|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469817|NCT00000378|4287774|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469818|NCT00000371|4287781|B3|United States||Region of Enrollment||participants|Number|55|55.0||||||
4469819|NCT00000371|4287782|B2|United States||Region of Enrollment||participants|Number|28|28.0||||||
4469820|NCT00000371|4287783|B1|United States||Region of Enrollment||participants|Number|27|27.0||||||
4469821|NCT00000371|4287781|B3||Male|Sex: Female, Male||Participants|Count of Participants|44|44.0||||||
4469822|NCT00000371|4287782|B2||Male|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4469823|NCT00000371|4287783|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4469824|NCT00000371|4287781|B3||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4469825|NCT00000371|4287782|B2||Female|Sex: Female, Male||Participants|Count of Participants|8|8.0||||||
4469826|NCT00000371|4287783|B1||Female|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4469827|NCT00000371|4287781|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469828|NCT00000371|4287782|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469829|NCT00000371|4287783|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469830|NCT00000371|4287781|B3||Between 18 and 65 years|Age||Participants|Count of Participants|55|55.0||||||
4469831|NCT00000371|4287782|B2||Between 18 and 65 years|Age||Participants|Count of Participants|28|28.0||||||
4469832|NCT00000371|4287783|B1||Between 18 and 65 years|Age||Participants|Count of Participants|27|27.0||||||
4469833|NCT00000371|4287781|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469834|NCT00000371|4287782|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469835|NCT00000371|4287783|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469836|NCT00000371|4287781|B3|||Age||Years|Mean|46.5|46.5|Standard Deviation|8.0|8.0|||
4469837|NCT00000371|4287782|B2|||Age||Years|Mean|47.0|47.0|Standard Deviation|8.6|8.6|||
4469838|NCT00000371|4287783|B1|||Age||Years|Mean|45.9|45.9|Standard Deviation|7.4|7.4|||
4469839|NCT00000620|4287790|B3|||Diabetes duration||years|Median|10|10.0|Inter-Quartile Range|||5.0|15.0|
4469840|NCT00000620|4287791|B2|||Diabetes duration||years|Median|10|10.0|Inter-Quartile Range|||5.0|15.0|
4469841|NCT00000620|4287792|B1|||Diabetes duration||years|Median|10|10.0|Inter-Quartile Range|||5.0|15.0|
4469842|NCT00000620|4287790|B3|||Triglycerides||mg/dL|Median|155|155.0|Inter-Quartile Range|||106.0|228.0|
4469843|NCT00000620|4287791|B2|||Triglycerides||mg/dL|Median|154|154.0|Inter-Quartile Range|||108.0|226.0|
4469844|NCT00000620|4287792|B1|||Triglycerides||mg/dL|Median|156|156.0|Inter-Quartile Range|||105.0|230.0|
4469845|NCT00000620|4287790|B3|HDL||Cholesterol||mg/dL|Mean|41.9|41.9|Standard Deviation|11.6|11.6|||
4469846|NCT00000620|4287791|B2|HDL||Cholesterol||mg/dL|Mean|41.9|41.9|Standard Deviation|11.5|11.5|||
4469847|NCT00000620|4287792|B1|HDL||Cholesterol||mg/dL|Mean|41.8|41.8|Standard Deviation|11.8|11.8|||
4469848|NCT00000620|4287790|B3|LDL||Cholesterol||mg/dL|Mean|104.9|104.9|Standard Deviation|33.9|33.9|||
4469849|NCT00000620|4287791|B2|LDL||Cholesterol||mg/dL|Mean|104.9|104.9|Standard Deviation|33.8|33.8|||
4469850|NCT00000620|4287792|B1|LDL||Cholesterol||mg/dL|Mean|104.9|104.9|Standard Deviation|34.0|34.0|||
4469851|NCT00000620|4287790|B3|Diastolic||Blood pressure||mm Hg|Mean|74.9|74.9|Standard Deviation|10.7|10.7|||
4469852|NCT00000620|4287791|B2|Diastolic||Blood pressure||mm Hg|Mean|75.0|75.0|Standard Deviation|10.7|10.7|||
4469853|NCT00000620|4287792|B1|Diastolic||Blood pressure||mm Hg|Mean|74.8|74.8|Standard Deviation|10.6|10.6|||
4469854|NCT00000620|4287790|B3|Systolic||Blood pressure||mm Hg|Mean|136.4|136.4|Standard Deviation|17.1|17.1|||
4469855|NCT00000620|4287791|B2|Systolic||Blood pressure||mm Hg|Mean|136.5|136.5|Standard Deviation|17.2|17.2|||
4469856|NCT00000620|4287792|B1|Systolic||Blood pressure||mm Hg|Mean|136.2|136.2|Standard Deviation|17.0|17.0|||
4469857|NCT00000620|4287790|B3|||Glycated hemoglobin||percent|Mean|8.3|8.3|Standard Deviation|1.1|1.1|||
4469858|NCT00000620|4287791|B2|||Glycated hemoglobin||percent|Mean|8.3|8.3|Standard Deviation|1.1|1.1|||
4469859|NCT00000620|4287792|B1|||Glycated hemoglobin||percent|Mean|8.3|8.3|Standard Deviation|1.1|1.1|||
4469860|NCT00000620|4287790|B3|No history of CVD event||Previous cardiovascular disease (CVD) event||participants|Number|6642|6642.0||||||
4469921|NCT00000575|4287816|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469861|NCT00000620|4287791|B2|No history of CVD event||Previous cardiovascular disease (CVD) event||participants|Number|3341|3341.0||||||
4469862|NCT00000620|4287792|B1|No history of CVD event||Previous cardiovascular disease (CVD) event||participants|Number|3301|3301.0||||||
4469863|NCT00000620|4287790|B3|History of CVD event||Previous cardiovascular disease (CVD) event||participants|Number|3609|3609.0||||||
4469864|NCT00000620|4287791|B2|History of CVD event||Previous cardiovascular disease (CVD) event||participants|Number|1782|1782.0||||||
4469865|NCT00000620|4287792|B1|History of CVD event||Previous cardiovascular disease (CVD) event||participants|Number|1827|1827.0||||||
4469866|NCT00000620|4287790|B3|Canada||Region of Enrollment||participants|Number|1508|1508.0||||||
4469867|NCT00000620|4287791|B2|Canada||Region of Enrollment||participants|Number|756|756.0||||||
4469868|NCT00000620|4287792|B1|Canada||Region of Enrollment||participants|Number|752|752.0||||||
4469869|NCT00000620|4287790|B3|United States||Region of Enrollment||participants|Number|8743|8743.0||||||
4469870|NCT00000620|4287791|B2|United States||Region of Enrollment||participants|Number|4367|4367.0||||||
4469871|NCT00000620|4287792|B1|United States||Region of Enrollment||participants|Number|4376|4376.0||||||
4469872|NCT00000620|4287790|B3|White||Race/Ethnicity, Customized||participants|Number|6604|6604.0||||||
4469873|NCT00000620|4287791|B2|White||Race/Ethnicity, Customized||participants|Number|3304|3304.0||||||
4469874|NCT00000620|4287792|B1|White||Race/Ethnicity, Customized||participants|Number|3300|3300.0||||||
4469875|NCT00000620|4287790|B3|Nonwhite||Race/Ethnicity, Customized||participants|Number|3647|3647.0||||||
4469876|NCT00000620|4287791|B2|Nonwhite||Race/Ethnicity, Customized||participants|Number|1819|1819.0||||||
4469877|NCT00000620|4287792|B1|Nonwhite||Race/Ethnicity, Customized||participants|Number|1828|1828.0||||||
4469878|NCT00000620|4287790|B3||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469879|NCT00000620|4287791|B2||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469880|NCT00000620|4287792|B1||Unknown or Not Reported|Ethnicity (NIH/OMB)||Participants|Count of Participants|0|0.0||||||
4469881|NCT00000620|4287790|B3||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|9514|9514.0||||||
4469882|NCT00000620|4287791|B2||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4744|4744.0||||||
4469883|NCT00000620|4287792|B1||Not Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|4770|4770.0||||||
4469884|NCT00000620|4287790|B3||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|737|737.0||||||
4469885|NCT00000620|4287791|B2||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|379|379.0||||||
4469886|NCT00000620|4287792|B1||Hispanic or Latino|Ethnicity (NIH/OMB)||Participants|Count of Participants|358|358.0||||||
4469887|NCT00000620|4287790|B3||Male|Gender||Participants|Count of Participants|6299|6299.0||||||
4469888|NCT00000620|4287791|B2||Male|Gender||Participants|Count of Participants|3154|3154.0||||||
4469889|NCT00000620|4287792|B1||Male|Gender||Participants|Count of Participants|3145|3145.0||||||
4469890|NCT00000620|4287790|B3||Female|Gender||Participants|Count of Participants|3952|3952.0||||||
4469891|NCT00000620|4287791|B2||Female|Gender||Participants|Count of Participants|1969|1969.0||||||
4469892|NCT00000620|4287792|B1||Female|Gender||Participants|Count of Participants|1983|1983.0||||||
4469893|NCT00000620|4287790|B3|||Age||years|Mean|62.2|62.2|Standard Deviation|6.8|6.8|||
4469894|NCT00000620|4287791|B2|||Age||years|Mean|62.2|62.2|Standard Deviation|6.8|6.8|||
4469895|NCT00000620|4287792|B1|||Age||years|Mean|62.2|62.2|Standard Deviation|6.8|6.8|||
4469896|NCT00000575|4287815|B4|Canada||Region of Enrollment||participants|Number|125|125.0||||||
4469897|NCT00000575|4287816|B3|Canada||Region of Enrollment||participants|Number|50|50.0||||||
4469898|NCT00000575|4287817|B2|Canada||Region of Enrollment||participants|Number|38|38.0||||||
4469899|NCT00000575|4287818|B1|Canada||Region of Enrollment||participants|Number|37|37.0||||||
4469900|NCT00000575|4287815|B4|United States||Region of Enrollment||participants|Number|916|916.0||||||
4469901|NCT00000575|4287816|B3|United States||Region of Enrollment||participants|Number|368|368.0||||||
4469902|NCT00000575|4287817|B2|United States||Region of Enrollment||participants|Number|274|274.0||||||
4469903|NCT00000575|4287818|B1|United States||Region of Enrollment||participants|Number|274|274.0||||||
4469904|NCT00000575|4287815|B4||Male|Sex: Female, Male||Participants|Count of Participants|621|621.0||||||
4469905|NCT00000575|4287816|B3||Male|Sex: Female, Male||Participants|Count of Participants|234|234.0||||||
4469906|NCT00000575|4287817|B2||Male|Sex: Female, Male||Participants|Count of Participants|206|206.0||||||
4469907|NCT00000575|4287818|B1||Male|Sex: Female, Male||Participants|Count of Participants|181|181.0||||||
4469908|NCT00000575|4287815|B4||Female|Sex: Female, Male||Participants|Count of Participants|420|420.0||||||
4469909|NCT00000575|4287816|B3||Female|Sex: Female, Male||Participants|Count of Participants|184|184.0||||||
4469910|NCT00000575|4287817|B2||Female|Sex: Female, Male||Participants|Count of Participants|106|106.0||||||
4469911|NCT00000575|4287818|B1||Female|Sex: Female, Male||Participants|Count of Participants|130|130.0||||||
4469912|NCT00000575|4287815|B4|||Age||years|Mean|8.9|8.9|Standard Deviation|2.1|2.1|||
4469913|NCT00000575|4287816|B3|||Age||years|Mean|9.0|9.0|Standard Deviation|2.2|2.2|||
4469914|NCT00000575|4287817|B2|||Age||years|Mean|8.8|8.8|Standard Deviation|2.1|2.1|||
4469915|NCT00000575|4287818|B1|||Age||years|Mean|9.0|9.0|Standard Deviation|2.1|2.1|||
4469916|NCT00000575|4287815|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469917|NCT00000575|4287816|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469918|NCT00000575|4287817|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469919|NCT00000575|4287818|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469920|NCT00000575|4287815|B4||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469922|NCT00000575|4287817|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469923|NCT00000575|4287818|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469924|NCT00000575|4287815|B4||<=18 years|Age||Participants|Count of Participants|1041|1041.0||||||
4469925|NCT00000575|4287816|B3||<=18 years|Age||Participants|Count of Participants|418|418.0||||||
4469926|NCT00000575|4287817|B2||<=18 years|Age||Participants|Count of Participants|312|312.0||||||
4469927|NCT00000575|4287818|B1||<=18 years|Age||Participants|Count of Participants|311|311.0||||||
4469928|NCT00000479|4287846|B5|United States||Region of Enrollment||participants|Number|39876|39876.0||||||
4469929|NCT00000479|4287847|B4|United States||Region of Enrollment||participants|Number|9971|9971.0||||||
4469930|NCT00000479|4287848|B3|United States||Region of Enrollment||participants|Number|9966|9966.0||||||
4469931|NCT00000479|4287849|B2|United States||Region of Enrollment||participants|Number|9971|9971.0||||||
4469932|NCT00000479|4287850|B1|United States||Region of Enrollment||participants|Number|9968|9968.0||||||
4469933|NCT00000479|4287846|B5||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4469934|NCT00000479|4287847|B4||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4469935|NCT00000479|4287848|B3||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4469936|NCT00000479|4287849|B2||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4469937|NCT00000479|4287850|B1||Male|Sex: Female, Male||Participants|Count of Participants|0|0.0||||||
4469938|NCT00000479|4287846|B5||Female|Sex: Female, Male||Participants|Count of Participants|39876|39876.0||||||
4469939|NCT00000479|4287847|B4||Female|Sex: Female, Male||Participants|Count of Participants|9971|9971.0||||||
4469940|NCT00000479|4287848|B3||Female|Sex: Female, Male||Participants|Count of Participants|9966|9966.0||||||
4469941|NCT00000479|4287849|B2||Female|Sex: Female, Male||Participants|Count of Participants|9971|9971.0||||||
4469942|NCT00000479|4287850|B1||Female|Sex: Female, Male||Participants|Count of Participants|9968|9968.0||||||
4469943|NCT00000479|4287846|B5|||Age||years|Mean|53.9|53.9|Standard Deviation|7.1|7.1|||
4469944|NCT00000479|4287847|B4|||Age||years|Mean|53.9|53.9|Standard Deviation|7.1|7.1|||
4469945|NCT00000479|4287848|B3|||Age||years|Mean|53.9|53.9|Standard Deviation|7.1|7.1|||
4469946|NCT00000479|4287849|B2|||Age||years|Mean|53.9|53.9|Standard Deviation|7.1|7.1|||
4469947|NCT00000479|4287850|B1|||Age||years|Mean|53.9|53.9|Standard Deviation|7.1|7.1|||
4469948|NCT00000479|4287846|B5||>=65 years|Age||Participants|Count of Participants|3968|3968.0||||||
4469949|NCT00000479|4287847|B4||>=65 years|Age||Participants|Count of Participants|987|987.0||||||
4469950|NCT00000479|4287848|B3||>=65 years|Age||Participants|Count of Participants|997|997.0||||||
4469951|NCT00000479|4287849|B2||>=65 years|Age||Participants|Count of Participants|997|997.0||||||
4469952|NCT00000479|4287850|B1||>=65 years|Age||Participants|Count of Participants|987|987.0||||||
4469953|NCT00000479|4287846|B5||Between 18 and 65 years|Age||Participants|Count of Participants|35908|35908.0||||||
4469954|NCT00000479|4287847|B4||Between 18 and 65 years|Age||Participants|Count of Participants|8984|8984.0||||||
4469955|NCT00000479|4287848|B3||Between 18 and 65 years|Age||Participants|Count of Participants|8969|8969.0||||||
4469956|NCT00000479|4287849|B2||Between 18 and 65 years|Age||Participants|Count of Participants|8974|8974.0||||||
4469957|NCT00000479|4287850|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8981|8981.0||||||
4469958|NCT00000479|4287846|B5||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469959|NCT00000479|4287847|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469960|NCT00000479|4287848|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469961|NCT00000479|4287849|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469962|NCT00000479|4287850|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4469963|NCT00004500|4287867|B3|||Gestational Age||weeks|Mean|39.9|39.9|Standard Deviation|1.21|1.21|||
4469964|NCT00004500|4287868|B2|||Gestational Age||weeks|Mean|39.7|39.7|Standard Deviation|1.09|1.09|||
4469965|NCT00004500|4287869|B1|||Gestational Age||weeks|Mean|40.0|40.0|Standard Deviation|1.30|1.3|||
4469966|NCT00004500|4287867|B3|United States||Region of Enrollment||participants|Number|69|69.0||||||
4469967|NCT00004500|4287868|B2|United States||Region of Enrollment||participants|Number|31|31.0||||||
4469968|NCT00004500|4287869|B1|United States||Region of Enrollment||participants|Number|38|38.0||||||
4469969|NCT00004500|4287867|B3||Male|Sex: Female, Male||Participants|Count of Participants|38|38.0||||||
4469970|NCT00004500|4287868|B2||Male|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4469971|NCT00004500|4287869|B1||Male|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4469972|NCT00004500|4287867|B3||Female|Sex: Female, Male||Participants|Count of Participants|31|31.0||||||
4469973|NCT00004500|4287868|B2||Female|Sex: Female, Male||Participants|Count of Participants|15|15.0||||||
4469974|NCT00004500|4287869|B1||Female|Sex: Female, Male||Participants|Count of Participants|16|16.0||||||
4469975|NCT00004500|4287867|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469976|NCT00004500|4287868|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469977|NCT00004500|4287869|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4469978|NCT00004500|4287867|B3||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469979|NCT00004500|4287868|B2||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469980|NCT00004500|4287869|B1||Between 18 and 65 years|Age||Participants|Count of Participants|0|0.0||||||
4469981|NCT00004500|4287867|B3||<=18 years|Age||Participants|Count of Participants|69|69.0||||||
4469982|NCT00004500|4287868|B2||<=18 years|Age||Participants|Count of Participants|31|31.0||||||
4469983|NCT00004500|4287869|B1||<=18 years|Age||Participants|Count of Participants|38|38.0||||||
4469984|NCT00004412|4287880|B4|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4469985|NCT00004412|4287881|B3|Israel||Region of Enrollment||participants|Number|1|1.0||||||
4469986|NCT00004412|4287882|B2|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4469987|NCT00004412|4287883|B1|Israel||Region of Enrollment||participants|Number|0|0.0||||||
4469988|NCT00004412|4287880|B4|United States||Region of Enrollment||participants|Number|22|22.0||||||
4469989|NCT00004412|4287881|B3|United States||Region of Enrollment||participants|Number|2|2.0||||||
4469990|NCT00004412|4287882|B2|United States||Region of Enrollment||participants|Number|12|12.0||||||
4469991|NCT00004412|4287883|B1|United States||Region of Enrollment||participants|Number|8|8.0||||||
4469992|NCT00004412|4287880|B4||Male|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4469993|NCT00004412|4287881|B3||Male|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4469994|NCT00004412|4287882|B2||Male|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4469995|NCT00004412|4287883|B1||Male|Sex: Female, Male||Participants|Count of Participants|3|3.0||||||
4469996|NCT00004412|4287880|B4||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4469997|NCT00004412|4287881|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4469998|NCT00004412|4287882|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4469999|NCT00004412|4287883|B1||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4470000|NCT00004412|4287880|B4|||Age||years|Mean|32|32.0|Standard Deviation|1.1547|1.1547|||
4470001|NCT00004412|4287881|B3|||Age||years|Mean|31|31.0|Standard Deviation|2.3094|2.3094|||
4470002|NCT00004412|4287882|B2|||Age||years|Mean|33|33.0|Standard Deviation|9.14985|9.14985|||
4470003|NCT00004412|4287883|B1|||Age||years|Mean|31|31.0|Standard Deviation|12.57478|12.57478|||
4470004|NCT00004412|4287880|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470005|NCT00004412|4287881|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470006|NCT00004412|4287882|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470007|NCT00004412|4287883|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470008|NCT00004412|4287880|B4||Between 18 and 65 years|Age||Participants|Count of Participants|23|23.0||||||
4470009|NCT00004412|4287881|B3||Between 18 and 65 years|Age||Participants|Count of Participants|3|3.0||||||
4470010|NCT00004412|4287882|B2||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4470011|NCT00004412|4287883|B1||Between 18 and 65 years|Age||Participants|Count of Participants|8|8.0||||||
4470012|NCT00004412|4287880|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470013|NCT00004412|4287881|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470014|NCT00004412|4287882|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470015|NCT00004412|4287883|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470016|NCT00000143|4287893|B3|United States||Region of Enrollment||participants|Number|61|61.0||||||
4470017|NCT00000143|4287894|B2|United States||Region of Enrollment||participants|Number|30|30.0||||||
4470018|NCT00000143|4287895|B1|United States||Region of Enrollment||participants|Number|31|31.0||||||
4470019|NCT00000143|4287893|B3||Male|Sex: Female, Male||Participants|Count of Participants|49|49.0||||||
4470020|NCT00000143|4287894|B2||Male|Sex: Female, Male||Participants|Count of Participants|25|25.0||||||
4470021|NCT00000143|4287895|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4470022|NCT00000143|4287893|B3||Female|Sex: Female, Male||Participants|Count of Participants|12|12.0||||||
4470023|NCT00000143|4287894|B2||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4470024|NCT00000143|4287895|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4470025|NCT00000143|4287893|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470026|NCT00000143|4287894|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470027|NCT00000143|4287895|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470028|NCT00000143|4287893|B3||Between 18 and 65 years|Age||Participants|Count of Participants|61|61.0||||||
4470029|NCT00000143|4287894|B2||Between 18 and 65 years|Age||Participants|Count of Participants|30|30.0||||||
4470030|NCT00000143|4287895|B1||Between 18 and 65 years|Age||Participants|Count of Participants|31|31.0||||||
4470031|NCT00000143|4287893|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470032|NCT00000143|4287894|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470033|NCT00000143|4287895|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470034|NCT00000142|4287902|B4||Male|Sex: Female, Male||Participants|Count of Participants|59|59.0||||||
4470035|NCT00000142|4287903|B3||Male|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4470036|NCT00000142|4287904|B2||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4470037|NCT00000142|4287905|B1||Male|Sex: Female, Male||Participants|Count of Participants|24|24.0||||||
4470038|NCT00000142|4287902|B4||Female|Sex: Female, Male||Participants|Count of Participants|5|5.0||||||
4470039|NCT00000142|4287903|B3||Female|Sex: Female, Male||Participants|Count of Participants|1|1.0||||||
4470040|NCT00000142|4287904|B2||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4470041|NCT00000142|4287905|B1||Female|Sex: Female, Male||Participants|Count of Participants|2|2.0||||||
4470042|NCT00000142|4287902|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470043|NCT00000142|4287903|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470044|NCT00000142|4287904|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470045|NCT00000142|4287905|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470046|NCT00000142|4287902|B4||Between 18 and 65 years|Age||Participants|Count of Participants|64|64.0||||||
4470047|NCT00000142|4287903|B3||Between 18 and 65 years|Age||Participants|Count of Participants|12|12.0||||||
4470048|NCT00000142|4287904|B2||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4470049|NCT00000142|4287905|B1||Between 18 and 65 years|Age||Participants|Count of Participants|26|26.0||||||
4470050|NCT00000142|4287902|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470051|NCT00000142|4287903|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470052|NCT00000142|4287904|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470053|NCT00000142|4287905|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470054|NCT00000136|4287915|B3|United States||Region of Enrollment||participants|Number|234|234.0||||||
4470055|NCT00000136|4287916|B2|United States||Region of Enrollment||participants|Number|127|127.0||||||
4470056|NCT00000136|4287917|B1|United States||Region of Enrollment||participants|Number|107|107.0||||||
4470057|NCT00000136|4287915|B3||Male|Sex: Female, Male||Participants|Count of Participants|214|214.0||||||
4470058|NCT00000136|4287916|B2||Male|Sex: Female, Male||Participants|Count of Participants|116|116.0||||||
4470059|NCT00000136|4287917|B1||Male|Sex: Female, Male||Participants|Count of Participants|98|98.0||||||
4470060|NCT00000136|4287915|B3||Female|Sex: Female, Male||Participants|Count of Participants|20|20.0||||||
4470061|NCT00000136|4287916|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4470062|NCT00000136|4287917|B1||Female|Sex: Female, Male||Participants|Count of Participants|9|9.0||||||
4470063|NCT00000136|4287915|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470064|NCT00000136|4287916|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470065|NCT00000136|4287917|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470066|NCT00000136|4287915|B3||Between 18 and 65 years|Age||Participants|Count of Participants|234|234.0||||||
4470067|NCT00000136|4287916|B2||Between 18 and 65 years|Age||Participants|Count of Participants|127|127.0||||||
4470068|NCT00000136|4287917|B1||Between 18 and 65 years|Age||Participants|Count of Participants|107|107.0||||||
4470069|NCT00000136|4287915|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470070|NCT00000136|4287916|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470071|NCT00000136|4287917|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470072|NCT00000135|4287924|B3|United States||Region of Enrollment||participants|Number|209|209.0||||||
4470073|NCT00000135|4287925|B2|United States||Region of Enrollment||participants|Number|105|105.0||||||
4470074|NCT00000135|4287926|B1|United States||Region of Enrollment||participants|Number|104|104.0||||||
4470075|NCT00000135|4287924|B3||Male|Sex: Female, Male||Participants|Count of Participants|187|187.0||||||
4470076|NCT00000135|4287925|B2||Male|Sex: Female, Male||Participants|Count of Participants|94|94.0||||||
4470077|NCT00000135|4287926|B1||Male|Sex: Female, Male||Participants|Count of Participants|93|93.0||||||
4470078|NCT00000135|4287924|B3||Female|Sex: Female, Male||Participants|Count of Participants|22|22.0||||||
4470079|NCT00000135|4287925|B2||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4470080|NCT00000135|4287926|B1||Female|Sex: Female, Male||Participants|Count of Participants|11|11.0||||||
4470081|NCT00000135|4287924|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470082|NCT00000135|4287925|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470083|NCT00000135|4287926|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470084|NCT00000135|4287924|B3||Between 18 and 65 years|Age||Participants|Count of Participants|209|209.0||||||
4470085|NCT00000135|4287925|B2||Between 18 and 65 years|Age||Participants|Count of Participants|105|105.0||||||
4470086|NCT00000135|4287926|B1||Between 18 and 65 years|Age||Participants|Count of Participants|104|104.0||||||
4470087|NCT00000135|4287924|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470088|NCT00000135|4287925|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470089|NCT00000135|4287926|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470090|NCT00000134|4287933|B4|United States||Region of Enrollment||participants|Number|279|279.0||||||
4470091|NCT00000134|4287934|B3|United States||Region of Enrollment||participants|Number|96|96.0||||||
4470092|NCT00000134|4287935|B2|United States||Region of Enrollment||participants|Number|94|94.0||||||
4470093|NCT00000134|4287936|B1|United States||Region of Enrollment||participants|Number|89|89.0||||||
4470094|NCT00000134|4287933|B4||Male|Sex: Female, Male||Participants|Count of Participants|256|256.0||||||
4470095|NCT00000134|4287934|B3||Male|Sex: Female, Male||Participants|Count of Participants|86|86.0||||||
4470096|NCT00000134|4287935|B2||Male|Sex: Female, Male||Participants|Count of Participants|88|88.0||||||
4470097|NCT00000134|4287936|B1||Male|Sex: Female, Male||Participants|Count of Participants|82|82.0||||||
4470098|NCT00000134|4287933|B4||Female|Sex: Female, Male||Participants|Count of Participants|23|23.0||||||
4470099|NCT00000134|4287934|B3||Female|Sex: Female, Male||Participants|Count of Participants|10|10.0||||||
4470100|NCT00000134|4287935|B2||Female|Sex: Female, Male||Participants|Count of Participants|6|6.0||||||
4470101|NCT00000134|4287936|B1||Female|Sex: Female, Male||Participants|Count of Participants|7|7.0||||||
4470102|NCT00000134|4287933|B4||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470103|NCT00000134|4287934|B3||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470104|NCT00000134|4287935|B2||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470105|NCT00000134|4287936|B1||>=65 years|Age||Participants|Count of Participants|0|0.0||||||
4470106|NCT00000134|4287933|B4||Between 18 and 65 years|Age||Participants|Count of Participants|279|279.0||||||
4470107|NCT00000134|4287934|B3||Between 18 and 65 years|Age||Participants|Count of Participants|96|96.0||||||
4470108|NCT00000134|4287935|B2||Between 18 and 65 years|Age||Participants|Count of Participants|94|94.0||||||
4470109|NCT00000134|4287936|B1||Between 18 and 65 years|Age||Participants|Count of Participants|89|89.0||||||
4470110|NCT00000134|4287933|B4||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470111|NCT00000134|4287934|B3||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470112|NCT00000134|4287935|B2||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470113|NCT00000134|4287936|B1||<=18 years|Age||Participants|Count of Participants|0|0.0||||||
4470114|NCT00000125|4287946|B3|Other||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4470115|NCT00000125|4287947|B2|Other||Race/Ethnicity, Customized||participants|Number|8|8.0||||||
4470116|NCT00000125|4287948|B1|Other||Race/Ethnicity, Customized||participants|Number|6|6.0||||||
4470117|NCT00000125|4287946|B3|White||Race/Ethnicity, Customized||participants|Number|1137|1137.0||||||
4470118|NCT00000125|4287947|B2|White||Race/Ethnicity, Customized||participants|Number|577|577.0||||||
4470119|NCT00000125|4287948|B1|White||Race/Ethnicity, Customized||participants|Number|560|560.0||||||
4470120|NCT00000125|4287946|B3|Hispanic||Race/Ethnicity, Customized||participants|Number|59|59.0||||||
4470121|NCT00000125|4287947|B2|Hispanic||Race/Ethnicity, Customized||participants|Number|24|24.0||||||
4470122|NCT00000125|4287948|B1|Hispanic||Race/Ethnicity, Customized||participants|Number|35|35.0||||||
4470123|NCT00000125|4287946|B3|African American||Race/Ethnicity, Customized||participants|Number|408|408.0||||||
4470124|NCT00000125|4287947|B2|African American||Race/Ethnicity, Customized||participants|Number|203|203.0||||||
4470125|NCT00000125|4287948|B1|African American||Race/Ethnicity, Customized||participants|Number|205|205.0||||||
4470126|NCT00000125|4287946|B3|Asian||Race/Ethnicity, Customized||participants|Number|14|14.0||||||
4470127|NCT00000125|4287947|B2|Asian||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4470128|NCT00000125|4287948|B1|Asian||Race/Ethnicity, Customized||participants|Number|10|10.0||||||
4470129|NCT00000125|4287946|B3|Native American||Race/Ethnicity, Customized||participants|Number|4|4.0||||||
4470130|NCT00000125|4287947|B2|Native American||Race/Ethnicity, Customized||participants|Number|1|1.0||||||
4470131|NCT00000125|4287948|B1|Native American||Race/Ethnicity, Customized||participants|Number|3|3.0||||||
4470132|NCT00000125|4287946|B3||Male|Sex: Female, Male||Participants|Count of Participants|931|931.0||||||
4470133|NCT00000125|4287947|B2||Male|Sex: Female, Male||Participants|Count of Participants|458|458.0||||||
4470134|NCT00000125|4287948|B1||Male|Sex: Female, Male||Participants|Count of Participants|473|473.0||||||
4470135|NCT00000125|4287946|B3||Female|Sex: Female, Male||Participants|Count of Participants|705|705.0||||||
4470136|NCT00000125|4287947|B2||Female|Sex: Female, Male||Participants|Count of Participants|359|359.0||||||
4470137|NCT00000125|4287948|B1||Female|Sex: Female, Male||Participants|Count of Participants|346|346.0||||||
4470138|NCT00000125|4287946|B3|||Age||years|Mean|55.4|55.4|Standard Deviation|9.6|9.6|||
4470139|NCT00000125|4287947|B2|||Age||years|Mean|55.2|55.2|Standard Deviation|9.5|9.5|||
4470140|NCT00000125|4287948|B1|||Age||years|Mean|55.6|55.6|Standard Deviation|9.7|9.7|||
